Citrus Sinensis ID: 046893

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------420-------430-------440-------450-------460----
Protein Sequence
MGICFSLEEQQRQRLRQQQQPSSSKENQGGNGAPVISDNLDSPGMKTASGSQVTPKNVTPVPPKKNVNDLRQNPGYSNVDIFTYNEMKLATKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETVQSQGAEEEMLQSGGGVVTLYEVPKLSSHNSGDKKRNQSGFSGSTEGESRRRNKPGNGRSKSEPPADREPCDFRNSSSNLENDEKSVSARK
Secondary Structure (PSIPRED)
ccccccccHHHHHHHHHccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccEEEcHHHHHHHHcccccccccccccccEEEEEEEcccccccccccEEEEEEccccccccHHHHHHHHHHHHcccccccccEEEEEccccEEEEEEEEcccccHHHHccccccccccHHHHHHHHHHHHHHHHHHHcccccccccccccccccccccccccccccccccccccccccccccccccccccccHHHHcccccccccccccHHHHHHHHHHccccccccccccccHHHHHccccccccccccccccccccccccHHHHHHHHHHHHHHHcccccccccHHHHHHHHHHHHHcccHHHHccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Secondary Structure Prediction (SSPRO)
ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccEEcHHHHHHHHccccHHHccccccccEEEEEEEccccccccccEEEEEEEEccccccccHHHHHHHHHHHHHcccccEEEEEEEEccccEEEEEEEcccccHHHHHcccccccccHHHHHHHHHHHHHHHHHHHcccccEEEEEccHccEEccccccccHcHcccccccccccccEEEEEEccccccccHHHHHcccccccccHHHHHHHHHHHHccccccccccccccHHHHHHHHHHHHccccHHHHcccHHcccccHHHHHHHHHHHHHHHcccccccccHHHHHHHHHHHHccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Coil and Loop (DISEMBL)
MGICFSLEEQQRQRLRqqqqpssskenqggngapvisdnldspgmktasgsqvtpknvtpvppkknvndlrqnpgysnvdifTYNEMKlatkffrpdyilgeggFGVVYKGvidenvrpgyKTTFVAIKELnrggyqgdrEWLAEVNYLGQLRHSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAflhgaerpviyrdfktsnillnadfsaklsdfglakdgpmgdqthvstrvmgtygyaapeyvmtghltarsdVYGFGVVLLEMLLGrravdksrpsrehNLVEWARPLLNNNKKVLRIldprlegqYTARTAMKVAGLAYQclsqnpkgrpvMSDVVALLETVQSQGAEEEMLqsgggvvtlyevpklsshnsgdkkrnqsgfsgstegesrrrnkpgngrskseppadrepcdfrnsssnlendeksvsark
Flexible Loop (DISEMBL)
mgicfsleEQQRQRLRqqqqpssskenqggngaPVISDNLDSPGMKTasgsqvtpknvtpvppkknvndlrqnpgysNVDIFTYNEMKLATKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGrravdksrpsrehnlvewarpllnnnkkVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETVQSQGAEEEMLQSGGGVVTLYEVPKLsshnsgdkkrnqsgfsgstegesrrrnkpgngrskseppadrepcdfrnsssnlendeksvsark
Low Complexity Region (SEG)
MGICFSleeqqrqrlrqqqqPSSSKENQGGNGAPVISDNLDSPGMKTASGSQvtpknvtpvppkknvnDLRQNPGYSNVDIFTYNEMKLATKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETVQSQGAEEEMLQSGGGVVTLYEVPKLSSHNSGDKKRNQSGFSGSTEGESRRRNKPGNGRSKSEPPADREPCDFRNSSSNLENDEKSVSARK
Disordered region (IsUnstruct)
**************************************************************************GYSNVDIFTYNEMKLATKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAV********HNLVEWARPLLNNNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQN****PVMSDVVALLET***************GVVTLY**********************************************************************
Disordered Region (DISOPRED)
MGIC**************************************************************************VDIFTYNEMKLATKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLET*******************************************************************************************
Disordered Region (DISEMBL)
MGICFSLEE*********************NGAPVISDNLDSPGMKTASGSQVTPKNVTPVPPKKNVNDLRQNPGYSNVDIFTYNEMKLATKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETVQSQGAEEEMLQSGGGVVTLYEVPKL**********************************************FRNSS**************
Disordered Region (DISPRO)
***************************************************************************YSNVDIFTYNEMKLATKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETVQS****************************************************************************************
Transmembrane Helix (TMHMM)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Transmembrane Helix (MEMSAT)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhhhhhoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (MEMSAT_SVM)
SSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (Phobius)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MGICFSLEEQQRQRLRQQQQPSSSKENQGGNGAPVISDNLDSPGMKTASGSQVTPKNVTPVPPKKNVNDLRQNPGYSNVDIFTYNEMKLATKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETVQSQGAEEEMLQSGGGVVTLYEVPKLSSHNSGDKKRNQSGFSGSTEGESRRRNKPGNGRSKSEPPADREPCDFRNSSSNLENDEKSVSARK
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	464	2.2.26 [Sep-21-2011]
Q8GXZ3	410	Serine/threonine-protein	no	no	0.670	0.758	0.710	1e-130
Q9LFP7	493	Probable receptor-like pr	no	no	0.637	0.600	0.653	1e-111
Q06548	410	Protein kinase APK1A, chl	no	no	0.698	0.790	0.598	1e-111
Q9FM85	408	Probable receptor-like pr	no	no	0.814	0.926	0.528	1e-111
P46573	412	Protein kinase APK1B, chl	no	no	0.655	0.737	0.621	1e-110
Q9SRH7	490	Receptor-like serine/thre	no	no	0.635	0.602	0.642	1e-108
P43293	389	Probable serine/threonine	no	no	0.655	0.781	0.590	1e-108
O48814	395	Serine/threonine-protein	no	no	0.637	0.749	0.617	1e-107
O49840	426	Protein kinase 2B, chloro	no	no	0.678	0.739	0.585	1e-104
Q8H186	389	Probable receptor-like pr	no	no	0.644	0.768	0.6	1e-104

>sp|Q8GXZ3|Y5102_ARATH Serine/threonine-protein kinase At5g01020 OS=Arabidopsis thaliana GN=At5g01020 PE=1 SV=1

 Score =  465 bits (1197), Expect = e-130,   Method: Compositional matrix adjust.
 Identities = 221/311 (71%), Positives = 254/311 (81%)

Query: 68  NDLRQNPGYSNVDIFTYNEMKLATKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVA 127
           +D R    Y+ V  FT  E++  TK FRPDYILGEGGFG VYKG ID+N+R G K+  VA
Sbjct: 43  DDSRTPISYAQVIPFTLFELETITKSFRPDYILGEGGFGTVYKGYIDDNLRVGLKSLPVA 102

Query: 128 IKELNRGGYQGDREWLAEVNYLGQLRHSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLL 187
           +K LN+ G QG REWL EVN+LGQLRH NLVKLIGYCCED+HR+LVYE+M  GSLE HL 
Sbjct: 103 VKVLNKEGLQGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHRLLVYEFMLRGSLENHLF 162

Query: 188 RRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAK 247
           R+    L+WSRRM IAL AAKGLAFLH AERPVIYRDFKTSNILL++D++AKLSDFGLAK
Sbjct: 163 RKTTAPLSWSRRMMIALGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAK 222

Query: 248 DGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPS 307
            GP GD+THVSTRVMGTYGYAAPEYVMTGHLTARSDVY FGVVLLEML GR++VDK+RPS
Sbjct: 223 AGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLEMLTGRKSVDKTRPS 282

Query: 308 REHNLVEWARPLLNNNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDV 367
           +E NLV+WARP LN+ +K+L+I+DPRLE QY+ R A K   LAY CLSQNPK RP+MSDV
Sbjct: 283 KEQNLVDWARPKLNDKRKLLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDV 342

Query: 368 VALLETVQSQG 378
           V  LE +Q  G
Sbjct: 343 VETLEPLQCTG 353

Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|Q9LFP7|Y5158_ARATH Probable receptor-like protein kinase At5g15080 OS=Arabidopsis thaliana GN=At5g15080 PE=1 SV=1

 Score =  402 bits (1033), Expect = e-111,   Method: Compositional matrix adjust.
 Identities = 198/303 (65%), Positives = 241/303 (79%), Gaps = 7/303 (2%)

Query: 77  SNVDIFTYNEMKLATKFFRPDYILGEGGFGVVYKGVIDEN----VRPGYKTTFVAIKELN 132
           S++  FT+N++KL+T+ FRP+ +LGEGGFG V+KG I+EN    V+PG   T VA+K LN
Sbjct: 125 SHLRKFTFNDLKLSTRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLT-VAVKTLN 183

Query: 133 RGGYQGDREWLAEVNYLGQLRHSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGC 192
             G QG +EWLAE+N+LG L H NLVKL+GYC ED+ R+LVYE+M  GSLE HL RR   
Sbjct: 184 PDGLQGHKEWLAEINFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRR-SL 242

Query: 193 MLTWSRRMKIALDAAKGLAFLHG-AERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPM 251
            L WS RMKIAL AAKGL+FLH  A +PVIYRDFKTSNILL+AD++AKLSDFGLAKD P 
Sbjct: 243 PLPWSIRMKIALGAAKGLSFLHEEALKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPD 302

Query: 252 GDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHN 311
             +THVSTRVMGTYGYAAPEYVMTGHLT++SDVY FGVVLLEML GRR++DK+RP+ EHN
Sbjct: 303 EGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHN 362

Query: 312 LVEWARPLLNNNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALL 371
           LVEWARP L + ++  R+LDPRLEG ++ + A KV  LA QCLS++PK RP MSDVV  L
Sbjct: 363 LVEWARPHLLDKRRFYRLLDPRLEGHFSIKGAQKVTQLAAQCLSRDPKIRPKMSDVVEAL 422

Query: 372 ETV 374
           + +
Sbjct: 423 KPL 425

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q06548|APK1A_ARATH Protein kinase APK1A, chloroplastic OS=Arabidopsis thaliana GN=APK1A PE=2 SV=1

 Score =  402 bits (1033), Expect = e-111,   Method: Compositional matrix adjust.
 Identities = 201/336 (59%), Positives = 254/336 (75%), Gaps = 12/336 (3%)

Query: 50  GSQVTPKNVTPVPPKKNVNDLRQNPGYSNVDIFTYNEMKLATKFFRPDYILGEGGFGVVY 109
           GS+ +  +V P P  +   ++ Q+P   N+  F++ E+K AT+ FRPD +LGEGGFG V+
Sbjct: 29  GSKASSVSVRPSP--RTEGEILQSP---NLKSFSFAELKSATRNFRPDSVLGEGGFGCVF 83

Query: 110 KGVIDENV----RPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVKLIGYCC 165
           KG IDE      RPG     +A+K+LN+ G+QG +EWLAEVNYLGQ  H +LVKLIGYC 
Sbjct: 84  KGWIDEKSLTASRPG-TGLVIAVKKLNQDGWQGHQEWLAEVNYLGQFSHRHLVKLIGYCL 142

Query: 166 EDEHRILVYEYMESGSLEKHLLRRVGCM--LTWSRRMKIALDAAKGLAFLHGAERPVIYR 223
           EDEHR+LVYE+M  GSLE HL RR      L+W  R+K+AL AAKGLAFLH +E  VIYR
Sbjct: 143 EDEHRLLVYEFMPRGSLENHLFRRGLYFQPLSWKLRLKVALGAAKGLAFLHSSETRVIYR 202

Query: 224 DFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSD 283
           DFKTSNILL+++++AKLSDFGLAKDGP+GD++HVSTRVMGT+GYAAPEY+ TGHLT +SD
Sbjct: 203 DFKTSNILLDSEYNAKLSDFGLAKDGPIGDKSHVSTRVMGTHGYAAPEYLATGHLTTKSD 262

Query: 284 VYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRILDPRLEGQYTARTA 343
           VY FGVVLLE+L GRRAVDK+RPS E NLVEWA+P L N +K+ R++D RL+ QY+   A
Sbjct: 263 VYSFGVVLLELLSGRRAVDKNRPSGERNLVEWAKPYLVNKRKIFRVIDNRLQDQYSMEEA 322

Query: 344 MKVAGLAYQCLSQNPKGRPVMSDVVALLETVQSQGA 379
            KVA L+ +CL+   K RP MS+VV+ LE +QS  A
Sbjct: 323 CKVATLSLRCLTTEIKLRPNMSEVVSHLEHIQSLNA 358

Possible bi-functional kinase. In vitro, it exhibits serine/threonine activity. In vivo, can phosphorylate tyrosine residues of limited substrates.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9FM85|Y5564_ARATH Probable receptor-like protein kinase At5g56460 OS=Arabidopsis thaliana GN=At5g56460 PE=1 SV=1

 Score =  401 bits (1030), Expect = e-111,   Method: Compositional matrix adjust.
 Identities = 214/405 (52%), Positives = 270/405 (66%), Gaps = 27/405 (6%)

Query: 1   MGICFSLEEQQRQRLRQQQQPSSSKENQGGNGAPVISDNLDSPGMKTASGSQVTPKNVTP 60
           MG C+   E    R+    +  S KE      +P + D       K     Q  P N   
Sbjct: 1   MGNCWCRFEPLNHRVSANAKSESPKEQ-----SPTVED-------KHIKEVQKLPSN--- 45

Query: 61  VPPKKNVNDLRQNPGYSNVDIFTYNEMKLATKFFRPDYILGEGGFGVVYKGVIDENV--R 118
               K V DLR++   + +  FTY E+K  T  FR D +LG GGFG VYKG I E++  +
Sbjct: 46  ---PKEVEDLRRDSAANPLIAFTYEELKNITSNFRQDRVLGGGGFGSVYKGFIKEDLGDQ 102

Query: 119 PGYKTTFVAIKELN-RGGYQGDREWLAEVNYLGQLRHSNLVKLIGYCCEDEHRILVYEYM 177
              +   VA+K  +    +QG REWLAEV +LGQL H NLVKLIGYCCED HR+L+YEYM
Sbjct: 103 EVPEPLPVAVKVHDGDNSFQGHREWLAEVIFLGQLSHPNLVKLIGYCCEDNHRVLIYEYM 162

Query: 178 ESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFS 237
             GS+E +L  RV   L+W+ RMKIA  AAKGLAFLH A++PVIYRDFKTSNILL+ D++
Sbjct: 163 ARGSVENNLFSRVLLPLSWAIRMKIAFGAAKGLAFLHEAKKPVIYRDFKTSNILLDMDYN 222

Query: 238 AKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLG 297
           AKLSDFGLAKDGP+GD++HVSTR+MGTYGYAAPEY+MTGHLT  SDVY FGVVLLE+L G
Sbjct: 223 AKLSDFGLAKDGPVGDKSHVSTRIMGTYGYAAPEYIMTGHLTPGSDVYSFGVVLLELLTG 282

Query: 298 RRAVDKSRPSREHNLVEWARPLLNNNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQN 357
           R+++DKSRP+RE NL++WA PLL   KKVL I+DP++  +Y  +   K A LAY CL++N
Sbjct: 283 RKSLDKSRPTREQNLIDWALPLLKEKKKVLNIVDPKMNCEYPVKAVQKAAMLAYHCLNRN 342

Query: 358 PKGRPVMSDVVALLETVQSQGAEEEML---QSGGGVVTLY-EVPK 398
           PK RP+M D+V  LE +Q+   EEE L        V+T+  E+PK
Sbjct: 343 PKARPLMRDIVDSLEPLQA--TEEEALLVPPVQKAVITIIDEMPK 385

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|P46573|APK1B_ARATH Protein kinase APK1B, chloroplastic OS=Arabidopsis thaliana GN=APK1B PE=2 SV=2

 Score =  399 bits (1024), Expect = e-110,   Method: Compositional matrix adjust.
 Identities = 195/314 (62%), Positives = 243/314 (77%), Gaps = 10/314 (3%)

Query: 69  DLRQNPGYSNVDIFTYNEMKLATKFFRPDYILGEGGFGVVYKGVIDENV----RPGYKTT 124
           ++ Q+P   N+  FT+ E+K AT+ FRPD +LGEGGFG V+KG IDE      +PG    
Sbjct: 47  EILQSP---NLKSFTFAELKAATRNFRPDSVLGEGGFGSVFKGWIDEQTLTASKPG-TGV 102

Query: 125 FVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVKLIGYCCEDEHRILVYEYMESGSLEK 184
            +A+K+LN+ G+QG +EWLAEVNYLGQ  H NLVKLIGYC EDEHR+LVYE+M  GSLE 
Sbjct: 103 VIAVKKLNQDGWQGHQEWLAEVNYLGQFSHPNLVKLIGYCLEDEHRLLVYEFMPRGSLEN 162

Query: 185 HLLRRVGCM--LTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSD 242
           HL RR      L+W+ R+K+AL AAKGLAFLH AE  VIYRDFKTSNILL+++++AKLSD
Sbjct: 163 HLFRRGSYFQPLSWTLRLKVALGAAKGLAFLHNAETSVIYRDFKTSNILLDSEYNAKLSD 222

Query: 243 FGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVD 302
           FGLAKDGP GD++HVSTR+MGTYGYAAPEY+ TGHLT +SDVY +GVVLLE+L GRRAVD
Sbjct: 223 FGLAKDGPTGDKSHVSTRIMGTYGYAAPEYLATGHLTTKSDVYSYGVVLLEVLSGRRAVD 282

Query: 303 KSRPSREHNLVEWARPLLNNNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRP 362
           K+RP  E  LVEWARPLL N +K+ R++D RL+ QY+   A KVA LA +CL+   K RP
Sbjct: 283 KNRPPGEQKLVEWARPLLANKRKLFRVIDNRLQDQYSMEEACKVATLALRCLTFEIKLRP 342

Query: 363 VMSDVVALLETVQS 376
            M++VV+ LE +Q+
Sbjct: 343 NMNEVVSHLEHIQT 356

Possible bi-functional kinase. In vitro, it exhibits serine/threonine activity. In vivo, can phosphorylate tyrosine residues of limited substrates.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9SRH7|Y3130_ARATH Receptor-like serine/threonine-protein kinase At3g01300 OS=Arabidopsis thaliana GN=At3g01300 PE=2 SV=1

 Score =  394 bits (1011), Expect = e-108,   Method: Compositional matrix adjust.
 Identities = 194/302 (64%), Positives = 239/302 (79%), Gaps = 7/302 (2%)

Query: 76  YSNVDIFTYNEMKLATKFFRPDYILGEGGFGVVYKGVIDEN----VRPGYKTTFVAIKEL 131
           YS++  F++ ++KLAT+ FRP+ +LGEGGFG V+KG ++EN    V+PG   T VA+K L
Sbjct: 118 YSHLKKFSFIDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLT-VAVKTL 176

Query: 132 NRGGYQGDREWLAEVNYLGQLRHSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVG 191
           N  G QG +EWLAE+NYLG L H NLVKL+GYC ED+ R+LVYE+M  GSLE HL RR  
Sbjct: 177 NPDGLQGHKEWLAEINYLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRR-S 235

Query: 192 CMLTWSRRMKIALDAAKGLAFLHG-AERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGP 250
             L WS RMKIAL AAKGL+FLH  A +PVIYRDFKTSNILL+ +++AKLSDFGLAKD P
Sbjct: 236 LPLPWSIRMKIALGAAKGLSFLHEEALKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDAP 295

Query: 251 MGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREH 310
              +THVSTRVMGTYGYAAPEYVMTGHLT++SDVY FGVVLLEML GRR++DK+RP+ EH
Sbjct: 296 DEGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEH 355

Query: 311 NLVEWARPLLNNNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVAL 370
           NLVEWARP L + ++  R+LDPRLEG ++ + A KV  LA QCLS++ K RP MS+VV +
Sbjct: 356 NLVEWARPHLLDKRRFYRLLDPRLEGHFSVKGAQKVTQLAAQCLSRDSKIRPKMSEVVEV 415

Query: 371 LE 372
           L+
Sbjct: 416 LK 417

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|P43293|NAK_ARATH Probable serine/threonine-protein kinase NAK OS=Arabidopsis thaliana GN=NAK PE=2 SV=2

 Score =  392 bits (1008), Expect = e-108,   Method: Compositional matrix adjust.
 Identities = 186/315 (59%), Positives = 247/315 (78%), Gaps = 11/315 (3%)

Query: 77  SNVDIFTYNEMKLATKFFRPDYILGEGGFGVVYKGVIDENV----RPGYKTTFVAIKELN 132
           +N+  F+ +E+K AT+ FRPD ++GEGGFG V+KG IDE+     +PG     +A+K LN
Sbjct: 51  ANLKNFSLSELKSATRNFRPDSVVGEGGFGCVFKGWIDESSLAPSKPG-TGIVIAVKRLN 109

Query: 133 RGGYQGDREWLAEVNYLGQLRHSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGC 192
           + G+QG REWLAE+NYLGQL H NLVKLIGYC E+EHR+LVYE+M  GSLE HL RR G 
Sbjct: 110 QEGFQGHREWLAEINYLGQLDHPNLVKLIGYCLEEEHRLLVYEFMTRGSLENHLFRR-GT 168

Query: 193 M---LTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDG 249
               L+W+ R+++AL AA+GLAFLH A+  VIYRDFK SNILL+++++AKLSDFGLA+DG
Sbjct: 169 FYQPLSWNTRVRMALGAARGLAFLHNAQPQVIYRDFKASNILLDSNYNAKLSDFGLARDG 228

Query: 250 PMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSRE 309
           PMGD +HVSTRVMGT GYAAPEY+ TGHL+ +SDVY FGVVLLE+L GRRA+DK++P  E
Sbjct: 229 PMGDNSHVSTRVMGTQGYAAPEYLATGHLSVKSDVYSFGVVLLELLSGRRAIDKNQPVGE 288

Query: 310 HNLVEWARPLLNNNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVA 369
           HNLV+WARP L N +++LR++DPRL+GQY+   A+K+A LA  C+S + K RP M+++V 
Sbjct: 289 HNLVDWARPYLTNKRRLLRVMDPRLQGQYSLTRALKIAVLALDCISIDAKSRPTMNEIVK 348

Query: 370 LLET--VQSQGAEEE 382
            +E   +Q + ++E+
Sbjct: 349 TMEELHIQKEASKEQ 363

May play a role in the regulation of plant growth and development.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O48814|BIK1_ARATH Serine/threonine-protein kinase BIK1 OS=Arabidopsis thaliana GN=BIK1 PE=1 SV=1

 Score =  389 bits (999), Expect = e-107,   Method: Compositional matrix adjust.
 Identities = 187/303 (61%), Positives = 233/303 (76%), Gaps = 7/303 (2%)

Query: 79  VDIFTYNEMKLATKFFRPDYILGEGGFGVVYKGVIDENV----RPGYKTTFVAIKELNRG 134
           V  FT+NE+KLAT+ FRPD ++GEGGFG V+KG +DE+     +PG     +A+K+LN+ 
Sbjct: 52  VKSFTFNELKLATRNFRPDSVIGEGGFGCVFKGWLDESTLTPTKPGTGLV-IAVKKLNQE 110

Query: 135 GYQGDREWLAEVNYLGQLRHSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCM- 193
           G+QG REWL E+NYLGQL H NLVKLIGYC EDEHR+LVYE+M+ GSLE HL RR     
Sbjct: 111 GFQGHREWLTEINYLGQLSHPNLVKLIGYCLEDEHRLLVYEFMQKGSLENHLFRRGAYFK 170

Query: 194 -LTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMG 252
            L W  R+ +ALDAAKGLAFLH     VIYRD K SNILL+AD++AKLSDFGLA+DGPMG
Sbjct: 171 PLPWFLRVNVALDAAKGLAFLHSDPVKVIYRDIKASNILLDADYNAKLSDFGLARDGPMG 230

Query: 253 DQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNL 312
           D ++VSTRVMGTYGYAAPEY+ +GHL ARSDVY FGV+LLE+L G+RA+D +RP++E NL
Sbjct: 231 DLSYVSTRVMGTYGYAAPEYMSSGHLNARSDVYSFGVLLLEILSGKRALDHNRPAKEENL 290

Query: 313 VEWARPLLNNNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLE 372
           V+WARP L + +KVL I+D RL+ QY    A+++A +A QCLS  PK RP M  VV  L+
Sbjct: 291 VDWARPYLTSKRKVLLIVDNRLDTQYLPEEAVRMASVAVQCLSFEPKSRPTMDQVVRALQ 350

Query: 373 TVQ 375
            +Q
Sbjct: 351 QLQ 353

Required to activate the resistance responses to necrotrophic pathogens. Phosphorylates FLS2 and BAK1.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O49840|APK2B_ARATH Protein kinase 2B, chloroplastic OS=Arabidopsis thaliana GN=APK2B PE=1 SV=1

 Score =  380 bits (975), Expect = e-104,   Method: Compositional matrix adjust.
 Identities = 189/323 (58%), Positives = 237/323 (73%), Gaps = 8/323 (2%)

Query: 58  VTPVPPKKNVNDLRQNPGYSNVDIFTYNEMKLATKFFRPDYILGEGGFGVVYKGVIDENV 117
           V  +P  +   ++  +P   N+  FT+NE+K AT+ FRPD +LGEGGFG V+KG ID   
Sbjct: 50  VESLPTPRTEGEILSSP---NLKAFTFNELKNATRNFRPDSLLGEGGFGYVFKGWIDGTT 106

Query: 118 ----RPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVKLIGYCCEDEHRILV 173
               +PG     VA+K+L   GYQG +EWL EVNYLGQL H NLVKL+GYC E E+R+LV
Sbjct: 107 LTASKPG-SGIVVAVKKLKTEGYQGHKEWLTEVNYLGQLSHPNLVKLVGYCVEGENRLLV 165

Query: 174 YEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLN 233
           YE+M  GSLE HL RR    LTW+ RMK+A+ AAKGL FLH A+  VIYRDFK +NILL+
Sbjct: 166 YEFMPKGSLENHLFRRGAQPLTWAIRMKVAIGAAKGLTFLHDAKSQVIYRDFKAANILLD 225

Query: 234 ADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLE 293
           A+F++KLSDFGLAK GP GD+THVST+VMGT+GYAAPEYV TG LTA+SDVY FGVVLLE
Sbjct: 226 AEFNSKLSDFGLAKAGPTGDKTHVSTQVMGTHGYAAPEYVATGRLTAKSDVYSFGVVLLE 285

Query: 294 MLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRILDPRLEGQYTARTAMKVAGLAYQC 353
           +L GRRAVDKS+   E +LV+WA P L + +K+ RI+D RL GQY  + A   A LA QC
Sbjct: 286 LLSGRRAVDKSKVGMEQSLVDWATPYLGDKRKLFRIMDTRLGGQYPQKGAYTAASLALQC 345

Query: 354 LSQNPKGRPVMSDVVALLETVQS 376
           L+ + K RP MS+V+A L+ ++S
Sbjct: 346 LNPDAKLRPKMSEVLAKLDQLES 368

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q8H186|Y3545_ARATH Probable receptor-like protein kinase At3g55450 OS=Arabidopsis thaliana GN=At3g55450 PE=1 SV=1

 Score =  379 bits (973), Expect = e-104,   Method: Compositional matrix adjust.
 Identities = 183/305 (60%), Positives = 228/305 (74%), Gaps = 6/305 (1%)

Query: 77  SNVDIFTYNEMKLATKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTT---FVAIKELNR 133
           + V  F++NE+KLAT+ FR D ++GEGGFG V++G +DE      K++    +A+K LN 
Sbjct: 44  TTVKSFSFNELKLATRNFRSDSVVGEGGFGCVFRGWLDETTLTPTKSSSGLVIAVKRLNP 103

Query: 134 GGYQGDREWLAEVNYLGQLRHSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLL---RRV 190
            G+QG REWL E+NYLGQL H NLVKLIGYC EDE R+LVYE+M  GSLE HL     + 
Sbjct: 104 DGFQGHREWLTEINYLGQLSHPNLVKLIGYCLEDEQRLLVYEFMHKGSLENHLFANGNKD 163

Query: 191 GCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGP 250
              L+W  R+K+ALDAAKGLAFLH     VIYRD K SNILL++DF+AKLSDFGLA+DGP
Sbjct: 164 FKPLSWILRIKVALDAAKGLAFLHSDPVKVIYRDIKASNILLDSDFNAKLSDFGLARDGP 223

Query: 251 MGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREH 310
           MG+Q++VSTRVMGT+GYAAPEYV TGHL ARSDVY FGVVLLE+L GR+A+D +RP++E 
Sbjct: 224 MGEQSYVSTRVMGTFGYAAPEYVSTGHLNARSDVYSFGVVLLELLCGRQALDHNRPAKEQ 283

Query: 311 NLVEWARPLLNNNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVAL 370
           NLV+WARP L + +KVL I+D RL  QY    A+++A +A QCLS  PK RP M  VV  
Sbjct: 284 NLVDWARPYLTSRRKVLLIVDTRLNSQYKPEGAVRLASIAVQCLSFEPKSRPTMDQVVRA 343

Query: 371 LETVQ 375
           L  +Q
Sbjct: 344 LVQLQ 348

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	464
359484947	512	PREDICTED: serine/threonine-protein kina	0.959	0.869	0.693	0.0
224118588	523	predicted protein [Populus trichocarpa]	0.862	0.764	0.740	1e-171
224090579	508	predicted protein [Populus trichocarpa]	0.926	0.846	0.652	1e-169
297736030	475	unnamed protein product [Vitis vinifera]	0.825	0.806	0.735	1e-168
356513239	378	PREDICTED: serine/threonine-protein kina	0.790	0.970	0.723	1e-167
22325532	442	protein kinase domain-containing protein	0.913	0.959	0.665	1e-166
19423982	442	putative protein kinase [Arabidopsis tha	0.913	0.959	0.663	1e-166
356523811	379	PREDICTED: serine/threonine-protein kina	0.790	0.968	0.719	1e-165
297835890	441	hypothetical protein ARALYDRAFT_480233 [	0.907	0.954	0.678	1e-164
255563878	438	Protein kinase APK1B, chloroplast precur	0.900	0.954	0.697	1e-163

>gi|359484947|ref|XP_002265117.2| PREDICTED: serine/threonine-protein kinase At5g01020-like [Vitis vinifera]

 Score =  641 bits (1653), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 328/473 (69%), Positives = 371/473 (78%), Gaps = 28/473 (5%)

Query: 1   MGICFSLEEQQRQ------RLRQQQQPSSSKENQGGNGAPVISDNLDSPGMKTASGSQVT 54
           MGICFS +E +         +      S +KEN+    +P       S G +TA+   V 
Sbjct: 57  MGICFSSQEHRSSINYNPVEVGHVPATSPTKENKEAATSP---RKPASDGRETATSIHVV 113

Query: 55  PKNVTPVPPKKNVNDLRQNPGYSNVDIFTYNEMKLATKFFRPDYILGEGGFGVVYKGVID 114
           PKNV          DLRQNPGY NVD+FTY EM+LATK FRPD ILGEGGFG+VYKGVID
Sbjct: 114 PKNV---------KDLRQNPGYWNVDVFTYEEMRLATKLFRPDQILGEGGFGIVYKGVID 164

Query: 115 ENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVKLIGYCCEDEHRILVY 174
           ENV+PGYKTT VAIKELN  G+QGDREWLAEVNYLGQL H NLVKLIG+CCED+HR+LVY
Sbjct: 165 ENVKPGYKTTQVAIKELNPEGFQGDREWLAEVNYLGQLSHPNLVKLIGFCCEDDHRLLVY 224

Query: 175 EYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNA 234
           EYM  GSLEKHL RRV   LTWS RMKIALDAAKGLAFLHGAER +IYRDFKTSNILL+A
Sbjct: 225 EYMACGSLEKHLFRRVCATLTWSTRMKIALDAAKGLAFLHGAERSIIYRDFKTSNILLDA 284

Query: 235 DFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEM 294
           +F AKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLE+
Sbjct: 285 NFRAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEL 344

Query: 295 LLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRILDPRLEGQYTARTAMKVAGLAYQCL 354
           L+GRRA+DKSRPSREHNLVEWARPLLN+NKK+LRILDPR+EGQY+ + A+KVA LAYQCL
Sbjct: 345 LIGRRAMDKSRPSREHNLVEWARPLLNHNKKLLRILDPRMEGQYSTKMALKVANLAYQCL 404

Query: 355 SQNPKGRPVMSDVVALLETV--QSQGAEEEMLQSGG-GVVTLYEVPKLSSHNSGDKKRNQ 411
           SQNPKGRPVMS VV +LET+  QS+  EE MLQSGG   VTLYEVPK  +H++ DKK+  
Sbjct: 405 SQNPKGRPVMSQVVEILETIATQSENQEEAMLQSGGSSCVTLYEVPK-DTHSNPDKKQKP 463

Query: 412 SGFSGSTEGESRRRNKPGNGRSKSEPPADREPCD-FRNSSSNLENDEKSVSAR 463
           +   G  +GE+ ++ KP NGRSKSEPP +   C  F +S    E+DEK VS R
Sbjct: 464 TNMDGE-KGETHQKRKPSNGRSKSEPPNEGGLCSPFVDS----ESDEKPVSPR 511

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224118588|ref|XP_002331399.1| predicted protein [Populus trichocarpa] gi|222873613|gb|EEF10744.1| predicted protein [Populus trichocarpa]

 Score =  608 bits (1568), Expect = e-171,   Method: Compositional matrix adjust.
 Identities = 305/412 (74%), Positives = 342/412 (83%), Gaps = 12/412 (2%)

Query: 59  TPVPPKKNVNDLRQNPGYSNVDIFTYNEMKLATKFFRPDYILGEGGFGVVYKGVIDENVR 118
           TP  PK NV DLR +PGY NVDIFTY EMKLATK FRPDYILGEGGFGVVYKGVIDE+VR
Sbjct: 39  TPSVPK-NVTDLRNSPGYGNVDIFTYEEMKLATKQFRPDYILGEGGFGVVYKGVIDESVR 97

Query: 119 PGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVKLIGYCCEDEHRILVYEYME 178
             YKTT+VAIKELN  G QGDREWLAEVNYLGQL HSNLVKLIGYCCEDEHR+LVYEYM 
Sbjct: 98  TLYKTTYVAIKELNPDGLQGDREWLAEVNYLGQLSHSNLVKLIGYCCEDEHRLLVYEYMA 157

Query: 179 SGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSA 238
           SGSLEKHL RRVGC LTWS+RMKIALDAAKGLAFLHGAER +IYRDFKTSNILL++DF+A
Sbjct: 158 SGSLEKHLFRRVGCTLTWSKRMKIALDAAKGLAFLHGAERSIIYRDFKTSNILLDSDFNA 217

Query: 239 KLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMT-GHLTARSDVYGFGVVLLEMLLG 297
           KLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMT GHLTARSDVYGFGVVLLE++LG
Sbjct: 218 KLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTAGHLTARSDVYGFGVVLLELVLG 277

Query: 298 RRAVDKSRPSREHNLVEWARPLLNNNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQN 357
           RRA+DKSRPSREHNLVEWARPLLN+NKKVLRILDPR+EGQY++R AMKVA LAYQCLSQN
Sbjct: 278 RRALDKSRPSREHNLVEWARPLLNHNKKVLRILDPRMEGQYSSRIAMKVANLAYQCLSQN 337

Query: 358 PKGRPVMSDVVALLETVQSQGAEEEMLQSGGGVVTLYEVPKLSSHNSGDKKRNQSGFSGS 417
           PKGRP+M+ VV LLE+VQS+  EE M ++ G  VTLYE P+   H  G K+RNQ+     
Sbjct: 338 PKGRPLMNQVVELLESVQSKD-EEAMFETTGRGVTLYEDPRRPPHTPG-KERNQARNHDY 395

Query: 418 TEGE-------SRRRNKPGNGRSKSEPPADREPCDF-RNSSSNLENDEKSVS 461
            EGE        ++RN+  +   + E P+   P +  RN + + ++ E+  S
Sbjct: 396 REGEPSPYSSSEKQRNRTRSHDHRKEEPSPHSPSEKQRNRTRSQDHREEEPS 447

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224090579|ref|XP_002309029.1| predicted protein [Populus trichocarpa] gi|222855005|gb|EEE92552.1| predicted protein [Populus trichocarpa]

 Score =  600 bits (1547), Expect = e-169,   Method: Compositional matrix adjust.
 Identities = 316/484 (65%), Positives = 357/484 (73%), Gaps = 54/484 (11%)

Query: 1   MGICFSLEEQQRQRLRQQQQPSSSKENQGGNGAPVISDNLDSPGMKTASGSQVTPKNVTP 60
           MGICFS +     ++ Q++Q  SSK NQ         D   SP +  A    V  K    
Sbjct: 15  MGICFSTDND---KIPQERQRLSSKGNQEAG-----HDYDHSPTISNAP-EVVEIKRTRS 65

Query: 61  VPP-KKNVNDLRQNPGYSNVDIFTYNEMKLATKFFRPDYILGEGGFGVVYKGVIDENVRP 119
           +P   KNV DLR +PGY NVDIFTY EM LATK FRPDYILGEGGFG VYKGV+D++VRP
Sbjct: 66  IPSIHKNVTDLRNSPGYGNVDIFTYEEMTLATKHFRPDYILGEGGFGAVYKGVLDKSVRP 125

Query: 120 GYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVKLIGYCCEDEHRILVYEYMES 179
           GYKTT+VAIKELN  G QGDREWLAEVNYLGQL H NLVKLIGYCCEDEHR+LVYEYM S
Sbjct: 126 GYKTTYVAIKELNPDGLQGDREWLAEVNYLGQLSHQNLVKLIGYCCEDEHRLLVYEYMAS 185

Query: 180 GSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAK 239
           GSLEKHL RRVGC LTWS+RM+IALDAAKGLAFLHGAER VIYRDFKTSNILL++DF+AK
Sbjct: 186 GSLEKHLFRRVGCTLTWSKRMRIALDAAKGLAFLHGAERSVIYRDFKTSNILLDSDFNAK 245

Query: 240 LSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRR 299
           LSDFGLAKDGPMGD THVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLE+LLGRR
Sbjct: 246 LSDFGLAKDGPMGDHTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLELLLGRR 305

Query: 300 AVDKSRPSREHNLVEWARPLLNNNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPK 359
           A+DKSRPS+EHNLVEWARPLLN+NKKVLRILD R+EGQY++R AMKVA LA QCLSQNPK
Sbjct: 306 AMDKSRPSQEHNLVEWARPLLNHNKKVLRILDLRMEGQYSSRIAMKVANLASQCLSQNPK 365

Query: 360 GRPVMSDVVALLETVQSQGAEEEMLQSGGGVVTLYEVPKLS------------------- 400
           GRP+M+ VV LLE++QS+  E  +L++ G  VTLYEVP+ S                   
Sbjct: 366 GRPLMNQVVELLESIQSKD-EAAVLETSGRDVTLYEVPRRSPYTPEKGRNQTRSHDHREG 424

Query: 401 ------------------------SHNSGDKKRNQSGFSGSTEGESRRRNKPGNGRSKSE 436
                                    H   +K+RN++      EGE RRR+KP N  S+SE
Sbjct: 425 EPSPYTPDEEGNRTKSLEHREGETPHTPSEKERNKTRSHDHREGEPRRRSKPANVGSRSE 484

Query: 437 PPAD 440
           PP +
Sbjct: 485 PPTE 488

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|297736030|emb|CBI24068.3| unnamed protein product [Vitis vinifera]

 Score =  596 bits (1537), Expect = e-168,   Method: Compositional matrix adjust.
 Identities = 297/404 (73%), Positives = 328/404 (81%), Gaps = 21/404 (5%)

Query: 1   MGICFSLEEQQRQ------RLRQQQQPSSSKENQGGNGAPVISDNLDSPGMKTASGSQVT 54
           MGICFS +E +         +      S +KEN+    +P       S G +TA+   V 
Sbjct: 81  MGICFSSQEHRSSINYNPVEVGHVPATSPTKENKEAATSP---RKPASDGRETATSIHVV 137

Query: 55  PKNVTPVPPKKNVNDLRQNPGYSNVDIFTYNEMKLATKFFRPDYILGEGGFGVVYKGVID 114
           PKNV          DLRQNPGY NVD+FTY EM+LATK FRPD ILGEGGFG+VYKGVID
Sbjct: 138 PKNV---------KDLRQNPGYWNVDVFTYEEMRLATKLFRPDQILGEGGFGIVYKGVID 188

Query: 115 ENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVKLIGYCCEDEHRILVY 174
           ENV+PGYKTT VAIKELN  G+QGDREWLAEVNYLGQL H NLVKLIG+CCED+HR+LVY
Sbjct: 189 ENVKPGYKTTQVAIKELNPEGFQGDREWLAEVNYLGQLSHPNLVKLIGFCCEDDHRLLVY 248

Query: 175 EYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNA 234
           EYM  GSLEKHL RRV   LTWS RMKIALDAAKGLAFLHGAER +IYRDFKTSNILL+A
Sbjct: 249 EYMACGSLEKHLFRRVCATLTWSTRMKIALDAAKGLAFLHGAERSIIYRDFKTSNILLDA 308

Query: 235 DFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEM 294
           +F AKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLE+
Sbjct: 309 NFRAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEL 368

Query: 295 LLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRILDPRLEGQYTARTAMKVAGLAYQCL 354
           L+GRRA+DKSRPSREHNLVEWARPLLN+NKK+LRILDPR+EGQY+ + A+KVA LAYQCL
Sbjct: 369 LIGRRAMDKSRPSREHNLVEWARPLLNHNKKLLRILDPRMEGQYSTKMALKVANLAYQCL 428

Query: 355 SQNPKGRPVMSDVVALLETV--QSQGAEEEMLQSGG-GVVTLYE 395
           SQNPKGRPVMS VV +LET+  QS+  EE MLQSGG   VTLYE
Sbjct: 429 SQNPKGRPVMSQVVEILETIATQSENQEEAMLQSGGSSCVTLYE 472

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356513239|ref|XP_003525321.1| PREDICTED: serine/threonine-protein kinase At5g01020-like [Glycine max]

 Score =  595 bits (1533), Expect = e-167,   Method: Compositional matrix adjust.
 Identities = 291/402 (72%), Positives = 328/402 (81%), Gaps = 35/402 (8%)

Query: 1   MGICFSLEEQQRQRLRQQQQPSSSKENQGGN--GAPVISDNLDSPGMKTASGSQVTPKNV 58
           MGICFS+E+Q    +      S++K    G+  GAP+ S                     
Sbjct: 1   MGICFSIEDQNHLSISD----SNAKPKPAGHESGAPLAS--------------------- 35

Query: 59  TPVPPKKNVNDLRQNPGYSNVDIFTYNEMKLATKFFRPDYILGEGGFGVVYKGVIDENVR 118
                  N+ DLR+  GYSNVDIFTY E++LATK FRPD+ILGEGGFGVVYKGVID +VR
Sbjct: 36  ------MNIKDLREGAGYSNVDIFTYEELRLATKHFRPDFILGEGGFGVVYKGVIDHSVR 89

Query: 119 PGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVKLIGYCCEDEHRILVYEYME 178
            GYK+T VAIKELNR G+QGDREWLAEVNYLGQ  H NLVKLIGYCCED+HR+LVYEYM 
Sbjct: 90  SGYKSTEVAIKELNREGFQGDREWLAEVNYLGQFSHPNLVKLIGYCCEDDHRLLVYEYMA 149

Query: 179 SGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSA 238
           SGSLEKHL RRVG  LTWS+RMKIAL AA+GLAFLHGAERP+IYRDFKTSNILL+ADF+A
Sbjct: 150 SGSLEKHLFRRVGSTLTWSKRMKIALHAARGLAFLHGAERPIIYRDFKTSNILLDADFNA 209

Query: 239 KLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGR 298
           KLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEML+GR
Sbjct: 210 KLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLIGR 269

Query: 299 RAVDKSRPSREHNLVEWARPLLNNNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNP 358
           RA+DKSRPSREHNLVEWARPLLN+NKK+L+ILDP+LEGQY+++TA+KVA LAYQCLSQNP
Sbjct: 270 RALDKSRPSREHNLVEWARPLLNHNKKLLKILDPKLEGQYSSKTALKVAHLAYQCLSQNP 329

Query: 359 KGRPVMSDVVALLETVQSQGAEEE--MLQSGGGVVTLYEVPK 398
           KGRP+MS VV +LE  QS+G  EE  MLQ+G   +TLYEVPK
Sbjct: 330 KGRPLMSQVVEILENFQSKGENEEDQMLQTGDTSITLYEVPK 371

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|22325532|ref|NP_178731.2| protein kinase domain-containing protein [Arabidopsis thaliana] gi|334184157|ref|NP_001189514.1| protein kinase domain-containing protein [Arabidopsis thaliana] gi|23297644|gb|AAN12999.1| putative protein kinase [Arabidopsis thaliana] gi|110741931|dbj|BAE98906.1| putative protein kinase [Arabidopsis thaliana] gi|330250944|gb|AEC06038.1| protein kinase domain-containing protein [Arabidopsis thaliana] gi|330250945|gb|AEC06039.1| protein kinase domain-containing protein [Arabidopsis thaliana]

 Score =  592 bits (1526), Expect = e-166,   Method: Compositional matrix adjust.
 Identities = 297/446 (66%), Positives = 341/446 (76%), Gaps = 22/446 (4%)

Query: 1   MGICFSLEEQQRQRLRQQQQPSSSKENQGGNGAPVISDNLDSPGMKTASGSQVTPKNVTP 60
           MGICFS E+Q  Q  +QQ  P   K+   G  A V     D   +        +     P
Sbjct: 1   MGICFSAEDQHYQFSQQQNYP---KKTTPGKKAAVYLMKSDCEDVVGKVSGSGSGGGGLP 57

Query: 61  VPPKKNVNDLRQNPGYSNVDIFTYNEMKLATKFFRPDYILGEGGFGVVYKGVIDENVRPG 120
           + PK N+ DL+ NPGY NVDIFTY EMK+ATK FRPDYILGEGGFGVVYKGVIDE+VR G
Sbjct: 58  LAPK-NIKDLQSNPGYENVDIFTYEEMKIATKQFRPDYILGEGGFGVVYKGVIDESVRVG 116

Query: 121 YKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVKLIGYCCEDEHRILVYEYMESG 180
           +K+T VAIKELN  G+QGDREWLAEVNYLGQL H NLVKLIGYCCED+HR+LVYEYM  G
Sbjct: 117 FKSTKVAIKELNPEGFQGDREWLAEVNYLGQLSHPNLVKLIGYCCEDDHRLLVYEYMAMG 176

Query: 181 SLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKL 240
           SLEKHL RRVGC LTW++RMKIALDAAKGLAFLHGAER +IYRD KT+NILL+  ++AKL
Sbjct: 177 SLEKHLFRRVGCTLTWTKRMKIALDAAKGLAFLHGAERSIIYRDLKTANILLDEGYNAKL 236

Query: 241 SDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRA 300
           SDFGLAKDGP GDQTHVSTRVMGTYGYAAPEYVMTGHLT+RSDVYGFGV+LLEMLLG+RA
Sbjct: 237 SDFGLAKDGPRGDQTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYGFGVLLLEMLLGKRA 296

Query: 301 VDKSRPSREHNLVEWARPLLNNNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKG 360
           +DKSR  REHNLVEWARPLLN+NKK+LRI+DPR++GQY  +  MKVAGLAYQCLSQNPKG
Sbjct: 297 MDKSRACREHNLVEWARPLLNHNKKLLRIIDPRMDGQYGTKALMKVAGLAYQCLSQNPKG 356

Query: 361 RPVMSDVVALLETVQSQG-AEEEM---LQSGGGVVTLYEVPKLSSHNSGDKKRNQSGFSG 416
           RP+M+ VV +LET++  G A+EE+   L S G  VTLYE                S   G
Sbjct: 357 RPLMNHVVEVLETLKDDGDAQEEVMTNLHSRGKSVTLYEA--------------SSDSQG 402

Query: 417 STEGESRRRNKPGNGRSKSEPPADRE 442
           + +G  +RR +P +GRSKSE   D E
Sbjct: 403 TRDGNGQRRRRPESGRSKSEAAVDTE 428

Source: Arabidopsis thaliana

Species: Arabidopsis thaliana

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|19423982|gb|AAL87287.1| putative protein kinase [Arabidopsis thaliana]

 Score =  590 bits (1520), Expect = e-166,   Method: Compositional matrix adjust.
 Identities = 296/446 (66%), Positives = 341/446 (76%), Gaps = 22/446 (4%)

Query: 1   MGICFSLEEQQRQRLRQQQQPSSSKENQGGNGAPVISDNLDSPGMKTASGSQVTPKNVTP 60
           MGICFS E+Q  Q  +QQ  P   K+   G  A V     D   +        +     P
Sbjct: 1   MGICFSAEDQHYQFSQQQNYP---KKTTPGKKAAVYLMKSDCEDVVGKVSGSGSGGGGLP 57

Query: 61  VPPKKNVNDLRQNPGYSNVDIFTYNEMKLATKFFRPDYILGEGGFGVVYKGVIDENVRPG 120
           +  +KN+ DL+ NPGY NVDIFTY EMK+ATK FRPDYILGEGGFGVVYKGVIDE+VR G
Sbjct: 58  LA-QKNIKDLQSNPGYENVDIFTYEEMKIATKQFRPDYILGEGGFGVVYKGVIDESVRVG 116

Query: 121 YKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVKLIGYCCEDEHRILVYEYMESG 180
           +K+T VAIKELN  G+QGDREWLAEVNYLGQL H NLVKLIGYCCED+HR+LVYEYM  G
Sbjct: 117 FKSTKVAIKELNPEGFQGDREWLAEVNYLGQLSHPNLVKLIGYCCEDDHRLLVYEYMAMG 176

Query: 181 SLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKL 240
           SLEKHL RRVGC LTW++RMKIALDAAKGLAFLHGAER +IYRD KT+NILL+  ++AKL
Sbjct: 177 SLEKHLFRRVGCTLTWTKRMKIALDAAKGLAFLHGAERSIIYRDLKTANILLDEGYNAKL 236

Query: 241 SDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRA 300
           SDFGLAKDGP GDQTHVSTRVMGTYGYAAPEYVMTGHLT+RSDVYGFGV+LLEMLLG+RA
Sbjct: 237 SDFGLAKDGPRGDQTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYGFGVLLLEMLLGKRA 296

Query: 301 VDKSRPSREHNLVEWARPLLNNNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKG 360
           +DKSR  REHNLVEWARPLLN+NKK+LRI+DPR++GQY  +  MKVAGLAYQCLSQNPKG
Sbjct: 297 MDKSRACREHNLVEWARPLLNHNKKLLRIIDPRMDGQYGTKALMKVAGLAYQCLSQNPKG 356

Query: 361 RPVMSDVVALLETVQSQG-AEEEM---LQSGGGVVTLYEVPKLSSHNSGDKKRNQSGFSG 416
           RP+M+ VV +LET++  G A+EE+   L S G  VTLYE                S   G
Sbjct: 357 RPLMNHVVEVLETLKDDGDAQEEVMTNLHSRGKSVTLYEA--------------SSDSQG 402

Query: 417 STEGESRRRNKPGNGRSKSEPPADRE 442
           + +G  +RR +P +GRSKSE   D E
Sbjct: 403 TRDGNGQRRRRPESGRSKSEAAVDTE 428

Source: Arabidopsis thaliana

Species: Arabidopsis thaliana

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356523811|ref|XP_003530528.1| PREDICTED: serine/threonine-protein kinase At5g01020-like [Glycine max]

 Score =  588 bits (1515), Expect = e-165,   Method: Compositional matrix adjust.
 Identities = 290/403 (71%), Positives = 326/403 (80%), Gaps = 36/403 (8%)

Query: 1   MGICFSLEEQQRQRLRQQQQPSSSKENQGG---NGAPVISDNLDSPGMKTASGSQVTPKN 57
           MGICFS+E+     +      S++K N+     +GAP+ S                    
Sbjct: 1   MGICFSIEDPNNLSISD----SNAKPNKPAGHESGAPLAS-------------------- 36

Query: 58  VTPVPPKKNVNDLRQNPGYSNVDIFTYNEMKLATKFFRPDYILGEGGFGVVYKGVIDENV 117
                   N+ DLR+  GYSNVDIFTY E++LATK FRPD+ILGEGGFGVVYKGVID +V
Sbjct: 37  -------MNIKDLREGAGYSNVDIFTYEELRLATKHFRPDFILGEGGFGVVYKGVIDHSV 89

Query: 118 RPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVKLIGYCCEDEHRILVYEYM 177
           R GY +T VAIKELNR G+QGDREWLAEVNYLGQ  H NLVKLIGY CED+HR+LVYEYM
Sbjct: 90  RSGYMSTEVAIKELNREGFQGDREWLAEVNYLGQFSHPNLVKLIGYSCEDDHRLLVYEYM 149

Query: 178 ESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFS 237
            SGSLEKHL RRVG  LTWS+RMKIAL AA+GLAFLHGAERP+IYRDFKTSNILL+ADF+
Sbjct: 150 ASGSLEKHLFRRVGSTLTWSKRMKIALHAARGLAFLHGAERPIIYRDFKTSNILLDADFN 209

Query: 238 AKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLG 297
           AKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEML+G
Sbjct: 210 AKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLIG 269

Query: 298 RRAVDKSRPSREHNLVEWARPLLNNNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQN 357
           RRA+DKSRPSREHNLVEWARPLLN+NKK+L+ILDP+LEGQY+ +TA+KVA LAYQCLSQN
Sbjct: 270 RRALDKSRPSREHNLVEWARPLLNHNKKLLKILDPKLEGQYSCKTALKVAHLAYQCLSQN 329

Query: 358 PKGRPVMSDVVALLETVQSQGAEEE--MLQSGGGVVTLYEVPK 398
           PKGRP+MS VV +LE  QS+G  EE  MLQ+GG  VTLYEVPK
Sbjct: 330 PKGRPLMSQVVEILENFQSKGGNEEDQMLQTGGTSVTLYEVPK 372

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|297835890|ref|XP_002885827.1| hypothetical protein ARALYDRAFT_480233 [Arabidopsis lyrata subsp. lyrata] gi|297331667|gb|EFH62086.1| hypothetical protein ARALYDRAFT_480233 [Arabidopsis lyrata subsp. lyrata]

 Score =  584 bits (1506), Expect = e-164,   Method: Compositional matrix adjust.
 Identities = 304/448 (67%), Positives = 345/448 (77%), Gaps = 27/448 (6%)

Query: 1   MGICFSLEEQQRQRLRQQQQPSSSKENQGGNGAPVI--SDNLDSPGMKTASGSQVTPKNV 58
           MGICFS E+ Q Q    QQQ    K   G N A  +  SD  DS G  +ASG        
Sbjct: 1   MGICFSAEDHQYQF--SQQQNYQKKTTPGKNSAVYLMKSDCQDSVGKVSASGGGGGLPLA 58

Query: 59  TPVPPKKNVNDLRQNPGYSNVDIFTYNEMKLATKFFRPDYILGEGGFGVVYKGVIDENVR 118
                 KN+ DL+ NPGY NVDIFTY EMK+ATK FRPDYILGEGGFGVVYKGVIDE+VR
Sbjct: 59  P-----KNIKDLQSNPGYENVDIFTYQEMKIATKQFRPDYILGEGGFGVVYKGVIDESVR 113

Query: 119 PGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVKLIGYCCEDEHRILVYEYME 178
            GYK+T VAIKELN  G+QGDREWLAEVNYLGQL H NLVKLIGYCCED+HR+LVYEYM 
Sbjct: 114 AGYKSTKVAIKELNPEGFQGDREWLAEVNYLGQLSHPNLVKLIGYCCEDDHRLLVYEYMA 173

Query: 179 SGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSA 238
            GSLEKHL RRVGC LTWS+RMKIALDAAKGLAFLHGAER +IYRD KT+NILL+  ++A
Sbjct: 174 MGSLEKHLFRRVGCTLTWSKRMKIALDAAKGLAFLHGAERSIIYRDLKTANILLDEGYNA 233

Query: 239 KLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGR 298
           KLSDFGLAKDGP GDQTHVSTRVMGTYGYAAPEYVMTGHLT+RSDVYGFGV+LLEMLLG+
Sbjct: 234 KLSDFGLAKDGPRGDQTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYGFGVLLLEMLLGK 293

Query: 299 RAVDKSRPSREHNLVEWARPLLNNNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNP 358
           RA+DKSRP REHNLVEWARPLLN+NKK+LRI+DPR++GQY  +  MKVAGLAYQCLSQNP
Sbjct: 294 RAMDKSRPCREHNLVEWARPLLNHNKKLLRIIDPRMDGQYGTKALMKVAGLAYQCLSQNP 353

Query: 359 KGRPVMSDVVALLETVQSQG-AEEEM---LQSGGGVVTLYEVPKLSSHNSGDKKRNQSGF 414
           KGRP+M+ VV +LET++  G A+EE+   L S G  VTLYE                S  
Sbjct: 354 KGRPLMNHVVEVLETLKEDGDAQEEVMTNLHSRGKSVTLYEA--------------SSDS 399

Query: 415 SGSTEGESRRRNKPGNGRSKSEPPADRE 442
            G+ +G+ +RR +P +GRSKSE   D +
Sbjct: 400 QGTRDGDGQRRRRPESGRSKSEASVDTD 427

Source: Arabidopsis lyrata subsp. lyrata

Species: Arabidopsis lyrata

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255563878|ref|XP_002522939.1| Protein kinase APK1B, chloroplast precursor, putative [Ricinus communis] gi|223537833|gb|EEF39450.1| Protein kinase APK1B, chloroplast precursor, putative [Ricinus communis]

 Score =  580 bits (1494), Expect = e-163,   Method: Compositional matrix adjust.
 Identities = 309/443 (69%), Positives = 343/443 (77%), Gaps = 25/443 (5%)

Query: 3   ICFSLEEQQRQRLRQQQQPSSSKEN---QGGNGAPVISDNLDSPGMKTASGSQVTPKNVT 59
           I F +  + +  L+        KEN   +  + +P   +  DS G K+AS +Q+ PKNVT
Sbjct: 8   IVFIMYCKTKSELKYYNDRGMLKENDTREDFDHSPSKLNKPDSIGAKSASSNQLVPKNVT 67

Query: 60  PVPPKKNVNDLRQNPGYSNVDIFTYNEMKLATKFFRPDYILGEGGFGVVYKGVIDENVRP 119
                    DLRQ+PGY NVDIFTY EM LATK FRPDYILGEGGFGVVYKGVID +VRP
Sbjct: 68  ---------DLRQSPGYGNVDIFTYEEMTLATKHFRPDYILGEGGFGVVYKGVIDASVRP 118

Query: 120 GYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVKLIGYCCEDEHRILVYEYMES 179
           GY+T  VAIKELN  G QGDREWLAEVNYLGQL H NLVKLIGYCCEDEHR+LVYEYM S
Sbjct: 119 GYETIVVAIKELNPDGLQGDREWLAEVNYLGQLSHPNLVKLIGYCCEDEHRLLVYEYMAS 178

Query: 180 GSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAK 239
           GSLEKHL RRVGC+LTWS+R+KIALDAAKGLAFLHGAER +IYRDFKTSNILL+++F+AK
Sbjct: 179 GSLEKHLFRRVGCILTWSKRLKIALDAAKGLAFLHGAERSIIYRDFKTSNILLDSNFNAK 238

Query: 240 LSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRR 299
           LSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLE+LLGRR
Sbjct: 239 LSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLELLLGRR 298

Query: 300 AVDKSRPSREHNLVEWARPLLNNNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPK 359
           A+DK RPSREHNLVEWARPLLN+NKKVLRILDPR+EGQYT +TAMKVA LAYQCLSQNPK
Sbjct: 299 ALDKGRPSREHNLVEWARPLLNHNKKVLRILDPRMEGQYTVKTAMKVANLAYQCLSQNPK 358

Query: 360 GRPVMSDVVALLETVQSQGAEEEMLQSGGGVVTLYEVPKLSSHNSGDKKRNQSGFSGSTE 419
           GRP+MS VV LLE VQ+Q  E+   QS    VTLYE P LS      KK           
Sbjct: 359 GRPLMSQVVELLEGVQTQD-EDAFFQSNDTGVTLYEDPGLSPFTPHGKK----------- 406

Query: 420 GESRRRNKPGNGRSKSEPPADRE 442
            +   R+    GRS SEP  D +
Sbjct: 407 -DPTTRSNQSKGRSNSEPSVDHD 428

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	464
TAIR|locus:2060167	442	AT2G07180 [Arabidopsis thalian	0.909	0.954	0.656	1.7e-146
TAIR|locus:2150019	410	AT5G01020 [Arabidopsis thalian	0.668	0.756	0.712	8.8e-118
TAIR|locus:2064712	462	RIPK "RPM1-induced protein kin	0.812	0.816	0.564	2.5e-106
TAIR|locus:2147805	493	AT5G15080 [Arabidopsis thalian	0.717	0.675	0.602	2.1e-100
TAIR|locus:2053240	423	PK1B "protein kinase 1B" [Arab	0.655	0.718	0.621	9.1e-100
TAIR|locus:2161093	408	AT5G56460 [Arabidopsis thalian	0.704	0.801	0.588	1.5e-99
TAIR|locus:2057770	424	ARSK1 "root-specific kinase 1"	0.775	0.849	0.535	3.1e-99
TAIR|locus:2180127	389	NAK [Arabidopsis thaliana (tax	0.657	0.784	0.592	5e-99
TAIR|locus:2100282	490	AT3G01300 [Arabidopsis thalian	0.756	0.716	0.563	6.4e-99
TAIR|locus:2039772	395	BIK1 "botrytis-induced kinase1	0.637	0.749	0.617	1.2e-97

TAIR|locus:2060167 AT2G07180 [Arabidopsis thaliana (taxid:3702)]

 Score = 1431 (508.8 bits), Expect = 1.7e-146, P = 1.7e-146
 Identities = 294/448 (65%), Positives = 334/448 (74%)

Query:     1 MGICFSXXXXXXXXXXXXXXPSSSKENQGGNGAPVI--SDNLDSPGMKTASGSQXXXXXX 58
             MGICFS              P   K   G   A  +  SD  D  G  + SGS       
Sbjct:     1 MGICFSAEDQHYQFSQQQNYPK--KTTPGKKAAVYLMKSDCEDVVGKVSGSGS----GGG 54

Query:    59 XXXXXXXXXXDLRQNPGYSNVDIFTYNEMKLATKFFRPDYILGEGGFGVVYKGVIDENVR 118
                       DL+ NPGY NVDIFTY EMK+ATK FRPDYILGEGGFGVVYKGVIDE+VR
Sbjct:    55 GLPLAPKNIKDLQSNPGYENVDIFTYEEMKIATKQFRPDYILGEGGFGVVYKGVIDESVR 114

Query:   119 PGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVKLIGYCCEDEHRILVYEYME 178
              G+K+T VAIKELN  G+QGDREWLAEVNYLGQL H NLVKLIGYCCED+HR+LVYEYM 
Sbjct:   115 VGFKSTKVAIKELNPEGFQGDREWLAEVNYLGQLSHPNLVKLIGYCCEDDHRLLVYEYMA 174

Query:   179 SGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSA 238
              GSLEKHL RRVGC LTW++RMKIALDAAKGLAFLHGAER +IYRD KT+NILL+  ++A
Sbjct:   175 MGSLEKHLFRRVGCTLTWTKRMKIALDAAKGLAFLHGAERSIIYRDLKTANILLDEGYNA 234

Query:   239 KLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGR 298
             KLSDFGLAKDGP GDQTHVSTRVMGTYGYAAPEYVMTGHLT+RSDVYGFGV+LLEMLLG+
Sbjct:   235 KLSDFGLAKDGPRGDQTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYGFGVLLLEMLLGK 294

Query:   299 RAVDKSRPSREHNLVEWARPLLNNNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNP 358
             RA+DKSR  REHNLVEWARPLLN+NKK+LRI+DPR++GQY  +  MKVAGLAYQCLSQNP
Sbjct:   295 RAMDKSRACREHNLVEWARPLLNHNKKLLRIIDPRMDGQYGTKALMKVAGLAYQCLSQNP 354

Query:   359 KGRPVMSDVVALLETVQSQG-AEEEM---LQSGGGVVTLYEVPKLSSHNSGDKKRNQSGF 414
             KGRP+M+ VV +LET++  G A+EE+   L S G  VTLYE        S D +      
Sbjct:   355 KGRPLMNHVVEVLETLKDDGDAQEEVMTNLHSRGKSVTLYEA-------SSDSQ------ 401

Query:   415 SGSTEGESRRRNKPGNGRSKSEPPADRE 442
              G+ +G  +RR +P +GRSKSE   D E
Sbjct:   402 -GTRDGNGQRRRRPESGRSKSEAAVDTE 428

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2150019 AT5G01020 [Arabidopsis thaliana (taxid:3702)]

 Score = 1160 (413.4 bits), Expect = 8.8e-118, P = 8.8e-118
 Identities = 221/310 (71%), Positives = 253/310 (81%)

Query:    69 DLRQNPGYSNVDIFTYNEMKLATKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAI 128
             D R    Y+ V  FT  E++  TK FRPDYILGEGGFG VYKG ID+N+R G K+  VA+
Sbjct:    44 DSRTPISYAQVIPFTLFELETITKSFRPDYILGEGGFGTVYKGYIDDNLRVGLKSLPVAV 103

Query:   129 KELNRGGYQGDREWLAEVNYLGQLRHSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLR 188
             K LN+ G QG REWL EVN+LGQLRH NLVKLIGYCCED+HR+LVYE+M  GSLE HL R
Sbjct:   104 KVLNKEGLQGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHRLLVYEFMLRGSLENHLFR 163

Query:   189 RVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKD 248
             +    L+WSRRM IAL AAKGLAFLH AERPVIYRDFKTSNILL++D++AKLSDFGLAK 
Sbjct:   164 KTTAPLSWSRRMMIALGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKA 223

Query:   249 GPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSR 308
             GP GD+THVSTRVMGTYGYAAPEYVMTGHLTARSDVY FGVVLLEML GR++VDK+RPS+
Sbjct:   224 GPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLEMLTGRKSVDKTRPSK 283

Query:   309 EHNLVEWARPLLNNNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVV 368
             E NLV+WARP LN+ +K+L+I+DPRLE QY+ R A K   LAY CLSQNPK RP+MSDVV
Sbjct:   284 EQNLVDWARPKLNDKRKLLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVV 343

Query:   369 ALLETVQSQG 378
               LE +Q  G
Sbjct:   344 ETLEPLQCTG 353

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0000394 "RNA splicing, via endonucleolytic cleavage and ligation" evidence=RCA

GO:0009086 "methionine biosynthetic process" evidence=RCA

GO:0032880 "regulation of protein localization" evidence=RCA

TAIR|locus:2064712 RIPK "RPM1-induced protein kinase" [Arabidopsis thaliana (taxid:3702)]

 Score = 1052 (375.4 bits), Expect = 2.5e-106, P = 2.5e-106
 Identities = 218/386 (56%), Positives = 261/386 (67%)

Query:    69 DLRQNPGYSNVDIFTYNEMKLATKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAI 128
             DL  +   S++ +FT  E+K+ T+ F     LGEGGFG V+KG ID+ +RPG K   VA+
Sbjct:    62 DLSISLAGSDLHVFTLAELKVITQSFSSTNFLGEGGFGPVHKGFIDDKLRPGLKAQPVAV 121

Query:   129 KELNRGGYQGDREWLAEVNYLGQLRHSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLR 188
             K L+  G QG REWL EV +LGQL+H NLVKLIGYCCE+EHR LVYE+M  GSLE  L R
Sbjct:   122 KLLDLEGLQGHREWLTEVMFLGQLKHKNLVKLIGYCCEEEHRTLVYEFMPRGSLENQLFR 181

Query:   189 RVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKD 248
             R    L WS RMKIA  AA GL FLH AE PVIYRDFK SNILL++D++AKLSDFGLAKD
Sbjct:   182 RYSASLPWSTRMKIAHGAATGLQFLHEAENPVIYRDFKASNILLDSDYTAKLSDFGLAKD 241

Query:   249 GPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSR 308
             GP GD THVSTRVMGT GYAAPEY+MTGHLTARSDVY FGVVLLE+L GRR+VDK R SR
Sbjct:   242 GPEGDDTHVSTRVMGTQGYAAPEYIMTGHLTARSDVYSFGVVLLELLTGRRSVDKKRSSR 301

Query:   309 EHNLVEWARPLLNNNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVV 368
             E NLV+WARP+LN+ +K+ RI+DPRLEGQY+   A K A LAYQCLS  PK RP MS VV
Sbjct:   302 EQNLVDWARPMLNDPRKLSRIMDPRLEGQYSETGARKAATLAYQCLSHRPKNRPCMSAVV 361

Query:   369 ALLETVQSQGAEEEMLQSGGGVVTLYEVP--KLSSHNSGDKKRNQSGFSGSTEGESRRRN 426
             ++L  ++        +  G    T+   P  K      G+K R  S      + +S    
Sbjct:   362 SILNDLKDYND----IPMGTFTYTVPNTPDNKEDDGRVGNKPRKSSHHHHHQQQQSNHPR 417

Query:   427 KPGNGRSKSEPPADREPCDFRNSSSN 452
                +  +KS  P  + P   RNS+ N
Sbjct:   418 SSPSPTTKSPSPTAKSP---RNSTEN 440

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0042742 "defense response to bacterium" evidence=IMP

GO:0000165 "MAPK cascade" evidence=RCA

GO:0006499 "N-terminal protein myristoylation" evidence=RCA

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0007154 "cell communication" evidence=RCA

GO:0009409 "response to cold" evidence=RCA

GO:0009414 "response to water deprivation" evidence=RCA

GO:0009611 "response to wounding" evidence=RCA

GO:0009625 "response to insect" evidence=RCA

GO:0009627 "systemic acquired resistance" evidence=RCA

GO:0009697 "salicylic acid biosynthetic process" evidence=RCA

GO:0009738 "abscisic acid mediated signaling pathway" evidence=RCA

GO:0009862 "systemic acquired resistance, salicylic acid mediated signaling pathway" evidence=RCA

GO:0009863 "salicylic acid mediated signaling pathway" evidence=RCA

GO:0009867 "jasmonic acid mediated signaling pathway" evidence=RCA

GO:0009963 "positive regulation of flavonoid biosynthetic process" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0016036 "cellular response to phosphate starvation" evidence=RCA

GO:0019375 "galactolipid biosynthetic process" evidence=RCA

GO:0030968 "endoplasmic reticulum unfolded protein response" evidence=RCA

GO:0031348 "negative regulation of defense response" evidence=RCA

GO:0042538 "hyperosmotic salinity response" evidence=RCA

GO:0042631 "cellular response to water deprivation" evidence=RCA

GO:0043069 "negative regulation of programmed cell death" evidence=RCA

GO:0045087 "innate immune response" evidence=RCA

GO:0050832 "defense response to fungus" evidence=RCA

TAIR|locus:2147805 AT5G15080 [Arabidopsis thaliana (taxid:3702)]

 Score = 996 (355.7 bits), Expect = 2.1e-100, P = 2.1e-100
 Identities = 211/350 (60%), Positives = 262/350 (74%)

Query:    77 SNVDIFTYNEMKLATKFFRPDYILGEGGFGVVYKGVIDEN----VRPGYKTTFVAIKELN 132
             S++  FT+N++KL+T+ FRP+ +LGEGGFG V+KG I+EN    V+PG   T VA+K LN
Sbjct:   125 SHLRKFTFNDLKLSTRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLT-VAVKTLN 183

Query:   133 RGGYQGDREWLAEVNYLGQLRHSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGC 192
               G QG +EWLAE+N+LG L H NLVKL+GYC ED+ R+LVYE+M  GSLE HL RR   
Sbjct:   184 PDGLQGHKEWLAEINFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRR-SL 242

Query:   193 MLTWSRRMKIALDAAKGLAFLHG-AERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPM 251
              L WS RMKIAL AAKGL+FLH  A +PVIYRDFKTSNILL+AD++AKLSDFGLAKD P 
Sbjct:   243 PLPWSIRMKIALGAAKGLSFLHEEALKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPD 302

Query:   252 GDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHN 311
               +THVSTRVMGTYGYAAPEYVMTGHLT++SDVY FGVVLLEML GRR++DK+RP+ EHN
Sbjct:   303 EGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHN 362

Query:   312 LVEWARPLLNNNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALL 371
             LVEWARP L + ++  R+LDPRLEG ++ + A KV  LA QCLS++PK RP MSDVV  L
Sbjct:   363 LVEWARPHLLDKRRFYRLLDPRLEGHFSIKGAQKVTQLAAQCLSRDPKIRPKMSDVVEAL 422

Query:   372 ETVQSQGAEEEMLQSGGGVVTLYEVPKLSSHNSGDKKRNQSGFSGSTEGE 421
             + +      ++M  S     T+ +  +L +  SG   R+Q GF GS  G+
Sbjct:   423 KPLPHL---KDMASSSYYFQTM-QAERLKN-GSG---RSQ-GF-GSRNGQ 462

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2053240 PK1B "protein kinase 1B" [Arabidopsis thaliana (taxid:3702)]

 Score = 990 (353.6 bits), Expect = 9.1e-100, P = 9.1e-100
 Identities = 195/314 (62%), Positives = 243/314 (77%)

Query:    69 DLRQNPGYSNVDIFTYNEMKLATKFFRPDYILGEGGFGVVYKGVIDENV----RPGYKTT 124
             ++ Q+P   N+  FT+ E+K AT+ FRPD +LGEGGFG V+KG IDE      +PG    
Sbjct:    58 EILQSP---NLKSFTFAELKAATRNFRPDSVLGEGGFGSVFKGWIDEQTLTASKPGTGVV 114

Query:   125 FVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVKLIGYCCEDEHRILVYEYMESGSLEK 184
              +A+K+LN+ G+QG +EWLAEVNYLGQ  H NLVKLIGYC EDEHR+LVYE+M  GSLE 
Sbjct:   115 -IAVKKLNQDGWQGHQEWLAEVNYLGQFSHPNLVKLIGYCLEDEHRLLVYEFMPRGSLEN 173

Query:   185 HLLRRVGCM--LTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSD 242
             HL RR      L+W+ R+K+AL AAKGLAFLH AE  VIYRDFKTSNILL+++++AKLSD
Sbjct:   174 HLFRRGSYFQPLSWTLRLKVALGAAKGLAFLHNAETSVIYRDFKTSNILLDSEYNAKLSD 233

Query:   243 FGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVD 302
             FGLAKDGP GD++HVSTR+MGTYGYAAPEY+ TGHLT +SDVY +GVVLLE+L GRRAVD
Sbjct:   234 FGLAKDGPTGDKSHVSTRIMGTYGYAAPEYLATGHLTTKSDVYSYGVVLLEVLSGRRAVD 293

Query:   303 KSRPSREHNLVEWARPLLNNNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRP 362
             K+RP  E  LVEWARPLL N +K+ R++D RL+ QY+   A KVA LA +CL+   K RP
Sbjct:   294 KNRPPGEQKLVEWARPLLANKRKLFRVIDNRLQDQYSMEEACKVATLALRCLTFEIKLRP 353

Query:   363 VMSDVVALLETVQS 376
              M++VV+ LE +Q+
Sbjct:   354 NMNEVVSHLEHIQT 367

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0009507 "chloroplast" evidence=ISM

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

TAIR|locus:2161093 AT5G56460 [Arabidopsis thaliana (taxid:3702)]

 Score = 988 (352.9 bits), Expect = 1.5e-99, P = 1.5e-99
 Identities = 199/338 (58%), Positives = 251/338 (74%)

Query:    69 DLRQNPGYSNVDIFTYNEMKLATKFFRPDYILGEGGFGVVYKGVIDENV--RPGYKTTFV 126
             DLR++   + +  FTY E+K  T  FR D +LG GGFG VYKG I E++  +   +   V
Sbjct:    51 DLRRDSAANPLIAFTYEELKNITSNFRQDRVLGGGGFGSVYKGFIKEDLGDQEVPEPLPV 110

Query:   127 AIKELNRG--GYQGDREWLAEVNYLGQLRHSNLVKLIGYCCEDEHRILVYEYMESGSLEK 184
             A+K ++ G   +QG REWLAEV +LGQL H NLVKLIGYCCED HR+L+YEYM  GS+E 
Sbjct:   111 AVK-VHDGDNSFQGHREWLAEVIFLGQLSHPNLVKLIGYCCEDNHRVLIYEYMARGSVEN 169

Query:   185 HLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFG 244
             +L  RV   L+W+ RMKIA  AAKGLAFLH A++PVIYRDFKTSNILL+ D++AKLSDFG
Sbjct:   170 NLFSRVLLPLSWAIRMKIAFGAAKGLAFLHEAKKPVIYRDFKTSNILLDMDYNAKLSDFG 229

Query:   245 LAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKS 304
             LAKDGP+GD++HVSTR+MGTYGYAAPEY+MTGHLT  SDVY FGVVLLE+L GR+++DKS
Sbjct:   230 LAKDGPVGDKSHVSTRIMGTYGYAAPEYIMTGHLTPGSDVYSFGVVLLELLTGRKSLDKS 289

Query:   305 RPSREHNLVEWARPLLNNNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVM 364
             RP+RE NL++WA PLL   KKVL I+DP++  +Y  +   K A LAY CL++NPK RP+M
Sbjct:   290 RPTREQNLIDWALPLLKEKKKVLNIVDPKMNCEYPVKAVQKAAMLAYHCLNRNPKARPLM 349

Query:   365 SDVVALLETVQSQGAEEEML---QSGGGVVTLY-EVPK 398
              D+V  LE +Q+   EEE L        V+T+  E+PK
Sbjct:   350 RDIVDSLEPLQA--TEEEALLVPPVQKAVITIIDEMPK 385

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009506 "plasmodesma" evidence=IDA

TAIR|locus:2057770 ARSK1 "root-specific kinase 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 985 (351.8 bits), Expect = 3.1e-99, P = 3.1e-99
 Identities = 194/362 (53%), Positives = 252/362 (69%)

Query:    69 DLRQNPGYSNVDIFTYNEMKLATKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAI 128
             DL  +     + +FT +E+++ T  F    +LGEGGFG VYKG ID+ V+PG +   VA+
Sbjct:    63 DLSHSFTSQKLRLFTLSELRVITHNFSRSNMLGEGGFGPVYKGFIDDKVKPGIEAQPVAV 122

Query:   129 KELNRGGYQGDREWLAEVNYLGQLRHSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLR 188
             K L+  G+QG REWLAE+ +LGQL + +LVKLIG+CCE+E R+LVYEYM  GSLE  L R
Sbjct:   123 KALDLHGHQGHREWLAEILFLGQLSNKHLVKLIGFCCEEEQRVLVYEYMPRGSLENQLFR 182

Query:   189 RVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKD 248
             R    + W  RMKIAL AAKGLAFLH AE+PVIYRDFKTSNILL++D++AKLSDFGLAKD
Sbjct:   183 RNSLAMAWGIRMKIALGAAKGLAFLHEAEKPVIYRDFKTSNILLDSDYNAKLSDFGLAKD 242

Query:   249 GPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSR 308
             GP G+ THV+TRVMGT GYAAPEY+MTGHLT  +DVY FGVVLLE++ G+R++D +R  R
Sbjct:   243 GPEGEHTHVTTRVMGTQGYAAPEYIMTGHLTTMNDVYSFGVVLLELITGKRSMDNTRTRR 302

Query:   309 EHNLVEWARPLLNNNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVV 368
             E +LVEWARP+L + +K+ RI+DPRL  Q+    A   A LAY+CLSQ+PK RP M +VV
Sbjct:   303 EQSLVEWARPMLRDQRKLERIIDPRLANQHKTEAAQVAASLAYKCLSQHPKYRPTMCEVV 362

Query:   369 ALLETVQSQGAEEEMLQSGGGVVTLYEVPKLSSHNSGDKKRNQSGFSGS-TEGESRRRNK 427
              +LE++Q     +    +        ++ K   H  G K+R    +S S    ES+ +  
Sbjct:   363 KVLESIQEVDIRKHDGNNNKEGKKFVDINKFRHHRKG-KRRVNIAYSDSLVYKESKAKQN 421

Query:   428 PG 429
              G
Sbjct:   422 DG 423

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0048765 "root hair cell differentiation" evidence=RCA

TAIR|locus:2180127 NAK [Arabidopsis thaliana (taxid:3702)]

 Score = 983 (351.1 bits), Expect = 5.0e-99, P = 5.0e-99
 Identities = 186/314 (59%), Positives = 247/314 (78%)

Query:    77 SNVDIFTYNEMKLATKFFRPDYILGEGGFGVVYKGVIDEN-VRPGYKTT--FVAIKELNR 133
             +N+  F+ +E+K AT+ FRPD ++GEGGFG V+KG IDE+ + P    T   +A+K LN+
Sbjct:    51 ANLKNFSLSELKSATRNFRPDSVVGEGGFGCVFKGWIDESSLAPSKPGTGIVIAVKRLNQ 110

Query:   134 GGYQGDREWLAEVNYLGQLRHSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCM 193
              G+QG REWLAE+NYLGQL H NLVKLIGYC E+EHR+LVYE+M  GSLE HL RR G  
Sbjct:   111 EGFQGHREWLAEINYLGQLDHPNLVKLIGYCLEEEHRLLVYEFMTRGSLENHLFRR-GTF 169

Query:   194 ---LTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGP 250
                L+W+ R+++AL AA+GLAFLH A+  VIYRDFK SNILL+++++AKLSDFGLA+DGP
Sbjct:   170 YQPLSWNTRVRMALGAARGLAFLHNAQPQVIYRDFKASNILLDSNYNAKLSDFGLARDGP 229

Query:   251 MGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREH 310
             MGD +HVSTRVMGT GYAAPEY+ TGHL+ +SDVY FGVVLLE+L GRRA+DK++P  EH
Sbjct:   230 MGDNSHVSTRVMGTQGYAAPEYLATGHLSVKSDVYSFGVVLLELLSGRRAIDKNQPVGEH 289

Query:   311 NLVEWARPLLNNNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVAL 370
             NLV+WARP L N +++LR++DPRL+GQY+   A+K+A LA  C+S + K RP M+++V  
Sbjct:   290 NLVDWARPYLTNKRRLLRVMDPRLQGQYSLTRALKIAVLALDCISIDAKSRPTMNEIVKT 349

Query:   371 LET--VQSQGAEEE 382
             +E   +Q + ++E+
Sbjct:   350 MEELHIQKEASKEQ 363

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0009507 "chloroplast" evidence=ISM

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

GO:0009617 "response to bacterium" evidence=RCA

GO:0045087 "innate immune response" evidence=RCA

TAIR|locus:2100282 AT3G01300 [Arabidopsis thaliana (taxid:3702)]

 Score = 982 (350.7 bits), Expect = 6.4e-99, P = 6.4e-99
 Identities = 208/369 (56%), Positives = 267/369 (72%)

Query:    76 YSNVDIFTYNEMKLATKFFRPDYILGEGGFGVVYKGVIDEN----VRPGYKTTFVAIKEL 131
             YS++  F++ ++KLAT+ FRP+ +LGEGGFG V+KG ++EN    V+PG   T VA+K L
Sbjct:   118 YSHLKKFSFIDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLT-VAVKTL 176

Query:   132 NRGGYQGDREWLAEVNYLGQLRHSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVG 191
             N  G QG +EWLAE+NYLG L H NLVKL+GYC ED+ R+LVYE+M  GSLE HL RR  
Sbjct:   177 NPDGLQGHKEWLAEINYLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRR-S 235

Query:   192 CMLTWSRRMKIALDAAKGLAFLHG-AERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGP 250
               L WS RMKIAL AAKGL+FLH  A +PVIYRDFKTSNILL+ +++AKLSDFGLAKD P
Sbjct:   236 LPLPWSIRMKIALGAAKGLSFLHEEALKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDAP 295

Query:   251 MGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREH 310
                +THVSTRVMGTYGYAAPEYVMTGHLT++SDVY FGVVLLEML GRR++DK+RP+ EH
Sbjct:   296 DEGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEH 355

Query:   311 NLVEWARPLLNNNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVAL 370
             NLVEWARP L + ++  R+LDPRLEG ++ + A KV  LA QCLS++ K RP MS+VV +
Sbjct:   356 NLVEWARPHLLDKRRFYRLLDPRLEGHFSVKGAQKVTQLAAQCLSRDSKIRPKMSEVVEV 415

Query:   371 LETVQSQGAEEEMLQSGGGVVTLYEVPKLSSHNSGDKKRNQSGFSGSTEGES--RRRNKP 428
             L+ +      ++M  +     T+ +  +L + +     R   GF GS  G+   R  + P
Sbjct:   416 LKPLPHL---KDMASASYYFQTM-QAERLKAGSGSGSGR---GF-GSRNGQPVFRTLSSP 467

Query:   429 GNGRSKSEP 437
              +G++ S P
Sbjct:   468 -HGQAGSSP 475

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2039772 BIK1 "botrytis-induced kinase1" [Arabidopsis thaliana (taxid:3702)]

 Score = 970 (346.5 bits), Expect = 1.2e-97, P = 1.2e-97
 Identities = 187/303 (61%), Positives = 233/303 (76%)

Query:    79 VDIFTYNEMKLATKFFRPDYILGEGGFGVVYKGVIDENV----RPGYKTTFVAIKELNRG 134
             V  FT+NE+KLAT+ FRPD ++GEGGFG V+KG +DE+     +PG     +A+K+LN+ 
Sbjct:    52 VKSFTFNELKLATRNFRPDSVIGEGGFGCVFKGWLDESTLTPTKPGTGLV-IAVKKLNQE 110

Query:   135 GYQGDREWLAEVNYLGQLRHSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCM- 193
             G+QG REWL E+NYLGQL H NLVKLIGYC EDEHR+LVYE+M+ GSLE HL RR     
Sbjct:   111 GFQGHREWLTEINYLGQLSHPNLVKLIGYCLEDEHRLLVYEFMQKGSLENHLFRRGAYFK 170

Query:   194 -LTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMG 252
              L W  R+ +ALDAAKGLAFLH     VIYRD K SNILL+AD++AKLSDFGLA+DGPMG
Sbjct:   171 PLPWFLRVNVALDAAKGLAFLHSDPVKVIYRDIKASNILLDADYNAKLSDFGLARDGPMG 230

Query:   253 DQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNL 312
             D ++VSTRVMGTYGYAAPEY+ +GHL ARSDVY FGV+LLE+L G+RA+D +RP++E NL
Sbjct:   231 DLSYVSTRVMGTYGYAAPEYMSSGHLNARSDVYSFGVLLLEILSGKRALDHNRPAKEENL 290

Query:   313 VEWARPLLNNNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLE 372
             V+WARP L + +KVL I+D RL+ QY    A+++A +A QCLS  PK RP M  VV  L+
Sbjct:   291 VDWARPYLTSKRKVLLIVDNRLDTQYLPEEAVRMASVAVQCLSFEPKSRPTMDQVVRALQ 350

Query:   373 TVQ 375
              +Q
Sbjct:   351 QLQ 353

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0009507 "chloroplast" evidence=ISM

GO:0016301 "kinase activity" evidence=ISS;IDA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005634 "nucleus" evidence=IDA

GO:0005730 "nucleolus" evidence=IDA

GO:0005737 "cytoplasm" evidence=IDA

GO:0005886 "plasma membrane" evidence=IDA

GO:0009620 "response to fungus" evidence=IEP

GO:0046777 "protein autophosphorylation" evidence=RCA;IDA

GO:0050832 "defense response to fungus" evidence=RCA;IMP

GO:0052033 "pathogen-associated molecular pattern dependent induction by symbiont of host innate immune response" evidence=IMP

GO:0002679 "respiratory burst involved in defense response" evidence=RCA

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0006865 "amino acid transport" evidence=RCA

GO:0009863 "salicylic acid mediated signaling pathway" evidence=RCA

GO:0010200 "response to chitin" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0043069 "negative regulation of programmed cell death" evidence=RCA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

No confident hit for EC number transfering in SWISSPROT detected by BLAST

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	0.946
3rd Layer	2.7.11	0.963

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Your Input: fgenesh4_pg.C_LG_VI000615 hypothetical protein (508 aa) (Populus trichocarpa)

Predicted Functional Partners:

Sorry, there are no predicted associations at the current settings.

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	464
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	1e-52
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	5e-48
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	1e-47
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	8e-47
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	2e-46
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	8e-46
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	5e-45
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	7e-33
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	5e-32
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	2e-31
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	3e-31
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	1e-29
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	1e-29
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	1e-28
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	1e-28
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	3e-28
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	8e-28
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	2e-27
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	2e-27
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	1e-26
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	2e-26
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	5e-26
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	1e-25
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	1e-25
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	2e-25
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	2e-25
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	3e-25
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	3e-25
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	9e-25
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	1e-24
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	5e-24
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	9e-24
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	1e-23
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	1e-23
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	2e-23
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	2e-23
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	3e-23
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	3e-23
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	3e-23
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	5e-23
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	5e-23
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	6e-23
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	6e-23
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	8e-23
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	8e-23
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	1e-22
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	1e-22
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	1e-22
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	4e-22
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	1e-21
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	3e-21
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	3e-21
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	4e-21
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	4e-21
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	5e-21
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	7e-21
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	7e-21
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	1e-20
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	2e-20
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	3e-20
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	3e-20
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	3e-20
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	6e-20
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	7e-20
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	8e-20
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	2e-19
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	2e-19
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	2e-19
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	3e-19
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	4e-19
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	6e-19
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	6e-19
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	8e-19
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	1e-18
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	1e-18
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	1e-18
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	3e-18
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	3e-18
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	3e-18
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	5e-18
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	6e-18
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	6e-18
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	6e-18
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	7e-18
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	8e-18
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	2e-17
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	2e-17
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	2e-17
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	2e-17
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	3e-17
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	4e-17
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	5e-17
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	5e-17
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	5e-17
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	6e-17
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	6e-17
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	7e-17
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	9e-17
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	1e-16
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	1e-16
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	1e-16
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	1e-16
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	1e-16
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	2e-16
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	2e-16
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	3e-16
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	4e-16
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	4e-16
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	4e-16
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	6e-16
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	8e-16
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	1e-15
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	1e-15
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	1e-15
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	1e-15
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	1e-15
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	1e-15
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	1e-15
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	2e-15
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	2e-15
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	2e-15
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	2e-15
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	3e-15
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	3e-15
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	3e-15
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	3e-15
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	4e-15
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	6e-15
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	7e-15
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	7e-15
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	8e-15
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	8e-15
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	8e-15
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	9e-15
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	1e-14
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	2e-14
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	2e-14
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	4e-14
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	5e-14
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	6e-14
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	7e-14
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	7e-14
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	8e-14
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	8e-14
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	8e-14
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	9e-14
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	1e-13
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	1e-13
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	1e-13
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	1e-13
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	1e-13
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	1e-13
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	1e-13
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	2e-13
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	2e-13
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	2e-13
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	2e-13
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	2e-13
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	2e-13
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	2e-13
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	2e-13
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	3e-13
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	3e-13
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	3e-13
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	3e-13
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	4e-13
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	4e-13
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	5e-13
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	5e-13
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	5e-13
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	6e-13
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	6e-13
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	6e-13
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	6e-13
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	7e-13
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	7e-13
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	8e-13
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	8e-13
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	9e-13
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	1e-12
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	1e-12
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	1e-12
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	1e-12
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	2e-12
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	2e-12
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	2e-12
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	3e-12
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	4e-12
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	5e-12
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	5e-12
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	5e-12
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	5e-12
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	6e-12
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	7e-12
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	9e-12
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	1e-11
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	1e-11
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	1e-11
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	1e-11
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	1e-11
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	2e-11
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	3e-11
cd05576	237	cd05576, STKc_RPK118_like, Catalytic domain of the	5e-11
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	5e-11
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	6e-11
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	7e-11
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	8e-11
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	8e-11
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	8e-11
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	8e-11
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	9e-11
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	1e-10
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	1e-10
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	2e-10
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	2e-10
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	2e-10
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	2e-10
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	3e-10
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	3e-10
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	3e-10
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	3e-10
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	3e-10
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	4e-10
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	4e-10
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	4e-10
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	4e-10
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	6e-10
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	7e-10
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	8e-10
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	9e-10
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	9e-10
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	1e-09
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	1e-09
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	1e-09
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	1e-09
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	1e-09
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	2e-09
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	2e-09
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	2e-09
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	2e-09
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	2e-09
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	3e-09
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	3e-09
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	3e-09
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	4e-09
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	5e-09
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	5e-09
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	5e-09
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	6e-09
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	7e-09
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	7e-09
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	9e-09
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	1e-08
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	1e-08
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	1e-08
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	2e-08
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	2e-08
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	2e-08
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	4e-08
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	4e-08
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	5e-08
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	5e-08
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	6e-08
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	6e-08
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	9e-08
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	9e-08
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	1e-07
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	2e-07
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	3e-07
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	4e-07
cd05076	274	cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do	5e-07
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	7e-07
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	7e-07
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	8e-07
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	1e-06
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	1e-06
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	1e-06
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	1e-06
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	1e-06
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	2e-06
PHA02988	283	PHA02988, PHA02988, hypothetical protein; Provisio	2e-06
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	2e-06
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	3e-06
cd05077	262	cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do	3e-06
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	4e-06
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	5e-06
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	1e-05
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	3e-05
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	6e-05
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	9e-05
cd05120	155	cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot	4e-04
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	6e-04
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	7e-04
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	0.001
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	0.001
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	0.001
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	0.001
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	0.002
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	0.003
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	0.003
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	0.004

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  175 bits (447), Expect = 1e-52
 Identities = 70/198 (35%), Positives = 105/198 (53%), Gaps = 14/198 (7%)

Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDRE-WLAEVNYLGQLRHSNLV 158
           LGEGGFG VY     +  +       VAIK + +       E  L E+  L +L H N+V
Sbjct: 1   LGEGGFGTVYLARDKKTGK------KVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIV 54

Query: 159 KLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAER 218
           KL G   ++ H  LV EY E GSL+  LL+     L+    ++I L   +GL +LH    
Sbjct: 55  KLYGVFEDENHLYLVMEYCEGGSLKD-LLKENEGKLSEDEILRILLQILEGLEYLH--SN 111

Query: 219 PVIYRDFKTSNILL-NADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVM-TG 276
            +I+RD K  NILL + +   KL+DFGL+K   +     +   ++GT  Y APE ++  G
Sbjct: 112 GIIHRDLKPENILLDSDNGKVKLADFGLSKL--LTSDKSLLKTIVGTPAYMAPEVLLGKG 169

Query: 277 HLTARSDVYGFGVVLLEM 294
           + + +SD++  GV+L E+
Sbjct: 170 YYSEKSDIWSLGVILYEL 187

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  165 bits (420), Expect = 5e-48
 Identities = 85/270 (31%), Positives = 126/270 (46%), Gaps = 32/270 (11%)

Query: 99  ILGEGGFGVVYKGV-IDENVRPGYKTTFVAIKELNRGG--YQGDREWLAEVNYLGQLRHS 155
            LG G FG VYK                VA+K L +     + D+    E+  L +L H 
Sbjct: 6   KLGSGSFGTVYKAKHKGTGKI-------VAVKILKKRSEKSKKDQTARREIRILRRLSHP 58

Query: 156 NLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHG 215
           N+V+LI    + +H  LV EY E G L  +L R     L+     KIAL   +GL +LH 
Sbjct: 59  NIVRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGGP--LSEDEAKKIALQILRGLEYLH- 115

Query: 216 AERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMT 275
               +I+RD K  NILL+ +   K++DFGLAK   +   + ++T V GT  Y APE ++ 
Sbjct: 116 -SNGIIHRDLKPENILLDENGVVKIADFGLAKKL-LKSSSSLTTFV-GTPWYMAPEVLLG 172

Query: 276 G-HLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRILDPRL 334
           G     + DV+  GV+L E+L G+                    +L+  + + RIL P L
Sbjct: 173 GNGYGPKVDVWSLGVILYELLTGK-------------PPFSGENILDQLQLIRRILGPPL 219

Query: 335 EGQYTARTAMK--VAGLAYQCLSQNPKGRP 362
           E      ++       L  +CL+++P  RP
Sbjct: 220 EFDEPKWSSGSEEAKDLIKKCLNKDPSKRP 249

Length = 260

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  164 bits (418), Expect = 1e-47
 Identities = 85/275 (30%), Positives = 127/275 (46%), Gaps = 24/275 (8%)

Query: 99  ILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRG-GYQGDREWLAEVNYLGQLRHSNL 157
            LGEG FG VYKG +    +   K   VA+K L      Q   E+L E   + +L H N+
Sbjct: 6   KLGEGAFGEVYKGTLKG--KGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNI 63

Query: 158 VKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAE 217
           VKL+G C E+E  ++V EYM  G L  +L +     L+ S  +  AL  A+G+ +L    
Sbjct: 64  VKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLE--S 121

Query: 218 RPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGH 277
           +  I+RD    N L+  +   K+SDFGL++D    D  +          + APE +  G 
Sbjct: 122 KNFIHRDLAARNCLVGENLVVKISDFGLSRDLY-DDDYYKVKGGKLPIRWMAPESLKEGK 180

Query: 278 LTARSDVYGFGVVLLEML-LGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRILDPRLEG 336
            T++SDV+ FGV+L E+  LG        P    +  E     L            RL  
Sbjct: 181 FTSKSDVWSFGVLLWEIFTLG------EEPYPGMSNAE-VLEYLKKGY--------RLPK 225

Query: 337 QYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALL 371
                  +    L  QC +++P+ RP  S++V +L
Sbjct: 226 PPNCPPELYK--LMLQCWAEDPEDRPTFSELVEIL 258

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  162 bits (412), Expect = 8e-47
 Identities = 72/198 (36%), Positives = 102/198 (51%), Gaps = 7/198 (3%)

Query: 99  ILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRG-GYQGDREWLAEVNYLGQLRHSNL 157
            LGEG FG VYKG +      G K   VA+K L      Q   E+L E   + +L H N+
Sbjct: 6   KLGEGAFGEVYKGKLKGK--GGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNV 63

Query: 158 VKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAE 217
           VKL+G C E+E   +V EYME G L    LR+    L+ S  +  AL  A+G+ +L    
Sbjct: 64  VKLLGVCTEEEPLYIVMEYMEGGDL-LSYLRKNRPKLSLSDLLSFALQIARGMEYLE--S 120

Query: 218 RPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGH 277
           +  I+RD    N L+  +   K+SDFGL++D    D  +          + APE +  G 
Sbjct: 121 KNFIHRDLAARNCLVGENLVVKISDFGLSRDLY-DDDYYRKRGGKLPIRWMAPESLKEGK 179

Query: 278 LTARSDVYGFGVVLLEML 295
            T++SDV+ FGV+L E+ 
Sbjct: 180 FTSKSDVWSFGVLLWEIF 197

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  161 bits (409), Expect = 2e-46
 Identities = 87/284 (30%), Positives = 134/284 (47%), Gaps = 44/284 (15%)

Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDR-EWLAEVNYLGQLRHSNLV 158
           LGEG FG VYKG +          T VA+K L  G  + +R E+L E + + +L H N+V
Sbjct: 7   LGEGAFGEVYKGTL--KGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIV 64

Query: 159 KLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAER 218
           +L+G C + E   +V EYM  G L   L +     LT    +++AL  AKG+ +L    +
Sbjct: 65  RLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEK-LTLKDLLQMALQIAKGMEYLE--SK 121

Query: 219 PVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVST------RVMGTYGYAAPEY 272
             ++RD    N L+  +   K+SDFGL++D    D            + M      APE 
Sbjct: 122 NFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWM------APES 175

Query: 273 VMTGHLTARSDVYGFGVVLLEML-LGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRILD 331
           +  G  T++SDV+ FGV+L E+  LG       +P           P ++N + +  + D
Sbjct: 176 LKDGKFTSKSDVWSFGVLLWEIFTLGE------QP----------YPGMSNEEVLELLED 219

Query: 332 ----PRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALL 371
               PR E         ++  L  QC + +P+ RP  S++V  L
Sbjct: 220 GYRLPRPEN-----CPDELYELMLQCWAYDPEDRPTFSELVEDL 258

Length = 258

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  159 bits (405), Expect = 8e-46
 Identities = 67/201 (33%), Positives = 100/201 (49%), Gaps = 14/201 (6%)

Query: 99  ILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDRE-WLAEVNYLGQLRHSNL 157
            LGEG FG VY      + + G     VAIK + +   + DRE  L E+  L +L+H N+
Sbjct: 6   KLGEGSFGKVYLAR---DKKTGKL---VAIKVIKKKKIKKDRERILREIKILKKLKHPNI 59

Query: 158 VKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAE 217
           V+L     +++   LV EY E G L   L +R    L+              L +LH   
Sbjct: 60  VRLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGR--LSEDEARFYLRQILSALEYLH--S 115

Query: 218 RPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGH 277
           + +++RD K  NILL+ D   KL+DFGLA+   +     ++T V GT  Y APE ++   
Sbjct: 116 KGIVHRDLKPENILLDEDGHVKLADFGLARQ--LDPGEKLTTFV-GTPEYMAPEVLLGKG 172

Query: 278 LTARSDVYGFGVVLLEMLLGR 298
                D++  GV+L E+L G+
Sbjct: 173 YGKAVDIWSLGVILYELLTGK 193

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  157 bits (399), Expect = 5e-45
 Identities = 87/292 (29%), Positives = 131/292 (44%), Gaps = 49/292 (16%)

Query: 99  ILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDR-EWLAEVNYLGQLRHSNL 157
            LGEG FG VYKG +        KTT VA+K L     + +R ++L E   + +L H N+
Sbjct: 2   KLGEGAFGEVYKGKLKGK---DGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNV 58

Query: 158 VKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCM-------LTWSRRMKIALDAAKGL 210
           V+L+G C E+E   LV EYME G L  +L +            L+    +  A+  AKG+
Sbjct: 59  VRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGM 118

Query: 211 AFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGP------MGDQTHVSTRVMGT 264
            +L    +  ++RD    N L+  D   K+SDFGL++D              +  R M  
Sbjct: 119 EYLA--SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWM-- 174

Query: 265 YGYAAPEYVMTGHLTARSDVYGFGVVLLEML-LGRRAVDKSRPSRE---HNLVEWARPLL 320
               APE +  G  T++SDV+ FGV+L E+  LG      + P        ++E+   L 
Sbjct: 175 ----APESLKDGIFTSKSDVWSFGVLLWEIFTLG------ATPYPGLSNEEVLEY---LR 221

Query: 321 NNNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLE 372
                  R+  P            ++  L   C   +P+ RP  S++V  LE
Sbjct: 222 KGY----RLPKPEYCPD-------ELYELMLSCWQLDPEDRPTFSELVERLE 262

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  124 bits (314), Expect = 7e-33
 Identities = 62/212 (29%), Positives = 102/212 (48%), Gaps = 26/212 (12%)

Query: 94  FRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLR 153
           F     +G+GGFG VYK     + R G     VAIK +     +   + + E+  L + +
Sbjct: 2   FEILEKIGKGGFGEVYKA---RHKRTG---KEVAIKVIKLESKEKKEKIINEIQILKKCK 55

Query: 154 HSNLVKLIG-YCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMK------IALDA 206
           H N+VK  G Y  +DE   +V E+   GSL K LL+      + ++ +       +  + 
Sbjct: 56  HPNIVKYYGSYLKKDE-LWIVMEFCSGGSL-KDLLK------STNQTLTESQIAYVCKEL 107

Query: 207 AKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYG 266
            KGL +LH     +I+RD K +NILL +D   KL DFGL+         +    ++GT  
Sbjct: 108 LKGLEYLH--SNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARN---TMVGTPY 162

Query: 267 YAAPEYVMTGHLTARSDVYGFGVVLLEMLLGR 298
           + APE +       ++D++  G+  +E+  G+
Sbjct: 163 WMAPEVINGKPYDYKADIWSLGITAIELAEGK 194

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  122 bits (308), Expect = 5e-32
 Identities = 72/206 (34%), Positives = 116/206 (56%), Gaps = 22/206 (10%)

Query: 99  ILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGD--REWLAEVNYLGQLRHSN 156
           ++G G FGVVYKG+   N+  G    FVAIK+++    + +  +  + E++ L  L+H N
Sbjct: 7   LIGRGAFGVVYKGL---NLETGD---FVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60

Query: 157 LVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGC---MLTWSRRMKIALDAAKGLAFL 213
           +VK IG     +   ++ EY E+GSL + ++++ G     L  +  +   L   +GLA+L
Sbjct: 61  IVKYIGSIETSDSLYIILEYAENGSLRQ-IIKKFGPFPESLV-AVYVYQVL---QGLAYL 115

Query: 214 HGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYV 273
           H  E+ VI+RD K +NIL   D   KL+DFG+A    + D +     V+GT  + APE +
Sbjct: 116 H--EQGVIHRDIKAANILTTKDGVVKLADFGVATK--LNDVSKDDASVVGTPYWMAPEVI 171

Query: 274 -MTGHLTARSDVYGFGVVLLEMLLGR 298
            M+G  TA SD++  G  ++E+L G 
Sbjct: 172 EMSGASTA-SDIWSLGCTVIELLTGN 196

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  121 bits (305), Expect = 2e-31
 Identities = 57/210 (27%), Positives = 101/210 (48%), Gaps = 24/210 (11%)

Query: 99  ILGEGGFGVVYKGVIDENVRPGYKTTFVAIKE--LNRGGYQGDREWLAEVNYLGQLRHSN 156
           +LG G FG VY  +  +          +A+K   L+    +       E+  L  L+H N
Sbjct: 7   LLGRGSFGSVYLALDKDT------GELMAVKSVELSGDSEEELEALEREIRILSSLQHPN 60

Query: 157 LVKLIGYCCEDEHR-ILVY-EYMESGSLEKHLLRRVGC-----MLTWSRRMKIALDAAKG 209
           +V+  G   ++E   + ++ EY+  GSL   LL++ G      +  ++R++       +G
Sbjct: 61  IVRYYGSERDEEKNTLNIFLEYVSGGSLS-SLLKKFGKLPEPVIRKYTRQI------LEG 113

Query: 210 LAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAA 269
           LA+LH     +++RD K +NIL+++D   KL+DFG AK     +    +  V GT  + A
Sbjct: 114 LAYLH--SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMA 171

Query: 270 PEYVMTGHLTARSDVYGFGVVLLEMLLGRR 299
           PE +        +D++  G  ++EM  G+ 
Sbjct: 172 PEVIRGEEYGRAADIWSLGCTVIEMATGKP 201

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score =  120 bits (303), Expect = 3e-31
 Identities = 64/195 (32%), Positives = 103/195 (52%), Gaps = 16/195 (8%)

Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVK 159
           +G+G FG V  G         Y+   VA+K L          +LAE + +  LRH NLV+
Sbjct: 14  IGKGEFGDVMLGD--------YRGQKVAVKCLKDDSTAAQ-AFLAEASVMTTLRHPNLVQ 64

Query: 160 LIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERP 219
           L+G   +     +V EYM  GSL  +L  R   ++T ++++  ALD  +G+ +L   E+ 
Sbjct: 65  LLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLE--EKN 122

Query: 220 VIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLT 279
            ++RD    N+L++ D  AK+SDFGLAK+     Q   S ++     + APE +     +
Sbjct: 123 FVHRDLAARNVLVSEDLVAKVSDFGLAKE---ASQGQDSGKL--PVKWTAPEALREKKFS 177

Query: 280 ARSDVYGFGVVLLEM 294
            +SDV+ FG++L E+
Sbjct: 178 TKSDVWSFGILLWEI 192

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score =  116 bits (293), Expect = 1e-29
 Identities = 66/202 (32%), Positives = 93/202 (46%), Gaps = 13/202 (6%)

Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNR-GGYQGDREWLAEVNYLGQLRHSNLV 158
           LGEG FG V     D           VA+K LN  G  Q   ++  E+  L  L H N+V
Sbjct: 12  LGEGHFGKVELCRYDPL--GDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIV 69

Query: 159 KLIGYCCEDEHRI---LVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHG 215
           K  G  CE        L+ EY+ SGSL +  L+R    +   R +  +    KG+ +L  
Sbjct: 70  KYKG-VCEKPGGRSLRLIMEYLPSGSL-RDYLQRHRDQINLKRLLLFSSQICKGMDYLG- 126

Query: 216 AERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVST--RVMGTYGYAAPEYV 273
             +  I+RD    NIL+ ++   K+SDFGLAK  P     +          + Y APE +
Sbjct: 127 -SQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWY-APECL 184

Query: 274 MTGHLTARSDVYGFGVVLLEML 295
            T   ++ SDV+ FGV L E+ 
Sbjct: 185 RTSKFSSASDVWSFGVTLYELF 206

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score =  116 bits (292), Expect = 1e-29
 Identities = 80/287 (27%), Positives = 125/287 (43%), Gaps = 34/287 (11%)

Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDRE-WLAEVNYLGQLRHSNLV 158
           LGEG FG V+ G    ++ P      VA+K L        R+ +  E   L   +H N+V
Sbjct: 13  LGEGAFGKVFLGEC-YHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIV 71

Query: 159 KLIGYCCEDEHRILVYEYMESGSLEKHL------LRRVGCM------LTWSRRMKIALDA 206
           K  G C E +  I+V+EYME G L K L         +         LT S+ ++IA+  
Sbjct: 72  KFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQI 131

Query: 207 AKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYG 266
           A G+ +L  A +  ++RD  T N L+  D   K+ DFG+++D    D   V    M    
Sbjct: 132 ASGMVYL--ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIR 189

Query: 267 YAAPEYVMTGHLTARSDVYGFGVVLLEML-LGRRAVDKSRPSREHNLVEWARPLLNNNKK 325
           +  PE +M    T  SDV+ FGVVL E+   G+      +P               +N++
Sbjct: 190 WMPPESIMYRKFTTESDVWSFGVVLWEIFTYGK------QPWYGL-----------SNEE 232

Query: 326 VLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLE 372
           V+  +      Q       +V  +   C  ++P+ R  + D+   L+
Sbjct: 233 VIECITQGRLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  116 bits (290), Expect = 1e-28
 Identities = 80/289 (27%), Positives = 122/289 (42%), Gaps = 29/289 (10%)

Query: 94  FRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREW---LAEVNYLG 150
           +R    LGEG FG VY                VA+K L +      +E    L E+  L 
Sbjct: 2   YRILRKLGEGSFGEVYLA---------RDRKLVALKVLAKKLESKSKEVERFLREIQILA 52

Query: 151 QLRH-SNLVKLIGYCCEDEHRILVYEYMESGSLEKHL-LRRVGCMLTWSRRMKIALDAAK 208
            L H  N+VKL  +  ++    LV EY++ GSLE  L        L+ S  + I      
Sbjct: 53  SLNHPPNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILS 112

Query: 209 GLAFLHGAERPVIYRDFKTSNILLNAD-FSAKLSDFGLAK----DGPMGDQTHVSTRVMG 263
            L +LH   + +I+RD K  NILL+ D    KL DFGLAK     G       + +  +G
Sbjct: 113 ALEYLH--SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVG 170

Query: 264 TYGYAAPEYVM---TGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLL 320
           T GY APE ++     + ++ SD++  G+ L E+L G    +  + S   +       L 
Sbjct: 171 TPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQT-----LK 225

Query: 321 NNNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVA 369
              +     L   L        +   + L  + L+++PK R   S  ++
Sbjct: 226 IILELPTPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLS 274

Length = 384

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score =  113 bits (285), Expect = 1e-28
 Identities = 82/287 (28%), Positives = 132/287 (45%), Gaps = 47/287 (16%)

Query: 99  ILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDR-EWLAEVNYLGQLRHSNL 157
           ++G G FG V +G +     PG K   VAIK L  G     R ++L E + +GQ  H N+
Sbjct: 11  VIGGGEFGEVCRGRLKL---PGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNI 67

Query: 158 VKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAE 217
           ++L G   +    +++ EYME+GSL+K L    G   T  + + +    A G+ +L  +E
Sbjct: 68  IRLEGVVTKSRPVMIITEYMENGSLDKFLRENDG-KFTVGQLVGMLRGIASGMKYL--SE 124

Query: 218 RPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYG------YAAPE 271
              ++RD    NIL+N++   K+SDFGL++     + T+       T G      + APE
Sbjct: 125 MNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYT------TKGGKIPIRWTAPE 178

Query: 272 YVMTGHLTARSDVYGFGVVLLE-MLLGRRAVDKSRPSREHNLVEWARPLLN-NNKKVLRI 329
            +     T+ SDV+ FG+V+ E M  G                   RP  + +N+ V++ 
Sbjct: 179 AIAYRKFTSASDVWSFGIVMWEVMSYGE------------------RPYWDMSNQDVIK- 219

Query: 330 LDPRLEGQYTARTAMKVAGLAYQ----CLSQNPKGRPVMSDVVALLE 372
               +E  Y     M      YQ    C  ++   RP  S +V+ L+
Sbjct: 220 ---AVEDGYRLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLD 263

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score =  112 bits (283), Expect = 3e-28
 Identities = 62/205 (30%), Positives = 103/205 (50%), Gaps = 12/205 (5%)

Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDR-EWLAEVNYLGQLRHSNLV 158
           LG+G FG+VY+G+    V  G   T VAIK +N      +R E+L E + + +    ++V
Sbjct: 14  LGQGSFGMVYEGLAK-GVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVV 72

Query: 159 KLIGYCCEDEHRILVYEYMESGSLEKHLLRR--------VGCMLTWSRRMKIALDAAKGL 210
           +L+G     +  ++V E M  G L+ +L  R             T  + +++A + A G+
Sbjct: 73  RLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGM 132

Query: 211 AFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAP 270
           A+L  A +  ++RD    N ++  D + K+ DFG+ +D    D      + +    + AP
Sbjct: 133 AYL--AAKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 190

Query: 271 EYVMTGHLTARSDVYGFGVVLLEML 295
           E +  G  T +SDV+ FGVVL EM 
Sbjct: 191 ESLKDGVFTTKSDVWSFGVVLWEMA 215

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score =  111 bits (280), Expect = 8e-28
 Identities = 65/210 (30%), Positives = 102/210 (48%), Gaps = 18/210 (8%)

Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDR-EWLAEVNYLGQLRHSNLV 158
           LGEG FG VYKG +          T VAIK L        + E+  E   +  L+H N+V
Sbjct: 13  LGEGAFGKVYKGEL-TGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIV 71

Query: 159 KLIGYCCEDEHRILVYEYMESGSLEKHLLRR-----VGC---------MLTWSRRMKIAL 204
            L+G C +++   +++EY+  G L + L+R      VG           L  S  + IA+
Sbjct: 72  CLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAI 131

Query: 205 DAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGT 264
             A G+ +L  +    ++RD    N L+    + K+SDFGL++D    D   V ++ +  
Sbjct: 132 QIAAGMEYL--SSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLP 189

Query: 265 YGYAAPEYVMTGHLTARSDVYGFGVVLLEM 294
             +  PE ++ G  T  SD++ FGVVL E+
Sbjct: 190 VRWMPPEAILYGKFTTESDIWSFGVVLWEI 219

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score =  109 bits (275), Expect = 2e-27
 Identities = 68/205 (33%), Positives = 93/205 (45%), Gaps = 21/205 (10%)

Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGG---YQGDREWLAEVNYLGQLRHSN 156
           LG+G FG V   V  ++    Y     A+K L +      +     L E N L ++ H  
Sbjct: 1   LGKGSFGKVLL-VRKKDTGKLY-----AMKVLKKKKIIKRKEVEHTLTERNILSRINHPF 54

Query: 157 LVKLIGYCC--EDEHRILVYEYMESGSLEKHLLRRVGCML-TWSRRMKIALDAAKGLAFL 213
           +VKL  +     +E   LV EY   G L  HL  + G      +R    A +    L +L
Sbjct: 55  IVKL--HYAFQTEEKLYLVLEYAPGGELFSHL-SKEGRFSEERARF--YAAEIVLALEYL 109

Query: 214 HGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYV 273
           H     +IYRD K  NILL+AD   KL+DFGLAK+         +T   GT  Y APE +
Sbjct: 110 H--SLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSR-TNTFC-GTPEYLAPEVL 165

Query: 274 MTGHLTARSDVYGFGVVLLEMLLGR 298
           +        D +  GV+L EML G+
Sbjct: 166 LGKGYGKAVDWWSLGVLLYEMLTGK 190

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score =  109 bits (275), Expect = 2e-27
 Identities = 76/276 (27%), Positives = 131/276 (47%), Gaps = 32/276 (11%)

Query: 98  YILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELN-RGGYQGDR-EWLAEVNYLGQLRHS 155
             +G+G FGVV+K V     R   K  + A+K+++     + +R E + E   L +L  S
Sbjct: 6   NKIGKGSFGVVFKVV-----RKADKRVY-AMKQIDLSKMNRREREEAIDEARVLAKLDSS 59

Query: 156 NLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHG 215
            +++      +     +V EY E+G L K L  + G  L   +  +  +    GLA LH 
Sbjct: 60  YIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLH- 118

Query: 216 AERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMT 275
             + +++RD K+ N+ L+A  + K+ D G+AK   + D T+ +  ++GT  Y +PE    
Sbjct: 119 -SKKILHRDIKSLNLFLDAYDNVKIGDLGVAK--LLSDNTNFANTIVGTPYYLSPELCED 175

Query: 276 GHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRILDPRLE 335
                +SDV+  GVVL E   G+   D    + +  L+           K++R + P + 
Sbjct: 176 KPYNEKSDVWALGVVLYECCTGKHPFDA---NNQGALI----------LKIIRGVFPPVS 222

Query: 336 GQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALL 371
             Y+     ++A L  QCL+++ + RP   D   LL
Sbjct: 223 QMYSQ----QLAQLIDQCLTKDYRQRP---DTFQLL 251

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score =  108 bits (270), Expect = 1e-26
 Identities = 86/277 (31%), Positives = 127/277 (45%), Gaps = 33/277 (11%)

Query: 99  ILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGY-QGDREWLAEVNYLGQLRHSNL 157
            LG G FG VY+G   + + PG     VA+K L +G   Q  +E+L E + +    H N+
Sbjct: 2   FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNI 61

Query: 158 VKLIGYCCEDEHRILVYEYMESGSLEKHLLRRV------GCMLTWSRRMKIALDAAKGLA 211
           VKL+G C  +E + ++ E ME G L    LR          +LT    + I LD AKG  
Sbjct: 62  VKLLGVCLLNEPQYIIMELMEGGDL-LSYLRDARVERFGPPLLTLKELLDICLDVAKGCV 120

Query: 212 FLHGAERPVIYRDFKTSNILL-----NADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYG 266
           +L   +   I+RD    N L+     +AD   K+ DFGLA+D    D        +    
Sbjct: 121 YLE--QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVR 178

Query: 267 YAAPEYVMTGHLTARSDVYGFGVVLLEML-LGRRAVDKSRPSREHNLVEWARPLLNNNKK 325
           + APE ++ G  T +SDV+ FGV++ E+L LG+      +P    N  E    +L +   
Sbjct: 179 WMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQ------QPYPALNNQE----VLQHVTA 228

Query: 326 VLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRP 362
             R+  P            K+  L   C +Q+P  RP
Sbjct: 229 GGRLQKPE-------NCPDKIYQLMTNCWAQDPSERP 258

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score =  106 bits (267), Expect = 2e-26
 Identities = 83/281 (29%), Positives = 141/281 (50%), Gaps = 34/281 (12%)

Query: 99  ILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDR-EWLAEVNYLGQLRHSNL 157
           ++G G FG V++G++     PG K   VAIK L  G  +  R ++L+E + +GQ  H N+
Sbjct: 12  VIGAGEFGEVFRGILK---MPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNI 68

Query: 158 VKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAE 217
           ++L G   + +  +++ EYME+G+L+K+L    G   +  + + +    A G+ +L  ++
Sbjct: 69  IRLEGVVTKFKPAMIITEYMENGALDKYLRDHDG-EFSSYQLVGMLRGIAAGMKYL--SD 125

Query: 218 RPVIYRDFKTSNILLNADFSAKLSDFGLAK---DGPMGDQTHVSTRVMGTYGYAAPEYVM 274
              ++RD    NIL+N++   K+SDFGL++   D P G  T    ++     + APE + 
Sbjct: 126 MNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKI--PIRWTAPEAIA 183

Query: 275 TGHLTARSDVYGFGVVLLE-MLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRILDP- 332
               T+ SDV+ FG+V+ E M  G R               W      +N +V++ ++  
Sbjct: 184 YRKFTSASDVWSFGIVMWEVMSFGERPY-------------WDM----SNHEVMKAINDG 226

Query: 333 -RLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLE 372
            RL       +A  V  L  QC  Q+   RP   D+V LL+
Sbjct: 227 FRLPAPMDCPSA--VYQLMLQCWQQDRARRPRFVDIVNLLD 265

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score =  106 bits (266), Expect = 5e-26
 Identities = 86/301 (28%), Positives = 128/301 (42%), Gaps = 46/301 (15%)

Query: 97  DYILGEGGFGVVYKGVIDE-NVRPGYKTTFVAIKELNRGGYQGD-REWLAEVNYLGQLRH 154
              LGEG FG V K        R GY T  VA+K L       + R+ L+E N L Q+ H
Sbjct: 5   GKTLGEGEFGKVVKATAFRLKGRAGYTT--VAVKMLKENASSSELRDLLSEFNLLKQVNH 62

Query: 155 SNLVKLIGYCCEDEHRILVYEYMESGSLEKHLL--RRVGC-------------------- 192
            +++KL G C +D   +L+ EY + GSL   L   R+VG                     
Sbjct: 63  PHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDER 122

Query: 193 MLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMG 252
            LT    +  A   ++G+ +L  AE  +++RD    N+L+      K+SDFGL++D    
Sbjct: 123 ALTMGDLISFAWQISRGMQYL--AEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEE 180

Query: 253 DQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEML-LGRRAVDKSRPSREHN 311
           D     ++      + A E +     T +SDV+ FGV+L E++ LG        P R  N
Sbjct: 181 DSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPERLFN 240

Query: 312 LVEWARPLLNNNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALL 371
           L+          K   R+  P          + ++  L   C  Q P  RP  +D+   L
Sbjct: 241 LL----------KTGYRMERPE-------NCSEEMYNLMLTCWKQEPDKRPTFADISKEL 283

Query: 372 E 372
           E
Sbjct: 284 E 284

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  105 bits (264), Expect = 1e-25
 Identities = 67/205 (32%), Positives = 105/205 (51%), Gaps = 22/205 (10%)

Query: 100 LGEGGFGVVYKGVIDENVRPGYKTT--FVAIKELNRGG-YQGDREWLAEVNYLGQLRHSN 156
           LG+G  GVVYK          +K T    A+K+++  G  +  ++ L E+  L       
Sbjct: 9   LGQGSSGVVYKVR--------HKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPY 60

Query: 157 LVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRM--KIALDAAKGLAFLH 214
           +VK  G   ++    +V EYM+ GSL   LL++VG        +   IA    KGL +LH
Sbjct: 61  VVKCYGAFYKEGEISIVLEYMDGGSLAD-LLKKVGK---IPEPVLAYIARQILKGLDYLH 116

Query: 215 GAERPVIYRDFKTSNILLNADFSAKLSDFGLAKD-GPMGDQTHVSTRVMGTYGYAAPEYV 273
             +R +I+RD K SN+L+N+    K++DFG++K      DQ +  T V GT  Y +PE +
Sbjct: 117 -TKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCN--TFV-GTVTYMSPERI 172

Query: 274 MTGHLTARSDVYGFGVVLLEMLLGR 298
                +  +D++  G+ LLE  LG+
Sbjct: 173 QGESYSYAADIWSLGLTLLECALGK 197

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score =  104 bits (262), Expect = 1e-25
 Identities = 66/195 (33%), Positives = 101/195 (51%), Gaps = 11/195 (5%)

Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVK 159
           LG G FG V++G+    VR       VAIK L        +++  EV  L +LRH +L+ 
Sbjct: 14  LGSGYFGEVWEGLWKNRVR-------VAIKILKSDDLLKQQDFQKEVQALKRLRHKHLIS 66

Query: 160 LIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERP 219
           L   C   E   ++ E ME GSL   L    G +L  +  + +A   A+G+A+L   E+ 
Sbjct: 67  LFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLE--EQN 124

Query: 220 VIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLT 279
            I+RD    NIL+  D   K++DFGLA+   + +  ++S+     Y + APE    G  +
Sbjct: 125 SIHRDLAARNILVGEDLVCKVADFGLAR--LIKEDVYLSSDKKIPYKWTAPEAASHGTFS 182

Query: 280 ARSDVYGFGVVLLEM 294
            +SDV+ FG++L EM
Sbjct: 183 TKSDVWSFGILLYEM 197

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score =  109 bits (275), Expect = 2e-25
 Identities = 85/281 (30%), Positives = 137/281 (48%), Gaps = 27/281 (9%)

Query: 99  ILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLV 158
           ++  G  G  YKG   +N        FV +KE+N      +    +E+  +G+L+H N+V
Sbjct: 697 VISRGKKGASYKGKSIKN-----GMQFV-VKEIN----DVNSIPSSEIADMGKLQHPNIV 746

Query: 159 KLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAER 218
           KLIG C  ++   L++EY+E  +L + L       L+W RR KIA+  AK L FLH    
Sbjct: 747 KLIGLCRSEKGAYLIHEYIEGKNLSEVLRN-----LSWERRRKIAIGIAKALRFLHCRCS 801

Query: 219 P-VIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGH 277
           P V+  +     I+++      L    L+  G +       T+   +  Y APE   T  
Sbjct: 802 PAVVVGNLSPEKIIIDGKDEPHLR---LSLPGLLC----TDTKCFISSAYVAPETRETKD 854

Query: 278 LTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRILDPRLEGQ 337
           +T +SD+YGFG++L+E+L G+   D        ++VEWAR   ++    + I DP + G 
Sbjct: 855 ITEKSDIYGFGLILIELLTGKSPADAEFGVHG-SIVEWARYCYSDCHLDMWI-DPSIRGD 912

Query: 338 YTA--RTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETVQS 376
            +      ++V  LA  C + +P  RP  +DV+  LE+   
Sbjct: 913 VSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASR 953

Length = 968

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score =  103 bits (259), Expect = 2e-25
 Identities = 64/195 (32%), Positives = 99/195 (50%), Gaps = 11/195 (5%)

Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDRE-WLAEVNYLGQLRHSNLV 158
           +G+G FG VYKGV+  N       T VA+K          +  +L E   L Q  H N+V
Sbjct: 3   IGKGNFGDVYKGVLKGN-------TEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIV 55

Query: 159 KLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAER 218
           KLIG C + +   +V E +  GSL    LR+    LT  + ++++LDAA G+ +L    +
Sbjct: 56  KLIGVCVQKQPIYIVMELVPGGSLLTF-LRKKKNRLTVKKLLQMSLDAAAGMEYLE--SK 112

Query: 219 PVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHL 278
             I+RD    N L+  +   K+SDFG++++   G  T           + APE +  G  
Sbjct: 113 NCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRY 172

Query: 279 TARSDVYGFGVVLLE 293
           T+ SDV+ +G++L E
Sbjct: 173 TSESDVWSYGILLWE 187

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score =  105 bits (262), Expect = 3e-25
 Identities = 80/303 (26%), Positives = 137/303 (45%), Gaps = 44/303 (14%)

Query: 100 LGEGGFGVVYKGVIDE-----------NVRPGYKTTFVAIKELNRGGYQGDR-EWLAEVN 147
           LGEG FG V+   +             NVR G +   VA+K L     +  R ++L EV 
Sbjct: 13  LGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKG-RPLLVAVKILRPDANKNARNDFLKEVK 71

Query: 148 YLGQLRHSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRV---------------GC 192
            L +L+  N+++L+G C +++   ++ EYME+G L + L                    C
Sbjct: 72  ILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHC 131

Query: 193 MLTWSRRM--KIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGP 250
           +   S      +AL  A G+ +L  +    ++RD  T N L+  + + K++DFG++++  
Sbjct: 132 LPAISYSSLLHVALQIASGMKYL--SSLNFVHRDLATRNCLVGENLTIKIADFGMSRNLY 189

Query: 251 MGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREH 310
            GD   +  R +    + A E ++ G  T  SDV+ FGV L E+L+  +       + E 
Sbjct: 190 AGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQPYGELTDE- 248

Query: 311 NLVEWARPLLNNNKKVLRILDPRL--EGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVV 368
            ++E A     +  + + +  P    +G Y          L  QC S++ + RP  SD+ 
Sbjct: 249 QVIENAGEFFRDQGRQVYLFRPPPCPQGLYE---------LMLQCWSRDCRERPSFSDIH 299

Query: 369 ALL 371
           A L
Sbjct: 300 AFL 302

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  103 bits (260), Expect = 3e-25
 Identities = 67/278 (24%), Positives = 117/278 (42%), Gaps = 43/278 (15%)

Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELN-RGGYQGDREW-LAEVNYLGQLRHSNL 157
           +G+G FG VY       VR         +KE++     + +RE  L EV  L +L H N+
Sbjct: 8   IGKGSFGKVYL------VRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNI 61

Query: 158 VKLIGYCCEDEHRILVYEYMESGSLEKHLLRR--VGCMLTWSRRMKIALDAAKGLAFLHG 215
           +K      E     +V EY + G L + + ++   G      + +   +     L +LH 
Sbjct: 62  IKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLH- 120

Query: 216 AERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPE---- 271
             R +++RD K  NI L ++   KL DFG++K   +     ++  V+GT  Y +PE    
Sbjct: 121 -SRKILHRDIKPQNIFLTSNGLVKLGDFGISKV--LSSTVDLAKTVVGTPYYLSPELCQN 177

Query: 272 --YVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRI 329
             Y        +SD++  G VL E+   +   +         L            K+L+ 
Sbjct: 178 KPY------NYKSDIWSLGCVLYELCTLKHPFEGENL---LELA----------LKILKG 218

Query: 330 LDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDV 367
             P +  QY++     +  L    L ++P+ RP ++ +
Sbjct: 219 QYPPIPSQYSSE----LRNLVSSLLQKDPEERPSIAQI 252

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score =  102 bits (256), Expect = 9e-25
 Identities = 74/276 (26%), Positives = 120/276 (43%), Gaps = 36/276 (13%)

Query: 100 LGEGGFGVV----YKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHS 155
           LG G FGVV    ++G ID           VAIK +  G    D +++ E   + +L H 
Sbjct: 12  LGSGQFGVVHLGKWRGKID-----------VAIKMIREGAMSED-DFIEEAKVMMKLSHP 59

Query: 156 NLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHG 215
           NLV+L G C +     +V EYM +G L  +L  R G  L     + +  D  + + +L  
Sbjct: 60  NLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKG-KLGTEWLLDMCSDVCEAMEYLE- 117

Query: 216 AERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMT 275
                I+RD    N L+  D   K+SDFGLA+   + DQ   S        +A PE    
Sbjct: 118 -SNGFIHRDLAARNCLVGEDNVVKVSDFGLAR-YVLDDQYTSSQGTKFPVKWAPPEVFDY 175

Query: 276 GHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRILDPRLE 335
              +++SDV+ FGV++ E+    +   +   + E         ++ +     R+  P+L 
Sbjct: 176 SRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSE---------VVESVSAGYRLYRPKL- 225

Query: 336 GQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALL 371
                    +V  + Y C  + P+ RP    +++ L
Sbjct: 226 ------APTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score =  103 bits (257), Expect = 1e-24
 Identities = 83/293 (28%), Positives = 129/293 (44%), Gaps = 25/293 (8%)

Query: 92  KFFRPDYILGEGGFGVVYKGVIDENVRPGYKTT--FVAIKELNRG-GYQGDREWLAEVNY 148
           ++ +   +LGEG FG V     D    P    T   VA+K L R  G Q    W  E+N 
Sbjct: 4   RYLKKIRVLGEGHFGKVSLYCYD----PANDGTGEMVAVKTLKRECGQQNTSGWKKEINI 59

Query: 149 LGQLRHSNLVKLIGYCCEDEHR---ILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALD 205
           L  L H N+VK  G CC ++      L+ EY+  GSL  +L +     L  ++ +  A  
Sbjct: 60  LKTLYHENIVKYKG-CCSEQGGKGLQLIMEYVPLGSLRDYLPKH---KLNLAQLLLFAQQ 115

Query: 206 AAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTH-VSTRVMGT 264
             +G+A+LH   +  I+RD    N+LL+ D   K+ DFGLAK  P G + + V       
Sbjct: 116 ICEGMAYLHS--QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSP 173

Query: 265 YGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNK 324
             + A E +     +  SDV+ FGV L E LL      +S P +   ++   +  +    
Sbjct: 174 VFWYAVECLKENKFSYASDVWSFGVTLYE-LLTHCDSKQSPPKKFEEMIGPKQGQMT--- 229

Query: 325 KVLRILDPRLEGQYTAR---TAMKVAGLAYQCLSQNPKGRPVMSDVVALLETV 374
            V+R+++    G           +V  L   C     K RP    ++ +L+ +
Sbjct: 230 -VVRLIELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEM 281

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score =  100 bits (251), Expect = 5e-24
 Identities = 61/209 (29%), Positives = 93/209 (44%), Gaps = 16/209 (7%)

Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVK 159
           LGEG FG V+      N+ P      VA+K L        +++  E   L  L+H ++V+
Sbjct: 13  LGEGAFGKVFLAEC-HNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVR 71

Query: 160 LIGYCCEDEHRILVYEYMESGSLEK---------HLL---RRVGC-MLTWSRRMKIALDA 206
             G C E    ++V+EYM  G L +          +L     V    LT  + + IA   
Sbjct: 72  FYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQI 131

Query: 207 AKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYG 266
           A G+ +L       ++RD  T N L+      K+ DFG+++D    D   V  R M    
Sbjct: 132 ASGMVYLASLH--FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 189

Query: 267 YAAPEYVMTGHLTARSDVYGFGVVLLEML 295
           +  PE ++    T  SD++ FGVVL E+ 
Sbjct: 190 WMPPESILYRKFTTESDIWSFGVVLWEIF 218

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score =  100 bits (250), Expect = 9e-24
 Identities = 61/205 (29%), Positives = 95/205 (46%), Gaps = 21/205 (10%)

Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQG--DREWLAEVNYLGQLRHSNL 157
           +GEG +GVVYK     +   G     VAIK++          +  L E+  L +L H N+
Sbjct: 7   IGEGTYGVVYKA---RDKLTG---EIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNI 60

Query: 158 VKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAE 217
           +KL+          LV+E+M++      L++     L  S          +GLAF H   
Sbjct: 61  IKLLDVFRHKGDLYLVFEFMDTDL--YKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHG 118

Query: 218 RPVIYRDFKTSNILLNADFSAKLSDFGLAK--DGPMGDQTH-VSTRVMGTYGYAAPEYVM 274
             +++RD K  N+L+N +   KL+DFGLA+    P+   TH V TR      Y APE ++
Sbjct: 119 --ILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTR-----WYRAPELLL 171

Query: 275 T-GHLTARSDVYGFGVVLLEMLLGR 298
                +   D++  G +  E+L  R
Sbjct: 172 GDKGYSTPVDIWSVGCIFAELLSRR 196

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 99.6 bits (248), Expect = 1e-23
 Identities = 77/266 (28%), Positives = 125/266 (46%), Gaps = 28/266 (10%)

Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVK 159
           +G G FG+V+ G   E  +       VAIK + R G   + +++ E   + +L H  LV+
Sbjct: 12  IGSGQFGLVWLGYWLEKRK-------VAIKTI-REGAMSEEDFIEEAQVMMKLSHPKLVQ 63

Query: 160 LIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERP 219
           L G C E     LV+E+ME G L  +L  + G   +    + + LD  +G+A+L      
Sbjct: 64  LYGVCTERSPICLVFEFMEHGCLSDYLRAQRG-KFSQETLLGMCLDVCEGMAYLE--SSN 120

Query: 220 VIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLT 279
           VI+RD    N L+  +   K+SDFG+ +   + DQ   ST       +++PE       +
Sbjct: 121 VIHRDLAARNCLVGENQVVKVSDFGMTR-FVLDDQYTSSTGTKFPVKWSSPEVFSFSKYS 179

Query: 280 ARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRILDPRLEGQYT 339
           ++SDV+ FGV++ E+    +   ++R + E  +VE     +N      R+  PRL  Q  
Sbjct: 180 SKSDVWSFGVLMWEVFSEGKTPYENRSNSE--VVE----TINAG---FRLYKPRLASQS- 229

Query: 340 ARTAMKVAGLAYQCLSQNPKGRPVMS 365
                 V  L   C  + P+ RP  S
Sbjct: 230 ------VYELMQHCWKERPEDRPSFS 249

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 99.1 bits (247), Expect = 1e-23
 Identities = 73/280 (26%), Positives = 127/280 (45%), Gaps = 33/280 (11%)

Query: 94  FRPDYILGEGGFG--VVYKGVIDENVRPGYKTTFVAIKELN--RGGYQGDREWLAEVNYL 149
           + P  +LG+G FG   +Y+   D+++        V  KE+N  R   +  R+ L E+  L
Sbjct: 2   YIPIRVLGKGAFGEATLYRRTEDDSL--------VVWKEVNLTRLSEKERRDALNEIVIL 53

Query: 150 GQLRHSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKG 209
             L+H N++    +  +D   ++  EY   G+L   ++R+ G +      +         
Sbjct: 54  SLLQHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSA 113

Query: 210 LAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAA 269
           ++++H A   +++RD KT NI L      KL DFG++K   +G +  ++  V+GT  Y +
Sbjct: 114 VSYIHKAG--ILHRDIKTLNIFLTKAGLIKLGDFGISKI--LGSEYSMAETVVGTPYYMS 169

Query: 270 PEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRI 329
           PE         +SD++  G VL E+L  +R  D + P    NLV          K V   
Sbjct: 170 PELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPL---NLV---------VKIVQGN 217

Query: 330 LDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVA 369
             P +   Y++        L +  L Q+P+ RP   +V+ 
Sbjct: 218 YTPVVSV-YSSELIS----LVHSLLQQDPEKRPTADEVLD 252

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 99.0 bits (247), Expect = 2e-23
 Identities = 63/199 (31%), Positives = 90/199 (45%), Gaps = 12/199 (6%)

Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGD-REWLAEVNYLGQLRHSNLV 158
           LG+G FGVV +G   E    G K   VA+K L          ++L E   +  L H NL+
Sbjct: 3   LGDGSFGVVRRG---EWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLI 59

Query: 159 KLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAER 218
           +L G        ++V E    GSL   L +        S     A+  A G+ +L    +
Sbjct: 60  RLYGVVL-THPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLE--SK 116

Query: 219 PVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVST---RVMGTYGYAAPEYVMT 275
             I+RD    NILL +D   K+ DFGL +  P  +  +V     +V   + + APE + T
Sbjct: 117 RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKV--PFAWCAPESLRT 174

Query: 276 GHLTARSDVYGFGVVLLEM 294
              +  SDV+ FGV L EM
Sbjct: 175 RTFSHASDVWMFGVTLWEM 193

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 99.7 bits (249), Expect = 2e-23
 Identities = 65/224 (29%), Positives = 103/224 (45%), Gaps = 29/224 (12%)

Query: 100 LGEGGFGVVYKGVIDENVRPGYKT-------------TFVAIKELNRGGYQGDR-EWLAE 145
           LGEG FG V+   + E       +               VA+K L        R ++L E
Sbjct: 13  LGEGQFGEVH---LCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKE 69

Query: 146 VNYLGQLRHSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGC---------MLTW 196
           V  L +L   N+ +L+G C  D    ++ EYME+G L + L + V            L++
Sbjct: 70  VKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSF 129

Query: 197 SRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTH 256
           S  + +A   A G+ +L       ++RD  T N L+  +++ K++DFG++++    D   
Sbjct: 130 STLLYMATQIASGMRYL--ESLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYR 187

Query: 257 VSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEML-LGRR 299
           V  R      + A E V+ G  T +SDV+ FGV L E+L L R 
Sbjct: 188 VQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCRE 231

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 99.0 bits (247), Expect = 3e-23
 Identities = 61/224 (27%), Positives = 109/224 (48%), Gaps = 20/224 (8%)

Query: 99  ILGEGGFGVVYKGV-IDENVRPGYKTTFVAIKEL-NRGGYQGDREWLAEVNYLGQLRHSN 156
           +LG G FG VYKGV I E  +       VAIK L      + ++E L E   +  + H +
Sbjct: 14  VLGSGAFGTVYKGVWIPEGEKVKIP---VAIKVLREETSPKANKEILDEAYVMASVDHPH 70

Query: 157 LVKLIGYCCEDEHRILVYEYMESGSLEKHLLR---RVGC--MLTWSRRMKIALDAAKGLA 211
           +V+L+G C   + + L+ + M  G L  ++      +G   +L W  ++      AKG++
Sbjct: 71  VVRLLGICLSSQVQ-LITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQI------AKGMS 123

Query: 212 FLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPE 271
           +L   E+ +++RD    N+L+      K++DFGLAK   + ++ + +        + A E
Sbjct: 124 YLE--EKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALE 181

Query: 272 YVMTGHLTARSDVYGFGVVLLE-MLLGRRAVDKSRPSREHNLVE 314
            ++    T +SDV+ +GV + E M  G +  +        +L+E
Sbjct: 182 SILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLE 225

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 98.4 bits (245), Expect = 3e-23
 Identities = 66/209 (31%), Positives = 114/209 (54%), Gaps = 17/209 (8%)

Query: 99  ILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGY--QGDREWLAEVNYLGQLRHSN 156
           ++G G FG V +G +     PG +  FVAIK L + GY  +  R++L+E + +GQ  H N
Sbjct: 11  VIGAGEFGEVCRGRLKL---PGKREIFVAIKTL-KSGYTEKQRRDFLSEASIMGQFDHPN 66

Query: 157 LVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGA 216
           ++ L G   +    +++ E+ME+G+L+   LR+     T  + + +    A G+ +L  +
Sbjct: 67  IIHLEGVVTKSRPVMIITEFMENGALDS-FLRQNDGQFTVIQLVGMLRGIAAGMKYL--S 123

Query: 217 ERPVIYRDFKTSNILLNADFSAKLSDFGLAK--DGPMGDQTHVSTRVMG---TYGYAAPE 271
           E   ++RD    NIL+N++   K+SDFGL++  +    D T+ S+  +G      + APE
Sbjct: 124 EMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSS--LGGKIPIRWTAPE 181

Query: 272 YVMTGHLTARSDVYGFGVVLLE-MLLGRR 299
            +     T+ SDV+ +G+V+ E M  G R
Sbjct: 182 AIAYRKFTSASDVWSYGIVMWEVMSYGER 210

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score = 98.2 bits (245), Expect = 3e-23
 Identities = 69/203 (33%), Positives = 101/203 (49%), Gaps = 18/203 (8%)

Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVK 159
           LG G FG V+ G  +        TT VA+K L  G    +  +L E   + +LRH  LV+
Sbjct: 14  LGAGQFGEVWMGTWN-------GTTKVAVKTLKPGTMSPE-AFLQEAQIMKKLRHDKLVQ 65

Query: 160 LIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERP 219
           L   C E+E   +V EYM  GSL   L    G  L   + + +A   A+G+A+L    R 
Sbjct: 66  LYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLE--SRN 123

Query: 220 VIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGT---YGYAAPEYVMTG 276
            I+RD    NIL+  +   K++DFGLA+   + +    + R  G      + APE    G
Sbjct: 124 YIHRDLAARNILVGENLVCKIADFGLAR---LIEDDEYTAR-EGAKFPIKWTAPEAANYG 179

Query: 277 HLTARSDVYGFGVVLLEML-LGR 298
             T +SDV+ FG++L E++  GR
Sbjct: 180 RFTIKSDVWSFGILLTEIVTYGR 202

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 98.4 bits (246), Expect = 5e-23
 Identities = 65/208 (31%), Positives = 103/208 (49%), Gaps = 24/208 (11%)

Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLA-----EVNYLGQLRH 154
           LGEG + VVYK    E  R       VAIK++  G  +  ++ +      E+  L +L+H
Sbjct: 8   LGEGTYAVVYKARDKETGRI------VAIKKIKLGERKEAKDGINFTALREIKLLQELKH 61

Query: 155 SNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLH 214
            N++ L+       +  LV+E+ME+  LEK +++    +LT +      L   +GL +LH
Sbjct: 62  PNIIGLLDVFGHKSNINLVFEFMET-DLEK-VIKDKSIVLTPADIKSYMLMTLRGLEYLH 119

Query: 215 GAERPVIYRDFKTSNILLNADFSAKLSDFGLAKD--GPMGDQTH-VSTRVMGTYGYAAPE 271
                +++RD K +N+L+ +D   KL+DFGLA+    P    TH V TR      Y APE
Sbjct: 120 --SNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVVTRW-----YRAPE 172

Query: 272 YVM-TGHLTARSDVYGFGVVLLEMLLGR 298
            +    H     D++  G +  E+LL  
Sbjct: 173 LLFGARHYGVGVDMWSVGCIFAELLLRV 200

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 97.5 bits (243), Expect = 5e-23
 Identities = 60/196 (30%), Positives = 98/196 (50%), Gaps = 11/196 (5%)

Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVK 159
           LG G FG V++G+ +        TT VA+K L  G      ++LAE   + +LRH  L++
Sbjct: 14  LGAGQFGEVWEGLWN-------NTTPVAVKTLKPGTMDPK-DFLAEAQIMKKLRHPKLIQ 65

Query: 160 LIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERP 219
           L   C  +E   +V E M+ GSL ++L    G  L   + + +A   A G+A+L    + 
Sbjct: 66  LYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLE--AQN 123

Query: 220 VIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLT 279
            I+RD    N+L+  +   K++DFGLA+     D             + APE  +    +
Sbjct: 124 YIHRDLAARNVLVGENNICKVADFGLARV-IKEDIYEAREGAKFPIKWTAPEAALYNRFS 182

Query: 280 ARSDVYGFGVVLLEML 295
            +SDV+ FG++L E++
Sbjct: 183 IKSDVWSFGILLTEIV 198

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score = 97.9 bits (245), Expect = 6e-23
 Identities = 66/217 (30%), Positives = 103/217 (47%), Gaps = 43/217 (19%)

Query: 99  ILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGD---REWLAEVNYLGQLRHS 155
            LGEG +GVVYK   D+          VA+K++ R   + +      L E++ L +L+H 
Sbjct: 6   KLGEGTYGVVYKA-RDKK-----TGEIVALKKI-RLDNEEEGIPSTALREISLLKELKHP 58

Query: 156 NLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAA-------- 207
           N+VKL+     +    LV+EY +   L+K+L            +    L           
Sbjct: 59  NIVKLLDVIHTERKLYLVFEYCDM-DLKKYL-----------DKRPGPLSPNLIKSIMYQ 106

Query: 208 --KGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKD--GPMGDQTHVSTRVMG 263
             +GLA+ H     +++RD K  NIL+N D   KL+DFGLA+    P+   TH    V+ 
Sbjct: 107 LLRGLAYCH--SHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTH---EVV- 160

Query: 264 TYGYAAPEYVM--TGHLTARSDVYGFGVVLLEMLLGR 298
           T  Y APE ++    + TA  D++  G +  EM+ G+
Sbjct: 161 TLWYRAPEILLGSKHYSTA-VDIWSVGCIFAEMITGK 196

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score = 97.7 bits (244), Expect = 6e-23
 Identities = 58/199 (29%), Positives = 94/199 (47%), Gaps = 14/199 (7%)

Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVK 159
           +GEG  G VYK     +   G +   VAIK++     Q     + E+  +   +H N+V 
Sbjct: 27  IGEGASGEVYKAT---DRATGKE---VAIKKMRLRK-QNKELIINEILIMKDCKHPNIVD 79

Query: 160 LIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERP 219
                   +   +V EYM+ GSL   ++ +    +   +   +  +  +GL +LH   + 
Sbjct: 80  YYDSYLVGDELWVVMEYMDGGSLTD-IITQNFVRMNEPQIAYVCREVLQGLEYLHS--QN 136

Query: 220 VIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHL- 278
           VI+RD K+ NILL+ D S KL+DFG A           S  V+GT  + APE V+     
Sbjct: 137 VIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNS--VVGTPYWMAPE-VIKRKDY 193

Query: 279 TARSDVYGFGVVLLEMLLG 297
             + D++  G++ +EM  G
Sbjct: 194 GPKVDIWSLGIMCIEMAEG 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 97.8 bits (243), Expect = 8e-23
 Identities = 67/208 (32%), Positives = 97/208 (46%), Gaps = 16/208 (7%)

Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVK 159
           LGEG FG V+      N+ P      VA+K L        +++  E   L  L+H ++VK
Sbjct: 13  LGEGAFGKVFLAEC-YNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVK 71

Query: 160 LIGYCCEDEHRILVYEYMESGSLEKHLLRRVG------------CMLTWSRRMKIALDAA 207
             G C E +  I+V+EYM+ G L K  LR  G              LT S+ + IA   A
Sbjct: 72  FYGVCVEGDPLIMVFEYMKHGDLNK-FLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIA 130

Query: 208 KGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGY 267
            G+ +L  A +  ++RD  T N L+  +   K+ DFG+++D    D   V    M    +
Sbjct: 131 AGMVYL--ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRW 188

Query: 268 AAPEYVMTGHLTARSDVYGFGVVLLEML 295
             PE +M    T  SDV+  GVVL E+ 
Sbjct: 189 MPPESIMYRKFTTESDVWSLGVVLWEIF 216

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 97.8 bits (243), Expect = 8e-23
 Identities = 65/210 (30%), Positives = 98/210 (46%), Gaps = 17/210 (8%)

Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVK 159
           LGEG FG V+      N+ P      VA+K L        +++  E   L  L+H ++VK
Sbjct: 13  LGEGAFGKVFLAEC-YNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVK 71

Query: 160 LIGYCCEDEHRILVYEYMESGSLEKHLL--------------RRVGCMLTWSRRMKIALD 205
             G C + +  I+V+EYM+ G L K L               R+    L  S+ + IA  
Sbjct: 72  FYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQ 131

Query: 206 AAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTY 265
            A G+ +L  A +  ++RD  T N L+ A+   K+ DFG+++D    D   V    M   
Sbjct: 132 IASGMVYL--ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI 189

Query: 266 GYAAPEYVMTGHLTARSDVYGFGVVLLEML 295
            +  PE +M    T  SDV+ FGV+L E+ 
Sbjct: 190 RWMPPESIMYRKFTTESDVWSFGVILWEIF 219

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 96.8 bits (241), Expect = 1e-22
 Identities = 65/198 (32%), Positives = 107/198 (54%), Gaps = 16/198 (8%)

Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVK 159
           LG G FG V+ G  + + +       VAIK L +G    +  +LAE N + QL+H  LV+
Sbjct: 14  LGAGQFGEVWMGYYNGHTK-------VAIKSLKQGSMSPE-AFLAEANLMKQLQHPRLVR 65

Query: 160 LIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERP 219
           L     + E   ++ EYME+GSL   L    G  LT ++ + +A   A+G+AF+    + 
Sbjct: 66  LYAVVTQ-EPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIE--RKN 122

Query: 220 VIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTY--GYAAPEYVMTGH 277
            I+RD + +NIL++     K++DFGLA+   + +    + R    +   + APE +  G 
Sbjct: 123 YIHRDLRAANILVSETLCCKIADFGLAR---LIEDNEYTAREGAKFPIKWTAPEAINYGT 179

Query: 278 LTARSDVYGFGVVLLEML 295
            T +SDV+ FG++L E++
Sbjct: 180 FTIKSDVWSFGILLTEIV 197

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 97.2 bits (242), Expect = 1e-22
 Identities = 60/220 (27%), Positives = 98/220 (44%), Gaps = 32/220 (14%)

Query: 100 LGEGGFGVVYK----GVIDENVRPGYKTTFVAIKELNRGGY-QGDREWLAEVNYLGQLRH 154
           +G+G FG V++    G++     P    T VA+K L          ++  E   + +  H
Sbjct: 13  IGQGAFGRVFQARAPGLL-----PYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDH 67

Query: 155 SNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVG--------------------CML 194
            N+VKL+G C   +   L++EYM  G L + L  R                        L
Sbjct: 68  PNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPL 127

Query: 195 TWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQ 254
           + + ++ IA   A G+A+L  +ER  ++RD  T N L+  +   K++DFGL+++    D 
Sbjct: 128 SCTEQLCIAKQVAAGMAYL--SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADY 185

Query: 255 THVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEM 294
              S        +  PE +     T  SDV+ +GVVL E+
Sbjct: 186 YKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEI 225

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score = 96.8 bits (242), Expect = 1e-22
 Identities = 62/209 (29%), Positives = 96/209 (45%), Gaps = 24/209 (11%)

Query: 99  ILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELN-RGGYQG-DREWLAEVNYLGQLRHSN 156
            +GEG +G VYK     N + G     VA+K++      +G     + E+  L +LRH N
Sbjct: 6   QIGEGTYGQVYKA---RNKKTG---ELVALKKIRMENEKEGFPITAIREIKLLQKLRHPN 59

Query: 157 LVKLIGYCCEDEHR--ILVYEYME---SGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLA 211
           +V+L             +V+EYM+   +G     LL       T S+         +GL 
Sbjct: 60  IVRLKEIVTSKGKGSIYMVFEYMDHDLTG-----LLDSPEVKFTESQIKCYMKQLLEGLQ 114

Query: 212 FLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPM-GDQTHVSTRVMGTYGYAAP 270
           +LH     +++RD K SNIL+N D   KL+DFGLA+  P     +   T  + T  Y  P
Sbjct: 115 YLHS--NGILHRDIKGSNILINNDGVLKLADFGLAR--PYTKRNSADYTNRVITLWYRPP 170

Query: 271 EYVM-TGHLTARSDVYGFGVVLLEMLLGR 298
           E ++         D++  G +L E+ LG+
Sbjct: 171 ELLLGATRYGPEVDMWSVGCILAELFLGK 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 95.1 bits (237), Expect = 4e-22
 Identities = 66/206 (32%), Positives = 99/206 (48%), Gaps = 26/206 (12%)

Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGD-REWLAEVNYLGQLRHSNLV 158
           LG G FG V KGV    +    K   VA+K L +       +E+L E + + QL H  +V
Sbjct: 3   LGHGNFGSVVKGVY---LMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIV 59

Query: 159 KLIGYCCEDEHRILVYEYMESGSLEKHLLRR----VGCMLTWSRRMKIALDAAKGLAFLH 214
           +LIG  C+ E  +LV E    G L K+L +R    V  +         A   A G+A+L 
Sbjct: 60  RLIG-VCKGEPLMLVMELAPLGPLLKYLKKRREIPVSDLKEL------AHQVAMGMAYLE 112

Query: 215 GAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYG-----YAA 269
              +  ++RD    N+LL     AK+SDFG+++    G   + +T    T G     + A
Sbjct: 113 --SKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRAT----TAGRWPLKWYA 166

Query: 270 PEYVMTGHLTARSDVYGFGVVLLEML 295
           PE +  G  +++SDV+ +GV L E  
Sbjct: 167 PECINYGKFSSKSDVWSYGVTLWEAF 192

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score = 93.5 bits (233), Expect = 1e-21
 Identities = 62/207 (29%), Positives = 97/207 (46%), Gaps = 13/207 (6%)

Query: 92  KFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQ 151
           + F     LGEG +G VYK +  E  +       VAIK +        +E + E++ L Q
Sbjct: 3   EVFDILEKLGEGSYGSVYKAIHKETGQV------VAIKVVPVEE--DLQEIIKEISILKQ 54

Query: 152 LRHSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLA 211
                +VK  G   ++    +V EY  +GS+   +++     LT      I     KGL 
Sbjct: 55  CDSPYIVKYYGSYFKNTDLWIVMEYCGAGSV-SDIMKITNKTLTEEEIAAILYQTLKGLE 113

Query: 212 FLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPE 271
           +LH      I+RD K  NILLN +  AKL+DFG++  G + D       V+GT  + APE
Sbjct: 114 YLH--SNKKIHRDIKAGNILLNEEGQAKLADFGVS--GQLTDTMAKRNTVIGTPFWMAPE 169

Query: 272 YVMTGHLTARSDVYGFGVVLLEMLLGR 298
            +       ++D++  G+  +EM  G+
Sbjct: 170 VIQEIGYNNKADIWSLGITAIEMAEGK 196

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score = 92.8 bits (231), Expect = 3e-21
 Identities = 81/292 (27%), Positives = 124/292 (42%), Gaps = 47/292 (16%)

Query: 95  RPDYILGEGGFGVVYKGV-IDENVRPGYKTTFVAIKELN--RGGYQGDREWLAEVNYLGQ 151
           R + I G G FG VY  V +D           +A+KE+       +  +E   E+  L  
Sbjct: 4   RGNKI-GGGTFGKVYTAVNLDTG-------ELMAVKEIRIQDNDPKTIKEIADEMKVLEL 55

Query: 152 LRHSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLA 211
           L+H NLVK  G     E   +  EY   G+LE+ L    G +L         L   +GLA
Sbjct: 56  LKHPNLVKYYGVEVHREKVYIFMEYCSGGTLEELL--EHGRILDEHVIRVYTLQLLEGLA 113

Query: 212 FLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVM----GTYGY 267
           +LH     +++RD K +NI L+ +   KL DFG A    + + T      +    GT  Y
Sbjct: 114 YLH--SHGIVHRDIKPANIFLDHNGVIKLGDFGCAVK--LKNNTTTMGEEVQSLAGTPAY 169

Query: 268 AAPEYV----MTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNN 323
            APE +      GH  A +D++  G V+LEM  G+R               W+   L+N 
Sbjct: 170 MAPEVITGGKGKGHGRA-ADIWSLGCVVLEMATGKRP--------------WSE--LDNE 212

Query: 324 KKVLRILDPRLEGQYTARTAMKVAGLAY--QCLSQNPKGRPVMSDVVALLET 373
            +++  +    +        +   G  +  +CL  +PK RP  S+   LL+ 
Sbjct: 213 FQIMFHVGAGHKPPIPDSLQLSPEGKDFLDRCLESDPKKRPTASE---LLQH 261

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 92.4 bits (229), Expect = 3e-21
 Identities = 81/284 (28%), Positives = 127/284 (44%), Gaps = 48/284 (16%)

Query: 99  ILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLV 158
            +G+G FG V  G         Y+   VA+K +        + +LAE + + QLRHSNLV
Sbjct: 13  TIGKGEFGDVMLG--------DYRGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLV 62

Query: 159 KLIGYCCEDEHRI-LVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAE 217
           +L+G   E++  + +V EYM  GSL  +L  R   +L     +K +LD  + + +L    
Sbjct: 63  QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANN 122

Query: 218 RPVIYRDFKTSNILLNADFSAKLSDFGLAKD-GPMGDQTHVSTRVMGTYGYAAPEYVMTG 276
              ++RD    N+L++ D  AK+SDFGL K+     D   +  +      + APE +   
Sbjct: 123 --FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVK------WTAPEALREK 174

Query: 277 HLTARSDVYGFGVVLLEML-LGRRAVDKSRPSREHNLVEWAR-PLLNNNKKVLRILDPRL 334
             + +SDV+ FG++L E+   GR              V + R PL    K V+    PR+
Sbjct: 175 KFSTKSDVWSFGILLWEIYSFGR--------------VPYPRIPL----KDVV----PRV 212

Query: 335 EGQYTARTAMKVAGLAY----QCLSQNPKGRPVMSDVVALLETV 374
           E  Y          + Y    QC   +   RP    +   LE +
Sbjct: 213 EKGYKMDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI 256

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score = 92.1 bits (229), Expect = 4e-21
 Identities = 61/213 (28%), Positives = 101/213 (47%), Gaps = 35/213 (16%)

Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRG-----GYQGDREWLAEVNYLGQLRH 154
           LG G FG VY+G+  ++        F A+KE++       G +  ++   E+  L +L+H
Sbjct: 8   LGSGSFGSVYEGLNLDD------GDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQH 61

Query: 155 SNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIAL---DAAKGLA 211
            N+V+ +G   E+++  +  E +  GSL K LL++ G          I L       GL 
Sbjct: 62  PNIVQYLGTEREEDNLYIFLELVPGGSLAK-LLKKYGSF----PEPVIRLYTRQILLGLE 116

Query: 212 FLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVM-----GTYG 266
           +LH   R  ++RD K +NIL++ +   KL+DFG+AK         V          G+  
Sbjct: 117 YLHD--RNTVHRDIKGANILVDTNGVVKLADFGMAK--------QVVEFSFAKSFKGSPY 166

Query: 267 YAAPEYVM-TGHLTARSDVYGFGVVLLEMLLGR 298
           + APE +   G     +D++  G  +LEM  G+
Sbjct: 167 WMAPEVIAQQGGYGLAADIWSLGCTVLEMATGK 199

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 92.5 bits (230), Expect = 4e-21
 Identities = 81/288 (28%), Positives = 119/288 (41%), Gaps = 38/288 (13%)

Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTF-VAIKELNRGGYQGDRE-WLAEVNYLGQLRHSNL 157
           LG G FG VY+G+     R G      VA+K L     + D   +L E   + +  H N+
Sbjct: 14  LGHGAFGEVYEGLYRG--RDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNI 71

Query: 158 VKLIGYCCEDEHRILVYEYMESGSLEKHLLR----RVG--CMLTWSRRMKIALDAAKGLA 211
           V+LIG   E   R ++ E M  G L K  LR    R      LT    +  A D AKG  
Sbjct: 72  VRLIGVSFERLPRFILLELMAGGDL-KSFLRENRPRPERPSSLTMKDLLFCARDVAKGCK 130

Query: 212 FLHGAERPVIYRDFKTSNILLN---ADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYA 268
           +L   E   I+RD    N LL        AK++DFG+A+D           R M    + 
Sbjct: 131 YLE--ENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWM 188

Query: 269 APEYVMTGHLTARSDVYGFGVVLLEML-LGRRAVDKSRPSREHNLVEWARPLLNNNKKVL 327
            PE  + G  T+++DV+ FGV+L E+  LG        P R              N++V+
Sbjct: 189 PPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPY----PGR-------------TNQEVM 231

Query: 328 RILDP--RLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLET 373
             +    RL+          V  +   C    P+ RP  + ++  ++ 
Sbjct: 232 EFVTGGGRLDPPKGCPGP--VYRIMTDCWQHTPEDRPNFATILERIQY 277

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 91.9 bits (228), Expect = 5e-21
 Identities = 65/206 (31%), Positives = 108/206 (52%), Gaps = 26/206 (12%)

Query: 99  ILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGD---REWLAEVNYLGQLRHS 155
           I+GEG FG V +G         Y    VA+K +     + D   + +L E   + +L H 
Sbjct: 13  IIGEGEFGAVLQG--------EYTGQKVAVKNI-----KCDVTAQAFLEETAVMTKLHHK 59

Query: 156 NLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHG 215
           NLV+L+G    +   I V E M  G+L   L  R   +++  + ++ +LD A+G+ +L  
Sbjct: 60  NLVRLLGVILHNGLYI-VMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLE- 117

Query: 216 AERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMG-DQTHVSTRVMGTYGYAAPEYVM 274
             + +++RD    NIL++ D  AK+SDFGLA+ G MG D + +  +      + APE + 
Sbjct: 118 -SKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPVK------WTAPEALK 170

Query: 275 TGHLTARSDVYGFGVVLLEMLLGRRA 300
               +++SDV+ +GV+L E+    RA
Sbjct: 171 HKKFSSKSDVWSYGVLLWEVFSYGRA 196

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 91.8 bits (228), Expect = 7e-21
 Identities = 67/282 (23%), Positives = 117/282 (41%), Gaps = 27/282 (9%)

Query: 99  ILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELN-RGGYQGDREWLAEVNYLGQLRHSNL 157
            LG G FG V+          G   T V +K L          E+  E++   +L H N+
Sbjct: 12  TLGRGEFGEVFLAKAKGIEEEG-GETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNV 70

Query: 158 VKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCM-------LTWSRRMKIALDAAKGL 210
           V+L+G C E E   ++ EY + G L++ L              L+  +++ +    A G+
Sbjct: 71  VRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGM 130

Query: 211 AFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAP 270
             L  A    ++RD    N L+++    K+S   L+KD     + +     +    + AP
Sbjct: 131 DHLSNAR--FVHRDLAARNCLVSSQREVKVSLLSLSKD-VYNSEYYKLRNALIPLRWLAP 187

Query: 271 EYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRIL 330
           E V     + +SDV+ FGV++ E+                   E     L++ + + R+ 
Sbjct: 188 EAVQEDDFSTKSDVWSFGVLMWEVF---------------TQGELPFYGLSDEEVLNRLQ 232

Query: 331 DPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLE 372
             +LE         ++  L  +C + NPK RP  S++V+ L 
Sbjct: 233 AGKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 91.5 bits (227), Expect = 7e-21
 Identities = 66/211 (31%), Positives = 112/211 (53%), Gaps = 15/211 (7%)

Query: 95  RPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGY--QGDREWLAEVNYLGQL 152
           + + ++G G FG V  G +     PG +   VAIK L + GY  +  R++L+E + +GQ 
Sbjct: 7   KIEKVIGAGEFGEVCSGRLK---LPGKREIPVAIKTL-KAGYTEKQRRDFLSEASIMGQF 62

Query: 153 RHSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAF 212
            H N++ L G   + +  ++V EYME+GSL+   LR+     T  + + +    A G+ +
Sbjct: 63  DHPNIIHLEGVVTKSKPVMIVTEYMENGSLDA-FLRKHDGQFTVIQLVGMLRGIASGMKY 121

Query: 213 LHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAK---DGPMGDQTHVSTRVMGTYGYAA 269
           L  ++   ++RD    NIL+N++   K+SDFGL++   D P    T    ++     + A
Sbjct: 122 L--SDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKI--PIRWTA 177

Query: 270 PEYVMTGHLTARSDVYGFGVVLLE-MLLGRR 299
           PE +     T+ SDV+ +G+V+ E M  G R
Sbjct: 178 PEAIAYRKFTSASDVWSYGIVMWEVMSYGER 208

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 90.7 bits (225), Expect = 1e-20
 Identities = 74/275 (26%), Positives = 130/275 (47%), Gaps = 34/275 (12%)

Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVK 159
           LG G FGVV+ G      R   K   VAIK +N G    + +++ E   + +L H  LV+
Sbjct: 12  LGSGQFGVVHLG----KWRAQIK---VAIKAINEGAMSEE-DFIEEAKVMMKLSHPKLVQ 63

Query: 160 LIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRM--KIALDAAKGLAFLHGAE 217
           L G C + +   +V E+ME+G L  +L +R G +   S+ M   +  D  +G+ +L   E
Sbjct: 64  LYGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKL---SKDMLLSMCQDVCEGMEYL---E 117

Query: 218 R-PVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTG 276
           R   I+RD    N L+++    K+SDFG+ +   + D+   S+       ++ PE     
Sbjct: 118 RNSFIHRDLAARNCLVSSTGVVKVSDFGMTR-YVLDDEYTSSSGAKFPVKWSPPEVFNFS 176

Query: 277 HLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRILDPRLEG 336
             +++SDV+ FGV++ E+       +   P  + +  E    +        R+  P+L  
Sbjct: 177 KYSSKSDVWSFGVLMWEVF-----TEGKMPFEKKSNYEVVEMISRGF----RLYRPKL-- 225

Query: 337 QYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALL 371
                 +M V  + Y C  + P+GRP  ++++  +
Sbjct: 226 -----ASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 90.1 bits (224), Expect = 2e-20
 Identities = 61/220 (27%), Positives = 94/220 (42%), Gaps = 17/220 (7%)

Query: 94  FRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRG---GYQGDREWLAEVNYLG 150
           F    ++G+G FG V   ++ +      K  F A+K +N+         R  L E   L 
Sbjct: 2   FELLRVIGKGAFGKVC--IVQKRDT---KKMF-AMKYMNKQKCVEKGSVRNVLNERRILQ 55

Query: 151 QLRHSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGL 210
           +L H  LV L     ++E+  LV + +  G L  HL ++V    +  +      +    L
Sbjct: 56  ELNHPFLVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKV--KFSEEQVKFWICEIVLAL 113

Query: 211 AFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAP 270
            +LH   + +I+RD K  NILL+      ++DF +A        T   T   GT GY AP
Sbjct: 114 EYLH--SKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLT---TSTSGTPGYMAP 168

Query: 271 EYVMTGHLTARSDVYGFGVVLLEMLLGRRAVD-KSRPSRE 309
           E +     +   D +  GV   E L G+R     SR  R+
Sbjct: 169 EVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRD 208

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 89.9 bits (223), Expect = 3e-20
 Identities = 78/290 (26%), Positives = 132/290 (45%), Gaps = 59/290 (20%)

Query: 100 LGEGGFGVV----YKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHS 155
           LG G FGVV    ++G  D           VAIK +  G    D E++ E   + +L H 
Sbjct: 12  LGTGQFGVVKYGKWRGQYD-----------VAIKMIKEGSMSED-EFIEEAKVMMKLSHE 59

Query: 156 NLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHG 215
            LV+L G C +     +V EYM +G L  + LR  G     S+ +++  D  +G+A+L  
Sbjct: 60  KLVQLYGVCTKQRPIYIVTEYMSNGCLLNY-LREHGKRFQPSQLLEMCKDVCEGMAYLES 118

Query: 216 AERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGT---YGYAAPEY 272
            +   I+RD    N L++     K+SDFGL++   + D  + S+  +G+     ++ PE 
Sbjct: 119 KQ--FIHRDLAARNCLVDDQGCVKVSDFGLSR--YVLDDEYTSS--VGSKFPVRWSPPEV 172

Query: 273 VMTGHLTARSDVYGFGVVLLEML-LGRRAVDKSRPSREHNLVEWARPLLNNNKKV----- 326
           ++    +++SDV+ FGV++ E+  LG+   +                  NN++ V     
Sbjct: 173 LLYSKFSSKSDVWAFGVLMWEVYSLGKMPYE----------------RFNNSETVEKVSQ 216

Query: 327 -LRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETVQ 375
            LR+  P L  +       KV  + Y C  +  + RP       LL +++
Sbjct: 217 GLRLYRPHLASE-------KVYAIMYSCWHEKAEERPTFQ---QLLSSIE 256

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 89.6 bits (223), Expect = 3e-20
 Identities = 58/215 (26%), Positives = 98/215 (45%), Gaps = 35/215 (16%)

Query: 98  YILGEGGFGVVYKGVIDENVRPGYKTT--FVAIKELNRGGY-QGDREWL-AEVNYLGQLR 153
             +G+G FG V K V         K+    +  KE++ G   + +++ L +EVN L +L+
Sbjct: 6   ETIGKGSFGTVRK-VRR-------KSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELK 57

Query: 154 HSNLVKLIGYCCEDEHRI---------LVYEYMESGSLEKHL--LRRVGCMLTWSRRMKI 202
           H N+V+          RI         +V EY E G L + +   ++    +      +I
Sbjct: 58  HPNIVRYY-------DRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRI 110

Query: 203 ALDAAKGLAFLHGAERP---VIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVST 259
                  L   H    P   V++RD K +NI L+A+ + KL DFGLAK   +G  +  + 
Sbjct: 111 LTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAK--ILGHDSSFAK 168

Query: 260 RVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEM 294
             +GT  Y +PE +       +SD++  G ++ E+
Sbjct: 169 TYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYEL 203

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 89.7 bits (222), Expect = 3e-20
 Identities = 81/282 (28%), Positives = 128/282 (45%), Gaps = 34/282 (12%)

Query: 94  FRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLR 153
            R +  LG+G FG V+ G  +        TT VAIK L + G      +L E   + +LR
Sbjct: 8   LRLEVKLGQGCFGEVWMGTWN-------GTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLR 59

Query: 154 HSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFL 213
           H  LV+L     E E   +V EYM  GSL   L   +G  L   + + +A   A G+A++
Sbjct: 60  HEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYV 118

Query: 214 HGAER-PVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTY--GYAAP 270
              ER   ++RD + +NIL+  +   K++DFGLA+   + +    + R    +   + AP
Sbjct: 119 ---ERMNYVHRDLRAANILVGENLVCKVADFGLAR---LIEDNEYTARQGAKFPIKWTAP 172

Query: 271 EYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRIL 330
           E  + G  T +SDV+ FG++L E+    R       +RE         +L+  ++  R+ 
Sbjct: 173 EAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE---------VLDQVERGYRMP 223

Query: 331 DPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLE 372
            P             +  L  QC  + P+ RP    + A LE
Sbjct: 224 CP-------PECPESLHDLMCQCWRKEPEERPTFEYLQAFLE 258

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 89.6 bits (222), Expect = 6e-20
 Identities = 63/238 (26%), Positives = 116/238 (48%), Gaps = 38/238 (15%)

Query: 82  FTYNEMKLATKFFRPDYILGEGGFGVVY------------KGVIDENVRPGYKTTFVAIK 129
           F   +++L  K       LGEG FG V+            +G  + + +P      VA+K
Sbjct: 2   FPRQQLRLKEK-------LGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQP----VLVAVK 50

Query: 130 ELNRGGYQGDR-EWLAEVNYLGQLRHSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLR 188
            L     +  R ++L E+  + +L++ N+++L+G C  D+   ++ EYME+G L + L +
Sbjct: 51  MLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQ 110

Query: 189 R-----------VGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFS 237
           R           +   ++ +  + +A+  A G+ +L  A    ++RD  T N L+   ++
Sbjct: 111 REIESTFTHANNIPS-VSIANLLYMAVQIASGMKYL--ASLNFVHRDLATRNCLVGNHYT 167

Query: 238 AKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEML 295
            K++DFG++++   GD   +  R +    + A E ++ G  T  SDV+ FGV L EM 
Sbjct: 168 IKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMF 225

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score = 88.5 bits (220), Expect = 7e-20
 Identities = 62/208 (29%), Positives = 99/208 (47%), Gaps = 29/208 (13%)

Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLA-EVNYLGQLRHSNLV 158
           LG G  GVV K +     RP  K   +A+K +     +  ++ +  E++ L +     +V
Sbjct: 9   LGAGNSGVVSKVLH----RPTGK--IMAVKTIRLEINEAIQKQILRELDILHKCNSPYIV 62

Query: 159 KLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAER 218
              G    +    +  EYM+ GSL+K +L+ V   +      KIA+   KGL +LH  + 
Sbjct: 63  GFYGAFYNNGDISICMEYMDGGSLDK-ILKEVQGRIPERILGKIAVAVLKGLTYLH-EKH 120

Query: 219 PVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVM--------GTYGYAAP 270
            +I+RD K SNIL+N+    KL DFG            VS +++        GT  Y AP
Sbjct: 121 KIIHRDVKPSNILVNSRGQIKLCDFG------------VSGQLVNSLAKTFVGTSSYMAP 168

Query: 271 EYVMTGHLTARSDVYGFGVVLLEMLLGR 298
           E +     + +SD++  G+ L+E+  GR
Sbjct: 169 ERIQGNDYSVKSDIWSLGLSLIELATGR 196

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 89.7 bits (223), Expect = 8e-20
 Identities = 67/214 (31%), Positives = 96/214 (44%), Gaps = 36/214 (16%)

Query: 99  ILGEGGFGVVYKGVIDENVRPGYKTT--FVAIKELNRGGY--QGDREW-LAEVNYLGQL- 152
           +LG+G FG V    + E      K T    A+K L +       D E  + E   L    
Sbjct: 2   VLGKGSFGKVL---LAE-----LKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAG 53

Query: 153 RHSNLVKLIGYCC--EDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMK------IAL 204
           +H  L +L  + C    +    V EY+  G L  H+ R        S R         A 
Sbjct: 54  KHPFLTQL--HSCFQTKDRLFFVMEYVNGGDLMFHIQR--------SGRFDEPRARFYAA 103

Query: 205 DAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGT 264
           +   GL FLH  ER +IYRD K  N+LL+++   K++DFG+ K+G +G  T  ++   GT
Sbjct: 104 EIVLGLQFLH--ERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVT--TSTFCGT 159

Query: 265 YGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGR 298
             Y APE +         D +  GV+L EML G+
Sbjct: 160 PDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQ 193

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 87.8 bits (217), Expect = 2e-19
 Identities = 61/215 (28%), Positives = 101/215 (46%), Gaps = 26/215 (12%)

Query: 100 LGEGGFGVVYKGVIDENVRPGYK-TTFVAIKELNRGGYQGDREW---LAEVNYLGQLRHS 155
           LGE  FG +YKG +     PG      VAIK L        ++W     E + + +L H 
Sbjct: 13  LGECAFGKIYKGHL---YLPGMDHAQLVAIKTLK--DINNPQQWGEFQQEASLMAELHHP 67

Query: 156 NLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRR-----VGCM----------LTWSRRM 200
           N+V L+G   +++   +++EY+  G L + L+ R     VGC           L     +
Sbjct: 68  NIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFL 127

Query: 201 KIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTR 260
            IA+  A G+ +L  +    +++D    NIL+      K+SD GL+++    D   V  +
Sbjct: 128 HIAIQIAAGMEYL--SSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPK 185

Query: 261 VMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEML 295
            +    +  PE +M G  ++ SD++ FGVVL E+ 
Sbjct: 186 SLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIF 220

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 87.6 bits (217), Expect = 2e-19
 Identities = 76/285 (26%), Positives = 128/285 (44%), Gaps = 38/285 (13%)

Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELN-------RGGYQGD---REWLAEVNYL 149
           LG G FG VYK  + +          +A+KE+N       +   + D    + ++EV  +
Sbjct: 8   LGSGAFGCVYK--VRKKNNGQ---NLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTII 62

Query: 150 G-QLRHSNLVKLIGYCCEDEHRILVYEYMESGSLEKHL--LRRVGCMLTWSRRMKIALDA 206
             QLRH N+V+      E++   +V + +E   L +H   L+      T  R   I +  
Sbjct: 63  KEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQM 122

Query: 207 AKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYG 266
              L +LH  E+ +++RD   +NI+L  D    ++DFGLAK      ++ + T V+GT  
Sbjct: 123 VLALRYLH-KEKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQ--KQPESKL-TSVVGTIL 178

Query: 267 YAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKV 326
           Y+ PE V       ++DV+ FG +L +M           P    N++  A       K V
Sbjct: 179 YSCPEIVKNEPYGEKADVWAFGCILYQM------CTLQPPFYSTNMLSLA------TKIV 226

Query: 327 LRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALL 371
             + +P  EG Y+      V  +   CL+ + + RP +  V A++
Sbjct: 227 EAVYEPLPEGMYSED----VTDVITSCLTPDAEARPDIIQVSAMI 267

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 87.7 bits (217), Expect = 2e-19
 Identities = 79/285 (27%), Positives = 137/285 (48%), Gaps = 34/285 (11%)

Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDR-EWLAEVNYLGQLRHSNLV 158
           LG+G FG+VY+G   + ++ G   T VA+K +N      +R E+L E + +      ++V
Sbjct: 14  LGQGSFGMVYEGNARDIIK-GEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 72

Query: 159 KLIGYCCEDEHRILVYEYMESGSLEKHL--LR-----RVGCMLTWSRRM-KIALDAAKGL 210
           +L+G   + +  ++V E M  G L+ +L  LR       G      + M ++A + A G+
Sbjct: 73  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 132

Query: 211 AFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAP 270
           A+L+   +  ++RD    N ++  DF+ K+ DFG+ +D    D      + +    + AP
Sbjct: 133 AYLNA--KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 190

Query: 271 EYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRIL 330
           E +  G  T  SD++ FGVVL E+                +L E     L +N++VL+ +
Sbjct: 191 ESLKDGVFTTSSDMWSFGVVLWEI---------------TSLAEQPYQGL-SNEQVLKFV 234

Query: 331 DPRLEGQYTAR---TAMKVAGLAYQCLSQNPKGRPVMSDVVALLE 372
              ++G Y  +      +V  L   C   NPK RP   ++V LL+
Sbjct: 235 ---MDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLK 276

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 87.2 bits (216), Expect = 3e-19
 Identities = 78/291 (26%), Positives = 129/291 (44%), Gaps = 39/291 (13%)

Query: 99  ILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGG--YQGDREWLAEVNYLGQLRHSN 156
           ILGEG FG V +G + ++     K   VA+K +      Y    E+L+E   +    H N
Sbjct: 6   ILGEGEFGSVMEGQLSQDDGSQLK---VAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPN 62

Query: 157 LVKLIGYCCEDEHR------ILVYEYMESGSLEKHLLR-RVGCM---LTWSRRMKIALDA 206
           ++KLIG C E          +++  +M+ G L   LL  R+G +   L     +K  +D 
Sbjct: 63  VMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDI 122

Query: 207 AKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGD---QTHVSTRVMG 263
           A G+ +L  + R  I+RD    N +L  D +  ++DFGL+K    GD   Q  ++   + 
Sbjct: 123 ALGMEYL--SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPV- 179

Query: 264 TYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNN 323
              + A E +     T++SDV+ FGV + E+    R          H + ++   L + N
Sbjct: 180 --KWIAIESLADRVYTSKSDVWAFGVTMWEIA--TRGQTPYPGVENHEIYDY---LRHGN 232

Query: 324 KKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETV 374
               R+  P            ++  L Y C   +PK RP  + +  +LE +
Sbjct: 233 ----RLKQP-------EDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 86.8 bits (215), Expect = 4e-19
 Identities = 82/285 (28%), Positives = 133/285 (46%), Gaps = 32/285 (11%)

Query: 99  ILGEGGFGVVYKG-VIDENVRPGYKTTFVAIKELNR-GGYQGDREWLAEVNYLGQLRHSN 156
           ++G+G FG VY G +ID +     +    A+K LNR    +   ++L E   +    H N
Sbjct: 2   VIGKGHFGCVYHGTLIDSD----GQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPN 57

Query: 157 LVKLIGYCCEDEHRILV-YEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHG 215
           ++ L+G C   E   LV   YM+ G L ++ +R      T    +   L  AKG+ +L  
Sbjct: 58  VLSLLGICLPSEGSPLVVLPYMKHGDL-RNFIRSETHNPTVKDLIGFGLQVAKGMEYL-- 114

Query: 216 AERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVS----TRVMGTYGYAAPE 271
           A +  ++RD    N +L+  F+ K++DFGLA+D  + D+ + S    T       + A E
Sbjct: 115 ASKKFVHRDLAARNCMLDESFTVKVADFGLARD--IYDKEYYSVHNHTGAKLPVKWMALE 172

Query: 272 YVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRILD 331
            + T   T +SDV+ FGV+L E L+ R A     P  + +  +    LL       R+L 
Sbjct: 173 SLQTQKFTTKSDVWSFGVLLWE-LMTRGA----PPYPDVDSFDITVYLLQGR----RLLQ 223

Query: 332 PRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETVQS 376
           P    +Y      +V      C    P+ RP  S++V+ +E + S
Sbjct: 224 P----EYCPDPLYEV---MLSCWHPKPEMRPTFSELVSRIEQIFS 261

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 86.2 bits (213), Expect = 6e-19
 Identities = 59/204 (28%), Positives = 107/204 (52%), Gaps = 12/204 (5%)

Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDR-EWLAEVNYLGQLRHSNLV 158
           LG+G FG+VY+G+    V+   +T  VAIK +N      +R E+L E + + +    ++V
Sbjct: 14  LGQGSFGMVYEGIAKGVVKDEPETR-VAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 72

Query: 159 KLIGYCCEDEHRILVYEYMESGSLEKHL--LRR------VGCMLTWSRRMKIALDAAKGL 210
           +L+G   + +  +++ E M  G L+ +L  LR       V    +  + +++A + A G+
Sbjct: 73  RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGM 132

Query: 211 AFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAP 270
           A+L+  +   ++RD    N ++  DF+ K+ DFG+ +D    D      + +    + +P
Sbjct: 133 AYLNANK--FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSP 190

Query: 271 EYVMTGHLTARSDVYGFGVVLLEM 294
           E +  G  T  SDV+ FGVVL E+
Sbjct: 191 ESLKDGVFTTYSDVWSFGVVLWEI 214

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score = 86.1 bits (214), Expect = 6e-19
 Identities = 65/237 (27%), Positives = 101/237 (42%), Gaps = 52/237 (21%)

Query: 94  FRPDYILGEGGFGVVYKGVIDENVRPGYKTTF--VAIKELNRGGYQGDREWLAE--VNY- 148
           F+   I+GEG F  V     +       K T    AIK L++      R+ + E  V Y 
Sbjct: 3   FKFGKIIGEGSFSTVVL-AKE-------KETNKEYAIKILDK------RQLIKEKKVKYV 48

Query: 149 ------LGQL-RHSNLVKLIGYCCEDEHRI-LVYEYMESGSLEKHLLRRVGCM-LTWSRR 199
                 L +L  H  ++KL  Y  +DE  +  V EY  +G L    +R+ G +    +R 
Sbjct: 49  KIEKEVLTRLNGHPGIIKLY-YTFQDEENLYFVLEYAPNGELL-QYIRKYGSLDEKCTRF 106

Query: 200 MKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGP--------- 250
              A +    L +LH   + +I+RD K  NILL+ D   K++DFG AK            
Sbjct: 107 --YAAEILLALEYLHS--KGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNK 162

Query: 251 -----MGDQTHVSTR----VMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGR 298
                +  Q   + R     +GT  Y +PE +        SD++  G ++ +ML G+
Sbjct: 163 GDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGK 219

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 86.7 bits (215), Expect = 8e-19
 Identities = 76/221 (34%), Positives = 104/221 (47%), Gaps = 41/221 (18%)

Query: 94  FRPDYILGEGGFGVVYKGVIDENVRPGYKTT--FVAIKELNRGGYQGDREWLA--EVNYL 149
           FR   +LG G FG V   ++ E     YK T    AIK L +G      + +A  EV  L
Sbjct: 1   FRCLAVLGRGHFGKV---LLAE-----YKKTGELYAIKALKKG------DIIARDEVESL 46

Query: 150 ----------GQLRHSNLVKLIGYCC--EDEHRILVYEYMESGSLEKHLLRRVGCMLTWS 197
                        RH  LV L  + C   ++H   V EY   G L  H+   V    +  
Sbjct: 47  MCEKRIFETANSERHPFLVNL--FACFQTEDHVCFVMEYAAGGDLMMHIHTDV---FSEP 101

Query: 198 RRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHV 257
           R +  A     GL +LH  E  ++YRD K  N+LL+ +   K++DFGL K+G MG     
Sbjct: 102 RAVFYAACVVLGLQYLH--ENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEG-MGFGDRT 158

Query: 258 STRVMGTYGYAAPEYVMTGHLTARS-DVYGFGVVLLEMLLG 297
           ST   GT  + APE V+T     R+ D +G GV++ EML+G
Sbjct: 159 ST-FCGTPEFLAPE-VLTETSYTRAVDWWGLGVLIYEMLVG 197

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 85.4 bits (211), Expect = 1e-18
 Identities = 61/203 (30%), Positives = 98/203 (48%), Gaps = 9/203 (4%)

Query: 99  ILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDRE-WLAEVNYLGQLRHSNL 157
           ILG G FG + +G +     P  +   VAI  L  G     R  +LAE   LGQ  HSN+
Sbjct: 12  ILGTGRFGELCRGCLK---LPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNI 68

Query: 158 VKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAE 217
           V+L G        ++V EYM +G+L+  L +  G  L   + M +    A G+ +L  +E
Sbjct: 69  VRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEG-QLVAGQLMGMLPGLASGMKYL--SE 125

Query: 218 RPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGH 277
              +++      +L+N+D   K+S F   ++    +  + +        +AAPE +   H
Sbjct: 126 MGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKS-EAIYTTMSGKSPVLWAAPEAIQYHH 184

Query: 278 LTARSDVYGFGVVLLE-MLLGRR 299
            ++ SDV+ FG+V+ E M  G R
Sbjct: 185 FSSASDVWSFGIVMWEVMSYGER 207

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 85.1 bits (210), Expect = 1e-18
 Identities = 78/276 (28%), Positives = 125/276 (45%), Gaps = 34/276 (12%)

Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVK 159
           LG G FG V+ G  + N +       VA+K L + G      +L E   + +LRH  LV+
Sbjct: 14  LGNGQFGEVWMGTWNGNTK-------VAVKTL-KPGTMSPESFLEEAQIMKKLRHDKLVQ 65

Query: 160 LIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAER- 218
           L     E E   +V EYM  GSL   L    G  L     + +A   A G+A++   ER 
Sbjct: 66  LYAVVSE-EPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYI---ERM 121

Query: 219 PVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTY--GYAAPEYVMTG 276
             I+RD +++NIL+      K++DFGLA+   + +    + R    +   + APE  + G
Sbjct: 122 NYIHRDLRSANILVGDGLVCKIADFGLAR---LIEDNEYTARQGAKFPIKWTAPEAALYG 178

Query: 277 HLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRILDPRLEG 336
             T +SDV+ FG++L E++   R                  P + NN++VL  ++     
Sbjct: 179 RFTIKSDVWSFGILLTELVTKGRV---------------PYPGM-NNREVLEQVERGYRM 222

Query: 337 QYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLE 372
                  + +  L  QC  ++P+ RP    + + LE
Sbjct: 223 PCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLE 258

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 85.2 bits (211), Expect = 1e-18
 Identities = 58/209 (27%), Positives = 86/209 (41%), Gaps = 28/209 (13%)

Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELN------RGGYQG---DREWLAEVNYLG 150
           LG+GGFG V         +        A K+L+      R G Q    +++ L +V    
Sbjct: 1   LGKGGFGEVCA------CQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKV---- 50

Query: 151 QLRHSNLVKLIGYCCED-EHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKG 209
               S  +  + Y  E  +   LV   M  G L+ H+          +R +  A     G
Sbjct: 51  ---SSRFIVSLAYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICG 107

Query: 210 LAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAA 269
           L  LH  +R ++YRD K  N+LL+   + ++SD GLA +   G +        GT GY A
Sbjct: 108 LEHLH--QRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRA---GTPGYMA 162

Query: 270 PEYVMTGHLTARSDVYGFGVVLLEMLLGR 298
           PE +         D +  G  L EM+ GR
Sbjct: 163 PEVLQGEVYDFSVDWFALGCTLYEMIAGR 191

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 84.0 bits (207), Expect = 3e-18
 Identities = 80/282 (28%), Positives = 126/282 (44%), Gaps = 34/282 (12%)

Query: 94  FRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLR 153
            R D  LG+G FG V+ G  +        TT VAIK L + G      +L E   + +LR
Sbjct: 8   LRLDVKLGQGCFGEVWMGTWN-------GTTKVAIKTL-KPGTMMPEAFLQEAQIMKKLR 59

Query: 154 HSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFL 213
           H  LV L     E E   +V E+M  GSL   L    G  L   + + +A   A G+A++
Sbjct: 60  HDKLVPLYAVVSE-EPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYI 118

Query: 214 HGAER-PVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTY--GYAAP 270
              ER   I+RD + +NIL+  +   K++DFGLA+   + +    + R    +   + AP
Sbjct: 119 ---ERMNYIHRDLRAANILVGDNLVCKIADFGLAR---LIEDNEYTARQGAKFPIKWTAP 172

Query: 271 EYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRIL 330
           E  + G  T +SDV+ FG++L E++   R       +RE         +L   ++  R+ 
Sbjct: 173 EAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNRE---------VLEQVERGYRMP 223

Query: 331 DPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLE 372
            P+            +  L   C  ++P  RP    + + LE
Sbjct: 224 CPQ-------GCPESLHELMKLCWKKDPDERPTFEYIQSFLE 258

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 83.9 bits (207), Expect = 3e-18
 Identities = 57/198 (28%), Positives = 101/198 (51%), Gaps = 15/198 (7%)

Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVK 159
           LG G FG V+ G  +        +T VA+K L + G    + +L E N +  L+H  LV+
Sbjct: 14  LGAGQFGEVWMGYYN-------NSTKVAVKTL-KPGTMSVQAFLEEANLMKTLQHDKLVR 65

Query: 160 LIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERP 219
           L     ++E   ++ EYM  GSL   L    G  +   + +  +   A+G+A++    + 
Sbjct: 66  LYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIE--RKN 123

Query: 220 VIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTY--GYAAPEYVMTGH 277
            I+RD + +N+L++     K++DFGLA+   + +    + R    +   + APE +  G 
Sbjct: 124 YIHRDLRAANVLVSESLMCKIADFGLAR---VIEDNEYTAREGAKFPIKWTAPEAINFGS 180

Query: 278 LTARSDVYGFGVVLLEML 295
            T +SDV+ FG++L E++
Sbjct: 181 FTIKSDVWSFGILLYEIV 198

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 84.5 bits (209), Expect = 3e-18
 Identities = 64/207 (30%), Positives = 97/207 (46%), Gaps = 23/207 (11%)

Query: 99  ILGEGGFGVVYK----GVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAE----VNYLG 150
            LG G FG V +    G+   +         VA+K L    +  +RE L      +++LG
Sbjct: 42  TLGAGAFGKVVEATAYGLSKSDA-----VMKVAVKMLKPTAHSSEREALMSELKIMSHLG 96

Query: 151 QLRHSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGL 210
              H N+V L+G C      +++ EY   G L   L R+    LT    +  +   AKG+
Sbjct: 97  N--HENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGM 154

Query: 211 AFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHV---STRVMGTYGY 267
           AFL  A +  I+RD    N+LL      K+ DFGLA+D  M D  +V   + R+     +
Sbjct: 155 AFL--ASKNCIHRDLAARNVLLTHGKIVKICDFGLARD-IMNDSNYVVKGNARL--PVKW 209

Query: 268 AAPEYVMTGHLTARSDVYGFGVVLLEM 294
            APE +     T  SDV+ +G++L E+
Sbjct: 210 MAPESIFNCVYTFESDVWSYGILLWEI 236

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 83.1 bits (205), Expect = 5e-18
 Identities = 61/196 (31%), Positives = 100/196 (51%), Gaps = 12/196 (6%)

Query: 99  ILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDR-EWLAEVNYLGQLRHSNL 157
           +LG+G FG V+KG + +        T VA+K       Q  + ++L+E   L Q  H N+
Sbjct: 2   LLGKGNFGEVFKGTLKDK-------TPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNI 54

Query: 158 VKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAE 217
           VKLIG C + +   +V E +  G      LR+    L   + +K ALDAA G+A+L    
Sbjct: 55  VKLIGVCTQRQPIYIVMELVPGGDFLS-FLRKKKDELKTKQLVKFALDAAAGMAYLE--S 111

Query: 218 RPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGH 277
           +  I+RD    N L+  +   K+SDFG+++    G  +    + +    + APE +  G 
Sbjct: 112 KNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQI-PIKWTAPEALNYGR 170

Query: 278 LTARSDVYGFGVVLLE 293
            ++ SDV+ +G++L E
Sbjct: 171 YSSESDVWSYGILLWE 186

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 83.1 bits (206), Expect = 6e-18
 Identities = 62/210 (29%), Positives = 99/210 (47%), Gaps = 31/210 (14%)

Query: 103 GGFGVVY---KGVIDENVRPGYKTT--FVAIKELNRGGYQGDR---EWLAEVNYLGQLRH 154
           G +G V+   K           K+T    AIK + +          + L E + L Q + 
Sbjct: 4   GAYGRVFLAKK-----------KSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQS 52

Query: 155 SNLVKLIGYCCEDEHRI-LVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFL 213
             +VKL  Y  + +  + LV EY+  G L   LL  VG +     R+ IA +    L +L
Sbjct: 53  PYVVKLY-YSFQGKKNLYLVMEYLPGGDL-ASLLENVGSLDEDVARIYIA-EIVLALEYL 109

Query: 214 HGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVS------TRVMGTYGY 267
           H     +I+RD K  NIL++++   KL+DFGL+K G +  Q +++       R++GT  Y
Sbjct: 110 H--SNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDY 167

Query: 268 AAPEYVMTGHLTARSDVYGFGVVLLEMLLG 297
            APE ++    +   D +  G +L E L+G
Sbjct: 168 IAPEVILGQGHSKTVDWWSLGCILYEFLVG 197

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 83.4 bits (207), Expect = 6e-18
 Identities = 72/270 (26%), Positives = 119/270 (44%), Gaps = 42/270 (15%)

Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLA-EVNYLGQLRHSNLV 158
           +G+G FG VYK +     +       VAIK ++    + + E +  E+ +L Q R   + 
Sbjct: 9   IGKGSFGEVYKAIDKRTNQV------VAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYIT 62

Query: 159 KLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAER 218
           K  G   +     ++ EY   GS    LL+     L  +    I  +   GL +LH  E 
Sbjct: 63  KYYGSFLKGSKLWIIMEYCGGGSC-LDLLKP--GKLDETYIAFILREVLLGLEYLHE-EG 118

Query: 219 PVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGD-QTHVSTRVMGTYGYAAPEYVMTGH 277
             I+RD K +NILL+ +   KL+DFG++  G +    +  +T V GT  + APE +    
Sbjct: 119 -KIHRDIKAANILLSEEGDVKLADFGVS--GQLTSTMSKRNTFV-GTPFWMAPEVIKQSG 174

Query: 278 LTARSDVYGFGVVLLEMLLGRRAVDKSRP-SREHNLVEWARPLLNNNKKVLRILD----P 332
              ++D++  G+  +E+  G        P S  H       P+     +VL ++     P
Sbjct: 175 YDEKADIWSLGITAIELAKG------EPPLSDLH-------PM-----RVLFLIPKNNPP 216

Query: 333 RLEGQYTARTAMKVAGLAYQCLSQNPKGRP 362
            LEG   ++           CL+++PK RP
Sbjct: 217 SLEGNKFSKP---FKDFVSLCLNKDPKERP 243

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 83.8 bits (207), Expect = 6e-18
 Identities = 71/292 (24%), Positives = 133/292 (45%), Gaps = 30/292 (10%)

Query: 100 LGEGGFGVVY-------KGVIDENVR---PGYKTTFVAIKELNRGGYQGDR-EWLAEVNY 148
           LGEG FG V+       +  +D++      G +   VA+K L     +  R ++L E+  
Sbjct: 13  LGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKI 72

Query: 149 LGQLRHSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRV---------GCMLTWSRR 199
           + +L+  N+++L+  C   +   ++ EYME+G L + L R              +++S  
Sbjct: 73  MSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTL 132

Query: 200 MKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVST 259
           + +A   A G+ +L       ++RD  T N L+  +++ K++DFG++++   GD   +  
Sbjct: 133 IFMATQIASGMKYLSSLN--FVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQG 190

Query: 260 RVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPL 319
           R +    + + E ++ G  T  SDV+ FGV L E+L   +    S+ S E  ++E     
Sbjct: 191 RAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQ-VIENTGEF 249

Query: 320 LNNNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALL 371
             +  + + +  P       A     +  L   C  +N K RP   ++ A L
Sbjct: 250 FRDQGRQVYLPKP-------ALCPDSLYKLMLSCWRRNAKERPSFQEIHATL 294

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 83.1 bits (206), Expect = 7e-18
 Identities = 60/207 (28%), Positives = 95/207 (45%), Gaps = 24/207 (11%)

Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKE--LNRGGYQGDREWLAEVNYLGQLRHSNL 157
           +GEG  G+V+K    E          VA+K+  L R       + L E+  L   +H  +
Sbjct: 8   IGEGAHGIVFKAKDRETGET------VALKKVALRRLEGGIPNQALREIKALQACQHPYV 61

Query: 158 VKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAE 217
           VKL+         +LV EYM S   E  +LR     L  ++         KG+A++H   
Sbjct: 62  VKLLDVFPHGSGFVLVMEYMPSDLSE--VLRDEERPLPEAQVKSYMRMLLKGVAYMHANG 119

Query: 218 RPVIYRDFKTSNILLNADFSAKLSDFGLA---KDGPMGDQTH-VSTRVMGTYGYAAPEYV 273
             +++RD K +N+L++AD   K++DFGLA    +      +H V+TR      Y APE +
Sbjct: 120 --IMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATR-----WYRAPE-L 171

Query: 274 MTG--HLTARSDVYGFGVVLLEMLLGR 298
           + G        D++  G +  E+L G 
Sbjct: 172 LYGARKYDPGVDLWAVGCIFAELLNGS 198

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 83.2 bits (206), Expect = 8e-18
 Identities = 65/211 (30%), Positives = 94/211 (44%), Gaps = 29/211 (13%)

Query: 99  ILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRG---GYQGDREWLAEVNYLGQLRHS 155
            LGEG  G V K  +           F A+K +        Q  ++ L E+      +  
Sbjct: 8   RLGEGAGGSVTKCRLKNT-----GMIF-ALKTITTDPNPDLQ--KQILRELEINKSCKSP 59

Query: 156 NLVKLIGYCCEDEHRILVY---EYMESGSLE---KHLLRRVGCMLTWSRRM--KIALDAA 207
            +VK  G    DE    +    EY E GSL+   K + +R G +     ++  KIA    
Sbjct: 60  YIVKYYG-AFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRI---GEKVLGKIAESVL 115

Query: 208 KGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGY 267
           KGL++LH   R +I+RD K SNILL      KL DFG++  G +     ++    GT  Y
Sbjct: 116 KGLSYLH--SRKIIHRDIKPSNILLTRKGQVKLCDFGVS--GELV--NSLAGTFTGTSFY 169

Query: 268 AAPEYVMTGHLTARSDVYGFGVVLLEMLLGR 298
            APE +     +  SDV+  G+ LLE+   R
Sbjct: 170 MAPERIQGKPYSITSDVWSLGLTLLEVAQNR 200

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 82.3 bits (203), Expect = 2e-17
 Identities = 66/219 (30%), Positives = 108/219 (49%), Gaps = 10/219 (4%)

Query: 99  ILGEGGFGVVYKGV-IDENVRPGYKTTFVAIKEL-NRGGYQGDREWLAEVNYLGQLRHSN 156
           +LG G FG V+KG+ I E      K   VAIK + +R G Q  +E    +  +G L H+ 
Sbjct: 14  LLGSGVFGTVHKGIWIPEG--DSIKIP-VAIKTIQDRSGRQTFQEITDHMLAMGSLDHAY 70

Query: 157 LVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGA 216
           +V+L+G C     + LV +    GSL  H+ +     L   R +   +  AKG+ +L   
Sbjct: 71  IVRLLGICPGASLQ-LVTQLSPLGSLLDHVRQHRDS-LDPQRLLNWCVQIAKGMYYLE-- 126

Query: 217 ERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTG 276
           E  +++R+    NILL +D   +++DFG+A      D+ +  +       + A E ++ G
Sbjct: 127 EHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFG 186

Query: 277 HLTARSDVYGFGVVLLEML-LGRRAVDKSRPSREHNLVE 314
             T +SDV+ +GV + EM+  G       RP    +L+E
Sbjct: 187 RYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLE 225

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 81.7 bits (202), Expect = 2e-17
 Identities = 56/206 (27%), Positives = 95/206 (46%), Gaps = 19/206 (9%)

Query: 96  PDYILGEGGFGVVYKGV----IDENVRPGYKTTFVAIKELNRGGYQGDRE-WLAEVNYLG 150
               +GEG FG VY+GV     +E +        VA+K          RE +L E   + 
Sbjct: 10  LGRCIGEGQFGDVYQGVYMSPENEKIA-------VAVKTCKNCTSPSVREKFLQEAYIMR 62

Query: 151 QLRHSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGL 210
           Q  H ++VKLIG    +    +V E    G L  +L       L  +  +  +   +  L
Sbjct: 63  QFDHPHIVKLIG-VITENPVWIVMELAPLGELRSYLQVNKY-SLDLASLILYSYQLSTAL 120

Query: 211 AFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHV-STRVMGTYGYAA 269
           A+L    +  ++RD    N+L+++    KL DFGL++   + D+++  +++      + A
Sbjct: 121 AYLES--KRFVHRDIAARNVLVSSPDCVKLGDFGLSR--YLEDESYYKASKGKLPIKWMA 176

Query: 270 PEYVMTGHLTARSDVYGFGVVLLEML 295
           PE +     T+ SDV+ FGV + E+L
Sbjct: 177 PESINFRRFTSASDVWMFGVCMWEIL 202

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 81.6 bits (201), Expect = 2e-17
 Identities = 72/275 (26%), Positives = 126/275 (45%), Gaps = 32/275 (11%)

Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVK 159
           LG G FG V+    +       K T VA+K + + G      +LAE N +  L+H  LVK
Sbjct: 14  LGAGQFGEVWMATYN-------KHTKVAVKTM-KPGSMSVEAFLAEANVMKTLQHDKLVK 65

Query: 160 LIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERP 219
           L     ++   I+  E+M  GSL   L    G      + +  +   A+G+AF+   +R 
Sbjct: 66  LHAVVTKEPIYIIT-EFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE--QRN 122

Query: 220 VIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTY--GYAAPEYVMTGH 277
            I+RD + +NIL++A    K++DFGLA+   + +    + R    +   + APE +  G 
Sbjct: 123 YIHRDLRAANILVSASLVCKIADFGLAR---VIEDNEYTAREGAKFPIKWTAPEAINFGS 179

Query: 278 LTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRILDPRLEGQ 337
            T +SDV+ FG++L+E++   R                  P + +N +V+R L+      
Sbjct: 180 FTIKSDVWSFGILLMEIVTYGRI---------------PYPGM-SNPEVIRALERGYRMP 223

Query: 338 YTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLE 372
                  ++  +  +C    P+ RP    + ++L+
Sbjct: 224 RPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLD 258

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 81.4 bits (201), Expect = 2e-17
 Identities = 61/212 (28%), Positives = 106/212 (50%), Gaps = 25/212 (11%)

Query: 99  ILGEGGFGVVYKGVIDENVRPGYKTTFVAIKEL----NRGGYQGD--REWLAEVNYLGQL 152
            LG G F   Y+     +V+ G   T +A+K++    N    Q +       E+  + +L
Sbjct: 7   QLGTGAFSSCYQA---RDVKTG---TLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARL 60

Query: 153 RHSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAF 212
            H ++++++G  CED H  L  E+M  GS+  HLL + G     +  +       +GL++
Sbjct: 61  NHPHIIRMLGATCEDSHFNLFVEWMAGGSV-SHLLSKYGA-FKEAVIINYTEQLLRGLSY 118

Query: 213 LHGAERPVIYRDFKTSNILLNAD-FSAKLSDFG----LAKDGPMGDQTHVSTRVMGTYGY 267
           LH  E  +I+RD K +N+L+++     +++DFG    LA  G    +     +++GT  +
Sbjct: 119 LH--ENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGE--FQGQLLGTIAF 174

Query: 268 AAPEYVMTGHLTARS-DVYGFGVVLLEMLLGR 298
            APE V+ G    RS DV+  G V++EM   +
Sbjct: 175 MAPE-VLRGEQYGRSCDVWSVGCVIIEMATAK 205

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 80.8 bits (199), Expect = 3e-17
 Identities = 63/199 (31%), Positives = 97/199 (48%), Gaps = 12/199 (6%)

Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDR-EWLAEVNYLGQLRHSNLV 158
           LG G FG V KGV     +   K   VAIK L     +  R E + E   + QL +  +V
Sbjct: 3   LGSGNFGCVKKGVY----KMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIV 58

Query: 159 KLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAER 218
           ++IG  CE E  +LV E    G L K L  +    +T S  +++    + G+ +L G  +
Sbjct: 59  RMIG-VCEAEALMLVMEMASGGPLNKFLSGKKD-EITVSNVVELMHQVSMGMKYLEG--K 114

Query: 219 PVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTY--GYAAPEYVMTG 276
             ++RD    N+LL     AK+SDFGL+K     D ++   R  G +   + APE +   
Sbjct: 115 NFVHRDLAARNVLLVNQHYAKISDFGLSK-ALGADDSYYKARSAGKWPLKWYAPECINFR 173

Query: 277 HLTARSDVYGFGVVLLEML 295
             ++RSDV+ +G+ + E  
Sbjct: 174 KFSSRSDVWSYGITMWEAF 192

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 81.3 bits (201), Expect = 4e-17
 Identities = 84/300 (28%), Positives = 130/300 (43%), Gaps = 51/300 (17%)

Query: 100 LGEGGFGVVYKGVIDENVRPGYKTT--FVAIKELNRGGYQGDREWLAEVNYLGQLRHSNL 157
           LG+G FG V     D    P    T   VA+K+L     +  R++  E+  L  L+H N+
Sbjct: 12  LGKGNFGSVELCRYD----PLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNI 67

Query: 158 VKLIGYCCEDEHR--ILVYEYMESGSL----EKHLLRRVGCMLTWSRRMKIALDAAKGLA 211
           VK  G C     R   LV EY+  GSL    +KH  R     L   + +  A    KG+ 
Sbjct: 68  VKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRER-----LDHRKLLLYASQICKGME 122

Query: 212 FLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMG---TYGYA 268
           +L    +  ++RD  T NIL+ ++   K+ DFGL K  P  D+ +   R  G    + Y 
Sbjct: 123 YL--GSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQ-DKEYYKVREPGESPIFWY- 178

Query: 269 APEYVMTGHLTARSDVYGFGVVLLEML-------------LGRRAVDKSRPSREHNLVEW 315
           APE +     +  SDV+ FGVVL E+              +     DK      ++L+E 
Sbjct: 179 APESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIE- 237

Query: 316 ARPLLNNNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETVQ 375
              LL NN ++     P   G        ++  +  +C + +P  RP  S++   +E ++
Sbjct: 238 ---LLKNNGRL-----PAPPG-----CPAEIYAIMKECWNNDPSQRPSFSELALQVEAIR 284

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 80.6 bits (199), Expect = 5e-17
 Identities = 74/272 (27%), Positives = 117/272 (43%), Gaps = 42/272 (15%)

Query: 99  ILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLA-EVNYLGQLRHS-- 155
           ++G G +G VY+G    +V  G     VA+K +N      D   +  EV  L QLR S  
Sbjct: 8   LIGRGAYGAVYRGK---HVPTG---RVVALKIINLDTPDDDVSDIQREVALLSQLRQSQP 61

Query: 156 -NLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCM--LTWSRRMKIALDAAKGLAF 212
            N+ K  G   +     ++ EY E GS+    L + G +     S  ++  L A   L +
Sbjct: 62  PNITKYYGSYLKGPRLWIIMEYAEGGSVRT--LMKAGPIAEKYISVIIREVLVA---LKY 116

Query: 213 LHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEY 272
           +H     VI+RD K +NIL+    + KL DFG+A    +   +   +  +GT  + APE 
Sbjct: 117 IHKV--GVIHRDIKAANILVTNTGNVKLCDFGVAAL--LNQNSSKRSTFVGTPYWMAPEV 172

Query: 273 VMTGHL-TARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRILD 331
           +  G     ++D++  G+ + EM  G          R   L+  ++P             
Sbjct: 173 ITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSKP------------- 219

Query: 332 PRLEGQYTARTAMK--VAGLAYQCLSQNPKGR 361
           PRLE    +   ++  VA     CL + PK R
Sbjct: 220 PRLEDNGYS-KLLREFVAA----CLDEEPKER 246

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 81.5 bits (202), Expect = 5e-17
 Identities = 70/225 (31%), Positives = 108/225 (48%), Gaps = 55/225 (24%)

Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKEL-----NRGGYQGDREWLAEVNYLGQLR- 153
           LG+G +G+V+K  ID   +       VA+K++     N    Q  R +  E+ +L +L  
Sbjct: 15  LGKGAYGIVWKA-IDRRTK-----EVVALKKIFDAFRNATDAQ--RTF-REIMFLQELGD 65

Query: 154 HSNLVKLIGYCCEDEHR-------ILVYEYMES---GSLEKHLLRRVGCMLTWSRRMKIA 203
           H N+VKL+     +  +        LV+EYME+     +  ++L  V        +  I 
Sbjct: 66  HPNIVKLL-----NVIKAENDKDIYLVFEYMETDLHAVIRANILEDV-------HKRYIM 113

Query: 204 LDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAK-----DGPMGDQT--- 255
               K L ++H     VI+RD K SNILLN+D   KL+DFGLA+     +    +     
Sbjct: 114 YQLLKALKYIHSGN--VIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTD 171

Query: 256 HVSTRVMGTYGYAAPEYVMTG--HLTARSDVYGFGVVLLEMLLGR 298
           +V+TR      Y APE ++ G    T   D++  G +L EMLLG+
Sbjct: 172 YVATR-----WYRAPE-ILLGSTRYTKGVDMWSVGCILGEMLLGK 210

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 80.8 bits (199), Expect = 5e-17
 Identities = 62/216 (28%), Positives = 104/216 (48%), Gaps = 14/216 (6%)

Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDR-EWLAEVNYLGQLRHSNLV 158
           LGEG +  V+KG      R       VA+KE+     +G     + EV+ L  L+H+N+V
Sbjct: 13  LGEGTYATVFKG------RSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIV 66

Query: 159 KLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAER 218
            L      +    LV+EY++S    K  L   G +++            +GL++ H  +R
Sbjct: 67  TLHDIIHTERCLTLVFEYLDSDL--KQYLDNCGNLMSMHNVKIFMFQLLRGLSYCH--KR 122

Query: 219 PVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVM-TGH 277
            +++RD K  N+L+N     KL+DFGLA+   +  +T+ +  V  T  Y  P+ ++ +  
Sbjct: 123 KILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVV--TLWYRPPDVLLGSTE 180

Query: 278 LTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLV 313
            +   D++G G +L EM  GR     S    E +L+
Sbjct: 181 YSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLI 216

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 80.7 bits (200), Expect = 6e-17
 Identities = 66/212 (31%), Positives = 100/212 (47%), Gaps = 35/212 (16%)

Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREW-----LAEVNYLGQL-R 153
           LG+G FG VY     E          VAIK++ +  Y     W     L EV  L +L  
Sbjct: 7   LGDGTFGSVYLARNKET------GELVAIKKMKKKFYS----WEECMNLREVKSLRKLNE 56

Query: 154 HSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFL 213
           H N+VKL     E++    V+EYME G+L + +  R G   + S    I     +GLA +
Sbjct: 57  HPNIVKLKEVFRENDELYFVFEYME-GNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHI 115

Query: 214 H--GAERPVIYRDFKTSNILLNADFSAKLSDFGLAKD----GPMGDQTHVSTRVMGTYGY 267
           H  G      +RD K  N+L++     K++DFGLA++     P  D  +VSTR      Y
Sbjct: 116 HKHG----FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTD--YVSTR-----WY 164

Query: 268 AAPEYVM-TGHLTARSDVYGFGVVLLEMLLGR 298
            APE ++ +   ++  D++  G ++ E+   R
Sbjct: 165 RAPEILLRSTSYSSPVDIWALGCIMAELYTLR 196

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 80.6 bits (199), Expect = 6e-17
 Identities = 62/202 (30%), Positives = 101/202 (50%), Gaps = 14/202 (6%)

Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGD-REWLAEVNYLGQLRHSNLV 158
           LGEG +  VYKG      R       VA+KE++    +G     + E++ + +L+H N+V
Sbjct: 8   LGEGTYATVYKG------RNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIV 61

Query: 159 KLIGYCCEDEHRILVYEYMESGSLEKHL-LRRVGCMLTWSRRMKIALDAAKGLAFLHGAE 217
           +L      +   +LV+EYM+   L+K++    V   L  +          KG+AF H  E
Sbjct: 62  RLHDVIHTENKLMLVFEYMD-KDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCH--E 118

Query: 218 RPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGH 277
             V++RD K  N+L+N     KL+DFGLA+   +   T  +  V  T  Y AP+ ++   
Sbjct: 119 NRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVV--TLWYRAPDVLLGSR 176

Query: 278 LTARS-DVYGFGVVLLEMLLGR 298
             + S D++  G ++ EM+ GR
Sbjct: 177 TYSTSIDIWSVGCIMAEMITGR 198

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 80.0 bits (197), Expect = 7e-17
 Identities = 60/207 (28%), Positives = 103/207 (49%), Gaps = 15/207 (7%)

Query: 99  ILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWL-AEVNYLGQLRHSNL 157
           +LG+G +G VY G+ ++      K   V +   N    + + E L  EV+ L  L+H N+
Sbjct: 7   VLGKGAYGTVYCGLTNQGQLIAVKQ--VELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNI 64

Query: 158 VKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCM--LTWSRRMKIALDAAKGLAFLHG 215
           V+ +G C +D    +  E++  GS+   +L R G +    + +  K  LD   G+A+LH 
Sbjct: 65  VQYLGTCLDDNTISIFMEFVPGGSISS-ILNRFGPLPEPVFCKYTKQILD---GVAYLH- 119

Query: 216 AERPVIYRDFKTSNILLNADFSAKLSDFGLAKD----GPMGDQTHVSTRVMGTYGYAAPE 271
               V++RD K +N++L  +   KL DFG A+     G  G  +++   + GT  + APE
Sbjct: 120 -NNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPE 178

Query: 272 YVMTGHLTARSDVYGFGVVLLEMLLGR 298
            +       +SD++  G  + EM  G+
Sbjct: 179 VINESGYGRKSDIWSIGCTVFEMATGK 205

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 80.2 bits (198), Expect = 9e-17
 Identities = 71/209 (33%), Positives = 99/209 (47%), Gaps = 38/209 (18%)

Query: 100 LGEGGFGVVY--KGVIDENVRPGYKTTFVAIKELNRGGYQGDREW---LAEVNYLGQLRH 154
           +G G FG VY  + V    V        VAIK+++  G Q + +W   + EV +L QLRH
Sbjct: 23  IGHGSFGAVYFARDVRTNEV--------VAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRH 74

Query: 155 SNLVKLIGYCCEDEHRI-LVYEY-MESGS--LEKHL--LRRVGCMLTWSRRMKIALDAAK 208
            N ++  G C   EH   LV EY + S S  LE H   L+ V           I   A +
Sbjct: 75  PNTIEYKG-CYLREHTAWLVMEYCLGSASDILEVHKKPLQEV-------EIAAICHGALQ 126

Query: 209 GLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYA 268
           GLA+LH  ER  I+RD K  NILL    + KL+DFG A           +   +GT  + 
Sbjct: 127 GLAYLHSHER--IHRDIKAGNILLTEPGTVKLADFGSAS------LVSPANSFVGTPYWM 178

Query: 269 APEYVMT---GHLTARSDVYGFGVVLLEM 294
           APE ++    G    + DV+  G+  +E+
Sbjct: 179 APEVILAMDEGQYDGKVDVWSLGITCIEL 207

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 80.2 bits (198), Expect = 1e-16
 Identities = 65/216 (30%), Positives = 98/216 (45%), Gaps = 20/216 (9%)

Query: 99  ILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGD-REWLAEVNYLGQL-RHSN 156
            LGEG FG V K        P   +T VA+K L     + D  + ++E+  +  + +H N
Sbjct: 19  PLGEGAFGQVVKAEAVGLDNPNETST-VAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 77

Query: 157 LVKLIGYCCEDEHRILVYEYMESGSLEKHLLRR---------VGCM-----LTWSRRMKI 202
           ++ L+G C ++    +V EY   G+L   L  R                  LT    +  
Sbjct: 78  IINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSF 137

Query: 203 ALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVM 262
           A   A+G+ FL  A +  I+RD    N+L+  D   K++DFGLA+D    D    +T   
Sbjct: 138 AYQVARGMEFL--ASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGR 195

Query: 263 GTYGYAAPEYVMTGHLTARSDVYGFGVVLLE-MLLG 297
               + APE +     T +SDV+ FGV+L E   LG
Sbjct: 196 LPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLG 231

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 79.8 bits (197), Expect = 1e-16
 Identities = 58/203 (28%), Positives = 97/203 (47%), Gaps = 22/203 (10%)

Query: 100 LGEGGFGVVYKGVIDENVRPGYKTT--FVAIKELNRGGYQGDREWLAEVNYLGQLRHSNL 157
           LG+G FG VYK          +K T  F A K +     +   +++ E++ L + +H N+
Sbjct: 13  LGDGAFGKVYKAQ--------HKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNI 64

Query: 158 VKLI-GYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGA 216
           V L   Y  E++  IL+ E+ + G+L+  ++  +   LT  +   +     + L FLH  
Sbjct: 65  VGLYEAYFYENKLWILI-EFCDGGALDS-IMLELERGLTEPQIRYVCRQMLEALNFLH-- 120

Query: 217 ERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTG 276
              VI+RD K  NILL  D   KL+DFG++       Q   +   +GT  + APE V   
Sbjct: 121 SHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDT--FIGTPYWMAPEVVACE 178

Query: 277 HLT-----ARSDVYGFGVVLLEM 294
                    ++D++  G+ L+E+
Sbjct: 179 TFKDNPYDYKADIWSLGITLIEL 201

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 79.8 bits (197), Expect = 1e-16
 Identities = 56/200 (28%), Positives = 98/200 (49%), Gaps = 14/200 (7%)

Query: 100 LGEGGFGVVYKGV-IDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLV 158
           LG G  G V K   I        K   +  K   R      ++ L E+  + + R   +V
Sbjct: 13  LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVR------KQILRELQIMHECRSPYIV 66

Query: 159 KLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAER 218
              G    + +  +  E+M+ GSL++  + + G  +      KIA+   +GL +L+   R
Sbjct: 67  SFYGAFLNENNICMCMEFMDCGSLDR--IYKKGGPIPVEILGKIAVAVVEGLTYLYNVHR 124

Query: 219 PVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHL 278
            +++RD K SNIL+N+    KL DFG++  G + +   ++   +GT  Y +PE +  G  
Sbjct: 125 -IMHRDIKPSNILVNSRGQIKLCDFGVS--GELINS--IADTFVGTSTYMSPERIQGGKY 179

Query: 279 TARSDVYGFGVVLLEMLLGR 298
           T +SDV+  G+ ++E+ LG+
Sbjct: 180 TVKSDVWSLGISIIELALGK 199

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 79.1 bits (195), Expect = 1e-16
 Identities = 56/209 (26%), Positives = 98/209 (46%), Gaps = 18/209 (8%)

Query: 99  ILGEGGFGVVY--KGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLA--EVNYLGQLRH 154
           ++G G FG+V+  +   D+ +        V IK++       D    A  E   L  L H
Sbjct: 7   VVGRGAFGIVHLCRRKADQKL--------VIIKQIPVEQMTKDERLAAQNECQVLKLLSH 58

Query: 155 SNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLH 214
            N+++      ED+  ++V EY   G+L +++ +R   +L     +   +     LA  H
Sbjct: 59  PNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQIL--LALHH 116

Query: 215 GAERPVIYRDFKTSNILLNA-DFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYV 273
              + +++RD KT NILL+      K+ DFG++K   +  ++   T V+GT  Y +PE  
Sbjct: 117 VHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKI--LSSKSKAYT-VVGTPCYISPELC 173

Query: 274 MTGHLTARSDVYGFGVVLLEMLLGRRAVD 302
                  +SD++  G VL E+   +RA +
Sbjct: 174 EGKPYNQKSDIWALGCVLYELASLKRAFE 202

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 79.5 bits (196), Expect = 1e-16
 Identities = 60/216 (27%), Positives = 103/216 (47%), Gaps = 28/216 (12%)

Query: 99  ILGEGGFGVVYKGVIDENVRPGYKTTFVAIK--ELNRGGYQGDREWL--------AEVNY 148
           ++G+G +G VY  +   NV  G     +A+K  EL                    +E+  
Sbjct: 8   LIGKGTYGRVYLAL---NVTTG---EMMAVKQVELPATIAGRHDSRQKDMVKALRSEIET 61

Query: 149 LGQLRHSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCM---LTWSRRMKIALD 205
           L  L H N+V+ +G+   +E+  +  EY+  GS+    LR  G     L      ++   
Sbjct: 62  LKDLDHLNIVQYLGFETTEEYLSIFLEYVPGGSIGS-CLRTYGRFEEQLVRFFTEQVL-- 118

Query: 206 AAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTY 265
             +GLA+LH   + +++RD K  N+L++AD   K+SDFG++K          +  + G+ 
Sbjct: 119 --EGLAYLH--SKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSV 174

Query: 266 GYAAPEYVMTGH--LTARSDVYGFGVVLLEMLLGRR 299
            + APE + +     +A+ D++  G V+LEM  GRR
Sbjct: 175 FWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRR 210

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 79.3 bits (195), Expect = 2e-16
 Identities = 79/303 (26%), Positives = 131/303 (43%), Gaps = 36/303 (11%)

Query: 86  EMKLATKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDRE-WLA 144
           E+ L+T  F  +  LGE  FG VYKG +     PG +T  VAIK L        RE +  
Sbjct: 1   EINLSTVRFMEE--LGEDRFGKVYKGHL-FGTAPGEQTQAVAIKTLKDKAEGPLREEFKH 57

Query: 145 EVNYLGQLRHSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRR--------------V 190
           E     +L+H N+V L+G   +++   +++ Y     L + L+ R              V
Sbjct: 58  EAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTV 117

Query: 191 GCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGP 250
              L  +  + I    A G+ FL  +   V+++D  T N+L+    + K+SD GL ++  
Sbjct: 118 KSTLEPADFVHIVTQIAAGMEFL--SSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVY 175

Query: 251 MGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREH 310
             D   +    +    + +PE +M G  +  SD++ +GVVL E+      +         
Sbjct: 176 AADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVF--SYGLQPYCGYSNQ 233

Query: 311 NLVEWARPLLNNNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVAL 370
           +++E  R     N++VL   D      YT         L  +C ++ P  RP   D+ + 
Sbjct: 234 DVIEMIR-----NRQVLPCPDDCPAWVYT---------LMLECWNEFPSRRPRFKDIHSR 279

Query: 371 LET 373
           L T
Sbjct: 280 LRT 282

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 78.7 bits (195), Expect = 2e-16
 Identities = 65/215 (30%), Positives = 94/215 (43%), Gaps = 46/215 (21%)

Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGY----QGDREWLAEVNYLGQLRHS 155
           LG G FG V        VR      + A+K L++       Q +   L E   L  +RH 
Sbjct: 9   LGTGSFGRVML------VRHKGSGKYYALKILSKAKIVKLKQVEHV-LNEKRILQSIRHP 61

Query: 156 NLVKLIGYCCEDEHRI-LVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAK------ 208
            LV L G   +D+  + LV EY+  G L    LR+ G         +     A+      
Sbjct: 62  FLVNLYG-SFQDDSNLYLVMEYVPGGEL-FSHLRKSG---------RFPEPVARFYAAQV 110

Query: 209 --GLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVM---G 263
              L +LH  +  ++YRD K  N+LL++D   K++DFG AK         V  R     G
Sbjct: 111 VLALEYLHSLD--IVYRDLKPENLLLDSDGYIKITDFGFAK--------RVKGRTYTLCG 160

Query: 264 TYGYAAPEYVM-TGHLTARSDVYGFGVVLLEMLLG 297
           T  Y APE ++  G+  A  D +  G+++ EML G
Sbjct: 161 TPEYLAPEIILSKGYGKA-VDWWALGILIYEMLAG 194

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 78.5 bits (194), Expect = 3e-16
 Identities = 65/222 (29%), Positives = 96/222 (43%), Gaps = 49/222 (22%)

Query: 99  ILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDR--EWLAEVNYLGQL-RHS 155
           ++GEG +G VYK     + + G     VAIK ++      D   E   E N L +   H 
Sbjct: 13  VIGEGTYGKVYKAR---HKKTGQL---VAIKIMD---IIEDEEEEIKEEYNILRKYSNHP 63

Query: 156 NLVKLIG-------YCCEDEHRILVYEYMESGS---LEKHLLRRVGCMLTWSRRMK---- 201
           N+    G          +D+   LV E    GS   L K L ++        +R+K    
Sbjct: 64  NIATFYGAFIKKNPPGNDDQ-LWLVMELCGGGSVTDLVKGLRKK-------GKRLKEEWI 115

Query: 202 --IALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVST 259
             I  +  +GLA+LH  E  VI+RD K  NILL  +   KL DFG++        + +  
Sbjct: 116 AYILRETLRGLAYLH--ENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQL----DSTLGR 169

Query: 260 R--VMGTYGYAAPEYVM-----TGHLTARSDVYGFGVVLLEM 294
           R   +GT  + APE +           ARSDV+  G+  +E+
Sbjct: 170 RNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIEL 211

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 77.9 bits (192), Expect = 4e-16
 Identities = 74/281 (26%), Positives = 119/281 (42%), Gaps = 47/281 (16%)

Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGY-QGDRE-WLAEVNYLGQLRHSNL 157
           LG+G +G VYK      V+      F A+KE++ G   Q +RE  + E+  L  + H N+
Sbjct: 8   LGKGSYGSVYK------VKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNI 61

Query: 158 VK-----LIGYCCEDEHRIL--VYEYMESGSLEKHLLRR--VGCMLTWSRRMKIALDAAK 208
           +      L G         L  V EY   G L K + +R     ++      +I +   +
Sbjct: 62  ISYKEAFLDG-------NKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLR 114

Query: 209 GLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYA 268
           GL  LH  E+ +++RD K++NILL A+   K+ D G++K   +  +    T  +GT  Y 
Sbjct: 115 GLQALH--EQKILHRDLKSANILLVANDLVKIGDLGISK---VLKKNMAKT-QIGTPHYM 168

Query: 269 APEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLR 328
           APE       + +SD++  G +L EM       +             AR + +   KV R
Sbjct: 169 APEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFE-------------ARSMQDLRYKVQR 215

Query: 329 ILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVA 369
              P +   Y+      +       L   PK RP    ++A
Sbjct: 216 GKYPPIPPIYSQ----DLQNFIRSMLQVKPKLRPNCDKILA 252

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 77.8 bits (192), Expect = 4e-16
 Identities = 78/283 (27%), Positives = 111/283 (39%), Gaps = 55/283 (19%)

Query: 100 LGEGGFGVVYKGV-IDENVRPGYKTTFVAIKELNRGGYQGD-REWLAEVNYLGQLRHSNL 157
           +G G   VVY  + +  N +       VAIK ++    Q    E   EV  + Q  H N+
Sbjct: 9   IGVGATAVVYAAICLPNNEK-------VAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNV 61

Query: 158 VKLIGYCCEDEHRILVYEYMESGSLE---KHLLRRVG----CMLTWSRRMKIALDAAKGL 210
           VK        +   LV  Y+  GSL    K    R G     + T      +  +  KGL
Sbjct: 62  VKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIAT------VLKEVLKGL 115

Query: 211 AFLHGAERPVIYRDFKTSNILLNADFSAKLSDFG----LAKDGPMGDQTHVSTRVMGTYG 266
            +LH   +  I+RD K  NILL  D S K++DFG    LA  G       V    +GT  
Sbjct: 116 EYLHSNGQ--IHRDIKAGNILLGEDGSVKIADFGVSASLADGG--DRTRKVRKTFVGTPC 171

Query: 267 YAAPEYVMTGH--LTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNK 324
           + APE VM        ++D++ FG+  +E+  G     K  P +   L       L N+ 
Sbjct: 172 WMAPE-VMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLML------TLQNDP 224

Query: 325 KVLRILDPRLEGQYTARTAMKVAGLAY-----QCLSQNPKGRP 362
                  P LE         K    ++      CL ++P  RP
Sbjct: 225 -------PSLE----TGADYKKYSKSFRKMISLCLQKDPSKRP 256

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 78.5 bits (193), Expect = 4e-16
 Identities = 59/201 (29%), Positives = 98/201 (48%), Gaps = 14/201 (6%)

Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDR-EWLAEVNYLGQLRHSNLV 158
           LGEG +  V+KG      R       VA+KE+     +G     + EV+ L  L+H+N+V
Sbjct: 14  LGEGTYATVFKG------RSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIV 67

Query: 159 KLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAER 218
            L      D+   LV+EY++     K  +   G +++            +GLA+ H   R
Sbjct: 68  TLHDIVHTDKSLTLVFEYLDKDL--KQYMDDCGNIMSMHNVKIFLYQILRGLAYCH--RR 123

Query: 219 PVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVM-TGH 277
            V++RD K  N+L+N     KL+DFGLA+   +  +T+ +  V  T  Y  P+ ++ +  
Sbjct: 124 KVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVV--TLWYRPPDVLLGSSE 181

Query: 278 LTARSDVYGFGVVLLEMLLGR 298
            + + D++G G +  EM  GR
Sbjct: 182 YSTQIDMWGVGCIFFEMASGR 202

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 77.2 bits (190), Expect = 6e-16
 Identities = 56/206 (27%), Positives = 89/206 (43%), Gaps = 17/206 (8%)

Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKEL-NRGGYQGDREWLAEVNYLGQLRHSNLV 158
           +G G FG V  G        G     V +KEL           +L EV    +L H N++
Sbjct: 3   IGNGWFGKVLLG----EAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVL 58

Query: 159 KLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRM---KIALDAAKGLAFLHG 215
           + +G C E    +LV E+   G L+ +L    G +   +++    ++A + A GL +LH 
Sbjct: 59  QCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQ 118

Query: 216 AERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYV-- 273
           A+   I+ D    N  L AD S K+ D+GLA +    D             + APE V  
Sbjct: 119 AD--FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEI 176

Query: 274 -----MTGHLTARSDVYGFGVVLLEM 294
                +    T +S+++  GV + E+
Sbjct: 177 RGQDLLPKDQTKKSNIWSLGVTMWEL 202

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 76.8 bits (189), Expect = 8e-16
 Identities = 56/198 (28%), Positives = 98/198 (49%), Gaps = 16/198 (8%)

Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVK 159
           LG G +G VY+GV  +     Y  T VA+K L     + + E+L E   + +++H NLV+
Sbjct: 14  LGGGQYGEVYEGVWKK-----YSLT-VAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQ 66

Query: 160 LIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERP 219
           L+G C  +    ++ E+M  G+L  +L       +     + +A   +  + +L   ++ 
Sbjct: 67  LLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE--KKN 124

Query: 220 VIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGT---YGYAAPEYVMTG 276
            I+RD    N L+  +   K++DFGL++   M   T+  T   G      + APE +   
Sbjct: 125 FIHRDLAARNCLVGENHLVKVADFGLSR--LMTGDTY--TAHAGAKFPIKWTAPESLAYN 180

Query: 277 HLTARSDVYGFGVVLLEM 294
             + +SDV+ FGV+L E+
Sbjct: 181 KFSIKSDVWAFGVLLWEI 198

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 76.5 bits (188), Expect = 1e-15
 Identities = 54/201 (26%), Positives = 96/201 (47%), Gaps = 17/201 (8%)

Query: 99  ILGEGGFGVVY--KGVIDENVRPGYKTTFVAIKELN--RGGYQGDREWLAEVNYLGQLRH 154
            +GEG FG +Y  K   D        +    IKE++  +   +       EV  L +++H
Sbjct: 7   KIGEGSFGKIYLAKAKSD--------SEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKH 58

Query: 155 SNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLH 214
            N+V       E+    +V EY + G L K + R+ G + +  + +   +  + GL  +H
Sbjct: 59  PNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIH 118

Query: 215 GAERPVIYRDFKTSNILLNAD-FSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYV 273
             +R +++RD K+ NI L+ +   AKL DFG+A+   + D   ++   +GT  Y +PE  
Sbjct: 119 --DRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQ--LNDSMELAYTCVGTPYYLSPEIC 174

Query: 274 MTGHLTARSDVYGFGVVLLEM 294
                  ++D++  G VL E+
Sbjct: 175 QNRPYNNKTDIWSLGCVLYEL 195

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 76.9 bits (189), Expect = 1e-15
 Identities = 61/200 (30%), Positives = 97/200 (48%), Gaps = 9/200 (4%)

Query: 100 LGEGGFGVVYKGVID-ENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLV 158
           LGEG FG V     D E    G +    ++K  + G +  D +   E+  L  L H N+V
Sbjct: 12  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLK--KEIEILRNLYHENIV 69

Query: 159 KLIGYCCEDEHR--ILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGA 216
           K  G C ED      L+ E++ SGSL+++L R     +   +++K A+   KG+ +L   
Sbjct: 70  KYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKN-KINLKQQLKYAVQICKGMDYL--G 126

Query: 217 ERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTH-VSTRVMGTYGYAAPEYVMT 275
            R  ++RD    N+L+ ++   K+ DFGL K      + + V   +     + APE ++ 
Sbjct: 127 SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQ 186

Query: 276 GHLTARSDVYGFGVVLLEML 295
                 SDV+ FGV L E+L
Sbjct: 187 SKFYIASDVWSFGVTLYELL 206

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 77.0 bits (189), Expect = 1e-15
 Identities = 63/215 (29%), Positives = 109/215 (50%), Gaps = 29/215 (13%)

Query: 99  ILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGD-REWLAEVNYLGQL-RHSN 156
           ++GEG FG V + +I ++   G K    AIK L     + D R++  E+  L +L  H N
Sbjct: 9   VIGEGNFGQVIRAMIKKD---GLKMN-AAIKMLKEFASENDHRDFAGELEVLCKLGHHPN 64

Query: 157 LVKLIGYCCEDEHRILVYEYMESGSLEKHLLR-RV-------------GCMLTWSRRMKI 202
           ++ L+G C    +  +  EY   G+L   L + RV                LT  + ++ 
Sbjct: 65  IINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQF 124

Query: 203 ALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVM 262
           A D A G+ +L  +E+  I+RD    N+L+  + ++K++DFGL++    G++ +V  + M
Sbjct: 125 ASDVATGMQYL--SEKQFIHRDLAARNVLVGENLASKIADFGLSR----GEEVYVK-KTM 177

Query: 263 GTYG--YAAPEYVMTGHLTARSDVYGFGVVLLEML 295
           G     + A E +     T +SDV+ FGV+L E++
Sbjct: 178 GRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIV 212

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 76.4 bits (188), Expect = 1e-15
 Identities = 62/207 (29%), Positives = 100/207 (48%), Gaps = 24/207 (11%)

Query: 99  ILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQ------- 151
           +LG+G FG VY      +V  G +   +A+K++         E   EVN L         
Sbjct: 9   LLGQGAFGRVYLCY---DVDTGRE---LAVKQVPFD--PDSPETKKEVNALECEIQLLKN 60

Query: 152 LRHSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLA 211
           L+H  +V+  G   +DE   +  EYM  GS++   L+  G  LT +   K      +G+ 
Sbjct: 61  LQHERIVQYYGCLRDDETLSIFMEYMPGGSVKDQ-LKAYGA-LTETVTRKYTRQILEGVE 118

Query: 212 FLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAK--DGPMGDQTHVSTRVMGTYGYAA 269
           +LH     +++RD K +NIL ++  + KL DFG +K         T + + V GT  + +
Sbjct: 119 YLHSNM--IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKS-VTGTPYWMS 175

Query: 270 PEYVMTGHLTAR-SDVYGFGVVLLEML 295
           PE V++G    R +DV+  G  ++EML
Sbjct: 176 PE-VISGEGYGRKADVWSVGCTVVEML 201

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 77.0 bits (190), Expect = 1e-15
 Identities = 65/213 (30%), Positives = 97/213 (45%), Gaps = 33/213 (15%)

Query: 99  ILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDRE-------WLAEVNYLGQ 151
            +GEG +G+VY+       R       VA+K++     + D E        L E+  L  
Sbjct: 14  RIGEGTYGIVYRA------RDTTSGEIVALKKV-----RMDNERDGIPISSLREITLLLN 62

Query: 152 LRHSNLVKLIGYCCED--EHRILVYEYMES--GSLEKHLLRRVGCMLTWSRRMKIALDAA 207
           LRH N+V+L         +   LV EY E    SL    L  +    + S+   + L   
Sbjct: 63  LRHPNIVELKEVVVGKHLDSIFLVMEYCEQDLASL----LDNMPTPFSESQVKCLMLQLL 118

Query: 208 KGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGY 267
           +GL +LH  E  +I+RD K SN+LL      K++DFGLA+    G      T  + T  Y
Sbjct: 119 RGLQYLH--ENFIIHRDLKVSNLLLTDKGCLKIADFGLAR--TYGLPAKPMTPKVVTLWY 174

Query: 268 AAPEYV--MTGHLTARSDVYGFGVVLLEMLLGR 298
            APE +   T + TA  D++  G +L E+L  +
Sbjct: 175 RAPELLLGCTTYTTA-IDMWAVGCILAELLAHK 206

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 76.1 bits (188), Expect = 1e-15
 Identities = 64/205 (31%), Positives = 95/205 (46%), Gaps = 22/205 (10%)

Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNR-----GGYQGDREWLAEVNYLGQLRH 154
           LG GGFG V   V  ++       TF A+K + +      G Q      +E   L +  H
Sbjct: 1   LGVGGFGRVEL-VKVKS----KNRTF-ALKCVKKRHIVETGQQ--EHIFSEKEILEECNH 52

Query: 155 SNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLH 214
             +VKL     + ++  ++ EY   G L   +LR  G    ++ R  IA        +LH
Sbjct: 53  PFIVKLYRTFKDKKYIYMLMEYCLGGEL-WTILRDRGLFDEYTARFYIAC-VVLAFEYLH 110

Query: 215 GAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVM 274
              R +IYRD K  N+LL+++   KL DFG AK    G +T       GT  Y APE ++
Sbjct: 111 --NRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWT---FCGTPEYVAPEIIL 165

Query: 275 T-GHLTARSDVYGFGVVLLEMLLGR 298
             G+  +  D +  G++L E+L GR
Sbjct: 166 NKGYDFS-VDYWSLGILLYELLTGR 189

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 77.4 bits (190), Expect = 1e-15
 Identities = 63/214 (29%), Positives = 104/214 (48%), Gaps = 21/214 (9%)

Query: 100 LGEGGFG--VVYKGVIDENVRPGYKTTFVAIKELNRGGYQGD-REWLAEVNYLGQL-RHS 155
           LGEG FG  V+ + +  +  +P  K   VA+K L       D  + ++E+  +  + +H 
Sbjct: 20  LGEGCFGQVVMAEAIGIDKDKPN-KPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHK 78

Query: 156 NLVKLIGYCCEDEHRILVYEYMESGSLEKHL-LRRVGCM-------------LTWSRRMK 201
           N++ L+G C +D    ++ EY   G+L ++L  RR   M             LT+   + 
Sbjct: 79  NIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVS 138

Query: 202 IALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRV 261
            A   A+G+ +L  A +  I+RD    N+L+  D   K++DFGLA+D    D    +T  
Sbjct: 139 CAYQVARGMEYL--ASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNG 196

Query: 262 MGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEML 295
                + APE +     T +SDV+ FGV+L E+ 
Sbjct: 197 RLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIF 230

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 76.8 bits (190), Expect = 2e-15
 Identities = 64/222 (28%), Positives = 97/222 (43%), Gaps = 46/222 (20%)

Query: 99  ILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNR-------GGYQGDREWLAEVNYLGQ 151
            +G G +GVV   V   + R G K   VAIK+++              +  L E+  L  
Sbjct: 7   PIGSGAYGVVCSAV---DKRTGRK---VAIKKISNVFDDLIDA-----KRILREIKLLRH 55

Query: 152 LRHSNLVKLI-----GYCCEDEHRILVYEYMESGSLEKHLLRRV---GCMLTWSRRMKIA 203
           LRH N++ L+         +     +V E ME+       L +V      LT        
Sbjct: 56  LRHENIIGLLDILRPPSPEDFNDVYIVTELMETD------LHKVIKSPQPLTDDHIQYFL 109

Query: 204 LDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAK-----DGPMGDQT-HV 257
               +GL +LH A   VI+RD K SNIL+N++   K+ DFGLA+     +   G  T +V
Sbjct: 110 YQILRGLKYLHSAN--VIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYV 167

Query: 258 STRVMGTYGYAAPEYVMTG-HLTARSDVYGFGVVLLEMLLGR 298
            TR      Y APE +++    T   D++  G +  E+L  +
Sbjct: 168 VTRW-----YRAPELLLSSSRYTKAIDIWSVGCIFAELLTRK 204

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 76.6 bits (188), Expect = 2e-15
 Identities = 63/213 (29%), Positives = 103/213 (48%), Gaps = 19/213 (8%)

Query: 100 LGEGGFG-VVYKGVIDENVRPGYKTTFVAIKELNRGGYQGD-REWLAEVNYLGQL-RHSN 156
           LGEG FG VV    I  +     + T VA+K L     + D  + ++E+  +  + +H N
Sbjct: 26  LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85

Query: 157 LVKLIGYCCEDEHRILVYEYMESGSLEKHL-LRRVGCM-------------LTWSRRMKI 202
           ++ L+G C +D    ++ EY   G+L ++L  RR   M             L++   +  
Sbjct: 86  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSC 145

Query: 203 ALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVM 262
           A   A+G+ +L  A +  I+RD    N+L+  D   K++DFGLA+D    D    +T   
Sbjct: 146 AYQVARGMEYL--ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGR 203

Query: 263 GTYGYAAPEYVMTGHLTARSDVYGFGVVLLEML 295
               + APE +     T +SDV+ FGV+L E+ 
Sbjct: 204 LPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIF 236

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 75.6 bits (186), Expect = 2e-15
 Identities = 69/271 (25%), Positives = 123/271 (45%), Gaps = 29/271 (10%)

Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELN--RGGYQGDREWLAEVNYLGQLRHSNL 157
           +GEG FG   K ++ ++   G +  +V IKE+N  +   +   E   EV  L  ++H N+
Sbjct: 8   IGEGSFG---KAILVKSKEDGKQ--YV-IKEINISKMSPKEREESRKEVAVLSNMKHPNI 61

Query: 158 VKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAE 217
           V+      E+ +  +V +Y E G L K +  + G +    + +   +     L  +H  +
Sbjct: 62  VQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVH--D 119

Query: 218 RPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGH 277
           R +++RD K+ NI L  D + KL DFG+A+   +     ++   +GT  Y +PE      
Sbjct: 120 RKILHRDIKSQNIFLTKDGTIKLGDFGIAR--VLNSTVELARTCIGTPYYLSPEICENRP 177

Query: 278 LTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRILDPRLEGQ 337
              +SD++  G VL EM   + A +        NLV           K++R   P +   
Sbjct: 178 YNNKSDIWALGCVLYEMCTLKHAFEAGNMK---NLV----------LKIIRGSYPPVSSH 224

Query: 338 YTARTAMKVAGLAYQCLSQNPKGRPVMSDVV 368
           Y+      V+    Q   +NP+ RP ++ ++
Sbjct: 225 YSYDLRNLVS----QLFKRNPRDRPSVNSIL 251

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 75.9 bits (186), Expect = 2e-15
 Identities = 60/215 (27%), Positives = 103/215 (47%), Gaps = 29/215 (13%)

Query: 99  ILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGD-REWLAEVNYLGQL-RHSN 156
           ++GEG FG V K  I ++   G +    AIK +     + D R++  E+  L +L  H N
Sbjct: 2   VIGEGNFGQVLKARIKKD---GLRMD-AAIKRMKEYASKDDHRDFAGELEVLCKLGHHPN 57

Query: 157 LVKLIGYCCEDEHRILVYEYMESGSL------------EKHLLRRVGCMLTWSRR--MKI 202
           ++ L+G C    +  L  EY   G+L            +           T S +  +  
Sbjct: 58  IINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHF 117

Query: 203 ALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVM 262
           A D A+G+ +L  +++  I+RD    NIL+  ++ AK++DFGL++    G + +V  + M
Sbjct: 118 AADVARGMDYL--SQKQFIHRDLAARNILVGENYVAKIADFGLSR----GQEVYVK-KTM 170

Query: 263 GTYG--YAAPEYVMTGHLTARSDVYGFGVVLLEML 295
           G     + A E +     T  SDV+ +GV+L E++
Sbjct: 171 GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIV 205

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 76.2 bits (187), Expect = 3e-15
 Identities = 65/207 (31%), Positives = 92/207 (44%), Gaps = 22/207 (10%)

Query: 99  ILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDRE---WLAEVNYLG-QLRH 154
           +LG+G FG V+   +           F AIK L +     D +    + E   L     H
Sbjct: 2   MLGKGSFGKVFLAELKGT------NQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEH 55

Query: 155 SNLVKLIGYCC--EDEHRILVYEYMESGSLEKHLLRRVGC-MLTWSRRMKIALDAAKGLA 211
             L  L  YC     E+   V EY+  G L  H+     C      R    A +   GL 
Sbjct: 56  PFLTHL--YCTFQTKENLFFVMEYLNGGDLMFHIQ---SCHKFDLPRATFYAAEIICGLQ 110

Query: 212 FLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPE 271
           FLH   + ++YRD K  NILL+ D   K++DFG+ K+  +GD    +    GT  Y APE
Sbjct: 111 FLH--SKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAK--TCTFCGTPDYIAPE 166

Query: 272 YVMTGHLTARSDVYGFGVVLLEMLLGR 298
            ++        D + FGV+L EML+G+
Sbjct: 167 ILLGQKYNTSVDWWSFGVLLYEMLIGQ 193

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 75.9 bits (187), Expect = 3e-15
 Identities = 43/130 (33%), Positives = 75/130 (57%), Gaps = 19/130 (14%)

Query: 175 EYMESGSLEKHLLRRVGCMLTWSRRM------KIALDAAKGLAFLHGAERPVIYRDFKTS 228
           E+M+ GSL++ +L++ G       R+      KI++   +GL +L   +  +++RD K S
Sbjct: 79  EHMDGGSLDQ-VLKKAG-------RIPENILGKISIAVLRGLTYLR-EKHKIMHRDVKPS 129

Query: 229 NILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFG 288
           NIL+N+    KL DFG++  G + D   ++   +GT  Y +PE +   H T +SD++  G
Sbjct: 130 NILVNSRGEIKLCDFGVS--GQLIDS--MANSFVGTRSYMSPERLQGTHYTVQSDIWSLG 185

Query: 289 VVLLEMLLGR 298
           + L+EM +GR
Sbjct: 186 LSLVEMAIGR 195

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 76.0 bits (187), Expect = 3e-15
 Identities = 65/210 (30%), Positives = 92/210 (43%), Gaps = 28/210 (13%)

Query: 99  ILGEGGFGVVY----KGVIDENVRPGYKTTFVAIKELNRGGYQGDRE---WLAEVNYLG- 150
           +LG+G FG V     KG             F AIK L +     D +    + E   L  
Sbjct: 2   VLGKGSFGKVMLAELKG----------TNEFFAIKALKKDVVLEDDDVECTMVERRVLAL 51

Query: 151 QLRHSNLVKLIGYCC--EDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAK 208
              H  L  L  +C     EH   V EY+  G L  H+          +R    A +   
Sbjct: 52  AWEHPFLTHL--FCTFQTKEHLFFVMEYLNGGDLMFHIQSSG--RFDEARARFYAAEIIC 107

Query: 209 GLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYA 268
           GL FLH  ++ +IYRD K  N+LL+ D   K++DFG+ K+   G+    ++   GT  Y 
Sbjct: 108 GLQFLH--KKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGK--ASTFCGTPDYI 163

Query: 269 APEYVMTGHLTARSDVYGFGVVLLEMLLGR 298
           APE +         D + FGV+L EML+G+
Sbjct: 164 APEILKGQKYNESVDWWSFGVLLYEMLIGQ 193

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 75.5 bits (186), Expect = 3e-15
 Identities = 64/205 (31%), Positives = 96/205 (46%), Gaps = 21/205 (10%)

Query: 99  ILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLA--EVNYLGQLRHSN 156
           ++GEG +G+V K    E  +       VAIK+          + +A  E+  L QLRH N
Sbjct: 8   LVGEGSYGMVMKCKHKETGQ------IVAIKKFLESEDDKMVKKIAMREIRMLKQLRHEN 61

Query: 157 LVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGA 216
           LV LI      +   LV+E+++   L+   L +    L  SR  K      +G+ F H  
Sbjct: 62  LVNLIEVFRRKKRLYLVFEFVDHTVLDD--LEKYPNGLDESRVRKYLFQILRGIEFCHSH 119

Query: 217 ERPVIYRDFKTSNILLNADFSAKLSDFGLAK--DGPMGDQT-HVSTRVMGTYGYAAPEYV 273
              +I+RD K  NIL++     KL DFG A+    P    T +V+TR      Y APE +
Sbjct: 120 N--IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVATR-----WYRAPELL 172

Query: 274 MTGHLTARS-DVYGFGVVLLEMLLG 297
           +      R+ D++  G ++ EML G
Sbjct: 173 VGDTKYGRAVDIWAVGCLVTEMLTG 197

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 75.0 bits (184), Expect = 4e-15
 Identities = 68/226 (30%), Positives = 101/226 (44%), Gaps = 28/226 (12%)

Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELN-RGGYQGDREWLAEVNYLGQLRHSNLV 158
           +G G FG V  G     V  GY    V +KEL      Q   ++L E      L+HSNL+
Sbjct: 3   IGNGWFGKVILG----EVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLL 58

Query: 159 KLIGYCCEDEHRILVYEYMESGSLEKHL-----LRRVGCMLTWSRRMKIALDAAKGLAFL 213
           + +G C E    +LV E+   G L+ +L        +    T  +RM  A + A GL  L
Sbjct: 59  QCLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRM--ACEIALGLLHL 116

Query: 214 HGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYV 273
           H  +   I+ D    N LL AD + K+ D+GL+ +    D      ++     + APE V
Sbjct: 117 H--KNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELV 174

Query: 274 --MTGHL-----TARSDVYGFGVVLLEML-LGRRAVDKSRPSREHN 311
             + G+L     T  S+V+  GV + E+  LG      S+P R  +
Sbjct: 175 DEVHGNLLVVDQTKESNVWSLGVTIWELFELG------SQPYRHLS 214

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 74.2 bits (182), Expect = 6e-15
 Identities = 61/196 (31%), Positives = 96/196 (48%), Gaps = 10/196 (5%)

Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVK 159
           LG G FG V KG+    ++   KT  V I + +        E L E N + QL +  +V+
Sbjct: 3   LGSGNFGTVKKGMY--KMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVR 60

Query: 160 LIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERP 219
           +IG  CE E  +LV E  E G L K L +     +T     ++    + G+ +L   E  
Sbjct: 61  MIG-ICEAESWMLVMELAELGPLNKFLQKNKH--VTEKNITELVHQVSMGMKYLE--ETN 115

Query: 220 VIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTY--GYAAPEYVMTGH 277
            ++RD    N+LL     AK+SDFGL+K     D+ +   +  G +   + APE +    
Sbjct: 116 FVHRDLAARNVLLVTQHYAKISDFGLSK-ALGADENYYKAKTHGKWPVKWYAPECMNYYK 174

Query: 278 LTARSDVYGFGVVLLE 293
            +++SDV+ FGV++ E
Sbjct: 175 FSSKSDVWSFGVLMWE 190

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 74.7 bits (184), Expect = 7e-15
 Identities = 60/205 (29%), Positives = 83/205 (40%), Gaps = 20/205 (9%)

Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKEL--NRGGYQGDREWLAEVNYLGQLRHSNL 157
           +GEG +GVV K               VAIK+   +       +  L EV  L QLRH N+
Sbjct: 9   VGEGAYGVVLKCRNKATGE------IVAIKKFKESEDDEDVKKTALREVKVLRQLRHENI 62

Query: 158 VKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAE 217
           V L           LV+EY+E   LE       G      R     L   + +A+ H   
Sbjct: 63  VNLKEAFRRKGRLYLVFEYVERTLLELLEASPGGLPPDAVRSYIWQL--LQAIAYCHSHN 120

Query: 218 RPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPE----YV 273
             +I+RD K  NIL++     KL DFG A+       + ++  V  T  Y APE      
Sbjct: 121 --IIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYV-ATRWYRAPELLVGDT 177

Query: 274 MTGHLTARSDVYGFGVVLLEMLLGR 298
             G      DV+  G ++ E+L G 
Sbjct: 178 NYG---KPVDVWAIGCIMAELLDGE 199

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 74.6 bits (183), Expect = 7e-15
 Identities = 74/279 (26%), Positives = 123/279 (44%), Gaps = 29/279 (10%)

Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQG-DREWLAEVNYLGQLRHSNLV 158
           LGEG +  VYKG+   N +       VA+K ++    +G     + E + L  L+H+N+V
Sbjct: 13  LGEGSYATVYKGISRINGQ------LVALKVISMKTEEGVPFTAIREASLLKGLKHANIV 66

Query: 159 KLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAER 218
            L       E    V+EYM +  L +++++  G +  ++ R+       +GLA++HG  +
Sbjct: 67  LLHDIIHTKETLTFVFEYMHT-DLAQYMIQHPGGLHPYNVRL-FMFQLLRGLAYIHG--Q 122

Query: 219 PVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVM-TGH 277
            +++RD K  N+L++     KL+DFGLA+   +  QT+ S  V  T  Y  P+ ++    
Sbjct: 123 HILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVV--TLWYRPPDVLLGATD 180

Query: 278 LTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWA-------------RPLLNNNK 324
            ++  D++G G + +EML G+ A        E     W                L N   
Sbjct: 181 YSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYKP 240

Query: 325 KVLRILDPRLEGQYTAR--TAMKVAGLAYQCLSQNPKGR 361
           +      P+       R     K   LA Q L   PK R
Sbjct: 241 EWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDR 279

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 74.8 bits (184), Expect = 8e-15
 Identities = 69/210 (32%), Positives = 103/210 (49%), Gaps = 29/210 (13%)

Query: 99  ILGEGGFGVVYKGVIDENVRPGYKTTFVAIKEL--------NRGGYQGDREWLAEVNYLG 150
           +LG+G FG V+   +   +         A+K L        +R   + +R+ LAEVN   
Sbjct: 3   VLGQGSFGKVF---LVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVN--- 56

Query: 151 QLRHSNLVKLIGYCCEDEHRI-LVYEYMESGSLEKHLLRRVGCMLTWSRRMKIAL-DAAK 208
              H  +VKL  Y  + E ++ L+ +++  G L   L + V  M T    +K  L + A 
Sbjct: 57  ---HPFIVKL-HYAFQTEGKLYLILDFLRGGDLFTRLSKEV--MFT-EEDVKFYLAELAL 109

Query: 209 GLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYA 268
            L  LH     +IYRD K  NILL+ +   KL+DFGL+K+    ++   S    GT  Y 
Sbjct: 110 ALDHLHSLG--IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS--FCGTVEYM 165

Query: 269 APEYV-MTGHLTARSDVYGFGVVLLEMLLG 297
           APE V   GH  + +D + FGV++ EML G
Sbjct: 166 APEVVNRRGHTQS-ADWWSFGVLMFEMLTG 194

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 73.9 bits (181), Expect = 8e-15
 Identities = 60/198 (30%), Positives = 94/198 (47%), Gaps = 16/198 (8%)

Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGD--REWLAEVNYLGQLRHSNL 157
           +G G FG V+ G      R     T VA+K   R     D   ++L E   L Q  H N+
Sbjct: 3   IGRGNFGEVFSG------RLRADNTPVAVKSC-RETLPPDLKAKFLQEARILKQYSHPNI 55

Query: 158 VKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAE 217
           V+LIG C + +   +V E ++ G      LR  G  L     +++  +AA G+ +L    
Sbjct: 56  VRLIGVCTQKQPIYIVMELVQGGDFLT-FLRTEGPRLKVKELIQMVENAAAGMEYLE--S 112

Query: 218 RPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGT--YGYAAPEYVMT 275
           +  I+RD    N L+      K+SDFG++++    D  + ST  M      + APE +  
Sbjct: 113 KHCIHRDLAARNCLVTEKNVLKISDFGMSRE--EEDGVYASTGGMKQIPVKWTAPEALNY 170

Query: 276 GHLTARSDVYGFGVVLLE 293
           G  ++ SDV+ FG++L E
Sbjct: 171 GRYSSESDVWSFGILLWE 188

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 74.1 bits (182), Expect = 8e-15
 Identities = 55/206 (26%), Positives = 96/206 (46%), Gaps = 18/206 (8%)

Query: 99  ILGEGGFGVVYKGV-IDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNL 157
           +LG+G +G+VY    +   VR       +AIKE+     +  +    E+     L+H N+
Sbjct: 15  VLGKGTYGIVYAARDLSTQVR-------IAIKEIPERDSRYVQPLHEEIALHSYLKHRNI 67

Query: 158 VKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKI-ALDAAKGLAFLHGA 216
           V+ +G   E+    +  E +  GSL   L  + G +    + +        +GL +LH  
Sbjct: 68  VQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLH-- 125

Query: 217 ERPVIYRDFKTSNILLNADFSA--KLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVM 274
           +  +++RD K  N+L+N  +S   K+SDFG +K   +      +    GT  Y APE + 
Sbjct: 126 DNQIVHRDIKGDNVLVNT-YSGVVKISDFGTSKR--LAGINPCTETFTGTLQYMAPEVID 182

Query: 275 TGH--LTARSDVYGFGVVLLEMLLGR 298
            G     A +D++  G  ++EM  G+
Sbjct: 183 KGPRGYGAPADIWSLGCTIVEMATGK 208

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 74.3 bits (182), Expect = 9e-15
 Identities = 59/201 (29%), Positives = 95/201 (47%), Gaps = 14/201 (6%)

Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDR-EWLAEVNYLGQLRHSNLV 158
           LGEG +  VYKG      R       VA+KE+     +G     + EV+ L  L+H+N+V
Sbjct: 14  LGEGTYATVYKG------RSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIV 67

Query: 159 KLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAER 218
            L      ++   LV+EY++     K  L   G  +             +GL + H   R
Sbjct: 68  TLHDIIHTEKSLTLVFEYLDKDL--KQYLDDCGNSINMHNVKLFLFQLLRGLNYCH--RR 123

Query: 219 PVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVM-TGH 277
            V++RD K  N+L+N     KL+DFGLA+   +  +T+ +  V  T  Y  P+ ++ +  
Sbjct: 124 KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVV--TLWYRPPDILLGSTD 181

Query: 278 LTARSDVYGFGVVLLEMLLGR 298
            + + D++G G +  EM  GR
Sbjct: 182 YSTQIDMWGVGCIFYEMSTGR 202

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 74.3 bits (182), Expect = 1e-14
 Identities = 63/218 (28%), Positives = 107/218 (49%), Gaps = 35/218 (16%)

Query: 99  ILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGD-REWLAEVNYLGQL-RHSN 156
           ++GEG FG V K  I ++   G +    AIK +     + D R++  E+  L +L  H N
Sbjct: 14  VIGEGNFGQVLKARIKKD---GLRMD-AAIKRMKEYASKDDHRDFAGELEVLCKLGHHPN 69

Query: 157 LVKLIGYCCEDEHRILVY---EYMESGSLEKHLLR--------------RVGCMLTWSRR 199
           ++ L+G C   EHR  +Y   EY   G+L   L +                   L+  + 
Sbjct: 70  IINLLGAC---EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 126

Query: 200 MKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVST 259
           +  A D A+G+ +L  +++  I+RD    NIL+  ++ AK++DFGL++    G + +V  
Sbjct: 127 LHFAADVARGMDYL--SQKQFIHRDLAARNILVGENYVAKIADFGLSR----GQEVYVK- 179

Query: 260 RVMGTYG--YAAPEYVMTGHLTARSDVYGFGVVLLEML 295
           + MG     + A E +     T  SDV+ +GV+L E++
Sbjct: 180 KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIV 217

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 73.7 bits (181), Expect = 2e-14
 Identities = 40/101 (39%), Positives = 56/101 (55%), Gaps = 6/101 (5%)

Query: 203 ALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVM 262
           A + A GL FLH   + +IYRD K  N++L+A+   K++DFG+ K+   G +T   TR  
Sbjct: 107 AAEIAIGLFFLH--SKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKT---TRTF 161

Query: 263 -GTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVD 302
            GT  Y APE +         D + FGV+L EML G+   D
Sbjct: 162 CGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFD 202

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 72.8 bits (178), Expect = 2e-14
 Identities = 58/211 (27%), Positives = 100/211 (47%), Gaps = 26/211 (12%)

Query: 100 LGEGGFGVVYKGVIDEN---VRPGYKTTFVAI---KELNRGGYQGDREWLAEVNYLGQLR 153
           LGEG FG V +G ++++   ++   KT  +AI    E+         ++L+E   + +  
Sbjct: 7   LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEM--------EDFLSEAVCMKEFD 58

Query: 154 HSNLVKLIGYCCEDEHR------ILVYEYMESGSLEKHLL-RRVG-CMLTWSRRM--KIA 203
           H N+++LIG C +          +++  +M+ G L   LL  R+G C      +M  K  
Sbjct: 59  HPNVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFM 118

Query: 204 LDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMG 263
            D A G+ +L  + +  I+RD    N +LN + +  ++DFGL+K    GD          
Sbjct: 119 TDIASGMEYL--SSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKM 176

Query: 264 TYGYAAPEYVMTGHLTARSDVYGFGVVLLEM 294
              + A E +     T +SDV+ FGV + E+
Sbjct: 177 PVKWIAIESLADRVYTTKSDVWSFGVTMWEI 207

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 72.1 bits (177), Expect = 4e-14
 Identities = 64/212 (30%), Positives = 103/212 (48%), Gaps = 29/212 (13%)

Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREW-------LAEVNYLGQL 152
           +GEG +GVVYK     N   G     VA+K++       D E        + E++ L +L
Sbjct: 8   IGEGTYGVVYKA---RNKLTG---EVVALKKIRL-----DTETEGVPSTAIREISLLKEL 56

Query: 153 RHSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAF 212
            H N+VKL+     +    LV+E++    L+K +       +             +GLAF
Sbjct: 57  NHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAF 115

Query: 213 LHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAK--DGPMGDQTHVSTRVMGTYGYAAP 270
            H + R V++RD K  N+L+N + + KL+DFGLA+    P+   TH    V+ T  Y AP
Sbjct: 116 CH-SHR-VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTH---EVV-TLWYRAP 169

Query: 271 EYVM-TGHLTARSDVYGFGVVLLEMLLGRRAV 301
           E ++   + +   D++  G +  EM+  RRA+
Sbjct: 170 EILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 200

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 72.2 bits (177), Expect = 5e-14
 Identities = 62/207 (29%), Positives = 100/207 (48%), Gaps = 16/207 (7%)

Query: 92  KFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQ 151
           K+ R + I G+G  G VY  +   +V  G +   VAIK++N          + E+  + +
Sbjct: 20  KYTRFEKI-GQGASGTVYTAI---DVATGQE---VAIKQMNLQQQPKKELIINEILVMRE 72

Query: 152 LRHSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLA 211
            +H N+V  +      +   +V EY+  GSL   +       +   +   +  +  + L 
Sbjct: 73  NKHPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALE 129

Query: 212 FLHGAERPVIYRDFKTSNILLNADFSAKLSDFGL-AKDGPMGDQTHVSTRVMGTYGYAAP 270
           FLH     VI+RD K+ NILL  D S KL+DFG  A+  P  +Q+  ST V GT  + AP
Sbjct: 130 FLHS--NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP--EQSKRSTMV-GTPYWMAP 184

Query: 271 EYVMTGHLTARSDVYGFGVVLLEMLLG 297
           E V       + D++  G++ +EM+ G
Sbjct: 185 EVVTRKAYGPKVDIWSLGIMAIEMVEG 211

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 71.6 bits (175), Expect = 6e-14
 Identities = 68/274 (24%), Positives = 119/274 (43%), Gaps = 39/274 (14%)

Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLA-EVNYLGQLRHSNLV 158
           +G+G FG V+KG+ +   +       VAIK ++    + + E +  E+  L Q     + 
Sbjct: 12  IGKGSFGEVFKGIDNRTQK------VVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65

Query: 159 KLIGYCCEDEHRILVYEYMESGS----LEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLH 214
           K  G   +D    ++ EY+  GS    LE   L         ++   I  +  KGL +LH
Sbjct: 66  KYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDE-------TQIATILREILKGLDYLH 118

Query: 215 GAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVM 274
             ++  I+RD K +N+LL+     KL+DFG+A  G + D        +GT  + APE + 
Sbjct: 119 SEKK--IHRDIKAANVLLSEHGEVKLADFGVA--GQLTDTQIKRNTFVGTPFWMAPEVIK 174

Query: 275 TGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRILDPRL 334
                +++D++  G+  +E+  G     +  P +   L+    P             P L
Sbjct: 175 QSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNP-------------PTL 221

Query: 335 EGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVV 368
           EG Y+      +      CL++ P  RP   +++
Sbjct: 222 EGNYSK----PLKEFVEACLNKEPSFRPTAKELL 251

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 71.7 bits (176), Expect = 7e-14
 Identities = 58/206 (28%), Positives = 98/206 (47%), Gaps = 21/206 (10%)

Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLA-----EVNYLGQLRH 154
           +GEG +GVVYKG    N + G     VA+K++     + + E +      E++ L +L+H
Sbjct: 8   IGEGTYGVVYKG---RNKKTG---QIVAMKKIR---LESEEEGVPSTAIREISLLKELQH 58

Query: 155 SNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLR-RVGCMLTWSRRMKIALDAAKGLAFL 213
            N+V L     ++    L++E++ S  L+K+L     G  +             +G+ F 
Sbjct: 59  PNIVCLQDVLMQESRLYLIFEFL-SMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFC 117

Query: 214 HGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYV 273
           H   R V++RD K  N+L++     KL+DFGLA+    G    V T  + T  Y APE +
Sbjct: 118 H--SRRVLHRDLKPQNLLIDNKGVIKLADFGLAR--AFGIPVRVYTHEVVTLWYRAPEVL 173

Query: 274 MTGHLTARS-DVYGFGVVLLEMLLGR 298
           +     +   D++  G +  EM   +
Sbjct: 174 LGSPRYSTPVDIWSIGTIFAEMATKK 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 72.0 bits (176), Expect = 7e-14
 Identities = 61/206 (29%), Positives = 94/206 (45%), Gaps = 32/206 (15%)

Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREW---LAEVNYLGQLRHSN 156
           +G G FG VY           +    VA+K+++  G Q + +W   + EV +L QL+H N
Sbjct: 29  IGHGSFGAVYFAT------NSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPN 82

Query: 157 LVKLIGYCCEDEHRILVYEYM---ESGSLEKHL--LRRVGCMLTWSRRMKIALDAAKGLA 211
            ++  G   ++    LV EY     S  LE H   L+ V           I   A +GLA
Sbjct: 83  TIEYKGCYLKEHTAWLVMEYCLGSASDLLEVHKKPLQEV-------EIAAITHGALQGLA 135

Query: 212 FLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPE 271
           +LH     +I+RD K  NILL      KL+DFG A       ++  +   +GT  + APE
Sbjct: 136 YLH--SHNMIHRDIKAGNILLTEPGQVKLADFGSAS------KSSPANSFVGTPYWMAPE 187

Query: 272 YVMT---GHLTARSDVYGFGVVLLEM 294
            ++    G    + DV+  G+  +E+
Sbjct: 188 VILAMDEGQYDGKVDVWSLGITCIEL 213

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 71.9 bits (176), Expect = 8e-14
 Identities = 45/131 (34%), Positives = 66/131 (50%), Gaps = 6/131 (4%)

Query: 168 EHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKT 227
           EH   V E++  G L  H+  +        R    A +   GL FLH   + +IYRD K 
Sbjct: 69  EHLFFVMEFLNGGDLMFHIQDK--GRFDLYRATFYAAEIVCGLQFLH--SKGIIYRDLKL 124

Query: 228 SNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGF 287
            N++L+ D   K++DFG+ K+   GD    ++   GT  Y APE +     T   D + F
Sbjct: 125 DNVMLDRDGHIKIADFGMCKENVFGDNR--ASTFCGTPDYIAPEILQGLKYTFSVDWWSF 182

Query: 288 GVVLLEMLLGR 298
           GV+L EML+G+
Sbjct: 183 GVLLYEMLIGQ 193

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 71.6 bits (175), Expect = 8e-14
 Identities = 65/219 (29%), Positives = 106/219 (48%), Gaps = 21/219 (9%)

Query: 99  ILGEGGFGVVYKGVIDENVRPGYKTTF-VAIKELNRG-GYQGDREWLAEVNYLGQLRHSN 156
           +LG G FG VYKG+    V  G      VAIK LN   G + + E++ E   +  + H +
Sbjct: 14  VLGSGAFGTVYKGIW---VPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPH 70

Query: 157 LVKLIGYCCEDEHRILVYEYMESGSLEKHLLRR---VGC--MLTWSRRMKIALDAAKGLA 211
           LV+L+G C     + LV + M  G L  ++      +G   +L W       +  AKG+ 
Sbjct: 71  LVRLLGVCLSPTIQ-LVTQLMPHGCLLDYVHEHKDNIGSQLLLNW------CVQIAKGMM 123

Query: 212 FLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPE 271
           +L   ER +++RD    N+L+ +    K++DFGLA+     ++ + +        + A E
Sbjct: 124 YLE--ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALE 181

Query: 272 YVMTGHLTARSDVYGFGVVLLE-MLLGRRAVDKSRPSRE 309
            +     T +SDV+ +GV + E M  G +  D   P+RE
Sbjct: 182 CIHYRKFTHQSDVWSYGVTIWELMTFGGKPYD-GIPTRE 219

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 71.3 bits (175), Expect = 8e-14
 Identities = 59/205 (28%), Positives = 101/205 (49%), Gaps = 22/205 (10%)

Query: 100 LGEGGFGVVYKGV--IDENVRPGYKTTFVAIKELNRGGYQGDR-EWLAEVNYLGQLRHSN 156
           LGEG +  VYKG   +            VA+KE+     +G     + E + L  L+H+N
Sbjct: 13  LGEGSYATVYKGRSKLTGQ--------LVALKEIRLEHEEGAPFTAIREASLLKDLKHAN 64

Query: 157 LVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIAL-DAAKGLAFLHG 215
           +V L       +   LV+EY+++  L++++    G +      +++ L    +GLA+ H 
Sbjct: 65  IVTLHDIIHTKKTLTLVFEYLDT-DLKQYMDDCGGGLSM--HNVRLFLFQLLRGLAYCHQ 121

Query: 216 AERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMT 275
             R V++RD K  N+L++     KL+DFGLA+   +  +T+ +  V  T  Y  P+ V+ 
Sbjct: 122 --RRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSNEVV--TLWYRPPD-VLL 176

Query: 276 G--HLTARSDVYGFGVVLLEMLLGR 298
           G    +   D++G G +  EM  GR
Sbjct: 177 GSTEYSTSLDMWGVGCIFYEMATGR 201

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 72.0 bits (176), Expect = 9e-14
 Identities = 58/169 (34%), Positives = 84/169 (49%), Gaps = 14/169 (8%)

Query: 139 DREWLAEVNYLGQLRHSNLVKLIGY--CCEDEHRI-LVYEYMESGSLEKHLLRRVGCMLT 195
           D +W+    ++ +   SN   L+G   C +   R+ LV EY+  G L  H+ R+      
Sbjct: 38  DIDWVQTEKHVFEQASSNPF-LVGLHSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEE 96

Query: 196 WSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDG--PMGD 253
            +R    A +    L FLH  ER +IYRD K  N+LL+AD   KL+D+G+ K+G  P GD
Sbjct: 97  HARFY--AAEICIALNFLH--ERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGP-GD 151

Query: 254 QTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVD 302
            T   +   GT  Y APE +         D +  GV++ EM+ GR   D
Sbjct: 152 TT---STFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFD 197

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 70.9 bits (174), Expect = 1e-13
 Identities = 57/204 (27%), Positives = 99/204 (48%), Gaps = 25/204 (12%)

Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWL-AEVNYLGQLRHSNLV 158
           +GEG  G+V    I  +   G +   VA+K+++    Q  RE L  EV  +   +H N+V
Sbjct: 27  IGEGSTGIV---CIATDKSTGRQ---VAVKKMDLRKQQ-RRELLFNEVVIMRDYQHPNIV 79

Query: 159 KLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMK-----IALDAAKGLAFL 213
           ++       +   +V E++E G+L          ++T +R  +     + L   K L+FL
Sbjct: 80  EMYSSYLVGDELWVVMEFLEGGALTD--------IVTHTRMNEEQIATVCLAVLKALSFL 131

Query: 214 HGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYV 273
           H   + VI+RD K+ +ILL +D   KLSDFG      +  +      ++GT  + APE +
Sbjct: 132 HA--QGVIHRDIKSDSILLTSDGRVKLSDFGFC--AQVSKEVPRRKSLVGTPYWMAPEVI 187

Query: 274 MTGHLTARSDVYGFGVVLLEMLLG 297
                    D++  G++++EM+ G
Sbjct: 188 SRLPYGTEVDIWSLGIMVIEMVDG 211

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 70.8 bits (173), Expect = 1e-13
 Identities = 74/282 (26%), Positives = 122/282 (43%), Gaps = 35/282 (12%)

Query: 88  KLATKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLA-EV 146
           +L TK  R    +G+G FG VYKG+  +N         VAIK ++    + + E +  E+
Sbjct: 4   ELFTKLER----IGKGSFGEVYKGI--DN----RTKEVVAIKIIDLEEAEDEIEDIQQEI 53

Query: 147 NYLGQLRHSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDA 206
             L Q     + +  G   +     ++ EY+  GS     L + G  L  +    I  + 
Sbjct: 54  TVLSQCDSPYITRYYGSYLKGTKLWIIMEYLGGGSALD--LLKPG-PLEETYIATILREI 110

Query: 207 AKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYG 266
            KGL +LH   +  I+RD K +N+LL+     KL+DFG+A  G + D        +GT  
Sbjct: 111 LKGLDYLHSERK--IHRDIKAANVLLSEQGDVKLADFGVA--GQLTDTQIKRNTFVGTPF 166

Query: 267 YAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKV 326
           + APE +       ++D++  G+  +E+  G        P R   L+    P        
Sbjct: 167 WMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSP-------- 218

Query: 327 LRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVV 368
                P LEGQY+             CL+++P+ RP   +++
Sbjct: 219 -----PTLEGQYSK----PFKEFVEACLNKDPRFRPTAKELL 251

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 70.6 bits (173), Expect = 1e-13
 Identities = 40/150 (26%), Positives = 67/150 (44%), Gaps = 17/150 (11%)

Query: 172 LVYEYMESGSLEKHLLRRVGCM-LTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNI 230
           LV EY+  G     L++ +G +   W++  +   +   G+  LH   R +I+RD K  N+
Sbjct: 74  LVMEYLNGGDCAS-LIKTLGGLPEDWAK--QYIAEVVLGVEDLHQ--RGIIHRDIKPENL 128

Query: 231 LLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVV 290
           L++     KL+DFGL+++G        + + +GT  Y APE ++       SD +  G V
Sbjct: 129 LIDQTGHLKLTDFGLSRNG------LENKKFVGTPDYLAPETILGVGDDKMSDWWSLGCV 182

Query: 291 LLEMLLGRRAVDKSRPSR-----EHNLVEW 315
           + E L G        P           + W
Sbjct: 183 IFEFLFGYPPFHAETPDAVFDNILSRRINW 212

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 71.2 bits (174), Expect = 1e-13
 Identities = 59/214 (27%), Positives = 104/214 (48%), Gaps = 21/214 (9%)

Query: 100 LGEGGFG--VVYKGVIDENVRPGYKTTFVAIKELNRGGYQGD-REWLAEVNYLGQL-RHS 155
           LGEG FG  V+ + +  +  +P    T VA+K L     + D  + ++E+  +  + +H 
Sbjct: 23  LGEGCFGQVVMAEALGIDKDKPKEAVT-VAVKMLKDDATEKDLSDLVSEMEMMKMIGKHK 81

Query: 156 NLVKLIGYCCEDEHRILVYEYMESGSLEKHL-LRRVGCM-------------LTWSRRMK 201
           N++ L+G C +D    ++ EY   G+L ++L  RR   M             +T+   + 
Sbjct: 82  NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVS 141

Query: 202 IALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRV 261
                A+G+ +L  A +  I+RD    N+L+  +   K++DFGLA+D    D    +T  
Sbjct: 142 CTYQVARGMEYL--ASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNG 199

Query: 262 MGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEML 295
                + APE +     T +SDV+ FGV++ E+ 
Sbjct: 200 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIF 233

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 71.0 bits (174), Expect = 1e-13
 Identities = 62/203 (30%), Positives = 89/203 (43%), Gaps = 16/203 (7%)

Query: 99  ILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREW---LAEVNYLGQ-LRH 154
           ++G+G FG V         +      F A+K L +      +E    +AE N L + ++H
Sbjct: 2   VIGKGSFGKVLL------AKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKH 55

Query: 155 SNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLH 214
             LV L       +    V +Y+  G L  HL +R        R    A + A  L +LH
Sbjct: 56  PFLVGLHYSFQTADKLYFVLDYVNGGELFFHL-QRERSFPE-PRARFYAAEIASALGYLH 113

Query: 215 GAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVM 274
                +IYRD K  NILL++     L+DFGL K+G    +T  ++   GT  Y APE + 
Sbjct: 114 SLN--IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKT--TSTFCGTPEYLAPEVLR 169

Query: 275 TGHLTARSDVYGFGVVLLEMLLG 297
                   D +  G VL EML G
Sbjct: 170 KQPYDRTVDWWCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 70.3 bits (172), Expect = 1e-13
 Identities = 61/220 (27%), Positives = 100/220 (45%), Gaps = 37/220 (16%)

Query: 99  ILGEGGFGVVYKGVIDENVRPGYKTTFVAIK--ELNRGGYQGDR------EWLA-EVNYL 149
           ++G G FG VY G+   N   G     +A+K  EL               + LA E+  L
Sbjct: 7   LIGSGSFGSVYLGM---NASSG---ELMAVKQVELPSVSASSKDRKRSMLDALAREIALL 60

Query: 150 GQLRHSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIAL----- 204
            +L+H N+V+ +G   + +H  +  EY+  GS        V  +L      +  L     
Sbjct: 61  KELQHENIVQYLGSSLDADHLNIFLEYVPGGS--------VAALLNNYGAFEETLVRNFV 112

Query: 205 -DAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKD-----GPMGDQTHVS 258
               KGL +LH   R +I+RD K +NIL++     K+SDFG++K                
Sbjct: 113 RQILKGLNYLH--NRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARP 170

Query: 259 TRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGR 298
           + + G+  + APE V     T ++D++  G +++EML G+
Sbjct: 171 S-LQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGK 209

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 71.0 bits (174), Expect = 1e-13
 Identities = 66/226 (29%), Positives = 107/226 (47%), Gaps = 50/226 (22%)

Query: 155 SNLVKLIGY--CCEDEHRI-LVYEYMESGSLEKHLLRRVGCMLTWSRRMK------IALD 205
           SN   L+G   C + E R+  V E++  G L  H+ R+        R++        + +
Sbjct: 53  SNHPFLVGLHSCFQTESRLFFVIEFVSGGDLMFHMQRQ--------RKLPEEHARFYSAE 104

Query: 206 AAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDG-PMGDQTHVSTRVMGT 264
            +  L FLH  ER +IYRD K  N+LL+A+   KL+D+G+ K+G   GD T   +   GT
Sbjct: 105 ISLALNFLH--ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTT---STFCGT 159

Query: 265 YGYAAPEYVMTGHLTARSDVYGF-------GVVLLEMLLGRRAVD--KSRPSREHNLVEW 315
             Y APE +       R + YGF       GV++ EM+ GR   D      + + N  ++
Sbjct: 160 PNYIAPEIL-------RGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDY 212

Query: 316 ARPLLNNNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGR 361
              ++   +K +RI  PR         ++K + +    L+++PK R
Sbjct: 213 LFQVI--LEKQIRI--PR-------SLSVKASSVLKGFLNKDPKER 247

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 71.0 bits (174), Expect = 2e-13
 Identities = 69/206 (33%), Positives = 94/206 (45%), Gaps = 21/206 (10%)

Query: 99  ILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDRE---WLAEVNYLGQLRHS 155
           +LG+G FG V        VR      + A+K L +       E    L E   L   RH 
Sbjct: 2   LLGKGTFGKVIL------VREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHP 55

Query: 156 NLVKLIGYCCEDEHRI-LVYEYMESGSLEKHLLR-RVGCMLTWSRRMKIALDAAKGLAFL 213
            L  L  Y  +   R+  V EY   G L  HL R RV    +  R      +    L +L
Sbjct: 56  FLTAL-KYSFQTHDRLCFVMEYANGGELFFHLSRERV---FSEDRARFYGAEIVSALGYL 111

Query: 214 HGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYV 273
           H     V+YRD K  N++L+ D   K++DFGL K+G + D   + T   GT  Y APE V
Sbjct: 112 H--SCDVVYRDLKLENLMLDKDGHIKITDFGLCKEG-ISDGATMKT-FCGTPEYLAPE-V 166

Query: 274 MTGHLTARS-DVYGFGVVLLEMLLGR 298
           +  +   R+ D +G GVV+ EM+ GR
Sbjct: 167 LEDNDYGRAVDWWGLGVVMYEMMCGR 192

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 70.4 bits (173), Expect = 2e-13
 Identities = 56/207 (27%), Positives = 100/207 (48%), Gaps = 24/207 (11%)

Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREW-----LAEVNYLGQLRH 154
           +GEG +GVVYK     +   G     VA+K++     + + E      + E++ L +L H
Sbjct: 7   IGEGTYGVVYKA---RDKLTG---EIVALKKIR---LETEDEGVPSTAIREISLLKELNH 57

Query: 155 SNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLH 214
            N+V+L+     +    LV+E+++   L+K++       L             +G+A+ H
Sbjct: 58  PNIVRLLDVVHSENKLYLVFEFLDL-DLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCH 116

Query: 215 GAERPVIYRDFKTSNILLNADFSAKLSDFGLAK--DGPMGDQTHVSTRVMGTYGYAAPEY 272
                V++RD K  N+L++ + + KL+DFGLA+    P+   TH    V+ T  Y APE 
Sbjct: 117 S--HRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTH---EVV-TLWYRAPEI 170

Query: 273 VMTG-HLTARSDVYGFGVVLLEMLLGR 298
           ++     +   D++  G +  EM+  R
Sbjct: 171 LLGSRQYSTPVDIWSIGCIFAEMVNRR 197

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 70.5 bits (173), Expect = 2e-13
 Identities = 70/210 (33%), Positives = 93/210 (44%), Gaps = 33/210 (15%)

Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGD----REWLAEVNYLGQLRHS 155
           +GEG +GVV+K       R       VAIK+      + D    +  L E+  L QL+H 
Sbjct: 9   IGEGSYGVVFK------CRNRETGQIVAIKKFVES--EDDPVIKKIALREIRMLKQLKHP 60

Query: 156 NLVKLIGYCCEDEHRILVYEYMES---GSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAF 212
           NLV LI          LV+EY +      LEK+  R V   L      KI     + + F
Sbjct: 61  NLVNLIEVFRRKRKLHLVFEYCDHTVLNELEKN-PRGVPEHLI----KKIIWQTLQAVNF 115

Query: 213 LHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAK--DGPMGDQT-HVSTRVMGTYGYAA 269
            H  +   I+RD K  NIL+      KL DFG A+   GP  D T +V+TR      Y A
Sbjct: 116 CH--KHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATR-----WYRA 168

Query: 270 PEYVMTGHLTARS--DVYGFGVVLLEMLLG 297
           PE ++ G        DV+  G V  E+L G
Sbjct: 169 PE-LLVGDTQYGPPVDVWAIGCVFAELLTG 197

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 70.0 bits (172), Expect = 2e-13
 Identities = 60/204 (29%), Positives = 91/204 (44%), Gaps = 26/204 (12%)

Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVK 159
           +G G +G VYK     ++  G     VAIK +             E++ L + RH N+V 
Sbjct: 11  IGSGTYGDVYKAR---DIATG---ELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVA 64

Query: 160 LIG-YCCEDEHRILVYEYMESGSLEK--HLLRRVGCMLTWSRRMKIALDAAKGLAFLHGA 216
             G Y   D+  I V EY   GSL+    + R     L+  +   +  +  KGLA+LH  
Sbjct: 65  YFGSYLRRDKLWI-VMEYCGGGSLQDIYQVTRGP---LSELQIAYVCRETLKGLAYLH-- 118

Query: 217 ERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTR---VMGTYGYAAPEYV 273
           E   I+RD K +NILL  D   KL+DFG++        T    +    +GT  + APE  
Sbjct: 119 ETGKIHRDIKGANILLTEDGDVKLADFGVS-----AQLTATIAKRKSFIGTPYWMAPEVA 173

Query: 274 ---MTGHLTARSDVYGFGVVLLEM 294
                G    + D++  G+  +E+
Sbjct: 174 AVERKGGYDGKCDIWALGITAIEL 197

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 70.6 bits (173), Expect = 2e-13
 Identities = 60/242 (24%), Positives = 100/242 (41%), Gaps = 39/242 (16%)

Query: 85  NEMKLATKFFRP-DYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELN----RGGYQGD 139
           N     ++ +      LGEG +G V K   D           VAIK++           D
Sbjct: 1   NMSFSISERYIQKGAHLGEGTYGKVEKA-YDTLTG-----KIVAIKKVKIIEISNDVTKD 54

Query: 140 REW----------LAEVNYLGQLRHSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRR 189
           R+           L E+  + +++H N++ L+    E +   LV + M S  L+K + R+
Sbjct: 55  RQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDVYVEGDFINLVMDIMAS-DLKKVVDRK 113

Query: 190 VGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAK-- 247
           +   LT S+   I L    GL  LH  +   ++RD   +NI +N+    K++DFGLA+  
Sbjct: 114 I--RLTESQVKCILLQILNGLNVLH--KWYFMHRDLSPANIFINSKGICKIADFGLARRY 169

Query: 248 -----DGPMGDQTHVSTRVMGTYG-----YAAPEYVMTGHLTARS-DVYGFGVVLLEMLL 296
                   +     +  R   T       Y APE +M       + D++  G +  E+L 
Sbjct: 170 GYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLT 229

Query: 297 GR 298
           G+
Sbjct: 230 GK 231

Length = 335

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 70.0 bits (171), Expect = 2e-13
 Identities = 60/200 (30%), Positives = 88/200 (44%), Gaps = 10/200 (5%)

Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVK 159
           LG+GGFG V   V  +N    Y    +  K L +    G++  L E   L ++    +V 
Sbjct: 1   LGKGGFGEVC-AVQVKNTGKMYACKKLDKKRLKKKS--GEKMALLEKEILEKVNSPFIVN 57

Query: 160 LIGYCCEDE-HRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAER 218
           L  Y  E + H  LV   M  G L+ H+       L   R +  +     G+  LH    
Sbjct: 58  L-AYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLH--SM 114

Query: 219 PVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHL 278
            ++YRD K  N+LL+   + +LSD GLA +   G      T+  GT GY APE +     
Sbjct: 115 DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTI---TQRAGTNGYMAPEILKEEPY 171

Query: 279 TARSDVYGFGVVLLEMLLGR 298
           +   D +  G  + EM+ GR
Sbjct: 172 SYPVDWFAMGCSIYEMVAGR 191

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 70.4 bits (173), Expect = 2e-13
 Identities = 67/228 (29%), Positives = 102/228 (44%), Gaps = 48/228 (21%)

Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKEL----NRGGYQGDREWLAEVNYLGQLRHS 155
           LGEG FG VYK      ++ G     VA+K++     + G+      L E+  L +L+H 
Sbjct: 16  LGEGTFGEVYKAR---QIKTG---RVVALKKILMHNEKDGFPITA--LREIKILKKLKHP 67

Query: 156 NLVKLIGYCCE---DEHRI-----LVYEYME---SGSLEKHLLR----RVGCMLTWSRRM 200
           N+V LI    E      R      +V  YM+   SG LE   ++    ++ C       M
Sbjct: 68  NVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCY------M 121

Query: 201 KIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAK---------DGPM 251
              L+   G+ +LH  E  +++RD K +NIL++     K++DFGLA+          G  
Sbjct: 122 LQLLE---GINYLH--ENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGG 176

Query: 252 GDQTHVSTRVMGTYGYAAPEYVM-TGHLTARSDVYGFGVVLLEMLLGR 298
           G  T   T ++ T  Y  PE ++     T   D++G G V  EM   R
Sbjct: 177 GGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRR 224

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 70.0 bits (171), Expect = 2e-13
 Identities = 56/200 (28%), Positives = 92/200 (46%), Gaps = 16/200 (8%)

Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVK 159
           LG+G FG VYK    E           A K ++    +   +++ E++ L    H N+VK
Sbjct: 13  LGDGAFGKVYKAQNKET------GVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVK 66

Query: 160 LIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERP 219
           L+     + +  ++ E+   G+++  +L  +   LT  +   +     + L +LH  E  
Sbjct: 67  LLDAFYYENNLWILIEFCAGGAVDAVMLE-LERPLTEPQIRVVCKQTLEALNYLH--ENK 123

Query: 220 VIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLT 279
           +I+RD K  NIL   D   KL+DFG++       Q   S   +GT  + APE VM     
Sbjct: 124 IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDS--FIGTPYWMAPEVVMCETSK 181

Query: 280 AR-----SDVYGFGVVLLEM 294
            R     +DV+  G+ L+EM
Sbjct: 182 DRPYDYKADVWSLGITLIEM 201

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 70.0 bits (171), Expect = 3e-13
 Identities = 59/215 (27%), Positives = 101/215 (46%), Gaps = 23/215 (10%)

Query: 100 LGEGGFGVVYKGV---IDENVRPGYKTTFVAIKELNRGGYQGD-REWLAEVNYLGQL-RH 154
           LGEG FG V +     ID++ RP    T VA+K L       D  + ++E+  +  + +H
Sbjct: 20  LGEGCFGQVVRAEAYGIDKS-RPDQTVT-VAVKMLKDNATDKDLADLISEMELMKLIGKH 77

Query: 155 SNLVKLIGYCCEDEHRILVYEYMESGSLEKHL-LRRVGCM-------------LTWSRRM 200
            N++ L+G C ++    ++ EY   G+L + L  RR                 L++   +
Sbjct: 78  KNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLV 137

Query: 201 KIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTR 260
             A   A+G+ +L    R  I+RD    N+L+  D   K++DFGLA+     D    ++ 
Sbjct: 138 SCAYQVARGMEYL--ESRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSN 195

Query: 261 VMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEML 295
                 + APE +     T +SDV+ FG+++ E+ 
Sbjct: 196 GRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIF 230

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 69.4 bits (170), Expect = 3e-13
 Identities = 51/201 (25%), Positives = 94/201 (46%), Gaps = 17/201 (8%)

Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKEL---NRGGYQGDREWLAEVNYLGQLRHSN 156
           +G+G F VVYK +   + R       VA+K++        +  ++ L E++ L QL H N
Sbjct: 10  IGKGQFSVVYKAICLLDGRV------VALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPN 63

Query: 157 LVKLIGYCCEDEHRILVYEYMESGSLE---KHLLRRVGCMLTWSRRMKIALDAAKGLAFL 213
           ++K +    E+    +V E  ++G L    KH  ++   ++      K  +     L  +
Sbjct: 64  VIKYLASFIENNELNIVLELADAGDLSRMIKHF-KKQKRLIPERTIWKYFVQLCSALEHM 122

Query: 214 HGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYV 273
           H   + +++RD K +N+ + A    KL D GL +      +T  +  ++GT  Y +PE +
Sbjct: 123 H--SKRIMHRDIKPANVFITATGVVKLGDLGLGRF--FSSKTTAAHSLVGTPYYMSPERI 178

Query: 274 MTGHLTARSDVYGFGVVLLEM 294
                  +SD++  G +L EM
Sbjct: 179 HENGYNFKSDIWSLGCLLYEM 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 70.0 bits (172), Expect = 3e-13
 Identities = 62/224 (27%), Positives = 103/224 (45%), Gaps = 42/224 (18%)

Query: 96  PDY----ILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQ--GDREWLAEVNYL 149
           P Y     +GEG +G+V       +   G K   VAIK+++   +Q    R  L E+  L
Sbjct: 5   PRYQNLSYIGEGAYGMVCSAT---HKPTGVK---VAIKKISPFEHQTFCQRT-LREIKIL 57

Query: 150 GQLRHSNLVKLIGYCC----EDEHRI-LVYEYMESGSLEKHLLRRVGCMLTWSRRMKIAL 204
            + +H N++ ++        E  + + +V E ME+       L ++       +   ++ 
Sbjct: 58  RRFKHENIIGILDIIRPPSFESFNDVYIVQELMETD------LYKL------IKTQHLSN 105

Query: 205 DAAK--------GLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAK-DGPMGDQT 255
           D  +        GL ++H A   V++RD K SN+LLN +   K+ DFGLA+   P  D T
Sbjct: 106 DHIQYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHT 163

Query: 256 HVSTRVMGTYGYAAPEYVMTGHLTARS-DVYGFGVVLLEMLLGR 298
              T  + T  Y APE ++      ++ D++  G +L EML  R
Sbjct: 164 GFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR 207

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 69.6 bits (171), Expect = 3e-13
 Identities = 63/217 (29%), Positives = 101/217 (46%), Gaps = 47/217 (21%)

Query: 102 EGGFGVVYKGVIDENVRPGYKTT--FVAIKELNRGGYQGDRE-----WLAEVNYLGQLRH 154
           EG +GVVY+           K T   VA+K+L     + ++E      L E+N L +L+H
Sbjct: 15  EGTYGVVYRAR--------DKKTGEIVALKKLK---MEKEKEGFPITSLREINILLKLQH 63

Query: 155 SNLVKL----IGYCCEDEHRI-LVYEYME---SGSLEKH----LLRRVGCMLTWSRRMKI 202
            N+V +    +G    +  +I +V EY+E      +E      L   V C+      M  
Sbjct: 64  PNIVTVKEVVVG---SNLDKIYMVMEYVEHDLKSLMETMKQPFLQSEVKCL------MLQ 114

Query: 203 ALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVM 262
            L    G+A LH  +  +++RD KTSN+LLN     K+ DFGLA+    G      T+++
Sbjct: 115 LLS---GVAHLH--DNWILHRDLKTSNLLLNNRGILKICDFGLAR--EYGSPLKPYTQLV 167

Query: 263 GTYGYAAPEYVM-TGHLTARSDVYGFGVVLLEMLLGR 298
            T  Y APE ++     +   D++  G +  E+L  +
Sbjct: 168 VTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKK 204

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 69.6 bits (170), Expect = 4e-13
 Identities = 63/232 (27%), Positives = 109/232 (46%), Gaps = 26/232 (11%)

Query: 94  FRPDYILGEGGFGVVYKGVID---ENVR-PGYKTTFVAIKELNRG-GYQGDREWLAEVNY 148
           F+   +LG G FG VYKG+     E V+ P      VAIKEL      + ++E L E   
Sbjct: 9   FKKIKVLGSGAFGTVYKGLWIPEGEKVKIP------VAIKELREATSPKANKEILDEAYV 62

Query: 149 LGQLRHSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLR---RVGC--MLTWSRRMKIA 203
           +  + + ++ +L+G C     + L+ + M  G L  ++      +G   +L W       
Sbjct: 63  MASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNW------C 115

Query: 204 LDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMG 263
           +  AKG+ +L   ER +++RD    N+L+      K++DFGLAK     ++ + +     
Sbjct: 116 VQIAKGMNYLE--ERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKV 173

Query: 264 TYGYAAPEYVMTGHLTARSDVYGFGVVLLE-MLLGRRAVDKSRPSREHNLVE 314
              + A E ++    T +SDV+ +GV + E M  G +  D    S   +++E
Sbjct: 174 PIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE 225

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 69.6 bits (170), Expect = 4e-13
 Identities = 68/205 (33%), Positives = 91/205 (44%), Gaps = 19/205 (9%)

Query: 99  ILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDRE---WLAEVNYLGQLRHS 155
           +LG+G FG V        VR      + A+K L +       E    + E   L   RH 
Sbjct: 2   LLGKGTFGKVIL------VREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHP 55

Query: 156 NLVKLIGYCCEDEHRI-LVYEYMESGSLEKHLLR-RVGCMLTWSRRMKIALDAAKGLAFL 213
            L  L  Y  +   R+  V EY   G L  HL R RV    T  R      +    L +L
Sbjct: 56  FLTAL-KYAFQTHDRLCFVMEYANGGELFFHLSRERV---FTEERARFYGAEIVSALEYL 111

Query: 214 HGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYV 273
           H   R V+YRD K  N++L+ D   K++DFGL K+G + D   + T   GT  Y APE +
Sbjct: 112 H--SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEG-ISDGATMKT-FCGTPEYLAPEVL 167

Query: 274 MTGHLTARSDVYGFGVVLLEMLLGR 298
                    D +G GVV+ EM+ GR
Sbjct: 168 EDNDYGRAVDWWGLGVVMYEMMCGR 192

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 69.5 bits (170), Expect = 5e-13
 Identities = 50/148 (33%), Positives = 71/148 (47%), Gaps = 10/148 (6%)

Query: 153 RHSNLVKLIGYCC-EDEHRIL-VYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGL 210
           +H  L  L  +CC + + R+  V EY+  G L   + R         R    A +    L
Sbjct: 54  KHPFLTAL--HCCFQTKDRLFFVMEYVNGGDLMFQIQR--SRKFDEPRSRFYAAEVTLAL 109

Query: 211 AFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAP 270
            FLH     VIYRD K  NILL+A+   KL+DFG+ K+G +   T  +T   GT  Y AP
Sbjct: 110 MFLH--RHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVT--TTTFCGTPDYIAP 165

Query: 271 EYVMTGHLTARSDVYGFGVVLLEMLLGR 298
           E +         D +  GV++ EM+ G+
Sbjct: 166 EILQELEYGPSVDWWALGVLMYEMMAGQ 193

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 69.6 bits (171), Expect = 5e-13
 Identities = 71/238 (29%), Positives = 92/238 (38%), Gaps = 58/238 (24%)

Query: 99  ILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELN------RGGYQGDREWLAEVNYLGQL 152
           ++G G FG V+       VR        A+K L       R      R   AE + L   
Sbjct: 8   VIGRGAFGEVWL------VRDKDTGQVYAMKVLRKSDMIKRNQIAHVR---AERDILADA 58

Query: 153 RHSNLVKLIGYCCEDEHRI-LVYEYMESGSLEKHLLRRVGCMLTWSR----RMKIALDAA 207
               +VKL  Y  +DE  + LV EYM  G L   L+R+       +R     + +ALD+ 
Sbjct: 59  DSPWIVKLY-YSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSV 117

Query: 208 KGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQT------------ 255
             L F+H        RD K  NIL++AD   KL+DFGL K                    
Sbjct: 118 HKLGFIH--------RDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLF 169

Query: 256 ----------HVSTRVM-----GTYGYAAPEYVMTGH-LTARSDVYGFGVVLLEMLLG 297
                     H   RV      GT  Y APE V+ G       D +  GV+L EML G
Sbjct: 170 RDNVLVRRRDHKQRRVRANSTVGTPDYIAPE-VLRGTPYGLECDWWSLGVILYEMLYG 226

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 71.0 bits (174), Expect = 5e-13
 Identities = 56/190 (29%), Positives = 88/190 (46%), Gaps = 20/190 (10%)

Query: 126 VAIKELNRGGYQGDRE---WLAEVNYLGQLRHSNLVKLIGY-CCEDEHRILVYEYMESGS 181
           VAIK L     + + +   +  E     +L H N+V L+            V+EY+   +
Sbjct: 6   VAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVPGRT 65

Query: 182 LEKHLLRRVGCM--LTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNA---DF 236
           L + +L   G +      R M   LDA   LA  H   + +++RD K  NI+++      
Sbjct: 66  L-REVLAADGALPAGETGRLMLQVLDA---LACAH--NQGIVHRDLKPQNIMVSQTGVRP 119

Query: 237 SAKLSDFGLAKDGP-MGD----QTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVL 291
            AK+ DFG+    P + D        +T V+GT  Y APE +    +T  SD+Y +G++ 
Sbjct: 120 HAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIF 179

Query: 292 LEMLLGRRAV 301
           LE L G+R V
Sbjct: 180 LECLTGQRVV 189

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 68.8 bits (168), Expect = 6e-13
 Identities = 74/304 (24%), Positives = 126/304 (41%), Gaps = 62/304 (20%)

Query: 99  ILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLV 158
           ILG G  G VYK           +   V +  L+    +  ++ ++E+  L +     ++
Sbjct: 8   ILGHGNGGTVYKAY----HLLTRRILAVKVIPLDIT-VELQKQIMSELEILYKCDSPYII 62

Query: 159 KLIGYCCEDEHRI-LVYEYMESGSLE------KHLLRRVGCMLTWSRRMKIALDAAKGLA 211
              G     E+RI +  E+M+ GSL+      +H+L R            IA+   KGL 
Sbjct: 63  GFYGAFFV-ENRISICTEFMDGGSLDVYRKIPEHVLGR------------IAVAVVKGLT 109

Query: 212 FLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPE 271
           +L   +  +++RD K SN+L+N     KL DFG++          ++   +GT  Y APE
Sbjct: 110 YLWSLK--ILHRDVKPSNMLVNTRGQVKLCDFGVSTQ----LVNSIAKTYVGTNAYMAPE 163

Query: 272 YVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLR--- 328
            +        SDV+  G+  +E+ LGR                +  P +  N+  L    
Sbjct: 164 RISGEQYGIHSDVWSLGISFMELALGR----------------FPYPQIQKNQGSLMPLQ 207

Query: 329 ----ILD---PRL-EGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETVQSQGAE 380
               I+D   P L  GQ++ +    +     QC+ + PK RP   +++     VQ     
Sbjct: 208 LLQCIVDEDPPVLPVGQFSEKFVHFIT----QCMRKQPKERPAPENLMDHPFIVQYNDGN 263

Query: 381 EEML 384
            E++
Sbjct: 264 AEVV 267

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 68.9 bits (168), Expect = 6e-13
 Identities = 63/202 (31%), Positives = 94/202 (46%), Gaps = 24/202 (11%)

Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREW---LAEVNYLGQLRHSN 156
           +G G FG VY      +VR    +  VAIK+++  G Q + +W   + EV +L +LRH N
Sbjct: 23  IGHGSFGAVY---FARDVR---NSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76

Query: 157 LVKLIGYCCEDEHRI-LVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHG 215
            ++  G C   EH   LV EY    + +  LL      L       +   A +GLA+LH 
Sbjct: 77  TIQYRG-CYLREHTAWLVMEYCLGSASD--LLEVHKKPLQEVEIAAVTHGALQGLAYLHS 133

Query: 216 AERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMT 275
               +I+RD K  NILL+     KL DFG A           +   +GT  + APE ++ 
Sbjct: 134 HN--MIHRDVKAGNILLSEPGLVKLGDFGSAS------IMAPANXFVGTPYWMAPEVILA 185

Query: 276 ---GHLTARSDVYGFGVVLLEM 294
              G    + DV+  G+  +E+
Sbjct: 186 MDEGQYDGKVDVWSLGITCIEL 207

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 69.3 bits (169), Expect = 6e-13
 Identities = 66/202 (32%), Positives = 93/202 (46%), Gaps = 12/202 (5%)

Query: 99  ILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLV 158
           +LG+G FG V   ++ E     Y    +  KE+     +     L E   L   RH  L 
Sbjct: 2   LLGKGTFGKVI--LVKEKATGRYYAMKILKKEVIVAKDEVAHT-LTENRVLQNSRHPFLT 58

Query: 159 KLIGYCCEDEHRI-LVYEYMESGSLEKHLLR-RVGCMLTWSRRMKIALDAAKGLAFLHGA 216
            L  Y  +   R+  V EY   G L  HL R RV    +  R      +    L +LH +
Sbjct: 59  AL-KYSFQTHDRLCFVMEYANGGELFFHLSRERV---FSEDRARFYGAEIVSALDYLH-S 113

Query: 217 ERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTG 276
           E+ V+YRD K  N++L+ D   K++DFGL K+G + D   + T   GT  Y APE +   
Sbjct: 114 EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEG-IKDGATMKT-FCGTPEYLAPEVLEDN 171

Query: 277 HLTARSDVYGFGVVLLEMLLGR 298
                 D +G GVV+ EM+ GR
Sbjct: 172 DYGRAVDWWGLGVVMYEMMCGR 193

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 68.9 bits (168), Expect = 6e-13
 Identities = 83/276 (30%), Positives = 117/276 (42%), Gaps = 38/276 (13%)

Query: 94  FRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRG---GYQGDREWLAEVNYLG 150
           FR   +LG+GGFG V        VR   K    A K+L +      +G+   L E   L 
Sbjct: 2   FRQYRVLGKGGFGEVCAC----QVRATGK--MYACKKLEKKRIKKRKGESMALNEKQILE 55

Query: 151 QLRHSNLVKLIGYCCEDEHRI-LVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKG 209
           ++ +S  V  + Y  E +  + LV   M  G L+ H+           R +  A +   G
Sbjct: 56  KV-NSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCG 114

Query: 210 LAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAA 269
           L  LH  ER ++YRD K  NILL+     ++SD GLA   P G QT +  RV GT GY A
Sbjct: 115 LEDLH-QER-IVYRDLKPENILLDDHGHIRISDLGLAVHVPEG-QT-IKGRV-GTVGYMA 169

Query: 270 PEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRI 329
           PE V     T   D +  G +L EM+ G+                   P     KK+ R 
Sbjct: 170 PEVVKNERYTFSPDWWALGCLLYEMIAGQ------------------SPFQQRKKKIKRE 211

Query: 330 LDPRL----EGQYTARTAMKVAGLAYQCLSQNPKGR 361
              RL    + +Y+ + +     L    L ++PK R
Sbjct: 212 EVERLVKEVQEEYSEKFSPDARSLCKMLLCKDPKER 247

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 69.2 bits (169), Expect = 7e-13
 Identities = 62/211 (29%), Positives = 96/211 (45%), Gaps = 32/211 (15%)

Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGD---REWLAEVNYLGQLRHSN 156
           +G G +G V   +   + R G K   VAIK+L R  +Q +   +    E+  L  ++H N
Sbjct: 23  VGSGAYGTVCSAL---DRRTGAK---VAIKKLYRP-FQSELFAKRAYRELRLLKHMKHEN 75

Query: 157 LVKLIGYCCEDEHR------ILVYEYMES--GSLEKHLLRRVGCMLTWSRRMKIALDAAK 208
           ++ L+     D          LV  +M +  G L KH        L+  R   +     K
Sbjct: 76  VIGLLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMKHE------KLSEDRIQFLVYQMLK 129

Query: 209 GLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYA 268
           GL ++H A   +I+RD K  N+ +N D   K+ DFGLA+        +V TR      Y 
Sbjct: 130 GLKYIHAAG--IIHRDLKPGNLAVNEDCELKILDFGLARQTDSEMTGYVVTR-----WYR 182

Query: 269 APEYVMTG-HLTARSDVYGFGVVLLEMLLGR 298
           APE ++   H T   D++  G ++ EML G+
Sbjct: 183 APEVILNWMHYTQTVDIWSVGCIMAEMLTGK 213

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 68.6 bits (168), Expect = 7e-13
 Identities = 64/203 (31%), Positives = 99/203 (48%), Gaps = 22/203 (10%)

Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVK 159
           +G G FG V+  V D      Y    +AI E+ R   + ++    E   L ++ H  +++
Sbjct: 9   VGTGTFGRVHL-VRDRISEHYYALKVMAIPEVIR--LKQEQHVHNEKRVLKEVSHPFIIR 65

Query: 160 LIGYCCEDEHRIL--VYEYMESGSLEKHLLRRVGCMLTWSRRMKI--ALDAAKGLAFLHG 215
           L  +  E + R L  + EY+  G L  +L R  G    +S    +  A +    L +LH 
Sbjct: 66  L--FWTEHDQRFLYMLMEYVPGGELFSYL-RNSG---RFSNSTGLFYASEIVCALEYLHS 119

Query: 216 AERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVM- 274
            E  ++YRD K  NILL+ +   KL+DFG AK   + D+T     + GT  Y APE +  
Sbjct: 120 KE--IVYRDLKPENILLDKEGHIKLTDFGFAKK--LRDRTWT---LCGTPEYLAPEVIQS 172

Query: 275 TGHLTARSDVYGFGVVLLEMLLG 297
            GH  A  D +  G+++ EML+G
Sbjct: 173 KGHNKA-VDWWALGILIYEMLVG 194

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 68.6 bits (167), Expect = 8e-13
 Identities = 66/229 (28%), Positives = 110/229 (48%), Gaps = 16/229 (6%)

Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVK 159
           +G+G  G V+  +   +V  G +   VAIK++N          + E+  + +L++ N+V 
Sbjct: 27  IGQGASGTVFTAI---DVATGQE---VAIKQINLQKQPKKELIINEILVMKELKNPNIVN 80

Query: 160 LIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERP 219
            +      +   +V EY+  GSL   +     CM   ++   +  +  + L FLH  +  
Sbjct: 81  FLDSFLVGDELFVVMEYLAGGSLTDVVTET--CM-DEAQIAAVCRECLQALEFLHANQ-- 135

Query: 220 VIYRDFKTSNILLNADFSAKLSDFGL-AKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHL 278
           VI+RD K+ N+LL  D S KL+DFG  A+  P  +Q+  ST V GT  + APE V     
Sbjct: 136 VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITP--EQSKRSTMV-GTPYWMAPEVVTRKAY 192

Query: 279 TARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEW-ARPLLNNNKKV 326
             + D++  G++ +EM+ G        P R   L+     P L N +K+
Sbjct: 193 GPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKL 241

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 68.9 bits (168), Expect = 8e-13
 Identities = 64/204 (31%), Positives = 92/204 (45%), Gaps = 17/204 (8%)

Query: 99  ILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDRE---WLAEVNYLGQLRHS 155
           +LG+G FG V        VR      + A+K L +       E    L E   L   RH 
Sbjct: 2   LLGKGTFGKVIL------VREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHP 55

Query: 156 NLVKLIGYCCEDEHRI-LVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLH 214
            L  L  Y  + + R+  V EY+  G L  HL R    + +  R      +    L +LH
Sbjct: 56  FLTSL-KYSFQTKDRLCFVMEYVNGGELFFHLSRER--VFSEDRTRFYGAEIVSALDYLH 112

Query: 215 GAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVM 274
             +  ++YRD K  N++L+ D   K++DFGL K+G + D   + T   GT  Y APE + 
Sbjct: 113 SGK--IVYRDLKLENLMLDKDGHIKITDFGLCKEG-ITDAATMKT-FCGTPEYLAPEVLE 168

Query: 275 TGHLTARSDVYGFGVVLLEMLLGR 298
                   D +G GVV+ EM+ GR
Sbjct: 169 DNDYGRAVDWWGLGVVMYEMMCGR 192

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 68.2 bits (166), Expect = 9e-13
 Identities = 73/289 (25%), Positives = 123/289 (42%), Gaps = 49/289 (16%)

Query: 88  KLATKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLA-EV 146
           +L TK  R    +G+G FG V+KG ID   +       VAIK ++    + + E +  E+
Sbjct: 4   ELFTKLER----IGKGSFGEVFKG-IDNRTQ-----QVVAIKIIDLEEAEDEIEDIQQEI 53

Query: 147 NYLGQLRHSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLR-------RVGCMLTWSRR 199
             L Q     + K  G   +     ++ EY+  GS    LLR       ++  ML     
Sbjct: 54  TVLSQCDSPYVTKYYGSYLKGTKLWIIMEYLGGGS-ALDLLRAGPFDEFQIATMLK---- 108

Query: 200 MKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVST 259
                +  KGL +LH  ++  I+RD K +N+LL+     KL+DFG+A  G + D      
Sbjct: 109 -----EILKGLDYLHSEKK--IHRDIKAANVLLSEQGDVKLADFGVA--GQLTDTQIKRN 159

Query: 260 RVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPL 319
             +GT  + APE +      +++D++  G+  +E+  G        P R   L+    P 
Sbjct: 160 TFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNP- 218

Query: 320 LNNNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVV 368
                       P L G+++             CL+++P  RP   +++
Sbjct: 219 ------------PTLTGEFSK----PFKEFIDACLNKDPSFRPTAKELL 251

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 68.5 bits (167), Expect = 1e-12
 Identities = 65/203 (32%), Positives = 92/203 (45%), Gaps = 16/203 (7%)

Query: 99  ILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREW---LAEVN-YLGQLRH 154
           ++G+G FG V         +     +F A+K L +      +E    +AE N  L  L+H
Sbjct: 2   VIGKGSFGKVLLA------KRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKH 55

Query: 155 SNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLH 214
             LV L       E    V +Y+  G L  HL +R  C L    R   A + A  + +LH
Sbjct: 56  PFLVGLHYSFQTAEKLYFVLDYVNGGELFFHL-QRERCFLEPRARF-YAAEVASAIGYLH 113

Query: 215 GAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVM 274
                +IYRD K  NILL++     L+DFGL K+G   ++T  ++   GT  Y APE + 
Sbjct: 114 SLN--IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEET--TSTFCGTPEYLAPEVLR 169

Query: 275 TGHLTARSDVYGFGVVLLEMLLG 297
                   D +  G VL EML G
Sbjct: 170 KEPYDRTVDWWCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 67.7 bits (166), Expect = 1e-12
 Identities = 59/227 (25%), Positives = 100/227 (44%), Gaps = 53/227 (23%)

Query: 99  ILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDRE-----WLAEVNYLGQLR 153
            +GEG +G VYK     ++  G    FVA+K++         E      L E+  L QL 
Sbjct: 6   EIGEGAYGTVYKA---RDLNTG---RFVALKKVR---VPLSEEGIPLSTLREIALLKQLE 56

Query: 154 ---HSNLVKLIGYC--CEDEHRI---LVYEYME------------SGSLEKHLLRRVGCM 193
              H N+V+L+  C     +  +   LV+E+++             G L    ++ +   
Sbjct: 57  SFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPG-LPPETIKDL--- 112

Query: 194 LTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGD 253
               R++       +G+ FLH + R +++RD K  NIL+ +D   K++DFGLA+   +  
Sbjct: 113 ---MRQL------LRGVDFLH-SHR-IVHRDLKPQNILVTSDGQVKIADFGLAR---IYS 158

Query: 254 QTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRA 300
                T V+ T  Y APE ++        D++  G +  E+   RR 
Sbjct: 159 FEMALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFR-RRP 204

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 68.0 bits (166), Expect = 1e-12
 Identities = 64/211 (30%), Positives = 94/211 (44%), Gaps = 32/211 (15%)

Query: 99  ILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDRE---WLAEVNYLGQLR-H 154
           +LG+G FG V    + E+ R        A+K L +     D +    + E   L   R H
Sbjct: 2   VLGKGSFGKVMLARLKESGR------LYAVKVLKKDVILQDDDVECTMTEKRILSLARNH 55

Query: 155 SNLVKLIGYCC--EDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMK------IALDA 206
             L +L  YCC    +    V E++  G L  H+ +        SRR         A + 
Sbjct: 56  PFLTQL--YCCFQTPDRLFFVMEFVNGGDLMFHIQK--------SRRFDEARARFYAAEI 105

Query: 207 AKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYG 266
              L FLH  ++ +IYRD K  N+LL+ +   KL+DFG+ K+G    +T  ++   GT  
Sbjct: 106 TSALMFLH--DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKT--TSTFCGTPD 161

Query: 267 YAAPEYVMTGHLTARSDVYGFGVVLLEMLLG 297
           Y APE +         D +  GV+L EML G
Sbjct: 162 YIAPEILQEMLYGPSVDWWAMGVLLYEMLCG 192

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 67.3 bits (164), Expect = 1e-12
 Identities = 74/289 (25%), Positives = 116/289 (40%), Gaps = 35/289 (12%)

Query: 99  ILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGD--REWLAEVNYLGQLRHSN 156
           +LG+G FG V +  +        K   VA+K L    +      E+L E   + +  H N
Sbjct: 6   MLGKGEFGSVREAQLKSEDGSFQK---VAVKMLKADIFSSSDIEEFLREAACMKEFDHPN 62

Query: 157 LVKLIGYCCEDEHR------ILVYEYMESGSLEKHLL-RRVG---CMLTWSRRMKIALDA 206
           ++KLIG       +      +++  +M+ G L   LL  R+G     L     ++  +D 
Sbjct: 63  VIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDI 122

Query: 207 AKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYG 266
           A G+ +L  + +  I+RD    N +LN + +  ++DFGL+K    GD             
Sbjct: 123 ASGMEYL--SSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVK 180

Query: 267 YAAPEYVMTGHLTARSDVYGFGVVLLE-MLLGRRAVDKSRPSREHNLVEWARPLLNNNKK 325
           + A E +     T  SDV+ FGV + E M  G+        S  +N       L+  N  
Sbjct: 181 WLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNY------LIKGN-- 232

Query: 326 VLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETV 374
             R+  P             V  L  QC S  PK RP    +   LE +
Sbjct: 233 --RLKQP-------PDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 67.8 bits (165), Expect = 2e-12
 Identities = 66/222 (29%), Positives = 100/222 (45%), Gaps = 32/222 (14%)

Query: 88  KLATKFFRPD--------YILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGD 139
           ++A  FF+ D          +G G FG VY      +VR       VAIK+++  G Q +
Sbjct: 13  EIAELFFKEDPEKLFTDLREIGHGSFGAVY---FARDVR---TNEVVAIKKMSYSGKQSN 66

Query: 140 REW---LAEVNYLGQLRHSNLVKLIGYCCEDEHRI-LVYEYMESGSLEKHLLRRVGCMLT 195
            +W   + EV +L +++H N ++  G C   EH   LV EY    + +  LL      L 
Sbjct: 67  EKWQDIIKEVKFLQRIKHPNSIEYKG-CYLREHTAWLVMEYCLGSASD--LLEVHKKPLQ 123

Query: 196 WSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQT 255
                 I   A +GLA+LH     +I+RD K  NILL      KL+DFG A         
Sbjct: 124 EVEIAAITHGALQGLAYLH--SHNMIHRDIKAGNILLTEPGQVKLADFGSAS------IA 175

Query: 256 HVSTRVMGTYGYAAPEYVMT---GHLTARSDVYGFGVVLLEM 294
             +   +GT  + APE ++    G    + DV+  G+  +E+
Sbjct: 176 SPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 217

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 67.8 bits (165), Expect = 2e-12
 Identities = 54/168 (32%), Positives = 84/168 (50%), Gaps = 12/168 (7%)

Query: 139 DREWLAEVNYLGQLRHSNLVKLIGY--CCEDEHRIL-VYEYMESGSLEKHLLRRVGCMLT 195
           D +W+    ++ + + SN   L+G   C + E R+  V EY+  G L  H+ R+      
Sbjct: 38  DIDWVQTEKHVFE-QASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEE 96

Query: 196 WSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPM-GDQ 254
            +R     +  A  L +LH  ER +IYRD K  N+LL+++   KL+D+G+ K+G   GD 
Sbjct: 97  HARFYSAEISLA--LNYLH--ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT 152

Query: 255 THVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVD 302
           T   +   GT  Y APE +         D +  GV++ EM+ GR   D
Sbjct: 153 T---STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 197

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 67.7 bits (165), Expect = 2e-12
 Identities = 45/132 (34%), Positives = 70/132 (53%), Gaps = 8/132 (6%)

Query: 172 LVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNIL 231
            V EY+  G L  H+ ++VG      + +  A + + GL FLH   R +IYRD K  N++
Sbjct: 78  FVMEYVNGGDLMYHI-QQVG-KFKEPQAVFYAAEISVGLFFLH--RRGIIYRDLKLDNVM 133

Query: 232 LNADFSAKLSDFGLAKDGPMGDQTHVSTRVM-GTYGYAAPEYVMTGHLTARSDVYGFGVV 290
           L+++   K++DFG+ K+  +     V+TR   GT  Y APE +         D + +GV+
Sbjct: 134 LDSEGHIKIADFGMCKEHMV---DGVTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVL 190

Query: 291 LLEMLLGRRAVD 302
           L EML G+   D
Sbjct: 191 LYEMLAGQPPFD 202

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 67.1 bits (164), Expect = 3e-12
 Identities = 71/217 (32%), Positives = 96/217 (44%), Gaps = 41/217 (18%)

Query: 99  ILGEGGFGVVYKGVIDENVRPGYKTT------FVAIKELNRGGY---QGDREWL-AEVNY 148
           +LG+GG+G V++      VR   K T        A+K L +      Q D     AE N 
Sbjct: 3   VLGKGGYGKVFQ------VR---KVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNI 53

Query: 149 LGQLRHSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAK 208
           L  ++H  +V LI          L+ EY+  G L  HL  R G  +          D A 
Sbjct: 54  LEAVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMHL-EREGIFME---------DTAC 103

Query: 209 ------GLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQ-THVSTRV 261
                  LA  H  ++ +IYRD K  NILL+A    KL+DFGL K+       TH     
Sbjct: 104 FYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHT---F 160

Query: 262 MGTYGYAAPEYVM-TGHLTARSDVYGFGVVLLEMLLG 297
            GT  Y APE +M +GH  A  D +  G ++ +ML G
Sbjct: 161 CGTIEYMAPEILMRSGHGKA-VDWWSLGALMYDMLTG 196

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 66.8 bits (163), Expect = 4e-12
 Identities = 53/171 (30%), Positives = 76/171 (44%), Gaps = 43/171 (25%)

Query: 145 EVNYLGQLRHSNLVKL----------IGYCCE----DEHRILVYEYMESGSLEKHLLRRV 190
           E+  L  LRH N++ L          I +  E    D HR+L      S  LEK  ++  
Sbjct: 59  ELKLLKHLRHENIISLSDIFISPLEDIYFVTELLGTDLHRLL-----TSRPLEKQFIQY- 112

Query: 191 GCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAK--D 248
                            +GL ++H A   V++RD K SNIL+N +   K+ DFGLA+  D
Sbjct: 113 -----------FLYQILRGLKYVHSAG--VVHRDLKPSNILINENCDLKICDFGLARIQD 159

Query: 249 GPMGDQTHVSTRVMGTYGYAAPEYVMTGH-LTARSDVYGFGVVLLEMLLGR 298
             M    +VSTR      Y APE ++T        D++  G +  EML G+
Sbjct: 160 PQM--TGYVSTRY-----YRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGK 203

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 66.2 bits (161), Expect = 5e-12
 Identities = 56/200 (28%), Positives = 93/200 (46%), Gaps = 16/200 (8%)

Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVK 159
           LG+G FG VYK    +N   G      A K +     +   +++ E+  L    H  +VK
Sbjct: 20  LGDGAFGKVYKA---KNKETG---ALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVK 73

Query: 160 LIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERP 219
           L+G    D    ++ E+   G+++  +L  +   LT  +   I     + L +LH  +  
Sbjct: 74  LLGAFYWDGKLWIMIEFCPGGAVDAIMLE-LDRGLTEPQIQVICRQMLEALQYLHSMK-- 130

Query: 220 VIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLT 279
           +I+RD K  N+LL  D   KL+DFG++       Q   S   +GT  + APE VM   + 
Sbjct: 131 IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDS--FIGTPYWMAPEVVMCETMK 188

Query: 280 A-----RSDVYGFGVVLLEM 294
                 ++D++  G+ L+EM
Sbjct: 189 DTPYDYKADIWSLGITLIEM 208

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 66.4 bits (162), Expect = 5e-12
 Identities = 58/203 (28%), Positives = 100/203 (49%), Gaps = 21/203 (10%)

Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDR----EWLAEVNYLGQLRHS 155
           +GEG +GVVYK       R       +A+K++     Q D       + E++ L +++H 
Sbjct: 10  IGEGTYGVVYKA------RDRVTNETIALKKIRLE--QEDEGVPSTAIREISLLKEMQHG 61

Query: 156 NLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIAL-DAAKGLAFLH 214
           N+V+L      ++   LV+EY++   L+KH +          R +K  L    +G+A+ H
Sbjct: 62  NIVRLQDVVHSEKRLYLVFEYLDL-DLKKH-MDSSPDFAKNPRLIKTYLYQILRGIAYCH 119

Query: 215 GAERPVIYRDFKTSNILLNADFSA-KLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYV 273
                V++RD K  N+L++   +A KL+DFGLA+    G      T  + T  Y APE +
Sbjct: 120 --SHRVLHRDLKPQNLLIDRRTNALKLADFGLAR--AFGIPVRTFTHEVVTLWYRAPEIL 175

Query: 274 M-TGHLTARSDVYGFGVVLLEML 295
           + + H +   D++  G +  EM+
Sbjct: 176 LGSRHYSTPVDIWSVGCIFAEMV 198

Length = 294

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 66.2 bits (161), Expect = 5e-12
 Identities = 69/222 (31%), Positives = 97/222 (43%), Gaps = 18/222 (8%)

Query: 94  FRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRG---GYQGDREWLAEVNYLG 150
           FR   +LG+GGFG V        VR   K    A K L +      +G+   L E   L 
Sbjct: 2   FRQYRVLGKGGFGEVCAC----QVRATGK--MYACKRLEKKRIKKRKGESMALNEKQILE 55

Query: 151 QLRHSNLVKLIGYCCEDEHRI-LVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKG 209
           ++ +S  V  + Y  E +  + LV   M  G L+ H+           R +  A +   G
Sbjct: 56  KV-NSQFVVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCG 114

Query: 210 LAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAA 269
           L  LH      +YRD K  NILL+     ++SD GLA   P G+   +  RV GT GY A
Sbjct: 115 LEDLH--RENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES--IRGRV-GTVGYMA 169

Query: 270 PEYVMTGHLTARSDVYGFGVVLLEMLLGRRAV--DKSRPSRE 309
           PE +     T   D +G G ++ EM+ G+      K +  RE
Sbjct: 170 PEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKRE 211

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 66.2 bits (161), Expect = 5e-12
 Identities = 50/195 (25%), Positives = 97/195 (49%), Gaps = 21/195 (10%)

Query: 145 EVNYLGQLRHSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRM---- 200
           E+  L +     +V   G    D    +  E+M+ GSL++        +L  ++R+    
Sbjct: 53  ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQ--------VLKEAKRIPEEI 104

Query: 201 --KIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVS 258
             K+++   +GLA+L   +  +++RD K SNIL+N+    KL DFG++  G + D   ++
Sbjct: 105 LGKVSIAVLRGLAYLR-EKHQIMHRDVKPSNILVNSRGEIKLCDFGVS--GQLIDS--MA 159

Query: 259 TRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARP 318
              +GT  Y +PE +   H + +SD++  G+ L+E+ +GR  +    P  +     + RP
Sbjct: 160 NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPP--PDAKELEAIFGRP 217

Query: 319 LLNNNKKVLRILDPR 333
           +++  +     + PR
Sbjct: 218 VVDGEEGEPHSISPR 232

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 65.9 bits (160), Expect = 6e-12
 Identities = 69/230 (30%), Positives = 110/230 (47%), Gaps = 18/230 (7%)

Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVK 159
           +G+G  G VY  +   ++  G +   VAIK++N          + E+  + + ++ N+V 
Sbjct: 27  IGQGASGTVYTAI---DIATGQE---VAIKQMNLQQQPKKELIINEILVMRENKNPNIVN 80

Query: 160 -LIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAER 218
            L  Y   DE  + V EY+  GSL   +     CM    +   +  +  + L FLH  + 
Sbjct: 81  YLDSYLVGDELWV-VMEYLAGGSLTDVVTET--CM-DEGQIAAVCRECLQALDFLHSNQ- 135

Query: 219 PVIYRDFKTSNILLNADFSAKLSDFGL-AKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGH 277
            VI+RD K+ NILL  D S KL+DFG  A+  P  +Q+  ST V GT  + APE V    
Sbjct: 136 -VIHRDIKSDNILLGMDGSVKLTDFGFCAQITP--EQSKRSTMV-GTPYWMAPEVVTRKA 191

Query: 278 LTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEW-ARPLLNNNKKV 326
              + D++  G++ +EM+ G        P R   L+     P L N +++
Sbjct: 192 YGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERL 241

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 66.0 bits (161), Expect = 7e-12
 Identities = 53/164 (32%), Positives = 81/164 (49%), Gaps = 27/164 (16%)

Query: 143 LAEVNYLGQLRHSNLVKLI-GYCCEDEHRI-LVYEYMESGSLEKHLLRRVGCMLTWSRRM 200
             E + L +L H  +V ++  +  +DE+R+  + E++  G L  HL R+ G         
Sbjct: 66  AQEKSILMELSHPFIVNMMCSF--QDENRVYFLLEFVVGGELFTHL-RKAG--------- 113

Query: 201 KIALDAAKG------LAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQ 254
           +   D AK       LAF +   + +IYRD K  N+LL+     K++DFG AK  P  D+
Sbjct: 114 RFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVP--DR 171

Query: 255 THVSTRVMGTYGYAAPEYVMT-GHLTARSDVYGFGVVLLEMLLG 297
           T     + GT  Y APE + + GH  A  D +  GV+L E + G
Sbjct: 172 TFT---LCGTPEYLAPEVIQSKGHGKA-VDWWTMGVLLYEFIAG 211

Length = 329

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 65.1 bits (158), Expect = 9e-12
 Identities = 65/233 (27%), Positives = 107/233 (45%), Gaps = 16/233 (6%)

Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVK 159
           +G+G  G VY  +   +V  G +   VAI+++N          + E+  + + ++ N+V 
Sbjct: 28  IGQGASGTVYTAM---DVATGQE---VAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 81

Query: 160 -LIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAER 218
            L  Y   DE  + V EY+  GSL   +     CM    +   +  +  + L FLH  + 
Sbjct: 82  YLDSYLVGDELWV-VMEYLAGGSLTDVVTET--CM-DEGQIAAVCRECLQALEFLHSNQ- 136

Query: 219 PVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHL 278
            VI+RD K+ NILL  D S KL+DFG      +  +    + ++GT  + APE V     
Sbjct: 137 -VIHRDIKSDNILLGMDGSVKLTDFGFCAQ--ITPEQSKRSTMVGTPYWMAPEVVTRKAY 193

Query: 279 TARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEW-ARPLLNNNKKVLRIL 330
             + D++  G++ +EM+ G        P R   L+     P L N +K+  I 
Sbjct: 194 GPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIF 246

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 65.0 bits (158), Expect = 1e-11
 Identities = 80/276 (28%), Positives = 120/276 (43%), Gaps = 38/276 (13%)

Query: 94  FRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRG---GYQGDREWLAEVNYLG 150
           FR   +LG+GGFG V        VR   K    A K+L +      +G+   L E   L 
Sbjct: 2   FRHYRVLGKGGFGEVCAC----QVRATGK--MYACKKLEKKRIKKRKGEAMALNEKRILE 55

Query: 151 QLRHSNLVKLIGYCCEDEHRI-LVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKG 209
           ++    +V L  Y  E +  + LV   M  G L+ H+           R +  A +   G
Sbjct: 56  KVNSRFVVSL-AYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCG 114

Query: 210 LAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAA 269
           L  L   ER ++YRD K  NILL+     ++SD GLA   P G+   V  RV GT GY A
Sbjct: 115 LEDLQ-RER-IVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET--VRGRV-GTVGYMA 169

Query: 270 PEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRI 329
           PE +     T   D +G G ++ EM+ G+       P R+              ++V R 
Sbjct: 170 PEVINNEKYTFSPDWWGLGCLIYEMIQGQ------SPFRKR------------KERVKRE 211

Query: 330 -LDPRL---EGQYTARTAMKVAGLAYQCLSQNPKGR 361
            +D R+   + +Y+ + +     +    L++NPK R
Sbjct: 212 EVDRRVKEDQEEYSEKFSEDAKSICRMLLTKNPKER 247

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 64.7 bits (157), Expect = 1e-11
 Identities = 63/222 (28%), Positives = 106/222 (47%), Gaps = 27/222 (12%)

Query: 99  ILGEGGFGVVYKGVI---DENVR-PGYKTTFVAIKELNRG-GYQGDREWLAEVNYLGQLR 153
           +LG G FG VYKG+     ENV+ P      VAIK L      + ++E L E   +  + 
Sbjct: 14  VLGSGAFGTVYKGIWIPDGENVKIP------VAIKVLRENTSPKANKEILDEAYVMAGVG 67

Query: 154 HSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLR---RVGC--MLTWSRRMKIALDAAK 208
              + +L+G C     + LV + M  G L  ++     R+G   +L W       +  AK
Sbjct: 68  SPYVCRLLGICLTSTVQ-LVTQLMPYGCLLDYVRENKDRIGSQDLLNW------CVQIAK 120

Query: 209 GLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYA 268
           G+++L   E  +++RD    N+L+ +    K++DFGLA+   + +  + +        + 
Sbjct: 121 GMSYLE--EVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWM 178

Query: 269 APEYVMTGHLTARSDVYGFGVVLLE-MLLGRRAVDKSRPSRE 309
           A E ++    T +SDV+ +GV + E M  G +  D   P+RE
Sbjct: 179 ALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYD-GIPARE 219

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 65.1 bits (158), Expect = 1e-11
 Identities = 46/154 (29%), Positives = 83/154 (53%), Gaps = 7/154 (4%)

Query: 145 EVNYLGQLRHSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIAL 204
           E+  L +     +V   G    D    +  E+M+ GSL++ +L++ G  +      K+++
Sbjct: 53  ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQ-VLKKAG-RIPEQILGKVSI 110

Query: 205 DAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGT 264
              KGL +L    + +++RD K SNIL+N+    KL DFG++  G + D   ++   +GT
Sbjct: 111 AVIKGLTYLREKHK-IMHRDVKPSNILVNSRGEIKLCDFGVS--GQLIDS--MANSFVGT 165

Query: 265 YGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGR 298
             Y +PE +   H + +SD++  G+ L+EM +GR
Sbjct: 166 RSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGR 199

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 64.8 bits (158), Expect = 1e-11
 Identities = 49/168 (29%), Positives = 73/168 (43%), Gaps = 27/168 (16%)

Query: 201 KIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTR 260
           KIA+   K L +LH ++  VI+RD K SN+L+N +   KL DFG++  G + D     T 
Sbjct: 107 KIAVSIVKALEYLH-SKLSVIHRDVKPSNVLINRNGQVKLCDFGIS--GYLVDSV-AKTI 162

Query: 261 VMGTYGYAAPEYV----MTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREH--NLVE 314
             G   Y APE +           +SDV+  G+ ++E+  GR   D  +   +    +VE
Sbjct: 163 DAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVE 222

Query: 315 WARPLLNNNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRP 362
              P L   K      D      +             +CL +N K RP
Sbjct: 223 EPSPQLPAEKFSPEFQD------FVN-----------KCLKKNYKERP 253

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 64.8 bits (158), Expect = 1e-11
 Identities = 61/224 (27%), Positives = 98/224 (43%), Gaps = 46/224 (20%)

Query: 99  ILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREW-----LAEVNYLGQLR 153
            +GEG +G VYK       R       VA+K++       ++E      + E+  L QL 
Sbjct: 14  QIGEGTYGQVYKA------RDKDTGELVALKKVR---LDNEKEGFPITAIREIKILRQLN 64

Query: 154 HSNLVKLIGYCCEDEHRI----------LVYEYMES---GSLEKHLLRRVGCMLTWSRR- 199
           H N+V L     + +  +          LV+EYM+    G LE         ++ +S   
Sbjct: 65  HRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESG-------LVHFSEDH 117

Query: 200 ----MKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQT 255
               MK  L+   GL + H  ++  ++RD K SNILLN     KL+DFGLA+     +  
Sbjct: 118 IKSFMKQLLE---GLNYCH--KKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESR 172

Query: 256 HVSTRVMGTYGYAAPEYVMTGHLTARS-DVYGFGVVLLEMLLGR 298
             + +V+ T  Y  PE ++       + DV+  G +L E+   +
Sbjct: 173 PYTNKVI-TLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKK 215

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 64.7 bits (158), Expect = 2e-11
 Identities = 60/228 (26%), Positives = 98/228 (42%), Gaps = 43/228 (18%)

Query: 94  FRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRG--GYQGDREWLAEVNYLGQ 151
           ++P   +G G +GVV   +   + R G K   VAIK++          +  L E+  L  
Sbjct: 7   YKPIENIGSGAYGVVCSAI---DTRSGKK---VAIKKIPHAFDVPTLAKRTLRELKILRH 60

Query: 152 LRHSNLVKLIG-YCCEDEHRILVY---EYMES---------GSLEKHLLRR-VGCMLTWS 197
            +H N++ +             VY   + MES           L +  +R  +  +L   
Sbjct: 61  FKHDNIIAIRDILRPPGADFKDVYVVMDLMESDLHHIIHSDQPLTEEHIRYFLYQLL--- 117

Query: 198 RRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAK--DGPMGDQT 255
                     +GL ++H A   VI+RD K SN+L+N D   ++ DFG+A+       +  
Sbjct: 118 ----------RGLKYIHSAN--VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHK 165

Query: 256 HVSTRVMGTYGYAAPE--YVMTGHLTARSDVYGFGVVLLEMLLGRRAV 301
           +  T  + T  Y APE    +  + TA  D++  G +  EM LGRR +
Sbjct: 166 YFMTEYVATRWYRAPELLLSLPEYTTA-IDMWSVGCIFAEM-LGRRQL 211

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 64.2 bits (157), Expect = 3e-11
 Identities = 53/215 (24%), Positives = 87/215 (40%), Gaps = 33/215 (15%)

Query: 101 GEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGD-------REWLAEVNYLGQLR 153
           G G +G VYK         G      AIK+      Q         RE    +  L +L+
Sbjct: 9   GRGTYGRVYKAKRKN----GKDGKEYAIKKFKGDKEQYTGISQSACRE----IALLRELK 60

Query: 154 HSNLVKLIGYCCEDEHRI--LVYEYMESGSLE--KHLLRRVGCMLTWSRRM--KIALDAA 207
           H N+V L+    E   +   L+++Y E    +  K   +     +     M   +     
Sbjct: 61  HENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSI--PPSMVKSLLWQIL 118

Query: 208 KGLAFLHGAERPVIYRDFKTSNILLNADFSA----KLSDFGLAK--DGPMGDQTHVSTRV 261
            G+ +LH     V++RD K +NIL+  +       K+ D GLA+  + P+     +   V
Sbjct: 119 NGVHYLH--SNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLD-PV 175

Query: 262 MGTYGYAAPEYVMTG-HLTARSDVYGFGVVLLEML 295
           + T  Y APE ++   H T   D++  G +  E+L
Sbjct: 176 VVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELL 210

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

 Score = 62.2 bits (151), Expect = 5e-11
 Identities = 50/179 (27%), Positives = 74/179 (41%), Gaps = 29/179 (16%)

Query: 156 NLVKLIGYCCEDEHRILVYEYMESGSLEKHLLR----RVGCMLTWSRRMKIALDAAKGLA 211
           N+V L  Y   ++   LV ++ E G L  H+ +       C+  W+  M +ALDA     
Sbjct: 46  NMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDA----- 100

Query: 212 FLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKD-GPMGDQTHVSTRVMGTYGYAAP 270
            LH     ++ RD   +NILL+     +L+ F    +     D   V         Y AP
Sbjct: 101 -LH--REGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVENM------YCAP 151

Query: 271 EYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPS--REH---NLVEW----ARPLL 320
           E       T   D +  G +L E+L G + + +  PS    H   N+ EW    AR LL
Sbjct: 152 EVGGISEETEACDWWSLGAILFELLTG-KTLVECHPSGINTHTTLNIPEWVSEEARSLL 209

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 63.5 bits (154), Expect = 5e-11
 Identities = 62/203 (30%), Positives = 89/203 (43%), Gaps = 16/203 (7%)

Query: 99  ILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREW---LAEVN-YLGQLRH 154
           ++G+G FG V   ++ +    G      A+K L +      +E    +AE N  L  ++H
Sbjct: 2   VIGKGSFGKV---LLAKRKLDG---KCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKH 55

Query: 155 SNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLH 214
             LV L       E    V +++  G L  HL R         R    A + A  L +LH
Sbjct: 56  PFLVGLHYSFQTTEKLYFVLDFVNGGELFFHLQRERS--FPEPRARFYAAEIASALGYLH 113

Query: 215 GAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVM 274
                ++YRD K  NILL++     L+DFGL K+G    Q+  +T   GT  Y APE + 
Sbjct: 114 SIN--IVYRDLKPENILLDSQGHVVLTDFGLCKEGI--AQSDTTTTFCGTPEYLAPEVIR 169

Query: 275 TGHLTARSDVYGFGVVLLEMLLG 297
                   D +  G VL EML G
Sbjct: 170 KQPYDNTVDWWCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 62.8 bits (152), Expect = 6e-11
 Identities = 55/203 (27%), Positives = 103/203 (50%), Gaps = 14/203 (6%)

Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDR-EWLAEVNYLGQLRHSNLV 158
           LGEG +  VYKG    N +       VA+K +     +G     + E + L  L+H+N+V
Sbjct: 13  LGEGSYATVYKGKSKVNGK------LVALKVIRLQEEEGTPFTAIREASLLKGLKHANIV 66

Query: 159 KLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAER 218
            L       E   LV+EY+ +  L +++ +  G +   + ++ +     +GL+++H  +R
Sbjct: 67  LLHDIIHTKETLTLVFEYVHT-DLCQYMDKHPGGLHPENVKLFL-FQLLRGLSYIH--QR 122

Query: 219 PVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVM-TGH 277
            +++RD K  N+L++     KL+DFGLA+   +   T+ +  V  T  Y  P+ ++ +  
Sbjct: 123 YILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVV--TLWYRPPDVLLGSTE 180

Query: 278 LTARSDVYGFGVVLLEMLLGRRA 300
            +   D++G G + +EM+ G  A
Sbjct: 181 YSTCLDMWGVGCIFVEMIQGVAA 203

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 62.3 bits (151), Expect = 7e-11
 Identities = 56/222 (25%), Positives = 99/222 (44%), Gaps = 28/222 (12%)

Query: 145 EVNYLGQLRHSNLVKLI-GYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIA 203
           E   L QL+H N+V     +  ED    +V  + E G L   L  + G +L  ++ ++  
Sbjct: 49  EAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWF 108

Query: 204 LDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMG 263
           +  A  L +LH  E+ +++RD KT N+ L      K+ D G+A+   + +Q  +++ ++G
Sbjct: 109 VQIAMALQYLH--EKHILHRDLKTQNVFLTRTNIIKVGDLGIAR--VLENQCDMASTLIG 164

Query: 264 TYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNN 323
           T  Y +PE         +SDV+  G  + EM   + A +                  + N
Sbjct: 165 TPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAK----------------DMN 208

Query: 324 KKVLRILD---PRLEGQYTARTAMKVAGLAYQCLSQNPKGRP 362
             V RI++   P +   Y+      +A +    LS+ P+ RP
Sbjct: 209 SLVYRIIEGKLPPMPKDYSPELGELIATM----LSKRPEKRP 246

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 62.5 bits (152), Expect = 8e-11
 Identities = 69/209 (33%), Positives = 98/209 (46%), Gaps = 16/209 (7%)

Query: 94  FRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRG---GYQGDREWLAEVNYLG 150
           FR   +LG+GGFG V        VR   K    A K+L +      +G+   L E   L 
Sbjct: 2   FRHYRVLGKGGFGEVCAC----QVRATGK--MYACKKLEKKRIKKRKGEAMALNEKQILE 55

Query: 151 QLRHSNLVKLIGYCCEDEHRI-LVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKG 209
           ++ +S  V  + Y  E +  + LV   M  G L+ H+           R +  A +   G
Sbjct: 56  KV-NSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCG 114

Query: 210 LAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAA 269
           L  LH  ER ++YRD K  NILL+     ++SD GLA + P G+   +  RV GT GY A
Sbjct: 115 LEDLH-RER-IVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET--IRGRV-GTVGYMA 169

Query: 270 PEYVMTGHLTARSDVYGFGVVLLEMLLGR 298
           PE V     T   D +G G ++ EM+ G+
Sbjct: 170 PEVVKNERYTFSPDWWGLGCLIYEMIEGK 198

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 63.2 bits (154), Expect = 8e-11
 Identities = 65/215 (30%), Positives = 106/215 (49%), Gaps = 23/215 (10%)

Query: 94  FRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNR--GGYQGDREWLAEVNYLGQ 151
             PD  +G G FGVV+  V D   R G +   VA+K++          +    E+  L  
Sbjct: 2   VEPDRPIGYGAFGVVW-SVTDP--RDGKR---VALKKMPNVFQNLVSCKRVFRELKMLCF 55

Query: 152 LRHSNLVKLI-----GYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIAL-D 205
            +H N++  +      +    E   +V E M+S  L K ++      L+ S  +K+ L  
Sbjct: 56  FKHDNVLSALDILQPPHIDPFEEIYVVTELMQS-DLHKIIVSPQP--LS-SDHVKVFLYQ 111

Query: 206 AAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTY 265
             +GL +LH A   +++RD K  N+L+N++   K+ DFGLA+     +  H++  V+  Y
Sbjct: 112 ILRGLKYLHSAG--ILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQY 169

Query: 266 GYAAPEYVM-TGHLTARSDVYGFGVVLLEMLLGRR 299
            Y APE +M + H T+  D++  G +  E LLGRR
Sbjct: 170 -YRAPEILMGSRHYTSAVDIWSVGCIFAE-LLGRR 202

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 63.1 bits (154), Expect = 8e-11
 Identities = 58/218 (26%), Positives = 92/218 (42%), Gaps = 46/218 (21%)

Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNR---------GGYQGDREWLAEVNYLG 150
           +G G +G V       + + G K   VAIK+L+R           Y+       E+  L 
Sbjct: 23  VGSGAYGQVCSAF---DTKTGRK---VAIKKLSRPFQSAIHAKRTYR-------ELRLLK 69

Query: 151 QLRHSNLVKLIGYCCEDEHR------ILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIAL 204
            + H N++ L+                LV   M +  L   +  +    L+      +  
Sbjct: 70  HMDHENVIGLLDVFTPASSLEDFQDVYLVTHLMGA-DLNNIVKCQK---LSDDHIQFLVY 125

Query: 205 DAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAK--DGPMGDQTHVSTRVM 262
              +GL ++H A   +I+RD K SNI +N D   K+ DFGLA+  D  M    +V+TR  
Sbjct: 126 QILRGLKYIHSAG--IIHRDLKPSNIAVNEDCELKILDFGLARHTDDEMTG--YVATR-- 179

Query: 263 GTYGYAAPEYVMT--GHLTARSDVYGFGVVLLEMLLGR 298
               Y APE +M    H     D++  G ++ E+L G+
Sbjct: 180 ---WYRAPE-IMLNWMHYNQTVDIWSVGCIMAELLTGK 213

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 62.7 bits (152), Expect = 8e-11
 Identities = 62/204 (30%), Positives = 93/204 (45%), Gaps = 18/204 (8%)

Query: 99  ILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDRE---WLAEVN-YLGQLRH 154
           ++G+G FG V         R   +  F A+K L +      +E    ++E N  L  ++H
Sbjct: 2   VIGKGSFGKVLLA------RHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKH 55

Query: 155 SNLVKLIGYCCEDEHRI-LVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFL 213
             LV L  +  +   ++  V +Y+  G L  HL +R  C L    R   A + A  L +L
Sbjct: 56  PFLVGL-HFSFQTADKLYFVLDYINGGELFYHL-QRERCFLEPRARF-YAAEIASALGYL 112

Query: 214 HGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYV 273
           H     ++YRD K  NILL++     L+DFGL K+    + T  ++   GT  Y APE +
Sbjct: 113 HSLN--IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGT--TSTFCGTPEYLAPEVL 168

Query: 274 MTGHLTARSDVYGFGVVLLEMLLG 297
                    D +  G VL EML G
Sbjct: 169 HKQPYDRTVDWWCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 62.8 bits (153), Expect = 9e-11
 Identities = 62/218 (28%), Positives = 94/218 (43%), Gaps = 30/218 (13%)

Query: 94  FRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRG--GYQGDREWLAEVNYLGQ 151
           + P   +G G +G+V       N     K   VAIK++          +  L E+  L  
Sbjct: 7   YVPIKPIGRGAYGIVCSAK---NSETNEK---VAIKKIANAFDNRIDAKRTLREIKLLRH 60

Query: 152 LRHSNLVKLIGYCCEDEHR------ILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALD 205
           L H N++ +        HR       +VYE M++   + H + R    L+          
Sbjct: 61  LDHENVIAIKD-IMPPPHREAFNDVYIVYELMDT---DLHQIIRSSQTLSDDHCQYFLYQ 116

Query: 206 AAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQ---THVSTRVM 262
             +GL ++H A   V++RD K SN+LLNA+   K+ DFGLA+           +V TR  
Sbjct: 117 LLRGLKYIHSAN--VLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVVTR-- 172

Query: 263 GTYGYAAPEYVMT-GHLTARSDVYGFGVVLLEMLLGRR 299
               Y APE ++     T   DV+  G +  E LLGR+
Sbjct: 173 ---WYRAPELLLNCSEYTTAIDVWSVGCIFAE-LLGRK 206

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 62.1 bits (151), Expect = 1e-10
 Identities = 56/211 (26%), Positives = 90/211 (42%), Gaps = 41/211 (19%)

Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREW-----LAEVNYLGQLRH 154
           +GEG +G V+K    E          VA+K   R     D E      L E+  L +L+H
Sbjct: 8   IGEGTYGTVFKAKNRET------HEIVALK---RVRLDDDDEGVPSSALREICLLKELKH 58

Query: 155 SNLVKLIGYCCEDEHRILVYEYME----------SGSLEKHLLRRVGCMLTWSRRMKIAL 204
            N+V+L      D+   LV+EY +          +G ++  +++                
Sbjct: 59  KNIVRLYDVLHSDKKLTLVFEYCDQDLKKYFDSCNGDIDPEIVK------------SFMF 106

Query: 205 DAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGT 264
              KGLAF H     V++RD K  N+L+N +   KL+DFGLA+    G      +  + T
Sbjct: 107 QLLKGLAFCH--SHNVLHRDLKPQNLLINKNGELKLADFGLAR--AFGIPVRCYSAEVVT 162

Query: 265 YGYAAPEYVMTGHLTARS-DVYGFGVVLLEM 294
             Y  P+ +    L + S D++  G +  E+
Sbjct: 163 LWYRPPDVLFGAKLYSTSIDMWSAGCIFAEL 193

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 61.6 bits (149), Expect = 1e-10
 Identities = 51/208 (24%), Positives = 94/208 (45%), Gaps = 19/208 (9%)

Query: 94  FRPDYILGEGGFGVVYKG--VIDENVRPGYKTTFVAIKEL---NRGGYQGDREWLAEVNY 148
           FR +  +G G F  VY+   ++D           VA+K++   +    +   + + E++ 
Sbjct: 4   FRIEKKIGRGQFSEVYRATCLLDG--------VPVALKKVQIFDLMDAKARADCIKEIDL 55

Query: 149 LGQLRHSNLVKLIGYCCEDEHRILVYEYMESGSLEKHL--LRRVGCMLTWSRRMKIALDA 206
           L QL H N++K      ED    +V E  ++G L + +   ++   ++      K  +  
Sbjct: 56  LKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQL 115

Query: 207 AKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYG 266
              L  +H   R V++RD K +N+ + A    KL D GL +      +T  +  ++GT  
Sbjct: 116 CSALEHMH--SRRVMHRDIKPANVFITATGVVKLGDLGLGRF--FSSKTTAAHSLVGTPY 171

Query: 267 YAAPEYVMTGHLTARSDVYGFGVVLLEM 294
           Y +PE +       +SD++  G +L EM
Sbjct: 172 YMSPERIHENGYNFKSDIWSLGCLLYEM 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 61.2 bits (148), Expect = 2e-10
 Identities = 51/210 (24%), Positives = 94/210 (44%), Gaps = 23/210 (10%)

Query: 94  FRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELN---RGGYQGDREWLAEVNYLG 150
           F+ +  +G G F  VY+     + +P      VA+K++        +  ++ + E++ L 
Sbjct: 4   FQIEKKIGRGQFSEVYRATCLLDRKP------VALKKVQIFEMMDAKARQDCVKEIDLLK 57

Query: 151 QLRHSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLL------RRVGCMLTWSRRMKIAL 204
           QL H N++K +    ED    +V E  ++G L + +       R +     W   +++  
Sbjct: 58  QLNHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCS 117

Query: 205 DAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGT 264
                 A  H   R V++RD K +N+ + A    KL D GL +      +T  +  ++GT
Sbjct: 118 ------AVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRF--FSSKTTAAHSLVGT 169

Query: 265 YGYAAPEYVMTGHLTARSDVYGFGVVLLEM 294
             Y +PE +       +SD++  G +L EM
Sbjct: 170 PYYMSPERIHENGYNFKSDIWSLGCLLYEM 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 61.6 bits (149), Expect = 2e-10
 Identities = 45/128 (35%), Positives = 68/128 (53%), Gaps = 8/128 (6%)

Query: 172 LVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNIL 231
            V EY+  G L   + ++VG        +  A + A GL FLH   + +IYRD K  N++
Sbjct: 78  FVMEYVNGGDLMYQI-QQVG-RFKEPHAVFYAAEIAIGLFFLH--SKGIIYRDLKLDNVM 133

Query: 232 LNADFSAKLSDFGLAKDGPMGDQTHVSTRVM-GTYGYAAPEYVMTGHLTARSDVYGFGVV 290
           L+++   K++DFG+ K+  M D   V+T+   GT  Y APE +         D + FGV+
Sbjct: 134 LDSEGHIKIADFGMCKEN-MWDG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVL 190

Query: 291 LLEMLLGR 298
           L EML G+
Sbjct: 191 LYEMLAGQ 198

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 61.2 bits (148), Expect = 2e-10
 Identities = 61/245 (24%), Positives = 105/245 (42%), Gaps = 22/245 (8%)

Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVK 159
           +GEG  G+V         R  +    VA+K ++    Q       EV  +   +H N+V+
Sbjct: 29  IGEGSTGIVCIA------REKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVE 82

Query: 160 LIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERP 219
           +       E   ++ E+++ G+L   ++ +    L   +   +     + L +LH   + 
Sbjct: 83  MYKSYLVGEELWVLMEFLQGGAL-TDIVSQT--RLNEEQIATVCESVLQALCYLHS--QG 137

Query: 220 VIYRDFKTSNILLNADFSAKLSDFG----LAKDGPMGDQTHVSTRVMGTYGYAAPEYVMT 275
           VI+RD K+ +ILL  D   KLSDFG    ++KD P          ++GT  + APE +  
Sbjct: 138 VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPK------RKSLVGTPYWMAPEVISR 191

Query: 276 GHLTARSDVYGFGVVLLEMLLGRRAVDKSRP-SREHNLVEWARPLLNNNKKVLRILDPRL 334
                  D++  G++++EM+ G        P      L +   P L N  K+  +L   L
Sbjct: 192 TPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNAHKISPVLRDFL 251

Query: 335 EGQYT 339
           E   T
Sbjct: 252 ERMLT 256

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 61.5 bits (149), Expect = 2e-10
 Identities = 60/223 (26%), Positives = 102/223 (45%), Gaps = 34/223 (15%)

Query: 88  KLATKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGD---REWLA 144
           +L  ++     + G G +G V   +   + R G K   VAIK+L+R  +Q +   +    
Sbjct: 12  ELPERYTSLKQV-GSGAYGSVCSAI---DKRTGEK---VAIKKLSRP-FQSEIFAKRAYR 63

Query: 145 EVNYLGQLRHSNLVKL--------IGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTW 196
           E+  L  ++H N++ L         G   +D +  LV  YM++      L + +G  L+ 
Sbjct: 64  ELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFY--LVMPYMQT-----DLQKIMGHPLSE 116

Query: 197 SRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTH 256
            +   +      GL ++H A   +I+RD K  N+ +N D   K+ DFGLA+        +
Sbjct: 117 DKVQYLVYQMLCGLKYIHSAG--IIHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGY 174

Query: 257 VSTRVMGTYGYAAPEYVMTG-HLTARSDVYGFGVVLLEMLLGR 298
           V TR      Y APE ++   H     D++  G ++ EML G+
Sbjct: 175 VVTR-----WYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGK 212

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 61.4 bits (149), Expect = 3e-10
 Identities = 61/215 (28%), Positives = 100/215 (46%), Gaps = 40/215 (18%)

Query: 99  ILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGD---REWLAEVNYLGQLRHS 155
            +G G  G VYK +     R        A+K +   G   D   R+   E+  L  + H 
Sbjct: 81  RIGSGAGGTVYKVIHRPTGRL------YALKVIY--GNHEDTVRRQICREIEILRDVNHP 132

Query: 156 NLVKLIGYCCED------EHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKG 209
           N+VK     C D      E ++L+ E+M+ GSLE   +     +   +R++        G
Sbjct: 133 NVVK-----CHDMFDHNGEIQVLL-EFMDGGSLEGTHIADEQFLADVARQI------LSG 180

Query: 210 LAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQT-HVSTRVMGTYGYA 268
           +A+LH   R +++RD K SN+L+N+  + K++DFG+++   +  QT       +GT  Y 
Sbjct: 181 IAYLH--RRHIVHRDIKPSNLLINSAKNVKIADFGVSR---ILAQTMDPCNSSVGTIAYM 235

Query: 269 APEYVMTGHLTAR-----SDVYGFGVVLLEMLLGR 298
           +PE + T            D++  GV +LE  LGR
Sbjct: 236 SPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGR 270

Length = 353

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 61.3 bits (149), Expect = 3e-10
 Identities = 61/213 (28%), Positives = 92/213 (43%), Gaps = 27/213 (12%)

Query: 99  ILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNR--GGYQGDREWLAEVNYLGQLRHSN 156
           ++G+G +GVV   +   +   G K   VAIK++N            L E+  L  LRH +
Sbjct: 7   VIGKGSYGVVCSAI---DTHTGEK---VAIKKINDVFEHVSDATRILREIKLLRLLRHPD 60

Query: 157 LVKLIGYCCEDEHR-----ILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLA 211
           +V++         R      +V+E MES   + H + +    LT            + L 
Sbjct: 61  IVEIKHIMLPPSRREFKDIYVVFELMES---DLHQVIKANDDLTPEHHQFFLYQLLRALK 117

Query: 212 FLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAK----DGPMGDQTHVSTRVMGTYGY 267
           ++H A   V +RD K  NIL NAD   K+ DFGLA+    D P        T  + T  Y
Sbjct: 118 YIHTAN--VFHRDLKPKNILANADCKLKICDFGLARVAFNDTP---TAIFWTDYVATRWY 172

Query: 268 AAPEYVMT--GHLTARSDVYGFGVVLLEMLLGR 298
            APE   +     T   D++  G +  E+L G+
Sbjct: 173 RAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK 205

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 60.8 bits (147), Expect = 3e-10
 Identities = 67/275 (24%), Positives = 121/275 (44%), Gaps = 40/275 (14%)

Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVK 159
           +GEG  G+V    +  + +       VA+K+++    Q       EV  +   +H N+V+
Sbjct: 28  IGEGSTGIVCIATVKSSGK------LVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVE 81

Query: 160 LI-GYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMK-----IALDAAKGLAFL 213
           +   Y   DE  + V E++E G+L          ++T +R  +     + L   K L+ L
Sbjct: 82  MYNSYLVGDELWV-VMEFLEGGALTD--------IVTHTRMNEEQIAAVCLAVLKALSVL 132

Query: 214 HGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYV 273
           H   + VI+RD K+ +ILL  D   KLSDFG      +  +      ++GT  + APE +
Sbjct: 133 HA--QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQ--VSKEVPRRKSLVGTPYWMAPELI 188

Query: 274 MTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRILDPR 333
                    D++  G++++EM      VD   P        +  P L   K +   L P+
Sbjct: 189 SRLPYGPEVDIWSLGIMVIEM------VDGEPPY-------FNEPPLKAMKMIRDNLPPK 235

Query: 334 LEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVV 368
           L+  +    ++K  G   + L ++P  R   ++++
Sbjct: 236 LKNLHKVSPSLK--GFLDRLLVRDPAQRATAAELL 268

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 60.6 bits (147), Expect = 3e-10
 Identities = 78/298 (26%), Positives = 127/298 (42%), Gaps = 45/298 (15%)

Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKE----LNRGGYQGDREWLAEVNYLGQLRHS 155
           LG+G +G VYK      V        +A+KE    L+   +    + + E++ L +    
Sbjct: 9   LGKGNYGSVYK------VLHRPTGVTMAMKEIRLELDESKF---NQIIMELDILHKAVSP 59

Query: 156 NLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRM-KIALDAAKGLAFLH 214
            +V   G    +    +  EYM++GSL+K     V         + +I     KGL FL 
Sbjct: 60  YIVDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLK 119

Query: 215 GAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVM 274
             E  +I+RD K +N+L+N +   KL DFG++  G +     ++   +G   Y APE + 
Sbjct: 120 -EEHNIIHRDVKPTNVLVNGNGQVKLCDFGVS--GNL--VASLAKTNIGCQSYMAPERIK 174

Query: 275 TGHLTAR------SDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLR 328
           +G           SDV+  G+ +LEM LGR       P    N+      +++ +     
Sbjct: 175 SGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYP---PETYANIFAQLSAIVDGDP---- 227

Query: 329 ILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLE---TVQSQGAEEEM 383
              P L   Y+      VA    +CL++ P  RP       LLE    V+ + A+ +M
Sbjct: 228 ---PTLPSGYSDDAQDFVA----KCLNKIPNRRP---TYAQLLEHPWLVKYKNADVDM 275

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 60.8 bits (147), Expect = 3e-10
 Identities = 46/157 (29%), Positives = 74/157 (47%), Gaps = 10/157 (6%)

Query: 145 EVNYLGQLRHSNLVKLIGYCCEDEHRI-LVYEYMESGSLEKHLLRRVGCMLTWSRRMKIA 203
           E   L  +R S  +  + Y  + + ++ L+ +Y+  G L  HL +R      +  +    
Sbjct: 54  ERQVLEHIRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRE----RFKEQEVQI 109

Query: 204 LDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMG 263
                 LA  H  +  +IYRD K  NILL+++    L+DFGL+K+    D+   +    G
Sbjct: 110 YSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEF-HEDEVERAYSFCG 168

Query: 264 TYGYAAPEYVM---TGHLTARSDVYGFGVVLLEMLLG 297
           T  Y AP+ V     GH  A  D +  GV++ E+L G
Sbjct: 169 TIEYMAPDIVRGGDGGHDKA-VDWWSMGVLMYELLTG 204

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 60.5 bits (147), Expect = 4e-10
 Identities = 65/213 (30%), Positives = 98/213 (46%), Gaps = 34/213 (15%)

Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLR-----H 154
           +G G  G VYK      +R       +A+K++ R    G++E    +  L  L      H
Sbjct: 23  IGSGTCGQVYK------MRFKKTGHVMAVKQMRR---TGNKEENKRI--LMDLDVVLKSH 71

Query: 155 S--NLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAF 212
               +VK  GY   D    +  E M +  L+K LL+R+   +      K+ +   K L +
Sbjct: 72  DCPYIVKCYGYFITDSDVFICMELMST-CLDK-LLKRIQGPIPEDILGKMTVAIVKALHY 129

Query: 213 L---HGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAA 269
           L   HG    VI+RD K SNILL+A  + KL DFG++  G + D +   TR  G   Y A
Sbjct: 130 LKEKHG----VIHRDVKPSNILLDASGNVKLCDFGIS--GRLVD-SKAKTRSAGCAAYMA 182

Query: 270 PEYV----MTGHLTARSDVYGFGVVLLEMLLGR 298
           PE +           R+DV+  G+ L+E+  G+
Sbjct: 183 PERIDPPDPNPKYDIRADVWSLGISLVELATGQ 215

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 60.9 bits (148), Expect = 4e-10
 Identities = 54/226 (23%), Positives = 98/226 (43%), Gaps = 37/226 (16%)

Query: 94  FRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLR 153
           +     LG G  G+V+  V  +  +       VA+K++     Q  +  L E+  + +L 
Sbjct: 7   YMDLRPLGCGSNGLVFSAVDSDCDKR------VAVKKIVLTDPQSVKHALREIKIIRRLD 60

Query: 154 HSNLVKLIGYCCEDEHRI--------------LVYEYMESGSLEKHLLRRV---GCMLTW 196
           H N+VK+          +              +V EYME+       L  V   G +   
Sbjct: 61  HDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETD------LANVLEQGPLSEE 114

Query: 197 SRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNA-DFSAKLSDFGLAK--DGPMGD 253
             R+       +GL ++H A   V++RD K +N+ +N  D   K+ DFGLA+  D     
Sbjct: 115 HARL-FMYQLLRGLKYIHSAN--VLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSH 171

Query: 254 QTHVSTRVMGTYGYAAPEYVMT-GHLTARSDVYGFGVVLLEMLLGR 298
           + ++S  ++  + Y +P  +++  + T   D++  G +  EML G+
Sbjct: 172 KGYLSEGLVTKW-YRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 216

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 59.9 bits (145), Expect = 4e-10
 Identities = 55/199 (27%), Positives = 93/199 (46%), Gaps = 12/199 (6%)

Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLA--EVNYLGQLRHSNL 157
           LG+G FG VY  V D+            +KE+  G    +    A  E   L +L H  +
Sbjct: 8   LGKGSFGTVYL-VKDKKAVAE--ERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAI 64

Query: 158 VKLIGYCCEDEHRILVYEYMESGSLEKHL--LRRVGCMLTWSRRMKIALDAAKGLAFLHG 215
           VK      E +   ++ EY E   L+  L  L+  G  L+ ++  +  +    G+ ++H 
Sbjct: 65  VKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMH- 123

Query: 216 AERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMT 275
            +R +++RD K  NI L  +   K+ DFG+++   MG    ++T   GT  Y +PE +  
Sbjct: 124 -QRRILHRDLKAKNIFLKNNL-LKIGDFGVSR-LLMG-SCDLATTFTGTPYYMSPEALKH 179

Query: 276 GHLTARSDVYGFGVVLLEM 294
               ++SD++  G +L EM
Sbjct: 180 QGYDSKSDIWSLGCILYEM 198

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 59.9 bits (145), Expect = 4e-10
 Identities = 63/211 (29%), Positives = 91/211 (43%), Gaps = 29/211 (13%)

Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELN------RGGYQG---DREWLAEVNYLG 150
           LG+GGFG V        +R   K    A K+LN      R GY+G   ++  LA+V    
Sbjct: 1   LGKGGFGEVSAC----QMRATGK--LYACKKLNKKRLKKRKGYEGAMVEKRILAKV---- 50

Query: 151 QLRHSNLVKLIGYCCEDEHRI-LVYEYMESGSLEKHL--LRRVGCMLTWSRRMKIALDAA 207
              HS  +  + Y  + +  + LV   M  G L  H+  +          R         
Sbjct: 51  ---HSRFIVSLAYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQII 107

Query: 208 KGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGY 267
            GL  LH  +R +IYRD K  N+LL+ D + ++SD GLA +  + D    +    GT G+
Sbjct: 108 SGLEHLH--QRRIIYRDLKPENVLLDNDGNVRISDLGLAVE--LKDGQSKTKGYAGTPGF 163

Query: 268 AAPEYVMTGHLTARSDVYGFGVVLLEMLLGR 298
            APE +         D +  GV L EM+  R
Sbjct: 164 MAPELLQGEEYDFSVDYFALGVTLYEMIAAR 194

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 59.8 bits (145), Expect = 6e-10
 Identities = 43/135 (31%), Positives = 65/135 (48%), Gaps = 21/135 (15%)

Query: 172 LVYEYMESGSLEKHLLRRVGCMLTWSR----RMKIALDAAKGLAFLHGAERPVIYRDFKT 227
           L+ +Y+  G L  HL +R     +  R     + +ALD       LH  +  +IYRD K 
Sbjct: 82  LILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDH------LH--QLGIIYRDIKL 133

Query: 228 SNILLNADFSAKLSDFGLAKD--GPMGDQTHVSTRVMGTYGYAAPEYVMT---GHLTARS 282
            NILL+++    L+DFGL+K+      ++ +      GT  Y APE +     GH  A  
Sbjct: 134 ENILLDSEGHVVLTDFGLSKEFLAEEEERAY---SFCGTIEYMAPEVIRGGSGGHDKA-V 189

Query: 283 DVYGFGVVLLEMLLG 297
           D +  GV+  E+L G
Sbjct: 190 DWWSLGVLTFELLTG 204

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 59.1 bits (143), Expect = 7e-10
 Identities = 70/292 (23%), Positives = 120/292 (41%), Gaps = 48/292 (16%)

Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELN-RGGYQGDREWLAEVNYLGQLRHSNLV 158
           +G G FG V    I            V +KEL      +   E+L + +    L+H N++
Sbjct: 3   IGNGWFGKVLLSEI----YTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNIL 58

Query: 159 KLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRR-------MKIALDAAKGLA 211
           + +G C E    +LV+EY E G L+ +L         W RR        ++A + A G+ 
Sbjct: 59  QCLGQCVEAIPYLLVFEYCELGDLKSYL-----SQEQWHRRNSQLLLLQRMACEIAAGVT 113

Query: 212 FLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPE 271
            +H  +   ++ D    N  L +D + K+ D+G+       D             + APE
Sbjct: 114 HMH--KHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPE 171

Query: 272 YV-------MTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNN-- 322
            V       +T   T  S+V+  GV L E+       + ++P    +L +  R +LN+  
Sbjct: 172 LVGEFHGGLITAEQTKPSNVWALGVTLWELF-----ENAAQPY--SHLSD--REVLNHVI 222

Query: 323 NKKVLRILDPRLEGQYTARTAMKVAGLAYQCLS---QNPKGRPVMSDVVALL 371
             + +++  P+LE  Y+ R         Y+ L     +P+ R    +V  LL
Sbjct: 223 KDQQVKLFKPQLELPYSERW--------YEVLQFCWLSPEKRATAEEVHRLL 266

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 59.6 bits (144), Expect = 8e-10
 Identities = 65/201 (32%), Positives = 84/201 (41%), Gaps = 15/201 (7%)

Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDRE---WLAEVNYLGQLRHSN 156
           +G+G FG V +      VR        A+K + +       E    LAE   L Q+    
Sbjct: 1   IGKGSFGKVMQ------VRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPF 54

Query: 157 LVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGA 216
           +V L       E   LV  ++  G L  HL +R G       R   A +    L  LH  
Sbjct: 55  IVPLKFSFQSPEKLYLVLAFINGGELFHHL-QREGRFDLSRARFYTA-ELLCALENLH-- 110

Query: 217 ERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTG 276
           +  VIYRD K  NILL+      L DFGL K   M D    +T   GT  Y APE ++  
Sbjct: 111 KFNVIYRDLKPENILLDYQGHIALCDFGLCKLN-MKDDDKTNT-FCGTPEYLAPELLLGH 168

Query: 277 HLTARSDVYGFGVVLLEMLLG 297
             T   D +  GV+L EML G
Sbjct: 169 GYTKAVDWWTLGVLLYEMLTG 189

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 59.3 bits (144), Expect = 9e-10
 Identities = 60/220 (27%), Positives = 96/220 (43%), Gaps = 45/220 (20%)

Query: 99  ILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREW-----LAEVNYLGQLR 153
            +G+G FG V+K       R       VA+K++     + ++E      L E+  L  L+
Sbjct: 19  KIGQGTFGEVFK------ARHKKTKQIVALKKVL---MENEKEGFPITALREIKILQLLK 69

Query: 154 HSNLVKLIGYC-----CEDEHR---ILVYEYMESGSLEKH----LLRRVGCMLTWSRRMK 201
           H N+V LI  C       + ++    LV+E+ E      H    LL       T S   K
Sbjct: 70  HENVVNLIEICRTKATPYNRYKGSFYLVFEFCE------HDLAGLLSNKNVKFTLSEIKK 123

Query: 202 IALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAK--DGPMGDQTHVST 259
           +      GL ++H  +  +++RD K +NIL+  D   KL+DFGLA+        + +  T
Sbjct: 124 VMKMLLNGLYYIHRNK--ILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYT 181

Query: 260 RVMGTYGYAAPEYVMTGHLTARS-----DVYGFGVVLLEM 294
             + T  Y  PE +    L  R      D++G G ++ EM
Sbjct: 182 NRVVTLWYRPPELL----LGERDYGPPIDMWGAGCIMAEM 217

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 59.7 bits (145), Expect = 9e-10
 Identities = 63/225 (28%), Positives = 99/225 (44%), Gaps = 28/225 (12%)

Query: 100 LGEGGFGVV----YKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLR-H 154
           LG+G +G+V         +E      K T V  K++        +  L E+  L   R H
Sbjct: 8   LGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILA------KRALRELKLLRHFRGH 61

Query: 155 SNLVKLIG-----YCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKG 209
            N+  L           +E    +Y Y E    + H + R G  LT +           G
Sbjct: 62  KNITCLYDMDIVFPGNFNE----LYLYEELMEADLHQIIRSGQPLTDAHFQSFIYQILCG 117

Query: 210 LAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAK---DGPMGDQTHVSTRVMGTYG 266
           L ++H A   V++RD K  N+L+NAD   K+ DFGLA+   + P  +   + T  + T  
Sbjct: 118 LKYIHSAN--VLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFM-TEYVATRW 174

Query: 267 YAAPEYVMTGHLTARS-DVYGFGVVLLEMLLGRRAVDKSRPSREH 310
           Y APE +++     ++ DV+  G +L E LLGR+ V K +   + 
Sbjct: 175 YRAPEIMLSFQSYTKAIDVWSVGCILAE-LLGRKPVFKGKDYVDQ 218

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 59.3 bits (144), Expect = 1e-09
 Identities = 67/249 (26%), Positives = 101/249 (40%), Gaps = 47/249 (18%)

Query: 100 LGEGGFGVVY---KGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNY-------L 149
           +G+GG+G V+   K    E          VA+K + +         L EV +       L
Sbjct: 9   VGQGGYGQVFLAKKKDTGE---------IVALKRMKKSLLF----KLNEVRHVLTERDIL 55

Query: 150 GQLRHSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRR-----MKIAL 204
              +   LVKL+    +DE+  L  EY+  G   + LL  +G +     R     M  A+
Sbjct: 56  TTTKSEWLVKLLYAFQDDEYLYLAMEYVPGGDF-RTLLNNLGVLSEDHARFYMAEMFEAV 114

Query: 205 DAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGT 264
           DA   L ++H        RD K  N L++A    KL+DFGL+K          +  V+G+
Sbjct: 115 DALHELGYIH--------RDLKPENFLIDASGHIKLTDFGLSKGI-----VTYANSVVGS 161

Query: 265 YGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREH-NLVEWA----RPL 319
             Y APE +         D +  G +L E L G      S P+    NL  W     RP+
Sbjct: 162 PDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPV 221

Query: 320 LNNNKKVLR 328
            ++ +  L 
Sbjct: 222 YDDPRFNLS 230

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 58.9 bits (142), Expect = 1e-09
 Identities = 58/209 (27%), Positives = 100/209 (47%), Gaps = 16/209 (7%)

Query: 94  FRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLA---EVNYLG 150
           +R   +LG+G FG VY   +  +V  G +     + + +    +  +E  A   E+  L 
Sbjct: 4   WRRGKLLGQGAFGRVY---LCYDVDTGRELAAKQV-QFDPESPETSKEVSALECEIQLLK 59

Query: 151 QLRHSNLVKLIGYCCED--EHRILVY-EYMESGSLEKHLLRRVGCMLTWSRRMKIALDAA 207
            L+H  +V+  G C  D  E  + ++ EYM  GS++  L  +    LT S   K      
Sbjct: 60  NLQHERIVQYYG-CLRDRAEKTLTIFMEYMPGGSVKDQL--KAYGALTESVTRKYTRQIL 116

Query: 208 KGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTR-VMGTYG 266
           +G+++LH     +++RD K +NIL ++  + KL DFG +K       +    R V GT  
Sbjct: 117 EGMSYLHS--NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPY 174

Query: 267 YAAPEYVMTGHLTARSDVYGFGVVLLEML 295
           + +PE +       ++DV+  G  ++EML
Sbjct: 175 WMSPEVISGEGYGRKADVWSLGCTVVEML 203

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 59.0 bits (142), Expect = 1e-09
 Identities = 72/284 (25%), Positives = 118/284 (41%), Gaps = 43/284 (15%)

Query: 99  ILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQL-RHSNL 157
           ++G G +G VYKG    +V+ G      AIK ++  G + + E   E+N L +   H N+
Sbjct: 13  LVGNGTYGQVYKG---RHVKTG---QLAAIKVMDVTGDE-EEEIKQEINMLKKYSHHRNI 65

Query: 158 VKLIGYCCE------DEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLA 211
               G   +      D+   LV E+  +GS+   +    G  L       I  +  +GL+
Sbjct: 66  ATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLS 125

Query: 212 FLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAK--DGPMGDQTHVSTRVMGTYGYAA 269
            LH  +  VI+RD K  N+LL  +   KL DFG++   D  +G +       +GT  + A
Sbjct: 126 HLH--QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRR----NTFIGTPYWMA 179

Query: 270 PEYVMTGH-----LTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNK 324
           PE +            +SD++  G+  +EM  G   +    P R   L+           
Sbjct: 180 PEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIP---------- 229

Query: 325 KVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVV 368
              R   PRL+ +   + + K       CL +N   RP    ++
Sbjct: 230 ---RNPAPRLKSK---KWSKKFQSFIESCLVKNHSQRPTTEQLM 267

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 59.0 bits (143), Expect = 1e-09
 Identities = 46/150 (30%), Positives = 71/150 (47%), Gaps = 19/150 (12%)

Query: 163 YCCED--EHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPV 220
           +C  +   H  +V EY+E G     LL+ +G +     RM  A +    L +LH     +
Sbjct: 67  FCSFETKRHLCMVMEYVEGGDCAT-LLKNIGALPVDMARMYFA-ETVLALEYLH--NYGI 122

Query: 221 IYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHV-------STR------VMGTYGY 267
           ++RD K  N+L+ +    KL+DFGL+K G M   T++        TR      V GT  Y
Sbjct: 123 VHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEY 182

Query: 268 AAPEYVMTGHLTARSDVYGFGVVLLEMLLG 297
            APE ++        D +  G++L E L+G
Sbjct: 183 IAPEVILRQGYGKPVDWWAMGIILYEFLVG 212

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 58.6 bits (142), Expect = 1e-09
 Identities = 57/210 (27%), Positives = 102/210 (48%), Gaps = 24/210 (11%)

Query: 99  ILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREW-LAEVNYLGQLRHSNL 157
           +L EG FG ++ G++  + +PG K   V +K +     +      L E   L  L H N+
Sbjct: 13  LLQEGTFGRIFYGIL-IDEKPG-KEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNI 70

Query: 158 VKLIGYCCEDEHRILV-YEYMESGSLEKHLLR------RVGCMLTWSRRMKIALDAAKGL 210
           + ++  C ED     V Y YM  G+L+  L +           L+  + + +A+  A G+
Sbjct: 71  LPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGM 130

Query: 211 AFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKD-GPM-----GDQTHVSTRVMGT 264
           ++LH  +R VI++D    N +++ +   K++D  L++D  PM     GD  +   + M  
Sbjct: 131 SYLH--KRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVKWM-- 186

Query: 265 YGYAAPEYVMTGHLTARSDVYGFGVVLLEM 294
               A E ++    ++ SDV+ FGV+L E+
Sbjct: 187 ----ALESLVNKEYSSASDVWSFGVLLWEL 212

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 58.4 bits (141), Expect = 2e-09
 Identities = 59/213 (27%), Positives = 95/213 (44%), Gaps = 24/213 (11%)

Query: 94  FRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKEL----NRGGY--QGDREWLAEVN 147
           + P   +G G +G VYK       R  +   FVA+K +    N  G      RE +A + 
Sbjct: 2   YEPVAEIGVGAYGTVYKA------RDPHSGHFVALKSVRVQTNEDGLPLSTVRE-VALLK 54

Query: 148 YLGQLRHSNLVKLIGYCC----EDEHRI-LVYEYMESGSLEKHLLRRVGCMLTWSRRMKI 202
            L    H N+V+L+  C     + E ++ LV+E+++   L  +L +     L       +
Sbjct: 55  RLEAFDHPNIVRLMDVCATSRTDRETKVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDL 113

Query: 203 ALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVM 262
                +GL FLH     +++RD K  NIL+ +    KL+DFGLA+   +       T V+
Sbjct: 114 MRQFLRGLDFLHA--NCIVHRDLKPENILVTSGGQVKLADFGLAR---IYSCQMALTPVV 168

Query: 263 GTYGYAAPEYVMTGHLTARSDVYGFGVVLLEML 295
            T  Y APE ++        D++  G +  EM 
Sbjct: 169 VTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMF 201

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 58.5 bits (141), Expect = 2e-09
 Identities = 72/278 (25%), Positives = 115/278 (41%), Gaps = 43/278 (15%)

Query: 99  ILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQL-RHSNL 157
           ++G G +G VYKG    +V+ G      AIK ++    + + E   E+N L +   H N+
Sbjct: 23  VVGNGTYGQVYKG---RHVKTG---QLAAIKVMDVTEDE-EEEIKLEINMLKKYSHHRNI 75

Query: 158 VKLIGYCCE------DEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLA 211
               G   +      D+   LV E+  +GS+   +    G  L       I  +  +GLA
Sbjct: 76  ATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLA 135

Query: 212 FLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAK--DGPMGDQTHVSTRVMGTYGYAA 269
            LH  +  VI+RD K  N+LL  +   KL DFG++   D  +G +       +GT  + A
Sbjct: 136 HLHAHK--VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRR----NTFIGTPYWMA 189

Query: 270 PEYVMTGH-----LTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNK 324
           PE +            RSD++  G+  +EM  G   +    P R   L+    P      
Sbjct: 190 PEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPP------ 243

Query: 325 KVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRP 362
                  P+L+ +   + + K       CL +N   RP
Sbjct: 244 -------PKLKSK---KWSKKFIDFIEGCLVKNYLSRP 271

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 58.5 bits (141), Expect = 2e-09
 Identities = 66/228 (28%), Positives = 96/228 (42%), Gaps = 43/228 (18%)

Query: 85  NEMKLAT-KFFRPDYILGEGGFG-VVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREW 142
           N+MK     F R    LG G FG V+     +E+  P      VAIK   +      ++ 
Sbjct: 25  NKMKYEDFNFIR---TLGTGSFGRVILATYKNEDFPP------VAIKRFEKSKIIKQKQV 75

Query: 143 ---LAEVNYLGQLRHSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRR------VGCM 193
               +E   L  + H   V L G   ++ +  LV E++  G     L R       VGC 
Sbjct: 76  DHVFSERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCF 135

Query: 194 LTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGD 253
                       A   L F +     ++YRD K  N+LL+ D   K++DFG AK      
Sbjct: 136 YA----------AQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKV----- 180

Query: 254 QTHVSTR---VMGTYGYAAPEYVMT-GHLTARSDVYGFGVVLLEMLLG 297
              V TR   + GT  Y APE ++  GH  A +D +  G+ + E+L+G
Sbjct: 181 ---VDTRTYTLCGTPEYIAPEILLNVGHGKA-ADWWTLGIFIYEILVG 224

Length = 340

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 57.7 bits (139), Expect = 2e-09
 Identities = 67/244 (27%), Positives = 104/244 (42%), Gaps = 24/244 (9%)

Query: 99  ILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGY---QGDREWLAEVNYLGQLRHS 155
           I+G GGFG VY        R        A+K L++      QG+   L E   L  +   
Sbjct: 1   IIGRGGFGEVY------GCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG 54

Query: 156 N--LVKLIGYCCEDEHRI-LVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAF 212
           +   +  + Y      ++  + + M  G L  HL +  G       R   A +   GL  
Sbjct: 55  DCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQH-GVFSEKEMRF-YATEIILGLEH 112

Query: 213 LHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEY 272
           +H   R V+YRD K +NILL+     ++SD GLA D     + H S   +GT+GY APE 
Sbjct: 113 MH--NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK-KKPHAS---VGTHGYMAPEV 166

Query: 273 VMTG-HLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRILD 331
           +  G    + +D +  G +L ++L G     + +   +H   E  R  L  N ++     
Sbjct: 167 LQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH---EIDRMTLTVNVELPDSFS 223

Query: 332 PRLE 335
           P L+
Sbjct: 224 PELK 227

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 58.1 bits (140), Expect = 2e-09
 Identities = 50/198 (25%), Positives = 90/198 (45%), Gaps = 13/198 (6%)

Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVK 159
           +GEG  G+V    I      G +   VA+K+++    Q       EV  +    H N+V 
Sbjct: 30  IGEGSTGIV---CIATEKHTGKQ---VAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVD 83

Query: 160 LIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERP 219
           +       +   +V E++E G+L   +       +   +   + L   + L++LH   + 
Sbjct: 84  MYNSYLVGDELWVVMEFLEGGALTDIVTH---TRMNEEQIATVCLSVLRALSYLH--NQG 138

Query: 220 VIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLT 279
           VI+RD K+ +ILL +D   KLSDFG      +  +      ++GT  + APE +      
Sbjct: 139 VIHRDIKSDSILLTSDGRIKLSDFGFCAQ--VSKEVPKRKSLVGTPYWMAPEVISRLPYG 196

Query: 280 ARSDVYGFGVVLLEMLLG 297
              D++  G++++EM+ G
Sbjct: 197 TEVDIWSLGIMVIEMIDG 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 58.1 bits (140), Expect = 3e-09
 Identities = 49/172 (28%), Positives = 75/172 (43%), Gaps = 23/172 (13%)

Query: 203 ALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHV---ST 259
           +   A+G+ FL  A R  I+RD    NILL+ +   K+ DFGLA+D    D  +V   S 
Sbjct: 180 SFQVARGMEFL--ASRKCIHRDLAARNILLSENNVVKICDFGLARD-IYKDPDYVRKGSA 236

Query: 260 RVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPL 319
           R+     + APE +     T +SDV+ FGV+L E+         S  +  +  V+     
Sbjct: 237 RL--PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIF--------SLGASPYPGVQINEEF 286

Query: 320 LNNNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALL 371
               K   R+  P            ++  +   C   +PK RP  S +V +L
Sbjct: 287 CQRLKDGTRMRAPEN-------ATPEIYRIMLACWQGDPKERPTFSALVEIL 331

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 57.1 bits (138), Expect = 3e-09
 Identities = 59/210 (28%), Positives = 97/210 (46%), Gaps = 28/210 (13%)

Query: 100 LGEGGFGVVYKGVI-----DENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRH 154
           LG+G F  +YKGV+      + V PG +   V +K L     +    +    + + QL H
Sbjct: 3   LGQGTFTNIYKGVLRVQSDLDIVGPG-QEVSVVLKVLGSDH-RDSLAFFETASLMSQLSH 60

Query: 155 SNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLH 214
            +LVKL G C  DE+ I+V EY++ G L+   L R    ++   ++ +A   A  L +L 
Sbjct: 61  KHLVKLYGVCVRDEN-IMVEEYVKFGPLDVF-LHREKNNVSLHWKLDVAKQLASALHYLE 118

Query: 215 GAERPVIYRDFKTSNILL--------NADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYG 266
             ++ +++ +    NIL+           F  KLSD G+     +  +     R+     
Sbjct: 119 --DKKLVHGNVCGKNILVARYGLNEGYVPF-IKLSDPGIPI--TVLSREERVERI----P 169

Query: 267 YAAPEYVMTGH--LTARSDVYGFGVVLLEM 294
           + APE +  G   LT  +D + FG  LLE+
Sbjct: 170 WIAPECIRNGQASLTIAADKWSFGTTLLEI 199

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 57.2 bits (138), Expect = 3e-09
 Identities = 70/271 (25%), Positives = 118/271 (43%), Gaps = 33/271 (12%)

Query: 100 LGEGGFGVVYKGVIDENVRPG-YKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLV 158
           LG+G F  ++KG+  E    G    T V +K L++        +    + + QL H +LV
Sbjct: 3   LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62

Query: 159 KLIGYC-CEDEHRILVYEYMESGSLEKHLLRRVGCM-LTWSRRMKIALDAAKGLAFLHGA 216
              G C C DE  I+V EY++ GSL+ +L +    + ++W  ++++A   A  L FL   
Sbjct: 63  LNYGVCVCGDES-IMVQEYVKFGSLDTYLKKNKNLINISW--KLEVAKQLAWALHFLE-- 117

Query: 217 ERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGT--YGYAAPEYVM 274
           ++ + + +    N+LL  +   K  +    K    G    V  + +      +  PE + 
Sbjct: 118 DKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEILLERIPWVPPECIE 177

Query: 275 TG-HLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPL--LNNNKKVLRILD 331
              +L+  +D + FG  L E+  G    DK              PL  L++ KK L+  +
Sbjct: 178 NPQNLSLAADKWSFGTTLWEIFSG---GDK--------------PLSALDSQKK-LQFYE 219

Query: 332 PRLEGQYTARTAMKVAGLAYQCLSQNPKGRP 362
            R   Q  A    ++A L  QC+   P  RP
Sbjct: 220 DRH--QLPAPKWTELANLINQCMDYEPDFRP 248

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 57.3 bits (138), Expect = 4e-09
 Identities = 58/209 (27%), Positives = 92/209 (44%), Gaps = 27/209 (12%)

Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLA-----EVNYLGQLR- 153
           +GEG +G V+K     +++ G +  FVA+K   R   Q   E +      EV  L  L  
Sbjct: 9   IGEGAYGKVFKA---RDLKNGGR--FVALK---RVRVQTGEEGMPLSTIREVAVLRHLET 60

Query: 154 --HSNLVKLIGYCC-----EDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDA 206
             H N+V+L   C       +    LV+E+++   L  +L +     +       +    
Sbjct: 61  FEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQL 119

Query: 207 AKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYG 266
            +GL FLH     V++RD K  NIL+ +    KL+DFGLA+   +       T V+ T  
Sbjct: 120 LRGLDFLHSHR--VVHRDLKPQNILVTSSGQIKLADFGLAR---IYSFQMALTSVVVTLW 174

Query: 267 YAAPEYVMTGHLTARSDVYGFGVVLLEML 295
           Y APE ++        D++  G +  EM 
Sbjct: 175 YRAPEVLLQSSYATPVDLWSVGCIFAEMF 203

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 56.9 bits (137), Expect = 5e-09
 Identities = 61/219 (27%), Positives = 96/219 (43%), Gaps = 27/219 (12%)

Query: 99  ILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGY---QGDREWLAEVNYLGQLRHS 155
           I+G GGFG VY        R        A+K L++      QG+   L E   L  +   
Sbjct: 1   IIGRGGFGEVY------GCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG 54

Query: 156 N--LVKLIGYCCEDEHRI-LVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAF 212
           +   +  + Y      ++  + + M  G L  HL +    + + +     A +   GL  
Sbjct: 55  DCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQH--GVFSEAEMRFYAAEIILGLEH 112

Query: 213 LHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEY 272
           +H   R V+YRD K +NILL+     ++SD GLA D     + H S   +GT+GY APE 
Sbjct: 113 MH--NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK-KKPHAS---VGTHGYMAPEV 166

Query: 273 VMTG-HLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREH 310
           +  G    + +D +  G +L ++L G        P R+H
Sbjct: 167 LQKGVAYDSSADWFSLGCMLFKLLRGH------SPFRQH 199

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 56.9 bits (138), Expect = 5e-09
 Identities = 56/209 (26%), Positives = 94/209 (44%), Gaps = 35/209 (16%)

Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLR------ 153
           +GEG F  V K    ++ + G    + AIK + +  ++     L +VN L +++      
Sbjct: 7   IGEGTFSEVLKA---QSRKTG---KYYAIKCMKKH-FKS----LEQVNNLREIQALRRLS 55

Query: 154 -HSNLVKLIGYCCEDEHR--ILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGL 210
            H N+++LI    + +     LV+E M+  +L + +  R    L   R         K L
Sbjct: 56  PHPNILRLIEVLFDRKTGRLALVFELMD-MNLYELIKGRKRP-LPEKRVKSYMYQLLKSL 113

Query: 211 AFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTH---VSTRVMGTYGY 267
             +H     + +RD K  NIL+  D   KL+DFG  + G      +   +STR      Y
Sbjct: 114 DHMHR--NGIFHRDIKPENILIKDD-ILKLADFGSCR-GIYSKPPYTEYISTR-----WY 164

Query: 268 AAPEYVMT-GHLTARSDVYGFGVVLLEML 295
            APE ++T G+   + D++  G V  E+L
Sbjct: 165 RAPECLLTDGYYGPKMDIWAVGCVFFEIL 193

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 57.3 bits (138), Expect = 5e-09
 Identities = 44/128 (34%), Positives = 62/128 (48%), Gaps = 9/128 (7%)

Query: 172 LVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNIL 231
           LV +YM  G L  HL ++ G       +  IA      LA  H  +  ++YRD K  NIL
Sbjct: 73  LVTDYMSGGELFWHL-QKEGRFSEDRAKFYIA---ELVLALEHLHKYDIVYRDLKPENIL 128

Query: 232 LNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVM--TGHLTARSDVYGFGV 289
           L+A     L DFGL+K     ++T  +    GT  Y APE ++   G+ T   D +  GV
Sbjct: 129 LDATGHIALCDFGLSKANLTDNKT--TNTFCGTTEYLAPEVLLDEKGY-TKHVDFWSLGV 185

Query: 290 VLLEMLLG 297
           ++ EM  G
Sbjct: 186 LVFEMCCG 193

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 56.9 bits (138), Expect = 6e-09
 Identities = 64/255 (25%), Positives = 92/255 (36%), Gaps = 78/255 (30%)

Query: 94  FRPDYILGEGGFGVVY----KG--------VIDENVRPGYKTTFVAIKELNRGGYQGDRE 141
           F+   +LG+G  G V+    KG        V+D       K   +   ++ R        
Sbjct: 3   FKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLD-------KKEMIKRNKVKRV------- 48

Query: 142 WLAEVNYLGQLRHSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMK 201
            L E   L  L H  L  L      + +  LV +Y   G L + L R+ G  L+      
Sbjct: 49  -LTEQEILATLDHPFLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLS------ 101

Query: 202 IALDAAK--------GLAFLH--GAERPVIYRDFKTSNILLNADFSAKLSDFGLAK---- 247
              + A+         L +LH  G    ++YRD K  NILL+      LSDF L+K    
Sbjct: 102 --EEVARFYAAEVLLALEYLHLLG----IVYRDLKPENILLHESGHIMLSDFDLSKQSDV 155

Query: 248 -DGPMGDQTHVSTRVM----------------------GTYGYAAPEYVM-TGHLTARSD 283
              P+       +R                        GT  Y APE +   GH  +  D
Sbjct: 156 EPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGH-GSAVD 214

Query: 284 VYGFGVVLLEMLLGR 298
            +  G++L EML G 
Sbjct: 215 WWTLGILLYEMLYGT 229

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 56.5 bits (136), Expect = 7e-09
 Identities = 52/202 (25%), Positives = 89/202 (44%), Gaps = 13/202 (6%)

Query: 99  ILGEGGFGVVYKGVIDENVRPGYKTTFVAIKEL--NRGGYQGDREWLAEVNYLGQLRHSN 156
           ++GEG +GVV K       R       VAIK+   +    +     L E+  L  L+  N
Sbjct: 8   VVGEGAYGVVLK------CRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQEN 61

Query: 157 LVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGA 216
           +V+L           LV+EY+E   LE  LL  +   +   +         K + + H  
Sbjct: 62  IVELKEAFRRRGKLYLVFEYVEKNMLE--LLEEMPNGVPPEKVRSYIYQLIKAIHWCHKN 119

Query: 217 ERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTG 276
           +  +++RD K  N+L++ +   KL DFG A++   G   +  T  + T  Y +PE ++  
Sbjct: 120 D--IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANY-TEYVATRWYRSPELLLGA 176

Query: 277 HLTARSDVYGFGVVLLEMLLGR 298
                 D++  G +L E+  G+
Sbjct: 177 PYGKAVDMWSVGCILGELSDGQ 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 56.5 bits (136), Expect = 7e-09
 Identities = 67/214 (31%), Positives = 93/214 (43%), Gaps = 36/214 (16%)

Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQL-RHSNLV 158
           +G+G +G VYK     N + G   +  A+K L+      D E  AE N L  L  H N+V
Sbjct: 30  IGKGTYGKVYKVT---NKKDG---SLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVV 82

Query: 159 KLIGYCCEDEHRI-----LVYEYMESGS---LEKHLLRRVGCMLTWSRRMKIALDAAKGL 210
           K  G   + +  +     LV E    GS   L K LL   G  L  +    I   A  GL
Sbjct: 83  KFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLIC-GQRLDEAMISYILYGALLGL 141

Query: 211 AFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRV-----MGTY 265
             LH     +I+RD K +NILL  +   KL DFG++           STR+     +GT 
Sbjct: 142 QHLHNNR--IIHRDVKGNNILLTTEGGVKLVDFGVSAQ-------LTSTRLRRNTSVGTP 192

Query: 266 GYAAPEYVMTGH-----LTARSDVYGFGVVLLEM 294
            + APE +           AR DV+  G+  +E+
Sbjct: 193 FWMAPEVIACEQQYDYSYDARCDVWSLGITAIEL 226

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 56.8 bits (137), Expect = 9e-09
 Identities = 36/104 (34%), Positives = 56/104 (53%), Gaps = 11/104 (10%)

Query: 200 MKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVST 259
           ++ +   A+G+ FL  A +  I+RD    N+LL     AK+ DFGLA+D  M D  +V  
Sbjct: 215 LRFSSQVAQGMDFL--ASKNCIHRDVAARNVLLTDGRVAKICDFGLARD-IMNDSNYV-- 269

Query: 260 RVMGT----YGYAAPEYVMTGHLTARSDVYGFGVVLLEML-LGR 298
            V G       + APE +     T +SDV+ +G++L E+  LG+
Sbjct: 270 -VKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGK 312

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 56.6 bits (136), Expect = 1e-08
 Identities = 67/270 (24%), Positives = 115/270 (42%), Gaps = 42/270 (15%)

Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQG---DREWLAEVNYLGQLRHSN 156
           +G G +G V       + + G +   VA+K+L+R  +Q     +    E+  L  ++H N
Sbjct: 25  VGSGAYGSVCAAF---DTKTGLR---VAVKKLSRP-FQSIIHAKRTYRELRLLKHMKHEN 77

Query: 157 LVKLIGYCCEDEHRILVYEYMESGSLEKHLL-----RRVGCM-LTWSRRMKIALDAAKGL 210
           ++ L+             E      L  HL+       V C  LT      +     +GL
Sbjct: 78  VIGLLDVFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 133

Query: 211 AFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAP 270
            ++H A+  +I+RD K SN+ +N D   K+ DFGLA+        +V+TR      Y AP
Sbjct: 134 KYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAP 186

Query: 271 EYVMTG-HLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRI 329
           E ++   H     D++  G ++ E+L GR       P  +H         ++  K +LR+
Sbjct: 187 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF----PGTDH---------IDQLKLILRL 233

Query: 330 LDPRLEGQYTARTAMKVAGLAYQCLSQNPK 359
           +      +   + + + A    Q L+Q PK
Sbjct: 234 VGTP-GAELLKKISSESARNYIQSLTQMPK 262

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 56.8 bits (137), Expect = 1e-08
 Identities = 48/183 (26%), Positives = 77/183 (42%), Gaps = 33/183 (18%)

Query: 210 LAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAA 269
           LA  H   + +I+RD K++NILL ++   KL DFG +K         V     GT  Y A
Sbjct: 154 LAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVA 213

Query: 270 PEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRI 329
           PE       + ++D++  GV+L E+L  +R  D                     + +  +
Sbjct: 214 PEIWRRKPYSKKADMFSLGVLLYELLTLKRPFD--------------------GENMEEV 253

Query: 330 LDPRLEGQYT---ARTAMKVAGLAYQCLSQNPKGRPVMSDVV----------ALLETVQS 376
           +   L G+Y       + ++  +    LS +PK RP  S ++           LLE VQ+
Sbjct: 254 MHKTLAGRYDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNMPICKLFISGLLEIVQT 313

Query: 377 QGA 379
           Q  
Sbjct: 314 QPG 316

Length = 496

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 56.3 bits (136), Expect = 1e-08
 Identities = 60/235 (25%), Positives = 99/235 (42%), Gaps = 49/235 (20%)

Query: 85  NEMKLATKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNR---------GG 135
            ++++  + F    ++G G FG V      + VR        A+K L++           
Sbjct: 36  TKLRMKAEDFDVIKVIGRGAFGEV------QLVRHKSSKQVYAMKLLSKFEMIKRSDSAF 89

Query: 136 YQGDREWLAEVNYLGQLRHSNLVKLIGYCCEDE-HRILVYEYMESGSLEKHLLRRVGCML 194
           +  +R+ +A  N       S  +  + Y  +D+ +  +V EYM  G L  +L+       
Sbjct: 90  FWEERDIMAHAN-------SEWIVQLHYAFQDDKYLYMVMEYMPGGDL-VNLMSNYDIPE 141

Query: 195 TWSR----RMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFG----LA 246
            W+R     + +ALDA   + F+H        RD K  N+LL+     KL+DFG    + 
Sbjct: 142 KWARFYTAEVVLALDAIHSMGFIH--------RDVKPDNMLLDKSGHLKLADFGTCMKMD 193

Query: 247 KDGPMGDQTHVSTRVMGTYGYAAPEYVMT----GHLTARSDVYGFGVVLLEMLLG 297
            +G         T V GT  Y +PE + +    G+     D +  GV L EML+G
Sbjct: 194 ANG----MVRCDTAV-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 243

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 56.2 bits (135), Expect = 2e-08
 Identities = 61/215 (28%), Positives = 96/215 (44%), Gaps = 37/215 (17%)

Query: 99  ILGEGGFGVVYKGVIDENVRPGYK----TTFVAIKELNRGGYQGDREWLAEVNYLGQLRH 154
           ++G G FG V + V  ++ R  Y     + F  IK  +   +  +R+ +A  N       
Sbjct: 50  VIGRGAFGEV-QLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFAN------S 102

Query: 155 SNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSR----RMKIALDAAKGL 210
             +V+L     +D +  +V EYM  G L  +L+        W+R     + +ALDA   +
Sbjct: 103 PWVVQLFYAFQDDRYLYMVMEYMPGGDL-VNLMSNYDVPEKWARFYTAEVVLALDAIHSM 161

Query: 211 AFLHGAERPVIYRDFKTSNILLNADFSAKLSDFG----LAKDGPMGDQTHVSTRVMGTYG 266
            F+H        RD K  N+LL+     KL+DFG    + K+G +   T V     GT  
Sbjct: 162 GFIH--------RDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-----GTPD 208

Query: 267 YAAPEYVMT----GHLTARSDVYGFGVVLLEMLLG 297
           Y +PE + +    G+     D +  GV L EML+G
Sbjct: 209 YISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 243

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 55.6 bits (134), Expect = 2e-08
 Identities = 40/121 (33%), Positives = 57/121 (47%), Gaps = 9/121 (7%)

Query: 193 MLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMG 252
            +T  RR+   L+A   LA+LHG  R +I+RD KT NI L+   +A L DFG A      
Sbjct: 187 AITIQRRL---LEA---LAYLHG--RGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAH 238

Query: 253 DQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAV-DKSRPSREHN 311
             T       GT    +PE +      A++D++  G+VL EM +    +  K   S    
Sbjct: 239 PDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQ 298

Query: 312 L 312
           L
Sbjct: 299 L 299

Length = 392

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 55.8 bits (134), Expect = 2e-08
 Identities = 44/156 (28%), Positives = 70/156 (44%)

Query: 144 AEVNYLGQLRHSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIA 203
           +E++ L    H  +VK       D+  +L+ EY   G L K + +R+   L +       
Sbjct: 114 SELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGL 173

Query: 204 LDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMG 263
           L     LA      R +++RD K++NI L      KL DFG +K         V++   G
Sbjct: 174 LFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCG 233

Query: 264 TYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRR 299
           T  Y APE       + ++D++  GV+L E+L   R
Sbjct: 234 TPYYLAPELWERKRYSKKADMWSLGVILYELLTLHR 269

Length = 478

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 53.9 bits (129), Expect = 4e-08
 Identities = 58/211 (27%), Positives = 101/211 (47%), Gaps = 20/211 (9%)

Query: 94  FRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKEL--NRGGYQGDREWLA---EVNY 148
           +R   +LG G FG VY     +  R       +A+K++  +    +  +E  A   E+  
Sbjct: 4   WRLGKLLGRGAFGEVYLCYDADTGRE------LAVKQVPFDPDSQETSKEVNALECEIQL 57

Query: 149 LGQLRHSNLVKLIGYCCED--EHRILVY-EYMESGSLEKHLLRRVGCMLTWSRRMKIALD 205
           L  LRH  +V+  G C  D  E ++ ++ EYM  GS+ K  L+  G  LT +   +    
Sbjct: 58  LKNLRHDRIVQYYG-CLRDPEEKKLSIFVEYMPGGSI-KDQLKAYGA-LTENVTRRYTRQ 114

Query: 206 AAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTR-VMGT 264
             +G+++LH     +++RD K +NIL ++  + KL DFG +K       +    + V GT
Sbjct: 115 ILQGVSYLHS--NMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGT 172

Query: 265 YGYAAPEYVMTGHLTARSDVYGFGVVLLEML 295
             + +PE +       ++DV+     ++EML
Sbjct: 173 PYWMSPEVISGEGYGRKADVWSVACTVVEML 203

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 53.8 bits (129), Expect = 4e-08
 Identities = 67/283 (23%), Positives = 117/283 (41%), Gaps = 50/283 (17%)

Query: 99  ILGEGGFGVVYKGVIDENVRPGYKTTFVAIKEL----NRGGYQGDREWLAEVNYLGQLRH 154
           ++GEG FG   + ++ ++V    K    A+KE+    +    +  R+   E   L +++H
Sbjct: 7   VVGEGSFG---RALLVQHVNSDQK---YAMKEIRLPKSSSAVEDSRK---EAVLLAKMKH 57

Query: 155 SNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVG------CMLTWSRRMKIALDAAK 208
            N+V        D H  +V EY + G L + +  + G       +L W  +M + +    
Sbjct: 58  PNIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQ--- 114

Query: 209 GLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAK--DGPMGDQTHVSTRVMGTYG 266
                H  E+ V++RD K+ NI L  +   KL DFG A+    P     +  T V GT  
Sbjct: 115 -----HIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPG---AYACTYV-GTPY 165

Query: 267 YAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKV 326
           Y  PE         +SD++  G +L E+   +     +          W   +L    KV
Sbjct: 166 YVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQAN---------SWKNLIL----KV 212

Query: 327 LRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVA 369
            +     L   Y+     ++  L  Q   +NP+ RP  + +++
Sbjct: 213 CQGSYKPLPSHYS----YELRSLIKQMFKRNPRSRPSATTILS 251

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 54.2 bits (130), Expect = 5e-08
 Identities = 45/156 (28%), Positives = 76/156 (48%), Gaps = 9/156 (5%)

Query: 145 EVNYLGQLRHSNLVKLIGYCCEDEHRI-LVYEYMESGSLEKHLLRRVGCMLTWSRRMKIA 203
           E N L  +R S  +  + Y  + E ++ L+ +Y+  G +  HL +R      +S      
Sbjct: 54  ERNVLEHVRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRD----NFSEDEVRF 109

Query: 204 LDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMG 263
                 LA  H  +  ++YRD K  NILL+++    L+DFGL+K+  + ++   +    G
Sbjct: 110 YSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEF-LSEEKERTYSFCG 168

Query: 264 TYGYAAPEYV--MTGHLTARSDVYGFGVVLLEMLLG 297
           T  Y APE +    GH  A  D +  G+++ E+L G
Sbjct: 169 TIEYMAPEIIRGKGGHGKA-VDWWSLGILIFELLTG 203

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 53.9 bits (129), Expect = 5e-08
 Identities = 69/229 (30%), Positives = 99/229 (43%), Gaps = 38/229 (16%)

Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLR-HSNLV 158
           +G+G +G V+K +   N + G K    A+K L+   +  D E  AE N L  L  H N+V
Sbjct: 26  IGKGTYGKVFKVL---NKKNGSKA---AVKILDPI-HDIDEEIEAEYNILKALSDHPNVV 78

Query: 159 KLIG-YCCED----EHRILVYEYMESGS---LEKHLLRRVGCMLTWSRRMK------IAL 204
           K  G Y  +D    +   LV E    GS   L K  L+R         RM+      I  
Sbjct: 79  KFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKR-------GERMEEPIIAYILH 131

Query: 205 DAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGT 264
           +A  GL  LH      I+RD K +NILL  +   KL DFG++    +          +GT
Sbjct: 132 EALMGLQHLH--VNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQ--LTSTRLRRNTSVGT 187

Query: 265 YGYAAPEYV-----MTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSR 308
             + APE +     +     AR DV+  G+  +E+  G   +    P R
Sbjct: 188 PFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMR 236

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 54.3 bits (131), Expect = 6e-08
 Identities = 30/90 (33%), Positives = 49/90 (54%), Gaps = 5/90 (5%)

Query: 209 GLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYA 268
           G+  LH A   +I+RD K SNI++ +D + K+ DFGLA+    G    ++  V+  Y Y 
Sbjct: 130 GIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVVTRY-YR 184

Query: 269 APEYVMTGHLTARSDVYGFGVVLLEMLLGR 298
           APE ++        D++  G ++ EM+ G 
Sbjct: 185 APEVILGMGYKENVDIWSVGCIMGEMIRGT 214

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 54.1 bits (130), Expect = 6e-08
 Identities = 28/88 (31%), Positives = 45/88 (51%), Gaps = 5/88 (5%)

Query: 208 KGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGY 267
           +GL +LH     +I+RD KT NI +N      + D G A+  P+     +   + GT   
Sbjct: 168 EGLRYLHAQR--IIHRDVKTENIFINDVDQVCIGDLGAAQ-FPVVAPAFLG--LAGTVET 222

Query: 268 AAPEYVMTGHLTARSDVYGFGVVLLEML 295
            APE +      +++D++  G+VL EML
Sbjct: 223 NAPEVLARDKYNSKADIWSAGIVLFEML 250

Length = 357

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 53.1 bits (128), Expect = 9e-08
 Identities = 38/101 (37%), Positives = 53/101 (52%), Gaps = 7/101 (6%)

Query: 201 KIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTR 260
           KIA+   K L +L   E  +I+RD K SNILL+ + + KL DFG++  G + D     TR
Sbjct: 111 KIAVATVKALNYLK-EELKIIHRDVKPSNILLDRNGNIKLCDFGIS--GQLVDSI-AKTR 166

Query: 261 VMGTYGYAAPEYVMTGHLTA---RSDVYGFGVVLLEMLLGR 298
             G   Y APE +          RSDV+  G+ L E+  G+
Sbjct: 167 DAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGK 207

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 53.6 bits (128), Expect = 9e-08
 Identities = 56/208 (26%), Positives = 95/208 (45%), Gaps = 32/208 (15%)

Query: 100 LGEGGFGVV---YKGVIDENVRPGYKTTFVAIKELNRGGYQGD---REWLAEVNYLGQLR 153
           +G G  G+V   Y  V+D NV         AIK+L+R  +Q     +    E+  +  + 
Sbjct: 25  IGSGAQGIVCAAYDAVLDRNV---------AIKKLSRP-FQNQTHAKRAYRELVLMKCVN 74

Query: 154 HSNLVKLIGYCC------EDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAA 207
           H N++ L+          E +   LV E M++     +L + +   L   R   +     
Sbjct: 75  HKNIISLLNVFTPQKSLEEFQDVYLVMELMDA-----NLCQVIQMELDHERMSYLLYQML 129

Query: 208 KGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGY 267
            G+  LH A   +I+RD K SNI++ +D + K+ DFGLA+    G    ++  V+  Y Y
Sbjct: 130 CGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVVTRY-Y 184

Query: 268 AAPEYVMTGHLTARSDVYGFGVVLLEML 295
            APE ++        D++  G ++ EM+
Sbjct: 185 RAPEVILGMGYKENVDIWSVGCIMGEMV 212

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 53.1 bits (127), Expect = 1e-07
 Identities = 66/249 (26%), Positives = 105/249 (42%), Gaps = 41/249 (16%)

Query: 70  LRQNPGYSNVDIFTYNEMKLATKFFR-----PDY----ILGEGGFGVVYKGVIDENVRPG 120
           LR+N    N+D F     K+  K  +      DY    ++G G FG V + V  ++ +  
Sbjct: 15  LRKN---KNIDNFLNRYEKIVRKIRKLQMKAEDYDVVKVIGRGAFGEV-QLVRHKSSQKV 70

Query: 121 YK----TTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVKLIGYCCEDEHRILVYEY 176
           Y     + F  IK  +   +  +R+ +A  N         +V+L     +D++  +V EY
Sbjct: 71  YAMKLLSKFEMIKRSDSAFFWEERDIMAFAN------SPWVVQLFCAFQDDKYLYMVMEY 124

Query: 177 MESGSLEKHLLRRVGCMLTWSR----RMKIALDAAKGLAFLHGAERPVIYRDFKTSNILL 232
           M  G L  +L+        W++     + +ALDA   +  +H        RD K  N+LL
Sbjct: 125 MPGGDL-VNLMSNYDVPEKWAKFYTAEVVLALDAIHSMGLIH--------RDVKPDNMLL 175

Query: 233 NADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMT----GHLTARSDVYGFG 288
           +     KL+DFG              T V GT  Y +PE + +    G+     D +  G
Sbjct: 176 DKHGHLKLADFGTCMKMDETGMVRCDTAV-GTPDYISPEVLKSQGGDGYYGRECDWWSVG 234

Query: 289 VVLLEMLLG 297
           V L EML+G
Sbjct: 235 VFLFEMLVG 243

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 52.1 bits (125), Expect = 2e-07
 Identities = 58/214 (27%), Positives = 92/214 (42%), Gaps = 32/214 (14%)

Query: 99  ILGEGGFGVVYKGVIDENVRPGYKTTFVAIK----ELNRGGYQGDREWLAEVNYLGQLRH 154
            +GEG +G VYK     +   G     VA+K    E++  G       L E++ L  L  
Sbjct: 8   KIGEGTYGKVYKA---RDKNTG---KLVALKKTRLEMDEEGIPPTA--LREISLLQMLSE 59

Query: 155 SN-LVKLIGYCCEDEHR-----ILVYEYMESGSLEKHLL---RRVGCMLTWSRRMKIALD 205
           S  +V+L+     +E        LV+EY++S  L+K +    R  G  L           
Sbjct: 60  SIYIVRLLDVEHVEEKNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQ 118

Query: 206 AAKGLAFLHGAERPVIYRDFKTSNILLNADFSA-KLSDFGLAKDG--PMGDQTHVSTRVM 262
             KG+A  H     V++RD K  N+L++      K++D GL +    P+   TH     +
Sbjct: 119 LLKGVAHCHK--HGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTH----EI 172

Query: 263 GTYGYAAPEYVMTG-HLTARSDVYGFGVVLLEML 295
            T  Y APE ++   H +   D++  G +  EM 
Sbjct: 173 VTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMS 206

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 52.0 bits (124), Expect = 3e-07
 Identities = 36/96 (37%), Positives = 51/96 (53%), Gaps = 8/96 (8%)

Query: 203 ALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHV---ST 259
           +   AKG+ FL  A R  I+RD    NILL+ +   K+ DFGLA+D    D  +V     
Sbjct: 185 SFQVAKGMEFL--ASRKCIHRDLAARNILLSENNVVKICDFGLARD-IYKDPDYVRKGDA 241

Query: 260 RVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEML 295
           R+     + APE +     T +SDV+ FGV+L E+ 
Sbjct: 242 RL--PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIF 275

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 51.8 bits (124), Expect = 4e-07
 Identities = 37/104 (35%), Positives = 54/104 (51%), Gaps = 8/104 (7%)

Query: 194 LTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGD 253
           LT    +  +   A+G+ FL  A R  I+RD    NILL+ +   K+ DFGLA+D    D
Sbjct: 170 LTLEDLISYSFQVARGMEFL--ASRKCIHRDLAARNILLSENNVVKICDFGLARD-IYKD 226

Query: 254 QTHV---STRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEM 294
             +V     R+     + APE +     T +SDV+ FGV+L E+
Sbjct: 227 PDYVRKGDARL--PLKWMAPESIFDKVYTTQSDVWSFGVLLWEI 268

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 50.7 bits (121), Expect = 5e-07
 Identities = 56/223 (25%), Positives = 95/223 (42%), Gaps = 37/223 (16%)

Query: 149 LGQLRHSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAK 208
           + Q+ H +L  + G C      I+V E++E G L+   LR+    +  + ++ +A   A 
Sbjct: 70  MSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDV-CLRKEKGRVPVAWKITVAQQLAS 128

Query: 209 GLAFLHGAERPVIYRDFKTSNILL-------NADFSAKLSDFGLAKDGPMGDQTHVSTRV 261
            L++L   ++ +++ +    NILL             KLSD G++    +  +  V  R+
Sbjct: 129 ALSYLE--DKNLVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSF-TALSREERVE-RI 184

Query: 262 MGTYGYAAPEYVMTG-HLTARSDVYGFGVVLLEMLLGRRAVDKSR-PSREHNLVEWARPL 319
                + APE V  G  L+  +D + FG  LLE+        K R PS +    E     
Sbjct: 185 ----PWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKERFYE----- 235

Query: 320 LNNNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRP 362
                K  R+ +P         +  ++A L  QCL+  P  RP
Sbjct: 236 -----KKHRLPEP---------SCKELATLISQCLTYEPTQRP 264

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 50.8 bits (121), Expect = 7e-07
 Identities = 54/209 (25%), Positives = 95/209 (45%), Gaps = 28/209 (13%)

Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQG---DREWLAEVNYLGQLRHSN 156
           +G G +G V     D  +R       VA+K+L+R  +Q     R    E+  L  ++H N
Sbjct: 23  VGSGAYGSVCSA-YDTRLRQK-----VAVKKLSRP-FQSLIHARRTYRELRLLKHMKHEN 75

Query: 157 LVKLI-----GYCCEDEHRILVYEYMESGSLEKHLLRRVGCM-LTWSRRMKIALDAAKGL 210
           ++ L+         E+ + +    Y+ +  +   L   V C  L+      +     +GL
Sbjct: 76  VIGLLDVFTPATSIENFNEV----YLVTNLMGADLNNIVKCQKLSDEHVQFLIYQLLRGL 131

Query: 211 AFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAP 270
            ++H A   +I+RD K SN+ +N D   ++ DFGLA+        +V+TR      Y AP
Sbjct: 132 KYIHSAG--IIHRDLKPSNVAVNEDCELRILDFGLARQADDEMTGYVATR-----WYRAP 184

Query: 271 EYVMTG-HLTARSDVYGFGVVLLEMLLGR 298
           E ++   H     D++  G ++ E+L G+
Sbjct: 185 EIMLNWMHYNQTVDIWSVGCIMAELLKGK 213

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 50.4 bits (120), Expect = 7e-07
 Identities = 54/200 (27%), Positives = 88/200 (44%), Gaps = 19/200 (9%)

Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWL--AEVNYLGQLRHSNL 157
           +G G +G VYK     N+  G +   V I +L      GD   L   E+  + + +H N+
Sbjct: 17  VGSGTYGDVYKA---RNLHTG-ELAAVKIIKLE----PGDDFSLIQQEIFMVKECKHCNI 68

Query: 158 VKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAE 217
           V   G     E   +  EY   GSL+   +  V   L+  +   +  +  +GLA+LH   
Sbjct: 69  VAYFGSYLSREKLWICMEYCGGGSLQD--IYHVTGPLSELQIAYVCRETLQGLAYLH--S 124

Query: 218 RPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVM--- 274
           +  ++RD K +NILL  +   KL+DFG+A    +          +GT  + APE      
Sbjct: 125 KGKMHRDIKGANILLTDNGDVKLADFGVA--AKITATIAKRKSFIGTPYWMAPEVAAVEK 182

Query: 275 TGHLTARSDVYGFGVVLLEM 294
            G      D++  G+  +E+
Sbjct: 183 NGGYNQLCDIWAVGITAIEL 202

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 50.4 bits (120), Expect = 8e-07
 Identities = 55/208 (26%), Positives = 95/208 (45%), Gaps = 26/208 (12%)

Query: 100 LGEGGFGVV---YKGVIDENVRPGYKTTFVAIKELNRGGYQGD---REWLAEVNYLGQLR 153
           +G G  G+V   Y  +++ NV         AIK+L+R  +Q     +    E+  +  + 
Sbjct: 32  IGSGAQGIVCAAYDAILERNV---------AIKKLSRP-FQNQTHAKRAYRELVLMKCVN 81

Query: 154 HSNLVKLIGYCCED---EHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGL 210
           H N++ L+         E    VY  ME   ++ +L + +   L   R   +      G+
Sbjct: 82  HKNIIGLLNVFTPQKSLEEFQDVYIVMEL--MDANLCQVIQMELDHERMSYLLYQMLCGI 139

Query: 211 AFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAP 270
             LH A   +I+RD K SNI++ +D + K+ DFGLA+    G    ++  V+  Y Y AP
Sbjct: 140 KHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVVTRY-YRAP 194

Query: 271 EYVMTGHLTARSDVYGFGVVLLEMLLGR 298
           E ++        D++  G ++ EM+ G 
Sbjct: 195 EVILGMGYKENVDIWSVGCIMGEMIKGG 222

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 50.4 bits (120), Expect = 1e-06
 Identities = 33/123 (26%), Positives = 54/123 (43%), Gaps = 4/123 (3%)

Query: 174 YEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLN 233
           Y         +  L      L++   +  +   A G+ FL  A +  ++RD    N+L+ 
Sbjct: 216 YLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFL--ASKNCVHRDLAARNVLIC 273

Query: 234 ADFSAKLSDFGLAKDGPMGDQTHVST-RVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLL 292
                K+ DFGLA+D  M D  ++S         + APE +     T  SDV+ FG++L 
Sbjct: 274 EGKLVKICDFGLARD-IMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLW 332

Query: 293 EML 295
           E+ 
Sbjct: 333 EIF 335

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 50.4 bits (120), Expect = 1e-06
 Identities = 61/218 (27%), Positives = 104/218 (47%), Gaps = 42/218 (19%)

Query: 99  ILGEGGFGVVYKGV-IDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNL 157
           I+G G FGVVY+ + ID + +       VAIK++ +     +RE L   N    L H N+
Sbjct: 73  IIGNGSFGVVYEAICIDTSEK-------VAIKKVLQDPQYKNRELLIMKN----LNHINI 121

Query: 158 VKLIGY-----CCEDEHRIL-----------VYEYMESGSLEKHLLRRVGCMLTWSRRMK 201
           + L  Y       ++E  I            V++YM+  +   H L      L +S ++ 
Sbjct: 122 IFLKDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKL-YSYQL- 179

Query: 202 IALDAAKGLAFLHGAERPVIYRDFKTSNILLNAD-FSAKLSDFGLAKDGPMGDQTHVSTR 260
                 + LA++H   + + +RD K  N+L++ +  + KL DFG AK+  +  Q  VS  
Sbjct: 180 -----CRALAYIH--SKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKN-LLAGQRSVS-- 229

Query: 261 VMGTYGYAAPEYVM-TGHLTARSDVYGFGVVLLEMLLG 297
            + +  Y APE ++   + T   D++  G ++ EM+LG
Sbjct: 230 YICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILG 267

Length = 440

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 50.3 bits (120), Expect = 1e-06
 Identities = 31/89 (34%), Positives = 44/89 (49%), Gaps = 2/89 (2%)

Query: 207 AKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYG 266
           AKG++FL  A +  I+RD    NILL      K+ DFGLA+D        V         
Sbjct: 224 AKGMSFL--ASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLPVK 281

Query: 267 YAAPEYVMTGHLTARSDVYGFGVVLLEML 295
           + APE +     T  SDV+ +G++L E+ 
Sbjct: 282 WMAPESIFNCVYTFESDVWSYGILLWEIF 310

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 50.4 bits (120), Expect = 1e-06
 Identities = 31/90 (34%), Positives = 47/90 (52%), Gaps = 4/90 (4%)

Query: 207 AKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVST-RVMGTY 265
           A+G+ FL  A +  ++RD    N+LL      K+ DFGLA+D  M D  +VS        
Sbjct: 247 ARGMEFL--ASKNCVHRDLAARNVLLAQGKIVKICDFGLARD-IMHDSNYVSKGSTFLPV 303

Query: 266 GYAAPEYVMTGHLTARSDVYGFGVVLLEML 295
            + APE +     T  SDV+ +G++L E+ 
Sbjct: 304 KWMAPESIFDNLYTTLSDVWSYGILLWEIF 333

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 49.6 bits (118), Expect = 1e-06
 Identities = 56/213 (26%), Positives = 99/213 (46%), Gaps = 18/213 (8%)

Query: 94  FRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKEL--NRGGYQGDREWLA---EVNY 148
           +R   +LG+G FG VY     +  R       +A+K++  +    +  +E  A   E+  
Sbjct: 4   WRLGKLLGQGAFGRVYLCYDADTGRE------LAVKQVQFDPESPETSKEVNALECEIQL 57

Query: 149 LGQLRHSNLVKLIGYCCEDEHRIL--VYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDA 206
           L  L H  +V+  G   +   R L    E+M  GS+ K  L+  G  LT +   K     
Sbjct: 58  LKNLLHERIVQYYGCLRDPMERTLSIFMEHMPGGSI-KDQLKSYGA-LTENVTRKYTRQI 115

Query: 207 AKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTR-VMGTY 265
            +G+++LH     +++RD K +NIL ++  + KL DFG +K       +    + V GT 
Sbjct: 116 LEGVSYLH--SNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTP 173

Query: 266 GYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGR 298
            + +PE +       ++D++  G  ++EML  +
Sbjct: 174 YWMSPEVISGEGYGRKADIWSVGCTVVEMLTEK 206

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 50.2 bits (120), Expect = 2e-06
 Identities = 51/231 (22%), Positives = 89/231 (38%), Gaps = 48/231 (20%)

Query: 99  ILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLV 158
           ++G+GG G VY      +     +     I+E         + +L E      L H  +V
Sbjct: 9   LIGKGGMGEVYLA---YDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIV 65

Query: 159 KLIGYCCEDEHRILVY---EYMESGSLEKHLLRRVGCMLTWSRR---------------M 200
            +   C + +    VY    Y+E  +L K LL+ V     W +                +
Sbjct: 66  PVYSICSDGD---PVYYTMPYIEGYTL-KSLLKSV-----WQKESLSKELAEKTSVGAFL 116

Query: 201 KIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAK------------D 248
            I       + ++H   + V++RD K  NILL       + D+G A             D
Sbjct: 117 SIFHKICATIEYVH--SKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDID 174

Query: 249 GPMGDQTH----VSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEML 295
               +  +    +  +++GT  Y APE ++    +  +D+Y  GV+L +ML
Sbjct: 175 VDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQML 225

Length = 932

>gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional

 Score = 48.6 bits (116), Expect = 2e-06
 Identities = 51/236 (21%), Positives = 101/236 (42%), Gaps = 32/236 (13%)

Query: 145 EVNYLGQLRHSNLVKLIGY---CCEDEHRI-LVYEYMESGSLEKHLLRRVGCMLTWSRRM 200
           E+  L ++  +N++K+ G+     +D  R+ L+ EY   G L + L +     L++  ++
Sbjct: 68  EIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVLDKEKD--LSFKTKL 125

Query: 201 KIALDAAKGLAFLHG-AERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVST 259
            +A+D  KGL  L+    +P  Y++  + + L+  ++  K+   GL K        +V+ 
Sbjct: 126 DMAIDCCKGLYNLYKYTNKP--YKNLTSVSFLVTENYKLKIICHGLEKILSSPPFKNVNF 183

Query: 260 RVMGTYGYAAPEYVMT--GHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWAR 317
            V     Y + + +       T + D+Y  GVVL E+  G+   +       ++L     
Sbjct: 184 MV-----YFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDL----- 233

Query: 318 PLLNNNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLET 373
            ++N N  +   LD  LE +               C S +   RP + +++  L  
Sbjct: 234 -IINKNNSLKLPLDCPLEIKCIVE----------ACTSHDSIKRPNIKEILYNLSL 278

Length = 283

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 49.0 bits (117), Expect = 2e-06
 Identities = 47/175 (26%), Positives = 71/175 (40%), Gaps = 43/175 (24%)

Query: 138 GDREWLAEVNYLGQLRHSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLT-- 195
           GDR W+  ++Y  Q              ++ +  LV +Y   G L   LL +    L   
Sbjct: 58  GDRRWITNLHYAFQ--------------DENNLYLVMDYYVGGDLLT-LLSKFEDRLPED 102

Query: 196 ----WSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFG----LAK 247
               +   M +A+D+   L ++H        RD K  N+LL+ +   +L+DFG    L  
Sbjct: 103 MARFYLAEMVLAIDSVHQLGYVH--------RDIKPDNVLLDKNGHIRLADFGSCLRLLA 154

Query: 248 DGPMGDQTHVSTRVMGTYGYAAPEYVM-----TGHLTARSDVYGFGVVLLEMLLG 297
           DG     T  S   +GT  Y +PE +       G      D +  GV + EML G
Sbjct: 155 DG-----TVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYG 204

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 48.9 bits (116), Expect = 3e-06
 Identities = 47/181 (25%), Positives = 83/181 (45%), Gaps = 20/181 (11%)

Query: 126 VAIKELNRGGYQGD---REWLAEVNYLGQLRHSNLVKLIGYCC------EDEHRILVYEY 176
           VA+K+L+R  +Q     +    E+  L  + H N++ L+          E +   LV E 
Sbjct: 49  VAVKKLSRP-FQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMEL 107

Query: 177 MESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADF 236
           M++     +L + +   L   R   +      G+  LH A   +I+RD K SNI++ +D 
Sbjct: 108 MDA-----NLCQVIHMELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDC 160

Query: 237 SAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLL 296
           + K+ DFGLA+         + T  + T  Y APE ++        D++  G ++ E++ 
Sbjct: 161 TLKILDFGLAR---TACTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVK 217

Query: 297 G 297
           G
Sbjct: 218 G 218

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 48.4 bits (115), Expect = 3e-06
 Identities = 72/292 (24%), Positives = 124/292 (42%), Gaps = 55/292 (18%)

Query: 100 LGEGGFGVVYKGVI---DENVRPGY---KTTFVAIKELNRGGYQGDREWLAEVNYLGQLR 153
           LG G    +Y G++   D++   GY   K   V +K L+         +    + + Q+ 
Sbjct: 3   LGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVS 62

Query: 154 HSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFL 213
           H ++V L G C  D   I+V E++E G L+   + R   +LT   + K+A   A  L++L
Sbjct: 63  HKHIVLLYGVCVRDVENIMVEEFVEFGPLDL-FMHRKSDVLTTPWKFKVAKQLASALSYL 121

Query: 214 HGAERPVIYRDFKTSNILLNAD--------FSAKLSDFGLAKDGPMGDQTHVSTR--VMG 263
              ++ +++ +  T NILL  +        F  KLSD G+    P+     V +R   + 
Sbjct: 122 E--DKDLVHGNVCTKNILLAREGIDGECGPF-IKLSDPGI----PIT----VLSRQECVE 170

Query: 264 TYGYAAPEYVM-TGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNN 322
              + APE V  + +L+  +D + FG  L E+       +   P ++  L E  R     
Sbjct: 171 RIPWIAPECVEDSKNLSIAADKWSFGTTLWEI-----CYNGEIPLKDKTLAEKER----- 220

Query: 323 NKKVLRILDPRLEGQY--TARTAMKVAGLAYQCLSQNPKGRP----VMSDVV 368
                       EGQ      +  ++A L   C++ +P  RP    +M D+ 
Sbjct: 221 ----------FYEGQCMLVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDIN 262

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 47.7 bits (113), Expect = 4e-06
 Identities = 50/198 (25%), Positives = 86/198 (43%), Gaps = 15/198 (7%)

Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVK 159
           +G G +G VYK     NV  G      AIK +     +       E+  +   +HSN+V 
Sbjct: 17  IGSGTYGDVYKA---RNVNTG---ELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVA 70

Query: 160 LIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERP 219
             G     +   +  E+   GSL+   +  V   L+ S+   ++ +  +GL +LH   + 
Sbjct: 71  YFGSYLRRDKLWICMEFCGGGSLQD--IYHVTGPLSESQIAYVSRETLQGLYYLHSKGK- 127

Query: 220 VIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMT---G 276
            ++RD K +NILL  +   KL+DFG++    +          +GT  + APE       G
Sbjct: 128 -MHRDIKGANILLTDNGHVKLADFGVSAQ--ITATIAKRKSFIGTPYWMAPEVAAVERKG 184

Query: 277 HLTARSDVYGFGVVLLEM 294
                 D++  G+  +E+
Sbjct: 185 GYNQLCDIWAVGITAIEL 202

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 48.1 bits (114), Expect = 5e-06
 Identities = 51/199 (25%), Positives = 82/199 (41%), Gaps = 41/199 (20%)

Query: 138 GDREWLAEVNYLGQLRHSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLT-- 195
           GD +W+  ++Y  Q              ++ +  LV +Y   G L   LL +    L   
Sbjct: 58  GDNQWITTLHYAFQ--------------DENNLYLVMDYYVGGDLLT-LLSKFEDRLPED 102

Query: 196 ----WSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPM 251
               +   M IA+D+   L ++H        RD K  NIL++ +   +L+DFG      M
Sbjct: 103 MARFYLAEMVIAIDSVHQLHYVH--------RDIKPDNILMDMNGHIRLADFGSCLK-LM 153

Query: 252 GDQTHVSTRVMGTYGYAAPEYVMT-----GHLTARSDVYGFGVVLLEMLLGRRAVDKSRP 306
            D T  S+  +GT  Y +PE +       G      D +  GV + EML G        P
Sbjct: 154 EDGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGE------TP 207

Query: 307 SREHNLVEWARPLLNNNKK 325
               +LVE    ++N+ ++
Sbjct: 208 FYAESLVETYGKIMNHKER 226

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 47.4 bits (113), Expect = 1e-05
 Identities = 58/259 (22%), Positives = 95/259 (36%), Gaps = 81/259 (31%)

Query: 94  FRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNR---------GGYQGDREWLA 144
           F    ++G G FG V        V+        A+K+L +            + +R+ LA
Sbjct: 3   FESIKVIGRGAFGEV------RLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILA 56

Query: 145 EVNYLGQLRHSNLVKLIGYCC--EDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMK- 201
           E +      +  +VKL  Y    ++ +  L+ EY+  G +   L+++     T++     
Sbjct: 57  EAD------NPWVVKL--YYSFQDENYLYLIMEYLPGGDMMTLLMKKD----TFTEEETR 104

Query: 202 -------IALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAK------- 247
                  +A+D+   L ++H        RD K  N+LL+A    KLSDFGL         
Sbjct: 105 FYIAETILAIDSIHKLGYIH--------RDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHR 156

Query: 248 -------------------DGPM--GDQTHVSTR--------VMGTYGYAAPEYVMTGHL 278
                                PM    +     R         +GT  Y APE  +    
Sbjct: 157 TEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGY 216

Query: 279 TARSDVYGFGVVLLEMLLG 297
               D +  GV++ EML+G
Sbjct: 217 NKECDWWSLGVIMYEMLVG 235

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 45.8 bits (108), Expect = 3e-05
 Identities = 42/166 (25%), Positives = 72/166 (43%), Gaps = 31/166 (18%)

Query: 145 EVNYLGQLRHSNLVKL--------IGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTW 196
           E+  LG+L H N++K+          Y    ++   +Y +M   + +     +   +L  
Sbjct: 213 EILALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFMYDEAFD----WKDRPLLKQ 268

Query: 197 SRR-MKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQT 255
           +R  MK  L A   + ++H  ++ +I+RD K  NI LN D    L DFG A         
Sbjct: 269 TRAIMKQLLCA---VEYIH--DKKLIHRDIKLENIFLNCDGKIVLGDFGTA-------MP 316

Query: 256 HVSTRVMGTYGYA------APEYVMTGHLTARSDVYGFGVVLLEML 295
               R    YG+       +PE +        +D++  G++LL+ML
Sbjct: 317 FEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDML 362

Length = 501

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 44.6 bits (105), Expect = 6e-05
 Identities = 49/203 (24%), Positives = 83/203 (40%), Gaps = 49/203 (24%)

Query: 138 GDREWLAEVNYLGQLRHSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLT-- 195
           GD +W+  ++Y  Q              ++ +  LV +Y   G L   LL +    L   
Sbjct: 58  GDCQWITTLHYAFQ--------------DENYLYLVMDYYVGGDLLT-LLSKFEDRLPED 102

Query: 196 ----WSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFG----LAK 247
               +   M +A+ +   L ++H        RD K  N+LL+ +   +L+DFG    + +
Sbjct: 103 MARFYIAEMVLAIHSIHQLHYVH--------RDIKPDNVLLDMNGHIRLADFGSCLKMNQ 154

Query: 248 DGPMGDQTHVSTRVMGTYGYAAPEYVMT-----GHLTARSDVYGFGVVLLEMLLGRRAVD 302
           DG     T  S+  +GT  Y +PE +       G      D +  GV + EML G     
Sbjct: 155 DG-----TVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGE---- 205

Query: 303 KSRPSREHNLVEWARPLLNNNKK 325
              P    +LVE    ++N+ ++
Sbjct: 206 --TPFYAESLVETYGKIMNHEER 226

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 44.2 bits (104), Expect = 9e-05
 Identities = 39/129 (30%), Positives = 49/129 (37%), Gaps = 41/129 (31%)

Query: 202 IALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLA--------------- 246
           +A+DA   L F+H        RD K  N+LL+A    KLSDFGL                
Sbjct: 112 LAIDAIHQLGFIH--------RDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNL 163

Query: 247 KDGPMGD---QTHVSTR---------------VMGTYGYAAPEYVMTGHLTARSDVYGFG 288
              P  D   Q   S R                +GT  Y APE  M        D +  G
Sbjct: 164 THNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLG 223

Query: 289 VVLLEMLLG 297
           V++ EML+G
Sbjct: 224 VIMYEMLIG 232

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

 Score = 40.5 bits (95), Expect = 4e-04
 Identities = 34/146 (23%), Positives = 55/146 (37%), Gaps = 14/146 (9%)

Query: 108 VYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLR-HSNLV-KLIGYCC 165
           +  G+ +     G K     +K         DRE   EV  L  L      V K++    
Sbjct: 6   LKGGLTNRVYLLGTKDEDYVLKINPSREKGADRE--REVAILQLLARKGLPVPKVLASGE 63

Query: 166 EDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPV-IYRD 224
            D    L+ E++E  +L++         ++   +  IA   A+ LA LH     V  + D
Sbjct: 64  SDGWSYLLMEWIEGETLDE---------VSEEEKEDIAEQLAELLAKLHQLPLLVLCHGD 114

Query: 225 FKTSNILLNADFSAKLSDFGLAKDGP 250
               NIL++      + D+  A  GP
Sbjct: 115 LHPGNILVDDGKILGIIDWEYAGYGP 140

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 41.6 bits (97), Expect = 6e-04
 Identities = 33/129 (25%), Positives = 48/129 (37%), Gaps = 41/129 (31%)

Query: 202 IALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQT------ 255
           +A+D+   L F+H        RD K  N+LL++    KLSDFGL        +T      
Sbjct: 112 LAIDSIHQLGFIH--------RDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNL 163

Query: 256 ---------------------------HVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFG 288
                                       ++   +GT  Y APE  M        D +  G
Sbjct: 164 NHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLG 223

Query: 289 VVLLEMLLG 297
           V++ EML+G
Sbjct: 224 VIMYEMLIG 232

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 41.5 bits (97), Expect = 7e-04
 Identities = 51/222 (22%), Positives = 83/222 (37%), Gaps = 50/222 (22%)

Query: 144 AEVNYLGQLRHSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIA 203
           AE + L +  +  +VKL     + ++   V +Y+  G +   L+R    M  +   +   
Sbjct: 50  AERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIR----MEVFPEVLARF 105

Query: 204 LDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLA----------------- 246
             A   LA     +   I+RD K  NIL++ D   KL+DFGL                  
Sbjct: 106 YIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSH 165

Query: 247 -KDGPM--------------GD-------------QTHVSTRVMGTYGYAAPEYVMTGHL 278
            +   M              GD             Q  ++  ++GT  Y APE ++    
Sbjct: 166 IRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGY 225

Query: 279 TARSDVYGFGVVLLEMLLGRRAVDKSRPSREH-NLVEWARPL 319
           T   D +  GV+L EML+G+       P+     ++ W   L
Sbjct: 226 TQLCDWWSVGVILFEMLVGQPPFLAPTPTETQLKVINWENTL 267

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 40.9 bits (96), Expect = 0.001
 Identities = 51/202 (25%), Positives = 78/202 (38%), Gaps = 57/202 (28%)

Query: 144 AEVNYLGQLRHSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIA 203
           AE + L +  +  +VKL     + ++   V +Y+  G +   LL R+G       R  IA
Sbjct: 50  AERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMS-LLIRLGIFEEDLARFYIA 108

Query: 204 -----LDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAK----------- 247
                +++   + F+H        RD K  NIL++ D   KL+DFGL             
Sbjct: 109 ELTCAIESVHKMGFIH--------RDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYY 160

Query: 248 ---DGPMGDQTHVSTRV---------------------------MGTYGYAAPEYVM-TG 276
              D    D    S                              +GT  Y APE ++ TG
Sbjct: 161 QKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTG 220

Query: 277 HLTARSDVYGFGVVLLEMLLGR 298
           + T   D +  GV+L EML+G+
Sbjct: 221 Y-TQLCDWWSVGVILYEMLVGQ 241

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 40.8 bits (96), Expect = 0.001
 Identities = 38/165 (23%), Positives = 66/165 (40%), Gaps = 23/165 (13%)

Query: 144 AEVNYLGQLRHSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIA 203
            E+    QL+H N++  +     D    +V   M  GS E  LL+           + IA
Sbjct: 48  QEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCED-LLKTH-FPEGLPE-LAIA 104

Query: 204 L---DAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLA--------KDGPMG 252
               D    L ++H   +  I+R  K S+ILL+ D    LS    +        +   + 
Sbjct: 105 FILKDVLNALDYIH--SKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVH 162

Query: 253 DQTHVSTRVMGTYGYAAPEYV---MTGHLTARSDVYGFGVVLLEM 294
           D    S + +    + +PE +   + G+   +SD+Y  G+   E+
Sbjct: 163 DFPKSSVKNL---PWLSPEVLQQNLQGY-NEKSDIYSVGITACEL 203

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 40.6 bits (95), Expect = 0.001
 Identities = 41/150 (27%), Positives = 61/150 (40%), Gaps = 25/150 (16%)

Query: 163 YCCEDEHRI-LVYEYMESGSLEKHLLRRVGCMLTWS------RRMKIALDAAKGLAFLHG 215
           Y  +D+  + LV EY   G L   LL R                + +A+ +   + ++H 
Sbjct: 68  YAFQDKDNLYLVMEYQPGGDLLS-LLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVH- 125

Query: 216 AERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMT 275
                  RD K  N+L++     KL+DFG A      ++   S   +GT  Y APE V+T
Sbjct: 126 -------RDIKPENVLIDRTGHIKLADFGSAA-RLTANKMVNSKLPVGTPDYIAPE-VLT 176

Query: 276 GHLTARSDVYG-------FGVVLLEMLLGR 298
                    YG        GV+  EM+ GR
Sbjct: 177 TMNGDGKGTYGVECDWWSLGVIAYEMIYGR 206

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 40.7 bits (95), Expect = 0.001
 Identities = 43/182 (23%), Positives = 70/182 (38%), Gaps = 24/182 (13%)

Query: 126 VAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVKLIGYCCEDEHRILVYEYMESGSLEKH 185
           V IK   RGG         E + L  + H ++++L G    ++   L+    ++      
Sbjct: 120 VVIKAGQRGGT------ATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRYKTD----- 168

Query: 186 LLRRVGCMLTWSRR------MKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAK 239
               + C L   R       + I     + + +LH  E  +I+RD K  NI +N      
Sbjct: 169 ----LYCYLAAKRNIAICDILAIERSVLRAIQYLH--ENRIIHRDIKAENIFINHPGDVC 222

Query: 240 LSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRR 299
           L DFG A   P+    +      GT    APE +         D++  G+VL EM     
Sbjct: 223 LGDFG-AACFPVDINANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHD 281

Query: 300 AV 301
           ++
Sbjct: 282 SL 283

Length = 391

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 40.0 bits (93), Expect = 0.002
 Identities = 53/228 (23%), Positives = 85/228 (37%), Gaps = 62/228 (27%)

Query: 144 AEVNYLGQLRHSNLVKLIGYCCEDEHRI-LVYEYMESGSLEKHLLRRVGCMLTWSRRMKI 202
           AE + L +  +  +V+L  Y  +D+  +  V +Y+  G +   LL R+G       R  I
Sbjct: 50  AERDILAEADNEWVVRLY-YSFQDKDNLYFVMDYIPGGDMMS-LLIRMGIFPEDLARFYI 107

Query: 203 A-----LDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGL------------ 245
           A     +++   + F+H        RD K  NIL++ D   KL+DFGL            
Sbjct: 108 AELTCAVESVHKMGFIH--------RDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKY 159

Query: 246 --AKDGPMGDQTHVSTR-------------------------------VMGTYGYAAPEY 272
             + D    D    S                                 ++GT  Y APE 
Sbjct: 160 YQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEV 219

Query: 273 VMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRP-SREHNLVEWARPL 319
           ++    T   D +  GV+L EML+G+       P   +  ++ W   L
Sbjct: 220 LLRTGYTQLCDWWSVGVILYEMLVGQPPFLAQTPLETQMKVINWQTSL 267

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 39.7 bits (92), Expect = 0.003
 Identities = 46/189 (24%), Positives = 84/189 (44%), Gaps = 33/189 (17%)

Query: 145 EVNYLGQLRHSNLVKLIGYCCEDEHRIL--VYEYMESGSLEKHLLR--------RVGCML 194
           EVN + +L+H N+V+ I       ++ L  + E+ ++G L +++ +            ++
Sbjct: 62  EVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIV 121

Query: 195 TWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNIL-----------------LNADFS 237
             +R++  AL     L      ER V++RD K  NI                  LN    
Sbjct: 122 DITRQLLHALAYCHNLKDGPNGER-VLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPI 180

Query: 238 AKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVM--TGHLTARSDVYGFGVVLLEML 295
           AK+ DFGL+K+  +    H     +GT  Y +PE ++  T     +SD++  G ++ E+ 
Sbjct: 181 AKIGDFGLSKNIGIESMAH---SCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELC 237

Query: 296 LGRRAVDKS 304
            G+    K+
Sbjct: 238 SGKTPFHKA 246

Length = 1021

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 39.5 bits (92), Expect = 0.003
 Identities = 27/76 (35%), Positives = 40/76 (52%), Gaps = 4/76 (5%)

Query: 172 LVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNIL 231
           LV EY+  G + K LL   G          I+ + A  L +LH     +I+RD K  N+L
Sbjct: 81  LVMEYLIGGDV-KSLLHIYGYFDEEMAVKYIS-EVALALDYLH--RHGIIHRDLKPDNML 136

Query: 232 LNADFSAKLSDFGLAK 247
           ++ +   KL+DFGL+K
Sbjct: 137 ISNEGHIKLTDFGLSK 152

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 39.1 bits (91), Expect = 0.004
 Identities = 18/45 (40%), Positives = 25/45 (55%), Gaps = 8/45 (17%)

Query: 202 IALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLA 246
           +A++A   L F+H        RD K  NIL++     KLSDFGL+
Sbjct: 112 LAIEAVHKLGFIH--------RDIKPDNILIDRGGHIKLSDFGLS 148

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	464
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
KOG0696	683	consensus Serine/threonine protein kinase [Signal	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	100.0
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	100.0
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	100.0
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	100.0
KOG0695	593	consensus Serine/threonine protein kinase [Signal	100.0
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	100.0
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	100.0
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	100.0
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	100.0
KOG1290	590	consensus Serine/threonine protein kinase [Signal	100.0
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	100.0
PLN03224	507	probable serine/threonine protein kinase; Provisio	100.0
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	100.0
KOG1027	903	consensus Serine/threonine protein kinase and endo	99.98
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	99.98
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.98
KOG1152	772	consensus Signal transduction serine/threonine kin	99.97
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	99.97
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	99.97
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.97
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.97
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.97
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.97
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.96
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.96
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.96
PLN00181	793	protein SPA1-RELATED; Provisional	99.95
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.94
PRK09188	365	serine/threonine protein kinase; Provisional	99.94
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.93
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.92
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.91
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.9
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.88
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.88
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.88
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.87
PRK12274	218	serine/threonine protein kinase; Provisional	99.86
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.85
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.85
PRK10345	210	hypothetical protein; Provisional	99.84
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.83
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.83
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.81
smart00090	237	RIO RIO-like kinase.	99.8
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.79
PRK14879	211	serine/threonine protein kinase; Provisional	99.79
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.77
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.77
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.76
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.71
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.68
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.68
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.67
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.58
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.52
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.51
KOG1243	690	consensus Protein kinase [General function predict	99.46
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.39
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.39
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.37
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.32
KOG3087	229	consensus Serine/threonine protein kinase [General	99.3
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.29
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.24
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.22
COG4248	637	Uncharacterized protein with protein kinase and he	99.07
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	99.02
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	98.98
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	98.91
KOG2137	700	consensus Protein kinase [Signal transduction mech	98.82
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.78
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.73
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.68
PRK09902	216	hypothetical protein; Provisional	98.64
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.56
KOG0576	829	consensus Mitogen-activated protein kinase kinase	98.48
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	98.44
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.43
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.4
KOG1235	538	consensus Predicted unusual protein kinase [Genera	98.31
PF01636	239	APH: Phosphotransferase enzyme family This family	98.28
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	98.27
PLN02876	822	acyl-CoA dehydrogenase	98.15
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	98.11
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	98.04
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	97.92
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	97.84
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	97.79
PRK10593	297	hypothetical protein; Provisional	97.78
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	97.77
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	97.75
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	97.73
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	97.7
PRK05231	319	homoserine kinase; Provisional	97.68
PRK09550	401	mtnK methylthioribose kinase; Reviewed	97.58
KOG1826	2724	consensus Ras GTPase activating protein RasGAP/neu	97.32
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	97.24
PLN02236	344	choline kinase	97.04
KOG2268	465	consensus Serine/threonine protein kinase [Signal	97.01
KOG1093	725	consensus Predicted protein kinase (contains TBC a	96.96
KOG2270	520	consensus Serine/threonine protein kinase involved	96.87
TIGR01767	370	MTRK 5-methylthioribose kinase. This enzyme is inv	96.78
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	96.72
TIGR02904	309	spore_ysxE spore coat protein YsxE. Members of thi	96.6
PF07387	308	Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099	96.59
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	96.52
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	96.52
PF01633	211	Choline_kinase: Choline/ethanolamine kinase; Inter	96.47
PRK12396	409	5-methylribose kinase; Reviewed	96.43
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	96.42
COG5072	488	ALK1 Serine/threonine kinase of the haspin family	96.39
PTZ00384	383	choline kinase; Provisional	96.14
PLN02756	418	S-methyl-5-thioribose kinase	96.1
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	95.88
PRK06148	1013	hypothetical protein; Provisional	95.51
COG3001	286	Uncharacterized protein conserved in bacteria [Fun	95.45
PRK11768	325	serine/threonine protein kinase; Provisional	95.39
KOG1236	565	consensus Predicted unusual protein kinase [Genera	95.01
PTZ00296	442	choline kinase; Provisional	94.85

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.7e-53  Score=415.72  Aligned_cols=290  Identities=58%  Similarity=0.962  Sum_probs=251.8

Q ss_pred             CccccchhHHHHHhcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCccHHHHHHHHHHHhcCCCCCc
Q 046893           78 NVDIFTYNEMKLATKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNL  157 (464)
Q Consensus        78 ~~~~~~~~~~~~~~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpni  157 (464)
                      ....|++.++..++++|...++||+|+||.||+|...+       ++.||||.+.........+|.+|+.+|.+++|||+
T Consensus        61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~-------~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nl  133 (361)
T KOG1187|consen   61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSD-------GTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNL  133 (361)
T ss_pred             CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECC-------CCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCc
Confidence            46679999999999999999999999999999999876       35699998876543315669999999999999999


Q ss_pred             ceEEEEEEeCC-eEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhc-CCCCeeeccCCCCceEecCC
Q 046893          158 VKLIGYCCEDE-HRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHG-AERPVIYRDFKTSNILLNAD  235 (464)
Q Consensus       158 v~l~~~~~~~~-~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~-~~~~ivHrDlkp~Nill~~~  235 (464)
                      |+|+|||.+.+ ..+||+|||.+|+|.++|....+..++|..+++||.++|.||+|||. +...|||||||++|||||++
T Consensus       134 v~LlGyC~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~  213 (361)
T KOG1187|consen  134 VKLLGYCLEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDED  213 (361)
T ss_pred             ccEEEEEecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCC
Confidence            99999999999 59999999999999999987544378999999999999999999996 34479999999999999999


Q ss_pred             CceEEcccCCccCCCCCCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHH
Q 046893          236 FSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEW  315 (464)
Q Consensus       236 ~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~  315 (464)
                      +.+||+|||+|+..... .........||.+|+|||++..+..+.|+|||||||+|+||++|+.+.+...+.....+++|
T Consensus       214 ~~aKlsDFGLa~~~~~~-~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w  292 (361)
T KOG1187|consen  214 FNAKLSDFGLAKLGPEG-DTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEW  292 (361)
T ss_pred             CCEEccCccCcccCCcc-ccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHH
Confidence            99999999999764331 22221111899999999999999999999999999999999999999988776667779999


Q ss_pred             HHHhhhcccchhhccCcccc-CccCH-HHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHh
Q 046893          316 ARPLLNNNKKVLRILDPRLE-GQYTA-RTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETVQS  376 (464)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~~-~~~~~-~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~~~  376 (464)
                      +.+.+... .+.+++|+.+. ..+.. .....+..++.+|++.+|.+||+|.+|++.|+.+..
T Consensus       293 ~~~~~~~~-~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~  354 (361)
T KOG1187|consen  293 AKPLLEEG-KLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILS  354 (361)
T ss_pred             HHHHHHCc-chhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhcc
Confidence            98888776 88899999987 66664 677789999999999999999999999999965543

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=3.6e-51  Score=382.59  Aligned_cols=252  Identities=25%  Similarity=0.375  Sum_probs=209.4

Q ss_pred             CCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCC-ccHHHHHHHHHHHhcCCCCCcceEEEEEEeCC-eE
Q 046893           93 FFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGY-QGDREWLAEVNYLGQLRHSNLVKLIGYCCEDE-HR  170 (464)
Q Consensus        93 ~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~-~~  170 (464)
                      +++....||+|..|+||++.+..+      ++.+|+|++..+.. ...+++.+|+++++..+|||||.+|+.|.... ..
T Consensus        80 dle~~~~lG~G~gG~V~kv~Hk~t------~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~i  153 (364)
T KOG0581|consen   80 DLERLGVLGSGNGGTVYKVRHKPT------GKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEI  153 (364)
T ss_pred             HhhhhhhcccCCCcEEEEEEEcCC------CeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceE
Confidence            455677899999999999998876      78899999954332 33478999999999999999999999999998 59


Q ss_pred             EEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCccCCC
Q 046893          171 ILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGP  250 (464)
Q Consensus       171 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~  250 (464)
                      .|+||||++|+|.+++...  +.+++.....|+.+|++||.|||. .++||||||||+||||+..|.|||||||.++...
T Consensus       154 sI~mEYMDgGSLd~~~k~~--g~i~E~~L~~ia~~VL~GL~YLh~-~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lv  230 (364)
T KOG0581|consen  154 SICMEYMDGGSLDDILKRV--GRIPEPVLGKIARAVLRGLSYLHE-ERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILV  230 (364)
T ss_pred             EeehhhcCCCCHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhh-ccCeeeccCCHHHeeeccCCCEEeccccccHHhh
Confidence            9999999999999987654  369999999999999999999994 3779999999999999999999999999998754


Q ss_pred             CCCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhcccchhhcc
Q 046893          251 MGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRIL  330 (464)
Q Consensus       251 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  330 (464)
                      ..    ...+++||..|||||.+.+..|+.++||||||++|+|+.+|+.||....+.. ....+....+..+        
T Consensus       231 nS----~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~-~~~~~Ll~~Iv~~--------  297 (364)
T KOG0581|consen  231 NS----IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPY-LDIFELLCAIVDE--------  297 (364)
T ss_pred             hh----hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCC-CCHHHHHHHHhcC--------
Confidence            33    4566899999999999999999999999999999999999999997652111 1122222222211        


Q ss_pred             CccccCccCH-HHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 046893          331 DPRLEGQYTA-RTAMKVAGLAYQCLSQNPKGRPVMSDVVA  369 (464)
Q Consensus       331 ~~~~~~~~~~-~~~~~l~~li~~cl~~dP~~RPs~~ev~~  369 (464)
                         ....++. .++.++..|+..||++||.+||++.++++
T Consensus       298 ---ppP~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~  334 (364)
T KOG0581|consen  298 ---PPPRLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQ  334 (364)
T ss_pred             ---CCCCCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence               1122333 37779999999999999999999999985

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=4.4e-51  Score=402.81  Aligned_cols=248  Identities=26%  Similarity=0.411  Sum_probs=209.7

Q ss_pred             cCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCC---ccHHHHHHHHHHHhcCCCCCcceEEEEEEeCC
Q 046893           92 KFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGY---QGDREWLAEVNYLGQLRHSNLVKLIGYCCEDE  168 (464)
Q Consensus        92 ~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~  168 (464)
                      .+|...+.||+|||+.||.+++..+      ++.||+|++.+...   ...+.+.+|++|.+.|+|||||+++++|++.+
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~t------ge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~   91 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDT------GEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSN   91 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCC------CcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCC
Confidence            5688999999999999999998665      77899999987433   23366889999999999999999999999999


Q ss_pred             eEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCccC
Q 046893          169 HRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKD  248 (464)
Q Consensus       169 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~  248 (464)
                      +.|||.|+|..++|..++.++.  .+++.++..++.||+.||.|||  +.+|||||||..|+||+++.+|||+|||||..
T Consensus        92 nVYivLELC~~~sL~el~Krrk--~ltEpEary~l~QIv~GlkYLH--~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~  167 (592)
T KOG0575|consen   92 NVYIVLELCHRGSLMELLKRRK--PLTEPEARYFLRQIVEGLKYLH--SLGIIHRDLKLGNLFLNENMNVKIGDFGLATQ  167 (592)
T ss_pred             ceEEEEEecCCccHHHHHHhcC--CCCcHHHHHHHHHHHHHHHHHH--hcCceecccchhheeecCcCcEEecccceeee
Confidence            9999999999999988877543  7999999999999999999999  56699999999999999999999999999998


Q ss_pred             CCCCCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhcccchhh
Q 046893          249 GPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLR  328 (464)
Q Consensus       249 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  328 (464)
                      .......  ..+.|||+.|+|||++....++..+||||+||+||-||+|++||....-...      ...+...      
T Consensus       168 le~~~Er--k~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vket------y~~Ik~~------  233 (592)
T KOG0575|consen  168 LEYDGER--KKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKET------YNKIKLN------  233 (592)
T ss_pred             ecCcccc--cceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHH------HHHHHhc------
Confidence            6544333  3458999999999999999999999999999999999999999986532211      1111111      


Q ss_pred             ccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 046893          329 ILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVA  369 (464)
Q Consensus       329 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  369 (464)
                            ....|...+.+..+||.++|+.||.+|||+++|+.
T Consensus       234 ------~Y~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~  268 (592)
T KOG0575|consen  234 ------EYSMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLD  268 (592)
T ss_pred             ------CcccccccCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence                  01223344557889999999999999999999984

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.4e-51  Score=388.06  Aligned_cols=256  Identities=26%  Similarity=0.377  Sum_probs=209.0

Q ss_pred             HHHhcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCcc-------HHHHHHHHHHHhcCCCCCcceE
Q 046893           88 KLATKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQG-------DREWLAEVNYLGQLRHSNLVKL  160 (464)
Q Consensus        88 ~~~~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~-------~~~~~~E~~~l~~l~hpniv~l  160 (464)
                      +...+.|.+.+.||+|+||.|-+|+...+      ++.||||++++.....       .....+|+++|++|+|||||++
T Consensus       168 ks~~d~yii~~~LGsGafg~Vkla~e~~t------gk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~  241 (475)
T KOG0615|consen  168 KSFNDYYIISKTLGSGAFGLVKLAYEKKT------GKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRI  241 (475)
T ss_pred             chhcceeEeeeeecCCceeEEEEEEEccc------CcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEE
Confidence            34678899999999999999999998876      7889999998643222       2335799999999999999999


Q ss_pred             EEEEEeCCeEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCC---Cc
Q 046893          161 IGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNAD---FS  237 (464)
Q Consensus       161 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~---~~  237 (464)
                      +++|...+..||||||+.||+|.+++..+.  .+.+..-..++.|++.||.|||  ++||+||||||+|||+..+   ..
T Consensus       242 ~d~f~~~ds~YmVlE~v~GGeLfd~vv~nk--~l~ed~~K~~f~Qll~avkYLH--~~GI~HRDiKPeNILl~~~~e~~l  317 (475)
T KOG0615|consen  242 KDFFEVPDSSYMVLEYVEGGELFDKVVANK--YLREDLGKLLFKQLLTAVKYLH--SQGIIHRDIKPENILLSNDAEDCL  317 (475)
T ss_pred             eeeeecCCceEEEEEEecCccHHHHHHhcc--ccccchhHHHHHHHHHHHHHHH--HcCcccccCCcceEEeccCCcceE
Confidence            999999999999999999999999998765  5788888999999999999999  6889999999999999655   78


Q ss_pred             eEEcccCCccCCCCCCCcceeeccccCCcccCccccccCC---CCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHH
Q 046893          238 AKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGH---LTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVE  314 (464)
Q Consensus       238 vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~  314 (464)
                      +||+|||+|+...   ....+.++|||+.|.|||++.++.   +..++|+|||||+||-+|+|.+||.......  .+.+
T Consensus       318 lKItDFGlAK~~g---~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~--sl~e  392 (475)
T KOG0615|consen  318 LKITDFGLAKVSG---EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDP--SLKE  392 (475)
T ss_pred             EEecccchhhccc---cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCc--cHHH
Confidence            9999999999743   344567799999999999998764   3347899999999999999999997643221  1111


Q ss_pred             HHHHhhhcccchhhccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 046893          315 WARPLLNNNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVA  369 (464)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  369 (464)
                      ..   ....        -.+.........++..+||.+||..||++||++.|++.
T Consensus       393 QI---~~G~--------y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~  436 (475)
T KOG0615|consen  393 QI---LKGR--------YAFGPLQWDRISEEALDLINWMLVVDPENRPSADEALN  436 (475)
T ss_pred             HH---hcCc--------ccccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhc
Confidence            11   1000        01112334567779999999999999999999999875

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-50  Score=394.64  Aligned_cols=258  Identities=32%  Similarity=0.550  Sum_probs=212.9

Q ss_pred             CCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCcc--HHHHHHHHHHHhcCCCCCcceEEEEEEeCC-eE
Q 046893           94 FRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQG--DREWLAEVNYLGQLRHSNLVKLIGYCCEDE-HR  170 (464)
Q Consensus        94 ~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~hpniv~l~~~~~~~~-~~  170 (464)
                      +.+.+.||.|+||+||+|.+...       ..||||++.......  .+.|.+|+.+|.+++|||||+++|++.+.. ..
T Consensus        43 l~~~~~iG~G~~g~V~~~~~~g~-------~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~  115 (362)
T KOG0192|consen   43 LPIEEVLGSGSFGTVYKGKWRGT-------DVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSL  115 (362)
T ss_pred             hhhhhhcccCCceeEEEEEeCCc-------eeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCce
Confidence            33445599999999999998753       239999998654333  358999999999999999999999999987 79


Q ss_pred             EEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCC-eeeccCCCCceEecCCC-ceEEcccCCccC
Q 046893          171 ILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERP-VIYRDFKTSNILLNADF-SAKLSDFGLAKD  248 (464)
Q Consensus       171 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~-ivHrDlkp~Nill~~~~-~vkl~DFGla~~  248 (464)
                      +|||||+++|+|.+++.......+++..++.|+.||+.||.|||  +.+ ||||||||+||||+.++ ++||+|||+++.
T Consensus       116 ~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH--~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~  193 (362)
T KOG0192|consen  116 CIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLH--SEGPIIHRDLKSDNILVDLKGKTLKIADFGLSRE  193 (362)
T ss_pred             EEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHh--cCCCeeecccChhhEEEcCCCCEEEECCCcccee
Confidence            99999999999999998754568999999999999999999999  455 99999999999999997 999999999986


Q ss_pred             CCCCCCcceeeccccCCcccCccccc--cCCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhcccch
Q 046893          249 GPMGDQTHVSTRVMGTYGYAAPEYVM--TGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKV  326 (464)
Q Consensus       249 ~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  326 (464)
                      .....  ...+...||+.|||||++.  ...|+.|+|||||||+||||+||+.||....+.      +.+....      
T Consensus       194 ~~~~~--~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~------~~~~~v~------  259 (362)
T KOG0192|consen  194 KVISK--TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPV------QVASAVV------  259 (362)
T ss_pred             ecccc--ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHH------HHHHHHH------
Confidence            43321  2233378999999999999  568999999999999999999999999876531      1111111      


Q ss_pred             hhccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhcC
Q 046893          327 LRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETVQSQG  378 (464)
Q Consensus       327 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~~~~~  378 (464)
                          ....+...+..++..+..||.+||..||..||++.+++..|+.+....
T Consensus       260 ----~~~~Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~  307 (362)
T KOG0192|consen  260 ----VGGLRPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHI  307 (362)
T ss_pred             ----hcCCCCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhh
Confidence                122223334447779999999999999999999999999999887643

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=7.2e-51  Score=383.68  Aligned_cols=202  Identities=32%  Similarity=0.494  Sum_probs=180.5

Q ss_pred             cCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCC--ccHHHHHHHHHHHhcCCCCCcceEEEEEEeCCe
Q 046893           92 KFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGY--QGDREWLAEVNYLGQLRHSNLVKLIGYCCEDEH  169 (464)
Q Consensus        92 ~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~  169 (464)
                      .+|.+.+.||+|+||+||+|++.+.      +..||||.+.....  ...+.+..|+.+|+.++|||||.+++++..++.
T Consensus        10 ~~y~~~~~iG~GsfavVykg~h~~~------~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~   83 (429)
T KOG0595|consen   10 GDYELSREIGSGSFAVVYKGRHKKS------GTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDF   83 (429)
T ss_pred             ccceehhhccCcceEEEEEeEeccC------CceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCe
Confidence            4588888899999999999999876      57799999987642  334567899999999999999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCC------CceEEccc
Q 046893          170 RILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNAD------FSAKLSDF  243 (464)
Q Consensus       170 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~------~~vkl~DF  243 (464)
                      .|||||||+||+|.+||.++.  .+++.++..++.||+.||++||  +++||||||||+||||+..      -.+||+||
T Consensus        84 i~lVMEyC~gGDLs~yi~~~~--~l~e~t~r~Fm~QLA~alq~L~--~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADF  159 (429)
T KOG0595|consen   84 IYLVMEYCNGGDLSDYIRRRG--RLPEATARHFMQQLASALQFLH--ENNIIHRDLKPQNILLSTTARNDTSPVLKIADF  159 (429)
T ss_pred             EEEEEEeCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH--HCCeeeccCCcceEEeccCCCCCCCceEEeccc
Confidence            999999999999999998865  6999999999999999999999  7889999999999999654      46899999


Q ss_pred             CCccCCCCCCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHhCCCCCCCCCC
Q 046893          244 GLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRP  306 (464)
Q Consensus       244 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~  306 (464)
                      |+|+....+   ....+.||++.|||||++....|+.|+|+||+|+|||+|++|+.||....+
T Consensus       160 GfAR~L~~~---~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~  219 (429)
T KOG0595|consen  160 GFARFLQPG---SMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETP  219 (429)
T ss_pred             chhhhCCch---hHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCH
Confidence            999976533   344568999999999999999999999999999999999999999986543

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.8e-51  Score=399.31  Aligned_cols=263  Identities=31%  Similarity=0.480  Sum_probs=226.6

Q ss_pred             HHHHHhcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCccHHHHHHHHHHHhcCCCCCcceEEEEEE
Q 046893           86 EMKLATKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVKLIGYCC  165 (464)
Q Consensus        86 ~~~~~~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~  165 (464)
                      .+.+....+.+++.||+|.||.||.|.+...       ..||+|.++.. ....+.|.+|+++|+.|+|+|||+++++|.
T Consensus       200 ~wei~r~~l~l~~~LG~G~FG~V~~g~~~~~-------~~vavk~ik~~-~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~  271 (468)
T KOG0197|consen  200 PWEIPREELKLIRELGSGQFGEVWLGKWNGS-------TKVAVKTIKEG-SMSPEAFLREAQIMKKLRHEKLVKLYGVCT  271 (468)
T ss_pred             CeeecHHHHHHHHHhcCCccceEEEEEEcCC-------CcccceEEecc-ccChhHHHHHHHHHHhCcccCeEEEEEEEe
Confidence            3344445566678899999999999999874       34899998765 344578999999999999999999999999


Q ss_pred             eCCeEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCC
Q 046893          166 EDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGL  245 (464)
Q Consensus       166 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGl  245 (464)
                      .++.+|||||||+.|+|.++|....+..+.....+.++.|||+|++||+  .+++|||||.++||||+++..|||+||||
T Consensus       272 ~~~piyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLe--s~~~IHRDLAARNiLV~~~~~vKIsDFGL  349 (468)
T KOG0197|consen  272 KQEPIYIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLE--SKNYIHRDLAARNILVDEDLVVKISDFGL  349 (468)
T ss_pred             cCCceEEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHH--hCCccchhhhhhheeeccCceEEEccccc
Confidence            9999999999999999999999866778999999999999999999999  57799999999999999999999999999


Q ss_pred             ccCCCCCCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHhhhccc
Q 046893          246 AKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLL-GRRAVDKSRPSREHNLVEWARPLLNNNK  324 (464)
Q Consensus       246 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~  324 (464)
                      |+.. .++.........-...|+|||.+..+.|+.|||||||||+||||+| |+.|+.+..                 +.
T Consensus       350 Ar~~-~d~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~ms-----------------n~  411 (468)
T KOG0197|consen  350 ARLI-GDDEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMS-----------------NE  411 (468)
T ss_pred             cccc-CCCceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCC-----------------HH
Confidence            9943 3333333344455778999999999999999999999999999999 888887654                 23


Q ss_pred             chhhccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHh
Q 046893          325 KVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETVQS  376 (464)
Q Consensus       325 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~~~  376 (464)
                      ++.+.++...+...|..||..+.+||..||+.+|++|||++.+...|+.+..
T Consensus       412 ev~~~le~GyRlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~  463 (468)
T KOG0197|consen  412 EVLELLERGYRLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFT  463 (468)
T ss_pred             HHHHHHhccCcCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhh
Confidence            4555667777778888999999999999999999999999999999988754

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-50  Score=376.43  Aligned_cols=243  Identities=27%  Similarity=0.381  Sum_probs=204.6

Q ss_pred             hcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCcc---HHHHHHHHHHHhcCCCCCcceEEEEEEeC
Q 046893           91 TKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQG---DREWLAEVNYLGQLRHSNLVKLIGYCCED  167 (464)
Q Consensus        91 ~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~hpniv~l~~~~~~~  167 (464)
                      .++|++.++||+|+||+||.++..++      ++.+|+|++++.....   .+....|..||..++||+||+++..|++.
T Consensus        24 ~~dF~~lkviGkG~fGkV~~Vrk~dt------~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~   97 (357)
T KOG0598|consen   24 PDDFEILKVIGKGSFGKVFQVRKKDT------GKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTE   97 (357)
T ss_pred             hhheeeeeeeeccCCceEEEEEEccc------CceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccC
Confidence            35689999999999999999987754      7889999998765433   35578999999999999999999999999


Q ss_pred             CeEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCcc
Q 046893          168 EHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAK  247 (464)
Q Consensus       168 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~  247 (464)
                      +.+|||+||+.||.|..+|.+..  .+++..+..++..|+.||.|||  +++||||||||+|||||.+|+++|+|||||+
T Consensus        98 ~kLylVld~~~GGeLf~hL~~eg--~F~E~~arfYlaEi~lAL~~LH--~~gIiyRDlKPENILLd~~GHi~LtDFgL~k  173 (357)
T KOG0598|consen   98 EKLYLVLDYLNGGELFYHLQREG--RFSEDRARFYLAEIVLALGYLH--SKGIIYRDLKPENILLDEQGHIKLTDFGLCK  173 (357)
T ss_pred             CeEEEEEeccCCccHHHHHHhcC--CcchhHHHHHHHHHHHHHHHHH--hCCeeeccCCHHHeeecCCCcEEEeccccch
Confidence            99999999999999999998754  6999999999999999999999  6789999999999999999999999999999


Q ss_pred             CCCCCCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhcccchh
Q 046893          248 DGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVL  327 (464)
Q Consensus       248 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  327 (464)
                      ......  ....++|||+.|||||++.+..|+..+|+||||+++|||++|.+||.....      ..+...+....    
T Consensus       174 ~~~~~~--~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~------~~~~~~I~~~k----  241 (357)
T KOG0598|consen  174 EDLKDG--DATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDV------KKMYDKILKGK----  241 (357)
T ss_pred             hcccCC--CccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccH------HHHHHHHhcCc----
Confidence            643322  234458999999999999999999999999999999999999999987542      22222222221    


Q ss_pred             hccCccccCccCHHHHHHHHHHHHHhhccCCCCCC
Q 046893          328 RILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRP  362 (464)
Q Consensus       328 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP  362 (464)
                             ....+...+.+..+|+.++|..||.+|.
T Consensus       242 -------~~~~p~~ls~~ardll~~LL~rdp~~RL  269 (357)
T KOG0598|consen  242 -------LPLPPGYLSEEARDLLKKLLKRDPRQRL  269 (357)
T ss_pred             -------CCCCCccCCHHHHHHHHHHhccCHHHhc
Confidence                   1112222445888999999999999996

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=5.4e-51  Score=366.50  Aligned_cols=251  Identities=24%  Similarity=0.360  Sum_probs=205.0

Q ss_pred             CCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCccH--HHHHHHHHHHhcCCCCCcceEEE-EEEeCCe
Q 046893           93 FFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGD--REWLAEVNYLGQLRHSNLVKLIG-YCCEDEH  169 (464)
Q Consensus        93 ~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~--~~~~~E~~~l~~l~hpniv~l~~-~~~~~~~  169 (464)
                      .|++.++||+|.||+||++.+..+      +..+|.|.++-......  ..+..|+.+|++|+|||||++++ .|.+++.
T Consensus        20 ~y~Il~~IG~GsFg~vykv~~~~~------g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~e   93 (375)
T KOG0591|consen   20 DYQILKKIGRGSFGEVYKVQCLLD------GKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNE   93 (375)
T ss_pred             HHHHHHHHcCCcchheEEeeeccC------cchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccch
Confidence            477788899999999999998875      67799999985443332  56889999999999999999998 4555555


Q ss_pred             -EEEEEeccCCCCHHHHHHh--hcCCCCCHHHHHHHHHHHHHHHHHHhcCCCC--eeeccCCCCceEecCCCceEEcccC
Q 046893          170 -RILVYEYMESGSLEKHLLR--RVGCMLTWSRRMKIALDAAKGLAFLHGAERP--VIYRDFKTSNILLNADFSAKLSDFG  244 (464)
Q Consensus       170 -~~lv~e~~~~g~L~~~l~~--~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~--ivHrDlkp~Nill~~~~~vkl~DFG  244 (464)
                       ++||||||.+|+|.+.|..  .....+++.++++++.|++.||..+|+.-.+  |+||||||.||+|+.+|.|||+|||
T Consensus        94 vlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfG  173 (375)
T KOG0591|consen   94 VLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFG  173 (375)
T ss_pred             hhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccch
Confidence             8999999999999998864  3345799999999999999999999962244  9999999999999999999999999


Q ss_pred             CccCCCCCCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhccc
Q 046893          245 LAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNK  324 (464)
Q Consensus       245 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  324 (464)
                      |++.+.  ..+......+||+.||+||.+.+.+|+.++||||+||++|||+.-+.||.+.      ++.+....+-..  
T Consensus       174 L~r~l~--s~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~------n~~~L~~KI~qg--  243 (375)
T KOG0591|consen  174 LGRFLS--SKTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD------NLLSLCKKIEQG--  243 (375)
T ss_pred             hHhHhc--chhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc------cHHHHHHHHHcC--
Confidence            999753  3344556689999999999999999999999999999999999999999875      333333222111  


Q ss_pred             chhhccCccccCccC-HHHHHHHHHHHHHhhccCCCCCCCHHHHH
Q 046893          325 KVLRILDPRLEGQYT-ARTAMKVAGLAYQCLSQNPKGRPVMSDVV  368 (464)
Q Consensus       325 ~~~~~~~~~~~~~~~-~~~~~~l~~li~~cl~~dP~~RPs~~ev~  368 (464)
                              .+ ...+ ...+..+..||..|+..||..||+.-.++
T Consensus       244 --------d~-~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v  279 (375)
T KOG0591|consen  244 --------DY-PPLPDEHYSTDLRELINMCIAVDPEQRPDTVPYV  279 (375)
T ss_pred             --------CC-CCCcHHHhhhHHHHHHHHHccCCcccCCCcchHH
Confidence                    11 1122 45566899999999999999999954333

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=1e-48  Score=355.14  Aligned_cols=264  Identities=25%  Similarity=0.334  Sum_probs=206.5

Q ss_pred             CCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCcc--HHHHHHHHHHHhcCCCCCcceEEEEEEeCCeE
Q 046893           93 FFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQG--DREWLAEVNYLGQLRHSNLVKLIGYCCEDEHR  170 (464)
Q Consensus        93 ~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~  170 (464)
                      .|+.+.++|+|+||+||++++.++      +++||||++.......  .+..++|+++|++|+|+|+|.++++|.....+
T Consensus         3 kYE~LgkvGEGSYGvV~KCrnk~T------gqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrkl   76 (396)
T KOG0593|consen    3 KYEKLGKVGEGSYGVVMKCRNKDT------GQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKL   76 (396)
T ss_pred             HHhhhhccccCcceEEEEeccCCc------ccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhccee
Confidence            477778899999999999998875      8999999986543322  25568999999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCccCCC
Q 046893          171 ILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGP  250 (464)
Q Consensus       171 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~  250 (464)
                      +||+|||+. ++.+.|.+.. ..++...+..+++|++.|+.|+|  ++++|||||||+||||+.+|.+||||||+|+...
T Consensus        77 hLVFE~~dh-TvL~eLe~~p-~G~~~~~vk~~l~Q~l~ai~~cH--k~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~  152 (396)
T KOG0593|consen   77 HLVFEYCDH-TVLHELERYP-NGVPSELVKKYLYQLLKAIHFCH--KNNCIHRDIKPENILITQNGVVKLCDFGFARTLS  152 (396)
T ss_pred             EEEeeecch-HHHHHHHhcc-CCCCHHHHHHHHHHHHHHhhhhh--hcCeecccCChhheEEecCCcEEeccchhhHhhc
Confidence            999999977 5545565543 35899999999999999999999  5669999999999999999999999999999765


Q ss_pred             CCCCcceeeccccCCcccCcccccc-CCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHH--------Hhhh
Q 046893          251 MGDQTHVSTRVMGTYGYAAPEYVMT-GHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWAR--------PLLN  321 (464)
Q Consensus       251 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~--------~~~~  321 (464)
                      .  .....+.++.|.||+|||.+.| ..|+..+||||+||++.||++|.+.|.+....+...++....        .++.
T Consensus       153 ~--pgd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~  230 (396)
T KOG0593|consen  153 A--PGDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFS  230 (396)
T ss_pred             C--CcchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhc
Confidence            2  2223345789999999999988 789999999999999999999999998866543332222111        1122


Q ss_pred             cccchhhccCccc------cCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 046893          322 NNKKVLRILDPRL------EGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVA  369 (464)
Q Consensus       322 ~~~~~~~~~~~~~------~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  369 (464)
                      .+.-+.-+.-|..      ...+ ......+.+|++.||..||++|++.++++.
T Consensus       231 ~N~~F~Gv~lP~~~~~epLe~k~-p~~s~~~ld~~k~cL~~dP~~R~sc~qll~  283 (396)
T KOG0593|consen  231 SNPFFHGVRLPEPEHPEPLERKY-PKISNVLLDLLKKCLKMDPDDRLSCEQLLH  283 (396)
T ss_pred             cCCceeeeecCCCCCccchhhhc-ccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence            2222111111111      1112 233447899999999999999999999874

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-47  Score=370.01  Aligned_cols=254  Identities=25%  Similarity=0.311  Sum_probs=210.0

Q ss_pred             HHHhcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCcc---HHHHHHHHHHHhcC-CCCCcceEEEE
Q 046893           88 KLATKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQG---DREWLAEVNYLGQL-RHSNLVKLIGY  163 (464)
Q Consensus        88 ~~~~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l-~hpniv~l~~~  163 (464)
                      ....++|.+.+.||+|+|++|++|+...+      ++.+|||++.+.-...   .+.+..|-.+|.+| .||.|++|+..
T Consensus        69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t------~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~T  142 (604)
T KOG0592|consen   69 KKTPNDFKFGKILGEGSYSTVVLAREKAT------GKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFT  142 (604)
T ss_pred             cCChhhcchhheeccccceeEEEeeecCC------CceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEE
Confidence            33456799999999999999999998875      6679999997643222   24466888999999 79999999999


Q ss_pred             EEeCCeEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEccc
Q 046893          164 CCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDF  243 (464)
Q Consensus       164 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DF  243 (464)
                      |.++..+|+|+||+++|+|.++|.+..  .|++.....++.+|+.||+|||  ++|||||||||+|||||.|+++||+||
T Consensus       143 FQD~~sLYFvLe~A~nGdll~~i~K~G--sfde~caR~YAAeIldAleylH--~~GIIHRDlKPENILLd~dmhikITDF  218 (604)
T KOG0592|consen  143 FQDEESLYFVLEYAPNGDLLDLIKKYG--SFDETCARFYAAEILDALEYLH--SNGIIHRDLKPENILLDKDGHIKITDF  218 (604)
T ss_pred             eecccceEEEEEecCCCcHHHHHHHhC--cchHHHHHHHHHHHHHHHHHHH--hcCceeccCChhheeEcCCCcEEEeec
Confidence            999999999999999999999998753  7999999999999999999999  677999999999999999999999999


Q ss_pred             CCccCCCCCCCc---------cee--eccccCCcccCccccccCCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccH
Q 046893          244 GLAKDGPMGDQT---------HVS--TRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNL  312 (464)
Q Consensus       244 Gla~~~~~~~~~---------~~~--~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~  312 (464)
                      |.|+........         ...  ..++||..|.+||++.....+..+|||+||||||.|+.|.+||.+.+...   +
T Consensus       219 GsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Neyl---i  295 (604)
T KOG0592|consen  219 GSAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYL---I  295 (604)
T ss_pred             cccccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHH---H
Confidence            999865332111         111  45899999999999999999999999999999999999999998765321   1


Q ss_pred             HHHHHHhhhcccchhhccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 046893          313 VEWARPLLNNNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVA  369 (464)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  369 (464)
                         ++.++.            +.-.++...++.+.+|+.+.|..||.+|++..+|.+
T Consensus       296 ---FqkI~~------------l~y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~  337 (604)
T KOG0592|consen  296 ---FQKIQA------------LDYEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKA  337 (604)
T ss_pred             ---HHHHHH------------hcccCCCCCCHHHHHHHHHHHccCccccccHHHHhh
Confidence               111111            112334445568999999999999999999987765

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.7e-47  Score=361.32  Aligned_cols=256  Identities=25%  Similarity=0.392  Sum_probs=205.9

Q ss_pred             cCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCccHHHHHHHHHHHhcCCCCCcceEEEEEEeCC--e
Q 046893           92 KFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVKLIGYCCEDE--H  169 (464)
Q Consensus        92 ~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~--~  169 (464)
                      .+|...+.||+|+||+||++.+.++      +...|||.+........+.+.+|+.+|.+|+|||||++++......  .
T Consensus        17 ~~~~~~~~lG~Gs~G~V~l~~~~~~------g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~   90 (313)
T KOG0198|consen   17 SNWSKGKLLGRGSFGSVYLATNKKT------GELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDE   90 (313)
T ss_pred             chhhhhccccCccceEEEEEEecCC------CcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCee
Confidence            3467778899999999999998875      6679999987653333566899999999999999999999754444  6


Q ss_pred             EEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecC-CCceEEcccCCccC
Q 046893          170 RILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNA-DFSAKLSDFGLAKD  248 (464)
Q Consensus       170 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~-~~~vkl~DFGla~~  248 (464)
                      ++++|||+.+|+|.+++.+..+ .|++..+..++.|++.||.|||  .++||||||||+||||+. ++.+||+|||+++.
T Consensus        91 ~~i~mEy~~~GsL~~~~~~~g~-~l~E~~v~~ytr~iL~GL~ylH--s~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~  167 (313)
T KOG0198|consen   91 YNIFMEYAPGGSLSDLIKRYGG-KLPEPLVRRYTRQILEGLAYLH--SKGIVHCDIKPANILLDPSNGDVKLADFGLAKK  167 (313)
T ss_pred             eEeeeeccCCCcHHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHH--hCCEeccCcccceEEEeCCCCeEEeccCccccc
Confidence            9999999999999999988766 7999999999999999999999  678999999999999999 79999999999986


Q ss_pred             CCC-CCCcceeeccccCCcccCccccccC-CCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhcccch
Q 046893          249 GPM-GDQTHVSTRVMGTYGYAAPEYVMTG-HLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKV  326 (464)
Q Consensus       249 ~~~-~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  326 (464)
                      ... .........+.||+.|||||++..+ ....++|||||||++.||+||..||...     ....++....       
T Consensus       168 ~~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~-----~~~~~~~~~i-------  235 (313)
T KOG0198|consen  168 LESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF-----FEEAEALLLI-------  235 (313)
T ss_pred             cccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh-----cchHHHHHHH-------
Confidence            543 1112223347899999999999853 3445999999999999999999999763     1111111111       


Q ss_pred             hhccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 046893          327 LRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALL  371 (464)
Q Consensus       327 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L  371 (464)
                         ........++...+.+..+|+.+|+..||.+|||+.+++...
T Consensus       236 ---g~~~~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hp  277 (313)
T KOG0198|consen  236 ---GREDSLPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHP  277 (313)
T ss_pred             ---hccCCCCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhCh
Confidence               111122245555677899999999999999999999998644

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=6.4e-47  Score=342.76  Aligned_cols=237  Identities=25%  Similarity=0.329  Sum_probs=202.3

Q ss_pred             cCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCccH---HHHHHHHHHHhcCCCCCcceEEEEEEeCC
Q 046893           92 KFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGD---REWLAEVNYLGQLRHSNLVKLIGYCCEDE  168 (464)
Q Consensus        92 ~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~---~~~~~E~~~l~~l~hpniv~l~~~~~~~~  168 (464)
                      ++|+..+.||.|+||+|.+++...+      +..+|+|++++...-..   +...+|.++|+.+.||+++++++.|.+.+
T Consensus        44 ~dfe~~~tlGtGSFGrV~LVr~k~~------g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~  117 (355)
T KOG0616|consen   44 QDFERLKTLGTGSFGRVHLVREKHS------GNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNS  117 (355)
T ss_pred             hhhhheeeeccCccceEEEEEEccC------CceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCC
Confidence            4588889999999999999988775      67899999987654333   34578999999999999999999999999


Q ss_pred             eEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCccC
Q 046893          169 HRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKD  248 (464)
Q Consensus       169 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~  248 (464)
                      .+||||||++||.|..++++..  ++++..+..+|.||+.||+|||  .++|++|||||+|||||.+|.+||+|||+|+.
T Consensus       118 ~lymvmeyv~GGElFS~Lrk~~--rF~e~~arFYAAeivlAleylH--~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~  193 (355)
T KOG0616|consen  118 NLYMVMEYVPGGELFSYLRKSG--RFSEPHARFYAAEIVLALEYLH--SLDIIYRDLKPENLLLDQNGHIKITDFGFAKR  193 (355)
T ss_pred             eEEEEEeccCCccHHHHHHhcC--CCCchhHHHHHHHHHHHHHHHH--hcCeeeccCChHHeeeccCCcEEEEeccceEE
Confidence            9999999999999999987643  7999999999999999999999  56699999999999999999999999999997


Q ss_pred             CCCCCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhcccchhh
Q 046893          249 GPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLR  328 (464)
Q Consensus       249 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  328 (464)
                      ...     ..-+.|||+.|+|||++..++|+.++|+|||||++|||+.|.+||...++.      .....++..+-    
T Consensus       194 v~~-----rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~------~iY~KI~~~~v----  258 (355)
T KOG0616|consen  194 VSG-----RTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPI------QIYEKILEGKV----  258 (355)
T ss_pred             ecC-----cEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChH------HHHHHHHhCcc----
Confidence            432     134589999999999999999999999999999999999999999987652      22222333322    


Q ss_pred             ccCccccCccCHHHHHHHHHHHHHhhccCCCCC
Q 046893          329 ILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGR  361 (464)
Q Consensus       329 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R  361 (464)
                              .++.....++.+|+.+.|+.|-.+|
T Consensus       259 --------~fP~~fs~~~kdLl~~LL~vD~t~R  283 (355)
T KOG0616|consen  259 --------KFPSYFSSDAKDLLKKLLQVDLTKR  283 (355)
T ss_pred             --------cCCcccCHHHHHHHHHHHhhhhHhh
Confidence                    2334444588999999999999999

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-46  Score=356.19  Aligned_cols=264  Identities=25%  Similarity=0.330  Sum_probs=214.9

Q ss_pred             HhcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCccH-HHHHHHHHHHhcCCCCCcceEEEEEEeCC
Q 046893           90 ATKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGD-REWLAEVNYLGQLRHSNLVKLIGYCCEDE  168 (464)
Q Consensus        90 ~~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~-~~~~~E~~~l~~l~hpniv~l~~~~~~~~  168 (464)
                      ..+.|++..+||.|..++||+|+....      +++||||+++.+..... ..+.+|+..|..++||||++++..|..++
T Consensus        24 n~~~YeL~e~IG~G~sa~V~~A~c~p~------~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~   97 (516)
T KOG0582|consen   24 NAKDYELQEVIGVGASAVVYLARCIPT------NEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDS   97 (516)
T ss_pred             CccceeEEEEEeccceeEeeeeeeccc------CCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecc
Confidence            346699999999999999999998875      68899999998766655 78899999999999999999999999999


Q ss_pred             eEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCccC
Q 046893          169 HRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKD  248 (464)
Q Consensus       169 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~  248 (464)
                      .+|+||.||.+|++.+.+.......+++..+..|+.+++.||.|||  .+|.||||||+.||||+.+|.|||+|||.+-.
T Consensus        98 ~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH--~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~  175 (516)
T KOG0582|consen   98 ELWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLH--QNGHIHRDVKAGNILIDSDGTVKLADFGVSAS  175 (516)
T ss_pred             eeEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHH--hcCceecccccccEEEcCCCcEEEcCceeeee
Confidence            9999999999999999998876667999999999999999999999  78899999999999999999999999998764


Q ss_pred             CCCC-CCccee-eccccCCcccCcccccc--CCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhccc
Q 046893          249 GPMG-DQTHVS-TRVMGTYGYAAPEYVMT--GHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNK  324 (464)
Q Consensus       249 ~~~~-~~~~~~-~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  324 (464)
                      .... ...... ..++||++|||||+++.  ..|+.|+|||||||+..||.+|..||....+.....        +.-..
T Consensus       176 l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl--------~tLqn  247 (516)
T KOG0582|consen  176 LFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLL--------LTLQN  247 (516)
T ss_pred             ecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHH--------HHhcC
Confidence            3322 222222 56899999999999643  579999999999999999999999998766543210        00111


Q ss_pred             chhhccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 046893          325 KVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVA  369 (464)
Q Consensus       325 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  369 (464)
                      ......-..+...........+..++..||..||.+|||++++++
T Consensus       248 ~pp~~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk  292 (516)
T KOG0582|consen  248 DPPTLLTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK  292 (516)
T ss_pred             CCCCcccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence            111111111122222334558999999999999999999999984

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=1.9e-47  Score=390.71  Aligned_cols=267  Identities=28%  Similarity=0.461  Sum_probs=226.7

Q ss_pred             hcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCc-cHHHHHHHHHHHhcCCCCCcceEEEEEEeCCe
Q 046893           91 TKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQ-GDREWLAEVNYLGQLRHSNLVKLIGYCCEDEH  169 (464)
Q Consensus        91 ~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~  169 (464)
                      ..+.+..+.||+|+||+||+|....- .+....+.||||.++..... ...+|.+|+++|..|+|||||+|+|+|.+++.
T Consensus       485 r~~i~~~~eLGegaFGkVf~a~~~~l-~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P  563 (774)
T KOG1026|consen  485 RSDIVFKEELGEGAFGKVFLAEAYGL-LPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDP  563 (774)
T ss_pred             hhheeehhhhcCchhhhhhhhhccCC-CCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCe
Confidence            34456677899999999999987654 23345788999999887665 56889999999999999999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHhhc--------CCC----CCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCc
Q 046893          170 RILVYEYMESGSLEKHLLRRV--------GCM----LTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFS  237 (464)
Q Consensus       170 ~~lv~e~~~~g~L~~~l~~~~--------~~~----l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~  237 (464)
                      .+||+|||..|+|.+||..+.        +..    |+..+.+.||.|||.|+.||-  .+.+|||||..+|+||.++..
T Consensus       564 ~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs--~~~FVHRDLATRNCLVge~l~  641 (774)
T KOG1026|consen  564 LCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLS--SHHFVHRDLATRNCLVGENLV  641 (774)
T ss_pred             eEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHH--hCcccccchhhhhceeccceE
Confidence            999999999999999997543        223    889999999999999999998  566999999999999999999


Q ss_pred             eEEcccCCccCCCCCCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHh-CCCCCCCCCCcccccHHHHH
Q 046893          238 AKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLL-GRRAVDKSRPSREHNLVEWA  316 (464)
Q Consensus       238 vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~  316 (464)
                      |||+||||++.....++++....-.-..+||+||.+..+.|+.+||||||||+|||+++ |+-||.+....+.       
T Consensus       642 VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EV-------  714 (774)
T KOG1026|consen  642 VKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEV-------  714 (774)
T ss_pred             EEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHH-------
Confidence            99999999998877787776655566789999999999999999999999999999998 9999987553221       


Q ss_pred             HHhhhcccchhhccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhc
Q 046893          317 RPLLNNNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETVQSQ  377 (464)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~~~~  377 (464)
                                .+.+...-.-..+..||.+++.||..||+..|.+||++++|-..|..+...
T Consensus       715 ----------Ie~i~~g~lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~  765 (774)
T KOG1026|consen  715 ----------IECIRAGQLLSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQA  765 (774)
T ss_pred             ----------HHHHHcCCcccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhc
Confidence                      111111122355778899999999999999999999999999999887654

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.2e-47  Score=371.76  Aligned_cols=251  Identities=25%  Similarity=0.368  Sum_probs=215.6

Q ss_pred             hcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCccHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeE
Q 046893           91 TKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVKLIGYCCEDEHR  170 (464)
Q Consensus        91 ~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~  170 (464)
                      ...|.....||+|+.|.||.|....+      ++.||||.++.......+-+++|+.+|+.++|+|||.+++.|...+.+
T Consensus       272 ~~~y~~~~kigqgaSG~vy~A~~~~~------~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deL  345 (550)
T KOG0578|consen  272 RSKYTDFKKIGQGATGGVYVARKIST------KQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDEL  345 (550)
T ss_pred             hhhhcchhhhccccccceeeeeeccC------CceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhccccee
Confidence            45677788999999999999998775      667999999987777777789999999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCccCCC
Q 046893          171 ILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGP  250 (464)
Q Consensus       171 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~  250 (464)
                      |+|||||+||+|.|.+...   .+++.++..|+.+++.||+|||  .++|+|||||.+|||++.+|.+||+|||+|..+.
T Consensus       346 WVVMEym~ggsLTDvVt~~---~~~E~qIA~Icre~l~aL~fLH--~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~  420 (550)
T KOG0578|consen  346 WVVMEYMEGGSLTDVVTKT---RMTEGQIAAICREILQGLKFLH--ARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQIS  420 (550)
T ss_pred             EEEEeecCCCchhhhhhcc---cccHHHHHHHHHHHHHHHHHHH--hcceeeeccccceeEeccCCcEEEeeeeeeeccc
Confidence            9999999999999988654   4999999999999999999999  6889999999999999999999999999998754


Q ss_pred             CCCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhcccchhhcc
Q 046893          251 MGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRIL  330 (464)
Q Consensus       251 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  330 (464)
                      ...  ....+.+||++|||||++....|+.++||||||++++||+.|.+||....+.....++.       .+       
T Consensus       421 ~~~--~KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa-------~n-------  484 (550)
T KOG0578|consen  421 EEQ--SKRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIA-------TN-------  484 (550)
T ss_pred             ccc--CccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHh-------hc-------
Confidence            332  24456899999999999999999999999999999999999999998766544332221       11       


Q ss_pred             CccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 046893          331 DPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVA  369 (464)
Q Consensus       331 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  369 (464)
                       ....-..+...+..+.+|+.+||..|+.+|+++.|+++
T Consensus       485 -g~P~lk~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~  522 (550)
T KOG0578|consen  485 -GTPKLKNPEKLSPELKDFLDRCLVVDVEQRASAKELLE  522 (550)
T ss_pred             -CCCCcCCccccCHHHHHHHHHHhhcchhcCCCHHHHhc
Confidence             11122334455669999999999999999999999986

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.8e-46  Score=366.76  Aligned_cols=256  Identities=27%  Similarity=0.363  Sum_probs=210.2

Q ss_pred             HHhcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCC----CC-ccHHHHHHHHHHHhcCC-CCCcceEEE
Q 046893           89 LATKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRG----GY-QGDREWLAEVNYLGQLR-HSNLVKLIG  162 (464)
Q Consensus        89 ~~~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~----~~-~~~~~~~~E~~~l~~l~-hpniv~l~~  162 (464)
                      ...+.|.+.+.||+|+||+|++|.+..+      +..||+|++++.    .. ...+.+.+|+.+++.+. ||||+++++
T Consensus        14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t------~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~e   87 (370)
T KOG0583|consen   14 LSIGKYELGRTLGSGSFGKVKLAKHRLT------GEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLE   87 (370)
T ss_pred             cccCceeeeeeecCCCCeeEEEeeeccC------CCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEE
Confidence            3456799999999999999999998765      577999988764    12 23355678999999998 999999999


Q ss_pred             EEEeCCeEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCC-CceEEc
Q 046893          163 YCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNAD-FSAKLS  241 (464)
Q Consensus       163 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~-~~vkl~  241 (464)
                      ++......++|||||.||+|.+++.+.  .++.+.++..++.|++.|++|||  .++|+||||||+|||++.+ +++||+
T Consensus        88 v~~t~~~~~ivmEy~~gGdL~~~i~~~--g~l~E~~ar~~F~Qlisav~y~H--~~gi~HRDLK~ENilld~~~~~~Kl~  163 (370)
T KOG0583|consen   88 VFATPTKIYIVMEYCSGGDLFDYIVNK--GRLKEDEARKYFRQLISAVAYCH--SRGIVHRDLKPENILLDGNEGNLKLS  163 (370)
T ss_pred             EEecCCeEEEEEEecCCccHHHHHHHc--CCCChHHHHHHHHHHHHHHHHHH--hCCEeeCCCCHHHEEecCCCCCEEEe
Confidence            999999999999999999999999883  37899999999999999999999  6779999999999999999 999999


Q ss_pred             ccCCccCCCCCCCcceeeccccCCcccCccccccCC-CC-cccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHh
Q 046893          242 DFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGH-LT-ARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPL  319 (464)
Q Consensus       242 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~  319 (464)
                      |||++....  .......+.+||+.|+|||++.+.. |+ .++|||||||+||.|++|+.||+....      ......+
T Consensus       164 DFG~s~~~~--~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~------~~l~~ki  235 (370)
T KOG0583|consen  164 DFGLSAISP--GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNV------PNLYRKI  235 (370)
T ss_pred             ccccccccC--CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccH------HHHHHHH
Confidence            999998753  2233445689999999999999877 76 789999999999999999999987332      2222222


Q ss_pred             hhcccchhhccCccccCccCHHH-HHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHH
Q 046893          320 LNNNKKVLRILDPRLEGQYTART-AMKVAGLAYQCLSQNPKGRPVMSDVVALLETVQ  375 (464)
Q Consensus       320 ~~~~~~~~~~~~~~~~~~~~~~~-~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~~  375 (464)
                      ....-.+            +... +.++..|+.+||..||.+|+++.+++ .-..++
T Consensus       236 ~~~~~~~------------p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~-~h~w~~  279 (370)
T KOG0583|consen  236 RKGEFKI------------PSYLLSPEARSLIEKMLVPDPSTRITLLEIL-EHPWFQ  279 (370)
T ss_pred             hcCCccC------------CCCcCCHHHHHHHHHHcCCCcccCCCHHHHh-hChhhc
Confidence            2221111            1222 45889999999999999999999998 444444

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-47  Score=367.15  Aligned_cols=269  Identities=24%  Similarity=0.334  Sum_probs=211.5

Q ss_pred             HHhcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCccHH-HHHHHHHHHhcCC-CCCcceEEEEEEe
Q 046893           89 LATKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDR-EWLAEVNYLGQLR-HSNLVKLIGYCCE  166 (464)
Q Consensus        89 ~~~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~-~~~~E~~~l~~l~-hpniv~l~~~~~~  166 (464)
                      ...++|.+++.||.|+||.||+|+....      ++.||||.+++.-....+ .-++|++.|++|+ |||||+|++++.+
T Consensus         7 ~~m~RY~~i~klGDGTfGsV~la~~~~~------~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d   80 (538)
T KOG0661|consen    7 IFMDRYTVIRKLGDGTFGSVYLAKSKET------GELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRD   80 (538)
T ss_pred             hHHHHHHHHHHhcCCcceeEEEeeecCC------CceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhc
Confidence            3456789999999999999999997765      677999999876544332 2368999999998 9999999999988


Q ss_pred             CC-eEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCC
Q 046893          167 DE-HRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGL  245 (464)
Q Consensus       167 ~~-~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGl  245 (464)
                      .+ .+|+|||||+ .+|++++..+ +..|++..+..|+.||+.||+|+|  .+|+.||||||+|||+.....|||+|||+
T Consensus        81 ~~~~L~fVfE~Md-~NLYqLmK~R-~r~fse~~irnim~QilqGL~hiH--k~GfFHRDlKPENiLi~~~~~iKiaDFGL  156 (538)
T KOG0661|consen   81 NDRILYFVFEFMD-CNLYQLMKDR-NRLFSESDIRNIMYQILQGLAHIH--KHGFFHRDLKPENILISGNDVIKIADFGL  156 (538)
T ss_pred             cCceEeeeHHhhh-hhHHHHHhhc-CCcCCHHHHHHHHHHHHHHHHHHH--hcCcccccCChhheEecccceeEeccccc
Confidence            87 9999999995 5999998877 778999999999999999999999  78899999999999999888999999999


Q ss_pred             ccCCCCCCCcceeeccccCCcccCccccc-cCCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHH-----Hh
Q 046893          246 AKDGPMGDQTHVSTRVMGTYGYAAPEYVM-TGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWAR-----PL  319 (464)
Q Consensus       246 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~-----~~  319 (464)
                      ||......   ..+.++.|.||+|||+++ .+.|+.+.||||+|||++|+.+-++.|.+....+...-+.-+.     ..
T Consensus       157 ARev~Skp---PYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~  233 (538)
T KOG0661|consen  157 AREVRSKP---PYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDS  233 (538)
T ss_pred             ccccccCC---CcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCcccc
Confidence            99754333   234578999999999886 4679999999999999999999999998866433321111100     00


Q ss_pred             hhcccchhhccCccc-------cCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 046893          320 LNNNKKVLRILDPRL-------EGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVAL  370 (464)
Q Consensus       320 ~~~~~~~~~~~~~~~-------~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  370 (464)
                      +..+..+...+.-.+       ...+-..++.+..+||.+||.+||++|||+.++++.
T Consensus       234 ~~eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~  291 (538)
T KOG0661|consen  234 WPEGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH  291 (538)
T ss_pred             chhHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence            001111111111111       111222367789999999999999999999999863

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=7.8e-46  Score=366.50  Aligned_cols=269  Identities=25%  Similarity=0.400  Sum_probs=207.8

Q ss_pred             HHhcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCC-ccHHHHHHHHHHHhcC-CCCCcceEEEEEEe
Q 046893           89 LATKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGY-QGDREWLAEVNYLGQL-RHSNLVKLIGYCCE  166 (464)
Q Consensus        89 ~~~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~  166 (464)
                      +..++|++.+.||+|+||.||+|.+.... ....+..||||++..... .....+.+|+.+|..+ +||||+++++++..
T Consensus         4 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~-~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~   82 (338)
T cd05102           4 FPRDRLRLGKVLGHGAFGKVVEASAFGID-KKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTK   82 (338)
T ss_pred             cchhHceeeeEeccCCcceEEEEEEeccC-CcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecC
Confidence            44567999999999999999999863211 112356799999875432 2235688999999999 89999999998876


Q ss_pred             CC-eEEEEEeccCCCCHHHHHHhhc-------------------------------------------------------
Q 046893          167 DE-HRILVYEYMESGSLEKHLLRRV-------------------------------------------------------  190 (464)
Q Consensus       167 ~~-~~~lv~e~~~~g~L~~~l~~~~-------------------------------------------------------  190 (464)
                      .+ ..++||||+++|+|.+++....                                                       
T Consensus        83 ~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (338)
T cd05102          83 PNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQE  162 (338)
T ss_pred             CCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchh
Confidence            44 6889999999999999886532                                                       


Q ss_pred             -----CCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCccCCCCCCCcceeeccccCC
Q 046893          191 -----GCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTY  265 (464)
Q Consensus       191 -----~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~  265 (464)
                           ...+++.++..++.|++.||.|||  .++|+||||||+|||++.++.+||+|||+++...............++.
T Consensus       163 ~~~~~~~~l~~~~~~~~~~qi~~aL~~LH--~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~  240 (338)
T cd05102         163 TDDLWKSPLTMEDLICYSFQVARGMEFLA--SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPL  240 (338)
T ss_pred             ccccccCCCCHHHHHHHHHHHHHHHHHHH--HCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCc
Confidence                 124788899999999999999999  6789999999999999999999999999998643322222222345678


Q ss_pred             cccCccccccCCCCcccchhcHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHhhhcccchhhccCccccCccCHHHHH
Q 046893          266 GYAAPEYVMTGHLTARSDVYGFGVVLLEMLL-GRRAVDKSRPSREHNLVEWARPLLNNNKKVLRILDPRLEGQYTARTAM  344 (464)
Q Consensus       266 ~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  344 (464)
                      .|+|||++.+..++.++|||||||+||||++ |..||.......     .... .+....          ....+..++.
T Consensus       241 ~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~-----~~~~-~~~~~~----------~~~~~~~~~~  304 (338)
T cd05102         241 KWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINE-----EFCQ-RLKDGT----------RMRAPENATP  304 (338)
T ss_pred             cccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccH-----HHHH-HHhcCC----------CCCCCCCCCH
Confidence            8999999999999999999999999999997 999997643211     1111 111110          0111233455


Q ss_pred             HHHHHHHHhhccCCCCCCCHHHHHHHHHHHHh
Q 046893          345 KVAGLAYQCLSQNPKGRPVMSDVVALLETVQS  376 (464)
Q Consensus       345 ~l~~li~~cl~~dP~~RPs~~ev~~~L~~~~~  376 (464)
                      .+.+|+.+||+.||.+||++.+|++.|+.+..
T Consensus       305 ~l~~li~~cl~~dp~~RPs~~el~~~l~~~~~  336 (338)
T cd05102         305 EIYRIMLACWQGDPKERPTFSALVEILGDLLQ  336 (338)
T ss_pred             HHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            89999999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.1e-46  Score=361.20  Aligned_cols=264  Identities=26%  Similarity=0.339  Sum_probs=206.1

Q ss_pred             hcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCc--cHHHHHHHHHHHhcCCCCCcceEEEEEEeC-
Q 046893           91 TKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQ--GDREWLAEVNYLGQLRHSNLVKLIGYCCED-  167 (464)
Q Consensus        91 ~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpniv~l~~~~~~~-  167 (464)
                      ...|+.+..||+|+||.||+|++..+      +++||+|++......  ......+||.||++|.||||++|.+...+. 
T Consensus       116 ~~~feki~kIGeGTyg~VYkAr~~~t------gkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~  189 (560)
T KOG0600|consen  116 ADSFEKIEKIGEGTYGQVYKARDLET------GKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKL  189 (560)
T ss_pred             hHHHHHHHHhcCcchhheeEeeeccc------CcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecC
Confidence            44577788899999999999998876      788999999765432  235568999999999999999999998877 


Q ss_pred             -CeEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCc
Q 046893          168 -EHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLA  246 (464)
Q Consensus       168 -~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla  246 (464)
                       ..+|||+|||+. +|.-++.. .+..|++.++..++.||+.||+|||  .++|+|||||.+|||||.+|.+||+|||||
T Consensus       190 ~~siYlVFeYMdh-DL~GLl~~-p~vkft~~qIKc~mkQLl~Gl~~cH--~~gvlHRDIK~SNiLidn~G~LKiaDFGLA  265 (560)
T KOG0600|consen  190 SGSIYLVFEYMDH-DLSGLLSS-PGVKFTEPQIKCYMKQLLEGLEYCH--SRGVLHRDIKGSNILIDNNGVLKIADFGLA  265 (560)
T ss_pred             CceEEEEEecccc-hhhhhhcC-CCcccChHHHHHHHHHHHHHHHHHh--hcCeeeccccccceEEcCCCCEEeccccce
Confidence             689999999976 88777654 3557999999999999999999999  788999999999999999999999999999


Q ss_pred             cCCCCCCCcceeeccccCCcccCccccccC-CCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhc---
Q 046893          247 KDGPMGDQTHVSTRVMGTYGYAAPEYVMTG-HLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNN---  322 (464)
Q Consensus       247 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~---  322 (464)
                      +.+....... .+..+-|.+|+|||.++|. .|+..+|+||.||||.||+.|++.|.+........  ..+ .+...   
T Consensus       266 r~y~~~~~~~-~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~--kIf-klcGSP~e  341 (560)
T KOG0600|consen  266 RFYTPSGSAP-YTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLH--KIF-KLCGSPTE  341 (560)
T ss_pred             eeccCCCCcc-cccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHH--HHH-HHhCCCCh
Confidence            9775544333 3446779999999999985 69999999999999999999999998765332211  111 11100   


Q ss_pred             -ccchhhc-----cCc------cccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 046893          323 -NKKVLRI-----LDP------RLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVA  369 (464)
Q Consensus       323 -~~~~~~~-----~~~------~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  369 (464)
                       .....++     +.+      .+.+. ....+....+|+..+|..||.+|.|+.+++.
T Consensus       342 ~~W~~~kLP~~~~~kp~~~y~r~l~E~-~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~  399 (560)
T KOG0600|consen  342 DYWPVSKLPHATIFKPQQPYKRRLRET-FKDFPASALDLLEKLLSLDPDKRGTASSALQ  399 (560)
T ss_pred             hccccccCCcccccCCCCcccchHHHH-hccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence             0110011     100      11111 2233557789999999999999999998874

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=8.1e-46  Score=330.94  Aligned_cols=264  Identities=27%  Similarity=0.370  Sum_probs=208.4

Q ss_pred             cCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCcc--HHHHHHHHHHHhcCCCCCcceEEEEEEeCCe
Q 046893           92 KFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQG--DREWLAEVNYLGQLRHSNLVKLIGYCCEDEH  169 (464)
Q Consensus        92 ~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~  169 (464)
                      .+|...++||+|.||.||+|++..+      ++.||||+++.....+  ....++|++.|+.++|+||+.++++|...+.
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~t------~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~   75 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTET------GKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSN   75 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecCC------CcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCc
Confidence            4677888999999999999999886      7779999998654332  3557899999999999999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCccCC
Q 046893          170 RILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDG  249 (464)
Q Consensus       170 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~  249 (464)
                      ..||+||++. +|+..|..+ ...++...+..++.+++.||+|||  .+.|+||||||.|+|++.+|.+||+|||+|+.+
T Consensus        76 l~lVfEfm~t-dLe~vIkd~-~i~l~pa~iK~y~~m~LkGl~y~H--~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f  151 (318)
T KOG0659|consen   76 LSLVFEFMPT-DLEVVIKDK-NIILSPADIKSYMLMTLKGLAYCH--SKWILHRDLKPNNLLISSDGQLKIADFGLARFF  151 (318)
T ss_pred             eEEEEEeccc-cHHHHhccc-ccccCHHHHHHHHHHHHHHHHHHH--hhhhhcccCCccceEEcCCCcEEeecccchhcc
Confidence            9999999965 998888765 457999999999999999999999  677999999999999999999999999999986


Q ss_pred             CCCCCcceeeccccCCcccCccccccC-CCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHh---------
Q 046893          250 PMGDQTHVSTRVMGTYGYAAPEYVMTG-HLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPL---------  319 (464)
Q Consensus       250 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~---------  319 (464)
                      ......  ....+-|.+|+|||.+.|. .|+..+||||.|||+.||+-|.+.|.+....+.  +...++.+         
T Consensus       152 ~~p~~~--~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQ--L~~If~~LGTP~~~~WP  227 (318)
T KOG0659|consen  152 GSPNRI--QTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQ--LSKIFRALGTPTPDQWP  227 (318)
T ss_pred             CCCCcc--cccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHH--HHHHHHHcCCCCcccCc
Confidence            544332  2234789999999988874 699999999999999999999988877554322  22222111         


Q ss_pred             -hhcccchhh--ccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 046893          320 -LNNNKKVLR--ILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVA  369 (464)
Q Consensus       320 -~~~~~~~~~--~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  369 (464)
                       +..-.+..+  .........+...+..+..+|+..||..||.+|.++.++++
T Consensus       228 ~~~~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~  280 (318)
T KOG0659|consen  228 EMTSLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALK  280 (318)
T ss_pred             cccccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhc
Confidence             111111111  11111122244455667799999999999999999999875

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.2e-45  Score=365.79  Aligned_cols=246  Identities=24%  Similarity=0.343  Sum_probs=207.4

Q ss_pred             CCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCcc---HHHHHHHHHHHhcCCCCCcceEEEEEEeCCeE
Q 046893           94 FRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQG---DREWLAEVNYLGQLRHSNLVKLIGYCCEDEHR  170 (464)
Q Consensus        94 ~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~  170 (464)
                      |++.+.||.|+-|.|.+|++..+      |+.+|||++.......   ...+.+|+-||+.+.||||+++|++|++..++
T Consensus        14 wkLgkTLG~Gstg~vrlakh~~T------GqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~l   87 (786)
T KOG0588|consen   14 WKLGKTLGKGSTGCVRLAKHAET------GQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHL   87 (786)
T ss_pred             eeccccccCCCCceehhhhcccc------cceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceE
Confidence            77888999999999999998775      8889999998763222   24578999999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCccCCC
Q 046893          171 ILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGP  250 (464)
Q Consensus       171 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~  250 (464)
                      |||.||++||.|++++.++.  ++++.++..++.||+.|+.|+|  ..+||||||||+|+|||..++|||+|||+|....
T Consensus        88 ylvlEyv~gGELFdylv~kG--~l~e~eaa~ff~QIi~gv~yCH--~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~  163 (786)
T KOG0588|consen   88 YLVLEYVPGGELFDYLVRKG--PLPEREAAHFFRQILDGVSYCH--AFNICHRDLKPENLLLDVKNNIKIADFGMASLEV  163 (786)
T ss_pred             EEEEEecCCchhHHHHHhhC--CCCCHHHHHHHHHHHHHHHHHh--hhcceeccCCchhhhhhcccCEeeeccceeeccc
Confidence            99999999999999998865  7999999999999999999999  5569999999999999999999999999998643


Q ss_pred             CCCCcceeeccccCCcccCccccccCCCC-cccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhcccchhhc
Q 046893          251 MGDQTHVSTRVMGTYGYAAPEYVMTGHLT-ARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRI  329 (464)
Q Consensus       251 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  329 (464)
                      .+   ....+.||.+.|.|||++.|..|+ .++||||+|||||.||+|+.||++.+      +-......-..   ..  
T Consensus       164 ~g---klLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdN------ir~LLlKV~~G---~f--  229 (786)
T KOG0588|consen  164 PG---KLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDN------IRVLLLKVQRG---VF--  229 (786)
T ss_pred             CC---ccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCcc------HHHHHHHHHcC---cc--
Confidence            32   344568999999999999999886 68999999999999999999998543      11111111111   11  


Q ss_pred             cCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 046893          330 LDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVAL  370 (464)
Q Consensus       330 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  370 (464)
                             +.+..++.+..+|+.+||..||.+|.|+.+|++.
T Consensus       230 -------~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kH  263 (786)
T KOG0588|consen  230 -------EMPSNISSEAQDLLRRMLDVDPSTRITTEEILKH  263 (786)
T ss_pred             -------cCCCcCCHHHHHHHHHHhccCccccccHHHHhhC
Confidence                   2234455688999999999999999999999863

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=1.5e-45  Score=358.26  Aligned_cols=250  Identities=24%  Similarity=0.333  Sum_probs=205.5

Q ss_pred             HHHhcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCccH---HHHHHHHHHHhcCCCCCcceEEEEE
Q 046893           88 KLATKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGD---REWLAEVNYLGQLRHSNLVKLIGYC  164 (464)
Q Consensus        88 ~~~~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~---~~~~~E~~~l~~l~hpniv~l~~~~  164 (464)
                      ++..++|.++..||+|+||.||+|+-.++      +.++|+|++++......   +.++.|-.+|....+|+||+|+..|
T Consensus       137 r~~~~DFe~Lk~IgkGAfGeVrLarKk~T------g~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsF  210 (550)
T KOG0605|consen  137 RLSLDDFELLKVIGKGAFGEVRLARKKDT------GEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSF  210 (550)
T ss_pred             cCCcccchhheeeccccceeEEEEEEccC------CcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEe
Confidence            44567899999999999999999987765      88999999998755433   4567899999999999999999999


Q ss_pred             EeCCeEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccC
Q 046893          165 CEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFG  244 (464)
Q Consensus       165 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFG  244 (464)
                      .+.+++||||||++||++..+|.+..  .|++..+..++.+++.||..||  +.|||||||||+|+|||..|++||+|||
T Consensus       211 QD~~~LYLiMEylPGGD~mTLL~~~~--~L~e~~arfYiaE~vlAI~~iH--~~gyIHRDIKPdNlLiD~~GHiKLSDFG  286 (550)
T KOG0605|consen  211 QDKEYLYLIMEYLPGGDMMTLLMRKD--TLTEDWARFYIAETVLAIESIH--QLGYIHRDIKPDNLLIDAKGHIKLSDFG  286 (550)
T ss_pred             cCCCeeEEEEEecCCccHHHHHHhcC--cCchHHHHHHHHHHHHHHHHHH--HcCcccccCChhheeecCCCCEeecccc
Confidence            99999999999999999999998754  7999999999999999999999  7789999999999999999999999999


Q ss_pred             CccCCCC----------------------CCCcc-----------------------eeeccccCCcccCccccccCCCC
Q 046893          245 LAKDGPM----------------------GDQTH-----------------------VSTRVMGTYGYAAPEYVMTGHLT  279 (464)
Q Consensus       245 la~~~~~----------------------~~~~~-----------------------~~~~~~gt~~y~aPE~~~~~~~~  279 (464)
                      ||.-...                      .+...                       .....+||+.|||||++.+..|+
T Consensus       287 Ls~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~  366 (550)
T KOG0605|consen  287 LSTGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYG  366 (550)
T ss_pred             ccchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCC
Confidence            9962111                      00000                       01126899999999999999999


Q ss_pred             cccchhcHHHHHHHHHhCCCCCCCCCCcccc-cHHHHHHHhhhcccchhhccCccccCccCHHHHHHHHHHHHHhhccCC
Q 046893          280 ARSDVYGFGVVLLEMLLGRRAVDKSRPSREH-NLVEWARPLLNNNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNP  358 (464)
Q Consensus       280 ~~~DvwslG~il~ell~g~~pf~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP  358 (464)
                      ..+|+||||||+||||.|-+||....+.... .++.|...+...               ....+..+..+||.+||. ||
T Consensus       367 ~~cDwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP---------------~~~~~s~eA~DLI~rll~-d~  430 (550)
T KOG0605|consen  367 KECDWWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFP---------------EEVDLSDEAKDLITRLLC-DP  430 (550)
T ss_pred             ccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCC---------------CcCcccHHHHHHHHHHhc-CH
Confidence            9999999999999999999999988765443 344443221111               111223588899999999 99


Q ss_pred             CCCCC
Q 046893          359 KGRPV  363 (464)
Q Consensus       359 ~~RPs  363 (464)
                      ..|.-
T Consensus       431 ~~RLG  435 (550)
T KOG0605|consen  431 ENRLG  435 (550)
T ss_pred             HHhcC
Confidence            99965

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=1.2e-45  Score=358.96  Aligned_cols=247  Identities=28%  Similarity=0.406  Sum_probs=209.2

Q ss_pred             cCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCcc--HHHHHHHHHHHhcCCCCCcceEEEEEEeCCe
Q 046893           92 KFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQG--DREWLAEVNYLGQLRHSNLVKLIGYCCEDEH  169 (464)
Q Consensus        92 ~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~  169 (464)
                      ++|.+.+.||+|+||+||||+.+.+      .+.||+|.+.+.....  .+.+.+|++|++.|+|||||.++++|+...+
T Consensus         2 e~yhv~e~iG~Gsfg~VYKgrrK~t------~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~   75 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFGRVYKGRRKYT------IQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAH   75 (808)
T ss_pred             cchhHHHHhcCCccceeeecccccc------eeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccce
Confidence            3577788899999999999986654      7889999997654332  3568899999999999999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCccCC
Q 046893          170 RILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDG  249 (464)
Q Consensus       170 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~  249 (464)
                      .++|.|||.| +|..+|...  +.++++.+..++.+++.||.|||  +.+|+|||+||.||||+..|.+|+||||+|+..
T Consensus        76 ~~vVte~a~g-~L~~il~~d--~~lpEe~v~~~a~~LVsaL~yLh--s~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m  150 (808)
T KOG0597|consen   76 LWVVTEYAVG-DLFTILEQD--GKLPEEQVRAIAYDLVSALYYLH--SNRILHRDMKPQNILLEKGGTLKLCDFGLARAM  150 (808)
T ss_pred             EEEEehhhhh-hHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHH--hcCcccccCCcceeeecCCCceeechhhhhhhc
Confidence            9999999976 999988764  47999999999999999999999  567999999999999999999999999999973


Q ss_pred             CCCCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhcccchhhc
Q 046893          250 PMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRI  329 (464)
Q Consensus       250 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  329 (464)
                        ...+...+.+.||+.|||||.+.+..|+..+|+||||||||||+.|++||....      +.+....+..+..     
T Consensus       151 --~~~t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~s------i~~Lv~~I~~d~v-----  217 (808)
T KOG0597|consen  151 --STNTSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARS------ITQLVKSILKDPV-----  217 (808)
T ss_pred             --ccCceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHH------HHHHHHHHhcCCC-----
Confidence              445667777899999999999999999999999999999999999999997532      2233332222211     


Q ss_pred             cCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 046893          330 LDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVA  369 (464)
Q Consensus       330 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  369 (464)
                             .++......+..|+...|.+||..|.+..+++.
T Consensus       218 -------~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~  250 (808)
T KOG0597|consen  218 -------KPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLG  250 (808)
T ss_pred             -------CCcccccHHHHHHHHHHhhcChhhcccHHHHhc
Confidence                   123345568889999999999999999998874

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-45  Score=365.70  Aligned_cols=247  Identities=30%  Similarity=0.441  Sum_probs=206.9

Q ss_pred             HHHHhcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCcc---HHHHHHHHHHHhcC-CCCCcceEEE
Q 046893           87 MKLATKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQG---DREWLAEVNYLGQL-RHSNLVKLIG  162 (464)
Q Consensus        87 ~~~~~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l-~hpniv~l~~  162 (464)
                      ..+.-++|++.++||+|.||+|++|....+      ++.+|||++++.....   .+..+.|.+|+... +||.++.++.
T Consensus       363 ~~~~l~~F~~l~vLGkGsFGkV~lae~k~~------~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~  436 (694)
T KOG0694|consen  363 GPLTLDDFRLLAVLGRGSFGKVLLAELKGT------NEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFS  436 (694)
T ss_pred             CcccccceEEEEEeccCcCceEEEEEEcCC------CcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeeccc
Confidence            345567899999999999999999998876      6789999999876433   35578898888877 5999999999


Q ss_pred             EEEeCCeEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcc
Q 046893          163 YCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSD  242 (464)
Q Consensus       163 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~D  242 (464)
                      +|...+++|+||||+.||++..++.   ...+++..+..++..|+.||.|||  +++|||||||.+|||||.+|++||+|
T Consensus       437 ~fQT~~~l~fvmey~~Ggdm~~~~~---~~~F~e~rarfyaAev~l~L~fLH--~~~IIYRDlKLdNiLLD~eGh~kiAD  511 (694)
T KOG0694|consen  437 CFQTKEHLFFVMEYVAGGDLMHHIH---TDVFSEPRARFYAAEVVLGLQFLH--ENGIIYRDLKLDNLLLDTEGHVKIAD  511 (694)
T ss_pred             ccccCCeEEEEEEecCCCcEEEEEe---cccccHHHHHHHHHHHHHHHHHHH--hcCceeeecchhheEEcccCcEEecc
Confidence            9999999999999999999644332   236999999999999999999999  77899999999999999999999999


Q ss_pred             cCCccCCCCCCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhc
Q 046893          243 FGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNN  322 (464)
Q Consensus       243 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~  322 (464)
                      ||+|+....  ....+.++|||+.|||||++.+..|+..+|+|||||+|||||.|..||.+....+      .+..++.+
T Consensus       512 FGlcKe~m~--~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee------~FdsI~~d  583 (694)
T KOG0694|consen  512 FGLCKEGMG--QGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEE------VFDSIVND  583 (694)
T ss_pred             cccccccCC--CCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHH------HHHHHhcC
Confidence            999997542  2235567999999999999999999999999999999999999999998765321      11111111


Q ss_pred             ccchhhccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCH
Q 046893          323 NKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVM  364 (464)
Q Consensus       323 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~  364 (464)
                                  ...|+..++.+...||+++|..+|++|.-+
T Consensus       584 ------------~~~yP~~ls~ea~~il~~ll~k~p~kRLG~  613 (694)
T KOG0694|consen  584 ------------EVRYPRFLSKEAIAIMRRLLRKNPEKRLGS  613 (694)
T ss_pred             ------------CCCCCCcccHHHHHHHHHHhccCcccccCC
Confidence                        113455566789999999999999999876

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-44  Score=370.93  Aligned_cols=266  Identities=24%  Similarity=0.320  Sum_probs=219.6

Q ss_pred             HHHhcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCccHHHHHHHHHHHhcCC-CCCcceEEE-EEE
Q 046893           88 KLATKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLR-HSNLVKLIG-YCC  165 (464)
Q Consensus        88 ~~~~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~-~~~  165 (464)
                      .+...++++.++|.+|||+.||+|.+...      +..+|+|++-..+....+.+.+|+++|+.|+ |+|||.+++ ...
T Consensus        33 ~Vg~~~v~V~~vLAEGGFa~VYla~~~~~------~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~  106 (738)
T KOG1989|consen   33 TVGSHRVTVEKVLAEGGFAQVYLAQDVKG------GKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAI  106 (738)
T ss_pred             EECCEEEEEEEEEccCCcEEEEEEEecCC------CceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccc
Confidence            34456688899999999999999998775      3669999987766666788899999999997 999999999 322


Q ss_pred             eC------CeEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceE
Q 046893          166 ED------EHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAK  239 (464)
Q Consensus       166 ~~------~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vk  239 (464)
                      ..      -.++|+||||.||.|-|++..+....|++.++++|+.|+++|+.+||.+..+|||||||-+||||+.+|.+|
T Consensus       107 ~~~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~K  186 (738)
T KOG1989|consen  107 NRSSNNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYK  186 (738)
T ss_pred             cccCCCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEE
Confidence            21      257899999999999999987776679999999999999999999999899999999999999999999999


Q ss_pred             EcccCCccCCCCCCCcc-------eeeccccCCcccCcccc---ccCCCCcccchhcHHHHHHHHHhCCCCCCCCCCccc
Q 046893          240 LSDFGLAKDGPMGDQTH-------VSTRVMGTYGYAAPEYV---MTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSRE  309 (464)
Q Consensus       240 l~DFGla~~~~~~~~~~-------~~~~~~gt~~y~aPE~~---~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~  309 (464)
                      |||||.|..........       ..-....|+.|+|||++   .+..+++|+|||||||+||.|+....||+....   
T Consensus       187 LCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~---  263 (738)
T KOG1989|consen  187 LCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGK---  263 (738)
T ss_pred             eCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcc---
Confidence            99999997432221110       01113579999999988   477899999999999999999999999987532   


Q ss_pred             ccHHHHHHHhhhcccchhhccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhcCh
Q 046893          310 HNLVEWARPLLNNNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETVQSQGA  379 (464)
Q Consensus       310 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~~~~~~  379 (464)
                                       ..|++..+.-.-.......|.+||+.||+.||.+||++-+|++.+-.+.....
T Consensus       264 -----------------laIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~~  316 (738)
T KOG1989|consen  264 -----------------LAILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKPC  316 (738)
T ss_pred             -----------------eeEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCCC
Confidence                             23344444433345677799999999999999999999999999988876543

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=5.5e-45  Score=358.13  Aligned_cols=267  Identities=26%  Similarity=0.435  Sum_probs=215.0

Q ss_pred             hHHHHHhcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCcc--HHHHHHHHHHHhcCCCCCcceEEE
Q 046893           85 NEMKLATKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQG--DREWLAEVNYLGQLRHSNLVKLIG  162 (464)
Q Consensus        85 ~~~~~~~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~hpniv~l~~  162 (464)
                      .++++....+.+...||+|.||+||+|.+..+         ||||+++-.....  .+.|.+|+.+|++-+|.||+=+.|
T Consensus       385 ~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whGd---------VAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG  455 (678)
T KOG0193|consen  385 EEWEIPPEEVLLGERIGSGSFGTVYRGRWHGD---------VAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMG  455 (678)
T ss_pred             cccccCHHHhhccceeccccccceeecccccc---------eEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeeh
Confidence            56677777788899999999999999999886         9999998765443  377999999999999999999999


Q ss_pred             EEEeCCeEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcc
Q 046893          163 YCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSD  242 (464)
Q Consensus       163 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~D  242 (464)
                      +|..... .||.-+|+|.+|+.+|+-.. ..|.+.+.+.||.||+.|+.|||  -++|||||||..||+|.+++.|||+|
T Consensus       456 ~~~~p~~-AIiTqwCeGsSLY~hlHv~e-tkfdm~~~idIAqQiaqGM~YLH--AK~IIHrDLKSnNIFl~~~~kVkIgD  531 (678)
T KOG0193|consen  456 ACMNPPL-AIITQWCEGSSLYTHLHVQE-TKFDMNTTIDIAQQIAQGMDYLH--AKNIIHRDLKSNNIFLHEDLKVKIGD  531 (678)
T ss_pred             hhcCCce-eeeehhccCchhhhhccchh-hhhhHHHHHHHHHHHHHhhhhhh--hhhhhhhhccccceEEccCCcEEEec
Confidence            9999887 89999999999999997543 46999999999999999999999  68899999999999999999999999


Q ss_pred             cCCccCCCCCCCcceeeccccCCcccCcccccc---CCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHh
Q 046893          243 FGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMT---GHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPL  319 (464)
Q Consensus       243 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~  319 (464)
                      |||+..........-.....|...|||||+++.   .+|++.+|||||||++|||++|..||......  +.+.     +
T Consensus       532 FGLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~d--qIif-----m  604 (678)
T KOG0193|consen  532 FGLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRD--QIIF-----M  604 (678)
T ss_pred             ccceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChh--heEE-----E
Confidence            999974322211112223467889999999975   46999999999999999999999999833211  1100     0


Q ss_pred             hhcccchhhccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhc
Q 046893          320 LNNNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETVQSQ  377 (464)
Q Consensus       320 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~~~~  377 (464)
                      +..+     .+.+++ ......|+.++.+|+..||..++++||.+.+|+..|+.+...
T Consensus       605 VGrG-----~l~pd~-s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~  656 (678)
T KOG0193|consen  605 VGRG-----YLMPDL-SKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPS  656 (678)
T ss_pred             eccc-----ccCccc-hhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhc
Confidence            1111     001111 122345778999999999999999999999999988877653

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.5e-46  Score=352.70  Aligned_cols=248  Identities=27%  Similarity=0.410  Sum_probs=210.1

Q ss_pred             CCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCcc-HHHHHHHHHHHhcCCCCCcceEEEEEEeCCeEE
Q 046893           93 FFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQG-DREWLAEVNYLGQLRHSNLVKLIGYCCEDEHRI  171 (464)
Q Consensus        93 ~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~  171 (464)
                      .|+...+||+|.||.||+|.+..+      ++.||+|++....... .+++..|+.+|.+++++||.++|+.|..+..++
T Consensus        14 ~~~~~~~IgrGsfG~Vyk~~d~~t------~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~Lw   87 (467)
T KOG0201|consen   14 LYTKLELIGRGSFGEVYKAIDNKT------KKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLW   87 (467)
T ss_pred             ccccchhccccccceeeeeeeccc------cceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHH
Confidence            466678899999999999998876      7789999998765444 477889999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCccCCCC
Q 046893          172 LVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPM  251 (464)
Q Consensus       172 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~  251 (464)
                      ++||||.||++.+.+..  +..+.+..+..++.+++.||.|||  ..+.+|||||+.|||+..+|.|||+|||.+.....
T Consensus        88 iiMey~~gGsv~~lL~~--~~~~~E~~i~~ilre~l~~l~ylH--~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~  163 (467)
T KOG0201|consen   88 IIMEYCGGGSVLDLLKS--GNILDEFEIAVILREVLKGLDYLH--SEKKIHRDIKAANILLSESGDVKLADFGVAGQLTN  163 (467)
T ss_pred             HHHHHhcCcchhhhhcc--CCCCccceeeeehHHHHHHhhhhh--hcceecccccccceeEeccCcEEEEecceeeeeec
Confidence            99999999999998764  335688888899999999999999  56699999999999999999999999999987543


Q ss_pred             CCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhcccchhhccC
Q 046893          252 GDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRILD  331 (464)
Q Consensus       252 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  331 (464)
                      ..  ....+++||+.|||||++.+..|+.|+||||||++.+||++|.+|+....+.....+             +.+-..
T Consensus       164 ~~--~rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlfl-------------Ipk~~P  228 (467)
T KOG0201|consen  164 TV--KRRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFL-------------IPKSAP  228 (467)
T ss_pred             hh--hccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEe-------------ccCCCC
Confidence            33  233669999999999999988999999999999999999999999988766433211             122223


Q ss_pred             ccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 046893          332 PRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVA  369 (464)
Q Consensus       332 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  369 (464)
                      |.+.+    .+...+.+|+..||..||+.||++.++++
T Consensus       229 P~L~~----~~S~~~kEFV~~CL~k~P~~RpsA~~LLK  262 (467)
T KOG0201|consen  229 PRLDG----DFSPPFKEFVEACLDKNPEFRPSAKELLK  262 (467)
T ss_pred             Ccccc----ccCHHHHHHHHHHhhcCcccCcCHHHHhh
Confidence            44444    44557999999999999999999999874

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-44  Score=381.87  Aligned_cols=268  Identities=28%  Similarity=0.419  Sum_probs=222.6

Q ss_pred             hcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCC-ccHHHHHHHHHHHhcCCCCCcceEEEEEEeCCe
Q 046893           91 TKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGY-QGDREWLAEVNYLGQLRHSNLVKLIGYCCEDEH  169 (464)
Q Consensus        91 ~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~  169 (464)
                      .....+.+.||+|+||.||.|...+...... ...||||.+.+... ....+|++|..+|+.++|||||+++|++.+...
T Consensus       691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~-~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~  769 (1025)
T KOG1095|consen  691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVS-PIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGP  769 (1025)
T ss_pred             hhheEeeeeeccccccceEEEEEecCCCCcc-ceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCC
Confidence            4556677889999999999999876533222 45699999987543 445789999999999999999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHhhc-----CCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccC
Q 046893          170 RILVYEYMESGSLEKHLLRRV-----GCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFG  244 (464)
Q Consensus       170 ~~lv~e~~~~g~L~~~l~~~~-----~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFG  244 (464)
                      .+|++|||.+|+|..+|.+..     ...+.....+.++.|||.|+.||+  .+++|||||..+|+||+....|||+|||
T Consensus       770 ~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe--~~~fvHRDLAaRNCLL~~~r~VKIaDFG  847 (1025)
T KOG1095|consen  770 PLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLE--SKHFVHRDLAARNCLLDERRVVKIADFG  847 (1025)
T ss_pred             cEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHH--hCCCcCcchhhhheeecccCcEEEcccc
Confidence            999999999999999998652     346899999999999999999999  6779999999999999999999999999


Q ss_pred             CccCCCCCCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHhhhcc
Q 046893          245 LAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLL-GRRAVDKSRPSREHNLVEWARPLLNNN  323 (464)
Q Consensus       245 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~  323 (464)
                      +|+.....+++.......-...|||||.+..+.|+.|+|||||||+|||+|+ |..||......+.      ....+.. 
T Consensus       848 lArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v------~~~~~~g-  920 (1025)
T KOG1095|consen  848 LARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEV------LLDVLEG-  920 (1025)
T ss_pred             hhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHH------HHHHHhC-
Confidence            9996655565555444445679999999999999999999999999999999 8899876543221      1111111 


Q ss_pred             cchhhccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhcC
Q 046893          324 KKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETVQSQG  378 (464)
Q Consensus       324 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~~~~~  378 (464)
                               . +-..+..|+..+++||..||+.+|++||++..|++.+..+....
T Consensus       921 ---------g-RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~  965 (1025)
T KOG1095|consen  921 ---------G-RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAA  965 (1025)
T ss_pred             ---------C-ccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhh
Confidence                     1 33557788999999999999999999999999999888776544

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=3.5e-45  Score=343.24  Aligned_cols=249  Identities=22%  Similarity=0.342  Sum_probs=209.5

Q ss_pred             HhcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCccHHH---HHHHHHHHhcCCCCCcceEEEEEEe
Q 046893           90 ATKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDRE---WLAEVNYLGQLRHSNLVKLIGYCCE  166 (464)
Q Consensus        90 ~~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~---~~~E~~~l~~l~hpniv~l~~~~~~  166 (464)
                      ...+|++.+.||+|+||+|-+|+....      +..||||.+++.......+   +.+|++||..|+||||+.++++|++
T Consensus        51 lkHRyE~~etLGkGTYGKVk~A~e~~s------gR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFEN  124 (668)
T KOG0611|consen   51 LKHRYEITETLGKGTYGKVKLAYEHKS------GREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFEN  124 (668)
T ss_pred             hhhHHHHHHHhcCCcccceeehhhccC------CcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcC
Confidence            346788899999999999999987765      6779999998876655544   6789999999999999999999999


Q ss_pred             CCeEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCc
Q 046893          167 DEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLA  246 (464)
Q Consensus       167 ~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla  246 (464)
                      .+...|||||..+|.|+||+.++.  .|++.++..++.||..|+.|+|  +++++|||||.+|||||.++++||+||||+
T Consensus       125 kdKIvivMEYaS~GeLYDYiSer~--~LsErEaRhfFRQIvSAVhYCH--knrVvHRDLKLENILLD~N~NiKIADFGLS  200 (668)
T KOG0611|consen  125 KDKIVIVMEYASGGELYDYISERG--SLSEREARHFFRQIVSAVHYCH--KNRVVHRDLKLENILLDQNNNIKIADFGLS  200 (668)
T ss_pred             CceEEEEEEecCCccHHHHHHHhc--cccHHHHHHHHHHHHHHHHHHh--hccceecccchhheeecCCCCeeeeccchh
Confidence            999999999999999999998865  6999999999999999999999  788999999999999999999999999999


Q ss_pred             cCCCCCCCcceeeccccCCcccCccccccCCCC-cccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhcccc
Q 046893          247 KDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLT-ARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKK  325 (464)
Q Consensus       247 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  325 (464)
                      ..+...   ....++||++.|.+||++.|.+|. ..+|-|||||+||-|+.|..||++...   ..++.   .+      
T Consensus       201 Nly~~~---kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dh---k~lvr---QI------  265 (668)
T KOG0611|consen  201 NLYADK---KFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDH---KRLVR---QI------  265 (668)
T ss_pred             hhhccc---cHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchH---HHHHH---Hh------
Confidence            875432   345569999999999999999885 689999999999999999999987531   11111   11      


Q ss_pred             hhhccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 046893          326 VLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVAL  370 (464)
Q Consensus       326 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  370 (464)
                          ....+.   ....+.....||++||-.+|++|.|+.+|...
T Consensus       266 ----s~GaYr---EP~~PSdA~gLIRwmLmVNP~RRATieDiAsH  303 (668)
T KOG0611|consen  266 ----SRGAYR---EPETPSDASGLIRWMLMVNPERRATIEDIASH  303 (668)
T ss_pred             ----hccccc---CCCCCchHHHHHHHHHhcCcccchhHHHHhhh
Confidence                111111   11223366789999999999999999998764

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=5.7e-44  Score=347.87  Aligned_cols=270  Identities=26%  Similarity=0.432  Sum_probs=207.4

Q ss_pred             hcCCCCCCceeecCceEEEEEEecCCCC----------CCccceEEEEEEccCCCCc-cHHHHHHHHHHHhcCCCCCcce
Q 046893           91 TKFFRPDYILGEGGFGVVYKGVIDENVR----------PGYKTTFVAIKELNRGGYQ-GDREWLAEVNYLGQLRHSNLVK  159 (464)
Q Consensus        91 ~~~~~~~~~lG~G~fg~Vy~a~~~~~~~----------~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~  159 (464)
                      .++|++.+.||+|+||.||+|.+.....          ....+..||+|.+...... ...+|.+|+.+|..++||||++
T Consensus         4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~   83 (304)
T cd05096           4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIR   83 (304)
T ss_pred             hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeE
Confidence            4578999999999999999998754321          1123457999998764322 2357899999999999999999


Q ss_pred             EEEEEEeCCeEEEEEeccCCCCHHHHHHhhc-----------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCeee
Q 046893          160 LIGYCCEDEHRILVYEYMESGSLEKHLLRRV-----------------GCMLTWSRRMKIALDAAKGLAFLHGAERPVIY  222 (464)
Q Consensus       160 l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-----------------~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH  222 (464)
                      +++++...+..++||||+.+|+|.+++....                 ...+++..++.++.|++.||.|||  ..+|+|
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH--~~~ivH  161 (304)
T cd05096          84 LLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLS--SLNFVH  161 (304)
T ss_pred             EEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHH--HCCccc
Confidence            9999999999999999999999999886432                 124678889999999999999999  567999


Q ss_pred             ccCCCCceEecCCCceEEcccCCccCCCCCCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHh--CCCC
Q 046893          223 RDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLL--GRRA  300 (464)
Q Consensus       223 rDlkp~Nill~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~--g~~p  300 (464)
                      |||||+|||++.++.+||+|||+++...............++..|+|||++.+..++.++||||||+++|||++  +..|
T Consensus       162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p  241 (304)
T cd05096         162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQP  241 (304)
T ss_pred             cCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCC
Confidence            99999999999999999999999986544333333334566889999999998899999999999999999987  5567


Q ss_pred             CCCCCCcccccHHHHHHHhhhcccchhhccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 046893          301 VDKSRPSREHNLVEWARPLLNNNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLE  372 (464)
Q Consensus       301 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~  372 (464)
                      |.....   ..........+......       .....+..++..+.+|+.+||+.||.+||++.+|.+.|+
T Consensus       242 ~~~~~~---~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~  303 (304)
T cd05096         242 YGELTD---EQVIENAGEFFRDQGRQ-------VYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT  303 (304)
T ss_pred             CCcCCH---HHHHHHHHHHhhhcccc-------ccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence            765432   11222222111111100       001112234568999999999999999999999998886

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.8e-45  Score=360.80  Aligned_cols=271  Identities=28%  Similarity=0.425  Sum_probs=218.2

Q ss_pred             hHHHHHhcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCC---CccHHHHHHHHHHHhcCCCCCcceEE
Q 046893           85 NEMKLATKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGG---YQGDREWLAEVNYLGQLRHSNLVKLI  161 (464)
Q Consensus        85 ~~~~~~~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~  161 (464)
                      ..+.+.-.+-.+.++||+|+||.||+|.+......  ....||||..+...   .....+|++|+++|+.++|||||+++
T Consensus       150 ~~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~--~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~y  227 (474)
T KOG0194|consen  150 QKWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGF--KVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFY  227 (474)
T ss_pred             cccEEeccCccccceeecccccEEEEEEEEecCCc--eeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEE
Confidence            34555556666778999999999999998764221  11228999987532   33457899999999999999999999


Q ss_pred             EEEEeCCeEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEc
Q 046893          162 GYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLS  241 (464)
Q Consensus       162 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~  241 (464)
                      |+...+..++||||+|.||+|.++|.+..+ .++..+++.++.+++.||+|||  .+++|||||..+|+|++.++.+||+
T Consensus       228 GVa~~~~Pl~ivmEl~~gGsL~~~L~k~~~-~v~~~ek~~~~~~AA~Gl~YLh--~k~~IHRDIAARNcL~~~~~~vKIS  304 (474)
T KOG0194|consen  228 GVAVLEEPLMLVMELCNGGSLDDYLKKNKK-SLPTLEKLRFCYDAARGLEYLH--SKNCIHRDIAARNCLYSKKGVVKIS  304 (474)
T ss_pred             EEEcCCCccEEEEEecCCCcHHHHHHhCCC-CCCHHHHHHHHHHHHhHHHHHH--HCCCcchhHhHHHheecCCCeEEeC
Confidence            999999999999999999999999988654 6999999999999999999999  6779999999999999999999999


Q ss_pred             ccCCccCCCCCCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHhh
Q 046893          242 DFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLL-GRRAVDKSRPSREHNLVEWARPLL  320 (464)
Q Consensus       242 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~  320 (464)
                      |||+++...  .+........-...|+|||.+..+-|+.++|||||||++||+++ |..||.+......      ..   
T Consensus       305 DFGLs~~~~--~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v------~~---  373 (474)
T KOG0194|consen  305 DFGLSRAGS--QYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEV------KA---  373 (474)
T ss_pred             ccccccCCc--ceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHH------HH---
Confidence            999998643  11111112235678999999999999999999999999999999 8889987653211      11   


Q ss_pred             hcccchhhccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhcC
Q 046893          321 NNNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETVQSQG  378 (464)
Q Consensus       321 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~~~~~  378 (464)
                             .++........+...+..+..++.+||..+|+.||+|.++.+.|+.+....
T Consensus       374 -------kI~~~~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~  424 (474)
T KOG0194|consen  374 -------KIVKNGYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKK  424 (474)
T ss_pred             -------HHHhcCccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhcc
Confidence                   111222333444566779999999999999999999999999999887654

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=3.9e-44  Score=358.82  Aligned_cols=269  Identities=23%  Similarity=0.361  Sum_probs=208.9

Q ss_pred             HHHhcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCc-cHHHHHHHHHHHhcC-CCCCcceEEEEEE
Q 046893           88 KLATKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQ-GDREWLAEVNYLGQL-RHSNLVKLIGYCC  165 (464)
Q Consensus        88 ~~~~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l-~hpniv~l~~~~~  165 (464)
                      ....++|.+.+.||+|+||.||+|++..... ......||+|++...... ....+.+|+.+++.+ +|+||+++++++.
T Consensus        34 ~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~  112 (374)
T cd05106          34 EFPRDNLQFGKTLGAGAFGKVVEATAFGLGK-EDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACT  112 (374)
T ss_pred             cccHHHceehheecCCCcccEEEEEEecCCc-ccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEec
Confidence            3445678999999999999999998654322 123456999999754332 235688999999999 8999999999999


Q ss_pred             eCCeEEEEEeccCCCCHHHHHHhhc-------------------------------------------------------
Q 046893          166 EDEHRILVYEYMESGSLEKHLLRRV-------------------------------------------------------  190 (464)
Q Consensus       166 ~~~~~~lv~e~~~~g~L~~~l~~~~-------------------------------------------------------  190 (464)
                      .....++||||+.+|+|.+++....                                                       
T Consensus       113 ~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  192 (374)
T cd05106         113 HGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSS  192 (374)
T ss_pred             CCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccc
Confidence            9999999999999999999886431                                                       


Q ss_pred             -------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCccCCCCCCCcce
Q 046893          191 -------------GCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHV  257 (464)
Q Consensus       191 -------------~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~~~~  257 (464)
                                   ...+++..++.++.|++.||.|||  .++|+||||||+|||++.++.+||+|||+++..........
T Consensus       193 ~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH--~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~  270 (374)
T cd05106         193 QSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLA--SKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVV  270 (374)
T ss_pred             ccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHH--HCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceee
Confidence                         124788899999999999999999  57799999999999999999999999999986433322222


Q ss_pred             eeccccCCcccCccccccCCCCcccchhcHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHhhhcccchhhccCccccC
Q 046893          258 STRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLL-GRRAVDKSRPSREHNLVEWARPLLNNNKKVLRILDPRLEG  336 (464)
Q Consensus       258 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  336 (464)
                      .....++..|+|||++.+..++.++|||||||++|||++ |+.||.......  .+..    ....          ....
T Consensus       271 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~--~~~~----~~~~----------~~~~  334 (374)
T cd05106         271 KGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS--KFYK----MVKR----------GYQM  334 (374)
T ss_pred             ccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccH--HHHH----HHHc----------ccCc
Confidence            223345678999999998899999999999999999997 999997543211  0111    1111          0111


Q ss_pred             ccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHH
Q 046893          337 QYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETVQ  375 (464)
Q Consensus       337 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~~  375 (464)
                      ..+...+.++.+++.+||+.||.+||++.+|++.|+.+.
T Consensus       335 ~~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~  373 (374)
T cd05106         335 SRPDFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL  373 (374)
T ss_pred             cCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence            111223458999999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=9.4e-44  Score=343.21  Aligned_cols=251  Identities=27%  Similarity=0.382  Sum_probs=201.3

Q ss_pred             CCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCC---ccHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeE
Q 046893           94 FRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGY---QGDREWLAEVNYLGQLRHSNLVKLIGYCCEDEHR  170 (464)
Q Consensus        94 ~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~  170 (464)
                      |++.+.||+|+||+||+|.+..+      ++.||+|.+.....   .....+.+|+.++..++|+||+++++++...+..
T Consensus         2 f~~~~~lg~G~~g~V~~~~~~~~------~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~   75 (285)
T cd05631           2 FRHYRVLGKGGFGEVCACQVRAT------GKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDAL   75 (285)
T ss_pred             ceEEEEEecCCCEEEEEEEEecC------CceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeE
Confidence            67788999999999999998765      66799999865432   2234578899999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCccCCC
Q 046893          171 ILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGP  250 (464)
Q Consensus       171 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~  250 (464)
                      ++||||+.+|+|.+++.......+++..+..++.|++.||.|||  ..+|+||||||+|||++.++.+||+|||++....
T Consensus        76 ~lv~e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH--~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~  153 (285)
T cd05631          76 CLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQ--RERIVYRDLKPENILLDDRGHIRISDLGLAVQIP  153 (285)
T ss_pred             EEEEEecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHH--hCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcC
Confidence            99999999999998886654456899999999999999999999  6779999999999999999999999999998643


Q ss_pred             CCCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhcccchhhcc
Q 046893          251 MGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRIL  330 (464)
Q Consensus       251 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  330 (464)
                      ...   ......||..|+|||++.+..++.++|||||||+||||++|+.||.........   +........        
T Consensus       154 ~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~---~~~~~~~~~--------  219 (285)
T cd05631         154 EGE---TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKR---EEVDRRVKE--------  219 (285)
T ss_pred             CCC---eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhH---HHHHHHhhc--------
Confidence            221   123457999999999999999999999999999999999999999865432111   100000000        


Q ss_pred             CccccCccCHHHHHHHHHHHHHhhccCCCCCCC-----HHHHHH
Q 046893          331 DPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPV-----MSDVVA  369 (464)
Q Consensus       331 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~ev~~  369 (464)
                         ....++...+..+.+|+.+||+.||.+||+     ++++++
T Consensus       220 ---~~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~  260 (285)
T cd05631         220 ---DQEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ  260 (285)
T ss_pred             ---ccccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence               011223334558899999999999999997     566654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=6.6e-44  Score=357.42  Aligned_cols=267  Identities=24%  Similarity=0.364  Sum_probs=206.8

Q ss_pred             HHHhcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCC-ccHHHHHHHHHHHhcC-CCCCcceEEEEEE
Q 046893           88 KLATKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGY-QGDREWLAEVNYLGQL-RHSNLVKLIGYCC  165 (464)
Q Consensus        88 ~~~~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~hpniv~l~~~~~  165 (464)
                      ....++|++.+.||+|+||+||+|.+..... ...+..||||+++.... .....+.+|+.+|..+ +||||+++++++.
T Consensus        31 ~~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~-~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~  109 (375)
T cd05104          31 EFPRNRLSFGKTLGAGAFGKVVEATAYGLFK-SDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACT  109 (375)
T ss_pred             ccchHHeehhheecCCccceEEEEEEecccc-CccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeec
Confidence            3345568899999999999999997532211 12356799999875432 2335688999999999 8999999999999


Q ss_pred             eCCeEEEEEeccCCCCHHHHHHhhc-------------------------------------------------------
Q 046893          166 EDEHRILVYEYMESGSLEKHLLRRV-------------------------------------------------------  190 (464)
Q Consensus       166 ~~~~~~lv~e~~~~g~L~~~l~~~~-------------------------------------------------------  190 (464)
                      ..+..++|||||++|+|.+++....                                                       
T Consensus       110 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~  189 (375)
T cd05104         110 VGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSV  189 (375)
T ss_pred             cCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccc
Confidence            9999999999999999999886532                                                       


Q ss_pred             ------------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCccCCCCC
Q 046893          191 ------------------GCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMG  252 (464)
Q Consensus       191 ------------------~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~  252 (464)
                                        ...+++..++.++.||+.||.|||  .++|+||||||+|||++.++.+||+|||+++.....
T Consensus       190 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH--~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~  267 (375)
T cd05104         190 RSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLA--SKNCIHRDLAARNILLTHGRITKICDFGLARDIRND  267 (375)
T ss_pred             ccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH--HCCeeccCCchhhEEEECCCcEEEecCccceeccCc
Confidence                              124788899999999999999999  577999999999999999999999999999865333


Q ss_pred             CCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHhhhcccchhhccC
Q 046893          253 DQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLL-GRRAVDKSRPSREHNLVEWARPLLNNNKKVLRILD  331 (464)
Q Consensus       253 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  331 (464)
                      ..........++..|+|||++.+..++.++|||||||++|||++ |..||.......  .+..+    +...        
T Consensus       268 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~--~~~~~----~~~~--------  333 (375)
T cd05104         268 SNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDS--KFYKM----IKEG--------  333 (375)
T ss_pred             ccccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchH--HHHHH----HHhC--------
Confidence            22222223445678999999999999999999999999999998 888886543211  11111    1111        


Q ss_pred             ccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q 046893          332 PRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLET  373 (464)
Q Consensus       332 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~  373 (464)
                        .....+...+.++.+|+.+||+.||.+||++.+|++.|+.
T Consensus       334 --~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~  373 (375)
T cd05104         334 --YRMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQ  373 (375)
T ss_pred             --ccCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHh
Confidence              0001112234588999999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=4.2e-44  Score=348.78  Aligned_cols=252  Identities=27%  Similarity=0.367  Sum_probs=213.9

Q ss_pred             cCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCccH--HHHHHHHHHHhcCCCCCcceEEEEEEeCCe
Q 046893           92 KFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGD--REWLAEVNYLGQLRHSNLVKLIGYCCEDEH  169 (464)
Q Consensus        92 ~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~--~~~~~E~~~l~~l~hpniv~l~~~~~~~~~  169 (464)
                      ++|..++.+|+|+||.+++.+.+..      ...+++|.+.-......  .....|+.+++++.|||||.+.+.|.+++.
T Consensus         4 ~~Ye~~~~iG~GafG~a~lvrhk~~------~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~   77 (426)
T KOG0589|consen    4 DNYEVLRQVGRGAFGSALLVRHKSD------DKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQ   77 (426)
T ss_pred             chhhhhhhcCccccchhhhhhhccC------CceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCc
Confidence            5688899999999999999877654      55799999876554333  356899999999999999999999999988


Q ss_pred             -EEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCccC
Q 046893          170 -RILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKD  248 (464)
Q Consensus       170 -~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~  248 (464)
                       .+|||+||+||+|.+.|.+..+..++++.++.|+.|++.|+.|||  .++|+|||||+.||+++.++.|||+|||+|+.
T Consensus        78 ~l~Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH--~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~  155 (426)
T KOG0589|consen   78 LLCIVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLH--ENRVLHRDLKCANIFLTKDKKVKLGDFGLAKI  155 (426)
T ss_pred             eEEEEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHH--hhhhhcccchhhhhhccccCceeecchhhhhh
Confidence             999999999999999999888888999999999999999999999  67799999999999999999999999999997


Q ss_pred             CCCCCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhcccchhh
Q 046893          249 GPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLR  328 (464)
Q Consensus       249 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  328 (464)
                      .....  ....+.+||+.||.||++.+.+|+.|+|||||||++|||++-+++|...+..      ..+...       ..
T Consensus       156 l~~~~--~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~------~Li~ki-------~~  220 (426)
T KOG0589|consen  156 LNPED--SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMS------ELILKI-------NR  220 (426)
T ss_pred             cCCch--hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchH------HHHHHH-------hh
Confidence            54433  3455689999999999999999999999999999999999999999875421      111111       11


Q ss_pred             ccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 046893          329 ILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVAL  370 (464)
Q Consensus       329 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  370 (464)
                      .    .....+.....++..||..||+.+|..||++.+++..
T Consensus       221 ~----~~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~  258 (426)
T KOG0589|consen  221 G----LYSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR  258 (426)
T ss_pred             c----cCCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence            1    1223444556689999999999999999999999875

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.4e-43  Score=334.46  Aligned_cols=253  Identities=26%  Similarity=0.330  Sum_probs=208.5

Q ss_pred             HHHHhcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCccH---HHHHHHHHHHhcCCCCCcceEEEE
Q 046893           87 MKLATKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGD---REWLAEVNYLGQLRHSNLVKLIGY  163 (464)
Q Consensus        87 ~~~~~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~---~~~~~E~~~l~~l~hpniv~l~~~  163 (464)
                      ..+..++|++++.||.|.-|+||++.+..+      +..+|+|++.+......   .+...|-+||+.++||.+..||..
T Consensus        72 ~~l~l~~f~llk~LG~GdiG~VyL~~l~~t------~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~  145 (459)
T KOG0610|consen   72 GSLGLRHFRLLKRLGCGDIGTVYLVELRGT------NCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYAS  145 (459)
T ss_pred             CccCHHHHHHHHHcCCCCceeEEEEEecCC------CceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhhe
Confidence            344556788889999999999999998876      57799999988655433   456779999999999999999999


Q ss_pred             EEeCCeEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEccc
Q 046893          164 CCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDF  243 (464)
Q Consensus       164 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DF  243 (464)
                      |+.++..|||||||.||+|..+++++.+..+++..+..++..++.||+|||  -.|||+|||||+||||-++|+|-|+||
T Consensus       146 fet~~~~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLH--mlGivYRDLKPENILvredGHIMLsDF  223 (459)
T KOG0610|consen  146 FETDKYSCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLH--MLGIVYRDLKPENILVREDGHIMLSDF  223 (459)
T ss_pred             eeccceeEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHH--hhceeeccCCcceeEEecCCcEEeeec
Confidence            999999999999999999999999988899999999999999999999999  677999999999999999999999999


Q ss_pred             CCccCCCC---------------------------------CCCc---------------------ceeeccccCCcccC
Q 046893          244 GLAKDGPM---------------------------------GDQT---------------------HVSTRVMGTYGYAA  269 (464)
Q Consensus       244 Gla~~~~~---------------------------------~~~~---------------------~~~~~~~gt~~y~a  269 (464)
                      .|+.....                                 ....                     .....++||-.|+|
T Consensus       224 DLS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlA  303 (459)
T KOG0610|consen  224 DLSLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLA  303 (459)
T ss_pred             cccccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCcccccccccccccc
Confidence            99763211                                 0000                     11224789999999


Q ss_pred             ccccccCCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhcccchhhccCccccCccCHHHHHHHHHH
Q 046893          270 PEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRILDPRLEGQYTARTAMKVAGL  349 (464)
Q Consensus       270 PE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  349 (464)
                      ||++.|...+.++|+|+|||+|||||.|..||.+......                +..++-..+.-......+..+.+|
T Consensus       304 PEvI~G~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~T----------------l~NIv~~~l~Fp~~~~vs~~akDL  367 (459)
T KOG0610|consen  304 PEVIRGEGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKET----------------LRNIVGQPLKFPEEPEVSSAAKDL  367 (459)
T ss_pred             ceeeecCCCCchhhHHHHHHHHHHHHhCCCCcCCCCchhh----------------HHHHhcCCCcCCCCCcchhHHHHH
Confidence            9999999999999999999999999999999998654322                112222211111112445688999


Q ss_pred             HHHhhccCCCCCCC
Q 046893          350 AYQCLSQNPKGRPV  363 (464)
Q Consensus       350 i~~cl~~dP~~RPs  363 (464)
                      |++.|.+||.+|..
T Consensus       368 Ir~LLvKdP~kRlg  381 (459)
T KOG0610|consen  368 IRKLLVKDPSKRLG  381 (459)
T ss_pred             HHHHhccChhhhhc
Confidence            99999999999987

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=2.9e-44  Score=330.21  Aligned_cols=263  Identities=24%  Similarity=0.293  Sum_probs=202.9

Q ss_pred             CCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCcc--HHHHHHHHHHHhcCCCCCcceEEEEEEeC--C
Q 046893           93 FFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQG--DREWLAEVNYLGQLRHSNLVKLIGYCCED--E  168 (464)
Q Consensus        93 ~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~hpniv~l~~~~~~~--~  168 (464)
                      .|+.++.|++|+||.||+|+++.+      +++||+|.++-+....  .-.-++||.+|.+++|||||.+..+....  +
T Consensus        77 efe~lnrI~EGtyGiVYRakdk~t------~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d  150 (419)
T KOG0663|consen   77 EFEKLNRIEEGTYGVVYRAKDKKT------DEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMD  150 (419)
T ss_pred             HHHHHhhcccCcceeEEEeccCCc------ceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccc
Confidence            366778899999999999998876      7889999997643211  13358999999999999999999877644  5


Q ss_pred             eEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCccC
Q 046893          169 HRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKD  248 (464)
Q Consensus       169 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~  248 (464)
                      ..|||||||+. +|..++..- ..++...++..++.|++.||+|||  +..|+|||||++|+|++..|.+||+|||+|+.
T Consensus       151 ~iy~VMe~~Eh-DLksl~d~m-~q~F~~~evK~L~~QlL~glk~lH--~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~  226 (419)
T KOG0663|consen  151 KIYIVMEYVEH-DLKSLMETM-KQPFLPGEVKTLMLQLLRGLKHLH--DNWILHRDLKTSNLLLSHKGILKIADFGLARE  226 (419)
T ss_pred             eeeeeHHHHHh-hHHHHHHhc-cCCCchHHHHHHHHHHHHHHHHHh--hceeEecccchhheeeccCCcEEecccchhhh
Confidence            79999999966 898877654 467999999999999999999999  67799999999999999999999999999998


Q ss_pred             CCCCCCcceeeccccCCcccCccccccC-CCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhcccch-
Q 046893          249 GPMGDQTHVSTRVMGTYGYAAPEYVMTG-HLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKV-  326 (464)
Q Consensus       249 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~-  326 (464)
                      +..  .....+..+-|.+|+|||.+.|. .|+..+|+||+|||+.||+++++.|.+......  +...+..+-.....+ 
T Consensus       227 ygs--p~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQ--l~~If~llGtPte~iw  302 (419)
T KOG0663|consen  227 YGS--PLKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQ--LDKIFKLLGTPSEAIW  302 (419)
T ss_pred             hcC--CcccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHH--HHHHHHHhCCCccccC
Confidence            643  33445567889999999999875 599999999999999999999999987654322  222221111111100 


Q ss_pred             --------------hhccCccccCccCHH-HHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 046893          327 --------------LRILDPRLEGQYTAR-TAMKVAGLAYQCLSQNPKGRPVMSDVVA  369 (464)
Q Consensus       327 --------------~~~~~~~~~~~~~~~-~~~~l~~li~~cl~~dP~~RPs~~ev~~  369 (464)
                                    .......+...+... ..+.-.+|+..+|..||.+|.|+++.++
T Consensus       303 pg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~  360 (419)
T KOG0663|consen  303 PGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLK  360 (419)
T ss_pred             CCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhc
Confidence                          001111112222222 3467789999999999999999998764

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=9.1e-44  Score=349.51  Aligned_cols=242  Identities=26%  Similarity=0.365  Sum_probs=196.1

Q ss_pred             CceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCC---ccHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeEEEEE
Q 046893           98 YILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGY---QGDREWLAEVNYLGQLRHSNLVKLIGYCCEDEHRILVY  174 (464)
Q Consensus        98 ~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~  174 (464)
                      +.||+|+||.||+|.+..+      ++.||+|++.....   .....+..|+.+++.++||||+++++++...+..+|||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~------~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~   74 (323)
T cd05571           1 KLLGKGTFGKVILVREKAT------GKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVM   74 (323)
T ss_pred             CeeeeCCCeEEEEEEECCC------CCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEE
Confidence            3699999999999998765      67799999875322   22345788999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCccCCCCCCC
Q 046893          175 EYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQ  254 (464)
Q Consensus       175 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~  254 (464)
                      ||+.+|+|.+++...  ..+++..+..++.||+.||.|||  ..+|+||||||+|||++.++.+||+|||+++...... 
T Consensus        75 e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~L~~lH--~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~-  149 (323)
T cd05571          75 EYANGGELFFHLSRE--RVFSEDRARFYGAEIVSALGYLH--SCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDG-  149 (323)
T ss_pred             eCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH--hCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCC-
Confidence            999999999988764  36899999999999999999999  6779999999999999999999999999997532211 


Q ss_pred             cceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhcccchhhccCccc
Q 046893          255 THVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRILDPRL  334 (464)
Q Consensus       255 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  334 (464)
                       ......+||+.|+|||++.+..++.++|||||||++|||++|+.||......      ..........        .  
T Consensus       150 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~------~~~~~~~~~~--------~--  212 (323)
T cd05571         150 -ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE------KLFELILMEE--------I--  212 (323)
T ss_pred             -CcccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHH------HHHHHHHcCC--------C--
Confidence             1223467999999999999999999999999999999999999999754311      1111111111        1  


Q ss_pred             cCccCHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHH
Q 046893          335 EGQYTARTAMKVAGLAYQCLSQNPKGRP-----VMSDVVA  369 (464)
Q Consensus       335 ~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~ev~~  369 (464)
                        .++...+..+.+|+.+||..||.+||     ++.++++
T Consensus       213 --~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~  250 (323)
T cd05571         213 --RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME  250 (323)
T ss_pred             --CCCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence              12233455889999999999999999     6777764

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=4e-43  Score=338.47  Aligned_cols=247  Identities=19%  Similarity=0.314  Sum_probs=199.8

Q ss_pred             CceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCcc---HHHHHHHHHHHhcCCCCCcceEEEEEEe----CCeE
Q 046893           98 YILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQG---DREWLAEVNYLGQLRHSNLVKLIGYCCE----DEHR  170 (464)
Q Consensus        98 ~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~hpniv~l~~~~~~----~~~~  170 (464)
                      ..||+|++|.||+|.+.        ++.||||.+.......   .+.+.+|+.+|.+++||||+++++++.+    ....
T Consensus        26 ~~i~~g~~~~v~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~   97 (283)
T PHA02988         26 VLIKENDQNSIYKGIFN--------NKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRL   97 (283)
T ss_pred             eEEeeCCceEEEEEEEC--------CEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCce
Confidence            56999999999999873        4679999987653333   3567799999999999999999999877    3478


Q ss_pred             EEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCccCCC
Q 046893          171 ILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGP  250 (464)
Q Consensus       171 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~  250 (464)
                      ++||||+++|+|.+++....  .+++...+.++.|++.||.|||. ..+++||||||+|||++.++.+||+|||+++...
T Consensus        98 ~lv~Ey~~~g~L~~~l~~~~--~~~~~~~~~i~~~i~~~l~~lH~-~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~  174 (283)
T PHA02988         98 SLILEYCTRGYLREVLDKEK--DLSFKTKLDMAIDCCKGLYNLYK-YTNKPYKNLTSVSFLVTENYKLKIICHGLEKILS  174 (283)
T ss_pred             EEEEEeCCCCcHHHHHhhCC--CCChhHHHHHHHHHHHHHHHHHh-cCCCCCCcCChhhEEECCCCcEEEcccchHhhhc
Confidence            99999999999999987643  68999999999999999999994 2368899999999999999999999999998543


Q ss_pred             CCCCcceeeccccCCcccCcccccc--CCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhcccchhh
Q 046893          251 MGDQTHVSTRVMGTYGYAAPEYVMT--GHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLR  328 (464)
Q Consensus       251 ~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  328 (464)
                      ...     ....|+..|+|||++.+  ..++.++|||||||++|||++|+.||......      ++.........    
T Consensus       175 ~~~-----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~------~~~~~i~~~~~----  239 (283)
T PHA02988        175 SPP-----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTK------EIYDLIINKNN----  239 (283)
T ss_pred             ccc-----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHH------HHHHHHHhcCC----
Confidence            211     23568899999999876  68999999999999999999999999864321      11111111111    


Q ss_pred             ccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHh
Q 046893          329 ILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETVQS  376 (464)
Q Consensus       329 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~~~  376 (464)
                            ....+..++..+.+|+.+||+.||.+|||+.++++.|+.++.
T Consensus       240 ------~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~~  281 (283)
T PHA02988        240 ------SLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYKF  281 (283)
T ss_pred             ------CCCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHh
Confidence                  111223456689999999999999999999999999998763

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6e-44  Score=332.80  Aligned_cols=268  Identities=25%  Similarity=0.335  Sum_probs=205.9

Q ss_pred             HhcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEcc--CCCCccHHHHHHHHHHHhcCCCCCcceEEEEEEe-
Q 046893           90 ATKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELN--RGGYQGDREWLAEVNYLGQLRHSNLVKLIGYCCE-  166 (464)
Q Consensus        90 ~~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~--~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-  166 (464)
                      ...+|...+.||+|+||.|+.|++..+      ++.||||++.  .......++.++|+++|+.++|+||+.+++++.. 
T Consensus        20 i~~~y~~~~~iG~GAyGvVcsA~~~~t------~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~   93 (359)
T KOG0660|consen   20 IPRYYVLIEPIGRGAYGVVCSAKDKRT------GEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPP   93 (359)
T ss_pred             ccceecccccccCcceeeEEEEEEcCC------CCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccc
Confidence            445677788999999999999999886      6779999987  3334445778999999999999999999998866 


Q ss_pred             ----CCeEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcc
Q 046893          167 ----DEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSD  242 (464)
Q Consensus       167 ----~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~D  242 (464)
                          -+..|+|+|+| +.+|.+.+...  ..|+...+..+++|+++||+|+|+++  |+||||||.|+|++.+..+||+|
T Consensus        94 ~~~~f~DvYiV~elM-etDL~~iik~~--~~L~d~H~q~f~YQiLrgLKyiHSAn--ViHRDLKPsNll~n~~c~lKI~D  168 (359)
T KOG0660|consen   94 SRDKFNDVYLVFELM-ETDLHQIIKSQ--QDLTDDHAQYFLYQILRGLKYIHSAN--VIHRDLKPSNLLLNADCDLKICD  168 (359)
T ss_pred             cccccceeEEehhHH-hhHHHHHHHcC--ccccHHHHHHHHHHHHHhcchhhccc--ccccccchhheeeccCCCEEecc
Confidence                34789999999 56998888654  35999999999999999999999655  99999999999999999999999


Q ss_pred             cCCccCCCCCCCcceeeccccCCcccCccccc-cCCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHh--
Q 046893          243 FGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVM-TGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPL--  319 (464)
Q Consensus       243 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~--  319 (464)
                      ||+|+...........+..+-|.+|.|||++. ...|+...||||.||||.||++|++.|.+........++......  
T Consensus       169 FGLAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~  248 (359)
T KOG0660|consen  169 FGLARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPS  248 (359)
T ss_pred             ccceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCC
Confidence            99999764332333446678999999999875 467999999999999999999999999886543332222111000  


Q ss_pred             ------hhcc--cchhhcc---Cc-cccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 046893          320 ------LNNN--KKVLRIL---DP-RLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVA  369 (464)
Q Consensus       320 ------~~~~--~~~~~~~---~~-~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  369 (464)
                            +...  ....+-+   .+ .+..-+ ........+|+.+||..||.+|+|+++.++
T Consensus       249 ~e~l~~i~s~~ar~yi~slp~~p~~~f~~~f-p~a~p~AidLlekmL~fdP~kRita~eAL~  309 (359)
T KOG0660|consen  249 EEDLQKIRSEKARPYIKSLPQIPKQPFSSIF-PNANPLAIDLLEKMLVFDPKKRITAEEALA  309 (359)
T ss_pred             HHHHHHhccHHHHHHHHhCCCCCCCCHHHHc-CCCCHHHHHHHHHHhccCccccCCHHHHhc
Confidence                  0000  0000000   00 011111 234457889999999999999999999875

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=3e-43  Score=338.95  Aligned_cols=262  Identities=29%  Similarity=0.473  Sum_probs=210.2

Q ss_pred             cCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCc-cHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeE
Q 046893           92 KFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQ-GDREWLAEVNYLGQLRHSNLVKLIGYCCEDEHR  170 (464)
Q Consensus        92 ~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~  170 (464)
                      ..|++.+.||+|+||.||+|.+..... ......||+|.+...... ....+.+|+.++..++||||+++++++......
T Consensus         5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~-~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~   83 (283)
T cd05048           5 SAVRFLEELGEGAFGKVYKGELTGPNE-RLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPT   83 (283)
T ss_pred             HHcchhhcccCccCCcEEEEEEecCCC-CcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCce
Confidence            458888999999999999998765421 234567999998754322 235688999999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHhhcC--------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCC
Q 046893          171 ILVYEYMESGSLEKHLLRRVG--------------CMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADF  236 (464)
Q Consensus       171 ~lv~e~~~~g~L~~~l~~~~~--------------~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~  236 (464)
                      +++|||+++++|.+++.....              ..+++..++.++.|++.||.|||  .++++|+||||+|||++.++
T Consensus        84 ~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH--~~~i~H~dlkp~Nil~~~~~  161 (283)
T cd05048          84 CMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLS--SHHFVHRDLAARNCLVGEGL  161 (283)
T ss_pred             EEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHH--hCCeeccccccceEEEcCCC
Confidence            999999999999999875421              35888999999999999999999  67799999999999999999


Q ss_pred             ceEEcccCCccCCCCCCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHh-CCCCCCCCCCcccccHHHH
Q 046893          237 SAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLL-GRRAVDKSRPSREHNLVEW  315 (464)
Q Consensus       237 ~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~  315 (464)
                      .++|+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..||.+....   .+..+
T Consensus       162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~---~~~~~  238 (283)
T cd05048         162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQ---EVIEM  238 (283)
T ss_pred             cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHH---HHHHH
Confidence            999999999986433333233334567889999999988899999999999999999998 99999764421   11111


Q ss_pred             HHHhhhcccchhhccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q 046893          316 ARPLLNNNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLET  373 (464)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~  373 (464)
                      .   .           .......+..++..+.+|+.+||+.||.+||++.+|++.|+.
T Consensus       239 i---~-----------~~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05048         239 I---R-----------SRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS  282 (283)
T ss_pred             H---H-----------cCCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence            1   0           011112234556789999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.2e-44  Score=319.08  Aligned_cols=250  Identities=26%  Similarity=0.385  Sum_probs=211.2

Q ss_pred             hcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCC---ccHHHHHHHHHHHhcCCCCCcceEEEEEEeC
Q 046893           91 TKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGY---QGDREWLAEVNYLGQLRHSNLVKLIGYCCED  167 (464)
Q Consensus        91 ~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~  167 (464)
                      -++|++.+.||+|-||.||+|+..++      .-+||+|++.++..   ....++.+|++|-..|+||||+++|++|.+.
T Consensus        21 l~dfeigr~LgkgkFG~vYlarekks------~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~   94 (281)
T KOG0580|consen   21 LDDFEIGRPLGKGKFGNVYLAREKKS------LFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDS   94 (281)
T ss_pred             hhhccccccccCCccccEeEeeeccC------CcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheecc
Confidence            35689999999999999999998775      67799999876532   2336788999999999999999999999999


Q ss_pred             CeEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCcc
Q 046893          168 EHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAK  247 (464)
Q Consensus       168 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~  247 (464)
                      ...||++||..+|+|...|.......+++.....++.|++.||.|+|  .++||||||||+|+|++.++.+||+|||.+.
T Consensus        95 ~riyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h--~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV  172 (281)
T KOG0580|consen   95 KRIYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCH--LKRVIHRDIKPENLLLGSAGELKIADFGWSV  172 (281)
T ss_pred             ceeEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhc--cCCcccCCCCHHHhccCCCCCeeccCCCcee
Confidence            99999999999999999998776778999999999999999999999  7889999999999999999999999999987


Q ss_pred             CCCCCCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhcccchh
Q 046893          248 DGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVL  327 (464)
Q Consensus       248 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  327 (464)
                      ...    .....+.|||..|.+||++.+..++..+|+|++|++.||++.|.+||........      ...+..     .
T Consensus       173 ~~p----~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~et------YkrI~k-----~  237 (281)
T KOG0580|consen  173 HAP----SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSET------YKRIRK-----V  237 (281)
T ss_pred             ecC----CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHH------HHHHHH-----c
Confidence            532    2334558999999999999999999999999999999999999999986542111      111110     1


Q ss_pred             hccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 046893          328 RILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVAL  370 (464)
Q Consensus       328 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  370 (464)
                      ++       .++...+....++|.+|+..+|.+|....++++.
T Consensus       238 ~~-------~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~h  273 (281)
T KOG0580|consen  238 DL-------KFPSTISGGAADLISRLLVKNPIERLALTEVMDH  273 (281)
T ss_pred             cc-------cCCcccChhHHHHHHHHhccCccccccHHHHhhh
Confidence            11       2233445588899999999999999999988764

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=3.7e-43  Score=335.53  Aligned_cols=260  Identities=25%  Similarity=0.397  Sum_probs=206.8

Q ss_pred             hcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCc-cHHHHHHHHHHHhcCCCCCcceEEEEEEeCCe
Q 046893           91 TKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQ-GDREWLAEVNYLGQLRHSNLVKLIGYCCEDEH  169 (464)
Q Consensus        91 ~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~  169 (464)
                      .+.|++.+.||+|+||.||+|.+....   .....||+|.++..... ....+.+|+.++..++||||+++++++...+.
T Consensus         4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~---~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~   80 (266)
T cd05064           4 NKSIKIERILGTGRFGELCRGCLKLPS---KRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNT   80 (266)
T ss_pred             hHHeEEeeeecccCCCeEEEEEEecCC---CceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCC
Confidence            456889999999999999999875432   23567999998764322 23568899999999999999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCccCC
Q 046893          170 RILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDG  249 (464)
Q Consensus       170 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~  249 (464)
                      .+|||||+++|+|.+++.... ..+++..++.++.|++.||+|||  +++++||||||+|||++.++.++|+|||.+...
T Consensus        81 ~~lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~~i~~al~~lH--~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~  157 (266)
T cd05064          81 MMIVTEYMSNGALDSFLRKHE-GQLVAGQLMGMLPGLASGMKYLS--EMGYVHKGLAAHKVLVNSDLVCKISGFRRLQED  157 (266)
T ss_pred             cEEEEEeCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHH--HCCEeeccccHhhEEEcCCCcEEECCCcccccc
Confidence            999999999999999887643 46899999999999999999999  677999999999999999999999999987653


Q ss_pred             CCCCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHhhhcccchhh
Q 046893          250 PMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLL-GRRAVDKSRPSREHNLVEWARPLLNNNKKVLR  328 (464)
Q Consensus       250 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  328 (464)
                      ..... .......++..|+|||.+.+..++.++|||||||++|||++ |..||.......   +..   . +...     
T Consensus       158 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~---~~~---~-~~~~-----  224 (266)
T cd05064         158 KSEAI-YTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQD---VIK---A-VEDG-----  224 (266)
T ss_pred             cccch-hcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH---HHH---H-HHCC-----
Confidence            22111 11112345678999999999999999999999999999875 999997543211   111   1 1111     


Q ss_pred             ccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHH
Q 046893          329 ILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETV  374 (464)
Q Consensus       329 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~  374 (464)
                           .....+..++..+.+++.+||+.+|.+||++.+|++.|+.+
T Consensus       225 -----~~~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~  265 (266)
T cd05064         225 -----FRLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM  265 (266)
T ss_pred             -----CCCCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence                 11112334566899999999999999999999999988754

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=8.4e-44  Score=340.53  Aligned_cols=257  Identities=26%  Similarity=0.338  Sum_probs=203.6

Q ss_pred             HHHhcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCC--------------ccHHHHHHHHHHHhcCC
Q 046893           88 KLATKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGY--------------QGDREWLAEVNYLGQLR  153 (464)
Q Consensus        88 ~~~~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~--------------~~~~~~~~E~~~l~~l~  153 (464)
                      ...-+.|++...||+|.||+|-+|++..+      ++.||||++.+...              ...+...+|+.||++|+
T Consensus        93 ~k~lNqy~l~~eiG~G~yGkVkLar~~~~------~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~  166 (576)
T KOG0585|consen   93 RKQLNQYELIKEIGSGQYGKVKLARDEVD------GKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLH  166 (576)
T ss_pred             ceehhheehhhhhcCCccceEEEEeecCC------CcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcC
Confidence            44557799999999999999999998875      78899999976321              11246789999999999


Q ss_pred             CCCcceEEEEEEeC--CeEEEEEeccCCCCHHHHHHhhcCCC-CCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCce
Q 046893          154 HSNLVKLIGYCCED--EHRILVYEYMESGSLEKHLLRRVGCM-LTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNI  230 (464)
Q Consensus       154 hpniv~l~~~~~~~--~~~~lv~e~~~~g~L~~~l~~~~~~~-l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Ni  230 (464)
                      |||||+|+++..+.  +.+|||+|||..|.+...-   .+.+ +.+.+++.++.+++.||+|||  .++||||||||+|+
T Consensus       167 H~nVV~LiEvLDDP~s~~~YlVley~s~G~v~w~p---~d~~els~~~Ar~ylrDvv~GLEYLH--~QgiiHRDIKPsNL  241 (576)
T KOG0585|consen  167 HPNVVKLIEVLDDPESDKLYLVLEYCSKGEVKWCP---PDKPELSEQQARKYLRDVVLGLEYLH--YQGIIHRDIKPSNL  241 (576)
T ss_pred             CcCeeEEEEeecCcccCceEEEEEeccCCccccCC---CCcccccHHHHHHHHHHHHHHHHHHH--hcCeeccccchhhe
Confidence            99999999998765  5899999999999885432   2334 999999999999999999999  56799999999999


Q ss_pred             EecCCCceEEcccCCccCCCCCC---CcceeeccccCCcccCccccccCC----CCcccchhcHHHHHHHHHhCCCCCCC
Q 046893          231 LLNADFSAKLSDFGLAKDGPMGD---QTHVSTRVMGTYGYAAPEYVMTGH----LTARSDVYGFGVVLLEMLLGRRAVDK  303 (464)
Q Consensus       231 ll~~~~~vkl~DFGla~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DvwslG~il~ell~g~~pf~~  303 (464)
                      ||+.+|+|||+|||.+.....+.   ........+||+.|+|||.+.++.    .+.+.||||+||+||.|+.|+.||.+
T Consensus       242 Ll~~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~  321 (576)
T KOG0585|consen  242 LLSSDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFD  321 (576)
T ss_pred             EEcCCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCccc
Confidence            99999999999999998652221   111223368999999999988733    35688999999999999999999986


Q ss_pred             CCCcccccHHHHHHHhhhcccchhhccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 046893          304 SRPSREHNLVEWARPLLNNNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALL  371 (464)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L  371 (464)
                      ...      .+....          +++..+.-....++.+.+.+||++||.+||..|.++.+|....
T Consensus       322 ~~~------~~l~~K----------Ivn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hp  373 (576)
T KOG0585|consen  322 DFE------LELFDK----------IVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHP  373 (576)
T ss_pred             chH------HHHHHH----------HhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecc
Confidence            542      222222          2233333233334566899999999999999999999987544

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=4e-43  Score=345.85  Aligned_cols=239  Identities=23%  Similarity=0.310  Sum_probs=196.6

Q ss_pred             cCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCC---ccHHHHHHHHHHHhcCCCCCcceEEEEEEeCC
Q 046893           92 KFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGY---QGDREWLAEVNYLGQLRHSNLVKLIGYCCEDE  168 (464)
Q Consensus        92 ~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~  168 (464)
                      ++|.+.+.||+|+||.||+|.+..+      ++.||+|++.....   .....+.+|+.+|..++||||+++++++..++
T Consensus        18 ~~y~~~~~lg~G~~g~V~~~~~~~~------~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~   91 (329)
T PTZ00263         18 SDFEMGETLGTGSFGRVRIAKHKGT------GEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDEN   91 (329)
T ss_pred             hheEEEEEEEecCCeEEEEEEECCC------CCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCC
Confidence            4588889999999999999998765      56799999865321   22356889999999999999999999999999


Q ss_pred             eEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCccC
Q 046893          169 HRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKD  248 (464)
Q Consensus       169 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~  248 (464)
                      ..++||||+.+|+|.+++....  .+++..+..++.|++.||.|||  .++|+||||||+|||++.++.+||+|||+++.
T Consensus        92 ~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH--~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~  167 (329)
T PTZ00263         92 RVYFLLEFVVGGELFTHLRKAG--RFPNDVAKFYHAELVLAFEYLH--SKDIIYRDLKPENLLLDNKGHVKVTDFGFAKK  167 (329)
T ss_pred             EEEEEEcCCCCChHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH--HCCeeecCCCHHHEEECCCCCEEEeeccCceE
Confidence            9999999999999999887643  6899999999999999999999  67799999999999999999999999999986


Q ss_pred             CCCCCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhcccchhh
Q 046893          249 GPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLR  328 (464)
Q Consensus       249 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  328 (464)
                      ....     .....||+.|+|||++.+..++.++|||||||++|+|++|..||....+.      +..........    
T Consensus       168 ~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~------~~~~~i~~~~~----  232 (329)
T PTZ00263        168 VPDR-----TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPF------RIYEKILAGRL----  232 (329)
T ss_pred             cCCC-----cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHH------HHHHHHhcCCc----
Confidence            4321     12367999999999999999999999999999999999999999764321      11111111100    


Q ss_pred             ccCccccCccCHHHHHHHHHHHHHhhccCCCCCCC
Q 046893          329 ILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPV  363 (464)
Q Consensus       329 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs  363 (464)
                              .++...+..+.+|+.+||+.||.+||+
T Consensus       233 --------~~p~~~~~~~~~li~~~L~~dP~~R~~  259 (329)
T PTZ00263        233 --------KFPNWFDGRARDLVKGLLQTDHTKRLG  259 (329)
T ss_pred             --------CCCCCCCHHHHHHHHHHhhcCHHHcCC
Confidence                    112223457889999999999999997

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.4e-43  Score=346.94  Aligned_cols=254  Identities=24%  Similarity=0.289  Sum_probs=203.6

Q ss_pred             cCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCC---ccHHHHHHHHHHHhcCCCCCcceEEEEEEeCC
Q 046893           92 KFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGY---QGDREWLAEVNYLGQLRHSNLVKLIGYCCEDE  168 (464)
Q Consensus        92 ~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~  168 (464)
                      ++|.+.+.||+|+||.||+|.+..+      ++.||+|++.....   .....+..|+.++..++||||+++++++...+
T Consensus         1 ~~y~~~~~ig~G~~g~Vy~~~~~~~------~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~   74 (333)
T cd05600           1 KDFQILTQVGQGGYGQVFLAKKKDT------GEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDE   74 (333)
T ss_pred             CCcEEEEEEeecCCeEEEEEEECCC------CCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCC
Confidence            3688899999999999999998765      56799999875321   23356789999999999999999999999999


Q ss_pred             eEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCccC
Q 046893          169 HRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKD  248 (464)
Q Consensus       169 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~  248 (464)
                      ..||||||+++++|.+++...  ..+++..+..++.|++.||.|||  ..+|+||||||+|||++.++.+||+|||+++.
T Consensus        75 ~~~lv~e~~~g~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH--~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~  150 (333)
T cd05600          75 YLYLAMEYVPGGDFRTLLNNL--GVLSEDHARFYMAEMFEAVDALH--ELGYIHRDLKPENFLIDASGHIKLTDFGLSKG  150 (333)
T ss_pred             EEEEEEeCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH--HCCccccCCCHHHEEECCCCCEEEEeCcCCcc
Confidence            999999999999999998654  36899999999999999999999  67799999999999999999999999999985


Q ss_pred             CCCCCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhcccchhh
Q 046893          249 GPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLR  328 (464)
Q Consensus       249 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  328 (464)
                      ...     ......||+.|+|||++.+..++.++|||||||+||||++|..||.........      ........    
T Consensus       151 ~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~------~~i~~~~~----  215 (333)
T cd05600         151 IVT-----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETW------ENLKYWKE----  215 (333)
T ss_pred             ccc-----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHH------HHHHhccc----
Confidence            432     223467999999999999999999999999999999999999999765432111      11110000    


Q ss_pred             ccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 046893          329 ILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVAL  370 (464)
Q Consensus       329 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  370 (464)
                      .+............+.++.+|+.+||..+|.+||++.+++..
T Consensus       216 ~~~~~~~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h  257 (333)
T cd05600         216 TLQRPVYDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH  257 (333)
T ss_pred             cccCCCCCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence            000000000012345588999999999999999999998753

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-43  Score=347.59  Aligned_cols=292  Identities=25%  Similarity=0.363  Sum_probs=241.5

Q ss_pred             hHHHHHhcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCccHHHHHHHHHHHhcCCCCCcceEEEEE
Q 046893           85 NEMKLATKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVKLIGYC  164 (464)
Q Consensus        85 ~~~~~~~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~  164 (464)
                      +++++.........+||-|.||.||.|+|++-      .-.||||.++.. ....++|+.|+.+|+.++|||+|+|+++|
T Consensus       260 DkWEmeRtdItMkhKLGGGQYGeVYeGvWKky------slTvAVKtLKED-tMeveEFLkEAAvMKeikHpNLVqLLGVC  332 (1157)
T KOG4278|consen  260 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKY------SLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVC  332 (1157)
T ss_pred             chhhccchheeeeeccCCCcccceeeeeeecc------ceeeehhhhhhc-chhHHHHHHHHHHHHhhcCccHHHHhhhh
Confidence            56677777788889999999999999999875      445999999754 45568999999999999999999999999


Q ss_pred             EeCCeEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccC
Q 046893          165 CEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFG  244 (464)
Q Consensus       165 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFG  244 (464)
                      ..+-..|||.|||..|+|.+||.+.....++....+.++.||..|+.||.  .+++|||||..+|+|+.++..|||+|||
T Consensus       333 T~EpPFYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLE--kknFIHRDLAARNCLVgEnhiVKvADFG  410 (1157)
T KOG4278|consen  333 THEPPFYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLE--KKNFIHRDLAARNCLVGENHIVKVADFG  410 (1157)
T ss_pred             ccCCCeEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHH--HhhhhhhhhhhhhccccccceEEeeccc
Confidence            99999999999999999999998876667888889999999999999999  7889999999999999999999999999


Q ss_pred             CccCCCCCCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHhhhcc
Q 046893          245 LAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLL-GRRAVDKSRPSREHNLVEWARPLLNNN  323 (464)
Q Consensus       245 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~  323 (464)
                      |++....+.++. .....-...|.|||-+....++.|+|||+|||+|||+.| |..||.+....                
T Consensus       411 LsRlMtgDTYTA-HAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlS----------------  473 (1157)
T KOG4278|consen  411 LSRLMTGDTYTA-HAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS----------------  473 (1157)
T ss_pred             hhhhhcCCceec-ccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHH----------------
Confidence            999865443332 222345678999999999999999999999999999998 88898775422                


Q ss_pred             cchhhccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhcCh-hhHh----h--hcCCceeEEeec
Q 046893          324 KKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETVQSQGA-EEEM----L--QSGGGVVTLYEV  396 (464)
Q Consensus       324 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~~~~~~-~~~~----~--~~~~~~~~~~~~  396 (464)
                       .+..+++..++..-+..|+..+++||+.||+++|.+||++.|+-..|+.+..... .++.    -  .....++.+...
T Consensus       474 -qVY~LLEkgyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~~sSisdEV~keLgk~~~~~sv~~l~~l  552 (1157)
T KOG4278|consen  474 -QVYGLLEKGYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFSSSSISDEVQKELGKNNDKKSVVPLPRL  552 (1157)
T ss_pred             -HHHHHHhccccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhccccccHHHHHHHhhccccccccccccc
Confidence             2334556677778888999999999999999999999999999999998765432 2211    1  122345556666


Q ss_pred             CCCCCCC
Q 046893          397 PKLSSHN  403 (464)
Q Consensus       397 p~~~~~~  403 (464)
                      |.+++..
T Consensus       553 p~lpskt  559 (1157)
T KOG4278|consen  553 PILPSKT  559 (1157)
T ss_pred             ccCccch
Confidence            6655543

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.9e-43  Score=342.65  Aligned_cols=243  Identities=28%  Similarity=0.329  Sum_probs=196.7

Q ss_pred             eeecCceEEEEEEecCCCCCCccceEEEEEEccCCC---CccHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeEEEEEec
Q 046893          100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGG---YQGDREWLAEVNYLGQLRHSNLVKLIGYCCEDEHRILVYEY  176 (464)
Q Consensus       100 lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~  176 (464)
                      ||+|+||.||+|.+..+      ++.||+|++....   ......+..|+.+|..++||||+++++++...+..++||||
T Consensus         1 lg~G~~g~Vy~~~~~~~------~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   74 (312)
T cd05585           1 IGKGSFGKVMQVRKRDT------QRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAF   74 (312)
T ss_pred             CCcCCCeEEEEEEECCC------CCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcC
Confidence            79999999999998765      5679999986432   22335678899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCccCCCCCCCcc
Q 046893          177 MESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTH  256 (464)
Q Consensus       177 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~~~  256 (464)
                      +++|+|.+++...  ..+++..+..++.|++.||.|||  .++|+||||||+|||++.++.+||+|||+++......  .
T Consensus        75 ~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH--~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~--~  148 (312)
T cd05585          75 INGGELFHHLQRE--GRFDLSRARFYTAELLCALENLH--KFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD--D  148 (312)
T ss_pred             CCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH--hCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCC--C
Confidence            9999999988764  36899999999999999999999  6779999999999999999999999999998532211  2


Q ss_pred             eeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhcccchhhccCccccC
Q 046893          257 VSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRILDPRLEG  336 (464)
Q Consensus       257 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  336 (464)
                      .....+||+.|+|||++.+..++.++|||||||++|+|++|+.||.....      .+..........            
T Consensus       149 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~------~~~~~~~~~~~~------------  210 (312)
T cd05585         149 KTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENV------NEMYRKILQEPL------------  210 (312)
T ss_pred             ccccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCH------HHHHHHHHcCCC------------
Confidence            23346799999999999999999999999999999999999999975431      122222221110            


Q ss_pred             ccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 046893          337 QYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLE  372 (464)
Q Consensus       337 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~  372 (464)
                      .++...+..+.+|+.+||..||.+||++..+.+.|.
T Consensus       211 ~~~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~  246 (312)
T cd05585         211 RFPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKN  246 (312)
T ss_pred             CCCCcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHc
Confidence            122334557899999999999999987655555554

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3e-43  Score=340.74  Aligned_cols=243  Identities=23%  Similarity=0.293  Sum_probs=199.4

Q ss_pred             CCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCC---ccHHHHHHHHHHHhcCCCCCcceEEEEEEeCCe
Q 046893           93 FFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGY---QGDREWLAEVNYLGQLRHSNLVKLIGYCCEDEH  169 (464)
Q Consensus        93 ~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~  169 (464)
                      +|++.+.||+|+||.||+|.+..+      ++.||+|++.....   .....+.+|+.+++.++||||+++++++.+.+.
T Consensus         2 ~y~~~~~lg~G~~g~Vy~~~~~~~------~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~   75 (291)
T cd05612           2 DLERIKTVGTGTFGRVHLVRDRIS------EHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRF   75 (291)
T ss_pred             CceeeeeeecCCCeEEEEEEEcCC------CCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCe
Confidence            688899999999999999998765      66799999865322   223567889999999999999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCccCC
Q 046893          170 RILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDG  249 (464)
Q Consensus       170 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~  249 (464)
                      .++||||+.+|+|.+++....  .+++..+..++.|++.||.|||  .++|+||||||+|||++.++.+||+|||+++..
T Consensus        76 ~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH--~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~  151 (291)
T cd05612          76 LYMLMEYVPGGELFSYLRNSG--RFSNSTGLFYASEIVCALEYLH--SKEIVYRDLKPENILLDKEGHIKLTDFGFAKKL  151 (291)
T ss_pred             EEEEEeCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH--HCCeeecCCCHHHeEECCCCCEEEEecCcchhc
Confidence            999999999999999987643  6899999999999999999999  677999999999999999999999999999864


Q ss_pred             CCCCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhcccchhhc
Q 046893          250 PMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRI  329 (464)
Q Consensus       250 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  329 (464)
                      ...     ....+||+.|+|||++.+..++.++|||||||++|+|++|+.||......      ...........     
T Consensus       152 ~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~------~~~~~i~~~~~-----  215 (291)
T cd05612         152 RDR-----TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPF------GIYEKILAGKL-----  215 (291)
T ss_pred             cCC-----cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHHhCCc-----
Confidence            321     12357999999999999999999999999999999999999999764321      11111111110     


Q ss_pred             cCccccCccCHHHHHHHHHHHHHhhccCCCCCCC-----HHHHH
Q 046893          330 LDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPV-----MSDVV  368 (464)
Q Consensus       330 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~ev~  368 (464)
                             .++...+..+.+|+.+||..||.+||+     +.+++
T Consensus       216 -------~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l  252 (291)
T cd05612         216 -------EFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVK  252 (291)
T ss_pred             -------CCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHh
Confidence                   112223457889999999999999995     66665

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=5.7e-43  Score=352.29  Aligned_cols=269  Identities=23%  Similarity=0.348  Sum_probs=210.1

Q ss_pred             HHHhcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCc-cHHHHHHHHHHHhcCC-CCCcceEEEEEE
Q 046893           88 KLATKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQ-GDREWLAEVNYLGQLR-HSNLVKLIGYCC  165 (464)
Q Consensus        88 ~~~~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~-hpniv~l~~~~~  165 (464)
                      ....++|++.++||+|+||.||+|.+....+ ...+..||||++...... ....+++|+.+|..+. ||||+++++++.
T Consensus        33 ~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~-~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~  111 (400)
T cd05105          33 EFPRDGLVLGRILGSGAFGKVVEGTAYGLSR-SQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACT  111 (400)
T ss_pred             eccccceehhheecCCCCceEEEEEEcccCC-CCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEc
Confidence            3446679999999999999999998754321 123457999999754332 2356899999999996 999999999999


Q ss_pred             eCCeEEEEEeccCCCCHHHHHHhhc-------------------------------------------------------
Q 046893          166 EDEHRILVYEYMESGSLEKHLLRRV-------------------------------------------------------  190 (464)
Q Consensus       166 ~~~~~~lv~e~~~~g~L~~~l~~~~-------------------------------------------------------  190 (464)
                      .....|||||||++|+|.+++....                                                       
T Consensus       112 ~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  191 (400)
T cd05105         112 KSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPM  191 (400)
T ss_pred             cCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchh
Confidence            9999999999999999999886531                                                       


Q ss_pred             ---------------------------------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceE
Q 046893          191 ---------------------------------------GCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNIL  231 (464)
Q Consensus       191 ---------------------------------------~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nil  231 (464)
                                                             ...+++..++.++.|++.||.|||  ..+|+||||||+|||
T Consensus       192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH--~~~ivH~dikp~Nil  269 (400)
T cd05105         192 LEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLA--SKNCVHRDLAARNVL  269 (400)
T ss_pred             hhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH--hCCeeCCCCChHhEE
Confidence                                                   124788889999999999999999  577999999999999


Q ss_pred             ecCCCceEEcccCCccCCCCCCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHh-CCCCCCCCCCcccc
Q 046893          232 LNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLL-GRRAVDKSRPSREH  310 (464)
Q Consensus       232 l~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~  310 (464)
                      ++.++.+||+|||+++...............++..|+|||++.+..++.++|||||||+||||++ |..||.......  
T Consensus       270 l~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~--  347 (400)
T cd05105         270 LAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDS--  347 (400)
T ss_pred             EeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhH--
Confidence            99999999999999986433222222233457788999999999899999999999999999997 999987532111  


Q ss_pred             cHHHHHHHhhhcccchhhccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHH
Q 046893          311 NLVEWARPLLNNNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETVQ  375 (464)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~~  375 (464)
                      .+.    ..+...          .....+..++..+.+++.+||+.||++||++.+|.+.|+.+.
T Consensus       348 ~~~----~~~~~~----------~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~  398 (400)
T cd05105         348 TFY----NKIKSG----------YRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLL  398 (400)
T ss_pred             HHH----HHHhcC----------CCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHc
Confidence            010    011110          111122345568999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=4.1e-44  Score=348.30  Aligned_cols=242  Identities=27%  Similarity=0.419  Sum_probs=201.2

Q ss_pred             CCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCccHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeEEEE
Q 046893           94 FRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVKLIGYCCEDEHRILV  173 (464)
Q Consensus        94 ~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv  173 (464)
                      ...++-||.|+-|-||+|+++.        +.||||+++.-.       ..+|+-|++|+||||+.+.++|...-.+|||
T Consensus       126 IsELeWlGSGaQGAVF~Grl~n--------etVAVKKV~elk-------ETdIKHLRkLkH~NII~FkGVCtqsPcyCIi  190 (904)
T KOG4721|consen  126 ISELEWLGSGAQGAVFLGRLHN--------ETVAVKKVRELK-------ETDIKHLRKLKHPNIITFKGVCTQSPCYCII  190 (904)
T ss_pred             hhhhhhhccCcccceeeeeccC--------ceehhHHHhhhh-------hhhHHHHHhccCcceeeEeeeecCCceeEEe
Confidence            3345679999999999999764        459999885321       2578889999999999999999999999999


Q ss_pred             EeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCccCCCCCC
Q 046893          174 YEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGD  253 (464)
Q Consensus       174 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~  253 (464)
                      ||||..|.|..+|..  +..+.......|..+|+.|+.|||.  ..|||||||.-||||..+..|||+|||-++..... 
T Consensus       191 MEfCa~GqL~~VLka--~~~itp~llv~Wsk~IA~GM~YLH~--hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~-  265 (904)
T KOG4721|consen  191 MEFCAQGQLYEVLKA--GRPITPSLLVDWSKGIAGGMNYLHL--HKIIHRDLKSPNILISYDDVVKISDFGTSKELSDK-  265 (904)
T ss_pred             eeccccccHHHHHhc--cCccCHHHHHHHHHHhhhhhHHHHH--hhHhhhccCCCceEeeccceEEeccccchHhhhhh-
Confidence            999999999998876  4478999999999999999999995  44999999999999999999999999999864322 


Q ss_pred             CcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhcccchhhccCcc
Q 046893          254 QTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRILDPR  333 (464)
Q Consensus       254 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  333 (464)
                        .....++||..|||||+++..+.+.|+|||||||+|||||||..||........    -|     ..+       ...
T Consensus       266 --STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAI----Iw-----GVG-------sNs  327 (904)
T KOG4721|consen  266 --STKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAI----IW-----GVG-------SNS  327 (904)
T ss_pred             --hhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchhee----EE-----ecc-------CCc
Confidence              233458999999999999999999999999999999999999999975332110    00     111       122


Q ss_pred             ccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q 046893          334 LEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLET  373 (464)
Q Consensus       334 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~  373 (464)
                      +.-..+..|+..+.-||++||...|..||++++++..|+.
T Consensus       328 L~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldI  367 (904)
T KOG4721|consen  328 LHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDI  367 (904)
T ss_pred             ccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhh
Confidence            2334566788899999999999999999999999987764

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=4.6e-43  Score=342.13  Aligned_cols=269  Identities=25%  Similarity=0.422  Sum_probs=224.7

Q ss_pred             HHHHhcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCccH-HHHHHHHHHHhcCCCCCcceEEEEEE
Q 046893           87 MKLATKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGD-REWLAEVNYLGQLRHSNLVKLIGYCC  165 (464)
Q Consensus        87 ~~~~~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~-~~~~~E~~~l~~l~hpniv~l~~~~~  165 (464)
                      .+...+...+.++||+|-||.|.++....       ...||||+++....... .+|.+|+++|.+|+|||||.|+++|.
T Consensus       533 ~EfPRs~L~~~ekiGeGqFGEVhLCeveg-------~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~  605 (807)
T KOG1094|consen  533 VEFPRSRLRFKEKIGEGQFGEVHLCEVEG-------PLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCV  605 (807)
T ss_pred             hhcchhheehhhhhcCcccceeEEEEecC-------ceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeee
Confidence            35567778899999999999999998654       47799999987665544 78999999999999999999999999


Q ss_pred             eCCeEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCC
Q 046893          166 EDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGL  245 (464)
Q Consensus       166 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGl  245 (464)
                      .++.+++|+|||++|+|.+++..+....+.......|+.||+.||+||.+  .++|||||.++|+|++.++++||+|||+
T Consensus       606 ~DePicmI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes--~nfVHrd~a~rNcLv~~e~~iKiadfgm  683 (807)
T KOG1094|consen  606 QDDPLCMITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLES--LNFVHRDLATRNCLVDGEFTIKIADFGM  683 (807)
T ss_pred             cCCchHHHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHh--hchhhccccccceeecCcccEEecCccc
Confidence            99999999999999999999998754444556677899999999999995  4599999999999999999999999999


Q ss_pred             ccCCCCCCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHh--CCCCCCCCCCcccccHHHHHHHhhhcc
Q 046893          246 AKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLL--GRRAVDKSRPSREHNLVEWARPLLNNN  323 (464)
Q Consensus       246 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~--g~~pf~~~~~~~~~~~~~~~~~~~~~~  323 (464)
                      ++....+++.+...+.+-..+|||+|.+..+.++.++|||+||++|||+++  ...||.....   .+.++-...++.. 
T Consensus       684 sR~lysg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~---e~vven~~~~~~~-  759 (807)
T KOG1094|consen  684 SRNLYSGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTD---EQVVENAGEFFRD-  759 (807)
T ss_pred             ccccccCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhH---HHHHHhhhhhcCC-
Confidence            998888888888888888999999999999999999999999999999875  6778865432   1222222222221 


Q ss_pred             cchhhccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHH
Q 046893          324 KKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETV  374 (464)
Q Consensus       324 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~  374 (464)
                            -........+..|+..++++|..||..+-.+||+++++...|.+.
T Consensus       760 ------~~~~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~  804 (807)
T KOG1094|consen  760 ------QGRQVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED  804 (807)
T ss_pred             ------CCcceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence                  112223344667888999999999999999999999999888654

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=7.4e-43  Score=344.25  Aligned_cols=264  Identities=23%  Similarity=0.321  Sum_probs=204.2

Q ss_pred             hcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCc-cHHHHHHHHHHHhcCCCCCcceEEEEEEeCCe
Q 046893           91 TKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQ-GDREWLAEVNYLGQLRHSNLVKLIGYCCEDEH  169 (464)
Q Consensus        91 ~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~  169 (464)
                      .++|++.+.||+|+||.||++.+..+      +..+|+|++...... ....+.+|+++|+.++||||+++++++..++.
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~------~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   77 (331)
T cd06649           4 DDDFERISELGAGNGGVVTKVQHKPS------GLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGE   77 (331)
T ss_pred             cccceEEEeecCCCCEEEEEEEECCC------CcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCE
Confidence            46799999999999999999998765      667999998754322 23568899999999999999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCccCC
Q 046893          170 RILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDG  249 (464)
Q Consensus       170 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~  249 (464)
                      .++||||+++++|.+++....  .+++..+..++.|++.||.|||+ ..+|+||||||+|||++.++.+||+|||++...
T Consensus        78 ~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH~-~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~  154 (331)
T cd06649          78 ISICMEHMDGGSLDQVLKEAK--RIPEEILGKVSIAVLRGLAYLRE-KHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQL  154 (331)
T ss_pred             EEEEeecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHhh-cCCEEcCCCChhhEEEcCCCcEEEccCcccccc
Confidence            999999999999999887643  58999999999999999999994 235999999999999999999999999999754


Q ss_pred             CCCCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHH-Hhhhcccc---
Q 046893          250 PMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWAR-PLLNNNKK---  325 (464)
Q Consensus       250 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~-~~~~~~~~---  325 (464)
                      ...    ......||..|+|||++.+..++.++|||||||++|||++|+.||.......   +..... +.......   
T Consensus       155 ~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~  227 (331)
T cd06649         155 IDS----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKE---LEAIFGRPVVDGEEGEPH  227 (331)
T ss_pred             ccc----ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHhcccccccccCCcc
Confidence            321    2234679999999999999999999999999999999999999996543211   111000 00000000   


Q ss_pred             -------------------------hhhcc----CccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 046893          326 -------------------------VLRIL----DPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVAL  370 (464)
Q Consensus       326 -------------------------~~~~~----~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  370 (464)
                                               ....+    ............+.++.+||.+||..||++||++.++++.
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h  301 (331)
T cd06649         228 SISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNH  301 (331)
T ss_pred             ccCcccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence                                     00000    0000000011245579999999999999999999999864

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=5.9e-43  Score=337.66  Aligned_cols=267  Identities=23%  Similarity=0.295  Sum_probs=201.3

Q ss_pred             cCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCC--ccHHHHHHHHHHHhcCCCCCcceEEEEEEeCCe
Q 046893           92 KFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGY--QGDREWLAEVNYLGQLRHSNLVKLIGYCCEDEH  169 (464)
Q Consensus        92 ~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~  169 (464)
                      ++|.+.+.||+|+||+||+|++..+      +..||+|++.....  .....+.+|+.+++.++||||+++++++..++.
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~------~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   74 (287)
T cd07848           1 NKFEVLGVVGEGAYGVVLKCRHKET------KEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGK   74 (287)
T ss_pred             CCceEEEEecccCCEEEEEEEECCC------CcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCE
Confidence            3688999999999999999998765      66799999875432  223567899999999999999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCccCC
Q 046893          170 RILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDG  249 (464)
Q Consensus       170 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~  249 (464)
                      .++||||+.++.|..+ ... ...+++..+..++.|++.||.|||  ..+|+||||||+||+++.++.+||+|||+++..
T Consensus        75 ~~lv~e~~~~~~l~~~-~~~-~~~~~~~~~~~~~~qi~~~L~~lH--~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~  150 (287)
T cd07848          75 LYLVFEYVEKNMLELL-EEM-PNGVPPEKVRSYIYQLIKAIHWCH--KNDIVHRDIKPENLLISHNDVLKLCDFGFARNL  150 (287)
T ss_pred             EEEEEecCCCCHHHHH-Hhc-CCCCCHHHHHHHHHHHHHHHHHHH--HCCeecCCCCHHHEEEcCCCcEEEeeccCcccc
Confidence            9999999988766544 332 346899999999999999999999  677999999999999999999999999999864


Q ss_pred             CCCCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHH--------Hhhh
Q 046893          250 PMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWAR--------PLLN  321 (464)
Q Consensus       250 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~--------~~~~  321 (464)
                      ...... ......||..|+|||++.+..++.++|||||||++|||++|+.||................        ..+.
T Consensus       151 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (287)
T cd07848         151 SEGSNA-NYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFY  229 (287)
T ss_pred             cccccc-cccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhh
Confidence            332211 2233579999999999999899999999999999999999999997644322111111000        0000


Q ss_pred             cccchhhccCccc------cCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 046893          322 NNKKVLRILDPRL------EGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVA  369 (464)
Q Consensus       322 ~~~~~~~~~~~~~------~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  369 (464)
                      ..........+..      ...+....+..+.+|+.+||+.||.+|||++++++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~  283 (287)
T cd07848         230 SNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN  283 (287)
T ss_pred             ccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            0000000000100      01111224567999999999999999999998874

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=9.1e-43  Score=343.08  Aligned_cols=242  Identities=26%  Similarity=0.372  Sum_probs=196.0

Q ss_pred             CceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCC---ccHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeEEEEE
Q 046893           98 YILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGY---QGDREWLAEVNYLGQLRHSNLVKLIGYCCEDEHRILVY  174 (464)
Q Consensus        98 ~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~  174 (464)
                      +.||+|+||.||++.+..+      +..||+|++.....   .....+.+|+++++.++||||+++++++...+..+|||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~------~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   74 (328)
T cd05593           1 KLLGKGTFGKVILVREKAS------GKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVM   74 (328)
T ss_pred             CeeeeCCCEEEEEEEECCC------CCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEE
Confidence            3599999999999998765      66799999875422   22356788999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCccCCCCCCC
Q 046893          175 EYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQ  254 (464)
Q Consensus       175 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~  254 (464)
                      ||+++|+|.+++...  ..+++..+..++.||+.||.|||  .++|+||||||+|||++.++.+||+|||+++.....  
T Consensus        75 Ey~~~g~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH--~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~--  148 (328)
T cd05593          75 EYVNGGELFFHLSRE--RVFSEDRTRFYGAEIVSALDYLH--SGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITD--  148 (328)
T ss_pred             eCCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH--hCCeEecccCHHHeEECCCCcEEEecCcCCccCCCc--
Confidence            999999998888654  36899999999999999999999  677999999999999999999999999998753221  


Q ss_pred             cceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhcccchhhccCccc
Q 046893          255 THVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRILDPRL  334 (464)
Q Consensus       255 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  334 (464)
                      .......+||+.|+|||++.+..++.++|||||||+||+|++|+.||......      +........        +.  
T Consensus       149 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~------~~~~~~~~~--------~~--  212 (328)
T cd05593         149 AATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE------KLFELILME--------DI--  212 (328)
T ss_pred             ccccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHH------HHHHHhccC--------Cc--
Confidence            11223467999999999999999999999999999999999999999754321      111111111        01  


Q ss_pred             cCccCHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHH
Q 046893          335 EGQYTARTAMKVAGLAYQCLSQNPKGRP-----VMSDVVA  369 (464)
Q Consensus       335 ~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~ev~~  369 (464)
                        .++...+..+.+|+.+||..||.+|+     ++.++++
T Consensus       213 --~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~  250 (328)
T cd05593         213 --KFPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMR  250 (328)
T ss_pred             --cCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhc
Confidence              12223455788999999999999997     7777764

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=7.9e-43  Score=360.08  Aligned_cols=252  Identities=21%  Similarity=0.266  Sum_probs=203.2

Q ss_pred             CCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCccHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeEEEE
Q 046893           94 FRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVKLIGYCCEDEHRILV  173 (464)
Q Consensus        94 ~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv  173 (464)
                      |.+.+.||+|+||.||+|....+     .+..||+|.+..........+..|+.+|+.++||||+++++++...+..|||
T Consensus        69 y~~~~~lg~G~~g~vy~a~~~~~-----~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv  143 (478)
T PTZ00267         69 YVLTTLVGRNPTTAAFVATRGSD-----PKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLI  143 (478)
T ss_pred             EEEEEEEEeCCCcEEEEEEEcCC-----CCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEE
Confidence            88889999999999999987653     1456888877554444445678899999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHHhh--cCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCccCCCC
Q 046893          174 YEYMESGSLEKHLLRR--VGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPM  251 (464)
Q Consensus       174 ~e~~~~g~L~~~l~~~--~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~  251 (464)
                      |||+++|+|.+++...  ....+++..+..++.|++.||.|||  .++|+||||||+||||+.++.+||+|||+++....
T Consensus       144 ~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH--~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~  221 (478)
T PTZ00267        144 MEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVH--SRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSD  221 (478)
T ss_pred             EECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH--hCCEEECCcCHHhEEECCCCcEEEEeCcCceecCC
Confidence            9999999999887643  2346889999999999999999999  67799999999999999999999999999986543


Q ss_pred             CCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhcccchhhccC
Q 046893          252 GDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRILD  331 (464)
Q Consensus       252 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  331 (464)
                      ..........+||+.|+|||++.+..++.++|||||||++|||++|+.||.....      .+..........       
T Consensus       222 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~------~~~~~~~~~~~~-------  288 (478)
T PTZ00267        222 SVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQ------REIMQQVLYGKY-------  288 (478)
T ss_pred             ccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHHhCCC-------
Confidence            3222234457899999999999999999999999999999999999999975431      111111111100       


Q ss_pred             ccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 046893          332 PRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVA  369 (464)
Q Consensus       332 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  369 (464)
                          ...+..++..+.+||.+||..||.+||++.+++.
T Consensus       289 ----~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~  322 (478)
T PTZ00267        289 ----DPFPCPVSSGMKALLDPLLSKNPALRPTTQQLLH  322 (478)
T ss_pred             ----CCCCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence                0112234457899999999999999999999864

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=8.6e-43  Score=334.87  Aligned_cols=264  Identities=24%  Similarity=0.397  Sum_probs=206.5

Q ss_pred             HHhcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCC-ccHHHHHHHHHHHhcCCCCCcceEEEEEEeC
Q 046893           89 LATKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGY-QGDREWLAEVNYLGQLRHSNLVKLIGYCCED  167 (464)
Q Consensus        89 ~~~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~  167 (464)
                      +..++|++.+.||+|+||.||+|.+..... ...+..||+|++..... ....++.+|+.+++.++||||+++++++...
T Consensus         3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~-~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~   81 (277)
T cd05062           3 VAREKITMSRELGQGSFGMVYEGIAKGVVK-DEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQG   81 (277)
T ss_pred             ccHHHceeeeeeccccCCeEEEEEeccCCC-CCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC
Confidence            456779999999999999999998754322 22356799999864332 2335688999999999999999999999999


Q ss_pred             CeEEEEEeccCCCCHHHHHHhhcC--------CCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceE
Q 046893          168 EHRILVYEYMESGSLEKHLLRRVG--------CMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAK  239 (464)
Q Consensus       168 ~~~~lv~e~~~~g~L~~~l~~~~~--------~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vk  239 (464)
                      ...++||||+.+++|.+++.....        ..+++..++.++.|++.||.|||  +.+++||||||+|||++.++.++
T Consensus        82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH--~~~~vH~dlkp~Nil~~~~~~~~  159 (277)
T cd05062          82 QPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLN--ANKFVHRDLAARNCMVAEDFTVK  159 (277)
T ss_pred             CCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHH--HCCcccCCcchheEEEcCCCCEE
Confidence            999999999999999999865321        23578889999999999999999  57799999999999999999999


Q ss_pred             EcccCCccCCCCCCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHH
Q 046893          240 LSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLL-GRRAVDKSRPSREHNLVEWARP  318 (464)
Q Consensus       240 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~  318 (464)
                      |+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..||......      +....
T Consensus       160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~------~~~~~  233 (277)
T cd05062         160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNE------QVLRF  233 (277)
T ss_pred             ECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH------HHHHH
Confidence            999999975433322222222456788999999998899999999999999999999 78888654321      11111


Q ss_pred             hhhcccchhhccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 046893          319 LLNNNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLE  372 (464)
Q Consensus       319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~  372 (464)
                      .... . .         ...+..++..+.+++.+||+.||.+||++.++++.|+
T Consensus       234 ~~~~-~-~---------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~  276 (277)
T cd05062         234 VMEG-G-L---------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK  276 (277)
T ss_pred             HHcC-C-c---------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence            1110 0 0         0112234558999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=9.8e-43  Score=331.89  Aligned_cols=257  Identities=25%  Similarity=0.352  Sum_probs=208.3

Q ss_pred             hcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCccHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeE
Q 046893           91 TKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVKLIGYCCEDEHR  170 (464)
Q Consensus        91 ~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~  170 (464)
                      ...|.+.+.||+|+||.||+|.+...      ++.||+|.+... ......+.+|+++++.++||||+++++++..++..
T Consensus         5 ~~~~~~~~~ig~g~~~~v~~~~~~~~------~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   77 (263)
T cd05052           5 RTDITMKHKLGGGQYGEVYEGVWKKY------SLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPF   77 (263)
T ss_pred             hHHeEEeeecCCcccceEEEEEEecC------CceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCc
Confidence            34577888999999999999998764      567999998654 23356789999999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCccCCC
Q 046893          171 ILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGP  250 (464)
Q Consensus       171 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~  250 (464)
                      ++||||+++++|.+++.......+++..++.++.|++.||.|||  .++++||||||+|||++.++.+||+|||++....
T Consensus        78 ~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH--~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~  155 (263)
T cd05052          78 YIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE--KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT  155 (263)
T ss_pred             EEEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH--hCCEeecccCcceEEEcCCCcEEeCCCccccccc
Confidence            99999999999999987655556899999999999999999999  6779999999999999999999999999998643


Q ss_pred             CCCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHhhhcccchhhc
Q 046893          251 MGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLL-GRRAVDKSRPSREHNLVEWARPLLNNNKKVLRI  329 (464)
Q Consensus       251 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  329 (464)
                      ..... ......++..|+|||.+.+..++.++|||||||++|||++ |..||.+...      .++.....         
T Consensus       156 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~------~~~~~~~~---------  219 (263)
T cd05052         156 GDTYT-AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL------SQVYELLE---------  219 (263)
T ss_pred             cceee-ccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH------HHHHHHHH---------
Confidence            32211 1112334668999999999999999999999999999998 8999865431      11111111         


Q ss_pred             cCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHH
Q 046893          330 LDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETV  374 (464)
Q Consensus       330 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~  374 (464)
                        .......+..++..+.+++.+||..||.+||++.++++.|+.+
T Consensus       220 --~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~  262 (263)
T cd05052         220 --KGYRMERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM  262 (263)
T ss_pred             --CCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence              1111122334556899999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=1.1e-42  Score=343.58  Aligned_cols=268  Identities=25%  Similarity=0.365  Sum_probs=207.5

Q ss_pred             HhcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCc-cHHHHHHHHHHHhcC-CCCCcceEEEEEEeC
Q 046893           90 ATKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQ-GDREWLAEVNYLGQL-RHSNLVKLIGYCCED  167 (464)
Q Consensus        90 ~~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~  167 (464)
                      ..++|++.+.||+|+||.||+|.+.... ....++.||+|++...... ....+..|+.++.++ +|+||+++++++...
T Consensus         5 ~~~~~~i~~~lG~G~fg~Vy~a~~~~~~-~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~   83 (337)
T cd05054           5 PRDRLKLGKPLGRGAFGKVIQASAFGIE-KSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKP   83 (337)
T ss_pred             CHHHhhhhcccccCcCceEEeccccccc-cccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecC
Confidence            4467999999999999999999764421 1223577999998754322 235678899999999 899999999987654


Q ss_pred             -CeEEEEEeccCCCCHHHHHHhhcC-------------------------------------------------------
Q 046893          168 -EHRILVYEYMESGSLEKHLLRRVG-------------------------------------------------------  191 (464)
Q Consensus       168 -~~~~lv~e~~~~g~L~~~l~~~~~-------------------------------------------------------  191 (464)
                       ...+++|||+++++|.+++.....                                                       
T Consensus        84 ~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  163 (337)
T cd05054          84 GGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGD  163 (337)
T ss_pred             CCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhh
Confidence             578899999999999998864321                                                       


Q ss_pred             ----CCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCccCCCCCCCcceeeccccCCcc
Q 046893          192 ----CMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGY  267 (464)
Q Consensus       192 ----~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y  267 (464)
                          ..+++..+..++.|++.||.|||  .++|+||||||+|||++.++.+||+|||+++...............++..|
T Consensus       164 ~~~~~~l~~~~~~~~~~qi~~aL~~lH--~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y  241 (337)
T cd05054         164 ELYKEPLTLEDLISYSFQVARGMEFLA--SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKW  241 (337)
T ss_pred             HHhhcCCCHHHHHHHHHHHHHHHHHHH--hCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccc
Confidence                25789999999999999999999  677999999999999999999999999999865333222222334567889


Q ss_pred             cCccccccCCCCcccchhcHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHhhhcccchhhccCccccCccCHHHHHHH
Q 046893          268 AAPEYVMTGHLTARSDVYGFGVVLLEMLL-GRRAVDKSRPSREHNLVEWARPLLNNNKKVLRILDPRLEGQYTARTAMKV  346 (464)
Q Consensus       268 ~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  346 (464)
                      +|||++.+..++.++|||||||+||||++ |..||.+.....      .....+...          .....+...+..+
T Consensus       242 ~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~------~~~~~~~~~----------~~~~~~~~~~~~~  305 (337)
T cd05054         242 MAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDE------EFCRRLKEG----------TRMRAPEYATPEI  305 (337)
T ss_pred             cCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccH------HHHHHHhcc----------CCCCCCccCCHHH
Confidence            99999999999999999999999999998 999997543211      011111111          0011122344578


Q ss_pred             HHHHHHhhccCCCCCCCHHHHHHHHHHHHh
Q 046893          347 AGLAYQCLSQNPKGRPVMSDVVALLETVQS  376 (464)
Q Consensus       347 ~~li~~cl~~dP~~RPs~~ev~~~L~~~~~  376 (464)
                      .+++.+||+.+|++||++.+|++.|+.+..
T Consensus       306 ~~l~~~cl~~~p~~RPs~~ell~~l~~~~~  335 (337)
T cd05054         306 YSIMLDCWHNNPEDRPTFSELVEILGDLLQ  335 (337)
T ss_pred             HHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            999999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=1.3e-42  Score=340.24  Aligned_cols=265  Identities=23%  Similarity=0.350  Sum_probs=207.0

Q ss_pred             hcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCC-ccHHHHHHHHHHHhcCCCCCcceEEEEEEeCCe
Q 046893           91 TKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGY-QGDREWLAEVNYLGQLRHSNLVKLIGYCCEDEH  169 (464)
Q Consensus        91 ~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~  169 (464)
                      ..+|++.+.||+|+||.||+|.+..+..  .....||+|++..... ....++..|+.+++.++||||+++++++... .
T Consensus         6 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~   82 (316)
T cd05108           6 ETEFKKIKVLGSGAFGTVYKGLWIPEGE--KVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-T   82 (316)
T ss_pred             hhhceeeeeeecCCCceEEEEEEecCCC--ccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-C
Confidence            3568999999999999999998754321  1134589999865432 3346788999999999999999999998765 5


Q ss_pred             EEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCccCC
Q 046893          170 RILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDG  249 (464)
Q Consensus       170 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~  249 (464)
                      .++|+||+.+|+|.+++.... ..+++..++.++.|++.||+|||  +++|+||||||+|||++.++.+||+|||+++..
T Consensus        83 ~~~v~e~~~~g~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~LH--~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~  159 (316)
T cd05108          83 VQLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLE--ERRLVHRDLAARNVLVKTPQHVKITDFGLAKLL  159 (316)
T ss_pred             ceeeeecCCCCCHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHHH--hcCeeccccchhheEecCCCcEEEccccccccc
Confidence            679999999999999987653 35889999999999999999999  677999999999999999999999999999865


Q ss_pred             CCCCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHhhhcccchhh
Q 046893          250 PMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLL-GRRAVDKSRPSREHNLVEWARPLLNNNKKVLR  328 (464)
Q Consensus       250 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  328 (464)
                      .............++..|+|||++.+..++.++|||||||++|||++ |..||.+.....   +..    .+...     
T Consensus       160 ~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~---~~~----~~~~~-----  227 (316)
T cd05108         160 GADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE---ISS----ILEKG-----  227 (316)
T ss_pred             cCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHH---HHH----HHhCC-----
Confidence            43332222222345678999999999999999999999999999997 999997643211   111    11111     


Q ss_pred             ccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhcC
Q 046893          329 ILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETVQSQG  378 (464)
Q Consensus       329 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~~~~~  378 (464)
                           .....+..++..+..++.+||..+|.+||++.+++..|..+....
T Consensus       228 -----~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~~  272 (316)
T cd05108         228 -----ERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP  272 (316)
T ss_pred             -----CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcCC
Confidence                 011112234457899999999999999999999999998776543

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=2.9e-42  Score=343.05  Aligned_cols=248  Identities=23%  Similarity=0.327  Sum_probs=192.0

Q ss_pred             cCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCc-cHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeE
Q 046893           92 KFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQ-GDREWLAEVNYLGQLRHSNLVKLIGYCCEDEHR  170 (464)
Q Consensus        92 ~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~  170 (464)
                      ..|...+.||+|+||.||+|.+..+      ++.||||++...... ....+.+|+.+++.++|+||+++++++...+..
T Consensus        74 ~~~~~~~~lg~G~~g~V~~~~~~~~------~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  147 (353)
T PLN00034         74 SELERVNRIGSGAGGTVYKVIHRPT------GRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEI  147 (353)
T ss_pred             HHHhhhhhccCCCCeEEEEEEECCC------CCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeE
Confidence            3456678899999999999998764      567999998654322 235688999999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCccCCC
Q 046893          171 ILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGP  250 (464)
Q Consensus       171 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~  250 (464)
                      ++||||+++++|.+..      .+.+..+..++.||+.||.|||  +.+|+||||||+||||+.++.+||+|||+++...
T Consensus       148 ~lv~e~~~~~~L~~~~------~~~~~~~~~i~~qi~~aL~~LH--~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~  219 (353)
T PLN00034        148 QVLLEFMDGGSLEGTH------IADEQFLADVARQILSGIAYLH--RRHIVHRDIKPSNLLINSAKNVKIADFGVSRILA  219 (353)
T ss_pred             EEEEecCCCCcccccc------cCCHHHHHHHHHHHHHHHHHHH--HCCEeecCCCHHHEEEcCCCCEEEcccccceecc
Confidence            9999999999986431      3567788899999999999999  6779999999999999999999999999998643


Q ss_pred             CCCCcceeeccccCCcccCcccccc-----CCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhcccc
Q 046893          251 MGDQTHVSTRVMGTYGYAAPEYVMT-----GHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKK  325 (464)
Q Consensus       251 ~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  325 (464)
                      ...  .......||..|+|||++..     ...+.++|||||||+||||++|+.||.......   ..........    
T Consensus       220 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~---~~~~~~~~~~----  290 (353)
T PLN00034        220 QTM--DPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGD---WASLMCAICM----  290 (353)
T ss_pred             ccc--ccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcc---HHHHHHHHhc----
Confidence            221  11233579999999998743     334568999999999999999999997432211   1111000000    


Q ss_pred             hhhccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 046893          326 VLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVA  369 (464)
Q Consensus       326 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  369 (464)
                             .........++..+.+||.+||..||.+||++.++++
T Consensus       291 -------~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~  327 (353)
T PLN00034        291 -------SQPPEAPATASREFRHFISCCLQREPAKRWSAMQLLQ  327 (353)
T ss_pred             -------cCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence                   0001112234558999999999999999999999875

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=1.9e-42  Score=340.08  Aligned_cols=242  Identities=27%  Similarity=0.369  Sum_probs=195.0

Q ss_pred             CceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCC---ccHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeEEEEE
Q 046893           98 YILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGY---QGDREWLAEVNYLGQLRHSNLVKLIGYCCEDEHRILVY  174 (464)
Q Consensus        98 ~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~  174 (464)
                      +.||+|+||.||++.+..+      +..||+|++.....   .....+..|+++++.++||||++++++|...+..+|||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~------~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~   74 (323)
T cd05595           1 KLLGKGTFGKVILVREKAT------GRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM   74 (323)
T ss_pred             CeeeeCCCEEEEEEEECCC------CCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEE
Confidence            3699999999999998764      66799999875322   22345678999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCccCCCCCCC
Q 046893          175 EYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQ  254 (464)
Q Consensus       175 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~  254 (464)
                      ||+.+|+|..++....  .+++..+..++.||+.||.|||  .++|+||||||+|||++.++.+||+|||+++...... 
T Consensus        75 E~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH--~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~-  149 (323)
T cd05595          75 EYANGGELFFHLSRER--VFTEERARFYGAEIVSALEYLH--SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG-  149 (323)
T ss_pred             eCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH--HCCeEecCCCHHHEEEcCCCCEEecccHHhccccCCC-
Confidence            9999999988876543  6899999999999999999999  6779999999999999999999999999987532211 


Q ss_pred             cceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhcccchhhccCccc
Q 046893          255 THVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRILDPRL  334 (464)
Q Consensus       255 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  334 (464)
                       .......||+.|+|||++.+..++.++|||||||++|||++|+.||......      ..........        .  
T Consensus       150 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~------~~~~~~~~~~--------~--  212 (323)
T cd05595         150 -ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE------RLFELILMEE--------I--  212 (323)
T ss_pred             -CccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHH------HHHHHHhcCC--------C--
Confidence             1223467999999999999999999999999999999999999999754321      1111111111        0  


Q ss_pred             cCccCHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHH
Q 046893          335 EGQYTARTAMKVAGLAYQCLSQNPKGRP-----VMSDVVA  369 (464)
Q Consensus       335 ~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~ev~~  369 (464)
                        .++...+..+.+|+.+||..||.+||     ++.++++
T Consensus       213 --~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~  250 (323)
T cd05595         213 --RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME  250 (323)
T ss_pred             --CCCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence              12223455889999999999999998     6777664

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=3.4e-42  Score=328.63  Aligned_cols=261  Identities=26%  Similarity=0.434  Sum_probs=207.7

Q ss_pred             hcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCc-cHHHHHHHHHHHhcCCCCCcceEEEEEEeCCe
Q 046893           91 TKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQ-GDREWLAEVNYLGQLRHSNLVKLIGYCCEDEH  169 (464)
Q Consensus        91 ~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~  169 (464)
                      .++|++.+.||+|+||+||+|.+.....   ....||||.+...... ....|..|+.++..++||||+++++++...+.
T Consensus         3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~---~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   79 (266)
T cd05033           3 PSYVTIEKVIGGGEFGEVCRGRLKLPGK---KEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRP   79 (266)
T ss_pred             hHHceeeeEecCCccceEEEEEEccCCC---CcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCc
Confidence            3568899999999999999999865311   2456999998754332 23578899999999999999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCccCC
Q 046893          170 RILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDG  249 (464)
Q Consensus       170 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~  249 (464)
                      .++||||+.+++|.+++.... ..+++..++.++.|++.||.|||  +++|+|+||||+|||++.++.++|+|||+++..
T Consensus        80 ~~iv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~Lh--~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~  156 (266)
T cd05033          80 VMIITEYMENGSLDKFLREND-GKFTVGQLVGMLRGIASGMKYLS--EMNYVHRDLAARNILVNSNLVCKVSDFGLSRRL  156 (266)
T ss_pred             eEEEEEcCCCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHH--hCCcccCCCCcceEEEcCCCCEEECccchhhcc
Confidence            999999999999999987653 36899999999999999999999  677999999999999999999999999999875


Q ss_pred             CCCCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHhhhcccchhh
Q 046893          250 PMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLL-GRRAVDKSRPSREHNLVEWARPLLNNNKKVLR  328 (464)
Q Consensus       250 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  328 (464)
                      .............++..|+|||.+.+..++.++||||||+++|+|++ |..||......   .+...   .. ..     
T Consensus       157 ~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~---~~~~~---~~-~~-----  224 (266)
T cd05033         157 EDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQ---DVIKA---VE-DG-----  224 (266)
T ss_pred             cccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHH---HHHHH---HH-cC-----
Confidence            42222222222345678999999998899999999999999999998 99998653311   11111   10 00     


Q ss_pred             ccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHH
Q 046893          329 ILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETV  374 (464)
Q Consensus       329 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~  374 (464)
                           .....+..++..+.+|+.+||+.+|.+||++.+|++.|+.+
T Consensus       225 -----~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~  265 (266)
T cd05033         225 -----YRLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM  265 (266)
T ss_pred             -----CCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence                 00011223456889999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=4.2e-43  Score=333.91  Aligned_cols=254  Identities=32%  Similarity=0.507  Sum_probs=197.4

Q ss_pred             CCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCc-cHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeEEEEEe
Q 046893           97 DYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQ-GDREWLAEVNYLGQLRHSNLVKLIGYCCEDEHRILVYE  175 (464)
Q Consensus        97 ~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e  175 (464)
                      .+.||.|.||.||+|.+..  .....+..|+||.++..... ....|.+|++++.+++||||+++++++...+..++|||
T Consensus         4 ~~~ig~G~fg~v~~~~~~~--~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e   81 (259)
T PF07714_consen    4 IKQIGEGSFGKVYRAEWKQ--KDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVME   81 (259)
T ss_dssp             EEEEEEESSEEEEEEEEES--TTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE
T ss_pred             eeEEccCCCcEEEEEEEEc--ccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccccccccc
Confidence            4679999999999999883  12234778999999654332 35789999999999999999999999998888999999


Q ss_pred             ccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCccCCCCCCCc
Q 046893          176 YMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQT  255 (464)
Q Consensus       176 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~~  255 (464)
                      |+.+|+|.++|.......+++..++.|+.|++.||.|||  +++++|+||+++|||++.++.+||+|||++.........
T Consensus        82 ~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh--~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~  159 (259)
T PF07714_consen   82 YCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLH--SNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKY  159 (259)
T ss_dssp             --TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHH--HTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSE
T ss_pred             ccccccccccccccccccccccccccccccccccccccc--ccccccccccccccccccccccccccccccccccccccc
Confidence            999999999998874567999999999999999999999  567999999999999999999999999999875333333


Q ss_pred             ceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHhhhcccchhhccCccc
Q 046893          256 HVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLL-GRRAVDKSRPSREHNLVEWARPLLNNNKKVLRILDPRL  334 (464)
Q Consensus       256 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  334 (464)
                      .......+...|+|||.+.+..++.++||||||+++|||++ |+.||.....      .++...+ ...          .
T Consensus       160 ~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~------~~~~~~~-~~~----------~  222 (259)
T PF07714_consen  160 KNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDN------EEIIEKL-KQG----------Q  222 (259)
T ss_dssp             EESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCH------HHHHHHH-HTT----------E
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccc------ccccccc-ccc----------c
Confidence            33333557788999999999899999999999999999999 7788765421      1111111 111          1


Q ss_pred             cCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 046893          335 EGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALL  371 (464)
Q Consensus       335 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L  371 (464)
                      ....+..++..+.+++..||..||.+||++.++++.|
T Consensus       223 ~~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L  259 (259)
T PF07714_consen  223 RLPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL  259 (259)
T ss_dssp             ETTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred             cceeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence            1122333456899999999999999999999999876

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=2.4e-42  Score=333.88  Aligned_cols=266  Identities=25%  Similarity=0.369  Sum_probs=200.1

Q ss_pred             cCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCC-ccHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeE
Q 046893           92 KFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGY-QGDREWLAEVNYLGQLRHSNLVKLIGYCCEDEHR  170 (464)
Q Consensus        92 ~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~  170 (464)
                      .+|++.+.||.|+||+||+|.+..+      +..||+|++..... .....+.+|+.+++.++||||+++++++..++..
T Consensus         5 ~~y~~~~~lg~G~~g~Vy~~~~~~~------~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~   78 (288)
T cd07871           5 ETYVKLDKLGEGTYATVFKGRSKLT------ENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCL   78 (288)
T ss_pred             ccceEeeEEecCCCEEEEEEEECCC------CCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeE
Confidence            4588899999999999999988764      56799999865432 2235678999999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCccCCC
Q 046893          171 ILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGP  250 (464)
Q Consensus       171 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~  250 (464)
                      ++||||+.+ +|.+++... +..+++..+..++.|++.||.|||  .++|+||||||+|||++.++.+||+|||+++...
T Consensus        79 ~lv~e~~~~-~l~~~l~~~-~~~~~~~~~~~~~~qi~~aL~~LH--~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~  154 (288)
T cd07871          79 TLVFEYLDS-DLKQYLDNC-GNLMSMHNVKIFMFQLLRGLSYCH--KRKILHRDLKPQNLLINEKGELKLADFGLARAKS  154 (288)
T ss_pred             EEEEeCCCc-CHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHH--hCCcccCCCCHHHEEECCCCCEEECcCcceeecc
Confidence            999999975 898887654 345789999999999999999999  6779999999999999999999999999997543


Q ss_pred             CCCCcceeeccccCCcccCcccccc-CCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHH--------HHhhh
Q 046893          251 MGDQTHVSTRVMGTYGYAAPEYVMT-GHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWA--------RPLLN  321 (464)
Q Consensus       251 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~--------~~~~~  321 (464)
                      ...  .......|+..|+|||++.+ ..++.++|||||||++|+|++|+.||...............        ++.+.
T Consensus       155 ~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (288)
T cd07871         155 VPT--KTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGIT  232 (288)
T ss_pred             CCC--ccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccc
Confidence            222  12233578999999998875 56899999999999999999999999765432211111000        00000


Q ss_pred             cccchhhccCccccC----ccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 046893          322 NNKKVLRILDPRLEG----QYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVA  369 (464)
Q Consensus       322 ~~~~~~~~~~~~~~~----~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  369 (464)
                      ........+.+....    ......+.++.+|+.+||..||.+|||++++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~  284 (288)
T cd07871         233 SNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR  284 (288)
T ss_pred             cchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence            011111111111100    001123457889999999999999999999874

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=2.8e-42  Score=333.34  Aligned_cols=267  Identities=27%  Similarity=0.440  Sum_probs=210.8

Q ss_pred             hcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCccHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeE
Q 046893           91 TKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVKLIGYCCEDEHR  170 (464)
Q Consensus        91 ~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~  170 (464)
                      .++|.+.+.||+|+||.||++.+.... .......+|+|.+..........+.+|+.++..++||||+++++++...+..
T Consensus         4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~-~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   82 (288)
T cd05093           4 RHNIVLKRELGEGAFGKVFLAECYNLC-PEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPL   82 (288)
T ss_pred             hHHeeeccccCCcCCeeEEeeEeccCC-CCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCcc
Confidence            456889999999999999999864321 1123556899998765444456789999999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHhhc-----------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceE
Q 046893          171 ILVYEYMESGSLEKHLLRRV-----------GCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAK  239 (464)
Q Consensus       171 ~lv~e~~~~g~L~~~l~~~~-----------~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vk  239 (464)
                      ++||||+.+++|.+++....           ...+++..++.++.|++.||+|||  .++++||||||+|||++.++.+|
T Consensus        83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH--~~~i~H~dlkp~Nili~~~~~~k  160 (288)
T cd05093          83 IMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLA--SQHFVHRDLATRNCLVGENLLVK  160 (288)
T ss_pred             EEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHH--hCCeeecccCcceEEEccCCcEE
Confidence            99999999999999986542           124899999999999999999999  67799999999999999999999


Q ss_pred             EcccCCccCCCCCCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHH
Q 046893          240 LSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLL-GRRAVDKSRPSREHNLVEWARP  318 (464)
Q Consensus       240 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~  318 (464)
                      |+|||+++...............++..|+|||++.+..++.++|||||||++|+|++ |..||.......   ...   .
T Consensus       161 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~---~~~---~  234 (288)
T cd05093         161 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE---VIE---C  234 (288)
T ss_pred             eccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH---HHH---H
Confidence            999999986433222222233456788999999998899999999999999999998 899987544211   111   1


Q ss_pred             hhhcccchhhccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhc
Q 046893          319 LLNNNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETVQSQ  377 (464)
Q Consensus       319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~~~~  377 (464)
                      .... .      ..    ..+..++..+.+|+.+||+.||.+||++.++++.|+.+...
T Consensus       235 i~~~-~------~~----~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~  282 (288)
T cd05093         235 ITQG-R------VL----QRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA  282 (288)
T ss_pred             HHcC-C------cC----CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHh
Confidence            1110 0      00    11112345799999999999999999999999999988653

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=2.8e-42  Score=333.86  Aligned_cols=266  Identities=26%  Similarity=0.418  Sum_probs=211.4

Q ss_pred             cCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCccHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeEE
Q 046893           92 KFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVKLIGYCCEDEHRI  171 (464)
Q Consensus        92 ~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~  171 (464)
                      .+|.+.+.||+|+||.||+|.+..... ......+++|.+..........+.+|+.+++.++||||+++++++......+
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~-~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   83 (291)
T cd05094           5 RDIVLKRELGEGAFGKVFLAECYNLSP-TKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLI   83 (291)
T ss_pred             HHeEEeeeecccCCCeEEEeEeeccCC-CCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceE
Confidence            457788899999999999998644211 1234568999987654444567889999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHhhc--------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCc
Q 046893          172 LVYEYMESGSLEKHLLRRV--------------GCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFS  237 (464)
Q Consensus       172 lv~e~~~~g~L~~~l~~~~--------------~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~  237 (464)
                      +||||+++++|.+++....              ...+++..++.++.|++.||.|||  .++|+||||||+|||++.++.
T Consensus        84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH--~~~i~H~dlkp~Nil~~~~~~  161 (291)
T cd05094          84 MVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLA--SQHFVHRDLATRNCLVGANLL  161 (291)
T ss_pred             EEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHH--hCCeeecccCcceEEEccCCc
Confidence            9999999999999986542              134889999999999999999999  677999999999999999999


Q ss_pred             eEEcccCCccCCCCCCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHh-CCCCCCCCCCcccccHHHHH
Q 046893          238 AKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLL-GRRAVDKSRPSREHNLVEWA  316 (464)
Q Consensus       238 vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~  316 (464)
                      ++|+|||++................|+..|+|||++.+..++.++|||||||++|||++ |..||.......   ..+. 
T Consensus       162 ~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~---~~~~-  237 (291)
T cd05094         162 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTE---VIEC-  237 (291)
T ss_pred             EEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHH-
Confidence            99999999976433332222333557889999999999999999999999999999998 999987643211   1111 


Q ss_pred             HHhhhcccchhhccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhc
Q 046893          317 RPLLNNNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETVQSQ  377 (464)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~~~~  377 (464)
                         +..          ......+..++..+.+|+.+||+.||.+||++.+|++.|+.+...
T Consensus       238 ---~~~----------~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~  285 (291)
T cd05094         238 ---ITQ----------GRVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKA  285 (291)
T ss_pred             ---HhC----------CCCCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhh
Confidence               000          000011223456899999999999999999999999999988653

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=1.9e-42  Score=332.69  Aligned_cols=262  Identities=29%  Similarity=0.451  Sum_probs=207.7

Q ss_pred             hcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCc-cHHHHHHHHHHHhcCCCCCcceEEEEEEeCCe
Q 046893           91 TKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQ-GDREWLAEVNYLGQLRHSNLVKLIGYCCEDEH  169 (464)
Q Consensus        91 ~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~  169 (464)
                      .+.|.+.+.||+|+||.||+|.+.... .......||+|.+...... ....+.+|+++|..+.|+||+++++++.....
T Consensus         4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~-~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   82 (280)
T cd05049           4 RDTIVLKRELGEGAFGKVFLGECYHLE-PENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDP   82 (280)
T ss_pred             hHHhhHHhhccccCCceEeeeeecccc-CcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCC
Confidence            345788889999999999999875431 1123567999998765433 34678999999999999999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHhhc------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCc
Q 046893          170 RILVYEYMESGSLEKHLLRRV------------GCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFS  237 (464)
Q Consensus       170 ~~lv~e~~~~g~L~~~l~~~~------------~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~  237 (464)
                      .++||||+++++|.+++....            ...+++..+..++.|++.||.|||  .++++||||||+|||++.++.
T Consensus        83 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH--~~~i~h~dlkp~nili~~~~~  160 (280)
T cd05049          83 PIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLA--SQHFVHRDLATRNCLVGYDLV  160 (280)
T ss_pred             eEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHh--hCCeeccccccceEEEcCCCe
Confidence            999999999999999987542            135788999999999999999999  677999999999999999999


Q ss_pred             eEEcccCCccCCCCCCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHh-CCCCCCCCCCcccccHHHHH
Q 046893          238 AKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLL-GRRAVDKSRPSREHNLVEWA  316 (464)
Q Consensus       238 vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~  316 (464)
                      +||+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..||.......   .....
T Consensus       161 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~---~~~~~  237 (280)
T cd05049         161 VKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEE---VIECI  237 (280)
T ss_pred             EEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHH---HHHHH
Confidence            99999999975433222222233456788999999999999999999999999999998 999987543211   11111


Q ss_pred             HHhhhcccchhhccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 046893          317 RPLLNNNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLE  372 (464)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~  372 (464)
                         . ..          .....+...+..+.+|+.+||..||.+||++.+|++.|+
T Consensus       238 ---~-~~----------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~  279 (280)
T cd05049         238 ---T-QG----------RLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ  279 (280)
T ss_pred             ---H-cC----------CcCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence               1 00          001112234568999999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.2e-42  Score=329.05  Aligned_cols=258  Identities=26%  Similarity=0.426  Sum_probs=207.1

Q ss_pred             HHhcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCccHHHHHHHHHHHhcCCCCCcceEEEEEEeCC
Q 046893           89 LATKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVKLIGYCCEDE  168 (464)
Q Consensus        89 ~~~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~  168 (464)
                      +..+.|++.+.||+|+||.||+|.+..       ++.||+|.+.... ....++.+|+.+++.++||||+++++++...+
T Consensus         3 ~~~~~~~~~~~lg~g~~~~v~~~~~~~-------~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   74 (261)
T cd05068           3 IDRTSIQLLRKLGAGQFGEVWEGLWNN-------TTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEE   74 (261)
T ss_pred             cchhheeeEEEecccCCccEEEEEecC-------CeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCC
Confidence            345678999999999999999998654       3458999986543 34567899999999999999999999999999


Q ss_pred             eEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCccC
Q 046893          169 HRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKD  248 (464)
Q Consensus       169 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~  248 (464)
                      ..++||||+.+++|.+++....+..+++..+..++.|++.||.|||  +.+|+||||||+||+++.++.+||+|||+++.
T Consensus        75 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH--~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~  152 (261)
T cd05068          75 PIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLE--AQNYIHRDLAARNVLVGENNICKVADFGLARV  152 (261)
T ss_pred             CeeeeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHH--hCCeeeccCCcceEEEcCCCCEEECCcceEEE
Confidence            9999999999999999987765567899999999999999999999  67799999999999999999999999999986


Q ss_pred             CCCCCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHhhhcccchh
Q 046893          249 GPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLL-GRRAVDKSRPSREHNLVEWARPLLNNNKKVL  327 (464)
Q Consensus       249 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  327 (464)
                      ....... ......++..|+|||++.+..++.++||||||+++|||++ |+.||.+.....   +..    .+...    
T Consensus       153 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---~~~----~~~~~----  220 (261)
T cd05068         153 IKEDIYE-AREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAE---VLQ----QVDQG----  220 (261)
T ss_pred             ccCCccc-ccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHH---HHH----HHHcC----
Confidence            5422111 1111223457999999998899999999999999999999 999997543211   111    11110    


Q ss_pred             hccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHH
Q 046893          328 RILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETV  374 (464)
Q Consensus       328 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~  374 (464)
                            .....+..++..+.+++.+||+.+|.+||++.+++..|+.+
T Consensus       221 ------~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~~  261 (261)
T cd05068         221 ------YRMPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLEDF  261 (261)
T ss_pred             ------CCCCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhcC
Confidence                  00111223456899999999999999999999999999853

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=2.1e-42  Score=334.31  Aligned_cols=264  Identities=23%  Similarity=0.321  Sum_probs=197.0

Q ss_pred             cCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCc--cHHHHHHHHHHHhcC---CCCCcceEEEEEEe
Q 046893           92 KFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQ--GDREWLAEVNYLGQL---RHSNLVKLIGYCCE  166 (464)
Q Consensus        92 ~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l---~hpniv~l~~~~~~  166 (464)
                      ++|++.+.||+|+||+||+|.+...     .+..||+|.+......  ....+.+|+.+++.+   .||||+++++++..
T Consensus         1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~   75 (290)
T cd07862           1 QQYECVAEIGEGAYGKVFKARDLKN-----GGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTV   75 (290)
T ss_pred             CCcceeeEeccCCCeEEEEEEEcCC-----CCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEec
Confidence            3688999999999999999987543     2567999988654322  224566777777665   69999999998853


Q ss_pred             -----CCeEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEc
Q 046893          167 -----DEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLS  241 (464)
Q Consensus       167 -----~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~  241 (464)
                           ....++||||+. ++|.+++.......+++..+..++.|++.||.|||  .++|+||||||+|||++.++.+||+
T Consensus        76 ~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH--~~~iiH~dlkp~Nil~~~~~~~kl~  152 (290)
T cd07862          76 SRTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH--SHRVVHRDLKPQNILVTSSGQIKLA  152 (290)
T ss_pred             ccCCCCCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH--HCCeeeCCCCHHHEEEcCCCCEEEc
Confidence                 456899999995 69999887655556899999999999999999999  6779999999999999999999999


Q ss_pred             ccCCccCCCCCCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhh
Q 046893          242 DFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLN  321 (464)
Q Consensus       242 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~  321 (464)
                      |||+++.....   .......||..|+|||++.+..++.++|||||||++|||++|+.||.+.......   ........
T Consensus       153 Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~---~~i~~~~~  226 (290)
T cd07862         153 DFGLARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQL---GKILDVIG  226 (290)
T ss_pred             cccceEeccCC---cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHH---HHHHHHhC
Confidence            99999864322   2233467999999999999889999999999999999999999999865432111   11100000


Q ss_pred             --cccchh-------hccCccc---cCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 046893          322 --NNKKVL-------RILDPRL---EGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVA  369 (464)
Q Consensus       322 --~~~~~~-------~~~~~~~---~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  369 (464)
                        ......       ..+....   ........+..+.+|+.+||+.||++||++.++++
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~  286 (290)
T cd07862         227 LPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  286 (290)
T ss_pred             CCChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence              000000       0000000   00111224557889999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=1e-42  Score=344.19  Aligned_cols=246  Identities=23%  Similarity=0.278  Sum_probs=199.2

Q ss_pred             cCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCC---ccHHHHHHHHHHHhcCCCCCcceEEEEEEeCC
Q 046893           92 KFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGY---QGDREWLAEVNYLGQLRHSNLVKLIGYCCEDE  168 (464)
Q Consensus        92 ~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~  168 (464)
                      ++|.+.+.||+|+||.||+|.+...     ....||+|++.....   .....+.+|+.++..++||||+++++++.+.+
T Consensus        30 ~~y~~~~~ig~G~~g~Vy~a~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~  104 (340)
T PTZ00426         30 EDFNFIRTLGTGSFGRVILATYKNE-----DFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDES  104 (340)
T ss_pred             hhcEEEEEEeecCCeEEEEEEEECC-----CCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCC
Confidence            4588889999999999999987653     135799998864321   22356788999999999999999999999999


Q ss_pred             eEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCccC
Q 046893          169 HRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKD  248 (464)
Q Consensus       169 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~  248 (464)
                      ..++||||+.+|+|.+++....  .+++..+..++.|++.||.|||  .++|+||||||+|||++.++.+||+|||+++.
T Consensus       105 ~~~lv~Ey~~~g~L~~~i~~~~--~~~~~~~~~~~~qi~~aL~~LH--~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~  180 (340)
T PTZ00426        105 YLYLVLEFVIGGEFFTFLRRNK--RFPNDVGCFYAAQIVLIFEYLQ--SLNIVYRDLKPENLLLDKDGFIKMTDFGFAKV  180 (340)
T ss_pred             EEEEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH--HCCeEccCCCHHHEEECCCCCEEEecCCCCee
Confidence            9999999999999999987643  6899999999999999999999  67799999999999999999999999999986


Q ss_pred             CCCCCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhcccchhh
Q 046893          249 GPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLR  328 (464)
Q Consensus       249 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  328 (464)
                      ....     .....||+.|+|||++.+..++.++|||||||++|||++|..||....+..      ..........    
T Consensus       181 ~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~------~~~~i~~~~~----  245 (340)
T PTZ00426        181 VDTR-----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLL------IYQKILEGII----  245 (340)
T ss_pred             cCCC-----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHH------HHHHHhcCCC----
Confidence            4221     224679999999999999899999999999999999999999997644211      1111111110    


Q ss_pred             ccCccccCccCHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHH
Q 046893          329 ILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRP-----VMSDVVA  369 (464)
Q Consensus       329 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~ev~~  369 (464)
                              .++...+..+.+++.+||+.||.+|+     +++++++
T Consensus       246 --------~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~  283 (340)
T PTZ00426        246 --------YFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKE  283 (340)
T ss_pred             --------CCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHc
Confidence                    11222345788999999999999995     6777654

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=1.5e-42  Score=329.98  Aligned_cols=257  Identities=24%  Similarity=0.409  Sum_probs=206.8

Q ss_pred             HhcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCccHHHHHHHHHHHhcCCCCCcceEEEEEEeCCe
Q 046893           90 ATKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVKLIGYCCEDEH  169 (464)
Q Consensus        90 ~~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~  169 (464)
                      ..++|++.+.||+|+||.||+|.+..       +..||+|.+.... ...+.+..|+.+++.++|+||+++++++...+.
T Consensus         4 ~~~~~~~~~~lg~g~~g~v~~~~~~~-------~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   75 (261)
T cd05072           4 PRESIKLVKKLGAGQFGEVWMGYYNN-------STKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEP   75 (261)
T ss_pred             chHHeEEeeecCCcCCceEEEEEecC-------CceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence            34668899999999999999998654       3458999876532 235678999999999999999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCccCC
Q 046893          170 RILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDG  249 (464)
Q Consensus       170 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~  249 (464)
                      .++||||+.+++|.+++....+..+++..++.++.|++.||.|||  ..+++||||||+||+++.++.++|+|||+++..
T Consensus        76 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH--~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~  153 (261)
T cd05072          76 IYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIE--RKNYIHRDLRAANVLVSESLMCKIADFGLARVI  153 (261)
T ss_pred             cEEEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH--HCCeeccccchhhEEecCCCcEEECCCccceec
Confidence            999999999999999997765667899999999999999999999  577999999999999999999999999999864


Q ss_pred             CCCCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHhhhcccchhh
Q 046893          250 PMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLL-GRRAVDKSRPSREHNLVEWARPLLNNNKKVLR  328 (464)
Q Consensus       250 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  328 (464)
                      ..... .......++..|+|||++.+..++.++|||||||++|+|++ |..||.......   .....    ...     
T Consensus       154 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~---~~~~~----~~~-----  220 (261)
T cd05072         154 EDNEY-TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSD---VMSAL----QRG-----  220 (261)
T ss_pred             CCCce-eccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHH---HHHHH----HcC-----
Confidence            32221 11222446778999999988889999999999999999998 999997543211   11111    100     


Q ss_pred             ccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHH
Q 046893          329 ILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETV  374 (464)
Q Consensus       329 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~  374 (464)
                       ...    .....++..+.+++.+||..+|++||+++++++.|+.+
T Consensus       221 -~~~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  261 (261)
T cd05072         221 -YRM----PRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDDF  261 (261)
T ss_pred             -CCC----CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence             000    11122445789999999999999999999999999853

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-43  Score=312.58  Aligned_cols=268  Identities=24%  Similarity=0.350  Sum_probs=211.8

Q ss_pred             HHHHhcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCccHHHHHHHHHHHhcCCCCCcceEEEEEEe
Q 046893           87 MKLATKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVKLIGYCCE  166 (464)
Q Consensus        87 ~~~~~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~  166 (464)
                      +-+..++|++.+.||+|||+-||++....+      +..+|+|++........+..++|++..+.++||||++++++...
T Consensus        16 v~In~~Ryri~~~LgeGGfsfv~LV~~~s~------~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~   89 (302)
T KOG2345|consen   16 VIINNKRYRIQRLLGEGGFSFVDLVKGLST------GHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLR   89 (302)
T ss_pred             EEEcCceEEEeeeecCCCceeeeeecccCc------ccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHH
Confidence            345568899999999999999999985554      66799999988776777889999999999999999999887644


Q ss_pred             C-----CeEEEEEeccCCCCHHHHHHhh--cCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceE
Q 046893          167 D-----EHRILVYEYMESGSLEKHLLRR--VGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAK  239 (464)
Q Consensus       167 ~-----~~~~lv~e~~~~g~L~~~l~~~--~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vk  239 (464)
                      +     ...||+++|...|+|.+.+...  .+..+++.+.+.|+.++++||++||+...++.||||||.|||+.+.+.++
T Consensus        90 ~~~D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~v  169 (302)
T KOG2345|consen   90 EEKDGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPV  169 (302)
T ss_pred             hhccCceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceE
Confidence            3     3589999999999999998754  35579999999999999999999997666799999999999999999999


Q ss_pred             EcccCCccCCCCCCCcce-------eeccccCCcccCccccc---cCCCCcccchhcHHHHHHHHHhCCCCCCCCCCccc
Q 046893          240 LSDFGLAKDGPMGDQTHV-------STRVMGTYGYAAPEYVM---TGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSRE  309 (464)
Q Consensus       240 l~DFGla~~~~~~~~~~~-------~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~  309 (464)
                      |.|||.++.....-....       ......|..|+|||.+.   +...+.++|||||||+||+|+.|..||+..-..  
T Consensus       170 l~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~--  247 (302)
T KOG2345|consen  170 LMDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQ--  247 (302)
T ss_pred             EEeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhc--
Confidence            999999985432211100       11245788999999885   445789999999999999999999999742210  


Q ss_pred             ccHHHHHHHhhhcccchhhccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHH
Q 046893          310 HNLVEWARPLLNNNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETV  374 (464)
Q Consensus       310 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~  374 (464)
                                  .+.-...+....+.-.-....++.+.+|+++||+.||.+||++.+++..+..+
T Consensus       248 ------------GgSlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~L  300 (302)
T KOG2345|consen  248 ------------GGSLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDL  300 (302)
T ss_pred             ------------CCeEEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhh
Confidence                        11111112222222122223567999999999999999999999999988765

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=3.1e-42  Score=346.58  Aligned_cols=262  Identities=19%  Similarity=0.207  Sum_probs=198.8

Q ss_pred             HhcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCccHHHHHHHHHHHhcCCCCCcceEEEEEEeCCe
Q 046893           90 ATKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVKLIGYCCEDEH  169 (464)
Q Consensus        90 ~~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~  169 (464)
                      ...+|.+.+.||+|+||.||+|.+..+      ++.||+|....      ..+.+|+++|+.|+||||++++++|.....
T Consensus        90 ~~~~y~~~~~lg~G~~g~V~~~~d~~~------~~~vaiK~~~~------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~  157 (391)
T PHA03212         90 EKAGFSILETFTPGAEGFAFACIDNKT------CEHVVIKAGQR------GGTATEAHILRAINHPSIIQLKGTFTYNKF  157 (391)
T ss_pred             ccCCcEEEEEEcCCCCeEEEEEEECCC------CCEEEEechhh------hhhHHHHHHHHhCCCCCCCCEeEEEEECCe
Confidence            346799999999999999999998775      56799997543      346789999999999999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCccCC
Q 046893          170 RILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDG  249 (464)
Q Consensus       170 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~  249 (464)
                      .++|||++ +++|..++....  .+++..++.++.|++.||.|||  .++|+||||||+|||++.++.+||+|||+++..
T Consensus       158 ~~lv~e~~-~~~L~~~l~~~~--~l~~~~~~~i~~qi~~aL~ylH--~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~  232 (391)
T PHA03212        158 TCLILPRY-KTDLYCYLAAKR--NIAICDILAIERSVLRAIQYLH--ENRIIHRDIKAENIFINHPGDVCLGDFGAACFP  232 (391)
T ss_pred             eEEEEecC-CCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH--hCCcccCCCChHhEEEcCCCCEEEEeCCccccc
Confidence            99999999 468988876643  5899999999999999999999  567999999999999999999999999999753


Q ss_pred             CCCCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccc-----cHHHHHHHhhh---
Q 046893          250 PMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREH-----NLVEWARPLLN---  321 (464)
Q Consensus       250 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~-----~~~~~~~~~~~---  321 (464)
                      .... ........||+.|+|||++.+..++.++|||||||+||||++|..||.........     .+.........   
T Consensus       233 ~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~  311 (391)
T PHA03212        233 VDIN-ANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPN  311 (391)
T ss_pred             cccc-ccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChh
Confidence            2211 11223468999999999999999999999999999999999999887643321110     01000000000   


Q ss_pred             -----cccchhhc---------cCccccCcc--CHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 046893          322 -----NNKKVLRI---------LDPRLEGQY--TARTAMKVAGLAYQCLSQNPKGRPVMSDVVA  369 (464)
Q Consensus       322 -----~~~~~~~~---------~~~~~~~~~--~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  369 (464)
                           ........         ..+.....+  ....+.++.+|+.+||+.||.+|||+.++++
T Consensus       312 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~  375 (391)
T PHA03212        312 EFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD  375 (391)
T ss_pred             hcCcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence                 00000000         000000000  1134568899999999999999999999984

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=5.5e-42  Score=331.56  Aligned_cols=264  Identities=28%  Similarity=0.397  Sum_probs=207.2

Q ss_pred             CCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCc-cHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeEE
Q 046893           93 FFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQ-GDREWLAEVNYLGQLRHSNLVKLIGYCCEDEHRI  171 (464)
Q Consensus        93 ~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~  171 (464)
                      +|++.+.||+|+||.||+|.+..... ......+++|.+...... ....+..|+.+++.++||||+++++++...+..+
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~-~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   79 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKG-RAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLL   79 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCC-CCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcE
Confidence            37788999999999999998754211 123456899988754332 2356889999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHhhc----------------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCc
Q 046893          172 LVYEYMESGSLEKHLLRRV----------------------GCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSN  229 (464)
Q Consensus       172 lv~e~~~~g~L~~~l~~~~----------------------~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~N  229 (464)
                      +||||+.+++|.+++....                      ...+++..++.++.|++.||.|||  +.+|+||||||+|
T Consensus        80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH--~~~ivH~dikp~n  157 (290)
T cd05045          80 LIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLA--EMKLVHRDLAARN  157 (290)
T ss_pred             EEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHH--HCCeehhhhhhhe
Confidence            9999999999999886421                      124789999999999999999999  6779999999999


Q ss_pred             eEecCCCceEEcccCCccCCCCCCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHh-CCCCCCCCCCcc
Q 046893          230 ILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLL-GRRAVDKSRPSR  308 (464)
Q Consensus       230 ill~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~  308 (464)
                      ||+++++.+||+|||+++...............++..|+|||++.+..++.++||||||+++|||++ |..||.+..+..
T Consensus       158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~  237 (290)
T cd05045         158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPER  237 (290)
T ss_pred             EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHH
Confidence            9999999999999999985433222112223456778999999988889999999999999999998 999997543211


Q ss_pred             cccHHHHHHHhhhcccchhhccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHh
Q 046893          309 EHNLVEWARPLLNNNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETVQS  376 (464)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~~~  376 (464)
                         +.++    ...          ......+..++..+.+|+.+||+.+|.+||++.++++.|+.+..
T Consensus       238 ---~~~~----~~~----------~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~  288 (290)
T cd05045         238 ---LFNL----LKT----------GYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMV  288 (290)
T ss_pred             ---HHHH----HhC----------CCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHh
Confidence               1111    111          11111223345589999999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=1.2e-42  Score=330.59  Aligned_cols=255  Identities=28%  Similarity=0.454  Sum_probs=209.5

Q ss_pred             hcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCccHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeE
Q 046893           91 TKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVKLIGYCCEDEHR  170 (464)
Q Consensus        91 ~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~  170 (464)
                      ...|.+.+.||.|+||.||+|.+..       +..+|+|++..........+..|+.+++.++||||+++++++...+..
T Consensus         5 ~~~y~~~~~ig~g~~~~vy~~~~~~-------~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   77 (261)
T cd05148           5 REEFTLERKLGSGYFGEVWEGLWKN-------RVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPV   77 (261)
T ss_pred             HHHHHHhhhhccCCCccEEEeEecC-------CCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCe
Confidence            4568889999999999999999765       345899998776554567789999999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCccCCC
Q 046893          171 ILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGP  250 (464)
Q Consensus       171 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~  250 (464)
                      ++||||+++++|.+++....+..+++..+..++.|++.||.|||  +++|+|+||||+||+++.++.+||+|||++....
T Consensus        78 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH--~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~  155 (261)
T cd05148          78 YIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLE--EQNSIHRDLAARNILVGEDLVCKVADFGLARLIK  155 (261)
T ss_pred             EEEEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHH--HCCeeccccCcceEEEcCCceEEEccccchhhcC
Confidence            99999999999999998766667899999999999999999999  6779999999999999999999999999997643


Q ss_pred             CCCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHhhhcccchhhc
Q 046893          251 MGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLL-GRRAVDKSRPSREHNLVEWARPLLNNNKKVLRI  329 (464)
Q Consensus       251 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  329 (464)
                      ....  ......++..|+|||.+.+..++.++||||||+++|+|++ |+.||......   .....   ..         
T Consensus       156 ~~~~--~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~---~~~~~---~~---------  218 (261)
T cd05148         156 EDVY--LSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNH---EVYDQ---IT---------  218 (261)
T ss_pred             Cccc--cccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHH---HHHHH---HH---------
Confidence            2211  1123456778999999988899999999999999999998 89999654311   11111   11         


Q ss_pred             cCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q 046893          330 LDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLET  373 (464)
Q Consensus       330 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~  373 (464)
                        .......+..++..+.+++.+||..||.+||++.++++.|+.
T Consensus       219 --~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~  260 (261)
T cd05148         219 --AGYRMPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDN  260 (261)
T ss_pred             --hCCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence              111112223445689999999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=3.7e-42  Score=331.50  Aligned_cols=261  Identities=26%  Similarity=0.421  Sum_probs=205.0

Q ss_pred             cCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCc-cHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeE
Q 046893           92 KFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQ-GDREWLAEVNYLGQLRHSNLVKLIGYCCEDEHR  170 (464)
Q Consensus        92 ~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~  170 (464)
                      ..|++.+.||+|+||+||+|.+.....  ..+..+|+|.+...... ....+.+|+.+++.++||||+++++++......
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~--~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~   82 (283)
T cd05090           5 SAVRFMEELGECAFGKIYKGHLYLPGM--DHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPV   82 (283)
T ss_pred             hhceeeeeccccCCcceEEEEEecCCC--CCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCce
Confidence            457888999999999999998643211  13567999998753322 235688999999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHhhc---------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCC
Q 046893          171 ILVYEYMESGSLEKHLLRRV---------------GCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNAD  235 (464)
Q Consensus       171 ~lv~e~~~~g~L~~~l~~~~---------------~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~  235 (464)
                      ++||||+.+++|.+++....               ...+++..++.++.|++.||.|||  +++|+||||||+|||++.+
T Consensus        83 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH--~~~i~H~dlkp~nili~~~  160 (283)
T cd05090          83 CMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLS--SHFFVHKDLAARNILIGEQ  160 (283)
T ss_pred             EEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH--hcCeehhccccceEEEcCC
Confidence            99999999999999885332               124788999999999999999999  6779999999999999999


Q ss_pred             CceEEcccCCccCCCCCCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHh-CCCCCCCCCCcccccHHH
Q 046893          236 FSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLL-GRRAVDKSRPSREHNLVE  314 (464)
Q Consensus       236 ~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~  314 (464)
                      +.+||+|||+++...............++..|+|||++.+..++.++|||||||+||||++ |..||.+....   .+.+
T Consensus       161 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~---~~~~  237 (283)
T cd05090         161 LHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQ---EVIE  237 (283)
T ss_pred             CcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH---HHHH
Confidence            9999999999986543332223334556788999999988889999999999999999998 98898754321   1111


Q ss_pred             HHHHhhhcccchhhccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q 046893          315 WARPLLNNNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLET  373 (464)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~  373 (464)
                      ..    ..          ......+..++..+.+++.+||+.||.+||++.+|.+.|..
T Consensus       238 ~~----~~----------~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05090         238 MV----RK----------RQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS  282 (283)
T ss_pred             HH----Hc----------CCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence            11    11          00011222345688999999999999999999999988763

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=6.4e-42  Score=336.43  Aligned_cols=245  Identities=27%  Similarity=0.374  Sum_probs=195.1

Q ss_pred             CceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCC----ccHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeEEEE
Q 046893           98 YILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGY----QGDREWLAEVNYLGQLRHSNLVKLIGYCCEDEHRILV  173 (464)
Q Consensus        98 ~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv  173 (464)
                      +.||+|+||.||++....+.   ..++.||+|++.....    .....+..|+.+|+.++||||+++++++..++..|+|
T Consensus         2 ~~lg~G~~g~V~~~~~~~~~---~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv   78 (323)
T cd05584           2 KVLGKGGYGKVFQVRKVTGA---DTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLI   78 (323)
T ss_pred             ceeeecCCeEEEEEEEcccC---CCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEE
Confidence            57999999999999865432   1367799999875321    2224567899999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCccCCCCCC
Q 046893          174 YEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGD  253 (464)
Q Consensus       174 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~  253 (464)
                      |||+.+++|.+++....  .+.+..+..++.|++.||.|||  .++|+||||||+|||++.++.+||+|||+++......
T Consensus        79 ~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH--~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  154 (323)
T cd05584          79 LEYLSGGELFMHLEREG--IFMEDTACFYLSEISLALEHLH--QQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG  154 (323)
T ss_pred             EeCCCCchHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH--HCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCC
Confidence            99999999999886643  6888999999999999999999  6779999999999999999999999999987532221


Q ss_pred             CcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhcccchhhccCcc
Q 046893          254 QTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRILDPR  333 (464)
Q Consensus       254 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  333 (464)
                        .......||+.|+|||++.+..++.++|||||||+||||++|+.||......      ...........         
T Consensus       155 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~------~~~~~~~~~~~---------  217 (323)
T cd05584         155 --TVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRK------KTIDKILKGKL---------  217 (323)
T ss_pred             --CcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHH------HHHHHHHcCCC---------
Confidence              1223467999999999999989999999999999999999999999764321      11111111110         


Q ss_pred             ccCccCHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHH
Q 046893          334 LEGQYTARTAMKVAGLAYQCLSQNPKGRP-----VMSDVVA  369 (464)
Q Consensus       334 ~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~ev~~  369 (464)
                         .++...+..+.+|+.+||+.||.+||     ++.++++
T Consensus       218 ---~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~  255 (323)
T cd05584         218 ---NLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS  255 (323)
T ss_pred             ---CCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence               11223345788999999999999999     6776654

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=2.5e-42  Score=340.65  Aligned_cols=202  Identities=26%  Similarity=0.363  Sum_probs=174.8

Q ss_pred             HhcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCC-ccHHHHHHHHHHHhcCCCCCcceEEEEEEeCC
Q 046893           90 ATKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGY-QGDREWLAEVNYLGQLRHSNLVKLIGYCCEDE  168 (464)
Q Consensus        90 ~~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~  168 (464)
                      ..++|++.+.||+|+||.||+|.+..+      +..+|+|.+..... .....+.+|+++++.++||||++++++|...+
T Consensus         3 ~~~~y~~~~~lg~g~~g~V~~~~~~~~------~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   76 (333)
T cd06650           3 KDDDFEKISELGAGNGGVVFKVSHKPS------GLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDG   76 (333)
T ss_pred             chhhhheeccccCCCCEEEEEEEECCC------CcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECC
Confidence            346799999999999999999998764      66799998875432 22356889999999999999999999999999


Q ss_pred             eEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCccC
Q 046893          169 HRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKD  248 (464)
Q Consensus       169 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~  248 (464)
                      ..++||||+.+++|.+++....  .+++..+..++.|++.||.|||+ ..+|+||||||+|||++.++.+||+|||++..
T Consensus        77 ~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~l~~~l~~lH~-~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~  153 (333)
T cd06650          77 EISICMEHMDGGSLDQVLKKAG--RIPEQILGKVSIAVIKGLTYLRE-KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQ  153 (333)
T ss_pred             EEEEEEecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHh-cCCEEecCCChhhEEEcCCCCEEEeeCCcchh
Confidence            9999999999999999987643  58999999999999999999994 23699999999999999999999999999875


Q ss_pred             CCCCCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHhCCCCCCCC
Q 046893          249 GPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKS  304 (464)
Q Consensus       249 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~  304 (464)
                      ....    ......|+..|+|||++.+..++.++|||||||++|+|++|+.||...
T Consensus       154 ~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~  205 (333)
T cd06650         154 LIDS----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPP  205 (333)
T ss_pred             hhhh----ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc
Confidence            4221    123357999999999999889999999999999999999999999754

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=1.1e-42  Score=346.90  Aligned_cols=267  Identities=23%  Similarity=0.277  Sum_probs=206.8

Q ss_pred             HHHhcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCccHHHHHHHHHHHhcCC-C-----CCcceEE
Q 046893           88 KLATKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLR-H-----SNLVKLI  161 (464)
Q Consensus        88 ~~~~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h-----pniv~l~  161 (464)
                      +...-+|.++++||+|+||.|.+|.+..+      ++.||||+++... .-..+-..|+.+|..|+ |     -|||+++
T Consensus       182 d~i~~rY~V~e~LGkGtFGQVvk~~d~~T------~e~VAIKIiKN~k-~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~  254 (586)
T KOG0667|consen  182 DHIAYRYEVLEVLGKGSFGQVVKAYDHKT------GEIVAIKIIKNKK-RFLRQAQIEIRILELLNKHDPDDKYNIVRML  254 (586)
T ss_pred             ceeEEEEEEEEEecccccceeEEEEecCC------CcEEEEEeeccCh-HHHHHHHHHHHHHHHHhccCCCCCeeEEEee
Confidence            44455889999999999999999999886      7889999998643 22345578999999996 4     3899999


Q ss_pred             EEEEeCCeEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCC--CceE
Q 046893          162 GYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNAD--FSAK  239 (464)
Q Consensus       162 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~--~~vk  239 (464)
                      ++|...++.|||+|++ .-+|+++|..+....|+...+..++.||+.||.+||  +.+|||+||||+||||.+-  ..||
T Consensus       255 d~F~fr~HlciVfELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~--~l~IIHcDLKPENILL~~~~r~~vK  331 (586)
T KOG0667|consen  255 DYFYFRNHLCIVFELL-STNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLH--ELGIIHCDLKPENILLKDPKRSRIK  331 (586)
T ss_pred             eccccccceeeeehhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH--hCCeeeccCChhheeeccCCcCcee
Confidence            9999999999999999 559999999888788999999999999999999999  6779999999999999543  4799


Q ss_pred             EcccCCccCCCCCCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHH---
Q 046893          240 LSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWA---  316 (464)
Q Consensus       240 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~---  316 (464)
                      |+|||.|......-.     ..+.+..|+|||++.|.+|+.+.||||||||++||++|.+.|.+....+....+.-.   
T Consensus       332 VIDFGSSc~~~q~vy-----tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~  406 (586)
T KOG0667|consen  332 VIDFGSSCFESQRVY-----TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGL  406 (586)
T ss_pred             EEecccccccCCcce-----eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCC
Confidence            999999986432221     467788899999999999999999999999999999999888876543322211100   


Q ss_pred             --HHhhhcccchhhccCc----------------------------------------cccCccCHHHHHHHHHHHHHhh
Q 046893          317 --RPLLNNNKKVLRILDP----------------------------------------RLEGQYTARTAMKVAGLAYQCL  354 (464)
Q Consensus       317 --~~~~~~~~~~~~~~~~----------------------------------------~~~~~~~~~~~~~l~~li~~cl  354 (464)
                        ..+++...+....++.                                        .+...+.......+.+|+++||
T Consensus       407 Pp~~mL~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L  486 (586)
T KOG0667|consen  407 PPPKMLDTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCL  486 (586)
T ss_pred             CCHHHHHhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHh
Confidence              0111111111111111                                        0011111233457899999999


Q ss_pred             ccCCCCCCCHHHHHH
Q 046893          355 SQNPKGRPVMSDVVA  369 (464)
Q Consensus       355 ~~dP~~RPs~~ev~~  369 (464)
                      .+||.+|+|..+.+.
T Consensus       487 ~~dP~~R~tp~qal~  501 (586)
T KOG0667|consen  487 EWDPAERITPAQALN  501 (586)
T ss_pred             ccCchhcCCHHHHhc
Confidence            999999999998874

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=1.2e-42  Score=341.80  Aligned_cols=243  Identities=27%  Similarity=0.372  Sum_probs=194.9

Q ss_pred             CceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCC---ccHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeEEEEE
Q 046893           98 YILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGY---QGDREWLAEVNYLGQLRHSNLVKLIGYCCEDEHRILVY  174 (464)
Q Consensus        98 ~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~  174 (464)
                      +.||+|+||.||+|.+..+      +..||+|++.....   .....+..|++++..++||||+++++++...+..+|||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~------~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~   74 (325)
T cd05594           1 KLLGKGTFGKVILVKEKAT------GRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVM   74 (325)
T ss_pred             CeeeeCCCEEEEEEEECCC------CCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEE
Confidence            3699999999999987664      66799999875322   22355678999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCccCCCCCCC
Q 046893          175 EYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQ  254 (464)
Q Consensus       175 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~  254 (464)
                      ||+.+|+|.+++....  .+++..+..++.||+.||.|||+ ..+|+||||||+|||++.++.+||+|||+++...... 
T Consensus        75 E~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~lH~-~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~-  150 (325)
T cd05594          75 EYANGGELFFHLSRER--VFSEDRARFYGAEIVSALDYLHS-EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG-  150 (325)
T ss_pred             eCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHh-cCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCC-
Confidence            9999999998876543  68999999999999999999994 2679999999999999999999999999987532211 


Q ss_pred             cceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhcccchhhccCccc
Q 046893          255 THVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRILDPRL  334 (464)
Q Consensus       255 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  334 (464)
                       .......||..|+|||++.+..++.++|||||||+||+|++|+.||......      ..........        .  
T Consensus       151 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~------~~~~~i~~~~--------~--  213 (325)
T cd05594         151 -ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE------KLFELILMEE--------I--  213 (325)
T ss_pred             -cccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHH------HHHHHHhcCC--------C--
Confidence             1223467999999999999999999999999999999999999999754321      1111111110        0  


Q ss_pred             cCccCHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHH
Q 046893          335 EGQYTARTAMKVAGLAYQCLSQNPKGRP-----VMSDVVA  369 (464)
Q Consensus       335 ~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~ev~~  369 (464)
                        .++...+..+.+|+.+||+.||.+|+     ++.++++
T Consensus       214 --~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~  251 (325)
T cd05594         214 --RFPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQ  251 (325)
T ss_pred             --CCCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhc
Confidence              11223345788999999999999997     7888764

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=2.7e-42  Score=346.72  Aligned_cols=253  Identities=23%  Similarity=0.304  Sum_probs=196.7

Q ss_pred             CCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCC---ccHHHHHHHHHHHhcCCCCCcceEEEEEEeCCe
Q 046893           93 FFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGY---QGDREWLAEVNYLGQLRHSNLVKLIGYCCEDEH  169 (464)
Q Consensus        93 ~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~  169 (464)
                      .|++++.||+|+||+||+|.+..+      ++.||+|++.....   .....+..|+.++..++||||+++++++.+.+.
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~~------~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~   75 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVDT------HALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDN   75 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECCC------CCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCE
Confidence            588889999999999999998765      66799999875432   223567899999999999999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCccCC
Q 046893          170 RILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDG  249 (464)
Q Consensus       170 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~  249 (464)
                      .++||||+++|+|.+++....  .+++..+..++.|++.||.|||  ..+|+||||||+||||+.++.+||+|||+++..
T Consensus        76 ~~lv~E~~~gg~L~~~l~~~~--~~~e~~~~~~~~qi~~aL~~LH--~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~  151 (381)
T cd05626          76 LYFVMDYIPGGDMMSLLIRME--VFPEVLARFYIAELTLAIESVH--KMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGF  151 (381)
T ss_pred             EEEEEecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH--hCCeeecCCcHHHEEECCCCCEEEeeCcCCccc
Confidence            999999999999999887643  6899999999999999999999  677999999999999999999999999998642


Q ss_pred             CCCCC---------------------------------------------cceeeccccCCcccCccccccCCCCcccch
Q 046893          250 PMGDQ---------------------------------------------THVSTRVMGTYGYAAPEYVMTGHLTARSDV  284 (464)
Q Consensus       250 ~~~~~---------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv  284 (464)
                      .....                                             .......+||+.|+|||++.+..++.++||
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~Di  231 (381)
T cd05626         152 RWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDW  231 (381)
T ss_pred             ccccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccce
Confidence            11000                                             001123579999999999999899999999


Q ss_pred             hcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhcccchhhccCccccCccCHHHHHHHHHHHHHh--hccCCCCCC
Q 046893          285 YGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRILDPRLEGQYTARTAMKVAGLAYQC--LSQNPKGRP  362 (464)
Q Consensus       285 wslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c--l~~dP~~RP  362 (464)
                      |||||+||||++|..||....+...      ..........        +........+.++.+|+.+|  +..++..||
T Consensus       232 wSlG~il~elltG~~Pf~~~~~~~~------~~~i~~~~~~--------~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~  297 (381)
T cd05626         232 WSVGVILFEMLVGQPPFLAPTPTET------QLKVINWENT--------LHIPPQVKLSPEAVDLITKLCCSAEERLGRN  297 (381)
T ss_pred             eehhhHHHHHHhCCCCCcCCCHHHH------HHHHHccccc--------cCCCCCCCCCHHHHHHHHHHccCcccccCCC
Confidence            9999999999999999976542211      0111110000        00001112344777888884  455666699


Q ss_pred             CHHHHHH
Q 046893          363 VMSDVVA  369 (464)
Q Consensus       363 s~~ev~~  369 (464)
                      ++.+++.
T Consensus       298 ~~~~~l~  304 (381)
T cd05626         298 GADDIKA  304 (381)
T ss_pred             CHHHHhc
Confidence            9999975

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-43  Score=356.56  Aligned_cols=270  Identities=24%  Similarity=0.429  Sum_probs=229.2

Q ss_pred             HHHhcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCcc-HHHHHHHHHHHhcCCCCCcceEEEEEEe
Q 046893           88 KLATKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQG-DREWLAEVNYLGQLRHSNLVKLIGYCCE  166 (464)
Q Consensus        88 ~~~~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~hpniv~l~~~~~~  166 (464)
                      ++......+.++||.|.||.||+|.++...+   ....||||.++....+. ..+|+.|+.||.+++||||++|-|+...
T Consensus       625 EId~s~i~Ie~VIGaGEFGEVc~GrLk~pgk---re~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTk  701 (996)
T KOG0196|consen  625 EIDPSCVKIEKVIGAGEFGEVCSGRLKLPGK---REITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTK  701 (996)
T ss_pred             hcChhheEEEEEEecccccceecccccCCCC---cceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEec
Confidence            4455667788999999999999999886543   35679999998754433 3679999999999999999999999999


Q ss_pred             CCeEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCc
Q 046893          167 DEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLA  246 (464)
Q Consensus       167 ~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla  246 (464)
                      ....+||.|||++|+|+.+|+++.+ .|.+.++..++..|+.|++||-  +.++|||||.++|||++.+..+|++||||+
T Consensus       702 s~PvMIiTEyMENGsLDsFLR~~DG-qftviQLVgMLrGIAsGMkYLs--dm~YVHRDLAARNILVNsnLvCKVsDFGLS  778 (996)
T KOG0196|consen  702 SKPVMIITEYMENGSLDSFLRQNDG-QFTVIQLVGMLRGIASGMKYLS--DMNYVHRDLAARNILVNSNLVCKVSDFGLS  778 (996)
T ss_pred             CceeEEEhhhhhCCcHHHHHhhcCC-ceEeehHHHHHHHHHHHhHHHh--hcCchhhhhhhhheeeccceEEEeccccce
Confidence            9999999999999999999988765 5999999999999999999999  677999999999999999999999999999


Q ss_pred             cCCCCCCCccee-eccccCCcccCccccccCCCCcccchhcHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHhhhccc
Q 046893          247 KDGPMGDQTHVS-TRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLL-GRRAVDKSRPSREHNLVEWARPLLNNNK  324 (464)
Q Consensus       247 ~~~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~  324 (464)
                      +....+...... ..-.=..+|.|||.+....++.++|||||||+|||.++ |..||....                 +.
T Consensus       779 Rvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmS-----------------NQ  841 (996)
T KOG0196|consen  779 RVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMS-----------------NQ  841 (996)
T ss_pred             eecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccc-----------------hH
Confidence            976443322111 11222578999999999999999999999999999887 999986543                 23


Q ss_pred             chhhccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhcChh
Q 046893          325 KVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETVQSQGAE  380 (464)
Q Consensus       325 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~~~~~~~  380 (464)
                      ++.+.++..++-.-+.+||..|.+||..||++|-.+||.+.+|+..|..+..+...
T Consensus       842 dVIkaIe~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP~S  897 (996)
T KOG0196|consen  842 DVIKAIEQGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNPNS  897 (996)
T ss_pred             HHHHHHHhccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCchh
Confidence            44555666677777889999999999999999999999999999999998876543

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=9.5e-42  Score=332.12  Aligned_cols=264  Identities=24%  Similarity=0.334  Sum_probs=197.6

Q ss_pred             cCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCc-cHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeE
Q 046893           92 KFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQ-GDREWLAEVNYLGQLRHSNLVKLIGYCCEDEHR  170 (464)
Q Consensus        92 ~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~  170 (464)
                      ++|.+.+.||+|+||+||+|.+..+      ++.||+|++...... ....+.+|+.+++.++||||+++++++......
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~------~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~   78 (303)
T cd07869           5 DSYEKLEKLGEGSYATVYKGKSKVN------GKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETL   78 (303)
T ss_pred             ccceEeeeEEecCCEEEEEEEECCC------CCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeE
Confidence            5689999999999999999998754      567999998754322 234678899999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCccCCC
Q 046893          171 ILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGP  250 (464)
Q Consensus       171 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~  250 (464)
                      ++||||+. ++|.+++.... ..++...+..++.|++.||.|||  +.+|+||||||+|||++.++.+||+|||+++...
T Consensus        79 ~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~al~~lH--~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~  154 (303)
T cd07869          79 TLVFEYVH-TDLCQYMDKHP-GGLHPENVKLFLFQLLRGLSYIH--QRYILHRDLKPQNLLISDTGELKLADFGLARAKS  154 (303)
T ss_pred             EEEEECCC-cCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHH--HCCeecCCCCHHHEEECCCCCEEECCCCcceecc
Confidence            99999995 68888876543 45889999999999999999999  6779999999999999999999999999987532


Q ss_pred             CCCCcceeeccccCCcccCcccccc-CCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhccc-c---
Q 046893          251 MGDQTHVSTRVMGTYGYAAPEYVMT-GHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNK-K---  325 (464)
Q Consensus       251 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-~---  325 (464)
                      ...  .......||..|+|||++.+ ..++.++|||||||++|+|++|..||.+......  ..+.....+.... .   
T Consensus       155 ~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~  230 (303)
T cd07869         155 VPS--HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQD--QLERIFLVLGTPNEDTWP  230 (303)
T ss_pred             CCC--ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHH--HHHHHHHHhCCCChhhcc
Confidence            211  12233578999999998875 4588899999999999999999999986432111  1111100000000 0   


Q ss_pred             -hh--hccCcc-ccCccC---------HHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 046893          326 -VL--RILDPR-LEGQYT---------ARTAMKVAGLAYQCLSQNPKGRPVMSDVVA  369 (464)
Q Consensus       326 -~~--~~~~~~-~~~~~~---------~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  369 (464)
                       ..  ....+. .....+         ......+.+|+.+||+.||.+|||+.++++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~  287 (303)
T cd07869         231 GVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS  287 (303)
T ss_pred             chhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence             00  000000 000000         011246789999999999999999999874

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=7.2e-42  Score=336.21  Aligned_cols=241  Identities=28%  Similarity=0.432  Sum_probs=191.8

Q ss_pred             CCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCC---ccHHHHHHHHHHH---hcCCCCCcceEEEEEEeC
Q 046893           94 FRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGY---QGDREWLAEVNYL---GQLRHSNLVKLIGYCCED  167 (464)
Q Consensus        94 ~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l---~~l~hpniv~l~~~~~~~  167 (464)
                      |++.+.||+|+||.||+|.+..+      ++.||||++.....   .....+..|++++   ..++||||+++++++...
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~------~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~   74 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKT------GELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTE   74 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCC------CCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcC
Confidence            66788999999999999998764      66799999875321   2234566666655   566899999999999999


Q ss_pred             CeEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCcc
Q 046893          168 EHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAK  247 (464)
Q Consensus       168 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~  247 (464)
                      +..|+||||+.+++|..++..   ..+++..+..++.|++.||.|||  +.+|+||||||+|||++.++.+||+|||+++
T Consensus        75 ~~~~lv~E~~~~~~L~~~~~~---~~l~~~~~~~~~~qi~~al~~lH--~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~  149 (324)
T cd05589          75 DHVCFVMEYAAGGDLMMHIHT---DVFSEPRAVFYAACVVLGLQYLH--ENKIVYRDLKLDNLLLDTEGFVKIADFGLCK  149 (324)
T ss_pred             CEEEEEEcCCCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHH--hCCeEecCCCHHHeEECCCCcEEeCcccCCc
Confidence            999999999999999887754   35899999999999999999999  6779999999999999999999999999987


Q ss_pred             CCCCCCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhcccchh
Q 046893          248 DGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVL  327 (464)
Q Consensus       248 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  327 (464)
                      ......  ......+|++.|+|||++.+..++.++|||||||++|||++|+.||......      +.........    
T Consensus       150 ~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~------~~~~~i~~~~----  217 (324)
T cd05589         150 EGMGFG--DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEE------EVFDSIVNDE----  217 (324)
T ss_pred             cCCCCC--CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHH------HHHHHHHhCC----
Confidence            532211  2233478999999999999999999999999999999999999999764321      1111111111    


Q ss_pred             hccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHH
Q 046893          328 RILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMS  365 (464)
Q Consensus       328 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~  365 (464)
                          .    .++...+..+.+++.+||..||.+||++.
T Consensus       218 ----~----~~p~~~~~~~~~li~~~L~~dP~~R~~~~  247 (324)
T cd05589         218 ----V----RYPRFLSREAISIMRRLLRRNPERRLGSG  247 (324)
T ss_pred             ----C----CCCCCCCHHHHHHHHHHhhcCHhHcCCCC
Confidence                0    12223455788999999999999999543

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=2.3e-42  Score=357.11  Aligned_cols=257  Identities=24%  Similarity=0.291  Sum_probs=205.5

Q ss_pred             HHHhcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCc--cHHHHHHHHHHHhcCCCCCcceEEEEEE
Q 046893           88 KLATKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQ--GDREWLAEVNYLGQLRHSNLVKLIGYCC  165 (464)
Q Consensus        88 ~~~~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpniv~l~~~~~  165 (464)
                      ....++|.+.+.||+|+||+||+|.+..+      ++.||||++......  ....+.+|+.++..++|+||+++++.+.
T Consensus        28 ~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~------g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~  101 (496)
T PTZ00283         28 KEQAKKYWISRVLGSGATGTVLCAKRVSD------GEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFA  101 (496)
T ss_pred             cccCCCEEEEEEEecCCCEEEEEEEEcCC------CCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeeccee
Confidence            33456899999999999999999987765      667999998754332  2356788999999999999999988765


Q ss_pred             eCC--------eEEEEEeccCCCCHHHHHHhhc--CCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCC
Q 046893          166 EDE--------HRILVYEYMESGSLEKHLLRRV--GCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNAD  235 (464)
Q Consensus       166 ~~~--------~~~lv~e~~~~g~L~~~l~~~~--~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~  235 (464)
                      ...        ..++||||+.+|+|.+++..+.  ...+++..+..++.|++.||.|||  .++|+||||||+||||+.+
T Consensus       102 ~~~~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH--~~~IiHrDLKP~NILl~~~  179 (496)
T PTZ00283        102 KKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVH--SKHMIHRDIKSANILLCSN  179 (496)
T ss_pred             cccccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH--hCCEecCCCCHHHEEEeCC
Confidence            432        3689999999999999886532  346899999999999999999999  6779999999999999999


Q ss_pred             CceEEcccCCccCCCCCCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHH
Q 046893          236 FSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEW  315 (464)
Q Consensus       236 ~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~  315 (464)
                      +.+||+|||+++..............+||+.|+|||++.+..++.++|||||||+||||++|+.||.....      .++
T Consensus       180 ~~vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~------~~~  253 (496)
T PTZ00283        180 GLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENM------EEV  253 (496)
T ss_pred             CCEEEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCH------HHH
Confidence            99999999999865433223333457899999999999999999999999999999999999999975431      122


Q ss_pred             HHHhhhcccchhhccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 046893          316 ARPLLNNNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVA  369 (464)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  369 (464)
                      ........           ....+..++..+.+|+.+||..||.+||++.+++.
T Consensus       254 ~~~~~~~~-----------~~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~  296 (496)
T PTZ00283        254 MHKTLAGR-----------YDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLN  296 (496)
T ss_pred             HHHHhcCC-----------CCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHh
Confidence            22111110           01122334568999999999999999999999875

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=5.1e-42  Score=332.14  Aligned_cols=269  Identities=26%  Similarity=0.384  Sum_probs=210.5

Q ss_pred             HHHHhcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCC-ccHHHHHHHHHHHhcC-CCCCcceEEEEE
Q 046893           87 MKLATKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGY-QGDREWLAEVNYLGQL-RHSNLVKLIGYC  164 (464)
Q Consensus        87 ~~~~~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~hpniv~l~~~~  164 (464)
                      +.+..++|.+.+.||+|+||.||+|.+..... ......+|+|.+..... .....+.+|+.++..+ +|+||+++++++
T Consensus         7 ~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~-~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~   85 (293)
T cd05053           7 WELPRDRLTLGKPLGEGAFGQVVKAEAVGLDN-PNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVC   85 (293)
T ss_pred             cccCHhHeEEeeEecccccccEEEEEEecCCC-CCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence            44556678899999999999999998764321 12346799999875432 2235688999999999 799999999999


Q ss_pred             EeCCeEEEEEeccCCCCHHHHHHhh--------------cCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCce
Q 046893          165 CEDEHRILVYEYMESGSLEKHLLRR--------------VGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNI  230 (464)
Q Consensus       165 ~~~~~~~lv~e~~~~g~L~~~l~~~--------------~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Ni  230 (464)
                      ...+..++||||+.+|+|..++..+              ....+++..++.++.|++.||.|||  +.+|+||||||+||
T Consensus        86 ~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH--~~~ivH~dlkp~Ni  163 (293)
T cd05053          86 TQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLA--SKKCIHRDLAARNV  163 (293)
T ss_pred             cCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH--HCCccccccceeeE
Confidence            9999999999999999999998642              2346899999999999999999999  67799999999999


Q ss_pred             EecCCCceEEcccCCccCCCCCCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHh-CCCCCCCCCCccc
Q 046893          231 LLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLL-GRRAVDKSRPSRE  309 (464)
Q Consensus       231 ll~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~  309 (464)
                      |++.++.+||+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..||....... 
T Consensus       164 l~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~-  242 (293)
T cd05053         164 LVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE-  242 (293)
T ss_pred             EEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHH-
Confidence            999999999999999986543322222222345678999999988899999999999999999997 999986543211 


Q ss_pred             ccHHHHHHHhhhcccchhhccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHH
Q 046893          310 HNLVEWARPLLNNNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETVQ  375 (464)
Q Consensus       310 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~~  375 (464)
                           ... .+..          ......+..++..+.+|+.+||..||.+|||+.++++.|+.+.
T Consensus       243 -----~~~-~~~~----------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~  292 (293)
T cd05053         243 -----LFK-LLKE----------GYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML  292 (293)
T ss_pred             -----HHH-HHHc----------CCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence                 111 1111          0111122234558999999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=6.8e-42  Score=337.08  Aligned_cols=244  Identities=24%  Similarity=0.358  Sum_probs=192.9

Q ss_pred             CceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCC---ccHHHHHHHHHHHhcC-CCCCcceEEEEEEeCCeEEEE
Q 046893           98 YILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGY---QGDREWLAEVNYLGQL-RHSNLVKLIGYCCEDEHRILV  173 (464)
Q Consensus        98 ~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~lv  173 (464)
                      ++||+|+||.||+|.+..+      +..||+|++.....   .....+..|..++..+ +||||+++++++...+..+||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~------~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv   74 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKT------RRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFV   74 (329)
T ss_pred             CeEeeCCCeEEEEEEECCC------CCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEE
Confidence            3699999999999998765      56799999975422   2234577899999988 799999999999999999999


Q ss_pred             EeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCccCCCCCC
Q 046893          174 YEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGD  253 (464)
Q Consensus       174 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~  253 (464)
                      |||+++|+|.+++.+.  ..+++..+..++.|++.||.|||  .++|+||||||+|||++.++.+||+|||+++......
T Consensus        75 ~e~~~~g~L~~~~~~~--~~l~~~~~~~~~~qi~~~l~~lH--~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~  150 (329)
T cd05588          75 IEFVSGGDLMFHMQRQ--RKLPEEHARFYSAEISLALNFLH--ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPG  150 (329)
T ss_pred             EeCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH--HCCeEecCCCHHHeEECCCCCEEECcCccccccccCC
Confidence            9999999998887654  36999999999999999999999  6779999999999999999999999999997422111


Q ss_pred             CcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHhCCCCCCCCCCcc--cccHHHHHHHhhhcccchhhccC
Q 046893          254 QTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSR--EHNLVEWARPLLNNNKKVLRILD  331 (464)
Q Consensus       254 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~  331 (464)
                        ......+||..|+|||++.+..++.++|||||||++|+|++|+.||.......  .....++....+...        
T Consensus       151 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~--------  220 (329)
T cd05588         151 --DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEK--------  220 (329)
T ss_pred             --CccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcC--------
Confidence              12234689999999999999999999999999999999999999997432211  111122222111111        


Q ss_pred             ccccCccCHHHHHHHHHHHHHhhccCCCCCCCH
Q 046893          332 PRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVM  364 (464)
Q Consensus       332 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~  364 (464)
                       .  ...+...+..+.+++.+||..||.+|+++
T Consensus       221 -~--~~~p~~~~~~~~~li~~~L~~dP~~R~~~  250 (329)
T cd05588         221 -Q--IRIPRSLSVKASSVLKGFLNKDPKERLGC  250 (329)
T ss_pred             -C--CCCCCCCCHHHHHHHHHHhccCHHHcCCC
Confidence             0  01222344578899999999999999984

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=5.1e-42  Score=338.41  Aligned_cols=250  Identities=24%  Similarity=0.317  Sum_probs=195.3

Q ss_pred             CCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCC----ccHHHHHHHHHHHhcC-CCCCcceEEEEEEeC
Q 046893           93 FFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGY----QGDREWLAEVNYLGQL-RHSNLVKLIGYCCED  167 (464)
Q Consensus        93 ~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~  167 (464)
                      +|++.+.||+|+||+||++......   ..+..||+|++.....    ...+.+..|+.++..+ +||||+++++++..+
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~---~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~   77 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGH---DTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTE   77 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccC---CCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecC
Confidence            4788899999999999999865321   2367799999864321    2234577899999999 599999999999999


Q ss_pred             CeEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCcc
Q 046893          168 EHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAK  247 (464)
Q Consensus       168 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~  247 (464)
                      +..++||||+.+|+|.+++..+.  .+++..+..++.||+.||.|||  +++|+||||||+|||++.++.+||+|||+++
T Consensus        78 ~~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH--~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~  153 (332)
T cd05614          78 AKLHLILDYVSGGEMFTHLYQRD--NFSEDEVRFYSGEIILALEHLH--KLGIVYRDIKLENILLDSEGHVVLTDFGLSK  153 (332)
T ss_pred             CEEEEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH--HCCcEecCCCHHHeEECCCCCEEEeeCcCCc
Confidence            99999999999999999887643  6899999999999999999999  6779999999999999999999999999998


Q ss_pred             CCCCCCCcceeeccccCCcccCccccccC-CCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhcccch
Q 046893          248 DGPMGDQTHVSTRVMGTYGYAAPEYVMTG-HLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKV  326 (464)
Q Consensus       248 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  326 (464)
                      ........ .....+||..|+|||++.+. .++.++|||||||+||||++|..||.........  .........     
T Consensus       154 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~--~~~~~~~~~-----  225 (332)
T cd05614         154 EFLSEEKE-RTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQ--SEVSRRILK-----  225 (332)
T ss_pred             cccccCCC-ccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCH--HHHHHHHhc-----
Confidence            64332221 22346799999999998865 4788999999999999999999999754322111  111111111     


Q ss_pred             hhccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCH
Q 046893          327 LRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVM  364 (464)
Q Consensus       327 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~  364 (464)
                         .++    .++...+..+.+|+.+||..||.+||++
T Consensus       226 ---~~~----~~~~~~~~~~~~li~~~l~~dp~~R~~~  256 (332)
T cd05614         226 ---CDP----PFPSFIGPEAQDLLHKLLRKDPKKRLGA  256 (332)
T ss_pred             ---CCC----CCCCCCCHHHHHHHHHHcCCCHHHcCCC
Confidence               111    1222344578899999999999999943

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=4.1e-42  Score=339.68  Aligned_cols=263  Identities=24%  Similarity=0.330  Sum_probs=196.0

Q ss_pred             CCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCC--CccHHHHHHHHHHHhcCCCCCcceEEEEEEeC---
Q 046893           93 FFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGG--YQGDREWLAEVNYLGQLRHSNLVKLIGYCCED---  167 (464)
Q Consensus        93 ~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~---  167 (464)
                      +|++.+.||+|+||.||+|++..+      +..||||.+....  ......+.+|+.+++.++||||+++++++...   
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~------~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~   74 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHT------GEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRR   74 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCC------CCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCC
Confidence            478889999999999999998765      5679999986432  22335688999999999999999999988643   


Q ss_pred             --CeEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCC
Q 046893          168 --EHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGL  245 (464)
Q Consensus       168 --~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGl  245 (464)
                        ...|+||||+ +++|.+++....  .+++..+..++.|++.||.|||  .++|+||||||+|||++.++.+||+|||+
T Consensus        75 ~~~~~~lv~e~~-~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH--~~~ivH~dlkp~NIll~~~~~~kL~Dfg~  149 (338)
T cd07859          75 EFKDIYVVFELM-ESDLHQVIKAND--DLTPEHHQFFLYQLLRALKYIH--TANVFHRDLKPKNILANADCKLKICDFGL  149 (338)
T ss_pred             CCceEEEEEecC-CCCHHHHHHhcc--cCCHHHHHHHHHHHHHHHHHHH--HCCeecCCCCHHHeEECCCCcEEEccCcc
Confidence              2579999999 468988886543  6899999999999999999999  56799999999999999999999999999


Q ss_pred             ccCCCCCCC-cceeeccccCCcccCcccccc--CCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhc
Q 046893          246 AKDGPMGDQ-THVSTRVMGTYGYAAPEYVMT--GHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNN  322 (464)
Q Consensus       246 a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~  322 (464)
                      ++....... ........||..|+|||++.+  ..++.++|||||||++|||++|+.||.+.......   ......+..
T Consensus       150 ~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~---~~~~~~~~~  226 (338)
T cd07859         150 ARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQL---DLITDLLGT  226 (338)
T ss_pred             ccccccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHH---HHHHHHhCC
Confidence            985432221 112234679999999998865  67899999999999999999999999764421111   100000000


Q ss_pred             c-------------cchhhccCccccCc---cCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 046893          323 N-------------KKVLRILDPRLEGQ---YTARTAMKVAGLAYQCLSQNPKGRPVMSDVVA  369 (464)
Q Consensus       323 ~-------------~~~~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  369 (464)
                      .             ......+.......   .....+..+.+|+.+||+.||.+||++.++++
T Consensus       227 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~  289 (338)
T cd07859         227 PSPETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALA  289 (338)
T ss_pred             CCHHHHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhc
Confidence            0             00000000000000   00123457889999999999999999999885

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=3.5e-42  Score=321.95  Aligned_cols=265  Identities=25%  Similarity=0.320  Sum_probs=202.2

Q ss_pred             CCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCc--cHHHHHHHHHHHhcCCCCC-cceEEEEEEeCC-
Q 046893           93 FFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQ--GDREWLAEVNYLGQLRHSN-LVKLIGYCCEDE-  168 (464)
Q Consensus        93 ~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpn-iv~l~~~~~~~~-  168 (464)
                      .|...++||+|+||+||+|+...+      ++.||+|++......  ......+|+.+|+.|+|+| |+.+++++...+ 
T Consensus        12 ~~~~~eklGeGtyg~Vykar~~~~------g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~   85 (323)
T KOG0594|consen   12 DYEKVEKLGEGTYGVVYKARSKRT------GKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNN   85 (323)
T ss_pred             HHHHHHHhCCCCceEEEEEEEecC------CCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccc
Confidence            355566799999999999998875      678999999765432  2355689999999999999 999999999887 


Q ss_pred             -----eEEEEEeccCCCCHHHHHHhhcC--CCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEc
Q 046893          169 -----HRILVYEYMESGSLEKHLLRRVG--CMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLS  241 (464)
Q Consensus       169 -----~~~lv~e~~~~g~L~~~l~~~~~--~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~  241 (464)
                           ..+|||||++. +|.+++.....  ..++...+..++.||+.||+|||  .++|+||||||+||||+.+|.+||+
T Consensus        86 ~~~~~~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H--~~~IlHRDLKPQNlLi~~~G~lKla  162 (323)
T KOG0594|consen   86 HRGIGKLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLH--SHGILHRDLKPQNLLISSSGVLKLA  162 (323)
T ss_pred             ccccceEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHH--hCCeecccCCcceEEECCCCcEeee
Confidence                 78999999954 99999876542  35777899999999999999999  5779999999999999999999999


Q ss_pred             ccCCccCCCCCCCcceeeccccCCcccCccccccC-CCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhh
Q 046893          242 DFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTG-HLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLL  320 (464)
Q Consensus       242 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~  320 (464)
                      |||+|+......  ...+..++|.+|+|||++.|. .|+...||||+|||++||++++..|.+....  .++...+.-+-
T Consensus       163 DFGlAra~~ip~--~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~--~ql~~If~~lG  238 (323)
T KOG0594|consen  163 DFGLARAFSIPM--RTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEI--DQLFRIFRLLG  238 (323)
T ss_pred             ccchHHHhcCCc--ccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHH--HHHHHHHHHcC
Confidence            999999654332  224457899999999999987 7999999999999999999999999876542  12222111111


Q ss_pred             hcc-cc---hhhccCc--ccc-----CccCH---HHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 046893          321 NNN-KK---VLRILDP--RLE-----GQYTA---RTAMKVAGLAYQCLSQNPKGRPVMSDVVAL  370 (464)
Q Consensus       321 ~~~-~~---~~~~~~~--~~~-----~~~~~---~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  370 (464)
                      ..+ ..   +....+-  .+.     ..+..   .......+++.+||+.+|.+|.|+..++..
T Consensus       239 tP~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h  302 (323)
T KOG0594|consen  239 TPNEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH  302 (323)
T ss_pred             CCCccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence            100 00   0000000  000     00011   111378899999999999999999988764

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=6.1e-42  Score=334.10  Aligned_cols=270  Identities=24%  Similarity=0.351  Sum_probs=209.5

Q ss_pred             HHhcCCCCCCceeecCceEEEEEEecCCCCC-CccceEEEEEEccCCCC-ccHHHHHHHHHHHhcC-CCCCcceEEEEEE
Q 046893           89 LATKFFRPDYILGEGGFGVVYKGVIDENVRP-GYKTTFVAIKELNRGGY-QGDREWLAEVNYLGQL-RHSNLVKLIGYCC  165 (464)
Q Consensus        89 ~~~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~-~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~hpniv~l~~~~~  165 (464)
                      +..++|.+.+.||+|+||.||+|.+...... ......+|+|.+..... ....++..|+.++..+ +||||+++++++.
T Consensus        15 ~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~   94 (307)
T cd05098          15 VPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT   94 (307)
T ss_pred             eehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEe
Confidence            3346789999999999999999986542211 11245699999875432 2335688899999999 7999999999999


Q ss_pred             eCCeEEEEEeccCCCCHHHHHHhhcC--------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceE
Q 046893          166 EDEHRILVYEYMESGSLEKHLLRRVG--------------CMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNIL  231 (464)
Q Consensus       166 ~~~~~~lv~e~~~~g~L~~~l~~~~~--------------~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nil  231 (464)
                      ..+..++||||+.+|+|.+++..+..              ..+++.+++.++.|++.||+|||  +++++||||||+|||
T Consensus        95 ~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH--~~gi~H~dlkp~Nil  172 (307)
T cd05098          95 QDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLA--SKKCIHRDLAARNVL  172 (307)
T ss_pred             cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHH--HCCcccccccHHheE
Confidence            99999999999999999999976421              24889999999999999999999  678999999999999


Q ss_pred             ecCCCceEEcccCCccCCCCCCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHh-CCCCCCCCCCcccc
Q 046893          232 LNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLL-GRRAVDKSRPSREH  310 (464)
Q Consensus       232 l~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~  310 (464)
                      ++.++.+||+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..||.....    
T Consensus       173 l~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~----  248 (307)
T cd05098         173 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV----  248 (307)
T ss_pred             EcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCH----
Confidence            99999999999999976432221111222334578999999998899999999999999999998 8888865331    


Q ss_pred             cHHHHHHHhhhcccchhhccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhc
Q 046893          311 NLVEWARPLLNNNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETVQSQ  377 (464)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~~~~  377 (464)
                        .+..... ..          ......+..++.++.+|+.+||..+|.+||++.+|++.|+.+...
T Consensus       249 --~~~~~~~-~~----------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~  302 (307)
T cd05098         249 --EELFKLL-KE----------GHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILAL  302 (307)
T ss_pred             --HHHHHHH-Hc----------CCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHH
Confidence              1111111 11          011112233456899999999999999999999999999987653

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6e-42  Score=330.60  Aligned_cols=252  Identities=27%  Similarity=0.376  Sum_probs=200.7

Q ss_pred             CCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCc---cHHHHHHHHHHHhcCCCCCcceEEEEEEeCCe
Q 046893           93 FFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQ---GDREWLAEVNYLGQLRHSNLVKLIGYCCEDEH  169 (464)
Q Consensus        93 ~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~  169 (464)
                      .|++.++||+|+||+||++.+..+      ++.||+|++......   ....+.+|+.+++.++||||+++++++..++.
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~------~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   74 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRAT------GKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDA   74 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCC------CceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCe
Confidence            477889999999999999997654      667999998653322   22456789999999999999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCccCC
Q 046893          170 RILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDG  249 (464)
Q Consensus       170 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~  249 (464)
                      .++||||+.+|+|.+++.......+++..+..++.|++.||.|||  +.+|+||||||+||++++++.++|+|||+++..
T Consensus        75 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH--~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~  152 (285)
T cd05605          75 LCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLH--RERIVYRDLKPENILLDDYGHIRISDLGLAVEI  152 (285)
T ss_pred             EEEEEeccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHH--HCCcEecCCCHHHEEECCCCCEEEeeCCCceec
Confidence            999999999999998886654456899999999999999999999  567999999999999999999999999999764


Q ss_pred             CCCCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhcccchhhc
Q 046893          250 PMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRI  329 (464)
Q Consensus       250 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  329 (464)
                      ....   ......|+..|+|||++.+..++.++|||||||++|||++|+.||.+......   .+.....+..       
T Consensus       153 ~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~---~~~~~~~~~~-------  219 (285)
T cd05605         153 PEGE---TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVK---REEVERRVKE-------  219 (285)
T ss_pred             CCCC---ccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhH---HHHHHHHhhh-------
Confidence            3222   12235799999999999988999999999999999999999999976432111   0111000000       


Q ss_pred             cCccccCccCHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHH
Q 046893          330 LDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRP-----VMSDVVA  369 (464)
Q Consensus       330 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~ev~~  369 (464)
                          ....++...+..+.+|+.+||..||.+||     ++.+++.
T Consensus       220 ----~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~  260 (285)
T cd05605         220 ----DQEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKA  260 (285)
T ss_pred             ----cccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhc
Confidence                01122333556789999999999999999     6666643

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=1.1e-41  Score=331.65  Aligned_cols=268  Identities=24%  Similarity=0.376  Sum_probs=210.3

Q ss_pred             HHHhcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCc-cHHHHHHHHHHHhcC-CCCCcceEEEEEE
Q 046893           88 KLATKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQ-GDREWLAEVNYLGQL-RHSNLVKLIGYCC  165 (464)
Q Consensus        88 ~~~~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l-~hpniv~l~~~~~  165 (464)
                      ....++|.+.+.||+|+||.||+|.+..... ......||+|.+...... ....+.+|+.+++++ +||||+++++++.
T Consensus        31 ~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~  109 (302)
T cd05055          31 EFPRNNLSFGKTLGAGAFGKVVEATAYGLSK-SDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACT  109 (302)
T ss_pred             cccHHHeEEcceeeccCCeeEEEEEEecCCC-CCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEe
Confidence            3455679999999999999999998643221 123567999998754322 235688999999999 7999999999999


Q ss_pred             eCCeEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCC
Q 046893          166 EDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGL  245 (464)
Q Consensus       166 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGl  245 (464)
                      ..+..++||||+.+|+|.+++.......+++.++..++.|++.||.|||  .++|+|+||||+|||++.++.++|+|||+
T Consensus       110 ~~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH--~~~ivH~dlkp~Nil~~~~~~~~l~dfg~  187 (302)
T cd05055         110 IGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLA--SKNCIHRDLAARNVLLTHGKIVKICDFGL  187 (302)
T ss_pred             cCCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH--HCCeehhhhccceEEEcCCCeEEECCCcc
Confidence            9999999999999999999987655445899999999999999999999  67799999999999999999999999999


Q ss_pred             ccCCCCCCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHhhhccc
Q 046893          246 AKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLL-GRRAVDKSRPSREHNLVEWARPLLNNNK  324 (464)
Q Consensus       246 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~  324 (464)
                      ++...............++..|+|||.+.+..++.++|||||||++|+|++ |..||........  +..    ..... 
T Consensus       188 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~--~~~----~~~~~-  260 (302)
T cd05055         188 ARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSK--FYK----LIKEG-  260 (302)
T ss_pred             cccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHH--HHH----HHHcC-
Confidence            986533322122223456788999999999999999999999999999998 9999875432110  111    11110 


Q ss_pred             chhhccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHH
Q 046893          325 KVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETV  374 (464)
Q Consensus       325 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~  374 (464)
                               .....+...+..+.+|+.+||..+|++||++.+++..|+.+
T Consensus       261 ---------~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~  301 (302)
T cd05055         261 ---------YRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ  301 (302)
T ss_pred             ---------CcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence                     01111122345899999999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=1.4e-41  Score=327.05  Aligned_cols=263  Identities=25%  Similarity=0.353  Sum_probs=203.9

Q ss_pred             cCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCC-ccHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeE
Q 046893           92 KFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGY-QGDREWLAEVNYLGQLRHSNLVKLIGYCCEDEHR  170 (464)
Q Consensus        92 ~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~  170 (464)
                      +.|++.+.||+|+||+||+|.+..+...  ....+++|.+..... ....++..|+.++..+.||||+++++++.. ...
T Consensus         7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~--~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~   83 (279)
T cd05111           7 TELRKLKLLGSGVFGTVHKGIWIPEGDS--IKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASL   83 (279)
T ss_pred             hhceeccccCccCCcceEEEEEcCCCCc--eeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-Ccc
Confidence            4578889999999999999998654211  123478888754322 223567788889999999999999998754 557


Q ss_pred             EEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCccCCC
Q 046893          171 ILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGP  250 (464)
Q Consensus       171 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~  250 (464)
                      ++++||+.+|+|.+++.... ..+++..+..|+.|++.||.|||  .++++||||||+|||++.++.+||+|||+++...
T Consensus        84 ~~i~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH--~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~  160 (279)
T cd05111          84 QLVTQLSPLGSLLDHVRQHR-DSLDPQRLLNWCVQIAKGMYYLE--EHRMVHRNLAARNILLKSDSIVQIADFGVADLLY  160 (279)
T ss_pred             EEEEEeCCCCcHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHH--HCCEeccccCcceEEEcCCCcEEEcCCccceecc
Confidence            88999999999999987543 46899999999999999999999  6779999999999999999999999999998654


Q ss_pred             CCCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHhhhcccchhhc
Q 046893          251 MGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLL-GRRAVDKSRPSREHNLVEWARPLLNNNKKVLRI  329 (464)
Q Consensus       251 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  329 (464)
                      ............++..|+|||.+.+..++.++|||||||++|||++ |..||.+..+..   ..++    +......   
T Consensus       161 ~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~---~~~~----~~~~~~~---  230 (279)
T cd05111         161 PDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHE---VPDL----LEKGERL---  230 (279)
T ss_pred             CCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH---HHHH----HHCCCcC---
Confidence            3332222334567788999999998899999999999999999998 999997654211   1111    1111100   


Q ss_pred             cCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhc
Q 046893          330 LDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETVQSQ  377 (464)
Q Consensus       330 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~~~~  377 (464)
                             ..+..++..+..++.+||..||.+||++.++++.|..+...
T Consensus       231 -------~~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~~  271 (279)
T cd05111         231 -------AQPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMARD  271 (279)
T ss_pred             -------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHhC
Confidence                   11112345788899999999999999999999999887654

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=7e-42  Score=329.22  Aligned_cols=262  Identities=26%  Similarity=0.438  Sum_probs=206.3

Q ss_pred             hcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCccHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeE
Q 046893           91 TKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVKLIGYCCEDEHR  170 (464)
Q Consensus        91 ~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~  170 (464)
                      .++|.+.+.||+|+||.||++...... ....+..+|+|.+..........+.+|+++++.++|+||+++++++......
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~-~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   82 (280)
T cd05092           4 RRDIVLKWELGEGAFGKVFLAECHNLL-PEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPL   82 (280)
T ss_pred             hHhceeccccCCccCCeEEEeEEecCC-CCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCce
Confidence            456788899999999999999754321 1223567899988765444456789999999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHhhcC-------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCc
Q 046893          171 ILVYEYMESGSLEKHLLRRVG-------------CMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFS  237 (464)
Q Consensus       171 ~lv~e~~~~g~L~~~l~~~~~-------------~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~  237 (464)
                      ++||||+.+++|.+++.....             ..+++..++.++.|++.||.|||  +.+++||||||+|||+++++.
T Consensus        83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH--~~~i~H~dlkp~nil~~~~~~  160 (280)
T cd05092          83 LMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLA--SLHFVHRDLATRNCLVGQGLV  160 (280)
T ss_pred             EEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHH--HCCeecccccHhhEEEcCCCC
Confidence            999999999999999875431             24889999999999999999999  677999999999999999999


Q ss_pred             eEEcccCCccCCCCCCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHh-CCCCCCCCCCcccccHHHHH
Q 046893          238 AKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLL-GRRAVDKSRPSREHNLVEWA  316 (464)
Q Consensus       238 vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~  316 (464)
                      +||+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..||........      .
T Consensus       161 ~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~------~  234 (280)
T cd05092         161 VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEA------I  234 (280)
T ss_pred             EEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHH------H
Confidence            99999999975433222222223445788999999999999999999999999999998 8999865432111      1


Q ss_pred             HHhhhcccchhhccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 046893          317 RPLLNNNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLE  372 (464)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~  372 (464)
                      ......           .....+..++..+.+|+.+||+.||.+||++.+|++.|+
T Consensus       235 ~~~~~~-----------~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~  279 (280)
T cd05092         235 ECITQG-----------RELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ  279 (280)
T ss_pred             HHHHcC-----------ccCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence            111000           000112234557899999999999999999999998885

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=9.4e-42  Score=322.84  Aligned_cols=248  Identities=26%  Similarity=0.403  Sum_probs=196.2

Q ss_pred             ceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCC-ccHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeEEEEEecc
Q 046893           99 ILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGY-QGDREWLAEVNYLGQLRHSNLVKLIGYCCEDEHRILVYEYM  177 (464)
Q Consensus        99 ~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~  177 (464)
                      .||+|+||.||+|.+..+      ++.+|+|.+..... .....+.+|+++++.++||||+++++++......++||||+
T Consensus         2 ~lg~g~~g~vy~~~~~~~------~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   75 (252)
T cd05084           2 RIGRGNFGEVFSGRLRAD------NTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELV   75 (252)
T ss_pred             ccCcccCccEEEEEEecC------CceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeec
Confidence            599999999999998764      56799998764322 23366889999999999999999999999999999999999


Q ss_pred             CCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCccCCCCCCCcce
Q 046893          178 ESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHV  257 (464)
Q Consensus       178 ~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~~~~  257 (464)
                      .+++|.+++... +..+++..++.++.|++.||.|||  .++|+||||||+|||++.++.+||+|||++...........
T Consensus        76 ~~~~L~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH--~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~  152 (252)
T cd05084          76 QGGDFLTFLRTE-GPRLKVKELIQMVENAAAGMEYLE--SKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYAST  152 (252)
T ss_pred             cCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHH--hCCccccccchheEEEcCCCcEEECccccCccccccccccc
Confidence            999999988654 346899999999999999999999  67799999999999999999999999999875432211111


Q ss_pred             eeccccCCcccCccccccCCCCcccchhcHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHhhhcccchhhccCccccC
Q 046893          258 STRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLL-GRRAVDKSRPSREHNLVEWARPLLNNNKKVLRILDPRLEG  336 (464)
Q Consensus       258 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  336 (464)
                      .....++..|+|||.+.+..++.++||||||+++|||++ |..||.......       ....+.          .....
T Consensus       153 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~-------~~~~~~----------~~~~~  215 (252)
T cd05084         153 GGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQ-------TREAIE----------QGVRL  215 (252)
T ss_pred             CCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHH-------HHHHHH----------cCCCC
Confidence            111223457999999998899999999999999999998 888886533211       001111          11111


Q ss_pred             ccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 046893          337 QYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLE  372 (464)
Q Consensus       337 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~  372 (464)
                      ..+..++..+.+|+.+||+.+|.+||++.++++.|.
T Consensus       216 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  251 (252)
T cd05084         216 PCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ  251 (252)
T ss_pred             CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence            223344568999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=8.2e-42  Score=324.14  Aligned_cols=251  Identities=27%  Similarity=0.456  Sum_probs=200.2

Q ss_pred             cCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCccHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeEE
Q 046893           92 KFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVKLIGYCCEDEHRI  171 (464)
Q Consensus        92 ~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~  171 (464)
                      +.|++.+.||+|+||.||+|.+..       +..+|+|.+.... .....+..|+.+|+.++||||+++++++...+..+
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~-------~~~~a~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   75 (256)
T cd05114           4 SELTFMKELGSGQFGVVHLGKWRA-------QIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLY   75 (256)
T ss_pred             HHcEEeeEecCCcCceEEEEEecc-------CceEEEEecccCC-ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEE
Confidence            457788899999999999998754       3458999876443 33467889999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCccCCCC
Q 046893          172 LVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPM  251 (464)
Q Consensus       172 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~  251 (464)
                      +||||+++|+|.+++.... ..+++..++.++.|++.||.|||  .++|+||||||+||+++.++.+||+|||+++....
T Consensus        76 iv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH--~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~  152 (256)
T cd05114          76 IVTEFMENGCLLNYLRQRQ-GKLSKDMLLSMCQDVCEGMEYLE--RNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLD  152 (256)
T ss_pred             EEEEcCCCCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHH--HCCccccccCcceEEEcCCCeEEECCCCCccccCC
Confidence            9999999999999887543 35899999999999999999999  67799999999999999999999999999986432


Q ss_pred             CCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHhhhcccchhhcc
Q 046893          252 GDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLL-GRRAVDKSRPSREHNLVEWARPLLNNNKKVLRIL  330 (464)
Q Consensus       252 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  330 (464)
                      .... ......++..|+|||++.+..++.++||||||+++|||++ |+.||......   ....   ......    ...
T Consensus       153 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~---~~~~---~i~~~~----~~~  221 (256)
T cd05114         153 DEYT-SSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNY---EVVE---MISRGF----RLY  221 (256)
T ss_pred             Ccee-ccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHH---HHHH---HHHCCC----CCC
Confidence            2211 1122345678999999988899999999999999999999 89998654321   1111   111110    001


Q ss_pred             CccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 046893          331 DPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALL  371 (464)
Q Consensus       331 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L  371 (464)
                      .       +...+..+.+|+.+||+.+|.+||++.+++..|
T Consensus       222 ~-------~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l  255 (256)
T cd05114         222 R-------PKLASMTVYEVMYSCWHEKPEGRPTFAELLRAI  255 (256)
T ss_pred             C-------CCCCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence            1       112345789999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=7.2e-42  Score=337.51  Aligned_cols=252  Identities=25%  Similarity=0.298  Sum_probs=212.5

Q ss_pred             HhcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCcc---HHHHHHHHHHHhcCC-CCCcceEEEEEE
Q 046893           90 ATKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQG---DREWLAEVNYLGQLR-HSNLVKLIGYCC  165 (464)
Q Consensus        90 ~~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~-hpniv~l~~~~~  165 (464)
                      ....|.+.+.||.|.||.||+++...+      ++.+|+|++.+.....   ...+.+|+.+|+++. |||||.++++|+
T Consensus        33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~t------g~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e  106 (382)
T KOG0032|consen   33 IKEKYELGRELGRGQFGVVYLCREKST------GKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFE  106 (382)
T ss_pred             ccccEEehhhhCCCCceEEEEEEecCC------CceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEE
Confidence            345688889999999999999998876      6779999998765533   357899999999998 999999999999


Q ss_pred             eCCeEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecC----CCceEEc
Q 046893          166 EDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNA----DFSAKLS  241 (464)
Q Consensus       166 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~----~~~vkl~  241 (464)
                      ....+++|||+|.||.|.+.|...   .+++..+..++.|++.++.|||  ..+|+||||||+|+|+..    ++.+|++
T Consensus       107 ~~~~~~lvmEL~~GGeLfd~i~~~---~~sE~da~~~~~~il~av~~lH--~~gvvHrDlKpEN~L~~~~~~~~~~ik~~  181 (382)
T KOG0032|consen  107 DPDSVYLVMELCEGGELFDRIVKK---HYSERDAAGIIRQILEAVKYLH--SLGVVHRDLKPENLLLASKDEGSGRIKLI  181 (382)
T ss_pred             cCCeEEEEEEecCCchHHHHHHHc---cCCHHHHHHHHHHHHHHHHHHH--hCCceeccCCHHHeeeccccCCCCcEEEe
Confidence            999999999999999999999886   2999999999999999999999  577999999999999943    3579999


Q ss_pred             ccCCccCCCCCCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhh
Q 046893          242 DFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLN  321 (464)
Q Consensus       242 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~  321 (464)
                      |||++.....   .......+||+.|+|||++....|+..+||||+|+++|.|++|..||.+........      ....
T Consensus       182 DFGla~~~~~---~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~------~i~~  252 (382)
T KOG0032|consen  182 DFGLAKFIKP---GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFL------AILR  252 (382)
T ss_pred             eCCCceEccC---CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHH------HHHc
Confidence            9999997544   334556899999999999999999999999999999999999999998765322211      1111


Q ss_pred             cccchhhccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 046893          322 NNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVA  369 (464)
Q Consensus       322 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  369 (464)
                      .        +..+...........+.+++..|+..||.+|+++.++++
T Consensus       253 ~--------~~~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~  292 (382)
T KOG0032|consen  253 G--------DFDFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQ  292 (382)
T ss_pred             C--------CCCCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhc
Confidence            1        123334444556678999999999999999999999987

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-42  Score=344.62  Aligned_cols=253  Identities=25%  Similarity=0.307  Sum_probs=203.1

Q ss_pred             cCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCC---ccHHHHHHHHHHHhcCCCCCcceEEEEEEeCC
Q 046893           92 KFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGY---QGDREWLAEVNYLGQLRHSNLVKLIGYCCEDE  168 (464)
Q Consensus        92 ~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~  168 (464)
                      ++|.+.+.||+|+||+||+|.+..+      ++.||||++.....   .....+..|+.++..++||||+++++++.+.+
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~------~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~   74 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDKDT------GQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEE   74 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEECCC------CCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCC
Confidence            3688899999999999999998764      66799999875321   23356788999999999999999999999999


Q ss_pred             eEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCccC
Q 046893          169 HRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKD  248 (464)
Q Consensus       169 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~  248 (464)
                      ..++||||+.+++|.+++...  ..+++..+..++.|++.||.|||  ..+|+||||||+||||+.++.+||+|||++..
T Consensus        75 ~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH--~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~  150 (350)
T cd05573          75 HLYLVMEYMPGGDLMNLLIRK--DVFPEETARFYIAELVLALDSVH--KLGFIHRDIKPDNILIDADGHIKLADFGLCKK  150 (350)
T ss_pred             eEEEEEcCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH--HCCeeccCCCHHHeEECCCCCEEeecCCCCcc
Confidence            999999999999999998765  36899999999999999999999  57799999999999999999999999999986


Q ss_pred             CCCCC---------------------------CcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHhCCCCC
Q 046893          249 GPMGD---------------------------QTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAV  301 (464)
Q Consensus       249 ~~~~~---------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf  301 (464)
                      .....                           .........||+.|+|||++.+..++.++|||||||+||||++|+.||
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf  230 (350)
T cd05573         151 MNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPF  230 (350)
T ss_pred             CcccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCC
Confidence            43322                           001223357999999999999999999999999999999999999999


Q ss_pred             CCCCCcccccHHHHHHHhhhcccchhhccCccccCccCHHHHHHHHHHHHHhhccCCCCCCC-HHHHHH
Q 046893          302 DKSRPSREHNLVEWARPLLNNNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPV-MSDVVA  369 (464)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-~~ev~~  369 (464)
                      .......      ....+......        +........+..+.+||..||. ||.+||+ +.++++
T Consensus       231 ~~~~~~~------~~~~i~~~~~~--------~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~  284 (350)
T cd05573         231 YSDTLQE------TYNKIINWKES--------LRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKS  284 (350)
T ss_pred             CCCCHHH------HHHHHhccCCc--------ccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhc
Confidence            8654211      11111110000        0000011145688999999997 9999999 999875

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=7.2e-42  Score=335.68  Aligned_cols=267  Identities=25%  Similarity=0.386  Sum_probs=224.6

Q ss_pred             HHHHhcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCC-ccHHHHHHHHHHHhcCCCCCcceEEEEEE
Q 046893           87 MKLATKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGY-QGDREWLAEVNYLGQLRHSNLVKLIGYCC  165 (464)
Q Consensus        87 ~~~~~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~  165 (464)
                      +.+......+.++||.|.||.||+|+...-.  +.....||||..+.+.. ...+.|+.|.-+|+.++|||||+++|+|.
T Consensus       384 yel~Re~Itl~r~iG~GqFGdVy~gvYt~~~--kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~  461 (974)
T KOG4257|consen  384 YELRRELITLKRLIGEGQFGDVYKGVYTDPE--KGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCV  461 (974)
T ss_pred             ceeehhhccHHHhhcCCcccceeeeEecccc--cCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeee
Confidence            3444455666788999999999999987642  23456799999987543 34577999999999999999999999997


Q ss_pred             eCCeEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCC
Q 046893          166 EDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGL  245 (464)
Q Consensus       166 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGl  245 (464)
                      +. ..+||||+++-|.|..||..+.. .|+..+...+++||+.+|.|||  .+++|||||..+|||+...-.|||+|||+
T Consensus       462 e~-P~WivmEL~~~GELr~yLq~nk~-sL~l~tL~ly~~Qi~talaYLe--SkrfVHRDIAaRNiLVsSp~CVKLaDFGL  537 (974)
T KOG4257|consen  462 EQ-PMWIVMELAPLGELREYLQQNKD-SLPLRTLTLYCYQICTALAYLE--SKRFVHRDIAARNILVSSPQCVKLADFGL  537 (974)
T ss_pred             cc-ceeEEEecccchhHHHHHHhccc-cchHHHHHHHHHHHHHHHHHHH--hhchhhhhhhhhheeecCcceeeecccch
Confidence            64 67899999999999999987654 6999999999999999999999  56799999999999999998999999999


Q ss_pred             ccCCCCCCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHhhhccc
Q 046893          246 AKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLL-GRRAVDKSRPSREHNLVEWARPLLNNNK  324 (464)
Q Consensus       246 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~  324 (464)
                      ++......+.+.. ...-...|||||.+.-..++.++|||-|||++||+|. |..||.+...                 .
T Consensus       538 SR~~ed~~yYkaS-~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkN-----------------s  599 (974)
T KOG4257|consen  538 SRYLEDDAYYKAS-RGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKN-----------------S  599 (974)
T ss_pred             hhhccccchhhcc-ccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccc-----------------c
Confidence            9987655554433 4455778999999999999999999999999999997 9999987543                 2


Q ss_pred             chhhccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhc
Q 046893          325 KVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETVQSQ  377 (464)
Q Consensus       325 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~~~~  377 (464)
                      ++.-.++..-+...+..|+..++.|+.+||+++|.+||.+.++.+.|.++...
T Consensus       600 DVI~~iEnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~qe  652 (974)
T KOG4257|consen  600 DVIGHIENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQE  652 (974)
T ss_pred             ceEEEecCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHHH
Confidence            33333455556677889999999999999999999999999999999988763

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=1.5e-41  Score=350.07  Aligned_cols=269  Identities=21%  Similarity=0.335  Sum_probs=195.1

Q ss_pred             hHHHHHhcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCccHHHHHHHHHHHhcCC------CCCcc
Q 046893           85 NEMKLATKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLR------HSNLV  158 (464)
Q Consensus        85 ~~~~~~~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~------hpniv  158 (464)
                      .++....++|++.++||+|+||+||+|.+...      ++.||||+++... .....+..|+.++..+.      |++|+
T Consensus       122 ~~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~------~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~  194 (467)
T PTZ00284        122 EDIDVSTQRFKILSLLGEGTFGKVVEAWDRKR------KEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLM  194 (467)
T ss_pred             CccccCCCcEEEEEEEEeccCEEEEEEEEcCC------CeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCccee
Confidence            34455678899999999999999999998764      6779999986432 22234556666666654      45688


Q ss_pred             eEEEEEEeC-CeEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCC-
Q 046893          159 KLIGYCCED-EHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADF-  236 (464)
Q Consensus       159 ~l~~~~~~~-~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~-  236 (464)
                      +++++|... .++|||||++ +++|.+++.+.  ..+++..+..|+.||+.||.|||+ ..+||||||||+||||+.++ 
T Consensus       195 ~i~~~~~~~~~~~~iv~~~~-g~~l~~~l~~~--~~l~~~~~~~i~~qi~~aL~yLH~-~~gIiHrDlKP~NILl~~~~~  270 (467)
T PTZ00284        195 KIQRYFQNETGHMCIVMPKY-GPCLLDWIMKH--GPFSHRHLAQIIFQTGVALDYFHT-ELHLMHTDLKPENILMETSDT  270 (467)
T ss_pred             eeEEEEEcCCceEEEEEecc-CCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHh-cCCeecCCCCHHHEEEecCCc
Confidence            999988765 5789999998 77898888764  369999999999999999999994 24799999999999998665 


Q ss_pred             ---------------ceEEcccCCccCCCCCCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHhCCCCC
Q 046893          237 ---------------SAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAV  301 (464)
Q Consensus       237 ---------------~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf  301 (464)
                                     .+||+|||++....     ......+||..|+|||++.+..|+.++|||||||+||||++|+.||
T Consensus       271 ~~~~~~~~~~~~~~~~vkl~DfG~~~~~~-----~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf  345 (467)
T PTZ00284        271 VVDPVTNRALPPDPCRVRICDLGGCCDER-----HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLY  345 (467)
T ss_pred             ccccccccccCCCCceEEECCCCccccCc-----cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCC
Confidence                           49999999886422     1223478999999999999999999999999999999999999999


Q ss_pred             CCCCCcccccHHH---------HHH--------HhhhcccchhhccCccc-----c--CccCHHHHHHHHHHHHHhhccC
Q 046893          302 DKSRPSREHNLVE---------WAR--------PLLNNNKKVLRILDPRL-----E--GQYTARTAMKVAGLAYQCLSQN  357 (464)
Q Consensus       302 ~~~~~~~~~~~~~---------~~~--------~~~~~~~~~~~~~~~~~-----~--~~~~~~~~~~l~~li~~cl~~d  357 (464)
                      ...........+.         |..        .++..........++..     .  ..........+.+||.+||..|
T Consensus       346 ~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~d  425 (467)
T PTZ00284        346 DTHDNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYD  425 (467)
T ss_pred             CCCChHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcC
Confidence            8654322111111         100        00000000000000000     0  0000012346789999999999


Q ss_pred             CCCCCCHHHHHH
Q 046893          358 PKGRPVMSDVVA  369 (464)
Q Consensus       358 P~~RPs~~ev~~  369 (464)
                      |.+|||+.++++
T Consensus       426 P~~R~ta~e~L~  437 (467)
T PTZ00284        426 RQKRLNARQMTT  437 (467)
T ss_pred             hhhCCCHHHHhc
Confidence            999999999985

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=6e-42  Score=335.54  Aligned_cols=239  Identities=28%  Similarity=0.426  Sum_probs=190.6

Q ss_pred             CceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCC---ccHHHHHHHHHHHhcC-CCCCcceEEEEEEeCCeEEEE
Q 046893           98 YILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGY---QGDREWLAEVNYLGQL-RHSNLVKLIGYCCEDEHRILV  173 (464)
Q Consensus        98 ~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~lv  173 (464)
                      +.||+|+||.||+|.+..+      ++.||+|++.....   .....+..|..++..+ +||||+++++++...+..++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~------~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv   74 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGT------NEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFV   74 (316)
T ss_pred             CeeeeCCCeEEEEEEECCC------CCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEE
Confidence            3699999999999998765      56799999875321   2224456677777654 899999999999999999999


Q ss_pred             EeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCccCCCCCC
Q 046893          174 YEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGD  253 (464)
Q Consensus       174 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~  253 (464)
                      |||+++|+|.+++....  .+++..+..++.|++.||.|||  .++|+||||||+|||++.++.+||+|||+++......
T Consensus        75 ~e~~~gg~L~~~~~~~~--~~~~~~~~~~~~qi~~al~~LH--~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~  150 (316)
T cd05592          75 MEYLNGGDLMFHIQSSG--RFDEARARFYAAEIICGLQFLH--KKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE  150 (316)
T ss_pred             EcCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH--HCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC
Confidence            99999999998886543  6899999999999999999999  6779999999999999999999999999997543222


Q ss_pred             CcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhcccchhhccCcc
Q 046893          254 QTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRILDPR  333 (464)
Q Consensus       254 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  333 (464)
                        ......+||..|+|||++.+..++.++|||||||++|||++|+.||.+....      +........        .  
T Consensus       151 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~------~~~~~i~~~--------~--  212 (316)
T cd05592         151 --GKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDED------ELFDSILND--------R--  212 (316)
T ss_pred             --CccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHH------HHHHHHHcC--------C--
Confidence              2233467999999999999999999999999999999999999999764321      111111111        0  


Q ss_pred             ccCccCHHHHHHHHHHHHHhhccCCCCCCCHHH
Q 046893          334 LEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSD  366 (464)
Q Consensus       334 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~e  366 (464)
                        ..++..++..+.+|+.+||+.||.+||++.+
T Consensus       213 --~~~~~~~~~~~~~ll~~~l~~~P~~R~~~~~  243 (316)
T cd05592         213 --PHFPRWISKEAKDCLSKLFERDPTKRLGVDG  243 (316)
T ss_pred             --CCCCCCCCHHHHHHHHHHccCCHHHcCCChH
Confidence              1122234457889999999999999999853

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=1.1e-41  Score=335.59  Aligned_cols=244  Identities=25%  Similarity=0.368  Sum_probs=191.9

Q ss_pred             CceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCC---ccHHHHHHHHHHHhcC-CCCCcceEEEEEEeCCeEEEE
Q 046893           98 YILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGY---QGDREWLAEVNYLGQL-RHSNLVKLIGYCCEDEHRILV  173 (464)
Q Consensus        98 ~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~lv  173 (464)
                      +.||+|+||+||+|.+..+      ++.||+|++.....   .....+..|+.++..+ +||||+++++++...+..++|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~------~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv   74 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKT------ERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV   74 (329)
T ss_pred             CeeeeCCCeEEEEEEECCC------CCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEE
Confidence            3699999999999998765      56799999876422   2234567888888776 799999999999999999999


Q ss_pred             EeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCccCCCCCC
Q 046893          174 YEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGD  253 (464)
Q Consensus       174 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~  253 (464)
                      |||+++|+|..++...  ..+++..+..++.|++.||.|||  .++|+||||||+|||++.++.+||+|||+++......
T Consensus        75 ~E~~~~~~L~~~~~~~--~~l~~~~~~~i~~qi~~~l~~lH--~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~  150 (329)
T cd05618          75 IEYVNGGDLMFHMQRQ--RKLPEEHARFYSAEISLALNYLH--ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG  150 (329)
T ss_pred             EeCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH--HCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCC
Confidence            9999999998887654  36899999999999999999999  6779999999999999999999999999997532211


Q ss_pred             CcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHhCCCCCCCCCCcc--cccHHHHHHHhhhcccchhhccC
Q 046893          254 QTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSR--EHNLVEWARPLLNNNKKVLRILD  331 (464)
Q Consensus       254 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~  331 (464)
                        ......+||..|+|||++.+..++.++|||||||++|+|++|+.||.......  ......+....+...        
T Consensus       151 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~--------  220 (329)
T cd05618         151 --DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK--------  220 (329)
T ss_pred             --CccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcC--------
Confidence              12234679999999999999999999999999999999999999996422111  111122221111110        


Q ss_pred             ccccCccCHHHHHHHHHHHHHhhccCCCCCCCH
Q 046893          332 PRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVM  364 (464)
Q Consensus       332 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~  364 (464)
                       .  ..++...+..+.+|+.+||..||.+||++
T Consensus       221 -~--~~~p~~~~~~~~~ll~~~L~~dP~~R~~~  250 (329)
T cd05618         221 -Q--IRIPRSLSVKAASVLKSFLNKDPKERLGC  250 (329)
T ss_pred             -C--CCCCCCCCHHHHHHHHHHhcCCHHHcCCC
Confidence             0  11223344578899999999999999985

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.6e-42  Score=344.82  Aligned_cols=253  Identities=22%  Similarity=0.296  Sum_probs=198.3

Q ss_pred             cCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCC---ccHHHHHHHHHHHhcCCCCCcceEEEEEEeCC
Q 046893           92 KFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGY---QGDREWLAEVNYLGQLRHSNLVKLIGYCCEDE  168 (464)
Q Consensus        92 ~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~  168 (464)
                      ++|++.+.||+|+||+||+|.+..+      ++.||||++.....   .....+..|+.+|..++||||+++++++.+.+
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~------~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~   74 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKKDT------GHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDEN   74 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEECCC------CCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCC
Confidence            3688899999999999999998765      66799999875321   22345778999999999999999999999999


Q ss_pred             eEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCccC
Q 046893          169 HRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKD  248 (464)
Q Consensus       169 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~  248 (464)
                      ..+|||||+.+|+|.+++....  .+++..+..++.|++.||.|||  +.+|+||||||+|||++.++.+||+|||+++.
T Consensus        75 ~~~lv~E~~~~g~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~lH--~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~  150 (364)
T cd05599          75 YLYLIMEYLPGGDMMTLLMKKD--TFTEEETRFYIAETILAIDSIH--KLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTG  150 (364)
T ss_pred             eEEEEECCCCCcHHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH--HCCeEeccCCHHHeEECCCCCEEEeeccccee
Confidence            9999999999999999887643  6899999999999999999999  67799999999999999999999999999875


Q ss_pred             CCCCCCc------------------------------------ceeeccccCCcccCccccccCCCCcccchhcHHHHHH
Q 046893          249 GPMGDQT------------------------------------HVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLL  292 (464)
Q Consensus       249 ~~~~~~~------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~  292 (464)
                      .......                                    ......+||+.|+|||++.+..++.++|||||||++|
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~  230 (364)
T cd05599         151 LKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMY  230 (364)
T ss_pred             ccccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHH
Confidence            3221100                                    0111247999999999999999999999999999999


Q ss_pred             HHHhCCCCCCCCCCcccccHHHHHHHhhhcccchhhccCccccCccCHHHHHHHHHHHHHhhccCCCCCCC---HHHHHH
Q 046893          293 EMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPV---MSDVVA  369 (464)
Q Consensus       293 ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs---~~ev~~  369 (464)
                      ||++|..||.......      ............        ........+..+.+||.+||. +|.+|++   +.+++.
T Consensus       231 el~~G~~Pf~~~~~~~------~~~~i~~~~~~~--------~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~  295 (364)
T cd05599         231 EMLVGYPPFCSDNPQE------TYRKIINWKETL--------QFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKS  295 (364)
T ss_pred             HhhcCCCCCCCCCHHH------HHHHHHcCCCcc--------CCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhc
Confidence            9999999997654211      111111111000        000011234578899999996 9999998   666654

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.5e-41  Score=324.86  Aligned_cols=259  Identities=27%  Similarity=0.417  Sum_probs=202.7

Q ss_pred             CCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCc--cHHHHHHHHHHHhcCCCCCcceEEEEEEeCCe--
Q 046893           94 FRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQ--GDREWLAEVNYLGQLRHSNLVKLIGYCCEDEH--  169 (464)
Q Consensus        94 ~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~--  169 (464)
                      |.+.+.||+|+||.||+|.+..+..   ....||+|.+......  ....+..|+.+++.++||||+++++++.....  
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~   77 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDG---SQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQ   77 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCC---CcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccc
Confidence            5678899999999999998765321   2466999998754322  23578899999999999999999998866554  


Q ss_pred             ----EEEEEeccCCCCHHHHHHhhc----CCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEc
Q 046893          170 ----RILVYEYMESGSLEKHLLRRV----GCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLS  241 (464)
Q Consensus       170 ----~~lv~e~~~~g~L~~~l~~~~----~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~  241 (464)
                          .++||||+++++|..++....    ...+++..++.++.|++.||.|||  +.+|+||||||+||++++++.+||+
T Consensus        78 ~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH--~~~i~H~dlkp~Nil~~~~~~~kl~  155 (273)
T cd05035          78 KIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLS--NRNFIHRDLAARNCMLREDMTVCVA  155 (273)
T ss_pred             cCcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHH--hCCeeccccchheEEECCCCeEEEC
Confidence                799999999999998885432    236899999999999999999999  6779999999999999999999999


Q ss_pred             ccCCccCCCCCCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHhh
Q 046893          242 DFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLL-GRRAVDKSRPSREHNLVEWARPLL  320 (464)
Q Consensus       242 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~  320 (464)
                      |||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..||......      ++.....
T Consensus       156 dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~------~~~~~~~  229 (273)
T cd05035         156 DFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENH------EIYDYLR  229 (273)
T ss_pred             CccceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHH------HHHHHHH
Confidence            9999986543332222222345678999999988899999999999999999999 88888654321      1111111


Q ss_pred             hcccchhhccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHH
Q 046893          321 NNNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETV  374 (464)
Q Consensus       321 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~  374 (464)
                      ..           .....+..++..+.+++.+||+.||.+||++.++++.|+.+
T Consensus       230 ~~-----------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~  272 (273)
T cd05035         230 HG-----------NRLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI  272 (273)
T ss_pred             cC-----------CCCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            10           01112233456899999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=5e-42  Score=342.63  Aligned_cols=204  Identities=25%  Similarity=0.325  Sum_probs=174.7

Q ss_pred             cCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCC---ccHHHHHHHHHHHhcCCCCCcceEEEEEEeCC
Q 046893           92 KFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGY---QGDREWLAEVNYLGQLRHSNLVKLIGYCCEDE  168 (464)
Q Consensus        92 ~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~  168 (464)
                      ++|++.+.||+|+||+||+|.+..+      ++.||+|++.....   .....+..|+.++..++||||+++++++.+..
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~~~------~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~   74 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKKDT------GHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKL   74 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEECCC------CCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCC
Confidence            3688899999999999999998764      66799999865322   12245778999999999999999999999999


Q ss_pred             eEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCccC
Q 046893          169 HRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKD  248 (464)
Q Consensus       169 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~  248 (464)
                      ..||||||+++|+|.+++.+.  ..+++..+..++.|++.||.|||  +++|+||||||+|||++.++.+||+|||+++.
T Consensus        75 ~~~lv~E~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~lH--~~givHrDlKp~NILi~~~~~vkL~DFGla~~  150 (363)
T cd05628          75 NLYLIMEFLPGGDMMTLLMKK--DTLTEEETQFYIAETVLAIDSIH--QLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTG  150 (363)
T ss_pred             eEEEEEcCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH--hCCeEecCCCHHHeEECCCCCEEEeeccCccc
Confidence            999999999999999998764  36899999999999999999999  67799999999999999999999999999975


Q ss_pred             CCCCCCc---------------------------------ceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHH
Q 046893          249 GPMGDQT---------------------------------HVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEML  295 (464)
Q Consensus       249 ~~~~~~~---------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell  295 (464)
                      .......                                 ......+||+.|+|||++.+..++.++|||||||+||||+
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell  230 (363)
T cd05628         151 LKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEML  230 (363)
T ss_pred             ccccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHH
Confidence            3221100                                 0112358999999999999999999999999999999999


Q ss_pred             hCCCCCCCCC
Q 046893          296 LGRRAVDKSR  305 (464)
Q Consensus       296 ~g~~pf~~~~  305 (464)
                      +|+.||....
T Consensus       231 ~G~~Pf~~~~  240 (363)
T cd05628         231 IGYPPFCSET  240 (363)
T ss_pred             hCCCCCCCCC
Confidence            9999997654

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=5.5e-42  Score=337.03  Aligned_cols=242  Identities=26%  Similarity=0.377  Sum_probs=194.7

Q ss_pred             CCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCC---CccHHHHHHHHHHHhcCCCC-CcceEEEEEEeCC
Q 046893           93 FFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGG---YQGDREWLAEVNYLGQLRHS-NLVKLIGYCCEDE  168 (464)
Q Consensus        93 ~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hp-niv~l~~~~~~~~  168 (464)
                      +|++.+.||+|+||.||+|.+..+      ++.||+|++....   ......+..|++++..+.|+ +|+++++++...+
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~------~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~   74 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGT------DELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMD   74 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCC------CCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCC
Confidence            478889999999999999998765      5679999987532   12335678899999999765 6888999999999


Q ss_pred             eEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCccC
Q 046893          169 HRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKD  248 (464)
Q Consensus       169 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~  248 (464)
                      ..|+||||+++|+|.+++....  .+++..+..++.|++.||.|||  .++|+||||||+|||++.++.+||+|||+++.
T Consensus        75 ~~~lv~E~~~~g~L~~~~~~~~--~~~~~~~~~~~~qi~~al~~lH--~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~  150 (324)
T cd05587          75 RLYFVMEYVNGGDLMYHIQQVG--KFKEPHAVFYAAEIAIGLFFLH--SKGIIYRDLKLDNVMLDAEGHIKIADFGMCKE  150 (324)
T ss_pred             EEEEEEcCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH--HCCeEecCCCHHHeEEcCCCCEEEeecCccee
Confidence            9999999999999998886543  6899999999999999999999  67799999999999999999999999999875


Q ss_pred             CCCCCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhcccchhh
Q 046893          249 GPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLR  328 (464)
Q Consensus       249 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  328 (464)
                      ......  .....+||..|+|||++.+..++.++|||||||++|+|++|+.||......      +.........     
T Consensus       151 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~------~~~~~i~~~~-----  217 (324)
T cd05587         151 NIFGGK--TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDED------ELFQSIMEHN-----  217 (324)
T ss_pred             cCCCCC--ceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH------HHHHHHHcCC-----
Confidence            322221  223467999999999999999999999999999999999999999764321      1111111110     


Q ss_pred             ccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCH
Q 046893          329 ILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVM  364 (464)
Q Consensus       329 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~  364 (464)
                             ..++...+..+.+|+.+||..||.+|++.
T Consensus       218 -------~~~~~~~~~~~~~li~~~l~~~P~~R~~~  246 (324)
T cd05587         218 -------VSYPKSLSKEAVSICKGLLTKHPAKRLGC  246 (324)
T ss_pred             -------CCCCCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence                   11222344578899999999999999987

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.4e-43  Score=343.20  Aligned_cols=252  Identities=25%  Similarity=0.413  Sum_probs=206.0

Q ss_pred             cCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCccHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeEE
Q 046893           92 KFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVKLIGYCCEDEHRI  171 (464)
Q Consensus        92 ~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~  171 (464)
                      +.|.++..||-|+||+||+|...+.      +-..|.|++........++|+.|+.||..+.||+||+|++.|..++.++
T Consensus        32 d~WeIiGELGDGAFGKVyKA~nket------~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLw  105 (1187)
T KOG0579|consen   32 DHWEIIGELGDGAFGKVYKAVNKET------KLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLW  105 (1187)
T ss_pred             HHHHHHhhhcCccchhhhhhhcccc------hhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceE
Confidence            3466677799999999999997754      4556788887766677788999999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCccCCCC
Q 046893          172 LVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPM  251 (464)
Q Consensus       172 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~  251 (464)
                      |+.|||.||-+...+... +..|.+..+..+++|++.||.|||  +++|||||||+.|||+.-+|.|+|+|||.+-..  
T Consensus       106 iliEFC~GGAVDaimlEL-~r~LtE~QIqvvc~q~ldALn~LH--s~~iIHRDLKAGNiL~TldGdirLADFGVSAKn--  180 (1187)
T KOG0579|consen  106 ILIEFCGGGAVDAIMLEL-GRVLTEDQIQVVCYQVLDALNWLH--SQNIIHRDLKAGNILLTLDGDIRLADFGVSAKN--  180 (1187)
T ss_pred             EEEeecCCchHhHHHHHh-ccccchHHHHHHHHHHHHHHHHHh--hcchhhhhccccceEEEecCcEeeecccccccc--
Confidence            999999999997776654 568999999999999999999999  677999999999999999999999999988642  


Q ss_pred             CCCcceeeccccCCcccCccccc-----cCCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhcccch
Q 046893          252 GDQTHVSTRVMGTYGYAAPEYVM-----TGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKV  326 (464)
Q Consensus       252 ~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  326 (464)
                      .........++||++|||||++.     ..+|+.++||||||++|.||..+.+|.....+...      ...+...    
T Consensus       181 ~~t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRV------llKiaKS----  250 (1187)
T KOG0579|consen  181 KSTRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRV------LLKIAKS----  250 (1187)
T ss_pred             hhHHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHH------HHHHhhc----
Confidence            22223345689999999999874     56899999999999999999999999876554321      1111111    


Q ss_pred             hhccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 046893          327 LRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVA  369 (464)
Q Consensus       327 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  369 (464)
                         -.|.+  -.+..+...+.+|+.+||..||..||++.++++
T Consensus       251 ---ePPTL--lqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~  288 (1187)
T KOG0579|consen  251 ---EPPTL--LQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLK  288 (1187)
T ss_pred             ---CCCcc--cCcchhhhHHHHHHHHHHhcCCccCCCHHHHhh
Confidence               01111  224456668999999999999999999998874

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=1.1e-41  Score=334.30  Aligned_cols=239  Identities=26%  Similarity=0.398  Sum_probs=192.4

Q ss_pred             CceeecCceEEEEEEecCCCCCCccceEEEEEEccCCC---CccHHHHHHHHHHHhcC-CCCCcceEEEEEEeCCeEEEE
Q 046893           98 YILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGG---YQGDREWLAEVNYLGQL-RHSNLVKLIGYCCEDEHRILV  173 (464)
Q Consensus        98 ~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~lv  173 (464)
                      +.||+|+||+||+|.+..+      ++.||+|++....   ......+..|..++..+ +||||+++++++...+.+|+|
T Consensus         1 ~~lg~G~~g~V~~~~~~~~------~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv   74 (320)
T cd05590           1 RVLGKGSFGKVMLARLKES------GRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFV   74 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCC------CCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEE
Confidence            3699999999999998764      6679999986532   12335567888888876 699999999999999999999


Q ss_pred             EeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCccCCCCCC
Q 046893          174 YEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGD  253 (464)
Q Consensus       174 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~  253 (464)
                      |||+++|+|.+++....  .+++..+..++.|++.||.|||  .++|+||||||+|||++.++.+||+|||+++......
T Consensus        75 ~Ey~~~g~L~~~i~~~~--~l~~~~~~~~~~ql~~~L~~lH--~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~  150 (320)
T cd05590          75 MEFVNGGDLMFHIQKSR--RFDEARARFYAAEITSALMFLH--DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG  150 (320)
T ss_pred             EcCCCCchHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH--HCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC
Confidence            99999999998886643  6899999999999999999999  6779999999999999999999999999987532221


Q ss_pred             CcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhcccchhhccCcc
Q 046893          254 QTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRILDPR  333 (464)
Q Consensus       254 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  333 (464)
                        .......||+.|+|||++.+..++.++|||||||++|+|++|+.||......      +..........         
T Consensus       151 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~------~~~~~i~~~~~---------  213 (320)
T cd05590         151 --KTTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENED------DLFEAILNDEV---------  213 (320)
T ss_pred             --CcccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHH------HHHHHHhcCCC---------
Confidence              1233467999999999999999999999999999999999999999764321      11111111110         


Q ss_pred             ccCccCHHHHHHHHHHHHHhhccCCCCCCCHHH
Q 046893          334 LEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSD  366 (464)
Q Consensus       334 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~e  366 (464)
                         .++...+..+.+|+.+||+.||.+||++.+
T Consensus       214 ---~~~~~~~~~~~~li~~~L~~dP~~R~~~~~  243 (320)
T cd05590         214 ---VYPTWLSQDAVDILKAFMTKNPTMRLGSLT  243 (320)
T ss_pred             ---CCCCCCCHHHHHHHHHHcccCHHHCCCCCC
Confidence               112224457899999999999999999844

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=7e-42  Score=329.49  Aligned_cols=261  Identities=26%  Similarity=0.372  Sum_probs=205.7

Q ss_pred             CCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCcc-HHHHHHHHHHHhcCCCCCcceEEEEEEeCCeEE
Q 046893           93 FFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQG-DREWLAEVNYLGQLRHSNLVKLIGYCCEDEHRI  171 (464)
Q Consensus        93 ~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~  171 (464)
                      .|++.+.||+|+||.||+|.+..+.. ...+..||+|++....... ...+..|+.++..++||||+++++++......+
T Consensus         6 ~~~~~~~lg~G~~g~V~~~~~~~~~~-~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~   84 (283)
T cd05091           6 TVRFMEELGEDRFGKVYKGHLFGTAP-GEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLS   84 (283)
T ss_pred             HHHHHHHhCCCCCCeEEEEEEecCCC-CCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceE
Confidence            46777889999999999998765321 2235679999997543322 356889999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHhhc--------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCc
Q 046893          172 LVYEYMESGSLEKHLLRRV--------------GCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFS  237 (464)
Q Consensus       172 lv~e~~~~g~L~~~l~~~~--------------~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~  237 (464)
                      +++||+.+++|.+++....              ...+++..++.++.|++.||.|||  +++|+||||||+|||+++++.
T Consensus        85 ~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH--~~gi~H~dlkp~Nil~~~~~~  162 (283)
T cd05091          85 MIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLS--SHHVVHKDLATRNVLVFDKLN  162 (283)
T ss_pred             EEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH--HcCccccccchhheEecCCCc
Confidence            9999999999999885321              134788899999999999999999  677999999999999999999


Q ss_pred             eEEcccCCccCCCCCCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHh-CCCCCCCCCCcccccHHHHH
Q 046893          238 AKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLL-GRRAVDKSRPSREHNLVEWA  316 (464)
Q Consensus       238 vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~  316 (464)
                      +||+|||+++...............+++.|+|||.+.+..++.++|||||||++|||++ |..||.+...      .++.
T Consensus       163 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~------~~~~  236 (283)
T cd05091         163 VKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN------QDVI  236 (283)
T ss_pred             eEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCH------HHHH
Confidence            99999999986543332222333456789999999988899999999999999999998 8888865432      1111


Q ss_pred             HHhhhcccchhhccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q 046893          317 RPLLNNNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLET  373 (464)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~  373 (464)
                      .......           ....+..++..+.+|+..||+.+|.+||++.+|+..|+.
T Consensus       237 ~~i~~~~-----------~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~  282 (283)
T cd05091         237 EMIRNRQ-----------VLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT  282 (283)
T ss_pred             HHHHcCC-----------cCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence            1111111           112233456689999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=1.3e-42  Score=324.49  Aligned_cols=266  Identities=24%  Similarity=0.369  Sum_probs=202.7

Q ss_pred             CCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCccHHHHHHHHHHHhcCCCCCcceEEEEEEeCC----
Q 046893           93 FFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVKLIGYCCEDE----  168 (464)
Q Consensus        93 ~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~----  168 (464)
                      .|...+++|.|+||.||+|+...+      .+.||||.+-.+..    .-.+|+++|+.+.|||||+++.+|....    
T Consensus        25 ~~~~~~liG~GsFg~Vyq~~~~e~------~~~vAIKKv~~d~r----~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~   94 (364)
T KOG0658|consen   25 SYEAVRLIGSGSFGVVYQAKLRET------EEEVAIKKVLQDKR----YKNRELQIMRKLDHPNIVRLLYFFSSSTESDE   94 (364)
T ss_pred             EEEeeEEEeecccceEEEEEEcCC------CceeEEEEecCCCC----cCcHHHHHHHhcCCcCeeeEEEEEEecCCCch
Confidence            366678899999999999998876      56799998754322    2247999999999999999998886542    


Q ss_pred             -eEEEEEeccCCCCHHHHHHhh--cCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCC-CceEEcccC
Q 046893          169 -HRILVYEYMESGSLEKHLLRR--VGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNAD-FSAKLSDFG  244 (464)
Q Consensus       169 -~~~lv~e~~~~g~L~~~l~~~--~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~-~~vkl~DFG  244 (464)
                       ...||||||+. +|.+++...  .+..++.-.+.-+..||++||.|||  ..+|+||||||.|+|+|.+ |.+||||||
T Consensus        95 ~~lnlVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh--~~~IcHRDIKPqNlLvD~~tg~LKicDFG  171 (364)
T KOG0658|consen   95 VYLNLVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLH--SHGICHRDIKPQNLLVDPDTGVLKICDFG  171 (364)
T ss_pred             hHHHHHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHH--hcCcccCCCChheEEEcCCCCeEEeccCC
Confidence             34689999965 999888742  2456888888899999999999999  4679999999999999977 899999999


Q ss_pred             CccCCCCCCCcceeeccccCCcccCccccccC-CCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhcc
Q 046893          245 LAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTG-HLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNN  323 (464)
Q Consensus       245 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~  323 (464)
                      .|+....+...   ..+.-|..|+|||.+.|. .|+.+.||||.||++.||+-|++.|.+...  ..++++.+.-+-...
T Consensus       172 SAK~L~~~epn---iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~--~dQL~eIik~lG~Pt  246 (364)
T KOG0658|consen  172 SAKVLVKGEPN---ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSS--VDQLVEIIKVLGTPT  246 (364)
T ss_pred             cceeeccCCCc---eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCH--HHHHHHHHHHhCCCC
Confidence            99976655433   335678899999999874 799999999999999999999999988543  344444443222111


Q ss_pred             cchhhccC--------cccc-----CccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH--HHHHHHh
Q 046893          324 KKVLRILD--------PRLE-----GQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVA--LLETVQS  376 (464)
Q Consensus       324 ~~~~~~~~--------~~~~-----~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~--~L~~~~~  376 (464)
                      ++....+.        +.+.     .-+....+.+..+|+.++|..+|.+|.++.+++.  ++.++..
T Consensus       247 ~e~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~  314 (364)
T KOG0658|consen  247 REDIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRD  314 (364)
T ss_pred             HHHHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhC
Confidence            11111111        1111     1234456778999999999999999999999873  4555443

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=6.7e-42  Score=328.35  Aligned_cols=264  Identities=27%  Similarity=0.420  Sum_probs=208.4

Q ss_pred             HHhcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCC-ccHHHHHHHHHHHhcCCCCCcceEEEEEEeC
Q 046893           89 LATKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGY-QGDREWLAEVNYLGQLRHSNLVKLIGYCCED  167 (464)
Q Consensus        89 ~~~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~  167 (464)
                      +..++|.+.+.||+|+||.||+|.+..... +.....||+|.+..... .....+.+|+.++..++||||+++++++...
T Consensus         3 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~-~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~   81 (277)
T cd05032           3 LPREKITLIRELGQGSFGMVYEGLAKGVVK-GEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTG   81 (277)
T ss_pred             cchHHeeEEeEecCCCCceEEEEEEeccCC-CCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCC
Confidence            345678899999999999999998865321 22356799999865432 2235688999999999999999999999999


Q ss_pred             CeEEEEEeccCCCCHHHHHHhhc--------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceE
Q 046893          168 EHRILVYEYMESGSLEKHLLRRV--------GCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAK  239 (464)
Q Consensus       168 ~~~~lv~e~~~~g~L~~~l~~~~--------~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vk  239 (464)
                      ...++||||+++++|.+++....        ...+++..++.++.|++.||.|||  ..+|+||||||+|||++.++.+|
T Consensus        82 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH--~~~i~H~di~p~nill~~~~~~k  159 (277)
T cd05032          82 QPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLA--AKKFVHRDLAARNCMVAEDLTVK  159 (277)
T ss_pred             CCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHH--hCCccccccChheEEEcCCCCEE
Confidence            99999999999999999986532        124788899999999999999999  67799999999999999999999


Q ss_pred             EcccCCccCCCCCCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHH
Q 046893          240 LSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLL-GRRAVDKSRPSREHNLVEWARP  318 (464)
Q Consensus       240 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~  318 (464)
                      |+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..||.......   ...+   
T Consensus       160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~---~~~~---  233 (277)
T cd05032         160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEE---VLKF---  233 (277)
T ss_pred             ECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHH---HHHH---
Confidence            999999986443332222233557889999999988889999999999999999998 898986543211   1111   


Q ss_pred             hhhcccchhhccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 046893          319 LLNNNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLE  372 (464)
Q Consensus       319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~  372 (464)
                       ....          .....+..++..+.+++.+||+.+|.+|||+.++++.|+
T Consensus       234 -~~~~----------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~  276 (277)
T cd05032         234 -VIDG----------GHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK  276 (277)
T ss_pred             -HhcC----------CCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence             1110          011122234568999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.2e-42  Score=344.95  Aligned_cols=253  Identities=20%  Similarity=0.275  Sum_probs=195.7

Q ss_pred             cCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCC---ccHHHHHHHHHHHhcCCCCCcceEEEEEEeCC
Q 046893           92 KFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGY---QGDREWLAEVNYLGQLRHSNLVKLIGYCCEDE  168 (464)
Q Consensus        92 ~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~  168 (464)
                      ++|.+.+.||+|+||+||+|.+..+      ++.||||++.....   .....+.+|++++..+.||||+++++++.+.+
T Consensus         1 ~~y~~~~~lG~G~~g~Vy~~~~~~~------~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~   74 (377)
T cd05629           1 EDFHTVKVIGKGAFGEVRLVQKKDT------GKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQ   74 (377)
T ss_pred             CCceEeEEEeecCCEEEEEEEECCC------CCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCC
Confidence            3688899999999999999988765      66799999864321   22356788999999999999999999999999


Q ss_pred             eEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCccC
Q 046893          169 HRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKD  248 (464)
Q Consensus       169 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~  248 (464)
                      ..||||||+++|+|.+++...  ..+++..+..++.|++.||.|||  ..+|+||||||+|||++.++.+||+|||+++.
T Consensus        75 ~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~ql~~aL~~LH--~~givHrDlkp~NIll~~~~~~kl~DfGla~~  150 (377)
T cd05629          75 YLYLIMEFLPGGDLMTMLIKY--DTFSEDVTRFYMAECVLAIEAVH--KLGFIHRDIKPDNILIDRGGHIKLSDFGLSTG  150 (377)
T ss_pred             eeEEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH--hCCeeccCCCHHHEEECCCCCEEEeecccccc
Confidence            999999999999999988754  36899999999999999999999  67799999999999999999999999999963


Q ss_pred             CCCCCCc---------------------------------------------ceeeccccCCcccCccccccCCCCcccc
Q 046893          249 GPMGDQT---------------------------------------------HVSTRVMGTYGYAAPEYVMTGHLTARSD  283 (464)
Q Consensus       249 ~~~~~~~---------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~D  283 (464)
                      +......                                             ......+||+.|+|||++.+..++.++|
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~D  230 (377)
T cd05629         151 FHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECD  230 (377)
T ss_pred             cccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCcee
Confidence            2110000                                             0001257999999999999999999999


Q ss_pred             hhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhcccchhhccCccccCccCHHHHHHHHHHHHHhhccCCCCC--
Q 046893          284 VYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGR--  361 (464)
Q Consensus       284 vwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R--  361 (464)
                      ||||||+||||++|..||.......      ...........+ ..  +.     ....+..+.+|+.+||. +|.+|  
T Consensus       231 iwSlGvil~elltG~~Pf~~~~~~~------~~~~i~~~~~~~-~~--p~-----~~~~s~~~~dli~~lL~-~~~~r~~  295 (377)
T cd05629         231 WWSLGAIMFECLIGWPPFCSENSHE------TYRKIINWRETL-YF--PD-----DIHLSVEAEDLIRRLIT-NAENRLG  295 (377)
T ss_pred             eEecchhhhhhhcCCCCCCCCCHHH------HHHHHHccCCcc-CC--CC-----CCCCCHHHHHHHHHHhc-CHhhcCC
Confidence            9999999999999999997644211      111111110000 00  00     01234578899999997 77765  


Q ss_pred             -CCHHHHHH
Q 046893          362 -PVMSDVVA  369 (464)
Q Consensus       362 -Ps~~ev~~  369 (464)
                       +++.+++.
T Consensus       296 r~~~~~~l~  304 (377)
T cd05629         296 RGGAHEIKS  304 (377)
T ss_pred             CCCHHHHhc
Confidence             57777764

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=1e-41  Score=343.01  Aligned_cols=270  Identities=22%  Similarity=0.331  Sum_probs=209.2

Q ss_pred             HHHHhcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCcc-HHHHHHHHHHHhcCC-CCCcceEEEEE
Q 046893           87 MKLATKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQG-DREWLAEVNYLGQLR-HSNLVKLIGYC  164 (464)
Q Consensus        87 ~~~~~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~-hpniv~l~~~~  164 (464)
                      +.+..++|.+.+.||+|+||.||+|.+.... .......||+|+++...... ...+..|+.+|..+. ||||+++++++
T Consensus        32 ~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~-~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~  110 (401)
T cd05107          32 WEMPRDNLVLGRTLGSGAFGRVVEATAHGLS-HSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGAC  110 (401)
T ss_pred             ceecHHHeehhhhccCCCceeEEEEEEcCCC-CCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEE
Confidence            3445556888899999999999999976421 11235679999997643322 346889999999997 99999999999


Q ss_pred             EeCCeEEEEEeccCCCCHHHHHHhhcC-----------------------------------------------------
Q 046893          165 CEDEHRILVYEYMESGSLEKHLLRRVG-----------------------------------------------------  191 (464)
Q Consensus       165 ~~~~~~~lv~e~~~~g~L~~~l~~~~~-----------------------------------------------------  191 (464)
                      ...+..++||||+.+|+|.+++.....                                                     
T Consensus       111 ~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  190 (401)
T cd05107         111 TKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYV  190 (401)
T ss_pred             ccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCcc
Confidence            999999999999999999999865321                                                     


Q ss_pred             -------------------------------------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCC
Q 046893          192 -------------------------------------------CMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTS  228 (464)
Q Consensus       192 -------------------------------------------~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~  228 (464)
                                                                 ..+++..++.++.|++.||.|||  .++|+||||||+
T Consensus       191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH--~~~ivHrdlkp~  268 (401)
T cd05107         191 PMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLA--SKNCVHRDLAAR  268 (401)
T ss_pred             chhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHh--cCCcCcccCCcc
Confidence                                                       13677788999999999999999  677999999999


Q ss_pred             ceEecCCCceEEcccCCccCCCCCCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHh-CCCCCCCCCCc
Q 046893          229 NILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLL-GRRAVDKSRPS  307 (464)
Q Consensus       229 Nill~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~  307 (464)
                      |||++.++.+||+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..||......
T Consensus       269 NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~  348 (401)
T cd05107         269 NVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMN  348 (401)
T ss_pred             eEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCch
Confidence            99999999999999999985432221111223457889999999998889999999999999999998 88898654321


Q ss_pred             ccccHHHHHHHhhhcccchhhccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHH
Q 046893          308 REHNLVEWARPLLNNNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETVQ  375 (464)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~~  375 (464)
                      .      .....+..          ......+..++.++.+|+.+||..+|.+||++++|+..|+.+.
T Consensus       349 ~------~~~~~~~~----------~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~  400 (401)
T cd05107         349 E------QFYNAIKR----------GYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL  400 (401)
T ss_pred             H------HHHHHHHc----------CCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence            1      11111111          1111122234568999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=4.8e-42  Score=345.12  Aligned_cols=251  Identities=23%  Similarity=0.303  Sum_probs=194.3

Q ss_pred             CCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCC---ccHHHHHHHHHHHhcCCCCCcceEEEEEEeCCe
Q 046893           93 FFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGY---QGDREWLAEVNYLGQLRHSNLVKLIGYCCEDEH  169 (464)
Q Consensus        93 ~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~  169 (464)
                      +|++.+.||+|+||+||+|.+..+      ++.||+|++.....   .....+.+|+.+++.++||||+++++++.+.+.
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~~~~------~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~   75 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARKVDT------KALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDN   75 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEECCC------CCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCE
Confidence            588899999999999999998765      66799999865322   123467889999999999999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCccCC
Q 046893          170 RILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDG  249 (464)
Q Consensus       170 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~  249 (464)
                      .|||||||++|+|.+++.+.  ..+++..+..++.||+.||.|||  ..+|+||||||+|||++.++.+||+|||++...
T Consensus        76 ~~lv~E~~~gg~L~~~l~~~--~~~~e~~~~~~~~qi~~al~~lH--~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~  151 (382)
T cd05625          76 LYFVMDYIPGGDMMSLLIRM--GIFPEDLARFYIAELTCAVESVH--KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGF  151 (382)
T ss_pred             EEEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH--hCCeecCCCCHHHEEECCCCCEEEeECCCCccc
Confidence            99999999999999988764  36889999999999999999999  567999999999999999999999999998532


Q ss_pred             CCCC---------------------------------------------CcceeeccccCCcccCccccccCCCCcccch
Q 046893          250 PMGD---------------------------------------------QTHVSTRVMGTYGYAAPEYVMTGHLTARSDV  284 (464)
Q Consensus       250 ~~~~---------------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv  284 (464)
                      ....                                             ........+||+.|+|||++.+..++.++||
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~Di  231 (382)
T cd05625         152 RWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDW  231 (382)
T ss_pred             cccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeE
Confidence            1000                                             0001123579999999999999999999999


Q ss_pred             hcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhcccchhhccCccccCccCHHHHHHHHHHHHHhhccCCCCCCC-
Q 046893          285 YGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPV-  363 (464)
Q Consensus       285 wslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-  363 (464)
                      |||||+||||++|+.||....+...      ........        ...........+.++.+++.+|+ .+|.+|++ 
T Consensus       232 wSlGvil~elltG~~Pf~~~~~~~~------~~~i~~~~--------~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~  296 (382)
T cd05625         232 WSVGVILYEMLVGQPPFLAQTPLET------QMKVINWQ--------TSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGK  296 (382)
T ss_pred             EechHHHHHHHhCCCCCCCCCHHHH------HHHHHccC--------CCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCC
Confidence            9999999999999999976543211      11111100        00000011123346778888876 59999987 


Q ss_pred             --HHHHH
Q 046893          364 --MSDVV  368 (464)
Q Consensus       364 --~~ev~  368 (464)
                        +.+++
T Consensus       297 ~~~~ei~  303 (382)
T cd05625         297 NGADEIK  303 (382)
T ss_pred             CCHHHHh
Confidence              66554

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=1.5e-41  Score=333.50  Aligned_cols=236  Identities=27%  Similarity=0.404  Sum_probs=189.6

Q ss_pred             CceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCC---ccHHHHHHHHHHHhcC-CCCCcceEEEEEEeCCeEEEE
Q 046893           98 YILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGY---QGDREWLAEVNYLGQL-RHSNLVKLIGYCCEDEHRILV  173 (464)
Q Consensus        98 ~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~lv  173 (464)
                      ++||+|+||.||+|.+..+      ++.||+|++.....   .....+..|.+++..+ +||||+++++++...+..|||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~------~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv   74 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGT------DEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFV   74 (321)
T ss_pred             CccccCCCeEEEEEEECCC------CCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEE
Confidence            3599999999999998764      56799999875321   2234567888888866 799999999999999999999


Q ss_pred             EeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCccCCCCCC
Q 046893          174 YEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGD  253 (464)
Q Consensus       174 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~  253 (464)
                      |||+++++|.+++...  ..+++..+..++.|++.||.|||  +++|+||||||+|||++.++.+||+|||+++......
T Consensus        75 ~E~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH--~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~  150 (321)
T cd05591          75 MEYVNGGDLMFQIQRS--RKFDEPRSRFYAAEVTLALMFLH--RHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG  150 (321)
T ss_pred             EeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH--HCCeeccCCCHHHeEECCCCCEEEeecccceecccCC
Confidence            9999999999888654  36899999999999999999999  6779999999999999999999999999997532222


Q ss_pred             CcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhcccchhhccCcc
Q 046893          254 QTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRILDPR  333 (464)
Q Consensus       254 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  333 (464)
                        ......+||..|+|||++.+..++.++|||||||++|+|++|+.||......      ..........        . 
T Consensus       151 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~------~~~~~i~~~~--------~-  213 (321)
T cd05591         151 --VTTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNED------DLFESILHDD--------V-  213 (321)
T ss_pred             --ccccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHH------HHHHHHHcCC--------C-
Confidence              1223467999999999999999999999999999999999999999765421      1111111111        0 


Q ss_pred             ccCccCHHHHHHHHHHHHHhhccCCCCCCC
Q 046893          334 LEGQYTARTAMKVAGLAYQCLSQNPKGRPV  363 (464)
Q Consensus       334 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs  363 (464)
                         .++...+.++.+|+.+||..||.+||+
T Consensus       214 ---~~p~~~~~~~~~ll~~~L~~dp~~R~~  240 (321)
T cd05591         214 ---LYPVWLSKEAVSILKAFMTKNPNKRLG  240 (321)
T ss_pred             ---CCCCCCCHHHHHHHHHHhccCHHHcCC
Confidence               112223457889999999999999993

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.7e-42  Score=331.28  Aligned_cols=248  Identities=22%  Similarity=0.327  Sum_probs=211.0

Q ss_pred             cCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCccH--HHHHHHHHHHhcCCCCCcceEEEEEEeCCe
Q 046893           92 KFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGD--REWLAEVNYLGQLRHSNLVKLIGYCCEDEH  169 (464)
Q Consensus        92 ~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~--~~~~~E~~~l~~l~hpniv~l~~~~~~~~~  169 (464)
                      .-|.+.+.||+|.|..|-+|++.-      +|+.||||++.+......  ..+..|++.|+.++|||||+||++......
T Consensus        18 GLYDLekTlG~GHFAVVKLArHVF------TGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTK   91 (864)
T KOG4717|consen   18 GLYDLEKTLGRGHFAVVKLARHVF------TGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTK   91 (864)
T ss_pred             eeehhhhhhcCCceehhhhhhhhc------ccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccce
Confidence            447888899999999999987654      488899999987655433  568899999999999999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEec-CCCceEEcccCCccC
Q 046893          170 RILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLN-ADFSAKLSDFGLAKD  248 (464)
Q Consensus       170 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~-~~~~vkl~DFGla~~  248 (464)
                      +|||+|+=++|+|+|||.++. ..+.+..+.+++.||+.|+.|+|  ...+|||||||+||.+. .-|-|||+|||++..
T Consensus        92 lyLiLELGD~GDl~DyImKHe-~Gl~E~La~kYF~QI~~AI~YCH--qLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNk  168 (864)
T KOG4717|consen   92 LYLILELGDGGDLFDYIMKHE-EGLNEDLAKKYFAQIVHAISYCH--QLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNK  168 (864)
T ss_pred             EEEEEEecCCchHHHHHHhhh-ccccHHHHHHHHHHHHHHHHHHh--hhhhhcccCCcceeEEeeecCceEeeecccccc
Confidence            999999999999999999875 35999999999999999999999  66799999999999874 558899999999988


Q ss_pred             CCCCCCcceeeccccCCcccCccccccCCCCc-ccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhcccchh
Q 046893          249 GPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTA-RSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVL  327 (464)
Q Consensus       249 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~-~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  327 (464)
                      +..+..   ..+.||...|-|||++.|..|+. ++||||||||||-|+||+.||...+..+...                
T Consensus       169 f~PG~k---L~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLT----------------  229 (864)
T KOG4717|consen  169 FQPGKK---LTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLT----------------  229 (864)
T ss_pred             CCCcch---hhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhh----------------
Confidence            766543   34589999999999999999985 6899999999999999999998776543322                


Q ss_pred             hccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 046893          328 RILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVA  369 (464)
Q Consensus       328 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  369 (464)
                      .++|-.  ...+.....+..+||..||..||++|.+.++|..
T Consensus       230 mImDCK--YtvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s  269 (864)
T KOG4717|consen  230 MIMDCK--YTVPSHVSKECRDLIQSMLVRDPKKRASLEEIVS  269 (864)
T ss_pred             hhhccc--ccCchhhhHHHHHHHHHHHhcCchhhccHHHHhc
Confidence            222222  2345566778999999999999999999999864

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=3.1e-42  Score=345.77  Aligned_cols=252  Identities=23%  Similarity=0.296  Sum_probs=196.4

Q ss_pred             CCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCC---ccHHHHHHHHHHHhcCCCCCcceEEEEEEeCCe
Q 046893           93 FFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGY---QGDREWLAEVNYLGQLRHSNLVKLIGYCCEDEH  169 (464)
Q Consensus        93 ~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~  169 (464)
                      .|++.+.||+|+||.||+|.+..+      ++.||||++.....   .....+.+|+.+|..++||||+++++++.+.+.
T Consensus         2 ~y~~~~~lG~G~~g~V~~a~~~~~------~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~   75 (376)
T cd05598           2 MFVKIKTIGIGAFGEVCLVRKVDT------NALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDN   75 (376)
T ss_pred             CceEEEEEEeCCCeEEEEEEECCC------CCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCE
Confidence            588999999999999999998765      67799999864321   223557889999999999999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCccCC
Q 046893          170 RILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDG  249 (464)
Q Consensus       170 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~  249 (464)
                      ++|||||+++|+|.+++....  .+++..+..++.||+.||.|||  ..+|+||||||+|||++.++.+||+|||+|..+
T Consensus        76 ~~lv~E~~~~g~L~~~i~~~~--~~~~~~~~~~~~qi~~al~~lH--~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~  151 (376)
T cd05598          76 LYFVMDYIPGGDMMSLLIRLG--IFEEDLARFYIAELTCAIESVH--KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGF  151 (376)
T ss_pred             EEEEEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH--HCCeEeCCCCHHHEEECCCCCEEEEeCCCCccc
Confidence            999999999999999987643  6889999999999999999999  677999999999999999999999999998532


Q ss_pred             CCCC-----------------------------------------CcceeeccccCCcccCccccccCCCCcccchhcHH
Q 046893          250 PMGD-----------------------------------------QTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFG  288 (464)
Q Consensus       250 ~~~~-----------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG  288 (464)
                      ....                                         ........+||+.|+|||++.+..++.++||||||
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG  231 (376)
T cd05598         152 RWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVG  231 (376)
T ss_pred             cccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeecc
Confidence            1000                                         00011235799999999999999999999999999


Q ss_pred             HHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhcccchhhccCccccCccCHHHHHHHHHHHHHhhccCCCCCC---CHH
Q 046893          289 VVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRP---VMS  365 (464)
Q Consensus       289 ~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP---s~~  365 (464)
                      |+||||++|+.||....+...      .........        .+........+..+.+++.+|+ .+|.+|+   ++.
T Consensus       232 vilyell~G~~Pf~~~~~~~~------~~~i~~~~~--------~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~  296 (376)
T cd05598         232 VILYEMLVGQPPFLADTPAET------QLKVINWET--------TLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGAD  296 (376)
T ss_pred             ceeeehhhCCCCCCCCCHHHH------HHHHhccCc--------cccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHH
Confidence            999999999999986543211      111111000        0000111123446778888876 5999999   777


Q ss_pred             HHHH
Q 046893          366 DVVA  369 (464)
Q Consensus       366 ev~~  369 (464)
                      +++.
T Consensus       297 ell~  300 (376)
T cd05598         297 EIKA  300 (376)
T ss_pred             HHhC
Confidence            7764

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=3e-41  Score=322.08  Aligned_cols=260  Identities=22%  Similarity=0.319  Sum_probs=207.0

Q ss_pred             cCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCC---ccHHHHHHHHHHHhcCCCCCcceEEEEEEeCC
Q 046893           92 KFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGY---QGDREWLAEVNYLGQLRHSNLVKLIGYCCEDE  168 (464)
Q Consensus        92 ~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~  168 (464)
                      .+|++.+.||+|+||.||+|.+..+      ++.||||.+.....   .....+.+|+.+++.++||||+++++++...+
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~~------~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   75 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLLD------RKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDN   75 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeCC------CCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECC
Confidence            4688999999999999999998764      56799998764322   22346789999999999999999999999999


Q ss_pred             eEEEEEeccCCCCHHHHHHhh--cCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCc
Q 046893          169 HRILVYEYMESGSLEKHLLRR--VGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLA  246 (464)
Q Consensus       169 ~~~lv~e~~~~g~L~~~l~~~--~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla  246 (464)
                      ..++||||+++++|.+++...  ....++...+..++.|++.||.|||  +++++|+||||+|||++.++.++|+|||++
T Consensus        76 ~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH--~~~i~H~dl~~~nil~~~~~~~~l~d~g~~  153 (267)
T cd08228          76 ELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMH--SRRVMHRDIKPANVFITATGVVKLGDLGLG  153 (267)
T ss_pred             eEEEEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHh--hCCeeCCCCCHHHEEEcCCCCEEECccccc
Confidence            999999999999999887542  2345889999999999999999999  677999999999999999999999999998


Q ss_pred             cCCCCCCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhcccch
Q 046893          247 KDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKV  326 (464)
Q Consensus       247 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  326 (464)
                      .......  .......|+..|+|||.+.+..++.++||||||+++|||++|+.||......    ...+......     
T Consensus       154 ~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~----~~~~~~~~~~-----  222 (267)
T cd08228         154 RFFSSKT--TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN----LFSLCQKIEQ-----  222 (267)
T ss_pred             eeccchh--HHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCcccccc----HHHHHHHHhc-----
Confidence            7643221  1122356889999999999888999999999999999999999999654321    1111111110     


Q ss_pred             hhccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHH
Q 046893          327 LRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETVQ  375 (464)
Q Consensus       327 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~~  375 (464)
                           ...........+..+.+++.+||..+|.+||++.+|+..|+.+.
T Consensus       223 -----~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~  266 (267)
T cd08228         223 -----CDYPPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH  266 (267)
T ss_pred             -----CCCCCCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence                 00111112234568999999999999999999999999998763

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=1.9e-41  Score=322.98  Aligned_cols=255  Identities=29%  Similarity=0.438  Sum_probs=204.0

Q ss_pred             hcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCccHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeE
Q 046893           91 TKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVKLIGYCCEDEHR  170 (464)
Q Consensus        91 ~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~  170 (464)
                      ..+|++.+.||+|+||.||+|.+...       ..||+|++.... .....+.+|+.+++.++||||+++++++. ....
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~~~-------~~valK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~   75 (262)
T cd05071           5 RESLRLEVKLGQGCFGEVWMGTWNGT-------TRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPI   75 (262)
T ss_pred             hHHeeEeeecCCCCCCcEEEEEecCC-------ceEEEEecccCc-cCHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCc
Confidence            45699999999999999999987553       348999987533 23467899999999999999999999874 4567


Q ss_pred             EEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCccCCC
Q 046893          171 ILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGP  250 (464)
Q Consensus       171 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~  250 (464)
                      ++||||+.+|+|.+++....+..+++..+..++.|++.||.|||  +.+++||||||+||+++.++.++|+|||+++...
T Consensus        76 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH--~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~  153 (262)
T cd05071          76 YIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE--RMNYVHRDLRAANILVGENLVCKVADFGLARLIE  153 (262)
T ss_pred             EEEEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHH--HCCccccccCcccEEEcCCCcEEeccCCceeecc
Confidence            89999999999999997655556899999999999999999999  6779999999999999999999999999997543


Q ss_pred             CCCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHhhhcccchhhc
Q 046893          251 MGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLL-GRRAVDKSRPSREHNLVEWARPLLNNNKKVLRI  329 (464)
Q Consensus       251 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  329 (464)
                      ..... ......++..|+|||++.+..++.++||||||+++|+|++ |..||.......      .......        
T Consensus       154 ~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~------~~~~~~~--------  218 (262)
T cd05071         154 DNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE------VLDQVER--------  218 (262)
T ss_pred             ccccc-cccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHH------HHHHHhc--------
Confidence            32221 1122446778999999988899999999999999999999 888886543211      0111100        


Q ss_pred             cCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHH
Q 046893          330 LDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETV  374 (464)
Q Consensus       330 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~  374 (464)
                         .........++..+.+|+.+||+.||.+||++.+++++|+..
T Consensus       219 ---~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~  260 (262)
T cd05071         219 ---GYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY  260 (262)
T ss_pred             ---CCCCCCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence               000111234556889999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=7.2e-42  Score=334.97  Aligned_cols=241  Identities=27%  Similarity=0.435  Sum_probs=192.1

Q ss_pred             CceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCC---ccHHHHHHHHHHHhcC-CCCCcceEEEEEEeCCeEEEE
Q 046893           98 YILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGY---QGDREWLAEVNYLGQL-RHSNLVKLIGYCCEDEHRILV  173 (464)
Q Consensus        98 ~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~lv  173 (464)
                      +.||+|+||.||+|.+..+      ++.||+|++.....   .....+..|..++..+ .||||+++++++...+..|+|
T Consensus         1 ~~lg~G~~g~V~~~~~~~~------~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv   74 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGK------GEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFV   74 (316)
T ss_pred             CeeeeCCCeEEEEEEECCC------CCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEE
Confidence            3699999999999998765      66799999875321   2234566788888754 899999999999999999999


Q ss_pred             EeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCccCCCCCC
Q 046893          174 YEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGD  253 (464)
Q Consensus       174 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~  253 (464)
                      |||+.+|+|..++...  ..+++..+..++.|++.||.|||  .++|+||||||+|||++.++.+||+|||+++......
T Consensus        75 ~E~~~~g~L~~~i~~~--~~~~~~~~~~~~~qi~~~l~~lH--~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  150 (316)
T cd05620          75 MEFLNGGDLMFHIQDK--GRFDLYRATFYAAEIVCGLQFLH--SKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD  150 (316)
T ss_pred             ECCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH--HCCeEecCCCHHHeEECCCCCEEeCccCCCeecccCC
Confidence            9999999999888664  36899999999999999999999  6779999999999999999999999999987532222


Q ss_pred             CcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhcccchhhccCcc
Q 046893          254 QTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRILDPR  333 (464)
Q Consensus       254 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  333 (464)
                        ......+||..|+|||++.+..++.++|||||||++|||++|+.||......   .+.+   .....        .+ 
T Consensus       151 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~---~~~~---~~~~~--------~~-  213 (316)
T cd05620         151 --NRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDED---ELFE---SIRVD--------TP-  213 (316)
T ss_pred             --CceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH---HHHH---HHHhC--------CC-
Confidence              1233478999999999999999999999999999999999999999754321   1111   11100        11 


Q ss_pred             ccCccCHHHHHHHHHHHHHhhccCCCCCCCHH-HHH
Q 046893          334 LEGQYTARTAMKVAGLAYQCLSQNPKGRPVMS-DVV  368 (464)
Q Consensus       334 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~-ev~  368 (464)
                         .++...+.++.+|+.+||+.||.+||++. +++
T Consensus       214 ---~~~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~  246 (316)
T cd05620         214 ---HYPRWITKESKDILEKLFERDPTRRLGVVGNIR  246 (316)
T ss_pred             ---CCCCCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence               11222345788999999999999999985 444

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=4.8e-42  Score=343.36  Aligned_cols=257  Identities=19%  Similarity=0.225  Sum_probs=201.6

Q ss_pred             HHHhcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCC---ccHHHHHHHHHHHhcCCCCCcceEEEEE
Q 046893           88 KLATKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGY---QGDREWLAEVNYLGQLRHSNLVKLIGYC  164 (464)
Q Consensus        88 ~~~~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~  164 (464)
                      .+..++|++.+.||+|+||.||+|.+..+      ++.||+|++.....   .....+..|+.+++.++||||+++++++
T Consensus        39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~------~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~  112 (370)
T cd05596          39 RMKAEDFDVIKVIGRGAFGEVQLVRHKSS------KQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAF  112 (370)
T ss_pred             CCCHHHcEEEEEEeeCCCEEEEEEEECCC------CCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEE
Confidence            34456799999999999999999998765      66799999864321   2234577899999999999999999999


Q ss_pred             EeCCeEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccC
Q 046893          165 CEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFG  244 (464)
Q Consensus       165 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFG  244 (464)
                      .+.+..++||||+++|+|.+++...   .+++..+..++.|++.||.|||  +++|+||||||+|||++.++.+||+|||
T Consensus       113 ~~~~~~~lv~Ey~~gg~L~~~l~~~---~l~~~~~~~~~~qi~~aL~~LH--~~~ivHrDLkp~NILl~~~~~~kL~DfG  187 (370)
T cd05596         113 QDDKYLYMVMEYMPGGDLVNLMSNY---DIPEKWARFYTAEVVLALDAIH--SMGFIHRDVKPDNMLLDKSGHLKLADFG  187 (370)
T ss_pred             ecCCEEEEEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHH--HCCeeccCCCHHHEEEcCCCCEEEEecc
Confidence            9999999999999999999988653   4889999999999999999999  6779999999999999999999999999


Q ss_pred             CccCCCCCCCcceeeccccCCcccCccccccC----CCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhh
Q 046893          245 LAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTG----HLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLL  320 (464)
Q Consensus       245 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~  320 (464)
                      ++........ ......+||+.|+|||++.+.    .++.++|||||||+||||++|+.||......      .......
T Consensus       188 ~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~------~~~~~i~  260 (370)
T cd05596         188 TCMKMDANGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV------GTYSKIM  260 (370)
T ss_pred             ceeeccCCCc-ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHH------HHHHHHH
Confidence            9976432211 122346799999999988653    4789999999999999999999999764421      1111111


Q ss_pred             hcccchhhccCccccCccCHHHHHHHHHHHHHhhccCCCC--CCCHHHHHHH
Q 046893          321 NNNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKG--RPVMSDVVAL  370 (464)
Q Consensus       321 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~ev~~~  370 (464)
                      .....        +.-......+..+.+|+.+||..+|.+  |+++.+++..
T Consensus       261 ~~~~~--------~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h  304 (370)
T cd05596         261 DHKNS--------LTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH  304 (370)
T ss_pred             cCCCc--------CCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence            11100        000011123558889999999999987  9999988753

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=1.2e-41  Score=326.90  Aligned_cols=262  Identities=26%  Similarity=0.369  Sum_probs=203.6

Q ss_pred             hcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCc-cHHHHHHHHHHHhcCCCCCcceEEEEEEeCCe
Q 046893           91 TKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQ-GDREWLAEVNYLGQLRHSNLVKLIGYCCEDEH  169 (464)
Q Consensus        91 ~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~  169 (464)
                      .++|.+.+.||+|+||.||+|.+...... .....||+|.+...... ....+..|+.+++.++|+||+++++++.+.+.
T Consensus         5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~-~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   83 (277)
T cd05036           5 RDSITLLRALGHGAFGEVYEGLYRGRDGD-AVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLP   83 (277)
T ss_pred             HHHcEeeeECCCCCCCcEEEEEEecCCCC-CCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence            45688899999999999999998652111 12567899988654322 23568899999999999999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHhhcC-----CCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCC---ceEEc
Q 046893          170 RILVYEYMESGSLEKHLLRRVG-----CMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADF---SAKLS  241 (464)
Q Consensus       170 ~~lv~e~~~~g~L~~~l~~~~~-----~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~---~vkl~  241 (464)
                      .++||||+.+++|.+++.....     ..+++..++.++.||+.||.|||  .++++||||||+|||++.++   .+||+
T Consensus        84 ~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH--~~~ivH~dlkp~nil~~~~~~~~~~kl~  161 (277)
T cd05036          84 RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLE--ENHFIHRDIAARNCLLTCKGPGRVAKIA  161 (277)
T ss_pred             cEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHH--HCCEeecccchheEEEeccCCCcceEec
Confidence            9999999999999999876432     25899999999999999999999  56799999999999997654   59999


Q ss_pred             ccCCccCCCCCCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHhh
Q 046893          242 DFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLL-GRRAVDKSRPSREHNLVEWARPLL  320 (464)
Q Consensus       242 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~  320 (464)
                      |||+++...............++..|+|||++.+..++.++|||||||++|||++ |..||.......      .... +
T Consensus       162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~------~~~~-~  234 (277)
T cd05036         162 DFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQE------VMEF-V  234 (277)
T ss_pred             cCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH------HHHH-H
Confidence            9999986532222111222334568999999998999999999999999999997 999997543211      1111 1


Q ss_pred             hcccchhhccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 046893          321 NNNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLE  372 (464)
Q Consensus       321 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~  372 (464)
                      ...          .....+..++..+.+++.+||+.+|++||++.+|++.|.
T Consensus       235 ~~~----------~~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~  276 (277)
T cd05036         235 TGG----------GRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ  276 (277)
T ss_pred             HcC----------CcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence            111          111122334568899999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=9.2e-42  Score=335.31  Aligned_cols=242  Identities=24%  Similarity=0.353  Sum_probs=194.8

Q ss_pred             CCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCC---ccHHHHHHHHHHHhcC-CCCCcceEEEEEEeCC
Q 046893           93 FFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGY---QGDREWLAEVNYLGQL-RHSNLVKLIGYCCEDE  168 (464)
Q Consensus        93 ~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~  168 (464)
                      +|.+.+.||+|+||.||+|.+..+      +..||+|++.....   .....+..|..++..+ +|++|+++++++...+
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~------~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~   74 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGT------DELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMD   74 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCC------CCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCC
Confidence            477889999999999999998764      56799999875422   1224567788888777 5899999999999999


Q ss_pred             eEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCccC
Q 046893          169 HRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKD  248 (464)
Q Consensus       169 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~  248 (464)
                      ..++||||+++|+|.+++....  .+++..+..++.|++.||.|||  .++|+||||||+|||++.++.+||+|||+++.
T Consensus        75 ~~~lv~E~~~~g~L~~~~~~~~--~~~~~~~~~~~~qi~~aL~~LH--~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~  150 (323)
T cd05616          75 RLYFVMEYVNGGDLMYQIQQVG--RFKEPHAVFYAAEIAIGLFFLH--SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKE  150 (323)
T ss_pred             EEEEEEcCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH--HCCEEecCCCHHHeEECCCCcEEEccCCCcee
Confidence            9999999999999998886543  6899999999999999999999  67799999999999999999999999999975


Q ss_pred             CCCCCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhcccchhh
Q 046893          249 GPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLR  328 (464)
Q Consensus       249 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  328 (464)
                      .....  ......+||+.|+|||++.+..++.++|||||||++|||++|+.||......      ..........     
T Consensus       151 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~------~~~~~i~~~~-----  217 (323)
T cd05616         151 NMWDG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED------ELFQSIMEHN-----  217 (323)
T ss_pred             cCCCC--CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHH------HHHHHHHhCC-----
Confidence            32221  1223467999999999999999999999999999999999999999764321      1111111111     


Q ss_pred             ccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCH
Q 046893          329 ILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVM  364 (464)
Q Consensus       329 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~  364 (464)
                             ..++...+.++.+|+.+||+.||.+|++.
T Consensus       218 -------~~~p~~~s~~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05616         218 -------VAYPKSMSKEAVAICKGLMTKHPGKRLGC  246 (323)
T ss_pred             -------CCCCCcCCHHHHHHHHHHcccCHHhcCCC
Confidence                   11222345578899999999999999985

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3e-42  Score=342.19  Aligned_cols=254  Identities=26%  Similarity=0.407  Sum_probs=216.1

Q ss_pred             CCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCc-cHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeEEEE
Q 046893           95 RPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQ-GDREWLAEVNYLGQLRHSNLVKLIGYCCEDEHRILV  173 (464)
Q Consensus        95 ~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv  173 (464)
                      .+.++||+|.||.|++|.|+.-   ..+...||||++...... ....|++|+.+|.+|+|||+++|||+..+ ....||
T Consensus       113 ~l~e~LG~GsFgvV~rg~Wt~p---sgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV  188 (1039)
T KOG0199|consen  113 KLYELLGEGSFGVVKRGTWTQP---SGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMV  188 (1039)
T ss_pred             HHHHHhcCcceeeEeeccccCC---CCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHH
Confidence            3456799999999999999863   334567999999876655 45789999999999999999999999887 678899


Q ss_pred             EeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCccCCCCCC
Q 046893          174 YEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGD  253 (464)
Q Consensus       174 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~  253 (464)
                      ||++..|+|.+.|.+.....|.......++.||+.||.||.  .+++|||||..+|+||.....|||+||||.+....++
T Consensus       189 ~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLe--skrlvHRDLAARNlllasprtVKI~DFGLmRaLg~ne  266 (1039)
T KOG0199|consen  189 FELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLE--SKRLVHRDLAARNLLLASPRTVKICDFGLMRALGENE  266 (1039)
T ss_pred             hhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHh--hhhhhhhhhhhhhheecccceeeeecccceeccCCCC
Confidence            99999999999998855667999999999999999999999  6779999999999999888899999999999776554


Q ss_pred             Ccce-eeccccCCcccCccccccCCCCcccchhcHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHhhhcccchhhccC
Q 046893          254 QTHV-STRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLL-GRRAVDKSRPSREHNLVEWARPLLNNNKKVLRILD  331 (464)
Q Consensus       254 ~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  331 (464)
                      .... .....-...|+|||.+....|+.++|||+|||+|||||+ |..||.+....                 .+++.+|
T Consensus       267 d~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~-----------------qIL~~iD  329 (1039)
T KOG0199|consen  267 DMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGI-----------------QILKNID  329 (1039)
T ss_pred             cceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHH-----------------HHHHhcc
Confidence            4333 223345678999999999999999999999999999999 88999876532                 3344455


Q ss_pred             ccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 046893          332 PRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALL  371 (464)
Q Consensus       332 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L  371 (464)
                      ....-..+..|+++|+++++.||..+|.+||++..|.+.+
T Consensus       330 ~~erLpRPk~csedIY~imk~cWah~paDRptFsair~~~  369 (1039)
T KOG0199|consen  330 AGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDL  369 (1039)
T ss_pred             ccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhH
Confidence            5555567888999999999999999999999999997544

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=1.6e-41  Score=330.59  Aligned_cols=270  Identities=23%  Similarity=0.342  Sum_probs=210.5

Q ss_pred             HHhcCCCCCCceeecCceEEEEEEecCCCC-CCccceEEEEEEccCCCC-ccHHHHHHHHHHHhcC-CCCCcceEEEEEE
Q 046893           89 LATKFFRPDYILGEGGFGVVYKGVIDENVR-PGYKTTFVAIKELNRGGY-QGDREWLAEVNYLGQL-RHSNLVKLIGYCC  165 (464)
Q Consensus        89 ~~~~~~~~~~~lG~G~fg~Vy~a~~~~~~~-~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~hpniv~l~~~~~  165 (464)
                      +...+|.+.+.||+|+||.||+|.+..... .......||+|.+..... .....+.+|+.++..+ .||||+++++++.
T Consensus        12 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~   91 (304)
T cd05101          12 FSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT   91 (304)
T ss_pred             ccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEe
Confidence            445678899999999999999997542111 112345799999865422 2336788999999999 8999999999999


Q ss_pred             eCCeEEEEEeccCCCCHHHHHHhhc--------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceE
Q 046893          166 EDEHRILVYEYMESGSLEKHLLRRV--------------GCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNIL  231 (464)
Q Consensus       166 ~~~~~~lv~e~~~~g~L~~~l~~~~--------------~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nil  231 (464)
                      .....++||||+.+|+|.+++....              ...+++..++.++.|++.||.|||  +++|+||||||+|||
T Consensus        92 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH--~~givH~dlkp~Nil  169 (304)
T cd05101          92 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLA--SQKCIHRDLAARNVL  169 (304)
T ss_pred             cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHH--HCCeeecccccceEE
Confidence            9999999999999999999987642              124788899999999999999999  677999999999999


Q ss_pred             ecCCCceEEcccCCccCCCCCCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHh-CCCCCCCCCCcccc
Q 046893          232 LNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLL-GRRAVDKSRPSREH  310 (464)
Q Consensus       232 l~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~  310 (464)
                      ++.++.+||+|||+++...............++..|+|||++.+..++.++||||||+++|+|++ |..||.....    
T Consensus       170 i~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~----  245 (304)
T cd05101         170 VTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV----  245 (304)
T ss_pred             EcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCH----
Confidence            99999999999999986543332222233456778999999988889999999999999999998 7888865431    


Q ss_pred             cHHHHHHHhhhcccchhhccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhc
Q 046893          311 NLVEWARPLLNNNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETVQSQ  377 (464)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~~~~  377 (464)
                        .++..... ..          .....+..++..+.+|+.+||..+|.+||++.++++.|+.+...
T Consensus       246 --~~~~~~~~-~~----------~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~  299 (304)
T cd05101         246 --EELFKLLK-EG----------HRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTL  299 (304)
T ss_pred             --HHHHHHHH-cC----------CcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHh
Confidence              12211111 11          01111234556899999999999999999999999999987654

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=2.5e-41  Score=325.02  Aligned_cols=265  Identities=21%  Similarity=0.330  Sum_probs=205.4

Q ss_pred             hcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCc-cHHHHHHHHHHHhcCCCCCcceEEEEEEeCCe
Q 046893           91 TKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQ-GDREWLAEVNYLGQLRHSNLVKLIGYCCEDEH  169 (464)
Q Consensus        91 ~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~  169 (464)
                      .++|++.+.||+|+||+||+|.+..+...  ....||+|++...... ....+..|+.++..+.||||+++++++... .
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~--~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~   82 (279)
T cd05109           6 ETELKKVKVLGSGAFGTVYKGIWIPDGEN--VKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-T   82 (279)
T ss_pred             hhheeeeeecCCCCCceEEEEEEecCCCc--cceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-C
Confidence            45688899999999999999987654221  1235899998654332 346788999999999999999999998754 5


Q ss_pred             EEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCccCC
Q 046893          170 RILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDG  249 (464)
Q Consensus       170 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~  249 (464)
                      .+++|||+++|+|.+++.... ..+++..++.++.|++.||.|||  +++|+||||||+|||++.++.+||+|||+++..
T Consensus        83 ~~l~~~~~~~g~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~lH--~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~  159 (279)
T cd05109          83 VQLVTQLMPYGCLLDYVRENK-DRIGSQDLLNWCVQIAKGMSYLE--EVRLVHRDLAARNVLVKSPNHVKITDFGLARLL  159 (279)
T ss_pred             cEEEEEcCCCCCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHH--HCCeeccccccceEEEcCCCcEEECCCCceeec
Confidence            679999999999999887643 36899999999999999999999  677999999999999999999999999999865


Q ss_pred             CCCCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHhhhcccchhh
Q 046893          250 PMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLL-GRRAVDKSRPSREHNLVEWARPLLNNNKKVLR  328 (464)
Q Consensus       250 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  328 (464)
                      .............++..|+|||.+.+..++.++|||||||++|||++ |..||......   .+..+.    ....    
T Consensus       160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~---~~~~~~----~~~~----  228 (279)
T cd05109         160 DIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAR---EIPDLL----EKGE----  228 (279)
T ss_pred             ccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHH---HHHHHH----HCCC----
Confidence            43222111222345678999999998899999999999999999998 89998654321   111111    1110    


Q ss_pred             ccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhcC
Q 046893          329 ILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETVQSQG  378 (464)
Q Consensus       329 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~~~~~  378 (464)
                            ....+..++..+.+++.+||..||..||++.++++.|+.+....
T Consensus       229 ------~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~~  272 (279)
T cd05109         229 ------RLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARDP  272 (279)
T ss_pred             ------cCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcCC
Confidence                  00112234557899999999999999999999999998775543

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=1.2e-41  Score=333.48  Aligned_cols=240  Identities=28%  Similarity=0.455  Sum_probs=191.5

Q ss_pred             CceeecCceEEEEEEecCCCCCCccceEEEEEEccCCC---CccHHHHHHHHHHHhc-CCCCCcceEEEEEEeCCeEEEE
Q 046893           98 YILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGG---YQGDREWLAEVNYLGQ-LRHSNLVKLIGYCCEDEHRILV  173 (464)
Q Consensus        98 ~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~-l~hpniv~l~~~~~~~~~~~lv  173 (464)
                      +.||+|+||+||+|.+..+      ++.||+|++....   ......+..|..++.. ++||||+++++++.+.+..++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~------~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv   74 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGT------NQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFV   74 (316)
T ss_pred             CeeeeCCCEEEEEEEECCC------CCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEE
Confidence            3699999999999998765      5679999987542   1223456677888876 4899999999999999999999


Q ss_pred             EeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCccCCCCCC
Q 046893          174 YEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGD  253 (464)
Q Consensus       174 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~  253 (464)
                      |||+++|+|.+++...  ..+++..+..++.|++.||.|||  .++|+||||||+|||++.++.+||+|||+++......
T Consensus        75 ~ey~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~LH--~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~  150 (316)
T cd05619          75 MEYLNGGDLMFHIQSC--HKFDLPRATFYAAEIICGLQFLH--SKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD  150 (316)
T ss_pred             EeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH--hCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCC
Confidence            9999999999988754  36899999999999999999999  6779999999999999999999999999987532222


Q ss_pred             CcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhcccchhhccCcc
Q 046893          254 QTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRILDPR  333 (464)
Q Consensus       254 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  333 (464)
                        .......||..|+|||++.+..++.++|||||||++|||++|+.||......      +........        .+.
T Consensus       151 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~------~~~~~i~~~--------~~~  214 (316)
T cd05619         151 --AKTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEE------ELFQSIRMD--------NPC  214 (316)
T ss_pred             --CceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHH------HHHHHHHhC--------CCC
Confidence              1223467999999999999999999999999999999999999999764321      111111000        111


Q ss_pred             ccCccCHHHHHHHHHHHHHhhccCCCCCCCHH-HH
Q 046893          334 LEGQYTARTAMKVAGLAYQCLSQNPKGRPVMS-DV  367 (464)
Q Consensus       334 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~-ev  367 (464)
                          ++...+..+.+|+.+||+.||.+||++. ++
T Consensus       215 ----~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l  245 (316)
T cd05619         215 ----YPRWLTREAKDILVKLFVREPERRLGVKGDI  245 (316)
T ss_pred             ----CCccCCHHHHHHHHHHhccCHhhcCCChHHH
Confidence                1222345788999999999999999997 44

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=3.1e-41  Score=325.09  Aligned_cols=275  Identities=28%  Similarity=0.408  Sum_probs=205.5

Q ss_pred             cCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCC-ccHHHHHHHHHHHhcCCCCCcceEEEEEEeC--C
Q 046893           92 KFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGY-QGDREWLAEVNYLGQLRHSNLVKLIGYCCED--E  168 (464)
Q Consensus        92 ~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~--~  168 (464)
                      ++|.+.+.||+|+||+||++.....  ....+..||+|.+..... .....+.+|+++|+.++||||+++++++...  .
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~--~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   81 (283)
T cd05080           4 RYLKKIRVLGEGHFGKVSLYCYDPA--NDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGK   81 (283)
T ss_pred             hhceeceecccCCCcEEEEeeEccc--cCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCc
Confidence            3458889999999999998765322  112356799999875432 2346788999999999999999999987654  4


Q ss_pred             eEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCccC
Q 046893          169 HRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKD  248 (464)
Q Consensus       169 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~  248 (464)
                      ..++||||+.+++|.+++...   .+++..++.++.|++.||.|||  +++|+||||||+|||++.++.+||+|||+++.
T Consensus        82 ~~~lv~e~~~~~~l~~~~~~~---~l~~~~~~~i~~~l~~~l~~lH--~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~  156 (283)
T cd05080          82 GLQLIMEYVPLGSLRDYLPKH---KLNLAQLLLFAQQICEGMAYLH--SQHYIHRDLAARNVLLDNDRLVKIGDFGLAKA  156 (283)
T ss_pred             eEEEEecCCCCCCHHHHHHHc---CCCHHHHHHHHHHHHHHHHHHH--HCCeeccccChheEEEcCCCcEEEeecccccc
Confidence            689999999999999988653   4899999999999999999999  67799999999999999999999999999986


Q ss_pred             CCCCCCcc-eeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhcccchh
Q 046893          249 GPMGDQTH-VSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVL  327 (464)
Q Consensus       249 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  327 (464)
                      ........ ......++..|+|||.+.+..++.++||||||+++|||++|..||........ ....+.... .......
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~-~~~~~~~~~-~~~~~~~  234 (283)
T cd05080         157 VPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFE-EMIGPKQGQ-MTVVRLI  234 (283)
T ss_pred             cCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhh-hhhcccccc-cchhhhh
Confidence            54322111 11223466779999999888999999999999999999999999865432110 000000000 0000111


Q ss_pred             hccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHH
Q 046893          328 RILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETVQ  375 (464)
Q Consensus       328 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~~  375 (464)
                      ..++.......+..++..+.+|+.+||+.+|.+||++.++++.|+.+.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~  282 (283)
T cd05080         235 ELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH  282 (283)
T ss_pred             hhhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence            111111122223345568999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=1.9e-41  Score=333.68  Aligned_cols=245  Identities=26%  Similarity=0.348  Sum_probs=194.3

Q ss_pred             CceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCc---cHHHHHHHHHHHhcC-CCCCcceEEEEEEeCCeEEEE
Q 046893           98 YILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQ---GDREWLAEVNYLGQL-RHSNLVKLIGYCCEDEHRILV  173 (464)
Q Consensus        98 ~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~lv  173 (464)
                      +.||+|+||+||+|.+..+      ++.||+|++......   ....+..|+.++..+ +||||+++++++...+..++|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~------~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv   74 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKN------DQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLV   74 (327)
T ss_pred             CeeeeCCCeEEEEEEECCC------CCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEE
Confidence            3699999999999998765      667999999764322   234577899999888 699999999999999999999


Q ss_pred             EeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCccCCCCCC
Q 046893          174 YEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGD  253 (464)
Q Consensus       174 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~  253 (464)
                      |||+++|+|..++....  .+++..+..++.|++.||.|||  .++|+||||||+|||++.++.+||+|||+++......
T Consensus        75 ~e~~~~~~L~~~~~~~~--~l~~~~~~~~~~qi~~al~~lH--~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~  150 (327)
T cd05617          75 IEYVNGGDLMFHMQRQR--KLPEEHARFYAAEICIALNFLH--ERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPG  150 (327)
T ss_pred             EeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH--HCCeeccCCCHHHEEEeCCCCEEEeccccceeccCCC
Confidence            99999999988876543  6999999999999999999999  6779999999999999999999999999997532211


Q ss_pred             CcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhcccchhhccCcc
Q 046893          254 QTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRILDPR  333 (464)
Q Consensus       254 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  333 (464)
                        ......+||+.|+|||++.+..++.++|||||||+||||++|+.||............++....+...         .
T Consensus       151 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~---------~  219 (327)
T cd05617         151 --DTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEK---------P  219 (327)
T ss_pred             --CceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhC---------C
Confidence              12334689999999999999999999999999999999999999997543322222222222111110         0


Q ss_pred             ccCccCHHHHHHHHHHHHHhhccCCCCCCCHH
Q 046893          334 LEGQYTARTAMKVAGLAYQCLSQNPKGRPVMS  365 (464)
Q Consensus       334 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~  365 (464)
                        ..++...+..+.+++.+||..||.+|+++.
T Consensus       220 --~~~p~~~~~~~~~li~~~L~~dP~~R~~~~  249 (327)
T cd05617         220 --IRIPRFLSVKASHVLKGFLNKDPKERLGCQ  249 (327)
T ss_pred             --CCCCCCCCHHHHHHHHHHhccCHHHcCCCC
Confidence              012223445788999999999999999864

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=1.7e-41  Score=322.73  Aligned_cols=256  Identities=29%  Similarity=0.460  Sum_probs=205.5

Q ss_pred             HHhcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCccHHHHHHHHHHHhcCCCCCcceEEEEEEeCC
Q 046893           89 LATKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVKLIGYCCEDE  168 (464)
Q Consensus        89 ~~~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~  168 (464)
                      +..+.|++.++||+|+||.||+|.+..       ++.||+|.+.... .....+.+|+.+++.++|+||+++++++. .+
T Consensus         3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~-------~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~   73 (260)
T cd05067           3 VPRETLKLVKKLGAGQFGEVWMGYYNG-------HTKVAIKSLKQGS-MSPEAFLAEANLMKQLQHPRLVRLYAVVT-QE   73 (260)
T ss_pred             cchHHceeeeeeccCccceEEeeecCC-------CceEEEEEecCCC-CcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cC
Confidence            345678999999999999999998654       4569999987543 33567899999999999999999999874 45


Q ss_pred             eEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCccC
Q 046893          169 HRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKD  248 (464)
Q Consensus       169 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~  248 (464)
                      ..++||||+.+++|.+++....+..+++..+..++.|++.||.|||  +.+++||||||+||+++.++.++|+|||++..
T Consensus        74 ~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH--~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~  151 (260)
T cd05067          74 PIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIE--RKNYIHRDLRAANILVSETLCCKIADFGLARL  151 (260)
T ss_pred             CcEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHh--cCCeecccccHHhEEEcCCCCEEEccCcceee
Confidence            7899999999999999987766667899999999999999999999  67799999999999999999999999999976


Q ss_pred             CCCCCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHhhhcccchh
Q 046893          249 GPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLL-GRRAVDKSRPSREHNLVEWARPLLNNNKKVL  327 (464)
Q Consensus       249 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  327 (464)
                      ...... .......++..|+|||++.+..++.++||||||+++|||++ |+.||.......   ....    +..     
T Consensus       152 ~~~~~~-~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~---~~~~----~~~-----  218 (260)
T cd05067         152 IEDNEY-TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPE---VIQN----LER-----  218 (260)
T ss_pred             cCCCCc-ccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHH---HHHH----HHc-----
Confidence            432221 11223456778999999988889999999999999999999 999997543211   1111    110     


Q ss_pred             hccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q 046893          328 RILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLET  373 (464)
Q Consensus       328 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~  373 (464)
                           ......+...+.++.+++.+||..+|++||++++++..|+.
T Consensus       219 -----~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  259 (260)
T cd05067         219 -----GYRMPRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED  259 (260)
T ss_pred             -----CCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence                 00111122344589999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=2.1e-41  Score=327.21  Aligned_cols=267  Identities=25%  Similarity=0.391  Sum_probs=207.2

Q ss_pred             HHhcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCC-ccHHHHHHHHHHHhcCCCCCcceEEEEEEeC
Q 046893           89 LATKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGY-QGDREWLAEVNYLGQLRHSNLVKLIGYCCED  167 (464)
Q Consensus        89 ~~~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~  167 (464)
                      +..++|.+.+.||+|+||.||+|...+.. .+.....||+|.+..... .....+.+|+.+++.++||||+++++++...
T Consensus         3 ~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~-~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   81 (288)
T cd05061           3 VSREKITLLRELGQGSFGMVYEGNARDII-KGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKG   81 (288)
T ss_pred             ccHHHceeeeeecCCCCcEEEEEEEeccC-CCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC
Confidence            45678999999999999999999865421 122355799998865432 2234578899999999999999999999999


Q ss_pred             CeEEEEEeccCCCCHHHHHHhhc--------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceE
Q 046893          168 EHRILVYEYMESGSLEKHLLRRV--------GCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAK  239 (464)
Q Consensus       168 ~~~~lv~e~~~~g~L~~~l~~~~--------~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vk  239 (464)
                      +..++||||+.+|+|.+++....        ...+.+..+..++.|++.||.|||  .++|+||||||+|||++.++.++
T Consensus        82 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH--~~~i~H~dikp~nili~~~~~~~  159 (288)
T cd05061          82 QPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLN--AKKFVHRDLAARNCMVAHDFTVK  159 (288)
T ss_pred             CCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHH--hCCCcCCCCChheEEEcCCCcEE
Confidence            99999999999999999987532        123567788999999999999999  67799999999999999999999


Q ss_pred             EcccCCccCCCCCCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHH
Q 046893          240 LSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLL-GRRAVDKSRPSREHNLVEWARP  318 (464)
Q Consensus       240 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~  318 (464)
                      |+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..||......      +....
T Consensus       160 L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~------~~~~~  233 (288)
T cd05061         160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNE------QVLKF  233 (288)
T ss_pred             ECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHH------HHHHH
Confidence            999999986433332222223456778999999998899999999999999999998 78888653321      11111


Q ss_pred             hhhcccchhhccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHH
Q 046893          319 LLNNNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETVQ  375 (464)
Q Consensus       319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~~  375 (464)
                      .....           ....+..++..+.+++.+||+.||.+||++.++++.|....
T Consensus       234 ~~~~~-----------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~  279 (288)
T cd05061         234 VMDGG-----------YLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL  279 (288)
T ss_pred             HHcCC-----------CCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence            11110           00112234568999999999999999999999999887653

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=1.7e-41  Score=322.74  Aligned_cols=255  Identities=28%  Similarity=0.440  Sum_probs=203.1

Q ss_pred             HhcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCccHHHHHHHHHHHhcCCCCCcceEEEEEEeCCe
Q 046893           90 ATKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVKLIGYCCEDEH  169 (464)
Q Consensus        90 ~~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~  169 (464)
                      ..++|++.+.||+|+||.||+|.+..       +..+|+|.+..... ....+.+|+.+++.++|+||+++++++. ...
T Consensus         4 ~~~~~~~~~~ig~g~~~~v~~~~~~~-------~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~   74 (260)
T cd05070           4 PRESLQLIKKLGNGQFGEVWMGTWNG-------NTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEP   74 (260)
T ss_pred             chHHhhhhheeccccCceEEEEEecC-------CceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCC
Confidence            34578899999999999999998654       34489998875433 3467899999999999999999999875 456


Q ss_pred             EEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCccCC
Q 046893          170 RILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDG  249 (464)
Q Consensus       170 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~  249 (464)
                      .++||||+.+++|.+++.......+++..+..++.|++.||.|||  +.+|+||||||+||+++.++.++|+|||++...
T Consensus        75 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH--~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~  152 (260)
T cd05070          75 IYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIE--RMNYIHRDLRSANILVGDGLVCKIADFGLARLI  152 (260)
T ss_pred             cEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH--HCCcccCCCccceEEEeCCceEEeCCceeeeec
Confidence            889999999999999987655556899999999999999999999  677999999999999999999999999999764


Q ss_pred             CCCCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHhhhcccchhh
Q 046893          250 PMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLL-GRRAVDKSRPSREHNLVEWARPLLNNNKKVLR  328 (464)
Q Consensus       250 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  328 (464)
                      ...... ......++..|+|||++.+..++.++||||||+++|+|++ |..||......      +.......       
T Consensus       153 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~------~~~~~~~~-------  218 (260)
T cd05070         153 EDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNR------EVLEQVER-------  218 (260)
T ss_pred             cCcccc-cccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHH------HHHHHHHc-------
Confidence            332211 1122345678999999988889999999999999999999 88898654321      11111110       


Q ss_pred             ccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q 046893          329 ILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLET  373 (464)
Q Consensus       329 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~  373 (464)
                          ......+...+..+.+|+.+||..+|.+||++.++.++|+.
T Consensus       219 ----~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  259 (260)
T cd05070         219 ----GYRMPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED  259 (260)
T ss_pred             ----CCCCCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence                01111223445689999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-43  Score=312.87  Aligned_cols=253  Identities=23%  Similarity=0.304  Sum_probs=204.8

Q ss_pred             HhcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCC--ccHHHHHHHHHHHhcCCCCCcceEEEEEEeC
Q 046893           90 ATKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGY--QGDREWLAEVNYLGQLRHSNLVKLIGYCCED  167 (464)
Q Consensus        90 ~~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~  167 (464)
                      ..+.|.+...||+|.|+.||++.+..+      ++.+|+|+++....  ...+++.+|++|-+.|+||||++|++.+.++
T Consensus         9 f~d~y~l~e~igkG~FSvVrRc~~~~t------g~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~   82 (355)
T KOG0033|consen    9 FSDNYDVKEELGKGAFSVVRRCVHKTT------GLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEE   82 (355)
T ss_pred             cchhhhHHHHHccCchHHHHHHHhccc------hHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhccc
Confidence            345677888999999999999887664      66688888865432  3457889999999999999999999999999


Q ss_pred             CeEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEec---CCCceEEcccC
Q 046893          168 EHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLN---ADFSAKLSDFG  244 (464)
Q Consensus       168 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~---~~~~vkl~DFG  244 (464)
                      ...|||+|+|.|++|..-|..+.  .+++..+-..+.||+.+|.|+|  .++|||||+||+|+||.   ...-+||+|||
T Consensus        83 ~~~ylvFe~m~G~dl~~eIV~R~--~ySEa~aSH~~rQiLeal~yCH--~n~IvHRDvkP~nllLASK~~~A~vKL~~FG  158 (355)
T KOG0033|consen   83 SFHYLVFDLVTGGELFEDIVARE--FYSEADASHCIQQILEALAYCH--SNGIVHRDLKPENLLLASKAKGAAVKLADFG  158 (355)
T ss_pred             ceeEEEEecccchHHHHHHHHHH--HHHHHHHHHHHHHHHHHHHHHH--hcCceeccCChhheeeeeccCCCceeecccc
Confidence            99999999999999988777653  5788889999999999999999  67899999999999994   33458999999


Q ss_pred             CccCCCCCCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhccc
Q 046893          245 LAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNK  324 (464)
Q Consensus       245 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  324 (464)
                      +|.....   ......+.||+.|||||++...+|+..+|||+.|||||-||.|.+||.+....   .+   +..++..  
T Consensus       159 vAi~l~~---g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~---rl---ye~I~~g--  227 (355)
T KOG0033|consen  159 LAIEVND---GEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH---RL---YEQIKAG--  227 (355)
T ss_pred             eEEEeCC---ccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHH---HH---HHHHhcc--
Confidence            9997652   22344578999999999999999999999999999999999999999874321   11   1122222  


Q ss_pred             chhhccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 046893          325 KVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVA  369 (464)
Q Consensus       325 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  369 (464)
                            +-.+.+.+.....++..+|+++||..||.+|.|+.|.+.
T Consensus       228 ------~yd~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~  266 (355)
T KOG0033|consen  228 ------AYDYPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALK  266 (355)
T ss_pred             ------ccCCCCcccCcCCHHHHHHHHHHhccChhhhccHHHHhC
Confidence                  112222233345568899999999999999999998764

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=3.1e-41  Score=331.55  Aligned_cols=238  Identities=28%  Similarity=0.385  Sum_probs=189.6

Q ss_pred             CceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCC---ccHHHHHHHHH-HHhcCCCCCcceEEEEEEeCCeEEEE
Q 046893           98 YILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGY---QGDREWLAEVN-YLGQLRHSNLVKLIGYCCEDEHRILV  173 (464)
Q Consensus        98 ~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~-~l~~l~hpniv~l~~~~~~~~~~~lv  173 (464)
                      +.||+|+||+||+|.+..+      ++.||+|++.....   .....+..|.. +++.++||||+++++++...+..++|
T Consensus         1 ~~lg~G~~g~V~~~~~~~~------~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv   74 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKAD------GKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFV   74 (323)
T ss_pred             CeeeeCCCeEEEEEEECCC------CCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEE
Confidence            3699999999999998765      66799999865321   12234555554 56789999999999999999999999


Q ss_pred             EeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCccCCCCCC
Q 046893          174 YEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGD  253 (464)
Q Consensus       174 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~  253 (464)
                      |||+.+|+|..++...  ..+++..+..++.||+.||.|||  .++|+||||||+|||++.++.+||+|||+++......
T Consensus        75 ~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH--~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~  150 (323)
T cd05575          75 LDYVNGGELFFHLQRE--RSFPEPRARFYAAEIASALGYLH--SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHS  150 (323)
T ss_pred             EcCCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH--HCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCC
Confidence            9999999999888764  36899999999999999999999  6779999999999999999999999999997532211


Q ss_pred             CcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhcccchhhccCcc
Q 046893          254 QTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRILDPR  333 (464)
Q Consensus       254 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  333 (464)
                        ......+||+.|+|||++.+..++.++|||||||++|||++|..||.....      .+.........        ..
T Consensus       151 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~------~~~~~~i~~~~--------~~  214 (323)
T cd05575         151 --KTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDT------AEMYDNILNKP--------LR  214 (323)
T ss_pred             --CccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCH------HHHHHHHHcCC--------CC
Confidence              223346799999999999999999999999999999999999999976431      11211111111        01


Q ss_pred             ccCccCHHHHHHHHHHHHHhhccCCCCCCCHH
Q 046893          334 LEGQYTARTAMKVAGLAYQCLSQNPKGRPVMS  365 (464)
Q Consensus       334 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~  365 (464)
                          .....+..+.+++.+||+.||.+||++.
T Consensus       215 ----~~~~~~~~~~~li~~~l~~~p~~R~~~~  242 (323)
T cd05575         215 ----LKPNISVSARHLLEGLLQKDRTKRLGAK  242 (323)
T ss_pred             ----CCCCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence                1112345788999999999999999986

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=9.7e-42  Score=340.90  Aligned_cols=257  Identities=19%  Similarity=0.229  Sum_probs=199.4

Q ss_pred             HHHHhcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCC---ccHHHHHHHHHHHhcCCCCCcceEEEE
Q 046893           87 MKLATKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGY---QGDREWLAEVNYLGQLRHSNLVKLIGY  163 (464)
Q Consensus        87 ~~~~~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~  163 (464)
                      .....++|++.+.||+|+||.||+|.+..+      ++.+|+|++.....   .....+.+|+.+++.++||||++++++
T Consensus        38 ~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~------~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~  111 (370)
T cd05621          38 LQMKAEDYDVVKVIGRGAFGEVQLVRHKSS------QKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCA  111 (370)
T ss_pred             cCCCHHHCeEEEEEEecCCeEEEEEEECCC------CCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEE
Confidence            344567899999999999999999998765      66799999864221   223457789999999999999999999


Q ss_pred             EEeCCeEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEccc
Q 046893          164 CCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDF  243 (464)
Q Consensus       164 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DF  243 (464)
                      +..++..|+||||+++|+|.+++...   .+++..+..++.||+.||.|||  .++|+||||||+|||++.++.+||+||
T Consensus       112 ~~~~~~~~lv~Ey~~gg~L~~~l~~~---~~~~~~~~~~~~qil~aL~~LH--~~~IvHrDLKp~NILl~~~~~~kL~DF  186 (370)
T cd05621         112 FQDDKYLYMVMEYMPGGDLVNLMSNY---DVPEKWAKFYTAEVVLALDAIH--SMGLIHRDVKPDNMLLDKHGHLKLADF  186 (370)
T ss_pred             EEcCCEEEEEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHH--HCCeEecCCCHHHEEECCCCCEEEEec
Confidence            99999999999999999999988643   4889999999999999999999  677999999999999999999999999


Q ss_pred             CCccCCCCCCCcceeeccccCCcccCccccccC----CCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHh
Q 046893          244 GLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTG----HLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPL  319 (464)
Q Consensus       244 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~  319 (464)
                      |++........ ......+||+.|+|||++.+.    .++.++|||||||+||||++|+.||......      ......
T Consensus       187 G~a~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~------~~~~~i  259 (370)
T cd05621         187 GTCMKMDETGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLV------GTYSKI  259 (370)
T ss_pred             ccceecccCCc-eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHH------HHHHHH
Confidence            99986432221 122346799999999998754    3788999999999999999999999764321      111111


Q ss_pred             hhcccchhhccCccccCccCHHHHHHHHHHHHHhhccCCCC--CCCHHHHHH
Q 046893          320 LNNNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKG--RPVMSDVVA  369 (464)
Q Consensus       320 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~ev~~  369 (464)
                      ......        +........+..+.+++..||..++.+  |+++.++++
T Consensus       260 ~~~~~~--------~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~  303 (370)
T cd05621         260 MDHKNS--------LNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQ  303 (370)
T ss_pred             HhCCcc--------cCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhc
Confidence            111110        000011123457888999999855543  788888775

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=4.2e-41  Score=326.10  Aligned_cols=270  Identities=26%  Similarity=0.418  Sum_probs=208.3

Q ss_pred             hcCCCCCCceeecCceEEEEEEecCCCC----------CCccceEEEEEEccCCCCc-cHHHHHHHHHHHhcCCCCCcce
Q 046893           91 TKFFRPDYILGEGGFGVVYKGVIDENVR----------PGYKTTFVAIKELNRGGYQ-GDREWLAEVNYLGQLRHSNLVK  159 (464)
Q Consensus        91 ~~~~~~~~~lG~G~fg~Vy~a~~~~~~~----------~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~  159 (464)
                      .++|++.+.||+|+||.||+|.+.....          .......||+|.+...... ....+.+|++++..++||||++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~   83 (296)
T cd05051           4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR   83 (296)
T ss_pred             hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence            4578999999999999999998765321          1113456899998754332 3467889999999999999999


Q ss_pred             EEEEEEeCCeEEEEEeccCCCCHHHHHHhhc---------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCce
Q 046893          160 LIGYCCEDEHRILVYEYMESGSLEKHLLRRV---------GCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNI  230 (464)
Q Consensus       160 l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~---------~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Ni  230 (464)
                      +++++..+...++||||+.+++|.+++....         ...+++..++.++.|++.||.|||  ..+|+||||||+||
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH--~~~i~H~dlkp~Ni  161 (296)
T cd05051          84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLE--SLNFVHRDLATRNC  161 (296)
T ss_pred             EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHH--HcCccccccchhce
Confidence            9999999999999999999999999987643         125899999999999999999999  57799999999999


Q ss_pred             EecCCCceEEcccCCccCCCCCCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHh--CCCCCCCCCCcc
Q 046893          231 LLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLL--GRRAVDKSRPSR  308 (464)
Q Consensus       231 ll~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~--g~~pf~~~~~~~  308 (464)
                      +++.++.++|+|||+++...............++..|+|||++.+..++.++|||||||++|||++  |..||.....  
T Consensus       162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~--  239 (296)
T cd05051         162 LVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTD--  239 (296)
T ss_pred             eecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcCh--
Confidence            999999999999999986443333333334567889999999988889999999999999999998  6677754331  


Q ss_pred             cccHHHHHHHhhhcccchhhccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 046893          309 EHNLVEWARPLLNNNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLE  372 (464)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~  372 (464)
                       ..........+...       ........+..++.++.+|+.+||+.||.+||++.+|+..|+
T Consensus       240 -~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~  295 (296)
T cd05051         240 -QQVIENAGHFFRDD-------GRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ  295 (296)
T ss_pred             -HHHHHHHHhccccc-------cccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence             11111111111110       001111112234468999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=3.4e-41  Score=329.90  Aligned_cols=269  Identities=24%  Similarity=0.373  Sum_probs=208.1

Q ss_pred             HhcCCCCCCceeecCceEEEEEEecCCCC-CCccceEEEEEEccCCCC-ccHHHHHHHHHHHhcC-CCCCcceEEEEEEe
Q 046893           90 ATKFFRPDYILGEGGFGVVYKGVIDENVR-PGYKTTFVAIKELNRGGY-QGDREWLAEVNYLGQL-RHSNLVKLIGYCCE  166 (464)
Q Consensus        90 ~~~~~~~~~~lG~G~fg~Vy~a~~~~~~~-~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~  166 (464)
                      ...+|.+.+.||+|+||.||+|.+..... .......+|+|.+..... .....+..|+++++.+ .||||+++++++..
T Consensus        10 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~   89 (314)
T cd05099          10 PRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQ   89 (314)
T ss_pred             cHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEcc
Confidence            34568889999999999999998643211 112345689999875432 2235688999999999 69999999999999


Q ss_pred             CCeEEEEEeccCCCCHHHHHHhhc--------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEe
Q 046893          167 DEHRILVYEYMESGSLEKHLLRRV--------------GCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILL  232 (464)
Q Consensus       167 ~~~~~lv~e~~~~g~L~~~l~~~~--------------~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill  232 (464)
                      .+..++||||+.+|+|.+++....              ...+++.++..++.|++.||.|||  .++|+||||||+|||+
T Consensus        90 ~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH--~~gi~H~dlkp~Nill  167 (314)
T cd05099          90 EGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLE--SRRCIHRDLAARNVLV  167 (314)
T ss_pred             CCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHH--HCCeeeccccceeEEE
Confidence            999999999999999999997542              135889999999999999999999  6779999999999999


Q ss_pred             cCCCceEEcccCCccCCCCCCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHh-CCCCCCCCCCccccc
Q 046893          233 NADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLL-GRRAVDKSRPSREHN  311 (464)
Q Consensus       233 ~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~  311 (464)
                      +.++.+||+|||+++...............++..|+|||++.+..++.++||||||+++|+|++ |..||.......   
T Consensus       168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~---  244 (314)
T cd05099         168 TEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEE---  244 (314)
T ss_pred             cCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHH---
Confidence            9999999999999986432222111122334567999999998899999999999999999999 888886543211   


Q ss_pred             HHHHHHHhhhcccchhhccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhc
Q 046893          312 LVEWARPLLNNNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETVQSQ  377 (464)
Q Consensus       312 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~~~~  377 (464)
                      +..    .+...          .....+..++..+.+|+.+||..+|.+||++.++++.|..+...
T Consensus       245 ~~~----~~~~~----------~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~  296 (314)
T cd05099         245 LFK----LLREG----------HRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAA  296 (314)
T ss_pred             HHH----HHHcC----------CCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHH
Confidence            111    11110          00112233455888999999999999999999999999987654

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=2.1e-41  Score=326.00  Aligned_cols=241  Identities=26%  Similarity=0.365  Sum_probs=191.2

Q ss_pred             eeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCc---cHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeEEEEEec
Q 046893          100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQ---GDREWLAEVNYLGQLRHSNLVKLIGYCCEDEHRILVYEY  176 (464)
Q Consensus       100 lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~  176 (464)
                      ||+|+||+||++.+..+      ++.||+|.+......   ....+..|+++++.++|+||+++++++......++||||
T Consensus         1 lg~G~~g~Vy~~~~~~~------~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~   74 (280)
T cd05608           1 LGKGGFGEVSACQMRAT------GKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTI   74 (280)
T ss_pred             CCCCCceeEEEEEEccC------CcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeC
Confidence            79999999999988765      567999998654322   224567899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHhh--cCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCccCCCCCCC
Q 046893          177 MESGSLEKHLLRR--VGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQ  254 (464)
Q Consensus       177 ~~~g~L~~~l~~~--~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~  254 (464)
                      +++|+|.+++...  ....+++..++.++.|++.||.|||  +++|+||||||+||+++.++.+||+|||++........
T Consensus        75 ~~~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH--~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~  152 (280)
T cd05608          75 MNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLH--QRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS  152 (280)
T ss_pred             CCCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHH--HCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCc
Confidence            9999998877542  2346899999999999999999999  67799999999999999999999999999976433221


Q ss_pred             cceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhcccchhhccCccc
Q 046893          255 THVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRILDPRL  334 (464)
Q Consensus       255 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  334 (464)
                        ......||..|+|||++.+..++.++|||||||++|||++|+.||........  ........          +... 
T Consensus       153 --~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~--~~~~~~~~----------~~~~-  217 (280)
T cd05608         153 --KTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVE--NKELKQRI----------LNDS-  217 (280)
T ss_pred             --cccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchh--HHHHHHhh----------cccC-
Confidence              22346799999999999999999999999999999999999999975432111  01111111          1110 


Q ss_pred             cCccCHHHHHHHHHHHHHhhccCCCCCCCH
Q 046893          335 EGQYTARTAMKVAGLAYQCLSQNPKGRPVM  364 (464)
Q Consensus       335 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~  364 (464)
                       ..++...+..+.+++.+||+.||.+||++
T Consensus       218 -~~~~~~~~~~~~~li~~~l~~~P~~R~~~  246 (280)
T cd05608         218 -VTYPDKFSPASKSFCEALLAKDPEKRLGF  246 (280)
T ss_pred             -CCCcccCCHHHHHHHHHHhcCCHHHhcCC
Confidence             12233455688999999999999999944

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=4.8e-41  Score=321.52  Aligned_cols=258  Identities=25%  Similarity=0.395  Sum_probs=198.3

Q ss_pred             CCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCC--ccHHHHHHHHHHHhcCCCCCcceEEEEEEeC----
Q 046893           94 FRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGY--QGDREWLAEVNYLGQLRHSNLVKLIGYCCED----  167 (464)
Q Consensus        94 ~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~----  167 (464)
                      |.+.+.||+|+||.||+|.+....    ....+|+|.++....  .....+..|+.+++.++||||+++++++...    
T Consensus         1 ~~i~~~ig~G~~g~V~~~~~~~~~----~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   76 (272)
T cd05075           1 LALGKTLGEGEFGSVMEGQLNQDD----SILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESE   76 (272)
T ss_pred             CccccccCcccCceEEEeEEccCC----CeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCccc
Confidence            356788999999999999876542    123589998865422  2236688999999999999999999987432    


Q ss_pred             --CeEEEEEeccCCCCHHHHHHhhc----CCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEc
Q 046893          168 --EHRILVYEYMESGSLEKHLLRRV----GCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLS  241 (464)
Q Consensus       168 --~~~~lv~e~~~~g~L~~~l~~~~----~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~  241 (464)
                        ...++||||+.+|+|.+++....    ...+++..+..++.|++.||.|||  +++|+||||||+|||++.++.+||+
T Consensus        77 ~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH--~~~i~H~dlkp~Nil~~~~~~~kl~  154 (272)
T cd05075          77 GYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLS--SKSFIHRDLAARNCMLNENMNVCVA  154 (272)
T ss_pred             CCCCcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHH--HCCeeccccchhheEEcCCCCEEEC
Confidence              24689999999999998875321    235889999999999999999999  6779999999999999999999999


Q ss_pred             ccCCccCCCCCCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHhh
Q 046893          242 DFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLL-GRRAVDKSRPSREHNLVEWARPLL  320 (464)
Q Consensus       242 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~  320 (464)
                      |||+++...............++..|+|||++.+..++.++||||||+++|||++ |+.||......   .+.+    .+
T Consensus       155 Dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~---~~~~----~~  227 (272)
T cd05075         155 DFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENS---EIYD----YL  227 (272)
T ss_pred             CCCcccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHH---HHHH----HH
Confidence            9999986543322111222356778999999998899999999999999999999 88888653321   1111    11


Q ss_pred             hcccchhhccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHH
Q 046893          321 NNNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETV  374 (464)
Q Consensus       321 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~  374 (464)
                      .....          ...+..++..+.+++.+||+.||++||++.++++.|+.+
T Consensus       228 ~~~~~----------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~  271 (272)
T cd05075         228 RQGNR----------LKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA  271 (272)
T ss_pred             HcCCC----------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence            11110          011123445789999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.2e-41  Score=327.14  Aligned_cols=270  Identities=25%  Similarity=0.413  Sum_probs=204.2

Q ss_pred             hcCCCCCCceeecCceEEEEEEecCCCC--------CCccceEEEEEEccCCCCc-cHHHHHHHHHHHhcCCCCCcceEE
Q 046893           91 TKFFRPDYILGEGGFGVVYKGVIDENVR--------PGYKTTFVAIKELNRGGYQ-GDREWLAEVNYLGQLRHSNLVKLI  161 (464)
Q Consensus        91 ~~~~~~~~~lG~G~fg~Vy~a~~~~~~~--------~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~  161 (464)
                      .++|++.+.||+|+||.||+|.+.....        .......||+|.+...... ....|.+|++++..++||||++++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~   83 (295)
T cd05097           4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLL   83 (295)
T ss_pred             hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence            4579999999999999999998754211        0112345899998754222 235688999999999999999999


Q ss_pred             EEEEeCCeEEEEEeccCCCCHHHHHHhhc----------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceE
Q 046893          162 GYCCEDEHRILVYEYMESGSLEKHLLRRV----------GCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNIL  231 (464)
Q Consensus       162 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~----------~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nil  231 (464)
                      +++...+..++||||+.+++|.+++....          ...+++..++.++.|++.||.|||  +.+++||||||+|||
T Consensus        84 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH--~~~i~H~dlkp~Nil  161 (295)
T cd05097          84 GVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLA--SLNFVHRDLATRNCL  161 (295)
T ss_pred             EEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHH--hcCeeccccChhhEE
Confidence            99999999999999999999999886432          124688899999999999999999  677999999999999


Q ss_pred             ecCCCceEEcccCCccCCCCCCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHh--CCCCCCCCCCccc
Q 046893          232 LNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLL--GRRAVDKSRPSRE  309 (464)
Q Consensus       232 l~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~--g~~pf~~~~~~~~  309 (464)
                      ++.++.+||+|||++................++..|+|||++.+..++.++|||||||++|+|++  |..||......  
T Consensus       162 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~--  239 (295)
T cd05097         162 VGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDE--  239 (295)
T ss_pred             EcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChH--
Confidence            99999999999999986433332222233456778999999998899999999999999999998  56677653321  


Q ss_pred             ccHHHHHHHhhhcccchhhccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 046893          310 HNLVEWARPLLNNNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLE  372 (464)
Q Consensus       310 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~  372 (464)
                       ................       .....+...+..+.+|+.+||+.||.+||++.+|++.|.
T Consensus       240 -~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~  294 (295)
T cd05097         240 -QVIENTGEFFRNQGRQ-------IYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR  294 (295)
T ss_pred             -HHHHHHHHhhhhcccc-------ccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence             1111111111110000       000112224458999999999999999999999998885

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=4.1e-41  Score=318.85  Aligned_cols=250  Identities=26%  Similarity=0.383  Sum_probs=204.1

Q ss_pred             CCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCC--ccHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeE
Q 046893           93 FFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGY--QGDREWLAEVNYLGQLRHSNLVKLIGYCCEDEHR  170 (464)
Q Consensus        93 ~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~  170 (464)
                      +|.+.+.||+|+||.||+|.+..+      ++.|++|.+.....  .....+..|+.+++.++||||+++++++...+..
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~------~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   74 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKAD------KRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKL   74 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCC------CcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEE
Confidence            367788999999999999998765      56799998864322  2346788999999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCccCCC
Q 046893          171 ILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGP  250 (464)
Q Consensus       171 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~  250 (464)
                      ++||||+++++|.+++....+..+++..++.++.|++.||.|||  +.+++|+||||+||+++.++.++|+|||+++...
T Consensus        75 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH--~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~  152 (256)
T cd08529          75 NIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLH--SKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLS  152 (256)
T ss_pred             EEEEEeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH--HCCcccCCCCcceEEEeCCCCEEEcccccceecc
Confidence            99999999999999988765567999999999999999999999  6789999999999999999999999999988643


Q ss_pred             CCCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhcccchhhcc
Q 046893          251 MGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRIL  330 (464)
Q Consensus       251 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  330 (464)
                      ...  .......|+..|+|||++.+..++.++||||||+++|+|++|+.||......   ..   .......        
T Consensus       153 ~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~---~~~~~~~--------  216 (256)
T cd08529         153 DNT--NFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQG---AL---ILKIIRG--------  216 (256)
T ss_pred             Ccc--chhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH---HH---HHHHHcC--------
Confidence            322  2223457899999999999999999999999999999999999999754311   11   1111100        


Q ss_pred             CccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 046893          331 DPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVA  369 (464)
Q Consensus       331 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  369 (464)
                         .....+...+..+.+++.+||+.+|++||++.+++.
T Consensus       217 ---~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~  252 (256)
T cd08529         217 ---VFPPVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLR  252 (256)
T ss_pred             ---CCCCCccccCHHHHHHHHHHccCCcccCcCHHHHhh
Confidence               011122234558999999999999999999999875

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=3.4e-41  Score=330.57  Aligned_cols=237  Identities=28%  Similarity=0.433  Sum_probs=191.4

Q ss_pred             CceeecCceEEEEEEecCCCCCCccceEEEEEEccCCC---CccHHHHHHHHHHHhcC-CCCCcceEEEEEEeCCeEEEE
Q 046893           98 YILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGG---YQGDREWLAEVNYLGQL-RHSNLVKLIGYCCEDEHRILV  173 (464)
Q Consensus        98 ~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~lv  173 (464)
                      +.||+|+||+||+|.+..+      ++.||||++....   ......+..|+.++..+ .||||+++++++...+..++|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~------~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv   74 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGT------DELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFV   74 (318)
T ss_pred             CeeeeCCCeEEEEEEECCC------CCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEE
Confidence            3699999999999998764      5679999987532   12234567888899888 699999999999999999999


Q ss_pred             EeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCccCCCCCC
Q 046893          174 YEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGD  253 (464)
Q Consensus       174 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~  253 (464)
                      |||+.+|+|.+++.+.  ..+++..+..++.|++.||.|||  .++|+||||||+|||++.++.+||+|||+++......
T Consensus        75 ~e~~~~~~L~~~~~~~--~~l~~~~~~~~~~qi~~~l~~LH--~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  150 (318)
T cd05570          75 MEYVNGGDLMFHIQRS--GRFDEPRARFYAAEIVLGLQFLH--ERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG  150 (318)
T ss_pred             EcCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH--hCCeEccCCCHHHeEECCCCcEEecccCCCeecCcCC
Confidence            9999999999888654  36899999999999999999999  6779999999999999999999999999987532222


Q ss_pred             CcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhcccchhhccCcc
Q 046893          254 QTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRILDPR  333 (464)
Q Consensus       254 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  333 (464)
                        ......+||..|+|||++.+..++.++|||||||++|+|++|+.||.....      ...........        . 
T Consensus       151 --~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~------~~~~~~i~~~~--------~-  213 (318)
T cd05570         151 --VTTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDE------DELFQSILEDE--------V-  213 (318)
T ss_pred             --CcccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCH------HHHHHHHHcCC--------C-
Confidence              122346799999999999999999999999999999999999999975431      11111111110        0 


Q ss_pred             ccCccCHHHHHHHHHHHHHhhccCCCCCCCH
Q 046893          334 LEGQYTARTAMKVAGLAYQCLSQNPKGRPVM  364 (464)
Q Consensus       334 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~  364 (464)
                         .++...+..+.+||.+||..||.+||++
T Consensus       214 ---~~~~~~~~~~~~li~~~l~~dP~~R~s~  241 (318)
T cd05570         214 ---RYPRWLSKEAKSILKSFLTKNPEKRLGC  241 (318)
T ss_pred             ---CCCCcCCHHHHHHHHHHccCCHHHcCCC
Confidence               1122345578999999999999999999

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=4.9e-42  Score=338.25  Aligned_cols=253  Identities=21%  Similarity=0.242  Sum_probs=200.3

Q ss_pred             cCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCC---ccHHHHHHHHHHHhcCCCCCcceEEEEEEeCC
Q 046893           92 KFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGY---QGDREWLAEVNYLGQLRHSNLVKLIGYCCEDE  168 (464)
Q Consensus        92 ~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~  168 (464)
                      ++|.+.+.||+|+||+||+|.+..+      ++.||+|++.....   .....+..|+.++..++||||+++++++.+.+
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~------~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~   74 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVREKAT------GDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKD   74 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEECCC------CCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCC
Confidence            3688899999999999999998765      66799999875422   23356788999999999999999999999999


Q ss_pred             eEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCccC
Q 046893          169 HRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKD  248 (464)
Q Consensus       169 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~  248 (464)
                      ..+|||||+++|+|.+++.+.. ..+++..+..++.|++.||.|||  ..+|+||||||+|||++.++.+||+|||++..
T Consensus        75 ~~~lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~qi~~aL~~lH--~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~  151 (330)
T cd05601          75 NLYLVMEYQPGGDLLSLLNRYE-DQFDEDMAQFYLAELVLAIHSVH--QMGYVHRDIKPENVLIDRTGHIKLADFGSAAR  151 (330)
T ss_pred             eEEEEECCCCCCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH--HCCeEcccCchHheEECCCCCEEeccCCCCeE
Confidence            9999999999999999887652 36899999999999999999999  67799999999999999999999999999986


Q ss_pred             CCCCCCcceeeccccCCcccCccccc------cCCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhc
Q 046893          249 GPMGDQTHVSTRVMGTYGYAAPEYVM------TGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNN  322 (464)
Q Consensus       249 ~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~  322 (464)
                      ....... ......||+.|+|||++.      +..++.++|||||||+||||++|+.||......      ......+..
T Consensus       152 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~------~~~~~i~~~  224 (330)
T cd05601         152 LTANKMV-NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSA------KTYNNIMNF  224 (330)
T ss_pred             CCCCCce-eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHH------HHHHHHHcC
Confidence            4332221 223357999999999986      456789999999999999999999999764321      111111111


Q ss_pred             ccchhhccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 046893          323 NKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVA  369 (464)
Q Consensus       323 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  369 (464)
                      . .....       ......+..+.+|+..||. +|.+||++.+++.
T Consensus       225 ~-~~~~~-------~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~  262 (330)
T cd05601         225 Q-RFLKF-------PEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCC  262 (330)
T ss_pred             C-CccCC-------CCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence            0 00000       0111234578899999998 9999999998863

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=9e-42  Score=334.62  Aligned_cols=242  Identities=26%  Similarity=0.328  Sum_probs=193.9

Q ss_pred             CceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCc--cHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeEEEEEe
Q 046893           98 YILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQ--GDREWLAEVNYLGQLRHSNLVKLIGYCCEDEHRILVYE  175 (464)
Q Consensus        98 ~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e  175 (464)
                      +.||+|+||.||++.+....   ..++.||+|++......  ....+..|+++|.+++||||+++++++...+..|+|||
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~---~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e   78 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGP---DAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILD   78 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccC---CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEc
Confidence            56999999999998764321   13678999998753221  23456789999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCccCCCCCCCc
Q 046893          176 YMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQT  255 (464)
Q Consensus       176 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~~  255 (464)
                      |+.+|+|.+++.+.  ..+++..+..++.|++.||.|||  ..+|+||||||+|||++.++.+||+|||+++......  
T Consensus        79 ~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH--~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~--  152 (318)
T cd05582          79 FLRGGDLFTRLSKE--VMFTEEDVKFYLAELALALDHLH--SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE--  152 (318)
T ss_pred             CCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH--HCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCC--
Confidence            99999999988654  36899999999999999999999  5779999999999999999999999999998643221  


Q ss_pred             ceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhcccchhhccCcccc
Q 046893          256 HVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRILDPRLE  335 (464)
Q Consensus       256 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  335 (464)
                      .......||..|+|||++.+..++.++|||||||++|||++|+.||......      +.........            
T Consensus       153 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~------~~~~~i~~~~------------  214 (318)
T cd05582         153 KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRK------ETMTMILKAK------------  214 (318)
T ss_pred             CceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHH------HHHHHHHcCC------------
Confidence            1223467999999999999888999999999999999999999999754321      1111111110            


Q ss_pred             CccCHHHHHHHHHHHHHhhccCCCCCCCHHH
Q 046893          336 GQYTARTAMKVAGLAYQCLSQNPKGRPVMSD  366 (464)
Q Consensus       336 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~e  366 (464)
                      ...+...+..+.+|+.+||+.||.+||++.+
T Consensus       215 ~~~p~~~~~~~~~li~~~l~~~P~~R~~a~~  245 (318)
T cd05582         215 LGMPQFLSPEAQSLLRALFKRNPANRLGAGP  245 (318)
T ss_pred             CCCCCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence            0122234457889999999999999999766

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=3.5e-41  Score=319.51  Aligned_cols=251  Identities=21%  Similarity=0.300  Sum_probs=203.5

Q ss_pred             CCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCC-CccHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeEE
Q 046893           93 FFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGG-YQGDREWLAEVNYLGQLRHSNLVKLIGYCCEDEHRI  171 (464)
Q Consensus        93 ~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~  171 (464)
                      +|.+.+.||.|+||.||++.+..+      +..+|+|.+.... ....+.+..|+.+++.++|+||+++++++...+..+
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~------~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   74 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNS------DQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLY   74 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCC------CceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEE
Confidence            477889999999999999987764      5668999886432 233466788999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCccCCCC
Q 046893          172 LVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPM  251 (464)
Q Consensus       172 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~  251 (464)
                      +||||+++++|.+++....+..++...++.++.|++.||.|||  +.+|+|+||||+||+++.++.++|+|||++.....
T Consensus        75 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH--~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~  152 (255)
T cd08219          75 IVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIH--EKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTS  152 (255)
T ss_pred             EEEeeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHh--hCCcccCCCCcceEEECCCCcEEEcccCcceeecc
Confidence            9999999999999887655567899999999999999999999  67799999999999999999999999999975432


Q ss_pred             CCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhcccchhhccC
Q 046893          252 GDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRILD  331 (464)
Q Consensus       252 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  331 (464)
                      ..  .......|+..|+|||++.+..++.++||||||+++|+|++|..||......      .........         
T Consensus       153 ~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~------~~~~~~~~~---------  215 (255)
T cd08219         153 PG--AYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWK------NLILKVCQG---------  215 (255)
T ss_pred             cc--cccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHH------HHHHHHhcC---------
Confidence            21  1223467899999999999888999999999999999999999999754321      111111110         


Q ss_pred             ccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 046893          332 PRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVAL  370 (464)
Q Consensus       332 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  370 (464)
                        .....+...+..+.+|+.+||+.||.+||++.+++..
T Consensus       216 --~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         216 --SYKPLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR  252 (255)
T ss_pred             --CCCCCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence              0011223345578999999999999999999999753

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=3.1e-41  Score=324.24  Aligned_cols=245  Identities=25%  Similarity=0.360  Sum_probs=194.5

Q ss_pred             eeecCceEEEEEEecCCCCCCccceEEEEEEccCCCC---ccHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeEEEEEec
Q 046893          100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGY---QGDREWLAEVNYLGQLRHSNLVKLIGYCCEDEHRILVYEY  176 (464)
Q Consensus       100 lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~  176 (464)
                      ||+|+||.||++.+..+      ++.+|+|.+.....   .....+..|+++++.++||||+++++++......++||||
T Consensus         1 lg~G~~g~Vy~~~~~~~------~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~   74 (277)
T cd05607           1 LGKGGFGEVCAVQVKNT------GKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSL   74 (277)
T ss_pred             CCCCCceEEEEEEEccC------CcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEec
Confidence            79999999999988764      67799999864322   1234456799999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCccCCCCCCCcc
Q 046893          177 MESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTH  256 (464)
Q Consensus       177 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~~~  256 (464)
                      +++++|.+++.......+++..++.++.|++.||.|||  +.+|+||||||+|||++.++.++|+|||++.......   
T Consensus        75 ~~g~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH--~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~---  149 (277)
T cd05607          75 MNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLH--SMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK---  149 (277)
T ss_pred             CCCCCHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH--HCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc---
Confidence            99999998887655556899999999999999999999  6779999999999999999999999999987643221   


Q ss_pred             eeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhcccchhhccCccccC
Q 046893          257 VSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRILDPRLEG  336 (464)
Q Consensus       257 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  336 (464)
                      ......|+..|+|||++.+..++.++|||||||++|||++|+.||.......  ...+........          ....
T Consensus       150 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~--~~~~~~~~~~~~----------~~~~  217 (277)
T cd05607         150 TITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKV--AKEELKRRTLED----------EVKF  217 (277)
T ss_pred             eeeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchh--hHHHHHHHhhcc----------cccc
Confidence            2233578999999999998889999999999999999999999997543211  111111111111          0000


Q ss_pred             ccCHHHHHHHHHHHHHhhccCCCCCCCHHHHH
Q 046893          337 QYTARTAMKVAGLAYQCLSQNPKGRPVMSDVV  368 (464)
Q Consensus       337 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~  368 (464)
                       .....+.++.+|+.+||+.||.+||++.+++
T Consensus       218 -~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~  248 (277)
T cd05607         218 -EHQNFTEESKDICRLFLAKKPEDRLGSREKN  248 (277)
T ss_pred             -ccccCCHHHHHHHHHHhccCHhhCCCCccch
Confidence             0112345789999999999999999998765

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=4.8e-41  Score=320.75  Aligned_cols=255  Identities=23%  Similarity=0.295  Sum_probs=201.4

Q ss_pred             hcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCccHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeE
Q 046893           91 TKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVKLIGYCCEDEHR  170 (464)
Q Consensus        91 ~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~  170 (464)
                      .++|++.+.||+|+||.||+|.+..+      ++.||+|++..........+.+|+.++..++||||+++++++...+..
T Consensus         8 ~~~y~~~~~lg~g~~g~vy~~~~~~~------~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~   81 (267)
T cd06646           8 QHDYELIQRVGSGTYGDVYKARNLHT------GELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKL   81 (267)
T ss_pred             hhhcchhheeecCCCeEEEEEEECCC------CeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEE
Confidence            34689999999999999999998664      667999998755444456678999999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCccCCC
Q 046893          171 ILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGP  250 (464)
Q Consensus       171 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~  250 (464)
                      ++||||+.+++|.+++...  ..+++..+..++.|++.||.|||  ..+|+||||||+||+++.++.+||+|||++....
T Consensus        82 ~iv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH--~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~  157 (267)
T cd06646          82 WICMEYCGGGSLQDIYHVT--GPLSELQIAYVCRETLQGLAYLH--SKGKMHRDIKGANILLTDNGDVKLADFGVAAKIT  157 (267)
T ss_pred             EEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH--HCCccccCCCHHHEEECCCCCEEECcCccceeec
Confidence            9999999999999988654  36899999999999999999999  6779999999999999999999999999998643


Q ss_pred             CCCCcceeeccccCCcccCccccc---cCCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhcccchh
Q 046893          251 MGDQTHVSTRVMGTYGYAAPEYVM---TGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVL  327 (464)
Q Consensus       251 ~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  327 (464)
                      ...  .......|+..|+|||.+.   ...++.++|||||||++|||++|+.||....+......  +    ..  .   
T Consensus       158 ~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~--~----~~--~---  224 (267)
T cd06646         158 ATI--AKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFL--M----SK--S---  224 (267)
T ss_pred             ccc--cccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhhee--e----ec--C---
Confidence            211  1122356889999999874   34578899999999999999999999865432211000  0    00  0   


Q ss_pred             hccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 046893          328 RILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVAL  370 (464)
Q Consensus       328 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  370 (464)
                      ....+...  .....+..+.+|+.+||..+|.+||+++++++.
T Consensus       225 ~~~~~~~~--~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  265 (267)
T cd06646         225 NFQPPKLK--DKTKWSSTFHNFVKISLTKNPKKRPTAERLLTH  265 (267)
T ss_pred             CCCCCCCc--cccccCHHHHHHHHHHhhCChhhCcCHHHHhcC
Confidence            00001110  111234588999999999999999999998864

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=3.8e-41  Score=323.83  Aligned_cols=267  Identities=22%  Similarity=0.349  Sum_probs=210.2

Q ss_pred             HHhcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCC-ccHHHHHHHHHHHhcCCCCCcceEEEEEEe-
Q 046893           89 LATKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGY-QGDREWLAEVNYLGQLRHSNLVKLIGYCCE-  166 (464)
Q Consensus        89 ~~~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-  166 (464)
                      +..++|.+.+.||+|+||.||+|.+....  ......|++|.+..... .....+.+|+.+++.++||||+++++++.. 
T Consensus         3 ~~~~~~~~~~~i~~g~~g~V~~~~~~~~~--~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~   80 (280)
T cd05043           3 ISRDRVTLSDLLQEGTFGRIFYGILIDEK--PGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIED   80 (280)
T ss_pred             cchhheEEeeeecccCCceEEEEEEecCC--CCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecC
Confidence            34567889999999999999999987531  12256789998865422 224668899999999999999999998766 


Q ss_pred             CCeEEEEEeccCCCCHHHHHHhhcC------CCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEE
Q 046893          167 DEHRILVYEYMESGSLEKHLLRRVG------CMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKL  240 (464)
Q Consensus       167 ~~~~~lv~e~~~~g~L~~~l~~~~~------~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl  240 (464)
                      ....++++||+.+++|.+++.....      ..+++..++.++.|++.||.|||  +.+++||||||+|||++.++.+||
T Consensus        81 ~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH--~~~i~H~di~p~nil~~~~~~~kl  158 (280)
T cd05043          81 GEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLH--KRGVIHKDIAARNCVIDEELQVKI  158 (280)
T ss_pred             CCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHH--HCCEeecccCHhhEEEcCCCcEEE
Confidence            4678999999999999999865422      45899999999999999999999  677999999999999999999999


Q ss_pred             cccCCccCCCCCCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHh
Q 046893          241 SDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLL-GRRAVDKSRPSREHNLVEWARPL  319 (464)
Q Consensus       241 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~  319 (464)
                      +|||+++...............++..|+|||++.+..++.++||||||+++||+++ |+.||....+.   .+..+..  
T Consensus       159 ~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~---~~~~~~~--  233 (280)
T cd05043         159 TDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPF---EMAAYLK--  233 (280)
T ss_pred             CCCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHH---HHHHHHH--
Confidence            99999986543332222233456778999999988889999999999999999999 99999764321   1111111  


Q ss_pred             hhcccchhhccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHh
Q 046893          320 LNNNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETVQS  376 (464)
Q Consensus       320 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~~~  376 (464)
                       ..           ........++..+.+++.+||..||++||++.++++.|+.+..
T Consensus       234 -~~-----------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~  278 (280)
T cd05043         234 -DG-----------YRLAQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHA  278 (280)
T ss_pred             -cC-----------CCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence             10           0111122345688999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=6.1e-41  Score=318.40  Aligned_cols=250  Identities=27%  Similarity=0.384  Sum_probs=196.3

Q ss_pred             ceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCc--cHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeEEEEEec
Q 046893           99 ILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQ--GDREWLAEVNYLGQLRHSNLVKLIGYCCEDEHRILVYEY  176 (464)
Q Consensus        99 ~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~  176 (464)
                      .||+|+||.||+|.+...    ..+..+|+|++......  ..+++..|+.+++.+.||||+++++++. .+..++||||
T Consensus         2 ~lg~G~~g~v~~~~~~~~----~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~   76 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMK----KSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMEL   76 (257)
T ss_pred             cCCCcCCcceEEeEEecC----CCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEec
Confidence            589999999999976432    12567999998654322  2367889999999999999999999875 4567899999


Q ss_pred             cCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCccCCCCCCCcc
Q 046893          177 MESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTH  256 (464)
Q Consensus       177 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~~~  256 (464)
                      +.+++|.+++....  .+++..+..++.|++.||.|||  +++|+||||||.|||++.++.+||+|||+++.........
T Consensus        77 ~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~al~~lH--~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~  152 (257)
T cd05116          77 AELGPLNKFLQKNK--HVTEKNITELVHQVSMGMKYLE--ETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYY  152 (257)
T ss_pred             CCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH--HCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCee
Confidence            99999999886543  6899999999999999999999  6779999999999999999999999999998643322211


Q ss_pred             -eeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHhhhcccchhhccCccc
Q 046893          257 -VSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLL-GRRAVDKSRPSREHNLVEWARPLLNNNKKVLRILDPRL  334 (464)
Q Consensus       257 -~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  334 (464)
                       ......++..|+|||.+....++.++|||||||++|||++ |..||......   .+...    +..          ..
T Consensus       153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~---~~~~~----i~~----------~~  215 (257)
T cd05116         153 KAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGN---EVTQM----IES----------GE  215 (257)
T ss_pred             eecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH---HHHHH----HHC----------CC
Confidence             1122344678999999988889999999999999999998 99999764321   11111    111          11


Q ss_pred             cCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHH
Q 046893          335 EGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETV  374 (464)
Q Consensus       335 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~  374 (464)
                      ....+..++..+.+||.+||+.||.+||++.+|...|+..
T Consensus       216 ~~~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~  255 (257)
T cd05116         216 RMECPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY  255 (257)
T ss_pred             CCCCCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence            1122334556899999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.7e-40  Score=334.79  Aligned_cols=268  Identities=22%  Similarity=0.253  Sum_probs=202.7

Q ss_pred             HHHhcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCccHHHHHHHHHHHhcCCCCCcceEEEEEEeC
Q 046893           88 KLATKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVKLIGYCCED  167 (464)
Q Consensus        88 ~~~~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~  167 (464)
                      .+...+|.+.+.||+|+||.||+|.....    ..+..||+|.+...     ..+.+|+++|+.++||||+++++++...
T Consensus        88 ~~~~~~y~i~~~Lg~G~~g~Vy~~~~~~~----~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~  158 (392)
T PHA03207         88 SVVRMQYNILSSLTPGSEGEVFVCTKHGD----EQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWK  158 (392)
T ss_pred             hhccCceEEEEeecCCCCeEEEEEEEcCC----ccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeC
Confidence            34456799999999999999999976432    13567899987643     2356899999999999999999999999


Q ss_pred             CeEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCcc
Q 046893          168 EHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAK  247 (464)
Q Consensus       168 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~  247 (464)
                      ...++|||++. ++|.+++..  ...+++..++.++.||+.||.|||  .++|+||||||+|||++.++.++|+|||+++
T Consensus       159 ~~~~lv~e~~~-~~l~~~l~~--~~~l~~~~~~~i~~ql~~aL~~LH--~~givHrDlkp~Nill~~~~~~~l~DfG~a~  233 (392)
T PHA03207        159 STVCMVMPKYK-CDLFTYVDR--SGPLPLEQAITIQRRLLEALAYLH--GRGIIHRDVKTENIFLDEPENAVLGDFGAAC  233 (392)
T ss_pred             CEEEEEehhcC-CCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHH--HCCccccCCCHHHEEEcCCCCEEEccCcccc
Confidence            99999999995 688888843  346999999999999999999999  6779999999999999999999999999997


Q ss_pred             CCCCCCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHhCCCCCCCCCCccccc-HHHHHHHhhhccc-c
Q 046893          248 DGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHN-LVEWARPLLNNNK-K  325 (464)
Q Consensus       248 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~-~~~~~~~~~~~~~-~  325 (464)
                      ...............||..|+|||++.+..++.++|||||||+||||++|+.||.+........ +..... .+.... .
T Consensus       234 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~-~~~~~~~~  312 (392)
T PHA03207        234 KLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIR-CMQVHPLE  312 (392)
T ss_pred             ccCcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHH-HhccCccc
Confidence            6544333223334679999999999999999999999999999999999999997654332111 111111 000000 0


Q ss_pred             --------h---hhccCccccCcc-------CHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 046893          326 --------V---LRILDPRLEGQY-------TARTAMKVAGLAYQCLSQNPKGRPVMSDVVAL  370 (464)
Q Consensus       326 --------~---~~~~~~~~~~~~-------~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  370 (464)
                              +   ...+.......+       ....+.++.++|.+||..||++||++.+++..
T Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~  375 (392)
T PHA03207        313 FPQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL  375 (392)
T ss_pred             cCCccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence                    0   000000000000       01124578899999999999999999999863

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=8.5e-41  Score=328.17  Aligned_cols=238  Identities=28%  Similarity=0.376  Sum_probs=188.7

Q ss_pred             CceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCC---ccHHHHHHHHH-HHhcCCCCCcceEEEEEEeCCeEEEE
Q 046893           98 YILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGY---QGDREWLAEVN-YLGQLRHSNLVKLIGYCCEDEHRILV  173 (464)
Q Consensus        98 ~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~-~l~~l~hpniv~l~~~~~~~~~~~lv  173 (464)
                      ++||+|+||.||+|.+..+      ++.||+|++.....   .....+..|.. +++.++||||+++++++...+..++|
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~------~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv   74 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSD------GSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFV   74 (321)
T ss_pred             CeeeeCCCEEEEEEEECCC------CCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEE
Confidence            3699999999999998765      66799999865322   12234555554 67889999999999999999999999


Q ss_pred             EeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCccCCCCCC
Q 046893          174 YEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGD  253 (464)
Q Consensus       174 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~  253 (464)
                      |||+++++|..++...  ..+++..+..++.||+.||.|||  ..+|+||||||+||||+.++.+||+|||+++..... 
T Consensus        75 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~L~~lH--~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~-  149 (321)
T cd05603          75 LDYVNGGELFFHLQRE--RCFLEPRARFYAAEVASAIGYLH--SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEP-  149 (321)
T ss_pred             EcCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH--HCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCC-
Confidence            9999999998887653  36889999999999999999999  677999999999999999999999999998753221 


Q ss_pred             CcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhcccchhhccCcc
Q 046893          254 QTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRILDPR  333 (464)
Q Consensus       254 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  333 (464)
                       .......+||+.|+|||++.+..++.++|||||||++|||++|..||.....      ...........          
T Consensus       150 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~------~~~~~~i~~~~----------  212 (321)
T cd05603         150 -EETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDV------SQMYDNILHKP----------  212 (321)
T ss_pred             -CCccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCH------HHHHHHHhcCC----------
Confidence             1223346799999999999998999999999999999999999999976431      11111111110          


Q ss_pred             ccCccCHHHHHHHHHHHHHhhccCCCCCCCHH
Q 046893          334 LEGQYTARTAMKVAGLAYQCLSQNPKGRPVMS  365 (464)
Q Consensus       334 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~  365 (464)
                        ..++......+.+++.+||+.||.+||+..
T Consensus       213 --~~~~~~~~~~~~~li~~~l~~~p~~R~~~~  242 (321)
T cd05603         213 --LQLPGGKTVAACDLLVGLLHKDQRRRLGAK  242 (321)
T ss_pred             --CCCCCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence              011223345788999999999999999864

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=3.9e-41  Score=333.58  Aligned_cols=268  Identities=26%  Similarity=0.376  Sum_probs=204.4

Q ss_pred             HhcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCc-cHHHHHHHHHHHhcC-CCCCcceEEEEEEeC
Q 046893           90 ATKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQ-GDREWLAEVNYLGQL-RHSNLVKLIGYCCED  167 (464)
Q Consensus        90 ~~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~  167 (464)
                      ..++|++.+.||+|+||.||+|.+... .....++.||||++...... ....+.+|+.+|.++ +||||+++++++...
T Consensus         5 ~~~~~~~~~~lG~G~fg~V~~~~~~~~-~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~   83 (343)
T cd05103           5 PRDRLKLGKPLGRGAFGQVIEADAFGI-DKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP   83 (343)
T ss_pred             chhHhcccccccCCccceEEEEeeccC-CccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecC
Confidence            456799999999999999999986432 11224678999999754322 235688999999999 689999999987654


Q ss_pred             -CeEEEEEeccCCCCHHHHHHhhcC-------------------------------------------------------
Q 046893          168 -EHRILVYEYMESGSLEKHLLRRVG-------------------------------------------------------  191 (464)
Q Consensus       168 -~~~~lv~e~~~~g~L~~~l~~~~~-------------------------------------------------------  191 (464)
                       ...++||||+++|+|.+++.....                                                       
T Consensus        84 ~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  163 (343)
T cd05103          84 GGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEE  163 (343)
T ss_pred             CCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchh
Confidence             467899999999999998864321                                                       


Q ss_pred             ----------CCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCccCCCCCCCcceeecc
Q 046893          192 ----------CMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRV  261 (464)
Q Consensus       192 ----------~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~~~~~~~~  261 (464)
                                ..+++..+..++.|++.||.|||  +++|+||||||+|||++.++.+||+|||++...............
T Consensus       164 ~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH--~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~  241 (343)
T cd05103         164 EEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLA--SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDA  241 (343)
T ss_pred             hhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHH--hCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCC
Confidence                      23678888999999999999999  677999999999999999999999999999864322221122224


Q ss_pred             ccCCcccCccccccCCCCcccchhcHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHhhhcccchhhccCccccCccCH
Q 046893          262 MGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLL-GRRAVDKSRPSREHNLVEWARPLLNNNKKVLRILDPRLEGQYTA  340 (464)
Q Consensus       262 ~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  340 (464)
                      .++..|+|||++.+..++.++||||||+++|+|++ |..||.......  .+.    ..+....          ....+.
T Consensus       242 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~--~~~----~~~~~~~----------~~~~~~  305 (343)
T cd05103         242 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE--EFC----RRLKEGT----------RMRAPD  305 (343)
T ss_pred             CCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccH--HHH----HHHhccC----------CCCCCC
Confidence            46678999999988899999999999999999997 999986532211  011    1111110          001111


Q ss_pred             HHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHh
Q 046893          341 RTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETVQS  376 (464)
Q Consensus       341 ~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~~~  376 (464)
                      ..+..+.+++..||+.||.+||++.+|++.|+.+..
T Consensus       306 ~~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~  341 (343)
T cd05103         306 YTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ  341 (343)
T ss_pred             CCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            233478999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=7.8e-41  Score=324.53  Aligned_cols=270  Identities=24%  Similarity=0.420  Sum_probs=204.7

Q ss_pred             hcCCCCCCceeecCceEEEEEEecCCC----------CCCccceEEEEEEccCCCCc-cHHHHHHHHHHHhcCCCCCcce
Q 046893           91 TKFFRPDYILGEGGFGVVYKGVIDENV----------RPGYKTTFVAIKELNRGGYQ-GDREWLAEVNYLGQLRHSNLVK  159 (464)
Q Consensus        91 ~~~~~~~~~lG~G~fg~Vy~a~~~~~~----------~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~  159 (464)
                      .++|++.+.||+|+||.||++.+....          ........+|+|.+...... ....+.+|+.+|+.++|+||++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~   83 (296)
T cd05095           4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIR   83 (296)
T ss_pred             hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcce
Confidence            356899999999999999998654321          11122456899998754322 3367889999999999999999


Q ss_pred             EEEEEEeCCeEEEEEeccCCCCHHHHHHhhcC---------CCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCce
Q 046893          160 LIGYCCEDEHRILVYEYMESGSLEKHLLRRVG---------CMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNI  230 (464)
Q Consensus       160 l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~---------~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Ni  230 (464)
                      +++++...+..++||||+.+++|.+++.....         ..+++.++..++.|++.||.|||  +.+|+||||||+||
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH--~~~i~H~dlkp~Ni  161 (296)
T cd05095          84 LLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLS--SLNFVHRDLATRNC  161 (296)
T ss_pred             EEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHH--HCCeecccCChheE
Confidence            99999999999999999999999999875421         24678899999999999999999  67799999999999


Q ss_pred             EecCCCceEEcccCCccCCCCCCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHh--CCCCCCCCCCcc
Q 046893          231 LLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLL--GRRAVDKSRPSR  308 (464)
Q Consensus       231 ll~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~--g~~pf~~~~~~~  308 (464)
                      |++.++.++|+|||+++...............++..|++||++.++.++.++|||||||++|||++  |..||.......
T Consensus       162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~  241 (296)
T cd05095         162 LVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQ  241 (296)
T ss_pred             EEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChHH
Confidence            999999999999999986433322222233445678999999888899999999999999999998  777886533211


Q ss_pred             cccHHHHHHHhhhcccchhhccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 046893          309 EHNLVEWARPLLNNNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLE  372 (464)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~  372 (464)
                         ........+.....       ......+..++..+.+|+.+||+.||.+||++.+|++.|+
T Consensus       242 ---~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~  295 (296)
T cd05095         242 ---VIENTGEFFRDQGR-------QVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLL  295 (296)
T ss_pred             ---HHHHHHHHHhhccc-------cccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence               11111111111000       0000112234568999999999999999999999999885

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=5.7e-41  Score=320.16  Aligned_cols=260  Identities=22%  Similarity=0.337  Sum_probs=207.1

Q ss_pred             cCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCc---cHHHHHHHHHHHhcCCCCCcceEEEEEEeCC
Q 046893           92 KFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQ---GDREWLAEVNYLGQLRHSNLVKLIGYCCEDE  168 (464)
Q Consensus        92 ~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~  168 (464)
                      .+|.+.+.||.|+||.||+|.+..+      +..+|||.+......   ...++.+|+.+++.+.||||+++++++..++
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~~~~------~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~   75 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATCLLD------GVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDN   75 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEeecCC------CceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCC
Confidence            3578888999999999999997664      567999987653322   2356889999999999999999999999999


Q ss_pred             eEEEEEeccCCCCHHHHHHhh--cCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCc
Q 046893          169 HRILVYEYMESGSLEKHLLRR--VGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLA  246 (464)
Q Consensus       169 ~~~lv~e~~~~g~L~~~l~~~--~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla  246 (464)
                      ..++||||+.+++|.+++...  ....+++..++.++.|++.||.|||  +++++|+||||+||+++.++.++|+|||++
T Consensus        76 ~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH--~~~i~H~dl~p~nili~~~~~~~l~dfg~~  153 (267)
T cd08229          76 ELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMH--SRRVMHRDIKPANVFITATGVVKLGDLGLG  153 (267)
T ss_pred             eEEEEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH--HCCeecCCCCHHHEEEcCCCCEEECcchhh
Confidence            999999999999999988642  2346899999999999999999999  677999999999999999999999999998


Q ss_pred             cCCCCCCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhcccch
Q 046893          247 KDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKV  326 (464)
Q Consensus       247 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  326 (464)
                      .......  .......|+..|+|||++.+..++.++||||||+++|+|++|..||......    ..++....       
T Consensus       154 ~~~~~~~--~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~----~~~~~~~~-------  220 (267)
T cd08229         154 RFFSSKT--TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN----LYSLCKKI-------  220 (267)
T ss_pred             hccccCC--cccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccch----HHHHhhhh-------
Confidence            7643222  1223357899999999998889999999999999999999999999754321    11111111       


Q ss_pred             hhccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHH
Q 046893          327 LRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETVQ  375 (464)
Q Consensus       327 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~~  375 (464)
                      .....+..   .....+..+.+++.+||..||.+|||+.+|++.++++.
T Consensus       221 ~~~~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~  266 (267)
T cd08229         221 EQCDYPPL---PSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH  266 (267)
T ss_pred             hcCCCCCC---CcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence            01111111   11235568999999999999999999999999988763

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=4e-41  Score=319.49  Aligned_cols=251  Identities=27%  Similarity=0.419  Sum_probs=199.7

Q ss_pred             cCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCccHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeEE
Q 046893           92 KFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVKLIGYCCEDEHRI  171 (464)
Q Consensus        92 ~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~  171 (464)
                      .+|++.+.||+|+||.||+|.+..       ...+|+|.+.... .....+.+|+.+++.++||||+++++++...+..+
T Consensus         4 ~~~~~~~~lg~G~~~~v~~~~~~~-------~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   75 (256)
T cd05059           4 SELTFLKELGSGQFGVVHLGKWRG-------KIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIF   75 (256)
T ss_pred             HHcchhhhhccCCCceEEEeEecC-------CccEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceE
Confidence            357888999999999999998653       2358999886533 23457889999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCccCCCC
Q 046893          172 LVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPM  251 (464)
Q Consensus       172 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~  251 (464)
                      +||||+++++|.+++..+.. .+++..++.++.|++.||.|||  ..+|+||||||+||+++.++.+||+|||+++....
T Consensus        76 lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~i~~qi~~~l~~lH--~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~  152 (256)
T cd05059          76 IVTEYMANGCLLNYLRERKG-KLGTEWLLDMCSDVCEAMEYLE--SNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLD  152 (256)
T ss_pred             EEEecCCCCCHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHH--HCCcccccccHhhEEECCCCcEEECCcccceeccc
Confidence            99999999999999876433 6899999999999999999999  67799999999999999999999999999975432


Q ss_pred             CCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHhhhcccchhhcc
Q 046893          252 GDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLL-GRRAVDKSRPSREHNLVEWARPLLNNNKKVLRIL  330 (464)
Q Consensus       252 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  330 (464)
                      ... .......++..|+|||.+.+..++.++||||||+++|+|++ |..||.......   ...   . +..        
T Consensus       153 ~~~-~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~---~~~---~-~~~--------  216 (256)
T cd05059         153 DQY-TSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSE---VVE---S-VSA--------  216 (256)
T ss_pred             ccc-cccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHH---HHH---H-HHc--------
Confidence            111 11111234557999999998899999999999999999999 888987543211   111   0 000        


Q ss_pred             CccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 046893          331 DPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALL  371 (464)
Q Consensus       331 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L  371 (464)
                        ......+..++..+.+|+.+||..+|++||++.++++.|
T Consensus       217 --~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l  255 (256)
T cd05059         217 --GYRLYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL  255 (256)
T ss_pred             --CCcCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence              011112223556899999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=2.7e-41  Score=320.78  Aligned_cols=252  Identities=26%  Similarity=0.401  Sum_probs=200.4

Q ss_pred             cCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCccHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeEE
Q 046893           92 KFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVKLIGYCCEDEHRI  171 (464)
Q Consensus        92 ~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~  171 (464)
                      ++|++.+.||+|+||.||+|.+...       ..+|+|.+.... .....+.+|+.++..++||||+++++++......+
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~-------~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   75 (256)
T cd05113           4 KDLTFLKELGTGQFGVVKYGKWRGQ-------YDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIY   75 (256)
T ss_pred             HHeEEeeEecCcccceEEEEEecCC-------CcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcE
Confidence            4578888999999999999986542       348999887543 34567899999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCccCCCC
Q 046893          172 LVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPM  251 (464)
Q Consensus       172 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~  251 (464)
                      +||||+.+++|.+++.... ..+++..++.++.|++.||.|||  ..+++|+||||+|||++.++.+||+|||+++....
T Consensus        76 lv~e~~~~~~l~~~i~~~~-~~~~~~~~~~~~~~i~~~l~~lH--~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~  152 (256)
T cd05113          76 IVTEYMSNGCLLNYLREHG-KRFQPSQLLEMCKDVCEGMAYLE--SKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLD  152 (256)
T ss_pred             EEEEcCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH--hCCeeccccCcceEEEcCCCCEEECCCccceecCC
Confidence            9999999999999887643 36899999999999999999999  67799999999999999999999999999875433


Q ss_pred             CCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHhhhcccchhhcc
Q 046893          252 GDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLL-GRRAVDKSRPSREHNLVEWARPLLNNNKKVLRIL  330 (464)
Q Consensus       252 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  330 (464)
                      ... .......++..|+|||++.+..++.++||||||+++|+|++ |..||......      +..........      
T Consensus       153 ~~~-~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~------~~~~~~~~~~~------  219 (256)
T cd05113         153 DEY-TSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNS------ETVEKVSQGLR------  219 (256)
T ss_pred             Cce-eecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHH------HHHHHHhcCCC------
Confidence            221 11112345678999999988889999999999999999998 99998754321      11111111100      


Q ss_pred             CccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 046893          331 DPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLE  372 (464)
Q Consensus       331 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~  372 (464)
                       .    ..+...+..+.+++.+||..+|.+||++.++++.|+
T Consensus       220 -~----~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~  256 (256)
T cd05113         220 -L----YRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE  256 (256)
T ss_pred             -C----CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence             0    111123458899999999999999999999988763

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=4.9e-41  Score=327.16  Aligned_cols=260  Identities=25%  Similarity=0.379  Sum_probs=202.4

Q ss_pred             cCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCC-ccHHHHHHHHHHHhcC-CCCCcceEEEEEEeCCe
Q 046893           92 KFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGY-QGDREWLAEVNYLGQL-RHSNLVKLIGYCCEDEH  169 (464)
Q Consensus        92 ~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~  169 (464)
                      ++|.+.+.||+|+||.||+|.+..+.    ....+|+|.+..... .....+.+|+.++.++ +||||+++++++..++.
T Consensus         7 ~~~~~~~~lg~G~~g~V~~a~~~~~~----~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~   82 (303)
T cd05088           7 NDIKFQDVIGEGNFGQVLKARIKKDG----LRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGY   82 (303)
T ss_pred             hhceeeeeecCCCCceEEEEEEccCC----ceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCC
Confidence            46888899999999999999976541    123467887654322 2335688999999999 89999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHhhc--------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCC
Q 046893          170 RILVYEYMESGSLEKHLLRRV--------------GCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNAD  235 (464)
Q Consensus       170 ~~lv~e~~~~g~L~~~l~~~~--------------~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~  235 (464)
                      +++||||+++++|.+++....              +..+++..++.++.|++.||+|||  +++|+||||||+|||++.+
T Consensus        83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH--~~gi~H~dlkp~Nili~~~  160 (303)
T cd05088          83 LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS--QKQFIHRDLAARNILVGEN  160 (303)
T ss_pred             ceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHH--hCCccccccchheEEecCC
Confidence            999999999999999986542              135789999999999999999999  6789999999999999999


Q ss_pred             CceEEcccCCccCCCCCCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHh-CCCCCCCCCCcccccHHH
Q 046893          236 FSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLL-GRRAVDKSRPSREHNLVE  314 (464)
Q Consensus       236 ~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~  314 (464)
                      +.+||+|||+++......   ......++..|+|||++.+..++.++|||||||++|||++ |..||......      +
T Consensus       161 ~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~------~  231 (303)
T cd05088         161 YVAKIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA------E  231 (303)
T ss_pred             CcEEeCccccCcccchhh---hcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChH------H
Confidence            999999999986421111   1111234667999999988889999999999999999998 99999654321      1


Q ss_pred             HHHHhhhcccchhhccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhc
Q 046893          315 WARPLLNNNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETVQSQ  377 (464)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~~~~  377 (464)
                      ...... .          ......+...+..+.+|+.+||+.+|.+||++.+++..|+.+...
T Consensus       232 ~~~~~~-~----------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~  283 (303)
T cd05088         232 LYEKLP-Q----------GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE  283 (303)
T ss_pred             HHHHHh-c----------CCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence            111110 0          001111222345789999999999999999999999999877544

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2.2e-40  Score=329.96  Aligned_cols=262  Identities=21%  Similarity=0.264  Sum_probs=194.4

Q ss_pred             HHhcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCccHHHHHHHHHHHhcCCCCCcceEEEEEEeCC
Q 046893           89 LATKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVKLIGYCCEDE  168 (464)
Q Consensus        89 ~~~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~  168 (464)
                      .....|++.+.||+|+||.||+|.+...      +..||+|+....      ....|+.+++.++||||+++++++....
T Consensus        63 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~------~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~  130 (357)
T PHA03209         63 VASLGYTVIKTLTPGSEGRVFVATKPGQ------PDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGA  130 (357)
T ss_pred             hhhcCcEEEEEecCCCCeEEEEEEECCC------CceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCC
Confidence            4456799999999999999999998764      566999985432      2356899999999999999999999999


Q ss_pred             eEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCccC
Q 046893          169 HRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKD  248 (464)
Q Consensus       169 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~  248 (464)
                      ..++|||++. ++|.+++... ...+++..++.|+.||+.||.|||  .++|+||||||+|||++.++.+||+|||+++.
T Consensus       131 ~~~lv~e~~~-~~l~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH--~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~  206 (357)
T PHA03209        131 ITCMVLPHYS-SDLYTYLTKR-SRPLPIDQALIIEKQILEGLRYLH--AQRIIHRDVKTENIFINDVDQVCIGDLGAAQF  206 (357)
T ss_pred             eeEEEEEccC-CcHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHH--HCCeecCCCCHHHEEECCCCCEEEecCccccc
Confidence            9999999994 6888887654 346899999999999999999999  57799999999999999999999999999974


Q ss_pred             CCCCCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHhCCCCCCCCCCccccc--------HHHHHHHhh
Q 046893          249 GPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHN--------LVEWARPLL  320 (464)
Q Consensus       249 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~--------~~~~~~~~~  320 (464)
                      ....   .......||..|+|||++.+..++.++|||||||++|||+++..++....+.....        +........
T Consensus       207 ~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~  283 (357)
T PHA03209        207 PVVA---PAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLK  283 (357)
T ss_pred             cccC---cccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhc
Confidence            3221   12233679999999999999999999999999999999999666554333222111        111000000


Q ss_pred             hcccchh---------hccCc--ccc---Ccc----CHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 046893          321 NNNKKVL---------RILDP--RLE---GQY----TARTAMKVAGLAYQCLSQNPKGRPVMSDVVA  369 (464)
Q Consensus       321 ~~~~~~~---------~~~~~--~~~---~~~----~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  369 (464)
                      .......         ..++.  ...   ..+    ....+..+.+||.+||+.||.+|||+.+++.
T Consensus       284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~  350 (357)
T PHA03209        284 VHPEEFPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILN  350 (357)
T ss_pred             cChhhcCCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhc
Confidence            0000000         00000  000   000    0122346677999999999999999999875

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=4.6e-41  Score=330.65  Aligned_cols=241  Identities=27%  Similarity=0.363  Sum_probs=189.6

Q ss_pred             CceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCC---ccHHHHHHHHH-HHhcCCCCCcceEEEEEEeCCeEEEE
Q 046893           98 YILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGY---QGDREWLAEVN-YLGQLRHSNLVKLIGYCCEDEHRILV  173 (464)
Q Consensus        98 ~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~-~l~~l~hpniv~l~~~~~~~~~~~lv  173 (464)
                      +.||+|+||+||+|.+..+      +..||+|++.....   .....+..|.. +++.+.||||+++++++...+..++|
T Consensus         1 ~~lg~G~fg~V~~~~~~~~------~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv   74 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAE------EKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFV   74 (325)
T ss_pred             CeeeeCCCeEEEEEEECCC------CCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEE
Confidence            3699999999999998765      56799999865321   12234444444 56788999999999999999999999


Q ss_pred             EeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCccCCCCCC
Q 046893          174 YEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGD  253 (464)
Q Consensus       174 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~  253 (464)
                      |||+.+++|.+++...  ..+.+..+..++.||+.||.|||  ..+|+||||||+|||++.++.+||+|||+++..... 
T Consensus        75 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~L~~lH--~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~-  149 (325)
T cd05602          75 LDYINGGELFYHLQRE--RCFLEPRARFYAAEIASALGYLH--SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEH-  149 (325)
T ss_pred             EeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH--HCCeEecCCCHHHeEECCCCCEEEccCCCCcccccC-
Confidence            9999999999988764  35888899999999999999999  677999999999999999999999999999753221 


Q ss_pred             CcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhcccchhhccCcc
Q 046893          254 QTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRILDPR  333 (464)
Q Consensus       254 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  333 (464)
                       .......+||+.|+|||++.+..++.++|||||||++|+|++|..||......      +.........        . 
T Consensus       150 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~------~~~~~i~~~~--------~-  213 (325)
T cd05602         150 -NGTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTA------EMYDNILNKP--------L-  213 (325)
T ss_pred             -CCCcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHH------HHHHHHHhCC--------c-
Confidence             11233467999999999999999999999999999999999999999754321      1111111110        0 


Q ss_pred             ccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHH
Q 046893          334 LEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVV  368 (464)
Q Consensus       334 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~  368 (464)
                         .+....+..+.+++.+||+.||.+||++.+.+
T Consensus       214 ---~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~  245 (325)
T cd05602         214 ---QLKPNITNSARHLLEGLLQKDRTKRLGAKDDF  245 (325)
T ss_pred             ---CCCCCCCHHHHHHHHHHcccCHHHCCCCCCCH
Confidence               11122345788999999999999999987543

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=5.5e-41  Score=320.54  Aligned_cols=261  Identities=27%  Similarity=0.439  Sum_probs=205.6

Q ss_pred             hcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCC-ccHHHHHHHHHHHhcCCCCCcceEEEEEEeCCe
Q 046893           91 TKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGY-QGDREWLAEVNYLGQLRHSNLVKLIGYCCEDEH  169 (464)
Q Consensus        91 ~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~  169 (464)
                      .++|...+.||+|+||.||+|.+.....   ....+|+|.+..... .....+..|++++..++||||+++++++...+.
T Consensus         4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~---~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   80 (268)
T cd05063           4 PSHITKQKVIGAGEFGEVFRGILKMPGR---KEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKP   80 (268)
T ss_pred             hHHceEeeEecCCCCccEEEEEEecCCC---CceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCC
Confidence            4567888999999999999999865321   235799999865422 234568899999999999999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCccCC
Q 046893          170 RILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDG  249 (464)
Q Consensus       170 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~  249 (464)
                      .++||||+.+++|.+++.... ..+++..+..++.|++.||.|||  +.+++||||||+||+++.++.+||+|||++...
T Consensus        81 ~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~al~~lH--~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~  157 (268)
T cd05063          81 AMIITEYMENGALDKYLRDHD-GEFSSYQLVGMLRGIAAGMKYLS--DMNYVHRDLAARNILVNSNLECKVSDFGLSRVL  157 (268)
T ss_pred             cEEEEEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH--HCCeeccccchhhEEEcCCCcEEECCCccceec
Confidence            999999999999999886543 46899999999999999999999  677999999999999999999999999999764


Q ss_pred             CCCCCcce-eeccccCCcccCccccccCCCCcccchhcHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHhhhcccchh
Q 046893          250 PMGDQTHV-STRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLL-GRRAVDKSRPSREHNLVEWARPLLNNNKKVL  327 (464)
Q Consensus       250 ~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  327 (464)
                      ........ ......+..|+|||++.+..++.++|||||||++|||++ |..||......      ++.......     
T Consensus       158 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~------~~~~~i~~~-----  226 (268)
T cd05063         158 EDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNH------EVMKAINDG-----  226 (268)
T ss_pred             ccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHH------HHHHHHhcC-----
Confidence            33221111 111223457999999988889999999999999999997 99999654321      111111100     


Q ss_pred             hccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHH
Q 046893          328 RILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETV  374 (464)
Q Consensus       328 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~  374 (464)
                            ........++..+.+++.+||..+|.+||++.+|++.|+++
T Consensus       227 ------~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~  267 (268)
T cd05063         227 ------FRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL  267 (268)
T ss_pred             ------CCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence                  01111223456889999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=9e-41  Score=317.93  Aligned_cols=253  Identities=23%  Similarity=0.307  Sum_probs=202.2

Q ss_pred             cCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCc-----cHHHHHHHHHHHhcCCCCCcceEEEEEEe
Q 046893           92 KFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQ-----GDREWLAEVNYLGQLRHSNLVKLIGYCCE  166 (464)
Q Consensus        92 ~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~hpniv~l~~~~~~  166 (464)
                      ++|.+.+.||+|+||.||+|.+..+      +..+|+|.+......     ....+.+|++++++++||||+++++++..
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~~------~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~   75 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVDT------GRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRD   75 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcCC------CcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEcc
Confidence            4688999999999999999987654      567999987643221     12457889999999999999999999999


Q ss_pred             CCeEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCc
Q 046893          167 DEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLA  246 (464)
Q Consensus       167 ~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla  246 (464)
                      .+..++||||+++++|.+++....  .+++..+..++.|++.||.|||  +.+|+||||+|+||+++.++.++|+|||++
T Consensus        76 ~~~~~~v~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lH--~~~i~H~dl~p~nilv~~~~~~~l~dfg~~  151 (263)
T cd06625          76 DETLSIFMEYMPGGSVKDQLKAYG--ALTETVTRKYTRQILEGVEYLH--SNMIVHRDIKGANILRDSAGNVKLGDFGAS  151 (263)
T ss_pred             CCeEEEEEEECCCCcHHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHH--hCCeecCCCCHHHEEEcCCCCEEEeecccc
Confidence            999999999999999999887643  5889999999999999999999  677999999999999999999999999999


Q ss_pred             cCCCCCCCcce-eeccccCCcccCccccccCCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhcccc
Q 046893          247 KDGPMGDQTHV-STRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKK  325 (464)
Q Consensus       247 ~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  325 (464)
                      +.......... .....|+..|+|||++.+..++.++||||||+++|+|++|+.||.......     . .....     
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-----~-~~~~~-----  220 (263)
T cd06625         152 KRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMA-----A-IFKIA-----  220 (263)
T ss_pred             eeccccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHH-----H-HHHHh-----
Confidence            75432211111 123568889999999999899999999999999999999999997543211     0 00000     


Q ss_pred             hhhccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 046893          326 VLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVAL  370 (464)
Q Consensus       326 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  370 (464)
                           .......++...+..+.+++.+||..+|.+||++.+++..
T Consensus       221 -----~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~  260 (263)
T cd06625         221 -----TQPTNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH  260 (263)
T ss_pred             -----ccCCCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence                 1111112333455688999999999999999999998753

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=6.5e-41  Score=325.31  Aligned_cols=260  Identities=25%  Similarity=0.373  Sum_probs=202.4

Q ss_pred             cCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCC-ccHHHHHHHHHHHhcC-CCCCcceEEEEEEeCCe
Q 046893           92 KFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGY-QGDREWLAEVNYLGQL-RHSNLVKLIGYCCEDEH  169 (464)
Q Consensus        92 ~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~  169 (464)
                      ++|++.+.||+|+||.||+|.+.....    ...+++|.++.... .....+..|+.++.++ +||||+++++++.....
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~----~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~   77 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDGL----KMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGY   77 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCCC----cceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCc
Confidence            468889999999999999998765421    22368887764222 2335688999999999 79999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHhhc--------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCC
Q 046893          170 RILVYEYMESGSLEKHLLRRV--------------GCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNAD  235 (464)
Q Consensus       170 ~~lv~e~~~~g~L~~~l~~~~--------------~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~  235 (464)
                      .++||||+++++|.+++....              ...+++..++.++.|++.||+|||  +++|+||||||+|||++.+
T Consensus        78 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH--~~~ivH~dlkp~Nill~~~  155 (297)
T cd05089          78 LYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLS--EKQFIHRDLAARNVLVGEN  155 (297)
T ss_pred             ceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHH--HCCcccCcCCcceEEECCC
Confidence            999999999999999986532              125889999999999999999999  6779999999999999999


Q ss_pred             CceEEcccCCccCCCCCCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHh-CCCCCCCCCCcccccHHH
Q 046893          236 FSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLL-GRRAVDKSRPSREHNLVE  314 (464)
Q Consensus       236 ~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~  314 (464)
                      +.+||+|||++.......   .......+..|+|||++.+..++.++|||||||++|||++ |..||......      +
T Consensus       156 ~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~------~  226 (297)
T cd05089         156 LASKIADFGLSRGEEVYV---KKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCA------E  226 (297)
T ss_pred             CeEEECCcCCCcccccee---ccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHH------H
Confidence            999999999986422111   1111223557999999988889999999999999999997 99999764321      1


Q ss_pred             HHHHhhhcccchhhccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhc
Q 046893          315 WARPLLNNNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETVQSQ  377 (464)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~~~~  377 (464)
                      +.....           .......+..++..+.+|+.+||..+|.+||++.+++..|+.+...
T Consensus       227 ~~~~~~-----------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~  278 (297)
T cd05089         227 LYEKLP-----------QGYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEA  278 (297)
T ss_pred             HHHHHh-----------cCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence            111110           0111112223455889999999999999999999999999877653

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=1.3e-40  Score=317.32  Aligned_cols=259  Identities=22%  Similarity=0.352  Sum_probs=207.9

Q ss_pred             cCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCC---ccHHHHHHHHHHHhcCCCCCcceEEEEEEeCC
Q 046893           92 KFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGY---QGDREWLAEVNYLGQLRHSNLVKLIGYCCEDE  168 (464)
Q Consensus        92 ~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~  168 (464)
                      ++|.+.+.||+|+||.||+|.+..+      ++.||+|.+.....   .....+.+|+++++.++|+||+++++++...+
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~~------~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~   75 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLLD------GRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENN   75 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcCC------CCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCC
Confidence            4688999999999999999998754      56799998764222   22457889999999999999999999999999


Q ss_pred             eEEEEEeccCCCCHHHHHHhh--cCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCc
Q 046893          169 HRILVYEYMESGSLEKHLLRR--VGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLA  246 (464)
Q Consensus       169 ~~~lv~e~~~~g~L~~~l~~~--~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla  246 (464)
                      ..++||||+++++|.+++...  .+..+++..++.++.|++.||.|||  ..+|+||||+|+||+++.++.++|+|||++
T Consensus        76 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh--~~~i~h~dl~p~nil~~~~~~~~l~d~~~~  153 (267)
T cd08224          76 ELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMH--SKRIMHRDIKPANVFITATGVVKLGDLGLG  153 (267)
T ss_pred             eEEEEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHH--hCCEecCCcChhhEEECCCCcEEEecccee
Confidence            999999999999999988642  2346899999999999999999999  677999999999999999999999999998


Q ss_pred             cCCCCCCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhcccch
Q 046893          247 KDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKV  326 (464)
Q Consensus       247 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  326 (464)
                      .......  .......|+..|+|||.+.+..++.++||||||+++|+|++|+.||.....    ...++.......    
T Consensus       154 ~~~~~~~--~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~----~~~~~~~~~~~~----  223 (267)
T cd08224         154 RFFSSKT--TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM----NLYSLCKKIEKC----  223 (267)
T ss_pred             eeccCCC--cccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCc----cHHHHHhhhhcC----
Confidence            7543221  112235688999999999988999999999999999999999999965431    111111111100    


Q ss_pred             hhccCccccCccC-HHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHH
Q 046893          327 LRILDPRLEGQYT-ARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETVQ  375 (464)
Q Consensus       327 ~~~~~~~~~~~~~-~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~~  375 (464)
                             .....+ ...+..+.+++.+||..+|.+||++.+|++.|+.+.
T Consensus       224 -------~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~  266 (267)
T cd08224         224 -------DYPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH  266 (267)
T ss_pred             -------CCCCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence                   001111 144558899999999999999999999999998764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=6.1e-41  Score=331.03  Aligned_cols=273  Identities=26%  Similarity=0.350  Sum_probs=211.2

Q ss_pred             HHHHhcCCCCCCceeecCceEEEEEEecCCCCC-CccceEEEEEEccCCCCc-cHHHHHHHHHHHhcC-CCCCcceEEEE
Q 046893           87 MKLATKFFRPDYILGEGGFGVVYKGVIDENVRP-GYKTTFVAIKELNRGGYQ-GDREWLAEVNYLGQL-RHSNLVKLIGY  163 (464)
Q Consensus        87 ~~~~~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~-~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l-~hpniv~l~~~  163 (464)
                      +++...+|.+.+.||+|+||.||+|.+....+. ......||+|.+...... ....+..|+.++.++ .||||++++++
T Consensus         7 ~~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~   86 (334)
T cd05100           7 WELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGA   86 (334)
T ss_pred             cccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEE
Confidence            345556799999999999999999986542211 122346899988754322 236788999999999 79999999999


Q ss_pred             EEeCCeEEEEEeccCCCCHHHHHHhhc--------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCc
Q 046893          164 CCEDEHRILVYEYMESGSLEKHLLRRV--------------GCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSN  229 (464)
Q Consensus       164 ~~~~~~~~lv~e~~~~g~L~~~l~~~~--------------~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~N  229 (464)
                      +...+..++||||+.+|+|.+++....              ...+++..++.++.|++.||.|||  +++|+||||||+|
T Consensus        87 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH--~~givH~dlkp~N  164 (334)
T cd05100          87 CTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLA--SQKCIHRDLAARN  164 (334)
T ss_pred             EccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHH--HCCeeccccccce
Confidence            999999999999999999999987532              134788999999999999999999  6779999999999


Q ss_pred             eEecCCCceEEcccCCccCCCCCCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHh-CCCCCCCCCCcc
Q 046893          230 ILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLL-GRRAVDKSRPSR  308 (464)
Q Consensus       230 ill~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~  308 (464)
                      ||++.++.+||+|||+++...............++..|+|||++.+..++.++||||||++||||++ |..||.....  
T Consensus       165 ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~--  242 (334)
T cd05100         165 VLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV--  242 (334)
T ss_pred             EEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCH--
Confidence            9999999999999999986433222212222344578999999999999999999999999999998 8888865431  


Q ss_pred             cccHHHHHHHhhhcccchhhccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhcC
Q 046893          309 EHNLVEWARPLLNNNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETVQSQG  378 (464)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~~~~~  378 (464)
                          .++.......           .....+..++..+.+|+.+||+.+|.+||++.++++.|+.+....
T Consensus       243 ----~~~~~~~~~~-----------~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~~  297 (334)
T cd05100         243 ----EELFKLLKEG-----------HRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVT  297 (334)
T ss_pred             ----HHHHHHHHcC-----------CCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhhc
Confidence                1221111110           111112234458899999999999999999999999999886543

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.6e-41  Score=319.68  Aligned_cols=257  Identities=30%  Similarity=0.471  Sum_probs=207.1

Q ss_pred             HHhcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCccHHHHHHHHHHHhcCCCCCcceEEEEEEeCC
Q 046893           89 LATKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVKLIGYCCEDE  168 (464)
Q Consensus        89 ~~~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~  168 (464)
                      +..++|++.+.||+|+||.||+|.+..       ...+|||.+.... ....++..|+.+++.++|+||+++++++....
T Consensus         3 ~~~~~~~i~~~ig~g~~~~v~~~~~~~-------~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   74 (261)
T cd05034           3 IPRESLKLERKLGAGQFGEVWMGTWNG-------TTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEE   74 (261)
T ss_pred             cchhheeeeeeeccCcceEEEEEEEcC-------CceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCC
Confidence            445779999999999999999998654       2458999887543 34567899999999999999999999999989


Q ss_pred             eEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCccC
Q 046893          169 HRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKD  248 (464)
Q Consensus       169 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~  248 (464)
                      ..++||||+++++|.+++....+..+++..+..++.|++.||.|||  +.+++|+||||+||+++.++.+||+|||+++.
T Consensus        75 ~~~~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh--~~~i~h~di~p~nili~~~~~~~l~d~g~~~~  152 (261)
T cd05034          75 PIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLE--SRNYIHRDLAARNILVGENLVCKIADFGLARL  152 (261)
T ss_pred             ceEEEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHH--hCCcccCCcchheEEEcCCCCEEECcccccee
Confidence            9999999999999999998766567999999999999999999999  67799999999999999999999999999876


Q ss_pred             CCCCCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHhhhcccchh
Q 046893          249 GPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLL-GRRAVDKSRPSREHNLVEWARPLLNNNKKVL  327 (464)
Q Consensus       249 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  327 (464)
                      ...... .......++..|+|||.+.+..++.++||||||+++|+|++ |+.||.+....   ....   .....     
T Consensus       153 ~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~---~~~~---~~~~~-----  220 (261)
T cd05034         153 IEDDEY-TAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNR---EVLE---QVERG-----  220 (261)
T ss_pred             ccchhh-hhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH---HHHH---HHHcC-----
Confidence            432211 11112335678999999998899999999999999999998 99999654321   1111   11100     


Q ss_pred             hccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q 046893          328 RILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLET  373 (464)
Q Consensus       328 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~  373 (464)
                            .....+...+..+.+++.+||..+|.+||++.++++.|+.
T Consensus       221 ------~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~  260 (261)
T cd05034         221 ------YRMPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED  260 (261)
T ss_pred             ------CCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence                  0011122235689999999999999999999999998874

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=5.4e-41  Score=323.98  Aligned_cols=251  Identities=27%  Similarity=0.398  Sum_probs=199.9

Q ss_pred             CCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCcc---HHHHHHHHHHHhcCCCCCcceEEEEEEeCCeE
Q 046893           94 FRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQG---DREWLAEVNYLGQLRHSNLVKLIGYCCEDEHR  170 (464)
Q Consensus        94 ~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~  170 (464)
                      |+..+.||+|+||.||+|.+..+      ++.||+|.+.......   ...+..|+.+++.++|+||+++++.+...+..
T Consensus         2 f~~~~~ig~G~~g~v~~~~~~~~------~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~   75 (285)
T cd05630           2 FRQYRVLGKGGFGEVCACQVRAT------GKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDAL   75 (285)
T ss_pred             ceeeEEeecCCCeEEEEEEEcCC------CceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEE
Confidence            67778899999999999998775      6679999886543222   24567899999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCccCCC
Q 046893          171 ILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGP  250 (464)
Q Consensus       171 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~  250 (464)
                      ++||||+.+++|.+++.......+++..+..++.|++.||.|||  ..+|+||||||+||+++.++.++|+|||++....
T Consensus        76 ~lv~e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH--~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~  153 (285)
T cd05630          76 CLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLH--QERIVYRDLKPENILLDDHGHIRISDLGLAVHVP  153 (285)
T ss_pred             EEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH--hCCEEeCCCCHHHEEECCCCCEEEeeccceeecC
Confidence            99999999999999886655556899999999999999999999  6779999999999999999999999999987533


Q ss_pred             CCCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhcccchhhcc
Q 046893          251 MGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRIL  330 (464)
Q Consensus       251 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  330 (464)
                      ...   ......|+..|+|||++.+..++.++|||||||++|+|++|+.||............   ......        
T Consensus       154 ~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~---~~~~~~--------  219 (285)
T cd05630         154 EGQ---TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEV---ERLVKE--------  219 (285)
T ss_pred             CCc---cccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHH---Hhhhhh--------
Confidence            221   112357999999999999999999999999999999999999999764321110000   000000        


Q ss_pred             CccccCccCHHHHHHHHHHHHHhhccCCCCCCC-----HHHHHH
Q 046893          331 DPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPV-----MSDVVA  369 (464)
Q Consensus       331 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~ev~~  369 (464)
                         ....+....+..+.+|+.+||+.||.+||+     +.++++
T Consensus       220 ---~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~  260 (285)
T cd05630         220 ---VQEEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE  260 (285)
T ss_pred             ---hhhhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence               001122234457889999999999999999     666664

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=3.8e-41  Score=331.23  Aligned_cols=240  Identities=27%  Similarity=0.352  Sum_probs=189.9

Q ss_pred             CceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCC---ccHHHHHHHHH-HHhcCCCCCcceEEEEEEeCCeEEEE
Q 046893           98 YILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGY---QGDREWLAEVN-YLGQLRHSNLVKLIGYCCEDEHRILV  173 (464)
Q Consensus        98 ~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~-~l~~l~hpniv~l~~~~~~~~~~~lv  173 (464)
                      +.||+|+||+||+|.+..+      ++.+|+|++.....   .....+..|.. +++.++||||+++++++...+..++|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~------~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv   74 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLD------GKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFV   74 (325)
T ss_pred             CceeeCCCeEEEEEEECCC------CCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEE
Confidence            3699999999999998765      67799999865321   22244555554 56778999999999999999999999


Q ss_pred             EeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCccCCCCCC
Q 046893          174 YEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGD  253 (464)
Q Consensus       174 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~  253 (464)
                      |||+.+|+|..++...  ..+++..+..++.||+.||.|||  ..+|+||||||+|||++.++.+||+|||+++......
T Consensus        75 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~lH--~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~  150 (325)
T cd05604          75 LDFVNGGELFFHLQRE--RSFPEPRARFYAAEIASALGYLH--SINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQS  150 (325)
T ss_pred             EcCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH--HCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCC
Confidence            9999999998887653  36899999999999999999999  6779999999999999999999999999987532211


Q ss_pred             CcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhcccchhhccCcc
Q 046893          254 QTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRILDPR  333 (464)
Q Consensus       254 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  333 (464)
                        ......+||..|+|||++.+..++.++|||||||++|||++|..||......      +.........        ..
T Consensus       151 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~------~~~~~~~~~~--------~~  214 (325)
T cd05604         151 --DTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVA------EMYDNILHKP--------LV  214 (325)
T ss_pred             --CCcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHH------HHHHHHHcCC--------cc
Confidence              1223467999999999999999999999999999999999999999764321      1111111110        00


Q ss_pred             ccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHH
Q 046893          334 LEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDV  367 (464)
Q Consensus       334 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev  367 (464)
                      +    ....+..+.+++.+||..+|.+||++.+.
T Consensus       215 ~----~~~~~~~~~~ll~~ll~~~p~~R~~~~~~  244 (325)
T cd05604         215 L----RPGASLTAWSILEELLEKDRQRRLGAKED  244 (325)
T ss_pred             C----CCCCCHHHHHHHHHHhccCHHhcCCCCCC
Confidence            1    11234478899999999999999998643

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=7.5e-41  Score=319.92  Aligned_cols=260  Identities=25%  Similarity=0.438  Sum_probs=204.2

Q ss_pred             cCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCC-ccHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeE
Q 046893           92 KFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGY-QGDREWLAEVNYLGQLRHSNLVKLIGYCCEDEHR  170 (464)
Q Consensus        92 ~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~  170 (464)
                      ..|++.+.||+|+||.||+|.+.....   ....||||.+..... .....|..|+.+++.++||||+++++++..+...
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~   80 (269)
T cd05065           4 SCVKIEEVIGAGEFGEVCRGRLKLPGK---REIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPV   80 (269)
T ss_pred             HHeEEEeEecCCCCCeEEEEEEecCCC---CceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCce
Confidence            347788999999999999999876422   145699999875422 2346789999999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCccCCC
Q 046893          171 ILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGP  250 (464)
Q Consensus       171 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~  250 (464)
                      ++||||+.+++|.+++... ...+++..++.++.|++.||.|||  +++++|+||||+|||++.++.+||+|||++....
T Consensus        81 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~~l~~al~~lH--~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~  157 (269)
T cd05065          81 MIITEFMENGALDSFLRQN-DGQFTVIQLVGMLRGIAAGMKYLS--EMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLE  157 (269)
T ss_pred             EEEEecCCCCcHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHH--HCCEeecccChheEEEcCCCcEEECCCccccccc
Confidence            9999999999999988654 346899999999999999999999  6779999999999999999999999999987543


Q ss_pred             CCCCcceeeccc---cCCcccCccccccCCCCcccchhcHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHhhhcccch
Q 046893          251 MGDQTHVSTRVM---GTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLL-GRRAVDKSRPSREHNLVEWARPLLNNNKKV  326 (464)
Q Consensus       251 ~~~~~~~~~~~~---gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  326 (464)
                      ............   .+..|+|||.+.+..++.++|||||||++|||++ |..||......   ....+..    ..   
T Consensus       158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~---~~~~~i~----~~---  227 (269)
T cd05065         158 DDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ---DVINAIE----QD---  227 (269)
T ss_pred             cCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHH---HHHHHHH----cC---
Confidence            322111111111   2457999999998999999999999999999886 99999754321   1111111    00   


Q ss_pred             hhccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHH
Q 046893          327 LRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETV  374 (464)
Q Consensus       327 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~  374 (464)
                             .....+..++..+.+++.+||..+|.+||++.+|+..|+.+
T Consensus       228 -------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  268 (269)
T cd05065         228 -------YRLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM  268 (269)
T ss_pred             -------CcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence                   00111223456789999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=6.3e-41  Score=320.22  Aligned_cols=255  Identities=31%  Similarity=0.504  Sum_probs=201.0

Q ss_pred             ceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCC-ccHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeEEEEEecc
Q 046893           99 ILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGY-QGDREWLAEVNYLGQLRHSNLVKLIGYCCEDEHRILVYEYM  177 (464)
Q Consensus        99 ~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~  177 (464)
                      .||+|+||.||+|.+.........+..+|+|.+..... .....+.+|+.+++.++||||+++++++......++||||+
T Consensus         2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~   81 (269)
T cd05044           2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMELM   81 (269)
T ss_pred             ccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEecc
Confidence            59999999999998865433333456799998865432 33467889999999999999999999999999999999999


Q ss_pred             CCCCHHHHHHhhc-----CCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCC-----ceEEcccCCcc
Q 046893          178 ESGSLEKHLLRRV-----GCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADF-----SAKLSDFGLAK  247 (464)
Q Consensus       178 ~~g~L~~~l~~~~-----~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~-----~vkl~DFGla~  247 (464)
                      ++++|.+++....     ...+++..++.++.|++.||.|||  ..+++|+||||+||+++.++     .++|+|||+++
T Consensus        82 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH--~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~~  159 (269)
T cd05044          82 EGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLE--QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLAR  159 (269)
T ss_pred             CCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHH--hCCcccCCCChheEEEecCCCCCCcceEECCccccc
Confidence            9999999987532     234788999999999999999999  57799999999999998877     89999999997


Q ss_pred             CCCCCCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHhhhcccch
Q 046893          248 DGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLL-GRRAVDKSRPSREHNLVEWARPLLNNNKKV  326 (464)
Q Consensus       248 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  326 (464)
                      ...............++..|+|||++.+..++.++|||||||++|+|++ |..||......   .....    +..    
T Consensus       160 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~---~~~~~----~~~----  228 (269)
T cd05044         160 DIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQ---EVLQH----VTA----  228 (269)
T ss_pred             ccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHH---HHHHH----Hhc----
Confidence            6433322222223456788999999999999999999999999999998 99998654321   11111    100    


Q ss_pred             hhccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 046893          327 LRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLE  372 (464)
Q Consensus       327 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~  372 (464)
                            ......+...+..+.+|+.+||..+|.+||++.+|++.|+
T Consensus       229 ------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~  268 (269)
T cd05044         229 ------GGRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ  268 (269)
T ss_pred             ------CCccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence                  0111122335568899999999999999999999999885

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-41  Score=336.54  Aligned_cols=245  Identities=25%  Similarity=0.379  Sum_probs=203.4

Q ss_pred             ceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCccHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeEEEEEeccC
Q 046893           99 ILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVKLIGYCCEDEHRILVYEYME  178 (464)
Q Consensus        99 ~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~  178 (464)
                      +||+|+||+||.|++..+      ...+|||.+.........-+..|+.+.++|+|.|||+++|.+.+.++.-|.||-++
T Consensus       582 VLGKGTYG~VYA~RD~~t------qvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVP  655 (1226)
T KOG4279|consen  582 VLGKGTYGTVYAARDMDT------QVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVP  655 (1226)
T ss_pred             EeecCceeEEEeeccccc------eeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCC
Confidence            699999999999998876      45589999876554555668899999999999999999999999999999999999


Q ss_pred             CCCHHHHHHhhcCCCC--CHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEec-CCCceEEcccCCccCCCCCCCc
Q 046893          179 SGSLEKHLLRRVGCML--TWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLN-ADFSAKLSDFGLAKDGPMGDQT  255 (464)
Q Consensus       179 ~g~L~~~l~~~~~~~l--~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~-~~~~vkl~DFGla~~~~~~~~~  255 (464)
                      ||+|.++|... .+++  ++.++..+..||++||.|||  ++.|||||||-+||||+ -.|.+||+|||-++...  ...
T Consensus       656 GGSLSsLLrsk-WGPlKDNEstm~fYtkQILeGLkYLH--en~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLA--gin  730 (1226)
T KOG4279|consen  656 GGSLSSLLRSK-WGPLKDNESTMNFYTKQILEGLKYLH--ENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLA--GIN  730 (1226)
T ss_pred             CCcHHHHHHhc-cCCCccchhHHHHHHHHHHHHhhhhh--hcceeeccccCCcEEEeeccceEEecccccchhhc--cCC
Confidence            99999988765 4467  88899999999999999999  67799999999999995 57899999999998743  334


Q ss_pred             ceeeccccCCcccCccccccC--CCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhcccchhhccCcc
Q 046893          256 HVSTRVMGTYGYAAPEYVMTG--HLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRILDPR  333 (464)
Q Consensus       256 ~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  333 (464)
                      ....++.||..|||||++..+  .|+.++|||||||++.||.||++||..........        +.-       ---.
T Consensus       731 P~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAM--------FkV-------GmyK  795 (1226)
T KOG4279|consen  731 PCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAM--------FKV-------GMYK  795 (1226)
T ss_pred             ccccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhh--------hhh-------ccee
Confidence            455678999999999999765  58999999999999999999999997544322111        100       0111


Q ss_pred             ccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 046893          334 LEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVA  369 (464)
Q Consensus       334 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  369 (464)
                      .....+.....+...+|.+|+..||.+||++.+++.
T Consensus       796 vHP~iPeelsaeak~FilrcFepd~~~R~sA~~LL~  831 (1226)
T KOG4279|consen  796 VHPPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQ  831 (1226)
T ss_pred             cCCCCcHHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence            223556777889999999999999999999999874

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=8.9e-41  Score=316.90  Aligned_cols=250  Identities=29%  Similarity=0.460  Sum_probs=204.8

Q ss_pred             hcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCccHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeE
Q 046893           91 TKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVKLIGYCCEDEHR  170 (464)
Q Consensus        91 ~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~  170 (464)
                      .++|++.+.||.|+||.||+|...        +..||+|.+..... ..+.+.+|+.+++.++|+||+++++++......
T Consensus         5 ~~~~~~~~~ig~g~~g~v~~~~~~--------~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   75 (256)
T cd05039           5 SKELKLGATIGKGEFGDVMLGDYR--------GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPL   75 (256)
T ss_pred             hhhccceeeeecCCCceEEEEEec--------CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCe
Confidence            456888999999999999999864        35689999976543 457789999999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCccCCC
Q 046893          171 ILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGP  250 (464)
Q Consensus       171 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~  250 (464)
                      ++||||+.+++|.+++.......+++..+..++.|++.||.|||  ..+++|+||||+||+++.++.+||+|||+++...
T Consensus        76 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh--~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~  153 (256)
T cd05039          76 YIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLE--EKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEAS  153 (256)
T ss_pred             EEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH--hCCccchhcccceEEEeCCCCEEEcccccccccc
Confidence            99999999999999987665456899999999999999999999  6779999999999999999999999999998642


Q ss_pred             CCCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHhhhcccchhhc
Q 046893          251 MGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLL-GRRAVDKSRPSREHNLVEWARPLLNNNKKVLRI  329 (464)
Q Consensus       251 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  329 (464)
                      ...     ....++..|+|||++.+..++.++||||||+++|+|++ |..||.......   +..    .+..       
T Consensus       154 ~~~-----~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~---~~~----~~~~-------  214 (256)
T cd05039         154 QGQ-----DSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---VVP----HVEK-------  214 (256)
T ss_pred             ccc-----ccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHH---HHH----HHhc-------
Confidence            211     12345677999999988889999999999999999997 999986543211   111    1111       


Q ss_pred             cCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q 046893          330 LDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLET  373 (464)
Q Consensus       330 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~  373 (464)
                         ......+..++..+.+++.+||..+|.+||++.++++.|+.
T Consensus       215 ---~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  255 (256)
T cd05039         215 ---GYRMEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLAL  255 (256)
T ss_pred             ---CCCCCCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence               01111222345689999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=4.4e-41  Score=330.45  Aligned_cols=243  Identities=25%  Similarity=0.360  Sum_probs=194.7

Q ss_pred             CCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCC---ccHHHHHHHHHHHhcCC-CCCcceEEEEEEeCC
Q 046893           93 FFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGY---QGDREWLAEVNYLGQLR-HSNLVKLIGYCCEDE  168 (464)
Q Consensus        93 ~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~  168 (464)
                      .|.+.+.||+|+||+||+|.+..+      ++.||+|++.....   .....+..|+.++..+. |++|+++++++...+
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~~------~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~   74 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKGT------DELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVD   74 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECCC------CCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCC
Confidence            367788999999999999998765      66799999875321   22355778889988885 577888999999999


Q ss_pred             eEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCccC
Q 046893          169 HRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKD  248 (464)
Q Consensus       169 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~  248 (464)
                      ..|+||||+++|+|.+++....  .+++..+..++.|++.||.|||  .++|+||||||+|||++.++.+||+|||+++.
T Consensus        75 ~~~lv~Ey~~~g~L~~~i~~~~--~l~~~~~~~i~~qi~~al~~lH--~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~  150 (323)
T cd05615          75 RLYFVMEYVNGGDLMYHIQQVG--KFKEPQAVFYAAEISVGLFFLH--RRGIIYRDLKLDNVMLDSEGHIKIADFGMCKE  150 (323)
T ss_pred             EEEEEEcCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH--HCCeeccCCCHHHeEECCCCCEEEeccccccc
Confidence            9999999999999999886543  6899999999999999999999  67799999999999999999999999999975


Q ss_pred             CCCCCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhcccchhh
Q 046893          249 GPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLR  328 (464)
Q Consensus       249 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  328 (464)
                      .....  .......||..|+|||++.+..++.++|||||||++|+|++|+.||......      ..........     
T Consensus       151 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~------~~~~~i~~~~-----  217 (323)
T cd05615         151 HMVDG--VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDED------ELFQSIMEHN-----  217 (323)
T ss_pred             cCCCC--ccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHH------HHHHHHHhCC-----
Confidence            32221  1223467999999999999999999999999999999999999999764321      1111111111     


Q ss_pred             ccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHH
Q 046893          329 ILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMS  365 (464)
Q Consensus       329 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~  365 (464)
                             ..++...+..+.+++.+||+.+|.+|++..
T Consensus       218 -------~~~p~~~~~~~~~li~~~l~~~p~~R~~~~  247 (323)
T cd05615         218 -------VSYPKSLSKEAVSICKGLMTKHPSKRLGCG  247 (323)
T ss_pred             -------CCCCccCCHHHHHHHHHHcccCHhhCCCCC
Confidence                   012223445788999999999999999864

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=2.8e-41  Score=344.85  Aligned_cols=262  Identities=24%  Similarity=0.345  Sum_probs=194.1

Q ss_pred             HhcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCccHHHHHHHHHHHhcCCCCCcceEEEEEEeC--
Q 046893           90 ATKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVKLIGYCCED--  167 (464)
Q Consensus        90 ~~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~--  167 (464)
                      ..++|.+.+.||+|+||.||+|.+..+      ++.||||++....    ....+|+.+|+.++||||+++++++...  
T Consensus        64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~------~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~  133 (440)
T PTZ00036         64 PNKSYKLGNIIGNGSFGVVYEAICIDT------SEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECF  133 (440)
T ss_pred             cCCeEEEeEEEEeCCCEEEEEEEECCC------CCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeeccc
Confidence            346799999999999999999998764      5679999885432    2345799999999999999999887532  


Q ss_pred             ------CeEEEEEeccCCCCHHHHHHh--hcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCC-ce
Q 046893          168 ------EHRILVYEYMESGSLEKHLLR--RVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADF-SA  238 (464)
Q Consensus       168 ------~~~~lv~e~~~~g~L~~~l~~--~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~-~v  238 (464)
                            ..+++||||+++ +|.+++..  ..+..+++..+..++.|++.||.|||  .++|+||||||+||||+.++ .+
T Consensus       134 ~~~~~~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH--~~~IiHrDLKp~NILl~~~~~~v  210 (440)
T PTZ00036        134 KKNEKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIH--SKFICHRDLKPQNLLIDPNTHTL  210 (440)
T ss_pred             ccCCCceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHH--HCCEecCCcCHHHEEEcCCCCce
Confidence                  246799999964 77776653  23457899999999999999999999  67799999999999998665 69


Q ss_pred             EEcccCCccCCCCCCCcceeeccccCCcccCccccccC-CCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHH
Q 046893          239 KLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTG-HLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWAR  317 (464)
Q Consensus       239 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~  317 (464)
                      ||+|||+|+......   ......||+.|+|||++.+. .++.++|||||||+||||++|.+||.+......  +.....
T Consensus       211 kL~DFGla~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~--~~~i~~  285 (440)
T PTZ00036        211 KLCDFGSAKNLLAGQ---RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQ--LVRIIQ  285 (440)
T ss_pred             eeeccccchhccCCC---CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH--HHHHHH
Confidence            999999998643322   12236789999999988764 699999999999999999999999976543211  111111


Q ss_pred             Hhhhcccc--------hhh-----ccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 046893          318 PLLNNNKK--------VLR-----ILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVA  369 (464)
Q Consensus       318 ~~~~~~~~--------~~~-----~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  369 (464)
                      ........        ...     .....+...++...+.++.+||.+||..||.+||++.+++.
T Consensus       286 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~  350 (440)
T PTZ00036        286 VLGTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALA  350 (440)
T ss_pred             HhCCCCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhC
Confidence            00000000        000     00011111223334568999999999999999999999873

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=1.2e-40  Score=318.25  Aligned_cols=261  Identities=25%  Similarity=0.415  Sum_probs=205.5

Q ss_pred             hcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCc-cHHHHHHHHHHHhcCCCCCcceEEEEEEeCCe
Q 046893           91 TKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQ-GDREWLAEVNYLGQLRHSNLVKLIGYCCEDEH  169 (464)
Q Consensus        91 ~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~  169 (464)
                      ..+|++.+.||+|+||.||+|.+..+..   ....+|+|.+...... ....+..|+.++..++||||+++++++...+.
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~---~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   79 (267)
T cd05066           3 ASCIKIEKVIGAGEFGEVCSGRLKLPGK---REIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKP   79 (267)
T ss_pred             HHHeEeeeeecccCCCceEEEEEecCCC---CceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCc
Confidence            3568889999999999999998754311   2456899998654322 23578899999999999999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCccCC
Q 046893          170 RILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDG  249 (464)
Q Consensus       170 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~  249 (464)
                      .++||||+++++|.+++.... ..+++.+++.++.|++.||.|||  +++++||||||+|||++.++.++|+|||++...
T Consensus        80 ~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH--~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~  156 (267)
T cd05066          80 VMIVTEYMENGSLDAFLRKHD-GQFTVIQLVGMLRGIASGMKYLS--DMGYVHRDLAARNILVNSNLVCKVSDFGLSRVL  156 (267)
T ss_pred             cEEEEEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH--HCCEeehhhchhcEEECCCCeEEeCCCCccccc
Confidence            999999999999999987643 46899999999999999999999  677999999999999999999999999999865


Q ss_pred             CCCCCcce-eeccccCCcccCccccccCCCCcccchhcHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHhhhcccchh
Q 046893          250 PMGDQTHV-STRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLL-GRRAVDKSRPSREHNLVEWARPLLNNNKKVL  327 (464)
Q Consensus       250 ~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  327 (464)
                      ........ .....++..|+|||++.+..++.++||||||+++||+++ |..||.......   .....   . ..    
T Consensus       157 ~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~---~~~~~---~-~~----  225 (267)
T cd05066         157 EDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQD---VIKAI---E-EG----  225 (267)
T ss_pred             ccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHH---HHHHH---h-CC----
Confidence            43221111 112234568999999998899999999999999999886 999997543211   11111   1 10    


Q ss_pred             hccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHH
Q 046893          328 RILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETV  374 (464)
Q Consensus       328 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~  374 (464)
                            .....+..++..+.+++.+||+.+|.+||++.++++.|..+
T Consensus       226 ------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  266 (267)
T cd05066         226 ------YRLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL  266 (267)
T ss_pred             ------CcCCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence                  00111223456889999999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=8.3e-41  Score=318.07  Aligned_cols=254  Identities=29%  Similarity=0.440  Sum_probs=201.9

Q ss_pred             hcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCccHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeE
Q 046893           91 TKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVKLIGYCCEDEHR  170 (464)
Q Consensus        91 ~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~  170 (464)
                      ..+|++...||+|+||.||+|.+...       ..+|+|.+.... .....+.+|+++++.+.||||+++++++. .+..
T Consensus         5 ~~~~~~~~~ig~g~~~~v~~~~~~~~-------~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~   75 (260)
T cd05069           5 RESLRLDVKLGQGCFGEVWMGTWNGT-------TKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPI   75 (260)
T ss_pred             hHHeeeeeeecCcCCCeEEEEEEcCC-------ceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCc
Confidence            35588889999999999999987553       348999876533 33467889999999999999999998875 4568


Q ss_pred             EEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCccCCC
Q 046893          171 ILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGP  250 (464)
Q Consensus       171 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~  250 (464)
                      ++||||+.+++|.+++.......+++..+..++.|++.||.|||  +.+++|+||||+||+++.++.++|+|||+++...
T Consensus        76 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH--~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~  153 (260)
T cd05069          76 YIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIE--RMNYIHRDLRAANILVGDNLVCKIADFGLARLIE  153 (260)
T ss_pred             EEEEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHH--hCCEeecccCcceEEEcCCCeEEECCCccceEcc
Confidence            89999999999999997655556899999999999999999999  6779999999999999999999999999997643


Q ss_pred             CCCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHhhhcccchhhc
Q 046893          251 MGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLL-GRRAVDKSRPSREHNLVEWARPLLNNNKKVLRI  329 (464)
Q Consensus       251 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  329 (464)
                      ..... ......++..|+|||.+.+..++.++||||||+++|+|++ |..||.......   ...+.    ...      
T Consensus       154 ~~~~~-~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---~~~~~----~~~------  219 (260)
T cd05069         154 DNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNRE---VLEQV----ERG------  219 (260)
T ss_pred             CCccc-ccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHH----HcC------
Confidence            22211 1122346778999999988899999999999999999999 899987643211   11111    000      


Q ss_pred             cCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q 046893          330 LDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLET  373 (464)
Q Consensus       330 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~  373 (464)
                          .....+...+..+.+++.+||..||.+||++.+|+++|+.
T Consensus       220 ----~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  259 (260)
T cd05069         220 ----YRMPCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED  259 (260)
T ss_pred             ----CCCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence                0011122345689999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=1.3e-40  Score=323.03  Aligned_cols=250  Identities=23%  Similarity=0.337  Sum_probs=203.4

Q ss_pred             cCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCccHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeEE
Q 046893           92 KFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVKLIGYCCEDEHRI  171 (464)
Q Consensus        92 ~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~  171 (464)
                      ++|++.+.||+|+||.||+|++..+      +..||+|.+..........+.+|+.+++.+.||||+++++++......+
T Consensus        20 ~~y~~~~~lg~g~~~~v~~~~~~~~------~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~   93 (296)
T cd06654          20 KKYTRFEKIGQGASGTVYTAMDVAT------GQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELW   93 (296)
T ss_pred             cceeeEEEecCCCCeEEEEEEECCC------CcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEE
Confidence            5688899999999999999987654      5679999987665555677889999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCccCCCC
Q 046893          172 LVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPM  251 (464)
Q Consensus       172 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~  251 (464)
                      +||||+.+++|.+++...   .+++..+..++.|++.||.|||  ..+|+||||||+|||++.++.+||+|||++.....
T Consensus        94 lv~e~~~~~~L~~~~~~~---~~~~~~~~~i~~ql~~aL~~LH--~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~  168 (296)
T cd06654          94 VVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLH--SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP  168 (296)
T ss_pred             EeecccCCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHH--HCCcccCCCCHHHEEEcCCCCEEECccccchhccc
Confidence            999999999999988643   4899999999999999999999  67799999999999999999999999999875332


Q ss_pred             CCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhcccchhhccC
Q 046893          252 GDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRILD  331 (464)
Q Consensus       252 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  331 (464)
                      ..  .......|+..|+|||.+.+..++.++|||||||++|+|++|+.||....+...     +.. ....         
T Consensus       169 ~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~-----~~~-~~~~---------  231 (296)
T cd06654         169 EQ--SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA-----LYL-IATN---------  231 (296)
T ss_pred             cc--cccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHh-----HHH-HhcC---------
Confidence            21  112235789999999999888899999999999999999999999976543111     100 0000         


Q ss_pred             ccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 046893          332 PRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVA  369 (464)
Q Consensus       332 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  369 (464)
                      .......+...+..+.+++.+||..||.+||++.+++.
T Consensus       232 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~  269 (296)
T cd06654         232 GTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ  269 (296)
T ss_pred             CCCCCCCccccCHHHHHHHHHHCcCCcccCcCHHHHhh
Confidence            00000112234457889999999999999999999986

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=8.2e-42  Score=332.11  Aligned_cols=255  Identities=22%  Similarity=0.306  Sum_probs=202.8

Q ss_pred             HHHhcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCC--ccHHHHHHHHHHHhcCC-CCCcceEEEEE
Q 046893           88 KLATKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGY--QGDREWLAEVNYLGQLR-HSNLVKLIGYC  164 (464)
Q Consensus        88 ~~~~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~-hpniv~l~~~~  164 (464)
                      .+..+.|++++.||+||.++||++...+       ...+|+|.+.....  ....-|..|+.+|.+|+ |.+||+|++|-
T Consensus       357 ~Vkg~~Yeilk~iG~GGSSkV~kV~~s~-------~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYE  429 (677)
T KOG0596|consen  357 KVKGREYEILKQIGSGGSSKVFKVLNSD-------KQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYE  429 (677)
T ss_pred             EECcchhhHHHhhcCCCcceeeeeecCC-------CcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeee
Confidence            3445669999999999999999998654       34577777654332  23356899999999995 99999999999


Q ss_pred             EeCCeEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccC
Q 046893          165 CEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFG  244 (464)
Q Consensus       165 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFG  244 (464)
                      ..++.+||||||= ..+|...|.+... .++...+..+..|++.++.++|  ..+|||.||||.|+|+- .|.+||+|||
T Consensus       430 v~d~~lYmvmE~G-d~DL~kiL~k~~~-~~~~~~lk~ywkqML~aV~~IH--~~gIVHSDLKPANFLlV-kG~LKLIDFG  504 (677)
T KOG0596|consen  430 VTDGYLYMVMECG-DIDLNKILKKKKS-IDPDWFLKFYWKQMLLAVKTIH--QHGIVHSDLKPANFLLV-KGRLKLIDFG  504 (677)
T ss_pred             ccCceEEEEeecc-cccHHHHHHhccC-CCchHHHHHHHHHHHHHHHHHH--HhceeecCCCcccEEEE-eeeEEeeeec
Confidence            9999999999975 5699888877654 3443477888999999999999  66799999999999995 6799999999


Q ss_pred             CccCCCCCCCcceeeccccCCcccCccccccCC-----------CCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHH
Q 046893          245 LAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGH-----------LTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLV  313 (464)
Q Consensus       245 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-----------~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~  313 (464)
                      +|.....+.........+||+.||+||.+....           .+.++||||||||||+|+.|+.||..-.        
T Consensus       505 IA~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~--------  576 (677)
T KOG0596|consen  505 IANAIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQII--------  576 (677)
T ss_pred             hhcccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHH--------
Confidence            999876665555666789999999999885432           5578999999999999999999997421        


Q ss_pred             HHHHHhhhcccchhhccCccccCccCHHHHH-HHHHHHHHhhccCCCCCCCHHHHHH
Q 046893          314 EWARPLLNNNKKVLRILDPRLEGQYTARTAM-KVAGLAYQCLSQNPKGRPVMSDVVA  369 (464)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~l~~li~~cl~~dP~~RPs~~ev~~  369 (464)
                             ....++..+.+|.....|+.-... ++.++|+.||+.||++||++.+++.
T Consensus       577 -------n~~aKl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLq  626 (677)
T KOG0596|consen  577 -------NQIAKLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQ  626 (677)
T ss_pred             -------HHHHHHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhc
Confidence                   111344556666554444433222 3899999999999999999999985

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=1.1e-40  Score=319.14  Aligned_cols=253  Identities=26%  Similarity=0.392  Sum_probs=199.5

Q ss_pred             HhcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCccHHHHHHHHHHHhcC-CCCCcceEEEEEEeC-
Q 046893           90 ATKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQL-RHSNLVKLIGYCCED-  167 (464)
Q Consensus        90 ~~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~-  167 (464)
                      ....|++.+.||+|+||.||+|.+...      ++.||+|++.... .....+..|+.++..+ +|+||+++++++... 
T Consensus         4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~------~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~   76 (272)
T cd06637           4 PAGIFELVELVGNGTYGQVYKGRHVKT------GQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKN   76 (272)
T ss_pred             hhhhhhHHHheeecCCeEEEEEEEcCC------CcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecC
Confidence            345688888999999999999988765      5679999986543 3446788999999998 699999999998753 


Q ss_pred             -----CeEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcc
Q 046893          168 -----EHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSD  242 (464)
Q Consensus       168 -----~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~D  242 (464)
                           ...++||||+.+++|.+++.......+++..+..++.|++.||.|||  .++|+|+||||+||+++.++.++|+|
T Consensus        77 ~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH--~~~ivh~dl~~~nili~~~~~~~l~D  154 (272)
T cd06637          77 PPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLH--QHKVIHRDIKGQNVLLTENAEVKLVD  154 (272)
T ss_pred             CCCCCcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH--HCCCccCCCCHHHEEECCCCCEEEcc
Confidence                 46899999999999999987755567899999999999999999999  56799999999999999999999999


Q ss_pred             cCCccCCCCCCCcceeeccccCCcccCccccc-----cCCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHH
Q 046893          243 FGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVM-----TGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWAR  317 (464)
Q Consensus       243 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~  317 (464)
                      ||++.......  .......|+..|+|||++.     +..++.++|||||||++|||++|..||....+...     ...
T Consensus       155 fg~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~-----~~~  227 (272)
T cd06637         155 FGVSAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRA-----LFL  227 (272)
T ss_pred             CCCceeccccc--ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHH-----HHH
Confidence            99997542211  1223467899999999886     34588899999999999999999999965432111     000


Q ss_pred             HhhhcccchhhccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 046893          318 PLLNNNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVA  369 (464)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  369 (464)
                        ...      .....   .....++..+.+|+.+||..||.+||++.++++
T Consensus       228 --~~~------~~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  268 (272)
T cd06637         228 --IPR------NPAPR---LKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMK  268 (272)
T ss_pred             --Hhc------CCCCC---CCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence              000      00000   111223457899999999999999999999874

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=1.6e-40  Score=319.58  Aligned_cols=250  Identities=24%  Similarity=0.363  Sum_probs=197.7

Q ss_pred             CCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCC-ccHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeEE
Q 046893           93 FFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGY-QGDREWLAEVNYLGQLRHSNLVKLIGYCCEDEHRI  171 (464)
Q Consensus        93 ~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~  171 (464)
                      +|++.+.||+|+||.||+|.+..+      +..||+|.+..... .....+.+|++++++++||||+++++++...+..+
T Consensus         2 ~~~~~~~lg~g~~~~v~~~~~~~~------~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   75 (279)
T cd06619           2 DIQYQEILGHGNGGTVYKAYHLLT------RRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRIS   75 (279)
T ss_pred             cchheeeeccCCCeEEEEEEEcCC------CcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEE
Confidence            577888999999999999988764      56799999865422 23356889999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCccCCCC
Q 046893          172 LVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPM  251 (464)
Q Consensus       172 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~  251 (464)
                      +||||+++++|..+.      .+++..+..++.|++.||.|||  +.+|+|+||||+|||++.++.++|+|||++.....
T Consensus        76 lv~e~~~~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH--~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~  147 (279)
T cd06619          76 ICTEFMDGGSLDVYR------KIPEHVLGRIAVAVVKGLTYLW--SLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVN  147 (279)
T ss_pred             EEEecCCCCChHHhh------cCCHHHHHHHHHHHHHHHHHHH--HCCEeeCCCCHHHEEECCCCCEEEeeCCcceeccc
Confidence            999999999996532      4788899999999999999999  67799999999999999999999999999975422


Q ss_pred             CCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHhCCCCCCCCCCccccc-HHHHHHHhhhcccchhhcc
Q 046893          252 GDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHN-LVEWARPLLNNNKKVLRIL  330 (464)
Q Consensus       252 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~  330 (464)
                      .    ......||..|+|||++.+..++.++||||||+++|+|++|+.||.......... ...+........       
T Consensus       148 ~----~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-------  216 (279)
T cd06619         148 S----IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDED-------  216 (279)
T ss_pred             c----cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccC-------
Confidence            1    2233679999999999999999999999999999999999999997543222111 111111111100       


Q ss_pred             CccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 046893          331 DPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVAL  370 (464)
Q Consensus       331 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  370 (464)
                      .+.+   .....+.++.+++.+||+.+|.+||++.+++..
T Consensus       217 ~~~~---~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~  253 (279)
T cd06619         217 PPVL---PVGQFSEKFVHFITQCMRKQPKERPAPENLMDH  253 (279)
T ss_pred             CCCC---CCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence            0110   011233478899999999999999999998753

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.3e-40  Score=339.33  Aligned_cols=264  Identities=20%  Similarity=0.228  Sum_probs=197.4

Q ss_pred             HhcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCccHHHHHHHHHHHhcCCCCCcceEEEEEEeCCe
Q 046893           90 ATKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVKLIGYCCEDEH  169 (464)
Q Consensus        90 ~~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~  169 (464)
                      ....|.+.+.||+|+||.||+|.+...      +..||||....      ..+.+|+++|++|+|+|||++++++...+.
T Consensus       167 ~~~gy~i~~~Lg~G~~G~Vy~a~~~~~------~~~vavK~~~~------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~  234 (461)
T PHA03211        167 AGLGFAIHRALTPGSEGCVFESSHPDY------PQRVVVKAGWY------ASSVHEARLLRRLSHPAVLALLDVRVVGGL  234 (461)
T ss_pred             ccCCeEEEEEEccCCCeEEEEEEECCC------CCEEEEecccc------cCHHHHHHHHHHCCCCCCCcEEEEEEECCE
Confidence            355799999999999999999998765      56799996432      345789999999999999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCccCC
Q 046893          170 RILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDG  249 (464)
Q Consensus       170 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~  249 (464)
                      .+||||++ .++|.+++.... ..+++..++.|+.|++.||.|||  .++|+||||||+||||+.++.+||+|||+++..
T Consensus       235 ~~lv~e~~-~~~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~yLH--~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~  310 (461)
T PHA03211        235 TCLVLPKY-RSDLYTYLGARL-RPLGLAQVTAVARQLLSAIDYIH--GEGIIHRDIKTENVLVNGPEDICLGDFGAACFA  310 (461)
T ss_pred             EEEEEEcc-CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH--HCCEEECcCCHHHEEECCCCCEEEcccCCceec
Confidence            99999999 468988876543 36999999999999999999999  677999999999999999999999999999864


Q ss_pred             CCCCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHhCCCCCCCCCCccc-----ccHHHHHHHhhhccc
Q 046893          250 PMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSRE-----HNLVEWARPLLNNNK  324 (464)
Q Consensus       250 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~-----~~~~~~~~~~~~~~~  324 (464)
                      .............||..|+|||++.+..++.++|||||||+||||++|..++........     ..+............
T Consensus       311 ~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~  390 (461)
T PHA03211        311 RGSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVD  390 (461)
T ss_pred             ccccccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccc
Confidence            332222223346799999999999999999999999999999999998876543221110     111111111000000


Q ss_pred             chhh---------c-------cCccccC-ccC--HHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 046893          325 KVLR---------I-------LDPRLEG-QYT--ARTAMKVAGLAYQCLSQNPKGRPVMSDVVA  369 (464)
Q Consensus       325 ~~~~---------~-------~~~~~~~-~~~--~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  369 (464)
                      ....         .       ..+.... .+.  ......+.+||.+||+.||.+|||+.|+++
T Consensus       391 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~  454 (461)
T PHA03211        391 EFPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLR  454 (461)
T ss_pred             cCCCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhh
Confidence            0000         0       0000000 000  012346889999999999999999999986

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=1.1e-40  Score=321.70  Aligned_cols=247  Identities=28%  Similarity=0.392  Sum_probs=196.9

Q ss_pred             CCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCc---cHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeE
Q 046893           94 FRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQ---GDREWLAEVNYLGQLRHSNLVKLIGYCCEDEHR  170 (464)
Q Consensus        94 ~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~  170 (464)
                      |+..+.||+|+||+||+|.+..+      ++.+|+|.+......   ....+.+|+.+|+.++|+||+++++++..++..
T Consensus         2 ~~~~~~lg~G~~g~vy~~~~~~~------~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~   75 (285)
T cd05632           2 FRQYRVLGKGGFGEVCACQVRAT------GKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDAL   75 (285)
T ss_pred             ceEEEEEecCCCeEEEEEEECCC------CcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEE
Confidence            66778899999999999998765      667999998654322   224567899999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCccCCC
Q 046893          171 ILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGP  250 (464)
Q Consensus       171 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~  250 (464)
                      ++||||+.+++|.+++.......+++..+..++.|++.||.|||  .++|+||||||+||+++.++.++|+|||++....
T Consensus        76 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH--~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~  153 (285)
T cd05632          76 CLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLH--RENTVYRDLKPENILLDDYGHIRISDLGLAVKIP  153 (285)
T ss_pred             EEEEEeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH--hCCeeecCCCHHHEEECCCCCEEEecCCcceecC
Confidence            99999999999998887655457999999999999999999999  6779999999999999999999999999987543


Q ss_pred             CCCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhcccchhhcc
Q 046893          251 MGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRIL  330 (464)
Q Consensus       251 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  330 (464)
                      ...   ......|+..|+|||++.+..++.++|||||||++|+|++|..||.........  ..+.....       .. 
T Consensus       154 ~~~---~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~--~~~~~~~~-------~~-  220 (285)
T cd05632         154 EGE---SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKR--EEVDRRVL-------ET-  220 (285)
T ss_pred             CCC---cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHH--HHHHHhhh-------cc-
Confidence            221   112357999999999999999999999999999999999999999764321110  11100000       00 


Q ss_pred             CccccCccCHHHHHHHHHHHHHhhccCCCCCCCHH
Q 046893          331 DPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMS  365 (464)
Q Consensus       331 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~  365 (464)
                      .    ..+....+..+.+|+..||+.||.+||++.
T Consensus       221 ~----~~~~~~~~~~~~~li~~~l~~~P~~R~~~~  251 (285)
T cd05632         221 E----EVYSAKFSEEAKSICKMLLTKDPKQRLGCQ  251 (285)
T ss_pred             c----cccCccCCHHHHHHHHHHccCCHhHcCCCc
Confidence            0    012223445788999999999999999943

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=1.4e-40  Score=320.69  Aligned_cols=275  Identities=24%  Similarity=0.357  Sum_probs=203.3

Q ss_pred             hcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCccHHHHHHHHHHHhcCCCCCcceEEEEEEeC--C
Q 046893           91 TKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVKLIGYCCED--E  168 (464)
Q Consensus        91 ~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~--~  168 (464)
                      .++|++.+.||+|+||.||+|.....  ....+..||+|.+..........+.+|++++..++||||+++++++...  .
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~~--~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~   80 (284)
T cd05081           3 ERHLKFIQQLGKGNFGSVELCRYDPL--QDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR   80 (284)
T ss_pred             cccceeeeeccCCCCceEEEEEecCC--cCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCC
Confidence            35688899999999999999975321  1123567999998765544456789999999999999999999987543  4


Q ss_pred             eEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCccC
Q 046893          169 HRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKD  248 (464)
Q Consensus       169 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~  248 (464)
                      ..++||||+++++|.+++.... ..+++..++.++.|++.||.|||  .++|+||||||+|||++.++.+||+|||+++.
T Consensus        81 ~~~lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~~l~~aL~~LH--~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~  157 (284)
T cd05081          81 NLRLVMEYLPYGSLRDYLQKHR-ERLDHRKLLLYASQICKGMEYLG--SKRYVHRDLATRNILVESENRVKIGDFGLTKV  157 (284)
T ss_pred             ceEEEEEecCCCCHHHHHHhcC-cCCCHHHHHHHHHHHHHHHHHHH--HCCceeccCCHhhEEECCCCeEEECCCccccc
Confidence            6899999999999999986542 35899999999999999999999  67799999999999999999999999999986


Q ss_pred             CCCCCCcc-eeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhcc---c
Q 046893          249 GPMGDQTH-VSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNN---K  324 (464)
Q Consensus       249 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~---~  324 (464)
                      ........ ......++..|+|||++.+..++.++||||||+++|||++|..++......    ............   .
T Consensus       158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~  233 (284)
T cd05081         158 LPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAE----FMRMMGNDKQGQMIVY  233 (284)
T ss_pred             ccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchh----hhhhcccccccccchH
Confidence            53322211 111123445699999999889999999999999999999988776432210    000000000000   0


Q ss_pred             chhhccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHH
Q 046893          325 KVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETV  374 (464)
Q Consensus       325 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~  374 (464)
                      .+...+........+..++..+.+|+.+||..+|.+|||+.+|++.|+.+
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~  283 (284)
T cd05081         234 HLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI  283 (284)
T ss_pred             HHHHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence            00011111111112233456899999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=1.4e-40  Score=315.71  Aligned_cols=249  Identities=28%  Similarity=0.388  Sum_probs=200.3

Q ss_pred             hcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCccHHHHHHHHHHHhcCCCCCcceEEEEEE-eCCe
Q 046893           91 TKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVKLIGYCC-EDEH  169 (464)
Q Consensus        91 ~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-~~~~  169 (464)
                      .++|.+.+.||+|+||.||+|...        +..+|+|.+...  .....+.+|+.+++.++|+||+++++++. ..+.
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~--------~~~~~~k~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   74 (256)
T cd05082           5 MKELKLLQTIGKGEFGDVMLGDYR--------GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGG   74 (256)
T ss_pred             HHhCeeeeeecccCCCeEEEEEEc--------CCcEEEEEeCCC--chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCc
Confidence            356888999999999999999754        345899988643  23467889999999999999999999764 4567


Q ss_pred             EEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCccCC
Q 046893          170 RILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDG  249 (464)
Q Consensus       170 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~  249 (464)
                      .++||||+++++|.+++.......+++..++.++.|++.||.|||  .++++||||||+||+++.++.+||+|||+++..
T Consensus        75 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH--~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~  152 (256)
T cd05082          75 LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE--ANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEA  152 (256)
T ss_pred             eEEEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH--hCCEeccccchheEEEcCCCcEEecCCccceec
Confidence            899999999999999987765556899999999999999999999  677999999999999999999999999998753


Q ss_pred             CCCCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHhhhcccchhh
Q 046893          250 PMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLL-GRRAVDKSRPSREHNLVEWARPLLNNNKKVLR  328 (464)
Q Consensus       250 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  328 (464)
                      ....     ....++..|+|||++.+..++.++|||||||++|+|++ |+.||.....      .+...... .      
T Consensus       153 ~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~------~~~~~~~~-~------  214 (256)
T cd05082         153 SSTQ-----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL------KDVVPRVE-K------  214 (256)
T ss_pred             cccC-----CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCH------HHHHHHHh-c------
Confidence            2211     12345668999999998899999999999999999997 9999864321      11111110 0      


Q ss_pred             ccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q 046893          329 ILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLET  373 (464)
Q Consensus       329 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~  373 (464)
                          ......+..++..+.+++.+||+.+|.+||++.++++.|+.
T Consensus       215 ----~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  255 (256)
T cd05082         215 ----GYKMDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEH  255 (256)
T ss_pred             ----CCCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhc
Confidence                11112223455689999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=3.4e-43  Score=318.61  Aligned_cols=248  Identities=27%  Similarity=0.377  Sum_probs=211.0

Q ss_pred             CCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCccHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeEEEE
Q 046893           94 FRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVKLIGYCCEDEHRILV  173 (464)
Q Consensus        94 ~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv  173 (464)
                      |.++.+||+|+||.||+|.+.+.      |.++|||.+...  .+..++.+|+.||+++..|+||++|+.|.....+++|
T Consensus        35 FDi~~KLGEGSYGSV~KAIH~Es------G~v~AIK~VPV~--sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIV  106 (502)
T KOG0574|consen   35 FDIVGKLGEGSYGSVHKAIHRES------GHVLAIKKVPVD--TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIV  106 (502)
T ss_pred             HHHHHHhcCCcchHHHHHHHhcc------CcEEEEEecCcc--chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEee
Confidence            55667899999999999998875      889999998753  4568899999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCccCCCCCC
Q 046893          174 YEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGD  253 (464)
Q Consensus       174 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~  253 (464)
                      ||||..|++.|.+.-+ +.+|++.++..++...+.||+|||  ...-||||||..||||+-+|..||+|||.|....  +
T Consensus       107 MEYCGAGSiSDI~R~R-~K~L~E~EIs~iL~~TLKGL~YLH--~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLT--D  181 (502)
T KOG0574|consen  107 MEYCGAGSISDIMRAR-RKPLSEQEISAVLRDTLKGLQYLH--DLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLT--D  181 (502)
T ss_pred             hhhcCCCcHHHHHHHh-cCCccHHHHHHHHHHHHhHHHHHH--HHHHHHhhcccccEEEcccchhhhhhccccchhh--h
Confidence            9999999999987654 458999999999999999999999  4558999999999999999999999999997642  3


Q ss_pred             CcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhcccchhhccCcc
Q 046893          254 QTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRILDPR  333 (464)
Q Consensus       254 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  333 (464)
                      ......++.||+.|||||++..-.|+.++||||||++..||..|++||....+....-.+               -..|.
T Consensus       182 TMAKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMI---------------PT~PP  246 (502)
T KOG0574|consen  182 TMAKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMI---------------PTKPP  246 (502)
T ss_pred             hHHhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEec---------------cCCCC
Confidence            333455689999999999999999999999999999999999999999876654321100               01223


Q ss_pred             ccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 046893          334 LEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVA  369 (464)
Q Consensus       334 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  369 (464)
                      ..-..+..++.++.+++++||-.+|++|-++..+++
T Consensus       247 PTF~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~  282 (502)
T KOG0574|consen  247 PTFKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCE  282 (502)
T ss_pred             CCCCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhh
Confidence            333456677889999999999999999999887764

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=1.1e-40  Score=325.60  Aligned_cols=266  Identities=25%  Similarity=0.365  Sum_probs=199.3

Q ss_pred             cCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCC-ccHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeE
Q 046893           92 KFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGY-QGDREWLAEVNYLGQLRHSNLVKLIGYCCEDEHR  170 (464)
Q Consensus        92 ~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~  170 (464)
                      ++|.+.+.||+|+||.||+|.+..+      +..||+|.+..... .....+.+|+.+++.++||||+++++++..++..
T Consensus         6 ~~y~~~~~lg~G~~g~Vy~~~~~~~------~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   79 (309)
T cd07872           6 ETYIKLEKLGEGTYATVFKGRSKLT------ENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSL   79 (309)
T ss_pred             CceEEEEEecccCCEEEEEEEecCC------CCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeE
Confidence            4588899999999999999987654      56799999875432 2234678899999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCccCCC
Q 046893          171 ILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGP  250 (464)
Q Consensus       171 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~  250 (464)
                      ++||||+.+ +|.+++... +..+++..+..++.|++.||.|||  .++|+||||||+|||++.++.+||+|||+++...
T Consensus        80 ~lv~e~~~~-~l~~~~~~~-~~~~~~~~~~~~~~qi~~aL~~lH--~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~  155 (309)
T cd07872          80 TLVFEYLDK-DLKQYMDDC-GNIMSMHNVKIFLYQILRGLAYCH--RRKVLHRDLKPQNLLINERGELKLADFGLARAKS  155 (309)
T ss_pred             EEEEeCCCC-CHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHH--HCCeecCCCCHHHEEECCCCCEEECccccceecC
Confidence            999999965 888877654 345889999999999999999999  6779999999999999999999999999997532


Q ss_pred             CCCCcceeeccccCCcccCcccccc-CCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHH--------HHhhh
Q 046893          251 MGDQTHVSTRVMGTYGYAAPEYVMT-GHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWA--------RPLLN  321 (464)
Q Consensus       251 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~--------~~~~~  321 (464)
                      ...  .......+|..|+|||++.+ ..++.++|||||||++|+|++|+.||...............        ++.+.
T Consensus       156 ~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (309)
T cd07872         156 VPT--KTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGIS  233 (309)
T ss_pred             CCc--cccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhc
Confidence            221  12223568999999998865 46889999999999999999999999765432221111000        00000


Q ss_pred             cccchhhccCcccc----CccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 046893          322 NNKKVLRILDPRLE----GQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVA  369 (464)
Q Consensus       322 ~~~~~~~~~~~~~~----~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  369 (464)
                      ..........+...    .......+.++.+|+.+||..||.+|||+.+++.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~  285 (309)
T cd07872         234 SNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK  285 (309)
T ss_pred             chhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence            00000000000000    0011124557889999999999999999999875

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.4e-40  Score=318.22  Aligned_cols=265  Identities=22%  Similarity=0.340  Sum_probs=207.8

Q ss_pred             hcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCc-cHHHHHHHHHHHhcCCCCCcceEEEEEEeCCe
Q 046893           91 TKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQ-GDREWLAEVNYLGQLRHSNLVKLIGYCCEDEH  169 (464)
Q Consensus        91 ~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~  169 (464)
                      ..+|++.+.||+|+||.||+|.+..+...  ....+|+|.+...... ....+.+|+.+++.++||||+++++++.. ..
T Consensus         6 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~--~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~   82 (279)
T cd05057           6 ETELEKIKVLGSGAFGTVYKGVWIPEGEK--VKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQ   82 (279)
T ss_pred             HHHcEEcceecCCCCccEEEEEEecCCCC--cceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-Cc
Confidence            35678889999999999999997654211  2346899988765432 23678899999999999999999999887 78


Q ss_pred             EEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCccCC
Q 046893          170 RILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDG  249 (464)
Q Consensus       170 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~  249 (464)
                      .++||||+.+|+|.+++.... ..+++..++.++.|++.||.|||  +.+|+||||||+|||++.++.+||+|||+++..
T Consensus        83 ~~~v~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~LH--~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~  159 (279)
T cd05057          83 VQLITQLMPLGCLLDYVRNHK-DNIGSQYLLNWCVQIAKGMSYLE--EKRLVHRDLAARNVLVKTPQHVKITDFGLAKLL  159 (279)
T ss_pred             eEEEEecCCCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHH--hCCEEecccCcceEEEcCCCeEEECCCcccccc
Confidence            899999999999999987653 35899999999999999999999  577999999999999999999999999999865


Q ss_pred             CCCCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHhhhcccchhh
Q 046893          250 PMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLL-GRRAVDKSRPSREHNLVEWARPLLNNNKKVLR  328 (464)
Q Consensus       250 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  328 (464)
                      .............++..|+|||.+....++.++||||||+++|||++ |+.||......      ++....... .    
T Consensus       160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~------~~~~~~~~~-~----  228 (279)
T cd05057         160 DVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAV------EIPDLLEKG-E----  228 (279)
T ss_pred             cCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHH------HHHHHHhCC-C----
Confidence            43222211122334678999999988899999999999999999998 99999764321      111111110 0    


Q ss_pred             ccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhcC
Q 046893          329 ILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETVQSQG  378 (464)
Q Consensus       329 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~~~~~  378 (464)
                            ....+..++..+.+++.+||..||.+||++.++++.|+.+....
T Consensus       229 ------~~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~~~  272 (279)
T cd05057         229 ------RLPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMARDP  272 (279)
T ss_pred             ------CCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhCC
Confidence                  00112223457889999999999999999999999999886543

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.8e-40  Score=315.17  Aligned_cols=252  Identities=28%  Similarity=0.443  Sum_probs=198.7

Q ss_pred             CceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCc-cHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeEEEEEec
Q 046893           98 YILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQ-GDREWLAEVNYLGQLRHSNLVKLIGYCCEDEHRILVYEY  176 (464)
Q Consensus        98 ~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~  176 (464)
                      ++||+|+||.||+|++.....   ....+|+|.+...... ....+..|+.+++.+.||||+++++++. .+..++||||
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~---~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~   76 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSG---KEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMEL   76 (257)
T ss_pred             CccCccCceeEEEeEeeccCC---CcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEe
Confidence            369999999999998755421   2357999998765442 3467889999999999999999999876 4568999999


Q ss_pred             cCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCccCCCCCCCcc
Q 046893          177 MESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTH  256 (464)
Q Consensus       177 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~~~  256 (464)
                      +.+++|.+++....  .+++..++.++.|++.||.|||  ..+++|+||||+|||++.++.+||+|||+++.........
T Consensus        77 ~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lh--~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~  152 (257)
T cd05060          77 APLGPLLKYLKKRR--EIPVSDLKELAHQVAMGMAYLE--SKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYY  152 (257)
T ss_pred             CCCCcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHh--hcCeeccCcccceEEEcCCCcEEeccccccceeecCCccc
Confidence            99999999987654  6899999999999999999999  6679999999999999999999999999998653332211


Q ss_pred             -eeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHhhhcccchhhccCccc
Q 046893          257 -VSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLL-GRRAVDKSRPSREHNLVEWARPLLNNNKKVLRILDPRL  334 (464)
Q Consensus       257 -~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  334 (464)
                       ......++..|+|||.+.+..++.++||||||+++|+|++ |..||.....   ..+..+..    ...          
T Consensus       153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~---~~~~~~~~----~~~----------  215 (257)
T cd05060         153 RATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKG---AEVIAMLE----SGE----------  215 (257)
T ss_pred             ccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCH---HHHHHHHH----cCC----------
Confidence             1111234567999999998899999999999999999998 9999975432   11222111    110          


Q ss_pred             cCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHH
Q 046893          335 EGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETV  374 (464)
Q Consensus       335 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~  374 (464)
                      ....+..++..+.+++.+||..+|.+||++.++++.|+.+
T Consensus       216 ~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~  255 (257)
T cd05060         216 RLPRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD  255 (257)
T ss_pred             cCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence            0112223445889999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=2.1e-41  Score=337.72  Aligned_cols=252  Identities=23%  Similarity=0.308  Sum_probs=195.5

Q ss_pred             CCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCC---CccHHHHHHHHHHHhcCCCCCcceEEEEEEeCCe
Q 046893           93 FFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGG---YQGDREWLAEVNYLGQLRHSNLVKLIGYCCEDEH  169 (464)
Q Consensus        93 ~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~  169 (464)
                      .|++.+.||+|+||+||+|.+..+      ++.||+|++....   ......+..|+.++..++||||+++++.+...+.
T Consensus         2 ~f~~~~~lG~G~~g~V~~~~~~~~------~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~   75 (360)
T cd05627           2 DFESLKVIGRGAFGEVRLVQKKDT------GHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRN   75 (360)
T ss_pred             CceEEEEEeeCCCEEEEEEEECCC------CCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCE
Confidence            588889999999999999998765      6679999986432   1223567889999999999999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCccCC
Q 046893          170 RILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDG  249 (464)
Q Consensus       170 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~  249 (464)
                      .+|||||+++|+|.+++.+..  .+++..+..++.|++.||.|||  .++|+||||||+||||+.++.+||+|||+++..
T Consensus        76 ~~lv~E~~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~~L~~lH--~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~  151 (360)
T cd05627          76 LYLIMEFLPGGDMMTLLMKKD--TLSEEATQFYIAETVLAIDAIH--QLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGL  151 (360)
T ss_pred             EEEEEeCCCCccHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH--HCCeEccCCCHHHEEECCCCCEEEeeccCCccc
Confidence            999999999999999887643  6899999999999999999999  677999999999999999999999999998743


Q ss_pred             CCCCCc---------------------------------ceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHh
Q 046893          250 PMGDQT---------------------------------HVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLL  296 (464)
Q Consensus       250 ~~~~~~---------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~  296 (464)
                      ......                                 ......+||+.|+|||++.+..++.++|||||||+||||++
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~t  231 (360)
T cd05627         152 KKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLI  231 (360)
T ss_pred             ccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeeccc
Confidence            211100                                 01123579999999999999999999999999999999999


Q ss_pred             CCCCCCCCCCcccccHHHHHHHhhhcccchhhccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 046893          297 GRRAVDKSRPSREHNLVEWARPLLNNNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVA  369 (464)
Q Consensus       297 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  369 (464)
                      |+.||....+..      ...........+ . +.+.      ...+..+.+||.+|+ .||.+|++...+.+
T Consensus       232 G~~Pf~~~~~~~------~~~~i~~~~~~~-~-~p~~------~~~s~~~~~li~~l~-~~p~~R~~~~~~~e  289 (360)
T cd05627         232 GYPPFCSETPQE------TYRKVMNWKETL-V-FPPE------VPISEKAKDLILRFC-TDSENRIGSNGVEE  289 (360)
T ss_pred             CCCCCCCCCHHH------HHHHHHcCCCce-e-cCCC------CCCCHHHHHHHHHhc-cChhhcCCCCCHHH
Confidence            999997654321      111111110000 0 0000      113347788888876 49999997543333

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=9.5e-41  Score=322.52  Aligned_cols=262  Identities=26%  Similarity=0.407  Sum_probs=204.6

Q ss_pred             hcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCC-ccHHHHHHHHHHHhcCCCCCcceEEEEEEeCCe
Q 046893           91 TKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGY-QGDREWLAEVNYLGQLRHSNLVKLIGYCCEDEH  169 (464)
Q Consensus        91 ~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~  169 (464)
                      .++|++.+.||+|+||.||+|.+... .++.....||+|.+..... ....++.+|+.+++.+.||||+++++++..+..
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~-~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~   82 (288)
T cd05050           4 RNNIEYVRDIGQGAFGRVFQARAPGL-LPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKP   82 (288)
T ss_pred             hHhceecccccccccccEEEEEEccc-CCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCc
Confidence            46689999999999999999986531 1122356799999875432 223668899999999999999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHhhc--------------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCc
Q 046893          170 RILVYEYMESGSLEKHLLRRV--------------------GCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSN  229 (464)
Q Consensus       170 ~~lv~e~~~~g~L~~~l~~~~--------------------~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~N  229 (464)
                      .++||||+++++|.+++....                    ...+++..++.++.|++.||.|||  .++++||||||+|
T Consensus        83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH--~~~i~H~dl~p~n  160 (288)
T cd05050          83 MCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLS--ERKFVHRDLATRN  160 (288)
T ss_pred             cEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHH--hCCeecccccHhh
Confidence            999999999999999986432                    124788899999999999999999  6779999999999


Q ss_pred             eEecCCCceEEcccCCccCCCCCCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHh-CCCCCCCCCCcc
Q 046893          230 ILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLL-GRRAVDKSRPSR  308 (464)
Q Consensus       230 ill~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~  308 (464)
                      ||++.++.++|+|||++................++..|+|||.+.+..++.++|||||||++|||++ |..||.+.... 
T Consensus       161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~-  239 (288)
T cd05050         161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHE-  239 (288)
T ss_pred             eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH-
Confidence            9999999999999999875433222222222345678999999998899999999999999999997 88888654321 


Q ss_pred             cccHHHHHHHhhhcccchhhccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 046893          309 EHNLVEWARPLLNNNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLE  372 (464)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~  372 (464)
                           ++.......  ..         ...+..++..+.+|+.+||+.||.+||++.+++..|+
T Consensus       240 -----~~~~~~~~~--~~---------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~  287 (288)
T cd05050         240 -----EVIYYVRDG--NV---------LSCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQ  287 (288)
T ss_pred             -----HHHHHHhcC--CC---------CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhh
Confidence                 111111111  00         0112234568999999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=2.3e-40  Score=314.69  Aligned_cols=250  Identities=27%  Similarity=0.383  Sum_probs=195.8

Q ss_pred             eeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCc-cHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeEEEEEeccC
Q 046893          100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQ-GDREWLAEVNYLGQLRHSNLVKLIGYCCEDEHRILVYEYME  178 (464)
Q Consensus       100 lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~  178 (464)
                      ||+|+||.||+|.+....    .+..||+|++...... ....+.+|+.+++.++||||+++++++. ....++||||++
T Consensus         3 ig~G~~g~v~~~~~~~~~----~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~   77 (257)
T cd05115           3 LGSGNFGCVKKGVYKMRK----KQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMAS   77 (257)
T ss_pred             cCCCCcccEEEEEEecCC----CceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCC
Confidence            899999999999875321    2456999998754322 2356889999999999999999999875 457899999999


Q ss_pred             CCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCccCCCCCCCcce-
Q 046893          179 SGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHV-  257 (464)
Q Consensus       179 ~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~~~~-  257 (464)
                      +++|.+++... ...+++..++.++.|++.||.|||  .++++||||||+|||++.++.+||+|||+++.......... 
T Consensus        78 ~~~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH--~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~  154 (257)
T cd05115          78 GGPLNKFLSGK-KDEITVSNVVELMHQVSMGMKYLE--GKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKA  154 (257)
T ss_pred             CCCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHH--hcCeeecccchheEEEcCCCcEEeccCCccccccCCccceec
Confidence            99999988653 236899999999999999999999  67799999999999999999999999999985433222111 


Q ss_pred             eeccccCCcccCccccccCCCCcccchhcHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHhhhcccchhhccCccccC
Q 046893          258 STRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLL-GRRAVDKSRPSREHNLVEWARPLLNNNKKVLRILDPRLEG  336 (464)
Q Consensus       258 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  336 (464)
                      .....++..|+|||++.+..++.++|||||||++|+|++ |..||.......      +.. .+..          ....
T Consensus       155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~------~~~-~~~~----------~~~~  217 (257)
T cd05115         155 RSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPE------VMS-FIEQ----------GKRL  217 (257)
T ss_pred             cCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHH------HHH-HHHC----------CCCC
Confidence            111234578999999988889999999999999999996 999997643211      111 1111          1111


Q ss_pred             ccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHH
Q 046893          337 QYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETV  374 (464)
Q Consensus       337 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~  374 (464)
                      ..+..++.++.+++.+||..+|++||++.+|.+.|+.+
T Consensus       218 ~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~  255 (257)
T cd05115         218 DCPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY  255 (257)
T ss_pred             CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence            22334556899999999999999999999999988764

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=1.5e-40  Score=321.03  Aligned_cols=262  Identities=25%  Similarity=0.321  Sum_probs=194.6

Q ss_pred             CCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCc--cHHHHHHHHHHHhcC---CCCCcceEEEEEEe-
Q 046893           93 FFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQ--GDREWLAEVNYLGQL---RHSNLVKLIGYCCE-  166 (464)
Q Consensus        93 ~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l---~hpniv~l~~~~~~-  166 (464)
                      +|++.+.||+|+||+||+|.+..+      ++.||+|.+......  ....+.+|+.+++.+   +||||+++++++.. 
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~------~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~   74 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHS------GHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATS   74 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCC------CcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccc
Confidence            478889999999999999998765      677999998653222  223456677777665   79999999998864 


Q ss_pred             ----CCeEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcc
Q 046893          167 ----DEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSD  242 (464)
Q Consensus       167 ----~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~D  242 (464)
                          ....++||||+. ++|.+++.......+++..+..++.|++.||.|||  ..+|+||||||+|||++.++.+||+|
T Consensus        75 ~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH--~~~ivH~dikp~Nili~~~~~~kl~d  151 (288)
T cd07863          75 RTDRETKVTLVFEHVD-QDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLH--ANCIVHRDLKPENILVTSGGQVKLAD  151 (288)
T ss_pred             cCCCCceEEEEEcccc-cCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH--hCCeecCCCCHHHEEECCCCCEEECc
Confidence                245799999996 48988887655456899999999999999999999  67799999999999999999999999


Q ss_pred             cCCccCCCCCCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhc
Q 046893          243 FGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNN  322 (464)
Q Consensus       243 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~  322 (464)
                      ||+++......   ......||..|+|||++.+..++.++|||||||++|+|++|++||........  +..... .+..
T Consensus       152 fg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~--~~~~~~-~~~~  225 (288)
T cd07863         152 FGLARIYSCQM---ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQ--LGKIFD-LIGL  225 (288)
T ss_pred             cCccccccCcc---cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHH--HHHHHH-HhCC
Confidence            99998643221   12235789999999999998999999999999999999999999975432211  111100 0000


Q ss_pred             --ccchh-------hccCc---cccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 046893          323 --NKKVL-------RILDP---RLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVA  369 (464)
Q Consensus       323 --~~~~~-------~~~~~---~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  369 (464)
                        .....       ..+.+   ..........+..+.+|+.+||+.||.+||++.+++.
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~  284 (288)
T cd07863         226 PPEDDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ  284 (288)
T ss_pred             CChhhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence              00000       00000   0000111234557889999999999999999998874

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=5.7e-41  Score=335.62  Aligned_cols=260  Identities=19%  Similarity=0.230  Sum_probs=200.9

Q ss_pred             hhHHHHHhcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCC---ccHHHHHHHHHHHhcCCCCCcceE
Q 046893           84 YNEMKLATKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGY---QGDREWLAEVNYLGQLRHSNLVKL  160 (464)
Q Consensus        84 ~~~~~~~~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~l  160 (464)
                      ..+..+..++|++.+.||+|+||.||+|.+..+      ++.+|+|++.....   .....+.+|+.+++.++||||+++
T Consensus        35 ~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~------~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~  108 (371)
T cd05622          35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKST------RKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQL  108 (371)
T ss_pred             HhhcCcchhhcEEEEEEeecCCeEEEEEEECCC------CcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeE
Confidence            445566678999999999999999999998765      66799999864221   223457789999999999999999


Q ss_pred             EEEEEeCCeEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEE
Q 046893          161 IGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKL  240 (464)
Q Consensus       161 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl  240 (464)
                      ++++......++||||+++|+|.+++...   .++...+..++.||+.||.|||  .++|+||||||+|||++.++.+||
T Consensus       109 ~~~~~~~~~~~lv~Ey~~gg~L~~~~~~~---~~~~~~~~~~~~qi~~aL~~LH--~~~ivHrDLkp~NIll~~~~~ikL  183 (371)
T cd05622         109 FYAFQDDRYLYMVMEYMPGGDLVNLMSNY---DVPEKWARFYTAEVVLALDAIH--SMGFIHRDVKPDNMLLDKSGHLKL  183 (371)
T ss_pred             EEEEEcCCEEEEEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHH--HCCEEeCCCCHHHEEECCCCCEEE
Confidence            99999999999999999999999988653   4889999999999999999999  677999999999999999999999


Q ss_pred             cccCCccCCCCCCCcceeeccccCCcccCccccccC----CCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHH
Q 046893          241 SDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTG----HLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWA  316 (464)
Q Consensus       241 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~  316 (464)
                      +|||+++...... .......+||+.|+|||++.+.    .++.++|||||||+||||++|..||......      ...
T Consensus       184 ~DfG~a~~~~~~~-~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~------~~~  256 (371)
T cd05622         184 ADFGTCMKMNKEG-MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV------GTY  256 (371)
T ss_pred             EeCCceeEcCcCC-cccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHH------HHH
Confidence            9999998643221 1122346799999999998754    3789999999999999999999999764321      111


Q ss_pred             HHhhhcccchhhccCccccCccCHHHHHHHHHHHHHhhccCCCC---CCCHHHHHHH
Q 046893          317 RPLLNNNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKG---RPVMSDVVAL  370 (464)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~---RPs~~ev~~~  370 (464)
                      ..+...... ...       ......+..+.+|+..||. +|..   |+++.++++.
T Consensus       257 ~~i~~~~~~-~~~-------~~~~~~s~~~~~li~~~L~-~~~~r~~r~~~~ei~~h  304 (371)
T cd05622         257 SKIMNHKNS-LTF-------PDDNDISKEAKNLICAFLT-DREVRLGRNGVEEIKRH  304 (371)
T ss_pred             HHHHcCCCc-ccC-------CCcCCCCHHHHHHHHHHcC-ChhhhcCCCCHHHHhcC
Confidence            111111100 000       1112344578899999998 4444   6777777654

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=1.5e-40  Score=316.37  Aligned_cols=256  Identities=26%  Similarity=0.445  Sum_probs=204.5

Q ss_pred             HHhcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCccHHHHHHHHHHHhcCCCCCcceEEEEEEeCC
Q 046893           89 LATKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVKLIGYCCEDE  168 (464)
Q Consensus        89 ~~~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~  168 (464)
                      +..++|++.+.||+|+||.||+|.+..       +..+|+|.+.... .....+.+|+.+++.++|+||+++++++.. .
T Consensus         3 ~~~~~~~~~~~lg~g~~~~vy~~~~~~-------~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~   73 (260)
T cd05073           3 IPRESLKLEKKLGAGQFGEVWMATYNK-------HTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-E   73 (260)
T ss_pred             ccccceeEEeEecCccceEEEEEEecC-------CccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-C
Confidence            445779999999999999999998654       3448999876532 234678899999999999999999999887 7


Q ss_pred             eEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCccC
Q 046893          169 HRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKD  248 (464)
Q Consensus       169 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~  248 (464)
                      ..+++|||+++++|.+++....+..+++..++.++.|++.||.|||  +.+++|+||||+||+++.++.+||+|||++..
T Consensus        74 ~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH--~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~  151 (260)
T cd05073          74 PIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE--QRNYIHRDLRAANILVSASLVCKIADFGLARV  151 (260)
T ss_pred             CeEEEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHH--hCCccccccCcceEEEcCCCcEEECCCcceee
Confidence            7899999999999999998765667899999999999999999999  67799999999999999999999999999975


Q ss_pred             CCCCCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHhhhcccchh
Q 046893          249 GPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLL-GRRAVDKSRPSREHNLVEWARPLLNNNKKVL  327 (464)
Q Consensus       249 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  327 (464)
                      ....... ......++..|+|||++.+..++.++|||||||++|+|++ |..||......   .+..+.    ...    
T Consensus       152 ~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~---~~~~~~----~~~----  219 (260)
T cd05073         152 IEDNEYT-AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP---EVIRAL----ERG----  219 (260)
T ss_pred             ccCCCcc-cccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHH---HHHHHH----hCC----
Confidence            4322211 1222346678999999998889999999999999999998 89999754321   111111    110    


Q ss_pred             hccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q 046893          328 RILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLET  373 (464)
Q Consensus       328 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~  373 (464)
                            .........+..+.+++.+||+.+|.+||++.++.+.|+.
T Consensus       220 ------~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~  259 (260)
T cd05073         220 ------YRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD  259 (260)
T ss_pred             ------CCCCCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence                  0111122345589999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=7.2e-41  Score=335.39  Aligned_cols=265  Identities=24%  Similarity=0.344  Sum_probs=197.3

Q ss_pred             CCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCC--CccHHHHHHHHHHHhcCCCCCcceEEEEEEeCC--
Q 046893           93 FFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGG--YQGDREWLAEVNYLGQLRHSNLVKLIGYCCEDE--  168 (464)
Q Consensus        93 ~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~--  168 (464)
                      .|++.+.||+|+||.||+|.+..+      ++.||||.+....  ....+.+.+|+.+|+.++||||+++++++...+  
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~------~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~   74 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRD------GKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHID   74 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCC------CCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCcc
Confidence            377889999999999999997654      5679999986532  223367889999999999999999999998776  


Q ss_pred             ---eEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCC
Q 046893          169 ---HRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGL  245 (464)
Q Consensus       169 ---~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGl  245 (464)
                         ..|+||||+. ++|.+++...  ..+++..+..++.|++.||.|||  ..+|+||||||+|||++.++.+||+|||+
T Consensus        75 ~~~~~~lv~e~~~-~~l~~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH--~~~ivH~dlkp~Nili~~~~~~kL~Dfg~  149 (372)
T cd07853          75 PFEEIYVVTELMQ-SDLHKIIVSP--QPLSSDHVKVFLYQILRGLKYLH--SAGILHRDIKPGNLLVNSNCVLKICDFGL  149 (372)
T ss_pred             ccceEEEEeeccc-cCHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHH--hCCeeCCCCChHHEEECCCCCEEeccccc
Confidence               7899999996 5888877553  36899999999999999999999  56799999999999999999999999999


Q ss_pred             ccCCCCCCCcceeeccccCCcccCccccccC-CCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHH--------
Q 046893          246 AKDGPMGDQTHVSTRVMGTYGYAAPEYVMTG-HLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWA--------  316 (464)
Q Consensus       246 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~--------  316 (464)
                      ++....... .......+|..|+|||++.+. .++.++|||||||++|||++|+.||.+..+......+...        
T Consensus       150 a~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~  228 (372)
T cd07853         150 ARVEEPDES-KHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEA  228 (372)
T ss_pred             eeecccCcc-ccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHH
Confidence            986433221 122335689999999998874 5789999999999999999999999865433211111000        


Q ss_pred             -HHhhhcc-cchhh-ccCc-ccc--CccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 046893          317 -RPLLNNN-KKVLR-ILDP-RLE--GQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVA  369 (464)
Q Consensus       317 -~~~~~~~-~~~~~-~~~~-~~~--~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  369 (464)
                       ....... ..+.. ...+ ...  .......+..+.+||.+||+.||.+||++.+++.
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~  287 (372)
T cd07853         229 MRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALA  287 (372)
T ss_pred             HHHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhc
Confidence             0000000 00000 0000 000  0111223457889999999999999999999875

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=1.9e-40  Score=330.76  Aligned_cols=264  Identities=22%  Similarity=0.309  Sum_probs=196.4

Q ss_pred             HhcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCC--ccHHHHHHHHHHHhcCCCCCcceEEEEEEeC
Q 046893           90 ATKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGY--QGDREWLAEVNYLGQLRHSNLVKLIGYCCED  167 (464)
Q Consensus        90 ~~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~  167 (464)
                      ..++|++.+.||+|+||.||+|.+...      +..||+|++.....  .....+.+|+.+++.++||||+++++++...
T Consensus        19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~   92 (359)
T cd07876          19 VLKRYQQLKPIGSGAQGIVCAAFDTVL------GINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQ   92 (359)
T ss_pred             hhhceEEEEEeecCCCEEEEEEEEcCC------CceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccC
Confidence            457799999999999999999987664      66799999865422  2345678999999999999999999988654


Q ss_pred             C------eEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEc
Q 046893          168 E------HRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLS  241 (464)
Q Consensus       168 ~------~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~  241 (464)
                      .      ..|+||||+.+ +|.+.+..    .++...+..++.|++.||.|||  ..+|+||||||+|||++.++.+||+
T Consensus        93 ~~~~~~~~~~lv~e~~~~-~l~~~~~~----~~~~~~~~~~~~qi~~~L~~LH--~~~ivHrDlkp~NIl~~~~~~~kl~  165 (359)
T cd07876          93 KSLEEFQDVYLVMELMDA-NLCQVIHM----ELDHERMSYLLYQMLCGIKHLH--SAGIIHRDLKPSNIVVKSDCTLKIL  165 (359)
T ss_pred             CCccccceeEEEEeCCCc-CHHHHHhc----cCCHHHHHHHHHHHHHHHHHHH--hCCcccCCCCHHHEEECCCCCEEEe
Confidence            3      57999999965 67666532    4788999999999999999999  6779999999999999999999999


Q ss_pred             ccCCccCCCCCCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHhCCCCCCCCCCccccc-HH-------
Q 046893          242 DFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHN-LV-------  313 (464)
Q Consensus       242 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~-~~-------  313 (464)
                      |||+++.....   .......||..|+|||++.+..++.++|||||||++|+|++|+.||.+........ ..       
T Consensus       166 Dfg~a~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~  242 (359)
T cd07876         166 DFGLARTACTN---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPS  242 (359)
T ss_pred             cCCCccccccC---ccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCc
Confidence            99999753221   12234678999999999999999999999999999999999999998653211100 00       


Q ss_pred             -HH-------HHHhhhcccchh-----hccCccc---cCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 046893          314 -EW-------ARPLLNNNKKVL-----RILDPRL---EGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVA  369 (464)
Q Consensus       314 -~~-------~~~~~~~~~~~~-----~~~~~~~---~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  369 (464)
                       ++       ............     .......   ...........+.+|+.+||..||.+|||+.+++.
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~  314 (359)
T cd07876         243 AEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALR  314 (359)
T ss_pred             HHHHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhc
Confidence             00       000000000000     0000000   00011123457899999999999999999999975

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=2.7e-40  Score=316.37  Aligned_cols=251  Identities=26%  Similarity=0.397  Sum_probs=195.9

Q ss_pred             ceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCC-ccHHHHHHHHHHHhcC-CCCCcceEEEEEEeCCeEEEEEec
Q 046893           99 ILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGY-QGDREWLAEVNYLGQL-RHSNLVKLIGYCCEDEHRILVYEY  176 (464)
Q Consensus        99 ~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~lv~e~  176 (464)
                      .||+|+||.||+|.+..+..    ...+++|.+..... .....+..|+.++..+ .||||+++++++...+..++||||
T Consensus         2 ~lg~g~~g~v~~~~~~~~~~----~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~   77 (270)
T cd05047           2 VIGEGNFGQVLKARIKKDGL----RMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEY   77 (270)
T ss_pred             cCCCCCCceEEEEEEcCCCC----eeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEe
Confidence            58999999999999866421    23578888864322 2335788999999999 799999999999999999999999


Q ss_pred             cCCCCHHHHHHhhc--------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcc
Q 046893          177 MESGSLEKHLLRRV--------------GCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSD  242 (464)
Q Consensus       177 ~~~g~L~~~l~~~~--------------~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~D  242 (464)
                      +++|+|.+++....              ...+++..++.++.|++.||+|||  +.+++||||||+|||++.++.+||+|
T Consensus        78 ~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH--~~~i~H~dikp~nili~~~~~~kl~d  155 (270)
T cd05047          78 APHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS--QKQFIHRDLAARNILVGENYVAKIAD  155 (270)
T ss_pred             CCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHH--HCCEeecccccceEEEcCCCeEEECC
Confidence            99999999987532              124789999999999999999999  67799999999999999999999999


Q ss_pred             cCCccCCCCCCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHhhh
Q 046893          243 FGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLL-GRRAVDKSRPSREHNLVEWARPLLN  321 (464)
Q Consensus       243 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~  321 (464)
                      ||++......   ........+..|+|||++.+..++.++|||||||++|||++ |..||......      +...... 
T Consensus       156 fgl~~~~~~~---~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~------~~~~~~~-  225 (270)
T cd05047         156 FGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA------ELYEKLP-  225 (270)
T ss_pred             CCCccccchh---hhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHH------HHHHHHh-
Confidence            9998632111   11111234567999999988889999999999999999997 99999653311      1111110 


Q ss_pred             cccchhhccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHH
Q 046893          322 NNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETVQ  375 (464)
Q Consensus       322 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~~  375 (464)
                                .......+..++..+.+|+.+||..+|.+||++.+++..|+.+.
T Consensus       226 ----------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~  269 (270)
T cd05047         226 ----------QGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML  269 (270)
T ss_pred             ----------CCCCCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence                      00111112234457899999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.8e-42  Score=334.07  Aligned_cols=245  Identities=29%  Similarity=0.408  Sum_probs=201.0

Q ss_pred             CCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCcc---HHHHHHHHHHHhcCCCCCcceEEEEEEeCCe
Q 046893           93 FFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQG---DREWLAEVNYLGQLRHSNLVKLIGYCCEDEH  169 (464)
Q Consensus        93 ~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~  169 (464)
                      .|.-++.||.|+||-||.|++..+      .++||||.+.-.....   ..++++|++.|+++.|||+|.+.++|..+..
T Consensus        27 lf~dLrEIGHGSFGAVYfArd~~n------~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~T  100 (948)
T KOG0577|consen   27 LFSDLREIGHGSFGAVYFARDVRN------SEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHT  100 (948)
T ss_pred             HHHHHHHhcCCccceeEEeeccCc------cceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccch
Confidence            366677899999999999998876      6789999997654433   3678999999999999999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCccCC
Q 046893          170 RILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDG  249 (464)
Q Consensus       170 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~  249 (464)
                      .||||||| -|+-.|++.-+. .++-+.++..|+.+.+.||.|||+  .+.||||||..||||.+.|.|||+|||.|...
T Consensus       101 aWLVMEYC-lGSAsDlleVhk-KplqEvEIAAi~~gaL~gLaYLHS--~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~  176 (948)
T KOG0577|consen  101 AWLVMEYC-LGSASDLLEVHK-KPLQEVEIAAITHGALQGLAYLHS--HNRIHRDIKAGNILLSEPGLVKLADFGSASIM  176 (948)
T ss_pred             HHHHHHHH-hccHHHHHHHHh-ccchHHHHHHHHHHHHHHHHHHHH--hhHHhhhccccceEecCCCeeeeccccchhhc
Confidence            99999999 457777765432 368999999999999999999995  44999999999999999999999999998753


Q ss_pred             CCCCCcceeeccccCCcccCccccc---cCCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhcccch
Q 046893          250 PMGDQTHVSTRVMGTYGYAAPEYVM---TGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKV  326 (464)
Q Consensus       250 ~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  326 (464)
                      .      ....++||++|||||++.   .+.|+-++|||||||+..||...++|+...+....      . ..+..+.  
T Consensus       177 ~------PAnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSA------L-YHIAQNe--  241 (948)
T KOG0577|consen  177 A------PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA------L-YHIAQNE--  241 (948)
T ss_pred             C------chhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHH------H-HHHHhcC--
Confidence            2      234589999999999986   57899999999999999999999999876542211      1 1111111  


Q ss_pred             hhccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 046893          327 LRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVA  369 (464)
Q Consensus       327 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  369 (464)
                          .|.+.   ...++..++.|+..||++-|.+|||..+++.
T Consensus       242 ----sPtLq---s~eWS~~F~~Fvd~CLqKipqeRptse~ll~  277 (948)
T KOG0577|consen  242 ----SPTLQ---SNEWSDYFRNFVDSCLQKIPQERPTSEELLK  277 (948)
T ss_pred             ----CCCCC---CchhHHHHHHHHHHHHhhCcccCCcHHHHhh
Confidence                12222   4567779999999999999999999998874

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-40  Score=327.96  Aligned_cols=255  Identities=20%  Similarity=0.236  Sum_probs=195.1

Q ss_pred             cCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCC---CccHHHHHHHHHHHhcCCCCCcceEEEEEEeCC
Q 046893           92 KFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGG---YQGDREWLAEVNYLGQLRHSNLVKLIGYCCEDE  168 (464)
Q Consensus        92 ~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~  168 (464)
                      ++|++.+.||+|+||+||++.+..+      ++.||+|++....   ......+..|+.++..++|+||+++++++.+.+
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~------~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~   74 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKNT------GQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDEN   74 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECCC------CCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCC
Confidence            3688899999999999999998765      5679999986421   122345788999999999999999999999999


Q ss_pred             eEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCccC
Q 046893          169 HRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKD  248 (464)
Q Consensus       169 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~  248 (464)
                      ..|+||||+.+|+|.+++.+. ...+++..+..++.||+.||.|||  .++|+||||||+|||++.++.+||+|||++..
T Consensus        75 ~~~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH--~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~  151 (331)
T cd05597          75 NLYLVMDYYVGGDLLTLLSKF-EDRLPEDMARFYLAEMVLAIDSVH--QLGYVHRDIKPDNVLLDKNGHIRLADFGSCLR  151 (331)
T ss_pred             eEEEEEecCCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHH--hCCeEECCCCHHHEEECCCCCEEEEECCceee
Confidence            999999999999999988653 346899999999999999999999  67799999999999999999999999999875


Q ss_pred             CCCCCCcceeeccccCCcccCcccccc-----CCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhcc
Q 046893          249 GPMGDQTHVSTRVMGTYGYAAPEYVMT-----GHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNN  323 (464)
Q Consensus       249 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~  323 (464)
                      ...... ......+||+.|+|||++..     ..++.++|||||||++|+|++|+.||.....      .+.........
T Consensus       152 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~------~~~~~~i~~~~  224 (331)
T cd05597         152 LLADGT-VQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESL------VETYGKIMNHK  224 (331)
T ss_pred             cCCCCC-ccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCH------HHHHHHHHcCC
Confidence            432221 11223569999999999863     4578899999999999999999999975432      11111111111


Q ss_pred             cchhhccCccccCccCHHHHHHHHHHHHHhhccCCCC--CCCHHHHHH
Q 046893          324 KKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKG--RPVMSDVVA  369 (464)
Q Consensus       324 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~ev~~  369 (464)
                      .. ..+  +    ......+..+.+|+.+||..++.+  |+++.+++.
T Consensus       225 ~~-~~~--~----~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~  265 (331)
T cd05597         225 EH-FQF--P----PDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKD  265 (331)
T ss_pred             Cc-ccC--C----CccCCCCHHHHHHHHHHccCcccccCCCCHHHHhc
Confidence            00 000  0    011124557888999988654433  678877764

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=2e-40  Score=314.57  Aligned_cols=253  Identities=27%  Similarity=0.398  Sum_probs=201.9

Q ss_pred             CceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCC-ccHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeEEEEEec
Q 046893           98 YILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGY-QGDREWLAEVNYLGQLRHSNLVKLIGYCCEDEHRILVYEY  176 (464)
Q Consensus        98 ~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~  176 (464)
                      +.||+|+||.||+|.+....   .....||+|.+..... ...+.+..|+.++++++||||+++++++.. ...++||||
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~---~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~   76 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSG---GKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTEL   76 (257)
T ss_pred             CcCCccCcccEEeeeEecCC---CCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEe
Confidence            35899999999999986531   1234689999987655 445778999999999999999999999988 889999999


Q ss_pred             cCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCccCCCCCCCc-
Q 046893          177 MESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQT-  255 (464)
Q Consensus       177 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~~-  255 (464)
                      +++++|.+++.......+++..++.++.|++.||.|||  +++++|+||||+||+++.++.+||+|||+++........ 
T Consensus        77 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH--~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~  154 (257)
T cd05040          77 APLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLE--SKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHY  154 (257)
T ss_pred             cCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHH--hCCccccccCcccEEEecCCEEEeccccccccccccccce
Confidence            99999999987754346899999999999999999999  678999999999999999999999999999865432211 


Q ss_pred             ceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHhhhcccchhhccCccc
Q 046893          256 HVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLL-GRRAVDKSRPSREHNLVEWARPLLNNNKKVLRILDPRL  334 (464)
Q Consensus       256 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  334 (464)
                      .......++..|+|||++.+..++.++|||||||++|+|++ |..||.......   ...   ......          .
T Consensus       155 ~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---~~~---~~~~~~----------~  218 (257)
T cd05040         155 VMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQ---ILK---KIDKEG----------E  218 (257)
T ss_pred             ecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHH---HHH---HHHhcC----------C
Confidence            11223457888999999998899999999999999999998 999996543211   111   111000          0


Q ss_pred             cCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 046893          335 EGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLE  372 (464)
Q Consensus       335 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~  372 (464)
                      ....+...+..+.+++.+||..+|.+||++.++++.|.
T Consensus       219 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  256 (257)
T cd05040         219 RLERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP  256 (257)
T ss_pred             cCCCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence            00112234568999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=3e-40  Score=313.31  Aligned_cols=253  Identities=32%  Similarity=0.484  Sum_probs=204.5

Q ss_pred             CceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCcc-HHHHHHHHHHHhcCCCCCcceEEEEEEeCCeEEEEEec
Q 046893           98 YILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQG-DREWLAEVNYLGQLRHSNLVKLIGYCCEDEHRILVYEY  176 (464)
Q Consensus        98 ~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~  176 (464)
                      +.||+|+||.||+|.+....   ..+..|++|.+....... ...+..|+.++..++|+||+++++++......++||||
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~---~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   77 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKD---GKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEY   77 (262)
T ss_pred             CccccCCceEEEEEEEecCC---CCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEe
Confidence            36999999999999987531   125569999987654433 56788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHhhc-------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCccCC
Q 046893          177 MESGSLEKHLLRRV-------GCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDG  249 (464)
Q Consensus       177 ~~~g~L~~~l~~~~-------~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~  249 (464)
                      +++++|.+++....       ...+++..++.++.|++.||.|||  +++|+|+||||+||+++.++.+||+|||++...
T Consensus        78 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH--~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~  155 (262)
T cd00192          78 MEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLA--SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDV  155 (262)
T ss_pred             ccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHH--cCCcccCccCcceEEECCCCcEEEccccccccc
Confidence            99999999987642       357899999999999999999999  677999999999999999999999999999875


Q ss_pred             CCCCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHhhhcccchhh
Q 046893          250 PMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLL-GRRAVDKSRPSREHNLVEWARPLLNNNKKVLR  328 (464)
Q Consensus       250 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  328 (464)
                      .............++..|+|||.+.+..++.++||||||+++|+|++ |..||......      +.......       
T Consensus       156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~------~~~~~~~~-------  222 (262)
T cd00192         156 YDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNE------EVLEYLRK-------  222 (262)
T ss_pred             ccccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHH------HHHHHHHc-------
Confidence            44332223334568889999999988899999999999999999999 69999765321      11111111       


Q ss_pred             ccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 046893          329 ILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLE  372 (464)
Q Consensus       329 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~  372 (464)
                          ......+..++.++.+++.+||..+|.+||++.++++.|+
T Consensus       223 ----~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~  262 (262)
T cd00192         223 ----GYRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE  262 (262)
T ss_pred             ----CCCCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence                1111223344668999999999999999999999998773

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=1.3e-40  Score=331.55  Aligned_cols=265  Identities=23%  Similarity=0.302  Sum_probs=197.5

Q ss_pred             HHhcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCC--ccHHHHHHHHHHHhcCCCCCcceEEEEEEe
Q 046893           89 LATKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGY--QGDREWLAEVNYLGQLRHSNLVKLIGYCCE  166 (464)
Q Consensus        89 ~~~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~l~~~~~~  166 (464)
                      ...++|++.+.||+|+||.||+|.+...      +..||||.+.....  .....+.+|+.+++.++||||+++++++..
T Consensus        14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~------~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~   87 (355)
T cd07874          14 TVLKRYQNLKPIGSGAQGIVCAAYDAVL------DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTP   87 (355)
T ss_pred             hhhhceeEEEEeeecCCEEEEEEEecCC------CceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeec
Confidence            3557899999999999999999987654      56799999875432  223567889999999999999999998865


Q ss_pred             C------CeEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEE
Q 046893          167 D------EHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKL  240 (464)
Q Consensus       167 ~------~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl  240 (464)
                      .      ...++||||+++ +|.+.+..    .+++..+..++.|++.||.|||  .++|+||||||+|||++.++.+||
T Consensus        88 ~~~~~~~~~~~lv~e~~~~-~l~~~~~~----~l~~~~~~~~~~qi~~aL~~LH--~~givHrDikp~Nill~~~~~~kl  160 (355)
T cd07874          88 QKSLEEFQDVYLVMELMDA-NLCQVIQM----ELDHERMSYLLYQMLCGIKHLH--SAGIIHRDLKPSNIVVKSDCTLKI  160 (355)
T ss_pred             cccccccceeEEEhhhhcc-cHHHHHhh----cCCHHHHHHHHHHHHHHHHHHH--hCCcccCCCChHHEEECCCCCEEE
Confidence            4      357999999965 67666643    4789999999999999999999  677999999999999999999999


Q ss_pred             cccCCccCCCCCCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccH-HH-----
Q 046893          241 SDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNL-VE-----  314 (464)
Q Consensus       241 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~-~~-----  314 (464)
                      +|||+++.....   .......||..|+|||++.+..++.++|||||||++|+|++|+.||.+......... ..     
T Consensus       161 ~Dfg~~~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~  237 (355)
T cd07874         161 LDFGLARTAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTP  237 (355)
T ss_pred             eeCcccccCCCc---cccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence            999999853221   122346799999999999999999999999999999999999999976542211100 00     


Q ss_pred             ---H-------HHHhhhcccchhhccCcc-----c---cCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 046893          315 ---W-------ARPLLNNNKKVLRILDPR-----L---EGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVA  369 (464)
Q Consensus       315 ---~-------~~~~~~~~~~~~~~~~~~-----~---~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  369 (464)
                         +       ................+.     .   ...........+.+|+.+||..||.+|||+.++++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~  310 (355)
T cd07874         238 CPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQ  310 (355)
T ss_pred             CHHHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhc
Confidence               0       000000000000000000     0   00111223457899999999999999999999985

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=1.5e-41  Score=304.36  Aligned_cols=255  Identities=25%  Similarity=0.346  Sum_probs=204.4

Q ss_pred             HHHhcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCC----ccH----HHHHHHHHHHhcC-CCCCcc
Q 046893           88 KLATKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGY----QGD----REWLAEVNYLGQL-RHSNLV  158 (464)
Q Consensus        88 ~~~~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~----~~~----~~~~~E~~~l~~l-~hpniv  158 (464)
                      +-.-..|...+.||.|..++|.++....+      +..+|+|++.....    +..    +.-..|+.||+++ -||+|+
T Consensus        13 ~~fy~~y~pkeilgrgvss~vrRci~k~t------~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II   86 (411)
T KOG0599|consen   13 KGFYAKYEPKEILGRGVSSVVRRCIHKET------GKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYII   86 (411)
T ss_pred             hhHHhhcChHHHhcccchhhhhhhhhccc------ccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEE
Confidence            34445677888999999999999887775      55588888764321    112    2346799999998 599999


Q ss_pred             eEEEEEEeCCeEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCce
Q 046893          159 KLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSA  238 (464)
Q Consensus       159 ~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~v  238 (464)
                      ++.++|+.+...++|+|+|+.|.|.|+|....  .+++.+...|+.|++.|+.|||  .++||||||||+|||++++.++
T Consensus        87 ~l~D~yes~sF~FlVFdl~prGELFDyLts~V--tlSEK~tR~iMrqlfegVeylH--a~~IVHRDLKpENILlddn~~i  162 (411)
T KOG0599|consen   87 DLQDVYESDAFVFLVFDLMPRGELFDYLTSKV--TLSEKETRRIMRQLFEGVEYLH--ARNIVHRDLKPENILLDDNMNI  162 (411)
T ss_pred             EeeeeccCcchhhhhhhhcccchHHHHhhhhe--eecHHHHHHHHHHHHHHHHHHH--HhhhhhcccChhheeeccccce
Confidence            99999999999999999999999999998876  7999999999999999999999  6779999999999999999999


Q ss_pred             EEcccCCccCCCCCCCcceeeccccCCcccCccccc------cCCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccH
Q 046893          239 KLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVM------TGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNL  312 (464)
Q Consensus       239 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~  312 (464)
                      ||+|||+|+....+..   ....|||++|+|||.+.      ...|+..+|+|++|||+|-||.|.+||.....      
T Consensus       163 ~isDFGFa~~l~~Gek---LrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQ------  233 (411)
T KOG0599|consen  163 KISDFGFACQLEPGEK---LRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQ------  233 (411)
T ss_pred             EEeccceeeccCCchh---HHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHH------
Confidence            9999999998765543   34589999999999885      24688899999999999999999999964210      


Q ss_pred             HHHHHHhhhcccchhhccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 046893          313 VEWARPLLNNNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVA  369 (464)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  369 (464)
                       -....++.++       .-.+......+.+....+||.+||+.||.+|.|++++++
T Consensus       234 -mlMLR~ImeG-------kyqF~speWadis~~~KdLIsrlLqVdp~~Ritake~La  282 (411)
T KOG0599|consen  234 -MLMLRMIMEG-------KYQFRSPEWADISATVKDLISRLLQVDPTKRITAKEALA  282 (411)
T ss_pred             -HHHHHHHHhc-------ccccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhc
Confidence             0111111111       111222333455668899999999999999999999985

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=3.6e-40  Score=315.32  Aligned_cols=255  Identities=27%  Similarity=0.400  Sum_probs=192.4

Q ss_pred             ceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCC-ccHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeEEEEEecc
Q 046893           99 ILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGY-QGDREWLAEVNYLGQLRHSNLVKLIGYCCEDEHRILVYEYM  177 (464)
Q Consensus        99 ~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~  177 (464)
                      .||+|+||.||+|.+...    .....+|+|.+..... .....+.+|+.+++.++||||+++++++.+....++||||+
T Consensus         2 ~lg~G~~g~Vy~~~~~~~----~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   77 (269)
T cd05087           2 EIGNGWFGKVILGEVNSG----YTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFC   77 (269)
T ss_pred             cccccCCceEEEEEEcCC----CCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECC
Confidence            589999999999986542    1245689998865432 23356888999999999999999999999999999999999


Q ss_pred             CCCCHHHHHHhhcC---CCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCccCCCCCCC
Q 046893          178 ESGSLEKHLLRRVG---CMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQ  254 (464)
Q Consensus       178 ~~g~L~~~l~~~~~---~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~  254 (464)
                      ++|+|.+++.....   ..+++..+..++.|++.||.|||  .++++||||||+||+++.++.+||+|||+++.......
T Consensus        78 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH--~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~  155 (269)
T cd05087          78 PLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLH--KNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDY  155 (269)
T ss_pred             CCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHH--HCCEeccccCcceEEEcCCCcEEECCccccccccCcce
Confidence            99999999865321   24567788899999999999999  67799999999999999999999999999975433222


Q ss_pred             cceeeccccCCcccCccccccC-------CCCcccchhcHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHhhhcccch
Q 046893          255 THVSTRVMGTYGYAAPEYVMTG-------HLTARSDVYGFGVVLLEMLL-GRRAVDKSRPSREHNLVEWARPLLNNNKKV  326 (464)
Q Consensus       255 ~~~~~~~~gt~~y~aPE~~~~~-------~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  326 (464)
                      ........|+..|+|||++.+.       .++.++||||||+++|||++ |..||........   ...   ...  ...
T Consensus       156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~---~~~---~~~--~~~  227 (269)
T cd05087         156 YVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQV---LTY---TVR--EQQ  227 (269)
T ss_pred             eecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHH---HHH---Hhh--ccc
Confidence            2222335678899999988642       35789999999999999996 9999975432211   110   000  111


Q ss_pred             hhccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 046893          327 LRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLE  372 (464)
Q Consensus       327 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~  372 (464)
                      .....+.+.    ...+..+.+++..|| .+|.+||++.+|+..|+
T Consensus       228 ~~~~~~~~~----~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~  268 (269)
T cd05087         228 LKLPKPRLK----LPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS  268 (269)
T ss_pred             CCCCCCccC----CCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence            111122221    123446888999999 68999999999998774

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=2.5e-40  Score=316.23  Aligned_cols=255  Identities=25%  Similarity=0.376  Sum_probs=190.9

Q ss_pred             ceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCC-ccHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeEEEEEecc
Q 046893           99 ILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGY-QGDREWLAEVNYLGQLRHSNLVKLIGYCCEDEHRILVYEYM  177 (464)
Q Consensus        99 ~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~  177 (464)
                      .||+|+||.||+|.....    .....+|+|.+..... .....+.+|+.+++.++||||+++++++......++||||+
T Consensus         2 ~lg~G~fg~v~~~~~~~~----~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~   77 (269)
T cd05042           2 EIGNGWFGKVLLGEAHRG----MSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFC   77 (269)
T ss_pred             cCCccCCceEEEEEEecC----CCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeC
Confidence            589999999999976443    1245689998764432 22356889999999999999999999999999999999999


Q ss_pred             CCCCHHHHHHhhcC---CCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCccCCCCCCC
Q 046893          178 ESGSLEKHLLRRVG---CMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQ  254 (464)
Q Consensus       178 ~~g~L~~~l~~~~~---~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~  254 (464)
                      .+|+|.+++.....   ..+.+..+..++.|++.||+|||  +++|+||||||+|||++.++.+||+|||++........
T Consensus        78 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH--~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~  155 (269)
T cd05042          78 PLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLH--QADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDY  155 (269)
T ss_pred             CCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHH--hcCEecccccHhheEecCCCcEEEeccccccccccchh
Confidence            99999999876432   23567888999999999999999  67799999999999999999999999999875332222


Q ss_pred             cceeeccccCCcccCcccccc-------CCCCcccchhcHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHhhhcccch
Q 046893          255 THVSTRVMGTYGYAAPEYVMT-------GHLTARSDVYGFGVVLLEMLL-GRRAVDKSRPSREHNLVEWARPLLNNNKKV  326 (464)
Q Consensus       255 ~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  326 (464)
                      ........++..|+|||++..       ..++.++|||||||++|||++ |..||.......      .........  .
T Consensus       156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~------~~~~~~~~~--~  227 (269)
T cd05042         156 YITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQ------VLKQVVREQ--D  227 (269)
T ss_pred             eeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHH------HHHHHhhcc--C
Confidence            212223456778999998743       356789999999999999999 788886543211      011111110  0


Q ss_pred             hhccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 046893          327 LRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLE  372 (464)
Q Consensus       327 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~  372 (464)
                      .....+    ......+..+..++..|| .||++||++++|++.|.
T Consensus       228 ~~~~~~----~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~  268 (269)
T cd05042         228 IKLPKP----QLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT  268 (269)
T ss_pred             ccCCCC----cccccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence            111112    222334457788999998 59999999999998873

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=3.5e-40  Score=321.91  Aligned_cols=262  Identities=24%  Similarity=0.338  Sum_probs=201.1

Q ss_pred             CCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCc-cHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeEE
Q 046893           93 FFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQ-GDREWLAEVNYLGQLRHSNLVKLIGYCCEDEHRI  171 (464)
Q Consensus        93 ~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~  171 (464)
                      +|++.+.||+|+||.||+|.+..+      +..+|+|.+...... ....+.+|++++.+++||||+++++++..++..+
T Consensus         2 ~~~~~~~lg~G~~g~v~~~~~~~~------~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   75 (308)
T cd06615           2 DFEKLGELGAGNGGVVTKVLHRPS------GLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEIS   75 (308)
T ss_pred             CceEEeeccCCCCeEEEEEEEcCC------CeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEE
Confidence            588899999999999999987765      567899988654222 2356889999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCccCCCC
Q 046893          172 LVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPM  251 (464)
Q Consensus       172 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~  251 (464)
                      +||||+++++|.+++...  ..+++..+..++.|++.||.|||+ ..+++|+||||+|||++.++.+||+|||++.....
T Consensus        76 lv~ey~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~-~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~  152 (308)
T cd06615          76 ICMEHMDGGSLDQVLKKA--GRIPENILGKISIAVLRGLTYLRE-KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID  152 (308)
T ss_pred             EEeeccCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHh-hCCEEECCCChHHEEEecCCcEEEccCCCcccccc
Confidence            999999999999998764  368999999999999999999994 24799999999999999999999999999875322


Q ss_pred             CCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhcccc------
Q 046893          252 GDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKK------  325 (464)
Q Consensus       252 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~------  325 (464)
                      .    ......|+..|+|||++.+..++.++||||||+++|+|++|+.||.......   ...+..........      
T Consensus       153 ~----~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~  225 (308)
T cd06615         153 S----MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKE---LEAMFGRPVSEGEAKESHRP  225 (308)
T ss_pred             c----ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhh---HHHhhcCccccccccCCccc
Confidence            1    1234678999999999988889999999999999999999999996543211   11111000000000      


Q ss_pred             -------------hhhccCc---cccCcc-CHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 046893          326 -------------VLRILDP---RLEGQY-TARTAMKVAGLAYQCLSQNPKGRPVMSDVVAL  370 (464)
Q Consensus       326 -------------~~~~~~~---~~~~~~-~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  370 (464)
                                   ..+..+.   ...... ....+.++.+|+.+||..||++||++.+++..
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~  287 (308)
T cd06615         226 VSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKH  287 (308)
T ss_pred             ccCCCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                         0000000   000000 01134578999999999999999999998864

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=2.7e-40  Score=352.00  Aligned_cols=263  Identities=21%  Similarity=0.306  Sum_probs=204.6

Q ss_pred             cCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCc---cHHHHHHHHHHHhcCCCCCcceEEEEEEeCC
Q 046893           92 KFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQ---GDREWLAEVNYLGQLRHSNLVKLIGYCCEDE  168 (464)
Q Consensus        92 ~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~  168 (464)
                      ++|++.++||+|+||.||+|.+..+      ++.||+|++......   ...++.+|++++..++||||+++++++.+.+
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d~~t------g~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~   75 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYDPVC------SRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGD   75 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEECCC------CcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCC
Confidence            4689999999999999999998765      567999998754222   2356889999999999999999999999999


Q ss_pred             eEEEEEeccCCCCHHHHHHhhc---------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceE
Q 046893          169 HRILVYEYMESGSLEKHLLRRV---------GCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAK  239 (464)
Q Consensus       169 ~~~lv~e~~~~g~L~~~l~~~~---------~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vk  239 (464)
                      ..++||||++|++|.+++....         ...+++..++.++.|++.||.|||  +++|+||||||+|||++.++.+|
T Consensus        76 ~lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLH--s~GIIHRDLKPeNILLd~dg~vK  153 (932)
T PRK13184         76 PVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVH--SKGVLHRDLKPDNILLGLFGEVV  153 (932)
T ss_pred             EEEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHH--HCCccccCCchheEEEcCCCCEE
Confidence            9999999999999999886421         124567788999999999999999  67799999999999999999999


Q ss_pred             EcccCCccCCCCCCC----------------cceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHhCCCCCCC
Q 046893          240 LSDFGLAKDGPMGDQ----------------THVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDK  303 (464)
Q Consensus       240 l~DFGla~~~~~~~~----------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~  303 (464)
                      |+|||+++.......                .......+||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus       154 LiDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~  233 (932)
T PRK13184        154 ILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRR  233 (932)
T ss_pred             EEecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCC
Confidence            999999986421100                0111235799999999999999999999999999999999999999975


Q ss_pred             CCCcccccHHHHHHHhhhcccchhhccCccccCccCHHHHHHHHHHHHHhhccCCCCCC-CHHHHHHHHHHHHhc
Q 046893          304 SRPSREHNLVEWARPLLNNNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRP-VMSDVVALLETVQSQ  377 (464)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-s~~ev~~~L~~~~~~  377 (464)
                      ......   . . ...         ...+... ......+..+.+++.+||..||++|| ++.++++.|+.....
T Consensus       234 ~~~~ki---~-~-~~~---------i~~P~~~-~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq~  293 (932)
T PRK13184        234 KKGRKI---S-Y-RDV---------ILSPIEV-APYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQG  293 (932)
T ss_pred             cchhhh---h-h-hhh---------ccChhhc-cccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhc
Confidence            322110   0 0 000         0011000 00123445788999999999999995 667788888876554

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=3e-40  Score=318.05  Aligned_cols=250  Identities=24%  Similarity=0.376  Sum_probs=198.6

Q ss_pred             CCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCccHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeEEEE
Q 046893           94 FRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVKLIGYCCEDEHRILV  173 (464)
Q Consensus        94 ~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv  173 (464)
                      |++.+.||.|+||.||+|.+..+      +..+++|.+..........+.+|+++++.++||||+++++++...+..++|
T Consensus         7 ~~i~~~lg~g~~g~v~~~~~~~~------~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v   80 (282)
T cd06643           7 WEIIGELGDGAFGKVYKAQNKET------GVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWIL   80 (282)
T ss_pred             HHHHhhcccCCCeEEEEEEECCC------CeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEE
Confidence            67778899999999999998765      567899998665444456788999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCccCCCCCC
Q 046893          174 YEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGD  253 (464)
Q Consensus       174 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~  253 (464)
                      |||+.+++|..++... ...+++..+..++.|++.||.|||  +.+++||||||+|||++.++.+||+|||++...... 
T Consensus        81 ~e~~~~~~l~~~~~~~-~~~l~~~~~~~~~~qi~~~L~~LH--~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~-  156 (282)
T cd06643          81 IEFCAGGAVDAVMLEL-ERPLTEPQIRVVCKQTLEALNYLH--ENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT-  156 (282)
T ss_pred             EEecCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHH--HCCeeecCCCcccEEEccCCCEEEcccccccccccc-
Confidence            9999999998877643 346899999999999999999999  577999999999999999999999999998753221 


Q ss_pred             CcceeeccccCCcccCccccc-----cCCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhcccchhh
Q 046893          254 QTHVSTRVMGTYGYAAPEYVM-----TGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLR  328 (464)
Q Consensus       254 ~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  328 (464)
                       ........|+..|+|||++.     +..++.++|||||||++|+|++|+.||.......      .........     
T Consensus       157 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~------~~~~~~~~~-----  224 (282)
T cd06643         157 -IQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMR------VLLKIAKSE-----  224 (282)
T ss_pred             -ccccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHH------HHHHHhhcC-----
Confidence             12223457899999999874     4557889999999999999999999997543211      111111000     


Q ss_pred             ccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 046893          329 ILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVA  369 (464)
Q Consensus       329 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  369 (464)
                        .+.  ...+..++..+.+||.+||+.||.+||++.+++.
T Consensus       225 --~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  261 (282)
T cd06643         225 --PPT--LAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQ  261 (282)
T ss_pred             --CCC--CCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence              000  0112234568899999999999999999998864

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=2.7e-40  Score=321.89  Aligned_cols=265  Identities=23%  Similarity=0.358  Sum_probs=204.9

Q ss_pred             hcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCcc-HHHHHHHHHHHhcCCCCCcceEEEEEEeCCe
Q 046893           91 TKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQG-DREWLAEVNYLGQLRHSNLVKLIGYCCEDEH  169 (464)
Q Consensus        91 ~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~  169 (464)
                      ..+|+..+.||+|+||.||+|.+..+...  ....+|+|.+....... ..++.+|+.+++.++||||+++++++... .
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~   82 (303)
T cd05110           6 ETELKRVKVLGSGAFGTVYKGIWVPEGET--VKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-T   82 (303)
T ss_pred             hhhceeccccccCCCccEEEEEEecCCCc--ceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-C
Confidence            35678888999999999999987654221  12458999887543322 34688999999999999999999988754 4


Q ss_pred             EEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCccCC
Q 046893          170 RILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDG  249 (464)
Q Consensus       170 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~  249 (464)
                      .++++||+++|+|.+++.... ..+++..++.++.|++.||.|||  .++|+||||||+|||++.++.+||+|||+++..
T Consensus        83 ~~~v~e~~~~g~l~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH--~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~  159 (303)
T cd05110          83 IQLVTQLMPHGCLLDYVHEHK-DNIGSQLLLNWCVQIAKGMMYLE--ERRLVHRDLAARNVLVKSPNHVKITDFGLARLL  159 (303)
T ss_pred             ceeeehhcCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHh--hcCeeccccccceeeecCCCceEEccccccccc
Confidence            679999999999999887643 35899999999999999999999  677999999999999999999999999999865


Q ss_pred             CCCCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHhhhcccchhh
Q 046893          250 PMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLL-GRRAVDKSRPSREHNLVEWARPLLNNNKKVLR  328 (464)
Q Consensus       250 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  328 (464)
                      .............++..|+|||++.+..++.++||||||+++|||++ |..||.+....   ....+    +......  
T Consensus       160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~---~~~~~----~~~~~~~--  230 (303)
T cd05110         160 EGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTR---EIPDL----LEKGERL--  230 (303)
T ss_pred             cCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHH---HHHHH----HHCCCCC--
Confidence            33222212222446778999999998999999999999999999997 89999754311   11111    1111110  


Q ss_pred             ccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhcC
Q 046893          329 ILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETVQSQG  378 (464)
Q Consensus       329 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~~~~~  378 (464)
                              ..+..++..+.+++..||..+|++||++.++++.|+.+....
T Consensus       231 --------~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~~  272 (303)
T cd05110         231 --------PQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARDP  272 (303)
T ss_pred             --------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhch
Confidence                    111223457899999999999999999999999999876543

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=1.1e-40  Score=316.42  Aligned_cols=253  Identities=29%  Similarity=0.490  Sum_probs=199.7

Q ss_pred             CCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCccHH--HHHHHHHHHhcCCCCCcceEEEEEEeCCeEE
Q 046893           94 FRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDR--EWLAEVNYLGQLRHSNLVKLIGYCCEDEHRI  171 (464)
Q Consensus        94 ~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~--~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~  171 (464)
                      |++.+.||+|+||+||++.+..+      ++.+|+|++.........  ....|+.++++++||||+++++++......+
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~------~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~   74 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKN------GQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLY   74 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTT------TEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCC------CeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccc
Confidence            56778999999999999998875      667999999876433332  2356999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCccCCCC
Q 046893          172 LVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPM  251 (464)
Q Consensus       172 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~  251 (464)
                      +||||+.+++|.+++...  ..+++..++.++.|++.||.+||  ..+|+|+||||+||+++.++.++|+|||++...  
T Consensus        75 ~v~~~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~L~~Lh--~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~--  148 (260)
T PF00069_consen   75 IVMEYCPGGSLQDYLQKN--KPLSEEEILKIAYQILEALAYLH--SKGIVHRDIKPENILLDENGEVKLIDFGSSVKL--  148 (260)
T ss_dssp             EEEEEETTEBHHHHHHHH--SSBBHHHHHHHHHHHHHHHHHHH--HTTEEESSBSGGGEEESTTSEEEESSGTTTEES--
T ss_pred             cccccccccccccccccc--ccccccccccccccccccccccc--ccccccccccccccccccccccccccccccccc--
Confidence            999999999999998743  36899999999999999999999  567999999999999999999999999999753  


Q ss_pred             CCCcceeeccccCCcccCccccc-cCCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhcccchhhcc
Q 046893          252 GDQTHVSTRVMGTYGYAAPEYVM-TGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRIL  330 (464)
Q Consensus       252 ~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  330 (464)
                      ...........++..|+|||++. +..++.++||||||+++|+|++|..||.............   ......  .    
T Consensus       149 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~---~~~~~~--~----  219 (260)
T PF00069_consen  149 SENNENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIE---KILKRP--L----  219 (260)
T ss_dssp             TSTTSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHH---HHHHTH--H----
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhh---hccccc--c----
Confidence            12222334567899999999998 8889999999999999999999999998652111111111   000000  0    


Q ss_pred             CccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 046893          331 DPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVA  369 (464)
Q Consensus       331 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  369 (464)
                      ....  .........+.+++.+||+.||.+||++.++++
T Consensus       220 ~~~~--~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~  256 (260)
T PF00069_consen  220 PSSS--QQSREKSEELRDLIKKMLSKDPEQRPSAEELLK  256 (260)
T ss_dssp             HHHT--TSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred             cccc--cccchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            0000  000001258999999999999999999999874

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=3.3e-40  Score=320.39  Aligned_cols=251  Identities=24%  Similarity=0.343  Sum_probs=204.3

Q ss_pred             hcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCccHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeE
Q 046893           91 TKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVKLIGYCCEDEHR  170 (464)
Q Consensus        91 ~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~  170 (464)
                      .++|.+.+.||+|+||.||+|.+..+      +..||+|.+..........+..|+.+++.++|+||+++++++...+..
T Consensus        18 ~~~y~~~~~lg~g~~g~v~~~~~~~~------~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~   91 (297)
T cd06656          18 KKKYTRFEKIGQGASGTVYTAIDIAT------GQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDEL   91 (297)
T ss_pred             hhhceeeeeeccCCCeEEEEEEECCC------CCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEE
Confidence            36789999999999999999997654      567999998765555557788999999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCccCCC
Q 046893          171 ILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGP  250 (464)
Q Consensus       171 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~  250 (464)
                      ++||||+++++|.+++.+.   .+++..+..++.|++.||.|||  +.+|+||||||+|||++.++.++|+|||++....
T Consensus        92 ~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~l~~~L~~LH--~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~  166 (297)
T cd06656          92 WVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALDFLH--SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQIT  166 (297)
T ss_pred             EEeecccCCCCHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHH--HCCcccCCCCHHHEEECCCCCEEECcCccceEcc
Confidence            9999999999999988653   4899999999999999999999  5679999999999999999999999999987543


Q ss_pred             CCCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhcccchhhcc
Q 046893          251 MGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRIL  330 (464)
Q Consensus       251 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  330 (464)
                      ...  .......|+..|+|||.+.+..++.++|||||||++|+|++|..||....+......      ...         
T Consensus       167 ~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~------~~~---------  229 (297)
T cd06656         167 PEQ--SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL------IAT---------  229 (297)
T ss_pred             CCc--cCcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheee------ecc---------
Confidence            221  112235789999999999988899999999999999999999999976443211100      000         


Q ss_pred             CccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 046893          331 DPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVA  369 (464)
Q Consensus       331 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  369 (464)
                      ........+...+..+.+|+.+||..+|.+||++.+++.
T Consensus       230 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  268 (297)
T cd06656         230 NGTPELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQ  268 (297)
T ss_pred             CCCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            000001122334557889999999999999999999986

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=2.3e-40  Score=353.80  Aligned_cols=256  Identities=22%  Similarity=0.367  Sum_probs=199.3

Q ss_pred             HHHhcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCc--cHHHHHHHHHHHhcCCCCCcceEEEEEE
Q 046893           88 KLATKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQ--GDREWLAEVNYLGQLRHSNLVKLIGYCC  165 (464)
Q Consensus        88 ~~~~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpniv~l~~~~~  165 (464)
                      .....+|.+.+.||+|+||+||+|.+...      +..+|+|++......  ....|..|+.+|..|+|||||+++++|.
T Consensus         9 e~~l~~YeIl~kLG~GgFGtVYLAkdk~t------g~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~   82 (1021)
T PTZ00266          9 ESRLNEYEVIKKIGNGRFGEVFLVKHKRT------QEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFL   82 (1021)
T ss_pred             ccccCCEEEEEEEecCCCeEEEEEEECCC------CeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEE
Confidence            44556799999999999999999998764      667999998754322  2356889999999999999999999886


Q ss_pred             eC--CeEEEEEeccCCCCHHHHHHhhc--CCCCCHHHHHHHHHHHHHHHHHHhcCC-----CCeeeccCCCCceEecC--
Q 046893          166 ED--EHRILVYEYMESGSLEKHLLRRV--GCMLTWSRRMKIALDAAKGLAFLHGAE-----RPVIYRDFKTSNILLNA--  234 (464)
Q Consensus       166 ~~--~~~~lv~e~~~~g~L~~~l~~~~--~~~l~~~~~~~i~~qi~~~l~~LH~~~-----~~ivHrDlkp~Nill~~--  234 (464)
                      ..  ..+||||||+.+|+|.++|....  ...+++..++.|+.||+.||.|||...     .+||||||||+||||+.  
T Consensus        83 de~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~  162 (1021)
T PTZ00266         83 NKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGI  162 (1021)
T ss_pred             ecCCCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCc
Confidence            54  57899999999999999886532  246999999999999999999999533     56999999999999954  


Q ss_pred             ---------------CCceEEcccCCccCCCCCCCcceeeccccCCcccCcccccc--CCCCcccchhcHHHHHHHHHhC
Q 046893          235 ---------------DFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMT--GHLTARSDVYGFGVVLLEMLLG  297 (464)
Q Consensus       235 ---------------~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~ell~g  297 (464)
                                     .+.+||+|||++.......   ......||+.|+|||++.+  ..++.++||||||||||||++|
T Consensus       163 ~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s---~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTG  239 (1021)
T PTZ00266        163 RHIGKITAQANNLNGRPIAKIGDFGLSKNIGIES---MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSG  239 (1021)
T ss_pred             cccccccccccccCCCCceEEccCCccccccccc---cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHC
Confidence                           2358999999998643221   2234679999999999864  4588999999999999999999


Q ss_pred             CCCCCCCCCcccccHHHHHHHhhhcccchhhccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 046893          298 RRAVDKSRPSREHNLVEWARPLLNNNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVA  369 (464)
Q Consensus       298 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  369 (464)
                      ..||.....     ...+... +...        +.+.   ....+..+.+||..||..+|.+||++.+++.
T Consensus       240 k~PF~~~~~-----~~qli~~-lk~~--------p~lp---i~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~  294 (1021)
T PTZ00266        240 KTPFHKANN-----FSQLISE-LKRG--------PDLP---IKGKSKELNILIKNLLNLSAKERPSALQCLG  294 (1021)
T ss_pred             CCCCCcCCc-----HHHHHHH-HhcC--------CCCC---cCCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence            999975432     1111111 1110        0000   0122457899999999999999999999984

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=3.5e-40  Score=317.98  Aligned_cols=269  Identities=26%  Similarity=0.368  Sum_probs=204.4

Q ss_pred             hcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCC-ccHHHHHHHHHHHhcCCCCCcceEEEEEEeC--
Q 046893           91 TKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGY-QGDREWLAEVNYLGQLRHSNLVKLIGYCCED--  167 (464)
Q Consensus        91 ~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~--  167 (464)
                      .+.|.+.+.||+|+||.||+|.+....  ...+..||+|.+..... .....+.+|+.+++.+.||||+++++++...  
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~--~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   80 (284)
T cd05079           3 KRFLKRIRDLGEGHFGKVELCRYDPEG--DNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGG   80 (284)
T ss_pred             hhhhhhceecCCCCceeEEEEEEccCC--CCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCC
Confidence            356788999999999999999864321  12366799999875432 2336788999999999999999999998875  


Q ss_pred             CeEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCcc
Q 046893          168 EHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAK  247 (464)
Q Consensus       168 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~  247 (464)
                      ...++||||+++++|.+++.+.. ..+++..++.++.|++.||.|||  +++|+||||||+||+++.++.++|+|||+++
T Consensus        81 ~~~~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~i~~~i~~aL~~lH--~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~  157 (284)
T cd05079          81 NGIKLIMEFLPSGSLKEYLPRNK-NKINLKQQLKYAVQICKGMDYLG--SRQYVHRDLAARNVLVESEHQVKIGDFGLTK  157 (284)
T ss_pred             CceEEEEEccCCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHH--HCCeeecccchheEEEcCCCCEEECCCcccc
Confidence            57899999999999999886543 35899999999999999999999  6789999999999999999999999999998


Q ss_pred             CCCCCCCc-ceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHhCCCCCCCCCCc--------ccccHHHHHHH
Q 046893          248 DGPMGDQT-HVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPS--------REHNLVEWARP  318 (464)
Q Consensus       248 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~--------~~~~~~~~~~~  318 (464)
                      ........ .......|+..|+|||++.+..++.++||||||+++|||++++.|+......        ...........
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (284)
T cd05079         158 AIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVR  237 (284)
T ss_pred             ccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHH
Confidence            65332211 1222356778899999998888999999999999999999987765321100        00000000000


Q ss_pred             hhhcccchhhccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHH
Q 046893          319 LLNNNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETV  374 (464)
Q Consensus       319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~  374 (464)
                      .+...          .....+..++..+.+|+.+||+.+|.+||++.+++..|+.+
T Consensus       238 ~~~~~----------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~  283 (284)
T cd05079         238 VLEEG----------KRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI  283 (284)
T ss_pred             HHHcC----------ccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence            11110          01111223456899999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=3.6e-40  Score=320.01  Aligned_cols=250  Identities=23%  Similarity=0.360  Sum_probs=203.6

Q ss_pred             cCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCccHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeEE
Q 046893           92 KFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVKLIGYCCEDEHRI  171 (464)
Q Consensus        92 ~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~  171 (464)
                      ++|.+.+.||.|+||.||+|++..+      ++.|++|.+..........+.+|+.+++.++||||+++++++...+..+
T Consensus        19 ~~y~~~~~lg~g~~g~vy~~~~~~~------~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~   92 (296)
T cd06655          19 KKYTRYEKIGQGASGTVFTAIDVAT------GQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELF   92 (296)
T ss_pred             ceEEEEEEEecCCCeEEEEEEEcCC------CcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEE
Confidence            4588889999999999999987664      6679999987655555677889999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCccCCCC
Q 046893          172 LVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPM  251 (464)
Q Consensus       172 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~  251 (464)
                      +||||+.+++|..++...   .+++..+..++.|++.||.|||  +.+++||||||+||+++.++.+||+|||++.....
T Consensus        93 lv~e~~~~~~L~~~~~~~---~l~~~~~~~i~~~l~~al~~LH--~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~  167 (296)
T cd06655          93 VVMEYLAGGSLTDVVTET---CMDEAQIAAVCRECLQALEFLH--ANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITP  167 (296)
T ss_pred             EEEEecCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHH--HCCcccCCCCHHHEEECCCCCEEEccCccchhccc
Confidence            999999999999987643   4899999999999999999999  57799999999999999999999999999875432


Q ss_pred             CCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhcccchhhccC
Q 046893          252 GDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRILD  331 (464)
Q Consensus       252 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  331 (464)
                      ...  ......|+..|+|||.+.+..++.++|||||||++|+|++|+.||....+....      ........       
T Consensus       168 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~------~~~~~~~~-------  232 (296)
T cd06655         168 EQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL------YLIATNGT-------  232 (296)
T ss_pred             ccc--cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH------HHHHhcCC-------
Confidence            221  123357899999999998888999999999999999999999999765432111      00000000       


Q ss_pred             ccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 046893          332 PRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVA  369 (464)
Q Consensus       332 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  369 (464)
                      +.  ...+...+..+.++|.+||..||.+||++.+++.
T Consensus       233 ~~--~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~  268 (296)
T cd06655         233 PE--LQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQ  268 (296)
T ss_pred             cc--cCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence            00  0112234457889999999999999999999874

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.5e-41  Score=330.25  Aligned_cols=237  Identities=26%  Similarity=0.331  Sum_probs=184.3

Q ss_pred             eeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCc---cHHHHHHHHHHHhcC---CCCCcceEEEEEEeCCeEEEE
Q 046893          100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQ---GDREWLAEVNYLGQL---RHSNLVKLIGYCCEDEHRILV  173 (464)
Q Consensus       100 lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l---~hpniv~l~~~~~~~~~~~lv  173 (464)
                      ||+|+||+||+|.+..+      ++.||+|++......   ....+..|..++..+   .||||+++++++...+..|+|
T Consensus         1 lG~G~~g~Vy~~~~~~~------~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv   74 (330)
T cd05586           1 IGKGTFGQVYQVRKKDT------RRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLV   74 (330)
T ss_pred             CCCCCceEEEEEEECCC------CCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEE
Confidence            79999999999998765      667999998643221   123345666776655   699999999999999999999


Q ss_pred             EeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCccCCCCCC
Q 046893          174 YEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGD  253 (464)
Q Consensus       174 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~  253 (464)
                      |||+.+|+|.+++.+.  ..+++..+..++.||+.||.|||  .++|+||||||+|||++.++.+||+|||+++......
T Consensus        75 ~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~qil~al~~LH--~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~  150 (330)
T cd05586          75 TDYMSGGELFWHLQKE--GRFSEDRAKFYIAELVLALEHLH--KYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDN  150 (330)
T ss_pred             EcCCCCChHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH--HCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC
Confidence            9999999999888754  36899999999999999999999  6779999999999999999999999999997532222


Q ss_pred             CcceeeccccCCcccCccccccC-CCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhcccchhhccCc
Q 046893          254 QTHVSTRVMGTYGYAAPEYVMTG-HLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRILDP  332 (464)
Q Consensus       254 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  332 (464)
                        ......+||..|+|||++.+. .++.++|||||||+||+|++|..||......      +..........        
T Consensus       151 --~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~------~~~~~i~~~~~--------  214 (330)
T cd05586         151 --KTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQ------QMYRNIAFGKV--------  214 (330)
T ss_pred             --CCccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHH------HHHHHHHcCCC--------
Confidence              122346799999999998764 5899999999999999999999999764321      11111111110        


Q ss_pred             cccCccCHHHHHHHHHHHHHhhccCCCCCCCHH
Q 046893          333 RLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMS  365 (464)
Q Consensus       333 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~  365 (464)
                      .+.   ....+..+.+|+.+||..||.+||++.
T Consensus       215 ~~~---~~~~~~~~~~li~~~L~~~P~~R~~~~  244 (330)
T cd05586         215 RFP---KNVLSDEGRQFVKGLLNRNPQHRLGAH  244 (330)
T ss_pred             CCC---CccCCHHHHHHHHHHcCCCHHHCCCCC
Confidence            000   011344788999999999999999543

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=2.5e-40  Score=326.34  Aligned_cols=255  Identities=20%  Similarity=0.233  Sum_probs=195.9

Q ss_pred             cCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCC---ccHHHHHHHHHHHhcCCCCCcceEEEEEEeCC
Q 046893           92 KFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGY---QGDREWLAEVNYLGQLRHSNLVKLIGYCCEDE  168 (464)
Q Consensus        92 ~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~  168 (464)
                      ++|.+.+.||+|+||+||++.+..+      ++.+|+|++.....   .....+..|+.++..++|+||+++++++...+
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~~~------~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~   74 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLKNA------DKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDEN   74 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCC------CCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCC
Confidence            3688899999999999999998765      56799999864211   12244778999999999999999999999999


Q ss_pred             eEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCccC
Q 046893          169 HRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKD  248 (464)
Q Consensus       169 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~  248 (464)
                      ..++||||+.+|+|.+++.+. ...+++..+..++.|++.||.|||  +++|+||||||+|||++.++.+||+|||++..
T Consensus        75 ~~~lv~ey~~~g~L~~~l~~~-~~~l~~~~~~~~~~qi~~al~~lH--~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~  151 (332)
T cd05623          75 NLYLVMDYYVGGDLLTLLSKF-EDRLPEDMARFYLAEMVIAIDSVH--QLHYVHRDIKPDNILMDMNGHIRLADFGSCLK  151 (332)
T ss_pred             EEEEEEeccCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHH--HCCeEecCCCHHHEEECCCCCEEEeecchhee
Confidence            999999999999999998764 236899999999999999999999  67799999999999999999999999999875


Q ss_pred             CCCCCCcceeeccccCCcccCccccc-----cCCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhcc
Q 046893          249 GPMGDQTHVSTRVMGTYGYAAPEYVM-----TGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNN  323 (464)
Q Consensus       249 ~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~  323 (464)
                      ..... .......+||+.|+|||++.     ...++.++|||||||+||||++|+.||.....      .+.........
T Consensus       152 ~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~------~~~~~~i~~~~  224 (332)
T cd05623         152 LMEDG-TVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESL------VETYGKIMNHK  224 (332)
T ss_pred             cccCC-cceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCH------HHHHHHHhCCC
Confidence            43222 12223367999999999886     34688999999999999999999999975432      12222222111


Q ss_pred             cchhhccCccccCccCHHHHHHHHHHHHHhhccCCCC--CCCHHHHHH
Q 046893          324 KKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKG--RPVMSDVVA  369 (464)
Q Consensus       324 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~ev~~  369 (464)
                      ...      .+ ......++..+.+|+.+||..++.+  |+++.++++
T Consensus       225 ~~~------~~-p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~  265 (332)
T cd05623         225 ERF------QF-PAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQ  265 (332)
T ss_pred             ccc------cC-CCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhC
Confidence            100      00 0111234567889999988665544  678877764

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=6.8e-40  Score=317.24  Aligned_cols=253  Identities=24%  Similarity=0.362  Sum_probs=200.9

Q ss_pred             hcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCccHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeE
Q 046893           91 TKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVKLIGYCCEDEHR  170 (464)
Q Consensus        91 ~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~  170 (464)
                      .+.|++.+.||.|+||.||+|.+..+      +..+++|.+..........+..|+.+++.++||||+++++++..++..
T Consensus        11 ~~~y~i~~~lg~g~~g~vy~~~~~~~------~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   84 (292)
T cd06644          11 NEVWEIIGELGDGAFGKVYKAKNKET------GALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKL   84 (292)
T ss_pred             chhhhhhheecCCCCeEEEEEEECCC------CceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeE
Confidence            35688999999999999999988765      567999998765544456788999999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCccCCC
Q 046893          171 ILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGP  250 (464)
Q Consensus       171 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~  250 (464)
                      ++||||+++++|..++.+. ...+++..+..++.|++.+|.|||  ..+++||||||+||+++.++.+||+|||++....
T Consensus        85 ~lv~e~~~~~~l~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lH--~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~  161 (292)
T cd06644          85 WIMIEFCPGGAVDAIMLEL-DRGLTEPQIQVICRQMLEALQYLH--SMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNV  161 (292)
T ss_pred             EEEEecCCCCcHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHh--cCCeeecCCCcceEEEcCCCCEEEccCccceecc
Confidence            9999999999998877554 346899999999999999999999  6779999999999999999999999999987532


Q ss_pred             CCCCcceeeccccCCcccCccccc-----cCCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhcccc
Q 046893          251 MGDQTHVSTRVMGTYGYAAPEYVM-----TGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKK  325 (464)
Q Consensus       251 ~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  325 (464)
                      ..  ........++..|+|||++.     ...++.++|||||||++|+|++|..||....+.      .........   
T Consensus       162 ~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~------~~~~~~~~~---  230 (292)
T cd06644         162 KT--LQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM------RVLLKIAKS---  230 (292)
T ss_pred             cc--ccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHH------HHHHHHhcC---
Confidence            21  11123356889999999885     345788999999999999999999999754321      111111110   


Q ss_pred             hhhccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 046893          326 VLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVA  369 (464)
Q Consensus       326 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  369 (464)
                          ..+.  ...+..++..+.+++.+||..||++||++.++++
T Consensus       231 ----~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  268 (292)
T cd06644         231 ----EPPT--LSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLE  268 (292)
T ss_pred             ----CCcc--CCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence                0010  0112234457889999999999999999999874

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=2.5e-40  Score=315.88  Aligned_cols=253  Identities=23%  Similarity=0.316  Sum_probs=199.3

Q ss_pred             cCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCccHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeEE
Q 046893           92 KFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVKLIGYCCEDEHRI  171 (464)
Q Consensus        92 ~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~  171 (464)
                      ++|.+.+.||+|+||.||+|.+..+      ++.||+|.+..........+.+|+.+++.++||||+++++++...+..+
T Consensus         9 ~~~~~~~~lg~g~~~~v~~~~~~~~------~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~   82 (267)
T cd06645           9 EDFELIQRIGSGTYGDVYKARNVNT------GELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLW   82 (267)
T ss_pred             HHHHHHHHhCCCCCeEEEEEEEcCC------CcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEE
Confidence            4577788899999999999988765      5679999987654444456788999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCccCCCC
Q 046893          172 LVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPM  251 (464)
Q Consensus       172 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~  251 (464)
                      +||||+.+++|.+++....  .+++.+++.++.|++.||.|||  ..+++|+||||+||+++.++.++|+|||++.....
T Consensus        83 lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH--~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~  158 (267)
T cd06645          83 ICMEFCGGGSLQDIYHVTG--PLSESQIAYVSRETLQGLYYLH--SKGKMHRDIKGANILLTDNGHVKLADFGVSAQITA  158 (267)
T ss_pred             EEEeccCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH--HCCeecCCCCHHHEEECCCCCEEECcceeeeEccC
Confidence            9999999999999886543  6899999999999999999999  56799999999999999999999999999875422


Q ss_pred             CCCcceeeccccCCcccCccccc---cCCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhcccchhh
Q 046893          252 GDQTHVSTRVMGTYGYAAPEYVM---TGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLR  328 (464)
Q Consensus       252 ~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  328 (464)
                      .  ........|+..|+|||++.   ...++.++|||||||++|+|++|..||....+....  ..    .....     
T Consensus       159 ~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~--~~----~~~~~-----  225 (267)
T cd06645         159 T--IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRAL--FL----MTKSN-----  225 (267)
T ss_pred             c--ccccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhH--Hh----hhccC-----
Confidence            1  11223467999999999874   456889999999999999999999998654322110  00    00000     


Q ss_pred             ccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 046893          329 ILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVA  369 (464)
Q Consensus       329 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  369 (464)
                      ...+....  ...++..+.+++.+||..+|++||++.+|++
T Consensus       226 ~~~~~~~~--~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~  264 (267)
T cd06645         226 FQPPKLKD--KMKWSNSFHHFVKMALTKNPKKRPTAEKLLQ  264 (267)
T ss_pred             CCCCcccc--cCCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence            00011100  0123346889999999999999999998874

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=4.9e-40  Score=311.68  Aligned_cols=251  Identities=25%  Similarity=0.392  Sum_probs=204.6

Q ss_pred             CCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCC--CccHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeE
Q 046893           93 FFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGG--YQGDREWLAEVNYLGQLRHSNLVKLIGYCCEDEHR  170 (464)
Q Consensus        93 ~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~  170 (464)
                      +|++.+.||.|+||.||.+....+      +..+++|.+....  ......+.+|+.++++++|+||+++++++.+.+..
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~------~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~   74 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTED------DSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTL   74 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCC------CcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeE
Confidence            588899999999999999987764      5668999876543  23346688999999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCccCCC
Q 046893          171 ILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGP  250 (464)
Q Consensus       171 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~  250 (464)
                      ++||||+++++|.+++....+..+++..+..++.|++.+|.|||  +.+++|+||+|+||+++.++.+||+|||++....
T Consensus        75 ~~~~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh--~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~  152 (256)
T cd08221          75 LIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIH--KAGILHRDIKTLNIFLTKAGLIKLGDFGISKILG  152 (256)
T ss_pred             EEEEEecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH--hCCccccCCChHhEEEeCCCCEEECcCcceEEcc
Confidence            99999999999999987765567899999999999999999999  5679999999999999999999999999998643


Q ss_pred             CCCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhcccchhhcc
Q 046893          251 MGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRIL  330 (464)
Q Consensus       251 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  330 (464)
                      ....  ......|+..|+|||++.+..++.++||||||+++|+|++|..||......      +.........       
T Consensus       153 ~~~~--~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~------~~~~~~~~~~-------  217 (256)
T cd08221         153 SEYS--MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPL------NLVVKIVQGN-------  217 (256)
T ss_pred             cccc--cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHH------HHHHHHHcCC-------
Confidence            3221  223467899999999998888999999999999999999999999754321      1111111110       


Q ss_pred             CccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 046893          331 DPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVAL  370 (464)
Q Consensus       331 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  370 (464)
                         .. ......+..+.+++.+||..+|.+||++.++++.
T Consensus       218 ---~~-~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~  253 (256)
T cd08221         218 ---YT-PVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQ  253 (256)
T ss_pred             ---CC-CCccccCHHHHHHHHHHcccCcccCCCHHHHhhC
Confidence               00 1112344578999999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=7.3e-40  Score=311.60  Aligned_cols=256  Identities=25%  Similarity=0.409  Sum_probs=194.3

Q ss_pred             CceeecCceEEEEEEecCCCCCCccceEEEEEEccCCC-CccHHHHHHHHHHHhcCCCCCcceEEEEEE-eCCeEEEEEe
Q 046893           98 YILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGG-YQGDREWLAEVNYLGQLRHSNLVKLIGYCC-EDEHRILVYE  175 (464)
Q Consensus        98 ~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-~~~~~~lv~e  175 (464)
                      +.||+|+||.||+|.+....   .....+|+|.+.... ......+..|+.+++.++||||+++++++. .+...++|||
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~---~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e   77 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSD---GQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLP   77 (262)
T ss_pred             CcccccCCceEEEEEEecCC---CceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEe
Confidence            35899999999999875432   124679999885432 223467889999999999999999999775 4556889999


Q ss_pred             ccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCccCCCCCCCc
Q 046893          176 YMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQT  255 (464)
Q Consensus       176 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~~  255 (464)
                      |+.+++|.+++.... ..+.+..++.++.|++.||.|||  ..+++||||||+|||++.++.+||+|||+++........
T Consensus        78 ~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH--~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~  154 (262)
T cd05058          78 YMKHGDLRNFIRSET-HNPTVKDLIGFGLQVAKGMEYLA--SKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYY  154 (262)
T ss_pred             cCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH--hCCccccccCcceEEEcCCCcEEECCccccccccCCcce
Confidence            999999999987543 34678888999999999999999  677999999999999999999999999999754321111


Q ss_pred             c--eeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHhC-CCCCCCCCCcccccHHHHHHHhhhcccchhhccCc
Q 046893          256 H--VSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLG-RRAVDKSRPSREHNLVEWARPLLNNNKKVLRILDP  332 (464)
Q Consensus       256 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  332 (464)
                      .  ......++..|+|||.+.+..++.++|||||||++|||++| .+||.....      .+........       ...
T Consensus       155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~------~~~~~~~~~~-------~~~  221 (262)
T cd05058         155 SVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDS------FDITVYLLQG-------RRL  221 (262)
T ss_pred             eecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCH------HHHHHHHhcC-------CCC
Confidence            1  11224567789999999888999999999999999999995 555543221      1111111110       000


Q ss_pred             cccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHh
Q 046893          333 RLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETVQS  376 (464)
Q Consensus       333 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~~~  376 (464)
                          ..+..++..+.+++.+||..+|++||++.+|+..|+.+..
T Consensus       222 ----~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~~  261 (262)
T cd05058         222 ----LQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIFS  261 (262)
T ss_pred             ----CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHhc
Confidence                1112234578999999999999999999999999988753

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=4.5e-40  Score=312.01  Aligned_cols=250  Identities=22%  Similarity=0.312  Sum_probs=201.2

Q ss_pred             CCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCC--ccHHHHHHHHHHHhcCCCCCcceEEEEEEe-CCe
Q 046893           93 FFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGY--QGDREWLAEVNYLGQLRHSNLVKLIGYCCE-DEH  169 (464)
Q Consensus        93 ~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~~~  169 (464)
                      .|++.+.||+|+||.||++.+..+      ++.||+|.+.....  .....+..|+.+++.++|+||+++++.+.. +..
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~------~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   74 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTD------GKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGL   74 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCC------CcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCE
Confidence            478899999999999999998664      55699999865432  223567889999999999999999998764 446


Q ss_pred             EEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCccCC
Q 046893          170 RILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDG  249 (464)
Q Consensus       170 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~  249 (464)
                      .++||||+++++|.+++....+..+++.+++.++.|++.||.|||  +.+|+||||||+||+++.++.++|+|||++...
T Consensus        75 ~~lv~e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH--~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~  152 (257)
T cd08223          75 LYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLH--EKHILHRDLKTQNVFLTRTNIIKVGDLGIARVL  152 (257)
T ss_pred             EEEEecccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH--hCCeeccCCCchhEEEecCCcEEEecccceEEe
Confidence            899999999999999987755567899999999999999999999  677999999999999999999999999999754


Q ss_pred             CCCCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhcccchhhc
Q 046893          250 PMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRI  329 (464)
Q Consensus       250 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  329 (464)
                      ...  ........|++.|+|||++.+..++.++||||||+++|+|++|+.||.....      ..+........      
T Consensus       153 ~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~------~~~~~~~~~~~------  218 (257)
T cd08223         153 ENQ--CDMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDM------NSLVYRIIEGK------  218 (257)
T ss_pred             ccc--CCccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCH------HHHHHHHHhcC------
Confidence            321  1223346789999999999999999999999999999999999999975431      11111111110      


Q ss_pred             cCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 046893          330 LDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVA  369 (464)
Q Consensus       330 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  369 (464)
                           ....+...+..+.+|+.+||+.||.+||++.++++
T Consensus       219 -----~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  253 (257)
T cd08223         219 -----LPPMPKDYSPELGELIATMLSKRPEKRPSVKSILR  253 (257)
T ss_pred             -----CCCCccccCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence                 01122334568999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.1e-40  Score=311.02  Aligned_cols=254  Identities=24%  Similarity=0.318  Sum_probs=204.6

Q ss_pred             cCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCccHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeEE
Q 046893           92 KFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVKLIGYCCEDEHRI  171 (464)
Q Consensus        92 ~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~  171 (464)
                      ++|++.+.||.|+||.||+|.+..+      ++.+++|++..........+.+|+.+++.++||||+++++++...+..+
T Consensus         3 ~~~~~~~~l~~g~~~~v~~~~~~~~------~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~   76 (262)
T cd06613           3 EDYELIQRIGSGTYGDVYKARDIAT------GELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLW   76 (262)
T ss_pred             cceEEEEEecCCCceEEEEeEecCC------CCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEE
Confidence            5688889999999999999998664      4569999987655445577899999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCccCCCC
Q 046893          172 LVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPM  251 (464)
Q Consensus       172 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~  251 (464)
                      ++|||+.+++|.+++... ...+++..+..++.|++.||.|||  ..+|+|+||+|+||+++.++.+||+|||++.....
T Consensus        77 l~~e~~~~~~l~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lh--~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~  153 (262)
T cd06613          77 IVMEYCGGGSLQDIYQVT-RGPLSELQIAYVCRETLKGLAYLH--ETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTA  153 (262)
T ss_pred             EEEeCCCCCcHHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHH--hCCceecCCChhhEEECCCCCEEECccccchhhhh
Confidence            999999999999987654 246899999999999999999999  67799999999999999999999999999875432


Q ss_pred             CCCcceeeccccCCcccCccccccC---CCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhcccchhh
Q 046893          252 GDQTHVSTRVMGTYGYAAPEYVMTG---HLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLR  328 (464)
Q Consensus       252 ~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  328 (464)
                      ..  .......++..|+|||.+.+.   .++.++||||||+++|+|++|..||....+....  ...    ...      
T Consensus       154 ~~--~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~--~~~----~~~------  219 (262)
T cd06613         154 TI--AKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRAL--FLI----SKS------  219 (262)
T ss_pred             hh--hccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHH--HHH----Hhc------
Confidence            11  122335789999999998776   8899999999999999999999999764422111  000    000      


Q ss_pred             ccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 046893          329 ILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVA  369 (464)
Q Consensus       329 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  369 (464)
                      .+.+ .........+..+.+++.+||..+|.+||++.+|+.
T Consensus       220 ~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  259 (262)
T cd06613         220 NFPP-PKLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ  259 (262)
T ss_pred             cCCC-ccccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            0000 011123345668999999999999999999999874

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=2.1e-40  Score=326.73  Aligned_cols=255  Identities=20%  Similarity=0.226  Sum_probs=195.2

Q ss_pred             cCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCC---ccHHHHHHHHHHHhcCCCCCcceEEEEEEeCC
Q 046893           92 KFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGY---QGDREWLAEVNYLGQLRHSNLVKLIGYCCEDE  168 (464)
Q Consensus        92 ~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~  168 (464)
                      ++|.+.+.||+|+||+||++.+..+      +..||+|++.....   .....+..|+.++..+.|+||+++++++...+
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~~------~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~   74 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKHT------ERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDEN   74 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECCC------CCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC
Confidence            3688899999999999999998765      56799999864221   12244778999999999999999999999999


Q ss_pred             eEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCccC
Q 046893          169 HRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKD  248 (464)
Q Consensus       169 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~  248 (464)
                      ..||||||+.+|+|.+++.+.. ..+++..+..++.|++.||.|||  .++|+||||||+|||++.++.+||+|||+++.
T Consensus        75 ~~~lv~Ey~~gg~L~~~l~~~~-~~l~~~~~~~~~~qi~~~L~~lH--~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~  151 (331)
T cd05624          75 YLYLVMDYYVGGDLLTLLSKFE-DRLPEDMARFYIAEMVLAIHSIH--QLHYVHRDIKPDNVLLDMNGHIRLADFGSCLK  151 (331)
T ss_pred             EEEEEEeCCCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH--HCCeeeccCchHHEEEcCCCCEEEEeccceee
Confidence            9999999999999999987642 36899999999999999999999  67799999999999999999999999999976


Q ss_pred             CCCCCCcceeeccccCCcccCcccccc-----CCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhcc
Q 046893          249 GPMGDQTHVSTRVMGTYGYAAPEYVMT-----GHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNN  323 (464)
Q Consensus       249 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~  323 (464)
                      ...... ......+||+.|+|||++.+     ..++.++|||||||+||+|++|+.||......      +.........
T Consensus       152 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~------~~~~~i~~~~  224 (331)
T cd05624         152 MNQDGT-VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLV------ETYGKIMNHE  224 (331)
T ss_pred             ccCCCc-eeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHH------HHHHHHHcCC
Confidence            432221 12233679999999998875     46888999999999999999999999754321      1111111111


Q ss_pred             cchhhccCccccCccCHHHHHHHHHHHHHhhccCCCC--CCCHHHHHH
Q 046893          324 KKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKG--RPVMSDVVA  369 (464)
Q Consensus       324 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~ev~~  369 (464)
                      ...      .+. ......+..+.+|+.+||..++.+  |+++.++++
T Consensus       225 ~~~------~~p-~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~  265 (331)
T cd05624         225 ERF------QFP-SHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKK  265 (331)
T ss_pred             Ccc------cCC-CccccCCHHHHHHHHHHccCchhhcCCCCHHHHhc
Confidence            000      000 111123457889999999865543  356666653

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=7e-40  Score=312.62  Aligned_cols=250  Identities=22%  Similarity=0.381  Sum_probs=199.7

Q ss_pred             CCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCcc---------HHHHHHHHHHHhcCCCCCcceEEEE
Q 046893           93 FFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQG---------DREWLAEVNYLGQLRHSNLVKLIGY  163 (464)
Q Consensus        93 ~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~---------~~~~~~E~~~l~~l~hpniv~l~~~  163 (464)
                      +|.+...||.|+||.||+|.+...      +..+|+|.+.......         .+.+.+|+.+++.++||||++++++
T Consensus         1 ~~~~~~~ig~g~~~~v~~a~~~~~------~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~   74 (267)
T cd06628           1 KWIKGALIGSGSFGSVYLGMNASS------GELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGS   74 (267)
T ss_pred             CccccceeecCCCeEEEEEEecCC------CcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEE
Confidence            477888999999999999997654      5669999886543221         1457789999999999999999999


Q ss_pred             EEeCCeEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEccc
Q 046893          164 CCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDF  243 (464)
Q Consensus       164 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DF  243 (464)
                      +...+..++||||+++++|.+++...  ..+++..+..++.|++.||.|||  +.+++||||+|+||+++.++.++|+||
T Consensus        75 ~~~~~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~l~~~l~~lH--~~~ivH~di~p~nil~~~~~~~~l~df  150 (267)
T cd06628          75 SLDADHLNIFLEYVPGGSVAALLNNY--GAFEETLVRNFVRQILKGLNYLH--NRGIIHRDIKGANILVDNKGGIKISDF  150 (267)
T ss_pred             EEeCCccEEEEEecCCCCHHHHHHhc--cCccHHHHHHHHHHHHHHHHHHH--hcCcccccCCHHHEEEcCCCCEEeccc
Confidence            99999999999999999999998764  36889999999999999999999  577999999999999999999999999


Q ss_pred             CCccCCCCCCC----cceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHh
Q 046893          244 GLAKDGPMGDQ----THVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPL  319 (464)
Q Consensus       244 Gla~~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~  319 (464)
                      |+++.......    ........|+..|+|||.+.+..++.++|||||||++|+|++|+.||.......  .    ... 
T Consensus       151 g~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~--~----~~~-  223 (267)
T cd06628         151 GISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQ--A----IFK-  223 (267)
T ss_pred             CCCcccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHH--H----HHH-
Confidence            99986542111    111123568899999999998889999999999999999999999997543211  0    000 


Q ss_pred             hhcccchhhccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 046893          320 LNNNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVA  369 (464)
Q Consensus       320 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  369 (464)
                            +.....+    ..+...+..+.+++.+||+.||.+||++.++++
T Consensus       224 ------~~~~~~~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  263 (267)
T cd06628         224 ------IGENASP----EIPSNISSEAIDFLEKTFEIDHNKRPTAAELLK  263 (267)
T ss_pred             ------HhccCCC----cCCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence                  0001111    122334568899999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.8e-40  Score=314.61  Aligned_cols=249  Identities=26%  Similarity=0.390  Sum_probs=202.6

Q ss_pred             cCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCC-CccHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeE
Q 046893           92 KFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGG-YQGDREWLAEVNYLGQLRHSNLVKLIGYCCEDEHR  170 (464)
Q Consensus        92 ~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~  170 (464)
                      ++|.+.+.||.|+||.||+|.+..+      ++.||+|.+.... ......+.+|+.+++.++|+||+++++++.++...
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~------~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   74 (274)
T cd06609           1 ELFTLLECIGKGSFGEVYKAIDKRT------NQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKL   74 (274)
T ss_pred             ChhhhhhhhcCCCCeEEEEEEECCC------CeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeE
Confidence            3578889999999999999998764      6779999987543 23345688999999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCccCCC
Q 046893          171 ILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGP  250 (464)
Q Consensus       171 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~  250 (464)
                      ++|+||+.+++|.+++...   .+++..+..++.|++.||.|||  ..+++|+||+|+||+++.++.++|+|||+++...
T Consensus        75 ~~v~e~~~~~~L~~~~~~~---~~~~~~~~~~~~ql~~~l~~lh--~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~  149 (274)
T cd06609          75 WIIMEYCGGGSCLDLLKPG---KLDETYIAFILREVLLGLEYLH--EEGKIHRDIKAANILLSEEGDVKLADFGVSGQLT  149 (274)
T ss_pred             EEEEEeeCCCcHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHH--hCCcccCCCCHHHEEECCCCCEEEcccccceeec
Confidence            9999999999999988654   6899999999999999999999  6779999999999999999999999999998653


Q ss_pred             CCCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhcccchhhcc
Q 046893          251 MGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRIL  330 (464)
Q Consensus       251 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  330 (464)
                      ...  .......|+..|+|||.+.+..++.++||||||+++|+|++|..||....+...      .....       ...
T Consensus       150 ~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~------~~~~~-------~~~  214 (274)
T cd06609         150 STM--SKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRV------LFLIP-------KNN  214 (274)
T ss_pred             ccc--cccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHH------HHHhh-------hcC
Confidence            321  222346788999999999988899999999999999999999999975432110      00000       001


Q ss_pred             CccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 046893          331 DPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVA  369 (464)
Q Consensus       331 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  369 (464)
                      .+.+...   ..+..+.+++.+||..+|++||++++++.
T Consensus       215 ~~~~~~~---~~~~~~~~~l~~~l~~~p~~Rpt~~~il~  250 (274)
T cd06609         215 PPSLEGN---KFSKPFKDFVSLCLNKDPKERPSAKELLK  250 (274)
T ss_pred             CCCCccc---ccCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence            1111111   14457899999999999999999999975

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-41  Score=310.81  Aligned_cols=243  Identities=28%  Similarity=0.369  Sum_probs=201.8

Q ss_pred             HhcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCccHHH---HHHHHHHHhcCCCCCcceEEEEEEe
Q 046893           90 ATKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDRE---WLAEVNYLGQLRHSNLVKLIGYCCE  166 (464)
Q Consensus        90 ~~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~---~~~E~~~l~~l~hpniv~l~~~~~~  166 (464)
                      ..++|..+++||+|.||+|.+++-+.+      ++.+|+|+++++......+   -+.|-++|+..+||.+..|...|..
T Consensus       166 Tm~dFdfLKvLGkGTFGKVIL~rEKat------~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt  239 (516)
T KOG0690|consen  166 TMEDFDFLKVLGKGTFGKVILCREKAT------GKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQT  239 (516)
T ss_pred             ccchhhHHHHhcCCccceEEEEeeccc------CceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhcc
Confidence            345677888999999999999876654      7889999999876655443   4679999999999999999999999


Q ss_pred             CCeEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCc
Q 046893          167 DEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLA  246 (464)
Q Consensus       167 ~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla  246 (464)
                      .+++|+||||+.||.|.-+|.+..  .+++.....+...|+.||.|||  .++||+||||.+|.|||.+|++||+|||+|
T Consensus       240 ~drlCFVMeyanGGeLf~HLsrer--~FsE~RtRFYGaEIvsAL~YLH--s~~ivYRDlKLENLlLDkDGHIKitDFGLC  315 (516)
T KOG0690|consen  240 QDRLCFVMEYANGGELFFHLSRER--VFSEDRTRFYGAEIVSALGYLH--SRNIVYRDLKLENLLLDKDGHIKITDFGLC  315 (516)
T ss_pred             CceEEEEEEEccCceEeeehhhhh--cccchhhhhhhHHHHHHhhhhh--hCCeeeeechhhhheeccCCceEeeecccc
Confidence            999999999999999988887644  6899999999999999999999  577999999999999999999999999999


Q ss_pred             cCCCCCCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhcccch
Q 046893          247 KDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKV  326 (464)
Q Consensus       247 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  326 (464)
                      +...  .......++|||+.|+|||++....|+..+|+|.+||++|||+||+.||........   .+   -++.+.-  
T Consensus       316 KE~I--~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kL---Fe---LIl~ed~--  385 (516)
T KOG0690|consen  316 KEEI--KYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKL---FE---LILMEDL--  385 (516)
T ss_pred             hhcc--cccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHH---HH---HHHhhhc--
Confidence            9632  233445679999999999999999999999999999999999999999986442211   11   1111111  


Q ss_pred             hhccCccccCccCHHHHHHHHHHHHHhhccCCCCCC
Q 046893          327 LRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRP  362 (464)
Q Consensus       327 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP  362 (464)
                                .++.....+...|+.-.|..||.+|.
T Consensus       386 ----------kFPr~ls~eAktLLsGLL~kdP~kRL  411 (516)
T KOG0690|consen  386 ----------KFPRTLSPEAKTLLSGLLKKDPKKRL  411 (516)
T ss_pred             ----------cCCccCCHHHHHHHHHHhhcChHhhc
Confidence                      23344445788899999999999995

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=5.1e-40  Score=316.17  Aligned_cols=268  Identities=28%  Similarity=0.371  Sum_probs=207.4

Q ss_pred             cCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCc-cHHHHHHHHHHHhcCCCCCcceEEEEEEe--CC
Q 046893           92 KFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQ-GDREWLAEVNYLGQLRHSNLVKLIGYCCE--DE  168 (464)
Q Consensus        92 ~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~--~~  168 (464)
                      ++|.+.+.||+|+||.||+|.+....  ...+..+|||.+...... ....|..|+++++.+.||||+++++++..  ..
T Consensus         4 ~~~~~~~~ig~g~~~~v~~~~~~~~~--~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~   81 (284)
T cd05038           4 RHLKFIKQLGEGHFGKVELCRYDPLG--DNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGR   81 (284)
T ss_pred             hhchhheeeccCCCeeEEEeeecCCC--CCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCC
Confidence            46778889999999999999875431  123677999998765443 35678999999999999999999999887  56


Q ss_pred             eEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCccC
Q 046893          169 HRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKD  248 (464)
Q Consensus       169 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~  248 (464)
                      ..++||||+++++|.+++.... ..+++..++.++.|++.||.|||  ..+++|+||||+||+++.++.++|+|||++..
T Consensus        82 ~~~lv~e~~~~~~l~~~l~~~~-~~~~~~~~~~~~~~l~~aL~~lH--~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~  158 (284)
T cd05038          82 SLRLIMEYLPSGSLRDYLQRHR-DQINLKRLLLFSSQICKGMDYLG--SQRYIHRDLAARNILVESEDLVKISDFGLAKV  158 (284)
T ss_pred             ceEEEEecCCCCCHHHHHHhCc-cccCHHHHHHHHHHHHHHHHHHH--hCCeecCCCCHHhEEEcCCCCEEEcccccccc
Confidence            7899999999999999987643 25899999999999999999999  67799999999999999999999999999986


Q ss_pred             CCCCCCc-ceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccc--------cHHHHHHHh
Q 046893          249 GPMGDQT-HVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREH--------NLVEWARPL  319 (464)
Q Consensus       249 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~--------~~~~~~~~~  319 (464)
                      ....... .......++..|+|||.+.+..++.++||||||+++|||++|..||.........        .........
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (284)
T cd05038         159 LPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLEL  238 (284)
T ss_pred             cccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHH
Confidence            5422211 1111234566799999998889999999999999999999999998653221100        001111111


Q ss_pred             hhcccchhhccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHH
Q 046893          320 LNNNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETV  374 (464)
Q Consensus       320 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~  374 (464)
                      +          ........+..++.++.+|+.+||..+|.+||++.+|+++|+.+
T Consensus       239 ~----------~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i  283 (284)
T cd05038         239 L----------KEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL  283 (284)
T ss_pred             H----------HcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence            1          11111112234456899999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=4.9e-40  Score=314.42  Aligned_cols=261  Identities=24%  Similarity=0.343  Sum_probs=204.2

Q ss_pred             hcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCC-ccHHHHHHHHHHHhcCCCCCcceEEEEEEeCCe
Q 046893           91 TKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGY-QGDREWLAEVNYLGQLRHSNLVKLIGYCCEDEH  169 (464)
Q Consensus        91 ~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~  169 (464)
                      .++|.+.+.||+|+||.||+|.+....   .....||||....... ...+.+.+|+.+++.+.||||+++++++.. ..
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~---~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~   80 (270)
T cd05056           5 REDITLGRCIGEGQFGDVYQGVYMSPE---NEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NP   80 (270)
T ss_pred             hhhceeeeeeCCccceeEEEEEEecCC---CCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CC
Confidence            456888899999999999999875431   1234589998865442 334678899999999999999999998875 45


Q ss_pred             EEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCccCC
Q 046893          170 RILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDG  249 (464)
Q Consensus       170 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~  249 (464)
                      .++||||+++++|.+++.... ..+++..++.++.|++.||.|||  +.+++|+||||+|||++.++.+||+|||+++..
T Consensus        81 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~l~~~l~~lH--~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~  157 (270)
T cd05056          81 VWIVMELAPLGELRSYLQVNK-YSLDLASLILYSYQLSTALAYLE--SKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYL  157 (270)
T ss_pred             cEEEEEcCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHH--hCCeeccccChheEEEecCCCeEEccCceeeec
Confidence            789999999999999986543 35899999999999999999999  677999999999999999999999999999754


Q ss_pred             CCCCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHhhhcccchhh
Q 046893          250 PMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLL-GRRAVDKSRPSREHNLVEWARPLLNNNKKVLR  328 (464)
Q Consensus       250 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  328 (464)
                      ..... .......++..|+|||.+.+..++.++||||||+++|||++ |..||.......   ...+   .. ...    
T Consensus       158 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~---~~~~---~~-~~~----  225 (270)
T cd05056         158 EDESY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNND---VIGR---IE-NGE----  225 (270)
T ss_pred             ccccc-eecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHH---HHHH---HH-cCC----
Confidence            33211 11122334568999999988889999999999999999996 999997543211   1111   00 000    


Q ss_pred             ccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHh
Q 046893          329 ILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETVQS  376 (464)
Q Consensus       329 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~~~  376 (464)
                            ....+..++..+.+++.+||..+|.+||++.++++.|+.+..
T Consensus       226 ------~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~  267 (270)
T cd05056         226 ------RLPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQ  267 (270)
T ss_pred             ------cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence                  001223445689999999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=9e-40  Score=308.97  Aligned_cols=248  Identities=29%  Similarity=0.447  Sum_probs=197.3

Q ss_pred             CceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCc-cHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeEEEEEec
Q 046893           98 YILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQ-GDREWLAEVNYLGQLRHSNLVKLIGYCCEDEHRILVYEY  176 (464)
Q Consensus        98 ~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~  176 (464)
                      ++||.|+||.||+|.+..       ++.||+|.+...... ....+..|+++++.+.|+||+++++++......++||||
T Consensus         1 ~~lg~g~~g~v~~~~~~~-------~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   73 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKG-------NTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMEL   73 (251)
T ss_pred             CccccCCCceEEEEEEeC-------CCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEc
Confidence            369999999999998754       345899988765443 346789999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCccCCCCCCCcc
Q 046893          177 MESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTH  256 (464)
Q Consensus       177 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~~~  256 (464)
                      +.+++|.+++.... ..+++..++.++.+++.+|.|||  +++++||||||+|||++.++.+||+|||++..........
T Consensus        74 ~~~~~l~~~l~~~~-~~~~~~~~~~~~~~~~~~l~~lH--~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~  150 (251)
T cd05041          74 VPGGSLLTFLRKKK-NRLTVKKLLQMSLDAAAGMEYLE--SKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTV  150 (251)
T ss_pred             CCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH--hCCEehhhcCcceEEEcCCCcEEEeeccccccccCCccee
Confidence            99999999886543 36889999999999999999999  6779999999999999999999999999998543221111


Q ss_pred             eeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHhhhcccchhhccCcccc
Q 046893          257 VSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLL-GRRAVDKSRPSREHNLVEWARPLLNNNKKVLRILDPRLE  335 (464)
Q Consensus       257 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  335 (464)
                      ......++..|+|||.+.+..++.++||||||+++|+|++ |..||........   ...    +.          ....
T Consensus       151 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~---~~~----~~----------~~~~  213 (251)
T cd05041         151 SDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQT---RER----IE----------SGYR  213 (251)
T ss_pred             ccccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHH---HHH----Hh----------cCCC
Confidence            1112234667999999988899999999999999999999 8888865432111   110    00          0011


Q ss_pred             CccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 046893          336 GQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLE  372 (464)
Q Consensus       336 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~  372 (464)
                      ...+...+..+.+|+.+||..+|.+||++.++++.|+
T Consensus       214 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~  250 (251)
T cd05041         214 MPAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ  250 (251)
T ss_pred             CCCCccCCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence            1122344568999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=9.5e-40  Score=308.63  Aligned_cols=246  Identities=28%  Similarity=0.430  Sum_probs=194.8

Q ss_pred             ceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCc-cHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeEEEEEecc
Q 046893           99 ILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQ-GDREWLAEVNYLGQLRHSNLVKLIGYCCEDEHRILVYEYM  177 (464)
Q Consensus        99 ~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~  177 (464)
                      +||+|+||.||+|....       +..+|+|.+...... ....+.+|+++++.++||||+++++++...+..++||||+
T Consensus         2 ~ig~g~~g~vy~~~~~~-------~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   74 (250)
T cd05085           2 LLGKGNFGEVFKGTLKD-------KTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELV   74 (250)
T ss_pred             ccCCCCCceEEEEEecC-------CcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECC
Confidence            68999999999998543       456899998754322 2346889999999999999999999999999999999999


Q ss_pred             CCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCccCCCCCCCcce
Q 046893          178 ESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHV  257 (464)
Q Consensus       178 ~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~~~~  257 (464)
                      ++++|.+++.... ..+.+..++.++.|++.+|.|||  .++++||||||+||+++.++.+||+|||++........ ..
T Consensus        75 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH--~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~-~~  150 (250)
T cd05085          75 PGGDFLSFLRKKK-DELKTKQLVKFALDAAAGMAYLE--SKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIY-SS  150 (250)
T ss_pred             CCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH--hCCeeecccChheEEEcCCCeEEECCCccceecccccc-cc
Confidence            9999999886543 35899999999999999999999  67799999999999999999999999999875322211 11


Q ss_pred             eeccccCCcccCccccccCCCCcccchhcHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHhhhcccchhhccCccccC
Q 046893          258 STRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLL-GRRAVDKSRPSREHNLVEWARPLLNNNKKVLRILDPRLEG  336 (464)
Q Consensus       258 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  336 (464)
                      .....++..|+|||++.+..++.++||||||+++|+|++ |..||.......   ...    ....          ....
T Consensus       151 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~---~~~----~~~~----------~~~~  213 (250)
T cd05085         151 SGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQ---ARE----QVEK----------GYRM  213 (250)
T ss_pred             CCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHH---HHH----HHHc----------CCCC
Confidence            112344677999999998889999999999999999998 999997543211   111    0100          0011


Q ss_pred             ccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 046893          337 QYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLE  372 (464)
Q Consensus       337 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~  372 (464)
                      ..+..++..+.+|+.+||..+|++||++.++++.|.
T Consensus       214 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~  249 (250)
T cd05085         214 SCPQKCPDDVYKVMQRCWDYKPENRPKFSELQKELA  249 (250)
T ss_pred             CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence            112234568999999999999999999999998774

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=8e-40  Score=311.89  Aligned_cols=245  Identities=24%  Similarity=0.379  Sum_probs=189.3

Q ss_pred             ceeecCceEEEEEEecCCCCC------CccceEEEEEEccCCCCccHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeEEE
Q 046893           99 ILGEGGFGVVYKGVIDENVRP------GYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVKLIGYCCEDEHRIL  172 (464)
Q Consensus        99 ~lG~G~fg~Vy~a~~~~~~~~------~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l  172 (464)
                      .||+|+||.||+|+.......      ......|++|.+..........+..|+.++..++||||+++++++......++
T Consensus         2 ~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~l   81 (262)
T cd05077           2 HLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENIM   81 (262)
T ss_pred             ccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCEE
Confidence            589999999999986432211      11234589998766544444678889999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCc-------eEEcccCC
Q 046893          173 VYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFS-------AKLSDFGL  245 (464)
Q Consensus       173 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~-------vkl~DFGl  245 (464)
                      ||||+++++|..++... ...+++..++.++.|++.||.|||  +++|+||||||+|||++.++.       ++++|||+
T Consensus        82 v~e~~~~~~l~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH--~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g~  158 (262)
T cd05077          82 VEEFVEFGPLDLFMHRK-SDVLTTPWKFKVAKQLASALSYLE--DKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGI  158 (262)
T ss_pred             EEecccCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHhh--hCCeECCCCCcccEEEecCCccCCCCceeEeCCCCC
Confidence            99999999998877654 346899999999999999999999  677999999999999976654       89999999


Q ss_pred             ccCCCCCCCcceeeccccCCcccCccccc-cCCCCcccchhcHHHHHHHHH-hCCCCCCCCCCcccccHHHHHHHhhhcc
Q 046893          246 AKDGPMGDQTHVSTRVMGTYGYAAPEYVM-TGHLTARSDVYGFGVVLLEML-LGRRAVDKSRPSREHNLVEWARPLLNNN  323 (464)
Q Consensus       246 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslG~il~ell-~g~~pf~~~~~~~~~~~~~~~~~~~~~~  323 (464)
                      +.....      .....|+..|+|||.+. +..++.++|||||||++|||+ .|..||........      . ......
T Consensus       159 ~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~------~-~~~~~~  225 (262)
T cd05077         159 PITVLS------RQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEK------E-RFYEGQ  225 (262)
T ss_pred             CccccC------cccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHH------H-HHHhcC
Confidence            875321      12246788999999886 567899999999999999998 48888765332110      0 000000


Q ss_pred             cchhhccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 046893          324 KKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALL  371 (464)
Q Consensus       324 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L  371 (464)
                         ..     .    .......+.+||.+||+.||.+||++.+|+..|
T Consensus       226 ---~~-----~----~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~  261 (262)
T cd05077         226 ---CM-----L----VTPSCKELADLMTHCMNYDPNQRPFFRAIMRDI  261 (262)
T ss_pred             ---cc-----C----CCCChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence               00     0    011234788999999999999999999998765

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=4e-40  Score=329.04  Aligned_cols=264  Identities=22%  Similarity=0.296  Sum_probs=196.2

Q ss_pred             HhcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCC--ccHHHHHHHHHHHhcCCCCCcceEEEEEEeC
Q 046893           90 ATKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGY--QGDREWLAEVNYLGQLRHSNLVKLIGYCCED  167 (464)
Q Consensus        90 ~~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~  167 (464)
                      ..++|.+.+.||+|+||.||+|.+...      ++.||||++.....  .....+.+|+.+++.++||||+++++++...
T Consensus        22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~------~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~   95 (364)
T cd07875          22 VLKRYQNLKPIGSGAQGIVCAAYDAIL------ERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQ   95 (364)
T ss_pred             hhcceeEEEEeecCCCeEEEEEEECCC------CcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccc
Confidence            456799999999999999999997764      56699999875322  2335678999999999999999999987543


Q ss_pred             ------CeEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEc
Q 046893          168 ------EHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLS  241 (464)
Q Consensus       168 ------~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~  241 (464)
                            ...|+||||+.+ +|.+.+..    .+++..+..++.|++.||.|||  .++|+||||||+|||++.++.+||+
T Consensus        96 ~~~~~~~~~~lv~e~~~~-~l~~~~~~----~~~~~~~~~~~~qi~~aL~~LH--~~~ivH~Dlkp~NIll~~~~~~kL~  168 (364)
T cd07875          96 KSLEEFQDVYIVMELMDA-NLCQVIQM----ELDHERMSYLLYQMLCGIKHLH--SAGIIHRDLKPSNIVVKSDCTLKIL  168 (364)
T ss_pred             ccccccCeEEEEEeCCCC-CHHHHHHh----cCCHHHHHHHHHHHHHHHHHHh--hCCeecCCCCHHHEEECCCCcEEEE
Confidence                  357999999965 77776643    4788999999999999999999  6779999999999999999999999


Q ss_pred             ccCCccCCCCCCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHH-H------
Q 046893          242 DFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLV-E------  314 (464)
Q Consensus       242 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~-~------  314 (464)
                      |||+++.....   .......||..|+|||++.+..++.++|||||||+||+|++|+.||.+.........+ .      
T Consensus       169 DfG~a~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~  245 (364)
T cd07875         169 DFGLARTAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPC  245 (364)
T ss_pred             eCCCccccCCC---CcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCC
Confidence            99999854221   1223467899999999999999999999999999999999999999765422111000 0      


Q ss_pred             --HH-------HHhhhcccchh-----hccCc---cccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 046893          315 --WA-------RPLLNNNKKVL-----RILDP---RLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVA  369 (464)
Q Consensus       315 --~~-------~~~~~~~~~~~-----~~~~~---~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  369 (464)
                        +.       ...........     .....   .............+.+|+.+||+.||.+|||+.++++
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~  317 (364)
T cd07875         246 PEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ  317 (364)
T ss_pred             HHHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence              00       00000000000     00000   0000111112347889999999999999999998875

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=1.6e-39  Score=312.18  Aligned_cols=248  Identities=23%  Similarity=0.345  Sum_probs=203.1

Q ss_pred             CCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCC-ccHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeEE
Q 046893           93 FFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGY-QGDREWLAEVNYLGQLRHSNLVKLIGYCCEDEHRI  171 (464)
Q Consensus        93 ~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~  171 (464)
                      .|...+.||.|+||.||+|.+..+      +..||+|++..... .....+.+|+.+++.+.||||+++++++......+
T Consensus         5 ~y~~~~~lg~g~~~~vy~~~~~~~------~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   78 (277)
T cd06640           5 LFTKLERIGKGSFGEVFKGIDNRT------QQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLW   78 (277)
T ss_pred             hhhhhhhcccCCCeEEEEEEEccC------CEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEE
Confidence            477788899999999999998764      56799999875432 23466889999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCccCCCC
Q 046893          172 LVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPM  251 (464)
Q Consensus       172 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~  251 (464)
                      +||||+.+++|.+++...   .+++..+..++.|++.||.|||  ..+++|+||+|+||+++.++.++|+|||++.....
T Consensus        79 lv~e~~~~~~L~~~i~~~---~l~~~~~~~~~~~l~~~l~~lh--~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~  153 (277)
T cd06640          79 IIMEYLGGGSALDLLRAG---PFDEFQIATMLKEILKGLDYLH--SEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTD  153 (277)
T ss_pred             EEEecCCCCcHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH--hCCccCcCCChhhEEEcCCCCEEEcccccceeccC
Confidence            999999999999988642   5899999999999999999999  67799999999999999999999999999976433


Q ss_pred             CCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhcccchhhccC
Q 046893          252 GDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRILD  331 (464)
Q Consensus       252 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  331 (464)
                      ..  .......++..|+|||++.+..++.++|||||||++|||++|..||....+.....                 ...
T Consensus       154 ~~--~~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~-----------------~~~  214 (277)
T cd06640         154 TQ--IKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLF-----------------LIP  214 (277)
T ss_pred             Cc--cccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhh-----------------hhh
Confidence            22  12233568889999999998889999999999999999999999997543221100                 001


Q ss_pred             ccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 046893          332 PRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVAL  370 (464)
Q Consensus       332 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  370 (464)
                      ..........++..+.+++.+||..+|.+||++.+++..
T Consensus       215 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  253 (277)
T cd06640         215 KNNPPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH  253 (277)
T ss_pred             cCCCCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence            111123344567789999999999999999999999754

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=5.5e-40  Score=315.10  Aligned_cols=245  Identities=24%  Similarity=0.364  Sum_probs=188.8

Q ss_pred             ceeecCceEEEEEEecCCC------------------CCCccceEEEEEEccCCCCccHHHHHHHHHHHhcCCCCCcceE
Q 046893           99 ILGEGGFGVVYKGVIDENV------------------RPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVKL  160 (464)
Q Consensus        99 ~lG~G~fg~Vy~a~~~~~~------------------~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l  160 (464)
                      .||+|+||.||+|......                  ........|++|++..........+.+|+.+++.++||||+++
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~   81 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV   81 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence            5999999999999854211                  1112335689999875433334678889999999999999999


Q ss_pred             EEEEEeCCeEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCC----
Q 046893          161 IGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADF----  236 (464)
Q Consensus       161 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~----  236 (464)
                      ++++......+|||||+++|+|..++... ...+++..++.++.|++.||.|||  +++|+||||||+|||++..+    
T Consensus        82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH--~~~iiH~dlkp~Nill~~~~~~~~  158 (274)
T cd05076          82 HGVCVRGSENIMVEEFVEHGPLDVCLRKE-KGRVPVAWKITVAQQLASALSYLE--DKNLVHGNVCAKNILLARLGLAEG  158 (274)
T ss_pred             EEEEEeCCceEEEEecCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHH--cCCccCCCCCcccEEEeccCcccC
Confidence            99999999999999999999998887653 346899999999999999999999  67899999999999997543    


Q ss_pred             ---ceEEcccCCccCCCCCCCcceeeccccCCcccCcccccc-CCCCcccchhcHHHHHHHHH-hCCCCCCCCCCccccc
Q 046893          237 ---SAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMT-GHLTARSDVYGFGVVLLEML-LGRRAVDKSRPSREHN  311 (464)
Q Consensus       237 ---~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell-~g~~pf~~~~~~~~~~  311 (464)
                         .+||+|||++......      ....++..|+|||.+.+ ..++.++|||||||++|||+ +|..||....+...  
T Consensus       159 ~~~~~kl~d~g~~~~~~~~------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~--  230 (274)
T cd05076         159 TSPFIKLSDPGVSFTALSR------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEK--  230 (274)
T ss_pred             ccceeeecCCccccccccc------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHH--
Confidence               4899999988643211      12357888999998865 56899999999999999995 69999876433211  


Q ss_pred             HHHHHHHhhhcccchhhccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 046893          312 LVEWARPLLNNNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALL  371 (464)
Q Consensus       312 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L  371 (464)
                       ..+    +...        ....    ......+.++|.+||+.+|.+||++.+|++.|
T Consensus       231 -~~~----~~~~--------~~~~----~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L  273 (274)
T cd05076         231 -ERF----YEKK--------HRLP----EPSCKELATLISQCLTYEPTQRPSFRTILRDL  273 (274)
T ss_pred             -HHH----HHhc--------cCCC----CCCChHHHHHHHHHcccChhhCcCHHHHHHhh
Confidence             111    1000        0011    11123688999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=3.4e-40  Score=326.86  Aligned_cols=261  Identities=22%  Similarity=0.303  Sum_probs=194.8

Q ss_pred             HhcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCC--ccHHHHHHHHHHHhcCCCCCcceEEEEEEeC
Q 046893           90 ATKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGY--QGDREWLAEVNYLGQLRHSNLVKLIGYCCED  167 (464)
Q Consensus        90 ~~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~  167 (464)
                      ..++|.+.+.||.|+||.||+|.+..+      +..||||++.....  .....+.+|+.+|+.++||||+++++++...
T Consensus        13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   86 (343)
T cd07878          13 VPERYQNLTPVGSGAYGSVCSAYDTRL------RQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPA   86 (343)
T ss_pred             hhhhhhhheecccCCCeEEEEEEECCC------CCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccc
Confidence            457899999999999999999998765      56799999875322  2235677899999999999999999987543


Q ss_pred             ------CeEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEc
Q 046893          168 ------EHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLS  241 (464)
Q Consensus       168 ------~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~  241 (464)
                            ...+++|+++ +++|.+++..   ..+++..+..++.|++.||.|||  ..+|+||||||+|||++.++.+||+
T Consensus        87 ~~~~~~~~~~~~~~~~-~~~l~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH--~~~ivHrdikp~Nil~~~~~~~kl~  160 (343)
T cd07878          87 TSIENFNEVYLVTNLM-GADLNNIVKC---QKLSDEHVQFLIYQLLRGLKYIH--SAGIIHRDLKPSNVAVNEDCELRIL  160 (343)
T ss_pred             ccccccCcEEEEeecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHH--HCCeecccCChhhEEECCCCCEEEc
Confidence                  3578999998 7899877643   35899999999999999999999  6779999999999999999999999


Q ss_pred             ccCCccCCCCCCCcceeeccccCCcccCcccccc-CCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhh
Q 046893          242 DFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMT-GHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLL  320 (464)
Q Consensus       242 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~  320 (464)
                      |||+++.....     .....||..|+|||++.+ ..++.++|||||||++|+|++|+.||........  +..+.....
T Consensus       161 Dfg~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~--~~~~~~~~~  233 (343)
T cd07878         161 DFGLARQADDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQ--LKRIMEVVG  233 (343)
T ss_pred             CCccceecCCC-----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHH--HHHHHHHhC
Confidence            99999864321     233579999999999877 5789999999999999999999999976432111  111100000


Q ss_pred             hcccchh---------hccC--ccccC----ccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 046893          321 NNNKKVL---------RILD--PRLEG----QYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVA  369 (464)
Q Consensus       321 ~~~~~~~---------~~~~--~~~~~----~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  369 (464)
                      .......         ..+.  +....    .........+.+|+.+||..||.+|||+.++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~  297 (343)
T cd07878         234 TPSPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALA  297 (343)
T ss_pred             CCCHHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            0000000         0000  00000    000112345789999999999999999999885

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=1.7e-39  Score=319.68  Aligned_cols=264  Identities=18%  Similarity=0.208  Sum_probs=195.4

Q ss_pred             CCCceeec--CceEEEEEEecCCCCCCccceEEEEEEccCCCCcc--HHHHHHHHHHHhcCCCCCcceEEEEEEeCCeEE
Q 046893           96 PDYILGEG--GFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQG--DREWLAEVNYLGQLRHSNLVKLIGYCCEDEHRI  171 (464)
Q Consensus        96 ~~~~lG~G--~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~  171 (464)
                      +..+||+|  +||+||++.+..+      ++.||+|.+.......  ...+.+|+.+++.++||||+++++++..++..+
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~~------~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~   75 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKPT------GEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELW   75 (327)
T ss_pred             hhhhccccccceEEEEEEeeccc------CcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEE
Confidence            45679999  7899999998765      6779999987643322  245678999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCccCCCC
Q 046893          172 LVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPM  251 (464)
Q Consensus       172 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~  251 (464)
                      +||||+++|+|.+++..+....+++..++.++.|++.||.|||  ..+|+||||||+|||++.++.++++||+.+.....
T Consensus        76 lv~e~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH--~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~  153 (327)
T cd08227          76 VVTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIH--HMGYVHRSVKASHILISVDGKVYLSGLRSNLSMIN  153 (327)
T ss_pred             EEEeccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH--HCCEecCCCChhhEEEecCCcEEEcccchhhcccc
Confidence            9999999999999987654456899999999999999999999  57799999999999999999999999986543211


Q ss_pred             CCC-c----ceeeccccCCcccCcccccc--CCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhh---
Q 046893          252 GDQ-T----HVSTRVMGTYGYAAPEYVMT--GHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLN---  321 (464)
Q Consensus       252 ~~~-~----~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~---  321 (464)
                      ... .    .......++..|+|||++.+  ..++.++|||||||++|||++|+.||.......  ...........   
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~--~~~~~~~~~~~~~~  231 (327)
T cd08227         154 HGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQ--MLLEKLNGTVPCLL  231 (327)
T ss_pred             ccccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhH--HHHHHhcCCccccc
Confidence            110 0    01122457788999999876  468999999999999999999999997533211  00000000000   


Q ss_pred             c-c----cc-------------hh---------hccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 046893          322 N-N----KK-------------VL---------RILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVA  369 (464)
Q Consensus       322 ~-~----~~-------------~~---------~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  369 (464)
                      . .    ..             ..         ..........+.......+.+|+.+||+.||.+|||+.++++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~  306 (327)
T cd08227         232 DTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLN  306 (327)
T ss_pred             cccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhc
Confidence            0 0    00             00         000000001122234568899999999999999999999986

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=8.5e-40  Score=313.52  Aligned_cols=261  Identities=25%  Similarity=0.373  Sum_probs=205.5

Q ss_pred             cCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCc-cHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeE
Q 046893           92 KFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQ-GDREWLAEVNYLGQLRHSNLVKLIGYCCEDEHR  170 (464)
Q Consensus        92 ~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~  170 (464)
                      ++|++.+.||+|+||.||+|....... ......+++|.+...... ....+..|+++++.++|+||+++++++.+.+..
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~-~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   83 (275)
T cd05046           5 SNLQEITTLGRGEFGEVFLAKAKGIEE-EGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPH   83 (275)
T ss_pred             HhceeeeeecccceeEEEEEEeccCCc-CCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcc
Confidence            568889999999999999999765433 233567999988654333 346789999999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHhhcC-------CCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEccc
Q 046893          171 ILVYEYMESGSLEKHLLRRVG-------CMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDF  243 (464)
Q Consensus       171 ~lv~e~~~~g~L~~~l~~~~~-------~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DF  243 (464)
                      ++||||+++++|.+++.....       ..+++..+..++.|++.||.|||  +.+|+||||||+|||++.++.++|+||
T Consensus        84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH--~~~i~H~dlkp~Nili~~~~~~~l~~~  161 (275)
T cd05046          84 YMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLS--NARFVHRDLAARNCLVSSQREVKVSLL  161 (275)
T ss_pred             eEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhh--hcCcccCcCccceEEEeCCCcEEEccc
Confidence            999999999999999876442       15899999999999999999999  567999999999999999999999999


Q ss_pred             CCccCCCCCCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHhhhc
Q 046893          244 GLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLL-GRRAVDKSRPSREHNLVEWARPLLNN  322 (464)
Q Consensus       244 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~  322 (464)
                      |++......... ......++..|+|||.+.+..++.++||||||+++|+|++ |..||......   .....   ... 
T Consensus       162 ~~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~---~~~~~---~~~-  233 (275)
T cd05046         162 SLSKDVYNSEYY-KLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDE---EVLNR---LQA-  233 (275)
T ss_pred             ccccccCccccc-ccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchH---HHHHH---HHc-
Confidence            998753222211 2223456778999999988889999999999999999999 78888643321   11111   000 


Q ss_pred             ccchhhccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 046893          323 NKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLE  372 (464)
Q Consensus       323 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~  372 (464)
                               ..........++..+.+++.+||..+|.+||++.+++..|.
T Consensus       234 ---------~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~  274 (275)
T cd05046         234 ---------GKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG  274 (275)
T ss_pred             ---------CCcCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence                     00001112234568999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=1.8e-40  Score=315.54  Aligned_cols=246  Identities=24%  Similarity=0.391  Sum_probs=191.0

Q ss_pred             ceeecCceEEEEEEecCCCCC-CccceEEEEEEccCCCCccHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeEEEEEecc
Q 046893           99 ILGEGGFGVVYKGVIDENVRP-GYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVKLIGYCCEDEHRILVYEYM  177 (464)
Q Consensus        99 ~lG~G~fg~Vy~a~~~~~~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~  177 (464)
                      .||+|+||.||+|.+...... ......+|+|.+..........+..|+.+++.++||||+++++++......++||||+
T Consensus         2 ~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~   81 (258)
T cd05078           2 SLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEYV   81 (258)
T ss_pred             CCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEecC
Confidence            599999999999987653221 1234458888876544344467889999999999999999999999999999999999


Q ss_pred             CCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCc--------eEEcccCCccCC
Q 046893          178 ESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFS--------AKLSDFGLAKDG  249 (464)
Q Consensus       178 ~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~--------vkl~DFGla~~~  249 (464)
                      ++|+|.+++.... ..+++..++.++.|++.||.|||  +++|+||||||+|||++.++.        ++++|||++...
T Consensus        82 ~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH--~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~~  158 (258)
T cd05078          82 KFGSLDTYLKKNK-NLINISWKLEVAKQLAWALHFLE--DKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITV  158 (258)
T ss_pred             CCCcHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHH--HCCeecCCCccceEEEecccccccCCCceEEeccccccccc
Confidence            9999999887543 36899999999999999999999  678999999999999977664        699999998653


Q ss_pred             CCCCCcceeeccccCCcccCcccccc-CCCCcccchhcHHHHHHHHHhCC-CCCCCCCCcccccHHHHHHHhhhcccchh
Q 046893          250 PMGDQTHVSTRVMGTYGYAAPEYVMT-GHLTARSDVYGFGVVLLEMLLGR-RAVDKSRPSREHNLVEWARPLLNNNKKVL  327 (464)
Q Consensus       250 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~g~-~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  327 (464)
                      ..      .....++..|+|||++.+ ..++.++||||||+++|+|++|. .||........   ..    .....    
T Consensus       159 ~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~---~~----~~~~~----  221 (258)
T cd05078         159 LP------KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKK---LQ----FYEDR----  221 (258)
T ss_pred             CC------chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHH---HH----HHHcc----
Confidence            22      123568889999999876 45899999999999999999985 55543322110   00    01110    


Q ss_pred             hccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 046893          328 RILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLE  372 (464)
Q Consensus       328 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~  372 (464)
                              ..++.....++.+|+.+||+.||++||++.++++.|+
T Consensus       222 --------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~  258 (258)
T cd05078         222 --------HQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN  258 (258)
T ss_pred             --------ccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence                    0112222347899999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8e-40  Score=320.39  Aligned_cols=250  Identities=26%  Similarity=0.332  Sum_probs=200.1

Q ss_pred             cCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCc---cHHHHHHHHHHHhcCCCCCcceEEEEEEeCC
Q 046893           92 KFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQ---GDREWLAEVNYLGQLRHSNLVKLIGYCCEDE  168 (464)
Q Consensus        92 ~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~  168 (464)
                      ++|.+.+.||+|+||.||+|.+..+      +..+|+|.+......   ....+..|++++..++||||+++++++....
T Consensus         1 ~~y~~~~~ig~g~~g~vy~~~~~~~------~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   74 (316)
T cd05574           1 KHFKKIKLLGKGDVGRVFLVRLKGT------GKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTET   74 (316)
T ss_pred             CceEEeeeecCCccEEEEEEEEcCC------CcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCC
Confidence            3688889999999999999988764      567999998765433   2356889999999999999999999999999


Q ss_pred             eEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCccC
Q 046893          169 HRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKD  248 (464)
Q Consensus       169 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~  248 (464)
                      ..++||||+.+++|.+++....+..+++..+..++.|++.||.|||  ..+++|+||||+||+++.++.++|+|||++..
T Consensus        75 ~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH--~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~  152 (316)
T cd05574          75 YLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLH--LLGIVYRDLKPENILLHESGHIMLSDFDLSKQ  152 (316)
T ss_pred             EEEEEEEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHH--HCCeeccCCChHHeEEcCCCCEEEeecchhhc
Confidence            9999999999999999887655567999999999999999999999  67799999999999999999999999999875


Q ss_pred             CCCCCCc---------------------------ceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHhCCCCC
Q 046893          249 GPMGDQT---------------------------HVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAV  301 (464)
Q Consensus       249 ~~~~~~~---------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf  301 (464)
                      .......                           .......||..|+|||++.+..++.++||||||+++|+|++|..||
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf  232 (316)
T cd05574         153 SDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPF  232 (316)
T ss_pred             ccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCC
Confidence            4221110                           0112357899999999999989999999999999999999999999


Q ss_pred             CCCCCcccccHHHHHHHhhhcccchhhccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHH
Q 046893          302 DKSRPSREHNLVEWARPLLNNNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMS  365 (464)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~  365 (464)
                      .......  .+    ....          ............+..+.+++.+||..||++||+..
T Consensus       233 ~~~~~~~--~~----~~~~----------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~  280 (316)
T cd05574         233 KGSNRDE--TF----SNIL----------KKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSK  280 (316)
T ss_pred             CCCchHH--HH----HHHh----------cCCccCCCccccCHHHHHHHHHHccCCHhHCCCch
Confidence            7644211  01    1111          11110011111456899999999999999999933

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.9e-40  Score=315.60  Aligned_cols=252  Identities=25%  Similarity=0.403  Sum_probs=201.1

Q ss_pred             cCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCccHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeEE
Q 046893           92 KFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVKLIGYCCEDEHRI  171 (464)
Q Consensus        92 ~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~  171 (464)
                      ++|++.+.||.|+||.||+|.+..+      +..+|+|.+..........+..|+.+++.++||||+++++++......+
T Consensus         5 ~~~~i~~~l~~g~~~~v~~~~~~~~------~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   78 (280)
T cd06611           5 DIWEIIGELGDGAFGKVYKAQHKET------GLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLW   78 (280)
T ss_pred             hHHHHHHHhcCCCCceEEEEEEcCC------CcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEE
Confidence            4588889999999999999998654      5679999987654444567889999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCccCCCC
Q 046893          172 LVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPM  251 (464)
Q Consensus       172 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~  251 (464)
                      +||||+++++|.+++... +..+++..++.++.|++.||.|||  +.+|+|+||||+||+++.++.++|+|||++.....
T Consensus        79 lv~e~~~~~~L~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lh--~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~  155 (280)
T cd06611          79 ILIEFCDGGALDSIMLEL-ERGLTEPQIRYVCRQMLEALNFLH--SHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKS  155 (280)
T ss_pred             EEeeccCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHH--HCCcccCCCChhhEEECCCCCEEEccCccchhhcc
Confidence            999999999999887654 346899999999999999999999  67799999999999999999999999999875432


Q ss_pred             CCCcceeeccccCCcccCccccc-----cCCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhcccch
Q 046893          252 GDQTHVSTRVMGTYGYAAPEYVM-----TGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKV  326 (464)
Q Consensus       252 ~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  326 (464)
                      ..  .......|+..|+|||++.     +..++.++||||||+++|+|++|+.||.......      .........   
T Consensus       156 ~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~------~~~~~~~~~---  224 (280)
T cd06611         156 TL--QKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMR------VLLKILKSE---  224 (280)
T ss_pred             cc--cccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHH------HHHHHhcCC---
Confidence            21  1223357899999999875     3457789999999999999999999997643211      111111100   


Q ss_pred             hhccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 046893          327 LRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVA  369 (464)
Q Consensus       327 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  369 (464)
                          .+.+  ..+..++..+.+++.+||..+|.+||++.++++
T Consensus       225 ----~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  261 (280)
T cd06611         225 ----PPTL--DQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLK  261 (280)
T ss_pred             ----CCCc--CCcccCCHHHHHHHHHHhccChhhCcCHHHHhc
Confidence                0000  112234457889999999999999999999875

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=1.1e-39  Score=311.53  Aligned_cols=254  Identities=22%  Similarity=0.346  Sum_probs=198.9

Q ss_pred             HhcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCccHHHHHHHHHHHhcCCCCCcceEEEEEEeCCe
Q 046893           90 ATKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVKLIGYCCEDEH  169 (464)
Q Consensus        90 ~~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~  169 (464)
                      ..+.+.....||+|+||.||+|.+..+      +..||+|.+........+.+.+|+.+++.++|+||+++++++...+.
T Consensus         6 ~~~~~~~~~~lg~g~~g~v~~~~~~~~------~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~   79 (268)
T cd06624           6 EYDENGERVVLGKGTYGIVYAARDLST------QVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGF   79 (268)
T ss_pred             ccccCCceEEEecCCceEEEEeEecCC------CcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCE
Confidence            344455556899999999999987664      56799998876555555778999999999999999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHhhcCCCC--CHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecC-CCceEEcccCCc
Q 046893          170 RILVYEYMESGSLEKHLLRRVGCML--TWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNA-DFSAKLSDFGLA  246 (464)
Q Consensus       170 ~~lv~e~~~~g~L~~~l~~~~~~~l--~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~-~~~vkl~DFGla  246 (464)
                      .++||||+.+++|.+++.... ..+  ++..+..++.|++.||.|||  .++|+||||||+||+++. ++.++|+|||++
T Consensus        80 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~qi~~al~~lH--~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~  156 (268)
T cd06624          80 FKIFMEQVPGGSLSALLRSKW-GPLKDNEQTIIFYTKQILEGLKYLH--DNQIVHRDIKGDNVLVNTYSGVVKISDFGTS  156 (268)
T ss_pred             EEEEEecCCCCCHHHHHHHhc-ccCCCcHHHHHHHHHHHHHHHHHHH--HCCEeecCCCHHHEEEcCCCCeEEEecchhh
Confidence            999999999999999887642 234  78888999999999999999  677999999999999976 678999999998


Q ss_pred             cCCCCCCCcceeeccccCCcccCccccccCC--CCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhccc
Q 046893          247 KDGPMGDQTHVSTRVMGTYGYAAPEYVMTGH--LTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNK  324 (464)
Q Consensus       247 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  324 (464)
                      .......  .......|+..|+|||++.+..  ++.++||||||+++|+|++|+.||........   ..+.....    
T Consensus       157 ~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~---~~~~~~~~----  227 (268)
T cd06624         157 KRLAGIN--PCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQA---AMFKVGMF----  227 (268)
T ss_pred             eecccCC--CccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhh---hHhhhhhh----
Confidence            7543211  1222356899999999886543  78899999999999999999999965332111   01100000    


Q ss_pred             chhhccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 046893          325 KVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVA  369 (464)
Q Consensus       325 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  369 (464)
                              .....++......+.+|+.+||+.+|.+||++.+++.
T Consensus       228 --------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~  264 (268)
T cd06624         228 --------KIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQ  264 (268)
T ss_pred             --------ccCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence                    0111223344567899999999999999999999875

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=7e-40  Score=315.66  Aligned_cols=264  Identities=23%  Similarity=0.285  Sum_probs=197.3

Q ss_pred             CCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCC--ccHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeE
Q 046893           93 FFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGY--QGDREWLAEVNYLGQLRHSNLVKLIGYCCEDEHR  170 (464)
Q Consensus        93 ~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~  170 (464)
                      .|++.+.||+|+||.||+|++..+      +..||+|.+.....  .....+.+|+.++..++||||+++++++..+...
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~------~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   74 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKT------GQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRL   74 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCC------CcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeE
Confidence            377888999999999999998764      56799998864322  2235678999999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCccCC
Q 046893          171 ILVYEYMESGSLEKHLLRRV-GCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDG  249 (464)
Q Consensus       171 ~lv~e~~~~g~L~~~l~~~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~  249 (464)
                      ++||||+. ++|.+++.... +..+++..+..++.|++.||.|||  ..+|+|+||||+|||++.++.+||+|||++...
T Consensus        75 ~~v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH--~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~  151 (285)
T cd07861          75 YLIFEFLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCH--SRRVLHRDLKPQNLLIDNKGVIKLADFGLARAF  151 (285)
T ss_pred             EEEEecCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHH--hCCeeecCCCHHHEEEcCCCcEEECcccceeec
Confidence            99999996 68888876533 256899999999999999999999  677999999999999999999999999999754


Q ss_pred             CCCCCcceeeccccCCcccCccccccC-CCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhh--------
Q 046893          250 PMGDQTHVSTRVMGTYGYAAPEYVMTG-HLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLL--------  320 (464)
Q Consensus       250 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~--------  320 (464)
                      ...  ........++..|+|||++.+. .++.++|||||||++|+|++|+.||........  .........        
T Consensus       152 ~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~  227 (285)
T cd07861         152 GIP--VRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQ--LFRIFRILGTPTEDVWP  227 (285)
T ss_pred             CCC--cccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHH--HHHHHHHhCCCChhhhh
Confidence            222  1122234678999999988654 578899999999999999999999976432111  000000000        


Q ss_pred             --hcccchhhccCc---cccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 046893          321 --NNNKKVLRILDP---RLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVA  369 (464)
Q Consensus       321 --~~~~~~~~~~~~---~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  369 (464)
                        ............   ..........+.++.+||.+||..||.+|||+.+|++
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~  281 (285)
T cd07861         228 GVTSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN  281 (285)
T ss_pred             cchhhHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence              000000000000   0000011124557889999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=6.2e-40  Score=315.74  Aligned_cols=257  Identities=26%  Similarity=0.385  Sum_probs=201.1

Q ss_pred             HHHHHhcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCccHHHHHHHHHHHhcC-CCCCcceEEEEE
Q 046893           86 EMKLATKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQL-RHSNLVKLIGYC  164 (464)
Q Consensus        86 ~~~~~~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~  164 (464)
                      ++......|++.+.||.|+||.||+|.+...      ++.+|+|++.... .....+..|+.++..+ +|+||+++++++
T Consensus        10 ~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~------~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~   82 (282)
T cd06636          10 ALRDPAGIFELVEVVGNGTYGQVYKGRHVKT------GQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAF   82 (282)
T ss_pred             hhcChhhhhhhheeeccCCCeEEEEEEEcCC------CcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeeh
Confidence            3444556789999999999999999998764      5679999986542 2335678899999998 699999999998


Q ss_pred             Ee------CCeEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCce
Q 046893          165 CE------DEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSA  238 (464)
Q Consensus       165 ~~------~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~v  238 (464)
                      ..      ....++||||+.+|+|.+++....+..+++..+..++.|++.||.|||  ..+|+|+||||+||+++.++.+
T Consensus        83 ~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH--~~~ivH~dl~~~nili~~~~~~  160 (282)
T cd06636          83 IKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLH--AHKVIHRDIKGQNVLLTENAEV  160 (282)
T ss_pred             hcccccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHH--HCCcccCCCCHHHEEECCCCCE
Confidence            53      457899999999999999987766667889999999999999999999  5779999999999999999999


Q ss_pred             EEcccCCccCCCCCCCcceeeccccCCcccCccccc-----cCCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHH
Q 046893          239 KLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVM-----TGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLV  313 (464)
Q Consensus       239 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~  313 (464)
                      +|+|||++.......  .......|+..|+|||++.     +..++.++|||||||++|||++|..||....+...... 
T Consensus       161 ~l~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~-  237 (282)
T cd06636         161 KLVDFGVSAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFL-  237 (282)
T ss_pred             EEeeCcchhhhhccc--cCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhh-
Confidence            999999987532211  1123367899999999875     34688899999999999999999999975432211100 


Q ss_pred             HHHHHhhhcccchhhccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 046893          314 EWARPLLNNNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVA  369 (464)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  369 (464)
                                  ......+.   .....++..+.+||.+||..||.+||++.++++
T Consensus       238 ------------~~~~~~~~---~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~  278 (282)
T cd06636         238 ------------IPRNPPPK---LKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK  278 (282)
T ss_pred             ------------HhhCCCCC---CcccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence                        00000111   111234458999999999999999999999864

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1.3e-39  Score=314.04  Aligned_cols=259  Identities=24%  Similarity=0.376  Sum_probs=205.4

Q ss_pred             hcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCC-ccHHHHHHHHHHHhcCCCCCcceEEEEEEeCCe
Q 046893           91 TKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGY-QGDREWLAEVNYLGQLRHSNLVKLIGYCCEDEH  169 (464)
Q Consensus        91 ~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~  169 (464)
                      .++|++.+.||+|+||+||+|.+..+      +..||+|++..... ...+.+.+|++++..++||||+++++++...+.
T Consensus         4 ~~~~~~~~~ig~g~~g~v~~~~~~~~------~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~   77 (284)
T cd06620           4 NEDLETISDLGAGNGGSVSKVKHIPT------GTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENN   77 (284)
T ss_pred             HHHHHHHHHcCCCCCeEEEEEEEcCC------CcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCE
Confidence            35678888999999999999998764      56799998765432 234678899999999999999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCccCC
Q 046893          170 RILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDG  249 (464)
Q Consensus       170 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~  249 (464)
                      +++||||+++++|.+++...  ..+++..+..++.+++.+|.|||+ ..+++||||||+||+++.++.++|+|||++...
T Consensus        78 ~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~-~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~  154 (284)
T cd06620          78 ICMCMEFMDCGSLDRIYKKG--GPIPVEILGKIAVAVVEGLTYLYN-VHRIMHRDIKPSNILVNSRGQIKLCDFGVSGEL  154 (284)
T ss_pred             EEEEEecCCCCCHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHH-hcCeeccCCCHHHEEECCCCcEEEccCCcccch
Confidence            99999999999999887653  368999999999999999999994 246999999999999999999999999998653


Q ss_pred             CCCCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHhCCCCCCCCCCcc-----cccHHHHHHHhhhccc
Q 046893          250 PMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSR-----EHNLVEWARPLLNNNK  324 (464)
Q Consensus       250 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~-----~~~~~~~~~~~~~~~~  324 (464)
                      ...    ......|+..|+|||++.+..++.++|||||||++|+|++|+.||.......     ...+.++........ 
T Consensus       155 ~~~----~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~-  229 (284)
T cd06620         155 INS----IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEP-  229 (284)
T ss_pred             hhh----ccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhcc-
Confidence            221    1223579999999999988899999999999999999999999998644321     111222222211110 


Q ss_pred             chhhccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 046893          325 KVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLE  372 (464)
Q Consensus       325 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~  372 (464)
                            .+.+.   ...++..+.+|+.+||..||.+||++.++++...
T Consensus       230 ------~~~~~---~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~  268 (284)
T cd06620         230 ------PPRLP---SSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPP  268 (284)
T ss_pred             ------CCCCC---chhcCHHHHHHHHHHhcCCcccCcCHHHHhcCcc
Confidence                  01110   1124567899999999999999999999987543

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=1.7e-39  Score=307.79  Aligned_cols=256  Identities=32%  Similarity=0.493  Sum_probs=202.9

Q ss_pred             CCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCc-cHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeEEE
Q 046893           94 FRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQ-GDREWLAEVNYLGQLRHSNLVKLIGYCCEDEHRIL  172 (464)
Q Consensus        94 ~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l  172 (464)
                      |.+.+.||.|+||.||+|.+.....  .....||+|++...... ....+..|+.++..++|+||+++++++.+.+..++
T Consensus         1 ~~~~~~lg~g~~g~v~~~~~~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   78 (258)
T smart00219        1 LTLGKKLGEGAFGEVYKGTLKGLSG--EKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMI   78 (258)
T ss_pred             CcccceeccCCCcceEEEEecCCCC--CCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEE
Confidence            3567889999999999999876421  22467999999765433 45678899999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCccCCCCC
Q 046893          173 VYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMG  252 (464)
Q Consensus       173 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~  252 (464)
                      +|||+++++|.+++.......+++..+..++.|++.||.|||  ..+++|+||||+||+++.++.++|+|||+++.....
T Consensus        79 i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh--~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~  156 (258)
T smart00219       79 VMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLE--SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDD  156 (258)
T ss_pred             EEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHh--cCCeeecccccceEEEccCCeEEEcccCCceecccc
Confidence            999999999999987654333899999999999999999999  677999999999999999999999999999865443


Q ss_pred             CCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHhhhcccchhhccC
Q 046893          253 DQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLL-GRRAVDKSRPSREHNLVEWARPLLNNNKKVLRILD  331 (464)
Q Consensus       253 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  331 (464)
                      ...... ...++..|+|||.+.+..++.++||||||+++|+|++ |..||.....   ..+.+   ......        
T Consensus       157 ~~~~~~-~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~---~~~~~---~~~~~~--------  221 (258)
T smart00219      157 DYYKKK-GGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSN---EEVLE---YLKKGY--------  221 (258)
T ss_pred             cccccc-cCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCH---HHHHH---HHhcCC--------
Confidence            222111 2347789999999988889999999999999999998 7888865321   11111   111110        


Q ss_pred             ccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 046893          332 PRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALL  371 (464)
Q Consensus       332 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L  371 (464)
                         ....+...+.++.+++.+||..||.+|||+.++++.|
T Consensus       222 ---~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l  258 (258)
T smart00219      222 ---RLPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL  258 (258)
T ss_pred             ---CCCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence               0111222456899999999999999999999998754

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=2.1e-39  Score=317.50  Aligned_cols=200  Identities=24%  Similarity=0.332  Sum_probs=160.8

Q ss_pred             CCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCccHHHHHHHHHHHhcCCCCCcceEEEEEEe--CCeEEEEE
Q 046893           97 DYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVKLIGYCCE--DEHRILVY  174 (464)
Q Consensus        97 ~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~--~~~~~lv~  174 (464)
                      .++||+|+||+||+|.+...    ..+..||+|.+....  ....+.+|+.+|+.++||||+++++++..  +...++||
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~----~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~   79 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDG----KDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLF   79 (317)
T ss_pred             ccccccCCCeEEEEEEEccC----CCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEE
Confidence            45799999999999986542    125679999986542  23457889999999999999999998864  45689999


Q ss_pred             eccCCCCHHHHHHhhc-------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEe----cCCCceEEccc
Q 046893          175 EYMESGSLEKHLLRRV-------GCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILL----NADFSAKLSDF  243 (464)
Q Consensus       175 e~~~~g~L~~~l~~~~-------~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill----~~~~~vkl~DF  243 (464)
                      ||+. ++|.+++....       ...+++..+..++.|++.||.|||  +.+|+||||||+|||+    +.++.+||+||
T Consensus        80 e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH--~~~ivHrDlkp~Nil~~~~~~~~~~~kl~Df  156 (317)
T cd07868          80 DYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH--ANWVLHRDLKPANILVMGEGPERGRVKIADM  156 (317)
T ss_pred             eccC-CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHH--hCCEEcCCCCHHHEEEecCCCCcCcEEEeec
Confidence            9995 58888775321       225889999999999999999999  6779999999999999    45678999999


Q ss_pred             CCccCCCCCCC-cceeeccccCCcccCccccccC-CCCcccchhcHHHHHHHHHhCCCCCCCCC
Q 046893          244 GLAKDGPMGDQ-THVSTRVMGTYGYAAPEYVMTG-HLTARSDVYGFGVVLLEMLLGRRAVDKSR  305 (464)
Q Consensus       244 Gla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~ell~g~~pf~~~~  305 (464)
                      |+++....... ........||+.|+|||++.+. .++.++|||||||++|+|++|+.||....
T Consensus       157 G~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~  220 (317)
T cd07868         157 GFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ  220 (317)
T ss_pred             CceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCc
Confidence            99986432211 1122346789999999998774 58999999999999999999999997543

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=1.6e-39  Score=307.97  Aligned_cols=250  Identities=27%  Similarity=0.376  Sum_probs=203.1

Q ss_pred             cCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCccHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeEE
Q 046893           92 KFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVKLIGYCCEDEHRI  171 (464)
Q Consensus        92 ~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~  171 (464)
                      ++|++.+.||.|+||.||+|.+..+      +..+++|.+.....  ...+.+|+++++.++||||+++++++......+
T Consensus         3 ~~y~~~~~i~~g~~~~v~~~~~~~~------~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~   74 (256)
T cd06612           3 EVFDILEKLGEGSYGSVYKAIHKET------GQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLW   74 (256)
T ss_pred             ccchhhhhhcCCCCeEEEEEEEcCC------CcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEE
Confidence            5688899999999999999998764      46699999865422  578899999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCccCCCC
Q 046893          172 LVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPM  251 (464)
Q Consensus       172 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~  251 (464)
                      ++|||+.+++|.+++... +..+++..+..++.|++.||.|||  +.+++|+||+|+||+++.++.++|+|||++.....
T Consensus        75 l~~e~~~~~~L~~~l~~~-~~~l~~~~~~~~~~~l~~~l~~lh--~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~  151 (256)
T cd06612          75 IVMEYCGAGSVSDIMKIT-NKTLTEEEIAAILYQTLKGLEYLH--SNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTD  151 (256)
T ss_pred             EEEecCCCCcHHHHHHhC-ccCCCHHHHHHHHHHHHHHHHHHH--HCCcccCCCCcceEEECCCCcEEEcccccchhccc
Confidence            999999999999988653 346899999999999999999999  66799999999999999999999999999986433


Q ss_pred             CCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhcccchhhccC
Q 046893          252 GDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRILD  331 (464)
Q Consensus       252 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  331 (464)
                      ..  .......|+..|+|||++.+..++.++||||||+++|+|++|+.||....+....  ..           +.....
T Consensus       152 ~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~--~~-----------~~~~~~  216 (256)
T cd06612         152 TM--AKRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAI--FM-----------IPNKPP  216 (256)
T ss_pred             Cc--cccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhh--hh-----------hccCCC
Confidence            22  1223356889999999999989999999999999999999999999754322110  00           000000


Q ss_pred             ccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 046893          332 PRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVA  369 (464)
Q Consensus       332 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  369 (464)
                      +  ....+...+..+.+++.+||+.||.+||++.+++.
T Consensus       217 ~--~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~  252 (256)
T cd06612         217 P--TLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ  252 (256)
T ss_pred             C--CCCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence            0  01112234457899999999999999999999875

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=8.1e-40  Score=310.07  Aligned_cols=246  Identities=29%  Similarity=0.461  Sum_probs=197.6

Q ss_pred             cCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCccHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeEE
Q 046893           92 KFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVKLIGYCCEDEHRI  171 (464)
Q Consensus        92 ~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~  171 (464)
                      +.|++.+.||+|+||.||++...        +..||+|.+...  .....+.+|+.++..++||||+++++++... ..+
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~--------~~~~~iK~~~~~--~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~   74 (254)
T cd05083           6 QKLTLGEIIGEGEFGAVLQGEYT--------GQKVAVKNIKCD--VTAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLY   74 (254)
T ss_pred             HHceeeeeeccCCCCceEecccC--------CCceEEEeecCc--chHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcE
Confidence            45888999999999999998642        445899988653  2346788999999999999999999998764 478


Q ss_pred             EEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCccCCCC
Q 046893          172 LVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPM  251 (464)
Q Consensus       172 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~  251 (464)
                      +||||+.+++|.+++.......+++..++.++.|++.||.|||  +.+++||||||+|||++.++.+||+|||++.....
T Consensus        75 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH--~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~  152 (254)
T cd05083          75 IVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLE--SKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSM  152 (254)
T ss_pred             EEEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHH--hCCeeccccCcceEEEcCCCcEEECCCccceeccc
Confidence            9999999999999987665556899999999999999999999  67799999999999999999999999999875322


Q ss_pred             CCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHhhhcccchhhcc
Q 046893          252 GDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLL-GRRAVDKSRPSREHNLVEWARPLLNNNKKVLRIL  330 (464)
Q Consensus       252 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  330 (464)
                      .     ......+..|+|||.+.+..++.++||||||+++|+|++ |+.||......      ++... ....       
T Consensus       153 ~-----~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~------~~~~~-~~~~-------  213 (254)
T cd05083         153 G-----VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLK------EVKEC-VEKG-------  213 (254)
T ss_pred             c-----CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHH------HHHHH-HhCC-------
Confidence            1     112334567999999988899999999999999999998 99998754321      11111 1110       


Q ss_pred             CccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 046893          331 DPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLE  372 (464)
Q Consensus       331 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~  372 (464)
                         .....+..++..+.+++.+||+.+|.+||++.++++.|+
T Consensus       214 ---~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~  252 (254)
T cd05083         214 ---YRMEPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLE  252 (254)
T ss_pred             ---CCCCCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHc
Confidence               111112234568899999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=5.9e-40  Score=315.14  Aligned_cols=246  Identities=24%  Similarity=0.349  Sum_probs=199.2

Q ss_pred             CCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCC-ccHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeEEE
Q 046893           94 FRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGY-QGDREWLAEVNYLGQLRHSNLVKLIGYCCEDEHRIL  172 (464)
Q Consensus        94 ~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l  172 (464)
                      |...+.||+|+||.||+|.+..+      +..||+|.+..... .....+.+|+.+++.++||||+++++++...+..++
T Consensus         6 y~~~~~l~~g~~~~vy~~~~~~~------~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   79 (277)
T cd06642           6 FTKLERIGKGSFGEVYKGIDNRT------KEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWI   79 (277)
T ss_pred             HHHHHHhcCCCCeeEEEEEEcCC------CeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEE
Confidence            55667799999999999988664      56799999875432 233568899999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCccCCCCC
Q 046893          173 VYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMG  252 (464)
Q Consensus       173 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~  252 (464)
                      ||||+++++|.+++..   ..+++..+..++.|++.||.|||  .++++|+||+|+||+++.++.++|+|||++......
T Consensus        80 v~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH--~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~  154 (277)
T cd06642          80 IMEYLGGGSALDLLKP---GPLEETYIATILREILKGLDYLH--SERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDT  154 (277)
T ss_pred             EEEccCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHh--cCCeeccCCChheEEEeCCCCEEEccccccccccCc
Confidence            9999999999988754   35899999999999999999999  678999999999999999999999999999764322


Q ss_pred             CCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhcccchhhccCc
Q 046893          253 DQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRILDP  332 (464)
Q Consensus       253 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  332 (464)
                      .  .......|+..|+|||++.+..++.++|||||||++|||++|+.||....+...      ... .          ..
T Consensus       155 ~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~------~~~-~----------~~  215 (277)
T cd06642         155 Q--IKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRV------LFL-I----------PK  215 (277)
T ss_pred             c--hhhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhH------Hhh-h----------hc
Confidence            1  122235688999999999998999999999999999999999999875432111      000 0          00


Q ss_pred             cccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 046893          333 RLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVA  369 (464)
Q Consensus       333 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  369 (464)
                      .........++..+.+++.+||..+|.+||++.+++.
T Consensus       216 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  252 (277)
T cd06642         216 NSPPTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLK  252 (277)
T ss_pred             CCCCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence            0111122234557899999999999999999999987

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=1.4e-39  Score=308.68  Aligned_cols=250  Identities=24%  Similarity=0.365  Sum_probs=203.2

Q ss_pred             CCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCC--ccHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeE
Q 046893           93 FFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGY--QGDREWLAEVNYLGQLRHSNLVKLIGYCCEDEHR  170 (464)
Q Consensus        93 ~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~  170 (464)
                      +|++.+.||+|+||.||++.+..+      +..||+|.+.....  ....++.+|+.+++.++||||+++++++...+..
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~------~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   74 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKED------GKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNL   74 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCC------CCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeE
Confidence            478889999999999999998765      56799998865322  2335788999999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCccCCC
Q 046893          171 ILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGP  250 (464)
Q Consensus       171 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~  250 (464)
                      ++||||+.+++|.+++.......+++..++.++.|++.||.|||  +.+++|+||+|+|||++.++.++|+|||++....
T Consensus        75 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh--~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~  152 (256)
T cd08218          75 YIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVH--DRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLN  152 (256)
T ss_pred             EEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH--hCCEecCCCCHHHEEEcCCCCEEEeeccceeecC
Confidence            99999999999999887655556899999999999999999999  5679999999999999999999999999997643


Q ss_pred             CCCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhcccchhhcc
Q 046893          251 MGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRIL  330 (464)
Q Consensus       251 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  330 (464)
                      ....  ......|+..|+|||++.+..++.++|||||||++|+|++|+.||.....      .+.........       
T Consensus       153 ~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~------~~~~~~~~~~~-------  217 (256)
T cd08218         153 STVE--LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNM------KNLVLKIIRGS-------  217 (256)
T ss_pred             cchh--hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCH------HHHHHHHhcCC-------
Confidence            2221  12235688999999999888899999999999999999999999865321      11111111110       


Q ss_pred             CccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 046893          331 DPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVA  369 (464)
Q Consensus       331 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  369 (464)
                          ....+...+..+.+++.+||+.+|.+||++.+|++
T Consensus       218 ----~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~  252 (256)
T cd08218         218 ----YPPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILE  252 (256)
T ss_pred             ----CCCCcccCCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence                01122334558999999999999999999999985

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=2.4e-39  Score=309.94  Aligned_cols=259  Identities=25%  Similarity=0.411  Sum_probs=199.8

Q ss_pred             CCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCC--ccHHHHHHHHHHHhcCCCCCcceEEEEEEeCC---
Q 046893           94 FRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGY--QGDREWLAEVNYLGQLRHSNLVKLIGYCCEDE---  168 (464)
Q Consensus        94 ~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~---  168 (464)
                      |.+.+.||+|+||.||+|.+....   ..+..||||++.....  ...+++.+|+++++.++||||+++++++....   
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~---~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   77 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSED---GSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKG   77 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccC---CCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCC
Confidence            567788999999999999876432   2367799999875432  23456889999999999999999999886542   


Q ss_pred             ---eEEEEEeccCCCCHHHHHHhhc----CCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEc
Q 046893          169 ---HRILVYEYMESGSLEKHLLRRV----GCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLS  241 (464)
Q Consensus       169 ---~~~lv~e~~~~g~L~~~l~~~~----~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~  241 (464)
                         ..++++||+.+|+|.+++....    ...+++..++.++.|++.||+|||  .++|+||||||+|||++.++.+||+
T Consensus        78 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH--~~~i~H~dikp~nili~~~~~~kl~  155 (273)
T cd05074          78 RLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLS--SKNFIHRDLAARNCMLNENMTVCVA  155 (273)
T ss_pred             cccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHH--hCCEeecccchhhEEEcCCCCEEEC
Confidence               3478999999999988875321    125789999999999999999999  6779999999999999999999999


Q ss_pred             ccCCccCCCCCCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHhh
Q 046893          242 DFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLL-GRRAVDKSRPSREHNLVEWARPLL  320 (464)
Q Consensus       242 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~  320 (464)
                      |||+++...............++..|++||.+.+..++.++|||||||++|+|++ |..||......   .+..+.   .
T Consensus       156 dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~---~~~~~~---~  229 (273)
T cd05074         156 DFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENS---EIYNYL---I  229 (273)
T ss_pred             cccccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHH---HHHHHH---H
Confidence            9999986533322222223456678999999998899999999999999999999 88888654321   111111   1


Q ss_pred             hcccchhhccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHH
Q 046893          321 NNNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETV  374 (464)
Q Consensus       321 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~  374 (464)
                      .. ...          ..+..++..+.+++.+||+.+|.+||++.+++..|+.+
T Consensus       230 ~~-~~~----------~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~  272 (273)
T cd05074         230 KG-NRL----------KQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI  272 (273)
T ss_pred             cC-CcC----------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            10 000          01122345899999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=2.3e-39  Score=306.83  Aligned_cols=249  Identities=24%  Similarity=0.366  Sum_probs=201.7

Q ss_pred             CCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCC--ccHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeE
Q 046893           93 FFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGY--QGDREWLAEVNYLGQLRHSNLVKLIGYCCEDEHR  170 (464)
Q Consensus        93 ~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~  170 (464)
                      +|++.+.||+|+||.||+|.+..+      +..+|+|.+.....  .....+..|+.+++.++||||+++++++..++..
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~------~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~   74 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKAD------QKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKAL   74 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCC------CcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEE
Confidence            478889999999999999998764      56799999875432  2346788999999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCC-ceEEcccCCccCC
Q 046893          171 ILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADF-SAKLSDFGLAKDG  249 (464)
Q Consensus       171 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~-~vkl~DFGla~~~  249 (464)
                      ++||||+++++|.+++....+..+++..+..++.|++.+|.|||  +++|+|+||+|+||+++.++ .+||+|||++...
T Consensus        75 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh--~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~  152 (256)
T cd08220          75 MIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVH--TKLILHRDLKTQNILLDKHKMVVKIGDFGISKIL  152 (256)
T ss_pred             EEEEecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH--hCCeecCCCCHHHEEEcCCCCEEEEccCCCceec
Confidence            99999999999999998765566899999999999999999999  67799999999999997554 5799999999864


Q ss_pred             CCCCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhcccchhhc
Q 046893          250 PMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRI  329 (464)
Q Consensus       250 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  329 (464)
                      ....   ......|+..|+|||.+.+..++.++||||||+++|+|++|..||......      ..........      
T Consensus       153 ~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~------~~~~~~~~~~------  217 (256)
T cd08220         153 SSKS---KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLP------ALVLKIMSGT------  217 (256)
T ss_pred             CCCc---cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchH------HHHHHHHhcC------
Confidence            3222   122356889999999999888999999999999999999999999764321      1111111100      


Q ss_pred             cCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 046893          330 LDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVA  369 (464)
Q Consensus       330 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  369 (464)
                           ....+...+..+.+++.+||..+|.+||++.+++.
T Consensus       218 -----~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~  252 (256)
T cd08220         218 -----FAPISDRYSPDLRQLILSMLNLDPSKRPQLSQIMA  252 (256)
T ss_pred             -----CCCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence                 01112234557899999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=2.1e-39  Score=307.66  Aligned_cols=244  Identities=26%  Similarity=0.405  Sum_probs=191.0

Q ss_pred             CceeecCceEEEEEEecCCCCC----CccceEEEEEEccCCCCccHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeEEEE
Q 046893           98 YILGEGGFGVVYKGVIDENVRP----GYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVKLIGYCCEDEHRILV  173 (464)
Q Consensus        98 ~~lG~G~fg~Vy~a~~~~~~~~----~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv  173 (464)
                      +.||+|+||.||+|.+......    ......+++|.+...... ...+.+|+.+++.++||||+++++++.. ...++|
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv   78 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV   78 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence            3599999999999998765311    122345788877654322 5788999999999999999999999888 778999


Q ss_pred             EeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCC-------ceEEcccCCc
Q 046893          174 YEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADF-------SAKLSDFGLA  246 (464)
Q Consensus       174 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~-------~vkl~DFGla  246 (464)
                      |||+.+|+|.+++..... .+++..++.++.|++.||.|||  +++|+||||||+|||++.++       .+||+|||++
T Consensus        79 ~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~i~~~l~~LH--~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a  155 (259)
T cd05037          79 EEYVKFGPLDVFLHREKN-NVSLHWKLDVAKQLASALHYLE--DKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIP  155 (259)
T ss_pred             EEcCCCCcHHHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHh--hCCeecccCccceEEEecCccccCCceeEEeCCCCcc
Confidence            999999999998876532 6899999999999999999999  67799999999999999887       7999999999


Q ss_pred             cCCCCCCCcceeeccccCCcccCccccccC--CCCcccchhcHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHhhhcc
Q 046893          247 KDGPMGDQTHVSTRVMGTYGYAAPEYVMTG--HLTARSDVYGFGVVLLEMLL-GRRAVDKSRPSREHNLVEWARPLLNNN  323 (464)
Q Consensus       247 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~  323 (464)
                      .....      .....++..|+|||++.+.  .++.++||||||+++|+|++ |..||.......   ...+.   . ..
T Consensus       156 ~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~---~~~~~---~-~~  222 (259)
T cd05037         156 ITVLS------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSE---KERFY---Q-DQ  222 (259)
T ss_pred             ccccc------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchh---HHHHH---h-cC
Confidence            86432      1224577889999998876  78999999999999999999 577776543211   11110   0 00


Q ss_pred             cchhhccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 046893          324 KKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALL  371 (464)
Q Consensus       324 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L  371 (464)
                      ..        .    +......+.+++.+||..+|.+||++.++++.|
T Consensus       223 ~~--------~----~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l  258 (259)
T cd05037         223 HR--------L----PMPDCAELANLINQCWTYDPTKRPSFRAILRDL  258 (259)
T ss_pred             CC--------C----CCCCchHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence            00        0    000115889999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=5.4e-39  Score=307.09  Aligned_cols=255  Identities=23%  Similarity=0.357  Sum_probs=189.9

Q ss_pred             ceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCC-ccHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeEEEEEecc
Q 046893           99 ILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGY-QGDREWLAEVNYLGQLRHSNLVKLIGYCCEDEHRILVYEYM  177 (464)
Q Consensus        99 ~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~  177 (464)
                      .||+|+||+||+|......    ....+++|.+..... .....+.+|+.+++.++||||+++++++......++||||+
T Consensus         2 ~lg~G~~g~v~~~~~~~~~----~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~   77 (268)
T cd05086           2 EIGNGWFGKVLLSEIYTDT----GVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYC   77 (268)
T ss_pred             cCCCCcCceEEEEEEEcCC----CcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecC
Confidence            5999999999999764431    134467777664432 33467899999999999999999999999999999999999


Q ss_pred             CCCCHHHHHHhhcC--CCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCccCCCCCCCc
Q 046893          178 ESGSLEKHLLRRVG--CMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQT  255 (464)
Q Consensus       178 ~~g~L~~~l~~~~~--~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~~  255 (464)
                      ++|+|.+++.+...  ..+++..+..++.|++.||.|||  +.+++||||||+|||++.++.+||+|||++.........
T Consensus        78 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH--~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~  155 (268)
T cd05086          78 ELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMH--KHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYI  155 (268)
T ss_pred             CCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHH--HCCeeccCCccceEEEcCCccEEecccccccccCcchhh
Confidence            99999999876432  34667778899999999999999  577999999999999999999999999998643222222


Q ss_pred             ceeeccccCCcccCcccccc-------CCCCcccchhcHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHhhhcccchh
Q 046893          256 HVSTRVMGTYGYAAPEYVMT-------GHLTARSDVYGFGVVLLEMLL-GRRAVDKSRPSREHNLVEWARPLLNNNKKVL  327 (464)
Q Consensus       256 ~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  327 (464)
                      .......|+..|+|||++..       ..++.++||||||+++|||++ |..||......      +.....+..  ...
T Consensus       156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~------~~~~~~~~~--~~~  227 (268)
T cd05086         156 ETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDR------EVLNHVIKD--QQV  227 (268)
T ss_pred             hcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHH------HHHHHHHhh--ccc
Confidence            22234678899999998743       245789999999999999997 56677543221      111111111  111


Q ss_pred             hccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 046893          328 RILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLE  372 (464)
Q Consensus       328 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~  372 (464)
                      ...++.+...    ....+.+++..|| .+|++||++.+|++.|.
T Consensus       228 ~~~~~~~~~~----~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~  267 (268)
T cd05086         228 KLFKPQLELP----YSERWYEVLQFCW-LSPEKRATAEEVHRLLT  267 (268)
T ss_pred             ccCCCccCCC----CcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence            2222322222    3347788999999 68999999999988773

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=1.4e-39  Score=316.46  Aligned_cols=263  Identities=24%  Similarity=0.366  Sum_probs=198.3

Q ss_pred             cCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCC-ccHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeE
Q 046893           92 KFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGY-QGDREWLAEVNYLGQLRHSNLVKLIGYCCEDEHR  170 (464)
Q Consensus        92 ~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~  170 (464)
                      ++|.+.+.||.|+||.||+|.+..+      ++.||+|.+..... .....+.+|+.+++.++||||+++++++...+..
T Consensus         6 ~~y~~~~~lg~g~~g~vy~~~~~~~------~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~   79 (301)
T cd07873           6 ETYIKLDKLGEGTYATVYKGRSKLT------DNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSL   79 (301)
T ss_pred             cceEEeeEeccCcCEEEEEEEEcCC------CcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeE
Confidence            4588889999999999999987754      56799999865432 2235678899999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCccCCC
Q 046893          171 ILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGP  250 (464)
Q Consensus       171 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~  250 (464)
                      ++||||+. ++|.+++... ...+++..+..++.|++.||.|||  ..+|+|+||||+|||++.++.+||+|||++....
T Consensus        80 ~lv~e~~~-~~l~~~l~~~-~~~~~~~~~~~~~~qi~~aL~~lH--~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~  155 (301)
T cd07873          80 TLVFEYLD-KDLKQYLDDC-GNSINMHNVKLFLFQLLRGLNYCH--RRKVLHRDLKPQNLLINERGELKLADFGLARAKS  155 (301)
T ss_pred             EEEEeccc-cCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHH--hCCeeCCCCCHHHEEECCCCcEEECcCcchhccC
Confidence            99999996 5898887654 346899999999999999999999  5779999999999999999999999999997533


Q ss_pred             CCCCcceeeccccCCcccCccccccC-CCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhc-------
Q 046893          251 MGDQTHVSTRVMGTYGYAAPEYVMTG-HLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNN-------  322 (464)
Q Consensus       251 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~-------  322 (464)
                      ...  .......++..|+|||++.+. .++.++|||||||++|+|++|+.||........   .......+..       
T Consensus       156 ~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~---~~~~~~~~~~~~~~~~~  230 (301)
T cd07873         156 IPT--KTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQ---LHFIFRILGTPTEETWP  230 (301)
T ss_pred             CCC--CcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHcCCCChhhch
Confidence            222  112234678999999988654 578899999999999999999999976542111   1111000000       


Q ss_pred             ----ccchhhccCccccC----ccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 046893          323 ----NKKVLRILDPRLEG----QYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVA  369 (464)
Q Consensus       323 ----~~~~~~~~~~~~~~----~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  369 (464)
                          .......-.+....    ......+..+.+||.+||..||.+|||+.+++.
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~  285 (301)
T cd07873         231 GILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK  285 (301)
T ss_pred             hhhccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence                00000000000000    011223457889999999999999999999875

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=3.9e-39  Score=307.57  Aligned_cols=251  Identities=22%  Similarity=0.296  Sum_probs=195.3

Q ss_pred             cCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCc-----cHHHHHHHHHHHhcCCCCCcceEEEEEEe
Q 046893           92 KFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQ-----GDREWLAEVNYLGQLRHSNLVKLIGYCCE  166 (464)
Q Consensus        92 ~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~hpniv~l~~~~~~  166 (464)
                      .+|...+.||+|+||.||+|.+..+      +..||+|.+......     ....+.+|+.+++.++||||+++++++..
T Consensus         2 ~~~~~~~~lg~g~~g~vy~~~~~~~------~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   75 (266)
T cd06651           2 INWRRGKLLGQGAFGRVYLCYDVDT------GRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRD   75 (266)
T ss_pred             CCccccceecCCCCEEEEEEEEcCC------CcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEc
Confidence            3588899999999999999987764      567999987643221     12457889999999999999999998875


Q ss_pred             C--CeEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccC
Q 046893          167 D--EHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFG  244 (464)
Q Consensus       167 ~--~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFG  244 (464)
                      .  ...+++|||+++++|.+++....  .+++...+.++.|++.||.|||  ..+|+||||||+||+++.++.+||+|||
T Consensus        76 ~~~~~~~l~~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~LH--~~~i~H~~l~p~nil~~~~~~~~l~dfg  151 (266)
T cd06651          76 RAEKTLTIFMEYMPGGSVKDQLKAYG--ALTESVTRKYTRQILEGMSYLH--SNMIVHRDIKGANILRDSAGNVKLGDFG  151 (266)
T ss_pred             CCCCEEEEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH--hCCeeeCCCCHHHEEECCCCCEEEccCC
Confidence            3  57889999999999999887543  5899999999999999999999  6779999999999999999999999999


Q ss_pred             CccCCCCCCC-cceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhcc
Q 046893          245 LAKDGPMGDQ-THVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNN  323 (464)
Q Consensus       245 la~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~  323 (464)
                      +++....... ........++..|+|||.+.+..++.++|||||||++|||++|+.||......      .......   
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~------~~~~~~~---  222 (266)
T cd06651         152 ASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAM------AAIFKIA---  222 (266)
T ss_pred             CccccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchH------HHHHHHh---
Confidence            9875432111 11112356889999999999988999999999999999999999999753211      1111110   


Q ss_pred             cchhhccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 046893          324 KKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVA  369 (464)
Q Consensus       324 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  369 (464)
                             .......++......+..++ .||..+|++||++++|+.
T Consensus       223 -------~~~~~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~  260 (266)
T cd06651         223 -------TQPTNPQLPSHISEHARDFL-GCIFVEARHRPSAEELLR  260 (266)
T ss_pred             -------cCCCCCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence                   00011122333445677777 788899999999999974

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=4.5e-39  Score=306.63  Aligned_cols=257  Identities=27%  Similarity=0.372  Sum_probs=204.7

Q ss_pred             cCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCC-ccHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeE
Q 046893           92 KFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGY-QGDREWLAEVNYLGQLRHSNLVKLIGYCCEDEHR  170 (464)
Q Consensus        92 ~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~  170 (464)
                      ++|++.+.||.|+||+||+|.+..+      +..+|+|++..... .....+.+|+.+++.++|+||+++++.+...+..
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~------~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   74 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLPN------NEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDEL   74 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcCC------CcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEE
Confidence            4688999999999999999987654      56699999865432 2346788999999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCccCC
Q 046893          171 ILVYEYMESGSLEKHLLRRVG-CMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDG  249 (464)
Q Consensus       171 ~lv~e~~~~g~L~~~l~~~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~  249 (464)
                      ++|||++.+++|.+++..... ..+++..+..++.|++.||.|||  +.+++||||+|+||++++++.++|+|||++...
T Consensus        75 ~iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh--~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~  152 (267)
T cd06610          75 WLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLH--SNGQIHRDIKAGNILLGEDGSVKIADFGVSASL  152 (267)
T ss_pred             EEEEeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH--hCCeecCCCCHHhEEEcCCCCEEEcccchHHHh
Confidence            999999999999999876432 46899999999999999999999  677999999999999999999999999998765


Q ss_pred             CCCCCcc--eeeccccCCcccCccccccC-CCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhcccch
Q 046893          250 PMGDQTH--VSTRVMGTYGYAAPEYVMTG-HLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKV  326 (464)
Q Consensus       250 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  326 (464)
                      .......  ......|+..|+|||++... .++.++|||||||++|+|++|+.||........  +...    ....   
T Consensus       153 ~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~--~~~~----~~~~---  223 (267)
T cd06610         153 ADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKV--LMLT----LQND---  223 (267)
T ss_pred             ccCccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhh--HHHH----hcCC---
Confidence            4432221  22345789999999998776 789999999999999999999999976543211  1111    1110   


Q ss_pred             hhccCccccCcc-CHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 046893          327 LRILDPRLEGQY-TARTAMKVAGLAYQCLSQNPKGRPVMSDVVA  369 (464)
Q Consensus       327 ~~~~~~~~~~~~-~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  369 (464)
                          .+.+.... ....+..+.+++.+||..||.+||++.+++.
T Consensus       224 ----~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~  263 (267)
T cd06610         224 ----PPSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK  263 (267)
T ss_pred             ----CCCcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence                11111110 1234568899999999999999999999875

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=1.9e-39  Score=307.66  Aligned_cols=251  Identities=27%  Similarity=0.446  Sum_probs=198.8

Q ss_pred             cCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCccHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeEE
Q 046893           92 KFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVKLIGYCCEDEHRI  171 (464)
Q Consensus        92 ~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~  171 (464)
                      ..|++.+.||+|+||.||+|.+..       +..+|+|.+.... .....+..|+++++.++||||+++++++......+
T Consensus         4 ~~~~~~~~ig~g~~g~v~~~~~~~-------~~~~~~k~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   75 (256)
T cd05112           4 SELTLVQEIGSGQFGLVWLGYWLE-------KRKVAIKTIREGA-MSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPIC   75 (256)
T ss_pred             hHeEEEeeecCcccceEEEEEEeC-------CCeEEEEECCCCC-CCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceE
Confidence            357788899999999999998753       3458999886543 33467889999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCccCCCC
Q 046893          172 LVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPM  251 (464)
Q Consensus       172 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~  251 (464)
                      +||||+.+++|.+++.... ..+++..+..++.|++.+|.|||  +.+++|+||||+||+++.++.+||+|||+++....
T Consensus        76 ~v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH--~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~  152 (256)
T cd05112          76 LVFEFMEHGCLSDYLRAQR-GKFSQETLLGMCLDVCEGMAYLE--SSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLD  152 (256)
T ss_pred             EEEEcCCCCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHH--HCCccccccccceEEEcCCCeEEECCCcceeeccc
Confidence            9999999999999886543 35889999999999999999999  67799999999999999999999999999875432


Q ss_pred             CCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHhhhcccchhhcc
Q 046893          252 GDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLL-GRRAVDKSRPSREHNLVEWARPLLNNNKKVLRIL  330 (464)
Q Consensus       252 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  330 (464)
                      ... .......++..|+|||.+.+..++.++||||||+++|||++ |..||.....      ..........    ....
T Consensus       153 ~~~-~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~------~~~~~~~~~~----~~~~  221 (256)
T cd05112         153 DQY-TSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSN------SEVVETINAG----FRLY  221 (256)
T ss_pred             Ccc-cccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCH------HHHHHHHhCC----CCCC
Confidence            211 11112345678999999998899999999999999999998 9999865321      1111111100    0111


Q ss_pred             CccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 046893          331 DPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALL  371 (464)
Q Consensus       331 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L  371 (464)
                      .+       ...+..+.+|+.+||+.+|++||++.++++.|
T Consensus       222 ~~-------~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l  255 (256)
T cd05112         222 KP-------RLASQSVYELMQHCWKERPEDRPSFSLLLHQL  255 (256)
T ss_pred             CC-------CCCCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence            11       12345899999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=3.6e-39  Score=307.49  Aligned_cols=251  Identities=24%  Similarity=0.400  Sum_probs=197.9

Q ss_pred             CCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCc------cHHHHHHHHHHHhcCCCCCcceEEEEEEe
Q 046893           93 FFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQ------GDREWLAEVNYLGQLRHSNLVKLIGYCCE  166 (464)
Q Consensus        93 ~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~hpniv~l~~~~~~  166 (464)
                      +|++.+.||.|+||.||+|....       +..+|+|.+......      ....+.+|+.+++.++|+||+++++++.+
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~~~-------~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~   73 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLTNQ-------GQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLD   73 (265)
T ss_pred             CccccceEeccCCeEEEEEEEcC-------CCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeec
Confidence            47888999999999999997643       456999988643211      12457889999999999999999999999


Q ss_pred             CCeEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCc
Q 046893          167 DEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLA  246 (464)
Q Consensus       167 ~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla  246 (464)
                      .+..++||||+++++|.+++.+..  .+++..+..++.|++.||.|||  ..+|+|+||+|+||+++.++.++|+|||++
T Consensus        74 ~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH--~~~i~H~dl~p~nil~~~~~~~~l~dfg~~  149 (265)
T cd06631          74 DNTISIFMEFVPGGSISSILNRFG--PLPEPVFCKYTKQILDGVAYLH--NNCVVHRDIKGNNVMLMPNGIIKLIDFGCA  149 (265)
T ss_pred             CCeEEEEEecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH--hCCcccCCcCHHhEEECCCCeEEeccchhh
Confidence            999999999999999999987643  5889999999999999999999  667999999999999999999999999998


Q ss_pred             cCCCCCC----CcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhc
Q 046893          247 KDGPMGD----QTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNN  322 (464)
Q Consensus       247 ~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~  322 (464)
                      .......    .........|+..|+|||++.+..++.++||||||+++|+|++|..||........  ...     ...
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~--~~~-----~~~  222 (265)
T cd06631         150 RRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAA--MFY-----IGA  222 (265)
T ss_pred             HhhhhccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHH--HHH-----hhh
Confidence            7532111    11112335689999999999988899999999999999999999999975432110  000     000


Q ss_pred             ccchhhccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 046893          323 NKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVA  369 (464)
Q Consensus       323 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  369 (464)
                      ...    ..+    ..+...+..+.+++.+||..+|.+||++.+++.
T Consensus       223 ~~~----~~~----~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~  261 (265)
T cd06631         223 HRG----LMP----RLPDSFSAAAIDFVTSCLTRDQHERPSALQLLR  261 (265)
T ss_pred             ccC----CCC----CCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            000    011    122234557899999999999999999998874

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=2.7e-39  Score=311.60  Aligned_cols=266  Identities=25%  Similarity=0.302  Sum_probs=199.1

Q ss_pred             cCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCC--ccHHHHHHHHHHHhcCCCCCcceEEEEEEeCCe
Q 046893           92 KFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGY--QGDREWLAEVNYLGQLRHSNLVKLIGYCCEDEH  169 (464)
Q Consensus        92 ~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~  169 (464)
                      ++|++...||+|+||.||+|.+..+      ++.||+|++.....  ...+.+.+|+.+++.++||||+++++++.....
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~------~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~   74 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNRET------GQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRK   74 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEECCC------CcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCE
Confidence            3688889999999999999998764      56799998864322  223567899999999999999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCccCC
Q 046893          170 RILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDG  249 (464)
Q Consensus       170 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~  249 (464)
                      .++||||++++.|..++...  ..+++..+..++.|++.||.|||  ..+++||||||+||+++.++.++|+|||++...
T Consensus        75 ~~~v~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~ql~~~l~~LH--~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~  150 (286)
T cd07847          75 LHLVFEYCDHTVLNELEKNP--RGVPEHLIKKIIWQTLQAVNFCH--KHNCIHRDVKPENILITKQGQIKLCDFGFARIL  150 (286)
T ss_pred             EEEEEeccCccHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHH--HCCceecCCChhhEEEcCCCcEEECccccceec
Confidence            99999999998887765442  35899999999999999999999  577999999999999999999999999999864


Q ss_pred             CCCCCcceeeccccCCcccCcccccc-CCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHH-HHHHhhh------
Q 046893          250 PMGDQTHVSTRVMGTYGYAAPEYVMT-GHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVE-WARPLLN------  321 (464)
Q Consensus       250 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~-~~~~~~~------  321 (464)
                      .....  ......++..|+|||++.+ ..++.++||||||+++|+|++|..||.+........... .......      
T Consensus       151 ~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (286)
T cd07847         151 TGPGD--DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIF  228 (286)
T ss_pred             CCCcc--cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhc
Confidence            33221  1223568889999999876 458899999999999999999999997654322111100 0000000      


Q ss_pred             -cccchhhccCccccCc-----cCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 046893          322 -NNKKVLRILDPRLEGQ-----YTARTAMKVAGLAYQCLSQNPKGRPVMSDVVA  369 (464)
Q Consensus       322 -~~~~~~~~~~~~~~~~-----~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  369 (464)
                       ...-......+.....     .....+..+.+|+.+||+.+|++||++.+++.
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~  282 (286)
T cd07847         229 STNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE  282 (286)
T ss_pred             ccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence             0000000000110000     01123567899999999999999999998874

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=1.4e-39  Score=316.11  Aligned_cols=248  Identities=22%  Similarity=0.339  Sum_probs=198.2

Q ss_pred             CCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCccHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeEEEEE
Q 046893           95 RPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVKLIGYCCEDEHRILVY  174 (464)
Q Consensus        95 ~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~  174 (464)
                      .....||+|+||.||+|.+...      +..||+|.+..........+.+|+.++..+.||||+++++++..++..++||
T Consensus        24 ~~~~~ig~g~~g~v~~~~~~~~------~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~   97 (297)
T cd06659          24 ENYIKIGEGSTGIVCIAREKHS------GRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLM   97 (297)
T ss_pred             HhhhhcCCCCceeEEEEEEcCC------CCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEE
Confidence            3345699999999999987654      5679999987654455567889999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCccCCCCCCC
Q 046893          175 EYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQ  254 (464)
Q Consensus       175 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~  254 (464)
                      ||+++++|..++...   .+++..++.++.|++.||.|||  +.+++||||||+||+++.++.+||+|||++....... 
T Consensus        98 e~~~~~~L~~~~~~~---~~~~~~~~~~~~qi~~~L~~LH--~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~-  171 (297)
T cd06659          98 EFLQGGALTDIVSQT---RLNEEQIATVCESVLQALCYLH--SQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV-  171 (297)
T ss_pred             ecCCCCCHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHH--hCCeecCCCCHHHeEEccCCcEEEeechhHhhccccc-
Confidence            999999998877542   5899999999999999999999  6779999999999999999999999999987533221 


Q ss_pred             cceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhcccchhhccCccc
Q 046893          255 THVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRILDPRL  334 (464)
Q Consensus       255 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  334 (464)
                       .......|+..|+|||++.+..++.++|||||||++|||++|..||....+...   ...   .....       ....
T Consensus       172 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~---~~~---~~~~~-------~~~~  237 (297)
T cd06659         172 -PKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQA---MKR---LRDSP-------PPKL  237 (297)
T ss_pred             -ccccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH---HHH---HhccC-------CCCc
Confidence             122336789999999999988999999999999999999999999975432111   110   00000       0000


Q ss_pred             cCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 046893          335 EGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVAL  370 (464)
Q Consensus       335 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  370 (464)
                        ......+..+.+++.+||+.+|.+||++.+++..
T Consensus       238 --~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~  271 (297)
T cd06659         238 --KNAHKISPVLRDFLERMLTREPQERATAQELLDH  271 (297)
T ss_pred             --cccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence              0111234578899999999999999999999873

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=2.8e-39  Score=311.89  Aligned_cols=252  Identities=26%  Similarity=0.376  Sum_probs=198.5

Q ss_pred             CCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCC-ccHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeEE
Q 046893           93 FFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGY-QGDREWLAEVNYLGQLRHSNLVKLIGYCCEDEHRI  171 (464)
Q Consensus        93 ~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~  171 (464)
                      +|++.+.||+|+||.||+|.+...      +..||+|.+..... .....+.+|+.++++++||||+++++++...+..+
T Consensus         2 ~~~~~~~ig~g~~g~v~~~~~~~~------~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~   75 (286)
T cd06622           2 EIEVLDELGKGNYGSVYKVLHRPT------GVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVY   75 (286)
T ss_pred             hhhhhhhhcccCCeEEEEEEEcCC------CcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEE
Confidence            578889999999999999998754      56799998865322 22357889999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCccCCC
Q 046893          172 LVYEYMESGSLEKHLLRRV-GCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGP  250 (464)
Q Consensus       172 lv~e~~~~g~L~~~l~~~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~  250 (464)
                      +||||+++++|..++.... ...+++..+..++.|++.||.|||+ ..+|+|+||||+||+++.++.+||+|||++....
T Consensus        76 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~-~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~  154 (286)
T cd06622          76 MCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKE-EHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLV  154 (286)
T ss_pred             EEEeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHh-cCCEeeCCCCHHHEEECCCCCEEEeecCCccccc
Confidence            9999999999988876531 2368999999999999999999994 3479999999999999999999999999987542


Q ss_pred             CCCCcceeeccccCCcccCccccccC------CCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhccc
Q 046893          251 MGDQTHVSTRVMGTYGYAAPEYVMTG------HLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNK  324 (464)
Q Consensus       251 ~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  324 (464)
                      ..    ......|+..|+|||.+.+.      .++.++|||||||++|+|++|+.||.......   .......      
T Consensus       155 ~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~---~~~~~~~------  221 (286)
T cd06622         155 AS----LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYAN---IFAQLSA------  221 (286)
T ss_pred             CC----ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhh---HHHHHHH------
Confidence            21    12235688899999988554      35789999999999999999999996543211   1110000      


Q ss_pred             chhhccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 046893          325 KVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVA  369 (464)
Q Consensus       325 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  369 (464)
                          +... .....+..++.++.+||.+||..+|.+||++.+++.
T Consensus       222 ----~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~  261 (286)
T cd06622         222 ----IVDG-DPPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLE  261 (286)
T ss_pred             ----Hhhc-CCCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhc
Confidence                0110 011223335668899999999999999999999886

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=2.8e-39  Score=311.78  Aligned_cols=260  Identities=27%  Similarity=0.342  Sum_probs=200.0

Q ss_pred             hHHHHHhcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCccHHHHHHHHHHHhcC-CCCCcceEEEE
Q 046893           85 NEMKLATKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQL-RHSNLVKLIGY  163 (464)
Q Consensus        85 ~~~~~~~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~  163 (464)
                      ..+....++|++.+.||+|+||.||+|.+...      ++.+|+|++.... .....+..|+.++..+ +||||++++++
T Consensus        11 ~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~------~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~   83 (286)
T cd06638          11 DSFPDPSDTWEIIETIGKGTYGKVFKVLNKKN------GSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGM   83 (286)
T ss_pred             ecCCCcccceeeeeeeccCCCcEEEEEEECCC------CceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeee
Confidence            44455677899999999999999999998764      5679999876432 2345678899999999 69999999998


Q ss_pred             EE-----eCCeEEEEEeccCCCCHHHHHHhh--cCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCC
Q 046893          164 CC-----EDEHRILVYEYMESGSLEKHLLRR--VGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADF  236 (464)
Q Consensus       164 ~~-----~~~~~~lv~e~~~~g~L~~~l~~~--~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~  236 (464)
                      +.     .++..++||||+++++|.+++...  ....+++..+..++.|++.||.|||  ..+|+||||||+||+++.++
T Consensus        84 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH--~~~i~H~dlkp~nili~~~~  161 (286)
T cd06638          84 YYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLH--VNKTIHRDVKGNNILLTTEG  161 (286)
T ss_pred             eeecccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHH--hCCccccCCCHHhEEECCCC
Confidence            74     345789999999999999887532  2346889999999999999999999  56799999999999999999


Q ss_pred             ceEEcccCCccCCCCCCCcceeeccccCCcccCcccccc-----CCCCcccchhcHHHHHHHHHhCCCCCCCCCCccccc
Q 046893          237 SAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMT-----GHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHN  311 (464)
Q Consensus       237 ~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~  311 (464)
                      .+||+|||+++.......  ......|+..|+|||++..     ..++.++|||||||++|||++|+.||........  
T Consensus       162 ~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~--  237 (286)
T cd06638         162 GVKLVDFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRA--  237 (286)
T ss_pred             CEEEccCCceeecccCCC--ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHH--
Confidence            999999999876432211  1223568999999998753     4578899999999999999999999975432111  


Q ss_pred             HHHHHHHhhhcccchhhccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 046893          312 LVEWARPLLNNNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVAL  370 (464)
Q Consensus       312 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  370 (464)
                      +..    .. .      ...+..  ..+..++..+.+|+.+||+.||++||++.++++.
T Consensus       238 ~~~----~~-~------~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~  283 (286)
T cd06638         238 LFK----IP-R------NPPPTL--HQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQH  283 (286)
T ss_pred             Hhh----cc-c------cCCCcc--cCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence            000    00 0      000000  0111234478999999999999999999999864

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=5.6e-39  Score=305.25  Aligned_cols=252  Identities=23%  Similarity=0.320  Sum_probs=201.3

Q ss_pred             CCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCc--cHHHHHHHHHHHhcCCCCCcceEEEEEEe--CC
Q 046893           93 FFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQ--GDREWLAEVNYLGQLRHSNLVKLIGYCCE--DE  168 (464)
Q Consensus        93 ~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpniv~l~~~~~~--~~  168 (464)
                      +|.+.+.||.|+||.||+|.+..+      +..+|+|.+......  ....+..|+.+++.++||||+++++++..  ..
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~------~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   74 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSD------GKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQ   74 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCC------CCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCC
Confidence            477888999999999999987764      567999998654332  23568889999999999999999998764  45


Q ss_pred             eEEEEEeccCCCCHHHHHHhh--cCCCCCHHHHHHHHHHHHHHHHHHhcC---CCCeeeccCCCCceEecCCCceEEccc
Q 046893          169 HRILVYEYMESGSLEKHLLRR--VGCMLTWSRRMKIALDAAKGLAFLHGA---ERPVIYRDFKTSNILLNADFSAKLSDF  243 (464)
Q Consensus       169 ~~~lv~e~~~~g~L~~~l~~~--~~~~l~~~~~~~i~~qi~~~l~~LH~~---~~~ivHrDlkp~Nill~~~~~vkl~DF  243 (464)
                      ..+++|||+++++|.+++...  .+..+++..++.++.|++.||.|||..   +.+++|+||||+||+++.++.+||+||
T Consensus        75 ~~~~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~  154 (265)
T cd08217          75 TLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDF  154 (265)
T ss_pred             EEEEEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecc
Confidence            689999999999999988653  235789999999999999999999943   466999999999999999999999999


Q ss_pred             CCccCCCCCCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhcc
Q 046893          244 GLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNN  323 (464)
Q Consensus       244 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~  323 (464)
                      |++........  ......|+..|+|||++.+..++.++||||||+++|+|++|+.||.....   ..+..   ...   
T Consensus       155 g~~~~~~~~~~--~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~---~~~~~---~~~---  223 (265)
T cd08217         155 GLAKILGHDSS--FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQ---LQLAS---KIK---  223 (265)
T ss_pred             cccccccCCcc--cccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCH---HHHHH---HHh---
Confidence            99986543221  12335789999999999988899999999999999999999999976431   11111   111   


Q ss_pred             cchhhccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 046893          324 KKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVA  369 (464)
Q Consensus       324 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  369 (464)
                              .......+...+..+.+++.+||..+|.+||++.+|++
T Consensus       224 --------~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~  261 (265)
T cd08217         224 --------EGKFRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQ  261 (265)
T ss_pred             --------cCCCCCCccccCHHHHHHHHHHccCCcccCCCHHHHhh
Confidence                    01111223344568999999999999999999999975

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=2.1e-39  Score=312.70  Aligned_cols=266  Identities=26%  Similarity=0.347  Sum_probs=200.5

Q ss_pred             CCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCC--ccHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeE
Q 046893           93 FFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGY--QGDREWLAEVNYLGQLRHSNLVKLIGYCCEDEHR  170 (464)
Q Consensus        93 ~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~  170 (464)
                      +|++.+.||+|+||.||+|.+..+      ++.||+|.++....  .....+.+|+++++.++|+||+++++++...+..
T Consensus         2 ~y~~~~~i~~g~~~~v~~~~~~~~------~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   75 (288)
T cd07833           2 KYEVLGVVGEGAYGVVLKCRNKAT------GEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRL   75 (288)
T ss_pred             ceeEEEEecccCCeeEEEEEeCCC------CcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEE
Confidence            588899999999999999998765      56799998865322  2336788999999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCccCCC
Q 046893          171 ILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGP  250 (464)
Q Consensus       171 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~  250 (464)
                      ++||||+.++.|..++..  ...+++..+..++.|++.||.|||  ..+++|+||+|+||+++.++.+||+|||++....
T Consensus        76 ~iv~e~~~~~~l~~~~~~--~~~~~~~~~~~~~~~i~~~l~~LH--~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~  151 (288)
T cd07833          76 YLVFEYVERTLLELLEAS--PGGLPPDAVRSYIWQLLQAIAYCH--SHNIIHRDIKPENILVSESGVLKLCDFGFARALR  151 (288)
T ss_pred             EEEEecCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHH--HCCeecCCCCHHHeEECCCCCEEEEeeecccccC
Confidence            999999988666554433  235899999999999999999999  6679999999999999999999999999998654


Q ss_pred             CCCCcceeeccccCCcccCccccccC-CCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHH--------Hhhh
Q 046893          251 MGDQTHVSTRVMGTYGYAAPEYVMTG-HLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWAR--------PLLN  321 (464)
Q Consensus       251 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~--------~~~~  321 (464)
                      .... .......++..|+|||++.+. .++.++||||||+++|+|++|+.||................        ..+.
T Consensus       152 ~~~~-~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (288)
T cd07833         152 ARPA-SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFS  230 (288)
T ss_pred             CCcc-ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcc
Confidence            3322 122346788999999999888 88999999999999999999999997543211100000000        0000


Q ss_pred             cccchh--hccCcc----ccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 046893          322 NNKKVL--RILDPR----LEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVA  369 (464)
Q Consensus       322 ~~~~~~--~~~~~~----~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  369 (464)
                      ......  +..+..    ....++..++..+.+||.+||..+|.+||++++++.
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  284 (288)
T cd07833         231 SNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ  284 (288)
T ss_pred             cCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence            000000  000000    011122334678999999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.1e-39  Score=307.43  Aligned_cols=254  Identities=28%  Similarity=0.390  Sum_probs=199.5

Q ss_pred             HhcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCccHHHHHHHHHHHhcC-CCCCcceEEEEEEeCC
Q 046893           90 ATKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQL-RHSNLVKLIGYCCEDE  168 (464)
Q Consensus        90 ~~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~  168 (464)
                      ..++|++.+.||.|+||.||+|.+..+      +..+++|++..... ....+..|+.+++.+ .|+||+++++++....
T Consensus         4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~------~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~   76 (275)
T cd06608           4 PTGIFELVEVIGEGTYGKVYKARHKKT------GQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKN   76 (275)
T ss_pred             chhheeheeeecCCCCeEEEEEEECCC------CcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecC
Confidence            346799999999999999999998654      56799999865432 346788999999999 6999999999997654


Q ss_pred             ------eEEEEEeccCCCCHHHHHHhhc--CCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEE
Q 046893          169 ------HRILVYEYMESGSLEKHLLRRV--GCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKL  240 (464)
Q Consensus       169 ------~~~lv~e~~~~g~L~~~l~~~~--~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl  240 (464)
                            ..++||||+++++|.+++....  +..+++..+..++.|++.||.|||  ..+++|+||+|+||+++.++.++|
T Consensus        77 ~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH--~~~i~H~~l~p~ni~~~~~~~~~l  154 (275)
T cd06608          77 PPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLH--ENKVIHRDIKGQNILLTKNAEVKL  154 (275)
T ss_pred             CCCcceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHh--cCCcccCCCCHHHEEEccCCeEEE
Confidence                  4899999999999999886543  457899999999999999999999  577999999999999999999999


Q ss_pred             cccCCccCCCCCCCcceeeccccCCcccCcccccc-----CCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHH
Q 046893          241 SDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMT-----GHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEW  315 (464)
Q Consensus       241 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~  315 (464)
                      +|||++......  ........|+..|+|||++..     ..++.++||||||++||+|++|..||.......  .+.. 
T Consensus       155 ~d~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~--~~~~-  229 (275)
T cd06608         155 VDFGVSAQLDST--LGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMR--ALFK-  229 (275)
T ss_pred             CCCccceecccc--hhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHH--HHHH-
Confidence            999998753221  122233568999999998753     347789999999999999999999997532211  1111 


Q ss_pred             HHHhhhcccchhhccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 046893          316 ARPLLNNNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVA  369 (464)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  369 (464)
                         ...       ...+.  .......+..+.+|+.+||..||.+|||+.++++
T Consensus       230 ---~~~-------~~~~~--~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~  271 (275)
T cd06608         230 ---IPR-------NPPPT--LKSPENWSKKFNDFISECLIKNYEQRPFMEELLE  271 (275)
T ss_pred             ---hhc-------cCCCC--CCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence               000       00011  1112234568899999999999999999999875

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=4.1e-39  Score=307.35  Aligned_cols=254  Identities=22%  Similarity=0.377  Sum_probs=201.1

Q ss_pred             CCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCc------cHHHHHHHHHHHhcCCCCCcceEEEEEEe
Q 046893           93 FFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQ------GDREWLAEVNYLGQLRHSNLVKLIGYCCE  166 (464)
Q Consensus        93 ~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~hpniv~l~~~~~~  166 (464)
                      +|+..+.||+|+||.||+|.+..+      ++.+|+|++......      ....+..|+.+++.++|+||+++++++.+
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~------~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~   74 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKT------GTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCE   74 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCC------CcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceecc
Confidence            477888999999999999987654      567999998653311      23568899999999999999999999999


Q ss_pred             CCeEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCC-ceEEcccCC
Q 046893          167 DEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADF-SAKLSDFGL  245 (464)
Q Consensus       167 ~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~-~vkl~DFGl  245 (464)
                      .+..++||||+.+++|.+++.+..  .+++..+..++.|++.||.|||  +++++|+||+|+||+++.++ .+||+|||+
T Consensus        75 ~~~~~~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~ql~~al~~LH--~~~i~H~~i~~~nil~~~~~~~~~l~dfg~  150 (268)
T cd06630          75 DSHFNLFVEWMAGGSVSHLLSKYG--AFKEAVIINYTEQLLRGLSYLH--ENQIIHRDVKGANLLIDSTGQRLRIADFGA  150 (268)
T ss_pred             CCeEEEEEeccCCCcHHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHH--hCCeecCCCCHHHEEEcCCCCEEEEccccc
Confidence            999999999999999999887543  6899999999999999999999  67799999999999998776 599999999


Q ss_pred             ccCCCCCCC--cceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhcc
Q 046893          246 AKDGPMGDQ--THVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNN  323 (464)
Q Consensus       246 a~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~  323 (464)
                      +........  ........|+..|+|||.+.+..++.++||||||+++|+|++|..||........   ......     
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~---~~~~~~-----  222 (268)
T cd06630         151 AARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNH---LALIFK-----  222 (268)
T ss_pred             ccccccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcch---HHHHHH-----
Confidence            876533211  1112235688999999999888899999999999999999999999965432111   111110     


Q ss_pred             cchhhccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 046893          324 KKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVA  369 (464)
Q Consensus       324 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  369 (464)
                           ..........+...+..+.+++.+||..+|.+||++.+++.
T Consensus       223 -----~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~  263 (268)
T cd06630         223 -----IASATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK  263 (268)
T ss_pred             -----HhccCCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence                 00111112334445668999999999999999999999874

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.3e-41  Score=317.77  Aligned_cols=253  Identities=26%  Similarity=0.376  Sum_probs=208.4

Q ss_pred             HHHhcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCC---ccHHHHHHHHHHHhcCCCCCcceEEEEE
Q 046893           88 KLATKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGY---QGDREWLAEVNYLGQLRHSNLVKLIGYC  164 (464)
Q Consensus        88 ~~~~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~  164 (464)
                      .+..+.|+.-++||+||||.||-+....+      |+.+|.|.+.+...   ......++|-.+|..++.+.||.+-..|
T Consensus       181 pvt~n~F~~~RvlGkGGFGEV~acqvraT------GKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAf  254 (591)
T KOG0986|consen  181 PVTKNTFRVYRVLGKGGFGEVCACQVRAT------GKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAF  254 (591)
T ss_pred             hccccceeeeEEEecccccceeEEEEecc------hhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeee
Confidence            44567789999999999999999887665      78899998865432   2234467899999999999999999999


Q ss_pred             EeCCeEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccC
Q 046893          165 CEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFG  244 (464)
Q Consensus       165 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFG  244 (464)
                      +..+.+||||..|+||+|.-+|.+..+..+++..++.++.+|+.||++||  ..+||+|||||+|||||+.|+|+|+|+|
T Consensus       255 eTkd~LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH--~~~iVYRDLKPeNILLDd~GhvRISDLG  332 (591)
T KOG0986|consen  255 ETKDALCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLH--RRRIVYRDLKPENILLDDHGHVRISDLG  332 (591)
T ss_pred             cCCCceEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHH--hcceeeccCChhheeeccCCCeEeeccc
Confidence            99999999999999999999998887778999999999999999999999  7889999999999999999999999999


Q ss_pred             CccCCCCCCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhccc
Q 046893          245 LAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNK  324 (464)
Q Consensus       245 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  324 (464)
                      ||.....+...   ...+||.+|||||++.++.|+...|+|||||+||||+.|+.||..-......             .
T Consensus       333 LAvei~~g~~~---~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~-------------e  396 (591)
T KOG0986|consen  333 LAVEIPEGKPI---RGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKR-------------E  396 (591)
T ss_pred             eEEecCCCCcc---ccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhH-------------H
Confidence            99976544322   2248999999999999999999999999999999999999999753321111             0


Q ss_pred             chhhccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHH
Q 046893          325 KVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMS  365 (464)
Q Consensus       325 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~  365 (464)
                      ++.+.. ......|+...+++...|.+..|..||.+|....
T Consensus       397 Evdrr~-~~~~~ey~~kFS~eakslc~~LL~Kdp~~RLGcr  436 (591)
T KOG0986|consen  397 EVDRRT-LEDPEEYSDKFSEEAKSLCEGLLTKDPEKRLGCR  436 (591)
T ss_pred             HHHHHH-hcchhhcccccCHHHHHHHHHHHccCHHHhccCC
Confidence            111100 1112345667777899999999999999997654

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=1.3e-39  Score=315.51  Aligned_cols=248  Identities=23%  Similarity=0.360  Sum_probs=197.5

Q ss_pred             CCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCccHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeEEEE
Q 046893           94 FRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVKLIGYCCEDEHRILV  173 (464)
Q Consensus        94 ~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv  173 (464)
                      |.....||+|+||.||++.+..+      +..||||.+........+.+.+|+.+++.++|+||+++++.+...+..++|
T Consensus        24 ~~~~~~lg~g~~g~v~~~~~~~~------~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv   97 (292)
T cd06658          24 LDSFIKIGEGSTGIVCIATEKHT------GKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVV   97 (292)
T ss_pred             HhhhhcccCCCCeEEEEEEECCC------CCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEE
Confidence            33345699999999999987654      567999998654444456788999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCccCCCCCC
Q 046893          174 YEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGD  253 (464)
Q Consensus       174 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~  253 (464)
                      |||+++++|.+++...   .+++.+++.++.|++.||.|||  ..+|+||||||+||+++.++.++|+|||++.......
T Consensus        98 ~e~~~~~~L~~~~~~~---~l~~~~~~~~~~qi~~~l~~LH--~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~  172 (292)
T cd06658          98 MEFLEGGALTDIVTHT---RMNEEQIATVCLSVLRALSYLH--NQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEV  172 (292)
T ss_pred             EeCCCCCcHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH--HCCEeecCCCHHHEEEcCCCCEEEccCcchhhccccc
Confidence            9999999999877532   5899999999999999999999  5679999999999999999999999999987532211


Q ss_pred             CcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhcccchhhccCcc
Q 046893          254 QTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRILDPR  333 (464)
Q Consensus       254 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  333 (464)
                        .......|+..|+|||.+.+..++.++||||||+++|||++|..||........   ...          +...+.+.
T Consensus       173 --~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~---~~~----------~~~~~~~~  237 (292)
T cd06658         173 --PKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQA---MRR----------IRDNLPPR  237 (292)
T ss_pred             --ccCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH---HHH----------HHhcCCCc
Confidence              122335689999999999888899999999999999999999999976432211   000          00111111


Q ss_pred             ccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 046893          334 LEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVA  369 (464)
Q Consensus       334 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  369 (464)
                      ...  ....+..+.+++.+||..||.+||++.++++
T Consensus       238 ~~~--~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~  271 (292)
T cd06658         238 VKD--SHKVSSVLRGFLDLMLVREPSQRATAQELLQ  271 (292)
T ss_pred             ccc--ccccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence            111  1123447889999999999999999999985

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=7.9e-39  Score=305.23  Aligned_cols=251  Identities=21%  Similarity=0.263  Sum_probs=196.1

Q ss_pred             cCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCC-----ccHHHHHHHHHHHhcCCCCCcceEEEEEEe
Q 046893           92 KFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGY-----QGDREWLAEVNYLGQLRHSNLVKLIGYCCE  166 (464)
Q Consensus        92 ~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~hpniv~l~~~~~~  166 (464)
                      .+|++.+.||+|+||.||+|.+..+      +..||+|.+.....     .....+.+|+.+++.+.||||+++++++.+
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~~~------~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~   75 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDADT------GRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRD   75 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEcCC------CcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEecc
Confidence            4688899999999999999998765      56799998753221     112467889999999999999999998876


Q ss_pred             C--CeEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccC
Q 046893          167 D--EHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFG  244 (464)
Q Consensus       167 ~--~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFG  244 (464)
                      .  ...++||||+++++|.+++....  .+++..+..++.|++.||.|||  ..+|+|+||||+||+++.++.++|+|||
T Consensus        76 ~~~~~~~~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~l~~~l~~lH--~~~i~H~dl~p~nil~~~~~~~~l~Dfg  151 (265)
T cd06652          76 PMERTLSIFMEHMPGGSIKDQLKSYG--ALTENVTRKYTRQILEGVSYLH--SNMIVHRDIKGANILRDSVGNVKLGDFG  151 (265)
T ss_pred             CCCceEEEEEEecCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH--hCCEecCCCCHHHEEecCCCCEEECcCc
Confidence            4  46789999999999999887543  5789999999999999999999  6679999999999999999999999999


Q ss_pred             CccCCCCCCCc-ceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhcc
Q 046893          245 LAKDGPMGDQT-HVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNN  323 (464)
Q Consensus       245 la~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~  323 (464)
                      +++........ .......|+..|+|||++.+..++.++||||||+++|+|++|+.||.......     . .....   
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~-----~-~~~~~---  222 (265)
T cd06652         152 ASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMA-----A-IFKIA---  222 (265)
T ss_pred             cccccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHH-----H-HHHHh---
Confidence            99754321111 11223568999999999988889999999999999999999999997532111     0 00000   


Q ss_pred             cchhhccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 046893          324 KKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVA  369 (464)
Q Consensus       324 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  369 (464)
                             ........+......+.+++.+||. +|.+||++++|+.
T Consensus       223 -------~~~~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~  260 (265)
T cd06652         223 -------TQPTNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLR  260 (265)
T ss_pred             -------cCCCCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence                   0011112334455578889999994 9999999999874

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=2.4e-39  Score=311.94  Aligned_cols=263  Identities=24%  Similarity=0.301  Sum_probs=195.9

Q ss_pred             CCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCc--cHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeE
Q 046893           93 FFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQ--GDREWLAEVNYLGQLRHSNLVKLIGYCCEDEHR  170 (464)
Q Consensus        93 ~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~  170 (464)
                      +|++.+.||+|+||.||+|.+..+      ++.+|+|.+......  ....+.+|+.+++.++||||+++++++.+....
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~------g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~   74 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRET------HEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKL   74 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCC------CcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCce
Confidence            477888999999999999998765      567999998653221  224577899999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCccCCC
Q 046893          171 ILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGP  250 (464)
Q Consensus       171 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~  250 (464)
                      ++||||+. ++|.+++... ...+++..++.++.||+.||.|||  .++|+||||||+||+++.++.+||+|||+++...
T Consensus        75 ~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH--~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~  150 (284)
T cd07839          75 TLVFEYCD-QDLKKYFDSC-NGDIDPEIVKSFMFQLLKGLAFCH--SHNVLHRDLKPQNLLINKNGELKLADFGLARAFG  150 (284)
T ss_pred             EEEEecCC-CCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHH--HCCEecCCCCHHHEEEcCCCcEEECccchhhccC
Confidence            99999996 5888877654 346899999999999999999999  5779999999999999999999999999998643


Q ss_pred             CCCCcceeeccccCCcccCccccccC-CCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhc-cc----
Q 046893          251 MGDQTHVSTRVMGTYGYAAPEYVMTG-HLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNN-NK----  324 (464)
Q Consensus       251 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~-~~----  324 (464)
                      ...  .......++..|+|||++.+. .++.++|||||||++|+|++|..||........ .+.... ..+.. ..    
T Consensus       151 ~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~-~~~~~~-~~~~~~~~~~~~  226 (284)
T cd07839         151 IPV--RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDD-QLKRIF-RLLGTPTEESWP  226 (284)
T ss_pred             CCC--CCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHH-HHHHHH-HHhCCCChHHhH
Confidence            222  112235678999999988765 478999999999999999999988754332111 110000 00000 00    


Q ss_pred             chhhccCc----ccc-----CccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 046893          325 KVLRILDP----RLE-----GQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVA  369 (464)
Q Consensus       325 ~~~~~~~~----~~~-----~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  369 (464)
                      .+....+.    ...     .......+..+.+|+.+||+.||.+|||+.+++.
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~  280 (284)
T cd07839         227 GVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ  280 (284)
T ss_pred             HhhhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence            00000000    000     0111234568889999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=5.7e-39  Score=307.31  Aligned_cols=255  Identities=24%  Similarity=0.382  Sum_probs=197.8

Q ss_pred             CCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCc----------cHHHHHHHHHHHhcCCCCCcceEEE
Q 046893           93 FFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQ----------GDREWLAEVNYLGQLRHSNLVKLIG  162 (464)
Q Consensus        93 ~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~----------~~~~~~~E~~~l~~l~hpniv~l~~  162 (464)
                      +|.+.+.||.|+||.||+|.+..+      ++.+|+|.+......          ..+.+..|+.+++.++||||+++++
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~------~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~   75 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTT------GEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLG   75 (272)
T ss_pred             ceeecceecccCceEEEEEeecCC------CceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEE
Confidence            477788999999999999987654      567999987532111          1135678999999999999999999


Q ss_pred             EEEeCCeEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcc
Q 046893          163 YCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSD  242 (464)
Q Consensus       163 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~D  242 (464)
                      ++...+..++||||+.+++|.+++...  ..+++..+..++.|++.||.|||  +.+++||||+|+||+++.++.++|+|
T Consensus        76 ~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH--~~~i~H~dl~~~nil~~~~~~~~l~d  151 (272)
T cd06629          76 FETTEEYLSIFLEYVPGGSIGSCLRTY--GRFEEQLVRFFTEQVLEGLAYLH--SKGILHRDLKADNLLVDADGICKISD  151 (272)
T ss_pred             EeccCCceEEEEecCCCCcHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHh--hCCeeecCCChhhEEEcCCCeEEEee
Confidence            999999999999999999999988765  36899999999999999999999  57799999999999999999999999


Q ss_pred             cCCccCCCCCCCcceeeccccCCcccCccccccCC--CCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhh
Q 046893          243 FGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGH--LTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLL  320 (464)
Q Consensus       243 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~  320 (464)
                      ||+++...............|+..|+|||.+....  ++.++||||||+++|+|++|..||......     ..+. ...
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~-----~~~~-~~~  225 (272)
T cd06629         152 FGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAI-----AAMF-KLG  225 (272)
T ss_pred             ccccccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchH-----HHHH-Hhh
Confidence            99997543221111223356899999999987654  889999999999999999999999643211     1111 000


Q ss_pred             hcccchhhccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 046893          321 NNNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVA  369 (464)
Q Consensus       321 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  369 (464)
                      ..  .    ............++..+.+++.+||..+|.+||++.+|+.
T Consensus       226 ~~--~----~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  268 (272)
T cd06629         226 NK--R----SAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQ  268 (272)
T ss_pred             cc--c----cCCcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhh
Confidence            00  0    0111111122234568999999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=7.5e-39  Score=309.71  Aligned_cols=244  Identities=26%  Similarity=0.353  Sum_probs=198.9

Q ss_pred             cCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCC---ccHHHHHHHHHHHhcCCCCCcceEEEEEEeCC
Q 046893           92 KFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGY---QGDREWLAEVNYLGQLRHSNLVKLIGYCCEDE  168 (464)
Q Consensus        92 ~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~  168 (464)
                      ++|.+.+.||+|+||.||++.+..+      ++.+|+|++.....   .....+.+|++++++++||||+++++++...+
T Consensus         1 ~~y~~~~~ig~g~~~~vy~~~~~~~------~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   74 (290)
T cd05580           1 DDFEFIKTLGTGSFGRVMLVRHKGS------GKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDS   74 (290)
T ss_pred             CceEEEEEeecCCCeEEEEEEEcCC------CCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCC
Confidence            3688889999999999999998764      56799999865322   22356789999999999999999999999999


Q ss_pred             eEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCccC
Q 046893          169 HRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKD  248 (464)
Q Consensus       169 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~  248 (464)
                      ..++||||+++++|.+++...  ..+++..+..++.|++.||.|||  ..+|+|+||+|+|||++.++.+||+|||++..
T Consensus        75 ~~~~v~e~~~~~~L~~~~~~~--~~l~~~~~~~~~~qil~~l~~lH--~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~  150 (290)
T cd05580          75 NLYLVMEYVPGGELFSHLRKS--GRFPEPVARFYAAQVVLALEYLH--SLDIVYRDLKPENLLLDSDGYIKITDFGFAKR  150 (290)
T ss_pred             eEEEEEecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH--HCCEecCCCCHHHEEECCCCCEEEeeCCCccc
Confidence            999999999999999988765  36899999999999999999999  67799999999999999999999999999986


Q ss_pred             CCCCCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhcccchhh
Q 046893          249 GPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLR  328 (464)
Q Consensus       249 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  328 (464)
                      ....     .....|+..|+|||.+.+..++.++||||||+++|+|++|..||......      ..........     
T Consensus       151 ~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~~~~~~~~~~-----  214 (290)
T cd05580         151 VKGR-----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPI------QIYEKILEGK-----  214 (290)
T ss_pred             cCCC-----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHhcCC-----
Confidence            4332     23357899999999998888999999999999999999999999754411      1111111110     


Q ss_pred             ccCccccCccCHHHHHHHHHHHHHhhccCCCCCC-----CHHHHH
Q 046893          329 ILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRP-----VMSDVV  368 (464)
Q Consensus       329 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~ev~  368 (464)
                         .    .++...+..+.+++.+||..||.+|+     ++.+++
T Consensus       215 ---~----~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~  252 (290)
T cd05580         215 ---V----RFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIK  252 (290)
T ss_pred             ---c----cCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHH
Confidence               0    12222355888999999999999998     555554

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=5.6e-39  Score=311.15  Aligned_cols=250  Identities=24%  Similarity=0.350  Sum_probs=202.3

Q ss_pred             cCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCccHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeEE
Q 046893           92 KFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVKLIGYCCEDEHRI  171 (464)
Q Consensus        92 ~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~  171 (464)
                      ++|.+.+.||+|+||.||+|.+..+      +..||+|.+..........+.+|+.+++.++||||+++++++...+..+
T Consensus        19 ~~~~~~~~lg~g~~g~v~~~~~~~~------~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~   92 (293)
T cd06647          19 KKYTRFEKIGQGASGTVYTAIDVAT------GQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELW   92 (293)
T ss_pred             hhceeeeEecCCCCeEEEEEEEcCC------CCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEE
Confidence            5788899999999999999987654      4569999986554445567889999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCccCCCC
Q 046893          172 LVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPM  251 (464)
Q Consensus       172 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~  251 (464)
                      +||||+++++|.+++.+.   .+++..+..++.|++.||.|||  +++++|+||||+||+++.++.++|+|||++.....
T Consensus        93 lv~e~~~~~~L~~~~~~~---~l~~~~~~~i~~~l~~al~~LH--~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~  167 (293)
T cd06647          93 VVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLH--SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP  167 (293)
T ss_pred             EEEecCCCCcHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHH--hCCEeeccCCHHHEEEcCCCCEEEccCcceecccc
Confidence            999999999999988653   4789999999999999999999  67799999999999999999999999999875432


Q ss_pred             CCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhcccchhhccC
Q 046893          252 GDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRILD  331 (464)
Q Consensus       252 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  331 (464)
                      ...  ......|+..|+|||.+.+..++.++||||||+++|+|++|+.||...........      ...         .
T Consensus       168 ~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~------~~~---------~  230 (293)
T cd06647         168 EQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL------IAT---------N  230 (293)
T ss_pred             ccc--ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheee------hhc---------C
Confidence            221  22335688999999999888899999999999999999999999976443211100      000         0


Q ss_pred             ccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 046893          332 PRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVA  369 (464)
Q Consensus       332 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  369 (464)
                      ...........+..+.+++.+||..+|.+||++.+++.
T Consensus       231 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~  268 (293)
T cd06647         231 GTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQ  268 (293)
T ss_pred             CCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            00001112234457889999999999999999999885

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=5e-39  Score=313.28  Aligned_cols=256  Identities=24%  Similarity=0.318  Sum_probs=202.0

Q ss_pred             CCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCC---ccHHHHHHHHHHHhcCCCCCcceEEEEEEeCCe
Q 046893           93 FFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGY---QGDREWLAEVNYLGQLRHSNLVKLIGYCCEDEH  169 (464)
Q Consensus        93 ~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~  169 (464)
                      +|.+.+.||+|+||.||++.+...      ++.|++|.+.....   .....+..|+++++.++||||+++++.+..++.
T Consensus         2 ~y~~~~~l~~g~~~~v~~~~~~~~------~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~   75 (305)
T cd05609           2 DFETIKLISNGAYGAVYLVRHKET------RQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRH   75 (305)
T ss_pred             CceEeeEeecCCCeeEEEEEECCC------CcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCE
Confidence            588889999999999999998765      56799998875432   123467789999999999999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCccCC
Q 046893          170 RILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDG  249 (464)
Q Consensus       170 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~  249 (464)
                      .++||||+.+++|.+++...  ..+++..+..++.|++.||.|||  ..+++||||||+||+++.++.+||+|||+++..
T Consensus        76 ~~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH--~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~  151 (305)
T cd05609          76 LCMVMEYVEGGDCATLLKNI--GALPVDMARMYFAETVLALEYLH--NYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIG  151 (305)
T ss_pred             EEEEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH--HCCccccCCchHHEEECCCCCEEEeeCCCcccc
Confidence            99999999999999998654  36899999999999999999999  577999999999999999999999999998742


Q ss_pred             CCCCCc-------------ceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHH
Q 046893          250 PMGDQT-------------HVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWA  316 (464)
Q Consensus       250 ~~~~~~-------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~  316 (464)
                      ......             .......|+..|+|||.+.+..++.++||||||+++|||++|..||.+....      ++.
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~------~~~  225 (305)
T cd05609         152 LMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPE------ELF  225 (305)
T ss_pred             CcCccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------HHH
Confidence            111100             0112246788999999998889999999999999999999999999754321      111


Q ss_pred             HHhhhcccchhhccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q 046893          317 RPLLNNNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLET  373 (464)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~  373 (464)
                      .......     ...+..    ....+..+.+|+.+||+.||.+||++.++.+.|+.
T Consensus       226 ~~~~~~~-----~~~~~~----~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~  273 (305)
T cd05609         226 GQVISDD-----IEWPEG----DEALPADAQDLISRLLRQNPLERLGTGGAFEVKQH  273 (305)
T ss_pred             HHHHhcc-----cCCCCc----cccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence            1111110     001111    11344578999999999999999998777777765

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=6.4e-39  Score=306.45  Aligned_cols=255  Identities=26%  Similarity=0.402  Sum_probs=200.3

Q ss_pred             CCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCC----------CccHHHHHHHHHHHhc-CCCCCcceEE
Q 046893           93 FFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGG----------YQGDREWLAEVNYLGQ-LRHSNLVKLI  161 (464)
Q Consensus        93 ~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~----------~~~~~~~~~E~~~l~~-l~hpniv~l~  161 (464)
                      +|.+.+.||+|+||.||+|.+..+     .+..+|+|.+....          .....++..|+.++.. ++||||++++
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~-----~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~   75 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNN-----GQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYY   75 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCC-----CCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEE
Confidence            477888999999999999998762     24678999875321          1122456788888865 7999999999


Q ss_pred             EEEEeCCeEEEEEeccCCCCHHHHHHh--hcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceE
Q 046893          162 GYCCEDEHRILVYEYMESGSLEKHLLR--RVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAK  239 (464)
Q Consensus       162 ~~~~~~~~~~lv~e~~~~g~L~~~l~~--~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vk  239 (464)
                      +++...+..++||||+.+++|.+++..  .....+++..++.++.|++.||.|||+ ..+++|+||+|+|||++.++.++
T Consensus        76 ~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~-~~~i~H~dl~~~nil~~~~~~~~  154 (269)
T cd08528          76 KTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHK-EKRIVHRDLTPNNIMLGEDDKVT  154 (269)
T ss_pred             eeEccCCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhcc-CCceeecCCCHHHEEECCCCcEE
Confidence            999999999999999999999988753  224468999999999999999999994 35699999999999999999999


Q ss_pred             EcccCCccCCCCCCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHh
Q 046893          240 LSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPL  319 (464)
Q Consensus       240 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~  319 (464)
                      |+|||++.......   ......|+..|+|||++.+..++.++||||||+++|+|++|+.||......      ......
T Consensus       155 l~dfg~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~------~~~~~~  225 (269)
T cd08528         155 ITDFGLAKQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNML------SLATKI  225 (269)
T ss_pred             Eecccceeeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHH------HHHHHH
Confidence            99999998643322   223467899999999999888999999999999999999999999654311      111111


Q ss_pred             hhcccchhhccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 046893          320 LNNNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLE  372 (464)
Q Consensus       320 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~  372 (464)
                      ....      ..+..    ....+..+.+++.+||+.||.+||++.++.++|+
T Consensus       226 ~~~~------~~~~~----~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~  268 (269)
T cd08528         226 VEAV------YEPLP----EGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS  268 (269)
T ss_pred             hhcc------CCcCC----cccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence            1110      00100    1123457899999999999999999999998875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=9.7e-39  Score=312.69  Aligned_cols=199  Identities=24%  Similarity=0.334  Sum_probs=159.9

Q ss_pred             CCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCccHHHHHHHHHHHhcCCCCCcceEEEEEEe--CCeEEEEE
Q 046893           97 DYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVKLIGYCCE--DEHRILVY  174 (464)
Q Consensus        97 ~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~--~~~~~lv~  174 (464)
                      ..+||+|+||+||+|.+....    .+..||+|.+....  ....+.+|+.+|+.++||||+++++++..  +...++||
T Consensus         6 g~~lG~G~~g~Vy~~~~~~~~----~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~   79 (317)
T cd07867           6 GCKVGRGTYGHVYKAKRKDGK----DEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLF   79 (317)
T ss_pred             ceEeccCCCeeEEEEEecCCC----ccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEE
Confidence            357999999999999865431    24679999886543  23467889999999999999999998854  46789999


Q ss_pred             eccCCCCHHHHHHhhc-------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEe----cCCCceEEccc
Q 046893          175 EYMESGSLEKHLLRRV-------GCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILL----NADFSAKLSDF  243 (464)
Q Consensus       175 e~~~~g~L~~~l~~~~-------~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill----~~~~~vkl~DF  243 (464)
                      ||+. ++|.+++....       ...+++..+..++.|++.||.|||  ..+|+||||||+|||+    +.++.+||+||
T Consensus        80 e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH--~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~Df  156 (317)
T cd07867          80 DYAE-HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLH--ANWVLHRDLKPANILVMGEGPERGRVKIADM  156 (317)
T ss_pred             eeeC-CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHH--hCCEEcCCCCHHHEEEccCCCCCCcEEEeec
Confidence            9995 58877775321       235889999999999999999999  5779999999999999    55678999999


Q ss_pred             CCccCCCCCCCc-ceeeccccCCcccCcccccc-CCCCcccchhcHHHHHHHHHhCCCCCCCC
Q 046893          244 GLAKDGPMGDQT-HVSTRVMGTYGYAAPEYVMT-GHLTARSDVYGFGVVLLEMLLGRRAVDKS  304 (464)
Q Consensus       244 Gla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~g~~pf~~~  304 (464)
                      |+++........ .......||..|+|||++.+ ..++.++|||||||++|||++|+.||...
T Consensus       157 G~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~  219 (317)
T cd07867         157 GFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR  219 (317)
T ss_pred             cceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence            999864332211 11233578999999999876 45899999999999999999999999754

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=9.2e-39  Score=306.94  Aligned_cols=247  Identities=24%  Similarity=0.355  Sum_probs=199.7

Q ss_pred             CCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCC-ccHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeEE
Q 046893           93 FFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGY-QGDREWLAEVNYLGQLRHSNLVKLIGYCCEDEHRI  171 (464)
Q Consensus        93 ~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~  171 (464)
                      -|.+.+.||.|+||.||+|.+..+      +..+|+|.+..... .....+.+|+.++..++||||+++++++..+...+
T Consensus         5 ~~~~~~~ig~G~~~~vy~~~~~~~------~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~   78 (277)
T cd06641           5 LFTKLEKIGKGSFGEVFKGIDNRT------QKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLW   78 (277)
T ss_pred             hhhhheeEeecCCeEEEEEEECCC------CcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEE
Confidence            377788899999999999987654      56799998765432 22356889999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCccCCCC
Q 046893          172 LVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPM  251 (464)
Q Consensus       172 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~  251 (464)
                      +||||+.+++|.+++...   .+++..+..++.|++.+|.|||  ..+++|+||+|+||+++.++.++|+|||++.....
T Consensus        79 lv~e~~~~~~l~~~i~~~---~~~~~~~~~~~~~l~~~l~~lh--~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~  153 (277)
T cd06641          79 IIMEYLGGGSALDLLEPG---PLDETQIATILREILKGLDYLH--SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTD  153 (277)
T ss_pred             EEEEeCCCCcHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHc--cCCeecCCCCHHhEEECCCCCEEEeecccceeccc
Confidence            999999999999887642   5899999999999999999999  67899999999999999999999999999875432


Q ss_pred             CCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhcccchhhccC
Q 046893          252 GDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRILD  331 (464)
Q Consensus       252 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  331 (464)
                      ..  .......|+..|+|||.+.+..++.++|||||||++|+|++|..||......      .+.......         
T Consensus       154 ~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~------~~~~~~~~~---------  216 (277)
T cd06641         154 TQ--IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPM------KVLFLIPKN---------  216 (277)
T ss_pred             ch--hhhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchH------HHHHHHhcC---------
Confidence            21  1223356889999999998888999999999999999999999999754321      111110000         


Q ss_pred             ccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 046893          332 PRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVA  369 (464)
Q Consensus       332 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  369 (464)
                        .........+..+.+++.+||..+|.+||++.+++.
T Consensus       217 --~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~  252 (277)
T cd06641         217 --NPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLK  252 (277)
T ss_pred             --CCCCCCcccCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence              011122234557889999999999999999999987

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=7.4e-39  Score=309.69  Aligned_cols=264  Identities=24%  Similarity=0.350  Sum_probs=195.8

Q ss_pred             cCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCc-cHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeE
Q 046893           92 KFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQ-GDREWLAEVNYLGQLRHSNLVKLIGYCCEDEHR  170 (464)
Q Consensus        92 ~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~  170 (464)
                      ++|++.+.||.|+||.||+|.+..+      ++.||+|.+...... ....+.+|+.+++.++|+||+++++++...+..
T Consensus         5 ~~y~~~~~lg~g~~~~vy~~~~~~~------~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   78 (291)
T cd07844           5 ETYKKLDKLGEGSYATVYKGRSKLT------GQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTL   78 (291)
T ss_pred             cceeEEEEEeecCCeEEEEEEEcCC------CcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeE
Confidence            5688889999999999999997654      567999998654322 234567899999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCccCCC
Q 046893          171 ILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGP  250 (464)
Q Consensus       171 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~  250 (464)
                      ++||||+.+ +|.+++.... ..+++..+..++.|++.||.|||  +.+|+||||||+|||++.++.+||+|||+++...
T Consensus        79 ~lv~e~~~~-~L~~~~~~~~-~~~~~~~~~~~~~ql~~al~~lH--~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~  154 (291)
T cd07844          79 TLVFEYLDT-DLKQYMDDCG-GGLSMHNVRLFLFQLLRGLAYCH--QRRVLHRDLKPQNLLISERGELKLADFGLARAKS  154 (291)
T ss_pred             EEEEecCCC-CHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHH--hCCeecccCCHHHEEEcCCCCEEECccccccccC
Confidence            999999974 9998886543 36899999999999999999999  6779999999999999999999999999987532


Q ss_pred             CCCCcceeeccccCCcccCcccccc-CCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhcc-cch--
Q 046893          251 MGDQTHVSTRVMGTYGYAAPEYVMT-GHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNN-KKV--  326 (464)
Q Consensus       251 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~-~~~--  326 (464)
                      ....  ......++..|+|||++.+ ..++.++||||||+++|+|++|+.||........  ........+... ...  
T Consensus       155 ~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~  230 (291)
T cd07844         155 VPSK--TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVED--QLHKIFRVLGTPTEETWP  230 (291)
T ss_pred             CCCc--cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHH--HHHHHHHhcCCCChhhhh
Confidence            2211  1122357889999998875 4588999999999999999999999965432111  000000000000 000  


Q ss_pred             --------hh----ccCccccCccCHHH--HHHHHHHHHHhhccCCCCCCCHHHHHH
Q 046893          327 --------LR----ILDPRLEGQYTART--AMKVAGLAYQCLSQNPKGRPVMSDVVA  369 (464)
Q Consensus       327 --------~~----~~~~~~~~~~~~~~--~~~l~~li~~cl~~dP~~RPs~~ev~~  369 (464)
                              ..    ...+..........  ...+.+++.+||+.+|.+||++.+++.
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~  287 (291)
T cd07844         231 GVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK  287 (291)
T ss_pred             hhhhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence                    00    00000000000011  147789999999999999999999874

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=7.2e-39  Score=303.64  Aligned_cols=248  Identities=25%  Similarity=0.386  Sum_probs=199.0

Q ss_pred             CCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCC-----ccHHHHHHHHHHHhcCCCCCcceEEEEEEeC
Q 046893           93 FFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGY-----QGDREWLAEVNYLGQLRHSNLVKLIGYCCED  167 (464)
Q Consensus        93 ~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~  167 (464)
                      +|+..+.||+|+||.||+|.+..+      +..|++|.+.....     ...+.+..|+.+++.++|+||+++++++...
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~------~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~   74 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDD------GDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREE   74 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCC------CcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecC
Confidence            477788999999999999998754      56699998765331     1335688999999999999999999999999


Q ss_pred             CeEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCcc
Q 046893          168 EHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAK  247 (464)
Q Consensus       168 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~  247 (464)
                      ...++||||+++++|.+++.+.  ..+++..+..++.|++.||.|||  ..+|+|+||+|+||+++.++.+||+|||++.
T Consensus        75 ~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH--~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~  150 (258)
T cd06632          75 DNLYIFLELVPGGSLAKLLKKY--GSFPEPVIRLYTRQILLGLEYLH--DRNTVHRDIKGANILVDTNGVVKLADFGMAK  150 (258)
T ss_pred             CeEEEEEEecCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH--HCCcccCCCCHHHEEECCCCCEEEccCccce
Confidence            9999999999999999988764  35899999999999999999999  5679999999999999999999999999987


Q ss_pred             CCCCCCCcceeeccccCCcccCccccccCC-CCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhcccch
Q 046893          248 DGPMGDQTHVSTRVMGTYGYAAPEYVMTGH-LTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKV  326 (464)
Q Consensus       248 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  326 (464)
                      ......   ......|+..|++||.+.... ++.++|+||||+++|+|++|+.||......      ......... .  
T Consensus       151 ~~~~~~---~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~------~~~~~~~~~-~--  218 (258)
T cd06632         151 QVVEFS---FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGV------AAVFKIGRS-K--  218 (258)
T ss_pred             eccccc---cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHH------HHHHHHHhc-c--
Confidence            643222   223467899999999987766 899999999999999999999999754311      111100000 0  


Q ss_pred             hhccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 046893          327 LRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVA  369 (464)
Q Consensus       327 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  369 (464)
                             .....+......+.+++.+||..+|.+||++.+++.
T Consensus       219 -------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  254 (258)
T cd06632         219 -------ELPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLE  254 (258)
T ss_pred             -------cCCCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence                   001122234457889999999999999999999874

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=7.3e-39  Score=310.80  Aligned_cols=263  Identities=26%  Similarity=0.333  Sum_probs=198.5

Q ss_pred             CCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCc-----cHHHHHHHHHHHhcCCCCCcceEEEEEEeC
Q 046893           93 FFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQ-----GDREWLAEVNYLGQLRHSNLVKLIGYCCED  167 (464)
Q Consensus        93 ~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~hpniv~l~~~~~~~  167 (464)
                      +|.+.+.||+|+||.||+|.+..+      ++.||||.+......     ....+..|+.+++.++|+||+++++++.+.
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~------~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~   74 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKET------GRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHK   74 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCC------CcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecC
Confidence            477788999999999999998765      567999998765432     234567899999999999999999999999


Q ss_pred             CeEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCcc
Q 046893          168 EHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAK  247 (464)
Q Consensus       168 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~  247 (464)
                      +..++||||+ +++|.+++.... ..+++..++.++.||+.||.|||  ..+|+|+||||+|||++.++.++|+|||+++
T Consensus        75 ~~~~lv~e~~-~~~L~~~i~~~~-~~~~~~~~~~~~~qi~~al~~lH--~~~i~H~dl~p~nill~~~~~~~l~dfg~~~  150 (298)
T cd07841          75 SNINLVFEFM-ETDLEKVIKDKS-IVLTPADIKSYMLMTLRGLEYLH--SNWILHRDLKPNNLLIASDGVLKLADFGLAR  150 (298)
T ss_pred             CEEEEEEccc-CCCHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHH--hCCeeecCCChhhEEEcCCCCEEEccceeee
Confidence            9999999999 889999886543 36899999999999999999999  6779999999999999999999999999998


Q ss_pred             CCCCCCCcceeeccccCCcccCcccccc-CCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhc----
Q 046893          248 DGPMGDQTHVSTRVMGTYGYAAPEYVMT-GHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNN----  322 (464)
Q Consensus       248 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~----  322 (464)
                      .......  ......++..|+|||.+.+ ..++.++|||||||++|||++|..+|........  +..........    
T Consensus       151 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~--~~~~~~~~~~~~~~~  226 (298)
T cd07841         151 SFGSPNR--KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQ--LGKIFEALGTPTEEN  226 (298)
T ss_pred             eccCCCc--cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHH--HHHHHHHcCCCchhh
Confidence            6533221  1223457888999998865 4678999999999999999999877765433211  11110000000    


Q ss_pred             ---ccchhhccCc-----cccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 046893          323 ---NKKVLRILDP-----RLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVA  369 (464)
Q Consensus       323 ---~~~~~~~~~~-----~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  369 (464)
                         ..........     ..........+..+.+++.+||..||++||++.+++.
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~  281 (298)
T cd07841         227 WPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALE  281 (298)
T ss_pred             hhhcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhh
Confidence               0000000000     0000111234568899999999999999999999986

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=9e-39  Score=307.61  Aligned_cols=251  Identities=25%  Similarity=0.364  Sum_probs=193.0

Q ss_pred             cCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCC-ccHHHHHHHHHH-HhcCCCCCcceEEEEEEeCCe
Q 046893           92 KFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGY-QGDREWLAEVNY-LGQLRHSNLVKLIGYCCEDEH  169 (464)
Q Consensus        92 ~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~-l~~l~hpniv~l~~~~~~~~~  169 (464)
                      ++|++.+.||+|+||.||+|.+..+      ++.||+|.+..... .....+..|+.+ ++.++||||+++++++..++.
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~------~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~   74 (283)
T cd06617           1 DDLEVIEELGRGAYGVVDKMRHVPT------GTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGD   74 (283)
T ss_pred             CCceEEEEecccCCeEEEEEEEcCC------CcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCc
Confidence            3588889999999999999998765      67799999875432 233456666665 566789999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHhh--cCCCCCHHHHHHHHHHHHHHHHHHhcCCC-CeeeccCCCCceEecCCCceEEcccCCc
Q 046893          170 RILVYEYMESGSLEKHLLRR--VGCMLTWSRRMKIALDAAKGLAFLHGAER-PVIYRDFKTSNILLNADFSAKLSDFGLA  246 (464)
Q Consensus       170 ~~lv~e~~~~g~L~~~l~~~--~~~~l~~~~~~~i~~qi~~~l~~LH~~~~-~ivHrDlkp~Nill~~~~~vkl~DFGla  246 (464)
                      .++||||++ |+|.+++...  ....+++..++.++.|++.||.|||  ++ +++||||||+|||++.++.+||+|||++
T Consensus        75 ~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH--~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~  151 (283)
T cd06617          75 VWICMEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLH--SKLSVIHRDVKPSNVLINRNGQVKLCDFGIS  151 (283)
T ss_pred             EEEEhhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHh--hcCCeecCCCCHHHEEECCCCCEEEeecccc
Confidence            999999996 6888877543  2346899999999999999999999  44 7999999999999999999999999999


Q ss_pred             cCCCCCCCcceeeccccCCcccCcccccc----CCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhc
Q 046893          247 KDGPMGDQTHVSTRVMGTYGYAAPEYVMT----GHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNN  322 (464)
Q Consensus       247 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~  322 (464)
                      ......   .......|+..|+|||++.+    ..++.++|||||||++|+|++|+.||......    .... ......
T Consensus       152 ~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~----~~~~-~~~~~~  223 (283)
T cd06617         152 GYLVDS---VAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTP----FQQL-KQVVEE  223 (283)
T ss_pred             cccccc---cccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccC----HHHH-HHHHhc
Confidence            864221   11223568899999998864    45788999999999999999999999643211    0110 000000


Q ss_pred             ccchhhccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 046893          323 NKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVA  369 (464)
Q Consensus       323 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  369 (464)
                             ..+.+.   ....+..+.+++.+||..+|.+||++.++++
T Consensus       224 -------~~~~~~---~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~  260 (283)
T cd06617         224 -------PSPQLP---AEKFSPEFQDFVNKCLKKNYKERPNYPELLQ  260 (283)
T ss_pred             -------CCCCCC---ccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence                   011110   1124557899999999999999999999985

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=1.1e-38  Score=308.63  Aligned_cols=262  Identities=27%  Similarity=0.348  Sum_probs=201.7

Q ss_pred             cchhHHHHHhcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCccHHHHHHHHHHHhcC-CCCCcceE
Q 046893           82 FTYNEMKLATKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQL-RHSNLVKL  160 (464)
Q Consensus        82 ~~~~~~~~~~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l  160 (464)
                      +...++....++|.+...||+|+||.||+|.+..+      ++.+|+|++.... .....+..|+.++..+ +||||+++
T Consensus        12 ~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~------~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~   84 (291)
T cd06639          12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKD------GSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKF   84 (291)
T ss_pred             hhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCC------CCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEE
Confidence            34445555678899999999999999999998764      6679999986532 2346678899999999 79999999


Q ss_pred             EEEEEeC-----CeEEEEEeccCCCCHHHHHHhh--cCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEec
Q 046893          161 IGYCCED-----EHRILVYEYMESGSLEKHLLRR--VGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLN  233 (464)
Q Consensus       161 ~~~~~~~-----~~~~lv~e~~~~g~L~~~l~~~--~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~  233 (464)
                      ++++...     +..++||||+++++|.+++...  .+..+++..++.++.|++.||.|||  ..+++||||||+||+++
T Consensus        85 ~~~~~~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH--~~~ivH~dlkp~nili~  162 (291)
T cd06639          85 YGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLH--NNRIIHRDVKGNNILLT  162 (291)
T ss_pred             EEEEEeccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHH--hCCeeccCCCHHHEEEc
Confidence            9998754     3589999999999999987542  2346899999999999999999999  67799999999999999


Q ss_pred             CCCceEEcccCCccCCCCCCCcceeeccccCCcccCccccccC-----CCCcccchhcHHHHHHHHHhCCCCCCCCCCcc
Q 046893          234 ADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTG-----HLTARSDVYGFGVVLLEMLLGRRAVDKSRPSR  308 (464)
Q Consensus       234 ~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DvwslG~il~ell~g~~pf~~~~~~~  308 (464)
                      .++.+||+|||++........  ......|+..|+|||++...     .++.++|||||||++|||++|+.||....+..
T Consensus       163 ~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~  240 (291)
T cd06639         163 TEGGVKLVDFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVK  240 (291)
T ss_pred             CCCCEEEeecccchhcccccc--cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHH
Confidence            999999999999886432221  12235689999999987543     36889999999999999999999997543211


Q ss_pred             cccHHHHHHHhhhcccchhhccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 046893          309 EHNLVEWARPLLNNNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVA  369 (464)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  369 (464)
                        .+..+    ...       ..+.+  ..+......+.+||.+||+.+|++||++.+++.
T Consensus       241 --~~~~~----~~~-------~~~~~--~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~  286 (291)
T cd06639         241 --TLFKI----PRN-------PPPTL--LHPEKWCRSFNHFISQCLIKDFEARPSVTHLLE  286 (291)
T ss_pred             --HHHHH----hcC-------CCCCC--CcccccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence              11111    000       00000  111223347899999999999999999999875

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=7.5e-39  Score=305.02  Aligned_cols=254  Identities=26%  Similarity=0.385  Sum_probs=202.3

Q ss_pred             CCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCC-ccHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeEE
Q 046893           93 FFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGY-QGDREWLAEVNYLGQLRHSNLVKLIGYCCEDEHRI  171 (464)
Q Consensus        93 ~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~  171 (464)
                      +|++.+.||.|+||.||+|.+..+      ++.+|+|.+..... .....+.+|+++++.+.||||+++++++...+..+
T Consensus         2 ~~~~~~~ig~g~~~~v~~~~~~~~------~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~   75 (265)
T cd06605           2 DLEYLGELGAGNSGVVSKVLHRPT------GKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDIS   75 (265)
T ss_pred             cchHHHHhcCCCCeEEEEEEEcCC------CcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEE
Confidence            577788999999999999998764      56799998876533 33467889999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCccCCCC
Q 046893          172 LVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPM  251 (464)
Q Consensus       172 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~  251 (464)
                      +||||+.+++|.+++.... ..+++..+..++.|++.||.|||+ ..+++|+||||+||+++.++.++|+|||++.....
T Consensus        76 lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~-~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~  153 (265)
T cd06605          76 ICMEYMDGGSLDKILKEVQ-GRIPERILGKIAVAVLKGLTYLHE-KHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVN  153 (265)
T ss_pred             EEEEecCCCcHHHHHHHcc-CCCCHHHHHHHHHHHHHHHHHHcC-CCCeecCCCCHHHEEECCCCCEEEeecccchhhHH
Confidence            9999999999999887643 478999999999999999999993 17799999999999999999999999999875322


Q ss_pred             CCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhcccchhhccC
Q 046893          252 GDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRILD  331 (464)
Q Consensus       252 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  331 (464)
                      ..    .....|+..|+|||.+.+..++.++||||||+++|+|++|..||....... ....+.........       .
T Consensus       154 ~~----~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~-~~~~~~~~~~~~~~-------~  221 (265)
T cd06605         154 SL----AKTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPP-DGIFELLQYIVNEP-------P  221 (265)
T ss_pred             HH----hhcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccccc-ccHHHHHHHHhcCC-------C
Confidence            11    112678899999999999999999999999999999999999997543211 11122222111110       0


Q ss_pred             ccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 046893          332 PRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVA  369 (464)
Q Consensus       332 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  369 (464)
                      +.+.   ....+..+.++|.+||..||.+||++.+++.
T Consensus       222 ~~~~---~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~  256 (265)
T cd06605         222 PRLP---SGKFSPDFQDFVNLCLIKDPRERPSYKELLE  256 (265)
T ss_pred             CCCC---hhhcCHHHHHHHHHHcCCCchhCcCHHHHhh
Confidence            1111   1114557899999999999999999999874

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=1.6e-38  Score=302.26  Aligned_cols=251  Identities=27%  Similarity=0.389  Sum_probs=205.4

Q ss_pred             CCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCC-ccHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeEE
Q 046893           93 FFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGY-QGDREWLAEVNYLGQLRHSNLVKLIGYCCEDEHRI  171 (464)
Q Consensus        93 ~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~  171 (464)
                      +|++.+.||+|+||.||+|.+..+      +..|++|++..... .....+..|+.++..++|+||+++++++...+..+
T Consensus         2 ~~~~~~~i~~g~~~~v~~~~~~~~------~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   75 (264)
T cd06623           2 DLERVKVLGQGSSGVVYKVRHKPT------GKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEIS   75 (264)
T ss_pred             cceeeeeeeecCCeEEEEEEEcCC------CcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEE
Confidence            578889999999999999998764      56799999876543 33567899999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC-CCeeeccCCCCceEecCCCceEEcccCCccCCC
Q 046893          172 LVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAE-RPVIYRDFKTSNILLNADFSAKLSDFGLAKDGP  250 (464)
Q Consensus       172 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~-~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~  250 (464)
                      +||||+++++|.+++...  ..+++..++.++.|++.||.|||  . .+++|+||+|+||+++.++.++|+|||++....
T Consensus        76 lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~l~~~l~~lh--~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~  151 (264)
T cd06623          76 IVLEYMDGGSLADLLKKV--GKIPEPVLAYIARQILKGLDYLH--TKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLE  151 (264)
T ss_pred             EEEEecCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHh--ccCCCccCCCCHHHEEECCCCCEEEccCccceecc
Confidence            999999999999998764  46899999999999999999999  6 779999999999999999999999999998643


Q ss_pred             CCCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhcccchhhcc
Q 046893          251 MGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRIL  330 (464)
Q Consensus       251 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  330 (464)
                      .....  .....++..|+|||.+.+..++.++||||||+++|+|++|..||..........+..+.   ...       .
T Consensus       152 ~~~~~--~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~---~~~-------~  219 (264)
T cd06623         152 NTLDQ--CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAI---CDG-------P  219 (264)
T ss_pred             cCCCc--ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHH---hcC-------C
Confidence            32221  12356889999999999889999999999999999999999999765431111111111   100       0


Q ss_pred             CccccCccCHH-HHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 046893          331 DPRLEGQYTAR-TAMKVAGLAYQCLSQNPKGRPVMSDVVA  369 (464)
Q Consensus       331 ~~~~~~~~~~~-~~~~l~~li~~cl~~dP~~RPs~~ev~~  369 (464)
                      .+    ..+.. .+..+.+++.+||..+|.+||++.++++
T Consensus       220 ~~----~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~  255 (264)
T cd06623         220 PP----SLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQ  255 (264)
T ss_pred             CC----CCCcccCCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence            11    11222 4568999999999999999999999986

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.1e-39  Score=322.90  Aligned_cols=246  Identities=24%  Similarity=0.368  Sum_probs=193.6

Q ss_pred             CCCCCCceeecCceEEEEEEecCCCCCCccceEEE---EEEccCCC-CccHHHHHHHHHHHhcCCCCCcceEEEEEEeCC
Q 046893           93 FFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVA---IKELNRGG-YQGDREWLAEVNYLGQLRHSNLVKLIGYCCEDE  168 (464)
Q Consensus        93 ~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~va---vK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~  168 (464)
                      +.+...+||+|+|-+||+|.+..+      +..||   ||.-.... ....++|..|+.+|+.|+|||||++|++|.+..
T Consensus        41 y~k~~evLGrGafKtVYka~De~~------giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~  114 (632)
T KOG0584|consen   41 YLKFDEVLGRGAFKTVYKAFDEEE------GIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTD  114 (632)
T ss_pred             eeehhhhcccccceeeeecccccc------chhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCC
Confidence            345566799999999999998765      33344   33322211 222377999999999999999999999998876


Q ss_pred             e--EEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCC-CceEEcccCC
Q 046893          169 H--RILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNAD-FSAKLSDFGL  245 (464)
Q Consensus       169 ~--~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~-~~vkl~DFGl  245 (464)
                      .  ..+|.|++..|+|..|+.+..  .++...+..|+.||+.||.|||+...+|||||||.+||+|+.+ |.|||+|+||
T Consensus       115 n~~in~iTEL~TSGtLr~Y~kk~~--~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGL  192 (632)
T KOG0584|consen  115 NKTINFITELFTSGTLREYRKKHR--RVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGL  192 (632)
T ss_pred             CceeeeeeecccCCcHHHHHHHhc--cCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhH
Confidence            5  778999999999999998865  6899999999999999999999999999999999999999654 8999999999


Q ss_pred             ccCCCCCCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhcc--
Q 046893          246 AKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNN--  323 (464)
Q Consensus       246 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~--  323 (464)
                      |.....    .....++||+.|||||+.. ..|+..+||||||++++||+|+..||..-..     -.+..+......  
T Consensus       193 Atl~r~----s~aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n-----~AQIYKKV~SGiKP  262 (632)
T KOG0584|consen  193 ATLLRK----SHAKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTN-----PAQIYKKVTSGIKP  262 (632)
T ss_pred             HHHhhc----cccceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCC-----HHHHHHHHHcCCCH
Confidence            986432    2223379999999999765 8899999999999999999999999965332     122222222211  


Q ss_pred             cchhhccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 046893          324 KKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVA  369 (464)
Q Consensus       324 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  369 (464)
                      ..+.+..            ..++.+||.+||.. ..+||++.|++.
T Consensus       263 ~sl~kV~------------dPevr~fIekCl~~-~~~R~sa~eLL~  295 (632)
T KOG0584|consen  263 AALSKVK------------DPEVREFIEKCLAT-KSERLSAKELLK  295 (632)
T ss_pred             HHhhccC------------CHHHHHHHHHHhcC-chhccCHHHHhh
Confidence            0111111            23789999999999 999999999984

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=2.6e-39  Score=311.89  Aligned_cols=265  Identities=27%  Similarity=0.372  Sum_probs=198.3

Q ss_pred             CCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCc--cHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeE
Q 046893           93 FFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQ--GDREWLAEVNYLGQLRHSNLVKLIGYCCEDEHR  170 (464)
Q Consensus        93 ~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~  170 (464)
                      +|++.+.||+|+||.||+|.+..+      ++.||+|.+......  ..+.+.+|+++++.++||||+++++++..++..
T Consensus         2 ~y~~~~~lg~g~~~~vy~~~~~~~------~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   75 (286)
T cd07846           2 KYENLGLVGEGSYGMVMKCKHKET------GQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRL   75 (286)
T ss_pred             ceeEeeeeccCCCeEEEEEEECCC------CCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeE
Confidence            578889999999999999998764      567999987653322  235678999999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCccCCC
Q 046893          171 ILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGP  250 (464)
Q Consensus       171 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~  250 (464)
                      ++||||++++.|..+....  ..+++..++.++.|++.||.|||  ..+++|+||+|+||+++.++.++|+|||++....
T Consensus        76 ~lv~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~LH--~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~  151 (286)
T cd07846          76 YLVFEFVDHTVLDDLEKYP--NGLDESRVRKYLFQILRGIEFCH--SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLA  151 (286)
T ss_pred             EEEEecCCccHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHH--HCCccccCCCHHHEEECCCCcEEEEeeeeeeecc
Confidence            9999999998887765443  35899999999999999999999  5679999999999999999999999999987643


Q ss_pred             CCCCcceeeccccCCcccCcccccc-CCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccc-cHHHHHH-------Hhhh
Q 046893          251 MGDQTHVSTRVMGTYGYAAPEYVMT-GHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREH-NLVEWAR-------PLLN  321 (464)
Q Consensus       251 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~-~~~~~~~-------~~~~  321 (464)
                      ...  .......++..|+|||++.+ ..++.++||||||+++|||++|+.||......... .+..+..       ..+.
T Consensus       152 ~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (286)
T cd07846         152 APG--EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQ  229 (286)
T ss_pred             CCc--cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhc
Confidence            322  22233568899999998875 45788999999999999999999998654321110 0010000       0000


Q ss_pred             cccchhhccCccccC-----ccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 046893          322 NNKKVLRILDPRLEG-----QYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVA  369 (464)
Q Consensus       322 ~~~~~~~~~~~~~~~-----~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  369 (464)
                      ..........+....     ......+..+.+|+.+||..+|.+||++.+++.
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~  282 (286)
T cd07846         230 KNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH  282 (286)
T ss_pred             cchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence            000000000000000     011234568999999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=1.4e-38  Score=307.03  Aligned_cols=248  Identities=23%  Similarity=0.365  Sum_probs=198.8

Q ss_pred             CCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCccHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeEEEE
Q 046893           94 FRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVKLIGYCCEDEHRILV  173 (464)
Q Consensus        94 ~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv  173 (464)
                      |...+.||+|+||.||+|.+..+      +..+++|.+........+.+.+|+.+++.+.||||+++++++...+..++|
T Consensus        21 ~~~~~~lg~g~~g~v~~~~~~~~------~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v   94 (285)
T cd06648          21 LDNFVKIGEGSTGIVCIATDKST------GRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVV   94 (285)
T ss_pred             hhcceEeccCCCeEEEEEEECCC------CCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEE
Confidence            44456899999999999987654      567999988654444456688999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCccCCCCCC
Q 046893          174 YEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGD  253 (464)
Q Consensus       174 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~  253 (464)
                      +||+.+++|.+++..   ..+++..+..++.|++.||.|||  +.+|+||||+|+||+++.++.++|+|||++.......
T Consensus        95 ~e~~~~~~L~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH--~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~  169 (285)
T cd06648          95 MEFLEGGALTDIVTH---TRMNEEQIATVCLAVLKALSFLH--AQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEV  169 (285)
T ss_pred             EeccCCCCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHH--hCCeecCCCChhhEEEcCCCcEEEcccccchhhccCC
Confidence            999999999998876   25899999999999999999999  5679999999999999999999999999887532211


Q ss_pred             CcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhcccchhhccCcc
Q 046893          254 QTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRILDPR  333 (464)
Q Consensus       254 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  333 (464)
                        .......|+..|+|||.+.+..++.++||||||+++|+|++|+.||....+.      .........       ..+.
T Consensus       170 --~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~------~~~~~~~~~-------~~~~  234 (285)
T cd06648         170 --PRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPL------QAMKRIRDN-------LPPK  234 (285)
T ss_pred             --cccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHH------HHHHHHHhc-------CCCC
Confidence              1223356899999999998888999999999999999999999999764321      111111111       0011


Q ss_pred             ccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 046893          334 LEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVA  369 (464)
Q Consensus       334 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  369 (464)
                      ..  .....+..+.+|+.+||..+|.+||++.++++
T Consensus       235 ~~--~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~  268 (285)
T cd06648         235 LK--NLHKVSPRLRSFLDRMLVRDPAQRATAAELLN  268 (285)
T ss_pred             Cc--ccccCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence            11  11124458999999999999999999999874

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.1e-38  Score=330.63  Aligned_cols=276  Identities=18%  Similarity=0.213  Sum_probs=189.8

Q ss_pred             HHhcCCCCCCceeecCceEEEEEEecCCCCCCc---------cceE----EEEEEccCCCCccHHHHHHHHHHHhcCCCC
Q 046893           89 LATKFFRPDYILGEGGFGVVYKGVIDENVRPGY---------KTTF----VAIKELNRGGYQGDREWLAEVNYLGQLRHS  155 (464)
Q Consensus        89 ~~~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~---------~~~~----vavK~~~~~~~~~~~~~~~E~~~l~~l~hp  155 (464)
                      ...++|++.+.||+|+||+||+|.+........         .+..    ++.|.+.. .......+.+|+.+|+.++||
T Consensus       145 ~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~-~~~~~~~~~~Ei~il~~l~Hp  223 (501)
T PHA03210        145 EFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKA-GSRAAIQLENEILALGRLNHE  223 (501)
T ss_pred             hhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhc-chHHHHHHHHHHHHHHhCCCC
Confidence            345789999999999999999987654211100         0000    11111111 112235678999999999999


Q ss_pred             CcceEEEEEEeCCeEEEEEeccCCCCHHHHHHhhc---CCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEe
Q 046893          156 NLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRV---GCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILL  232 (464)
Q Consensus       156 niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~---~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill  232 (464)
                      ||+++++++...+..|+||+++ +++|..++....   ........+..|+.||+.||.|||  .++||||||||+||||
T Consensus       224 nIv~l~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH--~~gIiHrDLKP~NILl  300 (501)
T PHA03210        224 NILKIEEILRSEANTYMITQKY-DFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIH--DKKLIHRDIKLENIFL  300 (501)
T ss_pred             CcCcEeEEEEECCeeEEEEecc-ccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHH--hCCeecCCCCHHHEEE
Confidence            9999999999999999999999 457777765432   112345667889999999999999  5779999999999999


Q ss_pred             cCCCceEEcccCCccCCCCCCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHhCCCC-CCCCCCccccc
Q 046893          233 NADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRA-VDKSRPSREHN  311 (464)
Q Consensus       233 ~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~p-f~~~~~~~~~~  311 (464)
                      +.++.+||+|||+++...... ........||..|+|||++.+..++.++|||||||+||||++|..+ |..........
T Consensus       301 ~~~~~vkL~DFGla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~  379 (501)
T PHA03210        301 NCDGKIVLGDFGTAMPFEKER-EAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQ  379 (501)
T ss_pred             CCCCCEEEEeCCCceecCccc-ccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHH
Confidence            999999999999998653322 1222346899999999999999999999999999999999998754 44332222222


Q ss_pred             HHHHHHHhhhccc-------chhhccCcccc----CccC-----HHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 046893          312 LVEWARPLLNNNK-------KVLRILDPRLE----GQYT-----ARTAMKVAGLAYQCLSQNPKGRPVMSDVVA  369 (464)
Q Consensus       312 ~~~~~~~~~~~~~-------~~~~~~~~~~~----~~~~-----~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  369 (464)
                      +.+....+.....       .+...++....    ...+     ...+..+.+++.+||..||.+||++.+++.
T Consensus       380 ~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~  453 (501)
T PHA03210        380 LLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLA  453 (501)
T ss_pred             HHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhh
Confidence            2221111100000       00011100000    0000     012346778899999999999999999985

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=9.9e-39  Score=307.67  Aligned_cols=263  Identities=22%  Similarity=0.273  Sum_probs=200.1

Q ss_pred             CCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCC--ccHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeE
Q 046893           93 FFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGY--QGDREWLAEVNYLGQLRHSNLVKLIGYCCEDEHR  170 (464)
Q Consensus        93 ~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~  170 (464)
                      +|++.+.||.|+||.||+|.+..+      +..||+|++.....  .....+.+|+.+++.++||||+++++++......
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~------~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~   74 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRET------GETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGF   74 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCC------CceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCee
Confidence            478889999999999999998765      56799999875432  2236788999999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCccCCC
Q 046893          171 ILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGP  250 (464)
Q Consensus       171 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~  250 (464)
                      ++||||+ +++|.+++.... ..+++..++.++.|++.||.|||  ..+++|+||||+||+++.++.++|+|||++....
T Consensus        75 ~~v~e~~-~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH--~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~  150 (286)
T cd07832          75 VLVMEYM-PSDLSEVLRDEE-RPLPEAQVKSYMRMLLKGVAYMH--ANGIMHRDLKPANLLISADGVLKIADFGLARLFS  150 (286)
T ss_pred             EEEeccc-CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH--HCCeecCCcCHHHEEEcCCCcEEEeeeeeccccc
Confidence            9999999 999999886543 46899999999999999999999  5679999999999999999999999999998654


Q ss_pred             CCCCcceeeccccCCcccCccccccC-CCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhcc------
Q 046893          251 MGDQTHVSTRVMGTYGYAAPEYVMTG-HLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNN------  323 (464)
Q Consensus       251 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~------  323 (464)
                      .... .......|+..|+|||++.+. .++.++||||||+++|||++|.++|.......   ...+....+...      
T Consensus       151 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~  226 (286)
T cd07832         151 EEEP-RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIE---QLAIVFRTLGTPNEETWP  226 (286)
T ss_pred             CCCC-CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHH---HHHHHHHHcCCCChHHHh
Confidence            3321 112235789999999988654 46899999999999999999988886543211   111111100000      


Q ss_pred             -----cchhhccCccc----cCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 046893          324 -----KKVLRILDPRL----EGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVA  369 (464)
Q Consensus       324 -----~~~~~~~~~~~----~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  369 (464)
                           .....+..+..    ........+..+.+|+.+||..+|.+||++++++.
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~  281 (286)
T cd07832         227 GLTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALR  281 (286)
T ss_pred             hccCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhh
Confidence                 00000000000    00011123468999999999999999999999875

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=2.5e-38  Score=301.07  Aligned_cols=253  Identities=28%  Similarity=0.394  Sum_probs=200.5

Q ss_pred             CCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCc--cHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeE
Q 046893           93 FFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQ--GDREWLAEVNYLGQLRHSNLVKLIGYCCEDEHR  170 (464)
Q Consensus        93 ~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~  170 (464)
                      +|.+.+.||+|+||.||+|.+..+      +..|++|.+......  ....+..|+.+++.++|+||+++++++...+..
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~------~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~   74 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDT------GELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKV   74 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCC------CcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEE
Confidence            478889999999999999987654      567999998765443  446788999999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCccCCC
Q 046893          171 ILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGP  250 (464)
Q Consensus       171 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~  250 (464)
                      ++|+||+++++|.+++...  ..+++..+..++.|++.||.|||  +.+|+|+||+|+||+++.++.+||+|||++....
T Consensus        75 ~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lh--~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~  150 (264)
T cd06626          75 YIFMEYCSGGTLEELLEHG--RILDEHVIRVYTLQLLEGLAYLH--SHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLK  150 (264)
T ss_pred             EEEEecCCCCcHHHHHhhc--CCCChHHHHHHHHHHHHHHHHHH--HCCcccCCCCHHHEEECCCCCEEEcccccccccC
Confidence            9999999999999988764  35889999999999999999999  6779999999999999999999999999998653


Q ss_pred             CCCCcce--eeccccCCcccCccccccCC---CCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhcccc
Q 046893          251 MGDQTHV--STRVMGTYGYAAPEYVMTGH---LTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKK  325 (464)
Q Consensus       251 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~---~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  325 (464)
                      .......  .....++..|+|||++.+..   ++.++||||||+++|+|++|+.||.......     .........   
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~-----~~~~~~~~~---  222 (264)
T cd06626         151 NNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEF-----QIMFHVGAG---  222 (264)
T ss_pred             CCCCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchH-----HHHHHHhcC---
Confidence            3222111  11356889999999988766   8899999999999999999999997543110     111000000   


Q ss_pred             hhhccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 046893          326 VLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVA  369 (464)
Q Consensus       326 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  369 (464)
                          ..+.+.  .....+..+.+++.+||+.+|.+||++.+++.
T Consensus       223 ----~~~~~~--~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~  260 (264)
T cd06626         223 ----HKPPIP--DSLQLSPEGKDFLDRCLESDPKKRPTASELLQ  260 (264)
T ss_pred             ----CCCCCC--cccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence                001110  11123557889999999999999999999864

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2e-38  Score=304.28  Aligned_cols=248  Identities=25%  Similarity=0.368  Sum_probs=198.2

Q ss_pred             CCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCC-ccHHHHHHHHHHHhcCC---CCCcceEEEEEEeCC
Q 046893           93 FFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGY-QGDREWLAEVNYLGQLR---HSNLVKLIGYCCEDE  168 (464)
Q Consensus        93 ~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~---hpniv~l~~~~~~~~  168 (464)
                      .|.+.+.||.|+||.||+|.+..+      +..||+|.+..... ....++.+|+.+++.+.   ||||+++++++....
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~------~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~   75 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPT------GRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGP   75 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCC------CcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCC
Confidence            477788999999999999998664      56799999865432 33466888999999986   999999999999999


Q ss_pred             eEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCccC
Q 046893          169 HRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKD  248 (464)
Q Consensus       169 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~  248 (464)
                      ..++||||+++++|.+++...   .+++..++.++.|++.||.|||  ..+|+|+||+|+||+++.++.++|+|||++..
T Consensus        76 ~~~lv~e~~~~~~L~~~~~~~---~l~~~~~~~i~~~i~~~l~~lh--~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~  150 (277)
T cd06917          76 RLWIIMEYAEGGSVRTLMKAG---PIAEKYISVIIREVLVALKYIH--KVGVIHRDIKAANILVTNTGNVKLCDFGVAAL  150 (277)
T ss_pred             EEEEEEecCCCCcHHHHHHcc---CCCHHHHHHHHHHHHHHHHHHH--hCCcccCCcCHHHEEEcCCCCEEEccCCceee
Confidence            999999999999999987543   6899999999999999999999  67799999999999999999999999999986


Q ss_pred             CCCCCCcceeeccccCCcccCcccccc-CCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhcccchh
Q 046893          249 GPMGDQTHVSTRVMGTYGYAAPEYVMT-GHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVL  327 (464)
Q Consensus       249 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  327 (464)
                      .....  .......|+..|+|||.+.+ ..++.++||||||+++|+|++|..||........      ... .      .
T Consensus       151 ~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~------~~~-~------~  215 (277)
T cd06917         151 LNQNS--SKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRA------MML-I------P  215 (277)
T ss_pred             cCCCc--cccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhh------hhc-c------c
Confidence            54332  12233578999999998865 4578999999999999999999999976432111      000 0      0


Q ss_pred             hccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 046893          328 RILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVA  369 (464)
Q Consensus       328 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  369 (464)
                      ....+.+...   ..+.++.+++.+||..||.+||++.+++.
T Consensus       216 ~~~~~~~~~~---~~~~~~~~~i~~~l~~~p~~R~~~~~il~  254 (277)
T cd06917         216 KSKPPRLEDN---GYSKLLREFVAACLDEEPKERLSAEELLK  254 (277)
T ss_pred             cCCCCCCCcc---cCCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence            0001111111   13457899999999999999999999975

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=2.3e-38  Score=307.01  Aligned_cols=262  Identities=16%  Similarity=0.163  Sum_probs=188.7

Q ss_pred             HHhcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCccH-----------HHHHHHHHHHhcCCCCCc
Q 046893           89 LATKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGD-----------REWLAEVNYLGQLRHSNL  157 (464)
Q Consensus        89 ~~~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~-----------~~~~~E~~~l~~l~hpni  157 (464)
                      +..++|.+.++||+|+||+||+|.+..+..   ....+|+|+.........           .....++..+..+.|+||
T Consensus         9 i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~---~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i   85 (294)
T PHA02882          9 ITGKEWKIDKLIGCGGFGCVYETQCASDHC---INNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGI   85 (294)
T ss_pred             cCCCceEEeeEEecCCCceEEEEEEcCCcc---cccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCC
Confidence            345679999999999999999998765411   133467776543322111           112234445667789999


Q ss_pred             ceEEEEEEeCC----eEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEec
Q 046893          158 VKLIGYCCEDE----HRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLN  233 (464)
Q Consensus       158 v~l~~~~~~~~----~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~  233 (464)
                      +++++++....    ..+++|+++. .++.+.+...  ...++..+..++.|++.||.|||  .++|+||||||+|||++
T Consensus        86 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH--~~~iiHrDiKp~Nill~  160 (294)
T PHA02882         86 PKYYGCGSFKRCRMYYRFILLEKLV-ENTKEIFKRI--KCKNKKLIKNIMKDMLTTLEYIH--EHGISHGDIKPENIMVD  160 (294)
T ss_pred             CcEEEeeeEecCCceEEEEEEehhc-cCHHHHHHhh--ccCCHHHHHHHHHHHHHHHHHHH--hCCeecCCCCHHHEEEc
Confidence            99998766543    4578888873 4676665443  24678889999999999999999  67799999999999999


Q ss_pred             CCCceEEcccCCccCCCCCCCc-----ceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHhCCCCCCCCCCcc
Q 046893          234 ADFSAKLSDFGLAKDGPMGDQT-----HVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSR  308 (464)
Q Consensus       234 ~~~~vkl~DFGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~  308 (464)
                      .++.++|+|||+|+........     .......||+.|+|||++.+..++.++|||||||+||||++|+.||.......
T Consensus       161 ~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~  240 (294)
T PHA02882        161 GNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNG  240 (294)
T ss_pred             CCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccch
Confidence            9999999999999865322111     11123579999999999999999999999999999999999999998653221


Q ss_pred             cccH---HHHHHHhhhcccchhhccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 046893          309 EHNL---VEWARPLLNNNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALL  371 (464)
Q Consensus       309 ~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L  371 (464)
                      ....   .++...+          .....   ....++..+.+++..||..+|.+||++.++++.|
T Consensus       241 ~~~~~~~~~~~~~~----------~~~~~---~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~  293 (294)
T PHA02882        241 NLIHAAKCDFIKRL----------HEGKI---KIKNANKFIYDFIECVTKLSYEEKPDYDALIKIF  293 (294)
T ss_pred             HHHHHhHHHHHHHh----------hhhhh---ccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence            1100   0111111          11110   0112356899999999999999999999999876

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=7.9e-39  Score=308.28  Aligned_cols=263  Identities=24%  Similarity=0.322  Sum_probs=198.1

Q ss_pred             CCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCc--cHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeE
Q 046893           93 FFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQ--GDREWLAEVNYLGQLRHSNLVKLIGYCCEDEHR  170 (464)
Q Consensus        93 ~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~  170 (464)
                      +|++.+.||.|+||.||+|++..+      ++.||||.+......  ....+..|++++++++||||+++++++.+.+..
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~------~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   74 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLT------GEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKL   74 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCC------CCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcE
Confidence            478889999999999999998764      567999988654322  235688999999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCccCCC
Q 046893          171 ILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGP  250 (464)
Q Consensus       171 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~  250 (464)
                      ++||||+. ++|..++....+..+++..+..++.|++.||.|||  ..+++|+||+|+||+++.++.+||+|||++....
T Consensus        75 ~~v~e~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh--~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~  151 (284)
T cd07860          75 YLVFEFLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCH--SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFG  151 (284)
T ss_pred             EEEeeccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH--HCCeecCCCCHHHEEECCCCCEEEeeccchhhcc
Confidence            99999995 68988887655567899999999999999999999  6779999999999999999999999999987543


Q ss_pred             CCCCcceeeccccCCcccCccccccCC-CCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhcccc----
Q 046893          251 MGDQTHVSTRVMGTYGYAAPEYVMTGH-LTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKK----  325 (464)
Q Consensus       251 ~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~----  325 (464)
                      ...  .......++..|+|||++.+.. ++.++||||||+++|+|++|+.||.......  .+.......-.....    
T Consensus       152 ~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~  227 (284)
T cd07860         152 VPV--RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEID--QLFRIFRTLGTPDEVVWPG  227 (284)
T ss_pred             cCc--cccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH--HHHHHHHHhCCCChhhhhh
Confidence            221  1122345788999999887644 6889999999999999999999997543211  111111100000000    


Q ss_pred             ----------hhhccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 046893          326 ----------VLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVA  369 (464)
Q Consensus       326 ----------~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  369 (464)
                                ........+ .......+..+.++|.+||+.||.+||++.+++.
T Consensus       228 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~  280 (284)
T cd07860         228 VTSLPDYKPSFPKWARQDF-SKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA  280 (284)
T ss_pred             hhHHHHHHhhcccccccCH-HHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence                      000000000 0001123457889999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=3e-38  Score=305.52  Aligned_cols=267  Identities=25%  Similarity=0.319  Sum_probs=196.1

Q ss_pred             hcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCcc-HHHHHHHHHHHhcCCCCCcceEEEEEEeCCe
Q 046893           91 TKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQG-DREWLAEVNYLGQLRHSNLVKLIGYCCEDEH  169 (464)
Q Consensus        91 ~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~  169 (464)
                      .++|++.+.||+|+||.||+|.+..+      +..||+|++....... ...+.+|+.+++.++|+||+++++++..++.
T Consensus         4 ~~~y~~~~~ig~g~~~~v~~~~~~~~------~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~   77 (291)
T cd07870           4 ATSYLNLEKLGEGSYATVYKGISRIN------GQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKET   77 (291)
T ss_pred             cceeEEEEEEEecCCEEEEEEEEcCC------CcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCe
Confidence            46788999999999999999998765      5669999986543222 3467889999999999999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCccCC
Q 046893          170 RILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDG  249 (464)
Q Consensus       170 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~  249 (464)
                      .++||||+. ++|.+++.... ..+.+..+..++.|++.||.|||  ..+|+|+||||+|||++.++.+||+|||+++..
T Consensus        78 ~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH--~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~  153 (291)
T cd07870          78 LTFVFEYMH-TDLAQYMIQHP-GGLHPYNVRLFMFQLLRGLAYIH--GQHILHRDLKPQNLLISYLGELKLADFGLARAK  153 (291)
T ss_pred             EEEEEeccc-CCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHH--hCCcccCCCChHHEEEcCCCcEEEecccccccc
Confidence            999999995 68877765543 35788889999999999999999  567999999999999999999999999999753


Q ss_pred             CCCCCcceeeccccCCcccCccccccC-CCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHH---------h
Q 046893          250 PMGDQTHVSTRVMGTYGYAAPEYVMTG-HLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARP---------L  319 (464)
Q Consensus       250 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~---------~  319 (464)
                      .....  ......++..|+|||++.+. .++.++|||||||++|+|++|..||.............|...         .
T Consensus       154 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (291)
T cd07870         154 SIPSQ--TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPG  231 (291)
T ss_pred             CCCCC--CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhh
Confidence            22211  12234678999999988764 578899999999999999999999976443211100000000         0


Q ss_pred             hhcccchhhccCcc-ccCcc-----CHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 046893          320 LNNNKKVLRILDPR-LEGQY-----TARTAMKVAGLAYQCLSQNPKGRPVMSDVVA  369 (464)
Q Consensus       320 ~~~~~~~~~~~~~~-~~~~~-----~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  369 (464)
                      +............. .....     ....+..+.+++.+||..||.+|||+.+++.
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~  287 (291)
T cd07870         232 VSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL  287 (291)
T ss_pred             hhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence            00000000000000 00000     0011357889999999999999999999864

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=5.6e-39  Score=304.91  Aligned_cols=248  Identities=25%  Similarity=0.328  Sum_probs=201.7

Q ss_pred             CCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCC---ccHHHHHHHHHHHhcCCCCCcceEEEEEEeCCe
Q 046893           93 FFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGY---QGDREWLAEVNYLGQLRHSNLVKLIGYCCEDEH  169 (464)
Q Consensus        93 ~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~  169 (464)
                      +|.+.+.||.|+||.||+|.+..+      ++.||+|++.....   ...+.+.+|++++++++||||+++++++.....
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~------~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   74 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDT------KKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEEN   74 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccC------CcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCe
Confidence            478889999999999999998754      56799999875432   234678899999999999999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCccCC
Q 046893          170 RILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDG  249 (464)
Q Consensus       170 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~  249 (464)
                      .++||||+.+++|.+++...  ..+++..+..++.|++.||.|||  ..+++|+||+|+||+++.++.++|+|||++...
T Consensus        75 ~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~lh--~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~  150 (258)
T cd05578          75 MYLVVDLLLGGDLRYHLSQK--VKFSEEQVKFWICEIVLALEYLH--SKGIIHRDIKPDNILLDEQGHVHITDFNIATKV  150 (258)
T ss_pred             EEEEEeCCCCCCHHHHHHhc--CCcCHHHHHHHHHHHHHHHHHHH--hCCeeccCCCHHHeEEcCCCCEEEeeccccccc
Confidence            99999999999999988765  36899999999999999999999  667999999999999999999999999998864


Q ss_pred             CCCCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhcccchhhc
Q 046893          250 PMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRI  329 (464)
Q Consensus       250 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  329 (464)
                      ....   ......|+..|+|||.+.+..++.++||||||+++|+|++|..||.......    ..+.......       
T Consensus       151 ~~~~---~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~----~~~~~~~~~~-------  216 (258)
T cd05578         151 TPDT---LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTI----RDQIRAKQET-------  216 (258)
T ss_pred             CCCc---cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccH----HHHHHHHhcc-------
Confidence            3322   1233568899999999988889999999999999999999999998654321    1111111110       


Q ss_pred             cCccccCccCHHHHHHHHHHHHHhhccCCCCCCCH--HHHH
Q 046893          330 LDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVM--SDVV  368 (464)
Q Consensus       330 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~--~ev~  368 (464)
                          .....+...+..+.+++.+||..||.+||++  .+++
T Consensus       217 ----~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~  253 (258)
T cd05578         217 ----ADVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLK  253 (258)
T ss_pred             ----ccccCcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence                1112233345689999999999999999999  5543

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=6.8e-38  Score=302.56  Aligned_cols=259  Identities=26%  Similarity=0.314  Sum_probs=200.1

Q ss_pred             CCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCC-ccHHHHHHHHHHHhcCCCCCcceEEEEEEeC--Ce
Q 046893           93 FFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGY-QGDREWLAEVNYLGQLRHSNLVKLIGYCCED--EH  169 (464)
Q Consensus        93 ~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~--~~  169 (464)
                      +|+..+.||.|+||.||+|.+..+      ++.+|+|.+..... .....+.+|+++++.++||||++++++|...  +.
T Consensus         2 ~~~~~~~lg~g~~~~v~~~~~~~~------~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~   75 (287)
T cd06621           2 KIVELSRLGEGAGGSVTKCRLKNT------GMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSS   75 (287)
T ss_pred             ceEEEEEeccCCceEEEEEEECCC------CeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCe
Confidence            577888999999999999998764      67799999875433 2346789999999999999999999988654  47


Q ss_pred             EEEEEeccCCCCHHHHHHhh--cCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCcc
Q 046893          170 RILVYEYMESGSLEKHLLRR--VGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAK  247 (464)
Q Consensus       170 ~~lv~e~~~~g~L~~~l~~~--~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~  247 (464)
                      +++||||+++++|.+++...  ....++...+..++.|++.||.|||  ..+++|+||+|+||+++.++.++|+|||++.
T Consensus        76 ~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH--~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~  153 (287)
T cd06621          76 IGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLH--SRKIIHRDIKPSNILLTRKGQVKLCDFGVSG  153 (287)
T ss_pred             EEEEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH--HCCcccCCCCHHHEEEecCCeEEEeeccccc
Confidence            89999999999998877542  2346899999999999999999999  6779999999999999999999999999987


Q ss_pred             CCCCCCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhcccchh
Q 046893          248 DGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVL  327 (464)
Q Consensus       248 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  327 (464)
                      ......    .....++..|+|||.+.+..++.++||||||+++|+|++|..||....... ....++.........  .
T Consensus       154 ~~~~~~----~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-~~~~~~~~~~~~~~~--~  226 (287)
T cd06621         154 ELVNSL----AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPP-LGPIELLSYIVNMPN--P  226 (287)
T ss_pred             cccccc----cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCC-CChHHHHHHHhcCCc--h
Confidence            543221    123567889999999998899999999999999999999999997653211 111111111111000  0


Q ss_pred             hccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 046893          328 RILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVA  369 (464)
Q Consensus       328 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  369 (464)
                      . +....  ......+..+.+|+.+||..+|.+||++.+++.
T Consensus       227 ~-~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~  265 (287)
T cd06621         227 E-LKDEP--GNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE  265 (287)
T ss_pred             h-hccCC--CCCCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence            0 00000  000123567899999999999999999999986

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=3.9e-39  Score=318.50  Aligned_cols=248  Identities=22%  Similarity=0.299  Sum_probs=205.3

Q ss_pred             hcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCccH--HHHHHHHHHHhcCCCCCcceEEEEEEeCC
Q 046893           91 TKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGD--REWLAEVNYLGQLRHSNLVKLIGYCCEDE  168 (464)
Q Consensus        91 ~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~--~~~~~E~~~l~~l~hpniv~l~~~~~~~~  168 (464)
                      ...|.+...||+|.|++|.+|++..+      +..||||.+.+......  ..+.+|+++|+.|+|||||+++.+.....
T Consensus        55 vg~y~i~~tig~g~f~~V~La~~~~t------~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~  128 (596)
T KOG0586|consen   55 VGLYVIIKTIGKGNFAKVKLARHILT------GTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEA  128 (596)
T ss_pred             ccceeeeeeeccceeEEEEeeEecCC------CceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecc
Confidence            45688999999999999999998775      66799999987654433  44789999999999999999999999999


Q ss_pred             eEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCccC
Q 046893          169 HRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKD  248 (464)
Q Consensus       169 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~  248 (464)
                      .+|+||||+.+|.+++++.++.  .+.+.++..++.|+..+++|||  .+.|||||||++||||+.+.++||+|||++..
T Consensus       129 ~lylV~eya~~ge~~~yl~~~g--r~~e~~ar~~F~q~vsaveYcH--~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~  204 (596)
T KOG0586|consen  129 TLYLVMEYASGGELFDYLVKHG--RMKEKEARAKFRQIVSAVEYCH--SKNIVHRDLKAENILLDENMNIKIADFGFSTF  204 (596)
T ss_pred             eeEEEEEeccCchhHHHHHhcc--cchhhhhhhhhHHHHHHHHHHh--hcceeccccchhhcccccccceeeecccccee
Confidence            9999999999999999998864  5666889999999999999999  67899999999999999999999999999997


Q ss_pred             CCCCCCcceeeccccCCcccCccccccCCCC-cccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhcccchh
Q 046893          249 GPMGDQTHVSTRVMGTYGYAAPEYVMTGHLT-ARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVL  327 (464)
Q Consensus       249 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  327 (464)
                      +..   .....++||++.|.|||++.+..|+ +.+|+||+|++||-|++|..||++..-....      .+.+.      
T Consensus       205 ~~~---~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr------~rvl~------  269 (596)
T KOG0586|consen  205 FDY---GLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELR------PRVLR------  269 (596)
T ss_pred             ecc---cccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCccccccc------chhee------
Confidence            643   3345669999999999999998765 7899999999999999999999975422111      00000      


Q ss_pred             hccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 046893          328 RILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVA  369 (464)
Q Consensus       328 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  369 (464)
                          ..+  ..+.....+..+||+++|-.+|.+|++++++.+
T Consensus       270 ----gk~--rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~  305 (596)
T KOG0586|consen  270 ----GKY--RIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMK  305 (596)
T ss_pred             ----eee--cccceeechhHHHHHHhhccCccccCCHHHhhh
Confidence                011  112222336778999999999999999998764

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=1e-38  Score=302.64  Aligned_cols=250  Identities=22%  Similarity=0.392  Sum_probs=200.9

Q ss_pred             CCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCC--ccHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeE
Q 046893           93 FFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGY--QGDREWLAEVNYLGQLRHSNLVKLIGYCCEDEHR  170 (464)
Q Consensus        93 ~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~  170 (464)
                      +|.+.+.||+|+||.||+|.+...      +..+|+|.+.....  .....+.+|+.+++.++|+||+++++++......
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~------~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~   74 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSD------SEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRL   74 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCC------CceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeE
Confidence            477888999999999999998765      55689999865422  2335678999999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCC-ceEEcccCCccCC
Q 046893          171 ILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADF-SAKLSDFGLAKDG  249 (464)
Q Consensus       171 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~-~vkl~DFGla~~~  249 (464)
                      ++||||+.+++|.+++....+..+++..+..++.|++.||.|||  ..+++|+||||+||+++.++ .+||+|||.+...
T Consensus        75 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh--~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~  152 (257)
T cd08225          75 FIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIH--DRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQL  152 (257)
T ss_pred             EEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH--HCCcccccCCHHHEEEcCCCCeEEecccccchhc
Confidence            99999999999999987765556899999999999999999999  56799999999999998876 4699999999764


Q ss_pred             CCCCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhcccchhhc
Q 046893          250 PMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRI  329 (464)
Q Consensus       250 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  329 (464)
                      ....  .......|+..|+|||++.+..++.++||||||+++|+|++|..||.....      .++........      
T Consensus       153 ~~~~--~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~------~~~~~~~~~~~------  218 (257)
T cd08225         153 NDSM--ELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNL------HQLVLKICQGY------  218 (257)
T ss_pred             cCCc--ccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccH------HHHHHHHhccc------
Confidence            3221  122234689999999999888899999999999999999999999965431      11221111110      


Q ss_pred             cCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 046893          330 LDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVA  369 (464)
Q Consensus       330 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  369 (464)
                      +.     ......+..+.+++.+||..+|++||++.+++.
T Consensus       219 ~~-----~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~  253 (257)
T cd08225         219 FA-----PISPNFSRDLRSLISQLFKVSPRDRPSITSILK  253 (257)
T ss_pred             CC-----CCCCCCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence            00     111233457999999999999999999999975

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=1.1e-38  Score=308.13  Aligned_cols=254  Identities=24%  Similarity=0.323  Sum_probs=194.8

Q ss_pred             CCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCC-ccHHHHHHHHHHHhcCC-CCCcceEEEEEEeCCeE
Q 046893           93 FFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGY-QGDREWLAEVNYLGQLR-HSNLVKLIGYCCEDEHR  170 (464)
Q Consensus        93 ~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~  170 (464)
                      +|.....||+|+||.||++.+..+      ++.+|+|.+..... .....+..|+.++.++. |+||+++++++..++..
T Consensus         5 ~~~~~~~lg~G~~g~vy~~~~~~~------~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~   78 (288)
T cd06616           5 DLKDLGEIGRGAFGTVNKMLHKPS------GTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDC   78 (288)
T ss_pred             HhHHHHHhCCCCceEEEEEEECCC------CCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcE
Confidence            455667899999999999998765      66799999875432 23456889999999996 99999999999999999


Q ss_pred             EEEEeccCCCCHHHHH---HhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCcc
Q 046893          171 ILVYEYMESGSLEKHL---LRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAK  247 (464)
Q Consensus       171 ~lv~e~~~~g~L~~~l---~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~  247 (464)
                      +++|||+. ++|.++.   .......+++..+..++.|++.||.|||+ ..+|+||||||+|||++.++.+||+|||+++
T Consensus        79 ~~~~e~~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~-~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~  156 (288)
T cd06616          79 WICMELMD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKE-ELKIIHRDVKPSNILLDRNGNIKLCDFGISG  156 (288)
T ss_pred             EEEEeccc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh-cCCeeccCCCHHHEEEccCCcEEEeecchhH
Confidence            99999985 4665543   22233568999999999999999999994 3479999999999999999999999999997


Q ss_pred             CCCCCCCcceeeccccCCcccCccccccC---CCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhccc
Q 046893          248 DGPMGDQTHVSTRVMGTYGYAAPEYVMTG---HLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNK  324 (464)
Q Consensus       248 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  324 (464)
                      ......   ......|+..|+|||++.+.   .++.++|||||||++|+|++|+.||.....     ..+........  
T Consensus       157 ~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-----~~~~~~~~~~~--  226 (288)
T cd06616         157 QLVDSI---AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS-----VFDQLTQVVKG--  226 (288)
T ss_pred             HhccCC---ccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch-----HHHHHhhhcCC--
Confidence            543221   11234688999999998766   689999999999999999999999975431     11111111110  


Q ss_pred             chhhccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 046893          325 KVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVA  369 (464)
Q Consensus       325 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  369 (464)
                           ..+.+.......++..+.+|+.+||+.||.+||++.+|+.
T Consensus       227 -----~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~  266 (288)
T cd06616         227 -----DPPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLE  266 (288)
T ss_pred             -----CCCcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence                 1111222222335568999999999999999999999985

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=4.3e-39  Score=288.67  Aligned_cols=250  Identities=26%  Similarity=0.382  Sum_probs=195.4

Q ss_pred             CCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCC-ccHHHHHHHHHHHhcC-CCCCcceEEEEEEeCCeEE
Q 046893           94 FRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGY-QGDREWLAEVNYLGQL-RHSNLVKLIGYCCEDEHRI  171 (464)
Q Consensus        94 ~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~  171 (464)
                      ...+..||.|+.|.||+++...+      +..+|||.+.+... +..++++..+.++... ..|+||+.+|+|..+...+
T Consensus        94 l~~l~dlGsGtcG~V~k~~~rs~------~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~  167 (391)
T KOG0983|consen   94 LENLGDLGSGTCGQVWKMRFRST------GHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVF  167 (391)
T ss_pred             hhhHHhhcCCCccceEEEEEccc------ceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHH
Confidence            34455699999999999998875      78899999987543 3446788888877665 4899999999999999999


Q ss_pred             EEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCccCCCC
Q 046893          172 LVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPM  251 (464)
Q Consensus       172 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~  251 (464)
                      +.||.| ...++.++. +...++++..+-++...++.||.||-. +.+|+|||+||+|||+|+.|++||||||++.....
T Consensus       168 IcMelM-s~C~ekLlk-rik~piPE~ilGk~tva~v~AL~YLKe-KH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvd  244 (391)
T KOG0983|consen  168 ICMELM-STCAEKLLK-RIKGPIPERILGKMTVAIVKALYYLKE-KHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVD  244 (391)
T ss_pred             HHHHHH-HHHHHHHHH-HhcCCchHHhhhhhHHHHHHHHHHHHH-hcceeecccCccceEEccCCCEEeecccccceeec
Confidence            999998 445655544 444579999999999999999999975 66799999999999999999999999999976433


Q ss_pred             CCCcceeeccccCCcccCcccccc---CCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhcccchhh
Q 046893          252 GDQTHVSTRVMGTYGYAAPEYVMT---GHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLR  328 (464)
Q Consensus       252 ~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  328 (464)
                      ..   ..+...|-+.|||||.+.-   ..|+.++||||||++|+||.||+.||.+-...  .   +.....+.+      
T Consensus       245 Sk---AhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~td--F---e~ltkvln~------  310 (391)
T KOG0983|consen  245 SK---AHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTD--F---EVLTKVLNE------  310 (391)
T ss_pred             cc---ccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCcc--H---HHHHHHHhc------
Confidence            22   2344679999999999864   36899999999999999999999999874321  1   111111211      


Q ss_pred             ccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 046893          329 ILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVA  369 (464)
Q Consensus       329 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  369 (464)
                       ..|.+.+.  ...+..+.+|+..||..|+.+||.+.++++
T Consensus       311 -ePP~L~~~--~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~  348 (391)
T KOG0983|consen  311 -EPPLLPGH--MGFSPDFQSFVKDCLTKDHRKRPKYNKLLE  348 (391)
T ss_pred             -CCCCCCcc--cCcCHHHHHHHHHHhhcCcccCcchHHHhc
Confidence             11222221  225668999999999999999999999875

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=6.6e-38  Score=305.65  Aligned_cols=248  Identities=28%  Similarity=0.387  Sum_probs=196.7

Q ss_pred             hcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCc---cHHHHHHHHHHHhcCCCCCcceEEEEEEeC
Q 046893           91 TKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQ---GDREWLAEVNYLGQLRHSNLVKLIGYCCED  167 (464)
Q Consensus        91 ~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~hpniv~l~~~~~~~  167 (464)
                      .+.|.+.+.||+|+||.||+|.+..+      ++.||+|++......   ....+.+|+.+++.++||||+++++++...
T Consensus        14 ~~~y~~~~~lg~g~~g~vy~~~~~~~------~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~   87 (307)
T cd06607          14 EKLFTDLREIGHGSFGAVYFARDVRT------NEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLRE   87 (307)
T ss_pred             chhhhhheeecCCCCeEEEEEEEcCC------CcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeC
Confidence            35588889999999999999998654      567999988643322   225688999999999999999999999999


Q ss_pred             CeEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCcc
Q 046893          168 EHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAK  247 (464)
Q Consensus       168 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~  247 (464)
                      +..++||||+. |+|.+++.... ..+++..+..++.|++.||.|||  ..+|+||||+|+||+++.++.++|+|||++.
T Consensus        88 ~~~~lv~e~~~-g~l~~~~~~~~-~~l~~~~~~~~~~ql~~~L~~LH--~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~  163 (307)
T cd06607          88 HTAWLVMEYCL-GSASDILEVHK-KPLQEVEIAAICHGALQGLAYLH--SHERIHRDIKAGNILLTEPGTVKLADFGSAS  163 (307)
T ss_pred             CeEEEEHHhhC-CCHHHHHHHcc-cCCCHHHHHHHHHHHHHHHHHHH--HCCceecCCCcccEEECCCCCEEEeecCcce
Confidence            99999999996 57777765432 36899999999999999999999  5679999999999999999999999999987


Q ss_pred             CCCCCCCcceeeccccCCcccCccccc---cCCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhccc
Q 046893          248 DGPMGDQTHVSTRVMGTYGYAAPEYVM---TGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNK  324 (464)
Q Consensus       248 ~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  324 (464)
                      .....      ....|+..|+|||++.   ...++.++||||||+++|||++|..||........      ........ 
T Consensus       164 ~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~------~~~~~~~~-  230 (307)
T cd06607         164 LVSPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA------LYHIAQND-  230 (307)
T ss_pred             ecCCC------CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHH------HHHHhcCC-
Confidence            53221      2356888999999874   35688999999999999999999999975432110      00000000 


Q ss_pred             chhhccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 046893          325 KVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVAL  370 (464)
Q Consensus       325 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  370 (464)
                            .+.   .....++..+.+++.+||..||.+||++.+++..
T Consensus       231 ------~~~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  267 (307)
T cd06607         231 ------SPT---LSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH  267 (307)
T ss_pred             ------CCC---CCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence                  000   1122355689999999999999999999999864

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=5.6e-38  Score=302.86  Aligned_cols=253  Identities=25%  Similarity=0.400  Sum_probs=203.8

Q ss_pred             HhcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCccHHHHHHHHHHHhcCCCCCcceEEEEEEeCCe
Q 046893           90 ATKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVKLIGYCCEDEH  169 (464)
Q Consensus        90 ~~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~  169 (464)
                      ..+.|.+...||+|+||.||+|.+...      +..+++|++..... ....+..|+.+++.++|+||+++++++...+.
T Consensus        17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~------~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   89 (286)
T cd06614          17 PRELYKNLEKIGEGASGEVYKATDRAT------GKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDE   89 (286)
T ss_pred             ccccchHhHhccCCCCeEEEEEEEccC------CcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCE
Confidence            455688888999999999999998754      56699999875433 45678899999999999999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCccCC
Q 046893          170 RILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDG  249 (464)
Q Consensus       170 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~  249 (464)
                      .++||||+++++|.+++.... ..+++..+..++.|++.||.|||  ..+|+|+||+|+||+++.++.++|+|||++...
T Consensus        90 ~~lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~lH--~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~  166 (286)
T cd06614          90 LWVVMEYMDGGSLTDIITQNF-VRMNEPQIAYVCREVLQGLEYLH--SQNVIHRDIKSDNILLSKDGSVKLADFGFAAQL  166 (286)
T ss_pred             EEEEEeccCCCcHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHH--hCCeeeCCCChhhEEEcCCCCEEECccchhhhh
Confidence            999999999999999987653 36999999999999999999999  677999999999999999999999999998754


Q ss_pred             CCCCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhcccchhhc
Q 046893          250 PMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRI  329 (464)
Q Consensus       250 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  329 (464)
                      ....  .......++..|++||.+.+..++.++||||||+++|+|++|..||....+...      .......  .    
T Consensus       167 ~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~------~~~~~~~--~----  232 (286)
T cd06614         167 TKEK--SKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRA------LFLITTK--G----  232 (286)
T ss_pred             ccch--hhhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHH------HHHHHhc--C----
Confidence            3221  112235688899999999888899999999999999999999999875432211      0000000  0    


Q ss_pred             cCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 046893          330 LDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVA  369 (464)
Q Consensus       330 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  369 (464)
                      . +..  .....++..+.+|+.+||+.+|.+||++.+++.
T Consensus       233 ~-~~~--~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~  269 (286)
T cd06614         233 I-PPL--KNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQ  269 (286)
T ss_pred             C-CCC--cchhhCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence            0 000  111224568999999999999999999999975

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=2.7e-38  Score=306.20  Aligned_cols=266  Identities=24%  Similarity=0.312  Sum_probs=198.3

Q ss_pred             cCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCcc--HHHHHHHHHHHhcCCCCCcceEEEEEEeC--
Q 046893           92 KFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQG--DREWLAEVNYLGQLRHSNLVKLIGYCCED--  167 (464)
Q Consensus        92 ~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~hpniv~l~~~~~~~--  167 (464)
                      ++|++.+.||.|+||.||+|.+..+      ++.+|+|.++......  ...+.+|+.++..+.||||+++++++...  
T Consensus         5 ~~y~~~~~lg~g~~~~v~~~~~~~~------~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~   78 (293)
T cd07843           5 DEYEKLNRIEEGTYGVVYRARDKKT------GEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNL   78 (293)
T ss_pred             hhhhhhhhhcCCCCeEEEEEEECCC------CcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCC
Confidence            3588889999999999999998764      5679999987543222  23567899999999999999999998887  


Q ss_pred             CeEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCcc
Q 046893          168 EHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAK  247 (464)
Q Consensus       168 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~  247 (464)
                      +..++||||+. ++|.+++.... ..+++..++.++.|++.||.|||  ..+++|+||||+|||++.++.+||+|||++.
T Consensus        79 ~~~~lv~e~~~-~~L~~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH--~~~i~H~dl~p~nili~~~~~~~l~d~g~~~  154 (293)
T cd07843          79 DKIYMVMEYVE-HDLKSLMETMK-QPFLQSEVKCLMLQLLSGVAHLH--DNWILHRDLKTSNLLLNNRGILKICDFGLAR  154 (293)
T ss_pred             CcEEEEehhcC-cCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHH--HCCeeeccCCHHHEEECCCCcEEEeecCcee
Confidence            89999999996 49988876543 36899999999999999999999  5679999999999999999999999999998


Q ss_pred             CCCCCCCcceeeccccCCcccCccccccC-CCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccH-HH---------HH
Q 046893          248 DGPMGDQTHVSTRVMGTYGYAAPEYVMTG-HLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNL-VE---------WA  316 (464)
Q Consensus       248 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~-~~---------~~  316 (464)
                      ......  .......++..|+|||.+.+. .++.++||||||+++|+|++|..||........... ..         |.
T Consensus       155 ~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~  232 (293)
T cd07843         155 EYGSPL--KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWP  232 (293)
T ss_pred             eccCCc--cccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHH
Confidence            654322  112235678899999988764 468899999999999999999999976442211100 00         00


Q ss_pred             HH-hhh--cccchhhccCccccCccCHH-HHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 046893          317 RP-LLN--NNKKVLRILDPRLEGQYTAR-TAMKVAGLAYQCLSQNPKGRPVMSDVVA  369 (464)
Q Consensus       317 ~~-~~~--~~~~~~~~~~~~~~~~~~~~-~~~~l~~li~~cl~~dP~~RPs~~ev~~  369 (464)
                      .. .+.  ............+...++.. .+..+.+||.+||+.+|++||++.+++.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~  289 (293)
T cd07843         233 GFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK  289 (293)
T ss_pred             HhhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence            00 000  00000000011111222222 3567899999999999999999999874

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=4.1e-38  Score=302.96  Aligned_cols=242  Identities=24%  Similarity=0.352  Sum_probs=186.1

Q ss_pred             ceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCc---cHHHHHHHHHHH---hcCCCCCcceEEEEEEeCCeEEE
Q 046893           99 ILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQ---GDREWLAEVNYL---GQLRHSNLVKLIGYCCEDEHRIL  172 (464)
Q Consensus        99 ~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l---~~l~hpniv~l~~~~~~~~~~~l  172 (464)
                      +||+|+||.||++.+..+      ++.+|+|.+......   ....+..|..++   ....||||+.+++++...+..++
T Consensus         1 ~lg~G~~g~Vy~~~~~~~------~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~l   74 (279)
T cd05633           1 IIGRGGFGEVYGCRKADT------GKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCF   74 (279)
T ss_pred             CcccCCCeEEEEEEECCC------CcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEE
Confidence            489999999999998764      667999988654322   122334444333   34479999999999999999999


Q ss_pred             EEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCccCCCCC
Q 046893          173 VYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMG  252 (464)
Q Consensus       173 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~  252 (464)
                      ||||+.+++|.+++..+.  .+++..+..++.|++.||.|||  ..+|+||||||+|||++.++.++|+|||++......
T Consensus        75 v~e~~~~~~L~~~i~~~~--~l~~~~~~~i~~qi~~al~~lH--~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~  150 (279)
T cd05633          75 ILDLMNGGDLHYHLSQHG--VFSEKEMRFYATEIILGLEHMH--NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK  150 (279)
T ss_pred             EEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH--HCCcCCCCCCHHHEEECCCCCEEEccCCcceecccc
Confidence            999999999998887543  6999999999999999999999  567999999999999999999999999998754221


Q ss_pred             CCcceeeccccCCcccCccccc-cCCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhcccchhhccC
Q 046893          253 DQTHVSTRVMGTYGYAAPEYVM-TGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRILD  331 (464)
Q Consensus       253 ~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  331 (464)
                      .    .....|+..|+|||.+. +..++.++|||||||++|+|++|..||..........+...   ..           
T Consensus       151 ~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~---~~-----------  212 (279)
T cd05633         151 K----PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRM---TL-----------  212 (279)
T ss_pred             C----ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHH---hh-----------
Confidence            1    12356999999999886 45689999999999999999999999976432211111100   00           


Q ss_pred             ccccCccCHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHH
Q 046893          332 PRLEGQYTARTAMKVAGLAYQCLSQNPKGRP-----VMSDVVA  369 (464)
Q Consensus       332 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~ev~~  369 (464)
                       ......+...+..+.+++.+||..||.+||     ++.++++
T Consensus       213 -~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~  254 (279)
T cd05633         213 -TVNVELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKE  254 (279)
T ss_pred             -cCCcCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHh
Confidence             011122334456889999999999999999     5777754

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=3.9e-38  Score=302.55  Aligned_cols=242  Identities=27%  Similarity=0.381  Sum_probs=191.5

Q ss_pred             eeecCceEEEEEEecCCCCCCccceEEEEEEccCCCC---ccHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeEEEEEec
Q 046893          100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGY---QGDREWLAEVNYLGQLRHSNLVKLIGYCCEDEHRILVYEY  176 (464)
Q Consensus       100 lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~  176 (464)
                      ||+|+||+||+|.+..+      ++.+|+|.+.....   .....+..|+.+|+.++||||+++++++...+..|+||||
T Consensus         1 lg~g~~g~vy~~~~~~~------~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   74 (277)
T cd05577           1 LGKGGFGEVCACQVKAT------GKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTL   74 (277)
T ss_pred             CCCCCceeEEEEEEcCC------CcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEec
Confidence            69999999999987764      66799998864322   2234567899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCccCCCCCCCcc
Q 046893          177 MESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTH  256 (464)
Q Consensus       177 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~~~  256 (464)
                      +++++|.+++.......+++..+..++.|++.||.|||  ..+++||||+|+||+++.++.++|+|||++......   .
T Consensus        75 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH--~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~---~  149 (277)
T cd05577          75 MNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLH--QRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGG---K  149 (277)
T ss_pred             CCCCcHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHH--hCCcccCCCCHHHEEECCCCCEEEccCcchhhhccC---C
Confidence            99999999987765456899999999999999999999  677999999999999999999999999998754321   1


Q ss_pred             eeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhcccchhhccCccccC
Q 046893          257 VSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRILDPRLEG  336 (464)
Q Consensus       257 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  336 (464)
                      ......++..|+|||++.+..++.++||||||+++|+|++|+.||.........  ........            ....
T Consensus       150 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~--~~~~~~~~------------~~~~  215 (277)
T cd05577         150 KIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEK--EELKRRTL------------EMAV  215 (277)
T ss_pred             ccccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccH--HHHHhccc------------cccc
Confidence            122356788999999998888999999999999999999999999764421111  00000000            0011


Q ss_pred             ccCHHHHHHHHHHHHHhhccCCCCCCCHHH
Q 046893          337 QYTARTAMKVAGLAYQCLSQNPKGRPVMSD  366 (464)
Q Consensus       337 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~e  366 (464)
                      .++...+..+.+++.+||+.||.+||++.+
T Consensus       216 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~~  245 (277)
T cd05577         216 EYPDKFSPEAKDLCEALLQKDPEKRLGCRG  245 (277)
T ss_pred             cCCccCCHHHHHHHHHHccCChhHccCCCc
Confidence            122234568899999999999999995444

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=4.7e-38  Score=307.49  Aligned_cols=269  Identities=21%  Similarity=0.258  Sum_probs=197.2

Q ss_pred             CCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCC---CccHHHHHHHHHHHhcCCCCCcceEEEEEEeC--
Q 046893           93 FFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGG---YQGDREWLAEVNYLGQLRHSNLVKLIGYCCED--  167 (464)
Q Consensus        93 ~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~--  167 (464)
                      .|.+...||+|+||.||+|.+...    ..+..||+|.+....   ......+.+|+.++..++||||+++++++...  
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~----~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   76 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNG----KDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHAD   76 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCC----CCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCC
Confidence            377888999999999999998662    125679999987633   22235678899999999999999999999988  


Q ss_pred             CeEEEEEeccCCCCHHHHHHhhc---CCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecC----CCceEE
Q 046893          168 EHRILVYEYMESGSLEKHLLRRV---GCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNA----DFSAKL  240 (464)
Q Consensus       168 ~~~~lv~e~~~~g~L~~~l~~~~---~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~----~~~vkl  240 (464)
                      ...++||||+.+ +|.+++....   ...+++..+..++.|++.||.|||  ..+|+||||||+|||++.    ++.+||
T Consensus        77 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH--~~~i~h~dlkp~Nil~~~~~~~~~~~kl  153 (316)
T cd07842          77 KSVYLLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLH--SNWVLHRDLKPANILVMGEGPERGVVKI  153 (316)
T ss_pred             ceEEEEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHH--hCCEeeCCCCHHHEEEcCCCCccceEEE
Confidence            889999999965 7777665332   236899999999999999999999  677999999999999998    899999


Q ss_pred             cccCCccCCCCCCC-cceeeccccCCcccCccccccC-CCCcccchhcHHHHHHHHHhCCCCCCCCCCcccc-------c
Q 046893          241 SDFGLAKDGPMGDQ-THVSTRVMGTYGYAAPEYVMTG-HLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREH-------N  311 (464)
Q Consensus       241 ~DFGla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~-------~  311 (464)
                      +|||++........ ........++..|+|||++.+. .++.++|||||||+||+|++|+.||.........       .
T Consensus       154 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~  233 (316)
T cd07842         154 GDLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQ  233 (316)
T ss_pred             CCCccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHH
Confidence            99999986433222 1122335788999999988764 5889999999999999999999999765433210       0


Q ss_pred             HHHHHHHhhhc-----------ccchhhccCccccCccC---------H--HHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 046893          312 LVEWARPLLNN-----------NKKVLRILDPRLEGQYT---------A--RTAMKVAGLAYQCLSQNPKGRPVMSDVVA  369 (464)
Q Consensus       312 ~~~~~~~~~~~-----------~~~~~~~~~~~~~~~~~---------~--~~~~~l~~li~~cl~~dP~~RPs~~ev~~  369 (464)
                      +..+.. .+..           ........+......+.         .  .....+.+++.+||+.||.+|||+.+++.
T Consensus       234 ~~~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~  312 (316)
T cd07842         234 LERIFE-VLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALE  312 (316)
T ss_pred             HHHHHH-HhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence            111100 0000           00000000000000000         0  23447889999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=5e-38  Score=297.32  Aligned_cols=250  Identities=24%  Similarity=0.377  Sum_probs=204.6

Q ss_pred             CCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCC--ccHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeE
Q 046893           93 FFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGY--QGDREWLAEVNYLGQLRHSNLVKLIGYCCEDEHR  170 (464)
Q Consensus        93 ~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~  170 (464)
                      +|.+.+.||.|+||.||++.+..+      +..+++|++.....  .....+..|+++++.++|||++++++.+......
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~------~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~   74 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSD------GKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKL   74 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCC------CcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEE
Confidence            477888999999999999998764      56799999876543  3446788999999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHhhc--CCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCccC
Q 046893          171 ILVYEYMESGSLEKHLLRRV--GCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKD  248 (464)
Q Consensus       171 ~lv~e~~~~g~L~~~l~~~~--~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~  248 (464)
                      ++||||+++++|.+++....  +..+++..+..++.+++.||.|||  ..+++|+||+|+||+++.++.++|+|||++..
T Consensus        75 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh--~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~  152 (258)
T cd08215          75 CIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLH--SRKILHRDIKPQNIFLTSNGLVKLGDFGISKV  152 (258)
T ss_pred             EEEEEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHH--hCCEecccCChHHeEEcCCCcEEECCccceee
Confidence            99999999999999887653  457999999999999999999999  56799999999999999999999999999986


Q ss_pred             CCCCCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhcccchhh
Q 046893          249 GPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLR  328 (464)
Q Consensus       249 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  328 (464)
                      .....  .......|+..|+|||.+.+..++.++||||||+++|+|++|..||......      +.........     
T Consensus       153 ~~~~~--~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~------~~~~~~~~~~-----  219 (258)
T cd08215         153 LSSTV--DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLL------ELALKILKGQ-----  219 (258)
T ss_pred             cccCc--ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHH------HHHHHHhcCC-----
Confidence            43322  2233457899999999998888999999999999999999999999654311      1111111110     


Q ss_pred             ccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 046893          329 ILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVA  369 (464)
Q Consensus       329 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  369 (464)
                            ....+...+..+.+++.+||..+|.+||++.+++.
T Consensus       220 ------~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~  254 (258)
T cd08215         220 ------YPPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQ  254 (258)
T ss_pred             ------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence                  11122234558899999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=2.9e-38  Score=304.16  Aligned_cols=263  Identities=22%  Similarity=0.289  Sum_probs=197.5

Q ss_pred             CCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCC--ccHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeEE
Q 046893           94 FRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGY--QGDREWLAEVNYLGQLRHSNLVKLIGYCCEDEHRI  171 (464)
Q Consensus        94 ~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~  171 (464)
                      |++.+.||.|++|.||+|.+..+      +..||+|++.....  .....+.+|+.+++.++||||+++++++.+.+..+
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~------~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~   74 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLT------GEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLY   74 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCC------CCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEE
Confidence            56778899999999999998764      56799998865432  22356788999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCccCCCC
Q 046893          172 LVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPM  251 (464)
Q Consensus       172 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~  251 (464)
                      +||||+. ++|.+++.......+++..++.++.|++.||.|||  .++++||||+|+||+++.++.++|+|||+++....
T Consensus        75 iv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH--~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~  151 (283)
T cd07835          75 LVFEFLD-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCH--SHRVLHRDLKPQNLLIDREGALKLADFGLARAFGV  151 (283)
T ss_pred             EEEeccC-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHH--HCCeeCCCCCHHHEEEcCCCcEEEeecccccccCC
Confidence            9999995 68999887655456899999999999999999999  57799999999999999999999999999975432


Q ss_pred             CCCcceeeccccCCcccCccccccC-CCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhccc------
Q 046893          252 GDQTHVSTRVMGTYGYAAPEYVMTG-HLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNK------  324 (464)
Q Consensus       252 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~------  324 (464)
                      ..  .......++..|+|||++.+. .++.++||||||+++|+|++|..||.......  .+............      
T Consensus       152 ~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~  227 (283)
T cd07835         152 PV--RTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEID--QLFRIFRTLGTPDEDVWPGV  227 (283)
T ss_pred             Cc--cccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHHhCCCChHHhhhh
Confidence            21  111224578899999988664 57889999999999999999999997643211  11111110000000      


Q ss_pred             ----chhhccC---ccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 046893          325 ----KVLRILD---PRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVA  369 (464)
Q Consensus       325 ----~~~~~~~---~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  369 (464)
                          .....+.   ...........+..+.+++.+||+.||.+||++.+++.
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~  279 (283)
T cd07835         228 TSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ  279 (283)
T ss_pred             hhchhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence                0000000   00000111223457889999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=8.5e-38  Score=295.68  Aligned_cols=252  Identities=24%  Similarity=0.355  Sum_probs=204.8

Q ss_pred             CCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCC--ccHHHHHHHHHHHhcCCCCCcceEEEEEEeC--C
Q 046893           93 FFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGY--QGDREWLAEVNYLGQLRHSNLVKLIGYCCED--E  168 (464)
Q Consensus        93 ~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~--~  168 (464)
                      +|.+.+.||+|+||.||+|.+..+      +..|++|++.....  .....+.+|+.++++++||||+++++++...  .
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~------~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   74 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDT------GELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKN   74 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCC------CcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCC
Confidence            367788999999999999998764      56799999876542  3356788999999999999999999999988  8


Q ss_pred             eEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCccC
Q 046893          169 HRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKD  248 (464)
Q Consensus       169 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~  248 (464)
                      ..++||||+.+++|.+++....  .+++..++.++.|++.+|.|||  +.+++|+||+|+||+++.++.++|+|||.+..
T Consensus        75 ~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh--~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~  150 (260)
T cd06606          75 TLNIFLEYVSGGSLSSLLKKFG--KLPEPVIRKYTRQILEGLAYLH--SNGIVHRDIKGANILVDSDGVVKLADFGCAKR  150 (260)
T ss_pred             eEEEEEEecCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH--HCCccccCCCHHHEEEcCCCCEEEcccccEEe
Confidence            9999999999999999987654  7899999999999999999999  57799999999999999999999999999986


Q ss_pred             CCCCCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhcccchhh
Q 046893          249 GPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLR  328 (464)
Q Consensus       249 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  328 (464)
                      ..............++..|+|||.+.+..++.++||||||+++|+|++|..||.....     ........         
T Consensus       151 ~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-----~~~~~~~~---------  216 (260)
T cd06606         151 LGDIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGN-----PMAALYKI---------  216 (260)
T ss_pred             cccccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc-----hHHHHHhc---------
Confidence            5443321112346789999999999888899999999999999999999999976541     11111111         


Q ss_pred             ccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 046893          329 ILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVA  369 (464)
Q Consensus       329 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  369 (464)
                       .........+...+..+.+++.+||..+|.+||++.+++.
T Consensus       217 -~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~  256 (260)
T cd06606         217 -GSSGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ  256 (260)
T ss_pred             -cccCCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence             1111112233344668999999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=6.2e-38  Score=311.93  Aligned_cols=264  Identities=23%  Similarity=0.295  Sum_probs=197.5

Q ss_pred             HhcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCC--CccHHHHHHHHHHHhcCCCCCcceEEEEEEeC
Q 046893           90 ATKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGG--YQGDREWLAEVNYLGQLRHSNLVKLIGYCCED  167 (464)
Q Consensus        90 ~~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~  167 (464)
                      ..++|++.+.||+|+||.||+|.+..+      +..||+|.+....  ......+.+|+.+++.++||||++++++|...
T Consensus        14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~------~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   87 (353)
T cd07850          14 VLKRYQNLKPIGSGAQGIVCAAYDTVT------GQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQ   87 (353)
T ss_pred             hhcceEEEEEeccCCCEEEEEEEECCC------CCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccC
Confidence            457799999999999999999998765      5679999986432  22335677899999999999999999988644


Q ss_pred             ------CeEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEc
Q 046893          168 ------EHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLS  241 (464)
Q Consensus       168 ------~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~  241 (464)
                            ...++||||+. ++|.+.+..    .++...+..++.|++.||.|||  ..+|+||||||+|||++.++.+||+
T Consensus        88 ~~~~~~~~~~lv~e~~~-~~l~~~~~~----~l~~~~~~~~~~ql~~aL~~LH--~~gi~H~dlkp~Nil~~~~~~~kL~  160 (353)
T cd07850          88 KSLEEFQDVYLVMELMD-ANLCQVIQM----DLDHERMSYLLYQMLCGIKHLH--SAGIIHRDLKPSNIVVKSDCTLKIL  160 (353)
T ss_pred             CCccccCcEEEEEeccC-CCHHHHHhh----cCCHHHHHHHHHHHHHHHHHHH--hCCeeeCCCCHHHEEECCCCCEEEc
Confidence                  35799999995 588887753    2889999999999999999999  5679999999999999999999999


Q ss_pred             ccCCccCCCCCCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHhCCCCCCCCCCccccc-H--------
Q 046893          242 DFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHN-L--------  312 (464)
Q Consensus       242 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~-~--------  312 (464)
                      |||+++......   ......|+..|+|||++.+..++.++|||||||++|+|++|+.||.......... +        
T Consensus       161 Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  237 (353)
T cd07850         161 DFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPS  237 (353)
T ss_pred             cCccceeCCCCC---CCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCC
Confidence            999998643221   1233568899999999999999999999999999999999999997543211100 0        


Q ss_pred             HHHHH-------Hhhhccc-----chhhccC----ccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 046893          313 VEWAR-------PLLNNNK-----KVLRILD----PRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVA  369 (464)
Q Consensus       313 ~~~~~-------~~~~~~~-----~~~~~~~----~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  369 (464)
                      .++..       .......     .....+.    +..........+..+.+++.+||+.||.+||++.+++.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~  310 (353)
T cd07850         238 DEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQ  310 (353)
T ss_pred             HHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhc
Confidence            00000       0000000     0000000    00011112234567899999999999999999999984

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=5.3e-38  Score=298.90  Aligned_cols=243  Identities=26%  Similarity=0.345  Sum_probs=195.9

Q ss_pred             eeecCceEEEEEEecCCCCCCccceEEEEEEccCCCC---ccHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeEEEEEec
Q 046893          100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGY---QGDREWLAEVNYLGQLRHSNLVKLIGYCCEDEHRILVYEY  176 (464)
Q Consensus       100 lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~  176 (464)
                      ||.|+||.||+|.+..+      ++.+|+|++.....   ...+.+.+|+.+++.++||||+++++++.+++..++||||
T Consensus         1 lg~g~~~~v~~~~~~~~------~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   74 (262)
T cd05572           1 LGVGGFGRVELVKVKSK------NRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEY   74 (262)
T ss_pred             CCCCCceEEEEEEECCC------CcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEec
Confidence            69999999999998764      56799999875432   2336688999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCccCCCCCCCcc
Q 046893          177 MESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTH  256 (464)
Q Consensus       177 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~~~  256 (464)
                      +++++|.+++.+..  .++...+..++.|++.||.|||  +.+++|+||+|+||+++.++.++|+|||++.......   
T Consensus        75 ~~~~~L~~~l~~~~--~l~~~~~~~~~~~i~~~l~~lH--~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~---  147 (262)
T cd05572          75 CLGGELWTILRDRG--LFDEYTARFYIACVVLAFEYLH--NRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---  147 (262)
T ss_pred             CCCCcHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHh--hCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc---
Confidence            99999999987643  5899999999999999999999  5779999999999999999999999999998653322   


Q ss_pred             eeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhcccchhhccCccccC
Q 046893          257 VSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRILDPRLEG  336 (464)
Q Consensus       257 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  336 (464)
                      ......|+..|++||.+.+..++.++|+||||+++|+|++|..||......    ..+......          ......
T Consensus       148 ~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----~~~~~~~~~----------~~~~~~  213 (262)
T cd05572         148 KTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDED----PMEIYNDIL----------KGNGKL  213 (262)
T ss_pred             ccccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCC----HHHHHHHHh----------ccCCCC
Confidence            122357899999999998888999999999999999999999999765421    111111111          111111


Q ss_pred             ccCHHHHHHHHHHHHHhhccCCCCCCC-----HHHHHH
Q 046893          337 QYTARTAMKVAGLAYQCLSQNPKGRPV-----MSDVVA  369 (464)
Q Consensus       337 ~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~ev~~  369 (464)
                      .++...+..+.+++.+||..+|.+||+     +.++++
T Consensus       214 ~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~  251 (262)
T cd05572         214 EFPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK  251 (262)
T ss_pred             CCCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence            223333568999999999999999999     555553

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=1.8e-37  Score=347.07  Aligned_cols=263  Identities=30%  Similarity=0.514  Sum_probs=209.8

Q ss_pred             hcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCccHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeE
Q 046893           91 TKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVKLIGYCCEDEHR  170 (464)
Q Consensus        91 ~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~  170 (464)
                      ...|....+||+|+||.||+|.+..+      +..||||.+......    ...|++++++++|||||++++++.+.+..
T Consensus       689 ~~~~~~~~~ig~G~~g~Vy~~~~~~~------~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~~~~~  758 (968)
T PLN00113        689 LSSLKEENVISRGKKGASYKGKSIKN------GMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRSEKGA  758 (968)
T ss_pred             HhhCCcccEEccCCCeeEEEEEECCC------CcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEcCCCC
Confidence            35677888999999999999998654      567999998653322    13568899999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcC-CCCeeeccCCCCceEecCCCceEEcccCCccCC
Q 046893          171 ILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGA-ERPVIYRDFKTSNILLNADFSAKLSDFGLAKDG  249 (464)
Q Consensus       171 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~-~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~  249 (464)
                      ++||||+++|+|.+++.     .++|..+..++.|++.||+|||.. ..+|+||||||+||+++.++..++. ||.....
T Consensus       759 ~lv~Ey~~~g~L~~~l~-----~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~  832 (968)
T PLN00113        759 YLIHEYIEGKNLSEVLR-----NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLL  832 (968)
T ss_pred             EEEEeCCCCCcHHHHHh-----cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccc
Confidence            99999999999999885     389999999999999999999953 5689999999999999998888775 6665432


Q ss_pred             CCCCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhcccchhhc
Q 046893          250 PMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRI  329 (464)
Q Consensus       250 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  329 (464)
                      ..      .....||..|+|||++.+..++.++|||||||++|||++|+.||+.... ....+.+|.+..... ......
T Consensus       833 ~~------~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~-~~~~~~~~~~~~~~~-~~~~~~  904 (968)
T PLN00113        833 CT------DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFG-VHGSIVEWARYCYSD-CHLDMW  904 (968)
T ss_pred             cc------CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccC-CCCcHHHHHHHhcCc-cchhhe
Confidence            11      1124688999999999999999999999999999999999999964332 234566676654332 223344


Q ss_pred             cCccccC--ccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhc
Q 046893          330 LDPRLEG--QYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETVQSQ  377 (464)
Q Consensus       330 ~~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~~~~  377 (464)
                      +++.+..  ........++.+++.+||+.||.+||+|.+|++.|+.+...
T Consensus       905 ~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~  954 (968)
T PLN00113        905 IDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRS  954 (968)
T ss_pred             eCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhcc
Confidence            4554432  23445666889999999999999999999999999887553

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=1.3e-37  Score=293.30  Aligned_cols=250  Identities=27%  Similarity=0.418  Sum_probs=202.9

Q ss_pred             CCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCccHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeEEE
Q 046893           93 FFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVKLIGYCCEDEHRIL  172 (464)
Q Consensus        93 ~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l  172 (464)
                      .|.+.+.||.|+||.||++.+..+      +..+++|++..........+.+|+.+++.++|+||+++++++......++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~------~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l   74 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKRT------GKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWI   74 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECCC------CcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEE
Confidence            367788999999999999998764      56799999877554455788999999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCccCCCCC
Q 046893          173 VYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMG  252 (464)
Q Consensus       173 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~  252 (464)
                      ++||+++++|.+++.... ..+++..+..++.|++.+|.|||  ..+++||||+|+||+++.++.++|+|||++......
T Consensus        75 ~~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh--~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~  151 (253)
T cd05122          75 VMEFCSGGSLKDLLKSTN-QTLTESQIAYVCKELLKGLEYLH--SNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDT  151 (253)
T ss_pred             EEecCCCCcHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHhh--cCCEecCCCCHHHEEEccCCeEEEeecccccccccc
Confidence            999999999999887653 46899999999999999999999  577999999999999999999999999999865433


Q ss_pred             CCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhcccchhhccCc
Q 046893          253 DQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRILDP  332 (464)
Q Consensus       253 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  332 (464)
                      ..   .....|+..|++||.+.+..++.++||||||+++|+|++|+.||.........   .   ....  ..     .+
T Consensus       152 ~~---~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~---~---~~~~--~~-----~~  215 (253)
T cd05122         152 KA---RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKAL---F---KIAT--NG-----PP  215 (253)
T ss_pred             cc---ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHH---H---HHHh--cC-----CC
Confidence            21   23467899999999998888999999999999999999999999754321110   0   0000  00     00


Q ss_pred             cccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 046893          333 RLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVA  369 (464)
Q Consensus       333 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  369 (464)
                      ...  .....+..+.+++.+||..||.+||++.+++.
T Consensus       216 ~~~--~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~  250 (253)
T cd05122         216 GLR--NPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLK  250 (253)
T ss_pred             CcC--cccccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            000  01112457999999999999999999999874

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-38  Score=287.20  Aligned_cols=251  Identities=22%  Similarity=0.234  Sum_probs=198.3

Q ss_pred             hcCCCCC-CceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCccHHHHHHHHHHHhcC-CCCCcceEEEEEEe--
Q 046893           91 TKFFRPD-YILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQL-RHSNLVKLIGYCCE--  166 (464)
Q Consensus        91 ~~~~~~~-~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~--  166 (464)
                      +++|.+. ++||-|-.|.|..+....+      ++.+|+|++...     ....+|+++.-.. .|||||.++++|.+  
T Consensus        60 tedY~is~qvLG~GinGkV~~C~~k~T------~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~  128 (400)
T KOG0604|consen   60 TEDYSISWQVLGAGINGKVVQCVHKRT------QEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSY  128 (400)
T ss_pred             hhhheehhhhhccccCCceEEEEeccc------hhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhc
Confidence            3444443 6799999999999987765      677999998643     3446788876555 59999999998764  


Q ss_pred             --CCeEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEec---CCCceEEc
Q 046893          167 --DEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLN---ADFSAKLS  241 (464)
Q Consensus       167 --~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~---~~~~vkl~  241 (464)
                        ...+.+|||.|+||.|...|..+....+++.++..|+.||+.|+.|||  ..+|.||||||+|+|..   .+..+||+
T Consensus       129 ~~rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH--~~nIAHRDlKpENLLyt~t~~na~lKLt  206 (400)
T KOG0604|consen  129 QGRKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLH--SMNIAHRDLKPENLLYTTTSPNAPLKLT  206 (400)
T ss_pred             cCceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHH--hcchhhccCChhheeeecCCCCcceEec
Confidence              356789999999999999999988888999999999999999999999  45699999999999994   45578999


Q ss_pred             ccCCccCCCCCCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhh
Q 046893          242 DFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLN  321 (464)
Q Consensus       242 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~  321 (464)
                      |||+|+.-..   .....+.|-|++|.|||++....|+..+|+||+||++|-||+|-+||.........           
T Consensus       207 DfGFAK~t~~---~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~ais-----------  272 (400)
T KOG0604|consen  207 DFGFAKETQE---PGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS-----------  272 (400)
T ss_pred             ccccccccCC---CccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCC-----------
Confidence            9999986321   22334578899999999998889999999999999999999999999764421100           


Q ss_pred             cccchhhcc--CccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 046893          322 NNKKVLRIL--DPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVA  369 (464)
Q Consensus       322 ~~~~~~~~~--~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  369 (464)
                       ...-.++.  .-.+........++...++|+.+|..+|.+|.++.++++
T Consensus       273 -pgMk~rI~~gqy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~  321 (400)
T KOG0604|consen  273 -PGMKRRIRTGQYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMD  321 (400)
T ss_pred             -hhHHhHhhccCccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhc
Confidence             00001111  112222334566788999999999999999999999875

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-38  Score=318.63  Aligned_cols=270  Identities=28%  Similarity=0.364  Sum_probs=204.7

Q ss_pred             CCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCc-cHHHHHHHHHHHhcCCCCCcceEEEEEEeCC----
Q 046893           94 FRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQ-GDREWLAEVNYLGQLRHSNLVKLIGYCCEDE----  168 (464)
Q Consensus        94 ~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~----  168 (464)
                      |...+.||+|+||.||+|++..+      |+.||||.++..... ..+.+.+|+++|++|+|+|||+++++-.+..    
T Consensus        15 W~~~e~LG~Ga~g~V~rgrnket------G~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~   88 (732)
T KOG4250|consen   15 WEMDERLGKGAFGNVYRGRNKET------GRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLV   88 (732)
T ss_pred             eeehhhhcCCccceeeeeccccc------ccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcc
Confidence            45567799999999999998876      788999999875533 3467889999999999999999998765443    


Q ss_pred             --eEEEEEeccCCCCHHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEe--cCCC--ceEEc
Q 046893          169 --HRILVYEYMESGSLEKHLLRRVG-CMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILL--NADF--SAKLS  241 (464)
Q Consensus       169 --~~~lv~e~~~~g~L~~~l~~~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill--~~~~--~vkl~  241 (464)
                        ...+|||||.||+|...+.+..+ ..|++.+.+.++..++.||.|||  +++||||||||.||++  ..+|  ..||+
T Consensus        89 ~~~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~Lr--En~IvHRDlKP~NIvl~~Gedgq~IyKLt  166 (732)
T KOG4250|consen   89 TRLPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLR--ENGIVHRDLKPGNIVLQIGEDGQSIYKLT  166 (732)
T ss_pred             cccceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHH--HcCceeccCCCCcEEEeecCCCceEEeee
Confidence              56899999999999999876433 47999999999999999999999  7789999999999998  3334  46999


Q ss_pred             ccCCccCCCCCCCcceeeccccCCcccCccccc-cCCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhh
Q 046893          242 DFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVM-TGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLL  320 (464)
Q Consensus       242 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~  320 (464)
                      |||.|+....+.   ....++||..|++||+.. .+.|+..+|.|||||++|++.||..||-......  +..+.++...
T Consensus       167 DfG~Arel~d~s---~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk--~~~~~~~~~~  241 (732)
T KOG4250|consen  167 DFGAARELDDNS---LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPK--NNKEIMWHII  241 (732)
T ss_pred             cccccccCCCCC---eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCcc--ccchhhhhhh
Confidence            999999754433   455689999999999887 4889999999999999999999999996433221  1112222222


Q ss_pred             hcccchhhc-cCc------------cccCccCHHHHHHHHHHHHHhhccCCCCCC--CHHHHHHHHHHHHh
Q 046893          321 NNNKKVLRI-LDP------------RLEGQYTARTAMKVAGLAYQCLSQNPKGRP--VMSDVVALLETVQS  376 (464)
Q Consensus       321 ~~~~~~~~~-~~~------------~~~~~~~~~~~~~l~~li~~cl~~dP~~RP--s~~ev~~~L~~~~~  376 (464)
                      ..+..-..+ ...            .............+-..+..+|..+|.+|-  ...++.+.+..+..
T Consensus       242 tkkp~~v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL~  312 (732)
T KOG4250|consen  242 TKKPSGVAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDILN  312 (732)
T ss_pred             ccCCCceeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHHh
Confidence            222111110 011            112223344555677778888899999998  67777776666654

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=8.5e-38  Score=300.97  Aligned_cols=264  Identities=25%  Similarity=0.348  Sum_probs=198.4

Q ss_pred             CCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCc-cHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeEE
Q 046893           93 FFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQ-GDREWLAEVNYLGQLRHSNLVKLIGYCCEDEHRI  171 (464)
Q Consensus        93 ~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~  171 (464)
                      +|++.+.||.|+||.||+|++..+      +..||||++...... ....+..|+.+++.++||||+++++++...+..+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~------~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   74 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTT------GEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLM   74 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCC------CeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEE
Confidence            478889999999999999998764      677999998764332 3456778999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCccCCC
Q 046893          172 LVYEYMESGSLEKHLLRRV-GCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGP  250 (464)
Q Consensus       172 lv~e~~~~g~L~~~l~~~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~  250 (464)
                      |||||+.+ +|.+++.... ...+++..+..++.|++.||.|||  ..+++||||||+||+++.++.++|+|||+++...
T Consensus        75 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH--~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~  151 (284)
T cd07836          75 LVFEYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCH--ENRVLHRDLKPQNLLINKRGELKLADFGLARAFG  151 (284)
T ss_pred             EEEecCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHH--HCCeeeCCCCHHHEEECCCCcEEEeecchhhhhc
Confidence            99999975 8888876543 246899999999999999999999  5679999999999999999999999999997543


Q ss_pred             CCCCcceeeccccCCcccCccccccC-CCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHh----------
Q 046893          251 MGDQTHVSTRVMGTYGYAAPEYVMTG-HLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPL----------  319 (464)
Q Consensus       251 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~----------  319 (464)
                      ...  .......++..|++||++.+. .++.++|||||||++|+|++|..||........  ........          
T Consensus       152 ~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~  227 (284)
T cd07836         152 IPV--NTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQ--LLKIFRIMGTPTESTWPG  227 (284)
T ss_pred             CCc--cccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHH--HHHHHHHhCCCChhhHHH
Confidence            221  112234678899999988664 578899999999999999999999976542211  11100000          


Q ss_pred             hhcccchhhccCc---cccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 046893          320 LNNNKKVLRILDP---RLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVA  369 (464)
Q Consensus       320 ~~~~~~~~~~~~~---~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  369 (464)
                      +............   .....+....+..+.+++.+||+.||.+||++.++++
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~  280 (284)
T cd07836         228 ISQLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ  280 (284)
T ss_pred             HhcCchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            0000000000000   0001111234567899999999999999999999874

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=7.5e-38  Score=305.12  Aligned_cols=268  Identities=23%  Similarity=0.323  Sum_probs=193.9

Q ss_pred             cCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCc--cHHHHHHHHHHHhcCCCCCcceEEEEEEeCC-
Q 046893           92 KFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQ--GDREWLAEVNYLGQLRHSNLVKLIGYCCEDE-  168 (464)
Q Consensus        92 ~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~-  168 (464)
                      ++|.+.+.||+|+||.||+|.+..+      +..||||.+......  ....+.+|+.+++.++||||+++++++.... 
T Consensus        12 ~~y~~~~~lg~g~~~~v~~~~~~~~------~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~   85 (310)
T cd07865          12 SKYEKLAKIGQGTFGEVFKARHKKT------KQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKAT   85 (310)
T ss_pred             hheEEEEEeecCCCEEEEEEEECCC------CcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccc
Confidence            4588899999999999999998764      677999988643222  2245678999999999999999999887654 


Q ss_pred             -------eEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEc
Q 046893          169 -------HRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLS  241 (464)
Q Consensus       169 -------~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~  241 (464)
                             ..++||||+. ++|.+++... ...+++.+++.++.|++.||.|||  ..+++|+||||+||+++.++.+||+
T Consensus        86 ~~~~~~~~~~lv~e~~~-~~l~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH--~~~i~H~dl~p~nil~~~~~~~kl~  161 (310)
T cd07865          86 PYNRYKGSFYLVFEFCE-HDLAGLLSNK-NVKFTLSEIKKVMKMLLNGLYYIH--RNKILHRDMKAANILITKDGILKLA  161 (310)
T ss_pred             cccCCCceEEEEEcCCC-cCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHH--HCCeeccCCCHHHEEECCCCcEEEC
Confidence                   4599999995 5888877554 346899999999999999999999  5679999999999999999999999


Q ss_pred             ccCCccCCCCCCCc--ceeeccccCCcccCccccccC-CCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHH
Q 046893          242 DFGLAKDGPMGDQT--HVSTRVMGTYGYAAPEYVMTG-HLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARP  318 (464)
Q Consensus       242 DFGla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~  318 (464)
                      |||++.........  .......++..|+|||.+.+. .++.++||||||+++|+|++|+.||.................
T Consensus       162 dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~  241 (310)
T cd07865         162 DFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCG  241 (310)
T ss_pred             cCCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Confidence            99999764332211  112235678899999988664 478899999999999999999999976543222111111100


Q ss_pred             hhh-----cccc--hh-hccCc-c----ccCcc-CHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 046893          319 LLN-----NNKK--VL-RILDP-R----LEGQY-TARTAMKVAGLAYQCLSQNPKGRPVMSDVVA  369 (464)
Q Consensus       319 ~~~-----~~~~--~~-~~~~~-~----~~~~~-~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  369 (464)
                      .+.     ....  .. ....+ .    ....+ .......+.+||.+||..||.+||++.++++
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~  306 (310)
T cd07865         242 SITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN  306 (310)
T ss_pred             CCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence            000     0000  00 00000 0    00000 0012346779999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=5.9e-38  Score=303.92  Aligned_cols=264  Identities=22%  Similarity=0.316  Sum_probs=195.9

Q ss_pred             cCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCC--ccHHHHHHHHHHHhcCCCCCcceEEEEEEeCCe
Q 046893           92 KFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGY--QGDREWLAEVNYLGQLRHSNLVKLIGYCCEDEH  169 (464)
Q Consensus        92 ~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~  169 (464)
                      ++|++.+.||.|+||.||+|.+..+      ++.||+|.+.....  .....+..|+++++.++||||+++++++.....
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~~~~------~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   75 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARDRVT------NETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKR   75 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEecCC------CcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCe
Confidence            4688889999999999999998664      56799999865432  223567889999999999999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecC-CCceEEcccCCccC
Q 046893          170 RILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNA-DFSAKLSDFGLAKD  248 (464)
Q Consensus       170 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~-~~~vkl~DFGla~~  248 (464)
                      .++||||++ ++|.+++.......+++..+..++.||+.||.|||  +++++|+||+|+||+++. ++.+||+|||++..
T Consensus        76 ~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH--~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~  152 (294)
T PLN00009         76 LYLVFEYLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCH--SHRVLHRDLKPQNLLIDRRTNALKLADFGLARA  152 (294)
T ss_pred             EEEEEeccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHH--hCCeeCCCCCcceEEEECCCCEEEEcccccccc
Confidence            999999995 58888876655445788889999999999999999  677999999999999985 55799999999975


Q ss_pred             CCCCCCcceeeccccCCcccCcccccc-CCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhcc-cch
Q 046893          249 GPMGDQTHVSTRVMGTYGYAAPEYVMT-GHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNN-KKV  326 (464)
Q Consensus       249 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~-~~~  326 (464)
                      ....  ........|+..|+|||++.+ ..++.++||||||+++|+|++|+.||.........  ..... ..... ...
T Consensus       153 ~~~~--~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~--~~~~~-~~~~~~~~~  227 (294)
T PLN00009        153 FGIP--VRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDEL--FKIFR-ILGTPNEET  227 (294)
T ss_pred             cCCC--ccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH--HHHHH-HhCCCChhh
Confidence            4322  111223467889999998876 45789999999999999999999999764322110  00000 00000 000


Q ss_pred             -------h---hcc---CccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 046893          327 -------L---RIL---DPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVA  369 (464)
Q Consensus       327 -------~---~~~---~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  369 (464)
                             .   ...   ............+..+.+++.+||+.+|.+||++.+++.
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~  283 (294)
T PLN00009        228 WPGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE  283 (294)
T ss_pred             ccccccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence                   0   000   000000011123457889999999999999999999885

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=6e-38  Score=303.83  Aligned_cols=265  Identities=22%  Similarity=0.277  Sum_probs=194.9

Q ss_pred             cCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCc--cHHHHHHHHHHHhcCC-CCCcceEEEEEEeCC
Q 046893           92 KFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQ--GDREWLAEVNYLGQLR-HSNLVKLIGYCCEDE  168 (464)
Q Consensus        92 ~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~  168 (464)
                      ++|++.+.||+|+||.||+|.+..+      ++.||+|.+......  ....+.+|+.+++.+. ||||+++++++...+
T Consensus         1 ~~y~~~~~lg~g~~g~vy~~~~~~~------~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~   74 (295)
T cd07837           1 DAYEKLEKIGEGTYGKVYKARDKNT------GKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEE   74 (295)
T ss_pred             CCceEeeEecccCCeEEEEEEECCC------CcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecC
Confidence            3588889999999999999998765      667999987654221  2356788999999995 699999999988766


Q ss_pred             e-----EEEEEeccCCCCHHHHHHhhc---CCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecC-CCceE
Q 046893          169 H-----RILVYEYMESGSLEKHLLRRV---GCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNA-DFSAK  239 (464)
Q Consensus       169 ~-----~~lv~e~~~~g~L~~~l~~~~---~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~-~~~vk  239 (464)
                      .     .|+||||+.+ +|.+++....   +..+++..++.++.||+.||.|||  .++|+||||||+||+++. ++.+|
T Consensus        75 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH--~~~i~H~dl~~~nil~~~~~~~~k  151 (295)
T cd07837          75 KNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCH--KHGVMHRDLKPQNLLVDKQKGLLK  151 (295)
T ss_pred             CCCCceEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHH--HCCeeecCCChHHEEEecCCCeEE
Confidence            5     8999999975 8988876542   236899999999999999999999  677999999999999998 88999


Q ss_pred             EcccCCccCCCCCCCcceeeccccCCcccCcccccc-CCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHH
Q 046893          240 LSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMT-GHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARP  318 (464)
Q Consensus       240 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~  318 (464)
                      |+|||+++.......  ......+++.|+|||++.+ ..++.++||||||+++|+|++|..||.........  ......
T Consensus       152 l~dfg~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~--~~~~~~  227 (295)
T cd07837         152 IADLGLGRAFSIPVK--SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQL--LHIFKL  227 (295)
T ss_pred             EeecccceecCCCcc--ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHH--HHHHHH
Confidence            999999975432211  1122357889999998865 45789999999999999999999999764322111  110000


Q ss_pred             hhhcccchh----hcc--------CccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 046893          319 LLNNNKKVL----RIL--------DPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVA  369 (464)
Q Consensus       319 ~~~~~~~~~----~~~--------~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  369 (464)
                      .........    ...        .+..........+..+.+||.+||..||.+||++.+++.
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~  290 (295)
T cd07837         228 LGTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT  290 (295)
T ss_pred             hCCCChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence            000000000    000        000000011224567899999999999999999998874

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.4e-39  Score=303.65  Aligned_cols=244  Identities=27%  Similarity=0.375  Sum_probs=202.5

Q ss_pred             hcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCccH---HHHHHHHHHHhcC-CCCCcceEEEEEEe
Q 046893           91 TKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGD---REWLAEVNYLGQL-RHSNLVKLIGYCCE  166 (464)
Q Consensus        91 ~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~---~~~~~E~~~l~~l-~hpniv~l~~~~~~  166 (464)
                      ..+|.++.+||+|+||+|.+|....+      .+.+|||++++......   +--+.|-++|... +-|.+++++.+|..
T Consensus       348 ~tDFnFl~VlGKGSFGKVlLaerkgt------dELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQT  421 (683)
T KOG0696|consen  348 ATDFNFLMVLGKGSFGKVLLAERKGT------DELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQT  421 (683)
T ss_pred             ecccceEEEeccCccceeeeecccCc------chhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhh
Confidence            45588889999999999999986654      67899999988654333   2235678888776 46789999999999


Q ss_pred             CCeEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCc
Q 046893          167 DEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLA  246 (464)
Q Consensus       167 ~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla  246 (464)
                      -+.+|+||||+.||+|.-+|.+-.  .+.+..+..+|..|+.||-+||  .++||+||||.+||+||.+|+|||+|||++
T Consensus       422 mDRLyFVMEyvnGGDLMyhiQQ~G--kFKEp~AvFYAaEiaigLFFLh--~kgIiYRDLKLDNvmLd~eGHiKi~DFGmc  497 (683)
T KOG0696|consen  422 MDRLYFVMEYVNGGDLMYHIQQVG--KFKEPVAVFYAAEIAIGLFFLH--SKGIIYRDLKLDNVMLDSEGHIKIADFGMC  497 (683)
T ss_pred             hhheeeEEEEecCchhhhHHHHhc--ccCCchhhhhhHHHHHHhhhhh--cCCeeeeeccccceEeccCCceEeeecccc
Confidence            999999999999999988887643  6889999999999999999999  788999999999999999999999999999


Q ss_pred             cCCCCCCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhcccch
Q 046893          247 KDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKV  326 (464)
Q Consensus       247 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  326 (464)
                      +....+..+  ..++|||+.|+|||++...+|+..+|+|||||+|||||.|++||++....      +.+..+++.+   
T Consensus       498 KEni~~~~T--TkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~------elF~aI~ehn---  566 (683)
T KOG0696|consen  498 KENIFDGVT--TKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDED------ELFQAIMEHN---  566 (683)
T ss_pred             cccccCCcc--eeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHH------HHHHHHHHcc---
Confidence            975554433  45699999999999999999999999999999999999999999986532      2222222221   


Q ss_pred             hhccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCH
Q 046893          327 LRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVM  364 (464)
Q Consensus       327 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~  364 (464)
                               -.|+...+.+...+++..|...|.+|...
T Consensus       567 ---------vsyPKslSkEAv~ickg~ltK~P~kRLGc  595 (683)
T KOG0696|consen  567 ---------VSYPKSLSKEAVAICKGLLTKHPGKRLGC  595 (683)
T ss_pred             ---------CcCcccccHHHHHHHHHHhhcCCccccCC
Confidence                     24566666788899999999999999543

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=5.9e-40  Score=345.53  Aligned_cols=254  Identities=30%  Similarity=0.384  Sum_probs=205.0

Q ss_pred             HhcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCc--cHHHHHHHHHHHhcCCCCCcceEEEEEEeC
Q 046893           90 ATKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQ--GDREWLAEVNYLGQLRHSNLVKLIGYCCED  167 (464)
Q Consensus        90 ~~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpniv~l~~~~~~~  167 (464)
                      .+-++.-...||.|.||.||-|++.++      |+..|+|-++.....  ....+.+|..+|..|+|||+|+++++-.++
T Consensus      1233 V~~rWqrg~~Ig~G~fG~VYtavN~~t------GellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHR 1306 (1509)
T KOG4645|consen 1233 VTFRWQRGNFIGGGTFGKVYTAVNLDT------GELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHR 1306 (1509)
T ss_pred             ceeeeccccccCCcceeeeEEeecCCc------cchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecH
Confidence            455667778899999999999998876      788999988754332  235678999999999999999999999999


Q ss_pred             CeEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCcc
Q 046893          168 EHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAK  247 (464)
Q Consensus       168 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~  247 (464)
                      +..+|.||||++|+|.+.+..  ++.+++.....+..|++.|+.|||  +.+||||||||+||||+.+|.+|++|||.|.
T Consensus      1307 ekv~IFMEyC~~GsLa~ll~~--gri~dE~vt~vyt~qll~gla~LH--~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ 1382 (1509)
T KOG4645|consen 1307 EKVYIFMEYCEGGSLASLLEH--GRIEDEMVTRVYTKQLLEGLAYLH--EHGIVHRDIKPANILLDFNGLIKYGDFGSAV 1382 (1509)
T ss_pred             HHHHHHHHHhccCcHHHHHHh--cchhhhhHHHHHHHHHHHHHHHHH--hcCceecCCCccceeeecCCcEEeeccccee
Confidence            999999999999999998764  345677777778899999999999  6679999999999999999999999999998


Q ss_pred             CCCCCCCc--ceeeccccCCcccCccccccC---CCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhc
Q 046893          248 DGPMGDQT--HVSTRVMGTYGYAAPEYVMTG---HLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNN  322 (464)
Q Consensus       248 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~---~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~  322 (464)
                      .......+  .......||+.|||||++.+.   ....++|||||||++.||+||+.||.....       +|+.     
T Consensus      1383 ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dn-------e~aI----- 1450 (1509)
T KOG4645|consen 1383 KIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDN-------EWAI----- 1450 (1509)
T ss_pred             EecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccc-------hhHH-----
Confidence            76543211  122347899999999999753   466789999999999999999999975432       1221     


Q ss_pred             ccchhhccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 046893          323 NKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVA  369 (464)
Q Consensus       323 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  369 (464)
                          .-.+-.....+++.....+-.+|+..||..||++|.++.++++
T Consensus      1451 ----My~V~~gh~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle 1493 (1509)
T KOG4645|consen 1451 ----MYHVAAGHKPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLE 1493 (1509)
T ss_pred             ----HhHHhccCCCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHH
Confidence                1112233344566667788999999999999999988776654

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=6.7e-39  Score=323.36  Aligned_cols=261  Identities=24%  Similarity=0.354  Sum_probs=218.0

Q ss_pred             CCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCC-CccHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeEEE
Q 046893           94 FRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGG-YQGDREWLAEVNYLGQLRHSNLVKLIGYCCEDEHRIL  172 (464)
Q Consensus        94 ~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l  172 (464)
                      ++..++||+|+||+||+|.+... ++. ....||||++.... .....+++.|+-+|..|.|||+++|++++.... +.|
T Consensus       698 lkk~kvLGsgAfGtV~kGiw~Pe-ge~-vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~ql  774 (1177)
T KOG1025|consen  698 LKKDKVLGSGAFGTVYKGIWIPE-GEN-VKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQL  774 (1177)
T ss_pred             hhhhceeccccceeEEeeeEecC-Cce-ecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHH
Confidence            34567899999999999998765 222 24579999986543 344588999999999999999999999998766 889


Q ss_pred             EEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCccCCCCC
Q 046893          173 VYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMG  252 (464)
Q Consensus       173 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~  252 (464)
                      |.+|++.|+|.|+++.+.+ .+.....+.|..||++||.|||  ++++|||||..+||||..-..+||.|||+++....+
T Consensus       775 vtq~mP~G~LlDyvr~hr~-~igsq~lLnw~~QIAkgM~YLe--~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d  851 (1177)
T KOG1025|consen  775 VTQLMPLGCLLDYVREHRD-NIGSQDLLNWCYQIAKGMKYLE--EQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPD  851 (1177)
T ss_pred             HHHhcccchHHHHHHHhhc-cccHHHHHHHHHHHHHHHHHHH--hcchhhhhhhhhheeecCCCeEEEEecchhhccCcc
Confidence            9999999999999988654 6889999999999999999999  788999999999999998889999999999987665


Q ss_pred             CCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHhhhcccchhhccC
Q 046893          253 DQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLL-GRRAVDKSRPSREHNLVEWARPLLNNNKKVLRILD  331 (464)
Q Consensus       253 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  331 (464)
                      +.........-.+.|||-|.+....|+.++|||||||++||++| |..|+++....                 ++.+++.
T Consensus       852 ~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~-----------------eI~dlle  914 (1177)
T KOG1025|consen  852 EKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAE-----------------EIPDLLE  914 (1177)
T ss_pred             cccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHH-----------------HhhHHHh
Confidence            54444444455678999999999999999999999999999998 99999876532                 2333333


Q ss_pred             ccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhc
Q 046893          332 PRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETVQSQ  377 (464)
Q Consensus       332 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~~~~  377 (464)
                      ...+-.-+..|+.+++.++.+||-.|+..||.++++.+.+.+..+.
T Consensus       915 ~geRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ard  960 (1177)
T KOG1025|consen  915 KGERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMARD  960 (1177)
T ss_pred             ccccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhcC
Confidence            3334455677888999999999999999999999999988876553

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=2.1e-37  Score=303.51  Aligned_cols=248  Identities=26%  Similarity=0.363  Sum_probs=196.0

Q ss_pred             CCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCc---cHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeE
Q 046893           94 FRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQ---GDREWLAEVNYLGQLRHSNLVKLIGYCCEDEHR  170 (464)
Q Consensus        94 ~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~  170 (464)
                      |...+.||+|+||.||+|.+..+      +..+|+|.+......   ....+..|+.+++.++|||++++++++..++..
T Consensus        27 f~~~~~lg~G~~~~v~~~~~~~~------~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~  100 (317)
T cd06635          27 FTDLREIGHGSFGAVYFARDVRT------NEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTA  100 (317)
T ss_pred             hhhhheeccCCCeEEEEEEEcCC------CcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeE
Confidence            67778899999999999998664      567999998654322   224688999999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCccCCC
Q 046893          171 ILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGP  250 (464)
Q Consensus       171 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~  250 (464)
                      ++||||+. |+|.+++... ...+++..+..++.|++.||.|||  ..+|+||||+|+||+++.++.++|+|||++....
T Consensus       101 ~lv~e~~~-g~l~~~~~~~-~~~l~~~~~~~i~~~i~~~l~~lH--~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~  176 (317)
T cd06635         101 WLVMEYCL-GSASDLLEVH-KKPLQEVEIAAITHGALQGLAYLH--SHNMIHRDIKAGNILLTEPGQVKLADFGSASIAS  176 (317)
T ss_pred             EEEEeCCC-CCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHH--HCCcccCCCCcccEEECCCCCEEEecCCCccccC
Confidence            99999996 5887776544 346899999999999999999999  6779999999999999999999999999987532


Q ss_pred             CCCCcceeeccccCCcccCccccc---cCCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhcccchh
Q 046893          251 MGDQTHVSTRVMGTYGYAAPEYVM---TGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVL  327 (464)
Q Consensus       251 ~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  327 (464)
                      .      .....|+..|+|||++.   ++.++.++|||||||++|+|++|..||.......      .........    
T Consensus       177 ~------~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~------~~~~~~~~~----  240 (317)
T cd06635         177 P------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS------ALYHIAQNE----  240 (317)
T ss_pred             C------cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHH------HHHHHHhcc----
Confidence            2      12356889999999874   4568899999999999999999999987542111      011111100    


Q ss_pred             hccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q 046893          328 RILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLET  373 (464)
Q Consensus       328 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~  373 (464)
                            .........+..+.+|+.+||+.+|.+||++.+++..+..
T Consensus       241 ------~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~  280 (317)
T cd06635         241 ------SPTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFV  280 (317)
T ss_pred             ------CCCCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhh
Confidence                  0001112344578999999999999999999999875543

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=8.5e-38  Score=308.95  Aligned_cols=268  Identities=26%  Similarity=0.369  Sum_probs=197.1

Q ss_pred             HhcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCC--CCccHHHHHHHHHHHhcC-CCCCcceEEEEEEe
Q 046893           90 ATKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRG--GYQGDREWLAEVNYLGQL-RHSNLVKLIGYCCE  166 (464)
Q Consensus        90 ~~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~  166 (464)
                      ..++|.+.+.||+|+||.||+|.+..+      ++.+|+|.+...  .......+..|+.++.++ +||||+++++++..
T Consensus         5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~------~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~   78 (337)
T cd07852           5 ILRKYEILQKLGKGAYGIVWKAIDRRT------KEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKA   78 (337)
T ss_pred             hhhHHHHhHhhcCCCCeeEEEEEEcCC------CeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeecc
Confidence            456788899999999999999998654      567999987542  122335577899999999 99999999998865


Q ss_pred             C--CeEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccC
Q 046893          167 D--EHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFG  244 (464)
Q Consensus       167 ~--~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFG  244 (464)
                      .  ...++||||+. ++|..++...   .+.+..+..++.|++.||.|||  +.+|+||||||+||+++.++.+||+|||
T Consensus        79 ~~~~~~~lv~e~~~-~~L~~~~~~~---~~~~~~~~~i~~qi~~~L~~LH--~~~i~H~dl~p~nill~~~~~~kl~d~g  152 (337)
T cd07852          79 ENDKDIYLVFEYME-TDLHAVIRAN---ILEDVHKRYIMYQLLKALKYIH--SGNVIHRDLKPSNILLNSDCRVKLADFG  152 (337)
T ss_pred             CCCceEEEEecccc-cCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH--HCCeecCCCCHHHEEEcCCCcEEEeecc
Confidence            4  36899999996 5998887653   5889999999999999999999  6779999999999999999999999999


Q ss_pred             CccCCCCCCCc---ceeeccccCCcccCcccccc-CCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHh-
Q 046893          245 LAKDGPMGDQT---HVSTRVMGTYGYAAPEYVMT-GHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPL-  319 (464)
Q Consensus       245 la~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~-  319 (464)
                      ++.........   .......|+..|+|||.+.+ ..++.++||||||+++|+|++|+.||.................. 
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~  232 (337)
T cd07852         153 LARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPP  232 (337)
T ss_pred             chhccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Confidence            99865433221   12234578999999998765 46788999999999999999999999754322111000000000 


Q ss_pred             -------h--hcccchhhccC-c--cccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 046893          320 -------L--NNNKKVLRILD-P--RLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVA  369 (464)
Q Consensus       320 -------~--~~~~~~~~~~~-~--~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  369 (464)
                             +  .....+..... .  ..........+..+.+++.+||+.||.+||++.+++.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~  294 (337)
T cd07852         233 SAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALE  294 (337)
T ss_pred             CHHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhh
Confidence                   0  00000000000 0  0000111124568999999999999999999999986

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2e-37  Score=295.45  Aligned_cols=251  Identities=22%  Similarity=0.285  Sum_probs=196.9

Q ss_pred             cCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCC-----CccHHHHHHHHHHHhcCCCCCcceEEEEEEe
Q 046893           92 KFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGG-----YQGDREWLAEVNYLGQLRHSNLVKLIGYCCE  166 (464)
Q Consensus        92 ~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~  166 (464)
                      .+|++.+.||+|+||.||+|.+..+      +..||+|.+....     ......+.+|+.+++.++|+||+++++++..
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~------~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~   75 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDADT------GRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRD   75 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcCC------CCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEc
Confidence            3688899999999999999998764      5679999875321     1223567889999999999999999999876


Q ss_pred             C--CeEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccC
Q 046893          167 D--EHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFG  244 (464)
Q Consensus       167 ~--~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFG  244 (464)
                      .  ..+++||||+++++|.+++....  .+++..+..++.|++.||.|||  ..+++|+||||+||+++.++.++|+|||
T Consensus        76 ~~~~~~~~v~e~~~~~~L~~~~~~~~--~l~~~~~~~~~~~i~~al~~LH--~~~i~H~dl~p~ni~i~~~~~~~l~dfg  151 (264)
T cd06653          76 PEEKKLSIFVEYMPGGSIKDQLKAYG--ALTENVTRRYTRQILQGVSYLH--SNMIVHRDIKGANILRDSAGNVKLGDFG  151 (264)
T ss_pred             CCCCEEEEEEEeCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH--hCCEecCCCCHHHEEEcCCCCEEECccc
Confidence            4  46889999999999999887543  5889999999999999999999  6679999999999999999999999999


Q ss_pred             CccCCCCCCC-cceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhcc
Q 046893          245 LAKDGPMGDQ-THVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNN  323 (464)
Q Consensus       245 la~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~  323 (464)
                      +++....... ........|+..|+|||++.+..++.++|||||||++|+|++|+.||.......  ..           
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--~~-----------  218 (264)
T cd06653         152 ASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMA--AI-----------  218 (264)
T ss_pred             cccccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHH--HH-----------
Confidence            9986432111 111123568999999999998889999999999999999999999997542111  00           


Q ss_pred             cchhhccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 046893          324 KKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVA  369 (464)
Q Consensus       324 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  369 (464)
                         ...........++......+.+++.+||. +|..||+..+++.
T Consensus       219 ---~~~~~~~~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~  260 (264)
T cd06653         219 ---FKIATQPTKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR  260 (264)
T ss_pred             ---HHHHcCCCCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence               01111111122344455689999999999 5799999998764

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=4.9e-38  Score=310.57  Aligned_cols=265  Identities=24%  Similarity=0.307  Sum_probs=195.3

Q ss_pred             hcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCC-ccHHHHHHHHHHHhcCCCCCcceEEEEEEeCC-
Q 046893           91 TKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGY-QGDREWLAEVNYLGQLRHSNLVKLIGYCCEDE-  168 (464)
Q Consensus        91 ~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~-  168 (464)
                      .++|.+.+.||+|+||.||+|.+..+      ++.||+|.+..... .....+..|+.+++.++||||+++++++.... 
T Consensus         4 ~~~y~i~~~lg~G~~g~vy~~~~~~~------~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~   77 (336)
T cd07849           4 GPRYQNLSYIGEGAYGMVCSATHKPT------GVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSF   77 (336)
T ss_pred             ccceEEEEEEEecCCeEEEEEEEcCC------CCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccc
Confidence            46799999999999999999998764      56799999864322 23356788999999999999999998876543 


Q ss_pred             ----eEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccC
Q 046893          169 ----HRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFG  244 (464)
Q Consensus       169 ----~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFG  244 (464)
                          ..++||||+. ++|.+++..   ..+++..+..++.|++.||.|||  ..+|+||||||+|||++.++.+||+|||
T Consensus        78 ~~~~~~~lv~e~~~-~~l~~~~~~---~~l~~~~~~~i~~ql~~aL~~LH--~~~ivH~dlkp~Nill~~~~~~kl~dfg  151 (336)
T cd07849          78 ESFNDVYIVQELME-TDLYKLIKT---QHLSNDHIQYFLYQILRGLKYIH--SANVLHRDLKPSNLLLNTNCDLKICDFG  151 (336)
T ss_pred             cccceEEEEehhcc-cCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHH--hCCeeccCCCHHHEEECCCCCEEECccc
Confidence                5799999995 588777653   35899999999999999999999  5679999999999999999999999999


Q ss_pred             CccCCCCCCC-cceeeccccCCcccCcccccc-CCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhc
Q 046893          245 LAKDGPMGDQ-THVSTRVMGTYGYAAPEYVMT-GHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNN  322 (464)
Q Consensus       245 la~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~  322 (464)
                      ++........ ........||..|+|||.+.+ ..++.++|||||||++|+|++|+.||.+......   .......+..
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~---~~~~~~~~~~  228 (336)
T cd07849         152 LARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQ---LNLILGVLGT  228 (336)
T ss_pred             ceeeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHcCC
Confidence            9976432211 111233578999999998755 5689999999999999999999999975432110   0000000000


Q ss_pred             c--cchhhccC-----------ccccC---ccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 046893          323 N--KKVLRILD-----------PRLEG---QYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVAL  370 (464)
Q Consensus       323 ~--~~~~~~~~-----------~~~~~---~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  370 (464)
                      .  .....+.+           .....   ......+..+.+|+.+||+.||.+||++.++++.
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h  292 (336)
T cd07849         229 PSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH  292 (336)
T ss_pred             CCHHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            0  00000000           00000   0011224578999999999999999999998864

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=1.3e-37  Score=306.52  Aligned_cols=267  Identities=20%  Similarity=0.261  Sum_probs=194.9

Q ss_pred             ceeec--CceEEEEEEecCCCCCCccceEEEEEEccCCCCc--cHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeEEEEE
Q 046893           99 ILGEG--GFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQ--GDREWLAEVNYLGQLRHSNLVKLIGYCCEDEHRILVY  174 (464)
Q Consensus        99 ~lG~G--~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~  174 (464)
                      .||.|  +||+||+|.+...      ++.||+|++......  ..+.+.+|+.+++.++||||++++++|...+..++||
T Consensus         5 ~ig~g~~~~~~v~~a~~~~~------~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~   78 (328)
T cd08226           5 EIGRGFCNLTSVYLARHTPT------GTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVIS   78 (328)
T ss_pred             HhCCcccCceeEEEEEEcCC------CcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEE
Confidence            46666  9999999998664      677999998754322  2356788999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCccCCCCCCC
Q 046893          175 EYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQ  254 (464)
Q Consensus       175 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~  254 (464)
                      ||+.+++|.+++.+.....+++..+..++.|++.||+|||  +.+|+||||||+|||++.++.++++||+.+........
T Consensus        79 e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH--~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~  156 (328)
T cd08226          79 PFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLH--QNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQ  156 (328)
T ss_pred             ecccCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHH--hCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCc
Confidence            9999999999887755456899999999999999999999  67799999999999999999999999986542211110


Q ss_pred             c-c----eeeccccCCcccCccccccC--CCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHh--------
Q 046893          255 T-H----VSTRVMGTYGYAAPEYVMTG--HLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPL--------  319 (464)
Q Consensus       255 ~-~----~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~--------  319 (464)
                      . .    ......++..|+|||++.+.  .++.++|||||||++|+|++|+.||.......  .........        
T Consensus       157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~  234 (328)
T cd08226         157 KAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQ--MLLQKLKGPPYSPLDIT  234 (328)
T ss_pred             cccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHH--HHHHHhcCCCCCCcccc
Confidence            0 0    01112356679999998763  47899999999999999999999997543211  011100000        


Q ss_pred             -h--------hccc---------c-----hhhccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH--HHHHH
Q 046893          320 -L--------NNNK---------K-----VLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVA--LLETV  374 (464)
Q Consensus       320 -~--------~~~~---------~-----~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~--~L~~~  374 (464)
                       .        ....         .     ........+.......+...+.+|+.+||..||.+|||+.++++  .++.+
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~  314 (328)
T cd08226         235 TFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQV  314 (328)
T ss_pred             ccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHH
Confidence             0        0000         0     00001111122223446678999999999999999999999974  44444


Q ss_pred             H
Q 046893          375 Q  375 (464)
Q Consensus       375 ~  375 (464)
                      .
T Consensus       315 ~  315 (328)
T cd08226         315 K  315 (328)
T ss_pred             H
Confidence            3

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=1.2e-37  Score=301.80  Aligned_cols=244  Identities=24%  Similarity=0.383  Sum_probs=195.4

Q ss_pred             CceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCccHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeEEEEEecc
Q 046893           98 YILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVKLIGYCCEDEHRILVYEYM  177 (464)
Q Consensus        98 ~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~  177 (464)
                      ..||+|+||.||+|.+..+      +..||||.+..........+.+|+.+++.++|+||+++++++...+..++||||+
T Consensus        26 ~~lg~g~~g~v~~~~~~~~------~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   99 (292)
T cd06657          26 IKIGEGSTGIVCIATVKSS------GKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL   99 (292)
T ss_pred             HHcCCCCCeEEEEEEEcCC------CeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecC
Confidence            4699999999999988764      6779999886544444567889999999999999999999999999999999999


Q ss_pred             CCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCccCCCCCCCcce
Q 046893          178 ESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHV  257 (464)
Q Consensus       178 ~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~~~~  257 (464)
                      ++++|.+++...   .+++..+..++.|++.||.|||  ..+++|+||+|+||+++.++.++|+|||++.......  ..
T Consensus       100 ~~~~L~~~~~~~---~~~~~~~~~~~~ql~~~l~~lH--~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~--~~  172 (292)
T cd06657         100 EGGALTDIVTHT---RMNEEQIAAVCLAVLKALSVLH--AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV--PR  172 (292)
T ss_pred             CCCcHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH--HCCeecCCCCHHHEEECCCCCEEEcccccceeccccc--cc
Confidence            999998876542   5899999999999999999999  5679999999999999999999999999987543221  11


Q ss_pred             eeccccCCcccCccccccCCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhcccchhhccCccccCc
Q 046893          258 STRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRILDPRLEGQ  337 (464)
Q Consensus       258 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  337 (464)
                      .....|+..|+|||.+.+..++.++||||||+++|+|++|..||........   ......          .+...+.  
T Consensus       173 ~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~---~~~~~~----------~~~~~~~--  237 (292)
T cd06657         173 RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKA---MKMIRD----------NLPPKLK--  237 (292)
T ss_pred             ccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHh----------hCCcccC--
Confidence            2335689999999999888899999999999999999999999975432111   111100          0111110  


Q ss_pred             cCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 046893          338 YTARTAMKVAGLAYQCLSQNPKGRPVMSDVVA  369 (464)
Q Consensus       338 ~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  369 (464)
                      .....+..+.+++.+||..+|.+||++.+++.
T Consensus       238 ~~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~  269 (292)
T cd06657         238 NLHKVSPSLKGFLDRLLVRDPAQRATAAELLK  269 (292)
T ss_pred             CcccCCHHHHHHHHHHHhCCcccCcCHHHHhc
Confidence            01123447889999999999999999999875

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=2.7e-37  Score=297.10  Aligned_cols=242  Identities=24%  Similarity=0.368  Sum_probs=186.7

Q ss_pred             ceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCc---cHHHHHHHH---HHHhcCCCCCcceEEEEEEeCCeEEE
Q 046893           99 ILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQ---GDREWLAEV---NYLGQLRHSNLVKLIGYCCEDEHRIL  172 (464)
Q Consensus        99 ~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~---~~l~~l~hpniv~l~~~~~~~~~~~l  172 (464)
                      +||+|+||.||+|.+..+      ++.||+|.+......   ....+..|.   .++....||||+++++++...+..++
T Consensus         1 ~ig~g~~g~Vy~~~~~~~------~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~   74 (278)
T cd05606           1 IIGRGGFGEVYGCRKADT------GKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSF   74 (278)
T ss_pred             CcccCCCeEEEEEEEecC------CCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEE
Confidence            489999999999987664      567999998654322   112233443   34445679999999999999999999


Q ss_pred             EEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCccCCCCC
Q 046893          173 VYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMG  252 (464)
Q Consensus       173 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~  252 (464)
                      ||||+.|++|.+++...  ..+++..+..++.|++.||.|||  +.+|+||||||+||+++.++.+||+|||++......
T Consensus        75 v~e~~~g~~L~~~l~~~--~~l~~~~~~~~~~ql~~~l~~lH--~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~  150 (278)
T cd05606          75 ILDLMNGGDLHYHLSQH--GVFSEAEMRFYAAEIILGLEHMH--NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK  150 (278)
T ss_pred             EEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH--HCCEEcCCCCHHHEEECCCCCEEEccCcCccccCcc
Confidence            99999999999887653  36999999999999999999999  577999999999999999999999999998754322


Q ss_pred             CCcceeeccccCCcccCccccccC-CCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhcccchhhccC
Q 046893          253 DQTHVSTRVMGTYGYAAPEYVMTG-HLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRILD  331 (464)
Q Consensus       253 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  331 (464)
                      .    .....|+..|+|||++.++ .++.++||||||+++|+|++|+.||.............   ...        ...
T Consensus       151 ~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~---~~~--------~~~  215 (278)
T cd05606         151 K----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDR---MTL--------TMA  215 (278)
T ss_pred             C----CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHH---Hhh--------ccC
Confidence            1    1235799999999998754 68999999999999999999999997653221111100   000        001


Q ss_pred             ccccCccCHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHH
Q 046893          332 PRLEGQYTARTAMKVAGLAYQCLSQNPKGRP-----VMSDVVA  369 (464)
Q Consensus       332 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~ev~~  369 (464)
                      .    ..+...+..+.+++.+||..+|.+||     ++.++++
T Consensus       216 ~----~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~  254 (278)
T cd05606         216 V----ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  254 (278)
T ss_pred             C----CCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence            1    12222356899999999999999999     8888764

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=1.2e-37  Score=303.98  Aligned_cols=266  Identities=25%  Similarity=0.320  Sum_probs=194.9

Q ss_pred             cCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCcc--HHHHHHHHHHHhcCCCCCcceEEEEEEeC--
Q 046893           92 KFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQG--DREWLAEVNYLGQLRHSNLVKLIGYCCED--  167 (464)
Q Consensus        92 ~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~hpniv~l~~~~~~~--  167 (464)
                      ++|++.+.||+|+||.||+|.+..+      ++.||+|.+.......  ...+.+|+.+++.++|+||+++++++...  
T Consensus         7 ~~y~~~~~ig~g~~~~v~~~~~~~~------~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~   80 (309)
T cd07845           7 TEFEKLNRIGEGTYGIVYRARDTTS------GEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHL   80 (309)
T ss_pred             cceeEeeeeeecCCEEEEEEEECCC------CcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCC
Confidence            5688899999999999999998764      6679999986443221  23467899999999999999999998765  


Q ss_pred             CeEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCcc
Q 046893          168 EHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAK  247 (464)
Q Consensus       168 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~  247 (464)
                      +..++||||+. ++|.+++... ...+++..+..++.|++.||.|||  ..+++||||||+||+++.++.+||+|||++.
T Consensus        81 ~~~~lv~e~~~-~~l~~~l~~~-~~~l~~~~~~~~~~qi~~~l~~lH--~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~  156 (309)
T cd07845          81 DSIFLVMEYCE-QDLASLLDNM-PTPFSESQVKCLMLQLLRGLQYLH--ENFIIHRDLKVSNLLLTDKGCLKIADFGLAR  156 (309)
T ss_pred             CeEEEEEecCC-CCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHH--hCCeecCCCCHHHEEECCCCCEEECccceee
Confidence            56899999996 4888877653 246899999999999999999999  5679999999999999999999999999998


Q ss_pred             CCCCCCCcceeeccccCCcccCcccccc-CCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHH-HHHH-------H
Q 046893          248 DGPMGDQTHVSTRVMGTYGYAAPEYVMT-GHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLV-EWAR-------P  318 (464)
Q Consensus       248 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~-~~~~-------~  318 (464)
                      ......  .......++..|+|||++.+ ..++.++|||||||++|||++|+.||...........+ .+..       +
T Consensus       157 ~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~  234 (309)
T cd07845         157 TYGLPA--KPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWP  234 (309)
T ss_pred             ecCCcc--CCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhch
Confidence            654322  11222346788999998875 46889999999999999999999999765432211100 0000       0


Q ss_pred             hhhcccc--hhhccCcccc--CccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 046893          319 LLNNNKK--VLRILDPRLE--GQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVA  369 (464)
Q Consensus       319 ~~~~~~~--~~~~~~~~~~--~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  369 (464)
                      .+.....  ..........  .......+..+.+||.+||+.||.+||++.+++.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~  289 (309)
T cd07845         235 GFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALE  289 (309)
T ss_pred             hhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence            0000000  0000000000  0000112457789999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=6.2e-38  Score=298.09  Aligned_cols=245  Identities=25%  Similarity=0.364  Sum_probs=197.0

Q ss_pred             eeecCceEEEEEEecCCCCCCccceEEEEEEccCCCC---ccHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeEEEEEec
Q 046893          100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGY---QGDREWLAEVNYLGQLRHSNLVKLIGYCCEDEHRILVYEY  176 (464)
Q Consensus       100 lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~  176 (464)
                      ||.|+||.||++.+..+      ++.+++|++.....   .....+.+|+++++.+.||||+++++++......++||||
T Consensus         1 lg~g~~~~vy~~~~~~~------~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~   74 (265)
T cd05579           1 ISKGAYGRVFLAKKKST------GDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEY   74 (265)
T ss_pred             CCCCCceEEEEEEECCC------CCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEec
Confidence            68999999999998764      56799999875433   2345688999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCccCCCCCCC--
Q 046893          177 MESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQ--  254 (464)
Q Consensus       177 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~--  254 (464)
                      +.+++|.+++.+..  .+++..+..++.|++.||.|||  +.+++|+||+|+||+++.++.++|+|||++........  
T Consensus        75 ~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~L~~lH--~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~  150 (265)
T cd05579          75 LPGGDLASLLENVG--SLDEDVARIYIAEIVLALEYLH--SNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQIN  150 (265)
T ss_pred             CCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH--HcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccc
Confidence            99999999887643  6899999999999999999999  67799999999999999999999999999875433221  


Q ss_pred             ----cceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhcccchhhcc
Q 046893          255 ----THVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRIL  330 (464)
Q Consensus       255 ----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  330 (464)
                          ........++..|+|||.+.+..++.++||||||+++|+|++|..||......      +..........      
T Consensus       151 ~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~------~~~~~~~~~~~------  218 (265)
T cd05579         151 LNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPE------EIFQNILNGKI------  218 (265)
T ss_pred             cccccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHhcCCc------
Confidence                11223356888999999998888999999999999999999999999754321      11111111000      


Q ss_pred             CccccCccCHH--HHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 046893          331 DPRLEGQYTAR--TAMKVAGLAYQCLSQNPKGRPVMSDVVALLE  372 (464)
Q Consensus       331 ~~~~~~~~~~~--~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~  372 (464)
                            ..+..  .+..+.+++.+||+.+|.+||++..+.+.|+
T Consensus       219 ------~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~  256 (265)
T cd05579         219 ------EWPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKN  256 (265)
T ss_pred             ------CCCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhc
Confidence                  01111  2568899999999999999999977766664

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=1.7e-37  Score=298.47  Aligned_cols=259  Identities=23%  Similarity=0.275  Sum_probs=193.1

Q ss_pred             CCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCC-ccHHHHHHHHHHHhcCC-CCCcceEEEEEEeC--Ce
Q 046893           94 FRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGY-QGDREWLAEVNYLGQLR-HSNLVKLIGYCCED--EH  169 (464)
Q Consensus        94 ~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~--~~  169 (464)
                      |++.+.||+|+||.||+|.+..+      +..||+|.+..... ........|+.++.++. |+||+++++++.+.  +.
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~------~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~   74 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKT------GKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGR   74 (282)
T ss_pred             CceEeeccccccceEEEEEEcCC------CcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCc
Confidence            56778899999999999998764      56799999865422 22234567899999885 99999999999987  88


Q ss_pred             EEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCccCC
Q 046893          170 RILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDG  249 (464)
Q Consensus       170 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~  249 (464)
                      .++||||+. ++|.+.+.... ..+++..++.++.|++.||.|||  ..+++||||+|+||+++. +.+||+|||+++..
T Consensus        75 ~~lv~e~~~-~~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~LH--~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~  149 (282)
T cd07831          75 LALVFELMD-MNLYELIKGRK-RPLPEKRVKSYMYQLLKSLDHMH--RNGIFHRDIKPENILIKD-DILKLADFGSCRGI  149 (282)
T ss_pred             EEEEEecCC-ccHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHH--HCCceecccCHHHEEEcC-CCeEEEeccccccc
Confidence            999999996 58888776543 36899999999999999999999  677999999999999999 99999999999864


Q ss_pred             CCCCCcceeeccccCCcccCcccccc-CCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhcccc-h-
Q 046893          250 PMGDQTHVSTRVMGTYGYAAPEYVMT-GHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKK-V-  326 (464)
Q Consensus       250 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~-~-  326 (464)
                      .....   .....++..|+|||++.. ..++.++|||||||++|||++|..||.+.....   .+.+.......... + 
T Consensus       150 ~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~---~~~~~~~~~~~~~~~~~  223 (282)
T cd07831         150 YSKPP---YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELD---QIAKIHDVLGTPDAEVL  223 (282)
T ss_pred             ccCCC---cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHH---HHHHHHHHcCCCCHHHH
Confidence            32211   123568899999997654 567889999999999999999999997654321   11111111100000 0 


Q ss_pred             --------hhccCcccc----CccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 046893          327 --------LRILDPRLE----GQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVA  369 (464)
Q Consensus       327 --------~~~~~~~~~----~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  369 (464)
                              .....+...    .......+..+.+||.+||..+|.+||++.+++.
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~  278 (282)
T cd07831         224 KKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR  278 (282)
T ss_pred             HhhcccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence                    000000000    0011234678999999999999999999999874

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.7e-37  Score=291.99  Aligned_cols=248  Identities=28%  Similarity=0.449  Sum_probs=202.1

Q ss_pred             CCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCC--ccHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeE
Q 046893           93 FFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGY--QGDREWLAEVNYLGQLRHSNLVKLIGYCCEDEHR  170 (464)
Q Consensus        93 ~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~  170 (464)
                      +|.+.+.||+|+||.||+|.+...      +..|++|.+.....  .....+.+|++++.++.|||++++++++...+..
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~------~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   74 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLET------GDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSL   74 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCC------CcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEE
Confidence            477889999999999999987654      56699999876544  2346788999999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCccCCC
Q 046893          171 ILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGP  250 (464)
Q Consensus       171 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~  250 (464)
                      ++||||+.+++|.+++...  ..+++..+..++.|++.||.|||  ..+|+||||+|+||+++.++.++|+|||++....
T Consensus        75 ~~v~e~~~~~~L~~~~~~~--~~l~~~~~~~~~~~i~~~l~~lH--~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~  150 (254)
T cd06627          75 YIILEYAENGSLRQIIKKF--GPFPESLVAVYVYQVLQGLAYLH--EQGVIHRDIKAANILTTKDGVVKLADFGVATKLN  150 (254)
T ss_pred             EEEEecCCCCcHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHh--hCCcccCCCCHHHEEECCCCCEEEeccccceecC
Confidence            9999999999999988765  36899999999999999999999  6779999999999999999999999999998654


Q ss_pred             CCCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhcccchhhcc
Q 046893          251 MGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRIL  330 (464)
Q Consensus       251 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  330 (464)
                      .....  .....|+..|+|||.+.+..++.++||||||+++|+|++|..||......     .... .....        
T Consensus       151 ~~~~~--~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~-----~~~~-~~~~~--------  214 (254)
T cd06627         151 DVSKD--DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPM-----AALF-RIVQD--------  214 (254)
T ss_pred             CCccc--ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHH-----HHHH-HHhcc--------
Confidence            33221  23357899999999998888899999999999999999999999754311     0000 00000        


Q ss_pred             CccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 046893          331 DPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVA  369 (464)
Q Consensus       331 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  369 (464)
                         .....+...+..+.+++.+||..+|++||++.+++.
T Consensus       215 ---~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~  250 (254)
T cd06627         215 ---DHPPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLK  250 (254)
T ss_pred             ---CCCCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence               011122234558899999999999999999999874

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-37  Score=295.93  Aligned_cols=245  Identities=23%  Similarity=0.295  Sum_probs=190.4

Q ss_pred             CceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCccH---HHHHHHHHHH-hcCCCCCcceEEEEEEeCCeEEEE
Q 046893           98 YILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGD---REWLAEVNYL-GQLRHSNLVKLIGYCCEDEHRILV  173 (464)
Q Consensus        98 ~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~---~~~~~E~~~l-~~l~hpniv~l~~~~~~~~~~~lv  173 (464)
                      +.||.|+||.||+|.+...      ++.||+|++........   ..+..|..++ ..+.|+||+++++++...+..++|
T Consensus         2 ~~l~~g~~~~v~~a~~~~~------~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv   75 (260)
T cd05611           2 KPISKGAFGSVYLAKKRST------GDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLV   75 (260)
T ss_pred             ccCCcCCCeeEEEEEecCC------CCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEE
Confidence            4589999999999998664      56799999865432221   2344454443 455899999999999999999999


Q ss_pred             EeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCccCCCCCC
Q 046893          174 YEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGD  253 (464)
Q Consensus       174 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~  253 (464)
                      |||+++++|.+++....  .+++..+..++.|++.||.|||  ..+++||||+|+||+++.++.++|+|||+++....  
T Consensus        76 ~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~lH--~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~--  149 (260)
T cd05611          76 MEYLNGGDCASLIKTLG--GLPEDWAKQYIAEVVLGVEDLH--QRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE--  149 (260)
T ss_pred             EeccCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH--HCCeecCCCCHHHeEECCCCcEEEeecccceeccc--
Confidence            99999999999886543  6899999999999999999999  56799999999999999999999999999875322  


Q ss_pred             CcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhcccchhhccCcc
Q 046893          254 QTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRILDPR  333 (464)
Q Consensus       254 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  333 (464)
                          .....|+..|+|||.+.+..++.++||||||+++|+|++|..||......      ..........        ..
T Consensus       150 ----~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~------~~~~~~~~~~--------~~  211 (260)
T cd05611         150 ----NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPD------AVFDNILSRR--------IN  211 (260)
T ss_pred             ----cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHH------HHHHHHHhcc--------cC
Confidence                22356889999999998888999999999999999999999999754321      1111111110        00


Q ss_pred             ccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 046893          334 LEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLE  372 (464)
Q Consensus       334 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~  372 (464)
                      ........++..+.+++.+||..+|++||++.++.+.|.
T Consensus       212 ~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~  250 (260)
T cd05611         212 WPEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKS  250 (260)
T ss_pred             CCCcccccCCHHHHHHHHHHccCCHHHccCCCcHHHHHc
Confidence            111112234568999999999999999998876666554

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=1.4e-37  Score=294.49  Aligned_cols=248  Identities=24%  Similarity=0.346  Sum_probs=201.5

Q ss_pred             CCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCC--ccHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeE
Q 046893           93 FFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGY--QGDREWLAEVNYLGQLRHSNLVKLIGYCCEDEHR  170 (464)
Q Consensus        93 ~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~  170 (464)
                      +|++.+.||+|+||.||++.+..+      ++.+++|.+.....  .....+..|+.+++.++|+||+++++++......
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~------~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   74 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSD------NQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKL   74 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCC------CCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEE
Confidence            477888999999999999987654      56799999875432  2235678899999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHhhc--CCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCccC
Q 046893          171 ILVYEYMESGSLEKHLLRRV--GCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKD  248 (464)
Q Consensus       171 ~lv~e~~~~g~L~~~l~~~~--~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~  248 (464)
                      ++||||+++++|.+++.+..  +..+++..++.++.|++.||.|||  ..+++|+||+|.||+++.++.+||+|||++..
T Consensus        75 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh--~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~  152 (256)
T cd08530          75 CIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH--EQKILHRDLKSANILLVANDLVKIGDLGISKV  152 (256)
T ss_pred             EEEehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHh--hCCcccCCCCcceEEEecCCcEEEeeccchhh
Confidence            99999999999999886522  346899999999999999999999  67799999999999999999999999999986


Q ss_pred             CCCCCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhcccchhh
Q 046893          249 GPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLR  328 (464)
Q Consensus       249 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  328 (464)
                      ....    ......|+..|++||.+.+..++.++|+||||+++|+|++|+.||......      +......        
T Consensus       153 ~~~~----~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~------~~~~~~~--------  214 (256)
T cd08530         153 LKKN----MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQ------DLRYKVQ--------  214 (256)
T ss_pred             hccC----CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHh--------
Confidence            5332    222356889999999999989999999999999999999999999754321      1111000        


Q ss_pred             ccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 046893          329 ILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVA  369 (464)
Q Consensus       329 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  369 (464)
                         .......+...+.++.+++.+||..+|.+||++.+++.
T Consensus       215 ---~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  252 (256)
T cd08530         215 ---RGKYPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILA  252 (256)
T ss_pred             ---cCCCCCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence               01111223345668999999999999999999999874

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=7.4e-38  Score=309.04  Aligned_cols=265  Identities=22%  Similarity=0.318  Sum_probs=197.9

Q ss_pred             hcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCC--ccHHHHHHHHHHHhcCCCCCcceEEEEEEe--
Q 046893           91 TKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGY--QGDREWLAEVNYLGQLRHSNLVKLIGYCCE--  166 (464)
Q Consensus        91 ~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~l~~~~~~--  166 (464)
                      ..+|.+.+.||.|+||.||+|.+..+      +..||+|++.....  .....+.+|+.+|+.++||||+++++++..  
T Consensus         4 ~~~y~~~~~lg~g~~g~v~~~~~~~~------~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~   77 (334)
T cd07855           4 GSRYKPIENIGSGAYGVVCSAIDTRS------GKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPG   77 (334)
T ss_pred             hhceeeeeeeecCCCeEEEEEEEcCC------CCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccC
Confidence            36789999999999999999998765      56799999875422  234567889999999999999999988753  


Q ss_pred             --CCeEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccC
Q 046893          167 --DEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFG  244 (464)
Q Consensus       167 --~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFG  244 (464)
                        ....++||||+. ++|.+++...  ..+++..+..++.|++.||.|||  ..+|+||||||+||+++.++.+||+|||
T Consensus        78 ~~~~~~~lv~e~~~-~~l~~~~~~~--~~~~~~~~~~i~~qi~~aL~~LH--~~~ivH~dlkp~Nil~~~~~~~kl~dfg  152 (334)
T cd07855          78 ADFKDVYVVMDLME-SDLHHIIHSD--QPLTEEHIRYFLYQLLRGLKYIH--SANVIHRDLKPSNLLVNEDCELRIGDFG  152 (334)
T ss_pred             CCCceEEEEEehhh-hhHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHH--HCCeecCCCCHHHEEEcCCCcEEecccc
Confidence              357899999995 6898887653  35899999999999999999999  5779999999999999999999999999


Q ss_pred             CccCCCCCCCc--ceeeccccCCcccCcccccc-CCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhh
Q 046893          245 LAKDGPMGDQT--HVSTRVMGTYGYAAPEYVMT-GHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLN  321 (464)
Q Consensus       245 la~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~  321 (464)
                      ++.........  .......|+..|+|||++.+ ..++.++|||||||++|+|++|+.||..........   .......
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~---~~~~~~g  229 (334)
T cd07855         153 MARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLK---LILSVLG  229 (334)
T ss_pred             cceeecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHH---HHHHHhC
Confidence            99754322211  12234578999999998765 468999999999999999999999997654321110   0000000


Q ss_pred             cc----------cchhhc---cCcccc---CccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 046893          322 NN----------KKVLRI---LDPRLE---GQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVA  369 (464)
Q Consensus       322 ~~----------~~~~~~---~~~~~~---~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  369 (464)
                      ..          ..+...   ......   .......+..+.+++.+||+.+|.+||++.+++.
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~  293 (334)
T cd07855         230 SPSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQ  293 (334)
T ss_pred             CChhHhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence            00          000000   000000   0111234568999999999999999999998875

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-37  Score=328.18  Aligned_cols=271  Identities=27%  Similarity=0.446  Sum_probs=217.8

Q ss_pred             HHHHHhcCCCCCCceeecCceEEEEEEecCCCCC-CccceEEEEEEccCCCCc-cHHHHHHHHHHHhcC-CCCCcceEEE
Q 046893           86 EMKLATKFFRPDYILGEGGFGVVYKGVIDENVRP-GYKTTFVAIKELNRGGYQ-GDREWLAEVNYLGQL-RHSNLVKLIG  162 (464)
Q Consensus        86 ~~~~~~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~-~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l-~hpniv~l~~  162 (464)
                      .+++..++..+.+.||+|.||.|++|........ ......||||.++..... ..+.+..|+++|+.+ .|+||+.+++
T Consensus       290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG  369 (609)
T KOG0200|consen  290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLG  369 (609)
T ss_pred             ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhhee
Confidence            4555566667777999999999999986643322 122567999999865444 346789999999999 6999999999


Q ss_pred             EEEeCCeEEEEEeccCCCCHHHHHHhhc--------C------CCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCC
Q 046893          163 YCCEDEHRILVYEYMESGSLEKHLLRRV--------G------CMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTS  228 (464)
Q Consensus       163 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~--------~------~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~  228 (464)
                      ++...+..++|+||+..|+|.+++....        +      ..+.....+.++.||+.|++||+  ++++|||||.++
T Consensus       370 ~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~--~~~~vHRDLAaR  447 (609)
T KOG0200|consen  370 ACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLA--SVPCVHRDLAAR  447 (609)
T ss_pred             eeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHh--hCCccchhhhhh
Confidence            9999999999999999999999998765        0      13889999999999999999999  677999999999


Q ss_pred             ceEecCCCceEEcccCCccCCCCCCCcceeeccc--cCCcccCccccccCCCCcccchhcHHHHHHHHHh-CCCCCCCCC
Q 046893          229 NILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVM--GTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLL-GRRAVDKSR  305 (464)
Q Consensus       229 Nill~~~~~vkl~DFGla~~~~~~~~~~~~~~~~--gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~  305 (464)
                      |||+..+..+||+|||+|+.....+...... -.  -...|||||.+....|+.++|||||||+||||++ |..||.+..
T Consensus       448 NVLi~~~~~~kIaDFGlar~~~~~~~y~~~~-~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~  526 (609)
T KOG0200|consen  448 NVLITKNKVIKIADFGLARDHYNKDYYRTKS-SAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIP  526 (609)
T ss_pred             hEEecCCCEEEEccccceeccCCCCceEecC-CCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCC
Confidence            9999999999999999999654444333221 12  2456999999999999999999999999999999 888887622


Q ss_pred             CcccccHHHHHHHhhhcccchhhccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHH
Q 046893          306 PSREHNLVEWARPLLNNNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETVQ  375 (464)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~~  375 (464)
                      ...  .              +.+.+....+...+..|..+++.+|+.||+.+|++||++.++.+.|+...
T Consensus       527 ~~~--~--------------l~~~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l  580 (609)
T KOG0200|consen  527 PTE--E--------------LLEFLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHL  580 (609)
T ss_pred             cHH--H--------------HHHHHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHH
Confidence            111  1              11122334444556677889999999999999999999999999998853

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=100.00  E-value=7.5e-39  Score=291.75  Aligned_cols=210  Identities=26%  Similarity=0.321  Sum_probs=172.6

Q ss_pred             hcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCc-c-HHHHHHHHHHHhcCCCCCcceEEEEEEe-C
Q 046893           91 TKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQ-G-DREWLAEVNYLGQLRHSNLVKLIGYCCE-D  167 (464)
Q Consensus        91 ~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~-~-~~~~~~E~~~l~~l~hpniv~l~~~~~~-~  167 (464)
                      -..|+....||+|+||.||+|+..++...  ....+|||.++.+... . .....+|+.+++.++||||+.|..+|.. +
T Consensus        23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~k--r~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d  100 (438)
T KOG0666|consen   23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDK--RTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHD  100 (438)
T ss_pred             HHHhhccceecccccceeeEeeeccCCcc--cchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccC
Confidence            34588899999999999999976654221  2346899998765321 1 1445789999999999999999998877 7


Q ss_pred             CeEEEEEeccCCCCHHHHHHhhc---CCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCC----CceEE
Q 046893          168 EHRILVYEYMESGSLEKHLLRRV---GCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNAD----FSAKL  240 (464)
Q Consensus       168 ~~~~lv~e~~~~g~L~~~l~~~~---~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~----~~vkl  240 (464)
                      ..++|++||.+. +|...|..+.   ...++...+..|+.||+.|+.|||+  +=|+||||||.||||..+    |.|||
T Consensus       101 ~~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~--NWvlHRDLKPaNIlvmgdgperG~VKI  177 (438)
T KOG0666|consen  101 KKVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHS--NWVLHRDLKPANILVMGDGPERGRVKI  177 (438)
T ss_pred             ceEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhh--hheeeccCCcceEEEeccCCccCeeEe
Confidence            899999999966 8988886443   3578999999999999999999994  559999999999999877    89999


Q ss_pred             cccCCccCCCCCCCcc-eeeccccCCcccCccccccC-CCCcccchhcHHHHHHHHHhCCCCCCCCC
Q 046893          241 SDFGLAKDGPMGDQTH-VSTRVMGTYGYAAPEYVMTG-HLTARSDVYGFGVVLLEMLLGRRAVDKSR  305 (464)
Q Consensus       241 ~DFGla~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~ell~g~~pf~~~~  305 (464)
                      +|||+++.+...-... ....++-|.+|+|||.+.|. .|+.+.||||.|||+.||++-.+.|.+..
T Consensus       178 aDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E  244 (438)
T KOG0666|consen  178 ADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGRE  244 (438)
T ss_pred             ecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchh
Confidence            9999999865443332 23457789999999999885 69999999999999999999999887643

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=9.5e-37  Score=291.52  Aligned_cols=246  Identities=20%  Similarity=0.219  Sum_probs=189.7

Q ss_pred             HHhcCCCCCCce--eecCceEEEEEEecCCCCCCccceEEEEEEccCCCCccHHHHHHHHHHHhcC-CCCCcceEEEEEE
Q 046893           89 LATKFFRPDYIL--GEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQL-RHSNLVKLIGYCC  165 (464)
Q Consensus        89 ~~~~~~~~~~~l--G~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~  165 (464)
                      ...+.|.+.+.+  |.|+||.||++....+      +..+|+|.+........     |+.....+ +||||+++++++.
T Consensus        11 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~------~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv~~~~~~~   79 (267)
T PHA03390         11 QFLKNCEIVKKLKLIDGKFGKVSVLKHKPT------QKLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNFIKLYYSVT   79 (267)
T ss_pred             HHHHhhccccceeecCCCceEEEEEEEcCC------CcEEEEEEEehhhcchh-----hHHHHHHhhcCCCEEEEEEEEe
Confidence            334566676666  9999999999987765      56789999865422211     22222222 6999999999999


Q ss_pred             eCCeEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCC-ceEEcccC
Q 046893          166 EDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADF-SAKLSDFG  244 (464)
Q Consensus       166 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~-~vkl~DFG  244 (464)
                      ..+..++||||+++++|.+++....  .+++..+..++.|++.||.|||  +.+++||||||+||+++.++ .++|+|||
T Consensus        80 ~~~~~~iv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lH--~~~i~H~dl~p~nil~~~~~~~~~l~dfg  155 (267)
T PHA03390         80 TLKGHVLIMDYIKDGDLFDLLKKEG--KLSEAEVKKIIRQLVEALNDLH--KHNIIHNDIKLENVLYDRAKDRIYLCDYG  155 (267)
T ss_pred             cCCeeEEEEEcCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH--hCCeeeCCCCHHHEEEeCCCCeEEEecCc
Confidence            9999999999999999999987653  7899999999999999999999  56799999999999999888 99999999


Q ss_pred             CccCCCCCCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhccc
Q 046893          245 LAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNK  324 (464)
Q Consensus       245 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  324 (464)
                      +++.....      ....|+..|+|||++.+..++.++||||||+++|+|++|..||...... ......+.... .   
T Consensus       156 ~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~-~~~~~~~~~~~-~---  224 (267)
T PHA03390        156 LCKIIGTP------SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDE-ELDLESLLKRQ-Q---  224 (267)
T ss_pred             cceecCCC------ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcc-hhhHHHHHHhh-c---
Confidence            98753221      2246899999999999989999999999999999999999999744321 11112221111 0   


Q ss_pred             chhhccCccccCccCHHHHHHHHHHHHHhhccCCCCCCC-HHHHHH
Q 046893          325 KVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPV-MSDVVA  369 (464)
Q Consensus       325 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-~~ev~~  369 (464)
                             .  ........+..+.+++.+||+.+|.+||+ ++++++
T Consensus       225 -------~--~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~  261 (267)
T PHA03390        225 -------K--KLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK  261 (267)
T ss_pred             -------c--cCCcccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence                   0  00112245568999999999999999995 587763

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=2.8e-37  Score=297.43  Aligned_cols=262  Identities=26%  Similarity=0.332  Sum_probs=197.5

Q ss_pred             CCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCC--CccHHHHHHHHHHHhcCCCCCcceEEEEEEeC--Ce
Q 046893           94 FRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGG--YQGDREWLAEVNYLGQLRHSNLVKLIGYCCED--EH  169 (464)
Q Consensus        94 ~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~--~~  169 (464)
                      |.+.+.||.|+||.||+|.+..+      ++.+|+|.+....  ......+..|+.+++.+.|+||+++++++...  +.
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~------~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   74 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKT------GELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGS   74 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCC------CeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCc
Confidence            56778899999999999998764      5679999997653  22335688999999999999999999999988  89


Q ss_pred             EEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCccCC
Q 046893          170 RILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDG  249 (464)
Q Consensus       170 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~  249 (464)
                      .++||||+.+ +|.+++.... ..+++..++.++.|++.||.|||  ..+++|+||+|+||+++.++.+||+|||++...
T Consensus        75 ~~lv~e~~~~-~l~~~~~~~~-~~~~~~~~~~i~~~i~~al~~LH--~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~  150 (287)
T cd07840          75 IYMVFEYMDH-DLTGLLDSPE-VKFTESQIKCYMKQLLEGLQYLH--SNGILHRDIKGSNILINNDGVLKLADFGLARPY  150 (287)
T ss_pred             EEEEeccccc-cHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHH--HCCceeccCcHHHeEEcCCCCEEEccccceeec
Confidence            9999999964 8988876542 46899999999999999999999  577999999999999999999999999999865


Q ss_pred             CCCCCcceeeccccCCcccCcccccc-CCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhcc-----
Q 046893          250 PMGDQTHVSTRVMGTYGYAAPEYVMT-GHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNN-----  323 (464)
Q Consensus       250 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~-----  323 (464)
                      ..... .......++..|+|||.+.+ ..++.++||||||+++|||++|+.||.........   ..........     
T Consensus       151 ~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~---~~~~~~~~~~~~~~~  226 (287)
T cd07840         151 TKRNS-ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQL---EKIFELCGSPTDENW  226 (287)
T ss_pred             cCCCc-ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHH---HHHHHHhCCCchhhc
Confidence            43321 11223457888999998765 45789999999999999999999999765432111   1100000000     


Q ss_pred             cchh-----------hccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 046893          324 KKVL-----------RILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVA  369 (464)
Q Consensus       324 ~~~~-----------~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  369 (464)
                      ....           ......+...+...++..+.+++.+||..+|.+||++.++++
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~  283 (287)
T cd07840         227 PGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ  283 (287)
T ss_pred             cccccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence            0000           000000111111113568899999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=3.6e-37  Score=297.54  Aligned_cols=260  Identities=25%  Similarity=0.327  Sum_probs=201.6

Q ss_pred             CCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCC----ccHHHHHHHHHHHhcC-CCCCcceEEEEEEeC
Q 046893           93 FFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGY----QGDREWLAEVNYLGQL-RHSNLVKLIGYCCED  167 (464)
Q Consensus        93 ~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~  167 (464)
                      +|.+.+.||+|+||.||++.+.....   .++.||||++.....    .....+..|+.++.++ +||||+++++.+...
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~~---~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~   77 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGHD---AGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTD   77 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEecccc---CCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecC
Confidence            36778899999999999998653321   256799998864322    2235678899999999 599999999999999


Q ss_pred             CeEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCcc
Q 046893          168 EHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAK  247 (464)
Q Consensus       168 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~  247 (464)
                      ...++||||+.+++|.+++...  ..+++..+..++.|++.+|.|||  ..+++||||+|.||+++.++.++|+|||+++
T Consensus        78 ~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH--~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~  153 (288)
T cd05583          78 TKLHLILDYVNGGELFTHLYQR--EHFTESEVRVYIAEIVLALDHLH--QLGIIYRDIKLENILLDSEGHVVLTDFGLSK  153 (288)
T ss_pred             CEEEEEEecCCCCcHHHHHhhc--CCcCHHHHHHHHHHHHHHHHHHH--HCCeeccCCCHHHeEECCCCCEEEEECcccc
Confidence            9999999999999999988654  36899999999999999999999  6779999999999999999999999999987


Q ss_pred             CCCCCCCcceeeccccCCcccCccccccCC--CCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhcccc
Q 046893          248 DGPMGDQTHVSTRVMGTYGYAAPEYVMTGH--LTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKK  325 (464)
Q Consensus       248 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  325 (464)
                      ........ ......|+..|+|||.+.+..  .+.++||||||+++|+|++|..||.......  ...+........   
T Consensus       154 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~--~~~~~~~~~~~~---  227 (288)
T cd05583         154 EFLAEEEE-RAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQN--SQSEISRRILKS---  227 (288)
T ss_pred             cccccccc-ccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccc--hHHHHHHHHHcc---
Confidence            64332211 122356899999999987654  7889999999999999999999996432111  111111111111   


Q ss_pred             hhhccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHH
Q 046893          326 VLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETV  374 (464)
Q Consensus       326 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~  374 (464)
                           .+    ..+...+..+.+++.+||+.||++|||+.++.+.|+..
T Consensus       228 -----~~----~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~  267 (288)
T cd05583         228 -----KP----PFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHP  267 (288)
T ss_pred             -----CC----CCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCc
Confidence                 11    11222445788999999999999999999998887754

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=7.9e-37  Score=295.43  Aligned_cols=254  Identities=24%  Similarity=0.341  Sum_probs=196.0

Q ss_pred             CCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCC----ccHHHHHHHHHHHhcC-CCCCcceEEEEEEeC
Q 046893           93 FFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGY----QGDREWLAEVNYLGQL-RHSNLVKLIGYCCED  167 (464)
Q Consensus        93 ~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~  167 (464)
                      +|++.+.||.|+||.||+|.+.....   .+..||+|++.....    ...+.+..|++++..+ +|+||+++++++..+
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~---~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~   77 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHD---SGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTD   77 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCC---CCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecC
Confidence            47788899999999999998754211   356799999875322    2235678899999999 599999999999999


Q ss_pred             CeEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCcc
Q 046893          168 EHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAK  247 (464)
Q Consensus       168 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~  247 (464)
                      ...++||||+++++|.+++....  .+++..+..++.|++.||.|||  ..+++||||+|+|||++.++.+||+|||++.
T Consensus        78 ~~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~al~~lH--~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~  153 (290)
T cd05613          78 TKLHLILDYINGGELFTHLSQRE--RFKEQEVQIYSGEIVLALEHLH--KLGIIYRDIKLENILLDSNGHVVLTDFGLSK  153 (290)
T ss_pred             CeEEEEEecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH--hCCeeccCCCHHHeEECCCCCEEEeeCccce
Confidence            99999999999999999987643  6889999999999999999999  6779999999999999999999999999998


Q ss_pred             CCCCCCCcceeeccccCCcccCccccccC--CCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhcccc
Q 046893          248 DGPMGDQTHVSTRVMGTYGYAAPEYVMTG--HLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKK  325 (464)
Q Consensus       248 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  325 (464)
                      ....... .......|+..|+|||.+.+.  .++.++||||||+++|+|++|..||......  .....+.......   
T Consensus       154 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~--~~~~~~~~~~~~~---  227 (290)
T cd05613         154 EFHEDEV-ERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEK--NSQAEISRRILKS---  227 (290)
T ss_pred             ecccccc-cccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCcc--ccHHHHHHHhhcc---
Confidence            6433221 112235689999999988753  4778999999999999999999999643221  1111221111111   


Q ss_pred             hhhccCccccCccCHHHHHHHHHHHHHhhccCCCCCC-----CHHHHH
Q 046893          326 VLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRP-----VMSDVV  368 (464)
Q Consensus       326 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~ev~  368 (464)
                           .+    .++...+..+.+++.+||+.||.+||     ++.+++
T Consensus       228 -----~~----~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~  266 (290)
T cd05613         228 -----EP----PYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIK  266 (290)
T ss_pred             -----CC----CCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHH
Confidence                 01    12233455788999999999999997     455554

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=1.4e-37  Score=307.54  Aligned_cols=263  Identities=24%  Similarity=0.339  Sum_probs=197.1

Q ss_pred             hcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCC--CccHHHHHHHHHHHhcCCCCCcceEEEEEEeC-
Q 046893           91 TKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGG--YQGDREWLAEVNYLGQLRHSNLVKLIGYCCED-  167 (464)
Q Consensus        91 ~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~-  167 (464)
                      .++|.+.+.||+|+||+||+|.+..+      +..||||.+....  ......+..|+.+++.++|+||+++++++... 
T Consensus         4 ~~~y~~~~~lg~G~~~~vy~~~~~~~------~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~   77 (337)
T cd07858           4 DTKYVPIKPIGRGAYGIVCSAKNSET------NEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPH   77 (337)
T ss_pred             ccceeEEEEeccCCCeEEEEEEecCC------CCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheeccc
Confidence            35688999999999999999997764      6679999886532  22335677899999999999999999987654 


Q ss_pred             ----CeEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEccc
Q 046893          168 ----EHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDF  243 (464)
Q Consensus       168 ----~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DF  243 (464)
                          ...++||||+. ++|.+++...  ..+++..+..++.|++.||.|||  .++++||||||+||+++.++.+||+||
T Consensus        78 ~~~~~~~~lv~e~~~-~~L~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH--~~~i~H~dlkp~Nil~~~~~~~kL~Df  152 (337)
T cd07858          78 REAFNDVYIVYELMD-TDLHQIIRSS--QTLSDDHCQYFLYQLLRGLKYIH--SANVLHRDLKPSNLLLNANCDLKICDF  152 (337)
T ss_pred             ccccCcEEEEEeCCC-CCHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHH--hCCEecCCCCHHHEEEcCCCCEEECcC
Confidence                35799999995 6898887653  36999999999999999999999  677999999999999999999999999


Q ss_pred             CCccCCCCCCCcceeeccccCCcccCcccccc-CCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhc
Q 046893          244 GLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMT-GHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNN  322 (464)
Q Consensus       244 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~  322 (464)
                      |+++......  .......++..|+|||.+.+ ..++.++|||||||++|+|++|+.||.+.......   ......+..
T Consensus       153 g~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~---~~~~~~~~~  227 (337)
T cd07858         153 GLARTTSEKG--DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQL---KLITELLGS  227 (337)
T ss_pred             ccccccCCCc--ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHH---HHHHHHhCC
Confidence            9998643322  22234568899999998765 46889999999999999999999999764321111   000000000


Q ss_pred             ----------ccchh---hcc----CccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 046893          323 ----------NKKVL---RIL----DPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVAL  370 (464)
Q Consensus       323 ----------~~~~~---~~~----~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  370 (464)
                                .....   +.+    ..... .....++..+.+|+.+||+.+|.+||++.+++..
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h  291 (337)
T cd07858         228 PSEEDLGFIRNEKARRYIRSLPYTPRQSFA-RLFPHANPLAIDLLEKMLVFDPSKRITVEEALAH  291 (337)
T ss_pred             CChHHhhhcCchhhhHHHHhcCcccccCHH-HHcccCCHHHHHHHHHHhcCChhhccCHHHHHcC
Confidence                      00000   000    00000 0112345678999999999999999999999864

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=4.2e-37  Score=295.75  Aligned_cols=261  Identities=25%  Similarity=0.296  Sum_probs=199.2

Q ss_pred             CCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCc--cHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeEE
Q 046893           94 FRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQ--GDREWLAEVNYLGQLRHSNLVKLIGYCCEDEHRI  171 (464)
Q Consensus        94 ~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~  171 (464)
                      |.+.+.||.|++|.||+|.+..+      ++.+++|.+......  ....+..|+.+++.++|+||+++++++...+..+
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~------~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   74 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLT------GEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLY   74 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCC------CcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEE
Confidence            56678899999999999997654      667999998754332  3467788999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCccCCCC
Q 046893          172 LVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPM  251 (464)
Q Consensus       172 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~  251 (464)
                      +||||+.+ +|.+++.... ..+++..+..++.|++.||.|||  ..+|+|+||||+||+++.++.++|+|||.+.....
T Consensus        75 ~v~e~~~~-~l~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~LH--~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~  150 (283)
T cd05118          75 LVFEFMDT-DLYKLIKDRQ-RGLPESLIKSYLYQLLQGLAFCH--SHGILHRDLKPENLLINTEGVLKLADFGLARSFGS  150 (283)
T ss_pred             EEEeccCC-CHHHHHHhhc-ccCCHHHHHHHHHHHHHHHHHHH--HCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCC
Confidence            99999965 8888776643 46899999999999999999999  67799999999999999999999999999976533


Q ss_pred             CCCcceeeccccCCcccCccccccC-CCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhcc-cch-hh
Q 046893          252 GDQTHVSTRVMGTYGYAAPEYVMTG-HLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNN-KKV-LR  328 (464)
Q Consensus       252 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~-~~~-~~  328 (464)
                      ..  .......++..|+|||.+.+. .++.++||||||+++|+|++|+.||.........   ......+... ... ..
T Consensus       151 ~~--~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~  225 (283)
T cd05118         151 PV--RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQL---FKIFRTLGTPDPEVWPK  225 (283)
T ss_pred             Cc--ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHHHHcCCCchHhccc
Confidence            22  122235688899999998876 7899999999999999999999999765432111   0000000000 000 00


Q ss_pred             cc-------------CccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 046893          329 IL-------------DPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVA  369 (464)
Q Consensus       329 ~~-------------~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  369 (464)
                      ..             ............+.++.++|.+||..||.+||++.+++.
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~  279 (283)
T cd05118         226 FTSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA  279 (283)
T ss_pred             chhhhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence            00             000001112345678999999999999999999999874

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=2.3e-37  Score=305.53  Aligned_cols=263  Identities=24%  Similarity=0.291  Sum_probs=194.7

Q ss_pred             cCCC-CCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCcc--------------HHHHHHHHHHHhcCCCCC
Q 046893           92 KFFR-PDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQG--------------DREWLAEVNYLGQLRHSN  156 (464)
Q Consensus        92 ~~~~-~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~--------------~~~~~~E~~~l~~l~hpn  156 (464)
                      ++|. +.+.||.|+||+||+|.+...      ++.||||++.......              ...+.+|+.+++.++|+|
T Consensus         8 ~ry~~~~~~ig~G~~g~vy~~~~~~~------~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~   81 (335)
T PTZ00024          8 ERYIQKGAHLGEGTYGKVEKAYDTLT------GKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHEN   81 (335)
T ss_pred             cchhhhhhcccCCCceeEEEEEECCC------CCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcc
Confidence            3444 557799999999999997654      5679999886543221              124778999999999999


Q ss_pred             cceEEEEEEeCCeEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCC
Q 046893          157 LVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADF  236 (464)
Q Consensus       157 iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~  236 (464)
                      |+++++++...+..++||||+. ++|.+++...  ..+++.....++.|++.||.|||  ..+|+|+||+|+||+++.++
T Consensus        82 iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~--~~~~~~~~~~~~~ql~~aL~~LH--~~~i~H~dl~~~nill~~~~  156 (335)
T PTZ00024         82 IMGLVDVYVEGDFINLVMDIMA-SDLKKVVDRK--IRLTESQVKCILLQILNGLNVLH--KWYFMHRDLSPANIFINSKG  156 (335)
T ss_pred             eeeeeEEEecCCcEEEEEeccc-cCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH--hCCeecccccHHHeEECCCC
Confidence            9999999999999999999996 6898888653  35899999999999999999999  67799999999999999999


Q ss_pred             ceEEcccCCccCCCCCC------------CcceeeccccCCcccCccccccC-CCCcccchhcHHHHHHHHHhCCCCCCC
Q 046893          237 SAKLSDFGLAKDGPMGD------------QTHVSTRVMGTYGYAAPEYVMTG-HLTARSDVYGFGVVLLEMLLGRRAVDK  303 (464)
Q Consensus       237 ~vkl~DFGla~~~~~~~------------~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~ell~g~~pf~~  303 (464)
                      .++|+|||+++......            .........++..|+|||.+.+. .++.++|||||||++|+|++|..||..
T Consensus       157 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~  236 (335)
T PTZ00024        157 ICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPG  236 (335)
T ss_pred             CEEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence            99999999997643111            01111224578899999998764 478999999999999999999999976


Q ss_pred             CCCcccccHHHHHHHhhhcccc--hhh------------ccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 046893          304 SRPSREHNLVEWARPLLNNNKK--VLR------------ILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVA  369 (464)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~~~--~~~------------~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  369 (464)
                      ......   .............  ...            ....... ......+..+.+++.+||+.+|.+||++.+++.
T Consensus       237 ~~~~~~---~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~  312 (335)
T PTZ00024        237 ENEIDQ---LGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLK-TIFPNASDDAIDLLQSLLKLNPLERISAKEALK  312 (335)
T ss_pred             CCHHHH---HHHHHHHhCCCchhhCcchhhcccccccCcCCcccHH-HhCcCCChHHHHHHHHHcCCCchhccCHHHHhc
Confidence            543211   1111110100000  000            0000000 011123457889999999999999999999985

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=3.6e-37  Score=299.38  Aligned_cols=266  Identities=24%  Similarity=0.296  Sum_probs=197.3

Q ss_pred             HHhcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCC--ccHHHHHHHHHHHhcCCCCCcceEEEEEEe
Q 046893           89 LATKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGY--QGDREWLAEVNYLGQLRHSNLVKLIGYCCE  166 (464)
Q Consensus        89 ~~~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~l~~~~~~  166 (464)
                      ...++|.+.+.||+|+||.||+|.+..+      ++.||+|.+.....  .....+..|+.+++.++||||+++++++.+
T Consensus         4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~------~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~   77 (302)
T cd07864           4 RCVDKFDIIGQIGEGTYGQVYKARDKDT------GELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTD   77 (302)
T ss_pred             hhhhhhheeeeecccCCEEEEEEEECCC------CcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecC
Confidence            3456789999999999999999998764      56799999865432  223567789999999999999999998876


Q ss_pred             CC----------eEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCC
Q 046893          167 DE----------HRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADF  236 (464)
Q Consensus       167 ~~----------~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~  236 (464)
                      ..          ..++||||+++ +|.+++... ...+++..+..++.|++.||.|||  ..+|+|+||||+||+++.++
T Consensus        78 ~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH--~~~i~H~dl~p~nili~~~~  153 (302)
T cd07864          78 KQDALDFKKDKGAFYLVFEYMDH-DLMGLLESG-LVHFSEDHIKSFMKQLLEGLNYCH--KKNFLHRDIKCSNILLNNKG  153 (302)
T ss_pred             cchhhhccccCCcEEEEEcccCc-cHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHH--hCCeecCCCCHHHEEECCCC
Confidence            55          78999999976 777776654 346899999999999999999999  66799999999999999999


Q ss_pred             ceEEcccCCccCCCCCCCcceeeccccCCcccCcccccc-CCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHH
Q 046893          237 SAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMT-GHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEW  315 (464)
Q Consensus       237 ~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~  315 (464)
                      .+||+|||++........ .......++..|+|||.+.+ ..++.++|||||||++|+|++|+.||.........  .. 
T Consensus       154 ~~kl~dfg~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~--~~-  229 (302)
T cd07864         154 QIKLADFGLARLYNSEES-RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQL--EL-  229 (302)
T ss_pred             cEEeCcccccccccCCcc-cccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHH--HH-
Confidence            999999999986533221 11122356788999998865 35788999999999999999999999754322111  11 


Q ss_pred             HHHhhhcc-c----chhhc-----cC------ccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 046893          316 ARPLLNNN-K----KVLRI-----LD------PRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVA  369 (464)
Q Consensus       316 ~~~~~~~~-~----~~~~~-----~~------~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  369 (464)
                      ........ .    .+...     .+      .... ......+..+.+++..||..||.+||++.+++.
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~  298 (302)
T cd07864         230 ISRLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLR-EEFSFIPTPALDLLDHMLTLDPSKRCTAEEALN  298 (302)
T ss_pred             HHHHhCCCChhhcccccccccccccccccccccchh-hhcCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            11100000 0    00000     00      0000 011123568899999999999999999998874

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=9.2e-37  Score=298.47  Aligned_cols=244  Identities=27%  Similarity=0.418  Sum_probs=192.8

Q ss_pred             CCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCc---cHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeE
Q 046893           94 FRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQ---GDREWLAEVNYLGQLRHSNLVKLIGYCCEDEHR  170 (464)
Q Consensus        94 ~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~  170 (464)
                      |.....||+|+||+||+|++..+      +..|++|.+......   ....+..|+.+++.++|||++++++++.+.+..
T Consensus        23 ~~~~~~lg~g~~g~v~~~~~~~~------~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   96 (313)
T cd06633          23 FVGLHEIGHGSFGAVYFATNSHT------NEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTA   96 (313)
T ss_pred             hhcceeeccCCCeEEEEEEECCC------CcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEE
Confidence            66667899999999999987654      667999998653322   224678899999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCccCCC
Q 046893          171 ILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGP  250 (464)
Q Consensus       171 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~  250 (464)
                      ++||||+. ++|.+++... ...+++..++.++.|++.+|.|||  ..+++|+||+|+||+++.++.+||+|||++....
T Consensus        97 ~lv~e~~~-~~l~~~l~~~-~~~l~~~~~~~~~~qi~~al~~LH--~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~  172 (313)
T cd06633          97 WLVMEYCL-GSASDLLEVH-KKPLQEVEIAAITHGALQGLAYLH--SHNMIHRDIKAGNILLTEPGQVKLADFGSASKSS  172 (313)
T ss_pred             EEEEecCC-CCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHH--HCCeecCCCChhhEEECCCCCEEEeecCCCcccC
Confidence            99999995 5787777554 346899999999999999999999  5679999999999999999999999999986422


Q ss_pred             CCCCcceeeccccCCcccCccccc---cCCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhcccchh
Q 046893          251 MGDQTHVSTRVMGTYGYAAPEYVM---TGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVL  327 (464)
Q Consensus       251 ~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  327 (464)
                      .      .....|+..|+|||++.   ...++.++|||||||++|+|++|..||........      ........    
T Consensus       173 ~------~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~------~~~~~~~~----  236 (313)
T cd06633         173 P------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA------LYHIAQND----  236 (313)
T ss_pred             C------CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHH------HHHHHhcC----
Confidence            1      22357899999999874   45688899999999999999999999876432111      11110000    


Q ss_pred             hccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 046893          328 RILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVA  369 (464)
Q Consensus       328 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  369 (464)
                         .+.   ......+..+.+|+.+||+.+|.+||++.+++.
T Consensus       237 ---~~~---~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~  272 (313)
T cd06633         237 ---SPT---LQSNEWTDSFRGFVDYCLQKIPQERPASAELLR  272 (313)
T ss_pred             ---CCC---CCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence               010   011123346889999999999999999999985

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=8.2e-37  Score=298.72  Aligned_cols=262  Identities=20%  Similarity=0.236  Sum_probs=191.0

Q ss_pred             CCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCC--CccHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeEEEE
Q 046893           96 PDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGG--YQGDREWLAEVNYLGQLRHSNLVKLIGYCCEDEHRILV  173 (464)
Q Consensus        96 ~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv  173 (464)
                      +.+.+|.|+++.||++  ..+      ++.||+|++....  ......+..|+.+++.++|+||+++++++...+..+++
T Consensus         6 i~~~~~~~~~v~~~~~--~~~------~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~   77 (314)
T cd08216           6 IGKCFEDLMIVHLAKH--KPT------NTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVV   77 (314)
T ss_pred             hhHhhcCCceEEEEEe--cCC------CCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEE
Confidence            3334445555545444  332      5679999987542  23346788999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCccCCCCCC
Q 046893          174 YEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGD  253 (464)
Q Consensus       174 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~  253 (464)
                      |||+.+++|.+++.......+++..+..++.|++.||.|||  +.+|+||||||+||+++.++.+||+|||.+.......
T Consensus        78 ~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH--~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~  155 (314)
T cd08216          78 SPLMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIH--SKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHG  155 (314)
T ss_pred             EeccCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH--HCCeecCCCCcceEEEecCCceEEecCccceeecccc
Confidence            99999999999988765557899999999999999999999  6679999999999999999999999999887543221


Q ss_pred             C-----cceeeccccCCcccCcccccc--CCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHh----hhc
Q 046893          254 Q-----THVSTRVMGTYGYAAPEYVMT--GHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPL----LNN  322 (464)
Q Consensus       254 ~-----~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~----~~~  322 (464)
                      .     ........++..|+|||++.+  ..++.++|||||||++|||++|..||.......  .+.+.....    +..
T Consensus       156 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~  233 (314)
T cd08216         156 KRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQ--MLLEKVRGTVPCLLDK  233 (314)
T ss_pred             ccccccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHhccCcccccc
Confidence            1     111223467888999998865  358899999999999999999999997643211  111110000    000


Q ss_pred             c------cchhh----ccC----ccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 046893          323 N------KKVLR----ILD----PRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVA  369 (464)
Q Consensus       323 ~------~~~~~----~~~----~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  369 (464)
                      .      .....    ..+    .............++.+|+.+||..||.+||++.++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~  294 (314)
T cd08216         234 STYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLN  294 (314)
T ss_pred             CchhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhc
Confidence            0      00000    000    00111223344568899999999999999999999986

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-37  Score=297.79  Aligned_cols=267  Identities=27%  Similarity=0.393  Sum_probs=203.5

Q ss_pred             CCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCccHHHHHHHHHHHhc--CCCCCcceEEEEEEeCC--
Q 046893           93 FFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQ--LRHSNLVKLIGYCCEDE--  168 (464)
Q Consensus        93 ~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~hpniv~l~~~~~~~~--  168 (464)
                      ...+..+||+|.||.||+|.+.+        +.||||++..   .....|.+|-+|...  |+|+||+++++.-....  
T Consensus       211 pl~l~eli~~Grfg~V~KaqL~~--------~~VAVKifp~---~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~  279 (534)
T KOG3653|consen  211 PLQLLELIGRGRFGCVWKAQLDN--------RLVAVKIFPE---QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTAD  279 (534)
T ss_pred             chhhHHHhhcCccceeehhhccC--------ceeEEEecCH---HHHHHHHhHHHHHhccCccchhHHHhhchhccCCcc
Confidence            34456789999999999998764        5699999864   445678888888776  58999999998765554  


Q ss_pred             --eEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhc-------CCCCeeeccCCCCceEecCCCceE
Q 046893          169 --HRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHG-------AERPVIYRDFKTSNILLNADFSAK  239 (464)
Q Consensus       169 --~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~-------~~~~ivHrDlkp~Nill~~~~~vk  239 (464)
                        .++||++|.+.|+|.++|..+.   ++|....+|+.-+++||+|||.       ++.+|+|||||..||||..|+.+-
T Consensus       280 ~~eywLVt~fh~kGsL~dyL~~nt---isw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTcc  356 (534)
T KOG3653|consen  280 RMEYWLVTEFHPKGSLCDYLKANT---ISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCC  356 (534)
T ss_pred             ccceeEEeeeccCCcHHHHHHhcc---ccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEE
Confidence              8999999999999999998764   9999999999999999999994       456899999999999999999999


Q ss_pred             EcccCCccCCCCCCCcceeeccccCCcccCccccccC-CCC-----cccchhcHHHHHHHHHhCCCCCC-CCCCccccc-
Q 046893          240 LSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTG-HLT-----ARSDVYGFGVVLLEMLLGRRAVD-KSRPSREHN-  311 (464)
Q Consensus       240 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~-----~~~DvwslG~il~ell~g~~pf~-~~~~~~~~~-  311 (464)
                      |+|||||..+..+.........+||.+|||||++.+. .+.     .+.||||+|.+||||++....++ +..+..... 
T Consensus       357 IaDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpf  436 (534)
T KOG3653|consen  357 IADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPF  436 (534)
T ss_pred             eeccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCch
Confidence            9999999987766555555558999999999988653 222     36899999999999999776554 222211111 


Q ss_pred             --------HHHHHHHhhhcccchhhccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhc
Q 046893          312 --------LVEWARPLLNNNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETVQSQ  377 (464)
Q Consensus       312 --------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~~~~  377 (464)
                              ..+-.+.++...+.-..+.+.....    .-...+++.+..||+.|++.|.|+.=+.+.+.++...
T Consensus       437 e~evG~hPt~e~mq~~VV~kK~RP~~p~~W~~h----~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~  506 (534)
T KOG3653|consen  437 EAEVGNHPTLEEMQELVVRKKQRPKIPDAWRKH----AGMAVLCETIEECWDHDAEARLTAGCVEERMAELMML  506 (534)
T ss_pred             hHHhcCCCCHHHHHHHHHhhccCCCChhhhhcC----ccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhcc
Confidence                    1222222222222222222221111    1234789999999999999999999999988877543

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-38  Score=330.47  Aligned_cols=258  Identities=23%  Similarity=0.255  Sum_probs=209.7

Q ss_pred             chhHHHHHhcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCc---cHHHHHHHHHHHhcCCCCCcce
Q 046893           83 TYNEMKLATKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQ---GDREWLAEVNYLGQLRHSNLVK  159 (464)
Q Consensus        83 ~~~~~~~~~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~hpniv~  159 (464)
                      ...++.+...+|.++++||+|+||.|.+++...+      +++||+|++++....   ...-|..|-.+|..-+.+-|+.
T Consensus        66 ~v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t------~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~  139 (1317)
T KOG0612|consen   66 KVKELRLKAEDFEILKVIGRGAFGEVALVRHKST------EKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQ  139 (1317)
T ss_pred             HHHHHhCCHHhhHHHHHhcccccceeEEEEeecc------ccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHH
Confidence            3457777889999999999999999999988775      788999999874332   2355888999999989999999


Q ss_pred             EEEEEEeCCeEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceE
Q 046893          160 LIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAK  239 (464)
Q Consensus       160 l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vk  239 (464)
                      ++..|.+++++|||||||+||+|..++.+..  .+++..+..++..|+.||.-||  ..|+|||||||+|||||..|++|
T Consensus       140 LhyAFQD~~~LYlVMdY~pGGDlltLlSk~~--~~pE~~ArFY~aEiVlAldslH--~mgyVHRDiKPDNvLld~~GHik  215 (1317)
T KOG0612|consen  140 LHYAFQDERYLYLVMDYMPGGDLLTLLSKFD--RLPEDWARFYTAEIVLALDSLH--SMGYVHRDIKPDNVLLDKSGHIK  215 (1317)
T ss_pred             HHHHhcCccceEEEEecccCchHHHHHhhcC--CChHHHHHHHHHHHHHHHHHHH--hccceeccCCcceeEecccCcEe
Confidence            9999999999999999999999999887654  7999999999999999999999  56799999999999999999999


Q ss_pred             EcccCCccCCCCCCCcceeeccccCCcccCccccc----c-CCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHH
Q 046893          240 LSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVM----T-GHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVE  314 (464)
Q Consensus       240 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~----~-~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~  314 (464)
                      |+|||.|-....+. .-.....+|||.|++||++.    + +.|+..+|+||+||++||||+|..||...      .+++
T Consensus       216 LADFGsClkm~~dG-~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYad------slve  288 (1317)
T KOG0612|consen  216 LADFGSCLKMDADG-TVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYAD------SLVE  288 (1317)
T ss_pred             eccchhHHhcCCCC-cEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHH------HHHH
Confidence            99999997654322 23344578999999999885    3 57999999999999999999999999753      3444


Q ss_pred             HHHHhhhcccchhhccCccccCccC--HHHHHHHHHHHHHhhccCCCCCCC---HHHHH
Q 046893          315 WARPLLNNNKKVLRILDPRLEGQYT--ARTAMKVAGLAYQCLSQNPKGRPV---MSDVV  368 (464)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~cl~~dP~~RPs---~~ev~  368 (464)
                      -...++.....          -.+|  ...+....+||.+.+ .+|..|..   ++++.
T Consensus       289 TY~KIm~hk~~----------l~FP~~~~VSeeakdLI~~ll-~~~e~RLgrngiedik  336 (1317)
T KOG0612|consen  289 TYGKIMNHKES----------LSFPDETDVSEEAKDLIEALL-CDREVRLGRNGIEDIK  336 (1317)
T ss_pred             HHHHHhchhhh----------cCCCcccccCHHHHHHHHHHh-cChhhhcccccHHHHH
Confidence            44444433111          1122  235668888888855 46888877   66654

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-36  Score=292.72  Aligned_cols=262  Identities=24%  Similarity=0.314  Sum_probs=194.7

Q ss_pred             CCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCcc--HHHHHHHHHHHhcC---CCCCcceEEEEEEeCC
Q 046893           94 FRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQG--DREWLAEVNYLGQL---RHSNLVKLIGYCCEDE  168 (464)
Q Consensus        94 ~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l---~hpniv~l~~~~~~~~  168 (464)
                      |++.+.||.|+||.||+|.+..+      +..+|+|.+.......  ...+..|+.++.++   .||||+++++++...+
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~------~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~   74 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNT------GRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPR   74 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCC------CCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeecc
Confidence            56778899999999999998764      5679999987432221  23466787777665   5999999999998877


Q ss_pred             e-----EEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEccc
Q 046893          169 H-----RILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDF  243 (464)
Q Consensus       169 ~-----~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DF  243 (464)
                      .     .+++|||+. ++|.+++.......+++..++.++.|++.||.|||  ..+++|+||+|+||+++.++.+||+||
T Consensus        75 ~~~~~~~~l~~e~~~-~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH--~~~i~h~~l~~~nili~~~~~~~l~df  151 (287)
T cd07838          75 TDRELKLTLVFEHVD-QDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLH--SHRIVHRDLKPQNILVTSDGQVKIADF  151 (287)
T ss_pred             CCCCceeEEEehhcc-cCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHH--HCCeeeccCChhhEEEccCCCEEEecc
Confidence            6     999999996 48988887654446899999999999999999999  567999999999999999999999999


Q ss_pred             CCccCCCCCCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhcc
Q 046893          244 GLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNN  323 (464)
Q Consensus       244 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~  323 (464)
                      |++........   .....++..|+|||++.+..++.++|||||||++|+|++|..||.......  .+..+........
T Consensus       152 g~~~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~--~~~~~~~~~~~~~  226 (287)
T cd07838         152 GLARIYSFEMA---LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEAD--QLDKIFDVIGLPS  226 (287)
T ss_pred             CcceeccCCcc---cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHH--HHHHHHHHcCCCC
Confidence            99976533221   123457889999999999999999999999999999999999987543211  1111111000000


Q ss_pred             c-c----h---hhccCcccc---CccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 046893          324 K-K----V---LRILDPRLE---GQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVA  369 (464)
Q Consensus       324 ~-~----~---~~~~~~~~~---~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  369 (464)
                      . .    .   .........   .......+..+.+++.+||+.||.+||++.+++.
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~  283 (287)
T cd07838         227 EEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ  283 (287)
T ss_pred             hHhcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence            0 0    0   000000000   1111234567889999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=6.8e-37  Score=294.52  Aligned_cols=264  Identities=27%  Similarity=0.360  Sum_probs=196.2

Q ss_pred             CCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCc-cHHHHHHHHHHHhcCC-CCCcceEEEEEEeCCeEE
Q 046893           94 FRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQ-GDREWLAEVNYLGQLR-HSNLVKLIGYCCEDEHRI  171 (464)
Q Consensus        94 ~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~~  171 (464)
                      |.+.+.||.|+||+||+|.+..+      ++.|+||.+...... ......+|+..+..+. ||||+++++++...+..+
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~------~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~   74 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKET------GELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELY   74 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCC------CcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEE
Confidence            56778899999999999998764      567999988654322 2234567999999998 999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCccCCCC
Q 046893          172 LVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPM  251 (464)
Q Consensus       172 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~  251 (464)
                      +||||+ +|+|.+++....+..+++..++.++.|++.+|.|||  ..+++|+||+|+||+++.++.++|+|||++.....
T Consensus        75 lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh--~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~  151 (283)
T cd07830          75 FVFEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIH--KHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRS  151 (283)
T ss_pred             EEEecC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHH--HCCcccCCCChhhEEEcCCCCEEEeecccceeccC
Confidence            999999 889999887765457899999999999999999999  56799999999999999999999999999975432


Q ss_pred             CCCcceeeccccCCcccCcccccc-CCCCcccchhcHHHHHHHHHhCCCCCCCCCCccccc-HHHHHHHh----hhcccc
Q 046893          252 GDQTHVSTRVMGTYGYAAPEYVMT-GHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHN-LVEWARPL----LNNNKK  325 (464)
Q Consensus       252 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~-~~~~~~~~----~~~~~~  325 (464)
                      ..   ......|+..|+|||++.+ ..++.++||||||+++|+|++|+.||.......... ...+....    ......
T Consensus       152 ~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (283)
T cd07830         152 RP---PYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYK  228 (283)
T ss_pred             CC---CcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhh
Confidence            21   1123568899999998754 457899999999999999999999997654321110 00000000    000000


Q ss_pred             hhhccCccc-------cCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 046893          326 VLRILDPRL-------EGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVA  369 (464)
Q Consensus       326 ~~~~~~~~~-------~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  369 (464)
                      .....+..+       ........+..+.+|+.+||..||.+||++.+++.
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  279 (283)
T cd07830         229 LASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ  279 (283)
T ss_pred             hhccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence            000000000       00111112457899999999999999999999874

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=1e-36  Score=297.49  Aligned_cols=249  Identities=27%  Similarity=0.364  Sum_probs=194.4

Q ss_pred             cCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCC---ccHHHHHHHHHHHhcCCCCCcceEEEEEEeCC
Q 046893           92 KFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGY---QGDREWLAEVNYLGQLRHSNLVKLIGYCCEDE  168 (464)
Q Consensus        92 ~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~  168 (464)
                      +.|...+.||+|+||.||+|++..+      +..+|+|.+.....   .....+.+|+++++.++|+|++++++++....
T Consensus        15 ~~~~~~~~lg~g~~g~v~~~~~~~~------~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   88 (308)
T cd06634          15 KLFSDLREIGHGSFGAVYFARDVRN------SEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREH   88 (308)
T ss_pred             HHHHHHHheeeCCCEEEEEEEEcCC------CcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCC
Confidence            3466678899999999999998764      56799998864322   22356788999999999999999999999999


Q ss_pred             eEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCccC
Q 046893          169 HRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKD  248 (464)
Q Consensus       169 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~  248 (464)
                      ..++||||+. |+|.+++... ...+++..+..++.|++.||.|||  ..+++||||+|+|||++.++.++|+|||++..
T Consensus        89 ~~~lv~e~~~-~~l~~~~~~~-~~~l~~~~~~~~~~~l~~~l~~LH--~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~  164 (308)
T cd06634          89 TAWLVMEYCL-GSASDLLEVH-KKPLQEVEIAAVTHGALQGLAYLH--SHNMIHRDVKAGNILLSEPGLVKLGDFGSASI  164 (308)
T ss_pred             eeEEEEEccC-CCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHH--hCCcccCCCCHHhEEECCCCcEEECCccccee
Confidence            9999999996 5887776543 346899999999999999999999  67799999999999999999999999999875


Q ss_pred             CCCCCCcceeeccccCCcccCccccc---cCCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhcccc
Q 046893          249 GPMGDQTHVSTRVMGTYGYAAPEYVM---TGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKK  325 (464)
Q Consensus       249 ~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  325 (464)
                      ...      .....|+..|+|||.+.   ...++.++|||||||++|+|++|..||.......      ........   
T Consensus       165 ~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~------~~~~~~~~---  229 (308)
T cd06634         165 MAP------ANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS------ALYHIAQN---  229 (308)
T ss_pred             ecC------cccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHH------HHHHHhhc---
Confidence            322      12356889999999875   3567889999999999999999999986532111      10000000   


Q ss_pred             hhhccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 046893          326 VLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLE  372 (464)
Q Consensus       326 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~  372 (464)
                          ..+.   ......+..+.+||.+||..+|.+||++.+++....
T Consensus       230 ----~~~~---~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~  269 (308)
T cd06634         230 ----ESPA---LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRF  269 (308)
T ss_pred             ----CCCC---cCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCcc
Confidence                0011   111234457889999999999999999999986543

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=2.5e-37  Score=296.74  Aligned_cols=249  Identities=25%  Similarity=0.333  Sum_probs=201.0

Q ss_pred             cCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCC---ccHHHHHHHHHHHhcCC-CCCcceEEEEEEeC
Q 046893           92 KFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGY---QGDREWLAEVNYLGQLR-HSNLVKLIGYCCED  167 (464)
Q Consensus        92 ~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~  167 (464)
                      ++|.+.+.||.|+||.||+|.+..+      +..||+|++.....   .....+..|+.+++++. ||||+++++++...
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~------~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~   74 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEKET------NKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDE   74 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEcCC------CCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCC
Confidence            3688889999999999999998764      66799999865322   22356788999999998 99999999999999


Q ss_pred             CeEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCcc
Q 046893          168 EHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAK  247 (464)
Q Consensus       168 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~  247 (464)
                      +..++||||+.+++|.+++.+..  .+++..++.++.|++.||.|||  +.+++|+||+|+||+++.++.++|+|||++.
T Consensus        75 ~~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~ql~~~l~~Lh--~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~  150 (280)
T cd05581          75 ENLYFVLEYAPNGELLQYIRKYG--SLDEKCTRFYAAEILLALEYLH--SKGIIHRDLKPENILLDKDMHIKITDFGTAK  150 (280)
T ss_pred             ceEEEEEcCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH--HCCeeecCCCHHHeEECCCCCEEecCCcccc
Confidence            99999999999999999987643  6999999999999999999999  6779999999999999999999999999988


Q ss_pred             CCCCCCC------------------cceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHhCCCCCCCCCCccc
Q 046893          248 DGPMGDQ------------------THVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSRE  309 (464)
Q Consensus       248 ~~~~~~~------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~  309 (464)
                      .......                  ........|+..|+|||++.+..++.++||||||+++|+|++|+.||......  
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~--  228 (280)
T cd05581         151 VLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEY--  228 (280)
T ss_pred             ccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHH--
Confidence            5433221                  12223356889999999998888999999999999999999999999765411  


Q ss_pred             ccHHHHHHHhhhcccchhhccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCH----HHHH
Q 046893          310 HNLVEWARPLLNNNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVM----SDVV  368 (464)
Q Consensus       310 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~----~ev~  368 (464)
                       ...   .....            ....++...+..+.+|+.+||+.+|.+||++    .+++
T Consensus       229 -~~~---~~~~~------------~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll  275 (280)
T cd05581         229 -LTF---QKILK------------LEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELK  275 (280)
T ss_pred             -HHH---HHHHh------------cCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHh
Confidence             111   11110            1111222335688999999999999999999    6665

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=7.3e-37  Score=296.68  Aligned_cols=254  Identities=25%  Similarity=0.368  Sum_probs=193.8

Q ss_pred             hcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCc-cHHHHHHHHHHHhcC-CCCCcceEEEEEEeCC
Q 046893           91 TKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQ-GDREWLAEVNYLGQL-RHSNLVKLIGYCCEDE  168 (464)
Q Consensus        91 ~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~  168 (464)
                      -+.|.+.+.||+|+||.||+|.+..+      +..||||.+...... ....+..|+.++..+ .||||+++++++....
T Consensus        14 ~~~~~~~~~lg~g~~~~v~~~~~~~~------~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~   87 (296)
T cd06618          14 LNDLENLGEIGSGTCGQVYKMRFKKT------GHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDS   87 (296)
T ss_pred             cchheeeeEeeccCCeEEEEEEECCC------CeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCC
Confidence            35688889999999999999998764      567999998754332 335567788777666 4999999999999999


Q ss_pred             eEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCccC
Q 046893          169 HRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKD  248 (464)
Q Consensus       169 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~  248 (464)
                      ..++||||+. ++|.+++... ...+++..+..++.|++.||.|||+ ..+|+||||+|+||+++.++.+||+|||++..
T Consensus        88 ~~~~v~e~~~-~~l~~l~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~-~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~  164 (296)
T cd06618          88 DVFICMELMS-TCLDKLLKRI-QGPIPEDILGKMTVAIVKALHYLKE-KHGVIHRDVKPSNILLDASGNVKLCDFGISGR  164 (296)
T ss_pred             eEEEEeeccC-cCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHh-hCCEecCCCcHHHEEEcCCCCEEECccccchh
Confidence            9999999984 5777766543 3478999999999999999999994 24799999999999999999999999999875


Q ss_pred             CCCCCCcceeeccccCCcccCccccccCC----CCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhccc
Q 046893          249 GPMGDQTHVSTRVMGTYGYAAPEYVMTGH----LTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNK  324 (464)
Q Consensus       249 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  324 (464)
                      .....   ......++..|+|||.+.+..    ++.++||||||+++|+|++|+.||......     .+.....+....
T Consensus       165 ~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-----~~~~~~~~~~~~  236 (296)
T cd06618         165 LVDSK---AKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE-----FEVLTKILQEEP  236 (296)
T ss_pred             ccCCC---cccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhH-----HHHHHHHhcCCC
Confidence            43221   112245788999999987553    888999999999999999999999653211     111111111110


Q ss_pred             chhhccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 046893          325 KVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVAL  370 (464)
Q Consensus       325 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  370 (464)
                             +..  .....++.++.+|+.+||..||.+||++.+++..
T Consensus       237 -------~~~--~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~  273 (296)
T cd06618         237 -------PSL--PPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH  273 (296)
T ss_pred             -------CCC--CCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence                   000  0011234578999999999999999999999754

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2e-37  Score=283.32  Aligned_cols=258  Identities=24%  Similarity=0.346  Sum_probs=196.3

Q ss_pred             CceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCccHHHHHHHHHHHhcCC-CCCcceEEEEEEeCCeEEEEEec
Q 046893           98 YILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLR-HSNLVKLIGYCCEDEHRILVYEY  176 (464)
Q Consensus        98 ~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~~lv~e~  176 (464)
                      ++||+|+|+.|--++...+      +..+|||++.+.......++.+|++++.+++ |+||+.|++||+++...|||||.
T Consensus        84 e~LGeGAyasVqtcv~i~t------~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEK  157 (463)
T KOG0607|consen   84 ELLGEGAYASVQTCVSIQT------GKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEK  157 (463)
T ss_pred             HHhcCccceeeeeeeeecc------chhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEec
Confidence            4699999999998887665      5669999998876666788999999999995 99999999999999999999999


Q ss_pred             cCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCC---ceEEcccCCccCCCCCC
Q 046893          177 MESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADF---SAKLSDFGLAKDGPMGD  253 (464)
Q Consensus       177 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~---~vkl~DFGla~~~~~~~  253 (464)
                      |.||.|..+|.++.  .+++.++..+..+|+.||.|||  .++|.||||||+|||...-.   -||||||.|........
T Consensus       158 m~GGplLshI~~~~--~F~E~EAs~vvkdia~aLdFlH--~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~  233 (463)
T KOG0607|consen  158 MRGGPLLSHIQKRK--HFNEREASRVVKDIASALDFLH--TKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNN  233 (463)
T ss_pred             ccCchHHHHHHHhh--hccHHHHHHHHHHHHHHHHHHh--hcCcccccCCccceeecCCCCcCceeeeccccccccccCC
Confidence            99999999998876  6999999999999999999999  89999999999999985443   37999999876322211


Q ss_pred             C-----cceeeccccCCcccCccccc-----cCCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhh--h
Q 046893          254 Q-----THVSTRVMGTYGYAAPEYVM-----TGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLL--N  321 (464)
Q Consensus       254 ~-----~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~--~  321 (464)
                      .     +....+.+|+..|||||++.     ...|+.++|.||||||||-||+|.+||.+.=..+-    -|-+...  .
T Consensus       234 ~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dC----GWdrGe~Cr~  309 (463)
T KOG0607|consen  234 DCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADC----GWDRGEVCRV  309 (463)
T ss_pred             CCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcC----CccCCCccHH
Confidence            1     11123468999999999873     23589999999999999999999999976321100    0100000  0


Q ss_pred             cccchhhccCc---cccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 046893          322 NNKKVLRILDP---RLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVA  369 (464)
Q Consensus       322 ~~~~~~~~~~~---~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  369 (464)
                      ...++.+-+..   .+.......++.+..+++...|..|+..|.++..++.
T Consensus       310 CQ~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vln  360 (463)
T KOG0607|consen  310 CQNKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN  360 (463)
T ss_pred             HHHHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence            00001111111   0111112345667889999999999999998887765

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3e-38  Score=299.51  Aligned_cols=272  Identities=24%  Similarity=0.380  Sum_probs=206.1

Q ss_pred             CCccccchhHHHHHhcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCccH-------HHHHHHHHHH
Q 046893           77 SNVDIFTYNEMKLATKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGD-------REWLAEVNYL  149 (464)
Q Consensus        77 ~~~~~~~~~~~~~~~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~-------~~~~~E~~~l  149 (464)
                      .+.+...+++-....++|.++.+||+|||+.||+|.+...      ...||||+-..+.....       +...+|.+|.
T Consensus       448 ~NEdnSQFkDHptLn~RYLlLhLLGrGGFSEVyKAFDl~E------qRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIH  521 (775)
T KOG1151|consen  448 HNEDNSQFKDHPTLNDRYLLLHLLGRGGFSEVYKAFDLTE------QRYVAVKIHQLNKNWRDEKKENYHKHACREYRIH  521 (775)
T ss_pred             cccchhhhccCcchHHHHHHHHHhccccHHHHHHhcccch------hheeeEeeehhccchhhHhhhhHHHHHHHHHhhh
Confidence            3444445556667788899999999999999999998765      56799998654322111       2356899999


Q ss_pred             hcCCCCCcceEEEEEEeC-CeEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCC
Q 046893          150 GQLRHSNLVKLIGYCCED-EHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTS  228 (464)
Q Consensus       150 ~~l~hpniv~l~~~~~~~-~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~  228 (464)
                      +.|.||.||++|++|.-+ +..|-|+|||+|.+|.-||..+.  .+++.++..|+.||+.||.||.....+|||-||||.
T Consensus       522 KeLDHpRIVKlYDyfslDtdsFCTVLEYceGNDLDFYLKQhk--lmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPg  599 (775)
T KOG1151|consen  522 KELDHPRIVKLYDYFSLDTDSFCTVLEYCEGNDLDFYLKQHK--LMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPG  599 (775)
T ss_pred             hccCcceeeeeeeeeeeccccceeeeeecCCCchhHHHHhhh--hhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCc
Confidence            999999999999999765 46789999999999988887765  689999999999999999999988899999999999


Q ss_pred             ceEec---CCCceEEcccCCccCCCCCCCc-----ceeeccccCCcccCccccccC----CCCcccchhcHHHHHHHHHh
Q 046893          229 NILLN---ADFSAKLSDFGLAKDGPMGDQT-----HVSTRVMGTYGYAAPEYVMTG----HLTARSDVYGFGVVLLEMLL  296 (464)
Q Consensus       229 Nill~---~~~~vkl~DFGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~----~~~~~~DvwslG~il~ell~  296 (464)
                      ||||-   .-|.+||+||||++......+.     .......||.||++||.+.-+    ..+.|+||||+|||+|..+.
T Consensus       600 NILLv~GtacGeIKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClY  679 (775)
T KOG1151|consen  600 NILLVNGTACGEIKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLY  679 (775)
T ss_pred             cEEEecCcccceeEeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhc
Confidence            99994   3478999999999976544333     234567899999999988533    47889999999999999999


Q ss_pred             CCCCCCCCCCcccccHHHHHHHhhhcccchhhccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHH
Q 046893          297 GRRAVDKSRPSREHNLVEWARPLLNNNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVV  368 (464)
Q Consensus       297 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~  368 (464)
                      |+.||.......  .       ++.. ..+.+..+-.+.  .......+...||++||++.-++|.+..++.
T Consensus       680 GrKPFGhnqsQQ--d-------ILqe-NTIlkAtEVqFP--~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA  739 (775)
T KOG1151|consen  680 GRKPFGHNQSQQ--D-------ILQE-NTILKATEVQFP--PKPVVSSEAKAFIRRCLAYRKEDRIDVQQLA  739 (775)
T ss_pred             cCCCCCCchhHH--H-------HHhh-hchhcceeccCC--CCCccCHHHHHHHHHHHHhhhhhhhhHHHHc
Confidence            999997543211  1       1111 111111111110  0112334778999999999999997765553

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.8e-37  Score=304.28  Aligned_cols=263  Identities=25%  Similarity=0.324  Sum_probs=199.9

Q ss_pred             CCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCC--CccHHHHHHHHHHHhcCCCCCcceEEEEEEeCC--
Q 046893           93 FFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGG--YQGDREWLAEVNYLGQLRHSNLVKLIGYCCEDE--  168 (464)
Q Consensus        93 ~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~--  168 (464)
                      +|.+.+.||.|+||.||+|.+..+      ++.||||.+....  ....+.+.+|+.+++.++||||+++++++....  
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~------~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   74 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRT------GRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPE   74 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCC------CcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcc
Confidence            478889999999999999997654      5679999987643  233467889999999999999999999988775  


Q ss_pred             ---eEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCC
Q 046893          169 ---HRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGL  245 (464)
Q Consensus       169 ---~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGl  245 (464)
                         ..|+||||+. ++|.+++....  .+++..++.++.|++.||.|||  ..+|+||||||.|||++.++.++|+|||+
T Consensus        75 ~~~~~~lv~e~~~-~~l~~~l~~~~--~l~~~~~~~i~~~l~~~l~~LH--~~gi~H~dlkp~nili~~~~~~~L~dfg~  149 (330)
T cd07834          75 DFNDVYIVTELME-TDLHKVIKSPQ--PLTDDHIQYFLYQILRGLKYLH--SANVIHRDLKPSNILVNSNCDLKICDFGL  149 (330)
T ss_pred             cccceEEEecchh-hhHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHH--hCCeecCCCCHHHEEEcCCCCEEEcccCc
Confidence               7899999996 58888876543  7999999999999999999999  57799999999999999999999999999


Q ss_pred             ccCCCCCCCc-ceeeccccCCcccCccccccC-CCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhh--
Q 046893          246 AKDGPMGDQT-HVSTRVMGTYGYAAPEYVMTG-HLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLN--  321 (464)
Q Consensus       246 a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~--  321 (464)
                      +......... .......++..|+|||++.+. .++.++||||||+++|+|++|+.||.........   ........  
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~---~~i~~~~~~~  226 (330)
T cd07834         150 ARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQL---NLIVEVLGTP  226 (330)
T ss_pred             eEeecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHH---HHHHHhcCCC
Confidence            9865433210 112335688999999999887 7999999999999999999999999765432110   00000000  


Q ss_pred             --------cccchhhccC---cc---ccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 046893          322 --------NNKKVLRILD---PR---LEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVA  369 (464)
Q Consensus       322 --------~~~~~~~~~~---~~---~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  369 (464)
                              ........+.   ..   .........+..+.+++.+||+.+|.+||++.+++.
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~  288 (330)
T cd07834         227 SEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALA  288 (330)
T ss_pred             ChhHhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence                    0000000000   00   000011224567899999999999999999999986

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=5.3e-37  Score=291.69  Aligned_cols=249  Identities=22%  Similarity=0.333  Sum_probs=193.0

Q ss_pred             CCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccC---CCC--ccHHHHHHHHHHHhcCCCCCcceEEEEEEeC
Q 046893           93 FFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNR---GGY--QGDREWLAEVNYLGQLRHSNLVKLIGYCCED  167 (464)
Q Consensus        93 ~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~---~~~--~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~  167 (464)
                      +|.+.+.||+|+||.||++.+...      +..+++|+++.   ...  .....+..|+.+++.++||||+++++++.+.
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   74 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKA------VAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLER   74 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCC------CCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcC
Confidence            478889999999999999987654      22234444332   211  2224566799999999999999999999999


Q ss_pred             CeEEEEEeccCCCCHHHHHHhh--cCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCC
Q 046893          168 EHRILVYEYMESGSLEKHLLRR--VGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGL  245 (464)
Q Consensus       168 ~~~~lv~e~~~~g~L~~~l~~~--~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGl  245 (464)
                      ...++||||+++++|.+++...  .+..+++..++.++.|++.||.|||  +.+++|+||+|+||+++. +.++|+|||+
T Consensus        75 ~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH--~~~i~h~~l~~~nili~~-~~~~l~d~g~  151 (260)
T cd08222          75 DAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMH--QRRILHRDLKAKNIFLKN-NLLKIGDFGV  151 (260)
T ss_pred             CceEEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHH--HcCccccCCChhheEeec-CCEeecccCc
Confidence            9999999999999999888642  2356899999999999999999999  677999999999999975 5799999999


Q ss_pred             ccCCCCCCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhcccc
Q 046893          246 AKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKK  325 (464)
Q Consensus       246 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  325 (464)
                      ++......  .......|+..|+|||.+.+..++.++|+||||+++|+|++|..||....      ...........   
T Consensus       152 ~~~~~~~~--~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~------~~~~~~~~~~~---  220 (260)
T cd08222         152 SRLLMGSC--DLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQN------FLSVVLRIVEG---  220 (260)
T ss_pred             eeecCCCc--ccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCcc------HHHHHHHHHcC---
Confidence            87643222  12234568899999999988889999999999999999999999996432      11111111110   


Q ss_pred             hhhccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 046893          326 VLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVA  369 (464)
Q Consensus       326 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  369 (464)
                          ..+    ..+..++..+.++|.+||..+|.+||++.+++.
T Consensus       221 ----~~~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  256 (260)
T cd08222         221 ----PTP----SLPETYSRQLNSIMQSMLNKDPSLRPSAAEILR  256 (260)
T ss_pred             ----CCC----CCcchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence                111    123445568999999999999999999999874

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-38  Score=295.90  Aligned_cols=271  Identities=20%  Similarity=0.260  Sum_probs=204.7

Q ss_pred             hhHHHHHhcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCccHHHHHHHHHHHhcCC--CCC----c
Q 046893           84 YNEMKLATKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLR--HSN----L  157 (464)
Q Consensus        84 ~~~~~~~~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--hpn----i  157 (464)
                      +........+|.+...||+|+||.|..+.+.+.      +..||||+++.-. .-.+..+-|+++|.++.  -|+    +
T Consensus        81 ~~~gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~------~~~vAlKIik~V~-kYreAa~iEi~vLqki~~~DP~g~~rc  153 (415)
T KOG0671|consen   81 YQVGDILTNRYEIVDLLGEGTFGKVVECWDRET------KEHVALKIIKNVD-KYREAALIEIEVLQKINESDPNGKFRC  153 (415)
T ss_pred             EEeccccccceehhhhhcCCcccceEEEeecCC------CceehHHHHHHHH-HHhhHHHHHHHHHHHHHhcCCCCceEE
Confidence            344455689999999999999999999988775      5679999986421 12244567999999993  233    7


Q ss_pred             ceEEEEEEeCCeEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecC---
Q 046893          158 VKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNA---  234 (464)
Q Consensus       158 v~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~---  234 (464)
                      |.+.++|.-.++.|||+|.+ |.++.+++..+.-.+++...+..|+.|++.+++|||  +.+++|.||||+|||+-.   
T Consensus       154 v~m~~wFdyrghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh--~~kl~HTDLKPENILfvss~~  230 (415)
T KOG0671|consen  154 VQMRDWFDYRGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLH--DLKLTHTDLKPENILFVSSEY  230 (415)
T ss_pred             EeeehhhhccCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHH--hcceeecCCChheEEEeccce
Confidence            88889999999999999998 779999999877778999999999999999999999  566999999999999831   


Q ss_pred             -----------------CCceEEcccCCccCCCCCCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHhC
Q 046893          235 -----------------DFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLG  297 (464)
Q Consensus       235 -----------------~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g  297 (464)
                                       +..|+|+|||.|+....   .  ...++.|..|+|||++++-.++.++||||+||||+||.+|
T Consensus       231 ~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e---~--hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG  305 (415)
T KOG0671|consen  231 FKTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHE---H--HSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTG  305 (415)
T ss_pred             EEEeccCCccceeccCCCcceEEEecCCcceecc---C--cceeeeccccCCchheeccCcCCccCceeeeeEEEEeecc
Confidence                             23589999999985221   1  2457889999999999999999999999999999999999


Q ss_pred             CCCCCCCCCcccccHHHHHHH--------------hhhcc----------cchhhccCccc----cCccCHHHHHHHHHH
Q 046893          298 RRAVDKSRPSREHNLVEWARP--------------LLNNN----------KKVLRILDPRL----EGQYTARTAMKVAGL  349 (464)
Q Consensus       298 ~~pf~~~~~~~~~~~~~~~~~--------------~~~~~----------~~~~~~~~~~~----~~~~~~~~~~~l~~l  349 (464)
                      ...|..-...+...+.+.+..              ++..+          ++....+++..    ...-.......|.+|
T Consensus       306 ~~LFqtHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDL  385 (415)
T KOG0671|consen  306 ETLFQTHENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDL  385 (415)
T ss_pred             ceecccCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHH
Confidence            999976553332222221111              00000          00000000000    001123445689999


Q ss_pred             HHHhhccCCCCCCCHHHHHH
Q 046893          350 AYQCLSQNPKGRPVMSDVVA  369 (464)
Q Consensus       350 i~~cl~~dP~~RPs~~ev~~  369 (464)
                      +++||..||.+|+|+.|++.
T Consensus       386 l~~mL~fDP~~RiTl~EAL~  405 (415)
T KOG0671|consen  386 LRRMLEFDPARRITLREALS  405 (415)
T ss_pred             HHHHHccCccccccHHHHhc
Confidence            99999999999999999874

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-37  Score=300.02  Aligned_cols=245  Identities=22%  Similarity=0.304  Sum_probs=198.0

Q ss_pred             CCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCc--cHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeEEEEE
Q 046893           97 DYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQ--GDREWLAEVNYLGQLRHSNLVKLIGYCCEDEHRILVY  174 (464)
Q Consensus        97 ~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~  174 (464)
                      .++||.|.||+||-|++..+      |+.||||++.+....  ....+.+|+.||+.+.||.||.+--.|+..+..++||
T Consensus       569 devLGSGQFG~VYgg~hRkt------GrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVM  642 (888)
T KOG4236|consen  569 DEVLGSGQFGTVYGGKHRKT------GRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVM  642 (888)
T ss_pred             HhhccCCcceeeecceeccc------CceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEe
Confidence            46899999999999998886      667999999876543  3466889999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCC---CceEEcccCCccCCCC
Q 046893          175 EYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNAD---FSAKLSDFGLAKDGPM  251 (464)
Q Consensus       175 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~---~~vkl~DFGla~~~~~  251 (464)
                      |.+.| ++...|.....+.|++.....++.||+.||.|||  .++|+|+||||+||||...   ..+||||||+|+....
T Consensus       643 EKl~G-DMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH--~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgE  719 (888)
T KOG4236|consen  643 EKLHG-DMLEMILSSEKGRLPERITKFLVTQILVALRYLH--FKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGE  719 (888)
T ss_pred             hhhcc-hHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhh--hcceeeccCCchheeeccCCCCCceeeccccceeecch
Confidence            99955 6556665555568999999999999999999999  7889999999999999543   4799999999997543


Q ss_pred             CCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhcccchhhccC
Q 046893          252 GDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRILD  331 (464)
Q Consensus       252 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  331 (464)
                      .   .....++||+.|+|||+++.+.|...-|+||.|||+|--|+|..||.......++     ++     +..  -+..
T Consensus       720 k---sFRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIndQ-----IQ-----NAa--FMyP  784 (888)
T KOG4236|consen  720 K---SFRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDINDQ-----IQ-----NAA--FMYP  784 (888)
T ss_pred             h---hhhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccchhHH-----hh-----ccc--cccC
Confidence            3   2344589999999999999999999999999999999999999999765422110     00     000  0111


Q ss_pred             ccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 046893          332 PRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVA  369 (464)
Q Consensus       332 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  369 (464)
                      +    .-..+......+||...|+..-.+|-+....+.
T Consensus       785 p----~PW~eis~~AidlIn~LLqVkm~kRysvdk~ls  818 (888)
T KOG4236|consen  785 P----NPWSEISPEAIDLINNLLQVKMRKRYSVDKSLS  818 (888)
T ss_pred             C----CchhhcCHHHHHHHHHHHHHHHHHhcchHhhcc
Confidence            1    112345557889999999999999999886653

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.4e-36  Score=301.24  Aligned_cols=266  Identities=21%  Similarity=0.270  Sum_probs=197.6

Q ss_pred             hHHHHHhcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCC--ccHHHHHHHHHHHhcCCCCCcceEEE
Q 046893           85 NEMKLATKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGY--QGDREWLAEVNYLGQLRHSNLVKLIG  162 (464)
Q Consensus        85 ~~~~~~~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~l~~  162 (464)
                      .++..+.++|.+.+.||+|+||.||+|.+..+      ++.||+|++.....  ...+.+.+|+.++..++||||+++++
T Consensus        10 ~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~------~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~   83 (345)
T cd07877          10 KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKT------GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD   83 (345)
T ss_pred             HHHhhccCceEEEEEeeecCCeEEEEEEEcCC------CeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceee
Confidence            45556778999999999999999999987654      67799999875322  22356788999999999999999999


Q ss_pred             EEEeC------CeEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCC
Q 046893          163 YCCED------EHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADF  236 (464)
Q Consensus       163 ~~~~~------~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~  236 (464)
                      ++...      ...+++++++ +++|.+++...   .+++..+..++.|++.||.|||  ..+|+||||||+||+++.++
T Consensus        84 ~~~~~~~~~~~~~~~lv~~~~-~~~L~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH--~~~ivH~dlkp~NIll~~~~  157 (345)
T cd07877          84 VFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQ---KLTDDHVQFLIYQILRGLKYIH--SADIIHRDLKPSNLAVNEDC  157 (345)
T ss_pred             eeeecccccccccEEEEehhc-ccCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH--HCCeeecCCChHHEEEcCCC
Confidence            88643      3468888887 78998876542   5899999999999999999999  67799999999999999999


Q ss_pred             ceEEcccCCccCCCCCCCcceeeccccCCcccCcccccc-CCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHH
Q 046893          237 SAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMT-GHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEW  315 (464)
Q Consensus       237 ~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~  315 (464)
                      .+||+|||+++....     ......|+..|+|||.+.+ ..++.++|||||||++|+|++|+.||.........  ...
T Consensus       158 ~~kl~dfg~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~--~~~  230 (345)
T cd07877         158 ELKILDFGLARHTDD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQL--KLI  230 (345)
T ss_pred             CEEEecccccccccc-----cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH--HHH
Confidence            999999999875321     1223578899999998866 56889999999999999999999999654322111  000


Q ss_pred             HHHhhhcccchh------------hccCccccC---ccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 046893          316 ARPLLNNNKKVL------------RILDPRLEG---QYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVA  369 (464)
Q Consensus       316 ~~~~~~~~~~~~------------~~~~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  369 (464)
                      ..........+.            ..+......   ......+..+.+||.+||+.||.+||++.+++.
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~  299 (345)
T cd07877         231 LRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA  299 (345)
T ss_pred             HHHhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhc
Confidence            000000000000            000000000   001123457889999999999999999998875

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=6.1e-37  Score=298.82  Aligned_cols=268  Identities=26%  Similarity=0.304  Sum_probs=193.2

Q ss_pred             hcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCc--cHHHHHHHHHHHhcCCCCCcceEEEEEEeCC
Q 046893           91 TKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQ--GDREWLAEVNYLGQLRHSNLVKLIGYCCEDE  168 (464)
Q Consensus        91 ~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~  168 (464)
                      .++|.+.+.||.|+||.||+|.+..+      ++.+|+|.+......  ....+.+|+++++.++||||+++++++....
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~~~------~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   80 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQIKT------GRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERP   80 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEECCC------CcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccc
Confidence            36789999999999999999998764      566899988643222  1245678999999999999999999875443


Q ss_pred             --------eEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEE
Q 046893          169 --------HRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKL  240 (464)
Q Consensus       169 --------~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl  240 (464)
                              ..++||||+.+ +|...+... ...+++..+..++.|++.||.|||  ..+|+|+||||+|||++.++.++|
T Consensus        81 ~~~~~~~~~~~lv~~~~~~-~l~~~~~~~-~~~~~~~~~~~i~~~l~~al~~lH--~~~i~H~dl~p~nil~~~~~~~~l  156 (311)
T cd07866          81 DKSKRKRGSVYMVTPYMDH-DLSGLLENP-SVKLTESQIKCYMLQLLEGINYLH--ENHILHRDIKAANILIDNQGILKI  156 (311)
T ss_pred             ccccccCceEEEEEecCCc-CHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHH--hCCeecCCCCHHHEEECCCCCEEE
Confidence                    46999999964 777766543 346999999999999999999999  577999999999999999999999


Q ss_pred             cccCCccCCCCCCCc---------ceeeccccCCcccCccccccC-CCCcccchhcHHHHHHHHHhCCCCCCCCCCcccc
Q 046893          241 SDFGLAKDGPMGDQT---------HVSTRVMGTYGYAAPEYVMTG-HLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREH  310 (464)
Q Consensus       241 ~DFGla~~~~~~~~~---------~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~  310 (464)
                      +|||+++........         .......|+..|+|||.+.+. .++.++|||||||++|+|++|+.||.+.......
T Consensus       157 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~  236 (311)
T cd07866         157 ADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQL  236 (311)
T ss_pred             CcCccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence            999999754322111         111234678899999987654 5889999999999999999999999764432111


Q ss_pred             cHHHHH-HHh----hhcccchhh--------ccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 046893          311 NLVEWA-RPL----LNNNKKVLR--------ILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVA  369 (464)
Q Consensus       311 ~~~~~~-~~~----~~~~~~~~~--------~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  369 (464)
                      ...... ...    ......+..        ...+.+... .......+.+++.+||..||.+||++.+++.
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~  307 (311)
T cd07866         237 HLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEER-FGKLGPEGLDLLSKLLSLDPYKRLTASDALE  307 (311)
T ss_pred             HHHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHH-cccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence            110000 000    000000000        000000000 0112357889999999999999999998874

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=7.1e-37  Score=302.99  Aligned_cols=267  Identities=22%  Similarity=0.310  Sum_probs=193.9

Q ss_pred             hcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCccHHHHHHHHHHHhcCCCCCcceEEEEEEeC---
Q 046893           91 TKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVKLIGYCCED---  167 (464)
Q Consensus        91 ~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~---  167 (464)
                      ..+|.+.+.||.|+||.||+|.+..+      ++.||+|.+........+.+.+|+.+++.++||||+++++++...   
T Consensus         4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~------~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~   77 (342)
T cd07854           4 GSRYMDLRPLGCGSNGLVFSAVDSDC------DKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSD   77 (342)
T ss_pred             CcceEEEEEecCCCCEEEEEEEECCC------CcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccc
Confidence            36789999999999999999998765      667999998766555567788999999999999999999776543   


Q ss_pred             -----------CeEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEec-CC
Q 046893          168 -----------EHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLN-AD  235 (464)
Q Consensus       168 -----------~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~-~~  235 (464)
                                 ...++||||+. ++|.+++..   ..+++..+..++.|++.||.|||  ..+|+||||||+||+++ .+
T Consensus        78 ~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~---~~l~~~~~~~~~~qi~~aL~~LH--~~givH~dikp~Nili~~~~  151 (342)
T cd07854          78 LTEDVGSLTELNSVYIVQEYME-TDLANVLEQ---GPLSEEHARLFMYQLLRGLKYIH--SANVLHRDLKPANVFINTED  151 (342)
T ss_pred             cccccccccccceEEEEeeccc-ccHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHH--hCCcccCCCCHHHEEEcCCC
Confidence                       35789999996 588887753   25899999999999999999999  67799999999999997 45


Q ss_pred             CceEEcccCCccCCCCCCCc-ceeeccccCCcccCcccccc-CCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHH
Q 046893          236 FSAKLSDFGLAKDGPMGDQT-HVSTRVMGTYGYAAPEYVMT-GHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLV  313 (464)
Q Consensus       236 ~~vkl~DFGla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~  313 (464)
                      +.+||+|||+++........ .......|+..|+|||++.+ ..++.++|||||||++|+|++|+.||....+.......
T Consensus       152 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~  231 (342)
T cd07854         152 LVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLI  231 (342)
T ss_pred             ceEEECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence            67899999999753221111 11122467889999997754 56888999999999999999999999765432211110


Q ss_pred             HHHHHhhh--cccchhhccC-----ccccC-----ccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 046893          314 EWARPLLN--NNKKVLRILD-----PRLEG-----QYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVA  369 (464)
Q Consensus       314 ~~~~~~~~--~~~~~~~~~~-----~~~~~-----~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  369 (464)
                      ....+...  ........+.     .....     ......+.++.+|+.+||..||.+||++.+++.
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  299 (342)
T cd07854         232 LESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM  299 (342)
T ss_pred             HHhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence            00000000  0000000000     00000     001123457889999999999999999999874

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=1.5e-37  Score=326.08  Aligned_cols=252  Identities=28%  Similarity=0.370  Sum_probs=185.9

Q ss_pred             hcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCC-CccHHHHHHHHHHHhcCCCCCcceEEEEEEe---
Q 046893           91 TKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGG-YQGDREWLAEVNYLGQLRHSNLVKLIGYCCE---  166 (464)
Q Consensus        91 ~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~---  166 (464)
                      ...|+.+.+||+||||.||+++++-+      +..||||++.... ......+.+|+.+|.+|+|||||+++..|.+   
T Consensus       478 ~~DFEEL~lLGkGGFG~VvkVRNKlD------Gr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~  551 (1351)
T KOG1035|consen  478 LNDFEELELLGKGGFGSVVKVRNKLD------GREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTA  551 (1351)
T ss_pred             hhhhHHHHHhcCCCCceEEEEeeccc------chhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCC
Confidence            34577888999999999999987765      6779999997654 1223567899999999999999998654320   


Q ss_pred             --------------------------------------------------------------------------------
Q 046893          167 --------------------------------------------------------------------------------  166 (464)
Q Consensus       167 --------------------------------------------------------------------------------  166 (464)
                                                                                                      
T Consensus       552 ~~~~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S  631 (1351)
T KOG1035|consen  552 ELTVLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLS  631 (1351)
T ss_pred             ccccccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccc
Confidence                                                                                            


Q ss_pred             ----------------------------C--------CeEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHH
Q 046893          167 ----------------------------D--------EHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGL  210 (464)
Q Consensus       167 ----------------------------~--------~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l  210 (464)
                                                  +        ..+||-||||+...|.+++.++.. .-.....+.++.+|++||
T Consensus       632 ~tS~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~-~~~~d~~wrLFreIlEGL  710 (1351)
T KOG1035|consen  632 NTSDSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHF-NSQRDEAWRLFREILEGL  710 (1351)
T ss_pred             cccccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhccc-chhhHHHHHHHHHHHHHH
Confidence                                        0        125788999998777777665431 114778899999999999


Q ss_pred             HHHhcCCCCeeeccCCCCceEecCCCceEEcccCCccCCC----C------------CCCcceeeccccCCcccCccccc
Q 046893          211 AFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGP----M------------GDQTHVSTRVMGTYGYAAPEYVM  274 (464)
Q Consensus       211 ~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~----~------------~~~~~~~~~~~gt~~y~aPE~~~  274 (464)
                      .|+|  +++||||||||.||+|+.++.|||+|||+|+...    .            +......+..+||.-|+|||++.
T Consensus       711 aYIH--~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~  788 (1351)
T KOG1035|consen  711 AYIH--DQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLS  788 (1351)
T ss_pred             HHHH--hCceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhc
Confidence            9999  6779999999999999999999999999998621    0            11111344578999999999887


Q ss_pred             cC---CCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhcccchhhccCcccc--CccCHHHHHHHHHH
Q 046893          275 TG---HLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRILDPRLE--GQYTARTAMKVAGL  349 (464)
Q Consensus       275 ~~---~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~l  349 (464)
                      +.   .|+.|+|+|||||||+||+.   ||.....        -+.-       +..+.+..+.  ..+.......-..+
T Consensus       789 ~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsME--------Ra~i-------L~~LR~g~iP~~~~f~~~~~~~e~sl  850 (1351)
T KOG1035|consen  789 DTSSNKYNSKIDMYSLGIVLFEMLY---PFGTSME--------RASI-------LTNLRKGSIPEPADFFDPEHPEEASL  850 (1351)
T ss_pred             ccccccccchhhhHHHHHHHHHHhc---cCCchHH--------HHHH-------HHhcccCCCCCCcccccccchHHHHH
Confidence            65   49999999999999999985   4543221        1110       0111111111  12222223355679


Q ss_pred             HHHhhccCCCCCCCHHHHHH
Q 046893          350 AYQCLSQNPKGRPVMSDVVA  369 (464)
Q Consensus       350 i~~cl~~dP~~RPs~~ev~~  369 (464)
                      |++|++.||.+|||+.+++.
T Consensus       851 I~~Ll~hdP~kRPtA~eLL~  870 (1351)
T KOG1035|consen  851 IRWLLSHDPSKRPTATELLN  870 (1351)
T ss_pred             HHHHhcCCCccCCCHHHHhh
Confidence            99999999999999999873

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.3e-36  Score=301.27  Aligned_cols=263  Identities=24%  Similarity=0.322  Sum_probs=195.0

Q ss_pred             HhcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCc--cHHHHHHHHHHHhcCCCCCcceEEEEEEeC
Q 046893           90 ATKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQ--GDREWLAEVNYLGQLRHSNLVKLIGYCCED  167 (464)
Q Consensus        90 ~~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpniv~l~~~~~~~  167 (464)
                      ..++|.+.+.||+|+||.||+|.+..+      +..||||++......  ....+.+|+.+|+.++||||+++++++..+
T Consensus        13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   86 (343)
T cd07880          13 VPDRYRDLKQVGSGAYGTVCSALDRRT------GAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPD   86 (343)
T ss_pred             cccceEEEEEeeecCCeEEEEEEECCC------CcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCC
Confidence            567799999999999999999987764      667999998643222  234678999999999999999999988765


Q ss_pred             C------eEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEc
Q 046893          168 E------HRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLS  241 (464)
Q Consensus       168 ~------~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~  241 (464)
                      .      ..++||||+ +++|.+++..   ..+++..+..++.|++.||.|||  ..+|+||||||+||+++.++.++|+
T Consensus        87 ~~~~~~~~~~lv~e~~-~~~l~~~~~~---~~l~~~~~~~i~~qi~~al~~LH--~~gi~H~dlkp~Nill~~~~~~kl~  160 (343)
T cd07880          87 LSLDRFHDFYLVMPFM-GTDLGKLMKH---EKLSEDRIQFLVYQMLKGLKYIH--AAGIIHRDLKPGNLAVNEDCELKIL  160 (343)
T ss_pred             ccccccceEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHH--hCCeecCCCCHHHEEEcCCCCEEEe
Confidence            4      458999999 7799887754   35899999999999999999999  6779999999999999999999999


Q ss_pred             ccCCccCCCCCCCcceeeccccCCcccCcccccc-CCCCcccchhcHHHHHHHHHhCCCCCCCCCCccccc-HH------
Q 046893          242 DFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMT-GHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHN-LV------  313 (464)
Q Consensus       242 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~-~~------  313 (464)
                      |||++......     .....++..|+|||++.+ ..++.++||||||+++|+|++|..||.......... ..      
T Consensus       161 dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  235 (343)
T cd07880         161 DFGLARQTDSE-----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTP  235 (343)
T ss_pred             ecccccccccC-----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence            99999753221     123567899999998876 458899999999999999999999997543211000 00      


Q ss_pred             --HHHHHhhhcc-cchhhccCccc---cCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 046893          314 --EWARPLLNNN-KKVLRILDPRL---EGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVA  369 (464)
Q Consensus       314 --~~~~~~~~~~-~~~~~~~~~~~---~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  369 (464)
                        ++...+.... ......+....   ........+..+.+++.+||+.||.+||++.+++.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~  297 (343)
T cd07880         236 SKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALA  297 (343)
T ss_pred             CHHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhc
Confidence              0000000000 00000000000   00011223447889999999999999999999883

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=1.1e-36  Score=299.71  Aligned_cols=266  Identities=23%  Similarity=0.282  Sum_probs=196.9

Q ss_pred             HHHHhcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCC--ccHHHHHHHHHHHhcCCCCCcceEEEEE
Q 046893           87 MKLATKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGY--QGDREWLAEVNYLGQLRHSNLVKLIGYC  164 (464)
Q Consensus        87 ~~~~~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~l~~~~  164 (464)
                      +...+++|.+.+.||.|+||.||+|.+..+      +..||+|.+.....  .....+..|+.++..++||||++++++|
T Consensus         5 ~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~------~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~   78 (328)
T cd07856           5 VFEITNRYVDLQPVGMGAFGLVCSARDQLT------GQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIF   78 (328)
T ss_pred             eeccccceEEEEeecccCCeEEEEEEECCC------CCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeE
Confidence            344678899999999999999999997764      66799998754321  2336678999999999999999999988


Q ss_pred             Ee-CCeEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEccc
Q 046893          165 CE-DEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDF  243 (464)
Q Consensus       165 ~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DF  243 (464)
                      .. ....++||||+ +++|..++..   ..+++..+..++.|++.||.|||  ..+|+||||+|.|||++.++.++|+||
T Consensus        79 ~~~~~~~~lv~e~~-~~~L~~~~~~---~~~~~~~~~~~~~ql~~aL~~LH--~~~iiH~dl~p~Nili~~~~~~~l~df  152 (328)
T cd07856          79 ISPLEDIYFVTELL-GTDLHRLLTS---RPLEKQFIQYFLYQILRGLKYVH--SAGVVHRDLKPSNILINENCDLKICDF  152 (328)
T ss_pred             ecCCCcEEEEeehh-ccCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHH--hCCcccCCCCHHHEeECCCCCEEeCcc
Confidence            76 56789999999 6689887653   25788889999999999999999  677999999999999999999999999


Q ss_pred             CCccCCCCCCCcceeeccccCCcccCcccccc-CCCCcccchhcHHHHHHHHHhCCCCCCCCCCccccc-HH--------
Q 046893          244 GLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMT-GHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHN-LV--------  313 (464)
Q Consensus       244 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~-~~--------  313 (464)
                      |++.....     ......++..|+|||.+.+ ..++.++||||||+++|+|++|+.||.......... +.        
T Consensus       153 g~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~  227 (328)
T cd07856         153 GLARIQDP-----QMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPD  227 (328)
T ss_pred             ccccccCC-----CcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCH
Confidence            99875321     1123567889999998766 568999999999999999999999997543211110 00        


Q ss_pred             HHHHHhhhcc-cchhhccC---ccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 046893          314 EWARPLLNNN-KKVLRILD---PRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVA  369 (464)
Q Consensus       314 ~~~~~~~~~~-~~~~~~~~---~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  369 (464)
                      ++........ ..+...+.   +..........+..+.++|.+||+.+|.+||++.+++.
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~  287 (328)
T cd07856         228 DVINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALA  287 (328)
T ss_pred             HHHHhccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            0110000000 00000000   00000011123468999999999999999999998864

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=100.00  E-value=3.2e-36  Score=321.61  Aligned_cols=146  Identities=27%  Similarity=0.345  Sum_probs=129.6

Q ss_pred             cCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCcc---HHHHHHHHHHHhcCCCCCcceEEEEEEeCC
Q 046893           92 KFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQG---DREWLAEVNYLGQLRHSNLVKLIGYCCEDE  168 (464)
Q Consensus        92 ~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~hpniv~l~~~~~~~~  168 (464)
                      ++|.+.+.||+|+||+||+|.+...      ++.||||++.......   ...+..|+.++..++||||+++++++....
T Consensus         4 ~~y~i~~~LG~G~fg~Vy~a~~~~~------~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~   77 (669)
T cd05610           4 EEFVIVKPISRGAFGKVYLGRKKNN------SKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSAN   77 (669)
T ss_pred             CCEEEEEEEecCCCeEEEEEEECCC------CcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECC
Confidence            5688899999999999999998764      5679999987543322   256788999999999999999999999999


Q ss_pred             eEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCcc
Q 046893          169 HRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAK  247 (464)
Q Consensus       169 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~  247 (464)
                      ..||||||+.+++|.+++....  .+++..++.|+.||+.||.|||  ..+||||||||+||||+.++.+||+|||+++
T Consensus        78 ~~~lVmEy~~g~~L~~li~~~~--~l~~~~~~~i~~qil~aL~yLH--~~gIiHrDLKP~NILl~~~g~vkL~DFGls~  152 (669)
T cd05610          78 NVYLVMEYLIGGDVKSLLHIYG--YFDEEMAVKYISEVALALDYLH--RHGIIHRDLKPDNMLISNEGHIKLTDFGLSK  152 (669)
T ss_pred             EEEEEEeCCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH--hCCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence            9999999999999999886543  5889999999999999999999  5679999999999999999999999999986

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=2e-36  Score=298.62  Aligned_cols=268  Identities=23%  Similarity=0.260  Sum_probs=191.4

Q ss_pred             CCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCC--CccHHHHHHHHHHHhcC-CCCCcceEEEEEEeC--
Q 046893           93 FFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGG--YQGDREWLAEVNYLGQL-RHSNLVKLIGYCCED--  167 (464)
Q Consensus        93 ~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~--  167 (464)
                      +|.+.+.||+|+||.||++.+....    .+..||+|.+....  ......+.+|+.+++++ .||||+++++++...  
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~----~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~   76 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETS----EEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPG   76 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCC----cCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccc
Confidence            4778889999999999999976531    14569999886432  12245678899999999 599999999875432  


Q ss_pred             --CeEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCC
Q 046893          168 --EHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGL  245 (464)
Q Consensus       168 --~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGl  245 (464)
                        ...+++|||+. ++|.+++...  ..+++..+..++.|++.||.|||  ..+|+||||||+|||++.++.+||+|||+
T Consensus        77 ~~~~~~~~~e~~~-~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH--~~givH~dlkp~Nili~~~~~~kl~Dfg~  151 (332)
T cd07857          77 NFNELYLYEELME-ADLHQIIRSG--QPLTDAHFQSFIYQILCGLKYIH--SANVLHRDLKPGNLLVNADCELKICDFGL  151 (332)
T ss_pred             cCCcEEEEEeccc-CCHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHH--hCCcccCCCCHHHeEEcCCCCEEeCcCCC
Confidence              45789999985 6898887653  36899999999999999999999  67799999999999999999999999999


Q ss_pred             ccCCCCCCCc--ceeeccccCCcccCcccccc-CCCCcccchhcHHHHHHHHHhCCCCCCCCCCccccc-HH--------
Q 046893          246 AKDGPMGDQT--HVSTRVMGTYGYAAPEYVMT-GHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHN-LV--------  313 (464)
Q Consensus       246 a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~-~~--------  313 (464)
                      ++........  .......||..|+|||++.+ ..++.++|||||||++|+|++|..||.......... ..        
T Consensus       152 a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  231 (332)
T cd07857         152 ARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDE  231 (332)
T ss_pred             ceecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCH
Confidence            9864322211  11233578999999998765 468999999999999999999999997643211000 00        


Q ss_pred             HHHHHhhhcc-cchhhccCcccc---CccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 046893          314 EWARPLLNNN-KKVLRILDPRLE---GQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVA  369 (464)
Q Consensus       314 ~~~~~~~~~~-~~~~~~~~~~~~---~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  369 (464)
                      ++........ ............   .......+..+.+|+.+||+.||.+||++.+++.
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~  291 (332)
T cd07857         232 ETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALE  291 (332)
T ss_pred             HHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            0000000000 000000000000   0001112457899999999999999999999863

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.3e-36  Score=301.12  Aligned_cols=263  Identities=22%  Similarity=0.317  Sum_probs=193.6

Q ss_pred             hcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCC--ccHHHHHHHHHHHhcCCCCCcceEEEEEEeCC
Q 046893           91 TKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGY--QGDREWLAEVNYLGQLRHSNLVKLIGYCCEDE  168 (464)
Q Consensus        91 ~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~  168 (464)
                      .++|.+...||+|+||.||+|++..+      ++.||+|++.....  .....+.+|+.+++.+.||||+++++++....
T Consensus        14 ~~~y~~~~~ig~g~~g~v~~~~~~~~------~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~   87 (342)
T cd07879          14 PERYTSLKQVGSGAYGSVCSAIDKRT------GEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAV   87 (342)
T ss_pred             ccceEEEEEeeecCCeEEEEEEeCCC------CcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccc
Confidence            46788999999999999999997654      56799999865321  12356789999999999999999999887543


Q ss_pred             ------eEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcc
Q 046893          169 ------HRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSD  242 (464)
Q Consensus       169 ------~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~D  242 (464)
                            .+++||||+. .+|..++    +..+++..+..++.|++.||.|||  ..+|+||||||+|||++.++.+||+|
T Consensus        88 ~~~~~~~~~lv~e~~~-~~l~~~~----~~~~~~~~~~~~~~qi~~aL~~LH--~~~i~H~dlkp~NIll~~~~~~kL~d  160 (342)
T cd07879          88 SGDEFQDFYLVMPYMQ-TDLQKIM----GHPLSEDKVQYLVYQMLCGLKYIH--SAGIIHRDLKPGNLAVNEDCELKILD  160 (342)
T ss_pred             cCCCCceEEEEecccc-cCHHHHH----cCCCCHHHHHHHHHHHHHHHHHHH--HCCcccCCCCHHHEEECCCCCEEEee
Confidence                  4699999995 4776654    235899999999999999999999  56799999999999999999999999


Q ss_pred             cCCccCCCCCCCcceeeccccCCcccCcccccc-CCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhh
Q 046893          243 FGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMT-GHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLN  321 (464)
Q Consensus       243 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~  321 (464)
                      ||+++.....     .....|+..|+|||++.+ ..++.++|||||||++|||++|+.||.+.......  .. ......
T Consensus       161 fg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~--~~-~~~~~~  232 (342)
T cd07879         161 FGLARHADAE-----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQL--TQ-ILKVTG  232 (342)
T ss_pred             CCCCcCCCCC-----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHH--HH-HHHhcC
Confidence            9999753221     123567889999998876 46889999999999999999999999764321110  00 000000


Q ss_pred             cc-------------cchhhccCccccCc---cCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH--HHHHH
Q 046893          322 NN-------------KKVLRILDPRLEGQ---YTARTAMKVAGLAYQCLSQNPKGRPVMSDVVA--LLETV  374 (464)
Q Consensus       322 ~~-------------~~~~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~--~L~~~  374 (464)
                      ..             ......+.......   .....+..+.+|+.+||+.||.+||++.+++.  .++.+
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~  303 (342)
T cd07879         233 VPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSF  303 (342)
T ss_pred             CCCHHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhc
Confidence            00             00000000000000   00123457889999999999999999999984  35544

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-38  Score=306.00  Aligned_cols=244  Identities=24%  Similarity=0.311  Sum_probs=204.4

Q ss_pred             hcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCcc---HHHHHHHHHHHhcCCCCCcceEEEEEEeC
Q 046893           91 TKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQG---DREWLAEVNYLGQLRHSNLVKLIGYCCED  167 (464)
Q Consensus        91 ~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~hpniv~l~~~~~~~  167 (464)
                      -.++..+..||-||||.|=++.....      ...+|+|++++...-.   .+.+..|-+||..++.|.||++|..|.+.
T Consensus       419 l~dl~~iaTLGvGgFGRVELV~~~~~------~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~  492 (732)
T KOG0614|consen  419 LSDLKRIATLGVGGFGRVELVKVNSQ------KATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDS  492 (732)
T ss_pred             hhhhhhhhhcccCccceEEEEEeccc------chHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccc
Confidence            44566777899999999999876653      2247888887654322   35577899999999999999999999999


Q ss_pred             CeEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCcc
Q 046893          168 EHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAK  247 (464)
Q Consensus       168 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~  247 (464)
                      .+.|++||-|-||.|+..+.++.  .|...+...++.++++|++|||  .++||+|||||+|.+|+.+|-+||.|||+|+
T Consensus       493 kyvYmLmEaClGGElWTiLrdRg--~Fdd~tarF~~acv~EAfeYLH--~k~iIYRDLKPENllLd~~Gy~KLVDFGFAK  568 (732)
T KOG0614|consen  493 KYVYMLMEACLGGELWTILRDRG--SFDDYTARFYVACVLEAFEYLH--RKGIIYRDLKPENLLLDNRGYLKLVDFGFAK  568 (732)
T ss_pred             hhhhhhHHhhcCchhhhhhhhcC--CcccchhhhhHHHHHHHHHHHH--hcCceeccCChhheeeccCCceEEeehhhHH
Confidence            99999999999999999988764  6899999999999999999999  6789999999999999999999999999999


Q ss_pred             CCCCCCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhcccchh
Q 046893          248 DGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVL  327 (464)
Q Consensus       248 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  327 (464)
                      ....+..+   -++|||+.|.|||++.++..+..+|.||||+++||||+|.+||.+..+...++++-.-           
T Consensus       569 ki~~g~KT---wTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkG-----------  634 (732)
T KOG0614|consen  569 KIGSGRKT---WTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKG-----------  634 (732)
T ss_pred             HhccCCce---eeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhh-----------
Confidence            87665543   3589999999999999999999999999999999999999999998876655443211           


Q ss_pred             hccCccccCccCHHHHHHHHHHHHHhhccCCCCCCC
Q 046893          328 RILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPV  363 (464)
Q Consensus       328 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs  363 (464)
                        +|..   .++........+||++.+..+|.+|..
T Consensus       635 --id~i---~~Pr~I~k~a~~Lik~LCr~~P~ERLG  665 (732)
T KOG0614|consen  635 --IDKI---EFPRRITKTATDLIKKLCRDNPTERLG  665 (732)
T ss_pred             --hhhh---hcccccchhHHHHHHHHHhcCcHhhhc
Confidence              1111   234445557788999999999999965

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=1.7e-36  Score=291.27  Aligned_cols=264  Identities=27%  Similarity=0.363  Sum_probs=197.8

Q ss_pred             CCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCC--CccHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeEE
Q 046893           94 FRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGG--YQGDREWLAEVNYLGQLRHSNLVKLIGYCCEDEHRI  171 (464)
Q Consensus        94 ~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~  171 (464)
                      |++...||+|+||.||+|....+      ++.+|+|++....  ......+..|+.+++.++|+||+++++++...+..+
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~------~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~   74 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKT------GEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLY   74 (282)
T ss_pred             CeeehcccccCcceEEEeeecCC------CcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceE
Confidence            55677899999999999998765      6679999987653  222356788999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCccCCCC
Q 046893          172 LVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPM  251 (464)
Q Consensus       172 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~  251 (464)
                      +||||+. ++|.+++.... ..+++..+..++.|++.||.|||  ..+|+||||+|+||+++.++.++|+|||+++....
T Consensus        75 ~v~e~~~-~~l~~~i~~~~-~~~~~~~~~~~~~~i~~~l~~LH--~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~  150 (282)
T cd07829          75 LVFEYCD-MDLKKYLDKRP-GPLSPNLIKSIMYQLLRGLAYCH--SHRILHRDLKPQNILINRDGVLKLADFGLARAFGI  150 (282)
T ss_pred             EEecCcC-cCHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHH--HCCcccCCCChheEEEcCCCCEEEecCCcccccCC
Confidence            9999997 59999887652 36899999999999999999999  57799999999999999999999999999986433


Q ss_pred             CCCcceeeccccCCcccCccccccC-CCCcccchhcHHHHHHHHHhCCCCCCCCCCccccc-HHHHH-------HHhhhc
Q 046893          252 GDQTHVSTRVMGTYGYAAPEYVMTG-HLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHN-LVEWA-------RPLLNN  322 (464)
Q Consensus       252 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~-~~~~~-------~~~~~~  322 (464)
                      ...  ......++..|+|||.+.+. .++.++|||||||++|||++|+.||.......... +....       +..+..
T Consensus       151 ~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (282)
T cd07829         151 PLR--TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTK  228 (282)
T ss_pred             Ccc--ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcc
Confidence            221  22234567889999998776 78999999999999999999999997644211100 00000       000000


Q ss_pred             c---cchhhccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 046893          323 N---KKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVA  369 (464)
Q Consensus       323 ~---~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  369 (464)
                      .   ...................+..+.+++.+||..||.+||++.+++.
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~  278 (282)
T cd07829         229 LPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK  278 (282)
T ss_pred             cccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence            0   0000000000000001112558999999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=9.2e-37  Score=258.01  Aligned_cols=262  Identities=24%  Similarity=0.313  Sum_probs=197.3

Q ss_pred             CCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCc--cHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeEE
Q 046893           94 FRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQ--GDREWLAEVNYLGQLRHSNLVKLIGYCCEDEHRI  171 (464)
Q Consensus        94 ~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~  171 (464)
                      |...++||+|.||+||+|++.++      .++||+|.+......  -....++|+.+|+.++|.|||+++++...++.+-
T Consensus         4 ydkmekigegtygtvfkarn~~t------~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkklt   77 (292)
T KOG0662|consen    4 YDKMEKIGEGTYGTVFKARNRET------HEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLT   77 (292)
T ss_pred             hHHHHhhcCCcceeeEecccCCc------cceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeE
Confidence            44556799999999999987775      788999998754322  2356789999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCccCCCC
Q 046893          172 LVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPM  251 (464)
Q Consensus       172 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~  251 (464)
                      ||+|||. .+|..+...- ++.+..+.+..++.|+++||.|+|+  .+++||||||.|.||+.+|.+||+|||+++.+..
T Consensus        78 lvfe~cd-qdlkkyfdsl-ng~~d~~~~rsfmlqllrgl~fchs--hnvlhrdlkpqnllin~ngelkladfglarafgi  153 (292)
T KOG0662|consen   78 LVFEFCD-QDLKKYFDSL-NGDLDPEIVRSFMLQLLRGLGFCHS--HNVLHRDLKPQNLLINRNGELKLADFGLARAFGI  153 (292)
T ss_pred             EeHHHhh-HHHHHHHHhc-CCcCCHHHHHHHHHHHHhhhhhhhh--hhhhhccCCcceEEeccCCcEEecccchhhhcCC
Confidence            9999995 4888776543 5579999999999999999999994  5699999999999999999999999999997543


Q ss_pred             CCCcceeeccccCCcccCccccccC-CCCcccchhcHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHhhhcc----cc
Q 046893          252 GDQTHVSTRVMGTYGYAAPEYVMTG-HLTARSDVYGFGVVLLEMLL-GRRAVDKSRPSREHNLVEWARPLLNNN----KK  325 (464)
Q Consensus       252 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~----~~  325 (464)
                        ........+-|.+|.+|.++.|. -|+...|+||-|||+.|+.. |++.|.+..-.  .++...++.+-...    ..
T Consensus       154 --pvrcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvd--dqlkrif~~lg~p~ed~wps  229 (292)
T KOG0662|consen  154 --PVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD--DQLKRIFRLLGTPTEDQWPS  229 (292)
T ss_pred             --ceEeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHH--HHHHHHHHHhCCCccccCCc
Confidence              23334446789999999999875 48899999999999999997 77767665422  22222222211111    11


Q ss_pred             hhhccCccccCccC---------HHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 046893          326 VLRILDPRLEGQYT---------ARTAMKVAGLAYQCLSQNPKGRPVMSDVVA  369 (464)
Q Consensus       326 ~~~~~~~~~~~~~~---------~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  369 (464)
                      +..+.|-....-|+         ......-.+|+.+.|..+|..|.++++.++
T Consensus       230 ~t~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalq  282 (292)
T KOG0662|consen  230 MTKLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQ  282 (292)
T ss_pred             cccCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhc
Confidence            12222221111111         122224578888999999999999887653

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-36  Score=308.31  Aligned_cols=255  Identities=25%  Similarity=0.364  Sum_probs=213.7

Q ss_pred             HHhcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCccHHHHHHHHHHHhcC-CCCCcceEEEEEEe-
Q 046893           89 LATKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQL-RHSNLVKLIGYCCE-  166 (464)
Q Consensus        89 ~~~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~-  166 (464)
                      .-+.-|++..+||.|.+|.||+++...+      ++..|+|+.... .+.++++..|.++|+.+ .|||++.++++|.. 
T Consensus        16 dp~d~~ei~evig~Gtygkv~k~k~~~~------~~~aa~kI~~~~-~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~   88 (953)
T KOG0587|consen   16 DPADIFEIIEVIGNGTYGKVYKGRHVKT------GQLAAIKIMDPT-EDEEEEIELEYNMLKKYSHHPNVATFYGAFIKK   88 (953)
T ss_pred             CCCCccEEEEEEeeccceeEEEEeeeec------CceeeeEeecCC-ccccHHHHHHHHHHHhccCCCCcceEEEEEEEe
Confidence            3455688899999999999999987775      677888887654 34557788899999988 69999999998864 


Q ss_pred             ----CCeEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcc
Q 046893          167 ----DEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSD  242 (464)
Q Consensus       167 ----~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~D  242 (464)
                          ++.++||||||.+|+.-|++....+..+.|..+..|+..++.||.+||  ...++|||||-.||||+.++.|||+|
T Consensus        89 ~~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH--~nkviHRDikG~NiLLT~e~~VKLvD  166 (953)
T KOG0587|consen   89 DPGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLH--NNKVIHRDIKGQNVLLTENAEVKLVD  166 (953)
T ss_pred             cCCCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHh--hcceeeecccCceEEEeccCcEEEee
Confidence                458999999999999999998888889999999999999999999999  67799999999999999999999999


Q ss_pred             cCCccCCCCCCCcceeeccccCCcccCcccccc-----CCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHH
Q 046893          243 FGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMT-----GHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWAR  317 (464)
Q Consensus       243 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~  317 (464)
                      ||++.....  ......+.+||+.|||||++..     ..|+.++|+||||++..||--|.+|+....+....       
T Consensus       167 FGvSaQlds--T~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraL-------  237 (953)
T KOG0587|consen  167 FGVSAQLDS--TVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRAL-------  237 (953)
T ss_pred             eeeeeeeec--ccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhh-------
Confidence            999986432  2334456899999999999963     35788999999999999999999999877654321       


Q ss_pred             HhhhcccchhhccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 046893          318 PLLNNNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVA  369 (464)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  369 (464)
                              +.-.-+|......+.....++.++|..||..|..+||++.+++.
T Consensus       238 --------F~IpRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~  281 (953)
T KOG0587|consen  238 --------FLIPRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK  281 (953)
T ss_pred             --------ccCCCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence                    11122444555567788889999999999999999999998874

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1e-36  Score=280.19  Aligned_cols=254  Identities=24%  Similarity=0.361  Sum_probs=199.2

Q ss_pred             HHHhcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCccHHH---HHHHHHHHhcC-CCCCcceEEEE
Q 046893           88 KLATKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDRE---WLAEVNYLGQL-RHSNLVKLIGY  163 (464)
Q Consensus        88 ~~~~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~---~~~E~~~l~~l-~hpniv~l~~~  163 (464)
                      .+.-++|.++++||+|+|++|.++.+.++      .+++|+|+++++-....+.   ...|-.+..+- +||.+|-++.+
T Consensus       246 ~l~l~df~ll~vigrgsyakvl~~~~~~t------~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhsc  319 (593)
T KOG0695|consen  246 GLGLQDFDLLRVIGRGSYAKVLLVRLKKT------DQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSC  319 (593)
T ss_pred             ccccccceeeeeecCcchhhhhheehccc------ceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhh
Confidence            34557799999999999999999988775      6789999998754433322   34566666665 69999999999


Q ss_pred             EEeCCeEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEccc
Q 046893          164 CCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDF  243 (464)
Q Consensus       164 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DF  243 (464)
                      |..+..+++|.||++||+|.-++.+..  .|+++.+..+...|+.||.|||  .++||+||||..|||||.+|++||+|+
T Consensus       320 fqtesrlffvieyv~ggdlmfhmqrqr--klpeeharfys~ei~lal~flh--~rgiiyrdlkldnvlldaeghikltdy  395 (593)
T KOG0695|consen  320 FQTESRLFFVIEYVNGGDLMFHMQRQR--KLPEEHARFYSAEICLALNFLH--ERGIIYRDLKLDNVLLDAEGHIKLTDY  395 (593)
T ss_pred             hcccceEEEEEEEecCcceeeehhhhh--cCcHHHhhhhhHHHHHHHHHHh--hcCeeeeeccccceEEccCCceeeccc
Confidence            999999999999999999977776644  6999999999999999999999  789999999999999999999999999


Q ss_pred             CCccCCCCCCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHhCCCCCCCCCC-cccccHHHHHHHhhhc
Q 046893          244 GLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRP-SREHNLVEWARPLLNN  322 (464)
Q Consensus       244 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~-~~~~~~~~~~~~~~~~  322 (464)
                      |+++....  ......++|||+.|+|||+++|..|+..+|+|+|||+++||+.|+.||+--.. ..+.+..++....+-+
T Consensus       396 gmcke~l~--~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvile  473 (593)
T KOG0695|consen  396 GMCKEGLG--PGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILE  473 (593)
T ss_pred             chhhcCCC--CCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhh
Confidence            99986432  22345669999999999999999999999999999999999999999974221 1122222222222111


Q ss_pred             ccchhhccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCH
Q 046893          323 NKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVM  364 (464)
Q Consensus       323 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~  364 (464)
                               ..+  ..+...+.....+++..|.+||.+|...
T Consensus       474 ---------kqi--riprslsvkas~vlkgflnkdp~erlgc  504 (593)
T KOG0695|consen  474 ---------KQI--RIPRSLSVKASHVLKGFLNKDPKERLGC  504 (593)
T ss_pred             ---------hcc--cccceeehhhHHHHHHhhcCCcHHhcCC
Confidence                     111  1122223355668888999999998543

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-36  Score=283.96  Aligned_cols=273  Identities=23%  Similarity=0.306  Sum_probs=226.9

Q ss_pred             hhHHHHHhcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCc-cHHHHHHHHHHHhcCCCCCcceEEE
Q 046893           84 YNEMKLATKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQ-GDREWLAEVNYLGQLRHSNLVKLIG  162 (464)
Q Consensus        84 ~~~~~~~~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~  162 (464)
                      ..++.+...++++..++-+|.||.||.|.+.+..... ..+.|-+|.++....+ ....++.|.-++..+.|||+..+.+
T Consensus       276 ~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n-~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~  354 (563)
T KOG1024|consen  276 LQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYN-DCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLG  354 (563)
T ss_pred             HHhhhhhhhheechhhhhcCchhheeeeeecccCCcc-hHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeE
Confidence            4577778888999999999999999999887543222 2344677887654433 3366889999999999999999999


Q ss_pred             EEEeC-CeEEEEEeccCCCCHHHHHHhhc------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCC
Q 046893          163 YCCED-EHRILVYEYMESGSLEKHLLRRV------GCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNAD  235 (464)
Q Consensus       163 ~~~~~-~~~~lv~e~~~~g~L~~~l~~~~------~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~  235 (464)
                      ++.++ ..+++++.++.-|+|..++..-.      ...++..+...++.|++.|++|||  +.+|||.||..+|++||+.
T Consensus       355 V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh--~~~ViHkDiAaRNCvIdd~  432 (563)
T KOG1024|consen  355 VSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLH--NHGVIHKDIAARNCVIDDQ  432 (563)
T ss_pred             EEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHH--hcCcccchhhhhcceehhh
Confidence            87665 56788999999999999997322      235777888999999999999999  6779999999999999999


Q ss_pred             CceEEcccCCccCCCCCCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHh-CCCCCCCCCCcccccHHH
Q 046893          236 FSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLL-GRRAVDKSRPSREHNLVE  314 (464)
Q Consensus       236 ~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~  314 (464)
                      ..|||+|=.+++.....++............||+||.+....|+..+|||||||+||||+| |+.|+....|.+.     
T Consensus       433 LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm-----  507 (563)
T KOG1024|consen  433 LQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEM-----  507 (563)
T ss_pred             eeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHH-----
Confidence            9999999999999888888888888888999999999999999999999999999999999 9999876654321     


Q ss_pred             HHHHhhhcccchhhccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHh
Q 046893          315 WARPLLNNNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETVQS  376 (464)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~~~  376 (464)
                                  ..++....+-..+..||.+++.+|.-||+.+|++||++++++.-|.++..
T Consensus       508 ------------~~ylkdGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~~  557 (563)
T KOG1024|consen  508 ------------EHYLKDGYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFHT  557 (563)
T ss_pred             ------------HHHHhccceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHH
Confidence                        12222333444566789999999999999999999999999999988754

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.3e-36  Score=281.40  Aligned_cols=237  Identities=30%  Similarity=0.370  Sum_probs=192.7

Q ss_pred             eeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCc---cHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeEEEEEec
Q 046893          100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQ---GDREWLAEVNYLGQLRHSNLVKLIGYCCEDEHRILVYEY  176 (464)
Q Consensus       100 lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~  176 (464)
                      ||.|+||.||++.+...      ++.+|+|++......   ....+..|+.+++.++||||+++++.+..+...++||||
T Consensus         1 lg~G~~~~v~~~~~~~~------~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   74 (250)
T cd05123           1 LGKGSFGKVLLVRKKDT------GKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEY   74 (250)
T ss_pred             CCCCCceEEEEEEECCC------CcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEec
Confidence            69999999999998654      567999998765332   335788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCccCCCCCCCcc
Q 046893          177 MESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTH  256 (464)
Q Consensus       177 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~~~  256 (464)
                      +.+++|.+++....  .+++..+..++.|++.||.|||  +.+++|+||+|+||+++.++.++|+|||++.......  .
T Consensus        75 ~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lh--~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~--~  148 (250)
T cd05123          75 APGGELFSHLSKEG--RFSEERARFYAAEIVLALEYLH--SLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG--S  148 (250)
T ss_pred             CCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH--HCCceecCCCcceEEEcCCCcEEEeecCcceecccCC--C
Confidence            99999999987643  5899999999999999999999  5779999999999999999999999999997643321  1


Q ss_pred             eeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhcccchhhccCccccC
Q 046893          257 VSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRILDPRLEG  336 (464)
Q Consensus       257 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  336 (464)
                      ......|+..|++||.+.+...+.++|+||||+++|+|++|..||.....      ..........            ..
T Consensus       149 ~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~------~~~~~~~~~~------------~~  210 (250)
T cd05123         149 RTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR------KEIYEKILKD------------PL  210 (250)
T ss_pred             cccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH------HHHHHHHhcC------------CC
Confidence            22346788999999999888899999999999999999999999965432      1111111110            01


Q ss_pred             ccCHHHHHHHHHHHHHhhccCCCCCCCHHH
Q 046893          337 QYTARTAMKVAGLAYQCLSQNPKGRPVMSD  366 (464)
Q Consensus       337 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~e  366 (464)
                      .++...+..+.+++.+||..||++||++.+
T Consensus       211 ~~~~~~~~~l~~~i~~~l~~~p~~R~~~~~  240 (250)
T cd05123         211 RFPEFLSPEARDLISGLLQKDPTKRLGSGG  240 (250)
T ss_pred             CCCCCCCHHHHHHHHHHhcCCHhhCCCccc
Confidence            122223558899999999999999999955

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1e-36  Score=302.99  Aligned_cols=241  Identities=23%  Similarity=0.262  Sum_probs=193.6

Q ss_pred             HhcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCccHHHHHHHHHHHhcC-CCCCcceEEEEEEeCC
Q 046893           90 ATKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQL-RHSNLVKLIGYCCEDE  168 (464)
Q Consensus        90 ~~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~  168 (464)
                      .+..|.+...||.|+|+.|-.+.+..+      .+..++|++.+....    ..+|+.++... +||||+++++.+.+..
T Consensus       320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t------~~~~~vkii~~~~~~----~~~e~~~~~~~~~h~niv~~~~v~~~~~  389 (612)
T KOG0603|consen  320 FTESYEFREELGEGSFSAVKYCESSPT------DQEPAVKIISKRADD----NQDEIPISLLVRDHPNIVKSHDVYEDGK  389 (612)
T ss_pred             cchhhccccccCCCCccceeeeecccc------ccchhheeccccccc----cccccchhhhhcCCCcceeecceecCCc
Confidence            356678888899999999999887765      556899998765222    23566555554 7999999999999999


Q ss_pred             eEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEe-cCCCceEEcccCCcc
Q 046893          169 HRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILL-NADFSAKLSDFGLAK  247 (464)
Q Consensus       169 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill-~~~~~vkl~DFGla~  247 (464)
                      +.|+|||++.|+-|.+.+....   ....++..|+.+|+.++.|||  .++||||||||+|||+ +..++++|+|||.++
T Consensus       390 ~~~~v~e~l~g~ell~ri~~~~---~~~~e~~~w~~~lv~Av~~LH--~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~  464 (612)
T KOG0603|consen  390 EIYLVMELLDGGELLRRIRSKP---EFCSEASQWAAELVSAVDYLH--EQGVVHRDLKPGNILLDGSAGHLRLTYFGFWS  464 (612)
T ss_pred             eeeeeehhccccHHHHHHHhcc---hhHHHHHHHHHHHHHHHHHHH--hcCeeecCCChhheeecCCCCcEEEEEechhh
Confidence            9999999999999988877653   333778889999999999999  6889999999999999 688999999999998


Q ss_pred             CCCCCCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhcccchh
Q 046893          248 DGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVL  327 (464)
Q Consensus       248 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  327 (464)
                      .....     ..+.+-|..|.|||++...+|+.++||||||++||+||+|+.||......  .++               
T Consensus       465 ~~~~~-----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~--~ei---------------  522 (612)
T KOG0603|consen  465 ELERS-----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG--IEI---------------  522 (612)
T ss_pred             hCchh-----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch--HHH---------------
Confidence            65432     12346788999999999999999999999999999999999999765432  000               


Q ss_pred             hccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 046893          328 RILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVA  369 (464)
Q Consensus       328 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  369 (464)
                        ......+.+....+....+|+.+||+.||.+||++.++..
T Consensus       523 --~~~i~~~~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~  562 (612)
T KOG0603|consen  523 --HTRIQMPKFSECVSDEAKDLLQQLLQVDPALRLGADEIGA  562 (612)
T ss_pred             --HHhhcCCccccccCHHHHHHHHHhccCChhhCcChhhhcc
Confidence              1111112223455668999999999999999999999864

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.3e-36  Score=301.29  Aligned_cols=263  Identities=22%  Similarity=0.302  Sum_probs=195.6

Q ss_pred             HhcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCC--CccHHHHHHHHHHHhcCCCCCcceEEEEEEeC
Q 046893           90 ATKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGG--YQGDREWLAEVNYLGQLRHSNLVKLIGYCCED  167 (464)
Q Consensus        90 ~~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~  167 (464)
                      ..++|.+...||+|+||.||+|.+..+      +..||+|++....  ......+.+|+.+++.+.||||+++++++...
T Consensus        13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~------~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   86 (343)
T cd07851          13 VPDRYQNLSPVGSGAYGQVCSAFDTKT------GRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPA   86 (343)
T ss_pred             ccCceEEEEEeccCCceEEEEEEECCC------CcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcc
Confidence            356789999999999999999998764      5679999986532  12235677899999999999999999887766


Q ss_pred             Ce------EEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEc
Q 046893          168 EH------RILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLS  241 (464)
Q Consensus       168 ~~------~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~  241 (464)
                      +.      .++|+||+ +++|.+++..   ..+++..+..++.|++.||.|||  ..+|+||||||+||+++.++.++|+
T Consensus        87 ~~~~~~~~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~~~~ql~~aL~~LH--~~gi~H~dlkp~Nill~~~~~~kL~  160 (343)
T cd07851          87 SSLEDFQDVYLVTHLM-GADLNNIVKC---QKLSDDHIQFLVYQILRGLKYIH--SAGIIHRDLKPSNIAVNEDCELKIL  160 (343)
T ss_pred             ccccccccEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHH--HCCeecCCCCHHHeEECCCCCEEEc
Confidence            54      89999999 6799888764   25899999999999999999999  5779999999999999999999999


Q ss_pred             ccCCccCCCCCCCcceeeccccCCcccCcccccc-CCCCcccchhcHHHHHHHHHhCCCCCCCCCCccccc-HHHHH---
Q 046893          242 DFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMT-GHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHN-LVEWA---  316 (464)
Q Consensus       242 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~-~~~~~---  316 (464)
                      |||++......     .....++..|+|||.+.+ ..++.++|||||||++|+|++|+.||.......... +.+..   
T Consensus       161 dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~  235 (343)
T cd07851         161 DFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTP  235 (343)
T ss_pred             ccccccccccc-----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCC
Confidence            99999864322     223568889999998865 367899999999999999999999997644321100 00000   


Q ss_pred             -----HHhhhcc-cchhhccCccccCc---cCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 046893          317 -----RPLLNNN-KKVLRILDPRLEGQ---YTARTAMKVAGLAYQCLSQNPKGRPVMSDVVA  369 (464)
Q Consensus       317 -----~~~~~~~-~~~~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  369 (464)
                           ....... ......+.......   .....+..+.+++.+||..||.+|||+.+|+.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~  297 (343)
T cd07851         236 DEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA  297 (343)
T ss_pred             CHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence                 0000000 00000000000000   01123558999999999999999999999874

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=100.00  E-value=3.8e-38  Score=281.59  Aligned_cols=253  Identities=24%  Similarity=0.293  Sum_probs=192.1

Q ss_pred             CCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCC-ccHHHHHHHHHHHh-cCCCCCcceEEEEEEeCCeEEE
Q 046893           95 RPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGY-QGDREWLAEVNYLG-QLRHSNLVKLIGYCCEDEHRIL  172 (464)
Q Consensus        95 ~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~-~l~hpniv~l~~~~~~~~~~~l  172 (464)
                      +-+..||.|+||+|++..+...      ++..|||.+..... ..+++++.|..... .-+.||||+++|.+..++..+|
T Consensus        67 qdlg~iG~G~fG~V~KM~hk~s------g~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWi  140 (361)
T KOG1006|consen   67 QDLGEIGNGAFGTVNKMLHKPS------GKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWI  140 (361)
T ss_pred             HHHHHhcCCcchhhhhhhcCcc------CcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceee
Confidence            3345699999999999887765      78899999987655 44577888887654 4479999999999999999999


Q ss_pred             EEeccCCCCHHHHHH---hhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCccCC
Q 046893          173 VYEYMESGSLEKHLL---RRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDG  249 (464)
Q Consensus       173 v~e~~~~g~L~~~l~---~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~  249 (464)
                      .||+|+ .+|..+..   ......+++..+-.|....+.||.||-. ...|||||+||+||||+..|.|||||||++...
T Consensus       141 CMELMd-~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~-~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqL  218 (361)
T KOG1006|consen  141 CMELMD-ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKE-ELKIIHRDVKPSNILLDRHGDVKLCDFGICGQL  218 (361)
T ss_pred             eHHHHh-hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHH-HhhhhhccCChhheEEecCCCEeeecccchHhH
Confidence            999994 47644332   2234578999999999999999999974 556999999999999999999999999999754


Q ss_pred             CCCCCcceeeccccCCcccCccccc--cCCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhcccchh
Q 046893          250 PMGDQTHVSTRVMGTYGYAAPEYVM--TGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVL  327 (464)
Q Consensus       250 ~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  327 (464)
                      ...-   ..+.-.|-..|||||.+.  +..|+-++||||||++|||+.||..|+.+...     ..+...........  
T Consensus       219 v~Si---AkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s-----vfeql~~Vv~gdpp--  288 (361)
T KOG1006|consen  219 VDSI---AKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS-----VFEQLCQVVIGDPP--  288 (361)
T ss_pred             HHHH---HhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH-----HHHHHHHHHcCCCC--
Confidence            3211   123356888899999985  34699999999999999999999999987542     11222111111111  


Q ss_pred             hccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 046893          328 RILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVA  369 (464)
Q Consensus       328 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  369 (464)
                       ++..   ..........+..+|..||.+|-..||.+.++.+
T Consensus       289 -~l~~---~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~  326 (361)
T KOG1006|consen  289 -ILLF---DKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKK  326 (361)
T ss_pred             -eecC---cccccccCHHHHHHHHHHhhcccccCcchhhhhc
Confidence             1111   1111234558999999999999999999999875

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.6e-36  Score=297.06  Aligned_cols=218  Identities=24%  Similarity=0.335  Sum_probs=182.4

Q ss_pred             chhHHHHHhcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCccH---HHHHHHHHHHhcCCCCCcce
Q 046893           83 TYNEMKLATKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGD---REWLAEVNYLGQLRHSNLVK  159 (464)
Q Consensus        83 ~~~~~~~~~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~---~~~~~E~~~l~~l~hpniv~  159 (464)
                      .....+....-|..++.||-|+||+|.++.-.++      ...+|+|.+.+.+....   .....|-.||..-..+-||+
T Consensus       620 RLkRaKMdKSmFvkik~iGvGAFGeV~Lv~KvDT------~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVr  693 (1034)
T KOG0608|consen  620 RLKRAKMDKSMFVKIKTIGVGAFGEVCLVRKVDT------RALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVR  693 (1034)
T ss_pred             HHHHhhccccceEEEeeecccccceeEEEeecch------hhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEE
Confidence            3344455667788899999999999999986664      55699999877544332   23567889999999999999


Q ss_pred             EEEEEEeCCeEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceE
Q 046893          160 LIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAK  239 (464)
Q Consensus       160 l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vk  239 (464)
                      ||..|.+.+.+|+||+|++||++..+|.+..  .|.+..+..++..+.+|+++.|  +.|+|||||||+|||||.+|+||
T Consensus       694 LyySFQDkdnLYFVMdYIPGGDmMSLLIrmg--IFeE~LARFYIAEltcAiesVH--kmGFIHRDiKPDNILIDrdGHIK  769 (1034)
T KOG0608|consen  694 LYYSFQDKDNLYFVMDYIPGGDMMSLLIRMG--IFEEDLARFYIAELTCAIESVH--KMGFIHRDIKPDNILIDRDGHIK  769 (1034)
T ss_pred             EEEEeccCCceEEEEeccCCccHHHHHHHhc--cCHHHHHHHHHHHHHHHHHHHH--hccceecccCccceEEccCCcee
Confidence            9999999999999999999999999888754  6899999999999999999999  78899999999999999999999


Q ss_pred             EcccCCccCCCC---------CCCc-------------------------------ceeeccccCCcccCccccccCCCC
Q 046893          240 LSDFGLAKDGPM---------GDQT-------------------------------HVSTRVMGTYGYAAPEYVMTGHLT  279 (464)
Q Consensus       240 l~DFGla~~~~~---------~~~~-------------------------------~~~~~~~gt~~y~aPE~~~~~~~~  279 (464)
                      |+|||||.-+..         ++..                               ......+||+.|+|||++....|+
T Consensus       770 LTDFGLCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~  849 (1034)
T KOG0608|consen  770 LTDFGLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYT  849 (1034)
T ss_pred             eeeccccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCcc
Confidence            999999972211         0000                               001236899999999999999999


Q ss_pred             cccchhcHHHHHHHHHhCCCCCCCCCCcccc
Q 046893          280 ARSDVYGFGVVLLEMLLGRRAVDKSRPSREH  310 (464)
Q Consensus       280 ~~~DvwslG~il~ell~g~~pf~~~~~~~~~  310 (464)
                      ..+|+||.|||||||+.|+.||....+...+
T Consensus       850 q~cdwws~gvil~em~~g~~pf~~~tp~~tq  880 (1034)
T KOG0608|consen  850 QLCDWWSVGVILYEMLVGQPPFLADTPGETQ  880 (1034)
T ss_pred             ccchhhHhhHHHHHHhhCCCCccCCCCCcce
Confidence            9999999999999999999999887776554

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=100.00  E-value=1.3e-35  Score=278.49  Aligned_cols=222  Identities=21%  Similarity=0.206  Sum_probs=177.7

Q ss_pred             cCceEEEEEEecCCCCCCccceEEEEEEccCCCCccHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeEEEEEeccCCCCH
Q 046893          103 GGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVKLIGYCCEDEHRILVYEYMESGSL  182 (464)
Q Consensus       103 G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g~L  182 (464)
                      |.||.||++.+..+      ++.+|+|.+....     .+..|...+....||||+++++++...+..++||||+.+|+|
T Consensus         4 g~~~~v~~~~~~~~------~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L   72 (237)
T cd05576           4 GVIDKVLLVMDTRT------QQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKL   72 (237)
T ss_pred             cccceEEEEEEccC------CcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCH
Confidence            89999999998775      6679999987542     233455555566799999999999999999999999999999


Q ss_pred             HHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCccCCCCCCCcceeeccc
Q 046893          183 EKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVM  262 (464)
Q Consensus       183 ~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~~~~~~~~~  262 (464)
                      .+++.+..  .+++..+..++.|++.||.|||  +++|+||||||+||+++.++.++|+|||++......     .....
T Consensus        73 ~~~l~~~~--~l~~~~~~~~~~ql~~~l~~lH--~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~-----~~~~~  143 (237)
T cd05576          73 WSHISKFL--NIPEECVKRWAAEMVVALDALH--REGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS-----CDGEA  143 (237)
T ss_pred             HHHHHHhc--CCCHHHHHHHHHHHHHHHHHHH--hCCeeccCCCHHHEEEcCCCCEEEecccchhccccc-----cccCC
Confidence            99887653  5899999999999999999999  678999999999999999999999999988653221     12245


Q ss_pred             cCCcccCccccccCCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhcccchhhccCccccCccCHHH
Q 046893          263 GTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRILDPRLEGQYTART  342 (464)
Q Consensus       263 gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  342 (464)
                      ++..|+|||.+.+..++.++||||||+++|||++|..||.......            ..          ......+...
T Consensus       144 ~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~------------~~----------~~~~~~~~~~  201 (237)
T cd05576         144 VENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI------------NT----------HTTLNIPEWV  201 (237)
T ss_pred             cCccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc------------cc----------ccccCCcccC
Confidence            6778999999988889999999999999999999998875322100            00          0000112233


Q ss_pred             HHHHHHHHHHhhccCCCCCCCHHH
Q 046893          343 AMKVAGLAYQCLSQNPKGRPVMSD  366 (464)
Q Consensus       343 ~~~l~~li~~cl~~dP~~RPs~~e  366 (464)
                      +..+.+++.+||+.||.+||++.+
T Consensus       202 ~~~~~~li~~~l~~dp~~R~~~~~  225 (237)
T cd05576         202 SEEARSLLQQLLQFNPTERLGAGV  225 (237)
T ss_pred             CHHHHHHHHHHccCCHHHhcCCCc
Confidence            457889999999999999999743

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4e-35  Score=279.21  Aligned_cols=266  Identities=29%  Similarity=0.434  Sum_probs=202.2

Q ss_pred             HHHhcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCccHHHHHHHHHHHhc--CCCCCcceEEEEEE
Q 046893           88 KLATKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQ--LRHSNLVKLIGYCC  165 (464)
Q Consensus        88 ~~~~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~hpniv~l~~~~~  165 (464)
                      ..+.+...+.+.||+|.||.||+|.+.        |+.||||++..   .++..+.+|.+|.+.  |+|+||+.+++.-.
T Consensus       207 RTiarqI~L~e~IGkGRyGEVwrG~wr--------Ge~VAVKiF~s---rdE~SWfrEtEIYqTvmLRHENILgFIaaD~  275 (513)
T KOG2052|consen  207 RTIARQIVLQEIIGKGRFGEVWRGRWR--------GEDVAVKIFSS---RDERSWFRETEIYQTVMLRHENILGFIAADN  275 (513)
T ss_pred             HhhhheeEEEEEecCccccceeecccc--------CCceEEEEecc---cchhhhhhHHHHHHHHHhccchhhhhhhccc
Confidence            345566788899999999999999986        45699999865   345678888888876  49999999998765


Q ss_pred             eCC----eEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhc------CCCCeeeccCCCCceEecCC
Q 046893          166 EDE----HRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHG------AERPVIYRDFKTSNILLNAD  235 (464)
Q Consensus       166 ~~~----~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~------~~~~ivHrDlkp~Nill~~~  235 (464)
                      .++    .++||.+|.+.|+|+|||.+.   .++....+++++-++.||++||-      -+..|.|||||..|||+..+
T Consensus       276 ~~~gs~TQLwLvTdYHe~GSL~DyL~r~---tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn  352 (513)
T KOG2052|consen  276 KDNGSWTQLWLVTDYHEHGSLYDYLNRN---TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKN  352 (513)
T ss_pred             cCCCceEEEEEeeecccCCcHHHHHhhc---cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccC
Confidence            543    579999999999999999874   59999999999999999999993      24569999999999999999


Q ss_pred             CceEEcccCCccCCCCCC--CcceeeccccCCcccCccccccC----CCC--cccchhcHHHHHHHHHhC----------
Q 046893          236 FSAKLSDFGLAKDGPMGD--QTHVSTRVMGTYGYAAPEYVMTG----HLT--ARSDVYGFGVVLLEMLLG----------  297 (464)
Q Consensus       236 ~~vkl~DFGla~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~----~~~--~~~DvwslG~il~ell~g----------  297 (464)
                      +.+-|+|+|||.......  .....+..+||.+|||||++...    .|.  ..+||||||.++||+...          
T Consensus       353 ~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey  432 (513)
T KOG2052|consen  353 GTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEY  432 (513)
T ss_pred             CcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhh
Confidence            999999999998654331  12234457899999999988542    222  358999999999999853          


Q ss_pred             CCCCCCCCCcccccHHHHHHHhhhcccchh--hccCccccCcc-CHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHH
Q 046893          298 RRAVDKSRPSREHNLVEWARPLLNNNKKVL--RILDPRLEGQY-TARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETV  374 (464)
Q Consensus       298 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~-~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~  374 (464)
                      +.||.+..+.+..         +++-+++.  +.+.|.+...+ ...+...+.+||+.||..+|..|.|+-.+.+.|.++
T Consensus       433 ~~Pyyd~Vp~DPs---------~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l  503 (513)
T KOG2052|consen  433 QLPYYDVVPSDPS---------FEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKL  503 (513)
T ss_pred             cCCcccCCCCCCC---------HHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHH
Confidence            4566654433211         11111111  11222222222 234566899999999999999999999999999887


Q ss_pred             Hh
Q 046893          375 QS  376 (464)
Q Consensus       375 ~~  376 (464)
                      .+
T Consensus       504 ~~  505 (513)
T KOG2052|consen  504 SN  505 (513)
T ss_pred             hc
Confidence            64

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.3e-36  Score=269.73  Aligned_cols=268  Identities=24%  Similarity=0.315  Sum_probs=193.2

Q ss_pred             CCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCC--CCccHHHHHHHHHHHhcCCCCCcceEEEEEEe----
Q 046893           93 FFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRG--GYQGDREWLAEVNYLGQLRHSNLVKLIGYCCE----  166 (464)
Q Consensus        93 ~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~----  166 (464)
                      .|+-..+||+|.||.||+|+..++      ++.||+|++--+  ...-....++|+++|..|.|+|++.+++.|..    
T Consensus        18 ~yek~~kigqGtfgeVFkAr~~n~------~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp   91 (376)
T KOG0669|consen   18 KYEKLAKIGQGTFGEVFKARSKNT------GKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATP   91 (376)
T ss_pred             HHHHHHhcCCchHHHHHHHhhcCc------cchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCC
Confidence            355567899999999999987765      566888775332  11122456899999999999999999887643    


Q ss_pred             ----CCeEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcc
Q 046893          167 ----DEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSD  242 (464)
Q Consensus       167 ----~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~D  242 (464)
                          ....||||.+|+. +|.-+|... ...++..++..++.+++.||.|+|  ...|+|||+||+|+||+.+|.+||+|
T Consensus        92 ~~r~r~t~ylVf~~ceh-DLaGlLsn~-~vr~sls~Ikk~Mk~Lm~GL~~iH--r~kilHRDmKaaNvLIt~dgilklAD  167 (376)
T KOG0669|consen   92 TNRDRATFYLVFDFCEH-DLAGLLSNR-KVRFSLSEIKKVMKGLMNGLYYIH--RNKILHRDMKAANVLITKDGILKLAD  167 (376)
T ss_pred             cccccceeeeeHHHhhh-hHHHHhcCc-cccccHHHHHHHHHHHHHHHHHHH--HhhHHhhcccHhhEEEcCCceEEeec
Confidence                2358999999965 888877654 346999999999999999999999  45599999999999999999999999


Q ss_pred             cCCccCCCCCCCc--ceeeccccCCcccCcccccc-CCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHH---
Q 046893          243 FGLAKDGPMGDQT--HVSTRVMGTYGYAAPEYVMT-GHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWA---  316 (464)
Q Consensus       243 FGla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~---  316 (464)
                      ||+++.+...+..  ...+..+-|.+|++||.+.| ..|+.+.|||.-|||+.||+++.+.|.+........++...   
T Consensus       168 FGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs  247 (376)
T KOG0669|consen  168 FGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGS  247 (376)
T ss_pred             cccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhcc
Confidence            9999865443221  11233456999999999887 47999999999999999999999988876543333332211   


Q ss_pred             -----HHhhhcccchhhcc-CccccCccC--------HHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 046893          317 -----RPLLNNNKKVLRIL-DPRLEGQYT--------ARTAMKVAGLAYQCLSQNPKGRPVMSDVVAL  370 (464)
Q Consensus       317 -----~~~~~~~~~~~~~~-~~~~~~~~~--------~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  370 (464)
                           |+.++.-.....+- .|...+.+.        -....+..+|+.++|..||.+|+++++++..
T Consensus       248 ~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh  315 (376)
T KOG0669|consen  248 ITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNH  315 (376)
T ss_pred             CCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhch
Confidence                 11111100000110 111111100        0012367789999999999999999998753

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=100.00  E-value=1.8e-33  Score=263.08  Aligned_cols=239  Identities=28%  Similarity=0.388  Sum_probs=191.8

Q ss_pred             CceEEEEEEecCCCCCCccceEEEEEEccCCCCcc-HHHHHHHHHHHhcCCCCCcceEEEEEEeCCeEEEEEeccCCCCH
Q 046893          104 GFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQG-DREWLAEVNYLGQLRHSNLVKLIGYCCEDEHRILVYEYMESGSL  182 (464)
Q Consensus       104 ~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g~L  182 (464)
                      +||.||+|.+..+      ++.+|+|++....... ...+..|++.++.++|+||+++++++......+++|||+.+++|
T Consensus         1 ~~g~v~~~~~~~~------~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L   74 (244)
T smart00220        1 SFGKVYLARDKKT------GKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDL   74 (244)
T ss_pred             CceEEEEEEECCC------CcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCH
Confidence            5899999998764      5679999987655444 57889999999999999999999999999999999999999999


Q ss_pred             HHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCccCCCCCCCcceeeccc
Q 046893          183 EKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVM  262 (464)
Q Consensus       183 ~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~~~~~~~~~  262 (464)
                      ..++....  .+++..++.++.+++.+|.|||  ..+++|+||+|.||+++.++.++|+|||++.......   ......
T Consensus        75 ~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh--~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~  147 (244)
T smart00220       75 FDLLKKRG--RLSEDEARFYARQILSALEYLH--SNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLTTFV  147 (244)
T ss_pred             HHHHHhcc--CCCHHHHHHHHHHHHHHHHHHH--HcCeecCCcCHHHeEECCCCcEEEccccceeeecccc---cccccc
Confidence            99887643  3899999999999999999999  5679999999999999999999999999998644322   223467


Q ss_pred             cCCcccCccccccCCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhcccchhhccCccccCccCHHH
Q 046893          263 GTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRILDPRLEGQYTART  342 (464)
Q Consensus       263 gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  342 (464)
                      ++..|++||.+.+..++.++||||||+++|+|++|..||......  ....++..   .....      .   .......
T Consensus       148 ~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~--~~~~~~~~---~~~~~------~---~~~~~~~  213 (244)
T smart00220      148 GTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQL--LELFKKIG---KPKPP------F---PPPEWKI  213 (244)
T ss_pred             CCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcH--HHHHHHHh---ccCCC------C---ccccccC
Confidence            889999999998888999999999999999999999999753111  11111110   00000      0   0000004


Q ss_pred             HHHHHHHHHHhhccCCCCCCCHHHHHH
Q 046893          343 AMKVAGLAYQCLSQNPKGRPVMSDVVA  369 (464)
Q Consensus       343 ~~~l~~li~~cl~~dP~~RPs~~ev~~  369 (464)
                      +..+.+++.+||..+|++||++.++++
T Consensus       214 ~~~~~~~i~~~l~~~p~~Rp~~~~~~~  240 (244)
T smart00220      214 SPEAKDLIRKLLVKDPEKRLTAEEALQ  240 (244)
T ss_pred             CHHHHHHHHHHccCCchhccCHHHHhh
Confidence            458899999999999999999999985

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=100.00  E-value=9e-34  Score=295.92  Aligned_cols=264  Identities=22%  Similarity=0.261  Sum_probs=169.5

Q ss_pred             HhcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCccHHHHHHHHHHHhcCCCCCcceEEEE------
Q 046893           90 ATKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVKLIGY------  163 (464)
Q Consensus        90 ~~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~------  163 (464)
                      ..++|.+.+.||+|+||.||+|++..+..  ..+..||+|.+.....  .+.+..|  .+....+.+++.++..      
T Consensus       130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~--~~~~~vAvK~~~~~~~--~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~  203 (566)
T PLN03225        130 KKDDFVLGKKLGEGAFGVVYKASLVNKQS--KKEGKYVLKKATEYGA--VEIWMNE--RVRRACPNSCADFVYGFLEPVS  203 (566)
T ss_pred             ccCCeEEeEEEeeCCCeEEEEEEEcCCcc--ccCcEEEEEEecccch--hHHHHHH--HHHhhchhhHHHHHHhhhcccc
Confidence            45789999999999999999999876422  2356799998764321  1222221  1222222233222221      


Q ss_pred             EEeCCeEEEEEeccCCCCHHHHHHhhcCC------------------CCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccC
Q 046893          164 CCEDEHRILVYEYMESGSLEKHLLRRVGC------------------MLTWSRRMKIALDAAKGLAFLHGAERPVIYRDF  225 (464)
Q Consensus       164 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~------------------~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDl  225 (464)
                      ...+...+|||||+.+++|.+++......                  ......+..++.|++.||.|||  +++|+||||
T Consensus       204 ~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH--~~gIiHRDL  281 (566)
T PLN03225        204 SKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLH--STGIVHRDV  281 (566)
T ss_pred             cccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHH--HCCEEeCcC
Confidence            24556789999999999999988653210                  1123345679999999999999  677999999


Q ss_pred             CCCceEecC-CCceEEcccCCccCCCCCCCcceeeccccCCcccCccccccC----------------------CCCccc
Q 046893          226 KTSNILLNA-DFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTG----------------------HLTARS  282 (464)
Q Consensus       226 kp~Nill~~-~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~~~~~  282 (464)
                      ||+||||+. ++.+||+|||+|+...... ......++|++.|+|||.+...                      .++.++
T Consensus       282 KP~NILl~~~~~~~KL~DFGlA~~l~~~~-~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~  360 (566)
T PLN03225        282 KPQNIIFSEGSGSFKIIDLGAAADLRVGI-NYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRF  360 (566)
T ss_pred             CHHHEEEeCCCCcEEEEeCCCcccccccc-ccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCc
Confidence            999999985 5789999999998643322 2223457899999999965322                      244567


Q ss_pred             chhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhccc---chhhccCccccCc------cCHHHHHHHHHHHHHh
Q 046893          283 DVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNK---KVLRILDPRLEGQ------YTARTAMKVAGLAYQC  353 (464)
Q Consensus       283 DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~------~~~~~~~~l~~li~~c  353 (464)
                      |||||||+||||+++..++...       +..+...+.....   .....+.+.....      ..........+|+.+|
T Consensus       361 DVwSlGviL~el~~~~~~~~~~-------~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~m  433 (566)
T PLN03225        361 DIYSAGLIFLQMAFPNLRSDSN-------LIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSM  433 (566)
T ss_pred             ccHHHHHHHHHHHhCcCCCchH-------HHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHH
Confidence            9999999999999987664421       1111111000000   0001111110000      0001122456899999


Q ss_pred             hccCCCCCCCHHHHHH
Q 046893          354 LSQNPKGRPVMSDVVA  369 (464)
Q Consensus       354 l~~dP~~RPs~~ev~~  369 (464)
                      |+.||.+|||+.++++
T Consensus       434 L~~dP~kR~ta~e~L~  449 (566)
T PLN03225        434 MRFKGRQRISAKAALA  449 (566)
T ss_pred             ccCCcccCCCHHHHhC
Confidence            9999999999999986

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.1e-33  Score=267.32  Aligned_cols=265  Identities=22%  Similarity=0.301  Sum_probs=197.4

Q ss_pred             hcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCccHHHHHHHHHHHhcCC-----CC---CcceEEE
Q 046893           91 TKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLR-----HS---NLVKLIG  162 (464)
Q Consensus        91 ~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----hp---niv~l~~  162 (464)
                      ..+|.+.++||+|.|++||+|.+..+      .+.||+|+.+.. ..-.+..+.||++|+++.     |+   .||+|++
T Consensus        77 ~gRY~v~rKLGWGHFSTVWLawDtq~------~r~VAlKVvKSA-qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD  149 (590)
T KOG1290|consen   77 GGRYHVQRKLGWGHFSTVWLAWDTQN------KRYVALKVVKSA-QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLD  149 (590)
T ss_pred             CceEEEEEeccccccceeEEEeeccC------CeEEEEEEEehh-hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeec
Confidence            37899999999999999999999876      667999998753 222355688999999983     33   5999999


Q ss_pred             EEEeC----CeEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCC---
Q 046893          163 YCCED----EHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNAD---  235 (464)
Q Consensus       163 ~~~~~----~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~---  235 (464)
                      +|...    .++|||+|++ |.+|..+|....-..++...+..|+.||+.||.|||. +.+|||.||||+||||...   
T Consensus       150 ~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~-ecgIIHTDlKPENvLl~~~e~~  227 (590)
T KOG1290|consen  150 HFKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHR-ECGIIHTDLKPENVLLCSTEID  227 (590)
T ss_pred             cceecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHH-hcCccccCCCcceeeeeccccc
Confidence            99754    5899999999 8899999987766779999999999999999999996 6789999999999998300   


Q ss_pred             --------------------------------------------------------------------------------
Q 046893          236 --------------------------------------------------------------------------------  235 (464)
Q Consensus       236 --------------------------------------------------------------------------------  235 (464)
                                                                                                      
T Consensus       228 ~~~~~~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~~s~n~~~  307 (590)
T KOG1290|consen  228 PAKDAREAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQESYNNEP  307 (590)
T ss_pred             hhhhhhhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhccccccccccccccccccc
Confidence                                                                                            


Q ss_pred             --------------------------------------------------------------------------------
Q 046893          236 --------------------------------------------------------------------------------  235 (464)
Q Consensus       236 --------------------------------------------------------------------------------  235 (464)
                                                                                                      
T Consensus       308 ~~n~~~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v~p~~~~~  387 (590)
T KOG1290|consen  308 RINGNESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLVNPDIPLP  387 (590)
T ss_pred             CCCccccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccccccccCCCCCCC
Confidence                                                                                            


Q ss_pred             ---CceEEcccCCccCCCCCCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHhCCCCCCCCC---Cccc
Q 046893          236 ---FSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSR---PSRE  309 (464)
Q Consensus       236 ---~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~---~~~~  309 (464)
                         ..|||+|||-|....     ...+.-+.|..|+|||++.|..|+..+||||++|++|||+||...|+...   ....
T Consensus       388 ~~di~vKIaDlGNACW~~-----khFT~DIQTRQYRapEVllGsgY~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y~rD  462 (590)
T KOG1290|consen  388 ECDIRVKIADLGNACWVH-----KHFTEDIQTRQYRAPEVLLGSGYSTSADIWSTACMAFELATGDYLFEPHSGENYSRD  462 (590)
T ss_pred             ccceeEEEeeccchhhhh-----hhhchhhhhhhccCcceeecCCCCCchhHHHHHHHHHHhhcCceeecCCCCCCCCcc
Confidence               014555555554311     11122456788999999999999999999999999999999999886422   2222


Q ss_pred             ccHHHHH--------HHhhhcccchhhccCcc-----------------c--cCccCHHHHHHHHHHHHHhhccCCCCCC
Q 046893          310 HNLVEWA--------RPLLNNNKKVLRILDPR-----------------L--EGQYTARTAMKVAGLAYQCLSQNPKGRP  362 (464)
Q Consensus       310 ~~~~~~~--------~~~~~~~~~~~~~~~~~-----------------~--~~~~~~~~~~~l~~li~~cl~~dP~~RP  362 (464)
                      .+.+..+        +.+...++....+++..                 +  ...++...+.++.+|+.-||+.+|++||
T Consensus       463 EDHiA~i~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLef~PeKR~  542 (590)
T KOG1290|consen  463 EDHIALIMELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLEFDPEKRP  542 (590)
T ss_pred             HHHHHHHHHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHhcCccccc
Confidence            2211111        11111111111122111                 0  1245677788999999999999999999


Q ss_pred             CHHHHHH
Q 046893          363 VMSDVVA  369 (464)
Q Consensus       363 s~~ev~~  369 (464)
                      |+.+++.
T Consensus       543 tA~~cl~  549 (590)
T KOG1290|consen  543 TAAQCLK  549 (590)
T ss_pred             cHHHHhc
Confidence            9999874

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=100.00  E-value=5.5e-34  Score=246.24  Aligned_cols=206  Identities=27%  Similarity=0.328  Sum_probs=167.1

Q ss_pred             HHHhcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCC-CccHHHHHHHHHHHhcC-CCCCcceEEEEEE
Q 046893           88 KLATKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGG-YQGDREWLAEVNYLGQL-RHSNLVKLIGYCC  165 (464)
Q Consensus        88 ~~~~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~  165 (464)
                      ++..+....+..||+|+||.|-+-++..      .++..|+|.+.... ...++++++|+++..+. .+|.+|.+|+.+.
T Consensus        42 eV~ad~L~~i~elGrGayG~vekmrh~~------sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~  115 (282)
T KOG0984|consen   42 EVPADDLVGIEELGRGAYGVVEKMRHIQ------SGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALF  115 (282)
T ss_pred             ccchhhhhhhhhhcCCccchhhheeecc------CCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhh
Confidence            4444555666779999999998776655      48999999987543 23446788899887665 7999999999999


Q ss_pred             eCCeEEEEEeccCCCCHHHHHHh--hcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEccc
Q 046893          166 EDEHRILVYEYMESGSLEKHLLR--RVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDF  243 (464)
Q Consensus       166 ~~~~~~lv~e~~~~g~L~~~l~~--~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DF  243 (464)
                      .....++.||.|+ .+|..+..+  ..+..+++..+-+|+..+..||.|||+ +..+||||+||+||||+.+|+||||||
T Consensus       116 regdvwIcME~M~-tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~-kL~vIHRDvKPsNiLIn~~GqVKiCDF  193 (282)
T KOG0984|consen  116 REGDVWICMELMD-TSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHS-KLSVIHRDVKPSNILINYDGQVKICDF  193 (282)
T ss_pred             ccccEEEeHHHhh-hhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHH-HhhhhhccCCcceEEEccCCcEEEccc
Confidence            9999999999994 488665543  236689999999999999999999996 667999999999999999999999999


Q ss_pred             CCccCCCCCCCcceeeccccCCcccCcccccc----CCCCcccchhcHHHHHHHHHhCCCCCCCC
Q 046893          244 GLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMT----GHLTARSDVYGFGVVLLEMLLGRRAVDKS  304 (464)
Q Consensus       244 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~DvwslG~il~ell~g~~pf~~~  304 (464)
                      |++......-.   .+--.|-..|||||.+..    ..|+-++||||||+++.||.+++.||+..
T Consensus       194 GIsG~L~dSiA---kt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w  255 (282)
T KOG0984|consen  194 GISGYLVDSIA---KTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESW  255 (282)
T ss_pred             ccceeehhhhH---HHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhcccccccc
Confidence            99975432211   111457778999998853    47999999999999999999999999764

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=100.00  E-value=1.2e-32  Score=280.77  Aligned_cols=267  Identities=21%  Similarity=0.288  Sum_probs=181.3

Q ss_pred             HHhcCCCCCCceeecCceEEEEEEecCCCC----------CCccceEEEEEEccCCCCccHHH--------------HHH
Q 046893           89 LATKFFRPDYILGEGGFGVVYKGVIDENVR----------PGYKTTFVAIKELNRGGYQGDRE--------------WLA  144 (464)
Q Consensus        89 ~~~~~~~~~~~lG~G~fg~Vy~a~~~~~~~----------~~~~~~~vavK~~~~~~~~~~~~--------------~~~  144 (464)
                      ...++|.+.++||+|+||+||+|.+.....          ....+..||||.+.........+              ...
T Consensus       142 ~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~v  221 (507)
T PLN03224        142 WSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMV  221 (507)
T ss_pred             ccccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHH
Confidence            356789999999999999999997633211          11234679999986543222222              334


Q ss_pred             HHHHHhcCCCCCc-----ceEEEEEEe--------CCeEEEEEeccCCCCHHHHHHhhcC--------------------
Q 046893          145 EVNYLGQLRHSNL-----VKLIGYCCE--------DEHRILVYEYMESGSLEKHLLRRVG--------------------  191 (464)
Q Consensus       145 E~~~l~~l~hpni-----v~l~~~~~~--------~~~~~lv~e~~~~g~L~~~l~~~~~--------------------  191 (464)
                      |+.++.+++|.++     ++++++|..        ....+|||||+.+++|.+++....+                    
T Consensus       222 E~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~  301 (507)
T PLN03224        222 EAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNM  301 (507)
T ss_pred             HHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhc
Confidence            6667777766544     667777653        3568999999999999998864321                    


Q ss_pred             --CCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCccCCCCCCCcceeeccccCCcccC
Q 046893          192 --CMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAA  269 (464)
Q Consensus       192 --~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~a  269 (464)
                        ..+++..+..++.|++.+|.|||  ..+|+||||||+|||++.++.+||+|||+++........ ......+|+.|+|
T Consensus       302 ~~~~~~~~~~~~i~~ql~~aL~~lH--~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~-~~~~g~~tp~Y~a  378 (507)
T PLN03224        302 PQDKRDINVIKGVMRQVLTGLRKLH--RIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINF-NPLYGMLDPRYSP  378 (507)
T ss_pred             ccccCCHHHHHHHHHHHHHHHHHHH--HCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCcc-CccccCCCcceeC
Confidence              12456788899999999999999  567999999999999999999999999999754322211 1112345789999


Q ss_pred             ccccccCC--------------------CC--cccchhcHHHHHHHHHhCCC-CCCCCCCccc------ccHHHHHHHhh
Q 046893          270 PEYVMTGH--------------------LT--ARSDVYGFGVVLLEMLLGRR-AVDKSRPSRE------HNLVEWARPLL  320 (464)
Q Consensus       270 PE~~~~~~--------------------~~--~~~DvwslG~il~ell~g~~-pf~~~~~~~~------~~~~~~~~~~~  320 (464)
                      ||.+....                    |+  .+.||||+||+||+|++|.. ||........      ..+..|..  .
T Consensus       379 PE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~--~  456 (507)
T PLN03224        379 PEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRM--Y  456 (507)
T ss_pred             hhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHh--h
Confidence            99875322                    11  24799999999999999875 6653221110      01111110  0


Q ss_pred             hcccchhhccCccccCccCHHHHHHHHHHHHHhhccCC---CCCCCHHHHHH
Q 046893          321 NNNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNP---KGRPVMSDVVA  369 (464)
Q Consensus       321 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP---~~RPs~~ev~~  369 (464)
                      .         .....-...........+|+.+||..+|   .+|+|+.++++
T Consensus       457 ~---------~~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~  499 (507)
T PLN03224        457 K---------GQKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALS  499 (507)
T ss_pred             c---------ccCCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhC
Confidence            0         0001111122345578899999999866   68999999875

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-34  Score=259.42  Aligned_cols=264  Identities=24%  Similarity=0.352  Sum_probs=193.0

Q ss_pred             CCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCC--CCccHHHHHHHHHHHhcCCCCCcceEEEEEEeCC---
Q 046893           94 FRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRG--GYQGDREWLAEVNYLGQLRHSNLVKLIGYCCEDE---  168 (464)
Q Consensus        94 ~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~---  168 (464)
                      .+..+.||-|+||.||.+++..+      ++.||+|++..-  ....-+.+.+|+++|..++|.|++..+++.....   
T Consensus        55 i~PDRPIGYGAFGVVWsVTDPRd------grrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~df  128 (449)
T KOG0664|consen   55 IQPDRPIGYGAFGVVWSVTDPRS------GKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSF  128 (449)
T ss_pred             CCCCCcccccceeEEEeccCCCC------ccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchH
Confidence            34567799999999999988765      666999987542  1223467889999999999999999988765543   


Q ss_pred             --eEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCc
Q 046893          169 --HRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLA  246 (464)
Q Consensus       169 --~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla  246 (464)
                        ..|+|.|+|.. +|...|...  ..++...+.-+++||++||+|||++  +|+||||||.|.|++.+..+||||||++
T Consensus       129 FqEiYV~TELmQS-DLHKIIVSP--Q~Ls~DHvKVFlYQILRGLKYLHsA--~ILHRDIKPGNLLVNSNCvLKICDFGLA  203 (449)
T KOG0664|consen  129 FQELYVLTELMQS-DLHKIIVSP--QALTPDHVKVFVYQILRGLKYLHTA--NILHRDIKPGNLLVNSNCILKICDFGLA  203 (449)
T ss_pred             HHHHHHHHHHHHh-hhhheeccC--CCCCcchhhhhHHHHHhhhHHHhhc--chhhccCCCccEEeccCceEEecccccc
Confidence              35778898854 787766543  3688889999999999999999964  4999999999999999999999999999


Q ss_pred             cCCCCCCCcceeeccccCCcccCccccccC-CCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHH--Hh----
Q 046893          247 KDGPMGDQTHVSTRVMGTYGYAAPEYVMTG-HLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWAR--PL----  319 (464)
Q Consensus       247 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~--~~----  319 (464)
                      +.....+.. .++..+-|.+|+|||+++|. .|+...||||.|||+.||+..+..|....+....+++....  +.    
T Consensus       204 Rvee~d~~~-hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaM  282 (449)
T KOG0664|consen  204 RTWDQRDRL-NMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAM  282 (449)
T ss_pred             cccchhhhh-hhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHH
Confidence            976554433 34456778999999999885 69999999999999999999999998776655443332111  00    


Q ss_pred             --hhcccchhhccC-----ccccC----ccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 046893          320 --LNNNKKVLRILD-----PRLEG----QYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVAL  370 (464)
Q Consensus       320 --~~~~~~~~~~~~-----~~~~~----~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  370 (464)
                        ..++.+ ..++.     |.+.-    .-+.....+...++.+++..||++|.+..+.+..
T Consensus       283 r~ACEGAk-~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~  343 (449)
T KOG0664|consen  283 KYACEGAK-NHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQH  343 (449)
T ss_pred             HHHhhhhH-HHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccc
Confidence              000000 01111     11100    0011222355678888999999999888776643

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=99.98  E-value=4.5e-33  Score=282.98  Aligned_cols=244  Identities=28%  Similarity=0.397  Sum_probs=183.3

Q ss_pred             CCCCCceeecCceE-EEEEEecCCCCCCccceEEEEEEccCCCCccHHHHHHHHHHHhcC-CCCCcceEEEEEEeCCeEE
Q 046893           94 FRPDYILGEGGFGV-VYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQL-RHSNLVKLIGYCCEDEHRI  171 (464)
Q Consensus        94 ~~~~~~lG~G~fg~-Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~  171 (464)
                      |...+++|.|+-|+ ||+|...        ++.||||.+-..   -.....+|+.+|+.- .|||||++++.-.++...|
T Consensus       511 ~~~~eilG~Gs~Gt~Vf~G~ye--------~R~VAVKrll~e---~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~Y  579 (903)
T KOG1027|consen  511 FSPKEILGYGSNGTVVFRGVYE--------GREVAVKRLLEE---FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLY  579 (903)
T ss_pred             eccHHHcccCCCCcEEEEEeeC--------CceehHHHHhhH---hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEE
Confidence            44445699999887 8999875        456999988542   223457899999888 6999999999888999999


Q ss_pred             EEEeccCCCCHHHHHHhh--cCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecC---C--CceEEcccC
Q 046893          172 LVYEYMESGSLEKHLLRR--VGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNA---D--FSAKLSDFG  244 (464)
Q Consensus       172 lv~e~~~~g~L~~~l~~~--~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~---~--~~vkl~DFG  244 (464)
                      |..|+| ..+|.+++...  ..........+.+..|++.||++||+  .+||||||||.||||+.   +  ..++|+|||
T Consensus       580 IalELC-~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHs--l~iVHRDLkPQNILI~~~~~~~~~ra~iSDfg  656 (903)
T KOG1027|consen  580 IALELC-ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHS--LKIVHRDLKPQNILISVPSADGTLRAKISDFG  656 (903)
T ss_pred             EEehHh-hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHh--cccccccCCCceEEEEccCCCcceeEEecccc
Confidence            999999 55999999763  11112224457788999999999996  55999999999999965   3  468999999


Q ss_pred             CccCCCCCCCc-ceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHhC-CCCCCCCCCcccccHHHHHHHhhhc
Q 046893          245 LAKDGPMGDQT-HVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLG-RRAVDKSRPSREHNLVEWARPLLNN  322 (464)
Q Consensus       245 la~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g-~~pf~~~~~~~~~~~~~~~~~~~~~  322 (464)
                      +++....+... .......||.+|+|||++....-+.++|||||||++|+.++| ..||...-.. ..+       ++..
T Consensus       657 lsKkl~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R-~~N-------Il~~  728 (903)
T KOG1027|consen  657 LSKKLAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLER-QAN-------ILTG  728 (903)
T ss_pred             cccccCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHh-hhh-------hhcC
Confidence            99987654322 224457899999999999988888899999999999999995 8899753211 111       1111


Q ss_pred             ccchhhccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHH
Q 046893          323 NKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVV  368 (464)
Q Consensus       323 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~  368 (464)
                      +..+..+ .+.     . .+  +..+||.+|++.+|..||++.+|+
T Consensus       729 ~~~L~~L-~~~-----~-d~--eA~dLI~~ml~~dP~~RPsa~~VL  765 (903)
T KOG1027|consen  729 NYTLVHL-EPL-----P-DC--EAKDLISRMLNPDPQLRPSATDVL  765 (903)
T ss_pred             ccceeee-ccC-----c-hH--HHHHHHHHhcCCCcccCCCHHHHh
Confidence            1111111 111     1 11  678999999999999999999997

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=99.98  E-value=3.8e-33  Score=269.55  Aligned_cols=212  Identities=23%  Similarity=0.222  Sum_probs=177.0

Q ss_pred             ccchhHHHHHhcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCccHHHHHHHHHHHhcCC------C
Q 046893           81 IFTYNEMKLATKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLR------H  154 (464)
Q Consensus        81 ~~~~~~~~~~~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~------h  154 (464)
                      +|.+.-.++...+|.+....|+|-|++|..|.+...      +..||||++..+.. ..+.=+.|++||+.|+      .
T Consensus       421 YYrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r------~~~vAiKIIRnNE~-M~KtGl~EleiLkKL~~AD~Edk  493 (752)
T KOG0670|consen  421 YYRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQAR------GQEVAIKIIRNNEV-MHKTGLKELEILKKLNDADPEDK  493 (752)
T ss_pred             eEEEehhhhhcceeEEEeccccceeeeeeeccccCC------CCeeEEEEeecchH-HhhhhhHHHHHHHHhhccCchhh
Confidence            567778889999999999999999999999988764      45799999976532 2344468999999995      2


Q ss_pred             CCcceEEEEEEeCCeEEEEEeccCCCCHHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEec
Q 046893          155 SNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRV-GCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLN  233 (464)
Q Consensus       155 pniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~  233 (464)
                      -++++|+..|...+++|||||-+ .-+|.++|.+.. +..|....+..++.|++.||..|-  ..+|+|.||||.|||++
T Consensus       494 ~Hclrl~r~F~hknHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK--~c~vlHaDIKPDNiLVN  570 (752)
T KOG0670|consen  494 FHCLRLFRHFKHKNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLK--KCGVLHADIKPDNILVN  570 (752)
T ss_pred             hHHHHHHHHhhhcceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHH--hcCeeecccCccceEec
Confidence            47999999999999999999988 558998887643 346888899999999999999999  56699999999999998


Q ss_pred             CCC-ceEEcccCCccCCCCCCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHhCCCCCCCCCC
Q 046893          234 ADF-SAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRP  306 (464)
Q Consensus       234 ~~~-~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~  306 (464)
                      +.. .+||||||.|-.......+    .+.-+..|.|||++.|..|+...|+||.||+||||.||+..|.+...
T Consensus       571 E~k~iLKLCDfGSA~~~~eneit----PYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TN  640 (752)
T KOG0670|consen  571 ESKNILKLCDFGSASFASENEIT----PYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTN  640 (752)
T ss_pred             cCcceeeeccCcccccccccccc----HHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCc
Confidence            764 5799999999865433322    23445569999999999999999999999999999999999987543

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.98  E-value=1.3e-33  Score=280.07  Aligned_cols=252  Identities=23%  Similarity=0.307  Sum_probs=205.0

Q ss_pred             cCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCccHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeEE
Q 046893           92 KFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVKLIGYCCEDEHRI  171 (464)
Q Consensus        92 ~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~  171 (464)
                      .+|.+.+.+|.|+||.||+|++...      ++..|+|+++.+......-+..|+-+++..+||||+.+++.+......+
T Consensus        15 ddyellqrvgsgTygdvyKaRd~~s------~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklw   88 (829)
T KOG0576|consen   15 DDYELLQRVGSGTYGDVYKARDKRS------GELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLW   88 (829)
T ss_pred             cchhheeeecCCcccchhhhccccc------CchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcE
Confidence            4688899999999999999998765      7779999998877676777889999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCccCCCC
Q 046893          172 LVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPM  251 (464)
Q Consensus       172 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~  251 (464)
                      +.||||.+|+|.+..+  ...++++.++..++...+.||+|||  +++-+|||||-.|||+++.|.+|+.|||.+-.+..
T Consensus        89 icMEycgggslQdiy~--~TgplselqiayvcRetl~gl~ylh--s~gk~hRdiKGanilltd~gDvklaDfgvsaqita  164 (829)
T KOG0576|consen   89 ICMEYCGGGSLQDIYH--VTGPLSELQIAYVCRETLQGLKYLH--SQGKIHRDIKGANILLTDEGDVKLADFGVSAQITA  164 (829)
T ss_pred             EEEEecCCCcccceee--ecccchhHHHHHHHhhhhccchhhh--cCCcccccccccceeecccCceeecccCchhhhhh
Confidence            9999999999988543  3457999999999999999999999  56689999999999999999999999999875432


Q ss_pred             CCCcceeeccccCCcccCcccc---ccCCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhcccchhh
Q 046893          252 GDQTHVSTRVMGTYGYAAPEYV---MTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLR  328 (464)
Q Consensus       252 ~~~~~~~~~~~gt~~y~aPE~~---~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  328 (464)
                        .......+.||++|||||+.   +.+.|...+|||++|++..|+-.-++|.....+.....+..      ..      
T Consensus       165 --ti~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmT------kS------  230 (829)
T KOG0576|consen  165 --TIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMT------KS------  230 (829)
T ss_pred             --hhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhh------cc------
Confidence              22234458999999999976   45789999999999999999998888876555433221111      11      


Q ss_pred             ccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHH
Q 046893          329 ILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVV  368 (464)
Q Consensus       329 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~  368 (464)
                      .+++.- -.-.......+.+|++.||..+|++||+++.++
T Consensus       231 ~~qpp~-lkDk~kws~~fh~fvK~altknpKkRptaeklL  269 (829)
T KOG0576|consen  231 GFQPPT-LKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLL  269 (829)
T ss_pred             CCCCCc-ccCCccchHHHHHHHHHHhcCCCccCCChhhhe
Confidence            111111 112334556899999999999999999998765

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.97  E-value=1.2e-32  Score=269.12  Aligned_cols=197  Identities=25%  Similarity=0.333  Sum_probs=167.8

Q ss_pred             cCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCccH--------HHHHHHHHHHhcCC---CCCcceE
Q 046893           92 KFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGD--------REWLAEVNYLGQLR---HSNLVKL  160 (464)
Q Consensus        92 ~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~--------~~~~~E~~~l~~l~---hpniv~l  160 (464)
                      ..|..++.||+|+||.|++|+++.+      ...|+||.+.++..-..        -.+-.|+.||..|+   |+||+++
T Consensus       561 s~yttlq~lG~GAyGkV~lai~K~n------~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKl  634 (772)
T KOG1152|consen  561 SDYTTLQPLGEGAYGKVNLAIHKEN------NYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKL  634 (772)
T ss_pred             ccceeeeeccccccceEEEeeeccc------ceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhh
Confidence            3488899999999999999999886      45699999977542211        11346999999997   9999999


Q ss_pred             EEEEEeCCeEEEEEecc-CCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceE
Q 046893          161 IGYCCEDEHRILVYEYM-ESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAK  239 (464)
Q Consensus       161 ~~~~~~~~~~~lv~e~~-~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vk  239 (464)
                      +++|++++++||+||-- +|-+|.++|..+.  .+.+.++..|+.|++.|+++||  +.+|||||||-+||+++.+|.+|
T Consensus       635 LdfFEddd~yyl~te~hg~gIDLFd~IE~kp--~m~E~eAk~IFkQV~agi~hlh--~~~ivhrdikdenvivd~~g~~k  710 (772)
T KOG1152|consen  635 LDFFEDDDYYYLETEVHGEGIDLFDFIEFKP--RMDEPEAKLIFKQVVAGIKHLH--DQGIVHRDIKDENVIVDSNGFVK  710 (772)
T ss_pred             hheeecCCeeEEEecCCCCCcchhhhhhccC--ccchHHHHHHHHHHHhcccccc--ccCceecccccccEEEecCCeEE
Confidence            99999999999999975 3458999997765  6999999999999999999999  67799999999999999999999


Q ss_pred             EcccCCccCCCCCCCcceeeccccCCcccCccccccCCCC-cccchhcHHHHHHHHHhCCCCCC
Q 046893          240 LSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLT-ARSDVYGFGVVLLEMLLGRRAVD  302 (464)
Q Consensus       240 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwslG~il~ell~g~~pf~  302 (464)
                      |+|||.|.....+.    ...++||..|.|||++.|..|- ..-|||+||++||-++....||.
T Consensus       711 lidfgsaa~~ksgp----fd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy  770 (772)
T KOG1152|consen  711 LIDFGSAAYTKSGP----FDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY  770 (772)
T ss_pred             EeeccchhhhcCCC----cceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence            99999987543332    2348999999999999887764 56899999999999999888875

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=99.97  E-value=3.6e-32  Score=238.42  Aligned_cols=259  Identities=19%  Similarity=0.285  Sum_probs=194.2

Q ss_pred             hcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCccHHHHHHHHHHHhcCC-CCCcceEEEEEEeC--
Q 046893           91 TKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLR-HSNLVKLIGYCCED--  167 (464)
Q Consensus        91 ~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~--  167 (464)
                      .++|++.+++|+|.|+.||.|....+      .+.++||+++.   -..+.+.+|+.||..|. ||||++++++..+.  
T Consensus        37 ~ddYeivrk~GRGKYSEVFeg~~~~~------~eK~ViKiLKP---VkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~S  107 (338)
T KOG0668|consen   37 QDDYEIVRKVGRGKYSEVFEGINITN------NEKCVIKILKP---VKKKKIKREIKILQNLRGGPNIIKLLDIVKDPES  107 (338)
T ss_pred             cchHHHHHHHcCccHhhHhcccccCC------CceEEEeeech---HHHHHHHHHHHHHHhccCCCCeeehhhhhcCccc
Confidence            46788999999999999999987665      56689999875   34577899999999997 99999999998765  


Q ss_pred             CeEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCC-CceEEcccCCc
Q 046893          168 EHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNAD-FSAKLSDFGLA  246 (464)
Q Consensus       168 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~-~~vkl~DFGla  246 (464)
                      ..+.||+||+++.+...+..     .|+.-.+...+.+++.||.|+|  +.||+|||+||.|++||.. ..++|+|+|+|
T Consensus       108 ktpaLiFE~v~n~Dfk~ly~-----tl~d~dIryY~~elLkALdyCH--S~GImHRDVKPhNvmIdh~~rkLrlIDWGLA  180 (338)
T KOG0668|consen  108 KTPSLIFEYVNNTDFKQLYP-----TLTDYDIRYYIYELLKALDYCH--SMGIMHRDVKPHNVMIDHELRKLRLIDWGLA  180 (338)
T ss_pred             cCchhHhhhhccccHHHHhh-----hhchhhHHHHHHHHHHHHhHHH--hcCcccccCCcceeeechhhceeeeeecchH
Confidence            46789999999877765432     4778888999999999999999  5779999999999999865 46999999999


Q ss_pred             cCCCCCCCcceeeccccCCcccCcccccc-CCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHh------
Q 046893          247 KDGPMGDQTHVSTRVMGTYGYAAPEYVMT-GHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPL------  319 (464)
Q Consensus       247 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~------  319 (464)
                      ..+..+.....   .+.+..|-.||.+.. ..|+..-|+|||||+|..|++.+.||....... .+++..+.-+      
T Consensus       181 EFYHp~~eYnV---RVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~-DQLVkIakVLGt~el~  256 (338)
T KOG0668|consen  181 EFYHPGKEYNV---RVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNY-DQLVKIAKVLGTDELY  256 (338)
T ss_pred             hhcCCCceeee---eeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCH-HHHHHHHHHhChHHHH
Confidence            98765544332   345677899998865 458899999999999999999999997654322 2333333211      


Q ss_pred             -------hhcccchhhccCccccCc--------cCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 046893          320 -------LNNNKKVLRILDPRLEGQ--------YTARTAMKVAGLAYQCLSQNPKGRPVMSDVVA  369 (464)
Q Consensus       320 -------~~~~~~~~~~~~~~~~~~--------~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  369 (464)
                             +.-+.....++.......        -.--...+..+|+.+.|..|-.+|+|+.|.++
T Consensus       257 ~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~  321 (338)
T KOG0668|consen  257 AYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMA  321 (338)
T ss_pred             HHHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhc
Confidence                   111111111111100000        00112357889999999999999999999864

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=99.97  E-value=5.5e-32  Score=248.26  Aligned_cols=257  Identities=23%  Similarity=0.314  Sum_probs=193.4

Q ss_pred             hcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCC--CCccHHHHHHHHHHHhcCCCCCcceEEEEEEeCC
Q 046893           91 TKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRG--GYQGDREWLAEVNYLGQLRHSNLVKLIGYCCEDE  168 (464)
Q Consensus        91 ~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~  168 (464)
                      ..+|.-.+.+|.|.- .|..|.+.-.      +..||+|.+...  .....++..+|+.++..+.|+||++++.+|.-..
T Consensus        16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~------~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~   88 (369)
T KOG0665|consen   16 PKRYVNLKPIGSGAQ-IVVAAFDQVL------GRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQK   88 (369)
T ss_pred             eeeeeeecccCCCCc-eEEecchhhc------cCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccc
Confidence            356777788999988 6767766543      566999987654  2233467789999999999999999999987554


Q ss_pred             ------eEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcc
Q 046893          169 ------HRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSD  242 (464)
Q Consensus       169 ------~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~D  242 (464)
                            ..|+||||| ..+|...+..    .+.-.++..|++|+++|+.|||  ..+|+||||||+||++..++.+||.|
T Consensus        89 ~l~~~~e~y~v~e~m-~~nl~~vi~~----elDH~tis~i~yq~~~~ik~lh--s~~IihRdLkPsnivv~~~~~lKi~d  161 (369)
T KOG0665|consen   89 TLEEFQEVYLVMELM-DANLCQVILM----ELDHETISYILYQMLCGIKHLH--SAGIIHRDLKPSNIVVNSDCTLKILD  161 (369)
T ss_pred             cHHHHHhHHHHHHhh-hhHHHHHHHH----hcchHHHHHHHHHHHHHHHHHH--hcceeecccCcccceecchhheeecc
Confidence                  579999999 5599888873    3778889999999999999999  45699999999999999999999999


Q ss_pred             cCCccCCCCCCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHH----
Q 046893          243 FGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARP----  318 (464)
Q Consensus       243 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~----  318 (464)
                      ||+|+.....   -..+.++.|..|.|||++.+-.|...+||||+||++.||++|+..|.+...     +.+|.+-    
T Consensus       162 fg~ar~e~~~---~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~-----idQ~~ki~~~l  233 (369)
T KOG0665|consen  162 FGLARTEDTD---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDH-----IDQWNKIIEQL  233 (369)
T ss_pred             chhhcccCcc---cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchH-----HHHHHHHHHHh
Confidence            9999864332   345568899999999999998899999999999999999999999976432     2222210    


Q ss_pred             -----------------hhhccc-----chhhcc-CccccC--ccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 046893          319 -----------------LLNNNK-----KVLRIL-DPRLEG--QYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVA  369 (464)
Q Consensus       319 -----------------~~~~~~-----~~~~~~-~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  369 (464)
                                       +.....     ...+.+ |..+..  ...........+++.+||-.||++|-++.+++.
T Consensus       234 gtpd~~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~  309 (369)
T KOG0665|consen  234 GTPDPSFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALR  309 (369)
T ss_pred             cCCCHHHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhc
Confidence                             000000     000011 111111  111223447889999999999999999998874

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.97  E-value=2.3e-31  Score=238.78  Aligned_cols=254  Identities=20%  Similarity=0.314  Sum_probs=190.4

Q ss_pred             hcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCccHHHHHHHHHHHhcC-CCCCcceEEEE-EEeCC
Q 046893           91 TKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQL-RHSNLVKLIGY-CCEDE  168 (464)
Q Consensus        91 ~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~-~~~~~  168 (464)
                      .+.|.+.+.||+|.||.+-++.+...      .+.+++|.+.+. .....+|.+|...--.| .|.||+.-|++ |...+
T Consensus        23 ~d~y~I~k~lgeG~FgkIlL~eHr~s------~t~ivlKavp~p-~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d   95 (378)
T KOG1345|consen   23 EDVYTINKQLGEGRFGKILLAEHRQS------KTRIVLKAVPRP-QTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSD   95 (378)
T ss_pred             hhhhhHHHHhcccceeeEEeeeccCC------ceEEEeeccCcc-hhhHHHHHHHhccceeeccchhhhHHHHHHhhcCc
Confidence            45588899999999999999988765      677999998764 45678999999876666 48899988864 67778


Q ss_pred             eEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEe--cCCCceEEcccCCc
Q 046893          169 HRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILL--NADFSAKLSDFGLA  246 (464)
Q Consensus       169 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill--~~~~~vkl~DFGla  246 (464)
                      .++++|||++.|+|..-+...   .+.+.....++.|++.||.|+|  ++++||||||.+||||  .+..+|||||||+.
T Consensus        96 ~YvF~qE~aP~gdL~snv~~~---GigE~~~K~v~~ql~SAi~fMH--sknlVHRdlK~eNiLif~~df~rvKlcDFG~t  170 (378)
T KOG1345|consen   96 AYVFVQEFAPRGDLRSNVEAA---GIGEANTKKVFAQLLSAIEFMH--SKNLVHRDLKAENILIFDADFYRVKLCDFGLT  170 (378)
T ss_pred             eEEEeeccCccchhhhhcCcc---cccHHHHHHHHHHHHHHHHHhh--ccchhhcccccceEEEecCCccEEEeeecccc
Confidence            899999999999998766543   4788888999999999999999  6779999999999999  23458999999998


Q ss_pred             cCCCCCCCcceeeccccCCcccCccccccC-----CCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhh
Q 046893          247 KDGPMGDQTHVSTRVMGTYGYAAPEYVMTG-----HLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLN  321 (464)
Q Consensus       247 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~  321 (464)
                      +....     ......-+..|.+||.....     ...+.+|||.||+|+|.+|+|..||... ........+|....-.
T Consensus       171 ~k~g~-----tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka-~~~d~~Y~~~~~w~~r  244 (378)
T KOG1345|consen  171 RKVGT-----TVKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKA-SIMDKPYWEWEQWLKR  244 (378)
T ss_pred             cccCc-----eehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhh-hccCchHHHHHHHhcc
Confidence            85321     11123345679999977532     2456799999999999999999999843 3334445555443332


Q ss_pred             cccchhhccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 046893          322 NNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALL  371 (464)
Q Consensus       322 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L  371 (464)
                      ....+.+.+         ....+.+..++++-|..++++|--+.++.++.
T Consensus       245 k~~~~P~~F---------~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~r  285 (378)
T KOG1345|consen  245 KNPALPKKF---------NPFSEKALRLFKKSLTPRFKDRCKIWTAKKMR  285 (378)
T ss_pred             cCccCchhh---------cccCHHHHHHHHHhcCCcccccchhHHHHHHH
Confidence            222222221         12334677899999999999995555554443

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.97  E-value=4.9e-30  Score=233.86  Aligned_cols=211  Identities=35%  Similarity=0.545  Sum_probs=180.9

Q ss_pred             eeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCc-cHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeEEEEEeccC
Q 046893          100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQ-GDREWLAEVNYLGQLRHSNLVKLIGYCCEDEHRILVYEYME  178 (464)
Q Consensus       100 lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~  178 (464)
                      ||+|++|.||++.+..+      ++.+++|++...... ....+.+|+++++.+.|++|+++++++......+++||++.
T Consensus         1 l~~g~~~~v~~~~~~~~------~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~   74 (215)
T cd00180           1 LGEGGFGTVYLARDKKT------GKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCE   74 (215)
T ss_pred             CCcCCceEEEEEEecCC------CcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCC
Confidence            68999999999998753      566999998765332 24678899999999999999999999999999999999999


Q ss_pred             CCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecC-CCceEEcccCCccCCCCCCCcce
Q 046893          179 SGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNA-DFSAKLSDFGLAKDGPMGDQTHV  257 (464)
Q Consensus       179 ~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~-~~~vkl~DFGla~~~~~~~~~~~  257 (464)
                      +++|.+++.... ..+++..+..++.+++.+|.+||  ..+++|+||+|.||+++. ++.++|+|||.+........  .
T Consensus        75 ~~~l~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh--~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~  149 (215)
T cd00180          75 GGSLKDLLKENE-GKLSEDEILRILLQILEGLEYLH--SNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--L  149 (215)
T ss_pred             CCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHH--hCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--h
Confidence            899999887642 35899999999999999999999  567999999999999998 89999999999986433221  1


Q ss_pred             eeccccCCcccCccccccC-CCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhcccchhhccCccccC
Q 046893          258 STRVMGTYGYAAPEYVMTG-HLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRILDPRLEG  336 (464)
Q Consensus       258 ~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  336 (464)
                      .....+...|++||.+... .++.+.|+|+||+++++|                                          
T Consensus       150 ~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l------------------------------------------  187 (215)
T cd00180         150 LKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL------------------------------------------  187 (215)
T ss_pred             hhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH------------------------------------------
Confidence            2235678889999998877 888999999999999998                                          


Q ss_pred             ccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 046893          337 QYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVAL  370 (464)
Q Consensus       337 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  370 (464)
                             ..+.+++..|+..+|.+||++.++++.
T Consensus       188 -------~~~~~~l~~~l~~~p~~R~~~~~l~~~  214 (215)
T cd00180         188 -------PELKDLIRKMLQKDPEKRPSAKEILEH  214 (215)
T ss_pred             -------HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence                   267889999999999999999998864

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.97  E-value=5.3e-30  Score=236.09  Aligned_cols=265  Identities=21%  Similarity=0.226  Sum_probs=212.8

Q ss_pred             hcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCccHHHHHHHHHHHhcCC-CCCcceEEEEEEeCCe
Q 046893           91 TKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLR-HSNLVKLIGYCCEDEH  169 (464)
Q Consensus        91 ~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~  169 (464)
                      .-+|++.++||+|.||.++.|++.-+      ++.||||.....+.  .-++..|.+..+.|. .++|..++.|..++.+
T Consensus        27 G~hyrVGkKIGeGsFG~lf~G~Nl~n------ne~VAIKfEPrkS~--APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~   98 (449)
T KOG1165|consen   27 GPHYRVGKKIGEGSFGVLFLGKNLYN------NEPVAIKFEPRKSE--APQLRDEYRTYKLLGGTEGIPQVYYFGQEGKY   98 (449)
T ss_pred             cccceeccccccCcceeeeccccccc------CceEEEEeccccCC--cchHHHHHHHHHHHcCCCCCCceeeeccccch
Confidence            34699999999999999999987654      77899999876432  346677888888884 6899999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecC-----CCceEEcccC
Q 046893          170 RILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNA-----DFSAKLSDFG  244 (464)
Q Consensus       170 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~-----~~~vkl~DFG  244 (464)
                      -.||||++ |.+|+|+ ....+..|+..+++.+|.|++.-++|+|  .+.+|+|||||+|+||..     ...|.|+|||
T Consensus        99 NiLVidLL-GPSLEDL-FD~CgR~FSvKTV~miA~Qmi~rie~vH--~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFG  174 (449)
T KOG1165|consen   99 NILVIDLL-GPSLEDL-FDLCGRRFSVKTVAMIAKQMITRIEYVH--EKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFG  174 (449)
T ss_pred             hhhhhhhh-CcCHHHH-HHHhcCcccHHhHHHHHHHHHHHHHHHH--hcceeecccCccceeecCCCCCCCceEEEEecc
Confidence            99999999 8899985 5667889999999999999999999999  677999999999999953     3468999999


Q ss_pred             CccCCCCCCCc-----ceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHh
Q 046893          245 LAKDGPMGDQT-----HVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPL  319 (464)
Q Consensus       245 la~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~  319 (464)
                      +|+.+......     .......||.+||+-..++|.+.+.+.|+-|||.+++++|-|..||.+........-.+     
T Consensus       175 mAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYe-----  249 (449)
T KOG1165|consen  175 MAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYE-----  249 (449)
T ss_pred             chhhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHH-----
Confidence            99976544322     12334679999999999999999999999999999999999999998865433222111     


Q ss_pred             hhcccchhhccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhc
Q 046893          320 LNNNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETVQSQ  377 (464)
Q Consensus       320 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~~~~  377 (464)
                           ++.+.........++...|.++..-+.-.-..+..+-|+++-+..+|..+...
T Consensus       250 -----KIGe~Kr~T~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvldr  302 (449)
T KOG1165|consen  250 -----KIGETKRSTPIEVLCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLDR  302 (449)
T ss_pred             -----HhccccccCCHHHHHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHh
Confidence                 11111112222344556778899999999999999999999999988887654

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.97  E-value=1.9e-29  Score=233.42  Aligned_cols=200  Identities=33%  Similarity=0.440  Sum_probs=171.2

Q ss_pred             CCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCc-cHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeEEE
Q 046893           94 FRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQ-GDREWLAEVNYLGQLRHSNLVKLIGYCCEDEHRIL  172 (464)
Q Consensus        94 ~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l  172 (464)
                      |.+.+.||.|+||.||+|.+..+      +..+|+|.+...... ....+.+|+..+..++|+|++++++++......++
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~------~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~   74 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGT------GELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYL   74 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCC------CcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEE
Confidence            55677899999999999998764      466999999865444 45778899999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCccCCCCC
Q 046893          173 VYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMG  252 (464)
Q Consensus       173 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~  252 (464)
                      ++|++.+++|.+++..... .+++..+..++.+++.+|.|||  ..+++|+||+|.||+++.++.++|+|||++......
T Consensus        75 v~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh--~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~  151 (225)
T smart00221       75 VMEYCEGGDLFDYLRKKGG-KLSEEEARFYLRQILEALEYLH--SLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRD  151 (225)
T ss_pred             EEeccCCCCHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHH--hCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCc
Confidence            9999999999998876432 2789999999999999999999  567999999999999999999999999999865433


Q ss_pred             CCcceeeccccCCcccCcccc-ccCCCCcccchhcHHHHHHHHHhCCCCCCC
Q 046893          253 DQTHVSTRVMGTYGYAAPEYV-MTGHLTARSDVYGFGVVLLEMLLGRRAVDK  303 (464)
Q Consensus       253 ~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~~DvwslG~il~ell~g~~pf~~  303 (464)
                      ... ......++..|++||.+ ....++.++|||+||+++++|++|+.||..
T Consensus       152 ~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~  202 (225)
T smart00221      152 LAA-LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG  202 (225)
T ss_pred             ccc-cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence            211 22335688899999988 666788899999999999999999999965

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.96  E-value=9.3e-30  Score=224.95  Aligned_cols=267  Identities=19%  Similarity=0.186  Sum_probs=213.2

Q ss_pred             HHhcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCccHHHHHHHHHHHhcCCC-CCcceEEEEEEeC
Q 046893           89 LATKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRH-SNLVKLIGYCCED  167 (464)
Q Consensus        89 ~~~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-pniv~l~~~~~~~  167 (464)
                      +....|++++.||.|+||.+|.|.....      ++.||||+......  ..++..|.++...|++ ..|..+..++.+.
T Consensus        12 iv~gky~lvrkiGsGSFGdIy~~~~i~~------ge~VAiK~Es~~a~--hpqL~yEskvY~iL~~g~GiP~i~~y~~e~   83 (341)
T KOG1163|consen   12 IVGGKYKLVRKIGSGSFGDIYLGISITS------GEEVAIKLESSKAK--HPQLLYESKVYRILQGGVGIPHIRHYGTEK   83 (341)
T ss_pred             eeccceEEEEeecCCchhheeeeeeccC------CceEEEEeecccCC--CcchhHHHHHHHHhccCCCCchhhhhcccc
Confidence            4456799999999999999999998775      77799999865432  2467789999999975 6788888889999


Q ss_pred             CeEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCC---CceEEcccC
Q 046893          168 EHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNAD---FSAKLSDFG  244 (464)
Q Consensus       168 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~---~~vkl~DFG  244 (464)
                      .+-.|||+++ |.+|++++. .....++..+++.++-|++.-++|+|  .+++|||||||+|+|+.-+   ..+.|+|||
T Consensus        84 ~ynvlVMdLL-GPsLEdLfn-fC~R~ftmkTvLMLaDQml~RiEyvH--~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFG  159 (341)
T KOG1163|consen   84 DYNVLVMDLL-GPSLEDLFN-FCSRRFTMKTVLMLADQMLSRIEYVH--LRNFIHRDIKPDNFLMGLGRHCNKLYLIDFG  159 (341)
T ss_pred             ccceeeeecc-CccHHHHHH-HHhhhhhHHhHHHHHHHHHHHHHHHH--hhccccccCCccceeeccccccceEEEEecc
Confidence            9999999999 889988654 34557999999999999999999999  7889999999999999644   468999999


Q ss_pred             CccCCCCCCCc-----ceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHh
Q 046893          245 LAKDGPMGDQT-----HVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPL  319 (464)
Q Consensus       245 la~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~  319 (464)
                      +|+.+......     .......||.+|.+--.+.+.+.+.+.|+-|+|.+|.++.-|..||.+..+....+-.+.    
T Consensus       160 LaKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEk----  235 (341)
T KOG1163|consen  160 LAKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEK----  235 (341)
T ss_pred             chhhhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHH----
Confidence            99976543221     123447899999999999999999999999999999999999999998765544333222    


Q ss_pred             hhcccchhhccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhc
Q 046893          320 LNNNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETVQSQ  377 (464)
Q Consensus       320 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~~~~  377 (464)
                            +.+..-......++...|.++.-.+..|-..-.++-|++.-+..++..+...
T Consensus       236 ------I~EkK~s~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLfr~  287 (341)
T KOG1163|consen  236 ------ISEKKMSTPIEVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILFRT  287 (341)
T ss_pred             ------HHHhhcCCCHHHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHHhh
Confidence                  2222222233344555667888899999999999999999988888776653

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.96  E-value=1.2e-29  Score=241.00  Aligned_cols=272  Identities=26%  Similarity=0.360  Sum_probs=200.4

Q ss_pred             hHHHHHhcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCccHHHHHHHHHHHhcC-CCCCcceEEEE
Q 046893           85 NEMKLATKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQL-RHSNLVKLIGY  163 (464)
Q Consensus        85 ~~~~~~~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~  163 (464)
                      ..+....+.|....+||+|.|++||+|++...   ......||+|.+...  .....+..|+++|..+ -+.||+++.++
T Consensus        29 q~~p~~~~~~~~v~kigeGsFssv~~a~~~~~---~~~~~~valk~i~~t--s~p~ri~~El~~L~~~gG~~ni~~~~~~  103 (418)
T KOG1167|consen   29 QDIPFISNAYKVVNKIGEGSFSSVYKATDIEQ---DTKRRYVALKAIYRT--SSPSRILNELEMLYRLGGSDNIIKLNGC  103 (418)
T ss_pred             hhhhhhhhhhhhhccccccchhhhhhhhHhhh---ccccceEeeeecccc--cCchHHHHHHHHHHHhccchhhhcchhh
Confidence            34566778899999999999999999987762   234678999998764  3446789999999999 48999999999


Q ss_pred             EEeCCeEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCC-CceEEcc
Q 046893          164 CCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNAD-FSAKLSD  242 (464)
Q Consensus       164 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~-~~vkl~D  242 (464)
                      +...+...+||||++.....+++.     .++...+..++..++.||.++|  .+|||||||||.|+|.+.. +.-.|+|
T Consensus       104 ~rnnd~v~ivlp~~~H~~f~~l~~-----~l~~~~i~~Yl~~ll~Al~~~h--~~GIvHRDiKpsNFL~n~~t~rg~LvD  176 (418)
T KOG1167|consen  104 FRNNDQVAIVLPYFEHDRFRDLYR-----SLSLAEIRWYLRNLLKALAHLH--KNGIVHRDIKPSNFLYNRRTQRGVLVD  176 (418)
T ss_pred             hccCCeeEEEecccCccCHHHHHh-----cCCHHHHHHHHHHHHHHhhhhh--ccCccccCCCccccccccccCCceEEe
Confidence            999999999999999988877664     3778999999999999999999  7889999999999999754 5679999


Q ss_pred             cCCccCCC-----------------C--CC---------------Cc--------ceeeccccCCcccCccccccC-CCC
Q 046893          243 FGLAKDGP-----------------M--GD---------------QT--------HVSTRVMGTYGYAAPEYVMTG-HLT  279 (464)
Q Consensus       243 FGla~~~~-----------------~--~~---------------~~--------~~~~~~~gt~~y~aPE~~~~~-~~~  279 (464)
                      ||+|....                 .  +.               ..        .......||++|.|||++... ..+
T Consensus       177 FgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~Qt  256 (418)
T KOG1167|consen  177 FGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQT  256 (418)
T ss_pred             chhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcC
Confidence            99997110                 0  00               00        001125699999999998764 578


Q ss_pred             cccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHH-----------Hhhhc-------c-----------cch-hhc
Q 046893          280 ARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWAR-----------PLLNN-------N-----------KKV-LRI  329 (464)
Q Consensus       280 ~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~-----------~~~~~-------~-----------~~~-~~~  329 (464)
                      .++||||.|||++-+++++.||........ .+.+.+-           .+...       +           ..+ .+.
T Consensus       257 taiDiws~GVI~Lslls~~~PFf~a~dd~~-al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~  335 (418)
T KOG1167|consen  257 TAIDIWSAGVILLSLLSRRYPFFKAKDDAD-ALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIES  335 (418)
T ss_pred             CccceeeccceeehhhccccccccCccccc-hHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhh
Confidence            899999999999999999999976543222 1211110           00000       0           000 000


Q ss_pred             cCc-----cccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 046893          330 LDP-----RLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVA  369 (464)
Q Consensus       330 ~~~-----~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  369 (464)
                      +.+     ..........+..+++|+.+||..||.+|.++++.+.
T Consensus       336 ~~~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALk  380 (418)
T KOG1167|consen  336 IYKSRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALK  380 (418)
T ss_pred             cccccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhc
Confidence            000     0000111223447899999999999999999999874

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.96  E-value=1.9e-28  Score=240.17  Aligned_cols=264  Identities=21%  Similarity=0.211  Sum_probs=202.0

Q ss_pred             CCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCccHHHHHHHHHHHhcCCC----CCcceEEEEE-EeC
Q 046893           93 FFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRH----SNLVKLIGYC-CED  167 (464)
Q Consensus        93 ~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h----pniv~l~~~~-~~~  167 (464)
                      +|.+.+.||+|+||.||++.+....     ...+|+|............+..|+.++..+..    .++..+++.+ ...
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~-----~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~   93 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEK-----NKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTE   93 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCC-----CeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCC
Confidence            7999999999999999999987642     35689998876533333367788888888863    5899999999 477


Q ss_pred             CeEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCC-----CceEEcc
Q 046893          168 EHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNAD-----FSAKLSD  242 (464)
Q Consensus       168 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~-----~~vkl~D  242 (464)
                      ...++||+++ |.+|.++........++..+++.|+.|++.+|.+||  +.+++||||||+|+++...     ..++|+|
T Consensus        94 ~~~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH--~~G~iHRDiKp~N~~~g~~~~~~~~~~~llD  170 (322)
T KOG1164|consen   94 DFNFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLH--SKGFIHRDIKPENFVVGQSSRSEVRTLYLLD  170 (322)
T ss_pred             ceeEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHH--hcCcccCCcCHHHeeecCCCCcccceEEEEe
Confidence            8899999998 889999876665578999999999999999999999  6779999999999999754     3699999


Q ss_pred             cCCccCCC--CCCC---cce---eeccccCCcccCccccccCCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHH
Q 046893          243 FGLAKDGP--MGDQ---THV---STRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVE  314 (464)
Q Consensus       243 FGla~~~~--~~~~---~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~  314 (464)
                      ||+++.+.  ....   ...   ...+.||..|+++.++.+.+.+.+.|+|||++++.+|+.|..||.............
T Consensus       171 fGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~  250 (322)
T KOG1164|consen  171 FGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFE  250 (322)
T ss_pred             cCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHH
Confidence            99999322  2211   111   223669999999999999999999999999999999999999997654332211111


Q ss_pred             HHHHhhhcccchhhccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhc
Q 046893          315 WARPLLNNNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETVQSQ  377 (464)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~~~~  377 (464)
                      ...             .......+....+..+..++..+-..+...+|++..+...|..+...
T Consensus       251 ~~~-------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~  300 (322)
T KOG1164|consen  251 KDP-------------RKLLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDS  300 (322)
T ss_pred             HHh-------------hhhccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHh
Confidence            000             00000002223445677777777779999999999999998876554

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.95  E-value=6.6e-29  Score=271.47  Aligned_cols=196  Identities=18%  Similarity=0.246  Sum_probs=138.1

Q ss_pred             cCCC-CCcceEEEEE-------EeCCeEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeee
Q 046893          151 QLRH-SNLVKLIGYC-------CEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIY  222 (464)
Q Consensus       151 ~l~h-pniv~l~~~~-------~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH  222 (464)
                      .++| .||++++++|       ......+++||++ +++|.++|... ...+++.+++.++.||+.||.|||  .++|+|
T Consensus        28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH--~~gIvH  103 (793)
T PLN00181         28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP-DRSVDAFECFHVFRQIVEIVNAAH--SQGIVV  103 (793)
T ss_pred             hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc-cccccHHHHHHHHHHHHHHHHHHH--hCCeee
Confidence            4445 5788888877       2334567888987 66999998643 346999999999999999999999  677999


Q ss_pred             ccCCCCceEecCC-------------------CceEEcccCCccCCCCCCC--------------cceeeccccCCcccC
Q 046893          223 RDFKTSNILLNAD-------------------FSAKLSDFGLAKDGPMGDQ--------------THVSTRVMGTYGYAA  269 (464)
Q Consensus       223 rDlkp~Nill~~~-------------------~~vkl~DFGla~~~~~~~~--------------~~~~~~~~gt~~y~a  269 (464)
                      |||||+||||+..                   +.+||+|||+++.......              .......+||++|||
T Consensus       104 rDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~A  183 (793)
T PLN00181        104 HNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTS  183 (793)
T ss_pred             ccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEC
Confidence            9999999999553                   4456666666653211000              000112468999999


Q ss_pred             ccccccCCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhcccchhhccCccccCccCHHHHHHHHHH
Q 046893          270 PEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRILDPRLEGQYTARTAMKVAGL  349 (464)
Q Consensus       270 PE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  349 (464)
                      ||++.+..|+.++|||||||+||||++|..|+.....    .+..+..          ..+.+...     ........+
T Consensus       184 PE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~----~~~~~~~----------~~~~~~~~-----~~~~~~~~~  244 (793)
T PLN00181        184 PEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSR----TMSSLRH----------RVLPPQIL-----LNWPKEASF  244 (793)
T ss_pred             hhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHH----HHHHHHH----------hhcChhhh-----hcCHHHHHH
Confidence            9999999999999999999999999999887653210    0001100          00111110     112245678


Q ss_pred             HHHhhccCCCCCCCHHHHHH
Q 046893          350 AYQCLSQNPKGRPVMSDVVA  369 (464)
Q Consensus       350 i~~cl~~dP~~RPs~~ev~~  369 (464)
                      +.+||+.+|.+||++.+++.
T Consensus       245 ~~~~L~~~P~~Rps~~eil~  264 (793)
T PLN00181        245 CLWLLHPEPSCRPSMSELLQ  264 (793)
T ss_pred             HHHhCCCChhhCcChHHHhh
Confidence            89999999999999999864

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.94  E-value=9.9e-27  Score=207.83  Aligned_cols=169  Identities=24%  Similarity=0.215  Sum_probs=126.3

Q ss_pred             CCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCccCCCCCCCcceee
Q 046893          180 GSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVST  259 (464)
Q Consensus       180 g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~~~~~~  259 (464)
                      |+|.+++..+ +..+++..++.|+.|++.||.|||  ..+      ||+|||++.++.+|+  ||+++.....       
T Consensus         1 GsL~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~lH--~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~-------   62 (176)
T smart00750        1 VSLADILEVR-GRPLNEEEIWAVCLQCLRALRELH--RQA------KSGNILLTWDGLLKL--DGSVAFKTPE-------   62 (176)
T ss_pred             CcHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHH--hcC------CcccEeEcCccceee--ccceEeeccc-------
Confidence            6899988754 346999999999999999999999  443      999999999999999  9998754221       


Q ss_pred             ccccCCcccCccccccCCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhcccchhhccCccccCccC
Q 046893          260 RVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRILDPRLEGQYT  339 (464)
Q Consensus       260 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  339 (464)
                      ...||+.|+|||++.+..++.++|||||||++|||++|+.||....... ..+..+......        ..+.. ....
T Consensus        63 ~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~-~~~~~~~~~~~~--------~~~~~-~~~~  132 (176)
T smart00750       63 QSRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELS-AILEILLNGMPA--------DDPRD-RSNL  132 (176)
T ss_pred             cCCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhc-HHHHHHHHHhcc--------CCccc-cccH
Confidence            1368999999999999999999999999999999999999996543211 111111111000        00000 0111


Q ss_pred             HHHHH--HHHHHHHHhhccCCCCCCCHHHHHHHHHHHHh
Q 046893          340 ARTAM--KVAGLAYQCLSQNPKGRPVMSDVVALLETVQS  376 (464)
Q Consensus       340 ~~~~~--~l~~li~~cl~~dP~~RPs~~ev~~~L~~~~~  376 (464)
                      .....  .+.+++.+||..+|.+||++.++++.+..+..
T Consensus       133 ~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~  171 (176)
T smart00750      133 ESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALFA  171 (176)
T ss_pred             HHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHHH
Confidence            22222  68999999999999999999999998876643

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.94  E-value=2.5e-26  Score=225.19  Aligned_cols=180  Identities=18%  Similarity=0.099  Sum_probs=133.4

Q ss_pred             HHHHhcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCC-----CccHHHHHHHHHHHhcCCCCCcceEE
Q 046893           87 MKLATKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGG-----YQGDREWLAEVNYLGQLRHSNLVKLI  161 (464)
Q Consensus        87 ~~~~~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~hpniv~l~  161 (464)
                      +......|.+.+.||+|+||+||+|.+...     .++.+|||++....     ......|.+|+++|+.++|+||++.+
T Consensus        13 ~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~-----~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l   87 (365)
T PRK09188         13 IPALSARFVETAVLKRDVFSTVERGYFAGD-----PGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQL   87 (365)
T ss_pred             cccccCCceEccEEeecCcEEEEEEEEcCC-----CCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEE
Confidence            345567799999999999999999987652     25568999865321     11235688999999999999998533


Q ss_pred             EEEEeCCeEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccC-CCCceEecCCCceEE
Q 046893          162 GYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDF-KTSNILLNADFSAKL  240 (464)
Q Consensus       162 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDl-kp~Nill~~~~~vkl  240 (464)
                      ..   .+..+|||||++|++|.. +. .    ..   ...++.|++.+|.|||  ..+|+|||| ||+|||++.++.+||
T Consensus        88 ~~---~~~~~LVmE~~~G~~L~~-~~-~----~~---~~~~~~~i~~aL~~lH--~~gIiHrDL~KP~NILv~~~~~ikL  153 (365)
T PRK09188         88 LA---TGKDGLVRGWTEGVPLHL-AR-P----HG---DPAWFRSAHRALRDLH--RAGITHNDLAKPQNWLMGPDGEAAV  153 (365)
T ss_pred             EE---cCCcEEEEEccCCCCHHH-hC-c----cc---hHHHHHHHHHHHHHHH--HCCCeeCCCCCcceEEEcCCCCEEE
Confidence            22   245799999999999962 21 1    11   1467889999999999  677999999 999999999999999


Q ss_pred             cccCCccCCCCCCCcce------eeccccCCcccCccccccCC------CCcccchh
Q 046893          241 SDFGLAKDGPMGDQTHV------STRVMGTYGYAAPEYVMTGH------LTARSDVY  285 (464)
Q Consensus       241 ~DFGla~~~~~~~~~~~------~~~~~gt~~y~aPE~~~~~~------~~~~~Dvw  285 (464)
                      +|||+|+..........      .....++..|+|||.+....      .+...|-|
T Consensus       154 iDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~~~~~~~~~~~~~dgW  210 (365)
T PRK09188        154 IDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPRERKILARKSLPSRIW  210 (365)
T ss_pred             EECccceecccCcchhhhhhhhhhhhhhccCccCCcccCChhhhccccccccccCcE
Confidence            99999986543221111      13467899999999886432      23346666

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.93  E-value=6e-24  Score=206.55  Aligned_cols=260  Identities=30%  Similarity=0.408  Sum_probs=195.1

Q ss_pred             CCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCc---cHHHHHHHHHHHhcCCCC-CcceEEEEEEeCCe
Q 046893           94 FRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQ---GDREWLAEVNYLGQLRHS-NLVKLIGYCCEDEH  169 (464)
Q Consensus        94 ~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~hp-niv~l~~~~~~~~~  169 (464)
                      |.+...||.|+||.||++.+.         ..+++|.+......   ....+.+|+.++..+.|+ +|+++++++.....
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~---------~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~   72 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR---------KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGS   72 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec---------cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCE
Confidence            667788999999999999876         34788888765433   256789999999999988 79999999987778


Q ss_pred             EEEEEeccCCCCHHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCC-ceEEcccCCcc
Q 046893          170 RILVYEYMESGSLEKHLLRRVG-CMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADF-SAKLSDFGLAK  247 (464)
Q Consensus       170 ~~lv~e~~~~g~L~~~l~~~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~-~vkl~DFGla~  247 (464)
                      .+++++++.+++|.+++..... ..+.......++.|++.++.|+|  ..+++|||+||+||+++..+ .++++|||+++
T Consensus        73 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H--~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~  150 (384)
T COG0515          73 LYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH--SKGIIHRDIKPENILLDRDGRVVKLIDFGLAK  150 (384)
T ss_pred             EEEEEecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHH--hCCeeccCCCHHHeeecCCCCeEEEeccCcce
Confidence            8999999999999866554321 25899999999999999999999  56699999999999999888 79999999998


Q ss_pred             CCCCCCCcc----eeeccccCCcccCcccccc---CCCCcccchhcHHHHHHHHHhCCCCCCCCCCc-ccccHHHHHHHh
Q 046893          248 DGPMGDQTH----VSTRVMGTYGYAAPEYVMT---GHLTARSDVYGFGVVLLEMLLGRRAVDKSRPS-REHNLVEWARPL  319 (464)
Q Consensus       248 ~~~~~~~~~----~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslG~il~ell~g~~pf~~~~~~-~~~~~~~~~~~~  319 (464)
                      .........    ......||..|+|||.+.+   ..+....|+||+|++++++++|..||...... ..........  
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~--  228 (384)
T COG0515         151 LLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIIL--  228 (384)
T ss_pred             ecCCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHH--
Confidence            543333221    2355789999999999987   57888999999999999999999997654421 0011111111  


Q ss_pred             hhcccchhhccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 046893          320 LNNNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVAL  370 (464)
Q Consensus       320 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  370 (464)
                       .....   .................+.+++..|+..+|..|.+.......
T Consensus       229 -~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~  275 (384)
T COG0515         229 -ELPTP---SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH  275 (384)
T ss_pred             -hcCCc---ccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence             11000   000000000002223478899999999999999998877654

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.92  E-value=2.6e-26  Score=239.36  Aligned_cols=261  Identities=19%  Similarity=0.251  Sum_probs=189.5

Q ss_pred             CCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCC-CCccH-HHHHHHHHHHhcCCCCCcceEEEEEEeCCeE
Q 046893           93 FFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRG-GYQGD-REWLAEVNYLGQLRHSNLVKLIGYCCEDEHR  170 (464)
Q Consensus        93 ~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~-~~~~~-~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~  170 (464)
                      +-....++|.|++|.|+.+....... .+..+.++++ .... ..... ..+..|+.+-..|.|||++..+..+.+....
T Consensus       319 y~~~~~~~g~ga~g~~~~~~~~~~~~-~~~~~~~r~~-~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~  396 (601)
T KOG0590|consen  319 YGKPGRVLGSGAYGSVRIAKRRSDLK-SFPEKEFRVR-VKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGI  396 (601)
T ss_pred             cCCccceeeecccCceEEEEecCCCc-cchhhhhhcc-cCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccc
Confidence            33567789999999887766544311 1122223333 2111 11111 2256788888889999998887776666555


Q ss_pred             EEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCccCCC
Q 046893          171 ILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGP  250 (464)
Q Consensus       171 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~  250 (464)
                      +-+||||++ +|..++...  ..+...++..++.|++.||.|||  ..+|.|||||++|+++..+|.+||+|||.+..+.
T Consensus       397 ~~~mE~~~~-Dlf~~~~~~--~~~~~~e~~c~fKqL~~Gv~y~h--~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~  471 (601)
T KOG0590|consen  397 LQSMEYCPY-DLFSLVMSN--GKLTPLEADCFFKQLLRGVKYLH--SMGLAHRDLKLENLLVTENGILKIIDFGAASVFR  471 (601)
T ss_pred             hhhhhcccH-HHHHHHhcc--cccchhhhhHHHHHHHHHHHHHH--hcCceeccCccccEEEecCCceEEeecCcceeec
Confidence            556999999 999988764  35889999999999999999999  5679999999999999999999999999998765


Q ss_pred             CCCCc--ceeeccccCCcccCccccccCCCCc-ccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhcccchh
Q 046893          251 MGDQT--HVSTRVMGTYGYAAPEYVMTGHLTA-RSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVL  327 (464)
Q Consensus       251 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~-~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  327 (464)
                      .....  .....++|+..|+|||++.+..|+. ..||||.|++++.|++|+.||............       .......
T Consensus       472 ~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~-------~~~~~~~  544 (601)
T KOG0590|consen  472 YPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKT-------NNYSDQR  544 (601)
T ss_pred             cCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhh-------hcccccc
Confidence            55444  5566789999999999999999987 489999999999999999999865543322100       0000000


Q ss_pred             hccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 046893          328 RILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVA  369 (464)
Q Consensus       328 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  369 (464)
                      .  ...-........+.....+|.+||+.||.+|-++.+|++
T Consensus       545 ~--~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~  584 (601)
T KOG0590|consen  545 N--IFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN  584 (601)
T ss_pred             c--cccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence            0  000011222345667889999999999999999999975

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.91  E-value=5e-25  Score=198.14  Aligned_cols=245  Identities=22%  Similarity=0.349  Sum_probs=193.3

Q ss_pred             CCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCcc--HHHHHHHHHHHhcCCCCCcceEEEEEEeCCeEEEEE
Q 046893           97 DYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQG--DREWLAEVNYLGQLRHSNLVKLIGYCCEDEHRILVY  174 (464)
Q Consensus        97 ~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~  174 (464)
                      ..+|.+...|..|+|++..+        -+++|+++......  .++|..|.-.|+.+.||||+.+++.|....++.++.
T Consensus       195 ~tkl~e~hsgelwrgrwqgn--------divakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~is  266 (448)
T KOG0195|consen  195 ITKLAESHSGELWRGRWQGN--------DIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIIS  266 (448)
T ss_pred             hhhhccCCCcccccccccCc--------chhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEee
Confidence            44588889999999998765        25667766443332  367889999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEc--ccCCccCCCCC
Q 046893          175 EYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLS--DFGLAKDGPMG  252 (464)
Q Consensus       175 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~--DFGla~~~~~~  252 (464)
                      .||+.|+|+..+....+......++.+++.++++|++|||+.+.-|.---|....|++|++.+.+|.  |--++-    .
T Consensus       267 q~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~kfsf----q  342 (448)
T KOG0195|consen  267 QYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTKFSF----Q  342 (448)
T ss_pred             eeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheecccceeee----e
Confidence            9999999999998876667788899999999999999999887766666789999999999887764  211111    0


Q ss_pred             CCcceeeccccCCcccCccccccCCCC---cccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhcccchhhc
Q 046893          253 DQTHVSTRVMGTYGYAAPEYVMTGHLT---ARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRI  329 (464)
Q Consensus       253 ~~~~~~~~~~gt~~y~aPE~~~~~~~~---~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  329 (464)
                      .     ....-.+.||+||.+...+-+   ..+|+|||.++||||.|...||....+.+-..                ++
T Consensus       343 e-----~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgm----------------ki  401 (448)
T KOG0195|consen  343 E-----VGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGM----------------KI  401 (448)
T ss_pred             c-----cccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhh----------------hh
Confidence            1     012346789999999877654   46899999999999999999998765432211                11


Q ss_pred             cCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHH
Q 046893          330 LDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETV  374 (464)
Q Consensus       330 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~  374 (464)
                      --..++-..+...+..+..||.-|+..||.+||.+..|+-.||..
T Consensus       402 aleglrv~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm  446 (448)
T KOG0195|consen  402 ALEGLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKM  446 (448)
T ss_pred             hhccccccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHh
Confidence            123344556677777999999999999999999999999988865

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.90  E-value=8.1e-24  Score=193.41  Aligned_cols=173  Identities=12%  Similarity=0.099  Sum_probs=133.4

Q ss_pred             HHHhcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCccHHH---------HHHHHHHHhcCCCCCcc
Q 046893           88 KLATKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDRE---------WLAEVNYLGQLRHSNLV  158 (464)
Q Consensus        88 ~~~~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~---------~~~E~~~l~~l~hpniv  158 (464)
                      ++...+|++.++||.|+||.||++.. .       +..+|||++..........         +.+|++.+.++.|++|.
T Consensus        27 ~~l~~~y~~~~~l~~~~f~~v~l~~~-~-------~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~   98 (232)
T PRK10359         27 DFLSYNIKTIKVFRNIDDTKVSLIDT-D-------YGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLA   98 (232)
T ss_pred             HHhhCceEEEEEecCCCceEEEEEec-C-------CCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCC
Confidence            56789999999999999999999644 2       2249999997543333322         57899999999999999


Q ss_pred             eEEEEEEeC--------CeEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCce
Q 046893          159 KLIGYCCED--------EHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNI  230 (464)
Q Consensus       159 ~l~~~~~~~--------~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Ni  230 (464)
                      .+.+++...        ...+|||||++|.+|.++..      ++.    ....+++.+|..||  ..+++|||+||+||
T Consensus        99 ~~~d~~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~------~~~----~~~~~i~~~l~~lH--~~gi~H~Dikp~Ni  166 (232)
T PRK10359         99 SLNDFYLLAERKTLRYAHTYIMLIEYIEGVELNDMPE------ISE----DVKAKIKASIESLH--QHGMVSGDPHKGNF  166 (232)
T ss_pred             cceEeeeecccccccccCCeEEEEEEECCccHHHhhh------ccH----HHHHHHHHHHHHHH--HcCCccCCCChHHE
Confidence            999886643        35789999999999977631      232    24558999999999  67799999999999


Q ss_pred             EecCCCceEEcccCCccCCCCCCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHH
Q 046893          231 LLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEML  295 (464)
Q Consensus       231 ll~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell  295 (464)
                      +++.+| ++|+|||...........              -.++....|+.++|+|+||+++..+.
T Consensus       167 li~~~g-i~liDfg~~~~~~e~~a~--------------d~~vler~y~~~~di~~lg~~~~~~~  216 (232)
T PRK10359        167 IVSKNG-LRIIDLSGKRCTAQRKAK--------------DRIDLERHYGIKNEIKDLGYYLLIYK  216 (232)
T ss_pred             EEeCCC-EEEEECCCcccccchhhH--------------HHHHHHhHhcccccccceeEeehHHH
Confidence            999888 999999988753211100              01345566778999999999987654

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.88  E-value=1.1e-22  Score=183.57  Aligned_cols=138  Identities=17%  Similarity=0.150  Sum_probs=105.3

Q ss_pred             CCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCc--c-------H-----------------HHHHHHHHHHh
Q 046893           97 DYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQ--G-------D-----------------REWLAEVNYLG  150 (464)
Q Consensus        97 ~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~--~-------~-----------------~~~~~E~~~l~  150 (464)
                      ...||+|+||.||+|.+. +      ++.||||+++.....  .       .                 .....|+++|.
T Consensus         2 ~~~ig~G~~~~Vy~a~~~-~------g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~   74 (190)
T cd05147           2 NGCISTGKEANVYHATTA-N------GEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLK   74 (190)
T ss_pred             CCccccccceEEEEEECC-C------CCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHH
Confidence            457999999999999875 3      567999998754211  1       0                 11234999999


Q ss_pred             cCCCCCcceEEEEEEeCCeEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHH-hcCCCCeeeccCCCCc
Q 046893          151 QLRHSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFL-HGAERPVIYRDFKTSN  229 (464)
Q Consensus       151 ~l~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~L-H~~~~~ivHrDlkp~N  229 (464)
                      .+.++++.....+...  ..+|||||+.+++|...+...  ..++...+..++.|++.+|.|| |  ..+|+||||||+|
T Consensus        75 ~l~~~~v~~p~~~~~~--~~~iVmE~i~g~~l~~~~~~~--~~~~~~~~~~i~~qi~~~L~~l~H--~~giiHrDlkP~N  148 (190)
T cd05147          75 RLVTAGIPCPEPILLK--SHVLVMEFIGDDGWAAPRLKD--APLSESKARELYLQVIQIMRILYQ--DCRLVHADLSEYN  148 (190)
T ss_pred             HHHHCCCCCCcEEEec--CCEEEEEEeCCCCCcchhhhc--CCCCHHHHHHHHHHHHHHHHHHHH--hCCcccCCCCHHH
Confidence            9988776443332222  238999999988776543332  3689999999999999999999 6  5679999999999


Q ss_pred             eEecCCCceEEcccCCccC
Q 046893          230 ILLNADFSAKLSDFGLAKD  248 (464)
Q Consensus       230 ill~~~~~vkl~DFGla~~  248 (464)
                      ||++ ++.++|+|||+|..
T Consensus       149 Ili~-~~~v~LiDFG~a~~  166 (190)
T cd05147         149 LLYH-DGKLYIIDVSQSVE  166 (190)
T ss_pred             EEEE-CCcEEEEEcccccc
Confidence            9998 47899999999974

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.88  E-value=7.9e-24  Score=211.25  Aligned_cols=229  Identities=26%  Similarity=0.345  Sum_probs=178.3

Q ss_pred             ceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCcc--HHHHHHHHHHHhcCC-CCCcceEEEEEEeCCeEEEEEe
Q 046893           99 ILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQG--DREWLAEVNYLGQLR-HSNLVKLIGYCCEDEHRILVYE  175 (464)
Q Consensus        99 ~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~~lv~e  175 (464)
                      ++|.|+||.|+++.-...   ...+..+|+|+++......  ......|..++..++ ||.+|++...+..+...+++++
T Consensus         1 vlg~g~~gkvfLvrk~~g---~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld   77 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAGG---ADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILD   77 (612)
T ss_pred             CCCcCCCcchHHHHHhcc---ccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhh
Confidence            379999999998653322   1246778888887543211  123456778888886 9999999999999999999999


Q ss_pred             ccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCccCCCCCCCc
Q 046893          176 YMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQT  255 (464)
Q Consensus       176 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~~  255 (464)
                      |..||.|...+.+..  .+.+.....+...++.+++++|  ..+|+|||+|++||+++.+|++++.|||+++....... 
T Consensus        78 ~~rgg~lft~l~~~~--~f~~~~~~~~~aelaLald~lh--~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~-  152 (612)
T KOG0603|consen   78 FLRGGDLFTRLSKEV--MFDELDVAFYLAELALALDHLH--KLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI-  152 (612)
T ss_pred             hcccchhhhccccCC--chHHHHHHHHHHHHHHHHhhcc--hhHHHHhcccccceeecccCccccCCchhhhHhHhhhh-
Confidence            999999988776543  5677777778888999999999  67799999999999999999999999999986432221 


Q ss_pred             ceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhcccchhhccCcccc
Q 046893          256 HVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRILDPRLE  335 (464)
Q Consensus       256 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  335 (464)
                           .|||..|||||++.  .....+|.||||++++||++|..||...          ....++.            ..
T Consensus       153 -----~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~~----------~~~~Il~------------~~  203 (612)
T KOG0603|consen  153 -----ACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGGD----------TMKRILK------------AE  203 (612)
T ss_pred             -----cccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCchH----------HHHHHhh------------hc
Confidence                 29999999999988  6788899999999999999999999761          1111111            11


Q ss_pred             CccCHHHHHHHHHHHHHhhccCCCCCCCH
Q 046893          336 GQYTARTAMKVAGLAYQCLSQNPKGRPVM  364 (464)
Q Consensus       336 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~  364 (464)
                      ...+.........++..++..+|..|.-.
T Consensus       204 ~~~p~~l~~~a~~~~~~l~~r~p~nrLg~  232 (612)
T KOG0603|consen  204 LEMPRELSAEARSLFRQLFKRNPENRLGA  232 (612)
T ss_pred             cCCchhhhHHHHHHHHHHHhhCHHHHhcc
Confidence            13344555678889999999999999655

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.88  E-value=1.3e-23  Score=219.54  Aligned_cols=248  Identities=22%  Similarity=0.263  Sum_probs=179.5

Q ss_pred             CCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCC-CccH---HHHHHHHHHHhcCCCCCcceEEEEEEeCC
Q 046893           93 FFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGG-YQGD---REWLAEVNYLGQLRHSNLVKLIGYCCEDE  168 (464)
Q Consensus        93 ~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~-~~~~---~~~~~E~~~l~~l~hpniv~l~~~~~~~~  168 (464)
                      .|...+.||.+.|=+|.+|.+.++       . |+||++-+.. ....   .+-+.|++ ...++|||++++.-+...+.
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~eG-------~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~k   94 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDREG-------L-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDK   94 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCCCc-------e-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhH
Confidence            466677899999999999987763       3 7888875543 2222   34445555 55668999999988877888


Q ss_pred             eEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCccC
Q 046893          169 HRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKD  248 (464)
Q Consensus       169 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~  248 (464)
                      ..|||-+|+.. +|+|.|..+.  .+...+...|+.|++.||.-+|  ..+|+|||||.+||||+.-+-+.|+||...+.
T Consensus        95 AAylvRqyvkh-nLyDRlSTRP--FL~~iEKkWiaFQLL~al~qcH--~~gVcHGDIKsENILiTSWNW~~LtDFAsFKP  169 (1431)
T KOG1240|consen   95 AAYLVRQYVKH-NLYDRLSTRP--FLVLIEKKWIAFQLLKALSQCH--KLGVCHGDIKSENILITSWNWLYLTDFASFKP  169 (1431)
T ss_pred             HHHHHHHHHhh-hhhhhhccch--HHHHHHHHHHHHHHHHHHHHHH--HcCccccccccceEEEeeechhhhhcccccCC
Confidence            88999999955 9999987765  6888889999999999999999  67799999999999999998999999987763


Q ss_pred             CCCC-----CCcceeeccccCCcccCccccccC----------C-CCcccchhcHHHHHHHHHh-CCCCCCCCCCccccc
Q 046893          249 GPMG-----DQTHVSTRVMGTYGYAAPEYVMTG----------H-LTARSDVYGFGVVLLEMLL-GRRAVDKSRPSREHN  311 (464)
Q Consensus       249 ~~~~-----~~~~~~~~~~gt~~y~aPE~~~~~----------~-~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~  311 (464)
                      ....     +......+-..-..|+|||.+...          . .+++-||||+||+++||++ |+++|.-+.      
T Consensus       170 tYLPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQ------  243 (1431)
T KOG1240|consen  170 TYLPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQ------  243 (1431)
T ss_pred             ccCCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHH------
Confidence            2211     112222223344579999987531          1 5678899999999999998 788886432      


Q ss_pred             HHHHHHHhhhcccchhhccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 046893          312 LVEWARPLLNNNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALL  371 (464)
Q Consensus       312 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L  371 (464)
                      +..+-..--......++.++           ...++.|+..|++.||.+|.++++++..-
T Consensus       244 L~aYr~~~~~~~e~~Le~Ie-----------d~~~Rnlil~Mi~rdPs~RlSAedyL~~y  292 (1431)
T KOG1240|consen  244 LLAYRSGNADDPEQLLEKIE-----------DVSLRNLILSMIQRDPSKRLSAEDYLQKY  292 (1431)
T ss_pred             HHhHhccCccCHHHHHHhCc-----------CccHHHHHHHHHccCchhccCHHHHHHhh
Confidence            11111000000011111111           12678899999999999999999998753

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.87  E-value=1.7e-21  Score=176.24  Aligned_cols=140  Identities=16%  Similarity=0.083  Sum_probs=108.0

Q ss_pred             CCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCcc--------------------------HHHHHHHHHHHh
Q 046893           97 DYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQG--------------------------DREWLAEVNYLG  150 (464)
Q Consensus        97 ~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~--------------------------~~~~~~E~~~l~  150 (464)
                      ...||+|+||.||+|.+. +      ++.||||+++......                          ...+..|...+.
T Consensus         2 ~~~ig~G~~~~Vy~a~~~-~------g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~   74 (190)
T cd05145           2 NGCISTGKEANVYHARTG-D------GEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLK   74 (190)
T ss_pred             CceeecCCCcEEEEEEcC-C------CCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHH
Confidence            457999999999999875 3      5679999987642110                          112357899999


Q ss_pred             cCCCCCcceEEEEEEeCCeEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCce
Q 046893          151 QLRHSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNI  230 (464)
Q Consensus       151 ~l~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Ni  230 (464)
                      ++.|++|.....+....  .+|||||+.|+++...+...  ..++......++.|++.+|.+||+ ..+|+||||||+||
T Consensus        75 ~l~~~~i~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~~--~~~~~~~~~~i~~~l~~~l~~lH~-~~givHrDlkP~NI  149 (190)
T cd05145          75 RLYEAGVPVPEPILLKK--NVLVMEFIGDDGSPAPRLKD--VPLEEEEAEELYEQVVEQMRRLYQ-EAGLVHGDLSEYNI  149 (190)
T ss_pred             HHHhCCCCCceEEEecC--CEEEEEEecCCCchhhhhhh--ccCCHHHHHHHHHHHHHHHHHHHH-hCCEecCCCChhhE
Confidence            99999875544443332  48999999887654432222  357888999999999999999994 16799999999999


Q ss_pred             EecCCCceEEcccCCccCC
Q 046893          231 LLNADFSAKLSDFGLAKDG  249 (464)
Q Consensus       231 ll~~~~~vkl~DFGla~~~  249 (464)
                      |++ ++.++|+|||++...
T Consensus       150 ll~-~~~~~liDFG~a~~~  167 (190)
T cd05145         150 LYH-DGKPYIIDVSQAVEL  167 (190)
T ss_pred             EEE-CCCEEEEEcccceec
Confidence            998 789999999999864

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.86  E-value=4.1e-21  Score=172.02  Aligned_cols=187  Identities=18%  Similarity=0.102  Sum_probs=135.4

Q ss_pred             CCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCccH----HHHHHHHHHHhcCC-CCCcceEEEEEEeCCeE
Q 046893           96 PDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGD----REWLAEVNYLGQLR-HSNLVKLIGYCCEDEHR  170 (464)
Q Consensus        96 ~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~----~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~  170 (464)
                      +...|++|+||+||.+...        +..++.+.+........    ..+.+|+++|++|. |++|.+++++    +..
T Consensus         6 ~~~~l~~~~f~~v~~~~~~--------~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~   73 (218)
T PRK12274          6 VNEPLKSDTFGRILLVRGG--------ERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGR   73 (218)
T ss_pred             cceeecCCCcceEEEeecC--------CceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCE
Confidence            4567999999999976542        34566666654332111    24789999999995 5889999886    346


Q ss_pred             EEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccC-CCCceEecCCCceEEcccCCccCC
Q 046893          171 ILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDF-KTSNILLNADFSAKLSDFGLAKDG  249 (464)
Q Consensus       171 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDl-kp~Nill~~~~~vkl~DFGla~~~  249 (464)
                      +++|||+.|.+|...+..        . ...++.|++.+|.++|  ..+|+|||| ||+|||++.++.++|+|||+|...
T Consensus        74 ~lvmeyI~G~~L~~~~~~--------~-~~~~~~qi~~~L~~lH--~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~  142 (218)
T PRK12274         74 HLDRSYLAGAAMYQRPPR--------G-DLAYFRAARRLLQQLH--RCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRG  142 (218)
T ss_pred             EEEEeeecCccHHhhhhh--------h-hHHHHHHHHHHHHHHH--HCcCccCCCCCcceEEEcCCCCEEEEECCCceec
Confidence            899999999998654321        1 1346789999999999  677999999 799999999999999999999854


Q ss_pred             CCCCCc----ce-------eeccccCCcccCccccccC-CCC-cccchhcHHHHHHHHHhCCCCCCCCC
Q 046893          250 PMGDQT----HV-------STRVMGTYGYAAPEYVMTG-HLT-ARSDVYGFGVVLLEMLLGRRAVDKSR  305 (464)
Q Consensus       250 ~~~~~~----~~-------~~~~~gt~~y~aPE~~~~~-~~~-~~~DvwslG~il~ell~g~~pf~~~~  305 (464)
                      .....-    ..       ......++.|++|+...-- ..+ ...++++.|+-+|.++|++.++..+.
T Consensus       143 ~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~  211 (218)
T PRK12274        143 NPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDN  211 (218)
T ss_pred             CCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccC
Confidence            322210    00       0112367778888754322 233 46799999999999999998876554

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.85  E-value=3e-21  Score=205.54  Aligned_cols=257  Identities=19%  Similarity=0.198  Sum_probs=185.1

Q ss_pred             hhHHHHHhcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCccHHHHHHHHHHHhcCC---CCCcceE
Q 046893           84 YNEMKLATKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLR---HSNLVKL  160 (464)
Q Consensus        84 ~~~~~~~~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---hpniv~l  160 (464)
                      ..+.++....|.+.+.||+|+||+||+|...+       ++.||+|+-+.....   +|.-=.+++.+|+   -+.|+.+
T Consensus       690 ~~~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~-------~~~~alK~e~P~~~W---EfYI~~q~~~RLk~~~~~~~~~~  759 (974)
T KOG1166|consen  690 NTEFEVGGEKFCISKEIGEGSYGSVYVATHSN-------GKLVALKVEKPPNPW---EFYICLQVMERLKPQMLPSIMHI  759 (974)
T ss_pred             cceeeecceeEEEEeeeccccceEEEEeecCC-------CcEEEEEeecCCCce---eeeehHHHHHhhchhhhcchHHH
Confidence            34556667778889999999999999998665       677999998765432   2332334444554   3456666


Q ss_pred             EEEEEeCCeEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEec-------
Q 046893          161 IGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLN-------  233 (464)
Q Consensus       161 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~-------  233 (464)
                      ...+.-.+..+||+||.+.|+|.+++..  ...+++..++.++.|++.-|+.||  ..+|||+||||+|+||.       
T Consensus       760 ~~a~~~~~~S~lv~ey~~~Gtlld~~N~--~~~m~e~lv~~~~~qml~ive~lH--~~~IIHgDiKPDNfll~~~~~~~~  835 (974)
T KOG1166|consen  760 SSAHVFQNASVLVSEYSPYGTLLDLINT--NKVMDEYLVMFFSCQMLRIVEHLH--AMGIIHGDIKPDNFLLRREICADS  835 (974)
T ss_pred             HHHHccCCcceeeeeccccccHHHhhcc--CCCCCchhhhHHHHHHHHHHHHHH--hcceecccCCcceeEeecccCCCC
Confidence            6666777788999999999999998873  346899999999999999999999  55699999999999993       


Q ss_pred             CCCceEEcccCCccCCCCCCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHH
Q 046893          234 ADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLV  313 (464)
Q Consensus       234 ~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~  313 (464)
                      +...++|+|||-+-....-.........++|-.+-.+|+..|..++..+|.|.|+-+++-||.|+..=            
T Consensus       836 ~~~~l~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~q------------  903 (974)
T KOG1166|consen  836 DSKGLYLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYME------------  903 (974)
T ss_pred             cccceEEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHHH------------
Confidence            23468999999987544333333445578899999999999999999999999999999999997321            


Q ss_pred             HHHHHhhhcccchhhccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhc
Q 046893          314 EWARPLLNNNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETVQSQ  377 (464)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~~~~  377 (464)
                           ...+.   ...++..+...+..   ....+|+..+|..|-..=|...++...|+++...
T Consensus       904 -----~~~g~---~~~~~~~~~Ry~~~---~~W~~~F~~lLN~~~~~~p~l~~lr~~~~~~~~~  956 (974)
T KOG1166|consen  904 -----VKNGS---SWMVKTNFPRYWKR---DMWNKFFDLLLNPDCDTLPNLQELRTELEEVLAE  956 (974)
T ss_pred             -----hcCCc---ceeccccchhhhhH---HHHHHHHHHHhCcCcccchhHHHHHHHHHHHHHH
Confidence                 00000   00011111101111   1344566677775555558888888888776544

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.85  E-value=1.4e-20  Score=177.27  Aligned_cols=232  Identities=19%  Similarity=0.236  Sum_probs=145.7

Q ss_pred             CCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCC---ccHHHHHHHHHHHhcCCC----------CCcceE
Q 046893           94 FRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGY---QGDREWLAEVNYLGQLRH----------SNLVKL  160 (464)
Q Consensus        94 ~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h----------pniv~l  160 (464)
                      +.....||.|+|+.||.+++..+      ++.+|+|+......   ...+.+.+|.-....+.+          -.++--
T Consensus        14 l~~~~~i~~g~~~~v~~v~d~~t------~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P   87 (288)
T PF14531_consen   14 LVRGRIIGKGGFSIVFEVTDVET------GEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVP   87 (288)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTT------TEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---
T ss_pred             EEEccccccCCceEEEEEEEccC------CceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEee
Confidence            34456799999999999999886      77899999754332   223556665544444322          112222


Q ss_pred             EEE---------EEeC---C-----eEEEEEeccCCCCHHHHHHh---hcC--CCCCHHHHHHHHHHHHHHHHHHhcCCC
Q 046893          161 IGY---------CCED---E-----HRILVYEYMESGSLEKHLLR---RVG--CMLTWSRRMKIALDAAKGLAFLHGAER  218 (464)
Q Consensus       161 ~~~---------~~~~---~-----~~~lv~e~~~~g~L~~~l~~---~~~--~~l~~~~~~~i~~qi~~~l~~LH~~~~  218 (464)
                      ++.         +...   +     ..+++|+.+ -++|.+++.-   ...  ..+....++.+..|++..+++||  ..
T Consensus        88 ~d~~~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh--~~  164 (288)
T PF14531_consen   88 LDLLRIPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLH--SY  164 (288)
T ss_dssp             SEEEEETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHH--HT
T ss_pred             eEEEEEcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHh--hc
Confidence            222         1111   1     236788888 4588877542   211  12445666778899999999999  56


Q ss_pred             CeeeccCCCCceEecCCCceEEcccCCccCCCCCCCcceeeccccCCcccCcccccc--------CCCCcccchhcHHHH
Q 046893          219 PVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMT--------GHLTARSDVYGFGVV  290 (464)
Q Consensus       219 ~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DvwslG~i  290 (464)
                      +++|+||+|+|+|++.+|.++|+||+......  ...   .....+..|.+||....        -.++.+.|.|+||++
T Consensus       165 GlVHgdi~~~nfll~~~G~v~Lg~F~~~~r~g--~~~---~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~  239 (288)
T PF14531_consen  165 GLVHGDIKPENFLLDQDGGVFLGDFSSLVRAG--TRY---RCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGIT  239 (288)
T ss_dssp             TEEEST-SGGGEEE-TTS-EEE--GGGEEETT--EEE---EGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHH
T ss_pred             ceEecccceeeEEEcCCCCEEEcChHHHeecC--cee---eccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHH
Confidence            79999999999999999999999999876522  111   11344577999996643        247889999999999


Q ss_pred             HHHHHhCCCCCCCCCCcccccHHHHHHHhhhcccchhhccCccccCccCHHHHHHHHHHHHHhhccCCCCC
Q 046893          291 LLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGR  361 (464)
Q Consensus       291 l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R  361 (464)
                      +|.|.||+.||....+.....                    ..+..  +...++.+..||..+|+.||.+|
T Consensus       240 ly~lWC~~lPf~~~~~~~~~~--------------------~~f~~--C~~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  240 LYSLWCGRLPFGLSSPEADPE--------------------WDFSR--CRDMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             HHHHHHSS-STCCCGGGSTSG--------------------GGGTT--SS---HHHHHHHHHHT-SSGGGS
T ss_pred             HHHHHHccCCCCCCCcccccc--------------------ccchh--cCCcCHHHHHHHHHHccCCcccC
Confidence            999999999998653221110                    01221  22677899999999999999987

>PRK10345 hypothetical protein; Provisional

Probab=99.84  E-value=3.2e-20  Score=169.15  Aligned_cols=136  Identities=20%  Similarity=0.212  Sum_probs=104.5

Q ss_pred             CCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCccHHHHHHHHHHHhcC-----CCCCcceEEEEEEeCC--
Q 046893           96 PDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQL-----RHSNLVKLIGYCCEDE--  168 (464)
Q Consensus        96 ~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-----~hpniv~l~~~~~~~~--  168 (464)
                      -...||+|+||.||.  +...      .. .+||++........+.+.+|+.+++.+     .||||+++++++.++.  
T Consensus         6 ~~~~LG~G~~~~Vy~--hp~~------~~-k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~   76 (210)
T PRK10345          6 EQSPLGTGRHRKCYA--HPED------AQ-RCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGT   76 (210)
T ss_pred             CcceecCCCceEEEE--CCCC------cC-eEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCC
Confidence            346799999999995  3322      22 368888765444567789999999999     5799999999998874  


Q ss_pred             -e-EEEEEec--cCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHH-HHHhcCCCCeeeccCCCCceEecC----CCceE
Q 046893          169 -H-RILVYEY--MESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGL-AFLHGAERPVIYRDFKTSNILLNA----DFSAK  239 (464)
Q Consensus       169 -~-~~lv~e~--~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l-~~LH~~~~~ivHrDlkp~Nill~~----~~~vk  239 (464)
                       . +.+||||  +.+++|.+++.+.   .+++.  ..++.|++.++ .|||  ..+|+||||||+|||++.    ++.++
T Consensus        77 g~v~~~I~e~~G~~~~tL~~~l~~~---~~~e~--~~~~~~~L~~l~~yLh--~~~IvhrDlKp~NILl~~~~~~~~~~~  149 (210)
T PRK10345         77 GYVYDVIADFDGKPSITLTEFAEQC---RYEED--VAQLRQLLKKLKRYLL--DNRIVTMELKPQNILCQRISESEVIPV  149 (210)
T ss_pred             eEEEEEEecCCCCcchhHHHHHHcc---cccHh--HHHHHHHHHHHHHHHH--HCCEeecCCCHHHEEEeccCCCCCcEE
Confidence             3 3478999  5579999999652   35555  35677888888 8999  677999999999999963    34799


Q ss_pred             EcccCCcc
Q 046893          240 LSDFGLAK  247 (464)
Q Consensus       240 l~DFGla~  247 (464)
                      |+||+.+.
T Consensus       150 LiDg~G~~  157 (210)
T PRK10345        150 VCDNIGES  157 (210)
T ss_pred             EEECCCCc
Confidence            99955443

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.83  E-value=2.5e-20  Score=186.32  Aligned_cols=220  Identities=25%  Similarity=0.382  Sum_probs=163.1

Q ss_pred             HhcCCCCCcceEEEEEEeCCeEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCC
Q 046893          149 LGQLRHSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTS  228 (464)
Q Consensus       149 l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~  228 (464)
                      |+.+.|.|+.++++.+.++...++|.+||..|+|.|.+... ...+++--...+..+++.||.|||..... .|+.|+..
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~-~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~-~hg~l~s~   78 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNE-DIKLDYFFILSFIRDISKGLAYLHNSPIG-YHGALKSS   78 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhcc-ccCccHHHHHHHHHHHHHHHHHHhcCcce-eeeeeccc
Confidence            45788999999999999999999999999999999998763 45688888899999999999999964433 99999999


Q ss_pred             ceEecCCCceEEcccCCccCCCCCCCcceeeccccCCcccCccccccCC-------CCcccchhcHHHHHHHHHhCCCCC
Q 046893          229 NILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGH-------LTARSDVYGFGVVLLEMLLGRRAV  301 (464)
Q Consensus       229 Nill~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-------~~~~~DvwslG~il~ell~g~~pf  301 (464)
                      |+++|....+||+|||+.................-...|.|||.+.+..       .+.+.||||||++++|+++...||
T Consensus        79 nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~  158 (484)
T KOG1023|consen   79 NCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPF  158 (484)
T ss_pred             cceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCcc
Confidence            9999999999999999987643211111112223455799999887631       466799999999999999999999


Q ss_pred             CCCCCcccccHHHHHHHhhhcccchhhccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhc
Q 046893          302 DKSRPSREHNLVEWARPLLNNNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETVQSQ  377 (464)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~~~~  377 (464)
                      .........  .+.+..+.....   ..+-|.+...  ......+..++..||..+|.+||++..+...++.+...
T Consensus       159 ~~~~~~~~~--~eii~~~~~~~~---~~~rP~i~~~--~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~~  227 (484)
T KOG1023|consen  159 DLRNLVEDP--DEIILRVKKGGS---NPFRPSIELL--NELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINKG  227 (484)
T ss_pred             ccccccCCh--HHHHHHHHhcCC---CCcCcchhhh--hhcchHHHHHHHHhcccChhhCccHHHHHhhhhhhccc
Confidence            864433222  122222111011   1111211111  13444788999999999999999999998888776654

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.83  E-value=6.6e-21  Score=199.28  Aligned_cols=209  Identities=25%  Similarity=0.322  Sum_probs=142.8

Q ss_pred             cCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCccHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeEE
Q 046893           92 KFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVKLIGYCCEDEHRI  171 (464)
Q Consensus        92 ~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~  171 (464)
                      .+|..+++|-.|+||-||..++..+      .+.+|+|+ ++..     .+++-  ++.....|.+|             
T Consensus        83 ~df~~IklisngAygavylvrh~~t------rqrfa~ki-Nkq~-----lilRn--ilt~a~npfvv-------------  135 (1205)
T KOG0606|consen   83 SDFNTIKLISNGAYGAVYLVRHKET------RQRFAMKI-NKQN-----LILRN--ILTFAGNPFVV-------------  135 (1205)
T ss_pred             cccceeEeeccCCCCceeeeecccc------ccchhhcc-cccc-----hhhhc--cccccCCccee-------------
Confidence            4577888999999999999987765      44578844 3321     11111  22222333333             


Q ss_pred             EEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCccCCCC
Q 046893          172 LVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPM  251 (464)
Q Consensus       172 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~  251 (464)
                              |+-...+..-  ..++...        +.+++|||  ..+|+|||+||+|.||..-|++|++|||+++....
T Consensus       136 --------gDc~tllk~~--g~lPvdm--------vla~Eylh--~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLm  195 (1205)
T KOG0606|consen  136 --------GDCATLLKNI--GPLPVDM--------VLAVEYLH--SYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLM  195 (1205)
T ss_pred             --------chhhhhcccC--CCCcchh--------hHHhHhhc--cCCeecCCCCCCcceeeecccccccchhhhhhhhh
Confidence                    2333333321  1344332        77899999  57799999999999999999999999999985432


Q ss_pred             CCCcc-------------eeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHH
Q 046893          252 GDQTH-------------VSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARP  318 (464)
Q Consensus       252 ~~~~~-------------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~  318 (464)
                      ...+.             ....++||+.|+|||++....|+..+|+|++|+|+||++.|..||++..+..      ++..
T Consensus       196 s~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpee------lfg~  269 (1205)
T KOG0606|consen  196 SLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEE------LFGQ  269 (1205)
T ss_pred             hccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHH------HHhh
Confidence            21111             1234699999999999999999999999999999999999999999876532      2222


Q ss_pred             hhhcccchhhccCccccCccCHHHHHHHHHHHHHhhccCCCCCC
Q 046893          319 LLNNNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRP  362 (464)
Q Consensus       319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP  362 (464)
                      ++.+...+.+-         ....+.+..+++.+.|+.+|..|-
T Consensus       270 visd~i~wpE~---------dea~p~Ea~dli~~LL~qnp~~Rl  304 (1205)
T KOG0606|consen  270 VISDDIEWPEE---------DEALPPEAQDLIEQLLRQNPLCRL  304 (1205)
T ss_pred             hhhhhcccccc---------CcCCCHHHHHHHHHHHHhChHhhc
Confidence            22222111111         122334788899999999999994

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.81  E-value=6.5e-21  Score=187.07  Aligned_cols=172  Identities=27%  Similarity=0.398  Sum_probs=130.2

Q ss_pred             eEEEEEeccCCCCHHHHHHh-hcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCcc
Q 046893          169 HRILVYEYMESGSLEKHLLR-RVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAK  247 (464)
Q Consensus       169 ~~~lv~e~~~~g~L~~~l~~-~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~  247 (464)
                      ++||.|++|.-.+|.++|.. ..+...++...+.|+.|++.|+.|     ++.+|+||||.||+...+..+||.|||+..
T Consensus       330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y-----k~~ihrdlkp~nif~~~d~q~kIgDFgl~t  404 (516)
T KOG1033|consen  330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY-----KGLIHRDLKPSNIFFSDDDQLKIGDFGLVT  404 (516)
T ss_pred             chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh-----ccchhhhccccccccccchhhhhhhhhhee
Confidence            57899999999999999973 445678899999999999999999     569999999999999989899999999988


Q ss_pred             CCCCCC----CcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHhhhc
Q 046893          248 DGPMGD----QTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLL-GRRAVDKSRPSREHNLVEWARPLLNN  322 (464)
Q Consensus       248 ~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~  322 (464)
                      ......    .....+...||.+||+||.+.+..|+.++||||||+||+||+. -...|.....     +     ..+. 
T Consensus       405 s~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~~t-----~-----~d~r-  473 (516)
T KOG1033|consen  405 SQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFERIAT-----L-----TDIR-  473 (516)
T ss_pred             ecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHHHHh-----h-----hhhh-
Confidence            654333    1223455789999999999999999999999999999999997 3333321100     0     0000 


Q ss_pred             ccchhhccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHH
Q 046893          323 NKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMS  365 (464)
Q Consensus       323 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~  365 (464)
                          ..++++.....++     .-..|+.++|...|.+||++.
T Consensus       474 ----~g~ip~~~~~d~p-----~e~~ll~~lls~~p~~RP~~~  507 (516)
T KOG1033|consen  474 ----DGIIPPEFLQDYP-----EEYTLLQQLLSPSPEERPSAI  507 (516)
T ss_pred             ----cCCCChHHhhcCc-----HHHHHHHHhcCCCcccCchHH
Confidence                0112222222333     345799999999999999443

>smart00090 RIO RIO-like kinase

Probab=99.80  E-value=1.6e-19  Score=168.44  Aligned_cols=141  Identities=18%  Similarity=0.174  Sum_probs=108.4

Q ss_pred             CCCCCCceeecCceEEEEEE-ecCCCCCCccceEEEEEEccCCCCc------------------------cHHHHHHHHH
Q 046893           93 FFRPDYILGEGGFGVVYKGV-IDENVRPGYKTTFVAIKELNRGGYQ------------------------GDREWLAEVN  147 (464)
Q Consensus        93 ~~~~~~~lG~G~fg~Vy~a~-~~~~~~~~~~~~~vavK~~~~~~~~------------------------~~~~~~~E~~  147 (464)
                      .|.+.+.||+|+||.||+|. +..+      ++.||+|++......                        ....+..|+.
T Consensus        29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~------g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~  102 (237)
T smart00090       29 LSAIGGCISTGKEANVYHALDFDGS------GKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFR  102 (237)
T ss_pred             hHHhCCeeccCcceeEEEEEecCCC------CcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHH
Confidence            48899999999999999998 4333      677999998753211                        0123568999


Q ss_pred             HHhcCCCC--CcceEEEEEEeCCeEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCC-eeecc
Q 046893          148 YLGQLRHS--NLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERP-VIYRD  224 (464)
Q Consensus       148 ~l~~l~hp--niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~-ivHrD  224 (464)
                      ++.++.+.  .+.+++++   . ..+|||||+.|.+|...+...  ..+.......++.|++.+|.+||  ..+ |+|||
T Consensus       103 ~L~~L~~~~i~~p~~~~~---~-~~~lV~E~~~g~~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~LH--~~g~iiH~D  174 (237)
T smart00090      103 NLQRLYEAGVPVPKPIAW---R-RNVLVMEFIGGDGLPAPRLKD--VEPEEEEEFELYDDILEEMRKLY--KEGELVHGD  174 (237)
T ss_pred             HHHHHHhcCCCCCeeeEe---c-CceEEEEEecCCccccccccc--CCcchHHHHHHHHHHHHHHHHHH--hcCCEEeCC
Confidence            99999753  23444432   2 348999999998886654332  24566677889999999999999  778 99999


Q ss_pred             CCCCceEecCCCceEEcccCCccC
Q 046893          225 FKTSNILLNADFSAKLSDFGLAKD  248 (464)
Q Consensus       225 lkp~Nill~~~~~vkl~DFGla~~  248 (464)
                      |||+||+++ ++.++|+|||++..
T Consensus       175 ikp~NIli~-~~~i~LiDFg~a~~  197 (237)
T smart00090      175 LSEYNILVH-DGKVVIIDVSQSVE  197 (237)
T ss_pred             CChhhEEEE-CCCEEEEEChhhhc
Confidence            999999999 88999999999874

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.79  E-value=4.6e-19  Score=167.68  Aligned_cols=198  Identities=19%  Similarity=0.228  Sum_probs=141.8

Q ss_pred             CCCCcceEEEEEEeC---------------------------CeEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHH
Q 046893          153 RHSNLVKLIGYCCED---------------------------EHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALD  205 (464)
Q Consensus       153 ~hpniv~l~~~~~~~---------------------------~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~q  205 (464)
                      .|||||+++++|.+.                           ..+|+||..++ .+|..++-.+   ..+.....-|+.|
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~-~tLr~yl~~~---~~s~r~~~~~laQ  349 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYR-QTLREYLWTR---HRSYRTGRVILAQ  349 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcch-hhHHHHHhcC---CCchHHHHHHHHH
Confidence            599999999877532                           24789999884 4898888654   3677788889999


Q ss_pred             HHHHHHHHhcCCCCeeeccCCCCceEe--cCCC--ceEEcccCCccCCCCCC----CcceeeccccCCcccCccccccCC
Q 046893          206 AAKGLAFLHGAERPVIYRDFKTSNILL--NADF--SAKLSDFGLAKDGPMGD----QTHVSTRVMGTYGYAAPEYVMTGH  277 (464)
Q Consensus       206 i~~~l~~LH~~~~~ivHrDlkp~Nill--~~~~--~vkl~DFGla~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~  277 (464)
                      +++|+.|||  .++|.|||||.+||||  |+|+  .+.|+|||.|-......    +....-..-|...-||||+....+
T Consensus       350 lLEav~hL~--~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~P  427 (598)
T KOG4158|consen  350 LLEAVTHLH--KHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVP  427 (598)
T ss_pred             HHHHHHHHH--HccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCC
Confidence            999999999  6779999999999998  4444  46899999886322211    111111245788899999875422


Q ss_pred             -----C-CcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhcccchhhccCccccCccCHHHHHHHHHHHH
Q 046893          278 -----L-TARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRILDPRLEGQYTARTAMKVAGLAY  351 (464)
Q Consensus       278 -----~-~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  351 (464)
                           . -.|+|.|+.|-+.||++....||.+..... .+...               .........+..++..+.+|+.
T Consensus       428 Gp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~-L~~r~---------------Yqe~qLPalp~~vpp~~rqlV~  491 (598)
T KOG4158|consen  428 GPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEML-LDTRT---------------YQESQLPALPSRVPPVARQLVF  491 (598)
T ss_pred             CCceeeccchhhhhhhhhhHHHHhccCCcccccchhe-echhh---------------hhhhhCCCCcccCChHHHHHHH
Confidence                 1 248999999999999999999998632110 00000               0111122345667779999999


Q ss_pred             HhhccCCCCCCCHHHHHHHHH
Q 046893          352 QCLSQNPKGRPVMSDVVALLE  372 (464)
Q Consensus       352 ~cl~~dP~~RPs~~ev~~~L~  372 (464)
                      ..|+.||.+|++..-....|.
T Consensus       492 ~lL~r~pskRvsp~iAANvl~  512 (598)
T KOG4158|consen  492 DLLKRDPSKRVSPNIAANVLN  512 (598)
T ss_pred             HHhcCCccccCCccHHHhHHH
Confidence            999999999998876555553

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.79  E-value=1e-18  Score=160.80  Aligned_cols=134  Identities=22%  Similarity=0.271  Sum_probs=109.8

Q ss_pred             CceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCcc--------HHHHHHHHHHHhcCCCCCcceEEEEEEeCCe
Q 046893           98 YILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQG--------DREWLAEVNYLGQLRHSNLVKLIGYCCEDEH  169 (464)
Q Consensus        98 ~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~--------~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~  169 (464)
                      +.||+|++|.||+|.+.        +..+++|+........        ...+.+|+.++..+.|++|.....++...+.
T Consensus         2 ~~l~~G~~~~vy~~~~~--------~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~   73 (211)
T PRK14879          2 KLIKRGAEAEIYLGDFL--------GIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPEN   73 (211)
T ss_pred             cccccCceEEEEEEeeC--------CCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCC
Confidence            56999999999999863        3347888765433211        1346789999999999998877777777788


Q ss_pred             EEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCccC
Q 046893          170 RILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKD  248 (464)
Q Consensus       170 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~  248 (464)
                      .++||||++|++|.+++....     . .+..++.+++.+|.+||  ..+++|+||+|.|||++ ++.++|+|||+++.
T Consensus        74 ~~lv~e~~~G~~L~~~~~~~~-----~-~~~~i~~~i~~~l~~lH--~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~  143 (211)
T PRK14879         74 FIIVMEYIEGEPLKDLINSNG-----M-EELELSREIGRLVGKLH--SAGIIHGDLTTSNMILS-GGKIYLIDFGLAEF  143 (211)
T ss_pred             CEEEEEEeCCcCHHHHHHhcc-----H-HHHHHHHHHHHHHHHHH--hCCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence            899999999999999875432     2 78889999999999999  67799999999999999 78999999998864

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.77  E-value=2.3e-18  Score=157.01  Aligned_cols=130  Identities=23%  Similarity=0.334  Sum_probs=102.9

Q ss_pred             ceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCcc--------HHHHHHHHHHHhcCCCCCcceEEEEEEeCCeE
Q 046893           99 ILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQG--------DREWLAEVNYLGQLRHSNLVKLIGYCCEDEHR  170 (464)
Q Consensus        99 ~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~--------~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~  170 (464)
                      .||+|+||.||+|.+.        +..+++|.........        ..++.+|++++..+.|+++.....++...+..
T Consensus         1 ~ig~G~~~~vy~~~~~--------~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~   72 (199)
T TIGR03724         1 LIAKGAEAIIYLGDFL--------GLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNK   72 (199)
T ss_pred             CCCCCceEEEEEeecC--------CccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCC
Confidence            3899999999999843        3448888754432211        24567899999999988765555555666777


Q ss_pred             EEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCccC
Q 046893          171 ILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKD  248 (464)
Q Consensus       171 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~  248 (464)
                      ++||||++|++|.+++....   .      .++.+++.+|.+||  ..+++|+|++|.||+++ ++.++|+|||+++.
T Consensus        73 ~lv~e~~~g~~l~~~~~~~~---~------~~~~~i~~~l~~lH--~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~  138 (199)
T TIGR03724        73 TIVMEYIEGKPLKDVIEEGN---D------ELLREIGRLVGKLH--KAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY  138 (199)
T ss_pred             EEEEEEECCccHHHHHhhcH---H------HHHHHHHHHHHHHH--HCCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence            89999999999988765421   1      78899999999999  67799999999999999 78999999999864

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.77  E-value=2.4e-18  Score=180.09  Aligned_cols=137  Identities=25%  Similarity=0.295  Sum_probs=108.7

Q ss_pred             hcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEc-cC-CCC------ccHHHHHHHHHHHhcCCCCCcceEEE
Q 046893           91 TKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKEL-NR-GGY------QGDREWLAEVNYLGQLRHSNLVKLIG  162 (464)
Q Consensus        91 ~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~-~~-~~~------~~~~~~~~E~~~l~~l~hpniv~l~~  162 (464)
                      ...|...+.||+|+||+||+|.+...      .  +++|+. .. ...      .....+.+|++++..++|++|+....
T Consensus       332 ~~~~~~~~~iG~G~~g~Vy~~~~~~~------~--~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~  403 (535)
T PRK09605        332 KRRKIPDHLIGKGAEADIKKGEYLGR------D--AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVI  403 (535)
T ss_pred             ccccCccceeccCCcEEEEEEeecCc------c--ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEE
Confidence            34456788999999999999987543      1  222221 11 111      11245789999999999999998887


Q ss_pred             EEEeCCeEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcc
Q 046893          163 YCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSD  242 (464)
Q Consensus       163 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~D  242 (464)
                      ++......++||||+++++|.+++.          ....++.+++.+|.|||  ..+++||||||+|||+ .++.++|+|
T Consensus       404 ~~~~~~~~~lv~E~~~g~~L~~~l~----------~~~~~~~~i~~~L~~lH--~~giiHrDlkp~NILl-~~~~~~liD  470 (535)
T PRK09605        404 YDVDPEEKTIVMEYIGGKDLKDVLE----------GNPELVRKVGEIVAKLH--KAGIVHGDLTTSNFIV-RDDRLYLID  470 (535)
T ss_pred             EEEeCCCCEEEEEecCCCcHHHHHH----------HHHHHHHHHHHHHHHHH--hCCCccCCCChHHEEE-ECCcEEEEe
Confidence            7777778899999999999988775          34678999999999999  6779999999999999 577999999


Q ss_pred             cCCccC
Q 046893          243 FGLAKD  248 (464)
Q Consensus       243 FGla~~  248 (464)
                      ||+++.
T Consensus       471 FGla~~  476 (535)
T PRK09605        471 FGLGKY  476 (535)
T ss_pred             Cccccc
Confidence            999974

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.76  E-value=4.8e-18  Score=154.81  Aligned_cols=140  Identities=17%  Similarity=0.123  Sum_probs=106.0

Q ss_pred             HHhcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCc----------------------cHHHHHHHH
Q 046893           89 LATKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQ----------------------GDREWLAEV  146 (464)
Q Consensus        89 ~~~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~----------------------~~~~~~~E~  146 (464)
                      .....|.+.+.||.|+||.||+|.+..       ++.||||++......                      ....+..|+
T Consensus        12 ~~~~~~~~~~~i~~G~~g~Vy~~~~~~-------g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~   84 (198)
T cd05144          12 KRGVVESLGNQIGVGKESDVYLALDPD-------GNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEF   84 (198)
T ss_pred             HcCchhhcCCccccCcceEEEEEEcCC-------CCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHH
Confidence            333348888999999999999998642       567999986543200                      011256788


Q ss_pred             HHHhcCCCCC--cceEEEEEEeCCeEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeecc
Q 046893          147 NYLGQLRHSN--LVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRD  224 (464)
Q Consensus       147 ~~l~~l~hpn--iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrD  224 (464)
                      .++..+.|++  +..+++.    ...++||||++|++|......        .....++.+++.++.++|  ..+|+|||
T Consensus        85 ~~l~~l~~~~i~v~~~~~~----~~~~lv~e~~~g~~L~~~~~~--------~~~~~~~~~i~~~l~~lh--~~gi~H~D  150 (198)
T cd05144          85 AALKALYEEGFPVPKPIDW----NRHAVVMEYIDGVELYRVRVL--------EDPEEVLDEILEEIVKAY--KHGIIHGD  150 (198)
T ss_pred             HHHHHHHHcCCCCCceeec----CCceEEEEEeCCcchhhcccc--------ccHHHHHHHHHHHHHHHH--HCCCCcCC
Confidence            8898887774  4444432    345899999999998664321        334578889999999999  57799999


Q ss_pred             CCCCceEecCCCceEEcccCCccCC
Q 046893          225 FKTSNILLNADFSAKLSDFGLAKDG  249 (464)
Q Consensus       225 lkp~Nill~~~~~vkl~DFGla~~~  249 (464)
                      |||+||+++.++.++|+|||++...
T Consensus       151 l~p~Nill~~~~~~~liDfg~~~~~  175 (198)
T cd05144         151 LSEFNILVDDDEKIYIIDWPQMVST  175 (198)
T ss_pred             CCcccEEEcCCCcEEEEECCccccC
Confidence            9999999999999999999999653

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.71  E-value=1.1e-18  Score=182.45  Aligned_cols=256  Identities=23%  Similarity=0.278  Sum_probs=189.2

Q ss_pred             CCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCC--CccHHHHHHHHHHHhcCC-CCCcceEEEEEEeCCeE
Q 046893           94 FRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGG--YQGDREWLAEVNYLGQLR-HSNLVKLIGYCCEDEHR  170 (464)
Q Consensus        94 ~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~  170 (464)
                      |.+.+.||+|+|+.|-......+     ....+|+|.+....  .........|..+-..+. |.|++.+++.....+..
T Consensus        22 ~~~~~~ig~gs~~~~~~~~~~~~-----~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~   96 (601)
T KOG0590|consen   22 YKLSRSIGKGSFSSSALASNSRD-----PESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSY   96 (601)
T ss_pred             ccccccccccccchhhhhhhcCC-----CcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccc
Confidence            56666799999999988765443     24457777766543  222244455777777776 99999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCC-ceEEcccCCccCC
Q 046893          171 ILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADF-SAKLSDFGLAKDG  249 (464)
Q Consensus       171 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~-~vkl~DFGla~~~  249 (464)
                      +++++|..|+++.+.+........+....-.++.|+..++.|+|. ..++.|+||||+|.+++..+ .+++.|||+|..+
T Consensus        97 ~~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~-~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~  175 (601)
T KOG0590|consen   97 LLSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHP-ENGVTHRDIKPSNSLLDESGSALKIADFGLATAY  175 (601)
T ss_pred             ccccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCc-ccccccCCCCCccchhccCCCcccCCCchhhccc
Confidence            999999999999887732222246667777889999999999994 45699999999999999999 9999999999987


Q ss_pred             CC-CCCcceeecccc-CCcccCccccccC-CCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhcccch
Q 046893          250 PM-GDQTHVSTRVMG-TYGYAAPEYVMTG-HLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKV  326 (464)
Q Consensus       250 ~~-~~~~~~~~~~~g-t~~y~aPE~~~~~-~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  326 (464)
                      .. ..........+| ++.|+|||...+. ......|+||+|+++.-+++|..||......... ...|...     .  
T Consensus       176 ~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~-~~~~~~~-----~--  247 (601)
T KOG0590|consen  176 RNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGR-YSSWKSN-----K--  247 (601)
T ss_pred             cccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccccc-ceeeccc-----c--
Confidence            66 444444555788 9999999988885 4567899999999999999999999865543311 1111110     0  


Q ss_pred             hhccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHH
Q 046893          327 LRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVV  368 (464)
Q Consensus       327 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~  368 (464)
                       .    ...............+++.+++..+|..|.+.+++.
T Consensus       248 -~----~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~  284 (601)
T KOG0590|consen  248 -G----RFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELK  284 (601)
T ss_pred             -c----ccccCccccCChhhhhcccccccCCchhcccccccc
Confidence             0    000111122333667888999999999999988774

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.68  E-value=2.2e-16  Score=142.32  Aligned_cols=137  Identities=20%  Similarity=0.180  Sum_probs=95.2

Q ss_pred             CCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCcc--HHH----------------------HHHHHHHHhcC
Q 046893           97 DYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQG--DRE----------------------WLAEVNYLGQL  152 (464)
Q Consensus        97 ~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~--~~~----------------------~~~E~~~l~~l  152 (464)
                      .+.||+|+||+||+|.+..       ++.||||++.......  ...                      ...|...+..+
T Consensus         2 ~~~lg~G~~g~Vy~a~~~~-------~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l   74 (187)
T cd05119           2 GGPIGTGKEADVYLALDGD-------GEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRL   74 (187)
T ss_pred             CcccccccceeEEEEECCC-------CCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHH
Confidence            4679999999999998652       5669999986532211  111                      13456666666


Q ss_pred             CCC--CcceEEEEEEeCCeEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCce
Q 046893          153 RHS--NLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNI  230 (464)
Q Consensus       153 ~hp--niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Ni  230 (464)
                      .+.  .+.+.+++    ...++||||+.++.+.........  .. .....++.+++.++.++|. ..+|+|+||||+||
T Consensus        75 ~~~~~~~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~--~~-~~~~~~~~~~~~~l~~lh~-~~~ivH~Dl~p~Ni  146 (187)
T cd05119          75 YEAGVPVPKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR--LL-EDPEELYDQILELMRKLYR-EAGLVHGDLSEYNI  146 (187)
T ss_pred             HHcCCCCCceEec----CCCEEEEEEeCCCCccChhhhhhh--hc-ccHHHHHHHHHHHHHHHhh-ccCcCcCCCChhhE
Confidence            433  24444443    245899999998544321111110  11 5677899999999999994 17799999999999


Q ss_pred             EecCCCceEEcccCCccCC
Q 046893          231 LLNADFSAKLSDFGLAKDG  249 (464)
Q Consensus       231 ll~~~~~vkl~DFGla~~~  249 (464)
                      +++ ++.++|+|||.+...
T Consensus       147 li~-~~~~~liDfg~a~~~  164 (187)
T cd05119         147 LVD-DGKVYIIDVPQAVEI  164 (187)
T ss_pred             EEE-CCcEEEEECcccccc
Confidence            999 889999999999753

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.68  E-value=3.7e-16  Score=134.97  Aligned_cols=134  Identities=21%  Similarity=0.141  Sum_probs=110.7

Q ss_pred             CCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCccHHHHHHHHHHHhcCCC--CCcceEEEEEEeCCeEEEE
Q 046893           96 PDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRH--SNLVKLIGYCCEDEHRILV  173 (464)
Q Consensus        96 ~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--pniv~l~~~~~~~~~~~lv  173 (464)
                      +.+.||.|.++.||++....        ..+++|.......  ...+..|+.++..+.|  .++.+++.++...+..+++
T Consensus         2 ~~~~i~~g~~~~v~~~~~~~--------~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v   71 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTKD--------EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLL   71 (155)
T ss_pred             cceecccccccceEEEEecC--------CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEE
Confidence            34679999999999998643        3489998865432  4578899999999976  5899999988888889999


Q ss_pred             EeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC-CCeeeccCCCCceEecCCCceEEcccCCccC
Q 046893          174 YEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAE-RPVIYRDFKTSNILLNADFSAKLSDFGLAKD  248 (464)
Q Consensus       174 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~-~~ivHrDlkp~Nill~~~~~vkl~DFGla~~  248 (464)
                      |||+.++.+..+         +......++.+++.+|.+||... .+++|+||+|+||+++..+.++++|||++..
T Consensus        72 ~e~~~g~~~~~~---------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~  138 (155)
T cd05120          72 MEWIEGETLDEV---------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY  138 (155)
T ss_pred             EEecCCeecccC---------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence            999988777543         45566778899999999999532 4799999999999999889999999999874

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.67  E-value=5.3e-16  Score=145.09  Aligned_cols=134  Identities=22%  Similarity=0.209  Sum_probs=100.8

Q ss_pred             Ccee-ecCceEEEEEEecCCCCCCccceEEEEEEccCCCC-------------ccHHHHHHHHHHHhcCCCCCc--ceEE
Q 046893           98 YILG-EGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGY-------------QGDREWLAEVNYLGQLRHSNL--VKLI  161 (464)
Q Consensus        98 ~~lG-~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~-------------~~~~~~~~E~~~l~~l~hpni--v~l~  161 (464)
                      ..|| .||.|+||.+...        +..++||.......             .....+.+|+.++..|.|++|  +..+
T Consensus        37 ~~lg~~~g~gtv~~v~~~--------~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl  108 (239)
T PRK01723         37 RVVGSAKGRGTTWFVQTP--------GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPI  108 (239)
T ss_pred             ceeecCCCCccEEEEEeC--------CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeE
Confidence            4587 8999999988754        23478887653211             122457889999999988775  6677


Q ss_pred             EEEEeCC----eEEEEEeccCC-CCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCC
Q 046893          162 GYCCEDE----HRILVYEYMES-GSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADF  236 (464)
Q Consensus       162 ~~~~~~~----~~~lv~e~~~~-g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~  236 (464)
                      ++.....    ..+||||+++| .+|.+++...   .++..    .+.+++.+|.+||  ..+|+||||||+|||++.++
T Consensus       109 ~~~~~~~~~~~~~~lV~e~l~G~~~L~~~l~~~---~l~~~----~~~~i~~~l~~lH--~~GI~HrDlkp~NILv~~~~  179 (239)
T PRK01723        109 AARVVRHGLFYRADILIERIEGARDLVALLQEA---PLSEE----QWQAIGQLIARFH--DAGVYHADLNAHNILLDPDG  179 (239)
T ss_pred             eeeeeecCcceeeeEEEEecCCCCCHHHHHhcC---CCCHH----HHHHHHHHHHHHH--HCCCCCCCCCchhEEEcCCC
Confidence            6644332    23599999997 6898877542   35544    3568999999999  67799999999999999888


Q ss_pred             ceEEcccCCccC
Q 046893          237 SAKLSDFGLAKD  248 (464)
Q Consensus       237 ~vkl~DFGla~~  248 (464)
                      .++|+|||.+..
T Consensus       180 ~v~LIDfg~~~~  191 (239)
T PRK01723        180 KFWLIDFDRGEL  191 (239)
T ss_pred             CEEEEECCCccc
Confidence            999999999875

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.58  E-value=9.2e-15  Score=146.64  Aligned_cols=254  Identities=23%  Similarity=0.255  Sum_probs=181.9

Q ss_pred             HhcCCCCCCceee--cCceEEEEEEecCCCCCCccceEEEEEEccCCCC--ccHHHHHHHHHHHhcC-CCCCcceEEEEE
Q 046893           90 ATKFFRPDYILGE--GGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGY--QGDREWLAEVNYLGQL-RHSNLVKLIGYC  164 (464)
Q Consensus        90 ~~~~~~~~~~lG~--G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l-~hpniv~l~~~~  164 (464)
                      ....|.+...+|.  |.+|.||.+....    ......+|+|.-+..-.  .....=++|+.-...+ .|+|.++.+..+
T Consensus       112 ~~~~~~~~~~~g~~~g~~~s~~~~~~~~----~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~  187 (524)
T KOG0601|consen  112 FDQRFPISSRTGSLPGSKGSVFKSRCTN----SESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAW  187 (524)
T ss_pred             hhhhcccccccccCCCCCceeecccCCc----ccCCcccccccccCCCCCccccccccchhhcccccCccccccccCccc
Confidence            3455778888999  9999999988632    11356688887433221  1222234566666666 599999999999


Q ss_pred             EeCCeEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHH----HHHHHhcCCCCeeeccCCCCceEecCC-CceE
Q 046893          165 CEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAK----GLAFLHGAERPVIYRDFKTSNILLNAD-FSAK  239 (464)
Q Consensus       165 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~----~l~~LH~~~~~ivHrDlkp~Nill~~~-~~vk  239 (464)
                      ...+..++-.|+| +.+|..+.... ...++...++.+..+...    ||.++|  ..+++|-|+||.||++..+ ..++
T Consensus       188 e~~~~lfiqtE~~-~~sl~~~~~~~-~~~~p~~~l~~~~~~~~~~~~~al~~~h--s~~~~~~~~kp~~i~~~~~~~s~~  263 (524)
T KOG0601|consen  188 EGSGILFIQTELC-GESLQSYCHTP-CNFLPDNLLWNSLRDWLSRDVTALSHLH--SNNIVHDDLKPANIFTTSDWTSCK  263 (524)
T ss_pred             ccCCcceeeeccc-cchhHHhhhcc-cccCCchhhhhHHhhhhhcccccccccC--CCcccccccchhheecccccceee
Confidence            9999999999999 56887776654 334788888888889888    999999  5679999999999999988 8899


Q ss_pred             EcccCCccCCCCCCCc---ceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHH
Q 046893          240 LSDFGLAKDGPMGDQT---HVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWA  316 (464)
Q Consensus       240 l~DFGla~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~  316 (464)
                      ++|||+..........   ....+..|...|++||.. .+-++..+|||+||.++.+..++...+...-.      ..|.
T Consensus       264 ~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~-~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~------~~W~  336 (524)
T KOG0601|consen  264 LTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELL-NGLATFASDIFSLGEVILEAILGSHLPSVGKN------SSWS  336 (524)
T ss_pred             cCCcceeEEccCCccccceeeeecCCCCceEeChhhh-ccccchHhhhcchhhhhHhhHhhcccccCCCC------CCcc
Confidence            9999999876544322   222334688899999954 56788999999999999999998776543210      0111


Q ss_pred             HHhhhcccchhhccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 046893          317 RPLLNNNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVA  369 (464)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  369 (464)
                      .  +      ..   ..+..++.......+...+..|++.+|..|++...+.+
T Consensus       337 ~--~------r~---~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~  378 (524)
T KOG0601|consen  337 Q--L------RQ---GYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA  378 (524)
T ss_pred             c--c------cc---ccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence            0  0      00   00122223233335666888999999999998887654

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.52  E-value=8.9e-15  Score=135.84  Aligned_cols=202  Identities=27%  Similarity=0.344  Sum_probs=139.4

Q ss_pred             HHHHhcCCCCCcceEEEEEEeCC-----eEEEEEeccCCCCHHHHHHhhc--CCCCCHHHHHHHHHHHHHHHHHHhcCCC
Q 046893          146 VNYLGQLRHSNLVKLIGYCCEDE-----HRILVYEYMESGSLEKHLLRRV--GCMLTWSRRMKIALDAAKGLAFLHGAER  218 (464)
Q Consensus       146 ~~~l~~l~hpniv~l~~~~~~~~-----~~~lv~e~~~~g~L~~~l~~~~--~~~l~~~~~~~i~~qi~~~l~~LH~~~~  218 (464)
                      +..|-++.|.|||+++.|+.+..     ...++.|||..|+|..+|++..  ...+....-.+|+-||+.||.|||++..
T Consensus       118 FdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~P  197 (458)
T KOG1266|consen  118 FDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDP  197 (458)
T ss_pred             HHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCC
Confidence            44555667999999999886544     4789999999999999997643  3457777888999999999999999999


Q ss_pred             CeeeccCCCCceEecCCCceEEcccCCccCCCCC---CCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHH
Q 046893          219 PVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMG---DQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEML  295 (464)
Q Consensus       219 ~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~---~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell  295 (464)
                      .|+|++|..+-|++..+|-+||.- +.-......   ..........|-++|.+||.=.....+..+|||+||....||.
T Consensus       198 piihgnlTc~tifiq~ngLIkig~-~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlema  276 (458)
T KOG1266|consen  198 PIIHGNLTCDTIFIQHNGLIKIGS-VAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMA  276 (458)
T ss_pred             ccccCCcchhheeecCCceEEecc-cCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHH
Confidence            999999999999999999888742 111000000   0001112235678899999877777888999999999999998


Q ss_pred             hCCCCCCCCCCcccccHHHHHHHhhhcccchhhccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHH
Q 046893          296 LGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVV  368 (464)
Q Consensus       296 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~  368 (464)
                      .+..--.......   .++..     ....+. .+...           .-..++.+|++..|..||+|.+++
T Consensus       277 ilEiq~tnseS~~---~~ee~-----ia~~i~-~len~-----------lqr~~i~kcl~~eP~~rp~ar~ll  329 (458)
T KOG1266|consen  277 ILEIQSTNSESKV---EVEEN-----IANVII-GLENG-----------LQRGSITKCLEGEPNGRPDARLLL  329 (458)
T ss_pred             HheeccCCCccee---ehhhh-----hhhhee-eccCc-----------cccCcCcccccCCCCCCcchhhhh
Confidence            8764321111100   00000     000000 01111           112477899999999999999875

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.51  E-value=5.9e-14  Score=142.45  Aligned_cols=139  Identities=19%  Similarity=0.135  Sum_probs=94.6

Q ss_pred             CceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCccH--------------------------------------
Q 046893           98 YILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGD--------------------------------------  139 (464)
Q Consensus        98 ~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~--------------------------------------  139 (464)
                      +.||.|++|.||+|++.+       |+.||||+.........                                      
T Consensus       123 ~plasaSigQVh~A~l~~-------G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~  195 (437)
T TIGR01982       123 KPLAAASIAQVHRARLVD-------GKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLR  195 (437)
T ss_pred             cceeeeehhheEEEEecC-------CCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHH
Confidence            579999999999999864       56799999865421100                                      


Q ss_pred             --HHHHHHHHHHhcC----CCCCcceEEEEE-EeCCeEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHH-HHH
Q 046893          140 --REWLAEVNYLGQL----RHSNLVKLIGYC-CEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAK-GLA  211 (464)
Q Consensus       140 --~~~~~E~~~l~~l----~hpniv~l~~~~-~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~-~l~  211 (464)
                        -+|..|++.+.++    .|.+-+.+-.++ ......+|||||++|++|.++...... ...   ...++..++. .+.
T Consensus       196 ~Eldf~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~-~~~---~~~ia~~~~~~~l~  271 (437)
T TIGR01982       196 RELDLRREAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA-GLD---RKALAENLARSFLN  271 (437)
T ss_pred             HHHCHHHHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhc-CCC---HHHHHHHHHHHHHH
Confidence              0134455555554    232223322222 223456899999999999887643221 122   3345555555 467


Q ss_pred             HHhcCCCCeeeccCCCCceEecCCCceEEcccCCccCC
Q 046893          212 FLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDG  249 (464)
Q Consensus       212 ~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~  249 (464)
                      .+|  ..+++|+|+||.||+++.++.++|+|||++...
T Consensus       272 ql~--~~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l  307 (437)
T TIGR01982       272 QVL--RDGFFHADLHPGNIFVLKDGKIIALDFGIVGRL  307 (437)
T ss_pred             HHH--hCCceeCCCCcccEEECCCCcEEEEeCCCeeEC
Confidence            788  577999999999999999999999999999764

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.46  E-value=2.2e-12  Score=130.85  Aligned_cols=229  Identities=17%  Similarity=0.168  Sum_probs=150.3

Q ss_pred             ceEEEEEEccCCCCccHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHH
Q 046893          123 TTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKI  202 (464)
Q Consensus       123 ~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i  202 (464)
                      +..|.|...+...........+-++.|+.|+||||+++++.+..+...|||.|.+.  .|..++.+.     ........
T Consensus        37 ~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l-----~~~~v~~G  109 (690)
T KOG1243|consen   37 GGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKEL-----GKEEVCLG  109 (690)
T ss_pred             CCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHh-----HHHHHHHH
Confidence            45577777666544334556778899999999999999999999999999999985  577777653     36667778


Q ss_pred             HHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCccCCCCCCCcceeeccccCCcccCccccccCCCCccc
Q 046893          203 ALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARS  282 (464)
Q Consensus       203 ~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~  282 (464)
                      +.||+.||.|||. +.+++|++|....|+++..|.+||++|.++........  ......---.|..|+.+....  -..
T Consensus       110 l~qIl~AL~FL~~-d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--~~~~~~~~~s~~~P~~~~~s~--~s~  184 (690)
T KOG1243|consen  110 LFQILAALSFLND-DCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--PAKSLYLIESFDDPEEIDPSE--WSI  184 (690)
T ss_pred             HHHHHHHHHHHhc-cCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--ccccchhhhcccChhhcCccc--cch
Confidence            8999999999985 67799999999999999999999999998865322111  001111122356666443222  346


Q ss_pred             chhcHHHHHHHHHhCCCCCCCCCCcc---cccHHHHH-HHhhhcccchhhccCccccCccCHHHHHHHHHHHHHhhccCC
Q 046893          283 DVYGFGVVLLEMLLGRRAVDKSRPSR---EHNLVEWA-RPLLNNNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNP  358 (464)
Q Consensus       283 DvwslG~il~ell~g~~pf~~~~~~~---~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP  358 (464)
                      |.|-|||++||++.|..+-...-...   ....++.. ..+...                ...-+ ...+++..|.....
T Consensus       185 D~~~Lg~li~el~ng~~~~~~~~~~~~~ipk~~~~~~~k~~~~~----------------~~~r~-n~~~~~~~~~~~~g  247 (690)
T KOG1243|consen  185 DSWGLGCLIEELFNGSLLTKTDLSNTGKIPKALIELYCKKLGAT----------------ELKRP-NKLRFILECRLLGG  247 (690)
T ss_pred             hhhhHHHHHHHHhCcccCcchhhhccCccchhHHHHHHHHhccc----------------ccccc-chhhHHHHHHhccc
Confidence            99999999999999932221110000   00011110 000000                00011 14566777777777


Q ss_pred             CCCCCHHHHHHHHHHHHhcChh
Q 046893          359 KGRPVMSDVVALLETVQSQGAE  380 (464)
Q Consensus       359 ~~RPs~~ev~~~L~~~~~~~~~  380 (464)
                      ..|=.+-++..+|+++.-...+
T Consensus       248 ff~n~fvd~~~fLeel~lks~~  269 (690)
T KOG1243|consen  248 FFRNDFVDTLLFLEELRLKSVE  269 (690)
T ss_pred             cccchHHHHHHHHHhcccCcHH
Confidence            7777777777777776655433

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.39  E-value=2.9e-13  Score=139.14  Aligned_cols=144  Identities=17%  Similarity=0.137  Sum_probs=92.9

Q ss_pred             hcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCcc--------------------------------
Q 046893           91 TKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQG--------------------------------  138 (464)
Q Consensus        91 ~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~--------------------------------  138 (464)
                      ...|.. +.||+|++|.||+|++.++      |+.||||+........                                
T Consensus       119 F~~fd~-~PlasaSiaQVh~A~l~~~------G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~  191 (537)
T PRK04750        119 FDDFDI-KPLASASIAQVHFARLKDN------GREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVA  191 (537)
T ss_pred             HHhcCh-hhhcCCCccEEEEEEECCC------CCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHH
Confidence            445666 6899999999999998764      5679999997542100                                


Q ss_pred             --H------HHHHHHHHHHhcCC----CCCcceEEEEEEe-CCeEEEEEeccCCCCHHHHHH-hhcCC---CCCHHHHHH
Q 046893          139 --D------REWLAEVNYLGQLR----HSNLVKLIGYCCE-DEHRILVYEYMESGSLEKHLL-RRVGC---MLTWSRRMK  201 (464)
Q Consensus       139 --~------~~~~~E~~~l~~l~----hpniv~l~~~~~~-~~~~~lv~e~~~~g~L~~~l~-~~~~~---~l~~~~~~~  201 (464)
                        .      -++.+|+..+.++.    +.+.+.+-.++.+ ....+|||||+.|+.|.++-. ...+.   .+....+..
T Consensus       192 e~~~~l~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~  271 (537)
T PRK04750        192 EFEKTLHDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEV  271 (537)
T ss_pred             HHHHHHHHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHH
Confidence              0      11344555555542    3333443333322 345689999999999977422 11111   122222333


Q ss_pred             HHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCC----ceEEcccCCccCCC
Q 046893          202 IALDAAKGLAFLHGAERPVIYRDFKTSNILLNADF----SAKLSDFGLAKDGP  250 (464)
Q Consensus       202 i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~----~vkl~DFGla~~~~  250 (464)
                      ++.|+       +  ..+++|+|+||.||+++.++    .++++|||++....
T Consensus       272 ~~~Qi-------f--~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~  315 (537)
T PRK04750        272 FFTQV-------F--RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLN  315 (537)
T ss_pred             HHHHH-------H--hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECC
Confidence            33333       3  35699999999999999888    99999999997643

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.39  E-value=1.3e-12  Score=115.54  Aligned_cols=129  Identities=19%  Similarity=0.105  Sum_probs=92.6

Q ss_pred             CceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCccHHHHHHHHHHHhcCCCCCcc-eEEEEEEeCCeEEEEEec
Q 046893           98 YILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLV-KLIGYCCEDEHRILVYEY  176 (464)
Q Consensus        98 ~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv-~l~~~~~~~~~~~lv~e~  176 (464)
                      +.|+.|.++.||++...        +..+++|+...... ....+..|+.++..+.+.+++ +++.+.  ....++||||
T Consensus         4 ~~l~~G~~~~vy~~~~~--------~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~   72 (170)
T cd05151           4 SPLKGGMTNKNYRVEVA--------NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEF   72 (170)
T ss_pred             eecCCcccCceEEEEEC--------CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEe
Confidence            45889999999998754        34589998755421 223457899999988655544 444433  3345799999


Q ss_pred             cCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC---CCeeeccCCCCceEecCCCceEEcccCCccC
Q 046893          177 MESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAE---RPVIYRDFKTSNILLNADFSAKLSDFGLAKD  248 (464)
Q Consensus       177 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~---~~ivHrDlkp~Nill~~~~~vkl~DFGla~~  248 (464)
                      ++|.++...  .     ..   ...++.+++.+|..||...   ..++|+|++|.||+++ ++.++|+|||.+..
T Consensus        73 i~G~~l~~~--~-----~~---~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~  136 (170)
T cd05151          73 IEGSELLTE--D-----FS---DPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM  136 (170)
T ss_pred             cCCCccccc--c-----cc---CHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence            999887542  0     11   1235678999999999533   1259999999999998 66899999998863

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.37  E-value=7.9e-12  Score=112.10  Aligned_cols=142  Identities=15%  Similarity=0.129  Sum_probs=97.5

Q ss_pred             CceeecCceEEEEEEecCCCCCCccceEEEEEEccCCC--Cc-------------------c-HHHH----HHHHHHHhc
Q 046893           98 YILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGG--YQ-------------------G-DREW----LAEVNYLGQ  151 (464)
Q Consensus        98 ~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~--~~-------------------~-~~~~----~~E~~~l~~  151 (464)
                      ..||.|--+.||.|...++......+..+|||+.+...  ..                   . ...+    .+|++.|.+
T Consensus         3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r   82 (197)
T cd05146           3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR   82 (197)
T ss_pred             CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence            46899999999999855321011124568999986421  00                   0 1122    279999999


Q ss_pred             CCC--CCcceEEEEEEeCCeEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHH-hcCCCCeeeccCCCC
Q 046893          152 LRH--SNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFL-HGAERPVIYRDFKTS  228 (464)
Q Consensus       152 l~h--pniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~L-H~~~~~ivHrDlkp~  228 (464)
                      +..  -++.+++++    ...+|||||+.+..+.....+.  ..++......+..+++.+|..| |  ..+|||+||++.
T Consensus        83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd--~~~~~~~~~~i~~~i~~~l~~l~H--~~glVHGDLs~~  154 (197)
T cd05146          83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD--AKLNDEEMKNAYYQVLSMMKQLYK--ECNLVHADLSEY  154 (197)
T ss_pred             HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc--cccCHHHHHHHHHHHHHHHHHHHH--hCCeecCCCCHH
Confidence            853  456666654    4567999999765442211121  2355566677889999999998 7  567999999999


Q ss_pred             ceEecCCCceEEcccCCccC
Q 046893          229 NILLNADFSAKLSDFGLAKD  248 (464)
Q Consensus       229 Nill~~~~~vkl~DFGla~~  248 (464)
                      |||++ ++.++|+|||.+..
T Consensus       155 NIL~~-~~~v~iIDF~qav~  173 (197)
T cd05146         155 NMLWH-DGKVWFIDVSQSVE  173 (197)
T ss_pred             HEEEE-CCcEEEEECCCcee
Confidence            99997 46899999998864

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.32  E-value=1.6e-12  Score=130.73  Aligned_cols=257  Identities=21%  Similarity=0.214  Sum_probs=176.8

Q ss_pred             ccchhH-HHHHhcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCccHHHH--HHHHHHHhcC-CCCC
Q 046893           81 IFTYNE-MKLATKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREW--LAEVNYLGQL-RHSN  156 (464)
Q Consensus        81 ~~~~~~-~~~~~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~--~~E~~~l~~l-~hpn  156 (464)
                      +|...+ ......+|-++..||.|.|+.|+.......     .+..+++|.+.........++  +.|+.+...+ .|.+
T Consensus       253 i~~~~~~~s~~~~df~~v~~i~~~~~~~~~~~~~r~~-----~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~  327 (524)
T KOG0601|consen  253 IFTTSDWTSCKLTDFGLVSKISDGNFSSVFKVSKRPE-----GDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLP  327 (524)
T ss_pred             eecccccceeecCCcceeEEccCCccccceeeeecCC-----CCceEeChhhhccccchHhhhcchhhhhHhhHhhcccc
Confidence            343334 334455688888999999999998763311     256688888876544433332  4667666666 5888


Q ss_pred             cceEEEEEEeCCeEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCC-
Q 046893          157 LVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNAD-  235 (464)
Q Consensus       157 iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~-  235 (464)
                      ++.++..|......|+--|||+++++...+.-  -..+....++.+..|++.++.++|  .+.++|+|+||.||++..+ 
T Consensus       328 ~~g~~~~W~~~r~~~ip~e~~~~~s~~l~~~~--~~~~d~~~~~~~~~q~~~~l~~i~--s~~~~~~d~~psni~i~~~~  403 (524)
T KOG0601|consen  328 SVGKNSSWSQLRQGYIPLEFCEGGSSSLRSVT--SQMLDEDPRLRLTAQILTALNVIH--SKLFVHLDVKPSNILISNDG  403 (524)
T ss_pred             cCCCCCCccccccccCchhhhcCcchhhhhHH--HHhcCcchhhhhHHHHHhcccccc--chhhhcccccccceeeccch
Confidence            99988888888888899999999998766632  336788889999999999999999  5679999999999999775 


Q ss_pred             CceEEcccCCccCCCCCCCcceeeccccCCccc--CccccccCCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHH
Q 046893          236 FSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYA--APEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLV  313 (464)
Q Consensus       236 ~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~--aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~  313 (464)
                      +..++.|||.+.......     .......+++  ++.......+..+.|+||||..+.+.++|...-....        
T Consensus       404 ~~~~~~~~~~~t~~~~~~-----~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~--------  470 (524)
T KOG0601|consen  404 FFSKLGDFGCWTRLAFSS-----GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGV--------  470 (524)
T ss_pred             hhhhccccccccccceec-----ccccccccccccchhhccccccccccccccccccccccccCcccCcccc--------
Confidence            778999999886422111     1123334444  4444456678899999999999999999875322211        


Q ss_pred             HHHHHhhhcccchhhccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 046893          314 EWARPLLNNNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLE  372 (464)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~  372 (464)
                      .|.        .+..-.-+..    +. ....+..+.+.+...++..||.+.++....+
T Consensus       471 ~~~--------~i~~~~~p~~----~~-~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~  516 (524)
T KOG0601|consen  471 QSL--------TIRSGDTPNL----PG-LKLQLQVLLKVMINPDRKRRPSAVELSLHSE  516 (524)
T ss_pred             cce--------eeecccccCC----Cc-hHHhhhhhhhhhcCCccccchhhhhhcccch
Confidence            110        0000001111    11 1146667788899999999999887765443

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.30  E-value=3.9e-11  Score=103.63  Aligned_cols=143  Identities=20%  Similarity=0.212  Sum_probs=104.8

Q ss_pred             CCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCcc--------HHHHHHHHHHHhcCCCCCcceEEEEEEeC
Q 046893           96 PDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQG--------DREWLAEVNYLGQLRHSNLVKLIGYCCED  167 (464)
Q Consensus        96 ~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~--------~~~~~~E~~~l~~l~hpniv~l~~~~~~~  167 (464)
                      ...+|-+|+-+.|+++.+.        ++...||.-....+..        ..+...|+++|.++.--.|.--.-+|.+.
T Consensus        11 ~l~likQGAEArv~~~~~~--------Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~   82 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSFS--------GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDT   82 (229)
T ss_pred             cceeeeccceeeEeeeccC--------CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEec
Confidence            3456889999999998865        4456666644332221        24567899999988644444333456666


Q ss_pred             CeEEEEEeccCC-CCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCC---ceEEccc
Q 046893          168 EHRILVYEYMES-GSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADF---SAKLSDF  243 (464)
Q Consensus       168 ~~~~lv~e~~~~-g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~---~vkl~DF  243 (464)
                      ..-.|+|||++| .++.+++...............++..|-..+.-||  ..+|||+||..+||+|..++   .+.|+||
T Consensus        83 ~~~~i~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH--~ndiiHGDLTTSNill~~~~~~~~~~lIdf  160 (229)
T KOG3087|consen   83 YGGQIYMEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLH--DNDIIHGDLTTSNILLRSDGNQITPILIDF  160 (229)
T ss_pred             CCCeEEEEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhh--hCCeecccccccceEEecCCCcCceEEEee
Confidence            677899999976 47888888776555555555788999999999999  66799999999999995544   3589999


Q ss_pred             CCccC
Q 046893          244 GLAKD  248 (464)
Q Consensus       244 Gla~~  248 (464)
                      |++..
T Consensus       161 gls~~  165 (229)
T KOG3087|consen  161 GLSSV  165 (229)
T ss_pred             cchhc
Confidence            99863

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.29  E-value=3.6e-11  Score=104.39  Aligned_cols=130  Identities=22%  Similarity=0.315  Sum_probs=95.8

Q ss_pred             ceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCccH--------HHHHHHHHHHhcCCCCCcceEEEEEEeCCeE
Q 046893           99 ILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGD--------REWLAEVNYLGQLRHSNLVKLIGYCCEDEHR  170 (464)
Q Consensus        99 ~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~--------~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~  170 (464)
                      .+++|+-+.||.+.+..        ..+++|.-....+...        ....+|+++|..+.--.|..-.-++.+....
T Consensus         3 ~i~~GAEa~i~~~~~~g--------~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~   74 (204)
T COG3642           3 LIKQGAEAIIYLTDFLG--------LPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNG   74 (204)
T ss_pred             hhhCCcceeEEeeeccC--------cceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCC
Confidence            57899999999986533        2356666444333221        3356899999988654444444455667777


Q ss_pred             EEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCccC
Q 046893          171 ILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKD  248 (464)
Q Consensus       171 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~  248 (464)
                      .|+|||++|..|.+++...         ...++..+-.-+.-||  ..+|||+||.++||++..+ .+.++||||+..
T Consensus        75 ~I~me~I~G~~lkd~l~~~---------~~~~~r~vG~~vg~lH--~~givHGDLTtsNiIl~~~-~i~~IDfGLg~~  140 (204)
T COG3642          75 LIVMEYIEGELLKDALEEA---------RPDLLREVGRLVGKLH--KAGIVHGDLTTSNIILSGG-RIYFIDFGLGEF  140 (204)
T ss_pred             EEEEEEeCChhHHHHHHhc---------chHHHHHHHHHHHHHH--hcCeecCCCccceEEEeCC-cEEEEECCcccc
Confidence            8999999998888887654         2456777788888999  6679999999999999765 499999999873

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.24  E-value=4.8e-11  Score=110.26  Aligned_cols=141  Identities=21%  Similarity=0.249  Sum_probs=105.8

Q ss_pred             CceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCC-ccHHHHHHHHHHHhcCCC--CCcceEEEEEEeC---CeEE
Q 046893           98 YILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGY-QGDREWLAEVNYLGQLRH--SNLVKLIGYCCED---EHRI  171 (464)
Q Consensus        98 ~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h--pniv~l~~~~~~~---~~~~  171 (464)
                      +.|+.|.++.||++...+       +..+++|....... .....+..|+.++..+.+  .++.+++.+....   +..+
T Consensus         4 ~~l~~G~~n~~~~v~~~~-------g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~   76 (223)
T cd05154           4 RQLSGGQSNLTYLLTAGG-------GRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPF   76 (223)
T ss_pred             eecCCCccceEEEEEecC-------CcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCce
Confidence            458999999999987643       34589998765332 134567899999999965  4467777776653   2568


Q ss_pred             EEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcC-----------------------------------
Q 046893          172 LVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGA-----------------------------------  216 (464)
Q Consensus       172 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~-----------------------------------  216 (464)
                      +||||++|.+|.+.+..   ..++......++.+++..|.+||+.                                   
T Consensus        77 ~v~e~i~G~~l~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  153 (223)
T cd05154          77 YVMERVDGRVLRDRLLR---PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDE  153 (223)
T ss_pred             EEEEEeCCEecCCCCCC---CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccc
Confidence            99999999888665431   2467777777888888888888842                                   


Q ss_pred             -------------------CCCeeeccCCCCceEecC--CCceEEcccCCccC
Q 046893          217 -------------------ERPVIYRDFKTSNILLNA--DFSAKLSDFGLAKD  248 (464)
Q Consensus       217 -------------------~~~ivHrDlkp~Nill~~--~~~vkl~DFGla~~  248 (464)
                                         ...++|+|+++.|||++.  ++.+.|+||+.+..
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~  206 (223)
T cd05154         154 PPAMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL  206 (223)
T ss_pred             cHHHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence                               134799999999999988  66789999998864

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.22  E-value=2.8e-12  Score=135.38  Aligned_cols=247  Identities=20%  Similarity=0.186  Sum_probs=162.1

Q ss_pred             CCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCc---cHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeE
Q 046893           94 FRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQ---GDREWLAEVNYLGQLRHSNLVKLIGYCCEDEHR  170 (464)
Q Consensus        94 ~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~  170 (464)
                      +.+.+-+-.|.|+.++.+.-...      +...++|+.......   ..+....+-.++-...+|.++...-.+.-....
T Consensus       806 ~~i~~p~qS~sp~ss~p~~pa~s------gh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~  879 (1205)
T KOG0606|consen  806 FEITKPSQSGSPSSSFPASPAGS------GHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPL  879 (1205)
T ss_pred             ceecccccCCCCcccccCCcccc------ccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCc
Confidence            44555677888888887643322      223344443322111   112223333333334456666655555567788


Q ss_pred             EEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCccCCC
Q 046893          171 ILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGP  250 (464)
Q Consensus       171 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~  250 (464)
                      +|||+|+.+++|...++...  ..+.+........+..+++|||+  ..++|+|++|.|+|+..++..++.|||......
T Consensus       880 ~L~~~~~~~~~~~Skl~~~~--~~saepaRs~i~~~vqs~e~L~s--~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg  955 (1205)
T KOG0606|consen  880 PLVGHYLNGGDLPSKLHNSG--CLSAEPARSPILERVQSLESLHS--SLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVG  955 (1205)
T ss_pred             chhhHHhccCCchhhhhcCC--CcccccccchhHHHHhhhhcccc--chhhcccccccchhhcccCCcccCccccccccc
Confidence            99999999999988876543  35555555566678889999994  448999999999999999999999998433111


Q ss_pred             CC-----------------------------CCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHhCCCCC
Q 046893          251 MG-----------------------------DQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAV  301 (464)
Q Consensus       251 ~~-----------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf  301 (464)
                      ..                             +.........||+.|.+||...+......+|+|++|++++|.++|..||
T Consensus       956 ~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~ 1035 (1205)
T KOG0606|consen  956 LIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPF 1035 (1205)
T ss_pred             cccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCC
Confidence            00                             0001122367999999999999999999999999999999999999999


Q ss_pred             CCCCCcccccHHHHHHHhhhcccchhhccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHH
Q 046893          302 DKSRPSREHNLVEWARPLLNNNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMS  365 (464)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~  365 (464)
                      ....+....      ..       +....-+.  ..-+...+....+++...+..+|.+|-.+.
T Consensus      1036 na~tpq~~f------~n-------i~~~~~~~--p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1036 NAETPQQIF------EN-------ILNRDIPW--PEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred             CCcchhhhh------hc-------cccCCCCC--CCCccccChhhhhhhhhhhccCchhccCcc
Confidence            876653321      10       11111111  111223344677888888999999997665

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=99.07  E-value=9.9e-09  Score=99.25  Aligned_cols=265  Identities=18%  Similarity=0.162  Sum_probs=157.8

Q ss_pred             CCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCccHHHHHHHHHHHhc-CCCCCcceEEE------EEEeC-
Q 046893           96 PDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQ-LRHSNLVKLIG------YCCED-  167 (464)
Q Consensus        96 ~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~-l~hpniv~l~~------~~~~~-  167 (464)
                      ..+.||+|+-+.+|-.---        +. .+.|+..........+.   +..|.. -.||-+-.-+.      +.-++ 
T Consensus        15 ~gr~LgqGgea~ly~l~e~--------~d-~VAKIYh~Pppa~~aqk---~a~la~~p~~p~~~~rvaWPqa~L~G~~~~   82 (637)
T COG4248          15 PGRPLGQGGEADLYTLGEV--------RD-QVAKIYHAPPPAAQAQK---VAELAATPDAPLLNYRVAWPQATLHGGRRG   82 (637)
T ss_pred             CCccccCCccceeeecchh--------hc-hhheeecCCCchHHHHH---HHHhccCCCCcchhhhhcccHHHhhCCCcc
Confidence            4567999999999953211        11 23355543322222222   222223 25664332111      11122 


Q ss_pred             CeEEEEEeccCCCCH-HHHHH----hhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcc
Q 046893          168 EHRILVYEYMESGSL-EKHLL----RRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSD  242 (464)
Q Consensus       168 ~~~~lv~e~~~~g~L-~~~l~----~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~D  242 (464)
                      ...-++|..+.+..= .+++.    ++......|.-.++.+..++.+.+.||  ..|.+-+|+.++|+|+.+++.|.|+|
T Consensus        83 ~~iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH--~~Gh~vGDVn~~~~lVsd~~~V~LVd  160 (637)
T COG4248          83 KVIGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLH--EHGHVVGDVNQNSFLVSDDSKVVLVD  160 (637)
T ss_pred             ceeEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHH--hcCCcccccCccceeeecCceEEEEc
Confidence            235678888876522 22211    112235789999999999999999999  55688899999999999999999998


Q ss_pred             cCCccCCCCCCCcceeeccccCCcccCccccc-----cCCCCcccchhcHHHHHHHHHhC-CCCCCCCCCcccc--cHH-
Q 046893          243 FGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVM-----TGHLTARSDVYGFGVVLLEMLLG-RRAVDKSRPSREH--NLV-  313 (464)
Q Consensus       243 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~ell~g-~~pf~~~~~~~~~--~~~-  313 (464)
                      =..-...   .........+|...|++||.-.     +..-+...|.|.||++++++|.| +.||.+.......  .+. 
T Consensus       161 sDsfqi~---~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~  237 (637)
T COG4248         161 SDSFQIN---ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLET  237 (637)
T ss_pred             ccceeec---cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchh
Confidence            5433322   2222333467999999999543     34556789999999999999996 9999864321110  011 


Q ss_pred             HHHHHhhhcccchhhccCccccCccCHHHHHHHHHHHHHhhccC--CCCCCCHHHHHHHHHHHHhc
Q 046893          314 EWARPLLNNNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQN--PKGRPVMSDVVALLETVQSQ  377 (464)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~d--P~~RPs~~ev~~~L~~~~~~  377 (464)
                      ..+...+....+-..-+.+....--....+..+..|+.+|+...  +.-||+.+.++..|..+...
T Consensus       238 ~Ia~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~  303 (637)
T COG4248         238 DIAHGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQ  303 (637)
T ss_pred             hhhcceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHh
Confidence            11111111111111111111111112334557888899998643  56899999999998877553

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=99.02  E-value=9.2e-09  Score=97.47  Aligned_cols=139  Identities=13%  Similarity=0.007  Sum_probs=95.8

Q ss_pred             eeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCc-----------cHHHHHHHHHHHhcCCCCC--cceEEEEEEe
Q 046893          100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQ-----------GDREWLAEVNYLGQLRHSN--LVKLIGYCCE  166 (464)
Q Consensus       100 lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~-----------~~~~~~~E~~~l~~l~hpn--iv~l~~~~~~  166 (464)
                      +-.-....|+++...        ++.+.||........           ....+.+|.+.+..|..-+  +..++.++..
T Consensus        30 v~~~~~rrvvr~~~~--------g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~  101 (268)
T PRK15123         30 FRELEGRRTLRFELA--------GKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGER  101 (268)
T ss_pred             EecCCCceEEEEEEC--------CEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEe
Confidence            333334446665432        456888866433211           1124678988888874332  3445555543


Q ss_pred             -----CCeEEEEEeccCCC-CHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecC------
Q 046893          167 -----DEHRILVYEYMESG-SLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNA------  234 (464)
Q Consensus       167 -----~~~~~lv~e~~~~g-~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~------  234 (464)
                           ....+||||++++. +|.+++...............++.+++..+.-||  ..+|+|+||++.|||++.      
T Consensus       102 ~~~~~~~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH--~~Gi~HgDL~~~NiLl~~~~~~~~  179 (268)
T PRK15123        102 GSNPATRTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMH--AAGINHRDCYICHFLLHLPFPGRE  179 (268)
T ss_pred             cCCCccceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHH--HCcCccCCCChhhEEEeccccCCC
Confidence                 23578999999876 7988875432334566777889999999999999  677999999999999975      


Q ss_pred             -CCceEEcccCCccC
Q 046893          235 -DFSAKLSDFGLAKD  248 (464)
Q Consensus       235 -~~~vkl~DFGla~~  248 (464)
                       ++.+.|+||+.++.
T Consensus       180 ~~~~~~LIDl~r~~~  194 (268)
T PRK15123        180 EDLKLSVIDLHRAQI  194 (268)
T ss_pred             CCceEEEEECCcccc
Confidence             46899999998853

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=98.98  E-value=1.1e-08  Score=101.22  Aligned_cols=168  Identities=17%  Similarity=0.186  Sum_probs=122.1

Q ss_pred             ceEEEEEEecCCCCCCccceEEEEEEccCCCCccHHHHHHHHHHHhcCCCCCcceEEEEEE----eCCeEEEEEeccCC-
Q 046893          105 FGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVKLIGYCC----EDEHRILVYEYMES-  179 (464)
Q Consensus       105 fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~----~~~~~~lv~e~~~~-  179 (464)
                      -.+.|++...-+      |..|++|++.............-++.++++.|+|||++.++|.    .+..++||++|.++ 
T Consensus       289 ~~Ttyk~~s~~D------G~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s  362 (655)
T KOG3741|consen  289 SITTYKATSNVD------GNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSS  362 (655)
T ss_pred             cceeEeeeeccC------CceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCC
Confidence            345777765543      6779999984433333333345678899999999999999886    34578999999976 


Q ss_pred             CCHHHHHHhhc-------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCc
Q 046893          180 GSLEKHLLRRV-------------GCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLA  246 (464)
Q Consensus       180 g~L~~~l~~~~-------------~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla  246 (464)
                      ++|.++.....             +...++..+|.++.|+..||.++|+  .|+.-+-|.+.+||++.+.+++|...|+.
T Consensus       363 ~TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHs--sGLAck~L~~~kIlv~G~~RIriS~C~i~  440 (655)
T KOG3741|consen  363 PTLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHS--SGLACKTLDLKKILVTGKMRIRISGCGIM  440 (655)
T ss_pred             chHHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHh--cCceeecccHhHeEeeCcceEEEecccce
Confidence            36766554221             2346789999999999999999995  44777999999999999989999887776


Q ss_pred             cCCCCCCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHhCCC
Q 046893          247 KDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRR  299 (464)
Q Consensus       247 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~  299 (464)
                      .....+.         +       |-+.   --.+-|.=.||.+++.|.||..
T Consensus       441 Dvl~~d~---------~-------~~le---~~Qq~D~~~lG~ll~aLAt~~~  474 (655)
T KOG3741|consen  441 DVLQEDP---------T-------EPLE---SQQQNDLRDLGLLLLALATGTE  474 (655)
T ss_pred             eeecCCC---------C-------cchh---HHhhhhHHHHHHHHHHHhhccc
Confidence            5432211         0       1111   1235688899999999999964

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.91  E-value=1.1e-08  Score=91.44  Aligned_cols=124  Identities=23%  Similarity=0.291  Sum_probs=76.9

Q ss_pred             EEEEEEecCCCCCCccceEEEEEEccCCC--Ccc------------------------HHHHHHHHHHHhcCCCC--Ccc
Q 046893          107 VVYKGVIDENVRPGYKTTFVAIKELNRGG--YQG------------------------DREWLAEVNYLGQLRHS--NLV  158 (464)
Q Consensus       107 ~Vy~a~~~~~~~~~~~~~~vavK~~~~~~--~~~------------------------~~~~~~E~~~l~~l~hp--niv  158 (464)
                      .||.|...+       +..+|+|+.....  ...                        .....+|++.|..+..-  ++.
T Consensus         1 ~Vy~~~~~~-------~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP   73 (188)
T PF01163_consen    1 DVYHAIDPD-------GEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVP   73 (188)
T ss_dssp             EEEEEEECT-------TEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS-
T ss_pred             CEEEEECCC-------CCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCC
Confidence            388888654       5679999976421  000                        01246799999999765  456


Q ss_pred             eEEEEEEeCCeEEEEEeccC--CCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHH-HhcCCCCeeeccCCCCceEecCC
Q 046893          159 KLIGYCCEDEHRILVYEYME--SGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAF-LHGAERPVIYRDFKTSNILLNAD  235 (464)
Q Consensus       159 ~l~~~~~~~~~~~lv~e~~~--~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~-LH~~~~~ivHrDlkp~Nill~~~  235 (464)
                      +++++.    ..+|||||+.  |..+.. +....   ++......++.+++..+.. +|  ..+|+|+||.+.|||++++
T Consensus        74 ~p~~~~----~~~ivME~I~~~G~~~~~-l~~~~---~~~~~~~~~~~~il~~~~~~~~--~~givHGDLs~~NIlv~~~  143 (188)
T PF01163_consen   74 KPYDYN----RNVIVMEYIGEDGVPLPR-LKDVD---LSPEEPKELLEEILEEIIKMLH--KAGIVHGDLSEYNILVDDG  143 (188)
T ss_dssp             -EEEEE----TTEEEEE--EETTEEGGC-HHHCG---GGGSTHHHHHHHHHHHHHHHHH--CTTEEESS-STTSEEEETT
T ss_pred             cEEEEe----CCEEEEEecCCCccchhh-HHhcc---ccchhHHHHHHHHHHHHHHHHH--hcCceecCCChhhEEeecc
Confidence            666442    2369999998  555543 33221   2234445667777775555 57  5679999999999999877


Q ss_pred             CceEEcccCCccC
Q 046893          236 FSAKLSDFGLAKD  248 (464)
Q Consensus       236 ~~vkl~DFGla~~  248 (464)
                       .+.|+|||.+..
T Consensus       144 -~~~iIDf~qav~  155 (188)
T PF01163_consen  144 -KVYIIDFGQAVD  155 (188)
T ss_dssp             -CEEE--GTTEEE
T ss_pred             -eEEEEecCccee
Confidence             999999998864

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=98.82  E-value=2e-09  Score=110.12  Aligned_cols=150  Identities=21%  Similarity=0.276  Sum_probs=104.1

Q ss_pred             HHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCccCCCCCCC------cce-eeccccCCcccCccccccC
Q 046893          204 LDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQ------THV-STRVMGTYGYAAPEYVMTG  276 (464)
Q Consensus       204 ~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~------~~~-~~~~~gt~~y~aPE~~~~~  276 (464)
                      .+++.||.|+|. .-++||+.|.|++|.++..+.+||+.|+++........      ... ..-..-...|.|||++.+.
T Consensus       106 ~~v~dgl~flh~-sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~  184 (700)
T KOG2137|consen  106 GNVADGLAFLHR-SAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGT  184 (700)
T ss_pred             hcccchhhhhcc-CcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhccc
Confidence            355699999995 45699999999999999999999999998864332111      100 0112245679999999998


Q ss_pred             CCCcccchhcHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHhhhcccchhhccCccccCccCHHHHHHHHHHHHHhhc
Q 046893          277 HLTARSDVYGFGVVLLEMLL-GRRAVDKSRPSREHNLVEWARPLLNNNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLS  355 (464)
Q Consensus       277 ~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~  355 (464)
                      ..+.++|+||||+++|.+.. |+.-+..........              .....+..-.-.+....+.++.+=+.+++.
T Consensus       185 ~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~--------------~~~~~~~~~~~~~s~~~p~el~~~l~k~l~  250 (700)
T KOG2137|consen  185 TNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYS--------------FSRNLLNAGAFGYSNNLPSELRESLKKLLN  250 (700)
T ss_pred             cccccccceeeeeEEEEEecCCcchhhccCCcchhh--------------hhhcccccccccccccCcHHHHHHHHHHhc
Confidence            88899999999999999995 554444332111110              011111122223445677789999999999


Q ss_pred             cCCCCCCCHHHHH
Q 046893          356 QNPKGRPVMSDVV  368 (464)
Q Consensus       356 ~dP~~RPs~~ev~  368 (464)
                      .+...||++..+.
T Consensus       251 ~~~~~rp~~~~l~  263 (700)
T KOG2137|consen  251 GDSAVRPTLDLLL  263 (700)
T ss_pred             CCcccCcchhhhh
Confidence            9999999776554

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.78  E-value=1.7e-07  Score=85.82  Aligned_cols=105  Identities=23%  Similarity=0.203  Sum_probs=82.3

Q ss_pred             HHHHHHHHHHhcCCC--CCcceEEEEEEeCC----eEEEEEeccCCC-CHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHH
Q 046893          140 REWLAEVNYLGQLRH--SNLVKLIGYCCEDE----HRILVYEYMESG-SLEKHLLRRVGCMLTWSRRMKIALDAAKGLAF  212 (464)
Q Consensus       140 ~~~~~E~~~l~~l~h--pniv~l~~~~~~~~----~~~lv~e~~~~g-~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~  212 (464)
                      ....+|...+..|..  =.+.+.+.+.....    ..+||+|++++. +|.+++....  .++......++.+++..+.-
T Consensus        56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~--~~~~~~~~~ll~~l~~~i~~  133 (206)
T PF06293_consen   56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWE--QLDPSQRRELLRALARLIAK  133 (206)
T ss_pred             hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhc--ccchhhHHHHHHHHHHHHHH
Confidence            456788888888743  33556666665532    458999999874 7888876533  25667778899999999999


Q ss_pred             HhcCCCCeeeccCCCCceEecCCC---ceEEcccCCccC
Q 046893          213 LHGAERPVIYRDFKTSNILLNADF---SAKLSDFGLAKD  248 (464)
Q Consensus       213 LH~~~~~ivHrDlkp~Nill~~~~---~vkl~DFGla~~  248 (464)
                      ||  ..+|+|+||++.|||++.+.   .+.|+||+-++.
T Consensus       134 lH--~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~  170 (206)
T PF06293_consen  134 LH--DAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF  170 (206)
T ss_pred             HH--HCcCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence            99  67799999999999998876   899999998764

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.73  E-value=5e-08  Score=89.99  Aligned_cols=147  Identities=19%  Similarity=0.150  Sum_probs=96.3

Q ss_pred             ccchhHHHHHhcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCC--Cc--------------------c
Q 046893           81 IFTYNEMKLATKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGG--YQ--------------------G  138 (464)
Q Consensus        81 ~~~~~~~~~~~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~--~~--------------------~  138 (464)
                      ..-...+..-..-+.+...||-|--+.||.|.+.+       +..+|||.-+...  +.                    .
T Consensus        80 ~LAL~~l~~r~~ve~iG~~IGvGKEsdVY~~~~~~-------g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~s  152 (304)
T COG0478          80 ALALHALVKRGIVEAIGTKIGVGKESDVYVAIDPK-------GRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVS  152 (304)
T ss_pred             HHHHHHHHHcChHHhhccccccCccceEEEEECCC-------CCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhH
Confidence            33334443334446778899999999999998764       5668998754211  00                    0


Q ss_pred             HHHHHHHHHHHhcCCCC--CcceEEEEEEeCCeEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcC
Q 046893          139 DREWLAEVNYLGQLRHS--NLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGA  216 (464)
Q Consensus       139 ~~~~~~E~~~l~~l~hp--niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~  216 (464)
                      .....+|.++|.+|.-.  .|.+.+++    +...+||||++|-.|...-       +.....-.++..|+.-+.-+-  
T Consensus       153 Rl~A~rEf~~L~~L~~~G~~VP~P~~~----nRHaVvMe~ieG~eL~~~r-------~~~en~~~il~~il~~~~~~~--  219 (304)
T COG0478         153 RLAAEREFEALQRLYPEGVKVPKPIAW----NRHAVVMEYIEGVELYRLR-------LDVENPDEILDKILEEVRKAY--  219 (304)
T ss_pred             HHHHHHHHHHHHHhhhcCCCCCCcccc----ccceeeeehcccceeeccc-------CcccCHHHHHHHHHHHHHHHH--
Confidence            01235799999998543  56665543    4557999999997775432       122222233334444443333  


Q ss_pred             CCCeeeccCCCCceEecCCCceEEcccCCcc
Q 046893          217 ERPVIYRDFKTSNILLNADFSAKLSDFGLAK  247 (464)
Q Consensus       217 ~~~ivHrDlkp~Nill~~~~~vkl~DFGla~  247 (464)
                      ..||||+||.+-|||++++|.+.++||--+.
T Consensus       220 ~~GiVHGDlSefNIlV~~dg~~~vIDwPQ~v  250 (304)
T COG0478         220 RRGIVHGDLSEFNILVTEDGDIVVIDWPQAV  250 (304)
T ss_pred             HcCccccCCchheEEEecCCCEEEEeCcccc
Confidence            3669999999999999999999999997554

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.68  E-value=8.5e-08  Score=98.36  Aligned_cols=140  Identities=16%  Similarity=0.159  Sum_probs=92.2

Q ss_pred             CceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCccHH-------------------------------------
Q 046893           98 YILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDR-------------------------------------  140 (464)
Q Consensus        98 ~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~-------------------------------------  140 (464)
                      .-|+.++-|.||+|++.+       |+.||||+....-.....                                     
T Consensus       131 ~PiAsASIaQVH~A~L~s-------G~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~  203 (517)
T COG0661         131 EPIASASIAQVHRAVLKS-------GEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLR  203 (517)
T ss_pred             CchhhhhHhhheeEEecC-------CCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHH
Confidence            568999999999999986       577999998764211100                                     


Q ss_pred             ---HHHHHHHHHhcCC-----CCCcceEEE-EEEeCCeEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHH
Q 046893          141 ---EWLAEVNYLGQLR-----HSNLVKLIG-YCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLA  211 (464)
Q Consensus       141 ---~~~~E~~~l~~l~-----hpniv~l~~-~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~  211 (464)
                         ++.+|...+.++.     .++| .+=. |+.-.+...|+|||++|-.+.+...-.. ..++...+.....++.--.-
T Consensus       204 ~ElDy~~EA~n~~~~~~nf~~~~~v-~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~-~g~d~k~ia~~~~~~f~~q~  281 (517)
T COG0661         204 EELDYRREAANAERFRENFKDDPDV-YVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS-AGIDRKELAELLVRAFLRQL  281 (517)
T ss_pred             HHhCHHHHHHHHHHHHHHcCCCCCe-EeceeehhccCCcEEEEEeeCCEecccHHHHHh-cCCCHHHHHHHHHHHHHHHH
Confidence               1234555555542     2332 2222 2233456689999999999988743222 23554454444444333333


Q ss_pred             HHhcCCCCeeeccCCCCceEecCCCceEEcccCCccCCC
Q 046893          212 FLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGP  250 (464)
Q Consensus       212 ~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~  250 (464)
                      +-|    +++|.|.+|.||+++.+|.+.+.|||+.....
T Consensus       282 ~~d----gffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~  316 (517)
T COG0661         282 LRD----GFFHADPHPGNILVRSDGRIVLLDFGIVGRLD  316 (517)
T ss_pred             Hhc----CccccCCCccceEEecCCcEEEEcCcceecCC
Confidence            334    49999999999999999999999999987643

>PRK09902 hypothetical protein; Provisional

Probab=98.64  E-value=7.8e-07  Score=80.21  Aligned_cols=138  Identities=14%  Similarity=0.072  Sum_probs=99.4

Q ss_pred             eeecCceEEEEEEecCCCCCCccceEEEEEEccCC---C---CccHHHHHHHHHHHhcCCC--CCcceEEEEEE-eC---
Q 046893          100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRG---G---YQGDREWLAEVNYLGQLRH--SNLVKLIGYCC-ED---  167 (464)
Q Consensus       100 lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~---~---~~~~~~~~~E~~~l~~l~h--pniv~l~~~~~-~~---  167 (464)
                      -|+||.+.|+......        ..+-+|.-...   .   ......|.+|+..|.+|..  -.+.++. ++. ..   
T Consensus        26 ~~rgG~SgV~r~~~~g--------~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~   96 (216)
T PRK09902         26 YRRNGMSGVQCVERNG--------KKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEG   96 (216)
T ss_pred             cCCCCcceEEEEEeCC--------cEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCC
Confidence            4678888899866543        23666665311   1   1245779999999999853  2345555 332 21   


Q ss_pred             -CeEEEEEeccCC-CCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCc--eEEccc
Q 046893          168 -EHRILVYEYMES-GSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFS--AKLSDF  243 (464)
Q Consensus       168 -~~~~lv~e~~~~-g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~--vkl~DF  243 (464)
                       -..+||+|-+.| -+|.+++.+..-...+......++.+++..+.-||  ..++.|+|+-+.|||++.++.  |+++||
T Consensus        97 ~~rA~LVTe~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH--~~Gv~Hgdly~khIll~~~g~~~v~lIDl  174 (216)
T PRK09902         97 EWRALLVTEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMH--SVNRQHGCCYVRHIYVKTEGKAEAGFLDL  174 (216)
T ss_pred             ceEEEEEEEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHH--HCCCcCCCCCHhheeecCCCCeeEEEEEh
Confidence             246899997753 48888876644345677778899999999999999  677999999999999986667  999999


Q ss_pred             CCccC
Q 046893          244 GLAKD  248 (464)
Q Consensus       244 Gla~~  248 (464)
                      .-++.
T Consensus       175 Ek~r~  179 (216)
T PRK09902        175 EKSRR  179 (216)
T ss_pred             hccch
Confidence            87764

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.56  E-value=1.1e-06  Score=81.42  Aligned_cols=138  Identities=17%  Similarity=0.145  Sum_probs=83.3

Q ss_pred             CceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCccHHHHHHHHHHHhcCCCC--CcceEEEEEEeCCeEEEEEe
Q 046893           98 YILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHS--NLVKLIGYCCEDEHRILVYE  175 (464)
Q Consensus        98 ~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp--niv~l~~~~~~~~~~~lv~e  175 (464)
                      ..||.|..+.||+..          +..+++|.....  .......+|.+++..+..-  .+.+++++....+...+|||
T Consensus         7 ~~i~~G~t~~~y~~~----------~~~~VlR~~~~~--~~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e   74 (226)
T TIGR02172         7 TQTGEGGNGESYTHK----------TGKWMLKLYNPG--FDKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYE   74 (226)
T ss_pred             eeecCCCCcceeEec----------CCCEEEEeCCCC--CCHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeee
Confidence            358999999999832          112677876542  2345578899999888533  35677888877788889999


Q ss_pred             ccCCCC-HHHHH--------------Hh----hcC---CCCCHHHHHH-HHH----------HHHH-HHHHHh--cCCCC
Q 046893          176 YMESGS-LEKHL--------------LR----RVG---CMLTWSRRMK-IAL----------DAAK-GLAFLH--GAERP  219 (464)
Q Consensus       176 ~~~~g~-L~~~l--------------~~----~~~---~~l~~~~~~~-i~~----------qi~~-~l~~LH--~~~~~  219 (464)
                      +++|.+ +...+              .+    -..   .......... +..          .+.. ...+|.  .....
T Consensus        75 ~i~G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~  154 (226)
T TIGR02172        75 LIVGKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTST  154 (226)
T ss_pred             ecCCccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCc
Confidence            998863 11111              00    000   0111111100 000          0011 112222  22345


Q ss_pred             eeeccCCCCceEecCCCceEEcccCCccC
Q 046893          220 VIYRDFKTSNILLNADFSAKLSDFGLAKD  248 (464)
Q Consensus       220 ivHrDlkp~Nill~~~~~vkl~DFGla~~  248 (464)
                      ++|+|+.|.||++++++ +.|+||+.+..
T Consensus       155 ~~HgD~~~~Nii~~~~~-~~iIDwe~a~~  182 (226)
T TIGR02172       155 CLHGDFQIGNLITSGKG-TYWIDLGDFGY  182 (226)
T ss_pred             eEecCCCCCcEEEcCCC-cEEEechhcCc
Confidence            78999999999999887 99999998763

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=98.48  E-value=2.1e-08  Score=101.73  Aligned_cols=184  Identities=16%  Similarity=0.101  Sum_probs=130.3

Q ss_pred             CCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCccHHHHHHHHHHHhcCCCCC-cceEEEEEEeCCeEEEEE
Q 046893           96 PDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSN-LVKLIGYCCEDEHRILVY  174 (464)
Q Consensus        96 ~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpn-iv~l~~~~~~~~~~~lv~  174 (464)
                      ....+++|++++++|.+...+       +.+..+.+...     ....-++++|.+++||| .+..++-+..+...+++|
T Consensus       246 ~fh~fvK~altknpKkRptae-------klL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~  313 (829)
T KOG0576|consen  246 FFHNFVKGALTKNPKKRPTAE-------KLLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPM  313 (829)
T ss_pred             HHHHHHHHHhcCCCccCCChh-------hheeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccchhh
Confidence            334578999999999775543       22335555432     34456888999999999 777777788888999999


Q ss_pred             eccCCC-CHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCccCCCCCC
Q 046893          175 EYMESG-SLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGD  253 (464)
Q Consensus       175 e~~~~g-~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~  253 (464)
                      +++.++ +-..... .....+..-+...+...-+.+++|||+..  =+|+|    |||..+ +..+..||+....+....
T Consensus       314 ~i~s~~rs~~~~~~-~se~~~~~~~~~~~~r~et~~l~~l~~~~--~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~  385 (829)
T KOG0576|consen  314 RICSTGRSSALEMT-VSEIALEQYQFAYPLRKETRPLAELHSSY--KVHRD----NILGSE-EEVKLLDFAVPPQLTRTM  385 (829)
T ss_pred             hhhcCCccccccCC-hhhHhhhhhhhhhhhhhhccccccccccc--ccCcc----cccccc-cccccccccCCcccCccc
Confidence            999877 2211110 00112333334455666778899999532  48998    887765 688999999887643322


Q ss_pred             CcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHhCCCCCC
Q 046893          254 QTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVD  302 (464)
Q Consensus       254 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~  302 (464)
                         ......+|+.|+|||+.....+..+.|+|++|+--.+|--|-+|-.
T Consensus       386 ---~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~  431 (829)
T KOG0576|consen  386 ---KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRS  431 (829)
T ss_pred             ---ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCC
Confidence               3445789999999999999999999999999987777777766543

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=98.44  E-value=2.5e-06  Score=80.13  Aligned_cols=137  Identities=20%  Similarity=0.151  Sum_probs=81.3

Q ss_pred             eeecCc-eEEEEEEecCCCCCCccceEEEEEEccCCCCccHHHHHHHHHHHhcCC-CCCcceEEEEEEeCCeEEEEEecc
Q 046893          100 LGEGGF-GVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLR-HSNLVKLIGYCCEDEHRILVYEYM  177 (464)
Q Consensus       100 lG~G~f-g~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~~lv~e~~  177 (464)
                      |-.|.. ..||+.....        ..+.+|+.....   ...+..|+++++.+. +--+.+++++....+..++|||++
T Consensus         6 ~~~g~~~~~v~~~~~~~--------~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i   74 (244)
T cd05150           6 VTEGQSGATVYRLDGKN--------PGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAV   74 (244)
T ss_pred             cCCCCCcCeEEEEcCCC--------CcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEee
Confidence            334444 7799875421        247888875432   335678888888873 444667788777766789999999


Q ss_pred             CCCCHHHHHH----------------hhc-----CCCCC--HHHHHHHHHH--------------------HHHHHHHHh
Q 046893          178 ESGSLEKHLL----------------RRV-----GCMLT--WSRRMKIALD--------------------AAKGLAFLH  214 (464)
Q Consensus       178 ~~g~L~~~l~----------------~~~-----~~~l~--~~~~~~i~~q--------------------i~~~l~~LH  214 (464)
                      +|.+|.....                +-.     ...+.  ..........                    +...+..|-
T Consensus        75 ~G~~l~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  154 (244)
T cd05150          75 PGVPAAALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELE  154 (244)
T ss_pred             CCccHhHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHH
Confidence            9987754320                000     00111  0000000000                    111112221


Q ss_pred             -----cCCCCeeeccCCCCceEecCCCceEEcccCCcc
Q 046893          215 -----GAERPVIYRDFKTSNILLNADFSAKLSDFGLAK  247 (464)
Q Consensus       215 -----~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~  247 (464)
                           .....++|+|+.|.|||+++++.+.|+||+.+.
T Consensus       155 ~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~  192 (244)
T cd05150         155 ATRPAEEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLG  192 (244)
T ss_pred             hhCCCcCceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence                 013458999999999999988778899999775

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.43  E-value=1.4e-06  Score=78.83  Aligned_cols=139  Identities=15%  Similarity=0.128  Sum_probs=89.1

Q ss_pred             HHHhcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCccHHHH---------HHHHHHHhcCCC---C
Q 046893           88 KLATKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREW---------LAEVNYLGQLRH---S  155 (464)
Q Consensus        88 ~~~~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~---------~~E~~~l~~l~h---p  155 (464)
                      .+...+|.+.+++-......|.+-...        +..+++|.........++.|         .+++..+..+..   -
T Consensus        27 ~i~~~~~~~~kv~k~~~r~~ValIei~--------~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~   98 (229)
T PF06176_consen   27 KILDNNYKIIKVFKNTKRNYVALIEID--------GKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFT   98 (229)
T ss_pred             HHHhCCceEEEeecCCCccEEEEEEEC--------CcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCcc
Confidence            456777888888887777777665432        45689998765443333332         234444444322   1


Q ss_pred             CcceEEEE-----EEeCCeEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCce
Q 046893          156 NLVKLIGY-----CCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNI  230 (464)
Q Consensus       156 niv~l~~~-----~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Ni  230 (464)
                      .+..++-+     +......+|||||++|..|.++..      ++.    .++..+..++.-||  ..|++|+|+.|.|+
T Consensus        99 ~~~~~yl~~ekk~~~~~~~~~ll~EYIeG~~l~d~~~------i~e----~~~~ki~~~ikqlH--~~G~~HGD~hpgNF  166 (229)
T PF06176_consen   99 EPADPYLAAEKKIFRYTSSYVLLMEYIEGVELNDIED------IDE----DLAEKIVEAIKQLH--KHGFYHGDPHPGNF  166 (229)
T ss_pred             ccccceeeeeeeeccceeEEEEEEEEecCeecccchh------cCH----HHHHHHHHHHHHHH--HcCCccCCCCcCcE
Confidence            22222222     222235578999999988866431      222    24456777899999  56799999999999


Q ss_pred             EecCCCceEEcccCCcc
Q 046893          231 LLNADFSAKLSDFGLAK  247 (464)
Q Consensus       231 ll~~~~~vkl~DFGla~  247 (464)
                      ++.++ .++++||+..+
T Consensus       167 lv~~~-~i~iID~~~k~  182 (229)
T PF06176_consen  167 LVSNN-GIRIIDTQGKR  182 (229)
T ss_pred             EEECC-cEEEEECcccc
Confidence            99865 59999998665

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.40  E-value=2.7e-06  Score=77.92  Aligned_cols=151  Identities=19%  Similarity=0.154  Sum_probs=94.4

Q ss_pred             chhHHHHHhcCCCCCCcee---ecCceEEEEEEecCCCCCCccceEEEEEEccCCCCccH-------------------H
Q 046893           83 TYNEMKLATKFFRPDYILG---EGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGD-------------------R  140 (464)
Q Consensus        83 ~~~~~~~~~~~~~~~~~lG---~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~-------------------~  140 (464)
                      +...+.-...+..+....|   .|--+.||+|...+       +..+|+|+.......-.                   .
T Consensus        36 t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~-------~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr  108 (268)
T COG1718          36 TLETLRRLLSRGVITELVGCISTGKEANVYLAETGD-------GRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRR  108 (268)
T ss_pred             HHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCC-------CceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHH
Confidence            3444445555566665555   56666799987532       45699999875322111                   1


Q ss_pred             H-----HHHHHHHHhcCC--CCCcceEEEEEEeCCeEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHH
Q 046893          141 E-----WLAEVNYLGQLR--HSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFL  213 (464)
Q Consensus       141 ~-----~~~E~~~l~~l~--hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~L  213 (464)
                      .     ..+|+..|.++.  +-.+.+-+.+..    ..|||||+....+  --..-.+..+...+...+..+++..+.-|
T Consensus       109 ~lv~~W~~kEf~NL~R~~eAGVrvP~Pi~~~~----nVLvMEfIg~~g~--pAP~LkDv~~e~~e~~~~~~~~v~~~~~l  182 (268)
T COG1718         109 KLVFAWARKEFRNLKRAYEAGVRVPEPIAFRN----NVLVMEFIGDDGL--PAPRLKDVPLELEEAEGLYEDVVEYMRRL  182 (268)
T ss_pred             HHHHHHHHHHHHHHHHHHHcCCCCCCceeecC----CeEEEEeccCCCC--CCCCcccCCcCchhHHHHHHHHHHHHHHH
Confidence            1     146888888874  333444444432    3699999954311  00111122334445666777888888777


Q ss_pred             hcCCCCeeeccCCCCceEecCCCceEEcccCCccC
Q 046893          214 HGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKD  248 (464)
Q Consensus       214 H~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~  248 (464)
                      -. .-++||+||..-|||+. ++.+.|+|||-|..
T Consensus       183 ~~-~a~LVHgDLSEyNiL~~-~~~p~iID~~QaV~  215 (268)
T COG1718         183 YK-EAGLVHGDLSEYNILVH-DGEPYIIDVSQAVT  215 (268)
T ss_pred             HH-hcCcccccchhhheEEE-CCeEEEEECccccc
Confidence            63 35599999999999998 78999999998864

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=98.31  E-value=2.8e-06  Score=87.04  Aligned_cols=136  Identities=17%  Similarity=0.133  Sum_probs=89.9

Q ss_pred             CceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCccH-------------------------------------H
Q 046893           98 YILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGD-------------------------------------R  140 (464)
Q Consensus        98 ~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~-------------------------------------~  140 (464)
                      +.||.-+.|.||+|+...       ++.||||+-+..-....                                     -
T Consensus       167 ~piaaASlaQVhrA~L~~-------G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~EL  239 (538)
T KOG1235|consen  167 EPIAAASLAQVHRARLKN-------GEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQEL  239 (538)
T ss_pred             chhhhcchhheEEEEecC-------CCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhc
Confidence            569999999999999876       67799999765321110                                     0


Q ss_pred             HHHHHHHHHhcC----CCCC------cceEEEEEEeCCeEEEEEeccCCCCHHHH--HHhhcCCCCCHHHHHHHHHHHHH
Q 046893          141 EWLAEVNYLGQL----RHSN------LVKLIGYCCEDEHRILVYEYMESGSLEKH--LLRRVGCMLTWSRRMKIALDAAK  208 (464)
Q Consensus       141 ~~~~E~~~l~~l----~hpn------iv~l~~~~~~~~~~~lv~e~~~~g~L~~~--l~~~~~~~l~~~~~~~i~~qi~~  208 (464)
                      +|..|++...++    .|-+      |.+++.  .-.....|+||||+|..+.|.  |.++   .++...+..-+.++..
T Consensus       240 DF~~EA~Nae~~~~~f~~~~~~~~V~VP~Vy~--~~st~RVLtME~~~G~~i~Dl~~i~~~---gi~~~~i~~~l~~~~~  314 (538)
T KOG1235|consen  240 DFTKEAKNAERFRENFKDFSLLTYVLVPKVYW--DLSTKRVLTMEYVDGIKINDLDAIDKR---GISPHDILNKLVEAYL  314 (538)
T ss_pred             chHHHHHhHHHHHHHHHhcccccceeCCeehh--hcCcceEEEEEecCCccCCCHHHHHHc---CCCHHHHHHHHHHHHH
Confidence            134455544433    3444      333332  223456899999999877654  3333   3666666555555444


Q ss_pred             HHHHHhcCCCCeeeccCCCCceEecC----CCceEEcccCCccCC
Q 046893          209 GLAFLHGAERPVIYRDFKTSNILLNA----DFSAKLSDFGLAKDG  249 (464)
Q Consensus       209 ~l~~LH~~~~~ivHrDlkp~Nill~~----~~~vkl~DFGla~~~  249 (464)
                      -+-+.|    |++|+|-+|.||++..    ++.+.+.|||+....
T Consensus       315 ~qIf~~----GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~i  355 (538)
T KOG1235|consen  315 EQIFKT----GFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVI  355 (538)
T ss_pred             HHHHhc----CCccCCCCCCcEEEecCCCCCccEEEEcccccccc
Confidence            344444    4999999999999983    678999999998754

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=98.28  E-value=7.7e-06  Score=75.82  Aligned_cols=140  Identities=19%  Similarity=0.141  Sum_probs=80.7

Q ss_pred             CceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCccHHHHHHHHHHHhcCCCC--CcceEEEEEEe---CCeEEE
Q 046893           98 YILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHS--NLVKLIGYCCE---DEHRIL  172 (464)
Q Consensus        98 ~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp--niv~l~~~~~~---~~~~~l  172 (464)
                      +.|+.|..+.||+....+        ..+++|.....  .....+..|..+++.|...  .+.+++.+...   ....++
T Consensus         3 ~~l~~G~~n~~~~v~~~~--------~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~   72 (239)
T PF01636_consen    3 RPLSGGFSNRVYRVTTDD--------GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYL   72 (239)
T ss_dssp             EEEEESSSSEEEEEEETT--------SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEE
T ss_pred             ccCCCCCeeeEEEEEECC--------cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceE
Confidence            468999999999987654        24889986543  3446778898888888433  34566654433   335789


Q ss_pred             EEeccCCCCHHH----------------HHH---hh--cCCCCCHHH---------HHHH------------HHHHHH-H
Q 046893          173 VYEYMESGSLEK----------------HLL---RR--VGCMLTWSR---------RMKI------------ALDAAK-G  209 (464)
Q Consensus       173 v~e~~~~g~L~~----------------~l~---~~--~~~~l~~~~---------~~~i------------~~qi~~-~  209 (464)
                      +|++++|..+..                .+.   ..  ....+....         ....            ...+.. .
T Consensus        73 ~~~~i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  152 (239)
T PF01636_consen   73 LMEYIPGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERL  152 (239)
T ss_dssp             EEEEESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHH
T ss_pred             EEEEeccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHH
Confidence            999999987766                111   11  001111110         0000            011111 2


Q ss_pred             HHHHh-----cCCCCeeeccCCCCceEec-CCCceEEcccCCcc
Q 046893          210 LAFLH-----GAERPVIYRDFKTSNILLN-ADFSAKLSDFGLAK  247 (464)
Q Consensus       210 l~~LH-----~~~~~ivHrDlkp~Nill~-~~~~vkl~DFGla~  247 (464)
                      +..++     .....++|+|+.|.|||++ .++.+-|+||+.+.
T Consensus       153 ~~~~~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~  196 (239)
T PF01636_consen  153 LQELEALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG  196 (239)
T ss_dssp             HHHHHHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred             HHHHHhhhccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence            23332     1356699999999999999 66667899998764

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=98.27  E-value=1.7e-05  Score=71.53  Aligned_cols=128  Identities=22%  Similarity=0.243  Sum_probs=87.8

Q ss_pred             CCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCC----------------CccHHHHHHHHHHHhcCC------C
Q 046893           97 DYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGG----------------YQGDREWLAEVNYLGQLR------H  154 (464)
Q Consensus        97 ~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~----------------~~~~~~~~~E~~~l~~l~------h  154 (464)
                      ...||+|+.-.||.-=...         ...||+.....                .....+..+|+.....+.      +
T Consensus         6 ~~~i~~G~~R~cy~HP~dp---------~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~   76 (199)
T PF10707_consen    6 SDLIAQGGERDCYQHPDDP---------NLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDW   76 (199)
T ss_pred             CcccccCCCceEEECCCCC---------CeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcc
Confidence            3469999999999732222         26888887654                122355666766665555      7


Q ss_pred             CCcceEEEEEEeCCeEEEEEeccCC------CCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCC
Q 046893          155 SNLVKLIGYCCEDEHRILVYEYMES------GSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTS  228 (464)
Q Consensus       155 pniv~l~~~~~~~~~~~lv~e~~~~------g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~  228 (464)
                      .+|.+++|+...+...-+|+|.+.+      -+|.+++.+.   .++. .....+.++.   .||-  +..|+.+||+|.
T Consensus        77 ~~i~r~~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~---~~~~-~~~~~L~~f~---~~l~--~~~Iv~~dl~~~  147 (199)
T PF10707_consen   77 SHIPRFYGFVETNLGLGLVVELIRDADGNISPTLEDYLKEG---GLTE-ELRQALDEFK---RYLL--DHHIVIRDLNPH  147 (199)
T ss_pred             cccccEeEEEecCCceEEEEEEEECCCCCcCccHHHHHHcC---CccH-HHHHHHHHHH---HHHH--HcCCeecCCCcc
Confidence            8899999999999999999998743      2688887543   3555 4444444444   4444  344999999999


Q ss_pred             ceEecCC---C-ceEEcc
Q 046893          229 NILLNAD---F-SAKLSD  242 (464)
Q Consensus       229 Nill~~~---~-~vkl~D  242 (464)
                      ||++...   . .+.|+|
T Consensus       148 NIv~~~~~~~~~~lvlID  165 (199)
T PF10707_consen  148 NIVVQRRDSGEFRLVLID  165 (199)
T ss_pred             cEEEEecCCCceEEEEEe
Confidence            9999432   2 578887

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>PLN02876 acyl-CoA dehydrogenase

Probab=98.15  E-value=3.2e-05  Score=85.41  Aligned_cols=81  Identities=16%  Similarity=0.225  Sum_probs=55.6

Q ss_pred             CCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCC-ccHHHHHHHHHHHhcCC-CCCc--ceEEEEEEeC---Ce
Q 046893           97 DYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGY-QGDREWLAEVNYLGQLR-HSNL--VKLIGYCCED---EH  169 (464)
Q Consensus        97 ~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-hpni--v~l~~~~~~~---~~  169 (464)
                      .+.|+.|.++.+|+.......    ....+++|+...... .....+.+|+++|+.+. |.+|  .+++.++.+.   +.
T Consensus        43 v~~l~gG~sn~ty~l~~~~~~----~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~  118 (822)
T PLN02876         43 VSQFGHGQSNPTFLLEVGNGG----SVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGT  118 (822)
T ss_pred             EEEeCCCCcCceEEEEECCCC----cceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCC
Confidence            456899999999997654321    113466776544322 23356889999999995 6654  7777777654   46


Q ss_pred             EEEEEeccCCCC
Q 046893          170 RILVYEYMESGS  181 (464)
Q Consensus       170 ~~lv~e~~~~g~  181 (464)
                      .|+||||++|..
T Consensus       119 ~flVME~v~G~~  130 (822)
T PLN02876        119 AFYIMEYLEGRI  130 (822)
T ss_pred             ceEEEEecCCcc
Confidence            789999998764

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=98.11  E-value=2.3e-05  Score=68.12  Aligned_cols=128  Identities=21%  Similarity=0.198  Sum_probs=84.0

Q ss_pred             CCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCccHHHHHHHHHHHhcCCCCCcce-EEEEEEeCCeEEEE
Q 046893           95 RPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVK-LIGYCCEDEHRILV  173 (464)
Q Consensus        95 ~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~-l~~~~~~~~~~~lv  173 (464)
                      +..+.||+|++|.||+|.+..        ..+|+|+-...  .....+..|+++|..+.-.++-+ ++.+..+    ++.
T Consensus        25 ~v~~~L~KG~~s~Vyl~~~~~--------~~~a~Kvrr~d--s~r~~l~kEakiLeil~g~~~~p~vy~yg~~----~i~   90 (201)
T COG2112          25 RVEKELAKGTTSVVYLGEWRG--------GEVALKVRRRD--SPRRNLEKEAKILEILAGEGVTPEVYFYGED----FIR   90 (201)
T ss_pred             hhhhhhhcccccEEEEeeccC--------ceEEEEEecCC--cchhhHHHHHHHHHHhhhcCCCceEEEechh----hhh
Confidence            445679999999999998764        35899987654  34467889999999987766654 4433322    356


Q ss_pred             EeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCC--CceEecCCCceEEcccCCccC
Q 046893          174 YEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKT--SNILLNADFSAKLSDFGLAKD  248 (464)
Q Consensus       174 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp--~Nill~~~~~vkl~DFGla~~  248 (464)
                      |||+.|-.|.+....     ..-..+.    .++..-.-|-  ..+|-|+.|.-  .||++ .++.+.|+||..|+.
T Consensus        91 me~i~G~~L~~~~~~-----~~rk~l~----~vlE~a~~LD--~~GI~H~El~~~~k~vlv-~~~~~~iIDFd~At~  155 (201)
T COG2112          91 MEYIDGRPLGKLEIG-----GDRKHLL----RVLEKAYKLD--RLGIEHGELSRPWKNVLV-NDRDVYIIDFDSATF  155 (201)
T ss_pred             hhhhcCcchhhhhhc-----ccHHHHH----HHHHHHHHHH--HhccchhhhcCCceeEEe-cCCcEEEEEccchhh
Confidence            999999888664331     1222322    3333322233  34577777753  45555 455999999998873

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=98.04  E-value=2.6e-05  Score=72.87  Aligned_cols=31  Identities=19%  Similarity=0.208  Sum_probs=26.0

Q ss_pred             CCeeeccCCCCceEecCCCceEEcccCCccC
Q 046893          218 RPVIYRDFKTSNILLNADFSAKLSDFGLAKD  248 (464)
Q Consensus       218 ~~ivHrDlkp~Nill~~~~~vkl~DFGla~~  248 (464)
                      ..++|+|+.+.|||+++++..-|+||+.+..
T Consensus       164 ~~l~HGD~~~~Nvlv~~~~i~giIDw~~a~~  194 (235)
T cd05155         164 PVWFHGDLAPGNLLVQDGRLSAVIDFGCLGV  194 (235)
T ss_pred             ceEEeCCCCCCcEEEECCCEEEEEeCcccCc
Confidence            4489999999999998765567999998753

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=97.92  E-value=3.9e-05  Score=68.91  Aligned_cols=98  Identities=30%  Similarity=0.287  Sum_probs=77.2

Q ss_pred             HHHHHHhcCCC-CCcceEEEEEEeCCeEEEEEeccCCCCHHHH---HHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC-C
Q 046893          144 AEVNYLGQLRH-SNLVKLIGYCCEDEHRILVYEYMESGSLEKH---LLRRVGCMLTWSRRMKIALDAAKGLAFLHGAE-R  218 (464)
Q Consensus       144 ~E~~~l~~l~h-pniv~l~~~~~~~~~~~lv~e~~~~g~L~~~---l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~-~  218 (464)
                      .|.-+|+.+++ +++.+++|+|-.    ++|.||+..+++...   +..  ....+|..+.+||.+++..+.+|+... .
T Consensus         8 ~E~lll~~l~~~~~~pk~lG~CG~----~~v~E~~~~~~~~~~~~~l~~--~~~~~w~~R~~iA~~lL~~l~~l~~~~~~   81 (188)
T PF12260_consen    8 NEPLLLQLLQGSEPFPKLLGSCGR----FYVVEYVGAGSLYGIYRPLSQ--FLQSPWEQRAKIALQLLELLEELDHGPLG   81 (188)
T ss_pred             cHHHHHHHcCCCCCCCCeeeECCC----EEEEEeecCcccccccccccc--ccccCHHHHHHHHHHHHHHHHHHhcCCCC
Confidence            57888888875 699999999943    679999987666421   111  124689999999999999999998421 2


Q ss_pred             CeeeccCCCCceEecCCCceEEcccCCcc
Q 046893          219 PVIYRDFKTSNILLNADFSAKLSDFGLAK  247 (464)
Q Consensus       219 ~ivHrDlkp~Nill~~~~~vkl~DFGla~  247 (464)
                      .+.-.|++++|+-+++++.+|++|...+-
T Consensus        82 ~~~lcDv~~~nfgv~~~~~lk~iDld~v~  110 (188)
T PF12260_consen   82 FFYLCDVSPDNFGVNDDGRLKLIDLDDVF  110 (188)
T ss_pred             cEEEeecchHHeEEeCCCcEEEEechhcc
Confidence            37779999999999999999999998764

Proteins in this uncharacterised family are described as transmembrane proteins.

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=97.84  E-value=0.00017  Score=67.21  Aligned_cols=75  Identities=16%  Similarity=0.072  Sum_probs=45.0

Q ss_pred             CceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCccHHHHHHHHHHHhcCCCCC-cceEEEEEEeCCeEEEEEec
Q 046893           98 YILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSN-LVKLIGYCCEDEHRILVYEY  176 (464)
Q Consensus        98 ~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpn-iv~l~~~~~~~~~~~lv~e~  176 (464)
                      +.|..|-...+|+......     .+..|++|+...... .......|+.++..+...+ ..+++..+.  +  .+||||
T Consensus         4 ~~l~gG~tN~~~~v~~~~~-----~~~~~vlR~~~~~~~-~~~d~~~E~~~~~~l~~~gl~P~v~~~~~--~--~~l~e~   73 (235)
T cd05157           4 KRFTGGITNKLVKVSNKED-----NQDAVLVRVYGNKTE-LIIDRERELRIHKLLSKHGLAPKLYATFQ--N--GLIYEF   73 (235)
T ss_pred             EEcCCcccceEEEEEcCCC-----CCCeEEEEEccCCcc-ceecHHHHHHHHHHHHhCCCCCeEEEEeC--C--cEEEEe
Confidence            3577788889998864421     123478887654321 1122346888888885333 344444332  2  479999


Q ss_pred             cCCCCH
Q 046893          177 MESGSL  182 (464)
Q Consensus       177 ~~~g~L  182 (464)
                      ++|.++
T Consensus        74 i~G~~l   79 (235)
T cd05157          74 IPGRTL   79 (235)
T ss_pred             eCCCcC
Confidence            998765

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>TIGR02721 ycfN_thiK thiamine kinase

Probab=97.79  E-value=0.00013  Score=69.15  Aligned_cols=136  Identities=17%  Similarity=0.090  Sum_probs=74.5

Q ss_pred             eeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCccHHHHHHHHHHHhcCCCCCcc-eEEEEEEeCCeEEEEEeccC
Q 046893          100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLV-KLIGYCCEDEHRILVYEYME  178 (464)
Q Consensus       100 lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv-~l~~~~~~~~~~~lv~e~~~  178 (464)
                      +..|-.+.+|+....        +..+++|..........-....|..+++.+..-.++ +++.++  .  .++||||++
T Consensus         4 ~~~G~tn~~y~~~~~--------~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~--~--~~~v~e~i~   71 (256)
T TIGR02721         4 LSGGLTNRSWRIEHP--------GISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVN--E--HWLLVEWLE   71 (256)
T ss_pred             CCCcCcCCeEEEEeC--------CccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEe--C--CEEEEEecc
Confidence            556788889987522        334778875433211111346788888888543333 333332  2  368999998


Q ss_pred             CCCHHH--------------HHHhhc-----CCCCCHHHH-HHHHHHH---------HHHHHHHhc------CCCCeeec
Q 046893          179 SGSLEK--------------HLLRRV-----GCMLTWSRR-MKIALDA---------AKGLAFLHG------AERPVIYR  223 (464)
Q Consensus       179 ~g~L~~--------------~l~~~~-----~~~l~~~~~-~~i~~qi---------~~~l~~LH~------~~~~ivHr  223 (464)
                      |..+..              .+.+-.     +..+..... ..+..++         ...+..+-.      ....++|+
T Consensus        72 G~~~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~  151 (256)
T TIGR02721        72 GEVITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHM  151 (256)
T ss_pred             CcccccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecC
Confidence            876532              111100     112222211 1111111         111111111      12358999


Q ss_pred             cCCCCceEecCCCceEEcccCCccC
Q 046893          224 DFKTSNILLNADFSAKLSDFGLAKD  248 (464)
Q Consensus       224 Dlkp~Nill~~~~~vkl~DFGla~~  248 (464)
                      |+.|.|||+++++ +.|+||..|..
T Consensus       152 Dl~~~Nil~~~~~-~~lIDwE~a~~  175 (256)
T TIGR02721       152 DVHAYNLVVTPQG-LKLIDWEYASD  175 (256)
T ss_pred             CCCcCcEEEeCCC-CEEEeccccCc
Confidence            9999999998876 78999998864

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>PRK10593 hypothetical protein; Provisional

Probab=97.78  E-value=0.00037  Score=67.49  Aligned_cols=76  Identities=11%  Similarity=0.034  Sum_probs=53.6

Q ss_pred             CCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCccHHHHHHHHHHHhcCCC---CCcceEEEEEEe---CCeE
Q 046893           97 DYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRH---SNLVKLIGYCCE---DEHR  170 (464)
Q Consensus        97 ~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h---pniv~l~~~~~~---~~~~  170 (464)
                      .+.||.|..+.||.....++        .+.+|..+.  ......+..|...|+.|..   -.+.++++++..   .+..
T Consensus        19 ~~~i~~G~~~~vy~~~~~~~--------~~~~k~~~~--~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~   88 (297)
T PRK10593         19 VECISEQPYAALWALYDSQG--------NPMPLMARS--FSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPD   88 (297)
T ss_pred             eeecCCccceeEEEEEcCCC--------CEEEEEecc--cccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCe
Confidence            45699999999999754332        256676432  1233578899999988843   357788887754   3668


Q ss_pred             EEEEeccCCCCH
Q 046893          171 ILVYEYMESGSL  182 (464)
Q Consensus       171 ~lv~e~~~~g~L  182 (464)
                      +||||+++|+++
T Consensus        89 ~LVmE~i~G~~~  100 (297)
T PRK10593         89 VLLLERLRGVSV  100 (297)
T ss_pred             EEEEeccCCEec
Confidence            999999998754

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=97.77  E-value=0.00021  Score=64.11  Aligned_cols=125  Identities=27%  Similarity=0.343  Sum_probs=87.1

Q ss_pred             cCCCCCCceeecCc-eEEEEEEecCCCCCCccceEEEEEEccCCCC----------c-----------cHHHHHHHHHHH
Q 046893           92 KFFRPDYILGEGGF-GVVYKGVIDENVRPGYKTTFVAIKELNRGGY----------Q-----------GDREWLAEVNYL  149 (464)
Q Consensus        92 ~~~~~~~~lG~G~f-g~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~----------~-----------~~~~~~~E~~~l  149 (464)
                      ..++.++.||.|.- |.||++...        +..+|+|+......          .           ...-|..|.+..
T Consensus        37 ~~I~flefLg~g~~~~~V~kv~I~--------g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAf  108 (207)
T PF13095_consen   37 DDIEFLEFLGHGSHDGYVFKVEID--------GRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAF  108 (207)
T ss_pred             CcEeeeeecCCCCceeEEEEEEEC--------CeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhh
Confidence            56788889999999 999999865        45799999332110          0           012367888888


Q ss_pred             hcCC---CCCc--ceEEEEEEeCC------------------eEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHH
Q 046893          150 GQLR---HSNL--VKLIGYCCEDE------------------HRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDA  206 (464)
Q Consensus       150 ~~l~---hpni--v~l~~~~~~~~------------------~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi  206 (464)
                      .+|+   +.++  |+++||..-..                  ...||.||++...           .+..    .-+.++
T Consensus       109 gRLke~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~-----------~~~~----~~~~~~  173 (207)
T PF13095_consen  109 GRLKEAGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP-----------PLQI----RDIPQM  173 (207)
T ss_pred             HHHHhccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc-----------ccch----hHHHHH
Confidence            7774   4456  89999874331                  2467888876533           1222    234577


Q ss_pred             HHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCc
Q 046893          207 AKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLA  246 (464)
Q Consensus       207 ~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla  246 (464)
                      .+-|..+|  ..+|+-+|+++.|..     .-||+|||.+
T Consensus       174 ~~dl~~~~--k~gI~~~Dv~~~ny~-----~G~lvDfs~~  206 (207)
T PF13095_consen  174 LRDLKILH--KLGIVPRDVKPRNYR-----GGKLVDFSSS  206 (207)
T ss_pred             HHHHHHHH--HCCeeeccCcccccc-----CCEEEecccC
Confidence            78888999  566999999999975     2389999864

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=97.75  E-value=8.3e-05  Score=81.04  Aligned_cols=195  Identities=18%  Similarity=0.200  Sum_probs=131.4

Q ss_pred             HHHHHHHhcCCCCCcceEEEEEEeCCeEE----EEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCC
Q 046893          143 LAEVNYLGQLRHSNLVKLIGYCCEDEHRI----LVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAER  218 (464)
Q Consensus       143 ~~E~~~l~~l~hpniv~l~~~~~~~~~~~----lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~  218 (464)
                      ..|+..+..+.|+|++.++.|..++...-    +..++|..-++...+....  ..+..+...+..++..||.|+|++. 
T Consensus       230 E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~--~i~~~~~r~~~~~~~~GL~~~h~~~-  306 (1351)
T KOG1035|consen  230 EIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVG--SIPLETLRILHQKLLEGLAYLHSLS-  306 (1351)
T ss_pred             HHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhcc--ccCHHHHHHHHHHHhhhHHHHHHhc-
Confidence            45677778889999999999877664433    3346777778877665432  6888999999999999999999643 


Q ss_pred             CeeeccCCCC---ceEecCCCceEEc--ccCCccCCCCCCCcceeeccccCCcccCccccccCCCCcc--cchhcHHHHH
Q 046893          219 PVIYRDFKTS---NILLNADFSAKLS--DFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTAR--SDVYGFGVVL  291 (464)
Q Consensus       219 ~ivHrDlkp~---Nill~~~~~vkl~--DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~--~DvwslG~il  291 (464)
                       ..|.-|...   +...+.++.+.+.  ||+..+........   ....-+..|.++|......+..+  .|+|.+|.++
T Consensus       307 -l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~---~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~  382 (1351)
T KOG1035|consen  307 -LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKS---FSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLL  382 (1351)
T ss_pred             -cceeEEecccccccccCccceeecchhhhcccccCCCcccc---hhhcCccccccccccccccchhhhhhHHHHHHHHH
Confidence             555544444   4445666777777  99988765433221   22334556788887766555544  7999999999


Q ss_pred             HHHHhCCCCCCCCCCcccccHHHHHHHhhhcccchhhccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 046893          292 LEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALL  371 (464)
Q Consensus       292 ~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L  371 (464)
                      ..+..|..+-....                   ....+++...        ...+.+...+|+.-+.++|++..+++...
T Consensus       383 ~~~~~~~~i~~~~~-------------------~~~~~l~~~~--------~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~  435 (1351)
T KOG1035|consen  383 LQLSQGEDISEKSA-------------------VPVSLLDVLS--------TSELLDALPKCLDEDSEERLSALELLTHP  435 (1351)
T ss_pred             hhhhhcCccccccc-------------------chhhhhcccc--------chhhhhhhhhhcchhhhhccchhhhhhch
Confidence            99998865432111                   0111111111        11456778889999999999999887644

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=97.73  E-value=0.00024  Score=68.77  Aligned_cols=140  Identities=19%  Similarity=0.140  Sum_probs=80.8

Q ss_pred             CCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCccHHHHHHHHHHHhcCCCC--CcceEEE------EEEeCC
Q 046893           97 DYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHS--NLVKLIG------YCCEDE  168 (464)
Q Consensus        97 ~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp--niv~l~~------~~~~~~  168 (464)
                      .+.|..|....+|+.....        ..+++|+...   .....+..|+.++..|.+-  .+.+++.      +....+
T Consensus        19 i~~i~~G~~n~~y~v~~~~--------~~~vLr~~~~---~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~   87 (296)
T cd05153          19 FEGISAGIENTNYFVTTDS--------GRYVLTLFEK---VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAG   87 (296)
T ss_pred             eecccCccccceEEEEeCC--------CcEEEEEcCC---CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCC
Confidence            3457778778999875432        2378888754   2335566788888777432  2444433      223345


Q ss_pred             eEEEEEeccCCCCHHH----HH----------Hhhc-C--------CCCCHHHHH----------HHHHHHHHHHHHHh-
Q 046893          169 HRILVYEYMESGSLEK----HL----------LRRV-G--------CMLTWSRRM----------KIALDAAKGLAFLH-  214 (464)
Q Consensus       169 ~~~lv~e~~~~g~L~~----~l----------~~~~-~--------~~l~~~~~~----------~i~~qi~~~l~~LH-  214 (464)
                      ..++||++++|..+..    .+          +... +        ....|....          .....+...+.++. 
T Consensus        88 ~~~~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~  167 (296)
T cd05153          88 KPAALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDA  167 (296)
T ss_pred             ceEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHh
Confidence            6789999998876421    00          0000 0        001111110          01111223333433 


Q ss_pred             ----cCCCCeeeccCCCCceEecCCCceEEcccCCcc
Q 046893          215 ----GAERPVIYRDFKTSNILLNADFSAKLSDFGLAK  247 (464)
Q Consensus       215 ----~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~  247 (464)
                          .....+||+|+.|.|||+++++.+.|+||+.+.
T Consensus       168 ~~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~  204 (296)
T cd05153         168 FDPSDLPRGVIHADLFRDNVLFDGDELSGVIDFYFAC  204 (296)
T ss_pred             hhhhcCCCcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence                123569999999999999988777899999875

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=97.70  E-value=0.00024  Score=69.03  Aligned_cols=80  Identities=19%  Similarity=0.152  Sum_probs=46.8

Q ss_pred             ceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCccHHHHHHHHHHHhcCCCCCc-ceEEEEEEeCCeEEEEEecc
Q 046893           99 ILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNL-VKLIGYCCEDEHRILVYEYM  177 (464)
Q Consensus        99 ~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpni-v~l~~~~~~~~~~~lv~e~~  177 (464)
                      .|..|-...||+............+..+++|+..... ........|+.++..+....+ .+++.++..    .+||||+
T Consensus         5 ~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v~e~i   79 (302)
T cd05156           5 KISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV-ELLIDRERELVVFARLSERNLGPKLYGIFPN----GRIEEFI   79 (302)
T ss_pred             EecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC-cceechHHHHHHHHHHHhCCCCCceEEEeCC----Cchhhee
Confidence            4556777789988654321111224568888865432 222345678888888743333 345555432    3689999


Q ss_pred             CCCCHH
Q 046893          178 ESGSLE  183 (464)
Q Consensus       178 ~~g~L~  183 (464)
                      +|..+.
T Consensus        80 ~G~~l~   85 (302)
T cd05156          80 PSRTLT   85 (302)
T ss_pred             CCCcCC
Confidence            887663

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>PRK05231 homoserine kinase; Provisional

Probab=97.68  E-value=0.0015  Score=63.93  Aligned_cols=32  Identities=31%  Similarity=0.379  Sum_probs=27.2

Q ss_pred             CCCeeeccCCCCceEecCCCceEEcccCCccC
Q 046893          217 ERPVIYRDFKTSNILLNADFSAKLSDFGLAKD  248 (464)
Q Consensus       217 ~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~  248 (464)
                      ..++||+|+.|.|||++.+...-|+||+.+..
T Consensus       186 p~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~  217 (319)
T PRK05231        186 PRGVIHADLFRDNVLFEGDRLSGFIDFYFACN  217 (319)
T ss_pred             CcccCCCCCCCCcEEEECCceEEEEecccccC
Confidence            45799999999999998765568999998863

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=97.58  E-value=0.001  Score=66.53  Aligned_cols=76  Identities=17%  Similarity=0.136  Sum_probs=51.7

Q ss_pred             CceeecCceEEEEEEecCCCCCCccceEEEEEEccCC------C-CccHHHHHHHHHHHhcCC---CCCcceEEEEEEeC
Q 046893           98 YILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRG------G-YQGDREWLAEVNYLGQLR---HSNLVKLIGYCCED  167 (464)
Q Consensus        98 ~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~------~-~~~~~~~~~E~~~l~~l~---hpniv~l~~~~~~~  167 (464)
                      +.||.|.+..||++.+.++      ++.|+||.-...      . .....++..|.+.|..+.   ..++.+++.+  +.
T Consensus        32 ~elggGn~N~VyrV~~~~g------~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~  103 (401)
T PRK09550         32 REIGDGNLNLVFRVSDTEG------GKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DE  103 (401)
T ss_pred             eEcCCCceEEEEEEEeCCC------CeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CC
Confidence            4689999999999987542      235888985321      1 123456777888888763   2456677765  34


Q ss_pred             CeEEEEEeccCCCC
Q 046893          168 EHRILVYEYMESGS  181 (464)
Q Consensus       168 ~~~~lv~e~~~~g~  181 (464)
                      +..++|||++++..
T Consensus       104 ~~~~lVME~L~~~~  117 (401)
T PRK09550        104 ELAVTVMEDLSDHK  117 (401)
T ss_pred             CCCEEEEecCCCcc
Confidence            56789999998643

>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]

Probab=97.32  E-value=2.4e-05  Score=86.93  Aligned_cols=157  Identities=15%  Similarity=0.015  Sum_probs=111.6

Q ss_pred             HHHHHHHhcCCCCCcceEEEEEEe--CCeEEEEEeccCCCCHHHHHHhhcC--CCCCHHHHHHHHHHHHHHHHHHhc---
Q 046893          143 LAEVNYLGQLRHSNLVKLIGYCCE--DEHRILVYEYMESGSLEKHLLRRVG--CMLTWSRRMKIALDAAKGLAFLHG---  215 (464)
Q Consensus       143 ~~E~~~l~~l~hpniv~l~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~--~~l~~~~~~~i~~qi~~~l~~LH~---  215 (464)
                      +.|...++...|+++.....-...  ...-+.+++|+.+|.+.+.|.+...  ..+...-+.....+...+..-+|+   
T Consensus      1277 l~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tn 1356 (2724)
T KOG1826|consen 1277 LSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTN 1356 (2724)
T ss_pred             hhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhccc
Confidence            455556666789888766554332  2345789999999999998876322  223333333333333556666663   


Q ss_pred             CCCCeeeccCCCCceEecCCCceEEcccCCccCCCCCCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHH
Q 046893          216 AERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEML  295 (464)
Q Consensus       216 ~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell  295 (464)
                      .+.-.+|++||+-|.+|..+..+|+.++|+.+.. . ..........+++.|++++....-.++.++|+|..|+.+|++.
T Consensus      1357 lg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIk-n-p~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs 1434 (2724)
T KOG1826|consen 1357 LGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIK-N-PVLSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRS 1434 (2724)
T ss_pred             CCccchhhhhhhhccceecCCccccccccccccc-C-chHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHh
Confidence            2344789999999999999999999999999831 1 1122233467888999999888888999999999999999988


Q ss_pred             hCCCCC
Q 046893          296 LGRRAV  301 (464)
Q Consensus       296 ~g~~pf  301 (464)
                      -|..+|
T Consensus      1435 ~~n~~f 1440 (2724)
T KOG1826|consen 1435 DGNAYF 1440 (2724)
T ss_pred             cccHHH
Confidence            887655

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=97.24  E-value=0.0056  Score=59.60  Aligned_cols=141  Identities=17%  Similarity=0.109  Sum_probs=78.8

Q ss_pred             CCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCccHHHHHHHHHHHhcCCCC--CcceEEEE------EEeCC
Q 046893           97 DYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHS--NLVKLIGY------CCEDE  168 (464)
Q Consensus        97 ~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp--niv~l~~~------~~~~~  168 (464)
                      .+.++.|....+|+.....       + .+++|+....  .....+..|++++..|...  .+.+++..      ....+
T Consensus        27 i~~~~~G~~n~~y~v~t~~-------~-~~vLK~~~~~--~~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g   96 (307)
T TIGR00938        27 LKGIAEGVENSNYLLTTDV-------G-RYILTLYEKR--VKAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAG   96 (307)
T ss_pred             ccccCCccccceEEEEeCC-------C-cEEEEEecCC--CCHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCC
Confidence            3456777778899875322       2 3677876442  1234555677777776322  23344331      12245


Q ss_pred             eEEEEEeccCCCCHH-----------HHH---Hhhc-CC--C-------CCHHHHHH------------HHHHHHHHHHH
Q 046893          169 HRILVYEYMESGSLE-----------KHL---LRRV-GC--M-------LTWSRRMK------------IALDAAKGLAF  212 (464)
Q Consensus       169 ~~~lv~e~~~~g~L~-----------~~l---~~~~-~~--~-------l~~~~~~~------------i~~qi~~~l~~  212 (464)
                      ..++||+|++|..+.           ..+   +... +.  .       -.|.....            ....+...+.+
T Consensus        97 ~~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~  176 (307)
T TIGR00938        97 KPACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDY  176 (307)
T ss_pred             eEEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHH
Confidence            678999999885431           111   1100 00  0       01111000            01112234444


Q ss_pred             Hh-----cCCCCeeeccCCCCceEecCCCceEEcccCCcc
Q 046893          213 LH-----GAERPVIYRDFKTSNILLNADFSAKLSDFGLAK  247 (464)
Q Consensus       213 LH-----~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~  247 (464)
                      +.     ....++||+|+.+.||+++.++.+.|+||+.+.
T Consensus       177 l~~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~  216 (307)
T TIGR00938       177 LDKFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC  216 (307)
T ss_pred             HHhhhhhcCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence            53     235689999999999999988777899999875

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>PLN02236 choline kinase

Probab=97.04  E-value=0.0055  Score=60.62  Aligned_cols=143  Identities=16%  Similarity=0.141  Sum_probs=79.0

Q ss_pred             ceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCccHHHHHHHHHHHhcCCCCCc-ceEEEEEEeCCeEEEEEecc
Q 046893           99 ILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNL-VKLIGYCCEDEHRILVYEYM  177 (464)
Q Consensus        99 ~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpni-v~l~~~~~~~~~~~lv~e~~  177 (464)
                      .|-.|-.-.+|++.......  ..+..|++|+...... ..-.-..|..+++.+..-++ .++++++...    .|.+|+
T Consensus        43 ~l~gGlTN~~y~v~~~~~~~--~~~~~~v~Ri~g~~t~-~~idR~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~efi  115 (344)
T PLN02236         43 PLKGAMTNEVFQIKWPTKEG--NLGRKVLVRIYGEGVE-LFFDRDDEIRTFECMSRHGQGPRLLGRFPNG----RVEEFI  115 (344)
T ss_pred             EcCCcccceeEEEEeCCCCC--CCCCeEEEEEccCCCC-eeechHHHHHHHHHHHHcCCCCceEEEECCc----eEEEee
Confidence            34457788899976533211  1235688888765432 11122578888888854333 3555655332    589999


Q ss_pred             CCCCHHHH--------------HH---hhc--CC--CCCHHHHHHHHHHH-----------------HHHHHHH----h-
Q 046893          178 ESGSLEKH--------------LL---RRV--GC--MLTWSRRMKIALDA-----------------AKGLAFL----H-  214 (464)
Q Consensus       178 ~~g~L~~~--------------l~---~~~--~~--~l~~~~~~~i~~qi-----------------~~~l~~L----H-  214 (464)
                      ++.+|...              +.   ...  +.  ...+..+..+..++                 ...+..|    . 
T Consensus       116 ~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~  195 (344)
T PLN02236        116 HARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSG  195 (344)
T ss_pred             CCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhcc
Confidence            87665311              00   000  00  11233333332221                 1111111    1 


Q ss_pred             -cCCCCeeeccCCCCceEecC-CCceEEcccCCccC
Q 046893          215 -GAERPVIYRDFKTSNILLNA-DFSAKLSDFGLAKD  248 (464)
Q Consensus       215 -~~~~~ivHrDlkp~Nill~~-~~~vkl~DFGla~~  248 (464)
                       .....++|+||++.|||+++ ++.+.|+||..|..
T Consensus       196 ~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~  231 (344)
T PLN02236        196 DDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY  231 (344)
T ss_pred             cCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence             12346899999999999976 46799999988763

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=97.01  E-value=0.0007  Score=64.54  Aligned_cols=134  Identities=16%  Similarity=0.113  Sum_probs=86.6

Q ss_pred             CCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCC--CC----------------ccH----HHHHHHHHHHh
Q 046893           93 FFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRG--GY----------------QGD----REWLAEVNYLG  150 (464)
Q Consensus        93 ~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~--~~----------------~~~----~~~~~E~~~l~  150 (464)
                      -+.+.+.||-|--+.||.+.+.+       ++..++|.-...  ++                .+.    -...+|+..|+
T Consensus        93 v~svGnqIGVGKESDIY~v~d~~-------G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmk  165 (465)
T KOG2268|consen   93 VESVGNQIGVGKESDIYVVADEE-------GNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMK  165 (465)
T ss_pred             hhhhccccccccccceEEEecCC-------CCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHH
Confidence            46778899999999999998765       445666653211  00                000    11246888888


Q ss_pred             cCC-CC-CcceEEEEEEeCCeEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCC
Q 046893          151 QLR-HS-NLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTS  228 (464)
Q Consensus       151 ~l~-hp-niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~  228 (464)
                      .|. |- -|.+.+++    +..++|||++.|-.|...- .    .....++..-+..   -+.-|.  ..|+||+|..-=
T Consensus       166 aL~e~gfpVPkpiD~----~RH~Vvmelv~g~Pl~~v~-~----v~d~~~ly~~lm~---~Iv~la--~~GlIHgDFNEF  231 (465)
T KOG2268|consen  166 ALYERGFPVPKPIDH----NRHCVVMELVDGYPLRQVR-H----VEDPPTLYDDLMG---LIVRLA--NHGLIHGDFNEF  231 (465)
T ss_pred             HHHHcCCCCCCcccc----cceeeHHHhhcccceeeee-e----cCChHHHHHHHHH---HHHHHH--HcCceecccchh
Confidence            874 32 24444443    4568999999998886532 1    1233333332222   233344  567999999999


Q ss_pred             ceEecCCCceEEcccCCcc
Q 046893          229 NILLNADFSAKLSDFGLAK  247 (464)
Q Consensus       229 Nill~~~~~vkl~DFGla~  247 (464)
                      ||++++++.++++||--+.
T Consensus       232 Nimv~dd~~i~vIDFPQmv  250 (465)
T KOG2268|consen  232 NIMVKDDDKIVVIDFPQMV  250 (465)
T ss_pred             eeEEecCCCEEEeechHhh
Confidence            9999999999999997543

>KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only]

Probab=96.96  E-value=0.0011  Score=66.88  Aligned_cols=164  Identities=24%  Similarity=0.311  Sum_probs=92.8

Q ss_pred             HHHHHHHHHHHhcCCCCCcceEEEEEEeC-CeEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC
Q 046893          139 DREWLAEVNYLGQLRHSNLVKLIGYCCED-EHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAE  217 (464)
Q Consensus       139 ~~~~~~E~~~l~~l~hpniv~l~~~~~~~-~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~  217 (464)
                      ...++-.+..++.+.|+|...++++.... ....+|||++ +.+|++.+..+.   +-..       ++.     -|  +
T Consensus        26 s~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~~~---l~~~-------s~~-----~~--~   87 (725)
T KOG1093|consen   26 SIQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKTGN---LKDE-------SLL-----AH--G   87 (725)
T ss_pred             HHHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHHhcc---cchh-------hhc-----cc--c
Confidence            35677788899999999999999877654 3578899999 669999876543   1111       000     12  2


Q ss_pred             CCeeeccCCCCceEecCCCceEEcccCCccCCCCCCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHhC
Q 046893          218 RPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLG  297 (464)
Q Consensus       218 ~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g  297 (464)
                        +.|-            +.++++| -++..      .   ....|                +|+|||++|.++.++.-|
T Consensus        88 --~~~~------------~~~~~td-~~~t~------~---~~~~~----------------pKsdVwsl~~i~~el~L~  127 (725)
T KOG1093|consen   88 --VLHL------------NIIYITD-HFLTK------Y---PSPIG----------------PKSDVWSLGFIILELYLG  127 (725)
T ss_pred             --ccee------------hhhhccc-ccccc------C---CCCCC----------------cchhhhhHHHHHHHHHHh
Confidence              3332            1234444 11110      0   00111                399999999999999999


Q ss_pred             CCCCCCCCCcccccHHHHHHHhhhcccchhhccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHH
Q 046893          298 RRAVDKSRPSREHNLVEWARPLLNNNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSD  366 (464)
Q Consensus       298 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~e  366 (464)
                      ...+......   ........+...+.......   ....+...++..++.+..+|+-..|..||...+
T Consensus       128 ~~l~~~~~~s---~~l~~i~k~~~~d~~~~~~a---~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~  190 (725)
T KOG1093|consen  128 ISLEAELTES---EYLEILLKYYTDDQELLSTA---MEHLIQLLADKKRLPLLKKCLWLEPIIRPLPME  190 (725)
T ss_pred             hHHHHHHHHH---HHHHHHHHhccCchhHHHHH---HHHHHHHhhhHhHHHHhccCCccccccccchhH
Confidence            8665432211   11111112221111111000   000223445667888999999999988875443

>KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning]

Probab=96.87  E-value=0.0035  Score=60.88  Aligned_cols=139  Identities=14%  Similarity=0.138  Sum_probs=88.3

Q ss_pred             CCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCC--cc--------------------HH---H-HHHHHHHHh
Q 046893           97 DYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGY--QG--------------------DR---E-WLAEVNYLG  150 (464)
Q Consensus        97 ~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~--~~--------------------~~---~-~~~E~~~l~  150 (464)
                      .-.|..|--+.||.|.-.+       |..+|||+.+.+-.  ..                    .+   . ...|++.|.
T Consensus       149 nGCiSTGKEANVYHat~~d-------G~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLk  221 (520)
T KOG2270|consen  149 NGCISTGKEANVYHATEED-------GSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLK  221 (520)
T ss_pred             ccccccCccceeEeeecCC-------CceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHH
Confidence            3467788888999987655       44589998864210  00                    01   1 136888888


Q ss_pred             cCCCCCcceEEEEEEeCCeEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCce
Q 046893          151 QLRHSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNI  230 (464)
Q Consensus       151 ~l~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Ni  230 (464)
                      +|....|. +-.-..-. ...|||+|+.......  ....+..++...+..+-.|++.-+.-|-. ..++||.||.--|+
T Consensus       222 Rl~~aGIP-~PePIlLk-~hVLVM~FlGrdgw~a--PkLKd~~ls~~ka~~~Y~~~v~~MR~lY~-~c~LVHADLSEfN~  296 (520)
T KOG2270|consen  222 RLNNAGIP-CPEPILLK-NHVLVMEFLGRDGWAA--PKLKDASLSTSKARELYQQCVRIMRRLYQ-KCRLVHADLSEFNL  296 (520)
T ss_pred             HHHhcCCC-CCCceeee-cceEeeeeccCCCCcC--cccccccCChHHHHHHHHHHHHHHHHHHH-Hhceeccchhhhhh
Confidence            88654422 11111111 2368999994322211  11123457777777777788777776653 45699999999999


Q ss_pred             EecCCCceEEcccCCccC
Q 046893          231 LLNADFSAKLSDFGLAKD  248 (464)
Q Consensus       231 ll~~~~~vkl~DFGla~~  248 (464)
                      |+. +|.++|+|-+-+..
T Consensus       297 Lyh-dG~lyiIDVSQSVE  313 (520)
T KOG2270|consen  297 LYH-DGKLYIIDVSQSVE  313 (520)
T ss_pred             eEE-CCEEEEEEcccccc
Confidence            995 67999999887653

>TIGR01767 MTRK 5-methylthioribose kinase

Probab=96.78  E-value=0.021  Score=56.18  Aligned_cols=74  Identities=14%  Similarity=0.095  Sum_probs=45.6

Q ss_pred             ceeecCceEEEEEEecCCCCCCccceEEEEEEccCC------C-CccHHHHHHHHHHHhcCC--CCC-cceEEEEEEeCC
Q 046893           99 ILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRG------G-YQGDREWLAEVNYLGQLR--HSN-LVKLIGYCCEDE  168 (464)
Q Consensus        99 ~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~------~-~~~~~~~~~E~~~l~~l~--hpn-iv~l~~~~~~~~  168 (464)
                      .||-|....||++.+..+      ++.|+||.-...      . .....+...|...|....  -|. +.+++  +.+++
T Consensus         2 EigdGnlN~VfrV~~~~g------~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy--~~D~e   73 (370)
T TIGR01767         2 EVGDGNLNLVFHVYDQEG------DRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIF--HFDTE   73 (370)
T ss_pred             cCCCCceEEEEEEEcCCC------CeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEE--EEccc
Confidence            479999999999986432      245888874321      1 122345567778777653  343 44444  33445


Q ss_pred             eEEEEEeccCCC
Q 046893          169 HRILVYEYMESG  180 (464)
Q Consensus       169 ~~~lv~e~~~~g  180 (464)
                      ...+|||+++..
T Consensus        74 ~~~~vMEdL~~~   85 (370)
T TIGR01767        74 MAVTVMEDLSHH   85 (370)
T ss_pred             cceehHhhCccc
Confidence            567999998543

This enzyme is involved in the methionine salvage pathway in certain bacteria.

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=96.72  E-value=0.01  Score=56.74  Aligned_cols=30  Identities=27%  Similarity=0.367  Sum_probs=25.4

Q ss_pred             CeeeccCCCCceEecCCCc-eEEcccCCccC
Q 046893          219 PVIYRDFKTSNILLNADFS-AKLSDFGLAKD  248 (464)
Q Consensus       219 ~ivHrDlkp~Nill~~~~~-vkl~DFGla~~  248 (464)
                      .++|+|++|.|||+++++. .-|+||+.+..
T Consensus       186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i  216 (276)
T cd05152         186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKV  216 (276)
T ss_pred             eeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence            4899999999999987555 56999998864

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>TIGR02904 spore_ysxE spore coat protein YsxE

Probab=96.60  E-value=0.031  Score=54.43  Aligned_cols=32  Identities=13%  Similarity=0.128  Sum_probs=28.6

Q ss_pred             CCCeeeccCCCCceEecCCCceEEcccCCccC
Q 046893          217 ERPVIYRDFKTSNILLNADFSAKLSDFGLAKD  248 (464)
Q Consensus       217 ~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~  248 (464)
                      ..++||+|+.+.|||+++++.+.|+||..+..
T Consensus       195 ~~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~  226 (309)
T TIGR02904       195 RTVLVHGKLSLSHFLYDETRGGYFINFEKASF  226 (309)
T ss_pred             ceeeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence            45799999999999999999999999998864

Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.

>PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length

Probab=96.59  E-value=0.011  Score=53.64  Aligned_cols=136  Identities=14%  Similarity=0.092  Sum_probs=84.2

Q ss_pred             EEEEEccCCCCc-cHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHH
Q 046893          126 VAIKELNRGGYQ-GDREWLAEVNYLGQLRHSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIAL  204 (464)
Q Consensus       126 vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~  204 (464)
                      ..+|++...... ...-|..+.+++.+++  .|+++..-  ..-.+-++.|+|.....           ...    .++.
T Consensus        88 L~lKKi~slp~~~~~~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~i-----------~~~----N~i~  148 (308)
T PF07387_consen   88 LFLKKIRSLPCCINDALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIKI-----------NFS----NFIT  148 (308)
T ss_pred             hhhhhccCCCcccchhhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCccc-----------chh----HHHH
Confidence            455555544333 4566788899998875  47887732  33356789999843211           110    1111


Q ss_pred             HHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCccCCCCCCCcceeeccccCCcccCccccccCCCCcccch
Q 046893          205 DAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDV  284 (464)
Q Consensus       205 qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv  284 (464)
                      .=+.+|.-.|+...+.+|+|..|+||+-|..|.+||.|=+..-.              .+..|.--|   ....+.++.+
T Consensus       149 agi~~L~~fH~~~~~~lHGD~np~NiM~D~~G~lKlVDP~~Ll~--------------~~V~~vN~~---Y~~lT~~aE~  211 (308)
T PF07387_consen  149 AGIKDLMDFHSENQHCLHGDCNPDNIMCDKFGYLKLVDPVCLLE--------------NQVNMVNIE---YESLTQEAEV  211 (308)
T ss_pred             HhHHHHHHhhccCCCeecCCCChhheeecCCCCEEecChhhhhh--------------heeeEEeee---ccccChHHHH
Confidence            11466778897788899999999999999999999999664321              111122211   1234556666


Q ss_pred             hcHHHHHHHHHhC
Q 046893          285 YGFGVVLLEMLLG  297 (464)
Q Consensus       285 wslG~il~ell~g  297 (464)
                      -+|=.-++++...
T Consensus       212 ~~fv~s~l~~v~~  224 (308)
T PF07387_consen  212 KVFVKSCLKLVEK  224 (308)
T ss_pred             HHHHHHHHHHHHH
Confidence            6666666666553

The function of this family is unknown.

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=96.52  E-value=0.024  Score=54.91  Aligned_cols=31  Identities=19%  Similarity=0.439  Sum_probs=28.0

Q ss_pred             CeeeccCCCCceEecCCCceEEcccCCccCC
Q 046893          219 PVIYRDFKTSNILLNADFSAKLSDFGLAKDG  249 (464)
Q Consensus       219 ~ivHrDlkp~Nill~~~~~vkl~DFGla~~~  249 (464)
                      .++|+|+.+.||+++.++-+=|+||+++...
T Consensus       199 ~lvHGD~~~gNlii~~~~~~gVlDwe~~~lG  229 (321)
T COG3173         199 VLVHGDYRPGNLIIDPGRPTGVLDWELATLG  229 (321)
T ss_pred             eeeeCCcccCCEEEeCCCeeEEEeccccccC
Confidence            5899999999999998888999999999853

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=96.52  E-value=0.085  Score=51.25  Aligned_cols=30  Identities=27%  Similarity=0.333  Sum_probs=26.1

Q ss_pred             CCCeeeccCCCCceEecCCCceEEcccCCcc
Q 046893          217 ERPVIYRDFKTSNILLNADFSAKLSDFGLAK  247 (464)
Q Consensus       217 ~~~ivHrDlkp~Nill~~~~~vkl~DFGla~  247 (464)
                      ..++||+|+.+.||+++. +.+.|+||+.+.
T Consensus       186 ~~~liHgD~~~~Nil~~~-~~i~lIDfd~~~  215 (313)
T TIGR02906       186 IRGFCHQDYAYHNILLKD-NEVYVIDFDYCT  215 (313)
T ss_pred             cCceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence            357999999999999987 678999999765

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2

Probab=96.47  E-value=0.0042  Score=56.84  Aligned_cols=30  Identities=37%  Similarity=0.407  Sum_probs=21.3

Q ss_pred             CCeeeccCCCCceEe-cCCCceEEcccCCcc
Q 046893          218 RPVIYRDFKTSNILL-NADFSAKLSDFGLAK  247 (464)
Q Consensus       218 ~~ivHrDlkp~Nill-~~~~~vkl~DFGla~  247 (464)
                      .-++|+||.+.|||+ +.++.++|+||..|.
T Consensus       143 ~v~cHnDl~~~Nil~~~~~~~~~lIDfEya~  173 (211)
T PF01633_consen  143 LVFCHNDLNPGNILINNKDGEVKLIDFEYAG  173 (211)
T ss_dssp             EEEE-S--SGGGEEETSSSSCEEE--GTT-E
T ss_pred             ceEeeccCccccEEeccCCCeEEEecHHHHh
Confidence            458899999999999 888999999998875

7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B ....

>PRK12396 5-methylribose kinase; Reviewed

Probab=96.43  E-value=0.012  Score=58.56  Aligned_cols=75  Identities=13%  Similarity=0.106  Sum_probs=46.9

Q ss_pred             CCceeecCceEEEEEEecCCCCCCccceEEEEEEccCC-----C-CccHHHHHHHHHHHhcCC--CCC-cceEEEEEEeC
Q 046893           97 DYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRG-----G-YQGDREWLAEVNYLGQLR--HSN-LVKLIGYCCED  167 (464)
Q Consensus        97 ~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~-----~-~~~~~~~~~E~~~l~~l~--hpn-iv~l~~~~~~~  167 (464)
                      .+.||-|.-..||++.+...      +..|+||.-...     + .....+...|...|+.+.  -|. +.+++.  .++
T Consensus        34 ~~eigdGnlN~VfrV~~~~~------~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~--~D~  105 (409)
T PRK12396         34 CKEIGDGNLNYVFRVWDEQK------NISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYL--FDS  105 (409)
T ss_pred             eeEcCCCceEEEEEEeeCCC------CceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEE--ECc
Confidence            34689999999999987421      234777764321     1 122356677888888763  343 444543  344


Q ss_pred             CeEEEEEeccCC
Q 046893          168 EHRILVYEYMES  179 (464)
Q Consensus       168 ~~~~lv~e~~~~  179 (464)
                      ....+|||+++.
T Consensus       106 e~~~~vMEdL~~  117 (409)
T PRK12396        106 VMNCCVMEDLSD  117 (409)
T ss_pred             HHhhHHHHhCcc
Confidence            556789999854

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=96.42  E-value=0.025  Score=55.70  Aligned_cols=142  Identities=15%  Similarity=0.179  Sum_probs=75.9

Q ss_pred             ceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCccHHHHHHHHHHHhcCCCCCc-ceEEEEEEeCCeEEEEEecc
Q 046893           99 ILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNL-VKLIGYCCEDEHRILVYEYM  177 (464)
Q Consensus        99 ~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpni-v~l~~~~~~~~~~~lv~e~~  177 (464)
                      .|-.|=...+|+........   ....|++++...... ..-.-.+|..+++.+..-++ .++++++. ..   +|.+|+
T Consensus        21 ~l~gGlTN~~~~v~~~~~~~---~~~~~v~Ri~g~~t~-~~IdR~~E~~il~~l~~~gl~P~~l~~~~-~G---~i~~fi   92 (330)
T PLN02421         21 RISGGITNLLLKVSVKEENG---NEVSVTVRLFGPNTD-YVIDRERELQAIKYLSAAGFGAKLLGVFG-NG---MIQSFI   92 (330)
T ss_pred             EeCCcccceEEEEEecCCCC---CCceEEEEEecCCcC-eEechHHHHHHHHHHHhcCCCCceeEEeC-Cc---Eeehhh
Confidence            34457777788876443210   123578887754322 11122478888888865444 35555553 22   588999


Q ss_pred             CCCCHHH--------------HHHhhcCCC------C-CHHHHHHHHHHH----------------------HHHHHH--
Q 046893          178 ESGSLEK--------------HLLRRVGCM------L-TWSRRMKIALDA----------------------AKGLAF--  212 (464)
Q Consensus       178 ~~g~L~~--------------~l~~~~~~~------l-~~~~~~~i~~qi----------------------~~~l~~--  212 (464)
                      ++..|..              .+.+-....      . .+..+..+..++                      ..-+..  
T Consensus        93 ~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~  172 (330)
T PLN02421         93 NARTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELK  172 (330)
T ss_pred             cCCCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHH
Confidence            7765521              111100100      1 123322222221                      111111  


Q ss_pred             -Hh---cCCCCeeeccCCCCceEecC-CCceEEcccCCccC
Q 046893          213 -LH---GAERPVIYRDFKTSNILLNA-DFSAKLSDFGLAKD  248 (464)
Q Consensus       213 -LH---~~~~~ivHrDlkp~Nill~~-~~~vkl~DFGla~~  248 (464)
                       +.   ....-++|.||.+.|||+++ ++.++++||..|..
T Consensus       173 ~~~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~  213 (330)
T PLN02421        173 EITDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY  213 (330)
T ss_pred             HHhccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence             11   11224799999999999974 56899999998753

>COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning]

Probab=96.39  E-value=0.01  Score=57.69  Aligned_cols=73  Identities=16%  Similarity=0.167  Sum_probs=55.6

Q ss_pred             CCeEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCc
Q 046893          167 DEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLA  246 (464)
Q Consensus       167 ~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla  246 (464)
                      ..+.|++|++- |+.|.- +.     ...+.++..++.+.+.-+.-+.. +-..-||||.-.||||+ +|+|-|+||-++
T Consensus       298 ~~y~yl~~kdh-gt~is~-ik-----~~~~~e~lsff~s~~sil~~lek-kf~fehrnlt~~niLId-~GnvtLIDfkls  368 (488)
T COG5072         298 TLYLYLHFKDH-GTPISI-IK-----ADRSEEELSFFWSCISILDILEK-KFPFEHRNLTLDNILID-EGNVTLIDFKLS  368 (488)
T ss_pred             ceEEEEEEecC-Cceeee-ee-----cccHHHHHHHHHHHHHHHhhhhh-cCCcccccccccceeee-cCceEEEEeeee
Confidence            34667888875 666632 11     24678888888887776666553 55688999999999999 999999999999


Q ss_pred             cC
Q 046893          247 KD  248 (464)
Q Consensus       247 ~~  248 (464)
                      +.
T Consensus       369 Rl  370 (488)
T COG5072         369 RL  370 (488)
T ss_pred             ec
Confidence            95

>PTZ00384 choline kinase; Provisional

Probab=96.14  E-value=0.056  Score=54.15  Aligned_cols=80  Identities=19%  Similarity=0.211  Sum_probs=44.8

Q ss_pred             ceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCccHHHHHHHHHHHhcCCCCCcc-eEEEEEEeCCeEEEEEecc
Q 046893           99 ILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLV-KLIGYCCEDEHRILVYEYM  177 (464)
Q Consensus        99 ~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv-~l~~~~~~~~~~~lv~e~~  177 (464)
                      .|..|-...+|++.........+..+.|.+....... ...-.-.+|+++++.+...++. ++++.+..    ++|.||+
T Consensus        57 ~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~~~-~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~~----g~l~efI  131 (383)
T PTZ00384         57 KMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSSTYN-SLVIDNDLQYNIAKLLGDNNFGPKIIGRFGD----FTIQEWV  131 (383)
T ss_pred             EeCCcccceEEEEEecCCCCCccccceEEEEeccCCC-ceEeccHHHHHHHHHHHhCCCCCeEEEecCC----EEEEEEe
Confidence            4555888889998754331111222334554432211 1111224688899998655544 45555532    5899999


Q ss_pred             CCCCHH
Q 046893          178 ESGSLE  183 (464)
Q Consensus       178 ~~g~L~  183 (464)
                      +|..|.
T Consensus       132 eGr~l~  137 (383)
T PTZ00384        132 EGNTMG  137 (383)
T ss_pred             ccccCC
Confidence            887663

>PLN02756 S-methyl-5-thioribose kinase

Probab=96.10  E-value=0.081  Score=53.06  Aligned_cols=73  Identities=15%  Similarity=0.109  Sum_probs=46.7

Q ss_pred             CCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCC-------ccHHHHHHHHHHHhcCC---CCCcceEEEEEEe
Q 046893           97 DYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGY-------QGDREWLAEVNYLGQLR---HSNLVKLIGYCCE  166 (464)
Q Consensus        97 ~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~E~~~l~~l~---hpniv~l~~~~~~  166 (464)
                      .+.||-|....||+..+..        ..++||.-.....       ....+-..|...|..+.   ..++.+++.++. 
T Consensus        37 ~~eiggGn~N~VyrV~~~~--------~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de-  107 (418)
T PLN02756         37 IKEVGDGNLNFVYIVVSSS--------GSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR-  107 (418)
T ss_pred             EEEcCCCceeeEEEEEcCC--------ccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC-
Confidence            3568999999999976532        2378887652111       12334445566666653   246777887766 


Q ss_pred             CCeEEEEEeccCC
Q 046893          167 DEHRILVYEYMES  179 (464)
Q Consensus       167 ~~~~~lv~e~~~~  179 (464)
                       +..+++||++++
T Consensus       108 -d~~vlvME~L~~  119 (418)
T PLN02756        108 -TMALIGMRYLEP  119 (418)
T ss_pred             -CCCEEEEeecCC
Confidence             446789999977

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=95.88  E-value=0.037  Score=53.12  Aligned_cols=73  Identities=19%  Similarity=0.221  Sum_probs=44.6

Q ss_pred             CCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCccHHHHHHHHHHHhcCC---CCCcceEEEEEEeCCeEEEE
Q 046893           97 DYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLR---HSNLVKLIGYCCEDEHRILV  173 (464)
Q Consensus        97 ~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---hpniv~l~~~~~~~~~~~lv  173 (464)
                      .+.|+.|....+|+... .       +..+.||+-..   .....|..|..-|+.|.   --.+.+++.+....+..+||
T Consensus        22 ~~~v~GG~i~~a~~~~~-~-------~~~~FvK~~~~---~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLl   90 (288)
T PF03881_consen   22 IEPVSGGDINEAYRLDT-D-------GGSYFVKVNSE---SGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLL   90 (288)
T ss_dssp             EEEE--SSSSEEEEEET-T-------S-EEEEEEEEG---GGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEE
T ss_pred             eEecCCCChhheEEEEC-C-------CccEEEEecCh---hhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEE
Confidence            34588899999998762 1       45588888652   22346778888888773   33577888888888788999


Q ss_pred             EeccCCC
Q 046893          174 YEYMESG  180 (464)
Q Consensus       174 ~e~~~~g  180 (464)
                      |||++.+
T Consensus        91 le~l~~~   97 (288)
T PF03881_consen   91 LEFLEMG   97 (288)
T ss_dssp             EE-----
T ss_pred             EEeecCC
Confidence            9999876

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>PRK06148 hypothetical protein; Provisional

Probab=95.51  E-value=0.12  Score=58.50  Aligned_cols=34  Identities=38%  Similarity=0.392  Sum_probs=27.9

Q ss_pred             cCCCCeeeccCCCCceEecCCC--ceE-EcccCCccC
Q 046893          215 GAERPVIYRDFKTSNILLNADF--SAK-LSDFGLAKD  248 (464)
Q Consensus       215 ~~~~~ivHrDlkp~Nill~~~~--~vk-l~DFGla~~  248 (464)
                      .....+||+|+.+.|||++.++  .+. |+|||.+..
T Consensus       200 ~Lp~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~  236 (1013)
T PRK06148        200 ALPAQVIHNDANDYNILVDADDGERISGLIDFGDAVH  236 (1013)
T ss_pred             cCCcceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence            4456799999999999998775  555 999998764

>COG3001 Uncharacterized protein conserved in bacteria [Function unknown]

Probab=95.45  E-value=0.21  Score=45.83  Aligned_cols=57  Identities=26%  Similarity=0.324  Sum_probs=41.4

Q ss_pred             eEEEEEEccCCCCccHHHHHHHHHHHhcCC---CCCcceEEEEEEeCCeEEEEEeccCCCCHH
Q 046893          124 TFVAIKELNRGGYQGDREWLAEVNYLGQLR---HSNLVKLIGYCCEDEHRILVYEYMESGSLE  183 (464)
Q Consensus       124 ~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---hpniv~l~~~~~~~~~~~lv~e~~~~g~L~  183 (464)
                      ..+-||+-..   .....|..|+.-|..|.   --.|.+++.+.....+.||||||++-+.+.
T Consensus        40 ~~~FvK~n~~---~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L~~~~~d   99 (286)
T COG3001          40 DPFFVKCNQR---EQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYLPTGPLD   99 (286)
T ss_pred             cceEEEecch---hhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeeccCCCCC
Confidence            3477886433   23356777877777663   356778888888999999999999887653

>PRK11768 serine/threonine protein kinase; Provisional

Probab=95.39  E-value=0.5  Score=46.35  Aligned_cols=30  Identities=23%  Similarity=0.244  Sum_probs=25.1

Q ss_pred             CCCeeeccCCCCceEecCCCceEEcccCCccC
Q 046893          217 ERPVIYRDFKTSNILLNADFSAKLSDFGLAKD  248 (464)
Q Consensus       217 ~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~  248 (464)
                      ..++||+|+.+.|||++ + .+.|+||+.+..
T Consensus       195 ~~~liHgD~h~~NvL~~-d-~~~iIDFDd~~~  224 (325)
T PRK11768        195 RLLRLHGDCHPGNILWR-D-GPHFVDLDDARM  224 (325)
T ss_pred             CccceecCCCchhcccc-C-CcEEEeCCCCCC
Confidence            45689999999999995 4 578999998763

>KOG1236 consensus Predicted unusual protein kinase [General function prediction only]

Probab=95.01  E-value=0.047  Score=54.03  Aligned_cols=60  Identities=17%  Similarity=0.116  Sum_probs=38.8

Q ss_pred             EEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEec
Q 046893          170 RILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLN  233 (464)
Q Consensus       170 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~  233 (464)
                      ..|+=+|..|-++..++....   .++.....++.--+.||--+-- -.+++|.||.|.||++-
T Consensus       320 ~vl~E~~~~Gl~v~~~v~~~~---~pe~l~kkva~lg~~AllkMl~-vDNFvHaDlHPGNVlir  379 (565)
T KOG1236|consen  320 LVLVETYERGLSVLRFVKWKS---QPEALVKKVAKLGVNALLKMLI-VDNFVHADLHPGNVLIR  379 (565)
T ss_pred             ceeeeeccccccHHhhhhccc---ChHHHHHHHHHHHHHHHHHHHH-hhcceecccCCCcEEEE
Confidence            346667888888888776543   4544555555544444443221 13499999999999994

>PTZ00296 choline kinase; Provisional

Probab=94.85  E-value=0.25  Score=50.57  Aligned_cols=80  Identities=9%  Similarity=0.040  Sum_probs=44.4

Q ss_pred             CceeecCceEEEEEEecCCCCC--CccceEEEEEEccCCCCccHHHHHHHHHHHhcCCCCCcc-eEEEEEEeCCeEEEEE
Q 046893           98 YILGEGGFGVVYKGVIDENVRP--GYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLV-KLIGYCCEDEHRILVY  174 (464)
Q Consensus        98 ~~lG~G~fg~Vy~a~~~~~~~~--~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv-~l~~~~~~~~~~~lv~  174 (464)
                      +.|..|-.-.+|++........  ...+..|.+++.......- -.-..|..+++.+..-+|. ++++.+.    -..|.
T Consensus       111 ~~l~gGlTN~~f~v~~~~~~~~~~~~~~~~~lvRiyG~~te~l-IdR~~E~~v~~~ls~~gi~P~l~~~f~----gg~I~  185 (442)
T PTZ00296        111 NQILSGLTNQLFEVSLKEETANNYPSIRRRVLFRIYGKDVDEL-YNPISEFEVYKTMSKYRIAPQLLNTFS----GGRIE  185 (442)
T ss_pred             EEecCcccCceEEEEecCCCCccccCcCceEEEEecCCCccce-eCHHHHHHHHHHHHHCCCCCceEEEeC----CCEEE
Confidence            4566677778888875432111  1123468888875432211 1224577777777544443 4555443    24678


Q ss_pred             eccCCCCH
Q 046893          175 EYMESGSL  182 (464)
Q Consensus       175 e~~~~g~L  182 (464)
                      ||++|..|
T Consensus       186 efi~g~~l  193 (442)
T PTZ00296        186 EWLYGDPL  193 (442)
T ss_pred             EeeCCccC
Confidence            99987644

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	464
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		7e-52
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		7e-51
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		7e-49
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		1e-47
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		4e-40
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		6e-40
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		4e-39
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		1e-36
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		7e-24
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		1e-23
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		6e-23
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		6e-23
2pl0_A	289	Lck Bound To Imatinib Length = 289		8e-23
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		9e-23
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		1e-22
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		1e-22
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		1e-22
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		1e-22
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		1e-22
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		1e-22
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		2e-22
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		2e-22
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		5e-22
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		6e-22
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		1e-21
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		6e-21
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		7e-21
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		1e-20
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		2e-20
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		3e-20
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		4e-20
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		4e-20
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		4e-20
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		5e-20
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		5e-20
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		5e-20
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		7e-20
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		7e-20
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		8e-20
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		8e-20
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-19
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		1e-19
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		1e-19
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		1e-19
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		1e-19
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		1e-19
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		1e-19
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		1e-19
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		1e-19
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		1e-19
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		1e-19
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		2e-19
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		2e-19
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		2e-19
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		2e-19
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		2e-19
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		2e-19
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		2e-19
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		3e-19
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		3e-19
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		3e-19
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		4e-19
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		4e-19
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		5e-19
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		5e-19
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		5e-19
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		5e-19
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		6e-19
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		6e-19
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		6e-19
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		6e-19
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		6e-19
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		6e-19
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		6e-19
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		6e-19
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		6e-19
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		6e-19
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		6e-19
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		6e-19
4h58_A	275	Braf In Complex With Compound 3 Length = 275		7e-19
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		7e-19
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		7e-19
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		7e-19
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		8e-19
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		8e-19
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		8e-19
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		8e-19
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		9e-19
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		1e-18
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		1e-18
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		1e-18
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		1e-18
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		1e-18
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		1e-18
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		1e-18
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		1e-18
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		1e-18
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		1e-18
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		1e-18
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		1e-18
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		2e-18
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		2e-18
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		2e-18
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		2e-18
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		2e-18
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		2e-18
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		2e-18
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-18
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		2e-18
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		2e-18
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		2e-18
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		3e-18
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-18
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-18
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		3e-18
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-18
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		3e-18
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		3e-18
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		5e-18
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		6e-18
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		6e-18
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		7e-18
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		7e-18
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		8e-18
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		8e-18
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		8e-18
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		1e-17
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		1e-17
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		1e-17
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		1e-17
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		1e-17
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		1e-17
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		2e-17
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		2e-17
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		2e-17
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		2e-17
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		2e-17
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		2e-17
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		2e-17
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		2e-17
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		2e-17
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		2e-17
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		2e-17
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		2e-17
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		2e-17
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		2e-17
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		3e-17
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		4e-17
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		4e-17
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		9e-17
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		1e-16
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		1e-16
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		1e-16
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		1e-16
3a4o_X	286	Lyn Kinase Domain Length = 286		2e-16
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		2e-16
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		6e-16
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		7e-16
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		8e-16
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		8e-16
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		9e-16
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		9e-16
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		1e-15
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-15
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		1e-15
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		1e-15
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		2e-15
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		2e-15
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		2e-15
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		2e-15
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		3e-15
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		4e-15
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		4e-15
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		4e-15
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		4e-15
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		4e-15
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		4e-15
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		4e-15
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		5e-15
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		6e-15
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		7e-15
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		7e-15
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		8e-15
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		9e-15
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		1e-14
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		1e-14
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		1e-14
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		2e-14
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		2e-14
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		2e-14
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		2e-14
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		2e-14
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		2e-14
4fl3_A	635	Structural And Biophysical Characterization Of The		2e-14
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		2e-14
4fl2_A	636	Structural And Biophysical Characterization Of The		2e-14
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		3e-14
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		3e-14
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		3e-14
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		3e-14
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		3e-14
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		3e-14
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		3e-14
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		3e-14
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		3e-14
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		4e-14
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		4e-14
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		4e-14
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		4e-14
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		5e-14
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		5e-14
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		5e-14
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		5e-14
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		5e-14
3g51_A	325	Structural Diversity Of The Active Conformation Of		5e-14
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		5e-14
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		5e-14
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		5e-14
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		5e-14
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		6e-14
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		6e-14
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		6e-14
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		6e-14
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		6e-14
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		6e-14
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		7e-14
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		7e-14
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		7e-14
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		7e-14
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		7e-14
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		7e-14
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		7e-14
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		7e-14
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		8e-14
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		8e-14
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		9e-14
3iok_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		9e-14
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		9e-14
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		9e-14
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		9e-14
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		9e-14
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		1e-13
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		1e-13
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		1e-13
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		1e-13
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-13
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		1e-13
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		1e-13
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		1e-13
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		1e-13
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		1e-13
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		1e-13
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		1e-13
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		1e-13
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		1e-13
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		1e-13
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		1e-13
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		1e-13
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		1e-13
3b2t_A	311	Structure Of Phosphotransferase Length = 311		1e-13
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		1e-13
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		1e-13
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		1e-13
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		1e-13
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		1e-13
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		1e-13
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		2e-13
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		2e-13
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		2e-13
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		2e-13
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		2e-13
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		2e-13
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-13
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		2e-13
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		2e-13
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		2e-13
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		2e-13
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		2e-13
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		2e-13
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		2e-13
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		2e-13
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		2e-13
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		2e-13
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		2e-13
3a7f_A	303	Human Mst3 Kinase Length = 303		2e-13
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		3e-13
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		3e-13
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		3e-13
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		3e-13
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-13
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		4e-13
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		4e-13
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		4e-13
1fvr_A	327	Tie2 Kinase Domain Length = 327		4e-13
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		5e-13
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		5e-13
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		5e-13
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		5e-13
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		5e-13
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		5e-13
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		6e-13
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		6e-13
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		6e-13
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		6e-13
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		6e-13
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		6e-13
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		6e-13
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		6e-13
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		6e-13
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		6e-13
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		6e-13
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		6e-13
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		7e-13
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		7e-13
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		7e-13
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		7e-13
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		7e-13
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		8e-13
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		8e-13
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		8e-13
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		8e-13
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		8e-13
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		8e-13
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		9e-13
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		9e-13
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		9e-13
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		9e-13
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		9e-13
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		9e-13
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		9e-13
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		9e-13
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		1e-12
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		1e-12
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		1e-12
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		1e-12
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		1e-12
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		1e-12
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		1e-12
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		1e-12
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		1e-12
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		1e-12
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		1e-12
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		1e-12
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		1e-12
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		1e-12
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		1e-12
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		1e-12
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		1e-12
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		1e-12
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		1e-12
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		2e-12
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		2e-12
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		2e-12
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		2e-12
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		2e-12
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		2e-12
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		2e-12
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		2e-12
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		2e-12
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		2e-12
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		2e-12
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		2e-12
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		2e-12
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		2e-12
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		2e-12
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		2e-12
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		2e-12
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		2e-12
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		2e-12
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		2e-12
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		2e-12
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		2e-12
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		2e-12
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		2e-12
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		2e-12
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		2e-12
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		2e-12
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		2e-12
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		2e-12
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		2e-12
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		2e-12
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		2e-12
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		2e-12
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		2e-12
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		2e-12
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		2e-12
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		2e-12
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		2e-12
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		2e-12
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		2e-12
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		2e-12
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		3e-12
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		3e-12
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		3e-12
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		3e-12
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		3e-12
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		3e-12
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		3e-12
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		3e-12
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		3e-12
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		3e-12
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		3e-12
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		3e-12
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		3e-12
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		3e-12
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		3e-12
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		3e-12
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		3e-12
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		3e-12
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		3e-12
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		4e-12
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		4e-12
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		4e-12
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		4e-12
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		4e-12
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		4e-12
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		4e-12
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		4e-12
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		4e-12
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		4e-12
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		4e-12
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		4e-12
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		4e-12
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		4e-12
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		4e-12
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		4e-12
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		4e-12
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		4e-12
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		4e-12
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		4e-12
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		4e-12
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		4e-12
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		4e-12
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		4e-12
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		4e-12
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		4e-12
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		4e-12
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		4e-12
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		5e-12
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		5e-12
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		5e-12
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		5e-12
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		5e-12
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		5e-12
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		6e-12
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		6e-12
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		6e-12
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		6e-12
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		6e-12
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		6e-12
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		7e-12
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		7e-12
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		7e-12
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		7e-12
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		7e-12
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		7e-12
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		7e-12
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		7e-12
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		7e-12
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		8e-12
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		8e-12
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		8e-12
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		8e-12
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		8e-12
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		8e-12
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		9e-12
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		9e-12
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		1e-11
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		1e-11
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-11
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		1e-11
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		1e-11
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		1e-11
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-11
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		1e-11
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		1e-11
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		1e-11
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		1e-11
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		1e-11
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		1e-11
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		1e-11
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		1e-11
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		1e-11
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		1e-11
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		1e-11
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-11
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		1e-11
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		1e-11
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		1e-11
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		1e-11
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		1e-11
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		1e-11
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		1e-11
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		1e-11
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		1e-11
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		1e-11
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		1e-11
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		1e-11
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		1e-11
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		1e-11
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		1e-11
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		1e-11
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		1e-11
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		1e-11
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		1e-11
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		1e-11
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		1e-11
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		1e-11
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		1e-11
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		1e-11
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		1e-11
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		1e-11
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		2e-11
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		2e-11
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		2e-11
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		2e-11
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		2e-11
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		2e-11
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		2e-11
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		2e-11
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		2e-11
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		2e-11
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		2e-11
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		2e-11
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		2e-11
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		2e-11
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		2e-11
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		2e-11
4fie_A	423	Full-Length Human Pak4 Length = 423		2e-11
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		2e-11
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		2e-11
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		2e-11
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-11
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		2e-11
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		2e-11
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		2e-11
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		2e-11
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		2e-11
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		2e-11
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		2e-11
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		2e-11
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		2e-11
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		2e-11
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		2e-11
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		2e-11
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-11
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-11
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		2e-11
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		3e-11
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		3e-11
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		3e-11
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		3e-11
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		3e-11
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		3e-11
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		3e-11
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		3e-11
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		3e-11
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		3e-11
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		4e-11
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		4e-11
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		4e-11
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		4e-11
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		4e-11
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		4e-11
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		5e-11
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		5e-11
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		5e-11
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		5e-11
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		5e-11
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		5e-11
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		5e-11
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		6e-11
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		6e-11
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		6e-11
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		6e-11
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		6e-11
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		7e-11
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		7e-11
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		8e-11
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		8e-11
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		8e-11
4exu_A	371	Mapk13, Inactive Form Length = 371		9e-11
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		9e-11
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		9e-11
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		1e-10
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		1e-10
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		1e-10
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		1e-10
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		1e-10
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		1e-10
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		1e-10
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		1e-10
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		1e-10
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		1e-10
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		1e-10
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		1e-10
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		2e-10
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		2e-10
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		2e-10
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		2e-10
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		2e-10
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		2e-10
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		3e-10
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		3e-10
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		3e-10
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		3e-10
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		4e-10
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		4e-10
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		4e-10
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		4e-10
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		4e-10
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		4e-10
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		5e-10
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		5e-10
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		5e-10
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		5e-10
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		6e-10
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		6e-10
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		6e-10
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		6e-10
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		7e-10
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		7e-10
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		8e-10
3kmw_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		8e-10
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		8e-10
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		8e-10
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		1e-09
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		1e-09
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		1e-09
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		1e-09
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		1e-09
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		1e-09
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		1e-09
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		2e-09
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		2e-09
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		2e-09
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		2e-09
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		2e-09
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		2e-09
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		2e-09
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		3e-09
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		3e-09
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		3e-09
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		3e-09
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		3e-09
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		3e-09
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		3e-09
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		3e-09
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		4e-09
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		4e-09
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		4e-09
2oza_B	366	Structure Of P38alpha Complex Length = 366		4e-09
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		4e-09
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		4e-09
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		4e-09
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		4e-09
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		4e-09
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		4e-09
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		4e-09
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		4e-09
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		4e-09
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		4e-09
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		4e-09
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		4e-09
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		4e-09
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		4e-09
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		4e-09
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		4e-09
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		4e-09
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		5e-09
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		5e-09
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		5e-09
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		5e-09
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		6e-09
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		6e-09
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		6e-09
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		6e-09
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		6e-09
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		6e-09
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		6e-09
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		6e-09
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		6e-09
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		6e-09
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		6e-09
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		6e-09
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		6e-09
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		6e-09
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		6e-09
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		6e-09
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		6e-09
2zmd_A	390	Crystal Structure Of Human Mps1 Catalytic Domain T6		6e-09
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		6e-09
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		6e-09
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		6e-09
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		7e-09
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		7e-09
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		7e-09
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		7e-09
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		7e-09
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		7e-09
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		7e-09
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		7e-09
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		7e-09
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		7e-09
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		7e-09
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		7e-09
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		7e-09
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		7e-09
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		7e-09
3h9f_A	313	Crystal Structure Of Human Dual Specificity Protein		7e-09
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		7e-09
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		7e-09
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		7e-09
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		8e-09
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		8e-09
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		8e-09
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		8e-09
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		8e-09
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		8e-09
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		8e-09
3hec_A	348	P38 In Complex With Imatinib Length = 348		8e-09
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		8e-09
3soa_A	444	Full-Length Human Camkii Length = 444		8e-09
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		9e-09
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		9e-09
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		9e-09
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		9e-09
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		9e-09
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		1e-08
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		1e-08
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		1e-08
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		1e-08
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		1e-08
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		1e-08
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		1e-08
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		1e-08
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		1e-08
4fvp_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain (		1e-08
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		1e-08
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		1e-08
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		1e-08
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		1e-08
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		1e-08
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		1e-08
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		1e-08
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		1e-08
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		1e-08
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		1e-08
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		1e-08
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		2e-08
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		2e-08
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		2e-08
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		2e-08
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		2e-08
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		2e-08
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		2e-08
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		2e-08
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		2e-08
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		2e-08
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		2e-08
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		2e-08
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		2e-08
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		2e-08
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		2e-08
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		2e-08
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		2e-08
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		2e-08
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		2e-08
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		2e-08
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		2e-08
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		2e-08
4fvr_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain M		2e-08
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		2e-08
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		3e-08
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		3e-08
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		3e-08
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		3e-08
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		3e-08
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		3e-08
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		3e-08
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		3e-08
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		3e-08
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		3e-08
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		4e-08
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		4e-08
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		4e-08
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		4e-08
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		4e-08
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		6e-08
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		6e-08
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		7e-08
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		7e-08
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		7e-08
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		7e-08
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		7e-08
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		8e-08
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		8e-08
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		8e-08
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		8e-08
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		8e-08
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		8e-08
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		8e-08
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		8e-08
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		8e-08
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		8e-08
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		8e-08
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		9e-08
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		9e-08
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		9e-08
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		9e-08
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		9e-08
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		1e-07
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		1e-07
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		1e-07
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		1e-07
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		1e-07
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		1e-07
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		1e-07
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		1e-07
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		1e-07
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		1e-07
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		1e-07
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		1e-07
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		1e-07
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		1e-07
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		1e-07
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		1e-07
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		1e-07
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		1e-07
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		1e-07
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		1e-07
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		1e-07
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		1e-07
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		1e-07
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		2e-07
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		2e-07
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		2e-07
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		2e-07
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		2e-07
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		2e-07
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		2e-07
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		2e-07
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		2e-07
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		2e-07
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		2e-07
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		2e-07
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		2e-07
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		2e-07
3kk8_A	284	Camkii Substrate Complex A Length = 284		2e-07
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		2e-07
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		3e-07
3kk9_A	282	Camkii Substrate Complex B Length = 282		3e-07
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		3e-07
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		3e-07
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		3e-07
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		3e-07
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		3e-07
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		3e-07
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		3e-07
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		3e-07
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		4e-07
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		4e-07
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		4e-07
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		4e-07
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		4e-07
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		4e-07
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		4e-07
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		4e-07
2h34_A	309	Apoenzyme Crystal Structure Of The Tuberculosis Ser		4e-07
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		4e-07
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		4e-07
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		4e-07
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		4e-07
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		4e-07
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		4e-07
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		4e-07
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		4e-07
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		4e-07
4ae9_A	343	Structure And Function Of The Human Sperm-specific		5e-07
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		5e-07
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		5e-07
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		5e-07
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		5e-07
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		5e-07
3kmu_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		5e-07
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		5e-07
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		5e-07
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		5e-07
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		6e-07
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		6e-07
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		6e-07
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		6e-07
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		6e-07
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		6e-07
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		6e-07
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		6e-07
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		6e-07
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		6e-07
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		6e-07
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		6e-07
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		6e-07
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		6e-07
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		6e-07
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		6e-07
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		6e-07
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		7e-07
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		7e-07
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		7e-07
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		7e-07
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		8e-07
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		8e-07
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		8e-07
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		8e-07
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		8e-07
4ae6_A	343	Structure And Function Of The Human Sperm-specific		8e-07
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		8e-07
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		8e-07
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		8e-07
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		8e-07
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		9e-07
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		9e-07
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		9e-07
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		9e-07
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		9e-07
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		9e-07
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		9e-07
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		1e-06
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		1e-06
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		1e-06
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		1e-06
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		1e-06
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		1e-06
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		1e-06
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		2e-06
3rp9_A	458	Crystal Structure Of The Apo Mapk From Toxoplasma G		2e-06
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		2e-06
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		2e-06
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		3e-06
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		3e-06
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		3e-06
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		3e-06
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		3e-06
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		4e-06
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		4e-06
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		5e-06
3fhr_A	336	High Resolution Crystal Structure Of Mitogen-Activa		6e-06
3r1n_A	317	Mk3 Kinase Bound To Compound 5b Length = 317		6e-06
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		6e-06
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		7e-06
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		9e-06
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		1e-05
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		2e-05
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		3e-05
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		4e-05
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		4e-05
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		4e-05
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		4e-05
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		4e-05
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		4e-05
1yhs_A	273	Crystal Structure Of Pim-1 Bound To Staurosporine L		4e-05
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		4e-05
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		4e-05
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		5e-05
4a7c_A	308	Crystal Structure Of Pim1 Kinase With Etp46546 Leng		5e-05
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		5e-05
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		5e-05
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		5e-05
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		5e-05
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		5e-05
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		5e-05
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		5e-05
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		5e-05
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		6e-05
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		7e-05
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		7e-05
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		8e-05
3c4e_A	273	Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7		8e-05
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		9e-05
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		9e-05
4dtk_A	276	Novel And Selective Pan-Pim Kinase Inhibitor Length		9e-05
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		1e-04
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		1e-04
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		1e-04
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		1e-04
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-04
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-04
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		2e-04
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-04
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		2e-04
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-04
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		2e-04
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		2e-04
4as0_A	273	Cyclometalated Phthalimides As Protein Kinase Inhib		4e-04
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		4e-04
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		8e-04

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score =  201 bits (511), Expect = 7e-52,   Method: Compositional matrix adjust.
 Identities = 120/289 (41%), Positives = 174/289 (60%), Gaps = 12/289 (4%)
Query: 86  EMKLATKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAE 145
           +++ AT  F   +++G G FG VYKGV+    R G K   VA+K       QG  E+  E
Sbjct: 33  DLEEATNNFDHKFLIGHGVFGKVYKGVL----RDGAK---VALKRRTPESSQGIEEFETE 85
Query: 146 VNYLGQLRHSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLL-RRVGCM-LTWSRRMKIA 203
           +  L   RH +LV LIG+C E    IL+Y+YME+G+L++HL    +  M ++W +R++I 
Sbjct: 86  IETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEIC 145
Query: 204 LDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMG 263
           + AA+GL +LH   R +I+RD K+ NILL+ +F  K++DFG++K G   DQTH+   V G
Sbjct: 146 IGAARGLHYLH--TRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLXXVVKG 203
Query: 264 TYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNN 323
           T GY  PEY + G LT +SDVY FGVVL E+L  R A+ +S P    NL EWA    +NN
Sbjct: 204 TLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVE-SHNN 262
Query: 324 KKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLE 372
            ++ +I+DP L  +    +  K    A +CL+ + + RP M DV+  LE
Sbjct: 263 GQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLE 311

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score =  198 bits (503), Expect = 7e-51,   Method: Compositional matrix adjust.
 Identities = 119/289 (41%), Positives = 173/289 (59%), Gaps = 12/289 (4%)
Query: 86  EMKLATKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAE 145
           +++ AT  F   +++G G FG VYKGV+    R G K   VA+K       QG  E+  E
Sbjct: 33  DLEEATNNFDHKFLIGHGVFGKVYKGVL----RDGAK---VALKRRTPESSQGIEEFETE 85
Query: 146 VNYLGQLRHSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLL-RRVGCM-LTWSRRMKIA 203
           +  L   RH +LV LIG+C E    IL+Y+YME+G+L++HL    +  M ++W +R++I 
Sbjct: 86  IETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEIC 145
Query: 204 LDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMG 263
           + AA+GL +LH   R +I+RD K+ NILL+ +F  K++DFG++K G    QTH+   V G
Sbjct: 146 IGAARGLHYLH--TRAIIHRDVKSINILLDENFVPKITDFGISKKGTELGQTHLXXVVKG 203
Query: 264 TYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNN 323
           T GY  PEY + G LT +SDVY FGVVL E+L  R A+ +S P    NL EWA    +NN
Sbjct: 204 TLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVE-SHNN 262
Query: 324 KKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLE 372
            ++ +I+DP L  +    +  K    A +CL+ + + RP M DV+  LE
Sbjct: 263 GQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLE 311

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score =  191 bits (485), Expect = 7e-49,   Method: Compositional matrix adjust.
 Identities = 116/297 (39%), Positives = 173/297 (58%), Gaps = 15/297 (5%)
Query: 82  FTYNEMKLATKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQG-DR 140
           F+  E+++A+  F    ILG GGFG VYKG + +        T VA+K L     QG + 
Sbjct: 28  FSLRELQVASDNFSNKNILGRGGFGKVYKGRLADG-------TLVAVKRLKEERXQGGEL 80
Query: 141 EWLAEVNYLGQLRHSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCM--LTWSR 198
           ++  EV  +    H NL++L G+C     R+LVY YM +GS+   L  R      L W +
Sbjct: 81  QFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPK 140
Query: 199 RMKIALDAAKGLAFLHGAERP-VIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHV 257
           R +IAL +A+GLA+LH    P +I+RD K +NILL+ +F A + DFGLAK     D  HV
Sbjct: 141 RQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD-XHV 199
Query: 258 STRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHN--LVEW 315
              V GT G+ APEY+ TG  + ++DV+G+GV+LLE++ G+RA D +R + + +  L++W
Sbjct: 200 XXAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDW 259
Query: 316 ARPLLNNNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLE 372
            + LL   KK+  ++D  L+G Y      ++  +A  C   +P  RP MS+VV +LE
Sbjct: 260 VKGLL-KEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLE 315

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score =  187 bits (474), Expect = 1e-47,   Method: Compositional matrix adjust.
 Identities = 114/297 (38%), Positives = 171/297 (57%), Gaps = 15/297 (5%)
Query: 82  FTYNEMKLATKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQG-DR 140
           F+  E+++A+  F    ILG GGFG VYKG + +          VA+K L     QG + 
Sbjct: 20  FSLRELQVASDNFXNKNILGRGGFGKVYKGRLADG-------XLVAVKRLKEERTQGGEL 72
Query: 141 EWLAEVNYLGQLRHSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCM--LTWSR 198
           ++  EV  +    H NL++L G+C     R+LVY YM +GS+   L  R      L W +
Sbjct: 73  QFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPK 132
Query: 199 RMKIALDAAKGLAFLHGAERP-VIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHV 257
           R +IAL +A+GLA+LH    P +I+RD K +NILL+ +F A + DFGLAK     D  HV
Sbjct: 133 RQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD-XHV 191
Query: 258 STRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHN--LVEW 315
              V G  G+ APEY+ TG  + ++DV+G+GV+LLE++ G+RA D +R + + +  L++W
Sbjct: 192 XXAVRGXIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDW 251
Query: 316 ARPLLNNNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLE 372
            + LL   KK+  ++D  L+G Y      ++  +A  C   +P  RP MS+VV +LE
Sbjct: 252 VKGLL-KEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLE 307

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  162 bits (410), Expect = 4e-40,   Method: Compositional matrix adjust.
 Identities = 112/307 (36%), Positives = 173/307 (56%), Gaps = 35/307 (11%)
Query: 82  FTYNEMKLATKFF--RPDYI----LGEGGFGVVYKGVIDENVRPGYKTTFVAIKEL---- 131
           F++ E+K  T  F  RP  +    +GEGGFGVVYKG ++         T VA+K+L    
Sbjct: 15  FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVN--------NTTVAVKKLAAMV 66
Query: 132 NRGGYQGDREWLAEVNYLGQLRHSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVG 191
           +    +  +++  E+  + + +H NLV+L+G+  + +   LVY YM +GSL    L R+ 
Sbjct: 67  DITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSL----LDRLS 122
Query: 192 CM-----LTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLA 246
           C+     L+W  R KIA  AA G+ FLH  E   I+RD K++NILL+  F+AK+SDFGLA
Sbjct: 123 CLDGTPPLSWHMRCKIAQGAANGINFLH--ENHHIHRDIKSANILLDEAFTAKISDFGLA 180
Query: 247 KDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRP 306
           +      QT + +R++GT  Y APE  + G +T +SD+Y FGVVLLE++ G  AVD+ R 
Sbjct: 181 RASEKFAQTVMXSRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITGLPAVDEHRE 239
Query: 307 SREHNLVEWARPLLNNNKKVLRILDPRL-EGQYTARTAMKVAGLAYQCLSQNPKGRPVMS 365
            +   L++    + +  K +   +D ++ +   T+  AM    +A QCL +    RP + 
Sbjct: 240 PQL--LLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAM--YSVASQCLHEKKNKRPDIK 295
Query: 366 DVVALLE 372
            V  LL+
Sbjct: 296 KVQQLLQ 302

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  161 bits (408), Expect = 6e-40,   Method: Compositional matrix adjust.
 Identities = 112/307 (36%), Positives = 172/307 (56%), Gaps = 35/307 (11%)
Query: 82  FTYNEMKLATKFF--RPDYI----LGEGGFGVVYKGVIDENVRPGYKTTFVAIKEL---- 131
           F++ E+K  T  F  RP  +    +GEGGFGVVYKG ++         T VA+K+L    
Sbjct: 15  FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVN--------NTTVAVKKLAAMV 66
Query: 132 NRGGYQGDREWLAEVNYLGQLRHSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVG 191
           +    +  +++  E+  + + +H NLV+L+G+  + +   LVY YM +GSL    L R+ 
Sbjct: 67  DITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSL----LDRLS 122
Query: 192 CM-----LTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLA 246
           C+     L+W  R KIA  AA G+ FLH  E   I+RD K++NILL+  F+AK+SDFGLA
Sbjct: 123 CLDGTPPLSWHMRCKIAQGAANGINFLH--ENHHIHRDIKSANILLDEAFTAKISDFGLA 180
Query: 247 KDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRP 306
           +      QT +  R++GT  Y APE  + G +T +SD+Y FGVVLLE++ G  AVD+ R 
Sbjct: 181 RASEKFAQTVMXXRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITGLPAVDEHRE 239
Query: 307 SREHNLVEWARPLLNNNKKVLRILDPRL-EGQYTARTAMKVAGLAYQCLSQNPKGRPVMS 365
            +   L++    + +  K +   +D ++ +   T+  AM    +A QCL +    RP + 
Sbjct: 240 PQL--LLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAM--YSVASQCLHEKKNKRPDIK 295
Query: 366 DVVALLE 372
            V  LL+
Sbjct: 296 KVQQLLQ 302

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score =  159 bits (401), Expect = 4e-39,   Method: Compositional matrix adjust.
 Identities = 111/307 (36%), Positives = 171/307 (55%), Gaps = 35/307 (11%)
Query: 82  FTYNEMKLATKFF--RPDYI----LGEGGFGVVYKGVIDENVRPGYKTTFVAIKEL---- 131
           F++ E+K  T  F  RP  +    +GEGGFGVVYKG ++         T VA+K+L    
Sbjct: 9   FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVN--------NTTVAVKKLAAMV 60
Query: 132 NRGGYQGDREWLAEVNYLGQLRHSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVG 191
           +    +  +++  E+  + + +H NLV+L+G+  + +   LVY YM +GSL    L R+ 
Sbjct: 61  DITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSL----LDRLS 116
Query: 192 CM-----LTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLA 246
           C+     L+W  R KIA  AA G+ FLH  E   I+RD K++NILL+  F+AK+SDFGLA
Sbjct: 117 CLDGTPPLSWHMRCKIAQGAANGINFLH--ENHHIHRDIKSANILLDEAFTAKISDFGLA 174
Query: 247 KDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRP 306
           +      Q  +  R++GT  Y APE  + G +T +SD+Y FGVVLLE++ G  AVD+ R 
Sbjct: 175 RASEKFAQXVMXXRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITGLPAVDEHRE 233
Query: 307 SREHNLVEWARPLLNNNKKVLRILDPRL-EGQYTARTAMKVAGLAYQCLSQNPKGRPVMS 365
            +   L++    + +  K +   +D ++ +   T+  AM    +A QCL +    RP + 
Sbjct: 234 PQL--LLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAM--YSVASQCLHEKKNKRPDIK 289
Query: 366 DVVALLE 372
            V  LL+
Sbjct: 290 KVQQLLQ 296

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score =  150 bits (380), Expect = 1e-36,   Method: Compositional matrix adjust.
 Identities = 107/306 (34%), Positives = 164/306 (53%), Gaps = 33/306 (10%)
Query: 82  FTYNEMKLATKFF--RPDYI----LGEGGFGVVYKGVIDENVRPGYKTTFVAIKEL---- 131
           F++ E+K  T  F  RP  +     GEGGFGVVYKG ++         T VA+K+L    
Sbjct: 6   FSFYELKNVTNNFDERPISVGGNKXGEGGFGVVYKGYVN--------NTTVAVKKLAAMV 57
Query: 132 NRGGYQGDREWLAEVNYLGQLRHSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVG 191
           +    +  +++  E+    + +H NLV+L+G+  + +   LVY Y  +GSL    L R+ 
Sbjct: 58  DITTEELKQQFDQEIKVXAKCQHENLVELLGFSSDGDDLCLVYVYXPNGSL----LDRLS 113
Query: 192 CM-----LTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLA 246
           C+     L+W  R KIA  AA G+ FLH  E   I+RD K++NILL+  F+AK+SDFGLA
Sbjct: 114 CLDGTPPLSWHXRCKIAQGAANGINFLH--ENHHIHRDIKSANILLDEAFTAKISDFGLA 171
Query: 247 KDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRP 306
           +      Q    +R++GT  Y APE  + G +T +SD+Y FGVVLLE++ G  AVD+ R 
Sbjct: 172 RASEKFAQXVXXSRIVGTTAYXAPE-ALRGEITPKSDIYSFGVVLLEIITGLPAVDEHRE 230
Query: 307 SREHNLVEWARPLLNNNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSD 366
            +   L++    + +  K +   +D +      + +      +A QCL +    RP +  
Sbjct: 231 PQL--LLDIKEEIEDEEKTIEDYIDKK-XNDADSTSVEAXYSVASQCLHEKKNKRPDIKK 287
Query: 367 VVALLE 372
           V  LL+
Sbjct: 288 VQQLLQ 293

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  108 bits (270), Expect = 7e-24,   Method: Compositional matrix adjust.
 Identities = 80/277 (28%), Positives = 138/277 (49%), Gaps = 33/277 (11%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDR--EWLAEVNYLGQLRHSNL 157
           +G G FG V+        R  +  + VA+K L    +  +R  E+L EV  + +LRH N+
Sbjct: 45  IGAGSFGTVH--------RAEWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNI 96
Query: 158 VKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGC--MLTWSRRMKIALDAAKGLAFLHG 215
           V  +G   +  +  +V EY+  GSL + LL + G    L   RR+ +A D AKG+ +LH 
Sbjct: 97  VLFMGAVTQPPNLSIVTEYLSRGSLYR-LLHKSGAREQLDERRRLSMAYDVAKGMNYLHN 155
Query: 216 AERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTR-VMGTYGYAAPEYVM 274
              P+++R+ K+ N+L++  ++ K+ DFGL++   +   T +S++   GT  + APE + 
Sbjct: 156 RNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSR---LKASTFLSSKSAAGTPEWMAPEVLR 212
Query: 275 TGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRILDPRL 334
                 +SDVY FGV+L E+   ++      P++    V +    L    ++ R L+P  
Sbjct: 213 DEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRL----EIPRNLNP-- 266
Query: 335 EGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALL 371
                     +VA +   C +  P  RP  + ++ LL
Sbjct: 267 ----------QVAAIIEGCWTNEPWKRPSFATIMDLL 293

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  107 bits (268), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 80/276 (28%), Positives = 133/276 (48%), Gaps = 31/276 (11%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDR--EWLAEVNYLGQLRHSNL 157
           +G G FG V+        R  +  + VA+K L    +  +R  E+L EV  + +LRH N+
Sbjct: 45  IGAGSFGTVH--------RAEWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNI 96
Query: 158 VKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGC--MLTWSRRMKIALDAAKGLAFLHG 215
           V  +G   +  +  +V EY+  GSL + LL + G    L   RR+ +A D AKG+ +LH 
Sbjct: 97  VLFMGAVTQPPNLSIVTEYLSRGSLYR-LLHKSGAREQLDERRRLSMAYDVAKGMNYLHN 155
Query: 216 AERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMT 275
              P+++RD K+ N+L++  ++ K+ DFGL++          S    GT  + APE +  
Sbjct: 156 RNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLK--ASXFLXSKXAAGTPEWMAPEVLRD 213
Query: 276 GHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRILDPRLE 335
                +SDVY FGV+L E+   ++      P++    V +    L    ++ R L+P   
Sbjct: 214 EPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRL----EIPRNLNP--- 266
Query: 336 GQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALL 371
                    +VA +   C +  P  RP  + ++ LL
Sbjct: 267 ---------QVAAIIEGCWTNEPWKRPSFATIMDLL 293

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score =  105 bits (261), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 68/198 (34%), Positives = 109/198 (55%), Gaps = 16/198 (8%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVK 159
           LG G FG V+ G  + + +       VA+K L +G    D  +LAE N + QL+H  LV+
Sbjct: 29  LGAGQFGEVWMGYYNGHTK-------VAVKSLKQGSMSPD-AFLAEANLMKQLQHQRLVR 80
Query: 160 LIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERP 219
           L     ++   I+  EYME+GSL   L    G  LT ++ + +A   A+G+AF+   ER 
Sbjct: 81  LYAVVTQEPIYIIT-EYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE--ERN 137
Query: 220 VIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTY--GYAAPEYVMTGH 277
            I+RD + +NIL++   S K++DFGLA+   + +    + R    +   + APE +  G 
Sbjct: 138 YIHRDLRAANILVSDTLSCKIADFGLAR---LIEDNEXTAREGAKFPIKWTAPEAINYGT 194
Query: 278 LTARSDVYGFGVVLLEML 295
            T +SDV+ FG++L E++
Sbjct: 195 FTIKSDVWSFGILLTEIV 212

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score =  105 bits (261), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 68/198 (34%), Positives = 109/198 (55%), Gaps = 16/198 (8%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVK 159
           LG G FG V+ G  + + +       VA+K L +G    D  +LAE N + QL+H  LV+
Sbjct: 27  LGAGQFGEVWMGYYNGHTK-------VAVKSLKQGSMSPD-AFLAEANLMKQLQHQRLVR 78
Query: 160 LIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERP 219
           L     ++   I+  EYME+GSL   L    G  LT ++ + +A   A+G+AF+   ER 
Sbjct: 79  LYAVVTQEPIYIIT-EYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE--ERN 135
Query: 220 VIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTY--GYAAPEYVMTGH 277
            I+RD + +NIL++   S K++DFGLA+   + +    + R    +   + APE +  G 
Sbjct: 136 YIHRDLRAANILVSDTLSCKIADFGLAR---LIEDNEXTAREGAKFPIKWTAPEAINYGT 192
Query: 278 LTARSDVYGFGVVLLEML 295
            T +SDV+ FG++L E++
Sbjct: 193 FTIKSDVWSFGILLTEIV 210

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score =  104 bits (260), Expect = 8e-23,   Method: Compositional matrix adjust.
 Identities = 68/198 (34%), Positives = 109/198 (55%), Gaps = 16/198 (8%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVK 159
           LG G FG V+ G  + + +       VA+K L +G    D  +LAE N + QL+H  LV+
Sbjct: 31  LGAGQFGEVWMGYYNGHTK-------VAVKSLKQGSMSPD-AFLAEANLMKQLQHQRLVR 82
Query: 160 LIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERP 219
           L     ++   I+  EYME+GSL   L    G  LT ++ + +A   A+G+AF+   ER 
Sbjct: 83  LYAVVTQEPIYIIT-EYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE--ERN 139
Query: 220 VIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTY--GYAAPEYVMTGH 277
            I+RD + +NIL++   S K++DFGLA+   + +    + R    +   + APE +  G 
Sbjct: 140 YIHRDLRAANILVSDTLSCKIADFGLAR---LIEDNEYTAREGAKFPIKWTAPEAINYGT 196
Query: 278 LTARSDVYGFGVVLLEML 295
            T +SDV+ FG++L E++
Sbjct: 197 FTIKSDVWSFGILLTEIV 214

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score =  104 bits (260), Expect = 9e-23,   Method: Compositional matrix adjust.
 Identities = 68/198 (34%), Positives = 109/198 (55%), Gaps = 16/198 (8%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVK 159
           LG G FG V+ G  + + +       VA+K L +G    D  +LAE N + QL+H  LV+
Sbjct: 30  LGAGQFGEVWMGYYNGHTK-------VAVKSLKQGSMSPD-AFLAEANLMKQLQHQRLVR 81
Query: 160 LIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERP 219
           L     ++   I+  EYME+GSL   L    G  LT ++ + +A   A+G+AF+   ER 
Sbjct: 82  LYAVVTQEPIYIIT-EYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE--ERN 138
Query: 220 VIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTY--GYAAPEYVMTGH 277
            I+RD + +NIL++   S K++DFGLA+   + +    + R    +   + APE +  G 
Sbjct: 139 YIHRDLRAANILVSDTLSCKIADFGLAR---LIEDNEXTAREGAKFPIKWTAPEAINYGT 195
Query: 278 LTARSDVYGFGVVLLEML 295
            T +SDV+ FG++L E++
Sbjct: 196 FTIKSDVWSFGILLTEIV 213

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score =  104 bits (260), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 68/198 (34%), Positives = 109/198 (55%), Gaps = 16/198 (8%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVK 159
           LG G FG V+ G  + + +       VA+K L +G    D  +LAE N + QL+H  LV+
Sbjct: 21  LGAGQFGEVWMGYYNGHTK-------VAVKSLKQGSMSPD-AFLAEANLMKQLQHQRLVR 72
Query: 160 LIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERP 219
           L     ++   I+  EYME+GSL   L    G  LT ++ + +A   A+G+AF+   ER 
Sbjct: 73  LYAVVTQEPIYIIT-EYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE--ERN 129
Query: 220 VIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTY--GYAAPEYVMTGH 277
            I+RD + +NIL++   S K++DFGLA+   + +    + R    +   + APE +  G 
Sbjct: 130 YIHRDLRAANILVSDTLSCKIADFGLAR---LIEDNEXTAREGAKFPIKWTAPEAINYGT 186
Query: 278 LTARSDVYGFGVVLLEML 295
            T +SDV+ FG++L E++
Sbjct: 187 FTIKSDVWSFGILLTEIV 204

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score =  104 bits (260), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 68/198 (34%), Positives = 109/198 (55%), Gaps = 16/198 (8%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVK 159
           LG G FG V+ G  + + +       VA+K L +G    D  +LAE N + QL+H  LV+
Sbjct: 27  LGAGQFGEVWMGYYNGHTK-------VAVKSLKQGSMSPD-AFLAEANLMKQLQHQRLVR 78
Query: 160 LIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERP 219
           L     ++   I+  EYME+GSL   L    G  LT ++ + +A   A+G+AF+   ER 
Sbjct: 79  LYAVVTQEPIYIIT-EYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE--ERN 135
Query: 220 VIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTY--GYAAPEYVMTGH 277
            I+RD + +NIL++   S K++DFGLA+   + +    + R    +   + APE +  G 
Sbjct: 136 YIHRDLRAANILVSDTLSCKIADFGLAR---LIEDNEYTAREGAKFPIKWTAPEAINYGT 192
Query: 278 LTARSDVYGFGVVLLEML 295
            T +SDV+ FG++L E++
Sbjct: 193 FTIKSDVWSFGILLTEIV 210

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score =  104 bits (259), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 68/198 (34%), Positives = 109/198 (55%), Gaps = 16/198 (8%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVK 159
           LG G FG V+ G  + + +       VA+K L +G    D  +LAE N + QL+H  LV+
Sbjct: 26  LGAGQFGEVWMGYYNGHTK-------VAVKSLKQGSMSPD-AFLAEANLMKQLQHQRLVR 77
Query: 160 LIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERP 219
           L     ++   I+  EYME+GSL   L    G  LT ++ + +A   A+G+AF+   ER 
Sbjct: 78  LYAVVTQEPIYIIT-EYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE--ERN 134
Query: 220 VIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTY--GYAAPEYVMTGH 277
            I+RD + +NIL++   S K++DFGLA+   + +    + R    +   + APE +  G 
Sbjct: 135 YIHRDLRAANILVSDTLSCKIADFGLAR---LIEDNEYTAREGAKFPIKWTAPEAINYGT 191
Query: 278 LTARSDVYGFGVVLLEML 295
            T +SDV+ FG++L E++
Sbjct: 192 FTIKSDVWSFGILLTEIV 209

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score =  104 bits (259), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 68/198 (34%), Positives = 109/198 (55%), Gaps = 16/198 (8%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVK 159
           LG G FG V+ G  + + +       VA+K L +G    D  +LAE N + QL+H  LV+
Sbjct: 23  LGAGQFGEVWMGYYNGHTK-------VAVKSLKQGSMSPD-AFLAEANLMKQLQHQRLVR 74
Query: 160 LIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERP 219
           L     ++   I+  EYME+GSL   L    G  LT ++ + +A   A+G+AF+   ER 
Sbjct: 75  LYAVVTQEPIYIIT-EYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE--ERN 131
Query: 220 VIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTY--GYAAPEYVMTGH 277
            I+RD + +NIL++   S K++DFGLA+   + +    + R    +   + APE +  G 
Sbjct: 132 YIHRDLRAANILVSDTLSCKIADFGLAR---LIEDNEXTAREGAKFPIKWTAPEAINYGT 188
Query: 278 LTARSDVYGFGVVLLEML 295
            T +SDV+ FG++L E++
Sbjct: 189 FTIKSDVWSFGILLTEIV 206

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score =  103 bits (258), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 68/198 (34%), Positives = 109/198 (55%), Gaps = 16/198 (8%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVK 159
           LG G FG V+ G  + + +       VA+K L +G    D  +LAE N + QL+H  LV+
Sbjct: 22  LGAGQFGEVWMGYYNGHTK-------VAVKSLKQGSMSPD-AFLAEANLMKQLQHQRLVR 73
Query: 160 LIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERP 219
           L     ++   I+  EYME+GSL   L    G  LT ++ + +A   A+G+AF+   ER 
Sbjct: 74  LYAVVTQEPIYIIT-EYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE--ERN 130
Query: 220 VIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTY--GYAAPEYVMTGH 277
            I+RD + +NIL++   S K++DFGLA+   + +    + R    +   + APE +  G 
Sbjct: 131 YIHRDLRAANILVSDTLSCKIADFGLAR---LIEDNEXTAREGAKFPIKWTAPEAINYGT 187
Query: 278 LTARSDVYGFGVVLLEML 295
            T +SDV+ FG++L E++
Sbjct: 188 FTIKSDVWSFGILLTEIV 205

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score =  103 bits (258), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 68/198 (34%), Positives = 109/198 (55%), Gaps = 16/198 (8%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVK 159
           LG G FG V+ G  + + +       VA+K L +G    D  +LAE N + QL+H  LV+
Sbjct: 21  LGAGQFGEVWMGYYNGHTK-------VAVKSLKQGSMSPD-AFLAEANLMKQLQHQRLVR 72
Query: 160 LIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERP 219
           L     ++   I+  EYME+GSL   L    G  LT ++ + +A   A+G+AF+   ER 
Sbjct: 73  LYAVVTQEPIYIIT-EYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE--ERN 129
Query: 220 VIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTY--GYAAPEYVMTGH 277
            I+RD + +NIL++   S K++DFGLA+   + +    + R    +   + APE +  G 
Sbjct: 130 YIHRDLRAANILVSDTLSCKIADFGLAR---LIEDNEXTAREGAKFPIKWTAPEAINYGT 186
Query: 278 LTARSDVYGFGVVLLEML 295
            T +SDV+ FG++L E++
Sbjct: 187 FTIKSDVWSFGILLTEIV 204

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score =  103 bits (258), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 68/198 (34%), Positives = 109/198 (55%), Gaps = 16/198 (8%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVK 159
           LG G FG V+ G  + + +       VA+K L +G    D  +LAE N + QL+H  LV+
Sbjct: 21  LGAGQFGEVWMGYYNGHTK-------VAVKSLKQGSMSPD-AFLAEANLMKQLQHQRLVR 72
Query: 160 LIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERP 219
           L     ++   I+  EYME+GSL   L    G  LT ++ + +A   A+G+AF+   ER 
Sbjct: 73  LYAVVTQEPIYIIT-EYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE--ERN 129
Query: 220 VIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTY--GYAAPEYVMTGH 277
            I+RD + +NIL++   S K++DFGLA+   + +    + R    +   + APE +  G 
Sbjct: 130 YIHRDLRAANILVSDTLSCKIADFGLAR---LIEDNEYTAREGAKFPIKWTAPEAINYGT 186
Query: 278 LTARSDVYGFGVVLLEML 295
            T +SDV+ FG++L E++
Sbjct: 187 FTIKSDVWSFGILLTEIV 204

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score =  103 bits (257), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 68/198 (34%), Positives = 109/198 (55%), Gaps = 16/198 (8%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVK 159
           LG G FG V+ G  + + +       VA+K L +G    D  +LAE N + QL+H  LV+
Sbjct: 16  LGAGQFGEVWMGYYNGHTK-------VAVKSLKQGSMSPD-AFLAEANLMKQLQHQRLVR 67
Query: 160 LIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERP 219
           L     ++   I+  EYME+GSL   L    G  LT ++ + +A   A+G+AF+   ER 
Sbjct: 68  LYAVVTQEPIYIIT-EYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE--ERN 124
Query: 220 VIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTY--GYAAPEYVMTGH 277
            I+RD + +NIL++   S K++DFGLA+   + +    + R    +   + APE +  G 
Sbjct: 125 YIHRDLRAANILVSDTLSCKIADFGLAR---LIEDNEYTAREGAKFPIKWTAPEAINYGT 181
Query: 278 LTARSDVYGFGVVLLEML 295
            T +SDV+ FG++L E++
Sbjct: 182 FTIKSDVWSFGILLTEIV 199

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score =  102 bits (253), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 78/278 (28%), Positives = 135/278 (48%), Gaps = 27/278 (9%)
Query: 99  ILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDR-EWLAEVNYLGQLRHSNL 157
           ++G G FG VYKG++  +   G K   VAIK L  G  +  R ++L E   +GQ  H N+
Sbjct: 51  VIGAGEFGEVYKGMLKTS--SGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNI 108
Query: 158 VKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAE 217
           ++L G   + +  +++ EYME+G+L+K L  + G   +  + + +    A G+ +L  A 
Sbjct: 109 IRLEGVISKYKPMMIITEYMENGALDKFLREKDG-EFSVLQLVGMLRGIAAGMKYL--AN 165
Query: 218 RPVIYRDFKTSNILLNADFSAKLSDFGLAK---DGPMGDQTHVSTRVMGTYGYAAPEYVM 274
              ++RD    NIL+N++   K+SDFGL++   D P    T    ++     + APE + 
Sbjct: 166 MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKI--PIRWTAPEAIS 223
Query: 275 TGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRILDPRL 334
               T+ SDV+ FG+V+ E++         RP  E            +N +V++ ++   
Sbjct: 224 YRKFTSASDVWSFGIVMWEVM-----TYGERPYWEL-----------SNHEVMKAINDGF 267
Query: 335 EGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLE 372
                      +  L  QC  Q    RP  +D+V++L+
Sbjct: 268 RLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILD 305

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score =  102 bits (253), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 67/198 (33%), Positives = 109/198 (55%), Gaps = 16/198 (8%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVK 159
           LG G FG V+ G  + + +       VA+K L +G    D  +LAE N + QL+H  LV+
Sbjct: 17  LGAGQFGEVWMGYYNGHTK-------VAVKSLKQGSMSPD-AFLAEANLMKQLQHQRLVR 68
Query: 160 LIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERP 219
           L     ++   I+  EYME+GSL   L    G  LT ++ + +A   A+G+AF+   ER 
Sbjct: 69  LYAVVTQEPIYIIT-EYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE--ERN 125
Query: 220 VIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTY--GYAAPEYVMTGH 277
            I+R+ + +NIL++   S K++DFGLA+   + +    + R    +   + APE +  G 
Sbjct: 126 YIHRNLRAANILVSDTLSCKIADFGLAR---LIEDNEYTAREGAKFPIKWTAPEAINYGT 182
Query: 278 LTARSDVYGFGVVLLEML 295
            T +SDV+ FG++L E++
Sbjct: 183 FTIKSDVWSFGILLTEIV 200

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score =  100 bits (250), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 67/198 (33%), Positives = 108/198 (54%), Gaps = 16/198 (8%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVK 159
           LG G  G V+ G  + + +       VA+K L +G    D  +LAE N + QL+H  LV+
Sbjct: 21  LGAGQAGEVWMGYYNGHTK-------VAVKSLKQGSMSPD-AFLAEANLMKQLQHQRLVR 72
Query: 160 LIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERP 219
           L     ++   I+  EYME+GSL   L    G  LT ++ + +A   A+G+AF+   ER 
Sbjct: 73  LYAVVTQEPIYIIT-EYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE--ERN 129
Query: 220 VIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTY--GYAAPEYVMTGH 277
            I+RD + +NIL++   S K++DFGLA+   + +    + R    +   + APE +  G 
Sbjct: 130 YIHRDLRAANILVSDTLSCKIADFGLAR---LIEDAEXTAREGAKFPIKWTAPEAINYGT 186
Query: 278 LTARSDVYGFGVVLLEML 295
            T +SDV+ FG++L E++
Sbjct: 187 FTIKSDVWSFGILLTEIV 204

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 98.6 bits (244), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 67/208 (32%), Positives = 97/208 (46%), Gaps = 16/208 (7%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVK 159
           LGEG FG V+      N+ P      VA+K L        +++  E   L  L+H ++VK
Sbjct: 21  LGEGAFGKVFLAEC-YNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVK 79
Query: 160 LIGYCCEDEHRILVYEYMESGSLEKHLLRRVG------------CMLTWSRRMKIALDAA 207
             G C E +  I+V+EYM+ G L K  LR  G              LT S+ + IA   A
Sbjct: 80  FYGVCVEGDPLIMVFEYMKHGDLNK-FLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIA 138
Query: 208 KGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGY 267
            G+ +L  A +  ++RD  T N L+  +   K+ DFG+++D    D   V    M    +
Sbjct: 139 AGMVYL--ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRW 196
Query: 268 AAPEYVMTGHLTARSDVYGFGVVLLEML 295
             PE +M    T  SDV+  GVVL E+ 
Sbjct: 197 MPPESIMYRKFTTESDVWSLGVVLWEIF 224

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 98.2 bits (243), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 81/290 (27%), Positives = 137/290 (47%), Gaps = 50/290 (17%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLA-------EVNYLGQL 152
           +G+GGFG+V+KG + ++       + VAIK L  G  +G+ E +        EV  +  L
Sbjct: 27  IGKGGFGLVHKGRLVKD------KSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNL 80
Query: 153 RHSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAF 212
            H N+VKL G         +V E++  G L   LL +    + WS ++++ LD A G+ +
Sbjct: 81  NHPNIVKLYGLMHNPPR--MVMEFVPCGDLYHRLLDKAHP-IKWSVKLRLMLDIALGIEY 137
Query: 213 LHGAERPVIYRDFKTSNILL-----NADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGY 267
           +     P+++RD ++ NI L     NA   AK++DFGL++        H  + ++G + +
Sbjct: 138 MQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQS-----VHSVSGLLGNFQW 192
Query: 268 AAPEYVMTGH--LTARSDVYGFGVVLLEMLLGRRAVDKSRPSREH--NLV--EWARPLLN 321
            APE +       T ++D Y F ++L  +L G    D+    +    N++  E  RP + 
Sbjct: 193 MAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRPTIP 252
Query: 322 NNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALL 371
            +        PRL      R  +++      C S +PK RP  S +V  L
Sbjct: 253 ED------CPPRL------RNVIEL------CWSGDPKKRPHFSYIVKEL 284

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 97.8 bits (242), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 65/210 (30%), Positives = 98/210 (46%), Gaps = 17/210 (8%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVK 159
           LGEG FG V+      N+ P      VA+K L        +++  E   L  L+H ++VK
Sbjct: 23  LGEGAFGKVFLAEC-YNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVK 81
Query: 160 LIGYCCEDEHRILVYEYMESGSLEKHLL--------------RRVGCMLTWSRRMKIALD 205
             G C + +  I+V+EYM+ G L K L               R+    L  S+ + IA  
Sbjct: 82  FYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQ 141
Query: 206 AAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTY 265
            A G+ +L  A +  ++RD  T N L+ A+   K+ DFG+++D    D   V    M   
Sbjct: 142 IASGMVYL--ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI 199
Query: 266 GYAAPEYVMTGHLTARSDVYGFGVVLLEML 295
            +  PE +M    T  SDV+ FGV+L E+ 
Sbjct: 200 RWMPPESIMYRKFTTESDVWSFGVILWEIF 229

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 75/279 (26%), Positives = 129/279 (46%), Gaps = 28/279 (10%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVK 159
           +G G FG+V+ G      +       VAIK + R G   + +++ E   + +L H  LV+
Sbjct: 15  IGSGQFGLVHLGYWLNKDK-------VAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQ 66
Query: 160 LIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERP 219
           L G C E     LV+E+ME G L  +L  + G +      + + LD  +G+A+L   E  
Sbjct: 67  LYGVCLEQAPICLVFEFMEHGCLSDYLRTQRG-LFAAETLLGMCLDVCEGMAYLE--EAS 123
Query: 220 VIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLT 279
           VI+RD    N L+  +   K+SDFG+ +   + DQ   ST       +A+PE       +
Sbjct: 124 VIHRDLAARNCLVGENQVIKVSDFGMTR-FVLDDQYTSSTGTKFPVKWASPEVFSFSRYS 182
Query: 280 ARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRILDPRLEGQYT 339
           ++SDV+ FGV++ E+    +   ++R + E         ++ +     R+  PRL   + 
Sbjct: 183 SKSDVWSFGVLMWEVFSEGKIPYENRSNSE---------VVEDISTGFRLYKPRLASTH- 232
Query: 340 ARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETVQSQG 378
                 V  +   C  + P+ RP  S ++  L  + + G
Sbjct: 233 ------VYQIMNHCWKERPEDRPAFSRLLRQLAAIAASG 265

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 96.7 bits (239), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 80/290 (27%), Positives = 136/290 (46%), Gaps = 50/290 (17%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLA-------EVNYLGQL 152
           +G+GGFG+V+KG + ++       + VAIK L  G  +G+ E +        EV  +  L
Sbjct: 27  IGKGGFGLVHKGRLVKD------KSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNL 80
Query: 153 RHSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAF 212
            H N+VKL G         +V E++  G L   LL +    + WS ++++ LD A G+ +
Sbjct: 81  NHPNIVKLYGLMHNPPR--MVMEFVPCGDLYHRLLDKAHP-IKWSVKLRLMLDIALGIEY 137
Query: 213 LHGAERPVIYRDFKTSNILL-----NADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGY 267
           +     P+++RD ++ NI L     NA   AK++DFG ++        H  + ++G + +
Sbjct: 138 MQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGTSQQS-----VHSVSGLLGNFQW 192
Query: 268 AAPEYVMTGH--LTARSDVYGFGVVLLEMLLGRRAVDKSRPSREH--NLV--EWARPLLN 321
            APE +       T ++D Y F ++L  +L G    D+    +    N++  E  RP + 
Sbjct: 193 MAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRPTIP 252
Query: 322 NNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALL 371
            +        PRL      R  +++      C S +PK RP  S +V  L
Sbjct: 253 ED------CPPRL------RNVIEL------CWSGDPKKRPHFSYIVKEL 284

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 96.3 bits (238), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 80/290 (27%), Positives = 136/290 (46%), Gaps = 50/290 (17%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLA-------EVNYLGQL 152
           +G+GGFG+V+KG + ++       + VAIK L  G  +G+ E +        EV  +  L
Sbjct: 27  IGKGGFGLVHKGRLVKD------KSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNL 80
Query: 153 RHSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAF 212
            H N+VKL G         +V E++  G L   LL +    + WS ++++ LD A G+ +
Sbjct: 81  NHPNIVKLYGLMHNPPR--MVMEFVPCGDLYHRLLDKAHP-IKWSVKLRLMLDIALGIEY 137
Query: 213 LHGAERPVIYRDFKTSNILL-----NADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGY 267
           +     P+++RD ++ NI L     NA   AK++DF L++        H  + ++G + +
Sbjct: 138 MQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFSLSQQS-----VHSVSGLLGNFQW 192
Query: 268 AAPEYVMTGH--LTARSDVYGFGVVLLEMLLGRRAVDKSRPSREH--NLV--EWARPLLN 321
            APE +       T ++D Y F ++L  +L G    D+    +    N++  E  RP + 
Sbjct: 193 MAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRPTIP 252
Query: 322 NNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALL 371
            +        PRL      R  +++      C S +PK RP  S +V  L
Sbjct: 253 ED------CPPRL------RNVIEL------CWSGDPKKRPHFSYIVKEL 284

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 95.9 bits (237), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 75/279 (26%), Positives = 128/279 (45%), Gaps = 28/279 (10%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVK 159
           +G G FG+V+ G      +       VAIK + R G   + +++ E   + +L H  LV+
Sbjct: 15  IGSGQFGLVHLGYWLNKDK-------VAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQ 66
Query: 160 LIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERP 219
           L G C E     LV+E+ME G L  +L  + G +      + + LD  +G+A+L   E  
Sbjct: 67  LYGVCLEQAPICLVFEFMEHGCLSDYLRTQRG-LFAAETLLGMCLDVCEGMAYLE--EAC 123
Query: 220 VIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLT 279
           VI+RD    N L+  +   K+SDFG+ +   + DQ   ST       +A+PE       +
Sbjct: 124 VIHRDLAARNCLVGENQVIKVSDFGMTR-FVLDDQYTSSTGTKFPVKWASPEVFSFSRYS 182
Query: 280 ARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRILDPRLEGQYT 339
           ++SDV+ FGV++ E+    +   ++R + E         ++ +     R+  PRL     
Sbjct: 183 SKSDVWSFGVLMWEVFSEGKIPYENRSNSE---------VVEDISTGFRLYKPRL----- 228
Query: 340 ARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETVQSQG 378
              +  V  +   C  + P+ RP  S ++  L  +   G
Sbjct: 229 --ASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAESG 265

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 95.9 bits (237), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 82/301 (27%), Positives = 140/301 (46%), Gaps = 36/301 (11%)
Query: 97  DYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDR-EWLAEVNYLGQLRHS 155
           D ++G G FG V  G +     P  K   VAIK L  G  +  R ++L E + +GQ  H 
Sbjct: 50  DKVVGAGEFGEVCSGRLK---LPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHP 106
Query: 156 NLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHG 215
           N+++L G   + +  ++V EYME+GSL+   LR+     T  + + +    A G+ +L  
Sbjct: 107 NIIRLEGVVTKSKPVMIVTEYMENGSLDS-FLRKHDAQFTVIQLVGMLRGIASGMKYL-- 163
Query: 216 AERPVIYRDFKTSNILLNADFSAKLSDFGLAK---DGPMGDQTHVSTRVMGTYGYAAPEY 272
           ++   ++RD    NIL+N++   K+SDFGLA+   D P    T    ++     + +PE 
Sbjct: 164 SDMGYVHRDLAARNILINSNLVCKVSDFGLARVLEDDPEAAYTTRGGKI--PIRWTSPEA 221
Query: 273 VMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRILDP 332
           +     T+ SDV+ +G+VL E++         RP  E            +N+ V++ +D 
Sbjct: 222 IAYRKFTSASDVWSYGIVLWEVM-----SYGERPYWEM-----------SNQDVIKAVD- 264
Query: 333 RLEGQYTARTAMKVAGLAYQ----CLSQNPKGRPVMSDVVALLETVQSQGAEEEMLQSGG 388
             EG Y     M      YQ    C  ++   RP    +V++L+ +       +++ S  
Sbjct: 265 --EG-YRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNPGSLKIITSAA 321
Query: 389 G 389
Sbjct: 322 A 322

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 95.9 bits (237), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 75/279 (26%), Positives = 128/279 (45%), Gaps = 28/279 (10%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVK 159
           +G G FG+V+ G      +       VAIK + R G   + +++ E   + +L H  LV+
Sbjct: 13  IGSGQFGLVHLGYWLNKDK-------VAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQ 64
Query: 160 LIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERP 219
           L G C E     LV+E+ME G L  +L  + G +      + + LD  +G+A+L   E  
Sbjct: 65  LYGVCLEQAPICLVFEFMEHGCLSDYLRTQRG-LFAAETLLGMCLDVCEGMAYLE--EAC 121
Query: 220 VIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLT 279
           VI+RD    N L+  +   K+SDFG+ +   + DQ   ST       +A+PE       +
Sbjct: 122 VIHRDLAARNCLVGENQVIKVSDFGMTR-FVLDDQYTSSTGTKFPVKWASPEVFSFSRYS 180
Query: 280 ARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRILDPRLEGQYT 339
           ++SDV+ FGV++ E+    +   ++R + E         ++ +     R+  PRL     
Sbjct: 181 SKSDVWSFGVLMWEVFSEGKIPYENRSNSE---------VVEDISTGFRLYKPRL----- 226
Query: 340 ARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETVQSQG 378
              +  V  +   C  + P+ RP  S ++  L  +   G
Sbjct: 227 --ASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAESG 263

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 95.9 bits (237), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 75/279 (26%), Positives = 127/279 (45%), Gaps = 28/279 (10%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVK 159
           +G G FG+V+ G      +       VAIK +  G    D +++ E   + +L H  LV+
Sbjct: 35  IGSGQFGLVHLGYWLNKDK-------VAIKTIKEGSMSED-DFIEEAEVMMKLSHPKLVQ 86
Query: 160 LIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERP 219
           L G C E     LV+E+ME G L  +L  + G +      + + LD  +G+A+L   E  
Sbjct: 87  LYGVCLEQAPICLVFEFMEHGCLSDYLRTQRG-LFAAETLLGMCLDVCEGMAYLE--EAC 143
Query: 220 VIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLT 279
           VI+RD    N L+  +   K+SDFG+ +   + DQ   ST       +A+PE       +
Sbjct: 144 VIHRDLAARNCLVGENQVIKVSDFGMTR-FVLDDQYTSSTGTKFPVKWASPEVFSFSRYS 202
Query: 280 ARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRILDPRLEGQYT 339
           ++SDV+ FGV++ E+    +   ++R + E         ++ +     R+  PRL   + 
Sbjct: 203 SKSDVWSFGVLMWEVFSEGKIPYENRSNSE---------VVEDISTGFRLYKPRLASTH- 252
Query: 340 ARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETVQSQG 378
                 V  +   C  + P+ RP  S ++  L  +   G
Sbjct: 253 ------VYQIMNHCWKERPEDRPAFSRLLRQLAEIAESG 285

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 95.5 bits (236), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 75/279 (26%), Positives = 128/279 (45%), Gaps = 28/279 (10%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVK 159
           +G G FG+V+ G      +       VAIK + R G   + +++ E   + +L H  LV+
Sbjct: 18  IGSGQFGLVHLGYWLNKDK-------VAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQ 69
Query: 160 LIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERP 219
           L G C E     LV+E+ME G L  +L  + G +      + + LD  +G+A+L   E  
Sbjct: 70  LYGVCLEQAPICLVFEFMEHGCLSDYLRTQRG-LFAAETLLGMCLDVCEGMAYLE--EAC 126
Query: 220 VIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLT 279
           VI+RD    N L+  +   K+SDFG+ +   + DQ   ST       +A+PE       +
Sbjct: 127 VIHRDLAARNCLVGENQVIKVSDFGMTR-FVLDDQYTSSTGTKFPVKWASPEVFSFSRYS 185
Query: 280 ARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRILDPRLEGQYT 339
           ++SDV+ FGV++ E+    +   ++R + E         ++ +     R+  PRL     
Sbjct: 186 SKSDVWSFGVLMWEVFSEGKIPYENRSNSE---------VVEDISTGFRLYKPRL----- 231
Query: 340 ARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETVQSQG 378
              +  V  +   C  + P+ RP  S ++  L  +   G
Sbjct: 232 --ASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAESG 268

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 95.1 bits (235), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 82/318 (25%), Positives = 151/318 (47%), Gaps = 34/318 (10%)
Query: 76  YSNVDIFTYNEMKLATKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGG 135
           +S  D++  +E ++A +       LG+G FG+VY+GV    V+   +T  VAIK +N   
Sbjct: 3   FSAADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETR-VAIKTVNEAA 61
Query: 136 YQGDR-EWLAEVNYLGQLRHSNLVKLIGYCCEDEHRILVYEYMESGSLEKHL--LR---- 188
              +R E+L E + + +    ++V+L+G   + +  +++ E M  G L+ +L  LR    
Sbjct: 62  SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEME 121
Query: 189 --RVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLA 246
              V    + S+ +++A + A G+A+L+  +   ++RD    N ++  DF+ K+ DFG+ 
Sbjct: 122 NNPVLAPPSLSKMIQMAGEIADGMAYLNANK--FVHRDLAARNCMVAEDFTVKIGDFGMT 179
Query: 247 KDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRP 306
           +D    D      + +    + +PE +  G  T  SDV+ FGVVL E+     A    +P
Sbjct: 180 RDIXETDXXRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI-----ATLAEQP 234
Query: 307 SREHNLVEWARPLLNNNKKVLRILDPRLEGQYTAR---TAMKVAGLAYQCLSQNPKGRPV 363
            +             +N++VLR +   +EG    +       +  L   C   NPK RP 
Sbjct: 235 YQGL-----------SNEQVLRFV---MEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPS 280
Query: 364 MSDVVALLETVQSQGAEE 381
             ++++ ++     G  E
Sbjct: 281 FLEIISSIKEEMEPGFRE 298

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 95.1 bits (235), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 81/301 (26%), Positives = 140/301 (46%), Gaps = 36/301 (11%)
Query: 97  DYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDR-EWLAEVNYLGQLRHS 155
           D ++G G FG V  G +     P  K   VAIK L  G  +  R ++L E + +GQ  H 
Sbjct: 50  DKVVGAGEFGEVCSGRLK---LPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHP 106
Query: 156 NLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHG 215
           N+++L G   + +  ++V EYME+GSL+   LR+     T  + + +    A G+ +L  
Sbjct: 107 NIIRLEGVVTKSKPVMIVTEYMENGSLDS-FLRKHDAQFTVIQLVGMLRGIASGMKYL-- 163
Query: 216 AERPVIYRDFKTSNILLNADFSAKLSDFGLAK---DGPMGDQTHVSTRVMGTYGYAAPEY 272
           ++   ++RD    NIL+N++   K+SDFGL++   D P    T    ++     + +PE 
Sbjct: 164 SDMGFVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKI--PIRWTSPEA 221
Query: 273 VMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRILDP 332
           +     T+ SDV+ +G+VL E++         RP  E            +N+ V++ +D 
Sbjct: 222 IAYRKFTSASDVWSYGIVLWEVM-----SYGERPYWEM-----------SNQDVIKAVD- 264
Query: 333 RLEGQYTARTAMKVAGLAYQ----CLSQNPKGRPVMSDVVALLETVQSQGAEEEMLQSGG 388
             EG Y     M      YQ    C  ++   RP    +V++L+ +       +++ S  
Sbjct: 265 --EG-YRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNPGSLKIITSAA 321
Query: 389 G 389
Sbjct: 322 A 322

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 95.1 bits (235), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 112/213 (52%), Gaps = 12/213 (5%)
Query: 88  KLATKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGY--QGDREWLAE 145
           ++   + + + ++G G FG V +G +     PG K + VAIK L +GGY  +  RE+L+E
Sbjct: 12  EIDVSYVKIEEVIGAGEFGEVCRGRLKA---PGKKESCVAIKTL-KGGYTERQRREFLSE 67
Query: 146 VNYLGQLRHSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALD 205
            + +GQ  H N+++L G        +++ E+ME+G+L+   LR      T  + + +   
Sbjct: 68  ASIMGQFEHPNIIRLEGVVTNSMPVMILTEFMENGALDS-FLRLNDGQFTVIQLVGMLRG 126
Query: 206 AAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMG-- 263
            A G+ +L  AE   ++RD    NIL+N++   K+SDFGL++           T  +G  
Sbjct: 127 IASGMRYL--AEMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTETSSLGGK 184
Query: 264 -TYGYAAPEYVMTGHLTARSDVYGFGVVLLEML 295
               + APE +     T+ SD + +G+V+ E++
Sbjct: 185 IPIRWTAPEAIAFRKFTSASDAWSYGIVMWEVM 217

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 94.7 bits (234), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 83/322 (25%), Positives = 151/322 (46%), Gaps = 35/322 (10%)
Query: 73  NPGY-SNVDIFTYNEMKLATKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKEL 131
           NP Y S  D++  +E ++A +       LG+G FG+VY+GV    V+   +T  VAIK +
Sbjct: 5   NPEYFSAADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETR-VAIKTV 63
Query: 132 NRGGYQGDR-EWLAEVNYLGQLRHSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRV 190
           N      +R E+L E + + +    ++V+L+G   + +  +++ E M  G L+ +L    
Sbjct: 64  NEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLR 123
Query: 191 GCML--------TWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSD 242
             M         + S+ +++A + A G+A+L+  +   ++RD    N ++  DF+ K+ D
Sbjct: 124 PAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK--FVHRDLAARNCMVAEDFTVKIGD 181
Query: 243 FGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVD 302
           FG+ +D    D      + +    + +PE +  G  T  SDV+ FGVVL E+     A  
Sbjct: 182 FGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI-----ATL 236
Query: 303 KSRPSREHNLVEWARPLLNNNKKVLRILDPRLEGQYTAR---TAMKVAGLAYQCLSQNPK 359
             +P +             +N++VLR +   +EG    +       +  L   C   NPK
Sbjct: 237 AEQPYQGL-----------SNEQVLRFV---MEGGLLDKPDNCPDMLFELMRMCWQYNPK 282
Query: 360 GRPVMSDVVALLETVQSQGAEE 381
            RP   ++++ ++     G  E
Sbjct: 283 MRPSFLEIISSIKEEMEPGFRE 304

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 81/301 (26%), Positives = 140/301 (46%), Gaps = 36/301 (11%)
Query: 97  DYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDR-EWLAEVNYLGQLRHS 155
           D ++G G FG V  G +     P  K   VAIK L  G  +  R ++L E + +GQ  H 
Sbjct: 50  DKVVGAGEFGEVCSGRLK---LPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHP 106
Query: 156 NLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHG 215
           N+++L G   + +  ++V EYME+GSL+   LR+     T  + + +    A G+ +L  
Sbjct: 107 NIIRLEGVVTKSKPVMIVTEYMENGSLDS-FLRKHDAQFTVIQLVGMLRGIASGMKYL-- 163
Query: 216 AERPVIYRDFKTSNILLNADFSAKLSDFGLAK---DGPMGDQTHVSTRVMGTYGYAAPEY 272
           ++   ++RD    NIL+N++   K+SDFGL++   D P    T    ++     + +PE 
Sbjct: 164 SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKI--PIRWTSPEA 221
Query: 273 VMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRILDP 332
           +     T+ SDV+ +G+VL E++         RP  E            +N+ V++ +D 
Sbjct: 222 IAYRKFTSASDVWSYGIVLWEVM-----SYGERPYWEM-----------SNQDVIKAVD- 264
Query: 333 RLEGQYTARTAMKVAGLAYQ----CLSQNPKGRPVMSDVVALLETVQSQGAEEEMLQSGG 388
             EG Y     M      YQ    C  ++   RP    +V++L+ +       +++ S  
Sbjct: 265 --EG-YRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNPGSLKIITSAA 321
Query: 389 G 389
Sbjct: 322 A 322

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 84/307 (27%), Positives = 140/307 (45%), Gaps = 39/307 (12%)
Query: 89  LATKFFRP-DYILGEGGFGVVYKGVIDENVRPGYKTT--FVAIKELNRGGYQGDREWLAE 145
           +  + FRP D I GE    V+ KG   + ++  ++ T   + +KEL R   +  R +L E
Sbjct: 2   MPHRIFRPSDLIHGE----VLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKE 57
Query: 146 VNYLGQLRHSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALD 205
           V  +  L H N++K IG   +D+    + EY++ G+L + +++ +     WS+R+  A D
Sbjct: 58  VKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTL-RGIIKSMDSQYPWSQRVSFAKD 116
Query: 206 AAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLA------KDGPMG------- 252
            A G+A+LH     +I+RD  + N L+  + +  ++DFGLA      K  P G       
Sbjct: 117 IASGMAYLHSMN--IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKP 174
Query: 253 DQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNL 312
           D+    T V+G   + APE +       + DV+ FG+VL E ++GR   D     R  + 
Sbjct: 175 DRKKRYT-VVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCE-IIGRVNADPDYLPRTMDF 232
Query: 313 VEWARPLLNNNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLE 372
               R  L+      R   P     +   T         +C   +P+ RP    +   LE
Sbjct: 233 GLNVRGFLD------RYCPPNCPPSFFPITV--------RCCDLDPEKRPSFVKLEHWLE 278
Query: 373 TVQSQGA 379
           T++   A
Sbjct: 279 TLRMHLA 285

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 81/301 (26%), Positives = 140/301 (46%), Gaps = 36/301 (11%)
Query: 97  DYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDR-EWLAEVNYLGQLRHS 155
           D ++G G FG V  G +     P  K   VAIK L  G  +  R ++L E + +GQ  H 
Sbjct: 50  DKVVGAGEFGEVCSGRLK---LPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHP 106
Query: 156 NLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHG 215
           N+++L G   + +  ++V EYME+GSL+   LR+     T  + + +    A G+ +L  
Sbjct: 107 NIIRLEGVVTKSKPVMIVTEYMENGSLDS-FLRKHDAQFTVIQLVGMLRGIASGMKYL-- 163
Query: 216 AERPVIYRDFKTSNILLNADFSAKLSDFGLAK---DGPMGDQTHVSTRVMGTYGYAAPEY 272
           ++   ++RD    NIL+N++   K+SDFGL++   D P    T    ++     + +PE 
Sbjct: 164 SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKI--PIRWTSPEA 221
Query: 273 VMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRILDP 332
           +     T+ SDV+ +G+VL E++         RP  E            +N+ V++ +D 
Sbjct: 222 IAYRKFTSASDVWSYGIVLWEVM-----SYGERPYWEM-----------SNQDVIKAVD- 264
Query: 333 RLEGQYTARTAMKVAGLAYQ----CLSQNPKGRPVMSDVVALLETVQSQGAEEEMLQSGG 388
             EG Y     M      YQ    C  ++   RP    +V++L+ +       +++ S  
Sbjct: 265 --EG-YRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNPGSLKIITSAA 321
Query: 389 G 389
Sbjct: 322 A 322

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 81/301 (26%), Positives = 140/301 (46%), Gaps = 36/301 (11%)
Query: 97  DYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDR-EWLAEVNYLGQLRHS 155
           D ++G G FG V  G +     P  K   VAIK L  G  +  R ++L E + +GQ  H 
Sbjct: 50  DKVVGAGEFGEVCSGRLK---LPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHP 106
Query: 156 NLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHG 215
           N+++L G   + +  ++V EYME+GSL+   LR+     T  + + +    A G+ +L  
Sbjct: 107 NIIRLEGVVTKSKPVMIVTEYMENGSLDS-FLRKHDAQFTVIQLVGMLRGIASGMKYL-- 163
Query: 216 AERPVIYRDFKTSNILLNADFSAKLSDFGLAK---DGPMGDQTHVSTRVMGTYGYAAPEY 272
           ++   ++RD    NIL+N++   K+SDFGL++   D P    T    ++     + +PE 
Sbjct: 164 SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKI--PIRWTSPEA 221
Query: 273 VMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRILDP 332
           +     T+ SDV+ +G+VL E++         RP  E            +N+ V++ +D 
Sbjct: 222 IAYRKFTSASDVWSYGIVLWEVM-----SYGERPYWEM-----------SNQDVIKAVD- 264
Query: 333 RLEGQYTARTAMKVAGLAYQ----CLSQNPKGRPVMSDVVALLETVQSQGAEEEMLQSGG 388
             EG Y     M      YQ    C  ++   RP    +V++L+ +       +++ S  
Sbjct: 265 --EG-YRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNPGSLKIITSAA 321
Query: 389 G 389
Sbjct: 322 A 322

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 81/301 (26%), Positives = 140/301 (46%), Gaps = 36/301 (11%)
Query: 97  DYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDR-EWLAEVNYLGQLRHS 155
           D ++G G FG V  G +     P  K   VAIK L  G  +  R ++L E + +GQ  H 
Sbjct: 50  DKVVGAGEFGEVCSGRLK---LPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHP 106
Query: 156 NLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHG 215
           N+++L G   + +  ++V EYME+GSL+   LR+     T  + + +    A G+ +L  
Sbjct: 107 NIIRLEGVVTKSKPVMIVTEYMENGSLDS-FLRKHDAQFTVIQLVGMLRGIASGMKYL-- 163
Query: 216 AERPVIYRDFKTSNILLNADFSAKLSDFGLAK---DGPMGDQTHVSTRVMGTYGYAAPEY 272
           ++   ++RD    NIL+N++   K+SDFGL++   D P    T    ++     + +PE 
Sbjct: 164 SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKI--PIRWTSPEA 221
Query: 273 VMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRILDP 332
           +     T+ SDV+ +G+VL E++         RP  E            +N+ V++ +D 
Sbjct: 222 IAYRKFTSASDVWSYGIVLWEVM-----SYGERPYWEM-----------SNQDVIKAVD- 264
Query: 333 RLEGQYTARTAMKVAGLAYQ----CLSQNPKGRPVMSDVVALLETVQSQGAEEEMLQSGG 388
             EG Y     M      YQ    C  ++   RP    +V++L+ +       +++ S  
Sbjct: 265 --EG-YRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNPGSLKIITSAA 321
Query: 389 G 389
Sbjct: 322 A 322

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 79/281 (28%), Positives = 125/281 (44%), Gaps = 32/281 (11%)
Query: 94  FRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLR 153
            R +  LG+G FG V+ G  +        TT VAIK L + G      +L E   + +LR
Sbjct: 269 LRLEVKLGQGCFGEVWMGTWN-------GTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLR 320
Query: 154 HSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFL 213
           H  LV+L     E E   +V EYM  GSL   L    G  L   + + +A   A G+A++
Sbjct: 321 HEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYV 379
Query: 214 HGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTY--GYAAPE 271
                  ++RD + +NIL+  +   K++DFGLA+   + +    + R    +   + APE
Sbjct: 380 ERMN--YVHRDLRAANILVGENLVCKVADFGLAR---LIEDNEYTARQGAKFPIKWTAPE 434
Query: 272 YVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRILD 331
             + G  T +SDV+ FG++L E+    R       +RE         +L+  ++  R+  
Sbjct: 435 AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE---------VLDQVERGYRMPC 485
Query: 332 PRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLE 372
           P             +  L  QC  + P+ RP    + A LE
Sbjct: 486 P-------PECPESLHDLMCQCWRKEPEERPTFEYLQAFLE 519

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 85/322 (26%), Positives = 153/322 (47%), Gaps = 35/322 (10%)
Query: 73  NPGY-SNVDIFTYNEMKLATKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKEL 131
           NP Y S  D++  +E ++A +       LG+G FG+VY+GV    V+   +T  VAIK +
Sbjct: 5   NPEYFSAADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETR-VAIKTV 63
Query: 132 NRGGYQGDR-EWLAEVNYLGQLRHSNLVKLIGYCCEDEHRILVYEYMESGSLEKHL--LR 188
           N      +R E+L E + + +    ++V+L+G   + +  +++ E M  G L+ +L  LR
Sbjct: 64  NEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLR 123
Query: 189 ------RVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSD 242
                  V    + S+ +++A + A G+A+L+  +   ++RD    N ++  DF+ K+ D
Sbjct: 124 PEMENNPVLAPPSLSKMIQMAGEIADGMAYLNANK--FVHRDLAARNCMVAEDFTVKIGD 181
Query: 243 FGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVD 302
           FG+ +D    D      + +    + +PE +  G  T  SDV+ FGVVL E+     A  
Sbjct: 182 FGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI-----ATL 236
Query: 303 KSRPSREHNLVEWARPLLNNNKKVLRILDPRLEGQYTAR---TAMKVAGLAYQCLSQNPK 359
             +P +             +N++VLR +   +EG    +       +  L   C   NPK
Sbjct: 237 AEQPYQGL-----------SNEQVLRFV---MEGGLLDKPDNCPDMLFELMRMCWQYNPK 282
Query: 360 GRPVMSDVVALLETVQSQGAEE 381
            RP   ++++ ++     G  E
Sbjct: 283 MRPSFLEIISSIKEEMEPGFRE 304

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 68/232 (29%), Positives = 120/232 (51%), Gaps = 23/232 (9%)
Query: 79  VDIFTYNEMKLATKFF---------RPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIK 129
           +D FT+ +   A + F         + + ++G G FG V  G +     PG +  FVAIK
Sbjct: 11  IDPFTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLK---LPGKREIFVAIK 67
Query: 130 ELNRGGYQGDR-EWLAEVNYLGQLRHSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLR 188
            L  G  +  R ++L+E + +GQ  H N++ L G   +    +++ E+ME+GSL+   LR
Sbjct: 68  TLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDS-FLR 126
Query: 189 RVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAK- 247
           +     T  + + +    A G+ +L  A+   ++RD    NIL+N++   K+SDFGL++ 
Sbjct: 127 QNDGQFTVIQLVGMLRGIAAGMKYL--ADMNYVHRDLAARNILVNSNLVCKVSDFGLSRF 184
Query: 248 -DGPMGDQTHVSTRVMG---TYGYAAPEYVMTGHLTARSDVYGFGVVLLEML 295
            +    D T+ S   +G      + APE +     T+ SDV+ +G+V+ E++
Sbjct: 185 LEDDTSDPTYTSA--LGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVM 234

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 81/301 (26%), Positives = 140/301 (46%), Gaps = 36/301 (11%)
Query: 97  DYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDR-EWLAEVNYLGQLRHS 155
           D ++G G FG V  G +     P  K   VAIK L  G  +  R ++L E + +GQ  H 
Sbjct: 48  DKVVGAGEFGEVCSGRLK---LPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHP 104
Query: 156 NLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHG 215
           N+++L G   + +  ++V EYME+GSL+   LR+     T  + + +    A G+ +L  
Sbjct: 105 NIIRLEGVVTKSKPVMIVTEYMENGSLDS-FLRKHDAQFTVIQLVGMLRGIASGMKYL-- 161
Query: 216 AERPVIYRDFKTSNILLNADFSAKLSDFGLAK---DGPMGDQTHVSTRVMGTYGYAAPEY 272
           ++   ++RD    NIL+N++   K+SDFGL++   D P    T    ++     + +PE 
Sbjct: 162 SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKI--PIRWTSPEA 219
Query: 273 VMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRILDP 332
           +     T+ SDV+ +G+VL E++         RP  E            +N+ V++ +D 
Sbjct: 220 IAYRKFTSASDVWSYGIVLWEVM-----SYGERPYWEM-----------SNQDVIKAVD- 262
Query: 333 RLEGQYTARTAMKVAGLAYQ----CLSQNPKGRPVMSDVVALLETVQSQGAEEEMLQSGG 388
             EG Y     M      YQ    C  ++   RP    +V++L+ +       +++ S  
Sbjct: 263 --EG-YRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNPGSLKIITSAA 319
Query: 389 G 389
Sbjct: 320 A 320

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 80/284 (28%), Positives = 135/284 (47%), Gaps = 36/284 (12%)
Query: 97  DYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDR-EWLAEVNYLGQLRHS 155
           D ++G G FG V  G +     P  K   VAIK L  G  +  R ++L E + +GQ  H 
Sbjct: 38  DKVVGAGEFGEVCSGRLK---LPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHP 94
Query: 156 NLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHG 215
           N+++L G   + +  ++V EYME+GSL+   LR+     T  + + +    A G+ +L  
Sbjct: 95  NIIRLEGVVTKSKPVMIVTEYMENGSLDS-FLRKHDAQFTVIQLVGMLRGIASGMKYL-- 151
Query: 216 AERPVIYRDFKTSNILLNADFSAKLSDFGLAK---DGPMGDQTHVSTRVMGTYGYAAPEY 272
           ++   ++RD    NIL+N++   K+SDFGL++   D P    T    ++     + +PE 
Sbjct: 152 SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKI--PIRWTSPEA 209
Query: 273 VMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRILDP 332
           +     T+ SDV+ +G+VL E++         RP  E            +N+ V++ +D 
Sbjct: 210 IAYRKFTSASDVWSYGIVLWEVM-----SYGERPYWEM-----------SNQDVIKAVD- 252
Query: 333 RLEGQYTARTAMKVAGLAYQ----CLSQNPKGRPVMSDVVALLE 372
             EG Y     M      YQ    C  ++   RP    +V++L+
Sbjct: 253 --EG-YRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILD 293

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 79/280 (28%), Positives = 133/280 (47%), Gaps = 30/280 (10%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGY--QGDREWLAEVNYLGQLRHSNL 157
           +G G FG VYKG    +V         A+K LN      Q  + +  EV  L + RH N+
Sbjct: 44  IGSGSFGTVYKGKWHGDV---------AVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNI 94
Query: 158 VKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAE 217
           +  +GY  + +  I V ++ E  SL  HL   +       + + IA   A+G+ +LH   
Sbjct: 95  LLFMGYSTKPQLAI-VTQWCEGSSLYHHL-HIIETKFEMIKLIDIARQTAQGMDYLHA-- 150
Query: 218 RPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGH 277
           + +I+RD K++NI L+ D + K+ DFGLA +      +H   ++ G+  + APE +    
Sbjct: 151 KSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQD 210
Query: 278 ---LTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRILDPRL 334
               + +SDVY FG+VL E++ G+        +R+  +    R  L+ +   +R   P+ 
Sbjct: 211 KNPYSFQSDVYAFGIVLYELMTGQLPYSNIN-NRDQIIFMVGRGYLSPDLSKVRSNCPK- 268
Query: 335 EGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETV 374
                   AMK   L  +CL +    RP+   ++A +E +
Sbjct: 269 --------AMK--RLMAECLKKKRDERPLFPQILASIELL 298

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 80/284 (28%), Positives = 135/284 (47%), Gaps = 36/284 (12%)
Query: 97  DYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDR-EWLAEVNYLGQLRHS 155
           D ++G G FG V  G +     P  K   VAIK L  G  +  R ++L E + +GQ  H 
Sbjct: 21  DKVVGAGEFGEVCSGRLK---LPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHP 77
Query: 156 NLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHG 215
           N+++L G   + +  ++V EYME+GSL+   LR+     T  + + +    A G+ +L  
Sbjct: 78  NIIRLEGVVTKSKPVMIVTEYMENGSLDS-FLRKHDAQFTVIQLVGMLRGIASGMKYL-- 134
Query: 216 AERPVIYRDFKTSNILLNADFSAKLSDFGLAK---DGPMGDQTHVSTRVMGTYGYAAPEY 272
           ++   ++RD    NIL+N++   K+SDFGL++   D P    T    ++     + +PE 
Sbjct: 135 SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKI--PIRWTSPEA 192
Query: 273 VMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRILDP 332
           +     T+ SDV+ +G+VL E++         RP  E            +N+ V++ +D 
Sbjct: 193 IAYRKFTSASDVWSYGIVLWEVM-----SYGERPYWEM-----------SNQDVIKAVD- 235
Query: 333 RLEGQYTARTAMKVAGLAYQ----CLSQNPKGRPVMSDVVALLE 372
             EG Y     M      YQ    C  ++   RP    +V++L+
Sbjct: 236 --EG-YRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILD 276

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 81/301 (26%), Positives = 139/301 (46%), Gaps = 36/301 (11%)
Query: 97  DYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDR-EWLAEVNYLGQLRHS 155
           D ++G G FG V  G +     P  K   VAIK L  G  +  R ++L E + +GQ  H 
Sbjct: 50  DKVVGAGEFGEVCSGRLK---LPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHP 106
Query: 156 NLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHG 215
           N+++L G   + +  ++V EYME+GSL+   LR+     T  + + +    A G+ +L  
Sbjct: 107 NIIRLEGVVTKSKPVMIVTEYMENGSLDS-FLRKHDAQFTVIQLVGMLRGIASGMKYL-- 163
Query: 216 AERPVIYRDFKTSNILLNADFSAKLSDFGLAK---DGPMGDQTHVSTRVMGTYGYAAPEY 272
           ++   ++RD    NIL+N++   K+SDFGL +   D P    T    ++     + +PE 
Sbjct: 164 SDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKI--PIRWTSPEA 221
Query: 273 VMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRILDP 332
           +     T+ SDV+ +G+VL E++         RP  E            +N+ V++ +D 
Sbjct: 222 IAYRKFTSASDVWSYGIVLWEVM-----SYGERPYWEM-----------SNQDVIKAVD- 264
Query: 333 RLEGQYTARTAMKVAGLAYQ----CLSQNPKGRPVMSDVVALLETVQSQGAEEEMLQSGG 388
             EG Y     M      YQ    C  ++   RP    +V++L+ +       +++ S  
Sbjct: 265 --EG-YRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNPGSLKIITSAA 321
Query: 389 G 389
Sbjct: 322 A 322

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 79/280 (28%), Positives = 133/280 (47%), Gaps = 30/280 (10%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGY--QGDREWLAEVNYLGQLRHSNL 157
           +G G FG VYKG    +V         A+K LN      Q  + +  EV  L + RH N+
Sbjct: 36  IGSGSFGTVYKGKWHGDV---------AVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNI 86
Query: 158 VKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAE 217
           +  +GY  + +  I V ++ E  SL  HL   +       + + IA   A+G+ +LH   
Sbjct: 87  LLFMGYSTKPQLAI-VTQWCEGSSLYHHL-HIIETKFEMIKLIDIARQTAQGMDYLHA-- 142
Query: 218 RPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGH 277
           + +I+RD K++NI L+ D + K+ DFGLA +      +H   ++ G+  + APE +    
Sbjct: 143 KSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQD 202
Query: 278 ---LTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRILDPRL 334
               + +SDVY FG+VL E++ G+        +R+  +    R  L+ +   +R   P+ 
Sbjct: 203 KNPYSFQSDVYAFGIVLYELMTGQLPYSNIN-NRDQIIFMVGRGYLSPDLSKVRSNCPK- 260
Query: 335 EGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETV 374
                   AMK   L  +CL +    RP+   ++A +E +
Sbjct: 261 --------AMK--RLMAECLKKKRDERPLFPQILASIELL 290

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 79/280 (28%), Positives = 133/280 (47%), Gaps = 30/280 (10%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGY--QGDREWLAEVNYLGQLRHSNL 157
           +G G FG VYKG    +V         A+K LN      Q  + +  EV  L + RH N+
Sbjct: 16  IGSGSFGTVYKGKWHGDV---------AVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNI 66
Query: 158 VKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAE 217
           +  +GY  + +  I V ++ E  SL  HL   +       + + IA   A+G+ +LH   
Sbjct: 67  LLFMGYSTKPQLAI-VTQWCEGSSLYHHL-HIIETKFEMIKLIDIARQTAQGMDYLHA-- 122
Query: 218 RPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMT-- 275
           + +I+RD K++NI L+ D + K+ DFGLA +      +H   ++ G+  + APE +    
Sbjct: 123 KSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQD 182
Query: 276 -GHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRILDPRL 334
               + +SDVY FG+VL E++ G+        +R+  +    R  L+ +   +R   P+ 
Sbjct: 183 KNPYSFQSDVYAFGIVLYELMTGQLPYSNIN-NRDQIIFMVGRGYLSPDLSKVRSNCPK- 240
Query: 335 EGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETV 374
                   AMK   L  +CL +    RP+   ++A +E +
Sbjct: 241 --------AMK--RLMAECLKKKRDERPLFPQILASIELL 270

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 65/215 (30%), Positives = 117/215 (54%), Gaps = 16/215 (7%)
Query: 88  KLATKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGY--QGDREWLAE 145
           ++   + + + ++G G FG V +G +     PG K + VAIK L +GGY  +  RE+L+E
Sbjct: 10  EIDVSYVKIEEVIGAGEFGEVCRGRLKA---PGKKESCVAIKTL-KGGYTERQRREFLSE 65
Query: 146 VNYLGQLRHSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALD 205
            + +GQ  H N+++L G        +++ E+ME+G+L+   LR      T  + + +   
Sbjct: 66  ASIMGQFEHPNIIRLEGVVTNSMPVMILTEFMENGALDS-FLRLNDGQFTVIQLVGMLRG 124
Query: 206 AAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAK--DGPMGDQTHVSTRVMG 263
            A G+ +L  AE   ++RD    NIL+N++   K+SDFGL++  +    D T+ S+  +G
Sbjct: 125 IASGMRYL--AEMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTYTSS--LG 180
Query: 264 ---TYGYAAPEYVMTGHLTARSDVYGFGVVLLEML 295
                 + APE +     T+ SD + +G+V+ E++
Sbjct: 181 GKIPIRWTAPEAIAFRKFTSASDAWSYGIVMWEVM 215

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 85/322 (26%), Positives = 153/322 (47%), Gaps = 35/322 (10%)
Query: 73  NPGY-SNVDIFTYNEMKLATKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKEL 131
           NP Y S  D++  +E ++A +       LG+G FG+VY+GV    V+   +T  VAIK +
Sbjct: 27  NPEYFSAADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETR-VAIKTV 85
Query: 132 NRGGYQGDR-EWLAEVNYLGQLRHSNLVKLIGYCCEDEHRILVYEYMESGSLEKHL--LR 188
           N      +R E+L E + + +    ++V+L+G   + +  +++ E M  G L+ +L  LR
Sbjct: 86  NEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLR 145
Query: 189 ------RVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSD 242
                  V    + S+ +++A + A G+A+L+  +   ++RD    N ++  DF+ K+ D
Sbjct: 146 PEMENNPVLAPPSLSKMIQMAGEIADGMAYLNANK--FVHRDLAARNCMVAEDFTVKIGD 203
Query: 243 FGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVD 302
           FG+ +D    D      + +    + +PE +  G  T  SDV+ FGVVL E+     A  
Sbjct: 204 FGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI-----ATL 258
Query: 303 KSRPSREHNLVEWARPLLNNNKKVLRILDPRLEGQYTAR---TAMKVAGLAYQCLSQNPK 359
             +P +             +N++VLR +   +EG    +       +  L   C   NPK
Sbjct: 259 AEQPYQGL-----------SNEQVLRFV---MEGGLLDKPDNCPDMLFELMRMCWQYNPK 304
Query: 360 GRPVMSDVVALLETVQSQGAEE 381
            RP   ++++ ++     G  E
Sbjct: 305 MRPSFLEIISSIKEEMEPGFRE 326

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 75/279 (26%), Positives = 127/279 (45%), Gaps = 28/279 (10%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVK 159
           +G G FG+V+ G      +       VAIK + R G   + +++ E   + +L H  LV+
Sbjct: 16  IGSGQFGLVHLGYWLNKDK-------VAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQ 67
Query: 160 LIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERP 219
           L G C E     LV E+ME G L  +L  + G +      + + LD  +G+A+L   E  
Sbjct: 68  LYGVCLEQAPICLVTEFMEHGCLSDYLRTQRG-LFAAETLLGMCLDVCEGMAYLE--EAC 124
Query: 220 VIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLT 279
           VI+RD    N L+  +   K+SDFG+ +   + DQ   ST       +A+PE       +
Sbjct: 125 VIHRDLAARNCLVGENQVIKVSDFGMTR-FVLDDQYTSSTGTKFPVKWASPEVFSFSRYS 183
Query: 280 ARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRILDPRLEGQYT 339
           ++SDV+ FGV++ E+    +   ++R + E         ++ +     R+  PRL     
Sbjct: 184 SKSDVWSFGVLMWEVFSEGKIPYENRSNSE---------VVEDISTGFRLYKPRL----- 229
Query: 340 ARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETVQSQG 378
              +  V  +   C  + P+ RP  S ++  L  +   G
Sbjct: 230 --ASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAESG 266

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 93.2 bits (230), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 82/318 (25%), Positives = 151/318 (47%), Gaps = 34/318 (10%)
Query: 76  YSNVDIFTYNEMKLATKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGG 135
           +S  D++  +E ++A +       LG+G FG+VY+GV    V+   +T  VAIK +N   
Sbjct: 3   FSAADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETR-VAIKTVNEAA 61
Query: 136 YQGDR-EWLAEVNYLGQLRHSNLVKLIGYCCEDEHRILVYEYMESGSLEKHL--LR---- 188
              +R E+L E + + +    ++V+L+G   + +  +++ E M  G L+ +L  LR    
Sbjct: 62  SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEME 121
Query: 189 --RVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLA 246
              V    + S+ +++A + A G+A+L+  +   ++RD    N ++  DF+ K+ DFG+ 
Sbjct: 122 NNPVLAPPSLSKMIQMAGEIADGMAYLNANK--FVHRDLAARNCMVAEDFTVKIGDFGMT 179
Query: 247 KDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRP 306
           +D    D      + +    + +PE +  G  T  SDV+ FGVVL E+     A    +P
Sbjct: 180 RDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI-----ATLAEQP 234
Query: 307 SREHNLVEWARPLLNNNKKVLRILDPRLEGQYTAR---TAMKVAGLAYQCLSQNPKGRPV 363
            +             +N++VLR +   +EG    +       +  L   C   NPK RP 
Sbjct: 235 YQGL-----------SNEQVLRFV---MEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPS 280
Query: 364 MSDVVALLETVQSQGAEE 381
             ++++ ++     G  E
Sbjct: 281 FLEIISSIKEEMEPGFRE 298

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 93.2 bits (230), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 83/317 (26%), Positives = 150/317 (47%), Gaps = 34/317 (10%)
Query: 77  SNVDIFTYNEMKLATKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGY 136
           S  D+F  +E ++A +       LG+G FG+VY+GV    V+   +T  VAIK +N    
Sbjct: 1   SAADVFVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETR-VAIKTVNEAAS 59
Query: 137 QGDR-EWLAEVNYLGQLRHSNLVKLIGYCCEDEHRILVYEYMESGSLEKHL--LR----- 188
             +R E+L E + + +    ++V+L+G   + +  +++ E M  G L+ +L  LR     
Sbjct: 60  MRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMEN 119
Query: 189 -RVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAK 247
             V    + S+ +++A + A G+A+L+  +   ++RD    N ++  DF+ K+ DFG+ +
Sbjct: 120 NPVLAPPSLSKMIQMAGEIADGMAYLNANK--FVHRDLAARNCMVAEDFTVKIGDFGMTR 177
Query: 248 DGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPS 307
           D    D      + +    + +PE +  G  T  SDV+ FGVVL E+     A    +P 
Sbjct: 178 DIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI-----ATLAEQPY 232
Query: 308 REHNLVEWARPLLNNNKKVLRILDPRLEGQYTAR---TAMKVAGLAYQCLSQNPKGRPVM 364
           +             +N++VLR +   +EG    +       +  L   C   NPK RP  
Sbjct: 233 QGL-----------SNEQVLRFV---MEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSF 278
Query: 365 SDVVALLETVQSQGAEE 381
            ++++ ++     G  E
Sbjct: 279 LEIISSIKEEMEPGFRE 295

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 78/281 (27%), Positives = 128/281 (45%), Gaps = 32/281 (11%)
Query: 94  FRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLR 153
            R +  LG+G FG V+ G  +        TT VAIK L + G      +L E   + +LR
Sbjct: 20  LRLEVKLGQGCFGEVWMGTWN-------GTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLR 71
Query: 154 HSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFL 213
           H  LV+L     E+   I++ EYM  GSL   L   +G  L   + + +A   A G+A++
Sbjct: 72  HEKLVQLYAVVSEEPIYIVI-EYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYV 130
Query: 214 HGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTY--GYAAPE 271
                  ++RD + +NIL+  +   K++DFGLA+   + +    + R    +   + APE
Sbjct: 131 ERMN--YVHRDLRAANILVGENLVCKVADFGLAR---LIEDNEXTARQGAKFPIKWTAPE 185
Query: 272 YVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRILD 331
             + G  T +SDV+ FG++L E+    R       +RE         +L+  ++  R+  
Sbjct: 186 AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE---------VLDQVERGYRMPC 236
Query: 332 PRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLE 372
           P             +  L  QC  ++P+ RP    + A LE
Sbjct: 237 P-------PECPESLHDLMCQCWRKDPEERPTFEYLQAFLE 270

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 92.8 bits (229), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 78/281 (27%), Positives = 128/281 (45%), Gaps = 32/281 (11%)
Query: 94  FRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLR 153
            R +  LG+G FG V+ G  +        TT VAIK L + G      +L E   + +LR
Sbjct: 20  LRLEVKLGQGCFGEVWMGTWN-------GTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLR 71
Query: 154 HSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFL 213
           H  LV+L     E+   I++ EYM  GSL   L   +G  L   + + +A   A G+A++
Sbjct: 72  HEKLVQLYAVVSEEPIYIVI-EYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYV 130
Query: 214 HGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTY--GYAAPE 271
                  ++RD + +NIL+  +   K++DFGLA+   + +    + R    +   + APE
Sbjct: 131 ERMN--YVHRDLRAANILVGENLVCKVADFGLAR---LIEDNEYTARQGAKFPIKWTAPE 185
Query: 272 YVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRILD 331
             + G  T +SDV+ FG++L E+    R       +RE         +L+  ++  R+  
Sbjct: 186 AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE---------VLDQVERGYRMPC 236
Query: 332 PRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLE 372
           P             +  L  QC  ++P+ RP    + A LE
Sbjct: 237 P-------PECPESLHDLMCQCWRKDPEERPTFEYLQAFLE 270

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 92.8 bits (229), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 76/285 (26%), Positives = 131/285 (45%), Gaps = 40/285 (14%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGY--QGDREWLAEVNYLGQLRHSNL 157
           +G G FG VYKG    +V         A+K LN      Q  + +  EV  L + RH N+
Sbjct: 32  IGSGSFGTVYKGKWHGDV---------AVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNI 82
Query: 158 VKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAE 217
           +  +GY  + +  I V ++ E  SL  HL           + + IA   A+G+ +LH   
Sbjct: 83  LLFMGYSTKPQLAI-VTQWCEGSSLYHHL-HASETKFEMKKLIDIARQTARGMDYLHA-- 138
Query: 218 RPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVM--- 274
           + +I+RD K++NI L+ D + K+ DFGLA +      +H   ++ G+  + APE +    
Sbjct: 139 KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQD 198
Query: 275 TGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRI----- 329
           +   + +SDVY FG+VL E++ G+                     +NN  +++ +     
Sbjct: 199 SNPYSFQSDVYAFGIVLYELMTGQLPYSN----------------INNRDQIIEMVGRGS 242
Query: 330 LDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETV 374
           L P L  +  +    ++  L  +CL +    RP    ++A +E +
Sbjct: 243 LSPDL-SKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEEL 286

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 92.4 bits (228), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 79/280 (28%), Positives = 132/280 (47%), Gaps = 30/280 (10%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGY--QGDREWLAEVNYLGQLRHSNL 157
           +G G FG VYKG    +V         A+K LN      Q  + +  EV  L + RH N+
Sbjct: 44  IGSGSFGTVYKGKWHGDV---------AVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNI 94
Query: 158 VKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAE 217
           +  +GY  + +  I V ++ E  SL  HL   +       + + IA   A+G+ +LH   
Sbjct: 95  LLFMGYSTKPQLAI-VTQWCEGSSLYHHL-HIIETKFEMIKLIDIARQTAQGMDYLHA-- 150
Query: 218 RPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGH 277
           + +I+RD K++NI L+ D + K+ DFGLA        +H   ++ G+  + APE +    
Sbjct: 151 KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQD 210
Query: 278 ---LTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRILDPRL 334
               + +SDVY FG+VL E++ G+        +R+  +    R  L+ +   +R   P+ 
Sbjct: 211 KNPYSFQSDVYAFGIVLYELMTGQLPYSNIN-NRDQIIFMVGRGYLSPDLSKVRSNCPK- 268
Query: 335 EGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETV 374
                   AMK   L  +CL +    RP+   ++A +E +
Sbjct: 269 --------AMK--RLMAECLKKKRDERPLFPQILASIELL 298

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 92.4 bits (228), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 79/280 (28%), Positives = 132/280 (47%), Gaps = 30/280 (10%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGY--QGDREWLAEVNYLGQLRHSNL 157
           +G G FG VYKG    +V         A+K LN      Q  + +  EV  L + RH N+
Sbjct: 43  IGSGSFGTVYKGKWHGDV---------AVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNI 93
Query: 158 VKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAE 217
           +  +GY  + +  I V ++ E  SL  HL   +       + + IA   A+G+ +LH   
Sbjct: 94  LLFMGYSTKPQLAI-VTQWCEGSSLYHHL-HIIETKFEMIKLIDIARQTAQGMDYLHA-- 149
Query: 218 RPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGH 277
           + +I+RD K++NI L+ D + K+ DFGLA        +H   ++ G+  + APE +    
Sbjct: 150 KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQD 209
Query: 278 ---LTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRILDPRL 334
               + +SDVY FG+VL E++ G+        +R+  +    R  L+ +   +R   P+ 
Sbjct: 210 KNPYSFQSDVYAFGIVLYELMTGQLPYSNIN-NRDQIIFMVGRGYLSPDLSKVRSNCPK- 267
Query: 335 EGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETV 374
                   AMK   L  +CL +    RP+   ++A +E +
Sbjct: 268 --------AMK--RLMAECLKKKRDERPLFPQILASIELL 297

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 92.4 bits (228), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 93/210 (44%), Gaps = 18/210 (8%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVK 159
           LGEG FG V+      N+ P      VA+K L        +++  E   L  L+H ++V+
Sbjct: 49  LGEGAFGKVFLAEC-HNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVR 107
Query: 160 LIGYCCEDEHRILVYEYMESGSLEKHLLRRVGC--------------MLTWSRRMKIALD 205
             G C E    ++V+EYM  G L +  LR  G                L   + + +A  
Sbjct: 108 FFGVCTEGRPLLMVFEYMRHGDLNR-FLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQ 166
Query: 206 AAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTY 265
            A G+ +L G     ++RD  T N L+      K+ DFG+++D    D   V  R M   
Sbjct: 167 VAAGMVYLAGLH--FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPI 224
Query: 266 GYAAPEYVMTGHLTARSDVYGFGVVLLEML 295
            +  PE ++    T  SDV+ FGVVL E+ 
Sbjct: 225 RWMPPESILYRKFTTESDVWSFGVVLWEIF 254

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 92.0 bits (227), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 79/281 (28%), Positives = 127/281 (45%), Gaps = 32/281 (11%)
Query: 94  FRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLR 153
            R +  LG+G FG V+ G  +        TT VAIK L + G      +L E   + +LR
Sbjct: 20  LRLEVKLGQGCFGEVWMGTWN-------GTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLR 71
Query: 154 HSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFL 213
           H  LV+L     E+   I V EYM  GSL   L   +G  L   + + +A   A G+A++
Sbjct: 72  HEKLVQLYAVVSEEPIYI-VTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYV 130
Query: 214 HGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTY--GYAAPE 271
                  ++RD + +NIL+  +   K++DFGLA+   + +    + R    +   + APE
Sbjct: 131 ERMN--YVHRDLRAANILVGENLVCKVADFGLAR---LIEDNEYTARQGAKFPIKWTAPE 185
Query: 272 YVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRILD 331
             + G  T +SDV+ FG++L E+    R       +RE         +L+  ++  R+  
Sbjct: 186 AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE---------VLDQVERGYRMPC 236
Query: 332 PRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLE 372
           P             +  L  QC  ++P+ RP    + A LE
Sbjct: 237 P-------PECPESLHDLMCQCWRKDPEERPTFEYLQAFLE 270

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 92.0 bits (227), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 79/280 (28%), Positives = 132/280 (47%), Gaps = 30/280 (10%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGY--QGDREWLAEVNYLGQLRHSNL 157
           +G G FG VYKG    +V         A+K LN      Q  + +  EV  L + RH N+
Sbjct: 21  IGSGSFGTVYKGKWHGDV---------AVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNI 71
Query: 158 VKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAE 217
           +  +GY  + +  I V ++ E  SL  HL   +       + + IA   A+G+ +LH   
Sbjct: 72  LLFMGYSTKPQLAI-VTQWCEGSSLYHHL-HIIETKFEMIKLIDIARQTAQGMDYLHA-- 127
Query: 218 RPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGH 277
           + +I+RD K++NI L+ D + K+ DFGLA        +H   ++ G+  + APE +    
Sbjct: 128 KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQD 187
Query: 278 ---LTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRILDPRL 334
               + +SDVY FG+VL E++ G+        +R+  +    R  L+ +   +R   P+ 
Sbjct: 188 KNPYSFQSDVYAFGIVLYELMTGQLPYSNIN-NRDQIIFMVGRGYLSPDLSKVRSNCPK- 245
Query: 335 EGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETV 374
                   AMK   L  +CL +    RP+   ++A +E +
Sbjct: 246 --------AMK--RLMAECLKKKRDERPLFPQILASIELL 275

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 92.0 bits (227), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 79/281 (28%), Positives = 127/281 (45%), Gaps = 32/281 (11%)
Query: 94  FRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLR 153
            R +  LG+G FG V+ G  +        TT VAIK L + G      +L E   + +LR
Sbjct: 11  LRLEVKLGQGCFGEVWMGTWN-------GTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLR 62
Query: 154 HSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFL 213
           H  LV+L     E+   I V EYM  GSL   L   +G  L   + + +A   A G+A++
Sbjct: 63  HEKLVQLYAVVSEEPIYI-VTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYV 121
Query: 214 HGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTY--GYAAPE 271
                  ++RD + +NIL+  +   K++DFGLA+   + +    + R    +   + APE
Sbjct: 122 ERMN--YVHRDLRAANILVGENLVCKVADFGLAR---LIEDNEYTARQGAKFPIKWTAPE 176
Query: 272 YVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRILD 331
             + G  T +SDV+ FG++L E+    R       +RE         +L+  ++  R+  
Sbjct: 177 AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE---------VLDQVERGYRMPC 227
Query: 332 PRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLE 372
           P             +  L  QC  ++P+ RP    + A LE
Sbjct: 228 P-------PECPESLHDLMCQCWRKDPEERPTFEYLQAFLE 261

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 92.0 bits (227), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 79/281 (28%), Positives = 125/281 (44%), Gaps = 32/281 (11%)
Query: 94  FRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLR 153
            R +  LG+G FG V+ G  +        TT VAIK L + G      +L E   + +LR
Sbjct: 10  LRLEVKLGQGCFGEVWMGTWN-------GTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLR 61
Query: 154 HSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFL 213
           H  LV+L     E+   I V EYM  GSL   L    G  L   + + +A   A G+A++
Sbjct: 62  HEKLVQLYAVVSEEPIXI-VTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYV 120
Query: 214 HGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTY--GYAAPE 271
                  ++RD + +NIL+  +   K++DFGLA+   + +    + R    +   + APE
Sbjct: 121 ERMN--YVHRDLRAANILVGENLVCKVADFGLAR---LIEDNEXTARQGAKFPIKWTAPE 175
Query: 272 YVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRILD 331
             + G  T +SDV+ FG++L E+    R       +RE         +L+  ++  R+  
Sbjct: 176 AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE---------VLDQVERGYRMPC 226
Query: 332 PRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLE 372
           P             +  L  QC  + P+ RP    + A LE
Sbjct: 227 P-------PECPESLHDLMCQCWRKEPEERPTFEYLQAFLE 260

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 92.0 bits (227), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 79/280 (28%), Positives = 132/280 (47%), Gaps = 30/280 (10%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGY--QGDREWLAEVNYLGQLRHSNL 157
           +G G FG VYKG    +V         A+K LN      Q  + +  EV  L + RH N+
Sbjct: 21  IGSGSFGTVYKGKWHGDV---------AVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNI 71
Query: 158 VKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAE 217
           +  +GY  + +  I V ++ E  SL  HL   +       + + IA   A+G+ +LH   
Sbjct: 72  LLFMGYSTKPQLAI-VTQWCEGSSLYHHL-HIIETKFEMIKLIDIARQTAQGMDYLHA-- 127
Query: 218 RPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGH 277
           + +I+RD K++NI L+ D + K+ DFGLA        +H   ++ G+  + APE +    
Sbjct: 128 KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQD 187
Query: 278 ---LTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRILDPRL 334
               + +SDVY FG+VL E++ G+        +R+  +    R  L+ +   +R   P+ 
Sbjct: 188 KNPYSFQSDVYAFGIVLYELMTGQLPYSNIN-NRDQIIFMVGRGYLSPDLSKVRSNCPK- 245
Query: 335 EGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETV 374
                   AMK   L  +CL +    RP+   ++A +E +
Sbjct: 246 --------AMK--RLMAECLKKKRDERPLFPQILASIELL 275

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 92.0 bits (227), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 79/280 (28%), Positives = 132/280 (47%), Gaps = 30/280 (10%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGY--QGDREWLAEVNYLGQLRHSNL 157
           +G G FG VYKG    +V         A+K LN      Q  + +  EV  L + RH N+
Sbjct: 18  IGSGSFGTVYKGKWHGDV---------AVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNI 68
Query: 158 VKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAE 217
           +  +GY  + +  I V ++ E  SL  HL   +       + + IA   A+G+ +LH   
Sbjct: 69  LLFMGYSTKPQLAI-VTQWCEGSSLYHHL-HIIETKFEMIKLIDIARQTAQGMDYLHA-- 124
Query: 218 RPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMT-- 275
           + +I+RD K++NI L+ D + K+ DFGLA        +H   ++ G+  + APE +    
Sbjct: 125 KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQD 184
Query: 276 -GHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRILDPRL 334
               + +SDVY FG+VL E++ G+        +R+  +    R  L+ +   +R   P+ 
Sbjct: 185 KNPYSFQSDVYAFGIVLYELMTGQLPYSNIN-NRDQIIFMVGRGYLSPDLSKVRSNCPK- 242
Query: 335 EGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETV 374
                   AMK   L  +CL +    RP+   ++A +E +
Sbjct: 243 --------AMK--RLMAECLKKKRDERPLFPQILASIELL 272

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 92.0 bits (227), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 78/284 (27%), Positives = 131/284 (46%), Gaps = 40/284 (14%)
Query: 100 LGEGGFGVV----YKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHS 155
           LG G FGVV    +KG  D           VA+K +  G    D E+  E   + +L H 
Sbjct: 16  LGSGQFGVVKLGKWKGQYD-----------VAVKMIKEGSMSED-EFFQEAQTMMKLSHP 63
Query: 156 NLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHG 215
            LVK  G C ++    +V EY+ +G L  + LR  G  L  S+ +++  D  +G+AFL  
Sbjct: 64  KLVKFYGVCSKEYPIYIVTEYISNGCLLNY-LRSHGKGLEPSQLLEMCYDVCEGMAFLES 122
Query: 216 AERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMT 275
            +   I+RD    N L++ D   K+SDFG+ +   + DQ   S        ++APE    
Sbjct: 123 HQ--FIHRDLAARNCLVDRDLCVKVSDFGMTR-YVLDDQYVSSVGTKFPVKWSAPEVFHY 179
Query: 276 GHLTARSDVYGFGVVLLEML-LGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRILD-PR 333
              +++SDV+ FG+++ E+  LG+   D                L  N++ VL++    R
Sbjct: 180 FKYSSKSDVWAFGILMWEVFSLGKMPYD----------------LYTNSEVVLKVSQGHR 223
Query: 334 LEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETVQSQ 377
           L   + A     +  + Y C  + P+ RP    +++ +E ++ +
Sbjct: 224 LYRPHLASDT--IYQIMYSCWHELPEKRPTFQQLLSSIEPLREK 265

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 92.0 bits (227), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 93/210 (44%), Gaps = 18/210 (8%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVK 159
           LGEG FG V+      N+ P      VA+K L        +++  E   L  L+H ++V+
Sbjct: 26  LGEGAFGKVFLAEC-HNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVR 84
Query: 160 LIGYCCEDEHRILVYEYMESGSLEKHLLRRVGC--------------MLTWSRRMKIALD 205
             G C E    ++V+EYM  G L +  LR  G                L   + + +A  
Sbjct: 85  FFGVCTEGRPLLMVFEYMRHGDLNR-FLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQ 143
Query: 206 AAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTY 265
            A G+ +L G     ++RD  T N L+      K+ DFG+++D    D   V  R M   
Sbjct: 144 VAAGMVYLAGLH--FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPI 201
Query: 266 GYAAPEYVMTGHLTARSDVYGFGVVLLEML 295
            +  PE ++    T  SDV+ FGVVL E+ 
Sbjct: 202 RWMPPESILYRKFTTESDVWSFGVVLWEIF 231

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 92.0 bits (227), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 93/210 (44%), Gaps = 18/210 (8%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVK 159
           LGEG FG V+      N+ P      VA+K L        +++  E   L  L+H ++V+
Sbjct: 20  LGEGAFGKVFLAEC-HNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVR 78
Query: 160 LIGYCCEDEHRILVYEYMESGSLEKHLLRRVGC--------------MLTWSRRMKIALD 205
             G C E    ++V+EYM  G L +  LR  G                L   + + +A  
Sbjct: 79  FFGVCTEGRPLLMVFEYMRHGDLNR-FLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQ 137
Query: 206 AAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTY 265
            A G+ +L G     ++RD  T N L+      K+ DFG+++D    D   V  R M   
Sbjct: 138 VAAGMVYLAGLH--FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPI 195
Query: 266 GYAAPEYVMTGHLTARSDVYGFGVVLLEML 295
            +  PE ++    T  SDV+ FGVVL E+ 
Sbjct: 196 RWMPPESILYRKFTTESDVWSFGVVLWEIF 225

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 92.0 bits (227), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 79/281 (28%), Positives = 127/281 (45%), Gaps = 32/281 (11%)
Query: 94  FRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLR 153
            R +  LG+G FG V+ G  +        TT VAIK L + G      +L E   + +LR
Sbjct: 9   LRLEVKLGQGCFGEVWMGTWN-------GTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLR 60
Query: 154 HSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFL 213
           H  LV+L     E+   I V EYM  GSL   L   +G  L   + + +A   A G+A++
Sbjct: 61  HEKLVQLYAVVSEEPIYI-VTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYV 119
Query: 214 HGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTY--GYAAPE 271
                  ++RD + +NIL+  +   K++DFGLA+   + +    + R    +   + APE
Sbjct: 120 ERMN--YVHRDLRAANILVGENLVCKVADFGLAR---LIEDNEYTARQGAKFPIKWTAPE 174
Query: 272 YVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRILD 331
             + G  T +SDV+ FG++L E+    R       +RE         +L+  ++  R+  
Sbjct: 175 AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE---------VLDQVERGYRMPC 225
Query: 332 PRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLE 372
           P             +  L  QC  ++P+ RP    + A LE
Sbjct: 226 P-------PECPESLHDLMCQCWRKDPEERPTFEYLQAFLE 259

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 92.0 bits (227), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 79/281 (28%), Positives = 125/281 (44%), Gaps = 32/281 (11%)
Query: 94  FRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLR 153
            R +  LG+G FG V+ G  +        TT VAIK L + G      +L E   + +LR
Sbjct: 186 LRLEVKLGQGCFGEVWMGTWN-------GTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLR 237
Query: 154 HSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFL 213
           H  LV+L     E E   +V EYM  GSL   L    G  L   + + +A   A G+A++
Sbjct: 238 HEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYV 296
Query: 214 HGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTY--GYAAPE 271
                  ++RD + +NIL+  +   K++DFGLA+   + +    + R    +   + APE
Sbjct: 297 ERMN--YVHRDLRAANILVGENLVCKVADFGLAR---LIEDNEYTARQGAKFPIKWTAPE 351
Query: 272 YVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRILD 331
             + G  T +SDV+ FG++L E+    R       +RE         +L+  ++  R+  
Sbjct: 352 AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE---------VLDQVERGYRMPC 402
Query: 332 PRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLE 372
           P             +  L  QC  + P+ RP    + A LE
Sbjct: 403 P-------PECPESLHDLMCQCWRKEPEERPTFEYLQAFLE 436

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 92.0 bits (227), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 79/281 (28%), Positives = 127/281 (45%), Gaps = 32/281 (11%)
Query: 94  FRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLR 153
            R +  LG+G FG V+ G  +        TT VAIK L + G      +L E   + +LR
Sbjct: 20  LRLEVKLGQGCFGEVWMGTWN-------GTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLR 71
Query: 154 HSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFL 213
           H  LV+L     E+   I V EYM  GSL   L   +G  L   + + +A   A G+A++
Sbjct: 72  HEKLVQLYAVVSEEPIYI-VCEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYV 130
Query: 214 HGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTY--GYAAPE 271
                  ++RD + +NIL+  +   K++DFGLA+   + +    + R    +   + APE
Sbjct: 131 ERMN--YVHRDLRAANILVGENLVCKVADFGLAR---LIEDNEYTARQGAKFPIKWTAPE 185
Query: 272 YVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRILD 331
             + G  T +SDV+ FG++L E+    R       +RE         +L+  ++  R+  
Sbjct: 186 AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE---------VLDQVERGYRMPC 236
Query: 332 PRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLE 372
           P             +  L  QC  ++P+ RP    + A LE
Sbjct: 237 P-------PECPESLHDLMCQCWRKDPEERPTFEYLQAFLE 270

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 92.0 bits (227), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 80/301 (26%), Positives = 139/301 (46%), Gaps = 36/301 (11%)
Query: 97  DYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDR-EWLAEVNYLGQLRHS 155
           D ++G G FG V  G +     P  K   VAIK L  G  +  R ++L E + +GQ  H 
Sbjct: 50  DKVVGAGEFGEVCSGRLK---LPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHP 106
Query: 156 NLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHG 215
           N+++L G   + +  ++V E ME+GSL+   LR+     T  + + +    A G+ +L  
Sbjct: 107 NIIRLEGVVTKSKPVMIVTEXMENGSLDS-FLRKHDAQFTVIQLVGMLRGIASGMKYL-- 163
Query: 216 AERPVIYRDFKTSNILLNADFSAKLSDFGLAK---DGPMGDQTHVSTRVMGTYGYAAPEY 272
           ++   ++RD    NIL+N++   K+SDFGL++   D P    T    ++     + +PE 
Sbjct: 164 SDMGAVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKI--PIRWTSPEA 221
Query: 273 VMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRILDP 332
           +     T+ SDV+ +G+VL E++         RP  E            +N+ V++ +D 
Sbjct: 222 IAYRKFTSASDVWSYGIVLWEVM-----SYGERPYWEM-----------SNQDVIKAVD- 264
Query: 333 RLEGQYTARTAMKVAGLAYQ----CLSQNPKGRPVMSDVVALLETVQSQGAEEEMLQSGG 388
             EG Y     M      YQ    C  ++   RP    +V++L+ +       +++ S  
Sbjct: 265 --EG-YRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNPGSLKIITSAA 321
Query: 389 G 389
Sbjct: 322 A 322

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 92.0 bits (227), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 79/280 (28%), Positives = 132/280 (47%), Gaps = 30/280 (10%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGY--QGDREWLAEVNYLGQLRHSNL 157
           +G G FG VYKG    +V         A+K LN      Q  + +  EV  L + RH N+
Sbjct: 16  IGSGSFGTVYKGKWHGDV---------AVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNI 66
Query: 158 VKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAE 217
           +  +GY  + +  I V ++ E  SL  HL   +       + + IA   A+G+ +LH   
Sbjct: 67  LLFMGYSTKPQLAI-VTQWCEGSSLYHHL-HIIETKFEMIKLIDIARQTAQGMDYLHA-- 122
Query: 218 RPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMT-- 275
           + +I+RD K++NI L+ D + K+ DFGLA        +H   ++ G+  + APE +    
Sbjct: 123 KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQD 182
Query: 276 -GHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRILDPRL 334
               + +SDVY FG+VL E++ G+        +R+  +    R  L+ +   +R   P+ 
Sbjct: 183 KNPYSFQSDVYAFGIVLYELMTGQLPYSNIN-NRDQIIFMVGRGYLSPDLSKVRSNCPK- 240
Query: 335 EGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETV 374
                   AMK   L  +CL +    RP+   ++A +E +
Sbjct: 241 --------AMK--RLMAECLKKKRDERPLFPQILASIELL 270

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 92.0 bits (227), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 79/281 (28%), Positives = 125/281 (44%), Gaps = 32/281 (11%)
Query: 94  FRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLR 153
            R +  LG+G FG V+ G  +        TT VAIK L + G      +L E   + +LR
Sbjct: 186 LRLEVKLGQGCFGEVWMGTWN-------GTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLR 237
Query: 154 HSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFL 213
           H  LV+L     E E   +V EYM  GSL   L    G  L   + + +A   A G+A++
Sbjct: 238 HEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYV 296
Query: 214 HGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTY--GYAAPE 271
                  ++RD + +NIL+  +   K++DFGLA+   + +    + R    +   + APE
Sbjct: 297 ERMN--YVHRDLRAANILVGENLVCKVADFGLAR---LIEDNEYTARQGAKFPIKWTAPE 351
Query: 272 YVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRILD 331
             + G  T +SDV+ FG++L E+    R       +RE         +L+  ++  R+  
Sbjct: 352 AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE---------VLDQVERGYRMPC 402
Query: 332 PRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLE 372
           P             +  L  QC  + P+ RP    + A LE
Sbjct: 403 P-------PECPESLHDLMCQCWRKEPEERPTFEYLQAFLE 436

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 92.0 bits (227), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 78/285 (27%), Positives = 136/285 (47%), Gaps = 34/285 (11%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDR-EWLAEVNYLGQLRHSNLV 158
           LG+G FG+VY+G   + ++ G   T VA+K +N      +R E+L E + +      ++V
Sbjct: 22  LGQGSFGMVYEGNARDIIK-GEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 80
Query: 159 KLIGYCCEDEHRILVYEYMESGSLEKHL--LRRVG------CMLTWSRRMKIALDAAKGL 210
           +L+G   + +  ++V E M  G L+ +L  LR            T    +++A + A G+
Sbjct: 81  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 140
Query: 211 AFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAP 270
           A+L+   +  ++RD    N ++  DF+ K+ DFG+ +D    D      + +    + AP
Sbjct: 141 AYLNA--KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMAP 198
Query: 271 EYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRIL 330
           E +  G  T  SD++ FGVVL E+                +L E     L +N++VL+ +
Sbjct: 199 ESLKDGVFTTSSDMWSFGVVLWEIT---------------SLAEQPYQGL-SNEQVLKFV 242
Query: 331 DPRLEGQYTAR---TAMKVAGLAYQCLSQNPKGRPVMSDVVALLE 372
              ++G Y  +      +V  L   C   NPK RP   ++V LL+
Sbjct: 243 ---MDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLK 284

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 91.7 bits (226), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 78/285 (27%), Positives = 136/285 (47%), Gaps = 34/285 (11%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDR-EWLAEVNYLGQLRHSNLV 158
           LG+G FG+VY+G   + ++ G   T VA+K +N      +R E+L E + +      ++V
Sbjct: 25  LGQGSFGMVYEGNARDIIK-GEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 83
Query: 159 KLIGYCCEDEHRILVYEYMESGSLEKHL--LRRVG------CMLTWSRRMKIALDAAKGL 210
           +L+G   + +  ++V E M  G L+ +L  LR            T    +++A + A G+
Sbjct: 84  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 143
Query: 211 AFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAP 270
           A+L+   +  ++RD    N ++  DF+ K+ DFG+ +D    D      + +    + AP
Sbjct: 144 AYLNA--KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMAP 201
Query: 271 EYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRIL 330
           E +  G  T  SD++ FGVVL E+                +L E     L +N++VL+ +
Sbjct: 202 ESLKDGVFTTSSDMWSFGVVLWEIT---------------SLAEQPYQGL-SNEQVLKFV 245
Query: 331 DPRLEGQYTAR---TAMKVAGLAYQCLSQNPKGRPVMSDVVALLE 372
              ++G Y  +      +V  L   C   NPK RP   ++V LL+
Sbjct: 246 ---MDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLK 287

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 91.7 bits (226), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 76/285 (26%), Positives = 130/285 (45%), Gaps = 40/285 (14%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGY--QGDREWLAEVNYLGQLRHSNL 157
           +G G FG VYKG    +V         A+K LN      Q  + +  EV  L + RH N+
Sbjct: 32  IGSGSFGTVYKGKWHGDV---------AVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNI 82
Query: 158 VKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAE 217
           +  +GY    +  I V ++ E  SL  HL           + + IA   A+G+ +LH   
Sbjct: 83  LLFMGYSTAPQLAI-VTQWCEGSSLYHHL-HASETKFEMKKLIDIARQTARGMDYLHA-- 138
Query: 218 RPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVM--- 274
           + +I+RD K++NI L+ D + K+ DFGLA +      +H   ++ G+  + APE +    
Sbjct: 139 KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQD 198
Query: 275 TGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRI----- 329
           +   + +SDVY FG+VL E++ G+                     +NN  +++ +     
Sbjct: 199 SNPYSFQSDVYAFGIVLYELMTGQLPYSN----------------INNRDQIIEMVGRGS 242
Query: 330 LDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETV 374
           L P L  +  +    ++  L  +CL +    RP    ++A +E +
Sbjct: 243 LSPDL-SKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEEL 286

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 91.7 bits (226), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 82/317 (25%), Positives = 150/317 (47%), Gaps = 34/317 (10%)
Query: 77  SNVDIFTYNEMKLATKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGY 136
           S  D++  +E ++A +       LG+G FG+VY+GV    V+   +T  VAIK +N    
Sbjct: 3   SAADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETR-VAIKTVNEAAS 61
Query: 137 QGDR-EWLAEVNYLGQLRHSNLVKLIGYCCEDEHRILVYEYMESGSLEKHL--LRR---- 189
             +R E+L E + + +    ++V+L+G   + +  +++ E M  G L+ +L  LR     
Sbjct: 62  MRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMEN 121
Query: 190 --VGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAK 247
             V    + S+ +++A + A G+A+L+  +   ++RD    N ++  DF+ K+ DFG+ +
Sbjct: 122 NPVLAPPSLSKMIQMAGEIADGMAYLNANK--FVHRDLAARNCMVAEDFTVKIGDFGMTR 179
Query: 248 DGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPS 307
           D    D      + +    + +PE +  G  T  SDV+ FGVVL E+     A    +P 
Sbjct: 180 DIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI-----ATLAEQPY 234
Query: 308 REHNLVEWARPLLNNNKKVLRILDPRLEGQYTAR---TAMKVAGLAYQCLSQNPKGRPVM 364
           +             +N++VLR +   +EG    +       +  L   C   NPK RP  
Sbjct: 235 QGL-----------SNEQVLRFV---MEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSF 280
Query: 365 SDVVALLETVQSQGAEE 381
            ++++ ++     G  E
Sbjct: 281 LEIISSIKEEMEPGFRE 297

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 91.7 bits (226), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 79/281 (28%), Positives = 126/281 (44%), Gaps = 32/281 (11%)
Query: 94  FRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLR 153
            R +  LG+G FG V+ G  +        TT VAIK L  G    +  +L E   + +LR
Sbjct: 187 LRLEVKLGQGCFGEVWMGTWN-------GTTRVAIKTLKPGNMSPE-AFLQEAQVMKKLR 238
Query: 154 HSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFL 213
           H  LV+L     E E   +V EYM  GSL   L   +G  L   + + +A   A G+A++
Sbjct: 239 HEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYV 297
Query: 214 HGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTY--GYAAPE 271
                  ++RD + +NIL+  +   K++DFGL   G + +    + R    +   + APE
Sbjct: 298 ERMN--YVHRDLRAANILVGENLVCKVADFGL---GRLIEDNEYTARQGAKFPIKWTAPE 352
Query: 272 YVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRILD 331
             + G  T +SDV+ FG++L E+    R       +RE         +L+  ++  R+  
Sbjct: 353 AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE---------VLDQVERGYRMPC 403
Query: 332 PRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLE 372
           P             +  L  QC  ++P+ RP    + A LE
Sbjct: 404 P-------PECPESLHDLMCQCWRKDPEERPTFEYLQAFLE 437

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 91.7 bits (226), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 82/317 (25%), Positives = 150/317 (47%), Gaps = 34/317 (10%)
Query: 77  SNVDIFTYNEMKLATKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGY 136
           S  D++  +E ++A +       LG+G FG+VY+GV    V+   +T  VAIK +N    
Sbjct: 3   SAADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETR-VAIKTVNEAAS 61
Query: 137 QGDR-EWLAEVNYLGQLRHSNLVKLIGYCCEDEHRILVYEYMESGSLEKHL--LRR---- 189
             +R E+L E + + +    ++V+L+G   + +  +++ E M  G L+ +L  LR     
Sbjct: 62  MRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMEN 121
Query: 190 --VGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAK 247
             V    + S+ +++A + A G+A+L+  +   ++RD    N ++  DF+ K+ DFG+ +
Sbjct: 122 NPVLAPPSLSKMIQMAGEIADGMAYLNANK--FVHRDLAARNCMVAEDFTVKIGDFGMTR 179
Query: 248 DGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPS 307
           D    D      + +    + +PE +  G  T  SDV+ FGVVL E+     A    +P 
Sbjct: 180 DIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI-----ATLAEQPY 234
Query: 308 REHNLVEWARPLLNNNKKVLRILDPRLEGQYTAR---TAMKVAGLAYQCLSQNPKGRPVM 364
           +             +N++VLR +   +EG    +       +  L   C   NPK RP  
Sbjct: 235 QGL-----------SNEQVLRFV---MEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSF 280
Query: 365 SDVVALLETVQSQGAEE 381
            ++++ ++     G  E
Sbjct: 281 LEIISSIKEEMEPGFRE 297

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 91.7 bits (226), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 89/300 (29%), Positives = 129/300 (43%), Gaps = 46/300 (15%)
Query: 100 LGEGGFGVVYKGV-IDENVRPGYKTTFVAIKELNRGGYQGD-REWLAEVNYLGQLRHSNL 157
           LGEG FG V K        R GY T  VA+K L       + R+ L+E N L Q+ H ++
Sbjct: 31  LGEGEFGKVVKATAFHLKGRAGYTT--VAVKMLKENASPSELRDLLSEFNVLKQVNHPHV 88
Query: 158 VKLIGYCCEDEHRILVYEYMESGSLEKHLL--RRVGC--------------------MLT 195
           +KL G C +D   +L+ EY + GSL   L   R+VG                      LT
Sbjct: 89  IKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALT 148
Query: 196 WSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQT 255
               +  A   ++G+ +L  AE  +++RD    NIL+      K+SDFGL++D    D  
Sbjct: 149 MGDLISFAWQISQGMQYL--AEMSLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSX 206
Query: 256 HVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEML-LGRRAVDKSRPSREHNLVE 314
              ++      + A E +     T +SDV+ FGV+L E++ LG        P R  NL++
Sbjct: 207 VKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPERLFNLLK 266
Query: 315 WARPLLNNNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETV 374
                             R+E        M    L  QC  Q P  RPV +D+   LE +
Sbjct: 267 TGH---------------RMERPDNCSEEM--YRLMLQCWKQEPDKRPVFADISKDLEKM 309

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 79/280 (28%), Positives = 131/280 (46%), Gaps = 30/280 (10%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGY--QGDREWLAEVNYLGQLRHSNL 157
           +G G FG VYKG    +V         A+K LN      Q  + +  EV  L + RH N+
Sbjct: 16  IGSGSFGTVYKGKWHGDV---------AVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNI 66
Query: 158 VKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAE 217
           +  +GY    +  I V ++ E  SL  HL   +       + + IA   A+G+ +LH   
Sbjct: 67  LLFMGYSTAPQLAI-VTQWCEGSSLYHHL-HIIETKFEMIKLIDIARQTAQGMDYLHA-- 122
Query: 218 RPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMT-- 275
           + +I+RD K++NI L+ D + K+ DFGLA        +H   ++ G+  + APE +    
Sbjct: 123 KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQD 182
Query: 276 -GHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRILDPRL 334
               + +SDVY FG+VL E++ G+        +R+  +    R  L+ +   +R   P+ 
Sbjct: 183 KNPYSFQSDVYAFGIVLYELMTGQLPYSNIN-NRDQIIFMVGRGYLSPDLSKVRSNCPK- 240
Query: 335 EGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETV 374
                   AMK   L  +CL +    RP+   ++A +E +
Sbjct: 241 --------AMK--RLMAECLKKKRDERPLFPQILASIELL 270

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 89/300 (29%), Positives = 129/300 (43%), Gaps = 46/300 (15%)
Query: 100 LGEGGFGVVYKGV-IDENVRPGYKTTFVAIKELNRGGYQGD-REWLAEVNYLGQLRHSNL 157
           LGEG FG V K        R GY T  VA+K L       + R+ L+E N L Q+ H ++
Sbjct: 31  LGEGEFGKVVKATAFHLKGRAGYTT--VAVKMLKENASPSELRDLLSEFNVLKQVNHPHV 88
Query: 158 VKLIGYCCEDEHRILVYEYMESGSLEKHLL--RRVGC--------------------MLT 195
           +KL G C +D   +L+ EY + GSL   L   R+VG                      LT
Sbjct: 89  IKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALT 148
Query: 196 WSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQT 255
               +  A   ++G+ +L  AE  +++RD    NIL+      K+SDFGL++D    D  
Sbjct: 149 MGDLISFAWQISQGMQYL--AEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSX 206
Query: 256 HVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEML-LGRRAVDKSRPSREHNLVE 314
              ++      + A E +     T +SDV+ FGV+L E++ LG        P R  NL++
Sbjct: 207 VKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPERLFNLLK 266
Query: 315 WARPLLNNNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETV 374
                             R+E        M    L  QC  Q P  RPV +D+   LE +
Sbjct: 267 TGH---------------RMERPDNCSEEM--YRLMLQCWKQEPDKRPVFADISKDLEKM 309

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 80/301 (26%), Positives = 139/301 (46%), Gaps = 36/301 (11%)
Query: 97  DYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDR-EWLAEVNYLGQLRHS 155
           D ++G G FG V  G +     P  K   VAIK L  G  +  R ++L E + +GQ  H 
Sbjct: 50  DKVVGAGEFGEVCSGRLK---LPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHP 106
Query: 156 NLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHG 215
           N+++L G   + +  ++V E ME+GSL+   LR+     T  + + +    A G+ +L  
Sbjct: 107 NIIRLEGVVTKSKPVMIVTEXMENGSLDS-FLRKHDAQFTVIQLVGMLRGIASGMKYL-- 163
Query: 216 AERPVIYRDFKTSNILLNADFSAKLSDFGLAK---DGPMGDQTHVSTRVMGTYGYAAPEY 272
           ++   ++RD    NIL+N++   K+SDFGL++   D P    T    ++     + +PE 
Sbjct: 164 SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKI--PIRWTSPEA 221
Query: 273 VMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRILDP 332
           +     T+ SDV+ +G+VL E++         RP  E            +N+ V++ +D 
Sbjct: 222 IAYRKFTSASDVWSYGIVLWEVM-----SYGERPYWEM-----------SNQDVIKAVD- 264
Query: 333 RLEGQYTARTAMKVAGLAYQ----CLSQNPKGRPVMSDVVALLETVQSQGAEEEMLQSGG 388
             EG Y     M      YQ    C  ++   RP    +V++L+ +       +++ S  
Sbjct: 265 --EG-YRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNPGSLKIITSAA 321
Query: 389 G 389
Sbjct: 322 A 322

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 79/281 (28%), Positives = 125/281 (44%), Gaps = 32/281 (11%)
Query: 94  FRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLR 153
            R +  LG+G FG V+ G  +        TT VAIK L + G      +L E   + +LR
Sbjct: 13  LRLEVKLGQGCFGEVWMGTWN-------GTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLR 64
Query: 154 HSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFL 213
           H  LV+L     E+   I V EYM  GSL   L    G  L   + + +A   A G+A++
Sbjct: 65  HEKLVQLYAVVSEEPIYI-VTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYV 123
Query: 214 HGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTY--GYAAPE 271
                  ++RD + +NIL+  +   K++DFGLA+   + +    + R    +   + APE
Sbjct: 124 ERMN--YVHRDLRAANILVGENLVCKVADFGLAR---LIEDNEYTARQGAKFPIKWTAPE 178
Query: 272 YVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRILD 331
             + G  T +SDV+ FG++L E+    R       +RE         +L+  ++  R+  
Sbjct: 179 AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE---------VLDQVERGYRMPC 229
Query: 332 PRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLE 372
           P             +  L  QC  + P+ RP    + A LE
Sbjct: 230 P-------PECPESLHDLMCQCWRKEPEERPTFEYLQAFLE 263

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 83/298 (27%), Positives = 140/298 (46%), Gaps = 53/298 (17%)
Query: 99  ILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLV 158
           ++G G FGVV K          ++   VAIK++     +  + ++ E+  L ++ H N+V
Sbjct: 16  VVGRGAFGVVCKA--------KWRAKDVAIKQIESESER--KAFIVELRQLSRVNHPNIV 65
Query: 159 KLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCM--LTWSRRMKIALDAAKGLAFLHGA 216
           KL G C       LV EY E GSL  ++L     +   T +  M   L  ++G+A+LH  
Sbjct: 66  KLYGACLNP--VCLVMEYAEGGSL-YNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSM 122
Query: 217 E-RPVIYRDFKTSNILLNADFSA-KLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVM 274
           + + +I+RD K  N+LL A  +  K+ DFG A D     QTH+ T   G+  + APE   
Sbjct: 123 QPKALIHRDLKPPNLLLVAGGTVLKICDFGTACD----IQTHM-TNNKGSAAWMAPEVFE 177
Query: 275 TGHLTARSDVYGFGVVLLEMLLGRRAVDK-SRPSREHNLVEWA------RPLLNNNKKVL 327
             + + + DV+ +G++L E++  R+  D+   P+     + WA       PL+ N  K  
Sbjct: 178 GSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFR---IMWAVHNGTRPPLIKNLPK-- 232
Query: 328 RILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETVQS--QGAEEEM 383
                             +  L  +C S++P  RP M ++V ++  +     GA+E +
Sbjct: 233 -----------------PIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGADEPL 273

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 78/281 (27%), Positives = 127/281 (45%), Gaps = 32/281 (11%)
Query: 94  FRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLR 153
            R +  LG+G FG V+ G  +        TT VAIK L + G      +L E   + ++R
Sbjct: 20  LRLEVKLGQGCFGEVWMGTWN-------GTTRVAIKTL-KPGTMSPEAFLQEAQVMKKIR 71
Query: 154 HSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFL 213
           H  LV+L     E+   I V EYM  GSL   L   +G  L   + + +A   A G+A++
Sbjct: 72  HEKLVQLYAVVSEEPIYI-VTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYV 130
Query: 214 HGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTY--GYAAPE 271
                  ++RD + +NIL+  +   K++DFGLA+   + +    + R    +   + APE
Sbjct: 131 ERMN--YVHRDLRAANILVGENLVCKVADFGLAR---LIEDNEYTARQGAKFPIKWTAPE 185
Query: 272 YVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRILD 331
             + G  T +SDV+ FG++L E+    R       +RE         +L+  ++  R+  
Sbjct: 186 AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE---------VLDQVERGYRMPC 236
Query: 332 PRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLE 372
           P             +  L  QC  ++P+ RP    + A LE
Sbjct: 237 P-------PECPESLHDLMCQCWRKDPEERPTFEYLQAFLE 270

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 79/314 (25%), Positives = 147/314 (46%), Gaps = 34/314 (10%)
Query: 80  DIFTYNEMKLATKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGD 139
           D++  +E ++A +       LG+G FG+VY+GV    V+   +T  VAIK +N      +
Sbjct: 3   DVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETR-VAIKTVNEAASMRE 61
Query: 140 R-EWLAEVNYLGQLRHSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCML---- 194
           R E+L E + + +    ++V+L+G   + +  +++ E M  G L+ +L      M     
Sbjct: 62  RIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPV 121
Query: 195 ----TWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGP 250
               + S+ +++A + A G+A+L+  +   ++RD    N ++  DF+ K+ DFG+ +D  
Sbjct: 122 LAPPSLSKMIQMAGEIADGMAYLNANK--FVHRDLAARNCMVAEDFTVKIGDFGMTRDIY 179
Query: 251 MGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREH 310
             D      + +    + +PE +  G  T  SDV+ FGVVL E+     A    +P +  
Sbjct: 180 ETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI-----ATLAEQPYQGL 234
Query: 311 NLVEWARPLLNNNKKVLRILDPRLEGQYTAR---TAMKVAGLAYQCLSQNPKGRPVMSDV 367
                      +N++VLR +   +EG    +       +  L   C   NPK RP   ++
Sbjct: 235 -----------SNEQVLRFV---MEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEI 280
Query: 368 VALLETVQSQGAEE 381
           ++ ++     G  E
Sbjct: 281 ISSIKEEMEPGFRE 294

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 79/281 (28%), Positives = 126/281 (44%), Gaps = 32/281 (11%)
Query: 94  FRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLR 153
            R +  LG+G FG V+ G  +        TT VAIK L + G      +L E   + +LR
Sbjct: 20  LRLEVKLGQGCFGEVWMGTWN-------GTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLR 71
Query: 154 HSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFL 213
           H  LV+L     E+   I V EYM  GSL   L   +G  L   + + +A   A G+A++
Sbjct: 72  HEKLVQLYAVVSEEPIYI-VTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYV 130
Query: 214 HGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTY--GYAAPE 271
                  ++RD   +NIL+  +   K++DFGLA+   + +    + R    +   + APE
Sbjct: 131 ERMN--YVHRDLAAANILVGENLVCKVADFGLAR---LIEDNEYTARQGAKFPIKWTAPE 185
Query: 272 YVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRILD 331
             + G  T +SDV+ FG++L E+    R       +RE         +L+  ++  R+  
Sbjct: 186 AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE---------VLDQVERGYRMPC 236
Query: 332 PRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLE 372
           P             +  L  QC  ++P+ RP    + A LE
Sbjct: 237 P-------PECPESLHDLMCQCWRKDPEERPTFEYLQAFLE 270

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 83/298 (27%), Positives = 140/298 (46%), Gaps = 53/298 (17%)
Query: 99  ILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLV 158
           ++G G FGVV K          ++   VAIK++     +  + ++ E+  L ++ H N+V
Sbjct: 15  VVGRGAFGVVCKA--------KWRAKDVAIKQIESESER--KAFIVELRQLSRVNHPNIV 64
Query: 159 KLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCM--LTWSRRMKIALDAAKGLAFLHGA 216
           KL G C       LV EY E GSL  ++L     +   T +  M   L  ++G+A+LH  
Sbjct: 65  KLYGACLNP--VCLVMEYAEGGSL-YNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSM 121
Query: 217 E-RPVIYRDFKTSNILLNADFSA-KLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVM 274
           + + +I+RD K  N+LL A  +  K+ DFG A D     QTH+ T   G+  + APE   
Sbjct: 122 QPKALIHRDLKPPNLLLVAGGTVLKICDFGTACD----IQTHM-TNNKGSAAWMAPEVFE 176
Query: 275 TGHLTARSDVYGFGVVLLEMLLGRRAVDK-SRPSREHNLVEWA------RPLLNNNKKVL 327
             + + + DV+ +G++L E++  R+  D+   P+     + WA       PL+ N  K  
Sbjct: 177 GSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFR---IMWAVHNGTRPPLIKNLPK-- 231
Query: 328 RILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETVQS--QGAEEEM 383
                             +  L  +C S++P  RP M ++V ++  +     GA+E +
Sbjct: 232 -----------------PIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGADEPL 272

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 79/281 (28%), Positives = 125/281 (44%), Gaps = 32/281 (11%)
Query: 94  FRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLR 153
            R +  LG+G FG V+ G  +        TT VAIK L + G      +L E   + +LR
Sbjct: 186 LRLEVKLGQGCFGEVWMGTWN-------GTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLR 237
Query: 154 HSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFL 213
           H  LV+L     E E   +V EYM  GSL   L    G  L   + + +A   A G+A++
Sbjct: 238 HEKLVQLYAVVSE-EPIYIVGEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYV 296
Query: 214 HGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTY--GYAAPE 271
                  ++RD + +NIL+  +   K++DFGLA+   + +    + R    +   + APE
Sbjct: 297 ERMN--YVHRDLRAANILVGENLVCKVADFGLAR---LIEDNEYTARQGAKFPIKWTAPE 351
Query: 272 YVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRILD 331
             + G  T +SDV+ FG++L E+    R       +RE         +L+  ++  R+  
Sbjct: 352 AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE---------VLDQVERGYRMPC 402
Query: 332 PRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLE 372
           P             +  L  QC  + P+ RP    + A LE
Sbjct: 403 P-------PECPESLHDLMCQCWRKEPEERPTFEYLQAFLE 436

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 79/284 (27%), Positives = 134/284 (47%), Gaps = 36/284 (12%)
Query: 97  DYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDR-EWLAEVNYLGQLRHS 155
           D ++G G FG V  G +     P  K   VAIK L  G  +  R ++L E + +GQ  H 
Sbjct: 21  DKVVGAGEFGEVCSGRLK---LPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHP 77
Query: 156 NLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHG 215
           N+++L G   + +  ++V E ME+GSL+   LR+     T  + + +    A G+ +L  
Sbjct: 78  NIIRLEGVVTKSKPVMIVTEXMENGSLDS-FLRKHDAQFTVIQLVGMLRGIASGMKYL-- 134
Query: 216 AERPVIYRDFKTSNILLNADFSAKLSDFGLAK---DGPMGDQTHVSTRVMGTYGYAAPEY 272
           ++   ++RD    NIL+N++   K+SDFGL++   D P    T    ++     + +PE 
Sbjct: 135 SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKI--PIRWTSPEA 192
Query: 273 VMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRILDP 332
           +     T+ SDV+ +G+VL E++         RP  E            +N+ V++ +D 
Sbjct: 193 IAYRKFTSASDVWSYGIVLWEVM-----SYGERPYWEM-----------SNQDVIKAVD- 235
Query: 333 RLEGQYTARTAMKVAGLAYQ----CLSQNPKGRPVMSDVVALLE 372
             EG Y     M      YQ    C  ++   RP    +V++L+
Sbjct: 236 --EG-YRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILD 276

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 89/300 (29%), Positives = 129/300 (43%), Gaps = 46/300 (15%)
Query: 100 LGEGGFGVVYKGV-IDENVRPGYKTTFVAIKELNRGGYQGD-REWLAEVNYLGQLRHSNL 157
           LGEG FG V K        R GY T  VA+K L       + R+ L+E N L Q+ H ++
Sbjct: 31  LGEGEFGKVVKATAFHLKGRAGYTT--VAVKMLKENASPSELRDLLSEFNVLKQVNHPHV 88
Query: 158 VKLIGYCCEDEHRILVYEYMESGSLEKHLL--RRVGC--------------------MLT 195
           +KL G C +D   +L+ EY + GSL   L   R+VG                      LT
Sbjct: 89  IKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALT 148
Query: 196 WSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQT 255
               +  A   ++G+ +L  AE  +++RD    NIL+      K+SDFGL++D    D  
Sbjct: 149 MGDLISFAWQISQGMQYL--AEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSY 206
Query: 256 HVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEML-LGRRAVDKSRPSREHNLVE 314
              ++      + A E +     T +SDV+ FGV+L E++ LG        P R  NL++
Sbjct: 207 VKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPERLFNLLK 266
Query: 315 WARPLLNNNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETV 374
                             R+E        M    L  QC  Q P  RPV +D+   LE +
Sbjct: 267 TGH---------------RMERPDNCSEEM--YRLMLQCWKQEPDKRPVFADISKDLEKM 309

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 78/281 (27%), Positives = 126/281 (44%), Gaps = 32/281 (11%)
Query: 94  FRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLR 153
            R +  LG+G FG V+ G  +        TT VAIK L + G      +L E   + +LR
Sbjct: 20  LRLEVKLGQGCFGEVWMGTWN-------GTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLR 71
Query: 154 HSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFL 213
           H  LV+L     E+   I V EYM  G L   L   +G  L   + + +A   A G+A++
Sbjct: 72  HEKLVQLYAVVSEEPIYI-VMEYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYV 130
Query: 214 HGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTY--GYAAPE 271
                  ++RD + +NIL+  +   K++DFGLA+   + +    + R    +   + APE
Sbjct: 131 ERMN--YVHRDLRAANILVGENLVCKVADFGLAR---LIEDNEYTARQGAKFPIKWTAPE 185
Query: 272 YVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRILD 331
             + G  T +SDV+ FG++L E+    R       +RE         +L+  ++  R+  
Sbjct: 186 AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE---------VLDQVERGYRMPC 236
Query: 332 PRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLE 372
           P             +  L  QC  ++P+ RP    + A LE
Sbjct: 237 P-------PECPESLHDLMCQCWRKDPEERPTFEYLQAFLE 270

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 78/294 (26%), Positives = 140/294 (47%), Gaps = 34/294 (11%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDR-EWLAEVNYLGQLRHSNLV 158
           LG+G FG+VY+GV    V+   +T  VAIK +N      +R E+L E + + +    ++V
Sbjct: 18  LGQGSFGMVYEGVAKGVVKDEPETR-VAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 76
Query: 159 KLIGYCCEDEHRILVYEYMESGSLEKHL--LRR------VGCMLTWSRRMKIALDAAKGL 210
           +L+G   + +  +++ E M  G L+ +L  LR       V    + S+ +++A + A G+
Sbjct: 77  RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGM 136
Query: 211 AFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAP 270
           A+L+  +   ++RD    N ++  DF+ K+ DFG+ +D    D      + +    + +P
Sbjct: 137 AYLNANK--FVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMSP 194
Query: 271 EYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRIL 330
           E +  G  T  SDV+ FGVVL E+     A    +P +             +N++VLR +
Sbjct: 195 ESLKDGVFTTYSDVWSFGVVLWEI-----ATLAEQPYQGL-----------SNEQVLRFV 238
Query: 331 DPRLEGQYTAR---TAMKVAGLAYQCLSQNPKGRPVMSDVVALLETVQSQGAEE 381
              +EG    +       +  L   C   NPK RP   ++++ ++     G  E
Sbjct: 239 ---MEGGLLDKPDNCPDMLLELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFRE 289

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 76/285 (26%), Positives = 130/285 (45%), Gaps = 40/285 (14%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGY--QGDREWLAEVNYLGQLRHSNL 157
           +G G FG VYKG    +V         A+K LN      Q  + +  EV  L + RH N+
Sbjct: 20  IGSGSFGTVYKGKWHGDV---------AVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNI 70
Query: 158 VKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAE 217
           +  +GY  + +  I V ++ E  SL  HL           + + IA   A+G+ +LH   
Sbjct: 71  LLFMGYSTKPQLAI-VTQWCEGSSLYHHL-HASETKFEMKKLIDIARQTARGMDYLHA-- 126
Query: 218 RPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVM--- 274
           + +I+RD K++NI L+ D + K+ DFGLA        +H   ++ G+  + APE +    
Sbjct: 127 KSIIHRDLKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQD 186
Query: 275 TGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRI----- 329
           +   + +SDVY FG+VL E++ G+                     +NN  +++ +     
Sbjct: 187 SNPYSFQSDVYAFGIVLYELMTGQLPYSN----------------INNRDQIIEMVGRGS 230
Query: 330 LDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETV 374
           L P L  +  +    ++  L  +CL +    RP    ++A +E +
Sbjct: 231 LSPDL-SKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEEL 274

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 85/301 (28%), Positives = 134/301 (44%), Gaps = 26/301 (8%)
Query: 99  ILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGD-REWLAEVNYLGQLRHSNL 157
           ++G G FG VY G + +N     K    A+K LNR    G+  ++L E   +    H N+
Sbjct: 38  VIGRGHFGCVYHGTLLDN---DGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 94
Query: 158 VKLIGYCCEDE-HRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGA 216
           + L+G C   E   ++V  YM+ G L ++ +R      T    +   L  AKG+ FL  A
Sbjct: 95  LSLLGICLRSEGSPLVVLPYMKHGDL-RNFIRNETHNPTVKDLIGFGLQVAKGMKFL--A 151
Query: 217 ERPVIYRDFKTSNILLNADFSAKLSDFGLAKD--GPMGDQTHVSTRVMGTYGYAAPEYVM 274
            +  ++RD    N +L+  F+ K++DFGLA+D      D  H  T       + A E + 
Sbjct: 152 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMLDKEFDSVHNKTGAKLPVKWMALESLQ 211
Query: 275 TGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRILDPRL 334
           T   T +SDV+ FGV+L E L+ R A     P  + N  +    LL       R+L P  
Sbjct: 212 TQKFTTKSDVWSFGVLLWE-LMTRGA----PPYPDVNTFDITVYLLQGR----RLLQP-- 260
Query: 335 EGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETVQSQGAEEEMLQSGGGVVTLY 394
             +Y      +V     +C     + RP  S++V+ +  + S    E  +      V + 
Sbjct: 261 --EYCPDPLYEV---MLKCWHPKAEMRPSFSELVSRISAIFSTFIGEHYVHVNATYVNVK 315
Query: 395 E 395
           E
Sbjct: 316 E 316

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 85/301 (28%), Positives = 134/301 (44%), Gaps = 26/301 (8%)
Query: 99  ILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGD-REWLAEVNYLGQLRHSNL 157
           ++G G FG VY G + +N     K    A+K LNR    G+  ++L E   +    H N+
Sbjct: 38  VIGRGHFGCVYHGTLLDN---DGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 94
Query: 158 VKLIGYCCEDE-HRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGA 216
           + L+G C   E   ++V  YM+ G L ++ +R      T    +   L  AKG+ FL  A
Sbjct: 95  LSLLGICLRSEGSPLVVLPYMKHGDL-RNFIRNETHNPTVKDLIGFGLQVAKGMKFL--A 151
Query: 217 ERPVIYRDFKTSNILLNADFSAKLSDFGLAKD--GPMGDQTHVSTRVMGTYGYAAPEYVM 274
            +  ++RD    N +L+  F+ K++DFGLA+D      D  H  T       + A E + 
Sbjct: 152 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQ 211
Query: 275 TGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRILDPRL 334
           T   T +SDV+ FGV+L E L+ R A     P  + N  +    LL       R+L P  
Sbjct: 212 TQKFTTKSDVWSFGVLLWE-LMTRGA----PPYPDVNTFDITVYLLQGR----RLLQP-- 260
Query: 335 EGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETVQSQGAEEEMLQSGGGVVTLY 394
             +Y      +V     +C     + RP  S++V+ +  + S    E  +      V + 
Sbjct: 261 --EYCPDPLYEV---MLKCWHPKAEMRPSFSELVSRISAIFSTFIGEHYVHVNATYVNVK 315
Query: 395 E 395
           E
Sbjct: 316 E 316

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 66/231 (28%), Positives = 119/231 (51%), Gaps = 23/231 (9%)
Query: 79  VDIFTYNEMKLATKFF---------RPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIK 129
           VD FT+ +   A + F         + + ++G G FG V  G +     PG +   VAIK
Sbjct: 7   VDPFTFEDPNQAVREFAKEIDASCIKIEKVIGVGEFGEVCSGRLKV---PGKREICVAIK 63
Query: 130 ELNRGGY--QGDREWLAEVNYLGQLRHSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLL 187
            L + GY  +  R++L+E + +GQ  H N++ L G   + +  +++ EYME+GSL+  L 
Sbjct: 64  TL-KAGYTDKQRRDFLSEASIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLR 122
Query: 188 RRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAK 247
           +  G   T  + + +      G+ +L  ++   ++RD    NIL+N++   K+SDFG+++
Sbjct: 123 KNDG-RFTVIQLVGMLRGIGSGMKYL--SDMSAVHRDLAARNILVNSNLVCKVSDFGMSR 179
Query: 248 ---DGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEML 295
              D P    T    ++     + APE +     T+ SDV+ +G+V+ E++
Sbjct: 180 VLEDDPEAAYTTRGGKI--PIRWTAPEAIAYRKFTSASDVWSYGIVMWEVM 228

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 78/281 (27%), Positives = 126/281 (44%), Gaps = 32/281 (11%)
Query: 94  FRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLR 153
            R +  LG+G FG V+ G  +        TT VAIK L + G      +L E   + +LR
Sbjct: 20  LRLEVKLGQGCFGEVWMGTWN-------GTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLR 71
Query: 154 HSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFL 213
           H  LV+L     E+   I V EYM  G L   L   +G  L   + + +A   A G+A++
Sbjct: 72  HEKLVQLYAVVSEEPIYI-VTEYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYV 130
Query: 214 HGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTY--GYAAPE 271
                  ++RD + +NIL+  +   K++DFGLA+   + +    + R    +   + APE
Sbjct: 131 ERMN--YVHRDLRAANILVGENLVCKVADFGLAR---LIEDNEYTARQGAKFPIKWTAPE 185
Query: 272 YVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRILD 331
             + G  T +SDV+ FG++L E+    R       +RE         +L+  ++  R+  
Sbjct: 186 AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE---------VLDQVERGYRMPC 236
Query: 332 PRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLE 372
           P             +  L  QC  ++P+ RP    + A LE
Sbjct: 237 P-------PECPESLHDLMCQCWRKDPEERPTFEYLQAFLE 270

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 64/201 (31%), Positives = 100/201 (49%), Gaps = 10/201 (4%)
Query: 99  ILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGD-REWLAEVNYLGQLRHSNL 157
           ++G G FG VY G + +N     K    A+K LNR    G+  ++L E   +    H N+
Sbjct: 96  VIGRGHFGCVYHGTLLDN---DGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 152
Query: 158 VKLIGYCCEDE-HRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGA 216
           + L+G C   E   ++V  YM+ G L ++ +R      T    +   L  AKG+ FL  A
Sbjct: 153 LSLLGICLRSEGSPLVVLPYMKHGDL-RNFIRNETHNPTVKDLIGFGLQVAKGMKFL--A 209
Query: 217 ERPVIYRDFKTSNILLNADFSAKLSDFGLAKD--GPMGDQTHVSTRVMGTYGYAAPEYVM 274
            +  ++RD    N +L+  F+ K++DFGLA+D      D  H  T       + A E + 
Sbjct: 210 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQ 269
Query: 275 TGHLTARSDVYGFGVVLLEML 295
           T   T +SDV+ FGV+L E++
Sbjct: 270 TQKFTTKSDVWSFGVLLWELM 290

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 78/281 (27%), Positives = 125/281 (44%), Gaps = 32/281 (11%)
Query: 94  FRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLR 153
            R +  LG+G FG V+ G  +        TT VAIK L + G      +L E   + +LR
Sbjct: 17  LRLEVKLGQGCFGEVWMGTWN-------GTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLR 68
Query: 154 HSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFL 213
           H  LV+L     E+   I V EYM  GSL   L    G  L   + + ++   A G+A++
Sbjct: 69  HEKLVQLYAVVSEEPIYI-VTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASGMAYV 127
Query: 214 HGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTY--GYAAPE 271
                  ++RD + +NIL+  +   K++DFGLA+   + +    + R    +   + APE
Sbjct: 128 ERMN--YVHRDLRAANILVGENLVCKVADFGLAR---LIEDNEYTARQGAKFPIKWTAPE 182
Query: 272 YVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRILD 331
             + G  T +SDV+ FG++L E+    R       +RE         +L+  ++  R+  
Sbjct: 183 AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE---------VLDQVERGYRMPC 233
Query: 332 PRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLE 372
           P             +  L  QC  + P+ RP    + A LE
Sbjct: 234 P-------PECPESLHDLMCQCWRKEPEERPTFEYLQAFLE 267

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 78/281 (27%), Positives = 125/281 (44%), Gaps = 32/281 (11%)
Query: 94  FRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLR 153
            R +  LG+G FG V+ G  +        TT VAIK L + G      +L E   + +LR
Sbjct: 17  LRLEVKLGQGCFGEVWMGTWN-------GTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLR 68
Query: 154 HSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFL 213
           H  LV+L     E+   I V EYM  GSL   L    G  L   + + ++   A G+A++
Sbjct: 69  HEKLVQLYAVVSEEPIYI-VTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASGMAYV 127
Query: 214 HGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTY--GYAAPE 271
                  ++RD + +NIL+  +   K++DFGLA+   + +    + R    +   + APE
Sbjct: 128 ERMN--YVHRDLRAANILVGENLVCKVADFGLAR---LIEDNEWTARQGAKFPIKWTAPE 182
Query: 272 YVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRILD 331
             + G  T +SDV+ FG++L E+    R       +RE         +L+  ++  R+  
Sbjct: 183 AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE---------VLDQVERGYRMPC 233
Query: 332 PRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLE 372
           P             +  L  QC  + P+ RP    + A LE
Sbjct: 234 P-------PECPESLHDLMCQCWRKEPEERPTFEYLQAFLE 267

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 78/285 (27%), Positives = 136/285 (47%), Gaps = 34/285 (11%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDR-EWLAEVNYLGQLRHSNLV 158
           LG+G FG+VY+G   + ++ G   T VA+K +N      +R E+L E + +      ++V
Sbjct: 24  LGQGSFGMVYEGNARDIIK-GEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 82
Query: 159 KLIGYCCEDEHRILVYEYMESGSLEKHL--LRRVG------CMLTWSRRMKIALDAAKGL 210
           +L+G   + +  ++V E M  G L+ +L  LR            T    +++A + A G+
Sbjct: 83  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 142
Query: 211 AFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAP 270
           A+L+   +  ++RD    N ++  DF+ K+ DFG+ +D    D      + +    + AP
Sbjct: 143 AYLNA--KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 200
Query: 271 EYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRIL 330
           E +  G  T  SD++ FGVVL E+                +L E     L +N++VL+ +
Sbjct: 201 ESLKDGVFTTSSDMWSFGVVLWEIT---------------SLAEQPYQGL-SNEQVLKFV 244
Query: 331 DPRLEGQYTAR---TAMKVAGLAYQCLSQNPKGRPVMSDVVALLE 372
              ++G Y  +      +V  L   C   NPK RP   ++V LL+
Sbjct: 245 ---MDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLK 286

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 90.1 bits (222), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 64/201 (31%), Positives = 100/201 (49%), Gaps = 10/201 (4%)
Query: 99  ILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGD-REWLAEVNYLGQLRHSNL 157
           ++G G FG VY G + +N     K    A+K LNR    G+  ++L E   +    H N+
Sbjct: 42  VIGRGHFGCVYHGTLLDN---DGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 98
Query: 158 VKLIGYCCEDE-HRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGA 216
           + L+G C   E   ++V  YM+ G L ++ +R      T    +   L  AKG+ FL  A
Sbjct: 99  LSLLGICLRSEGSPLVVLPYMKHGDL-RNFIRNETHNPTVKDLIGFGLQVAKGMKFL--A 155
Query: 217 ERPVIYRDFKTSNILLNADFSAKLSDFGLAKD--GPMGDQTHVSTRVMGTYGYAAPEYVM 274
            +  ++RD    N +L+  F+ K++DFGLA+D      D  H  T       + A E + 
Sbjct: 156 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQ 215
Query: 275 TGHLTARSDVYGFGVVLLEML 295
           T   T +SDV+ FGV+L E++
Sbjct: 216 TQKFTTKSDVWSFGVLLWELM 236

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 90.1 bits (222), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 64/201 (31%), Positives = 100/201 (49%), Gaps = 10/201 (4%)
Query: 99  ILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGD-REWLAEVNYLGQLRHSNL 157
           ++G G FG VY G + +N     K    A+K LNR    G+  ++L E   +    H N+
Sbjct: 37  VIGRGHFGCVYHGTLLDN---DGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 93
Query: 158 VKLIGYCCEDE-HRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGA 216
           + L+G C   E   ++V  YM+ G L ++ +R      T    +   L  AKG+ FL  A
Sbjct: 94  LSLLGICLRSEGSPLVVLPYMKHGDL-RNFIRNETHNPTVKDLIGFGLQVAKGMKFL--A 150
Query: 217 ERPVIYRDFKTSNILLNADFSAKLSDFGLAKD--GPMGDQTHVSTRVMGTYGYAAPEYVM 274
            +  ++RD    N +L+  F+ K++DFGLA+D      D  H  T       + A E + 
Sbjct: 151 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQ 210
Query: 275 TGHLTARSDVYGFGVVLLEML 295
           T   T +SDV+ FGV+L E++
Sbjct: 211 TQKFTTKSDVWSFGVLLWELM 231

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 90.1 bits (222), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 64/201 (31%), Positives = 100/201 (49%), Gaps = 10/201 (4%)
Query: 99  ILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGD-REWLAEVNYLGQLRHSNL 157
           ++G G FG VY G + +N     K    A+K LNR    G+  ++L E   +    H N+
Sbjct: 35  VIGRGHFGCVYHGTLLDN---DGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 91
Query: 158 VKLIGYCCEDE-HRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGA 216
           + L+G C   E   ++V  YM+ G L ++ +R      T    +   L  AKG+ FL  A
Sbjct: 92  LSLLGICLRSEGSPLVVLPYMKHGDL-RNFIRNETHNPTVKDLIGFGLQVAKGMKFL--A 148
Query: 217 ERPVIYRDFKTSNILLNADFSAKLSDFGLAKD--GPMGDQTHVSTRVMGTYGYAAPEYVM 274
            +  ++RD    N +L+  F+ K++DFGLA+D      D  H  T       + A E + 
Sbjct: 149 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQ 208
Query: 275 TGHLTARSDVYGFGVVLLEML 295
           T   T +SDV+ FGV+L E++
Sbjct: 209 TQKFTTKSDVWSFGVLLWELM 229

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 90.1 bits (222), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 64/201 (31%), Positives = 100/201 (49%), Gaps = 10/201 (4%)
Query: 99  ILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGD-REWLAEVNYLGQLRHSNL 157
           ++G G FG VY G + +N     K    A+K LNR    G+  ++L E   +    H N+
Sbjct: 37  VIGRGHFGCVYHGTLLDN---DGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 93
Query: 158 VKLIGYCCEDE-HRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGA 216
           + L+G C   E   ++V  YM+ G L ++ +R      T    +   L  AKG+ FL  A
Sbjct: 94  LSLLGICLRSEGSPLVVLPYMKHGDL-RNFIRNETHNPTVKDLIGFGLQVAKGMKFL--A 150
Query: 217 ERPVIYRDFKTSNILLNADFSAKLSDFGLAKD--GPMGDQTHVSTRVMGTYGYAAPEYVM 274
            +  ++RD    N +L+  F+ K++DFGLA+D      D  H  T       + A E + 
Sbjct: 151 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQ 210
Query: 275 TGHLTARSDVYGFGVVLLEML 295
           T   T +SDV+ FGV+L E++
Sbjct: 211 TQKFTTKSDVWSFGVLLWELM 231

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 78/285 (27%), Positives = 136/285 (47%), Gaps = 34/285 (11%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDR-EWLAEVNYLGQLRHSNLV 158
           LG+G FG+VY+G   + ++ G   T VA+K +N      +R E+L E + +      ++V
Sbjct: 25  LGQGSFGMVYEGNARDIIK-GEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 83
Query: 159 KLIGYCCEDEHRILVYEYMESGSLEKHL--LRRVG------CMLTWSRRMKIALDAAKGL 210
           +L+G   + +  ++V E M  G L+ +L  LR            T    +++A + A G+
Sbjct: 84  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 143
Query: 211 AFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAP 270
           A+L+   +  ++RD    N ++  DF+ K+ DFG+ +D    D      + +    + AP
Sbjct: 144 AYLNA--KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 201
Query: 271 EYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRIL 330
           E +  G  T  SD++ FGVVL E+                +L E     L +N++VL+ +
Sbjct: 202 ESLKDGVFTTSSDMWSFGVVLWEIT---------------SLAEQPYQGL-SNEQVLKFV 245
Query: 331 DPRLEGQYTAR---TAMKVAGLAYQCLSQNPKGRPVMSDVVALLE 372
              ++G Y  +      +V  L   C   NPK RP   ++V LL+
Sbjct: 246 ---MDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLK 287

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 77/285 (27%), Positives = 135/285 (47%), Gaps = 34/285 (11%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDR-EWLAEVNYLGQLRHSNLV 158
           LG+G FG+VY+G   + ++ G   T VA+K +N      +R E+L E + +      ++V
Sbjct: 25  LGQGSFGMVYEGNARDIIK-GEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 83
Query: 159 KLIGYCCEDEHRILVYEYMESGSLEKHL--LRRVG------CMLTWSRRMKIALDAAKGL 210
           +L+G   + +  ++V E M  G L+ +L  LR            T    +++A + A G+
Sbjct: 84  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 143
Query: 211 AFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAP 270
           A+L+   +  ++RD    N ++  DF+ K+ DFG+ +D    D      + +    + AP
Sbjct: 144 AYLNA--KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMAP 201
Query: 271 EYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRIL 330
           E +  G  T  SD++ FGVVL E+                +L E     L +N++VL+ +
Sbjct: 202 ESLKDGVFTTSSDMWSFGVVLWEIT---------------SLAEQPYQGL-SNEQVLKFV 245
Query: 331 DPRLEGQYTAR---TAMKVAGLAYQCLSQNPKGRPVMSDVVALLE 372
              ++G Y  +      +V  L   C   NP  RP   ++V LL+
Sbjct: 246 ---MDGGYLDQPDNCPERVTDLMRMCWQFNPNMRPTFLEIVNLLK 287

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 62/203 (30%), Positives = 108/203 (53%), Gaps = 14/203 (6%)
Query: 99  ILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDR-EWLAEVNYLGQLRHSNL 157
           ++G G FG V  G +     PG +  FVAIK L  G  +  R ++L+E + +GQ  H N+
Sbjct: 14  VIGAGEFGEVCSGHLK---LPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNV 70
Query: 158 VKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAE 217
           + L G   +    +++ E+ME+GSL+   LR+     T  + + +    A G+ +L  A+
Sbjct: 71  IHLEGVVTKSTPVMIITEFMENGSLDS-FLRQNDGQFTVIQLVGMLRGIAAGMKYL--AD 127
Query: 218 RPVIYRDFKTSNILLNADFSAKLSDFGLAK--DGPMGDQTHVSTRVMG---TYGYAAPEY 272
              ++R     NIL+N++   K+SDFGL++  +    D T+  T  +G      + APE 
Sbjct: 128 MNYVHRALAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTY--TSALGGKIPIRWTAPEA 185
Query: 273 VMTGHLTARSDVYGFGVVLLEML 295
           +     T+ SDV+ +G+V+ E++
Sbjct: 186 IQYRKFTSASDVWSYGIVMWEVM 208

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 89.0 bits (219), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 78/294 (26%), Positives = 140/294 (47%), Gaps = 34/294 (11%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDR-EWLAEVNYLGQLRHSNLV 158
           LG+G FG+VY+GV    V+   +T  VAIK +N      +R E+L E + + +    ++V
Sbjct: 20  LGQGSFGMVYEGVAKGVVKDEPETR-VAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 78
Query: 159 KLIGYCCEDEHRILVYEYMESGSLEKHL--LRR------VGCMLTWSRRMKIALDAAKGL 210
           +L+G   + +  +++ E M  G L+ +L  LR       V    + S+ +++A + A G+
Sbjct: 79  RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGM 138
Query: 211 AFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAP 270
           A+L+  +   ++RD    N ++  DF+ K+ DFG+ +D    D      + +    + +P
Sbjct: 139 AYLNANK--FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSP 196
Query: 271 EYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRIL 330
           E +  G  T  SDV+ FGVVL E+     A    +P +             +N++VLR +
Sbjct: 197 ESLKDGVFTTYSDVWSFGVVLWEI-----ATLAEQPYQGL-----------SNEQVLRFV 240
Query: 331 DPRLEGQYTAR---TAMKVAGLAYQCLSQNPKGRPVMSDVVALLETVQSQGAEE 381
              +EG    +       +  L   C   NPK RP   ++++ ++     G  E
Sbjct: 241 ---MEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFRE 291

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 89.0 bits (219), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 65/198 (32%), Positives = 103/198 (52%), Gaps = 22/198 (11%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVK 159
           +G+G FG V  G         Y+   VA+K +        + +LAE + + QLRHSNLV+
Sbjct: 20  IGKGEFGDVMLG--------DYRGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQ 69
Query: 160 LIGYCCEDEHRI-LVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAER 218
           L+G   E++  + +V EYM  GSL  +L  R   +L     +K +LD  + + +L G   
Sbjct: 70  LLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN- 128
Query: 219 PVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTY--GYAAPEYVMTG 276
             ++RD    N+L++ D  AK+SDFGL K+         ST+  G     + APE +   
Sbjct: 129 -FVHRDLAARNVLVSEDNVAKVSDFGLTKEAS-------STQDTGKLPVKWTAPEALREA 180
Query: 277 HLTARSDVYGFGVVLLEM 294
             + +SDV+ FG++L E+
Sbjct: 181 AFSTKSDVWSFGILLWEI 198

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 88.6 bits (218), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 88/288 (30%), Positives = 127/288 (44%), Gaps = 25/288 (8%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTT--FVAIKELNR-GGYQGDREWLAEVNYLGQLRHSN 156
           LGEG FG V     D    P    T   VA+K L    G Q    W  E++ L  L H +
Sbjct: 39  LGEGHFGKVSLYCYD----PTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEH 94
Query: 157 LVKLIGYCCEDEHRI---LVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFL 213
           ++K  G CCED       LV EY+  GSL  +L R     +  ++ +  A    +G+A+L
Sbjct: 95  IIKYKG-CCEDAGAASLQLVMEYVPLGSLRDYLPRH---SIGLAQLLLFAQQICEGMAYL 150
Query: 214 HGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTH-VSTRVMGTYGYAAPEY 272
           H      I+RD    N+LL+ D   K+ DFGLAK  P G + + V         + APE 
Sbjct: 151 HAQH--YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEXYRVREDGDSPVFWYAPEC 208
Query: 273 VMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRILDP 332
           +        SDV+ FGV L E LL      +S P++   L+  A+        VLR+ + 
Sbjct: 209 LKEYKFYYASDVWSFGVTLYE-LLTHCDSSQSPPTKFLELIGIAQ----GQMTVLRLTEL 263
Query: 333 RLEGQYTAR---TAMKVAGLAYQCLSQNPKGRPVMSDVVALLETVQSQ 377
              G+   R      +V  L   C       RP   +++ +L+TV  +
Sbjct: 264 LERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEK 311

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 88.6 bits (218), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 65/198 (32%), Positives = 103/198 (52%), Gaps = 22/198 (11%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVK 159
           +G+G FG V  G         Y+   VA+K +        + +LAE + + QLRHSNLV+
Sbjct: 14  IGKGEFGDVMLG--------DYRGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQ 63
Query: 160 LIGYCCEDEHRI-LVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAER 218
           L+G   E++  + +V EYM  GSL  +L  R   +L     +K +LD  + + +L G   
Sbjct: 64  LLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN- 122
Query: 219 PVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTY--GYAAPEYVMTG 276
             ++RD    N+L++ D  AK+SDFGL K+         ST+  G     + APE +   
Sbjct: 123 -FVHRDLAARNVLVSEDNVAKVSDFGLTKEAS-------STQDTGKLPVKWTAPEALREK 174
Query: 277 HLTARSDVYGFGVVLLEM 294
             + +SDV+ FG++L E+
Sbjct: 175 KFSTKSDVWSFGILLWEI 192

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 88.6 bits (218), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 65/198 (32%), Positives = 103/198 (52%), Gaps = 22/198 (11%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVK 159
           +G+G FG V  G         Y+   VA+K +        + +LAE + + QLRHSNLV+
Sbjct: 29  IGKGEFGDVMLG--------DYRGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQ 78
Query: 160 LIGYCCEDEHRI-LVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAER 218
           L+G   E++  + +V EYM  GSL  +L  R   +L     +K +LD  + + +L G   
Sbjct: 79  LLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN- 137
Query: 219 PVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTY--GYAAPEYVMTG 276
             ++RD    N+L++ D  AK+SDFGL K+         ST+  G     + APE +   
Sbjct: 138 -FVHRDLAARNVLVSEDNVAKVSDFGLTKEAS-------STQDTGKLPVKWTAPEALREK 189
Query: 277 HLTARSDVYGFGVVLLEM 294
             + +SDV+ FG++L E+
Sbjct: 190 KFSTKSDVWSFGILLWEI 207

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 88.2 bits (217), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 65/198 (32%), Positives = 103/198 (52%), Gaps = 22/198 (11%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVK 159
           +G+G FG V  G         Y+   VA+K +        + +LAE + + QLRHSNLV+
Sbjct: 201 IGKGEFGDVMLG--------DYRGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQ 250
Query: 160 LIGYCCEDEHRI-LVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAER 218
           L+G   E++  + +V EYM  GSL  +L  R   +L     +K +LD  + + +L G   
Sbjct: 251 LLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN- 309
Query: 219 PVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTY--GYAAPEYVMTG 276
             ++RD    N+L++ D  AK+SDFGL K+         ST+  G     + APE +   
Sbjct: 310 -FVHRDLAARNVLVSEDNVAKVSDFGLTKEAS-------STQDTGKLPVKWTAPEALREK 361
Query: 277 HLTARSDVYGFGVVLLEM 294
             + +SDV+ FG++L E+
Sbjct: 362 KFSTKSDVWSFGILLWEI 379

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 88.2 bits (217), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 61/196 (31%), Positives = 97/196 (49%), Gaps = 22/196 (11%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVK 159
           LG G FG V+    +       K T VA+K +  G    +  +LAE N +  L+H  LVK
Sbjct: 190 LGAGQFGEVWMATYN-------KHTKVAVKTMKPGSMSVE-AFLAEANVMKTLQHDKLVK 241
Query: 160 LIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERP 219
           L     ++   I+  E+M  GSL   L    G      + +  +   A+G+AF+   +R 
Sbjct: 242 LHAVVTKEPIYIIT-EFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE--QRN 298
Query: 220 VIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLT 279
            I+RD + +NIL++A    K++DFGLA+ G                 + APE +  G  T
Sbjct: 299 YIHRDLRAANILVSASLVCKIADFGLARVG-----------AKFPIKWTAPEAINFGSFT 347
Query: 280 ARSDVYGFGVVLLEML 295
            +SDV+ FG++L+E++
Sbjct: 348 IKSDVWSFGILLMEIV 363

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 88.2 bits (217), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 62/201 (30%), Positives = 105/201 (52%), Gaps = 12/201 (5%)
Query: 99  ILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDR-EWLAEVNYLGQLRHSNL 157
           ++G G FG V  G +     PG +   VAIK L  G  +  R ++L E + +GQ  H N+
Sbjct: 50  VIGAGEFGEVCSGRLK---LPGKRDVAVAIKTLKVGYTEKQRRDFLCEASIMGQFDHPNV 106
Query: 158 VKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAE 217
           V L G     +  ++V E+ME+G+L+   LR+     T  + + +    A G+ +L  A+
Sbjct: 107 VHLEGVVTRGKPVMIVIEFMENGALDA-FLRKHDGQFTVIQLVGMLRGIAAGMRYL--AD 163
Query: 218 RPVIYRDFKTSNILLNADFSAKLSDFGLAK---DGPMGDQTHVSTRVMGTYGYAAPEYVM 274
              ++RD    NIL+N++   K+SDFGL++   D P    T    ++     + APE + 
Sbjct: 164 MGYVHRDLAARNILVNSNLVCKVSDFGLSRVIEDDPEAVYTTTGGKI--PVRWTAPEAIQ 221
Query: 275 TGHLTARSDVYGFGVVLLEML 295
               T+ SDV+ +G+V+ E++
Sbjct: 222 YRKFTSASDVWSYGIVMWEVM 242

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 64/203 (31%), Positives = 102/203 (50%), Gaps = 14/203 (6%)
Query: 99  ILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGD-REWLAEVNYLGQLRHSNL 157
           ++G G FG VY G + +N     K    A+K LNR    G+  ++L E   +    H N+
Sbjct: 36  VIGRGHFGCVYHGTLLDN---DGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 92
Query: 158 VKLIGYCCEDE-HRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGA 216
           + L+G C   E   ++V  YM+ G L ++ +R      T    +   L  AKG+ +L  A
Sbjct: 93  LSLLGICLRSEGSPLVVLPYMKHGDL-RNFIRNETHNPTVKDLIGFGLQVAKGMKYL--A 149
Query: 217 ERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQ----THVSTRVMGTYGYAAPEY 272
            +  ++RD    N +L+  F+ K++DFGLA+D  M D+     H  T       + A E 
Sbjct: 150 SKKFVHRDLAARNCMLDEKFTVKVADFGLARD--MYDKEXXSVHNKTGAKLPVKWMALES 207
Query: 273 VMTGHLTARSDVYGFGVVLLEML 295
           + T   T +SDV+ FGV+L E++
Sbjct: 208 LQTQKFTTKSDVWSFGVLLWELM 230

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 61/198 (30%), Positives = 101/198 (51%), Gaps = 16/198 (8%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVK 159
           LG G FG V+    +       K T VA+K +  G    +  +LAE N +  L+H  LVK
Sbjct: 23  LGAGQFGEVWMATYN-------KHTKVAVKTMKPGSMSVE-AFLAEANVMKTLQHDKLVK 74
Query: 160 LIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERP 219
           L     ++   I+  E+M  GSL   L    G      + +  +   A+G+AF+   +R 
Sbjct: 75  LHAVVTKEPIYIIT-EFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE--QRN 131
Query: 220 VIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTY--GYAAPEYVMTGH 277
            I+RD + +NIL++A    K++DFGLA+   + +    + R    +   + APE +  G 
Sbjct: 132 YIHRDLRAANILVSASLVCKIADFGLAR---VIEDNEYTAREGAKFPIKWTAPEAINFGS 188
Query: 278 LTARSDVYGFGVVLLEML 295
            T +SDV+ FG++L+E++
Sbjct: 189 FTIKSDVWSFGILLMEIV 206

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 61/198 (30%), Positives = 101/198 (51%), Gaps = 16/198 (8%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVK 159
           LG G FG V+    +       K T VA+K +  G    +  +LAE N +  L+H  LVK
Sbjct: 196 LGAGQFGEVWMATYN-------KHTKVAVKTMKPGSMSVE-AFLAEANVMKTLQHDKLVK 247
Query: 160 LIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERP 219
           L     ++   I+  E+M  GSL   L    G      + +  +   A+G+AF+   +R 
Sbjct: 248 LHAVVTKEPIYIIT-EFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE--QRN 304
Query: 220 VIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTY--GYAAPEYVMTGH 277
            I+RD + +NIL++A    K++DFGLA+   + +    + R    +   + APE +  G 
Sbjct: 305 YIHRDLRAANILVSASLVCKIADFGLAR---VIEDNEYTAREGAKFPIKWTAPEAINFGS 361
Query: 278 LTARSDVYGFGVVLLEML 295
            T +SDV+ FG++L+E++
Sbjct: 362 FTIKSDVWSFGILLMEIV 379

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 75/275 (27%), Positives = 121/275 (44%), Gaps = 32/275 (11%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVK 159
           LG G FG V+ G  + N +       VAIK L + G      +L E   + +L+H  LV+
Sbjct: 17  LGNGQFGEVWMGTWNGNTK-------VAIKTL-KPGTMSPESFLEEAQIMKKLKHDKLVQ 68
Query: 160 LIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERP 219
           L     E+   I V EYM  GSL   L    G  L     + +A   A G+A++      
Sbjct: 69  LYAVVSEEPIYI-VTEYMNKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMN-- 125
Query: 220 VIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTY--GYAAPEYVMTGH 277
            I+RD +++NIL+      K++DFGLA+   + +    + R    +   + APE  + G 
Sbjct: 126 YIHRDLRSANILVGNGLICKIADFGLAR---LIEDNEXTARQGAKFPIKWTAPEAALYGR 182
Query: 278 LTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRILDPRLEGQ 337
            T +SDV+ FG++L E++   R      P               NN++VL  ++      
Sbjct: 183 FTIKSDVWSFGILLTELVTKGRV---PYPGM-------------NNREVLEQVERGYRMP 226
Query: 338 YTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLE 372
                 + +  L   C  ++P+ RP    + + LE
Sbjct: 227 CPQDCPISLHELMIHCWKKDPEERPTFEYLQSFLE 261

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 77/284 (27%), Positives = 134/284 (47%), Gaps = 36/284 (12%)
Query: 99  ILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDR-EWLAEVNYLGQLRHSNL 157
           ++G G FG V  G +     PG +   VAIK L  G  +  R ++L E + +GQ  H N+
Sbjct: 29  VIGAGEFGEVCSGRLK---LPGKRELPVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNI 85
Query: 158 VKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAE 217
           + L G   + +  ++V EYME+GSL+  L +  G   T  + + +    + G+ +L  ++
Sbjct: 86  IHLEGVVTKSKPVMIVTEYMENGSLDTFLKKNDG-QFTVIQLVGMLRGISAGMKYL--SD 142
Query: 218 RPVIYRDFKTSNILLNADFSAKLSDFGLAK---DGPMGDQTHVSTRVMGTYGYAAPEYVM 274
              ++RD    NIL+N++   K+SDFGL++   D P    T    ++     + APE + 
Sbjct: 143 MGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKI--PIRWTAPEAIA 200
Query: 275 TGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRILDPRL 334
               T+ SDV+ +G+V+ E++         RP  E             N+ V++ ++   
Sbjct: 201 FRKFTSASDVWSYGIVMWEVV-----SYGERPYWEM-----------TNQDVIKAVE--- 241
Query: 335 EGQYTARTAMKVAGLAYQ----CLSQNPKGRPVMSDVVALLETV 374
           EG Y   + M      YQ    C  +    RP   ++V +L+ +
Sbjct: 242 EG-YRLPSPMDCPAALYQLMLDCWQKERNSRPKFDEIVNMLDKL 284

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 64/203 (31%), Positives = 102/203 (50%), Gaps = 14/203 (6%)
Query: 99  ILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGD-REWLAEVNYLGQLRHSNL 157
           ++G G FG VY G + +N     K    A+K LNR    G+  ++L E   +    H N+
Sbjct: 37  VIGRGHFGCVYHGTLLDN---DGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 93
Query: 158 VKLIGYCCEDE-HRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGA 216
           + L+G C   E   ++V  YM+ G L ++ +R      T    +   L  AKG+ +L  A
Sbjct: 94  LSLLGICLRSEGSPLVVLPYMKHGDL-RNFIRNETHNPTVKDLIGFGLQVAKGMKYL--A 150
Query: 217 ERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQ----THVSTRVMGTYGYAAPEY 272
            +  ++RD    N +L+  F+ K++DFGLA+D  M D+     H  T       + A E 
Sbjct: 151 SKKFVHRDLAARNCMLDEKFTVKVADFGLARD--MYDKEYYSVHNKTGAKLPVKWMALES 208
Query: 273 VMTGHLTARSDVYGFGVVLLEML 295
           + T   T +SDV+ FGV+L E++
Sbjct: 209 LQTQKFTTKSDVWSFGVLLWELM 231

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 80/313 (25%), Positives = 147/313 (46%), Gaps = 34/313 (10%)
Query: 81  IFTYNEMKLATKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDR 140
           ++  +E ++A +       LG+G FG+VY+GV    V+   +T  VAIK +N      +R
Sbjct: 1   VYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETR-VAIKTVNEAASMRER 59
Query: 141 -EWLAEVNYLGQLRHSNLVKLIGYCCEDEHRILVYEYMESGSLEKHL--LRR------VG 191
            E+L E + + +    ++V+L+G   + +  +++ E M  G L+ +L  LR       V 
Sbjct: 60  IEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVL 119
Query: 192 CMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPM 251
              + S+ +++A + A G+A+L+  +   ++RD    N  +  DF+ K+ DFG+ +D   
Sbjct: 120 APPSLSKMIQMAGEIADGMAYLNANK--FVHRDLAARNCXVAEDFTVKIGDFGMTRDIYE 177
Query: 252 GDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHN 311
            D      + +    + +PE +  G  T  SDV+ FGVVL E+     A    +P +   
Sbjct: 178 TDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI-----ATLAEQPYQGL- 231
Query: 312 LVEWARPLLNNNKKVLRILDPRLEGQYTAR---TAMKVAGLAYQCLSQNPKGRPVMSDVV 368
                     +N++VLR +   +EG    +       +  L   C   NPK RP   +++
Sbjct: 232 ----------SNEQVLRFV---MEGGLLDKPDNCPDMLLELMRMCWQYNPKMRPSFLEII 278
Query: 369 ALLETVQSQGAEE 381
           + ++     G  E
Sbjct: 279 SSIKEEMEPGFRE 291

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 64/203 (31%), Positives = 102/203 (50%), Gaps = 14/203 (6%)
Query: 99  ILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGD-REWLAEVNYLGQLRHSNL 157
           ++G G FG VY G + +N     K    A+K LNR    G+  ++L E   +    H N+
Sbjct: 56  VIGRGHFGCVYHGTLLDN---DGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 112
Query: 158 VKLIGYCCEDE-HRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGA 216
           + L+G C   E   ++V  YM+ G L ++ +R      T    +   L  AKG+ +L  A
Sbjct: 113 LSLLGICLRSEGSPLVVLPYMKHGDL-RNFIRNETHNPTVKDLIGFGLQVAKGMKYL--A 169
Query: 217 ERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQ----THVSTRVMGTYGYAAPEY 272
            +  ++RD    N +L+  F+ K++DFGLA+D  M D+     H  T       + A E 
Sbjct: 170 SKKFVHRDLAARNCMLDEKFTVKVADFGLARD--MYDKEYYSVHNKTGAKLPVKWMALES 227
Query: 273 VMTGHLTARSDVYGFGVVLLEML 295
           + T   T +SDV+ FGV+L E++
Sbjct: 228 LQTQKFTTKSDVWSFGVLLWELM 250

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 87/288 (30%), Positives = 128/288 (44%), Gaps = 25/288 (8%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTT--FVAIKELNRG-GYQGDREWLAEVNYLGQLRHSN 156
           LGEG FG V     D    P    T   VA+K L    G Q    W  E++ L  L H +
Sbjct: 22  LGEGHFGKVSLYCYD----PTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEH 77
Query: 157 LVKLIGYCCEDEHRI---LVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFL 213
           ++K  G CCED+      LV EY+  GSL  +L R     +  ++ +  A    +G+A+L
Sbjct: 78  IIKYKG-CCEDQGEKSLQLVMEYVPLGSLRDYLPRH---SIGLAQLLLFAQQICEGMAYL 133
Query: 214 HGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTH-VSTRVMGTYGYAAPEY 272
           H      I+R+    N+LL+ D   K+ DFGLAK  P G + + V         + APE 
Sbjct: 134 HSQH--YIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPEC 191
Query: 273 VMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRILDP 332
           +        SDV+ FGV L E LL      +S P++   L+  A+        VLR+ + 
Sbjct: 192 LKEYKFYYASDVWSFGVTLYE-LLTHCDSSQSPPTKFLELIGIAQ----GQMTVLRLTEL 246
Query: 333 RLEGQYTAR---TAMKVAGLAYQCLSQNPKGRPVMSDVVALLETVQSQ 377
              G+   R      +V  L   C       RP   +++ +L+TV  +
Sbjct: 247 LERGERLPRPDKCPCEVYHLMKNCWETEASFRPTFENLIPILKTVHEK 294

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 87/288 (30%), Positives = 128/288 (44%), Gaps = 25/288 (8%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTT--FVAIKELNRG-GYQGDREWLAEVNYLGQLRHSN 156
           LGEG FG V     D    P    T   VA+K L    G Q    W  E++ L  L H +
Sbjct: 22  LGEGHFGKVSLYCYD----PTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEH 77
Query: 157 LVKLIGYCCEDE---HRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFL 213
           ++K  G CCED+      LV EY+  GSL  +L R     +  ++ +  A    +G+A+L
Sbjct: 78  IIKYKG-CCEDQGEKSLQLVMEYVPLGSLRDYLPRHS---IGLAQLLLFAQQICEGMAYL 133
Query: 214 HGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTH-VSTRVMGTYGYAAPEY 272
           H      I+R+    N+LL+ D   K+ DFGLAK  P G + + V         + APE 
Sbjct: 134 HAQH--YIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPEC 191
Query: 273 VMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRILDP 332
           +        SDV+ FGV L E LL      +S P++   L+  A+        VLR+ + 
Sbjct: 192 LKEYKFYYASDVWSFGVTLYE-LLTHCDSSQSPPTKFLELIGIAQ----GQMTVLRLTEL 246
Query: 333 RLEGQYTAR---TAMKVAGLAYQCLSQNPKGRPVMSDVVALLETVQSQ 377
              G+   R      +V  L   C       RP   +++ +L+TV  +
Sbjct: 247 LERGERLPRPDKCPCEVYHLMKNCWETEASFRPTFENLIPILKTVHEK 294

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 64/203 (31%), Positives = 102/203 (50%), Gaps = 14/203 (6%)
Query: 99  ILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGD-REWLAEVNYLGQLRHSNL 157
           ++G G FG VY G + +N     K    A+K LNR    G+  ++L E   +    H N+
Sbjct: 55  VIGRGHFGCVYHGTLLDN---DGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 111
Query: 158 VKLIGYCCEDE-HRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGA 216
           + L+G C   E   ++V  YM+ G L ++ +R      T    +   L  AKG+ +L  A
Sbjct: 112 LSLLGICLRSEGSPLVVLPYMKHGDL-RNFIRNETHNPTVKDLIGFGLQVAKGMKYL--A 168
Query: 217 ERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQ----THVSTRVMGTYGYAAPEY 272
            +  ++RD    N +L+  F+ K++DFGLA+D  M D+     H  T       + A E 
Sbjct: 169 SKKFVHRDLAARNCMLDEKFTVKVADFGLARD--MYDKEYYSVHNKTGAKLPVKWMALES 226
Query: 273 VMTGHLTARSDVYGFGVVLLEML 295
           + T   T +SDV+ FGV+L E++
Sbjct: 227 LQTQKFTTKSDVWSFGVLLWELM 249

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 108/202 (53%), Gaps = 14/202 (6%)
Query: 99  ILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGY--QGDREWLAEVNYLGQLRHSN 156
           ++G G FG V  G +     PG +   VAIK L + GY  +  R++L+E + +GQ  H N
Sbjct: 21  VIGVGEFGEVCSGRLKV---PGKREICVAIKTL-KAGYTDKQRRDFLSEASIMGQFDHPN 76
Query: 157 LVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGA 216
           ++ L G   + +  +++ EYME+GSL+  L +  G   T  + + +      G+ +L  +
Sbjct: 77  IIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDG-RFTVIQLVGMLRGIGSGMKYL--S 133
Query: 217 ERPVIYRDFKTSNILLNADFSAKLSDFGLAK---DGPMGDQTHVSTRVMGTYGYAAPEYV 273
           +   ++RD    NIL+N++   K+SDFG+++   D P    T    ++     + APE +
Sbjct: 134 DMSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKI--PIRWTAPEAI 191
Query: 274 MTGHLTARSDVYGFGVVLLEML 295
                T+ SDV+ +G+V+ E++
Sbjct: 192 AYRKFTSASDVWSYGIVMWEVM 213

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 64/203 (31%), Positives = 102/203 (50%), Gaps = 14/203 (6%)
Query: 99  ILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGD-REWLAEVNYLGQLRHSNL 157
           ++G G FG VY G + +N     K    A+K LNR    G+  ++L E   +    H N+
Sbjct: 29  VIGRGHFGCVYHGTLLDN---DGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 85
Query: 158 VKLIGYCCEDE-HRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGA 216
           + L+G C   E   ++V  YM+ G L ++ +R      T    +   L  AKG+ +L  A
Sbjct: 86  LSLLGICLRSEGSPLVVLPYMKHGDL-RNFIRNETHNPTVKDLIGFGLQVAKGMKYL--A 142
Query: 217 ERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQ----THVSTRVMGTYGYAAPEY 272
            +  ++RD    N +L+  F+ K++DFGLA+D  M D+     H  T       + A E 
Sbjct: 143 SKKFVHRDLAARNCMLDEKFTVKVADFGLARD--MYDKEYYSVHNKTGAKLPVKWMALES 200
Query: 273 VMTGHLTARSDVYGFGVVLLEML 295
           + T   T +SDV+ FGV+L E++
Sbjct: 201 LQTQKFTTKSDVWSFGVLLWELM 223

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 64/203 (31%), Positives = 102/203 (50%), Gaps = 14/203 (6%)
Query: 99  ILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGD-REWLAEVNYLGQLRHSNL 157
           ++G G FG VY G + +N     K    A+K LNR    G+  ++L E   +    H N+
Sbjct: 35  VIGRGHFGCVYHGTLLDN---DGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 91
Query: 158 VKLIGYCCEDE-HRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGA 216
           + L+G C   E   ++V  YM+ G L ++ +R      T    +   L  AKG+ +L  A
Sbjct: 92  LSLLGICLRSEGSPLVVLPYMKHGDL-RNFIRNETHNPTVKDLIGFGLQVAKGMKYL--A 148
Query: 217 ERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQ----THVSTRVMGTYGYAAPEY 272
            +  ++RD    N +L+  F+ K++DFGLA+D  M D+     H  T       + A E 
Sbjct: 149 SKKFVHRDLAARNCMLDEKFTVKVADFGLARD--MYDKEYYSVHNKTGAKLPVKWMALES 206
Query: 273 VMTGHLTARSDVYGFGVVLLEML 295
           + T   T +SDV+ FGV+L E++
Sbjct: 207 LQTQKFTTKSDVWSFGVLLWELM 229

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 64/203 (31%), Positives = 102/203 (50%), Gaps = 14/203 (6%)
Query: 99  ILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGD-REWLAEVNYLGQLRHSNL 157
           ++G G FG VY G + +N     K    A+K LNR    G+  ++L E   +    H N+
Sbjct: 36  VIGRGHFGCVYHGTLLDN---DGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 92
Query: 158 VKLIGYCCEDE-HRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGA 216
           + L+G C   E   ++V  YM+ G L ++ +R      T    +   L  AKG+ +L  A
Sbjct: 93  LSLLGICLRSEGSPLVVLPYMKHGDL-RNFIRNETHNPTVKDLIGFGLQVAKGMKYL--A 149
Query: 217 ERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQ----THVSTRVMGTYGYAAPEY 272
            +  ++RD    N +L+  F+ K++DFGLA+D  M D+     H  T       + A E 
Sbjct: 150 SKKFVHRDLAARNCMLDEKFTVKVADFGLARD--MYDKEYYSVHNKTGAKLPVKWMALES 207
Query: 273 VMTGHLTARSDVYGFGVVLLEML 295
           + T   T +SDV+ FGV+L E++
Sbjct: 208 LQTQKFTTKSDVWSFGVLLWELM 230

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 108/202 (53%), Gaps = 14/202 (6%)
Query: 99  ILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGY--QGDREWLAEVNYLGQLRHSN 156
           ++G G FG V  G +     PG +   VAIK L + GY  +  R++L+E + +GQ  H N
Sbjct: 15  VIGVGEFGEVCSGRLKV---PGKREICVAIKTL-KAGYTDKQRRDFLSEASIMGQFDHPN 70
Query: 157 LVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGA 216
           ++ L G   + +  +++ EYME+GSL+  L +  G   T  + + +      G+ +L  +
Sbjct: 71  IIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDG-RFTVIQLVGMLRGIGSGMKYL--S 127
Query: 217 ERPVIYRDFKTSNILLNADFSAKLSDFGLAK---DGPMGDQTHVSTRVMGTYGYAAPEYV 273
           +   ++RD    NIL+N++   K+SDFG+++   D P    T    ++     + APE +
Sbjct: 128 DMSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKI--PIRWTAPEAI 185
Query: 274 MTGHLTARSDVYGFGVVLLEML 295
                T+ SDV+ +G+V+ E++
Sbjct: 186 AYRKFTSASDVWSYGIVMWEVM 207

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 64/203 (31%), Positives = 102/203 (50%), Gaps = 14/203 (6%)
Query: 99  ILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGD-REWLAEVNYLGQLRHSNL 157
           ++G G FG VY G + +N     K    A+K LNR    G+  ++L E   +    H N+
Sbjct: 34  VIGRGHFGCVYHGTLLDN---DGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 90
Query: 158 VKLIGYCCEDE-HRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGA 216
           + L+G C   E   ++V  YM+ G L ++ +R      T    +   L  AKG+ +L  A
Sbjct: 91  LSLLGICLRSEGSPLVVLPYMKHGDL-RNFIRNETHNPTVKDLIGFGLQVAKGMKYL--A 147
Query: 217 ERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQ----THVSTRVMGTYGYAAPEY 272
            +  ++RD    N +L+  F+ K++DFGLA+D  M D+     H  T       + A E 
Sbjct: 148 SKKFVHRDLAARNCMLDEKFTVKVADFGLARD--MYDKEYYSVHNKTGAKLPVKWMALES 205
Query: 273 VMTGHLTARSDVYGFGVVLLEML 295
           + T   T +SDV+ FGV+L E++
Sbjct: 206 LQTQKFTTKSDVWSFGVLLWELM 228

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 64/203 (31%), Positives = 102/203 (50%), Gaps = 14/203 (6%)
Query: 99  ILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGD-REWLAEVNYLGQLRHSNL 157
           ++G G FG VY G + +N     K    A+K LNR    G+  ++L E   +    H N+
Sbjct: 37  VIGRGHFGCVYHGTLLDN---DGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 93
Query: 158 VKLIGYCCEDE-HRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGA 216
           + L+G C   E   ++V  YM+ G L ++ +R      T    +   L  AKG+ +L  A
Sbjct: 94  LSLLGICLRSEGSPLVVLPYMKHGDL-RNFIRNETHNPTVKDLIGFGLQVAKGMKYL--A 150
Query: 217 ERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQ----THVSTRVMGTYGYAAPEY 272
            +  ++RD    N +L+  F+ K++DFGLA+D  M D+     H  T       + A E 
Sbjct: 151 SKKFVHRDLAARNCMLDEKFTVKVADFGLARD--MYDKEYYSVHNKTGAKLPVKWMALES 208
Query: 273 VMTGHLTARSDVYGFGVVLLEML 295
           + T   T +SDV+ FGV+L E++
Sbjct: 209 LQTQKFTTKSDVWSFGVLLWELM 231

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 64/203 (31%), Positives = 102/203 (50%), Gaps = 14/203 (6%)
Query: 99  ILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGD-REWLAEVNYLGQLRHSNL 157
           ++G G FG VY G + +N     K    A+K LNR    G+  ++L E   +    H N+
Sbjct: 32  VIGRGHFGCVYHGTLLDN---DGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 88
Query: 158 VKLIGYCCEDE-HRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGA 216
           + L+G C   E   ++V  YM+ G L ++ +R      T    +   L  AKG+ +L  A
Sbjct: 89  LSLLGICLRSEGSPLVVLPYMKHGDL-RNFIRNETHNPTVKDLIGFGLQVAKGMKYL--A 145
Query: 217 ERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQ----THVSTRVMGTYGYAAPEY 272
            +  ++RD    N +L+  F+ K++DFGLA+D  M D+     H  T       + A E 
Sbjct: 146 SKKFVHRDLAARNCMLDEKFTVKVADFGLARD--MYDKEYYSVHNKTGAKLPVKWMALES 203
Query: 273 VMTGHLTARSDVYGFGVVLLEML 295
           + T   T +SDV+ FGV+L E++
Sbjct: 204 LQTQKFTTKSDVWSFGVLLWELM 226

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 77/285 (27%), Positives = 135/285 (47%), Gaps = 34/285 (11%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDR-EWLAEVNYLGQLRHSNLV 158
           LG+G FG+VY+G   + ++ G   T VA+K +N      +R E+L E + +      ++V
Sbjct: 25  LGQGSFGMVYEGNARDIIK-GEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 83
Query: 159 KLIGYCCEDEHRILVYEYMESGSLEKHL--LRRVG------CMLTWSRRMKIALDAAKGL 210
           +L+G   + +  ++V E M  G L+ +L  LR            T    +++A + A G+
Sbjct: 84  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 143
Query: 211 AFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAP 270
           A+L+   +  ++RD    N ++  DF+ K+ DFG+ +D           + +    + AP
Sbjct: 144 AYLNA--KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETAYYRKGGKGLLPVRWMAP 201
Query: 271 EYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRIL 330
           E +  G  T  SD++ FGVVL E+                +L E     L +N++VL+ +
Sbjct: 202 ESLKDGVFTTSSDMWSFGVVLWEIT---------------SLAEQPYQGL-SNEQVLKFV 245
Query: 331 DPRLEGQYTAR---TAMKVAGLAYQCLSQNPKGRPVMSDVVALLE 372
              ++G Y  +      +V  L   C   NPK RP   ++V LL+
Sbjct: 246 ---MDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLK 287

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 78/297 (26%), Positives = 133/297 (44%), Gaps = 60/297 (20%)
Query: 99  ILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWL----AEVNYLGQLRH 154
           I+G GGFG VY+          +    VA+K       +   + +     E      L+H
Sbjct: 14  IIGIGGFGKVYRAF--------WIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKH 65
Query: 155 SNLVKLIGYCCEDEHRILVYEYMESGSLEKHLL-RRV--GCMLTWSRRMKIALDAAKGLA 211
            N++ L G C ++ +  LV E+   G L + L  +R+    ++ W      A+  A+G+ 
Sbjct: 66  PNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGKRIPPDILVNW------AVQIARGMN 119
Query: 212 FLHG-AERPVIYRDFKTSNILL-----NADFS---AKLSDFGLAKDGPMGDQTHVSTRV- 261
           +LH  A  P+I+RD K+SNIL+     N D S    K++DFGLA+      + H +T++ 
Sbjct: 120 YLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR------EWHRTTKMS 173
Query: 262 -MGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGR---RAVDKSRPSREHNLVEWAR 317
             G Y + APE +     +  SDV+ +GV+L E+L G    R +D    +    + + A 
Sbjct: 174 AAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLAL 233
Query: 318 PLLNNNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETV 374
           P+ +   +                     A L   C + +P  RP  ++++  L T+
Sbjct: 234 PIPSTCPE-------------------PFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 76/285 (26%), Positives = 135/285 (47%), Gaps = 34/285 (11%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDR-EWLAEVNYLGQLRHSNLV 158
           LG+G FG+VY+G   + ++ G   T VA+K +N      +R E+L E + +      ++V
Sbjct: 26  LGQGSFGMVYEGNARDIIK-GEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 84
Query: 159 KLIGYCCEDEHRILVYEYMESGSLEKHL--LRRVG------CMLTWSRRMKIALDAAKGL 210
           +L+G   + +  ++V E M  G L+ +L  LR            T    +++A + A G+
Sbjct: 85  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 144
Query: 211 AFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAP 270
           A+L+   +  ++R+    N ++  DF+ K+ DFG+ +D    D      + +    + AP
Sbjct: 145 AYLNA--KKFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 202
Query: 271 EYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRIL 330
           E +  G  T  SD++ FGVVL E+                +L E     L +N++VL+ +
Sbjct: 203 ESLKDGVFTTSSDMWSFGVVLWEIT---------------SLAEQPYQGL-SNEQVLKFV 246
Query: 331 DPRLEGQYTAR---TAMKVAGLAYQCLSQNPKGRPVMSDVVALLE 372
              ++G Y  +      +V  L   C   NP  RP   ++V LL+
Sbjct: 247 ---MDGGYLDQPDNCPERVTDLMRMCWQFNPNMRPTFLEIVNLLK 288

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 76/285 (26%), Positives = 135/285 (47%), Gaps = 34/285 (11%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDR-EWLAEVNYLGQLRHSNLV 158
           LG+G FG+VY+G   + ++ G   T VA+K +N      +R E+L E + +      ++V
Sbjct: 25  LGQGSFGMVYEGNARDIIK-GEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 83
Query: 159 KLIGYCCEDEHRILVYEYMESGSLEKHL--LRRVG------CMLTWSRRMKIALDAAKGL 210
           +L+G   + +  ++V E M  G L+ +L  LR            T    +++A + A G+
Sbjct: 84  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 143
Query: 211 AFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAP 270
           A+L+   +  ++R+    N ++  DF+ K+ DFG+ +D    D      + +    + AP
Sbjct: 144 AYLNA--KKFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 201
Query: 271 EYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRIL 330
           E +  G  T  SD++ FGVVL E+                +L E     L +N++VL+ +
Sbjct: 202 ESLKDGVFTTSSDMWSFGVVLWEIT---------------SLAEQPYQGL-SNEQVLKFV 245
Query: 331 DPRLEGQYTAR---TAMKVAGLAYQCLSQNPKGRPVMSDVVALLE 372
              ++G Y  +      +V  L   C   NP  RP   ++V LL+
Sbjct: 246 ---MDGGYLDQPDNCPERVTDLMRMCWQFNPNMRPTFLEIVNLLK 287

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 84.7 bits (208), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 65/210 (30%), Positives = 101/210 (48%), Gaps = 15/210 (7%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGD-REWLAEVNYLGQLRHSNLV 158
           LGEG +G VYK +  E  +       VAIK++     + D +E + E++ + Q    ++V
Sbjct: 37  LGEGSYGSVYKAIHKETGQ------IVAIKQV---PVESDLQEIIKEISIMQQCDSPHVV 87
Query: 159 KLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAER 218
           K  G   ++    +V EY  +GS+   ++R     LT      I     KGL +LH   +
Sbjct: 88  KYYGSYFKNTDLWIVMEYCGAGSVSD-IIRLRNKTLTEDEIATILQSTLKGLEYLHFMRK 146
Query: 219 PVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHL 278
             I+RD K  NILLN +  AKL+DFG+A  G + D       V+GT  + APE +     
Sbjct: 147 --IHRDIKAGNILLNTEGHAKLADFGVA--GQLTDXMAKRNXVIGTPFWMAPEVIQEIGY 202
Query: 279 TARSDVYGFGVVLLEMLLGRRAVDKSRPSR 308
              +D++  G+  +EM  G+       P R
Sbjct: 203 NCVADIWSLGITAIEMAEGKPPYADIHPMR 232

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 75/285 (26%), Positives = 128/285 (44%), Gaps = 38/285 (13%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVK 159
           +G G FG VYKG    +V        + + +     +Q  R    EV  L + RH N++ 
Sbjct: 44  IGSGSFGTVYKGKWHGDV----AVKILKVVDPTPEQFQAFRN---EVAVLRKTRHVNILL 96
Query: 160 LIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERP 219
            +GY  +D   I V ++ E  SL KHL  +        + + IA   A+G+ +LH   + 
Sbjct: 97  FMGYMTKDNLAI-VTQWCEGSSLYKHLHVQ-ETKFQMFQLIDIARQTAQGMDYLHA--KN 152
Query: 220 VIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGH-- 277
           +I+RD K++NI L+   + K+ DFGLA        +    +  G+  + APE +      
Sbjct: 153 IIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNN 212
Query: 278 -LTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRIL-----D 331
             + +SDVY +G+VL E++ G                E     +NN  +++ ++      
Sbjct: 213 PFSFQSDVYSYGIVLYELMTG----------------ELPYSHINNRDQIIFMVGRGYAS 256
Query: 332 PRLEGQY-TARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETVQ 375
           P L   Y     AMK   L   C+ +  + RP+   +++ +E +Q
Sbjct: 257 PDLSKLYKNCPKAMK--RLVADCVKKVKEERPLFPQILSSIELLQ 299

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 88/291 (30%), Positives = 125/291 (42%), Gaps = 31/291 (10%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTT--FVAIKELNRG-GYQGDREWLAEVNYLGQLRHSN 156
           LGEG FG V     D    P    T   VA+K L  G G Q    W  E+  L  L H +
Sbjct: 17  LGEGHFGKVSLYCYD----PTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEH 72
Query: 157 LVKLIGYCCEDEHR---ILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFL 213
           +VK  G CCED+      LV EY+  GSL  +L R     +  ++ +  A    +G+A+L
Sbjct: 73  IVKYKG-CCEDQGEKSVQLVMEYVPLGSLRDYLPRHC---VGLAQLLLFAQQICEGMAYL 128
Query: 214 HGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTH-VSTRVMGTYGYAAPEY 272
           H      I+R     N+LL+ D   K+ DFGLAK  P G + + V         + APE 
Sbjct: 129 HAQH--YIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPEC 186
Query: 273 VMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNK---KVLRI 329
           +        SDV+ FGV L E+L        S  S      E    L+ + +    VLR+
Sbjct: 187 LKECKFYYASDVWSFGVTLYELL----TYCDSNQSPHTKFTE----LIGHTQGQMTVLRL 238
Query: 330 LDPRLEGQYTA---RTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETVQSQ 377
            +    G+      R   ++  L   C       RP   ++V +L+T Q +
Sbjct: 239 TELLERGERLPRPDRCPCEIYHLMKNCWETEASFRPTFQNLVPILQTAQEK 289

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 88/291 (30%), Positives = 125/291 (42%), Gaps = 31/291 (10%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTT--FVAIKELNRG-GYQGDREWLAEVNYLGQLRHSN 156
           LGEG FG V     D    P    T   VA+K L  G G Q    W  E+  L  L H +
Sbjct: 16  LGEGHFGKVSLYCYD----PTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEH 71
Query: 157 LVKLIGYCCEDEHR---ILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFL 213
           +VK  G CCED+      LV EY+  GSL  +L R     +  ++ +  A    +G+A+L
Sbjct: 72  IVKYKG-CCEDQGEKSVQLVMEYVPLGSLRDYLPRHC---VGLAQLLLFAQQICEGMAYL 127
Query: 214 HGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTH-VSTRVMGTYGYAAPEY 272
           H      I+R     N+LL+ D   K+ DFGLAK  P G + + V         + APE 
Sbjct: 128 HAQH--YIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPEC 185
Query: 273 VMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNK---KVLRI 329
           +        SDV+ FGV L E+L        S  S      E    L+ + +    VLR+
Sbjct: 186 LKECKFYYASDVWSFGVTLYELL----TYCDSNQSPHTKFTE----LIGHTQGQMTVLRL 237
Query: 330 LDPRLEGQYTA---RTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETVQSQ 377
            +    G+      R   ++  L   C       RP   ++V +L+T Q +
Sbjct: 238 TELLERGERLPRPDRCPCEIYHLMKNCWETEASFRPTFQNLVPILQTAQEK 288

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 63/202 (31%), Positives = 106/202 (52%), Gaps = 14/202 (6%)
Query: 99  ILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGY--QGDREWLAEVNYLGQLRHSN 156
           I+G G  G V  G +     PG +   VAIK L + GY  +  R++L+E + +GQ  H N
Sbjct: 56  IIGSGDSGEVCYGRLRV---PGQRDVPVAIKAL-KAGYTERQRRDFLSEASIMGQFDHPN 111
Query: 157 LVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGA 216
           +++L G        ++V EYME+GSL+   LR      T  + + +      G+ +L  +
Sbjct: 112 IIRLEGVVTRGRLAMIVTEYMENGSLDT-FLRTHDGQFTIMQLVGMLRGVGAGMRYL--S 168
Query: 217 ERPVIYRDFKTSNILLNADFSAKLSDFGLAK---DGPMGDQTHVSTRVMGTYGYAAPEYV 273
           +   ++RD    N+L++++   K+SDFGL++   D P  D  + +T       + APE +
Sbjct: 169 DLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDP--DAAYTTTGGKIPIRWTAPEAI 226
Query: 274 MTGHLTARSDVYGFGVVLLEML 295
                ++ SDV+ FGVV+ E+L
Sbjct: 227 AFRTFSSASDVWSFGVVMWEVL 248

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 56/198 (28%), Positives = 100/198 (50%), Gaps = 15/198 (7%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVK 159
           LG G FG V+ G  + + +       VA+K L + G    + +L E N +  L+H  LV+
Sbjct: 21  LGAGQFGEVWMGYYNNSTK-------VAVKTL-KPGTMSVQAFLEEANLMKTLQHDKLVR 72
Query: 160 LIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERP 219
           L      +E   ++ EYM  GSL   L    G  +   + +  +   A+G+A++    + 
Sbjct: 73  LYAVVTREEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIE--RKN 130
Query: 220 VIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTY--GYAAPEYVMTGH 277
            I+RD + +N+L++     K++DFGLA+   + +    + R    +   + APE +  G 
Sbjct: 131 YIHRDLRAANVLVSESLMCKIADFGLAR---VIEDNEYTAREGAKFPIKWTAPEAINFGC 187
Query: 278 LTARSDVYGFGVVLLEML 295
            T +SDV+ FG++L E++
Sbjct: 188 FTIKSDVWSFGILLYEIV 205

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 62/202 (30%), Positives = 105/202 (51%), Gaps = 14/202 (6%)
Query: 99  ILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGY--QGDREWLAEVNYLGQLRHSN 156
           I+G G  G V  G +     PG +   VAIK L + GY  +  R++L+E + +GQ  H N
Sbjct: 56  IIGSGDSGEVCYGRLRV---PGQRDVPVAIKAL-KAGYTERQRRDFLSEASIMGQFDHPN 111
Query: 157 LVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGA 216
           +++L G        ++V EYME+GSL+   LR      T  + + +      G+ +L  +
Sbjct: 112 IIRLEGVVTRGRLAMIVTEYMENGSLDT-FLRTHDGQFTIMQLVGMLRGVGAGMRYL--S 168
Query: 217 ERPVIYRDFKTSNILLNADFSAKLSDFGLAK---DGPMGDQTHVSTRVMGTYGYAAPEYV 273
           +   ++RD    N+L++++   K+SDFGL++   D P    T    ++     + APE +
Sbjct: 169 DLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAXTTTGGKI--PIRWTAPEAI 226
Query: 274 MTGHLTARSDVYGFGVVLLEML 295
                ++ SDV+ FGVV+ E+L
Sbjct: 227 AFRTFSSASDVWSFGVVMWEVL 248

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 66/218 (30%), Positives = 97/218 (44%), Gaps = 18/218 (8%)
Query: 86  EMKLATKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREW--- 142
           ++KL  + F    +LG+G FG V+     +         F AIK L +     D +    
Sbjct: 12  QIKLKIEDFELHKMLGKGSFGKVFLAEFKKT------NQFFAIKALKKDVVLMDDDVECT 65
Query: 143 LAEVNYLG-QLRHSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCM-LTWSRRM 200
           + E   L     H  L  +       E+   V EY+  G L  H+     C     SR  
Sbjct: 66  MVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHI---QSCHKFDLSRAT 122
Query: 201 KIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTR 260
             A +   GL FLH   + ++YRD K  NILL+ D   K++DFG+ K+  +GD    +  
Sbjct: 123 FYAAEIILGLQFLHS--KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK--TNE 178
Query: 261 VMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGR 298
             GT  Y APE ++        D + FGV+L EML+G+
Sbjct: 179 FCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQ 216

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 82.0 bits (201), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 101/213 (47%), Gaps = 19/213 (8%)
Query: 100 LGEGGFG-VVYKGVIDENVRPGYKTTFVAIKELNRGGYQGD-REWLAEVNYLGQL-RHSN 156
           LGEG FG VV    I  +     + T VA+K L     + D  + ++E+  +  + +H N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 157 LVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRR--------------MKI 202
           ++ L+G C +D    ++ EY   G+L ++L  R    L +S                +  
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEFSFNPSHNPEEQLSSKDLVSC 155
Query: 203 ALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVM 262
           A   A+G+ +L  A +  I+RD    N+L+  D   K++DFGLA+D    D    +T   
Sbjct: 156 AYQVARGMEYL--ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDXXKKTTNGR 213
Query: 263 GTYGYAAPEYVMTGHLTARSDVYGFGVVLLEML 295
               + APE +     T +SDV+ FGV+L E+ 
Sbjct: 214 LPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIF 246

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 81.6 bits (200), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 101/213 (47%), Gaps = 19/213 (8%)
Query: 100 LGEGGFG-VVYKGVIDENVRPGYKTTFVAIKELNRGGYQGD-REWLAEVNYLGQL-RHSN 156
           LGEG FG VV    I  +     + T VA+K L     + D  + ++E+  +  + +H N
Sbjct: 28  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 87
Query: 157 LVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRR--------------MKI 202
           ++ L+G C +D    ++ EY   G+L ++L  R    L +S                +  
Sbjct: 88  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 147
Query: 203 ALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVM 262
           A   A+G+ +L  A +  I+RD    N+L+  D   K++DFGLA+D    D    +T   
Sbjct: 148 AYQVARGMEYL--ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGR 205
Query: 263 GTYGYAAPEYVMTGHLTARSDVYGFGVVLLEML 295
               + APE +     T +SDV+ FGV+L E+ 
Sbjct: 206 LPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIF 238

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 81.6 bits (200), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 101/213 (47%), Gaps = 19/213 (8%)
Query: 100 LGEGGFG-VVYKGVIDENVRPGYKTTFVAIKELNRGGYQGD-REWLAEVNYLGQL-RHSN 156
           LGEG FG VV    I  +     + T VA+K L     + D  + ++E+  +  + +H N
Sbjct: 25  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 84
Query: 157 LVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRR--------------MKI 202
           ++ L+G C +D    ++ EY   G+L ++L  R    L +S                +  
Sbjct: 85  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 144
Query: 203 ALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVM 262
           A   A+G+ +L  A +  I+RD    N+L+  D   K++DFGLA+D    D    +T   
Sbjct: 145 AYQVARGMEYL--ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGR 202
Query: 263 GTYGYAAPEYVMTGHLTARSDVYGFGVVLLEML 295
               + APE +     T +SDV+ FGV+L E+ 
Sbjct: 203 LPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIF 235

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 81.6 bits (200), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 101/213 (47%), Gaps = 19/213 (8%)
Query: 100 LGEGGFG-VVYKGVIDENVRPGYKTTFVAIKELNRGGYQGD-REWLAEVNYLGQL-RHSN 156
           LGEG FG VV    I  +     + T VA+K L     + D  + ++E+  +  + +H N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 157 LVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRR--------------MKI 202
           ++ L+G C +D    ++ EY   G+L ++L  R    L +S                +  
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQAREPPGLEYSYNPSHNPEEQLSSKDLVSC 155
Query: 203 ALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVM 262
           A   A+G+ +L  A +  I+RD    N+L+  D   K++DFGLA+D    D    +T   
Sbjct: 156 AYQVARGMEYL--ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGR 213
Query: 263 GTYGYAAPEYVMTGHLTARSDVYGFGVVLLEML 295
               + APE +     T +SDV+ FGV+L E+ 
Sbjct: 214 LPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIF 246

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 81.6 bits (200), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 101/213 (47%), Gaps = 19/213 (8%)
Query: 100 LGEGGFG-VVYKGVIDENVRPGYKTTFVAIKELNRGGYQGD-REWLAEVNYLGQL-RHSN 156
           LGEG FG VV    I  +     + T VA+K L     + D  + ++E+  +  + +H N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 157 LVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRR--------------MKI 202
           ++ L+G C +D    ++ EY   G+L ++L  R    L +S                +  
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 155
Query: 203 ALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVM 262
           A   A+G+ +L  A +  I+RD    N+L+  D   K++DFGLA+D    D    +T   
Sbjct: 156 AYQVARGMEYL--ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGR 213
Query: 263 GTYGYAAPEYVMTGHLTARSDVYGFGVVLLEML 295
               + APE +     T +SDV+ FGV+L E+ 
Sbjct: 214 LPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIF 246

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 54/198 (27%), Positives = 101/198 (51%), Gaps = 15/198 (7%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVK 159
           LG G FG V+ G  + + +       VA+K L + G    + +L E N +  L+H  LV+
Sbjct: 20  LGAGQFGEVWMGYYNNSTK-------VAVKTL-KPGTMSVQAFLEEANLMKTLQHDKLVR 71
Query: 160 LIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERP 219
           L     ++E   ++ E+M  GSL   L    G  +   + +  +   A+G+A++    + 
Sbjct: 72  LYAVVTKEEPIYIITEFMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIE--RKN 129
Query: 220 VIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTY--GYAAPEYVMTGH 277
            I+RD + +N+L++     K++DFGLA+   + +    + R    +   + APE +  G 
Sbjct: 130 YIHRDLRAANVLVSESLMCKIADFGLAR---VIEDNEYTAREGAKFPIKWTAPEAINFGC 186
Query: 278 LTARSDVYGFGVVLLEML 295
            T +S+V+ FG++L E++
Sbjct: 187 FTIKSNVWSFGILLYEIV 204

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 101/213 (47%), Gaps = 19/213 (8%)
Query: 100 LGEGGFG-VVYKGVIDENVRPGYKTTFVAIKELNRGGYQGD-REWLAEVNYLGQL-RHSN 156
           LGEG FG VV    I  +     + T VA+K L     + D  + ++E+  +  + +H N
Sbjct: 29  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 88
Query: 157 LVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRR--------------MKI 202
           ++ L+G C +D    ++ EY   G+L ++L  R    L +S                +  
Sbjct: 89  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 148
Query: 203 ALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVM 262
           A   A+G+ +L  A +  I+RD    N+L+  D   K++DFGLA+D    D    +T   
Sbjct: 149 AYQVARGMEYL--ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGR 206
Query: 263 GTYGYAAPEYVMTGHLTARSDVYGFGVVLLEML 295
               + APE +     T +SDV+ FGV+L E+ 
Sbjct: 207 LPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIF 239

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 66/218 (30%), Positives = 97/218 (44%), Gaps = 18/218 (8%)
Query: 86  EMKLATKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREW--- 142
           ++KL  + F    +LG+G FG V+     +         F AIK L +     D +    
Sbjct: 11  QIKLKIEDFILHKMLGKGSFGKVFLAEFKKT------NQFFAIKALKKDVVLMDDDVECT 64
Query: 143 LAEVNYLG-QLRHSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCM-LTWSRRM 200
           + E   L     H  L  +       E+   V EY+  G L  H+     C     SR  
Sbjct: 65  MVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHI---QSCHKFDLSRAT 121
Query: 201 KIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTR 260
             A +   GL FLH   + ++YRD K  NILL+ D   K++DFG+ K+  +GD    +  
Sbjct: 122 FYAAEIILGLQFLHS--KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK--TNX 177
Query: 261 VMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGR 298
             GT  Y APE ++        D + FGV+L EML+G+
Sbjct: 178 FCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQ 215

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 101/213 (47%), Gaps = 19/213 (8%)
Query: 100 LGEGGFG-VVYKGVIDENVRPGYKTTFVAIKELNRGGYQGD-REWLAEVNYLGQL-RHSN 156
           LGEG FG VV    I  +     + T VA+K L     + D  + ++E+  +  + +H N
Sbjct: 77  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 136
Query: 157 LVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRR--------------MKI 202
           ++ L+G C +D    ++ EY   G+L ++L  R    L +S                +  
Sbjct: 137 IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 196
Query: 203 ALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVM 262
           A   A+G+ +L  A +  I+RD    N+L+  D   K++DFGLA+D    D    +T   
Sbjct: 197 AYQVARGMEYL--ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGR 254
Query: 263 GTYGYAAPEYVMTGHLTARSDVYGFGVVLLEML 295
               + APE +     T +SDV+ FGV+L E+ 
Sbjct: 255 LPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIF 287

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 75/276 (27%), Positives = 124/276 (44%), Gaps = 28/276 (10%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVK 159
           LG G FG VY+GV  +     Y  T VA+K L     + + E+L E   + +++H NLV+
Sbjct: 19  LGGGQFGEVYEGVWKK-----YSLT-VAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQ 71
Query: 160 LIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERP 219
           L+G C  +    ++ E+M  G+L  +L       ++    + +A   +  + +L   ++ 
Sbjct: 72  LLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE--KKN 129
Query: 220 VIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLT 279
            I+RD    N L+  +   K++DFGL++    GD             + APE +     +
Sbjct: 130 FIHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTXTAHAGAKFPIKWTAPESLAYNKFS 188
Query: 280 ARSDVYGFGVVLLEM-LLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRILDPRLEGQY 338
            +SDV+ FGV+L E+   G        PS+ + L+E          K  R+  P  EG  
Sbjct: 189 IKSDVWAFGVLLWEIATYGMSPYPGIDPSQVYELLE----------KDYRMERP--EG-- 234
Query: 339 TARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETV 374
                 KV  L   C   NP  RP  +++    ET+
Sbjct: 235 ---CPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 267

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 62/206 (30%), Positives = 99/206 (48%), Gaps = 22/206 (10%)
Query: 100 LGEGGFGVVYKG---VIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSN 156
           LG GG   VY     ++  N++   K  F+  +E      + +RE    V+   QL H N
Sbjct: 19  LGGGGMSTVYLAEDTIL--NIKVAIKAIFIPPREKEETLKRFERE----VHNSSQLSHQN 72
Query: 157 LVKLIGYCCEDEHRILVYEYMESGSL----EKHLLRRVGCMLTWSRRMKIALDAAKGLAF 212
           +V +I    ED+   LV EY+E  +L    E H    V   + ++ ++   LD  K    
Sbjct: 73  IVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQI---LDGIK---- 125
Query: 213 LHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEY 272
            H  +  +++RD K  NIL++++ + K+ DFG+AK       T  +  V+GT  Y +PE 
Sbjct: 126 -HAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQ-TNHVLGTVQYFSPEQ 183
Query: 273 VMTGHLTARSDVYGFGVVLLEMLLGR 298
                    +D+Y  G+VL EML+G 
Sbjct: 184 AKGEATDECTDIYSIGIVLYEMLVGE 209

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 69/271 (25%), Positives = 119/271 (43%), Gaps = 30/271 (11%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVK 159
           LG G FGVV  G      R  Y    VAIK +  G    D E++ E   +  L H  LV+
Sbjct: 32  LGTGQFGVVKYG----KWRGQYD---VAIKMIKEGSMSED-EFIEEAKVMMNLSHEKLVQ 83
Query: 160 LIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERP 219
           L G C +     ++ EYM +G L  + LR +       + +++  D  + + +L    + 
Sbjct: 84  LYGVCTKQRPIFIITEYMANGCLLNY-LREMRHRFQTQQLLEMCKDVCEAMEYLES--KQ 140
Query: 220 VIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLT 279
            ++RD    N L+N     K+SDFGL++   + D+   S        ++ PE +M    +
Sbjct: 141 FLHRDLAARNCLVNDQGVVKVSDFGLSR-YVLDDEETSSVGSKFPVRWSPPEVLMYSKFS 199
Query: 280 ARSDVYGFGVVLLEML-LGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRILDPRLEGQY 338
           ++SD++ FGV++ E+  LG+   ++   S     +           + LR+  P L  + 
Sbjct: 200 SKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHI----------AQGLRLYRPHLASE- 248
Query: 339 TARTAMKVAGLAYQCLSQNPKGRPVMSDVVA 369
                 KV  + Y C  +    RP    +++
Sbjct: 249 ------KVYTIMYSCWHEKADERPTFKILLS 273

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 101/213 (47%), Gaps = 19/213 (8%)
Query: 100 LGEGGFG-VVYKGVIDENVRPGYKTTFVAIKELNRGGYQGD-REWLAEVNYLGQL-RHSN 156
           LGEG FG VV    I  +     + T VA+K L     + D  + ++E+  +  + +H N
Sbjct: 21  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 80
Query: 157 LVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVG-----C---------MLTWSRRMKI 202
           ++ L+G C +D    ++ EY   G+L ++L  R       C          L+    +  
Sbjct: 81  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLVSC 140
Query: 203 ALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVM 262
           A   A+G+ +L  A +  I+RD    N+L+  D   K++DFGLA+D    D    +T   
Sbjct: 141 AYQVARGMEYL--ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGR 198
Query: 263 GTYGYAAPEYVMTGHLTARSDVYGFGVVLLEML 295
               + APE +     T +SDV+ FGV+L E+ 
Sbjct: 199 LPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIF 231

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 69/271 (25%), Positives = 119/271 (43%), Gaps = 30/271 (11%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVK 159
           LG G FGVV  G      R  Y    VAIK +  G    D E++ E   +  L H  LV+
Sbjct: 32  LGTGQFGVVKYG----KWRGQYD---VAIKMIKEGSMSED-EFIEEAKVMMNLSHEKLVQ 83
Query: 160 LIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERP 219
           L G C +     ++ EYM +G L  + LR +       + +++  D  + + +L    + 
Sbjct: 84  LYGVCTKQRPIFIITEYMANGCLLNY-LREMRHRFQTQQLLEMCKDVCEAMEYLES--KQ 140
Query: 220 VIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLT 279
            ++RD    N L+N     K+SDFGL++   + D+   S        ++ PE +M    +
Sbjct: 141 FLHRDLAARNCLVNDQGVVKVSDFGLSR-YVLDDEYTSSVGSKFPVRWSPPEVLMYSKFS 199
Query: 280 ARSDVYGFGVVLLEML-LGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRILDPRLEGQY 338
           ++SD++ FGV++ E+  LG+   ++   S     +           + LR+  P L  + 
Sbjct: 200 SKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHI----------AQGLRLYRPHLASE- 248
Query: 339 TARTAMKVAGLAYQCLSQNPKGRPVMSDVVA 369
                 KV  + Y C  +    RP    +++
Sbjct: 249 ------KVYTIMYSCWHEKADERPTFKILLS 273

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 69/271 (25%), Positives = 119/271 (43%), Gaps = 30/271 (11%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVK 159
           LG G FGVV  G      R  Y    VAIK +  G    D E++ E   +  L H  LV+
Sbjct: 16  LGTGQFGVVKYG----KWRGQYD---VAIKMIKEGSMSED-EFIEEAKVMMNLSHEKLVQ 67
Query: 160 LIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERP 219
           L G C +     ++ EYM +G L  + LR +       + +++  D  + + +L    + 
Sbjct: 68  LYGVCTKQRPIFIITEYMANGCLLNY-LREMRHRFQTQQLLEMCKDVCEAMEYLES--KQ 124
Query: 220 VIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLT 279
            ++RD    N L+N     K+SDFGL++   + D+   S        ++ PE +M    +
Sbjct: 125 FLHRDLAARNCLVNDQGVVKVSDFGLSR-YVLDDEYTSSVGSKFPVRWSPPEVLMYSKFS 183
Query: 280 ARSDVYGFGVVLLEML-LGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRILDPRLEGQY 338
           ++SD++ FGV++ E+  LG+   ++   S     +           + LR+  P L  + 
Sbjct: 184 SKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHI----------AQGLRLYRPHLASE- 232
Query: 339 TARTAMKVAGLAYQCLSQNPKGRPVMSDVVA 369
                 KV  + Y C  +    RP    +++
Sbjct: 233 ------KVYTIMYSCWHEKADERPTFKILLS 257

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 101/213 (47%), Gaps = 19/213 (8%)
Query: 100 LGEGGFG-VVYKGVIDENVRPGYKTTFVAIKELNRGGYQGD-REWLAEVNYLGQL-RHSN 156
           LGEG FG VV    I  +     + T VA+K L     + D  + ++E+  +  + +H N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 157 LVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVG-----C---------MLTWSRRMKI 202
           ++ L+G C +D    ++ EY   G+L ++L  R       C          L+    +  
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLVSC 155
Query: 203 ALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVM 262
           A   A+G+ +L  A +  I+RD    N+L+  D   K++DFGLA+D    D    +T   
Sbjct: 156 AYQVARGMEYL--ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGR 213
Query: 263 GTYGYAAPEYVMTGHLTARSDVYGFGVVLLEML 295
               + APE +     T +SDV+ FGV+L E+ 
Sbjct: 214 LPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIF 246

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 69/271 (25%), Positives = 119/271 (43%), Gaps = 30/271 (11%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVK 159
           LG G FGVV  G      R  Y    VAIK +  G    D E++ E   +  L H  LV+
Sbjct: 17  LGTGQFGVVKYG----KWRGQYD---VAIKMIKEGSMSED-EFIEEAKVMMNLSHEKLVQ 68
Query: 160 LIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERP 219
           L G C +     ++ EYM +G L  + LR +       + +++  D  + + +L    + 
Sbjct: 69  LYGVCTKQRPIFIITEYMANGCLLNY-LREMRHRFQTQQLLEMCKDVCEAMEYLES--KQ 125
Query: 220 VIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLT 279
            ++RD    N L+N     K+SDFGL++   + D+   S        ++ PE +M    +
Sbjct: 126 FLHRDLAARNCLVNDQGVVKVSDFGLSR-YVLDDEYTSSVGSKFPVRWSPPEVLMYSKFS 184
Query: 280 ARSDVYGFGVVLLEML-LGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRILDPRLEGQY 338
           ++SD++ FGV++ E+  LG+   ++   S     +           + LR+  P L  + 
Sbjct: 185 SKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHI----------AQGLRLYRPHLASE- 233
Query: 339 TARTAMKVAGLAYQCLSQNPKGRPVMSDVVA 369
                 KV  + Y C  +    RP    +++
Sbjct: 234 ------KVYTIMYSCWHEKADERPTFKILLS 258

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 69/271 (25%), Positives = 119/271 (43%), Gaps = 30/271 (11%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVK 159
           LG G FGVV  G      R  Y    VAIK +  G    D E++ E   +  L H  LV+
Sbjct: 23  LGTGQFGVVKYG----KWRGQYD---VAIKMIKEGSMSED-EFIEEAKVMMNLSHEKLVQ 74
Query: 160 LIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERP 219
           L G C +     ++ EYM +G L  + LR +       + +++  D  + + +L    + 
Sbjct: 75  LYGVCTKQRPIFIITEYMANGCLLNY-LREMRHRFQTQQLLEMCKDVCEAMEYLES--KQ 131
Query: 220 VIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLT 279
            ++RD    N L+N     K+SDFGL++   + D+   S        ++ PE +M    +
Sbjct: 132 FLHRDLAARNCLVNDQGVVKVSDFGLSR-YVLDDEYTSSVGSKFPVRWSPPEVLMYSKFS 190
Query: 280 ARSDVYGFGVVLLEML-LGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRILDPRLEGQY 338
           ++SD++ FGV++ E+  LG+   ++   S     +           + LR+  P L  + 
Sbjct: 191 SKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHI----------AQGLRLYRPHLASE- 239
Query: 339 TARTAMKVAGLAYQCLSQNPKGRPVMSDVVA 369
                 KV  + Y C  +    RP    +++
Sbjct: 240 ------KVYTIMYSCWHEKADERPTFKILLS 264

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 69/271 (25%), Positives = 119/271 (43%), Gaps = 30/271 (11%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVK 159
           LG G FGVV  G      R  Y    VAIK +  G    D E++ E   +  L H  LV+
Sbjct: 12  LGTGQFGVVKYG----KWRGQYD---VAIKMIKEGSMSED-EFIEEAKVMMNLSHEKLVQ 63
Query: 160 LIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERP 219
           L G C +     ++ EYM +G L  + LR +       + +++  D  + + +L    + 
Sbjct: 64  LYGVCTKQRPIFIITEYMANGCLLNY-LREMRHRFQTQQLLEMCKDVCEAMEYLES--KQ 120
Query: 220 VIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLT 279
            ++RD    N L+N     K+SDFGL++   + D+   S        ++ PE +M    +
Sbjct: 121 FLHRDLAARNCLVNDQGVVKVSDFGLSR-YVLDDEYTSSVGSKFPVRWSPPEVLMYSKFS 179
Query: 280 ARSDVYGFGVVLLEML-LGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRILDPRLEGQY 338
           ++SD++ FGV++ E+  LG+   ++   S     +           + LR+  P L  + 
Sbjct: 180 SKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHI----------AQGLRLYRPHLASE- 228
Query: 339 TARTAMKVAGLAYQCLSQNPKGRPVMSDVVA 369
                 KV  + Y C  +    RP    +++
Sbjct: 229 ------KVYTIMYSCWHEKADERPTFKILLS 253

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 74/276 (26%), Positives = 124/276 (44%), Gaps = 28/276 (10%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVK 159
           LG G +G VY+GV  +     Y  T VA+K L     + + E+L E   + +++H NLV+
Sbjct: 19  LGGGQYGEVYEGVWKK-----YSLT-VAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQ 71
Query: 160 LIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERP 219
           L+G C  +    ++ E+M  G+L  +L       ++    + +A   +  + +L   ++ 
Sbjct: 72  LLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE--KKN 129
Query: 220 VIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLT 279
            I+RD    N L+  +   K++DFGL++    GD             + APE +     +
Sbjct: 130 FIHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTXTAHAGAKFPIKWTAPESLAYNKFS 188
Query: 280 ARSDVYGFGVVLLEM-LLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRILDPRLEGQY 338
            +SDV+ FGV+L E+   G        PS+ + L+E          K  R+  P  EG  
Sbjct: 189 IKSDVWAFGVLLWEIATYGMSPYPGIDPSQVYELLE----------KDYRMERP--EG-- 234
Query: 339 TARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETV 374
                 KV  L   C   NP  RP  +++    ET+
Sbjct: 235 ---CPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 267

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 78/284 (27%), Positives = 124/284 (43%), Gaps = 36/284 (12%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDRE-WLAEVNYLGQLRHSNLV 158
           LGE  FG VYKG +     PG +T  VAIK L        RE +  E     +L+H N+V
Sbjct: 34  LGEDRFGKVYKGHL-FGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVV 92
Query: 159 KLIGYCCEDEHRILVYEYMESGSLEKHLLRR-----VGCMLTWSRRMKIALD-------- 205
            L+G   +D+   +++ Y   G L + L+ R     VG      R +K AL+        
Sbjct: 93  CLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDD-DRTVKSALEPPDFVHLV 151
Query: 206 --AAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMG 263
              A G+ +L  +   V+++D  T N+L+    + K+SD GL ++    D   +    + 
Sbjct: 152 AQIAAGMEYL--SSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLL 209
Query: 264 TYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNN 323
              + APE +M G  +  SD++ +GVVL E+      +         ++VE  R     N
Sbjct: 210 PIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVF--SYGLQPYCGYSNQDVVEMIR-----N 262
Query: 324 KKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDV 367
           ++VL   D              V  L  +C ++ P  RP   D+
Sbjct: 263 RQVLPCPD---------DCPAWVYALMIECWNEFPSRRPRFKDI 297

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 79.3 bits (194), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 78/284 (27%), Positives = 124/284 (43%), Gaps = 36/284 (12%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDRE-WLAEVNYLGQLRHSNLV 158
           LGE  FG VYKG +     PG +T  VAIK L        RE +  E     +L+H N+V
Sbjct: 17  LGEDRFGKVYKGHL-FGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVV 75
Query: 159 KLIGYCCEDEHRILVYEYMESGSLEKHLLRR-----VGCMLTWSRRMKIALD-------- 205
            L+G   +D+   +++ Y   G L + L+ R     VG      R +K AL+        
Sbjct: 76  CLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDD-DRTVKSALEPPDFVHLV 134
Query: 206 --AAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMG 263
              A G+ +L  +   V+++D  T N+L+    + K+SD GL ++    D   +    + 
Sbjct: 135 AQIAAGMEYL--SSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLL 192
Query: 264 TYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNN 323
              + APE +M G  +  SD++ +GVVL E+      +         ++VE  R     N
Sbjct: 193 PIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVF--SYGLQPYCGYSNQDVVEMIR-----N 245
Query: 324 KKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDV 367
           ++VL   D              V  L  +C ++ P  RP   D+
Sbjct: 246 RQVLPCPD---------DCPAWVYALMIECWNEFPSRRPRFKDI 280

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 70/272 (25%), Positives = 121/272 (44%), Gaps = 32/272 (11%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVK 159
           LG G FGVV  G      R  Y    VAIK +  G    D E++ E   +  L H  LV+
Sbjct: 17  LGTGQFGVVKYG----KWRGQYD---VAIKMIKEGSMSED-EFIEEAKVMMNLSHEKLVQ 68
Query: 160 LIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERP 219
           L G C +     ++ EYM +G L  + LR +       + +++  D  + + +L    + 
Sbjct: 69  LYGVCTKQRPIFIITEYMANGCLLNY-LREMRHRFQTQQLLEMCKDVCEAMEYLES--KQ 125
Query: 220 VIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTR-VMGTYGYAAPEYVMTGHL 278
            ++RD    N L+N     K+SDFGL++   + D  + S+R       ++ PE +M    
Sbjct: 126 FLHRDLAARNCLVNDQGVVKVSDFGLSR--YVLDDEYTSSRGSKFPVRWSPPEVLMYSKF 183
Query: 279 TARSDVYGFGVVLLEML-LGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRILDPRLEGQ 337
           +++SD++ FGV++ E+  LG+   ++   S     +           + LR+  P L  +
Sbjct: 184 SSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHI----------AQGLRLYRPHLASE 233
Query: 338 YTARTAMKVAGLAYQCLSQNPKGRPVMSDVVA 369
                  KV  + Y C  +    RP    +++
Sbjct: 234 -------KVYTIMYSCWHEKADERPTFKILLS 258

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 78.6 bits (192), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 74/276 (26%), Positives = 124/276 (44%), Gaps = 28/276 (10%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVK 159
           LG G +G VY+GV  +     Y  T VA+K L     + + E+L E   + +++H NLV+
Sbjct: 19  LGGGQYGEVYEGVWKK-----YSLT-VAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQ 71
Query: 160 LIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERP 219
           L+G C  +    ++ E+M  G+L  +L       ++    + +A   +  + +L   ++ 
Sbjct: 72  LLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE--KKN 129
Query: 220 VIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLT 279
            I+RD    N L+  +   K++DFGL++    GD             + APE +     +
Sbjct: 130 FIHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTFTAHAGAKFPIKWTAPESLAYNKFS 188
Query: 280 ARSDVYGFGVVLLEM-LLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRILDPRLEGQY 338
            +SDV+ FGV+L E+   G        PS+ + L+E          K  R+  P  EG  
Sbjct: 189 IKSDVWAFGVLLWEIATYGMSPYPGIDPSQVYELLE----------KDYRMERP--EG-- 234
Query: 339 TARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETV 374
                 KV  L   C   NP  RP  +++    ET+
Sbjct: 235 ---CPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 267

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 78.6 bits (192), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 65/209 (31%), Positives = 105/209 (50%), Gaps = 25/209 (11%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTT--FVAIKELNRGGYQGD-REWLAEVNYLGQLRHSN 156
           LG G +  VYKG+         KTT  +VA+KE+     +G     + E++ + +L+H N
Sbjct: 13  LGNGTYATVYKGL--------NKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHEN 64
Query: 157 LVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRV------GCMLTWSRRMKIALDAAKGL 210
           +V+L      +    LV+E+M++  L+K++  R       G  L   +  +  L   +GL
Sbjct: 65  IVRLYDVIHTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQL--LQGL 121
Query: 211 AFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAP 270
           AF H  E  +++RD K  N+L+N     KL DFGLA+   +   T  S  V  T  Y AP
Sbjct: 122 AFCH--ENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVV--TLWYRAP 177
Query: 271 EYVMTGHLTARS-DVYGFGVVLLEMLLGR 298
           + +M     + S D++  G +L EM+ G+
Sbjct: 178 DVLMGSRTYSTSIDIWSCGCILAEMITGK 206

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 78.6 bits (192), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 64/209 (30%), Positives = 100/209 (47%), Gaps = 11/209 (5%)
Query: 92  KFFRPDYILGEGGFGVVYKGVID-ENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLG 150
           +F +    LGEG FG V     D E    G +    ++K  + G +  D +   E+  L 
Sbjct: 21  RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLK--KEIEILR 78
Query: 151 QLRHSNLVKLIGYCCED--EHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAK 208
            L H N+VK  G C ED      L+ E++ SGSL+++L +     +   +++K A+   K
Sbjct: 79  NLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKN-KINLKQQLKYAVQICK 137
Query: 209 GLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAK--DGPMGDQTHVSTRVMGTYG 266
           G+ +L    R  ++RD    N+L+ ++   K+ DFGL K  +      T    R    + 
Sbjct: 138 GMDYL--GSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFW 195
Query: 267 YAAPEYVMTGHLTARSDVYGFGVVLLEML 295
           Y APE +M       SDV+ FGV L E+L
Sbjct: 196 Y-APECLMQSKFYIASDVWSFGVTLHELL 223

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 78.2 bits (191), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 66/202 (32%), Positives = 94/202 (46%), Gaps = 15/202 (7%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGY---QGDREWLAEVNYLGQLRHSN 156
           LG+G FGVV +G  D    P  KT  VA+K L        +   +++ EVN +  L H N
Sbjct: 20  LGDGSFGVVRRGEWDA---PSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRN 76
Query: 157 LVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCML--TWSRRMKIALDAAKGLAFLH 214
           L++L G       + +V E    GSL   L +  G  L  T SR    A+  A+G+ +L 
Sbjct: 77  LIRLYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSR---YAVQVAEGMGYLE 132
Query: 215 GAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGT-YGYAAPEYV 273
              +  I+RD    N+LL      K+ DFGL +  P  D  +V        + + APE +
Sbjct: 133 S--KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESL 190
Query: 274 MTGHLTARSDVYGFGVVLLEML 295
            T   +  SD + FGV L EM 
Sbjct: 191 KTRTFSHASDTWMFGVTLWEMF 212

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 63/201 (31%), Positives = 97/201 (48%), Gaps = 11/201 (5%)
Query: 100 LGEGGFGVVYKGVID-ENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLV 158
           LGEG FG V     D E    G +    ++K  + G +  D +   E+  L  L H N+V
Sbjct: 17  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLK--KEIEILRNLYHENIV 74
Query: 159 KLIGYCCED--EHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGA 216
           K  G C ED      L+ E++ SGSL+++L +     +   +++K A+   KG+ +L   
Sbjct: 75  KYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKN-KINLKQQLKYAVQICKGMDYL--G 131
Query: 217 ERPVIYRDFKTSNILLNADFSAKLSDFGLAK--DGPMGDQTHVSTRVMGTYGYAAPEYVM 274
            R  ++RD    N+L+ ++   K+ DFGL K  +      T    R    + Y APE +M
Sbjct: 132 SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWY-APECLM 190
Query: 275 TGHLTARSDVYGFGVVLLEML 295
                  SDV+ FGV L E+L
Sbjct: 191 QSKFYIASDVWSFGVTLHELL 211

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 83/298 (27%), Positives = 132/298 (44%), Gaps = 39/298 (13%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTT--FVAIKELNRGGYQGDREWLAEVNYLGQLRHSNL 157
           LG+G FG V     D    P    T   VA+K+L     +  R++  E+  L  L+H N+
Sbjct: 49  LGKGNFGSVEMCRYD----PLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 104
Query: 158 VKLIGYCCEDEHR--ILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHG 215
           VK  G C     R   L+ EY+  GSL  + L++    +   + ++      KG+ +L G
Sbjct: 105 VKYKGVCYSAGRRNLKLIMEYLPYGSLRDY-LQKHKERIDHIKLLQYTSQICKGMEYL-G 162
Query: 216 AERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGT--YGYAAPEYV 273
            +R  I+RD  T NIL+  +   K+ DFGL K  P  D+     +  G     + APE +
Sbjct: 163 TKR-YIHRDLATRNILVENENRVKIGDFGLTKVLPQ-DKEXXKVKEPGESPIFWYAPESL 220
Query: 274 MTGHLTARSDVYGFGVVLLEMLLGRRAVDKSR-PSRE-----------HNLVEWARPLLN 321
                +  SDV+ FGVVL E+      ++KS+ P  E             +V     LL 
Sbjct: 221 TESKFSVASDVWSFGVVLYELFT---YIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLK 277
Query: 322 NNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETVQSQGA 379
           NN ++     PR +G        ++  +  +C + N   RP   D+   ++ ++ Q A
Sbjct: 278 NNGRL-----PRPDG-----CPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQMA 325

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 83/298 (27%), Positives = 131/298 (43%), Gaps = 39/298 (13%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTT--FVAIKELNRGGYQGDREWLAEVNYLGQLRHSNL 157
           LG+G FG V     D    P    T   VA+K+L     +  R++  E+  L  L+H N+
Sbjct: 16  LGKGNFGSVEMCRYD----PLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 71
Query: 158 VKLIGYCCEDEHR--ILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHG 215
           VK  G C     R   L+ EY+  GSL  +L +     +   + ++      KG+ +L G
Sbjct: 72  VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKE-RIDHIKLLQYTSQICKGMEYL-G 129
Query: 216 AERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGT--YGYAAPEYV 273
            +R  I+RD  T NIL+  +   K+ DFGL K  P  D+     +  G     + APE +
Sbjct: 130 TKR-YIHRDLATRNILVENENRVKIGDFGLTKVLPQ-DKEXXKVKEPGESPIFWYAPESL 187
Query: 274 MTGHLTARSDVYGFGVVLLEMLLGRRAVDKSR-PSRE-----------HNLVEWARPLLN 321
                +  SDV+ FGVVL E+      ++KS+ P  E             +V     LL 
Sbjct: 188 TESKFSVASDVWSFGVVLYELFT---YIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLK 244
Query: 322 NNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETVQSQGA 379
           NN ++     PR +G        ++  +  +C + N   RP   D+   ++ ++ Q A
Sbjct: 245 NNGRL-----PRPDG-----CPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQMA 292

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 66/202 (32%), Positives = 94/202 (46%), Gaps = 15/202 (7%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGY---QGDREWLAEVNYLGQLRHSN 156
           LG+G FGVV +G  D    P  KT  VA+K L        +   +++ EVN +  L H N
Sbjct: 26  LGDGSFGVVRRGEWDA---PSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRN 82
Query: 157 LVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCML--TWSRRMKIALDAAKGLAFLH 214
           L++L G       + +V E    GSL   L +  G  L  T SR    A+  A+G+ +L 
Sbjct: 83  LIRLYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSR---YAVQVAEGMGYLE 138
Query: 215 GAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGT-YGYAAPEYV 273
              +  I+RD    N+LL      K+ DFGL +  P  D  +V        + + APE +
Sbjct: 139 S--KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESL 196
Query: 274 MTGHLTARSDVYGFGVVLLEML 295
            T   +  SD + FGV L EM 
Sbjct: 197 KTRTFSHASDTWMFGVTLWEMF 218

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 66/202 (32%), Positives = 101/202 (50%), Gaps = 12/202 (5%)
Query: 97  DYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGD-REWLAEVNYLGQLRHS 155
           D  LG G FG V +GV     R   K   VAIK L +G  + D  E + E   + QL + 
Sbjct: 15  DIELGCGNFGSVRQGV----YRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNP 70
Query: 156 NLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHG 215
            +V+LIG  C+ E  +LV E    G L K L+ +   +   S   ++    + G+ +L  
Sbjct: 71  YIVRLIG-VCQAEALMLVMEMAGGGPLHKFLVGKREEIPV-SNVAELLHQVSMGMKYLE- 127
Query: 216 AERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTY--GYAAPEYV 273
            E+  ++RD    N+LL     AK+SDFGL+K     D ++ + R  G +   + APE +
Sbjct: 128 -EKNFVHRDLAARNVLLVNRHYAKISDFGLSK-ALGADDSYYTARSAGKWPLKWYAPECI 185
Query: 274 MTGHLTARSDVYGFGVVLLEML 295
                ++RSDV+ +GV + E L
Sbjct: 186 NFRKFSSRSDVWSYGVTMWEAL 207

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 66/202 (32%), Positives = 94/202 (46%), Gaps = 15/202 (7%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGY---QGDREWLAEVNYLGQLRHSN 156
           LG+G FGVV +G  D    P  KT  VA+K L        +   +++ EVN +  L H N
Sbjct: 16  LGDGSFGVVRRGEWDA---PSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRN 72
Query: 157 LVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCML--TWSRRMKIALDAAKGLAFLH 214
           L++L G       + +V E    GSL   L +  G  L  T SR    A+  A+G+ +L 
Sbjct: 73  LIRLYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSR---YAVQVAEGMGYLE 128
Query: 215 GAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGT-YGYAAPEYV 273
              +  I+RD    N+LL      K+ DFGL +  P  D  +V        + + APE +
Sbjct: 129 S--KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESL 186
Query: 274 MTGHLTARSDVYGFGVVLLEML 295
            T   +  SD + FGV L EM 
Sbjct: 187 KTRTFSHASDTWMFGVTLWEMF 208

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 66/202 (32%), Positives = 94/202 (46%), Gaps = 15/202 (7%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGY---QGDREWLAEVNYLGQLRHSN 156
           LG+G FGVV +G  D    P  KT  VA+K L        +   +++ EVN +  L H N
Sbjct: 20  LGDGSFGVVRRGEWDA---PSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRN 76
Query: 157 LVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCML--TWSRRMKIALDAAKGLAFLH 214
           L++L G       + +V E    GSL   L +  G  L  T SR    A+  A+G+ +L 
Sbjct: 77  LIRLYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSR---YAVQVAEGMGYLE 132
Query: 215 GAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGT-YGYAAPEYV 273
              +  I+RD    N+LL      K+ DFGL +  P  D  +V        + + APE +
Sbjct: 133 S--KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESL 190
Query: 274 MTGHLTARSDVYGFGVVLLEML 295
            T   +  SD + FGV L EM 
Sbjct: 191 KTRTFSHASDTWMFGVTLWEMF 212

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 66/202 (32%), Positives = 94/202 (46%), Gaps = 15/202 (7%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGY---QGDREWLAEVNYLGQLRHSN 156
           LG+G FGVV +G  D    P  KT  VA+K L        +   +++ EVN +  L H N
Sbjct: 16  LGDGSFGVVRRGEWDA---PSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRN 72
Query: 157 LVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCML--TWSRRMKIALDAAKGLAFLH 214
           L++L G       + +V E    GSL   L +  G  L  T SR    A+  A+G+ +L 
Sbjct: 73  LIRLYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSR---YAVQVAEGMGYLE 128
Query: 215 GAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGT-YGYAAPEYV 273
              +  I+RD    N+LL      K+ DFGL +  P  D  +V        + + APE +
Sbjct: 129 S--KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESL 186
Query: 274 MTGHLTARSDVYGFGVVLLEML 295
            T   +  SD + FGV L EM 
Sbjct: 187 KTRTFSHASDTWMFGVTLWEMF 208

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 62/222 (27%), Positives = 98/222 (44%), Gaps = 32/222 (14%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNR---GGYQGDREWLAEVNYLGQLRHSN 156
           +GEG FG V++      + P    T VA+K L        Q D +   E   + +  + N
Sbjct: 55  IGEGAFGRVFQARA-PGLLPYEPFTMVAVKMLKEEASADMQADFQ--REAALMAEFDNPN 111
Query: 157 LVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVG----CMLTWS--------------- 197
           +VKL+G C   +   L++EYM  G L +  LR +     C L+ S               
Sbjct: 112 IVKLLGVCAVGKPMCLLFEYMAYGDLNE-FLRSMSPHTVCSLSHSDLSTRARVSSPGPPP 170
Query: 198 ----RRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGD 253
                ++ IA   A G+A+L  +ER  ++RD  T N L+  +   K++DFGL+++    D
Sbjct: 171 LSCAEQLCIARQVAAGMAYL--SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSAD 228
Query: 254 QTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEML 295
                        +  PE +     T  SDV+ +GVVL E+ 
Sbjct: 229 YYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIF 270

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 60/201 (29%), Positives = 94/201 (46%), Gaps = 10/201 (4%)
Query: 97  DYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSN 156
           D  LG G FG V KG              +   E N    +   E LAE N + QL +  
Sbjct: 374 DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKD--ELLAEANVMQQLDNPY 431
Query: 157 LVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGA 216
           +V++IG  CE E  +LV E  E G L K+L +     +     +++    + G+ +L   
Sbjct: 432 IVRMIG-ICEAESWMLVMEMAELGPLNKYLQQNR--HVKDKNIIELVHQVSMGMKYLE-- 486
Query: 217 ERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTY--GYAAPEYVM 274
           E   ++RD    N+LL     AK+SDFGL+K     D+ +   +  G +   + APE + 
Sbjct: 487 ESNFVHRDLAARNVLLVTQHYAKISDFGLSK-ALRADENYYKAQTHGKWPVKWYAPECIN 545
Query: 275 TGHLTARSDVYGFGVVLLEML 295
               +++SDV+ FGV++ E  
Sbjct: 546 YYKFSSKSDVWSFGVLMWEAF 566

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 67/207 (32%), Positives = 99/207 (47%), Gaps = 18/207 (8%)
Query: 97  DYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNR-GGYQGDREWLAEVNYLGQLRHS 155
           D ++G+G FGVVY G   E +         AIK L+R    Q    +L E   +  L H 
Sbjct: 26  DRVIGKGHFGVVYHG---EYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHP 82
Query: 156 NLVKLIGYCCEDE---HRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAF 212
           N++ LIG     E   H +L   YM  G L +  +R      T    +   L  A+G+ +
Sbjct: 83  NVLALIGIMLPPEGLPHVLL--PYMCHGDLLQ-FIRSPQRNPTVKDLISFGLQVARGMEY 139
Query: 213 LHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKD----GPMGDQTHVSTRVMGTYGYA 268
           L  AE+  ++RD    N +L+  F+ K++DFGLA+D         Q H   R+     + 
Sbjct: 140 L--AEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARL--PVKWT 195
Query: 269 APEYVMTGHLTARSDVYGFGVVLLEML 295
           A E + T   T +SDV+ FGV+L E+L
Sbjct: 196 ALESLQTYRFTTKSDVWSFGVLLWELL 222

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 60/201 (29%), Positives = 94/201 (46%), Gaps = 10/201 (4%)
Query: 97  DYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSN 156
           D  LG G FG V KG              +   E N    +   E LAE N + QL +  
Sbjct: 375 DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKD--ELLAEANVMQQLDNPY 432
Query: 157 LVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGA 216
           +V++IG  CE E  +LV E  E G L K+L +     +     +++    + G+ +L   
Sbjct: 433 IVRMIG-ICEAESWMLVMEMAELGPLNKYLQQNR--HVKDKNIIELVHQVSMGMKYLE-- 487
Query: 217 ERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTY--GYAAPEYVM 274
           E   ++RD    N+LL     AK+SDFGL+K     D+ +   +  G +   + APE + 
Sbjct: 488 ESNFVHRDLAARNVLLVTQHYAKISDFGLSK-ALRADENYYKAQTHGKWPVKWYAPECIN 546
Query: 275 TGHLTARSDVYGFGVVLLEML 295
               +++SDV+ FGV++ E  
Sbjct: 547 YYKFSSKSDVWSFGVLMWEAF 567

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 66/202 (32%), Positives = 93/202 (46%), Gaps = 15/202 (7%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGY---QGDREWLAEVNYLGQLRHSN 156
           LG+G FGVV +G  D    P  KT  VA+K L        +   +++ EVN +  L H N
Sbjct: 26  LGDGSFGVVRRGEWDA---PSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRN 82
Query: 157 LVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCML--TWSRRMKIALDAAKGLAFLH 214
           L++L G       + +V E    GSL   L +  G  L  T SR    A+  A+G+ +L 
Sbjct: 83  LIRLYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSR---YAVQVAEGMGYLE 138
Query: 215 GAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGT-YGYAAPEYV 273
              +  I+RD    N+LL      K+ DFGL +  P  D   V        + + APE +
Sbjct: 139 S--KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAPESL 196
Query: 274 MTGHLTARSDVYGFGVVLLEML 295
            T   +  SD + FGV L EM 
Sbjct: 197 KTRTFSHASDTWMFGVTLWEMF 218

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 104/214 (48%), Gaps = 21/214 (9%)
Query: 100 LGEGGFG--VVYKGVIDENVRPGYKTTFVAIKELNRGGYQGD-REWLAEVNYLGQL-RHS 155
           LGEG FG  V+ + V  +  +P    T VA+K L     + D  + ++E+  +  + +H 
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVT-VAVKMLKDDATEKDLSDLVSEMEMMKMIGKHK 101
Query: 156 NLVKLIGYCCEDEHRILVYEYMESGSLEKHL-LRRVGCM-------------LTWSRRMK 201
           N++ L+G C +D    ++ EY   G+L ++L  RR   M             +T+   + 
Sbjct: 102 NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEXSYDINRVPEEQMTFKDLVS 161
Query: 202 IALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRV 261
                A+G+ +L  A +  I+RD    N+L+  +   K++DFGLA+D    D    +T  
Sbjct: 162 CTYQLARGMEYL--ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKTTNG 219
Query: 262 MGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEML 295
                + APE +     T +SDV+ FGV++ E+ 
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIF 253

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 70/278 (25%), Positives = 121/278 (43%), Gaps = 32/278 (11%)
Query: 94  FRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGG-YQGD--REWLAEVNYLG 150
           F+   +LG+G F  VY+    E++  G +   VAIK +++   Y+    +    EV    
Sbjct: 13  FKVGNLLGKGSFAGVYRA---ESIHTGLE---VAIKMIDKKAMYKAGMVQRVQNEVKIHC 66
Query: 151 QLRHSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGL 210
           QL+H ++++L  Y  +  +  LV E   +G + ++L  RV        R         G+
Sbjct: 67  QLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEAR-HFMHQIITGM 125
Query: 211 AFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAP 270
            +LH     +++RD   SN+LL  + + K++DFGLA    M  + H +  + GT  Y +P
Sbjct: 126 LYLHS--HGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYT--LCGTPNYISP 181
Query: 271 EYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRIL 330
           E          SDV+  G +   +L+GR   D        N V  A              
Sbjct: 182 EIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLA-------------- 227
Query: 331 DPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVV 368
               + +  +  +++   L +Q L +NP  R  +S V+
Sbjct: 228 ----DYEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVL 261

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 65/202 (32%), Positives = 101/202 (50%), Gaps = 12/202 (5%)
Query: 97  DYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGD-REWLAEVNYLGQLRHS 155
           D  LG G FG V +GV     R   K   VAIK L +G  + D  E + E   + QL + 
Sbjct: 341 DIELGCGNFGSVRQGV----YRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNP 396
Query: 156 NLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHG 215
            +V+LIG  C+ E  +LV E    G L K L+ +    +  S   ++    + G+ +L  
Sbjct: 397 YIVRLIG-VCQAEALMLVMEMAGGGPLHKFLVGKRE-EIPVSNVAELLHQVSMGMKYLE- 453
Query: 216 AERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTY--GYAAPEYV 273
            E+  ++R+    N+LL     AK+SDFGL+K     D ++ + R  G +   + APE +
Sbjct: 454 -EKNFVHRNLAARNVLLVNRHYAKISDFGLSK-ALGADDSYYTARSAGKWPLKWYAPECI 511
Query: 274 MTGHLTARSDVYGFGVVLLEML 295
                ++RSDV+ +GV + E L
Sbjct: 512 NFRKFSSRSDVWSYGVTMWEAL 533

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 66/202 (32%), Positives = 93/202 (46%), Gaps = 15/202 (7%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGY---QGDREWLAEVNYLGQLRHSN 156
           LG+G FGVV +G  D    P  KT  VA+K L        +   +++ EVN +  L H N
Sbjct: 16  LGDGSFGVVRRGEWDA---PSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRN 72
Query: 157 LVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCML--TWSRRMKIALDAAKGLAFLH 214
           L++L G       + +V E    GSL   L +  G  L  T SR    A+  A+G+ +L 
Sbjct: 73  LIRLYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSR---YAVQVAEGMGYLE 128
Query: 215 GAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGT-YGYAAPEYV 273
              +  I+RD    N+LL      K+ DFGL +  P  D   V        + + APE +
Sbjct: 129 S--KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAPESL 186
Query: 274 MTGHLTARSDVYGFGVVLLEML 295
            T   +  SD + FGV L EM 
Sbjct: 187 KTRTFSHASDTWMFGVTLWEMF 208

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 94/203 (46%), Gaps = 16/203 (7%)
Query: 97  DYILGE----GGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGD--REWLAEVNYLG 150
           D +LGE    G FG V+ G +  +       T VA+K   R     D   ++L E   L 
Sbjct: 115 DLVLGEQIGRGNFGEVFSGRLRAD------NTLVAVKSC-RETLPPDLKAKFLQEARILK 167
Query: 151 QLRHSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGL 210
           Q  H N+V+LIG C + +   +V E ++ G      LR  G  L     +++  DAA G+
Sbjct: 168 QYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLT-FLRTEGARLRVKTLLQMVGDAAAGM 226
Query: 211 AFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAP 270
            +L    +  I+RD    N L+      K+SDFG++++   G              + AP
Sbjct: 227 EYLES--KCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVXAASGGLRQVPVKWTAP 284
Query: 271 EYVMTGHLTARSDVYGFGVVLLE 293
           E +  G  ++ SDV+ FG++L E
Sbjct: 285 EALNYGRYSSESDVWSFGILLWE 307

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 61/202 (30%), Positives = 94/202 (46%), Gaps = 22/202 (10%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVK 159
           LG G FG V KG              +   E N    +   E LAE N + QL +  +V+
Sbjct: 35  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKD--ELLAEANVMQQLDNPYIVR 92
Query: 160 LIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMK------IALDAAKGLAFL 213
           +IG  CE E  +LV E  E G L K+L +        +R +K      +    + G+ +L
Sbjct: 93  MIG-ICEAESWMLVMEMAELGPLNKYLQQ--------NRHVKDKNIIELVHQVSMGMKYL 143
Query: 214 HGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTY--GYAAPE 271
              E   ++RD    N+LL     AK+SDFGL+K     D+ +   +  G +   + APE
Sbjct: 144 E--ESNFVHRDLAARNVLLVTQHYAKISDFGLSK-ALRADENYYKAQTHGKWPVKWYAPE 200
Query: 272 YVMTGHLTARSDVYGFGVVLLE 293
            +     +++SDV+ FGV++ E
Sbjct: 201 CINYYKFSSKSDVWSFGVLMWE 222

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 61/202 (30%), Positives = 94/202 (46%), Gaps = 22/202 (10%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVK 159
           LG G FG V KG              +   E N    +   E LAE N + QL +  +V+
Sbjct: 35  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKD--ELLAEANVMQQLDNPYIVR 92
Query: 160 LIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMK------IALDAAKGLAFL 213
           +IG  CE E  +LV E  E G L K+L +        +R +K      +    + G+ +L
Sbjct: 93  MIG-ICEAESWMLVMEMAELGPLNKYLQQ--------NRHVKDKNIIELVHQVSMGMKYL 143
Query: 214 HGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTY--GYAAPE 271
              E   ++RD    N+LL     AK+SDFGL+K     D+ +   +  G +   + APE
Sbjct: 144 E--ESNFVHRDLAARNVLLVTQHYAKISDFGLSK-ALRADENYYKAQTHGKWPVKWYAPE 200
Query: 272 YVMTGHLTARSDVYGFGVVLLE 293
            +     +++SDV+ FGV++ E
Sbjct: 201 CINYYKFSSKSDVWSFGVLMWE 222

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 104/214 (48%), Gaps = 21/214 (9%)
Query: 100 LGEGGFG--VVYKGVIDENVRPGYKTTFVAIKELNRGGYQGD-REWLAEVNYLGQL-RHS 155
           LGEG FG  V+ + V  +  +P    T VA+K L     + D  + ++E+  +  + +H 
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVT-VAVKMLKDDATEKDLSDLVSEMEMMKMIGKHK 101
Query: 156 NLVKLIGYCCEDEHRILVYEYMESGSLEKHL-LRRVGCM-------------LTWSRRMK 201
           N++ L+G C +D    ++ EY   G+L ++L  RR   M             +T+   + 
Sbjct: 102 NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVS 161
Query: 202 IALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRV 261
                A+G+ +L  A +  I+RD    N+L+  +   K++DFGLA+D    D    +T  
Sbjct: 162 CTYQLARGMEYL--ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKTTNG 219
Query: 262 MGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEML 295
                + APE +     T +SDV+ FGV++ E+ 
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIF 253

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 61/202 (30%), Positives = 94/202 (46%), Gaps = 22/202 (10%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVK 159
           LG G FG V KG              +   E N    +   E LAE N + QL +  +V+
Sbjct: 33  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKD--ELLAEANVMQQLDNPYIVR 90
Query: 160 LIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMK------IALDAAKGLAFL 213
           +IG  CE E  +LV E  E G L K+L +        +R +K      +    + G+ +L
Sbjct: 91  MIG-ICEAESWMLVMEMAELGPLNKYLQQ--------NRHVKDKNIIELVHQVSMGMKYL 141
Query: 214 HGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTY--GYAAPE 271
              E   ++RD    N+LL     AK+SDFGL+K     D+ +   +  G +   + APE
Sbjct: 142 E--ESNFVHRDLAARNVLLVTQHYAKISDFGLSK-ALRADENYYKAQTHGKWPVKWYAPE 198
Query: 272 YVMTGHLTARSDVYGFGVVLLE 293
            +     +++SDV+ FGV++ E
Sbjct: 199 CINYYKFSSKSDVWSFGVLMWE 220

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 71/231 (30%), Positives = 112/231 (48%), Gaps = 48/231 (20%)
Query: 99  ILGEGGFGVVYKGVIDENVRPGYKTTFVAIKEL---NRGGYQGDREWLAEVNYLGQLRHS 155
           I   G FG V+K  +  +        FVA+K     ++  +Q +RE  +       ++H 
Sbjct: 22  IKARGRFGCVWKAQLMND--------FVAVKIFPLQDKQSWQSEREIFSTPG----MKHE 69
Query: 156 NLVKLI-----GYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGL 210
           NL++ I     G   E E   L+  + + GSL  +L    G ++TW+    +A   ++GL
Sbjct: 70  NLLQFIAAEKRGSNLEVE-LWLITAFHDKGSLTDYL---KGNIITWNELCHVAETMSRGL 125
Query: 211 AFLH---------GAERPVIYRDFKTSNILLNADFSAKLSDFGLA----KDGPMGDQTHV 257
           ++LH         G +  + +RDFK+ N+LL +D +A L+DFGLA       P GD TH 
Sbjct: 126 SYLHEDVPWCRGEGHKPSIAHRDFKSKNVLLKSDLTAVLADFGLAVRFEPGKPPGD-THG 184
Query: 258 STRVMGTYGYAAPEYVMTGHLT------ARSDVYGFGVVLLEMLLGRRAVD 302
               +GT  Y APE V+ G +        R D+Y  G+VL E++   +A D
Sbjct: 185 Q---VGTRRYMAPE-VLEGAINFQRDAFLRIDMYAMGLVLWELVSRCKAAD 231

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 65/201 (32%), Positives = 97/201 (48%), Gaps = 12/201 (5%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKT-TFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLV 158
           LG+G FG V     D     G  T   VA+K+L   G    R++  E+  L  L    +V
Sbjct: 18  LGKGNFGSVELCRYDPL---GDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIV 74
Query: 159 KL--IGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGA 216
           K   + Y    +   LV EY+ SG L +  L+R    L  SR +  +    KG+ +L   
Sbjct: 75  KYRGVSYGPGRQSLRLVMEYLPSGCL-RDFLQRHRARLDASRLLLYSSQICKGMEYL--G 131
Query: 217 ERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGT--YGYAAPEYVM 274
            R  ++RD    NIL+ ++   K++DFGLAK  P+ D+ +   R  G     + APE + 
Sbjct: 132 SRRCVHRDLAARNILVESEAHVKIADFGLAKLLPL-DKDYYVVREPGQSPIFWYAPESLS 190
Query: 275 TGHLTARSDVYGFGVVLLEML 295
               + +SDV+ FGVVL E+ 
Sbjct: 191 DNIFSRQSDVWSFGVVLYELF 211

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 75/296 (25%), Positives = 130/296 (43%), Gaps = 28/296 (9%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVK 159
           LG G +G VY+GV  +     Y  T VA+K L     + + E+L E   + +++H NLV+
Sbjct: 267 LGGGQYGEVYEGVWKK-----YSLT-VAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQ 319
Query: 160 LIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERP 219
           L+G C  +    ++ E+M  G+L  +L       +     + +A   +  + +L   ++ 
Sbjct: 320 LLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE--KKN 377
Query: 220 VIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLT 279
            I+R+    N L+  +   K++DFGL++    GD             + APE +     +
Sbjct: 378 FIHRNLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAPESLAYNKFS 436
Query: 280 ARSDVYGFGVVLLEM-LLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRILDPRLEGQY 338
            +SDV+ FGV+L E+   G         S+ + L+E          K  R+  P  EG  
Sbjct: 437 IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE----------KDYRMERP--EG-- 482
Query: 339 TARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETVQSQGAEEEMLQSGGGVVTLY 394
                 KV  L   C   NP  RP  +++    ET+  + +  + ++   G   LY
Sbjct: 483 ---CPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELGKENLY 535

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 94/203 (46%), Gaps = 16/203 (7%)
Query: 97  DYILGE----GGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGD--REWLAEVNYLG 150
           D +LGE    G FG V+ G +  +       T VA+K   R     D   ++L E   L 
Sbjct: 115 DLVLGEQIGRGNFGEVFSGRLRAD------NTLVAVKSC-RETLPPDLKAKFLQEARILK 167
Query: 151 QLRHSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGL 210
           Q  H N+V+LIG C + +   +V E ++ G      LR  G  L     +++  DAA G+
Sbjct: 168 QYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLT-FLRTEGARLRVKTLLQMVGDAAAGM 226
Query: 211 AFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAP 270
            +L    +  I+RD    N L+      K+SDFG++++   G              + AP
Sbjct: 227 EYLES--KCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAP 284
Query: 271 EYVMTGHLTARSDVYGFGVVLLE 293
           E +  G  ++ SDV+ FG++L E
Sbjct: 285 EALNYGRYSSESDVWSFGILLWE 307

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 61/202 (30%), Positives = 94/202 (46%), Gaps = 22/202 (10%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVK 159
           LG G FG V KG              +   E N    +   E LAE N + QL +  +V+
Sbjct: 19  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKD--ELLAEANVMQQLDNPYIVR 76
Query: 160 LIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMK------IALDAAKGLAFL 213
           +IG  CE E  +LV E  E G L K+L +        +R +K      +    + G+ +L
Sbjct: 77  MIG-ICEAESWMLVMEMAELGPLNKYLQQ--------NRHVKDKNIIELVHQVSMGMKYL 127
Query: 214 HGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTY--GYAAPE 271
              E   ++RD    N+LL     AK+SDFGL+K     D+ +   +  G +   + APE
Sbjct: 128 E--ESNFVHRDLAARNVLLVTQHYAKISDFGLSK-ALRADENYYKAQTHGKWPVKWYAPE 184
Query: 272 YVMTGHLTARSDVYGFGVVLLE 293
            +     +++SDV+ FGV++ E
Sbjct: 185 CINYYKFSSKSDVWSFGVLMWE 206

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 65/201 (32%), Positives = 97/201 (48%), Gaps = 12/201 (5%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKT-TFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLV 158
           LG+G FG V     D     G  T   VA+K+L   G    R++  E+  L  L    +V
Sbjct: 19  LGKGNFGSVELCRYDPL---GDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIV 75
Query: 159 KL--IGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGA 216
           K   + Y    +   LV EY+ SG L +  L+R    L  SR +  +    KG+ +L   
Sbjct: 76  KYRGVSYGPGRQSLRLVMEYLPSGCL-RDFLQRHRARLDASRLLLYSSQICKGMEYL--G 132
Query: 217 ERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGT--YGYAAPEYVM 274
            R  ++RD    NIL+ ++   K++DFGLAK  P+ D+ +   R  G     + APE + 
Sbjct: 133 SRRCVHRDLAARNILVESEAHVKIADFGLAKLLPL-DKDYYVVREPGQSPIFWYAPESLS 191
Query: 275 TGHLTARSDVYGFGVVLLEML 295
               + +SDV+ FGVVL E+ 
Sbjct: 192 DNIFSRQSDVWSFGVVLYELF 212

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 82/298 (27%), Positives = 130/298 (43%), Gaps = 39/298 (13%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTT--FVAIKELNRGGYQGDREWLAEVNYLGQLRHSNL 157
           LG+G FG V     D    P    T   VA+K+L     +  R++  E+  L  L+H N+
Sbjct: 18  LGKGNFGSVEMCRYD----PLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 73
Query: 158 VKLIGYCCEDEHR--ILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHG 215
           VK  G C     R   L+ EY+  GSL  +L +     +   + ++      KG+ +L G
Sbjct: 74  VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKE-RIDHIKLLQYTSQICKGMEYL-G 131
Query: 216 AERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGT--YGYAAPEYV 273
            +R  I+RD  T NIL+  +   K+ DFGL K  P  D+     +  G     + APE +
Sbjct: 132 TKR-YIHRDLATRNILVENENRVKIGDFGLTKVLPQ-DKEFFKVKEPGESPIFWYAPESL 189
Query: 274 MTGHLTARSDVYGFGVVLLEMLLGRRAVDKSR-PSRE-----------HNLVEWARPLLN 321
                +  SDV+ FGVVL E+      ++KS+ P  E             +V     LL 
Sbjct: 190 TESKFSVASDVWSFGVVLYELF---TYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLK 246
Query: 322 NNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETVQSQGA 379
           NN ++     PR +G        ++  +  +C + N   RP   D+   ++ ++   A
Sbjct: 247 NNGRL-----PRPDG-----CPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNMA 294

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 61/202 (30%), Positives = 94/202 (46%), Gaps = 22/202 (10%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVK 159
           LG G FG V KG              +   E N    +   E LAE N + QL +  +V+
Sbjct: 25  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKD--ELLAEANVMQQLDNPYIVR 82
Query: 160 LIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMK------IALDAAKGLAFL 213
           +IG  CE E  +LV E  E G L K+L +        +R +K      +    + G+ +L
Sbjct: 83  MIG-ICEAESWMLVMEMAELGPLNKYLQQ--------NRHVKDKNIIELVHQVSMGMKYL 133
Query: 214 HGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTY--GYAAPE 271
              E   ++RD    N+LL     AK+SDFGL+K     D+ +   +  G +   + APE
Sbjct: 134 E--ESNFVHRDLAARNVLLVTQHYAKISDFGLSK-ALRADENYYKAQTHGKWPVKWYAPE 190
Query: 272 YVMTGHLTARSDVYGFGVVLLE 293
            +     +++SDV+ FGV++ E
Sbjct: 191 CINYYKFSSKSDVWSFGVLMWE 212

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 68/205 (33%), Positives = 100/205 (48%), Gaps = 19/205 (9%)
Query: 99  ILGEGGFGVVY--KGVIDENVRPGYKTTFV---AIKELNRGGYQGDREWLAEVNYLGQLR 153
           +LG+G FG V+  K +   + R  Y    +    +K  +R   + +R+ L EVN      
Sbjct: 31  VLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVN------ 84
Query: 154 HSNLVKLIGYCCEDEHRI-LVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAF 212
           H  +VKL  Y  + E ++ L+ +++  G L   L + V  M T    +K  L A   LA 
Sbjct: 85  HPFIVKL-HYAFQTEGKLYLILDFLRGGDLFTRLSKEV--MFT-EEDVKFYL-AELALAL 139
Query: 213 LHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEY 272
            H     +IYRD K  NILL+ +   KL+DFGL+K+    D    +    GT  Y APE 
Sbjct: 140 DHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESI--DHEKKAYSFCGTVEYMAPEV 197
Query: 273 VMTGHLTARSDVYGFGVVLLEMLLG 297
           V     T  +D + FGV++ EML G
Sbjct: 198 VNRRGHTQSADWWSFGVLMFEMLTG 222

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 61/202 (30%), Positives = 94/202 (46%), Gaps = 22/202 (10%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVK 159
           LG G FG V KG              +   E N    +   E LAE N + QL +  +V+
Sbjct: 15  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKD--ELLAEANVMQQLDNPYIVR 72
Query: 160 LIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMK------IALDAAKGLAFL 213
           +IG  CE E  +LV E  E G L K+L +        +R +K      +    + G+ +L
Sbjct: 73  MIG-ICEAESWMLVMEMAELGPLNKYLQQ--------NRHVKDKNIIELVHQVSMGMKYL 123
Query: 214 HGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTY--GYAAPE 271
              E   ++RD    N+LL     AK+SDFGL+K     D+ +   +  G +   + APE
Sbjct: 124 E--ESNFVHRDLAARNVLLVTQHYAKISDFGLSK-ALRADENYYKAQTHGKWPVKWYAPE 180
Query: 272 YVMTGHLTARSDVYGFGVVLLE 293
            +     +++SDV+ FGV++ E
Sbjct: 181 CINYYKFSSKSDVWSFGVLMWE 202

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 82/298 (27%), Positives = 130/298 (43%), Gaps = 39/298 (13%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTT--FVAIKELNRGGYQGDREWLAEVNYLGQLRHSNL 157
           LG+G FG V     D    P    T   VA+K+L     +  R++  E+  L  L+H N+
Sbjct: 21  LGKGNFGSVEMCRYD----PLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 76
Query: 158 VKLIGYCCEDEHR--ILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHG 215
           VK  G C     R   L+ EY+  GSL  +L +     +   + ++      KG+ +L G
Sbjct: 77  VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKE-RIDHIKLLQYTSQICKGMEYL-G 134
Query: 216 AERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGT--YGYAAPEYV 273
            +R  I+RD  T NIL+  +   K+ DFGL K  P  D+     +  G     + APE +
Sbjct: 135 TKR-YIHRDLATRNILVENENRVKIGDFGLTKVLPQ-DKEXXKVKEPGESPIFWYAPESL 192
Query: 274 MTGHLTARSDVYGFGVVLLEMLLGRRAVDKSR-PSRE-----------HNLVEWARPLLN 321
                +  SDV+ FGVVL E+      ++KS+ P  E             +V     LL 
Sbjct: 193 TESKFSVASDVWSFGVVLYELFT---YIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLK 249
Query: 322 NNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETVQSQGA 379
           NN ++     PR +G        ++  +  +C + N   RP   D+   ++ ++   A
Sbjct: 250 NNGRL-----PRPDG-----CPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNMA 297

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 65/201 (32%), Positives = 97/201 (48%), Gaps = 12/201 (5%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKT-TFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLV 158
           LG+G FG V     D     G  T   VA+K+L   G    R++  E+  L  L    +V
Sbjct: 31  LGKGNFGSVELCRYDPL---GDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIV 87
Query: 159 KL--IGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGA 216
           K   + Y    +   LV EY+ SG L +  L+R    L  SR +  +    KG+ +L   
Sbjct: 88  KYRGVSYGPGRQSLRLVMEYLPSGCL-RDFLQRHRARLDASRLLLYSSQICKGMEYL--G 144
Query: 217 ERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGT--YGYAAPEYVM 274
            R  ++RD    NIL+ ++   K++DFGLAK  P+ D+ +   R  G     + APE + 
Sbjct: 145 SRRCVHRDLAARNILVESEAHVKIADFGLAKLLPL-DKDYYVVREPGQSPIFWYAPESLS 203
Query: 275 TGHLTARSDVYGFGVVLLEML 295
               + +SDV+ FGVVL E+ 
Sbjct: 204 DNIFSRQSDVWSFGVVLYELF 224

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 61/202 (30%), Positives = 94/202 (46%), Gaps = 22/202 (10%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVK 159
           LG G FG V KG              +   E N    +   E LAE N + QL +  +V+
Sbjct: 13  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKD--ELLAEANVMQQLDNPYIVR 70
Query: 160 LIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMK------IALDAAKGLAFL 213
           +IG  CE E  +LV E  E G L K+L +        +R +K      +    + G+ +L
Sbjct: 71  MIG-ICEAESWMLVMEMAELGPLNKYLQQ--------NRHVKDKNIIELVHQVSMGMKYL 121
Query: 214 HGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTY--GYAAPE 271
              E   ++RD    N+LL     AK+SDFGL+K     D+ +   +  G +   + APE
Sbjct: 122 E--ESNFVHRDLAARNVLLVTQHYAKISDFGLSK-ALRADENYYKAQTHGKWPVKWYAPE 178
Query: 272 YVMTGHLTARSDVYGFGVVLLE 293
            +     +++SDV+ FGV++ E
Sbjct: 179 CINYYKFSSKSDVWSFGVLMWE 200

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 82/298 (27%), Positives = 130/298 (43%), Gaps = 39/298 (13%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTT--FVAIKELNRGGYQGDREWLAEVNYLGQLRHSNL 157
           LG+G FG V     D    P    T   VA+K+L     +  R++  E+  L  L+H N+
Sbjct: 25  LGKGNFGSVEMCRYD----PLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 80
Query: 158 VKLIGYCCEDEHR--ILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHG 215
           VK  G C     R   L+ EY+  GSL  +L +     +   + ++      KG+ +L G
Sbjct: 81  VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKE-RIDHIKLLQYTSQICKGMEYL-G 138
Query: 216 AERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGT--YGYAAPEYV 273
            +R  I+RD  T NIL+  +   K+ DFGL K  P  D+     +  G     + APE +
Sbjct: 139 TKR-YIHRDLATRNILVENENRVKIGDFGLTKVLPQ-DKEXXKVKEPGESPIFWYAPESL 196
Query: 274 MTGHLTARSDVYGFGVVLLEMLLGRRAVDKSR-PSRE-----------HNLVEWARPLLN 321
                +  SDV+ FGVVL E+      ++KS+ P  E             +V     LL 
Sbjct: 197 TESKFSVASDVWSFGVVLYELFT---YIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLK 253
Query: 322 NNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETVQSQGA 379
           NN ++     PR +G        ++  +  +C + N   RP   D+   ++ ++   A
Sbjct: 254 NNGRL-----PRPDG-----CPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNMA 301

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 82/298 (27%), Positives = 130/298 (43%), Gaps = 39/298 (13%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTT--FVAIKELNRGGYQGDREWLAEVNYLGQLRHSNL 157
           LG+G FG V     D    P    T   VA+K+L     +  R++  E+  L  L+H N+
Sbjct: 23  LGKGNFGSVEMCRYD----PLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 78
Query: 158 VKLIGYCCEDEHR--ILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHG 215
           VK  G C     R   L+ EY+  GSL  +L +     +   + ++      KG+ +L G
Sbjct: 79  VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKE-RIDHIKLLQYTSQICKGMEYL-G 136
Query: 216 AERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGT--YGYAAPEYV 273
            +R  I+RD  T NIL+  +   K+ DFGL K  P  D+     +  G     + APE +
Sbjct: 137 TKR-YIHRDLATRNILVENENRVKIGDFGLTKVLPQ-DKEXXKVKEPGESPIFWYAPESL 194
Query: 274 MTGHLTARSDVYGFGVVLLEMLLGRRAVDKSR-PSRE-----------HNLVEWARPLLN 321
                +  SDV+ FGVVL E+      ++KS+ P  E             +V     LL 
Sbjct: 195 TESKFSVASDVWSFGVVLYELFT---YIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLK 251
Query: 322 NNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETVQSQGA 379
           NN ++     PR +G        ++  +  +C + N   RP   D+   ++ ++   A
Sbjct: 252 NNGRL-----PRPDG-----CPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNMA 299

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 82/298 (27%), Positives = 130/298 (43%), Gaps = 39/298 (13%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTT--FVAIKELNRGGYQGDREWLAEVNYLGQLRHSNL 157
           LG+G FG V     D    P    T   VA+K+L     +  R++  E+  L  L+H N+
Sbjct: 17  LGKGNFGSVEMCRYD----PLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 72
Query: 158 VKLIGYCCEDEHR--ILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHG 215
           VK  G C     R   L+ EY+  GSL  +L +     +   + ++      KG+ +L G
Sbjct: 73  VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKE-RIDHIKLLQYTSQICKGMEYL-G 130
Query: 216 AERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGT--YGYAAPEYV 273
            +R  I+RD  T NIL+  +   K+ DFGL K  P  D+     +  G     + APE +
Sbjct: 131 TKR-YIHRDLATRNILVENENRVKIGDFGLTKVLPQ-DKEXXKVKEPGESPIFWYAPESL 188
Query: 274 MTGHLTARSDVYGFGVVLLEMLLGRRAVDKSR-PSRE-----------HNLVEWARPLLN 321
                +  SDV+ FGVVL E+      ++KS+ P  E             +V     LL 
Sbjct: 189 TESKFSVASDVWSFGVVLYELFT---YIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLK 245
Query: 322 NNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETVQSQGA 379
           NN ++     PR +G        ++  +  +C + N   RP   D+   ++ ++   A
Sbjct: 246 NNGRL-----PRPDG-----CPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNMA 293

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 82/298 (27%), Positives = 130/298 (43%), Gaps = 39/298 (13%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTT--FVAIKELNRGGYQGDREWLAEVNYLGQLRHSNL 157
           LG+G FG V     D    P    T   VA+K+L     +  R++  E+  L  L+H N+
Sbjct: 18  LGKGNFGSVEMCRYD----PLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 73
Query: 158 VKLIGYCCEDEHR--ILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHG 215
           VK  G C     R   L+ EY+  GSL  +L +     +   + ++      KG+ +L G
Sbjct: 74  VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKE-RIDHIKLLQYTSQICKGMEYL-G 131
Query: 216 AERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGT--YGYAAPEYV 273
            +R  I+RD  T NIL+  +   K+ DFGL K  P  D+     +  G     + APE +
Sbjct: 132 TKR-YIHRDLATRNILVENENRVKIGDFGLTKVLPQ-DKEXXKVKEPGESPIFWYAPESL 189
Query: 274 MTGHLTARSDVYGFGVVLLEMLLGRRAVDKSR-PSRE-----------HNLVEWARPLLN 321
                +  SDV+ FGVVL E+      ++KS+ P  E             +V     LL 
Sbjct: 190 TESKFSVASDVWSFGVVLYELFT---YIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLK 246
Query: 322 NNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETVQSQGA 379
           NN ++     PR +G        ++  +  +C + N   RP   D+   ++ ++   A
Sbjct: 247 NNGRL-----PRPDG-----CPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNMA 294

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 82/298 (27%), Positives = 131/298 (43%), Gaps = 39/298 (13%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTT--FVAIKELNRGGYQGDREWLAEVNYLGQLRHSNL 157
           LG+G FG V     D    P    T   VA+K+L     +  R++  E+  L  L+H N+
Sbjct: 22  LGKGNFGSVEMCRYD----PLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 77
Query: 158 VKLIGYCCEDEHR--ILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHG 215
           VK  G C     R   L+ EY+  GSL  + L++    +   + ++      KG+ +L G
Sbjct: 78  VKYKGVCYSAGRRNLKLIMEYLPYGSLRDY-LQKHKERIDHIKLLQYTSQICKGMEYL-G 135
Query: 216 AERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGT--YGYAAPEYV 273
            +R  I+RD  T NIL+  +   K+ DFGL K  P  D+     +  G     + APE +
Sbjct: 136 TKR-YIHRDLATRNILVENENRVKIGDFGLTKVLPQ-DKEXXKVKEPGESPIFWYAPESL 193
Query: 274 MTGHLTARSDVYGFGVVLLEMLLGRRAVDKSR-PSRE-----------HNLVEWARPLLN 321
                +  SDV+ FGVVL E+      ++KS+ P  E             +V     LL 
Sbjct: 194 TESKFSVASDVWSFGVVLYELFT---YIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLK 250
Query: 322 NNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETVQSQGA 379
           NN ++     PR +G        ++  +  +C + N   RP   D+   ++ ++   A
Sbjct: 251 NNGRL-----PRPDG-----CPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNMA 298

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 75.5 bits (184), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 84/306 (27%), Positives = 134/306 (43%), Gaps = 42/306 (13%)
Query: 92  KFFRPDYILGEGGFGVVYKGVIDENVRPGYKTT--FVAIKELNRGGYQGDREWLAEVNYL 149
           KF R    LG+G FG V     D    P    T   VA+K+L     +  R++  E+  L
Sbjct: 16  KFLRQ---LGKGNFGSVEMCRYD----PLQDNTGEVVAVKKLQHSTEEHLRDFEREIEIL 68
Query: 150 GQLRHSNLVKLIGYCCEDEHR--ILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAA 207
             L+H N+VK  G C     R   L+ E++  GSL ++L +     +   + ++      
Sbjct: 69  KSLQHDNIVKYKGVCYSAGRRNLKLIMEFLPYGSLREYLQKHKE-RIDHIKLLQYTSQIC 127
Query: 208 KGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGT--Y 265
           KG+ +L G +R  I+RD  T NIL+  +   K+ DFGL K  P  D+     +  G    
Sbjct: 128 KGMEYL-GTKR-YIHRDLATRNILVENENRVKIGDFGLTKVLPQ-DKEXXKVKEPGESPI 184
Query: 266 GYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSR-PSRE-----------HNLV 313
            + APE +     +  SDV+ FGVVL E+      ++KS+ P  E             +V
Sbjct: 185 FWYAPESLTESKFSVASDVWSFGVVLYELFT---YIEKSKSPPAEFMRMIGNDKQGQMIV 241
Query: 314 EWARPLLNNNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLET 373
                LL NN ++     PR +G        ++  +  +C + N   RP   D+   ++ 
Sbjct: 242 FHLIELLKNNGRL-----PRPDG-----CPDEIYMIMTECWNNNVNQRPSFRDLALRVDQ 291
Query: 374 VQSQGA 379
           ++   A
Sbjct: 292 IRDNMA 297

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 82/298 (27%), Positives = 130/298 (43%), Gaps = 39/298 (13%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTT--FVAIKELNRGGYQGDREWLAEVNYLGQLRHSNL 157
           LG+G FG V     D    P    T   VA+K+L     +  R++  E+  L  L+H N+
Sbjct: 24  LGKGNFGSVEMCRYD----PLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 79
Query: 158 VKLIGYCCEDEHR--ILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHG 215
           VK  G C     R   L+ EY+  GSL  +L +     +   + ++      KG+ +L G
Sbjct: 80  VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKE-RIDHIKLLQYTSQICKGMEYL-G 137
Query: 216 AERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGT--YGYAAPEYV 273
            +R  I+RD  T NIL+  +   K+ DFGL K  P  D+     +  G     + APE +
Sbjct: 138 TKR-YIHRDLATRNILVENENRVKIGDFGLTKVLPQ-DKEXXKVKEPGESPIFWYAPESL 195
Query: 274 MTGHLTARSDVYGFGVVLLEMLLGRRAVDKSR-PSRE-----------HNLVEWARPLLN 321
                +  SDV+ FGVVL E+      ++KS+ P  E             +V     LL 
Sbjct: 196 TESKFSVASDVWSFGVVLYELFT---YIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLK 252
Query: 322 NNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETVQSQGA 379
           NN ++     PR +G        ++  +  +C + N   RP   D+   ++ ++   A
Sbjct: 253 NNGRL-----PRPDG-----CPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNMA 300

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 73/276 (26%), Positives = 122/276 (44%), Gaps = 28/276 (10%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVK 159
           LG G +G VY+GV  +     Y  T VA+K L     + + E+L E   + +++H NLV+
Sbjct: 22  LGGGQYGEVYEGVWKK-----YSLT-VAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQ 74
Query: 160 LIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERP 219
           L+G C  +    ++ E+M  G+L  +L       +     + +A   +  + +L   ++ 
Sbjct: 75  LLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE--KKN 132
Query: 220 VIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLT 279
            I+RD    N L+  +   K++DFGL++    GD             + APE +     +
Sbjct: 133 FIHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTXTAHAGAKFPIKWTAPESLAYNKFS 191
Query: 280 ARSDVYGFGVVLLEM-LLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRILDPRLEGQY 338
            +SDV+ FGV+L E+   G         S+ + L+E          K  R+  P  EG  
Sbjct: 192 IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE----------KDYRMERP--EG-- 237
Query: 339 TARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETV 374
                 KV  L   C   NP  RP  +++    ET+
Sbjct: 238 ---CPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 270

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 68/205 (33%), Positives = 100/205 (48%), Gaps = 19/205 (9%)
Query: 99  ILGEGGFGVVY--KGVIDENVRPGYKTTFV---AIKELNRGGYQGDREWLAEVNYLGQLR 153
           +LG+G FG V+  K +   + R  Y    +    +K  +R   + +R+ L EVN      
Sbjct: 32  VLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVN------ 85
Query: 154 HSNLVKLIGYCCEDEHRI-LVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAF 212
           H  +VKL  Y  + E ++ L+ +++  G L   L + V  M T    +K  L A   LA 
Sbjct: 86  HPFIVKL-HYAFQTEGKLYLILDFLRGGDLFTRLSKEV--MFT-EEDVKFYL-AELALAL 140
Query: 213 LHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEY 272
            H     +IYRD K  NILL+ +   KL+DFGL+K+    D    +    GT  Y APE 
Sbjct: 141 DHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESI--DHEKKAYSFCGTVEYMAPEV 198
Query: 273 VMTGHLTARSDVYGFGVVLLEMLLG 297
           V     T  +D + FGV++ EML G
Sbjct: 199 VNRRGHTQSADWWSFGVLMFEMLTG 223

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 72/276 (26%), Positives = 123/276 (44%), Gaps = 28/276 (10%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVK 159
           LG G +G VY+GV  +     Y  T VA+K L     + + E+L E   + +++H NLV+
Sbjct: 228 LGGGQYGEVYEGVWKK-----YSLT-VAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQ 280
Query: 160 LIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERP 219
           L+G C  +    ++ E+M  G+L  +L       ++    + +A   +  + +L   ++ 
Sbjct: 281 LLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE--KKN 338
Query: 220 VIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLT 279
            I+R+    N L+  +   K++DFGL++    GD             + APE +     +
Sbjct: 339 FIHRNLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAPESLAYNKFS 397
Query: 280 ARSDVYGFGVVLLEM-LLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRILDPRLEGQY 338
            +SDV+ FGV+L E+   G         S+ + L+E          K  R+  P  EG  
Sbjct: 398 IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE----------KDYRMERP--EG-- 443
Query: 339 TARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETV 374
                 KV  L   C   NP  RP  +++    ET+
Sbjct: 444 ---CPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 476

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 68/205 (33%), Positives = 100/205 (48%), Gaps = 19/205 (9%)
Query: 99  ILGEGGFGVVY--KGVIDENVRPGYKTTFV---AIKELNRGGYQGDREWLAEVNYLGQLR 153
           +LG+G FG V+  K +   + R  Y    +    +K  +R   + +R+ L EVN      
Sbjct: 31  VLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVN------ 84
Query: 154 HSNLVKLIGYCCEDEHRI-LVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAF 212
           H  +VKL  Y  + E ++ L+ +++  G L   L + V  M T    +K  L A   LA 
Sbjct: 85  HPFIVKL-HYAFQTEGKLYLILDFLRGGDLFTRLSKEV--MFT-EEDVKFYL-AELALAL 139
Query: 213 LHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEY 272
            H     +IYRD K  NILL+ +   KL+DFGL+K+    D    +    GT  Y APE 
Sbjct: 140 DHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESI--DHEKKAYSFCGTVEYMAPEV 197
Query: 273 VMTGHLTARSDVYGFGVVLLEMLLG 297
           V     T  +D + FGV++ EML G
Sbjct: 198 VNRRGHTQSADWWSFGVLMFEMLTG 222

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 78/287 (27%), Positives = 123/287 (42%), Gaps = 30/287 (10%)
Query: 99  ILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLA--EVNYLGQLRHSN 156
           ++GEG +G+V K       R       VAIK+          + +A  E+  L QLRH N
Sbjct: 32  LVGEGSYGMVMK------CRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHEN 85
Query: 157 LVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGA 216
           LV L+  C + +   LV+E+++   L+   L   G  L +    K       G+ F H  
Sbjct: 86  LVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPNG--LDYQVVQKYLFQIINGIGFCHSH 143
Query: 217 ERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTG 276
              +I+RD K  NIL++     KL DFG A+   +     V    + T  Y APE ++  
Sbjct: 144 N--IIHRDIKPENILVSQSGVVKLCDFGFAR--TLAAPGEVYDDEVATRWYRAPELLVGD 199
Query: 277 HLTARS-DVYGFGVVLLEMLLGRRAV--DKSRPSREH------NLVEWARPLLNNNKKVL 327
               ++ DV+  G ++ EM +G      D       H      NL+   + L N N    
Sbjct: 200 VKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFA 259
Query: 328 RILDPR------LEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVV 368
            +  P       LE +Y   + + V  LA +CL  +P  RP  ++++
Sbjct: 260 GVRLPEIKEREPLERRYPKLSEV-VIDLAKKCLHIDPDKRPFCAELL 305

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 73/276 (26%), Positives = 123/276 (44%), Gaps = 28/276 (10%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVK 159
           LG G +G VY+GV  +     Y  T VA+K L     + + E+L E   + +++H NLV+
Sbjct: 26  LGGGQYGEVYEGVWKK-----YSLT-VAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQ 78
Query: 160 LIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERP 219
           L+G C  +    ++ E+M  G+L  +L       ++    + +A   +  + +L   ++ 
Sbjct: 79  LLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE--KKN 136
Query: 220 VIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLT 279
            I+RD    N L+  +   K++DFGL++    GD             + APE +     +
Sbjct: 137 FIHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAPESLAYNKFS 195
Query: 280 ARSDVYGFGVVLLEM-LLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRILDPRLEGQY 338
            +SDV+ FGV+L E+   G         S+ + L+E          K  R+  P  EG  
Sbjct: 196 IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE----------KDYRMERP--EG-- 241
Query: 339 TARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETV 374
                 KV  L   C   NP  RP  +++    ET+
Sbjct: 242 ---CPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 274

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 75.1 bits (183), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 97/201 (48%), Gaps = 14/201 (6%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDR-EWLAEVNYLGQLRHSNLV 158
           LGEG +  VYKG      +       VA+KE+     +G     + EV+ L  L+H+N+V
Sbjct: 10  LGEGTYATVYKG------KSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIV 63
Query: 159 KLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAER 218
            L      ++   LV+EY++     K  L   G ++             +GLA+ H   +
Sbjct: 64  TLHDIIHTEKSLTLVFEYLDKDL--KQYLDDCGNIINMHNVKLFLFQLLRGLAYCH--RQ 119
Query: 219 PVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVM-TGH 277
            V++RD K  N+L+N     KL+DFGLA+   +  +T+ +  V  T  Y  P+ ++ +  
Sbjct: 120 KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVV--TLWYRPPDILLGSTD 177
Query: 278 LTARSDVYGFGVVLLEMLLGR 298
            + + D++G G +  EM  GR
Sbjct: 178 YSTQIDMWGVGCIFYEMATGR 198

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 75.1 bits (183), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 82/298 (27%), Positives = 130/298 (43%), Gaps = 39/298 (13%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTT--FVAIKELNRGGYQGDREWLAEVNYLGQLRHSNL 157
           LG+G FG V     D    P    T   VA+K+L     +  R++  E+  L  L+H N+
Sbjct: 18  LGKGNFGSVEMCRYD----PLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 73
Query: 158 VKLIGYCCEDEHR--ILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHG 215
           VK  G C     R   L+ EY+  GSL  +L +     +   + ++      KG+ +L G
Sbjct: 74  VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKE-RIDHIKLLQYTSQICKGMEYL-G 131
Query: 216 AERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGT--YGYAAPEYV 273
            +R  I+RD  T NIL+  +   K+ DFGL K  P  D+     +  G     + APE +
Sbjct: 132 TKR-YIHRDLATRNILVENENRVKIGDFGLTKVLPQ-DKEXXKVKEPGESPIFWYAPESL 189
Query: 274 MTGHLTARSDVYGFGVVLLEMLLGRRAVDKSR-PSRE-----------HNLVEWARPLLN 321
                +  SDV+ FGVVL E+      ++KS+ P  E             +V     LL 
Sbjct: 190 TESKFSVASDVWSFGVVLYELFT---YIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLK 246
Query: 322 NNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETVQSQGA 379
           NN ++     PR +G        ++  +  +C + N   RP   D+   ++ ++   A
Sbjct: 247 NNGRL-----PRPDG-----CPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNMA 294

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 75.1 bits (183), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 82/300 (27%), Positives = 132/300 (44%), Gaps = 39/300 (13%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTT--FVAIKELNRGGYQGDREWLAEVNYLGQLRHSNL 157
           LG+G FG V     D    P    T   VA+K+L     +  R++  E+  L  L+H N+
Sbjct: 19  LGKGNFGSVEMCRYD----PLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 74
Query: 158 VKLIGYCCEDEHR--ILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHG 215
           VK  G C     R   L+ EY+  GSL  +L +     +   + ++      KG+ +L G
Sbjct: 75  VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKE-RIDHIKLLQYTSQICKGMEYL-G 132
Query: 216 AERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGT--YGYAAPEYV 273
            +R  I+R+  T NIL+  +   K+ DFGL K  P  D+ +   +  G     + APE +
Sbjct: 133 TKR-YIHRNLATRNILVENENRVKIGDFGLTKVLPQ-DKEYYKVKEPGESPIFWYAPESL 190
Query: 274 MTGHLTARSDVYGFGVVLLEMLLGRRAVDKSR-PSRE-----------HNLVEWARPLLN 321
                +  SDV+ FGVVL E+      ++KS+ P  E             +V     LL 
Sbjct: 191 TESKFSVASDVWSFGVVLYELFT---YIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLK 247
Query: 322 NNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETVQSQGAEE 381
           NN ++     PR +G        ++  +  +C + N   RP   D+   ++ ++   A E
Sbjct: 248 NNGRL-----PRPDG-----CPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNMAGE 297

>pdb|3IOK|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 74.7 bits (182), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 82/298 (27%), Positives = 130/298 (43%), Gaps = 39/298 (13%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTT--FVAIKELNRGGYQGDREWLAEVNYLGQLRHSNL 157
           LG+G FG V     D    P    T   VA+K+L     +  R++  E+  L  L+H N+
Sbjct: 36  LGKGNFGSVEMCRYD----PLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 91
Query: 158 VKLIGYCCEDEHR--ILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHG 215
           VK  G C     R   L+ EY+  GSL  +L +     +   + ++      KG+ +L G
Sbjct: 92  VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKE-RIDHIKLLQYTSQICKGMEYL-G 149
Query: 216 AERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGT--YGYAAPEYV 273
            +R  I+RD  T NIL+  +   K+ DFGL K  P  D+     +  G     + APE +
Sbjct: 150 TKR-YIHRDLATRNILVENENRVKIGDFGLTKVLPQ-DKEXXKVKEPGESPIFWYAPESL 207
Query: 274 MTGHLTARSDVYGFGVVLLEMLLGRRAVDKSR-PSRE-----------HNLVEWARPLLN 321
                +  SDV+ FGVVL E+      ++KS+ P  E             +V     LL 
Sbjct: 208 TESKFSVASDVWSFGVVLYELF---TYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLK 264
Query: 322 NNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETVQSQGA 379
           NN ++     PR +G        ++  +  +C + N   RP   D+   ++ ++   A
Sbjct: 265 NNGRL-----PRPDG-----CPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNMA 312

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 74.7 bits (182), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 73/276 (26%), Positives = 123/276 (44%), Gaps = 28/276 (10%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVK 159
           LG G +G VY+GV  +     Y  T VA+K L     + + E+L E   + +++H NLV+
Sbjct: 21  LGGGQYGEVYEGVWKK-----YSLT-VAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQ 73
Query: 160 LIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERP 219
           L+G C  +    ++ E+M  G+L  +L       ++    + +A   +  + +L   ++ 
Sbjct: 74  LLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE--KKN 131
Query: 220 VIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLT 279
            I+RD    N L+  +   K++DFGL++    GD             + APE +     +
Sbjct: 132 FIHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAPESLAYNKFS 190
Query: 280 ARSDVYGFGVVLLEM-LLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRILDPRLEGQY 338
            +SDV+ FGV+L E+   G         S+ + L+E          K  R+  P  EG  
Sbjct: 191 IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE----------KDYRMERP--EG-- 236
Query: 339 TARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETV 374
                 KV  L   C   NP  RP  +++    ET+
Sbjct: 237 ---CPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 269

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 74.7 bits (182), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 104/214 (48%), Gaps = 21/214 (9%)
Query: 100 LGEGGFG--VVYKGVIDENVRPGYKTTFVAIKELNRGGYQGD-REWLAEVNYLGQL-RHS 155
           LGEG FG  V+ + V  +  +P    T VA+K L     + D  + ++E+  +  + +H 
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVT-VAVKMLKDDATEKDLSDLVSEMEMMKMIGKHK 101
Query: 156 NLVKLIGYCCEDEHRILVYEYMESGSLEKHL-LRRVGCM-------------LTWSRRMK 201
           N++ L+G C +D    ++ EY   G+L ++L  RR   M             +T+   + 
Sbjct: 102 NIITLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVS 161
Query: 202 IALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRV 261
                A+G+ +L  A +  I+RD    N+L+  +   K++DFGLA+D    D    +T  
Sbjct: 162 CTYQLARGMEYL--ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219
Query: 262 MGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEML 295
                + APE +     T +SDV+ FGV++ E+ 
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIF 253

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 74.7 bits (182), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 104/214 (48%), Gaps = 21/214 (9%)
Query: 100 LGEGGFG--VVYKGVIDENVRPGYKTTFVAIKELNRGGYQGD-REWLAEVNYLGQL-RHS 155
           LGEG FG  V+ + V  +  +P    T VA+K L     + D  + ++E+  +  + +H 
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVT-VAVKMLKDDATEKDLSDLVSEMEMMKMIGKHK 101
Query: 156 NLVKLIGYCCEDEHRILVYEYMESGSLEKHL-LRRVGCM-------------LTWSRRMK 201
           N++ L+G C +D    ++ EY   G+L ++L  RR   M             +T+   + 
Sbjct: 102 NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVS 161
Query: 202 IALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRV 261
                A+G+ +L  A +  I+RD    N+L+  +   K++DFGLA+D    D    +T  
Sbjct: 162 CTYQLARGMEYL--ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKNTTNG 219
Query: 262 MGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEML 295
                + APE +     T +SDV+ FGV++ E+ 
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIF 253

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 74.7 bits (182), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 104/214 (48%), Gaps = 21/214 (9%)
Query: 100 LGEGGFG--VVYKGVIDENVRPGYKTTFVAIKELNRGGYQGD-REWLAEVNYLGQL-RHS 155
           LGEG FG  V+ + V  +  +P    T VA+K L     + D  + ++E+  +  + +H 
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVT-VAVKMLKDDATEKDLSDLVSEMEMMKMIGKHK 101
Query: 156 NLVKLIGYCCEDEHRILVYEYMESGSLEKHL-LRRVGCM-------------LTWSRRMK 201
           N++ L+G C +D    ++ EY   G+L ++L  RR   M             +T+   + 
Sbjct: 102 NIIHLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVS 161
Query: 202 IALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRV 261
                A+G+ +L  A +  I+RD    N+L+  +   K++DFGLA+D    D    +T  
Sbjct: 162 CTYQLARGMEYL--ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219
Query: 262 MGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEML 295
                + APE +     T +SDV+ FGV++ E+ 
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIF 253

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 73/276 (26%), Positives = 123/276 (44%), Gaps = 28/276 (10%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVK 159
           LG G +G VY+GV  +     Y  T VA+K L     + + E+L E   + +++H NLV+
Sbjct: 21  LGGGQYGEVYEGVWKK-----YSLT-VAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQ 73
Query: 160 LIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERP 219
           L+G C  +    ++ E+M  G+L  +L       ++    + +A   +  + +L   ++ 
Sbjct: 74  LLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE--KKN 131
Query: 220 VIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLT 279
            I+RD    N L+  +   K++DFGL++    GD             + APE +     +
Sbjct: 132 FIHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAPESLAYNKFS 190
Query: 280 ARSDVYGFGVVLLEM-LLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRILDPRLEGQY 338
            +SDV+ FGV+L E+   G         S+ + L+E          K  R+  P  EG  
Sbjct: 191 IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE----------KDYRMERP--EG-- 236
Query: 339 TARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETV 374
                 KV  L   C   NP  RP  +++    ET+
Sbjct: 237 ---CPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 269

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 73/276 (26%), Positives = 122/276 (44%), Gaps = 28/276 (10%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVK 159
           LG G +G VY+GV  +     Y  T VA+K L     + + E+L E   + +++H NLV+
Sbjct: 26  LGGGQYGEVYEGVWKK-----YSLT-VAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQ 78
Query: 160 LIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERP 219
           L+G C  +    ++ E+M  G+L  +L       +     + +A   +  + +L   ++ 
Sbjct: 79  LLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE--KKN 136
Query: 220 VIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLT 279
            I+RD    N L+  +   K++DFGL++    GD             + APE +     +
Sbjct: 137 FIHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTXTAHAGAKFPIKWTAPESLAYNKFS 195
Query: 280 ARSDVYGFGVVLLEM-LLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRILDPRLEGQY 338
            +SDV+ FGV+L E+   G         S+ + L+E          K  R+  P  EG  
Sbjct: 196 IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE----------KDYRMERP--EG-- 241
Query: 339 TARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETV 374
                 KV  L   C   NP  RP  +++    ET+
Sbjct: 242 ---CPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 274

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 66/271 (24%), Positives = 119/271 (43%), Gaps = 29/271 (10%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELN--RGGYQGDREWLAEVNYLGQLRHSNL 157
           +GEG FG   K ++ ++   G +     IKE+N  R   +   E   EV  L  ++H N+
Sbjct: 32  IGEGSFG---KAILVKSTEDGRQYV---IKEINISRMSSKEREESRREVAVLANMKHPNI 85
Query: 158 VKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAE 217
           V+      E+    +V +Y E G L K +  + G +    + +   +     LA  H  +
Sbjct: 86  VQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQIC--LALKHVHD 143
Query: 218 RPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGH 277
           R +++RD K+ NI L  D + +L DFG+A+   +     ++   +GT  Y +PE      
Sbjct: 144 RKILHRDIKSQNIFLTKDGTVQLGDFGIAR--VLNSTVELARACIGTPYYLSPEICENKP 201
Query: 278 LTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRILDPRLEGQ 337
              +SD++  G VL E+   + A +             A  + N   K++    P +   
Sbjct: 202 YNNKSDIWALGCVLYELCTLKHAFE-------------AGSMKNLVLKIISGSFPPVSLH 248
Query: 338 YTARTAMKVAGLAYQCLSQNPKGRPVMSDVV 368
           Y+      +  L  Q   +NP+ RP ++ ++
Sbjct: 249 YS----YDLRSLVSQLFKRNPRDRPSVNSIL 275

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 73/276 (26%), Positives = 123/276 (44%), Gaps = 28/276 (10%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVK 159
           LG G +G VY+GV  +     Y  T VA+K L     + + E+L E   + +++H NLV+
Sbjct: 21  LGGGQYGEVYEGVWKK-----YSLT-VAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQ 73
Query: 160 LIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERP 219
           L+G C  +    ++ E+M  G+L  +L       ++    + +A   +  + +L   ++ 
Sbjct: 74  LLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE--KKN 131
Query: 220 VIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLT 279
            I+RD    N L+  +   K++DFGL++    GD             + APE +     +
Sbjct: 132 FIHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAPESLAYNKFS 190
Query: 280 ARSDVYGFGVVLLEM-LLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRILDPRLEGQY 338
            +SDV+ FGV+L E+   G         S+ + L+E          K  R+  P  EG  
Sbjct: 191 IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE----------KDYRMERP--EG-- 236
Query: 339 TARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETV 374
                 KV  L   C   NP  RP  +++    ET+
Sbjct: 237 ---CPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 269

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 104/214 (48%), Gaps = 21/214 (9%)
Query: 100 LGEGGFG--VVYKGVIDENVRPGYKTTFVAIKELNRGGYQGD-REWLAEVNYLGQL-RHS 155
           LGEG FG  V+ + V  +  +P    T VA+K L     + D  + ++E+  +  + +H 
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVT-VAVKMLKDDATEEDLSDLVSEMEMMKMIGKHK 101
Query: 156 NLVKLIGYCCEDEHRILVYEYMESGSLEKHL-LRRVGCM-------------LTWSRRMK 201
           N++ L+G C +D    ++ EY   G+L ++L  RR   M             +T+   + 
Sbjct: 102 NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVS 161
Query: 202 IALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRV 261
                A+G+ +L  A +  I+RD    N+L+  +   K++DFGLA+D    D    +T  
Sbjct: 162 CTYQLARGMEYL--ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219
Query: 262 MGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEML 295
                + APE +     T +SDV+ FGV++ E+ 
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIF 253

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 61/202 (30%), Positives = 93/202 (46%), Gaps = 22/202 (10%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVK 159
           LG G FG V KG              +   E N    +   E LAE N + QL +  +V+
Sbjct: 19  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKD--ELLAEANVMQQLDNPYIVR 76
Query: 160 LIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMK------IALDAAKGLAFL 213
           +IG  CE E  +LV E  E G L K+L +        +R +K      +    + G+ +L
Sbjct: 77  MIG-ICEAESWMLVMEMAELGPLNKYLQQ--------NRHVKDKNIIELVHQVSMGMKYL 127
Query: 214 HGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTY--GYAAPE 271
              E   ++RD    N+LL     AK+SDFGL+K     D+     +  G +   + APE
Sbjct: 128 E--ESNFVHRDLAARNVLLVTQHYAKISDFGLSK-ALRADENXYKAQTHGKWPVKWYAPE 184
Query: 272 YVMTGHLTARSDVYGFGVVLLE 293
            +     +++SDV+ FGV++ E
Sbjct: 185 CINYYKFSSKSDVWSFGVLMWE 206

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 106/220 (48%), Gaps = 22/220 (10%)
Query: 87  MKLATKFF-----RPDYILGEGGFGVVYKGV-IDENVRPGYKTTFVAIKELNRGGYQGDR 140
           MK+  + F     R   +LG G FG V+KGV I E            I+  ++ G Q  +
Sbjct: 3   MKVLARIFKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIE--DKSGRQSFQ 60
Query: 141 EWLAEVNYLGQLRHSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCM-----LT 195
                +  +G L H+++V+L+G C     + LV +Y+  GSL  H+ +  G +     L 
Sbjct: 61  AVTDHMLAIGSLDHAHIVRLLGLCPGSSLQ-LVTQYLPLGSLLDHVRQHRGALGPQLLLN 119
Query: 196 WSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQT 255
           W  ++      AKG+ +L   E  +++R+    N+LL +    +++DFG+A   P  D+ 
Sbjct: 120 WGVQI------AKGMYYLE--EHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQ 171
Query: 256 HVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEML 295
            + +       + A E +  G  T +SDV+ +GV + E++
Sbjct: 172 LLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELM 211

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 82/298 (27%), Positives = 129/298 (43%), Gaps = 39/298 (13%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTT--FVAIKELNRGGYQGDREWLAEVNYLGQLRHSNL 157
           LG+G FG V     D    P    T   VA+K+L     +  R++  E+  L  L+H N+
Sbjct: 21  LGKGNFGSVEMCRYD----PLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 76
Query: 158 VKLIGYCCEDEHR--ILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHG 215
           VK  G C     R   L+ EY+  GSL  +L       +   + ++      KG+ +L G
Sbjct: 77  VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQAHAE-RIDHIKLLQYTSQICKGMEYL-G 134
Query: 216 AERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGT--YGYAAPEYV 273
            +R  I+RD  T NIL+  +   K+ DFGL K  P  D+     +  G     + APE +
Sbjct: 135 TKR-YIHRDLATRNILVENENRVKIGDFGLTKVLPQ-DKEXXKVKEPGESPIFWYAPESL 192
Query: 274 MTGHLTARSDVYGFGVVLLEMLLGRRAVDKSR-PSRE-----------HNLVEWARPLLN 321
                +  SDV+ FGVVL E+      ++KS+ P  E             +V     LL 
Sbjct: 193 TESKFSVASDVWSFGVVLYELFT---YIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLK 249
Query: 322 NNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETVQSQGA 379
           NN ++     PR +G        ++  +  +C + N   RP   D+   ++ ++   A
Sbjct: 250 NNGRL-----PRPDG-----CPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNMA 297

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 104/214 (48%), Gaps = 21/214 (9%)
Query: 100 LGEGGFG--VVYKGVIDENVRPGYKTTFVAIKELNRGGYQGD-REWLAEVNYLGQL-RHS 155
           LGEG FG  V+ + V  +  +P    T VA+K L     + D  + ++E+  +  + +H 
Sbjct: 89  LGEGCFGQVVMAEAVGIDKDKPKEAVT-VAVKMLKDDATEKDLSDLVSEMEMMKMIGKHK 147
Query: 156 NLVKLIGYCCEDEHRILVYEYMESGSLEKHL-LRRVGCM-------------LTWSRRMK 201
           N++ L+G C +D    ++ EY   G+L ++L  RR   M             +T+   + 
Sbjct: 148 NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVS 207
Query: 202 IALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRV 261
                A+G+ +L  A +  I+RD    N+L+  +   K++DFGLA+D    D    +T  
Sbjct: 208 CTYQLARGMEYL--ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 265
Query: 262 MGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEML 295
                + APE +     T +SDV+ FGV++ E+ 
Sbjct: 266 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIF 299

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 73/276 (26%), Positives = 123/276 (44%), Gaps = 28/276 (10%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVK 159
           LG G +G VY+GV  +     Y  T VA+K L     + + E+L E   + +++H NLV+
Sbjct: 21  LGGGQYGEVYEGVWKK-----YSLT-VAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQ 73
Query: 160 LIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERP 219
           L+G C  +    ++ E+M  G+L  +L       ++    + +A   +  + +L   ++ 
Sbjct: 74  LLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE--KKN 131
Query: 220 VIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLT 279
            I+RD    N L+  +   K++DFGL++    GD             + APE +     +
Sbjct: 132 FIHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAPESLAYNKFS 190
Query: 280 ARSDVYGFGVVLLEM-LLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRILDPRLEGQY 338
            +SDV+ FGV+L E+   G         S+ + L+E          K  R+  P  EG  
Sbjct: 191 IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE----------KDYRMERP--EG-- 236
Query: 339 TARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETV 374
                 KV  L   C   NP  RP  +++    ET+
Sbjct: 237 ---CPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 269

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 64/219 (29%), Positives = 108/219 (49%), Gaps = 21/219 (9%)
Query: 99  ILGEGGFGVVYKGVIDENVRPGYKTTF-VAIKELNRG-GYQGDREWLAEVNYLGQLRHSN 156
           +LG G FG VYKG+    V  G      VAIK LN   G + + E++ E   +  + H +
Sbjct: 45  VLGSGAFGTVYKGIW---VPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPH 101
Query: 157 LVKLIGYCCEDEHRILVYEYMESGSLEKHLLRR---VG--CMLTWSRRMKIALDAAKGLA 211
           LV+L+G C     + LV + M  G L +++      +G   +L W       +  AKG+ 
Sbjct: 102 LVRLLGVCLSPTIQ-LVTQLMPHGCLLEYVHEHKDNIGSQLLLNW------CVQIAKGMM 154
Query: 212 FLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPE 271
           +L   ER +++RD    N+L+ +    K++DFGLA+     ++ + +        + A E
Sbjct: 155 YLE--ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALE 212
Query: 272 YVMTGHLTARSDVYGFGVVLLEML-LGRRAVDKSRPSRE 309
            +     T +SDV+ +GV + E++  G +  D   P+RE
Sbjct: 213 CIHYRKFTHQSDVWSYGVTIWELMTFGGKPYD-GIPTRE 250

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 100/203 (49%), Gaps = 17/203 (8%)
Query: 99  ILGEGGFGVVYKGV-IDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNL 157
           +LG G FG V+KGV I E            I+  ++ G Q  +     +  +G L H+++
Sbjct: 38  VLGSGVFGTVHKGVWIPEGESIKIPVCIKVIE--DKSGRQSFQAVTDHMLAIGSLDHAHI 95
Query: 158 VKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCM-----LTWSRRMKIALDAAKGLAF 212
           V+L+G C     + LV +Y+  GSL  H+ +  G +     L W  ++      AKG+ +
Sbjct: 96  VRLLGLCPGSSLQ-LVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQI------AKGMYY 148
Query: 213 LHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEY 272
           L   E  +++R+    N+LL +    +++DFG+A   P  D+  + +       + A E 
Sbjct: 149 LE--EHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALES 206
Query: 273 VMTGHLTARSDVYGFGVVLLEML 295
           +  G  T +SDV+ +GV + E++
Sbjct: 207 IHFGKYTHQSDVWSYGVTVWELM 229

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 64/219 (29%), Positives = 109/219 (49%), Gaps = 21/219 (9%)
Query: 99  ILGEGGFGVVYKGVIDENVRPGYKTTF-VAIKELNRG-GYQGDREWLAEVNYLGQLRHSN 156
           +LG G FG VYKG+    V  G      VAIK LN   G + + E++ E   +  + H +
Sbjct: 22  VLGSGAFGTVYKGIW---VPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPH 78
Query: 157 LVKLIGYCCEDEHRILVYEYMESGSLEKHLLRR---VG--CMLTWSRRMKIALDAAKGLA 211
           LV+L+G C     + LV + M  G L +++      +G   +L W  ++      AKG+ 
Sbjct: 79  LVRLLGVCLSPTIQ-LVTQLMPHGCLLEYVHEHKDNIGSQLLLNWCVQI------AKGMM 131
Query: 212 FLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPE 271
           +L   ER +++RD    N+L+ +    K++DFGLA+     ++ + +        + A E
Sbjct: 132 YLE--ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALE 189
Query: 272 YVMTGHLTARSDVYGFGVVLLEML-LGRRAVDKSRPSRE 309
            +     T +SDV+ +GV + E++  G +  D   P+RE
Sbjct: 190 CIHYRKFTHQSDVWSYGVTIWELMTFGGKPYD-GIPTRE 227

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 64/200 (32%), Positives = 93/200 (46%), Gaps = 10/200 (5%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKT-TFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLV 158
           LG+G FG V     D     G  T   VA+K+L   G    R++  E+  L  L    +V
Sbjct: 15  LGKGNFGSVELCRYDPL---GDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIV 71
Query: 159 KL--IGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGA 216
           K   + Y        LV EY+ SG L +  L+R    L  SR +  +    KG+ +L   
Sbjct: 72  KYRGVSYGPGRPELRLVMEYLPSGCL-RDFLQRHRARLDASRLLLYSSQICKGMEYL--G 128
Query: 217 ERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMG-DQTHVSTRVMGTYGYAAPEYVMT 275
            R  ++RD    NIL+ ++   K++DFGLAK  P+  D   V         + APE +  
Sbjct: 129 SRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDXXVVREPGQSPIFWYAPESLSD 188
Query: 276 GHLTARSDVYGFGVVLLEML 295
              + +SDV+ FGVVL E+ 
Sbjct: 189 NIFSRQSDVWSFGVVLYELF 208

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 65/213 (30%), Positives = 105/213 (49%), Gaps = 19/213 (8%)
Query: 90  ATKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQG-----DREWLA 144
           A ++ + D+ LGEG F  VYK   D+N         VAIK++  G         +R  L 
Sbjct: 9   AKRYEKLDF-LGEGQFATVYKAR-DKNT-----NQIVAIKKIKLGHRSEAKDGINRTALR 61
Query: 145 EVNYLGQLRHSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIAL 204
           E+  L +L H N++ L+       +  LV+++ME+  LE  +++    +LT S      L
Sbjct: 62  EIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMET-DLEV-IIKDNSLVLTPSHIKAYML 119
Query: 205 DAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGT 264
              +GL +LH  +  +++RD K +N+LL+ +   KL+DFGLAK    G         + T
Sbjct: 120 MTLQGLEYLH--QHWILHRDLKPNNLLLDENGVLKLADFGLAKS--FGSPNRAYXHQVVT 175
Query: 265 YGYAAPEYVMTGHLTARS-DVYGFGVVLLEMLL 296
             Y APE +    +     D++  G +L E+LL
Sbjct: 176 RWYRAPELLFGARMYGVGVDMWAVGCILAELLL 208

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 73/276 (26%), Positives = 122/276 (44%), Gaps = 28/276 (10%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVK 159
           LG G +G VY+GV  +     Y  T VA+K L     + + E+L E   + +++H NLV+
Sbjct: 26  LGGGQYGEVYEGVWKK-----YSLT-VAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQ 78
Query: 160 LIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERP 219
           L+G C  +    ++ E+M  G+L  +L       +     + +A   +  + +L   ++ 
Sbjct: 79  LLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE--KKN 136
Query: 220 VIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLT 279
            I+RD    N L+  +   K++DFGL++    GD             + APE +     +
Sbjct: 137 FIHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAPESLAYNKFS 195
Query: 280 ARSDVYGFGVVLLEM-LLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRILDPRLEGQY 338
            +SDV+ FGV+L E+   G         S+ + L+E          K  R+  P  EG  
Sbjct: 196 IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE----------KDYRMERP--EG-- 241
Query: 339 TARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETV 374
                 KV  L   C   NP  RP  +++    ET+
Sbjct: 242 ---CPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 274

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 73/276 (26%), Positives = 122/276 (44%), Gaps = 28/276 (10%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVK 159
           LG G +G VY+GV  +     Y  T VA+K L     + + E+L E   + +++H NLV+
Sbjct: 22  LGGGQYGEVYEGVWKK-----YSLT-VAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQ 74
Query: 160 LIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERP 219
           L+G C  +    ++ E+M  G+L  +L       +     + +A   +  + +L   ++ 
Sbjct: 75  LLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE--KKN 132
Query: 220 VIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLT 279
            I+RD    N L+  +   K++DFGL++    GD             + APE +     +
Sbjct: 133 FIHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAPAGAKFPIKWTAPESLAYNKFS 191
Query: 280 ARSDVYGFGVVLLEM-LLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRILDPRLEGQY 338
            +SDV+ FGV+L E+   G         S+ + L+E          K  R+  P  EG  
Sbjct: 192 IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE----------KDYRMERP--EG-- 237
Query: 339 TARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETV 374
                 KV  L   C   NP  RP  +++    ET+
Sbjct: 238 ---CPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 270

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 73/276 (26%), Positives = 122/276 (44%), Gaps = 28/276 (10%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVK 159
           LG G +G VY+GV  +     Y  T VA+K L     + + E+L E   + +++H NLV+
Sbjct: 23  LGGGQYGEVYEGVWKK-----YSLT-VAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQ 75
Query: 160 LIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERP 219
           L+G C  +    ++ E+M  G+L  +L       +     + +A   +  + +L   ++ 
Sbjct: 76  LLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE--KKN 133
Query: 220 VIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLT 279
            I+RD    N L+  +   K++DFGL++    GD             + APE +     +
Sbjct: 134 FIHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAPAGAKFPIKWTAPESLAYNKFS 192
Query: 280 ARSDVYGFGVVLLEM-LLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRILDPRLEGQY 338
            +SDV+ FGV+L E+   G         S+ + L+E          K  R+  P  EG  
Sbjct: 193 IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE----------KDYRMERP--EG-- 238
Query: 339 TARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETV 374
                 KV  L   C   NP  RP  +++    ET+
Sbjct: 239 ---CPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 271

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 104/214 (48%), Gaps = 21/214 (9%)
Query: 100 LGEGGFG--VVYKGVIDENVRPGYKTTFVAIKELNRGGYQGD-REWLAEVNYLGQL-RHS 155
           LGEG FG  V+ + V  +  +P    T VA+K L     + D  + ++E+  +  + +H 
Sbjct: 30  LGEGCFGQVVMAEAVGIDKDKPKEAVT-VAVKMLKDDATEKDLSDLVSEMEMMKMIGKHK 88
Query: 156 NLVKLIGYCCEDEHRILVYEYMESGSLEKHL-LRRVGCM-------------LTWSRRMK 201
           N++ L+G C +D    ++ EY   G+L ++L  RR   M             +T+   + 
Sbjct: 89  NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVS 148
Query: 202 IALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRV 261
                A+G+ +L  A +  I+RD    N+L+  +   K++DFGLA+D    D    +T  
Sbjct: 149 CTYQLARGMEYL--ASQKCIHRDLTARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 206
Query: 262 MGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEML 295
                + APE +     T +SDV+ FGV++ E+ 
Sbjct: 207 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIF 240

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 73/276 (26%), Positives = 122/276 (44%), Gaps = 28/276 (10%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVK 159
           LG G +G VY+GV  +     Y  T VA+K L     + + E+L E   + +++H NLV+
Sbjct: 26  LGGGQYGEVYEGVWKK-----YSLT-VAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQ 78
Query: 160 LIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERP 219
           L+G C  +    ++ E+M  G+L  +L       +     + +A   +  + +L   ++ 
Sbjct: 79  LLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE--KKN 136
Query: 220 VIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLT 279
            I+RD    N L+  +   K++DFGL++    GD             + APE +     +
Sbjct: 137 FIHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAPESLAYNKFS 195
Query: 280 ARSDVYGFGVVLLEM-LLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRILDPRLEGQY 338
            +SDV+ FGV+L E+   G         S+ + L+E          K  R+  P  EG  
Sbjct: 196 IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE----------KDYRMERP--EG-- 241
Query: 339 TARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETV 374
                 KV  L   C   NP  RP  +++    ET+
Sbjct: 242 ---CPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 274

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 104/214 (48%), Gaps = 21/214 (9%)
Query: 100 LGEGGFG--VVYKGVIDENVRPGYKTTFVAIKELNRGGYQGD-REWLAEVNYLGQL-RHS 155
           LGEG FG  V+ + V  +  +P    T VA+K L     + D  + ++E+  +  + +H 
Sbjct: 32  LGEGCFGQVVMAEAVGIDKDKPKEAVT-VAVKMLKDDATEKDLSDLVSEMEMMKMIGKHK 90
Query: 156 NLVKLIGYCCEDEHRILVYEYMESGSLEKHL-LRRVGCM-------------LTWSRRMK 201
           N++ L+G C +D    ++ EY   G+L ++L  RR   M             +T+   + 
Sbjct: 91  NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVS 150
Query: 202 IALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRV 261
                A+G+ +L  A +  I+RD    N+L+  +   K++DFGLA+D    D    +T  
Sbjct: 151 CTYQLARGMEYL--ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 208
Query: 262 MGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEML 295
                + APE +     T +SDV+ FGV++ E+ 
Sbjct: 209 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIF 242

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 81/294 (27%), Positives = 130/294 (44%), Gaps = 39/294 (13%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTT--FVAIKELNRGGYQGDREWLAEVNYLGQLRHSNL 157
           LG+G FG V     D    P    T   VA+K+L     +  R++  E+  L  L+H N+
Sbjct: 36  LGKGNFGSVEMCRYD----PLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 91
Query: 158 VKLIGYCCEDEHR--ILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHG 215
           VK  G C     R   L+ EY+  GSL  + L++    +   + ++      KG+ +L G
Sbjct: 92  VKYKGVCYSAGRRNLKLIMEYLPYGSLRDY-LQKHKERIDHIKLLQYTSQICKGMEYL-G 149
Query: 216 AERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGT--YGYAAPEYV 273
            +R  I+RD  T NIL+  +   K+ DFGL K  P  D+     +  G     + APE +
Sbjct: 150 TKR-YIHRDLATRNILVENENRVKIGDFGLTKVLPQ-DKEXXKVKEPGESPIFWYAPESL 207
Query: 274 MTGHLTARSDVYGFGVVLLEMLLGRRAVDKSR-PSRE-----------HNLVEWARPLLN 321
                +  SDV+ FGVVL E+      ++KS+ P  E             +V     LL 
Sbjct: 208 TESKFSVASDVWSFGVVLYELFT---YIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLK 264
Query: 322 NNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETVQ 375
           NN ++     PR +G        ++  +  +C + N   RP   D+   ++ ++
Sbjct: 265 NNGRL-----PRPDG-----CPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIR 308

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 73/276 (26%), Positives = 122/276 (44%), Gaps = 28/276 (10%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVK 159
           LG G +G VY+GV  +     Y  T VA+K L     + + E+L E   + +++H NLV+
Sbjct: 25  LGGGQYGEVYEGVWKK-----YSLT-VAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQ 77
Query: 160 LIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERP 219
           L+G C  +    ++ E+M  G+L  +L       +     + +A   +  + +L   ++ 
Sbjct: 78  LLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE--KKN 135
Query: 220 VIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLT 279
            I+RD    N L+  +   K++DFGL++    GD             + APE +     +
Sbjct: 136 FIHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAPESLAYNKFS 194
Query: 280 ARSDVYGFGVVLLEM-LLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRILDPRLEGQY 338
            +SDV+ FGV+L E+   G         S+ + L+E          K  R+  P  EG  
Sbjct: 195 IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE----------KDYRMERP--EG-- 240
Query: 339 TARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETV 374
                 KV  L   C   NP  RP  +++    ET+
Sbjct: 241 ---CPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 273

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 73/276 (26%), Positives = 122/276 (44%), Gaps = 28/276 (10%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVK 159
           LG G +G VY+GV  +     Y  T VA+K L     + + E+L E   + +++H NLV+
Sbjct: 26  LGGGQYGEVYEGVWKK-----YSLT-VAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQ 78
Query: 160 LIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERP 219
           L+G C  +    ++ E+M  G+L  +L       +     + +A   +  + +L   ++ 
Sbjct: 79  LLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE--KKN 136
Query: 220 VIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLT 279
            I+RD    N L+  +   K++DFGL++    GD             + APE +     +
Sbjct: 137 FIHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAPESLAYNKFS 195
Query: 280 ARSDVYGFGVVLLEM-LLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRILDPRLEGQY 338
            +SDV+ FGV+L E+   G         S+ + L+E          K  R+  P  EG  
Sbjct: 196 IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE----------KDYRMERP--EG-- 241
Query: 339 TARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETV 374
                 KV  L   C   NP  RP  +++    ET+
Sbjct: 242 ---CPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 274

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 93/339 (27%), Positives = 140/339 (41%), Gaps = 41/339 (12%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVK 159
           LGEG +G V   V     R   +   V I ++ R           E+     L H N+VK
Sbjct: 14  LGEGAYGEVQLAV----NRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVK 68
Query: 160 LIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERP 219
             G+  E   + L  EY   G L   +   +G     ++R    L A  G+ +LHG    
Sbjct: 69  FYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--GVVYLHGIG-- 124
Query: 220 VIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLT 279
           + +RD K  N+LL+   + K+SDFGLA      ++  +  ++ GT  Y APE +      
Sbjct: 125 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 184
Query: 280 ARS-DVYGFGVVLLEMLLGRRAVDK-SRPSREHNLVEWARPLLNNNKKVLRILDPRLEGQ 337
           A   DV+  G+VL  ML G    D+ S   +E++  +  +  LN  KK+           
Sbjct: 185 AEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKI----------- 233
Query: 338 YTARTAMKVAGLAYQCLSQNPKGRPVMSDVVA--LLETVQSQGAEEEMLQSGGGVVTLYE 395
            +A  A     L ++ L +NP  R  + D+           +GA+   + SGG       
Sbjct: 234 DSAPLA-----LLHKILVENPSARITIPDIKKDRWYNKPLKKGAKRPRVTSGG------- 281
Query: 396 VPKLSSHNSGDKKRNQSGFSGSTEGESRRRNKPGNGRSK 434
              +S   SG  K  QS    S    + R   PG+G SK
Sbjct: 282 ---VSESPSGFSKHIQSNLDFSPVNSASR--TPGSGWSK 315

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 104/214 (48%), Gaps = 21/214 (9%)
Query: 100 LGEGGFG--VVYKGVIDENVRPGYKTTFVAIKELNRGGYQGD-REWLAEVNYLGQL-RHS 155
           LGEG FG  V+ + V  +  +P    T VA+K L     + D  + ++E+  +  + +H 
Sbjct: 35  LGEGCFGQVVMAEAVGIDKDKPKEAVT-VAVKMLKDDATEKDLSDLVSEMEMMKMIGKHK 93
Query: 156 NLVKLIGYCCEDEHRILVYEYMESGSLEKHL-LRRVGCM-------------LTWSRRMK 201
           N++ L+G C +D    ++ EY   G+L ++L  RR   M             +T+   + 
Sbjct: 94  NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVS 153
Query: 202 IALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRV 261
                A+G+ +L  A +  I+RD    N+L+  +   K++DFGLA+D    D    +T  
Sbjct: 154 CTYQLARGMEYL--ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 211
Query: 262 MGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEML 295
                + APE +     T +SDV+ FGV++ E+ 
Sbjct: 212 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIF 245

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 73/276 (26%), Positives = 122/276 (44%), Gaps = 28/276 (10%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVK 159
           LG G +G VY+GV  +     Y  T VA+K L     + + E+L E   + +++H NLV+
Sbjct: 23  LGGGQYGEVYEGVWKK-----YSLT-VAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQ 75
Query: 160 LIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERP 219
           L+G C  +    ++ E+M  G+L  +L       +     + +A   +  + +L   ++ 
Sbjct: 76  LLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE--KKN 133
Query: 220 VIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLT 279
            I+RD    N L+  +   K++DFGL++    GD             + APE +     +
Sbjct: 134 FIHRDLAARNCLVGENHLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAPESLAYNKFS 192
Query: 280 ARSDVYGFGVVLLEM-LLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRILDPRLEGQY 338
            +SDV+ FGV+L E+   G         S+ + L+E          K  R+  P  EG  
Sbjct: 193 IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE----------KDYRMERP--EG-- 238
Query: 339 TARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETV 374
                 KV  L   C   NP  RP  +++    ET+
Sbjct: 239 ---CPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 271

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 63/211 (29%), Positives = 95/211 (45%), Gaps = 22/211 (10%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDRE-WLAEVNYLGQLRHSNLV 158
           LG GGFG V + +  +    G +   VAIK+  +     +RE W  E+  + +L H N+V
Sbjct: 22  LGTGGFGYVLRWIHQDT---GEQ---VAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVV 75
Query: 159 KL------IGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIAL-DAAKGLA 211
                   +     ++  +L  EY E G L K+L +   C       ++  L D +  L 
Sbjct: 76  SAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALR 135
Query: 212 FLHGAERPVIYRDFKTSNILLN---ADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYA 268
           +LH  E  +I+RD K  NI+L         K+ D G AK+    DQ  + T  +GT  Y 
Sbjct: 136 YLH--ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKEL---DQGELCTEFVGTLQYL 190
Query: 269 APEYVMTGHLTARSDVYGFGVVLLEMLLGRR 299
           APE +     T   D + FG +  E + G R
Sbjct: 191 APELLEQKKYTVTVDYWSFGTLAFECITGFR 221

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 93/339 (27%), Positives = 140/339 (41%), Gaps = 41/339 (12%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVK 159
           LGEG +G V   V     R   +   V I ++ R           E+     L H N+VK
Sbjct: 15  LGEGAYGEVQLAV----NRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVK 69
Query: 160 LIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERP 219
             G+  E   + L  EY   G L   +   +G     ++R    L A  G+ +LHG    
Sbjct: 70  FYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--GVVYLHGIG-- 125
Query: 220 VIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLT 279
           + +RD K  N+LL+   + K+SDFGLA      ++  +  ++ GT  Y APE +      
Sbjct: 126 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 185
Query: 280 ARS-DVYGFGVVLLEMLLGRRAVDK-SRPSREHNLVEWARPLLNNNKKVLRILDPRLEGQ 337
           A   DV+  G+VL  ML G    D+ S   +E++  +  +  LN  KK+           
Sbjct: 186 AEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKI----------- 234
Query: 338 YTARTAMKVAGLAYQCLSQNPKGRPVMSDVVA--LLETVQSQGAEEEMLQSGGGVVTLYE 395
            +A  A     L ++ L +NP  R  + D+           +GA+   + SGG       
Sbjct: 235 DSAPLA-----LLHKILVENPSARITIPDIKKDRWYNKPLKKGAKRPRVTSGG------- 282
Query: 396 VPKLSSHNSGDKKRNQSGFSGSTEGESRRRNKPGNGRSK 434
              +S   SG  K  QS    S    + R   PG+G SK
Sbjct: 283 ---VSESPSGFSKHIQSNLDFSPVNSASR--TPGSGWSK 316

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 63/211 (29%), Positives = 95/211 (45%), Gaps = 22/211 (10%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDRE-WLAEVNYLGQLRHSNLV 158
           LG GGFG V + +  +    G +   VAIK+  +     +RE W  E+  + +L H N+V
Sbjct: 23  LGTGGFGYVLRWIHQDT---GEQ---VAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVV 76
Query: 159 KL------IGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIAL-DAAKGLA 211
                   +     ++  +L  EY E G L K+L +   C       ++  L D +  L 
Sbjct: 77  SAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALR 136
Query: 212 FLHGAERPVIYRDFKTSNILLN---ADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYA 268
           +LH  E  +I+RD K  NI+L         K+ D G AK+    DQ  + T  +GT  Y 
Sbjct: 137 YLH--ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKEL---DQGELCTEFVGTLQYL 191
Query: 269 APEYVMTGHLTARSDVYGFGVVLLEMLLGRR 299
           APE +     T   D + FG +  E + G R
Sbjct: 192 APELLEQKKYTVTVDYWSFGTLAFECITGFR 222

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 73/276 (26%), Positives = 122/276 (44%), Gaps = 28/276 (10%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVK 159
           LG G +G VY+GV  +     Y  T VA+K L     + + E+L E   + +++H NLV+
Sbjct: 34  LGGGQYGEVYEGVWKK-----YSLT-VAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQ 86
Query: 160 LIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERP 219
           L+G C  +    ++ E+M  G+L  +L       +     + +A   +  + +L   ++ 
Sbjct: 87  LLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE--KKN 144
Query: 220 VIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLT 279
            I+RD    N L+  +   K++DFGL++    GD             + APE +     +
Sbjct: 145 FIHRDLAARNCLVGENHLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAPESLAYNKFS 203
Query: 280 ARSDVYGFGVVLLEM-LLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRILDPRLEGQY 338
            +SDV+ FGV+L E+   G         S+ + L+E          K  R+  P  EG  
Sbjct: 204 IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE----------KDYRMERP--EG-- 249
Query: 339 TARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETV 374
                 KV  L   C   NP  RP  +++    ET+
Sbjct: 250 ---CPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 282

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 104/214 (48%), Gaps = 21/214 (9%)
Query: 100 LGEGGFG--VVYKGVIDENVRPGYKTTFVAIKELNRGGYQGD-REWLAEVNYLGQL-RHS 155
           LGEG FG  V+ + V  +  +P    T VA+K L     + D  + ++E+  +  + +H 
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVT-VAVKMLKDDATEKDLSDLVSEMEMMKMIGKHK 101
Query: 156 NLVKLIGYCCEDEHRILVYEYMESGSLEKHL-LRRVGCM-------------LTWSRRMK 201
           N++ L+G C +D    ++ EY   G+L ++L  RR   M             +T+   + 
Sbjct: 102 NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVS 161
Query: 202 IALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRV 261
                A+G+ +L  A +  I+RD    N+L+  +   +++DFGLA+D    D    +T  
Sbjct: 162 CTYQLARGMEYL--ASQKCIHRDLAARNVLVTENNVMRIADFGLARDINNIDYYKKTTNG 219
Query: 262 MGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEML 295
                + APE +     T +SDV+ FGV++ E+ 
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIF 253

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 77/298 (25%), Positives = 123/298 (41%), Gaps = 43/298 (14%)
Query: 100 LGEGGFGVVYK----GVIDENVRPGYKTTFVAIKELNRGGYQGDREWL-AEVNYLGQL-R 153
           LG G FG V +    G+  E+         VA+K L    +  ++E L +E+  +  L +
Sbjct: 54  LGAGAFGKVVEATAFGLGKEDA-----VLKVAVKMLKSTAHADEKEALMSELKIMSHLGQ 108
Query: 154 HSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRV--------GCMLTWSRRMKIALD 205
           H N+V L+G C      +++ EY   G L   L R+         G  L     +  +  
Sbjct: 109 HENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHFSSQ 168
Query: 206 AAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTH-VSTRVMGT 264
            A+G+AFL  A +  I+RD    N+LL     AK+ DFGLA+D  M D  + V       
Sbjct: 169 VAQGMAFL--ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARD-IMNDSNYIVKGNARLP 225
Query: 265 YGYAAPEYVMTGHLTARSDVYGFGVVLLEML-LGRRAVDKSRPSREHNLVEWARPLLNNN 323
             + APE +     T +SDV+ +G++L E+  LG                    P +  N
Sbjct: 226 VKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPY----------------PGILVN 269
Query: 324 KKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETVQSQGAEE 381
            K  +++    +    A     +  +   C +  P  RP    + + L   Q Q  E+
Sbjct: 270 SKFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFL---QEQAQED 324

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 73/276 (26%), Positives = 122/276 (44%), Gaps = 28/276 (10%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVK 159
           LG G +G VY+GV  +     Y  T VA+K L     + + E+L E   + +++H NLV+
Sbjct: 23  LGGGQYGEVYEGVWKK-----YSLT-VAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQ 75
Query: 160 LIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERP 219
           L+G C  +    ++ E+M  G+L  +L       +     + +A   +  + +L   ++ 
Sbjct: 76  LLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE--KKN 133
Query: 220 VIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLT 279
            I+RD    N L+  +   K++DFGL++    GD             + APE +     +
Sbjct: 134 FIHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAPESLAYNKFS 192
Query: 280 ARSDVYGFGVVLLEM-LLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRILDPRLEGQY 338
            +SDV+ FGV+L E+   G         S+ + L+E          K  R+  P  EG  
Sbjct: 193 IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE----------KDYRMERP--EG-- 238
Query: 339 TARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETV 374
                 KV  L   C   NP  RP  +++    ET+
Sbjct: 239 ---CPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 271

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 77/298 (25%), Positives = 123/298 (41%), Gaps = 43/298 (14%)
Query: 100 LGEGGFGVVYK----GVIDENVRPGYKTTFVAIKELNRGGYQGDREWL-AEVNYLGQL-R 153
           LG G FG V +    G+  E+         VA+K L    +  ++E L +E+  +  L +
Sbjct: 46  LGAGAFGKVVEATAFGLGKEDA-----VLKVAVKMLKSTAHADEKEALMSELKIMSHLGQ 100
Query: 154 HSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRV--------GCMLTWSRRMKIALD 205
           H N+V L+G C      +++ EY   G L   L R+         G  L     +  +  
Sbjct: 101 HENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHFSSQ 160
Query: 206 AAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTH-VSTRVMGT 264
            A+G+AFL  A +  I+RD    N+LL     AK+ DFGLA+D  M D  + V       
Sbjct: 161 VAQGMAFL--ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARD-IMNDSNYIVKGNARLP 217
Query: 265 YGYAAPEYVMTGHLTARSDVYGFGVVLLEML-LGRRAVDKSRPSREHNLVEWARPLLNNN 323
             + APE +     T +SDV+ +G++L E+  LG                    P +  N
Sbjct: 218 VKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPY----------------PGILVN 261
Query: 324 KKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETVQSQGAEE 381
            K  +++    +    A     +  +   C +  P  RP    + + L   Q Q  E+
Sbjct: 262 SKFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFL---QEQAQED 316

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 91/207 (43%), Gaps = 16/207 (7%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTF-VAIKELNR-GGYQGDREWLAEVNYLGQLRHSNL 157
           LG G FG VY+G +  +  P   +   VA+K L      Q + ++L E   + +L H N+
Sbjct: 39  LGHGAFGEVYEGQV--SGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKLNHQNI 96
Query: 158 VKLIGYCCEDEHRILVYEYMESGSLEKHLLRRV------GCMLTWSRRMKIALDAAKGLA 211
           V+ IG   +   R ++ E M  G L K  LR           L     + +A D A G  
Sbjct: 97  VRCIGVSLQSLPRFILLELMAGGDL-KSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 155
Query: 212 FLHGAERPVIYRDFKTSNILLNADFS---AKLSDFGLAKDGPMGDQTHVSTRVMGTYGYA 268
           +L   E   I+RD    N LL        AK+ DFG+A+D             M    + 
Sbjct: 156 YLE--ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWM 213
Query: 269 APEYVMTGHLTARSDVYGFGVVLLEML 295
            PE  M G  T+++D + FGV+L E+ 
Sbjct: 214 PPEAFMEGIFTSKTDTWSFGVLLWEIF 240

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 73/276 (26%), Positives = 122/276 (44%), Gaps = 28/276 (10%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVK 159
           LG G +G VY+GV  +     Y  T VA+K L     + + E+L E   + +++H NLV+
Sbjct: 21  LGGGQYGEVYEGVWKK-----YSLT-VAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQ 73
Query: 160 LIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERP 219
           L+G C  +    ++ E+M  G+L  +L       +     + +A   +  + +L   ++ 
Sbjct: 74  LLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE--KKN 131
Query: 220 VIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLT 279
            I+RD    N L+  +   K++DFGL++    GD             + APE +     +
Sbjct: 132 FIHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAPESLAYNKFS 190
Query: 280 ARSDVYGFGVVLLEM-LLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRILDPRLEGQY 338
            +SDV+ FGV+L E+   G         S+ + L+E          K  R+  P  EG  
Sbjct: 191 IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE----------KDYRMERP--EG-- 236
Query: 339 TARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETV 374
                 KV  L   C   NP  RP  +++    ET+
Sbjct: 237 ---CPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 269

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 93/200 (46%), Gaps = 16/200 (8%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVK 159
           LG+G FG VYK    E       +   A K ++    +   +++ E++ L    H N+VK
Sbjct: 45  LGDGAFGKVYKAQNKET------SVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVK 98
Query: 160 LIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERP 219
           L+     + +  ++ E+   G+++  +L  +   LT S+   +       L +LH  +  
Sbjct: 99  LLDAFYYENNLWILIEFCAGGAVDAVMLE-LERPLTESQIQVVCKQTLDALNYLH--DNK 155
Query: 220 VIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLT 279
           +I+RD K  NIL   D   KL+DFG++       Q   S   +GT  + APE VM     
Sbjct: 156 IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDS--FIGTPYWMAPEVVMCETSK 213
Query: 280 AR-----SDVYGFGVVLLEM 294
            R     +DV+  G+ L+EM
Sbjct: 214 DRPYDYKADVWSLGITLIEM 233

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 93/200 (46%), Gaps = 16/200 (8%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVK 159
           LG+G FG VYK    E       +   A K ++    +   +++ E++ L    H N+VK
Sbjct: 45  LGDGAFGKVYKAQNKET------SVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVK 98
Query: 160 LIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERP 219
           L+     + +  ++ E+   G+++  +L  +   LT S+   +       L +LH  +  
Sbjct: 99  LLDAFYYENNLWILIEFCAGGAVDAVMLE-LERPLTESQIQVVCKQTLDALNYLH--DNK 155
Query: 220 VIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLT 279
           +I+RD K  NIL   D   KL+DFG++       Q   S   +GT  + APE VM     
Sbjct: 156 IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRXIQRRDS--FIGTPYWMAPEVVMCETSK 213
Query: 280 AR-----SDVYGFGVVLLEM 294
            R     +DV+  G+ L+EM
Sbjct: 214 DRPYDYKADVWSLGITLIEM 233

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 90/207 (43%), Gaps = 16/207 (7%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTF-VAIKELNR-GGYQGDREWLAEVNYLGQLRHSNL 157
           LG G FG VY+G +     P   +   VA+K L      Q + ++L E   + +L H N+
Sbjct: 53  LGHGAFGEVYEGQVSG--MPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKLNHQNI 110
Query: 158 VKLIGYCCEDEHRILVYEYMESGSLEKHLLRRV------GCMLTWSRRMKIALDAAKGLA 211
           V+ IG   +   R ++ E M  G L K  LR           L     + +A D A G  
Sbjct: 111 VRCIGVSLQSLPRFILLELMAGGDL-KSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 169
Query: 212 FLHGAERPVIYRDFKTSNILLNADFS---AKLSDFGLAKDGPMGDQTHVSTRVMGTYGYA 268
           +L   E   I+RD    N LL        AK+ DFG+A+D             M    + 
Sbjct: 170 YLE--ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWM 227
Query: 269 APEYVMTGHLTARSDVYGFGVVLLEML 295
            PE  M G  T+++D + FGV+L E+ 
Sbjct: 228 PPEAFMEGIFTSKTDTWSFGVLLWEIF 254

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 67/217 (30%), Positives = 98/217 (45%), Gaps = 36/217 (16%)
Query: 92  KFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKEL-NRGGYQGDRE-WLAEVNYL 149
           +F + D  +G G F  VYKG+  E       T  VA  EL +R   + +R+ +  E   L
Sbjct: 26  RFLKFDIEIGRGSFKTVYKGLDTET------TVEVAWCELQDRKLTKSERQRFKEEAEXL 79
Query: 150 GQLRHSNLVKLI--------GYCCEDEHRILVYEYMESGSLEKHLLR----RVGCMLTWS 197
             L+H N+V+          G  C     +LV E   SG+L+ +L R    ++  + +W 
Sbjct: 80  KGLQHPNIVRFYDSWESTVKGKKC----IVLVTELXTSGTLKTYLKRFKVXKIKVLRSWC 135
Query: 198 RRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADF-SAKLSDFGLAKDGPMGDQTH 256
           R++       KGL FLH    P+I+RD K  NI +     S K+ D GLA       +  
Sbjct: 136 RQI------LKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLA----TLKRAS 185
Query: 257 VSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLE 293
            +  V+GT  + APE     +     DVY FG   LE
Sbjct: 186 FAKAVIGTPEFXAPEXYEEKY-DESVDVYAFGXCXLE 221

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 78/300 (26%), Positives = 118/300 (39%), Gaps = 44/300 (14%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAE----VNYLGQLRHS 155
           LG G FG V +      ++     T VA+K L    +  +RE L      ++YLG   H 
Sbjct: 31  LGAGAFGKVVEATAYGLIKSDAAMT-VAVKMLKPSAHLTEREALMSELKVLSYLGN--HM 87
Query: 156 NLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRR---VGCMLTWSRRM------------ 200
           N+V L+G C      +++ EY   G L   L R+     C  T    M            
Sbjct: 88  NIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDL 147
Query: 201 -KIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVST 259
              +   AKG+AFL  A +  I+RD    NILL      K+ DFGLA+D        V  
Sbjct: 148 LSFSYQVAKGMAFL--ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKG 205
Query: 260 RVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRP--SREHNLVEWAR 317
                  + APE +     T  SDV+ +G+ L E+     +     P  S+ + ++    
Sbjct: 206 NARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMI---- 261
Query: 318 PLLNNNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETVQSQ 377
                 K+  R+L P            ++  +   C   +P  RP    +V L+E   S+
Sbjct: 262 ------KEGFRMLSPE-------HAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE 308

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 77/295 (26%), Positives = 116/295 (39%), Gaps = 44/295 (14%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAE----VNYLGQLRHS 155
           LG G FG V +      ++     T VA+K L    +  +RE L      ++YLG   H 
Sbjct: 47  LGAGAFGKVVEATAYGLIKSDAAMT-VAVKMLKPSAHLTEREALMSELKVLSYLGN--HM 103
Query: 156 NLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRR---VGCMLTWSRRM------------ 200
           N+V L+G C      +++ EY   G L   L R+     C  T    M            
Sbjct: 104 NIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDL 163
Query: 201 -KIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVST 259
              +   AKG+AFL  A +  I+RD    NILL      K+ DFGLA+D        V  
Sbjct: 164 LSFSYQVAKGMAFL--ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKG 221
Query: 260 RVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRP--SREHNLVEWAR 317
                  + APE +     T  SDV+ +G+ L E+     +     P  S+ + ++    
Sbjct: 222 NARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMI---- 277
Query: 318 PLLNNNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLE 372
                 K+  R+L P            ++  +   C   +P  RP    +V L+E
Sbjct: 278 ------KEGFRMLSPE-------HAPAEMYDIMKTCWDADPLKRPTFKQIVQLIE 319

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 69/270 (25%), Positives = 119/270 (44%), Gaps = 31/270 (11%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLA-EVNYLGQLRHSNLV 158
           +G+G FG V+KG+ +   +       VAIK ++    + + E +  E+  L Q     + 
Sbjct: 30  IGKGSFGEVFKGIDNRTQK------VVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 83
Query: 159 KLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAER 218
           K  G   +D    ++ EY+  GS     L   G  L  ++   I  +  KGL +LH  ++
Sbjct: 84  KYYGSYLKDTKLWIIMEYLGGGSALD--LLEPGP-LDETQIATILREILKGLDYLHSEKK 140
Query: 219 PVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHL 278
             I+RD K +N+LL+     KL+DFG+A  G + D        +GT  + APE +     
Sbjct: 141 --IHRDIKAANVLLSEHGEVKLADFGVA--GQLTDTQIKRNXFVGTPFWMAPEVIKQSAY 196
Query: 279 TARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRILDPRLEGQY 338
            +++D++  G+  +E+  G     +  P +   L+    P             P LEG Y
Sbjct: 197 DSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNP-------------PTLEGNY 243
Query: 339 TARTAMKVAGLAYQCLSQNPKGRPVMSDVV 368
           +      V      CL++ P  RP   +++
Sbjct: 244 SKPLKEFVEA----CLNKEPSFRPTAKELL 269

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 78/300 (26%), Positives = 118/300 (39%), Gaps = 44/300 (14%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAE----VNYLGQLRHS 155
           LG G FG V +      ++     T VA+K L    +  +RE L      ++YLG   H 
Sbjct: 54  LGAGAFGKVVEATAYGLIKSDAAMT-VAVKMLKPSAHLTEREALMSELKVLSYLGN--HM 110
Query: 156 NLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRR---VGCMLTWSRRM------------ 200
           N+V L+G C      +++ EY   G L   L R+     C  T    M            
Sbjct: 111 NIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDL 170
Query: 201 -KIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVST 259
              +   AKG+AFL  A +  I+RD    NILL      K+ DFGLA+D        V  
Sbjct: 171 LSFSYQVAKGMAFL--ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKG 228
Query: 260 RVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRP--SREHNLVEWAR 317
                  + APE +     T  SDV+ +G+ L E+     +     P  S+ + ++    
Sbjct: 229 NARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMI---- 284
Query: 318 PLLNNNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETVQSQ 377
                 K+  R+L P            ++  +   C   +P  RP    +V L+E   S+
Sbjct: 285 ------KEGFRMLSPE-------HAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE 331

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 73/276 (26%), Positives = 122/276 (44%), Gaps = 28/276 (10%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVK 159
           LG G +G VY+GV  +     Y  T VA+K L     + + E+L E   + +++H NLV+
Sbjct: 21  LGGGQYGEVYEGVWKK-----YSLT-VAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQ 73
Query: 160 LIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERP 219
           L+G C  +    ++ E+M  G+L  +L       +     + +A   +  + +L   ++ 
Sbjct: 74  LLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE--KKN 131
Query: 220 VIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLT 279
            I+RD    N L+  +   K++DFGL++    GD             + APE +     +
Sbjct: 132 FIHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAPESLAYNKFS 190
Query: 280 ARSDVYGFGVVLLEM-LLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRILDPRLEGQY 338
            +SDV+ FGV+L E+   G         S+ + L+E          K  R+  P  EG  
Sbjct: 191 IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE----------KDYRMERP--EG-- 236
Query: 339 TARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETV 374
                 KV  L   C   NP  RP  +++    ET+
Sbjct: 237 ---CPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 269

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 78/302 (25%), Positives = 118/302 (39%), Gaps = 44/302 (14%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAE----VNYLGQLRHS 155
           LG G FG V +      ++     T VA+K L    +  +RE L      ++YLG   H 
Sbjct: 49  LGAGAFGKVVEATAYGLIKSDAAMT-VAVKMLKPSAHLTEREALMSELKVLSYLGN--HM 105
Query: 156 NLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRR---VGCMLTWSRRM------------ 200
           N+V L+G C      +++ EY   G L   L R+     C  T    M            
Sbjct: 106 NIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDL 165
Query: 201 -KIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVST 259
              +   AKG+AFL  A +  I+RD    NILL      K+ DFGLA+D        V  
Sbjct: 166 LSFSYQVAKGMAFL--ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKG 223
Query: 260 RVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRP--SREHNLVEWAR 317
                  + APE +     T  SDV+ +G+ L E+     +     P  S+ + ++    
Sbjct: 224 NARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMI---- 279
Query: 318 PLLNNNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETVQSQ 377
                 K+  R+L P            ++  +   C   +P  RP    +V L+E   S+
Sbjct: 280 ------KEGFRMLSPE-------HAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE 326
Query: 378 GA 379
Sbjct: 327 ST 328

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 69/270 (25%), Positives = 119/270 (44%), Gaps = 31/270 (11%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLA-EVNYLGQLRHSNLV 158
           +G+G FG V+KG+ +   +       VAIK ++    + + E +  E+  L Q     + 
Sbjct: 35  IGKGSFGEVFKGIDNRTQK------VVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 88
Query: 159 KLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAER 218
           K  G   +D    ++ EY+  GS     L   G  L  ++   I  +  KGL +LH  ++
Sbjct: 89  KYYGSYLKDTKLWIIMEYLGGGSALD--LLEPGP-LDETQIATILREILKGLDYLHSEKK 145
Query: 219 PVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHL 278
             I+RD K +N+LL+     KL+DFG+A  G + D        +GT  + APE +     
Sbjct: 146 --IHRDIKAANVLLSEHGEVKLADFGVA--GQLTDTQIKRNTFVGTPFWMAPEVIKQSAY 201
Query: 279 TARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRILDPRLEGQY 338
            +++D++  G+  +E+  G     +  P +   L+    P             P LEG Y
Sbjct: 202 DSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNP-------------PTLEGNY 248
Query: 339 TARTAMKVAGLAYQCLSQNPKGRPVMSDVV 368
           +      V      CL++ P  RP   +++
Sbjct: 249 SKPLKEFVEA----CLNKEPSFRPTAKELL 274

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 103/214 (48%), Gaps = 21/214 (9%)
Query: 100 LGEGGFG--VVYKGVIDENVRPGYKTTFVAIKELNRGGYQGD-REWLAEVNYLGQL-RHS 155
           LGEG FG  V+ + V  +  +P    T VA+K L     + D  + ++E+  +  + +H 
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVT-VAVKMLKDDATEKDLSDLVSEMEMMKMIGKHK 101
Query: 156 NLVKLIGYCCEDEHRILVYEYMESGSLEKHL-LRRVGCM-------------LTWSRRMK 201
           N++ L+G C +D    ++  Y   G+L ++L  RR   M             +T+   + 
Sbjct: 102 NIINLLGACTQDGPLYVIVAYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVS 161
Query: 202 IALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRV 261
                A+G+ +L  A +  I+RD    N+L+  +   K++DFGLA+D    D    +T  
Sbjct: 162 CTYQLARGMEYL--ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219
Query: 262 MGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEML 295
                + APE +     T +SDV+ FGV++ E+ 
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIF 253

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 71/234 (30%), Positives = 111/234 (47%), Gaps = 18/234 (7%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVK 159
           +G+G  G VY  +   +V  G +   VAI+++N          + E+  + + ++ N+V 
Sbjct: 28  IGQGASGTVYTAM---DVATGQE---VAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 81
Query: 160 -LIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAER 218
            L  Y   DE  + V EY+  GSL   +     CM    +   +  +  + L FLH  + 
Sbjct: 82  YLDSYLVGDELWV-VMEYLAGGSLTDVVTET--CM-DEGQIAAVCRECLQALEFLHSNQ- 136
Query: 219 PVIYRDFKTSNILLNADFSAKLSDFGL-AKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGH 277
            VI+RD K+ NILL  D S KL+DFG  A+  P  +Q+  ST V GT  + APE V    
Sbjct: 137 -VIHRDIKSDNILLGMDGSVKLTDFGFCAQITP--EQSKRSTMV-GTPYWMAPEVVTRKA 192
Query: 278 LTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEW-ARPLLNNNKKVLRIL 330
              + D++  G++ +EM+ G        P R   L+     P L N +K+  I 
Sbjct: 193 YGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIF 246

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 77/304 (25%), Positives = 124/304 (40%), Gaps = 49/304 (16%)
Query: 100 LGEGGFGVVYK----GVIDENVRPGYKTTFVAIKELNRGGYQGDREWL-AEVNYLGQL-R 153
           LG G FG V +    G+  E+         VA+K L    +  ++E L +E+  +  L +
Sbjct: 54  LGAGAFGKVVEATAFGLGKEDA-----VLKVAVKMLKSTAHADEKEALMSELKIMSHLGQ 108
Query: 154 HSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRR-------------- 199
           H N+V L+G C      +++ EY   G L   L R+    L +S                
Sbjct: 109 HENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKRPPGLEYSYNPSHNPEEQLSSRDL 168
Query: 200 MKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTH-VS 258
           +  +   A+G+AFL  A +  I+RD    N+LL     AK+ DFGLA+D  M D  + V 
Sbjct: 169 LHFSSQVAQGMAFL--ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARD-IMNDSNYIVK 225
Query: 259 TRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEML-LGRRAVDKSRPSREHNLVEWAR 317
                   + APE +     T +SDV+ +G++L E+  LG                    
Sbjct: 226 GNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPY---------------- 269
Query: 318 PLLNNNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETVQSQ 377
           P +  N K  +++    +    A     +  +   C +  P  RP    + + L   Q Q
Sbjct: 270 PGILVNSKFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFL---QEQ 326
Query: 378 GAEE 381
             E+
Sbjct: 327 AQED 330

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 69/246 (28%), Positives = 119/246 (48%), Gaps = 42/246 (17%)
Query: 71  RQNPGYSNVDIFTYNEMKLATKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKE 130
           + NP  +   +  +N++K          ++GEG FG V K  I ++   G +    AIK 
Sbjct: 1   KNNPDPTIYPVLDWNDIKFQD-------VIGEGNFGQVLKARIKKD---GLRMD-AAIKR 49
Query: 131 LNRGGYQGD-REWLAEVNYLGQL-RHSNLVKLIGYCCEDEHRILVY---EYMESGSLEKH 185
           +     + D R++  E+  L +L  H N++ L+G C   EHR  +Y   EY   G+L   
Sbjct: 50  MKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGAC---EHRGYLYLAIEYAPHGNLLDF 106
Query: 186 LLR-RV-------------GCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNIL 231
           L + RV                L+  + +  A D A+G+ +L  +++  I+RD    NIL
Sbjct: 107 LRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYL--SQKQFIHRDLAARNIL 164
Query: 232 LNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYG--YAAPEYVMTGHLTARSDVYGFGV 289
           +  ++ AK++DFGL++    G + +V  + MG     + A E +     T  SDV+ +GV
Sbjct: 165 VGENYVAKIADFGLSR----GQEVYVK-KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGV 219
Query: 290 VLLEML 295
           +L E++
Sbjct: 220 LLWEIV 225

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 69/246 (28%), Positives = 119/246 (48%), Gaps = 42/246 (17%)
Query: 71  RQNPGYSNVDIFTYNEMKLATKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKE 130
           + NP  +   +  +N++K          ++GEG FG V K  I ++   G +    AIK 
Sbjct: 11  KNNPDPTIYPVLDWNDIKFQD-------VIGEGNFGQVLKARIKKD---GLRMD-AAIKR 59
Query: 131 LNRGGYQGD-REWLAEVNYLGQL-RHSNLVKLIGYCCEDEHRILVY---EYMESGSLEKH 185
           +     + D R++  E+  L +L  H N++ L+G C   EHR  +Y   EY   G+L   
Sbjct: 60  MKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGAC---EHRGYLYLAIEYAPHGNLLDF 116
Query: 186 LLR-RV-------------GCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNIL 231
           L + RV                L+  + +  A D A+G+ +L  +++  I+RD    NIL
Sbjct: 117 LRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYL--SQKQFIHRDLAARNIL 174
Query: 232 LNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYG--YAAPEYVMTGHLTARSDVYGFGV 289
           +  ++ AK++DFGL++    G + +V  + MG     + A E +     T  SDV+ +GV
Sbjct: 175 VGENYVAKIADFGLSR----GQEVYVK-KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGV 229
Query: 290 VLLEML 295
           +L E++
Sbjct: 230 LLWEIV 235

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 69/270 (25%), Positives = 119/270 (44%), Gaps = 31/270 (11%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLA-EVNYLGQLRHSNLV 158
           +G+G FG V+KG+ +   +       VAIK ++    + + E +  E+  L Q     + 
Sbjct: 15  IGKGSFGEVFKGIDNRTQK------VVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 68
Query: 159 KLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAER 218
           K  G   +D    ++ EY+  GS     L   G  L  ++   I  +  KGL +LH  ++
Sbjct: 69  KYYGSYLKDTKLWIIMEYLGGGSALD--LLEPGP-LDETQIATILREILKGLDYLHSEKK 125
Query: 219 PVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHL 278
             I+RD K +N+LL+     KL+DFG+A  G + D        +GT  + APE +     
Sbjct: 126 --IHRDIKAANVLLSEHGEVKLADFGVA--GQLTDTQIKRNXFVGTPFWMAPEVIKQSAY 181
Query: 279 TARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRILDPRLEGQY 338
            +++D++  G+  +E+  G     +  P +   L+    P             P LEG Y
Sbjct: 182 DSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNP-------------PTLEGNY 228
Query: 339 TARTAMKVAGLAYQCLSQNPKGRPVMSDVV 368
           +      V      CL++ P  RP   +++
Sbjct: 229 SKPLKEFVEA----CLNKEPSFRPTAKELL 254

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 69/270 (25%), Positives = 119/270 (44%), Gaps = 31/270 (11%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLA-EVNYLGQLRHSNLV 158
           +G+G FG V+KG+ +   +       VAIK ++    + + E +  E+  L Q     + 
Sbjct: 15  IGKGSFGEVFKGIDNRTQK------VVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 68
Query: 159 KLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAER 218
           K  G   +D    ++ EY+  GS     L   G  L  ++   I  +  KGL +LH  ++
Sbjct: 69  KYYGSYLKDTKLWIIMEYLGGGSALD--LLEPGP-LDETQIATILREILKGLDYLHSEKK 125
Query: 219 PVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHL 278
             I+RD K +N+LL+     KL+DFG+A  G + D        +GT  + APE +     
Sbjct: 126 --IHRDIKAANVLLSEHGEVKLADFGVA--GQLTDTQIKRNTFVGTPFWMAPEVIKQSAY 181
Query: 279 TARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRILDPRLEGQY 338
            +++D++  G+  +E+  G     +  P +   L+    P             P LEG Y
Sbjct: 182 DSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNP-------------PTLEGNY 228
Query: 339 TARTAMKVAGLAYQCLSQNPKGRPVMSDVV 368
           +      V      CL++ P  RP   +++
Sbjct: 229 SKPLKEFVEA----CLNKEPSFRPTAKELL 254

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 59/200 (29%), Positives = 95/200 (47%), Gaps = 14/200 (7%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIK-ELNRGGYQGDREWLAEVNYLGQLRHSNLV 158
           +GEG +GVVYK       +  Y  TF   K  L +         + E++ L +L+HSN+V
Sbjct: 10  IGEGTYGVVYKA------QNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIV 63
Query: 159 KLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAER 218
           KL       +  +LV+E+++     K LL      L         L    G+A+ H  +R
Sbjct: 64  KLYDVIHTKKRLVLVFEHLDQDL--KKLLDVCEGGLESVTAKSFLLQLLNGIAYCH--DR 119
Query: 219 PVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVM-TGH 277
            V++RD K  N+L+N +   K++DFGLA+    G      T  + T  Y AP+ +M +  
Sbjct: 120 RVLHRDLKPQNLLINREGELKIADFGLAR--AFGIPVRKYTHEIVTLWYRAPDVLMGSKK 177
Query: 278 LTARSDVYGFGVVLLEMLLG 297
            +   D++  G +  EM+ G
Sbjct: 178 YSTTIDIWSVGCIFAEMVNG 197

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 76/302 (25%), Positives = 123/302 (40%), Gaps = 47/302 (15%)
Query: 100 LGEGGFGVVYK----GVIDENVRPGYKTTFVAIKELNRGGYQGDREWL-AEVNYLGQL-R 153
           LG G FG V +    G+  E+         VA+K L    +  ++E L +E+  +  L +
Sbjct: 54  LGAGAFGKVVEATAFGLGKEDA-----VLKVAVKMLKSTAHADEKEALMSELKIMSHLGQ 108
Query: 154 HSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRR------------VGCMLTWSRRMK 201
           H N+V L+G C      +++ EY   G L   L R+                L+    + 
Sbjct: 109 HENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTLSTRDLLH 168
Query: 202 IALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTH-VSTR 260
            +   A+G+AFL  A +  I+RD    N+LL     AK+ DFGLA+D  M D  + V   
Sbjct: 169 FSSQVAQGMAFL--ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARD-IMNDSNYIVKGN 225
Query: 261 VMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEML-LGRRAVDKSRPSREHNLVEWARPL 319
                 + APE +     T +SDV+ +G++L E+  LG                    P 
Sbjct: 226 ARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPY----------------PG 269
Query: 320 LNNNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETVQSQGA 379
           +  N K  +++    +    A     +  +   C +  P  RP    + + L   Q Q  
Sbjct: 270 ILVNSKFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFL---QEQAQ 326
Query: 380 EE 381
           E+
Sbjct: 327 ED 328

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 55/200 (27%), Positives = 92/200 (46%), Gaps = 16/200 (8%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVK 159
           LG+G FG VYK    E       +   A K ++    +   +++ E++ L    H N+VK
Sbjct: 45  LGDGAFGKVYKAQNKET------SVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVK 98
Query: 160 LIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERP 219
           L+     + +  ++ E+   G+++  +L  +   LT S+   +       L +LH  +  
Sbjct: 99  LLDAFYYENNLWILIEFCAGGAVDAVMLE-LERPLTESQIQVVCKQTLDALNYLH--DNK 155
Query: 220 VIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLT 279
           +I+RD K  NIL   D   KL+DFG++       Q       +GT  + APE VM     
Sbjct: 156 IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRXIQRR--DXFIGTPYWMAPEVVMCETSK 213
Query: 280 AR-----SDVYGFGVVLLEM 294
            R     +DV+  G+ L+EM
Sbjct: 214 DRPYDYKADVWSLGITLIEM 233

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 89/207 (42%), Gaps = 16/207 (7%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTF-VAIKELNR-GGYQGDREWLAEVNYLGQLRHSNL 157
           LG G FG VY+G +     P   +   VA+K L      Q + ++L E   + +  H N+
Sbjct: 38  LGHGAFGEVYEGQVSG--MPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 95
Query: 158 VKLIGYCCEDEHRILVYEYMESGSLEKHLLRRV------GCMLTWSRRMKIALDAAKGLA 211
           V+ IG   +   R ++ E M  G L K  LR           L     + +A D A G  
Sbjct: 96  VRCIGVSLQSLPRFILLELMAGGDL-KSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 154
Query: 212 FLHGAERPVIYRDFKTSNILLNADFS---AKLSDFGLAKDGPMGDQTHVSTRVMGTYGYA 268
           +L   E   I+RD    N LL        AK+ DFG+A+D             M    + 
Sbjct: 155 YLE--ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWM 212
Query: 269 APEYVMTGHLTARSDVYGFGVVLLEML 295
            PE  M G  T+++D + FGV+L E+ 
Sbjct: 213 PPEAFMEGIFTSKTDTWSFGVLLWEIF 239

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 89/207 (42%), Gaps = 16/207 (7%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTF-VAIKELNR-GGYQGDREWLAEVNYLGQLRHSNL 157
           LG G FG VY+G +     P   +   VA+K L      Q + ++L E   + +  H N+
Sbjct: 53  LGHGAFGEVYEGQVSG--MPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 110
Query: 158 VKLIGYCCEDEHRILVYEYMESGSLEKHLLRRV------GCMLTWSRRMKIALDAAKGLA 211
           V+ IG   +   R ++ E M  G L K  LR           L     + +A D A G  
Sbjct: 111 VRCIGVSLQSLPRFILMELMAGGDL-KSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 169
Query: 212 FLHGAERPVIYRDFKTSNILLNADFS---AKLSDFGLAKDGPMGDQTHVSTRVMGTYGYA 268
           +L   E   I+RD    N LL        AK+ DFG+A+D             M    + 
Sbjct: 170 YLE--ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWM 227
Query: 269 APEYVMTGHLTARSDVYGFGVVLLEML 295
            PE  M G  T+++D + FGV+L E+ 
Sbjct: 228 PPEAFMEGIFTSKTDTWSFGVLLWEIF 254

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 90/207 (43%), Gaps = 16/207 (7%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTF-VAIKELNR-GGYQGDREWLAEVNYLGQLRHSNL 157
           LG G FG VY+G +  +  P   +   VA+K L      Q + ++L E   + +  H N+
Sbjct: 39  LGHGAFGEVYEGQV--SGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 96
Query: 158 VKLIGYCCEDEHRILVYEYMESGSLEKHLLRRV------GCMLTWSRRMKIALDAAKGLA 211
           V+ IG   +   R ++ E M  G L K  LR           L     + +A D A G  
Sbjct: 97  VRCIGVSLQSLPRFILLELMAGGDL-KSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 155
Query: 212 FLHGAERPVIYRDFKTSNILLNADFS---AKLSDFGLAKDGPMGDQTHVSTRVMGTYGYA 268
           +L   E   I+RD    N LL        AK+ DFG+A+D             M    + 
Sbjct: 156 YLE--ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWM 213
Query: 269 APEYVMTGHLTARSDVYGFGVVLLEML 295
            PE  M G  T+++D + FGV+L E+ 
Sbjct: 214 PPEAFMEGIFTSKTDTWSFGVLLWEIF 240

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 90/207 (43%), Gaps = 16/207 (7%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTF-VAIKELNR-GGYQGDREWLAEVNYLGQLRHSNL 157
           LG G FG VY+G +  +  P   +   VA+K L      Q + ++L E   + +  H N+
Sbjct: 55  LGHGAFGEVYEGQV--SGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 112
Query: 158 VKLIGYCCEDEHRILVYEYMESGSLEKHLLRRV------GCMLTWSRRMKIALDAAKGLA 211
           V+ IG   +   R ++ E M  G L K  LR           L     + +A D A G  
Sbjct: 113 VRCIGVSLQSLPRFILLELMAGGDL-KSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 171
Query: 212 FLHGAERPVIYRDFKTSNILLNADFS---AKLSDFGLAKDGPMGDQTHVSTRVMGTYGYA 268
           +L   E   I+RD    N LL        AK+ DFG+A+D             M    + 
Sbjct: 172 YLE--ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWM 229
Query: 269 APEYVMTGHLTARSDVYGFGVVLLEML 295
            PE  M G  T+++D + FGV+L E+ 
Sbjct: 230 PPEAFMEGIFTSKTDTWSFGVLLWEIF 256

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 89/207 (42%), Gaps = 16/207 (7%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTF-VAIKELNR-GGYQGDREWLAEVNYLGQLRHSNL 157
           LG G FG VY+G +     P   +   VA+K L      Q + ++L E   + +  H N+
Sbjct: 38  LGHGAFGEVYEGQVSG--MPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 95
Query: 158 VKLIGYCCEDEHRILVYEYMESGSLEKHLLRRV------GCMLTWSRRMKIALDAAKGLA 211
           V+ IG   +   R ++ E M  G L K  LR           L     + +A D A G  
Sbjct: 96  VRCIGVSLQSLPRFILMELMAGGDL-KSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 154
Query: 212 FLHGAERPVIYRDFKTSNILLNADFS---AKLSDFGLAKDGPMGDQTHVSTRVMGTYGYA 268
           +L   E   I+RD    N LL        AK+ DFG+A+D             M    + 
Sbjct: 155 YLE--ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWM 212
Query: 269 APEYVMTGHLTARSDVYGFGVVLLEML 295
            PE  M G  T+++D + FGV+L E+ 
Sbjct: 213 PPEAFMEGIFTSKTDTWSFGVLLWEIF 239

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 59/200 (29%), Positives = 95/200 (47%), Gaps = 14/200 (7%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIK-ELNRGGYQGDREWLAEVNYLGQLRHSNLV 158
           +GEG +GVVYK       +  Y  TF   K  L +         + E++ L +L+HSN+V
Sbjct: 10  IGEGTYGVVYKA------QNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIV 63
Query: 159 KLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAER 218
           KL       +  +LV+E+++     K LL      L         L    G+A+ H  +R
Sbjct: 64  KLYDVIHTKKRLVLVFEHLDQDL--KKLLDVCEGGLESVTAKSFLLQLLNGIAYCH--DR 119
Query: 219 PVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVM-TGH 277
            V++RD K  N+L+N +   K++DFGLA+    G      T  + T  Y AP+ +M +  
Sbjct: 120 RVLHRDLKPQNLLINREGELKIADFGLAR--AFGIPVRKYTHEVVTLWYRAPDVLMGSKK 177
Query: 278 LTARSDVYGFGVVLLEMLLG 297
            +   D++  G +  EM+ G
Sbjct: 178 YSTTIDIWSVGCIFAEMVNG 197

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 90/207 (43%), Gaps = 16/207 (7%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTF-VAIKELNR-GGYQGDREWLAEVNYLGQLRHSNL 157
           LG G FG VY+G +  +  P   +   VA+K L      Q + ++L E   + +  H N+
Sbjct: 65  LGHGAFGEVYEGQV--SGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 122
Query: 158 VKLIGYCCEDEHRILVYEYMESGSLEKHLLRRV------GCMLTWSRRMKIALDAAKGLA 211
           V+ IG   +   R ++ E M  G L K  LR           L     + +A D A G  
Sbjct: 123 VRCIGVSLQSLPRFILLELMAGGDL-KSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 181
Query: 212 FLHGAERPVIYRDFKTSNILLNADFS---AKLSDFGLAKDGPMGDQTHVSTRVMGTYGYA 268
           +L   E   I+RD    N LL        AK+ DFG+A+D             M    + 
Sbjct: 182 YLE--ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWM 239
Query: 269 APEYVMTGHLTARSDVYGFGVVLLEML 295
            PE  M G  T+++D + FGV+L E+ 
Sbjct: 240 PPEAFMEGIFTSKTDTWSFGVLLWEIF 266

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 90/207 (43%), Gaps = 16/207 (7%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTF-VAIKELNR-GGYQGDREWLAEVNYLGQLRHSNL 157
           LG G FG VY+G +  +  P   +   VA+K L      Q + ++L E   + +  H N+
Sbjct: 45  LGHGAFGEVYEGQV--SGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 102
Query: 158 VKLIGYCCEDEHRILVYEYMESGSLEKHLLRRV------GCMLTWSRRMKIALDAAKGLA 211
           V+ IG   +   R ++ E M  G L K  LR           L     + +A D A G  
Sbjct: 103 VRCIGVSLQSLPRFILLELMAGGDL-KSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 161
Query: 212 FLHGAERPVIYRDFKTSNILLNADFS---AKLSDFGLAKDGPMGDQTHVSTRVMGTYGYA 268
           +L   E   I+RD    N LL        AK+ DFG+A+D             M    + 
Sbjct: 162 YLE--ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWM 219
Query: 269 APEYVMTGHLTARSDVYGFGVVLLEML 295
            PE  M G  T+++D + FGV+L E+ 
Sbjct: 220 PPEAFMEGIFTSKTDTWSFGVLLWEIF 246

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 75/276 (27%), Positives = 122/276 (44%), Gaps = 28/276 (10%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVK 159
           LG G +G VY GV  +     Y  T VA+K L     + + E+L E   + +++H NLV+
Sbjct: 40  LGGGQYGEVYVGVWKK-----YSLT-VAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQ 92
Query: 160 LIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERP 219
           L+G C  +    +V EYM  G+L  +L       +T    + +A   +  + +L   ++ 
Sbjct: 93  LLGVCTLEPPFYIVTEYMPYGNLLDYLRECNREEVTAVVLLYMATQISSAMEYLE--KKN 150
Query: 220 VIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLT 279
            I+RD    N L+  +   K++DFGL++    GD             + APE +     +
Sbjct: 151 FIHRDLAARNCLVGENHVVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAPESLAYNTFS 209
Query: 280 ARSDVYGFGVVLLEM-LLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRILDPRLEGQY 338
            +SDV+ FGV+L E+   G         S+ ++L+E          K  R+  P  EG  
Sbjct: 210 IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYDLLE----------KGYRMEQP--EG-- 255
Query: 339 TARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETV 374
                 KV  L   C   +P  RP  ++     ET+
Sbjct: 256 ---CPPKVYELMRACWKWSPADRPSFAETHQAFETM 288

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 90/207 (43%), Gaps = 16/207 (7%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTF-VAIKELNR-GGYQGDREWLAEVNYLGQLRHSNL 157
           LG G FG VY+G +  +  P   +   VA+K L      Q + ++L E   + +  H N+
Sbjct: 39  LGHGAFGEVYEGQV--SGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 96
Query: 158 VKLIGYCCEDEHRILVYEYMESGSLEKHLLRRV------GCMLTWSRRMKIALDAAKGLA 211
           V+ IG   +   R ++ E M  G L K  LR           L     + +A D A G  
Sbjct: 97  VRCIGVSLQSLPRFILLELMAGGDL-KSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 155
Query: 212 FLHGAERPVIYRDFKTSNILLNADFS---AKLSDFGLAKDGPMGDQTHVSTRVMGTYGYA 268
           +L   E   I+RD    N LL        AK+ DFG+A+D             M    + 
Sbjct: 156 YLE--ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAQDIYRASYYRKGGCAMLPVKWM 213
Query: 269 APEYVMTGHLTARSDVYGFGVVLLEML 295
            PE  M G  T+++D + FGV+L E+ 
Sbjct: 214 PPEAFMEGIFTSKTDTWSFGVLLWEIF 240

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 59/200 (29%), Positives = 95/200 (47%), Gaps = 14/200 (7%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIK-ELNRGGYQGDREWLAEVNYLGQLRHSNLV 158
           +GEG +GVVYK       +  Y  TF   K  L +         + E++ L +L+HSN+V
Sbjct: 10  IGEGTYGVVYKA------QNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIV 63
Query: 159 KLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAER 218
           KL       +  +LV+E+++     K LL      L         L    G+A+ H  +R
Sbjct: 64  KLYDVIHTKKRLVLVFEHLDQDL--KKLLDVCEGGLESVTAKSFLLQLLNGIAYCH--DR 119
Query: 219 PVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVM-TGH 277
            V++RD K  N+L+N +   K++DFGLA+    G      T  + T  Y AP+ +M +  
Sbjct: 120 RVLHRDLKPQNLLINREGELKIADFGLAR--AFGIPVRKYTHEVVTLWYRAPDVLMGSKK 177
Query: 278 LTARSDVYGFGVVLLEMLLG 297
            +   D++  G +  EM+ G
Sbjct: 178 YSTTIDIWSVGCIFAEMVNG 197

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 82/304 (26%), Positives = 127/304 (41%), Gaps = 50/304 (16%)
Query: 100 LGEGGFGVVYKGVIDEN-VRPGYKTTFVAIKELNRGGYQG-DREWLAEVNYLGQLRHSNL 157
           +GEG +G+V     + N VR       VAIK+++   +Q   +  L E+  L + RH N+
Sbjct: 35  IGEGAYGMVCSAYDNLNKVR-------VAIKKISPFEHQTYCQRTLREIKILLRFRHENI 87
Query: 158 VKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCM-LTWSRRMKIALDAAKGLAFLHGA 216
           + +           +   Y+    +E  L + + C  L+            +GL ++H A
Sbjct: 88  IGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKCQHLSNDHICYFLYQILRGLKYIHSA 147
Query: 217 ERPVIYRDFKTSNILLNADFSAKLSDFGLAKDG-PMGDQTHVSTRVMGTYGYAAPEYVMT 275
              V++RD K SN+LLN     K+ DFGLA+   P  D T   T  + T  Y APE ++ 
Sbjct: 148 N--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 205
Query: 276 GH-LTARSDVYGFGVVLLEML------LGRRAVDK--------SRPSRE----------- 309
               T   D++  G +L EML       G+  +D+          PS+E           
Sbjct: 206 SKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKAR 265
Query: 310 --------HNLVEWARPLLNNNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQ--NPK 359
                    N V W R   N + K L +LD  L      R  ++ A LA+  L Q  +P 
Sbjct: 266 NYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQA-LAHPYLEQYYDPS 324
Query: 360 GRPV 363
             P+
Sbjct: 325 DEPI 328

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 67/272 (24%), Positives = 112/272 (41%), Gaps = 35/272 (12%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQG---DREWLAEVNYLGQLRHSN 156
           LG+G FG VY        R       +A+K L +   +    + +   EV     LRH N
Sbjct: 42  LGKGKFGNVYLA------REKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 95
Query: 157 LVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGA 216
           +++L GY  +     L+ EY   G++ + L +         R      + A  L++ H  
Sbjct: 96  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKL--SKFDEQRTATYITELANALSYCHS- 152
Query: 217 ERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTG 276
            + VI+RD K  N+LL +    K++DFG +   P   +    T + GT  Y  PE +   
Sbjct: 153 -KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----TTLCGTLDYLPPEMIEGR 207
Query: 277 HLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRILDPRLEG 336
               + D++  GV+  E L+G       +P  E N  +         K++ R+     E 
Sbjct: 208 MHDEKVDLWSLGVLCYEFLVG-------KPPFEANTYQ------ETYKRISRV-----EF 249
Query: 337 QYTARTAMKVAGLAYQCLSQNPKGRPVMSDVV 368
            +          L  + L  NP  RP++ +V+
Sbjct: 250 TFPDFVTEGARDLISRLLKHNPSQRPMLREVL 281

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 72.0 bits (175), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 89/207 (42%), Gaps = 16/207 (7%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTF-VAIKELNR-GGYQGDREWLAEVNYLGQLRHSNL 157
           LG G FG VY+G +     P   +   VA+K L      Q + ++L E   + +  H N+
Sbjct: 30  LGHGAFGEVYEGQVSG--MPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 87
Query: 158 VKLIGYCCEDEHRILVYEYMESGSLEKHLLRRV------GCMLTWSRRMKIALDAAKGLA 211
           V+ IG   +   R ++ E M  G L K  LR           L     + +A D A G  
Sbjct: 88  VRCIGVSLQSLPRFILLELMAGGDL-KSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 146
Query: 212 FLHGAERPVIYRDFKTSNILLNADFS---AKLSDFGLAKDGPMGDQTHVSTRVMGTYGYA 268
           +L   E   I+RD    N LL        AK+ DFG+A+D             M    + 
Sbjct: 147 YLE--ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWM 204
Query: 269 APEYVMTGHLTARSDVYGFGVVLLEML 295
            PE  M G  T+++D + FGV+L E+ 
Sbjct: 205 PPEAFMEGIFTSKTDTWSFGVLLWEIF 231

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 72.0 bits (175), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 45/127 (35%), Positives = 72/127 (56%), Gaps = 5/127 (3%)
Query: 172 LVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNIL 231
           +V EY++  +L + ++   G M T  R +++  DA + L F H  +  +I+RD K +NIL
Sbjct: 93  IVMEYVDGVTL-RDIVHTEGPM-TPKRAIEVIADACQALNFSH--QNGIIHRDVKPANIL 148
Query: 232 LNADFSAKLSDFGLAKD-GPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVV 290
           ++A  + K+ DFG+A+     G+    +  V+GT  Y +PE      + ARSDVY  G V
Sbjct: 149 ISATNAVKVVDFGIARAIADSGNSVXQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCV 208
Query: 291 LLEMLLG 297
           L E+L G
Sbjct: 209 LYEVLTG 215

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 72.0 bits (175), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 82/291 (28%), Positives = 130/291 (44%), Gaps = 37/291 (12%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDRE-WLAEVNYLGQLRHSNLV 158
           +GEG FG V++G+    + P      VAIK          RE +L E   + Q  H ++V
Sbjct: 398 IGEGQFGDVHQGIY---MSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 454
Query: 159 KLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAER 218
           KLIG   E+   I++ E    G L   L  R    L  +  +  A   +  LA+L    +
Sbjct: 455 KLIGVITENPVWIIM-ELCTLGELRSFLQVR-KFSLDLASLILYAYQLSTALAYLES--K 510
Query: 219 PVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHV-STRVMGTYGYAAPEYVMTGH 277
             ++RD    N+L++A    KL DFGL++   M D T+  +++      + APE +    
Sbjct: 511 RFVHRDIAARNVLVSATDCVKLGDFGLSRY--MEDSTYYKASKGKLPIKWMAPESINFRR 568
Query: 278 LTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPL--LNNNKKVLRILD-PRL 334
            T+ SDV+ FGV + E+L+             H +    +P   + NN  + RI +  RL
Sbjct: 569 FTSASDVWMFGVCMWEILM-------------HGV----KPFQGVKNNDVIGRIENGERL 611
Query: 335 EGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETVQSQGAEEEMLQ 385
                      +  L  +C + +P  RP  +++ A L T+     EEE LQ
Sbjct: 612 P--MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI----LEEEKLQ 656

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 72.0 bits (175), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 103/214 (48%), Gaps = 21/214 (9%)
Query: 100 LGEGGFG--VVYKGVIDENVRPGYKTTFVAIKELNRGGYQGD-REWLAEVNYLGQL-RHS 155
           LGEG FG  V+ + V  +  +P    T VA+K L     + D  + ++E+  +  + +H 
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVT-VAVKMLKDDATEKDLSDLVSEMEMMKMIGKHK 101
Query: 156 NLVKLIGYCCEDEHRILVYEYMESGSLEKHL-LRRVGCM-------------LTWSRRMK 201
           N++ L+G C +D    ++  Y   G+L ++L  RR   M             +T+   + 
Sbjct: 102 NIINLLGACTQDGPLYVIVGYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVS 161
Query: 202 IALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRV 261
                A+G+ +L  A +  I+RD    N+L+  +   K++DFGLA+D    D    +T  
Sbjct: 162 CTYQLARGMEYL--ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219
Query: 262 MGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEML 295
                + APE +     T +SDV+ FGV++ E+ 
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIF 253

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 72.0 bits (175), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 80/303 (26%), Positives = 127/303 (41%), Gaps = 49/303 (16%)
Query: 100 LGEGGFGVVYK----GVIDENVRPGYKTTFVAIKELNRGGYQGDREWL-AEVNYLGQL-R 153
           LG G FG V +    G+  E+         VA+K L    +  ++E L +E+  +  L +
Sbjct: 54  LGAGAFGKVVEATAFGLGKEDA-----VLKVAVKMLKSTAHADEKEALMSELKIMSHLGQ 108
Query: 154 HSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCML-----------TWSRR--M 200
           H N+V L+G C      +++ EY   G L  + LRR   +L           T S R  +
Sbjct: 109 HENIVNLLGACTHGGPVLVITEYCCYGDL-LNFLRRKSRVLETDPAFAIANSTASTRDLL 167
Query: 201 KIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTH-VST 259
             +   A+G+AFL  A +  I+RD    N+LL     AK+ DFGLA+D  M D  + V  
Sbjct: 168 HFSSQVAQGMAFL--ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARD-IMNDSNYIVKG 224
Query: 260 RVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEML-LGRRAVDKSRPSREHNLVEWARP 318
                  + APE +     T +SDV+ +G++L E+  LG                    P
Sbjct: 225 NARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPY----------------P 268
Query: 319 LLNNNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETVQSQG 378
            +  N K  +++    +    A     +  +   C +  P  RP    + + L   Q Q 
Sbjct: 269 GILVNSKFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFL---QEQA 325
Query: 379 AEE 381
            E+
Sbjct: 326 QED 328

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 96/205 (46%), Gaps = 15/205 (7%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKE--LNRGGYQGDREWLAEVNYLGQLRHSNL 157
           +GEG +GVVYK       R       VA+K+  L+          + E++ L +L H N+
Sbjct: 15  IGEGTYGVVYKA------RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 68
Query: 158 VKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAE 217
           VKL+     +    LV+E++    L+K +       +             +GLAF H   
Sbjct: 69  VKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR 127
Query: 218 RPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVM-TG 276
             V++RD K  N+L+N + + KL+DFGLA+    G      T  + T  Y APE ++   
Sbjct: 128 --VLHRDLKPQNLLINTEGAIKLADFGLARA--FGVPVRTYTHEVVTLWYRAPEILLGCK 183
Query: 277 HLTARSDVYGFGVVLLEMLLGRRAV 301
           + +   D++  G +  EM + RRA+
Sbjct: 184 YYSTAVDIWSLGCIFAEM-VTRRAL 207

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 70/285 (24%), Positives = 126/285 (44%), Gaps = 28/285 (9%)
Query: 99  ILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLV 158
           ILGEG FG V +G + +      K     +K L+    +   E+L+E   +    H N++
Sbjct: 41  ILGEGEFGSVMEGNLKQEDGTSLKVAVKTMK-LDNSSQREIEEFLSEAACMKDFSHPNVI 99
Query: 159 KLIGYCCEDEHR-----ILVYEYMESGSLEKHLL-RRVGC---MLTWSRRMKIALDAAKG 209
           +L+G C E   +     +++  +M+ G L  +LL  R+      +     +K  +D A G
Sbjct: 100 RLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALG 159
Query: 210 LAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAA 269
           + +L  + R  ++RD    N +L  D +  ++DFGL+K    GD             + A
Sbjct: 160 MEYL--SNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIA 217
Query: 270 PEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRI 329
            E +     T++SDV+ FGV + E  +  R +      + H + ++   LL+ ++  L+ 
Sbjct: 218 IESLADRVYTSKSDVWAFGVTMWE--IATRGMTPYPGVQNHEMYDY---LLHGHR--LKQ 270
Query: 330 LDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETV 374
            +  L+  Y          + Y C   +P  RP  S +   LE +
Sbjct: 271 PEDCLDELYE---------IMYSCWRTDPLDRPTFSVLRLQLEKL 306

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 68/272 (25%), Positives = 113/272 (41%), Gaps = 35/272 (12%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQG---DREWLAEVNYLGQLRHSN 156
           LG+G FG VY        R       +A+K L +   +    + +   EV     LRH N
Sbjct: 17  LGKGKFGNVYLA------REKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 70
Query: 157 LVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGA 216
           +++L GY  +     L+ EY   G++ + L +         R      + A  L++ H  
Sbjct: 71  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKL--SKFDEQRTATYITELANALSYCHS- 127
Query: 217 ERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTG 276
            + VI+RD K  N+LL +    K++DFG +   P   +T +S    GT  Y  PE +   
Sbjct: 128 -KRVIHRDIKPENLLLGSAGELKIADFGWSCHAPSSRRTTLS----GTLDYLPPEMIEGR 182
Query: 277 HLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRILDPRLEG 336
               + D++  GV+  E L+G       +P  E N  +         K++ R+     E 
Sbjct: 183 MHDEKVDLWSLGVLCYEFLVG-------KPPFEANTYQ------ETYKRISRV-----EF 224
Query: 337 QYTARTAMKVAGLAYQCLSQNPKGRPVMSDVV 368
            +          L  + L  NP  RP++ +V+
Sbjct: 225 TFPDFVTEGARDLISRLLKHNPSQRPMLREVL 256

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 96/205 (46%), Gaps = 15/205 (7%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKE--LNRGGYQGDREWLAEVNYLGQLRHSNL 157
           +GEG +GVVYK       R       VA+K+  L+          + E++ L +L H N+
Sbjct: 18  IGEGTYGVVYKA------RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 71
Query: 158 VKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAE 217
           VKL+     +    LV+E++    L+K +       +             +GLAF H   
Sbjct: 72  VKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR 130
Query: 218 RPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVM-TG 276
             V++RD K  N+L+N + + KL+DFGLA+    G      T  + T  Y APE ++   
Sbjct: 131 --VLHRDLKPQNLLINTEGAIKLADFGLARA--FGVPVRTYTHEVVTLWYRAPEILLGXK 186
Query: 277 HLTARSDVYGFGVVLLEMLLGRRAV 301
           + +   D++  G +  EM + RRA+
Sbjct: 187 YYSTAVDIWSLGCIFAEM-VTRRAL 210

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 90/207 (43%), Gaps = 16/207 (7%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTF-VAIKELNR-GGYQGDREWLAEVNYLGQLRHSNL 157
           LG G FG VY+G +  +  P   +   VA+K L      Q + ++L E   + +  H N+
Sbjct: 56  LGHGAFGEVYEGQV--SGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 113
Query: 158 VKLIGYCCEDEHRILVYEYMESGSLEKHLLRRV------GCMLTWSRRMKIALDAAKGLA 211
           V+ IG   +   R ++ E M  G L K  LR           L     + +A D A G  
Sbjct: 114 VRCIGVSLQSLPRFILLELMAGGDL-KSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 172
Query: 212 FLHGAERPVIYRDFKTSNILLNADFS---AKLSDFGLAKDGPMGDQTHVSTRVMGTYGYA 268
           +L   E   I+RD    N LL        AK+ DFG+A+D             M    + 
Sbjct: 173 YLE--ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWM 230
Query: 269 APEYVMTGHLTARSDVYGFGVVLLEML 295
            PE  M G  T+++D + FGV+L E+ 
Sbjct: 231 PPEAFMEGIFTSKTDTWSFGVLLWEIF 257

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 96/205 (46%), Gaps = 15/205 (7%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKE--LNRGGYQGDREWLAEVNYLGQLRHSNL 157
           +GEG +GVVYK       R       VA+K+  L+          + E++ L +L H N+
Sbjct: 18  IGEGTYGVVYKA------RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 71
Query: 158 VKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAE 217
           VKL+     +    LV+E++    L+K +       +             +GLAF H   
Sbjct: 72  VKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR 130
Query: 218 RPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVM-TG 276
             V++RD K  N+L+N + + KL+DFGLA+    G      T  + T  Y APE ++   
Sbjct: 131 --VLHRDLKPQNLLINTEGAIKLADFGLARA--FGVPVRTYTHEVVTLWYRAPEILLGCK 186
Query: 277 HLTARSDVYGFGVVLLEMLLGRRAV 301
           + +   D++  G +  EM + RRA+
Sbjct: 187 YYSTAVDIWSLGCIFAEM-VTRRAL 210

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 71.6 bits (174), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 100/207 (48%), Gaps = 26/207 (12%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLA-----EVNYLGQLRH 154
           +GEG +GVVYK           K +   I  L R     + E +      E++ L +L H
Sbjct: 29  VGEGTYGVVYKA----------KDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHH 78
Query: 155 SNLVKLIGYCCEDEHRILVYEYMESGSLEKHL-LRRVGCMLTWSRRMKIAL-DAAKGLAF 212
            N+V LI     +    LV+E+ME   L+K L   + G       ++KI L    +G+A 
Sbjct: 79  PNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDENKTGLQ---DSQIKIYLYQLLRGVAH 134
Query: 213 LHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEY 272
            H  +  +++RD K  N+L+N+D + KL+DFGLA+    G      T  + T  Y AP+ 
Sbjct: 135 CH--QHRILHRDLKPQNLLINSDGALKLADFGLAR--AFGIPVRSYTHEVVTLWYRAPDV 190
Query: 273 VM-TGHLTARSDVYGFGVVLLEMLLGR 298
           +M +   +   D++  G +  EM+ G+
Sbjct: 191 LMGSKKYSTSVDIWSIGCIFAEMITGK 217

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 71.6 bits (174), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 100/207 (48%), Gaps = 26/207 (12%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLA-----EVNYLGQLRH 154
           +GEG +GVVYK           K +   I  L R     + E +      E++ L +L H
Sbjct: 29  VGEGTYGVVYKA----------KDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHH 78
Query: 155 SNLVKLIGYCCEDEHRILVYEYMESGSLEKHL-LRRVGCMLTWSRRMKIAL-DAAKGLAF 212
            N+V LI     +    LV+E+ME   L+K L   + G       ++KI L    +G+A 
Sbjct: 79  PNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDENKTGLQ---DSQIKIYLYQLLRGVA- 133
Query: 213 LHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEY 272
            H  +  +++RD K  N+L+N+D + KL+DFGLA+    G      T  + T  Y AP+ 
Sbjct: 134 -HCHQHRILHRDLKPQNLLINSDGALKLADFGLAR--AFGIPVRSYTHEVVTLWYRAPDV 190
Query: 273 VM-TGHLTARSDVYGFGVVLLEMLLGR 298
           +M +   +   D++  G +  EM+ G+
Sbjct: 191 LMGSKKYSTSVDIWSIGCIFAEMITGK 217

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 71.6 bits (174), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 71/270 (26%), Positives = 119/270 (44%), Gaps = 31/270 (11%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLA-EVNYLGQLRHSNLV 158
           +G+G FG VYKG ID + +       VAIK ++    + + E +  E+  L Q     + 
Sbjct: 27  IGKGSFGEVYKG-IDNHTK-----EVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 80
Query: 159 KLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAER 218
           +  G   +     ++ EY+  GS     L + G  L  +    I  +  KGL +LH   +
Sbjct: 81  RYFGSYLKSTKLWIIMEYLGGGSALD--LLKPGP-LEETYIATILREILKGLDYLHSERK 137
Query: 219 PVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHL 278
             I+RD K +N+LL+     KL+DFG+A  G + D        +GT  + APE +     
Sbjct: 138 --IHRDIKAANVLLSEQGDVKLADFGVA--GQLTDTQIKRNXFVGTPFWMAPEVIKQSAY 193
Query: 279 TARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRILDPRLEGQY 338
             ++D++  G+  +E+  G        P R   L+    P             P LEGQ+
Sbjct: 194 DFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSP-------------PTLEGQH 240
Query: 339 TARTAMKVAGLAYQCLSQNPKGRPVMSDVV 368
           +      V      CL+++P+ RP   +++
Sbjct: 241 SKPFKEFVEA----CLNKDPRFRPTAKELL 266

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 71.6 bits (174), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 81/291 (27%), Positives = 131/291 (45%), Gaps = 37/291 (12%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDRE-WLAEVNYLGQLRHSNLV 158
           +GEG FG V++G+    + P      VAIK          RE +L E   + Q  H ++V
Sbjct: 398 IGEGQFGDVHQGIY---MSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 454
Query: 159 KLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAER 218
           KLIG   E+   I++ E    G L   L  R    L  +  +  A   +  LA+L    +
Sbjct: 455 KLIGVITENPVWIIM-ELCTLGELRSFLQVR-KFSLDLASLILYAYQLSTALAYLES--K 510
Query: 219 PVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHV-STRVMGTYGYAAPEYVMTGH 277
             ++RD    N+L++++   KL DFGL++   M D T+  +++      + APE +    
Sbjct: 511 RFVHRDIAARNVLVSSNDCVKLGDFGLSRY--MEDSTYYKASKGKLPIKWMAPESINFRR 568
Query: 278 LTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPL--LNNNKKVLRILD-PRL 334
            T+ SDV+ FGV + E+L+             H +    +P   + NN  + RI +  RL
Sbjct: 569 FTSASDVWMFGVCMWEILM-------------HGV----KPFQGVKNNDVIGRIENGERL 611
Query: 335 EGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETVQSQGAEEEMLQ 385
                      +  L  +C + +P  RP  +++ A L T+     EEE LQ
Sbjct: 612 P--MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI----LEEEKLQ 656

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 71.6 bits (174), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 90/207 (43%), Gaps = 16/207 (7%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTF-VAIKELNR-GGYQGDREWLAEVNYLGQLRHSNL 157
           LG G FG VY+G +  +  P   +   VA+K L      Q + ++L E   + +  H N+
Sbjct: 79  LGHGAFGEVYEGQV--SGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 136
Query: 158 VKLIGYCCEDEHRILVYEYMESGSLEKHLLRRV------GCMLTWSRRMKIALDAAKGLA 211
           V+ IG   +   R ++ E M  G L K  LR           L     + +A D A G  
Sbjct: 137 VRCIGVSLQSLPRFILLELMAGGDL-KSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 195
Query: 212 FLHGAERPVIYRDFKTSNILLNADFS---AKLSDFGLAKDGPMGDQTHVSTRVMGTYGYA 268
           +L   E   I+RD    N LL        AK+ DFG+A+D             M    + 
Sbjct: 196 YLE--ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWM 253
Query: 269 APEYVMTGHLTARSDVYGFGVVLLEML 295
            PE  M G  T+++D + FGV+L E+ 
Sbjct: 254 PPEAFMEGIFTSKTDTWSFGVLLWEIF 280

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 71.6 bits (174), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 85/309 (27%), Positives = 129/309 (41%), Gaps = 60/309 (19%)
Query: 100 LGEGGFGVVYKGVIDEN-VRPGYKTTFVAIKELNRGGYQGD-REWLAEVNYLGQLRHSNL 157
           +GEG +G+V     + N VR       VAIK+++   +Q   +  L E+  L + RH N+
Sbjct: 51  IGEGAYGMVCSAYDNVNKVR-------VAIKKISPFEHQTYCQRTLREIKILLRFRHENI 103
Query: 158 VKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMK------IALDAAKGLA 211
           + +      D  R    E M+   L  HL+      L  ++ +             +GL 
Sbjct: 104 IGI-----NDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLK 158
Query: 212 FLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDG-PMGDQTHVSTRVMGTYGYAAP 270
           ++H A   V++RD K SN+LLN     K+ DFGLA+   P  D T   T  + T  Y AP
Sbjct: 159 YIHSAN--VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 216
Query: 271 EYVMTGH-LTARSDVYGFGVVLLEML------LGRRAVDK--------SRPSRE------ 309
           E ++     T   D++  G +L EML       G+  +D+          PS+E      
Sbjct: 217 EIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCII 276
Query: 310 -------------HNLVEWARPLLNNNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQ 356
                         N V W R   N + K L +LD  L      R  ++ A LA+  L Q
Sbjct: 277 NLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQA-LAHPYLEQ 335
Query: 357 --NPKGRPV 363
             +P   P+
Sbjct: 336 YYDPSDEPI 344

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 71.6 bits (174), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 96/205 (46%), Gaps = 15/205 (7%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKE--LNRGGYQGDREWLAEVNYLGQLRHSNL 157
           +GEG +GVVYK       R       VA+K+  L+          + E++ L +L H N+
Sbjct: 10  IGEGTYGVVYKA------RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 158 VKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAE 217
           VKL+     +    LV+E++    L+K +       +             +GLAF H   
Sbjct: 64  VKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR 122
Query: 218 RPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVM-TG 276
             V++RD K  N+L+N + + KL+DFGLA+    G      T  + T  Y APE ++   
Sbjct: 123 --VLHRDLKPQNLLINTEGAIKLADFGLARA--FGVPVRTYTHEVVTLWYRAPEILLGCK 178
Query: 277 HLTARSDVYGFGVVLLEMLLGRRAV 301
           + +   D++  G +  EM + RRA+
Sbjct: 179 YYSTAVDIWSLGCIFAEM-VTRRAL 202

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 71.6 bits (174), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 78/311 (25%), Positives = 124/311 (39%), Gaps = 56/311 (18%)
Query: 100 LGEGGFGVVYK----GVIDENVRPGYKTTFVAIKELNRGGYQGDREWL-AEVNYLGQL-R 153
           LG G FG V +    G+  E+         VA+K L    +  ++E L +E+  +  L +
Sbjct: 39  LGAGAFGKVVEATAFGLGKEDA-----VLKVAVKMLKSTAHADEKEALMSELKIMSHLGQ 93
Query: 154 HSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRR-------------- 199
           H N+V L+G C      +++ EY   G L   L R+   ML  S                
Sbjct: 94  HENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEAMLGPSLAPGQDPEGLDKEDGR 153
Query: 200 -------MKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMG 252
                  +  +   A+G+AFL  A +  I+RD    N+LL     AK+ DFGLA+D  M 
Sbjct: 154 PLELRDLLHFSSQVAQGMAFL--ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARD-IMN 210
Query: 253 DQTH-VSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEML-LGRRAVDKSRPSREH 310
           D  + V         + APE +     T +SDV+ +G++L E+  LG             
Sbjct: 211 DSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPY--------- 261
Query: 311 NLVEWARPLLNNNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVAL 370
                  P +  N K  +++    +    A     +  +   C +  P  RP    + + 
Sbjct: 262 -------PGILVNSKFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSF 314
Query: 371 LETVQSQGAEE 381
           L   Q Q  E+
Sbjct: 315 L---QEQAQED 322

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 64/207 (30%), Positives = 100/207 (48%), Gaps = 23/207 (11%)
Query: 99  ILGEGGFGVVYKGVIDENVRPGYKTTFV-------AIKELNRGGYQGDREWLAEVNYLGQ 151
           +LG+G FG V+  ++ +  RP     +         +K  +R   + +R+ LA+VN    
Sbjct: 35  VLGQGSFGKVF--LVRKVTRPDSGHLYAMKVLKKATLKVRDRVRTKMERDILADVN---- 88
Query: 152 LRHSNLVKLIGYCCEDEHRI-LVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGL 210
             H  +VKL  Y  + E ++ L+ +++  G L   L + V  M T         + A GL
Sbjct: 89  --HPFVVKL-HYAFQTEGKLYLILDFLRGGDLFTRLSKEV--MFTEEDVKFYLAELALGL 143
Query: 211 AFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAP 270
             LH     +IYRD K  NILL+ +   KL+DFGL+K+    D    +    GT  Y AP
Sbjct: 144 DHLHSL--GIIYRDLKPENILLDEEGHIKLTDFGLSKEAI--DHEKKAYSFCGTVEYMAP 199
Query: 271 EYVMTGHLTARSDVYGFGVVLLEMLLG 297
           E V     +  +D + +GV++ EML G
Sbjct: 200 EVVNRQGHSHSADWWSYGVLMFEMLTG 226

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 96/205 (46%), Gaps = 15/205 (7%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKE--LNRGGYQGDREWLAEVNYLGQLRHSNL 157
           +GEG +GVVYK       R       VA+K+  L+          + E++ L +L H N+
Sbjct: 11  IGEGTYGVVYKA------RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 158 VKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAE 217
           VKL+     +    LV+E++    L+K +       +             +GLAF H   
Sbjct: 65  VKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR 123
Query: 218 RPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVM-TG 276
             V++RD K  N+L+N + + KL+DFGLA+    G      T  + T  Y APE ++   
Sbjct: 124 --VLHRDLKPQNLLINTEGAIKLADFGLARA--FGVPVRTYTHEVVTLWYRAPEILLGCK 179
Query: 277 HLTARSDVYGFGVVLLEMLLGRRAV 301
           + +   D++  G +  EM + RRA+
Sbjct: 180 YYSTAVDIWSLGCIFAEM-VTRRAL 203

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 68/272 (25%), Positives = 111/272 (40%), Gaps = 35/272 (12%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQG---DREWLAEVNYLGQLRHSN 156
           LG+G FG VY        R       +A+K L +   +    + +   EV     LRH N
Sbjct: 21  LGKGKFGNVYLA------REKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 74
Query: 157 LVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGA 216
           +++L GY  +     L+ EY   G + K L +         R      + A  L++ H  
Sbjct: 75  ILRLYGYFHDATRVYLILEYAPRGEVYKELQKL--SKFDEQRTATYITELANALSYCHS- 131
Query: 217 ERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTG 276
            + VI+RD K  N+LL +    K++DFG +   P   +    T + GT  Y  PE +   
Sbjct: 132 -KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----TTLCGTLDYLPPEMIEGR 186
Query: 277 HLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRILDPRLEG 336
               + D++  GV+  E L+G       +P  E N  +         K++ R+     E 
Sbjct: 187 MHDEKVDLWSLGVLCYEFLVG-------KPPFEANTYQ------ETYKRISRV-----EF 228
Query: 337 QYTARTAMKVAGLAYQCLSQNPKGRPVMSDVV 368
            +          L  + L  NP  RP++ +V+
Sbjct: 229 TFPDFVTEGARDLISRLLKHNPSQRPMLREVL 260

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 96/205 (46%), Gaps = 15/205 (7%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKE--LNRGGYQGDREWLAEVNYLGQLRHSNL 157
           +GEG +GVVYK       R       VA+K+  L+          + E++ L +L H N+
Sbjct: 12  IGEGTYGVVYKA------RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 65
Query: 158 VKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAE 217
           VKL+     +    LV+E++    L+K +       +             +GLAF H   
Sbjct: 66  VKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR 124
Query: 218 RPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVM-TG 276
             V++RD K  N+L+N + + KL+DFGLA+    G      T  + T  Y APE ++   
Sbjct: 125 --VLHRDLKPQNLLINTEGAIKLADFGLARA--FGVPVRTYTHEVVTLWYRAPEILLGCK 180
Query: 277 HLTARSDVYGFGVVLLEMLLGRRAV 301
           + +   D++  G +  EM + RRA+
Sbjct: 181 YYSTAVDIWSLGCIFAEM-VTRRAL 204

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 82/292 (28%), Positives = 132/292 (45%), Gaps = 39/292 (13%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDRE-WLAEVNYLGQLRHSNLV 158
           +GEG FG V++G+    + P      VAIK          RE +L E   + Q  H ++V
Sbjct: 18  IGEGQFGDVHQGIY---MSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 74
Query: 159 KLIGYCCEDEHRILVYEYMESGSLEKHL-LRRVGCMLTWSRRMKIALDAAKGLAFLHGAE 217
           KLIG   E+   I++ E    G L   L +R+    L  +  +  A   +  LA+L    
Sbjct: 75  KLIGVITENPVWIIM-ELCTLGELRSFLQVRKFS--LDLASLILYAYQLSTALAYLES-- 129
Query: 218 RPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHV-STRVMGTYGYAAPEYVMTG 276
           +  ++RD    N+L++A    KL DFGL++   M D T+  +++      + APE +   
Sbjct: 130 KRFVHRDIAARNVLVSATDCVKLGDFGLSRY--MEDSTYYKASKGKLPIKWMAPESINFR 187
Query: 277 HLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPL--LNNNKKVLRILD-PR 333
             T+ SDV+ FGV + E+L+             H +    +P   + NN  + RI +  R
Sbjct: 188 RFTSASDVWMFGVCMWEILM-------------HGV----KPFQGVKNNDVIGRIENGER 230
Query: 334 LEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETVQSQGAEEEMLQ 385
           L           +  L  +C + +P  RP  +++ A L T+     EEE LQ
Sbjct: 231 LP--MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI----LEEEKLQ 276

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 96/205 (46%), Gaps = 15/205 (7%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKE--LNRGGYQGDREWLAEVNYLGQLRHSNL 157
           +GEG +GVVYK       R       VA+K+  L+          + E++ L +L H N+
Sbjct: 11  IGEGTYGVVYKA------RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 158 VKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAE 217
           VKL+     +    LV+E++    L+K +       +             +GLAF H   
Sbjct: 65  VKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR 123
Query: 218 RPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVM-TG 276
             V++RD K  N+L+N + + KL+DFGLA+    G      T  + T  Y APE ++   
Sbjct: 124 --VLHRDLKPQNLLINTEGAIKLADFGLARA--FGVPVRTYTHEVVTLWYRAPEILLGXK 179
Query: 277 HLTARSDVYGFGVVLLEMLLGRRAV 301
           + +   D++  G +  EM + RRA+
Sbjct: 180 YYSTAVDIWSLGCIFAEM-VTRRAL 203

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 96/205 (46%), Gaps = 15/205 (7%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKE--LNRGGYQGDREWLAEVNYLGQLRHSNL 157
           +GEG +GVVYK       R       VA+K+  L+          + E++ L +L H N+
Sbjct: 11  IGEGTYGVVYKA------RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 158 VKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAE 217
           VKL+     +    LV+E++    L+K +       +             +GLAF H   
Sbjct: 65  VKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR 123
Query: 218 RPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVM-TG 276
             V++RD K  N+L+N + + KL+DFGLA+    G      T  + T  Y APE ++   
Sbjct: 124 --VLHRDLKPQNLLINTEGAIKLADFGLARA--FGVPVRTYTHEVVTLWYRAPEILLGCK 179
Query: 277 HLTARSDVYGFGVVLLEMLLGRRAV 301
           + +   D++  G +  EM + RRA+
Sbjct: 180 YYSTAVDIWSLGCIFAEM-VTRRAL 203

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 96/205 (46%), Gaps = 15/205 (7%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKE--LNRGGYQGDREWLAEVNYLGQLRHSNL 157
           +GEG +GVVYK       R       VA+K+  L+          + E++ L +L H N+
Sbjct: 10  IGEGTYGVVYKA------RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 158 VKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAE 217
           VKL+     +    LV+E++    L+K +       +             +GLAF H   
Sbjct: 64  VKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR 122
Query: 218 RPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVM-TG 276
             V++RD K  N+L+N + + KL+DFGLA+    G      T  + T  Y APE ++   
Sbjct: 123 --VLHRDLKPQNLLINTEGAIKLADFGLARA--FGVPVRTYTHEVVTLWYRAPEILLGCK 178
Query: 277 HLTARSDVYGFGVVLLEMLLGRRAV 301
           + +   D++  G +  EM + RRA+
Sbjct: 179 YYSTAVDIWSLGCIFAEM-VTRRAL 202

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 69/277 (24%), Positives = 119/277 (42%), Gaps = 45/277 (16%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLA-EVNYLGQLRHSNLV 158
           +G+G FG V+KG+ +   +       VAIK ++    + + E +  E+  L Q   S + 
Sbjct: 31  IGKGSFGEVFKGIDNRTQQ------VVAIKIIDLEEAEDEIEDIQQEITVLSQCDSSYVT 84
Query: 159 KLIGYCCEDEHRILVYEYMESGSLEKHLLR-------RVGCMLTWSRRMKIALDAAKGLA 211
           K  G   +     ++ EY+  GS    LLR       ++  ML          +  KGL 
Sbjct: 85  KYYGSYLKGSKLWIIMEYLGGGS-ALDLLRAGPFDEFQIATMLK---------EILKGLD 134
Query: 212 FLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPE 271
           +LH  ++  I+RD K +N+LL+     KL+DFG+A  G + D        +GT  + APE
Sbjct: 135 YLHSEKK--IHRDIKAANVLLSEQGDVKLADFGVA--GQLTDTQIKRNTFVGTPFWMAPE 190
Query: 272 YVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRILD 331
            +      +++D++  G+  +E+  G        P R   L+    P             
Sbjct: 191 VIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNP------------- 237
Query: 332 PRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVV 368
           P L G +T      +      CL+++P  RP   +++
Sbjct: 238 PTLVGDFTKSFKEFIDA----CLNKDPSFRPTAKELL 270

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 89/207 (42%), Gaps = 16/207 (7%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTF-VAIKELNRG-GYQGDREWLAEVNYLGQLRHSNL 157
           LG G FG VY+G +     P   +   VA+K L      Q + ++L E   + +  H N+
Sbjct: 53  LGHGAFGEVYEGQVSG--MPNDPSPLQVAVKTLPEVYSEQDELDFLMEALIISKFNHQNI 110
Query: 158 VKLIGYCCEDEHRILVYEYMESGSLEKHLLRRV------GCMLTWSRRMKIALDAAKGLA 211
           V+ IG   +   R ++ E M  G L K  LR           L     + +A D A G  
Sbjct: 111 VRCIGVSLQSLPRFILLELMAGGDL-KSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 169
Query: 212 FLHGAERPVIYRDFKTSNILLNADFS---AKLSDFGLAKDGPMGDQTHVSTRVMGTYGYA 268
           +L   E   I+RD    N LL        AK+ DFG+A+D             M    + 
Sbjct: 170 YLE--ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWM 227
Query: 269 APEYVMTGHLTARSDVYGFGVVLLEML 295
            PE  M G  T+++D + FGV+L E+ 
Sbjct: 228 PPEAFMEGIFTSKTDTWSFGVLLWEIF 254

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 99/205 (48%), Gaps = 15/205 (7%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKE--LNRGGYQGDREWLAEVNYLGQLRHSNL 157
           +GEG +GVVYK       R       VA+K+  L+          + E++ L +L H N+
Sbjct: 14  IGEGTYGVVYKA------RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 67
Query: 158 VKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAE 217
           VKL+     +    LV+E++ S  L+K +       +             +GLAF H   
Sbjct: 68  VKLLDVIHTENKLYLVFEFL-SMDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR 126
Query: 218 RPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVM-TG 276
             V++RD K  N+L+N + + KL+DFGLA+   +  +T+    V  T  Y APE ++   
Sbjct: 127 --VLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPEILLGCK 182
Query: 277 HLTARSDVYGFGVVLLEMLLGRRAV 301
           + +   D++  G +  EM + RRA+
Sbjct: 183 YYSTAVDIWSLGCIFAEM-VTRRAL 206

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 67/272 (24%), Positives = 112/272 (41%), Gaps = 35/272 (12%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQG---DREWLAEVNYLGQLRHSN 156
           LG+G FG VY        R       +A+K L +   +    + +   EV     LRH N
Sbjct: 33  LGKGKFGNVYLA------REKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 86
Query: 157 LVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGA 216
           +++L GY  +     L+ EY   G++ + L +         R      + A  L++ H  
Sbjct: 87  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKL--SKFDEQRTATYITELANALSYCHS- 143
Query: 217 ERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTG 276
            + VI+RD K  N+LL +    K++DFG +   P   +    T + GT  Y  PE +   
Sbjct: 144 -KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----TTLCGTLDYLPPEMIEGR 198
Query: 277 HLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRILDPRLEG 336
               + D++  GV+  E L+G       +P  E N  +         K++ R+     E 
Sbjct: 199 MHDEKVDLWSLGVLCYEFLVG-------KPPFEANTYQ------ETYKRISRV-----EF 240
Query: 337 QYTARTAMKVAGLAYQCLSQNPKGRPVMSDVV 368
            +          L  + L  NP  RP++ +V+
Sbjct: 241 TFPDFVTEGARDLISRLLKHNPSQRPMLREVL 272

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 63/206 (30%), Positives = 94/206 (45%), Gaps = 32/206 (15%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREW---LAEVNYLGQLRHSN 156
           +G G FG VY      +VR    +  VAIK+++  G Q + +W   + EV +L +LRH N
Sbjct: 62  IGHGSFGAVY---FARDVR---NSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 115
Query: 157 LVKLIGYCCEDEHRILVYEYM---ESGSLEKHL--LRRVGCMLTWSRRMKIALDAAKGLA 211
            ++  G    +    LV EY     S  LE H   L+ V           +   A +GLA
Sbjct: 116 TIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIA-------AVTHGALQGLA 168
Query: 212 FLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPE 271
           +LH     +I+RD K  NILL+     KL DFG A           +   +GT  + APE
Sbjct: 169 YLHSHN--MIHRDVKAGNILLSEPGLVKLGDFGSA------SIMAPANXFVGTPYWMAPE 220
Query: 272 YVMT---GHLTARSDVYGFGVVLLEM 294
            ++    G    + DV+  G+  +E+
Sbjct: 221 VILAMDEGQYDGKVDVWSLGITCIEL 246

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 99/205 (48%), Gaps = 15/205 (7%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKE--LNRGGYQGDREWLAEVNYLGQLRHSNL 157
           +GEG +GVVYK       R       VA+K+  L+          + E++ L +L H N+
Sbjct: 12  IGEGTYGVVYKA------RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 65
Query: 158 VKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAE 217
           VKL+     +    LV+E++ S  L+K +       +             +GLAF H   
Sbjct: 66  VKLLDVIHTENKLYLVFEFL-SMDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR 124
Query: 218 RPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVM-TG 276
             V++RD K  N+L+N + + KL+DFGLA+   +  +T+    V  T  Y APE ++   
Sbjct: 125 --VLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPEILLGCK 180
Query: 277 HLTARSDVYGFGVVLLEMLLGRRAV 301
           + +   D++  G +  EM + RRA+
Sbjct: 181 YYSTAVDIWSLGCIFAEM-VTRRAL 204

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 66/247 (26%), Positives = 118/247 (47%), Gaps = 42/247 (17%)
Query: 70  LRQNPGYSNVDIFTYNEMKLATKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIK 129
           ++ NP  +   +  +N++K          ++GEG FG V K  I ++   G +    AIK
Sbjct: 7   VKNNPDPTIYPVLDWNDIKFQD-------VIGEGNFGQVLKARIKKD---GLRMD-AAIK 55
Query: 130 ELNRGGYQGD-REWLAEVNYLGQL-RHSNLVKLIGYCCEDEHRILVY---EYMESGSLEK 184
            +     + D R++  E+  L +L  H N++ L+G C   EHR  +Y   EY   G+L  
Sbjct: 56  RMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGAC---EHRGYLYLAIEYAPHGNLLD 112
Query: 185 HLLRR--------------VGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNI 230
            L +                   L+  + +  A D A+G+ +L  +++  I+R+    NI
Sbjct: 113 FLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYL--SQKQFIHRNLAARNI 170
Query: 231 LLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYG--YAAPEYVMTGHLTARSDVYGFG 288
           L+  ++ AK++DFGL++    G + +V  + MG     + A E +     T  SDV+ +G
Sbjct: 171 LVGENYVAKIADFGLSR----GQEVYVK-KTMGRLPVRWMAIESLNYSVYTTNSDVWSYG 225
Query: 289 VVLLEML 295
           V+L E++
Sbjct: 226 VLLWEIV 232

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 94/203 (46%), Gaps = 11/203 (5%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVK 159
           +GEG +GVVYK     N   G       I+ L+          + E++ L +L H N+VK
Sbjct: 11  IGEGTYGVVYKA---RNKLTGEVVALXKIR-LDTETEGVPSTAIREISLLKELNHPNIVK 66
Query: 160 LIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERP 219
           L+     +    LV+E++    L+K +       +             +GLAF H     
Sbjct: 67  LLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR-- 123
Query: 220 VIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVM-TGHL 278
           V++RD K  N+L+N + + KL+DFGLA+    G      T  + T  Y APE ++   + 
Sbjct: 124 VLHRDLKPQNLLINTEGAIKLADFGLARA--FGVPVRTYTHEVVTLWYRAPEILLGCKYY 181
Query: 279 TARSDVYGFGVVLLEMLLGRRAV 301
           +   D++  G +  EM + RRA+
Sbjct: 182 STAVDIWSLGCIFAEM-VTRRAL 203

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 94/203 (46%), Gaps = 11/203 (5%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVK 159
           +GEG +GVVYK     N   G       I+ L+          + E++ L +L H N+VK
Sbjct: 10  IGEGTYGVVYKA---RNKLTGEVVALXKIR-LDTETEGVPSTAIREISLLKELNHPNIVK 65
Query: 160 LIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERP 219
           L+     +    LV+E++    L+K +       +             +GLAF H     
Sbjct: 66  LLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR-- 122
Query: 220 VIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVM-TGHL 278
           V++RD K  N+L+N + + KL+DFGLA+    G      T  + T  Y APE ++   + 
Sbjct: 123 VLHRDLKPQNLLINTEGAIKLADFGLARA--FGVPVRTYTHEVVTLWYRAPEILLGCKYY 180
Query: 279 TARSDVYGFGVVLLEMLLGRRAV 301
           +   D++  G +  EM + RRA+
Sbjct: 181 STAVDIWSLGCIFAEM-VTRRAL 202

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 67/272 (24%), Positives = 112/272 (41%), Gaps = 35/272 (12%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQG---DREWLAEVNYLGQLRHSN 156
           LG+G FG VY        R       +A+K L +   +    + +   EV     LRH N
Sbjct: 16  LGKGKFGNVYLA------REKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 69
Query: 157 LVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGA 216
           +++L GY  +     L+ EY   G++ + L +         R      + A  L++ H  
Sbjct: 70  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKL--SKFDEQRTATYITELANALSYCHS- 126
Query: 217 ERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTG 276
            + VI+RD K  N+LL +    K++DFG +   P   +T +     GT  Y  PE +   
Sbjct: 127 -KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTELC----GTLDYLPPEMIEGR 181
Query: 277 HLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRILDPRLEG 336
               + D++  GV+  E L+G       +P  E N  +         K++ R+     E 
Sbjct: 182 MHDEKVDLWSLGVLCYEFLVG-------KPPFEANTYQ------ETYKRISRV-----EF 223
Query: 337 QYTARTAMKVAGLAYQCLSQNPKGRPVMSDVV 368
            +          L  + L  NP  RP++ +V+
Sbjct: 224 TFPDFVTEGARDLISRLLKHNPSQRPMLREVL 255

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 44/127 (34%), Positives = 72/127 (56%), Gaps = 5/127 (3%)
Query: 172 LVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNIL 231
           +V EY++  +L + ++   G M T  R +++  DA + L F H  +  +I+RD K +NI+
Sbjct: 93  IVMEYVDGVTL-RDIVHTEGPM-TPKRAIEVIADACQALNFSH--QNGIIHRDVKPANIM 148
Query: 232 LNADFSAKLSDFGLAKD-GPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVV 290
           ++A  + K+ DFG+A+     G+    +  V+GT  Y +PE      + ARSDVY  G V
Sbjct: 149 ISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCV 208
Query: 291 LLEMLLG 297
           L E+L G
Sbjct: 209 LYEVLTG 215

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 44/127 (34%), Positives = 72/127 (56%), Gaps = 5/127 (3%)
Query: 172 LVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNIL 231
           +V EY++  +L + ++   G M T  R +++  DA + L F H  +  +I+RD K +NI+
Sbjct: 93  IVMEYVDGVTL-RDIVHTEGPM-TPKRAIEVIADACQALNFSH--QNGIIHRDVKPANIM 148
Query: 232 LNADFSAKLSDFGLAKD-GPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVV 290
           ++A  + K+ DFG+A+     G+    +  V+GT  Y +PE      + ARSDVY  G V
Sbjct: 149 ISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCV 208
Query: 291 LLEMLLG 297
           L E+L G
Sbjct: 209 LYEVLTG 215

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 70/234 (29%), Positives = 111/234 (47%), Gaps = 18/234 (7%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVK 159
           +G+G  G VY  +   +V  G +   VAI+++N          + E+  + + ++ N+V 
Sbjct: 29  IGQGASGTVYTAM---DVATGQE---VAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 82
Query: 160 -LIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAER 218
            L  Y   DE  + V EY+  GSL   +     CM    +   +  +  + L FLH  + 
Sbjct: 83  YLDSYLVGDELWV-VMEYLAGGSLTDVVTET--CM-DEGQIAAVCRECLQALEFLHSNQ- 137
Query: 219 PVIYRDFKTSNILLNADFSAKLSDFGL-AKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGH 277
            VI+R+ K+ NILL  D S KL+DFG  A+  P  +Q+  ST V GT  + APE V    
Sbjct: 138 -VIHRNIKSDNILLGMDGSVKLTDFGFCAQITP--EQSKRSTMV-GTPYWMAPEVVTRKA 193
Query: 278 LTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEW-ARPLLNNNKKVLRIL 330
              + D++  G++ +EM+ G        P R   L+     P L N +K+  I 
Sbjct: 194 YGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIF 247

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 81/292 (27%), Positives = 133/292 (45%), Gaps = 39/292 (13%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDRE-WLAEVNYLGQLRHSNLV 158
           +GEG FG V++G+    + P      VAIK          RE +L E   + Q  H ++V
Sbjct: 18  IGEGQFGDVHQGIY---MSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 74
Query: 159 KLIGYCCEDEHRILVYEYMESGSLEKHL-LRRVGCMLTWSRRMKIALDAAKGLAFLHGAE 217
           KLIG   E+   I++ E    G L   L +R+    L  +  +  A   +  LA+L    
Sbjct: 75  KLIGVITENPVWIIM-ELCTLGELRSFLQVRKYS--LDLASLILYAYQLSTALAYLES-- 129
Query: 218 RPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHV-STRVMGTYGYAAPEYVMTG 276
           +  ++RD    N+L++++   KL DFGL++   M D T+  +++      + APE +   
Sbjct: 130 KRFVHRDIAARNVLVSSNDCVKLGDFGLSRY--MEDSTYYKASKGKLPIKWMAPESINFR 187
Query: 277 HLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPL--LNNNKKVLRILD-PR 333
             T+ SDV+ FGV + E+L+             H +    +P   + NN  + RI +  R
Sbjct: 188 RFTSASDVWMFGVCMWEILM-------------HGV----KPFQGVKNNDVIGRIENGER 230
Query: 334 LEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETVQSQGAEEEMLQ 385
           L           +  L  +C + +P  RP  +++ A L T+     EEE LQ
Sbjct: 231 LP--MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI----LEEEKLQ 276

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 64/207 (30%), Positives = 95/207 (45%), Gaps = 34/207 (16%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREW---LAEVNYLGQLRHSN 156
           +G G FG VY      +VR    +  VAIK+++  G Q + +W   + EV +L +LRH N
Sbjct: 23  IGHGSFGAVY---FARDVR---NSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 157 LVKLIGYCCEDEHRILVYEYM---ESGSLEKHL--LRRVGCMLTWSRRMKIALDAAKGLA 211
            ++  G    +    LV EY     S  LE H   L+ V           +   A +GLA
Sbjct: 77  TIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIA-------AVTHGALQGLA 129
Query: 212 FLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKD-GPMGDQTHVSTRVMGTYGYAAP 270
           +LH     +I+RD K  NILL+     KL DFG A    P       +   +GT  + AP
Sbjct: 130 YLHSHN--MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP-------ANXFVGTPYWMAP 180
Query: 271 EYVMT---GHLTARSDVYGFGVVLLEM 294
           E ++    G    + DV+  G+  +E+
Sbjct: 181 EVILAMDEGQYDGKVDVWSLGITCIEL 207

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 65/233 (27%), Positives = 107/233 (45%), Gaps = 16/233 (6%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVK 159
           +G+G  G VY  +   +V  G +   VAI+++N          + E+  + + ++ N+V 
Sbjct: 28  IGQGASGTVYTAM---DVATGQE---VAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 81
Query: 160 -LIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAER 218
            L  Y   DE  + V EY+  GSL   +     CM    +   +  +  + L FLH  + 
Sbjct: 82  YLDSYLVGDELWV-VMEYLAGGSLTDVVTET--CM-DEGQIAAVCRECLQALEFLHSNQ- 136
Query: 219 PVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHL 278
            VI+RD K+ NILL  D S KL+DFG      +  +    + ++GT  + APE V     
Sbjct: 137 -VIHRDIKSDNILLGMDGSVKLTDFGFC--AQITPEQSKRSEMVGTPYWMAPEVVTRKAY 193
Query: 279 TARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEW-ARPLLNNNKKVLRIL 330
             + D++  G++ +EM+ G        P R   L+     P L N +K+  I 
Sbjct: 194 GPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIF 246

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 44/127 (34%), Positives = 72/127 (56%), Gaps = 5/127 (3%)
Query: 172 LVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNIL 231
           +V EY++  +L + ++   G M T  R +++  DA + L F H  +  +I+RD K +NI+
Sbjct: 93  IVMEYVDGVTL-RDIVHTEGPM-TPKRAIEVIADACQALNFSH--QNGIIHRDVKPANIM 148
Query: 232 LNADFSAKLSDFGLAKD-GPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVV 290
           ++A  + K+ DFG+A+     G+    +  V+GT  Y +PE      + ARSDVY  G V
Sbjct: 149 ISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCV 208
Query: 291 LLEMLLG 297
           L E+L G
Sbjct: 209 LYEVLTG 215

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 44/127 (34%), Positives = 72/127 (56%), Gaps = 5/127 (3%)
Query: 172 LVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNIL 231
           +V EY++  +L + ++   G M T  R +++  DA + L F H  +  +I+RD K +NI+
Sbjct: 93  IVMEYVDGVTL-RDIVHTEGPM-TPKRAIEVIADACQALNFSH--QNGIIHRDVKPANIM 148
Query: 232 LNADFSAKLSDFGLAKD-GPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVV 290
           ++A  + K+ DFG+A+     G+    +  V+GT  Y +PE      + ARSDVY  G V
Sbjct: 149 ISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCV 208
Query: 291 LLEMLLG 297
           L E+L G
Sbjct: 209 LYEVLTG 215

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 67/272 (24%), Positives = 112/272 (41%), Gaps = 35/272 (12%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQG---DREWLAEVNYLGQLRHSN 156
           LG+G FG VY        R       +A+K L +   +    + +   EV     LRH N
Sbjct: 17  LGKGKFGNVYLA------REKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 70
Query: 157 LVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGA 216
           +++L GY  +     L+ EY   G++ + L +         R      + A  L++ H  
Sbjct: 71  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKL--SKFDEQRTATYITELANALSYCHS- 127
Query: 217 ERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTG 276
            + VI+RD K  N+LL +    K++DFG +   P   +T +     GT  Y  PE +   
Sbjct: 128 -KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLC----GTLDYLPPEMIEGR 182
Query: 277 HLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRILDPRLEG 336
               + D++  GV+  E L+G       +P  E N  +         K++ R+     E 
Sbjct: 183 MHDEKVDLWSLGVLCYEFLVG-------KPPFEANTYQ------ETYKRISRV-----EF 224
Query: 337 QYTARTAMKVAGLAYQCLSQNPKGRPVMSDVV 368
            +          L  + L  NP  RP++ +V+
Sbjct: 225 TFPDFVTEGARDLISRLLKHNPSQRPMLREVL 256

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 67/272 (24%), Positives = 112/272 (41%), Gaps = 35/272 (12%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQG---DREWLAEVNYLGQLRHSN 156
           LG+G FG VY        R       +A+K L +   +    + +   EV     LRH N
Sbjct: 16  LGKGKFGNVYLA------REKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 69
Query: 157 LVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGA 216
           +++L GY  +     L+ EY   G++ + L +         R      + A  L++ H  
Sbjct: 70  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKL--SKFDEQRTATYITELANALSYCHS- 126
Query: 217 ERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTG 276
            + VI+RD K  N+LL +    K++DFG +   P   +    T + GT  Y  PE +   
Sbjct: 127 -KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----TTLCGTLDYLPPEMIEGR 181
Query: 277 HLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRILDPRLEG 336
               + D++  GV+  E L+G       +P  E N  +         K++ R+     E 
Sbjct: 182 MHDEKVDLWSLGVLCYEFLVG-------KPPFEANTYQ------ETYKRISRV-----EF 223
Query: 337 QYTARTAMKVAGLAYQCLSQNPKGRPVMSDVV 368
            +          L  + L  NP  RP++ +V+
Sbjct: 224 TFPDFVTEGARDLISRLLKHNPSQRPMLREVL 255

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 81/292 (27%), Positives = 133/292 (45%), Gaps = 39/292 (13%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDRE-WLAEVNYLGQLRHSNLV 158
           +GEG FG V++G+    + P      VAIK          RE +L E   + Q  H ++V
Sbjct: 18  IGEGQFGDVHQGIY---MSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 74
Query: 159 KLIGYCCEDEHRILVYEYMESGSLEKHL-LRRVGCMLTWSRRMKIALDAAKGLAFLHGAE 217
           KLIG   E+   I++ E    G L   L +R+    L  +  +  A   +  LA+L    
Sbjct: 75  KLIGVITENPVWIIM-ELCTLGELRSFLQVRKYS--LDLASLILYAYQLSTALAYLES-- 129
Query: 218 RPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHV-STRVMGTYGYAAPEYVMTG 276
           +  ++RD    N+L++++   KL DFGL++   M D T+  +++      + APE +   
Sbjct: 130 KRFVHRDIAARNVLVSSNDCVKLGDFGLSRY--MEDSTYYKASKGKLPIKWMAPESINFR 187
Query: 277 HLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPL--LNNNKKVLRILD-PR 333
             T+ SDV+ FGV + E+L+             H +    +P   + NN  + RI +  R
Sbjct: 188 RFTSASDVWMFGVCMWEILM-------------HGV----KPFQGVKNNDVIGRIENGER 230
Query: 334 LEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETVQSQGAEEEMLQ 385
           L           +  L  +C + +P  RP  +++ A L T+     EEE LQ
Sbjct: 231 LP--MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI----LEEEKLQ 276

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 98/205 (47%), Gaps = 15/205 (7%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKE--LNRGGYQGDREWLAEVNYLGQLRHSNL 157
           +GEG +GVVYK       R       VA+K+  L+          + E++ L +L H N+
Sbjct: 13  IGEGTYGVVYKA------RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 66
Query: 158 VKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAE 217
           VKL+     +    LV+E++    L+K +       +             +GLAF H   
Sbjct: 67  VKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR 125
Query: 218 RPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVM-TG 276
             V++RD K  N+L+N + + KL+DFGLA+   +  +T+    V  T  Y APE ++   
Sbjct: 126 --VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPEILLGCK 181
Query: 277 HLTARSDVYGFGVVLLEMLLGRRAV 301
           + +   D++  G +  EM + RRA+
Sbjct: 182 YYSTAVDIWSLGCIFAEM-VTRRAL 205

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 68/231 (29%), Positives = 103/231 (44%), Gaps = 39/231 (16%)
Query: 103 GGFGVVYKGVIDENVRPGYKTTFVAIKEL---NRGGYQGDREWLAEVNYLGQLRHSNLVK 159
           G FG V+K  +           +VA+K     ++  +Q + E    V  L  ++H N+++
Sbjct: 35  GRFGCVWKAQL--------LNEYVAVKIFPIQDKQSWQNEYE----VYSLPGMKHENILQ 82
Query: 160 LIGY----CCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLH- 214
            IG        D    L+  + E GSL   L   V   ++W+    IA   A+GLA+LH 
Sbjct: 83  FIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANV---VSWNELCHIAETMARGLAYLHE 139
Query: 215 ------GAERPVI-YRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGY 267
                    +P I +RD K+ N+LL  + +A ++DFGLA     G     +   +GT  Y
Sbjct: 140 DIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRY 199
Query: 268 AAPEYVMTGHLT------ARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNL 312
            APE V+ G +        R D+Y  G+VL E  L  R      P  E+ L
Sbjct: 200 MAPE-VLEGAINFQRDAFLRIDMYAMGLVLWE--LASRCTAADGPVDEYML 247

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 68/213 (31%), Positives = 101/213 (47%), Gaps = 30/213 (14%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTF---VAIKELNR-----GGYQGDREWLAEVNYLGQ 151
           LGEG FG          V+  Y TT    VA+K +N+        QG  E   E++YL  
Sbjct: 22  LGEGSFG---------KVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIE--REISYLRL 70
Query: 152 LRHSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLA 211
           LRH +++KL       +  I+V EY     L  ++++R       +RR    + +A    
Sbjct: 71  LRHPHIIKLYDVIKSKDEIIMVIEY-AGNELFDYIVQRDKMSEQEARRFFQQIISAVEYC 129
Query: 212 FLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPE 271
             H     +++RD K  N+LL+   + K++DFGL+    M D   + T   G+  YAAPE
Sbjct: 130 HRHK----IVHRDLKPENLLLDEHLNVKIADFGLS--NIMTDGNFLKTSC-GSPNYAAPE 182
Query: 272 YVMTGHLTA--RSDVYGFGVVLLEMLLGRRAVD 302
            V++G L A    DV+  GV+L  ML  R   D
Sbjct: 183 -VISGKLYAGPEVDVWSCGVILYVMLCRRLPFD 214

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 70/234 (29%), Positives = 110/234 (47%), Gaps = 18/234 (7%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVK 159
           +G+G  G VY  +   +V  G +   VAI+++N          + E+  + + ++ N+V 
Sbjct: 29  IGQGASGTVYTAM---DVATGQE---VAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 82
Query: 160 -LIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAER 218
            L  Y   DE  + V EY+  GSL   +     CM    +   +  +  + L FLH  + 
Sbjct: 83  YLDSYLVGDELWV-VMEYLAGGSLTDVVTET--CM-DEGQIAAVCRECLQALEFLHSNQ- 137
Query: 219 PVIYRDFKTSNILLNADFSAKLSDFGL-AKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGH 277
            VI+RD K+ NILL  D S KL+DFG  A+  P  +Q+  S  V GT  + APE V    
Sbjct: 138 -VIHRDIKSDNILLGMDGSVKLTDFGFCAQITP--EQSKRSXMV-GTPYWMAPEVVTRKA 193
Query: 278 LTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEW-ARPLLNNNKKVLRIL 330
              + D++  G++ +EM+ G        P R   L+     P L N +K+  I 
Sbjct: 194 YGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIF 247

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 67/272 (24%), Positives = 112/272 (41%), Gaps = 35/272 (12%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQG---DREWLAEVNYLGQLRHSN 156
           LG+G FG VY        R       +A+K L +   +    + +   EV     LRH N
Sbjct: 19  LGKGKFGNVYLA------REKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 72
Query: 157 LVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGA 216
           +++L GY  +     L+ EY   G++ + L +         R      + A  L++ H  
Sbjct: 73  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKL--SKFDEQRTATYITELANALSYCHS- 129
Query: 217 ERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTG 276
            + VI+RD K  N+LL +    K++DFG +   P   +    T + GT  Y  PE +   
Sbjct: 130 -KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----TTLCGTLDYLPPEMIEGR 184
Query: 277 HLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRILDPRLEG 336
               + D++  GV+  E L+G       +P  E N  +         K++ R+     E 
Sbjct: 185 MHDEKVDLWSLGVLCYEFLVG-------KPPFEANTYQ------ETYKRISRV-----EF 226
Query: 337 QYTARTAMKVAGLAYQCLSQNPKGRPVMSDVV 368
            +          L  + L  NP  RP++ +V+
Sbjct: 227 TFPDFVTEGARDLISRLLKHNPSQRPMLREVL 258

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 70/234 (29%), Positives = 110/234 (47%), Gaps = 18/234 (7%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVK 159
           +G+G  G VY  +   +V  G +   VAI+++N          + E+  + + ++ N+V 
Sbjct: 28  IGQGASGTVYTAM---DVATGQE---VAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 81
Query: 160 -LIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAER 218
            L  Y   DE  + V EY+  GSL   +     CM    +   +  +  + L FLH  + 
Sbjct: 82  YLDSYLVGDELWV-VMEYLAGGSLTDVVTET--CM-DEGQIAAVCRECLQALEFLHSNQ- 136
Query: 219 PVIYRDFKTSNILLNADFSAKLSDFGL-AKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGH 277
            VI+RD K+ NILL  D S KL+DFG  A+  P  +Q+  S  V GT  + APE V    
Sbjct: 137 -VIHRDIKSDNILLGMDGSVKLTDFGFCAQITP--EQSKRSXMV-GTPYWMAPEVVTRKA 192
Query: 278 LTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEW-ARPLLNNNKKVLRIL 330
              + D++  G++ +EM+ G        P R   L+     P L N +K+  I 
Sbjct: 193 YGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIF 246

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 98/205 (47%), Gaps = 15/205 (7%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKE--LNRGGYQGDREWLAEVNYLGQLRHSNL 157
           +GEG +GVVYK       R       VA+K+  L+          + E++ L +L H N+
Sbjct: 14  IGEGTYGVVYKA------RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 67
Query: 158 VKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAE 217
           VKL+     +    LV+E++    L+K +       +             +GLAF H   
Sbjct: 68  VKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR 126
Query: 218 RPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVM-TG 276
             V++RD K  N+L+N + + KL+DFGLA+   +  +T+    V  T  Y APE ++   
Sbjct: 127 --VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPEILLGCK 182
Query: 277 HLTARSDVYGFGVVLLEMLLGRRAV 301
           + +   D++  G +  EM + RRA+
Sbjct: 183 YYSTAVDIWSLGCIFAEM-VTRRAL 206

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 98/205 (47%), Gaps = 15/205 (7%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKE--LNRGGYQGDREWLAEVNYLGQLRHSNL 157
           +GEG +GVVYK       R       VA+K+  L+          + E++ L +L H N+
Sbjct: 11  IGEGTYGVVYKA------RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 158 VKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAE 217
           VKL+     +    LV+E++    L+K +       +             +GLAF H   
Sbjct: 65  VKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR 123
Query: 218 RPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVM-TG 276
             V++RD K  N+L+N + + KL+DFGLA+   +  +T+    V  T  Y APE ++   
Sbjct: 124 --VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPEILLGCK 179
Query: 277 HLTARSDVYGFGVVLLEMLLGRRAV 301
           + +   D++  G +  EM + RRA+
Sbjct: 180 YYSTAVDIWSLGCIFAEM-VTRRAL 203

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 76/295 (25%), Positives = 115/295 (38%), Gaps = 44/295 (14%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAE----VNYLGQLRHS 155
           LG G FG V +      ++     T VA+K L    +  +RE L      ++YLG   H 
Sbjct: 54  LGAGAFGKVVEATAYGLIKSDAAMT-VAVKMLKPSAHLTEREALMSELKVLSYLGN--HM 110
Query: 156 NLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRR---VGCMLTWSRRM------------ 200
           N+V L+G C      +++ EY   G L   L R+     C  T    M            
Sbjct: 111 NIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDL 170
Query: 201 -KIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVST 259
              +   AKG+AFL  A +  I+RD    NILL      K+ DFGLA+         V  
Sbjct: 171 LSFSYQVAKGMAFL--ASKNCIHRDLAARNILLTHGRITKICDFGLARHIKNDSNYVVKG 228
Query: 260 RVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRP--SREHNLVEWAR 317
                  + APE +     T  SDV+ +G+ L E+     +     P  S+ + ++    
Sbjct: 229 NARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMI---- 284
Query: 318 PLLNNNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLE 372
                 K+  R+L P            ++  +   C   +P  RP    +V L+E
Sbjct: 285 ------KEGFRMLSPE-------HAPAEMYDIMKTCWDADPLKRPTFKQIVQLIE 326

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 98/205 (47%), Gaps = 15/205 (7%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKE--LNRGGYQGDREWLAEVNYLGQLRHSNL 157
           +GEG +GVVYK       R       VA+K+  L+          + E++ L +L H N+
Sbjct: 11  IGEGTYGVVYKA------RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 158 VKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAE 217
           VKL+     +    LV+E++    L+K +       +             +GLAF H   
Sbjct: 65  VKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR 123
Query: 218 RPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVM-TG 276
             V++RD K  N+L+N + + KL+DFGLA+   +  +T+    V  T  Y APE ++   
Sbjct: 124 --VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPEILLGCK 179
Query: 277 HLTARSDVYGFGVVLLEMLLGRRAV 301
           + +   D++  G +  EM + RRA+
Sbjct: 180 YYSTAVDIWSLGCIFAEM-VTRRAL 203

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 98/205 (47%), Gaps = 15/205 (7%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKE--LNRGGYQGDREWLAEVNYLGQLRHSNL 157
           +GEG +GVVYK       R       VA+K+  L+          + E++ L +L H N+
Sbjct: 14  IGEGTYGVVYKA------RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 67
Query: 158 VKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAE 217
           VKL+     +    LV+E++    L+K +       +             +GLAF H   
Sbjct: 68  VKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR 126
Query: 218 RPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVM-TG 276
             V++RD K  N+L+N + + KL+DFGLA+   +  +T+    V  T  Y APE ++   
Sbjct: 127 --VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPEILLGCK 182
Query: 277 HLTARSDVYGFGVVLLEMLLGRRAV 301
           + +   D++  G +  EM + RRA+
Sbjct: 183 YYSTAVDIWSLGCIFAEM-VTRRAL 206

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 98/205 (47%), Gaps = 15/205 (7%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKE--LNRGGYQGDREWLAEVNYLGQLRHSNL 157
           +GEG +GVVYK       R       VA+K+  L+          + E++ L +L H N+
Sbjct: 13  IGEGTYGVVYKA------RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 66
Query: 158 VKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAE 217
           VKL+     +    LV+E++    L+K +       +             +GLAF H   
Sbjct: 67  VKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR 125
Query: 218 RPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVM-TG 276
             V++RD K  N+L+N + + KL+DFGLA+   +  +T+    V  T  Y APE ++   
Sbjct: 126 --VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPEILLGCK 181
Query: 277 HLTARSDVYGFGVVLLEMLLGRRAV 301
           + +   D++  G +  EM + RRA+
Sbjct: 182 YYSTAVDIWSLGCIFAEM-VTRRAL 205

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 68/213 (31%), Positives = 101/213 (47%), Gaps = 30/213 (14%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTF---VAIKELNR-----GGYQGDREWLAEVNYLGQ 151
           LGEG FG          V+  Y TT    VA+K +N+        QG  E   E++YL  
Sbjct: 12  LGEGSFG---------KVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIE--REISYLRL 60
Query: 152 LRHSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLA 211
           LRH +++KL       +  I+V EY     L  ++++R       +RR    + +A    
Sbjct: 61  LRHPHIIKLYDVIKSKDEIIMVIEY-AGNELFDYIVQRDKMSEQEARRFFQQIISAVEYC 119
Query: 212 FLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPE 271
             H     +++RD K  N+LL+   + K++DFGL+    M D   + T   G+  YAAPE
Sbjct: 120 HRHK----IVHRDLKPENLLLDEHLNVKIADFGLS--NIMTDGNFLKTSC-GSPNYAAPE 172
Query: 272 YVMTGHLTA--RSDVYGFGVVLLEMLLGRRAVD 302
            V++G L A    DV+  GV+L  ML  R   D
Sbjct: 173 -VISGKLYAGPEVDVWSCGVILYVMLCRRLPFD 204

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 67/272 (24%), Positives = 112/272 (41%), Gaps = 35/272 (12%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQG---DREWLAEVNYLGQLRHSN 156
           LG+G FG VY        R       +A+K L +   +    + +   EV     LRH N
Sbjct: 21  LGKGKFGNVYLA------REKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 74
Query: 157 LVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGA 216
           +++L GY  +     L+ EY   G++ + L +         R      + A  L++ H  
Sbjct: 75  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKL--SKFDEQRTATYITELANALSYCHS- 131
Query: 217 ERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTG 276
            + VI+RD K  N+LL +    K++DFG +   P   +    T + GT  Y  PE +   
Sbjct: 132 -KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----TTLCGTLDYLPPEMIEGR 186
Query: 277 HLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRILDPRLEG 336
               + D++  GV+  E L+G       +P  E N  +         K++ R+     E 
Sbjct: 187 MHDEKVDLWSLGVLCYEFLVG-------KPPFEANTYQ------ETYKRISRV-----EF 228
Query: 337 QYTARTAMKVAGLAYQCLSQNPKGRPVMSDVV 368
            +          L  + L  NP  RP++ +V+
Sbjct: 229 TFPDFVTEGARDLISRLLKHNPSQRPMLREVL 260

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 67/272 (24%), Positives = 112/272 (41%), Gaps = 35/272 (12%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQG---DREWLAEVNYLGQLRHSN 156
           LG+G FG VY        R       +A+K L +   +    + +   EV     LRH N
Sbjct: 16  LGKGKFGNVYLA------REKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 69
Query: 157 LVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGA 216
           +++L GY  +     L+ EY   G++ + L +         R      + A  L++ H  
Sbjct: 70  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKL--SKFDEQRTATYITELANALSYCHS- 126
Query: 217 ERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTG 276
            + VI+RD K  N+LL +    K++DFG +   P   +T +     GT  Y  PE +   
Sbjct: 127 -KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLC----GTLDYLPPEMIEGR 181
Query: 277 HLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRILDPRLEG 336
               + D++  GV+  E L+G       +P  E N  +         K++ R+     E 
Sbjct: 182 MHDEKVDLWSLGVLCYEFLVG-------KPPFEANTYQ------ETYKRISRV-----EF 223
Query: 337 QYTARTAMKVAGLAYQCLSQNPKGRPVMSDVV 368
            +          L  + L  NP  RP++ +V+
Sbjct: 224 TFPDFVTEGARDLISRLLKHNPSQRPMLREVL 255

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 98/205 (47%), Gaps = 15/205 (7%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKE--LNRGGYQGDREWLAEVNYLGQLRHSNL 157
           +GEG +GVVYK       R       VA+K+  L+          + E++ L +L H N+
Sbjct: 10  IGEGTYGVVYKA------RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 158 VKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAE 217
           VKL+     +    LV+E++    L+K +       +             +GLAF H   
Sbjct: 64  VKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR 122
Query: 218 RPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVM-TG 276
             V++RD K  N+L+N + + KL+DFGLA+   +  +T+    V  T  Y APE ++   
Sbjct: 123 --VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPEILLGCK 178
Query: 277 HLTARSDVYGFGVVLLEMLLGRRAV 301
           + +   D++  G +  EM + RRA+
Sbjct: 179 YYSTAVDIWSLGCIFAEM-VTRRAL 202

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 98/205 (47%), Gaps = 15/205 (7%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKE--LNRGGYQGDREWLAEVNYLGQLRHSNL 157
           +GEG +GVVYK       R       VA+K+  L+          + E++ L +L H N+
Sbjct: 13  IGEGTYGVVYKA------RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 66
Query: 158 VKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAE 217
           VKL+     +    LV+E++    L+K +       +             +GLAF H   
Sbjct: 67  VKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR 125
Query: 218 RPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVM-TG 276
             V++RD K  N+L+N + + KL+DFGLA+   +  +T+    V  T  Y APE ++   
Sbjct: 126 --VLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPEILLGCK 181
Query: 277 HLTARSDVYGFGVVLLEMLLGRRAV 301
           + +   D++  G +  EM + RRA+
Sbjct: 182 YYSTAVDIWSLGCIFAEM-VTRRAL 205

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 67/229 (29%), Positives = 106/229 (46%), Gaps = 25/229 (10%)
Query: 139 DREWLAEVNYLGQLRHSNLVKLIGY--CCEDEHRIL-VYEYMESGSLEKHLLRRVGCMLT 195
           D +W+    ++ + + SN   L+G   C + E R+  V EY+  G L  H+ R+      
Sbjct: 63  DIDWVQTEKHVFE-QASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEE 121
Query: 196 WSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPM-GDQ 254
            +R     +  A  L +LH  ER +IYRD K  N+LL+++   KL+D+G+ K+G   GD 
Sbjct: 122 HARFYSAEISLA--LNYLH--ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT 177
Query: 255 THVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVE 314
           T   +   GT  Y APE +         D +  GV++ EM+ GR   D    S       
Sbjct: 178 T---SXFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSS------- 227
Query: 315 WARPLLNNNKKVLRILDPRLEGQYTARTAM--KVAGLAYQCLSQNPKGR 361
              P  N    + +++   LE Q     +M  K A +    L+++PK R
Sbjct: 228 -DNPDQNTEDYLFQVI---LEKQIRIPRSMSVKAASVLKSFLNKDPKER 272

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 67/272 (24%), Positives = 112/272 (41%), Gaps = 35/272 (12%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQG---DREWLAEVNYLGQLRHSN 156
           LG+G FG VY        R       +A+K L +   +    + +   EV     LRH N
Sbjct: 16  LGKGKFGNVYLA------REKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 69
Query: 157 LVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGA 216
           +++L GY  +     L+ EY   G++ + L +         R      + A  L++ H  
Sbjct: 70  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKL--SKFDEQRTATYITELANALSYCHS- 126
Query: 217 ERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTG 276
            + VI+RD K  N+LL +    K++DFG +   P   +T +     GT  Y  PE +   
Sbjct: 127 -KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLC----GTLDYLPPEMIEGR 181
Query: 277 HLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRILDPRLEG 336
               + D++  GV+  E L+G       +P  E N  +         K++ R+     E 
Sbjct: 182 MHDEKVDLWSLGVLCYEFLVG-------KPPFEANTYQ------ETYKRISRV-----EF 223
Query: 337 QYTARTAMKVAGLAYQCLSQNPKGRPVMSDVV 368
            +          L  + L  NP  RP++ +V+
Sbjct: 224 TFPDFVTEGARDLISRLLKHNPSQRPMLREVL 255

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 98/205 (47%), Gaps = 15/205 (7%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKE--LNRGGYQGDREWLAEVNYLGQLRHSNL 157
           +GEG +GVVYK       R       VA+K+  L+          + E++ L +L H N+
Sbjct: 11  IGEGTYGVVYKA------RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 158 VKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAE 217
           VKL+     +    LV+E++    L+K +       +             +GLAF H   
Sbjct: 65  VKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR 123
Query: 218 RPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVM-TG 276
             V++RD K  N+L+N + + KL+DFGLA+   +  +T+    V  T  Y APE ++   
Sbjct: 124 --VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPEILLGCK 179
Query: 277 HLTARSDVYGFGVVLLEMLLGRRAV 301
           + +   D++  G +  EM + RRA+
Sbjct: 180 YYSTAVDIWSLGCIFAEM-VTRRAL 203

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 68/213 (31%), Positives = 101/213 (47%), Gaps = 30/213 (14%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTF---VAIKELNR-----GGYQGDREWLAEVNYLGQ 151
           LGEG FG          V+  Y TT    VA+K +N+        QG  E   E++YL  
Sbjct: 21  LGEGSFG---------KVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIE--REISYLRL 69
Query: 152 LRHSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLA 211
           LRH +++KL       +  I+V EY     L  ++++R       +RR    + +A    
Sbjct: 70  LRHPHIIKLYDVIKSKDEIIMVIEY-AGNELFDYIVQRDKMSEQEARRFFQQIISAVEYC 128
Query: 212 FLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPE 271
             H     +++RD K  N+LL+   + K++DFGL+    M D   + T   G+  YAAPE
Sbjct: 129 HRHK----IVHRDLKPENLLLDEHLNVKIADFGLS--NIMTDGNFLKTSC-GSPNYAAPE 181
Query: 272 YVMTGHLTA--RSDVYGFGVVLLEMLLGRRAVD 302
            V++G L A    DV+  GV+L  ML  R   D
Sbjct: 182 -VISGKLYAGPEVDVWSCGVILYVMLCRRLPFD 213

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 67/272 (24%), Positives = 112/272 (41%), Gaps = 35/272 (12%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQG---DREWLAEVNYLGQLRHSN 156
           LG+G FG VY        R       +A+K L +   +    + +   EV     LRH N
Sbjct: 21  LGKGKFGNVYLA------REKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 74
Query: 157 LVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGA 216
           +++L GY  +     L+ EY   G++ + L +         R      + A  L++ H  
Sbjct: 75  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKL--SKFDEQRTATYITELANALSYCHS- 131
Query: 217 ERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTG 276
            + VI+RD K  N+LL +    K++DFG +   P   +T +     GT  Y  PE +   
Sbjct: 132 -KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLC----GTLDYLPPEMIEGR 186
Query: 277 HLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRILDPRLEG 336
               + D++  GV+  E L+G       +P  E N  +         K++ R+     E 
Sbjct: 187 MHDEKVDLWSLGVLCYEFLVG-------KPPFEANTYQ------ETYKRISRV-----EF 228
Query: 337 QYTARTAMKVAGLAYQCLSQNPKGRPVMSDVV 368
            +          L  + L  NP  RP++ +V+
Sbjct: 229 TFPDFVTEGARDLISRLLKHNPSQRPMLREVL 260

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 98/205 (47%), Gaps = 15/205 (7%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKE--LNRGGYQGDREWLAEVNYLGQLRHSNL 157
           +GEG +GVVYK       R       VA+K+  L+          + E++ L +L H N+
Sbjct: 10  IGEGTYGVVYKA------RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 158 VKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAE 217
           VKL+     +    LV+E++    L+K +       +             +GLAF H   
Sbjct: 64  VKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR 122
Query: 218 RPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVM-TG 276
             V++RD K  N+L+N + + KL+DFGLA+   +  +T+    V  T  Y APE ++   
Sbjct: 123 --VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPEILLGCK 178
Query: 277 HLTARSDVYGFGVVLLEMLLGRRAV 301
           + +   D++  G +  EM + RRA+
Sbjct: 179 YYSTAVDIWSLGCIFAEM-VTRRAL 202

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 96/205 (46%), Gaps = 15/205 (7%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKE--LNRGGYQGDREWLAEVNYLGQLRHSNL 157
           +GEG +GVVYK       R       VA+K+  L+          + E++ L +L H N+
Sbjct: 11  IGEGTYGVVYKA------RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 158 VKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAE 217
           VKL+     +    LV+E++    L+K +       +             +GL+F H   
Sbjct: 65  VKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLSFCHSHR 123
Query: 218 RPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVM-TG 276
             V++RD K  N+L+N + + KL+DFGLA+    G      T  + T  Y APE ++   
Sbjct: 124 --VLHRDLKPQNLLINTEGAIKLADFGLARA--FGVPVRTYTHEVVTLWYRAPEILLGCK 179
Query: 277 HLTARSDVYGFGVVLLEMLLGRRAV 301
           + +   D++  G +  EM + RRA+
Sbjct: 180 YYSTAVDIWSLGCIFAEM-VTRRAL 203

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 83/316 (26%), Positives = 130/316 (41%), Gaps = 74/316 (23%)
Query: 100 LGEGGFGVVYKGVIDEN-VRPGYKTTFVAIKELNRGGYQG-DREWLAEVNYLGQLRHSNL 157
           +GEG +G+V     + N VR       VAIK+++   +Q   +  L E+  L + RH N+
Sbjct: 35  IGEGAYGMVCSAYDNLNKVR-------VAIKKISPFEHQTYXQRTLREIKILLRFRHENI 87
Query: 158 VKLIG-------------YCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIAL 204
           + +               Y  +D     +Y+ +++    +HL     C   +        
Sbjct: 88  IGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKT----QHLSNDHICYFLYQ------- 136
Query: 205 DAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDG-PMGDQTHVSTRVMG 263
              +GL ++H A   V++RD K SN+LLN     K+ DFGLA+   P  D T   T  + 
Sbjct: 137 -ILRGLKYIHSAN--VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVA 193
Query: 264 TYGYAAPEYVMTGH-LTARSDVYGFGVVLLEML------LGRRAVDK--------SRPSR 308
           T  Y APE ++     T   D++  G +L EML       G+  +D+          PS+
Sbjct: 194 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQ 253
Query: 309 E-------------------HNLVEWARPLLNNNKKVLRILDPRLEGQYTARTAMKVAGL 349
           E                    N V W R   N + K L +LD  L      R  ++ A L
Sbjct: 254 EDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQA-L 312
Query: 350 AYQCLSQ--NPKGRPV 363
           A+  L Q  +P   P+
Sbjct: 313 AHPYLEQYYDPSDEPI 328

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 81/292 (27%), Positives = 132/292 (45%), Gaps = 39/292 (13%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDRE-WLAEVNYLGQLRHSNLV 158
           +GEG FG V++G+    + P      VAIK          RE +L E   + Q  H ++V
Sbjct: 18  IGEGQFGDVHQGIY---MSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 74
Query: 159 KLIGYCCEDEHRILVYEYMESGSLEKHL-LRRVGCMLTWSRRMKIALDAAKGLAFLHGAE 217
           KLIG   E+   I++ E    G L   L +R+    L  +  +  A   +  LA+L    
Sbjct: 75  KLIGVITENPVWIIM-ELCTLGELRSFLQVRKFS--LDLASLILYAYQLSTALAYLES-- 129
Query: 218 RPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHV-STRVMGTYGYAAPEYVMTG 276
           +  ++RD    N+L++++   KL DFGL++   M D T   +++      + APE +   
Sbjct: 130 KRFVHRDIAARNVLVSSNDCVKLGDFGLSRY--MEDSTXXKASKGKLPIKWMAPESINFR 187
Query: 277 HLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPL--LNNNKKVLRILD-PR 333
             T+ SDV+ FGV + E+L+             H +    +P   + NN  + RI +  R
Sbjct: 188 RFTSASDVWMFGVCMWEILM-------------HGV----KPFQGVKNNDVIGRIENGER 230
Query: 334 LEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETVQSQGAEEEMLQ 385
           L           +  L  +C + +P  RP  +++ A L T+     EEE LQ
Sbjct: 231 LP--MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI----LEEEKLQ 276

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 98/205 (47%), Gaps = 15/205 (7%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKE--LNRGGYQGDREWLAEVNYLGQLRHSNL 157
           +GEG +GVVYK       R       VA+K+  L+          + E++ L +L H N+
Sbjct: 12  IGEGTYGVVYKA------RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 65
Query: 158 VKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAE 217
           VKL+     +    LV+E++    L+K +       +             +GLAF H   
Sbjct: 66  VKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR 124
Query: 218 RPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVM-TG 276
             V++RD K  N+L+N + + KL+DFGLA+   +  +T+    V  T  Y APE ++   
Sbjct: 125 --VLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPEILLGCK 180
Query: 277 HLTARSDVYGFGVVLLEMLLGRRAV 301
           + +   D++  G +  EM + RRA+
Sbjct: 181 YYSTAVDIWSLGCIFAEM-VTRRAL 204

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 98/205 (47%), Gaps = 15/205 (7%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKE--LNRGGYQGDREWLAEVNYLGQLRHSNL 157
           +GEG +GVVYK       R       VA+K+  L+          + E++ L +L H N+
Sbjct: 12  IGEGTYGVVYKA------RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 65
Query: 158 VKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAE 217
           VKL+     +    LV+E++    L+K +       +             +GLAF H   
Sbjct: 66  VKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR 124
Query: 218 RPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVM-TG 276
             V++RD K  N+L+N + + KL+DFGLA+   +  +T+    V  T  Y APE ++   
Sbjct: 125 --VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPEILLGCK 180
Query: 277 HLTARSDVYGFGVVLLEMLLGRRAV 301
           + +   D++  G +  EM + RRA+
Sbjct: 181 YYSTAVDIWSLGCIFAEM-VTRRAL 204

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 98/205 (47%), Gaps = 15/205 (7%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKE--LNRGGYQGDREWLAEVNYLGQLRHSNL 157
           +GEG +GVVYK       R       VA+K+  L+          + E++ L +L H N+
Sbjct: 15  IGEGTYGVVYKA------RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 68
Query: 158 VKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAE 217
           VKL+     +    LV+E++    L+K +       +             +GLAF H   
Sbjct: 69  VKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR 127
Query: 218 RPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVM-TG 276
             V++RD K  N+L+N + + KL+DFGLA+   +  +T+    V  T  Y APE ++   
Sbjct: 128 --VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPEILLGCK 183
Query: 277 HLTARSDVYGFGVVLLEMLLGRRAV 301
           + +   D++  G +  EM + RRA+
Sbjct: 184 YYSTAVDIWSLGCIFAEM-VTRRAL 207

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 64/223 (28%), Positives = 100/223 (44%), Gaps = 32/223 (14%)
Query: 99  ILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWL-AEVNYLGQL-RHSN 156
           +LG G FG V         + G     VA+K L       +RE L +E+  + QL  H N
Sbjct: 52  VLGSGAFGKVMNATAYGISKTGVSIQ-VAVKMLKEKADSSEREALMSELKMMTQLGSHEN 110
Query: 157 LVKLIGYCCEDEHRILVYEYMESGSLEKHL----------------LRRVG-----CMLT 195
           +V L+G C       L++EY   G L  +L                 +R+       +LT
Sbjct: 111 IVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLT 170
Query: 196 WSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQT 255
           +   +  A   AKG+ FL    +  ++RD    N+L+      K+ DFGLA+D  M D  
Sbjct: 171 FEDLLCFAYQVAKGMEFLEF--KSCVHRDLAARNVLVTHGKVVKICDFGLARD-IMSDSN 227
Query: 256 HV---STRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEML 295
           +V   + R+     + APE +  G  T +SDV+ +G++L E+ 
Sbjct: 228 YVVRGNARL--PVKWMAPESLFEGIYTIKSDVWSYGILLWEIF 268

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 67/272 (24%), Positives = 111/272 (40%), Gaps = 35/272 (12%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQG---DREWLAEVNYLGQLRHSN 156
           LG+G FG VY        R       +A+K L +   +    + +   EV     LRH N
Sbjct: 21  LGKGKFGNVYLA------REKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 74
Query: 157 LVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGA 216
           +++L GY  +     L+ EY   G++ + L +         R      + A  L++ H  
Sbjct: 75  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKL--SKFDEQRTATYITELANALSYCHS- 131
Query: 217 ERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTG 276
            + VI+RD K  N+LL +    K++DFG +   P   +    T + GT  Y  PE +   
Sbjct: 132 -KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----TTLCGTLDYLPPEXIEGR 186
Query: 277 HLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRILDPRLEG 336
               + D++  GV+  E L+G       +P  E N  +         K++ R+     E 
Sbjct: 187 XHDEKVDLWSLGVLCYEFLVG-------KPPFEANTYQ------ETYKRISRV-----EF 228
Query: 337 QYTARTAMKVAGLAYQCLSQNPKGRPVMSDVV 368
            +          L  + L  NP  RP + +V+
Sbjct: 229 TFPDFVTEGARDLISRLLKHNPSQRPXLREVL 260

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 98/205 (47%), Gaps = 15/205 (7%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKE--LNRGGYQGDREWLAEVNYLGQLRHSNL 157
           +GEG +GVVYK       R       VA+K+  L+          + E++ L +L H N+
Sbjct: 11  IGEGTYGVVYKA------RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 158 VKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAE 217
           VKL+     +    LV+E++    L+K +       +             +GLAF H   
Sbjct: 65  VKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR 123
Query: 218 RPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVM-TG 276
             V++RD K  N+L+N + + KL+DFGLA+   +  +T+    V  T  Y APE ++   
Sbjct: 124 --VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPEILLGCK 179
Query: 277 HLTARSDVYGFGVVLLEMLLGRRAV 301
           + +   D++  G +  EM + RRA+
Sbjct: 180 YYSTAVDIWSLGCIFAEM-VTRRAL 203

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 98/205 (47%), Gaps = 15/205 (7%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKE--LNRGGYQGDREWLAEVNYLGQLRHSNL 157
           +GEG +GVVYK       R       VA+K+  L+          + E++ L +L H N+
Sbjct: 12  IGEGTYGVVYKA------RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 65
Query: 158 VKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAE 217
           VKL+     +    LV+E++    L+K +       +             +GLAF H   
Sbjct: 66  VKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR 124
Query: 218 RPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVM-TG 276
             V++RD K  N+L+N + + KL+DFGLA+   +  +T+    V  T  Y APE ++   
Sbjct: 125 --VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPEILLGCK 180
Query: 277 HLTARSDVYGFGVVLLEMLLGRRAV 301
           + +   D++  G +  EM + RRA+
Sbjct: 181 YYSTAVDIWSLGCIFAEM-VTRRAL 204

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 68/213 (31%), Positives = 101/213 (47%), Gaps = 30/213 (14%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTF---VAIKELNR-----GGYQGDREWLAEVNYLGQ 151
           LGEG FG          V+  Y TT    VA+K +N+        QG  E   E++YL  
Sbjct: 16  LGEGSFG---------KVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIE--REISYLRL 64
Query: 152 LRHSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLA 211
           LRH +++KL       +  I+V EY     L  ++++R       +RR    + +A    
Sbjct: 65  LRHPHIIKLYDVIKSKDEIIMVIEY-AGNELFDYIVQRDKMSEQEARRFFQQIISAVEYC 123
Query: 212 FLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPE 271
             H     +++RD K  N+LL+   + K++DFGL+    M D   + T   G+  YAAPE
Sbjct: 124 HRHK----IVHRDLKPENLLLDEHLNVKIADFGLS--NIMTDGNFLKTSC-GSPNYAAPE 176
Query: 272 YVMTGHLTA--RSDVYGFGVVLLEMLLGRRAVD 302
            V++G L A    DV+  GV+L  ML  R   D
Sbjct: 177 -VISGKLYAGPEVDVWSCGVILYVMLCRRLPFD 208

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 67/272 (24%), Positives = 113/272 (41%), Gaps = 35/272 (12%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQG---DREWLAEVNYLGQLRHSN 156
           LG+G FG VY        R   +   +A+K L +   +    + +   EV     LRH N
Sbjct: 13  LGKGKFGNVYLA------REKQRKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 66
Query: 157 LVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGA 216
           +++L GY  +     L+ EY   G++ + L +         R      + A  L++ H  
Sbjct: 67  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKL--SKFDEQRTATYITELANALSYCHS- 123
Query: 217 ERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTG 276
            + VI+RD K  N+LL +    K++DFG +   P   +    T + GT  Y  PE +   
Sbjct: 124 -KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----TTLCGTLDYLPPEMIEGR 178
Query: 277 HLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRILDPRLEG 336
               + D++  GV+  E L+G       +P  E N  +         K++ R+     E 
Sbjct: 179 MHDEKVDLWSLGVLCYEFLVG-------KPPFEANTYQ------ETYKRISRV-----EF 220
Query: 337 QYTARTAMKVAGLAYQCLSQNPKGRPVMSDVV 368
            +          L  + L  NP  RP++ +V+
Sbjct: 221 TFPDFVTEGARDLISRLLKHNPSQRPMLREVL 252

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 64/209 (30%), Positives = 100/209 (47%), Gaps = 18/209 (8%)
Query: 99  ILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREW---LAEVNYLGQLRHS 155
           +LG+G FG V         R G +  + AIK L +     D +    + E   L  L   
Sbjct: 26  VLGKGSFGKVMLAD-----RKGTEELY-AIKILKKDVVIQDDDVECTMVEKRVLALLDKP 79
Query: 156 NLVKLIGYCCEDEHRI-LVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLH 214
             +  +  C +   R+  V EY+  G L  H+ ++VG      + +  A + + GL FLH
Sbjct: 80  PFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHI-QQVG-KFKEPQAVFYAAEISIGLFFLH 137
Query: 215 GAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTR-VMGTYGYAAPEYV 273
             +R +IYRD K  N++L+++   K++DFG+ K+  M     V+TR   GT  Y APE +
Sbjct: 138 --KRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMMDG---VTTREFCGTPDYIAPEII 192
Query: 274 MTGHLTARSDVYGFGVVLLEMLLGRRAVD 302
                    D + +GV+L EML G+   D
Sbjct: 193 AYQPYGKSVDWWAYGVLLYEMLAGQPPFD 221

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 67/272 (24%), Positives = 112/272 (41%), Gaps = 35/272 (12%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQG---DREWLAEVNYLGQLRHSN 156
           LG+G FG VY        R       +A+K L +   +    + +   EV     LRH N
Sbjct: 16  LGKGKFGNVYLA------REKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 69
Query: 157 LVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGA 216
           +++L GY  +     L+ EY   G++ + L +         R      + A  L++ H  
Sbjct: 70  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKL--SKFDEQRTATYITELANALSYCHS- 126
Query: 217 ERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTG 276
            + VI+RD K  N+LL +    K++DFG +   P   +T +     GT  Y  PE +   
Sbjct: 127 -KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTXLC----GTLDYLPPEMIEGR 181
Query: 277 HLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRILDPRLEG 336
               + D++  GV+  E L+G       +P  E N  +         K++ R+     E 
Sbjct: 182 MHDEKVDLWSLGVLCYEFLVG-------KPPFEANTYQ------ETYKRISRV-----EF 223
Query: 337 QYTARTAMKVAGLAYQCLSQNPKGRPVMSDVV 368
            +          L  + L  NP  RP++ +V+
Sbjct: 224 TFPDFVTEGARDLISRLLKHNPSQRPMLREVL 255

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 99/205 (48%), Gaps = 15/205 (7%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKE--LNRGGYQGDREWLAEVNYLGQLRHSNL 157
           +GEG +GVVYK       R       VA+K+  L+          + E++ L +L H N+
Sbjct: 14  IGEGTYGVVYKA------RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 67
Query: 158 VKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAE 217
           VKL+     +    LV+E+++   L+K +       +             +GLAF H   
Sbjct: 68  VKLLDVIHTENKLYLVFEHVDQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR 126
Query: 218 RPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVM-TG 276
             V++RD K  N+L+N + + KL+DFGLA+   +  +T+    V  T  Y APE ++   
Sbjct: 127 --VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPEILLGCK 182
Query: 277 HLTARSDVYGFGVVLLEMLLGRRAV 301
           + +   D++  G +  EM + RRA+
Sbjct: 183 YYSTAVDIWSLGCIFAEM-VTRRAL 206

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 44/127 (34%), Positives = 72/127 (56%), Gaps = 5/127 (3%)
Query: 172 LVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNIL 231
           +V EY++  +L + ++   G M T  R +++  DA + L F H  +  +I+RD K +NI+
Sbjct: 110 IVMEYVDGVTL-RDIVHTEGPM-TPKRAIEVIADACQALNFSH--QNGIIHRDVKPANIM 165
Query: 232 LNADFSAKLSDFGLAKD-GPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVV 290
           ++A  + K+ DFG+A+     G+    +  V+GT  Y +PE      + ARSDVY  G V
Sbjct: 166 ISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCV 225
Query: 291 LLEMLLG 297
           L E+L G
Sbjct: 226 LYEVLTG 232

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 64/201 (31%), Positives = 92/201 (45%), Gaps = 10/201 (4%)
Query: 99  ILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLV 158
           +LG+G FG V   ++ E     Y    +  KE+     +     L E   L   RH  L 
Sbjct: 155 LLGKGTFGKVI--LVKEKATGRYYAMKILKKEVIVAKDEVAHT-LTENRVLQNSRHPFLT 211
Query: 159 KLIGYCCEDEHRI-LVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAE 217
            L  Y  +   R+  V EY   G L  HL R    + +  R      +    L +LH +E
Sbjct: 212 AL-KYSFQTHDRLCFVMEYANGGELFFHLSRER--VFSEDRARFYGAEIVSALDYLH-SE 267
Query: 218 RPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGH 277
           + V+YRD K  N++L+ D   K++DFGL K+G + D   + T   GT  Y APE +    
Sbjct: 268 KNVVYRDLKLENLMLDKDGHIKITDFGLCKEG-IKDGATMKT-FCGTPEYLAPEVLEDND 325
Query: 278 LTARSDVYGFGVVLLEMLLGR 298
                D +G GVV+ EM+ GR
Sbjct: 326 YGRAVDWWGLGVVMYEMMCGR 346

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 76/286 (26%), Positives = 121/286 (42%), Gaps = 35/286 (12%)
Query: 94  FRPDYILGEGGFGVVYKGVIDENVRPGYKTT--FVAIKELNRGGYQGDREWLA-----EV 146
           F+   +LGEG +GVV            +K T   VAIK++       D+   A     E+
Sbjct: 13  FQLKSLLGEGAYGVVCSAT--------HKPTGEIVAIKKIE----PFDKPLFALRTLREI 60
Query: 147 NYLGQLRHSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGC-MLTWSRRMKIALD 205
             L   +H N++ +      D        Y+    ++  L R +   ML+          
Sbjct: 61  KILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQ 120
Query: 206 AAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAK---------DGPMGDQTH 256
             + +  LHG+   VI+RD K SN+L+N++   K+ DFGLA+           P G Q+ 
Sbjct: 121 TLRAVKVLHGSN--VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSG 178
Query: 257 VSTRVMGTYGYAAPEYVMTGHLTARS-DVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEW 315
           + T  + T  Y APE ++T    +R+ DV+  G +L E+ L RR +   R  R   L+ +
Sbjct: 179 M-TEXVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFL-RRPIFPGRDYRHQLLLIF 236
Query: 316 ARPLLNNNKKVLRILD-PRLEGQYTARTAMKVAGLAYQCLSQNPKG 360
                 ++   LR ++ PR      +      A L       NPKG
Sbjct: 237 GIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKG 282

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 64/201 (31%), Positives = 92/201 (45%), Gaps = 10/201 (4%)
Query: 99  ILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLV 158
           +LG+G FG V   ++ E     Y    +  KE+     +     L E   L   RH  L 
Sbjct: 158 LLGKGTFGKVI--LVKEKATGRYYAMKILKKEVIVAKDEVAHT-LTENRVLQNSRHPFLT 214
Query: 159 KLIGYCCEDEHRI-LVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAE 217
            L  Y  +   R+  V EY   G L  HL R    + +  R      +    L +LH +E
Sbjct: 215 AL-KYSFQTHDRLCFVMEYANGGELFFHLSRER--VFSEDRARFYGAEIVSALDYLH-SE 270
Query: 218 RPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGH 277
           + V+YRD K  N++L+ D   K++DFGL K+G + D   + T   GT  Y APE +    
Sbjct: 271 KNVVYRDLKLENLMLDKDGHIKITDFGLCKEG-IKDGATMKT-FCGTPEYLAPEVLEDND 328
Query: 278 LTARSDVYGFGVVLLEMLLGR 298
                D +G GVV+ EM+ GR
Sbjct: 329 YGRAVDWWGLGVVMYEMMCGR 349

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 67/272 (24%), Positives = 110/272 (40%), Gaps = 35/272 (12%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQG---DREWLAEVNYLGQLRHSN 156
           LG+G FG VY        R       +A+K L +   +    + +   EV     LRH N
Sbjct: 21  LGKGKFGNVYLA------REKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 74
Query: 157 LVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGA 216
           +++L GY  +     L+ EY   G + K L +         R      + A  L++ H  
Sbjct: 75  ILRLYGYFHDATRVYLILEYAPRGEVYKELQKL--SKFDEQRTATYITELANALSYCHS- 131
Query: 217 ERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTG 276
            + VI+RD K  N+LL +    K++DFG +   P   +      + GT  Y  PE +   
Sbjct: 132 -KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----XXLXGTLDYLPPEMIEGR 186
Query: 277 HLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRILDPRLEG 336
               + D++  GV+  E L+G       +P  E N  +         K++ R+     E 
Sbjct: 187 MHDEKVDLWSLGVLCYEFLVG-------KPPFEANTYQ------ETYKRISRV-----EF 228
Query: 337 QYTARTAMKVAGLAYQCLSQNPKGRPVMSDVV 368
            +          L  + L  NP  RP++ +V+
Sbjct: 229 TFPDFVTEGARDLISRLLKHNPSQRPMLREVL 260

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 83/316 (26%), Positives = 130/316 (41%), Gaps = 74/316 (23%)
Query: 100 LGEGGFGVVYKGVIDEN-VRPGYKTTFVAIKELNRGGYQGD-REWLAEVNYLGQLRHSNL 157
           +GEG +G+V     + N VR       VAIK+++   +Q   +  L E+  L + RH N+
Sbjct: 31  IGEGAYGMVCSAYDNVNKVR-------VAIKKISPFEHQTYCQRTLREIKILLRFRHENI 83
Query: 158 VKLIG-------------YCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIAL 204
           + +               Y  +D     +Y+ +++    +HL     C   +        
Sbjct: 84  IGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKT----QHLSNDHICYFLYQ------- 132
Query: 205 DAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDG-PMGDQTHVSTRVMG 263
              +GL ++H A   V++RD K SN+LLN     K+ DFGLA+   P  D T   T  + 
Sbjct: 133 -ILRGLKYIHSAN--VLHRDLKPSNLLLNTTXDLKIXDFGLARVADPDHDHTGFLTEYVA 189
Query: 264 TYGYAAPEYVMTGH-LTARSDVYGFGVVLLEML------LGRRAVDK--------SRPSR 308
           T  Y APE ++     T   D++  G +L EML       G+  +D+          PS+
Sbjct: 190 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQ 249
Query: 309 E-------------------HNLVEWARPLLNNNKKVLRILDPRLEGQYTARTAMKVAGL 349
           E                    N V W R   N + K L +LD  L      R  ++ A L
Sbjct: 250 EDLNXIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQA-L 308
Query: 350 AYQCLSQ--NPKGRPV 363
           A+  L Q  +P   P+
Sbjct: 309 AHPYLEQYYDPSDEPI 324

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 77/294 (26%), Positives = 133/294 (45%), Gaps = 44/294 (14%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDRE-WLAEVNYLGQLRHSNLV 158
           +GEG FG V++G+    + P      VAIK          RE +L E   + Q  H ++V
Sbjct: 21  IGEGQFGDVHQGIY---MSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 77
Query: 159 KLIGYCCEDEHRILVYEYMESGSLEKHLLRR-----VGCMLTWSRRMKIALDAAKGLAFL 213
           KLIG   E+   I++ E    G L   L  R     +  ++ ++ ++  AL   +   F+
Sbjct: 78  KLIGVITENPVWIIM-ELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFV 136
Query: 214 HGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHV-STRVMGTYGYAAPEY 272
           H        RD    N+L++++   KL DFGL++   M D T+  +++      + APE 
Sbjct: 137 H--------RDIAARNVLVSSNDCVKLGDFGLSRY--MEDSTYYKASKGKLPIKWMAPES 186
Query: 273 VMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPL--LNNNKKVLRIL 330
           +     T+ SDV+ FGV + E+L+             H +    +P   + NN  + RI 
Sbjct: 187 INFRRFTSASDVWMFGVCMWEILM-------------HGV----KPFQGVKNNDVIGRIE 229
Query: 331 D-PRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETV-QSQGAEEE 382
           +  RL           +  L  +C + +P  RP  +++ A L T+ + + A++E
Sbjct: 230 NGERLP--MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEEKAQQE 281

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 83/309 (26%), Positives = 129/309 (41%), Gaps = 60/309 (19%)
Query: 100 LGEGGFGVVYKGVIDEN-VRPGYKTTFVAIKELNRGGYQG-DREWLAEVNYLGQLRHSNL 157
           +GEG +G+V     + N VR       VAIK+++   +Q   +  L E+  L + RH N+
Sbjct: 39  IGEGAYGMVCSAYDNVNKVR-------VAIKKISPFEHQTYCQRTLREIKILLRFRHENI 91
Query: 158 VKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMK------IALDAAKGLA 211
           + +      D  R    E M+   + + L+      L  ++ +             +GL 
Sbjct: 92  IGI-----NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLK 146
Query: 212 FLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDG-PMGDQTHVSTRVMGTYGYAAP 270
           ++H A   V++RD K SN+LLN     K+ DFGLA+   P  D T   T  + T  Y AP
Sbjct: 147 YIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 204
Query: 271 EYVMTGH-LTARSDVYGFGVVLLEML------LGRRAVDK--------SRPSRE------ 309
           E ++     T   D++  G +L EML       G+  +D+          PS+E      
Sbjct: 205 EIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCII 264
Query: 310 -------------HNLVEWARPLLNNNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQ 356
                         N V W R   N + K L +LD  L      R  ++ A LA+  L Q
Sbjct: 265 NLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQA-LAHPYLEQ 323
Query: 357 --NPKGRPV 363
             +P   P+
Sbjct: 324 YYDPSDEPI 332

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 83/309 (26%), Positives = 129/309 (41%), Gaps = 60/309 (19%)
Query: 100 LGEGGFGVVYKGVIDEN-VRPGYKTTFVAIKELNRGGYQG-DREWLAEVNYLGQLRHSNL 157
           +GEG +G+V     + N VR       VAIK+++   +Q   +  L E+  L + RH N+
Sbjct: 31  IGEGAYGMVCSAYDNVNKVR-------VAIKKISPFEHQTYCQRTLREIKILLRFRHENI 83
Query: 158 VKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMK------IALDAAKGLA 211
           + +      D  R    E M+   + + L+      L  ++ +             +GL 
Sbjct: 84  IGI-----NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLK 138
Query: 212 FLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDG-PMGDQTHVSTRVMGTYGYAAP 270
           ++H A   V++RD K SN+LLN     K+ DFGLA+   P  D T   T  + T  Y AP
Sbjct: 139 YIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 196
Query: 271 EYVMTGH-LTARSDVYGFGVVLLEML------LGRRAVDK--------SRPSRE------ 309
           E ++     T   D++  G +L EML       G+  +D+          PS+E      
Sbjct: 197 EIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCII 256
Query: 310 -------------HNLVEWARPLLNNNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQ 356
                         N V W R   N + K L +LD  L      R  ++ A LA+  L Q
Sbjct: 257 NLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQA-LAHPYLEQ 315
Query: 357 --NPKGRPV 363
             +P   P+
Sbjct: 316 YYDPSDEPI 324

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 66/272 (24%), Positives = 111/272 (40%), Gaps = 35/272 (12%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQG---DREWLAEVNYLGQLRHSN 156
           LG+G FG VY        R       +A+K L +   +    + +   EV     LRH N
Sbjct: 42  LGKGKFGNVYLA------REKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 95
Query: 157 LVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGA 216
           +++L GY  +     L+ EY   G++ + L +         R      + A  L++ H  
Sbjct: 96  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKL--SKFDEQRTATYITELANALSYCHS- 152
Query: 217 ERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTG 276
            + VI+RD K  N+LL +    K++DFG +   P   +  +     GT  Y  PE +   
Sbjct: 153 -KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRDDLC----GTLDYLPPEMIEGR 207
Query: 277 HLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRILDPRLEG 336
               + D++  GV+  E L+G       +P  E N  +         K++ R+     E 
Sbjct: 208 MHDEKVDLWSLGVLCYEFLVG-------KPPFEANTYQ------ETYKRISRV-----EF 249
Query: 337 QYTARTAMKVAGLAYQCLSQNPKGRPVMSDVV 368
            +          L  + L  NP  RP++ +V+
Sbjct: 250 TFPDFVTEGARDLISRLLKHNPSQRPMLREVL 281

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 83/309 (26%), Positives = 129/309 (41%), Gaps = 60/309 (19%)
Query: 100 LGEGGFGVVYKGVIDEN-VRPGYKTTFVAIKELNRGGYQG-DREWLAEVNYLGQLRHSNL 157
           +GEG +G+V     + N VR       VAIK+++   +Q   +  L E+  L + RH N+
Sbjct: 33  IGEGAYGMVCSAYDNVNKVR-------VAIKKISPFEHQTYCQRTLREIKILLRFRHENI 85
Query: 158 VKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMK------IALDAAKGLA 211
           + +      D  R    E M+   + + L+      L  ++ +             +GL 
Sbjct: 86  IGI-----NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLK 140
Query: 212 FLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDG-PMGDQTHVSTRVMGTYGYAAP 270
           ++H A   V++RD K SN+LLN     K+ DFGLA+   P  D T   T  + T  Y AP
Sbjct: 141 YIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 198
Query: 271 EYVMTGH-LTARSDVYGFGVVLLEML------LGRRAVDK--------SRPSRE------ 309
           E ++     T   D++  G +L EML       G+  +D+          PS+E      
Sbjct: 199 EIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCII 258
Query: 310 -------------HNLVEWARPLLNNNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQ 356
                         N V W R   N + K L +LD  L      R  ++ A LA+  L Q
Sbjct: 259 NLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQA-LAHPYLEQ 317
Query: 357 --NPKGRPV 363
             +P   P+
Sbjct: 318 YYDPSDEPI 326

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 83/309 (26%), Positives = 129/309 (41%), Gaps = 60/309 (19%)
Query: 100 LGEGGFGVVYKGVIDEN-VRPGYKTTFVAIKELNRGGYQG-DREWLAEVNYLGQLRHSNL 157
           +GEG +G+V     + N VR       VAIK+++   +Q   +  L E+  L   RH N+
Sbjct: 33  IGEGAYGMVCSAYDNVNKVR-------VAIKKISPFEHQTYCQRTLREIKILLAFRHENI 85
Query: 158 VKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMK------IALDAAKGLA 211
           + +      D  R    E M+   + + L+      L  ++ +             +GL 
Sbjct: 86  IGI-----NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLK 140
Query: 212 FLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDG-PMGDQTHVSTRVMGTYGYAAP 270
           ++H A   V++RD K SN+LLN     K+ DFGLA+   P  D T   T  + T  Y AP
Sbjct: 141 YIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 198
Query: 271 EYVMTGH-LTARSDVYGFGVVLLEML------LGRRAVDK--------SRPSRE------ 309
           E ++     T   D++  G +L EML       G+  +D+          PS+E      
Sbjct: 199 EIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCII 258
Query: 310 -------------HNLVEWARPLLNNNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQ 356
                         N V W R   N + K L +LD  L      R  ++ A LA+  L+Q
Sbjct: 259 NLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQA-LAHPYLAQ 317
Query: 357 --NPKGRPV 363
             +P   P+
Sbjct: 318 YYDPSDEPI 326

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 83/316 (26%), Positives = 130/316 (41%), Gaps = 74/316 (23%)
Query: 100 LGEGGFGVVYKGVIDEN-VRPGYKTTFVAIKELNRGGYQGD-REWLAEVNYLGQLRHSNL 157
           +GEG +G+V     + N VR       VAIK+++   +Q   +  L E+  L + RH N+
Sbjct: 31  IGEGAYGMVCSAYDNVNKVR-------VAIKKISPFEHQTYCQRTLREIKILLRFRHENI 83
Query: 158 VKLIG-------------YCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIAL 204
           + +               Y  +D     +Y+ +++    +HL     C   +        
Sbjct: 84  IGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKT----QHLSNDHICYFLYQ------- 132
Query: 205 DAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDG-PMGDQTHVSTRVMG 263
              +GL ++H A   V++RD K SN+LLN     K+ DFGLA+   P  D T   T  + 
Sbjct: 133 -ILRGLKYIHSAN--VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVA 189
Query: 264 TYGYAAPEYVMTGH-LTARSDVYGFGVVLLEML------LGRRAVDK--------SRPSR 308
           T  Y APE ++     T   D++  G +L EML       G+  +D+          PS+
Sbjct: 190 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQ 249
Query: 309 E-------------------HNLVEWARPLLNNNKKVLRILDPRLEGQYTARTAMKVAGL 349
           E                    N V W R   N + K L +LD  L      R  ++ A L
Sbjct: 250 EDLNXIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQA-L 308
Query: 350 AYQCLSQ--NPKGRPV 363
           A+  L Q  +P   P+
Sbjct: 309 AHPYLEQYYDPSDEPI 324

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 67/272 (24%), Positives = 112/272 (41%), Gaps = 35/272 (12%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQG---DREWLAEVNYLGQLRHSN 156
           LG+G FG VY        R       +A+K L +   +    + +   EV     LRH N
Sbjct: 20  LGKGKFGNVYLA------REKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 73
Query: 157 LVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGA 216
           +++L GY  +     L+ EY   G++ + L +         R      + A  L++ H  
Sbjct: 74  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKL--SKFDEQRTATYITELANALSYCHS- 130
Query: 217 ERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTG 276
            + VI+RD K  N+LL +    K++DFG +   P   +    T + GT  Y  PE +   
Sbjct: 131 -KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----TTLCGTLDYLPPEMIEGR 185
Query: 277 HLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRILDPRLEG 336
               + D++  GV+  E L+G       +P  E N  +         K++ R+     E 
Sbjct: 186 MHDEKVDLWSLGVLCYEFLVG-------KPPFEANTYQ------ETYKRISRV-----EF 227
Query: 337 QYTARTAMKVAGLAYQCLSQNPKGRPVMSDVV 368
            +          L  + L  NP  RP++ +V+
Sbjct: 228 TFPDFVTEGARDLISRLLKHNPSQRPMLREVL 259

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 67/272 (24%), Positives = 112/272 (41%), Gaps = 35/272 (12%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQG---DREWLAEVNYLGQLRHSN 156
           LG+G FG VY        R       +A+K L +   +    + +   EV     LRH N
Sbjct: 15  LGKGKFGNVYLA------REKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 68
Query: 157 LVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGA 216
           +++L GY  +     L+ EY   G++ + L +         R      + A  L++ H  
Sbjct: 69  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKL--SKFDEQRTATYITELANALSYCHS- 125
Query: 217 ERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTG 276
            + VI+RD K  N+LL +    K++DFG +   P   +    T + GT  Y  PE +   
Sbjct: 126 -KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----TTLCGTLDYLPPEMIEGR 180
Query: 277 HLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRILDPRLEG 336
               + D++  GV+  E L+G       +P  E N  +         K++ R+     E 
Sbjct: 181 MHDEKVDLWSLGVLCYEFLVG-------KPPFEANTYQ------ETYKRISRV-----EF 222
Query: 337 QYTARTAMKVAGLAYQCLSQNPKGRPVMSDVV 368
            +          L  + L  NP  RP++ +V+
Sbjct: 223 TFPDFVTEGARDLISRLLKHNPSQRPMLREVL 254

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 101/208 (48%), Gaps = 21/208 (10%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKE--LNRGGYQGDREWLAEVNYLGQLRHSNL 157
           +GEG +GVVYK       R       VA+K+  L+          + E++ L +L H N+
Sbjct: 11  IGEGTYGVVYKA------RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 158 VKLIGYCCEDEHRILVYEYMESG---SLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLH 214
           VKL+     +    LV+E++       ++   L  +   L  S   ++     +GLAF H
Sbjct: 65  VKLLDVIHTENKLYLVFEFLHQDLKDFMDASALTGIPLPLIKSYLFQLL----QGLAFCH 120
Query: 215 GAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVM 274
                V++RD K  N+L+N + + KL+DFGLA+   +  +T+    V  T  Y APE ++
Sbjct: 121 SHR--VLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPEILL 176
Query: 275 -TGHLTARSDVYGFGVVLLEMLLGRRAV 301
              + +   D++  G +  EM + RRA+
Sbjct: 177 GCKYYSTAVDIWSLGCIFAEM-VTRRAL 203

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 82/310 (26%), Positives = 128/310 (41%), Gaps = 62/310 (20%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQG-DREWLAEVNYLGQLRHSNLV 158
           +GEG +G+V      ++VR     T VAIK+++   +Q   +  L E+  L + RH N++
Sbjct: 51  IGEGAYGMVSSAY--DHVR----KTRVAIKKISPFEHQTYCQRTLREIQILLRFRHENVI 104
Query: 159 KLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMK------IALDAAKGLAF 212
            +      D  R    E M    + + L+      L  S+++             +GL +
Sbjct: 105 GI-----RDILRASTLEAMRDVYIVQDLMETDLYKLLKSQQLSNDHICYFLYQILRGLKY 159
Query: 213 LHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDG-PMGDQTHVSTRVMGTYGYAAPE 271
           +H A   V++RD K SN+L+N     K+ DFGLA+   P  D T   T  + T  Y APE
Sbjct: 160 IHSAN--VLHRDLKPSNLLINTTCDLKICDFGLARIADPEHDHTGFLTEXVATRWYRAPE 217
Query: 272 YVMTGH-LTARSDVYGFGVVLLEMLLGR-------------------------------- 298
            ++     T   D++  G +L EML  R                                
Sbjct: 218 IMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIIN 277
Query: 299 ---RAVDKSRPSREHNLVEWARPLLNNNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLS 355
              R   +S PS+    V WA+    ++ K L +LD  L      R  ++ A LA+  L 
Sbjct: 278 MKARNYLQSLPSKTK--VAWAKLFPKSDSKALDLLDRMLTFNPNKRITVEEA-LAHPYLE 334
Query: 356 Q--NPKGRPV 363
           Q  +P   PV
Sbjct: 335 QYYDPTDEPV 344

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 101/208 (48%), Gaps = 21/208 (10%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKE--LNRGGYQGDREWLAEVNYLGQLRHSNL 157
           +GEG +GVVYK       R       VA+K+  L+          + E++ L +L H N+
Sbjct: 14  IGEGTYGVVYKA------RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 67
Query: 158 VKLIGYCCEDEHRILVYEYMESG---SLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLH 214
           VKL+     +    LV+E++       ++   L  +   L  S   ++     +GLAF H
Sbjct: 68  VKLLDVIHTENKLYLVFEFLHQDLKTFMDASALTGIPLPLIKSYLFQLL----QGLAFCH 123
Query: 215 GAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVM 274
                V++RD K  N+L+N + + KL+DFGLA+   +  +T+    V  T  Y APE ++
Sbjct: 124 SHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPEILL 179
Query: 275 -TGHLTARSDVYGFGVVLLEMLLGRRAV 301
              + +   D++  G +  EM + RRA+
Sbjct: 180 GCKYYSTAVDIWSLGCIFAEM-VTRRAL 206

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 76/286 (26%), Positives = 121/286 (42%), Gaps = 35/286 (12%)
Query: 94  FRPDYILGEGGFGVVYKGVIDENVRPGYKTT--FVAIKELNRGGYQGDREWLA-----EV 146
           F+   +LGEG +GVV            +K T   VAIK++       D+   A     E+
Sbjct: 13  FQLKSLLGEGAYGVVCSAT--------HKPTGEIVAIKKIE----PFDKPLFALRTLREI 60
Query: 147 NYLGQLRHSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGC-MLTWSRRMKIALD 205
             L   +H N++ +      D        Y+    ++  L R +   ML+          
Sbjct: 61  KILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQ 120
Query: 206 AAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAK---------DGPMGDQTH 256
             + +  LHG+   VI+RD K SN+L+N++   K+ DFGLA+           P G Q+ 
Sbjct: 121 TLRAVKVLHGSN--VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSG 178
Query: 257 VSTRVMGTYGYAAPEYVMTGHLTARS-DVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEW 315
           + T  + T  Y APE ++T    +R+ DV+  G +L E+ L RR +   R  R   L+ +
Sbjct: 179 M-TEYVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFL-RRPIFPGRDYRHQLLLIF 236
Query: 316 ARPLLNNNKKVLRILD-PRLEGQYTARTAMKVAGLAYQCLSQNPKG 360
                 ++   LR ++ PR      +      A L       NPKG
Sbjct: 237 GIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKG 282

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 62/203 (30%), Positives = 90/203 (44%), Gaps = 16/203 (7%)
Query: 99  ILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDRE---WLAEVN-YLGQLRH 154
           ++G+G FG V         R   +  F A+K L +      +E    ++E N  L  ++H
Sbjct: 45  VIGKGSFGKVLLA------RHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKH 98
Query: 155 SNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLH 214
             LV L       +    V +Y+  G L  HL +R  C L    R   A + A  L +LH
Sbjct: 99  PFLVGLHFSFQTADKLYFVLDYINGGELFYHL-QRERCFLEPRARF-YAAEIASALGYLH 156
Query: 215 GAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVM 274
                ++YRD K  NILL++     L+DFGL K+    + T  ++   GT  Y APE + 
Sbjct: 157 SLN--IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNST--TSTFCGTPEYLAPEVLH 212
Query: 275 TGHLTARSDVYGFGVVLLEMLLG 297
                   D +  G VL EML G
Sbjct: 213 KQPYDRTVDWWCLGAVLYEMLYG 235

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 83/309 (26%), Positives = 129/309 (41%), Gaps = 60/309 (19%)
Query: 100 LGEGGFGVVYKGVIDEN-VRPGYKTTFVAIKELNRGGYQG-DREWLAEVNYLGQLRHSNL 157
           +GEG +G+V     + N VR       VAIK+++   +Q   +  L E+  L + RH N+
Sbjct: 31  IGEGAYGMVCSAYDNVNKVR-------VAIKKISPFEHQTYCQRTLREIKILLRFRHENI 83
Query: 158 VKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMK------IALDAAKGLA 211
           + +      D  R    E M+   + + L+      L  ++ +             +GL 
Sbjct: 84  IGI-----NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLK 138
Query: 212 FLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDG-PMGDQTHVSTRVMGTYGYAAP 270
           ++H A   V++RD K SN+LLN     K+ DFGLA+   P  D T   T  + T  Y AP
Sbjct: 139 YIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 196
Query: 271 EYVMTGH-LTARSDVYGFGVVLLEML------LGRRAVDK--------SRPSRE------ 309
           E ++     T   D++  G +L EML       G+  +D+          PS+E      
Sbjct: 197 EIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCII 256
Query: 310 -------------HNLVEWARPLLNNNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQ 356
                         N V W R   N + K L +LD  L      R  ++ A LA+  L Q
Sbjct: 257 NLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQA-LAHPYLEQ 315
Query: 357 --NPKGRPV 363
             +P   P+
Sbjct: 316 YYDPSDEPI 324

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 54/168 (32%), Positives = 84/168 (50%), Gaps = 12/168 (7%)
Query: 139 DREWLAEVNYLGQLRHSNLVKLIGY--CCEDEHRIL-VYEYMESGSLEKHLLRRVGCMLT 195
           D +W+    ++ + + SN   L+G   C + E R+  V EY+  G L  H+ R+      
Sbjct: 95  DIDWVQTEKHVFE-QASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEE 153
Query: 196 WSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPM-GDQ 254
            +R     +  A  L +LH  ER +IYRD K  N+LL+++   KL+D+G+ K+G   GD 
Sbjct: 154 HARFYSAEISLA--LNYLH--ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT 209
Query: 255 THVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVD 302
           T   +   GT  Y APE +         D +  GV++ EM+ GR   D
Sbjct: 210 T---STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 254

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 83/309 (26%), Positives = 129/309 (41%), Gaps = 60/309 (19%)
Query: 100 LGEGGFGVVYKGVIDEN-VRPGYKTTFVAIKELNRGGYQG-DREWLAEVNYLGQLRHSNL 157
           +GEG +G+V     + N VR       VAIK+++   +Q   +  L E+  L + RH N+
Sbjct: 51  IGEGAYGMVCSAYDNVNKVR-------VAIKKISPFEHQTYCQRTLREIKILLRFRHENI 103
Query: 158 VKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMK------IALDAAKGLA 211
           + +      D  R    E M+   + + L+      L  ++ +             +GL 
Sbjct: 104 IGI-----NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLK 158
Query: 212 FLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDG-PMGDQTHVSTRVMGTYGYAAP 270
           ++H A   V++RD K SN+LLN     K+ DFGLA+   P  D T   T  + T  Y AP
Sbjct: 159 YIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 216
Query: 271 EYVMTGH-LTARSDVYGFGVVLLEML------LGRRAVDK--------SRPSRE------ 309
           E ++     T   D++  G +L EML       G+  +D+          PS+E      
Sbjct: 217 EIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCII 276
Query: 310 -------------HNLVEWARPLLNNNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQ 356
                         N V W R   N + K L +LD  L      R  ++ A LA+  L Q
Sbjct: 277 NLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQA-LAHPYLEQ 335
Query: 357 --NPKGRPV 363
             +P   P+
Sbjct: 336 YYDPSDEPI 344

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 83/309 (26%), Positives = 129/309 (41%), Gaps = 60/309 (19%)
Query: 100 LGEGGFGVVYKGVIDEN-VRPGYKTTFVAIKELNRGGYQGD-REWLAEVNYLGQLRHSNL 157
           +GEG +G+V     + N VR       VAIK+++   +Q   +  L E+  L + RH N+
Sbjct: 31  IGEGAYGMVCSAYDNVNKVR-------VAIKKISPFEHQTYCQRTLREIKILLRFRHENI 83
Query: 158 VKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMK------IALDAAKGLA 211
           + +      D  R    E M+   + + L+      L  ++ +             +GL 
Sbjct: 84  IGI-----NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLK 138
Query: 212 FLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDG-PMGDQTHVSTRVMGTYGYAAP 270
           ++H A   V++RD K SN+LLN     K+ DFGLA+   P  D T   T  + T  Y AP
Sbjct: 139 YIHSAN--VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 196
Query: 271 EYVMTGH-LTARSDVYGFGVVLLEML------LGRRAVDK--------SRPSRE------ 309
           E ++     T   D++  G +L EML       G+  +D+          PS+E      
Sbjct: 197 EIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCII 256
Query: 310 -------------HNLVEWARPLLNNNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQ 356
                         N V W R   N + K L +LD  L      R  ++ A LA+  L Q
Sbjct: 257 NLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQA-LAHPYLEQ 315
Query: 357 --NPKGRPV 363
             +P   P+
Sbjct: 316 YYDPSDEPI 324

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 98/213 (46%), Gaps = 31/213 (14%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKE--LNRGGYQGDREWLAEVNYLGQLRHSNL 157
           +GEG +GVVYK       R       VA+K+  L+          + E++ L +L H N+
Sbjct: 10  IGEGTYGVVYKA------RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 158 VKLIGYCCEDEHRILVYE--------YMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKG 209
           VKL+     +    LV+E        +M++ +L    L  +   L             +G
Sbjct: 64  VKLLDVIHTENKLYLVFEHVHQDLKTFMDASALTGIPLPLIKSYL---------FQLLQG 114
Query: 210 LAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAA 269
           LAF H     V++RD K  N+L+N + + KL+DFGLA+    G      T  + T  Y A
Sbjct: 115 LAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARA--FGVPVRTYTHEVVTLWYRA 170
Query: 270 PEYVM-TGHLTARSDVYGFGVVLLEMLLGRRAV 301
           PE ++   + +   D++  G +  EM + RRA+
Sbjct: 171 PEILLGCKYYSTAVDIWSLGCIFAEM-VTRRAL 202

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 46/161 (28%), Positives = 86/161 (53%), Gaps = 7/161 (4%)
Query: 141 EWLAEVNYLGQLRHSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRM 200
           + + E+  L +     +V   G    D    +  E+M+ GSL++ +L++ G  +      
Sbjct: 112 QIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQ-VLKKAG-RIPEQILG 169
Query: 201 KIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTR 260
           K+++   KGL +L    + +++RD K SNIL+N+    KL DFG++  G + D   ++  
Sbjct: 170 KVSIAVIKGLTYLREKHK-IMHRDVKPSNILVNSRGEIKLCDFGVS--GQLIDS--MANS 224
Query: 261 VMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAV 301
            +GT  Y +PE +   H + +SD++  G+ L+EM +GR  +
Sbjct: 225 FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 265

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 101/208 (48%), Gaps = 21/208 (10%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKE--LNRGGYQGDREWLAEVNYLGQLRHSNL 157
           +GEG +GVVYK       R       VA+K+  L+          + E++ L +L H N+
Sbjct: 14  IGEGTYGVVYKA------RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 67
Query: 158 VKLIGYCCEDEHRILVYEYME---SGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLH 214
           VKL+     +    LV+E++       ++   L  +   L  S   ++     +GLAF H
Sbjct: 68  VKLLDVIHTENKLYLVFEFLSMDLKDFMDASALTGIPLPLIKSYLFQLL----QGLAFCH 123
Query: 215 GAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVM 274
                V++RD K  N+L+N + + KL+DFGLA+   +  +T+    V  T  Y APE ++
Sbjct: 124 SHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPEILL 179
Query: 275 -TGHLTARSDVYGFGVVLLEMLLGRRAV 301
              + +   D++  G +  EM + RRA+
Sbjct: 180 GCKYYSTAVDIWSLGCIFAEM-VTRRAL 206

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 78/290 (26%), Positives = 134/290 (46%), Gaps = 36/290 (12%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDRE-WLAEVNYLGQLRHSNLV 158
           +GEG FG V++G+    + P      VAIK          RE +L E   + Q  H ++V
Sbjct: 15  IGEGQFGDVHQGIY---MSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 71
Query: 159 KLIGYCCEDEHRILVYEYMESGSLEKHL-LRRVGCMLTWSRRMKIALDAAKGLAFLHGAE 217
           KLIG   E+   I++ E    G L   L +R+    L  +  +  A   +  LA+L    
Sbjct: 72  KLIGVITENPVWIIM-ELCTLGELRSFLQVRKYS--LDLASLILYAYQLSTALAYLES-- 126
Query: 218 RPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHV-STRVMGTYGYAAPEYVMTG 276
           +  ++RD    N+L++++   KL DFGL++   M D T+  +++      + APE +   
Sbjct: 127 KRFVHRDIAARNVLVSSNDCVKLGDFGLSRY--MEDSTYYKASKGKLPIKWMAPESINFR 184
Query: 277 HLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPL--LNNNKKVLRILD-PR 333
             T+ SDV+ FGV + E+L+             H +    +P   + NN  + RI +  R
Sbjct: 185 RFTSASDVWMFGVCMWEILM-------------HGV----KPFQGVKNNDVIGRIENGER 227
Query: 334 LEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETV-QSQGAEEE 382
           L           +  L  +C + +P  RP  +++ A L T+ + + A++E
Sbjct: 228 LP--MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEEKAQQE 275

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 67/272 (24%), Positives = 112/272 (41%), Gaps = 35/272 (12%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQG---DREWLAEVNYLGQLRHSN 156
           LG+G FG VY        R       +A+K L +   +    + +   EV     LRH N
Sbjct: 19  LGKGKFGNVYLA------REKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 72
Query: 157 LVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGA 216
           +++L GY  +     L+ EY   G++ + L +         R      + A  L++ H  
Sbjct: 73  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKL--SKFDEQRTATYITELANALSYCHS- 129
Query: 217 ERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTG 276
            + VI+RD K  N+LL +    K++DFG +   P   +    T + GT  Y  PE +   
Sbjct: 130 -KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----TTLCGTLDYLPPEMIEGR 184
Query: 277 HLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRILDPRLEG 336
               + D++  GV+  E L+G       +P  E N  +         K++ R+     E 
Sbjct: 185 MHDEKVDLWSLGVLCYEFLVG-------KPPFEANTYQ------ETYKRISRV-----EF 226
Query: 337 QYTARTAMKVAGLAYQCLSQNPKGRPVMSDVV 368
            +          L  + L  NP  RP++ +V+
Sbjct: 227 TFPDFVTEGARDLISRLLKHNPSQRPMLREVL 258

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 65/209 (31%), Positives = 99/209 (47%), Gaps = 22/209 (10%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTF-VAIKELNRGGYQGDREWLA---EVNYLGQLRHS 155
           LGEG FG V        +   YKT   VA+K ++R   +     +    E++YL  LRH 
Sbjct: 17  LGEGSFGKV-------KLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHP 69
Query: 156 NLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHG 215
           +++KL          ++V EY   G L  +++ +        RR    +  A      H 
Sbjct: 70  HIIKLYDVITTPTDIVMVIEY-AGGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHK 128
Query: 216 AERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMT 275
               +++RD K  N+LL+ + + K++DFGL+    M D   + T   G+  YAAPE V+ 
Sbjct: 129 ----IVHRDLKPENLLLDDNLNVKIADFGLS--NIMTDGNFLKTSC-GSPNYAAPE-VIN 180
Query: 276 GHLTA--RSDVYGFGVVLLEMLLGRRAVD 302
           G L A    DV+  G+VL  ML+GR   D
Sbjct: 181 GKLYAGPEVDVWSCGIVLYVMLVGRLPFD 209

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 66/204 (32%), Positives = 90/204 (44%), Gaps = 17/204 (8%)
Query: 99  ILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDRE---WLAEVNYLGQLRHS 155
           +LG+G FG V        VR      + A+K L +       E    + E   L   RH 
Sbjct: 15  LLGKGTFGKVIL------VREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHP 68
Query: 156 NLVKLIGYCCEDEHRI-LVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLH 214
            L  L  Y  +   R+  V EY   G L  HL R    + T  R      +    L +LH
Sbjct: 69  FLTAL-KYAFQTHDRLCFVMEYANGGELFFHLSRER--VFTEERARFYGAEIVSALEYLH 125
Query: 215 GAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVM 274
              R V+YRD K  N++L+ D   K++DFGL K+G + D   + T   GT  Y APE + 
Sbjct: 126 S--RDVVYRDIKLENLMLDKDGHIKITDFGLCKEG-ISDGATMKT-FCGTPEYLAPEVLE 181
Query: 275 TGHLTARSDVYGFGVVLLEMLLGR 298
                   D +G GVV+ EM+ GR
Sbjct: 182 DNDYGRAVDWWGLGVVMYEMMCGR 205

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 83/309 (26%), Positives = 129/309 (41%), Gaps = 60/309 (19%)
Query: 100 LGEGGFGVVYKGVIDEN-VRPGYKTTFVAIKELNRGGYQGD-REWLAEVNYLGQLRHSNL 157
           +GEG +G+V     + N VR       VAIK+++   +Q   +  L E+  L + RH N+
Sbjct: 35  IGEGAYGMVCSAYDNLNKVR-------VAIKKISPFEHQTYCQRTLREIKILLRFRHENI 87
Query: 158 VKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMK------IALDAAKGLA 211
           + +      D  R    E M+   + + L+      L  ++ +             +GL 
Sbjct: 88  IGI-----NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLK 142
Query: 212 FLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDG-PMGDQTHVSTRVMGTYGYAAP 270
           ++H A   V++RD K SN+LLN     K+ DFGLA+   P  D T   T  + T  Y AP
Sbjct: 143 YIHSAN--VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 200
Query: 271 EYVMTGH-LTARSDVYGFGVVLLEML------LGRRAVDK--------SRPSRE------ 309
           E ++     T   D++  G +L EML       G+  +D+          PS+E      
Sbjct: 201 EIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCII 260
Query: 310 -------------HNLVEWARPLLNNNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQ 356
                         N V W R   N + K L +LD  L      R  ++ A LA+  L Q
Sbjct: 261 NLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQA-LAHPYLEQ 319
Query: 357 --NPKGRPV 363
             +P   P+
Sbjct: 320 YYDPSDEPI 328

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 77/294 (26%), Positives = 133/294 (45%), Gaps = 44/294 (14%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDRE-WLAEVNYLGQLRHSNLV 158
           +GEG FG V++G+    + P      VAIK          RE +L E   + Q  H ++V
Sbjct: 20  IGEGQFGDVHQGIY---MSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 76
Query: 159 KLIGYCCEDEHRILVYEYMESGSLEKHLLRR-----VGCMLTWSRRMKIALDAAKGLAFL 213
           KLIG   E+   I++ E    G L   L  R     +  ++ ++ ++  AL   +   F+
Sbjct: 77  KLIGVITENPVWIIM-ELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFV 135
Query: 214 HGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHV-STRVMGTYGYAAPEY 272
           H        RD    N+L++++   KL DFGL++   M D T+  +++      + APE 
Sbjct: 136 H--------RDIAARNVLVSSNDCVKLGDFGLSRY--MEDSTYYKASKGKLPIKWMAPES 185
Query: 273 VMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPL--LNNNKKVLRIL 330
           +     T+ SDV+ FGV + E+L+             H +    +P   + NN  + RI 
Sbjct: 186 INFRRFTSASDVWMFGVCMWEILM-------------HGV----KPFQGVKNNDVIGRIE 228
Query: 331 D-PRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETV-QSQGAEEE 382
           +  RL           +  L  +C + +P  RP  +++ A L T+ + + A++E
Sbjct: 229 NGERLP--MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEEKAQQE 280

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 83/309 (26%), Positives = 129/309 (41%), Gaps = 60/309 (19%)
Query: 100 LGEGGFGVVYKGVIDEN-VRPGYKTTFVAIKELNRGGYQG-DREWLAEVNYLGQLRHSNL 157
           +GEG +G+V     + N VR       VAIK+++   +Q   +  L E+  L + RH N+
Sbjct: 36  IGEGAYGMVCSAYDNLNKVR-------VAIKKISPFEHQTYCQRTLREIKILLRFRHENI 88
Query: 158 VKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMK------IALDAAKGLA 211
           + +      D  R    E M+   + + L+      L  ++ +             +GL 
Sbjct: 89  IGI-----NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLK 143
Query: 212 FLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDG-PMGDQTHVSTRVMGTYGYAAP 270
           ++H A   V++RD K SN+LLN     K+ DFGLA+   P  D T   T  + T  Y AP
Sbjct: 144 YIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 201
Query: 271 EYVMTGH-LTARSDVYGFGVVLLEML------LGRRAVDK--------SRPSRE------ 309
           E ++     T   D++  G +L EML       G+  +D+          PS+E      
Sbjct: 202 EIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCII 261
Query: 310 -------------HNLVEWARPLLNNNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQ 356
                         N V W R   N + K L +LD  L      R  ++ A LA+  L Q
Sbjct: 262 NLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQA-LAHPYLEQ 320
Query: 357 --NPKGRPV 363
             +P   P+
Sbjct: 321 YYDPSDEPI 329

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 83/309 (26%), Positives = 129/309 (41%), Gaps = 60/309 (19%)
Query: 100 LGEGGFGVVYKGVIDEN-VRPGYKTTFVAIKELNRGGYQG-DREWLAEVNYLGQLRHSNL 157
           +GEG +G+V     + N VR       VAIK+++   +Q   +  L E+  L + RH N+
Sbjct: 37  IGEGAYGMVCSAYDNLNKVR-------VAIKKISPFEHQTYCQRTLREIKILLRFRHENI 89
Query: 158 VKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMK------IALDAAKGLA 211
           + +      D  R    E M+   + + L+      L  ++ +             +GL 
Sbjct: 90  IGI-----NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLK 144
Query: 212 FLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDG-PMGDQTHVSTRVMGTYGYAAP 270
           ++H A   V++RD K SN+LLN     K+ DFGLA+   P  D T   T  + T  Y AP
Sbjct: 145 YIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 202
Query: 271 EYVMTGH-LTARSDVYGFGVVLLEML------LGRRAVDK--------SRPSRE------ 309
           E ++     T   D++  G +L EML       G+  +D+          PS+E      
Sbjct: 203 EIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCII 262
Query: 310 -------------HNLVEWARPLLNNNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQ 356
                         N V W R   N + K L +LD  L      R  ++ A LA+  L Q
Sbjct: 263 NLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQA-LAHPYLEQ 321
Query: 357 --NPKGRPV 363
             +P   P+
Sbjct: 322 YYDPSDEPI 330

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 83/309 (26%), Positives = 129/309 (41%), Gaps = 60/309 (19%)
Query: 100 LGEGGFGVVYKGVIDEN-VRPGYKTTFVAIKELNRGGYQG-DREWLAEVNYLGQLRHSNL 157
           +GEG +G+V     + N VR       VAIK+++   +Q   +  L E+  L + RH N+
Sbjct: 28  IGEGAYGMVCSAYDNLNKVR-------VAIKKISPFEHQTYCQRTLREIKILLRFRHENI 80
Query: 158 VKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMK------IALDAAKGLA 211
           + +      D  R    E M+   + + L+      L  ++ +             +GL 
Sbjct: 81  IGI-----NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLK 135
Query: 212 FLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDG-PMGDQTHVSTRVMGTYGYAAP 270
           ++H A   V++RD K SN+LLN     K+ DFGLA+   P  D T   T  + T  Y AP
Sbjct: 136 YIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 193
Query: 271 EYVMTGH-LTARSDVYGFGVVLLEML------LGRRAVDK--------SRPSRE------ 309
           E ++     T   D++  G +L EML       G+  +D+          PS+E      
Sbjct: 194 EIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCII 253
Query: 310 -------------HNLVEWARPLLNNNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQ 356
                         N V W R   N + K L +LD  L      R  ++ A LA+  L Q
Sbjct: 254 NLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQA-LAHPYLEQ 312
Query: 357 --NPKGRPV 363
             +P   P+
Sbjct: 313 YYDPSDEPI 321

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 83/309 (26%), Positives = 129/309 (41%), Gaps = 60/309 (19%)
Query: 100 LGEGGFGVVYKGVIDEN-VRPGYKTTFVAIKELNRGGYQG-DREWLAEVNYLGQLRHSNL 157
           +GEG +G+V     + N VR       VAIK+++   +Q   +  L E+  L + RH N+
Sbjct: 35  IGEGAYGMVCSAYDNLNKVR-------VAIKKISPFEHQTYCQRTLREIKILLRFRHENI 87
Query: 158 VKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMK------IALDAAKGLA 211
           + +      D  R    E M+   + + L+      L  ++ +             +GL 
Sbjct: 88  IGI-----NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLK 142
Query: 212 FLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDG-PMGDQTHVSTRVMGTYGYAAP 270
           ++H A   V++RD K SN+LLN     K+ DFGLA+   P  D T   T  + T  Y AP
Sbjct: 143 YIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 200
Query: 271 EYVMTGH-LTARSDVYGFGVVLLEML------LGRRAVDK--------SRPSRE------ 309
           E ++     T   D++  G +L EML       G+  +D+          PS+E      
Sbjct: 201 EIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCII 260
Query: 310 -------------HNLVEWARPLLNNNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQ 356
                         N V W R   N + K L +LD  L      R  ++ A LA+  L Q
Sbjct: 261 NLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQA-LAHPYLEQ 319
Query: 357 --NPKGRPV 363
             +P   P+
Sbjct: 320 YYDPSDEPI 328

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 83/309 (26%), Positives = 129/309 (41%), Gaps = 60/309 (19%)
Query: 100 LGEGGFGVVYKGVIDEN-VRPGYKTTFVAIKELNRGGYQGD-REWLAEVNYLGQLRHSNL 157
           +GEG +G+V     + N VR       VAIK+++   +Q   +  L E+  L   RH N+
Sbjct: 33  IGEGAYGMVCSAYDNVNKVR-------VAIKKISPFEHQTYCQRTLREIKILLAFRHENI 85
Query: 158 VKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMK------IALDAAKGLA 211
           + +      D  R    E M+   + + L+      L  ++ +             +GL 
Sbjct: 86  IGI-----NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLK 140
Query: 212 FLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDG-PMGDQTHVSTRVMGTYGYAAP 270
           ++H A   V++RD K SN+LLN     K+ DFGLA+   P  D T   T  + T  Y AP
Sbjct: 141 YIHSAN--VLHRDLKPSNLLLNTTSDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 198
Query: 271 EYVMTGH-LTARSDVYGFGVVLLEML------LGRRAVDK--------SRPSRE------ 309
           E ++     T   D++  G +L EML       G+  +D+          PS+E      
Sbjct: 199 EIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCGI 258
Query: 310 -------------HNLVEWARPLLNNNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQ 356
                         N V W R   N + K L +LD  L      R  ++ A LA+  L+Q
Sbjct: 259 NLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQA-LAHPYLAQ 317
Query: 357 --NPKGRPV 363
             +P   P+
Sbjct: 318 YYDPSDEPI 326

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 101/208 (48%), Gaps = 21/208 (10%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKE--LNRGGYQGDREWLAEVNYLGQLRHSNL 157
           +GEG +GVVYK       R       VA+K+  L+          + E++ L +L H N+
Sbjct: 13  IGEGTYGVVYKA------RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 66
Query: 158 VKLIGYCCEDEHRILVYEYME---SGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLH 214
           VKL+     +    LV+E++       ++   L  +   L  S   ++     +GLAF H
Sbjct: 67  VKLLDVIHTENKLYLVFEFLSMDLKDFMDASALTGIPLPLIKSYLFQLL----QGLAFCH 122
Query: 215 GAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVM 274
                V++RD K  N+L+N + + KL+DFGLA+   +  +T+    V  T  Y APE ++
Sbjct: 123 SHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPEILL 178
Query: 275 -TGHLTARSDVYGFGVVLLEMLLGRRAV 301
              + +   D++  G +  EM + RRA+
Sbjct: 179 GCKYYSTAVDIWSLGCIFAEM-VTRRAL 205

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 83/309 (26%), Positives = 129/309 (41%), Gaps = 60/309 (19%)
Query: 100 LGEGGFGVVYKGVIDEN-VRPGYKTTFVAIKELNRGGYQG-DREWLAEVNYLGQLRHSNL 157
           +GEG +G+V     + N VR       VAIK+++   +Q   +  L E+  L + RH N+
Sbjct: 29  IGEGAYGMVCSAYDNLNKVR-------VAIKKISPFEHQTYCQRTLREIKILLRFRHENI 81
Query: 158 VKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMK------IALDAAKGLA 211
           + +      D  R    E M+   + + L+      L  ++ +             +GL 
Sbjct: 82  IGI-----NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLK 136
Query: 212 FLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDG-PMGDQTHVSTRVMGTYGYAAP 270
           ++H A   V++RD K SN+LLN     K+ DFGLA+   P  D T   T  + T  Y AP
Sbjct: 137 YIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 194
Query: 271 EYVMTGH-LTARSDVYGFGVVLLEML------LGRRAVDK--------SRPSRE------ 309
           E ++     T   D++  G +L EML       G+  +D+          PS+E      
Sbjct: 195 EIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCII 254
Query: 310 -------------HNLVEWARPLLNNNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQ 356
                         N V W R   N + K L +LD  L      R  ++ A LA+  L Q
Sbjct: 255 NLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQA-LAHPYLEQ 313
Query: 357 --NPKGRPV 363
             +P   P+
Sbjct: 314 YYDPSDEPI 322

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 66/204 (32%), Positives = 90/204 (44%), Gaps = 17/204 (8%)
Query: 99  ILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDRE---WLAEVNYLGQLRHS 155
           +LG+G FG V        VR      + A+K L +       E    + E   L   RH 
Sbjct: 12  LLGKGTFGKVIL------VREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHP 65
Query: 156 NLVKLIGYCCEDEHRI-LVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLH 214
            L  L  Y  +   R+  V EY   G L  HL R    + T  R      +    L +LH
Sbjct: 66  FLTAL-KYAFQTHDRLCFVMEYANGGELFFHLSRER--VFTEERARFYGAEIVSALEYLH 122
Query: 215 GAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVM 274
              R V+YRD K  N++L+ D   K++DFGL K+G + D   + T   GT  Y APE + 
Sbjct: 123 S--RDVVYRDIKLENLMLDKDGHIKITDFGLCKEG-ISDGATMKT-FCGTPEYLAPEVLE 178
Query: 275 TGHLTARSDVYGFGVVLLEMLLGR 298
                   D +G GVV+ EM+ GR
Sbjct: 179 DNDYGRAVDWWGLGVVMYEMMCGR 202

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 66/204 (32%), Positives = 90/204 (44%), Gaps = 17/204 (8%)
Query: 99  ILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDRE---WLAEVNYLGQLRHS 155
           +LG+G FG V        VR      + A+K L +       E    + E   L   RH 
Sbjct: 12  LLGKGTFGKVIL------VREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHP 65
Query: 156 NLVKLIGYCCEDEHRI-LVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLH 214
            L  L  Y  +   R+  V EY   G L  HL R    + T  R      +    L +LH
Sbjct: 66  FLTAL-KYAFQTHDRLCFVMEYANGGELFFHLSRER--VFTEERARFYGAEIVSALEYLH 122
Query: 215 GAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVM 274
              R V+YRD K  N++L+ D   K++DFGL K+G + D   + T   GT  Y APE + 
Sbjct: 123 S--RDVVYRDIKLENLMLDKDGHIKITDFGLCKEG-ISDGATMKT-FCGTPEYLAPEVLE 178
Query: 275 TGHLTARSDVYGFGVVLLEMLLGR 298
                   D +G GVV+ EM+ GR
Sbjct: 179 DNDYGRAVDWWGLGVVMYEMMCGR 202

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 60/200 (30%), Positives = 99/200 (49%), Gaps = 13/200 (6%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDRE-WLAEVNYLGQLRHSNLV 158
           +GEG FG V++G+    + P      VAIK          RE +L E   + Q  H ++V
Sbjct: 23  IGEGQFGDVHQGIY---MSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 79
Query: 159 KLIGYCCEDEHRILVYEYMESGSLEKHL-LRRVGCMLTWSRRMKIALDAAKGLAFLHGAE 217
           KLIG   E+   I++ E    G L   L +R+    L  +  +  A   +  LA+L    
Sbjct: 80  KLIGVITENPVWIIM-ELCTLGELRSFLQVRKYS--LDLASLILYAYQLSTALAYLES-- 134
Query: 218 RPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHV-STRVMGTYGYAAPEYVMTG 276
           +  ++RD    N+L++++   KL DFGL++   M D T+  +++      + APE +   
Sbjct: 135 KRFVHRDIAARNVLVSSNDCVKLGDFGLSRY--MEDSTYYKASKGKLPIKWMAPESINFR 192
Query: 277 HLTARSDVYGFGVVLLEMLL 296
             T+ SDV+ FGV + E+L+
Sbjct: 193 RFTSASDVWMFGVCMWEILM 212

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 98/204 (48%), Gaps = 21/204 (10%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDRE-WLAEVNYLGQLRHSNLV 158
           +GEG FG V++G+    + P      VAIK          RE +L E   + Q  H ++V
Sbjct: 46  IGEGQFGDVHQGIY---MSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 102
Query: 159 KLIGYCCEDEHRILVYEYMESGSLEKHLLRR-----VGCMLTWSRRMKIALDAAKGLAFL 213
           KLIG   E+   I++ E    G L   L  R     +  ++ ++ ++  AL   +   F+
Sbjct: 103 KLIGVITENPVWIIM-ELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFV 161
Query: 214 HGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHV-STRVMGTYGYAAPEY 272
           H        RD    N+L++++   KL DFGL++   M D T+  +++      + APE 
Sbjct: 162 H--------RDIAARNVLVSSNDCVKLGDFGLSRY--MEDSTYYKASKGKLPIKWMAPES 211
Query: 273 VMTGHLTARSDVYGFGVVLLEMLL 296
           +     T+ SDV+ FGV + E+L+
Sbjct: 212 INFRRFTSASDVWMFGVCMWEILM 235

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 54/168 (32%), Positives = 84/168 (50%), Gaps = 12/168 (7%)
Query: 139 DREWLAEVNYLGQLRHSNLVKLIGY--CCEDEHRIL-VYEYMESGSLEKHLLRRVGCMLT 195
           D +W+    ++ + + SN   L+G   C + E R+  V EY+  G L  H+ R+      
Sbjct: 52  DIDWVQTEKHVFE-QASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEE 110
Query: 196 WSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPM-GDQ 254
            +R     +  A  L +LH  ER +IYRD K  N+LL+++   KL+D+G+ K+G   GD 
Sbjct: 111 HARFYSAEISLA--LNYLH--ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT 166
Query: 255 THVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVD 302
           T   +   GT  Y APE +         D +  GV++ EM+ GR   D
Sbjct: 167 T---SXFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 211

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 54/168 (32%), Positives = 84/168 (50%), Gaps = 12/168 (7%)
Query: 139 DREWLAEVNYLGQLRHSNLVKLIGY--CCEDEHRIL-VYEYMESGSLEKHLLRRVGCMLT 195
           D +W+    ++ + + SN   L+G   C + E R+  V EY+  G L  H+ R+      
Sbjct: 48  DIDWVQTEKHVFE-QASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEE 106
Query: 196 WSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPM-GDQ 254
            +R     +  A  L +LH  ER +IYRD K  N+LL+++   KL+D+G+ K+G   GD 
Sbjct: 107 HARFYSAEISLA--LNYLH--ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT 162
Query: 255 THVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVD 302
           T   +   GT  Y APE +         D +  GV++ EM+ GR   D
Sbjct: 163 T---SXFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 207

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 47/154 (30%), Positives = 77/154 (50%), Gaps = 6/154 (3%)
Query: 145 EVNYLGQLRHSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIAL 204
           E + + +L H   VKL     +DE       Y ++G L K++ R++G       R   A 
Sbjct: 82  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGCLLKYI-RKIGSFDETCTRFYTA- 139
Query: 205 DAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKD-GPMGDQTHVSTRVMG 263
           +    L +LHG  + +I+RD K  NILLN D   +++DFG AK   P   Q   ++ V G
Sbjct: 140 EIVSALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFV-G 196
Query: 264 TYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLG 297
           T  Y +PE +     +  SD++  G ++ +++ G
Sbjct: 197 TAQYVSPELLTEKSASKSSDLWALGCIIYQLVAG 230

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 62/200 (31%), Positives = 94/200 (47%), Gaps = 13/200 (6%)
Query: 99  ILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDRE-WLAEVNYLGQLRHSNL 157
           ILGEG FG VY+GV   +   G K   VA+K   +     ++E +++E   +  L H ++
Sbjct: 31  ILGEGFFGEVYEGVYTNH--KGEKIN-VAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHI 87
Query: 158 VKLIGYCCEDEHRIL--VYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHG 215
           VKLIG   E+   I+  +Y Y E G    H L R    L     +  +L   K +A+L  
Sbjct: 88  VKLIGIIEEEPTWIIMELYPYGELG----HYLERNKNSLKVLTLVLYSLQICKAMAYLES 143
Query: 216 AERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMT 275
                ++RD    NIL+ +    KL DFGL++     D    S   +    + +PE +  
Sbjct: 144 IN--CVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPI-KWMSPESINF 200
Query: 276 GHLTARSDVYGFGVVLLEML 295
              T  SDV+ F V + E+L
Sbjct: 201 RRFTTASDVWMFAVCMWEIL 220

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 66/272 (24%), Positives = 112/272 (41%), Gaps = 35/272 (12%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQG---DREWLAEVNYLGQLRHSN 156
           LG+G FG VY        R       +A+K L +   +    + +   EV     LRH N
Sbjct: 16  LGKGKFGNVYLA------REKNSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 69
Query: 157 LVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGA 216
           +++L GY  +     L+ EY   G++ + L +         R      + A  L++ H  
Sbjct: 70  ILRLYGYFHDSTRVYLILEYAPLGTVYRELQKL--SKFDEQRTATYITELANALSYCHS- 126
Query: 217 ERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTG 276
            + VI+RD K  N+LL +    K++DFG +   P   +  +     GT  Y  PE +   
Sbjct: 127 -KKVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRAALC----GTLDYLPPEMIEGR 181
Query: 277 HLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRILDPRLEG 336
               + D++  GV+  E L+G       +P  E N  +      +  K++ R+     E 
Sbjct: 182 MHDEKVDLWSLGVLCYEFLVG-------KPPFEANTYQ------DTYKRISRV-----EF 223
Query: 337 QYTARTAMKVAGLAYQCLSQNPKGRPVMSDVV 368
            +          L  + L  NP  RP++ +V+
Sbjct: 224 TFPDFVTEGARDLISRLLKHNPSQRPMLREVL 255

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 64/204 (31%), Positives = 97/204 (47%), Gaps = 15/204 (7%)
Query: 99  ILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRG----GYQGDREWLAEVNYLGQLRH 154
           +LG+GG+G V++      V         A+K L +       +      AE N L +++H
Sbjct: 24  VLGKGGYGKVFQV---RKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKH 80
Query: 155 SNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLH 214
             +V LI          L+ EY+  G L   L  R G  +  +    +A + +  L  LH
Sbjct: 81  PFIVDLIYAFQTGGKLYLILEYLSGGELFMQL-EREGIFMEDTACFYLA-EISMALGHLH 138
Query: 215 GAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVM 274
             ++ +IYRD K  NI+LN     KL+DFGL K+  + D T V+    GT  Y APE +M
Sbjct: 139 --QKGIIYRDLKPENIMLNHQGHVKLTDFGLCKES-IHDGT-VTHXFCGTIEYMAPEILM 194
Query: 275 -TGHLTARSDVYGFGVVLLEMLLG 297
            +GH  A  D +  G ++ +ML G
Sbjct: 195 RSGHNRA-VDWWSLGALMYDMLTG 217

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 47/155 (30%), Positives = 79/155 (50%), Gaps = 8/155 (5%)
Query: 145 EVNYLGQLRHSNLVKLIGYCCEDEHRILV-YEYMESGSLEKHLLRRVGCMLTWSRRMKIA 203
           E + + +L H   VKL  +C +D+ ++     Y ++G L K++ R++G       R   A
Sbjct: 87  ERDVMSRLDHPFFVKLY-FCFQDDEKLYFGLSYAKNGELLKYI-RKIGSFDETCTRFYTA 144
Query: 204 LDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKD-GPMGDQTHVSTRVM 262
            +    L +LHG  + +I+RD K  NILLN D   +++DFG AK   P   Q   +  V 
Sbjct: 145 -EIVSALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV- 200
Query: 263 GTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLG 297
           GT  Y +PE +        SD++  G ++ +++ G
Sbjct: 201 GTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 235

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 62/200 (31%), Positives = 94/200 (47%), Gaps = 13/200 (6%)
Query: 99  ILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDRE-WLAEVNYLGQLRHSNL 157
           ILGEG FG VY+GV   +   G K   VA+K   +     ++E +++E   +  L H ++
Sbjct: 15  ILGEGFFGEVYEGVYTNH--KGEKIN-VAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHI 71
Query: 158 VKLIGYCCEDEHRIL--VYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHG 215
           VKLIG   E+   I+  +Y Y E G    H L R    L     +  +L   K +A+L  
Sbjct: 72  VKLIGIIEEEPTWIIMELYPYGELG----HYLERNKNSLKVLTLVLYSLQICKAMAYLES 127
Query: 216 AERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMT 275
                ++RD    NIL+ +    KL DFGL++     D    S   +    + +PE +  
Sbjct: 128 IN--CVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPI-KWMSPESINF 184
Query: 276 GHLTARSDVYGFGVVLLEML 295
              T  SDV+ F V + E+L
Sbjct: 185 RRFTTASDVWMFAVCMWEIL 204

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 75/270 (27%), Positives = 116/270 (42%), Gaps = 27/270 (10%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVK 159
           LGEG +G V   V     R   +   V I ++ R           E+     L H N+VK
Sbjct: 15  LGEGAYGEVQLAV----NRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVK 69
Query: 160 LIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERP 219
             G+  E   + L  EY   G L   +   +G     ++R    L A  G+ +LHG    
Sbjct: 70  FYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--GVVYLHGIG-- 125
Query: 220 VIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLT 279
           + +RD K  N+LL+   + K+SDFGLA      ++  +  ++ GT  Y APE +      
Sbjct: 126 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 185
Query: 280 ARS-DVYGFGVVLLEMLLGRRAVDK-SRPSREHNLVEWARPLLNNNKKVLRILDPRLEGQ 337
           A   DV+  G+VL  ML G    D+ S   +E++  +  +  LN  KK+           
Sbjct: 186 AEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKI----------- 234
Query: 338 YTARTAMKVAGLAYQCLSQNPKGRPVMSDV 367
            +A  A     L ++ L +NP  R  + D+
Sbjct: 235 DSAPLA-----LLHKILVENPSARITIPDI 259

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 75/270 (27%), Positives = 116/270 (42%), Gaps = 27/270 (10%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVK 159
           LGEG +G V   V     R   +   V I ++ R           E+     L H N+VK
Sbjct: 15  LGEGAYGEVQLAV----NRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVK 69
Query: 160 LIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERP 219
             G+  E   + L  EY   G L   +   +G     ++R    L A  G+ +LHG    
Sbjct: 70  FYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--GVVYLHGIG-- 125
Query: 220 VIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLT 279
           + +RD K  N+LL+   + K+SDFGLA      ++  +  ++ GT  Y APE +      
Sbjct: 126 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 185
Query: 280 ARS-DVYGFGVVLLEMLLGRRAVDK-SRPSREHNLVEWARPLLNNNKKVLRILDPRLEGQ 337
           A   DV+  G+VL  ML G    D+ S   +E++  +  +  LN  KK+           
Sbjct: 186 AEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKI----------- 234
Query: 338 YTARTAMKVAGLAYQCLSQNPKGRPVMSDV 367
            +A  A     L ++ L +NP  R  + D+
Sbjct: 235 DSAPLA-----LLHKILVENPSARITIPDI 259

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 75/270 (27%), Positives = 116/270 (42%), Gaps = 27/270 (10%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVK 159
           LGEG +G V   V     R   +   V I ++ R           E+     L H N+VK
Sbjct: 15  LGEGAYGEVQLAV----NRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVK 69
Query: 160 LIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERP 219
             G+  E   + L  EY   G L   +   +G     ++R    L A  G+ +LHG    
Sbjct: 70  FYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--GVVYLHGIG-- 125
Query: 220 VIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLT 279
           + +RD K  N+LL+   + K+SDFGLA      ++  +  ++ GT  Y APE +      
Sbjct: 126 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 185
Query: 280 ARS-DVYGFGVVLLEMLLGRRAVDK-SRPSREHNLVEWARPLLNNNKKVLRILDPRLEGQ 337
           A   DV+  G+VL  ML G    D+ S   +E++  +  +  LN  KK+           
Sbjct: 186 AEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKI----------- 234
Query: 338 YTARTAMKVAGLAYQCLSQNPKGRPVMSDV 367
            +A  A     L ++ L +NP  R  + D+
Sbjct: 235 DSAPLA-----LLHKILVENPSARITIPDI 259

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 64/204 (31%), Positives = 97/204 (47%), Gaps = 15/204 (7%)
Query: 99  ILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRG----GYQGDREWLAEVNYLGQLRH 154
           +LG+GG+G V++      V         A+K L +       +      AE N L +++H
Sbjct: 24  VLGKGGYGKVFQV---RKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKH 80
Query: 155 SNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLH 214
             +V LI          L+ EY+  G L   L  R G  +  +    +A + +  L  LH
Sbjct: 81  PFIVDLIYAFQTGGKLYLILEYLSGGELFMQL-EREGIFMEDTACFYLA-EISMALGHLH 138
Query: 215 GAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVM 274
             ++ +IYRD K  NI+LN     KL+DFGL K+  + D T V+    GT  Y APE +M
Sbjct: 139 --QKGIIYRDLKPENIMLNHQGHVKLTDFGLCKES-IHDGT-VTHTFCGTIEYMAPEILM 194
Query: 275 -TGHLTARSDVYGFGVVLLEMLLG 297
            +GH  A  D +  G ++ +ML G
Sbjct: 195 RSGHNRA-VDWWSLGALMYDMLTG 217

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 62/200 (31%), Positives = 94/200 (47%), Gaps = 13/200 (6%)
Query: 99  ILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDRE-WLAEVNYLGQLRHSNL 157
           ILGEG FG VY+GV   +   G K   VA+K   +     ++E +++E   +  L H ++
Sbjct: 19  ILGEGFFGEVYEGVYTNH--KGEKIN-VAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHI 75
Query: 158 VKLIGYCCEDEHRIL--VYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHG 215
           VKLIG   E+   I+  +Y Y E G    H L R    L     +  +L   K +A+L  
Sbjct: 76  VKLIGIIEEEPTWIIMELYPYGELG----HYLERNKNSLKVLTLVLYSLQICKAMAYLES 131
Query: 216 AERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMT 275
                ++RD    NIL+ +    KL DFGL++     D    S   +    + +PE +  
Sbjct: 132 IN--CVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPI-KWMSPESINF 188
Query: 276 GHLTARSDVYGFGVVLLEML 295
              T  SDV+ F V + E+L
Sbjct: 189 RRFTTASDVWMFAVCMWEIL 208

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 57/221 (25%), Positives = 107/221 (48%), Gaps = 23/221 (10%)
Query: 141 EWLAEVNYLGQLRHSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRM 200
           + + E+  L +     +V   G    D    +  E+M+ GSL++ +L++ G  +      
Sbjct: 53  QIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQ-VLKKAG-RIPEQILG 110
Query: 201 KIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTR 260
           K+++   KGL +L    + +++RD K SNIL+N+    KL DFG++  G + D+  ++  
Sbjct: 111 KVSIAVIKGLTYLREKHK-IMHRDVKPSNILVNSRGEIKLCDFGVS--GQLIDE--MANE 165
Query: 261 VMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLL 320
            +GT  Y +PE +   H + +SD++  G+ L+EM +GR       P     + E    ++
Sbjct: 166 FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR------YPRPPMAIFELLDYIV 219
Query: 321 NNNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGR 361
           N          P+L    +A  +++      +CL +NP  R
Sbjct: 220 NEPP-------PKLP---SAVFSLEFQDFVNKCLIKNPAER 250

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 75/270 (27%), Positives = 116/270 (42%), Gaps = 27/270 (10%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVK 159
           LGEG +G V   V     R   +   V I ++ R           E+     L H N+VK
Sbjct: 14  LGEGAYGEVQLAV----NRVTEEAVAVKIVDMKRA-VDCPENIKKEIXINKMLNHENVVK 68
Query: 160 LIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERP 219
             G+  E   + L  EY   G L   +   +G     ++R    L A  G+ +LHG    
Sbjct: 69  FYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--GVVYLHGIG-- 124
Query: 220 VIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLT 279
           + +RD K  N+LL+   + K+SDFGLA      ++  +  ++ GT  Y APE +      
Sbjct: 125 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFH 184
Query: 280 ARS-DVYGFGVVLLEMLLGRRAVDK-SRPSREHNLVEWARPLLNNNKKVLRILDPRLEGQ 337
           A   DV+  G+VL  ML G    D+ S   +E++  +  +  LN  KK+           
Sbjct: 185 AEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKI----------- 233
Query: 338 YTARTAMKVAGLAYQCLSQNPKGRPVMSDV 367
            +A  A     L ++ L +NP  R  + D+
Sbjct: 234 DSAPLA-----LLHKILVENPSARITIPDI 258

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 75/270 (27%), Positives = 116/270 (42%), Gaps = 27/270 (10%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVK 159
           LGEG +G V   V     R   +   V I ++ R           E+     L H N+VK
Sbjct: 14  LGEGAYGEVQLAV----NRVTEEAVAVKIVDMKRA-VDCPENIKKEIXINKMLNHENVVK 68
Query: 160 LIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERP 219
             G+  E   + L  EY   G L   +   +G     ++R    L A  G+ +LHG    
Sbjct: 69  FYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--GVVYLHGIG-- 124
Query: 220 VIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLT 279
           + +RD K  N+LL+   + K+SDFGLA      ++  +  ++ GT  Y APE +      
Sbjct: 125 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 184
Query: 280 ARS-DVYGFGVVLLEMLLGRRAVDK-SRPSREHNLVEWARPLLNNNKKVLRILDPRLEGQ 337
           A   DV+  G+VL  ML G    D+ S   +E++  +  +  LN  KK+           
Sbjct: 185 AEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKI----------- 233
Query: 338 YTARTAMKVAGLAYQCLSQNPKGRPVMSDV 367
            +A  A     L ++ L +NP  R  + D+
Sbjct: 234 DSAPLA-----LLHKILVENPSARITIPDI 258

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 68.6 bits (166), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 47/154 (30%), Positives = 76/154 (49%), Gaps = 6/154 (3%)
Query: 145 EVNYLGQLRHSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIAL 204
           E + + +L H   VKL     +DE       Y ++G L K++ R++G       R   A 
Sbjct: 83  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI-RKIGSFDETCTRFYTA- 140
Query: 205 DAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKD-GPMGDQTHVSTRVMG 263
           +    L +LHG  + +I+RD K  NILLN D   +++DFG AK   P   Q   ++ V G
Sbjct: 141 EIVSALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFV-G 197
Query: 264 TYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLG 297
           T  Y +PE +        SD++  G ++ +++ G
Sbjct: 198 TAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 231

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 68.6 bits (166), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 59/228 (25%), Positives = 110/228 (48%), Gaps = 27/228 (11%)
Query: 141 EWLAEVNYLGQLRHSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRM 200
           + + E+  L +     +V   G    D    +  E+M+ GSL++ +L++ G  +      
Sbjct: 50  QIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQ-VLKKAG-RIPEQILG 107
Query: 201 KIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTR 260
           K+++   KGL +L    + +++RD K SNIL+N+    KL DFG++  G + D   ++  
Sbjct: 108 KVSIAVIKGLTYLREKHK-IMHRDVKPSNILVNSRGEIKLCDFGVS--GQLIDS--MANS 162
Query: 261 VMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLL 320
            +GT  Y +PE +   H + +SD++  G+ L+EM +GR       P    +  E +RP +
Sbjct: 163 FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR------YPIPPPDAKEDSRPPM 216
Query: 321 NNNKKVLRILD-------PRLEGQYTARTAMKVAGLAYQCLSQNPKGR 361
                +  +LD       P+L    +   +++      +CL +NP  R
Sbjct: 217 ----AIFELLDYIVNEPPPKLP---SGVFSLEFQDFVNKCLIKNPAER 257

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 68.6 bits (166), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 48/155 (30%), Positives = 75/155 (48%), Gaps = 21/155 (13%)
Query: 149 LGQLRHSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMK------I 202
           L  + H  ++++ G   + +   ++ +Y+E G L   LLR+       S+R         
Sbjct: 60  LSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFS-LLRK-------SQRFPNPVAKFY 111
Query: 203 ALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVM 262
           A +    L +LH  +  +IYRD K  NILL+ +   K++DFG AK  P      V+  + 
Sbjct: 112 AAEVCLALEYLHSKD--IIYRDLKPENILLDKNGHIKITDFGFAKYVP-----DVTYXLC 164
Query: 263 GTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLG 297
           GT  Y APE V T       D + FG+++ EML G
Sbjct: 165 GTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAG 199

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 68.6 bits (166), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 66/272 (24%), Positives = 112/272 (41%), Gaps = 35/272 (12%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQG---DREWLAEVNYLGQLRHSN 156
           LG+G FG VY        R       +A+K L +   +    + +   EV     LRH N
Sbjct: 18  LGKGKFGNVYLA------REKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 71
Query: 157 LVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGA 216
           +++L GY  +     L+ EY   G++ + L +         R      + A  L++ H  
Sbjct: 72  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKL--SKFDEQRTATYITELANALSYCHS- 128
Query: 217 ERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTG 276
            + VI+RD K  N+LL +    K+++FG +   P   +    T + GT  Y  PE +   
Sbjct: 129 -KRVIHRDIKPENLLLGSAGELKIANFGWSVHAPSSRR----TTLCGTLDYLPPEMIEGR 183
Query: 277 HLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRILDPRLEG 336
               + D++  GV+  E L+G       +P  E N  +         K++ R+     E 
Sbjct: 184 MHDEKVDLWSLGVLCYEFLVG-------KPPFEANTYQ------ETYKRISRV-----EF 225
Query: 337 QYTARTAMKVAGLAYQCLSQNPKGRPVMSDVV 368
            +          L  + L  NP  RP++ +V+
Sbjct: 226 TFPDFVTEGARDLISRLLKHNPSQRPMLREVL 257

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 66/272 (24%), Positives = 111/272 (40%), Gaps = 35/272 (12%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQG---DREWLAEVNYLGQLRHSN 156
           LG+G FG VY        R       +A+K L +   +    + +   EV     LRH N
Sbjct: 18  LGKGKFGNVYLA------REKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 71
Query: 157 LVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGA 216
           +++L GY  +     L+ EY   G++ + L +         R      + A  L++ H  
Sbjct: 72  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKL--SKFDEQRTATYITELANALSYCHS- 128
Query: 217 ERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTG 276
            + VI+RD K  N+LL +    K++DFG +   P   +  +     GT  Y  PE +   
Sbjct: 129 -KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRXXLC----GTLDYLPPEMIEGR 183
Query: 277 HLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRILDPRLEG 336
               + D++  GV+  E L+G       +P  E N  +         K++ R+     E 
Sbjct: 184 MHDEKVDLWSLGVLCYEFLVG-------KPPFEANTYQ------ETYKRISRV-----EF 225
Query: 337 QYTARTAMKVAGLAYQCLSQNPKGRPVMSDVV 368
            +          L  + L  NP  RP++ +V+
Sbjct: 226 TFPDFVTEGARDLISRLLKHNPSQRPMLREVL 257

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 75/270 (27%), Positives = 116/270 (42%), Gaps = 27/270 (10%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVK 159
           LGEG +G V   V     R   +   V I ++ R           E+     L H N+VK
Sbjct: 15  LGEGAYGEVQLAV----NRVTEEAVAVKIVDMKRA-VDCPENIKKEIXINKMLNHENVVK 69
Query: 160 LIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERP 219
             G+  E   + L  EY   G L   +   +G     ++R    L A  G+ +LHG    
Sbjct: 70  FYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--GVVYLHGIG-- 125
Query: 220 VIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLT 279
           + +RD K  N+LL+   + K+SDFGLA      ++  +  ++ GT  Y APE +      
Sbjct: 126 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFH 185
Query: 280 ARS-DVYGFGVVLLEMLLGRRAVDK-SRPSREHNLVEWARPLLNNNKKVLRILDPRLEGQ 337
           A   DV+  G+VL  ML G    D+ S   +E++  +  +  LN  KK+           
Sbjct: 186 AEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKI----------- 234
Query: 338 YTARTAMKVAGLAYQCLSQNPKGRPVMSDV 367
            +A  A     L ++ L +NP  R  + D+
Sbjct: 235 DSAPLA-----LLHKILVENPSARITIPDI 259

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 82/309 (26%), Positives = 129/309 (41%), Gaps = 60/309 (19%)
Query: 100 LGEGGFGVVYKGVIDEN-VRPGYKTTFVAIKELNRGGYQG-DREWLAEVNYLGQLRHSNL 157
           +GEG +G+V     + N VR       VAI++++   +Q   +  L E+  L + RH N+
Sbjct: 35  IGEGAYGMVCSAYDNLNKVR-------VAIRKISPFEHQTYCQRTLREIKILLRFRHENI 87
Query: 158 VKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMK------IALDAAKGLA 211
           + +      D  R    E M+   + + L+      L  ++ +             +GL 
Sbjct: 88  IGI-----NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLK 142
Query: 212 FLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDG-PMGDQTHVSTRVMGTYGYAAP 270
           ++H A   V++RD K SN+LLN     K+ DFGLA+   P  D T   T  + T  Y AP
Sbjct: 143 YIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 200
Query: 271 EYVMTGH-LTARSDVYGFGVVLLEML------LGRRAVDK--------SRPSRE------ 309
           E ++     T   D++  G +L EML       G+  +D+          PS+E      
Sbjct: 201 EIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCII 260
Query: 310 -------------HNLVEWARPLLNNNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQ 356
                         N V W R   N + K L +LD  L      R  ++ A LA+  L Q
Sbjct: 261 NLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQA-LAHPYLEQ 319
Query: 357 --NPKGRPV 363
             +P   P+
Sbjct: 320 YYDPSDEPI 328

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 66/272 (24%), Positives = 111/272 (40%), Gaps = 35/272 (12%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQG---DREWLAEVNYLGQLRHSN 156
           LG+G FG VY        R       +A+K L +   +    + +   EV     LRH N
Sbjct: 19  LGKGKFGNVYLA------REKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 72
Query: 157 LVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGA 216
           +++L GY  +     L+ EY   G++ + L +         R      + A  L++ H  
Sbjct: 73  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKL--SKFDEQRTATYITELANALSYCHS- 129
Query: 217 ERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTG 276
            + VI+RD K  N+LL +    K++DFG +   P   +  +     GT  Y  PE +   
Sbjct: 130 -KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRAALC----GTLDYLPPEMIEGR 184
Query: 277 HLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRILDPRLEG 336
               + D++  GV+  E L+G       +P  E N  +         K++ R+     E 
Sbjct: 185 MHDEKVDLWSLGVLCYEFLVG-------KPPFEANTYQ------ETYKRISRV-----EF 226
Query: 337 QYTARTAMKVAGLAYQCLSQNPKGRPVMSDVV 368
            +          L  + L  NP  RP++ +V+
Sbjct: 227 TFPDFVTEGARDLISRLLKHNPSQRPMLREVL 258

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 75/270 (27%), Positives = 116/270 (42%), Gaps = 27/270 (10%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVK 159
           LGEG +G V   V     R   +   V I ++ R           E+     L H N+VK
Sbjct: 15  LGEGAYGEVQLAV----NRVTEEAVAVKIVDMKRA-VDCPENIKKEICINAMLNHENVVK 69
Query: 160 LIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERP 219
             G+  E   + L  EY   G L   +   +G     ++R    L A  G+ +LHG    
Sbjct: 70  FYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--GVVYLHGIG-- 125
Query: 220 VIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLT 279
           + +RD K  N+LL+   + K+SDFGLA      ++  +  ++ GT  Y APE +      
Sbjct: 126 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 185
Query: 280 ARS-DVYGFGVVLLEMLLGRRAVDK-SRPSREHNLVEWARPLLNNNKKVLRILDPRLEGQ 337
           A   DV+  G+VL  ML G    D+ S   +E++  +  +  LN  KK+           
Sbjct: 186 AEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKI----------- 234
Query: 338 YTARTAMKVAGLAYQCLSQNPKGRPVMSDV 367
            +A  A     L ++ L +NP  R  + D+
Sbjct: 235 DSAPLA-----LLHKILVENPSARITIPDI 259

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 75/286 (26%), Positives = 120/286 (41%), Gaps = 35/286 (12%)
Query: 94  FRPDYILGEGGFGVVYKGVIDENVRPGYKTT--FVAIKELNRGGYQGDREWLA-----EV 146
           F+   +LGEG +GVV            +K T   VAIK++       D+   A     E+
Sbjct: 13  FQLKSLLGEGAYGVVCSAT--------HKPTGEIVAIKKIE----PFDKPLFALRTLREI 60
Query: 147 NYLGQLRHSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGC-MLTWSRRMKIALD 205
             L   +H N++ +      D        Y+    ++  L R +   ML+          
Sbjct: 61  KILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQ 120
Query: 206 AAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAK---------DGPMGDQTH 256
             + +  LHG+   VI+RD K SN+L+N++   K+ DFGLA+           P G Q+ 
Sbjct: 121 TLRAVKVLHGSN--VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSG 178
Query: 257 VSTRVMGTYGYAAPEYVMTGHLTARS-DVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEW 315
           +    + T  Y APE ++T    +R+ DV+  G +L E+ L RR +   R  R   L+ +
Sbjct: 179 M-VEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFL-RRPIFPGRDYRHQLLLIF 236
Query: 316 ARPLLNNNKKVLRILD-PRLEGQYTARTAMKVAGLAYQCLSQNPKG 360
                 ++   LR ++ PR      +      A L       NPKG
Sbjct: 237 GIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKG 282

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 46/161 (28%), Positives = 86/161 (53%), Gaps = 7/161 (4%)
Query: 141 EWLAEVNYLGQLRHSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRM 200
           + + E+  L +     +V   G    D    +  E+M+ GSL++ +L++ G  +      
Sbjct: 77  QIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQ-VLKKAG-RIPEQILG 134
Query: 201 KIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTR 260
           K+++   KGL +L    + +++RD K SNIL+N+    KL DFG++  G + D   ++  
Sbjct: 135 KVSIAVIKGLTYLREKHK-IMHRDVKPSNILVNSRGEIKLCDFGVS--GQLIDS--MANS 189
Query: 261 VMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAV 301
            +GT  Y +PE +   H + +SD++  G+ L+EM +GR  +
Sbjct: 190 FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 230

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 75/270 (27%), Positives = 116/270 (42%), Gaps = 27/270 (10%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVK 159
           LGEG +G V   V     R   +   V I ++ R           E+     L H N+VK
Sbjct: 14  LGEGAYGEVQLAV----NRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVK 68
Query: 160 LIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERP 219
             G+  E   + L  EY   G L   +   +G     ++R    L A  G+ +LHG    
Sbjct: 69  FYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--GVVYLHGIG-- 124
Query: 220 VIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLT 279
           + +RD K  N+LL+   + K+SDFGLA      ++  +  ++ GT  Y APE +      
Sbjct: 125 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFH 184
Query: 280 ARS-DVYGFGVVLLEMLLGRRAVDK-SRPSREHNLVEWARPLLNNNKKVLRILDPRLEGQ 337
           A   DV+  G+VL  ML G    D+ S   +E++  +  +  LN  KK+           
Sbjct: 185 AEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKI----------- 233
Query: 338 YTARTAMKVAGLAYQCLSQNPKGRPVMSDV 367
            +A  A     L ++ L +NP  R  + D+
Sbjct: 234 DSAPLA-----LLHKILVENPSARITIPDI 258

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 66/272 (24%), Positives = 111/272 (40%), Gaps = 35/272 (12%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQG---DREWLAEVNYLGQLRHSN 156
           LG+G FG VY        R       +A+K L +   +    + +   EV     LRH N
Sbjct: 17  LGKGKFGNVYLA------REKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 70
Query: 157 LVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGA 216
           +++L GY  +     L+ EY   G++ + L +         R      + A  L++ H  
Sbjct: 71  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKL--SKFDEQRTATYITELANALSYCHS- 127
Query: 217 ERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTG 276
            + VI+RD K  N+LL +    K++DFG +   P   +      + GT  Y  PE +   
Sbjct: 128 -KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----DTLCGTLDYLPPEMIEGR 182
Query: 277 HLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRILDPRLEG 336
               + D++  GV+  E L+G       +P  E N  +         K++ R+     E 
Sbjct: 183 MHDEKVDLWSLGVLCYEFLVG-------KPPFEANTYQ------ETYKRISRV-----EF 224
Query: 337 QYTARTAMKVAGLAYQCLSQNPKGRPVMSDVV 368
            +          L  + L  NP  RP++ +V+
Sbjct: 225 TFPDFVTEGARDLISRLLKHNPSQRPMLREVL 256

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 79/273 (28%), Positives = 115/273 (42%), Gaps = 32/273 (11%)
Query: 94  FRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLR 153
           FR   +LG+GGFG V    +      G       +++      +G+   L E   L ++ 
Sbjct: 186 FRQYRVLGKGGFGEVCACQVRAT---GKMYACKKLEKKRIKKRKGEAMALNEKQILEKV- 241
Query: 154 HSNLVKLIGYCCEDEHRI-LVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAF 212
           +S  V  + Y  E +  + LV   M  G L+ H+          +R +  A +   GL  
Sbjct: 242 NSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLED 301
Query: 213 LHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEY 272
           LH  ER ++YRD K  NILL+     ++SD GLA   P G QT +  RV GT GY APE 
Sbjct: 302 LH-RER-IVYRDLKPENILLDDHGHIRISDLGLAVHVPEG-QT-IKGRV-GTVGYMAPEV 356
Query: 273 VMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRILDP 332
           V     T   D +  G +L EM+ G+                   P     KK+ R    
Sbjct: 357 VKNERYTFSPDWWALGCLLYEMIAGQ------------------SPFQQRKKKIKREEVE 398
Query: 333 RL----EGQYTARTAMKVAGLAYQCLSQNPKGR 361
           RL      +Y+ R + +   L  Q L ++P  R
Sbjct: 399 RLVKEVPEEYSERFSPQARSLCSQLLCKDPAER 431

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 104/216 (48%), Gaps = 14/216 (6%)
Query: 87  MKLATKFFRPDYILGEGGFGVVYK-GVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAE 145
           M+L    F     LG G  GVV+K       +    K   + IK   R       + + E
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIR------NQIIRE 54
Query: 146 VNYLGQLRHSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALD 205
           +  L +     +V   G    D    +  E+M+ GSL++ +L++ G  +      K+++ 
Sbjct: 55  LQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQ-VLKKAG-RIPEQILGKVSIA 112
Query: 206 AAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTY 265
             KGL +L    + +++RD K SNIL+N+    KL DFG++  G + D   ++   +GT 
Sbjct: 113 VIKGLTYLREKHK-IMHRDVKPSNILVNSRGEIKLCDFGVS--GQLIDS--MANSFVGTR 167
Query: 266 GYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAV 301
            Y +PE +   H + +SD++  G+ L+EM +GR  +
Sbjct: 168 SYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 203

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 75/270 (27%), Positives = 116/270 (42%), Gaps = 27/270 (10%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVK 159
           LGEG +G V   V     R   +   V I ++ R           E+     L H N+VK
Sbjct: 14  LGEGAYGEVQLAV----NRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVK 68
Query: 160 LIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERP 219
             G+  E   + L  EY   G L   +   +G     ++R    L A  G+ +LHG    
Sbjct: 69  FYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--GVVYLHGIG-- 124
Query: 220 VIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLT 279
           + +RD K  N+LL+   + K+SDFGLA      ++  +  ++ GT  Y APE +      
Sbjct: 125 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFH 184
Query: 280 ARS-DVYGFGVVLLEMLLGRRAVDKSRPS-REHNLVEWARPLLNNNKKVLRILDPRLEGQ 337
           A   DV+  G+VL  ML G    D+   S +E++  +  +  LN  KK+           
Sbjct: 185 AEPVDVWSCGIVLTAMLAGELPWDQPSDSXQEYSDWKEKKTYLNPWKKI----------- 233
Query: 338 YTARTAMKVAGLAYQCLSQNPKGRPVMSDV 367
            +A  A     L ++ L +NP  R  + D+
Sbjct: 234 DSAPLA-----LLHKILVENPSARITIPDI 258

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 47/154 (30%), Positives = 75/154 (48%), Gaps = 6/154 (3%)
Query: 145 EVNYLGQLRHSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIAL 204
           E + + +L H   VKL     +DE       Y ++G L K++ R++G       R   A 
Sbjct: 59  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI-RKIGSFDETCTRFYTA- 116
Query: 205 DAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKD-GPMGDQTHVSTRVMG 263
           +    L +LHG  + +I+RD K  NILLN D   +++DFG AK   P   Q   +  V G
Sbjct: 117 EIVSALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV-G 173
Query: 264 TYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLG 297
           T  Y +PE +        SD++  G ++ +++ G
Sbjct: 174 TAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 207

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 73/270 (27%), Positives = 113/270 (41%), Gaps = 27/270 (10%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVK 159
           LGEG +G V   V     R   +   V I ++ R           E+     L H N+VK
Sbjct: 13  LGEGAYGEVQLAV----NRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVK 67
Query: 160 LIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERP 219
             G+  E   + L  EY   G L   +   +G     ++R    L A  G+ +LHG    
Sbjct: 68  FYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--GVVYLHGIG-- 123
Query: 220 VIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLT 279
           + +RD K  N+LL+   + K+SDFGLA      ++  +  ++ GT  Y APE +      
Sbjct: 124 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 183
Query: 280 ARS-DVYGFGVVLLEMLLGRRAVDK-SRPSREHNLVEWARPLLNNNKKVLRILDPRLEGQ 337
           A   DV+  G+VL  ML G    D+ S   +E++  +  +  LN  KK+           
Sbjct: 184 AEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKI----------- 232
Query: 338 YTARTAMKVAGLAYQCLSQNPKGRPVMSDV 367
                      L ++ L +NP  R  + D+
Sbjct: 233 -----DSAPLALLHKILVENPSARITIPDI 257

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 75/270 (27%), Positives = 116/270 (42%), Gaps = 27/270 (10%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVK 159
           LGEG +G V   V     R   +   V I ++ R           E+     L H N+VK
Sbjct: 14  LGEGAYGEVQLAV----NRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVK 68
Query: 160 LIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERP 219
             G+  E   + L  EY   G L   +   +G     ++R    L A  G+ +LHG    
Sbjct: 69  FYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--GVVYLHGIG-- 124
Query: 220 VIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLT 279
           + +RD K  N+LL+   + K+SDFGLA      ++  +  ++ GT  Y APE +      
Sbjct: 125 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 184
Query: 280 ARS-DVYGFGVVLLEMLLGRRAVDK-SRPSREHNLVEWARPLLNNNKKVLRILDPRLEGQ 337
           A   DV+  G+VL  ML G    D+ S   +E++  +  +  LN  KK+           
Sbjct: 185 AEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKI----------- 233
Query: 338 YTARTAMKVAGLAYQCLSQNPKGRPVMSDV 367
            +A  A     L ++ L +NP  R  + D+
Sbjct: 234 DSAPLA-----LLHKILVENPSARITIPDI 258

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 79/273 (28%), Positives = 115/273 (42%), Gaps = 32/273 (11%)
Query: 94  FRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLR 153
           FR   +LG+GGFG V    +      G       +++      +G+   L E   L ++ 
Sbjct: 186 FRQYRVLGKGGFGEVCACQVRAT---GKMYACKKLEKKRIKKRKGEAMALNEKQILEKV- 241
Query: 154 HSNLVKLIGYCCEDEHRI-LVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAF 212
           +S  V  + Y  E +  + LV   M  G L+ H+          +R +  A +   GL  
Sbjct: 242 NSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLED 301
Query: 213 LHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEY 272
           LH  ER ++YRD K  NILL+     ++SD GLA   P G QT +  RV GT GY APE 
Sbjct: 302 LH-RER-IVYRDLKPENILLDDHGHIRISDLGLAVHVPEG-QT-IKGRV-GTVGYMAPEV 356
Query: 273 VMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRILDP 332
           V     T   D +  G +L EM+ G+                   P     KK+ R    
Sbjct: 357 VKNERYTFSPDWWALGCLLYEMIAGQ------------------SPFQQRKKKIKREEVE 398
Query: 333 RL----EGQYTARTAMKVAGLAYQCLSQNPKGR 361
           RL      +Y+ R + +   L  Q L ++P  R
Sbjct: 399 RLVKEVPEEYSERFSPQARSLCSQLLCKDPAER 431

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 47/154 (30%), Positives = 75/154 (48%), Gaps = 6/154 (3%)
Query: 145 EVNYLGQLRHSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIAL 204
           E + + +L H   VKL     +DE       Y ++G L K++ R++G       R   A 
Sbjct: 60  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI-RKIGSFDETCTRFYTA- 117
Query: 205 DAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKD-GPMGDQTHVSTRVMG 263
           +    L +LHG  + +I+RD K  NILLN D   +++DFG AK   P   Q   +  V G
Sbjct: 118 EIVSALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV-G 174
Query: 264 TYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLG 297
           T  Y +PE +        SD++  G ++ +++ G
Sbjct: 175 TAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 208

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 93/214 (43%), Gaps = 24/214 (11%)
Query: 100 LGEGGFGVVYKGV---IDENVRPGYKTTFVAIKELNRGGYQGD-REWLAEVNYLGQL-RH 154
           LG G FG V +     ID+          VA+K L  G    + R  ++E+  L  +  H
Sbjct: 37  LGRGAFGQVIEADAFGIDKTA----TXRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 92
Query: 155 SNLVKLIGYCCEDEHRILVY-EYMESGSLEKHLLRR------------VGCMLTWSRRMK 201
            N+V L+G C +    ++V  E+ + G+L  +L  +                LT    + 
Sbjct: 93  LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKPEDLYKDFLTLEHLIX 152
Query: 202 IALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRV 261
            +   AKG+ FL  A R  I+RD    NILL+     K+ DFGLA+D             
Sbjct: 153 YSFQVAKGMEFL--ASRKXIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDA 210
Query: 262 MGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEML 295
                + APE +     T +SDV+ FGV+L E+ 
Sbjct: 211 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIF 244

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 63/201 (31%), Positives = 89/201 (44%), Gaps = 10/201 (4%)
Query: 99  ILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLV 158
           +LG+G FG V   ++ E     Y    +  KE+     +     L E   L   RH  L 
Sbjct: 17  LLGKGTFGKVI--LVKEKATGRYYAMKILKKEVIVAKDEVAHT-LTENRVLQNSRHPFLT 73
Query: 159 KLIGYCCEDEHRI-LVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAE 217
            L  Y  +   R+  V EY   G L  HL R    + +  R      +    L +LH +E
Sbjct: 74  AL-KYSFQTHDRLCFVMEYANGGELFFHLSRER--VFSEDRARFYGAEIVSALDYLH-SE 129
Query: 218 RPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGH 277
           + V+YRD K  N++L+ D   K++DFGL K+G     T       GT  Y APE +    
Sbjct: 130 KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT--MKXFCGTPEYLAPEVLEDND 187
Query: 278 LTARSDVYGFGVVLLEMLLGR 298
                D +G GVV+ EM+ GR
Sbjct: 188 YGRAVDWWGLGVVMYEMMCGR 208

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 53/200 (26%), Positives = 93/200 (46%), Gaps = 16/200 (8%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVK 159
           LG+G FG VYK    +N   G      A K +     +   +++ E+  L    H  +VK
Sbjct: 27  LGDGAFGKVYKA---KNKETG---ALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVK 80
Query: 160 LIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERP 219
           L+G    D    ++ E+   G+++  +L  +   LT  +   +     + L FLH   + 
Sbjct: 81  LLGAYYHDGKLWIMIEFCPGGAVDAIMLE-LDRGLTEPQIQVVCRQMLEALNFLHS--KR 137
Query: 220 VIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLT 279
           +I+RD K  N+L+  +   +L+DFG++       Q   S   +GT  + APE VM   + 
Sbjct: 138 IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDS--FIGTPYWMAPEVVMCETMK 195
Query: 280 -----ARSDVYGFGVVLLEM 294
                 ++D++  G+ L+EM
Sbjct: 196 DTPYDYKADIWSLGITLIEM 215

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 63/201 (31%), Positives = 89/201 (44%), Gaps = 10/201 (4%)
Query: 99  ILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLV 158
           +LG+G FG V   ++ E     Y    +  KE+     +     L E   L   RH  L 
Sbjct: 15  LLGKGTFGKVI--LVKEKATGRYYAMKILKKEVIVAKDEVAHT-LTENRVLQNSRHPFLT 71
Query: 159 KLIGYCCEDEHRI-LVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAE 217
            L  Y  +   R+  V EY   G L  HL R    + +  R      +    L +LH +E
Sbjct: 72  AL-KYSFQTHDRLCFVMEYANGGELFFHLSRER--VFSEDRARFYGAEIVSALDYLH-SE 127
Query: 218 RPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGH 277
           + V+YRD K  N++L+ D   K++DFGL K+G     T       GT  Y APE +    
Sbjct: 128 KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT--MKXFCGTPEYLAPEVLEDND 185
Query: 278 LTARSDVYGFGVVLLEMLLGR 298
                D +G GVV+ EM+ GR
Sbjct: 186 YGRAVDWWGLGVVMYEMMCGR 206

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 47/154 (30%), Positives = 75/154 (48%), Gaps = 6/154 (3%)
Query: 145 EVNYLGQLRHSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIAL 204
           E + + +L H   VKL     +DE       Y ++G L K++ R++G       R   A 
Sbjct: 80  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI-RKIGSFDETCTRFYTA- 137
Query: 205 DAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKD-GPMGDQTHVSTRVMG 263
           +    L +LHG  + +I+RD K  NILLN D   +++DFG AK   P   Q   +  V G
Sbjct: 138 EIVSALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANAFV-G 194
Query: 264 TYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLG 297
           T  Y +PE +        SD++  G ++ +++ G
Sbjct: 195 TAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 228

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 104/216 (48%), Gaps = 14/216 (6%)
Query: 87  MKLATKFFRPDYILGEGGFGVVYK-GVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAE 145
           M+L    F     LG G  GVV+K       +    K   + IK   R       + + E
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIR------NQIIRE 54
Query: 146 VNYLGQLRHSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALD 205
           +  L +     +V   G    D    +  E+M+ GSL++ +L++ G  +      K+++ 
Sbjct: 55  LQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQ-VLKKAG-RIPEQILGKVSIA 112
Query: 206 AAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTY 265
             KGL +L    + +++RD K SNIL+N+    KL DFG++  G + D   ++   +GT 
Sbjct: 113 VIKGLTYLREKHK-IMHRDVKPSNILVNSRGEIKLCDFGVS--GQLIDS--MANSFVGTR 167
Query: 266 GYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAV 301
            Y +PE +   H + +SD++  G+ L+EM +GR  +
Sbjct: 168 SYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 203

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 75/270 (27%), Positives = 116/270 (42%), Gaps = 27/270 (10%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVK 159
           LGEG +G V   V     R   +   V I ++ R           E+     L H N+VK
Sbjct: 14  LGEGAYGEVQLAV----NRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVK 68
Query: 160 LIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERP 219
             G+  E   + L  EY   G L   +   +G     ++R    L A  G+ +LHG    
Sbjct: 69  FYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--GVVYLHGIG-- 124
Query: 220 VIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLT 279
           + +RD K  N+LL+   + K+SDFGLA      ++  +  ++ GT  Y APE +      
Sbjct: 125 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 184
Query: 280 ARS-DVYGFGVVLLEMLLGRRAVDK-SRPSREHNLVEWARPLLNNNKKVLRILDPRLEGQ 337
           A   DV+  G+VL  ML G    D+ S   +E++  +  +  LN  KK+           
Sbjct: 185 AEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKI----------- 233
Query: 338 YTARTAMKVAGLAYQCLSQNPKGRPVMSDV 367
            +A  A     L ++ L +NP  R  + D+
Sbjct: 234 DSAPLA-----LLHKILVENPSARITIPDI 258

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 59/234 (25%), Positives = 107/234 (45%), Gaps = 30/234 (12%)
Query: 94  FRPDYILGEGGFGVVYKGVIDENVRPGYKTTF-VAIKELNRG-GYQGDREWLAEVNYLGQ 151
           F+   +LG G FG VYKG+    +  G K    VAIKEL      + ++E L E   +  
Sbjct: 21  FKKIKVLGSGAFGTVYKGLW---IPEGEKVKIPVAIKELREATSPKANKEILDEAYVMAS 77
Query: 152 LRHSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMK---------- 201
           + + ++ +L+G C     ++++             L   GC+L + R  K          
Sbjct: 78  VDNPHVCRLLGICLTSTVQLIMQ------------LMPFGCLLDYVREHKDNIGSQYLLN 125
Query: 202 IALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRV 261
             +  AKG+ +L   +R +++RD    N+L+      K++DFGLAK     ++ + +   
Sbjct: 126 WCVQIAKGMNYLE--DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 183
Query: 262 MGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEML-LGRRAVDKSRPSREHNLVE 314
                + A E ++    T +SDV+ +GV + E++  G +  D    S   +++E
Sbjct: 184 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE 237

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 75/270 (27%), Positives = 116/270 (42%), Gaps = 27/270 (10%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVK 159
           LGEG +G V   V     R   +   V I ++ R           E+     L H N+VK
Sbjct: 14  LGEGAYGEVQLAV----NRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVK 68
Query: 160 LIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERP 219
             G+  E   + L  EY   G L   +   +G     ++R    L A  G+ +LHG    
Sbjct: 69  FYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--GVVYLHGIG-- 124
Query: 220 VIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLT 279
           + +RD K  N+LL+   + K+SDFGLA      ++  +  ++ GT  Y APE +      
Sbjct: 125 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 184
Query: 280 ARS-DVYGFGVVLLEMLLGRRAVDK-SRPSREHNLVEWARPLLNNNKKVLRILDPRLEGQ 337
           A   DV+  G+VL  ML G    D+ S   +E++  +  +  LN  KK+           
Sbjct: 185 AEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKI----------- 233
Query: 338 YTARTAMKVAGLAYQCLSQNPKGRPVMSDV 367
            +A  A     L ++ L +NP  R  + D+
Sbjct: 234 DSAPLA-----LLHKILVENPSARITIPDI 258

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 47/154 (30%), Positives = 75/154 (48%), Gaps = 6/154 (3%)
Query: 145 EVNYLGQLRHSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIAL 204
           E + + +L H   VKL     +DE       Y ++G L K++ R++G       R   A 
Sbjct: 83  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI-RKIGSFDETCTRFYTA- 140
Query: 205 DAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKD-GPMGDQTHVSTRVMG 263
           +    L +LHG  + +I+RD K  NILLN D   +++DFG AK   P   Q   +  V G
Sbjct: 141 EIVSALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV-G 197
Query: 264 TYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLG 297
           T  Y +PE +        SD++  G ++ +++ G
Sbjct: 198 TAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 231

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 82/309 (26%), Positives = 128/309 (41%), Gaps = 60/309 (19%)
Query: 100 LGEGGFGVVYKGVIDEN-VRPGYKTTFVAIKELNRGGYQG-DREWLAEVNYLGQLRHSNL 157
           +GEG +G+V     + N VR       VAIK+++   +Q   +  L E+  L + RH N+
Sbjct: 29  IGEGAYGMVCSAYDNLNKVR-------VAIKKISPFEHQTYCQRTLREIKILLRFRHENI 81
Query: 158 VKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMK------IALDAAKGLA 211
           + +      D  R    E M+   + + L+      L  ++ +             +GL 
Sbjct: 82  IGI-----NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLK 136
Query: 212 FLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDG-PMGDQTHVSTRVMGTYGYAAP 270
           ++H A   V++RD K SN+LLN     K+ DFGLA+   P  D T   T  + T  Y AP
Sbjct: 137 YIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 194
Query: 271 EYVMTGH-LTARSDVYGFGVVLLEML------LGRRAVDK--------SRPSRE------ 309
           E ++     T   D++  G +L EML       G+  +D+          P +E      
Sbjct: 195 EIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPEQEDLNCII 254
Query: 310 -------------HNLVEWARPLLNNNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQ 356
                         N V W R   N + K L +LD  L      R  ++ A LA+  L Q
Sbjct: 255 NLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQA-LAHPYLEQ 313
Query: 357 --NPKGRPV 363
             +P   P+
Sbjct: 314 YYDPSDEPI 322

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 44/153 (28%), Positives = 74/153 (48%), Gaps = 4/153 (2%)
Query: 145 EVNYLGQLRHSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIAL 204
           E + + +L H   VKL     +DE       Y ++G L K++ R++G       R   A 
Sbjct: 58  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI-RKIGSFDETCTRFYTA- 115
Query: 205 DAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGT 264
           +    L +LHG  + +I+RD K  NILLN D   +++DFG AK      +   +   +GT
Sbjct: 116 EIVSALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 173
Query: 265 YGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLG 297
             Y +PE +        SD++  G ++ +++ G
Sbjct: 174 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 206

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 47/154 (30%), Positives = 75/154 (48%), Gaps = 6/154 (3%)
Query: 145 EVNYLGQLRHSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIAL 204
           E + + +L H   VKL     +DE       Y ++G L K++ R++G       R   A 
Sbjct: 80  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI-RKIGSFDETCTRFYTA- 137
Query: 205 DAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKD-GPMGDQTHVSTRVMG 263
           +    L +LHG  + +I+RD K  NILLN D   +++DFG AK   P   Q   +  V G
Sbjct: 138 EIVSALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV-G 194
Query: 264 TYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLG 297
           T  Y +PE +        SD++  G ++ +++ G
Sbjct: 195 TAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 228

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 47/154 (30%), Positives = 75/154 (48%), Gaps = 6/154 (3%)
Query: 145 EVNYLGQLRHSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIAL 204
           E + + +L H   VKL     +DE       Y ++G L K++ R++G       R   A 
Sbjct: 82  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI-RKIGSFDETCTRFYTA- 139
Query: 205 DAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKD-GPMGDQTHVSTRVMG 263
           +    L +LHG  + +I+RD K  NILLN D   +++DFG AK   P   Q   +  V G
Sbjct: 140 EIVSALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV-G 196
Query: 264 TYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLG 297
           T  Y +PE +        SD++  G ++ +++ G
Sbjct: 197 TAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 230

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 66/272 (24%), Positives = 111/272 (40%), Gaps = 35/272 (12%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQG---DREWLAEVNYLGQLRHSN 156
           LG+G FG VY        R       +A+K L +   +    + +   EV     LRH N
Sbjct: 16  LGKGKFGNVYLA------REKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 69
Query: 157 LVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGA 216
           +++L GY  +     L+ EY   G++ + L +         R      + A  L++ H  
Sbjct: 70  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKL--SKFDEQRTATYITELANALSYCHS- 126
Query: 217 ERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTG 276
            + VI+RD K  N+LL +    K++DFG +   P   +  +     GT  Y  PE +   
Sbjct: 127 -KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRAALC----GTLDYLPPEMIEGR 181
Query: 277 HLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRILDPRLEG 336
               + D++  GV+  E L+G       +P  E N  +         K++ R+     E 
Sbjct: 182 MHDEKVDLWSLGVLCYEFLVG-------KPPFEANTYQ------ETYKRISRV-----EF 223
Query: 337 QYTARTAMKVAGLAYQCLSQNPKGRPVMSDVV 368
            +          L  + L  NP  RP++ +V+
Sbjct: 224 TFPDFVTEGARDLISRLLKHNPSQRPMLREVL 255

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 66/272 (24%), Positives = 111/272 (40%), Gaps = 35/272 (12%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQG---DREWLAEVNYLGQLRHSN 156
           LG+G FG VY        R       +A+K L +   +    + +   EV     LRH N
Sbjct: 16  LGKGKFGNVYLA------REKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 69
Query: 157 LVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGA 216
           +++L GY  +     L+ EY   G++ + L +         R      + A  L++ H  
Sbjct: 70  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKL--SKFDEQRTATYITELANALSYCHS- 126
Query: 217 ERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTG 276
            + VI+RD K  N+LL +    K++DFG +   P   +  +     GT  Y  PE +   
Sbjct: 127 -KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRXXLC----GTLDYLPPEMIEGR 181
Query: 277 HLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRILDPRLEG 336
               + D++  GV+  E L+G       +P  E N  +         K++ R+     E 
Sbjct: 182 MHDEKVDLWSLGVLCYEFLVG-------KPPFEANTYQ------ETYKRISRV-----EF 223
Query: 337 QYTARTAMKVAGLAYQCLSQNPKGRPVMSDVV 368
            +          L  + L  NP  RP++ +V+
Sbjct: 224 TFPDFVTEGARDLISRLLKHNPSQRPMLREVL 255

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 47/154 (30%), Positives = 75/154 (48%), Gaps = 6/154 (3%)
Query: 145 EVNYLGQLRHSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIAL 204
           E + + +L H   VKL     +DE       Y ++G L K++ R++G       R   A 
Sbjct: 82  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI-RKIGSFDETCTRFYTA- 139
Query: 205 DAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKD-GPMGDQTHVSTRVMG 263
           +    L +LHG  + +I+RD K  NILLN D   +++DFG AK   P   Q   +  V G
Sbjct: 140 EIVSALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV-G 196
Query: 264 TYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLG 297
           T  Y +PE +        SD++  G ++ +++ G
Sbjct: 197 TAQYVSPELLTEKSAXKSSDLWALGCIIYQLVAG 230

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 66/272 (24%), Positives = 111/272 (40%), Gaps = 35/272 (12%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQG---DREWLAEVNYLGQLRHSN 156
           LG+G FG VY        R       +A+K L +   +    + +   EV     LRH N
Sbjct: 19  LGKGKFGNVYLA------REKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 72
Query: 157 LVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGA 216
           +++L GY  +     L+ EY   G++ + L +         R      + A  L++ H  
Sbjct: 73  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKL--SKFDEQRTATYITELANALSYCHS- 129
Query: 217 ERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTG 276
            + VI+RD K  N+LL +    K++DFG +   P   +  +     GT  Y  PE +   
Sbjct: 130 -KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRDDLC----GTLDYLPPEMIEGR 184
Query: 277 HLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRILDPRLEG 336
               + D++  GV+  E L+G       +P  E N  +         K++ R+     E 
Sbjct: 185 MHDEKVDLWSLGVLCYEFLVG-------KPPFEANTYQ------ETYKRISRV-----EF 226
Query: 337 QYTARTAMKVAGLAYQCLSQNPKGRPVMSDVV 368
            +          L  + L  NP  RP++ +V+
Sbjct: 227 TFPDFVTEGARDLISRLLKHNPSQRPMLREVL 258

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 47/154 (30%), Positives = 75/154 (48%), Gaps = 6/154 (3%)
Query: 145 EVNYLGQLRHSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIAL 204
           E + + +L H   VKL     +DE       Y ++G L K++ R++G       R   A 
Sbjct: 82  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI-RKIGSFDETCTRFYTA- 139
Query: 205 DAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKD-GPMGDQTHVSTRVMG 263
           +    L +LHG  + +I+RD K  NILLN D   +++DFG AK   P   Q   +  V G
Sbjct: 140 EIVSALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV-G 196
Query: 264 TYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLG 297
           T  Y +PE +        SD++  G ++ +++ G
Sbjct: 197 TAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 230

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 75/270 (27%), Positives = 116/270 (42%), Gaps = 27/270 (10%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVK 159
           LGEG +G V   V     R   +   V I ++ R           E+     L H N+VK
Sbjct: 14  LGEGAYGEVQLAV----NRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVK 68
Query: 160 LIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERP 219
             G+  E   + L  EY   G L   +   +G     ++R    L A  G+ +LHG    
Sbjct: 69  FYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--GVVYLHGIG-- 124
Query: 220 VIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLT 279
           + +RD K  N+LL+   + K+SDFGLA      ++  +  ++ GT  Y APE +      
Sbjct: 125 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 184
Query: 280 ARS-DVYGFGVVLLEMLLGRRAVDK-SRPSREHNLVEWARPLLNNNKKVLRILDPRLEGQ 337
           A   DV+  G+VL  ML G    D+ S   +E++  +  +  LN  KK+           
Sbjct: 185 AEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKI----------- 233
Query: 338 YTARTAMKVAGLAYQCLSQNPKGRPVMSDV 367
            +A  A     L ++ L +NP  R  + D+
Sbjct: 234 DSAPLA-----LLHKILVENPSARITIPDI 258

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 47/154 (30%), Positives = 75/154 (48%), Gaps = 6/154 (3%)
Query: 145 EVNYLGQLRHSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIAL 204
           E + + +L H   VKL     +DE       Y ++G L K++ R++G       R   A 
Sbjct: 80  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI-RKIGSFDETCTRFYTA- 137
Query: 205 DAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKD-GPMGDQTHVSTRVMG 263
           +    L +LHG  + +I+RD K  NILLN D   +++DFG AK   P   Q   +  V G
Sbjct: 138 EIVSALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV-G 194
Query: 264 TYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLG 297
           T  Y +PE +        SD++  G ++ +++ G
Sbjct: 195 TAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 228

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 47/154 (30%), Positives = 75/154 (48%), Gaps = 6/154 (3%)
Query: 145 EVNYLGQLRHSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIAL 204
           E + + +L H   VKL     +DE       Y ++G L K++ R++G       R   A 
Sbjct: 82  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI-RKIGSFDETCTRFYTA- 139
Query: 205 DAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKD-GPMGDQTHVSTRVMG 263
           +    L +LHG  + +I+RD K  NILLN D   +++DFG AK   P   Q   +  V G
Sbjct: 140 EIVSALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV-G 196
Query: 264 TYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLG 297
           T  Y +PE +        SD++  G ++ +++ G
Sbjct: 197 TAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 230

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 66/272 (24%), Positives = 112/272 (41%), Gaps = 35/272 (12%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQG---DREWLAEVNYLGQLRHSN 156
           LG+G FG VY        R       +A+K L +   +    + +   EV     LRH N
Sbjct: 19  LGKGKFGNVYLA------REKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 72
Query: 157 LVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGA 216
           +++L GY  +     L+ EY   G++ + L +         R      + A  L++ H  
Sbjct: 73  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKL--SKFDEQRTATYITELANALSYCHS- 129
Query: 217 ERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTG 276
            + VI+RD K  N+LL +    K+++FG +   P   +    T + GT  Y  PE +   
Sbjct: 130 -KRVIHRDIKPENLLLGSAGELKIANFGWSVHAPSSRR----TTLCGTLDYLPPEMIEGR 184
Query: 277 HLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRILDPRLEG 336
               + D++  GV+  E L+G       +P  E N  +         K++ R+     E 
Sbjct: 185 MHDEKVDLWSLGVLCYEFLVG-------KPPFEANTYQ------ETYKRISRV-----EF 226
Query: 337 QYTARTAMKVAGLAYQCLSQNPKGRPVMSDVV 368
            +          L  + L  NP  RP++ +V+
Sbjct: 227 TFPDFVTEGARDLISRLLKHNPSQRPMLREVL 258

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 75/270 (27%), Positives = 116/270 (42%), Gaps = 27/270 (10%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVK 159
           LGEG +G V   V     R   +   V I ++ R           E+     L H N+VK
Sbjct: 15  LGEGAYGEVQLAV----NRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVK 69
Query: 160 LIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERP 219
             G+  E   + L  EY   G L   +   +G     ++R    L A  G+ +LHG    
Sbjct: 70  FYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--GVVYLHGIG-- 125
Query: 220 VIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLT 279
           + +RD K  N+LL+   + K+SDFGLA      ++  +  ++ GT  Y APE +      
Sbjct: 126 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 185
Query: 280 ARS-DVYGFGVVLLEMLLGRRAVDK-SRPSREHNLVEWARPLLNNNKKVLRILDPRLEGQ 337
           A   DV+  G+VL  ML G    D+ S   +E++  +  +  LN  KK+           
Sbjct: 186 AEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKI----------- 234
Query: 338 YTARTAMKVAGLAYQCLSQNPKGRPVMSDV 367
            +A  A     L ++ L +NP  R  + D+
Sbjct: 235 DSAPLA-----LLHKILVENPSARITIPDI 259

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 65/204 (31%), Positives = 87/204 (42%), Gaps = 17/204 (8%)
Query: 99  ILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDRE---WLAEVNYLGQLRHS 155
           +LG+G FG V        VR      + A+K L +       E    + E   L   RH 
Sbjct: 12  LLGKGTFGKVIL------VREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHP 65
Query: 156 NLVKLIGYCCEDEHRI-LVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLH 214
            L  L  Y  +   R+  V EY   G L  HL R    + T  R      +    L +LH
Sbjct: 66  FLTAL-KYAFQTHDRLCFVMEYANGGELFFHLSRER--VFTEERARFYGAEIVSALEYLH 122
Query: 215 GAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVM 274
              R V+YRD K  N++L+ D   K++DFGL K+G     T       GT  Y APE + 
Sbjct: 123 S--RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT--MKXFCGTPEYLAPEVLE 178
Query: 275 TGHLTARSDVYGFGVVLLEMLLGR 298
                   D +G GVV+ EM+ GR
Sbjct: 179 DNDYGRAVDWWGLGVVMYEMMCGR 202

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 47/154 (30%), Positives = 75/154 (48%), Gaps = 6/154 (3%)
Query: 145 EVNYLGQLRHSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIAL 204
           E + + +L H   VKL     +DE       Y ++G L K++ R++G       R   A 
Sbjct: 85  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI-RKIGSFDETCTRFYTA- 142
Query: 205 DAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKD-GPMGDQTHVSTRVMG 263
           +    L +LHG  + +I+RD K  NILLN D   +++DFG AK   P   Q   +  V G
Sbjct: 143 EIVSALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV-G 199
Query: 264 TYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLG 297
           T  Y +PE +        SD++  G ++ +++ G
Sbjct: 200 TAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 233

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 47/154 (30%), Positives = 75/154 (48%), Gaps = 6/154 (3%)
Query: 145 EVNYLGQLRHSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIAL 204
           E + + +L H   VKL     +DE       Y ++G L K++ R++G       R   A 
Sbjct: 80  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI-RKIGSFDETCTRFYTA- 137
Query: 205 DAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKD-GPMGDQTHVSTRVMG 263
           +    L +LHG  + +I+RD K  NILLN D   +++DFG AK   P   Q   +  V G
Sbjct: 138 EIVSALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV-G 194
Query: 264 TYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLG 297
           T  Y +PE +        SD++  G ++ +++ G
Sbjct: 195 TAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 228

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 75/270 (27%), Positives = 116/270 (42%), Gaps = 27/270 (10%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVK 159
           LGEG +G V   V     R   +   V I ++ R           E+     L H N+VK
Sbjct: 14  LGEGAYGEVQLAV----NRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVK 68
Query: 160 LIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERP 219
             G+  E   + L  EY   G L   +   +G     ++R    L A  G+ +LHG    
Sbjct: 69  FYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--GVVYLHGIG-- 124
Query: 220 VIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLT 279
           + +RD K  N+LL+   + K+SDFGLA      ++  +  ++ GT  Y APE +      
Sbjct: 125 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFH 184
Query: 280 ARS-DVYGFGVVLLEMLLGRRAVDK-SRPSREHNLVEWARPLLNNNKKVLRILDPRLEGQ 337
           A   DV+  G+VL  ML G    D+ S   +E++  +  +  LN  KK+           
Sbjct: 185 AEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKI----------- 233
Query: 338 YTARTAMKVAGLAYQCLSQNPKGRPVMSDV 367
            +A  A     L ++ L +NP  R  + D+
Sbjct: 234 DSAPLA-----LLHKILVENPSARITIPDI 258

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 53/200 (26%), Positives = 93/200 (46%), Gaps = 16/200 (8%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVK 159
           LG+G FG VYK    +N   G      A K +     +   +++ E+  L    H  +VK
Sbjct: 19  LGDGAFGKVYKA---KNKETG---ALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVK 72
Query: 160 LIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERP 219
           L+G    D    ++ E+   G+++  +L  +   LT  +   +     + L FLH   + 
Sbjct: 73  LLGAYYHDGKLWIMIEFCPGGAVDAIMLE-LDRGLTEPQIQVVCRQMLEALNFLHS--KR 129
Query: 220 VIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLT 279
           +I+RD K  N+L+  +   +L+DFG++       Q   S   +GT  + APE VM   + 
Sbjct: 130 IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDS--FIGTPYWMAPEVVMCETMK 187
Query: 280 -----ARSDVYGFGVVLLEM 294
                 ++D++  G+ L+EM
Sbjct: 188 DTPYDYKADIWSLGITLIEM 207

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 63/201 (31%), Positives = 89/201 (44%), Gaps = 10/201 (4%)
Query: 99  ILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLV 158
           +LG+G FG V   ++ E     Y    +  KE+     +     L E   L   RH  L 
Sbjct: 16  LLGKGTFGKVI--LVKEKATGRYYAMKILKKEVIVAKDEVAHT-LTENRVLQNSRHPFLT 72
Query: 159 KLIGYCCEDEHRI-LVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAE 217
            L  Y  +   R+  V EY   G L  HL R    + +  R      +    L +LH +E
Sbjct: 73  AL-KYSFQTHDRLCFVMEYANGGELFFHLSRER--VFSEDRARFYGAEIVSALDYLH-SE 128
Query: 218 RPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGH 277
           + V+YRD K  N++L+ D   K++DFGL K+G     T       GT  Y APE +    
Sbjct: 129 KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT--MKXFCGTPEYLAPEVLEDND 186
Query: 278 LTARSDVYGFGVVLLEMLLGR 298
                D +G GVV+ EM+ GR
Sbjct: 187 YGRAVDWWGLGVVMYEMMCGR 207

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 55/214 (25%), Positives = 99/214 (46%), Gaps = 29/214 (13%)
Query: 94  FRPDYILGEGGFGVVYKGVIDENVRPGYKTTF-VAIKELNRG-GYQGDREWLAEVNYLGQ 151
           F+   +LG G FG VYKG+    +  G K    VAIKEL      + ++E L E   +  
Sbjct: 18  FKKIKVLGSGAFGTVYKGLW---IPEGEKVKIPVAIKELREATSPKANKEILDEAYVMAS 74
Query: 152 LRHSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMK---------- 201
           + + ++ +L+G C     ++++             L   GC+L + R  K          
Sbjct: 75  VDNPHVCRLLGICLTSTVQLIMQ------------LMPFGCLLDYVREHKDNIGSQYLLN 122
Query: 202 IALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRV 261
             +  AKG+ +L   +R +++RD    N+L+      K++DFGLAK     ++ + +   
Sbjct: 123 WCVQIAKGMNYLE--DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 180
Query: 262 MGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEML 295
                + A E ++    T +SDV+ +GV + E++
Sbjct: 181 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELM 214

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 75/270 (27%), Positives = 116/270 (42%), Gaps = 27/270 (10%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVK 159
           LGEG +G V   V     R   +   V I ++ R           E+     L H N+VK
Sbjct: 14  LGEGAYGEVQLAV----NRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVK 68
Query: 160 LIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERP 219
             G+  E   + L  EY   G L   +   +G     ++R    L A  G+ +LHG    
Sbjct: 69  FYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--GVVYLHGIG-- 124
Query: 220 VIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLT 279
           + +RD K  N+LL+   + K+SDFGLA      ++  +  ++ GT  Y APE +      
Sbjct: 125 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 184
Query: 280 ARS-DVYGFGVVLLEMLLGRRAVDK-SRPSREHNLVEWARPLLNNNKKVLRILDPRLEGQ 337
           A   DV+  G+VL  ML G    D+ S   +E++  +  +  LN  KK+           
Sbjct: 185 AEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKI----------- 233
Query: 338 YTARTAMKVAGLAYQCLSQNPKGRPVMSDV 367
            +A  A     L ++ L +NP  R  + D+
Sbjct: 234 DSAPLA-----LLHKILVENPSARITIPDI 258

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/234 (25%), Positives = 107/234 (45%), Gaps = 30/234 (12%)
Query: 94  FRPDYILGEGGFGVVYKGVIDENVRPGYKTTF-VAIKELNRG-GYQGDREWLAEVNYLGQ 151
           F+   +LG G FG VYKG+    +  G K    VAIKEL      + ++E L E   +  
Sbjct: 19  FKKIKVLGSGAFGTVYKGLW---IPEGEKVKIPVAIKELREATSPKANKEILDEAYVMAS 75
Query: 152 LRHSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMK---------- 201
           + + ++ +L+G C     ++++             L   GC+L + R  K          
Sbjct: 76  VDNPHVCRLLGICLTSTVQLIMQ------------LMPFGCLLDYVREHKDNIGSQYLLN 123
Query: 202 IALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRV 261
             +  AKG+ +L   +R +++RD    N+L+      K++DFGLAK     ++ + +   
Sbjct: 124 WCVQIAKGMNYLE--DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 181
Query: 262 MGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEML-LGRRAVDKSRPSREHNLVE 314
                + A E ++    T +SDV+ +GV + E++  G +  D    S   +++E
Sbjct: 182 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE 235

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 66/272 (24%), Positives = 111/272 (40%), Gaps = 35/272 (12%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQG---DREWLAEVNYLGQLRHSN 156
           LG+G FG VY        R       +A+K L +   +    + +   EV     LRH N
Sbjct: 19  LGKGKFGNVYLA------REKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 72
Query: 157 LVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGA 216
           +++L GY  +     L+ EY   G++ + L +         R      + A  L++ H  
Sbjct: 73  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKL--SKFDEQRTATYITELANALSYCHS- 129
Query: 217 ERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTG 276
            + VI+RD K  N+LL +    K++DFG +   P   +  +     GT  Y  PE +   
Sbjct: 130 -KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRXXLC----GTLDYLPPEMIEGR 184
Query: 277 HLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRILDPRLEG 336
               + D++  GV+  E L+G       +P  E N  +         K++ R+     E 
Sbjct: 185 MHDEKVDLWSLGVLCYEFLVG-------KPPFEANTYQ------ETYKRISRV-----EF 226
Query: 337 QYTARTAMKVAGLAYQCLSQNPKGRPVMSDVV 368
            +          L  + L  NP  RP++ +V+
Sbjct: 227 TFPDFVTEGARDLISRLLKHNPSQRPMLREVL 258

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 44/153 (28%), Positives = 74/153 (48%), Gaps = 4/153 (2%)
Query: 145 EVNYLGQLRHSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIAL 204
           E + + +L H   VKL     +DE       Y ++G L K++ R++G       R   A 
Sbjct: 57  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI-RKIGSFDETCTRFYTA- 114
Query: 205 DAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGT 264
           +    L +LHG  + +I+RD K  NILLN D   +++DFG AK      +   +   +GT
Sbjct: 115 EIVSALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 172
Query: 265 YGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLG 297
             Y +PE +        SD++  G ++ +++ G
Sbjct: 173 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 205

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 65/204 (31%), Positives = 87/204 (42%), Gaps = 17/204 (8%)
Query: 99  ILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDRE---WLAEVNYLGQLRHS 155
           +LG+G FG V        VR      + A+K L +       E    + E   L   RH 
Sbjct: 17  LLGKGTFGKVIL------VREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHP 70
Query: 156 NLVKLIGYCCEDEHRI-LVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLH 214
            L  L  Y  +   R+  V EY   G L  HL R    + T  R      +    L +LH
Sbjct: 71  FLTAL-KYAFQTHDRLCFVMEYANGGELFFHLSRER--VFTEERARFYGAEIVSALEYLH 127
Query: 215 GAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVM 274
              R V+YRD K  N++L+ D   K++DFGL K+G     T       GT  Y APE + 
Sbjct: 128 S--RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT--MKXFCGTPEYLAPEVLE 183
Query: 275 TGHLTARSDVYGFGVVLLEMLLGR 298
                   D +G GVV+ EM+ GR
Sbjct: 184 DNDYGRAVDWWGLGVVMYEMMCGR 207

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 47/154 (30%), Positives = 75/154 (48%), Gaps = 6/154 (3%)
Query: 145 EVNYLGQLRHSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIAL 204
           E + + +L H   VKL     +DE       Y ++G L K++ R++G       R   A 
Sbjct: 82  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI-RKIGSFDETCTRFYTA- 139
Query: 205 DAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKD-GPMGDQTHVSTRVMG 263
           +    L +LHG  + +I+RD K  NILLN D   +++DFG AK   P   Q   +  V G
Sbjct: 140 EIVSALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV-G 196
Query: 264 TYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLG 297
           T  Y +PE +        SD++  G ++ +++ G
Sbjct: 197 TAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 230

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/234 (25%), Positives = 107/234 (45%), Gaps = 30/234 (12%)
Query: 94  FRPDYILGEGGFGVVYKGVIDENVRPGYKTTF-VAIKELNRG-GYQGDREWLAEVNYLGQ 151
           F+   +LG G FG VYKG+    +  G K    VAIKEL      + ++E L E   +  
Sbjct: 20  FKKIKVLGSGAFGTVYKGLW---IPEGEKVKIPVAIKELREATSPKANKEILDEAYVMAS 76
Query: 152 LRHSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMK---------- 201
           + + ++ +L+G C     ++++             L   GC+L + R  K          
Sbjct: 77  VDNPHVCRLLGICLTSTVQLIMQ------------LMPFGCLLDYVREHKDNIGSQYLLN 124
Query: 202 IALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRV 261
             +  AKG+ +L   +R +++RD    N+L+      K++DFGLAK     ++ + +   
Sbjct: 125 WCVQIAKGMNYLE--DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 182
Query: 262 MGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEML-LGRRAVDKSRPSREHNLVE 314
                + A E ++    T +SDV+ +GV + E++  G +  D    S   +++E
Sbjct: 183 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE 236

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 75/270 (27%), Positives = 116/270 (42%), Gaps = 27/270 (10%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVK 159
           LGEG +G V   V     R   +   V I ++ R           E+     L H N+VK
Sbjct: 15  LGEGAYGEVQLAV----NRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVK 69
Query: 160 LIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERP 219
             G+  E   + L  EY   G L   +   +G     ++R    L A  G+ +LHG    
Sbjct: 70  FYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--GVVYLHGIG-- 125
Query: 220 VIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLT 279
           + +RD K  N+LL+   + K+SDFGLA      ++  +  ++ GT  Y APE +      
Sbjct: 126 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 185
Query: 280 ARS-DVYGFGVVLLEMLLGRRAVDK-SRPSREHNLVEWARPLLNNNKKVLRILDPRLEGQ 337
           A   DV+  G+VL  ML G    D+ S   +E++  +  +  LN  KK+           
Sbjct: 186 AEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKI----------- 234
Query: 338 YTARTAMKVAGLAYQCLSQNPKGRPVMSDV 367
            +A  A     L ++ L +NP  R  + D+
Sbjct: 235 DSAPLA-----LLHKILVENPSARITIPDI 259

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 65/204 (31%), Positives = 87/204 (42%), Gaps = 17/204 (8%)
Query: 99  ILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDRE---WLAEVNYLGQLRHS 155
           +LG+G FG V        VR      + A+K L +       E    + E   L   RH 
Sbjct: 12  LLGKGTFGKVIL------VREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHP 65
Query: 156 NLVKLIGYCCEDEHRI-LVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLH 214
            L  L  Y  +   R+  V EY   G L  HL R    + T  R      +    L +LH
Sbjct: 66  FLTAL-KYAFQTHDRLCFVMEYANGGELFFHLSRER--VFTEERARFYGAEIVSALEYLH 122
Query: 215 GAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVM 274
              R V+YRD K  N++L+ D   K++DFGL K+G     T       GT  Y APE + 
Sbjct: 123 S--RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT--MKXFCGTPEYLAPEVLE 178
Query: 275 TGHLTARSDVYGFGVVLLEMLLGR 298
                   D +G GVV+ EM+ GR
Sbjct: 179 DNDYGRAVDWWGLGVVMYEMMCGR 202

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 47/154 (30%), Positives = 76/154 (49%), Gaps = 6/154 (3%)
Query: 145 EVNYLGQLRHSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIAL 204
           E + + +L H   VKL     +DE       Y ++G L K++ R++G       R   A 
Sbjct: 79  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI-RKIGSFDETCTRFYTA- 136
Query: 205 DAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKD-GPMGDQTHVSTRVMG 263
           +    L +LHG  + +I+RD K  NILLN D   +++DFG AK   P   Q   ++ V G
Sbjct: 137 EIVSALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFV-G 193
Query: 264 TYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLG 297
           T  Y +PE +        SD++  G ++ +++ G
Sbjct: 194 TAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 227

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 46/161 (28%), Positives = 86/161 (53%), Gaps = 7/161 (4%)
Query: 141 EWLAEVNYLGQLRHSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRM 200
           + + E+  L +     +V   G    D    +  E+M+ GSL++ +L++ G  +      
Sbjct: 50  QIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQ-VLKKAG-RIPEQILG 107
Query: 201 KIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTR 260
           K+++   KGL +L    + +++RD K SNIL+N+    KL DFG++  G + D   ++  
Sbjct: 108 KVSIAVIKGLTYLREKHK-IMHRDVKPSNILVNSRGEIKLCDFGVS--GQLIDS--MANS 162
Query: 261 VMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAV 301
            +GT  Y +PE +   H + +SD++  G+ L+EM +GR  +
Sbjct: 163 FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 203

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 46/161 (28%), Positives = 86/161 (53%), Gaps = 7/161 (4%)
Query: 141 EWLAEVNYLGQLRHSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRM 200
           + + E+  L +     +V   G    D    +  E+M+ GSL++ +L++ G  +      
Sbjct: 50  QIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQ-VLKKAG-RIPEQILG 107
Query: 201 KIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTR 260
           K+++   KGL +L    + +++RD K SNIL+N+    KL DFG++  G + D   ++  
Sbjct: 108 KVSIAVIKGLTYLREKHK-IMHRDVKPSNILVNSRGEIKLCDFGVS--GQLIDS--MANS 162
Query: 261 VMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAV 301
            +GT  Y +PE +   H + +SD++  G+ L+EM +GR  +
Sbjct: 163 FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 203

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 93/215 (43%), Gaps = 25/215 (11%)
Query: 100 LGEGGFGVVYKGV---IDENVRPGYKTTFVAIKELNRGGYQGD-REWLAEVNYLGQL-RH 154
           LG G FG V +     ID+          VA+K L  G    + R  ++E+  L  +  H
Sbjct: 36  LGRGAFGQVIEADAFGIDKTA----TCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 91
Query: 155 SNLVKLIGYCCEDEHRILVY-EYMESGSLEKHLLRR-------------VGCMLTWSRRM 200
            N+V L+G C +    ++V  E+ + G+L  +L  +                 LT    +
Sbjct: 92  LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTPEDLYKDFLTLEHLI 151
Query: 201 KIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTR 260
             +   AKG+ FL  A R  I+RD    NILL+     K+ DFGLA+D            
Sbjct: 152 CYSFQVAKGMEFL--ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGD 209
Query: 261 VMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEML 295
                 + APE +     T +SDV+ FGV+L E+ 
Sbjct: 210 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIF 244

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 55/214 (25%), Positives = 99/214 (46%), Gaps = 29/214 (13%)
Query: 94  FRPDYILGEGGFGVVYKGVIDENVRPGYKTTF-VAIKELNRG-GYQGDREWLAEVNYLGQ 151
           F+   +LG G FG VYKG+    +  G K    VAIKEL      + ++E L E   +  
Sbjct: 17  FKKIKVLGSGAFGTVYKGLW---IPEGEKVKIPVAIKELREATSPKANKEILDEAYVMAS 73
Query: 152 LRHSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMK---------- 201
           + + ++ +L+G C     ++++             L   GC+L + R  K          
Sbjct: 74  VDNPHVCRLLGICLTSTVQLIMQ------------LMPFGCLLDYVREHKDNIGSQYLLN 121
Query: 202 IALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRV 261
             +  AKG+ +L   +R +++RD    N+L+      K++DFGLAK     ++ + +   
Sbjct: 122 WCVQIAKGMNYLE--DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 179
Query: 262 MGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEML 295
                + A E ++    T +SDV+ +GV + E++
Sbjct: 180 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELM 213

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 65/204 (31%), Positives = 87/204 (42%), Gaps = 17/204 (8%)
Query: 99  ILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDRE---WLAEVNYLGQLRHS 155
           +LG+G FG V        VR      + A+K L +       E    + E   L   RH 
Sbjct: 12  LLGKGTFGKVIL------VREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHP 65
Query: 156 NLVKLIGYCCEDEHRI-LVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLH 214
            L  L  Y  +   R+  V EY   G L  HL R    + T  R      +    L +LH
Sbjct: 66  FLTAL-KYAFQTHDRLCFVMEYANGGELFFHLSRER--VFTEERARFYGAEIVSALEYLH 122
Query: 215 GAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVM 274
              R V+YRD K  N++L+ D   K++DFGL K+G     T       GT  Y APE + 
Sbjct: 123 S--RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT--MKXFCGTPEYLAPEVLE 178
Query: 275 TGHLTARSDVYGFGVVLLEMLLGR 298
                   D +G GVV+ EM+ GR
Sbjct: 179 DNDYGRAVDWWGLGVVMYEMMCGR 202

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 55/214 (25%), Positives = 98/214 (45%), Gaps = 29/214 (13%)
Query: 94  FRPDYILGEGGFGVVYKGVIDENVRPGYKTTF-VAIKELNRG-GYQGDREWLAEVNYLGQ 151
           F+   +LG G FG VYKG+    +  G K    VAIKEL      + ++E L E   +  
Sbjct: 27  FKKIKVLGSGAFGTVYKGLW---IPEGEKVKIPVAIKELREATSPKANKEILDEAYVMAS 83
Query: 152 LRHSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMK---------- 201
           + + ++ +L+G C     +++              L   GC+L + R  K          
Sbjct: 84  VDNPHVCRLLGICLTSTVQLITQ------------LMPFGCLLDYVREHKDNIGSQYLLN 131
Query: 202 IALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRV 261
             +  AKG+ +L   +R +++RD    N+L+      K++DFGLAK     ++ + +   
Sbjct: 132 WCVQIAKGMNYLE--DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 189
Query: 262 MGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEML 295
                + A E ++    T +SDV+ +GV + E++
Sbjct: 190 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELM 223

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/234 (25%), Positives = 106/234 (45%), Gaps = 30/234 (12%)
Query: 94  FRPDYILGEGGFGVVYKGVIDENVRPGYKTTF-VAIKELNRG-GYQGDREWLAEVNYLGQ 151
           F+   +LG G FG VYKG+    +  G K    VAIKEL      + ++E L E   +  
Sbjct: 42  FKKIKVLGSGAFGTVYKGLW---IPEGEKVKIPVAIKELREATSPKANKEILDEAYVMAS 98
Query: 152 LRHSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMK---------- 201
           + + ++ +L+G C     +++              L   GC+L + R  K          
Sbjct: 99  VDNPHVCRLLGICLTSTVQLITQ------------LMPFGCLLDYVREHKDNIGSQYLLN 146
Query: 202 IALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRV 261
             +  AKG+ +L   +R +++RD    N+L+      K++DFGLAK     ++ + +   
Sbjct: 147 WCVQIAKGMNYLE--DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 204
Query: 262 MGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEML-LGRRAVDKSRPSREHNLVE 314
                + A E ++    T +SDV+ +GV + E++  G +  D    S   +++E
Sbjct: 205 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE 258

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 65/270 (24%), Positives = 117/270 (43%), Gaps = 30/270 (11%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVK 159
           +GEG  G+V    +  + +       VA+K+++    Q       EV  +   +H N+V+
Sbjct: 159 IGEGSTGIVCIATVRSSGK------LVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVE 212
Query: 160 LI-GYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAER 218
           +   Y   DE  + V E++E G+L   +       +   +   + L   + L+ LH    
Sbjct: 213 MYNSYLVGDELWV-VMEFLEGGALTDIV---THTRMNEEQIAAVCLAVLQALSVLHAQG- 267
Query: 219 PVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHL 278
            VI+RD K+ +ILL  D   KLSDFG      +  +      ++GT  + APE +     
Sbjct: 268 -VIHRDIKSDSILLTHDGRVKLSDFGFCAQ--VSKEVPRRKXLVGTPYWMAPELISRLPY 324
Query: 279 TARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRILDPRLEGQY 338
               D++  G++++EM      VD   P        +  P L   K +   L PRL+  +
Sbjct: 325 GPEVDIWSLGIMVIEM------VDGEPPY-------FNEPPLKAMKMIRDNLPPRLKNLH 371
Query: 339 TARTAMKVAGLAYQCLSQNPKGRPVMSDVV 368
               ++K  G   + L ++P  R   ++++
Sbjct: 372 KVSPSLK--GFLDRLLVRDPAQRATAAELL 399

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/234 (25%), Positives = 106/234 (45%), Gaps = 30/234 (12%)
Query: 94  FRPDYILGEGGFGVVYKGVIDENVRPGYKTTF-VAIKELNRG-GYQGDREWLAEVNYLGQ 151
           F+   +LG G FG VYKG+    +  G K    VAIKEL      + ++E L E   +  
Sbjct: 20  FKKIKVLGSGAFGTVYKGLW---IPEGEKVKIPVAIKELREATSPKANKEILDEAYVMAS 76
Query: 152 LRHSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMK---------- 201
           + + ++ +L+G C     +++              L   GC+L + R  K          
Sbjct: 77  VDNPHVCRLLGICLTSTVQLITQ------------LMPFGCLLDYVREHKDNIGSQYLLN 124
Query: 202 IALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRV 261
             +  AKG+ +L   +R +++RD    N+L+      K++DFGLAK     ++ + +   
Sbjct: 125 WCVQIAKGMNYLE--DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 182
Query: 262 MGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEML-LGRRAVDKSRPSREHNLVE 314
                + A E ++    T +SDV+ +GV + E++  G +  D    S   +++E
Sbjct: 183 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE 236

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 82/309 (26%), Positives = 128/309 (41%), Gaps = 60/309 (19%)
Query: 100 LGEGGFGVVYKGVIDEN-VRPGYKTTFVAIKELNRGGYQG-DREWLAEVNYLGQLRHSNL 157
           +GEG +G+V     + N VR       VAIK+++   +Q   +  L E+  L + RH N+
Sbjct: 35  IGEGAYGMVCSAYDNLNKVR-------VAIKKISPFEHQTYCQRTLREIKILLRFRHENI 87
Query: 158 VKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMK------IALDAAKGLA 211
           + +      D  R    E M+   + + L+      L  ++ +             +GL 
Sbjct: 88  IGI-----NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLK 142
Query: 212 FLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDG-PMGDQTHVSTRVMGTYGYAAP 270
           ++H A   V++RD K SN+LLN     K+ DFGLA+   P  D T      + T  Y AP
Sbjct: 143 YIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAP 200
Query: 271 EYVMTGH-LTARSDVYGFGVVLLEML------LGRRAVDK--------SRPSRE------ 309
           E ++     T   D++  G +L EML       G+  +D+          PS+E      
Sbjct: 201 EIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCII 260
Query: 310 -------------HNLVEWARPLLNNNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQ 356
                         N V W R   N + K L +LD  L      R  ++ A LA+  L Q
Sbjct: 261 NLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQA-LAHPYLEQ 319
Query: 357 --NPKGRPV 363
             +P   P+
Sbjct: 320 YYDPSDEPI 328

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 82/309 (26%), Positives = 128/309 (41%), Gaps = 60/309 (19%)
Query: 100 LGEGGFGVVYKGVIDEN-VRPGYKTTFVAIKELNRGGYQG-DREWLAEVNYLGQLRHSNL 157
           +GEG +G+V     + N VR       VAIK+++   +Q   +  L E+  L + RH N+
Sbjct: 36  IGEGAYGMVCSAYDNLNKVR-------VAIKKISPFEHQTYCQRTLREIKILLRFRHENI 88
Query: 158 VKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMK------IALDAAKGLA 211
           + +      D  R    E M+   + + L+      L  ++ +             +GL 
Sbjct: 89  IGI-----NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLK 143
Query: 212 FLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDG-PMGDQTHVSTRVMGTYGYAAP 270
           ++H A   V++RD K SN+LLN     K+ DFGLA+   P  D T      + T  Y AP
Sbjct: 144 YIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAP 201
Query: 271 EYVMTGH-LTARSDVYGFGVVLLEML------LGRRAVDK--------SRPSRE------ 309
           E ++     T   D++  G +L EML       G+  +D+          PS+E      
Sbjct: 202 EIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCII 261
Query: 310 -------------HNLVEWARPLLNNNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQ 356
                         N V W R   N + K L +LD  L      R  ++ A LA+  L Q
Sbjct: 262 NLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQA-LAHPYLEQ 320
Query: 357 --NPKGRPV 363
             +P   P+
Sbjct: 321 YYDPSDEPI 329

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 46/167 (27%), Positives = 87/167 (52%), Gaps = 19/167 (11%)
Query: 141 EWLAEVNYLGQLRHSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRM 200
           + + E+  L +     +V   G    D    +  E+M+ GSL++        +L  ++R+
Sbjct: 60  QIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQ--------VLKEAKRI 111
Query: 201 ------KIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQ 254
                 K+++   +GLA+L    + +++RD K SNIL+N+    KL DFG++  G + D 
Sbjct: 112 PEEILGKVSIAVLRGLAYLREKHQ-IMHRDVKPSNILVNSRGEIKLCDFGVS--GQLIDS 168
Query: 255 THVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAV 301
             ++   +GT  Y APE +   H + +SD++  G+ L+E+ +GR  +
Sbjct: 169 --MANSFVGTRSYMAPERLQGTHYSVQSDIWSMGLSLVELAVGRYPI 213

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 65/211 (30%), Positives = 101/211 (47%), Gaps = 17/211 (8%)
Query: 98  YILGEG-GFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDR---EWLAEVNYLGQLR 153
           Y+LG+  G G   K  I E+   G+K   VA+K LNR   +      +   E+  L   R
Sbjct: 13  YVLGDTLGVGTFGKVKIGEHQLTGHK---VAVKILNRQKIRSLDVVGKIKREIQNLKLFR 69
Query: 154 HSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFL 213
           H +++KL           +V EY+  G L  ++ +        +RR+   + +A      
Sbjct: 70  HPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHR 129
Query: 214 HGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYV 273
           H     V++RD K  N+LL+A  +AK++DFGL+    M D   + T   G+  YAAPE V
Sbjct: 130 HM----VVHRDLKPENVLLDAHMNAKIADFGLS--NMMSDGEFLRTSC-GSPNYAAPE-V 181
Query: 274 MTGHLTA--RSDVYGFGVVLLEMLLGRRAVD 302
           ++G L A    D++  GV+L  +L G    D
Sbjct: 182 ISGRLYAGPEVDIWSCGVILYALLCGTLPFD 212

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 48/203 (23%), Positives = 89/203 (43%), Gaps = 9/203 (4%)
Query: 94  FRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLR 153
           FR +  +G G F  VY+      +  G       ++  +    +   + + E++ L QL 
Sbjct: 34  FRIEKKIGRGQFSEVYRAAC---LLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLN 90
Query: 154 HSNLVKLIGYCCEDEHRILVYEYMESGSLEKHL--LRRVGCMLTWSRRMKIALDAAKGLA 211
           H N++K      ED    +V E  ++G L + +   ++   ++      K  +     L 
Sbjct: 91  HPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALE 150
Query: 212 FLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPE 271
            +H   R V++RD K +N+ + A    KL D GL +      +T  +  ++GT  Y +PE
Sbjct: 151 HMHS--RRVMHRDIKPANVFITATGVVKLGDLGLGRF--FSSKTTAAHSLVGTPYYMSPE 206
Query: 272 YVMTGHLTARSDVYGFGVVLLEM 294
            +       +SD++  G +L EM
Sbjct: 207 RIHENGYNFKSDIWSLGCLLYEM 229

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/234 (25%), Positives = 106/234 (45%), Gaps = 30/234 (12%)
Query: 94  FRPDYILGEGGFGVVYKGVIDENVRPGYKTTF-VAIKELNRG-GYQGDREWLAEVNYLGQ 151
           F+   +LG G FG VYKG+    +  G K    VAIKEL      + ++E L E   +  
Sbjct: 23  FKKIKVLGSGAFGTVYKGLW---IPEGEKVKIPVAIKELREATSPKANKEILDEAYVMAS 79
Query: 152 LRHSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMK---------- 201
           + + ++ +L+G C     +++              L   GC+L + R  K          
Sbjct: 80  VDNPHVCRLLGICLTSTVQLITQ------------LMPFGCLLDYVREHKDNIGSQYLLN 127
Query: 202 IALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRV 261
             +  AKG+ +L   +R +++RD    N+L+      K++DFGLAK     ++ + +   
Sbjct: 128 WCVQIAKGMNYLE--DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 185
Query: 262 MGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEML-LGRRAVDKSRPSREHNLVE 314
                + A E ++    T +SDV+ +GV + E++  G +  D    S   +++E
Sbjct: 186 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE 239

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/222 (27%), Positives = 103/222 (46%), Gaps = 33/222 (14%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLR-HSNLV 158
           LG+G +G+V+K +   + R G       I +  +      R +  E+  L +L  H N+V
Sbjct: 17  LGKGAYGIVWKSI---DRRTGEVVAVKKIFDAFQNSTDAQRTF-REIMILTELSGHENIV 72
Query: 159 KLIGYCCEDEHR--ILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGA 216
            L+     D  R   LV++YME+   + H + R   +L    +  +     K + +LH  
Sbjct: 73  NLLNVLRADNDRDVYLVFDYMET---DLHAVIRAN-ILEPVHKQYVVYQLIKVIKYLHSG 128
Query: 217 ERPVIYRDFKTSNILLNADFSAKLSDFGLAK----------DGPMG---------DQTHV 257
              +++RD K SNILLNA+   K++DFGL++          + P+          D   +
Sbjct: 129 --GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPI 186
Query: 258 STRVMGTYGYAAPEYVM-TGHLTARSDVYGFGVVLLEMLLGR 298
            T  + T  Y APE ++ +   T   D++  G +L E+L G+
Sbjct: 187 LTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 55/214 (25%), Positives = 98/214 (45%), Gaps = 29/214 (13%)
Query: 94  FRPDYILGEGGFGVVYKGVIDENVRPGYKTTF-VAIKELNRG-GYQGDREWLAEVNYLGQ 151
           F+   +LG G FG VYKG+    +  G K    VAIKEL      + ++E L E   +  
Sbjct: 19  FKKIKVLGSGAFGTVYKGLW---IPEGEKVKIPVAIKELREATSPKANKEILDEAYVMAS 75
Query: 152 LRHSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMK---------- 201
           + + ++ +L+G C     +++              L   GC+L + R  K          
Sbjct: 76  VDNPHVCRLLGICLTSTVQLITQ------------LMPFGCLLDYVREHKDNIGSQYLLN 123
Query: 202 IALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRV 261
             +  AKG+ +L   +R +++RD    N+L+      K++DFGLAK     ++ + +   
Sbjct: 124 WCVQIAKGMNYLE--DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 181
Query: 262 MGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEML 295
                + A E ++    T +SDV+ +GV + E++
Sbjct: 182 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELM 215

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 55/214 (25%), Positives = 98/214 (45%), Gaps = 29/214 (13%)
Query: 94  FRPDYILGEGGFGVVYKGVIDENVRPGYKTTF-VAIKELNRG-GYQGDREWLAEVNYLGQ 151
           F+   +LG G FG VYKG+    +  G K    VAIKEL      + ++E L E   +  
Sbjct: 17  FKKIKVLGSGAFGTVYKGLW---IPEGEKVKIPVAIKELREATSPKANKEILDEAYVMAS 73
Query: 152 LRHSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMK---------- 201
           + + ++ +L+G C     +++              L   GC+L + R  K          
Sbjct: 74  VDNPHVCRLLGICLTSTVQLITQ------------LMPFGCLLDYVREHKDNIGSQYLLN 121
Query: 202 IALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRV 261
             +  AKG+ +L   +R +++RD    N+L+      K++DFGLAK     ++ + +   
Sbjct: 122 WCVQIAKGMNYLE--DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 179
Query: 262 MGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEML 295
                + A E ++    T +SDV+ +GV + E++
Sbjct: 180 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELM 213

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/234 (25%), Positives = 106/234 (45%), Gaps = 30/234 (12%)
Query: 94  FRPDYILGEGGFGVVYKGVIDENVRPGYKTTF-VAIKELNRG-GYQGDREWLAEVNYLGQ 151
           F+   +LG G FG VYKG+    +  G K    VAIKEL      + ++E L E   +  
Sbjct: 20  FKKIKVLGSGAFGTVYKGLW---IPEGEKVKIPVAIKELREATSPKANKEILDEAYVMAS 76
Query: 152 LRHSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMK---------- 201
           + + ++ +L+G C     +++              L   GC+L + R  K          
Sbjct: 77  VDNPHVCRLLGICLTSTVQLITQ------------LMPFGCLLDYVREHKDNIGSQYLLN 124
Query: 202 IALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRV 261
             +  AKG+ +L   +R +++RD    N+L+      K++DFGLAK     ++ + +   
Sbjct: 125 WCVQIAKGMNYLE--DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 182
Query: 262 MGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEML-LGRRAVDKSRPSREHNLVE 314
                + A E ++    T +SDV+ +GV + E++  G +  D    S   +++E
Sbjct: 183 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE 236

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 55/214 (25%), Positives = 98/214 (45%), Gaps = 29/214 (13%)
Query: 94  FRPDYILGEGGFGVVYKGVIDENVRPGYKTTF-VAIKELNRG-GYQGDREWLAEVNYLGQ 151
           F+   +LG G FG VYKG+    +  G K    VAIKEL      + ++E L E   +  
Sbjct: 20  FKKIKVLGSGAFGTVYKGLW---IPEGEKVKIPVAIKELREATSPKANKEILDEAYVMAS 76
Query: 152 LRHSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMK---------- 201
           + + ++ +L+G C     +++              L   GC+L + R  K          
Sbjct: 77  VDNPHVCRLLGICLTSTVQLITQ------------LMPFGCLLDYVREHKDNIGSQYLLN 124
Query: 202 IALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRV 261
             +  AKG+ +L   +R +++RD    N+L+      K++DFGLAK     ++ + +   
Sbjct: 125 WCVQIAKGMNYLE--DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 182
Query: 262 MGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEML 295
                + A E ++    T +SDV+ +GV + E++
Sbjct: 183 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELM 216

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/234 (25%), Positives = 106/234 (45%), Gaps = 30/234 (12%)
Query: 94  FRPDYILGEGGFGVVYKGVIDENVRPGYKTTF-VAIKELNRG-GYQGDREWLAEVNYLGQ 151
           F+   +LG G FG VYKG+    +  G K    VAIKEL      + ++E L E   +  
Sbjct: 24  FKKIKVLGSGAFGTVYKGLW---IPEGEKVKIPVAIKELREATSPKANKEILDEAYVMAS 80
Query: 152 LRHSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMK---------- 201
           + + ++ +L+G C     +++              L   GC+L + R  K          
Sbjct: 81  VDNPHVCRLLGICLTSTVQLITQ------------LMPFGCLLDYVREHKDNIGSQYLLN 128
Query: 202 IALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRV 261
             +  AKG+ +L   +R +++RD    N+L+      K++DFGLAK     ++ + +   
Sbjct: 129 WCVQIAKGMNYLE--DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 186
Query: 262 MGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEML-LGRRAVDKSRPSREHNLVE 314
                + A E ++    T +SDV+ +GV + E++  G +  D    S   +++E
Sbjct: 187 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE 240

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 46/161 (28%), Positives = 86/161 (53%), Gaps = 7/161 (4%)
Query: 141 EWLAEVNYLGQLRHSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRM 200
           + + E+  L +     +V   G    D    +  E+M+ GSL++ +L++ G  +      
Sbjct: 69  QIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQ-VLKKAG-RIPEQILG 126
Query: 201 KIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTR 260
           K+++   KGL +L    + +++RD K SNIL+N+    KL DFG++  G + D   ++  
Sbjct: 127 KVSIAVIKGLTYLREKHK-IMHRDVKPSNILVNSRGEIKLCDFGVS--GQLIDS--MANS 181
Query: 261 VMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAV 301
            +GT  Y +PE +   H + +SD++  G+ L+EM +GR  +
Sbjct: 182 FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 222

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 65/215 (30%), Positives = 98/215 (45%), Gaps = 28/215 (13%)
Query: 100 LGEGGFGVVYKGV---IDENVRPGYKTTFVAIKELNRGGYQGD-REWLAEVNYLGQL-RH 154
           LG G FG V +     ID+          VA+K L  G    + R  ++E+  L  +  H
Sbjct: 35  LGRGAFGQVIEADAFGIDKTA----TXRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 90
Query: 155 SNLVKLIGYCCEDEHRILVY-EYMESGSLEKHLLRR----------VGCMLTWSRRMKIA 203
            N+V L+G C +    ++V  E+ + G+L  +L  +              LT    +  +
Sbjct: 91  LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLIXYS 150
Query: 204 LDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHV---STR 260
              AKG+ FL  A R  I+RD    NILL+     K+ DFGLA+D    D  +V     R
Sbjct: 151 FQVAKGMEFL--ASRKXIHRDLAARNILLSEKNVVKIXDFGLARDI-YKDPDYVRKGDAR 207
Query: 261 VMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEML 295
           +     + APE +     T +SDV+ FGV+L E+ 
Sbjct: 208 L--PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIF 240

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 47/154 (30%), Positives = 75/154 (48%), Gaps = 6/154 (3%)
Query: 145 EVNYLGQLRHSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIAL 204
           E + + +L H   VKL     +DE       Y ++G L K++ R++G       R   A 
Sbjct: 64  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI-RKIGSFDETCTRFYTA- 121
Query: 205 DAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKD-GPMGDQTHVSTRVMG 263
           +    L +LHG  + +I+RD K  NILLN D   +++DFG AK   P   Q   +  V G
Sbjct: 122 EIVSALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV-G 178
Query: 264 TYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLG 297
           T  Y +PE +        SD++  G ++ +++ G
Sbjct: 179 TAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 212

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 93/216 (43%), Gaps = 26/216 (12%)
Query: 100 LGEGGFGVVYKGV---IDENVRPGYKTTFVAIKELNRGGYQGD-REWLAEVNYLGQL-RH 154
           LG G FG V +     ID+          VA+K L  G    + R  ++E+  L  +  H
Sbjct: 26  LGRGAFGQVIEADAFGIDKTA----TCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 81
Query: 155 SNLVKLIGYCCEDEHRILVY-EYMESGSLEKHLLRR--------------VGCMLTWSRR 199
            N+V L+G C +    ++V  E+ + G+L  +L  +                  LT    
Sbjct: 82  LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 141
Query: 200 MKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVST 259
           +  +   AKG+ FL  A R  I+RD    NILL+     K+ DFGLA+D           
Sbjct: 142 ICYSFQVAKGMEFL--ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKG 199
Query: 260 RVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEML 295
                  + APE +     T +SDV+ FGV+L E+ 
Sbjct: 200 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIF 235

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 93/216 (43%), Gaps = 26/216 (12%)
Query: 100 LGEGGFGVVYKGV---IDENVRPGYKTTFVAIKELNRGGYQGD-REWLAEVNYLGQL-RH 154
           LG G FG V +     ID+          VA+K L  G    + R  ++E+  L  +  H
Sbjct: 26  LGRGAFGQVIEADAFGIDKTA----TCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 81
Query: 155 SNLVKLIGYCCEDEHRILVY-EYMESGSLEKHLLRR--------------VGCMLTWSRR 199
            N+V L+G C +    ++V  E+ + G+L  +L  +                  LT    
Sbjct: 82  LNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 141
Query: 200 MKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVST 259
           +  +   AKG+ FL  A R  I+RD    NILL+     K+ DFGLA+D           
Sbjct: 142 ICYSFQVAKGMEFL--ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKG 199
Query: 260 RVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEML 295
                  + APE +     T +SDV+ FGV+L E+ 
Sbjct: 200 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIF 235

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 93/216 (43%), Gaps = 26/216 (12%)
Query: 100 LGEGGFGVVYKGV---IDENVRPGYKTTFVAIKELNRGGYQGD-REWLAEVNYLGQL-RH 154
           LG G FG V +     ID+          VA+K L  G    + R  ++E+  L  +  H
Sbjct: 35  LGRGAFGQVIEADAFGIDKTA----TCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 90
Query: 155 SNLVKLIGYCCEDEHRILVY-EYMESGSLEKHLLRR--------------VGCMLTWSRR 199
            N+V L+G C +    ++V  E+ + G+L  +L  +                  LT    
Sbjct: 91  LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 150
Query: 200 MKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVST 259
           +  +   AKG+ FL  A R  I+RD    NILL+     K+ DFGLA+D           
Sbjct: 151 ICYSFQVAKGMEFL--ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKG 208
Query: 260 RVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEML 295
                  + APE +     T +SDV+ FGV+L E+ 
Sbjct: 209 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIF 244

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 106/221 (47%), Gaps = 25/221 (11%)
Query: 99  ILGEGGFGVVYKGVI---DENVRPGYKTTFVAIKELNRG-GYQGDREWLAEVNYLGQLRH 154
           +LG G FG VYKG+     ENV+       VAIK L      + ++E L E   +  +  
Sbjct: 24  VLGSGAFGTVYKGIWIPDGENVK-----IPVAIKVLRENTSPKANKEILDEAYVMAGVGS 78
Query: 155 SNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLR---RVGC--MLTWSRRMKIALDAAKG 209
             + +L+G C     + LV + M  G L  H+     R+G   +L W  ++      AKG
Sbjct: 79  PYVSRLLGICLTSTVQ-LVTQLMPYGCLLDHVRENRGRLGSQDLLNWCMQI------AKG 131
Query: 210 LAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAA 269
           +++L      +++RD    N+L+ +    K++DFGLA+   + +  + +        + A
Sbjct: 132 MSYLEDVR--LVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMA 189
Query: 270 PEYVMTGHLTARSDVYGFGVVLLEML-LGRRAVDKSRPSRE 309
            E ++    T +SDV+ +GV + E++  G +  D   P+RE
Sbjct: 190 LESILRRRFTHQSDVWSYGVTVWELMTFGAKPYD-GIPARE 229

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 101/211 (47%), Gaps = 17/211 (8%)
Query: 98  YILGEG-GFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDR---EWLAEVNYLGQLR 153
           YILG+  G G   K  + ++   G+K   VA+K LNR   +      +   E+  L   R
Sbjct: 18  YILGDTLGVGTFGKVKVGKHELTGHK---VAVKILNRQKIRSLDVVGKIRREIQNLKLFR 74
Query: 154 HSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFL 213
           H +++KL           +V EY+  G L  ++ +        SRR+   +    G+ + 
Sbjct: 75  HPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQI--LSGVDYC 132
Query: 214 HGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYV 273
           H     V++RD K  N+LL+A  +AK++DFGL+     G+    S    G+  YAAPE V
Sbjct: 133 H--RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRXSC---GSPNYAAPE-V 186
Query: 274 MTGHLTA--RSDVYGFGVVLLEMLLGRRAVD 302
           ++G L A    D++  GV+L  +L G    D
Sbjct: 187 ISGRLYAGPEVDIWSSGVILYALLCGTLPFD 217

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 63/218 (28%), Positives = 99/218 (45%), Gaps = 22/218 (10%)
Query: 152 LRHSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLA 211
           L H N+VK  G+  E   + L  EY   G L   +   +G     ++R    L A  G+ 
Sbjct: 61  LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--GVV 118
Query: 212 FLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPE 271
           +LHG    + +RD K  N+LL+   + K+SDFGLA      ++  +  ++ GT  Y APE
Sbjct: 119 YLHGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 176
Query: 272 YVMTGHLTARS-DVYGFGVVLLEMLLGRRAVDK-SRPSREHNLVEWARPLLNNNKKVLRI 329
            +      A   DV+  G+VL  ML G    D+ S   +E++  +  +  LN  KK+   
Sbjct: 177 LLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKI--- 233
Query: 330 LDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDV 367
                    +A  A     L ++ L +NP  R  + D+
Sbjct: 234 --------DSAPLA-----LLHKILVENPSARITIPDI 258

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 47/154 (30%), Positives = 75/154 (48%), Gaps = 6/154 (3%)
Query: 145 EVNYLGQLRHSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIAL 204
           E + + +L H   VKL     +DE       Y ++G L K++ R++G       R   A 
Sbjct: 79  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI-RKIGSFDETCTRFYTA- 136
Query: 205 DAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKD-GPMGDQTHVSTRVMG 263
           +    L +LHG  + +I+RD K  NILLN D   +++DFG AK   P   Q   +  V G
Sbjct: 137 EIVSALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV-G 193
Query: 264 TYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLG 297
           T  Y +PE +        SD++  G ++ +++ G
Sbjct: 194 TAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 227

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 101/209 (48%), Gaps = 19/209 (9%)
Query: 94  FRPDYILGEGGFGVVYKGVIDENVRPGYKTTF-VAIKELNRG-GYQGDREWLAEVNYLGQ 151
           F+   +LG G FG VYKG+    +  G K    VAIKEL      + ++E L E   +  
Sbjct: 18  FKKIKVLGSGAFGTVYKGLW---IPEGEKVKIPVAIKELREATSPKANKEILDEAYVMAS 74
Query: 152 LRHSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRR---VGC--MLTWSRRMKIALDA 206
           + + ++ +L+G C     + L+ + M  G L  ++      +G   +L W       +  
Sbjct: 75  VDNPHVCRLLGICLTSTVQ-LIMQLMPFGXLLDYVREHKDNIGSQYLLNW------CVQI 127
Query: 207 AKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYG 266
           AKG+ +L   +R +++RD    N+L+      K++DFGLAK     ++ + +        
Sbjct: 128 AKGMNYLE--DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 185
Query: 267 YAAPEYVMTGHLTARSDVYGFGVVLLEML 295
           + A E ++    T +SDV+ +GV + E++
Sbjct: 186 WMALESILHRIYTHQSDVWSYGVTVWELM 214

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 55/214 (25%), Positives = 98/214 (45%), Gaps = 29/214 (13%)
Query: 94  FRPDYILGEGGFGVVYKGVIDENVRPGYKTTF-VAIKELNRGGY-QGDREWLAEVNYLGQ 151
           F+   +LG G FG VYKG+    +  G K    VAIKEL      + ++E L E   +  
Sbjct: 17  FKKIKVLGSGAFGTVYKGLW---IPEGEKVKIPVAIKELREATSPKANKEILDEAYVMAS 73
Query: 152 LRHSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMK---------- 201
           + + ++ +L+G C     +++              L   GC+L + R  K          
Sbjct: 74  VDNPHVCRLLGICLTSTVQLITQ------------LMPFGCLLDYVREHKDNIGSQYLLN 121
Query: 202 IALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRV 261
             +  AKG+ +L   +R +++RD    N+L+      K++DFGLAK     ++ + +   
Sbjct: 122 WCVQIAKGMNYLE--DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 179
Query: 262 MGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEML 295
                + A E ++    T +SDV+ +GV + E++
Sbjct: 180 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELM 213

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 80/289 (27%), Positives = 135/289 (46%), Gaps = 44/289 (15%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWL--AEVNYLGQLRHSNL 157
           +G+G FG V++G         ++   VA+K  +    + +R W   AE+     LRH N+
Sbjct: 50  IGKGRFGEVWRG--------KWRGEEVAVKIFSS---REERSWFREAEIYQTVMLRHENI 98
Query: 158 VKLIGYCCEDE----HRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFL 213
           +  I    +D        LV +Y E GSL  +L R     +T    +K+AL  A GLA L
Sbjct: 99  LGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT---VTVEGMIKLALSTASGLAHL 155
Query: 214 H----GAE-RPVI-YRDFKTSNILLNADFSAKLSDFGLA-KDGPMGDQTHVS-TRVMGTY 265
           H    G + +P I +RD K+ NIL+  + +  ++D GLA +     D   ++    +GT 
Sbjct: 156 HMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTK 215
Query: 266 GYAAPEY----VMTGHLTA--RSDVYGFGVVLLEMLLGRRA----VDKSRPSREHNLVEW 315
            Y APE     +   H  +  R+D+Y  G+V  E  + RR     + +      ++LV  
Sbjct: 216 RYMAPEVLDDSINMKHFESFKRADIYAMGLVFWE--IARRCSIGGIHEDYQLPYYDLVP- 272
Query: 316 ARPLLNNNKKVL--RILDPRLEGQYTARTAMKV-AGLAYQCLSQNPKGR 361
           + P +   +KV+  + L P +  ++ +  A++V A +  +C   N   R
Sbjct: 273 SDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAAR 321

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 80/289 (27%), Positives = 135/289 (46%), Gaps = 44/289 (15%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWL--AEVNYLGQLRHSNL 157
           +G+G FG V++G         ++   VA+K  +    + +R W   AE+     LRH N+
Sbjct: 12  IGKGRFGEVWRG--------KWRGEEVAVKIFSS---REERSWFREAEIYQTVMLRHENI 60
Query: 158 VKLIGYCCEDE----HRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFL 213
           +  I    +D        LV +Y E GSL  +L R     +T    +K+AL  A GLA L
Sbjct: 61  LGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT---VTVEGMIKLALSTASGLAHL 117
Query: 214 H----GAE-RPVI-YRDFKTSNILLNADFSAKLSDFGLA-KDGPMGDQTHVS-TRVMGTY 265
           H    G + +P I +RD K+ NIL+  + +  ++D GLA +     D   ++    +GT 
Sbjct: 118 HMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTK 177
Query: 266 GYAAPEY----VMTGHLTA--RSDVYGFGVVLLEMLLGRRA----VDKSRPSREHNLVEW 315
            Y APE     +   H  +  R+D+Y  G+V  E  + RR     + +      ++LV  
Sbjct: 178 RYMAPEVLDDSINMKHFESFKRADIYAMGLVFWE--IARRCSIGGIHEDYQLPYYDLVP- 234
Query: 316 ARPLLNNNKKVL--RILDPRLEGQYTARTAMKV-AGLAYQCLSQNPKGR 361
           + P +   +KV+  + L P +  ++ +  A++V A +  +C   N   R
Sbjct: 235 SDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAAR 283

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 80/289 (27%), Positives = 135/289 (46%), Gaps = 44/289 (15%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWL--AEVNYLGQLRHSNL 157
           +G+G FG V++G         ++   VA+K  +    + +R W   AE+     LRH N+
Sbjct: 11  IGKGRFGEVWRG--------KWRGEEVAVKIFSS---REERSWFREAEIYQTVMLRHENI 59
Query: 158 VKLIGYCCEDE----HRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFL 213
           +  I    +D        LV +Y E GSL  +L R     +T    +K+AL  A GLA L
Sbjct: 60  LGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT---VTVEGMIKLALSTASGLAHL 116
Query: 214 H----GAE-RPVI-YRDFKTSNILLNADFSAKLSDFGLA-KDGPMGDQTHVS-TRVMGTY 265
           H    G + +P I +RD K+ NIL+  + +  ++D GLA +     D   ++    +GT 
Sbjct: 117 HMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTK 176
Query: 266 GYAAPEY----VMTGHLTA--RSDVYGFGVVLLEMLLGRRA----VDKSRPSREHNLVEW 315
            Y APE     +   H  +  R+D+Y  G+V  E  + RR     + +      ++LV  
Sbjct: 177 RYMAPEVLDDSINMKHFESFKRADIYAMGLVFWE--IARRCSIGGIHEDYQLPYYDLVP- 233
Query: 316 ARPLLNNNKKVL--RILDPRLEGQYTARTAMKV-AGLAYQCLSQNPKGR 361
           + P +   +KV+  + L P +  ++ +  A++V A +  +C   N   R
Sbjct: 234 SDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAAR 282

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 65/215 (30%), Positives = 98/215 (45%), Gaps = 28/215 (13%)
Query: 100 LGEGGFGVVYKGV---IDENVRPGYKTTFVAIKELNRGGYQGD-REWLAEVNYLGQL-RH 154
           LG G FG V +     ID+          VA+K L  G    + R  ++E+  L  +  H
Sbjct: 35  LGRGAFGQVIEADAFGIDKTA----TXRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 90
Query: 155 SNLVKLIGYCCEDEHRILVY-EYMESGSLEKHLLRR----------VGCMLTWSRRMKIA 203
            N+V L+G C +    ++V  E+ + G+L  +L  +              LT    +  +
Sbjct: 91  LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLICYS 150
Query: 204 LDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHV---STR 260
              AKG+ FL  A R  I+RD    NILL+     K+ DFGLA+D    D  +V     R
Sbjct: 151 FQVAKGMEFL--ASRKXIHRDLAARNILLSEKNVVKICDFGLARDI-YKDPDYVRKGDAR 207
Query: 261 VMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEML 295
           +     + APE +     T +SDV+ FGV+L E+ 
Sbjct: 208 L--PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIF 240

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 101/209 (48%), Gaps = 19/209 (9%)
Query: 94  FRPDYILGEGGFGVVYKGVIDENVRPGYKTTF-VAIKELNRG-GYQGDREWLAEVNYLGQ 151
           F+   +LG G FG VYKG+    +  G K    VAIKEL      + ++E L E   +  
Sbjct: 17  FKKIKVLGSGAFGTVYKGLW---IPEGEKVKIPVAIKELREATSPKANKEILDEAYVMAS 73
Query: 152 LRHSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRR---VGC--MLTWSRRMKIALDA 206
           + + ++ +L+G C     + L+ + M  G L  ++      +G   +L W       +  
Sbjct: 74  VDNPHVCRLLGICLTSTVQ-LITQLMPFGXLLDYVREHKDNIGSQYLLNW------CVQI 126
Query: 207 AKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYG 266
           AKG+ +L   +R +++RD    N+L+      K++DFGLAK     ++ + +        
Sbjct: 127 AKGMNYLE--DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 184
Query: 267 YAAPEYVMTGHLTARSDVYGFGVVLLEML 295
           + A E ++    T +SDV+ +GV + E++
Sbjct: 185 WMALESILHRIYTHQSDVWSYGVTVWELM 213

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 80/289 (27%), Positives = 135/289 (46%), Gaps = 44/289 (15%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWL--AEVNYLGQLRHSNL 157
           +G+G FG V++G         ++   VA+K  +    + +R W   AE+     LRH N+
Sbjct: 14  IGKGRFGEVWRG--------KWRGEEVAVKIFSS---REERSWFREAEIYQTVMLRHENI 62
Query: 158 VKLIGYCCEDE----HRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFL 213
           +  I    +D        LV +Y E GSL  +L R     +T    +K+AL  A GLA L
Sbjct: 63  LGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT---VTVEGMIKLALSTASGLAHL 119
Query: 214 H----GAE-RPVI-YRDFKTSNILLNADFSAKLSDFGLA-KDGPMGDQTHVS-TRVMGTY 265
           H    G + +P I +RD K+ NIL+  + +  ++D GLA +     D   ++    +GT 
Sbjct: 120 HMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTK 179
Query: 266 GYAAPEY----VMTGHLTA--RSDVYGFGVVLLEMLLGRRA----VDKSRPSREHNLVEW 315
            Y APE     +   H  +  R+D+Y  G+V  E  + RR     + +      ++LV  
Sbjct: 180 RYMAPEVLDDSINMKHFESFKRADIYAMGLVFWE--IARRCSIGGIHEDYQLPYYDLVP- 236
Query: 316 ARPLLNNNKKVL--RILDPRLEGQYTARTAMKV-AGLAYQCLSQNPKGR 361
           + P +   +KV+  + L P +  ++ +  A++V A +  +C   N   R
Sbjct: 237 SDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAAR 285

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 55/214 (25%), Positives = 98/214 (45%), Gaps = 29/214 (13%)
Query: 94  FRPDYILGEGGFGVVYKGVIDENVRPGYKTTF-VAIKELNRG-GYQGDREWLAEVNYLGQ 151
           F+   +LG G FG VYKG+    +  G K    VAIKEL      + ++E L E   +  
Sbjct: 11  FKKIKVLGSGAFGTVYKGLW---IPEGEKVKIPVAIKELREATSPKANKEILDEAYVMAS 67
Query: 152 LRHSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMK---------- 201
           + + ++ +L+G C     +++              L   GC+L + R  K          
Sbjct: 68  VDNPHVCRLLGICLTSTVQLITQ------------LMPFGCLLDYVREHKDNIGSQYLLN 115
Query: 202 IALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRV 261
             +  AKG+ +L   +R +++RD    N+L+      K++DFGLAK     ++ + +   
Sbjct: 116 WCVQIAKGMNYLE--DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 173
Query: 262 MGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEML 295
                + A E ++    T +SDV+ +GV + E++
Sbjct: 174 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELM 207

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 80/289 (27%), Positives = 135/289 (46%), Gaps = 44/289 (15%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWL--AEVNYLGQLRHSNL 157
           +G+G FG V++G         ++   VA+K  +    + +R W   AE+     LRH N+
Sbjct: 17  IGKGRFGEVWRG--------KWRGEEVAVKIFSS---REERSWFREAEIYQTVMLRHENI 65
Query: 158 VKLIGYCCEDE----HRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFL 213
           +  I    +D        LV +Y E GSL  +L R     +T    +K+AL  A GLA L
Sbjct: 66  LGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT---VTVEGMIKLALSTASGLAHL 122
Query: 214 H----GAE-RPVI-YRDFKTSNILLNADFSAKLSDFGLA-KDGPMGDQTHVS-TRVMGTY 265
           H    G + +P I +RD K+ NIL+  + +  ++D GLA +     D   ++    +GT 
Sbjct: 123 HMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTK 182
Query: 266 GYAAPEY----VMTGHLTA--RSDVYGFGVVLLEMLLGRRA----VDKSRPSREHNLVEW 315
            Y APE     +   H  +  R+D+Y  G+V  E  + RR     + +      ++LV  
Sbjct: 183 RYMAPEVLDDSINMKHFESFKRADIYAMGLVFWE--IARRCSIGGIHEDYQLPYYDLVP- 239
Query: 316 ARPLLNNNKKVL--RILDPRLEGQYTARTAMKV-AGLAYQCLSQNPKGR 361
           + P +   +KV+  + L P +  ++ +  A++V A +  +C   N   R
Sbjct: 240 SDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAAR 288

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 80/289 (27%), Positives = 135/289 (46%), Gaps = 44/289 (15%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWL--AEVNYLGQLRHSNL 157
           +G+G FG V++G         ++   VA+K  +    + +R W   AE+     LRH N+
Sbjct: 37  IGKGRFGEVWRG--------KWRGEEVAVKIFSS---REERSWFREAEIYQTVMLRHENI 85
Query: 158 VKLIGYCCEDE----HRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFL 213
           +  I    +D        LV +Y E GSL  +L R     +T    +K+AL  A GLA L
Sbjct: 86  LGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT---VTVEGMIKLALSTASGLAHL 142
Query: 214 H----GAE-RPVI-YRDFKTSNILLNADFSAKLSDFGLA-KDGPMGDQTHVS-TRVMGTY 265
           H    G + +P I +RD K+ NIL+  + +  ++D GLA +     D   ++    +GT 
Sbjct: 143 HMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTK 202
Query: 266 GYAAPEY----VMTGHLTA--RSDVYGFGVVLLEMLLGRRA----VDKSRPSREHNLVEW 315
            Y APE     +   H  +  R+D+Y  G+V  E  + RR     + +      ++LV  
Sbjct: 203 RYMAPEVLDDSINMKHFESFKRADIYAMGLVFWE--IARRCSIGGIHEDYQLPYYDLVP- 259
Query: 316 ARPLLNNNKKVL--RILDPRLEGQYTARTAMKV-AGLAYQCLSQNPKGR 361
           + P +   +KV+  + L P +  ++ +  A++V A +  +C   N   R
Sbjct: 260 SDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAAR 308

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 93/216 (43%), Gaps = 26/216 (12%)
Query: 100 LGEGGFGVVYKGV---IDENVRPGYKTTFVAIKELNRGGYQGD-REWLAEVNYLGQL-RH 154
           LG G FG V +     ID+          VA+K L  G    + R  ++E+  L  +  H
Sbjct: 35  LGRGAFGQVIEADAFGIDKTA----TCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 90
Query: 155 SNLVKLIGYCCEDEHRILVY-EYMESGSLEKHLLRR--------------VGCMLTWSRR 199
            N+V L+G C +    ++V  E+ + G+L  +L  +                  LT    
Sbjct: 91  LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 150
Query: 200 MKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVST 259
           +  +   AKG+ FL  A R  I+RD    NILL+     K+ DFGLA+D           
Sbjct: 151 ICYSFQVAKGMEFL--ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDXVRKG 208
Query: 260 RVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEML 295
                  + APE +     T +SDV+ FGV+L E+ 
Sbjct: 209 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIF 244

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 63/230 (27%), Positives = 104/230 (45%), Gaps = 51/230 (22%)
Query: 99  ILGEGGFGVVYKGVIDENVRPGYKTTFVAIKEL---NRGGYQGDREWLAEVNYLGQLRHS 155
           ++G G +G VYKG +DE  RP      VA+K     NR  +  ++     +  +  + H 
Sbjct: 20  LIGRGRYGAVYKGSLDE--RP------VAVKVFSFANRQNFINEKN----IYRVPLMEHD 67
Query: 156 NLVKLIGYCCEDE--------HRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAA 207
           N+ + I     DE          +LV EY  +GSL K+L         W    ++A    
Sbjct: 68  NIARFI---VGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTS---DWVSSCRLAHSVT 121
Query: 208 KGLAFLHGA------ERPVI-YRDFKTSNILLNADFSAKLSDFGLA------KDGPMGDQ 254
           +GLA+LH         +P I +RD  + N+L+  D +  +SDFGL+      +    G++
Sbjct: 122 RGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEE 181
Query: 255 THVSTRVMGTYGYAAPEYVMTGHLTARS--------DVYGFGVVLLEMLL 296
            + +   +GT  Y APE V+ G +  R         D+Y  G++  E+ +
Sbjct: 182 DNAAISEVGTIRYMAPE-VLEGAVNLRDXESALKQVDMYALGLIYWEIFM 230

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 65/219 (29%), Positives = 98/219 (44%), Gaps = 32/219 (14%)
Query: 100 LGEGGFGVVYKGV---IDENVRPGYKTTFVAIKELNRGGYQGD-REWLAEVNYLGQL-RH 154
           LG G FG V +     ID+          VA+K L  G    + R  ++E+  L  +  H
Sbjct: 37  LGRGAFGQVIEADAFGIDKTA----TCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 92
Query: 155 SNLVKLIGYCCEDEHRILVY-EYMESGSLEKHLLRR--------------VGCMLTWSRR 199
            N+V L+G C +    ++V  E+ + G+L  +L  +                  LT    
Sbjct: 93  LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKEAPEDLYKDFLTLEHL 152
Query: 200 MKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHV-- 257
           +  +   AKG+ FL  A R  I+RD    NILL+     K+ DFGLA+D    D  +V  
Sbjct: 153 ICYSFQVAKGMEFL--ASRKCIHRDLAARNILLSEKNVVKICDFGLARDI-YKDPDYVRK 209
Query: 258 -STRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEML 295
              R+     + APE +     T +SDV+ FGV+L E+ 
Sbjct: 210 GDARL--PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIF 246

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 78/295 (26%), Positives = 128/295 (43%), Gaps = 43/295 (14%)
Query: 95  RPDY----ILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDR-EWLAEVNYL 149
           R DY    ++G G   VV      +      K   VAIK +N    Q    E L E+  +
Sbjct: 14  RDDYELQEVIGSGATAVV------QAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAM 67
Query: 150 GQLRHSNLVKLIGYCCEDEHRILVYEYMESGS---LEKHLLRR---VGCMLTWSRRMKIA 203
            Q  H N+V         +   LV + +  GS   + KH++ +      +L  S    I 
Sbjct: 68  SQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATIL 127
Query: 204 LDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGL-AKDGPMGDQTHVSTR-- 260
            +  +GL +LH   +  I+RD K  NILL  D S +++DFG+ A     GD T    R  
Sbjct: 128 REVLEGLEYLHKNGQ--IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKT 185
Query: 261 VMGTYGYAAPEYV--MTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARP 318
            +GT  + APE +  + G+   ++D++ FG+  +E+  G     K  P +   L      
Sbjct: 186 FVGTPCWMAPEVMEQVRGY-DFKADIWSFGITAIELATGAAPYHKYPPMKVLMLT----- 239
Query: 319 LLNNNKKVLRILDPRLEGQYTARTAMKVAGLAYQ-----CLSQNPKGRPVMSDVV 368
            L N+        P LE     +  +K  G +++     CL ++P+ RP  ++++
Sbjct: 240 -LQNDP-------PSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELL 286

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 65/270 (24%), Positives = 118/270 (43%), Gaps = 30/270 (11%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVK 159
           +GEG  G+V    +  + +       VA+K+++    Q       EV  +   +H N+V+
Sbjct: 82  IGEGSTGIVCIATVRSSGK------LVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVE 135
Query: 160 LI-GYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAER 218
           +   Y   DE  + V E++E G+L   +       +   +   + L   + L+ LH   +
Sbjct: 136 MYNSYLVGDELWV-VMEFLEGGALTDIV---THTRMNEEQIAAVCLAVLQALSVLHA--Q 189
Query: 219 PVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHL 278
            VI+RD K+ +ILL  D   KLSDFG      +  +      ++GT  + APE +     
Sbjct: 190 GVIHRDIKSDSILLTHDGRVKLSDFGFCAQ--VSKEVPRRKXLVGTPYWMAPELISRLPY 247
Query: 279 TARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRILDPRLEGQY 338
               D++  G++++EM      VD   P        +  P L   K +   L PRL+  +
Sbjct: 248 GPEVDIWSLGIMVIEM------VDGEPPY-------FNEPPLKAMKMIRDNLPPRLKNLH 294
Query: 339 TARTAMKVAGLAYQCLSQNPKGRPVMSDVV 368
               ++K  G   + L ++P  R   ++++
Sbjct: 295 KVSPSLK--GFLDRLLVRDPAQRATAAELL 322

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 90/212 (42%), Gaps = 32/212 (15%)
Query: 99  ILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDRE---WLAEVNYLGQLR-H 154
           +LG+G FG V    + E           A+K L +     D +    + E   L   R H
Sbjct: 30  VLGKGSFGKVMLARVKET------GDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNH 83
Query: 155 SNLVKLIGYCC--EDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMK------IALDA 206
             L +L  +CC    +    V E++  G L  H+ +        SRR         A + 
Sbjct: 84  PFLTQL--FCCFQTPDRLFFVMEFVNGGDLMFHIQK--------SRRFDEARARFYAAEI 133
Query: 207 AKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYG 266
              L FLH  ++ +IYRD K  N+LL+ +   KL+DFG+ K+G     T  +    GT  
Sbjct: 134 ISALMFLH--DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVT--TATFCGTPD 189
Query: 267 YAAPEYVMTGHLTARSDVYGFGVVLLEMLLGR 298
           Y APE +         D +  GV+L EML G 
Sbjct: 190 YIAPEILQEMLYGPAVDWWAMGVLLYEMLCGH 221

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 65/219 (29%), Positives = 98/219 (44%), Gaps = 32/219 (14%)
Query: 100 LGEGGFGVVYKGV---IDENVRPGYKTTFVAIKELNRGGYQGD-REWLAEVNYLGQL-RH 154
           LG G FG V +     ID+          VA+K L  G    + R  ++E+  L  +  H
Sbjct: 72  LGRGAFGQVIEADAFGIDKTA----TCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 127
Query: 155 SNLVKLIGYCCEDEHRILVY-EYMESGSLEKHLLRR--------------VGCMLTWSRR 199
            N+V L+G C +    ++V  E+ + G+L  +L  +                  LT    
Sbjct: 128 LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 187
Query: 200 MKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHV-- 257
           +  +   AKG+ FL  A R  I+RD    NILL+     K+ DFGLA+D    D  +V  
Sbjct: 188 ICYSFQVAKGMEFL--ASRKCIHRDLAARNILLSEKNVVKICDFGLARD-IYKDPDYVRK 244
Query: 258 -STRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEML 295
              R+     + APE +     T +SDV+ FGV+L E+ 
Sbjct: 245 GDARL--PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIF 281

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 65/219 (29%), Positives = 98/219 (44%), Gaps = 32/219 (14%)
Query: 100 LGEGGFGVVYKGV---IDENVRPGYKTTFVAIKELNRGGYQGD-REWLAEVNYLGQL-RH 154
           LG G FG V +     ID+          VA+K L  G    + R  ++E+  L  +  H
Sbjct: 35  LGRGAFGQVIEADAFGIDKTA----TCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 90
Query: 155 SNLVKLIGYCCEDEHRILVY-EYMESGSLEKHLLRR--------------VGCMLTWSRR 199
            N+V L+G C +    ++V  E+ + G+L  +L  +                  LT    
Sbjct: 91  LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 150
Query: 200 MKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHV-- 257
           +  +   AKG+ FL  A R  I+RD    NILL+     K+ DFGLA+D    D  +V  
Sbjct: 151 ICYSFQVAKGMEFL--ASRKCIHRDLAARNILLSEKNVVKICDFGLARDI-YKDPDYVRK 207
Query: 258 -STRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEML 295
              R+     + APE +     T +SDV+ FGV+L E+ 
Sbjct: 208 GDARL--PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIF 244

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 65/219 (29%), Positives = 98/219 (44%), Gaps = 32/219 (14%)
Query: 100 LGEGGFGVVYKGV---IDENVRPGYKTTFVAIKELNRGGYQGD-REWLAEVNYLGQL-RH 154
           LG G FG V +     ID+          VA+K L  G    + R  ++E+  L  +  H
Sbjct: 26  LGRGAFGQVIEADAFGIDKTA----TCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 81
Query: 155 SNLVKLIGYCCEDEHRILVY-EYMESGSLEKHLLRR--------------VGCMLTWSRR 199
            N+V L+G C +    ++V  E+ + G+L  +L  +                  LT    
Sbjct: 82  LNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 141
Query: 200 MKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHV-- 257
           +  +   AKG+ FL  A R  I+RD    NILL+     K+ DFGLA+D    D  +V  
Sbjct: 142 ICYSFQVAKGMEFL--ASRKCIHRDLAARNILLSEKNVVKICDFGLARD-IYKDPDYVRK 198
Query: 258 -STRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEML 295
              R+     + APE +     T +SDV+ FGV+L E+ 
Sbjct: 199 GDARL--PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIF 235

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 93/216 (43%), Gaps = 26/216 (12%)
Query: 100 LGEGGFGVVYKGV---IDENVRPGYKTTFVAIKELNRGGYQGD-REWLAEVNYLGQL-RH 154
           LG G FG V +     ID+          VA+K L  G    + R  ++E+  L  +  H
Sbjct: 26  LGRGAFGQVIEADAFGIDKTA----TCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 81
Query: 155 SNLVKLIGYCCEDEHRILVY-EYMESGSLEKHLLRR--------------VGCMLTWSRR 199
            N+V L+G C +    ++V  E+ + G+L  +L  +                  LT    
Sbjct: 82  LNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 141
Query: 200 MKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVST 259
           +  +   AKG+ FL  A R  I+RD    NILL+     K+ DFGLA+D           
Sbjct: 142 ICYSFQVAKGMEFL--ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKG 199
Query: 260 RVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEML 295
                  + APE +     T +SDV+ FGV+L E+ 
Sbjct: 200 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIF 235

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 78/295 (26%), Positives = 128/295 (43%), Gaps = 43/295 (14%)
Query: 95  RPDY----ILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDR-EWLAEVNYL 149
           R DY    ++G G   VV      +      K   VAIK +N    Q    E L E+  +
Sbjct: 9   RDDYELQEVIGSGATAVV------QAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAM 62
Query: 150 GQLRHSNLVKLIGYCCEDEHRILVYEYMESGS---LEKHLLRR---VGCMLTWSRRMKIA 203
            Q  H N+V         +   LV + +  GS   + KH++ +      +L  S    I 
Sbjct: 63  SQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATIL 122
Query: 204 LDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGL-AKDGPMGDQTHVSTR-- 260
            +  +GL +LH   +  I+RD K  NILL  D S +++DFG+ A     GD T    R  
Sbjct: 123 REVLEGLEYLHKNGQ--IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKT 180
Query: 261 VMGTYGYAAPEYV--MTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARP 318
            +GT  + APE +  + G+   ++D++ FG+  +E+  G     K  P +   L      
Sbjct: 181 FVGTPCWMAPEVMEQVRGY-DFKADIWSFGITAIELATGAAPYHKYPPMKVLMLT----- 234
Query: 319 LLNNNKKVLRILDPRLEGQYTARTAMKVAGLAYQ-----CLSQNPKGRPVMSDVV 368
            L N+        P LE     +  +K  G +++     CL ++P+ RP  ++++
Sbjct: 235 -LQNDP-------PSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELL 281

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 54/201 (26%), Positives = 89/201 (44%), Gaps = 17/201 (8%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQG---DREWLAEVNYLGQLRHSN 156
           LG+G FG VY        R       +A+K L +   +    + +   EV     LRH N
Sbjct: 20  LGKGKFGNVYLA------RERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHPN 73
Query: 157 LVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGA 216
           +++L GY  +     L+ EY   G++ + L +         R      + A  L++ H  
Sbjct: 74  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKL--SRFDEQRTATYITELANALSYCHS- 130
Query: 217 ERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTG 276
            + VI+RD K  N+LL ++   K++DFG +   P   +    T + GT  Y  PE +   
Sbjct: 131 -KRVIHRDIKPENLLLGSNGELKIADFGWSVHAPSSRR----TTLCGTLDYLPPEMIEGR 185
Query: 277 HLTARSDVYGFGVVLLEMLLG 297
               + D++  GV+  E L+G
Sbjct: 186 MHDEKVDLWSLGVLCYEFLVG 206

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 100/211 (47%), Gaps = 17/211 (8%)
Query: 98  YILGEG-GFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDR---EWLAEVNYLGQLR 153
           Y+LG+  G G   K  I E+   G+K   VA+K LNR   +      +   E+  L   R
Sbjct: 13  YVLGDTLGVGTFGKVKIGEHQLTGHK---VAVKILNRQKIRSLDVVGKIKREIQNLKLFR 69
Query: 154 HSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFL 213
           H +++KL           +V EY+  G L  ++ +        +RR+   + +A      
Sbjct: 70  HPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHR 129
Query: 214 HGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYV 273
           H     V++RD K  N+LL+A  +AK++DFGL+     G+    S    G+  YAAPE V
Sbjct: 130 HM----VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRDSC---GSPNYAAPE-V 181
Query: 274 MTGHLTA--RSDVYGFGVVLLEMLLGRRAVD 302
           ++G L A    D++  GV+L  +L G    D
Sbjct: 182 ISGRLYAGPEVDIWSCGVILYALLCGTLPFD 212

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 67/273 (24%), Positives = 111/273 (40%), Gaps = 35/273 (12%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGD---REWLAEVNYLGQLRHSN 156
           LG+G FG VY        R       VA+K L +   + +    +   E+     L H N
Sbjct: 31  LGKGKFGNVYLA------REKKSHFIVALKVLFKSQIEKEGVEHQLRREIEIQAHLHHPN 84
Query: 157 LVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGA 216
           +++L  Y  +     L+ EY   G L K L +   C     R   I  + A  L + HG 
Sbjct: 85  ILRLYNYFYDRRRIYLILEYAPRGELYKELQK--SCTFDEQRTATIMEELADALMYCHG- 141
Query: 217 ERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTG 276
            + VI+RD K  N+LL      K++DFG +   P   +      + GT  Y  PE +   
Sbjct: 142 -KKVIHRDIKPENLLLGLKGELKIADFGWSVHAPSLRR----KTMCGTLDYLPPEMIEGR 196
Query: 277 HLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRILDPRLEG 336
               + D++  GV+  E+L+G    + +                ++N+   RI+  +++ 
Sbjct: 197 MHNEKVDLWCIGVLCYELLVGNPPFESA----------------SHNETYRRIV--KVDL 238
Query: 337 QYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVA 369
           ++ A        L  + L  NP  R  ++ V A
Sbjct: 239 KFPASVPTGAQDLISKLLRHNPSERLPLAQVSA 271

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 65/270 (24%), Positives = 118/270 (43%), Gaps = 30/270 (11%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVK 159
           +GEG  G+V    +  + +       VA+K+++    Q       EV  +   +H N+V+
Sbjct: 39  IGEGSTGIVCIATVRSSGK------LVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVE 92
Query: 160 LI-GYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAER 218
           +   Y   DE  + V E++E G+L   +       +   +   + L   + L+ LH   +
Sbjct: 93  MYNSYLVGDELWV-VMEFLEGGALTDIV---THTRMNEEQIAAVCLAVLQALSVLHA--Q 146
Query: 219 PVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHL 278
            VI+RD K+ +ILL  D   KLSDFG      +  +      ++GT  + APE +     
Sbjct: 147 GVIHRDIKSDSILLTHDGRVKLSDFGFCAQ--VSKEVPRRKXLVGTPYWMAPELISRLPY 204
Query: 279 TARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRILDPRLEGQY 338
               D++  G++++EM      VD   P        +  P L   K +   L PRL+  +
Sbjct: 205 GPEVDIWSLGIMVIEM------VDGEPPY-------FNEPPLKAMKMIRDNLPPRLKNLH 251
Query: 339 TARTAMKVAGLAYQCLSQNPKGRPVMSDVV 368
               ++K  G   + L ++P  R   ++++
Sbjct: 252 KVSPSLK--GFLDRLLVRDPAQRATAAELL 279

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 54/214 (25%), Positives = 98/214 (45%), Gaps = 29/214 (13%)
Query: 94  FRPDYILGEGGFGVVYKGVIDENVRPGYKTTF-VAIKELNRG-GYQGDREWLAEVNYLGQ 151
           F+   +L  G FG VYKG+    +  G K    VAIKEL      + ++E L E   +  
Sbjct: 24  FKKIKVLSSGAFGTVYKGLW---IPEGEKVKIPVAIKELREATSPKANKEILDEAYVMAS 80
Query: 152 LRHSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMK---------- 201
           + + ++ +L+G C     ++++             L   GC+L + R  K          
Sbjct: 81  VDNPHVCRLLGICLTSTVQLIMQ------------LMPFGCLLDYVREHKDNIGSQYLLN 128
Query: 202 IALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRV 261
             +  AKG+ +L   +R +++RD    N+L+      K++DFGLAK     ++ + +   
Sbjct: 129 WCVQIAKGMNYLE--DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 186
Query: 262 MGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEML 295
                + A E ++    T +SDV+ +GV + E++
Sbjct: 187 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELM 220

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 54/214 (25%), Positives = 98/214 (45%), Gaps = 29/214 (13%)
Query: 94  FRPDYILGEGGFGVVYKGVIDENVRPGYKTTF-VAIKELNRG-GYQGDREWLAEVNYLGQ 151
           F+   +LG G FG VYKG+    +  G K    VAIKEL      + ++E L E   +  
Sbjct: 19  FKKIKVLGSGAFGTVYKGLW---IPEGEKVKIPVAIKELREATSPKANKEILDEAYVMAS 75
Query: 152 LRHSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMK---------- 201
           + + ++ +L+G C     ++++             L   GC+L + R  K          
Sbjct: 76  VDNPHVCRLLGICLTSTVQLIMQ------------LMPFGCLLDYVREHKDNIGSQYLLN 123
Query: 202 IALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRV 261
             +  AKG+ +L   +R +++RD    N+L+      K++DFG AK     ++ + +   
Sbjct: 124 WCVQIAKGMNYLE--DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGG 181
Query: 262 MGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEML 295
                + A E ++    T +SDV+ +GV + E++
Sbjct: 182 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELM 215

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 101/216 (46%), Gaps = 20/216 (9%)
Query: 88  KLATKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGD---REWLA 144
           +L   +  P ++ G G +G V   +   + R G K   VAIK+L+R  +Q +   +    
Sbjct: 21  ELPKTYVSPTHV-GSGAYGSVCSAI---DKRSGEK---VAIKKLSRP-FQSEIFAKRAYR 72
Query: 145 EVNYLGQLRHSNLVKLIG-YCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIA 203
           E+  L  ++H N++ L+  +      R     Y+    ++  L + +G   +  +   + 
Sbjct: 73  ELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGLKFSEEKIQYLV 132
Query: 204 LDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMG 263
               KGL ++H A   V++RD K  N+ +N D   K+ DFGLA+        +V TR   
Sbjct: 133 YQMLKGLKYIHSAG--VVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTR--- 187
Query: 264 TYGYAAPEYVMTG-HLTARSDVYGFGVVLLEMLLGR 298
              Y APE +++  H     D++  G ++ EML G+
Sbjct: 188 --WYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 65.1 bits (157), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 101/216 (46%), Gaps = 20/216 (9%)
Query: 88  KLATKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGD---REWLA 144
           +L   +  P ++ G G +G V   +   + R G K   VAIK+L+R  +Q +   +    
Sbjct: 39  ELPKTYVSPTHV-GSGAYGSVCSAI---DKRSGEK---VAIKKLSRP-FQSEIFAKRAYR 90
Query: 145 EVNYLGQLRHSNLVKLIG-YCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIA 203
           E+  L  ++H N++ L+  +      R     Y+    ++  L + +G   +  +   + 
Sbjct: 91  ELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGMEFSEEKIQYLV 150
Query: 204 LDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMG 263
               KGL ++H A   V++RD K  N+ +N D   K+ DFGLA+        +V TR   
Sbjct: 151 YQMLKGLKYIHSAG--VVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTR--- 205
Query: 264 TYGYAAPEYVMTG-HLTARSDVYGFGVVLLEMLLGR 298
              Y APE +++  H     D++  G ++ EML G+
Sbjct: 206 --WYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 239

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 65.1 bits (157), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 65/270 (24%), Positives = 118/270 (43%), Gaps = 30/270 (11%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVK 159
           +GEG  G+V    +  + +       VA+K+++    Q       EV  +   +H N+V+
Sbjct: 37  IGEGSTGIVCIATVRSSGK------LVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVE 90
Query: 160 LI-GYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAER 218
           +   Y   DE  + V E++E G+L   +       +   +   + L   + L+ LH   +
Sbjct: 91  MYNSYLVGDELWV-VMEFLEGGALTDIV---THTRMNEEQIAAVCLAVLQALSVLHA--Q 144
Query: 219 PVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHL 278
            VI+RD K+ +ILL  D   KLSDFG      +  +      ++GT  + APE +     
Sbjct: 145 GVIHRDIKSDSILLTHDGRVKLSDFGFCAQ--VSKEVPRRKXLVGTPYWMAPELISRLPY 202
Query: 279 TARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRILDPRLEGQY 338
               D++  G++++EM      VD   P        +  P L   K +   L PRL+  +
Sbjct: 203 GPEVDIWSLGIMVIEM------VDGEPPY-------FNEPPLKAMKMIRDNLPPRLKNLH 249
Query: 339 TARTAMKVAGLAYQCLSQNPKGRPVMSDVV 368
               ++K  G   + L ++P  R   ++++
Sbjct: 250 KVSPSLK--GFLDRLLVRDPAQRATAAELL 277

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 54/214 (25%), Positives = 97/214 (45%), Gaps = 29/214 (13%)
Query: 94  FRPDYILGEGGFGVVYKGVIDENVRPGYKTTF-VAIKELNRG-GYQGDREWLAEVNYLGQ 151
           F+   +L  G FG VYKG+    +  G K    VAIKEL      + ++E L E   +  
Sbjct: 17  FKKIKVLSSGAFGTVYKGLW---IPEGEKVKIPVAIKELREATSPKANKEILDEAYVMAS 73
Query: 152 LRHSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMK---------- 201
           + + ++ +L+G C     +++              L   GC+L + R  K          
Sbjct: 74  VDNPHVCRLLGICLTSTVQLITQ------------LMPFGCLLDYVREHKDNIGSQYLLN 121
Query: 202 IALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRV 261
             +  AKG+ +L   +R +++RD    N+L+      K++DFGLAK     ++ + +   
Sbjct: 122 WCVQIAKGMNYLE--DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 179
Query: 262 MGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEML 295
                + A E ++    T +SDV+ +GV + E++
Sbjct: 180 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELM 213

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 54/214 (25%), Positives = 98/214 (45%), Gaps = 29/214 (13%)
Query: 94  FRPDYILGEGGFGVVYKGVIDENVRPGYKTTF-VAIKELNRG-GYQGDREWLAEVNYLGQ 151
           F+   +LG G FG VYKG+    +  G K    VAIKEL      + ++E L E   +  
Sbjct: 14  FKKIKVLGSGAFGTVYKGLW---IPEGEKVKIPVAIKELREATSPKANKEILDEAYVMAS 70
Query: 152 LRHSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMK---------- 201
           + + ++ +L+G C     +++              L   GC+L + R  K          
Sbjct: 71  VDNPHVCRLLGICLTSTVQLITQ------------LMPFGCLLDYVREHKDNIGSQYLLN 118
Query: 202 IALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRV 261
             +  A+G+ +L   +R +++RD    N+L+      K++DFGLAK     ++ + +   
Sbjct: 119 WCVQIAEGMNYLE--DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 176
Query: 262 MGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEML 295
                + A E ++    T +SDV+ +GV + E++
Sbjct: 177 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELM 210

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 54/214 (25%), Positives = 97/214 (45%), Gaps = 29/214 (13%)
Query: 94  FRPDYILGEGGFGVVYKGVIDENVRPGYKTTF-VAIKELNRG-GYQGDREWLAEVNYLGQ 151
           F+   +L  G FG VYKG+    +  G K    VAIKEL      + ++E L E   +  
Sbjct: 24  FKKIKVLSSGAFGTVYKGLW---IPEGEKVKIPVAIKELREATSPKANKEILDEAYVMAS 80
Query: 152 LRHSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMK---------- 201
           + + ++ +L+G C     +++              L   GC+L + R  K          
Sbjct: 81  VDNPHVCRLLGICLTSTVQLITQ------------LMPFGCLLDYVREHKDNIGSQYLLN 128
Query: 202 IALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRV 261
             +  AKG+ +L   +R +++RD    N+L+      K++DFGLAK     ++ + +   
Sbjct: 129 WCVQIAKGMNYLE--DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 186
Query: 262 MGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEML 295
                + A E ++    T +SDV+ +GV + E++
Sbjct: 187 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELM 220

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 54/214 (25%), Positives = 98/214 (45%), Gaps = 29/214 (13%)
Query: 94  FRPDYILGEGGFGVVYKGVIDENVRPGYKTTF-VAIKELNRG-GYQGDREWLAEVNYLGQ 151
           F+   +LG G FG VYKG+    +  G K    VAIKEL      + ++E L E   +  
Sbjct: 19  FKKIKVLGSGAFGTVYKGLW---IPEGEKVKIPVAIKELREATSPKANKEILDEAYVMAS 75
Query: 152 LRHSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMK---------- 201
           + + ++ +L+G C     ++++             L   GC+L + R  K          
Sbjct: 76  VDNPHVCRLLGICLTSTVQLIMQ------------LMPFGCLLDYVREHKDNIGSQYLLN 123
Query: 202 IALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRV 261
             +  AKG+ +L   +R +++RD    N+L+      K++DFG AK     ++ + +   
Sbjct: 124 WCVQIAKGMNYLE--DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGG 181
Query: 262 MGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEML 295
                + A E ++    T +SDV+ +GV + E++
Sbjct: 182 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELM 215

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 54/214 (25%), Positives = 97/214 (45%), Gaps = 29/214 (13%)
Query: 94  FRPDYILGEGGFGVVYKGVIDENVRPGYKTTF-VAIKELNRG-GYQGDREWLAEVNYLGQ 151
           F+   +LG G FG VYKG+    +  G K    VAIKEL      + ++E L E   +  
Sbjct: 19  FKKIKVLGSGAFGTVYKGLW---IPEGEKVKIPVAIKELREATSPKANKEILDEAYVMAS 75
Query: 152 LRHSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMK---------- 201
           + + ++ +L+G C     +++              L   GC+L + R  K          
Sbjct: 76  VDNPHVCRLLGICLTSTVQLITQ------------LMPFGCLLDYVREHKDNIGSQYLLN 123
Query: 202 IALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRV 261
             +  AKG+ +L   +R +++RD    N+L+      K++DFG AK     ++ + +   
Sbjct: 124 WCVQIAKGMNYLE--DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGG 181
Query: 262 MGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEML 295
                + A E ++    T +SDV+ +GV + E++
Sbjct: 182 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELM 215

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 54/214 (25%), Positives = 97/214 (45%), Gaps = 29/214 (13%)
Query: 94  FRPDYILGEGGFGVVYKGVIDENVRPGYKTTF-VAIKELNRG-GYQGDREWLAEVNYLGQ 151
           F+   +LG G FG VYKG+    +  G K    VAI EL      + ++E L E   +  
Sbjct: 51  FKKIKVLGSGAFGTVYKGLW---IPEGEKVKIPVAIMELREATSPKANKEILDEAYVMAS 107
Query: 152 LRHSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMK---------- 201
           + + ++ +L+G C     +++              L   GC+L + R  K          
Sbjct: 108 VDNPHVCRLLGICLTSTVQLITQ------------LMPFGCLLDYVREHKDNIGSQYLLN 155
Query: 202 IALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRV 261
             +  AKG+ +L   +R +++RD    N+L+      K++DFGLAK     ++ + +   
Sbjct: 156 WCVQIAKGMNYLE--DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 213
Query: 262 MGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEML 295
                + A E ++    T +SDV+ +GV + E++
Sbjct: 214 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELM 247

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 65/270 (24%), Positives = 118/270 (43%), Gaps = 30/270 (11%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVK 159
           +GEG  G+V    +  + +       VA+K+++    Q       EV  +   +H N+V+
Sbjct: 28  IGEGSTGIVCIATVRSSGK------LVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVE 81
Query: 160 LI-GYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAER 218
           +   Y   DE  + V E++E G+L   +       +   +   + L   + L+ LH   +
Sbjct: 82  MYNSYLVGDELWV-VMEFLEGGALTDIV---THTRMNEEQIAAVCLAVLQALSVLHA--Q 135
Query: 219 PVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHL 278
            VI+RD K+ +ILL  D   KLSDFG      +  +      ++GT  + APE +     
Sbjct: 136 GVIHRDIKSDSILLTHDGRVKLSDFGFCAQ--VSKEVPRRKXLVGTPYWMAPELISRLPY 193
Query: 279 TARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRILDPRLEGQY 338
               D++  G++++EM      VD   P        +  P L   K +   L PRL+  +
Sbjct: 194 GPEVDIWSLGIMVIEM------VDGEPPY-------FNEPPLKAMKMIRDNLPPRLKNLH 240
Query: 339 TARTAMKVAGLAYQCLSQNPKGRPVMSDVV 368
               ++K  G   + L ++P  R   ++++
Sbjct: 241 KVSPSLK--GFLDRLLVRDPAQRATAAELL 268

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 67/275 (24%), Positives = 120/275 (43%), Gaps = 40/275 (14%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVK 159
           +GEG  G+V    +  + +       VA+K+++    Q       EV  +   +H N+V+
Sbjct: 32  IGEGSTGIVCIATVRSSGK------LVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVE 85
Query: 160 LI-GYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRR-----MKIALDAAKGLAFL 213
           +   Y   DE  + V E++E G+L          ++T +R        + L   + L+ L
Sbjct: 86  MYNSYLVGDELWV-VMEFLEGGALTD--------IVTHTRMNEEQIAAVCLAVLQALSVL 136
Query: 214 HGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYV 273
           H   + VI+RD K+ +ILL  D   KLSDFG      +  +      ++GT  + APE +
Sbjct: 137 HA--QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQ--VSKEVPRRKXLVGTPYWMAPELI 192
Query: 274 MTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRILDPR 333
                    D++  G++++EM      VD   P        +  P L   K +   L PR
Sbjct: 193 SRLPYGPEVDIWSLGIMVIEM------VDGEPPY-------FNEPPLKAMKMIRDNLPPR 239
Query: 334 LEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVV 368
           L+  +    ++K  G   + L ++P  R   ++++
Sbjct: 240 LKNLHKVSPSLK--GFLDRLLVRDPAQRATAAELL 272

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 54/214 (25%), Positives = 98/214 (45%), Gaps = 29/214 (13%)
Query: 94  FRPDYILGEGGFGVVYKGVIDENVRPGYKTTF-VAIKELNRG-GYQGDREWLAEVNYLGQ 151
           F+   +LG G FG VYKG+    +  G K    VAIKEL      + ++E L E   +  
Sbjct: 21  FKKIKVLGSGAFGTVYKGLW---IPEGEKVKIPVAIKELREATSPKANKEILDEAYVMAS 77
Query: 152 LRHSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMK---------- 201
           + + ++ +L+G C     ++++             L   GC+L + R  K          
Sbjct: 78  VDNPHVCRLLGICLTSTVQLIMQ------------LMPFGCLLDYVREHKDNIGSQYLLN 125
Query: 202 IALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRV 261
             +  AKG+ +L   +R +++RD    N+L+      K++DFG AK     ++ + +   
Sbjct: 126 WCVQIAKGMNYLE--DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGG 183
Query: 262 MGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEML 295
                + A E ++    T +SDV+ +GV + E++
Sbjct: 184 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELM 217

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 88/203 (43%), Gaps = 11/203 (5%)
Query: 99  ILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLV 158
           +LG GGFG V+   +    +          +   R GYQG    + E   L ++ HS  +
Sbjct: 192 VLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGA---MVEKKILAKV-HSRFI 247
Query: 159 KLIGYCCEDEHRI-LVYEYMESGSLEKHL--LRRVGCMLTWSRRMKIALDAAKGLAFLHG 215
             + Y  E +  + LV   M  G +  H+  +          R +        GL  LH 
Sbjct: 248 VSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLH- 306
Query: 216 AERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMT 275
            +R +IYRD K  N+LL+ D + ++SD GLA +   G QT       GT G+ APE ++ 
Sbjct: 307 -QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAG-QTKTKGYA-GTPGFMAPELLLG 363
Query: 276 GHLTARSDVYGFGVVLLEMLLGR 298
                  D +  GV L EM+  R
Sbjct: 364 EEYDFSVDYFALGVTLYEMIAAR 386

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 54/214 (25%), Positives = 97/214 (45%), Gaps = 29/214 (13%)
Query: 94  FRPDYILGEGGFGVVYKGVIDENVRPGYKTTF-VAIKELNRG-GYQGDREWLAEVNYLGQ 151
           F+   +LG G FG VYKG+    +  G K    VAIKEL      + ++E L E   +  
Sbjct: 17  FKKIKVLGSGAFGTVYKGLW---IPEGEKVKIPVAIKELREATSPKANKEILDEAYVMAS 73
Query: 152 LRHSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMK---------- 201
           + + ++ +L+G C     +++              L   GC+L + R  K          
Sbjct: 74  VDNPHVCRLLGICLTSTVQLITQ------------LMPFGCLLDYVREHKDNIGSQYLLN 121
Query: 202 IALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRV 261
             +  AKG+ +L   +R +++RD    N+L+      K++DFG AK     ++ + +   
Sbjct: 122 WCVQIAKGMNYLE--DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGG 179
Query: 262 MGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEML 295
                + A E ++    T +SDV+ +GV + E++
Sbjct: 180 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELM 213

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 65/229 (28%), Positives = 98/229 (42%), Gaps = 38/229 (16%)
Query: 94  FRPDYILGEGGFGVVYKG---VIDENVRPGYKTTFVAIKELNRGGYQGDRE-WLAEVNYL 149
           F P   LG GGFGVV++    V D N          AIK +     +  RE  + EV  L
Sbjct: 7   FEPIQCLGRGGFGVVFEAKNKVDDCNY---------AIKRIRLPNRELAREKVMREVKAL 57
Query: 150 GQLRHSNLVKLIGYCCE-------DEHRILVYEYMESGSLEKHLLRRVG---CMLTWSRR 199
            +L H  +V+      E             VY Y++     K  L+      C +    R
Sbjct: 58  AKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERER 117
Query: 200 ---MKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGL--AKDGPMGDQ 254
              + I L  A+ + FLH   + +++RD K SNI    D   K+ DFGL  A D    +Q
Sbjct: 118 SVCLHIFLQIAEAVEFLHS--KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQ 175
Query: 255 THVS--------TRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEML 295
           T ++        T  +GT  Y +PE +     + + D++  G++L E+L
Sbjct: 176 TVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL 224

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 54/214 (25%), Positives = 97/214 (45%), Gaps = 29/214 (13%)
Query: 94  FRPDYILGEGGFGVVYKGVIDENVRPGYKTTF-VAIKELNRG-GYQGDREWLAEVNYLGQ 151
           F+   +LG G FG VYKG+    +  G K    VAIKEL      + ++E L E   +  
Sbjct: 24  FKKIKVLGSGAFGTVYKGLW---IPEGEKVKIPVAIKELREATSPKANKEILDEAYVMAS 80
Query: 152 LRHSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMK---------- 201
           + + ++ +L+G C     +++              L   GC+L + R  K          
Sbjct: 81  VDNPHVCRLLGICLTSTVQLITQ------------LMPFGCLLDYVREHKDNIGSQYLLN 128
Query: 202 IALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRV 261
             +  AKG+ +L   +R +++RD    N+L+      K++DFG AK     ++ + +   
Sbjct: 129 WCVQIAKGMNYLE--DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGG 186
Query: 262 MGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEML 295
                + A E ++    T +SDV+ +GV + E++
Sbjct: 187 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELM 220

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 63/211 (29%), Positives = 96/211 (45%), Gaps = 32/211 (15%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGD---REWLAEVNYLGQLRHSN 156
           +G G +G V   V   + R G K   VAIK+L R  +Q +   +    E+  L  +RH N
Sbjct: 33  VGSGAYGAVCSAV---DGRTGAK---VAIKKLYRP-FQSELFAKRAYRELRLLKHMRHEN 85
Query: 157 LVKLIGYCCEDE------HRILVYEYM--ESGSLEKHLLRRVGCMLTWSRRMKIALDAAK 208
           ++ L+     DE         LV  +M  + G L KH   ++G      R   +     K
Sbjct: 86  VIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKH--EKLGE----DRIQFLVYQMLK 139
Query: 209 GLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYA 268
           GL ++H A   +I+RD K  N+ +N D   K+ DFGLA+         V TR      Y 
Sbjct: 140 GLRYIHAAG--IIHRDLKPGNLAVNEDCELKILDFGLARQADSEMXGXVVTR-----WYR 192
Query: 269 APEYVMTG-HLTARSDVYGFGVVLLEMLLGR 298
           APE ++     T   D++  G ++ EM+ G+
Sbjct: 193 APEVILNWMRYTQTVDIWSVGCIMAEMITGK 223

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 90/206 (43%), Gaps = 17/206 (8%)
Query: 99  ILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQG---DREWLAEVNYLGQLRHS 155
           +LG GGFG V+   +    +          +   R GYQG   +++ LA+V       HS
Sbjct: 192 VLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKV-------HS 244
Query: 156 NLVKLIGYCCEDEHRI-LVYEYMESGSLEKHL--LRRVGCMLTWSRRMKIALDAAKGLAF 212
             +  + Y  E +  + LV   M  G +  H+  +          R +        GL  
Sbjct: 245 RFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEH 304
Query: 213 LHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEY 272
           LH  +R +IYRD K  N+LL+ D + ++SD GLA +   G QT       GT G+ APE 
Sbjct: 305 LH--QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAG-QTKTKGYA-GTPGFMAPEL 360
Query: 273 VMTGHLTARSDVYGFGVVLLEMLLGR 298
           ++        D +  GV L EM+  R
Sbjct: 361 LLGEEYDFSVDYFALGVTLYEMIAAR 386

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 90/206 (43%), Gaps = 17/206 (8%)
Query: 99  ILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQG---DREWLAEVNYLGQLRHS 155
           +LG GGFG V+   +    +          +   R GYQG   +++ LA+V       HS
Sbjct: 192 VLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKV-------HS 244
Query: 156 NLVKLIGYCCEDEHRI-LVYEYMESGSLEKHL--LRRVGCMLTWSRRMKIALDAAKGLAF 212
             +  + Y  E +  + LV   M  G +  H+  +          R +        GL  
Sbjct: 245 RFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEH 304
Query: 213 LHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEY 272
           LH  +R +IYRD K  N+LL+ D + ++SD GLA +   G QT       GT G+ APE 
Sbjct: 305 LH--QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAG-QTKTKGYA-GTPGFMAPEL 360
Query: 273 VMTGHLTARSDVYGFGVVLLEMLLGR 298
           ++        D +  GV L EM+  R
Sbjct: 361 LLGEEYDFSVDYFALGVTLYEMIAAR 386

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 61/220 (27%), Positives = 98/220 (44%), Gaps = 25/220 (11%)
Query: 89  LATKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLA---- 144
           +AT  + P   +G G +G VYK       R  +   FVA+K +      G    L     
Sbjct: 6   MATSRYEPVAEIGVGAYGTVYKA------RDPHSGHFVALKSVRVPNGGGGGGGLPISTV 59
Query: 145 -EVNYLGQLR---HSNLVKLIGYCC----EDEHRI-LVYEYMESGSLEKHLLRRVGCMLT 195
            EV  L +L    H N+V+L+  C     + E ++ LV+E+++   L  +L +     L 
Sbjct: 60  REVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLP 118
Query: 196 WSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQT 255
                 +     +GL FLH     +++RD K  NIL+ +  + KL+DFGLA+   +    
Sbjct: 119 AETIKDLMRQFLRGLDFLHA--NCIVHRDLKPENILVTSGGTVKLADFGLAR---IYSYQ 173
Query: 256 HVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEML 295
              T V+ T  Y APE ++        D++  G +  EM 
Sbjct: 174 MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMF 213

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 96/206 (46%), Gaps = 18/206 (8%)
Query: 99  ILGEGGFGVVYKGV-IDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNL 157
           +LG+G +G+VY G  +   VR       +AIKE+     +  +    E+     L+H N+
Sbjct: 29  VLGKGTYGIVYAGRDLSNQVR-------IAIKEIPERDSRYSQPLHEEIALHKHLKHKNI 81
Query: 158 VKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKI-ALDAAKGLAFLHGA 216
           V+ +G   E+    +  E +  GSL   L  + G +    + +        +GL +LH  
Sbjct: 82  VQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLH-- 139
Query: 217 ERPVIYRDFKTSNILLNADFSA--KLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVM 274
           +  +++RD K  N+L+N  +S   K+SDFG +K   +      +    GT  Y APE + 
Sbjct: 140 DNQIVHRDIKGDNVLINT-YSGVLKISDFGTSKR--LAGINPCTETFTGTLQYMAPEIID 196
Query: 275 TGH--LTARSDVYGFGVVLLEMLLGR 298
            G       +D++  G  ++EM  G+
Sbjct: 197 KGPRGYGKAADIWSLGCTIIEMATGK 222

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 90/206 (43%), Gaps = 17/206 (8%)
Query: 99  ILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQG---DREWLAEVNYLGQLRHS 155
           +LG GGFG V+   +    +          +   R GYQG   +++ LA+V       HS
Sbjct: 192 VLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKV-------HS 244
Query: 156 NLVKLIGYCCEDEHRI-LVYEYMESGSLEKHL--LRRVGCMLTWSRRMKIALDAAKGLAF 212
             +  + Y  E +  + LV   M  G +  H+  +          R +        GL  
Sbjct: 245 RFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEH 304
Query: 213 LHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEY 272
           LH  +R +IYRD K  N+LL+ D + ++SD GLA +   G QT       GT G+ APE 
Sbjct: 305 LH--QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAG-QTKTKGYA-GTPGFMAPEL 360
Query: 273 VMTGHLTARSDVYGFGVVLLEMLLGR 298
           ++        D +  GV L EM+  R
Sbjct: 361 LLGEEYDFSVDYFALGVTLYEMIAAR 386

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 99/218 (45%), Gaps = 24/218 (11%)
Query: 89  LATKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELN-RGGYQG-----DREW 142
           +AT  + P   +G G +G VYK       R  +   FVA+K +    G +G      RE 
Sbjct: 1   MATSRYEPVAEIGVGAYGTVYKA------RDPHSGHFVALKSVRVPNGEEGLPISTVRE- 53
Query: 143 LAEVNYLGQLRHSNLVKLIGYCC----EDEHRI-LVYEYMESGSLEKHLLRRVGCMLTWS 197
           +A +  L    H N+V+L+  C     + E ++ LV+E+++   L  +L +     L   
Sbjct: 54  VALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAE 112
Query: 198 RRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHV 257
               +     +GL FLH     +++RD K  NIL+ +  + KL+DFGLA+   +      
Sbjct: 113 TIKDLMRQFLRGLDFLHA--NCIVHRDLKPENILVTSGGTVKLADFGLAR---IYSYQMA 167
Query: 258 STRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEML 295
              V+ T  Y APE ++        D++  G +  EM 
Sbjct: 168 LAPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMF 205

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 67/224 (29%), Positives = 104/224 (46%), Gaps = 25/224 (11%)
Query: 79  VDIFTYNEMKLATKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQG 138
           VD     E+  AT   R    LG G FG V++    E+ + G++    A+K++    ++ 
Sbjct: 84  VDYEYREEVHWATHQLR----LGRGSFGEVHR---MEDKQTGFQ---CAVKKVRLEVFRA 133
Query: 139 DREWLAEVNYLGQLRHSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSR 198
           +     E+     L    +V L G   E     +  E +E GSL + L++  GC L   R
Sbjct: 134 E-----ELMACAGLTSPRIVPLYGAVREGPWVNIFMELLEGGSLGQ-LVKEQGC-LPEDR 186
Query: 199 RMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFS-AKLSDFG----LAKDGPMGD 253
            +     A +GL +LH   R +++ D K  N+LL++D S A L DFG    L  DG +G 
Sbjct: 187 ALYYLGQALEGLEYLH--SRRILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDG-LGK 243
Query: 254 QTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLG 297
                  + GT  + APE V+     A+ DV+    ++L ML G
Sbjct: 244 SLLTGDYIPGTETHMAPEVVLGRSCDAKVDVWSSCCMMLHMLNG 287

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 53/201 (26%), Positives = 88/201 (43%), Gaps = 17/201 (8%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQG---DREWLAEVNYLGQLRHSN 156
           LG+G FG VY        R       +A+K L +   +    + +   EV     LRH N
Sbjct: 20  LGKGKFGNVYLA------RERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHPN 73
Query: 157 LVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGA 216
           +++L GY  +     L+ EY   G++ + L +         R      + A  L++ H  
Sbjct: 74  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKL--SRFDEQRTATYITELANALSYCHS- 130
Query: 217 ERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTG 276
            + VI+RD K  N+LL ++   K++DFG +   P   +      + GT  Y  PE +   
Sbjct: 131 -KRVIHRDIKPENLLLGSNGELKIADFGWSVHAPSSRR----DTLCGTLDYLPPEMIEGR 185
Query: 277 HLTARSDVYGFGVVLLEMLLG 297
               + D++  GV+  E L+G
Sbjct: 186 MHDEKVDLWSLGVLCYEFLVG 206

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 72/284 (25%), Positives = 118/284 (41%), Gaps = 43/284 (15%)
Query: 99  ILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQL-RHSNL 157
           ++G G +G VYKG    +V+ G      AIK ++  G + + E   E+N L +   H N+
Sbjct: 31  LVGNGTYGQVYKG---RHVKTG---QLAAIKVMDVTGDE-EEEIKQEINMLKKYSHHRNI 83
Query: 158 VKLIGYCCE------DEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLA 211
               G   +      D+   LV E+  +GS+   +    G  L       I  +  +GL+
Sbjct: 84  ATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLS 143
Query: 212 FLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAK--DGPMGDQTHVSTRVMGTYGYAA 269
            LH  +  VI+RD K  N+LL  +   KL DFG++   D  +G +       +GT  + A
Sbjct: 144 HLH--QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRR----NTFIGTPYWMA 197
Query: 270 PEYVMTGH-----LTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNK 324
           PE +            +SD++  G+  +EM  G   +    P R   L+           
Sbjct: 198 PEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIP---------- 247
Query: 325 KVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVV 368
              R   PRL+ +   + + K       CL +N   RP    ++
Sbjct: 248 ---RNPAPRLKSK---KWSKKFQSFIESCLVKNHSQRPATEQLM 285

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 96/207 (46%), Gaps = 23/207 (11%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELN-RGGYQG-----DREWLAEVNYLGQLR 153
           +GEG +G V+K     +++ G +  FVA+K +  + G +G      RE +A + +L    
Sbjct: 19  IGEGAYGKVFKA---RDLKNGGR--FVALKRVRVQTGEEGMPLSTIRE-VAVLRHLETFE 72
Query: 154 HSNLVKLIGYCC-----EDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAK 208
           H N+V+L   C       +    LV+E+++   L  +L +     +       +     +
Sbjct: 73  HPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQLLR 131
Query: 209 GLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYA 268
           GL FLH     V++RD K  NIL+ +    KL+DFGLA+   +       T V+ T  Y 
Sbjct: 132 GLDFLHSHR--VVHRDLKPQNILVTSSGQIKLADFGLAR---IYSFQMALTSVVVTLWYR 186
Query: 269 APEYVMTGHLTARSDVYGFGVVLLEML 295
           APE ++        D++  G +  EM 
Sbjct: 187 APEVLLQSSYATPVDLWSVGCIFAEMF 213

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 99/218 (45%), Gaps = 24/218 (11%)
Query: 89  LATKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELN-RGGYQG-----DREW 142
           +AT  + P   +G G +G VYK       R  +   FVA+K +    G +G      RE 
Sbjct: 1   MATSRYEPVAEIGVGAYGTVYKA------RDPHSGHFVALKSVRVPNGEEGLPISTVRE- 53
Query: 143 LAEVNYLGQLRHSNLVKLIGYCC----EDEHRI-LVYEYMESGSLEKHLLRRVGCMLTWS 197
           +A +  L    H N+V+L+  C     + E ++ LV+E+++   L  +L +     L   
Sbjct: 54  VALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAE 112
Query: 198 RRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHV 257
               +     +GL FLH     +++RD K  NIL+ +  + KL+DFGLA+   +      
Sbjct: 113 TIKDLMRQFLRGLDFLHA--NCIVHRDLKPENILVTSGGTVKLADFGLAR---IYSYQMA 167
Query: 258 STRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEML 295
              V+ T  Y APE ++        D++  G +  EM 
Sbjct: 168 LDPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMF 205

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 42/127 (33%), Positives = 64/127 (50%), Gaps = 6/127 (4%)
Query: 172 LVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNIL 231
            V EY+  G L  H+ ++VG        +  A + A GL FL    + +IYRD K  N++
Sbjct: 419 FVMEYVNGGDLMYHI-QQVG-RFKEPHAVFYAAEIAIGLFFLQS--KGIIYRDLKLDNVM 474
Query: 232 LNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVL 291
           L+++   K++DFG+ K+      T  +    GT  Y APE +         D + FGV+L
Sbjct: 475 LDSEGHIKIADFGMCKENIWDGVT--TKXFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLL 532
Query: 292 LEMLLGR 298
            EML G+
Sbjct: 533 YEMLAGQ 539

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 96/206 (46%), Gaps = 18/206 (8%)
Query: 99  ILGEGGFGVVYKGV-IDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNL 157
           +LG+G +G+VY G  +   VR       +AIKE+     +  +    E+     L+H N+
Sbjct: 15  VLGKGTYGIVYAGRDLSNQVR-------IAIKEIPERDSRYSQPLHEEIALHKHLKHKNI 67
Query: 158 VKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKI-ALDAAKGLAFLHGA 216
           V+ +G   E+    +  E +  GSL   L  + G +    + +        +GL +LH  
Sbjct: 68  VQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLH-- 125
Query: 217 ERPVIYRDFKTSNILLNADFSA--KLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVM 274
           +  +++RD K  N+L+N  +S   K+SDFG +K   +      +    GT  Y APE + 
Sbjct: 126 DNQIVHRDIKGDNVLINT-YSGVLKISDFGTSKR--LAGINPCTETFTGTLQYMAPEIID 182
Query: 275 TGH--LTARSDVYGFGVVLLEMLLGR 298
            G       +D++  G  ++EM  G+
Sbjct: 183 KGPRGYGKAADIWSLGCTIIEMATGK 208

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 67/251 (26%), Positives = 107/251 (42%), Gaps = 33/251 (13%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDRE-----WLAEVNYLGQLRH 154
           +GEG +G V+K    E            I  L R     D E      L E+  L +L+H
Sbjct: 10  IGEGTYGTVFKAKNRETHE---------IVALKRVRLDDDDEGVPSSALREICLLKELKH 60
Query: 155 SNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLH 214
            N+V+L      D+   LV+E+ +   L+K+     G  L             KGL F H
Sbjct: 61  KNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNG-DLDPEIVKSFLFQLLKGLGFCH 118
Query: 215 GAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVM 274
              R V++RD K  N+L+N +   KL+DFGLA+    G      +  + T  Y  P+ + 
Sbjct: 119 S--RNVLHRDLKPQNLLINRNGELKLADFGLAR--AFGIPVRCYSAEVVTLWYRPPDVLF 174
Query: 275 TGHLTARS-DVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRILDPR 333
              L + S D++  G +  E+       + +RP    N V+      +  K++ R+L   
Sbjct: 175 GAKLYSTSIDMWSAGCIFAEL------ANAARPLFPGNDVD------DQLKRIFRLLGTP 222
Query: 334 LEGQYTARTAM 344
            E Q+ + T +
Sbjct: 223 TEEQWPSMTKL 233

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 61/224 (27%), Positives = 94/224 (41%), Gaps = 43/224 (19%)
Query: 94  FRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLR 153
           F+   ++G GGFG V+K       R   KT    IK +     + +RE    V  L +L 
Sbjct: 13  FKEIELIGSGGFGQVFKA----KHRIDGKT--YVIKRVKYNNEKAERE----VKALAKLD 62
Query: 154 HSNLVKLIGYCCED------------------EHRILVYEYMESGSLEKHLLRRVGCMLT 195
           H N+V   G  C D                  +   +  E+ + G+LE+ + +R G  L 
Sbjct: 63  HVNIVHYNG--CWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLD 120
Query: 196 WSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLA----KDGPM 251
               +++     KG+ ++H   + +I RD K SNI L      K+ DFGL      DG  
Sbjct: 121 KVLALELFEQITKGVDYIHS--KKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGK- 177
Query: 252 GDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEML 295
                   R  GT  Y +PE + +       D+Y  G++L E+L
Sbjct: 178 ------RXRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELL 215

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 67/224 (29%), Positives = 104/224 (46%), Gaps = 25/224 (11%)
Query: 79  VDIFTYNEMKLATKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQG 138
           VD     E+  AT   R    LG G FG V++    E+ + G++    A+K++    ++ 
Sbjct: 65  VDYEYREEVHWATHQLR----LGRGSFGEVHR---MEDKQTGFQC---AVKKVRLEVFRA 114
Query: 139 DREWLAEVNYLGQLRHSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSR 198
           +     E+     L    +V L G   E     +  E +E GSL + L++  GC L   R
Sbjct: 115 E-----ELMACAGLTSPRIVPLYGAVREGPWVNIFMELLEGGSLGQ-LVKEQGC-LPEDR 167
Query: 199 RMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFS-AKLSDFG----LAKDGPMGD 253
            +     A +GL +LH   R +++ D K  N+LL++D S A L DFG    L  DG +G 
Sbjct: 168 ALYYLGQALEGLEYLH--SRRILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDG-LGK 224
Query: 254 QTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLG 297
                  + GT  + APE V+     A+ DV+    ++L ML G
Sbjct: 225 DLLTGDYIPGTETHMAPEVVLGRSCDAKVDVWSSCCMMLHMLNG 268

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 79/295 (26%), Positives = 128/295 (43%), Gaps = 56/295 (18%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLG--QLRHSNL 157
           +G+G +G V++G         ++   VA+K  +    + ++ W  E        LRH N+
Sbjct: 45  VGKGRYGEVWRG--------SWQGENVAVKIFSS---RDEKSWFRETELYNTVMLRHENI 93
Query: 158 VKLIGYCCEDEHR----ILVYEYMESGSLEKHL----LRRVGCMLTWSRRMKIALDAAKG 209
           +  I       H      L+  Y E GSL  +L    L  V C+       +I L  A G
Sbjct: 94  LGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCL-------RIVLSIASG 146
Query: 210 LAFLH----GAE-RPVI-YRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRV-- 261
           LA LH    G + +P I +RD K+ NIL+  +    ++D GLA    M  Q+     V  
Sbjct: 147 LAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLA---VMHSQSTNQLDVGN 203
Query: 262 ---MGTYGYAAPEY------VMTGHLTARSDVYGFGVVLLEM---LLGRRAVDKSRPSRE 309
              +GT  Y APE       V       R D++ FG+VL E+   ++    V+  +P   
Sbjct: 204 NPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPF- 262
Query: 310 HNLVEWARPLLNNNKKVLRILD--PRLEGQYTAR-TAMKVAGLAYQCLSQNPKGR 361
           +++V    P   + +KV+ +    P +  ++ +  T   +A L  +C  QNP  R
Sbjct: 263 YDVVP-NDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSAR 316

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 99/218 (45%), Gaps = 24/218 (11%)
Query: 89  LATKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELN-RGGYQG-----DREW 142
           +AT  + P   +G G +G VYK       R  +   FVA+K +    G +G      RE 
Sbjct: 1   MATSRYEPVAEIGVGAYGTVYKA------RDPHSGHFVALKSVRVPNGEEGLPISTVRE- 53
Query: 143 LAEVNYLGQLRHSNLVKLIGYCC----EDEHRI-LVYEYMESGSLEKHLLRRVGCMLTWS 197
           +A +  L    H N+V+L+  C     + E ++ LV+E+++   L  +L +     L   
Sbjct: 54  VALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAE 112
Query: 198 RRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHV 257
               +     +GL FLH     +++RD K  NIL+ +  + KL+DFGLA+   +      
Sbjct: 113 TIKDLMRQFLRGLDFLHA--NCIVHRDLKPENILVTSGGTVKLADFGLAR---IYSYQMA 167
Query: 258 STRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEML 295
              V+ T  Y APE ++        D++  G +  EM 
Sbjct: 168 LFPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMF 205

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 63/241 (26%), Positives = 108/241 (44%), Gaps = 22/241 (9%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVK 159
           +GEG  G+V         R  +    VA+K ++    Q       EV  +   +H N+V+
Sbjct: 53  IGEGSTGIVCLA------REKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVE 106
Query: 160 LIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERP 219
           +       E   ++ E+++ G+L   ++ +V   L   +   +     + LA+LH   + 
Sbjct: 107 MYKSYLVGEELWVLMEFLQGGAL-TDIVSQVR--LNEEQIATVCEAVLQALAYLHA--QG 161
Query: 220 VIYRDFKTSNILLNADFSAKLSDFG----LAKDGPMGDQTHVSTRVMGTYGYAAPEYVMT 275
           VI+RD K+ +ILL  D   KLSDFG    ++KD P          ++GT  + APE +  
Sbjct: 162 VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPK------RKXLVGTPYWMAPEVISR 215
Query: 276 GHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHN-LVEWARPLLNNNKKVLRILDPRL 334
                  D++  G++++EM+ G        P +    L +   P L N+ KV  +L   L
Sbjct: 216 SLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNSHKVSPVLRDFL 275
Query: 335 E 335
           E
Sbjct: 276 E 276

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 91/218 (41%), Gaps = 19/218 (8%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGD---REWLAEVNYLGQLRHSN 156
           LG+G FG VY     +N         +A+K L +   + +    +   E+     LRH N
Sbjct: 23  LGKGKFGNVYLAREKQN------KFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPN 76
Query: 157 LVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGA 216
           ++++  Y  + +   L+ E+   G L K L +         R      + A  L + H  
Sbjct: 77  ILRMYNYFHDRKRIYLMLEFAPRGELYKELQKH--GRFDEQRSATFMEELADALHYCH-- 132
Query: 217 ERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVM-GTYGYAAPEYVMT 275
           ER VI+RD K  N+L+      K++DFG +   P      +  R M GT  Y  PE +  
Sbjct: 133 ERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPS-----LRRRXMCGTLDYLPPEMIEG 187
Query: 276 GHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLV 313
                + D++  GV+  E L+G    D    +  H  +
Sbjct: 188 KTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRI 225

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 79/296 (26%), Positives = 130/296 (43%), Gaps = 58/296 (19%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLG--QLRHSNL 157
           +G+G +G V++G         ++   VA+K  +    + ++ W  E        LRH N+
Sbjct: 16  VGKGRYGEVWRG--------SWQGENVAVKIFSS---RDEKSWFRETELYNTVMLRHENI 64
Query: 158 VKLIGYCCEDEHR----ILVYEYMESGSLEKHL----LRRVGCMLTWSRRMKIALDAAKG 209
           +  I       H      L+  Y E GSL  +L    L  V C+       +I L  A G
Sbjct: 65  LGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCL-------RIVLSIASG 117
Query: 210 LAFLH----GAE-RPVI-YRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRV-- 261
           LA LH    G + +P I +RD K+ NIL+  +    ++D GLA    M  Q+     V  
Sbjct: 118 LAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLA---VMHSQSTNQLDVGN 174
Query: 262 ---MGTYGYAAPEYVMTGHLTA-------RSDVYGFGVVLLEM---LLGRRAVDKSRPSR 308
              +GT  Y APE V+   +         R D++ FG+VL E+   ++    V+  +P  
Sbjct: 175 NPRVGTKRYMAPE-VLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPF 233
Query: 309 EHNLVEWARPLLNNNKKVLRILD--PRLEGQYTAR-TAMKVAGLAYQCLSQNPKGR 361
            +++V    P   + +KV+ +    P +  ++ +  T   +A L  +C  QNP  R
Sbjct: 234 -YDVVP-NDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSAR 287

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 79/296 (26%), Positives = 130/296 (43%), Gaps = 58/296 (19%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLG--QLRHSNL 157
           +G+G +G V++G         ++   VA+K  +    + ++ W  E        LRH N+
Sbjct: 16  VGKGRYGEVWRG--------SWQGENVAVKIFSS---RDEKSWFRETELYNTVMLRHENI 64
Query: 158 VKLIGYCCEDEHR----ILVYEYMESGSLEKHL----LRRVGCMLTWSRRMKIALDAAKG 209
           +  I       H      L+  Y E GSL  +L    L  V C+       +I L  A G
Sbjct: 65  LGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCL-------RIVLSIASG 117
Query: 210 LAFLH----GAE-RPVI-YRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRV-- 261
           LA LH    G + +P I +RD K+ NIL+  +    ++D GLA    M  Q+     V  
Sbjct: 118 LAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLA---VMHSQSTNQLDVGN 174
Query: 262 ---MGTYGYAAPEYVMTGHLTA-------RSDVYGFGVVLLEM---LLGRRAVDKSRPSR 308
              +GT  Y APE V+   +         R D++ FG+VL E+   ++    V+  +P  
Sbjct: 175 NPRVGTKRYMAPE-VLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPF 233
Query: 309 EHNLVEWARPLLNNNKKVLRILD--PRLEGQYTAR-TAMKVAGLAYQCLSQNPKGR 361
            +++V    P   + +KV+ +    P +  ++ +  T   +A L  +C  QNP  R
Sbjct: 234 -YDVVP-NDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSAR 287

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 91/218 (41%), Gaps = 19/218 (8%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGD---REWLAEVNYLGQLRHSN 156
           LG+G FG VY     +N         +A+K L +   + +    +   E+     LRH N
Sbjct: 22  LGKGKFGNVYLAREKQN------KFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPN 75
Query: 157 LVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGA 216
           ++++  Y  + +   L+ E+   G L K L +         R      + A  L + H  
Sbjct: 76  ILRMYNYFHDRKRIYLMLEFAPRGELYKELQKH--GRFDEQRSATFMEELADALHYCH-- 131
Query: 217 ERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVM-GTYGYAAPEYVMT 275
           ER VI+RD K  N+L+      K++DFG +   P      +  R M GT  Y  PE +  
Sbjct: 132 ERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPS-----LRRRXMCGTLDYLPPEMIEG 186
Query: 276 GHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLV 313
                + D++  GV+  E L+G    D    +  H  +
Sbjct: 187 KTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRI 224

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 44/136 (32%), Positives = 68/136 (50%), Gaps = 7/136 (5%)
Query: 164 CCEDEHRI-LVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIY 222
           C +   R+  V EY+  G L  H+ ++VG        +  A + A GL FL    + +IY
Sbjct: 89  CFQTMDRLYFVMEYVNGGDLMYHI-QQVG-RFKEPHAVFYAAEIAIGLFFLQS--KGIIY 144
Query: 223 RDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARS 282
           RD K  N++L+++   K++DFG+ K+      T  +    GT  Y APE +         
Sbjct: 145 RDLKLDNVMLDSEGHIKIADFGMCKENIWDGVT--TKXFCGTPDYIAPEIIAYQPYGKSV 202
Query: 283 DVYGFGVVLLEMLLGR 298
           D + FGV+L EML G+
Sbjct: 203 DWWAFGVLLYEMLAGQ 218

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 49/173 (28%), Positives = 80/173 (46%), Gaps = 25/173 (14%)
Query: 201 KIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTR 260
           KIA+   K L  LH ++  VI+RD K SN+L+NA    K+ DFG++  G + D     T 
Sbjct: 157 KIAVSIVKALEHLH-SKLSVIHRDVKPSNVLINALGQVKMCDFGIS--GYLVDSV-AKTI 212
Query: 261 VMGTYGYAAPEYV-----MTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEW 315
             G   Y APE +       G+ + +SD++  G+ ++E+ + R   D            W
Sbjct: 213 DAGCKPYMAPERINPELNQKGY-SVKSDIWSLGITMIELAILRFPYD-----------SW 260
Query: 316 ARPLLNNNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVV 368
             P     K+V+    P+L      + + +      QCL +N K RP   +++
Sbjct: 261 GTP-FQQLKQVVEEPSPQLPAD---KFSAEFVDFTSQCLKKNSKERPTYPELM 309

>pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 67/273 (24%), Positives = 119/273 (43%), Gaps = 51/273 (18%)
Query: 130 ELNRGGYQGD---------REWLA--------EVNYLGQLRHSNLVKLIGYCCEDE--HR 170
           EL +G +QG+         R+W          E   L    H N++ ++G C      H 
Sbjct: 25  ELWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHP 84
Query: 171 ILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRD-FKTSN 229
            L+  +M  GSL   L      ++  S+ +K ALD A+G+AFLH  E P+I R    + +
Sbjct: 85  TLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLE-PLIPRHALNSRS 143
Query: 230 ILLNADFSAKLSDFGLAKDGPMGDQ--THVSTRVMGTYGYAAPEYVMTG-HLTAR--SDV 284
           ++++ D +A++S         M D   +  S   M    + APE +      T R  +D+
Sbjct: 144 VMIDEDMTARIS---------MADVKFSFQSPGRMYAPAWVAPEALQKKPEDTNRRSADM 194
Query: 285 YGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRILDPRLEGQYTARTAM 344
           + F V+L E++           +RE    +     L+N +  +++    L        + 
Sbjct: 195 WSFAVLLWELV-----------TREVPFAD-----LSNMEIGMKVALEGLRPTIPPGISP 238
Query: 345 KVAGLAYQCLSQNPKGRPVMSDVVALLETVQSQ 377
            V+ L   C++++P  RP    +V +LE +Q +
Sbjct: 239 HVSKLMKICMNEDPAKRPKFDMIVPILEKMQDK 271

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 96/207 (46%), Gaps = 23/207 (11%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELN-RGGYQG-----DREWLAEVNYLGQLR 153
           +GEG +G V+K     +++ G +  FVA+K +  + G +G      RE +A + +L    
Sbjct: 19  IGEGAYGKVFKA---RDLKNGGR--FVALKRVRVQTGEEGMPLSTIRE-VAVLRHLETFE 72
Query: 154 HSNLVKLIGYCC-----EDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAK 208
           H N+V+L   C       +    LV+E+++   L  +L +     +       +     +
Sbjct: 73  HPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQLLR 131
Query: 209 GLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYA 268
           GL FLH     V++RD K  NIL+ +    KL+DFGLA+   +       T V+ T  Y 
Sbjct: 132 GLDFLHSHR--VVHRDLKPQNILVTSSGQIKLADFGLAR---IYSFQMALTSVVVTLWYR 186
Query: 269 APEYVMTGHLTARSDVYGFGVVLLEML 295
           APE ++        D++  G +  EM 
Sbjct: 187 APEVLLQSSYATPVDLWSVGCIFAEMF 213

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 96/207 (46%), Gaps = 23/207 (11%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELN-RGGYQG-----DREWLAEVNYLGQLR 153
           +GEG +G V+K     +++ G +  FVA+K +  + G +G      RE +A + +L    
Sbjct: 19  IGEGAYGKVFKA---RDLKNGGR--FVALKRVRVQTGEEGMPLSTIRE-VAVLRHLETFE 72
Query: 154 HSNLVKLIGYCC-----EDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAK 208
           H N+V+L   C       +    LV+E+++   L  +L +     +       +     +
Sbjct: 73  HPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQLLR 131
Query: 209 GLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYA 268
           GL FLH     V++RD K  NIL+ +    KL+DFGLA+   +       T V+ T  Y 
Sbjct: 132 GLDFLHSHR--VVHRDLKPQNILVTSSGQIKLADFGLAR---IYSFQMALTSVVVTLWYR 186
Query: 269 APEYVMTGHLTARSDVYGFGVVLLEML 295
           APE ++        D++  G +  EM 
Sbjct: 187 APEVLLQSSYATPVDLWSVGCIFAEMF 213

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 96/209 (45%), Gaps = 28/209 (13%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNR---GGYQGDREWLAEVNYLGQLRHSN 156
           +G G +G V       +V+ G K   +A+K+L+R         R +  E+  L  ++H N
Sbjct: 59  VGSGAYGSVCSSY---DVKSGLK---IAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHEN 111
Query: 157 LVKLI-----GYCCEDEHRILVYEYMESGSLEKHLLRRVGCM-LTWSRRMKIALDAAKGL 210
           ++ L+         E+ + + +  ++    L       V C  LT      +     +GL
Sbjct: 112 VIGLLDVFTPATSLEEFNDVYLVTHLMGADLNN----IVKCQKLTDDHVQFLIYQILRGL 167
Query: 211 AFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAP 270
            ++H A+  +I+RD K SN+ +N D   K+ DFGLA+        +V+TR      Y AP
Sbjct: 168 KYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAP 220
Query: 271 EYVMTG-HLTARSDVYGFGVVLLEMLLGR 298
           E ++   H     D++  G ++ E+L GR
Sbjct: 221 EIMLNWMHYNMTVDIWSVGCIMAELLTGR 249

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 51/183 (27%), Positives = 84/183 (45%), Gaps = 27/183 (14%)
Query: 130 ELNRGGYQGD--------REWLAEVNYLGQLRHSNLVKLIGYCCEDEHRILVYEYMESGS 181
           + ++G Y  D         E   E++ L  L H N++KL     + ++  LV E+ E G 
Sbjct: 73  QFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGE 132
Query: 182 LEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILL---NADFSA 238
           L + ++ R            I      G+ +LH  +  +++RD K  NILL   N+  + 
Sbjct: 133 LFEQIINRHK--FDECDAANIMKQILSGICYLH--KHNIVHRDIKPENILLENKNSLLNI 188
Query: 239 KLSDFGL----AKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEM 294
           K+ DFGL    +KD  + D+       +GT  Y APE V+      + DV+  GV++  +
Sbjct: 189 KIVDFGLSSFFSKDYKLRDR-------LGTAYYIAPE-VLKKKYNEKCDVWSCGVIMYIL 240
Query: 295 LLG 297
           L G
Sbjct: 241 LCG 243

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 78/325 (24%), Positives = 143/325 (44%), Gaps = 51/325 (15%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSN-LV 158
           +G GG   V++ V++E  +  Y   +V ++E +       R  +A +N L Q  HS+ ++
Sbjct: 16  IGSGGSSKVFQ-VLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQ--HSDKII 71
Query: 159 KLIGYCCEDEHRILVYEYMESGSLE-KHLLRRVGCMLTWSRR--MKIALDAAKGLAFLHG 215
           +L  Y   D++   +Y  ME G+++    L++   +  W R+   K  L+A   +   HG
Sbjct: 72  RLYDYEITDQY---IYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTI-HQHG 127
Query: 216 AERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYV-- 273
               +++ D K +N L+  D   KL DFG+A        + V    +GT  Y  PE +  
Sbjct: 128 ----IVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKD 182
Query: 274 ---------MTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNK 324
                        ++ +SDV+  G +L  M  G+    +               ++N   
Sbjct: 183 MSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQ---------------IINQIS 227
Query: 325 KVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVA----LLET----VQS 376
           K+  I+DP  E ++       +  +   CL ++PK R  + +++A     ++T      +
Sbjct: 228 KLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQMA 287
Query: 377 QGAEEEMLQSGGGVVTLYEVPKLSS 401
           +G  EEM    G +V L  VP+ S+
Sbjct: 288 KGTTEEMKYVLGQLVGLNLVPRGSA 312

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 94/204 (46%), Gaps = 25/204 (12%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVK 159
           +GEG  G+V    I      G +   VA+K+++    Q       EV  +    H N+V 
Sbjct: 53  IGEGSTGIV---CIATEKHTGKQ---VAVKKMDLRKQQRRELLFNEVVIMRDYHHDNVVD 106
Query: 160 LIG-YCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRR-----MKIALDAAKGLAFL 213
           +   Y   DE  + V E++E G+L          ++T +R        + L   + L++L
Sbjct: 107 MYSSYLVGDELWV-VMEFLEGGALTD--------IVTHTRMNEEQIATVCLSVLRALSYL 157
Query: 214 HGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYV 273
           H   + VI+RD K+ +ILL +D   KLSDFG      +  +      ++GT  + APE +
Sbjct: 158 HN--QGVIHRDIKSDSILLTSDGRIKLSDFGFCAQ--VSKEVPKRKXLVGTPYWMAPEVI 213
Query: 274 MTGHLTARSDVYGFGVVLLEMLLG 297
                    D++  G++++EM+ G
Sbjct: 214 SRLPYGTEVDIWSLGIMVIEMIDG 237

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 93/204 (45%), Gaps = 19/204 (9%)
Query: 99  ILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGD--REWLAEVNYLGQLRHSN 156
           +LG+G FG V K   D   +  Y     A+K +N+   +       L EV  L +L H N
Sbjct: 29  MLGKGSFGEVLK-CKDRITQQEY-----AVKVINKASAKNKDTSTILREVELLKKLDHPN 82
Query: 157 LVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGA 216
           ++KL     +     +V E    G L   +++R     +     +I      G+ ++H  
Sbjct: 83  IMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKR--FSEHDAARIIKQVFSGITYMH-- 138
Query: 217 ERPVIYRDFKTSNILLNA---DFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYV 273
           +  +++RD K  NILL +   D   K+ DFGL+        T +  R+ GT  Y APE V
Sbjct: 139 KHNIVHRDLKPENILLESKEKDCDIKIIDFGLS--TCFQQNTKMKDRI-GTAYYIAPE-V 194
Query: 274 MTGHLTARSDVYGFGVVLLEMLLG 297
           + G    + DV+  GV+L  +L G
Sbjct: 195 LRGTYDEKCDVWSAGVILYILLSG 218

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 61/237 (25%), Positives = 96/237 (40%), Gaps = 56/237 (23%)
Query: 94  FRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLR 153
           F+   ++G GGFG V+K       R   KT    I+ +     + +RE    V  L +L 
Sbjct: 14  FKEIELIGSGGFGQVFKA----KHRIDGKT--YVIRRVKYNNEKAERE----VKALAKLD 63
Query: 154 HSNLVKLIGYCCED-------------------------------EHRILVYEYMESGSL 182
           H N+V   G  C D                               +   +  E+ + G+L
Sbjct: 64  HVNIVHYNG--CWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTL 121
Query: 183 EKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSD 242
           E+ + +R G  L     +++     KG+ ++H   + +I+RD K SNI L      K+ D
Sbjct: 122 EQWIEKRRGEKLDKVLALELFEQITKGVDYIHS--KKLIHRDLKPSNIFLVDTKQVKIGD 179
Query: 243 FGLA----KDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEML 295
           FGL      DG         TR  GT  Y +PE + +       D+Y  G++L E+L
Sbjct: 180 FGLVTSLKNDGK-------RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELL 229

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 69/288 (23%), Positives = 118/288 (40%), Gaps = 33/288 (11%)
Query: 99  ILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGD--REWLAEVNYLGQLRHSN 156
           +LG+G FG V +  + +      K   VA+K L           E+L E   + +  H +
Sbjct: 30  MLGKGEFGSVREAQLKQEDGSFVK---VAVKMLKADIIASSDIEEFLREAACMKEFDHPH 86
Query: 157 LVKLIGYCCEDEHR------ILVYEYMESGSLEKHLL-RRVG---CMLTWSRRMKIALDA 206
           + KL+G       +      +++  +M+ G L   LL  R+G     L     ++  +D 
Sbjct: 87  VAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDI 146
Query: 207 AKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYG 266
           A G+ +L  + R  I+RD    N +L  D +  ++DFGL++    GD             
Sbjct: 147 ACGMEYL--SSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVK 204
Query: 267 YAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKV 326
           + A E +     T  SDV+ FGV + E++        +R    +  +E        N ++
Sbjct: 205 WLALESLADNLYTVHSDVWAFGVTMWEIM--------TRGQTPYAGIE--------NAEI 248
Query: 327 LRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETV 374
              L      +       +V  L YQC S +PK RP  + +   LE +
Sbjct: 249 YNYLIGGNRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENI 296

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 81/344 (23%), Positives = 145/344 (42%), Gaps = 58/344 (16%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSN-LV 158
           +G GG   V++ V++E  +  Y   +V ++E +       R  +A +N L Q  HS+ ++
Sbjct: 64  IGSGGSSKVFQ-VLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQ--HSDKII 119
Query: 159 KLIGYCCEDEHRILVYEYMESGSLE-KHLLRRVGCMLTWSRR--MKIALDAAKGLAFLHG 215
           +L  Y   D++   +Y  ME G+++    L++   +  W R+   K  L+A   +   HG
Sbjct: 120 RLYDYEITDQY---IYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTI-HQHG 175
Query: 216 AERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYV-- 273
               +++ D K +N L+  D   KL DFG+A        + V    +GT  Y  PE +  
Sbjct: 176 ----IVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKD 230
Query: 274 ---------MTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNK 324
                        ++ +SDV+  G +L  M  G+    +               ++N   
Sbjct: 231 MSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQ---------------IINQIS 275
Query: 325 KVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVA----LLET----VQS 376
           K+  I+DP  E ++       +  +   CL ++PK R  + +++A     ++T      +
Sbjct: 276 KLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQMA 335
Query: 377 QGAEEEMLQSGGGVV-------TLYEVPKLSSHNSGDKKRNQSG 413
           +G  EEM    G +V        L     L  H SG +  N S 
Sbjct: 336 KGTTEEMKYVLGQLVGLNSPNSILKAAKTLYEHYSGGESHNSSS 379

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 50/161 (31%), Positives = 79/161 (49%), Gaps = 16/161 (9%)
Query: 144 AEVNYLGQLRHSNLVKLIGYCCEDEHRI-LVYEYMESGSLEKHLLRRVGCMLTWSRRMKI 202
            E   L  +R S  +  + Y  + E ++ L+ +Y+  G L  HL +R        R  + 
Sbjct: 107 TERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQR-------ERFTEH 159
Query: 203 ALDAAKG---LAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVST 259
            +    G   LA  H  +  +IYRD K  NILL+++    L+DFGL+K+  + D+T  + 
Sbjct: 160 EVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEF-VADETERAY 218
Query: 260 RVMGTYGYAAPEYVM---TGHLTARSDVYGFGVVLLEMLLG 297
              GT  Y AP+ V    +GH  A  D +  GV++ E+L G
Sbjct: 219 DFCGTIEYMAPDIVRGGDSGHDKA-VDWWSLGVLMYELLTG 258

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 67/285 (23%), Positives = 125/285 (43%), Gaps = 43/285 (15%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSN-LV 158
           +G GG   V++ V++E  +  Y   +V ++E +       R  +A +N L Q  HS+ ++
Sbjct: 64  IGSGGSSKVFQ-VLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQ--HSDKII 119
Query: 159 KLIGYCCEDEHRILVYEYMESGSLE-KHLLRRVGCMLTWSRR--MKIALDAAKGLAFLHG 215
           +L  Y   D++   +Y  ME G+++    L++   +  W R+   K  L+A   +   HG
Sbjct: 120 RLYDYEITDQY---IYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTI-HQHG 175
Query: 216 AERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYV-- 273
               +++ D K +N L+  D   KL DFG+A        + V    +GT  Y  PE +  
Sbjct: 176 ----IVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKD 230
Query: 274 ---------MTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNK 324
                        ++ +SDV+  G +L  M  G+    +               ++N   
Sbjct: 231 MSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQ---------------IINQIS 275
Query: 325 KVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVA 369
           K+  I+DP  E ++       +  +   CL ++PK R  + +++A
Sbjct: 276 KLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA 320

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 63/247 (25%), Positives = 113/247 (45%), Gaps = 37/247 (14%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVK 159
           LG GG G+V+  V ++  +       VAIK++     Q  +  L E+  + +L H N+VK
Sbjct: 19  LGCGGNGLVFSAVDNDCDKR------VAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVK 72
Query: 160 L--------------IGYCCEDEHRILVYEYMES---GSLEKHLLRRVGCMLTWSRRMKI 202
           +              +G   E     +V EYME+     LE+      G +L    R+  
Sbjct: 73  VFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQ------GPLLEEHARL-F 125
Query: 203 ALDAAKGLAFLHGAERPVIYRDFKTSNILLNA-DFSAKLSDFGLAK--DGPMGDQTHVST 259
                +GL ++H A   V++RD K +N+ +N  D   K+ DFGLA+  D     + H+S 
Sbjct: 126 MYQLLRGLKYIHSAN--VLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSE 183
Query: 260 RVMGTYGYAAPEYVMT-GHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARP 318
            ++ T  Y +P  +++  + T   D++  G +  EML G+     +    +  L+  + P
Sbjct: 184 GLV-TKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIP 242
Query: 319 LLNNNKK 325
           +++   +
Sbjct: 243 VVHEEDR 249

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 93/204 (45%), Gaps = 19/204 (9%)
Query: 99  ILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLA-EVNYLGQLRHSNL 157
           +LG G F  V   ++ E+ R       VAIK + +   +G    +  E+  L +++H N+
Sbjct: 25  VLGTGAFSEV---ILAEDKR---TQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNI 78
Query: 158 VKLIGYCCEDEHRILVYEYMESGSLEKHLLRR-VGCMLTWSRRMKIALDAAKGLAFLHGA 216
           V L        H  L+ + +  G L   ++ +        SR +   LDA K   +LH  
Sbjct: 79  VALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVK---YLH-- 133
Query: 217 ERPVIYRDFKTSNIL---LNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYV 273
           +  +++RD K  N+L   L+ D    +SDFGL+K   M D   V +   GT GY APE +
Sbjct: 134 DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSK---MEDPGSVLSTACGTPGYVAPEVL 190
Query: 274 MTGHLTARSDVYGFGVVLLEMLLG 297
                +   D +  GV+   +L G
Sbjct: 191 AQKPYSKAVDCWSIGVIAYILLCG 214

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 84/358 (23%), Positives = 152/358 (42%), Gaps = 62/358 (17%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSN-LV 158
           +G GG   V++ V++E  +  Y   +V ++E +       R  +A +N L Q  HS+ ++
Sbjct: 17  IGSGGSSKVFQ-VLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQ--HSDKII 72
Query: 159 KLIGYCCEDEHRILVYEYMESGSLE-KHLLRRVGCMLTWSRR--MKIALDAAKGLAFLHG 215
           +L  Y   D++   +Y  ME G+++    L++   +  W R+   K  L+A   +   HG
Sbjct: 73  RLYDYEITDQY---IYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTI-HQHG 128
Query: 216 AERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYV-- 273
               +++ D K +N L+  D   KL DFG+A        + V    +GT  Y  PE +  
Sbjct: 129 ----IVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKD 183
Query: 274 ---------MTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNK 324
                        ++ +SDV+  G +L  M  G+    +               ++N   
Sbjct: 184 MSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQ---------------IINQIS 228
Query: 325 KVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVA----LLET----VQS 376
           K+  I+DP  E ++       +  +   CL ++PK R  + +++A     ++T      +
Sbjct: 229 KLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQMA 288
Query: 377 QGAEEEMLQSGGGVV-------TLYEVPKLSSHNSGDKKRNQSGFSGSTEGESRRRNK 427
           +G  EEM    G +V        L     L  H SG +  N    S S++   ++R K
Sbjct: 289 KGTTEEMKYVLGQLVGLNSPNSILKAAKTLYEHYSGGESHN----SSSSKTFEKKRGK 342

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 57/213 (26%), Positives = 95/213 (44%), Gaps = 26/213 (12%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGG--YQGDREWLAEVNYLGQLRHSNL 157
           +G G +GVV       + R       VAIK++          +  L E+  L   +H N+
Sbjct: 63  IGNGAYGVV------SSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNI 116
Query: 158 VKL-------IGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGL 210
           + +       + Y  E +   +V + MES   + H +      LT            +GL
Sbjct: 117 IAIKDILRPTVPYG-EFKSVYVVLDLMES---DLHQIIHSSQPLTLEHVRYFLYQLLRGL 172
Query: 211 AFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAK---DGPMGDQTHVSTRVMGTYGY 267
            ++H A+  VI+RD K SN+L+N +   K+ DFG+A+     P  +  +  T  + T  Y
Sbjct: 173 KYMHSAQ--VIHRDLKPSNLLVNENCELKIGDFGMARGLCTSP-AEHQYFMTEYVATRWY 229
Query: 268 AAPEYVMTGH-LTARSDVYGFGVVLLEMLLGRR 299
            APE +++ H  T   D++  G +  EML  R+
Sbjct: 230 RAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQ 262

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 80/294 (27%), Positives = 132/294 (44%), Gaps = 54/294 (18%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQ--LRHSNL 157
           +G+G +G V++G+        +    VA+K  +    + ++ W  E        LRH N+
Sbjct: 16  VGKGRYGEVWRGL--------WHGESVAVKIFSS---RDEQSWFRETEIYNTVLLRHDNI 64
Query: 158 VKLIGYCCED-------EHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGL 210
              +G+   D           L+  Y E GSL   L R+    L     +++A+ AA GL
Sbjct: 65  ---LGFIASDMTSRNSSTQLWLITHYHEHGSLYDFLQRQT---LEPHLALRLAVSAACGL 118
Query: 211 AFLH----GAE-RPVI-YRDFKTSNILLNADFSAKLSDFGLAKDGPMG-DQTHV--STRV 261
           A LH    G + +P I +RDFK+ N+L+ ++    ++D GLA     G D   +  + RV
Sbjct: 119 AHLHVEIFGTQGKPAIAHRDFKSRNVLVKSNLQCCIADLGLAVMHSQGSDYLDIGNNPRV 178
Query: 262 MGTYGYAAPEYVMTGHLT------ARSDVYGFGVVLLEMLLGRRA-----VDKSRPSREH 310
            GT  Y APE +     T        +D++ FG+VL E  + RR      V+  RP   +
Sbjct: 179 -GTKRYMAPEVLDEQIRTDCFESYKWTDIWAFGLVLWE--IARRTIVNGIVEDYRPPF-Y 234
Query: 311 NLVEWARPLLNNNKKVLRI--LDPRLEGQYTARTAMK-VAGLAYQCLSQNPKGR 361
           ++V    P   + KKV+ +    P +  +  A   +  +A +  +C   NP  R
Sbjct: 235 DVVP-NDPSFEDMKKVVCVDQQTPTIPNRLAADPVLSGLAQMMRECWYPNPSAR 287

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 87/201 (43%), Gaps = 16/201 (7%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWL-AEVNYLGQLRHSNLV 158
           LG G FGVV++ V +      +   FV         ++ D+E +  E+  +  LRH  LV
Sbjct: 59  LGTGAFGVVHR-VTERATGNNFAAKFVMTP------HESDKETVRKEIQTMSVLRHPTLV 111
Query: 159 KLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAER 218
            L     +D   +++YE+M  G L + +      M +    ++      KGL  +H  E 
Sbjct: 112 NLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKM-SEDEAVEYMRQVCKGLCHMH--EN 168
Query: 219 PVIYRDFKTSNILLNADFS--AKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTG 276
             ++ D K  NI+     S   KL DFGL           V+T   GT  +AAPE     
Sbjct: 169 NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT---GTAEFAAPEVAEGK 225
Query: 277 HLTARSDVYGFGVVLLEMLLG 297
            +   +D++  GV+   +L G
Sbjct: 226 PVGYYTDMWSVGVLSYILLSG 246

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 87/201 (43%), Gaps = 16/201 (7%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWL-AEVNYLGQLRHSNLV 158
           LG G FGVV++ V +      +   FV         ++ D+E +  E+  +  LRH  LV
Sbjct: 165 LGTGAFGVVHR-VTERATGNNFAAKFVMTP------HESDKETVRKEIQTMSVLRHPTLV 217
Query: 159 KLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAER 218
            L     +D   +++YE+M  G L + +      M +    ++      KGL  +H  E 
Sbjct: 218 NLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKM-SEDEAVEYMRQVCKGLCHMH--EN 274
Query: 219 PVIYRDFKTSNILLNADFS--AKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTG 276
             ++ D K  NI+     S   KL DFGL           V+T   GT  +AAPE     
Sbjct: 275 NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT---GTAEFAAPEVAEGK 331
Query: 277 HLTARSDVYGFGVVLLEMLLG 297
            +   +D++  GV+   +L G
Sbjct: 332 PVGYYTDMWSVGVLSYILLSG 352

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 96/209 (45%), Gaps = 28/209 (13%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNR---GGYQGDREWLAEVNYLGQLRHSN 156
           +G G +G V       + + G++   VA+K+L+R         R +  E+  L  ++H N
Sbjct: 30  VGSGAYGSVCAAF---DTKTGHR---VAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHEN 82
Query: 157 LVKLI-----GYCCEDEHRILVYEYMESGSLEKHLLRRVGCM-LTWSRRMKIALDAAKGL 210
           ++ L+         E+ + + +  ++    L       V C  LT      +     +GL
Sbjct: 83  VIGLLDVFTPARSLEEFNDVYLVTHLMGADLNN----IVKCQKLTDDHVQFLIYQILRGL 138
Query: 211 AFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAP 270
            ++H A+  +I+RD K SN+ +N D   K+ DFGLA+        +V+TR      Y AP
Sbjct: 139 KYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAP 191
Query: 271 EYVMTG-HLTARSDVYGFGVVLLEMLLGR 298
           E ++   H     D++  G ++ E+L GR
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 96/209 (45%), Gaps = 28/209 (13%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNR---GGYQGDREWLAEVNYLGQLRHSN 156
           +G G +G V       + + G++   VA+K+L+R         R +  E+  L  ++H N
Sbjct: 40  VGSGAYGSVCAAF---DTKTGHR---VAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHEN 92
Query: 157 LVKLI-----GYCCEDEHRILVYEYMESGSLEKHLLRRVGCM-LTWSRRMKIALDAAKGL 210
           ++ L+         E+ + + +  ++    L       V C  LT      +     +GL
Sbjct: 93  VIGLLDVFTPARSLEEFNDVYLVTHLMGADLNN----IVKCQKLTDDHVQFLIYQILRGL 148
Query: 211 AFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAP 270
            ++H A+  +I+RD K SN+ +N D   K+ DFGLA+        +V+TR      Y AP
Sbjct: 149 KYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAP 201
Query: 271 EYVMTG-HLTARSDVYGFGVVLLEMLLGR 298
           E ++   H     D++  G ++ E+L GR
Sbjct: 202 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 230

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 60/228 (26%), Positives = 94/228 (41%), Gaps = 43/228 (18%)
Query: 98  YILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNR--GGYQGDREWLAEVNYLGQLRHS 155
           +++G G +G VY    D+N         VAIK++NR        +  L E+  L +L+  
Sbjct: 32  HLIGRGSYGYVYLAY-DKNTEKN-----VAIKKVNRMFEDLIDCKRILREITILNRLKSD 85
Query: 156 NLVKLIGYCCEDEHRIL--VYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFL 213
            +++L      D+      +Y  +E    +   L +    LT      I  +   G  F+
Sbjct: 86  YIIRLYDLIIPDDLLKFDELYIVLEIADSDLKKLFKTPIFLTEEHIKTILYNLLLGENFI 145
Query: 214 HGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKD-------------------GPMGDQ 254
           H  E  +I+RD K +N LLN D S K+ DFGLA+                    GP    
Sbjct: 146 H--ESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKN 203
Query: 255 ------THVSTRVMGTYGYAAPEYVMTG-HLTARSDVYGFGVVLLEML 295
                 +HV TR      Y APE ++   + T   D++  G +  E+L
Sbjct: 204 LKKQLTSHVVTR-----WYRAPELILLQENYTKSIDIWSTGCIFAELL 246

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 66/251 (26%), Positives = 106/251 (42%), Gaps = 33/251 (13%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDRE-----WLAEVNYLGQLRH 154
           +GEG +G V+K    E            I  L R     D E      L E+  L +L+H
Sbjct: 10  IGEGTYGTVFKAKNRETHE---------IVALKRVRLDDDDEGVPSSALREICLLKELKH 60
Query: 155 SNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLH 214
            N+V+L      D+   LV+E+ +   L+K+     G  L             KGL F H
Sbjct: 61  KNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNG-DLDPEIVKSFLFQLLKGLGFCH 118
Query: 215 GAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVM 274
              R V++RD K  N+L+N +   KL++FGLA+    G      +  + T  Y  P+ + 
Sbjct: 119 S--RNVLHRDLKPQNLLINRNGELKLANFGLAR--AFGIPVRCYSAEVVTLWYRPPDVLF 174
Query: 275 TGHLTARS-DVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRILDPR 333
              L + S D++  G +  E+       +  RP    N V+      +  K++ R+L   
Sbjct: 175 GAKLYSTSIDMWSAGCIFAEL------ANAGRPLFPGNDVD------DQLKRIFRLLGTP 222
Query: 334 LEGQYTARTAM 344
            E Q+ + T +
Sbjct: 223 TEEQWPSMTKL 233

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 96/209 (45%), Gaps = 28/209 (13%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNR---GGYQGDREWLAEVNYLGQLRHSN 156
           +G G +G V       + + G++   VA+K+L+R         R +  E+  L  ++H N
Sbjct: 49  VGSGAYGSVCAAF---DTKTGHR---VAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHEN 101
Query: 157 LVKLI-----GYCCEDEHRILVYEYMESGSLEKHLLRRVGCM-LTWSRRMKIALDAAKGL 210
           ++ L+         E+ + + +  ++    L       V C  LT      +     +GL
Sbjct: 102 VIGLLDVFTPARSLEEFNDVYLVTHLMGADLNN----IVKCQKLTDDHVQFLIYQILRGL 157
Query: 211 AFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAP 270
            ++H A+  +I+RD K SN+ +N D   K+ DFGLA+        +V+TR      Y AP
Sbjct: 158 KYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAP 210
Query: 271 EYVMTG-HLTARSDVYGFGVVLLEMLLGR 298
           E ++   H     D++  G ++ E+L GR
Sbjct: 211 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 239

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 99/203 (48%), Gaps = 21/203 (10%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVK 159
           LG G FG V++    ++ + G++    A+K++    ++     + E+     L    +V 
Sbjct: 80  LGRGSFGEVHR---MKDKQTGFQC---AVKKVRLEVFR-----VEELVACAGLSSPRIVP 128
Query: 160 LIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERP 219
           L G   E     +  E +E GSL + L++++GC L   R +     A +GL +LH   R 
Sbjct: 129 LYGAVREGPWVNIFMELLEGGSLGQ-LIKQMGC-LPEDRALYYLGQALEGLEYLH--TRR 184
Query: 220 VIYRDFKTSNILLNADFS-AKLSDFG----LAKDGPMGDQTHVSTRVMGTYGYAAPEYVM 274
           +++ D K  N+LL++D S A L DFG    L  DG +G        + GT  + APE VM
Sbjct: 185 ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDG-LGKSLLTGDYIPGTETHMAPEVVM 243
Query: 275 TGHLTARSDVYGFGVVLLEMLLG 297
                A+ D++    ++L ML G
Sbjct: 244 GKPCDAKVDIWSSCCMMLHMLNG 266

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 67/285 (23%), Positives = 125/285 (43%), Gaps = 43/285 (15%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSN-LV 158
           +G GG   V++ V++E  +  Y   +V ++E +       R  +A +N L Q  HS+ ++
Sbjct: 20  IGSGGSSKVFQ-VLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQ--HSDKII 75
Query: 159 KLIGYCCEDEHRILVYEYMESGSLE-KHLLRRVGCMLTWSRR--MKIALDAAKGLAFLHG 215
           +L  Y   D++   +Y  ME G+++    L++   +  W R+   K  L+A   +   HG
Sbjct: 76  RLYDYEITDQY---IYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTI-HQHG 131
Query: 216 AERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYV-- 273
               +++ D K +N L+  D   KL DFG+A        + V    +GT  Y  PE +  
Sbjct: 132 ----IVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKD 186
Query: 274 ---------MTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNK 324
                        ++ +SDV+  G +L  M  G+    +               ++N   
Sbjct: 187 MSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQ---------------IINQIS 231
Query: 325 KVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVA 369
           K+  I+DP  E ++       +  +   CL ++PK R  + +++A
Sbjct: 232 KLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA 276

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 96/209 (45%), Gaps = 28/209 (13%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNR---GGYQGDREWLAEVNYLGQLRHSN 156
           +G G +G V       + + G++   VA+K+L+R         R +  E+  L  ++H N
Sbjct: 50  VGSGAYGSVCAAF---DTKTGHR---VAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHEN 102
Query: 157 LVKLI-----GYCCEDEHRILVYEYMESGSLEKHLLRRVGCM-LTWSRRMKIALDAAKGL 210
           ++ L+         E+ + + +  ++    L       V C  LT      +     +GL
Sbjct: 103 VIGLLDVFTPARSLEEFNDVYLVTHLMGADLNN----IVKCQKLTDDHVQFLIYQILRGL 158
Query: 211 AFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAP 270
            ++H A+  +I+RD K SN+ +N D   K+ DFGLA+        +V+TR      Y AP
Sbjct: 159 KYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAP 211
Query: 271 EYVMTG-HLTARSDVYGFGVVLLEMLLGR 298
           E ++   H     D++  G ++ E+L GR
Sbjct: 212 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 96/209 (45%), Gaps = 28/209 (13%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNR---GGYQGDREWLAEVNYLGQLRHSN 156
           +G G +G V       + + G++   VA+K+L+R         R +  E+  L  ++H N
Sbjct: 36  VGSGAYGSVCAAF---DTKTGHR---VAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHEN 88
Query: 157 LVKLI-----GYCCEDEHRILVYEYMESGSLEKHLLRRVGCM-LTWSRRMKIALDAAKGL 210
           ++ L+         E+ + + +  ++    L       V C  LT      +     +GL
Sbjct: 89  VIGLLDVFTPARSLEEFNDVYLVTHLMGADLNN----IVKCQKLTDDHVQFLIYQILRGL 144
Query: 211 AFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAP 270
            ++H A+  +I+RD K SN+ +N D   K+ DFGLA+        +V+TR      Y AP
Sbjct: 145 KYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAP 197
Query: 271 EYVMTG-HLTARSDVYGFGVVLLEMLLGR 298
           E ++   H     D++  G ++ E+L GR
Sbjct: 198 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 96/209 (45%), Gaps = 28/209 (13%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNR---GGYQGDREWLAEVNYLGQLRHSN 156
           +G G +G V       + + G++   VA+K+L+R         R +  E+  L  ++H N
Sbjct: 26  VGSGAYGSVCAAF---DTKTGHR---VAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHEN 78
Query: 157 LVKLI-----GYCCEDEHRILVYEYMESGSLEKHLLRRVGCM-LTWSRRMKIALDAAKGL 210
           ++ L+         E+ + + +  ++    L       V C  LT      +     +GL
Sbjct: 79  VIGLLDVFTPARSLEEFNDVYLVTHLMGADLNN----IVKCQKLTDDHVQFLIYQILRGL 134
Query: 211 AFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAP 270
            ++H A+  +I+RD K SN+ +N D   K+ DFGLA+        +V+TR      Y AP
Sbjct: 135 KYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAP 187
Query: 271 EYVMTG-HLTARSDVYGFGVVLLEMLLGR 298
           E ++   H     D++  G ++ E+L GR
Sbjct: 188 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 48/167 (28%), Positives = 76/167 (45%), Gaps = 25/167 (14%)
Query: 201 KIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTR 260
           KIA+   K L  LH ++  VI+RD K SN+L+NA    K+ DFG++  G + D       
Sbjct: 113 KIAVSIVKALEHLH-SKLSVIHRDVKPSNVLINALGQVKMCDFGIS--GYLVDDVAKDID 169
Query: 261 VMGTYGYAAPEYV-----MTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEW 315
             G   Y APE +       G+ + +SD++  G+ ++E+ + R   D            W
Sbjct: 170 A-GCKPYMAPERINPELNQKGY-SVKSDIWSLGITMIELAILRFPYD-----------SW 216
Query: 316 ARPLLNNNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRP 362
             P     K+V+    P+L      + + +      QCL +N K RP
Sbjct: 217 GTP-FQQLKQVVEEPSPQLPAD---KFSAEFVDFTSQCLKKNSKERP 259

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 48/180 (26%), Positives = 82/180 (45%), Gaps = 10/180 (5%)
Query: 126 VAIKELNRGGYQGD--REWLAEVNYLGQLRHSNLVKLIGYCCEDEHRILVYEYMESGSLE 183
           VA+K +++        ++   EV  +  L H N+VKL      ++   LV EY   G + 
Sbjct: 42  VAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVF 101
Query: 184 KHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDF 243
            +L+   G M     R K        + + H  ++ +++RD K  N+LL+AD + K++DF
Sbjct: 102 DYLVAH-GRMKEKEARAKFR-QIVSAVQYCH--QKFIVHRDLKAENLLLDADMNIKIADF 157
Query: 244 GLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTA-RSDVYGFGVVLLEMLLGRRAVD 302
           G + +   G++        G+  YAAPE            DV+  GV+L  ++ G    D
Sbjct: 158 GFSNEFTFGNKLDT---FCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 93/204 (45%), Gaps = 19/204 (9%)
Query: 99  ILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLA-EVNYLGQLRHSNL 157
           +LG G F  V   ++ E+ R       VAIK + +   +G    +  E+  L +++H N+
Sbjct: 25  VLGTGAFSEV---ILAEDKR---TQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNI 78
Query: 158 VKLIGYCCEDEHRILVYEYMESGSLEKHLLRR-VGCMLTWSRRMKIALDAAKGLAFLHGA 216
           V L        H  L+ + +  G L   ++ +        SR +   LDA K   +LH  
Sbjct: 79  VALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVK---YLH-- 133
Query: 217 ERPVIYRDFKTSNIL---LNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYV 273
           +  +++RD K  N+L   L+ D    +SDFGL+K   M D   V +   GT GY APE +
Sbjct: 134 DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSK---MEDPGSVLSTACGTPGYVAPEVL 190
Query: 274 MTGHLTARSDVYGFGVVLLEMLLG 297
                +   D +  GV+   +L G
Sbjct: 191 AQKPYSKAVDCWSIGVIAYILLCG 214

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 48/180 (26%), Positives = 82/180 (45%), Gaps = 10/180 (5%)
Query: 126 VAIKELNRGGYQGD--REWLAEVNYLGQLRHSNLVKLIGYCCEDEHRILVYEYMESGSLE 183
           VA+K +++        ++   EV  +  L H N+VKL      ++   LV EY   G + 
Sbjct: 42  VAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVF 101
Query: 184 KHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDF 243
            +L+   G M     R K        + + H  ++ +++RD K  N+LL+AD + K++DF
Sbjct: 102 DYLVAH-GRMKEKEARAKFR-QIVSAVQYCH--QKFIVHRDLKAENLLLDADMNIKIADF 157
Query: 244 GLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTA-RSDVYGFGVVLLEMLLGRRAVD 302
           G + +   G++        G+  YAAPE            DV+  GV+L  ++ G    D
Sbjct: 158 GFSNEFTFGNKLDT---FCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 93/204 (45%), Gaps = 19/204 (9%)
Query: 99  ILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGD--REWLAEVNYLGQLRHSN 156
           +LG+G FG V K   D   +  Y     A+K +N+   +       L EV  L +L H N
Sbjct: 29  MLGKGSFGEVLK-CKDRITQQEY-----AVKVINKASAKNKDTSTILREVELLKKLDHPN 82
Query: 157 LVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGA 216
           ++KL     +     +V E    G L   +++R     +     +I      G+ ++H  
Sbjct: 83  IMKLFEILEDSSSFYIVGELYTGGELFDEIIKRK--RFSEHDAARIIKQVFSGITYMH-- 138
Query: 217 ERPVIYRDFKTSNILLNA---DFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYV 273
           +  +++RD K  NILL +   D   K+ DFGL+        T +  R+ GT  Y APE V
Sbjct: 139 KHNIVHRDLKPENILLESKEKDCDIKIIDFGLS--TCFQQNTKMKDRI-GTAYYIAPE-V 194
Query: 274 MTGHLTARSDVYGFGVVLLEMLLG 297
           + G    + DV+  GV+L  +L G
Sbjct: 195 LRGTYDEKCDVWSAGVILYILLSG 218

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 97/209 (46%), Gaps = 29/209 (13%)
Query: 100 LGEGGFGVVYKGVIDENVRPG--YKTTFVAIKELNRGGYQG-DREWLAEVNYLGQLRHSN 156
           LG+G F VV + V    V  G  Y    +  K+L+   +Q  +RE  A +  L  L+H N
Sbjct: 30  LGKGAFSVVRRCV---KVLAGQEYAAKIINTKKLSARDHQKLERE--ARICRL--LKHPN 82
Query: 157 LVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGL-----A 211
           +V+L     E+ H  L+++ +  G L + ++         +R      DA+  +     A
Sbjct: 83  IVRLHDSISEEGHHYLIFDLVTGGELFEDIV---------AREYYSEADASHCIQQILEA 133
Query: 212 FLHGAERPVIYRDFKTSNILLNADF---SAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYA 268
            LH  +  V++RD K  N+LL +     + KL+DFGLA +     Q        GT GY 
Sbjct: 134 VLHCHQMGVVHRDLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFG--FAGTPGYL 191
Query: 269 APEYVMTGHLTARSDVYGFGVVLLEMLLG 297
           +PE +         D++  GV+L  +L+G
Sbjct: 192 SPEVLRKDPYGKPVDLWACGVILYILLVG 220

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 57/213 (26%), Positives = 95/213 (44%), Gaps = 26/213 (12%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGG--YQGDREWLAEVNYLGQLRHSNL 157
           +G G +GVV       + R       VAIK++          +  L E+  L   +H N+
Sbjct: 62  IGNGAYGVV------SSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNI 115
Query: 158 VKL-------IGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGL 210
           + +       + Y  E +   +V + MES   + H +      LT            +GL
Sbjct: 116 IAIKDILRPTVPYG-EFKSVYVVLDLMES---DLHQIIHSSQPLTLEHVRYFLYQLLRGL 171
Query: 211 AFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAK---DGPMGDQTHVSTRVMGTYGY 267
            ++H A+  VI+RD K SN+L+N +   K+ DFG+A+     P  +  +  T  + T  Y
Sbjct: 172 KYMHSAQ--VIHRDLKPSNLLVNENCELKIGDFGMARGLCTSP-AEHQYFMTEYVATRWY 228
Query: 268 AAPEYVMTGH-LTARSDVYGFGVVLLEMLLGRR 299
            APE +++ H  T   D++  G +  EML  R+
Sbjct: 229 RAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQ 261

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 95/209 (45%), Gaps = 28/209 (13%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNR---GGYQGDREWLAEVNYLGQLRHSN 156
           +G G +G V       + + G +   VA+K+L+R         R +  E+  L  ++H N
Sbjct: 30  VGSGAYGSVCAAF---DTKTGLR---VAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHEN 82
Query: 157 LVKLI-----GYCCEDEHRILVYEYMESGSLEKHLLRRVGCM-LTWSRRMKIALDAAKGL 210
           ++ L+         E+ + + +  ++    L       V C  LT      +     +GL
Sbjct: 83  VIGLLDVFTPARSLEEFNDVYLVTHLMGADLNN----IVKCQKLTDDHVQFLIYQILRGL 138
Query: 211 AFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAP 270
            ++H A+  +I+RD K SN+ +N D   K+ DFGLA+        +V+TR      Y AP
Sbjct: 139 KYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAP 191
Query: 271 EYVMTG-HLTARSDVYGFGVVLLEMLLGR 298
           E ++   H     D++  G ++ E+L GR
Sbjct: 192 EIMLNAMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 93/204 (45%), Gaps = 19/204 (9%)
Query: 99  ILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGD--REWLAEVNYLGQLRHSN 156
           +LG+G FG V K   D   +  Y     A+K +N+   +       L EV  L +L H N
Sbjct: 29  MLGKGSFGEVLK-CKDRITQQEY-----AVKVINKASAKNKDTSTILREVELLKKLDHPN 82
Query: 157 LVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGA 216
           ++KL     +     +V E    G L   +++R     +     +I      G+ ++H  
Sbjct: 83  IMKLFEILEDSSSFYIVGELYTGGELFDEIIKRK--RFSEHDAARIIKQVFSGITYMH-- 138
Query: 217 ERPVIYRDFKTSNILLNA---DFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYV 273
           +  +++RD K  NILL +   D   K+ DFGL+        T +  R+ GT  Y APE V
Sbjct: 139 KHNIVHRDLKPENILLESKEKDCDIKIIDFGLS--TCFQQNTKMKDRI-GTAYYIAPE-V 194
Query: 274 MTGHLTARSDVYGFGVVLLEMLLG 297
           + G    + DV+  GV+L  +L G
Sbjct: 195 LRGTYDEKCDVWSAGVILYILLSG 218

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 45/159 (28%), Positives = 73/159 (45%), Gaps = 8/159 (5%)
Query: 145 EVNYLGQLRHSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIAL 204
           EV  +  L H N+VKL      ++   LV EY   G +  +L+   G M     R K   
Sbjct: 56  EVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAH-GWMKEKEARAKFR- 113
Query: 205 DAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGT 264
                + + H  ++ +++RD K  N+LL+AD + K++DFG + +   G++        G+
Sbjct: 114 QIVSAVQYCH--QKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFC---GS 168
Query: 265 YGYAAPEYVMTGHLTA-RSDVYGFGVVLLEMLLGRRAVD 302
             YAAPE            DV+  GV+L  ++ G    D
Sbjct: 169 PPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 207

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 93/204 (45%), Gaps = 19/204 (9%)
Query: 99  ILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLA-EVNYLGQLRHSNL 157
           +LG G F  V   ++ E+ R       VAIK + +   +G    +  E+  L +++H N+
Sbjct: 25  VLGTGAFSEV---ILAEDKR---TQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNI 78
Query: 158 VKLIGYCCEDEHRILVYEYMESGSLEKHLLRR-VGCMLTWSRRMKIALDAAKGLAFLHGA 216
           V L        H  L+ + +  G L   ++ +        SR +   LDA K   +LH  
Sbjct: 79  VALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVK---YLH-- 133
Query: 217 ERPVIYRDFKTSNIL---LNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYV 273
           +  +++RD K  N+L   L+ D    +SDFGL+K   M D   V +   GT GY APE +
Sbjct: 134 DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSK---MEDPGSVLSTACGTPGYVAPEVL 190
Query: 274 MTGHLTARSDVYGFGVVLLEMLLG 297
                +   D +  GV+   +L G
Sbjct: 191 AQKPYSKAVDCWSIGVIAYILLCG 214

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 93/204 (45%), Gaps = 19/204 (9%)
Query: 99  ILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLA-EVNYLGQLRHSNL 157
           +LG G F  V   ++ E+ R       VAIK + +   +G    +  E+  L +++H N+
Sbjct: 25  VLGTGAFSEV---ILAEDKR---TQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNI 78
Query: 158 VKLIGYCCEDEHRILVYEYMESGSLEKHLLRR-VGCMLTWSRRMKIALDAAKGLAFLHGA 216
           V L        H  L+ + +  G L   ++ +        SR +   LDA K   +LH  
Sbjct: 79  VALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVK---YLH-- 133
Query: 217 ERPVIYRDFKTSNIL---LNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYV 273
           +  +++RD K  N+L   L+ D    +SDFGL+K   M D   V +   GT GY APE +
Sbjct: 134 DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSK---MEDPGSVLSTACGTPGYVAPEVL 190
Query: 274 MTGHLTARSDVYGFGVVLLEMLLG 297
                +   D +  GV+   +L G
Sbjct: 191 AQKPYSKAVDCWSIGVIAYILLCG 214

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 45/159 (28%), Positives = 73/159 (45%), Gaps = 8/159 (5%)
Query: 145 EVNYLGQLRHSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIAL 204
           EV  +  L H N+VKL      ++   LV EY   G +  +L+   G M     R K   
Sbjct: 63  EVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAH-GRMKEKEARAKFR- 120
Query: 205 DAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGT 264
                + + H  ++ +++RD K  N+LL+AD + K++DFG + +   G++        G+
Sbjct: 121 QIVSAVQYCH--QKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKL---DEFCGS 175
Query: 265 YGYAAPEYVMTGHLTA-RSDVYGFGVVLLEMLLGRRAVD 302
             YAAPE            DV+  GV+L  ++ G    D
Sbjct: 176 PPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 45/159 (28%), Positives = 73/159 (45%), Gaps = 8/159 (5%)
Query: 145 EVNYLGQLRHSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIAL 204
           EV  +  L H N+VKL      ++   LV EY   G +  +L+   G M     R K   
Sbjct: 63  EVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAH-GRMKEKEARAKFR- 120
Query: 205 DAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGT 264
                + + H  ++ +++RD K  N+LL+AD + K++DFG + +   G++        G+
Sbjct: 121 QIVSAVQYCH--QKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDT---FCGS 175
Query: 265 YGYAAPEYVMTGHLTA-RSDVYGFGVVLLEMLLGRRAVD 302
             YAAPE            DV+  GV+L  ++ G    D
Sbjct: 176 PPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 95/209 (45%), Gaps = 28/209 (13%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNR---GGYQGDREWLAEVNYLGQLRHSN 156
           +G G +G V       + + G +   VA+K+L+R         R +  E+  L  ++H N
Sbjct: 35  IGSGAYGSVCAAF---DTKTGLR---VAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHEN 87
Query: 157 LVKLI-----GYCCEDEHRILVYEYMESGSLEKHLLRRVGCM-LTWSRRMKIALDAAKGL 210
           ++ L+         E+ + + +  ++    L       V C  LT      +     +GL
Sbjct: 88  VIGLLDVFTPARSLEEFNDVYLVTHLMGADLNN----IVKCQKLTDDHVQFLIYQILRGL 143
Query: 211 AFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAP 270
            ++H A+  +I+RD K SN+ +N D   K+ DFGLA+        +V+TR      Y AP
Sbjct: 144 KYIHSAD--IIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMTGYVATR-----WYRAP 196
Query: 271 EYVMTG-HLTARSDVYGFGVVLLEMLLGR 298
           E ++   H     D++  G ++ E+L GR
Sbjct: 197 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 93/208 (44%), Gaps = 32/208 (15%)
Query: 100 LGEGGFGVV---YKGVIDENVRPGYKTTFVAIKELNR---GGYQGDREWLAEVNYLGQLR 153
           +G G  G+V   Y  V+D NV         AIK+L+R         R +  E+  +  + 
Sbjct: 32  IGSGAQGIVCAAYDAVLDRNV---------AIKKLSRPFQNQTHAKRAY-RELVLMKXVN 81
Query: 154 HSNLVKLIGYCC------EDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAA 207
           H N++ L+          E +   LV E M++      L + +   L   R   +     
Sbjct: 82  HKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN-----LXQVIQMELDHERMSYLLYQML 136
Query: 208 KGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGY 267
            G+  LH A   +I+RD K SNI++ +D + K+ DFGLA+    G    ++  V+  Y Y
Sbjct: 137 XGIKHLHSAG--IIHRDLKPSNIVVKSDXTLKILDFGLARTA--GTSFMMTPYVVTRY-Y 191
Query: 268 AAPEYVMTGHLTARSDVYGFGVVLLEML 295
            APE ++        D++  G ++ EM+
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMV 219

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 67/285 (23%), Positives = 125/285 (43%), Gaps = 43/285 (15%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSN-LV 158
           +G GG   V++ V++E  +  Y   +V ++E +       R  +A +N L Q  HS+ ++
Sbjct: 36  IGSGGSSKVFQ-VLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQ--HSDKII 91
Query: 159 KLIGYCCEDEHRILVYEYMESGSLE-KHLLRRVGCMLTWSRR--MKIALDAAKGLAFLHG 215
           +L  Y   D++   +Y  ME G+++    L++   +  W R+   K  L+A   +   HG
Sbjct: 92  RLYDYEITDQY---IYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTI-HQHG 147
Query: 216 AERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYV-- 273
               +++ D K +N L+  D   KL DFG+A        + V    +GT  Y  PE +  
Sbjct: 148 ----IVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKD 202
Query: 274 ---------MTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNK 324
                        ++ +SDV+  G +L  M  G+    +               ++N   
Sbjct: 203 MSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQ---------------IINQIS 247
Query: 325 KVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVA 369
           K+  I+DP  E ++       +  +   CL ++PK R  + +++A
Sbjct: 248 KLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA 292

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 61/241 (25%), Positives = 107/241 (44%), Gaps = 36/241 (14%)
Query: 71  RQNPGYSNVDIFTYNEMKLATKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKE 130
           R+N  +    +F  +   + +  ++   +LG+G FG V   ++ ++   G +     I +
Sbjct: 11  RENLYFQGPGMFVQHSTAIFSDRYKGQRVLGKGSFGEV---ILCKDKITGQECAVKVISK 67
Query: 131 LNRGGYQGDREWLAEVNYLGQLRHSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRV 190
                       L EV  L QL H N++KL  +  +  +  LV E    G L   ++   
Sbjct: 68  RQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEII--- 124
Query: 191 GCMLTWSRRMKIALDAAK-------GLAFLHGAERPVIYRDFKTSNILLNA---DFSAKL 240
                 SR+    +DAA+       G+ ++H  +  +++RD K  N+LL +   D + ++
Sbjct: 125 ------SRKRFSEVDAARIIRQVLSGITYMH--KNKIVHRDLKPENLLLESKSKDANIRI 176
Query: 241 SDFGLAK----DGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLL 296
            DFGL+        M D+       +GT  Y APE V+ G    + DV+  GV+L  +L 
Sbjct: 177 IDFGLSTHFEASKKMKDK-------IGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLS 228
Query: 297 G 297
           G
Sbjct: 229 G 229

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 96/209 (45%), Gaps = 28/209 (13%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNR---GGYQGDREWLAEVNYLGQLRHSN 156
           +G G +G V       + + G++   VA+K+L+R         R +  E+  L  ++H N
Sbjct: 26  VGSGAYGSVCAAF---DTKTGHR---VAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHEN 78
Query: 157 LVKLI-----GYCCEDEHRILVYEYMESGSLEKHLLRRVGCM-LTWSRRMKIALDAAKGL 210
           ++ L+         E+ + + +  ++    L       V C  LT      +     +GL
Sbjct: 79  VIGLLDVFTPARSLEEFNDVYLVTHLMGADLNN----IVKCAKLTDDHVQFLIYQILRGL 134
Query: 211 AFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAP 270
            ++H A+  +I+RD K SN+ +N D   K+ DFGLA+        +V+TR      Y AP
Sbjct: 135 KYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAP 187
Query: 271 EYVMTG-HLTARSDVYGFGVVLLEMLLGR 298
           E ++   H     D++  G ++ E+L GR
Sbjct: 188 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 99/218 (45%), Gaps = 25/218 (11%)
Query: 94  FRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGG------YQGDRE-WLAEV 146
           + P  ILG G   VV + +     +P  K   V I ++  GG       Q  RE  L EV
Sbjct: 19  YEPKEILGRGVSSVVRRCI----HKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEV 74
Query: 147 NYLGQLR-HSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALD 205
           + L ++  H N+++L      +    LV++ M+ G L  +L  +V      +R++  AL 
Sbjct: 75  DILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRAL- 133
Query: 206 AAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTY 265
             + +  LH     +++RD K  NILL+ D + KL+DFG +     G++      V GT 
Sbjct: 134 -LEVICALHKLN--IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLR---EVCGTP 187
Query: 266 GYAAPEYVMTGH------LTARSDVYGFGVVLLEMLLG 297
            Y APE +               D++  GV++  +L G
Sbjct: 188 SYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG 225

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 95/209 (45%), Gaps = 28/209 (13%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNR---GGYQGDREWLAEVNYLGQLRHSN 156
           +G G +G V       + + G +   VA+K+L+R         R +  E+  L  ++H N
Sbjct: 37  VGSGAYGSVCAAF---DTKTGLR---VAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHEN 89
Query: 157 LVKLI-----GYCCEDEHRILVYEYMESGSLEKHLLRRVGCM-LTWSRRMKIALDAAKGL 210
           ++ L+         E+ + + +  ++    L       V C  LT      +     +GL
Sbjct: 90  VIGLLDVFTPARSLEEFNDVYLVTHLMGADLNN----IVKCQKLTDDHVQFLIYQILRGL 145
Query: 211 AFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAP 270
            ++H A+  +I+RD K SN+ +N D   K+ DFGLA+        +V+TR      Y AP
Sbjct: 146 KYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYVATR-----WYRAP 198
Query: 271 EYVMTG-HLTARSDVYGFGVVLLEMLLGR 298
           E ++   H     D++  G ++ E+L GR
Sbjct: 199 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 99/218 (45%), Gaps = 25/218 (11%)
Query: 94  FRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGG------YQGDRE-WLAEV 146
           + P  ILG G   VV + +     +P  K   V I ++  GG       Q  RE  L EV
Sbjct: 6   YEPKEILGRGVSSVVRRCI----HKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEV 61
Query: 147 NYLGQLR-HSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALD 205
           + L ++  H N+++L      +    LV++ M+ G L  +L  +V      +R++  AL 
Sbjct: 62  DILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRAL- 120
Query: 206 AAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTY 265
             + +  LH     +++RD K  NILL+ D + KL+DFG +     G++      V GT 
Sbjct: 121 -LEVICALHKLN--IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLR---EVCGTP 174
Query: 266 GYAAPEYVMTGH------LTARSDVYGFGVVLLEMLLG 297
            Y APE +               D++  GV++  +L G
Sbjct: 175 SYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG 212

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 95/209 (45%), Gaps = 28/209 (13%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNR---GGYQGDREWLAEVNYLGQLRHSN 156
           +G G +G V       + + G +   VA+K+L+R         R +  E+  L  ++H N
Sbjct: 35  VGSGAYGSVCAAF---DTKTGLR---VAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHEN 87
Query: 157 LVKLI-----GYCCEDEHRILVYEYMESGSLEKHLLRRVGCM-LTWSRRMKIALDAAKGL 210
           ++ L+         E+ + + +  ++    L       V C  LT      +     +GL
Sbjct: 88  VIGLLDVFTPARSLEEFNDVYLVTHLMGADLNN----IVKCQKLTDDHVQFLIYQILRGL 143
Query: 211 AFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAP 270
            ++H A+  +I+RD K SN+ +N D   K+ DFGLA+        +V+TR      Y AP
Sbjct: 144 KYIHSAD--IIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMTGYVATR-----WYRAP 196
Query: 271 EYVMTG-HLTARSDVYGFGVVLLEMLLGR 298
           E ++   H     D++  G ++ E+L GR
Sbjct: 197 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 95/209 (45%), Gaps = 28/209 (13%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNR---GGYQGDREWLAEVNYLGQLRHSN 156
           +G G +G V       + + G +   VA+K+L+R         R +  E+  L  ++H N
Sbjct: 30  VGSGAYGSVCAAF---DTKTGLR---VAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHEN 82
Query: 157 LVKLI-----GYCCEDEHRILVYEYMESGSLEKHLLRRVGCM-LTWSRRMKIALDAAKGL 210
           ++ L+         E+ + + +  ++    L       V C  LT      +     +GL
Sbjct: 83  VIGLLDVFTPARSLEEFNDVYLVTHLMGADLNN----IVKCQKLTDDHVQFLIYQILRGL 138
Query: 211 AFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAP 270
            ++H A+  +I+RD K SN+ +N D   K+ DFGLA+        +V+TR      Y AP
Sbjct: 139 KYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAP 191
Query: 271 EYVMTG-HLTARSDVYGFGVVLLEMLLGR 298
           E ++   H     D++  G ++ E+L GR
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 95/209 (45%), Gaps = 28/209 (13%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNR---GGYQGDREWLAEVNYLGQLRHSN 156
           +G G +G V       + + G +   VA+K+L+R         R +  E+  L  ++H N
Sbjct: 30  VGSGAYGSVCAAF---DTKTGLR---VAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHEN 82
Query: 157 LVKLI-----GYCCEDEHRILVYEYMESGSLEKHLLRRVGCM-LTWSRRMKIALDAAKGL 210
           ++ L+         E+ + + +  ++    L       V C  LT      +     +GL
Sbjct: 83  VIGLLDVFTPARSLEEFNDVYLVTHLMGADLNN----IVKCQKLTDDHVQFLIYQILRGL 138
Query: 211 AFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAP 270
            ++H A+  +I+RD K SN+ +N D   K+ DFGLA+        +V+TR      Y AP
Sbjct: 139 KYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAP 191
Query: 271 EYVMTG-HLTARSDVYGFGVVLLEMLLGR 298
           E ++   H     D++  G ++ E+L GR
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 95/209 (45%), Gaps = 28/209 (13%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNR---GGYQGDREWLAEVNYLGQLRHSN 156
           +G G +G V       + + G +   VA+K+L+R         R +  E+  L  ++H N
Sbjct: 37  VGSGAYGSVCAAF---DTKTGLR---VAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHEN 89
Query: 157 LVKLI-----GYCCEDEHRILVYEYMESGSLEKHLLRRVGCM-LTWSRRMKIALDAAKGL 210
           ++ L+         E+ + + +  ++    L       V C  LT      +     +GL
Sbjct: 90  VIGLLDVFTPARSLEEFNDVYLVTHLMGADLNN----IVKCQKLTDDHVQFLIYQILRGL 145
Query: 211 AFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAP 270
            ++H A+  +I+RD K SN+ +N D   K+ DFGLA+        +V+TR      Y AP
Sbjct: 146 KYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYVATR-----WYRAP 198
Query: 271 EYVMTG-HLTARSDVYGFGVVLLEMLLGR 298
           E ++   H     D++  G ++ E+L GR
Sbjct: 199 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 76/285 (26%), Positives = 119/285 (41%), Gaps = 53/285 (18%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWL-AEVNYLGQLRHSNLV 158
           LG G FG V+   + E    G +     IK +N+   Q   E + AE+  L  L H N++
Sbjct: 30  LGSGAFGDVH---LVEERSSGLERV---IKTINKDRSQVPMEQIEAEIEVLKSLDHPNII 83
Query: 159 KLIGYCCEDEHRI-LVYEYMESGSLEKHLL--RRVGCMLTWSRRMKIALDAAKGLAFLHG 215
           K+     ED H + +V E  E G L + ++  +  G  L+     ++       LA+ H 
Sbjct: 84  KIFE-VFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHS 142
Query: 216 AERPVIYRDFKTSNILLNADFS----AKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPE 271
             + V+++D K  NIL   D S     K+ DFGLA+   +      ST   GT  Y APE
Sbjct: 143 --QHVVHKDLKPENILFQ-DTSPHSPIKIIDFGLAE---LFKSDEHSTNAAGTALYMAPE 196
Query: 272 YVMTGHLTARSDVYGFGVVLLEMLLG--------RRAVDKSRPSREHNLVEWARPLLNNN 323
            V    +T + D++  GVV+  +L G           V +    +E N     RPL    
Sbjct: 197 -VFKRDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVECRPLTPQA 255
Query: 324 KKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVV 368
             +L+                       Q L+++P+ RP  + V+
Sbjct: 256 VDLLK-----------------------QMLTKDPERRPSAAQVL 277

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 95/209 (45%), Gaps = 28/209 (13%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNR---GGYQGDREWLAEVNYLGQLRHSN 156
           +G G +G V       + + G +   VA+K+L+R         R +  E+  L  ++H N
Sbjct: 37  VGSGAYGSVCAAF---DTKTGLR---VAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHEN 89
Query: 157 LVKLI-----GYCCEDEHRILVYEYMESGSLEKHLLRRVGCM-LTWSRRMKIALDAAKGL 210
           ++ L+         E+ + + +  ++    L       V C  LT      +     +GL
Sbjct: 90  VIGLLDVFTPARSLEEFNDVYLVTHLMGADLNN----IVKCQKLTDDHVQFLIYQILRGL 145
Query: 211 AFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAP 270
            ++H A+  +I+RD K SN+ +N D   K+ DFGLA+        +V+TR      Y AP
Sbjct: 146 KYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYVATR-----WYRAP 198
Query: 271 EYVMTG-HLTARSDVYGFGVVLLEMLLGR 298
           E ++   H     D++  G ++ E+L GR
Sbjct: 199 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 95/209 (45%), Gaps = 28/209 (13%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNR---GGYQGDREWLAEVNYLGQLRHSN 156
           +G G +G V       + + G +   VA+K+L+R         R +  E+  L  ++H N
Sbjct: 30  VGSGAYGSVCAAF---DTKTGLR---VAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHEN 82
Query: 157 LVKLI-----GYCCEDEHRILVYEYMESGSLEKHLLRRVGCM-LTWSRRMKIALDAAKGL 210
           ++ L+         E+ + + +  ++    L       V C  LT      +     +GL
Sbjct: 83  VIGLLDVFTPARSLEEFNDVYLVTHLMGADLNN----IVKCQKLTDDHVQFLIYQILRGL 138
Query: 211 AFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAP 270
            ++H A+  +I+RD K SN+ +N D   K+ DFGLA+        +V+TR      Y AP
Sbjct: 139 KYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAP 191
Query: 271 EYVMTG-HLTARSDVYGFGVVLLEMLLGR 298
           E ++   H     D++  G ++ E+L GR
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 95/209 (45%), Gaps = 28/209 (13%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNR---GGYQGDREWLAEVNYLGQLRHSN 156
           +G G +G V       + + G +   VA+K+L+R         R +  E+  L  ++H N
Sbjct: 41  VGSGAYGSVCAAF---DTKTGLR---VAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHEN 93
Query: 157 LVKLI-----GYCCEDEHRILVYEYMESGSLEKHLLRRVGCM-LTWSRRMKIALDAAKGL 210
           ++ L+         E+ + + +  ++    L       V C  LT      +     +GL
Sbjct: 94  VIGLLDVFTPARSLEEFNDVYLVTHLMGADLNN----IVKCQKLTDDHVQFLIYQILRGL 149
Query: 211 AFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAP 270
            ++H A+  +I+RD K SN+ +N D   K+ DFGLA+        +V+TR      Y AP
Sbjct: 150 KYIHSAD--IIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMTGYVATR-----WYRAP 202
Query: 271 EYVMTG-HLTARSDVYGFGVVLLEMLLGR 298
           E ++   H     D++  G ++ E+L GR
Sbjct: 203 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 231

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 65/244 (26%), Positives = 104/244 (42%), Gaps = 25/244 (10%)
Query: 76  YSNVDIFTYNEMKLATKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGG 135
           + NV++     + L    F    I+G GGFG VY        R        A+K L++  
Sbjct: 176 WKNVEL----NIHLTMNDFSVHRIIGRGGFGEVY------GCRKADTGKMYAMKCLDKKR 225
Query: 136 Y---QGDREWLAEVNYLGQLRHSN--LVKLIGYCCEDEHRI-LVYEYMESGSLEKHLLRR 189
               QG+   L E   L  +   +   +  + Y      ++  + + M  G L  HL + 
Sbjct: 226 IKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQH 285
Query: 190 VGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDG 249
            G       R   A +   GL  +H   R V+YRD K +NILL+     ++SD GLA D 
Sbjct: 286 -GVFSEADMRF-YAAEIILGLEHMHN--RFVVYRDLKPANILLDEHGHVRISDLGLACDF 341
Query: 250 PMGDQTHVSTRVMGTYGYAAPEYVMTG-HLTARSDVYGFGVVLLEMLLGRRAVDKSRPSR 308
               + H S   +GT+GY APE +  G    + +D +  G +L ++L G     + +   
Sbjct: 342 S-KKKPHAS---VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD 397
Query: 309 EHNL 312
           +H +
Sbjct: 398 KHEI 401

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 65/244 (26%), Positives = 104/244 (42%), Gaps = 25/244 (10%)
Query: 76  YSNVDIFTYNEMKLATKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGG 135
           + NV++     + L    F    I+G GGFG VY        R        A+K L++  
Sbjct: 177 WKNVEL----NIHLTMNDFSVHRIIGRGGFGEVY------GCRKADTGKMYAMKCLDKKR 226
Query: 136 Y---QGDREWLAEVNYLGQLRHSN--LVKLIGYCCEDEHRI-LVYEYMESGSLEKHLLRR 189
               QG+   L E   L  +   +   +  + Y      ++  + + M  G L  HL + 
Sbjct: 227 IKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQH 286
Query: 190 VGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDG 249
            G       R   A +   GL  +H   R V+YRD K +NILL+     ++SD GLA D 
Sbjct: 287 -GVFSEADMRF-YAAEIILGLEHMHN--RFVVYRDLKPANILLDEHGHVRISDLGLACDF 342
Query: 250 PMGDQTHVSTRVMGTYGYAAPEYVMTG-HLTARSDVYGFGVVLLEMLLGRRAVDKSRPSR 308
               + H S   +GT+GY APE +  G    + +D +  G +L ++L G     + +   
Sbjct: 343 S-KKKPHAS---VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD 398
Query: 309 EHNL 312
           +H +
Sbjct: 399 KHEI 402

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 65/244 (26%), Positives = 104/244 (42%), Gaps = 25/244 (10%)
Query: 76  YSNVDIFTYNEMKLATKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGG 135
           + NV++     + L    F    I+G GGFG VY        R        A+K L++  
Sbjct: 177 WKNVEL----NIHLTMNDFSVHRIIGRGGFGEVY------GCRKADTGKMYAMKCLDKKR 226
Query: 136 Y---QGDREWLAEVNYLGQLRHSN--LVKLIGYCCEDEHRI-LVYEYMESGSLEKHLLRR 189
               QG+   L E   L  +   +   +  + Y      ++  + + M  G L  HL + 
Sbjct: 227 IKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQH 286
Query: 190 VGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDG 249
            G       R   A +   GL  +H   R V+YRD K +NILL+     ++SD GLA D 
Sbjct: 287 -GVFSEADMRF-YAAEIILGLEHMHN--RFVVYRDLKPANILLDEHGHVRISDLGLACDF 342
Query: 250 PMGDQTHVSTRVMGTYGYAAPEYVMTG-HLTARSDVYGFGVVLLEMLLGRRAVDKSRPSR 308
               + H S   +GT+GY APE +  G    + +D +  G +L ++L G     + +   
Sbjct: 343 S-KKKPHAS---VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD 398
Query: 309 EHNL 312
           +H +
Sbjct: 399 KHEI 402

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 48/180 (26%), Positives = 81/180 (45%), Gaps = 10/180 (5%)
Query: 126 VAIKELNRGGYQGD--REWLAEVNYLGQLRHSNLVKLIGYCCEDEHRILVYEYMESGSLE 183
           VA+K +++        ++   EV  +  L H N+VKL      ++   LV EY   G + 
Sbjct: 42  VAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVF 101
Query: 184 KHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDF 243
            +L+   G M     R K        + + H  ++ +++RD K  N+LL+AD + K++DF
Sbjct: 102 DYLVAH-GRMKEKEARAKFR-QIVSAVQYCH--QKFIVHRDLKAENLLLDADMNIKIADF 157
Query: 244 GLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTA-RSDVYGFGVVLLEMLLGRRAVD 302
           G + +   G++        G   YAAPE            DV+  GV+L  ++ G    D
Sbjct: 158 GFSNEFTFGNKLDA---FCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 65/244 (26%), Positives = 104/244 (42%), Gaps = 25/244 (10%)
Query: 76  YSNVDIFTYNEMKLATKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGG 135
           + NV++     + L    F    I+G GGFG VY        R        A+K L++  
Sbjct: 177 WKNVEL----NIHLTMNDFSVHRIIGRGGFGEVY------GCRKADTGKMYAMKCLDKKR 226
Query: 136 Y---QGDREWLAEVNYLGQLRHSN--LVKLIGYCCEDEHRI-LVYEYMESGSLEKHLLRR 189
               QG+   L E   L  +   +   +  + Y      ++  + + M  G L  HL + 
Sbjct: 227 IKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQH 286
Query: 190 VGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDG 249
            G       R   A +   GL  +H   R V+YRD K +NILL+     ++SD GLA D 
Sbjct: 287 -GVFSEADMRF-YAAEIILGLEHMHN--RFVVYRDLKPANILLDEHGHVRISDLGLACDF 342
Query: 250 PMGDQTHVSTRVMGTYGYAAPEYVMTG-HLTARSDVYGFGVVLLEMLLGRRAVDKSRPSR 308
               + H S   +GT+GY APE +  G    + +D +  G +L ++L G     + +   
Sbjct: 343 S-KKKPHAS---VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD 398
Query: 309 EHNL 312
           +H +
Sbjct: 399 KHEI 402

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 99/218 (45%), Gaps = 25/218 (11%)
Query: 94  FRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGG------YQGDRE-WLAEV 146
           + P  ILG G   VV + +     +P  K   V I ++  GG       Q  RE  L EV
Sbjct: 19  YEPKEILGRGVSSVVRRCI----HKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEV 74
Query: 147 NYLGQLR-HSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALD 205
           + L ++  H N+++L      +    LV++ M+ G L  +L  +V      +R++  AL 
Sbjct: 75  DILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRAL- 133
Query: 206 AAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTY 265
             + +  LH     +++RD K  NILL+ D + KL+DFG +     G++      V GT 
Sbjct: 134 -LEVICALHKLN--IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLR---SVCGTP 187
Query: 266 GYAAPEYVMTGH------LTARSDVYGFGVVLLEMLLG 297
            Y APE +               D++  GV++  +L G
Sbjct: 188 SYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG 225

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 95/207 (45%), Gaps = 16/207 (7%)
Query: 99  ILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLV 158
           ++G+G F VV +  I+      +    V + +          +   E +    L+H ++V
Sbjct: 31  VIGKGAFSVV-RRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIV 89
Query: 159 KLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWS-----RRMKIALDAAKGLAFL 213
           +L+     D    +V+E+M+   L   +++R      +S       M+  L+A   L + 
Sbjct: 90  ELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEA---LRYC 146
Query: 214 HGAERPVIYRDFKTSNILLNADFSA---KLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAP 270
           H  +  +I+RD K  N+LL +  ++   KL DFG+A    +G+   V+   +GT  + AP
Sbjct: 147 H--DNNIIHRDVKPENVLLASKENSAPVKLGDFGVAIQ--LGESGLVAGGRVGTPHFMAP 202
Query: 271 EYVMTGHLTARSDVYGFGVVLLEMLLG 297
           E V         DV+G GV+L  +L G
Sbjct: 203 EVVKREPYGKPVDVWGCGVILFILLSG 229

>pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 80/344 (23%), Positives = 144/344 (41%), Gaps = 58/344 (16%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSN-LV 158
           +G GG   V++ V++E  +  Y   +V ++E +       R  +A +N L Q  HS+ ++
Sbjct: 64  IGSGGSSKVFQ-VLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQ--HSDKII 119
Query: 159 KLIGYCCEDEHRILVYEYMESGSLE-KHLLRRVGCMLTWSRR--MKIALDAAKGLAFLHG 215
           +L  Y   D++   +Y  ME G+++    L++   +  W R+   K  L+A   +   HG
Sbjct: 120 RLYDYEITDQY---IYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTI-HQHG 175
Query: 216 AERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYV-- 273
               +++ D K +N L+  D   KL DFG+A        + V    +G   Y  PE +  
Sbjct: 176 ----IVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKD 230
Query: 274 ---------MTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNK 324
                        ++ +SDV+  G +L  M  G+    +               ++N   
Sbjct: 231 MSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQ---------------IINQIS 275
Query: 325 KVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVA----LLET----VQS 376
           K+  I+DP  E ++       +  +   CL ++PK R  + +++A     ++T      +
Sbjct: 276 KLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQMA 335
Query: 377 QGAEEEMLQSGGGVV-------TLYEVPKLSSHNSGDKKRNQSG 413
           +G  EEM    G +V        L     L  H SG +  N S 
Sbjct: 336 KGTTEEMKYVLGQLVGLNSPNSILKAAKTLYEHYSGGESHNSSS 379

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 95/209 (45%), Gaps = 28/209 (13%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNR---GGYQGDREWLAEVNYLGQLRHSN 156
           +G G +G V       + + G +   VA+K+L+R         R +  E+  L  ++H N
Sbjct: 30  VGSGAYGSVCAAF---DTKTGLR---VAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHEN 82
Query: 157 LVKLI-----GYCCEDEHRILVYEYMESGSLEKHLLRRVGCM-LTWSRRMKIALDAAKGL 210
           ++ L+         E+ + + +  ++    L       V C  LT      +     +GL
Sbjct: 83  VIGLLDVFTPARSLEEFNDVYLVTHLMGADLNN----IVKCQKLTDDHVQFLIYQILRGL 138
Query: 211 AFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAP 270
            ++H A+  +I+RD K SN+ +N D   K+ DFGLA+        +V+TR      Y AP
Sbjct: 139 KYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAP 191
Query: 271 EYVMTG-HLTARSDVYGFGVVLLEMLLGR 298
           E ++   H     D++  G ++ E+L GR
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 95/209 (45%), Gaps = 28/209 (13%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNR---GGYQGDREWLAEVNYLGQLRHSN 156
           +G G +G V       + + G +   VA+K+L+R         R +  E+  L  ++H N
Sbjct: 32  VGSGAYGSVCAAF---DTKTGLR---VAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHEN 84
Query: 157 LVKLI-----GYCCEDEHRILVYEYMESGSLEKHLLRRVGCM-LTWSRRMKIALDAAKGL 210
           ++ L+         E+ + + +  ++    L       V C  LT      +     +GL
Sbjct: 85  VIGLLDVFTPARSLEEFNDVYLVTHLMGADLNN----IVKCQKLTDDHVQFLIYQILRGL 140
Query: 211 AFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAP 270
            ++H A+  +I+RD K SN+ +N D   K+ DFGLA+        +V+TR      Y AP
Sbjct: 141 KYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAP 193
Query: 271 EYVMTG-HLTARSDVYGFGVVLLEMLLGR 298
           E ++   H     D++  G ++ E+L GR
Sbjct: 194 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 95/209 (45%), Gaps = 28/209 (13%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNR---GGYQGDREWLAEVNYLGQLRHSN 156
           +G G +G V       + + G +   VA+K+L+R         R +  E+  L  ++H N
Sbjct: 30  VGSGAYGSVCAAF---DTKTGLR---VAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHEN 82
Query: 157 LVKLI-----GYCCEDEHRILVYEYMESGSLEKHLLRRVGCM-LTWSRRMKIALDAAKGL 210
           ++ L+         E+ + + +  ++    L       V C  LT      +     +GL
Sbjct: 83  VIGLLDVFTPARSLEEFNDVYLVTHLMGADLNN----IVKCQKLTDDHVQFLIYQILRGL 138
Query: 211 AFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAP 270
            ++H A+  +I+RD K SN+ +N D   K+ DFGLA+        +V+TR      Y AP
Sbjct: 139 KYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAP 191
Query: 271 EYVMTG-HLTARSDVYGFGVVLLEMLLGR 298
           E ++   H     D++  G ++ E+L GR
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 58.9 bits (141), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 95/209 (45%), Gaps = 28/209 (13%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNR---GGYQGDREWLAEVNYLGQLRHSN 156
           +G G +G V       + + G +   VA+K+L+R         R +  E+  L  ++H N
Sbjct: 35  VGSGAYGSVCAAF---DTKTGLR---VAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHEN 87
Query: 157 LVKLI-----GYCCEDEHRILVYEYMESGSLEKHLLRRVGCM-LTWSRRMKIALDAAKGL 210
           ++ L+         E+ + + +  ++    L       V C  LT      +     +GL
Sbjct: 88  VIGLLDVFTPARSLEEFNDVYLVTHLMGADLNN----IVKCQKLTDDHVQFLIYQILRGL 143
Query: 211 AFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAP 270
            ++H A+  +I+RD K SN+ +N D   K+ DFGLA+        +V+TR      Y AP
Sbjct: 144 KYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAP 196
Query: 271 EYVMTG-HLTARSDVYGFGVVLLEMLLGR 298
           E ++   H     D++  G ++ E+L GR
Sbjct: 197 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 58.9 bits (141), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 95/209 (45%), Gaps = 28/209 (13%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNR---GGYQGDREWLAEVNYLGQLRHSN 156
           +G G +G V       + + G +   VA+K+L+R         R +  E+  L  ++H N
Sbjct: 29  VGSGAYGSVCAAF---DTKTGLR---VAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHEN 81
Query: 157 LVKLI-----GYCCEDEHRILVYEYMESGSLEKHLLRRVGCM-LTWSRRMKIALDAAKGL 210
           ++ L+         E+ + + +  ++    L       V C  LT      +     +GL
Sbjct: 82  VIGLLDVFTPARSLEEFNDVYLVTHLMGADLNN----IVKCQKLTDDHVQFLIYQILRGL 137
Query: 211 AFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAP 270
            ++H A+  +I+RD K SN+ +N D   K+ DFGLA+        +V+TR      Y AP
Sbjct: 138 KYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAP 190
Query: 271 EYVMTG-HLTARSDVYGFGVVLLEMLLGR 298
           E ++   H     D++  G ++ E+L GR
Sbjct: 191 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 219

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 95/209 (45%), Gaps = 28/209 (13%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNR---GGYQGDREWLAEVNYLGQLRHSN 156
           +G G +G V       + + G +   VA+K+L+R         R +  E+  L  ++H N
Sbjct: 42  VGSGAYGSVCAAF---DTKTGLR---VAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHEN 94
Query: 157 LVKLI-----GYCCEDEHRILVYEYMESGSLEKHLLRRVGCM-LTWSRRMKIALDAAKGL 210
           ++ L+         E+ + + +  ++    L       V C  LT      +     +GL
Sbjct: 95  VIGLLDVFTPARSLEEFNDVYLVTHLMGADLNN----IVKCQKLTDDHVQFLIYQILRGL 150
Query: 211 AFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAP 270
            ++H A+  +I+RD K SN+ +N D   K+ DFGLA+        +V+TR      Y AP
Sbjct: 151 KYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAP 203
Query: 271 EYVMTG-HLTARSDVYGFGVVLLEMLLGR 298
           E ++   H     D++  G ++ E+L GR
Sbjct: 204 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 95/209 (45%), Gaps = 28/209 (13%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNR---GGYQGDREWLAEVNYLGQLRHSN 156
           +G G +G V       + + G +   VA+K+L+R         R +  E+  L  ++H N
Sbjct: 42  VGSGAYGSVCAAF---DTKTGLR---VAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHEN 94
Query: 157 LVKLI-----GYCCEDEHRILVYEYMESGSLEKHLLRRVGCM-LTWSRRMKIALDAAKGL 210
           ++ L+         E+ + + +  ++    L       V C  LT      +     +GL
Sbjct: 95  VIGLLDVFTPARSLEEFNDVYLVTHLMGADLNN----IVKCQKLTDDHVQFLIYQILRGL 150
Query: 211 AFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAP 270
            ++H A+  +I+RD K SN+ +N D   K+ DFGLA+        +V+TR      Y AP
Sbjct: 151 KYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAP 203
Query: 271 EYVMTG-HLTARSDVYGFGVVLLEMLLGR 298
           E ++   H     D++  G ++ E+L GR
Sbjct: 204 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 95/209 (45%), Gaps = 28/209 (13%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNR---GGYQGDREWLAEVNYLGQLRHSN 156
           +G G +G V       + + G +   VA+K+L+R         R +  E+  L  ++H N
Sbjct: 53  VGSGAYGSVCAAF---DTKTGLR---VAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHEN 105
Query: 157 LVKLI-----GYCCEDEHRILVYEYMESGSLEKHLLRRVGCM-LTWSRRMKIALDAAKGL 210
           ++ L+         E+ + + +  ++    L       V C  LT      +     +GL
Sbjct: 106 VIGLLDVFTPARSLEEFNDVYLVTHLMGADLNN----IVKCQKLTDDHVQFLIYQILRGL 161
Query: 211 AFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAP 270
            ++H A+  +I+RD K SN+ +N D   K+ DFGLA+        +V+TR      Y AP
Sbjct: 162 KYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMXGYVATR-----WYRAP 214
Query: 271 EYVMTG-HLTARSDVYGFGVVLLEMLLGR 298
           E ++   H     D++  G ++ E+L GR
Sbjct: 215 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 243

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 95/209 (45%), Gaps = 28/209 (13%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNR---GGYQGDREWLAEVNYLGQLRHSN 156
           +G G +G V       + + G++   VA+K+L+R         R +  E+  L  ++H N
Sbjct: 30  VGSGAYGSVCAAF---DTKTGHR---VAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHEN 82
Query: 157 LVKLI-----GYCCEDEHRILVYEYMESGSLEKHLLRRVGCM-LTWSRRMKIALDAAKGL 210
           ++ L+         E+ + + +  ++    L       V C  LT      +     +GL
Sbjct: 83  VIGLLDVFTPARSLEEFNDVYLVTHLMGADLNN----IVKCQKLTDDHVQFLIYQILRGL 138
Query: 211 AFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAP 270
            ++H A+  +I+RD K SN+ +N D   K+ DFGLA+         V+TR      Y AP
Sbjct: 139 KYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMAGFVATR-----WYRAP 191
Query: 271 EYVMTG-HLTARSDVYGFGVVLLEMLLGR 298
           E ++   H     D++  G ++ E+L GR
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 99/203 (48%), Gaps = 21/203 (10%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVK 159
           +G G FG V++    ++ + G++    A+K++    ++     + E+     L    +V 
Sbjct: 66  VGRGSFGEVHR---MKDKQTGFQC---AVKKVRLEVFR-----VEELVACAGLSSPRIVP 114
Query: 160 LIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERP 219
           L G   E     +  E +E GSL + L++++GC L   R +     A +GL +LH   R 
Sbjct: 115 LYGAVREGPWVNIFMELLEGGSLGQ-LIKQMGC-LPEDRALYYLGQALEGLEYLH--TRR 170
Query: 220 VIYRDFKTSNILLNADFS-AKLSDFG----LAKDGPMGDQTHVSTRVMGTYGYAAPEYVM 274
           +++ D K  N+LL++D S A L DFG    L  DG +G        + GT  + APE VM
Sbjct: 171 ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDG-LGKSLLTGDYIPGTETHMAPEVVM 229
Query: 275 TGHLTARSDVYGFGVVLLEMLLG 297
                A+ D++    ++L ML G
Sbjct: 230 GKPCDAKVDIWSSCCMMLHMLNG 252

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 95/209 (45%), Gaps = 28/209 (13%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNR---GGYQGDREWLAEVNYLGQLRHSN 156
           +G G +G V       + + G +   VA+K+L+R         R +  E+  L  ++H N
Sbjct: 36  VGSGAYGSVCAAF---DTKTGLR---VAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHEN 88
Query: 157 LVKLI-----GYCCEDEHRILVYEYMESGSLEKHLLRRVGCM-LTWSRRMKIALDAAKGL 210
           ++ L+         E+ + + +  ++    L       V C  LT      +     +GL
Sbjct: 89  VIGLLDVFTPARSLEEFNDVYLVTHLMGADLNN----IVKCQKLTDDHVQFLIYQILRGL 144
Query: 211 AFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAP 270
            ++H A+  +I+RD K SN+ +N D   K+ DFGLA+        +V+TR      Y AP
Sbjct: 145 KYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAP 197
Query: 271 EYVMTG-HLTARSDVYGFGVVLLEMLLGR 298
           E ++   H     D++  G ++ E+L GR
Sbjct: 198 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 95/209 (45%), Gaps = 28/209 (13%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNR---GGYQGDREWLAEVNYLGQLRHSN 156
           +G G +G V       + + G++   VA+K+L+R         R +  E+  L  ++H N
Sbjct: 30  VGSGAYGSVCAAF---DTKTGHR---VAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHEN 82
Query: 157 LVKLI-----GYCCEDEHRILVYEYMESGSLEKHLLRRVGCM-LTWSRRMKIALDAAKGL 210
           ++ L+         E+ + + +  ++    L       V C  LT      +     +GL
Sbjct: 83  VIGLLDVFTPARSLEEFNDVYLVTHLMGADLNN----IVKCQKLTDDHVQFLIYQILRGL 138
Query: 211 AFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAP 270
            ++H A+  +I+RD K SN+ +N D   K+ DFGLA+         V+TR      Y AP
Sbjct: 139 KYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMAGFVATR-----WYRAP 191
Query: 271 EYVMTG-HLTARSDVYGFGVVLLEMLLGR 298
           E ++   H     D++  G ++ E+L GR
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 95/209 (45%), Gaps = 28/209 (13%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNR---GGYQGDREWLAEVNYLGQLRHSN 156
           +G G +G V       + + G +   VA+K+L+R         R +  E+  L  ++H N
Sbjct: 32  VGSGAYGSVCAAF---DTKTGLR---VAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHEN 84
Query: 157 LVKLI-----GYCCEDEHRILVYEYMESGSLEKHLLRRVGCM-LTWSRRMKIALDAAKGL 210
           ++ L+         E+ + + +  ++    L       V C  LT      +     +GL
Sbjct: 85  VIGLLDVFTPARSLEEFNDVYLVTHLMGADLNN----IVKCQKLTDDHVQFLIYQILRGL 140
Query: 211 AFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAP 270
            ++H A+  +I+RD K SN+ +N D   K+ DFGLA+        +V+TR      Y AP
Sbjct: 141 KYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAP 193
Query: 271 EYVMTG-HLTARSDVYGFGVVLLEMLLGR 298
           E ++   H     D++  G ++ E+L GR
Sbjct: 194 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 95/209 (45%), Gaps = 28/209 (13%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNR---GGYQGDREWLAEVNYLGQLRHSN 156
           +G G +G V       + + G +   VA+K+L+R         R +  E+  L  ++H N
Sbjct: 32  VGSGAYGSVCAAF---DTKTGLR---VAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHEN 84
Query: 157 LVKLI-----GYCCEDEHRILVYEYMESGSLEKHLLRRVGCM-LTWSRRMKIALDAAKGL 210
           ++ L+         E+ + + +  ++    L       V C  LT      +     +GL
Sbjct: 85  VIGLLDVFTPARSLEEFNDVYLVTHLMGADLNN----IVKCQKLTDDHVQFLIYQILRGL 140
Query: 211 AFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAP 270
            ++H A+  +I+RD K SN+ +N D   K+ DFGLA+        +V+TR      Y AP
Sbjct: 141 KYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAP 193
Query: 271 EYVMTG-HLTARSDVYGFGVVLLEMLLGR 298
           E ++   H     D++  G ++ E+L GR
Sbjct: 194 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 95/209 (45%), Gaps = 28/209 (13%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNR---GGYQGDREWLAEVNYLGQLRHSN 156
           +G G +G V       + + G +   VA+K+L+R         R +  E+  L  ++H N
Sbjct: 37  VGSGAYGSVCAAF---DTKTGLR---VAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHEN 89
Query: 157 LVKLI-----GYCCEDEHRILVYEYMESGSLEKHLLRRVGCM-LTWSRRMKIALDAAKGL 210
           ++ L+         E+ + + +  ++    L       V C  LT      +     +GL
Sbjct: 90  VIGLLDVFTPARSLEEFNDVYLVTHLMGADLNN----IVKCQKLTDDHVQFLIYQILRGL 145
Query: 211 AFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAP 270
            ++H A+  +I+RD K SN+ +N D   K+ DFGLA+        +V+TR      Y AP
Sbjct: 146 KYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAP 198
Query: 271 EYVMTG-HLTARSDVYGFGVVLLEMLLGR 298
           E ++   H     D++  G ++ E+L GR
Sbjct: 199 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 95/209 (45%), Gaps = 28/209 (13%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNR---GGYQGDREWLAEVNYLGQLRHSN 156
           +G G +G V       + + G +   VA+K+L+R         R +  E+  L  ++H N
Sbjct: 41  VGSGAYGSVCAAF---DTKTGLR---VAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHEN 93
Query: 157 LVKLI-----GYCCEDEHRILVYEYMESGSLEKHLLRRVGCM-LTWSRRMKIALDAAKGL 210
           ++ L+         E+ + + +  ++    L       V C  LT      +     +GL
Sbjct: 94  VIGLLDVFTPARSLEEFNDVYLVTHLMGADLNN----IVKCQKLTDDHVQFLIYQILRGL 149
Query: 211 AFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAP 270
            ++H A+  +I+RD K SN+ +N D   K+ DFGLA+        +V+TR      Y AP
Sbjct: 150 KYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAP 202
Query: 271 EYVMTG-HLTARSDVYGFGVVLLEMLLGR 298
           E ++   H     D++  G ++ E+L GR
Sbjct: 203 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 231

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 95/209 (45%), Gaps = 28/209 (13%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNR---GGYQGDREWLAEVNYLGQLRHSN 156
           +G G +G V       + + G +   VA+K+L+R         R +  E+  L  ++H N
Sbjct: 50  VGSGAYGSVCAAF---DTKTGLR---VAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHEN 102
Query: 157 LVKLI-----GYCCEDEHRILVYEYMESGSLEKHLLRRVGCM-LTWSRRMKIALDAAKGL 210
           ++ L+         E+ + + +  ++    L       V C  LT      +     +GL
Sbjct: 103 VIGLLDVFTPARSLEEFNDVYLVTHLMGADLNN----IVKCQKLTDDHVQFLIYQILRGL 158
Query: 211 AFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAP 270
            ++H A+  +I+RD K SN+ +N D   K+ DFGLA+        +V+TR      Y AP
Sbjct: 159 KYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAP 211
Query: 271 EYVMTG-HLTARSDVYGFGVVLLEMLLGR 298
           E ++   H     D++  G ++ E+L GR
Sbjct: 212 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 95/209 (45%), Gaps = 28/209 (13%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNR---GGYQGDREWLAEVNYLGQLRHSN 156
           +G G +G V       + + G +   VA+K+L+R         R +  E+  L  ++H N
Sbjct: 30  VGSGAYGSVCAAF---DTKTGLR---VAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHEN 82
Query: 157 LVKLI-----GYCCEDEHRILVYEYMESGSLEKHLLRRVGCM-LTWSRRMKIALDAAKGL 210
           ++ L+         E+ + + +  ++    L       V C  LT      +     +GL
Sbjct: 83  VIGLLDVFTPARSLEEFNDVYLVTHLMGADLNN----IVKCQKLTDDHVQFLIYQILRGL 138
Query: 211 AFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAP 270
            ++H A+  +I+RD K SN+ +N D   K+ DFGLA+        +V+TR      Y AP
Sbjct: 139 KYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAP 191
Query: 271 EYVMTG-HLTARSDVYGFGVVLLEMLLGR 298
           E ++   H     D++  G ++ E+L GR
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 67/285 (23%), Positives = 124/285 (43%), Gaps = 43/285 (15%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSN-LV 158
           +G GG   V++ V++E  +  Y   +V ++E +       R  +A +N L Q  HS+ ++
Sbjct: 36  IGSGGSSKVFQ-VLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQ--HSDKII 91
Query: 159 KLIGYCCEDEHRILVYEYMESGSLE-KHLLRRVGCMLTWSRR--MKIALDAAKGLAFLHG 215
           +L  Y   D++   +Y  ME G+++    L++   +  W R+   K  L+A   +   HG
Sbjct: 92  RLYDYEITDQY---IYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTI-HQHG 147
Query: 216 AERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYV-- 273
               +++ D K +N L+  D   KL DFG+A          V    +GT  Y  PE +  
Sbjct: 148 ----IVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDXXXVVKDSQVGTVNYMPPEAIKD 202
Query: 274 ---------MTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNK 324
                        ++ +SDV+  G +L  M  G+    +               ++N   
Sbjct: 203 MSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQ---------------IINQIS 247
Query: 325 KVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVA 369
           K+  I+DP  E ++       +  +   CL ++PK R  + +++A
Sbjct: 248 KLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA 292

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 95/209 (45%), Gaps = 28/209 (13%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNR---GGYQGDREWLAEVNYLGQLRHSN 156
           +G G +G V       + + G++   VA+K+L+R         R +  E+  L  ++H N
Sbjct: 50  VGSGAYGSVCAAF---DTKTGHR---VAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHEN 102
Query: 157 LVKLI-----GYCCEDEHRILVYEYMESGSLEKHLLRRVGCM-LTWSRRMKIALDAAKGL 210
           ++ L+         E+ + + +  ++    L       V C  LT      +     +GL
Sbjct: 103 VIGLLDVFTPARSLEEFNDVYLVTHLMGADLNN----IVKCQKLTDDHVQFLIYQILRGL 158
Query: 211 AFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAP 270
            ++H A+  +I+RD K SN+ +N D   K+ DFGLA+         V+TR      Y AP
Sbjct: 159 KYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMXGXVATR-----WYRAP 211
Query: 271 EYVMTG-HLTARSDVYGFGVVLLEMLLGR 298
           E ++   H     D++  G ++ E+L GR
Sbjct: 212 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 95/209 (45%), Gaps = 28/209 (13%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNR---GGYQGDREWLAEVNYLGQLRHSN 156
           +G G +G V       + + G +   VA+K+L+R         R +  E+  L  ++H N
Sbjct: 36  VGSGAYGSVCAAF---DTKTGLR---VAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHEN 88
Query: 157 LVKLI-----GYCCEDEHRILVYEYMESGSLEKHLLRRVGCM-LTWSRRMKIALDAAKGL 210
           ++ L+         E+ + + +  ++    L       V C  LT      +     +GL
Sbjct: 89  VIGLLDVFTPARSLEEFNDVYLVTHLMGADLNN----IVKCQKLTDDHVQFLIYQILRGL 144
Query: 211 AFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAP 270
            ++H A+  +I+RD K SN+ +N D   K+ DFGLA+        +V+TR      Y AP
Sbjct: 145 KYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAP 197
Query: 271 EYVMTG-HLTARSDVYGFGVVLLEMLLGR 298
           E ++   H     D++  G ++ E+L GR
Sbjct: 198 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 95/209 (45%), Gaps = 28/209 (13%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNR---GGYQGDREWLAEVNYLGQLRHSN 156
           +G G +G V       + + G +   VA+K+L+R         R +  E+  L  ++H N
Sbjct: 35  VGSGAYGSVCAAF---DTKTGLR---VAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHEN 87
Query: 157 LVKLI-----GYCCEDEHRILVYEYMESGSLEKHLLRRVGCM-LTWSRRMKIALDAAKGL 210
           ++ L+         E+ + + +  ++    L       V C  LT      +     +GL
Sbjct: 88  VIGLLDVFTPARSLEEFNDVYLVTHLMGADLNN----IVKCQKLTDDHVQFLIYQILRGL 143
Query: 211 AFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAP 270
            ++H A+  +I+RD K SN+ +N D   K+ DFGLA+        +V+TR      Y AP
Sbjct: 144 KYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAP 196
Query: 271 EYVMTG-HLTARSDVYGFGVVLLEMLLGR 298
           E ++   H     D++  G ++ E+L GR
Sbjct: 197 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 95/209 (45%), Gaps = 28/209 (13%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNR---GGYQGDREWLAEVNYLGQLRHSN 156
           +G G +G V       + + G +   VA+K+L+R         R +  E+  L  ++H N
Sbjct: 53  VGSGAYGSVCAAF---DTKTGLR---VAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHEN 105
Query: 157 LVKLI-----GYCCEDEHRILVYEYMESGSLEKHLLRRVGCM-LTWSRRMKIALDAAKGL 210
           ++ L+         E+ + + +  ++    L       V C  LT      +     +GL
Sbjct: 106 VIGLLDVFTPARSLEEFNDVYLVTHLMGADLNN----IVKCQKLTDDHVQFLIYQILRGL 161
Query: 211 AFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAP 270
            ++H A+  +I+RD K SN+ +N D   K+ DFGLA+        +V+TR      Y AP
Sbjct: 162 KYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAP 214
Query: 271 EYVMTG-HLTARSDVYGFGVVLLEMLLGR 298
           E ++   H     D++  G ++ E+L GR
Sbjct: 215 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 243

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 95/209 (45%), Gaps = 28/209 (13%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNR---GGYQGDREWLAEVNYLGQLRHSN 156
           +G G +G V       + + G +   VA+K+L+R         R +  E+  L  ++H N
Sbjct: 49  VGSGAYGSVCAAF---DTKTGLR---VAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHEN 101
Query: 157 LVKLI-----GYCCEDEHRILVYEYMESGSLEKHLLRRVGCM-LTWSRRMKIALDAAKGL 210
           ++ L+         E+ + + +  ++    L       V C  LT      +     +GL
Sbjct: 102 VIGLLDVFTPARSLEEFNDVYLVTHLMGADLNN----IVKCQKLTDDHVQFLIYQILRGL 157
Query: 211 AFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAP 270
            ++H A+  +I+RD K SN+ +N D   K+ DFGLA+        +V+TR      Y AP
Sbjct: 158 KYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAP 210
Query: 271 EYVMTG-HLTARSDVYGFGVVLLEMLLGR 298
           E ++   H     D++  G ++ E+L GR
Sbjct: 211 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 239

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 95/209 (45%), Gaps = 28/209 (13%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNR---GGYQGDREWLAEVNYLGQLRHSN 156
           +G G +G V       + + G +   VA+K+L+R         R +  E+  L  ++H N
Sbjct: 27  VGSGAYGSVCAAF---DTKTGLR---VAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHEN 79
Query: 157 LVKLI-----GYCCEDEHRILVYEYMESGSLEKHLLRRVGCM-LTWSRRMKIALDAAKGL 210
           ++ L+         E+ + + +  ++    L       V C  LT      +     +GL
Sbjct: 80  VIGLLDVFTPARSLEEFNDVYLVTHLMGADLNN----IVKCQKLTDDHVQFLIYQILRGL 135
Query: 211 AFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAP 270
            ++H A+  +I+RD K SN+ +N D   K+ DFGLA+        +V+TR      Y AP
Sbjct: 136 KYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAP 188
Query: 271 EYVMTG-HLTARSDVYGFGVVLLEMLLGR 298
           E ++   H     D++  G ++ E+L GR
Sbjct: 189 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 217

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 94/201 (46%), Gaps = 14/201 (6%)
Query: 99  ILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLV 158
           ILG G FG V+K    E    G K   +A K +   G +   E   E++ + QL H+NL+
Sbjct: 96  ILGGGRFGQVHKC---EETATGLK---LAAKIIKTRGMKDKEEVKNEISVMNQLDHANLI 149
Query: 159 KLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAER 218
           +L          +LV EY++ G L   ++      LT    +       +G+  +H  + 
Sbjct: 150 QLYDAFESKNDIVLVMEYVDGGELFDRIIDE-SYNLTELDTILFMKQICEGIRHMH--QM 206
Query: 219 PVIYRDFKTSNIL-LNADF-SAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTG 276
            +++ D K  NIL +N D    K+ DFGLA+     ++  V+    GT  + APE V   
Sbjct: 207 YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVN---FGTPEFLAPEVVNYD 263
Query: 277 HLTARSDVYGFGVVLLEMLLG 297
            ++  +D++  GV+   +L G
Sbjct: 264 FVSFPTDMWSVGVIAYMLLSG 284

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 95/209 (45%), Gaps = 28/209 (13%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNR---GGYQGDREWLAEVNYLGQLRHSN 156
           +G G +G V       + + G +   VA+K+L+R         R +  E+  L  ++H N
Sbjct: 30  VGSGAYGSVCAAF---DTKTGLR---VAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHEN 82
Query: 157 LVKLI-----GYCCEDEHRILVYEYMESGSLEKHLLRRVGCM-LTWSRRMKIALDAAKGL 210
           ++ L+         E+ + + +  ++    L       V C  LT      +     +GL
Sbjct: 83  VIGLLDVFTPARSLEEFNDVYLVTHLMGADLNN----IVKCQKLTDDHVQFLIYQILRGL 138
Query: 211 AFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAP 270
            ++H A+  +I+RD K SN+ +N D   K+ DFGLA+        +V+TR      Y AP
Sbjct: 139 KYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAP 191
Query: 271 EYVMTG-HLTARSDVYGFGVVLLEMLLGR 298
           E ++   H     D++  G ++ E+L GR
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 95/209 (45%), Gaps = 28/209 (13%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNR---GGYQGDREWLAEVNYLGQLRHSN 156
           +G G +G V       + + G +   VA+K+L+R         R +  E+  L  ++H N
Sbjct: 27  VGSGAYGSVCAAF---DTKTGLR---VAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHEN 79
Query: 157 LVKLI-----GYCCEDEHRILVYEYMESGSLEKHLLRRVGCM-LTWSRRMKIALDAAKGL 210
           ++ L+         E+ + + +  ++    L       V C  LT      +     +GL
Sbjct: 80  VIGLLDVFTPARSLEEFNDVYLVTHLMGADLNN----IVKCQKLTDDHVQFLIYQILRGL 135
Query: 211 AFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAP 270
            ++H A+  +I+RD K SN+ +N D   K+ DFGLA+        +V+TR      Y AP
Sbjct: 136 KYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAP 188
Query: 271 EYVMTG-HLTARSDVYGFGVVLLEMLLGR 298
           E ++   H     D++  G ++ E+L GR
Sbjct: 189 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 217

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 93/208 (44%), Gaps = 32/208 (15%)
Query: 100 LGEGGFGVV---YKGVIDENVRPGYKTTFVAIKELNR---GGYQGDREWLAEVNYLGQLR 153
           +G G  G+V   Y  V+D NV         AIK+L+R         R +  E+  +  + 
Sbjct: 32  IGSGAQGIVCAAYDAVLDRNV---------AIKKLSRPFQNQTHAKRAY-RELVLMKCVN 81
Query: 154 HSNLVKLIGYCC------EDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAA 207
           H N++ L+          E +   LV E M++      L + +   L   R   +     
Sbjct: 82  HKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN-----LXQVIQMELDHERMSYLLYQML 136
Query: 208 KGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGY 267
            G+  LH A   +I+RD K SNI++ +D + K+ DFGLA+    G    ++  V+  Y Y
Sbjct: 137 XGIKHLHSAG--IIHRDLKPSNIVVKSDXTLKILDFGLARTA--GTSFMMTPYVVTRY-Y 191
Query: 268 AAPEYVMTGHLTARSDVYGFGVVLLEML 295
            APE ++        D++  G ++ EM+
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMV 219

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 95/209 (45%), Gaps = 28/209 (13%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNR---GGYQGDREWLAEVNYLGQLRHSN 156
           +G G +G V       + + G +   VA+K+L+R         R +  E+  L  ++H N
Sbjct: 26  VGSGAYGSVCAAF---DTKTGLR---VAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHEN 78
Query: 157 LVKLI-----GYCCEDEHRILVYEYMESGSLEKHLLRRVGCM-LTWSRRMKIALDAAKGL 210
           ++ L+         E+ + + +  ++    L       V C  LT      +     +GL
Sbjct: 79  VIGLLDVFTPARSLEEFNDVYLVTHLMGADLNN----IVKCQKLTDDHVQFLIYQILRGL 134
Query: 211 AFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAP 270
            ++H A+  +I+RD K SN+ +N D   K+ DFGLA+        +V+TR      Y AP
Sbjct: 135 KYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAP 187
Query: 271 EYVMTG-HLTARSDVYGFGVVLLEMLLGR 298
           E ++   H     D++  G ++ E+L GR
Sbjct: 188 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 95/209 (45%), Gaps = 28/209 (13%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNR---GGYQGDREWLAEVNYLGQLRHSN 156
           +G G +G V       + + G +   VA+K+L+R         R +  E+  L  ++H N
Sbjct: 32  VGSGAYGSVCAAF---DTKTGLR---VAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHEN 84
Query: 157 LVKLI-----GYCCEDEHRILVYEYMESGSLEKHLLRRVGCM-LTWSRRMKIALDAAKGL 210
           ++ L+         E+ + + +  ++    L       V C  LT      +     +GL
Sbjct: 85  VIGLLDVFTPARSLEEFNDVYLVTHLMGADLNN----IVKCQKLTDDHVQFLIYQILRGL 140
Query: 211 AFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAP 270
            ++H A+  +I+RD K SN+ +N D   K+ DFGLA+        +V+TR      Y AP
Sbjct: 141 KYIHSAD--IIHRDLKPSNLAVNEDSELKILDFGLARHTDDEMTGYVATR-----WYRAP 193
Query: 271 EYVMTG-HLTARSDVYGFGVVLLEMLLGR 298
           E ++   H     D++  G ++ E+L GR
Sbjct: 194 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 97/209 (46%), Gaps = 29/209 (13%)
Query: 100 LGEGGFGVVYKGVIDENVRPG--YKTTFVAIKELNRGGYQG-DREWLAEVNYLGQLRHSN 156
           LG+G F VV + V    V  G  Y    +  K+L+   +Q  +RE  A +  L  L+H N
Sbjct: 19  LGKGAFSVVRRCV---KVLAGQEYAAMIINTKKLSARDHQKLERE--ARICRL--LKHPN 71
Query: 157 LVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGL-----A 211
           +V+L     E+ H  L+++ +  G L + ++         +R      DA+  +     A
Sbjct: 72  IVRLHDSISEEGHHYLIFDLVTGGELFEDIV---------AREYYSEADASHCIQQILEA 122
Query: 212 FLHGAERPVIYRDFKTSNILLNADF---SAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYA 268
            LH  +  V++R+ K  N+LL +     + KL+DFGLA +     Q        GT GY 
Sbjct: 123 VLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFG--FAGTPGYL 180
Query: 269 APEYVMTGHLTARSDVYGFGVVLLEMLLG 297
           +PE +         D++  GV+L  +L+G
Sbjct: 181 SPEVLRKDPYGKPVDLWACGVILYILLVG 209

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 58.5 bits (140), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 95/209 (45%), Gaps = 28/209 (13%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNR---GGYQGDREWLAEVNYLGQLRHSN 156
           +G G +G V       + + G++   VA+K+L+R         R +  E+  L  ++H N
Sbjct: 26  VGSGAYGSVCAAF---DTKTGHR---VAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHEN 78
Query: 157 LVKLI-----GYCCEDEHRILVYEYMESGSLEKHLLRRVGCM-LTWSRRMKIALDAAKGL 210
           ++ L+         E+ + + +  ++    L       V C  LT      +     +GL
Sbjct: 79  VIGLLDVFTPARSLEEFNDVYLVTHLMGADLNN----IVKCQKLTDDHVQFLIYQILRGL 134
Query: 211 AFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAP 270
            ++H A+  +I+RD K SN+ +N D   K+ DFGLA+         V+TR      Y AP
Sbjct: 135 KYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMAGFVATR-----WYRAP 187
Query: 271 EYVMTG-HLTARSDVYGFGVVLLEMLLGR 298
           E ++   H     D++  G ++ E+L GR
Sbjct: 188 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 95/209 (45%), Gaps = 28/209 (13%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNR---GGYQGDREWLAEVNYLGQLRHSN 156
           +G G +G V       + + G +   VA+K+L+R         R +  E+  L  ++H N
Sbjct: 28  VGSGAYGSVCAAF---DTKTGLR---VAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHEN 80
Query: 157 LVKLI-----GYCCEDEHRILVYEYMESGSLEKHLLRRVGCM-LTWSRRMKIALDAAKGL 210
           ++ L+         E+ + + +  ++    L       V C  LT      +     +GL
Sbjct: 81  VIGLLDVFTPARSLEEFNDVYLVTHLMGADLNN----IVKCQKLTDDHVQFLIYQILRGL 136
Query: 211 AFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAP 270
            ++H A+  +I+RD K SN+ +N D   K+ DFGLA+        +V+TR      Y AP
Sbjct: 137 KYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAP 189
Query: 271 EYVMTG-HLTARSDVYGFGVVLLEMLLGR 298
           E ++   H     D++  G ++ E+L GR
Sbjct: 190 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 218

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 95/209 (45%), Gaps = 28/209 (13%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNR---GGYQGDREWLAEVNYLGQLRHSN 156
           +G G +G V       + + G +   VA+K+L+R         R +  E+  L  ++H N
Sbjct: 36  VGSGAYGSVCAAF---DTKTGLR---VAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHEN 88
Query: 157 LVKLI-----GYCCEDEHRILVYEYMESGSLEKHLLRRVGCM-LTWSRRMKIALDAAKGL 210
           ++ L+         E+ + + +  ++    L       V C  LT      +     +GL
Sbjct: 89  VIGLLDVFTPARSLEEFNDVYLVTHLMGADLNN----IVKCQKLTDDHVQFLIYQILRGL 144
Query: 211 AFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAP 270
            ++H A+  +I+RD K SN+ +N D   K+ DFGLA+        +V+TR      Y AP
Sbjct: 145 KYIHSAD--IIHRDLKPSNLAVNEDSELKILDFGLARHTDDEMTGYVATR-----WYRAP 197
Query: 271 EYVMTG-HLTARSDVYGFGVVLLEMLLGR 298
           E ++   H     D++  G ++ E+L GR
Sbjct: 198 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 99/203 (48%), Gaps = 21/203 (10%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVK 159
           +G G FG V++    ++ + G++    A+K++    ++     + E+     L    +V 
Sbjct: 82  VGRGSFGEVHR---MKDKQTGFQC---AVKKVRLEVFR-----VEELVACAGLSSPRIVP 130
Query: 160 LIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERP 219
           L G   E     +  E +E GSL + L++++GC L   R +     A +GL +LH   R 
Sbjct: 131 LYGAVREGPWVNIFMELLEGGSLGQ-LIKQMGC-LPEDRALYYLGQALEGLEYLH--TRR 186
Query: 220 VIYRDFKTSNILLNADFS-AKLSDFG----LAKDGPMGDQTHVSTRVMGTYGYAAPEYVM 274
           +++ D K  N+LL++D S A L DFG    L  DG +G        + GT  + APE VM
Sbjct: 187 ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDG-LGKSLLTGDYIPGTETHMAPEVVM 245
Query: 275 TGHLTARSDVYGFGVVLLEMLLG 297
                A+ D++    ++L ML G
Sbjct: 246 GKPCDAKVDIWSSCCMMLHMLNG 268

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 44/159 (27%), Positives = 73/159 (45%), Gaps = 8/159 (5%)
Query: 145 EVNYLGQLRHSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIAL 204
           EV  +  L H N+VKL      ++   LV EY   G +  +L+   G M     R K   
Sbjct: 64  EVRIMKILNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAH-GRMKEKEARAKFR- 121
Query: 205 DAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGT 264
                + + H  ++ +++RD K  N+LL+ D + K++DFG + +  +G++        G+
Sbjct: 122 QIVSAVQYCH--QKYIVHRDLKAENLLLDGDMNIKIADFGFSNEFTVGNKLDT---FCGS 176
Query: 265 YGYAAPEYVMTGHLTA-RSDVYGFGVVLLEMLLGRRAVD 302
             YAAPE            DV+  GV+L  ++ G    D
Sbjct: 177 PPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 215

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 94/208 (45%), Gaps = 32/208 (15%)
Query: 100 LGEGGFGVV---YKGVIDENVRPGYKTTFVAIKELNRGGYQGD---REWLAEVNYLGQLR 153
           +G G  G+V   Y  V+D NV         AIK+L+R  +Q     +    E+  +  + 
Sbjct: 70  IGSGAQGIVCAAYDAVLDRNV---------AIKKLSRP-FQNQTHAKRAYRELVLMKCVN 119
Query: 154 HSNLVKLIGYCC------EDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAA 207
           H N++ L+          E +   LV E M++      L + +   L   R   +     
Sbjct: 120 HKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN-----LCQVIQMELDHERMSYLLYQML 174
Query: 208 KGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGY 267
            G+  LH A   +I+RD K SNI++ +D + K+ DFGLA+    G    ++  V+  Y Y
Sbjct: 175 CGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVVTRY-Y 229
Query: 268 AAPEYVMTGHLTARSDVYGFGVVLLEML 295
            APE ++        D++  G ++ EM+
Sbjct: 230 RAPEVILGMGYKENVDIWSVGCIMGEMV 257

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 91/207 (43%), Gaps = 11/207 (5%)
Query: 99  ILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLV 158
            LG+GGF   Y+ + D + +  +    V  K +    +Q ++    E+     L + ++V
Sbjct: 49  FLGKGGFAKCYE-ITDMDTKEVFAGKVVP-KSMLLKPHQKEK-MSTEIAIHKSLDNPHVV 105
Query: 159 KLIGYCCEDEHRILVYEYMESGSL-EKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAE 217
              G+  +D+   +V E     SL E H  R+    +T            +G+ +LH   
Sbjct: 106 GFHGFFEDDDFVYVVLEICRRRSLLELHKRRKA---VTEPEARYFMRQTIQGVQYLHNNR 162
Query: 218 RPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGH 277
             VI+RD K  N+ LN D   K+ DFGLA       +   +  + GT  Y APE +    
Sbjct: 163 --VIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKT--LCGTPNYIAPEVLCKKG 218
Query: 278 LTARSDVYGFGVVLLEMLLGRRAVDKS 304
            +   D++  G +L  +L+G+   + S
Sbjct: 219 HSFEVDIWSLGCILYTLLVGKPPFETS 245

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/228 (25%), Positives = 96/228 (42%), Gaps = 36/228 (15%)
Query: 94  FRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLR 153
           F    +LG+G FG V K       R    + + AIK++ R   +     L+EV  L  L 
Sbjct: 8   FEEIAVLGQGAFGQVVKA------RNALDSRYYAIKKI-RHTEEKLSTILSEVMLLASLN 60
Query: 154 HSNLVKLIGYCCEDEHRI-------------LVYEYMESGSLEKHLLRRVGCMLTWSRRM 200
           H  +V+      E  + +             +  EY E+G+L   L+             
Sbjct: 61  HQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYD-LIHSENLNQQRDEYW 119
Query: 201 KIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAK------DGPMGDQ 254
           ++     + L+++H   + +I+RD K  NI ++   + K+ DFGLAK      D    D 
Sbjct: 120 RLFRQILEALSYIHS--QGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDS 177
Query: 255 THVS------TRVMGTYGYAAPEYVM-TGHLTARSDVYGFGVVLLEML 295
            ++       T  +GT  Y A E +  TGH   + D+Y  G++  EM+
Sbjct: 178 QNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI 225

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 93/208 (44%), Gaps = 32/208 (15%)
Query: 100 LGEGGFGVV---YKGVIDENVRPGYKTTFVAIKELNR---GGYQGDREWLAEVNYLGQLR 153
           +G G  G+V   Y  V+D NV         AIK+L+R         R +  E+  +  + 
Sbjct: 25  IGSGAQGIVCAAYDAVLDRNV---------AIKKLSRPFQNQTHAKRAY-RELVLMKCVN 74
Query: 154 HSNLVKLIGYCC------EDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAA 207
           H N++ L+          E +   LV E M++      L + +   L   R   +     
Sbjct: 75  HKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN-----LXQVIQMELDHERMSYLLYQML 129
Query: 208 KGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGY 267
            G+  LH A   +I+RD K SNI++ +D + K+ DFGLA+    G    ++  V+  Y Y
Sbjct: 130 XGIKHLHSAG--IIHRDLKPSNIVVKSDXTLKILDFGLARTA--GTSFMMTPYVVTRY-Y 184
Query: 268 AAPEYVMTGHLTARSDVYGFGVVLLEML 295
            APE ++        D++  G ++ EM+
Sbjct: 185 RAPEVILGMGYKENVDIWSVGCIMGEMV 212

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 90/207 (43%), Gaps = 11/207 (5%)
Query: 99  ILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLV 158
            LG+GGF   Y+ + D + +  +    V  K +    +Q ++    E+     L + ++V
Sbjct: 49  FLGKGGFAKCYE-ITDMDTKEVFAGKVVP-KSMLLKPHQKEK-MSTEIAIHKSLDNPHVV 105
Query: 159 KLIGYCCEDEHRILVYEYMESGSL-EKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAE 217
              G+  +D+   +V E     SL E H  R+    +T            +G+ +LH   
Sbjct: 106 GFHGFFEDDDFVYVVLEICRRRSLLELHKRRKA---VTEPEARYFMRQTIQGVQYLHNNR 162
Query: 218 RPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGH 277
             VI+RD K  N+ LN D   K+ DFGLA       +      + GT  Y APE +    
Sbjct: 163 --VIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGER--KKXLCGTPNYIAPEVLCKKG 218
Query: 278 LTARSDVYGFGVVLLEMLLGRRAVDKS 304
            +   D++  G +L  +L+G+   + S
Sbjct: 219 HSFEVDIWSLGCILYTLLVGKPPFETS 245

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 90/206 (43%), Gaps = 17/206 (8%)
Query: 98  YILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGY-QGDREWL-AEVNYLGQLRHS 155
           Y +G G +G   K      +R       +  KEL+ G   + +++ L +EVN L +L+H 
Sbjct: 12  YTIGTGSYGRCQK------IRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 65
Query: 156 NLVKLIGYCCEDEHRIL--VYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFL 213
           N+V+      +  +  L  V EY E G L   + +             + +     LA  
Sbjct: 66  NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 125
Query: 214 HGAER-----PVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYA 268
               R      V++RD K +N+ L+   + KL DFGLA+   +   T  +   +GT  Y 
Sbjct: 126 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR--ILNHDTSFAKTFVGTPYYM 183
Query: 269 APEYVMTGHLTARSDVYGFGVVLLEM 294
           +PE +       +SD++  G +L E+
Sbjct: 184 SPEQMNRMSYNEKSDIWSLGCLLYEL 209

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 66/272 (24%), Positives = 115/272 (42%), Gaps = 31/272 (11%)
Query: 99  ILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLV 158
            LG+GGF   ++ + D + +  +    V  K L    +Q ++  + E++    L H ++V
Sbjct: 46  FLGKGGFAKCFE-ISDADTKEVFAGKIVP-KSLLLKPHQREKMSM-EISIHRSLAHQHVV 102
Query: 159 KLIGYCCEDEHRILVYEYMESGSL-EKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAE 217
              G+  +++   +V E     SL E H  R+    LT             G  +LH   
Sbjct: 103 GFHGFFEDNDFVFVVLELCRRRSLLELHKRRKA---LTEPEARYYLRQIVLGCQYLHRNR 159
Query: 218 RPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPM-GDQTHVSTRVMGTYGYAAPEYVMTG 276
             VI+RD K  N+ LN D   K+ DFGLA      G++  V   + GT  Y APE +   
Sbjct: 160 --VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV---LCGTPNYIAPEVLSKK 214
Query: 277 HLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRILDPRLEG 336
             +   DV+  G ++  +L+G+   + S       L E    +  N   + + ++P    
Sbjct: 215 GHSFEVDVWSIGCIMYTLLVGKPPFETS------CLKETYLRIKKNEYSIPKHINP---- 264
Query: 337 QYTARTAMKVAGLAYQCLSQNPKGRPVMSDVV 368
                     A L  + L  +P  RP +++++
Sbjct: 265 --------VAASLIQKMLQTDPTARPTINELL 288

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 93/208 (44%), Gaps = 32/208 (15%)
Query: 100 LGEGGFGVV---YKGVIDENVRPGYKTTFVAIKELNR---GGYQGDREWLAEVNYLGQLR 153
           +G G  G+V   Y  V+D NV         AIK+L+R         R +  E+  +  + 
Sbjct: 32  IGSGAQGIVCAAYDAVLDRNV---------AIKKLSRPFQNQTHAKRAY-RELVLMKXVN 81
Query: 154 HSNLVKLIGYCC------EDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAA 207
           H N++ L+          E +   LV E M++      L + +   L   R   +     
Sbjct: 82  HKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN-----LXQVIQMELDHERMSYLLYQML 136
Query: 208 KGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGY 267
            G+  LH A   +I+RD K SNI++ +D + K+ DFGLA+    G    ++  V+  Y Y
Sbjct: 137 CGIKHLHSAG--IIHRDLKPSNIVVKSDXTLKILDFGLARTA--GTSFMMTPYVVTRY-Y 191
Query: 268 AAPEYVMTGHLTARSDVYGFGVVLLEML 295
            APE ++        D++  G ++ EM+
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMV 219

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 66/272 (24%), Positives = 115/272 (42%), Gaps = 31/272 (11%)
Query: 99  ILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLV 158
            LG+GGF   ++ + D + +  +    V  K L    +Q ++  + E++    L H ++V
Sbjct: 48  FLGKGGFAKCFE-ISDADTKEVFAGKIVP-KSLLLKPHQREKMSM-EISIHRSLAHQHVV 104
Query: 159 KLIGYCCEDEHRILVYEYMESGSL-EKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAE 217
              G+  +++   +V E     SL E H  R+    LT             G  +LH   
Sbjct: 105 GFHGFFEDNDFVFVVLELCRRRSLLELHKRRKA---LTEPEARYYLRQIVLGCQYLHRNR 161
Query: 218 RPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPM-GDQTHVSTRVMGTYGYAAPEYVMTG 276
             VI+RD K  N+ LN D   K+ DFGLA      G++  V   + GT  Y APE +   
Sbjct: 162 --VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV---LCGTPNYIAPEVLSKK 216
Query: 277 HLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRILDPRLEG 336
             +   DV+  G ++  +L+G+   + S       L E    +  N   + + ++P    
Sbjct: 217 GHSFEVDVWSIGCIMYTLLVGKPPFETS------CLKETYLRIKKNEYSIPKHINP---- 266
Query: 337 QYTARTAMKVAGLAYQCLSQNPKGRPVMSDVV 368
                     A L  + L  +P  RP +++++
Sbjct: 267 --------VAASLIQKMLQTDPTARPTINELL 290

>pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 72/283 (25%), Positives = 121/283 (42%), Gaps = 45/283 (15%)
Query: 100 LGEGGFGVVYKGVIDENVRPG-YKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLV 158
           LG+G F  ++KGV  E    G    T V +K L++        +    + + +L H +LV
Sbjct: 16  LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLV 75
Query: 159 KLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCM-LTWSRRMKIALDAAKGLAFLHGAE 217
              G C   +  ILV E+++ GSL+ +L +   C+ + W  ++++A   A  + FL   E
Sbjct: 76  LNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILW--KLEVAKQLAAAMHFLE--E 131
Query: 218 RPVIYRDFKTSNILL---------NADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYA 268
             +I+ +    NILL         N  F  KLSD G++      D   +  R+     + 
Sbjct: 132 NTLIHGNVCAKNILLIREEDRKTGNPPF-IKLSDPGISITVLPKDI--LQERI----PWV 184
Query: 269 APEYVMT-GHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPL--LNNNKK 325
            PE +    +L   +D + FG  L E+  G                   +PL  L++ +K
Sbjct: 185 PPECIENPKNLNLATDKWSFGTTLWEICSGGD-----------------KPLSALDSQRK 227
Query: 326 VLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVV 368
            L+  + R   Q  A  A ++A L   C+   P  RP    ++
Sbjct: 228 -LQFYEDR--HQLPAPKAAELANLINNCMDYEPDHRPSFRAII 267

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 90/207 (43%), Gaps = 11/207 (5%)
Query: 99  ILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLV 158
            LG+GGF   Y+ + D + +  +    V  K +    +Q ++    E+     L + ++V
Sbjct: 49  FLGKGGFAKCYE-ITDMDTKEVFAGKVVP-KSMLLKPHQKEK-MSTEIAIHKSLDNPHVV 105
Query: 159 KLIGYCCEDEHRILVYEYMESGSL-EKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAE 217
              G+  +D+   +V E     SL E H  R+    +T            +G+ +LH   
Sbjct: 106 GFHGFFEDDDFVYVVLEICRRRSLLELHKRRKA---VTEPEARYFMRQTIQGVQYLHNNR 162
Query: 218 RPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGH 277
             VI+RD K  N+ LN D   K+ DFGLA       +      + GT  Y APE +    
Sbjct: 163 --VIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGER--KKDLCGTPNYIAPEVLCKKG 218
Query: 278 LTARSDVYGFGVVLLEMLLGRRAVDKS 304
            +   D++  G +L  +L+G+   + S
Sbjct: 219 HSFEVDIWSLGCILYTLLVGKPPFETS 245

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 96/215 (44%), Gaps = 37/215 (17%)
Query: 99  ILGEGGFGVVYKGVIDENVRPGYK----TTFVAIKELNRGGYQGDREWLAEVNYLGQLRH 154
           ++G G FG V + V  ++ R  Y     + F  IK  +   +  +R+ +A  N       
Sbjct: 76  VIGRGAFGEV-QLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFAN------S 128
Query: 155 SNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSR----RMKIALDAAKGL 210
             +V+L     +D +  +V EYM  G L  +L+        W+R     + +ALDA   +
Sbjct: 129 PWVVQLFYAFQDDRYLYMVMEYMPGGDL-VNLMSNYDVPEKWARFYTAEVVLALDAIHSM 187
Query: 211 AFLHGAERPVIYRDFKTSNILLNADFSAKLSDFG----LAKDGPMGDQTHVSTRVMGTYG 266
            F+H        RD K  N+LL+     KL+DFG    + K+G +   T V     GT  
Sbjct: 188 GFIH--------RDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-----GTPD 234
Query: 267 YAAPEYVMT----GHLTARSDVYGFGVVLLEMLLG 297
           Y +PE + +    G+     D +  GV L EML+G
Sbjct: 235 YISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 269

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 94/209 (44%), Gaps = 28/209 (13%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQG---DREWLAEVNYLGQLRHSN 156
           +G G +G V     D  +R       VA+K+L+R  +Q     R    E+  L  L+H N
Sbjct: 28  VGSGAYGSVCSAY-DARLRQK-----VAVKKLSRP-FQSLIHARRTYRELRLLKHLKHEN 80
Query: 157 LVKLI-----GYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMK-IALDAAKGL 210
           ++ L+         ED   +    Y+ +  +   L   V C       ++ +     +GL
Sbjct: 81  VIGLLDVFTPATSIEDFSEV----YLVTTLMGADLNNIVKCQALSDEHVQFLVYQLLRGL 136
Query: 211 AFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAP 270
            ++H A   +I+RD K SN+ +N D   ++ DFGLA+        +V+TR      Y AP
Sbjct: 137 KYIHSAG--IIHRDLKPSNVAVNEDCELRILDFGLARQADEEMTGYVATR-----WYRAP 189
Query: 271 EYVMTG-HLTARSDVYGFGVVLLEMLLGR 298
           E ++   H     D++  G ++ E+L G+
Sbjct: 190 EIMLNWMHYNQTVDIWSVGCIMAELLQGK 218

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 93/208 (44%), Gaps = 32/208 (15%)
Query: 100 LGEGGFGVV---YKGVIDENVRPGYKTTFVAIKELNR---GGYQGDREWLAEVNYLGQLR 153
           +G G  G+V   Y  V+D NV         AIK+L+R         R +  E+  +  + 
Sbjct: 32  IGSGAQGIVCAAYDAVLDRNV---------AIKKLSRPFQNQTHAKRAY-RELVLMKXVN 81
Query: 154 HSNLVKLIGYCC------EDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAA 207
           H N++ L+          E +   LV E M++      L + +   L   R   +     
Sbjct: 82  HKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN-----LCQVIQMELDHERMSYLLYQML 136
Query: 208 KGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGY 267
            G+  LH A   +I+RD K SNI++ +D + K+ DFGLA+    G    ++  V+  Y Y
Sbjct: 137 CGIKHLHSAG--IIHRDLKPSNIVVKSDXTLKILDFGLARTA--GTSFMMTPYVVTRY-Y 191
Query: 268 AAPEYVMTGHLTARSDVYGFGVVLLEML 295
            APE ++        D++  G ++ EM+
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMV 219

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 95/211 (45%), Gaps = 32/211 (15%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNR---GGYQGDREWLAEVNYLGQLRHSN 156
           +G G +G V       + + G +   VA+K+L+R         R +  E+  L  ++H N
Sbjct: 30  VGSGAYGSVCAAF---DTKTGLR---VAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHEN 82
Query: 157 LVKLI-----GYCCEDEHRILVYEYMESGSLEKHLLRRVGCM-LTWSRRMKIALDAAKGL 210
           ++ L+         E+ + + +  ++    L       V C  LT      +     +GL
Sbjct: 83  VIGLLDVFTPARSLEEFNDVYLVTHLMGADLNN----IVKCQKLTDDHVQFLIYQILRGL 138
Query: 211 AFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAK--DGPMGDQTHVSTRVMGTYGYA 268
            ++H A+  +I+RD K SN+ +N D   K+ DFGLA+  D  M       T  + T  Y 
Sbjct: 139 KYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM-------TGXVATRWYR 189
Query: 269 APEYVMTG-HLTARSDVYGFGVVLLEMLLGR 298
           APE ++   H     D++  G ++ E+L GR
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 90/206 (43%), Gaps = 17/206 (8%)
Query: 98  YILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGY-QGDREWL-AEVNYLGQLRHS 155
           Y +G G +G   K      +R       +  KEL+ G   + +++ L +EVN L +L+H 
Sbjct: 12  YTIGTGSYGRCQK------IRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 65
Query: 156 NLVKLIGYCCEDEHRIL--VYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFL 213
           N+V+      +  +  L  V EY E G L   + +             + +     LA  
Sbjct: 66  NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 125
Query: 214 HGAER-----PVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYA 268
               R      V++RD K +N+ L+   + KL DFGLA+   +   T  +   +GT  Y 
Sbjct: 126 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR--ILNHDTSFAKAFVGTPYYM 183
Query: 269 APEYVMTGHLTARSDVYGFGVVLLEM 294
           +PE +       +SD++  G +L E+
Sbjct: 184 SPEQMNRMSYNEKSDIWSLGCLLYEL 209

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 94/208 (45%), Gaps = 32/208 (15%)
Query: 100 LGEGGFGVV---YKGVIDENVRPGYKTTFVAIKELNRGGYQGD---REWLAEVNYLGQLR 153
           +G G  G+V   Y  V+D NV         AIK+L+R  +Q     +    E+  +  + 
Sbjct: 70  IGSGAQGIVCAAYDAVLDRNV---------AIKKLSRP-FQNQTHAKRAYRELVLMKCVN 119
Query: 154 HSNLVKLIGYCC------EDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAA 207
           H N++ L+          E +   LV E M++      L + +   L   R   +     
Sbjct: 120 HKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN-----LCQVIQMELDHERMSYLLYQML 174
Query: 208 KGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGY 267
            G+  LH A   +I+RD K SNI++ +D + K+ DFGLA+    G    ++  V+  Y Y
Sbjct: 175 CGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVVTRY-Y 229
Query: 268 AAPEYVMTGHLTARSDVYGFGVVLLEML 295
            APE ++        D++  G ++ EM+
Sbjct: 230 RAPEVILGMGYKENVDIWSVGCIMGEMV 257

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 93/208 (44%), Gaps = 32/208 (15%)
Query: 100 LGEGGFGVV---YKGVIDENVRPGYKTTFVAIKELNR---GGYQGDREWLAEVNYLGQLR 153
           +G G  G+V   Y  V+D NV         AIK+L+R         R +  E+  +  + 
Sbjct: 33  IGSGAQGIVCAAYDAVLDRNV---------AIKKLSRPFQNQTHAKRAY-RELVLMKCVN 82
Query: 154 HSNLVKLIGYCC------EDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAA 207
           H N++ L+          E +   LV E M++      L + +   L   R   +     
Sbjct: 83  HKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN-----LCQVIQMELDHERMSYLLYQML 137
Query: 208 KGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGY 267
            G+  LH A   +I+RD K SNI++ +D + K+ DFGLA+    G    ++  V+  Y Y
Sbjct: 138 CGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVVTRY-Y 192
Query: 268 AAPEYVMTGHLTARSDVYGFGVVLLEML 295
            APE ++        D++  G ++ EM+
Sbjct: 193 RAPEVILGMGYKENVDIWSVGCIMGEMV 220

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 95/208 (45%), Gaps = 27/208 (12%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIK----ELNRGGYQGDREWLAEVNYLGQLRHS 155
           LGEG +G VYK +             VAIK    E    G  G    + EV+ L +L+H 
Sbjct: 42  LGEGTYGEVYKAI------DTVTNETVAIKRIRLEHEEEGVPGTA--IREVSLLKELQHR 93
Query: 156 NLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIAL-DAAKGLAFLH 214
           N+++L      +    L++EY E+  L+K++ +     +   R +K  L     G+ F H
Sbjct: 94  NIIELKSVIHHNHRLHLIFEYAEN-DLKKYMDKNPDVSM---RVIKSFLYQLINGVNFCH 149
Query: 215 GAERPVIYRDFKTSNILLNADFSA-----KLSDFGLAKDGPMGDQTHVSTRVMGTYGYAA 269
              R  ++RD K  N+LL+   ++     K+ DFGLA+    G      T  + T  Y  
Sbjct: 150 S--RRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLAR--AFGIPIRQFTHEIITLWYRP 205
Query: 270 PEYVM-TGHLTARSDVYGFGVVLLEMLL 296
           PE ++ + H +   D++    +  EML+
Sbjct: 206 PEILLGSRHYSTSVDIWSIACIWAEMLM 233

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 99/209 (47%), Gaps = 29/209 (13%)
Query: 100 LGEGGFGVVYKGVIDENVRPG--YKTTFVAIKELNRGGYQG-DREWLAEVNYLGQLRHSN 156
           +G+G F VV + V    +  G  Y    +  K+L+   +Q  +RE  A +  L  L+HSN
Sbjct: 12  IGKGAFSVVRRCV---KLCTGHEYAAKIINTKKLSARDHQKLERE--ARICRL--LKHSN 64
Query: 157 LVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGL-----A 211
           +V+L     E+    LV++ +  G L + ++         +R      DA+  +     A
Sbjct: 65  IVRLHDSISEEGFHYLVFDLVTGGELFEDIV---------AREYYSEADASHCIQQILEA 115
Query: 212 FLHGAERPVIYRDFKTSNILLNADF---SAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYA 268
            LH  +  V++RD K  N+LL +     + KL+DFGLA +   GDQ        GT GY 
Sbjct: 116 VLHCHQMGVVHRDLKPENLLLASKCKGAAVKLADFGLAIE-VQGDQ-QAWFGFAGTPGYL 173
Query: 269 APEYVMTGHLTARSDVYGFGVVLLEMLLG 297
           +PE +         D++  GV+L  +L+G
Sbjct: 174 SPEVLRKEAYGKPVDIWACGVILYILLVG 202

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 44/159 (27%), Positives = 73/159 (45%), Gaps = 8/159 (5%)
Query: 145 EVNYLGQLRHSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIAL 204
           EV  +  L H N+VKL      ++   L+ EY   G +  +L+   G M     R K   
Sbjct: 61  EVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAH-GRMKEKEARSKFR- 118
Query: 205 DAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGT 264
                + + H  ++ +++RD K  N+LL+AD + K++DFG + +  +G +        G+
Sbjct: 119 QIVSAVQYCH--QKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDT---FCGS 173
Query: 265 YGYAAPEYVMTGHLTA-RSDVYGFGVVLLEMLLGRRAVD 302
             YAAPE            DV+  GV+L  ++ G    D
Sbjct: 174 PPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 212

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 93/208 (44%), Gaps = 32/208 (15%)
Query: 100 LGEGGFGVV---YKGVIDENVRPGYKTTFVAIKELNR---GGYQGDREWLAEVNYLGQLR 153
           +G G  G+V   Y  V+D NV         AIK+L+R         R +  E+  +  + 
Sbjct: 32  IGSGAQGIVCAAYDAVLDRNV---------AIKKLSRPFQNQTHAKRAY-RELVLMKCVN 81
Query: 154 HSNLVKLIGYCC------EDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAA 207
           H N++ L+          E +   LV E M++      L + +   L   R   +     
Sbjct: 82  HKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN-----LCQVIQMELDHERMSYLLYQML 136
Query: 208 KGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGY 267
            G+  LH A   +I+RD K SNI++ +D + K+ DFGLA+    G    ++  V+  Y Y
Sbjct: 137 CGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVVTRY-Y 191
Query: 268 AAPEYVMTGHLTARSDVYGFGVVLLEML 295
            APE ++        D++  G ++ EM+
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMV 219

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 44/160 (27%), Positives = 74/160 (46%), Gaps = 14/160 (8%)
Query: 145 EVNYLGQLR-HSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIA 203
           E + L Q+  H +++ LI          LV++ M  G L  +L  +V      +R +  +
Sbjct: 149 ETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRS 208
Query: 204 LDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMG 263
           L   + ++FLH     +++RD K  NILL+ +   +LSDFG +     G++      + G
Sbjct: 209 L--LEAVSFLHANN--IVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLR---ELCG 261
Query: 264 TYGYAAPEYVMTGHLTARS------DVYGFGVVLLEMLLG 297
           T GY APE +               D++  GV+L  +L G
Sbjct: 262 TPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAG 301

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 93/208 (44%), Gaps = 32/208 (15%)
Query: 100 LGEGGFGVV---YKGVIDENVRPGYKTTFVAIKELNR---GGYQGDREWLAEVNYLGQLR 153
           +G G  G+V   Y  V+D NV         AIK+L+R         R +  E+  +  + 
Sbjct: 32  IGSGAQGIVCAAYDAVLDRNV---------AIKKLSRPFQNQTHAKRAY-RELVLMKCVN 81
Query: 154 HSNLVKLIGYCC------EDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAA 207
           H N++ L+          E +   LV E M++      L + +   L   R   +     
Sbjct: 82  HKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN-----LCQVIQMELDHERMSYLLYQML 136
Query: 208 KGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGY 267
            G+  LH A   +I+RD K SNI++ +D + K+ DFGLA+    G    ++  V+  Y Y
Sbjct: 137 CGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVVTRY-Y 191
Query: 268 AAPEYVMTGHLTARSDVYGFGVVLLEML 295
            APE ++        D++  G ++ EM+
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMV 219

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 102/210 (48%), Gaps = 26/210 (12%)
Query: 99  ILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLV 158
           ++G G FGVVY+  + ++         VAIK++ +G    +RE    +  + +L H N+V
Sbjct: 27  VIGNGSFGVVYQAKLCDS------GELVAIKKVLQGKAFKNRE----LQIMRKLDHCNIV 76
Query: 159 KLIGYCC-----EDEHRI-LVYEYMESGS--LEKHLLRRVGCMLTWSRRMKIALDAAKGL 210
           +L  +       +DE  + LV +Y+ +    + +H  R    +     ++ +     + L
Sbjct: 77  RLRYFFYSSGEKKDEVYLNLVLDYVPATVYRVARHYSRAKQTLPVIYVKLYM-YQLFRSL 135
Query: 211 AFLHGAERPVIYRDFKTSNILLNADFSA-KLSDFGLAKDGPMGDQTHVSTRVMGTYGYAA 269
           A++H     + +RD K  N+LL+ D +  KL DFG AK    G+    +   + +  Y A
Sbjct: 136 AYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP---NVSXICSRYYRA 190
Query: 270 PEYVM-TGHLTARSDVYGFGVVLLEMLLGR 298
           PE +      T+  DV+  G VL E+LLG+
Sbjct: 191 PELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 93/208 (44%), Gaps = 32/208 (15%)
Query: 100 LGEGGFGVV---YKGVIDENVRPGYKTTFVAIKELNR---GGYQGDREWLAEVNYLGQLR 153
           +G G  G+V   Y  V+D NV         AIK+L+R         R +  E+  +  + 
Sbjct: 31  IGSGAQGIVCAAYDAVLDRNV---------AIKKLSRPFQNQTHAKRAY-RELVLMKCVN 80
Query: 154 HSNLVKLIGYCC------EDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAA 207
           H N++ L+          E +   LV E M++      L + +   L   R   +     
Sbjct: 81  HKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN-----LCQVIQMELDHERMSYLLYQML 135
Query: 208 KGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGY 267
            G+  LH A   +I+RD K SNI++ +D + K+ DFGLA+    G    ++  V+  Y Y
Sbjct: 136 CGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVVTRY-Y 190
Query: 268 AAPEYVMTGHLTARSDVYGFGVVLLEML 295
            APE ++        D++  G ++ EM+
Sbjct: 191 RAPEVILGMGYKENVDIWSVGCIMGEMV 218

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 90/207 (43%), Gaps = 11/207 (5%)
Query: 99  ILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLV 158
            LG+GGF   Y+ + D + +  +    V  K +    +Q ++    E+     L + ++V
Sbjct: 33  FLGKGGFAKCYE-ITDMDTKEVFAGKVVP-KSMLLKPHQKEK-MSTEIAIHKSLDNPHVV 89
Query: 159 KLIGYCCEDEHRILVYEYMESGSL-EKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAE 217
              G+  +D+   +V E     SL E H  R+    +T            +G+ +LH   
Sbjct: 90  GFHGFFEDDDFVYVVLEICRRRSLLELHKRRKA---VTEPEARYFMRQTIQGVQYLHNNR 146
Query: 218 RPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGH 277
             VI+RD K  N+ LN D   K+ DFGLA       +      + GT  Y APE +    
Sbjct: 147 --VIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGER--KKDLCGTPNYIAPEVLCKKG 202
Query: 278 LTARSDVYGFGVVLLEMLLGRRAVDKS 304
            +   D++  G +L  +L+G+   + S
Sbjct: 203 HSFEVDIWSLGCILYTLLVGKPPFETS 229

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 94/208 (45%), Gaps = 32/208 (15%)
Query: 100 LGEGGFGVV---YKGVIDENVRPGYKTTFVAIKELNRGGYQGD---REWLAEVNYLGQLR 153
           +G G  G+V   Y  V+D NV         AIK+L+R  +Q     +    E+  +  + 
Sbjct: 33  IGSGAQGIVCAAYDAVLDRNV---------AIKKLSRP-FQNQTHAKRAYRELVLMKCVN 82
Query: 154 HSNLVKLIGYCC------EDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAA 207
           H N++ L+          E +   LV E M++      L + +   L   R   +     
Sbjct: 83  HKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN-----LCQVIQMELDHERMSYLLYQML 137
Query: 208 KGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGY 267
            G+  LH A   +I+RD K SNI++ +D + K+ DFGLA+    G    ++  V+  Y Y
Sbjct: 138 CGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVVTRY-Y 192
Query: 268 AAPEYVMTGHLTARSDVYGFGVVLLEML 295
            APE ++        D++  G ++ EM+
Sbjct: 193 RAPEVILGMGYKENVDIWSVGCIMGEMV 220

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/209 (25%), Positives = 95/209 (45%), Gaps = 28/209 (13%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNR---GGYQGDREWLAEVNYLGQLRHSN 156
           +G G +G V       + + G +   VA+K+L++         R +  E+  L  ++H N
Sbjct: 42  VGSGAYGSVCAAF---DTKTGLR---VAVKKLSKPFQSIIHAKRTY-RELRLLKHMKHEN 94
Query: 157 LVKLI-----GYCCEDEHRILVYEYMESGSLEKHLLRRVGCM-LTWSRRMKIALDAAKGL 210
           ++ L+         E+ + + +  ++    L       V C  LT      +     +GL
Sbjct: 95  VIGLLDVFTPARSLEEFNDVYLVTHLMGADLNN----IVKCQKLTDDHVQFLIYQILRGL 150
Query: 211 AFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAP 270
            ++H A+  +I+RD K SN+ +N D   K+ DFGLA+        +V+TR      Y AP
Sbjct: 151 KYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAP 203
Query: 271 EYVMTG-HLTARSDVYGFGVVLLEMLLGR 298
           E ++   H     D++  G ++ E+L GR
Sbjct: 204 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 48/172 (27%), Positives = 76/172 (44%), Gaps = 25/172 (14%)
Query: 201 KIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTR 260
           KIA+   K L  LH ++  VI+RD K SN+L+NA    K  DFG++  G + D       
Sbjct: 140 KIAVSIVKALEHLH-SKLSVIHRDVKPSNVLINALGQVKXCDFGIS--GYLVDDVAKDID 196
Query: 261 VMGTYGYAAPEYV-----MTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEW 315
             G   Y APE +       G+ + +SD++  G+  +E+ + R   D            W
Sbjct: 197 A-GCKPYXAPERINPELNQKGY-SVKSDIWSLGITXIELAILRFPYDS-----------W 243
Query: 316 ARPLLNNNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDV 367
             P     K+V+    P+L      + + +      QCL +N K RP   ++
Sbjct: 244 GTP-FQQLKQVVEEPSPQLPAD---KFSAEFVDFTSQCLKKNSKERPTYPEL 291

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 96/215 (44%), Gaps = 37/215 (17%)
Query: 99  ILGEGGFGVVYKGVIDENVRPGYK----TTFVAIKELNRGGYQGDREWLAEVNYLGQLRH 154
           ++G G FG V + V  ++ R  Y     + F  IK  +   +  +R+ +A  N       
Sbjct: 81  VIGRGAFGEV-QLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFAN------S 133
Query: 155 SNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSR----RMKIALDAAKGL 210
             +V+L     +D +  +V EYM  G L  +L+        W+R     + +ALDA   +
Sbjct: 134 PWVVQLFYAFQDDRYLYMVMEYMPGGDL-VNLMSNYDVPEKWARFYTAEVVLALDAIHSM 192
Query: 211 AFLHGAERPVIYRDFKTSNILLNADFSAKLSDFG----LAKDGPMGDQTHVSTRVMGTYG 266
            F+H        RD K  N+LL+     KL+DFG    + K+G +   T V     GT  
Sbjct: 193 GFIH--------RDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-----GTPD 239
Query: 267 YAAPEYVMT----GHLTARSDVYGFGVVLLEMLLG 297
           Y +PE + +    G+     D +  GV L EML+G
Sbjct: 240 YISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 274

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 103/212 (48%), Gaps = 30/212 (14%)
Query: 99  ILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLV 158
           ++G G FGVVY+  + ++         VAIK++ +G    +RE    +  + +L H N+V
Sbjct: 27  VIGNGSFGVVYQAKLCDS------GELVAIKKVLQGKAFKNRE----LQIMRKLDHCNIV 76
Query: 159 KLIGYCC-----EDEHRI-LVYEYMESG--SLEKHLLRRVGCMLTWSRRMKIALDAAKGL 210
           +L  +       +DE  + LV +Y+      + +H  R    +     ++ +     + L
Sbjct: 77  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYM-YQLFRSL 135
Query: 211 AFLHGAERPVIYRDFKTSNILLNADFSA-KLSDFGLAKDGPMGDQ--THVSTRVMGTYGY 267
           A++H     + +RD K  N+LL+ D +  KL DFG AK    G+   +++ +R      Y
Sbjct: 136 AYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-----Y 188
Query: 268 AAPEYVM-TGHLTARSDVYGFGVVLLEMLLGR 298
            APE +      T+  DV+  G VL E+LLG+
Sbjct: 189 RAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 103/212 (48%), Gaps = 30/212 (14%)
Query: 99  ILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLV 158
           ++G G FGVVY+  + ++         VAIK++ +G    +RE    +  + +L H N+V
Sbjct: 27  VIGNGSFGVVYQAKLCDS------GELVAIKKVLQGKAFKNRE----LQIMRKLDHCNIV 76
Query: 159 KLIGYCC-----EDEHRI-LVYEYMESGS--LEKHLLRRVGCMLTWSRRMKIALDAAKGL 210
           +L  +       +DE  + LV +Y+      + +H  R    +     ++ +     + L
Sbjct: 77  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYM-YQLFRSL 135
Query: 211 AFLHGAERPVIYRDFKTSNILLNADFSA-KLSDFGLAKDGPMGDQ--THVSTRVMGTYGY 267
           A++H     + +RD K  N+LL+ D +  KL DFG AK    G+   +++ +R      Y
Sbjct: 136 AYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-----Y 188
Query: 268 AAPEYVM-TGHLTARSDVYGFGVVLLEMLLGR 298
            APE +      T+  DV+  G VL E+LLG+
Sbjct: 189 RAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 93/208 (44%), Gaps = 32/208 (15%)
Query: 100 LGEGGFGVV---YKGVIDENVRPGYKTTFVAIKELNR---GGYQGDREWLAEVNYLGQLR 153
           +G G  G+V   Y  V+D NV         AIK+L+R         R +  E+  +  + 
Sbjct: 26  IGSGAQGIVCAAYDAVLDRNV---------AIKKLSRPFQNQTHAKRAY-RELVLMKCVN 75
Query: 154 HSNLVKLIGYCC------EDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAA 207
           H N++ L+          E +   LV E M++      L + +   L   R   +     
Sbjct: 76  HKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN-----LCQVIQMELDHERMSYLLYQML 130
Query: 208 KGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGY 267
            G+  LH A   +I+RD K SNI++ +D + K+ DFGLA+    G    ++  V+  Y Y
Sbjct: 131 CGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVVTRY-Y 185
Query: 268 AAPEYVMTGHLTARSDVYGFGVVLLEML 295
            APE ++        D++  G ++ EM+
Sbjct: 186 RAPEVILGMGYKENVDIWSVGCIMGEMV 213

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 96/215 (44%), Gaps = 31/215 (14%)
Query: 94  FRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQG---DREWLAEVNYLG 150
            RP   +G G +G V     D  +R       VA+K+L+R  +Q     R    E+  L 
Sbjct: 33  LRP---VGSGAYGSVCSAY-DARLRQK-----VAVKKLSRP-FQSLIHARRTYRELRLLK 82
Query: 151 QLRHSNLVKLI-----GYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMK-IAL 204
            L+H N++ L+         ED   +    Y+ +  +   L   V C       ++ +  
Sbjct: 83  HLKHENVIGLLDVFTPATSIEDFSEV----YLVTTLMGADLNNIVKCQALSDEHVQFLVY 138
Query: 205 DAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGT 264
              +GL ++H A   +I+RD K SN+ +N D   ++ DFGLA+        +V+TR    
Sbjct: 139 QLLRGLKYIHSA--GIIHRDLKPSNVAVNEDSELRILDFGLARQADEEMTGYVATR---- 192
Query: 265 YGYAAPEYVMTG-HLTARSDVYGFGVVLLEMLLGR 298
             Y APE ++   H     D++  G ++ E+L G+
Sbjct: 193 -WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLQGK 226

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 93/208 (44%), Gaps = 32/208 (15%)
Query: 100 LGEGGFGVV---YKGVIDENVRPGYKTTFVAIKELNR---GGYQGDREWLAEVNYLGQLR 153
           +G G  G+V   Y  V+D NV         AIK+L+R         R +  E+  +  + 
Sbjct: 25  IGSGAQGIVCAAYDAVLDRNV---------AIKKLSRPFQNQTHAKRAY-RELVLMKCVN 74
Query: 154 HSNLVKLIGYCC------EDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAA 207
           H N++ L+          E +   LV E M++      L + +   L   R   +     
Sbjct: 75  HKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN-----LCQVIQMELDHERMSYLLYQML 129
Query: 208 KGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGY 267
            G+  LH A   +I+RD K SNI++ +D + K+ DFGLA+    G    ++  V+  Y Y
Sbjct: 130 CGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVVTRY-Y 184
Query: 268 AAPEYVMTGHLTARSDVYGFGVVLLEML 295
            APE ++        D++  G ++ EM+
Sbjct: 185 RAPEVILGMGYKENVDIWSVGCIMGEMV 212

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/209 (25%), Positives = 95/209 (45%), Gaps = 28/209 (13%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNR---GGYQGDREWLAEVNYLGQLRHSN 156
           +G G +G V       + + G +   VA+K+L+R         R +  E+  L  ++H N
Sbjct: 30  VGSGAYGSVCAAF---DTKTGLR---VAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHEN 82
Query: 157 LVKLI-----GYCCEDEHRILVYEYMESGSLEKHLLRRVGCM-LTWSRRMKIALDAAKGL 210
           ++ L+         E+ + + +  ++    L       V C  LT      +     +GL
Sbjct: 83  VIGLLDVFTPARSLEEFNDVYLVTHLMGADLNN----IVKCQKLTDDHVQFLIYQILRGL 138
Query: 211 AFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAP 270
            ++H A+  +I+RD K SN+ +N D   K+ D+GLA+        +V+TR      Y AP
Sbjct: 139 KYIHSAD--IIHRDLKPSNLAVNEDCELKILDYGLARHTDDEMTGYVATR-----WYRAP 191
Query: 271 EYVMTG-HLTARSDVYGFGVVLLEMLLGR 298
           E ++   H     D++  G ++ E+L GR
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 93/208 (44%), Gaps = 32/208 (15%)
Query: 100 LGEGGFGVV---YKGVIDENVRPGYKTTFVAIKELNR---GGYQGDREWLAEVNYLGQLR 153
           +G G  G+V   Y  V+D NV         AIK+L+R         R +  E+  +  + 
Sbjct: 26  IGSGAQGIVCAAYDAVLDRNV---------AIKKLSRPFQNQTHAKRAY-RELVLMKCVN 75
Query: 154 HSNLVKLIGYCC------EDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAA 207
           H N++ L+          E +   LV E M++      L + +   L   R   +     
Sbjct: 76  HKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN-----LCQVIQMELDHERMSYLLYQML 130
Query: 208 KGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGY 267
            G+  LH A   +I+RD K SNI++ +D + K+ DFGLA+    G    ++  V+  Y Y
Sbjct: 131 CGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVVTRY-Y 185
Query: 268 AAPEYVMTGHLTARSDVYGFGVVLLEML 295
            APE ++        D++  G ++ EM+
Sbjct: 186 RAPEVILGMGYKENVDIWSVGCIMGEMV 213

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 96/207 (46%), Gaps = 26/207 (12%)
Query: 100 LGEGGFGVV---YKGVIDENVRPGYKTTFVAIKELNRGGYQGD---REWLAEVNYLGQLR 153
           +G G  G+V   Y  +++ NV         AIK+L+R  +Q     +    E+  +  + 
Sbjct: 32  IGSGAQGIVCAAYDAILERNV---------AIKKLSRP-FQNQTHAKRAYRELVLMKVVN 81
Query: 154 HSNLVKLIGYCCED---EHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGL 210
           H N++ L+         E    VY  ME   ++ +L + +   L   R   +      G+
Sbjct: 82  HKNIIGLLNVFTPQKSLEEFQDVYIVMEL--MDANLSQVIQMELDHERMSYLLYQMLVGI 139
Query: 211 AFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAP 270
             LH A   +I+RD K SNI++ +D + K+ DFGLA+    G    ++  V+  Y Y AP
Sbjct: 140 KHLHSAG--IIHRDLKPSNIVVKSDATLKILDFGLARTA--GTSFMMTPYVVTRY-YRAP 194
Query: 271 EYVMTGHLTARSDVYGFGVVLLEMLLG 297
           E ++        D++  GV++ EM+ G
Sbjct: 195 EVILGMGYKENVDIWSVGVIMGEMIKG 221

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 96/207 (46%), Gaps = 26/207 (12%)
Query: 100 LGEGGFGVV---YKGVIDENVRPGYKTTFVAIKELNRGGYQGD---REWLAEVNYLGQLR 153
           +G G  G+V   Y  +++ NV         AIK+L+R  +Q     +    E+  +  + 
Sbjct: 32  IGSGAQGIVVAAYDAILERNV---------AIKKLSRP-FQNQTHAKRAYRELVLMKVVN 81
Query: 154 HSNLVKLIGYCCED---EHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGL 210
           H N++ L+         E    VY  ME   ++ +L + +   L   R   +      G+
Sbjct: 82  HKNIIGLLNVFTPQKSLEEFQDVYIVMEL--MDANLSQVIQMELDHERMSYLLYQMLVGI 139
Query: 211 AFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAP 270
             LH A   +I+RD K SNI++ +D + K+ DFGLA+    G    ++  V+  Y Y AP
Sbjct: 140 KHLHSAG--IIHRDLKPSNIVVKSDATLKILDFGLARTA--GTSFMMTPYVVTRY-YRAP 194
Query: 271 EYVMTGHLTARSDVYGFGVVLLEMLLG 297
           E ++        D++  GV++ EM+ G
Sbjct: 195 EVILGMGYKENVDIWSVGVIMGEMIKG 221

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 96/215 (44%), Gaps = 37/215 (17%)
Query: 99  ILGEGGFGVVYKGVIDENVRPGYK----TTFVAIKELNRGGYQGDREWLAEVNYLGQLRH 154
           ++G G FG V + V  ++ R  Y     + F  IK  +   +  +R+ +A  N       
Sbjct: 81  VIGRGAFGEV-QLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFAN------S 133
Query: 155 SNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSR----RMKIALDAAKGL 210
             +V+L     +D +  +V EYM  G L  +L+        W+R     + +ALDA   +
Sbjct: 134 PWVVQLFYAFQDDRYLYMVMEYMPGGDL-VNLMSNYDVPEKWARFYTAEVVLALDAIHSM 192
Query: 211 AFLHGAERPVIYRDFKTSNILLNADFSAKLSDFG----LAKDGPMGDQTHVSTRVMGTYG 266
            F+H        RD K  N+LL+     KL+DFG    + K+G +   T V     GT  
Sbjct: 193 GFIH--------RDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-----GTPD 239
Query: 267 YAAPEYVMT----GHLTARSDVYGFGVVLLEMLLG 297
           Y +PE + +    G+     D +  GV L EML+G
Sbjct: 240 YISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 274

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 64/271 (23%), Positives = 113/271 (41%), Gaps = 29/271 (10%)
Query: 99  ILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLV 158
            LG+GGF   ++ + D + +  +    V  K L    +Q ++  + E++    L H ++V
Sbjct: 28  FLGKGGFAKCFE-ISDADTKEVFAGKIVP-KSLLLKPHQREKMSM-EISIHRSLAHQHVV 84
Query: 159 KLIGYCCEDEHRILVYEYMESGSL-EKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAE 217
              G+  +++   +V E     SL E H  R+    LT             G  +LH   
Sbjct: 85  GFHGFFEDNDFVFVVLELCRRRSLLELHKRRKA---LTEPEARYYLRQIVLGCQYLHRNR 141
Query: 218 RPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGH 277
             VI+RD K  N+ LN D   K+ DFGLA       +   +  + GT  Y APE +    
Sbjct: 142 --VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKT--LCGTPNYIAPEVLSKKG 197
Query: 278 LTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRILDPRLEGQ 337
            +   DV+  G ++  +L+G+   + S       L E    +  N   + + ++P     
Sbjct: 198 HSFEVDVWSIGCIMYTLLVGKPPFETS------CLKETYLRIKKNEYSIPKHINP----- 246
Query: 338 YTARTAMKVAGLAYQCLSQNPKGRPVMSDVV 368
                    A L  + L  +P  RP +++++
Sbjct: 247 -------VAASLIQKMLQTDPTARPTINELL 270

>pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 75/284 (26%), Positives = 124/284 (43%), Gaps = 47/284 (16%)
Query: 100 LGEGGFGVVYKGVIDENVRPG-YKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLV 158
           LG+G F  ++KGV  E    G    T V +K L++        +    + + +L H +LV
Sbjct: 16  LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLV 75
Query: 159 KLIGYC-CEDEHRILVYEYMESGSLEKHLLRRVGCM-LTWSRRMKIALDAAKGLAFLHGA 216
              G C C DE+ ILV E+++ GSL+ +L +   C+ + W  ++++A   A  + FL   
Sbjct: 76  LNYGVCFCGDEN-ILVQEFVKFGSLDTYLKKNKNCINILW--KLEVAKQLAWAMHFLE-- 130
Query: 217 ERPVIYRDFKTSNILL---------NADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGY 267
           E  +I+ +    NILL         N  F  KLSD G++      D   +  R+     +
Sbjct: 131 ENTLIHGNVCAKNILLIREEDRKTGNPPF-IKLSDPGISITVLPKDI--LQERI----PW 183
Query: 268 AAPEYVMT-GHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPL--LNNNK 324
             PE +    +L   +D + FG  L E+  G                   +PL  L++ +
Sbjct: 184 VPPECIENPKNLNLATDKWSFGTTLWEICSGG-----------------DKPLSALDSQR 226
Query: 325 KVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVV 368
           K L+  + R   Q  A  A ++A L   C+   P  RP    ++
Sbjct: 227 K-LQFYEDR--HQLPAPKAAELANLINNCMDYEPDHRPSFRAII 267

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 52/208 (25%), Positives = 95/208 (45%), Gaps = 26/208 (12%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNR---GGYQGDREWLAEVNYLGQLRHSN 156
           +G G +G V       + + G +   VA+K+L+R         R +  E+  L  ++H N
Sbjct: 30  VGSGAYGSVCAAF---DTKTGLR---VAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHEN 82
Query: 157 LVKLI-----GYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLA 211
           ++ L+         E+ + + +  ++    L   +  +    LT      +     +GL 
Sbjct: 83  VIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKXQ---KLTDDHVQFLIYQILRGLK 139
Query: 212 FLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPE 271
           ++H A+  +I+RD K SN+ +N D   K+ DFGLA+        +V+TR      Y APE
Sbjct: 140 YIHSAD--IIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMTGYVATR-----WYRAPE 192
Query: 272 YVMTG-HLTARSDVYGFGVVLLEMLLGR 298
            ++   H     D++  G ++ E+L GR
Sbjct: 193 IMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 64/271 (23%), Positives = 112/271 (41%), Gaps = 29/271 (10%)
Query: 99  ILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLV 158
            LG+GGF   ++ + D + +  +    V  K L    +Q ++  + E++    L H ++V
Sbjct: 24  FLGKGGFAKCFE-ISDADTKEVFAGKIVP-KSLLLKPHQREKMSM-EISIHRSLAHQHVV 80
Query: 159 KLIGYCCEDEHRILVYEYMESGSL-EKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAE 217
              G+  +++   +V E     SL E H  R+    LT             G  +LH   
Sbjct: 81  GFHGFFEDNDFVFVVLELCRRRSLLELHKRRKA---LTEPEARYYLRQIVLGCQYLHRNR 137
Query: 218 RPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGH 277
             VI+RD K  N+ LN D   K+ DFGLA       +      + GT  Y APE +    
Sbjct: 138 --VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER--KKTLCGTPNYIAPEVLSKKG 193
Query: 278 LTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRILDPRLEGQ 337
            +   DV+  G ++  +L+G+   + S       L E    +  N   + + ++P     
Sbjct: 194 HSFEVDVWSIGCIMYTLLVGKPPFETS------CLKETYLRIKKNEYSIPKHINP----- 242
Query: 338 YTARTAMKVAGLAYQCLSQNPKGRPVMSDVV 368
                    A L  + L  +P  RP +++++
Sbjct: 243 -------VAASLIQKMLQTDPTARPTINELL 266

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 66/272 (24%), Positives = 115/272 (42%), Gaps = 31/272 (11%)
Query: 99  ILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLV 158
            LG+GGF   ++ + D + +  +    V  K L    +Q ++  + E++    L H ++V
Sbjct: 22  FLGKGGFAKCFE-ISDADTKEVFAGKIVP-KSLLLKPHQREKMSM-EISIHRSLAHQHVV 78
Query: 159 KLIGYCCEDEHRILVYEYMESGSL-EKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAE 217
              G+  +++   +V E     SL E H  R+    LT             G  +LH   
Sbjct: 79  GFHGFFEDNDFVFVVLELCRRRSLLELHKRRKA---LTEPEARYYLRQIVLGCQYLHRNR 135
Query: 218 RPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPM-GDQTHVSTRVMGTYGYAAPEYVMTG 276
             VI+RD K  N+ LN D   K+ DFGLA      G++  V   + GT  Y APE +   
Sbjct: 136 --VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV---LCGTPNYIAPEVLSKK 190
Query: 277 HLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRILDPRLEG 336
             +   DV+  G ++  +L+G+   + S       L E    +  N   + + ++P    
Sbjct: 191 GHSFEVDVWSIGCIMYTLLVGKPPFETS------CLKETYLRIKKNEYSIPKHINP---- 240
Query: 337 QYTARTAMKVAGLAYQCLSQNPKGRPVMSDVV 368
                     A L  + L  +P  RP +++++
Sbjct: 241 --------VAASLIQKMLQTDPTARPTINELL 264

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 44/159 (27%), Positives = 72/159 (45%), Gaps = 8/159 (5%)
Query: 145 EVNYLGQLRHSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIAL 204
           EV  +  L H N+VKL      ++   L+ EY   G +  +L+   G M     R K   
Sbjct: 64  EVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAH-GRMKEKEARSKFR- 121
Query: 205 DAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGT 264
                + + H  ++ +++RD K  N+LL+AD + K++DFG + +  +G +        G 
Sbjct: 122 QIVSAVQYCH--QKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDA---FCGA 176
Query: 265 YGYAAPEYVMTGHLTA-RSDVYGFGVVLLEMLLGRRAVD 302
             YAAPE            DV+  GV+L  ++ G    D
Sbjct: 177 PPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 215

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 64/271 (23%), Positives = 112/271 (41%), Gaps = 29/271 (10%)
Query: 99  ILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLV 158
            LG+GGF   ++ + D + +  +    V  K L    +Q ++  + E++    L H ++V
Sbjct: 24  FLGKGGFAKCFE-ISDADTKEVFAGKIVP-KSLLLKPHQREKMSM-EISIHRSLAHQHVV 80
Query: 159 KLIGYCCEDEHRILVYEYMESGSL-EKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAE 217
              G+  +++   +V E     SL E H  R+    LT             G  +LH   
Sbjct: 81  GFHGFFEDNDFVFVVLELCRRRSLLELHKRRKA---LTEPEARYYLRQIVLGCQYLHRNR 137
Query: 218 RPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGH 277
             VI+RD K  N+ LN D   K+ DFGLA       +      + GT  Y APE +    
Sbjct: 138 --VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER--KKTLCGTPNYIAPEVLSKKG 193
Query: 278 LTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRILDPRLEGQ 337
            +   DV+  G ++  +L+G+   + S       L E    +  N   + + ++P     
Sbjct: 194 HSFEVDVWSIGCIMYTLLVGKPPFETS------CLKETYLRIKKNEYSIPKHINP----- 242
Query: 338 YTARTAMKVAGLAYQCLSQNPKGRPVMSDVV 368
                    A L  + L  +P  RP +++++
Sbjct: 243 -------VAASLIQKMLQTDPTARPTINELL 266

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 53/209 (25%), Positives = 95/209 (45%), Gaps = 28/209 (13%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNR---GGYQGDREWLAEVNYLGQLRHSN 156
           +G G +G V       + + G++   VA+K+L+R         R +  E+  L  ++H N
Sbjct: 30  VGSGAYGSVCAAF---DTKTGHR---VAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHEN 82
Query: 157 LVKLI-----GYCCEDEHRILVYEYMESGSLEKHLLRRVGCM-LTWSRRMKIALDAAKGL 210
           ++ L+         E+ + + +  ++    L       V C  LT      +     +GL
Sbjct: 83  VIGLLDVFTPARSLEEFNDVYLVTHLMGADLNN----IVKCQKLTDDHVQFLIYQILRGL 138
Query: 211 AFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAP 270
            ++H A+  +I+RD K SN+ +N D   K+ DF LA+        +V+TR      Y AP
Sbjct: 139 KYIHSAD--IIHRDLKPSNLAVNEDCELKILDFYLARHTDDEMTGYVATR-----WYRAP 191
Query: 271 EYVMTG-HLTARSDVYGFGVVLLEMLLGR 298
           E ++   H     D++  G ++ E+L GR
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 66/246 (26%), Positives = 114/246 (46%), Gaps = 32/246 (13%)
Query: 99  ILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLV 158
           ++G G FGVVY+  + ++         VAIK++     Q  R    E+  + +L H N+V
Sbjct: 65  VIGNGSFGVVYQAKLCDS------GELVAIKKV----LQDKRFKNRELQIMRKLDHCNIV 114
Query: 159 KLIGYCC-----EDEHRI-LVYEYMESG--SLEKHLLRRVGCMLTWSRRMKIALDAAKGL 210
           +L  +       +DE  + LV +Y+      + +H  R    +     ++ +     + L
Sbjct: 115 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYM-YQLFRSL 173
Query: 211 AFLHGAERPVIYRDFKTSNILLNADFSA-KLSDFGLAKDGPMGDQ--THVSTRVMGTYGY 267
           A++H     + +RD K  N+LL+ D +  KL DFG AK    G+   +++ +R      Y
Sbjct: 174 AYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-----Y 226
Query: 268 AAPEYVM-TGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKV 326
            APE +      T+  DV+  G VL E+LLG+        S    LVE  + L    ++ 
Sbjct: 227 RAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGD--SGVDQLVEIIKVLGTPTREQ 284
Query: 327 LRILDP 332
           +R ++P
Sbjct: 285 IREMNP 290

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 52/208 (25%), Positives = 95/208 (45%), Gaps = 26/208 (12%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNR---GGYQGDREWLAEVNYLGQLRHSN 156
           +G G +G V       + + G +   VA+K+L+R         R +  E+  L  ++H N
Sbjct: 30  VGSGAYGSVCAAF---DTKTGLR---VAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHEN 82
Query: 157 LVKLI-----GYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLA 211
           ++ L+         E+ + + +  ++    L   +  +    LT      +     +GL 
Sbjct: 83  VIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKXQ---KLTDDHVQFLIYQILRGLK 139
Query: 212 FLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPE 271
           ++H A+  +I+RD K SN+ +N D   K+ DFGLA+        +V+TR      Y APE
Sbjct: 140 YIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAPE 192
Query: 272 YVMTG-HLTARSDVYGFGVVLLEMLLGR 298
            ++   H     D++  G ++ E+L GR
Sbjct: 193 IMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 95/207 (45%), Gaps = 26/207 (12%)
Query: 100 LGEGGFGVV---YKGVIDENVRPGYKTTFVAIKELNRGGYQGD---REWLAEVNYLGQLR 153
           +G G  G+V   Y  +++ NV         AIK+L+R  +Q     +    E+  +  + 
Sbjct: 32  IGSGAQGIVCAAYDAILERNV---------AIKKLSRP-FQNQTHAKRAYRELVLMKCVN 81
Query: 154 HSNLVKLIGYCCED---EHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGL 210
           H N++ L+         E    VY  ME   ++ +L + +   L   R   +      G+
Sbjct: 82  HKNIIGLLNVFTPQKSLEEFQDVYIVMEL--MDANLCQVIQMELDHERMSYLLYQMLCGI 139
Query: 211 AFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAP 270
             LH A   +I+RD K SNI++ +D + K+ DFGLA+    G    ++  V+  Y Y AP
Sbjct: 140 KHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPEVVTRY-YRAP 194
Query: 271 EYVMTGHLTARSDVYGFGVVLLEMLLG 297
           E ++        D++  G ++ EM+ G
Sbjct: 195 EVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 66/246 (26%), Positives = 114/246 (46%), Gaps = 32/246 (13%)
Query: 99  ILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLV 158
           ++G G FGVVY+  + ++         VAIK++     Q  R    E+  + +L H N+V
Sbjct: 63  VIGNGSFGVVYQAKLCDS------GELVAIKKV----LQDKRFKNRELQIMRKLDHCNIV 112
Query: 159 KLIGYCC-----EDEHRI-LVYEYMESG--SLEKHLLRRVGCMLTWSRRMKIALDAAKGL 210
           +L  +       +DE  + LV +Y+      + +H  R    +     ++ +     + L
Sbjct: 113 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYM-YQLFRSL 171
Query: 211 AFLHGAERPVIYRDFKTSNILLNADFSA-KLSDFGLAKDGPMGDQ--THVSTRVMGTYGY 267
           A++H     + +RD K  N+LL+ D +  KL DFG AK    G+   +++ +R      Y
Sbjct: 172 AYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-----Y 224
Query: 268 AAPEYVM-TGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKV 326
            APE +      T+  DV+  G VL E+LLG+        S    LVE  + L    ++ 
Sbjct: 225 RAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGD--SGVDQLVEIIKVLGTPTREQ 282
Query: 327 LRILDP 332
           +R ++P
Sbjct: 283 IREMNP 288

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 66/246 (26%), Positives = 114/246 (46%), Gaps = 32/246 (13%)
Query: 99  ILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLV 158
           ++G G FGVVY+  + ++         VAIK++     Q  R    E+  + +L H N+V
Sbjct: 106 VIGNGSFGVVYQAKLCDS------GELVAIKKV----LQDKRFKNRELQIMRKLDHCNIV 155
Query: 159 KLIGYCC-----EDEHRI-LVYEYMESG--SLEKHLLRRVGCMLTWSRRMKIALDAAKGL 210
           +L  +       +DE  + LV +Y+      + +H  R    +     ++ +     + L
Sbjct: 156 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYM-YQLFRSL 214
Query: 211 AFLHGAERPVIYRDFKTSNILLNADFSA-KLSDFGLAKDGPMGDQ--THVSTRVMGTYGY 267
           A++H     + +RD K  N+LL+ D +  KL DFG AK    G+   +++ +R      Y
Sbjct: 215 AYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-----Y 267
Query: 268 AAPEYVM-TGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKV 326
            APE +      T+  DV+  G VL E+LLG+        S    LVE  + L    ++ 
Sbjct: 268 RAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGD--SGVDQLVEIIKVLGTPTREQ 325
Query: 327 LRILDP 332
           +R ++P
Sbjct: 326 IREMNP 331

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 56/226 (24%), Positives = 92/226 (40%), Gaps = 36/226 (15%)
Query: 98  YILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNR--GGYQGDREWLAEVNYLGQLRHS 155
           +++G G +G VY    D+N         VAIK++NR        +  L E+  L +L+  
Sbjct: 34  HLIGRGSYGYVYLAY-DKNANKN-----VAIKKVNRMFEDLIDCKRILREITILNRLKSD 87
Query: 156 NLVKLIGYCCEDEHRIL--VYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFL 213
            +++L      ++      +Y  +E    +   L +    LT      I  +   G  F+
Sbjct: 88  YIIRLHDLIIPEDLLKFDELYIVLEIADSDLKKLFKTPIFLTEQHVKTILYNLLLGEKFI 147
Query: 214 HGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVS--------------- 258
           H  E  +I+RD K +N LLN D S K+ DFGLA+        H+                
Sbjct: 148 H--ESGIIHRDLKPANCLLNQDCSVKICDFGLARTINSDKDIHIVNDLEEKEENEEPGPH 205
Query: 259 --------TRVMGTYGYAAPEYVMTG-HLTARSDVYGFGVVLLEML 295
                   T  + T  Y APE ++   + T   D++  G +  E+L
Sbjct: 206 NKNLKKQLTSHVVTRWYRAPELILLQENYTNSIDIWSTGCIFAELL 251

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 66/246 (26%), Positives = 114/246 (46%), Gaps = 32/246 (13%)
Query: 99  ILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLV 158
           ++G G FGVVY+  + ++         VAIK++     Q  R    E+  + +L H N+V
Sbjct: 61  VIGNGSFGVVYQAKLCDS------GELVAIKKV----LQDKRFKNRELQIMRKLDHCNIV 110
Query: 159 KLIGYCC-----EDEHRI-LVYEYMESG--SLEKHLLRRVGCMLTWSRRMKIALDAAKGL 210
           +L  +       +DE  + LV +Y+      + +H  R    +     ++ +     + L
Sbjct: 111 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYM-YQLFRSL 169
Query: 211 AFLHGAERPVIYRDFKTSNILLNADFSA-KLSDFGLAKDGPMGDQ--THVSTRVMGTYGY 267
           A++H     + +RD K  N+LL+ D +  KL DFG AK    G+   +++ +R      Y
Sbjct: 170 AYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-----Y 222
Query: 268 AAPEYVM-TGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKV 326
            APE +      T+  DV+  G VL E+LLG+        S    LVE  + L    ++ 
Sbjct: 223 RAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGD--SGVDQLVEIIKVLGTPTREQ 280
Query: 327 LRILDP 332
           +R ++P
Sbjct: 281 IREMNP 286

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 66/246 (26%), Positives = 114/246 (46%), Gaps = 32/246 (13%)
Query: 99  ILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLV 158
           ++G G FGVVY+  + ++         VAIK++     Q  R    E+  + +L H N+V
Sbjct: 55  VIGNGSFGVVYQAKLCDS------GELVAIKKV----LQDKRFKNRELQIMRKLDHCNIV 104
Query: 159 KLIGYCC-----EDEHRI-LVYEYMESG--SLEKHLLRRVGCMLTWSRRMKIALDAAKGL 210
           +L  +       +DE  + LV +Y+      + +H  R    +     ++ +     + L
Sbjct: 105 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYM-YQLFRSL 163
Query: 211 AFLHGAERPVIYRDFKTSNILLNADFSA-KLSDFGLAKDGPMGDQ--THVSTRVMGTYGY 267
           A++H     + +RD K  N+LL+ D +  KL DFG AK    G+   +++ +R      Y
Sbjct: 164 AYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-----Y 216
Query: 268 AAPEYVM-TGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKV 326
            APE +      T+  DV+  G VL E+LLG+        S    LVE  + L    ++ 
Sbjct: 217 RAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGD--SGVDQLVEIIKVLGTPTREQ 274
Query: 327 LRILDP 332
           +R ++P
Sbjct: 275 IREMNP 280

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 89/206 (43%), Gaps = 17/206 (8%)
Query: 98  YILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGY-QGDREWL-AEVNYLGQLRHS 155
           Y +G G +G   K      +R       +  KEL+ G   + +++ L +EVN L +L+H 
Sbjct: 12  YTIGTGSYGRCQK------IRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 65
Query: 156 NLVKLIGYCCEDEHRIL--VYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFL 213
           N+V+      +  +  L  V EY E G L   + +             + +     LA  
Sbjct: 66  NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 125
Query: 214 HGAER-----PVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYA 268
               R      V++RD K +N+ L+   + KL DFGLA+   +      +   +GT  Y 
Sbjct: 126 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR--ILNHDEDFAKEFVGTPYYM 183
Query: 269 APEYVMTGHLTARSDVYGFGVVLLEM 294
           +PE +       +SD++  G +L E+
Sbjct: 184 SPEQMNRMSYNEKSDIWSLGCLLYEL 209

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 55/221 (24%), Positives = 93/221 (42%), Gaps = 19/221 (8%)
Query: 95  RPDYI--LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQL 152
           R D++  +G G FGV         +R       VA+K + RG    +      +N+   L
Sbjct: 21  RYDFVKDIGSGNFGVA------RLMRDKLTKELVAVKYIERGAAIDENVQREIINH-RSL 73
Query: 153 RHSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAF 212
           RH N+V+         H  ++ EY   G L + +          +R     L    G+++
Sbjct: 74  RHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQL--LSGVSY 131
Query: 213 LHGAERPVIYRDFKTSNILLNADFSA--KLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAP 270
            H  +  + +RD K  N LL+   +   K+ DFG +K   +  Q   +   +GT  Y AP
Sbjct: 132 CHSMQ--ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST---VGTPAYIAP 186
Query: 271 EYVMTGHLTAR-SDVYGFGVVLLEMLLGRRAVDKSRPSREH 310
           E ++      + +DV+  GV L  ML+G    +     R++
Sbjct: 187 EVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDY 227

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 65/244 (26%), Positives = 112/244 (45%), Gaps = 28/244 (11%)
Query: 99  ILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLV 158
           ++G G FGVVY+  + ++         VAIK++     Q  R    E+  + +L H N+V
Sbjct: 61  VIGNGSFGVVYQAKLCDS------GELVAIKKV----LQDKRFKNRELQIMRKLDHCNIV 110
Query: 159 KLIGYCC-----EDEHRI-LVYEYMESG--SLEKHLLRRVGCMLTWSRRMKIALDAAKGL 210
           +L  +       +DE  + LV +Y+      + +H  R    +     ++ +     + L
Sbjct: 111 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYM-YQLFRSL 169
Query: 211 AFLHGAERPVIYRDFKTSNILLNADFSA-KLSDFGLAKDGPMGDQTHVSTRVMGTYGYAA 269
           A++H     + +RD K  N+LL+ D +  KL DFG AK    G+    +   + +  Y A
Sbjct: 170 AYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP---NVSXICSRYYRA 224
Query: 270 PEYVM-TGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLR 328
           PE +      T+  DV+  G VL E+LLG+        S    LVE  + L    ++ +R
Sbjct: 225 PELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGD--SGVDQLVEIIKVLGTPTREQIR 282
Query: 329 ILDP 332
            ++P
Sbjct: 283 EMNP 286

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 101/212 (47%), Gaps = 30/212 (14%)
Query: 99  ILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLV 158
           ++G G FGVVY+  + ++         VAIK++     Q  R    E+  + +L H N+V
Sbjct: 40  VIGNGSFGVVYQAKLCDS------GELVAIKKV----LQDKRFKNRELQIMRKLDHCNIV 89
Query: 159 KLIGYCC-----EDEHRI-LVYEYMESG--SLEKHLLRRVGCMLTWSRRMKIALDAAKGL 210
           +L  +       +DE  + LV +Y+      + +H  R    +     ++ +     + L
Sbjct: 90  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYM-YQLFRSL 148
Query: 211 AFLHGAERPVIYRDFKTSNILLNADFSA-KLSDFGLAKDGPMGDQ--THVSTRVMGTYGY 267
           A++H     + +RD K  N+LL+ D +  KL DFG AK    G+   +++ +R      Y
Sbjct: 149 AYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-----Y 201
Query: 268 AAPEYVM-TGHLTARSDVYGFGVVLLEMLLGR 298
            APE +      T+  DV+  G VL E+LLG+
Sbjct: 202 RAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 233

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 55.5 bits (132), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 53/209 (25%), Positives = 94/209 (44%), Gaps = 28/209 (13%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNR---GGYQGDREWLAEVNYLGQLRHSN 156
           +G G +G V       + + G +   VA+K+L+R         R +  E+  L  ++H N
Sbjct: 30  VGSGAYGSVCAAF---DTKTGLR---VAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHEN 82
Query: 157 LVKLI-----GYCCEDEHRILVYEYMESGSLEKHLLRRVGCM-LTWSRRMKIALDAAKGL 210
           ++ L+         E+ + + +  ++    L       V C  LT      +     +GL
Sbjct: 83  VIGLLDVFTPARSLEEFNDVYLVTHLMGADLNN----IVKCQKLTDDHVQFLIYQILRGL 138
Query: 211 AFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAP 270
            ++H A+  +I+RD K SN+ +N D   K+  FGLA+        +V+TR      Y AP
Sbjct: 139 KYIHSAD--IIHRDLKPSNLAVNEDCELKILGFGLARHTDDEMTGYVATR-----WYRAP 191
Query: 271 EYVMTG-HLTARSDVYGFGVVLLEMLLGR 298
           E ++   H     D++  G ++ E+L GR
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 55.5 bits (132), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 84/201 (41%), Gaps = 17/201 (8%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVK 159
           +G G FGV         +R       VA+K + RG  + D     E+     LRH N+V+
Sbjct: 26  IGSGNFGVA------RLMRDKQSNELVAVKYIERGE-KIDENVKREIINHRSLRHPNIVR 78
Query: 160 LIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERP 219
                    H  +V EY   G L + +          +R     L    G+++ H  +  
Sbjct: 79  FKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQL--ISGVSYCHAMQ-- 134
Query: 220 VIYRDFKTSNILLNADFSA--KLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGH 277
           V +RD K  N LL+   +   K+ DFG +K   +  Q       +GT  Y APE ++   
Sbjct: 135 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLKKE 191
Query: 278 LTAR-SDVYGFGVVLLEMLLG 297
              + +DV+  GV L  ML+G
Sbjct: 192 YDGKVADVWSCGVTLYVMLVG 212

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 55.5 bits (132), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 101/212 (47%), Gaps = 30/212 (14%)
Query: 99  ILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLV 158
           ++G G FGVVY+  + ++         VAIK++     Q  R    E+  + +L H N+V
Sbjct: 32  VIGNGSFGVVYQAKLCDS------GELVAIKKV----LQDKRFKNRELQIMRKLDHCNIV 81
Query: 159 KLIGYCC-----EDEHRI-LVYEYMESG--SLEKHLLRRVGCMLTWSRRMKIALDAAKGL 210
           +L  +       +DE  + LV +Y+      + +H  R    +     ++ +     + L
Sbjct: 82  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYM-YQLFRSL 140
Query: 211 AFLHGAERPVIYRDFKTSNILLNADFSA-KLSDFGLAKDGPMGDQ--THVSTRVMGTYGY 267
           A++H     + +RD K  N+LL+ D +  KL DFG AK    G+   +++ +R      Y
Sbjct: 141 AYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-----Y 193
Query: 268 AAPEYVM-TGHLTARSDVYGFGVVLLEMLLGR 298
            APE +      T+  DV+  G VL E+LLG+
Sbjct: 194 RAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 225

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 55.5 bits (132), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 35/103 (33%), Positives = 48/103 (46%), Gaps = 2/103 (1%)
Query: 193 MLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMG 252
            LT    +  +   AKG+ FL  A R  I+RD    NILL+     K+ DFGLA+D    
Sbjct: 194 FLTLEHLICYSFQVAKGMEFL--ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKD 251
Query: 253 DQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEML 295
                         + APE +     T +SDV+ FGV+L E+ 
Sbjct: 252 PDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIF 294

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 55.5 bits (132), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 91/211 (43%), Gaps = 29/211 (13%)
Query: 99  ILGEGGFGVVYKGVIDENVRPGYK----TTFVAIKELNRGGYQGDREWLAEVNYLGQLRH 154
           ++G G FG V + V  +  +  Y     + F  IK  +   +  +R+ +A  N       
Sbjct: 82  VIGRGAFGEV-QLVRHKASQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFAN------S 134
Query: 155 SNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSR----RMKIALDAAKGL 210
             +V+L     +D++  +V EYM  G L  +L+        W++     + +ALDA   +
Sbjct: 135 PWVVQLFCAFQDDKYLYMVMEYMPGGDL-VNLMSNYDVPEKWAKFYTAEVVLALDAIHSM 193
Query: 211 AFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAP 270
             +H        RD K  N+LL+     KL+DFG           H  T V GT  Y +P
Sbjct: 194 GLIH--------RDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVHCDTAV-GTPDYISP 244
Query: 271 EYVMT----GHLTARSDVYGFGVVLLEMLLG 297
           E + +    G+     D +  GV L EML+G
Sbjct: 245 EVLKSQGGDGYYGRECDWWSVGVFLFEMLVG 275

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 95/207 (45%), Gaps = 26/207 (12%)
Query: 100 LGEGGFGVV---YKGVIDENVRPGYKTTFVAIKELNRGGYQGD---REWLAEVNYLGQLR 153
           +G G  G+V   Y  +++ NV         AIK+L+R  +Q     +    E+  +  + 
Sbjct: 32  IGSGAQGIVCAAYDAILERNV---------AIKKLSRP-FQNQTHAKRAYRELVLMKCVN 81
Query: 154 HSNLVKLIGYCCED---EHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGL 210
           H N++ L+         E    VY  ME   ++ +L + +   L   R   +      G+
Sbjct: 82  HKNIIGLLNVFTPQKSLEEFQDVYIVMEL--MDANLCQVIQMELDHERMSYLLYQMLCGI 139
Query: 211 AFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAP 270
             LH A   +I+RD K SNI++ +D + K+ DFGLA+    G    ++  V+  Y Y AP
Sbjct: 140 KHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVVTRY-YRAP 194
Query: 271 EYVMTGHLTARSDVYGFGVVLLEMLLG 297
           E ++        D++  G ++ EM+ G
Sbjct: 195 EVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 35/103 (33%), Positives = 48/103 (46%), Gaps = 2/103 (1%)
Query: 193 MLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMG 252
            LT    +  +   AKG+ FL  A R  I+RD    NILL+     K+ DFGLA+D    
Sbjct: 189 FLTLEHLICYSFQVAKGMEFL--ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKD 246
Query: 253 DQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEML 295
                         + APE +     T +SDV+ FGV+L E+ 
Sbjct: 247 PDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIF 289

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 95/207 (45%), Gaps = 26/207 (12%)
Query: 100 LGEGGFGVV---YKGVIDENVRPGYKTTFVAIKELNRGGYQGD---REWLAEVNYLGQLR 153
           +G G  G+V   Y  +++ NV         AIK+L+R  +Q     +    E+  +  + 
Sbjct: 33  IGSGAQGIVCAAYDAILERNV---------AIKKLSRP-FQNQTHAKRAYRELVLMKCVN 82
Query: 154 HSNLVKLIGYCCED---EHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGL 210
           H N++ L+         E    VY  ME   ++ +L + +   L   R   +      G+
Sbjct: 83  HKNIIGLLNVFTPQKSLEEFQDVYIVMEL--MDANLCQVIQMELDHERMSYLLYQMLCGI 140
Query: 211 AFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAP 270
             LH A   +I+RD K SNI++ +D + K+ DFGLA+    G    ++  V+  Y Y AP
Sbjct: 141 KHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVVTRY-YRAP 195
Query: 271 EYVMTGHLTARSDVYGFGVVLLEMLLG 297
           E ++        D++  G ++ EM+ G
Sbjct: 196 EVILGMGYKENVDIWSVGCIMGEMIKG 222

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 48/158 (30%), Positives = 70/158 (44%), Gaps = 15/158 (9%)
Query: 143 LAEVNYLGQLRHSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKI 202
           L E   L  +    LVKL     ++ +  +V EYM  G +  HL RR+G       R   
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHL-RRIGRFSEPHARF-Y 146
Query: 203 ALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTR-- 260
           A        +LH  +  +IYRD K  N+L++     K++DFG AK         V  R  
Sbjct: 147 AAQIVLTFEYLHSLD--LIYRDLKPENLLIDQQGYIKVADFGFAK--------RVKGRTW 196
Query: 261 -VMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLG 297
            + GT  Y APE +++       D +  GV++ EM  G
Sbjct: 197 XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 48/158 (30%), Positives = 70/158 (44%), Gaps = 15/158 (9%)
Query: 143 LAEVNYLGQLRHSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKI 202
           L E   L  +    LVKL     ++ +  +V EYM  G +  HL RR+G       R   
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHL-RRIGRFSEPHARF-Y 146
Query: 203 ALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTR-- 260
           A        +LH  +  +IYRD K  N+L++     K++DFG AK         V  R  
Sbjct: 147 AAQIVLTFEYLHSLD--LIYRDLKPENLLIDQQGYIKVADFGFAK--------RVKGRTW 196
Query: 261 -VMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLG 297
            + GT  Y APE +++       D +  GV++ EM  G
Sbjct: 197 XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 95/207 (45%), Gaps = 26/207 (12%)
Query: 100 LGEGGFGVV---YKGVIDENVRPGYKTTFVAIKELNRGGYQGD---REWLAEVNYLGQLR 153
           +G G  G+V   Y  +++ NV         AIK+L+R  +Q     +    E+  +  + 
Sbjct: 32  IGSGAQGIVCAAYDAILERNV---------AIKKLSRP-FQNQTHAKRAYRELVLMKCVN 81
Query: 154 HSNLVKLIGYCCED---EHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGL 210
           H N++ L+         E    VY  ME   ++ +L + +   L   R   +      G+
Sbjct: 82  HKNIIGLLNVFTPQKSLEEFQDVYIVMEL--MDANLCQVIQMELDHERMSYLLYQMLCGI 139
Query: 211 AFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAP 270
             LH A   +I+RD K SNI++ +D + K+ DFGLA+    G    ++  V+  Y Y AP
Sbjct: 140 KHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVVTRY-YRAP 194
Query: 271 EYVMTGHLTARSDVYGFGVVLLEMLLG 297
           E ++        D++  G ++ EM+ G
Sbjct: 195 EVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 35/103 (33%), Positives = 48/103 (46%), Gaps = 2/103 (1%)
Query: 193 MLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMG 252
            LT    +  +   AKG+ FL  A R  I+RD    NILL+     K+ DFGLA+D    
Sbjct: 196 FLTLEHLICYSFQVAKGMEFL--ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKD 253
Query: 253 DQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEML 295
                         + APE +     T +SDV+ FGV+L E+ 
Sbjct: 254 PDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIF 296

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 35/103 (33%), Positives = 48/103 (46%), Gaps = 2/103 (1%)
Query: 193 MLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMG 252
            LT    +  +   AKG+ FL  A R  I+RD    NILL+     K+ DFGLA+D    
Sbjct: 187 FLTLEHLICYSFQVAKGMEFL--ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKD 244
Query: 253 DQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEML 295
                         + APE +     T +SDV+ FGV+L E+ 
Sbjct: 245 PDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIF 287

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 57/228 (25%), Positives = 95/228 (41%), Gaps = 36/228 (15%)
Query: 94  FRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLR 153
           F    +LG+G FG V K       R    + + AIK++ R   +     L+EV  L  L 
Sbjct: 8   FEEIAVLGQGAFGQVVKA------RNALDSRYYAIKKI-RHTEEKLSTILSEVMLLASLN 60
Query: 154 HSNLVKLIGYCCEDEHRI-------------LVYEYMESGSLEKHLLRRVGCMLTWSRRM 200
           H  +V+      E  + +             +  EY E+ +L   L+             
Sbjct: 61  HQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENRTLYD-LIHSENLNQQRDEYW 119
Query: 201 KIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAK------DGPMGDQ 254
           ++     + L+++H   + +I+RD K  NI ++   + K+ DFGLAK      D    D 
Sbjct: 120 RLFRQILEALSYIHS--QGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDS 177
Query: 255 THVS------TRVMGTYGYAAPEYVM-TGHLTARSDVYGFGVVLLEML 295
            ++       T  +GT  Y A E +  TGH   + D+Y  G++  EM+
Sbjct: 178 QNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI 225

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 99/210 (47%), Gaps = 26/210 (12%)
Query: 99  ILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLV 158
           ++G G FGVVY+  + ++         VAIK++     Q  R    E+  + +L H N+V
Sbjct: 39  VIGNGSFGVVYQAKLCDS------GELVAIKKV----LQDKRFKNRELQIMRKLDHCNIV 88
Query: 159 KLIGYCC-----EDEHRI-LVYEYMESG--SLEKHLLRRVGCMLTWSRRMKIALDAAKGL 210
           +L  +       +DE  + LV +Y+      + +H  R    +     ++ +     + L
Sbjct: 89  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYM-YQLFRSL 147
Query: 211 AFLHGAERPVIYRDFKTSNILLNADFSA-KLSDFGLAKDGPMGDQTHVSTRVMGTYGYAA 269
           A++H     + +RD K  N+LL+ D +  KL DFG AK    G+    +   + +  Y A
Sbjct: 148 AYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP---NVSXICSRYYRA 202
Query: 270 PEYVM-TGHLTARSDVYGFGVVLLEMLLGR 298
           PE +      T+  DV+  G VL E+LLG+
Sbjct: 203 PELIFGATDYTSSIDVWSAGCVLAELLLGQ 232

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 99/210 (47%), Gaps = 26/210 (12%)
Query: 99  ILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLV 158
           ++G G FGVVY+  + ++         VAIK++     Q  R    E+  + +L H N+V
Sbjct: 46  VIGNGSFGVVYQAKLCDS------GELVAIKKV----LQDKRFKNRELQIMRKLDHCNIV 95
Query: 159 KLIGYCC-----EDEHRI-LVYEYMESG--SLEKHLLRRVGCMLTWSRRMKIALDAAKGL 210
           +L  +       +DE  + LV +Y+      + +H  R    +     ++ +     + L
Sbjct: 96  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYM-YQLFRSL 154
Query: 211 AFLHGAERPVIYRDFKTSNILLNADFSA-KLSDFGLAKDGPMGDQTHVSTRVMGTYGYAA 269
           A++H     + +RD K  N+LL+ D +  KL DFG AK    G+    +   + +  Y A
Sbjct: 155 AYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP---NVSXICSRYYRA 209
Query: 270 PEYVM-TGHLTARSDVYGFGVVLLEMLLGR 298
           PE +      T+  DV+  G VL E+LLG+
Sbjct: 210 PELIFGATDYTSSIDVWSAGCVLAELLLGQ 239

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 55.1 bits (131), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 99/210 (47%), Gaps = 26/210 (12%)
Query: 99  ILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLV 158
           ++G G FGVVY+  + ++         VAIK++     Q  R    E+  + +L H N+V
Sbjct: 35  VIGNGSFGVVYQAKLCDS------GELVAIKKV----LQDKRFKNRELQIMRKLDHCNIV 84
Query: 159 KLIGYCC-----EDEHRI-LVYEYMESG--SLEKHLLRRVGCMLTWSRRMKIALDAAKGL 210
           +L  +       +DE  + LV +Y+      + +H  R    +     ++ +     + L
Sbjct: 85  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYM-YQLFRSL 143
Query: 211 AFLHGAERPVIYRDFKTSNILLNADFSA-KLSDFGLAKDGPMGDQTHVSTRVMGTYGYAA 269
           A++H     + +RD K  N+LL+ D +  KL DFG AK    G+    +   + +  Y A
Sbjct: 144 AYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP---NVSXICSRYYRA 198
Query: 270 PEYVM-TGHLTARSDVYGFGVVLLEMLLGR 298
           PE +      T+  DV+  G VL E+LLG+
Sbjct: 199 PELIFGATDYTSSIDVWSAGCVLAELLLGQ 228

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 55.1 bits (131), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 53/209 (25%), Positives = 94/209 (44%), Gaps = 28/209 (13%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNR---GGYQGDREWLAEVNYLGQLRHSN 156
           +G G +G V       + + G +   VA+K+L+R         R +  E+  L  ++H N
Sbjct: 30  VGSGAYGSVCAAF---DTKTGLR---VAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHEN 82
Query: 157 LVKLI-----GYCCEDEHRILVYEYMESGSLEKHLLRRVGCM-LTWSRRMKIALDAAKGL 210
           ++ L+         E+ + + +  ++    L       V C  LT      +     +GL
Sbjct: 83  VIGLLDVFTPARSLEEFNDVYLVTHLMGADLNN----IVKCQKLTDDHVQFLIYQILRGL 138
Query: 211 AFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAP 270
            ++H A+  +I+RD K SN+ +N D   K+ D GLA+        +V+TR      Y AP
Sbjct: 139 KYIHSAD--IIHRDLKPSNLAVNEDCELKILDAGLARHTDDEMTGYVATR-----WYRAP 191
Query: 271 EYVMTG-HLTARSDVYGFGVVLLEMLLGR 298
           E ++   H     D++  G ++ E+L GR
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 55.1 bits (131), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 95/207 (45%), Gaps = 26/207 (12%)
Query: 100 LGEGGFGVV---YKGVIDENVRPGYKTTFVAIKELNRGGYQGD---REWLAEVNYLGQLR 153
           +G G  G+V   Y  +++ NV         AIK+L+R  +Q     +    E+  +  + 
Sbjct: 32  IGSGAQGIVCAAYDAILERNV---------AIKKLSRP-FQNQTHAKRAYRELVLMKVVN 81
Query: 154 HSNLVKLIGYCCED---EHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGL 210
           H N++ L+         E    VY  ME   ++ +L + +   L   R   +      G+
Sbjct: 82  HKNIIGLLNVFTPQKSLEEFQDVYIVMEL--MDANLSQVIQMELDHERMSYLLYQMLVGI 139
Query: 211 AFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAP 270
             LH A   +I+RD K SNI++ +D + K+ DFGLA+    G    ++  V+  Y Y AP
Sbjct: 140 KHLHSAG--IIHRDLKPSNIVVKSDATLKILDFGLARTA--GTSFMMTPYVVTRY-YRAP 194
Query: 271 EYVMTGHLTARSDVYGFGVVLLEMLLG 297
           E ++        D++  G ++ EM+ G
Sbjct: 195 EVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 55.1 bits (131), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 99/210 (47%), Gaps = 26/210 (12%)
Query: 99  ILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLV 158
           ++G G FGVVY+  + ++         VAIK++     Q  R    E+  + +L H N+V
Sbjct: 39  VIGNGSFGVVYQAKLCDS------GELVAIKKV----LQDKRFKNRELQIMRKLDHCNIV 88
Query: 159 KLIGYCC-----EDEHRI-LVYEYMESG--SLEKHLLRRVGCMLTWSRRMKIALDAAKGL 210
           +L  +       +DE  + LV +Y+      + +H  R    +     ++ +     + L
Sbjct: 89  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYM-YQLFRSL 147
Query: 211 AFLHGAERPVIYRDFKTSNILLNADFSA-KLSDFGLAKDGPMGDQTHVSTRVMGTYGYAA 269
           A++H     + +RD K  N+LL+ D +  KL DFG AK    G+    +   + +  Y A
Sbjct: 148 AYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP---NVSXICSRYYRA 202
Query: 270 PEYVM-TGHLTARSDVYGFGVVLLEMLLGR 298
           PE +      T+  DV+  G VL E+LLG+
Sbjct: 203 PELIFGATDYTSSIDVWSAGCVLAELLLGQ 232

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 55.1 bits (131), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 44/159 (27%), Positives = 70/159 (44%), Gaps = 8/159 (5%)
Query: 145 EVNYLGQLRHSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIAL 204
           EV     L H N+VKL      ++   LV EY   G +  +L+   G       R K   
Sbjct: 63  EVRIXKVLNHPNIVKLFEVIETEKTLYLVXEYASGGEVFDYLVAH-GRXKEKEARAKFR- 120
Query: 205 DAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGT 264
                + + H  ++ +++RD K  N+LL+AD + K++DFG + +   G++        G 
Sbjct: 121 QIVSAVQYCH--QKFIVHRDLKAENLLLDADXNIKIADFGFSNEFTFGNKLDA---FCGA 175
Query: 265 YGYAAPEYVMTGHLTA-RSDVYGFGVVLLEMLLGRRAVD 302
             YAAPE            DV+  GV+L  ++ G    D
Sbjct: 176 PPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 90/203 (44%), Gaps = 19/203 (9%)
Query: 99  ILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLV 158
           +LG G F  V+       V+        A+K + +     D     E+  L +++H N+V
Sbjct: 16  VLGSGAFSEVFL------VKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIV 69
Query: 159 KLIGYCCEDEHRILVYEYMESGSLEKHLLRR-VGCMLTWSRRMKIALDAAKGLAFLHGAE 217
            L        H  LV + +  G L   +L R V      S  ++  L A K   +LH  E
Sbjct: 70  TLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVK---YLH--E 124
Query: 218 RPVIYRDFKTSNIL-LNADFSAKL--SDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVM 274
             +++RD K  N+L L  + ++K+  +DFGL+K     +Q  + +   GT GY APE + 
Sbjct: 125 NGIVHRDLKPENLLYLTPEENSKIMITDFGLSK----MEQNGIMSTACGTPGYVAPEVLA 180
Query: 275 TGHLTARSDVYGFGVVLLEMLLG 297
               +   D +  GV+   +L G
Sbjct: 181 QKPYSKAVDCWSIGVITYILLCG 203

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 85/201 (42%), Gaps = 17/201 (8%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVK 159
           +G G FGV         +R       VA+K + RG  + D     E+     LRH N+V+
Sbjct: 27  IGAGNFGVA------RLMRDKQANELVAVKYIERGE-KIDENVKREIINHRSLRHPNIVR 79
Query: 160 LIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERP 219
                    H  +V EY   G L + +          +R     L    G+++ H  +  
Sbjct: 80  FKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQL--ISGVSYAHAMQ-- 135
Query: 220 VIYRDFKTSNILLNADFSA--KLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGH 277
           V +RD K  N LL+   +   K++DFG +K   +  Q       +GT  Y APE ++   
Sbjct: 136 VAHRDLKLENTLLDGSPAPRLKIADFGYSKASVLHSQ---PKSAVGTPAYIAPEVLLKKE 192
Query: 278 LTAR-SDVYGFGVVLLEMLLG 297
              + +DV+  GV L  ML+G
Sbjct: 193 YDGKVADVWSCGVTLYVMLVG 213

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 94/207 (45%), Gaps = 26/207 (12%)
Query: 100 LGEGGFGVV---YKGVIDENVRPGYKTTFVAIKELNRGGYQGD---REWLAEVNYLGQLR 153
           +G G  G+V   Y  +++ NV         AIK+L+R  +Q     +    E+  +  + 
Sbjct: 34  IGSGAQGIVCAAYDAILERNV---------AIKKLSRP-FQNQTHAKRAYRELVLMKCVN 83
Query: 154 HSNLVKLIGYCCED---EHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGL 210
           H N++ L+         E    VY  ME   ++ +L + +   L   R   +      G+
Sbjct: 84  HKNIIGLLNVFTPQKSLEEFQDVYIVMEL--MDANLCQVIQMELDHERMSYLLYQMLCGI 141
Query: 211 AFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAP 270
             LH A   +I+RD K SNI++ +D + K+ DFGLA+    G    +   V+  Y Y AP
Sbjct: 142 KHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMVPFVVTRY-YRAP 196
Query: 271 EYVMTGHLTARSDVYGFGVVLLEMLLG 297
           E ++        D++  G ++ EM+ G
Sbjct: 197 EVILGMGYKENVDIWSVGCIMGEMIKG 223

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 52/202 (25%), Positives = 93/202 (46%), Gaps = 16/202 (7%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVK 159
           LG+G F VV + V  +     +    +  K+L+   +Q       E     +L+H N+V+
Sbjct: 37  LGKGAFSVVRRCV-HKTTGLEFAAKIINTKKLSARDFQKLER---EARICRKLQHPNIVR 92
Query: 160 LIGYCCEDEHRILVYEYMESGSL-EKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAER 218
           L     E+    LV++ +  G L E  + R        S  ++  L++   +A+ H    
Sbjct: 93  LHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILES---IAYCHS--N 147
Query: 219 PVIYRDFKTSNILLNADF---SAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMT 275
            +++R+ K  N+LL +     + KL+DFGLA +    +  H      GT GY +PE +  
Sbjct: 148 GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWH---GFAGTPGYLSPEVLKK 204
Query: 276 GHLTARSDVYGFGVVLLEMLLG 297
              +   D++  GV+L  +L+G
Sbjct: 205 DPYSKPVDIWACGVILYILLVG 226

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 102/212 (48%), Gaps = 30/212 (14%)
Query: 99  ILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLV 158
           ++G G FGVVY+  + ++         VAIK++ +     +RE    +  + +L H N+V
Sbjct: 27  VIGNGSFGVVYQAKLCDS------GELVAIKKVLQDKRFKNRE----LQIMRKLDHCNIV 76
Query: 159 KLIGYCC-----EDEHRI-LVYEYMESG--SLEKHLLRRVGCMLTWSRRMKIALDAAKGL 210
           +L  +       +DE  + LV +Y+      + +H  R    +     ++ +     + L
Sbjct: 77  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYM-YQLFRSL 135
Query: 211 AFLHGAERPVIYRDFKTSNILLNADFSA-KLSDFGLAKDGPMGDQ--THVSTRVMGTYGY 267
           A++H     + +RD K  N+LL+ D +  KL DFG AK    G+   +++ +R      Y
Sbjct: 136 AYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-----Y 188
Query: 268 AAPEYVM-TGHLTARSDVYGFGVVLLEMLLGR 298
            APE +      T+  DV+  G VL E+LLG+
Sbjct: 189 RAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 51/208 (24%), Positives = 94/208 (45%), Gaps = 26/208 (12%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNR---GGYQGDREWLAEVNYLGQLRHSN 156
           +G G +G V       + + G +   VA+K+L+R         R +  E+  L  ++H N
Sbjct: 30  VGSGAYGSVCAAF---DTKTGLR---VAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHEN 82
Query: 157 LVKLI-----GYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLA 211
           ++ L+         E+ + + +  ++    L   +  +    LT      +     +GL 
Sbjct: 83  VIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKSQ---KLTDDHVQFLIYQILRGLK 139
Query: 212 FLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPE 271
           ++H A+  +I+RD K SN+ +N D   K+ DFGL +        +V+TR      Y APE
Sbjct: 140 YIHSAD--IIHRDLKPSNLAVNEDSELKILDFGLCRHTDDEMTGYVATR-----WYRAPE 192
Query: 272 YVMTG-HLTARSDVYGFGVVLLEMLLGR 298
            ++   H     D++  G ++ E+L GR
Sbjct: 193 IMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 57/221 (25%), Positives = 92/221 (41%), Gaps = 49/221 (22%)
Query: 100 LGEGGFGVVYKG-------------VIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEV 146
           +G+G FG V+K              V+ EN + G+  T                  L E+
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITA-----------------LREI 68
Query: 147 NYLGQLRHSNLVKLIGYC---------CEDEHRILVYEYMESGSLEKHLLRRVGCMLTWS 197
             L  L+H N+V LI  C         C+     LV+++ E       LL  V    T S
Sbjct: 69  KILQLLKHENVVNLIEICRTKASPYNRCKGS-IYLVFDFCEHDL--AGLLSNVLVKFTLS 125
Query: 198 RRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTH- 256
              ++      GL ++H  +  +++RD K +N+L+  D   KL+DFGLA+   +   +  
Sbjct: 126 EIKRVMQMLLNGLYYIHRNK--ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQP 183
Query: 257 --VSTRVMGTYGYAAPEYVM-TGHLTARSDVYGFGVVLLEM 294
                RV+ T  Y  PE ++         D++G G ++ EM
Sbjct: 184 NRYXNRVV-TLWYRPPELLLGERDYGPPIDLWGAGCIMAEM 223

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 71/257 (27%), Positives = 110/257 (42%), Gaps = 38/257 (14%)
Query: 94  FRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLR 153
           F+ + + G+G FG V  G      +       VAIK++ +     +RE L  +  L  L 
Sbjct: 25  FQVERMAGQGTFGTVQLG------KEKSTGMSVAIKKVIQDPRFRNRE-LQIMQDLAVLH 77
Query: 154 HSNLVKLIGYCC-------EDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRR------- 199
           H N+V+L  Y          D +  +V EY+         L R  C   + RR       
Sbjct: 78  HPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDT------LHR--CCRNYYRRQVAPPPI 129
Query: 200 -MKIAL-DAAKGLAFLHGAERPVIYRDFKTSNILLN-ADFSAKLSDFGLAKDGPMGDQTH 256
            +K+ L    + +  LH     V +RD K  N+L+N AD + KL DFG AK       + 
Sbjct: 130 LIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKL---SPSE 186
Query: 257 VSTRVMGTYGYAAPEYVM-TGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEW 315
            +   + +  Y APE +    H T   D++  G +  EM+LG         + +  L E 
Sbjct: 187 PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQ--LHEI 244
Query: 316 ARPLLNNNKKVLRILDP 332
            R L   +++VLR L+P
Sbjct: 245 VRVLGCPSREVLRKLNP 261

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 68/278 (24%), Positives = 112/278 (40%), Gaps = 39/278 (14%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVA---IKELNRGGYQGDREWLAEVNYLGQLRHSN 156
           LG G F VV K   +++    Y   F+     K   RG  + D E   EV+ L +++H N
Sbjct: 19  LGSGQFAVV-KKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIE--REVSILKEIQHPN 75
Query: 157 LVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGA 216
           ++ L          IL+ E +  G L   L  +    LT     +       G+ +LH  
Sbjct: 76  VITLHEVYENKTDVILILELVAGGELFDFLAEKES--LTEEEATEFLKQILNGVYYLHSL 133
Query: 217 ERPVIYRDFKTSNI-LLNADF---SAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEY 272
           +  + + D K  NI LL+ +      K+ DFGLA     G++      + GT  + APE 
Sbjct: 134 Q--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK---NIFGTPAFVAPEI 188
Query: 273 VMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKV----LR 328
           V    L   +D++  GV+   +L G                  A P L + K+     + 
Sbjct: 189 VNYEPLGLEADMWSIGVITYILLSG------------------ASPFLGDTKQETLANVS 230
Query: 329 ILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSD 366
            ++   E +Y + T+        + L ++PK R  + D
Sbjct: 231 AVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQD 268

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 83/203 (40%), Gaps = 19/203 (9%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKEL--NRGGYQGDREWLAEVNYLGQLRHSNL 157
           +GEG +GVV+K       R       VAIK+   +       +  L E+  L QL+H NL
Sbjct: 11  IGEGSYGVVFK------CRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNL 64
Query: 158 VKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAE 217
           V L+          LV+EY +   L  H L R    +       I     + + F H   
Sbjct: 65  VNLLEVFRRKRRLHLVFEYCDHTVL--HELDRYQRGVPEHLVKSITWQTLQAVNFCHKHN 122
Query: 218 RPVIYRDFKTSNILLNADFSAKLSDFGLAK--DGPMGDQTHVSTRVMGTYGYAAPEYVM- 274
              I+RD K  NIL+      KL DFG A+   GP    +      + T  Y +PE ++ 
Sbjct: 123 --CIHRDVKPENILITKHSVIKLCDFGFARLLTGP----SDYYDDEVATRWYRSPELLVG 176
Query: 275 TGHLTARSDVYGFGVVLLEMLLG 297
                   DV+  G V  E+L G
Sbjct: 177 DTQYGPPVDVWAIGCVFAELLSG 199

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 95/207 (45%), Gaps = 26/207 (12%)
Query: 100 LGEGGFGVV---YKGVIDENVRPGYKTTFVAIKELNRGGYQGD---REWLAEVNYLGQLR 153
           +G G  G+V   Y  +++ NV         AIK+L+R  +Q     +    E+  +  + 
Sbjct: 32  IGSGAQGIVCAAYDAILERNV---------AIKKLSRP-FQNQTHAKRAYRELVLMKVVN 81
Query: 154 HSNLVKLIGYCCED---EHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGL 210
           H N++ L+         E    VY  ME   ++ +L + +   L   R   +      G+
Sbjct: 82  HKNIIGLLNVFTPQKSLEEFQDVYIVMEL--MDANLSQVIQMELDHERMSYLLYQMLCGI 139
Query: 211 AFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAP 270
             LH A   +I+RD K SNI++ +D + K+ DFGLA+    G    ++  V+  Y Y AP
Sbjct: 140 KHLHSAG--IIHRDLKPSNIVVKSDATLKILDFGLARTA--GTSFMMTPYVVTRY-YRAP 194
Query: 271 EYVMTGHLTARSDVYGFGVVLLEMLLG 297
           E ++        D++  G ++ EM+ G
Sbjct: 195 EVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 53/209 (25%), Positives = 94/209 (44%), Gaps = 28/209 (13%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNR---GGYQGDREWLAEVNYLGQLRHSN 156
           +G G +G V       + + G +   VA+K+L+R         R +  E+  L  ++H N
Sbjct: 30  VGSGAYGSVCAAF---DTKTGLR---VAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHEN 82
Query: 157 LVKLI-----GYCCEDEHRILVYEYMESGSLEKHLLRRVGCM-LTWSRRMKIALDAAKGL 210
           ++ L+         E+ + + +  ++    L       V C  LT      +     +GL
Sbjct: 83  VIGLLDVFTPARSLEEFNDVYLVTHLMGADLNN----IVKCQKLTDDHVQFLIYQILRGL 138
Query: 211 AFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAP 270
            ++H A+  +I+RD K SN+ +N D   K+ D GLA+        +V+TR      Y AP
Sbjct: 139 KYIHSAD--IIHRDLKPSNLAVNEDCELKILDRGLARHTDDEMTGYVATR-----WYRAP 191
Query: 271 EYVMTG-HLTARSDVYGFGVVLLEMLLGR 298
           E ++   H     D++  G ++ E+L GR
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 95/207 (45%), Gaps = 26/207 (12%)
Query: 100 LGEGGFGVV---YKGVIDENVRPGYKTTFVAIKELNRGGYQGD---REWLAEVNYLGQLR 153
           +G G  G+V   Y  +++ NV         AIK+L+R  +Q     +    E+  +  + 
Sbjct: 32  IGSGAQGIVCAAYDAILERNV---------AIKKLSRP-FQNQTHAKRAYRELVLMKCVN 81
Query: 154 HSNLVKLIGYCCED---EHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGL 210
           H N++ L+         E    VY  ME   ++ +L + +   L   R   +      G+
Sbjct: 82  HKNIIGLLNVFTPQKSLEEFQDVYIVMEL--MDANLSQVIQMELDHERMSYLLYQMLCGI 139
Query: 211 AFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAP 270
             LH A   +I+RD K SNI++ +D + K+ DFGLA+    G    ++  V+  Y Y AP
Sbjct: 140 KHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVVTRY-YRAP 194
Query: 271 EYVMTGHLTARSDVYGFGVVLLEMLLG 297
           E ++        D++  G ++ EM+ G
Sbjct: 195 EVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 100/210 (47%), Gaps = 26/210 (12%)
Query: 99  ILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLV 158
           ++G G FGVVY+  + ++         VAIK++ +     +RE    +  + +L H N+V
Sbjct: 27  VIGNGSFGVVYQAKLCDS------GELVAIKKVLQDKRFKNRE----LQIMRKLDHCNIV 76
Query: 159 KLIGYCC-----EDEHRI-LVYEYMESG--SLEKHLLRRVGCMLTWSRRMKIALDAAKGL 210
           +L  +       +DE  + LV +Y+      + +H  R    +     ++ +     + L
Sbjct: 77  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYM-YQLFRSL 135
Query: 211 AFLHGAERPVIYRDFKTSNILLNADFSA-KLSDFGLAKDGPMGDQTHVSTRVMGTYGYAA 269
           A++H     + +RD K  N+LL+ D +  KL DFG AK    G+    +   + +  Y A
Sbjct: 136 AYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP---NVSXICSRYYRA 190
Query: 270 PEYVM-TGHLTARSDVYGFGVVLLEMLLGR 298
           PE +      T+  DV+  G VL E+LLG+
Sbjct: 191 PELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 55/214 (25%), Positives = 94/214 (43%), Gaps = 29/214 (13%)
Query: 94  FRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQG---DREWLAEVNYLG 150
            RP   +G G +G V     D  +R       VA+K+L+R  +Q     R    E+  L 
Sbjct: 33  LRP---VGSGAYGSVCSAY-DARLRQK-----VAVKKLSRP-FQSLIHARRTYRELRLLK 82
Query: 151 QLRHSNLVKLI-----GYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALD 205
            L+H N++ L+         ED   + +   +    L   +  +    L+      +   
Sbjct: 83  HLKHENVIGLLDVFTPATSIEDFSEVYLVTTLMGADLNNIVKSQA---LSDEHVQFLVYQ 139
Query: 206 AAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTY 265
             +GL ++H A   +I+RD K SN+ +N D   ++ DFGLA+        +V+TR     
Sbjct: 140 LLRGLKYIHSA--GIIHRDLKPSNVAVNEDSELRILDFGLARQADEEMTGYVATR----- 192
Query: 266 GYAAPEYVMTG-HLTARSDVYGFGVVLLEMLLGR 298
            Y APE ++   H     D++  G ++ E+L G+
Sbjct: 193 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLQGK 226

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 100/210 (47%), Gaps = 26/210 (12%)
Query: 99  ILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLV 158
           ++G G FGVVY+  + ++         VAIK++ +     +RE    +  + +L H N+V
Sbjct: 27  VIGNGSFGVVYQAKLCDS------GELVAIKKVLQDKRFKNRE----LQIMRKLDHCNIV 76
Query: 159 KLIGYCC-----EDEHRI-LVYEYMESG--SLEKHLLRRVGCMLTWSRRMKIALDAAKGL 210
           +L  +       +DE  + LV +Y+      + +H  R    +     ++ +     + L
Sbjct: 77  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYM-YQLFRSL 135
Query: 211 AFLHGAERPVIYRDFKTSNILLNADFSA-KLSDFGLAKDGPMGDQTHVSTRVMGTYGYAA 269
           A++H     + +RD K  N+LL+ D +  KL DFG AK    G+    +   + +  Y A
Sbjct: 136 AYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP---NVSXICSRYYRA 190
Query: 270 PEYVM-TGHLTARSDVYGFGVVLLEMLLGR 298
           PE +      T+  DV+  G VL E+LLG+
Sbjct: 191 PELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 94/213 (44%), Gaps = 24/213 (11%)
Query: 99  ILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLR-HSNL 157
           +LGEG +  V   V  +N +        A+K + +           EV  L Q + + N+
Sbjct: 20  LLGEGAYAKVQGAVSLQNGKE------YAVKIIEKQAGHSRSRVFREVETLYQCQGNKNI 73
Query: 158 VKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAE 217
           ++LI +  +D    LV+E ++ GS+  H+ ++           ++  D A  L FLH   
Sbjct: 74  LELIEFFEDDTRFYLVFEKLQGGSILAHIQKQK--HFNEREASRVVRDVAAALDFLH--T 129
Query: 218 RPVIYRDFKTSNILLNAD---FSAKLSDFGLAKDGPMGDQ-THVSTRVM----GTYGYAA 269
           + + +RD K  NIL  +       K+ DF L     + +  T ++T  +    G+  Y A
Sbjct: 130 KGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMA 189
Query: 270 PEY--VMTGHLT---ARSDVYGFGVVLLEMLLG 297
           PE   V T   T    R D++  GVVL  ML G
Sbjct: 190 PEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSG 222

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 92/209 (44%), Gaps = 25/209 (11%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFV-AIKELNRGGYQGDREWLAEVNYLGQLRHSNLV 158
           +G+G FG V+K     + + G K      + E  + G+      L E+  L  L+H N+V
Sbjct: 26  IGQGTFGEVFKA---RHRKTGQKVALKKVLMENEKEGFPITA--LREIKILQLLKHENVV 80
Query: 159 KLIGYC---------CEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKG 209
            LI  C         C+     LV+++ E       LL  V    T S   ++      G
Sbjct: 81  NLIEICRTKASPYNRCK-ASIYLVFDFCEHDL--AGLLSNVLVKFTLSEIKRVMQMLLNG 137
Query: 210 LAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTH---VSTRVMGTYG 266
           L ++H     +++RD K +N+L+  D   KL+DFGLA+   +   +       RV+ T  
Sbjct: 138 LYYIH--RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVV-TLW 194
Query: 267 YAAPEYVM-TGHLTARSDVYGFGVVLLEM 294
           Y  PE ++         D++G G ++ EM
Sbjct: 195 YRPPELLLGERDYGPPIDLWGAGCIMAEM 223

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 95/207 (45%), Gaps = 26/207 (12%)
Query: 100 LGEGGFGVV---YKGVIDENVRPGYKTTFVAIKELNRGGYQGD---REWLAEVNYLGQLR 153
           +G G  G+V   Y  +++ NV         AIK+L+R  +Q     +    E+  +  + 
Sbjct: 32  IGSGAQGIVCAAYDAILERNV---------AIKKLSRP-FQNQTHAKRAYRELVLMKCVN 81
Query: 154 HSNLVKLIGYCCED---EHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGL 210
           H N++ L+         E    VY  ME   ++ +L + +   L   R   +      G+
Sbjct: 82  HKNIIGLLNVFTPQKSLEEFQDVYIVMEL--MDANLSQVIQMELDHERMSYLLYQMLCGI 139
Query: 211 AFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAP 270
             LH A   +I+RD K SNI++ +D + K+ DFGLA+    G    ++  V+  Y Y AP
Sbjct: 140 KHLHSAG--IIHRDLKPSNIVVKSDATLKILDFGLARTA--GTSFMMTPYVVTRY-YRAP 194
Query: 271 EYVMTGHLTARSDVYGFGVVLLEMLLG 297
           E ++        D++  G ++ EM+ G
Sbjct: 195 EVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 99/210 (47%), Gaps = 26/210 (12%)
Query: 99  ILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLV 158
           ++G G FGVVY+  + ++         VAIK++     Q  R    E+  + +L H N+V
Sbjct: 28  VIGNGSFGVVYQAKLCDS------GELVAIKKV----LQDKRFKNRELQIMRKLDHCNIV 77
Query: 159 KLIGYCC-----EDEHRI-LVYEYMESG--SLEKHLLRRVGCMLTWSRRMKIALDAAKGL 210
           +L  +       +DE  + LV +Y+      + +H  R    +     ++ +     + L
Sbjct: 78  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYM-YQLFRSL 136
Query: 211 AFLHGAERPVIYRDFKTSNILLNADFSA-KLSDFGLAKDGPMGDQTHVSTRVMGTYGYAA 269
           A++H     + +RD K  N+LL+ D +  KL DFG AK    G+    +   + +  Y A
Sbjct: 137 AYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP---NVSXICSRYYRA 191
Query: 270 PEYVM-TGHLTARSDVYGFGVVLLEMLLGR 298
           PE +      T+  DV+  G VL E+LLG+
Sbjct: 192 PELIFGATDYTSSIDVWSAGCVLAELLLGQ 221

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 99/210 (47%), Gaps = 26/210 (12%)
Query: 99  ILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLV 158
           ++G G FGVVY+  + ++         VAIK++     Q  R    E+  + +L H N+V
Sbjct: 31  VIGNGSFGVVYQAKLCDS------GELVAIKKV----LQDKRFKNRELQIMRKLDHCNIV 80
Query: 159 KLIGYCC-----EDEHRI-LVYEYMESG--SLEKHLLRRVGCMLTWSRRMKIALDAAKGL 210
           +L  +       +DE  + LV +Y+      + +H  R    +     ++ +     + L
Sbjct: 81  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYM-YQLFRSL 139
Query: 211 AFLHGAERPVIYRDFKTSNILLNADFSA-KLSDFGLAKDGPMGDQTHVSTRVMGTYGYAA 269
           A++H     + +RD K  N+LL+ D +  KL DFG AK    G+    +   + +  Y A
Sbjct: 140 AYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP---NVSXICSRYYRA 194
Query: 270 PEYVM-TGHLTARSDVYGFGVVLLEMLLGR 298
           PE +      T+  DV+  G VL E+LLG+
Sbjct: 195 PELIFGATDYTSSIDVWSAGCVLAELLLGQ 224

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 72/295 (24%), Positives = 125/295 (42%), Gaps = 52/295 (17%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNR-----------------GGYQGDR-- 140
           +G+G +GVV K   +EN    Y    ++ K+L R                 GG    R  
Sbjct: 21  IGKGSYGVV-KLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGP 79
Query: 141 --EWLAEVNYLGQLRHSNLVKLIGYCCE--DEHRILVYEYMESGS-LEKHLLRRVGCMLT 195
             +   E+  L +L H N+VKL+    +  ++H  +V+E +  G  +E   L+     L+
Sbjct: 80  IEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKP----LS 135
Query: 196 WSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQT 255
             +      D  KG+ +LH   + +I+RD K SN+L+  D   K++DFG++ +    D  
Sbjct: 136 EDQARFYFQDLIKGIEYLH--YQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDAL 193
Query: 256 HVSTRVMGTYGYAAPEYVMTGH--LTARS-DVYGFGVVLLEMLLGRRAVDKSRPSREHNL 312
             +T  +GT  + APE +       + ++ DV+  GV L   + G+      R    H+ 
Sbjct: 194 LSNT--VGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCLHS- 250
Query: 313 VEWARPLLNNNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDV 367
                          +I    LE       A  +  L  + L +NP+ R V+ ++
Sbjct: 251 ---------------KIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEI 290

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 53/209 (25%), Positives = 94/209 (44%), Gaps = 28/209 (13%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNR---GGYQGDREWLAEVNYLGQLRHSN 156
           +G G +G V       + + G +   VA+K+L+R         R +  E+  L  ++H N
Sbjct: 30  VGSGAYGSVCAAF---DTKTGLR---VAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHEN 82
Query: 157 LVKLI-----GYCCEDEHRILVYEYMESGSLEKHLLRRVGCM-LTWSRRMKIALDAAKGL 210
           ++ L+         E+ + + +  ++    L       V C  LT      +     +GL
Sbjct: 83  VIGLLDVFTPARSLEEFNDVYLVTHLMGADLNN----IVKCQKLTDDHVQFLIYQILRGL 138
Query: 211 AFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAP 270
            ++H A+  +I+RD K SN+ +N D   K+ D GLA+        +V+TR      Y AP
Sbjct: 139 KYIHSAD--IIHRDLKPSNLAVNEDCELKILDGGLARHTDDEMTGYVATR-----WYRAP 191
Query: 271 EYVMTG-HLTARSDVYGFGVVLLEMLLGR 298
           E ++   H     D++  G ++ E+L GR
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 54/201 (26%), Positives = 83/201 (41%), Gaps = 17/201 (8%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVK 159
           +G G FGV         +R       VA+K + RG           +N+   LRH N+V+
Sbjct: 27  IGSGNFGVA------RLMRDKQSNELVAVKYIERGEKIAANVKREIINH-RSLRHPNIVR 79
Query: 160 LIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERP 219
                    H  +V EY   G L + +          +R     L    G+++ H  +  
Sbjct: 80  FKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQL--ISGVSYCHAMQ-- 135
Query: 220 VIYRDFKTSNILLNADFSA--KLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGH 277
           V +RD K  N LL+   +   K+ DFG +K   +  Q       +GT  Y APE ++   
Sbjct: 136 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLKKE 192
Query: 278 LTAR-SDVYGFGVVLLEMLLG 297
              + +DV+  GV L  ML+G
Sbjct: 193 YDGKVADVWSCGVTLYVMLVG 213

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 98/210 (46%), Gaps = 26/210 (12%)
Query: 99  ILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLV 158
           ++G G FGVVY+  + ++         VAIK++     Q  R    E+  + +L H N+V
Sbjct: 27  VIGNGSFGVVYQAKLCDS------GELVAIKKV----LQDKRFKNRELQIMRKLDHCNIV 76
Query: 159 KL--IGYCCEDEHRI----LVYEYMESG--SLEKHLLRRVGCMLTWSRRMKIALDAAKGL 210
           +L    Y   ++  +    LV +Y+      + +H  R    +     ++ +     + L
Sbjct: 77  RLRYFFYSSGEKKDVVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYM-YQLFRSL 135
Query: 211 AFLHGAERPVIYRDFKTSNILLNADFSA-KLSDFGLAKDGPMGDQTHVSTRVMGTYGYAA 269
           A++H     + +RD K  N+LL+ D +  KL DFG AK    G+    +   + +  Y A
Sbjct: 136 AYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP---NVSXICSRYYRA 190
Query: 270 PEYVM-TGHLTARSDVYGFGVVLLEMLLGR 298
           PE +      T+  DV+  G VL E+LLG+
Sbjct: 191 PELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 57/221 (25%), Positives = 91/221 (41%), Gaps = 49/221 (22%)
Query: 100 LGEGGFGVVYKG-------------VIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEV 146
           +G+G FG V+K              V+ EN + G+  T                  L E+
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITA-----------------LREI 68
Query: 147 NYLGQLRHSNLVKLIGYC---------CEDEHRILVYEYMESGSLEKHLLRRVGCMLTWS 197
             L  L+H N+V LI  C         C+     LV+++ E       LL  V    T S
Sbjct: 69  KILQLLKHENVVNLIEICRTKASPYNRCKGS-IYLVFDFCEHDL--AGLLSNVLVKFTLS 125
Query: 198 RRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTH- 256
              ++      GL ++H     +++RD K +N+L+  D   KL+DFGLA+   +   +  
Sbjct: 126 EIKRVMQMLLNGLYYIH--RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQP 183
Query: 257 --VSTRVMGTYGYAAPEYVM-TGHLTARSDVYGFGVVLLEM 294
                RV+ T  Y  PE ++         D++G G ++ EM
Sbjct: 184 NRYXNRVV-TLWYRPPELLLGERDYGPPIDLWGAGCIMAEM 223

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 38/132 (28%), Positives = 65/132 (49%), Gaps = 13/132 (9%)
Query: 172 LVYEYMESGSLEKH------LLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDF 225
           ++YEYME+ S+ K       L +   C +       I        +++H  E+ + +RD 
Sbjct: 120 IIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHN-EKNICHRDV 178
Query: 226 KTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVM--TGHLTARSD 283
           K SNIL++ +   KLSDFG ++   M D+    +R  GTY +  PE+    + +  A+ D
Sbjct: 179 KPSNILMDKNGRVKLSDFGESE--YMVDKKIKGSR--GTYEFMPPEFFSNESSYNGAKVD 234
Query: 284 VYGFGVVLLEML 295
           ++  G+ L  M 
Sbjct: 235 IWSLGICLYVMF 246

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 45/155 (29%), Positives = 69/155 (44%), Gaps = 9/155 (5%)
Query: 143 LAEVNYLGQLRHSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKI 202
           L E   L  +    LVKL     ++ +  +V EY+  G +  HL RR+G       R   
Sbjct: 110 LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL-RRIGRFSEPHARF-Y 167
Query: 203 ALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVM 262
           A        +LH  +  +IYRD K  N+L++     +++DFG AK       T     + 
Sbjct: 168 AAQIVLTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGATWT-----LC 220
Query: 263 GTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLG 297
           GT  Y APE +++       D +  GV++ EM  G
Sbjct: 221 GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 255

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 92/209 (44%), Gaps = 25/209 (11%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFV-AIKELNRGGYQGDREWLAEVNYLGQLRHSNLV 158
           +G+G FG V+K     + + G K      + E  + G+      L E+  L  L+H N+V
Sbjct: 25  IGQGTFGEVFKA---RHRKTGQKVALKKVLMENEKEGFPITA--LREIKILQLLKHENVV 79
Query: 159 KLIGYC---------CEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKG 209
            LI  C         C+     LV+++ E       LL  V    T S   ++      G
Sbjct: 80  NLIEICRTKASPYNRCKGS-IYLVFDFCEHDL--AGLLSNVLVKFTLSEIKRVMQMLLNG 136
Query: 210 LAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTH---VSTRVMGTYG 266
           L ++H     +++RD K +N+L+  D   KL+DFGLA+   +   +       RV+ T  
Sbjct: 137 LYYIH--RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVV-TLW 193
Query: 267 YAAPEYVM-TGHLTARSDVYGFGVVLLEM 294
           Y  PE ++         D++G G ++ EM
Sbjct: 194 YRPPELLLGERDYGPPIDLWGAGCIMAEM 222

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 63/238 (26%), Positives = 106/238 (44%), Gaps = 34/238 (14%)
Query: 77  SNVDIFT----YNEMKLATKFFRPDYIL----GEGGFGVVYKGVIDENVRPGYKTTFVAI 128
           S VD+ T    +  M   T+F   DY L    G+G F VV +  + +     Y    +  
Sbjct: 9   SGVDLGTENLYFQXMATCTRF-TDDYQLFEELGKGAFSVV-RRCVKKTPTQEYAAKIINT 66
Query: 129 KELNRGGYQG-DREWLAEVNYLGQLRHSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLL 187
           K+L+   +Q  +RE  A +  L  L+H N+V+L     E+    LV++ +  G L + ++
Sbjct: 67  KKLSARDHQKLERE--ARICRL--LKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIV 122
Query: 188 RRVGCMLTWSRRMKIALDAAKGLAFL-----HGAERPVIYRDFKTSNILLNADF---SAK 239
                    +R      DA+  +  +     H  +  +++RD K  N+LL +     + K
Sbjct: 123 ---------AREYYSEADASHCIHQILESVNHIHQHDIVHRDLKPENLLLASKCKGAAVK 173
Query: 240 LSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLG 297
           L+DFGLA +     Q        GT GY +PE +         D++  GV+L  +L+G
Sbjct: 174 LADFGLAIEVQGEQQAWFG--FAGTPGYLSPEVLRKDPYGKPVDIWACGVILYILLVG 229

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 57/219 (26%), Positives = 98/219 (44%), Gaps = 32/219 (14%)
Query: 100 LGEGGFGVV---YKGVIDENVRPGYKTTFVAIKELNRGGYQGD---REWLAEVNYLGQLR 153
           +G G  G+V   Y  +++ NV         AIK+L+R  +Q     +    E+  +  + 
Sbjct: 32  IGSGAQGIVCAAYDAILERNV---------AIKKLSRP-FQNQTHAKRAYRELVLMKCVN 81
Query: 154 HSNLVKLIGYCCED---EHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGL 210
           H N++ L+         E    VY  ME   ++ +L + +   L   R   +      G+
Sbjct: 82  HKNIIGLLNVFTPQKSLEEFQDVYIVMEL--MDANLCQVIQMELDHERMSYLLYQMLCGI 139
Query: 211 AFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAP 270
             LH A   +I+RD K SNI++ +D + K+ DFGLA+    G    +   V+  Y Y AP
Sbjct: 140 KHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMEPEVVTRY-YRAP 194
Query: 271 EYVMTGHLTARSDVYGFGVVLLEMLL------GRRAVDK 303
           E ++        D++  G ++ EM+       GR  +D+
Sbjct: 195 EVILGMGYKENVDIWSVGCIMGEMVCHKILFPGRDYIDQ 233

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 48/201 (23%), Positives = 91/201 (45%), Gaps = 14/201 (6%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVK 159
           LG+G F VV +  + +     +    +  K+L+   +Q       E     +L+H N+V+
Sbjct: 14  LGKGAFSVV-RRCVHKTTGLEFAAKIINTKKLSARDFQKLER---EARICRKLQHPNIVR 69
Query: 160 LIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERP 219
           L     E+    LV++ +  G L + ++ R     + +          + +A+ H     
Sbjct: 70  LHDSIQEESFHYLVFDLVTGGELFEDIVARE--FYSEADASHCIQQILESIAYCHS--NG 125
Query: 220 VIYRDFKTSNILLNADF---SAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTG 276
           +++R+ K  N+LL +     + KL+DFGLA +    +  H      GT GY +PE +   
Sbjct: 126 IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWH---GFAGTPGYLSPEVLKKD 182
Query: 277 HLTARSDVYGFGVVLLEMLLG 297
             +   D++  GV+L  +L+G
Sbjct: 183 PYSKPVDIWACGVILYILLVG 203

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 68/278 (24%), Positives = 112/278 (40%), Gaps = 39/278 (14%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVA---IKELNRGGYQGDREWLAEVNYLGQLRHSN 156
           LG G F VV K   +++    Y   F+     K   RG  + D E   EV+ L +++H N
Sbjct: 18  LGSGQFAVV-KKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIE--REVSILKEIQHPN 74
Query: 157 LVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGA 216
           ++ L          IL+ E +  G L   L  +    LT     +       G+ +LH  
Sbjct: 75  VITLHEVYENKTDVILILELVAGGELFDFLAEKES--LTEEEATEFLKQILNGVYYLHSL 132
Query: 217 ERPVIYRDFKTSNI-LLNADFS---AKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEY 272
           +  + + D K  NI LL+ +      K+ DFGLA     G++      + GT  + APE 
Sbjct: 133 Q--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF---KNIFGTPEFVAPEI 187
Query: 273 VMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKV----LR 328
           V    L   +D++  GV+   +L G                  A P L + K+     + 
Sbjct: 188 VNYEPLGLEADMWSIGVITYILLSG------------------ASPFLGDTKQETLANVS 229
Query: 329 ILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSD 366
            ++   E +Y + T+        + L ++PK R  + D
Sbjct: 230 AVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQD 267

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 68/278 (24%), Positives = 112/278 (40%), Gaps = 39/278 (14%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVA---IKELNRGGYQGDREWLAEVNYLGQLRHSN 156
           LG G F VV K   +++    Y   F+     K   RG  + D E   EV+ L +++H N
Sbjct: 18  LGSGQFAVV-KKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIE--REVSILKEIQHPN 74
Query: 157 LVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGA 216
           ++ L          IL+ E +  G L   L  +    LT     +       G+ +LH  
Sbjct: 75  VITLHEVYENKTDVILILELVAGGELFDFLAEKES--LTEEEATEFLKQILNGVYYLHSL 132
Query: 217 ERPVIYRDFKTSNI-LLNADFS---AKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEY 272
           +  + + D K  NI LL+ +      K+ DFGLA     G++      + GT  + APE 
Sbjct: 133 Q--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF---KNIFGTPEFVAPEI 187
Query: 273 VMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKV----LR 328
           V    L   +D++  GV+   +L G                  A P L + K+     + 
Sbjct: 188 VNYEPLGLEADMWSIGVITYILLSG------------------ASPFLGDTKQETLANVS 229
Query: 329 ILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSD 366
            ++   E +Y + T+        + L ++PK R  + D
Sbjct: 230 AVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQD 267

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 68/279 (24%), Positives = 112/279 (40%), Gaps = 41/279 (14%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVA---IKELNRGGYQGDREWLAEVNYLGQLRHSN 156
           LG G F VV K   +++    Y   F+     K   RG  + D E   EV+ L +++H N
Sbjct: 19  LGSGQFAVV-KKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIE--REVSILKEIQHPN 75
Query: 157 LVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGA 216
           ++ L          IL+ E +  G L   L  +    LT     +       G+ +LH  
Sbjct: 76  VITLHEVYENKTDVILILELVAGGELFDFLAEKES--LTEEEATEFLKQILNGVYYLHSL 133
Query: 217 ERPVIYRDFKTSNILLNADFSA-----KLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPE 271
           +  + + D K  NI+L  D +      K+ DFGLA     G++      + GT  + APE
Sbjct: 134 Q--IAHFDLKPENIML-LDRNVPKPRIKIIDFGLAHKIDFGNEF---KNIFGTPEFVAPE 187
Query: 272 YVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKV----L 327
            V    L   +D++  GV+   +L G                  A P L + K+     +
Sbjct: 188 IVNYEPLGLEADMWSIGVITYILLSG------------------ASPFLGDTKQETLANV 229
Query: 328 RILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSD 366
             ++   E +Y + T+        + L ++PK R  + D
Sbjct: 230 SAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQD 268

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 68/278 (24%), Positives = 112/278 (40%), Gaps = 39/278 (14%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVA---IKELNRGGYQGDREWLAEVNYLGQLRHSN 156
           LG G F VV K   +++    Y   F+     K   RG  + D E   EV+ L +++H N
Sbjct: 19  LGSGKFAVV-KKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIE--REVSILKEIQHPN 75
Query: 157 LVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGA 216
           ++ L          IL+ E +  G L   L  +    LT     +       G+ +LH  
Sbjct: 76  VITLHEVYENKTDVILILELVAGGELFDFLAEKES--LTEEEATEFLKQILNGVYYLHSL 133
Query: 217 ERPVIYRDFKTSNI-LLNADFS---AKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEY 272
           +  + + D K  NI LL+ +      K+ DFGLA     G++      + GT  + APE 
Sbjct: 134 Q--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF---KNIFGTPEFVAPEI 188
Query: 273 VMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKV----LR 328
           V    L   +D++  GV+   +L G                  A P L + K+     + 
Sbjct: 189 VNYEPLGLEADMWSIGVITYILLSG------------------ASPFLGDTKQETLANVS 230
Query: 329 ILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSD 366
            ++   E +Y + T+        + L ++PK R  + D
Sbjct: 231 AVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQD 268

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 68/278 (24%), Positives = 112/278 (40%), Gaps = 39/278 (14%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVA---IKELNRGGYQGDREWLAEVNYLGQLRHSN 156
           LG G F VV K   +++    Y   F+     K   RG  + D E   EV+ L +++H N
Sbjct: 19  LGSGQFAVV-KKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIE--REVSILKEIQHPN 75
Query: 157 LVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGA 216
           ++ L          IL+ E +  G L   L  +    LT     +       G+ +LH  
Sbjct: 76  VITLHEVYENKTDVILILELVAGGELFDFLAEKES--LTEEEATEFLKQILNGVYYLHSL 133
Query: 217 ERPVIYRDFKTSNI-LLNADF---SAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEY 272
           +  + + D K  NI LL+ +      K+ DFGLA     G++      + GT  + APE 
Sbjct: 134 Q--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK---NIFGTPEFVAPEI 188
Query: 273 VMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKV----LR 328
           V    L   +D++  GV+   +L G                  A P L + K+     + 
Sbjct: 189 VNYEPLGLEADMWSIGVITYILLSG------------------ASPFLGDTKQETLANVS 230
Query: 329 ILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSD 366
            ++   E +Y + T+        + L ++PK R  + D
Sbjct: 231 AVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQD 268

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 49/201 (24%), Positives = 91/201 (45%), Gaps = 14/201 (6%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVK 159
           LG+G F VV + V  +     +    +  K+L+   +Q       E     +L+H N+V+
Sbjct: 14  LGKGAFSVVRRCV-HKTTGLEFAAKIINTKKLSARDFQKLER---EARICRKLQHPNIVR 69
Query: 160 LIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERP 219
           L     E+    LV++ +  G L + ++ R     + +          + +A+ H     
Sbjct: 70  LHDSIQEESFHYLVFDLVTGGELFEDIVARE--FYSEADASHCIQQILESIAYCHS--NG 125
Query: 220 VIYRDFKTSNILLNADF---SAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTG 276
           +++R+ K  N+LL +     + KL+DFGLA +    +  H      GT GY +PE +   
Sbjct: 126 IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWH---GFAGTPGYLSPEVLKKD 182
Query: 277 HLTARSDVYGFGVVLLEMLLG 297
             +   D++  GV+L  +L+G
Sbjct: 183 PYSKPVDIWACGVILYILLVG 203

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 68/278 (24%), Positives = 112/278 (40%), Gaps = 39/278 (14%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVA---IKELNRGGYQGDREWLAEVNYLGQLRHSN 156
           LG G F VV K   +++    Y   F+     K   RG  + D E   EV+ L +++H N
Sbjct: 19  LGSGQFAVV-KKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIE--REVSILKEIQHPN 75
Query: 157 LVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGA 216
           ++ L          IL+ E +  G L   L  +    LT     +       G+ +LH  
Sbjct: 76  VITLHEVYENKTDVILILELVAGGELFDFLAEKES--LTEEEATEFLKQILNGVYYLHSL 133
Query: 217 ERPVIYRDFKTSNI-LLNADFS---AKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEY 272
           +  + + D K  NI LL+ +      K+ DFGLA     G++      + GT  + APE 
Sbjct: 134 Q--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF---KNIFGTPEFVAPEI 188
Query: 273 VMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKV----LR 328
           V    L   +D++  GV+   +L G                  A P L + K+     + 
Sbjct: 189 VNYEPLGLEADMWSIGVITYILLSG------------------ASPFLGDTKQETLANVS 230
Query: 329 ILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSD 366
            ++   E +Y + T+        + L ++PK R  + D
Sbjct: 231 AVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQD 268

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 57/219 (26%), Positives = 99/219 (45%), Gaps = 32/219 (14%)
Query: 100 LGEGGFGVV---YKGVIDENVRPGYKTTFVAIKELNRGGYQGD---REWLAEVNYLGQLR 153
           +G G  G+V   Y  +++ NV         AIK+L+R  +Q     +    E+  +  + 
Sbjct: 37  IGSGAQGIVCAAYDAILERNV---------AIKKLSRP-FQNQTHAKRAYRELVLMKCVN 86
Query: 154 HSNLVKLIGYCCED---EHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGL 210
           H N++ L+         E    VY  ME   ++ +L + +   L   R   +      G+
Sbjct: 87  HKNIIGLLNVFTPQKSLEEFQDVYIVMEL--MDANLCQVIQMELDHERMSYLLYQMLCGI 144
Query: 211 AFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAP 270
             LH A   +I+RD K SNI++ +D + K+ DFGLA+    G    ++  V+  Y Y AP
Sbjct: 145 KHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVVTRY-YRAP 199
Query: 271 EYVMTGHLTARSDVYGFGVVLLEMLL------GRRAVDK 303
           E ++        D++  G ++ EM+       GR  +D+
Sbjct: 200 EVILGMGYKENVDLWSVGCIMGEMVCHKILFPGRDYIDQ 238

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 49/201 (24%), Positives = 91/201 (45%), Gaps = 14/201 (6%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVK 159
           LG+G F VV + V  +     +    +  K+L+   +Q       E     +L+H N+V+
Sbjct: 13  LGKGAFSVVRRCV-HKTTGLEFAAKIINTKKLSARDFQKLER---EARICRKLQHPNIVR 68
Query: 160 LIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERP 219
           L     E+    LV++ +  G L + ++ R     + +          + +A+ H     
Sbjct: 69  LHDSIQEESFHYLVFDLVTGGELFEDIVARE--FYSEADASHCIQQILESIAYCHS--NG 124
Query: 220 VIYRDFKTSNILLNADF---SAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTG 276
           +++R+ K  N+LL +     + KL+DFGLA +    +  H      GT GY +PE +   
Sbjct: 125 IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWH---GFAGTPGYLSPEVLKKD 181
Query: 277 HLTARSDVYGFGVVLLEMLLG 297
             +   D++  GV+L  +L+G
Sbjct: 182 PYSKPVDIWACGVILYILLVG 202

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 94/219 (42%), Gaps = 24/219 (10%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVK 159
           LGEGGF  V    + E +  G+   F A+K +     Q   E   E +      H N+++
Sbjct: 37  LGEGGFSYV---DLVEGLHDGH---FYALKRILCHEQQDREEAQREADMHRLFNHPNILR 90
Query: 160 LIGYCCED----EHRILVYEYMESGSL--EKHLLRRVGCMLTWSRRMKIALDAAKGLAFL 213
           L+ YC  +        L+  + + G+L  E   L+  G  LT  + + + L   +GL  +
Sbjct: 91  LVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAI 150
Query: 214 HGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPM---GDQTHVSTRVMG----TYG 266
           H   +   +RD K +NILL  +    L D G      +   G +  ++ +       T  
Sbjct: 151 HA--KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTIS 208
Query: 267 YAAPE-YVMTGH--LTARSDVYGFGVVLLEMLLGRRAVD 302
           Y APE + +  H  +  R+DV+  G VL  M+ G    D
Sbjct: 209 YRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYD 247

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 68/278 (24%), Positives = 112/278 (40%), Gaps = 39/278 (14%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVA---IKELNRGGYQGDREWLAEVNYLGQLRHSN 156
           LG G F VV K   +++    Y   F+     K   RG  + D E   EV+ L +++H N
Sbjct: 19  LGSGQFAVV-KKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIE--REVSILKEIQHPN 75
Query: 157 LVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGA 216
           ++ L          IL+ E +  G L   L  +    LT     +       G+ +LH  
Sbjct: 76  VITLHEVYENKTDVILILELVAGGELFDFLAEKES--LTEEEATEFLKQILNGVYYLHSL 133
Query: 217 ERPVIYRDFKTSNI-LLNADFS---AKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEY 272
           +  + + D K  NI LL+ +      K+ DFGLA     G++      + GT  + APE 
Sbjct: 134 Q--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK---NIFGTPEFVAPEI 188
Query: 273 VMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKV----LR 328
           V    L   +D++  GV+   +L G                  A P L + K+     + 
Sbjct: 189 VNYEPLGLEADMWSIGVITYILLSG------------------ASPFLGDTKQETLANVS 230
Query: 329 ILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSD 366
            ++   E +Y + T+        + L ++PK R  + D
Sbjct: 231 AVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQD 268

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 68/278 (24%), Positives = 112/278 (40%), Gaps = 39/278 (14%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVA---IKELNRGGYQGDREWLAEVNYLGQLRHSN 156
           LG G F VV K   +++    Y   F+     K   RG  + D E   EV+ L +++H N
Sbjct: 19  LGSGVFAVV-KKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIE--REVSILKEIQHPN 75
Query: 157 LVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGA 216
           ++ L          IL+ E +  G L   L  +    LT     +       G+ +LH  
Sbjct: 76  VITLHEVYENKTDVILILELVAGGELFDFLAEKES--LTEEEATEFLKQILNGVYYLHSL 133
Query: 217 ERPVIYRDFKTSNI-LLNADFS---AKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEY 272
           +  + + D K  NI LL+ +      K+ DFGLA     G++      + GT  + APE 
Sbjct: 134 Q--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF---KNIFGTPEFVAPEI 188
Query: 273 VMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKV----LR 328
           V    L   +D++  GV+   +L G                  A P L + K+     + 
Sbjct: 189 VNYEPLGLEADMWSIGVITYILLSG------------------ASPFLGDTKQETLANVS 230
Query: 329 ILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSD 366
            ++   E +Y + T+        + L ++PK R  + D
Sbjct: 231 AVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQD 268

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 47/158 (29%), Positives = 70/158 (44%), Gaps = 15/158 (9%)
Query: 143 LAEVNYLGQLRHSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKI 202
           L E   L  +    LVKL     ++ +  +V EY+  G +  HL RR+G       R   
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHL-RRIGRFSEPHARF-Y 146
Query: 203 ALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTR-- 260
           A        +LH  +  +IYRD K  N+L++     K++DFG AK         V  R  
Sbjct: 147 AAQIVLTFEYLHSLD--LIYRDLKPENLLIDQQGYIKVADFGFAK--------RVKGRTW 196
Query: 261 -VMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLG 297
            + GT  Y APE +++       D +  GV++ EM  G
Sbjct: 197 XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 64/240 (26%), Positives = 108/240 (45%), Gaps = 41/240 (17%)
Query: 152 LRHSNLVKLIGYCCED-------EHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIAL 204
           +RH N+   +G+   D           L+ +Y E+GSL  +L       L     +K+A 
Sbjct: 88  MRHENI---LGFIAADIKGTGSWTQLYLITDYHENGSLYDYL---KSTTLDAKSMLKLAY 141
Query: 205 DAAKGLAFLHGAE-----RPVI-YRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHV- 257
            +  GL  LH        +P I +RD K+ NIL+  + +  ++D GLA    + D   V 
Sbjct: 142 SSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKF-ISDTNEVD 200
Query: 258 ---STRVMGTYGYAAPEYVMTG----HLTA--RSDVYGFGVVLLEMLLGRRAVD----KS 304
              +TRV GT  Y  PE +       H  +   +D+Y FG++L E  + RR V     + 
Sbjct: 201 IPPNTRV-GTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWE--VARRCVSGGIVEE 257
Query: 305 RPSREHNLVEWARPLLNNNKKVLRI--LDPRLEGQYTARTAMKVAG-LAYQCLSQNPKGR 361
                H+LV  + P   + ++++ I  L P    ++++   ++  G L  +C + NP  R
Sbjct: 258 YQLPYHDLVP-SDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASR 316

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 68/278 (24%), Positives = 112/278 (40%), Gaps = 39/278 (14%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVA---IKELNRGGYQGDREWLAEVNYLGQLRHSN 156
           LG G F VV K   +++    Y   F+     K   RG  + D E   EV+ L +++H N
Sbjct: 19  LGSGQFAVV-KKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIE--REVSILKEIQHPN 75
Query: 157 LVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGA 216
           ++ L          IL+ E +  G L   L  +    LT     +       G+ +LH  
Sbjct: 76  VITLHEVYENKTDVILILELVAGGELFDFLAEKES--LTEEEATEFLKQILNGVYYLHSL 133
Query: 217 ERPVIYRDFKTSNI-LLNADFS---AKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEY 272
           +  + + D K  NI LL+ +      K+ DFGLA     G++      + GT  + APE 
Sbjct: 134 Q--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK---NIFGTPEFVAPEI 188
Query: 273 VMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKV----LR 328
           V    L   +D++  GV+   +L G                  A P L + K+     + 
Sbjct: 189 VNYEPLGLEADMWSIGVITYILLSG------------------ASPFLGDTKQETLANVS 230
Query: 329 ILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSD 366
            ++   E +Y + T+        + L ++PK R  + D
Sbjct: 231 AVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQD 268

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 70/158 (44%), Gaps = 15/158 (9%)
Query: 143 LAEVNYLGQLRHSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKI 202
           L E   L  +    LVKL     ++ +  +V EY+  G +  HL RR+G       R   
Sbjct: 110 LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL-RRIGRFXEPHARF-Y 167
Query: 203 ALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTR-- 260
           A        +LH  +  +IYRD K  N+L++     +++DFG AK         V  R  
Sbjct: 168 AAQIVLTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTW 217
Query: 261 -VMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLG 297
            + GT  Y APE +++       D +  GV++ EM  G
Sbjct: 218 XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 255

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 47/158 (29%), Positives = 70/158 (44%), Gaps = 15/158 (9%)
Query: 143 LAEVNYLGQLRHSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKI 202
           L E   L  +    LVKL     ++ +  +V EY   G +  HL RR+G       R   
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHL-RRIGRFSEPHARF-Y 146
Query: 203 ALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTR-- 260
           A        +LH  +  +IYRD K  N++++     K++DFGLAK         V  R  
Sbjct: 147 AAQIVLTFEYLHSLD--LIYRDLKPENLMIDQQGYIKVTDFGLAK--------RVKGRTW 196
Query: 261 -VMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLG 297
            + GT  Y APE +++       D +  GV++ EM  G
Sbjct: 197 XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 68/278 (24%), Positives = 112/278 (40%), Gaps = 39/278 (14%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVA---IKELNRGGYQGDREWLAEVNYLGQLRHSN 156
           LG G F VV K   +++    Y   F+     K   RG  + D E   EV+ L +++H N
Sbjct: 19  LGSGQFAVV-KKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIE--REVSILKEIQHPN 75
Query: 157 LVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGA 216
           ++ L          IL+ E +  G L   L  +    LT     +       G+ +LH  
Sbjct: 76  VITLHEVYENKTDVILILELVAGGELFDFLAEKES--LTEEEATEFLKQILNGVYYLHSL 133
Query: 217 ERPVIYRDFKTSNI-LLNADFS---AKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEY 272
           +  + + D K  NI LL+ +      K+ DFGLA     G++      + GT  + APE 
Sbjct: 134 Q--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK---NIFGTPEFVAPEI 188
Query: 273 VMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKV----LR 328
           V    L   +D++  GV+   +L G                  A P L + K+     + 
Sbjct: 189 VNYEPLGLEADMWSIGVITYILLSG------------------ASPFLGDTKQETLANVS 230
Query: 329 ILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSD 366
            ++   E +Y + T+        + L ++PK R  + D
Sbjct: 231 AVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQD 268

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 57/219 (26%), Positives = 97/219 (44%), Gaps = 32/219 (14%)
Query: 100 LGEGGFGVV---YKGVIDENVRPGYKTTFVAIKELNR---GGYQGDREWLAEVNYLGQLR 153
           +G G  G+V   Y  +++ NV         AIK+L+R         R +  E+  +  + 
Sbjct: 32  IGSGAQGIVCAAYDAILERNV---------AIKKLSRPFQNQTHAKRAY-RELVLMKCVN 81
Query: 154 HSNLVKLIGYCCED---EHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGL 210
           H N++ L+         E    VY  ME   ++ +L + +   L   R   +      G+
Sbjct: 82  HKNIIGLLNVFTPQKSLEEFQDVYIVMEL--MDANLCQVIQMELDHERMSYLLYQMLCGI 139
Query: 211 AFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAP 270
             LH A   +I+RD K SNI++ +D + K+ DFGLA+    G    +   V+  Y Y AP
Sbjct: 140 KHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMEPEVVTRY-YRAP 194
Query: 271 EYVMTGHLTARSDVYGFGVVLLEMLL------GRRAVDK 303
           E ++        D++  G ++ EM+       GR  +D+
Sbjct: 195 EVILGMGYKENVDLWSVGCIMGEMVCHKILFPGRDYIDQ 233

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 68/278 (24%), Positives = 112/278 (40%), Gaps = 39/278 (14%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVA---IKELNRGGYQGDREWLAEVNYLGQLRHSN 156
           LG G F VV K   +++    Y   F+     K   RG  + D E   EV+ L +++H N
Sbjct: 19  LGSGQFAVV-KKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIE--REVSILKEIQHPN 75
Query: 157 LVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGA 216
           ++ L          IL+ E +  G L   L  +    LT     +       G+ +LH  
Sbjct: 76  VITLHEVYENKTDVILILELVAGGELFDFLAEKES--LTEEEATEFLKQILNGVYYLHSL 133
Query: 217 ERPVIYRDFKTSNI-LLNADFS---AKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEY 272
           +  + + D K  NI LL+ +      K+ DFGLA     G++      + GT  + APE 
Sbjct: 134 Q--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK---NIFGTPEFVAPEI 188
Query: 273 VMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKV----LR 328
           V    L   +D++  GV+   +L G                  A P L + K+     + 
Sbjct: 189 VNYEPLGLEADMWSIGVITYILLSG------------------ASPFLGDTKQETLANVS 230
Query: 329 ILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSD 366
            ++   E +Y + T+        + L ++PK R  + D
Sbjct: 231 AVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQD 268

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 70/158 (44%), Gaps = 15/158 (9%)
Query: 143 LAEVNYLGQLRHSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKI 202
           L E   L  +    LVKL     ++ +  +V EY+  G +  HL RR+G       R   
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL-RRIGRFXEPHARF-Y 146
Query: 203 ALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTR-- 260
           A        +LH  +  +IYRD K  N+L++     +++DFG AK         V  R  
Sbjct: 147 AAQIVLTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTW 196
Query: 261 -VMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLG 297
            + GT  Y APE +++       D +  GV++ EM  G
Sbjct: 197 XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 70/158 (44%), Gaps = 15/158 (9%)
Query: 143 LAEVNYLGQLRHSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKI 202
           L E   L  +    LVKL     ++ +  +V EY+  G +  HL RR+G       R   
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL-RRIGRFXEPHARF-Y 146
Query: 203 ALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTR-- 260
           A        +LH  +  +IYRD K  N+L++     +++DFG AK         V  R  
Sbjct: 147 AAQIVLTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTW 196
Query: 261 -VMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLG 297
            + GT  Y APE +++       D +  GV++ EM  G
Sbjct: 197 XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 70/158 (44%), Gaps = 15/158 (9%)
Query: 143 LAEVNYLGQLRHSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKI 202
           L E   L  +    LVKL     ++ +  +V EY+  G +  HL RR+G       R   
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL-RRIGRFXEPHARF-Y 146
Query: 203 ALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTR-- 260
           A        +LH  +  +IYRD K  N+L++     +++DFG AK         V  R  
Sbjct: 147 AAQIVLTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTW 196
Query: 261 -VMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLG 297
            + GT  Y APE +++       D +  GV++ EM  G
Sbjct: 197 XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 68/278 (24%), Positives = 112/278 (40%), Gaps = 39/278 (14%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVA---IKELNRGGYQGDREWLAEVNYLGQLRHSN 156
           LG G F VV K   +++    Y   F+     K   RG  + D E   EV+ L +++H N
Sbjct: 19  LGSGQFAVV-KKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIE--REVSILKEIQHPN 75
Query: 157 LVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGA 216
           ++ L          IL+ E +  G L   L  +    LT     +       G+ +LH  
Sbjct: 76  VITLHEVYENKTDVILILELVAGGELFDFLAEKES--LTEEEATEFLKQILNGVYYLHSL 133
Query: 217 ERPVIYRDFKTSNI-LLNADFS---AKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEY 272
           +  + + D K  NI LL+ +      K+ DFGLA     G++      + GT  + APE 
Sbjct: 134 Q--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK---NIFGTPEFVAPEI 188
Query: 273 VMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKV----LR 328
           V    L   +D++  GV+   +L G                  A P L + K+     + 
Sbjct: 189 VNYEPLGLEADMWSIGVITYILLSG------------------ASPFLGDTKQETLANVS 230
Query: 329 ILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSD 366
            ++   E +Y + T+        + L ++PK R  + D
Sbjct: 231 AVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQD 268

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 70/158 (44%), Gaps = 15/158 (9%)
Query: 143 LAEVNYLGQLRHSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKI 202
           L E   L  +    LVKL     ++ +  +V EY+  G +  HL RR+G       R   
Sbjct: 84  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL-RRIGRFXEPHARF-Y 141
Query: 203 ALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTR-- 260
           A        +LH  +  +IYRD K  N+L++     +++DFG AK         V  R  
Sbjct: 142 AAQIVLTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTW 191
Query: 261 -VMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLG 297
            + GT  Y APE +++       D +  GV++ EM  G
Sbjct: 192 XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 229

>pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 32/76 (42%), Positives = 39/76 (51%), Gaps = 1/76 (1%)
Query: 222 YRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTAR 281
           +RD K  NIL++AD  A L DFG+A        T +   V GT  Y APE     H T R
Sbjct: 157 HRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTV-GTLYYXAPERFSESHATYR 215
Query: 282 SDVYGFGVVLLEMLLG 297
           +D+Y    VL E L G
Sbjct: 216 ADIYALTCVLYECLTG 231

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 70/158 (44%), Gaps = 15/158 (9%)
Query: 143 LAEVNYLGQLRHSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKI 202
           L E   L  +    LVKL     ++ +  +V EY+  G +  HL RR+G       R   
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHL-RRIGRFXEPHARF-Y 146
Query: 203 ALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTR-- 260
           A        +LH  +  +IYRD K  N+L++     +++DFG AK         V  R  
Sbjct: 147 AAQIVLTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTW 196
Query: 261 -VMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLG 297
            + GT  Y APE +++       D +  GV++ EM  G
Sbjct: 197 XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 70/158 (44%), Gaps = 15/158 (9%)
Query: 143 LAEVNYLGQLRHSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKI 202
           L E   L  +    LVKL     ++ +  +V EY+  G +  HL RR+G       R   
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHL-RRIGRFXEPHARF-Y 146
Query: 203 ALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTR-- 260
           A        +LH  +  +IYRD K  N+L++     +++DFG AK         V  R  
Sbjct: 147 AAQIVLTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTW 196
Query: 261 -VMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLG 297
            + GT  Y APE +++       D +  GV++ EM  G
Sbjct: 197 XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 57/219 (26%), Positives = 98/219 (44%), Gaps = 32/219 (14%)
Query: 100 LGEGGFGVV---YKGVIDENVRPGYKTTFVAIKELNR---GGYQGDREWLAEVNYLGQLR 153
           +G G  G+V   Y  +++ NV         AIK+L+R         R +  E+  +  + 
Sbjct: 26  IGSGAQGIVCAAYDAILERNV---------AIKKLSRPFQNQTHAKRAY-RELVLMKCVN 75
Query: 154 HSNLVKLIGYCCED---EHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGL 210
           H N++ L+         E    VY  ME   ++ +L + +   L   R   +      G+
Sbjct: 76  HKNIIGLLNVFTPQKSLEEFQDVYIVMEL--MDANLCQVIQMELDHERMSYLLYQMLCGI 133
Query: 211 AFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAP 270
             LH A   +I+RD K SNI++ +D + K+ DFGLA+    G    ++  V+  Y Y AP
Sbjct: 134 KHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVVTRY-YRAP 188
Query: 271 EYVMTGHLTARSDVYGFGVVLLEMLL------GRRAVDK 303
           E ++        D++  G ++ EM+       GR  +D+
Sbjct: 189 EVILGMGYKENVDLWSVGCIMGEMVCHKILFPGRDYIDQ 227

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 70/158 (44%), Gaps = 15/158 (9%)
Query: 143 LAEVNYLGQLRHSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKI 202
           L E   L  +    LVKL     ++ +  +V EY+  G +  HL RR+G       R   
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL-RRIGRFAEPHARF-Y 146
Query: 203 ALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTR-- 260
           A        +LH  +  +IYRD K  N+L++     +++DFG AK         V  R  
Sbjct: 147 AAQIVLTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTW 196
Query: 261 -VMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLG 297
            + GT  Y APE +++       D +  GV++ EM  G
Sbjct: 197 XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 70/158 (44%), Gaps = 15/158 (9%)
Query: 143 LAEVNYLGQLRHSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKI 202
           L E   L  +    LVKL     ++ +  +V EY+  G +  HL RR+G       R   
Sbjct: 90  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHL-RRIGRFXEPHARF-Y 147
Query: 203 ALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTR-- 260
           A        +LH  +  +IYRD K  N+L++     +++DFG AK         V  R  
Sbjct: 148 AAQIVLTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTW 197
Query: 261 -VMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLG 297
            + GT  Y APE +++       D +  GV++ EM  G
Sbjct: 198 XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 70/158 (44%), Gaps = 15/158 (9%)
Query: 143 LAEVNYLGQLRHSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKI 202
           L E   L  +    LVKL     ++ +  +V EY+  G +  HL RR+G       R   
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL-RRIGRFSEPHARF-Y 146
Query: 203 ALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTR-- 260
           A        +LH  +  +IYRD K  N+L++     +++DFG AK         V  R  
Sbjct: 147 AAQIVLTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTW 196
Query: 261 -VMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLG 297
            + GT  Y APE +++       D +  GV++ EM  G
Sbjct: 197 XLXGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 45/155 (29%), Positives = 69/155 (44%), Gaps = 9/155 (5%)
Query: 143 LAEVNYLGQLRHSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKI 202
           L E   L  +    LVKL     ++ +  +V EY+  G +  HL RR+G       R   
Sbjct: 90  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHL-RRIGRFSEPHARF-Y 147
Query: 203 ALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVM 262
           A        +LH  +  +IYRD K  N+L++     +++DFG AK       T     + 
Sbjct: 148 AAQIVLTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWT-----LC 200
Query: 263 GTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLG 297
           GT  Y APE +++       D +  GV++ EM  G
Sbjct: 201 GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 91/204 (44%), Gaps = 22/204 (10%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLA-EVNYLGQLRHSNLV 158
           LG G FGVV++ V     R      FVA K +N   Y  D+  +  E++ + QL H  L+
Sbjct: 59  LGSGAFGVVHRCVEKATGR-----VFVA-KFIN-TPYPLDKYTVKNEISIMNQLHHPKLI 111
Query: 159 KLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGC---MLTWSRRMKIALDAAKGLAFLHG 215
            L     +    +L+ E++  G     L  R+      ++ +  +     A +GL  +H 
Sbjct: 112 NLHDAFEDKYEMVLILEFLSGGE----LFDRIAAEDYKMSEAEVINYMRQACEGLKHMH- 166
Query: 216 AERPVIYRDFKTSNILLNAD--FSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYV 273
            E  +++ D K  NI+       S K+ DFGLA      +   V+T    T  +AAPE V
Sbjct: 167 -EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTT---ATAEFAAPEIV 222
Query: 274 MTGHLTARSDVYGFGVVLLEMLLG 297
               +   +D++  GV+   +L G
Sbjct: 223 DREPVGFYTDMWAIGVLGYVLLSG 246

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 54/201 (26%), Positives = 83/201 (41%), Gaps = 17/201 (8%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVK 159
           +G G FGV         +R       VA+K + RG  + D     E+     LRH N+V+
Sbjct: 27  IGSGNFGVA------RLMRDKQSNELVAVKYIERGE-KIDENVKREIINHRSLRHPNIVR 79
Query: 160 LIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERP 219
                    H  +V EY   G L + +          +R     L    G+++ H  +  
Sbjct: 80  FKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQL--ISGVSYCHAMQ-- 135
Query: 220 VIYRDFKTSNILLNADFSA--KLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGH 277
           V +RD K  N LL+   +   K+  FG +K   +  Q       +GT  Y APE ++   
Sbjct: 136 VCHRDLKLENTLLDGSPAPRLKICAFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLKKE 192
Query: 278 LTAR-SDVYGFGVVLLEMLLG 297
              + +DV+  GV L  ML+G
Sbjct: 193 YDGKVADVWSCGVTLYVMLVG 213

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 70/158 (44%), Gaps = 15/158 (9%)
Query: 143 LAEVNYLGQLRHSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKI 202
           L E   L  +    LVKL     ++ +  +V EY+  G +  HL RR+G       R   
Sbjct: 82  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHL-RRIGRFXEPHARF-Y 139
Query: 203 ALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTR-- 260
           A        +LH  +  +IYRD K  N+L++     +++DFG AK         V  R  
Sbjct: 140 AAQIVLTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTW 189
Query: 261 -VMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLG 297
            + GT  Y APE +++       D +  GV++ EM  G
Sbjct: 190 XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 227

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 70/158 (44%), Gaps = 15/158 (9%)
Query: 143 LAEVNYLGQLRHSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKI 202
           L E   L  +    LVKL     ++ +  +V EY+  G +  HL RR+G       R   
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL-RRIGRFSEPHARF-Y 146
Query: 203 ALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTR-- 260
           A        +LH  +  +IYRD K  N+L++     +++DFG AK         V  R  
Sbjct: 147 AAQIVLTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTW 196
Query: 261 -VMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLG 297
            + GT  Y APE +++       D +  GV++ EM  G
Sbjct: 197 XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 70/158 (44%), Gaps = 15/158 (9%)
Query: 143 LAEVNYLGQLRHSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKI 202
           L E   L  +    LVKL     ++ +  +V EY+  G +  HL RR+G       R   
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL-RRIGRFSEPHARF-Y 146
Query: 203 ALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTR-- 260
           A        +LH  +  +IYRD K  N+L++     +++DFG AK         V  R  
Sbjct: 147 AAQIVLTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTW 196
Query: 261 -VMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLG 297
            + GT  Y APE +++       D +  GV++ EM  G
Sbjct: 197 XLAGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 69/158 (43%), Gaps = 15/158 (9%)
Query: 143 LAEVNYLGQLRHSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKI 202
           L E   L  +    LVKL     ++ +  +V EY   G +  HL RR+G       R   
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHL-RRIGRFXEPHARF-Y 146
Query: 203 ALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTR-- 260
           A        +LH  +  +IYRD K  N++++     K++DFG AK         V  R  
Sbjct: 147 AAQIVLTFEYLHSLD--LIYRDLKPENLMIDQQGYIKVTDFGFAK--------RVKGRTW 196
Query: 261 -VMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLG 297
            + GT  Y APE +++       D +  GV++ EM  G
Sbjct: 197 XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 54/201 (26%), Positives = 83/201 (41%), Gaps = 17/201 (8%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVK 159
           +G G FGV         +R       VA+K + RG  + D     E+     LRH N+V+
Sbjct: 27  IGSGNFGVA------RLMRDKQSNELVAVKYIERGE-KIDENVKREIINHRSLRHPNIVR 79
Query: 160 LIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERP 219
                    H  +V EY   G L + +          +R     L    G+++ H  +  
Sbjct: 80  FKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQL--ISGVSYCHAMQ-- 135
Query: 220 VIYRDFKTSNILLNADFSA--KLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGH 277
           V +RD K  N LL+   +   K+  FG +K   +  Q       +GT  Y APE ++   
Sbjct: 136 VCHRDLKLENTLLDGSPAPRLKICAFGYSKSSVLHSQ---PKDTVGTPAYIAPEVLLKKE 192
Query: 278 LTAR-SDVYGFGVVLLEMLLG 297
              + +DV+  GV L  ML+G
Sbjct: 193 YDGKVADVWSCGVTLYVMLVG 213

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 68/278 (24%), Positives = 112/278 (40%), Gaps = 39/278 (14%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVA---IKELNRGGYQGDREWLAEVNYLGQLRHSN 156
           LG G F VV K   +++    Y   F+     K   RG  + D E   EV+ L +++H N
Sbjct: 19  LGSGQFAVV-KKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIE--REVSILKEIQHPN 75
Query: 157 LVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGA 216
           ++ L          IL+ E +  G L   L  +    LT     +       G+ +LH  
Sbjct: 76  VITLHEVYENKTDVILIGELVAGGELFDFLAEKES--LTEEEATEFLKQILNGVYYLHSL 133
Query: 217 ERPVIYRDFKTSNI-LLNADFS---AKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEY 272
           +  + + D K  NI LL+ +      K+ DFGLA     G++      + GT  + APE 
Sbjct: 134 Q--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF---KNIFGTPEFVAPEI 188
Query: 273 VMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKV----LR 328
           V    L   +D++  GV+   +L G                  A P L + K+     + 
Sbjct: 189 VNYEPLGLEADMWSIGVITYILLSG------------------ASPFLGDTKQETLANVS 230
Query: 329 ILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSD 366
            ++   E +Y + T+        + L ++PK R  + D
Sbjct: 231 AVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQD 268

>pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 62/276 (22%), Positives = 107/276 (38%), Gaps = 57/276 (20%)
Query: 130 ELNRGGYQGD---------REWLA--------EVNYLGQLRHSNLVKLIGYCCEDE--HR 170
           EL +G +QG+         R+W          E   L    H N++ ++G C      H 
Sbjct: 25  ELWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHP 84
Query: 171 ILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRD-FKTSN 229
            L+  +   GSL   L      ++  S+ +K ALD A+G AFLH  E P+I R    + +
Sbjct: 85  TLITHWXPYGSLYNVLHEGTNFVVDQSQAVKFALDXARGXAFLHTLE-PLIPRHALNSRS 143
Query: 230 ILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTAR-------- 281
           + ++ D +A++S               V           AP +V    L  +        
Sbjct: 144 VXIDEDXTARIS------------XADVKFSFQSPGRXYAPAWVAPEALQKKPEDTNRRS 191
Query: 282 SDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRILDPRLEGQYTAR 341
           +D + F V+L E++           +RE    +     L+N +   ++    L       
Sbjct: 192 ADXWSFAVLLWELV-----------TREVPFAD-----LSNXEIGXKVALEGLRPTIPPG 235
Query: 342 TAMKVAGLAYQCLSQNPKGRPVMSDVVALLETVQSQ 377
            +  V+ L   C +++P  RP    +V +LE  Q +
Sbjct: 236 ISPHVSKLXKICXNEDPAKRPKFDXIVPILEKXQDK 271

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 57/228 (25%), Positives = 103/228 (45%), Gaps = 18/228 (7%)
Query: 77  SNVDIFTYNEMKLATKFFRPDYIL-----GEGGFGVVYKGVIDENVRPGYKTTFVAIKEL 131
           S VD+ T N    + + F   YIL     G G F VV +  I ++    Y   F+  +  
Sbjct: 9   SGVDLGTENLYFQSMENFNNFYILTSKELGRGKFAVV-RQCISKSTGQEYAAKFLKKR-- 65
Query: 132 NRGGYQGDREWLAEVNYLGQLRHSNLVKLIGYCCEDEHRI-LVYEYMESGSLEKHLLRRV 190
            R G     E L E+  L   +    V  +    E+   I L+ EY   G +    L  +
Sbjct: 66  -RRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPEL 124
Query: 191 GCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADF---SAKLSDFGLAK 247
             M++ +  +++     +G+ +LH  +  +++ D K  NILL++ +     K+ DFG+++
Sbjct: 125 AEMVSENDVIRLIKQILEGVYYLH--QNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSR 182
Query: 248 DGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEML 295
              +G    +   +MGT  Y APE +    +T  +D++  G++   +L
Sbjct: 183 K--IGHACELR-EIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLL 227

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 51/207 (24%), Positives = 91/207 (43%), Gaps = 16/207 (7%)
Query: 99  ILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLV 158
           ++G+G F VV +  I+      +    V + +          +   E +    L+H ++V
Sbjct: 33  VIGKGPFSVVRR-CINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIV 91
Query: 159 KLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWS-----RRMKIALDAAKGLAFL 213
           +L+     D    +V+E+M+   L   +++R      +S       M+  L+A   L + 
Sbjct: 92  ELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEA---LRYC 148
Query: 214 HGAERPVIYRDFKTSNILLNA---DFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAP 270
           H  +  +I+RD K   +LL +       KL  FG+A    +G+   V+   +GT  + AP
Sbjct: 149 H--DNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQ--LGESGLVAGGRVGTPHFMAP 204
Query: 271 EYVMTGHLTARSDVYGFGVVLLEMLLG 297
           E V         DV+G GV+L  +L G
Sbjct: 205 EVVKREPYGKPVDVWGCGVILFILLSG 231

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 92/211 (43%), Gaps = 19/211 (9%)
Query: 92  KFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLA-EVNYLG 150
           K F     LG G F  V   V+ E    G      A+K + +   +G    +  E+  L 
Sbjct: 22  KIFEFKETLGTGAFSEV---VLAEEKATG---KLFAVKCIPKKALKGKESSIENEIAVLR 75
Query: 151 QLRHSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRR-VGCMLTWSRRMKIALDAAKG 209
           +++H N+V L        H  LV + +  G L   ++ +        S  ++  LDA   
Sbjct: 76  KIKHENIVALEDIYESPNHLYLVMQLVSGGELFDRIVEKGFYTEKDASTLIRQVLDA--- 132
Query: 210 LAFLHGAERPVIYRDFKTSNILL-NADFSAKL--SDFGLAKDGPMGDQTHVSTRVMGTYG 266
           + +LH     +++RD K  N+L  + D  +K+  SDFGL+K    GD   V +   GT G
Sbjct: 133 VYYLH--RMGIVHRDLKPENLLYYSQDEESKIMISDFGLSKMEGKGD---VMSTACGTPG 187
Query: 267 YAAPEYVMTGHLTARSDVYGFGVVLLEMLLG 297
           Y APE +     +   D +  GV+   +L G
Sbjct: 188 YVAPEVLAQKPYSKAVDCWSIGVIAYILLCG 218

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 70/158 (44%), Gaps = 15/158 (9%)
Query: 143 LAEVNYLGQLRHSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKI 202
           L E   L  +    LVKL     ++ +  +V EY+  G +  HL RR+G       R   
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL-RRIGRFSEPHARF-Y 146
Query: 203 ALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTR-- 260
           A        +LH  +  +IYRD K  N+L++     +++DFG AK         V  R  
Sbjct: 147 AAQIVLTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTW 196
Query: 261 -VMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLG 297
            + GT  Y APE +++       D +  GV++ EM  G
Sbjct: 197 XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 70/158 (44%), Gaps = 15/158 (9%)
Query: 143 LAEVNYLGQLRHSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKI 202
           L E   L  +    LVKL     ++ +  +V EY+  G +  HL RR+G       R   
Sbjct: 90  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL-RRIGRFSEPHARF-Y 147
Query: 203 ALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTR-- 260
           A        +LH  +  +IYRD K  N+L++     +++DFG AK         V  R  
Sbjct: 148 AAQIVLTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTW 197
Query: 261 -VMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLG 297
            + GT  Y APE +++       D +  GV++ EM  G
Sbjct: 198 XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 44/144 (30%), Positives = 65/144 (45%), Gaps = 15/144 (10%)
Query: 157 LVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGA 216
           LVKL     ++ +  +V EY   G +  HL RR+G       R   A        +LH  
Sbjct: 104 LVKLEFSFKDNSNLYMVLEYAPGGEMFSHL-RRIGRFSEPHARF-YAAQIVLTFEYLHSL 161
Query: 217 ERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTR---VMGTYGYAAPEYV 273
           +  +IYRD K  N+L++     K++DFG AK         V  R   + GT  Y APE +
Sbjct: 162 D--LIYRDLKPENLLIDQQGYIKVADFGFAK--------RVKGRTWXLCGTPEYLAPEII 211
Query: 274 MTGHLTARSDVYGFGVVLLEMLLG 297
           ++       D +  GV++ EM  G
Sbjct: 212 LSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 85/203 (41%), Gaps = 13/203 (6%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLA-EVNYLGQLRHSNLV 158
           LG G F +V K    +     Y   F+  + L+       RE +  EVN L ++RH N++
Sbjct: 13  LGSGQFAIVRK-CRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNII 71
Query: 159 KLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAER 218
            L          +L+ E +  G L   L  +    LT     +       G+ +LH   +
Sbjct: 72  TLHDIFENKTDVVLILELVSGGELFDFLAEKES--LTEDEATQFLKQILDGVHYLHS--K 127
Query: 219 PVIYRDFKTSNILL----NADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVM 274
            + + D K  NI+L      +   KL DFG+A     G++      + GT  + APE V 
Sbjct: 128 RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEF---KNIFGTPEFVAPEIVN 184
Query: 275 TGHLTARSDVYGFGVVLLEMLLG 297
              L   +D++  GV+   +L G
Sbjct: 185 YEPLGLEADMWSIGVITYILLSG 207

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 70/158 (44%), Gaps = 15/158 (9%)
Query: 143 LAEVNYLGQLRHSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKI 202
           L E   L  +    LVKL     ++ +  +V EY+  G +  HL RR+G       R   
Sbjct: 110 LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHL-RRIGRFSEPHARF-Y 167
Query: 203 ALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTR-- 260
           A        +LH  +  +IYRD K  N+L++     +++DFG AK         V  R  
Sbjct: 168 AAQIVLTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTW 217
Query: 261 -VMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLG 297
            + GT  Y APE +++       D +  GV++ EM  G
Sbjct: 218 XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 255

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 70/158 (44%), Gaps = 15/158 (9%)
Query: 143 LAEVNYLGQLRHSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKI 202
           L E   L  +    LVKL     ++ +  +V EY+  G +  HL RR+G       R   
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL-RRIGRFSEPHARF-Y 146
Query: 203 ALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTR-- 260
           A        +LH  +  +IYRD K  N+L++     +++DFG AK         V  R  
Sbjct: 147 AAQIVLTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTW 196
Query: 261 -VMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLG 297
            + GT  Y APE +++       D +  GV++ EM  G
Sbjct: 197 XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 70/158 (44%), Gaps = 15/158 (9%)
Query: 143 LAEVNYLGQLRHSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKI 202
           L E   L  +    LVKL     ++ +  +V EY+  G +  HL RR+G       R   
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL-RRIGRFSEPHARF-Y 146
Query: 203 ALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTR-- 260
           A        +LH  +  +IYRD K  N+L++     +++DFG AK         V  R  
Sbjct: 147 AAQIVLTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTW 196
Query: 261 -VMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLG 297
            + GT  Y APE +++       D +  GV++ EM  G
Sbjct: 197 XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 70/158 (44%), Gaps = 15/158 (9%)
Query: 143 LAEVNYLGQLRHSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKI 202
           L E   L  +    LVKL     ++ +  +V EY+  G +  HL RR+G       R   
Sbjct: 89  LNEKRILQAVNFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHL-RRIGRFSEPHARF-Y 146
Query: 203 ALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTR-- 260
           A        +LH  +  +IYRD K  N+L++     +++DFG AK         V  R  
Sbjct: 147 AAQIVLTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTW 196
Query: 261 -VMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLG 297
            + GT  Y APE +++       D +  GV++ EM  G
Sbjct: 197 XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 70/158 (44%), Gaps = 15/158 (9%)
Query: 143 LAEVNYLGQLRHSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKI 202
           L E   L  +    LVKL     ++ +  +V EY+  G +  HL RR+G       R   
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL-RRIGRFSEPHARF-Y 146
Query: 203 ALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTR-- 260
           A        +LH  +  +IYRD K  N+L++     +++DFG AK         V  R  
Sbjct: 147 AAQIVLTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTW 196
Query: 261 -VMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLG 297
            + GT  Y APE +++       D +  GV++ EM  G
Sbjct: 197 XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 70/158 (44%), Gaps = 15/158 (9%)
Query: 143 LAEVNYLGQLRHSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKI 202
           L E   L  +    LVKL     ++ +  +V EY+  G +  HL RR+G       R   
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHL-RRIGRFSEPHARF-Y 146
Query: 203 ALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTR-- 260
           A        +LH  +  +IYRD K  N+L++     +++DFG AK         V  R  
Sbjct: 147 AAQIVLTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTW 196
Query: 261 -VMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLG 297
            + GT  Y APE +++       D +  GV++ EM  G
Sbjct: 197 XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 45/155 (29%), Positives = 69/155 (44%), Gaps = 9/155 (5%)
Query: 143 LAEVNYLGQLRHSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKI 202
           L E   L  +    LVKL     ++ +  +V EY+  G +  HL RR+G       R   
Sbjct: 75  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHL-RRIGRFSEPHARF-Y 132
Query: 203 ALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVM 262
           A        +LH  +  +IYRD K  N+L++     +++DFG AK       T     + 
Sbjct: 133 AAQIVLTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWT-----LC 185
Query: 263 GTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLG 297
           GT  Y APE +++       D +  GV++ EM  G
Sbjct: 186 GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 220

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 70/158 (44%), Gaps = 15/158 (9%)
Query: 143 LAEVNYLGQLRHSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKI 202
           L E   L  +    LVKL     ++ +  +V EY+  G +  HL RR+G       R   
Sbjct: 89  LNEKRILQAVNFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHL-RRIGRFSEPHARF-Y 146
Query: 203 ALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTR-- 260
           A        +LH  +  +IYRD K  N+L++     +++DFG AK         V  R  
Sbjct: 147 AAQIVLTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTW 196
Query: 261 -VMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLG 297
            + GT  Y APE +++       D +  GV++ EM  G
Sbjct: 197 XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 70/158 (44%), Gaps = 15/158 (9%)
Query: 143 LAEVNYLGQLRHSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKI 202
           L E   L  +    LVKL     ++ +  +V EY+  G +  HL RR+G       R   
Sbjct: 90  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHL-RRIGRFSEPHARF-Y 147
Query: 203 ALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTR-- 260
           A        +LH  +  +IYRD K  N+L++     +++DFG AK         V  R  
Sbjct: 148 AAQIVLTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTW 197
Query: 261 -VMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLG 297
            + GT  Y APE +++       D +  GV++ EM  G
Sbjct: 198 XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 70/158 (44%), Gaps = 15/158 (9%)
Query: 143 LAEVNYLGQLRHSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKI 202
           L E   L  +    LVKL     ++ +  +V EY+  G +  HL RR+G       R   
Sbjct: 90  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHL-RRIGRFSEPHARF-Y 147
Query: 203 ALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTR-- 260
           A        +LH  +  +IYRD K  N+L++     +++DFG AK         V  R  
Sbjct: 148 AAQIVLTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTW 197
Query: 261 -VMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLG 297
            + GT  Y APE +++       D +  GV++ EM  G
Sbjct: 198 XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 70/158 (44%), Gaps = 15/158 (9%)
Query: 143 LAEVNYLGQLRHSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKI 202
           L E   L  +    LVKL     ++ +  +V EY+  G +  HL RR+G       R   
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHL-RRIGRFSEPHARF-Y 146
Query: 203 ALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTR-- 260
           A        +LH  +  +IYRD K  N+L++     +++DFG AK         V  R  
Sbjct: 147 AAQIVLTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTW 196
Query: 261 -VMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLG 297
            + GT  Y APE +++       D +  GV++ EM  G
Sbjct: 197 XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 70/158 (44%), Gaps = 15/158 (9%)
Query: 143 LAEVNYLGQLRHSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKI 202
           L E   L  +    LVKL     ++ +  +V EY+  G +  HL RR+G       R   
Sbjct: 90  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHL-RRIGRFSEPHARF-Y 147
Query: 203 ALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTR-- 260
           A        +LH  +  +IYRD K  N+L++     +++DFG AK         V  R  
Sbjct: 148 AAQIVLTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTW 197
Query: 261 -VMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLG 297
            + GT  Y APE +++       D +  GV++ EM  G
Sbjct: 198 XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 70/158 (44%), Gaps = 15/158 (9%)
Query: 143 LAEVNYLGQLRHSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKI 202
           L E   L  +    LVKL     ++ +  +V EY+  G +  HL RR+G       R   
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHL-RRIGRFSEPHARF-Y 146
Query: 203 ALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTR-- 260
           A        +LH  +  +IYRD K  N+L++     +++DFG AK         V  R  
Sbjct: 147 AAQIVLTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTW 196
Query: 261 -VMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLG 297
            + GT  Y APE +++       D +  GV++ EM  G
Sbjct: 197 XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 70/158 (44%), Gaps = 15/158 (9%)
Query: 143 LAEVNYLGQLRHSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKI 202
           L E   L  +    LVKL     ++ +  +V EY+  G +  HL RR+G       R   
Sbjct: 89  LNEKRILQAVNFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHL-RRIGRFSEPHARF-Y 146
Query: 203 ALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTR-- 260
           A        +LH  +  +IYRD K  N+L++     +++DFG AK         V  R  
Sbjct: 147 AAQIVLTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTW 196
Query: 261 -VMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLG 297
            + GT  Y APE +++       D +  GV++ EM  G
Sbjct: 197 XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 70/158 (44%), Gaps = 15/158 (9%)
Query: 143 LAEVNYLGQLRHSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKI 202
           L E   L  +    LVKL     ++ +  +V EY+  G +  HL RR+G       R   
Sbjct: 90  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHL-RRIGRFSEPHARF-Y 147
Query: 203 ALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTR-- 260
           A        +LH  +  +IYRD K  N+L++     +++DFG AK         V  R  
Sbjct: 148 AAQIVLTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTW 197
Query: 261 -VMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLG 297
            + GT  Y APE +++       D +  GV++ EM  G
Sbjct: 198 XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 70/158 (44%), Gaps = 15/158 (9%)
Query: 143 LAEVNYLGQLRHSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKI 202
           L E   L  +    LVKL     ++ +  +V EY+  G +  HL RR+G       R   
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL-RRIGRFSEPHARF-Y 146
Query: 203 ALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTR-- 260
           A        +LH  +  +IYRD K  N+L++     +++DFG AK         V  R  
Sbjct: 147 AAQIVLTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTW 196
Query: 261 -VMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLG 297
            + GT  Y APE +++       D +  GV++ EM  G
Sbjct: 197 XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 85/203 (41%), Gaps = 13/203 (6%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLA-EVNYLGQLRHSNLV 158
           LG G F +V K    +     Y   F+  + L+       RE +  EVN L ++RH N++
Sbjct: 20  LGSGQFAIVRK-CRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNII 78
Query: 159 KLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAER 218
            L          +L+ E +  G L   L  +    LT     +       G+ +LH   +
Sbjct: 79  TLHDIFENKTDVVLILELVSGGELFDFLAEKES--LTEDEATQFLKQILDGVHYLHS--K 134
Query: 219 PVIYRDFKTSNILL----NADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVM 274
            + + D K  NI+L      +   KL DFG+A     G++      + GT  + APE V 
Sbjct: 135 RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEF---KNIFGTPEFVAPEIVN 191
Query: 275 TGHLTARSDVYGFGVVLLEMLLG 297
              L   +D++  GV+   +L G
Sbjct: 192 YEPLGLEADMWSIGVITYILLSG 214

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 52.0 bits (123), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 69/158 (43%), Gaps = 15/158 (9%)
Query: 143 LAEVNYLGQLRHSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKI 202
           L E   L  +    LVKL     ++ +  +V EY   G +  HL RR+G       R   
Sbjct: 90  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHL-RRIGRFSEPHARF-Y 147
Query: 203 ALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTR-- 260
           A        +LH  +  +IYRD K  N++++     K++DFG AK         V  R  
Sbjct: 148 AAQIVLTFEYLHSLD--LIYRDLKPENLMIDQQGYIKVTDFGFAK--------RVKGRTW 197
Query: 261 -VMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLG 297
            + GT  Y APE +++       D +  GV++ EM  G
Sbjct: 198 XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 52.0 bits (123), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 38/102 (37%), Positives = 50/102 (49%), Gaps = 8/102 (7%)
Query: 201 KIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTR 260
           KI L   K L  L    + +I+RD K SNILL+   + KL DFG++  G + D     TR
Sbjct: 129 KITLATVKALNHLKENLK-IIHRDIKPSNILLDRSGNIKLCDFGIS--GQLVDSI-AKTR 184
Query: 261 VMGTYGYAAPEYVMTGH----LTARSDVYGFGVVLLEMLLGR 298
             G   Y APE +           RSDV+  G+ L E+  GR
Sbjct: 185 DAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGR 226

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 52.0 bits (123), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 68/273 (24%), Positives = 113/273 (41%), Gaps = 26/273 (9%)
Query: 97  DYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLR-HS 155
           D  LGEG F +  K V  ++ +        A+K +++      ++   E+  L     H 
Sbjct: 16  DKPLGEGSFSICRKCVHKKSNQA------FAVKIISKRMEANTQK---EITALKLCEGHP 66
Query: 156 NLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHG 215
           N+VKL     +  H  LV E +  G L + + ++     T +  +   L +A      H 
Sbjct: 67  NIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVS----HM 122
Query: 216 AERPVIYRDFKTSNILL---NADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEY 272
            +  V++RD K  N+L    N +   K+ DFG A+  P  +Q  + T    T  YAAPE 
Sbjct: 123 HDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQP-LKTPCF-TLHYAAPEL 180
Query: 273 VMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRILDP 332
           +         D++  GV+L  ML G+       P + H+        +   KK+ +  D 
Sbjct: 181 LNQNGYDESCDLWSLGVILYTMLSGQ------VPFQSHDRSLTCTSAVEIMKKIKKG-DF 233
Query: 333 RLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMS 365
             EG+     + +   L    L+ +P  R  MS
Sbjct: 234 SFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMS 266

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score = 52.0 bits (123), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 51/207 (24%), Positives = 91/207 (43%), Gaps = 16/207 (7%)
Query: 99  ILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLV 158
           ++G+G F VV +  I+      +    V + +          +   E +    L+H ++V
Sbjct: 31  VIGKGPFSVV-RRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIV 89
Query: 159 KLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWS-----RRMKIALDAAKGLAFL 213
           +L+     D    +V+E+M+   L   +++R      +S       M+  L+A   L + 
Sbjct: 90  ELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEA---LRYC 146
Query: 214 HGAERPVIYRDFKTSNILLNA---DFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAP 270
           H  +  +I+RD K   +LL +       KL  FG+A    +G+   V+   +GT  + AP
Sbjct: 147 H--DNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQ--LGESGLVAGGRVGTPHFMAP 202
Query: 271 EYVMTGHLTARSDVYGFGVVLLEMLLG 297
           E V         DV+G GV+L  +L G
Sbjct: 203 EVVKREPYGKPVDVWGCGVILFILLSG 229

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 52.0 bits (123), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 70/158 (44%), Gaps = 15/158 (9%)
Query: 143 LAEVNYLGQLRHSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKI 202
           L E   L  +    LVKL     ++ +  +V EY   G +  HL RR+G       R   
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHL-RRIGRFSEPHARF-Y 146
Query: 203 ALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTR-- 260
           A        +LH  +  +IYRD K  N++++     +++DFGLAK         V  R  
Sbjct: 147 AAQIVLTFEYLHSLD--LIYRDLKPENLMIDQQGYIQVTDFGLAK--------RVKGRTW 196
Query: 261 -VMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLG 297
            + GT  Y APE +++       D +  GV++ EM  G
Sbjct: 197 XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 52.0 bits (123), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 70/158 (44%), Gaps = 15/158 (9%)
Query: 143 LAEVNYLGQLRHSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKI 202
           L E   L  +    LVKL     ++ +  +V EY+  G +  HL RR+G       R   
Sbjct: 82  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHL-RRIGRFSEPHARF-Y 139
Query: 203 ALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTR-- 260
           A        +LH  +  +IYRD K  N+L++     +++DFG AK         V  R  
Sbjct: 140 AAQIVLTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTW 189
Query: 261 -VMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLG 297
            + GT  Y APE +++       D +  GV++ EM  G
Sbjct: 190 XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 227

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 69/158 (43%), Gaps = 15/158 (9%)
Query: 143 LAEVNYLGQLRHSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKI 202
           L E   L  +    LVKL     ++ +  +V EY   G +  HL RR+G       R   
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHL-RRIGRFSEPHARF-Y 146
Query: 203 ALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTR-- 260
           A        +LH  +  +IYRD K  N++++     K++DFG AK         V  R  
Sbjct: 147 AAQIVLTFEYLHSLD--LIYRDLKPENLMIDQQGYIKVTDFGFAK--------RVKGRTW 196
Query: 261 -VMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLG 297
            + GT  Y APE +++       D +  GV++ EM  G
Sbjct: 197 XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 60/227 (26%), Positives = 105/227 (46%), Gaps = 41/227 (18%)
Query: 144 AEVNYLGQLRHSNLVKLIGYCCEDEHRILVYEYMESGSLEKHL-----LRRVGCMLTWSR 198
            E+  L +L H  ++K+  +   +++ I V E ME G L   +     L+   C L +  
Sbjct: 64  TEIEILKKLNHPCIIKIKNFFDAEDYYI-VLELMEGGELFDKVVGNKRLKEATCKL-YFY 121
Query: 199 RMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNA---DFSAKLSDFGLAKDGPMGDQT 255
           +M +A+       +LH  E  +I+RD K  N+LL++   D   K++DFG +K   +  +T
Sbjct: 122 QMLLAVQ------YLH--ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSK---ILGET 170
Query: 256 HVSTRVMGTYGYAAPEYVM---TGHLTARSDVYGFGVVLLEMLLGRRAVDKSR------- 305
            +   + GT  Y APE ++   T       D +  GV+L   L G     + R       
Sbjct: 171 SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKD 230
Query: 306 --PSREHNLVE--WA---RPLLNNNKKVLRILDPRLEGQYTARTAMK 345
              S ++N +   WA      L+  KK+L ++DP+   ++T   A++
Sbjct: 231 QITSGKYNFIPEVWAEVSEKALDLVKKLL-VVDPK--ARFTTEEALR 274

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 60/227 (26%), Positives = 105/227 (46%), Gaps = 41/227 (18%)
Query: 144 AEVNYLGQLRHSNLVKLIGYCCEDEHRILVYEYMESGSLEKHL-----LRRVGCMLTWSR 198
            E+  L +L H  ++K+  +   +++ I V E ME G L   +     L+   C L +  
Sbjct: 63  TEIEILKKLNHPCIIKIKNFFDAEDYYI-VLELMEGGELFDKVVGNKRLKEATCKL-YFY 120
Query: 199 RMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNA---DFSAKLSDFGLAKDGPMGDQT 255
           +M +A+       +LH  E  +I+RD K  N+LL++   D   K++DFG +K   +  +T
Sbjct: 121 QMLLAVQ------YLH--ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSK---ILGET 169
Query: 256 HVSTRVMGTYGYAAPEYVM---TGHLTARSDVYGFGVVLLEMLLGRRAVDKSR------- 305
            +   + GT  Y APE ++   T       D +  GV+L   L G     + R       
Sbjct: 170 SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKD 229
Query: 306 --PSREHNLVE--WA---RPLLNNNKKVLRILDPRLEGQYTARTAMK 345
              S ++N +   WA      L+  KK+L ++DP+   ++T   A++
Sbjct: 230 QITSGKYNFIPEVWAEVSEKALDLVKKLL-VVDPK--ARFTTEEALR 273

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 70/158 (44%), Gaps = 15/158 (9%)
Query: 143 LAEVNYLGQLRHSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKI 202
           L E   L  +    LVKL     ++ +  +V EY+  G +  HL RR+G       R   
Sbjct: 76  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL-RRIGRFSEPHARF-Y 133
Query: 203 ALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTR-- 260
           A        +LH  +  +IYRD K  N+L++     +++DFG AK         V  R  
Sbjct: 134 AAQIVLTFEYLHSLD--LIYRDLKPENLLIDEQGYIQVTDFGFAK--------RVKGRTW 183
Query: 261 -VMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLG 297
            + GT  Y APE +++       D +  GV++ EM  G
Sbjct: 184 XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 221

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 60/227 (26%), Positives = 105/227 (46%), Gaps = 41/227 (18%)
Query: 144 AEVNYLGQLRHSNLVKLIGYCCEDEHRILVYEYMESGSLEKHL-----LRRVGCMLTWSR 198
            E+  L +L H  ++K+  +   +++ I V E ME G L   +     L+   C L +  
Sbjct: 64  TEIEILKKLNHPCIIKIKNFFDAEDYYI-VLELMEGGELFDKVVGNKRLKEATCKL-YFY 121
Query: 199 RMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNA---DFSAKLSDFGLAKDGPMGDQT 255
           +M +A+       +LH  E  +I+RD K  N+LL++   D   K++DFG +K   +  +T
Sbjct: 122 QMLLAVQ------YLH--ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSK---ILGET 170
Query: 256 HVSTRVMGTYGYAAPEYVM---TGHLTARSDVYGFGVVLLEMLLGRRAVDKSR------- 305
            +   + GT  Y APE ++   T       D +  GV+L   L G     + R       
Sbjct: 171 SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKD 230
Query: 306 --PSREHNLVE--WA---RPLLNNNKKVLRILDPRLEGQYTARTAMK 345
              S ++N +   WA      L+  KK+L ++DP+   ++T   A++
Sbjct: 231 QITSGKYNFIPEVWAEVSEKALDLVKKLL-VVDPK--ARFTTEEALR 274

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 60/227 (26%), Positives = 105/227 (46%), Gaps = 41/227 (18%)
Query: 144 AEVNYLGQLRHSNLVKLIGYCCEDEHRILVYEYMESGSLEKHL-----LRRVGCMLTWSR 198
            E+  L +L H  ++K+  +   +++ I V E ME G L   +     L+   C L +  
Sbjct: 64  TEIEILKKLNHPCIIKIKNFFDAEDYYI-VLELMEGGELFDKVVGNKRLKEATCKL-YFY 121
Query: 199 RMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNA---DFSAKLSDFGLAKDGPMGDQT 255
           +M +A+       +LH  E  +I+RD K  N+LL++   D   K++DFG +K   +  +T
Sbjct: 122 QMLLAVQ------YLH--ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSK---ILGET 170
Query: 256 HVSTRVMGTYGYAAPEYVM---TGHLTARSDVYGFGVVLLEMLLGRRAVDKSR------- 305
            +   + GT  Y APE ++   T       D +  GV+L   L G     + R       
Sbjct: 171 SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKD 230
Query: 306 --PSREHNLVE--WA---RPLLNNNKKVLRILDPRLEGQYTARTAMK 345
              S ++N +   WA      L+  KK+L ++DP+   ++T   A++
Sbjct: 231 QITSGKYNFIPEVWAEVSEKALDLVKKLL-VVDPK--ARFTTEEALR 274

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 31/106 (29%), Positives = 54/106 (50%), Gaps = 12/106 (11%)
Query: 200 MKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGL--AKDGPMGDQTHV 257
           + I +  A+ + FLH   + +++RD K SNI    D   K+ DFGL  A D    +QT +
Sbjct: 167 LHIFIQIAEAVEFLHS--KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVL 224
Query: 258 STRV--------MGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEML 295
           +           +GT  Y +PE +   + + + D++  G++L E+L
Sbjct: 225 TPMPAYATHXGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELL 270

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 60/227 (26%), Positives = 105/227 (46%), Gaps = 41/227 (18%)
Query: 144 AEVNYLGQLRHSNLVKLIGYCCEDEHRILVYEYMESGSLEKHL-----LRRVGCMLTWSR 198
            E+  L +L H  ++K+  +   +++ I V E ME G L   +     L+   C L +  
Sbjct: 70  TEIEILKKLNHPCIIKIKNFFDAEDYYI-VLELMEGGELFDKVVGNKRLKEATCKL-YFY 127
Query: 199 RMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNA---DFSAKLSDFGLAKDGPMGDQT 255
           +M +A+       +LH  E  +I+RD K  N+LL++   D   K++DFG +K   +  +T
Sbjct: 128 QMLLAVQ------YLH--ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSK---ILGET 176
Query: 256 HVSTRVMGTYGYAAPEYVM---TGHLTARSDVYGFGVVLLEMLLGRRAVDKSR------- 305
            +   + GT  Y APE ++   T       D +  GV+L   L G     + R       
Sbjct: 177 SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKD 236
Query: 306 --PSREHNLVE--WA---RPLLNNNKKVLRILDPRLEGQYTARTAMK 345
              S ++N +   WA      L+  KK+L ++DP+   ++T   A++
Sbjct: 237 QITSGKYNFIPEVWAEVSEKALDLVKKLL-VVDPK--ARFTTEEALR 280

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 30/102 (29%), Positives = 49/102 (48%), Gaps = 2/102 (1%)
Query: 194 LTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGD 253
           +T    +  +   A+G+ FL  + R  I+RD    NILL+ +   K+ DFGLA+D     
Sbjct: 196 ITMEDLISYSFQVARGMEFL--SSRKCIHRDLAARNILLSENNVVKICDFGLARDIYKNP 253
Query: 254 QTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEML 295
                        + APE +     + +SDV+ +GV+L E+ 
Sbjct: 254 DYVRKGDTRLPLKWMAPESIFDKIYSTKSDVWSYGVLLWEIF 295

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 55/228 (24%), Positives = 93/228 (40%), Gaps = 36/228 (15%)
Query: 94  FRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLR 153
           F    +LG+G FG V K       R    + + AIK++ R   +     L+EV  L  L 
Sbjct: 8   FEEIAVLGQGAFGQVVKA------RNALDSRYYAIKKI-RHTEEKLSTILSEVXLLASLN 60
Query: 154 HSNLVKLIGYCCEDEHRI-------------LVYEYMESGSLEKHLLRRVGCMLTWSRRM 200
           H  +V+      E  + +             +  EY E+ +L   L+             
Sbjct: 61  HQYVVRYYAAWLERRNFVKPXTAVKKKSTLFIQXEYCENRTLYD-LIHSENLNQQRDEYW 119
Query: 201 KIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAK------DGPMGDQ 254
           ++     + L+++H   + +I+R+ K  NI ++   + K+ DFGLAK      D    D 
Sbjct: 120 RLFRQILEALSYIHS--QGIIHRNLKPXNIFIDESRNVKIGDFGLAKNVHRSLDILKLDS 177
Query: 255 THVS------TRVMGTYGYAAPEYVM-TGHLTARSDVYGFGVVLLEML 295
            ++       T  +GT  Y A E +  TGH   + D Y  G++  E +
Sbjct: 178 QNLPGSSDNLTSAIGTAXYVATEVLDGTGHYNEKIDXYSLGIIFFEXI 225

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 48/181 (26%), Positives = 82/181 (45%), Gaps = 20/181 (11%)
Query: 126 VAIKELNR---GGYQGDREWLAEVNYLGQLRHSNLVKLIGYCC------EDEHRILVYEY 176
           VA+K+L+R         R +  E+  L  + H N++ L+          E +   LV E 
Sbjct: 52  VAVKKLSRPFQNQTHAKRAY-RELVLLKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMEL 110
Query: 177 MESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADF 236
           M++      L + +   L   R   +      G+  LH A   +I+RD K SNI++ +D 
Sbjct: 111 MDAN-----LCQVIHMELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDC 163
Query: 237 SAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLL 296
           + K+ DFGLA+         + T  + T  Y APE ++     A  D++  G ++ E++ 
Sbjct: 164 TLKILDFGLARTACTN---FMMTPYVVTRYYRAPEVILGMGYAANVDIWSVGCIMGELVK 220
Query: 297 G 297
           G
Sbjct: 221 G 221

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 95/215 (44%), Gaps = 28/215 (13%)
Query: 91  TKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWL-AEVNYL 149
           + FF  +  LG G   +VY+       +P       A+K L +     D++ +  E+  L
Sbjct: 52  SDFFEVESELGRGATSIVYRCKQKGTQKP------YALKVLKK---TVDKKIVRTEIGVL 102
Query: 150 GQLRHSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAK- 208
            +L H N++KL           LV E +  G L   ++ +      +S R   A DA K 
Sbjct: 103 LRLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIVEKG----YYSERD--AADAVKQ 156
Query: 209 ---GLAFLHGAERPVIYRDFKTSNILLNA---DFSAKLSDFGLAKDGPMGDQTHVSTRVM 262
               +A+LH  E  +++RD K  N+L      D   K++DFGL+K   + +   +   V 
Sbjct: 157 ILEAVAYLH--ENGIVHRDLKPENLLYATPAPDAPLKIADFGLSK---IVEHQVLMKTVC 211
Query: 263 GTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLG 297
           GT GY APE +         D++  G++   +L G
Sbjct: 212 GTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCG 246

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 58/227 (25%), Positives = 103/227 (45%), Gaps = 41/227 (18%)
Query: 144 AEVNYLGQLRHSNLVKLIGYCCEDEHRILVYEYMESGSLEKHL-----LRRVGCMLTWSR 198
            E+  L +L H  ++K+  +   +++ I V E ME G L   +     L+   C L + +
Sbjct: 189 TEIEILKKLNHPCIIKIKNFFDAEDYYI-VLELMEGGELFDKVVGNKRLKEATCKLYFYQ 247
Query: 199 RMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNA---DFSAKLSDFGLAKDGPMGDQT 255
            +         + +LH  E  +I+RD K  N+LL++   D   K++DFG +K   +  +T
Sbjct: 248 MLL-------AVQYLH--ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSK---ILGET 295
Query: 256 HVSTRVMGTYGYAAPEYVM---TGHLTARSDVYGFGVVLLEMLLGRRAVDKSR------- 305
            +   + GT  Y APE ++   T       D +  GV+L   L G     + R       
Sbjct: 296 SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKD 355
Query: 306 --PSREHNLVE--WA---RPLLNNNKKVLRILDPRLEGQYTARTAMK 345
              S ++N +   WA      L+  KK+L ++DP+   ++T   A++
Sbjct: 356 QITSGKYNFIPEVWAEVSEKALDLVKKLL-VVDPK--ARFTTEEALR 399

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 84/203 (41%), Gaps = 13/203 (6%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLA-EVNYLGQLRHSNLV 158
           LG G F +V K    +     Y   F+  + L        RE +  EVN L ++RH N++
Sbjct: 34  LGSGQFAIVRK-CRQKGTGKEYAAKFIKKRRLXSSRRGVSREEIEREVNILREIRHPNII 92
Query: 159 KLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAER 218
            L          +L+ E +  G L   L  +    LT     +       G+ +LH   +
Sbjct: 93  TLHDIFENKTDVVLILELVSGGELFDFLAEKES--LTEDEATQFLKQILDGVHYLHS--K 148
Query: 219 PVIYRDFKTSNILL----NADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVM 274
            + + D K  NI+L      +   KL DFG+A     G++      + GT  + APE V 
Sbjct: 149 RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEF---KNIFGTPEFVAPEIVN 205
Query: 275 TGHLTARSDVYGFGVVLLEMLLG 297
              L   +D++  GV+   +L G
Sbjct: 206 YEPLGLEADMWSIGVITYILLSG 228

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 45/158 (28%), Positives = 70/158 (44%), Gaps = 15/158 (9%)
Query: 143 LAEVNYLGQLRHSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKI 202
           L E   L  +    LVKL     ++ +  +V EY+  G +  HL RR+G       R   
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL-RRIGRFSEPHARF-Y 146
Query: 203 ALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTR-- 260
           A        +LH  +  +IYRD K  N++++     +++DFG AK         V  R  
Sbjct: 147 AAQIVLTFEYLHSLD--LIYRDLKPENLIIDQQGYIQVTDFGFAK--------RVKGRTW 196
Query: 261 -VMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLG 297
            + GT  Y APE +++       D +  GV++ EM  G
Sbjct: 197 XLCGTPEYLAPEIIISKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 45/158 (28%), Positives = 70/158 (44%), Gaps = 15/158 (9%)
Query: 143 LAEVNYLGQLRHSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKI 202
           L E   L  +    LVKL     ++ +  +V EY+  G +  HL RR+G       R   
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL-RRIGRFSEPHARF-Y 146
Query: 203 ALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTR-- 260
           A        +LH  +  +IYRD K  N+L++     +++DFG AK         V  R  
Sbjct: 147 AAQIVLTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTW 196
Query: 261 -VMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLG 297
            + GT  Y APE +++       D +  GV++ +M  G
Sbjct: 197 XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYQMAAG 234

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 58/227 (25%), Positives = 103/227 (45%), Gaps = 41/227 (18%)
Query: 144 AEVNYLGQLRHSNLVKLIGYCCEDEHRILVYEYMESGSLEKHL-----LRRVGCMLTWSR 198
            E+  L +L H  ++K+  +   +++ I V E ME G L   +     L+   C L + +
Sbjct: 203 TEIEILKKLNHPCIIKIKNFFDAEDYYI-VLELMEGGELFDKVVGNKRLKEATCKLYFYQ 261
Query: 199 RMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNA---DFSAKLSDFGLAKDGPMGDQT 255
            +         + +LH  E  +I+RD K  N+LL++   D   K++DFG +K   +  +T
Sbjct: 262 MLL-------AVQYLH--ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSK---ILGET 309
Query: 256 HVSTRVMGTYGYAAPEYVM---TGHLTARSDVYGFGVVLLEMLLGRRAVDKSR------- 305
            +   + GT  Y APE ++   T       D +  GV+L   L G     + R       
Sbjct: 310 SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKD 369
Query: 306 --PSREHNLVE--WA---RPLLNNNKKVLRILDPRLEGQYTARTAMK 345
              S ++N +   WA      L+  KK+L ++DP+   ++T   A++
Sbjct: 370 QITSGKYNFIPEVWAEVSEKALDLVKKLL-VVDPK--ARFTTEEALR 413

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 77/342 (22%), Positives = 139/342 (40%), Gaps = 66/342 (19%)
Query: 82  FTYNEMKLATKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDRE 141
           F    ++L     R   +L EGGF  VY+    ++V  G +    A+K L     + +R 
Sbjct: 18  FVGQTVELGELRLRVRRVLAEGGFAFVYEA---QDVGSGRE---YALKRLLSNEEEKNRA 71
Query: 142 WLAEVNYLGQLR-HSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRV--GCMLTWSR 198
            + EV ++ +L  H N+V+   +C       +  E  ++G  E  LL  +  G ++ + +
Sbjct: 72  IIQEVCFMKKLSGHPNIVQ---FCSAAS---IGKEESDTGQAEFLLLTELCKGQLVEFLK 125
Query: 199 RM------------KIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLA 246
           +M            KI     + +  +H  + P+I+RD K  N+LL+   + KL DFG A
Sbjct: 126 KMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSA 185
Query: 247 KD-GPMGDQTHVSTRVM---------GTYGYAAPEYV---MTGHLTARSDVYGFGVVLLE 293
                  D +  + R            T  Y  PE +       +  + D++  G +L  
Sbjct: 186 TTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYL 245
Query: 294 MLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRILDPRLEGQYTARTAMKVAGLAYQC 353
           +             R+H   + A+  + N K  +    P  + QYT   ++  A L    
Sbjct: 246 LCF-----------RQHPFEDGAKLRIVNGKYSI----PPHDTQYTVFHSLIRAMLQV-- 288
Query: 354 LSQNPKGRPVMSDVVALLETVQS------QGAEEEMLQSGGG 389
              NP+ R  +++VV  L+ + +      +    E+L+  GG
Sbjct: 289 ---NPEERLSIAEVVHQLQEIAAARNVNPKSPITELLEQNGG 327

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 45/158 (28%), Positives = 68/158 (43%), Gaps = 15/158 (9%)
Query: 143 LAEVNYLGQLRHSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKI 202
           L E   L  +    L KL     ++ +  +V EY   G +  HL RR+G       R   
Sbjct: 90  LNEKRILQAVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHL-RRIGRFXEPHARF-Y 147
Query: 203 ALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTR-- 260
           A        +LH  +  +IYRD K  N++++     K++DFG AK         V  R  
Sbjct: 148 AAQIVLTFEYLHSLD--LIYRDLKPENLMIDQQGYIKVTDFGFAK--------RVKGRTW 197
Query: 261 -VMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLG 297
            + GT  Y APE +++       D +  GV++ EM  G
Sbjct: 198 XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 54/228 (23%), Positives = 95/228 (41%), Gaps = 38/228 (16%)
Query: 98  YILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNR--GGYQGDREWLAEVNYLGQLRHS 155
           +++G G +G V +           +   VAIK++ R        +  L E+  L +L H 
Sbjct: 59  HLIGTGSYGHVCEAY------DKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHD 112
Query: 156 NLVKLIGYCCEDEHRIL--VYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFL 213
           ++VK++      +      +Y  +E    +   L R    LT      +  +   G+ ++
Sbjct: 113 HVVKVLDIVIPKDVEKFDELYVVLEIADSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYV 172
Query: 214 HGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKD-------------GPMGDQTHVST- 259
           H A   +++RD K +N L+N D S K+ DFGLA+               P  D  ++ T 
Sbjct: 173 HSAG--ILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTF 230
Query: 260 --------RVMG---TYGYAAPEYVMTG-HLTARSDVYGFGVVLLEML 295
                   ++ G   T  Y APE ++   + T   DV+  G +  E+L
Sbjct: 231 PHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELL 278

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 45/158 (28%), Positives = 69/158 (43%), Gaps = 15/158 (9%)
Query: 143 LAEVNYLGQLRHSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKI 202
           L E   L  +    LVKL     ++ +  +V EY   G +  HL RR+G       R   
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHL-RRIGRFSEPHARF-Y 146
Query: 203 ALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTR-- 260
           A        +LH  +  +IYRD K  N++++     +++DFG AK         V  R  
Sbjct: 147 AAQIVLTFEYLHSLD--LIYRDLKPENLMIDQQGYIQVTDFGFAK--------RVKGRTW 196
Query: 261 -VMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLG 297
            + GT  Y APE +++       D +  GV++ EM  G
Sbjct: 197 XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 96/209 (45%), Gaps = 29/209 (13%)
Query: 100 LGEGGFGVVYKGVIDENVRPG--YKTTFVAIKELNRGGYQG-DREWLAEVNYLGQLRHSN 156
           LG+G F VV + +    +  G  Y    +  K+L+   +Q  +RE  A +  L  L+H N
Sbjct: 12  LGKGAFSVVRRCM---KIPTGQEYAAKIINTKKLSARDHQKLERE--ARICRL--LKHPN 64
Query: 157 LVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFL--- 213
           +V+L     E+    LV++ +  G L + ++         +R      DA+  +  +   
Sbjct: 65  IVRLHDSISEEGFHYLVFDLVTGGELFEDIV---------AREYYSEADASHCIQQILES 115
Query: 214 --HGAERPVIYRDFKTSNILLNAD---FSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYA 268
             H     +++RD K  N+LL +     + KL+DFGLA +   GDQ        GT GY 
Sbjct: 116 VNHCHLNGIVHRDLKPENLLLASKSKGAAVKLADFGLAIEV-QGDQ-QAWFGFAGTPGYL 173
Query: 269 APEYVMTGHLTARSDVYGFGVVLLEMLLG 297
           +PE +         D++  GV+L  +L+G
Sbjct: 174 SPEVLRKDPYGKPVDMWACGVILYILLVG 202

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 45/158 (28%), Positives = 68/158 (43%), Gaps = 15/158 (9%)
Query: 143 LAEVNYLGQLRHSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKI 202
           L E   L  +    L KL     ++ +  +V EY   G +  HL RR+G       R   
Sbjct: 90  LNEKRILQAVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHL-RRIGRFSEPHARF-Y 147
Query: 203 ALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTR-- 260
           A        +LH  +  +IYRD K  N++++     K++DFG AK         V  R  
Sbjct: 148 AAQIVLTFEYLHSLD--LIYRDLKPENLMIDQQGYIKVTDFGFAK--------RVKGRTW 197
Query: 261 -VMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLG 297
            + GT  Y APE +++       D +  GV++ EM  G
Sbjct: 198 XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 45/158 (28%), Positives = 68/158 (43%), Gaps = 15/158 (9%)
Query: 143 LAEVNYLGQLRHSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKI 202
           L E   L  +    L KL     ++ +  +V EY   G +  HL RR+G       R   
Sbjct: 90  LNEKRILQAVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHL-RRIGRFSEPHARF-Y 147
Query: 203 ALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTR-- 260
           A        +LH  +  +IYRD K  N++++     K++DFG AK         V  R  
Sbjct: 148 AAQIVLTFEYLHSLD--LIYRDLKPENLMIDQQGYIKVTDFGFAK--------RVKGRTW 197
Query: 261 -VMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLG 297
            + GT  Y APE +++       D +  GV++ EM  G
Sbjct: 198 XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 47/181 (25%), Positives = 81/181 (44%), Gaps = 20/181 (11%)
Query: 126 VAIKELNR---GGYQGDREWLAEVNYLGQLRHSNLVKLIGYCC------EDEHRILVYEY 176
           VA+K+L+R         R +  E+  L  + H N++ L+          E +   LV E 
Sbjct: 50  VAVKKLSRPFQNQTHAKRAY-RELVLLKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMEL 108
Query: 177 MESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADF 236
           M++      L + +   L   R   +      G+  LH A   +I+RD K SNI++ +D 
Sbjct: 109 MDAN-----LCQVIHMELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDC 161
Query: 237 SAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLL 296
           + K+ DFGLA+         + T  + T  Y APE ++        D++  G ++ E++ 
Sbjct: 162 TLKILDFGLART---ASTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVK 218
Query: 297 G 297
           G
Sbjct: 219 G 219

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 45/158 (28%), Positives = 69/158 (43%), Gaps = 15/158 (9%)
Query: 143 LAEVNYLGQLRHSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKI 202
           L E   L  +    LVKL     ++ +  +V EY+  G +  HL RR+G       R   
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL-RRIGRFSEPHARF-Y 146
Query: 203 ALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTR-- 260
           A        +LH  +  +IYRD K  N+L++     +++DFG AK         V  R  
Sbjct: 147 AAQIVLTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTW 196
Query: 261 -VMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLG 297
            + GT  Y AP  +++       D +  GV++ EM  G
Sbjct: 197 XLCGTPEYLAPAIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 50/224 (22%), Positives = 96/224 (42%), Gaps = 30/224 (13%)
Query: 99  ILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLV 158
           ++G+G FG VY G     V        + + ++ R      + +  EV    Q RH N+V
Sbjct: 40  LIGKGRFGQVYHGRWHGEVA-------IRLIDIERDNEDQLKAFKREVMAYRQTRHENVV 92
Query: 159 KLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAER 218
             +G C    H  ++    +  +L   ++R    +L  ++  +IA +  KG+ +LH   +
Sbjct: 93  LFMGACMSPPHLAIITSLCKGRTLYS-VVRDAKIVLDVNKTRQIAQEIVKGMGYLHA--K 149
Query: 219 PVIYRDFKTSNILLNADFSAKLSDFGL------AKDGPMGDQTHVSTRVMGTYGYAAPEY 272
            ++++D K+ N+  + +    ++DFGL       + G   D+  +     G   + APE 
Sbjct: 150 GILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQN---GWLCHLAPEI 205
Query: 273 VMTGH---------LTARSDVYGFGVVLLEMLLGRRAVDKSRPS 307
           +              +  SDV+  G +  E L  R    K++P+
Sbjct: 206 IRQLSPDTEEDKLPFSKHSDVFALGTIWYE-LHAREWPFKTQPA 248

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 96/209 (45%), Gaps = 29/209 (13%)
Query: 100 LGEGGFGVVYKGVIDENVRPG--YKTTFVAIKELNRGGYQG-DREWLAEVNYLGQLRHSN 156
           LG+G F VV + +    +  G  Y    +  K+L+   +Q  +RE  A +  L  L+H N
Sbjct: 12  LGKGAFSVVRRCM---KIPTGQEYAAKIINTKKLSARDHQKLERE--ARICRL--LKHPN 64
Query: 157 LVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFL--- 213
           +V+L     E+    LV++ +  G L + ++         +R      DA+  +  +   
Sbjct: 65  IVRLHDSISEEGFHYLVFDLVTGGELFEDIV---------AREYYSEADASHCIQQILES 115
Query: 214 --HGAERPVIYRDFKTSNILLNAD---FSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYA 268
             H     +++RD K  N+LL +     + KL+DFGLA +   GDQ        GT GY 
Sbjct: 116 VNHCHLNGIVHRDLKPENLLLASKSKGAAVKLADFGLAIEV-QGDQ-QAWFGFAGTPGYL 173
Query: 269 APEYVMTGHLTARSDVYGFGVVLLEMLLG 297
           +PE +         D++  GV+L  +L+G
Sbjct: 174 SPEVLRKDPYGKPVDMWACGVILYILLVG 202

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 45/164 (27%), Positives = 69/164 (42%), Gaps = 12/164 (7%)
Query: 140 REWLAEVNYLGQLRHSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRR 199
           R    E+  +  L H  LV L     ++E   +V + +  G L  HL + V         
Sbjct: 60  RNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFK---EET 116
Query: 200 MKIAL-DAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVS 258
           +K+ + +    L +L      +I+RD K  NILL+      ++DF +A   P   Q    
Sbjct: 117 VKLFICELVMALDYLQNQR--IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQI--- 171
Query: 259 TRVMGTYGYAAPEYVMT---GHLTARSDVYGFGVVLLEMLLGRR 299
           T + GT  Y APE   +      +   D +  GV   E+L GRR
Sbjct: 172 TTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRR 215

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 44/139 (31%), Positives = 62/139 (44%), Gaps = 17/139 (12%)
Query: 172 LVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNIL 231
           LV+E M  GS+  H+ +R            +  D A  L FLH   + + +RD K  NIL
Sbjct: 88  LVFEKMRGGSILSHIHKRR--HFNELEASVVVQDVASALDFLHN--KGIAHRDLKPENIL 143
Query: 232 L---NADFSAKLSDFGLAKDGPM-GDQTHVSTRVM----GTYGYAAPEYVMTGHLTA--- 280
               N     K+ DFGL     + GD + +ST  +    G+  Y APE V      A   
Sbjct: 144 CEHPNQVSPVKICDFGLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIY 203
Query: 281 --RSDVYGFGVVLLEMLLG 297
             R D++  GV+L  +L G
Sbjct: 204 DKRCDLWSLGVILYILLSG 222

>pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 37/130 (28%), Positives = 56/130 (43%), Gaps = 9/130 (6%)
Query: 171 ILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNI 230
           +++ E ME G L   +  R     T     +I  D    + FLH     + +RD K  N+
Sbjct: 102 LIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHN--IAHRDVKPENL 159
Query: 231 LLNA---DFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGF 287
           L  +   D   KL+DFG AK+     Q  + T     Y Y APE +         D++  
Sbjct: 160 LYTSKEKDAVLKLTDFGFAKE---TTQNALQTPCYTPY-YVAPEVLGPEKYDKSCDMWSL 215
Query: 288 GVVLLEMLLG 297
           GV++  +L G
Sbjct: 216 GVIMYILLCG 225

>pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 37/130 (28%), Positives = 56/130 (43%), Gaps = 9/130 (6%)
Query: 171 ILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNI 230
           +++ E ME G L   +  R     T     +I  D    + FLH     + +RD K  N+
Sbjct: 83  LIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHN--IAHRDVKPENL 140
Query: 231 LLNA---DFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGF 287
           L  +   D   KL+DFG AK+     Q  + T     Y Y APE +         D++  
Sbjct: 141 LYTSKEKDAVLKLTDFGFAKE---TTQNALQTPCYTPY-YVAPEVLGPEKYDKSCDMWSL 196
Query: 288 GVVLLEMLLG 297
           GV++  +L G
Sbjct: 197 GVIMYILLCG 206

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 45/158 (28%), Positives = 69/158 (43%), Gaps = 15/158 (9%)
Query: 143 LAEVNYLGQLRHSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKI 202
           L E   L  +    LVKL     ++ +  +V EY+  G +  HL RR+G       R   
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL-RRIGRFSEPHARF-Y 146
Query: 203 ALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTR-- 260
           A        +LH  +  +IYRD K  N+L++     +++DFG AK         V  R  
Sbjct: 147 AAQIVLTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTW 196
Query: 261 -VMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLG 297
            + GT    APE +++       D +  GV++ EM  G
Sbjct: 197 XLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 52/199 (26%), Positives = 82/199 (41%), Gaps = 41/199 (20%)
Query: 138 GDREWLAEVNYLGQLRHSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLT-- 195
           GD +W+  ++Y  Q              +D +  LV +Y   G L   LL +    L   
Sbjct: 131 GDSKWITTLHYAFQ--------------DDNNLYLVMDYYVGGDLLT-LLSKFEDRLPEE 175
Query: 196 ----WSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPM 251
               +   M IA+D+   L ++H        RD K  NIL++ +   +L+DFG      M
Sbjct: 176 MARFYLAEMVIAIDSVHQLHYVH--------RDIKPDNILMDMNGHIRLADFGSCL-KLM 226
Query: 252 GDQTHVSTRVMGTYGYAAPEYVMT-----GHLTARSDVYGFGVVLLEMLLGRRAVDKSRP 306
            D T  S+  +GT  Y +PE +       G      D +  GV + EML G        P
Sbjct: 227 EDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGE------TP 280
Query: 307 SREHNLVEWARPLLNNNKK 325
               +LVE    ++N+ ++
Sbjct: 281 FYAESLVETYGKIMNHKER 299

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 48.1 bits (113), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 94/209 (44%), Gaps = 25/209 (11%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGG-YQGDREWLAEVNYLGQLRHSN-L 157
           +G G  G V+K      +R       +A+K++ R G  + ++  L +++ + +      +
Sbjct: 33  MGSGTCGQVWK------MRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYI 86
Query: 158 VKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFL---H 214
           V+  G    +    +  E M  G+  + L +R+   +      K+ +   K L +L   H
Sbjct: 87  VQCFGTFITNTDVFIAMELM--GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKH 144
Query: 215 GAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVM 274
           G    VI+RD K SNILL+     KL DFG++  G + D      R  G   Y APE + 
Sbjct: 145 G----VIHRDVKPSNILLDERGQIKLCDFGIS--GRLVDD-KAKDRSAGCAAYMAPERID 197
Query: 275 TGHLT-----ARSDVYGFGVVLLEMLLGR 298
               T      R+DV+  G+ L+E+  G+
Sbjct: 198 PPDPTKPDYDIRADVWSLGISLVELATGQ 226

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 71/295 (24%), Positives = 116/295 (39%), Gaps = 79/295 (26%)
Query: 99  ILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNR------GGYQGDREWLAEVNYLGQL 152
           +LG GGFG VY G+   +  P      VAIK + +      G          EV  L ++
Sbjct: 15  LLGSGGFGSVYSGIRVSDNLP------VAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 68
Query: 153 R--HSNLVKLIGYCCEDEHRILVYEYMES-----------GSLEKHLLRRVGCMLTWSRR 199
               S +++L+ +    +  +L+ E ME            G+L++ L R       W   
Sbjct: 69  SSGFSGVIRLLDWFERPDSFVLILERMEPVQDLFDFITERGALQEELARS----FFWQ-- 122
Query: 200 MKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADF-SAKLSDFG---LAKDGPMGDQT 255
               L+A +     H     V++RD K  NIL++ +    KL DFG   L KD       
Sbjct: 123 ---VLEAVR-----HCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT------ 168
Query: 256 HVSTRVMGTYGYAAPEYVMTGHLTARS-DVYGFGVVLLEMLLGRRAVDKSRPSREHNLVE 314
            V T   GT  Y+ PE++       RS  V+  G++L +M+ G                 
Sbjct: 169 -VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP-------------- 213
Query: 315 WARPLLNNNKKVLRILDPRLEGQ--YTARTAMKVAGLAYQCLSQNPKGRPVMSDV 367
                  ++++++R       GQ  +  R + +   L   CL+  P  RP   ++
Sbjct: 214 -----FEHDEEIIR-------GQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEI 256

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 47/184 (25%), Positives = 73/184 (39%), Gaps = 38/184 (20%)
Query: 211 AFLHGAERPVIYRDFKTSNILLNADF-SAKLSDFG---LAKDGPMGDQTHVSTRVMGTYG 266
           A  H   R V++RD K  NIL++     AKL DFG   L  D P  D         GT  
Sbjct: 151 AIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTDFD-------GTRV 203
Query: 267 YAAPEYVMTGHLTA-RSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKK 325
           Y+ PE++      A  + V+  G++L +M+ G    +     R+  ++E           
Sbjct: 204 YSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFE-----RDQEILE----------- 247
Query: 326 VLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETVQSQGAEEEMLQ 385
                    E  + A  +     L  +CL+  P  RP + ++  LL+      AE+  L 
Sbjct: 248 --------AELHFPAHVSPDCCALIRRCLAPKPSSRPSLEEI--LLDPWMQTPAEDVPLN 297
Query: 386 SGGG 389
              G
Sbjct: 298 PSKG 301

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 43/139 (30%), Positives = 61/139 (43%), Gaps = 17/139 (12%)
Query: 172 LVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNIL 231
           LV+E M  GS+  H+ +R            +  D A  L FLH   + + +RD K  NIL
Sbjct: 88  LVFEKMRGGSILSHIHKRR--HFNELEASVVVQDVASALDFLHN--KGIAHRDLKPENIL 143
Query: 232 L---NADFSAKLSDFGLAKDGPM-GDQTHVSTRVM----GTYGYAAPEYVMTGHLTA--- 280
               N     K+ DF L     + GD + +ST  +    G+  Y APE V      A   
Sbjct: 144 CEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIY 203
Query: 281 --RSDVYGFGVVLLEMLLG 297
             R D++  GV+L  +L G
Sbjct: 204 DKRCDLWSLGVILYILLSG 222

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 95/212 (44%), Gaps = 31/212 (14%)
Query: 99  ILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLV 158
           ++G G FGVV++  + E+         VAIK++     Q  R    E+  +  ++H N+V
Sbjct: 47  VIGNGSFGVVFQAKLVESDE-------VAIKKV----LQDKRFKNRELQIMRIVKHPNVV 95
Query: 159 KLIGYCC-----EDEHRI-LVYEYMES----GSLEKHLLRRVGCMLTWSRRMKIALDAAK 208
            L  +       +DE  + LV EY+       S     L++   ML     M   L   +
Sbjct: 96  DLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLL---R 152
Query: 209 GLAFLHGAERPVIYRDFKTSNILLNADFSA-KLSDFGLAKDGPMGDQTHVSTRVMGTYGY 267
            LA++H     + +RD K  N+LL+      KL DFG AK    G+    +   + +  Y
Sbjct: 153 SLAYIHSIG--ICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEP---NVSXICSRYY 207
Query: 268 AAPEYVM-TGHLTARSDVYGFGVVLLEMLLGR 298
            APE +    + T   D++  G V+ E++ G+
Sbjct: 208 RAPELIFGATNYTTNIDIWSTGCVMAELMQGQ 239

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 63/263 (23%), Positives = 100/263 (38%), Gaps = 54/263 (20%)
Query: 86  EMKLATKFFRPDYILGEGGFGVV-----------YKGVIDENVRPGYKTTFVAIKELNRG 134
           EM+L  + F    ++G G FG V           Y   I        +      +E    
Sbjct: 84  EMQLHREDFEIIKVIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFREERDV 143
Query: 135 GYQGDREWLAEVNYLGQLRHSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCML 194
              GD +W+  ++Y  Q              ++ H  LV +Y   G L   LL +    L
Sbjct: 144 LVNGDCQWITALHYAFQ--------------DENHLYLVMDYYVGGDLLT-LLSKFEDKL 188
Query: 195 T------WSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKD 248
                  +   M +A+D+   L ++H        RD K  N+LL+ +   +L+DFG    
Sbjct: 189 PEDMARFYIGEMVLAIDSIHQLHYVH--------RDIKPDNVLLDVNGHIRLADFGSCL- 239
Query: 249 GPMGDQTHVSTRV-MGTYGYAAPEYVMT-----GHLTARSDVYGFGVVLLEMLLGRRAVD 302
             M D   V + V +GT  Y +PE +       G      D +  GV + EML G     
Sbjct: 240 -KMNDDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGE---- 294
Query: 303 KSRPSREHNLVEWARPLLNNNKK 325
              P    +LVE    ++N+ ++
Sbjct: 295 --TPFYAESLVETYGKIMNHEER 315

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 39/149 (26%), Positives = 67/149 (44%), Gaps = 10/149 (6%)
Query: 153 RHSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAF 212
           +H N++ L     + ++  +V E M+ G L   +LR+     +      +     K + +
Sbjct: 74  QHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQK--FFSEREASAVLFTITKTVEY 131
Query: 213 LHGAERPVIYRDFKTSNILLNADF----SAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYA 268
           LH   + V++RD K SNIL   +     S ++ DFG AK   +  +  +      T  + 
Sbjct: 132 LHA--QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQ--LRAENGLLMTPCYTANFV 187
Query: 269 APEYVMTGHLTARSDVYGFGVVLLEMLLG 297
           APE +      A  D++  GV+L  ML G
Sbjct: 188 APEVLERQGYDAACDIWSLGVLLYTMLTG 216

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 70/295 (23%), Positives = 116/295 (39%), Gaps = 79/295 (26%)
Query: 99  ILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNR------GGYQGDREWLAEVNYLGQL 152
           +LG GGFG VY G+   +  P      VAIK + +      G          EV  L ++
Sbjct: 30  LLGSGGFGSVYSGIRVSDNLP------VAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 83
Query: 153 R--HSNLVKLIGYCCEDEHRILVYE-----------YMESGSLEKHLLRRVGCMLTWSRR 199
               S +++L+ +    +  +L+ E             E G+L++ L R       W   
Sbjct: 84  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARS----FFWQ-- 137
Query: 200 MKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADF-SAKLSDFG---LAKDGPMGDQT 255
               L+A +     H     V++RD K  NIL++ +    KL DFG   L KD       
Sbjct: 138 ---VLEAVR-----HCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT------ 183
Query: 256 HVSTRVMGTYGYAAPEYVMTGHLTARS-DVYGFGVVLLEMLLGRRAVDKSRPSREHNLVE 314
            V T   GT  Y+ PE++       RS  V+  G++L +M+ G    +            
Sbjct: 184 -VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFE------------ 230
Query: 315 WARPLLNNNKKVLRILDPRLEGQ--YTARTAMKVAGLAYQCLSQNPKGRPVMSDV 367
                  ++++++R       GQ  +  R + +   L   CL+  P  RP   ++
Sbjct: 231 -------HDEEIIR-------GQVFFRQRVSXECQHLIRWCLALRPSDRPTFEEI 271

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 70/295 (23%), Positives = 116/295 (39%), Gaps = 79/295 (26%)
Query: 99  ILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNR------GGYQGDREWLAEVNYLGQL 152
           +LG GGFG VY G+   +  P      VAIK + +      G          EV  L ++
Sbjct: 58  LLGSGGFGSVYSGIRVSDNLP------VAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 111
Query: 153 R--HSNLVKLIGYCCEDEHRILVYE-----------YMESGSLEKHLLRRVGCMLTWSRR 199
               S +++L+ +    +  +L+ E             E G+L++ L R       W   
Sbjct: 112 SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARS----FFWQ-- 165
Query: 200 MKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADF-SAKLSDFG---LAKDGPMGDQT 255
               L+A +     H     V++RD K  NIL++ +    KL DFG   L KD       
Sbjct: 166 ---VLEAVR-----HCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT------ 211
Query: 256 HVSTRVMGTYGYAAPEYVMTGHLTARS-DVYGFGVVLLEMLLGRRAVDKSRPSREHNLVE 314
            V T   GT  Y+ PE++       RS  V+  G++L +M+ G    +            
Sbjct: 212 -VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFE------------ 258
Query: 315 WARPLLNNNKKVLRILDPRLEGQ--YTARTAMKVAGLAYQCLSQNPKGRPVMSDV 367
                  ++++++R       GQ  +  R + +   L   CL+  P  RP   ++
Sbjct: 259 -------HDEEIIR-------GQVFFRQRVSXECQHLIRWCLALRPSDRPTFEEI 299

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 70/295 (23%), Positives = 116/295 (39%), Gaps = 79/295 (26%)
Query: 99  ILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNR------GGYQGDREWLAEVNYLGQL 152
           +LG GGFG VY G+   +  P      VAIK + +      G          EV  L ++
Sbjct: 31  LLGSGGFGSVYSGIRVSDNLP------VAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 84
Query: 153 R--HSNLVKLIGYCCEDEHRILVYE-----------YMESGSLEKHLLRRVGCMLTWSRR 199
               S +++L+ +    +  +L+ E             E G+L++ L R       W   
Sbjct: 85  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARS----FFWQ-- 138
Query: 200 MKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADF-SAKLSDFG---LAKDGPMGDQT 255
               L+A +     H     V++RD K  NIL++ +    KL DFG   L KD       
Sbjct: 139 ---VLEAVR-----HCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT------ 184
Query: 256 HVSTRVMGTYGYAAPEYVMTGHLTARS-DVYGFGVVLLEMLLGRRAVDKSRPSREHNLVE 314
            V T   GT  Y+ PE++       RS  V+  G++L +M+ G    +            
Sbjct: 185 -VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFE------------ 231
Query: 315 WARPLLNNNKKVLRILDPRLEGQ--YTARTAMKVAGLAYQCLSQNPKGRPVMSDV 367
                  ++++++R       GQ  +  R + +   L   CL+  P  RP   ++
Sbjct: 232 -------HDEEIIR-------GQVFFRQRVSXECQHLIRWCLALRPSDRPTFEEI 272

>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 70/295 (23%), Positives = 115/295 (38%), Gaps = 79/295 (26%)
Query: 99  ILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNR------GGYQGDREWLAEVNYLGQL 152
           +LG GGFG VY G+   +  P      VAIK + +      G          EV  L ++
Sbjct: 11  LLGSGGFGSVYSGIRVSDNLP------VAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 64
Query: 153 R--HSNLVKLIGYCCEDEHRILVYE-----------YMESGSLEKHLLRRVGCMLTWSRR 199
               S +++L+ +    +  +L+ E             E G+L++ L R       W   
Sbjct: 65  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARS----FFWQ-- 118
Query: 200 MKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADF-SAKLSDFG---LAKDGPMGDQT 255
               L+A +     H     V++RD K  NIL++ +    KL DFG   L KD       
Sbjct: 119 ---VLEAVR-----HCHNXGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT------ 164
Query: 256 HVSTRVMGTYGYAAPEYVMTGHLTARS-DVYGFGVVLLEMLLGRRAVDKSRPSREHNLVE 314
            V T   GT  Y+ PE++       RS  V+  G++L +M+ G                 
Sbjct: 165 -VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP-------------- 209
Query: 315 WARPLLNNNKKVLRILDPRLEGQ--YTARTAMKVAGLAYQCLSQNPKGRPVMSDV 367
                  ++++++R       GQ  +  R + +   L   CL+  P  RP   ++
Sbjct: 210 -----FEHDEEIIR-------GQVFFRQRVSXECQHLIRWCLALRPSDRPTFEEI 252

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 70/295 (23%), Positives = 116/295 (39%), Gaps = 79/295 (26%)
Query: 99  ILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNR------GGYQGDREWLAEVNYLGQL 152
           +LG GGFG VY G+   +  P      VAIK + +      G          EV  L ++
Sbjct: 31  LLGSGGFGSVYSGIRVSDNLP------VAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 84
Query: 153 R--HSNLVKLIGYCCEDEHRILVYE-----------YMESGSLEKHLLRRVGCMLTWSRR 199
               S +++L+ +    +  +L+ E             E G+L++ L R       W   
Sbjct: 85  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARS----FFWQ-- 138
Query: 200 MKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADF-SAKLSDFG---LAKDGPMGDQT 255
               L+A +     H     V++RD K  NIL++ +    KL DFG   L KD       
Sbjct: 139 ---VLEAVR-----HCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT------ 184
Query: 256 HVSTRVMGTYGYAAPEYVMTGHLTARS-DVYGFGVVLLEMLLGRRAVDKSRPSREHNLVE 314
            V T   GT  Y+ PE++       RS  V+  G++L +M+ G    +            
Sbjct: 185 -VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFE------------ 231
Query: 315 WARPLLNNNKKVLRILDPRLEGQ--YTARTAMKVAGLAYQCLSQNPKGRPVMSDV 367
                  ++++++R       GQ  +  R + +   L   CL+  P  RP   ++
Sbjct: 232 -------HDEEIIR-------GQVFFRQRVSXECQHLIRWCLALRPXDRPTFEEI 272

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 63/263 (23%), Positives = 100/263 (38%), Gaps = 54/263 (20%)
Query: 86  EMKLATKFFRPDYILGEGGFGVV-----------YKGVIDENVRPGYKTTFVAIKELNRG 134
           EM+L  + F    ++G G FG V           Y   I        +      +E    
Sbjct: 68  EMQLHREDFEIIKVIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFREERDV 127
Query: 135 GYQGDREWLAEVNYLGQLRHSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCML 194
              GD +W+  ++Y  Q              ++ H  LV +Y   G L   LL +    L
Sbjct: 128 LVNGDCQWITALHYAFQ--------------DENHLYLVMDYYVGGDLLT-LLSKFEDKL 172
Query: 195 T------WSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKD 248
                  +   M +A+D+   L ++H        RD K  N+LL+ +   +L+DFG    
Sbjct: 173 PEDMARFYIGEMVLAIDSIHQLHYVH--------RDIKPDNVLLDVNGHIRLADFGSCL- 223
Query: 249 GPMGDQTHVSTRV-MGTYGYAAPEYVMT-----GHLTARSDVYGFGVVLLEMLLGRRAVD 302
             M D   V + V +GT  Y +PE +       G      D +  GV + EML G     
Sbjct: 224 -KMNDDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGE---- 278
Query: 303 KSRPSREHNLVEWARPLLNNNKK 325
              P    +LVE    ++N+ ++
Sbjct: 279 --TPFYAESLVETYGKIMNHEER 299

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 70/295 (23%), Positives = 116/295 (39%), Gaps = 79/295 (26%)
Query: 99  ILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNR------GGYQGDREWLAEVNYLGQL 152
           +LG GGFG VY G+   +  P      VAIK + +      G          EV  L ++
Sbjct: 16  LLGSGGFGSVYSGIRVSDNLP------VAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 69
Query: 153 R--HSNLVKLIGYCCEDEHRILVYE-----------YMESGSLEKHLLRRVGCMLTWSRR 199
               S +++L+ +    +  +L+ E             E G+L++ L R       W   
Sbjct: 70  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARS----FFWQ-- 123
Query: 200 MKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADF-SAKLSDFG---LAKDGPMGDQT 255
               L+A +     H     V++RD K  NIL++ +    KL DFG   L KD       
Sbjct: 124 ---VLEAVR-----HCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT------ 169
Query: 256 HVSTRVMGTYGYAAPEYVMTGHLTARS-DVYGFGVVLLEMLLGRRAVDKSRPSREHNLVE 314
            V T   GT  Y+ PE++       RS  V+  G++L +M+ G    +            
Sbjct: 170 -VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFE------------ 216
Query: 315 WARPLLNNNKKVLRILDPRLEGQ--YTARTAMKVAGLAYQCLSQNPKGRPVMSDV 367
                  ++++++R       GQ  +  R + +   L   CL+  P  RP   ++
Sbjct: 217 -------HDEEIIR-------GQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEI 257

>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 70/295 (23%), Positives = 116/295 (39%), Gaps = 79/295 (26%)
Query: 99  ILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNR------GGYQGDREWLAEVNYLGQL 152
           +LG GGFG VY G+   +  P      VAIK + +      G          EV  L ++
Sbjct: 38  LLGSGGFGSVYSGIRVSDNLP------VAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 91
Query: 153 R--HSNLVKLIGYCCEDEHRILVYE-----------YMESGSLEKHLLRRVGCMLTWSRR 199
               S +++L+ +    +  +L+ E             E G+L++ L R       W   
Sbjct: 92  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARS----FFWQ-- 145
Query: 200 MKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADF-SAKLSDFG---LAKDGPMGDQT 255
               L+A +     H     V++RD K  NIL++ +    KL DFG   L KD       
Sbjct: 146 ---VLEAVR-----HCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT------ 191
Query: 256 HVSTRVMGTYGYAAPEYVMTGHLTARS-DVYGFGVVLLEMLLGRRAVDKSRPSREHNLVE 314
            V T   GT  Y+ PE++       RS  V+  G++L +M+ G    +            
Sbjct: 192 -VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFE------------ 238
Query: 315 WARPLLNNNKKVLRILDPRLEGQ--YTARTAMKVAGLAYQCLSQNPKGRPVMSDV 367
                  ++++++R       GQ  +  R + +   L   CL+  P  RP   ++
Sbjct: 239 -------HDEEIIR-------GQVFFRQRVSXECQHLIRWCLALRPSDRPTFEEI 279

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 70/295 (23%), Positives = 116/295 (39%), Gaps = 79/295 (26%)
Query: 99  ILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNR------GGYQGDREWLAEVNYLGQL 152
           +LG GGFG VY G+   +  P      VAIK + +      G          EV  L ++
Sbjct: 58  LLGSGGFGSVYSGIRVSDNLP------VAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 111
Query: 153 R--HSNLVKLIGYCCEDEHRILVYE-----------YMESGSLEKHLLRRVGCMLTWSRR 199
               S +++L+ +    +  +L+ E             E G+L++ L R       W   
Sbjct: 112 SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARS----FFWQ-- 165
Query: 200 MKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADF-SAKLSDFG---LAKDGPMGDQT 255
               L+A +     H     V++RD K  NIL++ +    KL DFG   L KD       
Sbjct: 166 ---VLEAVR-----HCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT------ 211
Query: 256 HVSTRVMGTYGYAAPEYVMTGHLTARS-DVYGFGVVLLEMLLGRRAVDKSRPSREHNLVE 314
            V T   GT  Y+ PE++       RS  V+  G++L +M+ G    +            
Sbjct: 212 -VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFE------------ 258
Query: 315 WARPLLNNNKKVLRILDPRLEGQ--YTARTAMKVAGLAYQCLSQNPKGRPVMSDV 367
                  ++++++R       GQ  +  R + +   L   CL+  P  RP   ++
Sbjct: 259 -------HDEEIIR-------GQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEI 299

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 70/295 (23%), Positives = 116/295 (39%), Gaps = 79/295 (26%)
Query: 99  ILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNR------GGYQGDREWLAEVNYLGQL 152
           +LG GGFG VY G+   +  P      VAIK + +      G          EV  L ++
Sbjct: 31  LLGSGGFGSVYSGIRVSDNLP------VAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 84
Query: 153 R--HSNLVKLIGYCCEDEHRILVYE-----------YMESGSLEKHLLRRVGCMLTWSRR 199
               S +++L+ +    +  +L+ E             E G+L++ L R       W   
Sbjct: 85  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARS----FFWQ-- 138
Query: 200 MKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADF-SAKLSDFG---LAKDGPMGDQT 255
               L+A +     H     V++RD K  NIL++ +    KL DFG   L KD       
Sbjct: 139 ---VLEAVR-----HCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT------ 184
Query: 256 HVSTRVMGTYGYAAPEYVMTGHLTARS-DVYGFGVVLLEMLLGRRAVDKSRPSREHNLVE 314
            V T   GT  Y+ PE++       RS  V+  G++L +M+ G    +            
Sbjct: 185 -VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFE------------ 231
Query: 315 WARPLLNNNKKVLRILDPRLEGQ--YTARTAMKVAGLAYQCLSQNPKGRPVMSDV 367
                  ++++++R       GQ  +  R + +   L   CL+  P  RP   ++
Sbjct: 232 -------HDEEIIR-------GQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEI 272

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 70/295 (23%), Positives = 116/295 (39%), Gaps = 79/295 (26%)
Query: 99  ILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNR------GGYQGDREWLAEVNYLGQL 152
           +LG GGFG VY G+   +  P      VAIK + +      G          EV  L ++
Sbjct: 63  LLGSGGFGSVYSGIRVSDNLP------VAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 116
Query: 153 R--HSNLVKLIGYCCEDEHRILVYE-----------YMESGSLEKHLLRRVGCMLTWSRR 199
               S +++L+ +    +  +L+ E             E G+L++ L R       W   
Sbjct: 117 SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARS----FFWQ-- 170
Query: 200 MKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADF-SAKLSDFG---LAKDGPMGDQT 255
               L+A +     H     V++RD K  NIL++ +    KL DFG   L KD       
Sbjct: 171 ---VLEAVR-----HCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT------ 216
Query: 256 HVSTRVMGTYGYAAPEYVMTGHLTARS-DVYGFGVVLLEMLLGRRAVDKSRPSREHNLVE 314
            V T   GT  Y+ PE++       RS  V+  G++L +M+ G    +            
Sbjct: 217 -VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFE------------ 263
Query: 315 WARPLLNNNKKVLRILDPRLEGQ--YTARTAMKVAGLAYQCLSQNPKGRPVMSDV 367
                  ++++++R       GQ  +  R + +   L   CL+  P  RP   ++
Sbjct: 264 -------HDEEIIR-------GQVFFRQRVSXECQHLIRWCLALRPSDRPTFEEI 304

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 70/295 (23%), Positives = 116/295 (39%), Gaps = 79/295 (26%)
Query: 99  ILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNR------GGYQGDREWLAEVNYLGQL 152
           +LG GGFG VY G+   +  P      VAIK + +      G          EV  L ++
Sbjct: 50  LLGSGGFGSVYSGIRVSDNLP------VAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 103
Query: 153 R--HSNLVKLIGYCCEDEHRILVYE-----------YMESGSLEKHLLRRVGCMLTWSRR 199
               S +++L+ +    +  +L+ E             E G+L++ L R       W   
Sbjct: 104 SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARS----FFWQ-- 157
Query: 200 MKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADF-SAKLSDFG---LAKDGPMGDQT 255
               L+A +     H     V++RD K  NIL++ +    KL DFG   L KD       
Sbjct: 158 ---VLEAVR-----HCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT------ 203
Query: 256 HVSTRVMGTYGYAAPEYVMTGHLTARS-DVYGFGVVLLEMLLGRRAVDKSRPSREHNLVE 314
            V T   GT  Y+ PE++       RS  V+  G++L +M+ G    +            
Sbjct: 204 -VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFE------------ 250
Query: 315 WARPLLNNNKKVLRILDPRLEGQ--YTARTAMKVAGLAYQCLSQNPKGRPVMSDV 367
                  ++++++R       GQ  +  R + +   L   CL+  P  RP   ++
Sbjct: 251 -------HDEEIIR-------GQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEI 291

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 70/295 (23%), Positives = 116/295 (39%), Gaps = 79/295 (26%)
Query: 99  ILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNR------GGYQGDREWLAEVNYLGQL 152
           +LG GGFG VY G+   +  P      VAIK + +      G          EV  L ++
Sbjct: 30  LLGSGGFGSVYSGIRVSDNLP------VAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 83
Query: 153 R--HSNLVKLIGYCCEDEHRILVYE-----------YMESGSLEKHLLRRVGCMLTWSRR 199
               S +++L+ +    +  +L+ E             E G+L++ L R       W   
Sbjct: 84  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARS----FFWQ-- 137
Query: 200 MKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADF-SAKLSDFG---LAKDGPMGDQT 255
               L+A +     H     V++RD K  NIL++ +    KL DFG   L KD       
Sbjct: 138 ---VLEAVR-----HCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT------ 183
Query: 256 HVSTRVMGTYGYAAPEYVMTGHLTARS-DVYGFGVVLLEMLLGRRAVDKSRPSREHNLVE 314
            V T   GT  Y+ PE++       RS  V+  G++L +M+ G    +            
Sbjct: 184 -VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFE------------ 230
Query: 315 WARPLLNNNKKVLRILDPRLEGQ--YTARTAMKVAGLAYQCLSQNPKGRPVMSDV 367
                  ++++++R       GQ  +  R + +   L   CL+  P  RP   ++
Sbjct: 231 -------HDEEIIR-------GQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEI 271

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 70/295 (23%), Positives = 116/295 (39%), Gaps = 79/295 (26%)
Query: 99  ILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNR------GGYQGDREWLAEVNYLGQL 152
           +LG GGFG VY G+   +  P      VAIK + +      G          EV  L ++
Sbjct: 43  LLGSGGFGSVYSGIRVSDNLP------VAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 96
Query: 153 R--HSNLVKLIGYCCEDEHRILVYE-----------YMESGSLEKHLLRRVGCMLTWSRR 199
               S +++L+ +    +  +L+ E             E G+L++ L R       W   
Sbjct: 97  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARS----FFWQ-- 150
Query: 200 MKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADF-SAKLSDFG---LAKDGPMGDQT 255
               L+A +     H     V++RD K  NIL++ +    KL DFG   L KD       
Sbjct: 151 ---VLEAVR-----HCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT------ 196
Query: 256 HVSTRVMGTYGYAAPEYVMTGHLTARS-DVYGFGVVLLEMLLGRRAVDKSRPSREHNLVE 314
            V T   GT  Y+ PE++       RS  V+  G++L +M+ G    +            
Sbjct: 197 -VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFE------------ 243
Query: 315 WARPLLNNNKKVLRILDPRLEGQ--YTARTAMKVAGLAYQCLSQNPKGRPVMSDV 367
                  ++++++R       GQ  +  R + +   L   CL+  P  RP   ++
Sbjct: 244 -------HDEEIIR-------GQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEI 284

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 70/295 (23%), Positives = 115/295 (38%), Gaps = 79/295 (26%)
Query: 99  ILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNR------GGYQGDREWLAEVNYLGQL 152
           +LG GGFG VY G+   +  P      VAIK + +      G          EV  L ++
Sbjct: 16  LLGSGGFGSVYSGIRVSDNLP------VAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 69
Query: 153 R--HSNLVKLIGYCCEDEHRILVYE-----------YMESGSLEKHLLRRVGCMLTWSRR 199
               S +++L+ +    +  +L+ E             E G+L++ L R       W   
Sbjct: 70  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARS----FFWQ-- 123
Query: 200 MKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADF-SAKLSDFG---LAKDGPMGDQT 255
               L+A +     H     V++RD K  NIL++ +    KL DFG   L KD       
Sbjct: 124 ---VLEAVR-----HCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT------ 169
Query: 256 HVSTRVMGTYGYAAPEYVMTGHLTARS-DVYGFGVVLLEMLLGRRAVDKSRPSREHNLVE 314
            V T   GT  Y+ PE++       RS  V+  G++L +M+ G                 
Sbjct: 170 -VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP-------------- 214
Query: 315 WARPLLNNNKKVLRILDPRLEGQ--YTARTAMKVAGLAYQCLSQNPKGRPVMSDV 367
                  ++++++R       GQ  +  R + +   L   CL+  P  RP   ++
Sbjct: 215 -----FEHDEEIIR-------GQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEI 257

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 70/295 (23%), Positives = 115/295 (38%), Gaps = 79/295 (26%)
Query: 99  ILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNR------GGYQGDREWLAEVNYLGQL 152
           +LG GGFG VY G+   +  P      VAIK + +      G          EV  L ++
Sbjct: 15  LLGSGGFGSVYSGIRVSDNLP------VAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 68
Query: 153 R--HSNLVKLIGYCCEDEHRILVYE-----------YMESGSLEKHLLRRVGCMLTWSRR 199
               S +++L+ +    +  +L+ E             E G+L++ L R       W   
Sbjct: 69  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARS----FFWQ-- 122
Query: 200 MKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADF-SAKLSDFG---LAKDGPMGDQT 255
               L+A +     H     V++RD K  NIL++ +    KL DFG   L KD       
Sbjct: 123 ---VLEAVR-----HCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT------ 168
Query: 256 HVSTRVMGTYGYAAPEYVMTGHLTARS-DVYGFGVVLLEMLLGRRAVDKSRPSREHNLVE 314
            V T   GT  Y+ PE++       RS  V+  G++L +M+ G                 
Sbjct: 169 -VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP-------------- 213
Query: 315 WARPLLNNNKKVLRILDPRLEGQ--YTARTAMKVAGLAYQCLSQNPKGRPVMSDV 367
                  ++++++R       GQ  +  R + +   L   CL+  P  RP   ++
Sbjct: 214 -----FEHDEEIIR-------GQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEI 256

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 70/295 (23%), Positives = 115/295 (38%), Gaps = 79/295 (26%)
Query: 99  ILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNR------GGYQGDREWLAEVNYLGQL 152
           +LG GGFG VY G+   +  P      VAIK + +      G          EV  L ++
Sbjct: 16  LLGSGGFGSVYSGIRVSDNLP------VAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 69
Query: 153 R--HSNLVKLIGYCCEDEHRILVYE-----------YMESGSLEKHLLRRVGCMLTWSRR 199
               S +++L+ +    +  +L+ E             E G+L++ L R       W   
Sbjct: 70  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARS----FFWQ-- 123
Query: 200 MKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADF-SAKLSDFG---LAKDGPMGDQT 255
               L+A +     H     V++RD K  NIL++ +    KL DFG   L KD       
Sbjct: 124 ---VLEAVR-----HCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT------ 169
Query: 256 HVSTRVMGTYGYAAPEYVMTGHLTARS-DVYGFGVVLLEMLLGRRAVDKSRPSREHNLVE 314
            V T   GT  Y+ PE++       RS  V+  G++L +M+ G                 
Sbjct: 170 -VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP-------------- 214
Query: 315 WARPLLNNNKKVLRILDPRLEGQ--YTARTAMKVAGLAYQCLSQNPKGRPVMSDV 367
                  ++++++R       GQ  +  R + +   L   CL+  P  RP   ++
Sbjct: 215 -----FEHDEEIIR-------GQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEI 257

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 45.4 bits (106), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 87/204 (42%), Gaps = 15/204 (7%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQG--DREWLAEVNYLGQLRHSNL 157
           LG G F +V K   +++    Y   F+  K  +R   +G    E   EV+ L Q+ H N+
Sbjct: 20  LGSGQFAIV-KKCREKSTGLEYAAKFIK-KRQSRASRRGVCREEIEREVSILRQVLHPNI 77
Query: 158 VKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAE 217
           + L          +L+ E +  G L   L ++    L+             G+ +LH   
Sbjct: 78  ITLHDVYENRTDVVLILELVSGGELFDFLAQKES--LSEEEATSFIKQILDGVNYLHT-- 133
Query: 218 RPVIYRDFKTSNI-LLNADF---SAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYV 273
           + + + D K  NI LL+ +      KL DFGLA +   G +      + GT  + APE V
Sbjct: 134 KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF---KNIFGTPEFVAPEIV 190
Query: 274 MTGHLTARSDVYGFGVVLLEMLLG 297
               L   +D++  GV+   +L G
Sbjct: 191 NYEPLGLEADMWSIGVITYILLSG 214

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score = 45.4 bits (106), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 56/217 (25%), Positives = 83/217 (38%), Gaps = 26/217 (11%)
Query: 99  ILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGD----REWLAEVNYLGQLRH 154
            +  G +G V  GV  E +    K  F  + +        D    +  L E+  L    H
Sbjct: 29  FISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHH 88
Query: 155 SNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAK------ 208
            N++ L       E        M    L   L+R     +   +R+ I+    +      
Sbjct: 89  PNILGLRDIFVHFEE-----PAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFMYHI 143
Query: 209 --GLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAK-DGPMGDQTHVSTRVMGTY 265
             GL  LH  E  V++RD    NILL  +    + DF LA+ D    ++TH  T      
Sbjct: 144 LLGLHVLH--EAGVVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYVTH----R 197
Query: 266 GYAAPEYVMTGH-LTARSDVYGFGVVLLEMLLGRRAV 301
            Y APE VM     T   D++  G V+ EM   R+A+
Sbjct: 198 WYRAPELVMQFKGFTKLVDMWSAGCVMAEM-FNRKAL 233

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score = 45.1 bits (105), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 56/214 (26%), Positives = 86/214 (40%), Gaps = 20/214 (9%)
Query: 99  ILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGD----REWLAEVNYLGQLRH 154
            +  G +G V  GV  E +    K  F  + +        D    +  L E+  L    H
Sbjct: 29  FISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHH 88
Query: 155 SNLVKLIGYCCEDE----HRI-LVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKG 209
            N++ L       E    H++ LV E M +   +    +R+  +++             G
Sbjct: 89  PNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRI--VISPQHIQYFMYHILLG 146
Query: 210 LAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAK-DGPMGDQTHVSTRVMGTYGYA 268
           L  LH  E  V++RD    NILL  +    + DF LA+ D    ++TH  T       Y 
Sbjct: 147 LHVLH--EAGVVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYVTH----RWYR 200
Query: 269 APEYVMTGH-LTARSDVYGFGVVLLEMLLGRRAV 301
           APE VM     T   D++  G V+ EM   R+A+
Sbjct: 201 APELVMQFKGFTKLVDMWSAGCVMAEM-FNRKAL 233

>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273

Iteration: 1
 Score = 45.1 bits (105), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 70/295 (23%), Positives = 115/295 (38%), Gaps = 79/295 (26%)
Query: 99  ILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNR------GGYQGDREWLAEVNYLGQL 152
           +LG GGFG VY G+   +  P      VAIK + +      G          EV  L ++
Sbjct: 11  LLGSGGFGSVYSGIRVSDNLP------VAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 64
Query: 153 R--HSNLVKLIGYCCEDEHRILVYE-----------YMESGSLEKHLLRRVGCMLTWSRR 199
               S +++L+ +    +  +L+ E             E G+L++ L R       W   
Sbjct: 65  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARS----FFWQ-- 118
Query: 200 MKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADF-SAKLSDFG---LAKDGPMGDQT 255
               L+A +     H     V++RD K  NIL++ +    KL DFG   L KD       
Sbjct: 119 ---VLEAVR-----HCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT------ 164
Query: 256 HVSTRVMGTYGYAAPEYVMTGHLTARS-DVYGFGVVLLEMLLGRRAVDKSRPSREHNLVE 314
            V T   GT  Y+ PE++       RS  V+  G++L +M+ G                 
Sbjct: 165 -VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP-------------- 209
Query: 315 WARPLLNNNKKVLRILDPRLEGQ--YTARTAMKVAGLAYQCLSQNPKGRPVMSDV 367
                  ++++++R       GQ  +  R + +   L   CL+  P  RP   ++
Sbjct: 210 -----FEHDEEIIR-------GQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEI 252

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 45.1 bits (105), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 89/204 (43%), Gaps = 15/204 (7%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQG-DREWLA-EVNYLGQLRHSNL 157
           LG G F +V K   +++    Y   F+  K  +R   +G  RE +  EV+ L Q+ H N+
Sbjct: 20  LGSGQFAIV-KKCREKSTGLEYAAKFIK-KRQSRASRRGVSREEIEREVSILRQVLHHNV 77
Query: 158 VKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAE 217
           + L          +L+ E +  G L   L ++    L+             G+ +LH   
Sbjct: 78  ITLHDVYENRTDVVLILELVSGGELFDFLAQKES--LSEEEATSFIKQILDGVNYLHT-- 133
Query: 218 RPVIYRDFKTSNI-LLNADF---SAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYV 273
           + + + D K  NI LL+ +      KL DFGLA +   G +      + GT  + APE V
Sbjct: 134 KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF---KNIFGTPEFVAPEIV 190
Query: 274 MTGHLTARSDVYGFGVVLLEMLLG 297
               L   +D++  GV+   +L G
Sbjct: 191 NYEPLGLEADMWSIGVITYILLSG 214

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 45.1 bits (105), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 89/204 (43%), Gaps = 15/204 (7%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQG-DREWLA-EVNYLGQLRHSNL 157
           LG G F +V K   +++    Y   F+  K  +R   +G  RE +  EV+ L Q+ H N+
Sbjct: 20  LGSGQFAIV-KKCREKSTGLEYAAKFIK-KRQSRASRRGVSREEIEREVSILRQVLHHNV 77
Query: 158 VKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAE 217
           + L          +L+ E +  G L   L ++    L+             G+ +LH   
Sbjct: 78  ITLHDVYENRTDVVLILELVSGGELFDFLAQKES--LSEEEATSFIKQILDGVNYLHT-- 133
Query: 218 RPVIYRDFKTSNI-LLNADF---SAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYV 273
           + + + D K  NI LL+ +      KL DFGLA +   G +      + GT  + APE V
Sbjct: 134 KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF---KNIFGTPEFVAPEIV 190
Query: 274 MTGHLTARSDVYGFGVVLLEMLLG 297
               L   +D++  GV+   +L G
Sbjct: 191 NYEPLGLEADMWSIGVITYILLSG 214

>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276

Iteration: 1
 Score = 45.1 bits (105), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 70/295 (23%), Positives = 115/295 (38%), Gaps = 79/295 (26%)
Query: 99  ILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNR------GGYQGDREWLAEVNYLGQL 152
           +LG GGFG VY G+   +  P      VAIK + +      G          EV  L ++
Sbjct: 14  LLGSGGFGSVYSGIRVSDNLP------VAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 67
Query: 153 R--HSNLVKLIGYCCEDEHRILVYE-----------YMESGSLEKHLLRRVGCMLTWSRR 199
               S +++L+ +    +  +L+ E             E G+L++ L R       W   
Sbjct: 68  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARS----FFWQ-- 121
Query: 200 MKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADF-SAKLSDFG---LAKDGPMGDQT 255
               L+A +     H     V++RD K  NIL++ +    KL DFG   L KD       
Sbjct: 122 ---VLEAVR-----HCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT------ 167
Query: 256 HVSTRVMGTYGYAAPEYVMTGHLTARS-DVYGFGVVLLEMLLGRRAVDKSRPSREHNLVE 314
            V T   GT  Y+ PE++       RS  V+  G++L +M+ G                 
Sbjct: 168 -VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP-------------- 212
Query: 315 WARPLLNNNKKVLRILDPRLEGQ--YTARTAMKVAGLAYQCLSQNPKGRPVMSDV 367
                  ++++++R       GQ  +  R + +   L   CL+  P  RP   ++
Sbjct: 213 -----FEHDEEIIR-------GQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEI 255

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 89/204 (43%), Gaps = 15/204 (7%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQG-DREWLA-EVNYLGQLRHSNL 157
           LG G F +V K   +++    Y   F+  K  +R   +G  RE +  EV+ L Q+ H N+
Sbjct: 20  LGSGQFAIV-KKCREKSTGLEYAAKFIK-KRQSRASRRGVSREEIEREVSILRQVLHHNV 77
Query: 158 VKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAE 217
           + L          +L+ E +  G L   L ++    L+             G+ +LH   
Sbjct: 78  ITLHDVYENRTDVVLILELVSGGELFDFLAQKES--LSEEEATSFIKQILDGVNYLHT-- 133
Query: 218 RPVIYRDFKTSNI-LLNADF---SAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYV 273
           + + + D K  NI LL+ +      KL DFGLA +   G +      + GT  + APE V
Sbjct: 134 KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF---KNIFGTPEFVAPEIV 190
Query: 274 MTGHLTARSDVYGFGVVLLEMLLG 297
               L   +D++  GV+   +L G
Sbjct: 191 NYEPLGLEADMWSIGVITYILLSG 214

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 89/204 (43%), Gaps = 15/204 (7%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQG-DREWLA-EVNYLGQLRHSNL 157
           LG G F +V K   +++    Y   F+  K  +R   +G  RE +  EV+ L Q+ H N+
Sbjct: 20  LGSGQFAIV-KKCREKSTGLEYAAKFIK-KRQSRASRRGVSREEIEREVSILRQVLHHNV 77
Query: 158 VKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAE 217
           + L          +L+ E +  G L   L ++    L+             G+ +LH   
Sbjct: 78  ITLHDVYENRTDVVLILELVSGGELFDFLAQKES--LSEEEATSFIKQILDGVNYLHT-- 133
Query: 218 RPVIYRDFKTSNI-LLNADF---SAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYV 273
           + + + D K  NI LL+ +      KL DFGLA +   G +      + GT  + APE V
Sbjct: 134 KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF---KNIFGTPEFVAPEIV 190
Query: 274 MTGHLTARSDVYGFGVVLLEMLLG 297
               L   +D++  GV+   +L G
Sbjct: 191 NYEPLGLEADMWSIGVITYILLSG 214

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 89/204 (43%), Gaps = 15/204 (7%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQG-DREWLA-EVNYLGQLRHSNL 157
           LG G F +V K   +++    Y   F+  K  +R   +G  RE +  EV+ L Q+ H N+
Sbjct: 20  LGSGQFAIV-KKCREKSTGLEYAAKFIK-KRQSRASRRGVSREEIEREVSILRQVLHHNV 77
Query: 158 VKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAE 217
           + L          +L+ E +  G L   L ++    L+             G+ +LH   
Sbjct: 78  ITLHDVYENRTDVVLILELVSGGELFDFLAQKES--LSEEEATSFIKQILDGVNYLHT-- 133
Query: 218 RPVIYRDFKTSNI-LLNADF---SAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYV 273
           + + + D K  NI LL+ +      KL DFGLA +   G +      + GT  + APE V
Sbjct: 134 KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF---KNIFGTPEFVAPEIV 190
Query: 274 MTGHLTARSDVYGFGVVLLEMLLG 297
               L   +D++  GV+   +L G
Sbjct: 191 NYEPLGLEADMWSIGVITYILLSG 214

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 63/229 (27%), Positives = 97/229 (42%), Gaps = 24/229 (10%)
Query: 77  SNVDIFTYNEMKLATKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFV--AIKELNRG 134
           S VD+ T N +   +  F   Y++ E   GV   G   E  R  +K T +  A+K +++ 
Sbjct: 9   SGVDLGTEN-LYFQSMVFSDGYVVKET-IGV---GSYSECKRCVHKATNMEYAVKVIDKS 63
Query: 135 GYQGDREWLAEVNYLGQLRHSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCML 194
                 E    + Y GQ  H N++ L     + +H  LV E M  G L   +LR+     
Sbjct: 64  KRDPSEEIEILLRY-GQ--HPNIITLKDVYDDGKHVYLVTELMRGGELLDKILRQ---KF 117
Query: 195 TWSRRMKIALDA-AKGLAFLHGAERPVIYRDFKTSNILLNADFSA-----KLSDFGLAKD 248
              R     L    K + +LH   + V++RD K SNIL   D S      ++ DFG AK 
Sbjct: 118 FSEREASFVLHTIGKTVEYLHS--QGVVHRDLKPSNILY-VDESGNPECLRICDFGFAKQ 174
Query: 249 GPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLG 297
             +  +  +      T  + APE +         D++  G++L  ML G
Sbjct: 175 --LRAENGLLMTPCYTANFVAPEVLKRQGYDEGCDIWSLGILLYTMLAG 221

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 60/223 (26%), Positives = 93/223 (41%), Gaps = 51/223 (22%)
Query: 99  ILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNR------GGYQGDREWLAEVNYLGQL 152
           +LG GGFG VY G+   +  P      VAIK + +      G          EV  L ++
Sbjct: 44  LLGSGGFGSVYSGIRVSDNLP------VAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 97
Query: 153 R--HSNLVKLIGYCCEDEHRILVYE-----------YMESGSLEKHLLRRVGCMLTWSRR 199
               S +++L+ +    +  +L+ E             E G+L++ L R       W   
Sbjct: 98  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARS----FFWQ-- 151
Query: 200 MKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADF-SAKLSDFG---LAKDGPMGDQT 255
               L+A +     H     V++RD K  NIL++ +    KL DFG   L KD       
Sbjct: 152 ---VLEAVR-----HCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT------ 197
Query: 256 HVSTRVMGTYGYAAPEYVMTGHLTARS-DVYGFGVVLLEMLLG 297
            V T   GT  Y+ PE++       RS  V+  G++L +M+ G
Sbjct: 198 -VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 239

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 60/223 (26%), Positives = 93/223 (41%), Gaps = 51/223 (22%)
Query: 99  ILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNR------GGYQGDREWLAEVNYLGQL 152
           +LG GGFG VY G+   +  P      VAIK + +      G          EV  L ++
Sbjct: 44  LLGSGGFGSVYSGIRVSDNLP------VAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 97
Query: 153 R--HSNLVKLIGYCCEDEHRILVYE-----------YMESGSLEKHLLRRVGCMLTWSRR 199
               S +++L+ +    +  +L+ E             E G+L++ L R       W   
Sbjct: 98  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARS----FFWQ-- 151
Query: 200 MKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADF-SAKLSDFG---LAKDGPMGDQT 255
               L+A +     H     V++RD K  NIL++ +    KL DFG   L KD       
Sbjct: 152 ---VLEAVR-----HCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT------ 197
Query: 256 HVSTRVMGTYGYAAPEYVMTGHLTARS-DVYGFGVVLLEMLLG 297
            V T   GT  Y+ PE++       RS  V+  G++L +M+ G
Sbjct: 198 -VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 239

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 60/223 (26%), Positives = 93/223 (41%), Gaps = 51/223 (22%)
Query: 99  ILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNR------GGYQGDREWLAEVNYLGQL 152
           +LG GGFG VY G+   +  P      VAIK + +      G          EV  L ++
Sbjct: 43  LLGSGGFGSVYSGIRVSDNLP------VAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 96
Query: 153 R--HSNLVKLIGYCCEDEHRILVYE-----------YMESGSLEKHLLRRVGCMLTWSRR 199
               S +++L+ +    +  +L+ E             E G+L++ L R       W   
Sbjct: 97  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARS----FFWQ-- 150
Query: 200 MKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADF-SAKLSDFG---LAKDGPMGDQT 255
               L+A +     H     V++RD K  NIL++ +    KL DFG   L KD       
Sbjct: 151 ---VLEAVR-----HCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT------ 196
Query: 256 HVSTRVMGTYGYAAPEYVMTGHLTARS-DVYGFGVVLLEMLLG 297
            V T   GT  Y+ PE++       RS  V+  G++L +M+ G
Sbjct: 197 -VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 238

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 60/223 (26%), Positives = 93/223 (41%), Gaps = 51/223 (22%)
Query: 99  ILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNR------GGYQGDREWLAEVNYLGQL 152
           +LG GGFG VY G+   +  P      VAIK + +      G          EV  L ++
Sbjct: 44  LLGSGGFGSVYSGIRVSDNLP------VAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 97
Query: 153 R--HSNLVKLIGYCCEDEHRILVYE-----------YMESGSLEKHLLRRVGCMLTWSRR 199
               S +++L+ +    +  +L+ E             E G+L++ L R       W   
Sbjct: 98  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARS----FFWQ-- 151
Query: 200 MKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADF-SAKLSDFG---LAKDGPMGDQT 255
               L+A +     H     V++RD K  NIL++ +    KL DFG   L KD       
Sbjct: 152 ---VLEAVR-----HCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT------ 197
Query: 256 HVSTRVMGTYGYAAPEYVMTGHLTARS-DVYGFGVVLLEMLLG 297
            V T   GT  Y+ PE++       RS  V+  G++L +M+ G
Sbjct: 198 -VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 239

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 60/223 (26%), Positives = 93/223 (41%), Gaps = 51/223 (22%)
Query: 99  ILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNR------GGYQGDREWLAEVNYLGQL 152
           +LG GGFG VY G+   +  P      VAIK + +      G          EV  L ++
Sbjct: 43  LLGSGGFGSVYSGIRVSDNLP------VAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 96
Query: 153 R--HSNLVKLIGYCCEDEHRILVYE-----------YMESGSLEKHLLRRVGCMLTWSRR 199
               S +++L+ +    +  +L+ E             E G+L++ L R       W   
Sbjct: 97  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARS----FFWQ-- 150
Query: 200 MKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADF-SAKLSDFG---LAKDGPMGDQT 255
               L+A +     H     V++RD K  NIL++ +    KL DFG   L KD       
Sbjct: 151 ---VLEAVR-----HCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT------ 196
Query: 256 HVSTRVMGTYGYAAPEYVMTGHLTARS-DVYGFGVVLLEMLLG 297
            V T   GT  Y+ PE++       RS  V+  G++L +M+ G
Sbjct: 197 -VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 238

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 60/223 (26%), Positives = 93/223 (41%), Gaps = 51/223 (22%)
Query: 99  ILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNR------GGYQGDREWLAEVNYLGQL 152
           +LG GGFG VY G+   +  P      VAIK + +      G          EV  L ++
Sbjct: 44  LLGSGGFGSVYSGIRVSDNLP------VAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 97
Query: 153 R--HSNLVKLIGYCCEDEHRILVYE-----------YMESGSLEKHLLRRVGCMLTWSRR 199
               S +++L+ +    +  +L+ E             E G+L++ L R       W   
Sbjct: 98  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARS----FFWQ-- 151
Query: 200 MKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADF-SAKLSDFG---LAKDGPMGDQT 255
               L+A +     H     V++RD K  NIL++ +    KL DFG   L KD       
Sbjct: 152 ---VLEAVR-----HCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT------ 197
Query: 256 HVSTRVMGTYGYAAPEYVMTGHLTARS-DVYGFGVVLLEMLLG 297
            V T   GT  Y+ PE++       RS  V+  G++L +M+ G
Sbjct: 198 -VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 239

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 60/223 (26%), Positives = 93/223 (41%), Gaps = 51/223 (22%)
Query: 99  ILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNR------GGYQGDREWLAEVNYLGQL 152
           +LG GGFG VY G+   +  P      VAIK + +      G          EV  L ++
Sbjct: 43  LLGSGGFGSVYSGIRVSDNLP------VAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 96
Query: 153 R--HSNLVKLIGYCCEDEHRILVYE-----------YMESGSLEKHLLRRVGCMLTWSRR 199
               S +++L+ +    +  +L+ E             E G+L++ L R       W   
Sbjct: 97  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARS----FFWQ-- 150
Query: 200 MKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADF-SAKLSDFG---LAKDGPMGDQT 255
               L+A +     H     V++RD K  NIL++ +    KL DFG   L KD       
Sbjct: 151 ---VLEAVR-----HCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT------ 196
Query: 256 HVSTRVMGTYGYAAPEYVMTGHLTARS-DVYGFGVVLLEMLLG 297
            V T   GT  Y+ PE++       RS  V+  G++L +M+ G
Sbjct: 197 -VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 238

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 42/151 (27%), Positives = 65/151 (43%), Gaps = 14/151 (9%)
Query: 153 RHSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDA-AKGLA 211
           +H N++ L     + +H  LV E M  G L   +LR+        R     L    K + 
Sbjct: 79  QHPNIITLKDVYDDGKHVYLVTELMRGGELLDKILRQ---KFFSEREASFVLHTIGKTVE 135
Query: 212 FLHGAERPVIYRDFKTSNILLNADFSA-----KLSDFGLAKDGPMGDQTHVSTRVMGTYG 266
           +LH   + V++RD K SNIL   D S      ++ DFG AK   +  +  +      T  
Sbjct: 136 YLHS--QGVVHRDLKPSNILY-VDESGNPECLRICDFGFAKQ--LRAENGLLMTPCYTAN 190
Query: 267 YAAPEYVMTGHLTARSDVYGFGVVLLEMLLG 297
           + APE +         D++  G++L  ML G
Sbjct: 191 FVAPEVLKRQGYDEGCDIWSLGILLYTMLAG 221

>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 60/223 (26%), Positives = 93/223 (41%), Gaps = 51/223 (22%)
Query: 99  ILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNR------GGYQGDREWLAEVNYLGQL 152
           +LG GGFG VY G+   +  P      VAIK + +      G          EV  L ++
Sbjct: 11  LLGSGGFGSVYSGIRVSDNLP------VAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 64
Query: 153 R--HSNLVKLIGYCCEDEHRILVYE-----------YMESGSLEKHLLRRVGCMLTWSRR 199
               S +++L+ +    +  +L+ E             E G+L++ L R       W   
Sbjct: 65  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARS----FFWQ-- 118
Query: 200 MKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADF-SAKLSDFG---LAKDGPMGDQT 255
               L+A +     H     V++RD K  NIL++ +    KL DFG   L KD       
Sbjct: 119 ---VLEAVR-----HCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT------ 164
Query: 256 HVSTRVMGTYGYAAPEYVMTGHLTARS-DVYGFGVVLLEMLLG 297
            V T   GT  Y+ PE++       RS  V+  G++L +M+ G
Sbjct: 165 -VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 206

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 85/208 (40%), Gaps = 25/208 (12%)
Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLA---------EVNYLG 150
           LG G FG V+  V  E      K   V +K + +     D  W+          E+  L 
Sbjct: 32  LGSGAFGFVWTAVDKE------KNKEVVVKFIKKEKVLEDC-WIEDPKLGKVTLEIAILS 84
Query: 151 QLRHSNLVKLIGYCCEDEHRILVYEYMESG-SLEKHLLRRVGCMLTWSRRMKIALDAAKG 209
           ++ H+N++K++          LV E   SG  L   + R        +  +   L +A G
Sbjct: 85  RVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVG 144
Query: 210 LAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAA 269
              L    + +I+RD K  NI++  DF+ KL DFG A     G   +      GT  Y A
Sbjct: 145 YLRL----KDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYT---FCGTIEYCA 197
Query: 270 PEYVM-TGHLTARSDVYGFGVVLLEMLL 296
           PE +M   +     +++  GV L  ++ 
Sbjct: 198 PEVLMGNPYRGPELEMWSLGVTLYTLVF 225

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 41.6 bits (96), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 37/149 (24%), Positives = 65/149 (43%), Gaps = 10/149 (6%)
Query: 153 RHSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAF 212
           +H N++ L     + ++  +V E  + G L   +LR+     +      +     K + +
Sbjct: 74  QHPNIITLKDVYDDGKYVYVVTELXKGGELLDKILRQK--FFSEREASAVLFTITKTVEY 131
Query: 213 LHGAERPVIYRDFKTSNILLNADF----SAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYA 268
           LH   + V++RD K SNIL   +     S ++ DFG AK   +  +  +      T  + 
Sbjct: 132 LHA--QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQ--LRAENGLLXTPCYTANFV 187
Query: 269 APEYVMTGHLTARSDVYGFGVVLLEMLLG 297
           APE +      A  D++  GV+L   L G
Sbjct: 188 APEVLERQGYDAACDIWSLGVLLYTXLTG 216

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	464
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	1e-177
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	1e-171
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	1e-146
3soc_A	322	Activin receptor type-2A; structural genomics cons	1e-81
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	6e-64
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	1e-62
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	7e-61
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	2e-59
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	3e-58
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	4e-57
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	9e-57
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	8e-56
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	7e-55
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	9e-55
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	2e-54
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	9e-54
3q4u_A	301	Activin receptor type-1; structural genomics conso	9e-53
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	2e-52
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	9e-42
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	2e-39
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	1e-38
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	2e-38
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	2e-38
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	4e-38
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	7e-38
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	9e-38
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	1e-37
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	1e-37
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	3e-37
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	3e-37
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	4e-37
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	4e-37
4aoj_A	329	High affinity nerve growth factor receptor; transf	5e-37
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	6e-37
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	7e-37
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	8e-37
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	9e-37
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	1e-36
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	1e-36
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	1e-36
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	2e-36
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	3e-36
3pls_A	298	Macrophage-stimulating protein receptor; protein k	4e-36
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	5e-36
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	5e-36
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	5e-36
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	7e-36
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	2e-35
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	2e-35
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	3e-35
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	3e-35
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	4e-35
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	4e-35
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	6e-35
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	6e-35
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	8e-35
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	8e-35
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	3e-34
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	4e-34
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	4e-34
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	2e-33
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	3e-33
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	3e-33
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	4e-33
2a19_B	284	Interferon-induced, double-stranded RNA-activated	6e-33
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	9e-33
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	1e-32
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	1e-32
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	2e-32
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	3e-32
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	3e-32
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	6e-32
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	6e-32
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	8e-32
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	8e-32
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	9e-32
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	9e-32
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	2e-31
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	3e-31
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	3e-31
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	4e-31
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	3e-30
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	6e-30
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	2e-29
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	8e-29
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	2e-28
3ork_A	311	Serine/threonine protein kinase; structural genomi	3e-28
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	4e-28
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	8e-28
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	9e-28
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	1e-27
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	2e-27
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	6e-27
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	1e-26
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	1e-26
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	2e-26
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	3e-26
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	3e-26
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	5e-26
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	7e-26
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	3e-25
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	3e-25
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	2e-24
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	2e-24
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	2e-24
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	8e-24
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	1e-23
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	1e-23
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	2e-23
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	3e-23
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	3e-23
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	4e-23
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	4e-23
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	7e-23
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	1e-22
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	1e-22
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	1e-22
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	2e-22
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	2e-22
3o0g_A	292	Cell division protein kinase 5; kinase activator c	2e-22
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	2e-22
3niz_A	311	Rhodanese family protein; structural genomics, str	3e-22
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	4e-22
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	5e-22
3fme_A	290	Dual specificity mitogen-activated protein kinase;	6e-22
3aln_A	327	Dual specificity mitogen-activated protein kinase;	6e-22
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	8e-22
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	1e-21
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	1e-21
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	1e-21
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	1e-21
2dyl_A	318	Dual specificity mitogen-activated protein kinase	1e-21
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	1e-21
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	1e-21
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	3e-21
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	4e-21
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	6e-21
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	6e-21
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	1e-20
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	1e-20
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	1e-20
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	1e-20
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	2e-20
3an0_A	340	Dual specificity mitogen-activated protein kinase;	2e-20
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	2e-20
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	3e-20
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	2e-04
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	5e-20
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	6e-20
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	8e-20
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	8e-20
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	9e-20
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	1e-19
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	1e-19
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	1e-19
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	1e-19
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	1e-19
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	1e-19
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	1e-19
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	1e-19
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	2e-19
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	2e-19
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	2e-19
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	2e-19
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	3e-19
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	4e-19
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	5e-19
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	8e-19
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	9e-19
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	1e-18
3uqc_A	286	Probable conserved transmembrane protein; structur	1e-18
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	2e-18
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	2e-18
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	3e-18
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	3e-18
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	3e-18
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	4e-18
3bhy_A	283	Death-associated protein kinase 3; death associate	4e-18
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	4e-18
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	4e-18
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	4e-18
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	6e-18
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	6e-18
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	7e-18
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	7e-18
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	8e-18
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	9e-18
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	1e-17
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	1e-17
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	1e-17
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	1e-17
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	2e-17
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	2e-17
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	2e-17
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	2e-17
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	3e-17
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	3e-17
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	3e-17
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	4e-17
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	5e-17
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	6e-17
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	7e-17
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	8e-17
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	9e-17
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	1e-16
3rp9_A	458	Mitogen-activated protein kinase; structural genom	2e-16
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	2e-16
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	2e-16
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	2e-16
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	2e-16
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	4e-16
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	4e-16
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	6e-16
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	8e-16
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	1e-15
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	1e-15
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	1e-15
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	4e-15
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	4e-14
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	2e-10
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	4e-14
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	2e-13
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	5e-11
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	3e-10
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	1e-09
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	2e-09
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	3e-09
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	4e-09
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	9e-09
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	2e-08
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	2e-08
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	4e-08
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	9e-08
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	1e-07
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	4e-07
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	3e-04
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	4e-04

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  497 bits (1282), Expect = e-177
 Identities = 105/311 (33%), Positives = 167/311 (53%), Gaps = 25/311 (8%)

Query: 77  SNVDIFTYNEMKLATKFFRPDY------ILGEGGFGVVYKGVIDENVRPGYKTTFVAIKE 130
           +    F++ E+K  T  F           +GEGGFGVVYKG ++           VA+K+
Sbjct: 10  TRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTT--------VAVKK 61

Query: 131 L----NRGGYQGDREWLAEVNYLGQLRHSNLVKLIGYCCEDEHRILVYEYMESGSLEKHL 186
           L    +    +  +++  E+  + + +H NLV+L+G+  + +   LVY YM +GSL   L
Sbjct: 62  LAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRL 121

Query: 187 LRRVGC-MLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGL 245
               G   L+W  R KIA  AA G+ FLH  E   I+RD K++NILL+  F+AK+SDFGL
Sbjct: 122 SCLDGTPPLSWHMRCKIAQGAANGINFLH--ENHHIHRDIKSANILLDEAFTAKISDFGL 179

Query: 246 AKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSR 305
           A+      QT +++R++GT  Y APE  + G +T +SD+Y FGVVLLE++ G  AVD+ R
Sbjct: 180 ARASEKFAQTVMTSRIVGTTAYMAPEA-LRGEITPKSDIYSFGVVLLEIITGLPAVDEHR 238

Query: 306 PSREHNLVEWARPLLNNNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMS 365
                 L++    + +  K +   +D ++     + +   +  +A QCL +    RP + 
Sbjct: 239 E--PQLLLDIKEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIK 295

Query: 366 DVVALLETVQS 376
            V  LL+ + +
Sbjct: 296 KVQQLLQEMTA 306

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  482 bits (1243), Expect = e-171
 Identities = 118/293 (40%), Positives = 171/293 (58%), Gaps = 12/293 (4%)

Query: 82  FTYNEMKLATKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDRE 141
               +++ AT  F   +++G G FG VYKGV+ +          VA+K       QG  E
Sbjct: 29  VPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDG-------AKVALKRRTPESSQGIEE 81

Query: 142 WLAEVNYLGQLRHSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVG--CMLTWSRR 199
           +  E+  L   RH +LV LIG+C E    IL+Y+YME+G+L++HL         ++W +R
Sbjct: 82  FETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQR 141

Query: 200 MKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVST 259
           ++I + AA+GL +LH   R +I+RD K+ NILL+ +F  K++DFG++K G   DQTH+ST
Sbjct: 142 LEICIGAARGLHYLH--TRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLST 199

Query: 260 RVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPL 319
            V GT GY  PEY + G LT +SDVY FGVVL E+L  R A+ +S P    NL EWA   
Sbjct: 200 VVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVES 259

Query: 320 LNNNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLE 372
             NN ++ +I+DP L  +    +  K    A +CL+ + + RP M DV+  LE
Sbjct: 260 H-NNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLE 311

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  420 bits (1081), Expect = e-146
 Identities = 117/301 (38%), Positives = 176/301 (58%), Gaps = 15/301 (4%)

Query: 78  NVDIFTYNEMKLATKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQ 137
            +  F+  E+++A+  F    ILG GGFG VYKG + +        T VA+K L     Q
Sbjct: 16  QLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADG-------TLVAVKRLKEERTQ 68

Query: 138 G-DREWLAEVNYLGQLRHSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVG--CML 194
           G + ++  EV  +    H NL++L G+C     R+LVY YM +GS+   L  R      L
Sbjct: 69  GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPL 128

Query: 195 TWSRRMKIALDAAKGLAFLH-GAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGD 253
            W +R +IAL +A+GLA+LH   +  +I+RD K +NILL+ +F A + DFGLAK     D
Sbjct: 129 DWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 188

Query: 254 QTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREH--N 311
            THV+T V GT G+ APEY+ TG  + ++DV+G+GV+LLE++ G+RA D +R + +    
Sbjct: 189 -THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVM 247

Query: 312 LVEWARPLLNNNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALL 371
           L++W + LL   KK+  ++D  L+G Y      ++  +A  C   +P  RP MS+VV +L
Sbjct: 248 LLDWVKGLL-KEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRML 306

Query: 372 E 372
           E
Sbjct: 307 E 307

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  254 bits (651), Expect = 1e-81
 Identities = 73/319 (22%), Positives = 119/319 (37%), Gaps = 36/319 (11%)

Query: 82  FTYNEMKLATKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQG-DR 140
                +   +   +   +   G FG V+K  +           +VA+K       Q    
Sbjct: 14  LGTENLYFQSMPLQLLEVKARGRFGCVWKAQLLN--------EYVAVKIFPIQDKQSWQN 65

Query: 141 EWLAEVNYLGQLRHSNLVKLIGYCCEDEH----RILVYEYMESGSLEKHLLRRVGCMLTW 196
           E   EV  L  ++H N+++ IG             L+  + E GSL   L   V   ++W
Sbjct: 66  E--YEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANV---VSW 120

Query: 197 SRRMKIALDAAKGLAFLH-------GAERP-VIYRDFKTSNILLNADFSAKLSDFGLAKD 248
           +    IA   A+GLA+LH          +P + +RD K+ N+LL  + +A ++DFGLA  
Sbjct: 121 NELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALK 180

Query: 249 GPMGDQTHVSTRVMGTYGYAAPEYVMTGHL-----TARSDVYGFGVVLLEMLLGRRAVDK 303
              G     +   +GT  Y APE +            R D+Y  G+VL E+     A D 
Sbjct: 181 FEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADG 240

Query: 304 SRPSREHNLVE--WARPLLNNNKK--VLRILDPRLEGQYTARTAMK-VAGLAYQCLSQNP 358
                     E     P L + ++  V +   P L   +     M  +     +C   + 
Sbjct: 241 PVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDA 300

Query: 359 KGRPVMSDVVALLETVQSQ 377
           + R     V   +  +Q  
Sbjct: 301 EARLSAGCVGERITQMQRL 319

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  208 bits (532), Expect = 6e-64
 Identities = 61/340 (17%), Positives = 117/340 (34%), Gaps = 49/340 (14%)

Query: 82  FTYNEMKLATKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDRE 141
              +E  L     +   ++G G +G VYKG              VA+K  +    Q    
Sbjct: 3   AAASEPSLDLDNLKLLELIGRGRYGAVYKGS--------LDERPVAVKVFSFANRQ---N 51

Query: 142 WLAEVN--YLGQLRHSNLVKLIGYCCEDE-----HRILVYEYMESGSLEKHLLRRVGCML 194
           ++ E N   +  + H N+ + I              +LV EY  +GSL K+L        
Sbjct: 52  FINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT---S 108

Query: 195 TWSRRMKIALDAAKGLAFLH-------GAERPVIYRDFKTSNILLNADFSAKLSDFGLAK 247
            W    ++A    +GLA+LH         +  + +RD  + N+L+  D +  +SDFGL+ 
Sbjct: 109 DWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSM 168

Query: 248 ------DGPMGDQTHVSTRVMGTYGYAAPEYVM-------TGHLTARSDVYGFGVVLLEM 294
                     G++ + +   +GT  Y APE +              + D+Y  G++  E+
Sbjct: 169 RLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEI 228

Query: 295 LLGRRAVDKSRPSREHNL----VEWARPLLNNNKK--VLRILDPRLEGQYTARTAM--KV 346
            +    +       E+ +         P   + +         P+    +   +     +
Sbjct: 229 FMRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSL 288

Query: 347 AGLAYQCLSQNPKGRPVMSDVVALLETVQSQGAEEEMLQS 386
                 C  Q+ + R         +  +       + +  
Sbjct: 289 KETIEDCWDQDAEARLTAQXAEERMAELMMIWERNKSVSP 328

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  204 bits (522), Expect = 1e-62
 Identities = 74/281 (26%), Positives = 127/281 (45%), Gaps = 29/281 (10%)

Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGD--REWLAEVNYLGQLRHSNL 157
           +G G FG V++          +  + VA+K L    +  +   E+L EV  + +LRH N+
Sbjct: 45  IGAGSFGTVHRAE--------WHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNI 96

Query: 158 VKLIGYCCEDEHRILVYEYMESGSLEKHLLRR-VGCMLTWSRRMKIALDAAKGLAFLHGA 216
           V  +G   +  +  +V EY+  GSL + L +      L   RR+ +A D AKG+ +LH  
Sbjct: 97  VLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR 156

Query: 217 ERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTG 276
             P+++R+ K+ N+L++  ++ K+ DFGL++          S    GT  + APE +   
Sbjct: 157 NPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRL--KASTFLSSKSAAGTPEWMAPEVLRDE 214

Query: 277 HLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRILDPRLEG 336
               +SDVY FGV+L E+   +      +P    N  +    +        R+  PR   
Sbjct: 215 PSNEKSDVYSFGVILWELATLQ------QPWGNLNPAQVVAAVGFKC---KRLEIPR--- 262

Query: 337 QYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETVQSQ 377
                   +VA +   C +  P  RP  + ++ LL  +   
Sbjct: 263 ----NLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKS 299

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  198 bits (507), Expect = 7e-61
 Identities = 63/302 (20%), Positives = 121/302 (40%), Gaps = 47/302 (15%)

Query: 84  YNEMKLATKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGD--RE 141
           + ++   TK       L E   G ++KG         ++   + +K L    +     R+
Sbjct: 9   FKQLNFLTK-------LNENHSGELWKGR--------WQGNDIVVKVLKVRDWSTRKSRD 53

Query: 142 WLAEVNYLGQLRHSNLVKLIGYCCE--DEHRILVYEYMESGSLEKHLLRRVGCMLTWSRR 199
           +  E   L    H N++ ++G C      H  L+  +M  GSL   L      ++  S+ 
Sbjct: 54  FNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQA 113

Query: 200 MKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVST 259
           +K ALD A+G+AFLH  E  +      + +++++ D +A++S   +         +  S 
Sbjct: 114 VKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKF-------SFQSP 166

Query: 260 RVMGTYGYAAPEYVMTG----HLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEW 315
             M    + APE  +           +D++ F V+L E++          P  + + +E 
Sbjct: 167 GRMYAPAWVAPE-ALQKKPEDTNRRSADMWSFAVLLWELVTRE------VPFADLSNMEI 219

Query: 316 ARPLLNNNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETVQ 375
              +       LR   P          +  V+ L   C++++P  RP    +V +LE +Q
Sbjct: 220 GMKVALEG---LRPTIPP-------GISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQ 269

Query: 376 SQ 377
            +
Sbjct: 270 DK 271

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  196 bits (500), Expect = 2e-59
 Identities = 78/319 (24%), Positives = 132/319 (41%), Gaps = 50/319 (15%)

Query: 99  ILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLV 158
           ++G G FGVV K          ++   VAIK++        + ++ E+  L ++ H N+V
Sbjct: 15  VVGRGAFGVVCKAK--------WRAKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIV 64

Query: 159 KLIGYCCEDEHRILVYEYMESGSLEKHLL-RRVGCMLTWSRRMKIALDAAKGLAFLHGAE 217
           KL G C       LV EY E GSL   L         T +  M   L  ++G+A+LH  +
Sbjct: 65  KLYGACLN--PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQ 122

Query: 218 -RPVIYRDFKTSNILLNADFS-AKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMT 275
            + +I+RD K  N+LL A  +  K+ DFG A D          T   G+  + APE    
Sbjct: 123 PKALIHRDLKPPNLLLVAGGTVLKICDFGTACD-----IQTHMTNNKGSAAWMAPEVFEG 177

Query: 276 GHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRI---LDP 332
            + + + DV+ +G++L E++  R      +P  E     +      +N     +   L  
Sbjct: 178 SNYSEKCDVFSWGIILWEVITRR------KPFDEIGGPAFRIMWAVHNGTRPPLIKNLPK 231

Query: 333 RLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETVQSQGAEEEMLQSGGGVVT 392
            +              L  +C S++P  RP M ++V ++           +++   G   
Sbjct: 232 PI------------ESLMTRCWSKDPSQRPSMEEIVKIM---------THLMRYFPGADE 270

Query: 393 LYEVPKLSSHNSGDKKRNQ 411
             + P   S   G+  R +
Sbjct: 271 PLQYPCQHSLPPGEDGRVE 289

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  192 bits (490), Expect = 3e-58
 Identities = 77/295 (26%), Positives = 129/295 (43%), Gaps = 56/295 (18%)

Query: 99  ILGEGGFGVVYKGVIDENVRPGYKT--TFVAIKELNRGGYQGD-------REWLAEVNYL 149
            +G+GGFG+V+KG              + VAIK L  G  +G+       +E+  EV  +
Sbjct: 26  QIGKGGFGLVHKGR--------LVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIM 77

Query: 150 GQLRHSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKG 209
             L H N+VKL G         +V E++  G L  H L      + WS ++++ LD A G
Sbjct: 78  SNLNHPNIVKLYGLMHNPPR--MVMEFVPCGDL-YHRLLDKAHPIKWSVKLRLMLDIALG 134

Query: 210 LAFLHGAERPVIYRDFKTSNILL-----NADFSAKLSDFGLAKDGPMGDQTHVSTRVMGT 264
           + ++     P+++RD ++ NI L     NA   AK++DFGL++        H  + ++G 
Sbjct: 135 IEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ-----QSVHSVSGLLGN 189

Query: 265 YGYAAPEYVMTG---HLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNL--VEWARPL 319
           + + APE  +       T ++D Y F ++L  +L G        P  E++   +++   +
Sbjct: 190 FQWMAPE-TIGAEEESYTEKADTYSFAMILYTILTGE------GPFDEYSYGKIKFINMI 242

Query: 320 LNNNK--KVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLE 372
                   +     PRL              +   C S +PK RP  S +V  L 
Sbjct: 243 REEGLRPTIPEDCPPRL------------RNVIELCWSGDPKKRPHFSYIVKELS 285

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  189 bits (481), Expect = 4e-57
 Identities = 74/289 (25%), Positives = 121/289 (41%), Gaps = 44/289 (15%)

Query: 99  ILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGD----REWLAEVNYLGQLRH 154
           I+G GGFG VY+          +    VA+K       +           E      L+H
Sbjct: 14  IIGIGGFGKVYRAF--------WIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKH 65

Query: 155 SNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLH 214
            N++ L G C ++ +  LV E+   G L + L  +    +     +  A+  A+G+ +LH
Sbjct: 66  PNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGK---RIPPDILVNWAVQIARGMNYLH 122

Query: 215 G-AERPVIYRDFKTSNILLNADFS--------AKLSDFGLAKDGPMGDQTHVSTRVMGTY 265
             A  P+I+RD K+SNIL+              K++DFGLA+      +T   +   G Y
Sbjct: 123 DEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR---EWHRTTKMSAA-GAY 178

Query: 266 GYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKK 325
            + APE +     +  SDV+ +GV+L E+L G        P R  + +  A  +  N   
Sbjct: 179 AWMAPEVIRASMFSKGSDVWSYGVLLWELLTGE------VPFRGIDGLAVAYGVAMNK-- 230

Query: 326 VLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETV 374
            L +  P              A L   C + +P  RP  ++++  L T+
Sbjct: 231 -LALPIPS-------TCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  189 bits (482), Expect = 9e-57
 Identities = 72/301 (23%), Positives = 122/301 (40%), Gaps = 40/301 (13%)

Query: 100 LGEGGFGVVYKGVIDENVRPGYKTT--FVAIKELNRGGYQGDREWLAEVNYLGQLRHSNL 157
           LG+G FG   K          ++ T   + +KEL R   +  R +L EV  +  L H N+
Sbjct: 18  LGKGCFGQAIKVT--------HRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNV 69

Query: 158 VKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAE 217
           +K IG   +D+    + EY++ G+L   +++ +     WS+R+  A D A G+A+LH   
Sbjct: 70  LKFIGVLYKDKRLNFITEYIKGGTLRG-IIKSMDSQYPWSQRVSFAKDIASGMAYLH--S 126

Query: 218 RPVIYRDFKTSNILLNADFSAKLSDFGLAK------------DGPMGDQTHVSTRVMGTY 265
             +I+RD  + N L+  + +  ++DFGLA+                         V+G  
Sbjct: 127 MNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNP 186

Query: 266 GYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKK 325
            + APE +       + DV+ FG+VL E++    A     P      +        N + 
Sbjct: 187 YWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGL--------NVRG 238

Query: 326 VLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETVQSQGAEEEMLQ 385
            L    P                +  +C   +P+ RP    +   LET++   A    L 
Sbjct: 239 FLDRYCPP-------NCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLAGHLPLG 291

Query: 386 S 386
            
Sbjct: 292 P 292

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  186 bits (474), Expect = 8e-56
 Identities = 71/283 (25%), Positives = 122/283 (43%), Gaps = 30/283 (10%)

Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGD--REWLAEVNYLGQLRHSNL 157
           +G G FG VYKG         +    VA+K LN         + +  EV  L + RH N+
Sbjct: 32  IGSGSFGTVYKGK--------WHGD-VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNI 82

Query: 158 VKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAE 217
           +  +G         +V ++ E  SL  HL           + + IA   A+G+ +LH   
Sbjct: 83  LLFMG-YSTAPQLAIVTQWCEGSSLYHHL-HASETKFEMKKLIDIARQTARGMDYLH--A 138

Query: 218 RPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPE---YVM 274
           + +I+RD K++NI L+ D + K+ DFGLA +      +H   ++ G+  + APE      
Sbjct: 139 KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQD 198

Query: 275 TGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRILDPRL 334
           +   + +SDVY FG+VL E++ G+       P    N  +    ++        +   R 
Sbjct: 199 SNPYSFQSDVYAFGIVLYELMTGQ------LPYSNINNRDQIIEMVGRGSLSPDLSKVRS 252

Query: 335 EGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETVQSQ 377
                     ++  L  +CL +    RP    ++A +E +  +
Sbjct: 253 N------CPKRMKRLMAECLKKKRDERPSFPRILAEIEELARE 289

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  185 bits (471), Expect = 7e-55
 Identities = 61/304 (20%), Positives = 119/304 (39%), Gaps = 40/304 (13%)

Query: 99  ILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWL--AEVNYLGQLRHSN 156
            +G+G +G V+ G         ++   VA+K         +  W    E+     +RH N
Sbjct: 44  QIGKGRYGEVWMGK--------WRGEKVAVKVFF---TTEEASWFRETEIYQTVLMRHEN 92

Query: 157 LVKLIGYCCEDEHRI----LVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAF 212
           ++  I    +         L+ +Y E+GSL  +L       L     +K+A  +  GL  
Sbjct: 93  ILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKSTT---LDAKSMLKLAYSSVSGLCH 149

Query: 213 LH------GAERPVIYRDFKTSNILLNADFSAKLSDFGLA--KDGPMGDQTHVSTRVMGT 264
           LH        +  + +RD K+ NIL+  + +  ++D GLA        +        +GT
Sbjct: 150 LHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGT 209

Query: 265 YGYAAPEYVMTGHLTA-------RSDVYGFGVVLLEMLLGRRAVDKSRPSRE-HNLVEWA 316
             Y  PE V+   L          +D+Y FG++L E+     +       +  ++ +  +
Sbjct: 210 KRYMPPE-VLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPS 268

Query: 317 RPLLNNNKK--VLRILDPRLEGQYTARTAMK-VAGLAYQCLSQNPKGRPVMSDVVALLET 373
            P   + ++   ++ L P    ++++   ++ +  L  +C + NP  R     V   L  
Sbjct: 269 DPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAK 328

Query: 374 VQSQ 377
           +   
Sbjct: 329 MSES 332

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  181 bits (462), Expect = 9e-54
 Identities = 53/293 (18%), Positives = 113/293 (38%), Gaps = 43/293 (14%)

Query: 99  ILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGD--REWLAEVNYLGQLRHSN 156
           ++G+G FG VY G         +    VAI+ ++      D  + +  EV    Q RH N
Sbjct: 40  LIGKGRFGQVYHGR--------WHGE-VAIRLIDIERDNEDQLKAFKREVMAYRQTRHEN 90

Query: 157 LVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGA 216
           +V  +G C    H  ++    +  +L   ++R    +L  ++  +IA +  KG+ +LH  
Sbjct: 91  VVLFMGACMSPPHLAIITSLCKGRTL-YSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHA- 148

Query: 217 ERPVIYRDFKTSNILLNADFSAKLSDFGLAK---DGPMGDQTHVSTRVMGTYGYAAPEYV 273
            + ++++D K+ N+  + +    ++DFGL         G +        G   + APE +
Sbjct: 149 -KGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEII 206

Query: 274 MTG---------HLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNK 324
                         +  SDV+  G +  E+           P +          +     
Sbjct: 207 RQLSPDTEEDKLPFSKHSDVFALGTIWYELHARE------WPFKTQPAEAIIWQMGTG-- 258

Query: 325 KVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETVQSQ 377
             ++    ++          +++ +   C +   + RP  + ++ +LE +  +
Sbjct: 259 --MKPNLSQIG------MGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKR 303

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  178 bits (454), Expect = 9e-53
 Identities = 69/302 (22%), Positives = 117/302 (38%), Gaps = 46/302 (15%)

Query: 99  ILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAE--VNYLGQLRHSN 156
            +G+G +G V++G         ++   VA+K  +    + ++ W  E  +     LRH N
Sbjct: 15  CVGKGRYGEVWRGS--------WQGENVAVKIFSS---RDEKSWFRETELYNTVMLRHEN 63

Query: 157 LVKLIGYCCEDEHRI----LVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAF 212
           ++  I       H      L+  Y E GSL  +L       L     ++I L  A GLA 
Sbjct: 64  ILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTT---LDTVSCLRIVLSIASGLAH 120

Query: 213 LHGAER------PVIYRDFKTSNILLNADFSAKLSDFGLA--KDGPMGDQTHVSTRVMGT 264
           LH           + +RD K+ NIL+  +    ++D GLA             +   +GT
Sbjct: 121 LHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGT 180

Query: 265 YGYAAPEYVMTGHL-------TARSDVYGFGVVLLEMLLGRRAVDKSRPSRE--HNLVEW 315
             Y APE V+   +         R D++ FG+VL E+     +       +   +++V  
Sbjct: 181 KRYMAPE-VLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPN 239

Query: 316 ARPLLNNNKKV----LRILDPRLEGQYTARTAMK-VAGLAYQCLSQNPKGRPVMSDVVAL 370
                +  K V     R   P +  ++ +   +  +A L  +C  QNP  R     +   
Sbjct: 240 DPSFEDMRKVVCVDQQR---PNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKT 296

Query: 371 LE 372
           L 
Sbjct: 297 LT 298

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  179 bits (455), Expect = 2e-52
 Identities = 74/307 (24%), Positives = 126/307 (41%), Gaps = 46/307 (14%)

Query: 99  ILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAE--VNYLGQLRHSN 156
            +G+G FG V++G         ++   VA+K  +    + +R W  E  +     LRH N
Sbjct: 49  SIGKGRFGEVWRGK--------WRGEEVAVKIFS---SREERSWFREAEIYQTVMLRHEN 97

Query: 157 LVKLIGYCCEDEHRI----LVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAF 212
           ++  I    +D        LV +Y E GSL  +L R     +T    +K+AL  A GLA 
Sbjct: 98  ILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT---VTVEGMIKLALSTASGLAH 154

Query: 213 LH------GAERPVIYRDFKTSNILLNADFSAKLSDFGLA--KDGPMGDQTHVSTRVMGT 264
           LH        +  + +RD K+ NIL+  + +  ++D GLA   D             +GT
Sbjct: 155 LHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGT 214

Query: 265 YGYAAPEYVMTGHL-------TARSDVYGFGVVLLEMLLGRRAVDKSRPSR-EHNLVEWA 316
             Y APE V+   +         R+D+Y  G+V  E+             +  +  +  +
Sbjct: 215 KRYMAPE-VLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPS 273

Query: 317 RPLLNNNKKV-----LRILDPRLEGQYTARTAMK-VAGLAYQCLSQNPKGRPVMSDVVAL 370
            P +   +KV     LR   P +  ++ +  A++ +A +  +C   N   R     +   
Sbjct: 274 DPSVEEMRKVVCEQKLR---PNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 330

Query: 371 LETVQSQ 377
           L  +  Q
Sbjct: 331 LSQLSQQ 337

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  151 bits (384), Expect = 9e-42
 Identities = 70/285 (24%), Positives = 117/285 (41%), Gaps = 38/285 (13%)

Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDR-EWLAEVNYLGQLRHSNLV 158
           +G G FG V+ G +  +       T VA+K          + ++L E   L Q  H N+V
Sbjct: 122 IGRGNFGEVFSGRLRAD------NTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIV 175

Query: 159 KLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAER 218
           +LIG C + +   +V E ++ G      LR  G  L     +++  DAA G+ +L    +
Sbjct: 176 RLIGVCTQKQPIYIVMELVQGGDFLTF-LRTEGARLRVKTLLQMVGDAAAGMEYLE--SK 232

Query: 219 PVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHL 278
             I+RD    N L+      K+SDFG++++   G              + APE +  G  
Sbjct: 233 CCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRY 292

Query: 279 TARSDVYGFGVVLLEML-LGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRILD-----P 332
           ++ SDV+ FG++L E   LG        P               +N++    ++     P
Sbjct: 293 SSESDVWSFGILLWETFSLGA------SPYPNL-----------SNQQTREFVEKGGRLP 335

Query: 333 RLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETVQSQ 377
             E          V  L  QC +  P  RP  S +   L++++ +
Sbjct: 336 CPEL-----CPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKR 375

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  144 bits (364), Expect = 2e-39
 Identities = 75/290 (25%), Positives = 116/290 (40%), Gaps = 34/290 (11%)

Query: 99  ILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLV 158
            LG+G FG V     D           VA+K+L   G    R++  E+  L  L    +V
Sbjct: 30  QLGKGNFGSVELCRYD--PLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIV 87

Query: 159 KLIGYCCEDEHR--ILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGA 216
           K  G       +   LV EY+ SG L +  L+R    L  SR +  +    KG+ +L   
Sbjct: 88  KYRGVSYGPGRQSLRLVMEYLPSGCL-RDFLQRHRARLDASRLLLYSSQICKGMEYLG-- 144

Query: 217 ERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVST-------RVMGTYGYAA 269
            R  ++RD    NIL+ ++   K++DFGLAK  P+    +V                  A
Sbjct: 145 SRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWY------A 198

Query: 270 PEYVMTGHLTARSDVYGFGVVLLEML-LGRRAVDKSRPSREHNLVEWARPLLNNNKKVLR 328
           PE +     + +SDV+ FGVVL E+     ++   S         E   P      ++L 
Sbjct: 199 PESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVP---ALSRLLE 255

Query: 329 ILD-----PRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLET 373
           +L+     P            +V  L   C + +P+ RP  S +   L+ 
Sbjct: 256 LLEEGQRLPAPPA-----CPAEVHELMKLCWAPSPQDRPSFSALGPQLDM 300

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  140 bits (356), Expect = 1e-38
 Identities = 68/290 (23%), Positives = 112/290 (38%), Gaps = 27/290 (9%)

Query: 99  ILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLV 158
            LG+G FG V     D           VA+K+L     +  R++  E+  L  L+H N+V
Sbjct: 17  QLGKGNFGSVEMCRYDP--LQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIV 74

Query: 159 KLIGYCCEDEHR--ILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGA 216
           K  G C     R   L+ EY+  GSL +  L++    +   + ++      KG+ +L   
Sbjct: 75  KYKGVCYSAGRRNLKLIMEYLPYGSL-RDYLQKHKERIDHIKLLQYTSQICKGMEYLG-- 131

Query: 217 ERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVST-------RVMGTYGYAA 269
            +  I+RD  T NIL+  +   K+ DFGL K  P   +                     A
Sbjct: 132 TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWY------A 185

Query: 270 PEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLN-NNKKVLR 328
           PE +     +  SDV+ FGVVL E+           P  E   +             ++ 
Sbjct: 186 PESLTESKFSVASDVWSFGVVLYELF--TYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIE 243

Query: 329 ILDP--RLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETVQS 376
           +L    RL          ++  +  +C + N   RP   D+   ++ ++ 
Sbjct: 244 LLKNNGRLPR--PDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD 291

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  141 bits (357), Expect = 2e-38
 Identities = 69/291 (23%), Positives = 114/291 (39%), Gaps = 27/291 (9%)

Query: 99  ILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLV 158
            LG+G FG V     D           VA+K+L     +  R++  E+  L  L+H N+V
Sbjct: 48  QLGKGNFGSVEMCRYDP--LQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIV 105

Query: 159 KLIGYCCEDEHR--ILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGA 216
           K  G C     R   L+ EY+  GSL  + L++    +   + ++      KG+ +L   
Sbjct: 106 KYKGVCYSAGRRNLKLIMEYLPYGSLRDY-LQKHKERIDHIKLLQYTSQICKGMEYL--G 162

Query: 217 ERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVST-------RVMGTYGYAA 269
            +  I+RD  T NIL+  +   K+ DFGL K  P   + +                   A
Sbjct: 163 TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWY------A 216

Query: 270 PEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLN-NNKKVLR 328
           PE +     +  SDV+ FGVVL E+           P  E   +             ++ 
Sbjct: 217 PESLTESKFSVASDVWSFGVVLYELF--TYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIE 274

Query: 329 ILDP--RLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETVQSQ 377
           +L    RL          ++  +  +C + N   RP   D+   ++ ++ Q
Sbjct: 275 LLKNNGRLPR--PDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQ 323

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  140 bits (356), Expect = 2e-38
 Identities = 68/292 (23%), Positives = 109/292 (37%), Gaps = 35/292 (11%)

Query: 99  ILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRG-GYQGDREWLAEVNYLGQLRHSNL 157
            LGEG FG V     D           VA+K L    G     +   E+  L  L H N+
Sbjct: 28  DLGEGHFGKVELCRYD--PEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENI 85

Query: 158 VKLIGYCCEDEHR--ILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHG 215
           VK  G C ED      L+ E++ SGSL+++ L +    +   +++K A+   KG+ +L  
Sbjct: 86  VKYKGICTEDGGNGIKLIMEFLPSGSLKEY-LPKNKNKINLKQQLKYAVQICKGMDYL-- 142

Query: 216 AERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVST-------RVMGTYGYA 268
             R  ++RD    N+L+ ++   K+ DFGL K      + +                   
Sbjct: 143 GSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWY------ 196

Query: 269 APEYVMTGHLTARSDVYGFGVVLLEML-LGRRAVDKSRPSREHNLVEWARPLLNNNKKVL 327
           APE +M       SDV+ FGV L E+L              +       +       +++
Sbjct: 197 APECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQM---TVTRLV 253

Query: 328 RILD-----PRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETV 374
             L      P            +V  L  +C    P  R    +++   E +
Sbjct: 254 NTLKEGKRLPCPPN-----CPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEAL 300

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  140 bits (354), Expect = 4e-38
 Identities = 75/293 (25%), Positives = 117/293 (39%), Gaps = 33/293 (11%)

Query: 99  ILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRG-GYQGDREWLAEVNYLGQLRHSNL 157
            LGEG FG V       +         VA+K L    G Q    W  E++ L  L H ++
Sbjct: 38  DLGEGHFGKVSLYCY--DPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHI 95

Query: 158 VKLIGYCCEDEHR--ILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHG 215
           +K  G C +       LV EY+  GSL  +L R     +  ++ +  A    +G+A+LH 
Sbjct: 96  IKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRH---SIGLAQLLLFAQQICEGMAYLH- 151

Query: 216 AERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVST-------RVMGTYGYA 268
             +  I+RD    N+LL+ D   K+ DFGLAK  P G + +                   
Sbjct: 152 -AQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWY------ 204

Query: 269 APEYVMTGHLTARSDVYGFGVVLLEML-LGRRAVDKSRPSREHNLVEWARPLLNNNKKVL 327
           APE +        SDV+ FGV L E+L     +        E   +   +       ++ 
Sbjct: 205 APECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQM---TVLRLT 261

Query: 328 RILDPRLEGQYTARTAM---KVAGLAYQCLSQNPKGRPVMSDVVALLETVQSQ 377
            +L+    G+   R      +V  L   C       RP   +++ +L+TV  +
Sbjct: 262 ELLE---RGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEK 311

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  142 bits (360), Expect = 7e-38
 Identities = 76/282 (26%), Positives = 118/282 (41%), Gaps = 42/282 (14%)

Query: 99  ILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLV 158
            LG+G FG V+ G  +   R       VAIK L + G      +L E   + +LRH  LV
Sbjct: 191 KLGQGCFGEVWMGTWNGTTR-------VAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLV 242

Query: 159 KLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAER 218
           +L      +E   +V EYM  GSL   L    G  L   + + +A   A G+A++     
Sbjct: 243 QLYA-VVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYV--ERM 299

Query: 219 PVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHL 278
             ++RD + +NIL+  +   K++DFGLA+     ++            + APE  + G  
Sbjct: 300 NYVHRDLRAANILVGENLVCKVADFGLARL-IEDNEYTARQGAKFPIKWTAPEAALYGRF 358

Query: 279 TARSDVYGFGVVLLEML-LGRRAVDKSRPSREHNLVEWARPLLN-NNKKVLRILD----- 331
           T +SDV+ FG++L E+   GR                   P     N++VL  ++     
Sbjct: 359 TIKSDVWSFGILLTELTTKGR------------------VPYPGMVNREVLDQVERGYRM 400

Query: 332 PRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLET 373
           P             +  L  QC  + P+ RP    + A LE 
Sbjct: 401 PCPPE-----CPESLHDLMCQCWRKEPEERPTFEYLQAFLED 437

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  138 bits (350), Expect = 9e-38
 Identities = 64/214 (29%), Positives = 92/214 (42%), Gaps = 20/214 (9%)

Query: 92  KFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELN-RGGYQGDREWL-AEVNYL 149
           +F + D  +G G F  VYKG+   +         VA  EL  R   + +R+    E   L
Sbjct: 26  RFLKFDIEIGRGSFKTVYKGL---DTETT---VEVAWCELQDRKLTKSERQRFKEEAEML 79

Query: 150 GQLRHSNLVKLIGYC---CEDEHRILVY-EYMESGSLEKHLLRRVGCMLTWSRRMKIALD 205
             L+H N+V+         + +  I++  E M SG+L K  L+R   M            
Sbjct: 80  KGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTL-KTYLKRFKVM-KIKVLRSWCRQ 137

Query: 206 AAKGLAFLHGAERPVIYRDFKTSNILLNA-DFSAKLSDFGLAKDGPMGDQTHVSTRVMGT 264
             KGL FLH    P+I+RD K  NI +     S K+ D GLA    +   +     V+GT
Sbjct: 138 ILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT---LKRASFAKA-VIGT 193

Query: 265 YGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGR 298
             + APE     +     DVY FG+ +LEM    
Sbjct: 194 PEFMAPEMYEEKY-DESVDVYAFGMCMLEMATSE 226

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  138 bits (351), Expect = 1e-37
 Identities = 62/206 (30%), Positives = 103/206 (50%), Gaps = 13/206 (6%)

Query: 99  ILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDR-EWLAEVNYLGQLRHSNL 157
           I+G G  G V  G +     PG +   VAIK L  G  +  R ++L+E + +GQ  H N+
Sbjct: 56  IIGSGDSGEVCYGRL---RVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNI 112

Query: 158 VKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAE 217
           ++L G        ++V EYME+GSL    LR      T  + + +      G+ +L  ++
Sbjct: 113 IRLEGVVTRGRLAMIVTEYMENGSL-DTFLRTHDGQFTIMQLVGMLRGVGAGMRYL--SD 169

Query: 218 RPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGT---YGYAAPEYVM 274
              ++RD    N+L++++   K+SDFGL++   + D    +    G      + APE + 
Sbjct: 170 LGYVHRDLAARNVLVDSNLVCKVSDFGLSRV--LEDDPDAAYTTTGGKIPIRWTAPEAIA 227

Query: 275 TGHLTARSDVYGFGVVLLEML-LGRR 299
               ++ SDV+ FGVV+ E+L  G R
Sbjct: 228 FRTFSSASDVWSFGVVMWEVLAYGER 253

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  141 bits (358), Expect = 1e-37
 Identities = 64/203 (31%), Positives = 104/203 (51%), Gaps = 19/203 (9%)

Query: 99  ILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLV 158
            +G+G FG V  G         Y+   VA+K +        + +LAE + + QLRHSNLV
Sbjct: 200 TIGKGEFGDVMLGD--------YRGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLV 249

Query: 159 KLIGYCCEDEHRI-LVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAE 217
           +L+G   E++  + +V EYM  GSL  +L  R   +L     +K +LD  + + +L    
Sbjct: 250 QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL--EG 307

Query: 218 RPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGH 277
              ++RD    N+L++ D  AK+SDFGL K+      T  + ++     + APE +    
Sbjct: 308 NNFVHRDLAARNVLVSEDNVAKVSDFGLTKE---ASSTQDTGKL--PVKWTAPEALREKK 362

Query: 278 LTARSDVYGFGVVLLEML-LGRR 299
            + +SDV+ FG++L E+   GR 
Sbjct: 363 FSTKSDVWSFGILLWEIYSFGRV 385

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =  136 bits (345), Expect = 3e-37
 Identities = 64/207 (30%), Positives = 103/207 (49%), Gaps = 27/207 (13%)

Query: 99  ILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLV 158
            +G+G FG V  G         Y+   VA+K +        + +LAE + + QLRHSNLV
Sbjct: 28  TIGKGEFGDVMLGD--------YRGNKVAVKCIKNDAT--AQAFLAEASVMTQLRHSNLV 77

Query: 159 KLIGYCCEDEHRI-LVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAE 217
           +L+G   E++  + +V EYM  GSL  +L  R   +L     +K +LD  + + +L    
Sbjct: 78  QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL--EG 135

Query: 218 RPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRV----MGTYGYAAPEYV 273
              ++RD    N+L++ D  AK+SDFGL K+      T  + ++           APE +
Sbjct: 136 NNFVHRDLAARNVLVSEDNVAKVSDFGLTKE---ASSTQDTGKLPVKWT------APEAL 186

Query: 274 MTGHLTARSDVYGFGVVLLEML-LGRR 299
                + +SDV+ FG++L E+   GR 
Sbjct: 187 REKKFSTKSDVWSFGILLWEIYSFGRV 213

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  137 bits (348), Expect = 3e-37
 Identities = 51/203 (25%), Positives = 91/203 (44%), Gaps = 8/203 (3%)

Query: 99  ILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDR-EWLAEVNYLGQLRHSNL 157
           +LG G FG VYKG+             VAIKEL          E L E   +  + + ++
Sbjct: 22  VLGSGAFGTVYKGLWIPEGEKV--KIPVAIKELREATSPKANKEILDEAYVMASVDNPHV 79

Query: 158 VKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAE 217
            +L+G  C      L+ + M  G L  ++       +     +   +  AKG+ +L   +
Sbjct: 80  CRLLG-ICLTSTVQLITQLMPFGCLLDYVREHKD-NIGSQYLLNWCVQIAKGMNYL--ED 135

Query: 218 RPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGH 277
           R +++RD    N+L+      K++DFGLAK     ++ + +        + A E ++   
Sbjct: 136 RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI 195

Query: 278 LTARSDVYGFGVVLLEML-LGRR 299
            T +SDV+ +GV + E++  G +
Sbjct: 196 YTHQSDVWSYGVTVWELMTFGSK 218

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score =  136 bits (345), Expect = 4e-37
 Identities = 63/293 (21%), Positives = 115/293 (39%), Gaps = 45/293 (15%)

Query: 99  ILGEGGFGVVYKGV-IDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNL 157
            LG+G F  ++KGV  +         T V +K L++        +    + + +L H +L
Sbjct: 15  SLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHL 74

Query: 158 VKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAE 217
           V   G C   +  ILV E+++ GSL    L++    +    ++++A   A  + FL   E
Sbjct: 75  VLNYGVCVCGDENILVQEFVKFGSL-DTYLKKNKNCINILWKLEVAKQLAAAMHFL--EE 131

Query: 218 RPVIYRDFKTSNILLNADFS--------AKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAA 269
             +I+ +    NILL  +           KLSD G++      D        +       
Sbjct: 132 NTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERIPWV------P 185

Query: 270 PEYVMTG-HLTARSDVYGFGVVLLEML-LGRRAVDKSRPSREHNLVEWARPLLN-NNKKV 326
           PE +    +L   +D + FG  L E+   G                   +PL   ++++ 
Sbjct: 186 PECIENPKNLNLATDKWSFGTTLWEICSGGD------------------KPLSALDSQRK 227

Query: 327 LRILDP--RLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETVQSQ 377
           L+  +   +L     A  A ++A L   C+   P  RP    ++  L ++ + 
Sbjct: 228 LQFYEDRHQLP----APKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTP 276

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score =  138 bits (350), Expect = 4e-37
 Identities = 86/388 (22%), Positives = 147/388 (37%), Gaps = 47/388 (12%)

Query: 12  RQRLRQQQQPSSSKENQGGNGAPVISDNLDSPGMKTASGSQVTPKNVTPVPPKKNVNDLR 71
                 +++ S +       G+P +        + T+   +   +N+          DL 
Sbjct: 10  HHHHHGRRRASVAAGILVPRGSPGLDGICSIEELSTSLYKKAGSENLYFQGANTVHIDLS 69

Query: 72  Q-NPGY-SNVDIFTYNEMKLATKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIK 129
             NP     V         L   F     ++G G FG VY G +   +    K    A+K
Sbjct: 70  ALNPELVQAVQHVVIGPSSLIVHFNE---VIGRGHFGCVYHGTL---LDNDGKKIHCAVK 123

Query: 130 ELNRGGYQGDR-EWLAEVNYLGQLRHSNLVKLIGYCCEDEHRIL-VYEYMESGSLEKHLL 187
            LNR    G+  ++L E   +    H N++ L+G C   E   L V  YM+ G L ++ +
Sbjct: 124 SLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDL-RNFI 182

Query: 188 RRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAK 247
           R      T    +   L  AKG+ FL  A +  ++RD    N +L+  F+ K++DFGLA+
Sbjct: 183 RNETHNPTVKDLIGFGLQVAKGMKFL--ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 240

Query: 248 DGPMGDQTHVSTRVMG------TYGYAAPEYVMTGHLTARSDVYGFGVVLLEML-LGRRA 300
           D    +   V  +              A E + T   T +SDV+ FGV+L E++  G   
Sbjct: 241 DMYDKEFDSVHNKTGAKLPVKWM----ALESLQTQKFTTKSDVWSFGVLLWELMTRGA-- 294

Query: 301 VDKSRPSREHNLVEWARPLLNNNKKVLRILDPRLEGQYTAR---TAMKVAGLAYQCLSQN 357
                P  +            N   +   L    +G+   +       +  +  +C    
Sbjct: 295 ----PPYPDV-----------NTFDITVYLL---QGRRLLQPEYCPDPLYEVMLKCWHPK 336

Query: 358 PKGRPVMSDVVALLETVQSQGAEEEMLQ 385
            + RP  S++V+ +  + S    E  + 
Sbjct: 337 AEMRPSFSELVSRISAIFSTFIGEHYVH 364

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score =  137 bits (347), Expect = 5e-37
 Identities = 73/297 (24%), Positives = 118/297 (39%), Gaps = 52/297 (17%)

Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVK 159
           LGEG FG V+      N+ P      VA+K L        +++  E   L  L+H ++V+
Sbjct: 49  LGEGAFGKVFLAEC-HNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVR 107

Query: 160 LIGYCCEDEHRILVYEYMESGSLEKHLLRR-------------VGCMLTWSRRMKIALDA 206
             G C E    ++V+EYM  G L + L                    L   + + +A   
Sbjct: 108 FFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQV 167

Query: 207 AKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRV----- 261
           A G+ +L  A    ++RD  T N L+      K+ DFG+++D    D   V  R      
Sbjct: 168 AAGMVYL--AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 225

Query: 262 -MGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEML-LGRRAVDKSRPSREHNLVEWARPL 319
            M       PE ++    T  SDV+ FGVVL E+   G+      +P  +          
Sbjct: 226 WM------PPESILYRKFTTESDVWSFGVVLWEIFTYGK------QPWYQL--------- 264

Query: 320 LNNNKKVLRILDPRLEGQYTAR---TAMKVAGLAYQCLSQNPKGRPVMSDVVALLET 373
             +N + +  +    +G+   R      +V  +   C  + P+ R  + DV A L+ 
Sbjct: 265 --SNTEAIDCIT---QGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQA 316

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  137 bits (347), Expect = 6e-37
 Identities = 64/206 (31%), Positives = 106/206 (51%), Gaps = 12/206 (5%)

Query: 99  ILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDR-EWLAEVNYLGQLRHSNL 157
           ++G G FG VYKG++      G K   VAIK L  G  +  R ++L E   +GQ  H N+
Sbjct: 51  VIGAGEFGEVYKGML--KTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNI 108

Query: 158 VKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAE 217
           ++L G   + +  +++ EYME+G+L    LR      +  + + +    A G+ +L  A 
Sbjct: 109 IRLEGVISKYKPMMIITEYMENGAL-DKFLREKDGEFSVLQLVGMLRGIAAGMKYL--AN 165

Query: 218 RPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGT---YGYAAPEYVM 274
              ++RD    NIL+N++   K+SDFGL++   + D    +    G      + APE + 
Sbjct: 166 MNYVHRDLAARNILVNSNLVCKVSDFGLSRV--LEDDPEATYTTSGGKIPIRWTAPEAIS 223

Query: 275 TGHLTARSDVYGFGVVLLEML-LGRR 299
               T+ SDV+ FG+V+ E++  G R
Sbjct: 224 YRKFTSASDVWSFGIVMWEVMTYGER 249

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  140 bits (355), Expect = 7e-37
 Identities = 68/281 (24%), Positives = 118/281 (41%), Gaps = 38/281 (13%)

Query: 99  ILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLV 158
            LG G +G VY+GV  +       +  VA+K L +       E+L E   + +++H NLV
Sbjct: 227 KLGGGQYGEVYEGVWKK------YSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLV 279

Query: 159 KLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAER 218
           +L+G C  +    ++ E+M  G+L  +L       ++    + +A   +  + +L   ++
Sbjct: 280 QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL--EKK 337

Query: 219 PVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHL 278
             I+R+    N L+  +   K++DFGL++    GD             + APE +     
Sbjct: 338 NFIHRNLAARNCLVGENHLVKVADFGLSRL-MTGDTYTAHAGAKFPIKWTAPESLAYNKF 396

Query: 279 TARSDVYGFGVVLLEML-LGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRILD-----P 332
           + +SDV+ FGV+L E+   G        P               +  +V  +L+      
Sbjct: 397 SIKSDVWAFGVLLWEIATYGM------SPYPGI-----------DLSQVYELLEKDYRME 439

Query: 333 RLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLET 373
           R EG        KV  L   C   NP  RP  +++    ET
Sbjct: 440 RPEG-----CPEKVYELMRACWQWNPSDRPSFAEIHQAFET 475

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  138 bits (349), Expect = 8e-37
 Identities = 63/206 (30%), Positives = 105/206 (50%), Gaps = 13/206 (6%)

Query: 99  ILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDR-EWLAEVNYLGQLRHSNL 157
           ++G G FG V  G +     P  K   VAIK L  G  +  R ++L E + +GQ  H N+
Sbjct: 52  VVGAGEFGEVCSGRL---KLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNI 108

Query: 158 VKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAE 217
           ++L G   + +  ++V EYME+GSL    LR+     T  + + +    A G+ +L  ++
Sbjct: 109 IRLEGVVTKSKPVMIVTEYMENGSL-DSFLRKHDAQFTVIQLVGMLRGIASGMKYL--SD 165

Query: 218 RPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGT---YGYAAPEYVM 274
              ++RD    NIL+N++   K+SDFGL +   + D    +    G      + +PE + 
Sbjct: 166 MGYVHRDLAARNILINSNLVCKVSDFGLGRV--LEDDPEAAYTTRGGKIPIRWTSPEAIA 223

Query: 275 TGHLTARSDVYGFGVVLLEML-LGRR 299
               T+ SDV+ +G+VL E++  G R
Sbjct: 224 YRKFTSASDVWSYGIVLWEVMSYGER 249

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score =  136 bits (345), Expect = 9e-37
 Identities = 77/302 (25%), Positives = 133/302 (44%), Gaps = 48/302 (15%)

Query: 99  ILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDR-EWLAEVNYLGQLRHSNL 157
            LG+G FG+VY+GV  + V      T VAIK +N      +R E+L E + + +    ++
Sbjct: 32  ELGQGSFGMVYEGVA-KGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 90

Query: 158 VKLIGYCCEDEHRILVYEYMESGSLEKHLLRR--------VGCMLTWSRRMKIALDAAKG 209
           V+L+G   + +  +++ E M  G L+ +L           V    + S+ +++A + A G
Sbjct: 91  VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADG 150

Query: 210 LAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRV------MG 263
           +A+L       ++RD    N ++  DF+ K+ DFG+ +D    D      +       M 
Sbjct: 151 MAYL--NANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM- 207

Query: 264 TYGYAAPEYVMTGHLTARSDVYGFGVVLLEML-LGRRAVDKSRPSREHNLVEWARPLLNN 322
                +PE +  G  T  SDV+ FGVVL E+  L        +P +             +
Sbjct: 208 -----SPESLKDGVFTTYSDVWSFGVVLWEIATLAE------QPYQGL-----------S 245

Query: 323 NKKVLRILDPRLEGQYTARTA---MKVAGLAYQCLSQNPKGRPVMSDVVALLETVQSQGA 379
           N++VLR +    EG    +       +  L   C   NPK RP   ++++ ++     G 
Sbjct: 246 NEQVLRFVM---EGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGF 302

Query: 380 EE 381
            E
Sbjct: 303 RE 304

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  135 bits (343), Expect = 1e-36
 Identities = 79/333 (23%), Positives = 130/333 (39%), Gaps = 64/333 (19%)

Query: 78  NVDIFTYN-EMKLATKFFRPDY---------ILGEGGFGVVYKGVIDENVRPGYKTTFVA 127
           ++D+   N E+  A +               ++G G FG VY G +   +    K    A
Sbjct: 1   HIDLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTL---LDNDGKKIHCA 57

Query: 128 IKELNRGGYQGDR-EWLAEVNYLGQLRHSNLVKLIGYCCEDEHRIL-VYEYMESGSLEKH 185
           +K LNR    G+  ++L E   +    H N++ L+G C   E   L V  YM+ G L ++
Sbjct: 58  VKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDL-RN 116

Query: 186 LLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGL 245
            +R      T    +   L  AKG+ +L  A +  ++RD    N +L+  F+ K++DFGL
Sbjct: 117 FIRNETHNPTVKDLIGFGLQVAKGMKYL--ASKKFVHRDLAARNCMLDEKFTVKVADFGL 174

Query: 246 AKDGPMGDQTHVSTRVMG------TYGYAAPEYVMTGHLTARSDVYGFGVVLLEML-LGR 298
           A+D    +   V  +              A E + T   T +SDV+ FGV+L E++  G 
Sbjct: 175 ARDMYDKEYYSVHNKTGAKLPVKWM----ALESLQTQKFTTKSDVWSFGVLLWELMTRGA 230

Query: 299 RAVDKSRPSREHNLVEWARPLLNNNKKVLRILDP--RLE-------GQYTARTAMKVAGL 349
                  P  +            N   +   L    RL          Y          +
Sbjct: 231 ------PPYPDV-----------NTFDITVYLLQGRRLLQPEYCPDPLYE---------V 264

Query: 350 AYQCLSQNPKGRPVMSDVVALLETVQSQGAEEE 382
             +C     + RP  S++V+ +  + S    E 
Sbjct: 265 MLKCWHPKAEMRPSFSELVSRISAIFSTFIGEH 297

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  134 bits (340), Expect = 1e-36
 Identities = 61/205 (29%), Positives = 100/205 (48%), Gaps = 19/205 (9%)

Query: 99  ILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLV 158
            LG G FGVV  G              VA+K + + G   + E+  E   + +L H  LV
Sbjct: 15  ELGSGQFGVVKLGKWKGQYD-------VAVKMI-KEGSMSEDEFFQEAQTMMKLSHPKLV 66

Query: 159 KLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAER 218
           K  G C ++    +V EY+ +G L  + LR  G  L  S+ +++  D  +G+AFL     
Sbjct: 67  KFYGVCSKEYPIYIVTEYISNGCL-LNYLRSHGKGLEPSQLLEMCYDVCEGMAFL--ESH 123

Query: 219 PVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGT---YGYAAPEYVMT 275
             I+RD    N L++ D   K+SDFG+ +   + D  +     +GT     ++APE    
Sbjct: 124 QFIHRDLAARNCLVDRDLCVKVSDFGMTRY--VLDDQY--VSSVGTKFPVKWSAPEVFHY 179

Query: 276 GHLTARSDVYGFGVVLLEML-LGRR 299
              +++SDV+ FG+++ E+  LG+ 
Sbjct: 180 FKYSSKSDVWAFGILMWEVFSLGKM 204

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  140 bits (354), Expect = 1e-36
 Identities = 76/282 (26%), Positives = 118/282 (41%), Gaps = 42/282 (14%)

Query: 99  ILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLV 158
            LG+G FG V+ G  +   R       VAIK L + G      +L E   + +LRH  LV
Sbjct: 274 KLGQGCFGEVWMGTWNGTTR-------VAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLV 325

Query: 159 KLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAER 218
           +L      +E   +V EYM  GSL   L    G  L   + + +A   A G+A++     
Sbjct: 326 QLYA-VVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYV--ERM 382

Query: 219 PVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHL 278
             ++RD + +NIL+  +   K++DFGLA+     ++            + APE  + G  
Sbjct: 383 NYVHRDLRAANILVGENLVCKVADFGLARL-IEDNEYTARQGAKFPIKWTAPEAALYGRF 441

Query: 279 TARSDVYGFGVVLLEML-LGRRAVDKSRPSREHNLVEWARPLLN-NNKKVLRILD----- 331
           T +SDV+ FG++L E+   GR                   P     N++VL  ++     
Sbjct: 442 TIKSDVWSFGILLTELTTKGR------------------VPYPGMVNREVLDQVERGYRM 483

Query: 332 PRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLET 373
           P             +  L  QC  + P+ RP    + A LE 
Sbjct: 484 PCPPE-----CPESLHDLMCQCWRKEPEERPTFEYLQAFLED 520

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  134 bits (339), Expect = 2e-36
 Identities = 62/205 (30%), Positives = 98/205 (47%), Gaps = 19/205 (9%)

Query: 99  ILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLV 158
            +G G FG+V+ G              VAIK + R G   + +++ E   + +L H  LV
Sbjct: 15  EIGSGQFGLVHLGYW-------LNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLV 66

Query: 159 KLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAER 218
           +L G C E     LV E+ME G L    LR    +      + + LD  +G+A+L   E 
Sbjct: 67  QLYGVCLEQAPICLVTEFMEHGCL-SDYLRTQRGLFAAETLLGMCLDVCEGMAYL--EEA 123

Query: 219 PVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGT---YGYAAPEYVMT 275
            VI+RD    N L+  +   K+SDFG+ +   + D  +  T   GT     +A+PE    
Sbjct: 124 CVIHRDLAARNCLVGENQVIKVSDFGMTRF--VLDDQY--TSSTGTKFPVKWASPEVFSF 179

Query: 276 GHLTARSDVYGFGVVLLEML-LGRR 299
              +++SDV+ FGV++ E+   G+ 
Sbjct: 180 SRYSSKSDVWSFGVLMWEVFSEGKI 204

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  134 bits (339), Expect = 3e-36
 Identities = 63/211 (29%), Positives = 96/211 (45%), Gaps = 21/211 (9%)

Query: 97  DYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDR-EWLAEVNYLGQLRHS 155
           D  LG G FG V +GV     R   K   VAIK L +G  + D  E + E   + QL + 
Sbjct: 15  DIELGCGNFGSVRQGV----YRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNP 70

Query: 156 NLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHG 215
            +V+LIG C  +   + V E    G L K L       +  S   ++    + G+ +L  
Sbjct: 71  YIVRLIGVCQAEALML-VMEMAGGGPLHKFL-VGKREEIPVSNVAELLHQVSMGMKYL-- 126

Query: 216 AERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYG------YAA 269
            E+  ++RD    N+LL     AK+SDFGL+K     D  + +              + A
Sbjct: 127 EEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARS-----AGKWPLKWYA 181

Query: 270 PEYVMTGHLTARSDVYGFGVVLLEML-LGRR 299
           PE +     ++RSDV+ +GV + E L  G++
Sbjct: 182 PECINFRKFSSRSDVWSYGVTMWEALSYGQK 212

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score =  134 bits (339), Expect = 4e-36
 Identities = 75/299 (25%), Positives = 118/299 (39%), Gaps = 42/299 (14%)

Query: 99  ILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDR-EWLAEVNYLGQLRHSNL 157
           ++G+G FGVVY G     +         AIK L+R         +L E   +  L H N+
Sbjct: 28  VIGKGHFGVVYHGEY---IDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNV 84

Query: 158 VKLIGYCCEDEHRIL-VYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGA 216
           + LIG     E     +  YM  G L    +R      T    +   L  A+G+ +L  A
Sbjct: 85  LALIGIMLPPEGLPHVLLPYMCHGDL-LQFIRSPQRNPTVKDLISFGLQVARGMEYL--A 141

Query: 217 ERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMG------TYGYAAP 270
           E+  ++RD    N +L+  F+ K++DFGLA+D    +   V            T    A 
Sbjct: 142 EQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWT----AL 197

Query: 271 EYVMTGHLTARSDVYGFGVVLLEML-LGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRI 329
           E + T   T +SDV+ FGV+L E+L  G        P R             +   +   
Sbjct: 198 ESLQTYRFTTKSDVWSFGVLLWELLTRGA------PPYRHI-----------DPFDLTHF 240

Query: 330 LDPRLEGQYTARTA---MKVAGLAYQCLSQNPKGRPVMSDVVALLETVQSQGAEEEMLQ 385
           L    +G+   +       +  +  QC   +P  RP    +V  +E + S    +  +Q
Sbjct: 241 LA---QGRRLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALLGDHYVQ 296

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score =  133 bits (337), Expect = 5e-36
 Identities = 71/205 (34%), Positives = 109/205 (53%), Gaps = 19/205 (9%)

Query: 99  ILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLV 158
            LG G FG V+ G  + + +       VA+K L + G      +LAE N + QL+H  LV
Sbjct: 20  RLGAGQFGEVWMGYYNGHTK-------VAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLV 71

Query: 159 KLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAER 218
           +L       E   ++ EYME+GSL   L    G  LT ++ + +A   A+G+AF+   ER
Sbjct: 72  RLYA-VVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFI--EER 128

Query: 219 PVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGT---YGYAAPEYVMT 275
             I+RD + +NIL++   S K++DFGLA+   + D  +  T   G      + APE +  
Sbjct: 129 NYIHRDLRAANILVSDTLSCKIADFGLARL--IEDNEY--TAREGAKFPIKWTAPEAINY 184

Query: 276 GHLTARSDVYGFGVVLLEML-LGRR 299
           G  T +SDV+ FG++L E++  GR 
Sbjct: 185 GTFTIKSDVWSFGILLTEIVTHGRI 209

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score =  133 bits (338), Expect = 5e-36
 Identities = 75/298 (25%), Positives = 123/298 (41%), Gaps = 53/298 (17%)

Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVK 159
           LGEG FG V+      N+ P      VA+K L        +++  E   L  L+H ++VK
Sbjct: 23  LGEGAFGKVFLAEC-YNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVK 81

Query: 160 LIGYCCEDEHRILVYEYMESGSLEKHLLRR--------------VGCMLTWSRRMKIALD 205
             G C + +  I+V+EYM+ G L K L                     L  S+ + IA  
Sbjct: 82  FYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQ 141

Query: 206 AAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRV---- 261
            A G+ +L  A +  ++RD  T N L+ A+   K+ DFG+++D    D   V        
Sbjct: 142 IASGMVYL--ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI 199

Query: 262 --MGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEML-LGRRAVDKSRPSREHNLVEWARP 318
             M       PE +M    T  SDV+ FGV+L E+   G+      +P  +         
Sbjct: 200 RWM------PPESIMYRKFTTESDVWSFGVILWEIFTYGK------QPWFQL-------- 239

Query: 319 LLNNNKKVLRILDPRLEGQYTAR---TAMKVAGLAYQCLSQNPKGRPVMSDVVALLET 373
              +N +V+  +    +G+   R      +V  +   C  + P+ R  + ++  +L  
Sbjct: 240 ---SNTEVIECIT---QGRVLERPRVCPKEVYDVMLGCWQREPQQRLNIKEIYKILHA 291

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  134 bits (340), Expect = 5e-36
 Identities = 56/203 (27%), Positives = 96/203 (47%), Gaps = 8/203 (3%)

Query: 99  ILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRG-GYQGDREWLAEVNYLGQLRHSNL 157
           +LG G FG V+KGV             V IK +    G Q  +     +  +G L H+++
Sbjct: 20  VLGSGVFGTVHKGVWIPEGESI--KIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHI 77

Query: 158 VKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAE 217
           V+L+G  C      LV +Y+  GSL  H+ +  G  L     +   +  AKG+ +L   E
Sbjct: 78  VRLLG-LCPGSSLQLVTQYLPLGSLLDHVRQHRG-ALGPQLLLNWGVQIAKGMYYL--EE 133

Query: 218 RPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGH 277
             +++R+    N+LL +    +++DFG+A   P  D+  + +       + A E +  G 
Sbjct: 134 HGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGK 193

Query: 278 LTARSDVYGFGVVLLEML-LGRR 299
            T +SDV+ +GV + E++  G  
Sbjct: 194 YTHQSDVWSYGVTVWELMTFGAE 216

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  133 bits (336), Expect = 7e-36
 Identities = 56/205 (27%), Positives = 99/205 (48%), Gaps = 19/205 (9%)

Query: 99  ILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLV 158
            LG G FGVV  G              VAIK + + G   + E++ E   +  L H  LV
Sbjct: 31  ELGTGQFGVVKYGKW-------RGQYDVAIKMI-KEGSMSEDEFIEEAKVMMNLSHEKLV 82

Query: 159 KLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAER 218
           +L G C +     ++ EYM +G L  + LR +       + +++  D  + + +L    +
Sbjct: 83  QLYGVCTKQRPIFIITEYMANGCL-LNYLREMRHRFQTQQLLEMCKDVCEAMEYL--ESK 139

Query: 219 PVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGT---YGYAAPEYVMT 275
             ++RD    N L+N     K+SDFGL++   + D  +  T  +G+     ++ PE +M 
Sbjct: 140 QFLHRDLAARNCLVNDQGVVKVSDFGLSRY--VLDDEY--TSSVGSKFPVRWSPPEVLMY 195

Query: 276 GHLTARSDVYGFGVVLLEML-LGRR 299
              +++SD++ FGV++ E+  LG+ 
Sbjct: 196 SKFSSKSDIWAFGVLMWEIYSLGKM 220

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  131 bits (333), Expect = 2e-35
 Identities = 63/208 (30%), Positives = 92/208 (44%), Gaps = 16/208 (7%)

Query: 99  ILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRG---GYQGDREWLAEVNYLGQLRHS 155
            LG+G FGVV +G  D    P  KT  VA+K L        +   +++ EVN +  L H 
Sbjct: 25  KLGDGSFGVVRRGEWD---APSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHR 81

Query: 156 NLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHG 215
           NL++L G         +V E    GSL   L +  G         + A+  A+G+ +L  
Sbjct: 82  NLIRLYG-VVLTPPMKMVTELAPLGSLLDRLRKHQG-HFLLGTLSRYAVQVAEGMGYL-- 137

Query: 216 AERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGT---YGYAAPEY 272
             +  I+RD    N+LL      K+ DFGL +  P  D  +V          + + APE 
Sbjct: 138 ESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQE--HRKVPFAWCAPES 195

Query: 273 VMTGHLTARSDVYGFGVVLLEML-LGRR 299
           + T   +  SD + FGV L EM   G+ 
Sbjct: 196 LKTRTFSHASDTWMFGVTLWEMFTYGQE 223

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  132 bits (334), Expect = 2e-35
 Identities = 72/333 (21%), Positives = 122/333 (36%), Gaps = 50/333 (15%)

Query: 36  ISDNLDSPGMKTASGSQVTPKNVTPVPPKKNVNDLRQNPGYSNVDIFTYNEMKLATKFFR 95
              +L +  +   S  Q+ P+    V  +   ++  Q+PGY      ++ +       F+
Sbjct: 9   SGVDLGTENLYFQSMHQLQPR---RVSFRGEASETLQSPGYDPSRPESFFQQS-----FQ 60

Query: 96  PDYILGEGGFGVVYKGVIDENVRPGYKTT--FVAIKELNRGGYQGDRE---WLAEVNYLG 150
               LG G +G V+K           K      A+K      ++G ++    LAEV    
Sbjct: 61  RLSRLGHGSYGEVFKVR--------SKEDGRLYAVKRSMSP-FRGPKDRARKLAEVGSHE 111

Query: 151 QL-RHSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKG 209
           ++ +H   V+L     E     L  E     SL++H     G  L  ++      D    
Sbjct: 112 KVGQHPCCVRLEQAWEEGGILYLQTELCG-PSLQQHC-EAWGASLPEAQVWGYLRDTLLA 169

Query: 210 LAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAA 269
           LA LH   + +++ D K +NI L      KL DFGL  +  +G       +  G   Y A
Sbjct: 170 LAHLH--SQGLVHLDVKPANIFLGPRGRCKLGDFGLLVE--LGTAGAGEVQE-GDPRYMA 224

Query: 270 PEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRI 329
           PE +   + TA +DV+  G+ +LE+           P          + L          
Sbjct: 225 PELLQGSYGTA-ADVFSLGLTILEVACN-----MELPHGGEGW----QQLRQG------Y 268

Query: 330 LDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRP 362
           L P      ++   ++   +    L  +PK R 
Sbjct: 269 LPPEFTAGLSS--ELR--SVLVMMLEPDPKLRA 297

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score =  131 bits (332), Expect = 3e-35
 Identities = 60/210 (28%), Positives = 96/210 (45%), Gaps = 24/210 (11%)

Query: 99  ILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDR-EWLAEVNYLGQLRHSNL 157
           ILGEG FG VY+GV         +   VA+K   +     ++ ++++E   +  L H ++
Sbjct: 19  ILGEGFFGEVYEGVY---TNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHI 75

Query: 158 VKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAE 217
           VKLIG   E+E   ++ E    G L  H L R    L     +  +L   K +A+L    
Sbjct: 76  VKLIG-IIEEEPTWIIMELYPYGEL-GHYLERNKNSLKVLTLVLYSLQICKAMAYL--ES 131

Query: 218 RPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRV-------MGTYGYAAP 270
              ++RD    NIL+ +    KL DFGL++   + D+ +    V       M      +P
Sbjct: 132 INCVHRDIAVRNILVASPECVKLGDFGLSRY--IEDEDYYKASVTRLPIKWM------SP 183

Query: 271 EYVMTGHLTARSDVYGFGVVLLEML-LGRR 299
           E +     T  SDV+ F V + E+L  G++
Sbjct: 184 ESINFRRFTTASDVWMFAVCMWEILSFGKQ 213

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  132 bits (335), Expect = 3e-35
 Identities = 79/354 (22%), Positives = 138/354 (38%), Gaps = 39/354 (11%)

Query: 99  ILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREW---LAEVNYLGQLRHS 155
            +GEG FG          V+         IKE+N       +E      EV  L  ++H 
Sbjct: 31  KIGEGSFGKAIL------VKSTEDGRQYVIKEINISR-MSSKEREESRREVAVLANMKHP 83

Query: 156 NLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHG 215
           N+V+      E+    +V +Y E G L K +  + G +    + +   +     L  +H 
Sbjct: 84  NIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVH- 142

Query: 216 AERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMT 275
            +R +++RD K+ NI L  D + +L DFG+A+   +     ++   +GT  Y +PE    
Sbjct: 143 -DRKILHRDIKSQNIFLTKDGTVQLGDFGIARV--LNSTVELARACIGTPYYLSPEICEN 199

Query: 276 GHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRILDPRLE 335
                +SD++  G VL E+   + A +             A  + N   K++    P + 
Sbjct: 200 KPYNNKSDIWALGCVLYELCTLKHAFE-------------AGSMKNLVLKIISGSFPPVS 246

Query: 336 GQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLET--VQSQGAEEEMLQSGGGVVTL 393
             Y+      +  L  Q   +NP+ RP    V ++LE   +  +  +    Q       L
Sbjct: 247 LHYSY----DLRSLVSQLFKRNPRDRP---SVNSILEKGFIAKRIEKFLSPQLIAEEFCL 299

Query: 394 YEVPKLSSHNSGDKKRNQSGFSGSTEGESRRRNKPGNGRSKSEPPADREPCDFR 447
               K  S      KR  SG +  +   +++  KP        P A ++  D +
Sbjct: 300 KTFSKFGSQPI-PAKRPASGQNSISVMPAQKITKP--AAKYGIPLAYKKYGDKK 350

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score =  132 bits (334), Expect = 4e-35
 Identities = 60/211 (28%), Positives = 89/211 (42%), Gaps = 13/211 (6%)

Query: 99  ILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDR-EWLAEVNYLGQLRHSNL 157
            LG G FG VY+G +   +        VA+K L     + D  ++L E   + +  H N+
Sbjct: 37  GLGHGAFGEVYEGQV-SGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 95

Query: 158 VKLIGYCCEDEHRILVYEYMESGSLEKHLLRR-----VGCMLTWSRRMKIALDAAKGLAF 212
           V+ IG   +   R ++ E M  G L+  L            L     + +A D A G  +
Sbjct: 96  VRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 155

Query: 213 LHGAERPVIYRDFKTSNILLNA---DFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAA 269
           L   E   I+RD    N LL        AK+ DFG+A+D             M    +  
Sbjct: 156 L--EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMP 213

Query: 270 PEYVMTGHLTARSDVYGFGVVLLEML-LGRR 299
           PE  M G  T+++D + FGV+L E+  LG  
Sbjct: 214 PEAFMEGIFTSKTDTWSFGVLLWEIFSLGYM 244

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  134 bits (340), Expect = 4e-35
 Identities = 63/205 (30%), Positives = 103/205 (50%), Gaps = 19/205 (9%)

Query: 99  ILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLV 158
            LG G FG V+    +++ +       VA+K + + G      +LAE N +  L+H  LV
Sbjct: 195 KLGAGQFGEVWMATYNKHTK-------VAVKTM-KPGSMSVEAFLAEANVMKTLQHDKLV 246

Query: 159 KLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAER 218
           KL       E   ++ E+M  GSL   L    G      + +  +   A+G+AF+   +R
Sbjct: 247 KLHA-VVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFI--EQR 303

Query: 219 PVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGT---YGYAAPEYVMT 275
             I+RD + +NIL++A    K++DFGLA+   + D  +  T   G      + APE +  
Sbjct: 304 NYIHRDLRAANILVSASLVCKIADFGLARV--IEDNEY--TAREGAKFPIKWTAPEAINF 359

Query: 276 GHLTARSDVYGFGVVLLEML-LGRR 299
           G  T +SDV+ FG++L+E++  GR 
Sbjct: 360 GSFTIKSDVWSFGILLMEIVTYGRI 384

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score =  130 bits (330), Expect = 6e-35
 Identities = 63/222 (28%), Positives = 99/222 (44%), Gaps = 31/222 (13%)

Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDR-EWLAEVNYLGQLRHSNLV 158
           LGE  FG VYKG +     PG +T  VAIK L        R E+  E     +L+H N+V
Sbjct: 17  LGEDRFGKVYKGHL-FGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVV 75

Query: 159 KLIGYCCEDEHRILVYEYMESGSLEKHLLRR--------------VGCMLTWSRRMKIAL 204
            L+G   +D+   +++ Y   G L + L+ R              V   L     + +  
Sbjct: 76  CLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVA 135

Query: 205 DAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVST----- 259
             A G+ +L  +   V+++D  T N+L+    + K+SD GL ++    D   +       
Sbjct: 136 QIAAGMEYL--SSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLP 193

Query: 260 -RVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEML-LGRR 299
            R M      APE +M G  +  SD++ +GVVL E+   G +
Sbjct: 194 IRWM------APEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQ 229

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  131 bits (332), Expect = 6e-35
 Identities = 51/203 (25%), Positives = 91/203 (44%), Gaps = 8/203 (3%)

Query: 99  ILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDR-EWLAEVNYLGQLRHSNL 157
           +LG G FG VYKG+             VAIKEL          E L E   +  + + ++
Sbjct: 22  VLGSGAFGTVYKGLWIPEGEKV--KIPVAIKELREATSPKANKEILDEAYVMASVDNPHV 79

Query: 158 VKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAE 217
            +L+G  C      L+ + M  G L  ++       +     +   +  AKG+ +L   +
Sbjct: 80  CRLLG-ICLTSTVQLITQLMPFGCLLDYVREHKD-NIGSQYLLNWCVQIAKGMNYL--ED 135

Query: 218 RPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGH 277
           R +++RD    N+L+      K++DFGLAK     ++ + +        + A E ++   
Sbjct: 136 RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI 195

Query: 278 LTARSDVYGFGVVLLEML-LGRR 299
            T +SDV+ +GV + E++  G +
Sbjct: 196 YTHQSDVWSYGVTVWELMTFGSK 218

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  130 bits (329), Expect = 8e-35
 Identities = 54/214 (25%), Positives = 95/214 (44%), Gaps = 35/214 (16%)

Query: 99  ILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLV 158
            LG G +G VY+GV  +       +  VA+K L +       E+L E   + +++H NLV
Sbjct: 20  KLGGGQYGEVYEGVWKK------YSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLV 72

Query: 159 KLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAER 218
           +L+G C  +    ++ E+M  G+L  +L       ++    + +A   +  + +L   ++
Sbjct: 73  QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL--EKK 130

Query: 219 PVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYA---------- 268
             I+RD    N L+  +   K++DFGL+             R+M    Y           
Sbjct: 131 NFIHRDLAARNCLVGENHLVKVADFGLS-------------RLMTGDTYTAHAGAKFPIK 177

Query: 269 --APEYVMTGHLTARSDVYGFGVVLLEML-LGRR 299
             APE +     + +SDV+ FGV+L E+   G  
Sbjct: 178 WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMS 211

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score =  130 bits (328), Expect = 8e-35
 Identities = 59/210 (28%), Positives = 93/210 (44%), Gaps = 24/210 (11%)

Query: 99  ILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDR-EWLAEVNYLGQLRHSNL 157
            +GEG FG V++G+    + P      VAIK          R ++L E   + Q  H ++
Sbjct: 22  CIGEGQFGDVHQGIY---MSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHI 78

Query: 158 VKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAE 217
           VKLIG    +    ++ E    G L   L  R    L  +  +  A   +  LA+L    
Sbjct: 79  VKLIG-VITENPVWIIMELCTLGELRSFLQVRKY-SLDLASLILYAYQLSTALAYL--ES 134

Query: 218 RPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRV-------MGTYGYAAP 270
           +  ++RD    N+L++++   KL DFGL++   M D T+            M      AP
Sbjct: 135 KRFVHRDIAARNVLVSSNDCVKLGDFGLSRY--MEDSTYYKASKGKLPIKWM------AP 186

Query: 271 EYVMTGHLTARSDVYGFGVVLLEML-LGRR 299
           E +     T+ SDV+ FGV + E+L  G +
Sbjct: 187 ESINFRRFTSASDVWMFGVCMWEILMHGVK 216

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  128 bits (325), Expect = 3e-34
 Identities = 59/210 (28%), Positives = 94/210 (44%), Gaps = 23/210 (10%)

Query: 99  ILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDR--EWLAEVNYLGQLRHSN 156
            LG G FG V KG      +       VA+K L           E LAE N + QL +  
Sbjct: 24  ELGSGNFGTVKKGY----YQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPY 79

Query: 157 LVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGA 216
           +V++IG C  +   + V E  E G L K+L  +    +     +++    + G+ +L   
Sbjct: 80  IVRMIGICEAESWML-VMEMAELGPLNKYL--QQNRHVKDKNIIELVHQVSMGMKYL--E 134

Query: 217 ERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMG------TYGYAAP 270
           E   ++RD    N+LL     AK+SDFGL+K     D+ +   +  G           AP
Sbjct: 135 ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALR-ADENYYKAQTHGKWPVKWY----AP 189

Query: 271 EYVMTGHLTARSDVYGFGVVLLEML-LGRR 299
           E +     +++SDV+ FGV++ E    G++
Sbjct: 190 ECINYYKFSSKSDVWSFGVLMWEAFSYGQK 219

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  134 bits (339), Expect = 4e-34
 Identities = 58/208 (27%), Positives = 93/208 (44%), Gaps = 20/208 (9%)

Query: 99  ILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDR-EWLAEVNYLGQLRHSNL 157
            +GEG FG V++G+    + P      VAIK          R ++L E   + Q  H ++
Sbjct: 397 CIGEGQFGDVHQGIY---MSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHI 453

Query: 158 VKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAE 217
           VKLIG    +    ++ E    G L   L  R    L  +  +  A   +  LA+L    
Sbjct: 454 VKLIG-VITENPVWIIMELCTLGELRSFLQVRKFS-LDLASLILYAYQLSTALAYL--ES 509

Query: 218 RPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTR-----VMGTYGYAAPEY 272
           +  ++RD    N+L++++   KL DFGL++   M D T+         +       APE 
Sbjct: 510 KRFVHRDIAARNVLVSSNDCVKLGDFGLSRY--MEDSTYYKASKGKLPIKWM----APES 563

Query: 273 VMTGHLTARSDVYGFGVVLLEML-LGRR 299
           +     T+ SDV+ FGV + E+L  G +
Sbjct: 564 INFRRFTSASDVWMFGVCMWEILMHGVK 591

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score =  130 bits (329), Expect = 4e-34
 Identities = 60/211 (28%), Positives = 89/211 (42%), Gaps = 13/211 (6%)

Query: 99  ILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDR-EWLAEVNYLGQLRHSNL 157
            LG G FG VY+G +   +        VA+K L     + D  ++L E   + +  H N+
Sbjct: 78  GLGHGAFGEVYEGQV-SGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 136

Query: 158 VKLIGYCCEDEHRILVYEYMESGSLEKHLLRR-----VGCMLTWSRRMKIALDAAKGLAF 212
           V+ IG   +   R ++ E M  G L+  L            L     + +A D A G  +
Sbjct: 137 VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 196

Query: 213 LHGAERPVIYRDFKTSNILLNA---DFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAA 269
           L   E   I+RD    N LL        AK+ DFG+A+D             M    +  
Sbjct: 197 L--EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMP 254

Query: 270 PEYVMTGHLTARSDVYGFGVVLLEML-LGRR 299
           PE  M G  T+++D + FGV+L E+  LG  
Sbjct: 255 PEAFMEGIFTSKTDTWSFGVLLWEIFSLGYM 285

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  132 bits (333), Expect = 2e-33
 Identities = 62/208 (29%), Positives = 98/208 (47%), Gaps = 15/208 (7%)

Query: 97  DYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDR-EWLAEVNYLGQLRHS 155
           D  LG G FG V +GV     R   K   VAIK L +G  + D  E + E   + QL + 
Sbjct: 341 DIELGCGNFGSVRQGVY----RMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNP 396

Query: 156 NLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHG 215
            +V+LIG C  +   + V E    G L K L+ +    +  S   ++    + G+ +L  
Sbjct: 397 YIVRLIGVCQAEALML-VMEMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYL-- 452

Query: 216 AERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGT---YGYAAPEY 272
            E+  ++R+    N+LL     AK+SDFGL+K     D  + +           + APE 
Sbjct: 453 EEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARS--AGKWPLKWYAPEC 510

Query: 273 VMTGHLTARSDVYGFGVVLLEML-LGRR 299
           +     ++RSDV+ +GV + E L  G++
Sbjct: 511 INFRKFSSRSDVWSYGVTMWEALSYGQK 538

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score =  126 bits (319), Expect = 3e-33
 Identities = 55/218 (25%), Positives = 94/218 (43%), Gaps = 29/218 (13%)

Query: 99  ILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGD--REWLAEVNYLGQLRHSN 156
           ILGEG FG V +G +    +    +  VA+K +           E+L+E   +    H N
Sbjct: 41  ILGEGEFGSVMEGNL---KQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPN 97

Query: 157 LVKLIGYCCEDE-----HRILVYEYMESGSLEKHLLRR----VGCMLTWSRRMKIALDAA 207
           +++L+G C E         +++  +M+ G L  +LL          +     +K  +D A
Sbjct: 98  VIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIA 157

Query: 208 KGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRV------ 261
            G+ +L  + R  ++RD    N +L  D +  ++DFGL+K    GD              
Sbjct: 158 LGMEYL--SNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKW 215

Query: 262 MGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEML-LGR 298
           +      A E +     T++SDV+ FGV + E+   G 
Sbjct: 216 I------AIESLADRVYTSKSDVWAFGVTMWEIATRGM 247

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  126 bits (319), Expect = 3e-33
 Identities = 63/296 (21%), Positives = 108/296 (36%), Gaps = 45/296 (15%)

Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVK 159
           LGEGGF  V        V   +   F A+K +     Q   E   E +      H N+++
Sbjct: 37  LGEGGFSYVDL------VEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILR 90

Query: 160 LIGYCCEDEHR----ILVYEYMESGSLEKHLLRRV--GCMLTWSRRMKIALDAAKGLAFL 213
           L+ YC  +        L+  + + G+L   + R    G  LT  + + + L   +GL  +
Sbjct: 91  LVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAI 150

Query: 214 HGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVM-------GTYG 266
           H   +   +RD K +NILL  +    L D G      +  +       +        T  
Sbjct: 151 H--AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTIS 208

Query: 267 YAAPE------YVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLL 320
           Y APE      + +      R+DV+  G VL  M+ G    D      +           
Sbjct: 209 YRAPELFSVQSHCVIDE---RTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVA-------- 257

Query: 321 NNNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETVQS 376
                V   L      ++++     +  L    ++ +P  RP +  +++ LE +Q 
Sbjct: 258 ---LAVQNQLSIPQSPRHSSA----LWQLLNSMMTVDPHQRPHIPLLLSQLEALQP 306

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score =  126 bits (318), Expect = 4e-33
 Identities = 77/311 (24%), Positives = 115/311 (36%), Gaps = 56/311 (18%)

Query: 99  ILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDR-EWLAEVNYLGQL-RHSN 156
            LG G FG V +      +        VA+K L    +  +R   ++E+  L  L  H N
Sbjct: 30  TLGAGAFGKVVEATA-YGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMN 88

Query: 157 LVKLIGYCCEDEHRILVYEYMESGSLEKHLLRR-----------------VGCMLTWSRR 199
           +V L+G C      +++ EY   G L  + LRR                     L     
Sbjct: 89  IVNLLGACTIGGPTLVITEYCCYGDL-LNFLRRKRDSFICSKTSPAIMEDDELALDLEDL 147

Query: 200 MKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVST 259
           +  +   AKG+AFL  A +  I+RD    NILL      K+ DFGLA+D        V  
Sbjct: 148 LSFSYQVAKGMAFL--ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKG 205

Query: 260 ------RVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEML-LGRRAVDKSRPSREHNL 312
                 + M      APE +     T  SDV+ +G+ L E+  LG        P      
Sbjct: 206 NARLPVKWM------APESIFNCVYTFESDVWSYGIFLWELFSLGS------SPY----- 248

Query: 313 VEWARPLLNNNKKVLRILDP--RLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVAL 370
                P +  + K  +++    R+     A   M    +   C   +P  RP    +V L
Sbjct: 249 -----PGMPVDSKFYKMIKEGFRMLSPEHAPAEM--YDIMKTCWDADPLKRPTFKQIVQL 301

Query: 371 LETVQSQGAEE 381
           +E   S+    
Sbjct: 302 IEKQISESTNH 312

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  125 bits (315), Expect = 6e-33
 Identities = 65/296 (21%), Positives = 109/296 (36%), Gaps = 61/296 (20%)

Query: 94  FRPDY----ILGEGGFGVVYKGVIDENVRPGYKTT--FVAIKELNRGGYQGDREWLAEVN 147
           F  D+    ++G GGFG V+K           +       IK +       + +   EV 
Sbjct: 9   FGMDFKEIELIGSGGFGQVFK-AKH-------RIDGKTYVIKRVK----YNNEKAEREVK 56

Query: 148 YLGQLRHSNLVKLIGYCCEDEHRI----------------LVYEYMESGSLEKHLLRRVG 191
            L +L H N+V   G     ++                  +  E+ + G+LE+ + +R G
Sbjct: 57  ALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRG 116

Query: 192 CMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPM 251
             L     +++     KG+ ++H   + +I RD K SNI L      K+ DFGL      
Sbjct: 117 EKLDKVLALELFEQITKGVDYIH--SKKLINRDLKPSNIFLVDTKQVKIGDFGLVT---S 171

Query: 252 GDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHN 311
                  TR  GT  Y +PE + +       D+Y  G++L E+L                
Sbjct: 172 LKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHV-------------- 217

Query: 312 LVEWARPLLNNNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDV 367
                      +K    + D  +   +      K   L  + LS+ P+ RP  S++
Sbjct: 218 ----CDTAFETSKFFTDLRDGIISDIFDK----KEKTLLQKLLSKKPEDRPNTSEI 265

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score =  126 bits (318), Expect = 9e-33
 Identities = 68/281 (24%), Positives = 117/281 (41%), Gaps = 44/281 (15%)

Query: 52  QVTPKNVTPVPPKKNVNDLRQNPGYSNVDIFTYNEMKLATKFFRPDYI----LGEGGFGV 107
           +     +T +P +  ++ L  NP Y  + +   N   L+ ++ R +      +GEG FG 
Sbjct: 4   ESAAVTLTTLPSELLLDRLHPNPMYQRMPL-LLNPKLLSLEYPRNNIEYVRDIGEGAFGR 62

Query: 108 VYKGVIDENVRPGYKTTFVAIKELNRGGYQGDR-EWLAEVNYLGQLRHSNLVKLIGYCCE 166
           V++      + P    T VA+K L        + ++  E   + +  + N+VKL+G C  
Sbjct: 63  VFQARA-PGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAV 121

Query: 167 DEHRILVYEYMESGSLEKHLLRR----------------------VGCMLTWSRRMKIAL 204
            +   L++EYM  G L + L                             L+ + ++ IA 
Sbjct: 122 GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIAR 181

Query: 205 DAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRV--- 261
             A G+A+L  +ER  ++RD  T N L+  +   K++DFGL+++    D           
Sbjct: 182 QVAAGMAYL--SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIP 239

Query: 262 ---MGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEML-LGR 298
              M       PE +     T  SDV+ +GVVL E+   G 
Sbjct: 240 IRWM------PPESIFYNRYTTESDVWAYGVVLWEIFSYGL 274

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score =  125 bits (316), Expect = 1e-32
 Identities = 75/311 (24%), Positives = 118/311 (37%), Gaps = 55/311 (17%)

Query: 99  ILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDR-EWLAEVNYLGQL-RHSN 156
            LG G FG V +      +        VA+K L  G    +    ++E+  L  +  H N
Sbjct: 34  PLGRGAFGQVIEADA-FGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 92

Query: 157 LVKLIGYCC-EDEHRILVYEYMESGSLEKHLLRR--------------VGCMLTWSRRMK 201
           +V L+G C       +++ E+ + G+L  +L  +                  LT    + 
Sbjct: 93  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 152

Query: 202 IALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVST-- 259
            +   AKG+ FL  A R  I+RD    NILL+     K+ DFGLA+D             
Sbjct: 153 YSFQVAKGMEFL--ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA 210

Query: 260 ----RVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEML-LGRRAVDKSRPSREHNLVE 314
               + M      APE +     T +SDV+ FGV+L E+  LG        P        
Sbjct: 211 RLPLKWM------APETIFDRVYTIQSDVWSFGVLLWEIFSLGA------SPY------- 251

Query: 315 WARPLLNNNKKVLRILDPRLEGQYTARTAM---KVAGLAYQCLSQNPKGRPVMSDVVALL 371
              P +  +++  R L    EG           ++      C    P  RP  S++V  L
Sbjct: 252 ---PGVKIDEEFCRRLK---EGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 305

Query: 372 ETVQSQGAEEE 382
             +    A+++
Sbjct: 306 GNLLQANAQQD 316

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score =  125 bits (316), Expect = 1e-32
 Identities = 68/310 (21%), Positives = 119/310 (38%), Gaps = 53/310 (17%)

Query: 99  ILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDR--EWLAEVNYLGQLRHSN 156
           +LG+G FG V +  +    +       VA+K L           E+L E   + +  H +
Sbjct: 30  MLGKGEFGSVREAQL---KQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPH 86

Query: 157 LVKLIGYCCEDEHRI------LVYEYMESGSLEKHLLRRV----GCMLTWSRRMKIALDA 206
           + KL+G       +       ++  +M+ G L   LL          L     ++  +D 
Sbjct: 87  VAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDI 146

Query: 207 AKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGD--QTHVSTRV--- 261
           A G+ +L  + R  I+RD    N +L  D +  ++DFGL++    GD  +   ++++   
Sbjct: 147 ACGMEYL--SSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVK 204

Query: 262 -MGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEML-LGRRAVDKSRPSREHNLVEWARPL 319
            +      A E +     T  SDV+ FGV + E++  G+       P             
Sbjct: 205 WL------ALESLADNLYTVHSDVWAFGVTMWEIMTRGQ------TPYAGI--------- 243

Query: 320 LNNNKKVLRILDPRLEGQYTAR---TAMKVAGLAYQCLSQNPKGRPVMSDVVALLETVQS 376
              N ++   L     G    +      +V  L YQC S +PK RP  + +   LE +  
Sbjct: 244 --ENAEIYNYLI---GGNRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILG 298

Query: 377 QGAEEEMLQS 386
             +     Q 
Sbjct: 299 HLSVLSTSQD 308

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score =  124 bits (313), Expect = 2e-32
 Identities = 65/230 (28%), Positives = 100/230 (43%), Gaps = 39/230 (16%)

Query: 99  ILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDR-EWLAEVNYLGQLRHSNL 157
            LGEG FG V K     +++     T VA+K L       +  + L+E N L Q+ H ++
Sbjct: 30  TLGEGEFGKVVKATA-FHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHV 88

Query: 158 VKLIGYCCEDEHRILVYEYMESGSLEKHLLRR----------------------VGCMLT 195
           +KL G C +D   +L+ EY + GSL   L                             LT
Sbjct: 89  IKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALT 148

Query: 196 WSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQT 255
               +  A   ++G+ +L  AE  +++RD    NIL+      K+SDFGL++D    D  
Sbjct: 149 MGDLISFAWQISQGMQYL--AEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSY 206

Query: 256 HVST------RVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEML-LGR 298
              +      + M      A E +     T +SDV+ FGV+L E++ LG 
Sbjct: 207 VKRSQGRIPVKWM------AIESLFDHIYTTQSDVWSFGVLLWEIVTLGG 250

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score =  124 bits (314), Expect = 3e-32
 Identities = 63/254 (24%), Positives = 106/254 (41%), Gaps = 46/254 (18%)

Query: 72  QNPGYSNVDIFTYNEMKLATKFFRPDYI-----LGEGGFGVVYKGVIDENVRPGYKTTFV 126
            + G +N D   Y            + I     +GEG FG V K  I    +        
Sbjct: 7   HHHGKNNPDPTIYPV-------LDWNDIKFQDVIGEGNFGQVLKARI----KKDGLRMDA 55

Query: 127 AIKELNRGGYQGDR-EWLAEVNYLGQL-RHSNLVKLIGYCCEDEHRILVYEYMESGSLEK 184
           AIK +     + D  ++  E+  L +L  H N++ L+G C    +  L  EY   G+L  
Sbjct: 56  AIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLD 115

Query: 185 HLLRR--------------VGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNI 230
            L +                   L+  + +  A D A+G+ +L  +++  I+RD    NI
Sbjct: 116 FLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYL--SQKQFIHRDLAARNI 173

Query: 231 LLNADFSAKLSDFGLAKDGPMGDQTHVSTRV----MGTYGYAAPEYVMTGHLTARSDVYG 286
           L+  ++ AK++DFGL++   +  +     R+    M      A E +     T  SDV+ 
Sbjct: 174 LVGENYVAKIADFGLSRGQEVYVKKT-MGRLPVRWM------AIESLNYSVYTTNSDVWS 226

Query: 287 FGVVLLEML-LGRR 299
           +GV+L E++ LG  
Sbjct: 227 YGVLLWEIVSLGGT 240

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score =  124 bits (314), Expect = 3e-32
 Identities = 71/309 (22%), Positives = 119/309 (38%), Gaps = 54/309 (17%)

Query: 99  ILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDR-EWLAEVNYLGQL-RHSN 156
            LG G FG V +      +        VA+K L    +  ++   ++E+  +  L +H N
Sbjct: 53  TLGAGAFGKVVEATA-FGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHEN 111

Query: 157 LVKLIGYCCEDEHRILVYEYMESGSLEKHLLRR-------------VGCMLTWSRRMKIA 203
           +V L+G C      +++ EY   G L  + LRR                  +    +  +
Sbjct: 112 IVNLLGACTHGGPVLVITEYCCYGDL-LNFLRRKSRVLETDPAFAIANSTASTRDLLHFS 170

Query: 204 LDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVST---- 259
              A+G+AFL  A +  I+RD    N+LL     AK+ DFGLA+D        V      
Sbjct: 171 SQVAQGMAFL--ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARL 228

Query: 260 --RVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEML-LGRRAVDKSRPSREHNLVEWA 316
             + M      APE +     T +SDV+ +G++L E+  LG        P          
Sbjct: 229 PVKWM------APESIFDCVYTVQSDVWSYGILLWEIFSLGL------NPY--------- 267

Query: 317 RPLLNNNKKVLRILDPRLEGQYTAR---TAMKVAGLAYQCLSQNPKGRPVMSDVVALLET 373
            P +  N K  +++    +G   A+       +  +   C +  P  RP    + + L+ 
Sbjct: 268 -PGILVNSKFYKLVK---DGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQE 323

Query: 374 VQSQGAEEE 382
              +   E 
Sbjct: 324 QAQEDRRER 332

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  123 bits (310), Expect = 6e-32
 Identities = 61/304 (20%), Positives = 109/304 (35%), Gaps = 66/304 (21%)

Query: 94  FRPDY----ILGEGGFGVVYKGVIDENVRPGYKTT--FVAIKELNRGGYQGDREWL-AEV 146
           +  D+    +LG+G FG V K                + AIK++     +     + +EV
Sbjct: 4   YASDFEEIAVLGQGAFGQVVKAR--------NALDSRYYAIKKIRH--TEEKLSTILSEV 53

Query: 147 NYLGQLRHSNLVKLIGYCCEDEHRI-------------LVYEYMESGSLEKHLLRRVGCM 193
             L  L H  +V+      E  + +             +  EY E+G+L   +       
Sbjct: 54  MLLASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSE-NLN 112

Query: 194 LTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAK------ 247
                  ++     + L+++H   + +I+RD K  NI ++   + K+ DFGLAK      
Sbjct: 113 QQRDEYWRLFRQILEALSYIH--SQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSL 170

Query: 248 -------DGPMGDQTHVSTRVMGTYGYAAPEYVM--TGHLTARSDVYGFGVVLLEMLLGR 298
                      G   ++++ + GT  Y A E V+  TGH   + D+Y  G++  EM+   
Sbjct: 171 DILKLDSQNLPGSSDNLTSAI-GTAMYVATE-VLDGTGHYNEKIDMYSLGIIFFEMIYP- 227

Query: 299 RAVDKSRPSREHNLVEWARPLLNNNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNP 358
                   S     V     +L   + V     P  +             +    +  +P
Sbjct: 228 -------FSTGMERVN----ILKKLRSVSIEFPPDFDDNKMK----VEKKIIRLLIDHDP 272

Query: 359 KGRP 362
             RP
Sbjct: 273 NKRP 276

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  123 bits (310), Expect = 6e-32
 Identities = 69/332 (20%), Positives = 126/332 (37%), Gaps = 52/332 (15%)

Query: 50  GSQVTPKNVTPVPPKKNVNDLRQNPGYSNVDIFTYNEMKLATKFFRPDYILGEGGFGVVY 109
             Q       PVP  +    LR + GY+ +  F   +             +G G F  VY
Sbjct: 2   DEQSQGMQGPPVPQFQPQKALRPDMGYNTLANFRIEKK------------IGRGQFSEVY 49

Query: 110 KGVIDENVRPGYKTTFVAIKELNRGGYQGDRE---WLAEVNYLGQLRHSNLVKLIGYCCE 166
           +      +  G     VA+K++        +     + E++ L QL H N++K      E
Sbjct: 50  RA---ACLLDG---VPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIE 103

Query: 167 DEHRILVYEYMESGSLEKHL--LRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRD 224
           D    +V E  ++G L + +   ++   ++      K  +     L  +H   R V++RD
Sbjct: 104 DNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMH--SRRVMHRD 161

Query: 225 FKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDV 284
            K +N+ + A    KL D GL +      +T  +  ++GT  Y +PE +       +SD+
Sbjct: 162 IKPANVFITATGVVKLGDLGLGRF--FSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDI 219

Query: 285 YGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRIL----DPRLEGQYTA 340
           +  G +L EM   +                +    +N      +I      P     Y+ 
Sbjct: 220 WSLGCLLYEMAALQSP--------------FYGDKMNLYSLCKKIEQCDYPPLPSDHYSE 265

Query: 341 RTAMKVAGLAYQCLSQNPKGRPVMSDVVALLE 372
               ++  L   C++ +P+ RP   DV  + +
Sbjct: 266 ----ELRQLVNMCINPDPEKRP---DVTYVYD 290

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score =  123 bits (311), Expect = 8e-32
 Identities = 58/223 (26%), Positives = 101/223 (45%), Gaps = 32/223 (14%)

Query: 100 LGEGGFGVVYKG-VIDENVRPGYKTTFVAIKELNRGGYQGDR-EWLAEVNYLGQL-RHSN 156
           LGEG FG V     +  +     +   VA+K L     + D  + ++E+  +  + +H N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102

Query: 157 LVKLIGYCCEDEHRILVYEYMESGSLEKHLLRR--------------VGCMLTWSRRMKI 202
           ++ L+G C +D    ++ EY   G+L ++L  R                  +T+   +  
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162

Query: 203 ALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVST--- 259
               A+G+ +L  A +  I+RD    N+L+  +   K++DFGLA+D    D    +T   
Sbjct: 163 TYQLARGMEYL--ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGR 220

Query: 260 ---RVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEML-LGR 298
              + M      APE +     T +SDV+ FGV++ E+  LG 
Sbjct: 221 LPVKWM------APEALFDRVYTHQSDVWSFGVLMWEIFTLGG 257

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score =  124 bits (313), Expect = 8e-32
 Identities = 71/311 (22%), Positives = 127/311 (40%), Gaps = 55/311 (17%)

Query: 99  ILGEGGFGVVYKG-VIDENVRPGYKTTFVAIKELNRGGYQGDR-EWLAEVNYLGQL-RHS 155
            LGEG FG V     +  +     +   VA+K L     + D  + ++E+  +  + +H 
Sbjct: 88  PLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHK 147

Query: 156 NLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRR--------------VGCMLTWSRRMK 201
           N++ L+G C +D    ++ EY   G+L ++L  R                  +T+   + 
Sbjct: 148 NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVS 207

Query: 202 IALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVST-- 259
                A+G+ +L  A +  I+RD    N+L+  +   K++DFGLA+D    D    +T  
Sbjct: 208 CTYQLARGMEYL--ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 265

Query: 260 ----RVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEML-LGRRAVDKSRPSREHNLVE 314
               + M      APE +     T +SDV+ FGV++ E+  LG        P        
Sbjct: 266 RLPVKWM------APEALFDRVYTHQSDVWSFGVLMWEIFTLGG------SPYPGI---- 309

Query: 315 WARPLLNNNKKVLRILDPRLEGQYTARTA---MKVAGLAYQCLSQNPKGRPVMSDVVALL 371
                    +++ ++L    EG    + A    ++  +   C    P  RP    +V  L
Sbjct: 310 -------PVEELFKLLK---EGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 359

Query: 372 ETVQSQGAEEE 382
           + + +    EE
Sbjct: 360 DRILTLTTNEE 370

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  122 bits (308), Expect = 9e-32
 Identities = 61/206 (29%), Positives = 93/206 (45%), Gaps = 20/206 (9%)

Query: 100 LGEGGFGVVYKGVIDENV-RPGYKTTFVAIKELNRGGYQGDREWLA----EVNYLGQLRH 154
           LG GG   VY    D  +         VAIK +     +   E L     EV+   QL H
Sbjct: 19  LGGGGMSTVYLAE-DTILNIK------VAIKAI-FIPPREKEETLKRFEREVHNSSQLSH 70

Query: 155 SNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLH 214
            N+V +I    ED+   LV EY+E  +L    +   G  L+    +        G+   H
Sbjct: 71  QNIVSMIDVDEEDDCYYLVMEYIEGPTL-SEYIESHG-PLSVDTAINFTNQILDGIKHAH 128

Query: 215 GAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVST-RVMGTYGYAAPEYV 273
                +++RD K  NIL++++ + K+ DFG+AK   + + +   T  V+GT  Y +PE  
Sbjct: 129 DMR--IVHRDIKPQNILIDSNKTLKIFDFGIAK--ALSETSLTQTNHVLGTVQYFSPEQA 184

Query: 274 MTGHLTARSDVYGFGVVLLEMLLGRR 299
                   +D+Y  G+VL EML+G  
Sbjct: 185 KGEATDECTDIYSIGIVLYEMLVGEP 210

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  122 bits (309), Expect = 9e-32
 Identities = 58/205 (28%), Positives = 81/205 (39%), Gaps = 18/205 (8%)

Query: 100 LGEGGFGVVYKGVIDENV-RPGYKTTFVAIKELNRGGYQGDREWLA----EVNYLGQLRH 154
           +G GG G VY+   D    R       VA+K +       D  +      E    G+L+ 
Sbjct: 42  VGRGGMGDVYEAE-DTVRERI------VALKLM-SETLSSDPVFRTRMQREARTAGRLQE 93

Query: 155 SNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLH 214
            ++V +  +   D    +    +    L   +LRR G  L   R + I       L   H
Sbjct: 94  PHVVPIHDFGEIDGQLYVDMRLINGVDL-AAMLRRQGP-LAPPRAVAIVRQIGSALDAAH 151

Query: 215 GAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVM 274
                  +RD K  NIL++AD  A L DFG+A        T +    +GT  Y APE   
Sbjct: 152 --AAGATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGN-TVGTLYYMAPERFS 208

Query: 275 TGHLTARSDVYGFGVVLLEMLLGRR 299
             H T R+D+Y    VL E L G  
Sbjct: 209 ESHATYRADIYALTCVLYECLTGSP 233

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score =  123 bits (310), Expect = 2e-31
 Identities = 63/223 (28%), Positives = 102/223 (45%), Gaps = 32/223 (14%)

Query: 100 LGEGGFGVVYKGV-IDENVRPGYKTTFVAIKELNRGGYQGDR-EWLAEVNYLGQL-RHSN 156
           LGEG FG V     I  +     + T VA+K L     + D  + ++E+  +  + +H N
Sbjct: 77  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 136

Query: 157 LVKLIGYCCEDEHRILVYEYMESGSLEKHLLRR--------------VGCMLTWSRRMKI 202
           ++ L+G C +D    ++ EY   G+L ++L  R                  L+    +  
Sbjct: 137 IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 196

Query: 203 ALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVST--- 259
           A   A+G+ +L  A +  I+RD    N+L+  D   K++DFGLA+D    D    +T   
Sbjct: 197 AYQVARGMEYL--ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGR 254

Query: 260 ---RVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEML-LGR 298
              + M      APE +     T +SDV+ FGV+L E+  LG 
Sbjct: 255 LPVKWM------APEALFDRIYTHQSDVWSFGVLLWEIFTLGG 291

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score =  122 bits (307), Expect = 3e-31
 Identities = 69/317 (21%), Positives = 120/317 (37%), Gaps = 61/317 (19%)

Query: 99  ILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDR-EWLAEVNYLGQL-RHSN 156
           +LG G FG V        +     +  VA+K L       +R   ++E+  + QL  H N
Sbjct: 52  VLGSGAFGKVMNATA-YGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHEN 110

Query: 157 LVKLIGYCCEDEHRILVYEYMESGSLEKHLLRR----------------------VGCML 194
           +V L+G C       L++EY   G L  + LR                          +L
Sbjct: 111 IVNLLGACTLSGPIYLIFEYCCYGDL-LNYLRSKREKFSEDEIEYENQKRLEEEEDLNVL 169

Query: 195 TWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQ 254
           T+   +  A   AKG+ FL    +  ++RD    N+L+      K+ DFGLA+D      
Sbjct: 170 TFEDLLCFAYQVAKGMEFL--EFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSN 227

Query: 255 THVST------RVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEML-LGRRAVDKSRPS 307
             V        + M      APE +  G  T +SDV+ +G++L E+  LG        P 
Sbjct: 228 YVVRGNARLPVKWM------APESLFEGIYTIKSDVWSYGILLWEIFSLGV------NPY 275

Query: 308 REHNLVEWARPLLNNNKKVLRILDP--RLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMS 365
                     P +  +    +++    +++  + A   +    +   C + + + RP   
Sbjct: 276 ----------PGIPVDANFYKLIQNGFKMDQPFYATEEI--YIIMQSCWAFDSRKRPSFP 323

Query: 366 DVVALLETVQSQGAEEE 382
           ++ + L    +   E  
Sbjct: 324 NLTSFLGCQLADAEEAM 340

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  120 bits (303), Expect = 3e-31
 Identities = 61/290 (21%), Positives = 113/290 (38%), Gaps = 34/290 (11%)

Query: 87  MKLATKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGY-QGDREWL-A 144
           M    + +   Y +G G +G   K      +R       +  KEL+ G   + +++ L +
Sbjct: 1   MPSRAEDYEVLYTIGTGSYGRCQK------IRRKSDGKILVWKELDYGSMTEAEKQMLVS 54

Query: 145 EVNYLGQLRHSNLVKLIGYCCEDEHRIL--VYEYMESGSLEKHL--LRRVGCMLTWSRRM 200
           EVN L +L+H N+V+      +  +  L  V EY E G L   +    +    L     +
Sbjct: 55  EVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVL 114

Query: 201 KIALDAAKGLAFLH---GAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHV 257
           ++       L   H        V++RD K +N+ L+   + KL DFGLA+   +   T  
Sbjct: 115 RVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI--LNHDTSF 172

Query: 258 STRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWAR 317
           +   +GT  Y +PE +       +SD++  G +L E+                     A 
Sbjct: 173 AKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFT-------------AF 219

Query: 318 PLLNNNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDV 367
                  K+      R+  +Y+     ++  +  + L+     RP + ++
Sbjct: 220 SQKELAGKIREGKFRRIPYRYSD----ELNEIITRMLNLKDYHRPSVEEI 265

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  125 bits (316), Expect = 4e-31
 Identities = 52/211 (24%), Positives = 90/211 (42%), Gaps = 35/211 (16%)

Query: 100 LGEGGFGVVYKGVIDENV--RPGYKTTFVAIKELNRGGYQGDREWLA----EVNYLGQLR 153
           +  GG G +Y  + D NV  RP      V +K L    + GD E  A    E  +L ++ 
Sbjct: 88  IAHGGLGWIYLAL-DRNVNGRP------VVLKGLV---HSGDAEAQAMAMAERQFLAEVV 137

Query: 154 HSNLVKLIGYCCEDEHRI-----LVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAK 208
           H ++V++  +    +        +V EY+   SL++   ++    L  +  +   L+   
Sbjct: 138 HPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQK----LPVAEAIAYLLEILP 193

Query: 209 GLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYA 268
            L++LH     ++Y D K  NI+L  +   KL D G      + +       + GT G+ 
Sbjct: 194 ALSYLH--SIGLVYNDLKPENIMLTEE-QLKLIDLGAVS--RI-NSFGY---LYGTPGFQ 244

Query: 269 APEYVMTGHLTARSDVYGFGVVLLEMLLGRR 299
           APE ++    T  +D+Y  G  L  + L   
Sbjct: 245 APE-IVRTGPTVATDIYTVGRTLAALTLDLP 274

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  119 bits (299), Expect = 3e-30
 Identities = 56/219 (25%), Positives = 97/219 (44%), Gaps = 21/219 (9%)

Query: 86  EMKLATKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAE 145
           E +    +      +G G FG V++     + + G+     A+K++    ++ +     E
Sbjct: 52  EYREEVHWMTHQPRVGRGSFGEVHRMK---DKQTGF---QCAVKKVRLEVFRVE-----E 100

Query: 146 VNYLGQLRHSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALD 205
           +     L    +V L G   E     +  E +E GSL + L++++GC+    R +     
Sbjct: 101 LVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQ-LIKQMGCL-PEDRALYYLGQ 158

Query: 206 AAKGLAFLHGAERPVIYRDFKTSNILLNAD-FSAKLSDFGLAK---DGPMGDQTHVSTRV 261
           A +GL +LH   R +++ D K  N+LL++D   A L DFG A       +G        +
Sbjct: 159 ALEGLEYLH--TRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYI 216

Query: 262 MGTYGYAAPEYVM-TGHLTARSDVYGFGVVLLEMLLGRR 299
            GT  + APE VM      A+ D++    ++L ML G  
Sbjct: 217 PGTETHMAPEVVMGKPC-DAKVDIWSSCCMMLHMLNGCH 254

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  122 bits (306), Expect = 6e-30
 Identities = 61/212 (28%), Positives = 91/212 (42%), Gaps = 22/212 (10%)

Query: 99  ILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDRE-WLAEVNYLGQLRHSNL 157
            LG GGFG V + +   +   G +   VAIK+  +     +RE W  E+  + +L H N+
Sbjct: 21  RLGTGGFGYVLRWI---HQDTGEQ---VAIKQCRQELSPKNRERWCLEIQIMKKLNHPNV 74

Query: 158 VKLI------GYCCEDEHRILVYEYMESGSLEKHLLRR-VGCMLTWSRRMKIALDAAKGL 210
           V              ++  +L  EY E G L K+L +    C L       +  D +  L
Sbjct: 75  VSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSAL 134

Query: 211 AFLHGAERPVIYRDFKTSNILLNADFSA---KLSDFGLAKDGPMGDQTHVSTRVMGTYGY 267
            +LH  E  +I+RD K  NI+L         K+ D G AK+  +      +  V GT  Y
Sbjct: 135 RYLH--ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKE--LDQGELCTEFV-GTLQY 189

Query: 268 AAPEYVMTGHLTARSDVYGFGVVLLEMLLGRR 299
            APE +     T   D + FG +  E + G R
Sbjct: 190 LAPELLEQKKYTVTVDYWSFGTLAFECITGFR 221

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  116 bits (293), Expect = 2e-29
 Identities = 40/227 (17%), Positives = 71/227 (31%), Gaps = 17/227 (7%)

Query: 86  EMKLATKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAE 145
           E +L +K     ++LGEG F  VY+     ++          +K                
Sbjct: 59  EFQLGSKLVYVHHLLGEGAFAQVYE-ATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQL 117

Query: 146 VNYLGQLRHSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRR---VGCMLTWSRRMKI 202
           +  L        +K           +LV E    G+L   +         ++     +  
Sbjct: 118 MERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISF 177

Query: 203 ALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSA-----------KLSDFGLAKDGPM 251
           A+     +  +H  E  +I+ D K  N +L   F              L D G + D  +
Sbjct: 178 AMRMLYMIEQVHDCE--IIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKL 235

Query: 252 GDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGR 298
             +  + T    T G+   E +       + D +G    +  ML G 
Sbjct: 236 FPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGT 282

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  114 bits (287), Expect = 8e-29
 Identities = 64/292 (21%), Positives = 106/292 (36%), Gaps = 51/292 (17%)

Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDRE-WLAEVNYLGQLRHSNLV 158
           LG GGFGVV++       +        AIK +     +  RE  + EV  L +L H  +V
Sbjct: 13  LGRGGFGVVFE------AKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIV 66

Query: 159 KLIGYCCEDE---------HRILVY---EYMESGSLEKHL-LRRVGCMLTWSRRMKIALD 205
           +      E            ++ +Y   +     +L+  +  R        S  + I L 
Sbjct: 67  RYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQ 126

Query: 206 AAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAK----------DGPMGDQT 255
            A+ + FLH   + +++RD K SNI    D   K+ DFGL                    
Sbjct: 127 IAEAVEFLH--SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAY 184

Query: 256 HVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEW 315
              T  +GT  Y +PE +     + + D++  G++L E+L           S +      
Sbjct: 185 ARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL--------YPFSTQME---- 232

Query: 316 ARPLLNNNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDV 367
            R     + + L+   P L  Q           +    LS +P  RP   ++
Sbjct: 233 -RVRTLTDVRNLKF--PPLFTQKYP----CEYVMVQDMLSPSPMERPEAINI 277

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  113 bits (285), Expect = 2e-28
 Identities = 54/225 (24%), Positives = 85/225 (37%), Gaps = 31/225 (13%)

Query: 92  KFFRPDYILGEGGFGVVYKGVIDENVRPGYKTT--FVAIKELNRGGYQGDRE-WLAEVNY 148
             +    ILG+G    V++G         +K T    AIK  N   +    +  + E   
Sbjct: 9   HLWLLSDILGQGATANVFRGR--------HKKTGDLFAIKVFNNISFLRPVDVQMREFEV 60

Query: 149 LGQLRHSNLVKLIGY--CCEDEHRILVYEYMESGSLEKHLLRR-VGCMLTWSRRMKIALD 205
           L +L H N+VKL          H++L+ E+   GSL   L        L  S  + +  D
Sbjct: 61  LKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRD 120

Query: 206 AAKGLAFLHGAERPVIYRDFKTSNILL----NADFSAKLSDFGLAKDGPMGDQTHVSTRV 261
              G+  L   E  +++R+ K  NI+     +     KL+DFG A++  + D     +  
Sbjct: 121 VVGGMNHLR--ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE--LEDDEQFVSLY 176

Query: 262 MGTYGYAAPEYVMTGHL--------TARSDVYGFGVVLLEMLLGR 298
            GT  Y  P+      L         A  D++  GV       G 
Sbjct: 177 -GTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  113 bits (284), Expect = 3e-28
 Identities = 61/212 (28%), Positives = 96/212 (45%), Gaps = 26/212 (12%)

Query: 100 LGEGGFGVVYKGVIDENV-RPGYKTTFVAIKELNRGGYQGDREWLA----EVNYLGQLRH 154
           LG GG   V+    D    R       VA+K L R     D  +      E      L H
Sbjct: 20  LGFGGMSEVHLAR-DLRDHRD------VAVKVL-RADLARDPSFYLRFRREAQNAAALNH 71

Query: 155 SNLVKLIGYCCEDEHRI----LVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGL 210
             +V +      +        +V EY++  +L + ++   G  +T  R +++  DA + L
Sbjct: 72  PAIVAVYDTGEAETPAGPLPYIVMEYVDGVTL-RDIVHTEGP-MTPKRAIEVIADACQAL 129

Query: 211 AFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTR---VMGTYGY 267
            F H     +I+RD K +NI+++A  + K+ DFG+A+   + D  +  T+   V+GT  Y
Sbjct: 130 NFSHQNG--IIHRDVKPANIMISATNAVKVMDFGIAR--AIADSGNSVTQTAAVIGTAQY 185

Query: 268 AAPEYVMTGHLTARSDVYGFGVVLLEMLLGRR 299
            +PE      + ARSDVY  G VL E+L G  
Sbjct: 186 LSPEQARGDSVDARSDVYSLGCVLYEVLTGEP 217

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  112 bits (282), Expect = 4e-28
 Identities = 52/206 (25%), Positives = 92/206 (44%), Gaps = 16/206 (7%)

Query: 99  ILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLV 158
           +LG+G +G+VY G    ++        +AIKE+     +  +    E+     L+H N+V
Sbjct: 29  VLGKGTYGIVYAGR---DLSNQV---RIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIV 82

Query: 159 KLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCM-LTWSRRMKIALDAAKGLAFLHGAE 217
           + +G   E+    +  E +  GSL   L  + G +               +GL +LH  +
Sbjct: 83  QYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLH--D 140

Query: 218 RPVIYRDFKTSNILLNA-DFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYV--- 273
             +++RD K  N+L+N      K+SDFG +K   +      +    GT  Y APE +   
Sbjct: 141 NQIVHRDIKGDNVLINTYSGVLKISDFGTSKR--LAGINPCTETFTGTLQYMAPEIIDKG 198

Query: 274 MTGHLTARSDVYGFGVVLLEMLLGRR 299
             G+    +D++  G  ++EM  G+ 
Sbjct: 199 PRGY-GKAADIWSLGCTIIEMATGKP 223

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  113 bits (284), Expect = 8e-28
 Identities = 56/227 (24%), Positives = 89/227 (39%), Gaps = 35/227 (15%)

Query: 92  KFFRPDYILGEGGFGVVYKGVIDENVRPGYKTT--FVAIKELNRGGYQGDRE-WLAEVNY 148
             +    ILG+G    V++G         +K T    AIK  N   +    +  + E   
Sbjct: 9   HLWLLSDILGQGATANVFRGR--------HKKTGDLFAIKVFNNISFLRPVDVQMREFEV 60

Query: 149 LGQLRHSNLVKLIGYCCEDE----HRILVYEYMESGSLEKHLLRR-VGCMLTWSRRMKIA 203
           L +L H N+VKL  +  E+E    H++L+ E+   GSL   L        L  S  + + 
Sbjct: 61  LKKLNHKNIVKL--FAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVL 118

Query: 204 LDAAKGLAFLHGAERPVIYRDFKTSNILL----NADFSAKLSDFGLAKDGPMGDQTHVST 259
            D   G+  L   E  +++R+ K  NI+     +     KL+DFG A++  + D     +
Sbjct: 119 RDVVGGMNHLR--ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE--LEDDEQFVS 174

Query: 260 RVMGTYGYAAPEYVMTGHL--------TARSDVYGFGVVLLEMLLGR 298
              GT  Y  P+      L         A  D++  GV       G 
Sbjct: 175 LY-GTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  112 bits (282), Expect = 9e-28
 Identities = 50/267 (18%), Positives = 98/267 (36%), Gaps = 50/267 (18%)

Query: 63  PKKNVNDLRQNPGYSNVDIFTYNEMKLATKFFRPDYI----LGEGGFGVVYKGVIDENVR 118
           P  ++ D+  N  YSN+        +     +  DY     L +G F  +          
Sbjct: 2   PLGSMKDILSN--YSNLIYLNKYVKE--KDKYINDYRIIRTLNQGKFNKIILCE------ 51

Query: 119 PGYKTTFVAIKELNRGGYQGDREWLA-----------------EVNYLGQLRHSNLVKLI 161
                 F A+K+  +   +  R++                   E+  +  +++   +   
Sbjct: 52  --KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCE 109

Query: 162 GYCCEDEHRI-LVYEYMESGSLEKHLLRRVGCMLTWSRRM------KIALDAAKGLAFLH 214
           G    +   + ++YEYME+ S+ K           ++  +       I        +++H
Sbjct: 110 GII-TNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIH 168

Query: 215 GAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVM 274
             E+ + +RD K SNIL++ +   KLSDFG ++         +     GTY +  PE   
Sbjct: 169 -NEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDK---KIKG-SRGTYEFMPPE-FF 222

Query: 275 TGHLT---ARSDVYGFGVVLLEMLLGR 298
           +   +   A+ D++  G+ L  M    
Sbjct: 223 SNESSYNGAKVDIWSLGICLYVMFYNV 249

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  111 bits (280), Expect = 1e-27
 Identities = 57/299 (19%), Positives = 107/299 (35%), Gaps = 48/299 (16%)

Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLR-HSNLV 158
           L EGGF  VY+       +        A+K L     + +R  + EV ++ +L  H N+V
Sbjct: 36  LAEGGFAFVYE------AQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIV 89

Query: 159 KLIGYCCEDEHR--------ILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGL 210
           +        +          +L+ E  +   +E          L+    +KI     + +
Sbjct: 90  QFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAV 149

Query: 211 AFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLA---KDGPMGDQTHVSTRVM----- 262
             +H  + P+I+RD K  N+LL+   + KL DFG A      P    +     ++     
Sbjct: 150 QHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEIT 209

Query: 263 --GTYGYAAPEYV-MTGHL--TARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWAR 317
              T  Y  PE + +  +     + D++  G +L  +   +   +               
Sbjct: 210 RNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDG------------- 256

Query: 318 PLLNNNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETVQS 376
                    LRI++ +               L    L  NP+ R  +++VV  L+ + +
Sbjct: 257 -------AKLRIVNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAA 308

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  110 bits (278), Expect = 2e-27
 Identities = 59/286 (20%), Positives = 111/286 (38%), Gaps = 49/286 (17%)

Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGD--REWLAEVNYLGQLRHSNL 157
           +G GG   V++ V++E           AIK +N           +  E+ YL +L+  + 
Sbjct: 36  IGSGGSSKVFQ-VLNEK------KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 88

Query: 158 --VKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHG 215
             ++L  Y   D++  +V E      L   L ++    +    R     +  + +  +H 
Sbjct: 89  KIIRLYDYEITDQYIYMVMECGN-IDLNSWLKKKKS--IDPWERKSYWKNMLEAVHTIH- 144

Query: 216 AERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVM- 274
            +  +++ D K +N L+  D   KL DFG+A        + V    +GT  Y  PE +  
Sbjct: 145 -QHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKD 202

Query: 275 ----------TGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARP---LLN 321
                        ++ +SDV+  G +L  M  G+                   P   ++N
Sbjct: 203 MSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK------------------TPFQQIIN 244

Query: 322 NNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDV 367
              K+  I+DP  E ++       +  +   CL ++PK R  + ++
Sbjct: 245 QISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPEL 290

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  111 bits (278), Expect = 6e-27
 Identities = 77/417 (18%), Positives = 148/417 (35%), Gaps = 69/417 (16%)

Query: 42  SPGMKTASGSQVTPKNVTPVPPKKNVNDLRQNPG--YSNVDIFTYNEMKLATKFFRPDYI 99
             GMK  + ++   +++       + +D   +      +V    Y+ +K           
Sbjct: 14  GSGMKETAAAKFERQHMDSPDLGTDDDDKASSSANECISVKGRIYSILKQ---------- 63

Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGD--REWLAEVNYLGQLRHSNL 157
           +G GG   V++ V++E           AIK +N           +  E+ YL +L+  + 
Sbjct: 64  IGSGGSSKVFQ-VLNEK------KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 116

Query: 158 --VKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHG 215
             ++L  Y   D++  +V E      L   L ++    +    R     +  + +  +H 
Sbjct: 117 KIIRLYDYEITDQYIYMVMECGN-IDLNSWLKKKKS--IDPWERKSYWKNMLEAVHTIH- 172

Query: 216 AERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVM- 274
            +  +++ D K +N L+  D   KL DFG+A        + V    +G   Y  PE +  
Sbjct: 173 -QHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKD 230

Query: 275 ----------TGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNK 324
                        ++ +SDV+  G +L  M  G+    +               ++N   
Sbjct: 231 MSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQ---------------IINQIS 275

Query: 325 KVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLE-----------T 373
           K+  I+DP  E ++       +  +   CL ++PK R  + +   LL             
Sbjct: 276 KLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPE---LLAHPYVQIQTHPVN 332

Query: 374 VQSQGAEEEMLQSGGGVVTLYEVPKLSSHNSGDKKRNQSGFSGSTEGESRRRNKPGN 430
             ++G  EEM    G +V L     +        +    G S ++        K G 
Sbjct: 333 QMAKGTTEEMKYVLGQLVGLNSPNSILKAAKTLYEHYSGGESHNSSSSKTFEKKRGK 389

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  109 bits (273), Expect = 1e-26
 Identities = 58/283 (20%), Positives = 113/283 (39%), Gaps = 43/283 (15%)

Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGD--REWLAEVNYLGQLRHSNL 157
           +G GG   V++  ++E           AIK +N           +  E+ YL +L+  + 
Sbjct: 17  IGSGGSSKVFQV-LNEK------KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 69

Query: 158 --VKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHG 215
             ++L  Y   D++  +V E   +  L    L++    +    R     +  + +  +H 
Sbjct: 70  KIIRLYDYEITDQYIYMVMEC-GNIDL-NSWLKKKKS-IDPWERKSYWKNMLEAVHTIH- 125

Query: 216 AERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVM- 274
            +  +++ D K +N L+  D   KL DFG+A        + V    +GT  Y  PE +  
Sbjct: 126 -QHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKD 183

Query: 275 ----------TGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNK 324
                        ++ +SDV+  G +L  M  G+       P        + + ++N   
Sbjct: 184 MSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK------TP--------FQQ-IINQIS 228

Query: 325 KVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDV 367
           K+  I+DP  E ++       +  +   CL ++PK R  + ++
Sbjct: 229 KLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPEL 271

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  107 bits (270), Expect = 1e-26
 Identities = 55/294 (18%), Positives = 96/294 (32%), Gaps = 71/294 (24%)

Query: 100 LGEGGFGVVYKGVIDENVRPGYKTT--FVAIKELNRG--GYQGDREWLAEVNYLGQL-RH 154
           +G G FG V+K V         +      AIK   +   G   ++  L EV     L +H
Sbjct: 19  IGSGEFGSVFKCV--------KRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQH 70

Query: 155 SNLVKLIGYCCEDEHRILVYEYMESGSLEKHLL--RRVGCMLTWSRRMKIALDAAKGLAF 212
           S++V+      ED+H ++  EY   GSL   +    R+      +    + L   +GL +
Sbjct: 71  SHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRY 130

Query: 213 LHGAERPVIYRDFKTSNILLNAD-------------------FSAKLSDFGLAKDGPMGD 253
           +H     +++ D K SNI ++                        K+ D G         
Sbjct: 131 IH--SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVT-----R 183

Query: 254 QTHVSTRVMGTYGYAAPEYVM--TGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHN 311
            +       G   + A E +     HL   +D++   + ++                   
Sbjct: 184 ISSPQVEE-GDSRFLANEVLQENYTHLPK-ADIFALALTVVCAAGA-------------- 227

Query: 312 LVEWARPLLNNNKKVLRILD---PRLEGQYTARTAMKVAGLAYQCLSQNPKGRP 362
                 PL  N  +   I     PR+    +         L    +  +P+ RP
Sbjct: 228 -----EPLPRNGDQWHEIRQGRLPRIPQVLSQ--EFT--ELLKVMIHPDPERRP 272

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  109 bits (275), Expect = 2e-26
 Identities = 60/286 (20%), Positives = 107/286 (37%), Gaps = 42/286 (14%)

Query: 94  FRPDYILGEGGFG-VVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQL 152
           F P  +LG G  G +VY+G+        +    VA+K +    +        EV  L + 
Sbjct: 26  FCPKDVLGHGAEGTIVYRGM--------FDNRDVAVKRILPECFSFADR---EVQLLRES 74

Query: 153 -RHSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLA 211
             H N+++      + + + +  E     +L++++ ++          + +      GLA
Sbjct: 75  DEHPNVIRYFCTEKDRQFQYIAIELCA-ATLQEYVEQK-DFAHLGLEPITLLQQTTSGLA 132

Query: 212 FLHGAERPVIYRDFKTSNILL-----NADFSAKLSDFGLAK--DGPMGDQTHVSTRVMGT 264
            LH     +++RD K  NIL+     +    A +SDFGL K         +  S    GT
Sbjct: 133 HLH--SLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVP-GT 189

Query: 265 YGYAAPEYV---MTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLN 321
            G+ APE +      + T   D++  G V   ++            R+ N++        
Sbjct: 190 EGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANIL-------- 241

Query: 322 NNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDV 367
                L  L P       AR       L  + ++ +P+ RP    V
Sbjct: 242 LGACSLDCLHPEKHEDVIARE------LIEKMIAMDPQKRPSAKHV 281

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  106 bits (267), Expect = 3e-26
 Identities = 56/205 (27%), Positives = 90/205 (43%), Gaps = 23/205 (11%)

Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLA-----EVNYLGQLRH 154
           LG+G FG VY        +  +    +A+K L +   Q ++E +      E+     LRH
Sbjct: 22  LGKGKFGNVYLA---REKQNKF---IMALKVLFKS--QLEKEGVEHQLRREIEIQSHLRH 73

Query: 155 SNLVKLIGYCCEDEHRI-LVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFL 213
            N++++  Y   D  RI L+ E+   G L K L ++ G          +  + A  L + 
Sbjct: 74  PNILRMYNYF-HDRKRIYLMLEFAPRGELYKEL-QKHGRFDEQRSATFME-ELADALHYC 130

Query: 214 HGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYV 273
           H  ER VI+RD K  N+L+      K++DFG +   P   +        GT  Y  PE +
Sbjct: 131 H--ERKVIHRDIKPENLLMGYKGELKIADFGWSVHAP-SLRRRTMC---GTLDYLPPEMI 184

Query: 274 MTGHLTARSDVYGFGVVLLEMLLGR 298
                  + D++  GV+  E L+G 
Sbjct: 185 EGKTHDEKVDLWCAGVLCYEFLVGM 209

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  106 bits (267), Expect = 3e-26
 Identities = 61/204 (29%), Positives = 101/204 (49%), Gaps = 18/204 (8%)

Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQ--GDREWLA-EVNYLGQLRHSN 156
           LG+G F  VY+    E++  G +   VAIK +++      G  + +  EV    QL+H +
Sbjct: 19  LGKGSFAGVYRA---ESIHTGLE---VAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPS 72

Query: 157 LVKLIGYCCEDEHRI-LVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHG 215
           +++L  Y  ED + + LV E   +G + ++L  RV        R  +      G+ +LH 
Sbjct: 73  ILELYNYF-EDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMH-QIITGMLYLH- 129

Query: 216 AERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVM- 274
               +++RD   SN+LL  + + K++DFGLA    M  + H  T + GT  Y +PE    
Sbjct: 130 -SHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKH-YT-LCGTPNYISPEIATR 186

Query: 275 TGHLTARSDVYGFGVVLLEMLLGR 298
           + H    SDV+  G +   +L+GR
Sbjct: 187 SAH-GLESDVWSLGCMFYTLLIGR 209

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  105 bits (265), Expect = 5e-26
 Identities = 54/206 (26%), Positives = 92/206 (44%), Gaps = 25/206 (12%)

Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLA-----EVNYLGQLRH 154
           LG+G FG VY        +  +    +A+K L +   Q ++  +      EV     LRH
Sbjct: 17  LGKGKFGNVYLA---REKQSKF---ILALKVLFKA--QLEKAGVEHQLRREVEIQSHLRH 68

Query: 155 SNLVKLIGYCCEDEHRI-LVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFL 213
            N+++L GY   D  R+ L+ EY   G++ + L +++              + A  L++ 
Sbjct: 69  PNILRLYGYF-HDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTA-TYITELANALSYC 125

Query: 214 HGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVM-GTYGYAAPEY 272
           H   + VI+RD K  N+LL +    K++DFG +   P           + GT  Y  PE 
Sbjct: 126 H--SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP-----SSRRTDLCGTLDYLPPEM 178

Query: 273 VMTGHLTARSDVYGFGVVLLEMLLGR 298
           +       + D++  GV+  E L+G+
Sbjct: 179 IEGRMHDEKVDLWSLGVLCYEFLVGK 204

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  107 bits (268), Expect = 7e-26
 Identities = 58/202 (28%), Positives = 102/202 (50%), Gaps = 18/202 (8%)

Query: 100 LGEGGFGVVYKGVIDENVRPGYKTT--FVAIKELNRGGYQGDREWLA-EVNYLGQLRHSN 156
           LG G  GVV+K          +K +   +A K ++       R  +  E+  L +     
Sbjct: 41  LGAGNGGVVFKVS--------HKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 92

Query: 157 LVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGA 216
           +V   G    D    +  E+M+ GSL++ +L++ G  +      K+++   KGL +L   
Sbjct: 93  IVGFYGAFYSDGEISICMEHMDGGSLDQ-VLKKAGR-IPEQILGKVSIAVIKGLTYLR-E 149

Query: 217 ERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTG 276
           +  +++RD K SNIL+N+    KL DFG++  G + D +  ++ V GT  Y +PE +   
Sbjct: 150 KHKIMHRDVKPSNILVNSRGEIKLCDFGVS--GQLID-SMANSFV-GTRSYMSPERLQGT 205

Query: 277 HLTARSDVYGFGVVLLEMLLGR 298
           H + +SD++  G+ L+EM +GR
Sbjct: 206 HYSVQSDIWSMGLSLVEMAVGR 227

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score =  104 bits (262), Expect = 3e-25
 Identities = 61/216 (28%), Positives = 85/216 (39%), Gaps = 43/216 (19%)

Query: 100 LGEGGFGVVYKGVIDENVRPGYKTT--FVAIKELNRGGYQGDREW-----LAEVNYLGQL 152
           +GEG +GVV+K           + T   VAIK+        D        L E+  L QL
Sbjct: 11  IGEGSYGVVFKCR--------NRDTGQIVAIKKFLESE---DDPVIKKIALREIRMLKQL 59

Query: 153 RHSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAF 212
           +H NLV L+          LV+EY +  ++  H L R    +       I     + + F
Sbjct: 60  KHPNLVNLLEVFRRKRRLHLVFEYCDH-TV-LHELDRYQRGVPEHLVKSITWQTLQAVNF 117

Query: 213 LHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKD--GPMGDQTH-VSTRVMGTYGYAA 269
            H  +   I+RD K  NIL+      KL DFG A+   GP       V+TR      Y +
Sbjct: 118 CH--KHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATR-----WYRS 170

Query: 270 PEYVMTGHLTARSDVYGFGV-------VLLEMLLGR 298
           PE ++          YG  V       V  E+L G 
Sbjct: 171 PELLV------GDTQYGPPVDVWAIGCVFAELLSGV 200

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  104 bits (261), Expect = 3e-25
 Identities = 75/283 (26%), Positives = 121/283 (42%), Gaps = 51/283 (18%)

Query: 91  TKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWL-AEVNYL 149
            + F     +G+G FG V+KG+   + R       VAIK ++    + + E +  E+  L
Sbjct: 21  EELFTKLEKIGKGSFGEVFKGI---DNRTQ---KVVAIKIIDLEEAEDEIEDIQQEITVL 74

Query: 150 GQLRHSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIAL---DA 206
            Q     + K  G   +D    ++ EY+  GS    LL   G +       +IA    + 
Sbjct: 75  SQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSA-LDLLEP-GPL----DETQIATILREI 128

Query: 207 AKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYG 266
            KGL +LH      I+RD K +N+LL+     KL+DFG+A  G + D        +GT  
Sbjct: 129 LKGLDYLH--SEKKIHRDIKAANVLLSEHGEVKLADFGVA--GQLTDTQIKRNTFVGTPF 184

Query: 267 YAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNK-K 325
           + APE +      +++D++  G+  +E+  G        P           P    +  K
Sbjct: 185 WMAPEVIKQSAYDSKADIWSLGITAIELARG-------EP-----------PHSELHPMK 226

Query: 326 VLRILD----PRLEGQYTARTAMK--VAGLAYQCLSQNPKGRP 362
           VL ++     P LEG Y+    +K  V      CL++ P  RP
Sbjct: 227 VLFLIPKNNPPTLEGNYSK--PLKEFVE----ACLNKEPSFRP 263

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  101 bits (255), Expect = 2e-24
 Identities = 55/205 (26%), Positives = 87/205 (42%), Gaps = 21/205 (10%)

Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQ--GDREWLA-EVNYLGQLRHSN 156
           LG+GGF   ++     +          A K + +        RE ++ E++    L H +
Sbjct: 23  LGKGGFAKCFEI---SDADTKEV---FAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQH 76

Query: 157 LVKLIGYCCEDEHRI-LVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHG 215
           +V   G+  ED   + +V E     SL +   RR   +     R         G  +LH 
Sbjct: 77  VVGFHGFF-EDNDFVFVVLELCRRRSLLELHKRR-KALTEPEAR-YYLRQIVLGCQYLH- 132

Query: 216 AERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVM-GTYGYAAPEYVM 274
               VI+RD K  N+ LN D   K+ DFGLA       +     +V+ GT  Y APE + 
Sbjct: 133 -RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERK---KVLCGTPNYIAPEVLS 188

Query: 275 -TGHLTARSDVYGFGVVLLEMLLGR 298
             GH +   DV+  G ++  +L+G+
Sbjct: 189 KKGH-SFEVDVWSIGCIMYTLLVGK 212

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  104 bits (260), Expect = 2e-24
 Identities = 49/233 (21%), Positives = 79/233 (33%), Gaps = 43/233 (18%)

Query: 92  KFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQ 151
                + ILG G  G V      +          VA+K +             E+  L +
Sbjct: 15  NLVVSEKILGYGSSGTVVFQGSFQGRP-------VAVKRMLIDFCDIALM---EIKLLTE 64

Query: 152 L-RHSNLVKLIGYCCEDEHRILVYEYMESGSL-----EKHLLRRVGCMLTWSRRMKIALD 205
              H N+++       D    +  E     +L      K++      +      + +   
Sbjct: 65  SDDHPNVIRYYCSETTDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQ 123

Query: 206 AAKGLAFLHGAERPVIYRDFKTSNILL-------------NADFSAKLSDFGLAK---DG 249
            A G+A LH     +I+RD K  NIL+               +    +SDFGL K    G
Sbjct: 124 IASGVAHLH--SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSG 181

Query: 250 PMGDQTHVSTRVMGTYGYAAPE-------YVMTGHLTARSDVYGFGVVLLEML 295
               +T+++    GT G+ APE             LT   D++  G V   +L
Sbjct: 182 QSSFRTNLNNPS-GTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYIL 233

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score =  102 bits (256), Expect = 2e-24
 Identities = 60/210 (28%), Positives = 90/210 (42%), Gaps = 31/210 (14%)

Query: 100 LGEGGFGVVYKGVIDENVRPGYKTT--FVAIKELNRGGYQGDREW-----LAEVNYLGQL 152
           +GEG +G+V K           K T   VAIK+        D +      + E+  L QL
Sbjct: 33  VGEGSYGMVMKCR--------NKDTGRIVAIKKFLESD---DDKMVKKIAMREIKLLKQL 81

Query: 153 RHSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAF 212
           RH NLV L+  C + +   LV+E+++  ++    L      L +    K       G+ F
Sbjct: 82  RHENLVNLLEVCKKKKRWYLVFEFVDH-TI-LDDLELFPNGLDYQVVQKYLFQIINGIGF 139

Query: 213 LHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKD--GPMGDQTH-VSTRVMGTYGYAA 269
            H     +I+RD K  NIL++     KL DFG A+    P       V+TR      Y A
Sbjct: 140 CH--SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATR-----WYRA 192

Query: 270 PEYVM-TGHLTARSDVYGFGVVLLEMLLGR 298
           PE ++         DV+  G ++ EM +G 
Sbjct: 193 PELLVGDVKYGKAVDVWAIGCLVTEMFMGE 222

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  101 bits (253), Expect = 8e-24
 Identities = 39/307 (12%), Positives = 74/307 (24%), Gaps = 59/307 (19%)

Query: 99  ILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREW---LAEVNYLGQLRHS 155
            L  G   VV+      +V         A+K    G      E            +L   
Sbjct: 69  PLRVGDRSVVFLVR---DVERLED---FALKVFTMGAENSRSELERLHEATFAAARLLGE 122

Query: 156 NLVKLIGYC--------------------------CEDEHRILVYEYMESGSLEK--HLL 187
           +  +                                   + +L+        LE     L
Sbjct: 123 SPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTL 181

Query: 188 RRVGCM---LTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFG 244
             V              +     +  A L    + +++  F   N+ +  D    L D  
Sbjct: 182 DFVYVFRGDEGILALHILTAQLIRLAANLQ--SKGLVHGHFTPDNLFIMPDGRLMLGDVS 239

Query: 245 LAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHL--TARSDVYGFGVVLLEMLLGRRAVD 302
                 +G +   S+       YA  E++       T   + +  G+ +  +        
Sbjct: 240 ALW--KVGTRGPASS---VPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFG 294

Query: 303 KSRPSREHNLVEWARPLLNNNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRP 362
              P  +     W RP L             L           V  L  + L+ + + R 
Sbjct: 295 LVTPGIKG---SWKRPSL------RVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRL 345

Query: 363 VMSDVVA 369
           +  + + 
Sbjct: 346 LPLEAME 352

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  100 bits (251), Expect = 1e-23
 Identities = 55/205 (26%), Positives = 87/205 (42%), Gaps = 21/205 (10%)

Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQ--GDREWLA-EVNYLGQLRHSN 156
           LG+GGF   ++     +          A K + +        RE ++ E++    L H +
Sbjct: 49  LGKGGFAKCFEI---SDADTKEV---FAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQH 102

Query: 157 LVKLIGYCCEDEHRI-LVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHG 215
           +V   G+  ED   + +V E     SL +   RR   +     R         G  +LH 
Sbjct: 103 VVGFHGFF-EDNDFVFVVLELCRRRSLLELHKRR-KALTEPEAR-YYLRQIVLGCQYLH- 158

Query: 216 AERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVM-GTYGYAAPEYVM 274
               VI+RD K  N+ LN D   K+ DFGLA       +     +V+ GT  Y APE + 
Sbjct: 159 -RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERK---KVLCGTPNYIAPEVLS 214

Query: 275 -TGHLTARSDVYGFGVVLLEMLLGR 298
             GH +   DV+  G ++  +L+G+
Sbjct: 215 KKGH-SFEVDVWSIGCIMYTLLVGK 238

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score = 99.7 bits (249), Expect = 1e-23
 Identities = 53/213 (24%), Positives = 93/213 (43%), Gaps = 25/213 (11%)

Query: 91  TKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLG 150
            K +     +G+G  G VY  +   +V  G +   VAI+++N          + E+  + 
Sbjct: 19  KKKYTRFEKIGQGASGTVYTAM---DVATGQE---VAIRQMNLQQQPKKELIINEILVMR 72

Query: 151 QLRHSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMK------IAL 204
           + ++ N+V  +      +   +V EY+  GSL           +     M       +  
Sbjct: 73  ENKNPNIVNYLDSYLVGDELWVVMEYLAGGSL---------TDVVTETCMDEGQIAAVCR 123

Query: 205 DAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGT 264
           +  + L FLH     VI+RD K+ NILL  D S KL+DFG      +  +    + ++GT
Sbjct: 124 ECLQALEFLH--SNQVIHRDIKSDNILLGMDGSVKLTDFGFC--AQITPEQSKRSTMVGT 179

Query: 265 YGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLG 297
             + APE V       + D++  G++ +EM+ G
Sbjct: 180 PYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEG 212

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score =  102 bits (255), Expect = 2e-23
 Identities = 62/206 (30%), Positives = 89/206 (43%), Gaps = 20/206 (9%)

Query: 99  ILGEGGFGVVYKGVIDENVRPGYKTT--FVAIKELNRGGYQGDREW---LAEVNYLGQLR 153
           +LG+GGFG V         +   + T    A K+L +   +  +     L E   L ++ 
Sbjct: 191 VLGKGGFGEVCA------CQ--VRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVN 242

Query: 154 HSNLVKLIGYCCEDEHRI-LVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAF 212
              +V L  Y  E +  + LV   M  G L+ H+          +R +  A +   GL  
Sbjct: 243 SRFVVSLA-YAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLED 301

Query: 213 LHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEY 272
           LH     ++YRD K  NILL+     ++SD GLA   P G       RV GT GY APE 
Sbjct: 302 LH--RERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIK--GRV-GTVGYMAPEV 356

Query: 273 VMTGHLTARSDVYGFGVVLLEMLLGR 298
           V     T   D +  G +L EM+ G+
Sbjct: 357 VKNERYTFSPDWWALGCLLYEMIAGQ 382

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score =  101 bits (253), Expect = 3e-23
 Identities = 60/215 (27%), Positives = 89/215 (41%), Gaps = 35/215 (16%)

Query: 99  ILGEGGFGVVYKGVIDENVRPGYKTT--FVAIKELNRGGYQGDREW---LAEVNYLGQLR 153
           +LG GGFG V+        +   K T    A K+LN+   +  + +   + E   L ++ 
Sbjct: 192 VLGRGGFGEVFA------CQ--MKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVH 243

Query: 154 HSNLVKLIGYCCEDEHRI-LVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAK---- 208
              +V L  Y  E +  + LV   M  G +  H+                    A     
Sbjct: 244 SRFIVSLA-YAFETKTDLCLVMTIMNGGDIRYHIYNVD------EDNPGFQEPRAIFYTA 296

Query: 209 ----GLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGT 264
               GL  LH  +R +IYRD K  N+LL+ D + ++SD GLA +   G          GT
Sbjct: 297 QIVSGLEHLH--QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK-TKGYA-GT 352

Query: 265 YGYAAPEYVMTGHLTARS-DVYGFGVVLLEMLLGR 298
            G+ APE ++ G     S D +  GV L EM+  R
Sbjct: 353 PGFMAPE-LLLGEEYDFSVDYFALGVTLYEMIAAR 386

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score = 98.8 bits (247), Expect = 3e-23
 Identities = 59/209 (28%), Positives = 100/209 (47%), Gaps = 25/209 (11%)

Query: 100 LGEGGFGVVYKGVIDENVRPGYKTT--FVAIKELNRGGYQG-DREWLAEVNYLGQLRHSN 156
           LG G +  VYKG ++       KTT  +VA+KE+     +G     + E++ + +L+H N
Sbjct: 13  LGNGTYATVYKG-LN-------KTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHEN 64

Query: 157 LVKLIGYCCEDEHRILVYEYMES---GSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFL 213
           +V+L      +    LV+E+M++     ++   +      L  +          +GLAF 
Sbjct: 65  IVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFC 124

Query: 214 HGAERPVIYRDFKTSNILLNADFSAKLSDFGLA--KDGPMGDQTHVSTRVMGTYGYAAPE 271
           H  E  +++RD K  N+L+N     KL DFGLA     P+   +     V+ T  Y AP+
Sbjct: 125 H--ENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSS---EVV-TLWYRAPD 178

Query: 272 YVMTG--HLTARSDVYGFGVVLLEMLLGR 298
            V+ G    +   D++  G +L EM+ G+
Sbjct: 179 -VLMGSRTYSTSIDIWSCGCILAEMITGK 206

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  100 bits (249), Expect = 4e-23
 Identities = 38/299 (12%), Positives = 77/299 (25%), Gaps = 72/299 (24%)

Query: 99  ILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGD---REWLAEVNYLGQLR-- 153
           +LG+       +    E            +              ++   EV  L  LR  
Sbjct: 85  VLGQEDPYAYLEATDQETGES------FEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGI 138

Query: 154 --------------------HSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCM 193
                                    K+I    ++    ++  +     ++ +L      +
Sbjct: 139 KNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVL 198

Query: 194 ---------LTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFG 244
                    L    R+++ L   + LA LH     +++   +  +I+L+      L+ F 
Sbjct: 199 LSHSSTHKSLVHHARLQLTLQVIRLLASLH--HYGLVHTYLRPVDIVLDQRGGVFLTGFE 256

Query: 245 LAKDGPMGDQTHVSTRVMGTYGYAAPEYVM----------TGHLTARSDVYGFGVVLLEM 294
                  G     S       G+A PE                +T   D +  G+ +  +
Sbjct: 257 HLV--RDGA----SAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWI 310

Query: 295 LLGRRAVDKSRP--------SREHNLVEWARPLLNNNKKVLRILDPRLEGQYTARTAMK 345
                                   N+ +  R L      +   L    E +     AM+
Sbjct: 311 WCADLPNTDDAALGGSEWIFRSCKNIPQPVRAL------LEGFLRYPKEDRLLPLQAME 363

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score = 98.6 bits (246), Expect = 4e-23
 Identities = 49/213 (23%), Positives = 87/213 (40%), Gaps = 25/213 (11%)

Query: 91  TKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLG 150
                    +GEG  G+V           G +   VA+K ++    Q       EV  + 
Sbjct: 44  RLLLDSYVKIGEGSTGIVCLAR---EKHSGRQ---VAVKMMDLRKQQRRELLFNEVVIMR 97

Query: 151 QLRHSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMK------IAL 204
             +H N+V++       E   ++ E+++ G+L           +    R+       +  
Sbjct: 98  DYQHFNVVEMYKSYLVGEELWVLMEFLQGGAL---------TDIVSQVRLNEEQIATVCE 148

Query: 205 DAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGT 264
              + LA+LH   + VI+RD K+ +ILL  D   KLSDFG      +         ++GT
Sbjct: 149 AVLQALAYLH--AQGVIHRDIKSDSILLTLDGRVKLSDFGFC--AQISKDVPKRKSLVGT 204

Query: 265 YGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLG 297
             + APE +         D++  G++++EM+ G
Sbjct: 205 PYWMAPEVISRSLYATEVDIWSLGIMVIEMVDG 237

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score = 98.9 bits (247), Expect = 7e-23
 Identities = 61/278 (21%), Positives = 108/278 (38%), Gaps = 62/278 (22%)

Query: 44  GMKTASGSQVTPKNVTPVPPKKNVNDLRQNPGYSNVDI-FTYNEMKLATKFFRPDYILGE 102
           G  T S + +    + P+     V  +  + G +       Y   K          ++G 
Sbjct: 1   GSFTMSNAPLNGVKLNPLDDPNKVIKVLASDGKTGEQREIAYTNCK----------VIGN 50

Query: 103 GGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVKLIG 162
           G FGVV++  + E       +  VAIK++     Q  R    E+  +  ++H N+V L  
Sbjct: 51  GSFGVVFQAKLVE-------SDEVAIKKV----LQDKRFKNRELQIMRIVKHPNVVDLKA 99

Query: 163 YCCEDEHRI------LVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAK-------- 208
           +   +  +       LV EY+   ++ +              +  + +   K        
Sbjct: 100 FFYSNGDKKDEVFLNLVLEYVPE-TVYRASRHY------AKLKQTMPMLLIKLYMYQLLR 152

Query: 209 GLAFLHGAERPVIYRDFKTSNILLNADFSA-KLSDFGLAK----DGPMGDQTH-VSTRVM 262
            LA++H     + +RD K  N+LL+      KL DFG AK      P       + +R  
Sbjct: 153 SLAYIHSIG--ICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPN---VSYICSR-- 205

Query: 263 GTYGYAAPEYVMTG--HLTARSDVYGFGVVLLEMLLGR 298
             Y Y APE ++ G  + T   D++  G V+ E++ G+
Sbjct: 206 --Y-YRAPE-LIFGATNYTTNIDIWSTGCVMAELMQGQ 239

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score = 97.0 bits (242), Expect = 1e-22
 Identities = 68/282 (24%), Positives = 110/282 (39%), Gaps = 43/282 (15%)

Query: 100 LGEGGFGVVYKGVIDENVRPGYKTT--FVAIKELNRGGYQGDREWLA-EVNYLGQLRHSN 156
           +G G   VV                   VAIK +N    Q   + L  E+  + Q  H N
Sbjct: 23  IGSGATAVVQAAY--------CAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 74

Query: 157 LVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRM----KIAL---DAAKG 209
           +V         +   LV + +  GS+   +++ +         +     IA    +  +G
Sbjct: 75  IVSYYTSFVVKDELWLVMKLLSGGSV-LDIIKHIVAKGEHKSGVLDESTIATILREVLEG 133

Query: 210 LAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGL-AKDGPMGDQTHVSTR--VMGTYG 266
           L +LH  +   I+RD K  NILL  D S +++DFG+ A     GD T    R   +GT  
Sbjct: 134 LEYLH--KNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPC 191

Query: 267 YAAPEYVMTGHL-TARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKK 325
           + APE +        ++D++ FG+  +E+  G     K  P +          L   N  
Sbjct: 192 WMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMK-------VLMLTLQNDP 244

Query: 326 VLRILDPRLEGQYTARTAMKVAGLAY-----QCLSQNPKGRP 362
                 P LE     +  +K  G ++      CL ++P+ RP
Sbjct: 245 ------PSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRP 280

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score = 97.0 bits (242), Expect = 1e-22
 Identities = 63/208 (30%), Positives = 97/208 (46%), Gaps = 15/208 (7%)

Query: 91  TKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWL-AEVNYL 149
            + F     LGEG +G VYK     +   G     VAIK++     + D + +  E++ +
Sbjct: 28  EEVFDVLEKLGEGSYGSVYKA---IHKETGQI---VAIKQVP---VESDLQEIIKEISIM 78

Query: 150 GQLRHSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKG 209
            Q    ++VK  G   ++    +V EY  +GS+   ++R     LT      I     KG
Sbjct: 79  QQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSD-IIRLRNKTLTEDEIATILQSTLKG 137

Query: 210 LAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAA 269
           L +LH      I+RD K  NILLN +  AKL+DFG+A  G + D       V+GT  + A
Sbjct: 138 LEYLH--FMRKIHRDIKAGNILLNTEGHAKLADFGVA--GQLTDTMAKRNTVIGTPFWMA 193

Query: 270 PEYVMTGHLTARSDVYGFGVVLLEMLLG 297
           PE +        +D++  G+  +EM  G
Sbjct: 194 PEVIQEIGYNCVADIWSLGITAIEMAEG 221

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score = 97.3 bits (243), Expect = 1e-22
 Identities = 70/214 (32%), Positives = 105/214 (49%), Gaps = 36/214 (16%)

Query: 100 LGEGGFGVVYKGVIDENVRPGYKTT--FVAIKELNRGGYQGDRE-----WLAEVNYLGQL 152
           LGEG F  VYK   D       K T   VAIK++  G     ++      L E+  L +L
Sbjct: 18  LGEGQFATVYKA-RD-------KNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQEL 69

Query: 153 RHSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAF 212
            H N++ L+       +  LV+++ME+  LE  +++    +LT S      L   +GL +
Sbjct: 70  SHPNIIGLLDAFGHKSNISLVFDFMET-DLEV-IIKDNSLVLTPSHIKAYMLMTLQGLEY 127

Query: 213 LHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAK--DGPMGDQTH-VSTRVMGTYGYAA 269
           LH  +  +++RD K +N+LL+ +   KL+DFGLAK    P    TH V TR      Y A
Sbjct: 128 LH--QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTR-----WYRA 180

Query: 270 PEYVMTGHLTARS-----DVYGFGVVLLEMLLGR 298
           PE ++ G   AR      D++  G +L E+LL  
Sbjct: 181 PE-LLFG---ARMYGVGVDMWAVGCILAELLLRV 210

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score = 96.9 bits (242), Expect = 2e-22
 Identities = 60/204 (29%), Positives = 96/204 (47%), Gaps = 20/204 (9%)

Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQG-DREWLAEVNYLGQLRHSNLV 158
           LGEG +  VYKG              VA+KE+     +G     + EV+ L  L+H+N+V
Sbjct: 10  LGEGTYATVYKGKSKLTDN------LVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIV 63

Query: 159 KLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAER 218
            L      ++   LV+EY++   L++  L   G ++             +GLA+ H   +
Sbjct: 64  TLHDIIHTEKSLTLVFEYLDK-DLKQ-YLDDCGNIINMHNVKLFLFQLLRGLAYCH--RQ 119

Query: 219 PVIYRDFKTSNILLNADFSAKLSDFGLA--KDGPMGDQTHVSTRVMGTYGYAAPEYVMTG 276
            V++RD K  N+L+N     KL+DFGLA  K  P     +    V+ T  Y  P+ ++ G
Sbjct: 120 KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDN---EVV-TLWYRPPD-ILLG 174

Query: 277 --HLTARSDVYGFGVVLLEMLLGR 298
               + + D++G G +  EM  GR
Sbjct: 175 STDYSTQIDMWGVGCIFYEMATGR 198

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score = 96.1 bits (240), Expect = 2e-22
 Identities = 57/212 (26%), Positives = 92/212 (43%), Gaps = 31/212 (14%)

Query: 100 LGEGGFGVVYKGVIDENVRPGYKTT--FVAIKELNRGGYQGDRE-----WLAEVNYLGQL 152
           +GEG +G V+K   +       + T   VA+K +       D E      L E+  L +L
Sbjct: 10  IGEGTYGTVFKA-KN-------RETHEIVALKRVR---LDDDDEGVPSSALREICLLKEL 58

Query: 153 RHSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAF 212
           +H N+V+L      D+   LV+E+ +   L+K         L             KGL F
Sbjct: 59  KHKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKK-YFDSCNGDLDPEIVKSFLFQLLKGLGF 116

Query: 213 LHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKD--GPMGDQTHVSTRVMGTYGYAAP 270
            H   R V++RD K  N+L+N +   KL++FGLA+    P+   +     V+ T  Y  P
Sbjct: 117 CH--SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSA---EVV-TLWYRPP 170

Query: 271 EYVMTG--HLTARSDVYGFGVVLLEMLLGRRA 300
           + V+ G    +   D++  G +  E+    R 
Sbjct: 171 D-VLFGAKLYSTSIDMWSAGCIFAELANAGRP 201

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score = 96.2 bits (240), Expect = 2e-22
 Identities = 50/215 (23%), Positives = 91/215 (42%), Gaps = 22/215 (10%)

Query: 91  TKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLG 150
            + +     LG+G FG VYK     N   G      A K +     +   +++ E+  L 
Sbjct: 18  NEVWEIVGELGDGAFGKVYKAK---NKETG---ALAAAKVIETKSEEELEDYIVEIEILA 71

Query: 151 QLRHSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIAL---DAA 207
              H  +VKL+G    D    ++ E+   G+++  +L     +       +I +      
Sbjct: 72  TCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGL----TEPQIQVVCRQML 127

Query: 208 KGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGY 267
           + L FLH   + +I+RD K  N+L+  +   +L+DFG++               +GT  +
Sbjct: 128 EALNFLH--SKRIIHRDLKAGNVLMTLEGDIRLADFGVS--AKNLKTLQKRDSFIGTPYW 183

Query: 268 AAPEYVMTGHLT-----ARSDVYGFGVVLLEMLLG 297
            APE VM   +       ++D++  G+ L+EM   
Sbjct: 184 MAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQI 218

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score = 96.1 bits (240), Expect = 3e-22
 Identities = 63/209 (30%), Positives = 101/209 (48%), Gaps = 30/209 (14%)

Query: 100 LGEGGFGVVYKGVIDENVRPGYKTT-FVAIKELNRGGYQGDRE-----WLAEVNYLGQLR 153
           +GEG +GVVYK   D            VA+K +       + E      + E++ L +L 
Sbjct: 29  VGEGTYGVVYKA-KD-------SQGRIVALKRIR---LDAEDEGIPSTAIREISLLKELH 77

Query: 154 HSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFL 213
           H N+V LI     +    LV+E+ME   L+K +L      L  S+         +G+A  
Sbjct: 78  HPNIVSLIDVIHSERCLTLVFEFMEK-DLKK-VLDENKTGLQDSQIKIYLYQLLRGVAHC 135

Query: 214 HGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKD--GPMGDQTHVSTRVMGTYGYAAPE 271
           H  +  +++RD K  N+L+N+D + KL+DFGLA+    P+   TH    V+ T  Y AP+
Sbjct: 136 H--QHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTH---EVV-TLWYRAPD 189

Query: 272 YVMTG--HLTARSDVYGFGVVLLEMLLGR 298
            V+ G    +   D++  G +  EM+ G+
Sbjct: 190 -VLMGSKKYSTSVDIWSIGCIFAEMITGK 217

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score = 95.4 bits (238), Expect = 4e-22
 Identities = 56/209 (26%), Positives = 94/209 (44%), Gaps = 25/209 (11%)

Query: 99  ILGEGGFGVVYKGVIDENVRPGYKTT--FVAIKELNRGGYQGDREW---LAEVNYLGQLR 153
           ILGEG F  V         R     T    AIK L +     + +      E + + +L 
Sbjct: 37  ILGEGSFSTVVL------AR--ELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD 88

Query: 154 HSNLVKLIGYCCEDEHRI-LVYEYMESGSLEKHLLRRVGCMLTWSRRMKIA--LDAAKGL 210
           H   VKL  +  +D+ ++     Y ++G L K++ R++G       R   A  + A   L
Sbjct: 89  HPFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYI-RKIGSFDETCTRFYTAEIVSA---L 143

Query: 211 AFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAP 270
            +LH   + +I+RD K  NILLN D   +++DFG AK      +   +   +GT  Y +P
Sbjct: 144 EYLH--GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSP 201

Query: 271 EYVMT-GHLTARSDVYGFGVVLLEMLLGR 298
           E +       + SD++  G ++ +++ G 
Sbjct: 202 ELLTEKSACKS-SDLWALGCIIYQLVAGL 229

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score = 94.9 bits (237), Expect = 5e-22
 Identities = 60/209 (28%), Positives = 102/209 (48%), Gaps = 30/209 (14%)

Query: 100 LGEGGFGVVYKGVIDENVRPGYKTT-FVAIKELNRGGYQGDRE-----WLAEVNYLGQLR 153
           +GEG +GVVYK   +             A+K++     + + E      + E++ L +L+
Sbjct: 10  IGEGTYGVVYKA-QN-------NYGETFALKKIR---LEKEDEGIPSTTIREISILKELK 58

Query: 154 HSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFL 213
           HSN+VKL       +  +LV+E+++   L+K LL      L         L    G+A+ 
Sbjct: 59  HSNIVKLYDVIHTKKRLVLVFEHLDQ-DLKK-LLDVCEGGLESVTAKSFLLQLLNGIAYC 116

Query: 214 HGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKD--GPMGDQTHVSTRVMGTYGYAAPE 271
           H  +R V++RD K  N+L+N +   K++DFGLA+    P+   TH    ++ T  Y AP+
Sbjct: 117 H--DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTH---EIV-TLWYRAPD 170

Query: 272 YVMTG--HLTARSDVYGFGVVLLEMLLGR 298
            V+ G    +   D++  G +  EM+ G 
Sbjct: 171 -VLMGSKKYSTTIDIWSVGCIFAEMVNGT 198

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score = 94.6 bits (236), Expect = 6e-22
 Identities = 67/278 (24%), Positives = 117/278 (42%), Gaps = 48/278 (17%)

Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREW-LAEVN-YLGQLRHSNL 157
           LG G +GVV K     +V  G     +A+K +       +++  L +++  +  +     
Sbjct: 15  LGRGAYGVVEKMR---HVPSG---QIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFT 68

Query: 158 VKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRM------KIALDAAKGLA 211
           V   G    +    +  E M+  SL+K   ++V   +   + +      KIA+   K L 
Sbjct: 69  VTFYGALFREGDVWICMELMD-TSLDK-FYKQV---IDKGQTIPEDILGKIAVSIVKALE 123

Query: 212 FLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPE 271
            LH ++  VI+RD K SN+L+NA    K+ DFG++  G + D         G   Y APE
Sbjct: 124 HLH-SKLSVIHRDVKPSNVLINALGQVKMCDFGIS--GYLVD-DVAKDIDAGCKPYMAPE 179

Query: 272 YVMTGHL----TARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARP--LLNNNKK 325
            +         + +SD++  G+ ++E+ + R                W  P   L    +
Sbjct: 180 RINPELNQKGYSVKSDIWSLGITMIELAILR-----------FPYDSWGTPFQQLK---Q 225

Query: 326 VLRILDPRL-EGQYTARTAMKVAGLAYQCLSQNPKGRP 362
           V+    P+L   +++A      +    QCL +N K RP
Sbjct: 226 VVEEPSPQLPADKFSAEFVDFTS----QCLKKNSKERP 259

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score = 95.5 bits (238), Expect = 6e-22
 Identities = 55/211 (26%), Positives = 88/211 (41%), Gaps = 26/211 (12%)

Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREW-LAEVN-YLGQLRHSNL 157
           +G G +G V K V   +   G     +A+K +     + +++  L +++  +       +
Sbjct: 30  IGRGAYGSVNKMV---HKPSG---QIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYI 83

Query: 158 VKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRM------KIALDAAKGLA 211
           V+  G    +    +  E M   S +K   + V         +      KI L   K L 
Sbjct: 84  VQFYGALFREGDCWICMELMS-TSFDK-FYKYV--YSVLDDVIPEEILGKITLATVKALN 139

Query: 212 FLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPE 271
            L      +I+RD K SNILL+   + KL DFG++  G + D +   TR  G   Y APE
Sbjct: 140 HLK-ENLKIIHRDIKPSNILLDRSGNIKLCDFGIS--GQLVD-SIAKTRDAGCRPYMAPE 195

Query: 272 YVMTGHL----TARSDVYGFGVVLLEMLLGR 298
            +           RSDV+  G+ L E+  GR
Sbjct: 196 RIDPSASRQGYDVRSDVWSLGITLYELATGR 226

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 96.0 bits (239), Expect = 8e-22
 Identities = 51/229 (22%), Positives = 98/229 (42%), Gaps = 30/229 (13%)

Query: 88  KLATKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVN 147
           ++   F      +G G +G VYK       + G      A+K++   G         E+ 
Sbjct: 17  RVEDLFEYEGCKVGRGTYGHVYKAK----RKDGKDDKDYALKQIEGTGI--SMSACREIA 70

Query: 148 YLGQLRHSNLVKLIGYCCED-EHRI-LVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALD 205
            L +L+H N++ L        + ++ L+++Y E   L  H+++         + +++   
Sbjct: 71  LLRELKHPNVISLQKVFLSHADRKVWLLFDYAEH-DL-WHIIKFHRASKANKKPVQLPRG 128

Query: 206 AAK--------GLAFLHGAERPVIYRDFKTSNILLNADFSA----KLSDFGLAK--DGPM 251
             K        G+ +LH     V++RD K +NIL+  +       K++D G A+  + P+
Sbjct: 129 MVKSLLYQILDGIHYLH--ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPL 186

Query: 252 GDQTHVSTRVMGTYGYAAPEYVMTG--HLTARSDVYGFGVVLLEMLLGR 298
                +   V+ T+ Y APE ++ G  H T   D++  G +  E+L   
Sbjct: 187 KPLADLDPVVV-TFWYRAPE-LLLGARHYTKAIDIWAIGCIFAELLTSE 233

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score = 95.4 bits (237), Expect = 1e-21
 Identities = 45/216 (20%), Positives = 74/216 (34%), Gaps = 35/216 (16%)

Query: 101 GEGGFGVVYKGVIDENVRPGYKTT--FVAIKELNRGGYQGDR--EWLAEVNYLGQLRHSN 156
           G      V            YK T  +V ++ +N      +       E++      H N
Sbjct: 36  GFEDLMTVNLAR--------YKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPN 87

Query: 157 LVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMK---IAL---DAAKGL 210
           +V        D    +V  +M  GS  K L+        +   M    IA       K L
Sbjct: 88  IVPYRATFIADNELWVVTSFMAYGSA-KDLICT-----HFMDGMNELAIAYILQGVLKAL 141

Query: 211 AFLHGAERPVIYRDFKTSNILLNADFSAKLSDFG----LAKDGPMGDQTHVSTRVM-GTY 265
            ++H      ++R  K S+IL++ D    LS       +   G      H   +      
Sbjct: 142 DYIH--HMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVL 199

Query: 266 GYAAPEYVMTGHL---TARSDVYGFGVVLLEMLLGR 298
            + +PE V+  +L    A+SD+Y  G+   E+  G 
Sbjct: 200 PWLSPE-VLQQNLQGYDAKSDIYSVGITACELANGH 234

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score = 93.5 bits (233), Expect = 1e-21
 Identities = 61/219 (27%), Positives = 94/219 (42%), Gaps = 30/219 (13%)

Query: 91  TKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTT--FVAIKELNRGGYQGDREWLA-EVN 147
              F     LG G FG V+            +++     IK +N+   Q   E +  E+ 
Sbjct: 21  DDLFIFKRKLGSGAFGDVHLVE--------ERSSGLERVIKTINKDRSQVPMEQIEAEIE 72

Query: 148 YLGQLRHSNLVKLIGYCCEDEHRI-LVYEYMESGSLEKHLLRRVGCMLTWSRR-----MK 201
            L  L H N++K+     ED H + +V E  E G L + ++         S       MK
Sbjct: 73  VLKSLDHPNIIKIFEV-FEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMK 131

Query: 202 IALDAAKGLAFLHGAERPVIYRDFKTSNILL---NADFSAKLSDFGLAKDGPMGDQTHVS 258
             ++A   LA+ H   + V+++D K  NIL    +     K+ DFGLA+   +      S
Sbjct: 132 QMMNA---LAYFH--SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAE---LFKSDEHS 183

Query: 259 TRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLG 297
           T   GT  Y APE V    +T + D++  GVV+  +L G
Sbjct: 184 TNAAGTALYMAPE-VFKRDVTFKCDIWSAGVVMYFLLTG 221

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score = 95.1 bits (236), Expect = 1e-21
 Identities = 23/245 (9%), Positives = 61/245 (24%), Gaps = 59/245 (24%)

Query: 99  ILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDRE----------------- 141
           +LG+       +     +   G       +                              
Sbjct: 80  VLGQEDPYAYLEAT---DQETGES---FEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGI 133

Query: 142 -----------WLAEVNYLGQLRHSNLVKLIGYCCEDEHRILVYEYM-ESGSLEKHL--- 186
                      ++   + +   +   ++++     +       + Y     +L+      
Sbjct: 134 KNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVL 193

Query: 187 --LRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFG 244
                    L    R+++ L   + LA LH     +++   +  +I+L+      L+ F 
Sbjct: 194 LSHSSTHKSLVHHARLQLTLQVIRLLASLH--HYGLVHTYLRPVDIVLDQRGGVFLTGFE 251

Query: 245 LAKDGPMGDQTHVSTRVMGTYGYAAPEYVMT-----------GHLTARSDVYGFGVVLLE 293
                    +         + G+  PE                 +T   D +  G+V+  
Sbjct: 252 HLV------RDGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYW 305

Query: 294 MLLGR 298
           +    
Sbjct: 306 IWCAD 310

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score = 96.3 bits (240), Expect = 1e-21
 Identities = 61/259 (23%), Positives = 99/259 (38%), Gaps = 42/259 (16%)

Query: 55  PKNVTPVPPKKNVNDLRQNPGYSNVDIFTYNEMKLATKFFRPDYILGEGGFGVVYKGVID 114
             + +         DL+  PG     +F  ++    ++ ++    LG G +G V      
Sbjct: 5   HHHSSGRENLYFQGDLQATPG-----MFITSKKGHLSEMYQRVKKLGSGAYGEVLLCR-- 57

Query: 115 ENVRPGYKTT--FVAIKELNRGGYQG-DREWLA-EVNYLGQLRHSNLVKLIGYCCEDEHR 170
                  K T    AIK + +          L  EV  L  L H N++KL  +  ED+  
Sbjct: 58  ------DKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDF-FEDKRN 110

Query: 171 I-LVYEYMESGSL------EKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYR 223
             LV E  + G L                ++     +K  L     + +LH  +  +++R
Sbjct: 111 YYLVMECYKGGELFDEIIHRMKFNEVDAAVI-----IKQVLSG---VTYLH--KHNIVHR 160

Query: 224 DFKTSNILL---NADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTA 280
           D K  N+LL     D   K+ DFGL+    + +        +GT  Y APE V+      
Sbjct: 161 DLKPENLLLESKEKDALIKIVDFGLSA---VFENQKKMKERLGTAYYIAPE-VLRKKYDE 216

Query: 281 RSDVYGFGVVLLEMLLGRR 299
           + DV+  GV+L  +L G  
Sbjct: 217 KCDVWSIGVILFILLAGYP 235

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score = 94.0 bits (234), Expect = 1e-21
 Identities = 51/206 (24%), Positives = 91/206 (44%), Gaps = 19/206 (9%)

Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREW-LAEVNYL-GQLRHSNL 157
           +G G  G V+K       + G     +A+K++ R G + + +  L +++ +        +
Sbjct: 33  MGSGTCGQVWKMR---FRKTG---HVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYI 86

Query: 158 VKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAE 217
           V+  G    +    +  E M + + +  L +R+   +      K+ +   K L +L   +
Sbjct: 87  VQCFGTFITNTDVFIAMELMGTCAEK--LKKRMQGPIPERILGKMTVAIVKALYYLK-EK 143

Query: 218 RPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGH 277
             VI+RD K SNILL+     KL DFG++  G + D      R  G   Y APE +    
Sbjct: 144 HGVIHRDVKPSNILLDERGQIKLCDFGIS--GRLVD-DKAKDRSAGCAAYMAPERIDPPD 200

Query: 278 L-----TARSDVYGFGVVLLEMLLGR 298
                   R+DV+  G+ L+E+  G+
Sbjct: 201 PTKPDYDIRADVWSLGISLVELATGQ 226

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score = 95.9 bits (239), Expect = 1e-21
 Identities = 62/251 (24%), Positives = 106/251 (42%), Gaps = 43/251 (17%)

Query: 63  PKKNVNDLRQNPGYSNVDIFTYNEMKLATKFFRPDYILGEGGFGVVYKGVIDENVRPGYK 122
           P   ++ L   P      +F  +   + +  ++   +LG+G FG V             K
Sbjct: 2   PGSMMDHLHATP-----GMFVQHSTAIFSDRYKGQRVLGKGSFGEVILCK--------DK 48

Query: 123 TT--FVAIKELNRGGYQG--DREWLA-EVNYLGQLRHSNLVKLIGYCCEDEHRI-LVYEY 176
            T    A+K +++   +   D+E L  EV  L QL H N++KL  +  ED+    LV E 
Sbjct: 49  ITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEF-FEDKGYFYLVGEV 107

Query: 177 MESGSL------EKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNI 230
              G L       K         +     ++  L     + ++H  +  +++RD K  N+
Sbjct: 108 YTGGELFDEIISRKRFSEVDAARI-----IRQVLSG---ITYMH--KNKIVHRDLKPENL 157

Query: 231 LL---NADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGF 287
           LL   + D + ++ DFGL+      + +      +GT  Y APE V+ G    + DV+  
Sbjct: 158 LLESKSKDANIRIIDFGLST---HFEASKKMKDKIGTAYYIAPE-VLHGTYDEKCDVWST 213

Query: 288 GVVLLEMLLGR 298
           GV+L  +L G 
Sbjct: 214 GVILYILLSGC 224

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score = 96.9 bits (241), Expect = 1e-21
 Identities = 62/214 (28%), Positives = 91/214 (42%), Gaps = 35/214 (16%)

Query: 99  ILGEGGFGVVYKGVIDENVRPGYKTT--FVAIKELN------RGGYQ---GDREWLAEVN 147
           I+G GGFG VY        R     T    A+K L+      + G      +R  L+ V+
Sbjct: 196 IIGRGGFGEVYG------CR--KADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVS 247

Query: 148 YLGQLRHSNLVKLIGYCCEDEHRI-LVYEYMESGSLEKHLLRRVGCMLTWSRRMKI-ALD 205
                    +V +  Y      ++  + + M  G L  HL  + G        M+  A +
Sbjct: 248 ---TGDCPFIVCMS-YAFHTPDKLSFILDLMNGGDLHYHL-SQHGVFS--EADMRFYAAE 300

Query: 206 AAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTY 265
              GL  +H   R V+YRD K +NILL+     ++SD GLA D     + H    V GT+
Sbjct: 301 IILGLEHMH--NRFVVYRDLKPANILLDEHGHVRISDLGLACDFS-KKKPH--ASV-GTH 354

Query: 266 GYAAPEYVMTGHLTARS-DVYGFGVVLLEMLLGR 298
           GY APE +  G     S D +  G +L ++L G 
Sbjct: 355 GYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGH 388

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score = 93.6 bits (233), Expect = 3e-21
 Identities = 68/261 (26%), Positives = 108/261 (41%), Gaps = 38/261 (14%)

Query: 48  ASGSQVTPKNVTPVPPKKNVNDLRQNPGYSNVDIFTYNEMKLATKFFRPDYILGEGGFGV 107
            + +      + P+P       L       + D+          K F     +G G FG 
Sbjct: 16  TTENLYFQGAMDPMPAGGRAGSL------KDPDVAELFFKDDPEKLFSDLREIGHGSFGA 69

Query: 108 VYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREW---LAEVNYLGQLRHSNLVKLIGYC 164
           VY      +VR       VAIK+++  G Q + +W   + EV +L +LRH N ++  G  
Sbjct: 70  VYFAR---DVRNS---EVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCY 123

Query: 165 CEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIAL---DAAKGLAFLHGAERPVI 221
             +    LV EY   GS    L      +    + ++IA     A +GLA+LH     +I
Sbjct: 124 LREHTAWLVMEYCL-GSASDLLEVHKKPL----QEVEIAAVTHGALQGLAYLH--SHNMI 176

Query: 222 YRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTR--VMGTYGYAAPEYVMT---G 276
           +RD K  NILL+     KL DFG A        + ++     +GT  + APE ++    G
Sbjct: 177 HRDVKAGNILLSEPGLVKLGDFGSA--------SIMAPANSFVGTPYWMAPEVILAMDEG 228

Query: 277 HLTARSDVYGFGVVLLEMLLG 297
               + DV+  G+  +E+   
Sbjct: 229 QYDGKVDVWSLGITCIELAER 249

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score = 94.8 bits (236), Expect = 4e-21
 Identities = 56/264 (21%), Positives = 95/264 (35%), Gaps = 46/264 (17%)

Query: 60  PVPPKKNVNDLRQNPGYSNVDIFTYNEMKLATKFFRPDYILGEGGFGVVYKGVIDENVRP 119
                    +L       N  ++   +     + +     LG G +G V           
Sbjct: 4   HHHHSSGRENLYFQGIAINPGMYVRKKEGKIGESYFKVRKLGSGAYGEVLLCK------- 56

Query: 120 GYKTT--FVAIKELNR------------GGYQGDREWLA-EVNYLGQLRHSNLVKLIGYC 164
             K      AIK + +               +   E +  E++ L  L H N++KL    
Sbjct: 57  -EKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVF 115

Query: 165 CEDEHRILVYEYMESGSL------EKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAER 218
            + ++  LV E+ E G L                 +     MK  L     + +LH  + 
Sbjct: 116 EDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANI-----MKQILSG---ICYLH--KH 165

Query: 219 PVIYRDFKTSNILL---NADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMT 275
            +++RD K  NILL   N+  + K+ DFGL+       + +     +GT  Y APE V+ 
Sbjct: 166 NIVHRDIKPENILLENKNSLLNIKIVDFGLSS---FFSKDYKLRDRLGTAYYIAPE-VLK 221

Query: 276 GHLTARSDVYGFGVVLLEMLLGRR 299
                + DV+  GV++  +L G  
Sbjct: 222 KKYNEKCDVWSCGVIMYILLCGYP 245

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score = 93.6 bits (233), Expect = 6e-21
 Identities = 58/222 (26%), Positives = 96/222 (43%), Gaps = 50/222 (22%)

Query: 99  ILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLV 158
           ++G G FGVVY+  + ++         VAIK++     Q  R    E+  + +L H N+V
Sbjct: 61  VIGNGSFGVVYQAKLCDSGEL------VAIKKV----LQDKRFKNRELQIMRKLDHCNIV 110

Query: 159 KLIGYCCEDEHRI------LVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAK---- 208
           +L  +      +       LV +Y+   ++ +              +  + +   K    
Sbjct: 111 RLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHY------SRAKQTLPVIYVKLYMY 163

Query: 209 ----GLAFLHGAERPVIYRDFKTSNILLNADFSA-KLSDFGLAK----DGPMGDQTH-VS 258
                LA++H     + +RD K  N+LL+ D +  KL DFG AK      P       + 
Sbjct: 164 QLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN---VSYIC 218

Query: 259 TRVMGTYGYAAPEYVMTG--HLTARSDVYGFGVVLLEMLLGR 298
           +R    Y Y APE ++ G    T+  DV+  G VL E+LLG+
Sbjct: 219 SR----Y-YRAPE-LIFGATDYTSSIDVWSAGCVLAELLLGQ 254

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score = 91.5 bits (228), Expect = 6e-21
 Identities = 59/209 (28%), Positives = 87/209 (41%), Gaps = 28/209 (13%)

Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLA-EVNYLGQLRHSNLV 158
           LGEG +G V   V   N         VA+K ++        E +  E+     L H N+V
Sbjct: 15  LGEGAYGEVQLAV---NRVTEEA---VAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 68

Query: 159 KLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAK-------GLA 211
           K  G+  E   + L  EY   G L   +             M    DA +       G+ 
Sbjct: 69  KFYGHRREGNIQYLFLEYCSGGELFDRIEPD--------IGMPEP-DAQRFFHQLMAGVV 119

Query: 212 FLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPE 271
           +LHG    + +RD K  N+LL+   + K+SDFGLA      ++  +  ++ GT  Y APE
Sbjct: 120 YLHG--IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 177

Query: 272 YVMTGHL--TARSDVYGFGVVLLEMLLGR 298
            ++          DV+  G+VL  ML G 
Sbjct: 178 -LLKRREFHAEPVDVWSCGIVLTAMLAGE 205

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score = 92.5 bits (230), Expect = 1e-20
 Identities = 65/310 (20%), Positives = 119/310 (38%), Gaps = 57/310 (18%)

Query: 8   EEQQRQRLRQQQQPSSSKENQGGNGAPVISDNLDSPGMKTASGSQVTPKNVTPVPPKKNV 67
           +E++R R   +  P+ ++E +      +            ++      K +    PK   
Sbjct: 17  KERRRARREIRHLPNLNREQRRAFIRSL------RDDPSQSANLLAEAKKLNDAQPKGTE 70

Query: 68  NDLRQNPGYSNVDIFTYNEMKLATKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTT--F 125
           N   Q+ G  + ++  +   K   + + P  ++G G   VV + V        ++ T   
Sbjct: 71  NLYFQSMGPED-ELPDWAAAKEFYQKYDPKDVIGRGVSSVVRRCV--------HRATGHE 121

Query: 126 VAIKELNR-------GGYQGDREWLA-EVNYLGQLR-HSNLVKLIGYCCEDEHRI-LVYE 175
            A+K +            +  RE    E + L Q+  H +++ LI    E    + LV++
Sbjct: 122 FAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSY-ESSSFMFLVFD 180

Query: 176 YMESGSLEKHLLRRVGCMLTWSRRMKIALDAAK-------GLAFLHGAERPVIYRDFKTS 228
            M  G L  +L  +V      S +     +           ++FLH     +++RD K  
Sbjct: 181 LMRKGELFDYLTEKV----ALSEK-----ETRSIMRSLLEAVSFLH--ANNIVHRDLKPE 229

Query: 229 NILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGF- 287
           NILL+ +   +LSDFG +    +     +     GT GY APE ++   +      YG  
Sbjct: 230 NILLDDNMQIRLSDFGFSCH--LEPGEKLRELC-GTPGYLAPE-ILKCSMDETHPGYGKE 285

Query: 288 ------GVVL 291
                 GV+L
Sbjct: 286 VDLWACGVIL 295

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score = 92.8 bits (231), Expect = 1e-20
 Identities = 65/255 (25%), Positives = 103/255 (40%), Gaps = 55/255 (21%)

Query: 75  GYSNVDIFTYNEMK-----LATKFFRPDYI----LGEGGFGVVYKGVIDENVRPGYKTT- 124
             S   +F + ++      +  K  R +YI    LG G  G V             + T 
Sbjct: 109 SLSRNKVFVFFDLTVDDQSVYPKALRDEYIMSKTLGSGACGEVKLAF--------ERKTC 160

Query: 125 -FVAIKELNRGGYQGDREWLA--------EVNYLGQLRHSNLVKLIGYCCEDEHRILVYE 175
             VAI+ +++  +       A        E+  L +L H  ++K+  +  + E   +V E
Sbjct: 161 KKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNF-FDAEDYYIVLE 219

Query: 176 YMESGSL------EKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSN 229
            ME G L       K L      +          L A   + +LH  E  +I+RD K  N
Sbjct: 220 LMEGGELFDKVVGNKRLKEATCKLY-----FYQMLLA---VQYLH--ENGIIHRDLKPEN 269

Query: 230 ILLNA---DFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTAR----S 282
           +LL++   D   K++DFG +K   +G+ + + T   GT  Y APE V+    TA      
Sbjct: 270 VLLSSQEEDCLIKITDFGHSKI--LGETSLMRTLC-GTPTYLAPE-VLVSVGTAGYNRAV 325

Query: 283 DVYGFGVVLLEMLLG 297
           D +  GV+L   L G
Sbjct: 326 DCWSLGVILFICLSG 340

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score = 92.4 bits (230), Expect = 1e-20
 Identities = 58/218 (26%), Positives = 86/218 (39%), Gaps = 43/218 (19%)

Query: 100 LGEGGFGVVYKGVIDENVRPGYKTT--FVAIKELNRGGYQGDREW---LAEVNYLGQLRH 154
           +G+G FG V        V+     T    A+K +N+       E      E+  +  L H
Sbjct: 23  IGKGSFGKVCI------VQ--KNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEH 74

Query: 155 SNLVKLIGYCCEDEHRI-LVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAK----- 208
             LV L  Y  +DE  + +V + +  G L  HL           + +    +  K     
Sbjct: 75  PFLVNLW-YSFQDEEDMFMVVDLLLGGDLRYHL----------QQNVHFKEETVKLFICE 123

Query: 209 ---GLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTY 265
               L +L    + +I+RD K  NILL+      ++DF +A   P   Q    T + GT 
Sbjct: 124 LVMALDYLQ--NQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQI---TTMAGTK 178

Query: 266 GYAAPEYVM----TGHLTARSDVYGFGVVLLEMLLGRR 299
            Y APE        G+  A  D +  GV   E+L GRR
Sbjct: 179 PYMAPEMFSSRKGAGYSFA-VDWWSLGVTAYELLRGRR 215

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 91.2 bits (227), Expect = 1e-20
 Identities = 56/215 (26%), Positives = 97/215 (45%), Gaps = 37/215 (17%)

Query: 100 LGEGGFGVVYKGVIDENVRPGYKTT--FVAIKELNRGGYQGDRE-----WLAEVNYLGQL 152
           LGEG +G VYK +           T   VAIK +     + + E      + EV+ L +L
Sbjct: 42  LGEGTYGEVYKAI--------DTVTNETVAIKRIR---LEHEEEGVPGTAIREVSLLKEL 90

Query: 153 RHSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAF 212
           +H N+++L      +    L++EY E+  L+K++ +     ++             G+ F
Sbjct: 91  QHRNIIELKSVIHHNHRLHLIFEYAEN-DLKKYMDKNPD--VSMRVIKSFLYQLINGVNF 147

Query: 213 LHGAERPVIYRDFKTSNILLNADFSA-----KLSDFGLAKD--GPMGDQTHVSTRVMGTY 265
            H   R  ++RD K  N+LL+   ++     K+ DFGLA+    P+   TH    ++ T 
Sbjct: 148 CH--SRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTH---EII-TL 201

Query: 266 GYAAPEYVMTG--HLTARSDVYGFGVVLLEMLLGR 298
            Y  PE ++ G  H +   D++    +  EML+  
Sbjct: 202 WYRPPE-ILLGSRHYSTSVDIWSIACIWAEMLMKT 235

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score = 90.8 bits (226), Expect = 2e-20
 Identities = 65/238 (27%), Positives = 98/238 (41%), Gaps = 50/238 (21%)

Query: 87  MKLATKFFRPDYI----LGEGGFGVVYKGVIDENVRPGYKTT--FVAIKELNRGGYQGDR 140
           M +  K  R +YI    LG G  G V             + T   VAIK +++  +    
Sbjct: 1   MSVYPKALRDEYIMSKTLGSGACGEVKLAF--------ERKTCKKVAIKIISKRKFAIGS 52

Query: 141 EWLA--------EVNYLGQLRHSNLVKLIGYCCEDEHRILVYEYMESGSL------EKHL 186
              A        E+  L +L H  ++K+  +  + E   +V E ME G L       K L
Sbjct: 53  AREADPALNVETEIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRL 111

Query: 187 LRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNA---DFSAKLSDF 243
                 +          L A   + +LH  E  +I+RD K  N+LL++   D   K++DF
Sbjct: 112 KEATCKLY-----FYQMLLA---VQYLH--ENGIIHRDLKPENVLLSSQEEDCLIKITDF 161

Query: 244 GLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTAR----SDVYGFGVVLLEMLLG 297
           G +K   +G+ + + T   GT  Y APE V+    TA      D +  GV+L   L G
Sbjct: 162 GHSK--ILGETSLMRTLC-GTPTYLAPE-VLVSVGTAGYNRAVDCWSLGVILFICLSG 215

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score = 90.8 bits (226), Expect = 2e-20
 Identities = 59/209 (28%), Positives = 87/209 (41%), Gaps = 28/209 (13%)

Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLA-EVNYLGQLRHSNLV 158
           LGEG +G V   V   N         VA+K ++        E +  E+     L H N+V
Sbjct: 15  LGEGAYGEVQLAV---NRVTEEA---VAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 68

Query: 159 KLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAK-------GLA 211
           K  G+  E   + L  EY   G L   +             M    DA +       G+ 
Sbjct: 69  KFYGHRREGNIQYLFLEYCSGGELFDRIEPD--------IGMPEP-DAQRFFHQLMAGVV 119

Query: 212 FLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPE 271
           +LHG    + +RD K  N+LL+   + K+SDFGLA      ++  +  ++ GT  Y APE
Sbjct: 120 YLHG--IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 177

Query: 272 YVMTGHL--TARSDVYGFGVVLLEMLLGR 298
            ++          DV+  G+VL  ML G 
Sbjct: 178 -LLKRREFHAEPVDVWSCGIVLTAMLAGE 205

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score = 90.3 bits (224), Expect = 3e-20
 Identities = 42/240 (17%), Positives = 83/240 (34%), Gaps = 32/240 (13%)

Query: 139 DREWLAEVNYLGQLRHSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCM-LTWS 197
                 ++  +      N V  +       +  +  +     +L+  + RR         
Sbjct: 105 MDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHG 164

Query: 198 RRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKD--------- 248
             + I +  A+ + FLH   + +++RD K SNI    D   K+ DFGL            
Sbjct: 165 VCLHIFIQIAEAVEFLH--SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQT 222

Query: 249 -GPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPS 307
                      T  +GT  Y +PE +   + + + D++  G++L E+L           S
Sbjct: 223 VLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELL--------YSFS 274

Query: 308 REHNLVEWARPLLNNNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDV 367
            +   V     ++ + +            +Y      +   +    LS +P  RP  +D+
Sbjct: 275 TQMERVR----IITDVRN--LKFPLLFTQKYP-----QEHMMVQDMLSPSPTERPEATDI 323

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score = 42.6 bits (100), Expect = 2e-04
 Identities = 21/89 (23%), Positives = 33/89 (37%), Gaps = 11/89 (12%)

Query: 94  FRPDY----ILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDRE-WLAEVNY 148
           +  D+     +G GGFGVV++       +        AIK +     +  RE  + EV  
Sbjct: 4   YLTDFEPIQCMGRGGFGVVFE------AKNKVDDCNYAIKRIRLPNRELAREKVMREVKA 57

Query: 149 LGQLRHSNLVKLIGYCCEDEHRILVYEYM 177
           L +L H  +V+      E        E  
Sbjct: 58  LAKLEHPGIVRYFNAWLETPPEKWQEEMD 86

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score = 91.3 bits (227), Expect = 5e-20
 Identities = 58/215 (26%), Positives = 87/215 (40%), Gaps = 37/215 (17%)

Query: 99  ILGEGGFGVVYKGVIDENVRPGYKTT--FVAIKELNRGGYQG-DREWLA-EVNYLGQLRH 154
           +LG+G FG V K           + T    A+K +N+   +  D   +  EV  L +L H
Sbjct: 29  MLGKGSFGEVLKCK--------DRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80

Query: 155 SNLVKLIGYCCEDEHRI-LVYEYMESGSL------EKHLLRRVGCMLTWSRRMKIALDAA 207
            N++KL     ED     +V E    G L       K         +     +K      
Sbjct: 81  PNIMKLFEI-LEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARI-----IKQVFSG- 133

Query: 208 KGLAFLHGAERPVIYRDFKTSNILL---NADFSAKLSDFGLAKDGPMGDQTHVSTRVMGT 264
             + ++H  +  +++RD K  NILL     D   K+ DFGL+       Q       +GT
Sbjct: 134 --ITYMH--KHNIVHRDLKPENILLESKEKDCDIKIIDFGLST---CFQQNTKMKDRIGT 186

Query: 265 YGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRR 299
             Y APE V+ G    + DV+  GV+L  +L G  
Sbjct: 187 AYYIAPE-VLRGTYDEKCDVWSAGVILYILLSGTP 220

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 90.9 bits (226), Expect = 6e-20
 Identities = 68/207 (32%), Positives = 92/207 (44%), Gaps = 24/207 (11%)

Query: 100 LGEGGFGVVYKGVIDENVRPGYKTT--FVAIKELNRGGYQGDREW---LAEVNYLGQLRH 154
           LG+G FG V        V+   K T  + A+K L +       E    L E   L   RH
Sbjct: 156 LGKGTFGKVIL------VK--EKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH 207

Query: 155 SNLVKLIGYCC--EDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAF 212
             L  L         +    V EY   G L  HL  R         R   A +    L +
Sbjct: 208 PFLTAL--KYSFQTHDRLCFVMEYANGGELFFHL-SRERVFSEDRARFYGA-EIVSALDY 263

Query: 213 LHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEY 272
           LH  E+ V+YRD K  N++L+ D   K++DFGL K+G + D   + T   GT  Y APE 
Sbjct: 264 LHS-EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEG-IKDGATMKT-FCGTPEYLAPE- 319

Query: 273 VMTGHLTARS-DVYGFGVVLLEMLLGR 298
           V+  +   R+ D +G GVV+ EM+ GR
Sbjct: 320 VLEDNDYGRAVDWWGLGVVMYEMMCGR 346

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score = 89.7 bits (223), Expect = 8e-20
 Identities = 58/234 (24%), Positives = 102/234 (43%), Gaps = 36/234 (15%)

Query: 86  EMKLATKFFRPDY----ILGEGGFGVVYKGVIDENVRPGYKTT--FVAIKELN----RGG 135
           +M      F   Y    ++G+G F VV + +         + T    A+K ++       
Sbjct: 14  DMADDDVLFEDVYELCEVIGKGPFSVVRRCI--------NRETGQQFAVKIVDVAKFTSS 65

Query: 136 YQGDREWLA-EVNYLGQLRHSNLVKLIGYCCEDEHRI-LVYEYMESGSLEKHLLRRVGCM 193
                E L  E +    L+H ++V+L+      +  + +V+E+M+   L   +++R    
Sbjct: 66  PGLSTEDLKREASICHMLKHPHIVELLET-YSSDGMLYMVFEFMDGADLCFEIVKRADAG 124

Query: 194 LTWSRR-----MKIALDAAKGLAFLHGAERPVIYRDFKTSNILL-NADFSA--KLSDFGL 245
             +S       M+  L+A   L + H  +  +I+RD K   +LL + + SA  KL  FG+
Sbjct: 125 FVYSEAVASHYMRQILEA---LRYCH--DNNIIHRDVKPHCVLLASKENSAPVKLGGFGV 179

Query: 246 AKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRR 299
           A    +G+   V+   +GT  + APE V         DV+G GV+L  +L G  
Sbjct: 180 AIQ--LGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCL 231

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score = 88.9 bits (221), Expect = 8e-20
 Identities = 51/215 (23%), Positives = 88/215 (40%), Gaps = 33/215 (15%)

Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLA----EVNYLGQLRHS 155
           LGEG +G V + +   +     +    A+K L +   +      A    E+  L +LRH 
Sbjct: 13  LGEGSYGKVKEVL---DSETLCR---RAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHK 66

Query: 156 NLVKL--IGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAK----- 208
           N+++L  + Y  E +   +V EY   G  E  +L  V       +R  +   A       
Sbjct: 67  NVIQLVDVLYNEEKQKMYMVMEYCVCGMQE--MLDSVP-----EKRFPVC-QAHGYFCQL 118

Query: 209 --GLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYG 266
             GL +LH   + ++++D K  N+LL    + K+S  G+A+               G+  
Sbjct: 119 IDGLEYLHS--QGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPA 176

Query: 267 YAAPEYVMTGHLT---ARSDVYGFGVVLLEMLLGR 298
           +  PE +  G  T    + D++  GV L  +  G 
Sbjct: 177 FQPPE-IANGLDTFSGFKVDIWSAGVTLYNITTGL 210

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 91.2 bits (226), Expect = 9e-20
 Identities = 66/306 (21%), Positives = 110/306 (35%), Gaps = 38/306 (12%)

Query: 3   ICFSLEEQQRQRLRQQQQPSSSKENQGGNGAPVISDNLDSPGMKTASGSQVTPKNVTPVP 62
              S  ++       +       E       P  S+  +    K                
Sbjct: 262 FGISELQKAGVDGWFKLLSQEEGEYFNVPVPPEGSEGNEELRQKFERAKIGQGTKAPEEK 321

Query: 63  PKKNVNDLRQNPGYSNVDIFTYNEMKLATKFFRPDYILGEGGFGVVYKGVIDENVRPGYK 122
               ++    N     + +  +N + +          LG+G FG V             K
Sbjct: 322 TANTISKFDNNGNRDRMKLTDFNFLMV----------LGKGSFGKVML------SE--RK 363

Query: 123 TT--FVAIKELNRGGYQGDREW---LAEVNYLGQ-LRHSNLVKLIGYCC--EDEHRILVY 174
            T    A+K L +     D +    + E   L    +   L +L  + C    +    V 
Sbjct: 364 GTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQL--HSCFQTMDRLYFVM 421

Query: 175 EYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNA 234
           EY+  G L  H+ +           +  A + A GL FL    + +IYRD K  N++L++
Sbjct: 422 EYVNGGDLMYHIQQVG--RFKEPHAVFYAAEIAIGLFFLQ--SKGIIYRDLKLDNVMLDS 477

Query: 235 DFSAKLSDFGLAKDGPMGDQTHVSTRVM-GTYGYAAPEYVMTGHLTARS-DVYGFGVVLL 292
           +   K++DFG+ K+      T   T+   GT  Y APE ++      +S D + FGV+L 
Sbjct: 478 EGHIKIADFGMCKENIWDGVT---TKTFCGTPDYIAPE-IIAYQPYGKSVDWWAFGVLLY 533

Query: 293 EMLLGR 298
           EML G+
Sbjct: 534 EMLAGQ 539

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 89.3 bits (222), Expect = 1e-19
 Identities = 62/222 (27%), Positives = 90/222 (40%), Gaps = 44/222 (19%)

Query: 99  ILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLV 158
           + G+G FG V  G              VAIK++ +     +RE L  +  L  L H N+V
Sbjct: 30  MAGQGTFGTVQLGKEKSTGMS------VAIKKVIQDPRFRNRE-LQIMQDLAVLHHPNIV 82

Query: 159 KLIGY-------CCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAA---- 207
           +L  Y          D +  +V EY+         L R         R ++A        
Sbjct: 83  QLQSYFYTLGERDRRDIYLNVVMEYVPDT------LHRC---CRNYYRRQVAPPPILIKV 133

Query: 208 ------KGLAFLHGAERPVIYRDFKTSNILLN-ADFSAKLSDFGLAKD-GPMGDQTH-VS 258
                 + +  LH     V +RD K  N+L+N AD + KL DFG AK   P       + 
Sbjct: 134 FLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYIC 193

Query: 259 TRVMGTYGYAAPEYVMTG--HLTARSDVYGFGVVLLEMLLGR 298
           +R    Y Y APE ++ G  H T   D++  G +  EM+LG 
Sbjct: 194 SR----Y-YRAPE-LIFGNQHYTTAVDIWSVGCIFAEMMLGE 229

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 88.8 bits (221), Expect = 1e-19
 Identities = 65/217 (29%), Positives = 92/217 (42%), Gaps = 41/217 (18%)

Query: 100 LGEGGFGVVYKGVIDENVR-PGYKTT--FVAIKELNRG---GYQGDREW-LAEVNYLGQL 152
           LG+GG+G V++      VR      T    A+K L +        D     AE N L ++
Sbjct: 25  LGKGGYGKVFQ------VRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEV 78

Query: 153 RHSNLVKLIGYCCEDEHRI-LVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAK--- 208
           +H  +V LI Y  +   ++ L+ EY+  G L   L           R      D A    
Sbjct: 79  KHPFIVDLI-YAFQTGGKLYLILEYLSGGELFMQL----------EREGIFMEDTACFYL 127

Query: 209 -----GLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVM- 262
                 L  LH  ++ +IYRD K  NI+LN     KL+DFGL K+          T    
Sbjct: 128 AEISMALGHLH--QKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTV---THTFC 182

Query: 263 GTYGYAAPEYVM-TGHLTARSDVYGFGVVLLEMLLGR 298
           GT  Y APE +M +GH     D +  G ++ +ML G 
Sbjct: 183 GTIEYMAPEILMRSGH-NRAVDWWSLGALMYDMLTGA 218

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 88.8 bits (221), Expect = 1e-19
 Identities = 67/216 (31%), Positives = 90/216 (41%), Gaps = 43/216 (19%)

Query: 100 LGEGGFGVVYKGVIDENVRPGYKTT--FVAIKELNRGGYQGDREW---LAEVNYLGQLRH 154
           LG+G FG V        VR   K T  + A+K L +       E    + E   L   RH
Sbjct: 13  LGKGTFGKVIL------VR--EKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64

Query: 155 SNLVKLIGYCC--EDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAK---- 208
             L  L         +    V EY   G L  HL          SR      + A+    
Sbjct: 65  PFLTAL--KYAFQTHDRLCFVMEYANGGELFFHL----------SRERVFTEERARFYGA 112

Query: 209 ----GLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVM-G 263
                L +LH   R V+YRD K  N++L+ D   K++DFGL K+G     T    +   G
Sbjct: 113 EIVSALEYLH--SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT---MKTFCG 167

Query: 264 TYGYAAPEYVMTGHLTARS-DVYGFGVVLLEMLLGR 298
           T  Y APE V+  +   R+ D +G GVV+ EM+ GR
Sbjct: 168 TPEYLAPE-VLEDNDYGRAVDWWGLGVVMYEMMCGR 202

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 88.9 bits (221), Expect = 1e-19
 Identities = 54/226 (23%), Positives = 84/226 (37%), Gaps = 39/226 (17%)

Query: 94  FRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQG------DREWLA--- 144
           +     +  G +G V  GV  E +        VAIK +      G         +L    
Sbjct: 24  YTVQRFISSGSYGAVCAGVDSEGIP-------VAIKRVFNTVSDGRTVNILSDSFLCKRV 76

Query: 145 --EVNYLGQLRHSNLVKL----IGYCCEDEHRI-LVYEYMESGSLEKHLLRRVGCMLTWS 197
             E+  L    H N++ L    + +     H++ LV E M +  L + ++     +++  
Sbjct: 77  LREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQ-VIHDQRIVISPQ 134

Query: 198 RRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLA----KDGPMGD 253
                      GL  LH A   V++RD    NILL  +    + DF LA     D     
Sbjct: 135 HIQYFMYHILLGLHVLHEAG--VVHRDLHPGNILLADNNDITICDFNLAREDTADANKTH 192

Query: 254 QTHVSTRVMGTYGYAAPEYVMT-GHLTARSDVYGFGVVLLEMLLGR 298
             +V+ R      Y APE VM     T   D++  G V+ EM   +
Sbjct: 193 --YVTHRW-----YRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score = 87.7 bits (218), Expect = 1e-19
 Identities = 61/225 (27%), Positives = 91/225 (40%), Gaps = 41/225 (18%)

Query: 91  TKFFRPDY----ILGEGGFGVVYKGVIDENVRPGYKTT--FVAIKELNRGGYQG-DREWL 143
              F   Y    +LG+G FG V K           + T    A+K +N+   +  D   +
Sbjct: 17  QGTFAERYNIVCMLGKGSFGEVLKCK--------DRITQQEYAVKVINKASAKNKDTSTI 68

Query: 144 -AEVNYLGQLRHSNLVKLIGYCCEDEHRI-LVYEYMESGSL------EKHLLRRVGCMLT 195
             EV  L +L H N++KL     ED     +V E    G L       K         + 
Sbjct: 69  LREVELLKKLDHPNIMKLFEI-LEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARI- 126

Query: 196 WSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILL---NADFSAKLSDFGLAKDGPMG 252
               +K        + ++H  +  +++RD K  NILL     D   K+ DFGL+      
Sbjct: 127 ----IKQVFSG---ITYMH--KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTC--FQ 175

Query: 253 DQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLG 297
             T +  R+ GT  Y APE V+ G    + DV+  GV+L  +L G
Sbjct: 176 QNTKMKDRI-GTAYYIAPE-VLRGTYDEKCDVWSAGVILYILLSG 218

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 88.8 bits (221), Expect = 1e-19
 Identities = 57/215 (26%), Positives = 94/215 (43%), Gaps = 29/215 (13%)

Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDRE-----WLAEVNYLGQLRH 154
           +G+G FG V+K     + + G     VA+K++     + ++E      L E+  L  L+H
Sbjct: 25  IGQGTFGEVFKAR---HRKTG---QKVALKKVL---MENEKEGFPITALREIKILQLLKH 75

Query: 155 SNLVKLIGYCCEDEHRI--------LVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDA 206
            N+V LI  C               LV+++ E   L   LL  V    T S   ++    
Sbjct: 76  ENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAG-LLSNVLVKFTLSEIKRVMQML 133

Query: 207 AKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAK--DGPMGDQTHVSTRVMGT 264
             GL ++H     +++RD K +N+L+  D   KL+DFGLA+        Q +  T  + T
Sbjct: 134 LNGLYYIH--RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVT 191

Query: 265 YGYAAPEYVM-TGHLTARSDVYGFGVVLLEMLLGR 298
             Y  PE ++         D++G G ++ EM    
Sbjct: 192 LWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRS 226

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score = 87.7 bits (218), Expect = 1e-19
 Identities = 60/239 (25%), Positives = 97/239 (40%), Gaps = 55/239 (23%)

Query: 90  ATKFFRPDY----ILGEGGFGVVYKGVIDENVRPGYKTT--FVAIK--------ELNRGG 135
           +T  F  +Y    ILG G   VV + +        +K T    A+K          +   
Sbjct: 11  STHGFYENYEPKEILGRGVSSVVRRCI--------HKPTCKEYAVKIIDVTGGGSFSAEE 62

Query: 136 YQGDREWLA-EVNYLGQL-RHSNLVKLIGYCCEDEHRI-LVYEYMESGSLEKHLLRRVGC 192
            Q  RE    EV+ L ++  H N+++L     E      LV++ M+ G L  +L  +V  
Sbjct: 63  VQELREATLKEVDILRKVSGHPNIIQLKDTY-ETNTFFFLVFDLMKKGELFDYLTEKV-- 119

Query: 193 MLTWSRRMKIALDAAK-------GLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGL 245
             T S +     +  K        +  LH  +  +++RD K  NILL+ D + KL+DFG 
Sbjct: 120 --TLSEK-----ETRKIMRALLEVICALH--KLNIVHRDLKPENILLDDDMNIKLTDFGF 170

Query: 246 AKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGF-------GVVLLEMLLG 297
           +    +     +     GT  Y APE ++   +      YG        GV++  +L G
Sbjct: 171 SCQ--LDPGEKLREVC-GTPSYLAPE-IIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG 225

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score = 88.7 bits (220), Expect = 1e-19
 Identities = 59/263 (22%), Positives = 92/263 (34%), Gaps = 71/263 (26%)

Query: 94  FRPDYI----LGEGGFGVVYKGVIDENVRPGYKTT--FVAIKELNR----GGYQGDREWL 143
            +  Y     +G+G +GVV   +           T    AIK +N+         D E +
Sbjct: 24  LQKKYHLKGAIGQGSYGVVRVAI--------ENQTRAIRAIKIMNKNKIRQINPKDVERI 75

Query: 144 A-EVNYLGQLRHSNLVKLIGYCCEDEHRI-LVYEYMESGSLEKHLLRRVGCMLTWSRRMK 201
             EV  + +L H N+ +L     EDE  I LV E    G L   L   +           
Sbjct: 76  KTEVRLMKKLHHPNIARLYE-VYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDV 134

Query: 202 IAL-------------------------------DAAK-------GLAFLHGAERPVIYR 223
           +                                   +         L +LH   + + +R
Sbjct: 135 VKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLH--NQGICHR 192

Query: 224 DFKTSNILLNADFSA--KLSDFGLAK---DGPMGDQTHVSTRVMGTYGYAAPEYVMTGHL 278
           D K  N L + + S   KL DFGL+K       G+   ++T+  GT  + APE V+    
Sbjct: 193 DIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKA-GTPYFVAPE-VLNTTN 250

Query: 279 ---TARSDVYGFGVVLLEMLLGR 298
                + D +  GV+L  +L+G 
Sbjct: 251 ESYGPKCDAWSAGVLLHLLLMGA 273

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 88.0 bits (219), Expect = 2e-19
 Identities = 56/214 (26%), Positives = 94/214 (43%), Gaps = 29/214 (13%)

Query: 100 LGEGGFGVVYKGVIDENVRPGYKTT--FVAIKELNRGGYQGDREW-----LAEVNYLGQL 152
           +G G +G VYK   D         +  FVA+K +      G         + EV  L +L
Sbjct: 17  IGVGAYGTVYKA-RD-------PHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRL 68

Query: 153 R---HSNLVKLI----GYCCEDEHRI-LVYEYMESGSLEKHLLRRVGCMLTWSRRMKIAL 204
               H N+V+L+        + E ++ LV+E+++   L  +L +     L       +  
Sbjct: 69  EAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMR 127

Query: 205 DAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGT 264
              +GL FLH     +++RD K  NIL+ +  + KL+DFGLA+      Q  ++  V+ T
Sbjct: 128 QFLRGLDFLH--ANCIVHRDLKPENILVTSGGTVKLADFGLAR--IYSYQMALTPVVV-T 182

Query: 265 YGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGR 298
             Y APE ++        D++  G +  EM   +
Sbjct: 183 LWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 216

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 88.0 bits (219), Expect = 2e-19
 Identities = 58/214 (27%), Positives = 94/214 (43%), Gaps = 31/214 (14%)

Query: 100 LGEGGFGVVYKGVIDENVRPGYKTT--FVAIKELNRGGYQGDRE-----WLAEVNYLGQL 152
           +GEG +G V+K   D       K    FVA+K +     Q   E      + EV  L  L
Sbjct: 19  IGEGAYGKVFKA-RDL------KNGGRFVALKRVR---VQTGEEGMPLSTIREVAVLRHL 68

Query: 153 R---HSNLVKLI----GYCCEDEHRI-LVYEYMESGSLEKHLLRRVGCMLTWSRRMKIAL 204
               H N+V+L         + E ++ LV+E+++   L  +L +     +       +  
Sbjct: 69  ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMF 127

Query: 205 DAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGT 264
              +GL FLH     V++RD K  NIL+ +    KL+DFGLA+      Q  +++ V+ T
Sbjct: 128 QLLRGLDFLH--SHRVVHRDLKPQNILVTSSGQIKLADFGLAR--IYSFQMALTSVVV-T 182

Query: 265 YGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGR 298
             Y APE ++        D++  G +  EM   +
Sbjct: 183 LWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score = 87.8 bits (218), Expect = 2e-19
 Identities = 73/311 (23%), Positives = 122/311 (39%), Gaps = 76/311 (24%)

Query: 91  TKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLG 150
              F    ++G G +G VYKG    +V+ G      AIK ++  G   + E   E+N L 
Sbjct: 23  AGIFELVELVGNGTYGQVYKGR---HVKTG---QLAAIKVMDVTG-DEEEEIKQEINMLK 75

Query: 151 QL-RHSNLVKLIG-----YCCEDEHRI-LVYEYMESGSLEKHLLRRVGCMLTWSRRMK-- 201
           +   H N+    G          + ++ LV E+  +GS+   L++      T    +K  
Sbjct: 76  KYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSV-TDLIK-----NTKGNTLKEE 129

Query: 202 ----IALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHV 257
               I  +  +GL+ LH  +  VI+RD K  N+LL  +   KL DFG++           
Sbjct: 130 WIAYICREILRGLSHLH--QHKVIHRDIKGQNVLLTENAEVKLVDFGVS-----AQLDRT 182

Query: 258 STR---VMGTYGYAAPEYVMTGHLT-----ARSDVYGFGVVLLEMLLGRRAVDKSRPSRE 309
             R    +GT  + APE +            +SD++  G+  +EM  G        P   
Sbjct: 183 VGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEG-------AP--- 232

Query: 310 HNLVEWARPLLNNNKKVLRIL-------DPRLEG-QYTARTAMKVAGLAYQCLSQNPKGR 361
                   PL + +   +R L        PRL+  +++ +    +      CL +N   R
Sbjct: 233 --------PLCDMHP--MRALFLIPRNPAPRLKSKKWSKKFQSFIE----SCLVKNHSQR 278

Query: 362 PVMSDVVALLE 372
           P       L++
Sbjct: 279 PATEQ---LMK 286

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 89.0 bits (221), Expect = 2e-19
 Identities = 52/214 (24%), Positives = 81/214 (37%), Gaps = 28/214 (13%)

Query: 99  ILGEGGFGVVYKGVIDENVRPGYKTT--FVAIKELNRGGYQGDRE---WLAEVNYLGQLR 153
           ++G G F  V        V+   K T    A+K +N+       E   +  E + L    
Sbjct: 68  VIGRGAFSEVAV------VK--MKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGD 119

Query: 154 HSNLVKLIGYCCEDEHRI-LVYEYMESGSLEKHLLRRVGCMLTWSR-RMKIALDAAKGLA 211
              + +L  +  +DE+ + LV EY   G L   LL + G  +     R  +A +    + 
Sbjct: 120 RRWITQLH-FAFQDENYLYLVMEYYVGGDL-LTLLSKFGERIPAEMARFYLA-EIVMAID 176

Query: 212 FLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPE 271
            +H      ++RD K  NILL+     +L+DFG                V GT  Y +PE
Sbjct: 177 SVH--RLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAV-GTPDYLSPE 233

Query: 272 YVMTGHLTARSDVYG-------FGVVLLEMLLGR 298
            +        +  YG        GV   EM  G+
Sbjct: 234 ILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQ 267

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score = 86.5 bits (215), Expect = 3e-19
 Identities = 55/211 (26%), Positives = 84/211 (39%), Gaps = 35/211 (16%)

Query: 99  ILGEGGFGVVYKGVIDENVRPGYKTT--FVAIKELNRGGYQGDREWLAEVNYLGQLRHSN 156
            +G G +G V   V         K T    A K++ +   +    +  E+  +  L H N
Sbjct: 16  TIGRGSWGEVKIAV--------QKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPN 67

Query: 157 LVKLIGYCCEDEHRI-LVYEYMESGSL------EKHLLRRVGCMLTWSRRMKIALDAAKG 209
           +++L     ED   I LV E    G L      ++         +     MK  L A   
Sbjct: 68  IIRLYET-FEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARI-----MKDVLSA--- 118

Query: 210 LAFLHGAERPVIYRDFKTSNILL---NADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYG 266
           +A+ H  +  V +RD K  N L    + D   KL DFGLA          + T+V GT  
Sbjct: 119 VAYCH--KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAAR--FKPGKMMRTKV-GTPY 173

Query: 267 YAAPEYVMTGHLTARSDVYGFGVVLLEMLLG 297
           Y +P+ V+ G      D +  GV++  +L G
Sbjct: 174 YVSPQ-VLEGLYGPECDEWSAGVMMYVLLCG 203

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score = 87.8 bits (218), Expect = 4e-19
 Identities = 64/293 (21%), Positives = 103/293 (35%), Gaps = 46/293 (15%)

Query: 26  ENQGGNGAPVISDNLDSPGMK--------------TASGSQVTPKNVTPVPPKKNVNDLR 71
            +   +G  + ++NL    MK                  S        PV  K+      
Sbjct: 5   HHHHSSGVDLGTENLYFQSMKNSGDQDSRSGHNEAKEVWSNADLTERMPVKSKRTSALAV 64

Query: 72  QNPGYSNVDIFTYNEMKLATKFFRPDY------ILGEGGFGVVYKGVIDENVRPGYKTT- 124
             P       F +  +          Y      ILG G FG V+K             T 
Sbjct: 65  DIPAPPAP--FDHRIVTAKQGAVNSFYTVSKTEILGGGRFGQVHKCE--------ETATG 114

Query: 125 -FVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVKLIGYCCEDEHRILVYEYMESGSLE 183
             +A K +   G +   E   E++ + QL H+NL++L          +LV EY++ G L 
Sbjct: 115 LKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELF 174

Query: 184 KHLLRRVGCMLT---WSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILL--NADFSA 238
             ++      LT       MK   +   G+  +H  +  +++ D K  NIL         
Sbjct: 175 DRIIDE-SYNLTELDTILFMKQICE---GIRHMH--QMYILHLDLKPENILCVNRDAKQI 228

Query: 239 KLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVL 291
           K+ DFGLA+               GT  + APE V    ++  +D++  GV+ 
Sbjct: 229 KIIDFGLAR---RYKPREKLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIA 278

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score = 87.9 bits (218), Expect = 5e-19
 Identities = 53/261 (20%), Positives = 96/261 (36%), Gaps = 23/261 (8%)

Query: 45  MKTASGSQVTPKNVTPVPPKKNVNDLRQNPGYSNVDIFTYNEMKLATKFFRPDYI----L 100
           M+ +         V        +ND  +         +    +++        Y     L
Sbjct: 1   MRGSHHHHHHGSKVRGKYDGPKINDYDKFYE-DIWKKYVPQPVEVKQGSVYDYYDILEEL 59

Query: 101 GEGGFGVVYKGVIDENVRPGYKTT--FVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLV 158
           G G FGVV++ V         K T      K +N            E++ + QL H  L+
Sbjct: 60  GSGAFGVVHRCV--------EKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLI 111

Query: 159 KLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAER 218
            L     +    +L+ E++  G L   +       ++ +  +     A +GL  +H  E 
Sbjct: 112 NLHDAFEDKYEMVLILEFLSGGELFDRIAAE-DYKMSEAEVINYMRQACEGLKHMH--EH 168

Query: 219 PVIYRDFKTSNILLNADFSA--KLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTG 276
            +++ D K  NI+     ++  K+ DFGLA      +   +      T  +AAPE V   
Sbjct: 169 SIVHLDIKPENIMCETKKASSVKIIDFGLAT---KLNPDEIVKVTTATAEFAAPEIVDRE 225

Query: 277 HLTARSDVYGFGVVLLEMLLG 297
            +   +D++  GV+   +L G
Sbjct: 226 PVGFYTDMWAIGVLGYVLLSG 246

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 86.6 bits (215), Expect = 8e-19
 Identities = 72/304 (23%), Positives = 112/304 (36%), Gaps = 65/304 (21%)

Query: 15  LRQQQQPSSSKENQGGNGAPVISDNLDSPGMKTASGSQVTPKNVTPVPPKKNVNDLRQNP 74
           +         +    G  A   +D  D          ++   N+T    K  + +     
Sbjct: 1   MAHHHHHHEEEGGSSGGAAGTSADGGDGGEQLLTVKHELRTANLTGHAEKVGIEN----- 55

Query: 75  GYSNVDIFTYNEMKLATKFFRPDYILGEGGFGVVYKGVIDENVR-PGYKTT--FVAIKEL 131
                              F    +LG G +G V+       VR      T    A+K L
Sbjct: 56  -------------------FELLKVLGTGAYGKVFL------VRKISGHDTGKLYAMKVL 90

Query: 132 NRG---GYQGDREW-LAEVNYLGQLRHSN-LVKLIGYCCEDEHRI-LVYEYMESGSLEKH 185
            +          E    E   L  +R S  LV L  Y  + E ++ L+ +Y+  G L  H
Sbjct: 91  KKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLH-YAFQTETKLHLILDYINGGELFTH 149

Query: 186 LLRRVGCMLTWSRRMKIALDAAK--------GLAFLHGAERPVIYRDFKTSNILLNADFS 237
           L          S+R +      +         L  LH  +  +IYRD K  NILL+++  
Sbjct: 150 L----------SQRERFTEHEVQIYVGEIVLALEHLH--KLGIIYRDIKLENILLDSNGH 197

Query: 238 AKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVM---TGHLTARSDVYGFGVVLLEM 294
             L+DFGL+K+  + D+T  +    GT  Y AP+ V    +GH  A  D +  GV++ E+
Sbjct: 198 VVLTDFGLSKEF-VADETERAYDFCGTIEYMAPDIVRGGDSGHDKA-VDWWSLGVLMYEL 255

Query: 295 LLGR 298
           L G 
Sbjct: 256 LTGA 259

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score = 88.0 bits (218), Expect = 9e-19
 Identities = 58/282 (20%), Positives = 98/282 (34%), Gaps = 24/282 (8%)

Query: 26  ENQGGNGAP-VISDNLDSPGMKTASGSQVTPKNVTPVPPKKNVNDLRQNPGYSNV-DIFT 83
           EN+ G   P   +  +  PG +              +   K       +    ++   + 
Sbjct: 85  ENKHGQSKPCEPTAPVLIPGDERKRRRGYDVDEQGKIVRGKGTVSSNYDNYVFDIWKQYY 144

Query: 84  YNEMKLATKFFRPDYI----LGEGGFGVVYKGVIDENVRPGYKTT--FVAIKELNRGGYQ 137
              +++        Y     LG G FGVV++           + T    A K +      
Sbjct: 145 PQPVEIKHDHVLDHYDIHEELGTGAFGVVHRVT--------ERATGNNFAAKFVMTPHES 196

Query: 138 GDREWLAEVNYLGQLRHSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWS 197
                  E+  +  LRH  LV L     +D   +++YE+M  G L + +       ++  
Sbjct: 197 DKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNK-MSED 255

Query: 198 RRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILL--NADFSAKLSDFGLAKDGPMGDQT 255
             ++      KGL  +H  E   ++ D K  NI+         KL DFGL       D  
Sbjct: 256 EAVEYMRQVCKGLCHMH--ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTA---HLDPK 310

Query: 256 HVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLG 297
                  GT  +AAPE      +   +D++  GV+   +L G
Sbjct: 311 QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSG 352

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 85.7 bits (213), Expect = 1e-18
 Identities = 61/215 (28%), Positives = 93/215 (43%), Gaps = 39/215 (18%)

Query: 100 LGEGGFGVVYKGVIDENVR-PGYKTT--FVAIKELNRGGYQGDREW--LAEVNYLGQLRH 154
           LG+G FG V+       V+           A+K L +   +         E + L ++ H
Sbjct: 32  LGQGSFGKVFL------VKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNH 85

Query: 155 SNLVKLIGYCCEDEHRI-LVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAK----- 208
             +VKL  Y  + E ++ L+ +++  G L   L          S+ +    +  K     
Sbjct: 86  PFIVKLH-YAFQTEGKLYLILDFLRGGDLFTRL----------SKEVMFTEEDVKFYLAE 134

Query: 209 ---GLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVM-GT 264
               L  LH     +IYRD K  NILL+ +   KL+DFGL+K+    ++         GT
Sbjct: 135 LALALDHLH--SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKK---AYSFCGT 189

Query: 265 YGYAAPEYVM-TGHLTARSDVYGFGVVLLEMLLGR 298
             Y APE V   GH T  +D + FGV++ EML G 
Sbjct: 190 VEYMAPEVVNRRGH-TQSADWWSFGVLMFEMLTGT 223

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 84.8 bits (210), Expect = 1e-18
 Identities = 37/295 (12%), Positives = 89/295 (30%), Gaps = 58/295 (19%)

Query: 94  FRPDYILGEGGFGVVYKGVIDENV-RPGYKTTFVAIKELNRGGYQGD---REWLAEVNYL 149
           +R     G       ++ + D  + R       VA+  ++  G   D   +E L+    L
Sbjct: 33  YRLLIFHGGVPPLQFWQAL-DTALDRQ------VALTFVDPQGVLPDDVLQETLSRTLRL 85

Query: 150 GQLRHSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKG 209
            ++    + +++         ++V E++  GSL++          +    ++     A  
Sbjct: 86  SRIDKPGVARVLDVVHTRAGGLVVAEWIRGGSLQEVADTS----PSPVGAIRAMQSLAAA 141

Query: 210 LAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAA 269
               H     V       S + ++ D    L+                            
Sbjct: 142 ADAAH--RAGVALSIDHPSRVRVSIDGDVVLAYPA----------------------TMP 177

Query: 270 PEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRI 329
                      + D+ G G  L  +L+ R  + ++      + +  A             
Sbjct: 178 DA-------NPQDDIRGIGASLYALLVNRWPLPEAGVR---SGLAPAERDTAGQPIEPAD 227

Query: 330 LDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETVQSQGAEEEML 384
           +D  +  Q        ++ +A + +  +   R   S ++ L++   +     E+L
Sbjct: 228 IDRDIPFQ--------ISAVAARSVQGDGGIRSA-STLLNLMQQATAVADRTEVL 273

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score = 85.0 bits (211), Expect = 2e-18
 Identities = 61/218 (27%), Positives = 91/218 (41%), Gaps = 34/218 (15%)

Query: 99  ILGEGGFGVVYKGVIDENVRPGYKTT--FVAIKELNRGGYQGDREWLAEVNYLGQLR-HS 155
           +LGEG    V   +           T    A+K + +           EV  L Q + H 
Sbjct: 20  VLGEGAHARVQTCI--------NLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHR 71

Query: 156 NLVKLIGYCCEDEHRI-LVYEYMESGSLEKHLLRRVGCMLTWSRRM--KIALDAAKGLAF 212
           N+++LI +  E+E R  LV+E M  GS+  H+ +R      ++      +  D A  L F
Sbjct: 72  NVLELIEFF-EEEDRFYLVFEKMRGGSILSHIHKRR----HFNELEASVVVQDVASALDF 126

Query: 213 LHGAERPVIYRDFKTSNILL---NADFSAKLSDFGLAKD-GPMGDQTHVSTRVM----GT 264
           LH   + + +RD K  NIL    N     K+ DF L       GD + +ST  +    G+
Sbjct: 127 LH--NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGS 184

Query: 265 YGYAAPEYVMTGHLTARS-----DVYGFGVVLLEMLLG 297
             Y APE V      A       D++  GV+L  +L G
Sbjct: 185 AEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSG 222

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score = 84.5 bits (210), Expect = 2e-18
 Identities = 51/219 (23%), Positives = 84/219 (38%), Gaps = 51/219 (23%)

Query: 99  ILGEGGFGVVYKGVIDENVRPGYKTT--FVAIKELNRGGYQGDREWLAEVNYLGQLRHSN 156
           +LG G F  V+            + T    A+K + +     D     E+  L +++H N
Sbjct: 16  VLGSGAFSEVFLVK--------QRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHEN 67

Query: 157 LVKLIGYCCEDEHRI-LVYEYMESGSL-----------EK---HLLRRVGCMLTWSRRMK 201
           +V L     E      LV + +  G L           EK    ++++V           
Sbjct: 68  IVTLEDI-YESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQV----------- 115

Query: 202 IALDAAKGLAFLHGAERPVIYRDFKTSNILL---NADFSAKLSDFGLAKDGPMGDQTHVS 258
                   + +LH  E  +++RD K  N+L      +    ++DFGL+K   M     +S
Sbjct: 116 -----LSAVKYLH--ENGIVHRDLKPENLLYLTPEENSKIMITDFGLSK---MEQNGIMS 165

Query: 259 TRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLG 297
           T   GT GY APE +     +   D +  GV+   +L G
Sbjct: 166 TAC-GTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCG 203

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 85.1 bits (211), Expect = 3e-18
 Identities = 54/211 (25%), Positives = 82/211 (38%), Gaps = 35/211 (16%)

Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLA-EVNYLGQLRHSNLV 158
           +G G FGV        +         VA+K + RG      E +  E+     LRH N+V
Sbjct: 28  IGSGNFGVARLM---RDKLTKEL---VAVKYIERG--AAIDENVQREIINHRSLRHPNIV 79

Query: 159 KLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAK-------GLA 211
           +         H  ++ EY   G L + +            R     +A         G++
Sbjct: 80  RFKEVILTPTHLAIIMEYASGGELYERICNA--------GRFSED-EARFFFQQLLSGVS 130

Query: 212 FLHGAERPVIYRDFKTSNILLNADFSA--KLSDFGLAKDGPMGDQTHVSTRVMGTYGYAA 269
           + H     + +RD K  N LL+   +   K+ DFG +K   +  Q    + V GT  Y A
Sbjct: 131 YCH--SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK--STV-GTPAYIA 185

Query: 270 PEYVMTGHL--TARSDVYGFGVVLLEMLLGR 298
           PE V+         +DV+  GV L  ML+G 
Sbjct: 186 PE-VLLRQEYDGKIADVWSCGVTLYVMLVGA 215

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 83.4 bits (207), Expect = 3e-18
 Identities = 62/213 (29%), Positives = 97/213 (45%), Gaps = 37/213 (17%)

Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRG--GYQGDREWLA-EVNYLGQLRHSN 156
           LG G FG V  G   E+   G+K   VA+K LNR           +  E+  L   RH +
Sbjct: 19  LGVGTFGKVKIG---EHQLTGHK---VAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPH 72

Query: 157 LVKLIGY-CCEDEHRI-LVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAK------ 208
           ++KL  Y          +V EY+  G L  ++ +          R++   +A +      
Sbjct: 73  IIKL--YQVISTPTDFFMVMEYVSGGELFDYICKH--------GRVEEM-EARRLFQQIL 121

Query: 209 -GLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGY 267
             + + H     V++RD K  N+LL+A  +AK++DFGL+     G+    S    G+  Y
Sbjct: 122 SAVDYCH--RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC---GSPNY 176

Query: 268 AAPEYVMTGHL--TARSDVYGFGVVLLEMLLGR 298
           AAPE V++G L      D++  GV+L  +L G 
Sbjct: 177 AAPE-VISGRLYAGPEVDIWSCGVILYALLCGT 208

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score = 84.3 bits (209), Expect = 3e-18
 Identities = 56/214 (26%), Positives = 94/214 (43%), Gaps = 40/214 (18%)

Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLA----EVNYLGQLRHS 155
           +G+G F  V       ++  G +   VAIK +++   Q +   L     EV  +  L H 
Sbjct: 23  IGKGNFAKVKLA---RHILTGRE---VAIKIIDKT--QLNPTSLQKLFREVRIMKILNHP 74

Query: 156 NLVKLIGY-CCEDEHRI-LVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAK----- 208
           N+VKL  +   E E  + L+ EY   G +  +L+           RMK   +A       
Sbjct: 75  NIVKL--FEVIETEKTLYLIMEYASGGEVFDYLVAH--------GRMKEK-EARSKFRQI 123

Query: 209 --GLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYG 266
              + + H  ++ +++RD K  N+LL+AD + K++DFG + +        +     G   
Sbjct: 124 VSAVQYCH--QKRIVHRDLKAENLLLDADMNIKIADFGFSNE--FTVGGKLDAFC-GAPP 178

Query: 267 YAAPEYVMTGHL--TARSDVYGFGVVLLEMLLGR 298
           YAAPE +  G        DV+  GV+L  ++ G 
Sbjct: 179 YAAPE-LFQGKKYDGPEVDVWSLGVILYTLVSGS 211

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 84.6 bits (210), Expect = 4e-18
 Identities = 58/217 (26%), Positives = 89/217 (41%), Gaps = 44/217 (20%)

Query: 100 LGEGGFGVVYKGVIDENVRPGYKTT--FVAIKELNRGGYQGDREW---LAEVNYLGQ-LR 153
           LG+G FG V             K T    A+K L +     D +    + E   L    +
Sbjct: 28  LGKGSFGKVML------SE--RKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGK 79

Query: 154 HSNLVKLIGYCC--EDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAK--- 208
              L +L  + C    +    V EY+  G L  H+           +  +     A    
Sbjct: 80  PPFLTQL--HSCFQTMDRLYFVMEYVNGGDLMYHI----------QQVGRFKEPHAVFYA 127

Query: 209 -----GLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVM- 262
                GL FL    + +IYRD K  N++L+++   K++DFG+ K+      T   T+   
Sbjct: 128 AEIAIGLFFLQ--SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVT---TKTFC 182

Query: 263 GTYGYAAPEYVMTGHLTARS-DVYGFGVVLLEMLLGR 298
           GT  Y APE ++      +S D + FGV+L EML G+
Sbjct: 183 GTPDYIAPE-IIAYQPYGKSVDWWAFGVLLYEMLAGQ 218

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score = 83.4 bits (207), Expect = 4e-18
 Identities = 52/210 (24%), Positives = 81/210 (38%), Gaps = 39/210 (18%)

Query: 100 LGEGGFGVVYKGVIDENVRPGYKTT-------FVAIKELNRGGYQGDREWLA-EVNYLGQ 151
           LG G F +V K           K T       F+  + L+       RE +  EVN L +
Sbjct: 13  LGSGQFAIVRKCR--------QKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILRE 64

Query: 152 LRHSNLVKLIGYCCEDEHRILVYEYMESGSL------EKHLLRRVGCMLTWSRRMKIALD 205
           +RH N++ L          +L+ E +  G L      ++ L             +K  LD
Sbjct: 65  IRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQF-----LKQILD 119

Query: 206 AAKGLAFLHGAERPVIYRDFKTSNILL----NADFSAKLSDFGLAKDGPMGDQTHVSTRV 261
              G+ +LH   + + + D K  NI+L      +   KL DFG+A    +          
Sbjct: 120 ---GVHYLH--SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHK--IEAGNEFKNIF 172

Query: 262 MGTYGYAAPEYVMTGHLTARSDVYGFGVVL 291
            GT  + APE V    L   +D++  GV+ 
Sbjct: 173 -GTPEFVAPEIVNYEPLGLEADMWSIGVIT 201

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score = 83.8 bits (208), Expect = 4e-18
 Identities = 55/217 (25%), Positives = 85/217 (39%), Gaps = 39/217 (17%)

Query: 99  ILGEGGFGVVYKGVIDENVRPGYKTT-------FVAIKELNRGGYQGDREWLA-EVNYLG 150
            LG G F +V K           K+T       F+  ++         RE +  EV+ L 
Sbjct: 19  ELGSGQFAIVKKCR--------EKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILR 70

Query: 151 QLRHSNLVKLIGYCCEDEHRILVYEYMESGSL------EKHLLRRVGCMLTWSRRMKIAL 204
           Q+ H N++ L          +L+ E +  G L      ++ L             +K  L
Sbjct: 71  QVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSF-----IKQIL 125

Query: 205 DAAKGLAFLHGAERPVIYRDFKTSNILL---NADFSA-KLSDFGLAKDGPMGDQTHVSTR 260
           D   G+ +LH   + + + D K  NI+L   N      KL DFGLA +  + D       
Sbjct: 126 D---GVNYLH--TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE--IEDGVEFKNI 178

Query: 261 VMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLG 297
             GT  + APE V    L   +D++  GV+   +L G
Sbjct: 179 F-GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 84.2 bits (209), Expect = 4e-18
 Identities = 64/215 (29%), Positives = 91/215 (42%), Gaps = 40/215 (18%)

Query: 100 LGEGGFGVVYKGVIDENVRPGYKTT--FVAIKELNRGGYQGDREW---LAEVNYLGQ-LR 153
           LG+G FG V+           +K T  F AIK L +     D +    + E   L     
Sbjct: 25  LGKGSFGKVFL------AE--FKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 76

Query: 154 HSNLVKLIGYCCEDEHRI-LVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAK---- 208
           H  L  +     + +  +  V EY+  G L  H+              K  L  A     
Sbjct: 77  HPFLTHMF-CTFQTKENLFFVMEYLNGGDLMYHI----------QSCHKFDLSRATFYAA 125

Query: 209 ----GLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVM-G 263
               GL FLH   + ++YRD K  NILL+ D   K++DFG+ K+  +GD     T    G
Sbjct: 126 EIILGLQFLH--SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK---TNTFCG 180

Query: 264 TYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGR 298
           T  Y APE ++        D + FGV+L EML+G+
Sbjct: 181 TPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQ 215

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 84.3 bits (209), Expect = 4e-18
 Identities = 57/212 (26%), Positives = 92/212 (43%), Gaps = 38/212 (17%)

Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREW---LAEVNYLGQLRHSN 156
           LG G FG V        V+        A+K L++      ++    L E   L  +    
Sbjct: 49  LGTGSFGRVML------VKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102

Query: 157 LVKLIGYCCEDEHRI-LVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAK------- 208
           LVKL  +  +D   + +V EY+  G +  HL RR+G         + +   A+       
Sbjct: 103 LVKLE-FSFKDNSNLYMVMEYVAGGEMFSHL-RRIG---------RFSEPHARFYAAQIV 151

Query: 209 -GLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGY 267
               +LH     +IYRD K  N+L++     +++DFG AK   +  +T   T + GT   
Sbjct: 152 LTFEYLH--SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR--VKGRTW--T-LCGTPEA 204

Query: 268 AAPEYVMT-GHLTARSDVYGFGVVLLEMLLGR 298
            APE +++ G+  A  D +  GV++ EM  G 
Sbjct: 205 LAPEIILSKGYNKA-VDWWALGVLIYEMAAGY 235

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 84.2 bits (209), Expect = 6e-18
 Identities = 64/213 (30%), Positives = 94/213 (44%), Gaps = 36/213 (16%)

Query: 100 LGEGGFGVVYKGVIDENVRPGYKTT--FVAIKELNRGGYQGDREW---LAEVNYLGQ-LR 153
           +G+G FG V         R  +K    F A+K L +      +E    ++E N L + ++
Sbjct: 46  IGKGSFGKVLL------AR--HKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVK 97

Query: 154 HSNLVKLIGYCCEDEHRI-LVYEYMESGSLEKHLLRRVGCMLTWSRRMK-----IALDAA 207
           H  LV L  +  +   ++  V +Y+  G L  HL +R  C L    R +     IA    
Sbjct: 98  HPFLVGLH-FSFQTADKLYFVLDYINGGELFYHL-QRERCFLE--PRARFYAAEIAS--- 150

Query: 208 KGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVM-GTYG 266
             L +LH     ++YRD K  NILL++     L+DFGL K+    + T   T    GT  
Sbjct: 151 -ALGYLH--SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNST---TSTFCGTPE 204

Query: 267 YAAPEYVM-TGHLTARSDVYGFGVVLLEMLLGR 298
           Y APE +    +     D +  G VL EML G 
Sbjct: 205 YLAPEVLHKQPY-DRTVDWWCLGAVLYEMLYGL 236

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score = 83.0 bits (206), Expect = 6e-18
 Identities = 58/223 (26%), Positives = 98/223 (43%), Gaps = 40/223 (17%)

Query: 91  TKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTT--FVAIKELNRGGYQG-DREWLA-EV 146
           +  +     LG+G F VV + V        +KTT    A K +N       D + L  E 
Sbjct: 5   SDNYDVKEELGKGAFSVVRRCV--------HKTTGLEFAAKIINTKKLSARDFQKLEREA 56

Query: 147 NYLGQLRHSNLVKLIGYCCEDEHRI-LVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALD 205
               +L+H N+V+L     ++E    LV++ +  G L + ++ R      +S       D
Sbjct: 57  RICRKLQHPNIVRLHDS-IQEESFHYLVFDLVTGGELFEDIVARE----FYSEA-----D 106

Query: 206 AAK-------GLAFLHGAERPVIYRDFKTSNILL---NADFSAKLSDFGLAKDGPMGDQT 255
           A+         +A+ H     +++R+ K  N+LL       + KL+DFGLA +  + D  
Sbjct: 107 ASHCIQQILESIAYCH--SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIE--VNDSE 162

Query: 256 HVSTRVMGTYGYAAPEYVMTGHL-TARSDVYGFGVVLLEMLLG 297
                  GT GY +PE V+     +   D++  GV+L  +L+G
Sbjct: 163 AWHGFA-GTPGYLSPE-VLKKDPYSKPVDIWACGVILYILLVG 203

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 83.9 bits (208), Expect = 7e-18
 Identities = 63/253 (24%), Positives = 107/253 (42%), Gaps = 59/253 (23%)

Query: 70  LRQNPGYSNVDIFTYNEMKLATKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIK 129
           L +  G+   D+      +L   +      +G G +G V   +   + R G K   VAIK
Sbjct: 4   LIRKKGFYKQDVNK-TAWELPKTY-VSPTHVGSGAYGSVCSAI---DKRSGEK---VAIK 55

Query: 130 ELNRGGYQGDREWLA-----EVNYLGQLRHSNLVKLI-----GYCCEDEHRI-LVYEYME 178
           +L+R       E  A     E+  L  ++H N++ L+          + +   LV  +M+
Sbjct: 56  KLSR---PFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQ 112

Query: 179 SGSLEKHLLRRVGCMLTWSRRMKIALDAA----------KGLAFLHGAERPVIYRDFKTS 228
           +       L+++         M +               KGL ++H A   V++RD K  
Sbjct: 113 TD------LQKI---------MGLKFSEEKIQYLVYQMLKGLKYIHSAG--VVHRDLKPG 155

Query: 229 NILLNADFSAKLSDFGLAK--DGPMGDQTHVSTRVMGTYGYAAPEYVMT-GHLTARSDVY 285
           N+ +N D   K+ DFGLA+  D  M    +V TR    + Y APE +++  H     D++
Sbjct: 156 NLAVNEDCELKILDFGLARHADAEMTG--YVVTR----W-YRAPEVILSWMHYNQTVDIW 208

Query: 286 GFGVVLLEMLLGR 298
             G ++ EML G+
Sbjct: 209 SVGCIMAEMLTGK 221

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 83.4 bits (207), Expect = 7e-18
 Identities = 59/212 (27%), Positives = 95/212 (44%), Gaps = 38/212 (17%)

Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREW---LAEVNYLGQLRHSN 156
           LG G FG V+       +R  +   + A+K L +      ++      E   L  + H  
Sbjct: 14  LGTGSFGRVHL------IRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPF 67

Query: 157 LVKLIGYCCEDEHRI-LVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAK------- 208
           ++++     +D  +I ++ +Y+E G L   L R+           +     AK       
Sbjct: 68  IIRMW-GTFQDAQQIFMIMDYIEGGELFSLL-RKSQ---------RFPNPVAKFYAAEVC 116

Query: 209 -GLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGY 267
             L +LH   + +IYRD K  NILL+ +   K++DFG AK     D T+  T + GT  Y
Sbjct: 117 LALEYLH--SKDIIYRDLKPENILLDKNGHIKITDFGFAKYV--PDVTY--T-LCGTPDY 169

Query: 268 AAPEYVMT-GHLTARSDVYGFGVVLLEMLLGR 298
            APE V T  +  +  D + FG+++ EML G 
Sbjct: 170 IAPEVVSTKPYNKS-IDWWSFGILIYEMLAGY 200

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 83.4 bits (207), Expect = 8e-18
 Identities = 64/217 (29%), Positives = 96/217 (44%), Gaps = 42/217 (19%)

Query: 99  ILGEGGFGVVYKGVIDENVRPGYKTT--FVAIKELNRGGYQGDREW---LAEVNYLGQ-L 152
           ++G G +  V        VR   K T    A+K + +     D +      E +   Q  
Sbjct: 16  VIGRGSYAKVLL------VR--LKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQAS 67

Query: 153 RHSNLVKLIGYCCEDEHRI-LVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAK--- 208
            H  LV L   C + E R+  V EY+  G L  H+           R+ K+  + A+   
Sbjct: 68  NHPFLVGLH-SCFQTESRLFFVIEYVNGGDLMFHM----------QRQRKLPEEHARFYS 116

Query: 209 -----GLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVM- 262
                 L +LH  ER +IYRD K  N+LL+++   KL+D+G+ K+G     T   T    
Sbjct: 117 AEISLALNYLH--ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT---TSTFC 171

Query: 263 GTYGYAAPEYVMTGHLTARS-DVYGFGVVLLEMLLGR 298
           GT  Y APE ++ G     S D +  GV++ EM+ GR
Sbjct: 172 GTPNYIAPE-ILRGEDYGFSVDWWALGVLMFEMMAGR 207

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score = 83.6 bits (207), Expect = 9e-18
 Identities = 55/225 (24%), Positives = 86/225 (38%), Gaps = 39/225 (17%)

Query: 91  TKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTT-------FVAIKELNRGGYQGDREWL 143
             F+     LG G F +V K           K+T       F+  ++         RE +
Sbjct: 11  EDFYDIGEELGSGQFAIVKKCR--------EKSTGLEYAAKFIKKRQSRASRRGVCREEI 62

Query: 144 -AEVNYLGQLRHSNLVKLIGYCCEDEHRILVYEYMESGSL------EKHLLRRVGCMLTW 196
             EV+ L Q+ H N++ L          +L+ E +  G L      ++ L          
Sbjct: 63  EREVSILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSF-- 120

Query: 197 SRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILL---NADFSA-KLSDFGLAKDGPMG 252
              +K  LD   G+ +LH   + + + D K  NI+L   N      KL DFGLA      
Sbjct: 121 ---IKQILD---GVNYLH--TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH---EI 169

Query: 253 DQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLG 297
           +       + GT  + APE V    L   +D++  GV+   +L G
Sbjct: 170 EDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 83.4 bits (207), Expect = 1e-17
 Identities = 62/216 (28%), Positives = 90/216 (41%), Gaps = 42/216 (19%)

Query: 100 LGEGGFGVVYKGVIDENVRPGYKTT--FVAIKELNRGGYQGDREW---LAEVNYLGQ-LR 153
           LG+G FG V         R   K T    A+K L +     D +    + E   L     
Sbjct: 31  LGKGSFGKVML------AR--VKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARN 82

Query: 154 HSNLVKLIGYCCEDEHRI-LVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAK---- 208
           H  L +L   C +   R+  V E++  G L  H+           +  +     A+    
Sbjct: 83  HPFLTQLF-CCFQTPDRLFFVMEFVNGGDLMFHI----------QKSRRFDEARARFYAA 131

Query: 209 ----GLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVM-G 263
                L FLH  ++ +IYRD K  N+LL+ +   KL+DFG+ K+G     T   T    G
Sbjct: 132 EIISALMFLH--DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVT---TATFCG 186

Query: 264 TYGYAAPEYVMTGHLTARS-DVYGFGVVLLEMLLGR 298
           T  Y APE ++   L   + D +  GV+L EML G 
Sbjct: 187 TPDYIAPE-ILQEMLYGPAVDWWAMGVLLYEMLCGH 221

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score = 82.8 bits (205), Expect = 1e-17
 Identities = 53/213 (24%), Positives = 84/213 (39%), Gaps = 31/213 (14%)

Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRG--GYQGDREWLA----EVNYLGQLR 153
           LG GGFG VY G+    V        VAIK + +      G+         EV  L ++ 
Sbjct: 51  LGSGGFGSVYSGI---RVSDNLP---VAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 104

Query: 154 HS--NLVKLIGYCCEDEHRILVYEYME-SGSLEKHLLRRVGCMLTWSRRMKIALDAAKGL 210
                +++L+ +    +  +L+ E  E    L   +  R G +     R        + +
Sbjct: 105 SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITER-GALQEELAR-SFFWQVLEAV 162

Query: 211 AFLHGAERPVIYRDFKTSNILLNAD-FSAKLSDFGLA---KDGPMGDQTHVSTRVMGTYG 266
              H     V++RD K  NIL++ +    KL DFG     KD              GT  
Sbjct: 163 RHCH--NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY--TDFD-----GTRV 213

Query: 267 YAAPEYVMTGHLTARS-DVYGFGVVLLEMLLGR 298
           Y+ PE++       RS  V+  G++L +M+ G 
Sbjct: 214 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGD 246

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score = 82.7 bits (205), Expect = 1e-17
 Identities = 55/215 (25%), Positives = 89/215 (41%), Gaps = 29/215 (13%)

Query: 92  KFFRPDYILGEGGFGVVYKGVIDENVRPGYKTT--FVAIKELNRGGYQGDREWLAEVNYL 149
                D  LGEG F +  K V        +K +    A+K +++      ++   E+  L
Sbjct: 11  DLDLKDKPLGEGSFSICRKCV--------HKKSNQAFAVKIISKRMEANTQK---EITAL 59

Query: 150 GQLR-HSNLVKLIGYCCEDEHRI-LVYEYMESGSLEKHLLRRVGCMLTWSRRM--KIALD 205
                H N+VKL      D+    LV E +  G L + + ++      +S      I   
Sbjct: 60  KLCEGHPNIVKLHEV-FHDQLHTFLVMELLNGGELFERIKKKK----HFSETEASYIMRK 114

Query: 206 AAKGLAFLHGAERPVIYRDFKTSNILL---NADFSAKLSDFGLAKDGPMGDQTHVSTRVM 262
               ++ +H  +  V++RD K  N+L    N +   K+ DFG A+  P  +Q  + T   
Sbjct: 115 LVSAVSHMH--DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQP-LKTPC- 170

Query: 263 GTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLG 297
            T  YAAPE +         D++  GV+L  ML G
Sbjct: 171 FTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSG 205

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score = 82.4 bits (204), Expect = 1e-17
 Identities = 54/218 (24%), Positives = 84/218 (38%), Gaps = 39/218 (17%)

Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLA---------EVNYLG 150
           LG+GGFG V+ G     +    +   VAIK + R        W           EV  L 
Sbjct: 39  LGKGGFGTVFAGH---RLTDRLQ---VAIKVIPR---NRVLGWSPLSDSVTCPLEVALLW 89

Query: 151 QLR----HSNLVKLIGYCCEDEHRILVYEYMESGS-LEKHLLRRVGCMLTWSRRMKIALD 205
           ++     H  +++L+ +    E  +LV E       L  ++  + G +     R      
Sbjct: 90  KVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEK-GPLGEGPSR-CFFGQ 147

Query: 206 AAKGLAFLHGAERPVIYRDFKTSNILLNAD-FSAKLSDFGLA---KDGPMGDQTHVSTRV 261
               +   H   R V++RD K  NIL++     AKL DFG      D P           
Sbjct: 148 VVAAIQHCH--SRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPY--TDFD---- 199

Query: 262 MGTYGYAAPEYVMTGHLTARS-DVYGFGVVLLEMLLGR 298
            GT  Y+ PE++      A    V+  G++L +M+ G 
Sbjct: 200 -GTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGD 236

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score = 82.3 bits (204), Expect = 2e-17
 Identities = 50/203 (24%), Positives = 85/203 (41%), Gaps = 27/203 (13%)

Query: 100 LGEGGFGVVYKGVIDENVRPGYKTT--FVAIKELN-RGGYQGDREWLA-EVNYLGQLRHS 155
           LG G F VV + +         K+T    A K L  R   Q  R  +  E+  L   +  
Sbjct: 37  LGRGKFAVVRQCI--------SKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSC 88

Query: 156 -NLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLT---WSRRMKIALDAAKGLA 211
             ++ L          IL+ EY   G +    L  +  M++     R +K  L+   G+ 
Sbjct: 89  PRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILE---GVY 145

Query: 212 FLHGAERPVIYRDFKTSNILL---NADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYA 268
           +LH  +  +++ D K  NILL         K+ DFG+++   +G    +   + GT  Y 
Sbjct: 146 YLH--QNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRK--IGHACELREIM-GTPEYL 200

Query: 269 APEYVMTGHLTARSDVYGFGVVL 291
           APE +    +T  +D++  G++ 
Sbjct: 201 APEILNYDPITTATDMWNIGIIA 223

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 82.8 bits (205), Expect = 2e-17
 Identities = 63/217 (29%), Positives = 96/217 (44%), Gaps = 42/217 (19%)

Query: 99  ILGEGGFGVVYKGVIDENVRPGYKTT--FVAIKELNRGGYQGDREW---LAEVNYLGQ-L 152
           ++G G +  V        VR   K T    A++ + +     D +      E +   Q  
Sbjct: 59  VIGRGSYAKVLL------VR--LKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQAS 110

Query: 153 RHSNLVKLIGYCCEDEHRI-LVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAK--- 208
            H  LV L   C + E R+  V EY+  G L  H+           R+ K+  + A+   
Sbjct: 111 NHPFLVGLH-SCFQTESRLFFVIEYVNGGDLMFHM----------QRQRKLPEEHARFYS 159

Query: 209 -----GLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVM- 262
                 L +LH  ER +IYRD K  N+LL+++   KL+D+G+ K+G     T   T    
Sbjct: 160 AEISLALNYLH--ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT---TSTFC 214

Query: 263 GTYGYAAPEYVMTGHLTARS-DVYGFGVVLLEMLLGR 298
           GT  Y APE ++ G     S D +  GV++ EM+ GR
Sbjct: 215 GTPNYIAPE-ILRGEDYGFSVDWWALGVLMFEMMAGR 250

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score = 81.9 bits (203), Expect = 2e-17
 Identities = 40/208 (19%), Positives = 75/208 (36%), Gaps = 34/208 (16%)

Query: 100 LGEGGFGVVYKGVIDENVRPGYKTT--FVAIKELNRGGYQGDREWLA-EVNYLGQLRHSN 156
           LG G FG+V++ V          ++      K +   G   D+  +  E++ L   RH N
Sbjct: 13  LGRGEFGIVHRCV--------ETSSKKTYMAKFVKVKG--TDQVLVKKEISILNIARHRN 62

Query: 157 LVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGA 216
           ++ L       E  ++++E++    + + +       L     +       + L FLH  
Sbjct: 63  ILHLHESFESMEELVMIFEFISGLDIFERINTS-AFELNEREIVSYVHQVCEALQFLH-- 119

Query: 217 ERPVIYRDFKTSNILLNADFSA--KLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVM 274
              + + D +  NI+     S+  K+ +FG A+             +     Y APE   
Sbjct: 120 SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQAR---QLKPGDNFRLLFTAPEYYAPEVH- 175

Query: 275 TGHLTARSDVYGFGV------VLLEMLL 296
                 + DV            L+ +LL
Sbjct: 176 ------QHDVVSTATDMWSLGTLVYVLL 197

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 82.4 bits (204), Expect = 2e-17
 Identities = 54/230 (23%), Positives = 93/230 (40%), Gaps = 58/230 (25%)

Query: 94  FRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLA-----EVNY 148
           ++    +G G  G+V       +         VAIK+L+R       +  A     E+  
Sbjct: 27  YQNLKPIGSGAQGIVCAAY---DAILERN---VAIKKLSR---PFQNQTHAKRAYRELVL 77

Query: 149 LGQLRHSNLVKLI-----GYCCEDEHRI-LVYEYMESGSLEKHLLRRVGCMLTWSRRMKI 202
           +  + H N++ L+         E+   + +V E M++       L +V         +++
Sbjct: 78  MKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN------LCQV---------IQM 122

Query: 203 ALDAA----------KGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLA----KD 248
            LD             G+  LH A   +I+RD K SNI++ +D + K+ DFGLA      
Sbjct: 123 ELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 180

Query: 249 GPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGR 298
             M    +V TR      Y APE ++        D++  G ++ EM+ G 
Sbjct: 181 FMMTP--YVVTRY-----YRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 223

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 83.0 bits (205), Expect = 3e-17
 Identities = 55/257 (21%), Positives = 109/257 (42%), Gaps = 36/257 (14%)

Query: 55  PKNVTPVPPKKNVNDLRQNPGYSNVDIFTYNEMKLATKFFRPDYILGEGGFGVVYKGVID 114
             +V+ +    N++  + +  + +V++   +   +  ++ +    +G G  G+V      
Sbjct: 27  QVDVSYIAKHYNMSKSKVDNQFYSVEVGD-STFTVLKRY-QNLKPIGSGAQGIVCAAY-- 82

Query: 115 ENVRPGYKTTFVAIKELNRGGYQGDREWLA-----EVNYLGQLRHSNLVKLI-----GYC 164
            +         VAIK+L+R       +  A     E+  +  + H N++ L+        
Sbjct: 83  -DAVLDRN---VAIKKLSR---PFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKT 135

Query: 165 CEDEHRI-LVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYR 223
            E+   + LV E M++     +L + +   L   R   +      G+  LH A   +I+R
Sbjct: 136 LEEFQDVYLVMELMDA-----NLCQVIQMELDHERMSYLLYQMLCGIKHLHSAG--IIHR 188

Query: 224 DFKTSNILLNADFSAKLSDFGLAKDGPMGDQT--HVSTRVMGTYGYAAPEYVMTGHLTAR 281
           D K SNI++ +D + K+ DFGLA+          +V TR      Y APE ++       
Sbjct: 189 DLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY-----YRAPEVILGMGYKEN 243

Query: 282 SDVYGFGVVLLEMLLGR 298
            D++  G ++ EM+  +
Sbjct: 244 VDIWSVGCIMGEMVRHK 260

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 82.5 bits (204), Expect = 3e-17
 Identities = 48/217 (22%), Positives = 80/217 (36%), Gaps = 36/217 (16%)

Query: 99  ILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDRE---WLAEVNYLGQLRHS 155
           ++G G FG V        V+        A+K LN+       E   +  E + L      
Sbjct: 81  VIGRGAFGEVAV------VKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSK 134

Query: 156 NLVKLIGYCCEDEHRI-LVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAK------ 208
            +  L  Y  +D++ + LV +Y   G L   L +            ++  + A+      
Sbjct: 135 WITTLH-YAFQDDNNLYLVMDYYVGGDLLTLLSKFED---------RLPEEMARFYLAEM 184

Query: 209 --GLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYG 266
              +  +H  +   ++RD K  NIL++ +   +L+DFG             S  V GT  
Sbjct: 185 VIAIDSVH--QLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAV-GTPD 241

Query: 267 YAAPEYVMTGHLTARS-----DVYGFGVVLLEMLLGR 298
           Y +PE +              D +  GV + EML G 
Sbjct: 242 YISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGE 278

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score = 81.5 bits (202), Expect = 3e-17
 Identities = 50/210 (23%), Positives = 79/210 (37%), Gaps = 39/210 (18%)

Query: 100 LGEGGFGVVYKGVIDENVRPGYKTT-------FVAIKELNRGGYQGDREWLA-EVNYLGQ 151
           LG G F VV K           K+T       F+  +          RE +  EV+ L +
Sbjct: 19  LGSGQFAVVKKCR--------EKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70

Query: 152 LRHSNLVKLIGYCCEDEHRILVYEYMESGSL------EKHLLRRVGCMLTWSRRMKIALD 205
           ++H N++ L          IL+ E +  G L      ++ L             +K  L+
Sbjct: 71  IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEF-----LKQILN 125

Query: 206 AAKGLAFLHGAERPVIYRDFKTSNILL----NADFSAKLSDFGLAKDGPMGDQTHVSTRV 261
               + +LH     + + D K  NI+L          K+ DFGLA      D  +    +
Sbjct: 126 G---VYYLH--SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH---KIDFGNEFKNI 177

Query: 262 MGTYGYAAPEYVMTGHLTARSDVYGFGVVL 291
            GT  + APE V    L   +D++  GV+ 
Sbjct: 178 FGTPEFVAPEIVNYEPLGLEADMWSIGVIT 207

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score = 81.6 bits (202), Expect = 4e-17
 Identities = 52/215 (24%), Positives = 90/215 (41%), Gaps = 36/215 (16%)

Query: 91  TKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTT--FVAIKELNRGGYQG-DREWLA-EV 146
           +  +     LG+G F VV + V        +KTT    A K +N       D + L  E 
Sbjct: 28  SDNYDVKEELGKGAFSVVRRCV--------HKTTGLEFAAKIINTKKLSARDFQKLEREA 79

Query: 147 NYLGQLRHSNLVKLIGYCCEDEHRI-LVYEYMESGSL------EKHLLRRVGCMLTWSRR 199
               +L+H N+V+L     ++E    LV++ +  G L       +               
Sbjct: 80  RICRKLQHPNIVRLHDS-IQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHC----- 133

Query: 200 MKIALDAAKGLAFLHGAERPVIYRDFKTSNILL---NADFSAKLSDFGLAKDGPMGDQTH 256
           ++  L++   +A+ H     +++R+ K  N+LL       + KL+DFGLA +  + D   
Sbjct: 134 IQQILES---IAYCH--SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIE--VNDSEA 186

Query: 257 VSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVL 291
                 GT GY +PE +     +   D++  GV+L
Sbjct: 187 WHGFA-GTPGYLSPEVLKKDPYSKPVDIWACGVIL 220

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score = 81.2 bits (201), Expect = 5e-17
 Identities = 62/264 (23%), Positives = 102/264 (38%), Gaps = 44/264 (16%)

Query: 42  SPGMKTASGSQVTPKNVTPVPPKKNVNDLRQNPGYSNVDIFTYNEMKLATKFFRPDYILG 101
                      +  ++++ V            P Y        +     + FF  +  LG
Sbjct: 7   HSSGVDLGTENLYFQSMSSVTASAAPGTASLVPDYW----IDGSNRDALSDFFEVESELG 62

Query: 102 EGGFGVVYKGVIDENVRPGYKTT--FVAIKELNRGGYQGDREWL-AEVNYLGQLRHSNLV 158
            G   +VY+           K T    A+K L +     D++ +  E+  L +L H N++
Sbjct: 63  RGATSIVYRCK--------QKGTQKPYALKVLKK---TVDKKIVRTEIGVLLRLSHPNII 111

Query: 159 KLIGYCCEDEHRI-LVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAK-------GL 210
           KL     E    I LV E +  G L   ++ +      +S R     DAA         +
Sbjct: 112 KLKEI-FETPTEISLVLELVTGGELFDRIVEKG----YYSER-----DAADAVKQILEAV 161

Query: 211 AFLHGAERPVIYRDFKTSNILL---NADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGY 267
           A+LH  E  +++RD K  N+L      D   K++DFGL+K   +  Q  + T   GT GY
Sbjct: 162 AYLH--ENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKI--VEHQVLMKTVC-GTPGY 216

Query: 268 AAPEYVMTGHLTARSDVYGFGVVL 291
            APE +         D++  G++ 
Sbjct: 217 CAPEILRGCAYGPEVDMWSVGIIT 240

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 81.7 bits (202), Expect = 6e-17
 Identities = 54/221 (24%), Positives = 83/221 (37%), Gaps = 47/221 (21%)

Query: 99  ILGEGGFGVVYKGVIDENVRPGYKTT--FVAIKELNRGGYQGDRE---WLAEVNYLGQLR 153
           ++G G FG V        VR  +K+T    A+K L++       +   +  E + +    
Sbjct: 76  VIGRGAFGEVQL------VR--HKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFAN 127

Query: 154 HSNLVKLIGYCCEDEHRI-LVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAK---- 208
              +V+L  Y  +D+  + +V EYM  G L   +               +    A+    
Sbjct: 128 SPWVVQLF-YAFQDDRYLYMVMEYMPGGDLVNLM-----------SNYDVPEKWARFYTA 175

Query: 209 ----GLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGT 264
                L  +H      I+RD K  N+LL+     KL+DFG              T V GT
Sbjct: 176 EVVLALDAIH--SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-GT 232

Query: 265 YGYAAPEYVMTGHLTARSDVYG-------FGVVLLEMLLGR 298
             Y +PE + +         YG        GV L EML+G 
Sbjct: 233 PDYISPEVLKS---QGGDGYYGRECDWWSVGVFLYEMLVGD 270

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score = 80.5 bits (199), Expect = 7e-17
 Identities = 52/217 (23%), Positives = 86/217 (39%), Gaps = 39/217 (17%)

Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNR----GGYQGDREWLA----EVNYLGQ 151
           LG G FG V+  V   +     +   V +K + +         +   L     E+  L +
Sbjct: 32  LGSGAFGFVWTAV---DKEKNKE---VVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSR 85

Query: 152 LRHSNLVKLIGYCCEDEHRILVYEYMESGS-LEKHLLRRVGCMLTWSRRMKIALDAAK-- 208
           + H+N++K++          LV E   SG  L   + R          R+   L A+   
Sbjct: 86  VEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRH--------PRLDEPL-ASYIF 136

Query: 209 -----GLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMG 263
                 + +L    + +I+RD K  NI++  DF+ KL DFG A     G   +      G
Sbjct: 137 RQLVSAVGYLR--LKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTFC---G 191

Query: 264 TYGYAAPEYVMTGHL--TARSDVYGFGVVLLEMLLGR 298
           T  Y APE V+ G+       +++  GV L  ++   
Sbjct: 192 TIEYCAPE-VLMGNPYRGPELEMWSLGVTLYTLVFEE 227

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score = 80.5 bits (199), Expect = 8e-17
 Identities = 53/211 (25%), Positives = 81/211 (38%), Gaps = 33/211 (15%)

Query: 99  ILGEGGFGVVYKGVIDENVRPGYKTT--FVAIKELNRGGYQGDREWLA-EVNYLGQL-RH 154
           +LG G  G V +          ++ T    A+K L       D      EV++  Q    
Sbjct: 36  VLGLGVNGKVLECF--------HRRTGQKCALKLLY------DSPKARQEVDHHWQASGG 81

Query: 155 SNLVKLIGYCCEDEHRI-----LVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKG 209
            ++V ++    E+ H       ++ E ME G L   +  R     T     +I  D    
Sbjct: 82  PHIVCILDV-YENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTA 140

Query: 210 LAFLHGAERPVIYRDFKTSNILL---NADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYG 266
           + FLH     + +RD K  N+L      D   KL+DFG AK      Q  + T    T  
Sbjct: 141 IQFLH--SHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAK---ETTQNALQTPC-YTPY 194

Query: 267 YAAPEYVMTGHLTARSDVYGFGVVLLEMLLG 297
           Y APE +         D++  GV++  +L G
Sbjct: 195 YVAPEVLGPEKYDKSCDMWSLGVIMYILLCG 225

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 81.4 bits (201), Expect = 9e-17
 Identities = 60/211 (28%), Positives = 96/211 (45%), Gaps = 33/211 (15%)

Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRG--GYQGDREWLA-EVNYLGQLRHSN 156
           LG G FG V  G   ++   G+K   VA+K LNR           +  E+  L   RH +
Sbjct: 24  LGVGTFGKVKVG---KHELTGHK---VAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPH 77

Query: 157 LVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAK-------G 209
           ++KL           +V EY+  G L  ++ +          R+    ++ +       G
Sbjct: 78  IIKLYQVISTPSDIFMVMEYVSGGELFDYICKN--------GRLDEK-ESRRLFQQILSG 128

Query: 210 LAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAA 269
           + + H     V++RD K  N+LL+A  +AK++DFGL+     G+    S    G+  YAA
Sbjct: 129 VDYCHR--HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC---GSPNYAA 183

Query: 270 PEYVMTGHL--TARSDVYGFGVVLLEMLLGR 298
           PE V++G L      D++  GV+L  +L G 
Sbjct: 184 PE-VISGRLYAGPEVDIWSSGVILYALLCGT 213

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score = 79.2 bits (196), Expect = 1e-16
 Identities = 56/230 (24%), Positives = 95/230 (41%), Gaps = 44/230 (19%)

Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNR----------------------GGYQ 137
           +G+G +GVV       N          A+K L++                      GG  
Sbjct: 21  IGKGSYGVVKLAY---NENDNTY---YAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCI 74

Query: 138 GDREWLA----EVNYLGQLRHSNLVKL--IGYCCEDEHRILVYEYMESGSLEKHLLRRVG 191
             R  +     E+  L +L H N+VKL  +     ++H  +V+E +  G + +  +  + 
Sbjct: 75  QPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVME--VPTLK 132

Query: 192 CMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPM 251
            +     R     D  KG+ +LH   + +I+RD K SN+L+  D   K++DFG++ +   
Sbjct: 133 PLSEDQAR-FYFQDLIKGIEYLH--YQKIIHRDIKPSNLLVGEDGHIKIADFGVSNE-FK 188

Query: 252 GDQTHVSTRVMGTYGYAAPEYVMTGHLT---ARSDVYGFGVVLLEMLLGR 298
           G    +S  V GT  + APE +            DV+  GV L   + G+
Sbjct: 189 GSDALLSNTV-GTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQ 237

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 80.6 bits (199), Expect = 2e-16
 Identities = 53/306 (17%), Positives = 103/306 (33%), Gaps = 58/306 (18%)

Query: 44  GMKTASGSQVTPKNVTPVPPKKNVNDLRQNPGYSNVDIFTYNEMKLATKF-----FRPDY 98
             + A+  Q        V   +     R+    S     T +  +  + +     +   +
Sbjct: 3   SHEAAAAQQHNSGTQHTVSGSQQEGQQRKQHHSSK---PTASMPRPHSDWQIPDRYEIRH 59

Query: 99  ILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLA-----EVNYLGQLR 153
           ++G G +G V +     +         VAIK++ R     +          E+  L +L 
Sbjct: 60  LIGTGSYGHVCEAY---DKLEKRV---VAIKKILR---VFEDLIDCKRILREIAILNRLN 110

Query: 154 HSNLVKLI-----GYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAK 208
           H ++VK++         + +   +V E  +S   +K    R    LT      +  +   
Sbjct: 111 HDHVVKVLDIVIPKDVEKFDELYVVLEIADS-DFKKLF--RTPVYLTELHIKTLLYNLLV 167

Query: 209 GLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLA---------KDGPMGDQTHVST 259
           G+ ++H A   +++RD K +N L+N D S K+ DFGLA                      
Sbjct: 168 GVKYVHSAG--ILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDM 225

Query: 260 RVMGTYGYAAPEYVMTGHLTAR----------SDVYGFGV-------VLLEMLLGRRAVD 302
            ++        +  +TGH+  R           + Y   +       +  E+L   +   
Sbjct: 226 NLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENV 285

Query: 303 KSRPSR 308
                R
Sbjct: 286 AYHADR 291

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 80.2 bits (198), Expect = 2e-16
 Identities = 53/269 (19%), Positives = 95/269 (35%), Gaps = 36/269 (13%)

Query: 41  DSPGMKTASGSQVTPKNVTPVPPKKNVNDLRQNPGYSNVDIFTYNEMKLATKFFRPDYIL 100
            +P       +   P      PP       +Q P +         +  +   +     +L
Sbjct: 15  PAPAPPPQPPTPALPHPPAQPPPPPP----QQFPQFHVKSGLQIKKNAIIDDYKVTSQVL 70

Query: 101 GEGGFGVVYKGVIDENVRPGYKTT--FVAIKELNRGGYQGDREWLA-EVNYLGQL-RHSN 156
           G G  G V +           K T    A+K L       D      EV    +  +  +
Sbjct: 71  GLGINGKVLQIF--------NKRTQEKFALKMLQ------DCPKARREVELHWRASQCPH 116

Query: 157 LVKLIGYCCEDEHRI-----LVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLA 211
           +V+++    E+ +       +V E ++ G L   +  R     T     +I     + + 
Sbjct: 117 IVRIVDV-YENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQ 175

Query: 212 FLHGAERPVIYRDFKTSNILL---NADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYA 268
           +LH     + +RD K  N+L      +   KL+DFG AK+    +   ++T    T  Y 
Sbjct: 176 YLH--SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS--LTTPC-YTPYYV 230

Query: 269 APEYVMTGHLTARSDVYGFGVVLLEMLLG 297
           APE +         D++  GV++  +L G
Sbjct: 231 APEVLGPEKYDKSCDMWSLGVIMYILLCG 259

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score = 79.3 bits (196), Expect = 2e-16
 Identities = 53/227 (23%), Positives = 95/227 (41%), Gaps = 35/227 (15%)

Query: 85  NEMKLATKFFRPDY----ILGEGGFGVVYKGVIDENVRPGYKTT--FVAIKELNRGGYQG 138
            ++   +  F   Y     +G G + V  + +        +K T    A+K +++     
Sbjct: 11  QQLHRNSIQFTDGYEVKEDIGVGSYSVCKRCI--------HKATNMEFAVKIIDKSKRDP 62

Query: 139 DREWLAEVNYLGQL-RHSNLVKLIGYCCEDEHRI-LVYEYMESGSLEKHLLRRVGCMLTW 196
             E    +  L +  +H N++ L     +D   + +V E M+ G L   +LR+      +
Sbjct: 63  TEE----IEILLRYGQHPNIITLKDV-YDDGKYVYVVTELMKGGELLDKILRQK----FF 113

Query: 197 SRRM--KIALDAAKGLAFLHGAERPVIYRDFKTSNILL---NADFSA-KLSDFGLAKDGP 250
           S R    +     K + +LH   + V++RD K SNIL    + +  + ++ DFG AK   
Sbjct: 114 SEREASAVLFTITKTVEYLH--AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLR 171

Query: 251 MGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLG 297
             +   + T    T  + APE +      A  D++  GV+L  ML G
Sbjct: 172 AENGL-LMTPC-YTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTG 216

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score = 80.0 bits (198), Expect = 2e-16
 Identities = 51/216 (23%), Positives = 87/216 (40%), Gaps = 37/216 (17%)

Query: 91  TKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTT--FVAIKELN-RGGYQGDREWLA-EV 146
           T+ ++    LG+G F VV + V                A   +N +     D + L  E 
Sbjct: 10  TEEYQLFEELGKGAFSVVRRCV--------KVLAGQEYAAMIINTKKLSARDHQKLEREA 61

Query: 147 NYLGQLRHSNLVKLIGYCCEDEHRI-LVYEYMESGSL------EKHLLRRVGCMLTWSRR 199
                L+H N+V+L      +E    L+++ +  G L       ++              
Sbjct: 62  RICRLLKHPNIVRLHDS-ISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHC----- 115

Query: 200 MKIALDAAKGLAFLHGAERPVIYRDFKTSNILL---NADFSAKLSDFGLAKDGPMGDQTH 256
           ++  L+A   +   H  +  V++R+ K  N+LL       + KL+DFGLA +   G+Q  
Sbjct: 116 IQQILEA---VLHCH--QMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVE-GEQQA 169

Query: 257 VSTRVMGTYGYAAPEYVMTGHL-TARSDVYGFGVVL 291
                 GT GY +PE V+         D++  GV+L
Sbjct: 170 WFGFA-GTPGYLSPE-VLRKDPYGKPVDLWACGVIL 203

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 79.0 bits (195), Expect = 4e-16
 Identities = 49/247 (19%), Positives = 88/247 (35%), Gaps = 45/247 (18%)

Query: 94  FRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLA-----EVNY 148
           +   +++G G +G VY      +         VAIK++NR     +          E+  
Sbjct: 28  YIIKHLIGRGSYGYVYLAY---DKNTEKN---VAIKKVNR---MFEDLIDCKRILREITI 78

Query: 149 LGQLRHSNLVKLI-----GYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIA 203
           L +L+   +++L          + +   +V E  +S  L    L +    LT      I 
Sbjct: 79  LNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIADS-DL--KKLFKTPIFLTEEHIKTIL 135

Query: 204 LDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLA----KDGPMGDQTHVST 259
            +   G  F+H +   +I+RD K +N LLN D S K+ DFGLA     +        +  
Sbjct: 136 YNLLLGENFIHESG--IIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEE 193

Query: 260 RVMGTYGYAAPEYVMTGHLTAR----------SDVYGFGV-------VLLEMLLGRRAVD 302
                      +  +T H+  R           + Y   +       +  E+L   ++  
Sbjct: 194 NEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHI 253

Query: 303 KSRPSRE 309
               +R 
Sbjct: 254 NDPTNRF 260

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 78.1 bits (193), Expect = 4e-16
 Identities = 61/213 (28%), Positives = 98/213 (46%), Gaps = 38/213 (17%)

Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRG--GYQGDREWLA-EVNYLGQLRHSN 156
           LGEG FG V       + +   K   VA+K ++R           +  E++YL  LRH +
Sbjct: 17  LGEGSFGKVKLA---THYKTQQK---VALKFISRQLLKKSDMHMRVEREISYLKLLRHPH 70

Query: 157 LVKLIGY-CCEDEHRI-LVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAK------ 208
           ++KL  Y        I +V EY   G L  +++ +        +RM    +  +      
Sbjct: 71  IIKL--YDVITTPTDIVMVIEYA-GGELFDYIVEK--------KRMTED-EGRRFFQQII 118

Query: 209 -GLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGY 267
             + + H     +++RD K  N+LL+ + + K++DFGL+     G+    S    G+  Y
Sbjct: 119 CAIEYCH--RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSC---GSPNY 173

Query: 268 AAPEYVMTGHL--TARSDVYGFGVVLLEMLLGR 298
           AAPE V+ G L      DV+  G+VL  ML+GR
Sbjct: 174 AAPE-VINGKLYAGPEVDVWSCGIVLYVMLVGR 205

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 78.1 bits (193), Expect = 6e-16
 Identities = 64/219 (29%), Positives = 96/219 (43%), Gaps = 36/219 (16%)

Query: 94  FRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLA-----EVNY 148
           +R    +G G +G V   V   + R G K   VAIK+L R       E  A     E+  
Sbjct: 27  YRDLQPVGSGAYGAVCSAV---DGRTGAK---VAIKKLYR---PFQSELFAKRAYRELRL 77

Query: 149 LGQLRHSNLVKLI-----GYCCEDEHRI-LVYEYMESGSLEKHLLRRVGCMLTWSRRMKI 202
           L  +RH N++ L+         +D     LV  +M +  L K +       L   R   +
Sbjct: 78  LKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGT-DLGKLMKHEK---LGEDRIQFL 133

Query: 203 ALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAK--DGPMGDQTHVSTR 260
                KGL ++H A   +I+RD K  N+ +N D   K+ DFGLA+  D  M    +V TR
Sbjct: 134 VYQMLKGLRYIHAAG--IIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTG--YVVTR 189

Query: 261 VMGTYGYAAPEYVMT-GHLTARSDVYGFGVVLLEMLLGR 298
                 Y APE ++     T   D++  G ++ EM+ G+
Sbjct: 190 W-----YRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 77.9 bits (192), Expect = 8e-16
 Identities = 57/254 (22%), Positives = 91/254 (35%), Gaps = 82/254 (32%)

Query: 99  ILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLV 158
            LG G FG+V +    E+          A+K++     Q  R    E++ +  L H N++
Sbjct: 14  TLGTGSFGIVCEVFDIES------GKRFALKKV----LQDPRYKNRELDIMKVLDHVNII 63

Query: 159 KL--IGYCCEDEHRI------------------------------------LVYEYMESG 180
           KL    Y   DE                                       ++ EY+   
Sbjct: 64  KLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD- 122

Query: 181 SLEKHLLRRVGCMLTWSRRMKIALDAAK--------GLAFLHGAERPVIYRDFKTSNILL 232
           +L K L               I ++            + F+H     + +RD K  N+L+
Sbjct: 123 TLHKVLKS------FIRSGRSIPMNLISIYIYQLFRAVGFIHSLG--ICHRDIKPQNLLV 174

Query: 233 NA-DFSAKLSDFGLAK----DGPMGDQTH-VSTRVMGTYGYAAPEYVMTG--HLTARSDV 284
           N+ D + KL DFG AK      P       + +R    + Y APE +M G    T   D+
Sbjct: 175 NSKDNTLKLCDFGSAKKLIPSEPS---VAYICSR----F-YRAPE-LMLGATEYTPSIDL 225

Query: 285 YGFGVVLLEMLLGR 298
           +  G V  E++LG+
Sbjct: 226 WSIGCVFGELILGK 239

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 77.3 bits (191), Expect = 1e-15
 Identities = 59/234 (25%), Positives = 94/234 (40%), Gaps = 62/234 (26%)

Query: 94  FRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGD-REWLAEVNYLGQL 152
           +     +GEG +G+V       +     +   VAIK+++   +Q   +  L E+  L + 
Sbjct: 29  YTNLSYIGEGAYGMVCSAY---DNLNKVR---VAIKKISPFEHQTYCQRTLREIKILLRF 82

Query: 153 RHSNLVKLI-----GYCCEDEHRILVYEYME--------SGSL-EKH-------LLRRVG 191
           RH N++ +          + +   +V + ME        +  L   H       +LR   
Sbjct: 83  RHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILR--- 139

Query: 192 CMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLA----- 246
                            GL ++H A   V++RD K SN+LLN     K+ DFGLA     
Sbjct: 140 -----------------GLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADP 180

Query: 247 KDGPMGDQT-HVSTRVMGTYGYAAPEYVMT-GHLTARSDVYGFGVVLLEMLLGR 298
                G  T +V+TR      Y APE ++     T   D++  G +L EML  R
Sbjct: 181 DHDHTGFLTEYVATR-----WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 77.4 bits (191), Expect = 1e-15
 Identities = 57/244 (23%), Positives = 106/244 (43%), Gaps = 42/244 (17%)

Query: 71  RQNPGYSNVDIFTYNEMKLATKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKE 130
           ++ P +   ++      ++  ++ +    +G G +G V       + + G +   VA+K+
Sbjct: 10  QERPTFYRQELN-KTIWEVPERY-QNLSPVGSGAYGSVCAAF---DTKTGLR---VAVKK 61

Query: 131 LNRGGYQGDREWLA-----EVNYLGQLRHSNLVKLI-----GYCCEDEHRI-LVYEYMES 179
           L+R          A     E+  L  ++H N++ L+         E+ + + LV   M +
Sbjct: 62  LSR---PFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGA 118

Query: 180 GSLEKHLLRRV--GCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFS 237
                  L  +     LT      +     +GL ++H A+  +I+RD K SN+ +N D  
Sbjct: 119 D------LNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCE 170

Query: 238 AKLSDFGLAK--DGPMGDQTHVSTRVMGTYGYAAPEYVMT-GHLTARSDVYGFGVVLLEM 294
            K+ DFGLA+     M    +V+TR      Y APE ++   H     D++  G ++ E+
Sbjct: 171 LKILDFGLARHTADEMTG--YVATRW-----YRAPEIMLNWMHYNQTVDIWSVGCIMAEL 223

Query: 295 LLGR 298
           L GR
Sbjct: 224 LTGR 227

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 76.9 bits (190), Expect = 1e-15
 Identities = 57/226 (25%), Positives = 92/226 (40%), Gaps = 39/226 (17%)

Query: 94  FRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLA-----EVNY 148
           F+   +LGEG +GVV       +   G     VAIK++       D+   A     E+  
Sbjct: 13  FQLKSLLGEGAYGVVCSAT---HKPTGEI---VAIKKIE----PFDKPLFALRTLREIKI 62

Query: 149 LGQLRHSNLVKLI-----GYCCEDEHRILVYEYMESGSLEKHLLRRV--GCMLTWSRRMK 201
           L   +H N++ +                ++ E M++       L RV    ML+      
Sbjct: 63  LKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTD------LHRVISTQMLSDDHIQY 116

Query: 202 IALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLA----KDGPMGDQTHV 257
                 + +  LHG+   VI+RD K SN+L+N++   K+ DFGLA    +      +   
Sbjct: 117 FIYQTLRAVKVLHGSN--VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTG 174

Query: 258 STRVMGTY----GYAAPEYVMTGHL-TARSDVYGFGVVLLEMLLGR 298
               M  +     Y APE ++T    +   DV+  G +L E+ L R
Sbjct: 175 QQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 75.0 bits (185), Expect = 4e-15
 Identities = 57/248 (22%), Positives = 94/248 (37%), Gaps = 81/248 (32%)

Query: 94  FRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLA-----EVNY 148
           +     LG GG G+V+  V   +     +   VAIK++                  E+  
Sbjct: 13  YMDLKPLGCGGNGLVFSAV---DNDCDKR---VAIKKIVL-----TDPQSVKHALREIKI 61

Query: 149 LGQLRHSNLVKLI-------------GYCCEDEHRI-LVYEYME--------SGSL-EKH 185
           + +L H N+VK+                   + + + +V EYME         G L E+H
Sbjct: 62  IRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEEH 121

Query: 186 -------LLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNA-DFS 237
                  LLR                    GL ++H A   V++RD K +N+ +N  D  
Sbjct: 122 ARLFMYQLLR--------------------GLKYIHSAN--VLHRDLKPANLFINTEDLV 159

Query: 238 AKLSDFGLA-----KDGPMGDQT-HVSTRVMGTYGYAAPEYVMT-GHLTARSDVYGFGVV 290
            K+ DFGLA          G  +  + T+      Y +P  +++  + T   D++  G +
Sbjct: 160 LKIGDFGLARIMDPHYSHKGHLSEGLVTK-----WYRSPRLLLSPNNYTKAIDMWAAGCI 214

Query: 291 LLEMLLGR 298
             EML G+
Sbjct: 215 FAEMLTGK 222

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 72.7 bits (178), Expect = 4e-14
 Identities = 51/190 (26%), Positives = 73/190 (38%), Gaps = 23/190 (12%)

Query: 194 LTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGD 253
           LT    +  +   AKG+ FL  A R  I+RD    NILL+     K+ DFGLA+D     
Sbjct: 190 LTLEHLICYSFQVAKGMEFL--ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDP 247

Query: 254 QTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEML-LGRRAVDKSRPSREHNL 312
                        + APE +     T +SDV+ FGV+L E+  LG        P      
Sbjct: 248 DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGA------SPY----- 296

Query: 313 VEWARPLLNNNKKVLRILDP--RLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVAL 370
                P +  +++  R L    R+         M        C    P  RP  S++V  
Sbjct: 297 -----PGVKIDEEFCRRLKEGTRMRAPDYTTPEM--YQTMLDCWHGEPSQRPTFSELVEH 349

Query: 371 LETVQSQGAE 380
           L  +    A+
Sbjct: 350 LGNLLQANAQ 359

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 61.1 bits (148), Expect = 2e-10
 Identities = 24/99 (24%), Positives = 43/99 (43%), Gaps = 4/99 (4%)

Query: 99  ILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDR-EWLAEVNYLGQL-RHSN 156
            LG G FG V +      +        VA+K L  G    +    ++E+  L  +  H N
Sbjct: 29  PLGRGAFGQVIEADA-FGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 87

Query: 157 LVKLIGYCCEDEHRILV-YEYMESGSLEKHLLRRVGCML 194
           +V L+G C +    ++V  E+ + G+L  +L  +    +
Sbjct: 88  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFV 126

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 72.3 bits (178), Expect = 4e-14
 Identities = 51/258 (19%), Positives = 100/258 (38%), Gaps = 47/258 (18%)

Query: 59  TPVPPK----KNVNDLRQNPGYSNVDIFTYNEMKLATKFFRPD-YIL----GEGGFGVVY 109
            PVP +     +VN   +   Y + +           ++   D Y L    G G +  V+
Sbjct: 2   GPVPSRARVYTDVN-THRPREYWDYESHV-------VEWGNQDDYQLVRKLGRGKYSEVF 53

Query: 110 KGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLR-HSNLVKLIGYCCEDE 168
           + +   N+    K   V +K L        ++   E+  L  LR   N++ L     +  
Sbjct: 54  EAI---NITNNEK---VVVKILKP---VKKKKIKREIKILENLRGGPNIITLADIVKDPV 104

Query: 169 HR--ILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFK 226
            R   LV+E++ +    K L + +          +I     K L + H     +++RD K
Sbjct: 105 SRTPALVFEHVNNTDF-KQLYQTLTDYDIRFYMYEIL----KALDYCHSMG--IMHRDVK 157

Query: 227 TSNILLNADFSA-KLSDFGLAKDG-PMGDQTH-VSTRVMGTYGYAAPEYVMTG--HLTAR 281
             N++++ +    +L D+GLA+   P  +    V++R      +  PE ++         
Sbjct: 158 PHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRY-----FKGPE-LLVDYQMYDYS 211

Query: 282 SDVYGFGVVLLEMLLGRR 299
            D++  G +L  M+  + 
Sbjct: 212 LDMWSLGCMLASMIFRKE 229

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 70.5 bits (173), Expect = 2e-13
 Identities = 55/249 (22%), Positives = 93/249 (37%), Gaps = 75/249 (30%)

Query: 94  FRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLA-----EVNY 148
           +     LG+G +G+V+K +   + R G     VA+K++            A     E+  
Sbjct: 11  YELVKKLGKGAYGIVWKSI---DRRTGEV---VAVKKIFDAF---QNSTDAQRTFREIMI 61

Query: 149 LGQLR-HSNLVKL--IGYCCEDEHRILVYEYME--------SGSL-EKH-------LLRR 189
           L +L  H N+V L  +     D    LV++YME        +  L   H       L++ 
Sbjct: 62  LTELSGHENIVNLLNVLRADNDRDVYLVFDYMETDLHAVIRANILEPVHKQYVVYQLIK- 120

Query: 190 VGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDG 249
                               + +LH     +++RD K SNILLNA+   K++DFGL++  
Sbjct: 121 -------------------VIKYLHSGG--LLHRDMKPSNILLNAECHVKVADFGLSRSF 159

Query: 250 PMGDQTHVSTRVMGTYGYAAP--------EYVMT------------GHLTARSDVYGFGV 289
               +   +  +                 +YV T               T   D++  G 
Sbjct: 160 VNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGC 219

Query: 290 VLLEMLLGR 298
           +L E+L G+
Sbjct: 220 ILGEILCGK 228

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 62.8 bits (153), Expect = 5e-11
 Identities = 39/227 (17%), Positives = 77/227 (33%), Gaps = 39/227 (17%)

Query: 100 LGEGGFGVVYKG--VIDENVRPGYKTTFVAIK----------ELNRGGYQGDREWLAEVN 147
                 G++Y+           G +    ++K          E N          + +  
Sbjct: 50  QTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWK 109

Query: 148 YLGQLRHSNLVKLIGY-CCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDA 206
            L       +   +G+   +D++R LV   +   SL+  L      +L+    +++A   
Sbjct: 110 KLYSTPLLAIPTCMGFGVHQDKYRFLVLPSLGR-SLQSALDVSPKHVLSERSVLQVACRL 168

Query: 207 AKGLAFLHGAERPVIYRDFKTSNILLNADFSAK--LSDFGLAK---DGPMGDQTHVSTR- 260
              L FLH  E   ++ +    NI ++ +  ++  L+ +G A            HV+   
Sbjct: 169 LDALEFLH--ENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCP----SGKHVAYVE 222

Query: 261 -----VMGTYGYAAPEYVMTGHL----TARSDVYGFGVVLLEMLLGR 298
                  G   + +    M  H     + RSD+   G  +L+ L G 
Sbjct: 223 GSRSPHEGDLEFIS----MDLHKGCGPSRRSDLQSLGYCMLKWLYGF 265

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 60.0 bits (146), Expect = 3e-10
 Identities = 39/164 (23%), Positives = 63/164 (38%), Gaps = 35/164 (21%)

Query: 99  ILGEGGFGVVYKGVIDENVRPGYKTT--FVAIKELNRGGYQGDREWLA-EVNYLGQL-RH 154
           +LG G  G V +           K T    A+K L       D      EV    +  + 
Sbjct: 25  VLGLGINGKVLQIF--------NKRTQEKFALKMLQ------DCPKARREVELHWRASQC 70

Query: 155 SNLVKLIGYCCEDEHRI-----LVYEYMESGSLEKHLLRRVGCMLT---WSRRMKIALDA 206
            ++V+++    E+ +       +V E ++ G L   +  R     T    S  MK   +A
Sbjct: 71  PHIVRIVDV-YENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEA 129

Query: 207 AKGLAFLHGAERPVIYRDFKTSNILL---NADFSAKLSDFGLAK 247
              + +LH     + +RD K  N+L      +   KL+DFG AK
Sbjct: 130 ---IQYLH--SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 168

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 58.1 bits (141), Expect = 1e-09
 Identities = 56/224 (25%), Positives = 87/224 (38%), Gaps = 39/224 (17%)

Query: 94  FRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIK-ELNRGGYQGDREWLAEVNYLGQL 152
           ++    +GEG FGV+++G    N+        VAIK E  R      R+   E      L
Sbjct: 12  YKVGRRIGEGSFGVIFEG---TNLLNN---QQVAIKFEPRRSDAPQLRD---EYRTYKLL 62

Query: 153 RHSNLV-KLIGYCCEDEHRILVYEYMESG-SLEKHLLRRVGCMLTWSRRMKIALDAAKGL 210
                +  +  +  E  H +LV + +  G SLE  LL   G   +       A      +
Sbjct: 63  AGCTGIPNVYYFGQEGLHNVLVIDLL--GPSLE-DLLDLCGRKFSVKTVAMAAKQMLARV 119

Query: 211 AFLHGAERPVIYRDFKTSNILLNADFSAK-----LSDFGLAK---DGPMGDQTHVSTR-- 260
             +H  E+ ++YRD K  N L+    S       + DFG+ K   D     + H+  R  
Sbjct: 120 QSIH--EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDP--VTKQHIPYREK 175

Query: 261 --VMGTYGYAAPEYVMTGHL----TARSDVYGFGVVLLEMLLGR 298
             + GT  Y +    +  HL    + R D+   G V +  L G 
Sbjct: 176 KNLSGTARYMS----INTHLGREQSRRDDLEALGHVFMYFLRGS 215

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 58.2 bits (141), Expect = 2e-09
 Identities = 42/232 (18%), Positives = 84/232 (36%), Gaps = 37/232 (15%)

Query: 94  FRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREW-----LAEVNY 148
           ++    +G+GGFG +Y   ++ +   G       +K           E       A+   
Sbjct: 37  WKVGLPIGQGGFGCIYLADMNSSESVGSDAP-CVVKVEPSDNGPLFTELKFYQRAAKPEQ 95

Query: 149 LGQLRHSNLVKLIG----------YCCEDEHRILVYEYMESG-SLEKHLLRRVGCMLTWS 197
           + +   +  +K +G                +R ++ +    G  L+K +        +  
Sbjct: 96  IQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF--GSDLQK-IYEANAKRFSRK 152

Query: 198 RRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAK--LSDFGLAKD-GPMGDQ 254
             ++++L     L ++H  E   ++ D K SN+LLN     +  L D+GLA    P G  
Sbjct: 153 TVLQLSLRILDILEYIH--EHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVH 210

Query: 255 THVSTR----VMGTYGYAAPEYVMTGHL----TARSDVYGFGVVLLEMLLGR 298
              +        GT  + +    +  H     + R D+   G  +++ L G 
Sbjct: 211 KAYAADPKRCHDGTIEFTS----IDAHNGVAPSRRGDLEILGYCMIQWLTGH 258

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 57.4 bits (139), Expect = 3e-09
 Identities = 51/220 (23%), Positives = 84/220 (38%), Gaps = 33/220 (15%)

Query: 94  FRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIK-ELNRGGYQGDREWLAEVNYLGQL 152
           +R    +G G FG +Y G    ++  G     VAIK E  +  +        E      +
Sbjct: 11  YRLGRKIGSGSFGDIYLG---TDIAAG---EEVAIKLECVKTKHPQ---LHIESKIYKMM 61

Query: 153 RHSNLV-KLIGYCCEDEHRILVYEYMESG-SLEKHLLRRVGCMLTWSRRMKIALDAAKGL 210
           +    +  +     E ++ ++V E +  G SLE  L        +    + +A      +
Sbjct: 62  QGGVGIPTIRWCGAEGDYNVMVMELL--GPSLE-DLFNFCSRKFSLKTVLLLADQMISRI 118

Query: 211 AFLHGAERPVIYRDFKTSNILLNADFSAK---LSDFGLAKD-GPMGDQTHVSTR----VM 262
            ++H   +  I+RD K  N L+          + DFGLAK         H+  R    + 
Sbjct: 119 EYIH--SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLT 176

Query: 263 GTYGYAAPEYVMTGHL----TARSDVYGFGVVLLEMLLGR 298
           GT  YA+    +  HL    + R D+   G VL+   LG 
Sbjct: 177 GTARYAS----INTHLGIEQSRRDDLESLGYVLMYFNLGS 212

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 57.2 bits (137), Expect = 4e-09
 Identities = 35/195 (17%), Positives = 56/195 (28%), Gaps = 59/195 (30%)

Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIK--------ELNRGGYQGDREWLAEVNYLGQ 151
           +GEG FG V++ +           T VAIK         +N    +   E L E+    +
Sbjct: 28  IGEGVFGEVFQTI--------ADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKE 79

Query: 152 L---------RHSNLVKLIGYCC------------------------------EDEHRIL 172
           L         R    + L    C                              +D+   +
Sbjct: 80  LSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFI 139

Query: 173 VYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILL 232
           V E+   G   + +  +   + + +    I       LA    A     +RD    N+LL
Sbjct: 140 VLEFEFGGIDLEQMRTK---LSSLATAKSILHQLTASLAVAE-ASLRFEHRDLHWGNVLL 195

Query: 233 NADFSAKLSDFGLAK 247
                 KL      K
Sbjct: 196 KKTSLKKLHYTLNGK 210

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 55.9 bits (135), Expect = 9e-09
 Identities = 44/228 (19%), Positives = 83/228 (36%), Gaps = 44/228 (19%)

Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREW-----LAEVNYLGQLRH 154
           +G GGFG++Y            K     +K   +       E      +A+ + + +   
Sbjct: 45  IGSGGFGLIYLA---FPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIE 101

Query: 155 SNLVKLIG----YCC------EDEHRILVYEYMESG-SLEKHLLRRVGCMLTWSRRM--K 201
              +  +G    Y           +R +V E +  G  L+K +  + G      +    +
Sbjct: 102 RKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERL--GIDLQK-ISGQNGTF---KKSTVLQ 155

Query: 202 IALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAK--LSDFGLAKD-GPMGDQTHVS 258
           + +     L ++H  E   ++ D K +N+LL      +  L+D+GL+    P G+     
Sbjct: 156 LGIRMLDVLEYIH--ENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQ 213

Query: 259 TRV----MGTYGYAAPEYVMTGHL----TARSDVYGFGVVLLEMLLGR 298
                   GT  + +    +  H     + RSDV   G  +L  L G+
Sbjct: 214 ENPRKGHNGTIEFTS----LDAHKGVALSRRSDVEILGYCMLRWLCGK 257

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 55.5 bits (134), Expect = 2e-08
 Identities = 40/225 (17%), Positives = 81/225 (36%), Gaps = 43/225 (19%)

Query: 99  ILGEGGFGVVYKGVIDENVRPGYKT-TFVAIKEL-NRGGY--QGDREWLAEVNYLGQLR- 153
            LG G F  V+    D          T VA+K +     Y          E+  L ++  
Sbjct: 26  KLGWGHFSTVWL-AKD------MVNNTHVAMKIVRGDKVYTEAA----EDEIKLLQRVND 74

Query: 154 ----------HSNLVKLIGY----CCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRR 199
                      ++++KL+ +         H ++V+E +   +L   + +     +     
Sbjct: 75  ADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYV 133

Query: 200 MKIALDAAKGLAFLHGAERPVIYRDFKTSNILLN------ADFSAKLSDFGLAKDGPMGD 253
            +I+     GL ++H     +I+ D K  N+L+            K++D G A       
Sbjct: 134 KQISKQLLLGLDYMHRRCG-IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHY 192

Query: 254 QTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGR 298
              + TR      Y +PE ++       +D++    ++ E++ G 
Sbjct: 193 TNSIQTRE-----YRSPEVLLGAPWGCGADIWSTACLIFELITGD 232

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 54.7 bits (132), Expect = 2e-08
 Identities = 59/255 (23%), Positives = 92/255 (36%), Gaps = 36/255 (14%)

Query: 60  PVPPKKNVNDLRQNPGYSNVD---IFTYNEMKLATKFFRPDYILGEGGFGVVYKGVIDEN 116
                        N GY + +   I    E     ++      +G+G FG V K   D  
Sbjct: 21  QSMSSHKKERKVYNDGYDDDNYDYIVKNGEK-WMDRYEIDSL-IGKGSFGQVVK-AYDR- 76

Query: 117 VRPGYKT-TFVAIKEL-NRGGY--QGDREWLAEVNYLGQLRH------SNLVKLIGYCCE 166
                    +VAIK + N+  +  Q       EV  L  +          +V L  +   
Sbjct: 77  -----VEQEWVAIKIIKNKKAFLNQA----QIEVRLLELMNKHDTEMKYYIVHLKRHFMF 127

Query: 167 DEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFK 226
             H  LV+E + S +L   L       ++ +   K A      L FL   E  +I+ D K
Sbjct: 128 RNHLCLVFEML-SYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLK 186

Query: 227 TSNILLNADFSA--KLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHL-TARSD 283
             NILL     +  K+ DFG +         ++ +R      Y +PE V+ G       D
Sbjct: 187 PENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRF-----YRSPE-VLLGMPYDLAID 240

Query: 284 VYGFGVVLLEMLLGR 298
           ++  G +L+EM  G 
Sbjct: 241 MWSLGCILVEMHTGE 255

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 53.5 bits (129), Expect = 4e-08
 Identities = 51/224 (22%), Positives = 86/224 (38%), Gaps = 39/224 (17%)

Query: 94  FRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIK-ELNRGGYQGDREWLAEVNYLGQL 152
           FR    +G G FG +  G    N+       +VAIK E  +           E  +  QL
Sbjct: 11  FRVGKKIGCGNFGELRLGK---NLYTN---EYVAIKLEPMKSRAPQLHL---EYRFYKQL 61

Query: 153 RHSNLV-KLIGYCCEDEHRILVYEYMESG-SLEKHLLRRVGCMLTWSRRMKIALDAAKGL 210
              + + ++  +    ++  +V E +  G SLE  L        +    + IA+     +
Sbjct: 62  GSGDGIPQVYYFGPCGKYNAMVLELL--GPSLE-DLFDLCDRTFSLKTVLMIAIQLISRM 118

Query: 211 AFLHGAERPVIYRDFKTSNILLNADFSAK-----LSDFGLAK---DGPMGDQTHVSTR-- 260
            ++H   + +IYRD K  N L+    +       + DF LAK   D     + H+  R  
Sbjct: 119 EYVH--SKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDP--ETKKHIPYREH 174

Query: 261 --VMGTYGYAAPEYVMTGHL----TARSDVYGFGVVLLEMLLGR 298
             + GT  Y +    +  HL    + R D+   G + +  L G 
Sbjct: 175 KSLTGTARYMS----INTHLGKEQSRRDDLEALGHMFMYFLRGS 214

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 53.2 bits (128), Expect = 9e-08
 Identities = 54/215 (25%), Positives = 88/215 (40%), Gaps = 37/215 (17%)

Query: 99  ILGEGGFGVVYKGVIDENVRPGYKT-TFVAIKEL-NRGGY--QGDREWLAEVNYLGQLRH 154
           ++G+G FG V K   D       K    VA+K + N   +  Q       E+  L  LR 
Sbjct: 104 VIGKGSFGQVVK-AYDH------KVHQHVALKMVRNEKRFHRQA----AEEIRILEHLRK 152

Query: 155 ------SNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRR---VGCMLTWSRRMKIALD 205
                  N++ ++       H  + +E + S +L + L+++    G  L   R  K A  
Sbjct: 153 QDKDNTMNVIHMLENFTFRNHICMTFELL-SMNLYE-LIKKNKFQGFSLPLVR--KFAHS 208

Query: 206 AAKGLAFLHGAERPVIYRDFKTSNILLNADFSA--KLSDFGLAKDGPMGDQTHVSTRVMG 263
             + L  LH     +I+ D K  NILL     +  K+ DFG +        T++ +R   
Sbjct: 209 ILQCLDALHKNR--IIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYTYIQSRF-- 264

Query: 264 TYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGR 298
              Y APE ++        D++  G +L E+L G 
Sbjct: 265 ---YRAPEVILGARYGMPIDMWSLGCILAELLTGY 296

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 53.1 bits (127), Expect = 1e-07
 Identities = 54/219 (24%), Positives = 86/219 (39%), Gaps = 31/219 (14%)

Query: 94  FRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIK-ELNRGGYQGDREWLAEVNYLGQL 152
           FR    +G G FG +Y G    N++       VAIK E  +  +        E      L
Sbjct: 9   FRLGRKIGSGSFGEIYLG---TNIQTN---EEVAIKLENVKTKHPQLLY---ESKIYRIL 59

Query: 153 RHSNLV-KLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLA 211
           +    +  +  +  E ++ +LV + +   SLE  L       L+    + +A      + 
Sbjct: 60  QGGTGIPNVRWFGVEGDYNVLVMDLLGP-SLE-DLFNFCSRKLSLKTVLMLADQMINRVE 117

Query: 212 FLHGAERPVIYRDFKTSNILLNADFSAK---LSDFGLAKD-GPMGDQTHVSTR----VMG 263
           F+H   +  ++RD K  N L+     A    + DFGLAK         H+  R    + G
Sbjct: 118 FVH--SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTG 175

Query: 264 TYGYAAPEYVMTGHL----TARSDVYGFGVVLLEMLLGR 298
           T  YA+    +  HL    + R D+   G VL+  L G 
Sbjct: 176 TARYAS----VNTHLGIEQSRRDDLESLGYVLMYFLRGS 210

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 51.1 bits (122), Expect = 4e-07
 Identities = 43/262 (16%), Positives = 76/262 (29%), Gaps = 77/262 (29%)

Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVK 159
           LG G F  V+               FVA+K +    +  +     E+  L  +R+S+   
Sbjct: 45  LGWGHFSTVWL------SWDIQGKKFVAMKVVKSAEHYTETALD-EIRLLKSVRNSD-PN 96

Query: 160 LIGYCC-------------EDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDA 206
                                 H  +V+E +    L K +++     L      KI    
Sbjct: 97  DPNREMVVQLLDDFKISGVNGTHICMVFEVLGH-HLLKWIIKSNYQGLPLPCVKKIIQQV 155

Query: 207 AKGLAFLHGAERPVIYRDFKTSNILLNAD------------------------------- 235
            +GL +LH  +  +I+ D K  NILL+ +                               
Sbjct: 156 LQGLDYLH-TKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAP 214

Query: 236 ------------------FSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGH 277
                                K++D G A          + TR      Y + E ++   
Sbjct: 215 ATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQ-----YRSLEVLIGSG 269

Query: 278 LTARSDVYGFGVVLLEMLLGRR 299
               +D++    +  E+  G  
Sbjct: 270 YNTPADIWSTACMAFELATGDY 291

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 42.5 bits (99), Expect = 3e-04
 Identities = 54/444 (12%), Positives = 122/444 (27%), Gaps = 142/444 (31%)

Query: 45  MKTASGS-QVTPKNVTPVPPKKNVNDLRQNPGYSNVDIFTYNEMKLATKFFRPDYILGEG 103
           M   +G  Q   K++  V     V++          D+    +  L+ +    D+I+   
Sbjct: 7   MDFETGEHQYQYKDILSVFEDAFVDNFDCK------DVQDMPKSILSKEEI--DHIIMSK 58

Query: 104 G--------FGV-------VYKGVIDENVRPGYKTTFVAIKE------LNRGGYQGDREW 142
                    F         + +  ++E +R  YK     IK       +    Y   R+ 
Sbjct: 59  DAVSGTLRLFWTLLSKQEEMVQKFVEEVLRINYKFLMSPIKTEQRQPSMMTRMYIEQRDR 118

Query: 143 LAEVN-----Y--------------LGQLRHSNLV---------K--LIGYCCEDEHRIL 172
           L   N     Y              L +LR +  V         K  +    C   +++ 
Sbjct: 119 LYNDNQVFAKYNVSRLQPYLKLRQALLELRPAKNVLIDGVLGSGKTWVALDVCLS-YKVQ 177

Query: 173 ------VYEYMESGSLEKH---------LLRRVGCMLT----WSRRMKIALDAAKG--LA 211
                 ++ ++   +             LL ++    T     S  +K+ + + +     
Sbjct: 178 CKMDFKIF-WLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRR 236

Query: 212 FLHGAERP---VIYRDFKTSNILLNA-DFSAKL----SDFGLAKDGPMGDQTHVST---- 259
            L         ++  + + +    NA + S K+        +         TH+S     
Sbjct: 237 LLKSKPYENCLLVLLNVQNAKA-WNAFNLSCKILLTTRFKQVTDFLSAATTTHISLDHHS 295

Query: 260 -------------RVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRP 306
                        + +       P  V+T +    S            ++      +   
Sbjct: 296 MTLTPDEVKSLLLKYLDCRPQDLPREVLTTNPRRLS------------IIA--ESIRDGL 341

Query: 307 SREHNLVEWARPLLNNNKKV----LRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRP 362
           +   N   W     +    +    L +L+P    +             +  LS  P    
Sbjct: 342 ATWDN---WKHVNCDKLTTIIESSLNVLEPAEYRKM------------FDRLSVFPPSAH 386

Query: 363 VMSDVVALLETVQSQGAEEEMLQS 386
           + + +++L+     +     ++  
Sbjct: 387 IPTILLSLIWFDVIKSDVMVVVNK 410

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score = 41.5 bits (98), Expect = 4e-04
 Identities = 57/233 (24%), Positives = 86/233 (36%), Gaps = 57/233 (24%)

Query: 99  ILGEGGFGVVYKGVIDENVRPGYKTTFVAIKEL-NRGGY--QGDREWLAEVNYLGQLRH- 154
            LGEG FG V +  ID           VA+K + N   Y         +E+  L  L   
Sbjct: 21  TLGEGAFGKVVE-CIDHK----AGGRHVAVKIVKNVDRYCEAA----RSEIQVLEHLNTT 71

Query: 155 -----SNLVKLIGYCCEDEHRILVYEYMESGSL-EKHLLRRVGCM-LTWSRRMKIALDAA 207
                   V+++ +     H  +V+E +   S  +   ++  G +        K+A    
Sbjct: 72  DPNSTFRCVQMLEWFEHHGHICIVFELL-GLSTYD--FIKENGFLPFRLDHIRKMAYQIC 128

Query: 208 KGLAFLHGAERPVIYRDFKTSNILLN-------------------ADFSAKLSDFGLAKD 248
           K + FLH  +  + + D K  NIL                      +   K+ DFG A  
Sbjct: 129 KSVNFLHSNK--LTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATY 186

Query: 249 GPMGDQTH---VSTRVMGTYGYAAPEYVM-TGHLTARSDVYGFGVVLLEMLLG 297
               D+ H   VSTR      Y APE ++  G      DV+  G +L+E  LG
Sbjct: 187 ---DDEHHSTLVSTRH-----YRAPEVILALGWSQP-CDVWSIGCILIEYYLG 230

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	464
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.97
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.95
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.91
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.83
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.71
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.38
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.23
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	99.15
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	99.04
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.76
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.62
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.6
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.57
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.44
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.34
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	98.26
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	98.2
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	97.78
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.76
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.62
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	97.45
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	97.45
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	97.43
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	97.3
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	97.27
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	97.27
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	97.17
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	97.13
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	96.79
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	96.66
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	96.63
3mes_A	424	Choline kinase; malaria, structural genomics, stru	94.23
4ann_A	215	ESSB; membrane protein, membrane secretion, ESS ty	91.02
4ano_A	219	ESSB; membrane protein, membrane secretion, ESS ty	90.44
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	85.7
3cxl_A	463	N-chimerin; SH2, RHO-GAP, structural genomics cons	84.87

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=3.6e-60  Score=457.15  Aligned_cols=267  Identities=27%  Similarity=0.419  Sum_probs=217.1

Q ss_pred             hcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCccHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeE
Q 046893           91 TKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVKLIGYCCEDEHR  170 (464)
Q Consensus        91 ~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~  170 (464)
                      .++|.+.+.||+|+||+||+|.+.... ....+..||||+++.......++|.+|+++|++|+|||||+++++|.+.+..
T Consensus        12 r~~~~l~~~lG~G~fG~Vy~a~~~~~~-~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~   90 (299)
T 4asz_A           12 RHNIVLKRELGEGAFGKVFLAECYNLC-PEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPL   90 (299)
T ss_dssp             GGGEEEEEEEEC--CCCEEEEEECSCC-----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSE
T ss_pred             HHHeEEeeEEeeCCCcEEEEEEECCcc-cCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEE
Confidence            356788899999999999999876421 1224678999999876555567899999999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHhhc-----------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceE
Q 046893          171 ILVYEYMESGSLEKHLLRRV-----------GCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAK  239 (464)
Q Consensus       171 ~lv~e~~~~g~L~~~l~~~~-----------~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vk  239 (464)
                      +||||||++|+|.++|....           ...+++..++.|+.||+.||.|||  .++||||||||+||||+.++.+|
T Consensus        91 ~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH--~~~iiHRDlKp~NILl~~~~~~K  168 (299)
T 4asz_A           91 IMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLA--SQHFVHRDLATRNCLVGENLLVK  168 (299)
T ss_dssp             EEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCSGGGEEECGGGCEE
T ss_pred             EEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHH--hCCcccCccCHhhEEECCCCcEE
Confidence            99999999999999997532           346999999999999999999999  57799999999999999999999


Q ss_pred             EcccCCccCCCCCCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHH
Q 046893          240 LSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLL-GRRAVDKSRPSREHNLVEWARP  318 (464)
Q Consensus       240 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~  318 (464)
                      |+|||+|+...............||+.|||||++.+..|+.++|||||||+||||+| |+.||.+....      +....
T Consensus       169 i~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~------~~~~~  242 (299)
T 4asz_A          169 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNN------EVIEC  242 (299)
T ss_dssp             ECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH------HHHHH
T ss_pred             ECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHH------HHHHH
Confidence            999999986443333333344679999999999999999999999999999999998 89999865421      11111


Q ss_pred             hhhcccchhhccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhc
Q 046893          319 LLNNNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETVQSQ  377 (464)
Q Consensus       319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~~~~  377 (464)
                      +...           .....+..++.++.+||.+||+.||.+|||+.+|...|+.+.+.
T Consensus       243 i~~~-----------~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~  290 (299)
T 4asz_A          243 ITQG-----------RVLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKA  290 (299)
T ss_dssp             HHHT-----------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHcC-----------CCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence            1111           11123445667899999999999999999999999999987653

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=1.9e-59  Score=458.12  Aligned_cols=266  Identities=26%  Similarity=0.425  Sum_probs=210.4

Q ss_pred             cCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCccHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeEE
Q 046893           92 KFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVKLIGYCCEDEHRI  171 (464)
Q Consensus        92 ~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~  171 (464)
                      ++|.+.+.||+|+||+||+|++.... ....++.||||+++.......++|.+|+++|++|+|||||+++++|.+.+..|
T Consensus        41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~-~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~  119 (329)
T 4aoj_A           41 RDIVLKWELGEGAFGKVFLAECHNLL-PEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLL  119 (329)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEESSSC-C---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEE
T ss_pred             HHeEEEEEEccCCCcEEEEEEECCcc-cCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence            45677889999999999999876421 12246789999998765555678999999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHhhc-------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCce
Q 046893          172 LVYEYMESGSLEKHLLRRV-------------GCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSA  238 (464)
Q Consensus       172 lv~e~~~~g~L~~~l~~~~-------------~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~v  238 (464)
                      ||||||++|+|.+++....             ...+++.+++.|+.||+.||.|||  .++||||||||+||||+.++.+
T Consensus       120 lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH--~~~iiHRDLKp~NILl~~~~~~  197 (329)
T 4aoj_A          120 MVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLA--GLHFVHRDLATRNCLVGQGLVV  197 (329)
T ss_dssp             EEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCCGGGEEEETTTEE
T ss_pred             EEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHh--cCCeecccccHhhEEECCCCcE
Confidence            9999999999999987542             236899999999999999999999  5679999999999999999999


Q ss_pred             EEcccCCccCCCCCCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHh-CCCCCCCCCCcccccHHHHHH
Q 046893          239 KLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLL-GRRAVDKSRPSREHNLVEWAR  317 (464)
Q Consensus       239 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~  317 (464)
                      ||+|||+|+..............+||+.|||||++.+..|+.++|||||||+||||+| |+.||.+....      +...
T Consensus       198 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~------~~~~  271 (329)
T 4aoj_A          198 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNT------EAID  271 (329)
T ss_dssp             EECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHH------HHHH
T ss_pred             EEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHH------HHHH
Confidence            9999999987654444444556789999999999999999999999999999999999 89999765421      1111


Q ss_pred             HhhhcccchhhccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhc
Q 046893          318 PLLNNNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETVQSQ  377 (464)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~~~~  377 (464)
                      .+...           .....+..++.++.+||.+||+.||.+|||+.+|++.|+.+.+.
T Consensus       272 ~i~~g-----------~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~  320 (329)
T 4aoj_A          272 CITQG-----------RELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQA  320 (329)
T ss_dssp             HHHHT-----------CCCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred             HHHcC-----------CCCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhC
Confidence            11111           11123445667899999999999999999999999999988654

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=4.5e-59  Score=456.24  Aligned_cols=251  Identities=24%  Similarity=0.365  Sum_probs=205.3

Q ss_pred             cCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCcc--HHHHHHHHHHHhcCCCCCcceEEEEEEeCCe
Q 046893           92 KFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQG--DREWLAEVNYLGQLRHSNLVKLIGYCCEDEH  169 (464)
Q Consensus        92 ~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~  169 (464)
                      ++|++++.||+|+||+||+|++..+      ++.||||++.......  .+.+.+|+++|+.|+|||||+++++|.+++.
T Consensus        24 e~Y~~~~~lG~G~fg~V~~a~~~~~------~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~   97 (350)
T 4b9d_A           24 EKYVRLQKIGEGSFGKAILVKSTED------GRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGS   97 (350)
T ss_dssp             CCEEEEEEC------CEEEEEETTT------CCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTE
T ss_pred             cceEEeEEEecCCCeEEEEEEECCC------CCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCE
Confidence            4699999999999999999998775      6779999997654332  3678999999999999999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCccCC
Q 046893          170 RILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDG  249 (464)
Q Consensus       170 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~  249 (464)
                      +|||||||+||+|.++|..+.+..+++..++.|+.||+.||.|||  +++||||||||+||||+.+|.+||+|||+|+..
T Consensus        98 ~yiVmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH--~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~  175 (350)
T 4b9d_A           98 LYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVH--DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVL  175 (350)
T ss_dssp             EEEEEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH--HTTCEETTCCGGGEEECTTCCEEECSTTEESCC
T ss_pred             EEEEEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHH--HCCeeeccCCHHHEEECCCCCEEEcccccceee
Confidence            999999999999999998776667899999999999999999999  577999999999999999999999999999864


Q ss_pred             CCCCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhcccchhhc
Q 046893          250 PMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRI  329 (464)
Q Consensus       250 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  329 (464)
                      ..  ........+||+.|||||++.+..|+.++|||||||+||||++|+.||.+...      .+.........      
T Consensus       176 ~~--~~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~------~~~~~~i~~~~------  241 (350)
T 4b9d_A          176 NS--TVELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSM------KNLVLKIISGS------  241 (350)
T ss_dssp             CH--HHHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH------HHHHHHHHHTC------
T ss_pred             cC--CcccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH------HHHHHHHHcCC------
Confidence            22  12223457899999999999999999999999999999999999999976432      22222222211      


Q ss_pred             cCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 046893          330 LDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVA  369 (464)
Q Consensus       330 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  369 (464)
                       .+    ..+..++.++.+||.+||+.||.+|||+.++++
T Consensus       242 -~~----~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~  276 (350)
T 4b9d_A          242 -FP----PVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILE  276 (350)
T ss_dssp             -CC----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             -CC----CCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence             01    122334568999999999999999999999975

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=1.1e-58  Score=447.06  Aligned_cols=264  Identities=25%  Similarity=0.420  Sum_probs=206.5

Q ss_pred             HHhcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCc--cHHHHHHHHHHHhcCCCCCcceEEEEEEe
Q 046893           89 LATKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQ--GDREWLAEVNYLGQLRHSNLVKLIGYCCE  166 (464)
Q Consensus        89 ~~~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpniv~l~~~~~~  166 (464)
                      +..+.|.+.+.||+|+||+||+|++..+         ||||+++.....  ..+.|.+|+.+|++++|||||++++++.+
T Consensus        33 i~~~~l~l~~~iG~G~fG~Vy~~~~~~~---------vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~  103 (307)
T 3omv_A           33 IEASEVMLSTRIGSGSFGTVYKGKWHGD---------VAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK  103 (307)
T ss_dssp             CCTTSCCEEEECCCCSSSEEEEEESSSE---------EEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS
T ss_pred             EcHHHeEEeeEEeeCCCcEEEEEEECCc---------EEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC
Confidence            4456788899999999999999986542         899998754332  23679999999999999999999998754


Q ss_pred             CCeEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCc
Q 046893          167 DEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLA  246 (464)
Q Consensus       167 ~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla  246 (464)
                       +.++||||||++|+|.++|.... ..+++..++.|+.||+.||.|||  .++||||||||+||||+.++.+||+|||+|
T Consensus       104 -~~~~iVmEy~~gGsL~~~l~~~~-~~l~~~~~~~i~~qia~gL~yLH--~~~IiHRDlKp~NILl~~~~~~Ki~DFGla  179 (307)
T 3omv_A          104 -DNLAIVTQWCEGSSLYKHLHVQE-TKFQMFQLIDIARQTAQGMDYLH--AKNIIHRDMKSNNIFLHEGLTVKIGDFGLA  179 (307)
T ss_dssp             -SSCEEEEECCSSCBHHHHHHTSC-CCCCHHHHHHHHHHHHHHHHHHH--HTTCBCSCCCSSSEEEETTEEEEECCCSSC
T ss_pred             -CeEEEEEEcCCCCCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHH--HCCccCCccCHHHEEECCCCcEEEeeccCc
Confidence             56899999999999999987643 46999999999999999999999  567999999999999999999999999999


Q ss_pred             cCCCCCCCcceeeccccCCcccCcccccc---CCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhcc
Q 046893          247 KDGPMGDQTHVSTRVMGTYGYAAPEYVMT---GHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNN  323 (464)
Q Consensus       247 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~  323 (464)
                      +..............+||+.|||||++.+   ..|+.++|||||||+||||+||+.||.+.....      .....+...
T Consensus       180 ~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~------~~~~~~~~~  253 (307)
T 3omv_A          180 TVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRD------QIIFMVGRG  253 (307)
T ss_dssp             BC------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH------HHHHHHHTT
T ss_pred             eecccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHH------HHHHHHhcC
Confidence            86544333334455789999999999864   358999999999999999999999997654221      111111111


Q ss_pred             cchhhccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhc
Q 046893          324 KKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETVQSQ  377 (464)
Q Consensus       324 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~~~~  377 (464)
                           ...+.+ ...+..++..+.+||.+||+.||.+|||+.+|++.|+.++..
T Consensus       254 -----~~~p~~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~  301 (307)
T 3omv_A          254 -----YASPDL-SKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHS  301 (307)
T ss_dssp             -----CCCCCS-TTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTT
T ss_pred             -----CCCCCc-ccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcc
Confidence                 111111 123445667899999999999999999999999999887643

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=4.8e-59  Score=451.13  Aligned_cols=262  Identities=27%  Similarity=0.398  Sum_probs=212.0

Q ss_pred             CCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCC-ccHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeEE
Q 046893           93 FFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGY-QGDREWLAEVNYLGQLRHSNLVKLIGYCCEDEHRI  171 (464)
Q Consensus        93 ~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~  171 (464)
                      .+++.+.||+|+||+||+|.+... .....++.||||+++.... ...++|.+|+.+|++++|||||+++++|.+++..+
T Consensus        27 ~~~~~~~lG~G~fG~Vykg~~~~~-~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~  105 (308)
T 4gt4_A           27 AVRFMEELGEDRFGKVYKGHLFGP-APGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLS  105 (308)
T ss_dssp             GEEEEEEEEECSSCEEEEEEEC--------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred             HCeEeeEeccCCCcEEEEEEEcCC-ccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEE
Confidence            356678899999999999987532 1122467899999975433 33478999999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHhhc--------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCc
Q 046893          172 LVYEYMESGSLEKHLLRRV--------------GCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFS  237 (464)
Q Consensus       172 lv~e~~~~g~L~~~l~~~~--------------~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~  237 (464)
                      ||||||++|+|.++|..+.              ...+++..++.|+.||+.||.|||  .++||||||||+||||+.++.
T Consensus       106 lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH--~~~iiHRDLK~~NILl~~~~~  183 (308)
T 4gt4_A          106 MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLS--SHHVVHKDLATRNVLVYDKLN  183 (308)
T ss_dssp             EEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCSGGGEEECGGGC
T ss_pred             EEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHH--hCCCCCCCccccceEECCCCC
Confidence            9999999999999996532              235899999999999999999999  567999999999999999999


Q ss_pred             eEEcccCCccCCCCCCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHh-CCCCCCCCCCcccccHHHHH
Q 046893          238 AKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLL-GRRAVDKSRPSREHNLVEWA  316 (464)
Q Consensus       238 vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~  316 (464)
                      +||+|||+|+.....+........+||+.|||||++.++.|+.++|||||||+||||+| |+.||.+....   .+..  
T Consensus       184 ~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~---~~~~--  258 (308)
T 4gt4_A          184 VKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ---DVVE--  258 (308)
T ss_dssp             EEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHH---HHHH--
T ss_pred             EEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHH---HHHH--
Confidence            99999999986544443344455789999999999999999999999999999999998 89999865421   1111  


Q ss_pred             HHhhhcccchhhccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHH
Q 046893          317 RPLLNNNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETV  374 (464)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~  374 (464)
                       .+..           ......+..++..+.+||.+||+.||.+|||+.+|++.|+.+
T Consensus       259 -~i~~-----------~~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~  304 (308)
T 4gt4_A          259 -MIRN-----------RQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW  304 (308)
T ss_dssp             -HHHT-----------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred             -HHHc-----------CCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence             1111           111123445677899999999999999999999999999754

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=2.6e-58  Score=450.19  Aligned_cols=250  Identities=23%  Similarity=0.380  Sum_probs=209.5

Q ss_pred             cCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCccHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeEE
Q 046893           92 KFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVKLIGYCCEDEHRI  171 (464)
Q Consensus        92 ~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~  171 (464)
                      ..|++.+.||+|+||+||+|++..+      ++.||||++........+.+.+|+.+|+.++|||||+++++|.+++.+|
T Consensus        74 ~~y~~~~~iG~G~fG~V~~a~~~~t------g~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~  147 (346)
T 4fih_A           74 SYLDNFIKIGEGSTGIVCIATVRSS------GKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELW  147 (346)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTT------CCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred             HhcEEeEEeecCcCeEEEEEEECCC------CCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence            5689999999999999999998875      6789999997655555667899999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCccCCCC
Q 046893          172 LVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPM  251 (464)
Q Consensus       172 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~  251 (464)
                      ||||||+||+|.+++.+.   .+++..+..++.||+.||.|||  .++||||||||+||||+.+|.+||+|||+|+....
T Consensus       148 ivmEy~~gg~L~~~l~~~---~l~e~~~~~~~~qi~~aL~ylH--~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~  222 (346)
T 4fih_A          148 VVMEFLEGGALTDIVTHT---RMNEEQIAAVCLAVLQALSVLH--AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK  222 (346)
T ss_dssp             EEECCCTTEEHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCS
T ss_pred             EEEeCCCCCcHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH--HCCcccccCCHHHEEECCCCCEEEecCcCceecCC
Confidence            999999999999988653   5999999999999999999999  57799999999999999999999999999986533


Q ss_pred             CCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhcccchhhccC
Q 046893          252 GDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRILD  331 (464)
Q Consensus       252 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  331 (464)
                      .  .......+||+.|||||++.+..|+.++|||||||+||||++|+.||.+.....      ....+...       ..
T Consensus       223 ~--~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~------~~~~i~~~-------~~  287 (346)
T 4fih_A          223 E--VPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK------AMKMIRDN-------LP  287 (346)
T ss_dssp             S--SCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH------HHHHHHHS-------SC
T ss_pred             C--CCcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH------HHHHHHcC-------CC
Confidence            2  223345899999999999999999999999999999999999999998654221      11111111       11


Q ss_pred             ccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 046893          332 PRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVA  369 (464)
Q Consensus       332 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  369 (464)
                      +.+  .....++.++.+||.+||..||.+|||+.++++
T Consensus       288 ~~~--~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~  323 (346)
T 4fih_A          288 PRL--KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLK  323 (346)
T ss_dssp             CCC--SCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             CCC--CccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            111  112334568899999999999999999998864

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=1.3e-57  Score=438.90  Aligned_cols=250  Identities=22%  Similarity=0.263  Sum_probs=210.7

Q ss_pred             cCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCC---CccHHHHHHHHHHHhcCCCCCcceEEEEEEeCC
Q 046893           92 KFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGG---YQGDREWLAEVNYLGQLRHSNLVKLIGYCCEDE  168 (464)
Q Consensus        92 ~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~  168 (464)
                      ++|++.+.||+|+||+||+|++..+      ++.||||++.+..   ....+.+.+|+++|+.|+|||||+++++|.+++
T Consensus        32 ~dy~i~~~lG~G~fg~V~~a~~~~~------~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~  105 (311)
T 4aw0_A           32 EDFKFGKILGEGSFSTVVLARELAT------SREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDE  105 (311)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTT------CCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred             cccEEEEEEecccCeEEEEEEECCC------CCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCC
Confidence            3588999999999999999998875      6789999997532   233467899999999999999999999999999


Q ss_pred             eEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCccC
Q 046893          169 HRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKD  248 (464)
Q Consensus       169 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~  248 (464)
                      .+|||||||+||+|.+++.+..  .+++..+..++.||+.||.|||  .++||||||||+||||+.++.+||+|||+|+.
T Consensus       106 ~~yivmEy~~gG~L~~~i~~~~--~l~e~~~~~~~~qi~~al~ylH--~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~  181 (311)
T 4aw0_A          106 KLYFGLSYAKNGELLKYIRKIG--SFDETCTRFYTAEIVSALEYLH--GKGIIHRDLKPENILLNEDMHIQITDFGTAKV  181 (311)
T ss_dssp             EEEEEECCCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred             EEEEEEecCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH--HCCCccCCCCHHHeEEcCCCCEEEEEcCCcee
Confidence            9999999999999999997754  6999999999999999999999  57799999999999999999999999999997


Q ss_pred             CCCCCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhcccchhh
Q 046893          249 GPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLR  328 (464)
Q Consensus       249 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  328 (464)
                      .............+||+.|||||++.+..|+.++|||||||+||||++|+.||.+...      .+.........     
T Consensus       182 ~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~------~~~~~~i~~~~-----  250 (311)
T 4aw0_A          182 LSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE------GLIFAKIIKLE-----  250 (311)
T ss_dssp             CCTTTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHTC-----
T ss_pred             cCCCCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHHcCC-----
Confidence            6544444445568999999999999999999999999999999999999999976432      12222222211     


Q ss_pred             ccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 046893          329 ILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVA  369 (464)
Q Consensus       329 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  369 (464)
                         .    .++...+.++.+||.+||..||.+|||+.+++.
T Consensus       251 ---~----~~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~~  284 (311)
T 4aw0_A          251 ---Y----DFPEKFFPKARDLVEKLLVLDATKRLGCEEMEG  284 (311)
T ss_dssp             ---C----CCCTTCCHHHHHHHHHHSCSSGGGSTTSGGGTC
T ss_pred             ---C----CCCcccCHHHHHHHHHHccCCHhHCcChHHHcC
Confidence               1    122234457899999999999999999998753

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=2.9e-57  Score=441.38  Aligned_cols=255  Identities=22%  Similarity=0.227  Sum_probs=208.4

Q ss_pred             cCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCccHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeEE
Q 046893           92 KFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVKLIGYCCEDEHRI  171 (464)
Q Consensus        92 ~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~  171 (464)
                      +.|++.++||+|+||+||+|++..+      ++.||||+++.....     .+|+.+|+.|+|||||+++++|.+++.+|
T Consensus        58 ~~~~~~~~lG~G~fG~Vy~a~~~~~------g~~vAiK~i~~~~~~-----~~E~~il~~l~HpnIV~l~~~~~~~~~~~  126 (336)
T 4g3f_A           58 HWMTHQPRVGRGSFGEVHRMKDKQT------GFQCAVKKVRLEVFR-----VEELVACAGLSSPRIVPLYGAVREGPWVN  126 (336)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETTT------CCEEEEEEEETTTCC-----THHHHTTTTCCCTTBCCEEEEEEETTEEE
T ss_pred             hheEeCcEeccCCCeEEEEEEECCC------CCEEEEEEECHHHhH-----HHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence            4577788899999999999998775      678999999765332     47999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCC-ceEEcccCCccCCC
Q 046893          172 LVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADF-SAKLSDFGLAKDGP  250 (464)
Q Consensus       172 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~-~vkl~DFGla~~~~  250 (464)
                      ||||||+||+|.++|.+..  .+++..+..++.||+.||.|||  .++||||||||+||||+.+| .+||+|||+|+...
T Consensus       127 ivmEy~~gg~L~~~l~~~~--~l~e~~~~~~~~qi~~aL~ylH--~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~  202 (336)
T 4g3f_A          127 IFMELLEGGSLGQLIKQMG--CLPEDRALYYLGQALEGLEYLH--TRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQ  202 (336)
T ss_dssp             EEECCCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHH--TTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC-
T ss_pred             EEEeccCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH--HCCceecccCHHHEEEeCCCCEEEEeeCCCCeEcc
Confidence            9999999999999997654  6999999999999999999999  67799999999999999887 69999999998654


Q ss_pred             CCCCc---ceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhcccchh
Q 046893          251 MGDQT---HVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVL  327 (464)
Q Consensus       251 ~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  327 (464)
                      .....   .....++||+.|||||++.+..|+.++|||||||+||||++|+.||.+........      .+......  
T Consensus       203 ~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~------~i~~~~~~--  274 (336)
T 4g3f_A          203 PDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCL------KIASEPPP--  274 (336)
T ss_dssp             -----------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHH------HHHHSCCG--
T ss_pred             CCCcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHH------HHHcCCCC--
Confidence            32211   12334689999999999999999999999999999999999999998654332211      11111111  


Q ss_pred             hccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHh
Q 046893          328 RILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETVQS  376 (464)
Q Consensus       328 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~~~  376 (464)
                             ...++..++..+.+||.+||+.||.+|||+.|+++.|..+..
T Consensus       275 -------~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~  316 (336)
T 4g3f_A          275 -------IREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQ  316 (336)
T ss_dssp             -------GGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             -------chhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHh
Confidence                   112334456689999999999999999999999998876654

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=8.3e-58  Score=450.16  Aligned_cols=276  Identities=25%  Similarity=0.334  Sum_probs=224.3

Q ss_pred             chhHHHHHhcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCcc-HHHHHHHHHHHhcCCC-CCcceE
Q 046893           83 TYNEMKLATKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQG-DREWLAEVNYLGQLRH-SNLVKL  160 (464)
Q Consensus        83 ~~~~~~~~~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h-pniv~l  160 (464)
                      ...++++..++|++.+.||+|+||+||+|.+.... ....++.||||++....... .+.|.+|+++|.++.| ||||++
T Consensus        55 ~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~-~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l  133 (353)
T 4ase_A           55 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGID-KTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL  133 (353)
T ss_dssp             CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSS-STTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             CCcccEecHHHeEEeeEEecCCCeEEEEEEEcCCC-cccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEE
Confidence            34566777889999999999999999999987542 23456789999997654433 3678999999999965 999999


Q ss_pred             EEEEEeC-CeEEEEEeccCCCCHHHHHHhhc--------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccC
Q 046893          161 IGYCCED-EHRILVYEYMESGSLEKHLLRRV--------------GCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDF  225 (464)
Q Consensus       161 ~~~~~~~-~~~~lv~e~~~~g~L~~~l~~~~--------------~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDl  225 (464)
                      +++|.+. +.++||||||++|+|.++|....              ...+++..++.++.||+.||.|||  .++||||||
T Consensus       134 ~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH--~~~iiHRDL  211 (353)
T 4ase_A          134 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA--SRKCIHRDL  211 (353)
T ss_dssp             EEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHH--HTTCCCSCC
T ss_pred             EEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHh--hCCeecCcc
Confidence            9998765 56899999999999999997542              235899999999999999999999  567999999


Q ss_pred             CCCceEecCCCceEEcccCCccCCCCCCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHh-CCCCCCCC
Q 046893          226 KTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLL-GRRAVDKS  304 (464)
Q Consensus       226 kp~Nill~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~  304 (464)
                      ||+||||+.++.+||+|||+|+..............+||+.|||||++.+..|+.++|||||||+||||+| |+.||.+.
T Consensus       212 K~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~  291 (353)
T 4ase_A          212 AARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV  291 (353)
T ss_dssp             SGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred             CccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCC
Confidence            99999999999999999999997654444444556789999999999999999999999999999999998 99999865


Q ss_pred             CCcccccHHHHHHHhhhcccchhhccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhc
Q 046893          305 RPSREHNLVEWARPLLNNNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETVQSQ  377 (464)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~~~~  377 (464)
                      ....      .+...+..          ......+..++.++.+||.+||+.||.+|||+.+|++.|+.+.+.
T Consensus       292 ~~~~------~~~~~i~~----------g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~  348 (353)
T 4ase_A          292 KIDE------EFCRRLKE----------GTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA  348 (353)
T ss_dssp             CCSH------HHHHHHHH----------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             CHHH------HHHHHHHc----------CCCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHH
Confidence            4221      11111111          111223444566899999999999999999999999999887643

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=5.3e-57  Score=432.20  Aligned_cols=248  Identities=28%  Similarity=0.414  Sum_probs=197.8

Q ss_pred             CCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCc--cHHHHHHHHHHHhcCCCCCcceEEEEEEe----C
Q 046893           94 FRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQ--GDREWLAEVNYLGQLRHSNLVKLIGYCCE----D  167 (464)
Q Consensus        94 ~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpniv~l~~~~~~----~  167 (464)
                      |++.+.||+|+||+||+|.+..+      +..||+|++......  ..+.|.+|+++|+.|+|||||+++++|..    +
T Consensus        28 ~~~~~~iG~G~fg~Vy~a~~~~~------~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~  101 (290)
T 3fpq_A           28 LKFDIEIGRGSFKTVYKGLDTET------TVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGK  101 (290)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTT------CCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTE
T ss_pred             EEeeeEEecCcCcEEEEEEECCC------CeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCC
Confidence            45667899999999999998775      667999998654332  23668999999999999999999999875    3


Q ss_pred             CeEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecC-CCceEEcccCCc
Q 046893          168 EHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNA-DFSAKLSDFGLA  246 (464)
Q Consensus       168 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~-~~~vkl~DFGla  246 (464)
                      ..+|||||||+||+|.+++.+..  .+++..+..|+.||+.||.|||+.+.+||||||||+||||+. ++.+||+|||+|
T Consensus       102 ~~~~lvmEy~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla  179 (290)
T 3fpq_A          102 KCIVLVTELMTSGTLKTYLKRFK--VMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLA  179 (290)
T ss_dssp             EEEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGG
T ss_pred             cEEEEEEeCCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCC
Confidence            46899999999999999997654  699999999999999999999954444999999999999974 789999999999


Q ss_pred             cCCCCCCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhcccch
Q 046893          247 KDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKV  326 (464)
Q Consensus       247 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  326 (464)
                      +....    ......+||+.|||||++.+ .|+.++|||||||+||||+||+.||.+....     ..........    
T Consensus       180 ~~~~~----~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~-----~~~~~~i~~~----  245 (290)
T 3fpq_A          180 TLKRA----SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNA-----AQIYRRVTSG----  245 (290)
T ss_dssp             GGCCT----TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH-----HHHHHHHTTT----
T ss_pred             EeCCC----CccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcH-----HHHHHHHHcC----
Confidence            85322    22345799999999998865 6999999999999999999999999754321     1111111111    


Q ss_pred             hhccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 046893          327 LRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVA  369 (464)
Q Consensus       327 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  369 (464)
                         ..+   ..++...+.++.+||.+||+.||.+|||+.++++
T Consensus       246 ---~~~---~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~  282 (290)
T 3fpq_A          246 ---VKP---ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN  282 (290)
T ss_dssp             ---CCC---GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             ---CCC---CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence               001   1112223447899999999999999999999874

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=3.5e-57  Score=452.82  Aligned_cols=251  Identities=23%  Similarity=0.379  Sum_probs=210.5

Q ss_pred             hcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCccHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeE
Q 046893           91 TKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVKLIGYCCEDEHR  170 (464)
Q Consensus        91 ~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~  170 (464)
                      .++|++.+.||+|+||+||+|++..+      ++.||||++........+.+.+|+.+|+.|+|||||+++++|.+++.+
T Consensus       150 ~~~y~~~~~iG~G~fG~V~~a~~~~t------g~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~  223 (423)
T 4fie_A          150 RSYLDNFIKIGEGSTGIVCIATVRSS------GKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDEL  223 (423)
T ss_dssp             GGTEEEEEEEEECSSCEEEEEEETTT------CCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred             hHhcEeeeEeccCcCcEEEEEEECCC------CCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEE
Confidence            36799999999999999999998875      678999999876666667789999999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCccCCC
Q 046893          171 ILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGP  250 (464)
Q Consensus       171 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~  250 (464)
                      |||||||+||+|.+++...   .+++..+..|+.||+.||.|||  .++||||||||+||||+.+|.+||+|||+|+...
T Consensus       224 ~iVmEy~~gG~L~~~i~~~---~l~e~~~~~~~~qil~aL~ylH--~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~  298 (423)
T 4fie_A          224 WVVMEFLEGGALTDIVTHT---RMNEEQIAAVCLAVLQALSVLH--AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVS  298 (423)
T ss_dssp             EEEEECCTTEEHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCSTTTEEECTTCCEEECCCTTCEECC
T ss_pred             EEEEeCCCCCcHHHHHhcc---CCCHHHHHHHHHHHHHHHHHHH--HCCeecccCCHHHEEEcCCCCEEEecCccceECC
Confidence            9999999999999988653   4999999999999999999999  5779999999999999999999999999998653


Q ss_pred             CCCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhcccchhhcc
Q 046893          251 MGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRIL  330 (464)
Q Consensus       251 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  330 (464)
                      ..  .......+||+.|||||++.+..|+.++|||||||+||||++|+.||.+.....      ....+...       .
T Consensus       299 ~~--~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~------~~~~i~~~-------~  363 (423)
T 4fie_A          299 KE--VPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK------AMKMIRDN-------L  363 (423)
T ss_dssp             SS--CCCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH------HHHHHHHS-------C
T ss_pred             CC--CccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH------HHHHHHcC-------C
Confidence            32  223345799999999999999999999999999999999999999997654221      11111111       1


Q ss_pred             CccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 046893          331 DPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVA  369 (464)
Q Consensus       331 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  369 (464)
                      .+.+  .....++.++.+||.+||..||.+|||+.++++
T Consensus       364 ~~~~--~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~  400 (423)
T 4fie_A          364 PPRL--KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLK  400 (423)
T ss_dssp             CCCC--SCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             CCCC--cccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            1111  112234558899999999999999999998864

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=1e-55  Score=419.74  Aligned_cols=246  Identities=25%  Similarity=0.340  Sum_probs=192.2

Q ss_pred             cCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCC---ccHHHHHHHHHHHhcCCCCCcceEEEEEEeCC
Q 046893           92 KFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGY---QGDREWLAEVNYLGQLRHSNLVKLIGYCCEDE  168 (464)
Q Consensus        92 ~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~  168 (464)
                      ++|++.+.||+|+||+||+|.+..+      ++.||||++.....   .....+.+|+++|+.++|||||++++++.+++
T Consensus        13 g~Y~i~~~lG~G~fg~V~~~~~~~~------~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~   86 (275)
T 3hyh_A           13 GNYQIVKTLGEGSFGKVKLAYHTTT------GQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKD   86 (275)
T ss_dssp             -CCEEEEEEEC---CCEEEEECTTT------CCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred             eCeEEEEEEecCcCeEEEEEEECCC------CCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECC
Confidence            4699999999999999999998765      67899999976432   23467899999999999999999999999999


Q ss_pred             eEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCccC
Q 046893          169 HRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKD  248 (464)
Q Consensus       169 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~  248 (464)
                      .+||||||| +|+|.+++.++.  .+++..+..++.||+.||+|||  +++|+||||||+||||+.++.+||+|||+|+.
T Consensus        87 ~~~ivmEy~-~g~L~~~l~~~~--~l~e~~~~~~~~qi~~al~ylH--~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~  161 (275)
T 3hyh_A           87 EIIMVIEYA-GNELFDYIVQRD--KMSEQEARRFFQQIISAVEYCH--RHKIVHRDLKPENLLLDEHLNVKIADFGLSNI  161 (275)
T ss_dssp             EEEEEEECC-CEEHHHHHHHSC--SCCHHHHHHHHHHHHHHHHHHH--HTTCCCCCCCTTTEEECTTCCEEECCSSCC--
T ss_pred             EEEEEEeCC-CCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH--HCCcccccCChHHeEECCCCCEEEeecCCCee
Confidence            999999999 679999987653  6999999999999999999999  57799999999999999999999999999986


Q ss_pred             CCCCCCcceeeccccCCcccCccccccCCC-CcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhcccchh
Q 046893          249 GPMGDQTHVSTRVMGTYGYAAPEYVMTGHL-TARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVL  327 (464)
Q Consensus       249 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  327 (464)
                      ....   ......+||+.|||||++.+..| +.++|||||||+||+|++|+.||.+...      .+.........    
T Consensus       162 ~~~~---~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~------~~~~~~i~~~~----  228 (275)
T 3hyh_A          162 MTDG---NFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESI------PVLFKNISNGV----  228 (275)
T ss_dssp             ----------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHTC----
T ss_pred             cCCC---CccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCH------HHHHHHHHcCC----
Confidence            4322   22345789999999999998876 5799999999999999999999976431      12222221111    


Q ss_pred             hccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 046893          328 RILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVA  369 (464)
Q Consensus       328 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  369 (464)
                          .    .++...+.++.+|+.+||+.||.+|||+.++++
T Consensus       229 ----~----~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~  262 (275)
T 3hyh_A          229 ----Y----TLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQ  262 (275)
T ss_dssp             ----C----CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             ----C----CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence                1    122234558899999999999999999999875

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=4.2e-56  Score=428.15  Aligned_cols=247  Identities=26%  Similarity=0.325  Sum_probs=197.3

Q ss_pred             cCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCC--ccHHHHHHHHHHHhcCCCCCcceEEEEEEeCCe
Q 046893           92 KFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGY--QGDREWLAEVNYLGQLRHSNLVKLIGYCCEDEH  169 (464)
Q Consensus        92 ~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~  169 (464)
                      ++|++.+.||+|+||+||+|++..+.   ..++.||||+++....  .....+.+|+++|+.++|||||+++++|.+++.
T Consensus        24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~---~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~  100 (304)
T 3ubd_A           24 SQFELLKVLGQGSFGKVFLVKKISGS---DARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGK  100 (304)
T ss_dssp             GGEEEEEEEECGGGCEEEEEEECSST---TTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTE
T ss_pred             cccEEEEEEecCCCeEEEEEEEccCC---CCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCE
Confidence            46899999999999999999875431   2367899999975432  123467889999999999999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCccCC
Q 046893          170 RILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDG  249 (464)
Q Consensus       170 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~  249 (464)
                      +|||||||+||+|.+++.+..  .+++..+..++.||+.||.|||  +++||||||||+|||++.+|.+||+|||+|+..
T Consensus       101 ~~ivmEy~~gg~L~~~l~~~~--~l~e~~~~~~~~qi~~aL~ylH--~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~  176 (304)
T 3ubd_A          101 LYLILDFLRGGDLFTRLSKEV--MFTEEDVKFYLAELALALDHLH--SLGIIYRDLKPENILLDEEGHIKLTDFGLSKES  176 (304)
T ss_dssp             EEEEECCCTTCEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHH--HTTCCCSSCCGGGEEECTTSCEEEESSEEEEC-
T ss_pred             EEEEEEcCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH--HCCCcCCCCCHHHeEEcCCCCEEecccccceec
Confidence            999999999999999997754  6999999999999999999999  577999999999999999999999999999864


Q ss_pred             CCCCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhcccchhhc
Q 046893          250 PMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRI  329 (464)
Q Consensus       250 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  329 (464)
                      ....  ......+||+.|||||++.+..|+.++|||||||+||||++|+.||.+....      +.........      
T Consensus       177 ~~~~--~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~------~~~~~i~~~~------  242 (304)
T 3ubd_A          177 IDHE--KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRK------ETMTMILKAK------  242 (304)
T ss_dssp             ------CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHHCC------
T ss_pred             cCCC--ccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHH------HHHHHHHcCC------
Confidence            3222  2334578999999999999999999999999999999999999999864321      2222222111      


Q ss_pred             cCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHH
Q 046893          330 LDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMS  365 (464)
Q Consensus       330 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~  365 (464)
                        .    .++..++.++.+||.+||+.||.+|||+.
T Consensus       243 --~----~~p~~~s~~~~~li~~~L~~dP~~R~ta~  272 (304)
T 3ubd_A          243 --L----GMPQFLSPEAQSLLRMLFKRNPANRLGAG  272 (304)
T ss_dssp             --C----CCCTTSCHHHHHHHHHHTCSSGGGSTTCS
T ss_pred             --C----CCCCcCCHHHHHHHHHHcccCHHHCCCCC
Confidence              1    12233456889999999999999999963

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=6.2e-55  Score=422.72  Aligned_cols=266  Identities=26%  Similarity=0.364  Sum_probs=200.3

Q ss_pred             cCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCccHHHHH--HHHHHHhcCCCCCcceEEEEEEeCC-
Q 046893           92 KFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWL--AEVNYLGQLRHSNLVKLIGYCCEDE-  168 (464)
Q Consensus        92 ~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~--~E~~~l~~l~hpniv~l~~~~~~~~-  168 (464)
                      ++|.+.+.||+|+||+||+|++.        ++.||||+++..   ....+.  .|+..+..++|||||++++++.+++ 
T Consensus         3 r~i~L~~~iG~G~fG~Vy~~~~~--------g~~VAvK~l~~~---~~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~   71 (303)
T 3hmm_A            3 RTIVLQESIGKGRFGEVWRGKWR--------GEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNG   71 (303)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEET--------TEEEEEEEECGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECS
T ss_pred             cEEEEEEEEeeCCCeEEEEEEEC--------CEEEEEEEECcc---chhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCC
Confidence            45778889999999999999873        567999998653   233333  4566667889999999999998764 


Q ss_pred             ---eEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcC------CCCeeeccCCCCceEecCCCceE
Q 046893          169 ---HRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGA------ERPVIYRDFKTSNILLNADFSAK  239 (464)
Q Consensus       169 ---~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~------~~~ivHrDlkp~Nill~~~~~vk  239 (464)
                         .+|||||||++|+|.+++...   .+++..++.++.|++.||.|||+.      ..+||||||||+||||+.++.+|
T Consensus        72 ~~~~~~lV~Ey~~~gsL~~~l~~~---~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~K  148 (303)
T 3hmm_A           72 TWTQLWLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCC  148 (303)
T ss_dssp             SSEEEEEEEECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEE
T ss_pred             CceEEEEEecCCCCCcHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEE
Confidence               579999999999999999764   489999999999999999999953      34899999999999999999999


Q ss_pred             EcccCCccCCCCCCCc--ceeeccccCCcccCccccccC------CCCcccchhcHHHHHHHHHhCCCCCCCCCCccc--
Q 046893          240 LSDFGLAKDGPMGDQT--HVSTRVMGTYGYAAPEYVMTG------HLTARSDVYGFGVVLLEMLLGRRAVDKSRPSRE--  309 (464)
Q Consensus       240 l~DFGla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~------~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~--  309 (464)
                      |+|||+|+........  ......+||+.|||||++.+.      .|+.++|||||||+||||+||..||........  
T Consensus       149 i~DFGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~  228 (303)
T 3hmm_A          149 IADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPY  228 (303)
T ss_dssp             ECCCTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTT
T ss_pred             EEeCCCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccc
Confidence            9999999864332221  122346899999999998764      467899999999999999999887754322110  


Q ss_pred             -------ccHHHHHHHhhhcccchhhccCccccCc-cCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhc
Q 046893          310 -------HNLVEWARPLLNNNKKVLRILDPRLEGQ-YTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETVQSQ  377 (464)
Q Consensus       310 -------~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~~~~  377 (464)
                             .....+......      ..+.+.+... ....++..+.+|+.+||+.||.+|||+.+|++.|+.+...
T Consensus       229 ~~~~~~~~~~~~~~~~~~~------~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~  298 (303)
T 3hmm_A          229 YDLVPSDPSVEEMRKVVCE------QKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ  298 (303)
T ss_dssp             TTTSCSSCCHHHHHHHHTT------SCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             hhcccccchHHHHHHHHhc------ccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHH
Confidence                   011111111111      1122222221 1235667899999999999999999999999999988653

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=1.4e-53  Score=411.72  Aligned_cols=250  Identities=23%  Similarity=0.342  Sum_probs=186.6

Q ss_pred             CCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCc-cHHHHHHHHHHHhcCCCCCcceEEEEEEeCC---
Q 046893           93 FFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQ-GDREWLAEVNYLGQLRHSNLVKLIGYCCEDE---  168 (464)
Q Consensus        93 ~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~---  168 (464)
                      +|++.+.||+|+||+||+|++..+      ++.||||++...... ..+.+.+|+++|+.|+|||||+++++|.+.+   
T Consensus         6 dy~~~~~lG~G~fg~V~~a~~~~~------~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~   79 (299)
T 4g31_A            6 DFEPIQCLGRGGFGVVFEAKNKVD------DCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTE   79 (299)
T ss_dssp             HEEEEEEEEECC--EEEEEEETTT------CCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC---
T ss_pred             hCEEeeEEecCCCeEEEEEEECCC------CCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccc
Confidence            488899999999999999998765      677999999754433 2367899999999999999999999987654   


Q ss_pred             ---------eEEEEEeccCCCCHHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCce
Q 046893          169 ---------HRILVYEYMESGSLEKHLLRRVG-CMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSA  238 (464)
Q Consensus       169 ---------~~~lv~e~~~~g~L~~~l~~~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~v  238 (464)
                               ..|||||||++|+|.+++..+.. ....+..++.|+.||+.||+|||  .++||||||||+||||+.++.+
T Consensus        80 ~~~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH--~~~IiHRDlKp~NILl~~~~~v  157 (299)
T 4g31_A           80 KLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLH--SKGLMHRDLKPSNIFFTMDDVV  157 (299)
T ss_dssp             -------CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHH--HTTCCCCCCCGGGEEECTTCCE
T ss_pred             cccccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHH--HCcCccccCcHHHeEECCCCcE
Confidence                     36999999999999999976432 23566778899999999999999  5679999999999999999999


Q ss_pred             EEcccCCccCCCCCCCc----------ceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHhCCCCCCCCCCcc
Q 046893          239 KLSDFGLAKDGPMGDQT----------HVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSR  308 (464)
Q Consensus       239 kl~DFGla~~~~~~~~~----------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~  308 (464)
                      ||+|||+|+........          ......+||+.|||||++.+..|+.++|||||||+||||++   ||....   
T Consensus       158 Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~---  231 (299)
T 4g31_A          158 KVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQM---  231 (299)
T ss_dssp             EECCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHH---
T ss_pred             EEccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCcc---
Confidence            99999999865432211          11234689999999999999999999999999999999996   775311   


Q ss_pred             cccHHHHHHHhhhcccchhhccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 046893          309 EHNLVEWARPLLNNNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVA  369 (464)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  369 (464)
                        ..........          ..... .........+.+||.+||+.||.+|||+.++++
T Consensus       232 --~~~~~~~~~~----------~~~~p-~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~  279 (299)
T 4g31_A          232 --ERVRTLTDVR----------NLKFP-PLFTQKYPCEYVMVQDMLSPSPMERPEAINIIE  279 (299)
T ss_dssp             --HHHHHHHHHH----------TTCCC-HHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             --HHHHHHHHHh----------cCCCC-CCCcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence              1111110000          00000 111223345678999999999999999999875

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.1e-51  Score=413.31  Aligned_cols=265  Identities=23%  Similarity=0.288  Sum_probs=201.0

Q ss_pred             cCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCc--cHHHHHHHHHHHhcCCCCCcceEEEEEEe---
Q 046893           92 KFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQ--GDREWLAEVNYLGQLRHSNLVKLIGYCCE---  166 (464)
Q Consensus        92 ~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpniv~l~~~~~~---  166 (464)
                      ++|++.+.||+|+||+||+|++..+      ++.||||++......  ..+.+++|+++|+.|+|||||++++++..   
T Consensus        54 ~~Y~~~~~lG~G~fG~V~~a~~~~t------~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~  127 (398)
T 4b99_A           54 DEYEIIETIGNGAYGVVSSARRRLT------GQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVP  127 (398)
T ss_dssp             SSEEEEEEEEECSSCEEEEEEETTT------CCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSC
T ss_pred             CCeEEEEEEecccCeEEEEEEECCC------CCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccc
Confidence            5799999999999999999998775      678999999764332  23568899999999999999999998764   


Q ss_pred             ---CCeEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEccc
Q 046893          167 ---DEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDF  243 (464)
Q Consensus       167 ---~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DF  243 (464)
                         .+.+|||||||. |+|.+++.+.  ..+++..+..++.||+.||.|||  .++||||||||+|||++.++.+||+||
T Consensus       128 ~~~~~~~~ivmE~~~-g~L~~~i~~~--~~l~~~~~~~~~~qil~al~ylH--~~~iiHRDlKP~NIl~~~~~~~Ki~DF  202 (398)
T 4b99_A          128 YGEFKSVYVVLDLME-SDLHQIIHSS--QPLTLEHVRYFLYQLLRGLKYMH--SAQVIHRDLKPSNLLVNENCELKIGDF  202 (398)
T ss_dssp             TTTCCCEEEEEECCS-EEHHHHHTSS--SCCCHHHHHHHHHHHHHHHHHHH--HTTCBCCCCCGGGEEECTTCCEEECCC
T ss_pred             cccCCEEEEEEeCCC-CCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH--HCcCcCCCcCccccccCCCCCEEEeec
Confidence               357899999995 6899988764  37999999999999999999999  567999999999999999999999999


Q ss_pred             CCccCCCCCC--CcceeeccccCCcccCccccccC-CCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhh
Q 046893          244 GLAKDGPMGD--QTHVSTRVMGTYGYAAPEYVMTG-HLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLL  320 (464)
Q Consensus       244 Gla~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~  320 (464)
                      |+|+......  ........+||+.|||||++.+. .|+.++||||||||||||++|+.||.+.........+.  ....
T Consensus       203 Gla~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~--~~~g  280 (398)
T 4b99_A          203 GMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIM--MVLG  280 (398)
T ss_dssp             TTCBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHH--HHHC
T ss_pred             ceeeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHH--HhcC
Confidence            9998653321  12234457999999999998875 57999999999999999999999998754322111110  0000


Q ss_pred             hcccch------------hhccCcccc---CccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 046893          321 NNNKKV------------LRILDPRLE---GQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVA  369 (464)
Q Consensus       321 ~~~~~~------------~~~~~~~~~---~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  369 (464)
                      ......            ...+.+...   .......+.++.+||.+||..||.+|||+.++++
T Consensus       281 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~  344 (398)
T 4b99_A          281 TPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALR  344 (398)
T ss_dssp             CCCGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             CCChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence            000000            000000000   0011123457889999999999999999998864

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=6.6e-51  Score=403.29  Aligned_cols=206  Identities=26%  Similarity=0.332  Sum_probs=173.1

Q ss_pred             HHHhcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCccHHHHHHHHHHHhcC-CCCCcceEEEEEEe
Q 046893           88 KLATKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQL-RHSNLVKLIGYCCE  166 (464)
Q Consensus        88 ~~~~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~  166 (464)
                      ....++|++.+.||+|+||+||+|++....   ..++.||||.+...  .....+.+|+++|..+ +|||||+++++|.+
T Consensus        17 p~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~---~~~~~vAiK~i~~~--~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~   91 (361)
T 4f9c_A           17 PQLSNVFKIEDKIGEGTFSSVYLATAQLQV---GPEEKIALKHLIPT--SHPIRIAAELQCLTVAGGQDNVMGVKYCFRK   91 (361)
T ss_dssp             GGGGGTCEEEEEEEECSSEEEEEEEEEBTT---SCEEEEEEEEECTT--SCHHHHHHHHHHHHHTCSBTTBCCCSEEEEE
T ss_pred             CCccCcEEEEEEEecccCcEEEEEEEcccC---CCCCEEEEEEEccc--cCHHHHHHHHHHHHHhcCCCCCceEEEEEEE
Confidence            345688999999999999999999875321   23678999998654  3346788999999998 69999999999999


Q ss_pred             CCeEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCC-CceEEcccCC
Q 046893          167 DEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNAD-FSAKLSDFGL  245 (464)
Q Consensus       167 ~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~-~~vkl~DFGl  245 (464)
                      .++.|||||||++|+|.+++.     .+++.++..++.|++.||.|||  +++||||||||+||||+.+ +.+||+|||+
T Consensus        92 ~~~~~lvmE~~~g~~L~~~~~-----~l~~~~~~~~~~qll~al~ylH--~~gIiHRDiKPeNiLl~~~~~~~kl~DFGl  164 (361)
T 4f9c_A           92 NDHVVIAMPYLEHESFLDILN-----SLSFQEVREYMLNLFKALKRIH--QFGIVHRDVKPSNFLYNRRLKKYALVDFGL  164 (361)
T ss_dssp             TTEEEEEEECCCCCCHHHHHT-----TCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred             CCEEEEEEeCCCcccHHHHHc-----CCCHHHHHHHHHHHHHHHHHHH--HCCeEeCcCCHHHeEEeCCCCeEEECcCCC
Confidence            999999999999999999873     4899999999999999999999  5779999999999999876 7999999999


Q ss_pred             ccCCCCCCC--------------------------cceeeccccCCcccCccccccC-CCCcccchhcHHHHHHHHHhCC
Q 046893          246 AKDGPMGDQ--------------------------THVSTRVMGTYGYAAPEYVMTG-HLTARSDVYGFGVVLLEMLLGR  298 (464)
Q Consensus       246 a~~~~~~~~--------------------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~ell~g~  298 (464)
                      |+.......                          .......+||+.|+|||++.+. .|+.++||||+|||||||++|+
T Consensus       165 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~  244 (361)
T 4f9c_A          165 AQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGR  244 (361)
T ss_dssp             CEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTC
T ss_pred             CcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCC
Confidence            975432211                          0112346899999999999875 5899999999999999999999


Q ss_pred             CCCCCCC
Q 046893          299 RAVDKSR  305 (464)
Q Consensus       299 ~pf~~~~  305 (464)
                      .||....
T Consensus       245 ~Pf~~~~  251 (361)
T 4f9c_A          245 YPFYKAS  251 (361)
T ss_dssp             SSSSCCS
T ss_pred             CCCCCCC
Confidence            9997544

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=2e-50  Score=421.66  Aligned_cols=245  Identities=24%  Similarity=0.326  Sum_probs=198.0

Q ss_pred             hcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCC---ccHHHHH---HHHHHHhcCCCCCcceEEEEE
Q 046893           91 TKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGY---QGDREWL---AEVNYLGQLRHSNLVKLIGYC  164 (464)
Q Consensus        91 ~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~---~E~~~l~~l~hpniv~l~~~~  164 (464)
                      -++|++.++||+|+||+||+|++..+      ++.||||++.+...   .....+.   .++.+++.++|||||+++++|
T Consensus       188 lddf~i~k~LG~G~fG~V~la~~~~t------g~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f  261 (689)
T 3v5w_A          188 MNDFSVHRIIGRGGFGEVYGCRKADT------GKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAF  261 (689)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTT------CCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEE
T ss_pred             hHHeEEEEEEecccCeEEEEEEECCC------CCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEE
Confidence            45799999999999999999998775      77899999864321   1222233   346777888999999999999


Q ss_pred             EeCCeEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccC
Q 046893          165 CEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFG  244 (464)
Q Consensus       165 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFG  244 (464)
                      .+.+.+|||||||+||+|.++|.+..  .+++..+..++.||+.||.|||  .++||||||||+||||+.+|++||+|||
T Consensus       262 ~~~~~lylVmEy~~GGdL~~~l~~~~--~l~E~~a~~y~~qIl~aL~yLH--~~gIiHRDLKPeNILld~~G~vKL~DFG  337 (689)
T 3v5w_A          262 HTPDKLSFILDLMNGGDLHYHLSQHG--VFSEADMRFYAAEIILGLEHMH--NRFVVYRDLKPANILLDEHGHVRISDLG  337 (689)
T ss_dssp             ECSSEEEEEECCCCSCBHHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHH--TTTEECCCCSGGGEEECTTSCEEECCCT
T ss_pred             EECCEEEEEEecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH--HCCccccCCchHHeEEeCCCCEEecccc
Confidence            99999999999999999999998754  6999999999999999999999  6779999999999999999999999999


Q ss_pred             CccCCCCCCCcceeeccccCCcccCcccccc-CCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhcc
Q 046893          245 LAKDGPMGDQTHVSTRVMGTYGYAAPEYVMT-GHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNN  323 (464)
Q Consensus       245 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~  323 (464)
                      +|+.....    .....+||+.|||||++.+ ..|+.++||||||||||||++|+.||.+......   .+.........
T Consensus       338 lA~~~~~~----~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~---~~i~~~i~~~~  410 (689)
T 3v5w_A          338 LACDFSKK----KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK---HEIDRMTLTMA  410 (689)
T ss_dssp             TCEECSSC----CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCH---HHHHHHHHHCC
T ss_pred             eeeecCCC----CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH---HHHHHhhcCCC
Confidence            99865332    2234799999999999964 5799999999999999999999999976432221   11111111111


Q ss_pred             cchhhccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCH
Q 046893          324 KKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVM  364 (464)
Q Consensus       324 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~  364 (464)
                              .    .++...+.++.+||.+||..||.+|++.
T Consensus       411 --------~----~~p~~~S~~a~dLI~~lL~~dP~~Rl~~  439 (689)
T 3v5w_A          411 --------V----ELPDSFSPELRSLLEGLLQRDVNRRLGC  439 (689)
T ss_dssp             --------C----CCCTTSCHHHHHHHHHHTCSCGGGCTTC
T ss_pred             --------C----CCCccCCHHHHHHHHHHccCCHhHCCCC
Confidence                    1    2233345688999999999999999983

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=1.2e-50  Score=424.82  Aligned_cols=253  Identities=21%  Similarity=0.272  Sum_probs=209.8

Q ss_pred             hcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCccHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeE
Q 046893           91 TKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVKLIGYCCEDEHR  170 (464)
Q Consensus        91 ~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~  170 (464)
                      .++|++.+.||+|+||+||+|.+..+      ++.||+|++........+.+.+|+.+|+.|+|||||+++++|.+.+.+
T Consensus       156 l~~Y~i~~~lG~G~fg~V~~~~~~~t------g~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~  229 (573)
T 3uto_A          156 LDHYDIHEELGTGAFGVVHRVTERAT------GNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEM  229 (573)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTT------CCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEE
T ss_pred             ccccEEEEEEeeccCeEEEEEEECCC------CCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEE
Confidence            36799999999999999999998775      678999999776555557788999999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCC--CceEEcccCCccC
Q 046893          171 ILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNAD--FSAKLSDFGLAKD  248 (464)
Q Consensus       171 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~--~~vkl~DFGla~~  248 (464)
                      |||||||+||+|.++|.... ..+++..+..++.||+.||.|||  .++|+||||||+||||+.+  +.+||+|||+|+.
T Consensus       230 ~iv~E~~~gg~L~~~i~~~~-~~l~e~~~~~~~~qi~~al~ylH--~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~  306 (573)
T 3uto_A          230 VMIYEFMSGGELFEKVADEH-NKMSEDEAVEYMRQVCKGLCHMH--ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAH  306 (573)
T ss_dssp             EEEEECCCCCBHHHHHTCTT-SCEEHHHHHHHHHHHHHHHHHHH--HTTEECCCCCGGGEEESSSSCCCEEECCCSSCEE
T ss_pred             EEEEeecCCCcHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHH--HCCeeeccCChhhccccCCCCCCEEEeeccceeE
Confidence            99999999999999986543 36999999999999999999999  5779999999999999754  8999999999987


Q ss_pred             CCCCCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhcccchhh
Q 046893          249 GPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLR  328 (464)
Q Consensus       249 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  328 (464)
                      .....   .....+||+.|||||++.+..|+.++|||||||+||||++|..||.+....      +....+....     
T Consensus       307 ~~~~~---~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~------~~~~~i~~~~-----  372 (573)
T 3uto_A          307 LDPKQ---SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDD------ETLRNVKSCD-----  372 (573)
T ss_dssp             CCTTS---EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH------HHHHHHHTTC-----
T ss_pred             ccCCC---ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH------HHHHHHHhCC-----
Confidence            54322   334578999999999999999999999999999999999999999865421      1111111111     


Q ss_pred             ccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 046893          329 ILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVA  369 (464)
Q Consensus       329 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  369 (464)
                         ..+.......++..+.+||.+||..||.+||++.++++
T Consensus       373 ---~~~~~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~  410 (573)
T 3uto_A          373 ---WNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALE  410 (573)
T ss_dssp             ---CCCCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             ---CCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence               11111122234557889999999999999999999875

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=2.4e-49  Score=387.19  Aligned_cols=279  Identities=42%  Similarity=0.710  Sum_probs=237.4

Q ss_pred             HHHhcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCccHHHHHHHHHHHhcCCCCCcceEEEEEEeC
Q 046893           88 KLATKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVKLIGYCCED  167 (464)
Q Consensus        88 ~~~~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~  167 (464)
                      ....++|++.+.||+|+||.||+|.+..       +..||||++..........+.+|+.+++.++||||+++++++...
T Consensus        35 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~-------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~  107 (321)
T 2qkw_B           35 EEATNNFDHKFLIGHGVFGKVYKGVLRD-------GAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDER  107 (321)
T ss_dssp             CCCCCCCSCCCCSCBCSSSEEEEEECTT-------CCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCT
T ss_pred             HHHHhccCccceeecCCCeeEEEEEECC-------CCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCC
Confidence            3456789999999999999999998643       567999998876666667899999999999999999999999999


Q ss_pred             CeEEEEEeccCCCCHHHHHHhhc--CCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCC
Q 046893          168 EHRILVYEYMESGSLEKHLLRRV--GCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGL  245 (464)
Q Consensus       168 ~~~~lv~e~~~~g~L~~~l~~~~--~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGl  245 (464)
                      +..++||||+++|+|.+++....  ...+++..++.++.|++.||.|||  .++|+||||||+|||++.++.+||+|||+
T Consensus       108 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH--~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~  185 (321)
T 2qkw_B          108 NEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLH--TRAIIHRDVKSINILLDENFVPKITDFGI  185 (321)
T ss_dssp             TCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCCSTTEEECTTCCEEECCCTT
T ss_pred             CeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhc--CCCeecCCCCHHHEEECCCCCEEEeeccc
Confidence            99999999999999999886543  235899999999999999999999  56799999999999999999999999999


Q ss_pred             ccCCCCCCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhcccc
Q 046893          246 AKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKK  325 (464)
Q Consensus       246 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  325 (464)
                      ++...............||+.|+|||++.+..++.++||||||+++|||++|+.||....+........|...... ...
T Consensus       186 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~  264 (321)
T 2qkw_B          186 SKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHN-NGQ  264 (321)
T ss_dssp             CEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHT-TTC
T ss_pred             ccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccc-ccc
Confidence            9864433333333446799999999999999999999999999999999999999988777666666666554332 234


Q ss_pred             hhhccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHh
Q 046893          326 VLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETVQS  376 (464)
Q Consensus       326 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~~~  376 (464)
                      +...+++.+.......++..+.+++.+||+.||.+||++.+|++.|+.+..
T Consensus       265 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~  315 (321)
T 2qkw_B          265 LEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALR  315 (321)
T ss_dssp             CCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhh
Confidence            445566666677788899999999999999999999999999999998764

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=8.4e-48  Score=372.30  Aligned_cols=251  Identities=24%  Similarity=0.351  Sum_probs=208.7

Q ss_pred             hcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCccHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeE
Q 046893           91 TKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVKLIGYCCEDEHR  170 (464)
Q Consensus        91 ~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~  170 (464)
                      .++|++.+.||+|+||+||+|.+..+      ++.||||++........+.+.+|+.+++.++||||+++++++...+..
T Consensus        19 ~~~y~~~~~lg~G~~g~V~~~~~~~~------~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~   92 (297)
T 3fxz_A           19 KKKYTRFEKIGQGASGTVYTAMDVAT------GQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDEL   92 (297)
T ss_dssp             GGTBCCCEEEEEETTEEEEEEEBTTT------CCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred             hhceeeeeeeccCCCeEEEEEEECCC------CcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEE
Confidence            46799999999999999999997665      677999998766556667889999999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCccCCC
Q 046893          171 ILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGP  250 (464)
Q Consensus       171 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~  250 (464)
                      ++||||+.+|+|.+++...   .+++..+..++.|++.||.|||  .++|+||||||+|||++.++.+||+|||++....
T Consensus        93 ~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH--~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~  167 (297)
T 3fxz_A           93 WVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLH--SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQIT  167 (297)
T ss_dssp             EEEEECCTTCBHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred             EEEEECCCCCCHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHH--hCCceeCCCCHHHEEECCCCCEEEeeCCCceecC
Confidence            9999999999999988764   4899999999999999999999  5679999999999999999999999999998643


Q ss_pred             CCCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhcccchhhcc
Q 046893          251 MGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRIL  330 (464)
Q Consensus       251 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  330 (464)
                      ...  .......||+.|+|||++.+..++.++|||||||++|+|++|+.||........      ........       
T Consensus       168 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~------~~~~~~~~-------  232 (297)
T 3fxz_A          168 PEQ--SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA------LYLIATNG-------  232 (297)
T ss_dssp             STT--CCBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH------HHHHHHHC-------
T ss_pred             Ccc--cccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH------HHHHHhCC-------
Confidence            322  223446899999999999999999999999999999999999999976542211      11111000       


Q ss_pred             CccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 046893          331 DPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVA  369 (464)
Q Consensus       331 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  369 (464)
                      .+  ....+...+..+.+|+.+||+.||.+|||+.++++
T Consensus       233 ~~--~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  269 (297)
T 3fxz_A          233 TP--ELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQ  269 (297)
T ss_dssp             SC--CCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             CC--CCCCccccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence            00  01112334557899999999999999999999975

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=4.9e-48  Score=378.52  Aligned_cols=289  Identities=40%  Similarity=0.710  Sum_probs=237.1

Q ss_pred             CCccccchhHHHHHhcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCc-cHHHHHHHHHHHhcCCCC
Q 046893           77 SNVDIFTYNEMKLATKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQ-GDREWLAEVNYLGQLRHS  155 (464)
Q Consensus        77 ~~~~~~~~~~~~~~~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hp  155 (464)
                      .....++..++....++|.+.+.||+|+||.||+|.+..       ++.||||++...... ....+.+|+.++..++||
T Consensus        15 ~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~-------~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~   87 (326)
T 3uim_A           15 GQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLAD-------GTLVAVKRLKEERTQGGELQFQTEVEMISMAVHR   87 (326)
T ss_dssp             CCCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSS-------SCCEEEEECCC-----CCCHHHHHHHGGGTCCCT
T ss_pred             CccceecHHHHHHHhhccccceeEecCCCcEEEEEEecC-------CCEEEEEEeccccCchHHHHHHHHHHHHHhccCC
Confidence            345568889999999999999999999999999997543       456999998764322 224688999999999999


Q ss_pred             CcceEEEEEEeCCeEEEEEeccCCCCHHHHHHhhc--CCCCCHHHHHHHHHHHHHHHHHHhcC-CCCeeeccCCCCceEe
Q 046893          156 NLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRV--GCMLTWSRRMKIALDAAKGLAFLHGA-ERPVIYRDFKTSNILL  232 (464)
Q Consensus       156 niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~--~~~l~~~~~~~i~~qi~~~l~~LH~~-~~~ivHrDlkp~Nill  232 (464)
                      ||+++++++...+..++||||+.+|+|.+++....  ...+++..+..++.|++.||.|||+. ..+|+||||||+|||+
T Consensus        88 ~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~  167 (326)
T 3uim_A           88 NLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILL  167 (326)
T ss_dssp             TBCCCCEEECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEE
T ss_pred             CccceEEEEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEE
Confidence            99999999999999999999999999999987653  23599999999999999999999942 1179999999999999


Q ss_pred             cCCCceEEcccCCccCCCCCCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHhCCCCCCCCC--Ccccc
Q 046893          233 NADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSR--PSREH  310 (464)
Q Consensus       233 ~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~--~~~~~  310 (464)
                      +.++.+||+|||+++...... ........||+.|+|||++.+..++.++|||||||++|+|++|+.||....  .....
T Consensus       168 ~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~  246 (326)
T 3uim_A          168 DEEFEAVVGDFGLAKLMDYKD-THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDV  246 (326)
T ss_dssp             CTTCCEEECCCSSCEECCSSS-SCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCS
T ss_pred             CCCCCEEeccCccccccCccc-ccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccch
Confidence            999999999999998654322 223344679999999999999999999999999999999999999996321  12223


Q ss_pred             cHHHHHHHhhhcccchhhccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHH
Q 046893          311 NLVEWARPLLNNNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETV  374 (464)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~  374 (464)
                      ....|....... .......+......+....+..+.+|+.+||+.||.+|||+.+|++.|+..
T Consensus       247 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~  309 (326)
T 3uim_A          247 MLLDWVKGLLKE-KKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGD  309 (326)
T ss_dssp             BHHHHHTTTTSS-CCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTS
T ss_pred             hHHHHHHHHhhc-hhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCc
Confidence            455555544332 345556667777778888999999999999999999999999999999853

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=5.6e-48  Score=385.06  Aligned_cols=269  Identities=23%  Similarity=0.340  Sum_probs=216.8

Q ss_pred             HhcCCCCCCceeecCceEEEEEEecCCCC-CCccceEEEEEEccCCCCc-cHHHHHHHHHHHhcC-CCCCcceEEEEEEe
Q 046893           90 ATKFFRPDYILGEGGFGVVYKGVIDENVR-PGYKTTFVAIKELNRGGYQ-GDREWLAEVNYLGQL-RHSNLVKLIGYCCE  166 (464)
Q Consensus        90 ~~~~~~~~~~lG~G~fg~Vy~a~~~~~~~-~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l-~hpniv~l~~~~~~  166 (464)
                      ..++|++.+.||+|+||.||+|.+..... ....+..||||++...... ....+.+|+.+|+.+ +||||+++++++..
T Consensus        79 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~  158 (370)
T 2psq_A           79 PRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ  158 (370)
T ss_dssp             CGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECS
T ss_pred             cHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEcc
Confidence            34678899999999999999998753221 1234678999999765332 235789999999999 89999999999999


Q ss_pred             CCeEEEEEeccCCCCHHHHHHhhc--------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEe
Q 046893          167 DEHRILVYEYMESGSLEKHLLRRV--------------GCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILL  232 (464)
Q Consensus       167 ~~~~~lv~e~~~~g~L~~~l~~~~--------------~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill  232 (464)
                      .+..|+||||+.+|+|.+++....              ...+++..++.++.||+.||.|||  .++|+||||||+||||
T Consensus       159 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH--~~~ivHrDlkp~NIll  236 (370)
T 2psq_A          159 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA--SQKCIHRDLAARNVLV  236 (370)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCCGGGEEE
T ss_pred             CCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHH--hCCeeccccchhhEEE
Confidence            999999999999999999997643              135899999999999999999999  5679999999999999


Q ss_pred             cCCCceEEcccCCccCCCCCCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHh-CCCCCCCCCCccccc
Q 046893          233 NADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLL-GRRAVDKSRPSREHN  311 (464)
Q Consensus       233 ~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~  311 (464)
                      +.++.+||+|||+++...............||+.|+|||++.+..++.++|||||||+||||++ |..||.+.....   
T Consensus       237 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~---  313 (370)
T 2psq_A          237 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE---  313 (370)
T ss_dssp             CTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG---
T ss_pred             CCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHH---
Confidence            9999999999999986544333333334567889999999999999999999999999999999 999997654221   


Q ss_pred             HHHHHHHhhhcccchhhccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhc
Q 046893          312 LVEWARPLLNNNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETVQSQ  377 (464)
Q Consensus       312 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~~~~  377 (464)
                      +....    .          .......+..++..+.+||.+||+.||.+||++.++++.|+.+...
T Consensus       314 ~~~~~----~----------~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~~  365 (370)
T 2psq_A          314 LFKLL----K----------EGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTL  365 (370)
T ss_dssp             HHHHH----H----------TTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHHHH----h----------cCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence            11111    1          1111122334556899999999999999999999999999988653

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=9.2e-48  Score=373.98  Aligned_cols=263  Identities=27%  Similarity=0.388  Sum_probs=213.1

Q ss_pred             hcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCccHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeE
Q 046893           91 TKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVKLIGYCCEDEHR  170 (464)
Q Consensus        91 ~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~  170 (464)
                      .++|++.+.||+|+||+||+|.+..+      +..||+|++..........+.+|+.+++.++||||+++++++.+++..
T Consensus         9 ~~~~~~~~~lG~G~~g~V~~~~~~~~------~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~   82 (310)
T 3s95_A            9 PSDLIHGEVLGKGCFGQAIKVTHRET------GEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRL   82 (310)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEETTT------CCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEE
T ss_pred             hhHeeccceecCCCCEEEEEEEECCC------CcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCee
Confidence            35688899999999999999998765      667999998765555567899999999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCccCCC
Q 046893          171 ILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGP  250 (464)
Q Consensus       171 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~  250 (464)
                      ++||||+.+++|.+++... ...+++..++.++.|++.||.|||  +++|+||||||+|||++.++.+||+|||+++...
T Consensus        83 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH--~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  159 (310)
T 3s95_A           83 NFITEYIKGGTLRGIIKSM-DSQYPWSQRVSFAKDIASGMAYLH--SMNIIHRDLNSHNCLVRENKNVVVADFGLARLMV  159 (310)
T ss_dssp             EEEEECCTTCBHHHHHHHC-CTTSCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSTTSEEECTTSCEEECCCTTCEECC
T ss_pred             EEEEEecCCCcHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHH--hCCccCCCCCcCeEEECCCCCEEEeecccceecc
Confidence            9999999999999998764 346999999999999999999999  5679999999999999999999999999998643


Q ss_pred             CCCCcc------------eeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHH
Q 046893          251 MGDQTH------------VSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARP  318 (464)
Q Consensus       251 ~~~~~~------------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~  318 (464)
                      ......            .....+||+.|+|||++.+..++.++||||||+++|||++|..||...........      
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~------  233 (310)
T 3s95_A          160 DEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFG------  233 (310)
T ss_dssp             --------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSS------
T ss_pred             cccccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHh------
Confidence            322111            11146799999999999999999999999999999999999999875433221100      


Q ss_pred             hhhcccchhhccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhc
Q 046893          319 LLNNNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETVQSQ  377 (464)
Q Consensus       319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~~~~  377 (464)
                           ......++.    ..+..++..+.+|+.+||+.||.+||++.++++.|+.+...
T Consensus       234 -----~~~~~~~~~----~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~  283 (310)
T 3s95_A          234 -----LNVRGFLDR----YCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMH  283 (310)
T ss_dssp             -----BCHHHHHHH----TCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             -----hhhhccccc----cCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence                 000000011    11223344788999999999999999999999999988754

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=1.5e-47  Score=374.73  Aligned_cols=274  Identities=24%  Similarity=0.312  Sum_probs=209.1

Q ss_pred             HhcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCccHHHHHHHHHHHhcCCCCCcceEEEEEEeCC-
Q 046893           90 ATKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVKLIGYCCEDE-  168 (464)
Q Consensus        90 ~~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~-  168 (464)
                      ..++|++.+.||+|+||+||+|.+.        ++.||||++.... .....+..|+.+|..++||||+++++++.... 
T Consensus        22 ~~~~y~~~~~lg~G~~g~Vy~~~~~--------~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~   92 (322)
T 3soc_A           22 QSMPLQLLEVKARGRFGCVWKAQLL--------NEYVAVKIFPIQD-KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTS   92 (322)
T ss_dssp             TTEEEEEEEEEECSTTCEEEEEEET--------TEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECS
T ss_pred             chhhchhhheecccCceEEEEEEEC--------CCEEEEEEeecCc-hHHHHHHHHHHHHhcCCCCCchhhcceeccCCC
Confidence            3467899999999999999999864        4679999986532 22345567899999999999999999998754 


Q ss_pred             ---eEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCC----------CeeeccCCCCceEecCC
Q 046893          169 ---HRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAER----------PVIYRDFKTSNILLNAD  235 (464)
Q Consensus       169 ---~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~----------~ivHrDlkp~Nill~~~  235 (464)
                         ..++||||+++|+|.+++...   .+++..++.++.|++.||.|||  ..          +|+||||||+|||++.+
T Consensus        93 ~~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~qi~~al~~LH--~~~~~l~~~~~~~ivH~Dlkp~Nill~~~  167 (322)
T 3soc_A           93 VDVDLWLITAFHEKGSLSDFLKAN---VVSWNELCHIAETMARGLAYLH--EDIPGLKDGHKPAISHRDIKSKNVLLKNN  167 (322)
T ss_dssp             SSEEEEEEEECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHT--CCEEEETTEEECEEECSCCSGGGEEECTT
T ss_pred             CCceEEEEEecCCCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHH--hhccccccccCCCEEeCCCChHhEEECCC
Confidence               479999999999999998764   4999999999999999999999  45          79999999999999999


Q ss_pred             CceEEcccCCccCCCCCCCcceeeccccCCcccCcccccc-----CCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccc
Q 046893          236 FSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMT-----GHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREH  310 (464)
Q Consensus       236 ~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~  310 (464)
                      +.+||+|||+++...............||+.|+|||++.+     ..++.++|||||||++|||++|+.||.+.......
T Consensus       168 ~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~  247 (322)
T 3soc_A          168 LTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYML  247 (322)
T ss_dssp             CCEEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCC
T ss_pred             CeEEEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhcc
Confidence            9999999999976543333333344689999999999886     35667899999999999999999999865443222


Q ss_pred             cHHHHHHHhhhcc----cchhhccCccccCc-cCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhc
Q 046893          311 NLVEWARPLLNNN----KKVLRILDPRLEGQ-YTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETVQSQ  377 (464)
Q Consensus       311 ~~~~~~~~~~~~~----~~~~~~~~~~~~~~-~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~~~~  377 (464)
                      .+...........    ........+.+... ....++..+.+||.+||+.||.+|||+.+|++.|+.+.+.
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~~  319 (322)
T 3soc_A          248 PFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRL  319 (322)
T ss_dssp             TTHHHHCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             chhhhhccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence            2211100000000    00000111111111 1234566799999999999999999999999999988753

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=2.5e-47  Score=373.76  Aligned_cols=265  Identities=25%  Similarity=0.388  Sum_probs=212.5

Q ss_pred             hcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCc-cHHHHHHHHHHHhcCCCCCcceEEEEEEeCCe
Q 046893           91 TKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQ-GDREWLAEVNYLGQLRHSNLVKLIGYCCEDEH  169 (464)
Q Consensus        91 ~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~  169 (464)
                      .++|++.+.||+|+||+||+|.+..+..   .+..||||++...... ..+.+.+|+.+|+.++||||+++++++...+.
T Consensus        48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  124 (325)
T 3kul_A           48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQ---RDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRL  124 (325)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECCTTS---CCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGC
T ss_pred             hhHeEEeeEEEeCCCcEEEEEEEecCCC---CCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCc
Confidence            4568899999999999999999875422   3567999999764332 33678999999999999999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCccCC
Q 046893          170 RILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDG  249 (464)
Q Consensus       170 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~  249 (464)
                      .+|||||+++++|.+++... ...+++..++.++.|++.||.|||  ..+|+||||||+||||+.++.+||+|||+++..
T Consensus       125 ~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~L~~LH--~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~  201 (325)
T 3kul_A          125 AMIVTEYMENGSLDTFLRTH-DGQFTIMQLVGMLRGVGAGMRYLS--DLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVL  201 (325)
T ss_dssp             CEEEEECCTTCBHHHHHHTT-TTCSCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGEEECTTCCEEECCCSSCEEC
T ss_pred             cEEEeeCCCCCcHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHH--HCCeeCCCCCcceEEECCCCCEEECCCCccccc
Confidence            99999999999999998654 346999999999999999999999  567999999999999999999999999999865


Q ss_pred             CCCCCc-ceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHhhhcccchh
Q 046893          250 PMGDQT-HVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLL-GRRAVDKSRPSREHNLVEWARPLLNNNKKVL  327 (464)
Q Consensus       250 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  327 (464)
                      ...... .......+|..|+|||++.+..++.++|||||||++|||++ |..||.......   +..   ...       
T Consensus       202 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~---~~~---~~~-------  268 (325)
T 3kul_A          202 EDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRD---VIS---SVE-------  268 (325)
T ss_dssp             C----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHH---HHH---HHH-------
T ss_pred             ccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHH---HHH---HHH-------
Confidence            433221 12223456888999999999999999999999999999999 999997643211   111   111       


Q ss_pred             hccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhcC
Q 046893          328 RILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETVQSQG  378 (464)
Q Consensus       328 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~~~~~  378 (464)
                          .......+..++..+.+|+.+||..||.+||++.+|++.|+.+....
T Consensus       269 ----~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~  315 (325)
T 3kul_A          269 ----EGYRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSP  315 (325)
T ss_dssp             ----TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSC
T ss_pred             ----cCCCCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCc
Confidence                11111223345568999999999999999999999999999987654

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=2.1e-47  Score=371.69  Aligned_cols=263  Identities=27%  Similarity=0.418  Sum_probs=204.4

Q ss_pred             HHHHhcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCcc--HHHHHHHHHHHhcCCCCCcceEEEEE
Q 046893           87 MKLATKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQG--DREWLAEVNYLGQLRHSNLVKLIGYC  164 (464)
Q Consensus        87 ~~~~~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~hpniv~l~~~~  164 (464)
                      +.+...+|++.+.||+|+||+||+|.+.        ++.||||++.......  ...+.+|+.+|+.++||||+++++++
T Consensus        32 ~~i~~~~y~i~~~lG~G~~g~V~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~  103 (309)
T 3p86_A           32 MDIPWCDLNIKEKIGAGSFGTVHRAEWH--------GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAV  103 (309)
T ss_dssp             CBCCGGGEEEEEEEEECSSEEEEEEEET--------TEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             ccCChhHceeeeEeecCCCeEEEEEEEC--------CCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence            3445567899999999999999999763        4569999987654333  25688999999999999999999999


Q ss_pred             EeCCeEEEEEeccCCCCHHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHhcCCCC--eeeccCCCCceEecCCCceEEc
Q 046893          165 CEDEHRILVYEYMESGSLEKHLLRRVG-CMLTWSRRMKIALDAAKGLAFLHGAERP--VIYRDFKTSNILLNADFSAKLS  241 (464)
Q Consensus       165 ~~~~~~~lv~e~~~~g~L~~~l~~~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~~~--ivHrDlkp~Nill~~~~~vkl~  241 (464)
                      ......++||||+.+|+|.+++..... ..+++..++.++.|++.||.|||  ..+  |+||||||+|||++.++.+||+
T Consensus       104 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH--~~~~~ivH~Dikp~NIll~~~~~~kL~  181 (309)
T 3p86_A          104 TQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH--NRNPPIVHRNLKSPNLLVDKKYTVKVC  181 (309)
T ss_dssp             CSTTCCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHH--TSSSCCCCTTCCGGGEEECTTCCEEEC
T ss_pred             EECCceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHH--cCCCCEECCCCChhhEEEeCCCcEEEC
Confidence            999999999999999999999875321 23899999999999999999999  566  9999999999999999999999


Q ss_pred             ccCCccCCCCCCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhh
Q 046893          242 DFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLN  321 (464)
Q Consensus       242 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~  321 (464)
                      |||+++.....  ........||+.|+|||++.+..++.++|||||||++|+|++|+.||.......      .......
T Consensus       182 Dfg~a~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~------~~~~~~~  253 (309)
T 3p86_A          182 DFGLSRLKAST--FLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQ------VVAAVGF  253 (309)
T ss_dssp             CCC-------------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHH------HHHHHHH
T ss_pred             CCCCCcccccc--ccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH------HHHHHHh
Confidence            99999753222  122334679999999999999999999999999999999999999997654211      1111100


Q ss_pred             cccchhhccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhc
Q 046893          322 NNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETVQSQ  377 (464)
Q Consensus       322 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~~~~  377 (464)
                      .          ......+..++..+.+||.+||+.||.+||++.++++.|+.+...
T Consensus       254 ~----------~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~  299 (309)
T 3p86_A          254 K----------CKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKS  299 (309)
T ss_dssp             S----------CCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC-
T ss_pred             c----------CCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence            0          011122334456899999999999999999999999999988754

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.5e-47  Score=382.12  Aligned_cols=272  Identities=25%  Similarity=0.347  Sum_probs=219.2

Q ss_pred             HHHhcCCCCCCceeecCceEEEEEEecCCCC-CCccceEEEEEEccCCCCc-cHHHHHHHHHHHhcC-CCCCcceEEEEE
Q 046893           88 KLATKFFRPDYILGEGGFGVVYKGVIDENVR-PGYKTTFVAIKELNRGGYQ-GDREWLAEVNYLGQL-RHSNLVKLIGYC  164 (464)
Q Consensus        88 ~~~~~~~~~~~~lG~G~fg~Vy~a~~~~~~~-~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l-~hpniv~l~~~~  164 (464)
                      .+..++|.+.+.||+|+||+||+|.+..... ....+..||||++...... ....+.+|+++++.+ +||||+++++++
T Consensus        65 ~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~  144 (382)
T 3tt0_A           65 ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGAC  144 (382)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             ccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeee
Confidence            3455779999999999999999999764322 1234577999999765332 236788999999999 899999999999


Q ss_pred             EeCCeEEEEEeccCCCCHHHHHHhhcC--------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCce
Q 046893          165 CEDEHRILVYEYMESGSLEKHLLRRVG--------------CMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNI  230 (464)
Q Consensus       165 ~~~~~~~lv~e~~~~g~L~~~l~~~~~--------------~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Ni  230 (464)
                      ...+..++||||+.+|+|.+++.....              ..+++..++.|+.|++.||.|||  ..+|+||||||+||
T Consensus       145 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH--~~~ivH~Dlkp~NI  222 (382)
T 3tt0_A          145 TQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA--SKKCIHRDLAARNV  222 (382)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCCGGGE
T ss_pred             ccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHH--hCCEecCCCCcceE
Confidence            999999999999999999999976541              35899999999999999999999  56799999999999


Q ss_pred             EecCCCceEEcccCCccCCCCCCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHh-CCCCCCCCCCccc
Q 046893          231 LLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLL-GRRAVDKSRPSRE  309 (464)
Q Consensus       231 ll~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~  309 (464)
                      ||+.++.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|+|++ |..||......  
T Consensus       223 ll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~--  300 (382)
T 3tt0_A          223 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE--  300 (382)
T ss_dssp             EECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH--
T ss_pred             EEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH--
Confidence            999999999999999986544333333444678899999999999999999999999999999999 99999764321  


Q ss_pred             ccHHHHHHHhhhcccchhhccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhcC
Q 046893          310 HNLVEWARPLLNNNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETVQSQG  378 (464)
Q Consensus       310 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~~~~~  378 (464)
                          +...... ..          .....+..++..+.+|+.+||+.||.+||++.+|++.|+.+....
T Consensus       301 ----~~~~~~~-~~----------~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~  354 (382)
T 3tt0_A          301 ----ELFKLLK-EG----------HRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALT  354 (382)
T ss_dssp             ----HHHHHHH-TT----------CCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHS
T ss_pred             ----HHHHHHH-cC----------CCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHH
Confidence                1111111 11          111122334558999999999999999999999999999887543

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=1.3e-46  Score=368.91  Aligned_cols=248  Identities=23%  Similarity=0.327  Sum_probs=205.5

Q ss_pred             hcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCc--cHHHHHHHHHHHhcCCCCCcceEEEEEEeCC
Q 046893           91 TKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQ--GDREWLAEVNYLGQLRHSNLVKLIGYCCEDE  168 (464)
Q Consensus        91 ~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~  168 (464)
                      .++|++.+.||+|+||.||+|.+..+      ++.||||++......  ....+.+|+++|+.++||||+++++++...+
T Consensus        14 ~~~y~~~~~lG~G~~g~V~~a~~~~~------~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~   87 (328)
T 3fe3_A           14 IGNYRLLKTIGKGNFAKVKLARHILT------GREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEK   87 (328)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTT------CCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred             cCCEEEEEEEeeCCCEEEEEEEECCC------CCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECC
Confidence            35689999999999999999998765      677999998754332  2356889999999999999999999999999


Q ss_pred             eEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCccC
Q 046893          169 HRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKD  248 (464)
Q Consensus       169 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~  248 (464)
                      ..++||||+++|+|.+++....  .+++..+..++.|++.||.|||  ..+|+||||||+|||++.++.+||+|||+++.
T Consensus        88 ~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~al~~lH--~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~  163 (328)
T 3fe3_A           88 TLYLIMEYASGGEVFDYLVAHG--RMKEKEARSKFRQIVSAVQYCH--QKRIVHRDLKAENLLLDADMNIKIADFGFSNE  163 (328)
T ss_dssp             EEEEEECCCTTCBHHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCCGGGEEECTTSCEEECSTTCCGG
T ss_pred             EEEEEEECCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH--HCCEeccCCCHHHEEEcCCCCEEEeeccCcee
Confidence            9999999999999999987754  6999999999999999999999  56799999999999999999999999999986


Q ss_pred             CCCCCCcceeeccccCCcccCccccccCCCC-cccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhcccchh
Q 046893          249 GPMGDQTHVSTRVMGTYGYAAPEYVMTGHLT-ARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVL  327 (464)
Q Consensus       249 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  327 (464)
                      .....   .....+||+.|+|||++.+..++ .++|||||||+||+|++|+.||.+...      .+..........   
T Consensus       164 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~------~~~~~~i~~~~~---  231 (328)
T 3fe3_A          164 FTVGG---KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNL------KELRERVLRGKY---  231 (328)
T ss_dssp             GSSSC---GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHCCC---
T ss_pred             cCCCC---ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCH------HHHHHHHHhCCC---
Confidence            43322   23457899999999999988775 789999999999999999999976432      122222211111   


Q ss_pred             hccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 046893          328 RILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVA  369 (464)
Q Consensus       328 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  369 (464)
                               ..+...+..+.+|+.+||..||.+|||+.++++
T Consensus       232 ---------~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~  264 (328)
T 3fe3_A          232 ---------RIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMK  264 (328)
T ss_dssp             ---------CCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTT
T ss_pred             ---------CCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence                     112223457889999999999999999999875

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=9e-47  Score=364.49  Aligned_cols=264  Identities=23%  Similarity=0.325  Sum_probs=208.5

Q ss_pred             HhcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCcc---HHHHHHHHHHHhcCCCCCcceEEEEEEe
Q 046893           90 ATKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQG---DREWLAEVNYLGQLRHSNLVKLIGYCCE  166 (464)
Q Consensus        90 ~~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~hpniv~l~~~~~~  166 (464)
                      ..++|++.+.||+|+||.||+|.+..+      +..||+|++.......   .+.+.+|+.++..++||||+++++++..
T Consensus         9 ~~~~y~i~~~lg~G~~g~V~~~~~~~~------~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~   82 (294)
T 4eqm_A            9 INERYKIVDKLGGGGMSTVYLAEDTIL------NIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEE   82 (294)
T ss_dssp             EETTEEEEEEEEEETTEEEEEEEETTT------CSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEEC
T ss_pred             hhccEEEEEEEccCCCEEEEEEEECCC------CCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeee
Confidence            356799999999999999999998765      5679999986543322   3568899999999999999999999999


Q ss_pred             CCeEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCc
Q 046893          167 DEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLA  246 (464)
Q Consensus       167 ~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla  246 (464)
                      .+..++||||+++++|.+++....  .+++..++.++.|++.||.|||  ..+|+||||||+|||++.++.+||+|||++
T Consensus        83 ~~~~~lv~e~~~g~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH--~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~  158 (294)
T 4eqm_A           83 DDCYYLVMEYIEGPTLSEYIESHG--PLSVDTAINFTNQILDGIKHAH--DMRIVHRDIKPQNILIDSNKTLKIFDFGIA  158 (294)
T ss_dssp             SSEEEEEEECCCSCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHH--HTTCCCCCCCGGGEEECTTSCEEECCCSSS
T ss_pred             CCeEEEEEeCCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH--HCCcccCCCCHHHEEECCCCCEEEEeCCCc
Confidence            999999999999999999987654  6999999999999999999999  567999999999999999999999999999


Q ss_pred             cCCCCCCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhcccch
Q 046893          247 KDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKV  326 (464)
Q Consensus       247 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  326 (464)
                      +....... .......||+.|+|||++.+..++.++||||||+++|+|++|+.||.+....      ......+...   
T Consensus       159 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~------~~~~~~~~~~---  228 (294)
T 4eqm_A          159 KALSETSL-TQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAV------SIAIKHIQDS---  228 (294)
T ss_dssp             TTC--------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHH------HHHHHHHSSC---
T ss_pred             cccccccc-cccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChH------HHHHHHhhcc---
Confidence            86433221 2233467999999999999999999999999999999999999999764321      1111111110   


Q ss_pred             hhccCccccCccCHHHHHHHHHHHHHhhccCCCCCC-CHHHHHHHHHHHHhc
Q 046893          327 LRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRP-VMSDVVALLETVQSQ  377 (464)
Q Consensus       327 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-s~~ev~~~L~~~~~~  377 (464)
                          .+.........++..+.+++.+||+.||.+|| ++.++.+.|+.+...
T Consensus       229 ----~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~  276 (294)
T 4eqm_A          229 ----VPNVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHE  276 (294)
T ss_dssp             ----CCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSS
T ss_pred             ----CCCcchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhh
Confidence                11111122233456899999999999999998 899999998876543

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=9.5e-48  Score=384.48  Aligned_cols=264  Identities=25%  Similarity=0.379  Sum_probs=212.6

Q ss_pred             HHHHhcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCc-cHHHHHHHHHHHhcCCCCCcceEEEEEE
Q 046893           87 MKLATKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQ-GDREWLAEVNYLGQLRHSNLVKLIGYCC  165 (464)
Q Consensus        87 ~~~~~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~  165 (464)
                      +.+..++|.+.+.||+|+||.||+|.+..+      ++.||||++...... ....+.+|+++|+.++||||+++++++.
T Consensus       109 ~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~  182 (377)
T 3cbl_A          109 WVLNHEDLVLGEQIGRGNFGEVFSGRLRAD------NTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCT  182 (377)
T ss_dssp             TBCCGGGEEEEEEEEEETTEEEEEEEETTT------CCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEEC
T ss_pred             cEEchHHeEEeeEeccCCCCeEEEEEEecC------CeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEe
Confidence            344556788999999999999999998754      567999998754222 2245789999999999999999999999


Q ss_pred             eCCeEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCC
Q 046893          166 EDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGL  245 (464)
Q Consensus       166 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGl  245 (464)
                      ..+..+|||||+++|+|.+++... +..+++..++.++.|++.||.|||  .++|+||||||+|||++.++.+||+|||+
T Consensus       183 ~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~LH--~~~ivHrDlkp~Nil~~~~~~~kl~DfG~  259 (377)
T 3cbl_A          183 QKQPIYIVMELVQGGDFLTFLRTE-GARLRVKTLLQMVGDAAAGMEYLE--SKCCIHRDLAARNCLVTEKNVLKISDFGM  259 (377)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHHH-GGGCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGEEECTTCCEEECCGGG
T ss_pred             cCCCcEEEEEcCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHH--HCCcCCcccCHHHEEEcCCCcEEECcCCC
Confidence            999999999999999999998764 335899999999999999999999  56799999999999999999999999999


Q ss_pred             ccCCCCCCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHhhhccc
Q 046893          246 AKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLL-GRRAVDKSRPSREHNLVEWARPLLNNNK  324 (464)
Q Consensus       246 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~  324 (464)
                      ++...............++..|+|||++.+..++.++|||||||+||||++ |..||.......   ..+    .+..  
T Consensus       260 s~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~---~~~----~~~~--  330 (377)
T 3cbl_A          260 SREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQ---TRE----FVEK--  330 (377)
T ss_dssp             CEECTTSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHH---HHH----HHHT--
T ss_pred             ceecCCCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH---HHH----HHHc--
Confidence            986432211111112345778999999999999999999999999999998 999997643211   111    1111  


Q ss_pred             chhhccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHh
Q 046893          325 KVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETVQS  376 (464)
Q Consensus       325 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~~~  376 (464)
                              ......+..++..+.+||.+||+.||.+|||+.+|++.|+.+..
T Consensus       331 --------~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~  374 (377)
T 3cbl_A          331 --------GGRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRK  374 (377)
T ss_dssp             --------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             --------CCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHh
Confidence                    11112233456689999999999999999999999999998864

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=3.3e-46  Score=367.30  Aligned_cols=249  Identities=27%  Similarity=0.348  Sum_probs=205.4

Q ss_pred             hcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCC---CccHHHHHHHHHHHhcCCCCCcceEEEEEEeC
Q 046893           91 TKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGG---YQGDREWLAEVNYLGQLRHSNLVKLIGYCCED  167 (464)
Q Consensus        91 ~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~  167 (464)
                      .++|++.+.||+|+||+||+|.+..+      ++.||+|++....   ......+.+|+.+|+.++||||+++++++...
T Consensus         4 ~~~y~~~~~lG~G~fg~V~~~~~~~~------~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~   77 (337)
T 1o6l_A            4 MNDFDYLKLLGKGTFGKVILVREKAT------GRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTH   77 (337)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTT------CCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECS
T ss_pred             hHHeEEEEEEecCCCeEEEEEEECCC------CCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeC
Confidence            35688999999999999999998765      6779999986531   23346788999999999999999999999999


Q ss_pred             CeEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCcc
Q 046893          168 EHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAK  247 (464)
Q Consensus       168 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~  247 (464)
                      +..+|||||+++|+|.+++....  .+++..+..++.||+.||.|||  .++|+||||||+||||+.++.+||+|||+++
T Consensus        78 ~~~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH--~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~  153 (337)
T 1o6l_A           78 DRLCFVMEYANGGELFFHLSRER--VFTEERARFYGAEIVSALEYLH--SRDVVYRDIKLENLMLDKDGHIKITDFGLCK  153 (337)
T ss_dssp             SEEEEEEECCTTCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHH--HTTCBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred             CEEEEEEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH--HCCeecCcCCHHHEEECCCCCEEEeeccchh
Confidence            99999999999999999887653  6899999999999999999999  5679999999999999999999999999998


Q ss_pred             CCCCCCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhcccchh
Q 046893          248 DGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVL  327 (464)
Q Consensus       248 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  327 (464)
                      ......  ......+||+.|+|||++.+..++.++|||||||++|||++|+.||.....      ............   
T Consensus       154 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~------~~~~~~i~~~~~---  222 (337)
T 1o6l_A          154 EGISDG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH------ERLFELILMEEI---  222 (337)
T ss_dssp             CSCCTT--CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHCCC---
T ss_pred             hcccCC--CcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCH------HHHHHHHHcCCC---
Confidence            632222  223457899999999999999999999999999999999999999976432      111111111110   


Q ss_pred             hccCccccCccCHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHH
Q 046893          328 RILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRP-----VMSDVVA  369 (464)
Q Consensus       328 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~ev~~  369 (464)
                               .++...+..+.+||.+||+.||.+||     ++.++++
T Consensus       223 ---------~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~  260 (337)
T 1o6l_A          223 ---------RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME  260 (337)
T ss_dssp             ---------CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             ---------CCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHc
Confidence                     12233455889999999999999999     7887764

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=2.4e-47  Score=378.46  Aligned_cols=276  Identities=25%  Similarity=0.367  Sum_probs=219.6

Q ss_pred             cchhHHHHHhcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCcc-HHHHHHHHHHHhcC-CCCCcce
Q 046893           82 FTYNEMKLATKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQG-DREWLAEVNYLGQL-RHSNLVK  159 (464)
Q Consensus        82 ~~~~~~~~~~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l-~hpniv~  159 (464)
                      +....+.+..++|++.+.||+|+||.||+|.+... .....++.||||++....... ...+.+|+.+|..+ +||||++
T Consensus        12 ~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~-~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~   90 (359)
T 3vhe_A           12 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGI-DKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVN   90 (359)
T ss_dssp             CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESS-SSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred             CCcccccccccceeeceeecCCCCceEEEEEeccc-cccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceee
Confidence            34556677788999999999999999999986542 122357889999997653332 35689999999999 7999999


Q ss_pred             EEEEEEeCC-eEEEEEeccCCCCHHHHHHhhcC-----------------------------------------------
Q 046893          160 LIGYCCEDE-HRILVYEYMESGSLEKHLLRRVG-----------------------------------------------  191 (464)
Q Consensus       160 l~~~~~~~~-~~~lv~e~~~~g~L~~~l~~~~~-----------------------------------------------  191 (464)
                      +++++...+ ..++||||+.+|+|.+++.....                                               
T Consensus        91 ~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  170 (359)
T 3vhe_A           91 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEE  170 (359)
T ss_dssp             EEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-----------------------------------------
T ss_pred             eeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccc
Confidence            999998765 48999999999999999976432                                               


Q ss_pred             -----------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCccCCCCCCC
Q 046893          192 -----------------CMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQ  254 (464)
Q Consensus       192 -----------------~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~  254 (464)
                                       ..+++..++.++.|++.||.|||  .++|+||||||+||||+.++.+||+|||+++.......
T Consensus       171 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH--~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~  248 (359)
T 3vhe_A          171 KSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLA--SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD  248 (359)
T ss_dssp             -------------CTTTTCBCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTT
T ss_pred             cccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHH--HCCcccCCCChhhEEEcCCCcEEEEeccceeeeccccc
Confidence                             12899999999999999999999  56799999999999999999999999999986544433


Q ss_pred             cceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHhhhcccchhhccCcc
Q 046893          255 THVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLL-GRRAVDKSRPSREHNLVEWARPLLNNNKKVLRILDPR  333 (464)
Q Consensus       255 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  333 (464)
                      ........||+.|+|||++.+..++.++|||||||++|||++ |..||.+......  +..    .+..          .
T Consensus       249 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~--~~~----~~~~----------~  312 (359)
T 3vhe_A          249 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE--FCR----RLKE----------G  312 (359)
T ss_dssp             CEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHH--HHH----HHHH----------T
T ss_pred             chhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHH--HHH----HHHc----------C
Confidence            334445678999999999999999999999999999999998 9999976543211  111    1110          0


Q ss_pred             ccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHh
Q 046893          334 LEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETVQS  376 (464)
Q Consensus       334 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~~~  376 (464)
                      .....+..++..+.+|+.+||+.||.+||++.+|++.|+.+..
T Consensus       313 ~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~  355 (359)
T 3vhe_A          313 TRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ  355 (359)
T ss_dssp             CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHH
Confidence            1111222344589999999999999999999999999998764

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=1.8e-45  Score=357.12  Aligned_cols=283  Identities=37%  Similarity=0.595  Sum_probs=228.1

Q ss_pred             ccccchhHHHHHhcCCCCC------CceeecCceEEEEEEecCCCCCCccceEEEEEEccCCC----CccHHHHHHHHHH
Q 046893           79 VDIFTYNEMKLATKFFRPD------YILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGG----YQGDREWLAEVNY  148 (464)
Q Consensus        79 ~~~~~~~~~~~~~~~~~~~------~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~E~~~  148 (464)
                      ...|.+.++..++++|...      +.||+|+||.||+|.+.        ++.||||++....    ......+.+|+.+
T Consensus        12 ~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~~--------~~~vavK~~~~~~~~~~~~~~~~~~~E~~~   83 (307)
T 2nru_A           12 FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVN--------NTTVAVKKLAAMVDITTEELKQQFDQEIKV   83 (307)
T ss_dssp             CEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEESS--------SCEEEEEEECCCTTSCTTTHHHHHHHHHHH
T ss_pred             CCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEEC--------CceEEEEEEecccCcchHHHHHHHHHHHHH
Confidence            3467788888888888877      88999999999999863        4569999986532    2234678999999


Q ss_pred             HhcCCCCCcceEEEEEEeCCeEEEEEeccCCCCHHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCC
Q 046893          149 LGQLRHSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRV-GCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKT  227 (464)
Q Consensus       149 l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp  227 (464)
                      ++.++||||+++++++...+..++||||+++++|.+++.... ...+++..++.++.|++.||.|||  ..+|+||||||
T Consensus        84 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH--~~~i~H~dlkp  161 (307)
T 2nru_A           84 MAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLH--ENHHIHRDIKS  161 (307)
T ss_dssp             HHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCCG
T ss_pred             HHhcCCCCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHh--cCCeecCCCCH
Confidence            999999999999999999999999999999999999987532 346999999999999999999999  56799999999


Q ss_pred             CceEecCCCceEEcccCCccCCCCCCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHhCCCCCCCCCCc
Q 046893          228 SNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPS  307 (464)
Q Consensus       228 ~Nill~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~  307 (464)
                      +|||++.++.+||+|||+++...............||+.|+|||++.+ .++.++||||||+++|+|++|..||......
T Consensus       162 ~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~  240 (307)
T 2nru_A          162 ANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREP  240 (307)
T ss_dssp             GGEEECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSS
T ss_pred             HHEEEcCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcch
Confidence            999999999999999999986543333333445689999999998765 5889999999999999999999999865432


Q ss_pred             ccccHHHHHHHhhhcccchhhccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHH
Q 046893          308 REHNLVEWARPLLNNNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETVQ  375 (464)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~~  375 (464)
                      .  .+..+..........+...++..+ ...+...+..+.+++.+||+.||.+||++.+|++.|+.+.
T Consensus       241 ~--~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~  305 (307)
T 2nru_A          241 Q--LLLDIKEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMT  305 (307)
T ss_dssp             S--BTTHHHHHHHTTSCCHHHHSCSSC-SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC
T ss_pred             H--HHHHHHHHhhhhhhhhhhhccccc-cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence            2  122222222222333333444433 3456677889999999999999999999999999999875

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=4.8e-47  Score=369.07  Aligned_cols=270  Identities=29%  Similarity=0.384  Sum_probs=217.1

Q ss_pred             HHHHhcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCC-ccHHHHHHHHHHHhcCCCCCcceEEEEEE
Q 046893           87 MKLATKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGY-QGDREWLAEVNYLGQLRHSNLVKLIGYCC  165 (464)
Q Consensus        87 ~~~~~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~  165 (464)
                      +.+..++|.+.+.||+|+||.||+|.+.... ....+..||||++..... .....+.+|+.+|+.++||||+++++++.
T Consensus        18 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~-~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~   96 (314)
T 2ivs_A           18 WEFPRKNLVLGKTLGEGEFGKVVKATAFHLK-GRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACS   96 (314)
T ss_dssp             TBCCGGGEEEEEEEEECSSSEEEEEEEETGG-GCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC
T ss_pred             cccchhheeeeeeecccCCeeEEEEEEeccC-cccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEe
Confidence            3445677999999999999999999875421 112357899999976432 22367889999999999999999999999


Q ss_pred             eCCeEEEEEeccCCCCHHHHHHhhcC----------------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCeeec
Q 046893          166 EDEHRILVYEYMESGSLEKHLLRRVG----------------------CMLTWSRRMKIALDAAKGLAFLHGAERPVIYR  223 (464)
Q Consensus       166 ~~~~~~lv~e~~~~g~L~~~l~~~~~----------------------~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHr  223 (464)
                      ..+..++||||+.+++|.+++.....                      ..+++..++.++.|++.||.|||  .++|+||
T Consensus        97 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH--~~~ivH~  174 (314)
T 2ivs_A           97 QDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLA--EMKLVHR  174 (314)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHH--HTTEECC
T ss_pred             cCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHH--HCCCccc
Confidence            99999999999999999999976432                      24899999999999999999999  5679999


Q ss_pred             cCCCCceEecCCCceEEcccCCccCCCCCCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHh-CCCCCC
Q 046893          224 DFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLL-GRRAVD  302 (464)
Q Consensus       224 Dlkp~Nill~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~  302 (464)
                      ||||+|||++.++.+||+|||+++...............||+.|+|||++.+..++.++||||||+++|+|++ |..||.
T Consensus       175 dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~  254 (314)
T 2ivs_A          175 DLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYP  254 (314)
T ss_dssp             CCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred             ccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCC
Confidence            9999999999999999999999986543333223334567889999999999999999999999999999999 999997


Q ss_pred             CCCCcccccHHHHHHHhhhcccchhhccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHh
Q 046893          303 KSRPSREHNLVEWARPLLNNNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETVQS  376 (464)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~~~  376 (464)
                      ......   +....    ..          ......+..++..+.+|+.+||+.||.+||++.++++.|+.+..
T Consensus       255 ~~~~~~---~~~~~----~~----------~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~  311 (314)
T 2ivs_A          255 GIPPER---LFNLL----KT----------GHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMV  311 (314)
T ss_dssp             TCCGGG---HHHHH----HT----------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCCHHH---HHHHh----hc----------CCcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            654321   11111    11          01112223445689999999999999999999999999998765

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=8e-47  Score=369.85  Aligned_cols=253  Identities=25%  Similarity=0.319  Sum_probs=202.6

Q ss_pred             cCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCc-cHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeE
Q 046893           92 KFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQ-GDREWLAEVNYLGQLRHSNLVKLIGYCCEDEHR  170 (464)
Q Consensus        92 ~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~  170 (464)
                      ++|++.+.||+|+||+||+|.+..+      ++.||||++...... ..+.+.+|+.+++.++||||+++++++.+.+..
T Consensus         7 ~~y~i~~~lG~G~~g~V~~~~~~~~------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~   80 (323)
T 3tki_A            7 EDWDLVQTLGEGAYGEVQLAVNRVT------EEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQ   80 (323)
T ss_dssp             TCEEEEEEEEEETTEEEEEEEETTT------CCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             hhceeeeEEecCCCEEEEEEEECCC------CcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeE
Confidence            5789999999999999999998765      667999998654322 235688999999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCccCCC
Q 046893          171 ILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGP  250 (464)
Q Consensus       171 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~  250 (464)
                      ++||||+++++|.+++...  ..+++..+..++.|++.||.|||  .++|+||||||+|||++.++.+||+|||+++...
T Consensus        81 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH--~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  156 (323)
T 3tki_A           81 YLFLEYCSGGELFDRIEPD--IGMPEPDAQRFFHQLMAGVVYLH--GIGITHRDIKPENLLLDERDNLKISDFGLATVFR  156 (323)
T ss_dssp             EEEEECCTTEEGGGGSBTT--TBCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGEEECTTCCEEECCCTTCEECE
T ss_pred             EEEEEcCCCCcHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHH--HCCccccccchHHEEEeCCCCEEEEEeeccceec
Confidence            9999999999999987654  35999999999999999999999  5779999999999999999999999999998654


Q ss_pred             CCCCcceeeccccCCcccCccccccCCC-CcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhcccchhhc
Q 046893          251 MGDQTHVSTRVMGTYGYAAPEYVMTGHL-TARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRI  329 (464)
Q Consensus       251 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  329 (464)
                      ...........+||+.|+|||++.+..+ +.++|||||||+||+|++|+.||........ ....+..    .       
T Consensus       157 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-~~~~~~~----~-------  224 (323)
T 3tki_A          157 YNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ-EYSDWKE----K-------  224 (323)
T ss_dssp             ETTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSH-HHHHHHT----T-------
T ss_pred             cCCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHH-HHHHHhc----c-------
Confidence            3333333445789999999999988775 7789999999999999999999976543211 1111111    0       


Q ss_pred             cCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 046893          330 LDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVA  369 (464)
Q Consensus       330 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  369 (464)
                         ..........+..+.+|+.+||..||.+|||+.++++
T Consensus       225 ---~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~  261 (323)
T 3tki_A          225 ---KTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKK  261 (323)
T ss_dssp             ---CTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             ---cccCCccccCCHHHHHHHHHHccCChhhCcCHHHHhh
Confidence               0000111233457889999999999999999998864

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=8.4e-47  Score=369.24  Aligned_cols=269  Identities=24%  Similarity=0.368  Sum_probs=198.3

Q ss_pred             HHHhcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCC--CccHHHHHHHHHHHhcCCCCCcceEEEEEE
Q 046893           88 KLATKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGG--YQGDREWLAEVNYLGQLRHSNLVKLIGYCC  165 (464)
Q Consensus        88 ~~~~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~  165 (464)
                      .+..++|++.+.||+|+||+||+|.+..+..   ....||||++....  ....+.+.+|+.+++.++||||+++++++.
T Consensus        19 ~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~   95 (323)
T 3qup_A           19 LIPEQQFTLGRMLGKGEFGSVREAQLKQEDG---SFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSL   95 (323)
T ss_dssp             BCC---CEEEEEEEEETTEEEEEEEC----------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEE
T ss_pred             ccChhHeEEeceecccCCeEEEEEEEcccCC---cceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceee
Confidence            3456779999999999999999998765421   12369999987643  233467899999999999999999999998


Q ss_pred             eCCeE------EEEEeccCCCCHHHHHHhhcC----CCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCC
Q 046893          166 EDEHR------ILVYEYMESGSLEKHLLRRVG----CMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNAD  235 (464)
Q Consensus       166 ~~~~~------~lv~e~~~~g~L~~~l~~~~~----~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~  235 (464)
                      .....      ++||||+.+|+|.+++.....    ..+++..++.++.|++.||.|||  .++|+||||||+|||++.+
T Consensus        96 ~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH--~~~ivH~Dikp~NIli~~~  173 (323)
T 3qup_A           96 RSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLS--SRNFIHRDLAARNCMLAED  173 (323)
T ss_dssp             CC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCSGGGEEECTT
T ss_pred             ccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHH--cCCcccCCCCcceEEEcCC
Confidence            87655      999999999999999865432    25899999999999999999999  5679999999999999999


Q ss_pred             CceEEcccCCccCCCCCCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHh-CCCCCCCCCCcccccHHH
Q 046893          236 FSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLL-GRRAVDKSRPSREHNLVE  314 (464)
Q Consensus       236 ~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~  314 (464)
                      +.+||+|||+++...............+++.|+|||++.+..++.++|||||||++|+|++ |..||.......   ...
T Consensus       174 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~---~~~  250 (323)
T 3qup_A          174 MTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAE---IYN  250 (323)
T ss_dssp             SCEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---HHH
T ss_pred             CCEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHH---HHH
Confidence            9999999999986544333333334567889999999999999999999999999999999 999997654321   111


Q ss_pred             HHHHhhhcccchhhccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhcC
Q 046893          315 WARPLLNNNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETVQSQG  378 (464)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~~~~~  378 (464)
                         .....           .....+..++..+.+|+.+||+.||.+||++.++++.|+.+....
T Consensus       251 ---~~~~~-----------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~  300 (323)
T 3qup_A          251 ---YLIGG-----------NRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHL  300 (323)
T ss_dssp             ---HHHTT-----------CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred             ---HHhcC-----------CCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence               11111           011122334458999999999999999999999999999987654

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=1.5e-46  Score=368.42  Aligned_cols=264  Identities=22%  Similarity=0.338  Sum_probs=205.8

Q ss_pred             hcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCC-CccHHHHHHHHHHHhcCCCCCcceEEEEEEeCCe
Q 046893           91 TKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGG-YQGDREWLAEVNYLGQLRHSNLVKLIGYCCEDEH  169 (464)
Q Consensus        91 ~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~  169 (464)
                      .++|++.+.||+|+||+||+|.+..+...  ....||+|.+.... ......+.+|+.+++.++||||+++++++.... 
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-   90 (327)
T 3poz_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEK--VKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-   90 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECC------CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-
T ss_pred             HHHcccceEEeeCCCeEEEEEEEcCCCce--EEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-
Confidence            35688899999999999999997654221  13357899886433 234578999999999999999999999998765 


Q ss_pred             EEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCccCC
Q 046893          170 RILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDG  249 (464)
Q Consensus       170 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~  249 (464)
                      .++||||+.+|+|.+++.... ..+++..++.|+.|++.||.|||  .++|+||||||+|||++.++.+||+|||+++..
T Consensus        91 ~~~v~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~LH--~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~  167 (327)
T 3poz_A           91 VQLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLE--DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL  167 (327)
T ss_dssp             EEEEEECCTTCBHHHHHHHST-TSCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCCGGGEEEEETTEEEECCTTHHHHH
T ss_pred             eEEEEEecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHh--hCCeeCCCCChheEEECCCCCEEEccCcceeEc
Confidence            778999999999999987643 46999999999999999999999  567999999999999999999999999999865


Q ss_pred             CCCCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHhhhcccchhh
Q 046893          250 PMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLL-GRRAVDKSRPSREHNLVEWARPLLNNNKKVLR  328 (464)
Q Consensus       250 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  328 (464)
                      .............||..|+|||++.+..++.++|||||||++|||++ |+.||.......   +....            
T Consensus       168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~---~~~~~------------  232 (327)
T 3poz_A          168 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE---ISSIL------------  232 (327)
T ss_dssp             TTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---HHHHH------------
T ss_pred             cCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHH---HHHHH------------
Confidence            44333333344567889999999999999999999999999999999 999998654322   11111            


Q ss_pred             ccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhc
Q 046893          329 ILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETVQSQ  377 (464)
Q Consensus       329 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~~~~  377 (464)
                        ........+..++..+.+|+.+||+.||.+||++.++++.|+.+...
T Consensus       233 --~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~~  279 (327)
T 3poz_A          233 --EKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD  279 (327)
T ss_dssp             --HTTCCCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHTS
T ss_pred             --HcCCCCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhh
Confidence              11111122333455899999999999999999999999999988664

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=6.5e-46  Score=363.06  Aligned_cols=261  Identities=22%  Similarity=0.339  Sum_probs=211.0

Q ss_pred             ccchhHHHHHhcC----------CCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCccHHHHHHHHHHHh
Q 046893           81 IFTYNEMKLATKF----------FRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLG  150 (464)
Q Consensus        81 ~~~~~~~~~~~~~----------~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~  150 (464)
                      .+++.+++.+.+.          |...+.||+|+||.||+|.+..+      ++.||||++........+.+.+|+.+++
T Consensus        24 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~------g~~vavK~~~~~~~~~~~~~~~E~~~l~   97 (321)
T 2c30_A           24 VVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHS------GRQVAVKMMDLRKQQRRELLFNEVVIMR   97 (321)
T ss_dssp             -CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTT------CCEEEEEEEETTTCCSHHHHHHHHHHHT
T ss_pred             cCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCC------CcEEEEEEEeccchhHHHHHHHHHHHHH
Confidence            4555565555443          66667899999999999998754      6679999998766666678999999999


Q ss_pred             cCCCCCcceEEEEEEeCCeEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCce
Q 046893          151 QLRHSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNI  230 (464)
Q Consensus       151 ~l~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Ni  230 (464)
                      .++||||+++++++...+..++||||+++++|.+++...   .+++..+..++.|++.||.|||  ..+|+||||||+||
T Consensus        98 ~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~---~l~~~~~~~i~~qi~~~L~~LH--~~~ivH~Dlkp~NI  172 (321)
T 2c30_A           98 DYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQV---RLNEEQIATVCEAVLQALAYLH--AQGVIHRDIKSDSI  172 (321)
T ss_dssp             TCCCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTTC---CCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGE
T ss_pred             hCCCCCcceEEEEEEECCEEEEEEecCCCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHH--HCCeecCCCCHHHE
Confidence            999999999999999999999999999999999987643   5999999999999999999999  56799999999999


Q ss_pred             EecCCCceEEcccCCccCCCCCCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccc
Q 046893          231 LLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREH  310 (464)
Q Consensus       231 ll~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~  310 (464)
                      |++.++.+||+|||+++......  .......||+.|+|||++.+..++.++||||||+++|+|++|+.||......   
T Consensus       173 ll~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~---  247 (321)
T 2c30_A          173 LLTLDGRVKLSDFGFCAQISKDV--PKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPV---  247 (321)
T ss_dssp             EECTTCCEEECCCTTCEECCSSS--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH---
T ss_pred             EECCCCcEEEeeeeeeeecccCc--cccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---
Confidence            99999999999999998643322  1233468999999999999999999999999999999999999999764321   


Q ss_pred             cHHHHHHHhhhcccchhhccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 046893          311 NLVEWARPLLNNNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVA  369 (464)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  369 (464)
                         +........       ..+.+  ......+..+.+|+.+||+.||.+||++.++++
T Consensus       248 ---~~~~~~~~~-------~~~~~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  294 (321)
T 2c30_A          248 ---QAMKRLRDS-------PPPKL--KNSHKVSPVLRDFLERMLVRDPQERATAQELLD  294 (321)
T ss_dssp             ---HHHHHHHHS-------SCCCC--TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             ---HHHHHHhcC-------CCCCc--CccccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence               111111111       11111  111233457899999999999999999999986

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=3.2e-46  Score=370.69  Aligned_cols=253  Identities=22%  Similarity=0.284  Sum_probs=206.3

Q ss_pred             HhcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCc------cHHHHHHHHHHHhcCCCCCcceEEEE
Q 046893           90 ATKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQ------GDREWLAEVNYLGQLRHSNLVKLIGY  163 (464)
Q Consensus        90 ~~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~hpniv~l~~~  163 (464)
                      ..++|.+.+.||+|+||+||+|.+..+      ++.||+|++......      ....+.+|+.+|+.++||||++++++
T Consensus        10 ~~~~y~~~~~LG~G~fg~V~~~~~~~~------~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~   83 (361)
T 2yab_A           10 VEDFYDIGEELGSGQFAIVKKCREKST------GLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDV   83 (361)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTT------CCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred             hhhceEEeeEEeeCcCEEEEEEEECCC------CCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEE
Confidence            346799999999999999999998765      677999999764332      24678999999999999999999999


Q ss_pred             EEeCCeEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCC----ceE
Q 046893          164 CCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADF----SAK  239 (464)
Q Consensus       164 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~----~vk  239 (464)
                      +.+....+|||||+.+|+|.+++...  ..+++..+..++.||+.||.|||  ..+|+||||||+|||++.++    .+|
T Consensus        84 ~~~~~~~~lv~e~~~gg~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH--~~givHrDlkp~NIll~~~~~~~~~vk  159 (361)
T 2yab_A           84 YENRTDVVLILELVSGGELFDFLAQK--ESLSEEEATSFIKQILDGVNYLH--TKKIAHFDLKPENIMLLDKNIPIPHIK  159 (361)
T ss_dssp             EECSSEEEEEEECCCSCBHHHHHTTC--SCCBHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEESCTTSSSCCEE
T ss_pred             EEeCCEEEEEEEcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH--HCCcccCCCCHHHEEEeCCCCCccCEE
Confidence            99999999999999999999998654  36999999999999999999999  56799999999999998776    799


Q ss_pred             EcccCCccCCCCCCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHh
Q 046893          240 LSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPL  319 (464)
Q Consensus       240 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~  319 (464)
                      |+|||+++......   .....+||+.|+|||++.+..++.++|||||||++|+|++|..||.+....      +....+
T Consensus       160 l~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~------~~~~~i  230 (361)
T 2yab_A          160 LIDFGLAHEIEDGV---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ------ETLANI  230 (361)
T ss_dssp             ECCCSSCEECCTTC---CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH------HHHHHH
T ss_pred             EEecCCceEcCCCC---ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHH
Confidence            99999998654322   223468999999999999999999999999999999999999999764321      111111


Q ss_pred             hhcccchhhccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 046893          320 LNNNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVA  369 (464)
Q Consensus       320 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  369 (464)
                      .....        .+...+....+..+.+||.+||..||.+|||+.++++
T Consensus       231 ~~~~~--------~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  272 (361)
T 2yab_A          231 TAVSY--------DFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALR  272 (361)
T ss_dssp             HTTCC--------CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             HhcCC--------CCCchhccCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            11110        0111111223457899999999999999999999874

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=3e-47  Score=379.40  Aligned_cols=269  Identities=25%  Similarity=0.332  Sum_probs=212.1

Q ss_pred             HhcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCC-ccHHHHHHHHHHHhcCCCCCcceEEEEEEeCC
Q 046893           90 ATKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGY-QGDREWLAEVNYLGQLRHSNLVKLIGYCCEDE  168 (464)
Q Consensus        90 ~~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~  168 (464)
                      ..++|++.+.||+|+||+||+|.+... .....+..||||++..... .....+.+|+.++..++||||+++++++....
T Consensus        69 ~~~~~~~~~~LG~G~fg~Vy~~~~~~~-~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~  147 (367)
T 3l9p_A           69 PRKNITLIRGLGHGAFGEVYEGQVSGM-PNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSL  147 (367)
T ss_dssp             CGGGEEEEEECCCCSSSCEEEEEECC------CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             CHhHeEEeeEeeeCCCEEEEEEEEccC-CCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCC
Confidence            346788999999999999999996542 1122467899999865432 23356889999999999999999999999999


Q ss_pred             eEEEEEeccCCCCHHHHHHhhcC-----CCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCC---ceEE
Q 046893          169 HRILVYEYMESGSLEKHLLRRVG-----CMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADF---SAKL  240 (464)
Q Consensus       169 ~~~lv~e~~~~g~L~~~l~~~~~-----~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~---~vkl  240 (464)
                      ..++||||+.+|+|.+++.....     ..+++..++.++.||+.||.|||  .++|+||||||+||||+.++   .+||
T Consensus       148 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH--~~~ivHrDlkp~NIll~~~~~~~~~kL  225 (367)
T 3l9p_A          148 PRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE--ENHFIHRDIAARNCLLTCPGPGRVAKI  225 (367)
T ss_dssp             SCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCCGGGEEESCSSTTCCEEE
T ss_pred             CCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHH--hCCeeCCCCChhhEEEecCCCCceEEE
Confidence            99999999999999999976532     35899999999999999999999  56799999999999998554   5999


Q ss_pred             cccCCccCCCCCCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHh
Q 046893          241 SDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLL-GRRAVDKSRPSREHNLVEWARPL  319 (464)
Q Consensus       241 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~  319 (464)
                      +|||+++...............||+.|+|||++.+..++.++|||||||+||||++ |..||......      +.....
T Consensus       226 ~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~------~~~~~i  299 (367)
T 3l9p_A          226 GDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ------EVLEFV  299 (367)
T ss_dssp             CCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH------HHHHHH
T ss_pred             CCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH------HHHHHH
Confidence            99999974322222222334678999999999999999999999999999999998 99999764321      111111


Q ss_pred             hhcccchhhccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhcC
Q 046893          320 LNNNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETVQSQG  378 (464)
Q Consensus       320 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~~~~~  378 (464)
                      ...           .....+..++..+.+|+.+||+.||.+||++.+|++.|+.+....
T Consensus       300 ~~~-----------~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~~  347 (367)
T 3l9p_A          300 TSG-----------GRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDP  347 (367)
T ss_dssp             HTT-----------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCH
T ss_pred             HcC-----------CCCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhCh
Confidence            111           111122334558999999999999999999999999999887653

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=2.6e-46  Score=367.18  Aligned_cols=265  Identities=17%  Similarity=0.179  Sum_probs=211.4

Q ss_pred             HhcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCccHHHHHHHHHHHhcC-CCCCcceEEEEEEeCC
Q 046893           90 ATKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQL-RHSNLVKLIGYCCEDE  168 (464)
Q Consensus        90 ~~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~  168 (464)
                      ..++|++.+.||+|+||+||+|.+..+      ++.||||++.....  ...+..|+.+++.+ +||||+++++++...+
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~------~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~   78 (330)
T 2izr_A            7 VGPNFRVGKKIGCGNFGELRLGKNLYT------NEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGPCGK   78 (330)
T ss_dssp             ETTTEEEEEECCC-CTTSEEEEEETTT------TEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEEETT
T ss_pred             EcCCeEEEEEeeccCCceEEEEEECCC------CcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEecCC
Confidence            346799999999999999999997664      67899999875432  24578999999999 8999999999999999


Q ss_pred             eEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCc-----eEEccc
Q 046893          169 HRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFS-----AKLSDF  243 (464)
Q Consensus       169 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~-----vkl~DF  243 (464)
                      ..++||||+ +++|.+++... ...+++..++.++.|++.||.|||  ..+|+||||||+|||++.++.     +||+||
T Consensus        79 ~~~lv~e~~-~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH--~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DF  154 (330)
T 2izr_A           79 YNAMVLELL-GPSLEDLFDLC-DRTFSLKTVLMIAIQLISRMEYVH--SKNLIYRDVKPENFLIGRPGNKTQQVIHIIDF  154 (330)
T ss_dssp             EEEEEEECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCCGGGEEECCGGGTCTTSEEECCC
T ss_pred             ccEEEEEeC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHH--hCCeeccCCCHHHeeeccCCCCCCceEEEEEc
Confidence            999999999 99999998764 347999999999999999999999  567999999999999998887     999999


Q ss_pred             CCccCCCCCCCcc-----eeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHH
Q 046893          244 GLAKDGPMGDQTH-----VSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARP  318 (464)
Q Consensus       244 Gla~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~  318 (464)
                      |+++.........     ......||+.|+|||++.+..++.++|||||||+||||++|+.||.+.............  
T Consensus       155 g~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i--  232 (330)
T 2izr_A          155 ALAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKI--  232 (330)
T ss_dssp             TTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHH--
T ss_pred             ccceeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHH--
Confidence            9998643322111     123578999999999999999999999999999999999999999875433222111111  


Q ss_pred             hhhcccchhhccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhc
Q 046893          319 LLNNNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETVQSQ  377 (464)
Q Consensus       319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~~~~  377 (464)
                       .....       +.........++ .+.+|+..||+.||.+||++.+|.+.|+.+...
T Consensus       233 -~~~~~-------~~~~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~  282 (330)
T 2izr_A          233 -GDTKR-------ATPIEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDR  282 (330)
T ss_dssp             -HHHHH-------HSCHHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHH
T ss_pred             -Hhhhc-------cCCHHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHH
Confidence             10000       000001111234 899999999999999999999999999987654

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=1.3e-46  Score=370.75  Aligned_cols=272  Identities=25%  Similarity=0.378  Sum_probs=216.4

Q ss_pred             HHHHHhcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCc-cHHHHHHHHHHHhcCCCCCcceEEEEE
Q 046893           86 EMKLATKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQ-GDREWLAEVNYLGQLRHSNLVKLIGYC  164 (464)
Q Consensus        86 ~~~~~~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~  164 (464)
                      .+.+..++|++.+.||+|+||.||+|.+.... ....++.||||++...... ....+.+|+.+++.++||||+++++++
T Consensus        41 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~-~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~  119 (343)
T 1luf_A           41 SLEYPRNNIEYVRDIGEGAFGRVFQARAPGLL-PYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVC  119 (343)
T ss_dssp             HTBCCGGGCEEEEEEEECSSCEEEEEEEETSS-TTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             eeEecHHHCeeeeeeeecCCeeEEEEEecCcC-CCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence            33456688999999999999999999986421 1123678999999765332 236789999999999999999999999


Q ss_pred             EeCCeEEEEEeccCCCCHHHHHHhhc----------------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCeee
Q 046893          165 CEDEHRILVYEYMESGSLEKHLLRRV----------------------GCMLTWSRRMKIALDAAKGLAFLHGAERPVIY  222 (464)
Q Consensus       165 ~~~~~~~lv~e~~~~g~L~~~l~~~~----------------------~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH  222 (464)
                      ...+..++||||+++|+|.+++....                      ...+++..++.++.||+.||.|||  .++|+|
T Consensus       120 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH--~~~ivH  197 (343)
T 1luf_A          120 AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS--ERKFVH  197 (343)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHH--HTTCCC
T ss_pred             ccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHH--hCCeec
Confidence            99999999999999999999997642                      146899999999999999999999  567999


Q ss_pred             ccCCCCceEecCCCceEEcccCCccCCCCCCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHh-CCCCC
Q 046893          223 RDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLL-GRRAV  301 (464)
Q Consensus       223 rDlkp~Nill~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf  301 (464)
                      |||||+|||++.++.+||+|||+++...............||+.|+|||++.+..++.++||||||+++|+|++ |..||
T Consensus       198 ~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~  277 (343)
T 1luf_A          198 RDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPY  277 (343)
T ss_dssp             SCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred             CCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcC
Confidence            99999999999999999999999975432222222334678999999999999999999999999999999999 99999


Q ss_pred             CCCCCcccccHHHHHHHhhhcccchhhccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhc
Q 046893          302 DKSRPSREHNLVEWARPLLNNNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETVQSQ  377 (464)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~~~~  377 (464)
                      ......      +.........           ....+..++..+.+|+.+||+.||.+||++.+|++.|+.+...
T Consensus       278 ~~~~~~------~~~~~~~~~~-----------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~  336 (343)
T 1luf_A          278 YGMAHE------EVIYYVRDGN-----------ILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCER  336 (343)
T ss_dssp             TTSCHH------HHHHHHHTTC-----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC-
T ss_pred             CCCChH------HHHHHHhCCC-----------cCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhh
Confidence            764321      1111111110           0112234456899999999999999999999999999987654

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=2.5e-46  Score=373.48  Aligned_cols=266  Identities=25%  Similarity=0.411  Sum_probs=202.2

Q ss_pred             HhcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCc-cHHHHHHHHHHHhcCCCCCcceEEEEEEeCC
Q 046893           90 ATKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQ-GDREWLAEVNYLGQLRHSNLVKLIGYCCEDE  168 (464)
Q Consensus        90 ~~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~  168 (464)
                      ...+|.+.+.||+|+||.||+|.+....   ..+..||||++...... ....|.+|+.+|.+++||||+++++++...+
T Consensus        43 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~---~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~  119 (373)
T 2qol_A           43 DATNISIDKVVGAGEFGEVCSGRLKLPS---KKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSK  119 (373)
T ss_dssp             CGGGCCCCEEEEECSSSEEEEC-CBCTT---SCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred             CHhhceeeeEEeeCCCeEEEEEEEecCC---CCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCC
Confidence            3467999999999999999999876321   12566999999764322 3367899999999999999999999999999


Q ss_pred             eEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCccC
Q 046893          169 HRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKD  248 (464)
Q Consensus       169 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~  248 (464)
                      ..+|||||+++|+|.+++... +..+++..++.++.|++.||.|||  ..+|+||||||+|||++.++.+||+|||+++.
T Consensus       120 ~~~lv~e~~~~~sL~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH--~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~  196 (373)
T 2qol_A          120 PVMIVTEYMENGSLDSFLRKH-DAQFTVIQLVGMLRGIASGMKYLS--DMGYVHRDLAARNILINSNLVCKVSDFGLGRV  196 (373)
T ss_dssp             SCEEEEECCTTCBHHHHHHTT-TTCSCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCCGGGEEECTTCCEEECCC-----
T ss_pred             ceEEEEeCCCCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHH--HCCeeCCCCCcceEEEcCCCCEEECcCccccc
Confidence            999999999999999998754 346999999999999999999999  56799999999999999999999999999986


Q ss_pred             CCCCCCcc-eeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHhhhcccch
Q 046893          249 GPMGDQTH-VSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLL-GRRAVDKSRPSREHNLVEWARPLLNNNKKV  326 (464)
Q Consensus       249 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  326 (464)
                      ........ ......+|..|+|||++.+..++.++|||||||+||||++ |+.||......      +..... .     
T Consensus       197 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~------~~~~~i-~-----  264 (373)
T 2qol_A          197 LEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQ------DVIKAV-D-----  264 (373)
T ss_dssp             -----------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHH------HHHHHH-H-----
T ss_pred             cccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHH------HHHHHH-H-----
Confidence            53322111 1122346788999999999999999999999999999998 99999764321      111111 1     


Q ss_pred             hhccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhcC
Q 046893          327 LRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETVQSQG  378 (464)
Q Consensus       327 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~~~~~  378 (464)
                           .......+..++..+.+|+.+||+.||.+||++.+|++.|+.+....
T Consensus       265 -----~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~~  311 (373)
T 2qol_A          265 -----EGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNP  311 (373)
T ss_dssp             -----TTEECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCG
T ss_pred             -----cCCCCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhCc
Confidence                 11111222345568999999999999999999999999999987654

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=1.4e-46  Score=368.41  Aligned_cols=264  Identities=23%  Similarity=0.325  Sum_probs=207.1

Q ss_pred             hcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCC-CccHHHHHHHHHHHhcCCCCCcceEEEEEEeCCe
Q 046893           91 TKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGG-YQGDREWLAEVNYLGQLRHSNLVKLIGYCCEDEH  169 (464)
Q Consensus        91 ~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~  169 (464)
                      .++|++.+.||+|+||+||+|.+..+...  ....||+|.+.... ......+.+|+.++..++||||+++++++. ++.
T Consensus        12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~--~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~   88 (325)
T 3kex_A           12 ETELRKLKVLGSGVFGTVHKGVWIPEGES--IKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSS   88 (325)
T ss_dssp             TTTEEEEEEEECCSSCEEEEEEECCTTCS--CCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSS
T ss_pred             HhHceeeeeeeecCCceEEEEEEcCCCce--EEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCc
Confidence            35688899999999999999998764221  23458888875433 222356778999999999999999999886 456


Q ss_pred             EEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCccCC
Q 046893          170 RILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDG  249 (464)
Q Consensus       170 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~  249 (464)
                      .++||||+.+|+|.+++.... ..+++..++.++.|++.||.|||  ..+|+||||||+|||++.++.+||+|||+++..
T Consensus        89 ~~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH--~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~  165 (325)
T 3kex_A           89 LQLVTQYLPLGSLLDHVRQHR-GALGPQLLLNWGVQIAKGMYYLE--EHGMVHRNLAARNVLLKSPSQVQVADFGVADLL  165 (325)
T ss_dssp             EEEEEECCTTCBSHHHHHSSG-GGSCTTHHHHHHHHHHHHHHHHH--HTTCCCSCCSSTTEEESSSSCEEECSCSGGGGS
T ss_pred             cEEEEEeCCCCCHHHHHHHcc-ccCCHHHHHHHHHHHHHHHHHHH--hCCCCCCccchheEEECCCCeEEECCCCccccc
Confidence            889999999999999987642 36899999999999999999999  567999999999999999999999999999876


Q ss_pred             CCCCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHhhhcccchhh
Q 046893          250 PMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLL-GRRAVDKSRPSREHNLVEWARPLLNNNKKVLR  328 (464)
Q Consensus       250 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  328 (464)
                      .............||..|+|||++.+..++.++|||||||++|+|++ |+.||........   ....    ...     
T Consensus       166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~---~~~~----~~~-----  233 (325)
T 3kex_A          166 PPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEV---PDLL----EKG-----  233 (325)
T ss_dssp             CCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHH---HHHH----HTT-----
T ss_pred             CcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHH---HHHH----HcC-----
Confidence            54444444455678899999999999999999999999999999999 9999986543221   1111    110     


Q ss_pred             ccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhc
Q 046893          329 ILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETVQSQ  377 (464)
Q Consensus       329 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~~~~  377 (464)
                           .....+..++..+.+|+.+||..||.+||++.++++.|+.+...
T Consensus       234 -----~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~~  277 (325)
T 3kex_A          234 -----ERLAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMARD  277 (325)
T ss_dssp             -----CBCCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTTS
T ss_pred             -----CCCCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence                 01111222334678899999999999999999999999988654

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=2.9e-46  Score=370.01  Aligned_cols=246  Identities=26%  Similarity=0.387  Sum_probs=197.5

Q ss_pred             HHhcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCC---CccHHHHHHHHHHHhcC-CCCCcceEEEEE
Q 046893           89 LATKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGG---YQGDREWLAEVNYLGQL-RHSNLVKLIGYC  164 (464)
Q Consensus        89 ~~~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~hpniv~l~~~~  164 (464)
                      +..++|++.+.||+|+||+||+|.+..+      ++.||||++....   ......+..|..+|..+ +||||+++++++
T Consensus        20 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~------~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~   93 (353)
T 3txo_A           20 LGIDNFEFIRVLGKGSFGKVMLARVKET------GDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCF   93 (353)
T ss_dssp             ---CCEEEEEEEEEETTEEEEEEEETTT------CCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEE
T ss_pred             CchhheEEEEEEeeCCCEEEEEEEEcCC------CCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEE
Confidence            3446799999999999999999998765      6779999987531   12335678899999988 799999999999


Q ss_pred             EeCCeEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccC
Q 046893          165 CEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFG  244 (464)
Q Consensus       165 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFG  244 (464)
                      ...+..||||||+.+|+|.+++.+..  .+++..+..++.||+.||.|||  .++|+||||||+||||+.++.+||+|||
T Consensus        94 ~~~~~~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH--~~givHrDlkp~NILl~~~g~ikL~DFG  169 (353)
T 3txo_A           94 QTPDRLFFVMEFVNGGDLMFHIQKSR--RFDEARARFYAAEIISALMFLH--DKGIIYRDLKLDNVLLDHEGHCKLADFG  169 (353)
T ss_dssp             ECSSEEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHH--HTTCBCCCCCGGGEEECTTSCEEECCCT
T ss_pred             EeCCEEEEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH--HCCCcccCCCHHHEEECCCCCEEEcccc
Confidence            99999999999999999999987654  6999999999999999999999  5679999999999999999999999999


Q ss_pred             CccCCCCCCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhccc
Q 046893          245 LAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNK  324 (464)
Q Consensus       245 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  324 (464)
                      +|+.....  .......+||+.|+|||++.+..++.++|||||||++|||++|+.||......      +....+.....
T Consensus       170 ~a~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~------~~~~~i~~~~~  241 (353)
T 3txo_A          170 MCKEGICN--GVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENED------DLFEAILNDEV  241 (353)
T ss_dssp             TCBCSCC-----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHHCCC
T ss_pred             ceeecccC--CccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHH------HHHHHHHcCCC
Confidence            99853322  22334578999999999999999999999999999999999999999765321      12222222111


Q ss_pred             chhhccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCH
Q 046893          325 KVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVM  364 (464)
Q Consensus       325 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~  364 (464)
                                  .++...+..+.+|+.+||..||.+||++
T Consensus       242 ------------~~p~~~~~~~~~li~~lL~~dP~~R~~~  269 (353)
T 3txo_A          242 ------------VYPTWLHEDATGILKSFMTKNPTMRLGS  269 (353)
T ss_dssp             ------------CCCTTSCHHHHHHHHHHTCSSGGGSTTS
T ss_pred             ------------CCCCCCCHHHHHHHHHHhhhCHHHccCC
Confidence                        1222344578899999999999999998

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=3.1e-46  Score=382.08  Aligned_cols=256  Identities=28%  Similarity=0.408  Sum_probs=211.4

Q ss_pred             HHHhcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCccHHHHHHHHHHHhcCCCCCcceEEEEEEeC
Q 046893           88 KLATKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVKLIGYCCED  167 (464)
Q Consensus        88 ~~~~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~  167 (464)
                      .+..++|++.+.||+|+||.||+|.+.        ++.||||+++...  ..+.|.+|+.+|+.++||||+++++++...
T Consensus       189 ~i~~~~~~~~~~lG~G~fg~V~~~~~~--------~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~  258 (450)
T 1k9a_A          189 ALNMKELKLLQTIGKGEFGDVMLGDYR--------GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEE  258 (450)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEET--------TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECT
T ss_pred             ccChHHeEEEeeecCcCCeeEEEEEec--------CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcC
Confidence            345677888999999999999999864        4579999997653  457899999999999999999999998776


Q ss_pred             C-eEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCc
Q 046893          168 E-HRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLA  246 (464)
Q Consensus       168 ~-~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla  246 (464)
                      . ..+|||||+.+|+|.+++.......+++..++.++.|++.||.|||  .++|+||||||+|||++.++.+||+|||++
T Consensus       259 ~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH--~~~ivHrDlkp~Nill~~~~~~kl~DfG~a  336 (450)
T 1k9a_A          259 KGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE--GNNFVHRDLAARNVLVSEDNVAKVSDFGLT  336 (450)
T ss_dssp             TSCEEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred             CCceEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH--hCCeeCCCCCHhhEEECCCCCEEEeeCCCc
Confidence            5 7899999999999999998765555899999999999999999999  567999999999999999999999999999


Q ss_pred             cCCCCCCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHhhhcccc
Q 046893          247 KDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLL-GRRAVDKSRPSREHNLVEWARPLLNNNKK  325 (464)
Q Consensus       247 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  325 (464)
                      +.....     .....++..|+|||++.+..++.++|||||||+||||++ |+.||.......   ....    +.    
T Consensus       337 ~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~---~~~~----i~----  400 (450)
T 1k9a_A          337 KEASST-----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---VVPR----VE----  400 (450)
T ss_dssp             EECC-----------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTT---HHHH----HH----
T ss_pred             cccccc-----ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHH----HH----
Confidence            853221     122467889999999999999999999999999999998 999997654322   1111    11    


Q ss_pred             hhhccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhc
Q 046893          326 VLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETVQSQ  377 (464)
Q Consensus       326 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~~~~  377 (464)
                            .......+..++..+.+||.+||+.||.+||++.++++.|+.+...
T Consensus       401 ------~~~~~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~~  446 (450)
T 1k9a_A          401 ------KGYKMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTH  446 (450)
T ss_dssp             ------TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             ------cCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHh
Confidence                  1111223345667899999999999999999999999999988654

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=8.3e-46  Score=371.42  Aligned_cols=250  Identities=24%  Similarity=0.352  Sum_probs=201.0

Q ss_pred             hcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCcc---HHHHHHHHHHHhcC-CCCCcceEEEEEEe
Q 046893           91 TKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQG---DREWLAEVNYLGQL-RHSNLVKLIGYCCE  166 (464)
Q Consensus        91 ~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l-~hpniv~l~~~~~~  166 (464)
                      .++|++.++||+|+||+||+|++..+      ++.||+|+++......   ...+..|..+|..+ +||||++++++|..
T Consensus        51 ~~~y~~~~~LG~G~fG~V~~~~~~~~------~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~  124 (396)
T 4dc2_A           51 LQDFDLLRVIGRGSYAKVLLVRLKKT------DRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQT  124 (396)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTT------TEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred             hhHcEEEEEEeeCCCeEEEEEEECCC------CCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEE
Confidence            35688999999999999999998765      7789999997543222   24578899999887 89999999999999


Q ss_pred             CCeEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCc
Q 046893          167 DEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLA  246 (464)
Q Consensus       167 ~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla  246 (464)
                      .+..+|||||+++|+|.+++.+..  .+++..+..++.||+.||.|||  .++|+||||||+||||+.++.+||+|||+|
T Consensus       125 ~~~~~lV~E~~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~LH--~~givHrDLKp~NILl~~~g~ikL~DFGla  200 (396)
T 4dc2_A          125 ESRLFFVIEYVNGGDLMFHMQRQR--KLPEEHARFYSAEISLALNYLH--ERGIIYRDLKLDNVLLDSEGHIKLTDYGMC  200 (396)
T ss_dssp             SSEEEEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHH--HTTCBCCCCCGGGEEECTTSCEEECCCTTC
T ss_pred             CCEEEEEEEcCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH--HCCEEeccCCHHHEEECCCCCEEEeeccee
Confidence            999999999999999999887654  6999999999999999999999  567999999999999999999999999999


Q ss_pred             cCCCCCCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHhCCCCCCCCCCccc--ccHHH-HHHHhhhcc
Q 046893          247 KDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSRE--HNLVE-WARPLLNNN  323 (464)
Q Consensus       247 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~--~~~~~-~~~~~~~~~  323 (464)
                      +......  ......+||+.|+|||++.+..++.++|||||||+||||++|+.||........  ..... .........
T Consensus       201 ~~~~~~~--~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~  278 (396)
T 4dc2_A          201 KEGLRPG--DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ  278 (396)
T ss_dssp             BCCCCTT--CCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCC
T ss_pred             eecccCC--CccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccc
Confidence            8532222  233457899999999999999999999999999999999999999975332111  11111 111111111


Q ss_pred             cchhhccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCH
Q 046893          324 KKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVM  364 (464)
Q Consensus       324 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~  364 (464)
                                  ..++...+..+.+||.+||+.||.+||++
T Consensus       279 ------------~~~p~~~s~~~~~li~~lL~~dP~~R~~~  307 (396)
T 4dc2_A          279 ------------IRIPRSLSVKAASVLKSFLNKDPKERLGC  307 (396)
T ss_dssp             ------------CCCCTTSCHHHHHHHHHHTCSCTTTSTTC
T ss_pred             ------------cCCCCcCCHHHHHHHHHHhcCCHhHcCCC
Confidence                        11223345588999999999999999997

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=2.7e-46  Score=356.07  Aligned_cols=259  Identities=26%  Similarity=0.407  Sum_probs=211.2

Q ss_pred             HhcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCccHHHHHHHHHHHhcCCCCCcceEEEEEEeCCe
Q 046893           90 ATKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVKLIGYCCEDEH  169 (464)
Q Consensus        90 ~~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~  169 (464)
                      ..++|++.+.||+|+||+||+|.+..       +..||+|++.... ...+.+.+|+.+++.++||||+++++++.+.+.
T Consensus         8 ~~~~y~~~~~lg~G~~g~V~~~~~~~-------~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~   79 (269)
T 4hcu_A            8 DPSELTFVQEIGSGQFGLVHLGYWLN-------KDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAP   79 (269)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETT-------TEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred             ChhhceeeheecCCCccEEEEEEecC-------CCeEEEEEecccc-cCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCc
Confidence            34668889999999999999999764       4569999997643 345779999999999999999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCccCC
Q 046893          170 RILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDG  249 (464)
Q Consensus       170 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~  249 (464)
                      .++||||+++++|.+++.... ..+++..++.++.|++.||.|||  ..+|+||||||+|||++.++.+||+|||+++..
T Consensus        80 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lH--~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~  156 (269)
T 4hcu_A           80 ICLVFEFMEHGCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLE--EACVIHRDLAARNCLVGENQVIKVSDFGMTRFV  156 (269)
T ss_dssp             EEEEEECCTTCBHHHHHHTTT-TCCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCCGGGEEECGGGCEEECCTTGGGGB
T ss_pred             eEEEEEeCCCCcHHHHHHhcC-cccCHHHHHHHHHHHHHHHHHHH--hCCeecCCcchheEEEcCCCCEEeccccccccc
Confidence            999999999999999986543 46899999999999999999999  567999999999999999999999999999854


Q ss_pred             CCCCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHhhhcccchhh
Q 046893          250 PMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLL-GRRAVDKSRPSREHNLVEWARPLLNNNKKVLR  328 (464)
Q Consensus       250 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  328 (464)
                      .... ........||..|+|||++.+..++.++||||||+++|+|++ |+.||......      +........      
T Consensus       157 ~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~------~~~~~~~~~------  223 (269)
T 4hcu_A          157 LDDQ-YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS------EVVEDISTG------  223 (269)
T ss_dssp             CCHH-HHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH------HHHHHHHTT------
T ss_pred             cccc-cccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHH------HHHHHHhcC------
Confidence            3221 112223567888999999999999999999999999999999 99999764321      111111111      


Q ss_pred             ccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhc
Q 046893          329 ILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETVQSQ  377 (464)
Q Consensus       329 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~~~~  377 (464)
                           .....+...+..+.+|+.+||+.||.+||++.++++.|+.+...
T Consensus       224 -----~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~~  267 (269)
T 4hcu_A          224 -----FRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES  267 (269)
T ss_dssp             -----CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             -----ccCCCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHHc
Confidence                 11111222345789999999999999999999999999988754

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=7e-47  Score=391.22  Aligned_cols=263  Identities=24%  Similarity=0.369  Sum_probs=218.1

Q ss_pred             HHHhcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCccHHHHHHHHHHHhcCCCCCcceEEEEEEeC
Q 046893           88 KLATKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVKLIGYCCED  167 (464)
Q Consensus        88 ~~~~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~  167 (464)
                      .+....|.+.+.||+|+||.||+|.+...      +..||||++.... ...+.|.+|+.+|+.++||||+++++++...
T Consensus       216 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~------~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~  288 (495)
T 1opk_A          216 EMERTDITMKHKLGGGQYGEVYEGVWKKY------SLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTRE  288 (495)
T ss_dssp             BCCGGGEEEEEESGGGTTSSEEEEEEGGG------TEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             ccCHHHceeeeEecCCCCeEEEEEEEcCC------CeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence            34556788899999999999999998764      6779999997643 3467899999999999999999999999999


Q ss_pred             CeEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCcc
Q 046893          168 EHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAK  247 (464)
Q Consensus       168 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~  247 (464)
                      ...+|||||+.+|+|.+++.......+++..++.++.||+.||.|||  .++|+||||||+||||+.++.+||+|||+++
T Consensus       289 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH--~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~  366 (495)
T 1opk_A          289 PPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE--KKNFIHRNLAARNCLVGENHLVKVADFGLSR  366 (495)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGEEECGGGCEEECCTTCEE
T ss_pred             CcEEEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHH--hCCcccCCCChhhEEECCCCcEEEeecccce
Confidence            99999999999999999998765567999999999999999999999  5679999999999999999999999999998


Q ss_pred             CCCCCCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHhhhcccch
Q 046893          248 DGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLL-GRRAVDKSRPSREHNLVEWARPLLNNNKKV  326 (464)
Q Consensus       248 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  326 (464)
                      ...... ........++..|+|||++.+..++.++|||||||+||||++ |..||.+.....   +.+.           
T Consensus       367 ~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~---~~~~-----------  431 (495)
T 1opk_A          367 LMTGDT-YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ---VYEL-----------  431 (495)
T ss_dssp             CCTTCC-EECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG---HHHH-----------
T ss_pred             eccCCc-eeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHH---HHHH-----------
Confidence            653322 222233456789999999999999999999999999999999 999997654221   1111           


Q ss_pred             hhccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhc
Q 046893          327 LRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETVQSQ  377 (464)
Q Consensus       327 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~~~~  377 (464)
                         +........+..++..+.+||.+||+.||.+||++.+|++.|+.+...
T Consensus       432 ---~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~~  479 (495)
T 1opk_A          432 ---LEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE  479 (495)
T ss_dssp             ---HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCSS
T ss_pred             ---HHcCCCCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHhc
Confidence               111112223345567899999999999999999999999999987544

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=2.2e-46  Score=361.49  Aligned_cols=279  Identities=23%  Similarity=0.336  Sum_probs=210.2

Q ss_pred             HhcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCccHHHHHHHHHHHhcCCCCCcceEEEEEEeC--
Q 046893           90 ATKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVKLIGYCCED--  167 (464)
Q Consensus        90 ~~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~--  167 (464)
                      ..++|++.+.||+|+||+||+|.+...  ....++.||||++........+.+.+|+.+|..++||||+++++++...  
T Consensus         8 ~~~~~~~~~~lg~G~~g~V~~~~~~~~--~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   85 (295)
T 3ugc_A            8 EERHLKFLQQLGKGNFGSVEMCRYDPL--QDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGR   85 (295)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEECTT--CSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHH
T ss_pred             CHHHhhhhheeeccCCEEEEEEEEecc--cCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCC
Confidence            456789999999999999999985421  1124788999999866545557789999999999999999999998653  


Q ss_pred             CeEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCcc
Q 046893          168 EHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAK  247 (464)
Q Consensus       168 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~  247 (464)
                      ...++||||+++++|.+++.... ..+++..++.++.|++.||.|||  ..+|+||||||+|||++.++.+||+|||+++
T Consensus        86 ~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH--~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~  162 (295)
T 3ugc_A           86 RNLKLIMEYLPYGSLRDYLQKHK-ERIDHIKLLQYTSQICKGMEYLG--TKRYIHRDLATRNILVENENRVKIGDFGLTK  162 (295)
T ss_dssp             TSCEEEEECCTTCBHHHHHHHCG-GGCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCSGGGEEEEETTEEEECCCCSCC
T ss_pred             CceEEEEEeCCCCCHHHHHHhcc-cccCHHHHHHHHHHHHHHHHHHh--cCCcccCCCCHhhEEEcCCCeEEEccCcccc
Confidence            56899999999999999987653 35899999999999999999999  5679999999999999999999999999998


Q ss_pred             CCCCCCCc-ceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhc---c
Q 046893          248 DGPMGDQT-HVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNN---N  323 (464)
Q Consensus       248 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~---~  323 (464)
                      ........ .......|+..|+|||++.+..++.++||||||+++|+|++|..||......    ...........   .
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~----~~~~~~~~~~~~~~~  238 (295)
T 3ugc_A          163 VLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAE----FMRMIGNDKQGQMIV  238 (295)
T ss_dssp             -------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHH----HHHHHCTTCCTHHHH
T ss_pred             cccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHH----HHhhhcCccccchhH
Confidence            65332211 2223356788899999999999999999999999999999999988642110    00000000000   0


Q ss_pred             cchhhccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhc
Q 046893          324 KKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETVQSQ  377 (464)
Q Consensus       324 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~~~~  377 (464)
                      ......+........+..++..+.+|+.+||+.||.+|||+.++++.|+.+...
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~  292 (295)
T 3ugc_A          239 FHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDN  292 (295)
T ss_dssp             HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             HHHHHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHh
Confidence            000111111112223445567899999999999999999999999999988654

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.6e-46  Score=370.45  Aligned_cols=274  Identities=23%  Similarity=0.363  Sum_probs=215.0

Q ss_pred             HHHHhcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCC-ccHHHHHHHHHHHhcC-CCCCcceEEEEE
Q 046893           87 MKLATKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGY-QGDREWLAEVNYLGQL-RHSNLVKLIGYC  164 (464)
Q Consensus        87 ~~~~~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~hpniv~l~~~~  164 (464)
                      +.+..++|.+.+.||+|+||.||+|.+..... ...+..||||++..... .....+.+|+.+|..+ .||||+++++++
T Consensus        40 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~  118 (344)
T 1rjb_A           40 WEFPRENLEFGKVLGSGAFGKVMNATAYGISK-TGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGAC  118 (344)
T ss_dssp             GBCCGGGEEEEEEEEECSSEEEEEEEEESCSS-SSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             cccCHHHceeeeeecCCCCceeEEeeeecccc-CCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence            34556789999999999999999999743211 12467899999975432 2346789999999999 899999999999


Q ss_pred             EeCCeEEEEEeccCCCCHHHHHHhhcC---------------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCeeec
Q 046893          165 CEDEHRILVYEYMESGSLEKHLLRRVG---------------------CMLTWSRRMKIALDAAKGLAFLHGAERPVIYR  223 (464)
Q Consensus       165 ~~~~~~~lv~e~~~~g~L~~~l~~~~~---------------------~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHr  223 (464)
                      ...+..++||||+++|+|.+++.....                     ..+++..++.++.|++.||.|||  ..+|+||
T Consensus       119 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH--~~~ivH~  196 (344)
T 1rjb_A          119 TLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE--FKSCVHR  196 (344)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHH--HTTEEET
T ss_pred             eeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHH--hCCcccC
Confidence            999999999999999999999976532                     23799999999999999999999  5679999


Q ss_pred             cCCCCceEecCCCceEEcccCCccCCCCCCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHh-CCCCCC
Q 046893          224 DFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLL-GRRAVD  302 (464)
Q Consensus       224 Dlkp~Nill~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~  302 (464)
                      ||||+||||+.++.+||+|||++................||+.|+|||++.+..++.++||||||++||+|++ |..||.
T Consensus       197 Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~  276 (344)
T 1rjb_A          197 DLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYP  276 (344)
T ss_dssp             TCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSST
T ss_pred             CCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcc
Confidence            9999999999999999999999986543333333444668899999999999999999999999999999998 999997


Q ss_pred             CCCCcccccHHHHHHHhhhcccchhhccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhcCh
Q 046893          303 KSRPSREHNLVEWARPLLNNNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETVQSQGA  379 (464)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~~~~~~  379 (464)
                      ......  .+..    .+..          ......+..++..+.+|+.+||..||.+||++.++++.|+.+.....
T Consensus       277 ~~~~~~--~~~~----~~~~----------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~  337 (344)
T 1rjb_A          277 GIPVDA--NFYK----LIQN----------GFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADAE  337 (344)
T ss_dssp             TCCCSH--HHHH----HHHT----------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC----
T ss_pred             cCCcHH--HHHH----HHhc----------CCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHHH
Confidence            654221  1111    1111          11112223345689999999999999999999999999998866543

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=4.3e-46  Score=362.15  Aligned_cols=271  Identities=24%  Similarity=0.366  Sum_probs=217.6

Q ss_pred             HHHhcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCc-cHHHHHHHHHHHhcC-CCCCcceEEEEEE
Q 046893           88 KLATKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQ-GDREWLAEVNYLGQL-RHSNLVKLIGYCC  165 (464)
Q Consensus        88 ~~~~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l-~hpniv~l~~~~~  165 (464)
                      .+..++|++.+.||+|+||.||+|.+.... ....+..||||++...... ....+.+|+.++..+ +||||+++++++.
T Consensus        19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~-~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~   97 (313)
T 1t46_A           19 EFPRNRLSFGKTLGAGAFGKVVEATAYGLI-KSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACT   97 (313)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEEESSS-STTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             ccChhhhhHHHhhCccCCcceEEEEEeecc-ccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEe
Confidence            345567999999999999999999864321 1224678999999765432 346788999999999 8999999999999


Q ss_pred             eCCeEEEEEeccCCCCHHHHHHhhcC----------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCc
Q 046893          166 EDEHRILVYEYMESGSLEKHLLRRVG----------------CMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSN  229 (464)
Q Consensus       166 ~~~~~~lv~e~~~~g~L~~~l~~~~~----------------~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~N  229 (464)
                      ..+..++||||+++|+|.+++.....                ..+++..++.++.|++.||.|||  ..+|+||||||+|
T Consensus        98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH--~~~i~H~dlkp~N  175 (313)
T 1t46_A           98 IGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA--SKNCIHRDLAARN  175 (313)
T ss_dssp             SSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCSGGG
T ss_pred             cCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH--HCCeecCCCccce
Confidence            99999999999999999999976542                24899999999999999999999  5679999999999


Q ss_pred             eEecCCCceEEcccCCccCCCCCCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHh-CCCCCCCCCCcc
Q 046893          230 ILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLL-GRRAVDKSRPSR  308 (464)
Q Consensus       230 ill~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~  308 (464)
                      ||++.++.+||+|||+++...............||+.|+|||++.+..++.++||||||+++|+|++ |..||.......
T Consensus       176 il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~  255 (313)
T 1t46_A          176 ILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS  255 (313)
T ss_dssp             EEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSH
T ss_pred             EEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchh
Confidence            9999999999999999987654443333444668889999999999999999999999999999999 999997654221


Q ss_pred             cccHHHHHHHhhhcccchhhccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhc
Q 046893          309 EHNLVEWARPLLNNNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETVQSQ  377 (464)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~~~~  377 (464)
                        .+...    +..          ......+...+..+.+|+.+||+.||.+||++.++++.|+.+...
T Consensus       256 --~~~~~----~~~----------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~  308 (313)
T 1t46_A          256 --KFYKM----IKE----------GFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE  308 (313)
T ss_dssp             --HHHHH----HHH----------TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             --HHHHH----hcc----------CCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHH
Confidence              11111    111          011111223445899999999999999999999999999987654

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=5.9e-46  Score=364.32  Aligned_cols=265  Identities=22%  Similarity=0.334  Sum_probs=205.7

Q ss_pred             hcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCC-CccHHHHHHHHHHHhcCCCCCcceEEEEEEeCCe
Q 046893           91 TKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGG-YQGDREWLAEVNYLGQLRHSNLVKLIGYCCEDEH  169 (464)
Q Consensus        91 ~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~  169 (464)
                      .++|++.+.||+|+||+||+|.+..+...  ....||+|.+.... ......+.+|+.+++.++||||+++++++.... 
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~--~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-   90 (327)
T 3lzb_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEK--VKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-   90 (327)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEECCTTCS--CCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-
T ss_pred             HhHceEEEEeeeCCCeEEEEEEEcCCCce--EEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-
Confidence            45689999999999999999998765322  23357888876433 344578999999999999999999999998765 


Q ss_pred             EEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCccCC
Q 046893          170 RILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDG  249 (464)
Q Consensus       170 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~  249 (464)
                      .++||||+.+|+|.+++.... ..+++..++.|+.|++.||.|||  .++|+||||||+|||++.++.+||+|||+++..
T Consensus        91 ~~~v~~~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH--~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~  167 (327)
T 3lzb_A           91 VQLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLE--DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL  167 (327)
T ss_dssp             EEEEECCCSSCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCCGGGEEEEETTEEEECCTTC----
T ss_pred             ceEEEEecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHh--hCCCcCCCCCHHHEEEcCCCCEEEccCcceeEc
Confidence            788999999999999987653 46999999999999999999999  567999999999999999999999999999865


Q ss_pred             CCCCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHhhhcccchhh
Q 046893          250 PMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLL-GRRAVDKSRPSREHNLVEWARPLLNNNKKVLR  328 (464)
Q Consensus       250 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  328 (464)
                      .............||..|+|||++.+..++.++|||||||++|||++ |..||.......   +....            
T Consensus       168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~---~~~~~------------  232 (327)
T 3lzb_A          168 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE---ISSIL------------  232 (327)
T ss_dssp             ------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---HHHHH------------
T ss_pred             cCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHH---HHHHH------------
Confidence            44333333334567889999999999999999999999999999999 999997654322   11111            


Q ss_pred             ccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhcC
Q 046893          329 ILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETVQSQG  378 (464)
Q Consensus       329 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~~~~~  378 (464)
                        ........+..++..+.+|+.+||..||.+||++.++++.|+.+....
T Consensus       233 --~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~  280 (327)
T 3lzb_A          233 --EKGERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARDP  280 (327)
T ss_dssp             --HTTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTSH
T ss_pred             --HcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhCc
Confidence              111111223334558999999999999999999999999999987653

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=2.5e-46  Score=355.93  Aligned_cols=260  Identities=25%  Similarity=0.377  Sum_probs=211.1

Q ss_pred             HHhcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCccHHHHHHHHHHHhcCCCCCcceEEEEEEeCC
Q 046893           89 LATKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVKLIGYCCEDE  168 (464)
Q Consensus        89 ~~~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~  168 (464)
                      +..++|++.+.||+|+||.||+|.+..       +..||+|++.... ....++.+|+.++..++||||+++++++...+
T Consensus         5 l~~~~y~~~~~lg~G~~g~V~~~~~~~-------~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~   76 (268)
T 3sxs_A            5 LKREEITLLKELGSGQFGVVKLGKWKG-------QYDVAVKMIKEGS-MSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEY   76 (268)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEETT-------TEEEEEEEECBTT-BCHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             echhheeeeeeeccCCCceEEEEEecC-------ceeEEEEEeccCC-CcHHHHHHHHHHHHhCCCCCEeeEEEEEccCC
Confidence            345678999999999999999998764       4569999997653 34567899999999999999999999999999


Q ss_pred             eEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCccC
Q 046893          169 HRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKD  248 (464)
Q Consensus       169 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~  248 (464)
                      ..++||||+++++|.+++.... ..+++..++.++.|++.||.|||  ..+|+||||||+|||++.++.+||+|||++..
T Consensus        77 ~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH--~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~  153 (268)
T 3sxs_A           77 PIYIVTEYISNGCLLNYLRSHG-KGLEPSQLLEMCYDVCEGMAFLE--SHQFIHRDLAARNCLVDRDLCVKVSDFGMTRY  153 (268)
T ss_dssp             SEEEEEECCTTCBHHHHHHHHG-GGCCHHHHHHHHHHHHHHHHHHH--HTTEEESSCSGGGEEECTTCCEEECCTTCEEE
T ss_pred             ceEEEEEccCCCcHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHH--HCCeecCCcCcceEEECCCCCEEEccCcccee
Confidence            9999999999999999987653 35899999999999999999999  56799999999999999999999999999986


Q ss_pred             CCCCCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHhhhcccchh
Q 046893          249 GPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLL-GRRAVDKSRPSREHNLVEWARPLLNNNKKVL  327 (464)
Q Consensus       249 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  327 (464)
                      ...... .......||..|+|||++.+..++.++||||||+++|+|++ |+.||.......      .........    
T Consensus       154 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~------~~~~~~~~~----  222 (268)
T 3sxs_A          154 VLDDQY-VSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSE------VVLKVSQGH----  222 (268)
T ss_dssp             CCTTCE-EECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHH------HHHHHHTTC----
T ss_pred             cchhhh-hcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHH------HHHHHHcCC----
Confidence            533322 22233557788999999999999999999999999999999 999997543211      111111110    


Q ss_pred             hccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhc
Q 046893          328 RILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETVQSQ  377 (464)
Q Consensus       328 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~~~~  377 (464)
                             ....+...+..+.+|+.+||+.||.+|||+.++++.|+.+...
T Consensus       223 -------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~  265 (268)
T 3sxs_A          223 -------RLYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREK  265 (268)
T ss_dssp             -------CCCCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC-
T ss_pred             -------CCCCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhc
Confidence                   0111222345789999999999999999999999999887643

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=5.4e-46  Score=356.37  Aligned_cols=263  Identities=24%  Similarity=0.340  Sum_probs=200.4

Q ss_pred             HHhcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCc-cHHHHHHHHHHHhcCCCCCcceEEEEEEeC
Q 046893           89 LATKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQ-GDREWLAEVNYLGQLRHSNLVKLIGYCCED  167 (464)
Q Consensus        89 ~~~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~  167 (464)
                      +..++|++.+.||+|+||.||+|.+.....   .+..||+|++...... ..+.+.+|+.+++.++||||+++++++. +
T Consensus        12 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~   87 (281)
T 1mp8_A           12 IQRERIELGRCIGEGQFGDVHQGIYMSPEN---PALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-E   87 (281)
T ss_dssp             CCGGGEEEEEEEEECSSSEEEEEEECCC-----CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-S
T ss_pred             EehHHeEEEeEeeecCCeeEEEEEEecCCC---CceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-c
Confidence            345678999999999999999999865422   2567999998764332 2366889999999999999999999984 5


Q ss_pred             CeEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCcc
Q 046893          168 EHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAK  247 (464)
Q Consensus       168 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~  247 (464)
                      +..++||||+.+++|.+++... ...+++..++.++.|++.||.|||  ..+|+||||||+|||++.++.+||+|||+++
T Consensus        88 ~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH--~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~  164 (281)
T 1mp8_A           88 NPVWIIMELCTLGELRSFLQVR-KYSLDLASLILYAYQLSTALAYLE--SKRFVHRDIAARNVLVSSNDCVKLGDFGLSR  164 (281)
T ss_dssp             SSCEEEEECCTTEEHHHHHHHT-TTTSCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCSGGGEEEEETTEEEECC-----
T ss_pred             CccEEEEecCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHH--hCCeecccccHHHEEECCCCCEEECcccccc
Confidence            6789999999999999998754 346899999999999999999999  5679999999999999999999999999998


Q ss_pred             CCCCCCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHhhhcccch
Q 046893          248 DGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLL-GRRAVDKSRPSREHNLVEWARPLLNNNKKV  326 (464)
Q Consensus       248 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  326 (464)
                      ....... .......+|+.|+|||++.+..++.++||||||+++|||++ |..||.......   .....   ...    
T Consensus       165 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~---~~~~i---~~~----  233 (281)
T 1mp8_A          165 YMEDSTY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND---VIGRI---ENG----  233 (281)
T ss_dssp             ---------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---HHHHH---HTT----
T ss_pred             ccCcccc-cccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHH---HHHHH---HcC----
Confidence            6533221 12233467889999999999999999999999999999997 999997654321   11111   100    


Q ss_pred             hhccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHh
Q 046893          327 LRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETVQS  376 (464)
Q Consensus       327 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~~~  376 (464)
                             .....+..++..+.+|+.+||+.||.+||++.++++.|+.+..
T Consensus       234 -------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~  276 (281)
T 1mp8_A          234 -------ERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE  276 (281)
T ss_dssp             -------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             -------CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence                   0111233455689999999999999999999999999998865

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=7.6e-47  Score=387.08  Aligned_cols=262  Identities=26%  Similarity=0.435  Sum_probs=213.4

Q ss_pred             HHHHHhcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCccHHHHHHHHHHHhcCCCCCcceEEEEEE
Q 046893           86 EMKLATKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVKLIGYCC  165 (464)
Q Consensus        86 ~~~~~~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~  165 (464)
                      .+.+..++|.+.+.||+|+||+||+|.+..       +..||||+++... ...+.|.+|+.+|+.++||||+++++++.
T Consensus       182 ~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~-------~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~  253 (454)
T 1qcf_A          182 AWEIPRESLKLEKKLGAGQFGEVWMATYNK-------HTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT  253 (454)
T ss_dssp             CSBCCGGGEEEEEEEECCSSEEEEEEEETT-------TEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC
T ss_pred             ceeechHHeEEEEEcccCCceEEEEEEECC-------ccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe
Confidence            345566789999999999999999998754       4569999997643 45678999999999999999999999986


Q ss_pred             eCCeEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCC
Q 046893          166 EDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGL  245 (464)
Q Consensus       166 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGl  245 (464)
                       .+..+|||||+.+|+|.+++....+..+++..++.++.||+.||.|||  .++|+||||||+||||+.++.+||+|||+
T Consensus       254 -~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH--~~~ivHrDlkp~Nill~~~~~~kl~DFG~  330 (454)
T 1qcf_A          254 -KEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE--QRNYIHRDLRAANILVSASLVCKIADFGL  330 (454)
T ss_dssp             -SSSCEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHH--HTTCCCSSCSGGGEEECTTCCEEECSTTG
T ss_pred             -CCccEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH--hCCccCCCCCHHHEEECCCCcEEEeeCCC
Confidence             667899999999999999997654446899999999999999999999  56799999999999999999999999999


Q ss_pred             ccCCCCCCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHhhhccc
Q 046893          246 AKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLL-GRRAVDKSRPSREHNLVEWARPLLNNNK  324 (464)
Q Consensus       246 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~  324 (464)
                      ++...... ........+|..|+|||++.+..++.++|||||||+||||++ |+.||.+....      +....+...  
T Consensus       331 a~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~------~~~~~i~~~--  401 (454)
T 1qcf_A          331 ARVIEDNE-YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP------EVIRALERG--  401 (454)
T ss_dssp             GGGBCCHH-HHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH------HHHHHHHHT--
T ss_pred             ceEcCCCc-eeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHH------HHHHHHHcC--
Confidence            98643211 111223457789999999999999999999999999999999 99999764321      111111111  


Q ss_pred             chhhccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHh
Q 046893          325 KVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETVQS  376 (464)
Q Consensus       325 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~~~  376 (464)
                               .....+..++..+.+||.+||+.||.+|||+.+|++.|+.+..
T Consensus       402 ---------~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~  444 (454)
T 1qcf_A          402 ---------YRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYT  444 (454)
T ss_dssp             ---------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSS
T ss_pred             ---------CCCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHh
Confidence                     1112233456689999999999999999999999999998754

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=1.3e-45  Score=375.92  Aligned_cols=254  Identities=21%  Similarity=0.267  Sum_probs=205.1

Q ss_pred             HhcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCc--cHHHHHHHHHHHhcCCCCCcceEEEEEEeC
Q 046893           90 ATKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQ--GDREWLAEVNYLGQLRHSNLVKLIGYCCED  167 (464)
Q Consensus        90 ~~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpniv~l~~~~~~~  167 (464)
                      ..++|++.+.||+|+||+||+|.+..+      ++.+|+|++......  ....+.+|+.+|+.++||||+++++++.+.
T Consensus         9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~~------~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~   82 (444)
T 3soa_A            9 FTEEYQLFEELGKGAFSVVRRCVKVLA------GQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEE   82 (444)
T ss_dssp             HHHHEEEEEEEEEC--CEEEEEEETTT------TEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECS
T ss_pred             ccCCeEEEEEeccCCCeEEEEEEECCC------CcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEEC
Confidence            456799999999999999999998765      678999998765432  235688999999999999999999999999


Q ss_pred             CeEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEec---CCCceEEcccC
Q 046893          168 EHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLN---ADFSAKLSDFG  244 (464)
Q Consensus       168 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~---~~~~vkl~DFG  244 (464)
                      +..++|||||.+|+|.+++....  .+++..+..++.||+.||.|||  .++|+||||||+|||++   .++.+||+|||
T Consensus        83 ~~~~lv~E~~~gg~L~~~i~~~~--~~~e~~~~~i~~qil~aL~~lH--~~givHrDlKp~NIll~~~~~~~~vkL~DFG  158 (444)
T 3soa_A           83 GHHYLIFDLVTGGELFEDIVARE--YYSEADASHCIQQILEAVLHCH--QMGVVHRNLKPENLLLASKLKGAAVKLADFG  158 (444)
T ss_dssp             SEEEEEECCCBCCBHHHHHHHCS--CCCHHHHHHHHHHHHHHHHHHH--HTTCBCCCCSSTTEEESBSSTTCCEEECCCS
T ss_pred             CEEEEEEEeCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH--HCCccccCCCHHHEEEeccCCCCcEEEccCc
Confidence            99999999999999999987653  6999999999999999999999  56799999999999998   46789999999


Q ss_pred             CccCCCCCCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhccc
Q 046893          245 LAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNK  324 (464)
Q Consensus       245 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  324 (464)
                      +++......  ......+||+.|+|||++.+..++.++|||||||++|+|++|..||.+....      +..........
T Consensus       159 ~a~~~~~~~--~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~------~~~~~i~~~~~  230 (444)
T 3soa_A          159 LAIEVEGEQ--QAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQH------RLYQQIKAGAY  230 (444)
T ss_dssp             SCBCCCTTC--CBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHH------HHHHHHHHTCC
T ss_pred             eeEEecCCC--ceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHH------HHHHHHHhCCC
Confidence            998654322  2233478999999999999999999999999999999999999999764321      11111111110


Q ss_pred             chhhccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 046893          325 KVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVA  369 (464)
Q Consensus       325 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  369 (464)
                      .        .........+..+.+||.+||+.||.+||++.++++
T Consensus       231 ~--------~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~  267 (444)
T 3soa_A          231 D--------FPSPEWDTVTPEAKDLINKMLTINPSKRITAAEALK  267 (444)
T ss_dssp             C--------CCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             C--------CCccccccCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence            0        111111234458899999999999999999999975

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=2.1e-46  Score=360.22  Aligned_cols=265  Identities=24%  Similarity=0.361  Sum_probs=219.3

Q ss_pred             HHHHhcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCccHHHHHHHHHHHhcCCCCCcceEEEEEEe
Q 046893           87 MKLATKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVKLIGYCCE  166 (464)
Q Consensus        87 ~~~~~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~  166 (464)
                      +.+..++|++.+.||+|+||+||+|.+..+      +..||+|++... ....+.+.+|+.+++.++||||+++++++..
T Consensus         8 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~------~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~   80 (288)
T 3kfa_A            8 WEMERTDITMKHKLGGGQYGEVYEGVWKKY------SLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR   80 (288)
T ss_dssp             TBCCGGGEEEEEESGGGTTCSEEEEEEGGG------TEEEEEEEECSC-STHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             ccccccceeEEeecCCCCceeEEEeEecCC------CEEEEEEecCcC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEcc
Confidence            344567799999999999999999998764      677999998754 3345778999999999999999999999999


Q ss_pred             CCeEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCc
Q 046893          167 DEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLA  246 (464)
Q Consensus       167 ~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla  246 (464)
                      .+..++||||+.+++|.+++.......+++..++.++.|++.||.|||  ..+|+||||||+|||++.++.+||+|||++
T Consensus        81 ~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH--~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~  158 (288)
T 3kfa_A           81 EPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE--KKNFIHRDLAARNCLVGENHLVKVADFGLS  158 (288)
T ss_dssp             SSSEEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHH--HHTCCCSCCSGGGEEECGGGCEEECCCCGG
T ss_pred             CCCEEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHH--HCCccCCCCCcceEEEcCCCCEEEccCccc
Confidence            999999999999999999998766667999999999999999999999  567999999999999999999999999999


Q ss_pred             cCCCCCCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHhhhcccc
Q 046893          247 KDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLL-GRRAVDKSRPSREHNLVEWARPLLNNNKK  325 (464)
Q Consensus       247 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  325 (464)
                      ....... ........||+.|+|||++.+..++.++||||||+++|+|++ |..||.......   ..+..         
T Consensus       159 ~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~---~~~~~---------  225 (288)
T 3kfa_A          159 RLMTGDT-YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ---VYELL---------  225 (288)
T ss_dssp             GTSCSSS-SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG---HHHHH---------
T ss_pred             eeccCCc-cccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHH---------
Confidence            8654322 223334567889999999999999999999999999999999 999997654221   11111         


Q ss_pred             hhhccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhcC
Q 046893          326 VLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETVQSQG  378 (464)
Q Consensus       326 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~~~~~  378 (464)
                           ........+..++..+.+|+.+||..||.+||++.++++.|+.+....
T Consensus       226 -----~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~~  273 (288)
T 3kfa_A          226 -----EKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQES  273 (288)
T ss_dssp             -----HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             -----hccCCCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHhc
Confidence                 111111223344568999999999999999999999999999877643

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=8.4e-46  Score=363.04  Aligned_cols=252  Identities=24%  Similarity=0.315  Sum_probs=205.2

Q ss_pred             hcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCc------cHHHHHHHHHHHhcCCCCCcceEEEEE
Q 046893           91 TKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQ------GDREWLAEVNYLGQLRHSNLVKLIGYC  164 (464)
Q Consensus        91 ~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~hpniv~l~~~~  164 (464)
                      .++|.+.+.||+|+||.||+|.+..+      +..||+|++......      ....+.+|+.+|+.++||||+++++++
T Consensus        10 ~~~y~~~~~lG~G~~g~V~~~~~~~~------~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~   83 (326)
T 2y0a_A           10 DDYYDTGEELGSGQFAVVKKCREKST------GLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVY   83 (326)
T ss_dssp             HHHEEEEEEEECCSSEEEEEEEETTT------CCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             ccceEeceEEeeCCCeEEEEEEECCC------CcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEE
Confidence            45689999999999999999998765      667999998754322      356789999999999999999999999


Q ss_pred             EeCCeEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCC----ceEE
Q 046893          165 CEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADF----SAKL  240 (464)
Q Consensus       165 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~----~vkl  240 (464)
                      ......++||||+.+++|.+++...  ..+++..++.++.|++.||.|||  ..+|+||||||+|||++.++    .+||
T Consensus        84 ~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH--~~~ivH~Dlkp~NIll~~~~~~~~~~kl  159 (326)
T 2y0a_A           84 ENKTDVILILELVAGGELFDFLAEK--ESLTEEEATEFLKQILNGVYYLH--SLQIAHFDLKPENIMLLDRNVPKPRIKI  159 (326)
T ss_dssp             ECSSEEEEEEECCCSCBHHHHHTTS--SCCBHHHHHHHHHHHHHHHHHHH--HTTEECCCCCGGGEEESCSSSSSCCEEE
T ss_pred             EeCCEEEEEEEcCCCCCHHHHHHhc--CCcCHHHHHHHHHHHHHHHHHHH--HCCeEcCCCCHHHEEEecCCCCCCCEEE
Confidence            9999999999999999999998654  36999999999999999999999  56799999999999998877    7999


Q ss_pred             cccCCccCCCCCCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhh
Q 046893          241 SDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLL  320 (464)
Q Consensus       241 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~  320 (464)
                      +|||+++......   ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+....      +......
T Consensus       160 ~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~------~~~~~~~  230 (326)
T 2y0a_A          160 IDFGLAHKIDFGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ------ETLANVS  230 (326)
T ss_dssp             CCCTTCEECCTTS---CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH------HHHHHHH
T ss_pred             EECCCCeECCCCC---ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHH------HHHHHHH
Confidence            9999998653322   223467999999999999899999999999999999999999999764321      1111111


Q ss_pred             hcccchhhccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 046893          321 NNNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVA  369 (464)
Q Consensus       321 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  369 (464)
                      ...        ...........+..+.+|+.+||..||.+|||+.++++
T Consensus       231 ~~~--------~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  271 (326)
T 2y0a_A          231 AVN--------YEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ  271 (326)
T ss_dssp             HTC--------CCCCHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             hcC--------CCcCccccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            110        00111111223457889999999999999999999986

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=5.4e-45  Score=355.99  Aligned_cols=272  Identities=21%  Similarity=0.273  Sum_probs=213.3

Q ss_pred             hcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCC-ccHHHHHHHHHHHhcCCCCCcceEEEEEEeCC-
Q 046893           91 TKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGY-QGDREWLAEVNYLGQLRHSNLVKLIGYCCEDE-  168 (464)
Q Consensus        91 ~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~-  168 (464)
                      .++|++.+.||+|+||+||+|.+..+      ++.||||++..... .....+.+|+++|+.++||||+++++++.... 
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   81 (319)
T 4euu_A            8 NHLWLLSDILGQGATANVFRGRHKKT------GDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTT   81 (319)
T ss_dssp             SEEEEEEEEEEECSSEEEEEEEETTT------CCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTT
T ss_pred             CCCEEEEEEecCCCCeEEEEEEECCC------CcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCC
Confidence            46789999999999999999998765      66799999875432 33467889999999999999999999998765 


Q ss_pred             -eEEEEEeccCCCCHHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEe----cCCCceEEcc
Q 046893          169 -HRILVYEYMESGSLEKHLLRRVG-CMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILL----NADFSAKLSD  242 (464)
Q Consensus       169 -~~~lv~e~~~~g~L~~~l~~~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill----~~~~~vkl~D  242 (464)
                       ..+|||||+++++|.+++..... ..+++..++.++.|++.||.|||  ..+|+||||||+|||+    +.++.+||+|
T Consensus        82 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH--~~~ivH~Dlkp~NIll~~~~~~~~~~kL~D  159 (319)
T 4euu_A           82 RHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR--ENGIVHRNIKPGNIMRVIGEDGQSVYKLTD  159 (319)
T ss_dssp             CCEEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGEEEEECTTSCEEEEECC
T ss_pred             ceEEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH--HCCEecCCCCHHHEEEeccCCCCceEEEcc
Confidence             78999999999999999876432 34999999999999999999999  5679999999999999    7788899999


Q ss_pred             cCCccCCCCCCCcceeeccccCCcccCccccc--------cCCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHH
Q 046893          243 FGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVM--------TGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVE  314 (464)
Q Consensus       243 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~  314 (464)
                      ||+++......   ......||..|+|||++.        +..++.++|||||||++|||++|+.||.........  .+
T Consensus       160 fg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~--~~  234 (319)
T 4euu_A          160 FGAARELEDDE---QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRN--KE  234 (319)
T ss_dssp             CTTCEECCTTC---CBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGC--HH
T ss_pred             CCCceecCCCC---ceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchh--HH
Confidence            99998654332   223467999999999886        578999999999999999999999999754332211  11


Q ss_pred             HHHHhhhccc-c----hhhcc--------CccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHH
Q 046893          315 WARPLLNNNK-K----VLRIL--------DPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETVQ  375 (464)
Q Consensus       315 ~~~~~~~~~~-~----~~~~~--------~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~~  375 (464)
                      .....+.... .    +....        .-.....+....+..+.+|+.+||+.||.+||++.++++...+..
T Consensus       235 ~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~  308 (319)
T 4euu_A          235 VMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDIL  308 (319)
T ss_dssp             HHHHHHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHT
T ss_pred             HHHHHhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHh
Confidence            1221211110 0    00000        011122455778889999999999999999999999998776543

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=1.5e-45  Score=355.92  Aligned_cols=266  Identities=20%  Similarity=0.198  Sum_probs=212.9

Q ss_pred             HhcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCccHHHHHHHHHHHhcC-CCCCcceEEEEEEeCC
Q 046893           90 ATKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQL-RHSNLVKLIGYCCEDE  168 (464)
Q Consensus        90 ~~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~  168 (464)
                      ..++|++.+.||+|+||.||+|.+..+      ++.||||++....  ....+.+|+.++..+ +|+||+++++++....
T Consensus         8 ~~~~y~~~~~lg~G~~g~V~~~~~~~~------~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~   79 (298)
T 1csn_A            8 VGVHYKVGRRIGEGSFGVIFEGTNLLN------NQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGL   79 (298)
T ss_dssp             ETTTEEEEEEEEECSSCEEEEEEETTT------TEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETT
T ss_pred             cccceEEEEEEeecCCEEEEEEEECCC------CcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCc
Confidence            456799999999999999999997664      6789999986543  234578899999999 7999999999999999


Q ss_pred             eEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCc-----eEEccc
Q 046893          169 HRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFS-----AKLSDF  243 (464)
Q Consensus       169 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~-----vkl~DF  243 (464)
                      ..++||||+ +++|.+++... +..+++..++.++.|++.||.|||  .++|+||||||+|||++.++.     +||+||
T Consensus        80 ~~~lv~e~~-~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH--~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Df  155 (298)
T 1csn_A           80 HNVLVIDLL-GPSLEDLLDLC-GRKFSVKTVAMAAKQMLARVQSIH--EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDF  155 (298)
T ss_dssp             EEEEEEECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHH--TTTEECCCCCGGGEEECCSSSTTTTCEEECCC
T ss_pred             eeEEEEEec-CCCHHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHH--hCCEecCCCCHHHEEeccCCCCCCCeEEEEEC
Confidence            999999999 99999998764 346999999999999999999999  677999999999999987765     999999


Q ss_pred             CCccCCCCCCCc-----ceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHH
Q 046893          244 GLAKDGPMGDQT-----HVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARP  318 (464)
Q Consensus       244 Gla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~  318 (464)
                      |+++........     .......||+.|+|||++.+..++.++||||||+++|||++|+.||.................
T Consensus       156 g~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~  235 (298)
T 1csn_A          156 GMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGE  235 (298)
T ss_dssp             TTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHH
T ss_pred             ccccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHh
Confidence            999864432221     123446799999999999999999999999999999999999999987543332222211110


Q ss_pred             hhhcccchhhccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhc
Q 046893          319 LLNNNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETVQSQ  377 (464)
Q Consensus       319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~~~~  377 (464)
                      ...          ..........++..+.+|+.+||+.||.+||++.+|++.|+.+...
T Consensus       236 ~~~----------~~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~  284 (298)
T 1csn_A          236 KKQ----------STPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLER  284 (298)
T ss_dssp             HHH----------HSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHH
T ss_pred             hcc----------CccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHh
Confidence            000          0000011123445899999999999999999999999999988654

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=9.7e-46  Score=366.34  Aligned_cols=255  Identities=22%  Similarity=0.322  Sum_probs=204.3

Q ss_pred             HhcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCC-----CCccHHHHHHHHHHHhcCCCCCcceEEEEE
Q 046893           90 ATKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRG-----GYQGDREWLAEVNYLGQLRHSNLVKLIGYC  164 (464)
Q Consensus        90 ~~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~hpniv~l~~~~  164 (464)
                      ..++|++.+.||+|+||+||+|.+..+      ++.||||++...     .......+.+|+.+++.++||||+++++++
T Consensus        22 ~~~~y~~~~~lG~G~~g~V~~~~~~~~------~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~   95 (351)
T 3c0i_A           22 FEDVYELCEVIGKGPFSVVRRCINRET------GQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETY   95 (351)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTT------CCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             cccceEEeeEEeeCCCEEEEEEEECCC------CCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEE
Confidence            345699999999999999999998765      677999998532     122457789999999999999999999999


Q ss_pred             EeCCeEEEEEeccCCCCHHHHHHhhc--CCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCc---eE
Q 046893          165 CEDEHRILVYEYMESGSLEKHLLRRV--GCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFS---AK  239 (464)
Q Consensus       165 ~~~~~~~lv~e~~~~g~L~~~l~~~~--~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~---vk  239 (464)
                      ...+..+||||||++++|.+++....  +..+++..+..++.||+.||.|||  .++|+||||||+|||++.++.   +|
T Consensus        96 ~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH--~~~ivHrDlkp~NIl~~~~~~~~~vk  173 (351)
T 3c0i_A           96 SSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCH--DNNIIHRDVKPHCVLLASKENSAPVK  173 (351)
T ss_dssp             EETTEEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGEEECSSSTTCCEE
T ss_pred             EeCCEEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHH--HCCceeccCChHHeEEecCCCCCcEE
Confidence            99999999999999999988886542  345899999999999999999999  567999999999999976654   99


Q ss_pred             EcccCCccCCCCCCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHh
Q 046893          240 LSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPL  319 (464)
Q Consensus       240 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~  319 (464)
                      |+|||+++......  ......+||+.|+|||++.+..++.++|||||||+||+|++|..||.+...       ......
T Consensus       174 l~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~-------~~~~~i  244 (351)
T 3c0i_A          174 LGGFGVAIQLGESG--LVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKE-------RLFEGI  244 (351)
T ss_dssp             ECCCTTCEECCTTS--CBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHH-------HHHHHH
T ss_pred             EecCcceeEecCCC--eeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHH-------HHHHHH
Confidence            99999998653322  223346899999999999999999999999999999999999999976321       111111


Q ss_pred             hhcccchhhccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 046893          320 LNNNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVA  369 (464)
Q Consensus       320 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  369 (464)
                      ......    ..+..    ....+..+.+||.+||..||.+||++.++++
T Consensus       245 ~~~~~~----~~~~~----~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~  286 (351)
T 3c0i_A          245 IKGKYK----MNPRQ----WSHISESAKDLVRRMLMLDPAERITVYEALN  286 (351)
T ss_dssp             HHTCCC----CCHHH----HTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             HcCCCC----CCccc----cccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            111100    00000    0123457899999999999999999999985

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=4.9e-46  Score=374.78  Aligned_cols=251  Identities=19%  Similarity=0.223  Sum_probs=191.3

Q ss_pred             CCCCC-CceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCccHHHHHHHHHHHhc-CCCCCcceEEEEEEe----
Q 046893           93 FFRPD-YILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQ-LRHSNLVKLIGYCCE----  166 (464)
Q Consensus        93 ~~~~~-~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~-l~hpniv~l~~~~~~----  166 (464)
                      +|.+. ++||+|+||+||+|.+..+      ++.||||++..     ...+.+|+.++.+ ++||||++++++|..    
T Consensus        62 ~y~~~~~~LG~G~~g~V~~~~~~~~------~~~vAiK~~~~-----~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~  130 (400)
T 1nxk_A           62 DYKVTSQVLGLGINGKVLQIFNKRT------QEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAG  130 (400)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETTT------CCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETT
T ss_pred             cceeccceeeeccCeEEEEEEECCC------CCEEEEEEeCc-----chhHHHHHHHHHHhcCCCCcceEeEEEeecccC
Confidence            45454 7899999999999998765      67799999863     2456788888744 589999999999876    


Q ss_pred             CCeEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecC---CCceEEccc
Q 046893          167 DEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNA---DFSAKLSDF  243 (464)
Q Consensus       167 ~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~---~~~vkl~DF  243 (464)
                      ...+|||||||.+|+|.+++.......+++..+..|+.||+.||.|||  ..+|+||||||+||||+.   ++.+||+||
T Consensus       131 ~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH--~~~ivHrDlkp~Nill~~~~~~~~~kl~DF  208 (400)
T 1nxk_A          131 RKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH--SINIAHRDVKPENLLYTSKRPNAILKLTDF  208 (400)
T ss_dssp             EEEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHH--HTTEECCCCCGGGEEESSSSTTCCEEECCC
T ss_pred             CcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH--HCCccccCcCcceEEEecCCCCccEEEEec
Confidence            567899999999999999998765557999999999999999999999  567999999999999987   789999999


Q ss_pred             CCccCCCCCCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccc-cHHHHHHHhhhc
Q 046893          244 GLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREH-NLVEWARPLLNN  322 (464)
Q Consensus       244 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~-~~~~~~~~~~~~  322 (464)
                      |+++.....   ......+||+.|+|||++.+..++.++|||||||+||||++|+.||......... ......   ...
T Consensus       209 G~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i---~~~  282 (400)
T 1nxk_A          209 GFAKETTSH---NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRI---RMG  282 (400)
T ss_dssp             TTCEECC--------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHH---HHT
T ss_pred             ccccccCCC---CccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHH---HcC
Confidence            999864322   1233478999999999999999999999999999999999999999765432211 111111   000


Q ss_pred             ccchhhccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 046893          323 NKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVAL  370 (464)
Q Consensus       323 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  370 (464)
                      .        ..+.......++..+.+||.+||..||.+|||+.++++.
T Consensus       283 ~--------~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h  322 (400)
T 1nxk_A          283 Q--------YEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH  322 (400)
T ss_dssp             C--------CCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             c--------ccCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence            0        000001112345588999999999999999999999863

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=3.7e-45  Score=357.11  Aligned_cols=245  Identities=26%  Similarity=0.350  Sum_probs=203.5

Q ss_pred             cCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCC---CccHHHHHHHHHHHhcCCCCCcceEEEEEEeCC
Q 046893           92 KFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGG---YQGDREWLAEVNYLGQLRHSNLVKLIGYCCEDE  168 (464)
Q Consensus        92 ~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~  168 (464)
                      ++|++.+.||+|+||+||+|.+..+      ++.||+|++....   ......+.+|+.+++.++||||+++++++.+..
T Consensus         6 ~~y~~~~~lG~G~~g~V~~~~~~~~------~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~   79 (318)
T 1fot_A            6 QDFQILRTLGTGSFGRVHLIRSRHN------GRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQ   79 (318)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTT------CCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSS
T ss_pred             HHcEEEEEEeeCCCEEEEEEEECCC------CCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCC
Confidence            5688999999999999999998765      6779999986532   223466789999999999999999999999999


Q ss_pred             eEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCccC
Q 046893          169 HRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKD  248 (464)
Q Consensus       169 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~  248 (464)
                      ..|+||||+++|+|.+++....  .+++..+..++.||+.||.|||  .++|+||||||+|||++.++.+||+|||+++.
T Consensus        80 ~~~lv~e~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH--~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~  155 (318)
T 1fot_A           80 QIFMIMDYIEGGELFSLLRKSQ--RFPNPVAKFYAAEVCLALEYLH--SKDIIYRDLKPENILLDKNGHIKITDFGFAKY  155 (318)
T ss_dssp             EEEEEECCCCSCBHHHHHHHTS--SCCHHHHHHHHHHHHHHHHHHH--TTTEECCCCCGGGEEECTTSCEEECCCSSCEE
T ss_pred             EEEEEEeCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH--HCCccccCCChheEEEcCCCCEEEeecCccee
Confidence            9999999999999999987643  6899999999999999999999  67799999999999999999999999999986


Q ss_pred             CCCCCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhcccchhh
Q 046893          249 GPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLR  328 (464)
Q Consensus       249 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  328 (464)
                      ...     .....+||+.|+|||++.+..++.++|||||||++|||++|+.||.....      ............    
T Consensus       156 ~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~------~~~~~~i~~~~~----  220 (318)
T 1fot_A          156 VPD-----VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNT------MKTYEKILNAEL----  220 (318)
T ss_dssp             CSS-----CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH------HHHHHHHHHCCC----
T ss_pred             cCC-----ccccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH------HHHHHHHHhCCC----
Confidence            422     12346899999999999999999999999999999999999999976432      111222222111    


Q ss_pred             ccCccccCccCHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHH
Q 046893          329 ILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRP-----VMSDVVA  369 (464)
Q Consensus       329 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~ev~~  369 (464)
                              .++...+..+.+|+.+||..||.+||     ++.++++
T Consensus       221 --------~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~  258 (318)
T 1fot_A          221 --------RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN  258 (318)
T ss_dssp             --------CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred             --------CCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence                    12223445889999999999999999     7777763

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=1.3e-45  Score=368.69  Aligned_cols=250  Identities=24%  Similarity=0.324  Sum_probs=203.4

Q ss_pred             hcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCC---CccHHHHHHHHHHHhcCCCCCcceEEEEEEeC
Q 046893           91 TKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGG---YQGDREWLAEVNYLGQLRHSNLVKLIGYCCED  167 (464)
Q Consensus        91 ~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~  167 (464)
                      .++|++.+.||+|+||.||+|.+..+      ++.||+|++....   ......+.+|+.+|+.++||||++++++|.+.
T Consensus        14 ~~~y~i~~~LG~G~fG~V~~~~~~~~------~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~   87 (384)
T 4fr4_A           14 FDHFEILRAIGKGSFGKVCIVQKNDT------KKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDE   87 (384)
T ss_dssp             GGGEEEEEEEECCTTCCEEEEEETTT------CCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECS
T ss_pred             hHHeEEEEEEeeCCCeEEEEEEECCC------CCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeC
Confidence            35688999999999999999998765      6779999986432   22346788999999999999999999999999


Q ss_pred             CeEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCcc
Q 046893          168 EHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAK  247 (464)
Q Consensus       168 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~  247 (464)
                      +..|+||||+.+|+|.+++...  ..+++..+..++.||+.||.|||  ..+|+||||||+||||+.++.+||+|||+++
T Consensus        88 ~~~~lv~e~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH--~~givHrDlkp~NIll~~~g~vkL~DFG~a~  163 (384)
T 4fr4_A           88 EDMFMVVDLLLGGDLRYHLQQN--VHFKEETVKLFICELVMALDYLQ--NQRIIHRDMKPDNILLDEHGHVHITDFNIAA  163 (384)
T ss_dssp             SEEEEEECCCTTEEHHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred             CEEEEEEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH--HCCceeccCcHHHeEECCCCCEEEeccceee
Confidence            9999999999999999988764  36999999999999999999999  5679999999999999999999999999998


Q ss_pred             CCCCCCCcceeeccccCCcccCcccccc---CCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhccc
Q 046893          248 DGPMGDQTHVSTRVMGTYGYAAPEYVMT---GHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNK  324 (464)
Q Consensus       248 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  324 (464)
                      ......   .....+||+.|+|||++.+   ..++.++|||||||+||||++|+.||..........+....   ...  
T Consensus       164 ~~~~~~---~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~---~~~--  235 (384)
T 4fr4_A          164 MLPRET---QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTF---ETT--  235 (384)
T ss_dssp             ECCTTC---CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHH---HHC--
T ss_pred             eccCCC---ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHH---hhc--
Confidence            643322   2345789999999999864   45899999999999999999999999765433222222111   111  


Q ss_pred             chhhccCccccCccCHHHHHHHHHHHHHhhccCCCCCCC-HHHHH
Q 046893          325 KVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPV-MSDVV  368 (464)
Q Consensus       325 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-~~ev~  368 (464)
                                ...++..++..+.+||.+||..||.+||+ +.+|+
T Consensus       236 ----------~~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~  270 (384)
T 4fr4_A          236 ----------VVTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQ  270 (384)
T ss_dssp             ----------CCCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHH
T ss_pred             ----------ccCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHH
Confidence                      01122334558999999999999999998 55554

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.2e-45  Score=361.12  Aligned_cols=252  Identities=17%  Similarity=0.232  Sum_probs=205.9

Q ss_pred             hcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCccHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeE
Q 046893           91 TKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVKLIGYCCEDEHR  170 (464)
Q Consensus        91 ~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~  170 (464)
                      .++|++.+.||+|+||.||+|.+..+      +..||+|++... ......+.+|+.+|+.++||||+++++++.+.+..
T Consensus         4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~------~~~~a~K~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~   76 (321)
T 1tki_A            4 YEKYMIAEDLGRGEFGIVHRCVETSS------KKTYMAKFVKVK-GTDQVLVKKEISILNIARHRNILHLHESFESMEEL   76 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTT------TEEEEEEEECCC-THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEE
T ss_pred             hhceEeeeEEecCCCeEEEEEEECCC------CcEEEEEEEecC-cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEE
Confidence            46789999999999999999998765      678999998754 23446688999999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecC--CCceEEcccCCccC
Q 046893          171 ILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNA--DFSAKLSDFGLAKD  248 (464)
Q Consensus       171 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~--~~~vkl~DFGla~~  248 (464)
                      ++||||+++++|.+++... ...+++..++.++.|++.||.|||  ..+|+||||||+|||++.  ++.+||+|||+++.
T Consensus        77 ~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH--~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~  153 (321)
T 1tki_A           77 VMIFEFISGLDIFERINTS-AFELNEREIVSYVHQVCEALQFLH--SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQ  153 (321)
T ss_dssp             EEEECCCCCCBHHHHHTSS-SCCCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCCGGGEEESSSSCCCEEECCCTTCEE
T ss_pred             EEEEEeCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHH--HCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeE
Confidence            9999999999999988653 346999999999999999999999  567999999999999987  78999999999987


Q ss_pred             CCCCCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhcccchhh
Q 046893          249 GPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLR  328 (464)
Q Consensus       249 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  328 (464)
                      .....   ......||+.|+|||++.+..++.++|||||||++|+|++|..||......      +...........   
T Consensus       154 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~------~~~~~i~~~~~~---  221 (321)
T 1tki_A          154 LKPGD---NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQ------QIIENIMNAEYT---  221 (321)
T ss_dssp             CCTTC---EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHH------HHHHHHHHTCCC---
T ss_pred             CCCCC---ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHH------HHHHHHHcCCCC---
Confidence            54332   233467999999999999888999999999999999999999999764321      111111111110   


Q ss_pred             ccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 046893          329 ILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVA  369 (464)
Q Consensus       329 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  369 (464)
                           .........+..+.+|+.+||..||.+|||+.++++
T Consensus       222 -----~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~  257 (321)
T 1tki_A          222 -----FDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQ  257 (321)
T ss_dssp             -----CCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             -----CChhhhccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence                 000011123457899999999999999999999986

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=9.8e-46  Score=364.96  Aligned_cols=251  Identities=29%  Similarity=0.444  Sum_probs=204.1

Q ss_pred             HHHhcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCC---CccHHHHHHHHHHHhcC-CCCCcceEEEE
Q 046893           88 KLATKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGG---YQGDREWLAEVNYLGQL-RHSNLVKLIGY  163 (464)
Q Consensus        88 ~~~~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~hpniv~l~~~  163 (464)
                      .+..++|.+.+.||+|+||+||+|.+..+      ++.||||++....   ......+..|..+|..+ +||||++++++
T Consensus        13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~------~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~   86 (345)
T 1xjd_A           13 KLKIEDFILHKMLGKGSFGKVFLAEFKKT------NQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCT   86 (345)
T ss_dssp             ---CTTEEEEEEEEECSSSEEEEEEETTT------TEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEE
T ss_pred             CCChHHeEEEEEEeeCCCeEEEEEEECCC------CCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEE
Confidence            34557799999999999999999998765      7789999987532   22345678899999876 89999999999


Q ss_pred             EEeCCeEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEccc
Q 046893          164 CCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDF  243 (464)
Q Consensus       164 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DF  243 (464)
                      +.+.+..||||||+++|+|.+++....  .+++..+..++.||+.||.|||  .++|+||||||+||||+.++.+||+||
T Consensus        87 ~~~~~~~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH--~~~ivHrDlkp~NIll~~~g~vkL~DF  162 (345)
T 1xjd_A           87 FQTKENLFFVMEYLNGGDLMYHIQSCH--KFDLSRATFYAAEIILGLQFLH--SKGIVYRDLKLDNILLDKDGHIKIADF  162 (345)
T ss_dssp             EECSSEEEEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHH--HTTCBCCCCCGGGEEECTTSCEEECCC
T ss_pred             EEeCCEEEEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH--HCCeEeCCCChhhEEECCCCCEEEeEC
Confidence            999999999999999999999987653  6899999999999999999999  567999999999999999999999999


Q ss_pred             CCccCCCCCCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhcc
Q 046893          244 GLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNN  323 (464)
Q Consensus       244 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~  323 (464)
                      |+++......  ......+||+.|+|||++.+..++.++|||||||++|||++|+.||.+....      +....+....
T Consensus       163 G~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~------~~~~~i~~~~  234 (345)
T 1xjd_A          163 GMCKENMLGD--AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEE------ELFHSIRMDN  234 (345)
T ss_dssp             TTCBCCCCTT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHHCC
T ss_pred             hhhhhcccCC--CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHH------HHHHHHHhCC
Confidence            9998643222  2234578999999999999999999999999999999999999999764321      1111111111


Q ss_pred             cchhhccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHH-HHH
Q 046893          324 KKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMS-DVV  368 (464)
Q Consensus       324 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~-ev~  368 (464)
                              +    .++...+..+.+||.+||..||.+||++. +++
T Consensus       235 --------~----~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~  268 (345)
T 1xjd_A          235 --------P----FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIR  268 (345)
T ss_dssp             --------C----CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred             --------C----CCCcccCHHHHHHHHHHhcCCHhHcCCChHHHH
Confidence                    1    12223445889999999999999999997 543

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=4.4e-45  Score=360.58  Aligned_cols=249  Identities=25%  Similarity=0.353  Sum_probs=200.4

Q ss_pred             cCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCcc---HHHHHHHHHHHhcC-CCCCcceEEEEEEeC
Q 046893           92 KFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQG---DREWLAEVNYLGQL-RHSNLVKLIGYCCED  167 (464)
Q Consensus        92 ~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l-~hpniv~l~~~~~~~  167 (464)
                      ++|++.+.||+|+||.||+|.+..+      ++.||+|++.......   ...+.+|+.++..+ +||||+++++++...
T Consensus         9 ~~y~~~~~lG~G~fg~V~~~~~~~~------~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~   82 (345)
T 3a8x_A            9 QDFDLLRVIGRGSYAKVLLVRLKKT------DRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTE   82 (345)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTT------TEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECS
T ss_pred             hheEEEEEEEecCCeEEEEEEECCC------CCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeC
Confidence            4688899999999999999998765      6789999997643322   34578899999988 899999999999999


Q ss_pred             CeEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCcc
Q 046893          168 EHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAK  247 (464)
Q Consensus       168 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~  247 (464)
                      +..||||||+.+|+|.+++....  .+++..+..++.||+.||.|||  .++|+||||||+||||+.++.+||+|||+++
T Consensus        83 ~~~~lv~e~~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~LH--~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~  158 (345)
T 3a8x_A           83 SRLFFVIEYVNGGDLMFHMQRQR--KLPEEHARFYSAEISLALNYLH--ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCK  158 (345)
T ss_dssp             SEEEEEECCCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHH--HTTCBCCCCCGGGEEECTTSCEEECCGGGCB
T ss_pred             CEEEEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH--HCCceecCCCHHHEEECCCCCEEEEeccccc
Confidence            99999999999999999987653  6999999999999999999999  5679999999999999999999999999998


Q ss_pred             CCCCCCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccc--cHHH-HHHHhhhccc
Q 046893          248 DGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREH--NLVE-WARPLLNNNK  324 (464)
Q Consensus       248 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~--~~~~-~~~~~~~~~~  324 (464)
                      ......  ......+||+.|+|||++.+..++.++|||||||++|||++|+.||.........  .... ......... 
T Consensus       159 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~-  235 (345)
T 3a8x_A          159 EGLRPG--DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ-  235 (345)
T ss_dssp             CSCCTT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCC-
T ss_pred             cccCCC--CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCC-
Confidence            532222  2234578999999999999999999999999999999999999999753221110  1111 111111110 


Q ss_pred             chhhccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCH
Q 046893          325 KVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVM  364 (464)
Q Consensus       325 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~  364 (464)
                                 ..++...+..+.+||.+||..||.+||++
T Consensus       236 -----------~~~p~~~s~~~~~li~~lL~~dP~~R~~~  264 (345)
T 3a8x_A          236 -----------IRIPRSLSVKAASVLKSFLNKDPKERLGC  264 (345)
T ss_dssp             -----------CCCCTTSCHHHHHHHHHHTCSSTTTSTTC
T ss_pred             -----------CCCCCCCCHHHHHHHHHHhcCCHhHCCCC
Confidence                       11223345588999999999999999996

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=3.6e-45  Score=362.02  Aligned_cols=246  Identities=24%  Similarity=0.342  Sum_probs=202.1

Q ss_pred             HHhcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCC---CccHHHHHHHHHHHhcC-CCCCcceEEEEE
Q 046893           89 LATKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGG---YQGDREWLAEVNYLGQL-RHSNLVKLIGYC  164 (464)
Q Consensus        89 ~~~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~hpniv~l~~~~  164 (464)
                      +..++|++.+.||+|+||+||+|.+..+      ++.||||++....   ......+..|..+|..+ +||||+++++++
T Consensus        17 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~------~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~   90 (353)
T 2i0e_A           17 MKLTDFNFLMVLGKGSFGKVMLSERKGT------DELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCF   90 (353)
T ss_dssp             --CTTEEEEEEEEEETTEEEEEEEETTE------EEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEE
T ss_pred             CchHHcEEEEEEeeCCCEEEEEEEECCC------CCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEE
Confidence            3446799999999999999999998764      7789999987532   23346678999999988 799999999999


Q ss_pred             EeCCeEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccC
Q 046893          165 CEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFG  244 (464)
Q Consensus       165 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFG  244 (464)
                      ...+..||||||++||+|.+++....  .+++..++.++.||+.||.|||  .++|+||||||+||||+.++.+||+|||
T Consensus        91 ~~~~~~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH--~~givHrDlkp~NIll~~~g~vkL~DFG  166 (353)
T 2i0e_A           91 QTMDRLYFVMEYVNGGDLMYHIQQVG--RFKEPHAVFYAAEIAIGLFFLQ--SKGIIYRDLKLDNVMLDSEGHIKIADFG  166 (353)
T ss_dssp             ECSSEEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHH--HTTCBCCCCCGGGEEECTTSCEEECCCT
T ss_pred             EcCCEEEEEEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH--HCCEEeccCCHHHEEEcCCCcEEEEeCC
Confidence            99999999999999999999987653  5999999999999999999999  5679999999999999999999999999


Q ss_pred             CccCCCCCCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhccc
Q 046893          245 LAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNK  324 (464)
Q Consensus       245 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  324 (464)
                      +++......  ......+||+.|+|||++.+..++.++|||||||++|||++|+.||.+...      .+....+.....
T Consensus       167 ~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~------~~~~~~i~~~~~  238 (353)
T 2i0e_A          167 MCKENIWDG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE------DELFQSIMEHNV  238 (353)
T ss_dssp             TCBCCCCTT--CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHCCC
T ss_pred             cccccccCC--cccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCH------HHHHHHHHhCCC
Confidence            998632222  223457899999999999999999999999999999999999999976432      122222222111


Q ss_pred             chhhccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCH
Q 046893          325 KVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVM  364 (464)
Q Consensus       325 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~  364 (464)
                                  .++...+..+.+||.+||..||.+||++
T Consensus       239 ------------~~p~~~s~~~~~li~~lL~~dP~~R~~~  266 (353)
T 2i0e_A          239 ------------AYPKSMSKEAVAICKGLMTKHPGKRLGC  266 (353)
T ss_dssp             ------------CCCTTSCHHHHHHHHHHTCSCTTSCTTC
T ss_pred             ------------CCCCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence                        1223345588999999999999999975

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=3.4e-46  Score=366.48  Aligned_cols=271  Identities=23%  Similarity=0.357  Sum_probs=215.9

Q ss_pred             HHHhcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCc-cHHHHHHHHHHHhcC-CCCCcceEEEEEE
Q 046893           88 KLATKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQ-GDREWLAEVNYLGQL-RHSNLVKLIGYCC  165 (464)
Q Consensus        88 ~~~~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l-~hpniv~l~~~~~  165 (464)
                      .+..++|.+.+.||+|+||.||+|.+..... ......||+|++...... ....+.+|+.+|..+ +||||+++++++.
T Consensus        42 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~  120 (333)
T 2i1m_A           42 EFPRNNLQFGKTLGAGAFGKVVEATAFGLGK-EDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACT  120 (333)
T ss_dssp             BCCTTSEEEEEEEEECSSEEEEEEEETTCSS-SCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             cCCHHHceeeeEeccCCCcceEEEEecCCCc-ccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEe
Confidence            3445778999999999999999999876422 223457999999765332 346688999999999 8999999999999


Q ss_pred             eCCeEEEEEeccCCCCHHHHHHhhc------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEec
Q 046893          166 EDEHRILVYEYMESGSLEKHLLRRV------------GCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLN  233 (464)
Q Consensus       166 ~~~~~~lv~e~~~~g~L~~~l~~~~------------~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~  233 (464)
                      ..+..++||||+++|+|.+++....            ...+++..++.++.|++.||.|||  ..+|+||||||+|||++
T Consensus       121 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH--~~~ivH~Dlkp~NIl~~  198 (333)
T 2i1m_A          121 HGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLA--SKNCIHRDVAARNVLLT  198 (333)
T ss_dssp             SSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGCEEE
T ss_pred             cCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHh--cCCcccCCcccceEEEC
Confidence            9999999999999999999987542            346899999999999999999999  56799999999999999


Q ss_pred             CCCceEEcccCCccCCCCCCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHh-CCCCCCCCCCcccccH
Q 046893          234 ADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLL-GRRAVDKSRPSREHNL  312 (464)
Q Consensus       234 ~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~  312 (464)
                      .++.+||+|||+++...............||+.|+|||++.+..++.++||||||+++|+|++ |..||........  +
T Consensus       199 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~--~  276 (333)
T 2i1m_A          199 NGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSK--F  276 (333)
T ss_dssp             GGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHH--H
T ss_pred             CCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHH--H
Confidence            999999999999986433333333334567889999999999999999999999999999998 9999976442211  1


Q ss_pred             HHHHHHhhhcccchhhccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhc
Q 046893          313 VEWARPLLNNNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETVQSQ  377 (464)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~~~~  377 (464)
                      ...    ...          ......+..++..+.+|+.+||+.||.+||++.+|++.|+.+...
T Consensus       277 ~~~----~~~----------~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~  327 (333)
T 2i1m_A          277 YKL----VKD----------GYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQE  327 (333)
T ss_dssp             HHH----HHH----------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHH----Hhc----------CCCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHHh
Confidence            111    111          011111223345889999999999999999999999999987653

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=1.6e-45  Score=366.28  Aligned_cols=253  Identities=21%  Similarity=0.294  Sum_probs=205.0

Q ss_pred             HhcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCc--cHHHHHHHHHHHhcCCCCCcceEEEEEEeC
Q 046893           90 ATKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQ--GDREWLAEVNYLGQLRHSNLVKLIGYCCED  167 (464)
Q Consensus        90 ~~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpniv~l~~~~~~~  167 (464)
                      ..++|++.+.||+|+||.||+|.+..+      +..||+|++......  ....+.+|+.+++.++||||+++++++.+.
T Consensus        27 ~~~~y~~~~~lG~G~~g~V~~~~~~~~------~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~  100 (362)
T 2bdw_A           27 FSDNYDVKEELGKGAFSVVRRCVHKTT------GLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEE  100 (362)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTT------CCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred             cccCeEEeeEEecCCCeEEEEEEECCC------CCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeC
Confidence            456799999999999999999998765      667999999765433  235688999999999999999999999999


Q ss_pred             CeEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCC---CceEEcccC
Q 046893          168 EHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNAD---FSAKLSDFG  244 (464)
Q Consensus       168 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~---~~vkl~DFG  244 (464)
                      +..++||||+.+|+|.+++....  .+++..+..++.||+.||.|||  .++|+||||||+|||++.+   +.+||+|||
T Consensus       101 ~~~~lv~e~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~al~~lH--~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG  176 (362)
T 2bdw_A          101 SFHYLVFDLVTGGELFEDIVARE--FYSEADASHCIQQILESIAYCH--SNGIVHRNLKPENLLLASKAKGAAVKLADFG  176 (362)
T ss_dssp             SEEEEEECCCCSCBHHHHHTTCS--CCCHHHHHHHHHHHHHHHHHHH--HTTCBCCCCSGGGEEESCSSTTCCEEECCCT
T ss_pred             CEEEEEEecCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH--HCCeEeccCchHHEEEecCCCCCCEEEeecC
Confidence            99999999999999999887643  6899999999999999999999  5679999999999999765   459999999


Q ss_pred             CccCCCCCCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhccc
Q 046893          245 LAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNK  324 (464)
Q Consensus       245 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  324 (464)
                      ++.......   .....+||+.|+|||++.+..++.++|||||||++|+|++|..||......      +..........
T Consensus       177 ~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~------~~~~~i~~~~~  247 (362)
T 2bdw_A          177 LAIEVNDSE---AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH------RLYAQIKAGAY  247 (362)
T ss_dssp             TCBCCTTCC---SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHHTCC
T ss_pred             cceEecCCc---ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH------HHHHHHHhCCC
Confidence            998654322   223468999999999999989999999999999999999999999764321      11111111110


Q ss_pred             chhhccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 046893          325 KVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVA  369 (464)
Q Consensus       325 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  369 (464)
                      .        ........++..+.+||.+||..||.+||++.++++
T Consensus       248 ~--------~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  284 (362)
T 2bdw_A          248 D--------YPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALK  284 (362)
T ss_dssp             C--------CCTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             C--------CCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence            0        001111234458899999999999999999999875

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=7.8e-46  Score=364.34  Aligned_cols=246  Identities=23%  Similarity=0.323  Sum_probs=202.2

Q ss_pred             cCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCC---CccHHHHHHHHHHHhcCCCCCcceEEEEEEeCC
Q 046893           92 KFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGG---YQGDREWLAEVNYLGQLRHSNLVKLIGYCCEDE  168 (464)
Q Consensus        92 ~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~  168 (464)
                      ++|++.+.||+|+||+||+|.+..+      ++.||||++....   ......+.+|+.+|+.++||||+++++++...+
T Consensus         9 ~~Y~i~~~lG~G~~g~V~~a~~~~~------~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~   82 (336)
T 3h4j_B            9 GPYIIRETLGEGSFGKVKLATHYKT------QQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPT   82 (336)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTT------CCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred             CCEEEEEEEecCCCeEEEEEEECCC------CCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCC
Confidence            5689999999999999999998765      6779999986421   122357889999999999999999999999999


Q ss_pred             eEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCccC
Q 046893          169 HRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKD  248 (464)
Q Consensus       169 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~  248 (464)
                      ..++||||+ +|+|.+++....  .+++..+..++.|++.||.|||  ..+|+||||||+|||++.++.+||+|||++..
T Consensus        83 ~~~lv~E~~-~g~l~~~l~~~~--~l~~~~~~~i~~qi~~aL~~LH--~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~  157 (336)
T 3h4j_B           83 DIVMVIEYA-GGELFDYIVEKK--RMTEDEGRRFFQQIICAIEYCH--RHKIVHRDLKPENLLLDDNLNVKIADFGLSNI  157 (336)
T ss_dssp             EEEEEECCC-CEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHH--HHTCCCCCCSTTTEEECTTCCEEECCSSCTBT
T ss_pred             EEEEEEECC-CCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH--HCCeEecCCchhhEEEcCCCCEEEEEecccee
Confidence            999999999 789999887654  6999999999999999999999  56799999999999999999999999999986


Q ss_pred             CCCCCCcceeeccccCCcccCccccccCCC-CcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhcccchh
Q 046893          249 GPMGDQTHVSTRVMGTYGYAAPEYVMTGHL-TARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVL  327 (464)
Q Consensus       249 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  327 (464)
                      .....   .....+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.........                 
T Consensus       158 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~-----------------  217 (336)
T 3h4j_B          158 MTDGN---FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLF-----------------  217 (336)
T ss_dssp             TTTSB---TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCB-----------------
T ss_pred             ccCCc---ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHH-----------------
Confidence            43322   2234689999999999988776 68999999999999999999999764321110                 


Q ss_pred             hccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 046893          328 RILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVA  369 (464)
Q Consensus       328 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  369 (464)
                      ..+.. .....+...+..+.+|+.+||..||.+|||+.++++
T Consensus       218 ~~i~~-~~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~  258 (336)
T 3h4j_B          218 KKVNS-CVYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRR  258 (336)
T ss_dssp             CCCCS-SCCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTT
T ss_pred             HHHHc-CCCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence            00000 011123334568899999999999999999999875

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=5.2e-46  Score=365.61  Aligned_cols=271  Identities=23%  Similarity=0.342  Sum_probs=215.0

Q ss_pred             HHhcCCCCCCceeecCceEEEEEEecCCCC-CCccceEEEEEEccCCCCc-cHHHHHHHHHHHhcC-CCCCcceEEEEEE
Q 046893           89 LATKFFRPDYILGEGGFGVVYKGVIDENVR-PGYKTTFVAIKELNRGGYQ-GDREWLAEVNYLGQL-RHSNLVKLIGYCC  165 (464)
Q Consensus        89 ~~~~~~~~~~~lG~G~fg~Vy~a~~~~~~~-~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l-~hpniv~l~~~~~  165 (464)
                      +..++|++.+.||+|+||.||+|.+..... ....+..||||++...... ....+.+|+.+++.+ +||||+++++++.
T Consensus        32 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~  111 (334)
T 2pvf_A           32 FPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT  111 (334)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             CCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEc
Confidence            345678999999999999999999764221 1124667999999765332 236688999999999 8999999999999


Q ss_pred             eCCeEEEEEeccCCCCHHHHHHhhcC--------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceE
Q 046893          166 EDEHRILVYEYMESGSLEKHLLRRVG--------------CMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNIL  231 (464)
Q Consensus       166 ~~~~~~lv~e~~~~g~L~~~l~~~~~--------------~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nil  231 (464)
                      ..+..++||||+.+|+|.+++.....              ..+++..++.++.|++.||.|||  ..+|+||||||+|||
T Consensus       112 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH--~~~ivH~Dlkp~NIl  189 (334)
T 2pvf_A          112 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA--SQKCIHRDLAARNVL  189 (334)
T ss_dssp             SSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGEE
T ss_pred             cCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH--hCCeeCCCCccceEE
Confidence            99999999999999999999976431              24899999999999999999999  567999999999999


Q ss_pred             ecCCCceEEcccCCccCCCCCCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHh-CCCCCCCCCCcccc
Q 046893          232 LNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLL-GRRAVDKSRPSREH  310 (464)
Q Consensus       232 l~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~  310 (464)
                      ++.++.+||+|||+++...............+|+.|+|||++.+..++.++||||||+++|+|++ |..||.+....   
T Consensus       190 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~---  266 (334)
T 2pvf_A          190 VTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE---  266 (334)
T ss_dssp             ECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHH---
T ss_pred             EcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHH---
Confidence            99999999999999986544333233334567889999999999899999999999999999999 99999764321   


Q ss_pred             cHHHHHHHhhhcccchhhccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhcC
Q 046893          311 NLVEWARPLLNNNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETVQSQG  378 (464)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~~~~~  378 (464)
                         +........           .....+..++..+.+|+.+||..||.+||++.++++.|+.+....
T Consensus       267 ---~~~~~~~~~-----------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~~  320 (334)
T 2pvf_A          267 ---ELFKLLKEG-----------HRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLT  320 (334)
T ss_dssp             ---HHHHHHHHT-----------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             ---HHHHHHhcC-----------CCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhcc
Confidence               111111111           011122334568999999999999999999999999999987644

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=2.8e-46  Score=365.28  Aligned_cols=277  Identities=25%  Similarity=0.380  Sum_probs=218.2

Q ss_pred             cchhHHHHHhcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCc-cHHHHHHHHHHHhcCCCCCcceE
Q 046893           82 FTYNEMKLATKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQ-GDREWLAEVNYLGQLRHSNLVKL  160 (464)
Q Consensus        82 ~~~~~~~~~~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l  160 (464)
                      +...++.+..++|++.+.||+|+||.||+|.+.... ....+..||||++...... ....+.+|+.+++.++||||+++
T Consensus        15 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~-~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~   93 (322)
T 1p4o_A           15 YVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVV-KDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRL   93 (322)
T ss_dssp             CCCCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEE-TTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCE
T ss_pred             cChhhhcchhhheeeeeEeccCCceEEEeeeecCcc-CCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeee
Confidence            344455667788999999999999999999876311 1123678999999754332 23568899999999999999999


Q ss_pred             EEEEEeCCeEEEEEeccCCCCHHHHHHhhc--------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEe
Q 046893          161 IGYCCEDEHRILVYEYMESGSLEKHLLRRV--------GCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILL  232 (464)
Q Consensus       161 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~--------~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill  232 (464)
                      ++++...+..++||||+.+|+|.+++....        ...+++..++.++.|++.||.|||  .++|+||||||+|||+
T Consensus        94 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH--~~~i~H~dikp~NIli  171 (322)
T 1p4o_A           94 LGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLN--ANKFVHRDLAARNCMV  171 (322)
T ss_dssp             EEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHH--HTTCBCSCCSGGGEEE
T ss_pred             EEEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHH--HCCCccCCCccceEEE
Confidence            999999999999999999999999987532        135799999999999999999999  5679999999999999


Q ss_pred             cCCCceEEcccCCccCCCCCCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHh-CCCCCCCCCCccccc
Q 046893          233 NADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLL-GRRAVDKSRPSREHN  311 (464)
Q Consensus       233 ~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~  311 (464)
                      +.++.+||+|||+++...............||+.|+|||++.+..++.++||||||+++|+|++ |..||......    
T Consensus       172 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~----  247 (322)
T 1p4o_A          172 AEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE----  247 (322)
T ss_dssp             CTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHH----
T ss_pred             cCCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHH----
Confidence            9999999999999985432222222333567899999999999999999999999999999999 88998764321    


Q ss_pred             HHHHHHHhhhcccchhhccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhcC
Q 046893          312 LVEWARPLLNNNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETVQSQG  378 (464)
Q Consensus       312 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~~~~~  378 (464)
                        +.........           ....+..++..+.+|+.+||+.||.+||++.++++.|+.+....
T Consensus       248 --~~~~~~~~~~-----------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~~~  301 (322)
T 1p4o_A          248 --QVLRFVMEGG-----------LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPG  301 (322)
T ss_dssp             --HHHHHHHTTC-----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTT
T ss_pred             --HHHHHHHcCC-----------cCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhccC
Confidence              1111111110           01122334568999999999999999999999999998776543

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=2.5e-45  Score=352.65  Aligned_cols=253  Identities=28%  Similarity=0.514  Sum_probs=203.0

Q ss_pred             cCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCccH-------HHHHHHHHHHhcCCCCCcceEEEEE
Q 046893           92 KFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGD-------REWLAEVNYLGQLRHSNLVKLIGYC  164 (464)
Q Consensus        92 ~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~-------~~~~~E~~~l~~l~hpniv~l~~~~  164 (464)
                      ++|++.+.||+|+||+||+|.+..+      ++.||+|++........       +.+.+|+.+++.++||||+++++++
T Consensus        19 ~~y~~~~~lg~G~~g~V~~~~~~~~------~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~   92 (287)
T 4f0f_A           19 NEIEYEKQIGKGGFGLVHKGRLVKD------KSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLM   92 (287)
T ss_dssp             TTEEEEEECCCCSSSCEEEEEETTT------CCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred             ccceehhccccCCceeEEEEEEcCC------ceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheee
Confidence            5688889999999999999998765      66799999865433221       5788999999999999999999998


Q ss_pred             EeCCeEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCC--eeeccCCCCceEecCCCc-----
Q 046893          165 CEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERP--VIYRDFKTSNILLNADFS-----  237 (464)
Q Consensus       165 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~--ivHrDlkp~Nill~~~~~-----  237 (464)
                      .+..  ++||||+.+++|.+++... ...+++..++.++.|++.||.|||  ..+  |+||||||+|||++.++.     
T Consensus        93 ~~~~--~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~l~~~l~~lH--~~~~~ivH~dikp~Nil~~~~~~~~~~~  167 (287)
T 4f0f_A           93 HNPP--RMVMEFVPCGDLYHRLLDK-AHPIKWSVKLRLMLDIALGIEYMQ--NQNPPIVHRDLRSPNIFLQSLDENAPVC  167 (287)
T ss_dssp             TTTT--EEEEECCTTCBHHHHHHCT-TSCCCHHHHHHHHHHHHHHHHHHH--TSSSCCBCSCCSGGGEEESCCCTTCSCC
T ss_pred             cCCC--eEEEEecCCCCHHHHHhcc-cCCccHHHHHHHHHHHHHHHHHHH--hCCCCeecCCCCcceEEEeccCCCCcee
Confidence            6655  6999999999999988664 346999999999999999999999  556  999999999999987776     


Q ss_pred             eEEcccCCccCCCCCCCcceeeccccCCcccCccccc--cCCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHH
Q 046893          238 AKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVM--TGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEW  315 (464)
Q Consensus       238 vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~  315 (464)
                      +||+|||+++....     ......||+.|+|||++.  ...++.++|||||||++|+|++|+.||........    .+
T Consensus       168 ~kl~Dfg~~~~~~~-----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~----~~  238 (287)
T 4f0f_A          168 AKVADFGLSQQSVH-----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKI----KF  238 (287)
T ss_dssp             EEECCCTTCBCCSS-----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHH----HH
T ss_pred             EEeCCCCccccccc-----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHH----HH
Confidence            99999999985322     233468999999999984  45678999999999999999999999976543211    11


Q ss_pred             HHHhhhcccchhhccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHH
Q 046893          316 ARPLLNNNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETV  374 (464)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~  374 (464)
                      .....          ........+..++..+.+|+.+||+.||.+||++.++++.|+.+
T Consensus       239 ~~~~~----------~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l  287 (287)
T 4f0f_A          239 INMIR----------EEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL  287 (287)
T ss_dssp             HHHHH----------HSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred             HHHHh----------ccCCCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence            11111          11111223334556899999999999999999999999998753

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=3.3e-46  Score=382.10  Aligned_cols=262  Identities=29%  Similarity=0.432  Sum_probs=208.6

Q ss_pred             HHHHhcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCccHHHHHHHHHHHhcCCCCCcceEEEEEEe
Q 046893           87 MKLATKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVKLIGYCCE  166 (464)
Q Consensus        87 ~~~~~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~  166 (464)
                      +.+..++|++.+.||+|+||.||+|.+..       +..||||++.... ...+.|.+|+.+|+.++||||+++++++.+
T Consensus       179 ~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~-------~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~  250 (452)
T 1fmk_A          179 WEIPRESLRLEVKLGQGCFGEVWMGTWNG-------TTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE  250 (452)
T ss_dssp             SBCCGGGEEEEEEEEECSSCEEEEEEETT-------TEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             cccChhHceeeeeecCCCCeEEEEEEECC-------CceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC
Confidence            34456778899999999999999999865       3459999997653 345789999999999999999999999876


Q ss_pred             CCeEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCc
Q 046893          167 DEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLA  246 (464)
Q Consensus       167 ~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla  246 (464)
                       +..+|||||+.+|+|.+++....+..+++..++.++.|++.||.|||  .++|+||||||+|||++.++.+||+|||++
T Consensus       251 -~~~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH--~~~ivHrDlkp~Nill~~~~~~kl~DfG~a  327 (452)
T 1fmk_A          251 -EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE--RMNYVHRDLRAANILVGENLVCKVADFGLA  327 (452)
T ss_dssp             -SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCSGGGEEECGGGCEEECCCCTT
T ss_pred             -CceEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH--hCCeeCCCCChhhEEECCCCCEEECCCccc
Confidence             67899999999999999997654556999999999999999999999  567999999999999999999999999999


Q ss_pred             cCCCCCCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHhhhcccc
Q 046893          247 KDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLL-GRRAVDKSRPSREHNLVEWARPLLNNNKK  325 (464)
Q Consensus       247 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  325 (464)
                      +....... .......++..|+|||++.+..++.++|||||||+||||++ |+.||.+....      +...... .   
T Consensus       328 ~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~------~~~~~i~-~---  396 (452)
T 1fmk_A          328 RLIEDNEY-TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR------EVLDQVE-R---  396 (452)
T ss_dssp             C---------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH------HHHHHHH-T---
T ss_pred             eecCCCce-ecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHH------HHHHHHH-c---
Confidence            86433221 12233557889999999999999999999999999999999 99999764321      1111111 1   


Q ss_pred             hhhccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhc
Q 046893          326 VLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETVQSQ  377 (464)
Q Consensus       326 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~~~~  377 (464)
                             ......+..++..+.+||.+||+.||.+|||+.+|++.|+.+...
T Consensus       397 -------~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~  441 (452)
T 1fmk_A          397 -------GYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS  441 (452)
T ss_dssp             -------TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred             -------CCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhcc
Confidence                   111122334566899999999999999999999999999987543

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=8.9e-46  Score=356.44  Aligned_cols=263  Identities=27%  Similarity=0.466  Sum_probs=196.4

Q ss_pred             HHhcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCcc--HHHHHHHHHHHhcCCCCCcceEEEEEEe
Q 046893           89 LATKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQG--DREWLAEVNYLGQLRHSNLVKLIGYCCE  166 (464)
Q Consensus        89 ~~~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~hpniv~l~~~~~~  166 (464)
                      +..++|++.+.||+|+||+||+|.+..         .||+|++.......  ...+.+|+.+|+.++||||+++++++ .
T Consensus        21 i~~~~y~~~~~lG~G~~g~Vy~~~~~~---------~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~   90 (289)
T 3og7_A           21 IPDGQITVGQRIGSGSFGTVYKGKWHG---------DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-T   90 (289)
T ss_dssp             CCTTSCEEEEEEEECSSEEEEEEESSS---------EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-C
T ss_pred             cCccceeeeeEecCCCCeEEEEEEEcC---------ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-c
Confidence            345679999999999999999998643         28999987554332  36688999999999999999999965 5


Q ss_pred             CCeEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCc
Q 046893          167 DEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLA  246 (464)
Q Consensus       167 ~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla  246 (464)
                      ....++||||+.+++|.+++... ...+++..++.++.|++.||.|||  ..+|+||||||+|||++.++.+||+|||++
T Consensus        91 ~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~L~~lH--~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~  167 (289)
T 3og7_A           91 APQLAIVTQWCEGSSLYHHLHAS-ETKFEMKKLIDIARQTARGMDYLH--AKSIIHRDLKSNNIFLHEDNTVKIGDFGLA  167 (289)
T ss_dssp             SSSCEEEEECCCEEEHHHHHTTC----CCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCCGGGEEEETTTEEEECCCC--
T ss_pred             CCccEEEEEecCCCcHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHH--hCCcccccCccceEEECCCCCEEEccceec
Confidence            56789999999999999988654 346999999999999999999999  567999999999999999999999999999


Q ss_pred             cCCCCCCCcceeeccccCCcccCccccc---cCCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhcc
Q 046893          247 KDGPMGDQTHVSTRVMGTYGYAAPEYVM---TGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNN  323 (464)
Q Consensus       247 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~  323 (464)
                      +...............||+.|+|||++.   +..++.++||||||+++|+|++|+.||.......  .+....    ...
T Consensus       168 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~--~~~~~~----~~~  241 (289)
T 3og7_A          168 TEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD--QIIEMV----GRG  241 (289)
T ss_dssp             ----------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHH--HHHHHH----HHT
T ss_pred             cccccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHH--HHHHHh----ccc
Confidence            8644322233334467999999999986   5678899999999999999999999997643221  111111    110


Q ss_pred             cchhhccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHh
Q 046893          324 KKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETVQS  376 (464)
Q Consensus       324 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~~~  376 (464)
                           ...+. .......++..+.+|+.+||+.||.+||++.++++.|+.+..
T Consensus       242 -----~~~~~-~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~  288 (289)
T 3og7_A          242 -----SLSPD-LSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR  288 (289)
T ss_dssp             -----SCCCC-TTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred             -----ccCcc-hhhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence                 00111 111223445689999999999999999999999999998753

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=9.1e-46  Score=357.88  Aligned_cols=250  Identities=24%  Similarity=0.342  Sum_probs=195.8

Q ss_pred             hcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCc--------------------------cHHHHHH
Q 046893           91 TKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQ--------------------------GDREWLA  144 (464)
Q Consensus        91 ~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~--------------------------~~~~~~~  144 (464)
                      .++|++.+.||+|+||.||+|.+..+      ++.||||++......                          ..+.+.+
T Consensus        12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~------~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   85 (298)
T 2zv2_A           12 LNQYTLKDEIGKGSYGVVKLAYNEND------NTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQ   85 (298)
T ss_dssp             ETTEEEEEEEEC--CCEEEEEEETTT------TEEEEEEEEECC-------------------------------CHHHH
T ss_pred             ecceEEEeEEeecCCEEEEEEEECCC------CcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHH
Confidence            35688999999999999999998765      678999998754321                          1245789


Q ss_pred             HHHHHhcCCCCCcceEEEEEEe--CCeEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeee
Q 046893          145 EVNYLGQLRHSNLVKLIGYCCE--DEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIY  222 (464)
Q Consensus       145 E~~~l~~l~hpniv~l~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivH  222 (464)
                      |+.+|+.++||||+++++++..  ....++||||+++++|.+++.   ...+++..++.++.|++.||.|||  ..+|+|
T Consensus        86 E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH--~~~ivH  160 (298)
T 2zv2_A           86 EIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT---LKPLSEDQARFYFQDLIKGIEYLH--YQKIIH  160 (298)
T ss_dssp             HHHHHHTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC---SSCCCHHHHHHHHHHHHHHHHHHH--HTTEEC
T ss_pred             HHHHHHhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHH--HCCeec
Confidence            9999999999999999999987  568999999999999977543   236999999999999999999999  567999


Q ss_pred             ccCCCCceEecCCCceEEcccCCccCCCCCCCcceeeccccCCcccCccccccCC---CCcccchhcHHHHHHHHHhCCC
Q 046893          223 RDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGH---LTARSDVYGFGVVLLEMLLGRR  299 (464)
Q Consensus       223 rDlkp~Nill~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~DvwslG~il~ell~g~~  299 (464)
                      |||||+|||++.++.+||+|||+++......  .......||+.|+|||++.+..   ++.++|||||||++|+|++|+.
T Consensus       161 ~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~  238 (298)
T 2zv2_A          161 RDIKPSNLLVGEDGHIKIADFGVSNEFKGSD--ALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQC  238 (298)
T ss_dssp             CCCCGGGEEECTTSCEEECCCTTCEECSSSS--CEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSC
T ss_pred             cCCCHHHEEECCCCCEEEecCCCcccccccc--ccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCC
Confidence            9999999999999999999999998643322  2234468999999999987765   4778999999999999999999


Q ss_pred             CCCCCCCcccccHHHHHHHhhhcccchhhccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 046893          300 AVDKSRPSREHNLVEWARPLLNNNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVA  369 (464)
Q Consensus       300 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  369 (464)
                      ||.....      ..+.........      ..    ......+..+.+||.+||+.||.+||++.++++
T Consensus       239 pf~~~~~------~~~~~~~~~~~~------~~----~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~  292 (298)
T 2zv2_A          239 PFMDERI------MCLHSKIKSQAL------EF----PDQPDIAEDLKDLITRMLDKNPESRIVVPEIKL  292 (298)
T ss_dssp             SSCCSSH------HHHHHHHHHCCC------CC----CSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             CCCCccH------HHHHHHHhcccC------CC----CCccccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence            9976431      111111111100      00    011123457899999999999999999999864

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=1.7e-45  Score=350.07  Aligned_cols=255  Identities=23%  Similarity=0.328  Sum_probs=206.0

Q ss_pred             hcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCc--cHHHHHHHHHHHhcCCCCCcceEEEEEEeC-
Q 046893           91 TKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQ--GDREWLAEVNYLGQLRHSNLVKLIGYCCED-  167 (464)
Q Consensus        91 ~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpniv~l~~~~~~~-  167 (464)
                      .++|++.+.||+|+||.||+|.+.        ++.||||++......  ..+.+.+|+.+++.++||||+++++++... 
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~--------~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   80 (271)
T 3kmu_A            9 FKQLNFLTKLNENHSGELWKGRWQ--------GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPP   80 (271)
T ss_dssp             GGGCEEEEEEEEETTEEEEEEEET--------TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTT
T ss_pred             HHHhHHHHHhcCCCcceEEEEEEC--------CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCC
Confidence            356888999999999999999874        456999998765433  235789999999999999999999999887 


Q ss_pred             -CeEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCc
Q 046893          168 -EHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLA  246 (464)
Q Consensus       168 -~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla  246 (464)
                       ...++||||+++|+|.+++.......+++..++.++.|++.||.|||+.+..|+||||||+|||++.++.++|+|||++
T Consensus        81 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~  160 (271)
T 3kmu_A           81 APHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVK  160 (271)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGGGSC
T ss_pred             CCCeEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEeccce
Confidence             7889999999999999999876555699999999999999999999943333999999999999999999999998887


Q ss_pred             cCCCCCCCcceeeccccCCcccCccccccCCCCc---ccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhcc
Q 046893          247 KDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTA---RSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNN  323 (464)
Q Consensus       247 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~---~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~  323 (464)
                      .....       ....||+.|+|||++.+..++.   ++||||||+++|||++|+.||......      ........  
T Consensus       161 ~~~~~-------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~------~~~~~~~~--  225 (271)
T 3kmu_A          161 FSFQS-------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNM------EIGMKVAL--  225 (271)
T ss_dssp             CTTSC-------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHH------HHHHHHHH--
T ss_pred             eeecc-------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChH------HHHHHHHh--
Confidence            54221       2357899999999998765554   799999999999999999999764321      11111111  


Q ss_pred             cchhhccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHh
Q 046893          324 KKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETVQS  376 (464)
Q Consensus       324 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~~~  376 (464)
                              .......+..++..+.+|+.+||+.||.+|||+.++++.|+.+..
T Consensus       226 --------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~  270 (271)
T 3kmu_A          226 --------EGLRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD  270 (271)
T ss_dssp             --------SCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred             --------cCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence                    111112233455689999999999999999999999999998753

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=3.8e-45  Score=352.45  Aligned_cols=265  Identities=23%  Similarity=0.298  Sum_probs=201.3

Q ss_pred             cCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCc--cHHHHHHHHHHHhcCCCCCcceEEEEEEeCCe
Q 046893           92 KFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQ--GDREWLAEVNYLGQLRHSNLVKLIGYCCEDEH  169 (464)
Q Consensus        92 ~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~  169 (464)
                      ++|++.+.||+|+||+||+|.+..+      ++.||+|++......  ....+.+|+.+++.++||||+++++++.+.+.
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   75 (292)
T 3o0g_A            2 QKYEKLEKIGEGTYGTVFKAKNRET------HEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKK   75 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTT------CCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTE
T ss_pred             CCceeeeEecCCCCeEEEEEEECCC------CceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCE
Confidence            4688899999999999999998765      677999998754432  23678899999999999999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCccCC
Q 046893          170 RILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDG  249 (464)
Q Consensus       170 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~  249 (464)
                      .++||||+.+ +|.+++... ...+++..+..++.|++.||.|||  .++|+||||||+|||++.++.+||+|||+++..
T Consensus        76 ~~lv~e~~~~-~l~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lH--~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~  151 (292)
T 3o0g_A           76 LTLVFEFCDQ-DLKKYFDSC-NGDLDPEIVKSFLFQLLKGLGFCH--SRNVLHRDLKPQNLLINRNGELKLANFGLARAF  151 (292)
T ss_dssp             EEEEEECCSE-EHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred             EEEEEecCCC-CHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHH--hCCeecCCCCHHHEEEcCCCCEEEeecccceec
Confidence            9999999975 666666543 346999999999999999999999  567999999999999999999999999999864


Q ss_pred             CCCCCcceeeccccCCcccCccccccCC-CCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhccc----
Q 046893          250 PMGDQTHVSTRVMGTYGYAAPEYVMTGH-LTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNK----  324 (464)
Q Consensus       250 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~----  324 (464)
                      ...  ........||..|+|||++.+.. ++.++|||||||++|+|++|..||........ .+............    
T Consensus       152 ~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~-~~~~i~~~~~~~~~~~~~  228 (292)
T 3o0g_A          152 GIP--VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDD-QLKRIFRLLGTPTEEQWP  228 (292)
T ss_dssp             CSC--CSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHH-HHHHHHHHHCCCCTTTCT
T ss_pred             CCc--cccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHH-HHHHHHHHhCCCChhhhh
Confidence            322  22234467999999999998765 89999999999999999999888654332111 11111110000000    


Q ss_pred             chhhccC---------ccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 046893          325 KVLRILD---------PRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVA  369 (464)
Q Consensus       325 ~~~~~~~---------~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  369 (464)
                      ......+         ...........+..+.+|+.+||+.||.+|||+.++++
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  282 (292)
T 3o0g_A          229 SMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ  282 (292)
T ss_dssp             TGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             hhcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence            0000000         00001112234568899999999999999999999874

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=1.7e-45  Score=368.69  Aligned_cols=253  Identities=21%  Similarity=0.282  Sum_probs=206.3

Q ss_pred             hcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCccHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeE
Q 046893           91 TKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVKLIGYCCEDEHR  170 (464)
Q Consensus        91 ~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~  170 (464)
                      .++|++.+.||+|+||.||+|.+..+      ++.||+|++..........+.+|+.+|+.++||||+++++++.+....
T Consensus        50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~------~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~  123 (387)
T 1kob_A           50 YDYYDILEELGSGAFGVVHRCVEKAT------GRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEM  123 (387)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTT------CCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEE
T ss_pred             ccceEEEEEEecCCCEEEEEEEECCC------CCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEE
Confidence            35799999999999999999998765      667999999765444456788999999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecC--CCceEEcccCCccC
Q 046893          171 ILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNA--DFSAKLSDFGLAKD  248 (464)
Q Consensus       171 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~--~~~vkl~DFGla~~  248 (464)
                      +|||||+.+|+|.+++... +..+++..++.++.||+.||.|||  ..+|+||||||+|||++.  ++.+||+|||+++.
T Consensus       124 ~lv~E~~~gg~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH--~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~  200 (387)
T 1kob_A          124 VLILEFLSGGELFDRIAAE-DYKMSEAEVINYMRQACEGLKHMH--EHSIVHLDIKPENIMCETKKASSVKIIDFGLATK  200 (387)
T ss_dssp             EEEEECCCCCBHHHHTTCT-TCCBCHHHHHHHHHHHHHHHHHHH--HTTEECCCCCGGGEEESSTTCCCEEECCCTTCEE
T ss_pred             EEEEEcCCCCcHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHH--hCCeeecccchHHeEEecCCCCceEEEeccccee
Confidence            9999999999999988654 346899999999999999999999  567999999999999974  47799999999986


Q ss_pred             CCCCCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhcccchhh
Q 046893          249 GPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLR  328 (464)
Q Consensus       249 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  328 (464)
                      .....   ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+....      +.........     
T Consensus       201 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~------~~~~~i~~~~-----  266 (387)
T 1kob_A          201 LNPDE---IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL------ETLQNVKRCD-----  266 (387)
T ss_dssp             CCTTS---CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH------HHHHHHHHCC-----
T ss_pred             cCCCc---ceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHH------HHHHHHHhCC-----
Confidence            53322   223457999999999999999999999999999999999999999764321      1111111110     


Q ss_pred             ccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 046893          329 ILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVA  369 (464)
Q Consensus       329 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  369 (464)
                         ...........+..+.+||.+||..||.+||++.++++
T Consensus       267 ---~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~  304 (387)
T 1kob_A          267 ---WEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE  304 (387)
T ss_dssp             ---CCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             ---CCCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence               01111122234558899999999999999999999875

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=9.6e-46  Score=360.21  Aligned_cols=276  Identities=25%  Similarity=0.358  Sum_probs=218.1

Q ss_pred             chhHHHHHhcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCc-cHHHHHHHHHHHhcC-CCCCcceE
Q 046893           83 TYNEMKLATKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQ-GDREWLAEVNYLGQL-RHSNLVKL  160 (464)
Q Consensus        83 ~~~~~~~~~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l-~hpniv~l  160 (464)
                      ....+.+..++|++.+.||+|+||+||+|.+... .....++.||||++...... ....+.+|+.++..+ +||||+++
T Consensus        18 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~-~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~   96 (316)
T 2xir_A           18 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGI-DKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL   96 (316)
T ss_dssp             CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESS-SSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             cccceecchhheeeeeEEcCCCceeEEEEEEecC-CccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeE
Confidence            3445566778899999999999999999986532 11234788999999765432 235688999999999 79999999


Q ss_pred             EEEEEeCC-eEEEEEeccCCCCHHHHHHhhcC--------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccC
Q 046893          161 IGYCCEDE-HRILVYEYMESGSLEKHLLRRVG--------------CMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDF  225 (464)
Q Consensus       161 ~~~~~~~~-~~~lv~e~~~~g~L~~~l~~~~~--------------~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDl  225 (464)
                      ++++...+ ..++||||+.+++|.+++.....              ..+++..++.++.|++.||.|||  ..+|+||||
T Consensus        97 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH--~~~i~H~di  174 (316)
T 2xir_A           97 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA--SRKCIHRDL  174 (316)
T ss_dssp             EEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHH--HTTCCCSCC
T ss_pred             EEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHH--hCCcccccC
Confidence            99987754 58999999999999999976532              12889999999999999999999  567999999


Q ss_pred             CCCceEecCCCceEEcccCCccCCCCCCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHh-CCCCCCCC
Q 046893          226 KTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLL-GRRAVDKS  304 (464)
Q Consensus       226 kp~Nill~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~  304 (464)
                      ||+|||++.++.+||+|||+++...............||+.|+|||++.+..++.++||||||+++|+|++ |..||...
T Consensus       175 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~  254 (316)
T 2xir_A          175 AARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV  254 (316)
T ss_dssp             SGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred             ccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCccc
Confidence            99999999999999999999986544333333444678999999999999999999999999999999998 99999765


Q ss_pred             CCcccccHHHHHHHhhhcccchhhccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhc
Q 046893          305 RPSREHNLVEWARPLLNNNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETVQSQ  377 (464)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~~~~  377 (464)
                      .....  +...   ....           .....+..++..+.+++.+||+.||.+||++.++++.|+.+...
T Consensus       255 ~~~~~--~~~~---~~~~-----------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~  311 (316)
T 2xir_A          255 KIDEE--FCRR---LKEG-----------TRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA  311 (316)
T ss_dssp             CCSHH--HHHH---HHHT-----------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             chhHH--HHHH---hccC-----------ccCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhh
Confidence            42211  1111   1100           00111223445899999999999999999999999999987653

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=2.7e-45  Score=357.01  Aligned_cols=263  Identities=24%  Similarity=0.334  Sum_probs=199.3

Q ss_pred             hcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCc--cHHHHHHHHHHHhcCCCCCcceEEEEEEeCC
Q 046893           91 TKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQ--GDREWLAEVNYLGQLRHSNLVKLIGYCCEDE  168 (464)
Q Consensus        91 ~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~  168 (464)
                      .++|++.+.||+|+||+||+|.+..       ++.||+|++......  ....+.+|+.+|+.++||||+++++++...+
T Consensus        20 ~~~y~~~~~lG~G~~g~V~~~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~   92 (311)
T 3niz_A           20 MEKYQKLEKVGEGTYGVVYKAKDSQ-------GRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSER   92 (311)
T ss_dssp             SCEEEEEEEEEECSSCEEEEEEETT-------SCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSS
T ss_pred             HhhhHhhhhccCCCCeEEEEEEECC-------CCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCC
Confidence            3568899999999999999998743       567999998754322  2367889999999999999999999999999


Q ss_pred             eEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCccC
Q 046893          169 HRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKD  248 (464)
Q Consensus       169 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~  248 (464)
                      ..++||||+.+ +|.+++... ...+++..+..++.|++.||.|||  +.+|+||||||+|||++.++.+||+|||+++.
T Consensus        93 ~~~lv~e~~~~-~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~LH--~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~  168 (311)
T 3niz_A           93 CLTLVFEFMEK-DLKKVLDEN-KTGLQDSQIKIYLYQLLRGVAHCH--QHRILHRDLKPQNLLINSDGALKLADFGLARA  168 (311)
T ss_dssp             CEEEEEECCSE-EHHHHHHTC-TTCCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             EEEEEEcCCCC-CHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHH--HCCcccCCCchHhEEECCCCCEEEccCcCcee
Confidence            99999999975 888887654 346999999999999999999999  56799999999999999999999999999986


Q ss_pred             CCCCCCcceeeccccCCcccCcccccc-CCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhcc-c-c
Q 046893          249 GPMGDQTHVSTRVMGTYGYAAPEYVMT-GHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNN-K-K  325 (464)
Q Consensus       249 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~-~-~  325 (464)
                      .....  .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.......  .... ..+... . .
T Consensus       169 ~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~--~~i~-~~~~~~~~~~  243 (311)
T 3niz_A          169 FGIPV--RSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQL--PKIF-SILGTPNPRE  243 (311)
T ss_dssp             TTSCC--C---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHH--HHHH-HHHCCCCTTT
T ss_pred             cCCCc--ccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHH--HHHH-HHHCCCChHH
Confidence            43221  22334678999999999876 56899999999999999999999999865433221  1111 111000 0 0


Q ss_pred             h-------------hhccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 046893          326 V-------------LRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVA  369 (464)
Q Consensus       326 ~-------------~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  369 (464)
                      .             ................+.++.+||.+||+.||.+|||+.++++
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  300 (311)
T 3niz_A          244 WPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN  300 (311)
T ss_dssp             SGGGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             hhhhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence            0             0000000001111223457889999999999999999999875

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=1.5e-45  Score=353.54  Aligned_cols=259  Identities=25%  Similarity=0.377  Sum_probs=207.5

Q ss_pred             HHhcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCccHHHHHHHHHHHhcCCCCCcceEEEEEEeCC
Q 046893           89 LATKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVKLIGYCCEDE  168 (464)
Q Consensus        89 ~~~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~  168 (464)
                      +..++|++.+.||+|+||.||+|.+..       +..||+|++.... ....++.+|++++..++||||+++++++...+
T Consensus        21 ~~~~~y~~~~~lg~G~~g~V~~~~~~~-------~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~   92 (283)
T 3gen_A           21 IDPKDLTFLKELGTGQFGVVKYGKWRG-------QYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQR   92 (283)
T ss_dssp             CCGGGEEEEEECC---CEEEEEEEETT-------TEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred             CCHHHHHhHhhcCCCCCceEEEEEEcC-------CCeEEEEEecCCC-CCHHHHHHHHHHHhcCCCCCEeeEEEEEecCC
Confidence            345678899999999999999998764       4569999997653 34577899999999999999999999999999


Q ss_pred             eEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCccC
Q 046893          169 HRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKD  248 (464)
Q Consensus       169 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~  248 (464)
                      ..++||||+.+++|.+++.... ..+++..++.++.|++.||.|||  .++|+||||||+|||++.++.+||+|||+++.
T Consensus        93 ~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH--~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~  169 (283)
T 3gen_A           93 PIFIITEYMANGCLLNYLREMR-HRFQTQQLLEMCKDVCEAMEYLE--SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRY  169 (283)
T ss_dssp             SEEEEECCCTTCBHHHHHHCGG-GCCCHHHHHHHHHHHHHHHHHHH--HTTCCCSSCSGGGEEECTTSCEEECSTTGGGG
T ss_pred             CeEEEEeccCCCcHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHH--HCCccCCCCccceEEEcCCCCEEEcccccccc
Confidence            9999999999999999987632 35999999999999999999999  56799999999999999999999999999985


Q ss_pred             CCCCCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHhhhcccchh
Q 046893          249 GPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLL-GRRAVDKSRPSREHNLVEWARPLLNNNKKVL  327 (464)
Q Consensus       249 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  327 (464)
                      ..... ........||+.|+|||++.+..++.++||||||+++|+|++ |+.||......      +........     
T Consensus       170 ~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~------~~~~~~~~~-----  237 (283)
T 3gen_A          170 VLDDE-YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS------ETAEHIAQG-----  237 (283)
T ss_dssp             BCCHH-HHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHH------HHHHHHHTT-----
T ss_pred             ccccc-cccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChh------HHHHHHhcc-----
Confidence            43221 111223457788999999999999999999999999999998 99999764421      111111111     


Q ss_pred             hccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHh
Q 046893          328 RILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETVQS  376 (464)
Q Consensus       328 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~~~  376 (464)
                            .....+...+..+.+|+.+||+.||.+||++.++++.|+.+..
T Consensus       238 ------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~  280 (283)
T 3gen_A          238 ------LRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMD  280 (283)
T ss_dssp             ------CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ------cCCCCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhh
Confidence                  1111122234588999999999999999999999999998764

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=2.7e-45  Score=356.94  Aligned_cols=269  Identities=24%  Similarity=0.396  Sum_probs=203.4

Q ss_pred             HHHHhcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCc--cHHHHHHHHHHHhcCCCCCcceEEEEE
Q 046893           87 MKLATKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQ--GDREWLAEVNYLGQLRHSNLVKLIGYC  164 (464)
Q Consensus        87 ~~~~~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpniv~l~~~~  164 (464)
                      +.+..++|.+.+.||+|+||.||+|.+.....   .+..||+|++......  ....+.+|+.+++.++||||+++++++
T Consensus        29 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~  105 (313)
T 3brb_A           29 VVIDRNLLILGKILGEGEFGSVMEGNLKQEDG---TSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVC  105 (313)
T ss_dssp             TBCCGGGEEEEEEEEC-CCCCEEEEEEECTTS---CEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEE
T ss_pred             cccCHHHeeeccceeecCCeEEEEEEEeccCC---ceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEE
Confidence            34456779999999999999999998765322   3668999998765332  235688999999999999999999999


Q ss_pred             EeCC-----eEEEEEeccCCCCHHHHHHhh----cCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCC
Q 046893          165 CEDE-----HRILVYEYMESGSLEKHLLRR----VGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNAD  235 (464)
Q Consensus       165 ~~~~-----~~~lv~e~~~~g~L~~~l~~~----~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~  235 (464)
                      ....     ..++||||+.+++|.+++...    ....+++..++.++.|++.||.|||  .++|+||||||+|||++.+
T Consensus       106 ~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH--~~~ivH~dikp~NIli~~~  183 (313)
T 3brb_A          106 IEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLS--NRNFLHRDLAARNCMLRDD  183 (313)
T ss_dssp             EC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHH--TTTCCCCCCSGGGEEECTT
T ss_pred             eeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHH--hCCcccCCCCcceEEEcCC
Confidence            8765     359999999999999998542    2346999999999999999999999  6779999999999999999


Q ss_pred             CceEEcccCCccCCCCCCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHh-CCCCCCCCCCcccccHHH
Q 046893          236 FSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLL-GRRAVDKSRPSREHNLVE  314 (464)
Q Consensus       236 ~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~  314 (464)
                      +.+||+|||+++...............+++.|+|||.+.+..++.++||||||+++|+|++ |..||.......   ...
T Consensus       184 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~---~~~  260 (313)
T 3brb_A          184 MTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHE---MYD  260 (313)
T ss_dssp             SCEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG---HHH
T ss_pred             CcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHH---HHH
Confidence            9999999999986544332233334567889999999999999999999999999999999 888987654221   111


Q ss_pred             HHHHhhhcccchhhccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhc
Q 046893          315 WARPLLNNNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETVQSQ  377 (464)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~~~~  377 (464)
                      .   ....           .....+..++..+.+|+.+||..||.+||++.++++.|+.+...
T Consensus       261 ~---~~~~-----------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~  309 (313)
T 3brb_A          261 Y---LLHG-----------HRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLES  309 (313)
T ss_dssp             H---HHTT-----------CCCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             H---HHcC-----------CCCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence            1   1111           01112233445899999999999999999999999999988654

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=2.3e-45  Score=365.00  Aligned_cols=252  Identities=22%  Similarity=0.317  Sum_probs=193.8

Q ss_pred             cCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCccHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeEE
Q 046893           92 KFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVKLIGYCCEDEHRI  171 (464)
Q Consensus        92 ~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~  171 (464)
                      ++|++.+.||+|+||+||+|.+..+      ++.||||++..... ....+.+|+.+++.++||||+++++++...+..+
T Consensus        20 ~~y~~~~~lG~G~~g~V~~~~~~~~------~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~   92 (361)
T 3uc3_A           20 DRYDFVKDIGSGNFGVARLMRDKLT------KELVAVKYIERGAA-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLA   92 (361)
T ss_dssp             TTEEEEEEESSSTTSSEEEEEETTT------CCEEEEEEEESSTT-SCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             CcEEEEEEeccCCCEEEEEEEECCC------CcEEEEEEEecCcc-ccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEE
Confidence            5688999999999999999998765      67799999976432 3467889999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCc--eEEcccCCccCC
Q 046893          172 LVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFS--AKLSDFGLAKDG  249 (464)
Q Consensus       172 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~--vkl~DFGla~~~  249 (464)
                      +||||+.+|+|.+++....  .+++..+..++.|++.||.|||  .++|+||||||+||||+.++.  +||+|||+++..
T Consensus        93 lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~ql~~~L~~LH--~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~  168 (361)
T 3uc3_A           93 IIMEYASGGELYERICNAG--RFSEDEARFFFQQLLSGVSYCH--SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSS  168 (361)
T ss_dssp             EEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHH--HTTCCSCCCCGGGEEECSSSSCCEEECCCCCC---
T ss_pred             EEEEeCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH--HCCcccCCCCHHHEEEcCCCCceEEEeecCccccc
Confidence            9999999999999987654  6999999999999999999999  567999999999999987765  999999999743


Q ss_pred             CCCCCcceeeccccCCcccCccccccCCCCcc-cchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhcccchhh
Q 046893          250 PMGDQTHVSTRVMGTYGYAAPEYVMTGHLTAR-SDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLR  328 (464)
Q Consensus       250 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  328 (464)
                      ...   ......+||+.|+|||++.+..++.+ +|||||||++|+|++|+.||........  ............     
T Consensus       169 ~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~--~~~~~~~~~~~~-----  238 (361)
T 3uc3_A          169 VLH---SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRD--YRKTIQRILSVK-----  238 (361)
T ss_dssp             ---------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCC--HHHHHHHHHTTC-----
T ss_pred             ccc---CCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHH--HHHHHHHHhcCC-----
Confidence            222   12234679999999999988887665 8999999999999999999976443221  112111111111     


Q ss_pred             ccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 046893          329 ILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVA  369 (464)
Q Consensus       329 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  369 (464)
                           .........+..+.+||.+||..||.+|||+.++++
T Consensus       239 -----~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~  274 (361)
T 3uc3_A          239 -----YSIPDDIRISPECCHLISRIFVADPATRISIPEIKT  274 (361)
T ss_dssp             -----CCCCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             -----CCCCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHh
Confidence                 000111123457889999999999999999999976

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=6.7e-45  Score=359.91  Aligned_cols=245  Identities=23%  Similarity=0.291  Sum_probs=203.7

Q ss_pred             cCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCC---CccHHHHHHHHHHHhcCCCCCcceEEEEEEeCC
Q 046893           92 KFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGG---YQGDREWLAEVNYLGQLRHSNLVKLIGYCCEDE  168 (464)
Q Consensus        92 ~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~  168 (464)
                      ++|++.+.||+|+||.||+|.+..+      ++.||+|++....   ......+.+|+++|+.++||||+++++++.+.+
T Consensus        41 ~~y~~~~~lG~G~~g~V~~~~~~~~------~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~  114 (350)
T 1rdq_E           41 DQFDRIKTLGTGSFGRVMLVKHKES------GNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNS  114 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTT------CCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred             HHCEEEEEeecCcCcEEEEEEECCC------CCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCC
Confidence            5688899999999999999998765      6779999986432   223467889999999999999999999999999


Q ss_pred             eEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCccC
Q 046893          169 HRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKD  248 (464)
Q Consensus       169 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~  248 (464)
                      ..||||||+++|+|.+++.+..  .+++..+..++.||+.||.|||  .++|+||||||+||||+.++.+||+|||+++.
T Consensus       115 ~~~lv~e~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH--~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~  190 (350)
T 1rdq_E          115 NLYMVMEYVAGGEMFSHLRRIG--RFSEPHARFYAAQIVLTFEYLH--SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR  190 (350)
T ss_dssp             EEEEEEECCTTCBHHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred             EEEEEEcCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH--HCCcccccCccceEEECCCCCEEEccccccee
Confidence            9999999999999999987653  6999999999999999999999  56799999999999999999999999999986


Q ss_pred             CCCCCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhcccchhh
Q 046893          249 GPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLR  328 (464)
Q Consensus       249 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  328 (464)
                      ....     ....+||+.|+|||++.+..++.++|||||||++|||++|..||.....      .+....+.....    
T Consensus       191 ~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~------~~~~~~i~~~~~----  255 (350)
T 1rdq_E          191 VKGR-----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP------IQIYEKIVSGKV----  255 (350)
T ss_dssp             CSSC-----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHCCC----
T ss_pred             ccCC-----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCH------HHHHHHHHcCCC----
Confidence            4321     2346899999999999999999999999999999999999999976432      112222221110    


Q ss_pred             ccCccccCccCHHHHHHHHHHHHHhhccCCCCCCC-----HHHHHH
Q 046893          329 ILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPV-----MSDVVA  369 (464)
Q Consensus       329 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~ev~~  369 (464)
                              .++...+..+.+||.+||+.||.+||+     +.+|++
T Consensus       256 --------~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~  293 (350)
T 1rdq_E          256 --------RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN  293 (350)
T ss_dssp             --------CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred             --------CCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence                    122234558899999999999999998     666653

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=4.3e-46  Score=378.22  Aligned_cols=263  Identities=21%  Similarity=0.239  Sum_probs=208.3

Q ss_pred             hhHHHHHhcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCC---ccHHHHHHHHHHHhcCCCCCcceE
Q 046893           84 YNEMKLATKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGY---QGDREWLAEVNYLGQLRHSNLVKL  160 (464)
Q Consensus        84 ~~~~~~~~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~l  160 (464)
                      +.++.+..++|++.++||+|+||+||+|.+..+      ++.||+|++.....   .....+..|+.++..++||||+++
T Consensus        66 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~------~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l  139 (437)
T 4aw2_A           66 VKQMRLHREDFEILKVIGRGAFGEVAVVKLKNA------DKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTL  139 (437)
T ss_dssp             HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTT------TEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCE
T ss_pred             hhcccCChhheEEEEEEEeCCCEEEEEEEEcCC------CcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEE
Confidence            445566778999999999999999999998765      67899999864211   112337889999999999999999


Q ss_pred             EEEEEeCCeEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEE
Q 046893          161 IGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKL  240 (464)
Q Consensus       161 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl  240 (464)
                      +++|.+.+..|||||||.+|+|.+++.+. ...+++..+..++.|++.||.|||  .++|+||||||+||||+.++.+||
T Consensus       140 ~~~~~~~~~~~lV~Ey~~gg~L~~~l~~~-~~~l~e~~~~~~~~qi~~aL~~LH--~~giiHrDLKp~NILl~~~g~vkL  216 (437)
T 4aw2_A          140 HYAFQDDNNLYLVMDYYVGGDLLTLLSKF-EDRLPEEMARFYLAEMVIAIDSVH--QLHYVHRDIKPDNILMDMNGHIRL  216 (437)
T ss_dssp             EEEEECSSEEEEEECCCTTCBHHHHHHTT-TTCCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEECTTSCEEE
T ss_pred             EEEEeeCCEEEEEEecCCCCcHHHHHHHc-cCCCCHHHHHHHHHHHHHHHHHHH--hCCeEecccCHHHeeEcCCCCEEE
Confidence            99999999999999999999999998763 346999999999999999999999  567999999999999999999999


Q ss_pred             cccCCccCCCCCCCcceeeccccCCcccCccccc-----cCCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHH
Q 046893          241 SDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVM-----TGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEW  315 (464)
Q Consensus       241 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~  315 (464)
                      +|||+|+...... .......+||+.|+|||++.     ...++.++|||||||+||||++|+.||.+....      +.
T Consensus       217 ~DFGla~~~~~~~-~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~------~~  289 (437)
T 4aw2_A          217 ADFGSCLKLMEDG-TVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLV------ET  289 (437)
T ss_dssp             CCCTTCEECCTTS-CEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHH------HH
T ss_pred             cchhhhhhcccCC-CcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChh------HH
Confidence            9999997643322 22334478999999999987     467899999999999999999999999864421      11


Q ss_pred             HHHhhhcccchhhccCccccCccCHHHHHHHHHHHHHhhccCCCC--CCCHHHHHH
Q 046893          316 ARPLLNNNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKG--RPVMSDVVA  369 (464)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~ev~~  369 (464)
                      ...++....   ...-+..    ....+..+.+||.+||..+|++  ||++.++++
T Consensus       290 ~~~i~~~~~---~~~~p~~----~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~  338 (437)
T 4aw2_A          290 YGKIMNHKE---RFQFPTQ----VTDVSENAKDLIRRLICSREHRLGQNGIEDFKK  338 (437)
T ss_dssp             HHHHHTHHH---HCCCCSS----CCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHT
T ss_pred             HHhhhhccc---cccCCcc----cccCCHHHHHHHHHHhcccccccCCCCHHHHhC
Confidence            111111100   0001111    1123457889999999888888  999998874

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=3.8e-45  Score=355.97  Aligned_cols=248  Identities=25%  Similarity=0.280  Sum_probs=194.5

Q ss_pred             HHhcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCcc--HHHHHHHHHHHhcC-CCCCcceEEEEEE
Q 046893           89 LATKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQG--DREWLAEVNYLGQL-RHSNLVKLIGYCC  165 (464)
Q Consensus        89 ~~~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l-~hpniv~l~~~~~  165 (464)
                      ...++|++.++||+|+||+||+|.+..+      ++.||||++.......  ...+..|+..+..+ .||||+++++++.
T Consensus        54 ~~~~~y~~~~~LG~G~~g~Vy~~~~~~~------~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~  127 (311)
T 3p1a_A           54 FFQQSFQRLSRLGHGSYGEVFKVRSKED------GRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWE  127 (311)
T ss_dssp             HHHHHEEEEEEEEEETTEEEEEEEETTT------SCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred             hhhhheeeeheeccCCCeEEEEEEECCC------CeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEE
Confidence            3456799999999999999999998765      6779999986543322  23455566655555 8999999999999


Q ss_pred             eCCeEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCC
Q 046893          166 EDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGL  245 (464)
Q Consensus       166 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGl  245 (464)
                      +.+..+|||||+ +++|.+++... +..+++..++.++.|++.||.|||  ..+|+||||||+||||+.++.+||+|||+
T Consensus       128 ~~~~~~lv~e~~-~~~L~~~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH--~~~ivH~Dikp~NIll~~~~~~kl~DFG~  203 (311)
T 3p1a_A          128 EGGILYLQTELC-GPSLQQHCEAW-GASLPEAQVWGYLRDTLLALAHLH--SQGLVHLDVKPANIFLGPRGRCKLGDFGL  203 (311)
T ss_dssp             ETTEEEEEEECC-CCBHHHHHHHH-CSCCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEECGGGCEEECCCTT
T ss_pred             eCCEEEEEEecc-CCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHH--HCCEecCCCCHHHEEECCCCCEEEcccee
Confidence            999999999999 77999988765 346999999999999999999999  56799999999999999999999999999


Q ss_pred             ccCCCCCCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhcccc
Q 046893          246 AKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKK  325 (464)
Q Consensus       246 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  325 (464)
                      +.......   ......||+.|+|||++.+ .++.++|||||||++|||++|..||....        .|.  .+..   
T Consensus       204 a~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~--------~~~--~~~~---  266 (311)
T 3p1a_A          204 LVELGTAG---AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGE--------GWQ--QLRQ---  266 (311)
T ss_dssp             CEECC---------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHH--------HHH--HHTT---
T ss_pred             eeecccCC---CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCcc--------HHH--HHhc---
Confidence            98643222   2334679999999998876 79999999999999999999977765421        010  0100   


Q ss_pred             hhhccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 046893          326 VLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVA  369 (464)
Q Consensus       326 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  369 (464)
                            ......+....+..+.+|+.+||+.||.+|||+.++++
T Consensus       267 ------~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~  304 (311)
T 3p1a_A          267 ------GYLPPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLA  304 (311)
T ss_dssp             ------TCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             ------cCCCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence                  00111112234458999999999999999999999875

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=5e-45  Score=356.09  Aligned_cols=265  Identities=23%  Similarity=0.365  Sum_probs=190.0

Q ss_pred             hcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCC-ccHHHHHHHHHHHhcCCCCCcceEEEEEEeCCe
Q 046893           91 TKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGY-QGDREWLAEVNYLGQLRHSNLVKLIGYCCEDEH  169 (464)
Q Consensus        91 ~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~  169 (464)
                      .++|++.+.||+|+||+||+|.+..+      ++.||+|++..... .....+.+|+.+|+.++||||+++++++..++.
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~------~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~   77 (317)
T 2pmi_A            4 SSQFKQLEKLGNGTYATVYKGLNKTT------GVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENK   77 (317)
T ss_dssp             ---------------CEEEEEECSSS------CCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTE
T ss_pred             ccceeEeeEECCCCCEEEEEEEECCC------CcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCe
Confidence            35789999999999999999987664      67799999875432 233678899999999999999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHhhc----CCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCC
Q 046893          170 RILVYEYMESGSLEKHLLRRV----GCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGL  245 (464)
Q Consensus       170 ~~lv~e~~~~g~L~~~l~~~~----~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGl  245 (464)
                      .+|||||+. ++|.+++....    ...+++..+..++.|++.||.|||  .++|+||||||+|||++.++.+||+|||+
T Consensus        78 ~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH--~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~  154 (317)
T 2pmi_A           78 LTLVFEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCH--ENKILHRDLKPQNLLINKRGQLKLGDFGL  154 (317)
T ss_dssp             EEEEEECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCCGGGEEECTTCCEEECCCSS
T ss_pred             EEEEEEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHH--HCCeeeCCCChHHeEEcCCCCEEECcCcc
Confidence            999999997 59999887543    135899999999999999999999  56799999999999999999999999999


Q ss_pred             ccCCCCCCCcceeeccccCCcccCcccccc-CCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhcc-
Q 046893          246 AKDGPMGDQTHVSTRVMGTYGYAAPEYVMT-GHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNN-  323 (464)
Q Consensus       246 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~-  323 (464)
                      ++......  .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+......   .......+... 
T Consensus       155 ~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~---~~~i~~~~~~~~  229 (317)
T 2pmi_A          155 ARAFGIPV--NTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQ---LKLIFDIMGTPN  229 (317)
T ss_dssp             CEETTSCC--CCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHHHHHHHCSCC
T ss_pred             ceecCCCc--ccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH---HHHHHHHhCCCC
Confidence            98643221  12234679999999999876 4689999999999999999999999976543211   11111110000 


Q ss_pred             cc----hhh--ccCccc------------cCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 046893          324 KK----VLR--ILDPRL------------EGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVA  369 (464)
Q Consensus       324 ~~----~~~--~~~~~~------------~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  369 (464)
                      ..    +..  ...+..            ........+..+.+|+.+||+.||.+|||+.++++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~  293 (317)
T 2pmi_A          230 ESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALH  293 (317)
T ss_dssp             TTTCGGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             hhHhhhhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence            00    000  000000            00111123458999999999999999999998874

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.4e-45  Score=363.99  Aligned_cols=253  Identities=22%  Similarity=0.352  Sum_probs=196.6

Q ss_pred             HhcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCcc--HHHHHHHHHHHhcCCC--CCcceEEEEEE
Q 046893           90 ATKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQG--DREWLAEVNYLGQLRH--SNLVKLIGYCC  165 (464)
Q Consensus        90 ~~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~h--pniv~l~~~~~  165 (464)
                      ..++|++.+.||+|+||.||+|.+..       ++.||||++.......  ...+.+|+.+|..++|  |||+++++++.
T Consensus         7 ~~~~y~i~~~lG~G~~g~Vy~~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~   79 (343)
T 3dbq_A            7 KGRIYSILKQIGSGGSSKVFQVLNEK-------KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEI   79 (343)
T ss_dssp             SSCEEEEEEEESCCSSEEEEEEECTT-------SCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEE
T ss_pred             ecCEEEEEEEEecCCCeEEEEEEeCC-------CCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEe
Confidence            35679999999999999999998743       5679999987654332  3668899999999976  99999999999


Q ss_pred             eCCeEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCC
Q 046893          166 EDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGL  245 (464)
Q Consensus       166 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGl  245 (464)
                      .....+||||+ .+++|.+++....  .+++..+..++.|++.||.|||  ..+|+||||||+||||+ ++.+||+|||+
T Consensus        80 ~~~~~~lv~e~-~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~al~~lH--~~~iiHrDikp~NIll~-~~~~kl~DFG~  153 (343)
T 3dbq_A           80 TDQYIYMVMEC-GNIDLNSWLKKKK--SIDPWERKSYWKNMLEAVHTIH--QHGIVHSDLKPANFLIV-DGMLKLIDFGI  153 (343)
T ss_dssp             CSSEEEEEECC-CSEEHHHHHHHSC--CCCHHHHHHHHHHHHHHHHHHH--HTTCCCCCCCGGGEEEE-TTEEEECCCSS
T ss_pred             eCCEEEEEEeC-CCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH--hCCeecCCCCcceEEEE-CCcEEEeeccc
Confidence            99999999995 5889999987643  6899999999999999999999  56799999999999997 67899999999


Q ss_pred             ccCCCCCCCcceeeccccCCcccCcccccc-----------CCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHH
Q 046893          246 AKDGPMGDQTHVSTRVMGTYGYAAPEYVMT-----------GHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVE  314 (464)
Q Consensus       246 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~  314 (464)
                      ++..............+||+.|+|||++.+           ..++.++|||||||+||+|++|+.||......     ..
T Consensus       154 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-----~~  228 (343)
T 3dbq_A          154 ANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ-----IS  228 (343)
T ss_dssp             SCCC------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSH-----HH
T ss_pred             ccccCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhH-----HH
Confidence            987544333333445789999999999865           67899999999999999999999999753321     11


Q ss_pred             HHHHhhhcccchhhccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 046893          315 WARPLLNNNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVAL  370 (464)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  370 (464)
                      ..          ...+++.....++...+..+.+|+.+||+.||.+|||+.++++.
T Consensus       229 ~~----------~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~h  274 (343)
T 3dbq_A          229 KL----------HAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH  274 (343)
T ss_dssp             HH----------HHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             HH----------HHHhcCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhC
Confidence            11          11122222223333344578999999999999999999999863

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=6.6e-45  Score=365.35  Aligned_cols=269  Identities=17%  Similarity=0.212  Sum_probs=204.4

Q ss_pred             hcCCCCCCceeec--CceEEEEEEecCCCCCCccceEEEEEEccCCCCcc--HHHHHHHHHHHhcCCCCCcceEEEEEEe
Q 046893           91 TKFFRPDYILGEG--GFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQG--DREWLAEVNYLGQLRHSNLVKLIGYCCE  166 (464)
Q Consensus        91 ~~~~~~~~~lG~G--~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~hpniv~l~~~~~~  166 (464)
                      .++|++.+.||+|  +||+||+|.+..+      ++.||||++.......  ...+.+|+.+|+.++||||+++++++..
T Consensus        24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~   97 (389)
T 3gni_B           24 GGCYELLTVIGKGFEDLMTVNLARYKPT------GEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIA   97 (389)
T ss_dssp             GGGEEEEEEEEEETTTTEEEEEEEETTT------CCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred             CCcEEEEecccCCcCCceEEEEEEEcCC------CCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEE
Confidence            3568999999999  9999999998765      6779999997643322  3567889999999999999999999999


Q ss_pred             CCeEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCc
Q 046893          167 DEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLA  246 (464)
Q Consensus       167 ~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla  246 (464)
                      .+..++|||||++|+|.+++.......+++..+..++.||+.||.|||  .++|+||||||+||||+.++.+||+|||++
T Consensus        98 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH--~~~ivHrDlkp~NIll~~~~~~kl~dfg~~  175 (389)
T 3gni_B           98 DNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIH--HMGYVHRSVKASHILISVDGKVYLSGLRSN  175 (389)
T ss_dssp             TTEEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEECTTCCEEECCGGGC
T ss_pred             CCEEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHH--hCCeecCCCCHHHEEEcCCCCEEEcccccc
Confidence            999999999999999999998765567999999999999999999999  567999999999999999999999999988


Q ss_pred             cCCCCCCC-----cceeeccccCCcccCcccccc--CCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHh
Q 046893          247 KDGPMGDQ-----THVSTRVMGTYGYAAPEYVMT--GHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPL  319 (464)
Q Consensus       247 ~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~  319 (464)
                      ........     .......+||..|+|||++.+  ..++.++|||||||++|||++|+.||.+.......  .......
T Consensus       176 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~--~~~~~~~  253 (389)
T 3gni_B          176 LSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQML--LEKLNGT  253 (389)
T ss_dssp             EECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHH--HHC----
T ss_pred             eeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHH--HHHhcCC
Confidence            64321111     111223579999999999987  67999999999999999999999999764432211  1100000


Q ss_pred             hh----cc----cc-------------hhhcc---------CccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 046893          320 LN----NN----KK-------------VLRIL---------DPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVA  369 (464)
Q Consensus       320 ~~----~~----~~-------------~~~~~---------~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  369 (464)
                      ..    ..    ..             ....+         .......+....+..+.+||.+||+.||.+|||+.++++
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~  333 (389)
T 3gni_B          254 VPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLN  333 (389)
T ss_dssp             ----------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             CCccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence            00    00    00             00000         000011123344568999999999999999999999874

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=3.1e-45  Score=358.84  Aligned_cols=250  Identities=24%  Similarity=0.338  Sum_probs=180.1

Q ss_pred             CCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCccHHHHHHHHHHHhcCC-CCCcceEEEEEEeCCeEEEEEe
Q 046893           97 DYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLR-HSNLVKLIGYCCEDEHRILVYE  175 (464)
Q Consensus        97 ~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~~lv~e  175 (464)
                      .+.||+|+||+||+|.+..+      ++.||||++...   ....+.+|+.++..+. ||||+++++++.+....+||||
T Consensus        16 ~~~lG~G~~g~V~~~~~~~~------~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e   86 (325)
T 3kn6_A           16 DKPLGEGSFSICRKCVHKKS------NQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVME   86 (325)
T ss_dssp             SCCSEEETTEEEEEEEETTT------CCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEC
T ss_pred             CCccccCCCeEEEEEEECCC------CCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEE
Confidence            47899999999999998765      677999998652   4467789999999997 9999999999999999999999


Q ss_pred             ccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCC---ceEEcccCCccCCCCC
Q 046893          176 YMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADF---SAKLSDFGLAKDGPMG  252 (464)
Q Consensus       176 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~---~vkl~DFGla~~~~~~  252 (464)
                      |+++|+|.+++...  ..+++..+..++.|++.||.|||  .++|+||||||+|||++.++   .+||+|||+++.....
T Consensus        87 ~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH--~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~  162 (325)
T 3kn6_A           87 LLNGGELFERIKKK--KHFSETEASYIMRKLVSAVSHMH--DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPD  162 (325)
T ss_dssp             CCCSCBHHHHHHHC--SCCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC-
T ss_pred             ccCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH--HCCCeecCCCHHHEEEecCCCcccEEEeccccceecCCC
Confidence            99999999998764  36999999999999999999999  56799999999999997665   8999999999864332


Q ss_pred             CCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccc-cHHHHHHHhhhcccchhhccC
Q 046893          253 DQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREH-NLVEWARPLLNNNKKVLRILD  331 (464)
Q Consensus       253 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~  331 (464)
                      .  ......+||+.|+|||++.+..++.++|||||||++|+|++|+.||......... ...+.........        
T Consensus       163 ~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~--------  232 (325)
T 3kn6_A          163 N--QPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGD--------  232 (325)
T ss_dssp             -----------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTC--------
T ss_pred             C--CcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCC--------
Confidence            2  2233467899999999999999999999999999999999999999765432111 1122211111110        


Q ss_pred             ccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 046893          332 PRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVA  369 (464)
Q Consensus       332 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  369 (464)
                      ...........+..+.+||.+||..||.+||++.++++
T Consensus       233 ~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~  270 (325)
T 3kn6_A          233 FSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRY  270 (325)
T ss_dssp             CCCCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTT
T ss_pred             CCCCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhc
Confidence            01111111234568999999999999999999998863

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=4.4e-46  Score=375.30  Aligned_cols=259  Identities=19%  Similarity=0.230  Sum_probs=206.2

Q ss_pred             hHHHHHhcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCC---CccHHHHHHHHHHHhcCCCCCcceEE
Q 046893           85 NEMKLATKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGG---YQGDREWLAEVNYLGQLRHSNLVKLI  161 (464)
Q Consensus        85 ~~~~~~~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~  161 (464)
                      .++.+..++|++.+.||+|+||+||+|.+..+      ++.||+|++....   ......+.+|+.++..++||||++++
T Consensus        62 ~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~------~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~  135 (410)
T 3v8s_A           62 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKST------RKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF  135 (410)
T ss_dssp             HHHSCCGGGEEEEEEEEECSSEEEEEEEETTT------CCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEE
T ss_pred             HhcccCccccEEEEEEEcCCCEEEEEEEECCC------CcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEE
Confidence            34455678899999999999999999998765      6779999986421   11223478899999999999999999


Q ss_pred             EEEEeCCeEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEc
Q 046893          162 GYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLS  241 (464)
Q Consensus       162 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~  241 (464)
                      ++|.+.+..|||||||+||+|.+++...   .+++..+..++.||+.||.|||  .++|+||||||+||||+.++.+||+
T Consensus       136 ~~~~~~~~~~lV~E~~~gg~L~~~l~~~---~~~e~~~~~~~~qi~~aL~~LH--~~givHrDLKp~NILl~~~g~ikL~  210 (410)
T 3v8s_A          136 YAFQDDRYLYMVMEYMPGGDLVNLMSNY---DVPEKWARFYTAEVVLALDAIH--SMGFIHRDVKPDNMLLDKSGHLKLA  210 (410)
T ss_dssp             EEEECSSEEEEEECCCTTEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEECTTSCEEEC
T ss_pred             EEEEECCEEEEEEeCCCCCcHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH--HCCeEeccCCHHHeeECCCCCEEEe
Confidence            9999999999999999999999988653   5899999999999999999999  5679999999999999999999999


Q ss_pred             ccCCccCCCCCCCcceeeccccCCcccCccccccCC----CCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHH
Q 046893          242 DFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGH----LTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWAR  317 (464)
Q Consensus       242 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~  317 (464)
                      |||+|+...... .......+||+.|+|||++.+..    ++.++|||||||+||||++|+.||......      ....
T Consensus       211 DFG~a~~~~~~~-~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~------~~~~  283 (410)
T 3v8s_A          211 DFGTCMKMNKEG-MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV------GTYS  283 (410)
T ss_dssp             CCTTCEECCTTS-EEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHH------HHHH
T ss_pred             ccceeEeeccCC-cccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChh------hHHH
Confidence            999998643322 12233578999999999998765    889999999999999999999999864321      1111


Q ss_pred             HhhhcccchhhccCccccCccCHHHHHHHHHHHHHhhccCCCC--CCCHHHHHH
Q 046893          318 PLLNNNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKG--RPVMSDVVA  369 (464)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~ev~~  369 (464)
                      .++.....+   .-+     .....+..+.+||.+||..+|.+  ||++.+|++
T Consensus       284 ~i~~~~~~~---~~p-----~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~  329 (410)
T 3v8s_A          284 KIMNHKNSL---TFP-----DDNDISKEAKNLICAFLTDREVRLGRNGVEEIKR  329 (410)
T ss_dssp             HHHTHHHHC---CCC-----TTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHT
T ss_pred             HHHhccccc---cCC-----CcccccHHHHHHHHHHccChhhhCCCCCHHHHhc
Confidence            111110000   001     01123457899999999999988  999998875

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=1.3e-44  Score=354.76  Aligned_cols=252  Identities=25%  Similarity=0.353  Sum_probs=194.5

Q ss_pred             hcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCC----ccHHHHHHHHHHHhcCCCCCcceEEEEEEe
Q 046893           91 TKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGY----QGDREWLAEVNYLGQLRHSNLVKLIGYCCE  166 (464)
Q Consensus        91 ~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l~hpniv~l~~~~~~  166 (464)
                      .++|++.+.||+|+||.||+|.+....   ..++.||+|++.....    .....+.+|+.+|+.++||||+++++++..
T Consensus        16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~---~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~   92 (327)
T 3a62_A           16 PECFELLRVLGKGGYGKVFQVRKVTGA---NTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQT   92 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECSST---TTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEEC
T ss_pred             HHHeEEEEEEEeCCCEEEEEEEEeccC---CCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEc
Confidence            456889999999999999999875321   1367899999976432    223457889999999999999999999999


Q ss_pred             CCeEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCc
Q 046893          167 DEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLA  246 (464)
Q Consensus       167 ~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla  246 (464)
                      .+..+|||||+.+++|.+++....  .+++..+..++.||+.||.|||  .++|+||||||+||||+.++.+||+|||++
T Consensus        93 ~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~al~~lH--~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~  168 (327)
T 3a62_A           93 GGKLYLILEYLSGGELFMQLEREG--IFMEDTACFYLAEISMALGHLH--QKGIIYRDLKPENIMLNHQGHVKLTDFGLC  168 (327)
T ss_dssp             SSCEEEEEECCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHH--HTTCCCCCCCTTTEEECTTSCEEECCCSCC
T ss_pred             CCEEEEEEeCCCCCcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHH--hCCEEcccCCHHHeEECCCCcEEEEeCCcc
Confidence            999999999999999999987653  6899999999999999999999  567999999999999999999999999999


Q ss_pred             cCCCCCCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhcccch
Q 046893          247 KDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKV  326 (464)
Q Consensus       247 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  326 (464)
                      +......  ......+||+.|+|||++.+..++.++|||||||++|+|++|+.||......      ...........  
T Consensus       169 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~------~~~~~i~~~~~--  238 (327)
T 3a62_A          169 KESIHDG--TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRK------KTIDKILKCKL--  238 (327)
T ss_dssp             ------------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH------HHHHHHHHTCC--
T ss_pred             cccccCC--ccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHH------HHHHHHHhCCC--
Confidence            7532221  2234468999999999999999999999999999999999999999764321      11111111110  


Q ss_pred             hhccCccccCccCHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHH
Q 046893          327 LRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRP-----VMSDVVA  369 (464)
Q Consensus       327 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~ev~~  369 (464)
                                .++...+..+.+||.+||..||.+||     ++.++++
T Consensus       239 ----------~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~  276 (327)
T 3a62_A          239 ----------NLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQA  276 (327)
T ss_dssp             ----------CCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred             ----------CCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence                      12223445889999999999999999     5555543

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=1.5e-45  Score=352.65  Aligned_cols=264  Identities=30%  Similarity=0.448  Sum_probs=212.3

Q ss_pred             HHHHHhcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCccHHHHHHHHHHHhcCCCCCcceEEEEEE
Q 046893           86 EMKLATKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVKLIGYCC  165 (464)
Q Consensus        86 ~~~~~~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~  165 (464)
                      ++.+..++|++.+.||+|+||.||+|.+..       +..||+|++.... .....+.+|+++++.++||||+++++++.
T Consensus         7 ~~~v~~~~y~~~~~lg~G~~g~Vy~~~~~~-------~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~   78 (279)
T 1qpc_A            7 EWEVPRETLKLVERLGAGQFGEVWMGYYNG-------HTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVT   78 (279)
T ss_dssp             TTBCCGGGEEEEEEEEEETTEEEEEEEETT-------TEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             hcccCHHhhhheeeecCCCCeEEEEEEEcC-------CcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEc
Confidence            344556789999999999999999998754       4569999987643 34578899999999999999999999886


Q ss_pred             eCCeEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCC
Q 046893          166 EDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGL  245 (464)
Q Consensus       166 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGl  245 (464)
                       .+..++||||+.+++|.+++....+..+++..++.++.|++.||.|||  ..+|+||||||+|||++.++.+||+|||+
T Consensus        79 -~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH--~~~i~H~dikp~Nil~~~~~~~kl~Dfg~  155 (279)
T 1qpc_A           79 -QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE--ERNYIHRDLRAANILVSDTLSCKIADFGL  155 (279)
T ss_dssp             -SSSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGEEECTTSCEEECCCTT
T ss_pred             -CCCcEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHH--HCCeeccCCCHhhEEEcCCCCEEECCCcc
Confidence             456889999999999999987654346999999999999999999999  56799999999999999999999999999


Q ss_pred             ccCCCCCCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHhhhccc
Q 046893          246 AKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLL-GRRAVDKSRPSREHNLVEWARPLLNNNK  324 (464)
Q Consensus       246 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~  324 (464)
                      +........ .......++..|+|||++.+..++.++||||||+++|+|++ |+.||......      +........  
T Consensus       156 ~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~------~~~~~~~~~--  226 (279)
T 1qpc_A          156 ARLIEDNEY-TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP------EVIQNLERG--  226 (279)
T ss_dssp             CEECSSSCE-ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHH------HHHHHHHTT--
T ss_pred             cccccCccc-ccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHH------HHHHHHhcc--
Confidence            986533221 12223567889999999998899999999999999999999 99999764321      111111110  


Q ss_pred             chhhccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhcC
Q 046893          325 KVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETVQSQG  378 (464)
Q Consensus       325 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~~~~~  378 (464)
                               .....+..++..+.+|+.+||..||.+||++.++++.|+.+....
T Consensus       227 ---------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~  271 (279)
T 1qpc_A          227 ---------YRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTAT  271 (279)
T ss_dssp             ---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred             ---------cCCCCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHhc
Confidence                     111122334568999999999999999999999999999886543

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=5e-45  Score=372.82  Aligned_cols=250  Identities=26%  Similarity=0.358  Sum_probs=196.2

Q ss_pred             hcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCC---CCccHHHHHHHHHHHhcCCCCCcceEEEEEEeC
Q 046893           91 TKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRG---GYQGDREWLAEVNYLGQLRHSNLVKLIGYCCED  167 (464)
Q Consensus        91 ~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~  167 (464)
                      .++|++.+.||+|+||.||+|.+..+      ++.||||++...   .......+.+|+.+|+.++||||+++++++...
T Consensus       147 ~~~y~~~~~lG~G~~g~V~~~~~~~~------~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~  220 (446)
T 4ejn_A          147 MNEFEYLKLLGKGTFGKVILVKEKAT------GRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTH  220 (446)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTT------CCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEET
T ss_pred             hHHcEEeEEEeeCcCEEEEEEEEcCC------CCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeC
Confidence            35688999999999999999998765      677999998653   222335678899999999999999999999999


Q ss_pred             CeEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCcc
Q 046893          168 EHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAK  247 (464)
Q Consensus       168 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~  247 (464)
                      +..+|||||+++|+|.+++....  .+++..+..++.||+.||.|||+ .++|+||||||+||||+.++.+||+|||+|+
T Consensus       221 ~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~-~~giiHrDlkp~NIll~~~~~~kl~DFG~a~  297 (446)
T 4ejn_A          221 DRLCFVMEYANGGELFFHLSRER--VFSEDRARFYGAEIVSALDYLHS-EKNVVYRDLKLENLMLDKDGHIKITDFGLCK  297 (446)
T ss_dssp             TEEEEEECCCSSCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHH-HTCCCCCCCCGGGEEECSSSCEEECCCCCCC
T ss_pred             CEEEEEEeeCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHhh-cCCEEECCCCHHHEEECCCCCEEEccCCCce
Confidence            99999999999999999887654  69999999999999999999994 1679999999999999999999999999998


Q ss_pred             CCCCCCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhcccchh
Q 046893          248 DGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVL  327 (464)
Q Consensus       248 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  327 (464)
                      .....  .......+||+.|+|||++.+..++.++|||||||+||||++|+.||......      ...........   
T Consensus       298 ~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~------~~~~~i~~~~~---  366 (446)
T 4ejn_A          298 EGIKD--GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE------KLFELILMEEI---  366 (446)
T ss_dssp             TTCC-------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHHCCC---
T ss_pred             eccCC--CcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHH------HHHHHHHhCCC---
Confidence            53222  22234478999999999999999999999999999999999999999764321      11111111111   


Q ss_pred             hccCccccCccCHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHH
Q 046893          328 RILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRP-----VMSDVVA  369 (464)
Q Consensus       328 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~ev~~  369 (464)
                               .++...+..+.+||.+||+.||.+||     ++.++++
T Consensus       367 ---------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~  404 (446)
T 4ejn_A          367 ---------RFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ  404 (446)
T ss_dssp             ---------CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             ---------CCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence                     12223445889999999999999999     8888864

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=3.8e-45  Score=367.13  Aligned_cols=252  Identities=21%  Similarity=0.349  Sum_probs=196.6

Q ss_pred             hcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCc--cHHHHHHHHHHHhcCC--CCCcceEEEEEEe
Q 046893           91 TKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQ--GDREWLAEVNYLGQLR--HSNLVKLIGYCCE  166 (464)
Q Consensus        91 ~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~--hpniv~l~~~~~~  166 (464)
                      .++|++.+.||+|+||+||+|.+..       ++.||||++......  ....+.+|+.+|..+.  ||||+++++++..
T Consensus        55 ~~~y~~~~~LG~G~fg~Vy~~~~~~-------~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~  127 (390)
T 2zmd_A           55 GRIYSILKQIGSGGSSKVFQVLNEK-------KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT  127 (390)
T ss_dssp             TEEEEEEEEEECCSSEEEEEEECTT-------CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC
T ss_pred             CCceEEEEEEccCCCeEEEEEEcCC-------CCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEec
Confidence            3569999999999999999998643       467999998764332  2367899999999996  5999999999999


Q ss_pred             CCeEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCc
Q 046893          167 DEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLA  246 (464)
Q Consensus       167 ~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla  246 (464)
                      .+..+|||| +.+++|.+++....  .+++..+..++.||+.||.|||  ..+|+||||||+||||+ ++.+||+|||++
T Consensus       128 ~~~~~lv~E-~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~lH--~~~ivHrDlkp~NIll~-~~~~kl~DFG~a  201 (390)
T 2zmd_A          128 DQYIYMVME-CGNIDLNSWLKKKK--SIDPWERKSYWKNMLEAVHTIH--QHGIVHSDLKPANFLIV-DGMLKLIDFGIA  201 (390)
T ss_dssp             SSEEEEEEE-CCSEEHHHHHHHCS--SCCHHHHHHHHHHHHHHHHHHH--TTTCCCCCCCGGGEEES-SSCEEECCCSSS
T ss_pred             CCEEEEEEe-cCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH--HCCeeecCCCHHHEEEE-CCeEEEEecCcc
Confidence            999999999 55889999987653  6899999999999999999999  67799999999999995 579999999999


Q ss_pred             cCCCCCCCcceeeccccCCcccCcccccc-----------CCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHH
Q 046893          247 KDGPMGDQTHVSTRVMGTYGYAAPEYVMT-----------GHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEW  315 (464)
Q Consensus       247 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~  315 (464)
                      +..............+||+.|+|||++.+           ..++.++||||||||||||++|+.||......     ...
T Consensus       202 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~-----~~~  276 (390)
T 2zmd_A          202 NQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ-----ISK  276 (390)
T ss_dssp             CCC---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCH-----HHH
T ss_pred             ccccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHH-----HHH
Confidence            87543333323345789999999999865           46889999999999999999999999754311     111


Q ss_pred             HHHhhhcccchhhccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 046893          316 ARPLLNNNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVAL  370 (464)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  370 (464)
                      ....          +++.....++...+..+.+||.+||..||.+||++.++++.
T Consensus       277 ~~~~----------~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h  321 (390)
T 2zmd_A          277 LHAI----------IDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH  321 (390)
T ss_dssp             HHHH----------HCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             HHHH----------hCccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence            1111          12222222222234578999999999999999999999853

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=8.1e-45  Score=357.08  Aligned_cols=267  Identities=26%  Similarity=0.422  Sum_probs=206.1

Q ss_pred             HhcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCc-cHHHHHHHHHHHhcCCCCCcceEEEEEEeCC
Q 046893           90 ATKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQ-GDREWLAEVNYLGQLRHSNLVKLIGYCCEDE  168 (464)
Q Consensus        90 ~~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~  168 (464)
                      ...+|.+.+.||+|+||+||+|.+.....  ..+..||||++...... ....+.+|+.++..++||||+++++++...+
T Consensus        42 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~  119 (333)
T 1mqb_A           42 HPSCVTRQKVIGAGEFGEVYKGMLKTSSG--KKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYK  119 (333)
T ss_dssp             CTTTEEEEEEEEECSSSEEEEEEEEC-----CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred             ChHHhhcccEEecCCCeEEEEEEEecCCC--CccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCC
Confidence            34567888999999999999998765421  13467999998754322 2356889999999999999999999999999


Q ss_pred             eEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCccC
Q 046893          169 HRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKD  248 (464)
Q Consensus       169 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~  248 (464)
                      ..+|||||+.+++|.+++... ...+++..++.++.|++.||.|||  ..+|+||||||+|||++.++.+||+|||+++.
T Consensus       120 ~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH--~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~  196 (333)
T 1mqb_A          120 PMMIITEYMENGALDKFLREK-DGEFSVLQLVGMLRGIAAGMKYLA--NMNYVHRDLAARNILVNSNLVCKVSDFGLSRV  196 (333)
T ss_dssp             SEEEEEECCTTEEHHHHHHHT-TTCSCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred             CcEEEEeCCCCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHH--hCCeeCCCCChheEEECCCCcEEECCCCcchh
Confidence            999999999999999998764 346999999999999999999999  56799999999999999999999999999986


Q ss_pred             CCCCCCc-ceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHhhhcccch
Q 046893          249 GPMGDQT-HVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLL-GRRAVDKSRPSREHNLVEWARPLLNNNKKV  326 (464)
Q Consensus       249 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  326 (464)
                      ....... .......+|..|+|||++.+..++.++||||||+++|||++ |+.||......      +........    
T Consensus       197 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~------~~~~~~~~~----  266 (333)
T 1mqb_A          197 LEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNH------EVMKAINDG----  266 (333)
T ss_dssp             --------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH------HHHHHHHTT----
T ss_pred             hccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHH------HHHHHHHCC----
Confidence            4332211 11222456889999999999999999999999999999999 99999754321      111111110    


Q ss_pred             hhccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhcC
Q 046893          327 LRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETVQSQG  378 (464)
Q Consensus       327 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~~~~~  378 (464)
                             .....+..++..+.+|+.+||+.||.+||++.++++.|+.+....
T Consensus       267 -------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~  311 (333)
T 1mqb_A          267 -------FRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAP  311 (333)
T ss_dssp             -------CCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSG
T ss_pred             -------CcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcc
Confidence                   011122234568999999999999999999999999999887644

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=4.5e-45  Score=363.32  Aligned_cols=276  Identities=16%  Similarity=0.176  Sum_probs=207.1

Q ss_pred             HhcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCccH-----------HHHHHHHHHHhcCCCCCcc
Q 046893           90 ATKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGD-----------REWLAEVNYLGQLRHSNLV  158 (464)
Q Consensus        90 ~~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~-----------~~~~~E~~~l~~l~hpniv  158 (464)
                      ..++|++.+.||+|+||.||+|.+..+.. ...++.||||++........           ..+..|+..+..++||||+
T Consensus        33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~-~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv  111 (364)
T 3op5_A           33 AAAAWKVGLPIGQGGFGCIYLADMNSSES-VGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVP  111 (364)
T ss_dssp             TCCEEEEEEECCCC-CCEEEEEEECCSSC-CCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSC
T ss_pred             CCCeEEEEEEEecCCCeEEEEeeecCccc-cccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCC
Confidence            34579999999999999999998866421 12346699999876432111           1234566677888999999


Q ss_pred             eEEEEEEeC----CeEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEec-
Q 046893          159 KLIGYCCED----EHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLN-  233 (464)
Q Consensus       159 ~l~~~~~~~----~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~-  233 (464)
                      ++++++...    ...+|||||+ +++|.+++... +..+++..++.|+.||+.||.|||  .++|+||||||+||||+ 
T Consensus       112 ~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~-~~~l~~~~~~~i~~qi~~~l~~lH--~~~iiHrDlkp~Nill~~  187 (364)
T 3op5_A          112 KYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEAN-AKRFSRKTVLQLSLRILDILEYIH--EHEYVHGDIKASNLLLNY  187 (364)
T ss_dssp             CEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHT-TSCCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCCGGGEEEES
T ss_pred             eEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHH--HCCeEEecCCHHHEEEec
Confidence            999998775    4689999999 99999988764 357999999999999999999999  56799999999999998 


Q ss_pred             -CCCceEEcccCCccCCCCCCCc-----ceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHhCCCCCCCCCCc
Q 046893          234 -ADFSAKLSDFGLAKDGPMGDQT-----HVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPS  307 (464)
Q Consensus       234 -~~~~vkl~DFGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~  307 (464)
                       .++.+||+|||+++........     .......||+.|+|||++.+..++.++|||||||+||||++|+.||.+....
T Consensus       188 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~  267 (364)
T 3op5_A          188 KNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKD  267 (364)
T ss_dssp             SCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTC
T ss_pred             CCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccC
Confidence             8899999999999754322111     1113356999999999999999999999999999999999999999853322


Q ss_pred             ccccHHHHHHHhhhcccchhhccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhc
Q 046893          308 REHNLVEWARPLLNNNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETVQSQ  377 (464)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~~~~  377 (464)
                      .  ....+......  ..+...+++.+.   ...++..+.+|+..||..||.+||++.+|++.|+.+...
T Consensus       268 ~--~~~~~~~~~~~--~~~~~~~~~~~~---~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~  330 (364)
T 3op5_A          268 P--KYVRDSKIRYR--ENIASLMDKCFP---AANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKA  330 (364)
T ss_dssp             H--HHHHHHHHHHH--HCHHHHHHHHSC---TTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHH
T ss_pred             H--HHHHHHHHHhh--hhHHHHHHHhcc---cccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Confidence            1  11111111110  111222222111   112345899999999999999999999999999987654

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=9.5e-45  Score=351.04  Aligned_cols=270  Identities=26%  Similarity=0.372  Sum_probs=209.0

Q ss_pred             hcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCC-CccHHHHHHHHHHHhcCCCCCcceEEEEEEeC--
Q 046893           91 TKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGG-YQGDREWLAEVNYLGQLRHSNLVKLIGYCCED--  167 (464)
Q Consensus        91 ~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~--  167 (464)
                      .++|++.+.||+|+||.||+|.+....  ...++.||+|++.... ......+.+|+.+|+.++||||+++++++...  
T Consensus        20 ~~~~~~~~~lg~G~~g~V~~~~~~~~~--~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~   97 (302)
T 4e5w_A           20 KRFLKRIRDLGEGHFGKVELCRYDPEG--DNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGG   97 (302)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEECTTS--SSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---
T ss_pred             hhhhhhhhccCCCCceEEEEEEEcccc--CccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCC
Confidence            345888899999999999999853221  1247889999987543 23347789999999999999999999999877  


Q ss_pred             CeEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCcc
Q 046893          168 EHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAK  247 (464)
Q Consensus       168 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~  247 (464)
                      ...++||||+++++|.+++.... ..+++..++.++.|++.||.|||  .++|+||||||+|||++.++.+||+|||+++
T Consensus        98 ~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH--~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~  174 (302)
T 4e5w_A           98 NGIKLIMEFLPSGSLKEYLPKNK-NKINLKQQLKYAVQICKGMDYLG--SRQYVHRDLAARNVLVESEHQVKIGDFGLTK  174 (302)
T ss_dssp             CCEEEEEECCTTCBHHHHHHHHT-TTCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGEEEEETTEEEECCCTTCE
T ss_pred             ceEEEEEEeCCCCcHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHhh--cCCcccCCCchheEEEcCCCCEEECcccccc
Confidence            67899999999999999986553 46999999999999999999999  5679999999999999999999999999998


Q ss_pred             CCCCCCCc-ceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHhCCCCCCCCC--------CcccccHHHHHHH
Q 046893          248 DGPMGDQT-HVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSR--------PSREHNLVEWARP  318 (464)
Q Consensus       248 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~--------~~~~~~~~~~~~~  318 (464)
                      ........ .......||..|+|||++.+..++.++||||||+++|+|++|..|+....        +.........   
T Consensus       175 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~---  251 (302)
T 4e5w_A          175 AIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTR---  251 (302)
T ss_dssp             ECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHH---
T ss_pred             cccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHH---
Confidence            65433221 22334678899999999999999999999999999999999998865321        0000000000   


Q ss_pred             hhhcccchhhccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHH
Q 046893          319 LLNNNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETVQ  375 (464)
Q Consensus       319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~~  375 (464)
                             +...+........+..++..+.+|+.+||+.||.+|||+.++++.|+.+.
T Consensus       252 -------~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll  301 (302)
T 4e5w_A          252 -------LVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL  301 (302)
T ss_dssp             -------HHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             -------HHHHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence                   11111111122233345568999999999999999999999999999874

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=1.6e-44  Score=349.17  Aligned_cols=264  Identities=25%  Similarity=0.373  Sum_probs=202.1

Q ss_pred             HhcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCccHHHHHHHHHHHhc--CCCCCcceEEEEEEeC
Q 046893           90 ATKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQ--LRHSNLVKLIGYCCED  167 (464)
Q Consensus        90 ~~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~hpniv~l~~~~~~~  167 (464)
                      ..++|++.+.||+|+||+||+|.+.        ++.||||++...   ....+..|.+++..  ++||||+++++++...
T Consensus         6 ~~~~y~~~~~lg~G~~g~V~~~~~~--------~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~   74 (301)
T 3q4u_A            6 VARDITLLECVGKGRYGEVWRGSWQ--------GENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTS   74 (301)
T ss_dssp             CGGGCEEEEEEEECSSEEEEEEEET--------TEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEE
T ss_pred             ccCcEEEEEeeccCCCcEEEEEEEC--------CEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccc
Confidence            4567999999999999999999863        567999998642   34556667777666  7999999999987553


Q ss_pred             ----CeEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcC------CCCeeeccCCCCceEecCCCc
Q 046893          168 ----EHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGA------ERPVIYRDFKTSNILLNADFS  237 (464)
Q Consensus       168 ----~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~------~~~ivHrDlkp~Nill~~~~~  237 (464)
                          ...++||||+++|+|.+++...   .+++..++.++.|++.||.|||..      .++|+||||||+|||++.++.
T Consensus        75 ~~~~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~  151 (301)
T 3q4u_A           75 RHSSTQLWLITHYHEMGSLYDYLQLT---TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQ  151 (301)
T ss_dssp             ETTEEEEEEEECCCTTCBHHHHHTTC---CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSC
T ss_pred             cCCCceeEEehhhccCCCHHHHHhhc---ccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCC
Confidence                4689999999999999998543   599999999999999999999932      456999999999999999999


Q ss_pred             eEEcccCCccCCCCCCCcc--eeeccccCCcccCccccccC------CCCcccchhcHHHHHHHHHhC----------CC
Q 046893          238 AKLSDFGLAKDGPMGDQTH--VSTRVMGTYGYAAPEYVMTG------HLTARSDVYGFGVVLLEMLLG----------RR  299 (464)
Q Consensus       238 vkl~DFGla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~~~~~DvwslG~il~ell~g----------~~  299 (464)
                      +||+|||+++.........  ......||+.|+|||++.+.      .++.++|||||||++|||++|          ..
T Consensus       152 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~  231 (301)
T 3q4u_A          152 CCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKP  231 (301)
T ss_dssp             EEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCC
T ss_pred             EEEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccc
Confidence            9999999997533222111  12235799999999999876      455799999999999999999          78


Q ss_pred             CCCCCCCcccccHHHHHHHhhhcccchhhccCccc-cCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHH
Q 046893          300 AVDKSRPSREHNLVEWARPLLNNNKKVLRILDPRL-EGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETV  374 (464)
Q Consensus       300 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~  374 (464)
                      ||......... .... ........     ..+.+ ...+...++..+.+|+.+||+.||.+|||+.+|++.|+.+
T Consensus       232 pf~~~~~~~~~-~~~~-~~~~~~~~-----~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i  300 (301)
T 3q4u_A          232 PFYDVVPNDPS-FEDM-RKVVCVDQ-----QRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI  300 (301)
T ss_dssp             TTTTTSCSSCC-HHHH-HHHHTTSC-----CCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred             cccccCCCCcc-hhhh-hHHHhccC-----CCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence            88654332221 1111 11111110     01111 1123345778999999999999999999999999999875

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=3.6e-45  Score=348.39  Aligned_cols=251  Identities=27%  Similarity=0.421  Sum_probs=193.7

Q ss_pred             hcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCc----cHHHHHHHHHHHhcCCCCCcceEEEEEEe
Q 046893           91 TKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQ----GDREWLAEVNYLGQLRHSNLVKLIGYCCE  166 (464)
Q Consensus        91 ~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~----~~~~~~~E~~~l~~l~hpniv~l~~~~~~  166 (464)
                      .++|++.+.||+|+||.||+|.+.        +..||||++......    ..+.+.+|+.+++.++||||+++++++..
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   77 (271)
T 3dtc_A            6 FAELTLEEIIGIGGFGKVYRAFWI--------GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLK   77 (271)
T ss_dssp             TTSEEEEEEEEEETTEEEEEEEET--------TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECC
T ss_pred             hhheeeeeeeccCCCeEEEEEEEc--------CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEec
Confidence            356888999999999999999864        456999998754322    23678899999999999999999999999


Q ss_pred             CCeEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCC---eeeccCCCCceEecC--------C
Q 046893          167 DEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERP---VIYRDFKTSNILLNA--------D  235 (464)
Q Consensus       167 ~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~---ivHrDlkp~Nill~~--------~  235 (464)
                      .+..++||||+++++|.+++..   ..+++..++.++.|++.||.|||+  ++   |+||||||+|||++.        +
T Consensus        78 ~~~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~i~~~l~~~l~~lH~--~~~~~i~H~dikp~Nil~~~~~~~~~~~~  152 (271)
T 3dtc_A           78 EPNLCLVMEFARGGPLNRVLSG---KRIPPDILVNWAVQIARGMNYLHD--EAIVPIIHRDLKSSNILILQKVENGDLSN  152 (271)
T ss_dssp             C--CEEEEECCTTEEHHHHHTS---SCCCHHHHHHHHHHHHHHHHHHHH--SSSSCCCCSCCSGGGEEESSCCSSSCCSS
T ss_pred             CCceEEEEEcCCCCCHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHh--CCCCceeecCCchHHEEEecccccccccC
Confidence            9999999999999999988753   369999999999999999999994  55   999999999999986        6


Q ss_pred             CceEEcccCCccCCCCCCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHH
Q 046893          236 FSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEW  315 (464)
Q Consensus       236 ~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~  315 (464)
                      +.+||+|||+++......    .....||+.|+|||++.+..++.++||||||+++|+|++|+.||.......      .
T Consensus       153 ~~~kl~Dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~------~  222 (271)
T 3dtc_A          153 KILKITDFGLAREWHRTT----KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLA------V  222 (271)
T ss_dssp             CCEEECCCCC-----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHH------H
T ss_pred             cceEEccCCccccccccc----ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH------H
Confidence            789999999998543221    223579999999999999999999999999999999999999997643211      1


Q ss_pred             HHHhhhcccchhhccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHH
Q 046893          316 ARPLLNNNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETV  374 (464)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~  374 (464)
                      .....          ........+..++..+.+|+.+||+.||.+||++.++++.|+.+
T Consensus       223 ~~~~~----------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l  271 (271)
T 3dtc_A          223 AYGVA----------MNKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI  271 (271)
T ss_dssp             HHHHH----------TSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred             HHhhh----------cCCCCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence            11111          11111122334456899999999999999999999999998753

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=4.8e-45  Score=363.72  Aligned_cols=245  Identities=27%  Similarity=0.350  Sum_probs=193.8

Q ss_pred             cCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCc---cHHHHHHHHHH-HhcCCCCCcceEEEEEEeC
Q 046893           92 KFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQ---GDREWLAEVNY-LGQLRHSNLVKLIGYCCED  167 (464)
Q Consensus        92 ~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~-l~~l~hpniv~l~~~~~~~  167 (464)
                      ++|++.+.||+|+||+||+|++..+      ++.||||++......   ....+..|..+ ++.++||||+++++++...
T Consensus        38 ~~y~~~~~lG~G~fg~V~~~~~~~~------~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~  111 (373)
T 2r5t_A           38 SDFHFLKVIGKGSFGKVLLARHKAE------EVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTA  111 (373)
T ss_dssp             GGEEEEEEEECCTTCEEEEEEETTT------CCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECS
T ss_pred             hheEEEEEEeeCCCeEEEEEEEcCC------CCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeC
Confidence            5688999999999999999998765      677999999764322   23456677776 5678999999999999999


Q ss_pred             CeEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCcc
Q 046893          168 EHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAK  247 (464)
Q Consensus       168 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~  247 (464)
                      +..||||||+.||+|.+++.+..  .+++..+..++.||+.||.|||  .++|+||||||+||||+.++.+||+|||+++
T Consensus       112 ~~~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH--~~givHrDlkp~NIll~~~g~ikL~DFG~a~  187 (373)
T 2r5t_A          112 DKLYFVLDYINGGELFYHLQRER--CFLEPRARFYAAEIASALGYLH--SLNIVYRDLKPENILLDSQGHIVLTDFGLCK  187 (373)
T ss_dssp             SEEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHH--HTTCCCCCCCGGGEEECTTSCEEECCCCBCG
T ss_pred             CEEEEEEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH--HCCceecCCCHHHEEECCCCCEEEeeCcccc
Confidence            99999999999999999987653  6899999999999999999999  5679999999999999999999999999998


Q ss_pred             CCCCCCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhcccchh
Q 046893          248 DGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVL  327 (464)
Q Consensus       248 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  327 (464)
                      .....  .......+||+.|+|||++.+..++.++|||||||++|||++|..||.....      .+....++....   
T Consensus       188 ~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~------~~~~~~i~~~~~---  256 (373)
T 2r5t_A          188 ENIEH--NSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNT------AEMYDNILNKPL---  256 (373)
T ss_dssp             GGBCC--CCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBH------HHHHHHHHHSCC---
T ss_pred             ccccC--CCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCH------HHHHHHHHhccc---
Confidence            53221  1223457899999999999999999999999999999999999999976432      122222222110   


Q ss_pred             hccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHH
Q 046893          328 RILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSD  366 (464)
Q Consensus       328 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~e  366 (464)
                               .++...+..+.+||.+||+.||.+||++.+
T Consensus       257 ---------~~~~~~~~~~~~li~~lL~~dp~~R~~~~~  286 (373)
T 2r5t_A          257 ---------QLKPNITNSARHLLEGLLQKDRTKRLGAKD  286 (373)
T ss_dssp             ---------CCCSSSCHHHHHHHHHHTCSSGGGSTTTTT
T ss_pred             ---------CCCCCCCHHHHHHHHHHcccCHHhCCCCCC
Confidence                     112233457899999999999999999864

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=5.5e-46  Score=388.01  Aligned_cols=261  Identities=29%  Similarity=0.433  Sum_probs=212.2

Q ss_pred             HHHHhcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCccHHHHHHHHHHHhcCCCCCcceEEEEEEe
Q 046893           87 MKLATKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVKLIGYCCE  166 (464)
Q Consensus        87 ~~~~~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~  166 (464)
                      +++..++|++.+.||+|+||.||+|.+..       +..||||++.... ...+.|.+|+++|+.++||||+++++++.+
T Consensus       262 ~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~-------~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~  333 (535)
T 2h8h_A          262 WEIPRESLRLEVKLGQGCFGEVWMGTWNG-------TTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE  333 (535)
T ss_dssp             SBCCGGGEEEEEEEEECSSEEEEEEEETT-------TEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             eecchhhhhhheecccCCCeEEEEEEECC-------CceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee
Confidence            34556678889999999999999999865       3459999997654 345789999999999999999999999866


Q ss_pred             CCeEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCc
Q 046893          167 DEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLA  246 (464)
Q Consensus       167 ~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla  246 (464)
                       +..+|||||+.+|+|.+++....+..+++..++.|+.||+.||.|||  .++|+||||||+||||+.++.+||+|||++
T Consensus       334 -~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH--~~~ivHrDlkp~NIll~~~~~~kl~DFG~a  410 (535)
T 2h8h_A          334 -EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE--RMNYVHRDLRAANILVGENLVCKVADFGLA  410 (535)
T ss_dssp             -SSCEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCSGGGEEECGGGCEEECCTTST
T ss_pred             -ccceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHH--hCCeeCCCCCHhhEEEcCCCcEEEcccccc
Confidence             67899999999999999997654456999999999999999999999  567999999999999999999999999999


Q ss_pred             cCCCCCCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHhhhcccc
Q 046893          247 KDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLL-GRRAVDKSRPSREHNLVEWARPLLNNNKK  325 (464)
Q Consensus       247 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  325 (464)
                      +...... ........++..|+|||++.+..++.++|||||||+||||++ |+.||.+....      +....+. .   
T Consensus       411 ~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~------~~~~~i~-~---  479 (535)
T 2h8h_A          411 RLIEDNE-YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR------EVLDQVE-R---  479 (535)
T ss_dssp             TTCCCHH-HHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHH------HHHHHHH-T---
T ss_pred             eecCCCc-eecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH------HHHHHHH-c---
Confidence            8643211 111223457889999999999999999999999999999999 99999764321      1111111 1   


Q ss_pred             hhhccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHh
Q 046893          326 VLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETVQS  376 (464)
Q Consensus       326 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~~~  376 (464)
                             ......+..++..+.+||.+||+.||.+||++.+|++.|+.+..
T Consensus       480 -------~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~  523 (535)
T 2h8h_A          480 -------GYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT  523 (535)
T ss_dssp             -------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSC
T ss_pred             -------CCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhh
Confidence                   11112233456689999999999999999999999999997754

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=2.5e-45  Score=348.56  Aligned_cols=259  Identities=26%  Similarity=0.399  Sum_probs=210.6

Q ss_pred             HhcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCccHHHHHHHHHHHhcCCCCCcceEEEEEEeCCe
Q 046893           90 ATKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVKLIGYCCEDEH  169 (464)
Q Consensus        90 ~~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~  169 (464)
                      ..++|++.+.||+|+||.||+|.+..       +..||+|++.... ...+.+.+|+.+++.++||||+++++++...+.
T Consensus         6 ~~~~y~~~~~lg~G~~g~V~~~~~~~-------~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   77 (267)
T 3t9t_A            6 DPSELTFVQEIGSGQFGLVHLGYWLN-------KDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAP   77 (267)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETT-------TEEEEEEEECTTT-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred             chhheeeeeEecCCCceeEEEEEecC-------CCeEEEEEccccC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence            34678889999999999999998764       4569999997654 345778999999999999999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCccCC
Q 046893          170 RILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDG  249 (464)
Q Consensus       170 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~  249 (464)
                      .++||||+++++|.+++... ...+++..++.++.|++.||.|||  .++|+||||||+|||++.++.+||+|||+++..
T Consensus        78 ~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH--~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~  154 (267)
T 3t9t_A           78 ICLVTEFMEHGCLSDYLRTQ-RGLFAAETLLGMCLDVCEGMAYLE--EACVIHRDLAARNCLVGENQVIKVSDFGMTRFV  154 (267)
T ss_dssp             CEEEECCCTTCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHH--HTTCCCSSCCGGGEEECGGGCEEECCTTGGGGB
T ss_pred             eEEEEeCCCCCcHHHHHhhC-cccCCHHHHHHHHHHHHHHHHHHH--hCCcccCCCchheEEECCCCCEEEccccccccc
Confidence            99999999999999998764 346899999999999999999999  567999999999999999999999999999854


Q ss_pred             CCCCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHhhhcccchhh
Q 046893          250 PMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLL-GRRAVDKSRPSREHNLVEWARPLLNNNKKVLR  328 (464)
Q Consensus       250 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  328 (464)
                      .... ........|+..|+|||++.+..++.++||||||+++|+|++ |+.||......      +........      
T Consensus       155 ~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~------~~~~~i~~~------  221 (267)
T 3t9t_A          155 LDDQ-YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS------EVVEDISTG------  221 (267)
T ss_dssp             CCHH-HHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH------HHHHHHHTT------
T ss_pred             cccc-ccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHH------HHHHHHhcC------
Confidence            3211 111223567889999999998999999999999999999999 89999764321      111111111      


Q ss_pred             ccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhc
Q 046893          329 ILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETVQSQ  377 (464)
Q Consensus       329 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~~~~  377 (464)
                           .....+...+..+.+|+.+||+.||.+||++.++++.|+.+...
T Consensus       222 -----~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~  265 (267)
T 3t9t_A          222 -----FRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES  265 (267)
T ss_dssp             -----CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             -----CcCCCCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence                 00111222345889999999999999999999999999988653

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=5.9e-45  Score=349.04  Aligned_cols=263  Identities=25%  Similarity=0.321  Sum_probs=208.0

Q ss_pred             HhcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCC-ccHHHHHHHHHHHhcCCCCCcceEEEEEEeCC
Q 046893           90 ATKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGY-QGDREWLAEVNYLGQLRHSNLVKLIGYCCEDE  168 (464)
Q Consensus        90 ~~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~  168 (464)
                      ..++|++.+.||+|+||+||+|.+.....   .+..||+|++..... .....+.+|+.+++.++||||+++++++.+ +
T Consensus        10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~   85 (281)
T 3cc6_A           10 AREDVVLNRILGEGFFGEVYEGVYTNHKG---EKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-E   85 (281)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEEECTTC---CEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-S
T ss_pred             cccceEEEEEEEecCCeeEEEeEEcCCCC---CcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-C
Confidence            34678899999999999999998765422   356799999876532 234678999999999999999999999765 4


Q ss_pred             eEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCccC
Q 046893          169 HRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKD  248 (464)
Q Consensus       169 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~  248 (464)
                      ..++||||+.+++|.+++... ...+++..++.++.|++.||.|||  ..+|+||||||+|||++.++.+||+|||++..
T Consensus        86 ~~~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH--~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~  162 (281)
T 3cc6_A           86 PTWIIMELYPYGELGHYLERN-KNSLKVLTLVLYSLQICKAMAYLE--SINCVHRDIAVRNILVASPECVKLGDFGLSRY  162 (281)
T ss_dssp             SCEEEEECCTTCBHHHHHHHH-TTTCCHHHHHHHHHHHHHHHHHHH--HTTCCCCCCSGGGEEEEETTEEEECCCCGGGC
T ss_pred             CCEEEEecCCCCCHHHHHHhc-cccCCHHHHHHHHHHHHHHHHHHH--HCCcccCCCccceEEECCCCcEEeCccCCCcc
Confidence            568999999999999998764 346899999999999999999999  56799999999999999999999999999986


Q ss_pred             CCCCCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHhhhcccchh
Q 046893          249 GPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLL-GRRAVDKSRPSREHNLVEWARPLLNNNKKVL  327 (464)
Q Consensus       249 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  327 (464)
                      ...... .......||..|+|||++.+..++.++||||||+++|+|++ |+.||.......   ......   ..     
T Consensus       163 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~---~~~~~~---~~-----  230 (281)
T 3cc6_A          163 IEDEDY-YKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKD---VIGVLE---KG-----  230 (281)
T ss_dssp             C----------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGG---HHHHHH---HT-----
T ss_pred             cccccc-cccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHH---HHHHHh---cC-----
Confidence            533221 12233567889999999999999999999999999999998 999997543221   111110   00     


Q ss_pred             hccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhc
Q 046893          328 RILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETVQSQ  377 (464)
Q Consensus       328 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~~~~  377 (464)
                            .....+..++..+.+|+.+||..||.+||++.++++.|+.+...
T Consensus       231 ------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~  274 (281)
T 3cc6_A          231 ------DRLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQM  274 (281)
T ss_dssp             ------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ------CCCCCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHHh
Confidence                  00111223445899999999999999999999999999988764

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=1.6e-45  Score=361.05  Aligned_cols=279  Identities=26%  Similarity=0.351  Sum_probs=213.5

Q ss_pred             hcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCccHHHHHHHHHHHhcCCCCCcceEEEEEE--eCC
Q 046893           91 TKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVKLIGYCC--EDE  168 (464)
Q Consensus        91 ~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~--~~~  168 (464)
                      .++|++.+.||+|+||.||+|.+....  ...+..||||++........+.+.+|+++++.++||||+++++++.  ...
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~--~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   99 (327)
T 3lxl_A           22 ERHLKYISQLGKGNFGSVELCRYDPLG--DNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQ   99 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECTTS--SSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSC
T ss_pred             hhhhhhhhhccCCCCeEEEEEEeccCC--CCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCc
Confidence            356889999999999999999853211  1247789999998765555577899999999999999999999887  456


Q ss_pred             eEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCccC
Q 046893          169 HRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKD  248 (464)
Q Consensus       169 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~  248 (464)
                      ..++||||+++++|.+++.... ..+++..++.++.|++.||.|||  ..+|+||||||+|||++.++.+||+|||+++.
T Consensus       100 ~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH--~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~  176 (327)
T 3lxl_A          100 SLRLVMEYLPSGCLRDFLQRHR-ARLDASRLLLYSSQICKGMEYLG--SRRCVHRDLAARNILVESEAHVKIADFGLAKL  176 (327)
T ss_dssp             EEEEEEECCTTCBHHHHHHHHG-GGCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGEEEEETTEEEECCGGGCEE
T ss_pred             eEEEEEeecCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHH--hCCccCCCCChhhEEECCCCCEEEccccccee
Confidence            7899999999999999987643 25899999999999999999999  56799999999999999999999999999986


Q ss_pred             CCCCCCc-ceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHH--Hhhhcccc
Q 046893          249 GPMGDQT-HVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWAR--PLLNNNKK  325 (464)
Q Consensus       249 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~--~~~~~~~~  325 (464)
                      ....... .......||..|+|||++.+..++.++||||||+++|+|++|+.||......    ......  ........
T Consensus       177 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~----~~~~~~~~~~~~~~~~  252 (327)
T 3lxl_A          177 LPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAE----FLRMMGCERDVPALSR  252 (327)
T ss_dssp             CCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHH----HHHHCC----CCHHHH
T ss_pred             cccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccch----hhhhcccccccccHHH
Confidence            5433221 1223356888999999999999999999999999999999999998653210    000000  00000001


Q ss_pred             hhhccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhcC
Q 046893          326 VLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETVQSQG  378 (464)
Q Consensus       326 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~~~~~  378 (464)
                      +...+........+..++..+.+|+.+||+.||.+||++.++++.|+.+....
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~  305 (327)
T 3lxl_A          253 LLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGS  305 (327)
T ss_dssp             HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC----
T ss_pred             HHHHhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhh
Confidence            11111222222334455678999999999999999999999999999876543

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=3.9e-45  Score=361.68  Aligned_cols=252  Identities=23%  Similarity=0.325  Sum_probs=190.5

Q ss_pred             HhcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCccHHHHHHHHHHHhcCCCCCcceEEEEEEeCCe
Q 046893           90 ATKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVKLIGYCCEDEH  169 (464)
Q Consensus        90 ~~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~  169 (464)
                      ..++|++.+.||+|+||.||+|.+..+      ++.||||++....  ..+.+.+|+.+|..++||||+++++++...+.
T Consensus        51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~------~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  122 (349)
T 2w4o_A           51 LSDFFEVESELGRGATSIVYRCKQKGT------QKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTE  122 (349)
T ss_dssp             GGGTEEEEEEEEECSSEEEEEEEETTT------CCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSE
T ss_pred             ccCcEEEeeEEeeCCCEEEEEEEECCC------CcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCe
Confidence            456799999999999999999998764      5679999987542  34567899999999999999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecC---CCceEEcccCCc
Q 046893          170 RILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNA---DFSAKLSDFGLA  246 (464)
Q Consensus       170 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~---~~~vkl~DFGla  246 (464)
                      .++||||+.+++|.+++...  ..+++..++.++.|++.||.|||  ..+|+||||||+|||++.   ++.+||+|||++
T Consensus       123 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~L~~LH--~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a  198 (349)
T 2w4o_A          123 ISLVLELVTGGELFDRIVEK--GYYSERDAADAVKQILEAVAYLH--ENGIVHRDLKPENLLYATPAPDAPLKIADFGLS  198 (349)
T ss_dssp             EEEEECCCCSCBHHHHHTTC--SSCCHHHHHHHHHHHHHHHHHHH--HTTCCCCCCCGGGEEESSSSTTCCEEECCCC--
T ss_pred             EEEEEEeCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH--HCCeEecCCCcccEEEecCCCCCCEEEccCccc
Confidence            99999999999999988764  36899999999999999999999  567999999999999975   889999999999


Q ss_pred             cCCCCCCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhcccch
Q 046893          247 KDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKV  326 (464)
Q Consensus       247 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  326 (464)
                      +.....   .......||+.|+|||++.+..++.++|||||||+||||++|..||.......     ...........  
T Consensus       199 ~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-----~~~~~i~~~~~--  268 (349)
T 2w4o_A          199 KIVEHQ---VLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQ-----FMFRRILNCEY--  268 (349)
T ss_dssp             -----------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHH-----HHHHHHHTTCC--
T ss_pred             cccCcc---cccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccH-----HHHHHHHhCCC--
Confidence            864322   12334679999999999999999999999999999999999999997643211     01111111110  


Q ss_pred             hhccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 046893          327 LRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVA  369 (464)
Q Consensus       327 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  369 (464)
                            ..........+..+.+||.+||..||.+||++.++++
T Consensus       269 ------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  305 (349)
T 2w4o_A          269 ------YFISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQ  305 (349)
T ss_dssp             ------CCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             ------ccCCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence                  0111112234558899999999999999999999875

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=6.4e-45  Score=359.02  Aligned_cols=253  Identities=22%  Similarity=0.300  Sum_probs=201.4

Q ss_pred             HhcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCccHHHHHHHHHHHhcC-CCCCcceEEEEEEeCC
Q 046893           90 ATKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQL-RHSNLVKLIGYCCEDE  168 (464)
Q Consensus        90 ~~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~  168 (464)
                      ..++|++.+.||+|+||+||+|.+..+      ++.||||++......    +.+|+++|.++ .||||+++++++.+.+
T Consensus        20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~------~~~~avK~~~~~~~~----~~~E~~~l~~~~~hp~iv~~~~~~~~~~   89 (342)
T 2qr7_A           20 FTDGYEVKEDIGVGSYSVCKRCIHKAT------NMEFAVKIIDKSKRD----PTEEIEILLRYGQHPNIITLKDVYDDGK   89 (342)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTT------TEEEEEEEEETTTCC----CHHHHHHHHHHTTSTTBCCEEEEEECSS
T ss_pred             ccccEEEEEEEeeCCCEEEEEEEECCC------CCEEEEEEEEcccCC----hHHHHHHHHHhcCCCCcCeEEEEEEcCC
Confidence            456699999999999999999998765      678999999765432    34688888887 7999999999999999


Q ss_pred             eEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCC----CceEEcccC
Q 046893          169 HRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNAD----FSAKLSDFG  244 (464)
Q Consensus       169 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~----~~vkl~DFG  244 (464)
                      ..|+||||+.+|+|.+++....  .+++..+..++.||+.||.|||  ..+|+||||||+|||+..+    +.+||+|||
T Consensus        90 ~~~lv~E~~~gg~L~~~i~~~~--~~~~~~~~~~~~qi~~al~~lH--~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg  165 (342)
T 2qr7_A           90 YVYVVTELMKGGELLDKILRQK--FFSEREASAVLFTITKTVEYLH--AQGVVHRDLKPSNILYVDESGNPESIRICDFG  165 (342)
T ss_dssp             EEEEEECCCCSCBHHHHHHTCT--TCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCCGGGEEESSSSCSGGGEEECCCT
T ss_pred             EEEEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH--HCCcEeccCCHHHEEEecCCCCcCeEEEEECC
Confidence            9999999999999999987643  6999999999999999999999  5679999999999998433    359999999


Q ss_pred             CccCCCCCCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhccc
Q 046893          245 LAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNK  324 (464)
Q Consensus       245 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  324 (464)
                      +++......  ......+||+.|+|||++.+..++.++|||||||++|+|++|..||........   .+....+.... 
T Consensus       166 ~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~---~~~~~~i~~~~-  239 (342)
T 2qr7_A          166 FAKQLRAEN--GLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTP---EEILARIGSGK-  239 (342)
T ss_dssp             TCEECBCTT--CCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCH---HHHHHHHHHCC-
T ss_pred             CcccCcCCC--CceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCH---HHHHHHHccCC-
Confidence            998643322  223346899999999999888899999999999999999999999976432221   12221111111 


Q ss_pred             chhhccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 046893          325 KVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVA  369 (464)
Q Consensus       325 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  369 (464)
                             ..+...+....+..+.+||.+||..||.+||++.++++
T Consensus       240 -------~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~  277 (342)
T 2qr7_A          240 -------FSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLR  277 (342)
T ss_dssp             -------CCCCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             -------cccCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence                   11111222334568899999999999999999999875

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=9.2e-45  Score=350.30  Aligned_cols=264  Identities=25%  Similarity=0.348  Sum_probs=206.7

Q ss_pred             CCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCc-cHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeE-
Q 046893           93 FFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQ-GDREWLAEVNYLGQLRHSNLVKLIGYCCEDEHR-  170 (464)
Q Consensus        93 ~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~-  170 (464)
                      .|.+.+.||+|+||+||+|.+..+..   .+..||+|++...... ..+.+.+|+.+++.++||||+++++++...+.. 
T Consensus        22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   98 (298)
T 3pls_A           22 VTHSDRVIGKGHFGVVYHGEYIDQAQ---NRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLP   98 (298)
T ss_dssp             EEEEEEEEEEETTEEEEEEEEECSSS---CEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCC
T ss_pred             EEccCceeccCCCceEEEEEEecCCC---ceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCc
Confidence            35566889999999999999765432   2557999998764332 336788999999999999999999999876655 


Q ss_pred             EEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCccCCC
Q 046893          171 ILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGP  250 (464)
Q Consensus       171 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~  250 (464)
                      ++||||+.+++|.+++... ...+++..++.++.|++.||.|||  ..+|+||||||+|||++.++.+||+|||+++...
T Consensus        99 ~~v~e~~~~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH--~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~  175 (298)
T 3pls_A           99 HVLLPYMCHGDLLQFIRSP-QRNPTVKDLISFGLQVARGMEYLA--EQKFVHRDLAARNCMLDESFTVKVADFGLARDIL  175 (298)
T ss_dssp             EEEECCCTTCBHHHHHHCT-TCCCBHHHHHHHHHHHHHHHHHHH--HTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTT
T ss_pred             EEEEecccCCCHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHH--hCCcccCCCCcceEEEcCCCcEEeCcCCCccccc
Confidence            9999999999999998653 346899999999999999999999  5679999999999999999999999999998543


Q ss_pred             CCCC--cceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhcccchhh
Q 046893          251 MGDQ--THVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLR  328 (464)
Q Consensus       251 ~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  328 (464)
                      ....  ........||..|+|||.+.+..++.++||||||+++|+|++|..||......  ..+.....    .      
T Consensus       176 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~--~~~~~~~~----~------  243 (298)
T 3pls_A          176 DREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDP--FDLTHFLA----Q------  243 (298)
T ss_dssp             TGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCG--GGHHHHHH----T------
T ss_pred             CCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCH--HHHHHHhh----c------
Confidence            3221  11223357889999999999999999999999999999999966555432211  11111110    0      


Q ss_pred             ccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhcC
Q 046893          329 ILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETVQSQG  378 (464)
Q Consensus       329 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~~~~~  378 (464)
                          ......+..++..+.+|+.+||+.||.+|||+.++++.|+.+....
T Consensus       244 ----~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l  289 (298)
T 3pls_A          244 ----GRRLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSAL  289 (298)
T ss_dssp             ----TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred             ----CCCCCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHH
Confidence                0011122234458999999999999999999999999999887643

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=4.8e-45  Score=351.60  Aligned_cols=265  Identities=27%  Similarity=0.376  Sum_probs=208.2

Q ss_pred             HhcCCCCCC-ceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCcc--HHHHHHHHHHHhcCCCCCcceEEEEEEe
Q 046893           90 ATKFFRPDY-ILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQG--DREWLAEVNYLGQLRHSNLVKLIGYCCE  166 (464)
Q Consensus        90 ~~~~~~~~~-~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~hpniv~l~~~~~~  166 (464)
                      ..++|.+.. .||+|+||.||+|.+...    ..+..||||++.......  ...+.+|+.+++.++||||+++++++ .
T Consensus        14 ~~~~y~~~~~~lg~G~~g~Vy~~~~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~   88 (291)
T 1xbb_A           14 DRKLLTLEDKELGSGNFGTVKKGYYQMK----KVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-E   88 (291)
T ss_dssp             CGGGEEEEEEEEEECSSEEEEEEEEECS----SSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-E
T ss_pred             cchhhhhccCccccccCeeeEeeeecCC----CceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-C
Confidence            345677777 899999999999976432    136789999997653322  46789999999999999999999999 5


Q ss_pred             CCeEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCc
Q 046893          167 DEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLA  246 (464)
Q Consensus       167 ~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla  246 (464)
                      .+..++||||+.+++|.+++...  ..+++..++.++.|++.||.|||  ..+|+||||||+|||++.++.+||+|||++
T Consensus        89 ~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH--~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~  164 (291)
T 1xbb_A           89 AESWMLVMEMAELGPLNKYLQQN--RHVKDKNIIELVHQVSMGMKYLE--ESNFVHRDLAARNVLLVTQHYAKISDFGLS  164 (291)
T ss_dssp             SSSEEEEEECCTTEEHHHHHHHC--TTCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGEEEEETTEEEECCCTTC
T ss_pred             CCCcEEEEEeCCCCCHHHHHHhC--cCCCHHHHHHHHHHHHHHHHHHH--hCCeEcCCCCcceEEEeCCCcEEEccCCcc
Confidence            67789999999999999998764  36999999999999999999999  567999999999999999999999999999


Q ss_pred             cCCCCCCCc-ceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHhhhccc
Q 046893          247 KDGPMGDQT-HVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLL-GRRAVDKSRPSREHNLVEWARPLLNNNK  324 (464)
Q Consensus       247 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~  324 (464)
                      +........ .......||..|+|||++.+..++.++||||||+++|+|++ |+.||.......   +...    +... 
T Consensus       165 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~---~~~~----~~~~-  236 (291)
T 1xbb_A          165 KALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE---VTAM----LEKG-  236 (291)
T ss_dssp             EECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH---HHHH----HHTT-
T ss_pred             eeeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHH---HHHH----HHcC-
Confidence            865433221 11222456789999999998899999999999999999999 999997644211   1111    1110 


Q ss_pred             chhhccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhcChh
Q 046893          325 KVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETVQSQGAE  380 (464)
Q Consensus       325 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~~~~~~~  380 (464)
                               .....+..++..+.+|+.+||+.||.+||++.++++.|+.+......
T Consensus       237 ---------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~  283 (291)
T 1xbb_A          237 ---------ERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVN  283 (291)
T ss_dssp             ---------CCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHHHH
T ss_pred             ---------CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhh
Confidence                     11122334556899999999999999999999999999998765443

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=5.6e-45  Score=352.09  Aligned_cols=265  Identities=25%  Similarity=0.404  Sum_probs=204.6

Q ss_pred             hcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCc-cHHHHHHHHHHHhcCCCCCcceEEEEEE-eCC
Q 046893           91 TKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQ-GDREWLAEVNYLGQLRHSNLVKLIGYCC-EDE  168 (464)
Q Consensus        91 ~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~-~~~  168 (464)
                      ..+|++.+.||+|+||+||+|.+..+..   ....+|+|.+...... ....+.+|+.+++.++||||+++++++. .++
T Consensus        24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~---~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  100 (298)
T 3f66_A           24 SLIVHFNEVIGRGHFGCVYHGTLLDNDG---KKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEG  100 (298)
T ss_dssp             GEEEEEEEEEEEETTEEEEEEEEC--------CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSS
T ss_pred             ceehhhcceeeecCCceEEEEEEecCCC---ceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCC
Confidence            3458888999999999999998765422   2456899998764332 3367889999999999999999999864 456


Q ss_pred             eEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCccC
Q 046893          169 HRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKD  248 (464)
Q Consensus       169 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~  248 (464)
                      ..++||||+.+|+|.+++... ...+++..++.++.|++.||.|||  .++|+||||||+|||++.++.+||+|||+++.
T Consensus       101 ~~~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~ql~~~l~~lH--~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~  177 (298)
T 3f66_A          101 SPLVVLPYMKHGDLRNFIRNE-THNPTVKDLIGFGLQVAKGMKYLA--SKKFVHRDLAARNCMLDEKFTVKVADFGLARD  177 (298)
T ss_dssp             CCEEEEECCTTCBHHHHHHCT-TCCCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCSGGGEEECTTCCEEECSCGGGCC
T ss_pred             ceEEEEeCCCCCCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHH--hCCccCCCCchheEEECCCCCEEECccccccc
Confidence            789999999999999998654 346899999999999999999999  56799999999999999999999999999986


Q ss_pred             CCCCCC--cceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHhhhcccc
Q 046893          249 GPMGDQ--THVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLL-GRRAVDKSRPSREHNLVEWARPLLNNNKK  325 (464)
Q Consensus       249 ~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  325 (464)
                      ......  ........||+.|+|||.+.+..++.++||||||+++|+|++ |.+||.......   ....   .....  
T Consensus       178 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~---~~~~---~~~~~--  249 (298)
T 3f66_A          178 MYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD---ITVY---LLQGR--  249 (298)
T ss_dssp             CSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTT---HHHH---HHTTC--
T ss_pred             ccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHH---HHHH---HhcCC--
Confidence            533221  112233568889999999999999999999999999999999 555565433221   1111   11110  


Q ss_pred             hhhccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhcC
Q 046893          326 VLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETVQSQG  378 (464)
Q Consensus       326 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~~~~~  378 (464)
                               ....+..++..+.+|+.+||+.||.+||++.++++.|+.+....
T Consensus       250 ---------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~  293 (298)
T 3f66_A          250 ---------RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF  293 (298)
T ss_dssp             ---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTS
T ss_pred             ---------CCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence                     01112223457999999999999999999999999999987654

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=4.2e-45  Score=356.76  Aligned_cols=277  Identities=27%  Similarity=0.392  Sum_probs=210.6

Q ss_pred             cCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCc-cHHHHHHHHHHHhcCCCCCcceEEEEEEeC--C
Q 046893           92 KFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQ-GDREWLAEVNYLGQLRHSNLVKLIGYCCED--E  168 (464)
Q Consensus        92 ~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~--~  168 (464)
                      ++|++.+.||+|+||+||++.+...  ....++.||||++...... ....+.+|+.+|+.++||||+++++++...  .
T Consensus        31 r~~~~~~~lG~G~~g~V~~~~~~~~--~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  108 (318)
T 3lxp_A           31 RYLKKIRDLGEGHFGKVSLYCYDPT--NDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAA  108 (318)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEECSC--C--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTT
T ss_pred             HHHhhhheecCCCCeEEEEEEEccC--CCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCc
Confidence            3458899999999999999875432  1224788999999765332 236689999999999999999999999884  6


Q ss_pred             eEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCccC
Q 046893          169 HRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKD  248 (464)
Q Consensus       169 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~  248 (464)
                      ..++||||+++++|.+++...   .+++..++.++.|++.||.|||  ..+|+||||||+|||++.++.+||+|||+++.
T Consensus       109 ~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~i~~~l~~~l~~LH--~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~  183 (318)
T 3lxp_A          109 SLQLVMEYVPLGSLRDYLPRH---SIGLAQLLLFAQQICEGMAYLH--AQHYIHRDLAARNVLLDNDRLVKIGDFGLAKA  183 (318)
T ss_dssp             EEEEEECCCTTCBHHHHGGGS---CCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGEEECTTCCEEECCGGGCEE
T ss_pred             eEEEEEecccCCcHHHHHhhC---CCCHHHHHHHHHHHHHHHHHHH--hCCccCCCCchheEEEcCCCCEEECCcccccc
Confidence            789999999999999988654   4899999999999999999999  56799999999999999999999999999987


Q ss_pred             CCCCCCc-ceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhcccchh
Q 046893          249 GPMGDQT-HVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVL  327 (464)
Q Consensus       249 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  327 (464)
                      ....... .......||..|+|||++.+..++.++||||||+++|+|++|+.||....... .....+..... ....+.
T Consensus       184 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~-~~~~~~~~~~~-~~~~~~  261 (318)
T 3lxp_A          184 VPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKF-LELIGIAQGQM-TVLRLT  261 (318)
T ss_dssp             CCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHH-HHHHCSCCHHH-HHHHHH
T ss_pred             ccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhh-hhhhcccccch-hHHHHH
Confidence            5443221 22334568899999999999999999999999999999999999986431100 00000000000 000111


Q ss_pred             hccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhc
Q 046893          328 RILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETVQSQ  377 (464)
Q Consensus       328 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~~~~  377 (464)
                      ..+........+..++..+.+||.+||+.||.+||++.++++.|+.+...
T Consensus       262 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~  311 (318)
T 3lxp_A          262 ELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEK  311 (318)
T ss_dssp             HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHHhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHh
Confidence            11122222233444566899999999999999999999999999988654

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=3.3e-45  Score=363.53  Aligned_cols=209  Identities=25%  Similarity=0.317  Sum_probs=181.4

Q ss_pred             cchhHHHHHhcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCccHHHHHHHHHHHhcCC-----CCC
Q 046893           82 FTYNEMKLATKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLR-----HSN  156 (464)
Q Consensus        82 ~~~~~~~~~~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----hpn  156 (464)
                      +.+.+..+..++|++.+.||+|+||+||+|.+..+      ++.||||++... ......+..|+.+++.+.     |||
T Consensus        25 ~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~------~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~   97 (360)
T 3llt_A           25 FSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDN------KKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNN   97 (360)
T ss_dssp             CCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTT------CCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGG
T ss_pred             eeeecceEecCEEEEEEEEcccCCeEEEEEEECCC------CeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCC
Confidence            44555566778999999999999999999998765      667999998642 223456778999999986     999


Q ss_pred             cceEEEEEEeCCeEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecC--
Q 046893          157 LVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNA--  234 (464)
Q Consensus       157 iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~--  234 (464)
                      |+++++++...+..+|||||+ +++|.+++.......+++..+..++.||+.||.|||  .++|+||||||+||||+.  
T Consensus        98 iv~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH--~~~ivHrDlkp~NIll~~~~  174 (360)
T 3llt_A           98 IVKYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLR--KMSLTHTDLKPENILLDDPY  174 (360)
T ss_dssp             BCCEEEEEEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGEEESCTT
T ss_pred             eecccceeeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH--HCCeeeCCCCcccEEEcccc
Confidence            999999999999999999999 999999998766567999999999999999999999  567999999999999975  


Q ss_pred             -----------------------CCceEEcccCCccCCCCCCCcceeeccccCCcccCccccccCCCCcccchhcHHHHH
Q 046893          235 -----------------------DFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVL  291 (464)
Q Consensus       235 -----------------------~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il  291 (464)
                                             ++.+||+|||+++....     ......||+.|+|||++.+..++.++|||||||+|
T Consensus       175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il  249 (360)
T 3llt_A          175 FEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSD-----YHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVL  249 (360)
T ss_dssp             CCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTS-----CCCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHH
T ss_pred             ccccccchhcccccccccccccCCCCEEEEeccCceecCC-----CCcCccCcccccCcHHHcCCCCCCccchHHHHHHH
Confidence                                   78999999999985322     12346799999999999999999999999999999


Q ss_pred             HHHHhCCCCCCCCC
Q 046893          292 LEMLLGRRAVDKSR  305 (464)
Q Consensus       292 ~ell~g~~pf~~~~  305 (464)
                      |+|++|+.||....
T Consensus       250 ~ell~g~~pf~~~~  263 (360)
T 3llt_A          250 AELYTGSLLFRTHE  263 (360)
T ss_dssp             HHHHHSSCSCCCSS
T ss_pred             HHHHHCCCCCCCCc
Confidence            99999999997654

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.3e-45  Score=366.35  Aligned_cols=264  Identities=25%  Similarity=0.401  Sum_probs=199.3

Q ss_pred             CCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCC-ccHHHHHHHHHHHhcCCCCCcceEEEEEEe-CCeE
Q 046893           93 FFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGY-QGDREWLAEVNYLGQLRHSNLVKLIGYCCE-DEHR  170 (464)
Q Consensus        93 ~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~~~~  170 (464)
                      .|.+.+.||+|+||+||+|.+....   .....||+|.+..... .....+.+|+.+++.++||||+++++++.. ++..
T Consensus        90 ~~~~~~~LG~G~fg~Vy~~~~~~~~---~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~  166 (373)
T 3c1x_A           90 IVHFNEVIGRGHFGCVYHGTLLDND---GKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSP  166 (373)
T ss_dssp             EEEEEEEEECCSSSEEEEEEEEETT---TEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCC
T ss_pred             eeecCcEeeeCCCeEEEEEEEECCC---CcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCe
Confidence            3667788999999999999875431   1245789999875433 334678999999999999999999998754 4678


Q ss_pred             EEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCccCCC
Q 046893          171 ILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGP  250 (464)
Q Consensus       171 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~  250 (464)
                      ++||||+.+|+|.+++... ...+++..++.++.|++.||.|||  .++|+||||||+||||+.++.+||+|||+++...
T Consensus       167 ~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH--~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~  243 (373)
T 3c1x_A          167 LVVLPYMKHGDLRNFIRNE-THNPTVKDLIGFGLQVAKGMKFLA--SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMY  243 (373)
T ss_dssp             EEEEECCTTCBHHHHHHCT-TCCCBHHHHHHHHHHHHHHHHHHH--HTTCCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred             EEEEECCCCCCHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHH--HCCEecCccchheEEECCCCCEEEeecccccccc
Confidence            9999999999999998654 346899999999999999999999  5679999999999999999999999999998643


Q ss_pred             CCCCc--ceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHhhhcccchh
Q 046893          251 MGDQT--HVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLL-GRRAVDKSRPSREHNLVEWARPLLNNNKKVL  327 (464)
Q Consensus       251 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  327 (464)
                      .....  .......||+.|+|||++.+..++.++|||||||++|||++ |.+||.......   .....   ... .   
T Consensus       244 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~---~~~~~---~~~-~---  313 (373)
T 3c1x_A          244 DKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD---ITVYL---LQG-R---  313 (373)
T ss_dssp             --------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSC---HHHHH---HTT-C---
T ss_pred             ccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHH---HHHHH---HcC-C---
Confidence            32211  11233567889999999999999999999999999999999 677776544322   11111   111 0   


Q ss_pred             hccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhcCh
Q 046893          328 RILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETVQSQGA  379 (464)
Q Consensus       328 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~~~~~~  379 (464)
                             ....+..++..+.+|+.+||+.||.+||++.++++.|+.+.....
T Consensus       314 -------~~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~  358 (373)
T 3c1x_A          314 -------RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI  358 (373)
T ss_dssp             -------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCC
T ss_pred             -------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcc
Confidence                   011123345689999999999999999999999999999876543

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=8.4e-45  Score=352.78  Aligned_cols=266  Identities=26%  Similarity=0.324  Sum_probs=200.3

Q ss_pred             HHhcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCC-----ccHHHHHHHHHHHhcC---CCCCcceE
Q 046893           89 LATKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGY-----QGDREWLAEVNYLGQL---RHSNLVKL  160 (464)
Q Consensus        89 ~~~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l---~hpniv~l  160 (464)
                      +..++|++.+.||+|+||+||+|.+..+      ++.||||++.....     .....+.+|+.+++.+   .||||+++
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~------~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~   79 (308)
T 3g33_A            6 MATSRYEPVAEIGVGAYGTVYKARDPHS------GHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRL   79 (308)
T ss_dssp             ----CCEEEEEECCSSSCCEEEEECTTT------CCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCE
T ss_pred             ccccceEEEEEEecCCCeEEEEEEECCC------CcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEe
Confidence            4567899999999999999999997664      67799999864221     1234667788777776   49999999


Q ss_pred             EEEEEeCC-----eEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCC
Q 046893          161 IGYCCEDE-----HRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNAD  235 (464)
Q Consensus       161 ~~~~~~~~-----~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~  235 (464)
                      ++++....     ..++||||+. ++|.+++.......+++..+..++.|++.||.|||  .++|+||||||+|||++.+
T Consensus        80 ~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH--~~~ivH~Dlkp~Nil~~~~  156 (308)
T 3g33_A           80 MDVCATSRTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLH--ANCIVHRDLKPENILVTSG  156 (308)
T ss_dssp             EEEEEECCSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCCTTTEEECTT
T ss_pred             eeeeeccCCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH--HCCcccCCCCHHHEEEcCC
Confidence            99998765     5899999996 59999998766556999999999999999999999  5679999999999999999


Q ss_pred             CceEEcccCCccCCCCCCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHH
Q 046893          236 FSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEW  315 (464)
Q Consensus       236 ~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~  315 (464)
                      +.+||+|||+++......   ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+......  +...
T Consensus       157 ~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~--~~~i  231 (308)
T 3g33_A          157 GTVKLADFGLARIYSYQM---ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQ--LGKI  231 (308)
T ss_dssp             SCEEECSCSCTTTSTTCC---CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHH--HHHH
T ss_pred             CCEEEeeCccccccCCCc---ccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHH
Confidence            999999999998643222   23446899999999999999999999999999999999999999976542211  1111


Q ss_pred             HHHhhhcc--cchhh-------ccC---ccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 046893          316 ARPLLNNN--KKVLR-------ILD---PRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVA  369 (464)
Q Consensus       316 ~~~~~~~~--~~~~~-------~~~---~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  369 (464)
                      . ..+...  .....       .+.   +..........+..+.+||.+||+.||.+|||+.++++
T Consensus       232 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  296 (308)
T 3g33_A          232 F-DLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ  296 (308)
T ss_dssp             H-HHHCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             H-HHhCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence            1 110000  00000       000   00000111234458899999999999999999999874

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.1e-45  Score=372.55  Aligned_cols=262  Identities=21%  Similarity=0.218  Sum_probs=205.4

Q ss_pred             hhHHHHHhcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCC---ccHHHHHHHHHHHhcCCCCCcceE
Q 046893           84 YNEMKLATKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGY---QGDREWLAEVNYLGQLRHSNLVKL  160 (464)
Q Consensus        84 ~~~~~~~~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~l  160 (464)
                      ..+..+..++|++.+.||+|+||+||+|.+..+      ++.||||++.+...   .....+.+|..+|..++||||+++
T Consensus        53 ~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~------~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l  126 (412)
T 2vd5_A           53 LKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQT------GQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQL  126 (412)
T ss_dssp             HHHHSCCGGGEEEEEEEEECSSCEEEEEEETTT------CCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCE
T ss_pred             hhhccCChhhEEEEEEEeeCCCeEEEEEEECCC------CCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeE
Confidence            445556678999999999999999999998764      67899999865221   112347889999999999999999


Q ss_pred             EEEEEeCCeEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEE
Q 046893          161 IGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKL  240 (464)
Q Consensus       161 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl  240 (464)
                      +++|.+.+..||||||+++|+|.+++.+. +..+++..+..++.||+.||.|||  .++|+||||||+||||+.++.+||
T Consensus       127 ~~~~~~~~~~~lVmE~~~gg~L~~~l~~~-~~~l~~~~~~~~~~qi~~aL~~LH--~~giiHrDLKp~NILld~~g~vkL  203 (412)
T 2vd5_A          127 HFAFQDENYLYLVMEYYVGGDLLTLLSKF-GERIPAEMARFYLAEIVMAIDSVH--RLGYVHRDIKPDNILLDRCGHIRL  203 (412)
T ss_dssp             EEEEECSSEEEEEECCCCSCBHHHHHHHH-SSCCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEECTTSCEEE
T ss_pred             EEEEeeCCEEEEEEcCCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHH--HCCeeecccCHHHeeecCCCCEEE
Confidence            99999999999999999999999998764 346999999999999999999999  567999999999999999999999


Q ss_pred             cccCCccCCCCCCCcceeeccccCCcccCccccc-------cCCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHH
Q 046893          241 SDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVM-------TGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLV  313 (464)
Q Consensus       241 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~  313 (464)
                      +|||+++...... .......+||+.|+|||++.       +..|+.++|||||||++|||++|+.||......      
T Consensus       204 ~DFGla~~~~~~~-~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~------  276 (412)
T 2vd5_A          204 ADFGSCLKLRADG-TVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTA------  276 (412)
T ss_dssp             CCCTTCEECCTTS-CEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHH------
T ss_pred             eechhheeccCCC-ccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHH------
Confidence            9999998653322 12233468999999999987       357899999999999999999999999764321      


Q ss_pred             HHHHHhhhcccchhhccCccccCccCHHHHHHHHHHHHHhhccCCCCC---CCHHHHHH
Q 046893          314 EWARPLLNNNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGR---PVMSDVVA  369 (464)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R---Ps~~ev~~  369 (464)
                      +....++.....   ...+.    .....+.++.+||.+||. +|.+|   |++.++++
T Consensus       277 ~~~~~i~~~~~~---~~~p~----~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~  327 (412)
T 2vd5_A          277 ETYGKIVHYKEH---LSLPL----VDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRT  327 (412)
T ss_dssp             HHHHHHHTHHHH---CCCC--------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHT
T ss_pred             HHHHHHHhcccC---cCCCc----cccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhc
Confidence            111111110000   00011    112344588999999999 99998   57777753

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=1.2e-45  Score=355.01  Aligned_cols=260  Identities=23%  Similarity=0.350  Sum_probs=205.6

Q ss_pred             hcCCCCCCceeecCceEEEEEEecCCCC-CCccceEEEEEEccCCCCccHHHHHHHHHHHhcCCCCCcceEEEEEEeCCe
Q 046893           91 TKFFRPDYILGEGGFGVVYKGVIDENVR-PGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVKLIGYCCEDEH  169 (464)
Q Consensus        91 ~~~~~~~~~lG~G~fg~Vy~a~~~~~~~-~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~  169 (464)
                      .++|.+.+.||+|+||+||+|.+..+.. .......||+|++........+.+.+|+.+++.++||||+++++++...+.
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   86 (289)
T 4fvq_A            7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDE   86 (289)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTC
T ss_pred             hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCC
Confidence            4568899999999999999998776422 112236799999876555566789999999999999999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCc--------eEEc
Q 046893          170 RILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFS--------AKLS  241 (464)
Q Consensus       170 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~--------vkl~  241 (464)
                      .++||||+.+++|.+++.... ..+++..++.++.|++.||.|||  .++|+||||||+|||++.++.        +||+
T Consensus        87 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~LH--~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~  163 (289)
T 4fvq_A           87 NILVQEFVKFGSLDTYLKKNK-NCINILWKLEVAKQLAAAMHFLE--ENTLIHGNVCAKNILLIREEDRKTGNPPFIKLS  163 (289)
T ss_dssp             CEEEEECCTTCBHHHHHHHTG-GGCCHHHHHHHHHHHHHHHHHHH--HTTCCCCCCCGGGEEEEECCBGGGTBCCEEEEC
T ss_pred             CEEEEECCCCCCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHh--hCCeECCCcCcceEEEecCCcccccccceeeec
Confidence            999999999999999987653 34899999999999999999999  567999999999999988877        9999


Q ss_pred             ccCCccCCCCCCCcceeeccccCCcccCcccccc-CCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhh
Q 046893          242 DFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMT-GHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLL  320 (464)
Q Consensus       242 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~  320 (464)
                      |||++.....      .....||..|+|||++.+ ..++.++||||||+++|+|++|..|+.......  ....    ..
T Consensus       164 Dfg~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~--~~~~----~~  231 (289)
T 4fvq_A          164 DPGISITVLP------KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQ--RKLQ----FY  231 (289)
T ss_dssp             CCCSCTTTSC------HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH--HHHH----HH
T ss_pred             cCcccccccC------ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchH--HHHH----Hh
Confidence            9999975321      123568999999999987 779999999999999999999655544322111  0111    11


Q ss_pred             hcccchhhccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhc
Q 046893          321 NNNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETVQSQ  377 (464)
Q Consensus       321 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~~~~  377 (464)
                      .....        +    +...+..+.+|+.+||+.||.+|||+.++++.|+.+...
T Consensus       232 ~~~~~--------~----~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p  276 (289)
T 4fvq_A          232 EDRHQ--------L----PAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTP  276 (289)
T ss_dssp             HTTCC--------C----CCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC--
T ss_pred             hccCC--------C----CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCC
Confidence            11100        0    111123688999999999999999999999999987653

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=8.3e-45  Score=355.74  Aligned_cols=252  Identities=23%  Similarity=0.336  Sum_probs=195.9

Q ss_pred             hcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCC-ccHHHHHHHHHHHhcCCCCCcceEEEEEEeCC-
Q 046893           91 TKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGY-QGDREWLAEVNYLGQLRHSNLVKLIGYCCEDE-  168 (464)
Q Consensus        91 ~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~-  168 (464)
                      .++|++.+.||+|+||.||+|++..+      ++.||||++..... ...+.+.+|+.+|+.++||||++++++|.+.. 
T Consensus         5 ~~~y~~~~~lG~G~~g~V~~a~~~~~------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~   78 (332)
T 3qd2_B            5 LTDFEPIQCMGRGGFGVVFEAKNKVD------DCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPP   78 (332)
T ss_dssp             HHHEEEEEEEECC-CSEEEEEEETTT------CCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCS
T ss_pred             hhcCceeeEecCCCCeEEEEEEEcCC------CcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEecc
Confidence            35688999999999999999998765      66799999875433 34477899999999999999999999986653 


Q ss_pred             --------------------------------------------------------eEEEEEeccCCCCHHHHHHhhcC-
Q 046893          169 --------------------------------------------------------HRILVYEYMESGSLEKHLLRRVG-  191 (464)
Q Consensus       169 --------------------------------------------------------~~~lv~e~~~~g~L~~~l~~~~~-  191 (464)
                                                                              ..++|||||++++|.+++..... 
T Consensus        79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~  158 (332)
T 3qd2_B           79 EKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSL  158 (332)
T ss_dssp             CHHHHHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSG
T ss_pred             chhhhhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCc
Confidence                                                                    38999999999999999876432 


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCccCCCCCCCc----------ceeecc
Q 046893          192 CMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQT----------HVSTRV  261 (464)
Q Consensus       192 ~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~~----------~~~~~~  261 (464)
                      ....+..++.++.|++.||.|||  +++|+||||||+||||+.++.+||+|||+++........          ......
T Consensus       159 ~~~~~~~~~~i~~qi~~aL~~LH--~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~  236 (332)
T 3qd2_B          159 EDREHGVCLHIFIQIAEAVEFLH--SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQ  236 (332)
T ss_dssp             GGSCHHHHHHHHHHHHHHHHHHH--HTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSC
T ss_pred             cchhhHHHHHHHHHHHHHHHHHH--hCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhcccccccccccccccc
Confidence            23567778999999999999999  567999999999999999999999999999865433211          122346


Q ss_pred             ccCCcccCccccccCCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhcccchhhccCccccCccCHH
Q 046893          262 MGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRILDPRLEGQYTAR  341 (464)
Q Consensus       262 ~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  341 (464)
                      .||+.|+|||++.+..++.++|||||||++|||++|..|+...        ........          .. ........
T Consensus       237 ~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~--------~~~~~~~~----------~~-~~~~~~~~  297 (332)
T 3qd2_B          237 VGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMER--------VRIITDVR----------NL-KFPLLFTQ  297 (332)
T ss_dssp             C-CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHH--------HHHHHHHH----------TT-CCCHHHHH
T ss_pred             CCCcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHH--------HHHHHHhh----------cc-CCCccccc
Confidence            7999999999999999999999999999999999987654210        01000000          00 00111223


Q ss_pred             HHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 046893          342 TAMKVAGLAYQCLSQNPKGRPVMSDVVA  369 (464)
Q Consensus       342 ~~~~l~~li~~cl~~dP~~RPs~~ev~~  369 (464)
                      ....+.+|+.+||+.||.+||++.++++
T Consensus       298 ~~~~~~~li~~~l~~~p~~Rps~~~~l~  325 (332)
T 3qd2_B          298 KYPQEHMMVQDMLSPSPTERPEATDIIE  325 (332)
T ss_dssp             HCHHHHHHHHHHHCSSGGGSCCHHHHHH
T ss_pred             CChhHHHHHHHHccCCCCcCCCHHHHhh
Confidence            3457789999999999999999999875

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=2e-44  Score=350.38  Aligned_cols=263  Identities=22%  Similarity=0.331  Sum_probs=199.8

Q ss_pred             cCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCc---cHHHHHHHHHHHhcCCCCCcceEEEEEEeCC
Q 046893           92 KFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQ---GDREWLAEVNYLGQLRHSNLVKLIGYCCEDE  168 (464)
Q Consensus        92 ~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~  168 (464)
                      ++|++.+.||+|+||.||+|.+..+      +..||+|++......   ....+.+|+.+++.++||||+++++++...+
T Consensus        32 ~~y~~~~~lg~G~~g~Vy~~~~~~~------~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~  105 (310)
T 2wqm_A           32 ANFRIEKKIGRGQFSEVYRAACLLD------GVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDN  105 (310)
T ss_dssp             GGEEEEEEEECC--CEEEEEEETTT------CCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETT
T ss_pred             cceEEEEeecCCCCceEEEEEEcCC------CceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC
Confidence            4588999999999999999998764      567999998754322   2356889999999999999999999999999


Q ss_pred             eEEEEEeccCCCCHHHHHHhh--cCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCc
Q 046893          169 HRILVYEYMESGSLEKHLLRR--VGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLA  246 (464)
Q Consensus       169 ~~~lv~e~~~~g~L~~~l~~~--~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla  246 (464)
                      ..++||||+.+++|.+++...  ....+++..++.++.|++.||.|||  ..+|+||||||+|||++.++.+||+|||++
T Consensus       106 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH--~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~  183 (310)
T 2wqm_A          106 ELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMH--SRRVMHRDIKPANVFITATGVVKLGDLGLG  183 (310)
T ss_dssp             EEEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH--HTTCCCCCCCGGGEEECTTSCEEECCC---
T ss_pred             cEEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHh--hCCeeCCCCcHHHEEEcCCCCEEEEeccce
Confidence            999999999999999988642  2456899999999999999999999  567999999999999999999999999999


Q ss_pred             cCCCCCCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhcccch
Q 046893          247 KDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKV  326 (464)
Q Consensus       247 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  326 (464)
                      +.....  ........|+..|+|||++.+..++.++||||||+++|+|++|+.||.+....    ...+........   
T Consensus       184 ~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~----~~~~~~~~~~~~---  254 (310)
T 2wqm_A          184 RFFSSK--TTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN----LYSLCKKIEQCD---  254 (310)
T ss_dssp             -----------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CC----HHHHHHHHHTTC---
T ss_pred             eeecCC--CccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchh----HHHHHHHhhccc---
Confidence            764322  12223467999999999999999999999999999999999999999754321    111111111100   


Q ss_pred             hhccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhcC
Q 046893          327 LRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETVQSQG  378 (464)
Q Consensus       327 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~~~~~  378 (464)
                          .+.   .....++..+.+|+.+||..||.+||++.+|++.|+.+....
T Consensus       255 ----~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~  299 (310)
T 2wqm_A          255 ----YPP---LPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACT  299 (310)
T ss_dssp             ----SCC---CCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             ----CCC---CcccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhh
Confidence                010   111234458999999999999999999999999999987643

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.5e-43  Score=347.92  Aligned_cols=273  Identities=23%  Similarity=0.338  Sum_probs=206.6

Q ss_pred             hhHHHHHhcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCccHHHHHHHHHHHhcC--CCCCcceEE
Q 046893           84 YNEMKLATKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQL--RHSNLVKLI  161 (464)
Q Consensus        84 ~~~~~~~~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l--~hpniv~l~  161 (464)
                      ........++|++.+.||+|+||.||+|.+.        ++.||||++...   ....+..|.+++..+  +||||++++
T Consensus        29 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~--------~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~   97 (337)
T 3mdy_A           29 LLVQRTIAKQIQMVKQIGKGRYGEVWMGKWR--------GEKVAVKVFFTT---EEASWFRETEIYQTVLMRHENILGFI   97 (337)
T ss_dssp             HHHHTTHHHHCEEEEEEEEETTEEEEEEEET--------TEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEE
T ss_pred             cccccccccceEEEeEeecCCCeEEEEEEEC--------CceEEEEEEecc---ccchhhhHHHHHHHHhhcCCCeeeEE
Confidence            3344556678999999999999999999864        467999998542   344556666666665  899999999


Q ss_pred             EEEEeC----CeEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcC------CCCeeeccCCCCceE
Q 046893          162 GYCCED----EHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGA------ERPVIYRDFKTSNIL  231 (464)
Q Consensus       162 ~~~~~~----~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~------~~~ivHrDlkp~Nil  231 (464)
                      +++...    ...++||||+++|+|.+++...   .+++..++.++.|++.||.|||+.      ..+|+||||||+|||
T Consensus        98 ~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nil  174 (337)
T 3mdy_A           98 AADIKGTGSWTQLYLITDYHENGSLYDYLKST---TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNIL  174 (337)
T ss_dssp             EEEEESCGGGCEEEEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEE
T ss_pred             EEEccCCCCCCceEEEEeccCCCcHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEE
Confidence            999888    7899999999999999998654   599999999999999999999953      228999999999999


Q ss_pred             ecCCCceEEcccCCccCCCCCCCcc--eeeccccCCcccCccccccCCCCcc------cchhcHHHHHHHHHhC------
Q 046893          232 LNADFSAKLSDFGLAKDGPMGDQTH--VSTRVMGTYGYAAPEYVMTGHLTAR------SDVYGFGVVLLEMLLG------  297 (464)
Q Consensus       232 l~~~~~vkl~DFGla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~------~DvwslG~il~ell~g------  297 (464)
                      ++.++.+||+|||+++.........  ......||+.|+|||++.+..++..      +|||||||++|||++|      
T Consensus       175 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~  254 (337)
T 3mdy_A          175 VKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGI  254 (337)
T ss_dssp             ECTTSCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTB
T ss_pred             ECCCCCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccc
Confidence            9999999999999997543322111  1224679999999999988776665      9999999999999999      


Q ss_pred             ----CCCCCCCCCcccccHHHHHHHhhhcccchhhccCccccCc-cCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 046893          298 ----RRAVDKSRPSREHNLVEWARPLLNNNKKVLRILDPRLEGQ-YTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLE  372 (464)
Q Consensus       298 ----~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~  372 (464)
                          ..||......... ... .......     ....+..... ....++..+.+|+.+||+.||.+||++.+|++.|+
T Consensus       255 ~~~~~~p~~~~~~~~~~-~~~-~~~~~~~-----~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~  327 (337)
T 3mdy_A          255 VEEYQLPYHDLVPSDPS-YED-MREIVCI-----KKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLA  327 (337)
T ss_dssp             CCCCCCTTTTTSCSSCC-HHH-HHHHHTT-----SCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHH
T ss_pred             cccccccHhhhcCCCCc-hhh-hHHHHhh-----hccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHH
Confidence                5666543322211 111 1111100     1111111111 12367889999999999999999999999999999


Q ss_pred             HHHhc
Q 046893          373 TVQSQ  377 (464)
Q Consensus       373 ~~~~~  377 (464)
                      .+...
T Consensus       328 ~l~~~  332 (337)
T 3mdy_A          328 KMSES  332 (337)
T ss_dssp             HHHHT
T ss_pred             HHHhh
Confidence            88754

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=8.8e-45  Score=349.33  Aligned_cols=262  Identities=25%  Similarity=0.344  Sum_probs=197.1

Q ss_pred             cCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCc--cHHHHHHHHHHHhcCCCCCcceEEEEEEeCCe
Q 046893           92 KFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQ--GDREWLAEVNYLGQLRHSNLVKLIGYCCEDEH  169 (464)
Q Consensus        92 ~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~  169 (464)
                      ++|++.+.||+|+||+||+|.+..       ++.||+|++......  ....+.+|+.+++.++||||+++++++...+.
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~-------~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   74 (288)
T 1ob3_A            2 EKYHGLEKIGEGTYGVVYKAQNNY-------GETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKR   74 (288)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETT-------SCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSC
T ss_pred             ccchhhhhcccCCCEEEEEEEcCC-------CCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCe
Confidence            468889999999999999998732       567999998654322  23678899999999999999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCccCC
Q 046893          170 RILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDG  249 (464)
Q Consensus       170 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~  249 (464)
                      .++||||+.+ +|.+++... ...+++..+..++.|++.||.|||  .++|+||||||+|||++.++.+||+|||+++..
T Consensus        75 ~~lv~e~~~~-~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH--~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~  150 (288)
T 1ob3_A           75 LVLVFEHLDQ-DLKKLLDVC-EGGLESVTAKSFLLQLLNGIAYCH--DRRVLHRDLKPQNLLINREGELKIADFGLARAF  150 (288)
T ss_dssp             EEEEEECCSE-EHHHHHHTS-TTCCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCCGGGEEECTTSCEEECCTTHHHHH
T ss_pred             EEEEEEecCC-CHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHH--HCCeecCCCCHHHEEEcCCCCEEEeECcccccc
Confidence            9999999975 998888654 346899999999999999999999  567999999999999999999999999999753


Q ss_pred             CCCCCcceeeccccCCcccCccccccC-CCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhcc-----
Q 046893          250 PMGDQTHVSTRVMGTYGYAAPEYVMTG-HLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNN-----  323 (464)
Q Consensus       250 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~-----  323 (464)
                      ...  ........||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.....  .+..... .+...     
T Consensus       151 ~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~--~~~~~~~-~~~~~~~~~~  225 (288)
T 1ob3_A          151 GIP--VRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEAD--QLMRIFR-ILGTPNSKNW  225 (288)
T ss_dssp             CC-----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHHHHHH-HHCCCCTTTS
T ss_pred             Ccc--ccccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHH-HHCCCChhhc
Confidence            221  1122345789999999998764 58999999999999999999999997643211  1111111 00000     


Q ss_pred             cchh--hccCccc-------cCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 046893          324 KKVL--RILDPRL-------EGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVA  369 (464)
Q Consensus       324 ~~~~--~~~~~~~-------~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  369 (464)
                      ....  ...++.+       ...+....+..+.+|+.+||+.||.+|||+.++++
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  280 (288)
T 1ob3_A          226 PNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE  280 (288)
T ss_dssp             TTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             hhhhcccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence            0000  0001110       11122234568899999999999999999999874

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=1.5e-44  Score=351.49  Aligned_cols=262  Identities=23%  Similarity=0.266  Sum_probs=201.0

Q ss_pred             hcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCcc---HHHHHHHHHHHhcCCCCCcceEEEEEEeC
Q 046893           91 TKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQG---DREWLAEVNYLGQLRHSNLVKLIGYCCED  167 (464)
Q Consensus        91 ~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~hpniv~l~~~~~~~  167 (464)
                      .++|++.+.||+|+||.||+|.+..+      ++.||+|++.......   ...+.+|+.++..++||||+++++++...
T Consensus        33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~------~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~  106 (309)
T 2h34_A           33 FGPYRLRRLVGRGGMGDVYEAEDTVR------ERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEID  106 (309)
T ss_dssp             -CCEEEEEEEEECSSSEEEEEEETTT------TEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEET
T ss_pred             eccEEEEEEEcCCCCeeEEEEEEcCC------CeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeC
Confidence            35789999999999999999998764      6789999987543222   26688999999999999999999999999


Q ss_pred             CeEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCcc
Q 046893          168 EHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAK  247 (464)
Q Consensus       168 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~  247 (464)
                      +..++||||+++++|.+++....  .+++..++.++.|++.||.|||  ..+|+||||||+|||++.++.+||+|||++.
T Consensus       107 ~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH--~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~  182 (309)
T 2h34_A          107 GQLYVDMRLINGVDLAAMLRRQG--PLAPPRAVAIVRQIGSALDAAH--AAGATHRDVKPENILVSADDFAYLVDFGIAS  182 (309)
T ss_dssp             TEEEEEEECCCCEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCCGGGEEECTTSCEEECSCCC--
T ss_pred             CeEEEEEEecCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH--HCcCCcCCCChHHEEEcCCCCEEEecCccCc
Confidence            99999999999999999987653  6899999999999999999999  5679999999999999999999999999997


Q ss_pred             CCCCCCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhcccchh
Q 046893          248 DGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVL  327 (464)
Q Consensus       248 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  327 (464)
                      ....... .......||..|+|||++.+..++.++||||||+++|+|++|+.||......       .....+...... 
T Consensus       183 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-------~~~~~~~~~~~~-  253 (309)
T 2h34_A          183 ATTDEKL-TQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLS-------VMGAHINQAIPR-  253 (309)
T ss_dssp             ---------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHH-------HHHHHHHSCCCC-
T ss_pred             ccccccc-ccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHH-------HHHHHhccCCCC-
Confidence            6433221 1223467999999999999999999999999999999999999999764311       111111111000 


Q ss_pred             hccCccccCccCHHHHHHHHHHHHHhhccCCCCCC-CHHHHHHHHHHHHhcC
Q 046893          328 RILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRP-VMSDVVALLETVQSQG  378 (464)
Q Consensus       328 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-s~~ev~~~L~~~~~~~  378 (464)
                             .......++..+.+|+.+||+.||.+|| ++.++++.|+.+....
T Consensus       254 -------~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~  298 (309)
T 2h34_A          254 -------PSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATA  298 (309)
T ss_dssp             -------GGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC--
T ss_pred             -------ccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhh
Confidence                   1112233445789999999999999999 9999999998876544

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=2.7e-45  Score=350.82  Aligned_cols=255  Identities=28%  Similarity=0.404  Sum_probs=201.8

Q ss_pred             HHhcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCccHHHHHHHHHHHhcCCCCCcceEEEEEEeC-
Q 046893           89 LATKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVKLIGYCCED-  167 (464)
Q Consensus        89 ~~~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~-  167 (464)
                      +..++|++.+.||+|+||+||+|.+.        ++.||||++....  ..+.+.+|+.+++.++||||+++++++... 
T Consensus        18 ~~~~~y~~~~~lg~G~~g~V~~~~~~--------~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   87 (278)
T 1byg_A           18 LNMKELKLLQTIGKGEFGDVMLGDYR--------GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEK   87 (278)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEET--------TEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC-
T ss_pred             CChhhceEEeEEecCCCceEEEEEEc--------CCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC
Confidence            34567899999999999999999764        4579999987542  456789999999999999999999987654 


Q ss_pred             CeEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCcc
Q 046893          168 EHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAK  247 (464)
Q Consensus       168 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~  247 (464)
                      +..++||||+++++|.+++.......+++..++.++.|++.||.|||  .++|+||||||+|||++.++.+||+|||++.
T Consensus        88 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH--~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~  165 (278)
T 1byg_A           88 GGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE--GNNFVHRDLAARNVLVSEDNVAKVSDFGLTK  165 (278)
T ss_dssp             -CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCSGGGEEECTTSCEEECCCCC--
T ss_pred             CceEEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHH--hCCccccCCCcceEEEeCCCcEEEeeccccc
Confidence            47899999999999999997654334899999999999999999999  5679999999999999999999999999997


Q ss_pred             CCCCCCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHhhhcccch
Q 046893          248 DGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLL-GRRAVDKSRPSREHNLVEWARPLLNNNKKV  326 (464)
Q Consensus       248 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  326 (464)
                      .....     .....++..|+|||++.+..++.++||||||+++|+|++ |+.||.......   ....    +      
T Consensus       166 ~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~---~~~~----~------  227 (278)
T 1byg_A          166 EASST-----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---VVPR----V------  227 (278)
T ss_dssp             ---------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG---HHHH----H------
T ss_pred             ccccc-----ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHH----H------
Confidence            53321     122467889999999999999999999999999999998 999997643211   1111    0      


Q ss_pred             hhccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhc
Q 046893          327 LRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETVQSQ  377 (464)
Q Consensus       327 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~~~~  377 (464)
                          ........+..++..+.+|+.+||+.||.+||++.++++.|+.+...
T Consensus       228 ----~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~~  274 (278)
T 1byg_A          228 ----EKGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH  274 (278)
T ss_dssp             ----TTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ----hcCCCCCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHhh
Confidence                01111122334556899999999999999999999999999988654

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=9.7e-45  Score=352.98  Aligned_cols=260  Identities=25%  Similarity=0.321  Sum_probs=197.4

Q ss_pred             hcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCcc---HHHHHHHHHHHhcCCCCCcceEEEEEEeC
Q 046893           91 TKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQG---DREWLAEVNYLGQLRHSNLVKLIGYCCED  167 (464)
Q Consensus        91 ~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~hpniv~l~~~~~~~  167 (464)
                      .++|++.+.||+|+||.||+|.+..+      ++.||||++.......   ...+.+|+.++..++||||+++++++...
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~------~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~   84 (311)
T 3ork_A           11 SDRYELGEILGFGGMSEVHLARDLRD------HRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAE   84 (311)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTT------TEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEE
T ss_pred             cCcEEEEEEEccCCCEEEEEEEECCC------CceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeecc
Confidence            46799999999999999999998765      6789999997654333   24688999999999999999999998765


Q ss_pred             C----eEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEccc
Q 046893          168 E----HRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDF  243 (464)
Q Consensus       168 ~----~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DF  243 (464)
                      .    ..|+||||+++++|.+++....  .+++..++.++.|++.||.|||  .++|+||||||+|||++.++.+||+||
T Consensus        85 ~~~~~~~~lv~e~~~g~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH--~~~ivH~dlkp~Nil~~~~~~~kl~Df  160 (311)
T 3ork_A           85 TPAGPLPYIVMEYVDGVTLRDIVHTEG--PMTPKRAIEVIADACQALNFSH--QNGIIHRDVKPANIMISATNAVKVMDF  160 (311)
T ss_dssp             ETTEEEEEEEEECCCEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHH--HTTCCCCCCCGGGEEEETTSCEEECCC
T ss_pred             CCCCcccEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH--HCCCCcCCCCHHHEEEcCCCCEEEeec
Confidence            4    3499999999999999987653  6999999999999999999999  567999999999999999999999999


Q ss_pred             CCccCCCCCCCc-ceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhc
Q 046893          244 GLAKDGPMGDQT-HVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNN  322 (464)
Q Consensus       244 Gla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~  322 (464)
                      |+++........ .......||+.|+|||++.+..++.++||||||+++|+|++|+.||......      .........
T Consensus       161 g~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~------~~~~~~~~~  234 (311)
T 3ork_A          161 GIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPV------SVAYQHVRE  234 (311)
T ss_dssp             SCC------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH------HHHHHHHHC
T ss_pred             cCcccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChH------HHHHHHhcC
Confidence            999864332211 2223467999999999999999999999999999999999999999764421      111111111


Q ss_pred             ccchhhccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHH-HHHHHH
Q 046893          323 NKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVV-ALLETV  374 (464)
Q Consensus       323 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~-~~L~~~  374 (464)
                      ....        .......++..+.+|+.+||+.||.+||+..+++ +.|..+
T Consensus       235 ~~~~--------~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~  279 (311)
T 3ork_A          235 DPIP--------PSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV  279 (311)
T ss_dssp             CCCC--------HHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred             CCCC--------cccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHH
Confidence            1100        0011122445789999999999999999766654 455443

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=1e-44  Score=377.42  Aligned_cols=256  Identities=27%  Similarity=0.390  Sum_probs=208.1

Q ss_pred             HHhcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCC---CccHHHHHHHHHHHhcCCCCCcceEEEEEE
Q 046893           89 LATKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGG---YQGDREWLAEVNYLGQLRHSNLVKLIGYCC  165 (464)
Q Consensus        89 ~~~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~  165 (464)
                      +..++|++.++||+|+||.||+|.+..+      ++.||+|++....   ......+.+|+.+|..++||||+++++++.
T Consensus       181 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~t------g~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~  254 (576)
T 2acx_A          181 VTKNTFRQYRVLGKGGFGEVCACQVRAT------GKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYE  254 (576)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEETTT------CCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred             ccccceEEEEEEeeCCCEEEEEEEECCC------CCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEe
Confidence            3456799999999999999999998765      6789999986432   223456789999999999999999999999


Q ss_pred             eCCeEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCC
Q 046893          166 EDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGL  245 (464)
Q Consensus       166 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGl  245 (464)
                      +.+..||||||++||+|.+++.......+++..++.++.||+.||.|||  .++|+||||||+||||+.++.+||+|||+
T Consensus       255 ~~~~l~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH--~~gIvHrDLKPeNILld~~g~vKL~DFGl  332 (576)
T 2acx_A          255 TKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLH--RERIVYRDLKPENILLDDHGHIRISDLGL  332 (576)
T ss_dssp             CSSEEEEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCCGGGEEECTTSCEEECCCTT
T ss_pred             eCCEEEEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH--HCCEeccCCchheEEEeCCCCeEEEeccc
Confidence            9999999999999999999987755456999999999999999999999  56799999999999999999999999999


Q ss_pred             ccCCCCCCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhcccc
Q 046893          246 AKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKK  325 (464)
Q Consensus       246 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  325 (464)
                      ++......   .....+||+.|+|||++.+..++.++|||||||+||||++|+.||.........  ..........   
T Consensus       333 a~~~~~~~---~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~--~~i~~~i~~~---  404 (576)
T 2acx_A          333 AVHVPEGQ---TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKR--EEVERLVKEV---  404 (576)
T ss_dssp             CEECCTTC---CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCH--HHHHHHHHHC---
T ss_pred             ceecccCc---cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhH--HHHHHHhhcc---
Confidence            98653322   223468999999999999999999999999999999999999999865432211  1111111111   


Q ss_pred             hhhccCccccCccCHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHH
Q 046893          326 VLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRP-----VMSDVVA  369 (464)
Q Consensus       326 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~ev~~  369 (464)
                               ...++...+..+.+||.+||..||.+||     ++.+|++
T Consensus       405 ---------~~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~  444 (576)
T 2acx_A          405 ---------PEEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKE  444 (576)
T ss_dssp             ---------CCCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred             ---------cccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHh
Confidence                     0112233455899999999999999999     5666653

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=1.2e-44  Score=354.90  Aligned_cols=258  Identities=26%  Similarity=0.390  Sum_probs=205.4

Q ss_pred             cCCCCCCceeecCceEEEEEEecCCCCCCccce--EEEEEEccCCC-CccHHHHHHHHHHHhcC-CCCCcceEEEEEEeC
Q 046893           92 KFFRPDYILGEGGFGVVYKGVIDENVRPGYKTT--FVAIKELNRGG-YQGDREWLAEVNYLGQL-RHSNLVKLIGYCCED  167 (464)
Q Consensus        92 ~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~--~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~  167 (464)
                      ++|++.+.||+|+||.||+|.+..+      +.  .+|+|.+.... ......+.+|+.++..+ +||||+++++++...
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~------~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~   98 (327)
T 1fvr_A           25 NDIKFQDVIGEGNFGQVLKARIKKD------GLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR   98 (327)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEET------TEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEET
T ss_pred             HHccceeeeecCCCceEEEEEEccC------CcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeC
Confidence            5688899999999999999998764      33  35999886532 22335688999999999 899999999999999


Q ss_pred             CeEEEEEeccCCCCHHHHHHhhc--------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEec
Q 046893          168 EHRILVYEYMESGSLEKHLLRRV--------------GCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLN  233 (464)
Q Consensus       168 ~~~~lv~e~~~~g~L~~~l~~~~--------------~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~  233 (464)
                      +..++||||+++++|.+++....              ...+++..++.++.|++.||.|||  .++|+||||||+|||++
T Consensus        99 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH--~~~ivH~dlkp~NIl~~  176 (327)
T 1fvr_A           99 GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS--QKQFIHRDLAARNILVG  176 (327)
T ss_dssp             TEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGEEEC
T ss_pred             CceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH--hCCccCCCCccceEEEc
Confidence            99999999999999999987542              246899999999999999999999  56799999999999999


Q ss_pred             CCCceEEcccCCccCCCCCCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHh-CCCCCCCCCCcccccH
Q 046893          234 ADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLL-GRRAVDKSRPSREHNL  312 (464)
Q Consensus       234 ~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~  312 (464)
                      .++.+||+|||+++....   ........++..|+|||++.+..++.++||||||+++|+|++ |+.||......     
T Consensus       177 ~~~~~kL~Dfg~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~-----  248 (327)
T 1fvr_A          177 ENYVAKIADFGLSRGQEV---YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA-----  248 (327)
T ss_dssp             GGGCEEECCTTCEESSCE---ECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-----
T ss_pred             CCCeEEEcccCcCccccc---cccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHH-----
Confidence            999999999999974321   111223467889999999998899999999999999999998 99999764321     


Q ss_pred             HHHHHHhhhcccchhhccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhc
Q 046893          313 VEWARPLLNNNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETVQSQ  377 (464)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~~~~  377 (464)
                       +.......           ......+..++..+.+|+.+||..||.+||++.++++.|+.+...
T Consensus       249 -~~~~~~~~-----------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~  301 (327)
T 1fvr_A          249 -ELYEKLPQ-----------GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE  301 (327)
T ss_dssp             -HHHHHGGG-----------TCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred             -HHHHHhhc-----------CCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence             11111111           011112233456899999999999999999999999999987654

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=1.4e-44  Score=360.90  Aligned_cols=247  Identities=23%  Similarity=0.290  Sum_probs=197.0

Q ss_pred             CCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCccHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeEEEEEec
Q 046893           97 DYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVKLIGYCCEDEHRILVYEY  176 (464)
Q Consensus        97 ~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~  176 (464)
                      .+.||+|+||.||+|.+..+      ++.||+|++..........+.+|+.+|..++||||+++++++...+..+|||||
T Consensus        94 ~~~lG~G~~g~Vy~a~~~~~------g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~  167 (373)
T 2x4f_A           94 TEILGGGRFGQVHKCEETAT------GLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEY  167 (373)
T ss_dssp             EEECC-----CEEEEEETTT------CCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             ceEEecCcCEEEEEEEEcCC------CcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeC
Confidence            56799999999999998765      677999999876555567899999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEe--cCCCceEEcccCCccCCCCCCC
Q 046893          177 MESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILL--NADFSAKLSDFGLAKDGPMGDQ  254 (464)
Q Consensus       177 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill--~~~~~vkl~DFGla~~~~~~~~  254 (464)
                      +++++|.+++.... ..+++..++.++.||+.||.|||  ..+|+||||||+|||+  +.++.+||+|||+++...... 
T Consensus       168 ~~~~~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH--~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~-  243 (373)
T 2x4f_A          168 VDGGELFDRIIDES-YNLTELDTILFMKQICEGIRHMH--QMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE-  243 (373)
T ss_dssp             CTTCEEHHHHHHTG-GGCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTC-
T ss_pred             CCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH--HCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCcc-
Confidence            99999999887542 35899999999999999999999  5679999999999999  567899999999998654322 


Q ss_pred             cceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhcccchhhccCccc
Q 046893          255 THVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRILDPRL  334 (464)
Q Consensus       255 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  334 (464)
                        .....+||+.|+|||++.+..++.++|||||||+||||++|+.||.+....      +....++.....        +
T Consensus       244 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~------~~~~~i~~~~~~--------~  307 (373)
T 2x4f_A          244 --KLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDA------ETLNNILACRWD--------L  307 (373)
T ss_dssp             --BCCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHH------HHHHHHHHTCCC--------S
T ss_pred             --ccccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHHhccCC--------C
Confidence              223357999999999999999999999999999999999999999765421      111111111110        0


Q ss_pred             cCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 046893          335 EGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVA  369 (464)
Q Consensus       335 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  369 (464)
                      ........+..+.+||.+||+.||.+||++.++++
T Consensus       308 ~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~  342 (373)
T 2x4f_A          308 EDEEFQDISEEAKEFISKLLIKEKSWRISASEALK  342 (373)
T ss_dssp             CSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             ChhhhccCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            01111223458899999999999999999999986

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=2e-44  Score=344.44  Aligned_cols=252  Identities=21%  Similarity=0.288  Sum_probs=204.9

Q ss_pred             HhcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCccHHHHHHHHHHHhcCCCCCcceEEEEEEeCCe
Q 046893           90 ATKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVKLIGYCCEDEH  169 (464)
Q Consensus        90 ~~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~  169 (464)
                      ..++|++.+.||+|+||.||+|.+..+      +..||+|++..........+.+|+.+++.++||||+++++++.....
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~------~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~   80 (277)
T 3f3z_A            7 INQYYTLENTIGRGSWGEVKIAVQKGT------RIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTD   80 (277)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTT------CCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSE
T ss_pred             hhhhEEeeeEEeecCCEEEEEEEeCCC------CcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCe
Confidence            346799999999999999999998765      56799999876655667889999999999999999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEe---cCCCceEEcccCCc
Q 046893          170 RILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILL---NADFSAKLSDFGLA  246 (464)
Q Consensus       170 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill---~~~~~vkl~DFGla  246 (464)
                      .++||||+.+++|.+++....  .+++..++.++.|++.||.|||  .++|+||||||+|||+   +.++.+||+|||++
T Consensus        81 ~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~i~~~i~~~l~~lH--~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~  156 (277)
T 3f3z_A           81 IYLVMELCTGGELFERVVHKR--VFRESDAARIMKDVLSAVAYCH--KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLA  156 (277)
T ss_dssp             EEEEEECCCSCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEESSSSTTCCEEECCCTTC
T ss_pred             EEEEEeccCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH--HCCccCCCCCHHHEEEecCCCCCcEEEEecccc
Confidence            999999999999999887654  5899999999999999999999  5679999999999999   78899999999999


Q ss_pred             cCCCCCCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhcccch
Q 046893          247 KDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKV  326 (464)
Q Consensus       247 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  326 (464)
                      .......   ......||+.|+|||++.+ .++.++||||||+++|+|++|+.||......      +............
T Consensus       157 ~~~~~~~---~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~------~~~~~~~~~~~~~  226 (277)
T 3f3z_A          157 ARFKPGK---MMRTKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPPFSAPTDS------EVMLKIREGTFTF  226 (277)
T ss_dssp             EECCTTS---CBCCCCSCTTTCCHHHHTT-CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHHCCCCC
T ss_pred             eeccCcc---chhccCCCCCccChHHhcc-cCCchhhehhHHHHHHHHHHCCCCCCCCCHH------HHHHHHHhCCCCC
Confidence            8643322   2234679999999998765 4999999999999999999999999764321      1111111110000


Q ss_pred             hhccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 046893          327 LRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVA  369 (464)
Q Consensus       327 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  369 (464)
                              ........+..+.+|+.+||+.||.+||++.++++
T Consensus       227 --------~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~  261 (277)
T 3f3z_A          227 --------PEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALE  261 (277)
T ss_dssp             --------CHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             --------CchhhhcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence                    00000123458899999999999999999999975

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=2.7e-44  Score=369.36  Aligned_cols=264  Identities=21%  Similarity=0.240  Sum_probs=209.4

Q ss_pred             hcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCccHHHHHHHHHHHhcCCC-CCcceEEEEEEeCCe
Q 046893           91 TKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRH-SNLVKLIGYCCEDEH  169 (464)
Q Consensus        91 ~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-pniv~l~~~~~~~~~  169 (464)
                      .++|++.++||+|+||.||+|.+..+      ++.||||++.....  ...+..|++++..|.| ++|..+..++...+.
T Consensus         6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~------~~~vAvK~~~~~~~--~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~   77 (483)
T 3sv0_A            6 GNKFRLGRKIGSGSFGEIYLGTNIQT------NEEVAIKLENVKTK--HPQLLYESKIYRILQGGTGIPNVRWFGVEGDY   77 (483)
T ss_dssp             TTTEECCCCCEECSSCEEEEEEETTT------CCEEEEEEEETTCS--SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTE
T ss_pred             CCcEEEEEEEeeCCCEEEEEEEECCC------CcEEEEEEeccccc--cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCE
Confidence            46799999999999999999998765      66799998865433  2457899999999976 566667777788889


Q ss_pred             EEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEe---cCCCceEEcccCCc
Q 046893          170 RILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILL---NADFSAKLSDFGLA  246 (464)
Q Consensus       170 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill---~~~~~vkl~DFGla  246 (464)
                      .+|||||+ +++|.+++... ...+++..++.|+.||+.||.|||  .++||||||||+||||   +.++.+||+|||++
T Consensus        78 ~~lvme~~-g~sL~~ll~~~-~~~l~~~~~~~i~~qi~~aL~yLH--~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla  153 (483)
T 3sv0_A           78 NVLVMDLL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVH--SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLA  153 (483)
T ss_dssp             EEEEEECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCCGGGEEECCGGGTTCEEECCCTTC
T ss_pred             EEEEEECC-CCCHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHH--HCCEeecccCcceEEEecCCCCCeEEEEeCCcc
Confidence            99999999 99999988653 346999999999999999999999  5679999999999999   68899999999999


Q ss_pred             cCCCCCCCc-----ceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHH-Hhh
Q 046893          247 KDGPMGDQT-----HVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWAR-PLL  320 (464)
Q Consensus       247 ~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~-~~~  320 (464)
                      +........     .......||..|+|||++.+..++.++|||||||+||||++|+.||................ ..+
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~  233 (483)
T 3sv0_A          154 KKYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV  233 (483)
T ss_dssp             EECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHH
T ss_pred             eeccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccc
Confidence            865433221     11235789999999999999999999999999999999999999998755433222222111 111


Q ss_pred             hcccchhhccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhc
Q 046893          321 NNNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETVQSQ  377 (464)
Q Consensus       321 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~~~~  377 (464)
                      ...      +     ..+...++.++.+||..||+.||.+||++.+|+++|+.+...
T Consensus       234 ~~~------~-----~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~  279 (483)
T 3sv0_A          234 ATS------I-----EALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIR  279 (483)
T ss_dssp             HSC------H-----HHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHH
T ss_pred             ccc------H-----HHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHH
Confidence            000      0     011112345899999999999999999999999999988653

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=4.8e-44  Score=348.49  Aligned_cols=260  Identities=23%  Similarity=0.280  Sum_probs=198.1

Q ss_pred             cCCCCC-CceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCccHHHHHHHHHHHhcC-CCCCcceEEEEEEeCCe
Q 046893           92 KFFRPD-YILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQL-RHSNLVKLIGYCCEDEH  169 (464)
Q Consensus        92 ~~~~~~-~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~  169 (464)
                      +.|++. +.||+|+||+||+|.+..+      ++.||||++..........+.+|+.+|.++ .||||+++++++.+.+.
T Consensus        12 ~~y~i~~~~lg~G~~g~V~~~~~~~~------~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~   85 (316)
T 2ac3_A           12 DVYQLQEDVLGEGAHARVQTCINLIT------SQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDR   85 (316)
T ss_dssp             TSCEECCCCCCCCSSEEEEEEECSSS------CCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTE
T ss_pred             eeEEecCceecCCceEEEEEEEEcCC------CcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCE
Confidence            457774 7899999999999987654      667999999776555667899999999985 79999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCc---eEEcccCCc
Q 046893          170 RILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFS---AKLSDFGLA  246 (464)
Q Consensus       170 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~---vkl~DFGla  246 (464)
                      .++||||+++++|.+++....  .+++..+..++.|++.||.|||  .++|+||||||+|||++.++.   +||+|||++
T Consensus        86 ~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH--~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~  161 (316)
T 2ac3_A           86 FYLVFEKMRGGSILSHIHKRR--HFNELEASVVVQDVASALDFLH--NKGIAHRDLKPENILCEHPNQVSPVKICDFDLG  161 (316)
T ss_dssp             EEEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHH--HTTCCCCCCCGGGEEESCSSSSCSEEECCTTCC
T ss_pred             EEEEEEcCCCCcHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHH--hCCceeCCCCHHHEEEccCCCcCceEEEEccCc
Confidence            999999999999999997753  6899999999999999999999  567999999999999987765   999999999


Q ss_pred             cCCCCCCC-----cceeeccccCCcccCcccccc-----CCCCcccchhcHHHHHHHHHhCCCCCCCCCCccccc-----
Q 046893          247 KDGPMGDQ-----THVSTRVMGTYGYAAPEYVMT-----GHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHN-----  311 (464)
Q Consensus       247 ~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~-----  311 (464)
                      +.......     .......+||..|+|||++.+     ..++.++|||||||++|+|++|+.||..........     
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~  241 (316)
T 2ac3_A          162 SGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEA  241 (316)
T ss_dssp             C-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----C
T ss_pred             cccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCccccccccccccccc
Confidence            75432211     111223569999999999875     568899999999999999999999998654322100     


Q ss_pred             ----HHHHHHHhhhcccchhhccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 046893          312 ----LVEWARPLLNNNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVA  369 (464)
Q Consensus       312 ----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  369 (464)
                          .............        .+........+..+.+|+.+||..||.+||++.++++
T Consensus       242 ~~~~~~~~~~~i~~~~~--------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  295 (316)
T 2ac3_A          242 CPACQNMLFESIQEGKY--------EFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQ  295 (316)
T ss_dssp             CHHHHHHHHHHHHHCCC--------CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             chhHHHHHHHHHhccCc--------ccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence                0000111111000        0000000123457899999999999999999999875

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=3.8e-44  Score=348.38  Aligned_cols=266  Identities=24%  Similarity=0.307  Sum_probs=198.3

Q ss_pred             cCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCcc--HHHHHHHHHHHhcCCCCCcceEEEEEEeCCe
Q 046893           92 KFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQG--DREWLAEVNYLGQLRHSNLVKLIGYCCEDEH  169 (464)
Q Consensus        92 ~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~  169 (464)
                      ++|++.+.||+|+||+||+|.+..+      ++.||+|++.......  .+.+.+|+.+++.++||||+++++++...+.
T Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~   76 (311)
T 4agu_A            3 EKYEKIGKIGEGSYGVVFKCRNRDT------GQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRR   76 (311)
T ss_dssp             CCEEEEEEEEECSSEEEEEEEETTT------CCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTE
T ss_pred             ccceEeeEEeecCCeEEEEEEeCCC------CcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCe
Confidence            5788999999999999999998765      6679999986554332  3567899999999999999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCccCC
Q 046893          170 RILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDG  249 (464)
Q Consensus       170 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~  249 (464)
                      .++||||+.+++|.+++...  ..+++..+..++.|++.||.|||  ..+|+||||||+|||++.++.+||+|||+++..
T Consensus        77 ~~lv~e~~~~~~l~~~~~~~--~~~~~~~~~~i~~~l~~~l~~lH--~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~  152 (311)
T 4agu_A           77 LHLVFEYCDHTVLHELDRYQ--RGVPEHLVKSITWQTLQAVNFCH--KHNCIHRDVKPENILITKHSVIKLCDFGFARLL  152 (311)
T ss_dssp             EEEEEECCSEEHHHHHHHTS--SCCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred             EEEEEEeCCCchHHHHHhhh--cCCCHHHHHHHHHHHHHHHHHHH--HCCCcCCCCChhhEEEcCCCCEEEeeCCCchhc
Confidence            99999999999998877653  36999999999999999999999  567999999999999999999999999999864


Q ss_pred             CCCCCcceeeccccCCcccCcccccc-CCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHH--------HHhh
Q 046893          250 PMGDQTHVSTRVMGTYGYAAPEYVMT-GHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWA--------RPLL  320 (464)
Q Consensus       250 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~--------~~~~  320 (464)
                      ....  .......||..|+|||++.+ ..++.++||||||+++|+|++|+.||.+.............        ...+
T Consensus       153 ~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (311)
T 4agu_A          153 TGPS--DYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVF  230 (311)
T ss_dssp             C--------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHH
T ss_pred             cCcc--cccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccccc
Confidence            3222  22234679999999999876 67899999999999999999999999765432211111100        0000


Q ss_pred             hcccchhh--ccCccccCc---cCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 046893          321 NNNKKVLR--ILDPRLEGQ---YTARTAMKVAGLAYQCLSQNPKGRPVMSDVVA  369 (464)
Q Consensus       321 ~~~~~~~~--~~~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  369 (464)
                      ........  ..++.....   .....+..+.+|+.+||+.||.+|||+.++++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  284 (311)
T 4agu_A          231 STNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLH  284 (311)
T ss_dssp             HTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHT
T ss_pred             ccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhc
Confidence            00000000  000000000   01224557899999999999999999999975

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.6e-44  Score=347.16  Aligned_cols=261  Identities=26%  Similarity=0.369  Sum_probs=207.3

Q ss_pred             cCCCCCC-ceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCC-ccHHHHHHHHHHHhcCCCCCcceEEEEEEeCCe
Q 046893           92 KFFRPDY-ILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGY-QGDREWLAEVNYLGQLRHSNLVKLIGYCCEDEH  169 (464)
Q Consensus        92 ~~~~~~~-~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~  169 (464)
                      ++|.+.. .||+|+||.||+|.+....    .+..||||++..... ...+.+.+|+.+++.++||||+++++++ ..+.
T Consensus         9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~   83 (287)
T 1u59_A            9 DNLLIADIELGCGNFGSVRQGVYRMRK----KQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEA   83 (287)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC-------CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSS
T ss_pred             HHhhhhhccccccCceeEEEeEeccCC----CcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCC
Confidence            4455555 8999999999999865321    256799999976533 2346788999999999999999999999 5567


Q ss_pred             EEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCccCC
Q 046893          170 RILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDG  249 (464)
Q Consensus       170 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~  249 (464)
                      .++||||+.+++|.+++... ...+++..++.++.|++.||.|||  ..+|+||||||+|||++.++.+||+|||+++..
T Consensus        84 ~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH--~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~  160 (287)
T 1u59_A           84 LMLVMEMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLE--EKNFVHRDLAARNVLLVNRHYAKISDFGLSKAL  160 (287)
T ss_dssp             EEEEEECCTTEEHHHHHTTC-TTTSCHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred             cEEEEEeCCCCCHHHHHHhC-CccCCHHHHHHHHHHHHHHHHHHH--HCCEeeCCCchheEEEcCCCCEEECcccceeee
Confidence            89999999999999988653 346999999999999999999999  567999999999999999999999999999865


Q ss_pred             CCCCCc-ceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHhhhcccchh
Q 046893          250 PMGDQT-HVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLL-GRRAVDKSRPSREHNLVEWARPLLNNNKKVL  327 (464)
Q Consensus       250 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  327 (464)
                      ...... .......||+.|+|||++.+..++.++||||||+++|+|++ |+.||.......   +...   ....     
T Consensus       161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~---~~~~---i~~~-----  229 (287)
T 1u59_A          161 GADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE---VMAF---IEQG-----  229 (287)
T ss_dssp             TTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHH---HHHH---HHTT-----
T ss_pred             ccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHH---HHHH---HhcC-----
Confidence            332221 11223457899999999998899999999999999999998 999997654211   1111   1110     


Q ss_pred             hccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhc
Q 046893          328 RILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETVQSQ  377 (464)
Q Consensus       328 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~~~~  377 (464)
                            .....+..++..+.+|+.+||..||.+||++.++++.|+.+...
T Consensus       230 ------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~  273 (287)
T 1u59_A          230 ------KRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS  273 (287)
T ss_dssp             ------CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ------CcCCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence                  11122334556899999999999999999999999999988654

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=1.7e-44  Score=352.76  Aligned_cols=252  Identities=22%  Similarity=0.286  Sum_probs=205.1

Q ss_pred             hcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCc------cHHHHHHHHHHHhcCCCCCcceEEEEE
Q 046893           91 TKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQ------GDREWLAEVNYLGQLRHSNLVKLIGYC  164 (464)
Q Consensus        91 ~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~hpniv~l~~~~  164 (464)
                      .++|++.+.||+|+||.||+|.+..+      ++.||+|++......      ....+.+|+.+++.++||||+++++++
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~------~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~   84 (321)
T 2a2a_A           11 EDFYDIGEELGSGQFAIVKKCREKST------GLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVY   84 (321)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTT------CCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             hccEEEeeEeeecCCEEEEEEEECCC------CeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEE
Confidence            45699999999999999999998765      667999998754322      356789999999999999999999999


Q ss_pred             EeCCeEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCC----ceEE
Q 046893          165 CEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADF----SAKL  240 (464)
Q Consensus       165 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~----~vkl  240 (464)
                      ......++||||+.+++|.+++...  ..+++..++.++.|++.||.|||  ..+|+||||||+|||++.++    .+||
T Consensus        85 ~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~lH--~~~ivH~dikp~NIl~~~~~~~~~~~kl  160 (321)
T 2a2a_A           85 ENRTDVVLILELVSGGELFDFLAQK--ESLSEEEATSFIKQILDGVNYLH--TKKIAHFDLKPENIMLLDKNIPIPHIKL  160 (321)
T ss_dssp             ECSSEEEEEECCCCSCBHHHHHHTC--SCEEHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEESCTTSSSCCEEE
T ss_pred             ecCCEEEEEEEcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH--hCCeecCCCChHHEEEecCCCCcCCEEE
Confidence            9999999999999999999998764  36899999999999999999999  56799999999999998887    7999


Q ss_pred             cccCCccCCCCCCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhh
Q 046893          241 SDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLL  320 (464)
Q Consensus       241 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~  320 (464)
                      +|||+++......   ......||+.|+|||++.+..++.++||||||+++|+|++|..||......      +......
T Consensus       161 ~Dfg~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~------~~~~~i~  231 (321)
T 2a2a_A          161 IDFGLAHEIEDGV---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ------ETLANIT  231 (321)
T ss_dssp             CCCTTCEECCTTC---CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH------HHHHHHH
T ss_pred             ccCccceecCccc---cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHH------HHHHHHH
Confidence            9999998643322   223467999999999999999999999999999999999999999764321      1111111


Q ss_pred             hcccchhhccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 046893          321 NNNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVA  369 (464)
Q Consensus       321 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  369 (464)
                      ....        ..........+..+.+|+.+||..||.+||++.++++
T Consensus       232 ~~~~--------~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~  272 (321)
T 2a2a_A          232 SVSY--------DFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALR  272 (321)
T ss_dssp             TTCC--------CCCHHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred             hccc--------ccChhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence            1100        0000111123457899999999999999999999986

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=3.6e-44  Score=345.67  Aligned_cols=265  Identities=19%  Similarity=0.203  Sum_probs=205.2

Q ss_pred             HhcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCccHHHHHHHHHHHhcCCCCCcceEEEE-EEeCC
Q 046893           90 ATKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVKLIGY-CCEDE  168 (464)
Q Consensus        90 ~~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~-~~~~~  168 (464)
                      ..++|++.+.||+|+||+||+|.+..+      ++.||||++.....  ...+..|+.++..++|++++..+.+ +...+
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~------~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~   78 (296)
T 4hgt_A            7 VGNRYRLGRKIGSGSFGDIYLGTDIAA------GEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGD   78 (296)
T ss_dssp             ----CEEEEEEEECSSSEEEEEEETTT------TEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETT
T ss_pred             cCCceEEeeeecCCCCeEEEEEEEcCC------CceEEEEeeccccc--chHHHHHHHHHHHhcCCCCCCeeeeecCCCC
Confidence            457799999999999999999998664      67899998755322  2357889999999988876666654 46778


Q ss_pred             eEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEe---cCCCceEEcccCC
Q 046893          169 HRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILL---NADFSAKLSDFGL  245 (464)
Q Consensus       169 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill---~~~~~vkl~DFGl  245 (464)
                      ..++||||+ +++|.+++... ...+++..++.++.|++.||.|||  ..+|+||||||+|||+   +.++.+||+|||+
T Consensus        79 ~~~lv~e~~-~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH--~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~  154 (296)
T 4hgt_A           79 YNVMVMELL-GPSLEDLFNFC-SRKFSLKTVLLLADQMISRIEYIH--SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGL  154 (296)
T ss_dssp             EEEEEEECC-CCBHHHHHHHT-TSCCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGEEECCGGGTTCEEECCCTT
T ss_pred             ceEEEEEcc-CCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHH--HCCeecCCCCHHHeeeeccCCCCeEEEecCcc
Confidence            899999999 99999988753 346999999999999999999999  5679999999999999   7889999999999


Q ss_pred             ccCCCCCCCc-----ceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHH-HHh
Q 046893          246 AKDGPMGDQT-----HVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWA-RPL  319 (464)
Q Consensus       246 a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~-~~~  319 (464)
                      ++........     .......||+.|+|||++.+..++.++|||||||++|+|++|+.||............... ...
T Consensus       155 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  234 (296)
T 4hgt_A          155 AKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKK  234 (296)
T ss_dssp             CEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHH
T ss_pred             ceeccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhccc
Confidence            9865433221     1223468999999999999999999999999999999999999999875544333222211 111


Q ss_pred             hhcccchhhccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhc
Q 046893          320 LNNNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETVQSQ  377 (464)
Q Consensus       320 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~~~~  377 (464)
                      ....           .......++..+.+|+.+||+.||.+||++.+|++.|+.+...
T Consensus       235 ~~~~-----------~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~  281 (296)
T 4hgt_A          235 MSTP-----------IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR  281 (296)
T ss_dssp             HHSC-----------HHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHH
T ss_pred             ccch-----------hhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHH
Confidence            1100           0001112345899999999999999999999999999988654

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.5e-44  Score=363.62  Aligned_cols=274  Identities=20%  Similarity=0.270  Sum_probs=214.7

Q ss_pred             hcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCC-ccHHHHHHHHHHHhcCCCCCcceEEEEEEeCC-
Q 046893           91 TKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGY-QGDREWLAEVNYLGQLRHSNLVKLIGYCCEDE-  168 (464)
Q Consensus        91 ~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~-  168 (464)
                      .++|++.+.||+|+||+||+|.+..+      ++.||||++..... .....+.+|+.+|+.++||||+++++++.... 
T Consensus         8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~------~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~   81 (396)
T 4eut_A            8 NHLWLLSDILGQGATANVFRGRHKKT------GDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTT   81 (396)
T ss_dssp             SEEEEEEEEEEECSSEEEEEEEETTT------CCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTT
T ss_pred             CCceEEEEEEEcCCCeEEEEEEECCC------CcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCC
Confidence            46789999999999999999998765      66799999875432 33467889999999999999999999998765 


Q ss_pred             -eEEEEEeccCCCCHHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEe----cCCCceEEcc
Q 046893          169 -HRILVYEYMESGSLEKHLLRRVG-CMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILL----NADFSAKLSD  242 (464)
Q Consensus       169 -~~~lv~e~~~~g~L~~~l~~~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill----~~~~~vkl~D  242 (464)
                       ..+|||||+++|+|.+++..... ..+++..++.++.|++.||.|||  ..+|+||||||+|||+    +.++.+||+|
T Consensus        82 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH--~~~ivH~Dlkp~NIll~~~~~~~~~~kL~D  159 (396)
T 4eut_A           82 RHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR--ENGIVHRNIKPGNIMRVIGEDGQSVYKLTD  159 (396)
T ss_dssp             CCEEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCCGGGEEEEECTTSCEEEEECC
T ss_pred             CeeEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHH--HCCEEECCcCHHHEEEeecCCCceeEEEec
Confidence             78999999999999998876432 34999999999999999999999  5679999999999999    7778899999


Q ss_pred             cCCccCCCCCCCcceeeccccCCcccCcccccc--------CCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHH
Q 046893          243 FGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMT--------GHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVE  314 (464)
Q Consensus       243 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~  314 (464)
                      ||+++......   ......||..|+|||++.+        ..++.++|||||||++|||++|+.||.........  .+
T Consensus       160 FG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~--~~  234 (396)
T 4eut_A          160 FGAARELEDDE---QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRN--KE  234 (396)
T ss_dssp             GGGCEECCCGG---GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTC--HH
T ss_pred             CCCceEccCCC---ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccch--HH
Confidence            99998643322   2234679999999998865        56788999999999999999999999754322111  11


Q ss_pred             HHHHhhhcccc-h----hhcc--------CccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhc
Q 046893          315 WARPLLNNNKK-V----LRIL--------DPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETVQSQ  377 (464)
Q Consensus       315 ~~~~~~~~~~~-~----~~~~--------~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~~~~  377 (464)
                      .....+..... .    ....        +......+....+..+.+++.+||+.||.+||++.++++.++.+...
T Consensus       235 ~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~  310 (396)
T 4eut_A          235 VMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHR  310 (396)
T ss_dssp             HHHHHHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTC
T ss_pred             HHHHHhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhc
Confidence            12222211100 0    0000        01112244577888999999999999999999999999999887664

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=1.2e-44  Score=371.33  Aligned_cols=194  Identities=25%  Similarity=0.369  Sum_probs=153.0

Q ss_pred             cCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCc--cHHHHHHHHHHHhcCCCCCcceEEEEEEeC--
Q 046893           92 KFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQ--GDREWLAEVNYLGQLRHSNLVKLIGYCCED--  167 (464)
Q Consensus        92 ~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpniv~l~~~~~~~--  167 (464)
                      ++|++.+.||+|+||+||+|.+..+      ++.||||++......  ..+.+.+|+.+|+.++||||+++++++...  
T Consensus        53 ~~y~~~~~lG~G~~g~V~~~~~~~~------~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  126 (458)
T 3rp9_A           53 DRYEIRHLIGTGSYGHVCEAYDKLE------KRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDV  126 (458)
T ss_dssp             TTEEECCC-------CEEEEEECC--------CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCT
T ss_pred             CCeEEeeEeeecCCeEEEEEEECCC------CcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCc
Confidence            5799999999999999999998765      677999998654322  236788999999999999999999998543  


Q ss_pred             ---CeEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccC
Q 046893          168 ---EHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFG  244 (464)
Q Consensus       168 ---~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFG  244 (464)
                         ...||||||+ +++|.+++...  ..+++..+..++.||+.||.|||  ..+|+||||||+||||+.++.+||+|||
T Consensus       127 ~~~~~~~lv~e~~-~~~L~~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH--~~~iiHrDlKp~NILl~~~~~~kl~DFG  201 (458)
T 3rp9_A          127 EKFDELYVVLEIA-DSDFKKLFRTP--VYLTELHIKTLLYNLLVGVKYVH--SAGILHRDLKPANCLVNQDCSVKVCDFG  201 (458)
T ss_dssp             TTCCCEEEEECCC-SEEHHHHHHSS--CCCCHHHHHHHHHHHHHHHHHHH--HTTCBCCCCCGGGEEECTTCCEEECCCT
T ss_pred             ccCceEEEEEecc-ccchhhhcccC--CCCCHHHHHHHHHHHHHHHHHHH--hCCcCCCCCChhhEEECCCCCEeecccc
Confidence               5789999998 56999888653  36999999999999999999999  5679999999999999999999999999


Q ss_pred             CccCCCCCCCc-------------------------ceeeccccCCcccCcccc-ccCCCCcccchhcHHHHHHHHHh
Q 046893          245 LAKDGPMGDQT-------------------------HVSTRVMGTYGYAAPEYV-MTGHLTARSDVYGFGVVLLEMLL  296 (464)
Q Consensus       245 la~~~~~~~~~-------------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~~DvwslG~il~ell~  296 (464)
                      +|+........                         ......+||++|+|||++ .+..|+.++||||||||||||++
T Consensus       202 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~ellt  279 (458)
T 3rp9_A          202 LARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLN  279 (458)
T ss_dssp             TCBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHT
T ss_pred             cchhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHH
Confidence            99865322110                         123446899999999976 45679999999999999999999

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=1.3e-44  Score=346.28  Aligned_cols=247  Identities=25%  Similarity=0.410  Sum_probs=201.2

Q ss_pred             hcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCC---ccHHHHHHHHHHHhcCCCCCcceEEEEEEeC
Q 046893           91 TKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGY---QGDREWLAEVNYLGQLRHSNLVKLIGYCCED  167 (464)
Q Consensus        91 ~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~  167 (464)
                      .++|++.+.||+|+||+||+|.+..+      +..||+|++.....   .....+.+|+.+++.++||||+++++++.+.
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~------~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   81 (279)
T 3fdn_A            8 LEDFEIGRPLGKGKFGNVYLAREKQS------KFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDA   81 (279)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTT------CCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred             cccEEEeeEEecCCCeEEEEEEEccC------CcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecC
Confidence            45688999999999999999998765      66799999854321   2235688999999999999999999999999


Q ss_pred             CeEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCcc
Q 046893          168 EHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAK  247 (464)
Q Consensus       168 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~  247 (464)
                      ...++||||+++++|.+++....  .+++..++.++.|++.||.|||  ..+|+||||||+|||++.++.+||+|||++.
T Consensus        82 ~~~~lv~e~~~~~~l~~~l~~~~--~~~~~~~~~~~~qi~~~l~~LH--~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~  157 (279)
T 3fdn_A           82 TRVYLILEYAPLGTVYRELQKLS--KFDEQRTATYITELANALSYCH--SKRVIHRDIKPENLLLGSAGELKIADFGWSV  157 (279)
T ss_dssp             SEEEEEECCCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHH--TTTCEECCCCGGGEEECTTSCEEECSCCEES
T ss_pred             CEEEEEEecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH--hCCEecccCChHhEEEcCCCCEEEEeccccc
Confidence            99999999999999999987654  6899999999999999999999  6779999999999999999999999999986


Q ss_pred             CCCCCCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhcccchh
Q 046893          248 DGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVL  327 (464)
Q Consensus       248 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  327 (464)
                      .....    ......||..|+|||++.+..++.++||||||+++|+|++|..||......      +........     
T Consensus       158 ~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~~~~~~~~~-----  222 (279)
T 3fdn_A          158 HAPSS----RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ------ETYKRISRV-----  222 (279)
T ss_dssp             CC------------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHH------HHHHHHHHT-----
T ss_pred             cCCcc----cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHH------HHHHHHHhC-----
Confidence            53222    123467999999999999999999999999999999999999999754321      111111110     


Q ss_pred             hccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 046893          328 RILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVA  369 (464)
Q Consensus       328 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  369 (464)
                         ..    .++...+..+.+|+.+||+.||.+||++.++++
T Consensus       223 ---~~----~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~  257 (279)
T 3fdn_A          223 ---EF----TFPDFVTEGARDLISRLLKHNPSQRPMLREVLE  257 (279)
T ss_dssp             ---CC----CCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred             ---CC----CCCCcCCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence               11    122234457889999999999999999999986

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=3.5e-44  Score=343.91  Aligned_cols=252  Identities=21%  Similarity=0.297  Sum_probs=204.0

Q ss_pred             hcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCc--cHHHHHHHHHHHhcCCCCCcceEEEEEEeCC
Q 046893           91 TKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQ--GDREWLAEVNYLGQLRHSNLVKLIGYCCEDE  168 (464)
Q Consensus        91 ~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~  168 (464)
                      .++|++.+.||+|+||.||+|.+..+      +..||+|++......  ....+.+|+.+++.++||||+++++++...+
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~------~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   78 (284)
T 3kk8_A            5 SDNYDVKEELGKGAFSVVRRCVHKTT------GLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEES   78 (284)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTT------CCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred             hhhhhhhhhhcCcCCeEEEEEEEcCC------CceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCC
Confidence            46799999999999999999998765      667999998654332  2356789999999999999999999999999


Q ss_pred             eEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCc---eEEcccCC
Q 046893          169 HRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFS---AKLSDFGL  245 (464)
Q Consensus       169 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~---vkl~DFGl  245 (464)
                      ..++||||+.+++|.+++....  .+++..+..++.|++.||.|||  ..+|+||||||+|||++.++.   +||+|||+
T Consensus        79 ~~~~v~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH--~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~  154 (284)
T 3kk8_A           79 FHYLVFDLVTGGELFEDIVARE--FYSEADASHCIQQILESIAYCH--SNGIVHRNLKPENLLLASKAKGAAVKLADFGL  154 (284)
T ss_dssp             EEEEEECCCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCCGGGEEESSSSTTCCEEECCCTT
T ss_pred             EEEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH--HCCcCcCCCCHHHEEEecCCCCCcEEEeecee
Confidence            9999999999999999887654  6899999999999999999999  567999999999999976655   99999999


Q ss_pred             ccCCCCCCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhcccc
Q 046893          246 AKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKK  325 (464)
Q Consensus       246 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  325 (464)
                      +.......   ......||+.|+|||++.+..++.++||||||+++|+|++|+.||......      ............
T Consensus       155 ~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~------~~~~~~~~~~~~  225 (284)
T 3kk8_A          155 AIEVNDSE---AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH------RLYAQIKAGAYD  225 (284)
T ss_dssp             CEECCSSC---BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHHTCCC
T ss_pred             eEEcccCc---cccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchh------HHHHHHHhcccc
Confidence            97643222   223467999999999999999999999999999999999999999764321      111111111000


Q ss_pred             hhhccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 046893          326 VLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVA  369 (464)
Q Consensus       326 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  369 (464)
                              .........+..+.+|+.+||+.||.+||++.++++
T Consensus       226 --------~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  261 (284)
T 3kk8_A          226 --------YPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALK  261 (284)
T ss_dssp             --------CCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             --------CCchhhcccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence                    001111233457899999999999999999999986

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=4.3e-45  Score=356.03  Aligned_cols=265  Identities=24%  Similarity=0.332  Sum_probs=205.1

Q ss_pred             HhcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCccHHHHHHHHHHHhcCCCCCcceEEEEEEe---
Q 046893           90 ATKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVKLIGYCCE---  166 (464)
Q Consensus        90 ~~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~---  166 (464)
                      ..++|++.+.||+|+||.||+|.+..+      ++.||||++..........+.+|+.+++.++||||+++++++..   
T Consensus        27 ~~~~y~~~~~lg~G~~g~V~~~~~~~~------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  100 (317)
T 2buj_A           27 DNKHYLFIQKLGEGGFSYVDLVEGLHD------GHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERG  100 (317)
T ss_dssp             TTEEEEEEEEEEC--CEEEEEEEETTT------CCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEET
T ss_pred             CCeEEEEEEEecCCCCeEEEEEEecCC------CcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccC
Confidence            456799999999999999999998664      67799999876544455778999999999999999999999873   


Q ss_pred             -CCeEEEEEeccCCCCHHHHHHhh--cCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEccc
Q 046893          167 -DEHRILVYEYMESGSLEKHLLRR--VGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDF  243 (464)
Q Consensus       167 -~~~~~lv~e~~~~g~L~~~l~~~--~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DF  243 (464)
                       ....++||||+.+|+|.+++...  .+..+++..++.++.|++.||.|||  ..+|+||||||+|||++.++.+||+||
T Consensus       101 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH--~~~ivH~dlkp~NIl~~~~~~~kl~df  178 (317)
T 2buj_A          101 AKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIH--AKGYAHRDLKPTNILLGDEGQPVLMDL  178 (317)
T ss_dssp             TEEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCCGGGEEECTTSCEEECCC
T ss_pred             CCceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH--hCCcccCCCCHHHEEEcCCCCEEEEec
Confidence             34789999999999999988763  2457999999999999999999999  567999999999999999999999999


Q ss_pred             CCccCCCCCCCcc-------eeeccccCCcccCccccccCC---CCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHH
Q 046893          244 GLAKDGPMGDQTH-------VSTRVMGTYGYAAPEYVMTGH---LTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLV  313 (464)
Q Consensus       244 Gla~~~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~---~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~  313 (464)
                      |++..........       ......||+.|+|||++.+..   ++.++||||||+++|+|++|+.||....... ..+.
T Consensus       179 g~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-~~~~  257 (317)
T 2buj_A          179 GSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKG-DSVA  257 (317)
T ss_dssp             SSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTT-SCHH
T ss_pred             CcchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhccc-chhh
Confidence            9987532111000       012245799999999987554   7889999999999999999999995311100 0011


Q ss_pred             HHHHHhhhcccchhhccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhc
Q 046893          314 EWARPLLNNNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETVQSQ  377 (464)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~~~~  377 (464)
                      ..    ...          ..........+..+.+|+.+||+.||.+||++.++++.|+.+...
T Consensus       258 ~~----~~~----------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~  307 (317)
T 2buj_A          258 LA----VQN----------QLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPP  307 (317)
T ss_dssp             HH----HHC----------C--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCC
T ss_pred             HH----hhc----------cCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCC
Confidence            00    000          001111223345899999999999999999999999999987644

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.1e-44  Score=363.60  Aligned_cols=266  Identities=25%  Similarity=0.352  Sum_probs=191.3

Q ss_pred             HHhcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCC--ccHHHHHHHHHHHhcCC-CCCcceEEEEEE
Q 046893           89 LATKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGY--QGDREWLAEVNYLGQLR-HSNLVKLIGYCC  165 (464)
Q Consensus        89 ~~~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~-hpniv~l~~~~~  165 (464)
                      ...++|++.+.||+|+||.||+|.+..+      ++.||||++.....  .....+.+|+.+|..+. ||||+++++++.
T Consensus         6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~------~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~   79 (388)
T 3oz6_A            6 HVLRKYELVKKLGKGAYGIVWKSIDRRT------GEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLR   79 (388)
T ss_dssp             HHHTTEEEEEC-------CEEEEEETTT------CCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEE
T ss_pred             cccCceEEEEEeeeCCCeEEEEEEECCC------CCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEe
Confidence            4567899999999999999999998765      67799999865322  23356789999999997 999999999998


Q ss_pred             eCC--eEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEccc
Q 046893          166 EDE--HRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDF  243 (464)
Q Consensus       166 ~~~--~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DF  243 (464)
                      ..+  ..|||||||. ++|.+++...   .+++..+..++.|++.||.|||  ..+|+||||||+||||+.++.+||+||
T Consensus        80 ~~~~~~~~lv~e~~~-~~L~~~~~~~---~~~~~~~~~i~~qi~~~L~~LH--~~~ivHrDlkp~NIll~~~~~~kl~DF  153 (388)
T 3oz6_A           80 ADNDRDVYLVFDYME-TDLHAVIRAN---ILEPVHKQYVVYQLIKVIKYLH--SGGLLHRDMKPSNILLNAECHVKVADF  153 (388)
T ss_dssp             CTTSSCEEEEEECCS-EEHHHHHHHT---CCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCCGGGEEECTTCCEEECCC
T ss_pred             cCCCCEEEEEecccC-cCHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH--hCCEEeCCCCHHHeEEcCCCCEEecCC
Confidence            654  7899999996 5898888653   5899999999999999999999  567999999999999999999999999


Q ss_pred             CCccCCCCCC-------------------CcceeeccccCCcccCcccccc-CCCCcccchhcHHHHHHHHHhCCCCCCC
Q 046893          244 GLAKDGPMGD-------------------QTHVSTRVMGTYGYAAPEYVMT-GHLTARSDVYGFGVVLLEMLLGRRAVDK  303 (464)
Q Consensus       244 Gla~~~~~~~-------------------~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~g~~pf~~  303 (464)
                      |+|+......                   ........+||+.|+|||++.+ ..++.++|||||||+||||++|+.||.+
T Consensus       154 G~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~  233 (388)
T 3oz6_A          154 GLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPG  233 (388)
T ss_dssp             TTCEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred             cccccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCC
Confidence            9998542210                   1112334689999999999987 6799999999999999999999999986


Q ss_pred             CCCcccccHHHHHHHhhhcc-cc-hhhcc------------------CccccCcc------------CHHHHHHHHHHHH
Q 046893          304 SRPSREHNLVEWARPLLNNN-KK-VLRIL------------------DPRLEGQY------------TARTAMKVAGLAY  351 (464)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~-~~-~~~~~------------------~~~~~~~~------------~~~~~~~l~~li~  351 (464)
                      ......  +.... ..+... .. +..+.                  .......+            ...++..+.+|+.
T Consensus       234 ~~~~~~--~~~i~-~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~  310 (388)
T 3oz6_A          234 SSTMNQ--LERII-GVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLD  310 (388)
T ss_dssp             SSHHHH--HHHHH-HHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHH
T ss_pred             CCHHHH--HHHHH-HhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHH
Confidence            542211  11110 000000 00 00000                  00000000            0123457899999


Q ss_pred             HhhccCCCCCCCHHHHHH
Q 046893          352 QCLSQNPKGRPVMSDVVA  369 (464)
Q Consensus       352 ~cl~~dP~~RPs~~ev~~  369 (464)
                      +||..||.+|||+.++++
T Consensus       311 ~~L~~dP~~R~t~~e~l~  328 (388)
T 3oz6_A          311 KLLQFNPNKRISANDALK  328 (388)
T ss_dssp             HHCCSSGGGSCCHHHHTT
T ss_pred             HhhccCcccCCCHHHHhC
Confidence            999999999999998875

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=2.7e-44  Score=380.59  Aligned_cols=258  Identities=26%  Similarity=0.372  Sum_probs=203.7

Q ss_pred             CCCCC-ceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCC-ccHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeEE
Q 046893           94 FRPDY-ILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGY-QGDREWLAEVNYLGQLRHSNLVKLIGYCCEDEHRI  171 (464)
Q Consensus        94 ~~~~~-~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~  171 (464)
                      +.+.. .||+|+||.||+|.+....    .+..||||+++.... ...+.+.+|+++|+.++||||+++++++.. +..+
T Consensus       337 ~~~~~~~LG~G~fG~Vy~~~~~~~~----~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~  411 (613)
T 2ozo_A          337 LLIADIELGCGNFGSVRQGVYRMRK----KQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALM  411 (613)
T ss_dssp             EEEEEEEEEECSSSEEEEEEEECSS----CEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEE
T ss_pred             eeEcCcEEecCCCcEEEEEEEecCC----CcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeE
Confidence            33334 7999999999999876431    256799999976533 345789999999999999999999999876 5689


Q ss_pred             EEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCccCCCC
Q 046893          172 LVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPM  251 (464)
Q Consensus       172 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~  251 (464)
                      |||||+.+|+|.+++... ...+++..++.++.||+.||.|||  .++|+||||||+||||+.++.+||+|||+++....
T Consensus       412 lv~E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~LH--~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~  488 (613)
T 2ozo_A          412 LVMEMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLE--EKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGA  488 (613)
T ss_dssp             EEEECCTTCBHHHHHTTC-TTTSCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC-
T ss_pred             EEEEeCCCCcHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHH--HCCEEcCcCCHHHEEEcCCCcEEEeeccCcccccC
Confidence            999999999999998654 346999999999999999999999  56799999999999999999999999999986533


Q ss_pred             CCCc-ceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHhhhcccchhhc
Q 046893          252 GDQT-HVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLL-GRRAVDKSRPSREHNLVEWARPLLNNNKKVLRI  329 (464)
Q Consensus       252 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  329 (464)
                      .... .......+|+.|+|||++.+..++.++|||||||+||||++ |+.||.......   +...    +..       
T Consensus       489 ~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~---~~~~----i~~-------  554 (613)
T 2ozo_A          489 DDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE---VMAF----IEQ-------  554 (613)
T ss_dssp             -------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHH---HHHH----HHT-------
T ss_pred             CCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHH---HHHH----HHc-------
Confidence            2211 11222446789999999999999999999999999999998 999998654321   1111    111       


Q ss_pred             cCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHh
Q 046893          330 LDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETVQS  376 (464)
Q Consensus       330 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~~~  376 (464)
                         ......+..++..+.+||.+||..||.+||++.+|++.|+.+..
T Consensus       555 ---~~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~  598 (613)
T 2ozo_A          555 ---GKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYY  598 (613)
T ss_dssp             ---TCCCCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             ---CCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHH
Confidence               11122334566789999999999999999999999999998754

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=4.2e-45  Score=358.01  Aligned_cols=269  Identities=25%  Similarity=0.354  Sum_probs=206.2

Q ss_pred             HhcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCC-ccHHHHHHHHHHHhcCCCCCcceEEEEEEeCC
Q 046893           90 ATKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGY-QGDREWLAEVNYLGQLRHSNLVKLIGYCCEDE  168 (464)
Q Consensus        90 ~~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~  168 (464)
                      ..++|++.+.||+|+||.||+|.+.... ....+..||||++..... .....+.+|+.+++.++||||+++++++....
T Consensus        28 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~-~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~  106 (327)
T 2yfx_A           28 PRKNITLIRGLGHGAFGEVYEGQVSGMP-NDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSL  106 (327)
T ss_dssp             CGGGCEEEEECC--CSSCEEEEEC---------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             ChhheEEEEEEcCCCCeeEEEEEEcCCC-CCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCC
Confidence            4567999999999999999999854311 112366799999965432 23467889999999999999999999999999


Q ss_pred             eEEEEEeccCCCCHHHHHHhhcC-----CCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecC---CCceEE
Q 046893          169 HRILVYEYMESGSLEKHLLRRVG-----CMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNA---DFSAKL  240 (464)
Q Consensus       169 ~~~lv~e~~~~g~L~~~l~~~~~-----~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~---~~~vkl  240 (464)
                      ..++||||+++++|.+++.....     ..+++..++.++.|++.||.|||  ..+|+||||||+|||++.   +..+||
T Consensus       107 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH--~~~i~H~dlkp~NIli~~~~~~~~~kl  184 (327)
T 2yfx_A          107 PRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE--ENHFIHRDIAARNCLLTCPGPGRVAKI  184 (327)
T ss_dssp             SCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCCGGGEEESCSSTTCCEEE
T ss_pred             CcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHh--hCCeecCcCCHhHEEEecCCCcceEEE
Confidence            99999999999999999976532     35899999999999999999999  567999999999999984   446999


Q ss_pred             cccCCccCCCCCCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHh
Q 046893          241 SDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLL-GRRAVDKSRPSREHNLVEWARPL  319 (464)
Q Consensus       241 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~  319 (464)
                      +|||+++...............||+.|+|||++.+..++.++||||||+++|+|++ |..||......   .+...   .
T Consensus       185 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~---~~~~~---~  258 (327)
T 2yfx_A          185 GDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ---EVLEF---V  258 (327)
T ss_dssp             CCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH---HHHHH---H
T ss_pred             CccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHH---HHHHH---H
Confidence            99999874322222223334678999999999999999999999999999999998 99999764321   11111   1


Q ss_pred             hhcccchhhccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhcC
Q 046893          320 LNNNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETVQSQG  378 (464)
Q Consensus       320 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~~~~~  378 (464)
                      ...           .....+..++..+.+|+.+||+.||.+||++.++++.|+.+....
T Consensus       259 ~~~-----------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~  306 (327)
T 2yfx_A          259 TSG-----------GRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDP  306 (327)
T ss_dssp             HTT-----------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCH
T ss_pred             hcC-----------CCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcCH
Confidence            111           011122334558999999999999999999999999999876643

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=1e-44  Score=347.33  Aligned_cols=253  Identities=26%  Similarity=0.369  Sum_probs=206.6

Q ss_pred             HHhcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCccHHHHHHHHHHHhcCCCCCcceEEEEEEe--
Q 046893           89 LATKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVKLIGYCCE--  166 (464)
Q Consensus        89 ~~~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~--  166 (464)
                      ....+|++.+.||+|+||.||+|.+..+      ++.||+|++....    ..+.+|+.+++.++||||+++++++..  
T Consensus         8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~------~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   77 (284)
T 2a19_B            8 RFGMDFKEIELIGSGGFGQVFKAKHRID------GKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFD   77 (284)
T ss_dssp             HHHHHEEEEEEEECSSSCCEEEEEETTT------CCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEE
T ss_pred             hhccccceeeeeccCCceEEEEEEEcCC------CeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccc
Confidence            3456789999999999999999998754      5679999987543    356789999999999999999998865  


Q ss_pred             --------------CCeEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEe
Q 046893          167 --------------DEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILL  232 (464)
Q Consensus       167 --------------~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill  232 (464)
                                    ....++||||+++++|.+++....+..+++..++.++.|++.||.|||  ..+|+||||||+|||+
T Consensus        78 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH--~~~i~H~dlkp~Nil~  155 (284)
T 2a19_B           78 YDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIH--SKKLINRDLKPSNIFL  155 (284)
T ss_dssp             EC---------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGEEE
T ss_pred             cCcccccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH--hCCeeeccCCHHHEEE
Confidence                          445899999999999999998765567999999999999999999999  5679999999999999


Q ss_pred             cCCCceEEcccCCccCCCCCCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccH
Q 046893          233 NADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNL  312 (464)
Q Consensus       233 ~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~  312 (464)
                      +.++.+||+|||++.......   ......||+.|+|||++.+..++.++||||||+++|+|++|..||....       
T Consensus       156 ~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~-------  225 (284)
T 2a19_B          156 VDTKQVKIGDFGLVTSLKNDG---KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETS-------  225 (284)
T ss_dssp             EETTEEEECCCTTCEESSCCS---CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHH-------
T ss_pred             cCCCCEEECcchhheeccccc---cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHH-------
Confidence            999999999999998653322   1233579999999999999999999999999999999999998874210       


Q ss_pred             HHHHHHhhhcccchhhccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhcC
Q 046893          313 VEWARPLLNNNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETVQSQG  378 (464)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~~~~~  378 (464)
                       .+.....          ...+    +...+..+.+|+.+||..||.+||++.++++.|+.+....
T Consensus       226 -~~~~~~~----------~~~~----~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~  276 (284)
T 2a19_B          226 -KFFTDLR----------DGII----SDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSP  276 (284)
T ss_dssp             -HHHHHHH----------TTCC----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC--
T ss_pred             -HHHHHhh----------cccc----cccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCC
Confidence             1111110          1111    1223347889999999999999999999999999887544

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=3.6e-44  Score=367.77  Aligned_cols=247  Identities=25%  Similarity=0.348  Sum_probs=204.0

Q ss_pred             cCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCC---CccHHHHHHHHHHHhcCCCCCcceEEEEEEeCC
Q 046893           92 KFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGG---YQGDREWLAEVNYLGQLRHSNLVKLIGYCCEDE  168 (464)
Q Consensus        92 ~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~  168 (464)
                      ++|.+.+.||+|+||.||+|.+..+      ++.||||++....   ......+.+|+.+|+.++||||+++++++...+
T Consensus        16 ~~Y~l~~~LG~G~fg~V~~a~~~~~------g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~   89 (476)
T 2y94_A           16 GHYILGDTLGVGTFGKVKVGKHELT------GHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPS   89 (476)
T ss_dssp             TTEEEEEEEECCSSSCEEEEEETTT------CCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred             cCEEEEEEEeeCCCeEEEEEEECCC------CCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC
Confidence            5688899999999999999998764      6779999986532   123457889999999999999999999999999


Q ss_pred             eEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCccC
Q 046893          169 HRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKD  248 (464)
Q Consensus       169 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~  248 (464)
                      ..+|||||+.+|+|.+++...  ..+++..+..++.||+.||.|||  ..+|+||||||+|||++.++.+||+|||+++.
T Consensus        90 ~~~lv~E~~~gg~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH--~~givHrDLkp~NIll~~~~~vkL~DFG~a~~  165 (476)
T 2y94_A           90 DIFMVMEYVSGGELFDYICKN--GRLDEKESRRLFQQILSGVDYCH--RHMVVHRDLKPENVLLDAHMNAKIADFGLSNM  165 (476)
T ss_dssp             EEEEEEECCSSEEHHHHTTSS--SSCCHHHHHHHHHHHHHHHHHHH--TTTEECSCCSGGGEEECTTCCEEECCCSSCEE
T ss_pred             EEEEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH--HCCCCcccccHHHEEEecCCCeEEEeccchhh
Confidence            999999999999999988653  36999999999999999999999  67799999999999999999999999999986


Q ss_pred             CCCCCCcceeeccccCCcccCccccccCCC-CcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhcccchh
Q 046893          249 GPMGDQTHVSTRVMGTYGYAAPEYVMTGHL-TARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVL  327 (464)
Q Consensus       249 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  327 (464)
                      .....   .....+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||......      ..........    
T Consensus       166 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~------~~~~~i~~~~----  232 (476)
T 2y94_A          166 MSDGE---FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVP------TLFKKICDGI----  232 (476)
T ss_dssp             CCTTC---CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSH------HHHHHHHTTC----
T ss_pred             ccccc---cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHH------HHHHHHhcCC----
Confidence            54322   2334689999999999988765 68999999999999999999999764321      1111111110    


Q ss_pred             hccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 046893          328 RILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVA  369 (464)
Q Consensus       328 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  369 (464)
                            .  ..+...+..+.+||.+||..||.+|||+.++++
T Consensus       233 ------~--~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~  266 (476)
T 2y94_A          233 ------F--YTPQYLNPSVISLLKHMLQVDPMKRATIKDIRE  266 (476)
T ss_dssp             ------C--CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             ------c--CCCccCCHHHHHHHHHHcCCCchhCcCHHHHHh
Confidence                  0  112223457899999999999999999999986

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=1e-44  Score=358.12  Aligned_cols=270  Identities=17%  Similarity=0.170  Sum_probs=199.3

Q ss_pred             hcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCcc-----------HHHHHHHHHHHhcCCCCCcce
Q 046893           91 TKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQG-----------DREWLAEVNYLGQLRHSNLVK  159 (464)
Q Consensus        91 ~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~-----------~~~~~~E~~~l~~l~hpniv~  159 (464)
                      .++|++.+.||+|+||.||+|.+....   ..+..+|||++.......           ...+.+|+.++..+.||||++
T Consensus        36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~---~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~  112 (345)
T 2v62_A           36 GNQWVLGKKIGSGGFGLIYLAFPTNKP---EKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPL  112 (345)
T ss_dssp             SCEEEEEEEC------CEEEEEESSSC---GGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCC
T ss_pred             CceEEEEeeEeecCCeEEEEEEecCCC---CccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcce
Confidence            456889999999999999999987521   125679999987653221           123567889999999999999


Q ss_pred             EEEEEEe----CCeEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCC
Q 046893          160 LIGYCCE----DEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNAD  235 (464)
Q Consensus       160 l~~~~~~----~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~  235 (464)
                      +++++..    ....+|||||+ +++|.+++....  .+++..++.++.|++.||.|||  ..+|+||||||+|||++.+
T Consensus       113 ~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH--~~~ivH~Dlkp~NIll~~~  187 (345)
T 2v62_A          113 FYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNG--TFKKSTVLQLGIRMLDVLEYIH--ENEYVHGDIKAANLLLGYK  187 (345)
T ss_dssp             EEEEEEEESSSCEEEEEEEECE-EEEHHHHCBGGG--BCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGEEEESS
T ss_pred             eecccccccCCCcEEEEEEecc-CCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH--hCCeeCCCcCHHHEEEccC
Confidence            9999988    77899999999 999999887654  6999999999999999999999  5679999999999999887


Q ss_pred             C--ceEEcccCCccCCCCCCC-----cceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHhCCCCCCCCCCcc
Q 046893          236 F--SAKLSDFGLAKDGPMGDQ-----THVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSR  308 (464)
Q Consensus       236 ~--~vkl~DFGla~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~  308 (464)
                      +  .+||+|||+++.......     ........||..|+|||++.+..++.++|||||||+||||++|+.||.......
T Consensus       188 ~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~  267 (345)
T 2v62_A          188 NPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDP  267 (345)
T ss_dssp             STTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCH
T ss_pred             CCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCcccccccc
Confidence            7  999999999976432211     111234679999999999999999999999999999999999999996432211


Q ss_pred             cccHHHHHHHhhhcccchhhccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHH
Q 046893          309 EHNLVEWARPLLNNNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETVQ  375 (464)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~~  375 (464)
                      . ................   +.....   ...++..+.+|+..||..||.+||++.+|++.|+.+.
T Consensus       268 ~-~~~~~~~~~~~~~~~~---~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~  327 (345)
T 2v62_A          268 V-AVQTAKTNLLDELPQS---VLKWAP---SGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHG  327 (345)
T ss_dssp             H-HHHHHHHHHHHTTTHH---HHHHSC---TTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTC
T ss_pred             H-HHHHHHHhhcccccHH---HHhhcc---ccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccC
Confidence            1 1111111111100000   000000   0123458999999999999999999999999997653

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=7.6e-44  Score=343.55  Aligned_cols=265  Identities=19%  Similarity=0.200  Sum_probs=208.5

Q ss_pred             hcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCccHHHHHHHHHHHhcCCCCCcceEEEE-EEeCCe
Q 046893           91 TKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVKLIGY-CCEDEH  169 (464)
Q Consensus        91 ~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~-~~~~~~  169 (464)
                      .++|++.+.||+|+||.||+|.+..+      ++.||||++.....  ...+.+|+.++..+.|++++..+.+ +.....
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~------~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~   79 (296)
T 3uzp_A            8 GNRYRLGRKIGSGSFGDIYLGTDIAA------GEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDY   79 (296)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTT------TEEEEEEEEESCSS--CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTE
T ss_pred             ccEEEEEEEEccCCCeEEEEEEEcCC------CcEEEEEEecCCcc--hhHHHHHHHHHHHhhcCCCCCccccccCCCCc
Confidence            46799999999999999999998664      67899999875432  2468899999999998876665554 466778


Q ss_pred             EEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEe---cCCCceEEcccCCc
Q 046893          170 RILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILL---NADFSAKLSDFGLA  246 (464)
Q Consensus       170 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill---~~~~~vkl~DFGla  246 (464)
                      .++||||+ +++|.+++... ...+++..++.++.|++.||.|||  .++|+||||||+|||+   +.++.+||+|||++
T Consensus        80 ~~lv~e~~-~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH--~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~  155 (296)
T 3uzp_A           80 NVMVMELL-GPSLEDLFNFC-SRKFSLKTVLLLADQMISRIEYIH--SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLA  155 (296)
T ss_dssp             EEEEEECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCCGGGEEECCGGGTTCEEECCCTTC
T ss_pred             eEEEEEec-CCCHHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHH--hCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCc
Confidence            89999999 89999988643 346999999999999999999999  5679999999999999   48889999999999


Q ss_pred             cCCCCCCCc-----ceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHH-Hhh
Q 046893          247 KDGPMGDQT-----HVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWAR-PLL  320 (464)
Q Consensus       247 ~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~-~~~  320 (464)
                      +........     .......||+.|+|||++.+..++.++|||||||++|+|++|+.||................ ...
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  235 (296)
T 3uzp_A          156 KKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKM  235 (296)
T ss_dssp             EECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHH
T ss_pred             ccccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhccccc
Confidence            864433221     11234689999999999999999999999999999999999999998754433322222111 111


Q ss_pred             hcccchhhccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhcC
Q 046893          321 NNNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETVQSQG  378 (464)
Q Consensus       321 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~~~~~  378 (464)
                      ...       .+    .....++..+.+|+.+||+.||.+||++.+|++.|+.+....
T Consensus       236 ~~~-------~~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~  282 (296)
T 3uzp_A          236 STP-------IE----VLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ  282 (296)
T ss_dssp             HSC-------HH----HHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHT
T ss_pred             CCc-------hH----HHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhc
Confidence            100       00    011223457999999999999999999999999999886543

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=1.5e-44  Score=344.98  Aligned_cols=254  Identities=25%  Similarity=0.337  Sum_probs=204.1

Q ss_pred             hcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCC-ccHHHHHHHHHHHhcCCCCCcceEEEEEEeCCe
Q 046893           91 TKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGY-QGDREWLAEVNYLGQLRHSNLVKLIGYCCEDEH  169 (464)
Q Consensus        91 ~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~  169 (464)
                      .++|++.+.||+|+||.||+|.+..+      ++.||+|++..... .....+.+|+.+++.++||||+++++++.+.+.
T Consensus         6 ~~~y~~~~~lg~G~~g~V~~~~~~~~------~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   79 (276)
T 2yex_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVT------EEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNI   79 (276)
T ss_dssp             HHHEEEEEEEEECSSSEEEEEEETTT------CCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTE
T ss_pred             ecceEEEEEeecCCCcEEEEEEECCC------CcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCE
Confidence            35688999999999999999998764      56799999864332 334678899999999999999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCccCC
Q 046893          170 RILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDG  249 (464)
Q Consensus       170 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~  249 (464)
                      .++||||+++++|.+++...  ..+++..++.++.|++.||.|||  ..+|+||||||+||+++.++.+||+|||++...
T Consensus        80 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH--~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~  155 (276)
T 2yex_A           80 QYLFLEYCSGGELFDRIEPD--IGMPEPDAQRFFHQLMAGVVYLH--GIGITHRDIKPENLLLDERDNLKISDFGLATVF  155 (276)
T ss_dssp             EEEEEECCTTEEGGGGSBTT--TBCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred             EEEEEEecCCCcHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHH--hCCeeccCCChHHEEEccCCCEEEeeCCCcccc
Confidence            99999999999999987643  36899999999999999999999  567999999999999999999999999999764


Q ss_pred             CCCCCcceeeccccCCcccCccccccCCC-CcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhcccchhh
Q 046893          250 PMGDQTHVSTRVMGTYGYAAPEYVMTGHL-TARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLR  328 (464)
Q Consensus       250 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  328 (464)
                      .............||..|+|||++.+..+ +.++||||||+++|+|++|+.||........ ....|..    . ...  
T Consensus       156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~~~~~~----~-~~~--  227 (276)
T 2yex_A          156 RYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ-EYSDWKE----K-KTY--  227 (276)
T ss_dssp             EETTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSH-HHHHHHT----T-CTT--
T ss_pred             CCCcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHH-HHHHhhh----c-ccc--
Confidence            33222223344679999999999987765 7789999999999999999999976543211 1111111    0 000  


Q ss_pred             ccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 046893          329 ILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVA  369 (464)
Q Consensus       329 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  369 (464)
                       .      ......+..+.+|+.+||..||.+||++.++++
T Consensus       228 -~------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  261 (276)
T 2yex_A          228 -L------NPWKKIDSAPLALLHKILVENPSARITIPDIKK  261 (276)
T ss_dssp             -S------TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             -c------CchhhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence             0      011223457889999999999999999998874

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=2.3e-44  Score=355.87  Aligned_cols=247  Identities=28%  Similarity=0.392  Sum_probs=200.4

Q ss_pred             cCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCcc---HHHHHHHHHHHhcCCCCCcceEEEEEEeCC
Q 046893           92 KFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQG---DREWLAEVNYLGQLRHSNLVKLIGYCCEDE  168 (464)
Q Consensus        92 ~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~hpniv~l~~~~~~~~  168 (464)
                      +.|.+.+.||+|+||+||+|.+..+      ++.||||++.......   ...+.+|+.+|+.++||||+++++++...+
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~a~~~~~------~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~  127 (348)
T 1u5q_A           54 KLFSDLREIGHGSFGAVYFARDVRN------SEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREH  127 (348)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTT------TEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred             hheeeeeEEccCCCEEEEEEEEccC------CeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECC
Confidence            4588889999999999999998764      6789999987653332   256889999999999999999999999999


Q ss_pred             eEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCccC
Q 046893          169 HRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKD  248 (464)
Q Consensus       169 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~  248 (464)
                      ..+|||||+. |+|.+++... ...+++..+..++.|++.||.|||  ..+|+||||||+|||++.++.+||+|||+++.
T Consensus       128 ~~~lv~e~~~-g~l~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH--~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~  203 (348)
T 1u5q_A          128 TAWLVMEYCL-GSASDLLEVH-KKPLQEVEIAAVTHGALQGLAYLH--SHNMIHRDVKAGNILLSEPGLVKLGDFGSASI  203 (348)
T ss_dssp             EEEEEEECCS-EEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHH--HTTCBCCCCSGGGEEEETTTEEEECCCTTCBS
T ss_pred             eEEEEEecCC-CCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHH--hCCeeeCCCCHHHEEECCCCCEEEeeccCcee
Confidence            9999999996 5888877654 346999999999999999999999  56799999999999999999999999999986


Q ss_pred             CCCCCCcceeeccccCCcccCccccc---cCCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhcccc
Q 046893          249 GPMGDQTHVSTRVMGTYGYAAPEYVM---TGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKK  325 (464)
Q Consensus       249 ~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  325 (464)
                      ...      .....||+.|+|||++.   +..++.++|||||||++|||++|+.||......      ..........  
T Consensus       204 ~~~------~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~------~~~~~~~~~~--  269 (348)
T 1u5q_A          204 MAP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM------SALYHIAQNE--  269 (348)
T ss_dssp             SSS------BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH------HHHHHHHHSC--
T ss_pred             cCC------CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH------HHHHHHHhcC--
Confidence            432      12367999999999885   567899999999999999999999999764321      1111111111  


Q ss_pred             hhhccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 046893          326 VLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVAL  370 (464)
Q Consensus       326 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  370 (464)
                           .+..   ....++..+.+||.+||+.||.+||++.++++.
T Consensus       270 -----~~~~---~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h  306 (348)
T 1u5q_A          270 -----SPAL---QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH  306 (348)
T ss_dssp             -----CCCC---CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred             -----CCCC---CCCCCCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence                 1111   112234578899999999999999999999863

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=3.8e-44  Score=356.73  Aligned_cols=264  Identities=17%  Similarity=0.181  Sum_probs=208.7

Q ss_pred             HHHHHhcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCccHHHHHHHHHHHhcCC---CCCcceEEE
Q 046893           86 EMKLATKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLR---HSNLVKLIG  162 (464)
Q Consensus        86 ~~~~~~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---hpniv~l~~  162 (464)
                      ++.+..++|.+.+.||+|+||+||+|.+... .....++.||||++...   ...++..|++++..+.   |+||+++++
T Consensus        59 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~-~~~~~~~~vavK~~~~~---~~~~~~~e~~~~~~l~~~~~~~iv~~~~  134 (365)
T 3e7e_A           59 EFQLGSKLVYVHHLLGEGAFAQVYEATQGDL-NDAKNKQKFVLKVQKPA---NPWEFYIGTQLMERLKPSMQHMFMKFYS  134 (365)
T ss_dssp             EEECSSSEEEEEEEEEECSSEEEEEEEC--------CCCCEEEEEESSC---CHHHHHHHHHHHHHSCGGGGGGBCCEEE
T ss_pred             eEEECCEEEEEEEEeeccCCEEEEEEEecCC-cccccCcEEEEEEeCCC---ChhHHHHHHHHHHHhhhhhhhhhhhhhe
Confidence            3345567899999999999999999964331 11224677999999753   4567788888888886   999999999


Q ss_pred             EEEeCCeEEEEEeccCCCCHHHHHHhh---cCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecC-----
Q 046893          163 YCCEDEHRILVYEYMESGSLEKHLLRR---VGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNA-----  234 (464)
Q Consensus       163 ~~~~~~~~~lv~e~~~~g~L~~~l~~~---~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~-----  234 (464)
                      ++...+..+||||||++|+|.+++...   ....+++..++.|+.||+.||.|||  .++|+||||||+||||+.     
T Consensus       135 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH--~~~ivHrDiKp~NIll~~~~~~~  212 (365)
T 3e7e_A          135 AHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVH--DCEIIHGDIKPDNFILGNGFLEQ  212 (365)
T ss_dssp             EEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHH--TTTEECCCCSGGGEEECGGGTCC
T ss_pred             eeecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHh--hCCeecCCCCHHHEEecccccCc
Confidence            999999999999999999999999753   2346999999999999999999999  577999999999999988     


Q ss_pred             ------CCceEEcccCCccCCCCCCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHhCCCCCCCCCCcc
Q 046893          235 ------DFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSR  308 (464)
Q Consensus       235 ------~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~  308 (464)
                            ++.+||+|||+|+..............+||+.|+|||++.+..++.++|||||||+||||++|+.||.......
T Consensus       213 ~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~  292 (365)
T 3e7e_A          213 DDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGE  292 (365)
T ss_dssp             ------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTE
T ss_pred             cccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCc
Confidence                  89999999999975432233334455789999999999999999999999999999999999999986432110


Q ss_pred             cccHHHHHHHhhhcccchhhccCccccCccCHHHHHHHHHHHHHhhccCCCCC-CCHHHHHHHHHHHHhc
Q 046893          309 EHNLVEWARPLLNNNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGR-PVMSDVVALLETVQSQ  377 (464)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R-Ps~~ev~~~L~~~~~~  377 (464)
                                     ..+    ...+...   .....+.+++..||+.+|.+| |++.++.+.|+.+...
T Consensus       293 ---------------~~~----~~~~~~~---~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~  340 (365)
T 3e7e_A          293 ---------------CKP----EGLFRRL---PHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQ  340 (365)
T ss_dssp             ---------------EEE----CSCCTTC---SSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHH
T ss_pred             ---------------eee----chhcccc---CcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHH
Confidence                           000    0111111   124477889999999999999 7788888888877654

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=2e-44  Score=350.22  Aligned_cols=254  Identities=29%  Similarity=0.465  Sum_probs=198.1

Q ss_pred             cCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCccHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeEE
Q 046893           92 KFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVKLIGYCCEDEHRI  171 (464)
Q Consensus        92 ~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~  171 (464)
                      ++|++.+.||+|+||+||+|.+.        ++.||||++...  ...+.+.+|+++|+.++||||+++++++.  +..+
T Consensus         8 ~~~~~~~~lg~G~~g~V~~~~~~--------~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~   75 (307)
T 2eva_A            8 KEIEVEEVVGRGAFGVVCKAKWR--------AKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACL--NPVC   75 (307)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEET--------TEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTE
T ss_pred             hHeeeeeEeecCCCceEEEEEEC--------CeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcE
Confidence            56888899999999999999864        356999998653  34577899999999999999999999876  3478


Q ss_pred             EEEeccCCCCHHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHhcCC-CCeeeccCCCCceEecCCCc-eEEcccCCccC
Q 046893          172 LVYEYMESGSLEKHLLRRVG-CMLTWSRRMKIALDAAKGLAFLHGAE-RPVIYRDFKTSNILLNADFS-AKLSDFGLAKD  248 (464)
Q Consensus       172 lv~e~~~~g~L~~~l~~~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~-~~ivHrDlkp~Nill~~~~~-vkl~DFGla~~  248 (464)
                      +||||+++++|.+++..... ..+++..++.++.|++.||.|||+.. ++|+||||||+|||++.++. +||+|||++..
T Consensus        76 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~  155 (307)
T 2eva_A           76 LVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACD  155 (307)
T ss_dssp             EEEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC---
T ss_pred             EEEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccc
Confidence            99999999999999875432 24789999999999999999999532 68999999999999988886 79999999975


Q ss_pred             CCCCCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhcccchhh
Q 046893          249 GPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLR  328 (464)
Q Consensus       249 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  328 (464)
                      ....     .....||+.|+|||++.+..++.++||||||+++|||++|+.||.......    ..........      
T Consensus       156 ~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~----~~~~~~~~~~------  220 (307)
T 2eva_A          156 IQTH-----MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPA----FRIMWAVHNG------  220 (307)
T ss_dssp             --------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSH----HHHHHHHHTT------
T ss_pred             cccc-----cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccH----HHHHHHHhcC------
Confidence            3221     223569999999999999999999999999999999999999997543211    1111111110      


Q ss_pred             ccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhc
Q 046893          329 ILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETVQSQ  377 (464)
Q Consensus       329 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~~~~  377 (464)
                       ..+    .....++..+.+|+.+||+.||.+|||+.++++.|+.+...
T Consensus       221 -~~~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~  264 (307)
T 2eva_A          221 -TRP----PLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRY  264 (307)
T ss_dssp             -CCC----CCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGG
T ss_pred             -CCC----CcccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHh
Confidence             011    12223445789999999999999999999999999988653

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=1.2e-44  Score=356.10  Aligned_cols=243  Identities=23%  Similarity=0.310  Sum_probs=201.4

Q ss_pred             HhcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCc--------cHHHHHHHHHHHhcCCCCCcceEE
Q 046893           90 ATKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQ--------GDREWLAEVNYLGQLRHSNLVKLI  161 (464)
Q Consensus        90 ~~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l~hpniv~l~  161 (464)
                      ..++|++.+.||+|+||+||+|.+..+      ++.||||++......        ....+.+|+.+|+.++||||++++
T Consensus        22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~------~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~   95 (335)
T 3dls_A           22 YSQKYSTMSPLGSGAFGFVWTAVDKEK------NKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVL   95 (335)
T ss_dssp             HHHHEEEEEECSSSSSCSEEEEEETTT------TEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEE
T ss_pred             cccceEEEeEEEecCCEEEEEEEECCC------CcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEE
Confidence            456799999999999999999998765      678999998765321        123467899999999999999999


Q ss_pred             EEEEeCCeEEEEEeccCCC-CHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEE
Q 046893          162 GYCCEDEHRILVYEYMESG-SLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKL  240 (464)
Q Consensus       162 ~~~~~~~~~~lv~e~~~~g-~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl  240 (464)
                      +++...+..++||||+.+| +|.+++....  .+++..+..++.|++.||.|||  .++|+||||||+|||++.++.+||
T Consensus        96 ~~~~~~~~~~lv~e~~~~g~~l~~~~~~~~--~l~~~~~~~i~~qi~~~L~~LH--~~~ivH~Dlkp~NIll~~~~~~kL  171 (335)
T 3dls_A           96 DIFENQGFFQLVMEKHGSGLDLFAFIDRHP--RLDEPLASYIFRQLVSAVGYLR--LKDIIHRDIKDENIVIAEDFTIKL  171 (335)
T ss_dssp             EEEECSSEEEEEEECCTTSCBHHHHHHTCC--CCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGEEECTTSCEEE
T ss_pred             EEEeeCCEEEEEEEeCCCCccHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH--hCCeEEeccCHHHEEEcCCCcEEE
Confidence            9999999999999999776 9999887643  6999999999999999999999  567999999999999999999999


Q ss_pred             cccCCccCCCCCCCcceeeccccCCcccCccccccCCC-CcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHh
Q 046893          241 SDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHL-TARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPL  319 (464)
Q Consensus       241 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~  319 (464)
                      +|||+++......   .....+||+.|+|||++.+..+ +.++|||||||++|+|++|..||......            
T Consensus       172 ~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~------------  236 (335)
T 3dls_A          172 IDFGSAAYLERGK---LFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET------------  236 (335)
T ss_dssp             CCCTTCEECCTTC---CBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG------------
T ss_pred             eecccceECCCCC---ceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH------------
Confidence            9999998654322   2234679999999999988876 78999999999999999999999652210            


Q ss_pred             hhcccchhhccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 046893          320 LNNNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVA  369 (464)
Q Consensus       320 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  369 (464)
                            ......      .+..++..+.+|+.+||+.||.+||++.++++
T Consensus       237 ------~~~~~~------~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~  274 (335)
T 3dls_A          237 ------VEAAIH------PPYLVSKELMSLVSGLLQPVPERRTTLEKLVT  274 (335)
T ss_dssp             ------TTTCCC------CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ------HhhccC------CCcccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence                  000000      11123457899999999999999999999986

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=3.5e-44  Score=344.71  Aligned_cols=251  Identities=25%  Similarity=0.321  Sum_probs=197.1

Q ss_pred             cCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCC-CccHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeE
Q 046893           92 KFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGG-YQGDREWLAEVNYLGQLRHSNLVKLIGYCCEDEHR  170 (464)
Q Consensus        92 ~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~  170 (464)
                      ++|.+.+.||+|+||+||+|.+..+      +..+|+|++.... ......+.+|+++|+.++||||+++++++......
T Consensus        22 ~~y~~~~~lg~G~~g~V~~~~~~~~------~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~   95 (285)
T 3is5_A           22 DLFIFKRKLGSGAFGDVHLVEERSS------GLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNM   95 (285)
T ss_dssp             HHEEEEEEEEECSSCEEEEEEETTT------CCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred             hheeecceeccCCCeEEEEEEEccC------CceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeE
Confidence            5688999999999999999998765      5679999986543 23457889999999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHhh--cCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEe---cCCCceEEcccCC
Q 046893          171 ILVYEYMESGSLEKHLLRR--VGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILL---NADFSAKLSDFGL  245 (464)
Q Consensus       171 ~lv~e~~~~g~L~~~l~~~--~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill---~~~~~vkl~DFGl  245 (464)
                      ++||||+++++|.+++...  .+..+++..++.++.|++.||.|||  ..+|+||||||+|||+   +.++.+||+|||+
T Consensus        96 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH--~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~  173 (285)
T 3is5_A           96 YIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFH--SQHVVHKDLKPENILFQDTSPHSPIKIIDFGL  173 (285)
T ss_dssp             EEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHH--HTTCCCCCCSGGGEEESSSSTTCCEEECCCCC
T ss_pred             EEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHH--hCCEEECCCCHHHEEEecCCCCCCEEEEeeec
Confidence            9999999999999988653  2457999999999999999999999  5679999999999999   4567899999999


Q ss_pred             ccCCCCCCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhcccc
Q 046893          246 AKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKK  325 (464)
Q Consensus       246 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  325 (464)
                      ++......   ......||..|+|||++. ..++.++||||||+++|+|++|+.||......      +.........  
T Consensus       174 a~~~~~~~---~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~------~~~~~~~~~~--  241 (285)
T 3is5_A          174 AELFKSDE---HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLE------EVQQKATYKE--  241 (285)
T ss_dssp             CCC-------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHHCC--
T ss_pred             ceecCCcc---cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHH------HHHhhhccCC--
Confidence            98643322   233467999999999875 57899999999999999999999999764321      1111111110  


Q ss_pred             hhhccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 046893          326 VLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVA  369 (464)
Q Consensus       326 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  369 (464)
                            +..... ....+..+.+|+.+||+.||.+||++.++++
T Consensus       242 ------~~~~~~-~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  278 (285)
T 3is5_A          242 ------PNYAVE-CRPLTPQAVDLLKQMLTKDPERRPSAAQVLH  278 (285)
T ss_dssp             ------CCCCC---CCCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred             ------cccccc-cCcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence                  000000 0112347889999999999999999999874

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=5.3e-44  Score=370.86  Aligned_cols=252  Identities=25%  Similarity=0.368  Sum_probs=205.3

Q ss_pred             HhcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCC---CccHHHHHHHHHHHhcCCCCCcceEEEEEEe
Q 046893           90 ATKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGG---YQGDREWLAEVNYLGQLRHSNLVKLIGYCCE  166 (464)
Q Consensus        90 ~~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~  166 (464)
                      ..++|.+.++||+|+||+||+|.+..+      ++.||+|++....   ......+..|+.+|..++||||+++++++..
T Consensus       183 ~~~~f~~~~~LG~G~fG~Vy~a~~~~t------g~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~  256 (543)
T 3c4z_A          183 GEDWFLDFRVLGRGGFGEVFACQMKAT------GKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFET  256 (543)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEETTT------CCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred             ChhheEEEEEEeeCCCeEEEEEEECCC------CcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEee
Confidence            346788899999999999999998765      6789999986532   1234568899999999999999999999999


Q ss_pred             CCeEEEEEeccCCCCHHHHHHhhc--CCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccC
Q 046893          167 DEHRILVYEYMESGSLEKHLLRRV--GCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFG  244 (464)
Q Consensus       167 ~~~~~lv~e~~~~g~L~~~l~~~~--~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFG  244 (464)
                      ....||||||++||+|.+++....  ...+++..++.++.||+.||.|||  .++|+||||||+||||+.+|.+||+|||
T Consensus       257 ~~~l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH--~~gIvHrDLKP~NILl~~~g~vkL~DFG  334 (543)
T 3c4z_A          257 KTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLH--QRNIIYRDLKPENVLLDDDGNVRISDLG  334 (543)
T ss_dssp             SSEEEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCCGGGEEECTTSCEEECCCT
T ss_pred             CCEEEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHH--HcCCcccCCChHHEEEeCCCCEEEeecc
Confidence            999999999999999999987643  346999999999999999999999  5679999999999999999999999999


Q ss_pred             CccCCCCCCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhccc
Q 046893          245 LAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNK  324 (464)
Q Consensus       245 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  324 (464)
                      +++......  ......+||+.|+|||++.+..++.++|||||||+||||++|+.||.......  ...++........ 
T Consensus       335 la~~~~~~~--~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~--~~~~~~~~i~~~~-  409 (543)
T 3c4z_A          335 LAVELKAGQ--TKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKV--ENKELKQRVLEQA-  409 (543)
T ss_dssp             TCEECCTTC--CCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCC--CHHHHHHHHHHCC-
T ss_pred             eeeeccCCC--cccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccch--hHHHHHHHHhhcc-
Confidence            998643322  12334689999999999999999999999999999999999999998653221  1122222222111 


Q ss_pred             chhhccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHH
Q 046893          325 KVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMS  365 (464)
Q Consensus       325 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~  365 (464)
                                 ..++...+..+.+||.+||..||.+||++.
T Consensus       410 -----------~~~p~~~s~~~~~li~~lL~~dP~~R~~~~  439 (543)
T 3c4z_A          410 -----------VTYPDKFSPASKDFCEALLQKDPEKRLGFR  439 (543)
T ss_dssp             -----------CCCCTTSCHHHHHHHHHHSCSSGGGSCCCB
T ss_pred             -----------cCCCcccCHHHHHHHHHhccCCHhHCCCCc
Confidence                       112233456889999999999999999864

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=2.5e-44  Score=381.95  Aligned_cols=253  Identities=27%  Similarity=0.377  Sum_probs=200.5

Q ss_pred             CceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCC--ccHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeEEEEEe
Q 046893           98 YILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGY--QGDREWLAEVNYLGQLRHSNLVKLIGYCCEDEHRILVYE  175 (464)
Q Consensus        98 ~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e  175 (464)
                      +.||+|+||+||+|.+...    ..++.||||+++....  ...+++.+|+++|..++|||||++++++.. +..+||||
T Consensus       375 ~~LG~G~fG~Vy~~~~~~~----~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E  449 (635)
T 4fl3_A          375 KELGSGNFGTVKKGYYQMK----KVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVME  449 (635)
T ss_dssp             EEEEECSSEEEEEEEEECS----SCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEE
T ss_pred             CEeccCCCEEEEEEEEcCC----CcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEE
Confidence            4799999999999976542    1367899999976432  234789999999999999999999999864 56889999


Q ss_pred             ccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCccCCCCCCC-
Q 046893          176 YMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQ-  254 (464)
Q Consensus       176 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~-  254 (464)
                      |+.+|+|.+++...  ..+++..++.|+.||+.||.|||  .++|+||||||+||||+.++.+||+|||+++....... 
T Consensus       450 ~~~~g~L~~~l~~~--~~l~~~~~~~i~~qi~~~L~yLH--~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~  525 (635)
T 4fl3_A          450 MAELGPLNKYLQQN--RHVKDKNIIELVHQVSMGMKYLE--ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY  525 (635)
T ss_dssp             CCTTEEHHHHHHHC--TTCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC----
T ss_pred             ccCCCCHHHHHhhC--CCCCHHHHHHHHHHHHHHHHHHH--HCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCccc
Confidence            99999999999754  36999999999999999999999  56799999999999999999999999999986543322 


Q ss_pred             cceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHhhhcccchhhccCcc
Q 046893          255 THVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLL-GRRAVDKSRPSREHNLVEWARPLLNNNKKVLRILDPR  333 (464)
Q Consensus       255 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  333 (464)
                      ........||+.|+|||++.+..++.++|||||||+||||++ |+.||.+.....   +..    .+          ...
T Consensus       526 ~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~---~~~----~i----------~~~  588 (635)
T 4fl3_A          526 YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE---VTA----ML----------EKG  588 (635)
T ss_dssp             ---------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH---HHH----HH----------HTT
T ss_pred             cccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH---HHH----HH----------HcC
Confidence            122233567889999999999999999999999999999998 999997654211   111    11          111


Q ss_pred             ccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHh
Q 046893          334 LEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETVQS  376 (464)
Q Consensus       334 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~~~  376 (464)
                      .....+..++..+.+||.+||+.||.+||++.+|++.|+.+..
T Consensus       589 ~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~  631 (635)
T 4fl3_A          589 ERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY  631 (635)
T ss_dssp             CCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             CCCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence            1122334456789999999999999999999999999998754

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=2.2e-44  Score=355.27  Aligned_cols=261  Identities=22%  Similarity=0.256  Sum_probs=200.4

Q ss_pred             HHHHhcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCC-----CCccHHHHHHHHHHHhcCCCCCcceEE
Q 046893           87 MKLATKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRG-----GYQGDREWLAEVNYLGQLRHSNLVKLI  161 (464)
Q Consensus        87 ~~~~~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~hpniv~l~  161 (464)
                      +....++|++.+.||+|+||+||+|.+..+      +..||+|++...     .......+.+|+.+++.++||||++++
T Consensus        21 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~------~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~   94 (345)
T 3hko_A           21 LLELQKKYHLKGAIGQGSYGVVRVAIENQT------RAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLY   94 (345)
T ss_dssp             HHHHHHHEEEEEEEEECSSCEEEEEEETTT------CCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             hhhhhhheeecceeeecCCeEEEEEEECCC------CceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceee
Confidence            445677899999999999999999998765      667999998643     223446789999999999999999999


Q ss_pred             EEEEeCCeEEEEEeccCCCCHHHHHHhhc--------------------------------------CCCCCHHHHHHHH
Q 046893          162 GYCCEDEHRILVYEYMESGSLEKHLLRRV--------------------------------------GCMLTWSRRMKIA  203 (464)
Q Consensus       162 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~--------------------------------------~~~l~~~~~~~i~  203 (464)
                      +++.+.+..+|||||+++|+|.+++....                                      ...+++..++.++
T Consensus        95 ~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~  174 (345)
T 3hko_A           95 EVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIM  174 (345)
T ss_dssp             EEEECSSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHH
T ss_pred             hhhccCCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHH
Confidence            99999999999999999999999874210                                      1123577788999


Q ss_pred             HHHHHHHHHHhcCCCCeeeccCCCCceEecCCC--ceEEcccCCccCCCCCC--CcceeeccccCCcccCcccccc--CC
Q 046893          204 LDAAKGLAFLHGAERPVIYRDFKTSNILLNADF--SAKLSDFGLAKDGPMGD--QTHVSTRVMGTYGYAAPEYVMT--GH  277 (464)
Q Consensus       204 ~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~--~vkl~DFGla~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~--~~  277 (464)
                      .|++.||.|||  ..+|+||||||+||||+.++  .+||+|||+++......  .........||+.|+|||++.+  ..
T Consensus       175 ~qi~~~l~~LH--~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~  252 (345)
T 3hko_A          175 RQIFSALHYLH--NQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNES  252 (345)
T ss_dssp             HHHHHHHHHHH--HTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSC
T ss_pred             HHHHHHHHHHH--HCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCC
Confidence            99999999999  56799999999999998766  89999999997532211  1112334679999999999875  67


Q ss_pred             CCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhcccchhhccCccccCccCHHHHHHHHHHHHHhhccC
Q 046893          278 LTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQN  357 (464)
Q Consensus       278 ~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~d  357 (464)
                      ++.++|||||||+||||++|+.||......      +...........        .........+..+.+||.+||+.|
T Consensus       253 ~~~~~DiwslG~il~el~~g~~pf~~~~~~------~~~~~~~~~~~~--------~~~~~~~~~~~~~~~li~~~l~~~  318 (345)
T 3hko_A          253 YGPKCDAWSAGVLLHLLLMGAVPFPGVNDA------DTISQVLNKKLC--------FENPNYNVLSPLARDLLSNLLNRN  318 (345)
T ss_dssp             CCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHHCCCC--------TTSGGGGGSCHHHHHHHHHHSCSC
T ss_pred             CCcHHHHHHHHHHHHHHHHCCCCCCCCChH------HHHHHHHhcccc--------cCCcccccCCHHHHHHHHHHcCCC
Confidence            899999999999999999999999765421      111111111110        001111123458899999999999


Q ss_pred             CCCCCCHHHHHH
Q 046893          358 PKGRPVMSDVVA  369 (464)
Q Consensus       358 P~~RPs~~ev~~  369 (464)
                      |.+||++.++++
T Consensus       319 p~~Rps~~~~l~  330 (345)
T 3hko_A          319 VDERFDAMRALQ  330 (345)
T ss_dssp             TTTSCCHHHHHH
T ss_pred             hhHCCCHHHHhc
Confidence            999999999975

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=5.1e-44  Score=346.58  Aligned_cols=252  Identities=22%  Similarity=0.325  Sum_probs=203.5

Q ss_pred             HhcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCccHHHHHHHHHHHhcCCCCCcceEEEEEEeCCe
Q 046893           90 ATKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVKLIGYCCEDEH  169 (464)
Q Consensus        90 ~~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~  169 (464)
                      ..++|.+.+.||+|+||.||+|.+..+      ++.||+|++..........+.+|+.+++.++||||+++++++...+.
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~------~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   80 (304)
T 2jam_A            7 IRKTFIFMEVLGSGAFSEVFLVKQRLT------GKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTH   80 (304)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTT------CCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred             hhccceeeeeccCCCCceEEEEEECCC------CCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCE
Confidence            456789999999999999999998764      66799999986554455678899999999999999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEe---cCCCceEEcccCCc
Q 046893          170 RILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILL---NADFSAKLSDFGLA  246 (464)
Q Consensus       170 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill---~~~~~vkl~DFGla  246 (464)
                      .++||||+++++|.+++....  .+++..+..++.|++.||.|||  ..+|+||||||+|||+   +.++.+||+|||++
T Consensus        81 ~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH--~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~  156 (304)
T 2jam_A           81 YYLVMQLVSGGELFDRILERG--VYTEKDASLVIQQVLSAVKYLH--ENGIVHRDLKPENLLYLTPEENSKIMITDFGLS  156 (304)
T ss_dssp             EEEEECCCCSCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHH--HTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTT
T ss_pred             EEEEEEcCCCccHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH--HCCccccCCCHHHEEEecCCCCCCEEEccCCcc
Confidence            999999999999999887654  6899999999999999999999  5679999999999999   78889999999999


Q ss_pred             cCCCCCCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhcccch
Q 046893          247 KDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKV  326 (464)
Q Consensus       247 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  326 (464)
                      +.....    ......||+.|+|||++.+..++.++||||||+++|+|++|..||......      .....+.....  
T Consensus       157 ~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~------~~~~~i~~~~~--  224 (304)
T 2jam_A          157 KMEQNG----IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETES------KLFEKIKEGYY--  224 (304)
T ss_dssp             CCCCCB----TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHH------HHHHHHHHCCC--
T ss_pred             eecCCC----ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH------HHHHHHHcCCC--
Confidence            753221    123357999999999999999999999999999999999999999764321      11111111110  


Q ss_pred             hhccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 046893          327 LRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVA  369 (464)
Q Consensus       327 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  369 (464)
                            ..........+..+.+|+.+||..||.+||++.++++
T Consensus       225 ------~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  261 (304)
T 2jam_A          225 ------EFESPFWDDISESAKDFICHLLEKDPNERYTCEKALS  261 (304)
T ss_dssp             ------CCCTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             ------CCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence                  0111122234558999999999999999999999985

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=8.4e-44  Score=342.63  Aligned_cols=250  Identities=28%  Similarity=0.404  Sum_probs=197.3

Q ss_pred             cCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCc--cHHHHHHHHHHHhcCCCCCcceEEEEEEe---
Q 046893           92 KFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQ--GDREWLAEVNYLGQLRHSNLVKLIGYCCE---  166 (464)
Q Consensus        92 ~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpniv~l~~~~~~---  166 (464)
                      ++|++.+.||+|+||.||+|.+..+      +..||+|++......  ....+.+|+.+|+.++||||+++++++..   
T Consensus        26 ~~~~~~~~lg~G~~g~Vy~~~~~~~------~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~   99 (290)
T 1t4h_A           26 RFLKFDIEIGRGSFKTVYKGLDTET------TVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVK   99 (290)
T ss_dssp             CEEEEEEEEEECSSEEEEEEEETTT------CCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESS
T ss_pred             eeEEeeeeccCCCCeEEEEeEecCC------ceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccC
Confidence            3477888899999999999998765      667999998654322  23568899999999999999999999876   


Q ss_pred             -CCeEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEec-CCCceEEcccC
Q 046893          167 -DEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLN-ADFSAKLSDFG  244 (464)
Q Consensus       167 -~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~-~~~~vkl~DFG  244 (464)
                       ....++||||+++++|.+++....  .+++..++.++.|++.||.|||+.+.+|+||||||+|||++ .++.+||+|||
T Consensus       100 ~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg  177 (290)
T 1t4h_A          100 GKKCIVLVTELMTSGTLKTYLKRFK--VMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLG  177 (290)
T ss_dssp             SCEEEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTT
T ss_pred             CCceEEEEEEecCCCCHHHHHHHcc--CCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCC
Confidence             456899999999999999997653  68999999999999999999994333399999999999997 78899999999


Q ss_pred             CccCCCCCCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhccc
Q 046893          245 LAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNK  324 (464)
Q Consensus       245 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  324 (464)
                      ++......    ......||+.|+|||++. ..++.++||||||+++|+|++|+.||......     ..........  
T Consensus       178 ~~~~~~~~----~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~-----~~~~~~~~~~--  245 (290)
T 1t4h_A          178 LATLKRAS----FAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNA-----AQIYRRVTSG--  245 (290)
T ss_dssp             GGGGCCTT----SBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH-----HHHHHHHTTT--
T ss_pred             Cccccccc----ccccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcH-----HHHHHHHhcc--
Confidence            99753322    223467999999999776 46999999999999999999999999764321     1111111111  


Q ss_pred             chhhccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 046893          325 KVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVA  369 (464)
Q Consensus       325 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  369 (464)
                              .....++...+..+.+|+.+||+.||.+|||+.++++
T Consensus       246 --------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  282 (290)
T 1t4h_A          246 --------VKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN  282 (290)
T ss_dssp             --------CCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             --------CCccccCCCCCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence                    0001112222347899999999999999999999875

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=1.8e-44  Score=354.08  Aligned_cols=263  Identities=23%  Similarity=0.296  Sum_probs=192.4

Q ss_pred             cCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCcc--HHHHHHHHHHHhcCCCCCcceEEEEEEeCCe
Q 046893           92 KFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQG--DREWLAEVNYLGQLRHSNLVKLIGYCCEDEH  169 (464)
Q Consensus        92 ~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~  169 (464)
                      ++|++.+.||+|+||+||+|.+..+      ++.||||++.......  ...+.+|+.+|+.++||||+++++++...+.
T Consensus        34 ~~y~~~~~lg~G~~g~V~~~~~~~~------~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  107 (329)
T 3gbz_A           34 DRYRRITKLGEGTYGEVYKAIDTVT------NETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHR  107 (329)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEETTT------TEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTE
T ss_pred             hhEEEEEEEEecCCeEEEEEEECCC------CceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCE
Confidence            4688999999999999999998765      7789999997543322  3557899999999999999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEe-----cCCCceEEcccC
Q 046893          170 RILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILL-----NADFSAKLSDFG  244 (464)
Q Consensus       170 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill-----~~~~~vkl~DFG  244 (464)
                      .+|||||+.+ +|.+++....  .+++..+..++.||+.||.|||  .++|+||||||+||||     +.++.+||+|||
T Consensus       108 ~~lv~e~~~~-~L~~~~~~~~--~~~~~~~~~i~~ql~~~l~~LH--~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg  182 (329)
T 3gbz_A          108 LHLIFEYAEN-DLKKYMDKNP--DVSMRVIKSFLYQLINGVNFCH--SRRCLHRDLKPQNLLLSVSDASETPVLKIGDFG  182 (329)
T ss_dssp             EEEEEECCSE-EHHHHHHHCT--TCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCCGGGEEEEC-----CCEEEECCTT
T ss_pred             EEEEEecCCC-CHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHH--hCCEECCCCCHHHEEEecCCCCccceEEECcCC
Confidence            9999999974 9999887653  5999999999999999999999  5679999999999999     455569999999


Q ss_pred             CccCCCCCCCcceeeccccCCcccCccccccC-CCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhcc
Q 046893          245 LAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTG-HLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNN  323 (464)
Q Consensus       245 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~  323 (464)
                      +++.....  ........||..|+|||++.+. .++.++|||||||++|+|++|+.||.......  .+...........
T Consensus       183 ~a~~~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~--~~~~~~~~~~~~~  258 (329)
T 3gbz_A          183 LARAFGIP--IRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEID--QLFKIFEVLGLPD  258 (329)
T ss_dssp             HHHHHC-------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHHHHCCCC
T ss_pred             CccccCCc--ccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHH--HHHHHHHHhCCCc
Confidence            99754322  1222346789999999999874 58999999999999999999999997654221  1111111000000


Q ss_pred             -cc-------------hhhccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 046893          324 -KK-------------VLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVA  369 (464)
Q Consensus       324 -~~-------------~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  369 (464)
                       ..             ........+........+..+.+||.+||+.||.+|||+.++++
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  318 (329)
T 3gbz_A          259 DTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE  318 (329)
T ss_dssp             TTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             hhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence             00             00000000000111123458899999999999999999999875

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=4.1e-44  Score=350.89  Aligned_cols=275  Identities=24%  Similarity=0.356  Sum_probs=211.7

Q ss_pred             HhcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCccHHHHHHHHHHHhcCCCCCcceEEEEEEeCC-
Q 046893           90 ATKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVKLIGYCCEDE-  168 (464)
Q Consensus        90 ~~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~-  168 (464)
                      ..++|++.+.||+|+||.||+|.+....  ...++.||||++..........+.+|+.+++.++||||+++++++...+ 
T Consensus        39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~--~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  116 (326)
T 2w1i_A           39 EERHLKFLQQLGKGNFGSVEMCRYDPLQ--DNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGR  116 (326)
T ss_dssp             CGGGEEEEEEEECCSSEEEEEEEECTTS--SSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC---
T ss_pred             CHHHceeeeeeccCCCeEEEEEEecccc--CCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCC
Confidence            3456889999999999999999853211  1247889999998765555678999999999999999999999886654 


Q ss_pred             -eEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCcc
Q 046893          169 -HRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAK  247 (464)
Q Consensus       169 -~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~  247 (464)
                       ..++||||+++++|.+++.... ..+++..++.++.|++.||.|||  ..+|+||||||+|||++.++.+||+|||+++
T Consensus       117 ~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH--~~~ivH~dikp~NIli~~~~~~kL~Dfg~~~  193 (326)
T 2w1i_A          117 RNLKLIMEYLPYGSLRDYLQKHK-ERIDHIKLLQYTSQICKGMEYLG--TKRYIHRDLATRNILVENENRVKIGDFGLTK  193 (326)
T ss_dssp             -CCEEEECCCTTCBHHHHHHHST-TSSCHHHHHHHHHHHHHHHHHHH--HTTEECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred             CceEEEEECCCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHH--hCCEeccCCCcceEEEcCCCcEEEecCcchh
Confidence             7899999999999999987653 46899999999999999999999  5679999999999999999999999999998


Q ss_pred             CCCCCCCc-ceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhcc---
Q 046893          248 DGPMGDQT-HVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNN---  323 (464)
Q Consensus       248 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~---  323 (464)
                      ........ .......++..|+|||++.+..++.++||||||+++|+|++|..||.....    .+...   .....   
T Consensus       194 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~----~~~~~---~~~~~~~~  266 (326)
T 2w1i_A          194 VLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPA----EFMRM---IGNDKQGQ  266 (326)
T ss_dssp             ECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHH----HHHHH---HCTTCCTH
T ss_pred             hccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHH----HHHHh---hccccchh
Confidence            65433221 112234678889999999998999999999999999999999998864210    00000   00000   


Q ss_pred             ---cchhhccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHh
Q 046893          324 ---KKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETVQS  376 (464)
Q Consensus       324 ---~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~~~  376 (464)
                         ..+...+........+..++..+.+||.+||..||.+||++.+|++.|+.+..
T Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~  322 (326)
T 2w1i_A          267 MIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD  322 (326)
T ss_dssp             HHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             hhHHHHHHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence               00011111111112234456689999999999999999999999999998864

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=1.8e-44  Score=354.16  Aligned_cols=264  Identities=26%  Similarity=0.404  Sum_probs=199.5

Q ss_pred             cCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCcc--HHHHHHHHHHHhcCCCCCcceEEEEEEeCCe
Q 046893           92 KFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQG--DREWLAEVNYLGQLRHSNLVKLIGYCCEDEH  169 (464)
Q Consensus        92 ~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~  169 (464)
                      ++|++.+.||+|+||.||+|.+..+      ++.||||++.......  ...+.+|+.+++.++||||+++++++...+.
T Consensus        25 ~~y~~~~~lg~G~~g~V~~~~~~~~------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   98 (331)
T 4aaa_A           25 EKYENLGLVGEGSYGMVMKCRNKDT------GRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKR   98 (331)
T ss_dssp             GGEEEEEEGGGGTTSSEEEEEETTT------CCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTE
T ss_pred             hhheeeeEEeecCCEEEEEEEECCC------CceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCE
Confidence            4688899999999999999998765      6779999986544332  3557899999999999999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCccCC
Q 046893          170 RILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDG  249 (464)
Q Consensus       170 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~  249 (464)
                      .++||||+.+++|.+++...  ..+++..+..++.|++.||.|||  ..+|+||||||+|||++.++.+||+|||+++..
T Consensus        99 ~~lv~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~qi~~~l~~LH--~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~  174 (331)
T 4aaa_A           99 WYLVFEFVDHTILDDLELFP--NGLDYQVVQKYLFQIINGIGFCH--SHNIIHRDIKPENILVSQSGVVKLCDFGFARTL  174 (331)
T ss_dssp             EEEEEECCSEEHHHHHHHST--TCCCHHHHHHHHHHHHHHHHHHH--HTTCCCCCCCGGGEEECTTSCEEECCCTTC---
T ss_pred             EEEEEecCCcchHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHH--HCCEEccCcChheEEEcCCCcEEEEeCCCceee
Confidence            99999999998888776543  36999999999999999999999  567999999999999999999999999999764


Q ss_pred             CCCCCcceeeccccCCcccCccccccC-CCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHH----------H
Q 046893          250 PMGDQTHVSTRVMGTYGYAAPEYVMTG-HLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWAR----------P  318 (464)
Q Consensus       250 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~----------~  318 (464)
                      ....  .......||..|+|||++.+. .++.++|||||||++|+|++|+.||........  +.....          .
T Consensus       175 ~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~  250 (331)
T 4aaa_A          175 AAPG--EVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQ--LYHIMMCLGNLIPRHQE  250 (331)
T ss_dssp             -----------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH--HHHHHHHHCSCCHHHHH
T ss_pred             cCCc--cccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHH--HHHHHHHhCCCChhhhh
Confidence            3221  223346799999999998875 789999999999999999999999976543211  111100          0


Q ss_pred             hhhcccchhhccCcccc-----CccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 046893          319 LLNNNKKVLRILDPRLE-----GQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVA  369 (464)
Q Consensus       319 ~~~~~~~~~~~~~~~~~-----~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  369 (464)
                      .+...........+...     ......++..+.+|+.+||+.||.+||++.++++
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~  306 (331)
T 4aaa_A          251 LFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH  306 (331)
T ss_dssp             HHHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred             HhhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence            00111000001111111     1111234568999999999999999999999885

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=8.9e-44  Score=349.96  Aligned_cols=249  Identities=23%  Similarity=0.341  Sum_probs=204.8

Q ss_pred             hcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCC---ccHHHHHHHHHHHhcCCCCCcceEEEEEEeC
Q 046893           91 TKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGY---QGDREWLAEVNYLGQLRHSNLVKLIGYCCED  167 (464)
Q Consensus        91 ~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~  167 (464)
                      .++|.+.+.||+|+||.||+|.+..+      ++.||+|++.....   .....+.+|+.+++.++||||+++++++.+.
T Consensus        40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~------~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~  113 (335)
T 2owb_A           40 RRRYVRGRFLGKGGFAKCFEISDADT------KEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDN  113 (335)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTT------CCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECS
T ss_pred             CCceEEEEEEeeCCCeEEEEEEECCC------CCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecC
Confidence            35688999999999999999998765      66799999865432   2335688999999999999999999999999


Q ss_pred             CeEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCcc
Q 046893          168 EHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAK  247 (464)
Q Consensus       168 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~  247 (464)
                      +..++||||+.+++|.+++....  .+++..++.++.|++.||.|||  .++|+||||||+|||++.++.+||+|||+++
T Consensus       114 ~~~~lv~e~~~~~~L~~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH--~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~  189 (335)
T 2owb_A          114 DFVFVVLELCRRRSLLELHKRRK--ALTEPEARYYLRQIVLGCQYLH--RNRVIHRDLKLGNLFLNEDLEVKIGDFGLAT  189 (335)
T ss_dssp             SEEEEEECCCTTCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             CeEEEEEecCCCCCHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHH--HCCCEecCCCchhEEEcCCCCEEEeeccCce
Confidence            99999999999999999887643  6899999999999999999999  5679999999999999999999999999998


Q ss_pred             CCCCCCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhcccchh
Q 046893          248 DGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVL  327 (464)
Q Consensus       248 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  327 (464)
                      .......  ......||..|+|||++.+..++.++||||||+++|+|++|+.||......      +.........    
T Consensus       190 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~------~~~~~~~~~~----  257 (335)
T 2owb_A          190 KVEYDGE--RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLK------ETYLRIKKNE----  257 (335)
T ss_dssp             ECCSTTC--CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHH------HHHHHHHHTC----
T ss_pred             ecccCcc--cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHH------HHHHHHhcCC----
Confidence            6432221  223467999999999999999999999999999999999999999764311      1111111110    


Q ss_pred             hccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 046893          328 RILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVA  369 (464)
Q Consensus       328 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  369 (464)
                          .    .++..++..+.+||.+||+.||.+||++.++++
T Consensus       258 ----~----~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  291 (335)
T 2owb_A          258 ----Y----SIPKHINPVAASLIQKMLQTDPTARPTINELLN  291 (335)
T ss_dssp             ----C----CCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred             ----C----CCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                0    112233457889999999999999999999875

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=2e-44  Score=356.91  Aligned_cols=273  Identities=15%  Similarity=0.208  Sum_probs=207.6

Q ss_pred             hcCCCCCCceeecCceEEEEEEecCCCCC--CccceEEEEEEccCCCCccHHHHHHHHHHHhcCCCCCcce---------
Q 046893           91 TKFFRPDYILGEGGFGVVYKGVIDENVRP--GYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVK---------  159 (464)
Q Consensus        91 ~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~--~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~---------  159 (464)
                      .++|++.+.||+|+||.||+|.+..+...  ...++.||+|++...     ..+.+|+.+++.++||||++         
T Consensus        41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~  115 (352)
T 2jii_A           41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTP  115 (352)
T ss_dssp             SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred             CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCC
Confidence            35689999999999999999998753110  002567999998754     35789999999999999887         


Q ss_pred             ------EEEEEEe-CCeEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEe
Q 046893          160 ------LIGYCCE-DEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILL  232 (464)
Q Consensus       160 ------l~~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill  232 (464)
                            +++++.. ....+|||||+ +++|.+++.......+++..++.++.|++.||.|||  .++|+||||||+|||+
T Consensus       116 ~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH--~~~ivH~Dikp~NIl~  192 (352)
T 2jii_A          116 LLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLH--ENEYVHGNVTAENIFV  192 (352)
T ss_dssp             TCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHH--HTTCBCSCCCGGGEEE
T ss_pred             ccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHH--hCCccCCCCCHHHEEE
Confidence                  6777776 67899999999 999999998754457999999999999999999999  5679999999999999


Q ss_pred             cCCC--ceEEcccCCccCCCCCCCc-----ceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHhCCCCCCCCC
Q 046893          233 NADF--SAKLSDFGLAKDGPMGDQT-----HVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSR  305 (464)
Q Consensus       233 ~~~~--~vkl~DFGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~  305 (464)
                      +.++  .+||+|||+++........     .......||+.|+|||++.+..++.++|||||||+||||++|+.||....
T Consensus       193 ~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~  272 (352)
T 2jii_A          193 DPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCL  272 (352)
T ss_dssp             ETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGT
T ss_pred             cCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccCC
Confidence            9988  8999999999864322111     11233589999999999999999999999999999999999999998654


Q ss_pred             CcccccHHHHHHHhhhcccchhhccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhcC
Q 046893          306 PSREHNLVEWARPLLNNNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETVQSQG  378 (464)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~~~~~  378 (464)
                      .... .+.............   ......   .....+..+.+|+.+||..||.+||++.+|++.|+.+....
T Consensus       273 ~~~~-~~~~~~~~~~~~~~~---~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~  338 (352)
T 2jii_A          273 PNTE-DIMKQKQKFVDKPGP---FVGPCG---HWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDL  338 (352)
T ss_dssp             TCHH-HHHHHHHHHHHSCCC---EECTTS---CEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred             cCHH-HHHHHHHhccCChhh---hhhhcc---ccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhc
Confidence            2211 111211111111111   111000   00122458999999999999999999999999999886543

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=5e-44  Score=341.92  Aligned_cols=249  Identities=24%  Similarity=0.369  Sum_probs=182.6

Q ss_pred             cCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCC---CccHHHHHHHHHHHhcCCCCCcceEEEEEEeCC
Q 046893           92 KFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGG---YQGDREWLAEVNYLGQLRHSNLVKLIGYCCEDE  168 (464)
Q Consensus        92 ~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~  168 (464)
                      ++|++.+.||+|+||.||+|.+..+      ++.||+|++....   ......+.+|+.+++.++||||+++++++...+
T Consensus        11 ~~y~~~~~lg~G~~g~Vy~~~~~~~------~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   84 (278)
T 3cok_A           11 EDFKVGNLLGKGSFAGVYRAESIHT------GLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSN   84 (278)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTT------CCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSS
T ss_pred             ccceeeeeecCCCceEEEEEEEccC------CceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCC
Confidence            4688899999999999999998654      6679999986432   122367889999999999999999999999999


Q ss_pred             eEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCccC
Q 046893          169 HRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKD  248 (464)
Q Consensus       169 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~  248 (464)
                      ..++||||+++++|.+++... ...+++..++.++.|++.||.|||  ..+|+||||||+|||++.++.+||+|||++..
T Consensus        85 ~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH--~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~  161 (278)
T 3cok_A           85 YVYLVLEMCHNGEMNRYLKNR-VKPFSENEARHFMHQIITGMLYLH--SHGILHRDLTLSNLLLTRNMNIKIADFGLATQ  161 (278)
T ss_dssp             EEEEEEECCTTEEHHHHHHTC-SSCCCHHHHHHHHHHHHHHHHHHH--HTTEECSSCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             eEEEEEecCCCCcHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHH--HCCeecCCCCHHHEEEcCCCCEEEEeecceee
Confidence            999999999999999988754 346899999999999999999999  56799999999999999999999999999986


Q ss_pred             CCCCCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhcccchhh
Q 046893          249 GPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLR  328 (464)
Q Consensus       249 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  328 (464)
                      ......  ......||+.|+|||++.+..++.++||||||+++|+|++|+.||.........      .          .
T Consensus       162 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~------~----------~  223 (278)
T 3cok_A          162 LKMPHE--KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTL------N----------K  223 (278)
T ss_dssp             CC------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC---------------------
T ss_pred             ccCCCC--cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHH------H----------H
Confidence            432221  222367999999999999989999999999999999999999999764322110      0          0


Q ss_pred             ccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 046893          329 ILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVA  369 (464)
Q Consensus       329 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  369 (464)
                      .....  ...+...+..+.+|+.+||+.||.+||++.++++
T Consensus       224 ~~~~~--~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  262 (278)
T 3cok_A          224 VVLAD--YEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLD  262 (278)
T ss_dssp             CCSSC--CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             Hhhcc--cCCccccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence            00000  0122234458899999999999999999999875

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=7.7e-44  Score=365.27  Aligned_cols=261  Identities=22%  Similarity=0.284  Sum_probs=194.8

Q ss_pred             hcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCC--CccHHHHHHHHHHHhcCCCCCcceEEEEEEeC-
Q 046893           91 TKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGG--YQGDREWLAEVNYLGQLRHSNLVKLIGYCCED-  167 (464)
Q Consensus        91 ~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~-  167 (464)
                      .++|++.+.||+|+||+||+|.+..+      ++.||||++....  ......+.+|+.+|+.++||||+++++++... 
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~a~~~~~------~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~  134 (464)
T 3ttj_A           61 LKRYQNLKPIGSGAQGIVCAAYDAVL------DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQK  134 (464)
T ss_dssp             ETTEEEEEEEEECSSCEEEEEEETTT------TEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCC
T ss_pred             cCCeEEEEEeecCCCeEEEEEEECCC------CCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCC
Confidence            56799999999999999999998765      6789999997542  22346688999999999999999999999655 


Q ss_pred             -----CeEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcc
Q 046893          168 -----EHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSD  242 (464)
Q Consensus       168 -----~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~D  242 (464)
                           ...||||||+.+ +|.+.+..    .+++..+..++.||+.||.|||  ..+|+||||||+||||+.++.+||+|
T Consensus       135 ~~~~~~~~~lv~E~~~~-~l~~~~~~----~l~~~~~~~~~~qil~aL~~lH--~~~iiHrDlkp~NIll~~~~~~kl~D  207 (464)
T 3ttj_A          135 TLEEFQDVYLVMELMDA-NLCQVIQM----ELDHERMSYLLYQMLCGIKHLH--SAGIIHRDLKPSNIVVKSDCTLKILD  207 (464)
T ss_dssp             STTTCCEEEEEEECCSE-EHHHHHTS----CCCHHHHHHHHHHHHHHHHHHH--HTTCCCCCCCGGGEEECTTSCEEECC
T ss_pred             ccccCCeEEEEEeCCCC-CHHHHHhh----cCCHHHHHHHHHHHHHHHHHHH--HCCcccCCCChHhEEEeCCCCEEEEE
Confidence                 467999999976 56666642    4899999999999999999999  56799999999999999999999999


Q ss_pred             cCCccCCCCCCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHH----
Q 046893          243 FGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARP----  318 (464)
Q Consensus       243 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~----  318 (464)
                      ||+++.....   ......+||+.|+|||++.+..|+.++|||||||+||||++|+.||.+......  +......    
T Consensus       208 FG~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~--~~~i~~~lg~p  282 (464)
T 3ttj_A          208 FGLARTAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQ--WNKVIEQLGTP  282 (464)
T ss_dssp             CCCC-----C---CCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHHHHHCSC
T ss_pred             EEeeeecCCC---cccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHhcCCC
Confidence            9999864322   223447899999999999999999999999999999999999999986542211  1111000    


Q ss_pred             --------------hhhcccc-----hhhccCccc---cCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 046893          319 --------------LLNNNKK-----VLRILDPRL---EGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVA  369 (464)
Q Consensus       319 --------------~~~~~~~-----~~~~~~~~~---~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  369 (464)
                                    .+.....     ....+...+   ........+..+.+|+.+||..||.+|||+.++++
T Consensus       283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~  355 (464)
T 3ttj_A          283 CPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ  355 (464)
T ss_dssp             CHHHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             CHHHHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence                          0000000     000000000   00011223567999999999999999999999875

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=2.4e-44  Score=353.22  Aligned_cols=262  Identities=23%  Similarity=0.311  Sum_probs=189.4

Q ss_pred             HHhcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCccHHHHHHHHHHHhcCC-CCCcceEEEEEEe-
Q 046893           89 LATKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLR-HSNLVKLIGYCCE-  166 (464)
Q Consensus        89 ~~~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~-  166 (464)
                      +...+|++.+.||+|+||.||+|.+..+      ++.||||++..........+.+|+.++..+. ||||+++++++.. 
T Consensus        25 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~   98 (337)
T 3ll6_A           25 LGELRLRVRRVLAEGGFAFVYEAQDVGS------GREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIG   98 (337)
T ss_dssp             ETTEEEEEEEEEECCSSEEEEEEEETTT------CCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEEC
T ss_pred             ccCceEEEEEEEccCCceEEEEEEECCC------CcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhcccccccc
Confidence            3446799999999999999999998764      6679999986654455577899999999996 9999999999853 


Q ss_pred             -------CCeEEEEEeccCCCCHHHHHHhh-cCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCce
Q 046893          167 -------DEHRILVYEYMESGSLEKHLLRR-VGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSA  238 (464)
Q Consensus       167 -------~~~~~lv~e~~~~g~L~~~l~~~-~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~v  238 (464)
                             ....++||||+. |+|.+++... ....+++..++.++.||+.||.|||+.+.+|+||||||+||||+.++.+
T Consensus        99 ~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~~  177 (337)
T 3ll6_A           99 KEESDTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTI  177 (337)
T ss_dssp             TTTSTTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSCE
T ss_pred             ccccccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCCE
Confidence                   345899999995 6998988652 2346999999999999999999999433339999999999999999999


Q ss_pred             EEcccCCccCCCCCCCcc----------eeeccccCCcccCcccc---ccCCCCcccchhcHHHHHHHHHhCCCCCCCCC
Q 046893          239 KLSDFGLAKDGPMGDQTH----------VSTRVMGTYGYAAPEYV---MTGHLTARSDVYGFGVVLLEMLLGRRAVDKSR  305 (464)
Q Consensus       239 kl~DFGla~~~~~~~~~~----------~~~~~~gt~~y~aPE~~---~~~~~~~~~DvwslG~il~ell~g~~pf~~~~  305 (464)
                      ||+|||+++.........          ......||+.|+|||++   .+..++.++|||||||++|+|++|+.||....
T Consensus       178 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~  257 (337)
T 3ll6_A          178 KLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGA  257 (337)
T ss_dssp             EBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC----
T ss_pred             EEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchh
Confidence            999999998654322111          11135699999999988   56778999999999999999999999997533


Q ss_pred             CcccccHHHHHHHhhhcccchhhccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhc
Q 046893          306 PSREHNLVEWARPLLNNNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETVQSQ  377 (464)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~~~~  377 (464)
                      ...      .    ..          ...........+..+.+|+.+||+.||.+||++.++++.|+.+...
T Consensus       258 ~~~------~----~~----------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~  309 (337)
T 3ll6_A          258 KLR------I----VN----------GKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAA  309 (337)
T ss_dssp             ----------------------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHH------h----hc----------CcccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence            211      0    00          0000001111223578899999999999999999999999988653

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=1.7e-43  Score=347.59  Aligned_cols=269  Identities=22%  Similarity=0.353  Sum_probs=197.8

Q ss_pred             hcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCccHHHHHHHHHHH--hcCCCCCcceEEEEEEe--
Q 046893           91 TKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYL--GQLRHSNLVKLIGYCCE--  166 (464)
Q Consensus        91 ~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l--~~l~hpniv~l~~~~~~--  166 (464)
                      .++|++.+.||+|+||.||+|.+.        ++.||||++...   ....+..|..++  ..++||||+++++++..  
T Consensus        12 ~~~y~~~~~lg~G~~g~Vy~~~~~--------~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~   80 (336)
T 3g2f_A           12 LDNLKLLELIGRGRYGAVYKGSLD--------ERPVAVKVFSFA---NRQNFINEKNIYRVPLMEHDNIARFIVGDERVT   80 (336)
T ss_dssp             TTSEEEEEEEEECSSEEEEEEEET--------TEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEEC
T ss_pred             hHHhheeeecccCCCeEEEEEEEC--------CeEEEEEEeecc---chhhHHHHHHHHHHHhccCcchhhheecccccc
Confidence            356888999999999999999763        567999998643   334455555554  45899999999986543  


Q ss_pred             ---CCeEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcC-------CCCeeeccCCCCceEecCCC
Q 046893          167 ---DEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGA-------ERPVIYRDFKTSNILLNADF  236 (464)
Q Consensus       167 ---~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~-------~~~ivHrDlkp~Nill~~~~  236 (464)
                         ...++|||||+++|+|.+++...   .+++..++.++.|++.||.|||+.       ..+|+||||||+||||+.++
T Consensus        81 ~~~~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~  157 (336)
T 3g2f_A           81 ADGRMEYLLVMEYYPNGSLXKYLSLH---TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDG  157 (336)
T ss_dssp             TTSCEEEEEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTS
T ss_pred             cCCCceEEEEEecCCCCcHHHHHhhc---ccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCC
Confidence               23678999999999999998654   368999999999999999999943       11899999999999999999


Q ss_pred             ceEEcccCCccCCCCCC------CcceeeccccCCcccCcccccc-------CCCCcccchhcHHHHHHHHHhCCCCCCC
Q 046893          237 SAKLSDFGLAKDGPMGD------QTHVSTRVMGTYGYAAPEYVMT-------GHLTARSDVYGFGVVLLEMLLGRRAVDK  303 (464)
Q Consensus       237 ~vkl~DFGla~~~~~~~------~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DvwslG~il~ell~g~~pf~~  303 (464)
                      .+||+|||+++......      .........||+.|+|||++.+       ..++.++|||||||++|||++|..||..
T Consensus       158 ~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~  237 (336)
T 3g2f_A          158 TCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFP  237 (336)
T ss_dssp             CEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGST
T ss_pred             cEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCC
Confidence            99999999998643221      1112234679999999999876       4567789999999999999999887754


Q ss_pred             CCCcccccH--H---------HHHHHhhhcccchhhccCccccCc--cCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 046893          304 SRPSREHNL--V---------EWARPLLNNNKKVLRILDPRLEGQ--YTARTAMKVAGLAYQCLSQNPKGRPVMSDVVAL  370 (464)
Q Consensus       304 ~~~~~~~~~--~---------~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  370 (464)
                      .........  .         ...........     ..+.+...  ....++..+.+||.+||+.||.+|||+.++++.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~  312 (336)
T 3g2f_A          238 GESVPEYQMAFQTEVGNHPTFEDMQVLVSREK-----QRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEER  312 (336)
T ss_dssp             TSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSC-----CCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred             ccchhHHHHhhhcccCCCchHHHHHhhhcccc-----cCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHH
Confidence            333221110  0         00000011000     01111111  123466789999999999999999999999999


Q ss_pred             HHHHHhcC
Q 046893          371 LETVQSQG  378 (464)
Q Consensus       371 L~~~~~~~  378 (464)
                      |+.+....
T Consensus       313 L~~ll~~~  320 (336)
T 3g2f_A          313 MAELMMIW  320 (336)
T ss_dssp             HHHHHHCC
T ss_pred             HHHHHHHH
Confidence            99987654

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=5.2e-44  Score=342.60  Aligned_cols=259  Identities=23%  Similarity=0.321  Sum_probs=205.5

Q ss_pred             HhcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCc------cHHHHHHHHHHHhcCCCCCcceEEEE
Q 046893           90 ATKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQ------GDREWLAEVNYLGQLRHSNLVKLIGY  163 (464)
Q Consensus        90 ~~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~hpniv~l~~~  163 (464)
                      ..++|++.+.||+|+||.||+|.+..+      ++.||+|++......      ....+.+|+.+++.++||||++++++
T Consensus         3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~------~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~   76 (283)
T 3bhy_A            3 VEDHYEMGEELGSGQFAIVRKCRQKGT------GKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDI   76 (283)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTT------CCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             hhhhhhhHHhhcccCceEEEEEEEcCC------CCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhhe
Confidence            346789999999999999999998765      567999998754321      35778999999999999999999999


Q ss_pred             EEeCCeEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCC----ceE
Q 046893          164 CCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADF----SAK  239 (464)
Q Consensus       164 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~----~vk  239 (464)
                      +......++||||+.+++|.+++....  .+++..++.++.|++.||.|||  ..+|+||||||+|||++.++    .+|
T Consensus        77 ~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH--~~~i~H~dl~p~Nil~~~~~~~~~~~k  152 (283)
T 3bhy_A           77 FENKTDVVLILELVSGGELFDFLAEKE--SLTEDEATQFLKQILDGVHYLH--SKRIAHFDLKPENIMLLDKNVPNPRIK  152 (283)
T ss_dssp             EECSSEEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGEEESCSSSSSCCEE
T ss_pred             ecCCCeEEEEEeecCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH--hCCccCCCCChHHEEEecCCCCCCceE
Confidence            999999999999999999999987643  6899999999999999999999  56799999999999998877    899


Q ss_pred             EcccCCccCCCCCCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHh
Q 046893          240 LSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPL  319 (464)
Q Consensus       240 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~  319 (464)
                      |+|||++.......   ......||+.|+|||++.+..++.++||||||+++|+|++|..||......      +.....
T Consensus       153 l~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~~~~~~  223 (283)
T 3bhy_A          153 LIDFGIAHKIEAGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQ------ETLTNI  223 (283)
T ss_dssp             ECCCTTCEECC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHH------HHHHHH
T ss_pred             EEecccceeccCCC---cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchH------HHHHHh
Confidence            99999998643222   123457999999999999999999999999999999999999999764321      111111


Q ss_pred             hhcccchhhccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH--HHHHHH
Q 046893          320 LNNNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVA--LLETVQ  375 (464)
Q Consensus       320 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~--~L~~~~  375 (464)
                      ....        ...........+..+.+|+.+||..||.+||++.++++  .++.+.
T Consensus       224 ~~~~--------~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~  273 (283)
T 3bhy_A          224 SAVN--------YDFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIR  273 (283)
T ss_dssp             HTTC--------CCCCHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHH
T ss_pred             Hhcc--------cCCcchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHHH
Confidence            1110        00111111223457899999999999999999999986  455544

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=2.2e-44  Score=353.10  Aligned_cols=261  Identities=20%  Similarity=0.272  Sum_probs=206.6

Q ss_pred             hhHHHHHhcCCCCC-CceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCC--ccHHHHHHHHHHHhcC-CCCCcce
Q 046893           84 YNEMKLATKFFRPD-YILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGY--QGDREWLAEVNYLGQL-RHSNLVK  159 (464)
Q Consensus        84 ~~~~~~~~~~~~~~-~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l-~hpniv~  159 (464)
                      +..++...++|.+. +.||+|+||+||+|.+..+      ++.||+|++.....  .....+.+|+.++..+ .||||++
T Consensus        20 ~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~------~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~   93 (327)
T 3lm5_A           20 FQSMENFNNFYILTSKELGRGKFAVVRQCISKST------GQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVIN   93 (327)
T ss_dssp             SBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTT------CCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCC
T ss_pred             HHHHHhhhhEEeeccceeCCCCCeEEEEEEECCC------CCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEE
Confidence            44556667778887 8999999999999998765      67799999875432  2357789999999999 5699999


Q ss_pred             EEEEEEeCCeEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecC---CC
Q 046893          160 LIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNA---DF  236 (464)
Q Consensus       160 l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~---~~  236 (464)
                      +++++...+..++||||+.+|+|.+++.......+++..++.++.|++.||.|||  .++|+||||||+|||++.   ++
T Consensus        94 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH--~~givH~Dikp~NIl~~~~~~~~  171 (327)
T 3lm5_A           94 LHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLH--QNNIVHLDLKPQNILLSSIYPLG  171 (327)
T ss_dssp             EEEEEECSSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCCGGGEEESCBTTBC
T ss_pred             EEEEEEeCCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH--HCCeecCcCChHHEEEecCCCCC
Confidence            9999999999999999999999999886655567999999999999999999999  567999999999999987   78


Q ss_pred             ceEEcccCCccCCCCCCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHH
Q 046893          237 SAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWA  316 (464)
Q Consensus       237 ~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~  316 (464)
                      .+||+|||+++......   ......||+.|+|||++.+..++.++||||||+++|+|++|+.||.......      ..
T Consensus       172 ~~kL~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~------~~  242 (327)
T 3lm5_A          172 DIKIVDFGMSRKIGHAC---ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQE------TY  242 (327)
T ss_dssp             CEEECCGGGCEEC------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HH
T ss_pred             cEEEeeCccccccCCcc---ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchH------HH
Confidence            99999999998643222   2234679999999999999999999999999999999999999997643211      11


Q ss_pred             HHhhhcccchhhccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 046893          317 RPLLNNNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVA  369 (464)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  369 (464)
                      ......        ...........++..+.+||.+||+.||.+||++.++++
T Consensus       243 ~~i~~~--------~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~  287 (327)
T 3lm5_A          243 LNISQV--------NVDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLS  287 (327)
T ss_dssp             HHHHHT--------CCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             HHHHhc--------ccccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhC
Confidence            111111        111111122234557899999999999999999999874

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=5.5e-44  Score=346.09  Aligned_cols=249  Identities=24%  Similarity=0.369  Sum_probs=204.7

Q ss_pred             cCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCC-ccHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeE
Q 046893           92 KFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGY-QGDREWLAEVNYLGQLRHSNLVKLIGYCCEDEHR  170 (464)
Q Consensus        92 ~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~  170 (464)
                      +.|++.+.||+|+||.||+|.+..+      ++.||||++..... .....+.+|+.++..+.||||+++++++......
T Consensus        22 ~~y~~~~~lg~G~~g~V~~~~~~~~------~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   95 (303)
T 3a7i_A           22 ELFTKLEKIGKGSFGEVFKGIDNRT------QKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKL   95 (303)
T ss_dssp             GTEEEEEEEEECSSSEEEEEEETTT------CCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred             HHHHHhhhhcccCCeEEEEEEECCC------CcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeE
Confidence            4588889999999999999998764      66799999875543 3457789999999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCccCCC
Q 046893          171 ILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGP  250 (464)
Q Consensus       171 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~  250 (464)
                      ++||||+.+++|.+++..   ..+++..++.++.|++.||.|||  ..+|+||||||+|||++.++.+||+|||++....
T Consensus        96 ~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH--~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~  170 (303)
T 3a7i_A           96 WIIMEYLGGGSALDLLEP---GPLDETQIATILREILKGLDYLH--SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLT  170 (303)
T ss_dssp             EEEEECCTTEEHHHHHTT---SCCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEECTTSCEEECCCTTCEECB
T ss_pred             EEEEEeCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHH--HCCCccCCCChheEEECCCCCEEEeecccceecC
Confidence            999999999999998864   35999999999999999999999  5679999999999999999999999999997643


Q ss_pred             CCCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhcccchhhcc
Q 046893          251 MGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRIL  330 (464)
Q Consensus       251 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  330 (464)
                      ...  .......||..|+|||++.+..++.++||||||+++|+|++|+.||.......      ........       .
T Consensus       171 ~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~------~~~~~~~~-------~  235 (303)
T 3a7i_A          171 DTQ--IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMK------VLFLIPKN-------N  235 (303)
T ss_dssp             TTB--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH------HHHHHHHS-------C
T ss_pred             ccc--cccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHH------HHHHhhcC-------C
Confidence            221  12234679999999999999999999999999999999999999997643211      11111100       1


Q ss_pred             CccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 046893          331 DPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVAL  370 (464)
Q Consensus       331 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  370 (464)
                      .+.+    ...++..+.+|+.+||..||.+||++.++++.
T Consensus       236 ~~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  271 (303)
T 3a7i_A          236 PPTL----EGNYSKPLKEFVEACLNKEPSFRPTAKELLKH  271 (303)
T ss_dssp             CCCC----CSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTC
T ss_pred             CCCC----ccccCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence            1111    22234578999999999999999999999864

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.5e-44  Score=353.77  Aligned_cols=263  Identities=25%  Similarity=0.371  Sum_probs=194.2

Q ss_pred             cCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCccH-HHHHHHHHHHhcCCCCCcceEEEEEEeCCeE
Q 046893           92 KFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGD-REWLAEVNYLGQLRHSNLVKLIGYCCEDEHR  170 (464)
Q Consensus        92 ~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~-~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~  170 (464)
                      ++|++.+.||+|+||+||+|.+..+      ++.||+|++........ ..+.+|+.+|+.++||||+++++++...+..
T Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   75 (324)
T 3mtl_A            2 ETYIKLDKLGEGTYATVYKGKSKLT------DNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSL   75 (324)
T ss_dssp             CSEEEEEEEEECSSEEEEEEEETTT------CCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCE
T ss_pred             CceEEEEEEcCCCCEEEEEEEECCC------CcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEE
Confidence            4688899999999999999998765      66799999865432211 2355799999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCccCCC
Q 046893          171 ILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGP  250 (464)
Q Consensus       171 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~  250 (464)
                      ++||||+. |+|.+++... +..+++..+..++.|++.||.|||  ..+|+||||||+|||++.++.+||+|||+++...
T Consensus        76 ~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~aL~~LH--~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~  151 (324)
T 3mtl_A           76 TLVFEYLD-KDLKQYLDDC-GNIINMHNVKLFLFQLLRGLAYCH--RQKVLHRDLKPQNLLINERGELKLADFGLARAKS  151 (324)
T ss_dssp             EEEEECCS-EEHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHH--HTTEEESSCCGGGEEECTTCCEEECSSSEEECC-
T ss_pred             EEEecccc-cCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHH--HCCccCCCcCHHHEEECCCCCEEEccCccccccc
Confidence            99999996 5998888764 346999999999999999999999  5679999999999999999999999999998543


Q ss_pred             CCCCcceeeccccCCcccCcccccc-CCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhcc--cchh
Q 046893          251 MGDQTHVSTRVMGTYGYAAPEYVMT-GHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNN--KKVL  327 (464)
Q Consensus       251 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~--~~~~  327 (464)
                      ..  ........||..|+|||++.+ ..++.++|||||||++|+|++|+.||.+.....   ........+...  ....
T Consensus       152 ~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~---~~~~i~~~~~~~~~~~~~  226 (324)
T 3mtl_A          152 IP--TKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEE---QLHFIFRILGTPTEETWP  226 (324)
T ss_dssp             -------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHHHCCCCTTTST
T ss_pred             CC--ccccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHhCCCChHhch
Confidence            22  222334678999999999876 568999999999999999999999998654221   111111111100  0000


Q ss_pred             hc---------cCcccc----CccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 046893          328 RI---------LDPRLE----GQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVA  369 (464)
Q Consensus       328 ~~---------~~~~~~----~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  369 (464)
                      ..         ..+...    .......+..+.+|+.+||+.||.+|||+.++++
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  281 (324)
T 3mtl_A          227 GILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMK  281 (324)
T ss_dssp             TGGGCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             hhhcchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhc
Confidence            00         000000    0011123457889999999999999999999875

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=2.2e-43  Score=340.35  Aligned_cols=249  Identities=23%  Similarity=0.341  Sum_probs=204.6

Q ss_pred             hcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCC---ccHHHHHHHHHHHhcCCCCCcceEEEEEEeC
Q 046893           91 TKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGY---QGDREWLAEVNYLGQLRHSNLVKLIGYCCED  167 (464)
Q Consensus        91 ~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~  167 (464)
                      .++|.+.+.||+|+||.||+|.+..+      ++.||+|++.....   .....+.+|+.+++.+.||||+++++++...
T Consensus        14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~------~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~   87 (294)
T 2rku_A           14 RRRYVRGRFLGKGGFAKCFEISDADT------KEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDN   87 (294)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTT------CCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECS
T ss_pred             ccceEEEEEEeecCCEEEEEEEECCC------CceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccC
Confidence            35688999999999999999998765      66799999865432   2235688999999999999999999999999


Q ss_pred             CeEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCcc
Q 046893          168 EHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAK  247 (464)
Q Consensus       168 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~  247 (464)
                      +..++||||+++++|.+++....  .+++..++.++.|++.||.|||  ..+|+||||||+|||++.++.+||+|||++.
T Consensus        88 ~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH--~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~  163 (294)
T 2rku_A           88 DFVFVVLELCRRRSLLELHKRRK--ALTEPEARYYLRQIVLGCQYLH--RNRVIHRDLKLGNLFLNEDLEVKIGDFGLAT  163 (294)
T ss_dssp             SEEEEEEECCTTCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             CEEEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH--HCCccccCCChHhEEEcCCCCEEEEeccCce
Confidence            99999999999999999887643  6899999999999999999999  5679999999999999999999999999998


Q ss_pred             CCCCCCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhcccchh
Q 046893          248 DGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVL  327 (464)
Q Consensus       248 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  327 (464)
                      .......  ......||..|+|||++.+..++.++||||||+++|+|++|+.||......      +.........    
T Consensus       164 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~------~~~~~~~~~~----  231 (294)
T 2rku_A          164 KVEYDGE--RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLK------ETYLRIKKNE----  231 (294)
T ss_dssp             ECCSTTC--CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHH------HHHHHHHTTC----
T ss_pred             ecccCcc--ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHhhcc----
Confidence            6432221  223467999999999999989999999999999999999999999764321      1111111110    


Q ss_pred             hccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 046893          328 RILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVA  369 (464)
Q Consensus       328 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  369 (464)
                          .    ..+...+..+.+|+.+||+.||.+||++.++++
T Consensus       232 ----~----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~  265 (294)
T 2rku_A          232 ----Y----SIPKHINPVAASLIQKMLQTDPTARPTINELLN  265 (294)
T ss_dssp             ----C----CCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred             ----C----CCccccCHHHHHHHHHHcccChhhCcCHHHHhh
Confidence                0    112233457889999999999999999999875

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=1.1e-43  Score=342.27  Aligned_cols=251  Identities=23%  Similarity=0.380  Sum_probs=198.3

Q ss_pred             CCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCccHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeEEEE
Q 046893           94 FRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVKLIGYCCEDEHRILV  173 (464)
Q Consensus        94 ~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv  173 (464)
                      |....+||+|+||.||+|.+..+      +..||||.+..........+.+|+.+++.++||||+++++++...+..++|
T Consensus        24 ~~~~~~lg~G~~g~Vy~~~~~~~------~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   97 (295)
T 2clq_A           24 NGDRVVLGKGTYGIVYAGRDLSN------QVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIF   97 (295)
T ss_dssp             TSSBCEEEECSSSEEEEEEETTT------CCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             CCCcEEEeecCcEEEEEEEECCC------CeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEE
Confidence            45556899999999999998765      667999999776555567889999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecC-CCceEEcccCCccCCCC
Q 046893          174 YEYMESGSLEKHLLRRVG-CMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNA-DFSAKLSDFGLAKDGPM  251 (464)
Q Consensus       174 ~e~~~~g~L~~~l~~~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~-~~~vkl~DFGla~~~~~  251 (464)
                      |||+++++|.+++....+ ..+++..+..++.|++.||.|||  ..+|+||||||+|||++. ++.+||+|||+++....
T Consensus        98 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH--~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~  175 (295)
T 2clq_A           98 MEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLH--DNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAG  175 (295)
T ss_dssp             EECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC
T ss_pred             EEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHH--hCCEEccCCChhhEEEECCCCCEEEeecccccccCC
Confidence            999999999999876532 35678999999999999999999  567999999999999987 89999999999986432


Q ss_pred             CCCcceeeccccCCcccCccccccCC--CCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhcccchhhc
Q 046893          252 GDQTHVSTRVMGTYGYAAPEYVMTGH--LTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRI  329 (464)
Q Consensus       252 ~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  329 (464)
                      ..  .......||..|+|||++.+..  ++.++||||||+++|+|++|+.||........   ..+.....        .
T Consensus       176 ~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~---~~~~~~~~--------~  242 (295)
T 2clq_A          176 IN--PCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQA---AMFKVGMF--------K  242 (295)
T ss_dssp             -------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHH---HHHHHHHH--------C
T ss_pred             CC--CcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhH---HHHhhccc--------c
Confidence            21  1223467999999999987654  88999999999999999999999965322111   00000000        0


Q ss_pred             cCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 046893          330 LDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVA  369 (464)
Q Consensus       330 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  369 (464)
                      ..+    ..+..++..+.+|+.+||+.||.+||++.+++.
T Consensus       243 ~~~----~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  278 (295)
T 2clq_A          243 VHP----EIPESMSAEAKAFILKCFEPDPDKRACANDLLV  278 (295)
T ss_dssp             CCC----CCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred             ccc----cccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            111    222334558899999999999999999999874

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=5e-43  Score=344.99  Aligned_cols=274  Identities=26%  Similarity=0.370  Sum_probs=212.5

Q ss_pred             chhHHHHHhcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCccHHHHHHHHHHHhc--CCCCCcceE
Q 046893           83 TYNEMKLATKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQ--LRHSNLVKL  160 (464)
Q Consensus        83 ~~~~~~~~~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~hpniv~l  160 (464)
                      +........++|++.+.||+|+||.||+|.+.        ++.||||++..   .....+..|++++..  ++||||+++
T Consensus        33 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~--------~~~vavK~~~~---~~~~~~~~e~~~~~~~~l~h~ni~~~  101 (342)
T 1b6c_B           33 PLLVQRTIARTIVLQESIGKGRFGEVWRGKWR--------GEEVAVKIFSS---REERSWFREAEIYQTVMLRHENILGF  101 (342)
T ss_dssp             CHHHHHHHHHHCEEEEEEEEETTEEEEEEEET--------TEEEEEEEECG---GGHHHHHHHHHHHHHSCCCCTTBCCE
T ss_pred             ceeecccccccEEEEeeecCCCCcEEEEEEEc--------CccEEEEEeCc---hhHHHHHHHHHHHHHhhcCCCcEEEE
Confidence            34445667788999999999999999999873        46799999864   245677889998887  789999999


Q ss_pred             EEEEEeCC----eEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcC------CCCeeeccCCCCce
Q 046893          161 IGYCCEDE----HRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGA------ERPVIYRDFKTSNI  230 (464)
Q Consensus       161 ~~~~~~~~----~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~------~~~ivHrDlkp~Ni  230 (464)
                      ++++....    ..++||||+.+|+|.+++.+.   .+++..++.++.|++.||.|||..      ..+|+||||||+||
T Consensus       102 ~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NI  178 (342)
T 1b6c_B          102 IAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNI  178 (342)
T ss_dssp             EEEEECCCSSCCCEEEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGE
T ss_pred             EeeecccCCccceeEEEEeecCCCcHHHHHhcc---CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHE
Confidence            99998876    789999999999999998653   589999999999999999999932      45699999999999


Q ss_pred             EecCCCceEEcccCCccCCCCCCCcc--eeeccccCCcccCccccccC------CCCcccchhcHHHHHHHHHhC-----
Q 046893          231 LLNADFSAKLSDFGLAKDGPMGDQTH--VSTRVMGTYGYAAPEYVMTG------HLTARSDVYGFGVVLLEMLLG-----  297 (464)
Q Consensus       231 ll~~~~~vkl~DFGla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~~~~~DvwslG~il~ell~g-----  297 (464)
                      ||+.++.+||+|||+++.........  ......||+.|+|||++.+.      .++.++|||||||+||||++|     
T Consensus       179 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~  258 (342)
T 1b6c_B          179 LVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGG  258 (342)
T ss_dssp             EECTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTT
T ss_pred             EECCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCC
Confidence            99999999999999997543322111  12346799999999998765      334689999999999999999     


Q ss_pred             -----CCCCCCCCCcccccHHHHHHHhhhcccchhhccCccccCc-cCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 046893          298 -----RRAVDKSRPSREHNLVEWARPLLNNNKKVLRILDPRLEGQ-YTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALL  371 (464)
Q Consensus       298 -----~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L  371 (464)
                           ..||........ ....+.......      .+.+.+... ....++..+.+|+.+||+.||.+||++.+|++.|
T Consensus       259 ~~~~~~~p~~~~~~~~~-~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L  331 (342)
T 1b6c_B          259 IHEDYQLPYYDLVPSDP-SVEEMRKVVCEQ------KLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTL  331 (342)
T ss_dssp             BCCCCCCTTTTTSCSSC-CHHHHHHHHTTS------CCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHH
T ss_pred             cccccccCccccCcCcc-cHHHHHHHHHHH------HhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHH
Confidence                 678765433211 111221111111      111211111 2346677899999999999999999999999999


Q ss_pred             HHHHhc
Q 046893          372 ETVQSQ  377 (464)
Q Consensus       372 ~~~~~~  377 (464)
                      +.+...
T Consensus       332 ~~i~~~  337 (342)
T 1b6c_B          332 SQLSQQ  337 (342)
T ss_dssp             HHHHHT
T ss_pred             HHHHHH
Confidence            988654

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.4e-44  Score=352.21  Aligned_cols=254  Identities=27%  Similarity=0.407  Sum_probs=197.9

Q ss_pred             HHhcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCccHHHHHHHHHHHhcC-CCCCcceEEEEEEe-
Q 046893           89 LATKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQL-RHSNLVKLIGYCCE-  166 (464)
Q Consensus        89 ~~~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~-  166 (464)
                      ...++|++.+.||+|+||.||+|.+..+      ++.||||++.... .....+.+|+.++..+ .||||+++++++.. 
T Consensus        21 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~------~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~   93 (326)
T 2x7f_A           21 DPAGIFELVELVGNGTYGQVYKGRHVKT------GQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKK   93 (326)
T ss_dssp             CCTTTEEEEEEEEEETTEEEEEEEETTT------CCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEEEEC
T ss_pred             CCCCcEEEEEEeccCCCEEEEEEEECCC------CCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEEeec
Confidence            3456799999999999999999998764      5679999987543 3456788999999998 79999999999987 


Q ss_pred             -----CCeEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEc
Q 046893          167 -----DEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLS  241 (464)
Q Consensus       167 -----~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~  241 (464)
                           .+..++||||+.+++|.+++.......+++..++.++.|++.||.|||  ..+|+||||||+|||++.++.+||+
T Consensus        94 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH--~~~ivH~dlkp~NIl~~~~~~~kl~  171 (326)
T 2x7f_A           94 NPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLH--QHKVIHRDIKGQNVLLTENAEVKLV  171 (326)
T ss_dssp             C--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHH--HTTCCCCCCSGGGEEECTTCCEEEC
T ss_pred             cCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH--HCCccccCCcHHHEEEcCCCCEEEe
Confidence                 468899999999999999998765557999999999999999999999  5679999999999999999999999


Q ss_pred             ccCCccCCCCCCCcceeeccccCCcccCccccc-----cCCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHH
Q 046893          242 DFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVM-----TGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWA  316 (464)
Q Consensus       242 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~  316 (464)
                      |||++......  ........||..|+|||++.     +..++.++|||||||++|+|++|..||........      .
T Consensus       172 Dfg~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~------~  243 (326)
T 2x7f_A          172 DFGVSAQLDRT--VGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRA------L  243 (326)
T ss_dssp             CCTTTC---------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHH------H
T ss_pred             eCcCceecCcC--ccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHH------H
Confidence            99999864321  11223467999999999987     56789999999999999999999999975432111      0


Q ss_pred             HHhhhcccchhhccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 046893          317 RPLLNNNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVA  369 (464)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  369 (464)
                      ......       ..+..   ....++..+.+||.+||..||.+||++.++++
T Consensus       244 ~~~~~~-------~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  286 (326)
T 2x7f_A          244 FLIPRN-------PAPRL---KSKKWSKKFQSFIESCLVKNHSQRPATEQLMK  286 (326)
T ss_dssp             HHHHHS-------CCCCC---SCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             HHhhcC-------ccccC---CccccCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence            001110       01111   11223458899999999999999999999986

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=9.9e-44  Score=341.08  Aligned_cols=247  Identities=26%  Similarity=0.371  Sum_probs=204.2

Q ss_pred             hcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCC---CccHHHHHHHHHHHhcCCCCCcceEEEEEEeC
Q 046893           91 TKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGG---YQGDREWLAEVNYLGQLRHSNLVKLIGYCCED  167 (464)
Q Consensus        91 ~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~  167 (464)
                      .++|.+.+.||+|+||.||+|.+..+      +..||+|++....   ......+.+|+.+++.++||||+++++++...
T Consensus        13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~------~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   86 (284)
T 2vgo_A           13 IDDFDIGRPLGKGKFGNVYLAREKQN------KFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDR   86 (284)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTT------TEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECS
T ss_pred             hhhceeeheecCCCCeEEEEEEEcCC------CcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcC
Confidence            35688899999999999999998764      6779999986431   22346788999999999999999999999999


Q ss_pred             CeEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCcc
Q 046893          168 EHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAK  247 (464)
Q Consensus       168 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~  247 (464)
                      +..++||||+++++|.+++....  .+++..++.++.|++.||.|||  ..+|+||||||+|||++.++.+||+|||++.
T Consensus        87 ~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH--~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~  162 (284)
T 2vgo_A           87 KRIYLMLEFAPRGELYKELQKHG--RFDEQRSATFMEELADALHYCH--ERKVIHRDIKPENLLMGYKGELKIADFGWSV  162 (284)
T ss_dssp             SEEEEEECCCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHH--TTTEECCCCSGGGEEECTTCCEEECCCTTCE
T ss_pred             CEEEEEEEeCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH--HCCceecCCCHHHEEEcCCCCEEEecccccc
Confidence            99999999999999999987654  6899999999999999999999  6779999999999999999999999999987


Q ss_pred             CCCCCCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhcccchh
Q 046893          248 DGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVL  327 (464)
Q Consensus       248 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  327 (464)
                      .....    ......|+..|+|||++.+..++.++||||||+++|+|++|..||......      +........     
T Consensus       163 ~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~------~~~~~~~~~-----  227 (284)
T 2vgo_A          163 HAPSL----RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHT------ETHRRIVNV-----  227 (284)
T ss_dssp             ECSSS----CBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH------HHHHHHHTT-----
T ss_pred             cCccc----ccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHh------HHHHHHhcc-----
Confidence            54321    123467999999999999999999999999999999999999999764321      111111111     


Q ss_pred             hccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 046893          328 RILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVA  369 (464)
Q Consensus       328 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  369 (464)
                         +.    .++...+..+.+|+.+||..||.+||++.++++
T Consensus       228 ---~~----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~  262 (284)
T 2vgo_A          228 ---DL----KFPPFLSDGSKDLISKLLRYHPPQRLPLKGVME  262 (284)
T ss_dssp             ---CC----CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             ---cc----CCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhh
Confidence               11    122234458899999999999999999999975

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=3.1e-44  Score=345.38  Aligned_cols=264  Identities=27%  Similarity=0.369  Sum_probs=199.7

Q ss_pred             hcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCC---ccHHHHHHHHHHHhcCCCCCcceEEEEEEeC
Q 046893           91 TKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGY---QGDREWLAEVNYLGQLRHSNLVKLIGYCCED  167 (464)
Q Consensus        91 ~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~  167 (464)
                      .++|++.+.||+|+||+||+|.+.....   ....||||++.....   ...+.+.+|+++++.++||||+++++++...
T Consensus        17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   93 (291)
T 1u46_A           17 EKDLRLLEKLGDGSFGVVRRGEWDAPSG---KTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP   93 (291)
T ss_dssp             GGGEEEEEECC----CCCEEEEEECTTS---CEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             hhHeeeeeeecCCCceeEEEEEeccCCC---ceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccC
Confidence            3568899999999999999998754321   245689999875432   2346788999999999999999999999876


Q ss_pred             CeEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCcc
Q 046893          168 EHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAK  247 (464)
Q Consensus       168 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~  247 (464)
                      . .++||||+.+++|.+++.... ..+++..++.++.|++.||.|||  ..+|+||||||+|||++.++.+||+|||++.
T Consensus        94 ~-~~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH--~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~  169 (291)
T 1u46_A           94 P-MKMVTELAPLGSLLDRLRKHQ-GHFLLGTLSRYAVQVAEGMGYLE--SKRFIHRDLAARNLLLATRDLVKIGDFGLMR  169 (291)
T ss_dssp             S-CEEEEECCTTCBHHHHHHHHG-GGSCHHHHHHHHHHHHHHHHHHH--HTTEECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred             C-ceeeEecccCCCHHHHHHhcc-CCcCHHHHHHHHHHHHHHHHHHH--hCCcccCCCchheEEEcCCCCEEEccccccc
Confidence            5 889999999999999987653 35899999999999999999999  5679999999999999999999999999998


Q ss_pred             CCCCCCCcc-eeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHhhhcccc
Q 046893          248 DGPMGDQTH-VSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLL-GRRAVDKSRPSREHNLVEWARPLLNNNKK  325 (464)
Q Consensus       248 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  325 (464)
                      ......... ......+|..|+|||++.+..++.++||||||+++|+|++ |+.||......      +.........  
T Consensus       170 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~------~~~~~~~~~~--  241 (291)
T 1u46_A          170 ALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS------QILHKIDKEG--  241 (291)
T ss_dssp             ECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHH------HHHHHHHTSC--
T ss_pred             cccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHH------HHHHHHHccC--
Confidence            654332221 2233567889999999998899999999999999999999 99999765321      1111111111  


Q ss_pred             hhhccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhc
Q 046893          326 VLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETVQSQ  377 (464)
Q Consensus       326 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~~~~  377 (464)
                              .....+..++..+.+++.+||..||.+||++.++++.|+.+...
T Consensus       242 --------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~  285 (291)
T 1u46_A          242 --------ERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPT  285 (291)
T ss_dssp             --------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC--
T ss_pred             --------CCCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCcc
Confidence                    01112233456899999999999999999999999999987654

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=5.6e-44  Score=363.49  Aligned_cols=200  Identities=28%  Similarity=0.382  Sum_probs=165.8

Q ss_pred             hcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCc--cHHHHHHHHHHHhcCCCCCcceEEEEEEeC-
Q 046893           91 TKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQ--GDREWLAEVNYLGQLRHSNLVKLIGYCCED-  167 (464)
Q Consensus        91 ~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpniv~l~~~~~~~-  167 (464)
                      .++|++.+.||+|+||.||+|.+..+      ++.||||++......  ..+.+.+|+.+|+.++||||+++++++... 
T Consensus        25 ~~~y~~~~~lG~G~~g~V~~a~~~~~------~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~   98 (432)
T 3n9x_A           25 PDNYIIKHLIGRGSYGYVYLAYDKNT------EKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDD   98 (432)
T ss_dssp             CTTEEEEEEEEEETTEEEEEEEETTT------TEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSC
T ss_pred             cCCEEEEEEEeecCCEEEEEEEECCC------CcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCC
Confidence            45799999999999999999998765      678999999754322  236788999999999999999999999776 


Q ss_pred             ----CeEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEccc
Q 046893          168 ----EHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDF  243 (464)
Q Consensus       168 ----~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DF  243 (464)
                          ...||||||+. ++|.+++...  ..+++..+..++.||+.||.|||  ..+|+||||||+||||+.++.+||+||
T Consensus        99 ~~~~~~~~lv~e~~~-~~L~~~~~~~--~~l~~~~~~~i~~qil~aL~~LH--~~givHrDlkp~NILl~~~~~~kL~DF  173 (432)
T 3n9x_A           99 LLKFDELYIVLEIAD-SDLKKLFKTP--IFLTEEHIKTILYNLLLGENFIH--ESGIIHRDLKPANCLLNQDCSVKVCDF  173 (432)
T ss_dssp             TTTCCCEEEEEECCS-EEHHHHHHSS--CCCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCCGGGEEECTTCCEEECCC
T ss_pred             CCcCCeEEEEEecCC-cCHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHH--HCCCCCCCCCHHHeEECCCCCEEEccC
Confidence                57899999995 5999988653  46999999999999999999999  566999999999999999999999999


Q ss_pred             CCccCCCCCCCc--------------------ceeeccccCCcccCcccc-ccCCCCcccchhcHHHHHHHHHhCCCCC
Q 046893          244 GLAKDGPMGDQT--------------------HVSTRVMGTYGYAAPEYV-MTGHLTARSDVYGFGVVLLEMLLGRRAV  301 (464)
Q Consensus       244 Gla~~~~~~~~~--------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~~DvwslG~il~ell~g~~pf  301 (464)
                      |+++........                    ......+||++|+|||++ .+..++.++||||||||||||++|..||
T Consensus       174 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~  252 (432)
T 3n9x_A          174 GLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSH  252 (432)
T ss_dssp             TTCEEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTT
T ss_pred             CCcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccc
Confidence            999865332211                    123457899999999986 4567999999999999999999855444

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=2.1e-44  Score=344.60  Aligned_cols=254  Identities=22%  Similarity=0.321  Sum_probs=202.1

Q ss_pred             hcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCc--cHHHHHHHHHHHhcCCCCCcceEEEEEEe--
Q 046893           91 TKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQ--GDREWLAEVNYLGQLRHSNLVKLIGYCCE--  166 (464)
Q Consensus        91 ~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpniv~l~~~~~~--  166 (464)
                      .++|++.+.||+|+||.||+|.+..+      ++.||+|++......  ....+.+|+.+++.++||||+++++++..  
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~------~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   78 (279)
T 2w5a_A            5 AEDYEVLYTIGTGSYGRCQKIRRKSD------GKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRT   78 (279)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTT------CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGG
T ss_pred             hhheeeehhccCCCCcEEEEEEECCC------CcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCC
Confidence            35688999999999999999998765      677999999765432  23568899999999999999999998864  


Q ss_pred             CCeEEEEEeccCCCCHHHHHHhhc--CCCCCHHHHHHHHHHHHHHHHHHhcCCCC-----eeeccCCCCceEecCCCceE
Q 046893          167 DEHRILVYEYMESGSLEKHLLRRV--GCMLTWSRRMKIALDAAKGLAFLHGAERP-----VIYRDFKTSNILLNADFSAK  239 (464)
Q Consensus       167 ~~~~~lv~e~~~~g~L~~~l~~~~--~~~l~~~~~~~i~~qi~~~l~~LH~~~~~-----ivHrDlkp~Nill~~~~~vk  239 (464)
                      ....++||||+++++|.+++....  ...+++..++.++.|++.||.|||  ..+     |+||||||+|||++.++.+|
T Consensus        79 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH--~~~~~~~~ivH~dl~p~NIl~~~~~~~k  156 (279)
T 2w5a_A           79 NTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECH--RRSDGGHTVLHRDLKPANVFLDGKQNVK  156 (279)
T ss_dssp             GTEEEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH--HHC------CCCCCSGGGEEECSSSCEE
T ss_pred             CceEEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHh--cccCCCCeeEEeccchhhEEEcCCCCEE
Confidence            568999999999999999987542  345899999999999999999999  455     99999999999999999999


Q ss_pred             EcccCCccCCCCCCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHh
Q 046893          240 LSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPL  319 (464)
Q Consensus       240 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~  319 (464)
                      |+|||+++......  .......||..|+|||++.+..++.++||||||+++|+|++|+.||......      +.....
T Consensus       157 l~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~~~~~i  228 (279)
T 2w5a_A          157 LGDFGLARILNHDT--SFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQK------ELAGKI  228 (279)
T ss_dssp             ECCCCHHHHC---C--HHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHH
T ss_pred             EecCchheeecccc--ccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHH------HHHHHH
Confidence            99999997643221  1223357999999999999999999999999999999999999999764321      111111


Q ss_pred             hhcccchhhccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 046893          320 LNNNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALL  371 (464)
Q Consensus       320 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L  371 (464)
                      ....       .+    ..+..++..+.+|+.+||+.||.+||++.+|++.+
T Consensus       229 ~~~~-------~~----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~  269 (279)
T 2w5a_A          229 REGK-------FR----RIPYRYSDELNEIITRMLNLKDYHRPSVEEILENP  269 (279)
T ss_dssp             HHTC-------CC----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTST
T ss_pred             hhcc-------cc----cCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhCh
Confidence            1110       01    12223455899999999999999999999998754

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=3.1e-44  Score=356.54  Aligned_cols=267  Identities=22%  Similarity=0.306  Sum_probs=203.2

Q ss_pred             HhcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCc-cHHHHHHHHHHHhcCCCCCcceEEEEEEeCC
Q 046893           90 ATKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQ-GDREWLAEVNYLGQLRHSNLVKLIGYCCEDE  168 (464)
Q Consensus        90 ~~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~  168 (464)
                      ..++|++.+.||+|+||+||+|.+..+      +..||+|++...... ....+.+|+.+|+.++||||+++++++...+
T Consensus        31 ~~~~y~~~~~lg~G~~g~V~~~~~~~~------~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~  104 (360)
T 3eqc_A           31 KDDDFEKISELGAGNGGVVFKVSHKPS------GLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDG  104 (360)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTT------CCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETT
T ss_pred             ccccceeeeeecCCCCeEEEEEEECCC------CcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECC
Confidence            356799999999999999999998765      677999998765322 2366889999999999999999999999999


Q ss_pred             eEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCccC
Q 046893          169 HRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKD  248 (464)
Q Consensus       169 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~  248 (464)
                      ..++||||+++++|.+++....  .+++..+..++.|++.||.|||+ ..+|+||||||+|||++.++.+||+|||++..
T Consensus       105 ~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~~i~~~l~~lh~-~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~  181 (360)
T 3eqc_A          105 EISICMEHMDGGSLDQVLKKAG--RIPEQILGKVSIAVIKGLTYLRE-KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQ  181 (360)
T ss_dssp             EEEEEECCCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHH-HHCCCCSCCSGGGEEECTTCCEEECCCCCCHH
T ss_pred             EEEEEEECCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH-hCCEEcCCccHHHEEECCCCCEEEEECCCCcc
Confidence            9999999999999999987654  58999999999999999999994 12699999999999999999999999999864


Q ss_pred             CCCCCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHH---------HH--
Q 046893          249 GPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEW---------AR--  317 (464)
Q Consensus       249 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~---------~~--  317 (464)
                      ...    .......||+.|+|||++.+..++.++|||||||++|+|++|+.||..............         ..  
T Consensus       182 ~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  257 (360)
T 3eqc_A          182 LID----SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRP  257 (360)
T ss_dssp             HHH----HC----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC--------------
T ss_pred             ccc----ccccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCc
Confidence            211    122346799999999999999999999999999999999999999976432111000000         00  


Q ss_pred             -----------Hhhhcccchhh----ccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 046893          318 -----------PLLNNNKKVLR----ILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVA  369 (464)
Q Consensus       318 -----------~~~~~~~~~~~----~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  369 (464)
                                 ...........    +.............+..+.+||.+||+.||.+|||+.++++
T Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  324 (360)
T 3eqc_A          258 RTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV  324 (360)
T ss_dssp             ----------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             ccCCCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence                       00000000000    00000000111223457999999999999999999999985

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=1e-43  Score=340.64  Aligned_cols=245  Identities=20%  Similarity=0.276  Sum_probs=197.3

Q ss_pred             hcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCC--ccHHHHHHHHHHHhcC-CCCCcceEEEEEEeC
Q 046893           91 TKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGY--QGDREWLAEVNYLGQL-RHSNLVKLIGYCCED  167 (464)
Q Consensus        91 ~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~  167 (464)
                      .++|++.+.||+|+||+||+|.+..+      ++.||+|++.....  .....+.+|+.++..+ +||||+++++++.+.
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~------~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~   83 (289)
T 1x8b_A           10 TTEFHELEKIGSGEFGSVFKCVKRLD------GCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAED   83 (289)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTT------CCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEET
T ss_pred             cchhhhhhhhcCCCceEEEEEEEcCC------CceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecC
Confidence            46689999999999999999998765      66799999876432  3346788999999999 899999999999999


Q ss_pred             CeEEEEEeccCCCCHHHHHHhhc--CCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCC----------
Q 046893          168 EHRILVYEYMESGSLEKHLLRRV--GCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNAD----------  235 (464)
Q Consensus       168 ~~~~lv~e~~~~g~L~~~l~~~~--~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~----------  235 (464)
                      +..++||||+++++|.+++....  ...+++..++.++.|++.||.|||  .++|+||||||+|||++.+          
T Consensus        84 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH--~~~ivH~Dikp~NIl~~~~~~~~~~~~~~  161 (289)
T 1x8b_A           84 DHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIH--SMSLVHMDIKPSNIFISRTSIPNAASEEG  161 (289)
T ss_dssp             TEEEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGEEEC------------
T ss_pred             CeEEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHH--hCCEeecCCCHHHEEEcCCCCCccccccc
Confidence            99999999999999999987642  246899999999999999999999  5679999999999999844          


Q ss_pred             ---------CceEEcccCCccCCCCCCCcceeeccccCCcccCccccccC-CCCcccchhcHHHHHHHHHhCCCCCCCCC
Q 046893          236 ---------FSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTG-HLTARSDVYGFGVVLLEMLLGRRAVDKSR  305 (464)
Q Consensus       236 ---------~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~ell~g~~pf~~~~  305 (464)
                               ..+||+|||++......      ....||..|+|||++.+. .++.++|||||||++|+|++|..++....
T Consensus       162 ~~~~~~~~~~~~kl~Dfg~~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~  235 (289)
T 1x8b_A          162 DEDDWASNKVMFKIGDLGHVTRISSP------QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGD  235 (289)
T ss_dssp             --------CCCEEECCCTTCEETTCS------CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSH
T ss_pred             ccccccCCceEEEEcccccccccCCc------cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchh
Confidence                     47999999999864322      124699999999998766 56789999999999999999987764321


Q ss_pred             CcccccHHHHHHHhhhcccchhhccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 046893          306 PSREHNLVEWARPLLNNNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVA  369 (464)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  369 (464)
                           ....    ...       ...+    ..+..++..+.+|+.+||+.||.+||++.++++
T Consensus       236 -----~~~~----~~~-------~~~~----~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  279 (289)
T 1x8b_A          236 -----QWHE----IRQ-------GRLP----RIPQVLSQEFTELLKVMIHPDPERRPSAMALVK  279 (289)
T ss_dssp             -----HHHH----HHT-------TCCC----CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             -----HHHH----HHc-------CCCC----CCCcccCHHHHHHHHHHhCCCcccCCCHHHHhh
Confidence                 1111    100       0011    122234458999999999999999999999874

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=4.3e-44  Score=362.82  Aligned_cols=255  Identities=23%  Similarity=0.302  Sum_probs=192.5

Q ss_pred             HHHhcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCC--------ccHHHHHHHHHHHhcCCCCCcce
Q 046893           88 KLATKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGY--------QGDREWLAEVNYLGQLRHSNLVK  159 (464)
Q Consensus        88 ~~~~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~hpniv~  159 (464)
                      ....++|.+.+.||+|+||+||+|.+..+      ++.||||++.....        .....+.+|+.+|+.++||||++
T Consensus       131 ~~~~~~y~~~~~LG~G~~g~V~~a~~~~~------~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~  204 (419)
T 3i6u_A          131 KALRDEYIMSKTLGSGACGEVKLAFERKT------CKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIK  204 (419)
T ss_dssp             HHHHTTEEEEEEEEECSSSEEEEEEETTT------CCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCC
T ss_pred             hhhhccEEEEeEEeeCCCeEEEEEEECCC------CcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEee
Confidence            34578899999999999999999998775      66799999865321        11124789999999999999999


Q ss_pred             EEEEEEeCCeEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCC---C
Q 046893          160 LIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNAD---F  236 (464)
Q Consensus       160 l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~---~  236 (464)
                      +++++. .+..++||||+.+|+|.+++...  ..+++..+..++.|++.||.|||  .++|+||||||+|||++.+   +
T Consensus       205 l~~~~~-~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH--~~~ivHrDlkp~NIll~~~~~~~  279 (419)
T 3i6u_A          205 IKNFFD-AEDYYIVLELMEGGELFDKVVGN--KRLKEATCKLYFYQMLLAVQYLH--ENGIIHRDLKPENVLLSSQEEDC  279 (419)
T ss_dssp             CCEEEE-SSEEEEEEECCTTCBGGGGTSSS--CCCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCCGGGEEESSSSSSC
T ss_pred             EEEEEe-cCceEEEEEcCCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHH--HCCccccCCChHhEEEecCCCcc
Confidence            999975 45689999999999999887654  36999999999999999999999  5679999999999999654   4


Q ss_pred             ceEEcccCCccCCCCCCCcceeeccccCCcccCcccccc---CCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHH
Q 046893          237 SAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMT---GHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLV  313 (464)
Q Consensus       237 ~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~  313 (464)
                      .+||+|||+++....   .......+||+.|+|||++.+   ..++.++|||||||+||+|++|..||.......  .+.
T Consensus       280 ~~kl~DFG~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~--~~~  354 (419)
T 3i6u_A          280 LIKITDFGHSKILGE---TSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV--SLK  354 (419)
T ss_dssp             CEEECCSSTTTSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSC--CHH
T ss_pred             eEEEeecccceecCC---CccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchH--HHH
Confidence            599999999986432   222344789999999999863   578889999999999999999999997643221  111


Q ss_pred             HHHHHhhhcccchhhccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 046893          314 EWARPLLNNNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVA  369 (464)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  369 (464)
                      ....   ....        ..........+..+.+|+.+||+.||.+||++.++++
T Consensus       355 ~~i~---~~~~--------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  399 (419)
T 3i6u_A          355 DQIT---SGKY--------NFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR  399 (419)
T ss_dssp             HHHH---TTCC--------CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             HHHh---cCCC--------CCCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence            1110   0000        0000011123457899999999999999999999875

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=1.4e-43  Score=378.72  Aligned_cols=247  Identities=23%  Similarity=0.342  Sum_probs=203.4

Q ss_pred             HHHhcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCC---CccHHHHHHHHHHHhcC-CCCCcceEEEE
Q 046893           88 KLATKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGG---YQGDREWLAEVNYLGQL-RHSNLVKLIGY  163 (464)
Q Consensus        88 ~~~~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~hpniv~l~~~  163 (464)
                      .+...+|++.++||+|+||+||+|.+..+      ++.||||++....   ......+..|..+|..+ +||||++++++
T Consensus       337 ~~~~~~f~~~~~LG~G~fG~V~~~~~~~~------~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~  410 (674)
T 3pfq_A          337 RMKLTDFNFLMVLGKGSFGKVMLSERKGT------DELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSC  410 (674)
T ss_dssp             ---CTTEEEEEESSBTTTBCEEEEEESSS------CCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEE
T ss_pred             cccccceEEEEEEccCCCEEEEEEEECCC------CcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEE
Confidence            34456799999999999999999998765      6779999987431   22335678899999988 79999999999


Q ss_pred             EEeCCeEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEccc
Q 046893          164 CCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDF  243 (464)
Q Consensus       164 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DF  243 (464)
                      +.+.+.+||||||+.+|+|.+++....  .+++..++.++.||+.||.|||  .++||||||||+||||+.++.+||+||
T Consensus       411 ~~~~~~~~lV~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH--~~gIiHrDLKp~NILl~~~g~ikL~DF  486 (674)
T 3pfq_A          411 FQTMDRLYFVMEYVNGGDLMYHIQQVG--RFKEPHAVFYAAEIAIGLFFLQ--SKGIIYRDLKLDNVMLDSEGHIKIADF  486 (674)
T ss_dssp             CBCSSEEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHH--HTSEECCCCCSTTEEECSSSCEEECCC
T ss_pred             EEeCCEEEEEEeCcCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH--hCCeEeccCChhhEEEcCCCcEEEeec
Confidence            999999999999999999999998754  6999999999999999999999  567999999999999999999999999


Q ss_pred             CCccCCCCCCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhcc
Q 046893          244 GLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNN  323 (464)
Q Consensus       244 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~  323 (464)
                      |+|+......  ......+||+.|+|||++.+..|+.++|||||||+||||++|+.||.+...      .+....++...
T Consensus       487 Gla~~~~~~~--~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~------~~~~~~i~~~~  558 (674)
T 3pfq_A          487 GMCKENIWDG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE------DELFQSIMEHN  558 (674)
T ss_dssp             TTCEECCCTT--CCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHSSC
T ss_pred             ceeeccccCC--cccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCH------HHHHHHHHhCC
Confidence            9998633222  223457899999999999999999999999999999999999999986432      12222222211


Q ss_pred             cchhhccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCH
Q 046893          324 KKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVM  364 (464)
Q Consensus       324 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~  364 (464)
                                  ..++...+.++.+||.+||..||.+||++
T Consensus       559 ------------~~~p~~~s~~~~~li~~lL~~dP~~R~~~  587 (674)
T 3pfq_A          559 ------------VAYPKSMSKEAVAICKGLMTKHPGKRLGC  587 (674)
T ss_dssp             ------------CCCCTTSCHHHHHHHHHHSCSSSTTCTTC
T ss_pred             ------------CCCCccCCHHHHHHHHHHccCCHHHCCCC
Confidence                        12233445689999999999999999998

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=7e-43  Score=338.38  Aligned_cols=252  Identities=19%  Similarity=0.255  Sum_probs=200.3

Q ss_pred             hcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCC----CccHHHHHHHHHHHhcCCCCCcceEEEEEE-
Q 046893           91 TKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGG----YQGDREWLAEVNYLGQLRHSNLVKLIGYCC-  165 (464)
Q Consensus        91 ~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-  165 (464)
                      .++|++.+.||+|+||.||+|.+..+      +..||+|++....    ......+.+|+.+++.++||||+++++++. 
T Consensus         4 ~~~y~i~~~lg~G~~g~V~~~~~~~~------~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~   77 (305)
T 2wtk_C            4 IGKYLMGDLLGEGSYGKVKEVLDSET------LCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYN   77 (305)
T ss_dssp             -CCBCCCCEEEECSSCEEEEEEBTTT------CCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred             ccceeEeeEEecCCCeEEEEEEECCC------CcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEc
Confidence            46799999999999999999998764      6679999986532    233467899999999999999999999984 


Q ss_pred             -eCCeEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccC
Q 046893          166 -EDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFG  244 (464)
Q Consensus       166 -~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFG  244 (464)
                       +....++||||+.++ |.+++.......+++..++.++.|++.||.|||  .++|+||||||+|||++.++.+||+|||
T Consensus        78 ~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH--~~~i~H~dlkp~NIl~~~~~~~kl~dfg  154 (305)
T 2wtk_C           78 EEKQKMYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLH--SQGIVHKDIKPGNLLLTTGGTLKISALG  154 (305)
T ss_dssp             C---CEEEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGEEECTTCCEEECCCT
T ss_pred             CCCCeEEEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHH--HCCeeecCCCcccEEEcCCCcEEeeccc
Confidence             445789999999876 778777655667999999999999999999999  5679999999999999999999999999


Q ss_pred             CccCCCCCCCcceeeccccCCcccCccccccCC--CCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhc
Q 046893          245 LAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGH--LTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNN  322 (464)
Q Consensus       245 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~  322 (464)
                      ++................||..|+|||++.+..  ++.++||||||+++|+|++|+.||.....      .+....+...
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~------~~~~~~i~~~  228 (305)
T 2wtk_C          155 VAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNI------YKLFENIGKG  228 (305)
T ss_dssp             TCEECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSH------HHHHHHHHHC
T ss_pred             cccccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchH------HHHHHHHhcC
Confidence            998654333333334567999999999987644  47799999999999999999999976431      1111111111


Q ss_pred             ccchhhccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 046893          323 NKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVA  369 (464)
Q Consensus       323 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  369 (464)
                      .        .    ..+..++..+.+|+.+||..||.+||++.++++
T Consensus       229 ~--------~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  263 (305)
T 2wtk_C          229 S--------Y----AIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQ  263 (305)
T ss_dssp             C--------C----CCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             C--------C----CCCCccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            0        0    112234457889999999999999999999985

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=8.1e-44  Score=351.82  Aligned_cols=266  Identities=26%  Similarity=0.333  Sum_probs=196.5

Q ss_pred             HhcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCcc-----HHHHHHHHHHHhcCCCCCcceEEEEE
Q 046893           90 ATKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQG-----DREWLAEVNYLGQLRHSNLVKLIGYC  164 (464)
Q Consensus        90 ~~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~-----~~~~~~E~~~l~~l~hpniv~l~~~~  164 (464)
                      ..++|++.+.||+|+||.||+|.+..+      ++.||||++.......     ...+.+|+.+++.++||||+++++++
T Consensus         8 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~------~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~   81 (346)
T 1ua2_A            8 RAKRYEKLDFLGEGQFATVYKARDKNT------NQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAF   81 (346)
T ss_dssp             -----CEEEEEEEETTEEEEEEECSSC------CSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             HhcccEEEeEEeecCCEEEEEEEECCC------CcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEE
Confidence            456799999999999999999998764      6679999987532211     24678999999999999999999999


Q ss_pred             EeCCeEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccC
Q 046893          165 CEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFG  244 (464)
Q Consensus       165 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFG  244 (464)
                      ...+..++||||+.+ +|.+++... ...+++..+..++.|++.||.|||  ..+|+||||||+|||++.++.+||+|||
T Consensus        82 ~~~~~~~lv~e~~~~-~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH--~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg  157 (346)
T 1ua2_A           82 GHKSNISLVFDFMET-DLEVIIKDN-SLVLTPSHIKAYMLMTLQGLEYLH--QHWILHRDLKPNNLLLDENGVLKLADFG  157 (346)
T ss_dssp             CCTTCCEEEEECCSE-EHHHHHTTC-CSSCCSSHHHHHHHHHHHHHHHHH--HTTCCCCCCCGGGEEECTTCCEEECCCG
T ss_pred             eeCCceEEEEEcCCC-CHHHHHHhc-CcCCCHHHHHHHHHHHHHHHHHHH--HCCEECCCCCHHHEEEcCCCCEEEEecc
Confidence            999999999999976 888887654 346899999999999999999999  5679999999999999999999999999


Q ss_pred             CccCCCCCCCcceeeccccCCcccCccccccC-CCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhcc
Q 046893          245 LAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTG-HLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNN  323 (464)
Q Consensus       245 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~  323 (464)
                      +++......  .......||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.....  .+...........
T Consensus       158 ~a~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~--~~~~i~~~~~~~~  233 (346)
T 1ua2_A          158 LAKSFGSPN--RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLD--QLTRIFETLGTPT  233 (346)
T ss_dssp             GGSTTTSCC--CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHHHHCCCC
T ss_pred             cceeccCCc--ccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHH--HHHHHHHHcCCCC
Confidence            998643222  223346799999999998764 58999999999999999999999997654211  1111111100000


Q ss_pred             ----cchhhccCc---ccc-----CccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 046893          324 ----KKVLRILDP---RLE-----GQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVA  369 (464)
Q Consensus       324 ----~~~~~~~~~---~~~-----~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  369 (464)
                          .......+.   ...     .......+..+.+||.+||..||.+|||+.++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  291 (346)
T 1ua2_A          234 EEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK  291 (346)
T ss_dssp             TTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             hhhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhc
Confidence                000000000   000     0011233468999999999999999999999875

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=1.5e-43  Score=365.90  Aligned_cols=251  Identities=23%  Similarity=0.314  Sum_probs=201.4

Q ss_pred             hcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCC--CccHHHHHHHHHHHhcCCCCCcceEEEEEEeCC
Q 046893           91 TKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGG--YQGDREWLAEVNYLGQLRHSNLVKLIGYCCEDE  168 (464)
Q Consensus        91 ~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~  168 (464)
                      .++|++.+.||+|+||+||+|.+..+      ++.||||++....  ......+.+|+.+|+.++||||+++++++....
T Consensus        21 ~~~y~~~~~lG~G~~g~V~~~~~~~~------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~   94 (486)
T 3mwu_A           21 AERYNIVCMLGKGSFGEVLKCKDRIT------QQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSS   94 (486)
T ss_dssp             HHHEEEEEEEECCSSSEEEEEEETTT------CCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred             hcceEEeEEEeecCCEEEEEEEECCC------CCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCC
Confidence            45699999999999999999998765      6679999985421  234567899999999999999999999999999


Q ss_pred             eEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEec---CCCceEEcccCC
Q 046893          169 HRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLN---ADFSAKLSDFGL  245 (464)
Q Consensus       169 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~---~~~~vkl~DFGl  245 (464)
                      ..++|||||.+|+|.+++....  .+++..+..++.||+.||.|||  .++|+||||||+|||++   .++.+||+|||+
T Consensus        95 ~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~i~~qi~~al~~lH--~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~  170 (486)
T 3mwu_A           95 SFYIVGELYTGGELFDEIIKRK--RFSEHDAARIIKQVFSGITYMH--KHNIVHRDLKPENILLESKEKDCDIKIIDFGL  170 (486)
T ss_dssp             EEEEEECCCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCSGGGEEESSSSTTCCEEECSCSC
T ss_pred             EEEEEEEcCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH--HCCeEeccCchHHEEEecCCCCCCEEEEECCc
Confidence            9999999999999999887654  6999999999999999999999  56799999999999994   456799999999


Q ss_pred             ccCCCCCCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhcccc
Q 046893          246 AKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKK  325 (464)
Q Consensus       246 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  325 (464)
                      ++......   .....+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+....      +.......... 
T Consensus       171 a~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~------~~~~~i~~~~~-  239 (486)
T 3mwu_A          171 STCFQQNT---KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEY------DILKRVETGKY-  239 (486)
T ss_dssp             TTTBCCC-------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHHTCC-
T ss_pred             CeECCCCC---ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHHhCCC-
Confidence            98643322   2334679999999998875 5999999999999999999999999765321      11111111100 


Q ss_pred             hhhccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 046893          326 VLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVA  369 (464)
Q Consensus       326 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  369 (464)
                             .........++..+.+||.+||..||.+|||+.++++
T Consensus       240 -------~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~  276 (486)
T 3mwu_A          240 -------AFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLE  276 (486)
T ss_dssp             -------CSCSGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             -------CCCCcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence                   0011111234457899999999999999999999986

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=1.6e-43  Score=366.24  Aligned_cols=252  Identities=23%  Similarity=0.326  Sum_probs=198.7

Q ss_pred             HhcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCC--CccHHHHHHHHHHHhcCCCCCcceEEEEEEeC
Q 046893           90 ATKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGG--YQGDREWLAEVNYLGQLRHSNLVKLIGYCCED  167 (464)
Q Consensus        90 ~~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~  167 (464)
                      ..++|++.+.||+|+||+||+|.+..+      +..||+|++....  ......+.+|+.+|+.++||||+++++++...
T Consensus        35 ~~~~y~~~~~lG~G~~g~V~~~~~~~~------~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~  108 (494)
T 3lij_A           35 LSEMYQRVKKLGSGAYGEVLLCRDKVT------HVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDK  108 (494)
T ss_dssp             HHHHEEEEEEEECC---EEEEEEETTT------CCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred             hhcCeEEeeEEecCCCEEEEEEEECCC------CcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeC
Confidence            345699999999999999999998765      6679999987543  22346789999999999999999999999999


Q ss_pred             CeEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecC---CCceEEcccC
Q 046893          168 EHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNA---DFSAKLSDFG  244 (464)
Q Consensus       168 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~---~~~vkl~DFG  244 (464)
                      ...++|||||.+|+|.+++....  .+++..+..++.||+.||.|||  .++|+||||||+|||++.   ++.+||+|||
T Consensus       109 ~~~~lv~e~~~~g~L~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH--~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG  184 (494)
T 3lij_A          109 RNYYLVMECYKGGELFDEIIHRM--KFNEVDAAVIIKQVLSGVTYLH--KHNIVHRDLKPENLLLESKEKDALIKIVDFG  184 (494)
T ss_dssp             SEEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGEEESCSSTTCCEEECCCT
T ss_pred             CEEEEEEecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH--HCCceeccCChhhEEEeCCCCCCcEEEEECC
Confidence            99999999999999999887654  6899999999999999999999  567999999999999975   4559999999


Q ss_pred             CccCCCCCCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhccc
Q 046893          245 LAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNK  324 (464)
Q Consensus       245 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  324 (464)
                      +++......   .....+||+.|+|||++. ..++.++|||||||++|+|++|..||.+....      +..........
T Consensus       185 ~a~~~~~~~---~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~------~~~~~i~~~~~  254 (494)
T 3lij_A          185 LSAVFENQK---KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQ------EILRKVEKGKY  254 (494)
T ss_dssp             TCEECBTTB---CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHHTCC
T ss_pred             CCeECCCCc---cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHHhCCC
Confidence            998643222   233468999999999876 57999999999999999999999999765421      11111111110


Q ss_pred             chhhccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 046893          325 KVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVA  369 (464)
Q Consensus       325 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  369 (464)
                      .    +..    ......+..+.+||.+||+.||.+|||+.++++
T Consensus       255 ~----~~~----~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~  291 (494)
T 3lij_A          255 T----FDS----PEWKNVSEGAKDLIKQMLQFDSQRRISAQQALE  291 (494)
T ss_dssp             C----CCS----GGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             C----CCc----hhcccCCHHHHHHHHHHCCCChhhCccHHHHhc
Confidence            0    001    111223457899999999999999999999885

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=2.5e-43  Score=343.10  Aligned_cols=253  Identities=28%  Similarity=0.380  Sum_probs=200.4

Q ss_pred             HHhcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCccHHHHHHHHHHHhcCCCCCcceEEEEEEeCC
Q 046893           89 LATKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVKLIGYCCEDE  168 (464)
Q Consensus        89 ~~~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~  168 (464)
                      ...++|.+.+.||+|+||.||+|.+..+      ++.||+|++....  ....+.+|+.++..++||||+++++++...+
T Consensus        26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~------~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   97 (314)
T 3com_A           26 QPEEVFDVLEKLGEGSYGSVYKAIHKET------GQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNT   97 (314)
T ss_dssp             ----CEEEEEECC----CEEEEEEETTT------CCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETT
T ss_pred             cchhhhhhheeeccCCCeEEEEEEECCC------CCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCC
Confidence            3456799999999999999999998764      6679999987643  3467899999999999999999999999999


Q ss_pred             eEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCccC
Q 046893          169 HRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKD  248 (464)
Q Consensus       169 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~  248 (464)
                      ..++||||+.+++|.+++... ...+++..++.++.|++.||.|||  ..+|+|+||||+|||++.++.+||+|||++..
T Consensus        98 ~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH--~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~  174 (314)
T 3com_A           98 DLWIVMEYCGAGSVSDIIRLR-NKTLTEDEIATILQSTLKGLEYLH--FMRKIHRDIKAGNILLNTEGHAKLADFGVAGQ  174 (314)
T ss_dssp             EEEEEEECCTTEEHHHHHHHH-TCCCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred             EEEEEeecCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHH--hCCCcCCCcCHHHEEECCCCCEEEeecccchh
Confidence            999999999999999988643 346999999999999999999999  56799999999999999999999999999976


Q ss_pred             CCCCCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhcccchhh
Q 046893          249 GPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLR  328 (464)
Q Consensus       249 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  328 (464)
                      ....  ........||..|+|||++.+..++.++||||||+++|+|++|+.||.......      .........     
T Consensus       175 ~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~------~~~~~~~~~-----  241 (314)
T 3com_A          175 LTDT--MAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMR------AIFMIPTNP-----  241 (314)
T ss_dssp             CBTT--BSCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHH------HHHHHHHSC-----
T ss_pred             hhhh--ccccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHH------HHHHHhcCC-----
Confidence            4322  122334679999999999999999999999999999999999999997643211      010000000     


Q ss_pred             ccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 046893          329 ILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVA  369 (464)
Q Consensus       329 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  369 (464)
                        .+.+  ..+..++..+.+|+.+||..||.+||++.++++
T Consensus       242 --~~~~--~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~  278 (314)
T 3com_A          242 --PPTF--RKPELWSDNFTDFVKQCLVKSPEQRATATQLLQ  278 (314)
T ss_dssp             --CCCC--SSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             --Cccc--CCcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence              0000  112233458899999999999999999999985

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=2.5e-43  Score=358.26  Aligned_cols=201  Identities=21%  Similarity=0.263  Sum_probs=173.8

Q ss_pred             HhcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCccHHHHHHHHHHHhcC------CCCCcceEEEE
Q 046893           90 ATKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQL------RHSNLVKLIGY  163 (464)
Q Consensus        90 ~~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l------~hpniv~l~~~  163 (464)
                      ...+|++.+.||+|+||+||+|.+..+      ++.||||++... ......+..|+.++..+      .|+||++++++
T Consensus        95 ~~~ry~~~~~LG~G~fg~V~~a~~~~~------~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~  167 (429)
T 3kvw_A           95 VAYRYEVLKVIGKGSFGQVVKAYDHKV------HQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLEN  167 (429)
T ss_dssp             ETTTEEEEEEEEESSSEEEEEEEETTT------TEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEE
T ss_pred             ccCcEEEEEEcccCccEEEEEEEECCC------CcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEee
Confidence            345799999999999999999998765      678999999753 22235677788888776      57899999999


Q ss_pred             EEeCCeEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCc--eEEc
Q 046893          164 CCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFS--AKLS  241 (464)
Q Consensus       164 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~--vkl~  241 (464)
                      +...+..+|||||+. ++|.+++.......+++..+..++.||+.||.|||  ..+|+||||||+||||+.++.  +||+
T Consensus       168 ~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH--~~~ivHrDlKp~NILl~~~~~~~vkL~  244 (429)
T 3kvw_A          168 FTFRNHICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALH--KNRIIHCDLKPENILLKQQGRSGIKVI  244 (429)
T ss_dssp             EEETTEEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH--HHTEECSCCSGGGEEESSTTSCCEEEC
T ss_pred             cccCCeEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH--HCCeecCCCCHHHeEEccCCCcceEEe
Confidence            999999999999995 69999988766566999999999999999999999  567999999999999999887  9999


Q ss_pred             ccCCccCCCCCCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHhCCCCCCCCC
Q 046893          242 DFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSR  305 (464)
Q Consensus       242 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~  305 (464)
                      |||+++.....     ....+||+.|+|||++.+..++.++|||||||+||||++|..||.+..
T Consensus       245 DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~  303 (429)
T 3kvw_A          245 DFGSSCYEHQR-----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGED  303 (429)
T ss_dssp             CCTTCEETTCC-----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             ecccceecCCc-----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCC
Confidence            99999753221     223689999999999999999999999999999999999999997654

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=2.4e-43  Score=353.28  Aligned_cols=264  Identities=23%  Similarity=0.294  Sum_probs=197.6

Q ss_pred             HHHhcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCccHHHHHHHHHHHhcCCCCCcceEEEEEEe-
Q 046893           88 KLATKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVKLIGYCCE-  166 (464)
Q Consensus        88 ~~~~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-  166 (464)
                      ....++|++.+.||+|+||+||+|.+..+      ++.||||++......    ..+|+.+|+.++||||++++++|.. 
T Consensus         3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~------~~~vAiK~~~~~~~~----~~~E~~il~~l~hpnIv~l~~~~~~~   72 (383)
T 3eb0_A            3 ETSSKKYSLGKTLGTGSFGIVCEVFDIES------GKRFALKKVLQDPRY----KNRELDIMKVLDHVNIIKLVDYFYTT   72 (383)
T ss_dssp             ---CTTEEEEEEEECC-CEEEEEEEETTT------CCEEEEEEEECCTTS----CCHHHHHHTTCCCTTBCCEEEEEEEC
T ss_pred             ccccceEEEEEEEEeccCEEEEEEEECCC------CCEEEEEEEecCcch----HHHHHHHHHHcCCCCccchhheeeec
Confidence            34567899999999999999999998765      677999998654322    2379999999999999999999844 


Q ss_pred             -------------------------------------CCeEEEEEeccCCCCHHHHHHh--hcCCCCCHHHHHHHHHHHH
Q 046893          167 -------------------------------------DEHRILVYEYMESGSLEKHLLR--RVGCMLTWSRRMKIALDAA  207 (464)
Q Consensus       167 -------------------------------------~~~~~lv~e~~~~g~L~~~l~~--~~~~~l~~~~~~~i~~qi~  207 (464)
                                                           ....++||||+. ++|.+.+..  ..+..+++..+..++.||+
T Consensus        73 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~  151 (383)
T 3eb0_A           73 GDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLF  151 (383)
T ss_dssp             -------------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHH
T ss_pred             CcccccccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHH
Confidence                                                 334889999997 588777754  2345799999999999999


Q ss_pred             HHHHHHhcCCCCeeeccCCCCceEec-CCCceEEcccCCccCCCCCCCcceeeccccCCcccCccccccC-CCCcccchh
Q 046893          208 KGLAFLHGAERPVIYRDFKTSNILLN-ADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTG-HLTARSDVY  285 (464)
Q Consensus       208 ~~l~~LH~~~~~ivHrDlkp~Nill~-~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dvw  285 (464)
                      .||.|||  ..+|+||||||+|||++ .++.+||+|||+++......   ......||..|+|||++.+. .++.++|||
T Consensus       152 ~aL~~LH--~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw  226 (383)
T 3eb0_A          152 RAVGFIH--SLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE---PSVAYICSRFYRAPELMLGATEYTPSIDLW  226 (383)
T ss_dssp             HHHHHHH--TTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS---CCCCCCCCSSCCCHHHHTTCSSCCTHHHHH
T ss_pred             HHHHHHH--HCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC---CCcCcccCCCccCHHHhcCCCCCCcchhhh
Confidence            9999999  67799999999999997 68899999999998643322   22346789999999998875 489999999


Q ss_pred             cHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhccc-------------chhhccCccccCccCHHHHHHHHHHHHH
Q 046893          286 GFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNK-------------KVLRILDPRLEGQYTARTAMKVAGLAYQ  352 (464)
Q Consensus       286 slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-------------~~~~~~~~~~~~~~~~~~~~~l~~li~~  352 (464)
                      ||||++|||++|+.||.+.....  .+.......-....             .............++...+..+.+|+.+
T Consensus       227 slG~il~ell~g~~pf~~~~~~~--~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  304 (383)
T 3eb0_A          227 SIGCVFGELILGKPLFSGETSID--QLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQ  304 (383)
T ss_dssp             HHHHHHHHHHHSSCSSCCSSHHH--HHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHH
T ss_pred             hHHHHHHHHHhCCCCCCCCChHH--HHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHH
Confidence            99999999999999998654221  11111110000000             0000011111112333455689999999


Q ss_pred             hhccCCCCCCCHHHHHH
Q 046893          353 CLSQNPKGRPVMSDVVA  369 (464)
Q Consensus       353 cl~~dP~~RPs~~ev~~  369 (464)
                      ||..||.+|||+.++++
T Consensus       305 ~L~~dP~~R~t~~e~l~  321 (383)
T 3eb0_A          305 ILRYEPDLRINPYEAMA  321 (383)
T ss_dssp             HCCSSGGGSCCHHHHHT
T ss_pred             HccCChhhCCCHHHHhc
Confidence            99999999999999984

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=8e-45  Score=363.26  Aligned_cols=248  Identities=15%  Similarity=0.152  Sum_probs=191.2

Q ss_pred             hcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCC---CCccHHHHHHHH---HHHhcCCCCCcceEE---
Q 046893           91 TKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRG---GYQGDREWLAEV---NYLGQLRHSNLVKLI---  161 (464)
Q Consensus        91 ~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~---~~l~~l~hpniv~l~---  161 (464)
                      .++|++.+.||+|+||+||+|.+..+      ++.||||++...   .....+.+.+|+   ++|+.++||||++++   
T Consensus        72 ~~~y~~~~~lG~G~~g~V~~a~~~~~------~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~  145 (377)
T 3byv_A           72 PRTLVRGTVLGQEDPYAYLEATDQET------GESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRF  145 (377)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEC-CC------CCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCB
T ss_pred             CceEEEcceeecCCCEEEEEEEECCC------CcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhh
Confidence            46788899999999999999998654      667999998743   223447788999   555556899999998   


Q ss_pred             ----EEEEeCCe-----------------EEEEEeccCCCCHHHHHHhhcC-----CCCCHHHHHHHHHHHHHHHHHHhc
Q 046893          162 ----GYCCEDEH-----------------RILVYEYMESGSLEKHLLRRVG-----CMLTWSRRMKIALDAAKGLAFLHG  215 (464)
Q Consensus       162 ----~~~~~~~~-----------------~~lv~e~~~~g~L~~~l~~~~~-----~~l~~~~~~~i~~qi~~~l~~LH~  215 (464)
                          +++...+.                 .||||||+ +|+|.+++.....     ..+++..++.|+.||+.||.||| 
T Consensus       146 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH-  223 (377)
T 3byv_A          146 IFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLH-  223 (377)
T ss_dssp             CCCSEEEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHH-
T ss_pred             hhhhhhhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHH-
Confidence                77665542                 78999999 6799999976431     12335888899999999999999 


Q ss_pred             CCCCeeeccCCCCceEecCCCceEEcccCCccCCCCCCCcceeeccccCCcccCccccccC-----------CCCcccch
Q 046893          216 AERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTG-----------HLTARSDV  284 (464)
Q Consensus       216 ~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~~Dv  284 (464)
                       ..+|+||||||+||||+.++.+||+|||+++....     .....+| +.|+|||++.+.           .++.++||
T Consensus       224 -~~~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Dv  296 (377)
T 3byv_A          224 -HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDA  296 (377)
T ss_dssp             -HTTEECSCCCGGGEEECTTCCEEECCGGGCEETTC-----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHH
T ss_pred             -hCCeecCCCCHHHEEEcCCCCEEEEechhheecCC-----cccCCCC-cCccChhhhcccccccccccccccCChhhhH
Confidence             56799999999999999999999999999985221     2344678 999999999887           89999999


Q ss_pred             hcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhcccchhhccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCH
Q 046893          285 YGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVM  364 (464)
Q Consensus       285 wslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~  364 (464)
                      |||||+||||++|+.||.........                ..+...      ...++..+.+||.+||+.||.+||++
T Consensus       297 wSlG~il~elltg~~Pf~~~~~~~~~----------------~~~~~~------~~~~~~~~~~li~~~L~~dp~~Rpt~  354 (377)
T 3byv_A          297 WALGLVIYWIWCADLPITKDAALGGS----------------EWIFRS------CKNIPQPVRALLEGFLRYPKEDRLLP  354 (377)
T ss_dssp             HHHHHHHHHHHHSSCCC------CCS----------------GGGGSS------CCCCCHHHHHHHHHHTCSSGGGCCCH
T ss_pred             HHHHHHHHHHHHCCCCCcccccccch----------------hhhhhh------ccCCCHHHHHHHHHHcCCCchhCCCH
Confidence            99999999999999999764322111                000000      01234578999999999999999999


Q ss_pred             HHHHH--HHHHHH
Q 046893          365 SDVVA--LLETVQ  375 (464)
Q Consensus       365 ~ev~~--~L~~~~  375 (464)
                      .++++  .+..+.
T Consensus       355 ~e~l~hp~f~~~~  367 (377)
T 3byv_A          355 LQAMETPEYEQLR  367 (377)
T ss_dssp             HHHHTSHHHHHHH
T ss_pred             HHHhhChHHHHHH
Confidence            99985  455443

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=6.7e-44  Score=353.68  Aligned_cols=257  Identities=25%  Similarity=0.328  Sum_probs=201.6

Q ss_pred             cCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCC----ccHHHHHHHHHHHhcC-CCCCcceEEEEEEe
Q 046893           92 KFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGY----QGDREWLAEVNYLGQL-RHSNLVKLIGYCCE  166 (464)
Q Consensus        92 ~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~  166 (464)
                      ++|++.+.||+|+||.||+|.+....   ..++.||||++.....    .....+.+|+.+|..+ +||||+++++++..
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~~~~~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~  130 (355)
T 1vzo_A           54 ENFELLKVLGTGAYGKVFLVRKISGH---DTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT  130 (355)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSST---TTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEE
T ss_pred             cceEEEEEeccCCCEEEEEEEEcccC---CCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEee
Confidence            56889999999999999999975321   1367899999875321    2234567899999999 69999999999999


Q ss_pred             CCeEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCc
Q 046893          167 DEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLA  246 (464)
Q Consensus       167 ~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla  246 (464)
                      .+..+|||||+.+++|.+++....  .+++..+..++.|++.||.|||  .++|+||||||+||||+.++.+||+|||++
T Consensus       131 ~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH--~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a  206 (355)
T 1vzo_A          131 ETKLHLILDYINGGELFTHLSQRE--RFTEHEVQIYVGEIVLALEHLH--KLGIIYRDIKLENILLDSNGHVVLTDFGLS  206 (355)
T ss_dssp             TTEEEEEECCCCSCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHH--HTTCCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred             CceEEEEeecCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH--HCCcccCCCCHHHEEECCCCcEEEeeCCCC
Confidence            999999999999999999997654  6899999999999999999999  567999999999999999999999999999


Q ss_pred             cCCCCCCCcceeeccccCCcccCcccccc--CCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhccc
Q 046893          247 KDGPMGDQTHVSTRVMGTYGYAAPEYVMT--GHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNK  324 (464)
Q Consensus       247 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  324 (464)
                      +...... .......+||+.|+|||++.+  ..++.++|||||||+||||++|+.||........  ...+.......  
T Consensus       207 ~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~--~~~~~~~~~~~--  281 (355)
T 1vzo_A          207 KEFVADE-TERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNS--QAEISRRILKS--  281 (355)
T ss_dssp             EECCGGG-GGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCC--HHHHHHHHHHC--
T ss_pred             eecccCC-CCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccch--HHHHHHHHhcc--
Confidence            8643222 222334689999999999986  3478999999999999999999999975443221  12222211111  


Q ss_pred             chhhccCccccCccCHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 046893          325 KVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRP-----VMSDVVAL  370 (464)
Q Consensus       325 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~ev~~~  370 (464)
                            .+    .++...+..+.+||.+||..||.+||     ++.++++.
T Consensus       282 ------~~----~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h  322 (355)
T 1vzo_A          282 ------EP----PYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH  322 (355)
T ss_dssp             ------CC----CCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred             ------CC----CCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcC
Confidence                  11    12233445788999999999999999     88887653

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=6.5e-44  Score=358.25  Aligned_cols=265  Identities=20%  Similarity=0.228  Sum_probs=204.5

Q ss_pred             HhcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCccHHHHHHHHHHHhcCC--------CCCcceEE
Q 046893           90 ATKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLR--------HSNLVKLI  161 (464)
Q Consensus        90 ~~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--------hpniv~l~  161 (464)
                      ..++|++.+.||+|+||+||+|.+..+      ++.||||++... ......+.+|+.+|+.+.        |+||++++
T Consensus        35 ~~~~y~~~~~lg~G~~g~V~~~~~~~~------~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~  107 (397)
T 1wak_A           35 FNGRYHVIRKLGWGHFSTVWLSWDIQG------KKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLL  107 (397)
T ss_dssp             ETTTEEEEEEEEECSSEEEEEEEETTT------TEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEE
T ss_pred             cCCeEEEEEEeeecCCeeEEEEEecCC------CeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeee
Confidence            457899999999999999999998765      678999999753 223467889999999885        78899999


Q ss_pred             EEEE----eCCeEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCC-CeeeccCCCCceEecCCC
Q 046893          162 GYCC----EDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAER-PVIYRDFKTSNILLNADF  236 (464)
Q Consensus       162 ~~~~----~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~-~ivHrDlkp~Nill~~~~  236 (464)
                      +++.    .....+|||||+ +++|.+++.......+++..++.++.||+.||.|||  .+ +|+||||||+||||+.++
T Consensus       108 ~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH--~~~givHrDikp~NIll~~~~  184 (397)
T 1wak_A          108 DDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLH--TKCRIIHTDIKPENILLSVNE  184 (397)
T ss_dssp             EEEEEEETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHH--HTTCEECCCCSGGGEEECCCH
T ss_pred             cceeecCCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH--HhCCEecCCCCHHHeeEeccc
Confidence            9987    456889999999 667878777665567999999999999999999999  45 799999999999998775


Q ss_pred             -------------------------------------------------ceEEcccCCccCCCCCCCcceeeccccCCcc
Q 046893          237 -------------------------------------------------SAKLSDFGLAKDGPMGDQTHVSTRVMGTYGY  267 (464)
Q Consensus       237 -------------------------------------------------~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y  267 (464)
                                                                       .+||+|||+++.....     ....+||..|
T Consensus       185 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-----~~~~~gt~~y  259 (397)
T 1wak_A          185 QYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-----FTEDIQTRQY  259 (397)
T ss_dssp             HHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-----SCSCCSCGGG
T ss_pred             hhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc-----CccCCCCCcc
Confidence                                                             7999999999864321     2335799999


Q ss_pred             cCccccccCCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHH---Hhhhcc------------------cch
Q 046893          268 AAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWAR---PLLNNN------------------KKV  326 (464)
Q Consensus       268 ~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~---~~~~~~------------------~~~  326 (464)
                      +|||++.+..++.++|||||||+||||++|+.||................   ..+...                  ...
T Consensus       260 ~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~  339 (397)
T 1wak_A          260 RSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDL  339 (397)
T ss_dssp             CCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSB
T ss_pred             cCChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCcccc
Confidence            99999999999999999999999999999999997654332211111111   111000                  000


Q ss_pred             hhccCcc---------ccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 046893          327 LRILDPR---------LEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVA  369 (464)
Q Consensus       327 ~~~~~~~---------~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  369 (464)
                      ..+....         ....++...+..+.+||.+||+.||.+|||+.++++
T Consensus       340 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  391 (397)
T 1wak_A          340 KHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR  391 (397)
T ss_dssp             SSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred             ccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence            0000000         001235667788999999999999999999999875

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=8.5e-44  Score=367.49  Aligned_cols=252  Identities=23%  Similarity=0.320  Sum_probs=204.6

Q ss_pred             HhcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCC---CccHHHHHHHHHHHhcCCCCCcceEEEEEEe
Q 046893           90 ATKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGG---YQGDREWLAEVNYLGQLRHSNLVKLIGYCCE  166 (464)
Q Consensus        90 ~~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~  166 (464)
                      ..++|++.+.||+|+||+||+|.+..+      ++.||||++....   ......+.+|+.+|+.++||||+++++++..
T Consensus        24 ~~~~y~~~~~lg~G~~g~V~~~~~~~~------~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~   97 (484)
T 3nyv_A           24 FSDRYKGQRVLGKGSFGEVILCKDKIT------GQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFED   97 (484)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTT------CCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred             ccCceEEeeEEecCCCEEEEEEEECCC------CCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEe
Confidence            446799999999999999999998765      6779999986543   2345778999999999999999999999999


Q ss_pred             CCeEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEe---cCCCceEEccc
Q 046893          167 DEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILL---NADFSAKLSDF  243 (464)
Q Consensus       167 ~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill---~~~~~vkl~DF  243 (464)
                      .+..++||||+.+|+|.+++....  .+++..++.++.|++.||.|||  .++|+||||||+|||+   +.++.+||+||
T Consensus        98 ~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH--~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Df  173 (484)
T 3nyv_A           98 KGYFYLVGEVYTGGELFDEIISRK--RFSEVDAARIIRQVLSGITYMH--KNKIVHRDLKPENLLLESKSKDANIRIIDF  173 (484)
T ss_dssp             SSEEEEEECCCCSCBHHHHHHTCS--CCBHHHHHHHHHHHHHHHHHHH--HTTCCCSCCCGGGEEESSSSTTCCEEECCT
T ss_pred             CCEEEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH--HCCeeeCCCCHHHEEEecCCCCCcEEEEee
Confidence            999999999999999999887643  6999999999999999999999  5679999999999999   56789999999


Q ss_pred             CCccCCCCCCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhcc
Q 046893          244 GLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNN  323 (464)
Q Consensus       244 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~  323 (464)
                      |+++......   .....+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+....      +.........
T Consensus       174 g~a~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~------~~~~~i~~~~  243 (484)
T 3nyv_A          174 GLSTHFEASK---KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEY------DILKKVEKGK  243 (484)
T ss_dssp             THHHHBCCCC---SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHHCC
T ss_pred             eeeEEccccc---ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHH------HHHHHHHcCC
Confidence            9998643322   2234679999999998866 6999999999999999999999999865421      1111111110


Q ss_pred             cchhhccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 046893          324 KKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVA  369 (464)
Q Consensus       324 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  369 (464)
                      .        ..........+..+.+||.+||+.||.+|||+.++++
T Consensus       244 ~--------~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~  281 (484)
T 3nyv_A          244 Y--------TFELPQWKKVSESAKDLIRKMLTYVPSMRISARDALD  281 (484)
T ss_dssp             C--------CCCSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             C--------CCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhh
Confidence            0        0011111234558899999999999999999999985

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=2.3e-43  Score=365.97  Aligned_cols=252  Identities=21%  Similarity=0.289  Sum_probs=200.6

Q ss_pred             HhcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCC-------------ccHHHHHHHHHHHhcCCCCC
Q 046893           90 ATKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGY-------------QGDREWLAEVNYLGQLRHSN  156 (464)
Q Consensus        90 ~~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~-------------~~~~~~~~E~~~l~~l~hpn  156 (464)
                      ..++|++.+.||+|+||+||+|.+..+      +..||+|++.....             .....+.+|+.+|+.++|||
T Consensus        34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~------~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpn  107 (504)
T 3q5i_A           34 IGESYFKVRKLGSGAYGEVLLCKEKNG------HSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPN  107 (504)
T ss_dssp             GGGTEEEEEEEEC--CEEEEEEEETTT------CCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTT
T ss_pred             cccceEEEeEecccCCeEEEEEEECCC------CcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCC
Confidence            457799999999999999999998765      66799999875432             22467889999999999999


Q ss_pred             cceEEEEEEeCCeEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCC
Q 046893          157 LVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADF  236 (464)
Q Consensus       157 iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~  236 (464)
                      |+++++++.+....+||||||.+|+|.+++....  .+++..++.++.||+.||.|||  ..+|+||||||+|||++.++
T Consensus       108 iv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH--~~~ivH~Dlkp~Nil~~~~~  183 (504)
T 3q5i_A          108 IIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRH--KFDECDAANIMKQILSGICYLH--KHNIVHRDIKPENILLENKN  183 (504)
T ss_dssp             BCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGEEESSTT
T ss_pred             CCeEEEEEEcCCEEEEEEecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH--HCCeEeCCCcHHHEEEecCC
Confidence            9999999999999999999999999999887654  6999999999999999999999  56799999999999998776


Q ss_pred             ---ceEEcccCCccCCCCCCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHH
Q 046893          237 ---SAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLV  313 (464)
Q Consensus       237 ---~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~  313 (464)
                         .+||+|||+++......   .....+||+.|+|||++. ..++.++|||||||++|+|++|..||.+....      
T Consensus       184 ~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~------  253 (504)
T 3q5i_A          184 SLLNIKIVDFGLSSFFSKDY---KLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQ------  253 (504)
T ss_dssp             CCSSEEECCCTTCEECCTTS---CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------
T ss_pred             CCccEEEEECCCCEEcCCCC---ccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHH------
Confidence               69999999998653322   223467999999999876 56999999999999999999999999865421      


Q ss_pred             HHHHHhhhcccchhhccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 046893          314 EWARPLLNNNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVA  369 (464)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  369 (464)
                      +...........        .........+..+.+|+.+||..||.+|||+.++++
T Consensus       254 ~~~~~i~~~~~~--------~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~  301 (504)
T 3q5i_A          254 DIIKKVEKGKYY--------FDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALN  301 (504)
T ss_dssp             HHHHHHHHCCCC--------CCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             HHHHHHHcCCCC--------CCccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence            111111111000        000001123457899999999999999999999975

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.3e-43  Score=353.17  Aligned_cols=260  Identities=25%  Similarity=0.325  Sum_probs=194.8

Q ss_pred             hcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCc--cHHHHHHHHHHHhcCCCCCcceEEEEEEeCC
Q 046893           91 TKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQ--GDREWLAEVNYLGQLRHSNLVKLIGYCCEDE  168 (464)
Q Consensus        91 ~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~  168 (464)
                      .++|++.+.||+|+||.||+|.+..+      ++.||||++......  ..+.+.+|+++|+.++||||+++++++....
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~a~~~~~------~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~   97 (367)
T 1cm8_A           24 RAVYRDLQPVGSGAYGAVCSAVDGRT------GAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDE   97 (367)
T ss_dssp             BSSEEEEEEC------CEEEEEETTT------CCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCS
T ss_pred             cceEEEeEEeeecCCeEEEEEEECCC------CCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCC
Confidence            46789999999999999999998765      677999998654322  2356889999999999999999999998763


Q ss_pred             ------eEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcc
Q 046893          169 ------HRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSD  242 (464)
Q Consensus       169 ------~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~D  242 (464)
                            ..|+||||+ +++|.+++...   .+++..+..++.|++.||.|||  ..+|+||||||+|||++.++.+||+|
T Consensus        98 ~~~~~~~~~lv~e~~-~~~L~~~~~~~---~l~~~~~~~~~~qi~~~L~~LH--~~~ivH~Dlkp~NIll~~~~~~kl~D  171 (367)
T 1cm8_A           98 TLDDFTDFYLVMPFM-GTDLGKLMKHE---KLGEDRIQFLVYQMLKGLRYIH--AAGIIHRDLKPGNLAVNEDCELKILD  171 (367)
T ss_dssp             STTTCCCCEEEEECC-SEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCCGGGEEECTTCCEEECC
T ss_pred             ccccCceEEEEEecC-CCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH--HCCccccCcCHHHEEEcCCCCEEEEe
Confidence                  469999999 88999988653   5899999999999999999999  56799999999999999999999999


Q ss_pred             cCCccCCCCCCCcceeeccccCCcccCcccccc-CCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhh
Q 046893          243 FGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMT-GHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLN  321 (464)
Q Consensus       243 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~  321 (464)
                      ||+++....     .....+||..|+|||++.+ ..++.++|||||||++|||++|+.||.+......  +.........
T Consensus       172 fg~a~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~--l~~i~~~~g~  244 (367)
T 1cm8_A          172 FGLARQADS-----EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQ--LKEIMKVTGT  244 (367)
T ss_dssp             CTTCEECCS-----SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHHHHHCC
T ss_pred             eeccccccc-----ccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHhcCC
Confidence            999986432     1234689999999999887 6799999999999999999999999986542211  1111000000


Q ss_pred             cccch------------hhcc---CccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 046893          322 NNKKV------------LRIL---DPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVA  369 (464)
Q Consensus       322 ~~~~~------------~~~~---~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  369 (464)
                      .....            ...+   ............+..+.+|+.+||..||.+|||+.++++
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~  307 (367)
T 1cm8_A          245 PPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA  307 (367)
T ss_dssp             CCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             CCHHHHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhc
Confidence            00000            0000   000001122234568899999999999999999999876

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=7.3e-44  Score=344.83  Aligned_cols=254  Identities=22%  Similarity=0.374  Sum_probs=199.4

Q ss_pred             HhcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCccHHHHHHHHHHHhcCCCCCcceEEEEEEeCCe
Q 046893           90 ATKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVKLIGYCCEDEH  169 (464)
Q Consensus        90 ~~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~  169 (464)
                      ..++|++.+.||+|+||.||+|.+..+      +..||+|++..........+.+|+.++..++||||+++++++...+.
T Consensus        17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~------~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   90 (302)
T 2j7t_A           17 PNEVWEIVGELGDGAFGKVYKAKNKET------GALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGK   90 (302)
T ss_dssp             GGGTEEEEEEEECSTTCCEEEEEETTT------CCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-C
T ss_pred             CccceeecceeccCCCeEEEEEEEcCC------CcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCe
Confidence            346789999999999999999998764      66799999977666667889999999999999999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCccCC
Q 046893          170 RILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDG  249 (464)
Q Consensus       170 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~  249 (464)
                      .++||||+++++|.+++... ...+++..++.++.|++.||.|||  ..+|+||||||+|||++.++.+||+|||++...
T Consensus        91 ~~lv~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH--~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~  167 (302)
T 2j7t_A           91 LWIMIEFCPGGAVDAIMLEL-DRGLTEPQIQVVCRQMLEALNFLH--SKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKN  167 (302)
T ss_dssp             EEEEEECCTTEEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHH--HTTCCCCCCSGGGEEECTTSCEEECCCHHHHHH
T ss_pred             EEEEEEeCCCCcHHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHh--cCCcccCCCCHHHEEECCCCCEEEEECCCCccc
Confidence            99999999999999988654 346999999999999999999999  567999999999999999999999999987531


Q ss_pred             CCCCCcceeeccccCCcccCccccc-----cCCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhccc
Q 046893          250 PMGDQTHVSTRVMGTYGYAAPEYVM-----TGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNK  324 (464)
Q Consensus       250 ~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  324 (464)
                      .  ..........||..|+|||++.     +..++.++||||||+++|+|++|..||......      ...........
T Consensus       168 ~--~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~~~~~~~~~~~  239 (302)
T 2j7t_A          168 L--KTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM------RVLLKIAKSDP  239 (302)
T ss_dssp             H--HHHHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHH------HHHHHHHHSCC
T ss_pred             c--ccccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHH------HHHHHHhccCC
Confidence            1  0111122357999999999883     667899999999999999999999999764321      11111111100


Q ss_pred             chhhccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 046893          325 KVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVA  369 (464)
Q Consensus       325 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  369 (464)
                             +  ....+..++..+.+|+.+||+.||.+||++.++++
T Consensus       240 -------~--~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  275 (302)
T 2j7t_A          240 -------P--TLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLE  275 (302)
T ss_dssp             -------C--CCSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred             -------c--ccCCccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence                   0  00112234457899999999999999999999875

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=8.4e-44  Score=342.21  Aligned_cols=258  Identities=23%  Similarity=0.315  Sum_probs=189.3

Q ss_pred             HHhcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCcc-H-HHHHHHHHHHhcCCCCCcceEEEEEEe
Q 046893           89 LATKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQG-D-REWLAEVNYLGQLRHSNLVKLIGYCCE  166 (464)
Q Consensus        89 ~~~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~-~-~~~~~E~~~l~~l~hpniv~l~~~~~~  166 (464)
                      +..++|++.+.||+|+||+||+|.+..+      ++.||+|++....... . ..+..+...++.+.||||+++++++..
T Consensus         4 i~~~~y~~~~~lg~G~~g~V~~~~~~~~------~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~   77 (290)
T 3fme_A            4 VKADDLEPIMELGRGAYGVVEKMRHVPS------GQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFR   77 (290)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTT------TEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred             ccHHhhhhHHhcCCCCCeEEEEEEecCC------CeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeec
Confidence            3456799999999999999999998765      6789999987643222 2 234455556888899999999999999


Q ss_pred             CCeEEEEEeccCCCCHHHHHHhh--cCCCCCHHHHHHHHHHHHHHHHHHhcCCC-CeeeccCCCCceEecCCCceEEccc
Q 046893          167 DEHRILVYEYMESGSLEKHLLRR--VGCMLTWSRRMKIALDAAKGLAFLHGAER-PVIYRDFKTSNILLNADFSAKLSDF  243 (464)
Q Consensus       167 ~~~~~lv~e~~~~g~L~~~l~~~--~~~~l~~~~~~~i~~qi~~~l~~LH~~~~-~ivHrDlkp~Nill~~~~~vkl~DF  243 (464)
                      .+..++||||++ |+|.+++...  .+..+++..++.++.|++.||.|||  .+ +|+||||||+|||++.++.+||+||
T Consensus        78 ~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH--~~~~i~H~dlkp~Nil~~~~~~~kl~Df  154 (290)
T 3fme_A           78 EGDVWICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLH--SKLSVIHRDVKPSNVLINALGQVKMCDF  154 (290)
T ss_dssp             SSSEEEEEECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH--HHSCCCCCCCSGGGCEECTTCCEEBCCC
T ss_pred             cCCEEEEEehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHh--hcCCeecCCCCHHHEEECCCCCEEEeec
Confidence            999999999996 4888877542  3457999999999999999999999  45 7999999999999999999999999


Q ss_pred             CCccCCCCCCCcceeeccccCCcccCcccc----ccCCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHh
Q 046893          244 GLAKDGPMGDQTHVSTRVMGTYGYAAPEYV----MTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPL  319 (464)
Q Consensus       244 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~  319 (464)
                      |+++......   ......||+.|+|||++    .+..++.++||||||+++|+|++|+.||......    .... ...
T Consensus       155 g~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----~~~~-~~~  226 (290)
T 3fme_A          155 GISGYLVDDV---AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTP----FQQL-KQV  226 (290)
T ss_dssp             ------------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCH----HHHH-HHH
T ss_pred             CCcccccccc---cccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCch----HHHH-HHH
Confidence            9998643322   22335799999999996    5667899999999999999999999999753221    1111 111


Q ss_pred             hhcccchhhccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH--HHHH
Q 046893          320 LNNNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVA--LLET  373 (464)
Q Consensus       320 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~--~L~~  373 (464)
                      ....       .+.   ......+..+.+|+.+||+.||.+|||+.++++  .+..
T Consensus       227 ~~~~-------~~~---~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~  272 (290)
T 3fme_A          227 VEEP-------SPQ---LPADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTL  272 (290)
T ss_dssp             HHSC-------CCC---CCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHH
T ss_pred             hccC-------CCC---cccccCCHHHHHHHHHHhhcChhhCcCHHHHHhCccccc
Confidence            1110       010   111223457899999999999999999999986  4443

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=5.1e-43  Score=348.64  Aligned_cols=258  Identities=24%  Similarity=0.335  Sum_probs=204.8

Q ss_pred             hHHHHHhcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCc--------cHHHHHHHHHHHhcC-CCC
Q 046893           85 NEMKLATKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQ--------GDREWLAEVNYLGQL-RHS  155 (464)
Q Consensus        85 ~~~~~~~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l-~hp  155 (464)
                      .......++|.+.+.||+|+||.||+|.+..+      ++.||||++......        ....+.+|+.++..+ .||
T Consensus        87 ~~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~------g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp  160 (365)
T 2y7j_A           87 AAAKEFYQKYDPKDVIGRGVSSVVRRCVHRAT------GHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHP  160 (365)
T ss_dssp             HHHHHHHHHEEEEEEEEECSSEEEEEEEETTT------CCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCT
T ss_pred             hhhhhhhhhcccceEEecCCCEEEEEEEECCC------CcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCC
Confidence            34455567899999999999999999998754      667999998654321        124577899999999 799


Q ss_pred             CcceEEEEEEeCCeEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCC
Q 046893          156 NLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNAD  235 (464)
Q Consensus       156 niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~  235 (464)
                      ||+++++++......+|||||+.+++|.+++....  .+++..+..++.||+.||.|||  ..+|+||||||+|||++.+
T Consensus       161 ~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~--~l~~~~~~~i~~qi~~~L~~LH--~~gi~H~Dlkp~NIl~~~~  236 (365)
T 2y7j_A          161 HIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKV--ALSEKETRSIMRSLLEAVSFLH--ANNIVHRDLKPENILLDDN  236 (365)
T ss_dssp             TBCCEEEEEEBSSEEEEEECCCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGEEECTT
T ss_pred             CEeEEEEEEeeCCEEEEEEEeCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH--hCCeecCCCCHHHEEECCC
Confidence            99999999999999999999999999999987653  6999999999999999999999  5679999999999999999


Q ss_pred             CceEEcccCCccCCCCCCCcceeeccccCCcccCcccccc------CCCCcccchhcHHHHHHHHHhCCCCCCCCCCccc
Q 046893          236 FSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMT------GHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSRE  309 (464)
Q Consensus       236 ~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~  309 (464)
                      +.+||+|||++.......   .....+||+.|+|||++.+      ..++.++|||||||++|+|++|..||......  
T Consensus       237 ~~ikl~DfG~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~--  311 (365)
T 2y7j_A          237 MQIRLSDFGFSCHLEPGE---KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQI--  311 (365)
T ss_dssp             CCEEECCCTTCEECCTTC---CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH--
T ss_pred             CCEEEEecCcccccCCCc---ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHH--
Confidence            999999999998654322   2234689999999998864      35889999999999999999999999764321  


Q ss_pred             ccHHHHHHHhhhcccchhhccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 046893          310 HNLVEWARPLLNNNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVA  369 (464)
Q Consensus       310 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  369 (464)
                          .............   ..+.     ....+..+.+|+.+||+.||.+||++.++++
T Consensus       312 ----~~~~~i~~~~~~~---~~~~-----~~~~~~~~~~li~~~L~~dP~~Rps~~ell~  359 (365)
T 2y7j_A          312 ----LMLRMIMEGQYQF---SSPE-----WDDRSSTVKDLISRLLQVDPEARLTAEQALQ  359 (365)
T ss_dssp             ----HHHHHHHHTCCCC---CHHH-----HSSSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             ----HHHHHHHhCCCCC---CCcc-----cccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence                1111111110000   0000     0112347899999999999999999999875

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=4.6e-44  Score=346.08  Aligned_cols=264  Identities=23%  Similarity=0.352  Sum_probs=186.5

Q ss_pred             HHHhcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCC-ccHHHHHHHHHHHhcCCCCCcceEEEEEEe
Q 046893           88 KLATKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGY-QGDREWLAEVNYLGQLRHSNLVKLIGYCCE  166 (464)
Q Consensus        88 ~~~~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~  166 (464)
                      .+..++|++.+.||+|+||.||+|.+..+      ++.||||++..... .....+.+|+.++..++||||+++++++..
T Consensus        11 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~------~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   84 (303)
T 2vwi_A           11 SINRDDYELQEVIGSGATAVVQAAYCAPK------KEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVV   84 (303)
T ss_dssp             --CCCCCEEEEECC---CCCEEEEEC----------CEEEEECCC----------------CCCCCCCTTBCCEEEEEES
T ss_pred             ccchhhhhhhheeccccceEEEEEEECCC------CcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEee
Confidence            44567899999999999999999987654      56799999865432 234668899999999999999999999999


Q ss_pred             CCeEEEEEeccCCCCHHHHHHhh------cCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEE
Q 046893          167 DEHRILVYEYMESGSLEKHLLRR------VGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKL  240 (464)
Q Consensus       167 ~~~~~lv~e~~~~g~L~~~l~~~------~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl  240 (464)
                      .+..++||||+++++|.+++...      ....+++..++.++.|++.||.|||  ..+|+||||||+|||++.++.+||
T Consensus        85 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH--~~~i~H~dl~p~Nil~~~~~~~kl  162 (303)
T 2vwi_A           85 KDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLH--KNGQIHRDVKAGNILLGEDGSVQI  162 (303)
T ss_dssp             SSCEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHH--HTTCCCCCCSGGGEEECTTCCEEE
T ss_pred             cCCcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHH--hCCCCCCCCChhhEEEcCCCCEEE
Confidence            99999999999999999988642      2346899999999999999999999  567999999999999999999999


Q ss_pred             cccCCccCCCCCCC---cceeeccccCCcccCcccccc-CCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHH
Q 046893          241 SDFGLAKDGPMGDQ---THVSTRVMGTYGYAAPEYVMT-GHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWA  316 (464)
Q Consensus       241 ~DFGla~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~  316 (464)
                      +|||++........   ........||+.|+|||++.+ ..++.++||||||+++|+|++|+.||.........  ..  
T Consensus       163 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~--~~--  238 (303)
T 2vwi_A          163 ADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVL--ML--  238 (303)
T ss_dssp             CCCHHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHH--HH--
T ss_pred             EeccchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHH--HH--
Confidence            99999875433211   112234679999999998876 56899999999999999999999999765432211  00  


Q ss_pred             HHhhhcc-cchh-hccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 046893          317 RPLLNNN-KKVL-RILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVA  369 (464)
Q Consensus       317 ~~~~~~~-~~~~-~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  369 (464)
                        ..... .... ...+..    .....+..+.+|+.+||+.||.+||++.++++
T Consensus       239 --~~~~~~~~~~~~~~~~~----~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  287 (303)
T 2vwi_A          239 --TLQNDPPSLETGVQDKE----MLKKYGKSFRKMISLCLQKDPEKRPTAAELLR  287 (303)
T ss_dssp             --HHTSSCCCTTC-----C----CCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             --HhccCCCccccccccch----hhhhhhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence              11111 0000 001111    11223457899999999999999999999975

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=4e-43  Score=344.09  Aligned_cols=258  Identities=18%  Similarity=0.275  Sum_probs=199.1

Q ss_pred             cCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCccHHHHHHHHHHHhcCC-CCCcceEEEEEEe--CC
Q 046893           92 KFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLR-HSNLVKLIGYCCE--DE  168 (464)
Q Consensus        92 ~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~--~~  168 (464)
                      ++|++.+.||+|+||+||+|.+..+      ++.||||++...   ....+.+|+.+|+.+. ||||+++++++..  ..
T Consensus        36 ~~y~~~~~lg~G~~g~V~~~~~~~~------~~~vavK~~~~~---~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~  106 (330)
T 3nsz_A           36 DDYQLVRKLGRGKYSEVFEAINITN------NEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSR  106 (330)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTT------CCEEEEEEECSC---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTC
T ss_pred             CceEEEEEecccCCeEEEEEEECCC------CcEEEEEEeccc---chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCC
Confidence            5689999999999999999998765      667999998743   3577899999999997 9999999999998  66


Q ss_pred             eEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCC-ceEEcccCCcc
Q 046893          169 HRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADF-SAKLSDFGLAK  247 (464)
Q Consensus       169 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~-~vkl~DFGla~  247 (464)
                      ..++||||+.+++|.+++.     .+++..+..++.|++.||.|||  .++|+||||||+|||++.++ .+||+|||+++
T Consensus       107 ~~~lv~e~~~~~~l~~~~~-----~~~~~~~~~~~~qi~~~l~~lH--~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~  179 (330)
T 3nsz_A          107 TPALVFEHVNNTDFKQLYQ-----TLTDYDIRFYMYEILKALDYCH--SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAE  179 (330)
T ss_dssp             CEEEEEECCCCCCHHHHGG-----GCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred             ceEEEEeccCchhHHHHHH-----hCCHHHHHHHHHHHHHHHHHHH--hCCeeeCCCCHHHEEEcCCCCEEEEEeCCCce
Confidence            8899999999999988764     3899999999999999999999  56799999999999998776 89999999998


Q ss_pred             CCCCCCCcceeeccccCCcccCcccccc-CCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHh-------
Q 046893          248 DGPMGDQTHVSTRVMGTYGYAAPEYVMT-GHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPL-------  319 (464)
Q Consensus       248 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~-------  319 (464)
                      .......   .....||..|+|||++.+ ..++.++|||||||+||+|++|+.||........ .+.......       
T Consensus       180 ~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~-~l~~~~~~~~~~~~~~  255 (330)
T 3nsz_A          180 FYHPGQE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYD-QLVRIAKVLGTEDLYD  255 (330)
T ss_dssp             ECCTTCC---CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHH-HHHHHHHHHCHHHHHH
T ss_pred             EcCCCCc---cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHH-HHHHHHHhcCCchhhh
Confidence            6433222   234679999999999877 6799999999999999999999999965432211 111110000       


Q ss_pred             -hhc-c----cchhhcc--------CccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 046893          320 -LNN-N----KKVLRIL--------DPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVA  369 (464)
Q Consensus       320 -~~~-~----~~~~~~~--------~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  369 (464)
                       +.. .    ......+        ............+..+.+||.+||+.||.+|||+.++++
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~  319 (330)
T 3nsz_A          256 YIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME  319 (330)
T ss_dssp             HHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             HHHHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence             000 0    0000000        000111112224568999999999999999999999975

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=4.2e-43  Score=347.20  Aligned_cols=265  Identities=23%  Similarity=0.303  Sum_probs=198.8

Q ss_pred             cCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCc--cHHHHHHHHHHHhcCCCCCcceEEEEEEe---
Q 046893           92 KFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQ--GDREWLAEVNYLGQLRHSNLVKLIGYCCE---  166 (464)
Q Consensus        92 ~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpniv~l~~~~~~---  166 (464)
                      ++|++.+.||+|+||+||+|.+..+      ++.||||++......  ....+.+|+.+|+.++||||+++++++..   
T Consensus        17 ~~y~~~~~lg~G~~g~V~~~~~~~~------~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   90 (351)
T 3mi9_A           17 SKYEKLAKIGQGTFGEVFKARHRKT------GQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKAS   90 (351)
T ss_dssp             GGEEEEEECSSCSTTSEEEEEETTT------CCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--
T ss_pred             cceeEEEEEecCCCcEEEEEEECCC------CCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeecccc
Confidence            5688999999999999999998765      667999998654322  23678899999999999999999999987   


Q ss_pred             -----CCeEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEc
Q 046893          167 -----DEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLS  241 (464)
Q Consensus       167 -----~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~  241 (464)
                           .+..++||||+.+ +|.+.+.... ..+++..+..++.|++.||.|||  .++|+||||||+|||++.++.+||+
T Consensus        91 ~~~~~~~~~~lv~e~~~~-~l~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH--~~~ivH~Dlkp~NIl~~~~~~~kl~  166 (351)
T 3mi9_A           91 PYNRCKGSIYLVFDFCEH-DLAGLLSNVL-VKFTLSEIKRVMQMLLNGLYYIH--RNKILHRDMKAANVLITRDGVLKLA  166 (351)
T ss_dssp             ------CEEEEEEECCSE-EHHHHHHCTT-SCCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEECTTSCEEEC
T ss_pred             ccccCCceEEEEEeccCC-CHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHH--HCCeeCCCCCHHHEEEcCCCCEEEc
Confidence                 4468999999975 7877776543 46999999999999999999999  5679999999999999999999999


Q ss_pred             ccCCccCCCCCC--CcceeeccccCCcccCcccccc-CCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHH
Q 046893          242 DFGLAKDGPMGD--QTHVSTRVMGTYGYAAPEYVMT-GHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARP  318 (464)
Q Consensus       242 DFGla~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~  318 (464)
                      |||+++......  .........||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+........   ....
T Consensus       167 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~---~i~~  243 (351)
T 3mi9_A          167 DFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLA---LISQ  243 (351)
T ss_dssp             CCTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH---HHHH
T ss_pred             cchhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHH---HHHH
Confidence            999998643221  1122334679999999998876 468999999999999999999999998654321111   1111


Q ss_pred             hhhcc-cch---------hhccCcc--ccCccCH-----HHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 046893          319 LLNNN-KKV---------LRILDPR--LEGQYTA-----RTAMKVAGLAYQCLSQNPKGRPVMSDVVA  369 (464)
Q Consensus       319 ~~~~~-~~~---------~~~~~~~--~~~~~~~-----~~~~~l~~li~~cl~~dP~~RPs~~ev~~  369 (464)
                      ..... ...         ...+...  .......     ..+..+.+||.+||+.||.+|||+.++++
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  311 (351)
T 3mi9_A          244 LCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN  311 (351)
T ss_dssp             HHCCCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HhCCCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhC
Confidence            10000 000         0000000  0000000     01346889999999999999999999875

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=4.6e-43  Score=355.43  Aligned_cols=260  Identities=25%  Similarity=0.347  Sum_probs=194.1

Q ss_pred             cCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCccHHHHHHHHHHHhcCCCCCcceEEEEEEeC----
Q 046893           92 KFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVKLIGYCCED----  167 (464)
Q Consensus        92 ~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~----  167 (464)
                      .+|++.+.||+|+||+||+|.+..+      ++.||||++.....    .+.+|+++|+.++||||++++++|...    
T Consensus        54 ~~y~~~~~lG~G~fg~Vy~~~~~~~------~~~vaiK~~~~~~~----~~~~E~~il~~l~hpniv~l~~~~~~~~~~~  123 (420)
T 1j1b_A           54 VSYTDTKVIGNGSFGVVYQAKLCDS------GELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKK  123 (420)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTT------CCEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEEETTT
T ss_pred             ceEEeeeEEeeCCCEEEEEEEECCC------CcEEEEEEecccch----hHHHHHHHHHHcCCCCccceeeEEeccCCCC
Confidence            3588889999999999999998765      67799999865422    234799999999999999999988542    


Q ss_pred             --CeEEEEEeccCCCCHHHHHHh--hcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCC-CceEEcc
Q 046893          168 --EHRILVYEYMESGSLEKHLLR--RVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNAD-FSAKLSD  242 (464)
Q Consensus       168 --~~~~lv~e~~~~g~L~~~l~~--~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~-~~vkl~D  242 (464)
                        ...++||||+.+ +|.+.+..  .....+++..+..++.||+.||.|||  ..+|+||||||+||||+.+ +.+||+|
T Consensus       124 ~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH--~~~ivHrDlkp~NILl~~~~~~~kl~D  200 (420)
T 1j1b_A          124 DEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH--SFGICHRDIKPQNLLLDPDTAVLKLCD  200 (420)
T ss_dssp             TEEEEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH--TTTEECSCCSGGGEEEETTTTEEEECC
T ss_pred             cceeEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH--HCCccccCCChhhEEEeCCCCeEEecc
Confidence              246799999975 67666543  23457999999999999999999999  6779999999999999865 5689999


Q ss_pred             cCCccCCCCCCCcceeeccccCCcccCccccccC-CCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhh
Q 046893          243 FGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTG-HLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLN  321 (464)
Q Consensus       243 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~  321 (464)
                      ||+++.......   ....+||..|+|||++.+. .++.++|||||||+||||++|+.||.+....  ..+.+....+-.
T Consensus       201 FG~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~--~~l~~i~~~lg~  275 (420)
T 1j1b_A          201 FGSAKQLVRGEP---NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGV--DQLVEIIKVLGT  275 (420)
T ss_dssp             CTTCEECCTTCC---CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHHHHCS
T ss_pred             chhhhhcccCCC---ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHHhCC
Confidence            999986533221   2346799999999998765 7999999999999999999999999875421  122222211100


Q ss_pred             cccc--------hhhccCccc-----cCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 046893          322 NNKK--------VLRILDPRL-----EGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVA  369 (464)
Q Consensus       322 ~~~~--------~~~~~~~~~-----~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  369 (464)
                      ....        ......+.+     ...+....+.++.+||.+||..||.+||++.++++
T Consensus       276 p~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~  336 (420)
T 1j1b_A          276 PTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA  336 (420)
T ss_dssp             CCHHHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             CCHHHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhC
Confidence            0000        000000110     01122334568999999999999999999999875

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=1.1e-42  Score=332.15  Aligned_cols=249  Identities=24%  Similarity=0.324  Sum_probs=195.5

Q ss_pred             HhcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCC---CccHHHHHHHHHHHhcCCCCCcceEEEEEEe
Q 046893           90 ATKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGG---YQGDREWLAEVNYLGQLRHSNLVKLIGYCCE  166 (464)
Q Consensus        90 ~~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~  166 (464)
                      ..++|++.+.||+|+||.||+|.+..+      ++.||||++....   ......+.+|+.+++.++||||+++++++..
T Consensus         9 ~~~~y~i~~~lg~G~~g~V~~~~~~~~------~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   82 (276)
T 2h6d_A            9 KIGHYVLGDTLGVGTFGKVKIGEHQLT------GHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVIST   82 (276)
T ss_dssp             EETTEEEEEEEEECSSEEEEEEEETTT------CCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC
T ss_pred             eeccEEEEeeecCCCCeEEEEEEECCC------CceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEec
Confidence            346789999999999999999998754      5679999986432   2234578899999999999999999999999


Q ss_pred             CCeEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCc
Q 046893          167 DEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLA  246 (464)
Q Consensus       167 ~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla  246 (464)
                      .+..++||||+.+++|.+++....  .+++..++.++.|++.||.|||  ..+|+||||||+|||++.++.+||+|||++
T Consensus        83 ~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH--~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~  158 (276)
T 2h6d_A           83 PTDFFMVMEYVSGGELFDYICKHG--RVEEMEARRLFQQILSAVDYCH--RHMVVHRDLKPENVLLDAHMNAKIADFGLS  158 (276)
T ss_dssp             SSEEEEEEECCCSCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHH--HHCSSCCCCCGGGEEECTTSCEEECCCCGG
T ss_pred             CCeEEEEEeccCCCcHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHH--HCCCccCCCChhhEEECCCCCEEEeecccc
Confidence            999999999999999999987653  5899999999999999999999  567999999999999999999999999999


Q ss_pred             cCCCCCCCcceeeccccCCcccCccccccCCC-CcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhcccc
Q 046893          247 KDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHL-TARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKK  325 (464)
Q Consensus       247 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  325 (464)
                      .......   ......||+.|+|||++.+..+ +.++||||||+++|+|++|+.||......      ..........  
T Consensus       159 ~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~------~~~~~~~~~~--  227 (276)
T 2h6d_A          159 NMMSDGE---FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVP------TLFKKIRGGV--  227 (276)
T ss_dssp             GCCCC----------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHHCC--
T ss_pred             cccCCCc---ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHH------HHHHHhhcCc--
Confidence            8643322   2234579999999999987765 68999999999999999999999754311      1111111110  


Q ss_pred             hhhccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 046893          326 VLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVA  369 (464)
Q Consensus       326 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  369 (464)
                            .    ..+...+..+.+|+.+||+.||.+||++.++++
T Consensus       228 ------~----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~  261 (276)
T 2h6d_A          228 ------F----YIPEYLNRSVATLLMHMLQVDPLKRATIKDIRE  261 (276)
T ss_dssp             ------C----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ------c----cCchhcCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence                  0    112223457899999999999999999999986

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=8.7e-43  Score=347.75  Aligned_cols=261  Identities=21%  Similarity=0.279  Sum_probs=192.3

Q ss_pred             hcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCc--cHHHHHHHHHHHhcCCCCCcceEEEEEEeCC
Q 046893           91 TKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQ--GDREWLAEVNYLGQLRHSNLVKLIGYCCEDE  168 (464)
Q Consensus        91 ~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~  168 (464)
                      .++|++.+.||+|+||.||+|.+..+      ++.||||++......  ....+.+|+.+++.++||||+++++++...+
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~~~~~~~------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~   97 (371)
T 2xrw_A           24 LKRYQNLKPIGSGAQGIVCAAYDAIL------ERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQK   97 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTT------TEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCC
T ss_pred             hhheeEeeeeEecCCEEEEEEEECCC------CceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccc
Confidence            46799999999999999999998765      677999998754322  2356889999999999999999999997765


Q ss_pred             ------eEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcc
Q 046893          169 ------HRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSD  242 (464)
Q Consensus       169 ------~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~D  242 (464)
                            ..++||||+.+ +|.+++..    .+++..+..++.|++.||.|||  .++|+||||||+|||++.++.+||+|
T Consensus        98 ~~~~~~~~~lv~e~~~~-~l~~~~~~----~~~~~~~~~i~~qi~~al~~lH--~~~ivH~Dlkp~NIl~~~~~~~kl~D  170 (371)
T 2xrw_A           98 SLEEFQDVYIVMELMDA-NLCQVIQM----ELDHERMSYLLYQMLCGIKHLH--SAGIIHRDLKPSNIVVKSDCTLKILD  170 (371)
T ss_dssp             STTTCCEEEEEEECCSE-EHHHHHHS----CCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCCGGGEEECTTSCEEECC
T ss_pred             ccccccceEEEEEcCCC-CHHHHHhh----ccCHHHHHHHHHHHHHHHHHHH--HCCeecccCCHHHEEEcCCCCEEEEE
Confidence                  78999999965 78887742    4899999999999999999999  56799999999999999999999999


Q ss_pred             cCCccCCCCCCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHH-----
Q 046893          243 FGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWAR-----  317 (464)
Q Consensus       243 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~-----  317 (464)
                      ||+++.....   .......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+......  +.....     
T Consensus       171 fg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~--~~~i~~~~~~~  245 (371)
T 2xrw_A          171 FGLARTAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQ--WNKVIEQLGTP  245 (371)
T ss_dssp             CCC-------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHHC-CCCC
T ss_pred             eecccccccc---cccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHHhCCC
Confidence            9999864321   122346899999999999999999999999999999999999999976542111  000000     


Q ss_pred             -------------Hhhhcccc-----hhhccCccc---cCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 046893          318 -------------PLLNNNKK-----VLRILDPRL---EGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVA  369 (464)
Q Consensus       318 -------------~~~~~~~~-----~~~~~~~~~---~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  369 (464)
                                   ........     ....+....   ........+..+.+|+.+||..||.+|||+.++++
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~  318 (371)
T 2xrw_A          246 CPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ  318 (371)
T ss_dssp             CHHHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             CHHHHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhC
Confidence                         00000000     000000000   00112234678999999999999999999999975

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=2.1e-43  Score=345.24  Aligned_cols=253  Identities=23%  Similarity=0.310  Sum_probs=196.7

Q ss_pred             HhcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCC--------ccHHHHHHHHHHHhcCCCCCcceEE
Q 046893           90 ATKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGY--------QGDREWLAEVNYLGQLRHSNLVKLI  161 (464)
Q Consensus        90 ~~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~hpniv~l~  161 (464)
                      ..++|++.+.||+|+||.||+|.+..+      ++.||||++.....        .....+.+|+.+|+.++||||++++
T Consensus         8 l~~~y~~~~~lg~G~~g~V~~~~~~~~------~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~   81 (322)
T 2ycf_A            8 LRDEYIMSKTLGSGACGEVKLAFERKT------CKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIK   81 (322)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTT------TEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEE
T ss_pred             hhhceeEeeEEecCCCEEEEEEEEcCC------CcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEe
Confidence            456799999999999999999998765      67899999875422        1123478999999999999999999


Q ss_pred             EEEEeCCeEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCc---e
Q 046893          162 GYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFS---A  238 (464)
Q Consensus       162 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~---v  238 (464)
                      +++.... .++||||+.+++|.+++...  ..+++..++.++.|++.||.|||  .++|+||||||+|||++.++.   +
T Consensus        82 ~~~~~~~-~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH--~~~ivH~dlkp~NIl~~~~~~~~~~  156 (322)
T 2ycf_A           82 NFFDAED-YYIVLELMEGGELFDKVVGN--KRLKEATCKLYFYQMLLAVQYLH--ENGIIHRDLKPENVLLSSQEEDCLI  156 (322)
T ss_dssp             EEEESSS-EEEEEECCTTEETHHHHSTT--CCCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEESSSSSSCCE
T ss_pred             eEEcCCc-eEEEEecCCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHH--HCCeeccCCCHHHEEEecCCCCCeE
Confidence            9987665 89999999999999988654  36999999999999999999999  567999999999999987654   9


Q ss_pred             EEcccCCccCCCCCCCcceeeccccCCcccCccccc---cCCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHH
Q 046893          239 KLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVM---TGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEW  315 (464)
Q Consensus       239 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~  315 (464)
                      ||+|||+++.....   .......||..|+|||++.   +..++.++|||||||++|+|++|..||.......  .+...
T Consensus       157 kl~Dfg~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--~~~~~  231 (322)
T 2ycf_A          157 KITDFGHSKILGET---SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV--SLKDQ  231 (322)
T ss_dssp             EECCCTTCEECCCC---HHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSS--CHHHH
T ss_pred             EEccCccceecccc---cccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHH--HHHHH
Confidence            99999999864321   1223467999999999874   4678999999999999999999999997644321  11111


Q ss_pred             HHHhhhcccchhhccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 046893          316 ARPLLNNNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVA  369 (464)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  369 (464)
                      ..   .....    ..+.    .....+..+.+|+.+||..||.+||++.++++
T Consensus       232 ~~---~~~~~----~~~~----~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~  274 (322)
T 2ycf_A          232 IT---SGKYN----FIPE----VWAEVSEKALDLVKKLLVVDPKARFTTEEALR  274 (322)
T ss_dssp             HH---HTCCC----CCHH----HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             HH---hCccc----cCch----hhhhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence            11   00000    0000    11123458899999999999999999999875

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=9.1e-43  Score=348.96  Aligned_cols=205  Identities=24%  Similarity=0.257  Sum_probs=175.2

Q ss_pred             HHHhcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCccHHHHHHHHHHHhcCC-CC-----CcceEE
Q 046893           88 KLATKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLR-HS-----NLVKLI  161 (464)
Q Consensus        88 ~~~~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hp-----niv~l~  161 (464)
                      ....++|++.+.||+|+||+||+|.+..+      ++.||||++... ......+..|+.++..+. |+     +|++++
T Consensus        50 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~------~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~  122 (382)
T 2vx3_A           50 EKWMDRYEIDSLIGKGSFGQVVKAYDRVE------QEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLK  122 (382)
T ss_dssp             CEETTTEEEEEEEEEETTEEEEEEEETTT------TEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEE
T ss_pred             CEeeeeEEEEEEEeecCCEEEEEEEEcCC------CcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEee
Confidence            44567899999999999999999998765      678999999743 122356778888888874 55     499999


Q ss_pred             EEEEeCCeEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEec--CCCceE
Q 046893          162 GYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLN--ADFSAK  239 (464)
Q Consensus       162 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~--~~~~vk  239 (464)
                      +++...+..+|||||+. ++|.+++.......+++..+..++.|++.||.|||+++.+|+||||||+||||+  .++.+|
T Consensus       123 ~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~k  201 (382)
T 2vx3_A          123 RHFMFRNHLCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIK  201 (382)
T ss_dssp             EEEEETTEEEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEE
T ss_pred             eeeccCCceEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEE
Confidence            99999999999999995 599999987655569999999999999999999997667899999999999994  577899


Q ss_pred             EcccCCccCCCCCCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHhCCCCCCCCC
Q 046893          240 LSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSR  305 (464)
Q Consensus       240 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~  305 (464)
                      |+|||+++.....     .....||+.|+|||++.+..++.++|||||||+||||++|+.||.+..
T Consensus       202 L~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~  262 (382)
T 2vx3_A          202 IVDFGSSCQLGQR-----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGAN  262 (382)
T ss_dssp             ECCCTTCEETTCC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             EEeccCceecccc-----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence            9999999864321     234689999999999999999999999999999999999999998654

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=2.9e-43  Score=375.13  Aligned_cols=266  Identities=23%  Similarity=0.346  Sum_probs=209.6

Q ss_pred             HHHHHhcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCc-cHHHHHHHHHHHhcCCCCCcceEEEEE
Q 046893           86 EMKLATKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQ-GDREWLAEVNYLGQLRHSNLVKLIGYC  164 (464)
Q Consensus        86 ~~~~~~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~  164 (464)
                      +..+..++|++.+.||+|+||+||+|.+.....   .+..||||.+...... ..+.+.+|+.+|+.++||||+++++++
T Consensus       384 ~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~  460 (656)
T 2j0j_A          384 DYEIQRERIELGRCIGEGQFGDVHQGIYMSPEN---PAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVI  460 (656)
T ss_dssp             GTBCCGGGEEEEEEEECCSSCCEEEEEECCSSS---CCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             ccccccccEEEeeEEeeCCCEEEEEEEEecCCC---ccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence            344556779999999999999999999865422   3567999998754332 236789999999999999999999998


Q ss_pred             EeCCeEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccC
Q 046893          165 CEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFG  244 (464)
Q Consensus       165 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFG  244 (464)
                      . ++..++||||+.+|+|.+++... ...+++..++.++.|++.||.|||  .++|+||||||+|||++.++.+||+|||
T Consensus       461 ~-~~~~~lv~E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH--~~givHrDikp~NILl~~~~~vkL~DFG  536 (656)
T 2j0j_A          461 T-ENPVWIIMELCTLGELRSFLQVR-KFSLDLASLILYAYQLSTALAYLE--SKRFVHRDIAARNVLVSSNDCVKLGDFG  536 (656)
T ss_dssp             C-SSSCEEEEECCTTCBHHHHHHHT-TTTCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCSGGGEEEEETTEEEECCCC
T ss_pred             e-cCceEEEEEcCCCCcHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHH--hCCccccccchHhEEEeCCCCEEEEecC
Confidence            4 56689999999999999998754 346899999999999999999999  5679999999999999999999999999


Q ss_pred             CccCCCCCCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHhhhcc
Q 046893          245 LAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLL-GRRAVDKSRPSREHNLVEWARPLLNNN  323 (464)
Q Consensus       245 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~  323 (464)
                      +++....... .......||+.|+|||++.+..++.++|||||||++|||++ |..||.+.....   ...   ..... 
T Consensus       537 ~a~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~---~~~---~i~~~-  608 (656)
T 2j0j_A          537 LSRYMEDSTY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND---VIG---RIENG-  608 (656)
T ss_dssp             CCCSCCC-----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH---HHH---HHHHT-
T ss_pred             CCeecCCCcc-eeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHH---HHH---HHHcC-
Confidence            9986533222 12233567889999999999999999999999999999997 999997643211   111   11111 


Q ss_pred             cchhhccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHh
Q 046893          324 KKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETVQS  376 (464)
Q Consensus       324 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~~~  376 (464)
                                .....+..++..+.+||.+||..||.+||++.+|++.|+.+..
T Consensus       609 ----------~~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~  651 (656)
T 2j0j_A          609 ----------ERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE  651 (656)
T ss_dssp             ----------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ----------CCCCCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHH
Confidence                      0111233455689999999999999999999999999998764

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=1.1e-42  Score=346.06  Aligned_cols=264  Identities=25%  Similarity=0.313  Sum_probs=200.4

Q ss_pred             hcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCcc-HHHHHHHHHHHhcCCCCCcceEEEEEEeC--
Q 046893           91 TKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQG-DREWLAEVNYLGQLRHSNLVKLIGYCCED--  167 (464)
Q Consensus        91 ~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~hpniv~l~~~~~~~--  167 (464)
                      ..+|++.+.||+|+||.||+|.+..+      +..||||++....... ...+.+|+++|..++||||+++++++...  
T Consensus        26 ~~~y~~~~~lG~G~~g~V~~~~~~~~------~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~   99 (364)
T 3qyz_A           26 GPRYTNLSYIGEGAYGMVCSAYDNLN------KVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTI   99 (364)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTT------TEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSST
T ss_pred             cccEEEEEEeecCCCeEEEEEEECCC------CeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCc
Confidence            45799999999999999999998765      6789999987543322 36788999999999999999999999765  


Q ss_pred             ---CeEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccC
Q 046893          168 ---EHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFG  244 (464)
Q Consensus       168 ---~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFG  244 (464)
                         ...++||||+. ++|.+++...   .+++..++.++.|++.||.|||  .++|+||||||+|||++.++.+||+|||
T Consensus       100 ~~~~~~~iv~e~~~-~~L~~~l~~~---~~~~~~~~~i~~qi~~aL~~LH--~~~ivH~Dikp~NIl~~~~~~~kl~Dfg  173 (364)
T 3qyz_A          100 EQMKDVYIVQDLME-TDLYKLLKTQ---HLSNDHICYFLYQILRGLKYIH--SANVLHRDLKPSNLLLNTTCDLKICDFG  173 (364)
T ss_dssp             TTCCCEEEEEECCS-EEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCCGGGEEECTTCCEEECCCT
T ss_pred             cccceEEEEEcccC-cCHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHH--HCCeecCCCChHhEEECCCCCEEEEeCc
Confidence               36899999996 5999988653   5999999999999999999999  5679999999999999999999999999


Q ss_pred             CccCCCCCCC-cceeeccccCCcccCcccccc-CCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhc
Q 046893          245 LAKDGPMGDQ-THVSTRVMGTYGYAAPEYVMT-GHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNN  322 (464)
Q Consensus       245 la~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~  322 (464)
                      +++....... .......+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.........   ....+..
T Consensus       174 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~---i~~~~~~  250 (364)
T 3qyz_A          174 LARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNH---ILGILGS  250 (364)
T ss_dssp             TCEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHH---HHHHHCS
T ss_pred             ceEecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHH---HHHHhCC
Confidence            9986432211 111234689999999998764 4589999999999999999999999977543322111   1100000


Q ss_pred             c-cc-h------------hhccCc--cccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 046893          323 N-KK-V------------LRILDP--RLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVA  369 (464)
Q Consensus       323 ~-~~-~------------~~~~~~--~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  369 (464)
                      . .. +            ......  ..........+..+.+||.+||..||.+|||+.++++
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  313 (364)
T 3qyz_A          251 PSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA  313 (364)
T ss_dssp             CCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             CCHHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            0 00 0            000000  0000111223457899999999999999999999875

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=2.3e-43  Score=351.91  Aligned_cols=253  Identities=12%  Similarity=0.026  Sum_probs=182.4

Q ss_pred             cCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCcc---HHHHHHHH---HHHhcCCCCCcceEE----
Q 046893           92 KFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQG---DREWLAEV---NYLGQLRHSNLVKLI----  161 (464)
Q Consensus        92 ~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~---~~l~~l~hpniv~l~----  161 (464)
                      ..|.+.+.||+|+||+||+|.+..+      ++.||||++.......   ...+.+|+   .+|+. +||||++++    
T Consensus        62 ~~y~~~~~lG~G~~g~V~~~~~~~~------~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~-~hp~iv~~~~~~~  134 (371)
T 3q60_A           62 RKLKLVEPLRVGDRSVVFLVRDVER------LEDFALKVFTMGAENSRSELERLHEATFAAARLLG-ESPEEARDRRRLL  134 (371)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTT------TEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC-----------CBC
T ss_pred             eeeeeeeeccCCCCEEEEEEEECCC------CceeEEEEEEecccccccHHHHHHHHHHHHHHhcc-cChhhhhhceeEE
Confidence            3478889999999999999998765      6789999998754322   34567774   45555 799988755    


Q ss_pred             ---EEEEeC-----------------CeEEEEEeccCCCCHHHHHHhhcCCCCCHHHH------HHHHHHHHHHHHHHhc
Q 046893          162 ---GYCCED-----------------EHRILVYEYMESGSLEKHLLRRVGCMLTWSRR------MKIALDAAKGLAFLHG  215 (464)
Q Consensus       162 ---~~~~~~-----------------~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~------~~i~~qi~~~l~~LH~  215 (464)
                         +++...                 ...+|||||+. |+|.+++.... ..+.+..+      +.++.||+.||.||| 
T Consensus       135 ~p~d~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~-~~~~~~~~~~~~vk~~i~~qi~~aL~~LH-  211 (371)
T 3q60_A          135 LPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLD-FVYVFRGDEGILALHILTAQLIRLAANLQ-  211 (371)
T ss_dssp             CCCEEEEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHH-HSCCCCHHHHHHHHHHHHHHHHHHHHHHH-
T ss_pred             eeehheecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhc-cccchhhhhhhhhHHHHHHHHHHHHHHHH-
Confidence               555443                 33799999998 89999997642 23566666      788899999999999 


Q ss_pred             CCCCeeeccCCCCceEecCCCceEEcccCCccCCCCCCCcceeeccccCCcccCcccccc--CCCCcccchhcHHHHHHH
Q 046893          216 AERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMT--GHLTARSDVYGFGVVLLE  293 (464)
Q Consensus       216 ~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~e  293 (464)
                       .++|+||||||+||||+.++.+||+|||+++....     ......||+.|+|||++.+  ..++.++|||||||+|||
T Consensus       212 -~~~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~e  285 (371)
T 3q60_A          212 -SKGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGT-----RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYR  285 (371)
T ss_dssp             -HTTEEETTCSGGGEEECTTSCEEECCGGGEEETTC-----EEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHH
T ss_pred             -HCCCccCcCCHHHEEECCCCCEEEEecceeeecCC-----CccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHH
Confidence             56799999999999999999999999999986421     1224567799999999987  679999999999999999


Q ss_pred             HHhCCCCCCCCCCcccccHHHHHHHhhhcccchhhccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 046893          294 MLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVA  369 (464)
Q Consensus       294 ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  369 (464)
                      |++|+.||....+......        . ...................++..+.+||.+||+.||.+||++.++++
T Consensus       286 lltg~~Pf~~~~~~~~~~~--------~-~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  352 (371)
T 3q60_A          286 VWCLFLPFGLVTPGIKGSW--------K-RPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME  352 (371)
T ss_dssp             HHHSSCSTTBCCTTCTTCC--------C-BCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred             HHhCCCCCCCcCcccccch--------h-hhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            9999999987643211100        0 00000001111111112244568999999999999999999999974

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=1.5e-43  Score=344.72  Aligned_cols=258  Identities=21%  Similarity=0.362  Sum_probs=197.7

Q ss_pred             hhHHHHHhcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCc--cHHHHHHHHHHHhcCC--CCCcce
Q 046893           84 YNEMKLATKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQ--GDREWLAEVNYLGQLR--HSNLVK  159 (464)
Q Consensus        84 ~~~~~~~~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~--hpniv~  159 (464)
                      +..+.+..++|++.+.||+|+||.||+|.+..       ++.||||++......  ....+.+|+.++..+.  ||||++
T Consensus        20 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~   92 (313)
T 3cek_A           20 FQSMSVKGRIYSILKQIGSGGSSKVFQVLNEK-------KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIR   92 (313)
T ss_dssp             CCEEEETTEEEEEEEEEECCSSEEEEEEECTT-------CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCC
T ss_pred             eeeeeeccceEEEEEEecCCCCEEEEEEEcCC-------CcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEE
Confidence            34445566789999999999999999998743       567999998754332  3367889999999997  599999


Q ss_pred             EEEEEEeCCeEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceE
Q 046893          160 LIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAK  239 (464)
Q Consensus       160 l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vk  239 (464)
                      +++++...+..++||| +.+++|.+++....  .+++..++.++.|++.||.|||  ..+|+||||||+|||++ ++.+|
T Consensus        93 ~~~~~~~~~~~~lv~e-~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH--~~~ivH~dlkp~NIl~~-~~~~k  166 (313)
T 3cek_A           93 LYDYEITDQYIYMVME-CGNIDLNSWLKKKK--SIDPWERKSYWKNMLEAVHTIH--QHGIVHSDLKPANFLIV-DGMLK  166 (313)
T ss_dssp             EEEEEECSSEEEEEEC-CCSEEHHHHHHHCS--SCCHHHHHHHHHHHHHHHHHHH--HTTCCCCCCCGGGEEEE-TTEEE
T ss_pred             EEEEeecCCEEEEEEe-cCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH--HCCceecCCCcccEEEE-CCeEE
Confidence            9999999999999999 55889999987643  6899999999999999999999  56799999999999996 48999


Q ss_pred             EcccCCccCCCCCCCcceeeccccCCcccCcccccc-----------CCCCcccchhcHHHHHHHHHhCCCCCCCCCCcc
Q 046893          240 LSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMT-----------GHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSR  308 (464)
Q Consensus       240 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~  308 (464)
                      |+|||+++...............||+.|+|||++.+           ..++.++||||||+++|+|++|+.||...... 
T Consensus       167 L~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~-  245 (313)
T 3cek_A          167 LIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ-  245 (313)
T ss_dssp             ECCCSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSH-
T ss_pred             EeeccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHH-
Confidence            999999986543332223334679999999999875           46888999999999999999999999754321 


Q ss_pred             cccHHHHHHHhhhcccchhhccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 046893          309 EHNLVEWARPLLNNNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVA  369 (464)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  369 (464)
                          .......          +++.....++...+..+.+|+.+||..||.+||++.++++
T Consensus       246 ----~~~~~~~----------~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  292 (313)
T 3cek_A          246 ----ISKLHAI----------IDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA  292 (313)
T ss_dssp             ----HHHHHHH----------HCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             ----HHHHHHH----------HhcccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhc
Confidence                1111111          1121222222233458899999999999999999999985

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=1.4e-42  Score=335.24  Aligned_cols=252  Identities=25%  Similarity=0.335  Sum_probs=202.5

Q ss_pred             hcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCC---------ccHHHHHHHHHHHhcCC-CCCcceE
Q 046893           91 TKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGY---------QGDREWLAEVNYLGQLR-HSNLVKL  160 (464)
Q Consensus        91 ~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~---------~~~~~~~~E~~~l~~l~-hpniv~l  160 (464)
                      .++|++.+.||+|+||.||+|.+..+      ++.||||++.....         .....+.+|+.+++.+. ||||+++
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~~~------~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~   89 (298)
T 1phk_A           16 YENYEPKEILGRGVSSVVRRCIHKPT------CKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQL   89 (298)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTT------TEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCE
T ss_pred             hhccceeeeecCCCceEEEEEEEcCc------CceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeee
Confidence            45788999999999999999998765      67899999875431         11245789999999995 9999999


Q ss_pred             EEEEEeCCeEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEE
Q 046893          161 IGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKL  240 (464)
Q Consensus       161 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl  240 (464)
                      ++++...+..++||||+++++|.+++....  .+++..++.++.|++.||.|||  ..+|+||||||+|||++.++.+||
T Consensus        90 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH--~~~i~H~dl~p~Nil~~~~~~~kl  165 (298)
T 1phk_A           90 KDTYETNTFFFLVFDLMKKGELFDYLTEKV--TLSEKETRKIMRALLEVICALH--KLNIVHRDLKPENILLDDDMNIKL  165 (298)
T ss_dssp             EEEEECSSEEEEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGEEECTTCCEEE
T ss_pred             eeeeccCCeEEEEEeccCCCcHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHH--HCCcccCCCCcceEEEcCCCcEEE
Confidence            999999999999999999999999987653  6899999999999999999999  567999999999999999999999


Q ss_pred             cccCCccCCCCCCCcceeeccccCCcccCccccc------cCCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHH
Q 046893          241 SDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVM------TGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVE  314 (464)
Q Consensus       241 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~  314 (464)
                      +|||++.......   ......||..|+|||++.      ...++.++||||||+++|+|++|+.||......      .
T Consensus       166 ~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~------~  236 (298)
T 1phk_A          166 TDFGFSCQLDPGE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQM------L  236 (298)
T ss_dssp             CCCTTCEECCTTC---CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------H
T ss_pred             ecccchhhcCCCc---ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHH------H
Confidence            9999998643322   223467999999999885      456889999999999999999999999754321      1


Q ss_pred             HHHHhhhcccchhhccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 046893          315 WARPLLNNNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVA  369 (464)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  369 (464)
                      ...........        .........+..+.+|+.+||..||.+||++.++++
T Consensus       237 ~~~~~~~~~~~--------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  283 (298)
T 1phk_A          237 MLRMIMSGNYQ--------FGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA  283 (298)
T ss_dssp             HHHHHHHTCCC--------CCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             HHHHHhcCCcc--------cCcccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence            11111111100        001111234558999999999999999999999874

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=1.7e-42  Score=340.12  Aligned_cols=263  Identities=21%  Similarity=0.263  Sum_probs=203.4

Q ss_pred             HhcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCccHHHHHHHHHHHhcCCCC------CcceEEEE
Q 046893           90 ATKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHS------NLVKLIGY  163 (464)
Q Consensus        90 ~~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp------niv~l~~~  163 (464)
                      ..++|++.+.||+|+||+||+|.+...     .++.||||++... ......+.+|+.++..++|+      +|++++++
T Consensus        12 ~~~~y~~~~~lg~G~~g~V~~~~~~~~-----~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~   85 (339)
T 1z57_A           12 LSARYEIVDTLGEGAFGKVVECIDHKA-----GGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEW   85 (339)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEETTT-----TTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEE
T ss_pred             ccCceEEEEEEecCCCeEEEEEEecCC-----CCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecc
Confidence            456799999999999999999987432     3678999998653 22346678899999888655      59999999


Q ss_pred             EEeCCeEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecC---------
Q 046893          164 CCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNA---------  234 (464)
Q Consensus       164 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~---------  234 (464)
                      +...+..++||||+ +++|.+++.......+++..+..++.|++.||.|||  .++|+||||||+|||++.         
T Consensus        86 ~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH--~~~ivH~Dlkp~Nil~~~~~~~~~~~~  162 (339)
T 1z57_A           86 FEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLH--SNKLTHTDLKPENILFVQSDYTEAYNP  162 (339)
T ss_dssp             EEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCCGGGEEESCCCEEEEEC-
T ss_pred             cccCCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHH--HCCCcCCCCCHHHEEEeccccccccCC
Confidence            99999999999999 889999998765557899999999999999999999  567999999999999987         


Q ss_pred             ----------CCceEEcccCCccCCCCCCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHhCCCCCCCC
Q 046893          235 ----------DFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKS  304 (464)
Q Consensus       235 ----------~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~  304 (464)
                                ++.+||+|||+++.....     .....||+.|+|||++.+..++.++|||||||++|||++|..||...
T Consensus       163 ~~~~~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~  237 (339)
T 1z57_A          163 KIKRDERTLINPDIKVVDFGSATYDDEH-----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTH  237 (339)
T ss_dssp             ---CEEEEESCCCEEECCCSSCEETTSC-----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             ccccccccccCCCceEeeCcccccCccc-----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCC
Confidence                      668999999999863221     23467999999999999999999999999999999999999999765


Q ss_pred             CCcccccHHHHHHHhhhcc-cch---------------------------hhccCc-cccCccCHHHHHHHHHHHHHhhc
Q 046893          305 RPSREHNLVEWARPLLNNN-KKV---------------------------LRILDP-RLEGQYTARTAMKVAGLAYQCLS  355 (464)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~-~~~---------------------------~~~~~~-~~~~~~~~~~~~~l~~li~~cl~  355 (464)
                      .........   ....... ...                           .....+ ..........+..+.+|+.+||+
T Consensus       238 ~~~~~~~~~---~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~  314 (339)
T 1z57_A          238 DSKEHLAMM---ERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLE  314 (339)
T ss_dssp             CHHHHHHHH---HHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTC
T ss_pred             ChHHHHHHH---HHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhC
Confidence            432111111   1110000 000                           000000 00011233556789999999999


Q ss_pred             cCCCCCCCHHHHHH
Q 046893          356 QNPKGRPVMSDVVA  369 (464)
Q Consensus       356 ~dP~~RPs~~ev~~  369 (464)
                      .||.+|||+.++++
T Consensus       315 ~dP~~Rpt~~ell~  328 (339)
T 1z57_A          315 YDPAKRITLREALK  328 (339)
T ss_dssp             SSTTTSCCHHHHTT
T ss_pred             cCcccccCHHHHhc
Confidence            99999999999874

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=1.4e-42  Score=339.51  Aligned_cols=266  Identities=24%  Similarity=0.311  Sum_probs=200.7

Q ss_pred             HhcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCC--ccHHHHHHHHHHHhcC---CCCCcceEEEEE
Q 046893           90 ATKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGY--QGDREWLAEVNYLGQL---RHSNLVKLIGYC  164 (464)
Q Consensus        90 ~~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~hpniv~l~~~~  164 (464)
                      ..++|++.+.||+|+||.||+|.+...     .++.||+|++.....  .....+.+|+.+++.+   .||||+++++++
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~   83 (326)
T 1blx_A            9 ADQQYECVAEIGEGAYGKVFKARDLKN-----GGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVC   83 (326)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTT-----TTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEE
T ss_pred             chhceeeeeeecccccEEEEEEEecCC-----CCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeee
Confidence            346799999999999999999998532     267899999864321  1123456777777665   899999999998


Q ss_pred             E-----eCCeEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceE
Q 046893          165 C-----EDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAK  239 (464)
Q Consensus       165 ~-----~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vk  239 (464)
                      .     .....++||||+. |+|.+++.......+++..++.++.|++.||.|||  ..+|+||||||+|||++.++.+|
T Consensus        84 ~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH--~~gi~H~dlkp~Nili~~~~~~k  160 (326)
T 1blx_A           84 TVSRTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH--SHRVVHRDLKPQNILVTSSGQIK  160 (326)
T ss_dssp             EEEECSSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHH--HTTCCCCCCCGGGEEECTTCCEE
T ss_pred             eecccCCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH--HCCceeccCCHHHeEEcCCCCEE
Confidence            7     4567899999997 69999988765556999999999999999999999  56799999999999999999999


Q ss_pred             EcccCCccCCCCCCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHh
Q 046893          240 LSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPL  319 (464)
Q Consensus       240 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~  319 (464)
                      |+|||+++....   ........||..|+|||++.+..++.++||||||+++|+|++|+.||.+......   .......
T Consensus       161 l~Dfg~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~---~~~i~~~  234 (326)
T 1blx_A          161 LADFGLARIYSF---QMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQ---LGKILDV  234 (326)
T ss_dssp             ECSCCSCCCCCG---GGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHHHHHH
T ss_pred             EecCcccccccC---CCCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHH---HHHHHHH
Confidence            999999986432   1223346799999999999999999999999999999999999999986542211   1111100


Q ss_pred             hhcc--cchh----------hccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 046893          320 LNNN--KKVL----------RILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVA  369 (464)
Q Consensus       320 ~~~~--~~~~----------~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  369 (464)
                      +...  ....          ..........+....+..+.+|+.+||..||.+||++.++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  296 (326)
T 1blx_A          235 IGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  296 (326)
T ss_dssp             HCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             cCCCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence            0000  0000          000000111122334568899999999999999999999874

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=5.4e-44  Score=348.44  Aligned_cols=264  Identities=20%  Similarity=0.339  Sum_probs=201.5

Q ss_pred             hHHHHHhcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCC--ccHHHHHHHHHHHhcCCCCCcceEEE
Q 046893           85 NEMKLATKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGY--QGDREWLAEVNYLGQLRHSNLVKLIG  162 (464)
Q Consensus        85 ~~~~~~~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~l~~  162 (464)
                      .++.+..++|++.+.||+|+||.||+|.+...         +|+|++.....  ...+.+.+|+.+++.++||||+++++
T Consensus        26 ~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~~---------~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~   96 (319)
T 2y4i_B           26 QEWDIPFEQLEIGELIGKGRFGQVYHGRWHGE---------VAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMG   96 (319)
T ss_dssp             GGSSSCCSCEECCCBCCCSSSSEEEEEEESSS---------EEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCE
T ss_pred             ccccCCHHHeEEeeEeccCCceEEEEEEEcCe---------EEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEE
Confidence            34445567799999999999999999987543         89999875432  22345778999999999999999999


Q ss_pred             EEEeCCeEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcc
Q 046893          163 YCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSD  242 (464)
Q Consensus       163 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~D  242 (464)
                      ++...+..++||||+.+++|.+++... ...+++..++.++.|++.||.|||  ..+|+||||||+|||++ ++.+||+|
T Consensus        97 ~~~~~~~~~iv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH--~~~i~H~dlkp~NIl~~-~~~~~l~D  172 (319)
T 2y4i_B           97 ACMSPPHLAIITSLCKGRTLYSVVRDA-KIVLDVNKTRQIAQEIVKGMGYLH--AKGILHKDLKSKNVFYD-NGKVVITD  172 (319)
T ss_dssp             EEECSSCEEEECBCCCSEEHHHHTTSS-CCCCCSHHHHHHHHHHHHHHHHHH--HTTCCCCCCCSTTEEEC---CCEECC
T ss_pred             EEecCCceEEEeecccCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHH--hCCccccCCChhhEEEe-CCCEEEee
Confidence            999999999999999999999988653 346899999999999999999999  56799999999999998 67999999


Q ss_pred             cCCccCCCCCC---CcceeeccccCCcccCcccccc---------CCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccc
Q 046893          243 FGLAKDGPMGD---QTHVSTRVMGTYGYAAPEYVMT---------GHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREH  310 (464)
Q Consensus       243 FGla~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~---------~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~  310 (464)
                      ||+++......   .........||..|+|||++.+         ..++.++||||||+++|+|++|+.||......   
T Consensus       173 fg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~---  249 (319)
T 2y4i_B          173 FGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAE---  249 (319)
T ss_dssp             CSCCC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHH---
T ss_pred             cCCccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---
Confidence            99987532211   1112233569999999998864         45788999999999999999999999764321   


Q ss_pred             cHHHHHHHhhhcccchhhccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhc
Q 046893          311 NLVEWARPLLNNNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETVQSQ  377 (464)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~~~~  377 (464)
                         .........       ..+...   ...++..+.+|+.+||..||.+||++.++++.|+.+...
T Consensus       250 ---~~~~~~~~~-------~~~~~~---~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~  303 (319)
T 2y4i_B          250 ---AIIWQMGTG-------MKPNLS---QIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKR  303 (319)
T ss_dssp             ---HHHHHHHTT-------CCCCCC---CSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC---
T ss_pred             ---HHHHHhccC-------CCCCCC---cCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHh
Confidence               111111111       111111   112334788999999999999999999999999987654

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=5.4e-43  Score=348.57  Aligned_cols=259  Identities=22%  Similarity=0.295  Sum_probs=183.3

Q ss_pred             hcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCC--ccHHHHHHHHHHHhcCCCCCcceEEEEEEeC-
Q 046893           91 TKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGY--QGDREWLAEVNYLGQLRHSNLVKLIGYCCED-  167 (464)
Q Consensus        91 ~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~-  167 (464)
                      .++|++.+.||+|+||.||+|.+..+      ++.||||++.....  .....+.+|+.+|+.++||||+++++++... 
T Consensus        28 ~~~y~~~~~lG~G~~g~V~~a~~~~~------~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~  101 (367)
T 2fst_X           28 PERYQNLSPVGSGAYGSVCAAFDTKT------GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPAR  101 (367)
T ss_dssp             ETTEEEEEECC----CCEEEEEETTT------TEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCS
T ss_pred             CCceEEeeEEeecCCeEEEEEEECCC------CCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCC
Confidence            46799999999999999999998765      67899999875432  2336788999999999999999999998754 


Q ss_pred             -----CeEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcc
Q 046893          168 -----EHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSD  242 (464)
Q Consensus       168 -----~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~D  242 (464)
                           ...++||||+ +++|.+++..   ..+++..+..++.||+.||.|||  ..+|+||||||+|||++.++.+||+|
T Consensus       102 ~~~~~~~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH--~~givH~Dlkp~NIll~~~~~~kL~D  175 (367)
T 2fst_X          102 SLEEFNDVYLVTHLM-GADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIH--SADIIHRDLKPSNLAVNEDCELKILD  175 (367)
T ss_dssp             SGGGCCCCEEEEECC-CEECC--------CCCCHHHHHHHHHHHHHHHHHHH--HTTCCCCCCCGGGEEECTTCCEEECC
T ss_pred             ccccCCeEEEEeccc-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHH--HCCeeeCCCCHhhEEECCCCCEEEee
Confidence                 5679999999 7899888764   35999999999999999999999  56799999999999999999999999


Q ss_pred             cCCccCCCCCCCcceeeccccCCcccCcccccc-CCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhh
Q 046893          243 FGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMT-GHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLN  321 (464)
Q Consensus       243 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~  321 (464)
                      ||+++....     ......||..|+|||++.+ ..++.++|||||||++|||++|+.||.+......  +.. ....+.
T Consensus       176 FG~a~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~--l~~-i~~~~g  247 (367)
T 2fst_X          176 FGLARHTAD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ--LKL-ILRLVG  247 (367)
T ss_dssp             --------------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHH--HHH-HHHHHC
T ss_pred             ccccccccc-----cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHH-HHHHhC
Confidence            999986322     1234689999999999887 6799999999999999999999999976542211  111 111100


Q ss_pred             cc-cch------------hhccCcccc---CccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 046893          322 NN-KKV------------LRILDPRLE---GQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVA  369 (464)
Q Consensus       322 ~~-~~~------------~~~~~~~~~---~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  369 (464)
                      .. ...            ...+.....   .......+..+.+|+.+||..||.+|||+.++++
T Consensus       248 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~  311 (367)
T 2fst_X          248 TPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA  311 (367)
T ss_dssp             SCCHHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             CCCHHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhc
Confidence            00 000            000000000   0011123457899999999999999999999875

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=4.8e-43  Score=348.19  Aligned_cols=270  Identities=22%  Similarity=0.258  Sum_probs=197.4

Q ss_pred             chhHHHHHhcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCcc-----------HHHHHHHHHHHhc
Q 046893           83 TYNEMKLATKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQG-----------DREWLAEVNYLGQ  151 (464)
Q Consensus        83 ~~~~~~~~~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~-----------~~~~~~E~~~l~~  151 (464)
                      ...++....++|++.+.||+|+||.||+|.+..       +..||||++.......           .+.+.+|+.+|+.
T Consensus        13 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~   85 (362)
T 3pg1_A           13 LIAELHAMQSPYTVQRFISSGSYGAVCAGVDSE-------GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNH   85 (362)
T ss_dssp             HHHHHHHTTCSCEEEEEEEEETTEEEEEEECTT-------SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHhccceEEeEEeccCCCEEEEEEECCC-------CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHh
Confidence            345777888999999999999999999998643       5679999986432211           2678999999999


Q ss_pred             CCCCCcceEEEEEEeC-----CeEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCC
Q 046893          152 LRHSNLVKLIGYCCED-----EHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFK  226 (464)
Q Consensus       152 l~hpniv~l~~~~~~~-----~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlk  226 (464)
                      ++||||+++++++...     ...++||||+. |+|.+++... ...+++..+..++.|++.||.|||  ..+|+|||||
T Consensus        86 l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH--~~~ivH~Dlk  161 (362)
T 3pg1_A           86 FHHPNILGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQ-RIVISPQHIQYFMYHILLGLHVLH--EAGVVHRDLH  161 (362)
T ss_dssp             CCCTTBCCCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCT-TSCCCHHHHHHHHHHHHHHHHHHH--HTTCCCCCCC
T ss_pred             CCCcCccceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHH--HCcCEecCCC
Confidence            9999999999998543     36899999997 5888887654 346999999999999999999999  5679999999


Q ss_pred             CCceEecCCCceEEcccCCccCCCCCCCcceeeccccCCcccCcccccc-CCCCcccchhcHHHHHHHHHhCCCCCCCCC
Q 046893          227 TSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMT-GHLTARSDVYGFGVVLLEMLLGRRAVDKSR  305 (464)
Q Consensus       227 p~Nill~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~g~~pf~~~~  305 (464)
                      |+|||++.++.+||+|||+++......   ......||..|+|||++.+ ..++.++|||||||++|+|++|+.||.+..
T Consensus       162 p~NIl~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~  238 (362)
T 3pg1_A          162 PGNILLADNNDITICDFNLAREDTADA---NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGST  238 (362)
T ss_dssp             GGGEEECTTCCEEECCTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred             hHHEEEcCCCCEEEEecCccccccccc---ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCC
Confidence            999999999999999999997532221   2234679999999999877 679999999999999999999999998654


Q ss_pred             CcccccHHHHHHHhhhcc----------cchhhcc-------CccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHH
Q 046893          306 PSREHNLVEWARPLLNNN----------KKVLRIL-------DPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVV  368 (464)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~----------~~~~~~~-------~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~  368 (464)
                      .....   ..........          ......+       ............+..+.+|+.+||+.||.+|||+.+++
T Consensus       239 ~~~~~---~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell  315 (362)
T 3pg1_A          239 FYNQL---NKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQAL  315 (362)
T ss_dssp             HHHHH---HHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred             HHHHH---HHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHH
Confidence            21111   1000000000          0000000       00000111223345789999999999999999999987


Q ss_pred             H
Q 046893          369 A  369 (464)
Q Consensus       369 ~  369 (464)
                      +
T Consensus       316 ~  316 (362)
T 3pg1_A          316 R  316 (362)
T ss_dssp             T
T ss_pred             c
Confidence            5

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=3e-42  Score=341.96  Aligned_cols=271  Identities=24%  Similarity=0.292  Sum_probs=191.6

Q ss_pred             HHHHHhcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCccHHHHHHHHHHHhcCCCCCcceEEEEEE
Q 046893           86 EMKLATKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVKLIGYCC  165 (464)
Q Consensus        86 ~~~~~~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~  165 (464)
                      ......++|++.+.||+|+||+||+|.+..+      ++.||||++..... ....+..+++.+..++||||+++++++.
T Consensus        17 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~------~~~vavK~~~~~~~-~~~~~~~~~~~l~~l~h~niv~~~~~~~   89 (360)
T 3e3p_A           17 RSRKEMDRFQVERMAGQGTFGTVQLGKEKST------GMSVAIKKVIQDPR-FRNRELQIMQDLAVLHHPNIVQLQSYFY   89 (360)
T ss_dssp             HHHHHHTTEEEC----------CEEEEETTT------CCEEEEEEEECCTT-CCCHHHHHHHHHHHHCCTTBCCEEEEEE
T ss_pred             hchhhccceEEEEEEecCCCeEEEEEEECCC------CCEEEEEEEecCcc-ccHHHHHHHHHHHhcCCCCcccHHHhhh
Confidence            3455667899999999999999999998765      66799998865432 2345677888889999999999999987


Q ss_pred             eCCe-------EEEEEeccCCCCHHHHHHh--hcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecC-C
Q 046893          166 EDEH-------RILVYEYMESGSLEKHLLR--RVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNA-D  235 (464)
Q Consensus       166 ~~~~-------~~lv~e~~~~g~L~~~l~~--~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~-~  235 (464)
                      ....       .++||||+.+ +|.+.+..  .....+++..+..++.|++.||.|||.+.++|+||||||+||||+. +
T Consensus        90 ~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~  168 (360)
T 3e3p_A           90 TLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEAD  168 (360)
T ss_dssp             EECSSCTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTT
T ss_pred             ccccccccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCC
Confidence            6433       7899999976 66555543  2345689999999999999999999965677999999999999986 8


Q ss_pred             CceEEcccCCccCCCCCCCcceeeccccCCcccCccccccCC-CCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHH
Q 046893          236 FSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGH-LTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVE  314 (464)
Q Consensus       236 ~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~  314 (464)
                      +.+||+|||+++......   ......||..|+|||++.+.. ++.++|||||||++|+|++|+.||.......  .+..
T Consensus       169 ~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~--~~~~  243 (360)
T 3e3p_A          169 GTLKLCDFGSAKKLSPSE---PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAG--QLHE  243 (360)
T ss_dssp             TEEEECCCTTCBCCCTTS---CCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHH
T ss_pred             CcEEEeeCCCceecCCCC---CcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHH--HHHH
Confidence            999999999998654322   223467999999999987654 8999999999999999999999998754221  1111


Q ss_pred             HHHHhhhcccchhhccCcc----------------ccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 046893          315 WARPLLNNNKKVLRILDPR----------------LEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVA  369 (464)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~----------------~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  369 (464)
                      ...............+++.                .........+..+.+|+.+||+.||.+|||+.++++
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  314 (360)
T 3e3p_A          244 IVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALC  314 (360)
T ss_dssp             HHHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             HHHHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhc
Confidence            1111100000110000000                001112224668999999999999999999999874

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=2.9e-42  Score=337.73  Aligned_cols=256  Identities=23%  Similarity=0.318  Sum_probs=180.2

Q ss_pred             HhcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCc-cHHHHHHHHH-HHhcCCCCCcceEEEEEEeC
Q 046893           90 ATKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQ-GDREWLAEVN-YLGQLRHSNLVKLIGYCCED  167 (464)
Q Consensus        90 ~~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~-~l~~l~hpniv~l~~~~~~~  167 (464)
                      ..++|++.+.||+|+||.||+|.+..+      ++.||||++...... ....+..|+. +++.++||||+++++++...
T Consensus        20 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~------~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~   93 (327)
T 3aln_A           20 TAEDLKDLGEIGRGAYGSVNKMVHKPS------GQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFRE   93 (327)
T ss_dssp             CSCSEEC-CEEEECSSEEEEEEEETTT------TEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECS
T ss_pred             CHHHhhehheeccCCCEEEEEEEEcCC------CCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeC
Confidence            346788999999999999999998764      678999999765332 2345566666 77778999999999999999


Q ss_pred             CeEEEEEeccCCCCHHHHHHh---hcCCCCCHHHHHHHHHHHHHHHHHHhcCCC-CeeeccCCCCceEecCCCceEEccc
Q 046893          168 EHRILVYEYMESGSLEKHLLR---RVGCMLTWSRRMKIALDAAKGLAFLHGAER-PVIYRDFKTSNILLNADFSAKLSDF  243 (464)
Q Consensus       168 ~~~~lv~e~~~~g~L~~~l~~---~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~-~ivHrDlkp~Nill~~~~~vkl~DF  243 (464)
                      +..++||||+.+ +|.+++..   .....+++..+..++.|++.||.|||  .. +|+||||||+|||++.++.+||+||
T Consensus        94 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH--~~~~ivH~dlkp~NIll~~~~~~kl~Df  170 (327)
T 3aln_A           94 GDCWICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLK--ENLKIIHRDIKPSNILLDRSGNIKLCDF  170 (327)
T ss_dssp             SEEEEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHH--HHHSCCCSCCCGGGEEEETTTEEEECCC
T ss_pred             CceEEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHh--ccCCEeECCCCHHHEEEcCCCCEEEccC
Confidence            999999999975 88777653   22457899999999999999999999  45 7999999999999999999999999


Q ss_pred             CCccCCCCCCCcceeeccccCCcccCcccc----ccCCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHh
Q 046893          244 GLAKDGPMGDQTHVSTRVMGTYGYAAPEYV----MTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPL  319 (464)
Q Consensus       244 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~  319 (464)
                      |+++......   ......||..|+|||++    .+..++.++||||||+++|+|++|+.||.......     +...  
T Consensus       171 g~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-----~~~~--  240 (327)
T 3aln_A          171 GISGQLVDSI---AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVF-----DQLT--  240 (327)
T ss_dssp             SSSCC---------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC------------C--
T ss_pred             CCceeccccc---ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHH-----HHHH--
Confidence            9998643221   22234799999999998    46678999999999999999999999997643210     0000  


Q ss_pred             hhcccchhhccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 046893          320 LNNNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVA  369 (464)
Q Consensus       320 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  369 (464)
                           .+.....+.+.......++..+.+|+.+||..||.+||++.++++
T Consensus       241 -----~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  285 (327)
T 3aln_A          241 -----QVVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLK  285 (327)
T ss_dssp             -----CCCCSCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             -----HHhcCCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence                 011111111111112234558999999999999999999999975

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=2.3e-42  Score=348.77  Aligned_cols=205  Identities=23%  Similarity=0.336  Sum_probs=156.0

Q ss_pred             cCCCC-CCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCccHHHHHHHHHHHhcCCCCCcceEEEEEEe--CC
Q 046893           92 KFFRP-DYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVKLIGYCCE--DE  168 (464)
Q Consensus        92 ~~~~~-~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~--~~  168 (464)
                      +.|.+ .++||+|+||+||+|.+....    .+..||||++....  ....+.+|+.+|+.++||||+++++++..  ..
T Consensus        20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~----~~~~vaiK~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~   93 (405)
T 3rgf_A           20 DLFEYEGCKVGRGTYGHVYKAKRKDGK----DDKDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADR   93 (405)
T ss_dssp             HHEECSSCCCC-----EEEEEEESSSS----CCCCEEEEECSSSS--CCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTT
T ss_pred             hhhhhcCcEeeecCCeEEEEEEEccCC----CCeEEEEEEECCCC--CCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCC
Confidence            44555 568999999999999976421    25669999997543  23568899999999999999999999965  67


Q ss_pred             eEEEEEeccCCCCHHHHHHhhc-------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEe----cCCCc
Q 046893          169 HRILVYEYMESGSLEKHLLRRV-------GCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILL----NADFS  237 (464)
Q Consensus       169 ~~~lv~e~~~~g~L~~~l~~~~-------~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill----~~~~~  237 (464)
                      ..+|||||+. ++|.+++....       ...+++..++.|+.||+.||.|||  ..+|+||||||+||||    +.++.
T Consensus        94 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH--~~~ivH~Dlkp~NIll~~~~~~~~~  170 (405)
T 3rgf_A           94 KVWLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH--ANWVLHRDLKPANILVMGEGPERGR  170 (405)
T ss_dssp             EEEEEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHH--HTTCCCCCCCGGGEEECCSSTTTTC
T ss_pred             eEEEEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHH--hCCEeCCCcCHHHeEEecCCCCCCc
Confidence            8999999996 58888775322       124899999999999999999999  5679999999999999    67789


Q ss_pred             eEEcccCCccCCCCCCC-cceeeccccCCcccCccccccC-CCCcccchhcHHHHHHHHHhCCCCCCCCC
Q 046893          238 AKLSDFGLAKDGPMGDQ-THVSTRVMGTYGYAAPEYVMTG-HLTARSDVYGFGVVLLEMLLGRRAVDKSR  305 (464)
Q Consensus       238 vkl~DFGla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~ell~g~~pf~~~~  305 (464)
                      +||+|||+++....... .......+||+.|+|||++.+. .++.++|||||||+||+|++|+.||....
T Consensus       171 ~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~  240 (405)
T 3rgf_A          171 VKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ  240 (405)
T ss_dssp             EEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC
T ss_pred             EEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCcc
Confidence            99999999986532211 1223346899999999999874 58999999999999999999999997644

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=1.1e-42  Score=346.67  Aligned_cols=264  Identities=17%  Similarity=0.219  Sum_probs=200.0

Q ss_pred             hcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCccHHHHHHHHHHHhcCC-----------CCCcce
Q 046893           91 TKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLR-----------HSNLVK  159 (464)
Q Consensus        91 ~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------hpniv~  159 (464)
                      .++|++.+.||+|+||+||+|.+..+      ++.||||++... ......+.+|+.+++.+.           ||||++
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~------~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~   90 (373)
T 1q8y_A           18 DARYILVRKLGWGHFSTVWLAKDMVN------NTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILK   90 (373)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTT------TEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCC
T ss_pred             CCeEEEEEeeeecCCeEEEEEEecCC------CcEEEEEEecCC-ccchhhhhHHHHHHHHhhcccccchhccccchHHH
Confidence            45799999999999999999998765      678999998753 223466788999998886           899999


Q ss_pred             EEEEEEeCC----eEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCC-CeeeccCCCCceEec-
Q 046893          160 LIGYCCEDE----HRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAER-PVIYRDFKTSNILLN-  233 (464)
Q Consensus       160 l~~~~~~~~----~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~-~ivHrDlkp~Nill~-  233 (464)
                      +++++...+    ..++||||+ +++|.+++.......+++..++.++.||+.||.|||  .+ +|+||||||+||||+ 
T Consensus        91 ~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH--~~~~ivH~Dikp~NIll~~  167 (373)
T 1q8y_A           91 LLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMH--RRCGIIHTDIKPENVLMEI  167 (373)
T ss_dssp             CCEEEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHH--HTTCEECSCCSGGGEEEEE
T ss_pred             HHHHhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHH--hcCCEEecCCChHHeEEec
Confidence            999988654    789999999 889999998765567999999999999999999999  45 799999999999994 


Q ss_pred             -----CCCceEEcccCCccCCCCCCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHhCCCCCCCCCCcc
Q 046893          234 -----ADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSR  308 (464)
Q Consensus       234 -----~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~  308 (464)
                           ..+.+||+|||+++.....     .....||+.|+|||++.+..++.++|||||||+||||++|+.||.......
T Consensus       168 ~~~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~  242 (373)
T 1q8y_A          168 VDSPENLIQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHS  242 (373)
T ss_dssp             EETTTTEEEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC-------
T ss_pred             cCCCcCcceEEEcccccccccCCC-----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccc
Confidence                 4447999999999864321     233579999999999999999999999999999999999999998654321


Q ss_pred             cccHHHHHHHhhh---c------------------ccchhhccCc---------cccCccCHHHHHHHHHHHHHhhccCC
Q 046893          309 EHNLVEWARPLLN---N------------------NKKVLRILDP---------RLEGQYTARTAMKVAGLAYQCLSQNP  358 (464)
Q Consensus       309 ~~~~~~~~~~~~~---~------------------~~~~~~~~~~---------~~~~~~~~~~~~~l~~li~~cl~~dP  358 (464)
                      ..........+..   .                  ......+...         .....++...+..+.+||.+||+.||
T Consensus       243 ~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP  322 (373)
T 1q8y_A          243 YTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDP  322 (373)
T ss_dssp             --CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSST
T ss_pred             cCChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCc
Confidence            1111111111000   0                  0000000000         00113456778899999999999999


Q ss_pred             CCCCCHHHHHH
Q 046893          359 KGRPVMSDVVA  369 (464)
Q Consensus       359 ~~RPs~~ev~~  369 (464)
                      .+|||+.++++
T Consensus       323 ~~Rpt~~ell~  333 (373)
T 1q8y_A          323 RKRADAGGLVN  333 (373)
T ss_dssp             TTCBCHHHHHT
T ss_pred             cccCCHHHHhh
Confidence            99999999875

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=8.2e-43  Score=345.07  Aligned_cols=264  Identities=23%  Similarity=0.312  Sum_probs=198.0

Q ss_pred             hcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCc-cHHHHHHHHHHHhcCCCCCcceEEEEEEeC--
Q 046893           91 TKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQ-GDREWLAEVNYLGQLRHSNLVKLIGYCCED--  167 (464)
Q Consensus        91 ~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~--  167 (464)
                      .++|.+.+.||+|+||.||+|.+..+      ++.||||++...... ....+.+|+.+++.++||||+++++++...  
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~------~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   83 (353)
T 2b9h_A           10 SSDFQLKSLLGEGAYGVVCSATHKPT------GEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSF   83 (353)
T ss_dssp             CTTEEEEEEEEECSSEEEEEEEETTT------TEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCS
T ss_pred             ccceEEeeEEcCCCCeEEEEEEECCC------CcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeeccccc
Confidence            45788999999999999999998764      678999999654322 235678999999999999999999988764  


Q ss_pred             ---CeEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccC
Q 046893          168 ---EHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFG  244 (464)
Q Consensus       168 ---~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFG  244 (464)
                         ...++||||+. ++|.+++...   .+++..+..++.|++.||.|||  ..+|+||||||+|||++.++.+||+|||
T Consensus        84 ~~~~~~~lv~e~~~-~~L~~~~~~~---~~~~~~~~~~~~qi~~~L~~LH--~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg  157 (353)
T 2b9h_A           84 ENFNEVYIIQELMQ-TDLHRVISTQ---MLSDDHIQYFIYQTLRAVKVLH--GSNVIHRDLKPSNLLINSNCDLKVCDFG  157 (353)
T ss_dssp             TTCCCEEEEECCCS-EEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCCGGGEEECTTCCEEECCCT
T ss_pred             CccceEEEEEeccC-ccHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHH--HCCeecCCCCHHHeEEcCCCcEEEEecc
Confidence               67899999996 5999888653   5999999999999999999999  5679999999999999999999999999


Q ss_pred             CccCCCCCCCcc--------eeeccccCCcccCcccccc-CCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHH
Q 046893          245 LAKDGPMGDQTH--------VSTRVMGTYGYAAPEYVMT-GHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEW  315 (464)
Q Consensus       245 la~~~~~~~~~~--------~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~  315 (464)
                      +++.........        .....+||..|+|||++.+ ..++.++|||||||++|+|++|+.||.+......  + ..
T Consensus       158 ~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~-~~  234 (353)
T 2b9h_A          158 LARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQ--L-LL  234 (353)
T ss_dssp             TCEECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH--H-HH
T ss_pred             cccccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHH--H-HH
Confidence            998643221110        1223579999999998765 6789999999999999999999999986542111  0 00


Q ss_pred             HHHhhhccc---c--------hhhc---cC---ccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 046893          316 ARPLLNNNK---K--------VLRI---LD---PRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVA  369 (464)
Q Consensus       316 ~~~~~~~~~---~--------~~~~---~~---~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  369 (464)
                      .........   .        ....   +.   ...........+..+.+|+.+||..||.+||++.++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  305 (353)
T 2b9h_A          235 IFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALE  305 (353)
T ss_dssp             HHHHHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HHHHhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence            000000000   0        0000   00   00000111234568899999999999999999999875

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=9.1e-43  Score=344.07  Aligned_cols=261  Identities=20%  Similarity=0.275  Sum_probs=203.1

Q ss_pred             hcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCcc-----------------HHHHHHHHHHHhcCC
Q 046893           91 TKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQG-----------------DREWLAEVNYLGQLR  153 (464)
Q Consensus        91 ~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~-----------------~~~~~~E~~~l~~l~  153 (464)
                      .++|++.+.||+|+||.||+|.+  +      ++.||||++.......                 ...+.+|+.++..++
T Consensus        30 ~~~y~~~~~lg~G~~g~V~~~~~--~------~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~  101 (348)
T 2pml_X           30 INDYRIIRTLNQGKFNKIILCEK--D------NKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIK  101 (348)
T ss_dssp             ETTEEEEEEEECCSSCCEEEEEE--T------TEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCC
T ss_pred             cCceEEEEEEcCCCCeEEEEEEc--C------CceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCC
Confidence            46799999999999999999998  2      6779999986432111                 178899999999999


Q ss_pred             CCCcceEEEEEEeCCeEEEEEeccCCCCHHHH------HHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCC
Q 046893          154 HSNLVKLIGYCCEDEHRILVYEYMESGSLEKH------LLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKT  227 (464)
Q Consensus       154 hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~------l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp  227 (464)
                      ||||+++++++.+.+..++||||+++++|.++      +.......+++..++.++.|++.||.|||+ ..+|+||||||
T Consensus       102 h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~~i~H~dl~p  180 (348)
T 2pml_X          102 NEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHN-EKNICHRDVKP  180 (348)
T ss_dssp             CTTBCCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHH-TSCEECCCCCG
T ss_pred             CCCcceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhc-cCCEeecCCCh
Confidence            99999999999999999999999999999988      554435679999999999999999999994 27799999999


Q ss_pred             CceEecCCCceEEcccCCccCCCCCCCcceeeccccCCcccCccccccC-CCCc-ccchhcHHHHHHHHHhCCCCCCCCC
Q 046893          228 SNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTG-HLTA-RSDVYGFGVVLLEMLLGRRAVDKSR  305 (464)
Q Consensus       228 ~Nill~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-~~DvwslG~il~ell~g~~pf~~~~  305 (464)
                      +|||++.++.+||+|||++......    ......||..|+|||++.+. .++. ++||||||+++|+|++|..||....
T Consensus       181 ~Nil~~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~  256 (348)
T 2pml_X          181 SNILMDKNGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKI  256 (348)
T ss_dssp             GGEEECTTSCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             HhEEEcCCCcEEEeccccccccccc----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence            9999999999999999999864322    33446799999999999877 6766 9999999999999999999998654


Q ss_pred             CcccccHHHHHHHhhhcccchhh-------ccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 046893          306 PSREHNLVEWARPLLNNNKKVLR-------ILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVA  369 (464)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  369 (464)
                      ..  ..+   .............       ..............+..+.+|+.+||+.||.+||++.++++
T Consensus       257 ~~--~~~---~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~  322 (348)
T 2pml_X          257 SL--VEL---FNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK  322 (348)
T ss_dssp             CS--HHH---HHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             cH--HHH---HHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            31  111   1111111100000       00000000011334568999999999999999999999986

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=2.4e-42  Score=347.24  Aligned_cols=260  Identities=22%  Similarity=0.315  Sum_probs=191.6

Q ss_pred             hcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCccHHHHHHHHHHHhcCCCCCcceEEEEEEeCC--
Q 046893           91 TKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVKLIGYCCEDE--  168 (464)
Q Consensus        91 ~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~--  168 (464)
                      ..+|++.+.||+|+||+||+|.+..+      +. ||+|++......    ..+|+++|+.++||||++++++|....  
T Consensus        39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~------~~-~aikk~~~~~~~----~~~E~~il~~l~h~niv~l~~~~~~~~~~  107 (394)
T 4e7w_A           39 EIAYTNCKVIGNGSFGVVFQAKLVES------DE-VAIKKVLQDKRF----KNRELQIMRIVKHPNVVDLKAFFYSNGDK  107 (394)
T ss_dssp             EEEEEEEEEEEEETTEEEEEEEETTT------EE-EEEEEEECCTTS----CCHHHHHHHTCCCTTBCCEEEEEEEESSS
T ss_pred             cceEEEeEEEeeCCCeEEEEEEECCC------Ce-EEEEEEecCcch----HHHHHHHHHhCCCCCcceEEEEEEecCCC
Confidence            34688999999999999999998664      33 777776543221    236999999999999999999986543  


Q ss_pred             ----eEEEEEeccCCCCHHHHHHh--hcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEec-CCCceEEc
Q 046893          169 ----HRILVYEYMESGSLEKHLLR--RVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLN-ADFSAKLS  241 (464)
Q Consensus       169 ----~~~lv~e~~~~g~L~~~l~~--~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~-~~~~vkl~  241 (464)
                          ..++||||+.++ |...+..  .....+++..+..++.|++.||.|||  ..+|+||||||+||||+ .++.+||+
T Consensus       108 ~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH--~~~ivHrDlkp~Nill~~~~~~~kL~  184 (394)
T 4e7w_A          108 KDEVFLNLVLEYVPET-VYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIH--SIGICHRDIKPQNLLLDPPSGVLKLI  184 (394)
T ss_dssp             SSCEEEEEEEECCSEE-HHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGEEEETTTTEEEEC
T ss_pred             CCceEEEEEeeccCcc-HHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH--HCCccCCCCCHHHEEEcCCCCcEEEe
Confidence                378999999764 4444432  22457999999999999999999999  56799999999999998 78999999


Q ss_pred             ccCCccCCCCCCCcceeeccccCCcccCccccccC-CCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhh
Q 046893          242 DFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTG-HLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLL  320 (464)
Q Consensus       242 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~  320 (464)
                      |||+++......   ......||+.|+|||++.+. .++.++|||||||+||||++|+.||.+.....  .+.......-
T Consensus       185 DFG~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~--~l~~i~~~~g  259 (394)
T 4e7w_A          185 DFGSAKILIAGE---PNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGID--QLVEIIKVLG  259 (394)
T ss_dssp             CCTTCEECCTTC---CCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHHHHC
T ss_pred             eCCCcccccCCC---CCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHHhC
Confidence            999998653322   22346789999999998765 59999999999999999999999998754221  1222111100


Q ss_pred             hcccc--------hh-----hccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 046893          321 NNNKK--------VL-----RILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVA  369 (464)
Q Consensus       321 ~~~~~--------~~-----~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  369 (464)
                      .....        ..     ......+...+....+.++.+|+.+||..||.+||++.++++
T Consensus       260 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  321 (394)
T 4e7w_A          260 TPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALC  321 (394)
T ss_dssp             CCCHHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             CCCHHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhc
Confidence            00000        00     000011111122234568999999999999999999999875

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=1.7e-42  Score=340.92  Aligned_cols=253  Identities=20%  Similarity=0.233  Sum_probs=173.4

Q ss_pred             hcCCCCC-CceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCccHHHHHHHHHHHhcCCCCCcceEEEEEEe---
Q 046893           91 TKFFRPD-YILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVKLIGYCCE---  166 (464)
Q Consensus        91 ~~~~~~~-~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~---  166 (464)
                      .++|.+. ++||+|+||+||+|.+..+      ++.||||++...    ..........+..+.||||+++++++..   
T Consensus        27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~------~~~vavK~~~~~----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~   96 (336)
T 3fhr_A           27 TDDYQLSKQVLGLGVNGKVLECFHRRT------GQKCALKLLYDS----PKARQEVDHHWQASGGPHIVCILDVYENMHH   96 (336)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEETTT------CCEEEEEEEESS----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEET
T ss_pred             cceeEecceeeeeCCCeEEEEEEECCC------CCEEEEEEecCc----HHHHHHHHHHHHhcCCCChHHHHHHHhhccC
Confidence            3567774 4699999999999998765      667999998652    1222223334566799999999999876   


Q ss_pred             -CCeEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecC---CCceEEcc
Q 046893          167 -DEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNA---DFSAKLSD  242 (464)
Q Consensus       167 -~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~---~~~vkl~D  242 (464)
                       ....++||||+.+|+|.+++.......+++..++.++.|++.||.|||  .++|+||||||+|||++.   ++.+||+|
T Consensus        97 ~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH--~~~ivH~dlkp~NIll~~~~~~~~~kl~D  174 (336)
T 3fhr_A           97 GKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLH--SHNIAHRDVKPENLLYTSKEKDAVLKLTD  174 (336)
T ss_dssp             TEEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGEEESCSSTTCCEEECC
T ss_pred             CCceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH--hCCeecCCCCHHHEEEEecCCCceEEEec
Confidence             456899999999999999998766567999999999999999999999  567999999999999975   45599999


Q ss_pred             cCCccCCCCCCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhc
Q 046893          243 FGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNN  322 (464)
Q Consensus       243 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~  322 (464)
                      ||+++.....    ......||+.|+|||++.+..++.++||||||+++|+|++|..||...........  .....   
T Consensus       175 fg~~~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~--~~~~~---  245 (336)
T 3fhr_A          175 FGFAKETTQN----ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPG--MKRRI---  245 (336)
T ss_dssp             CTTCEEC--------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC---------------------
T ss_pred             cccceecccc----ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhh--HHHhh---
Confidence            9999854321    22346789999999999888999999999999999999999999976432211000  00000   


Q ss_pred             ccchhhccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 046893          323 NKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVA  369 (464)
Q Consensus       323 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  369 (464)
                           ..............++..+.+|+.+||..||.+|||+.++++
T Consensus       246 -----~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  287 (336)
T 3fhr_A          246 -----RLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMN  287 (336)
T ss_dssp             ----------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             -----hccccccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence                 000001111111234558899999999999999999999986

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=1.5e-42  Score=337.96  Aligned_cols=265  Identities=23%  Similarity=0.311  Sum_probs=193.5

Q ss_pred             hcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCccHHHHHHHHHHHhcCCCCCcceEEEEEE-----
Q 046893           91 TKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVKLIGYCC-----  165 (464)
Q Consensus        91 ~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-----  165 (464)
                      .++|++.+.||+|+||.||+|.+..+      ++.||+|++........+.+.+|+.+++.++||||+++++++.     
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~------~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~   83 (320)
T 2i6l_A           10 GSRYMDLKPLGCGGNGLVFSAVDNDC------DKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQ   83 (320)
T ss_dssp             TTTEEEEEECC-----CEEEEEETTT------TEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCB
T ss_pred             CCceeEEEEeccCCCeEEEEEEECCC------CeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccc
Confidence            46789999999999999999998764      6789999987654445577899999999999999999999873     


Q ss_pred             ---------eCCeEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEec-CC
Q 046893          166 ---------EDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLN-AD  235 (464)
Q Consensus       166 ---------~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~-~~  235 (464)
                               .....++||||+. |+|.+++..   ..+++..++.++.|++.||.|||  ..+|+||||||+|||++ .+
T Consensus        84 ~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH--~~~i~H~dlkp~Nil~~~~~  157 (320)
T 2i6l_A           84 LTDDVGSLTELNSVYIVQEYME-TDLANVLEQ---GPLLEEHARLFMYQLLRGLKYIH--SANVLHRDLKPANLFINTED  157 (320)
T ss_dssp             CCC----CCSCSEEEEEEECCS-EEHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHH--HTTCBCCCCSGGGEEEETTT
T ss_pred             cccccccccccCceeEEeeccC-CCHHHHhhc---CCccHHHHHHHHHHHHHHHHHHH--hCCEecCCCCHHHEEEcCCC
Confidence                     4468899999997 599998854   35899999999999999999999  56799999999999997 56


Q ss_pred             CceEEcccCCccCCCCCCC-cceeeccccCCcccCcccccc-CCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHH
Q 046893          236 FSAKLSDFGLAKDGPMGDQ-THVSTRVMGTYGYAAPEYVMT-GHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLV  313 (464)
Q Consensus       236 ~~vkl~DFGla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~  313 (464)
                      +.+||+|||+++....... ........||..|+|||.+.+ ..++.++||||||+++|||++|+.||..........  
T Consensus       158 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~--  235 (320)
T 2i6l_A          158 LVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQ--  235 (320)
T ss_dssp             TEEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH--
T ss_pred             CeEEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHH--
Confidence            7999999999986432211 112233568999999998865 678999999999999999999999998654321110  


Q ss_pred             HHHHHhhhc----ccchhhc--------c-Ccc-ccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 046893          314 EWARPLLNN----NKKVLRI--------L-DPR-LEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVA  369 (464)
Q Consensus       314 ~~~~~~~~~----~~~~~~~--------~-~~~-~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  369 (464)
                      .........    ...+...        . .+. .........+..+.+|+.+||+.||.+||++.++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  305 (320)
T 2i6l_A          236 LILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALS  305 (320)
T ss_dssp             HHHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             HHHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhC
Confidence            000000000    0000000        0 000 000111234568999999999999999999999975

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=4.9e-42  Score=342.35  Aligned_cols=259  Identities=23%  Similarity=0.319  Sum_probs=195.8

Q ss_pred             hcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCcc--HHHHHHHHHHHhcCCCCCcceEEEEEEeCC
Q 046893           91 TKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQG--DREWLAEVNYLGQLRHSNLVKLIGYCCEDE  168 (464)
Q Consensus        91 ~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~hpniv~l~~~~~~~~  168 (464)
                      .++|.+.+.||+|+||+||+|.+..+      ++.||||++.......  ...+.+|+.+++.++||||+++++++...+
T Consensus        41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~------~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~  114 (371)
T 4exu_A           41 PKTYVSPTHVGSGAYGSVCSAIDKRS------GEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPAS  114 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTT------TEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCS
T ss_pred             cccEEEEeEEecCCCeEEEEEEECCC------CCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccC
Confidence            46799999999999999999998765      7789999997643332  367889999999999999999999998776


Q ss_pred             eE------EEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcc
Q 046893          169 HR------ILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSD  242 (464)
Q Consensus       169 ~~------~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~D  242 (464)
                      ..      ++||||+. ++|.+++.    ..+++..+..++.|++.||.|||  ..+|+||||||+|||++.++.+||+|
T Consensus       115 ~~~~~~~~~lv~e~~~-~~l~~~~~----~~~~~~~~~~i~~qi~~aL~~LH--~~~ivH~Dikp~NIll~~~~~~kL~D  187 (371)
T 4exu_A          115 SLRNFYDFYLVMPFMQ-TDLQKIMG----MEFSEEKIQYLVYQMLKGLKYIH--SAGVVHRDLKPGNLAVNEDCELKILD  187 (371)
T ss_dssp             SSTTCCCCEEEEECCC-EEHHHHTT----SCCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCCGGGEEECTTCCEEECS
T ss_pred             CcccceeEEEEEcccc-ccHHHHhh----cCCCHHHHHHHHHHHHHHHHHHH--HCCCcCCCcCHHHeEECCCCCEEEEe
Confidence            54      99999996 58877653    35899999999999999999999  56799999999999999999999999


Q ss_pred             cCCccCCCCCCCcceeeccccCCcccCcccccc-CCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhh
Q 046893          243 FGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMT-GHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLN  321 (464)
Q Consensus       243 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~  321 (464)
                      ||+++....     ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+......  +.......-.
T Consensus       188 fg~a~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~--~~~i~~~~~~  260 (371)
T 4exu_A          188 FGLARHADA-----EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQ--LTQILKVTGV  260 (371)
T ss_dssp             TTCC-------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHH--HHHHHHHHCC
T ss_pred             cCccccccc-----CcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHH--HHHHHHHhCC
Confidence            999985322     1234679999999999887 6899999999999999999999999976442111  1111000000


Q ss_pred             cccchh------------hccCcccc---CccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 046893          322 NNKKVL------------RILDPRLE---GQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVA  369 (464)
Q Consensus       322 ~~~~~~------------~~~~~~~~---~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  369 (464)
                      ......            ..+.....   .......+..+.+||.+||+.||.+|||+.++++
T Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  323 (371)
T 4exu_A          261 PGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT  323 (371)
T ss_dssp             CCHHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             CcHHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhc
Confidence            000000            00000000   0111223568999999999999999999998874

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=8e-42  Score=337.64  Aligned_cols=263  Identities=19%  Similarity=0.230  Sum_probs=202.2

Q ss_pred             HhcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCccHHHHHHHHHHHhcCCCCC------cceEEEE
Q 046893           90 ATKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSN------LVKLIGY  163 (464)
Q Consensus        90 ~~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpn------iv~l~~~  163 (464)
                      ..++|++.+.||+|+||+||+|.+...     .+..||+|++... ......+.+|+.+++.+.|++      ++.++++
T Consensus        17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~-----~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~   90 (355)
T 2eu9_A           17 LQERYEIVGNLGEGTFGKVVECLDHAR-----GKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDW   90 (355)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEETTT-----TTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEE
T ss_pred             ecccEEEEEEeeccCCeEEEEEEecCC-----CceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeee
Confidence            456799999999999999999998654     2367999998653 233466788999999887655      8999999


Q ss_pred             EEeCCeEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEe-----------
Q 046893          164 CCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILL-----------  232 (464)
Q Consensus       164 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill-----------  232 (464)
                      +...+..+|||||+ +++|.+++.......+++..++.++.||+.||.|||  .++|+||||||+||||           
T Consensus        91 ~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH--~~~ivH~Dlkp~NIll~~~~~~~~~~~  167 (355)
T 2eu9_A           91 FNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLH--ENQLTHTDLKPENILFVNSEFETLYNE  167 (355)
T ss_dssp             EEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH--TTTEECCCCCGGGEEESCCCEEEEECC
T ss_pred             eeeCCeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH--HCCcccCCCCHHHEEEecccccccccc
Confidence            99999999999999 678888887765567999999999999999999999  6779999999999999           


Q ss_pred             --------cCCCceEEcccCCccCCCCCCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHhCCCCCCCC
Q 046893          233 --------NADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKS  304 (464)
Q Consensus       233 --------~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~  304 (464)
                              +.++.+||+|||+++.....     .....||+.|+|||++.+..++.++|||||||+||||++|+.||...
T Consensus       168 ~~~~~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~  242 (355)
T 2eu9_A          168 HKSCEEKSVKNTSIRVADFGSATFDHEH-----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTH  242 (355)
T ss_dssp             C-CCCEEEESCCCEEECCCTTCEETTSC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             cccccccccCCCcEEEeecCcccccccc-----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCC
Confidence                    56789999999999853221     23467999999999999999999999999999999999999999865


Q ss_pred             CCcccccHHHHHHHhhhcc--------cchhhc--------------------cCc-cccCccCHHHHHHHHHHHHHhhc
Q 046893          305 RPSREHNLVEWARPLLNNN--------KKVLRI--------------------LDP-RLEGQYTARTAMKVAGLAYQCLS  355 (464)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~--------~~~~~~--------------------~~~-~~~~~~~~~~~~~l~~li~~cl~  355 (464)
                      ......   ..........        ......                    ..+ ..........+..+.+||.+||+
T Consensus       243 ~~~~~~---~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~  319 (355)
T 2eu9_A          243 ENREHL---VMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLE  319 (355)
T ss_dssp             SHHHHH---HHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTC
T ss_pred             CHHHHH---HHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhc
Confidence            422111   1111111000        000000                    000 00001123446689999999999


Q ss_pred             cCCCCCCCHHHHHH
Q 046893          356 QNPKGRPVMSDVVA  369 (464)
Q Consensus       356 ~dP~~RPs~~ev~~  369 (464)
                      .||.+|||+.++++
T Consensus       320 ~dP~~Rpt~~e~l~  333 (355)
T 2eu9_A          320 FDPAQRITLAEALL  333 (355)
T ss_dssp             SSTTTSCCHHHHTT
T ss_pred             CChhhCcCHHHHhc
Confidence            99999999999874

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=4.2e-42  Score=330.30  Aligned_cols=254  Identities=22%  Similarity=0.306  Sum_probs=202.5

Q ss_pred             HHHhcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCC--CccHHHHHHHHHHHhcCCCCCcceEEEEEE
Q 046893           88 KLATKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGG--YQGDREWLAEVNYLGQLRHSNLVKLIGYCC  165 (464)
Q Consensus        88 ~~~~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~  165 (464)
                      ....++|++.+.||+|+||.||+|.+..+      ++.||+|++....  ......+.+|+.+++.++||||+++++++.
T Consensus        18 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~------~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~   91 (287)
T 2wei_A           18 GTFAERYNIVCMLGKGSFGEVLKCKDRIT------QQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILE   91 (287)
T ss_dssp             HHHHHHEEEEEEEEEETTEEEEEEEETTT------CCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred             HHHhhcceeeEEEcCCCCEEEEEEEEcCC------CcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEe
Confidence            34567899999999999999999998764      5679999986532  234577899999999999999999999999


Q ss_pred             eCCeEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCC---CceEEcc
Q 046893          166 EDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNAD---FSAKLSD  242 (464)
Q Consensus       166 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~---~~vkl~D  242 (464)
                      ..+..++||||+.+++|.+++....  .+++..++.++.|++.||.|||  ..+|+||||||+|||++.+   +.+||+|
T Consensus        92 ~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH--~~~i~H~dl~p~NIlv~~~~~~~~~kL~D  167 (287)
T 2wei_A           92 DSSSFYIVGELYTGGELFDEIIKRK--RFSEHDAARIIKQVFSGITYMH--KHNIVHRDLKPENILLESKEKDCDIKIID  167 (287)
T ss_dssp             CSSEEEEEECCCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCCGGGEEESCSSTTCCEEECS
T ss_pred             CCCeEEEEEEccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH--HCCeeccCCChhhEEEecCCCcccEEEec
Confidence            9999999999999999999887654  6899999999999999999999  5679999999999999654   4699999


Q ss_pred             cCCccCCCCCCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhc
Q 046893          243 FGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNN  322 (464)
Q Consensus       243 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~  322 (464)
                      ||++.......   ......||..|+|||++.+ .++.++||||||+++|+|++|..||......      +........
T Consensus       168 fg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~------~~~~~~~~~  237 (287)
T 2wei_A          168 FGLSTCFQQNT---KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEY------DILKRVETG  237 (287)
T ss_dssp             TTGGGTBCCCS---SCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHHC
T ss_pred             cCcceeecCCC---ccccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHH------HHHHHHHcC
Confidence            99998643222   1223568999999998765 5899999999999999999999999764321      111111111


Q ss_pred             ccchhhccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 046893          323 NKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVA  369 (464)
Q Consensus       323 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  369 (464)
                      ...    .+.    ......+..+.+|+.+||..||.+||++.++++
T Consensus       238 ~~~----~~~----~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  276 (287)
T 2wei_A          238 KYA----FDL----PQWRTISDDAKDLIRKMLTFHPSLRITATQCLE  276 (287)
T ss_dssp             CCC----CCS----GGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCC----CCc----hhhhhcCHHHHHHHHHHcccChhhCcCHHHHhc
Confidence            000    000    011223457899999999999999999999986

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=2.6e-42  Score=333.36  Aligned_cols=253  Identities=22%  Similarity=0.346  Sum_probs=192.0

Q ss_pred             hcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCccHHHHHHHHHHHhcCCCCCcceEEEEEEe----
Q 046893           91 TKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVKLIGYCCE----  166 (464)
Q Consensus        91 ~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~----  166 (464)
                      .++|++.+.||+|+||.||+|.+..+      ++.||||++... ......+.+|+.+++.++||||+++++++.+    
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~------~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   77 (303)
T 1zy4_A            5 ASDFEEIAVLGQGAFGQVVKARNALD------SRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNF   77 (303)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTT------CCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCC
T ss_pred             cccchhhheeccCCcEEEEEEEEcCC------CeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcch
Confidence            45688999999999999999998764      667999998642 2234678899999999999999999998865    


Q ss_pred             ---------CCeEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCc
Q 046893          167 ---------DEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFS  237 (464)
Q Consensus       167 ---------~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~  237 (464)
                               ....++||||+++++|.+++... +..+++..++.++.|++.||.|||  ..+|+||||||+|||++.++.
T Consensus        78 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH--~~~i~H~dlkp~Nil~~~~~~  154 (303)
T 1zy4_A           78 VKPMTAVKKKSTLFIQMEYCENGTLYDLIHSE-NLNQQRDEYWRLFRQILEALSYIH--SQGIIHRDLKPMNIFIDESRN  154 (303)
T ss_dssp             CC------CEEEEEEEEECCCSCBHHHHHHHS-CGGGCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCCGGGEEECTTSC
T ss_pred             hhhhcccccCCceEEEEecCCCCCHHHhhhcc-ccccchHHHHHHHHHHHHHHHHHH--hCCeecccCCHHhEEEcCCCC
Confidence                     35689999999999999998754 345788999999999999999999  567999999999999999999


Q ss_pred             eEEcccCCccCCCCCCC------------cceeeccccCCcccCccccccC-CCCcccchhcHHHHHHHHHhCCCCCCCC
Q 046893          238 AKLSDFGLAKDGPMGDQ------------THVSTRVMGTYGYAAPEYVMTG-HLTARSDVYGFGVVLLEMLLGRRAVDKS  304 (464)
Q Consensus       238 vkl~DFGla~~~~~~~~------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~ell~g~~pf~~~  304 (464)
                      +||+|||+++.......            ........||..|+|||++.+. .++.++|||||||++|+|++   ||...
T Consensus       155 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~  231 (303)
T 1zy4_A          155 VKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTG  231 (303)
T ss_dssp             EEECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSH
T ss_pred             EEEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCc
Confidence            99999999986432110            1122346799999999998764 68999999999999999998   44321


Q ss_pred             CCcccccHHHHHHHhhhcccchhhccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 046893          305 RPSREHNLVEWARPLLNNNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVA  369 (464)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  369 (464)
                           ............        ....+...+....+..+.+|+.+||+.||.+||++.++++
T Consensus       232 -----~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  283 (303)
T 1zy4_A          232 -----MERVNILKKLRS--------VSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN  283 (303)
T ss_dssp             -----HHHHHHHHHHHS--------TTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             -----hhHHHHHHhccc--------cccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhC
Confidence                 111111111111        1111222334445567899999999999999999999985

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.2e-42  Score=336.22  Aligned_cols=244  Identities=25%  Similarity=0.380  Sum_probs=190.8

Q ss_pred             HHHhcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCcc------HHHHHHHHHHHhcC----CCCCc
Q 046893           88 KLATKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQG------DREWLAEVNYLGQL----RHSNL  157 (464)
Q Consensus        88 ~~~~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~------~~~~~~E~~~l~~l----~hpni  157 (464)
                      ....++|++.+.||+|+||.||+|.+..+      ++.||||++.......      ...+.+|+.++..+    .||||
T Consensus        27 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~------~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i  100 (312)
T 2iwi_A           27 EAFEAEYRLGPLLGKGGFGTVFAGHRLTD------RLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGV  100 (312)
T ss_dssp             ------CEEEEEEEEETTEEEEEEECTTT------CCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSB
T ss_pred             hhhhhceEEeeEEEcCCCEEEEEEEEccC------CeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCe
Confidence            44567899999999999999999987664      6679999997654322      22345788888888    89999


Q ss_pred             ceEEEEEEeCCeEEEEEec-cCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEec-CC
Q 046893          158 VKLIGYCCEDEHRILVYEY-MESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLN-AD  235 (464)
Q Consensus       158 v~l~~~~~~~~~~~lv~e~-~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~-~~  235 (464)
                      +++++++...+..++|||+ +.+++|.+++....  .+++..++.++.|++.||.|||  ..+|+||||||+|||++ .+
T Consensus       101 ~~~~~~~~~~~~~~~v~e~~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH--~~~i~H~dlkp~Nil~~~~~  176 (312)
T 2iwi_A          101 IRLLDWFETQEGFMLVLERPLPAQDLFDYITEKG--PLGEGPSRCFFGQVVAAIQHCH--SRGVVHRDIKDENILIDLRR  176 (312)
T ss_dssp             CCEEEEC-----CEEEEECCSSEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHH--HHTEECCCCSGGGEEEETTT
T ss_pred             eeEEEEEecCCeEEEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH--HCCeeecCCChhhEEEeCCC
Confidence            9999999999999999999 78999999987754  6899999999999999999999  56799999999999998 88


Q ss_pred             CceEEcccCCccCCCCCCCcceeeccccCCcccCccccccCCCC-cccchhcHHHHHHHHHhCCCCCCCCCCcccccHHH
Q 046893          236 FSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLT-ARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVE  314 (464)
Q Consensus       236 ~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~  314 (464)
                      +.+||+|||+++......    .....||..|+|||++.+..+. .++||||||+++|+|++|+.||....        +
T Consensus       177 ~~~kl~dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~--------~  244 (312)
T 2iwi_A          177 GCAKLIDFGSGALLHDEP----YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ--------E  244 (312)
T ss_dssp             TEEEECCCSSCEECCSSC----BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH--------H
T ss_pred             CeEEEEEcchhhhcccCc----ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH--------H
Confidence            999999999998653322    2346799999999998877664 58999999999999999999996421        0


Q ss_pred             HHHHhhhcccchhhccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 046893          315 WARPLLNNNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVA  369 (464)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  369 (464)
                          .....        .    .++...+..+.+||.+||+.||.+||++.++++
T Consensus       245 ----~~~~~--------~----~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~  283 (312)
T 2iwi_A          245 ----ILEAE--------L----HFPAHVSPDCCALIRRCLAPKPSSRPSLEEILL  283 (312)
T ss_dssp             ----HHHTC--------C----CCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             ----Hhhhc--------c----CCcccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence                00000        0    112234457899999999999999999999975

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=3.9e-42  Score=336.07  Aligned_cols=247  Identities=23%  Similarity=0.360  Sum_probs=199.2

Q ss_pred             hHHHHHhcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCc------cHHHHHHHHHHHhcCC--CCC
Q 046893           85 NEMKLATKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQ------GDREWLAEVNYLGQLR--HSN  156 (464)
Q Consensus        85 ~~~~~~~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~--hpn  156 (464)
                      .+.....++|++.+.||+|+||.||+|.+..+      ++.||||++......      ....+..|+.+++.+.  |||
T Consensus        36 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~------~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~  109 (320)
T 3a99_A           36 KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSD------NLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG  109 (320)
T ss_dssp             ----CCTTTEEEEEECSSSSSCEEEEEEETTT------TEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCS
T ss_pred             cccCCccCceEEEEEEeeCCCeEEEEEEECCC------CcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCC
Confidence            34455667899999999999999999998765      678999998754322      1244668999999996  599


Q ss_pred             cceEEEEEEeCCeEEEEEeccCC-CCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEec-C
Q 046893          157 LVKLIGYCCEDEHRILVYEYMES-GSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLN-A  234 (464)
Q Consensus       157 iv~l~~~~~~~~~~~lv~e~~~~-g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~-~  234 (464)
                      |+++++++...+..++|||++.+ ++|.+++....  .+++..++.++.|++.||.|||  ..+|+||||||+|||++ .
T Consensus       110 i~~~~~~~~~~~~~~lv~e~~~~~~~L~~~l~~~~--~l~~~~~~~i~~qi~~~L~~LH--~~~ivH~Dlkp~NIll~~~  185 (320)
T 3a99_A          110 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERG--ALQEELARSFFWQVLEAVRHCH--NCGVLHRDIKDENILIDLN  185 (320)
T ss_dssp             BCCEEEEEECSSEEEEEEECCSSEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEEETT
T ss_pred             ceEEEEEEecCCcEEEEEEcCCCCccHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHH--HCCcEeCCCCHHHEEEeCC
Confidence            99999999999999999999976 89999987653  6899999999999999999999  56799999999999998 7


Q ss_pred             CCceEEcccCCccCCCCCCCcceeeccccCCcccCccccccCCC-CcccchhcHHHHHHHHHhCCCCCCCCCCcccccHH
Q 046893          235 DFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHL-TARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLV  313 (464)
Q Consensus       235 ~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~  313 (464)
                      ++.+||+|||+++.....    ......||+.|+|||++.+..+ +.++||||||+++|||++|+.||....        
T Consensus       186 ~~~~kL~Dfg~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~--------  253 (320)
T 3a99_A          186 RGELKLIDFGSGALLKDT----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE--------  253 (320)
T ss_dssp             TTEEEECCCTTCEECCSS----CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH--------
T ss_pred             CCCEEEeeCccccccccc----cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh--------
Confidence            889999999999864322    1234679999999999987766 688999999999999999999996421        


Q ss_pred             HHHHHhhhcccchhhccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 046893          314 EWARPLLNNNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVA  369 (464)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  369 (464)
                      .    .....        .    .+....+..+.+||.+||+.||.+||++.++++
T Consensus       254 ~----~~~~~--------~----~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  293 (320)
T 3a99_A          254 E----IIRGQ--------V----FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQN  293 (320)
T ss_dssp             H----HHHCC--------C----CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             h----hhccc--------c----cccccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            0    00000        0    011223457899999999999999999999976

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=1.7e-41  Score=336.06  Aligned_cols=259  Identities=23%  Similarity=0.310  Sum_probs=195.5

Q ss_pred             hcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCcc--HHHHHHHHHHHhcCCCCCcceEEEEEEeCC
Q 046893           91 TKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQG--DREWLAEVNYLGQLRHSNLVKLIGYCCEDE  168 (464)
Q Consensus        91 ~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~hpniv~l~~~~~~~~  168 (464)
                      .++|.+.+.||+|+||.||+|.+..+      ++.||||++.......  ...+.+|+.+++.++||||+++++++....
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~------~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   96 (353)
T 3coi_A           23 PKTYVSPTHVGSGAYGSVCSAIDKRS------GEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPAS   96 (353)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTT------TEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCS
T ss_pred             CceEEEeeeEecCCCeEEEEEEECCC------CCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEeccc
Confidence            46788999999999999999998765      6789999987643322  356889999999999999999999998765


Q ss_pred             e------EEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcc
Q 046893          169 H------RILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSD  242 (464)
Q Consensus       169 ~------~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~D  242 (464)
                      .      .++||||+. ++|.+++.    ..+++..+..++.|++.||.|||  ..+|+||||||+|||++.++.+||+|
T Consensus        97 ~~~~~~~~~lv~e~~~-~~l~~~~~----~~~~~~~~~~i~~qi~~al~~LH--~~~ivH~dlkp~NIl~~~~~~~kl~D  169 (353)
T 3coi_A           97 SLRNFYDFYLVMPFMQ-TDLQKIMG----LKFSEEKIQYLVYQMLKGLKYIH--SAGVVHRDLKPGNLAVNEDCELKILD  169 (353)
T ss_dssp             SGGGCCCCEEEEECCS-EEGGGTTT----SCCCHHHHHHHHHHHHHHHHHHH--HTTCCCSSCCGGGEEECTTCCEEECS
T ss_pred             ccccceeEEEEecccc-CCHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH--HCCcccCCCCHHHEeECCCCcEEEee
Confidence            4      499999996 58877653    25899999999999999999999  56799999999999999999999999


Q ss_pred             cCCccCCCCCCCcceeeccccCCcccCcccccc-CCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhh
Q 046893          243 FGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMT-GHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLN  321 (464)
Q Consensus       243 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~  321 (464)
                      ||+++....     ......||..|+|||++.+ ..++.++|||||||++|+|++|+.||.+......  +.......-.
T Consensus       170 fg~~~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~--~~~i~~~~~~  242 (353)
T 3coi_A          170 FGLARHADA-----EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQ--LTQILKVTGV  242 (353)
T ss_dssp             TTCTTC-------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHH--HHHHHHHHCB
T ss_pred             cccccCCCC-----CccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHHhCC
Confidence            999985322     1234678999999999887 6789999999999999999999999986542211  1110000000


Q ss_pred             cccc------------hhhccCcc---ccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 046893          322 NNKK------------VLRILDPR---LEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVA  369 (464)
Q Consensus       322 ~~~~------------~~~~~~~~---~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  369 (464)
                      ....            ....+...   .........+..+.+|+.+||..||.+||++.++++
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  305 (353)
T 3coi_A          243 PGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT  305 (353)
T ss_dssp             CCHHHHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             CCHHHHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence            0000            00000000   001122344568999999999999999999998874

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=2.4e-41  Score=329.43  Aligned_cols=253  Identities=23%  Similarity=0.312  Sum_probs=180.0

Q ss_pred             hcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCccH--HHHHHHHHHHhcCCCCCcceEEEEEEeCC
Q 046893           91 TKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGD--REWLAEVNYLGQLRHSNLVKLIGYCCEDE  168 (464)
Q Consensus        91 ~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~--~~~~~E~~~l~~l~hpniv~l~~~~~~~~  168 (464)
                      .++|++.+.||+|+||.||+|.+..+      ++.||||++........  ..+..+..+++.++||||+++++++...+
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~~~------~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~   97 (318)
T 2dyl_A           24 INDLENLGEMGSGTCGQVWKMRFRKT------GHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNT   97 (318)
T ss_dssp             GGGEEEEEEC------CEEEEEETTT------CCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred             hccccccceeeecCCeeEEEEEEecC------CeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCC
Confidence            35688889999999999999998764      66799999976543222  23445556788889999999999999999


Q ss_pred             eEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCccC
Q 046893          169 HRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKD  248 (464)
Q Consensus       169 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~  248 (464)
                      ..++||||+ ++.+..++. .....+++..++.++.|++.||.|||+. .+|+||||||+|||++.++.+||+|||++..
T Consensus        98 ~~~lv~e~~-~~~~~~l~~-~~~~~~~~~~~~~~~~~i~~~l~~lH~~-~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~  174 (318)
T 2dyl_A           98 DVFIAMELM-GTCAEKLKK-RMQGPIPERILGKMTVAIVKALYYLKEK-HGVIHRDVKPSNILLDERGQIKLCDFGISGR  174 (318)
T ss_dssp             EEEEEECCC-SEEHHHHHH-HHTSCCCHHHHHHHHHHHHHHHHHHHHH-HCCCCCCCCGGGEEECTTSCEEECCCTTC--
T ss_pred             cEEEEEecc-CCcHHHHHH-HhccCCCHHHHHHHHHHHHHHHHHHHhh-CCEEeCCCCHHHEEECCCCCEEEEECCCchh
Confidence            999999999 555655443 3345799999999999999999999941 2799999999999999999999999999975


Q ss_pred             CCCCCCcceeeccccCCcccCccccc-----cCCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhcc
Q 046893          249 GPMGDQTHVSTRVMGTYGYAAPEYVM-----TGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNN  323 (464)
Q Consensus       249 ~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~  323 (464)
                      .....   ......||+.|+|||++.     +..++.++||||||+++|+|++|+.||......     .+.........
T Consensus       175 ~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-----~~~~~~~~~~~  246 (318)
T 2dyl_A          175 LVDDK---AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTD-----FEVLTKVLQEE  246 (318)
T ss_dssp             ---------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSH-----HHHHHHHHHSC
T ss_pred             ccCCc---cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCcc-----HHHHHHHhccC
Confidence            43221   223457999999999984     557889999999999999999999999753321     11111111111


Q ss_pred             cchhhccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 046893          324 KKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVA  369 (464)
Q Consensus       324 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  369 (464)
                      .       +.+.  ....++..+.+|+.+||+.||.+||++.++++
T Consensus       247 ~-------~~~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  283 (318)
T 2dyl_A          247 P-------PLLP--GHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLE  283 (318)
T ss_dssp             C-------CCCC--SSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             C-------CCCC--ccCCCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence            0       1110  01123457899999999999999999999985

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=5.5e-41  Score=341.56  Aligned_cols=252  Identities=22%  Similarity=0.260  Sum_probs=184.4

Q ss_pred             cCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCccHHHHHHHHHHHhcC-CCCCcceEEEEEEeCCeE
Q 046893           92 KFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQL-RHSNLVKLIGYCCEDEHR  170 (464)
Q Consensus        92 ~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~  170 (464)
                      +.|.+.++||+|+||+||.+....       ++.||||++...   ....+.+|+.+|..+ +||||+++++++...+..
T Consensus        15 ~~~~~~~~LG~G~~g~V~~~~~~~-------g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~   84 (434)
T 2rio_A           15 NLVVSEKILGYGSSGTVVFQGSFQ-------GRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFL   84 (434)
T ss_dssp             SCEEEEEEEEECSTTCEEEEEESS-------SSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEE
T ss_pred             heeeccCeEeeCCCeEEEEEEEEC-------CeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeE
Confidence            446667889999999998654322       567999998642   345678999999876 899999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHhhcCCC-----CCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCC----------
Q 046893          171 ILVYEYMESGSLEKHLLRRVGCM-----LTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNAD----------  235 (464)
Q Consensus       171 ~lv~e~~~~g~L~~~l~~~~~~~-----l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~----------  235 (464)
                      +||||||. |+|.+++.......     ..+..++.++.||+.||.|||  .++|+||||||+||||+.+          
T Consensus        85 ~lv~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH--~~~ivHrDLkp~NILl~~~~~~~~~~~~~  161 (434)
T 2rio_A           85 YIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH--SLKIIHRDLKPQNILVSTSSRFTADQQTG  161 (434)
T ss_dssp             EEEECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEEECCHHHHSCCTTC
T ss_pred             EEEEecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHH--HCCccccCCChHhEEEecCcccccccccC
Confidence            99999995 69999987643211     123345779999999999999  5679999999999999654          


Q ss_pred             ---CceEEcccCCccCCCCCCCc--ceeeccccCCcccCcccccc-------CCCCcccchhcHHHHHHHHHh-CCCCCC
Q 046893          236 ---FSAKLSDFGLAKDGPMGDQT--HVSTRVMGTYGYAAPEYVMT-------GHLTARSDVYGFGVVLLEMLL-GRRAVD  302 (464)
Q Consensus       236 ---~~vkl~DFGla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DvwslG~il~ell~-g~~pf~  302 (464)
                         +.+||+|||+++........  .......||+.|+|||++.+       ..++.++|||||||++|||++ |..||.
T Consensus       162 ~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~  241 (434)
T 2rio_A          162 AENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFG  241 (434)
T ss_dssp             CCSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTC
T ss_pred             CCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCC
Confidence               48999999999865433211  11234679999999999876       678999999999999999999 999996


Q ss_pred             CCCCcccccHHHHHHHhhhcccchhhccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 046893          303 KSRPSREHNLVEWARPLLNNNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVA  369 (464)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  369 (464)
                      ......    ...    +.....     .+..........+.++.+||.+||+.||.+||++.+|++
T Consensus       242 ~~~~~~----~~i----~~~~~~-----~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~  295 (434)
T 2rio_A          242 DKYSRE----SNI----IRGIFS-----LDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR  295 (434)
T ss_dssp             STTTHH----HHH----HHTCCC-----CCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             CchhhH----HHH----hcCCCC-----cccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence            543211    111    111000     011111223456778999999999999999999999975

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=3.5e-40  Score=317.09  Aligned_cols=236  Identities=13%  Similarity=0.126  Sum_probs=186.1

Q ss_pred             HhcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCcc---HHHHHHHHHHHhcCCCCCcceEEEEEEe
Q 046893           90 ATKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQG---DREWLAEVNYLGQLRHSNLVKLIGYCCE  166 (464)
Q Consensus        90 ~~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~hpniv~l~~~~~~  166 (464)
                      ..++|++.+.||+|+||.||+|.+..+      ++.||||++.......   ...+.+|+.++..++||||+++++++..
T Consensus        29 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~------~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~  102 (286)
T 3uqc_A           29 ANGRYRLLIFHGGVPPLQFWQALDTAL------DRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHT  102 (286)
T ss_dssp             TTTTEEEEEEEEBSTTCEEEEEEETTT------TEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEE
T ss_pred             ecCcEEEEEEEcccCCeEEEEEEecCC------CceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEE
Confidence            346799999999999999999998764      6789999997654332   2678999999999999999999999999


Q ss_pred             CCeEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCc
Q 046893          167 DEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLA  246 (464)
Q Consensus       167 ~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla  246 (464)
                      .+..||||||++|++|.+++...    ....++..|+.|++.||.|||  .++|+||||||+||||+.++.+||+++|  
T Consensus       103 ~~~~~lv~e~~~g~~L~~~l~~~----~~~~~~~~i~~ql~~aL~~lH--~~givH~Dikp~NIll~~~g~~kl~~~~--  174 (286)
T 3uqc_A          103 RAGGLVVAEWIRGGSLQEVADTS----PSPVGAIRAMQSLAAAADAAH--RAGVALSIDHPSRVRVSIDGDVVLAYPA--  174 (286)
T ss_dssp             TTEEEEEEECCCEEEHHHHHTTC----CCHHHHHHHHHHHHHHHHHHH--HTTCCCCCCSGGGEEEETTSCEEECSCC--
T ss_pred             CCcEEEEEEecCCCCHHHHHhcC----CChHHHHHHHHHHHHHHHHHH--HCCCccCCCCcccEEEcCCCCEEEEecc--
Confidence            99999999999999999988432    456678899999999999999  5679999999999999999999998543  


Q ss_pred             cCCCCCCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhcccch
Q 046893          247 KDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKV  326 (464)
Q Consensus       247 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  326 (464)
                                          |++       .++.++|||||||+||||++|+.||.+.........         ....+
T Consensus       175 --------------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~---------~~~~~  218 (286)
T 3uqc_A          175 --------------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAP---------AERDT  218 (286)
T ss_dssp             --------------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEE---------CCBCT
T ss_pred             --------------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHH---------HHHHh
Confidence                                333       368899999999999999999999987543221100         00000


Q ss_pred             hhccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhcC
Q 046893          327 LRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETVQSQG  378 (464)
Q Consensus       327 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~~~~~  378 (464)
                      ..  ...........++..+.+|+.+||+.||.+| |+.++++.|+.+....
T Consensus       219 ~~--~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~~  267 (286)
T 3uqc_A          219 AG--QPIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAVA  267 (286)
T ss_dssp             TS--CBCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC--
T ss_pred             cc--CCCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhccC
Confidence            00  0000011122345689999999999999999 9999999999876543

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.4e-40  Score=337.97  Aligned_cols=250  Identities=23%  Similarity=0.303  Sum_probs=183.6

Q ss_pred             hcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCccHHHHHHHHHHHhcC-CCCCcceEEEEEEeCCe
Q 046893           91 TKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQL-RHSNLVKLIGYCCEDEH  169 (464)
Q Consensus        91 ~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~  169 (464)
                      ..+|.+.++||+|+||+||......       ++.||||++......   .+.+|+.+|+.+ +||||+++++++.+...
T Consensus        23 ~~~y~~~~~LG~G~~G~V~~~~~~~-------~~~vAvK~~~~~~~~---~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~   92 (432)
T 3p23_A           23 KISFCPKDVLGHGAEGTIVYRGMFD-------NRDVAVKRILPECFS---FADREVQLLRESDEHPNVIRYFCTEKDRQF   92 (432)
T ss_dssp             TEEEEEEEEEEECGGGCEEEEEESS-------SSEEEEEEECTTTEE---ECHHHHHHHHHSCCCTTBCCEEEEEEETTE
T ss_pred             cEEEecCCeeecCcCEEEEEEEEeC-------CeEEEEEEECHHHHH---HHHHHHHHHHhccCCCCcCeEEEEEecCCE
Confidence            3458888999999999966433222       566999998654322   356899999999 79999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecC-----CCceEEcccC
Q 046893          170 RILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNA-----DFSAKLSDFG  244 (464)
Q Consensus       170 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~-----~~~vkl~DFG  244 (464)
                      .|||||||. |+|.+++.... ..+....++.++.||+.||.|||  ..+|+||||||+||||+.     ...+||+|||
T Consensus        93 ~~lv~E~~~-g~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH--~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG  168 (432)
T 3p23_A           93 QYIAIELCA-ATLQEYVEQKD-FAHLGLEPITLLQQTTSGLAHLH--SLNIVHRDLKPHNILISMPNAHGKIKAMISDFG  168 (432)
T ss_dssp             EEEEEECCS-EEHHHHHHSSS-CCCCSSCHHHHHHHHHHHHHHHH--HTTCCCCCCSTTSEEECCCBTTTBCCEEECCTT
T ss_pred             EEEEEECCC-CCHHHHHHhcC-CCccchhHHHHHHHHHHHHHHHH--HCcCEeCCCCHHHEEEecCCCCCceeEEEeccc
Confidence            999999995 59999987653 34555567789999999999999  567999999999999943     3358899999


Q ss_pred             CccCCCCCCC-cceeeccccCCcccCccccc---cCCCCcccchhcHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHh
Q 046893          245 LAKDGPMGDQ-THVSTRVMGTYGYAAPEYVM---TGHLTARSDVYGFGVVLLEMLL-GRRAVDKSRPSREHNLVEWARPL  319 (464)
Q Consensus       245 la~~~~~~~~-~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~  319 (464)
                      +++....... .......+||+.|+|||++.   +..++.++|||||||++|||++ |..||.......       ....
T Consensus       169 ~a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~-------~~~~  241 (432)
T 3p23_A          169 LCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQ-------ANIL  241 (432)
T ss_dssp             EEECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHH-------HHHH
T ss_pred             ceeeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHH-------HHHH
Confidence            9986543221 12234468999999999987   4567889999999999999999 999986432111       0000


Q ss_pred             hhcccchhhccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 046893          320 LNNNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVA  369 (464)
Q Consensus       320 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  369 (464)
                      ... ..      .. ........+..+.+||.+||+.||.+||++.+|++
T Consensus       242 ~~~-~~------~~-~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~  283 (432)
T 3p23_A          242 LGA-CS------LD-CLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK  283 (432)
T ss_dssp             TTC-CC------CT-TSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             hcc-CC------cc-ccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence            000 00      00 00112234557889999999999999999999984

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=9.6e-41  Score=351.03  Aligned_cols=270  Identities=26%  Similarity=0.348  Sum_probs=203.2

Q ss_pred             cCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCC-ccHHHHHHHHHHHhcCCCCCcceEEEEEEe----
Q 046893           92 KFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGY-QGDREWLAEVNYLGQLRHSNLVKLIGYCCE----  166 (464)
Q Consensus        92 ~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~----  166 (464)
                      ++|++.+.||+|+||.||+|.+..+      +..||||++..... .....+.+|+.+|+.++||||+++++++..    
T Consensus        14 grY~i~~~LG~G~fG~Vyla~~~~t------g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~   87 (676)
T 3qa8_A           14 GPWEMKERLGTGGFGYVLRWIHQDT------GEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKL   87 (676)
T ss_dssp             ---CCCCCCCBCSSSBCCCCCCTTT------TCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCC
T ss_pred             CCeEEEEEEeeCCCeEEEEEEECCC------CcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccc
Confidence            5799999999999999999987654      56699999876432 223668899999999999999999998755    


Q ss_pred             --CCeEEEEEeccCCCCHHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCc---eEE
Q 046893          167 --DEHRILVYEYMESGSLEKHLLRRV-GCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFS---AKL  240 (464)
Q Consensus       167 --~~~~~lv~e~~~~g~L~~~l~~~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~---vkl  240 (464)
                        .+..++||||+++|+|.+++.... ...+++..++.++.|++.||.|||  ..+|+||||||+|||++.++.   +||
T Consensus        88 ~~~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLH--s~gIVHrDLKP~NILl~~~g~~~~vKL  165 (676)
T 3qa8_A           88 APNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLH--ENRIIHRDLKPENIVLQPGPQRLIHKI  165 (676)
T ss_dssp             CTTSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHH--HTTBCCCCCCSTTEEEECCSSSCEEEE
T ss_pred             cCCCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHH--HCCCccCCCCHHHeEeecCCCceeEEE
Confidence              667899999999999999987643 235899999999999999999999  567999999999999987664   999


Q ss_pred             cccCCccCCCCCCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhh
Q 046893          241 SDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLL  320 (464)
Q Consensus       241 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~  320 (464)
                      +|||++.......   ......||..|+|||++.+..++.++|||||||++|+|++|..||.....     ...|.....
T Consensus       166 ~DFG~a~~~~~~~---~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~-----~~~~~~~i~  237 (676)
T 3qa8_A          166 IDLGYAKELDQGE---LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQ-----PVQWHGKVR  237 (676)
T ss_dssp             CSCCCCCBTTSCC---CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCH-----HHHSSTTCC
T ss_pred             ccccccccccccc---ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccc-----hhhhhhhhh
Confidence            9999998654322   22346899999999999999999999999999999999999999975321     111111110


Q ss_pred             hcccc---hhhcc--------CccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHH-----HHHHHHHHHhc
Q 046893          321 NNNKK---VLRIL--------DPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSD-----VVALLETVQSQ  377 (464)
Q Consensus       321 ~~~~~---~~~~~--------~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~e-----v~~~L~~~~~~  377 (464)
                      .....   .....        .......+....+..+.+|+.+||..||.+||++.+     +...++.+...
T Consensus       238 ~~~~~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL~~  310 (676)
T 3qa8_A          238 EKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSILSL  310 (676)
T ss_dssp             ------CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHHCC
T ss_pred             cccchhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHHhc
Confidence            00000   00000        001122344567789999999999999999999988     45666665543

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=2.8e-40  Score=354.79  Aligned_cols=245  Identities=23%  Similarity=0.346  Sum_probs=194.6

Q ss_pred             HHhcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCC-ccHHHHHHHHHHHhcCCCCCcceEEEEEEeC
Q 046893           89 LATKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGY-QGDREWLAEVNYLGQLRHSNLVKLIGYCCED  167 (464)
Q Consensus        89 ~~~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~  167 (464)
                      +..++|++.+.||+|+||+||+|.+...     .++.||||++..... .....+.+|+.+|..++||||+++++++...
T Consensus        77 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~  151 (681)
T 2pzi_A           77 IVAGQYEVKGCIAHGGLGWIYLALDRNV-----NGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHT  151 (681)
T ss_dssp             EETTTEEEEEEEEEETTEEEEEEEEGGG-----TTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEE
T ss_pred             EeCCceEEEEEEeeCCCeEEEEEEEcCC-----CCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeec
Confidence            3457899999999999999999998642     257799999865432 2335688999999999999999999999876


Q ss_pred             Ce-----EEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcc
Q 046893          168 EH-----RILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSD  242 (464)
Q Consensus       168 ~~-----~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~D  242 (464)
                      +.     .||||||++|++|.+++..    .+++..++.|+.||+.||.|||  .++||||||||+||||+.+ .+||+|
T Consensus       152 ~~~~~~~~~lv~E~~~g~~L~~~~~~----~l~~~~~~~~~~qi~~aL~~lH--~~giiHrDlkp~NIll~~~-~~kl~D  224 (681)
T 2pzi_A          152 DRHGDPVGYIVMEYVGGQSLKRSKGQ----KLPVAEAIAYLLEILPALSYLH--SIGLVYNDLKPENIMLTEE-QLKLID  224 (681)
T ss_dssp             CTTSCEEEEEEEECCCCEECC----C----CCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEECSS-CEEECC
T ss_pred             CCCCCceeEEEEEeCCCCcHHHHHhC----CCCHHHHHHHHHHHHHHHHHHH--HCCCeecccChHHeEEeCC-cEEEEe
Confidence            65     7999999999999887643    5899999999999999999999  5679999999999999875 999999


Q ss_pred             cCCccCCCCCCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhc
Q 046893          243 FGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNN  322 (464)
Q Consensus       243 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~  322 (464)
                      ||+++.....      ....||+.|+|||++.+. ++.++|||||||+||+|++|..||.......              
T Consensus       225 FG~a~~~~~~------~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~~~~~~~~~~~--------------  283 (681)
T 2pzi_A          225 LGAVSRINSF------GYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPTRNGRYVDG--------------  283 (681)
T ss_dssp             CTTCEETTCC------SCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCCCEETTEECSS--------------
T ss_pred             cccchhcccC------CccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhCCCCCccccccc--------------
Confidence            9999864322      346799999999988765 4889999999999999999998876421100              


Q ss_pred             ccchhhccCccccCccCHHHHHHHHHHHHHhhccCCCCCCC-HHHHHHHHHHHHh
Q 046893          323 NKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPV-MSDVVALLETVQS  376 (464)
Q Consensus       323 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-~~ev~~~L~~~~~  376 (464)
                         +   .    ........+..+.+||.+||+.||.+||+ ++++...|..+..
T Consensus       284 ---~---~----~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~  328 (681)
T 2pzi_A          284 ---L---P----EDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVLR  328 (681)
T ss_dssp             ---C---C----TTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHH
T ss_pred             ---c---c----ccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHHH
Confidence               0   0    00011123357889999999999999995 5667777776553

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=7.9e-40  Score=316.52  Aligned_cols=230  Identities=19%  Similarity=0.251  Sum_probs=178.1

Q ss_pred             CCCCC-CceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCccHHHHHHHHHHH-hcCCCCCcceEEEEEEe----
Q 046893           93 FFRPD-YILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYL-GQLRHSNLVKLIGYCCE----  166 (464)
Q Consensus        93 ~~~~~-~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l-~~l~hpniv~l~~~~~~----  166 (464)
                      +|.+. +.||+|+||.||+|.+..+      ++.||+|++..     ...+.+|+.++ +.++||||+++++++..    
T Consensus        18 ~y~~~~~~lg~G~~g~V~~~~~~~~------~~~vaiK~~~~-----~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~   86 (299)
T 3m2w_A           18 DYKVTSQVLGLGINGKVLQIFNKRT------QEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAG   86 (299)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETTT------CCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETT
T ss_pred             chhhcCcccccCCCeEEEEEEEcCC------CcEEEEEEecc-----cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCC
Confidence            35554 7899999999999998765      66799999864     24677888888 55689999999999987    


Q ss_pred             CCeEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecC---CCceEEccc
Q 046893          167 DEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNA---DFSAKLSDF  243 (464)
Q Consensus       167 ~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~---~~~vkl~DF  243 (464)
                      ....++||||+++|+|.+++....+..+++..++.++.|++.||.|||  ..+|+||||||+|||++.   ++.+||+||
T Consensus        87 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH--~~~i~H~dlkp~Nil~~~~~~~~~~kl~Df  164 (299)
T 3m2w_A           87 RKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH--SINIAHRDVKPENLLYTSKRPNAILKLTDF  164 (299)
T ss_dssp             EEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEESSSSTTCCEEECCC
T ss_pred             CceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH--hCCcccCCCCHHHEEEecCCCCCcEEEecc
Confidence            678899999999999999998766567999999999999999999999  567999999999999987   788999999


Q ss_pred             CCccCCCCCCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhcc
Q 046893          244 GLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNN  323 (464)
Q Consensus       244 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~  323 (464)
                      |++...                        .+..++.++|||||||++|+|++|+.||.........          ...
T Consensus       165 g~a~~~------------------------~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~----------~~~  210 (299)
T 3m2w_A          165 GFAKET------------------------TGEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS----------PGM  210 (299)
T ss_dssp             TTCEEC------------------------TTCGGGGHHHHHHHHHHHHHHHHSSCSCCC-----------------CCS
T ss_pred             cccccc------------------------ccccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhh----------HHH
Confidence            998642                        1245788999999999999999999999754321100          000


Q ss_pred             cchhhccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 046893          324 KKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVA  369 (464)
Q Consensus       324 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  369 (464)
                      ..................++..+.+|+.+||+.||.+||++.++++
T Consensus       211 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~  256 (299)
T 3m2w_A          211 KTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN  256 (299)
T ss_dssp             CCSSCTTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             HHHHhhccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence            0000000000000000224568999999999999999999999986

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=2.3e-40  Score=334.90  Aligned_cols=241  Identities=16%  Similarity=0.124  Sum_probs=180.4

Q ss_pred             cCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCc---cHHHHHHHHHHHhcCCC-CCcc---------
Q 046893           92 KFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQ---GDREWLAEVNYLGQLRH-SNLV---------  158 (464)
Q Consensus        92 ~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h-pniv---------  158 (464)
                      ..|...++||+|+||+||+|.+..+      ++.||||++......   ..+.+.+|+.++..+.| .|+.         
T Consensus        78 ~~~~~~~~LG~G~fG~Vy~a~~~~~------g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~  151 (413)
T 3dzo_A           78 RTLVRGTVLGQEDPYAYLEATDQET------GESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFI  151 (413)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTT------CCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBC
T ss_pred             eeEEEecccccCCCEEEEEEEecCC------CCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccc
Confidence            4467778999999999999998765      667999998743322   24678899999999977 2211         


Q ss_pred             e------------EEEEEEe-----CCeEEEEEeccCCCCHHHHHHh-----hcCCCCCHHHHHHHHHHHHHHHHHHhcC
Q 046893          159 K------------LIGYCCE-----DEHRILVYEYMESGSLEKHLLR-----RVGCMLTWSRRMKIALDAAKGLAFLHGA  216 (464)
Q Consensus       159 ~------------l~~~~~~-----~~~~~lv~e~~~~g~L~~~l~~-----~~~~~l~~~~~~~i~~qi~~~l~~LH~~  216 (464)
                      .            ++.++..     ...++++|+++ +++|.+++..     ..+..+++..++.++.|++.||.|||  
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH--  228 (413)
T 3dzo_A          152 FPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLH--  228 (413)
T ss_dssp             CCCEEEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHH--
T ss_pred             cchhhcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHH--
Confidence            1            1111111     22467888876 6799988842     22335788899999999999999999  


Q ss_pred             CCCeeeccCCCCceEecCCCceEEcccCCccCCCCCCCcceeeccccCCcccCcccc----------ccCCCCcccchhc
Q 046893          217 ERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYV----------MTGHLTARSDVYG  286 (464)
Q Consensus       217 ~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~~~Dvws  286 (464)
                      .++|+||||||+||||+.++.+||+|||+++....     .....+| +.|+|||++          .+..++.++||||
T Consensus       229 ~~~iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwS  302 (413)
T 3dzo_A          229 HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-----SAVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWT  302 (413)
T ss_dssp             HTTEECSCCCGGGEEECTTCCEEECCGGGCEETTE-----EECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHH
T ss_pred             hCCcccCCcccceEEEecCCeEEEEeccceeecCC-----ccccCCC-CceeCchhhhccccccccccCcCCCchhhHHH
Confidence            56799999999999999999999999999885321     1344678 999999999          5556888999999


Q ss_pred             HHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhcccchhhccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHH
Q 046893          287 FGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSD  366 (464)
Q Consensus       287 lG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~e  366 (464)
                      |||+||||++|+.||.........                ..++...      ..++..+.+||.+||+.||.+||++.+
T Consensus       303 lGvil~elltg~~Pf~~~~~~~~~----------------~~~~~~~------~~~~~~~~~li~~~l~~dP~~Rpt~~~  360 (413)
T 3dzo_A          303 LGLAIYWIWCADLPNTDDAALGGS----------------EWIFRSC------KNIPQPVRALLEGFLRYPKEDRLLPLQ  360 (413)
T ss_dssp             HHHHHHHHHHSSCCCCTTGGGSCS----------------GGGGSSC------CCCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             HHHHHHHHHHCCCCCCCcchhhhH----------------HHHHhhc------ccCCHHHHHHHHHHccCChhhCcCHHH
Confidence            999999999999999764322110                0011100      122357999999999999999999988


Q ss_pred             HHH
Q 046893          367 VVA  369 (464)
Q Consensus       367 v~~  369 (464)
                      +++
T Consensus       361 ~l~  363 (413)
T 3dzo_A          361 AME  363 (413)
T ss_dssp             HTT
T ss_pred             HHh
Confidence            864

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=2.7e-39  Score=317.96  Aligned_cols=241  Identities=18%  Similarity=0.191  Sum_probs=183.3

Q ss_pred             HhcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCC--------ccHHHHHHHHHHHhcCC--------
Q 046893           90 ATKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGY--------QGDREWLAEVNYLGQLR--------  153 (464)
Q Consensus        90 ~~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~--------  153 (464)
                      ..++|++.+.||+|+||+||+|++.        ++.||||++.....        ...+.+.+|+.+|+.++        
T Consensus        18 ~~~~y~~~~~lG~G~~g~V~~~~~~--------~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~   89 (336)
T 2vuw_A           18 PTEKLQRCEKIGEGVFGEVFQTIAD--------HTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCN   89 (336)
T ss_dssp             CHHHHHTCEEEEEETTEEEEEEEET--------TEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSS
T ss_pred             ccccchheeeecccCceEEEEEEeC--------CceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccc
Confidence            3566889999999999999999872        47799999976432        22367889999988885        


Q ss_pred             -CCCcceEEEEEE------------------------------eCCeEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHH
Q 046893          154 -HSNLVKLIGYCC------------------------------EDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKI  202 (464)
Q Consensus       154 -hpniv~l~~~~~------------------------------~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i  202 (464)
                       ||||+++++++.                              ..+..|||||||.+|+|.+.+.+   ..+++..+..+
T Consensus        90 ~h~niv~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~---~~~~~~~~~~i  166 (336)
T 2vuw_A           90 RTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT---KLSSLATAKSI  166 (336)
T ss_dssp             BCCCBCCEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT---TCCCHHHHHHH
T ss_pred             cCCchhhhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh---cCCCHHHHHHH
Confidence             888888887654                              26789999999999977666643   35899999999


Q ss_pred             HHHHHHHHHHHh-cCCCCeeeccCCCCceEecCCC--------------------ceEEcccCCccCCCCCCCcceeecc
Q 046893          203 ALDAAKGLAFLH-GAERPVIYRDFKTSNILLNADF--------------------SAKLSDFGLAKDGPMGDQTHVSTRV  261 (464)
Q Consensus       203 ~~qi~~~l~~LH-~~~~~ivHrDlkp~Nill~~~~--------------------~vkl~DFGla~~~~~~~~~~~~~~~  261 (464)
                      +.||+.||.||| +.  +|+||||||+||||+.++                    .+||+|||+|+....       ...
T Consensus       167 ~~qi~~aL~~lH~~~--~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~-------~~~  237 (336)
T 2vuw_A          167 LHQLTASLAVAEASL--RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD-------GIV  237 (336)
T ss_dssp             HHHHHHHHHHHHHHH--CCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET-------TEE
T ss_pred             HHHHHHHHHHHHHhC--CEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC-------CcE
Confidence            999999999999 64  599999999999999887                    899999999986422       135


Q ss_pred             ccCCcccCccccccCCCCcccchhcHHHH-HHHHHhCCCCCCCCCCcccccHHHHHHHhhhcccchhh--ccCccccCcc
Q 046893          262 MGTYGYAAPEYVMTGHLTARSDVYGFGVV-LLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLR--ILDPRLEGQY  338 (464)
Q Consensus       262 ~gt~~y~aPE~~~~~~~~~~~DvwslG~i-l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~  338 (464)
                      +||+.|+|||++.+.. +.++||||||++ .+++++|..||...         .|......   .+..  ..........
T Consensus       238 ~gt~~y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~---------~~~~~~~~---~~~~~~~~~~~~~~~~  304 (336)
T 2vuw_A          238 VFCDVSMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNV---------LWLHYLTD---KMLKQMTFKTKCNTPA  304 (336)
T ss_dssp             ECCCCTTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHH---------HHHHHHHH---HHHHTCCCSSCCCSHH
T ss_pred             EEeecccChhhhcCCC-ccceehhhhhCCCCcccccccCCCcch---------hhhhHHHH---hhhhhhccCcccchhh
Confidence            7999999999998766 889999998777 77788898887421         11111110   0000  0111112223


Q ss_pred             CHHHHHHHHHHHHHhhccCCCCCCCHHHHH
Q 046893          339 TARTAMKVAGLAYQCLSQNPKGRPVMSDVV  368 (464)
Q Consensus       339 ~~~~~~~l~~li~~cl~~dP~~RPs~~ev~  368 (464)
                      ....+.++.+||.+||+.|     |+.+++
T Consensus       305 ~~~~s~~~~dli~~~L~~d-----sa~e~l  329 (336)
T 2vuw_A          305 MKQIKRKIQEFHRTMLNFS-----SATDLL  329 (336)
T ss_dssp             HHHHHHHHHHHHHHGGGSS-----SHHHHH
T ss_pred             hhhcCHHHHHHHHHHhccC-----CHHHHH
Confidence            4567889999999999977     787776

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.97  E-value=1.5e-33  Score=295.06  Aligned_cols=185  Identities=15%  Similarity=0.040  Sum_probs=128.3

Q ss_pred             eeecCceEEEEEEecCCCCCCccceEEEEEEccCCCC----------ccHHHHHHHHHHHhcC-CCCCcceEEEEEEeCC
Q 046893          100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGY----------QGDREWLAEVNYLGQL-RHSNLVKLIGYCCEDE  168 (464)
Q Consensus       100 lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~----------~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~  168 (464)
                      ++.|++|.+..++      ..+.++.+|+|++.....          ...++|.+|+++|+++ .|+||+++++++++++
T Consensus       242 ~~~~~~~~h~~~r------r~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~  315 (569)
T 4azs_A          242 PYAGAGLAHKRSR------RYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQ  315 (569)
T ss_dssp             -C--------CCE------EEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSS
T ss_pred             cccCCcccccccc------cccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECC
Confidence            4555555554332      234567799999975421          1125689999999999 7999999999999999


Q ss_pred             eEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCccC
Q 046893          169 HRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKD  248 (464)
Q Consensus       169 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~  248 (464)
                      ..|||||||+|++|.++|.+.  ..++..   .|+.||+.||.|||  .++||||||||+||||+.+|.+||+|||+|+.
T Consensus       316 ~~yLVMEyv~G~~L~d~i~~~--~~l~~~---~I~~QIl~AL~ylH--~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~  388 (569)
T 4azs_A          316 SGWLVMEKLPGRLLSDMLAAG--EEIDRE---KILGSLLRSLAALE--KQGFWHDDVRPWNVMVDARQHARLIDFGSIVT  388 (569)
T ss_dssp             EEEEEEECCCSEEHHHHHHTT--CCCCHH---HHHHHHHHHHHHHH--HTTCEESCCCGGGEEECTTSCEEECCCTTEES
T ss_pred             EEEEEEecCCCCcHHHHHHhC--CCCCHH---HHHHHHHHHHHHHH--HCCceeccCchHhEEECCCCCEEEeecccCee
Confidence            999999999999999999764  356654   47899999999999  67799999999999999999999999999986


Q ss_pred             CCCCCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHhCCCC
Q 046893          249 GPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRA  300 (464)
Q Consensus       249 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~p  300 (464)
                      .....  ......+||+.|||||++.+ .+..++|+||+|+++++|.++..+
T Consensus       389 ~~~~~--~~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~  437 (569)
T 4azs_A          389 TPQDC--SWPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSN  437 (569)
T ss_dssp             CC-----CCSHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred             CCCCC--ccccCceechhhccHHHhCC-CCCCcccccccccchhhhccccch
Confidence            53322  23345789999999998875 567789999999998887766444

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.95  E-value=1.9e-29  Score=262.69  Aligned_cols=185  Identities=18%  Similarity=0.236  Sum_probs=142.2

Q ss_pred             CCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCcc--------HHHHHHHHHHHhcCCCCCcceEEEEEEe
Q 046893           95 RPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQG--------DREWLAEVNYLGQLRHSNLVKLIGYCCE  166 (464)
Q Consensus        95 ~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~--------~~~~~~E~~~l~~l~hpniv~l~~~~~~  166 (464)
                      ...++||+|+||+||+|...        +..+++|.........        .+.+.+|+++|++++||||+++..++..
T Consensus       339 ~~~~~LG~G~fg~Vy~~~~~--------~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~  410 (540)
T 3en9_A          339 IPEHLIGKGAEADIKRDSYL--------DFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVD  410 (540)
T ss_dssp             ---------CCEEEEEEECS--------SCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEE
T ss_pred             CCCCEEeeCCCEEEEEEEEC--------CCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEe
Confidence            44568999999999999533        3457888764432221        2347899999999999999966666667


Q ss_pred             CCeEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCc
Q 046893          167 DEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLA  246 (464)
Q Consensus       167 ~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla  246 (464)
                      .+..+|||||+++++|.+++..          +..++.|++.||.|||  .++|+||||||+|||++.  .+||+|||++
T Consensus       411 ~~~~~lVmE~~~ggsL~~~l~~----------~~~i~~qi~~aL~~LH--~~gIiHrDiKp~NILl~~--~~kL~DFGla  476 (540)
T 3en9_A          411 LDNKRIMMSYINGKLAKDVIED----------NLDIAYKIGEIVGKLH--KNDVIHNDLTTSNFIFDK--DLYIIDFGLG  476 (540)
T ss_dssp             TTTTEEEEECCCSEEHHHHSTT----------CTHHHHHHHHHHHHHH--HTTEECTTCCTTSEEESS--SEEECCCTTC
T ss_pred             CCccEEEEECCCCCCHHHHHHH----------HHHHHHHHHHHHHHHH--HCcCccCCCCHHHEEECC--eEEEEECccC
Confidence            7888999999999999998764          4689999999999999  567999999999999998  9999999999


Q ss_pred             cCCCCCCCcc-----eeeccccCCcccCcccccc--CCCCcccchhcHHHHHHHHHhCCCCC
Q 046893          247 KDGPMGDQTH-----VSTRVMGTYGYAAPEYVMT--GHLTARSDVYGFGVVLLEMLLGRRAV  301 (464)
Q Consensus       247 ~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~ell~g~~pf  301 (464)
                      +.........     .....+||+.|||||++..  ..|+..+|+|+..+-..+.+.++.+|
T Consensus       477 ~~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY  538 (540)
T 3en9_A          477 KISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY  538 (540)
T ss_dssp             EECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred             EECCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence            9753321111     1235789999999999987  66888899999999999888877655

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.91  E-value=1.7e-25  Score=213.99  Aligned_cols=164  Identities=15%  Similarity=0.110  Sum_probs=124.2

Q ss_pred             HHHHHhcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCC------------------ccHHHHHHHHH
Q 046893           86 EMKLATKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGY------------------QGDREWLAEVN  147 (464)
Q Consensus        86 ~~~~~~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~E~~  147 (464)
                      .+......|.+.+.||+|+||.||+|.+ .+      ++.||+|++.....                  .....+.+|+.
T Consensus        84 ~~~~~~~~~~~~~~iG~G~~g~Vy~~~~-~~------g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~  156 (282)
T 1zar_A           84 RLVRSGKVDAIGKLMGEGKESAVFNCYS-EK------FGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFR  156 (282)
T ss_dssp             HHHHTTSCSEEEEEEEECSSEEEEEEEE-TT------TEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHH
T ss_pred             HHHhCCeEEEecCEeccCCCceEEEEEe-CC------CCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHH
Confidence            3344455677779999999999999998 43      67799999864321                  12356889999


Q ss_pred             HHhcCCCCCcceEEEEEEeCCeEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCC
Q 046893          148 YLGQLRHSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKT  227 (464)
Q Consensus       148 ~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp  227 (464)
                      +|+.++  | +++.+++.. +..++||||++|++|.+ +.      .  .....++.|++.||.|||  ..+|+||||||
T Consensus       157 ~l~~l~--~-~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~------~--~~~~~i~~qi~~~l~~lH--~~giiHrDlkp  221 (282)
T 1zar_A          157 ALQKLQ--G-LAVPKVYAW-EGNAVLMELIDAKELYR-VR------V--ENPDEVLDMILEEVAKFY--HRGIVHGDLSQ  221 (282)
T ss_dssp             HHHHTT--T-SSSCCEEEE-ETTEEEEECCCCEEGGG-CC------C--SCHHHHHHHHHHHHHHHH--HTTEECSCCST
T ss_pred             HHHhcc--C-CCcCeEEec-cceEEEEEecCCCcHHH-cc------h--hhHHHHHHHHHHHHHHHH--HCCCEeCCCCH
Confidence            999998  4 566665544 45699999999999987 31      1  234469999999999999  56799999999


Q ss_pred             CceEecCCCceEEcccCCccCCCCCCCcceeeccccCCcccCcccccc----------CCCCcccchhcH
Q 046893          228 SNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMT----------GHLTARSDVYGF  287 (464)
Q Consensus       228 ~Nill~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----------~~~~~~~Dvwsl  287 (464)
                      +|||++ ++.+||+|||+|+.               +..|+|||++..          ..|...+|+|.+
T Consensus       222 ~NILl~-~~~vkl~DFG~a~~---------------~~~~~a~e~l~rdv~~i~~~f~~~~~~~~~~~~~  275 (282)
T 1zar_A          222 YNVLVS-EEGIWIIDFPQSVE---------------VGEEGWREILERDVRNIITYFSRTYRTEKDINSA  275 (282)
T ss_dssp             TSEEEE-TTEEEECCCTTCEE---------------TTSTTHHHHHHHHHHHHHHHHHHHHCCCCCHHHH
T ss_pred             HHEEEE-CCcEEEEECCCCeE---------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCChHHH
Confidence            999999 99999999999863               345789998753          344555666543

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.83  E-value=5.3e-21  Score=180.42  Aligned_cols=136  Identities=15%  Similarity=0.058  Sum_probs=103.0

Q ss_pred             CCCCCceeecCceEEEEEEecCCCCCCccceE--EEEEEccCCCCc------------------------cHHHHHHHHH
Q 046893           94 FRPDYILGEGGFGVVYKGVIDENVRPGYKTTF--VAIKELNRGGYQ------------------------GDREWLAEVN  147 (464)
Q Consensus        94 ~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~--vavK~~~~~~~~------------------------~~~~~~~E~~  147 (464)
                      |.+...||+|+||.||+|.+..+      ++.  ||||+++.....                        ....+.+|+.
T Consensus        49 ~~i~~~ig~G~~g~Vy~a~~~~~------g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~  122 (258)
T 1zth_A           49 TAMGGVISTGKEANVFYADGVFD------GKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFR  122 (258)
T ss_dssp             EEEEEEEEECSSEEEEEEEEEET------TEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHH
T ss_pred             hhhCCEEeecceEEEEEEEEcCC------CcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHH
Confidence            56788999999999999987433      567  999987543111                        0125788999


Q ss_pred             HHhcCCCCCc--ceEEEEEEeCCeEEEEEeccCC-C----CHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHh-cCCCC
Q 046893          148 YLGQLRHSNL--VKLIGYCCEDEHRILVYEYMES-G----SLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLH-GAERP  219 (464)
Q Consensus       148 ~l~~l~hpni--v~l~~~~~~~~~~~lv~e~~~~-g----~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH-~~~~~  219 (464)
                      +|..+.|++|  ..++++    +..+|||||+.+ |    +|.++...     .++..+..++.|++.+|.||| ..  +
T Consensus       123 ~l~~l~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~-----~~~~~~~~i~~qi~~~l~~lH~~~--g  191 (258)
T 1zth_A          123 NLERAKEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE-----LKELDVEGIFNDVVENVKRLYQEA--E  191 (258)
T ss_dssp             HHHHHHHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG-----GGGSCHHHHHHHHHHHHHHHHHTS--C
T ss_pred             HHHHHHhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc-----cChHHHHHHHHHHHHHHHHHHHHC--C
Confidence            9999988754  344432    356899999942 3    67665432     234567789999999999999 64  5


Q ss_pred             eeeccCCCCceEecCCCceEEcccCCccC
Q 046893          220 VIYRDFKTSNILLNADFSAKLSDFGLAKD  248 (464)
Q Consensus       220 ivHrDlkp~Nill~~~~~vkl~DFGla~~  248 (464)
                      |+||||||+|||++.  .++|+|||+|..
T Consensus       192 ivHrDlkp~NILl~~--~~~liDFG~a~~  218 (258)
T 1zth_A          192 LVHADLSEYNIMYID--KVYFIDMGQAVT  218 (258)
T ss_dssp             EECSSCSTTSEEESS--SEEECCCTTCEE
T ss_pred             EEeCCCCHHHEEEcC--cEEEEECccccc
Confidence            999999999999987  999999999975

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.71  E-value=1.3e-18  Score=171.26  Aligned_cols=137  Identities=12%  Similarity=0.100  Sum_probs=96.0

Q ss_pred             CCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCC-----c---------cHHH--------HHHHHHHHh
Q 046893           93 FFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGY-----Q---------GDRE--------WLAEVNYLG  150 (464)
Q Consensus        93 ~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~-----~---------~~~~--------~~~E~~~l~  150 (464)
                      -|++...||.|+||.||+|.+..       ++.||||+++....     .         ....        ..+|...|.
T Consensus        96 iY~I~~~IG~Gk~a~VY~a~d~~-------G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~  168 (397)
T 4gyi_A           96 VYSVGSRIGVGKESDIMIVADEK-------GKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMK  168 (397)
T ss_dssp             CSEEEEEEEECSSEEEEEEECTT-------CCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHH
T ss_pred             EEEecCEeeeCCceEEEEEECCC-------CCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHH
Confidence            38899999999999999998753       56799998753210     0         0111        134677777


Q ss_pred             cCCCCCcceEEEEEEeCCeEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCce
Q 046893          151 QLRHSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNI  230 (464)
Q Consensus       151 ~l~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Ni  230 (464)
                      ++.+.++.-..-+...  ..+|||||++|++|.++.        .......++.|++.+|.|||  ..+||||||||.||
T Consensus       169 rL~~~gv~vp~p~~~~--~~~LVME~i~G~~L~~l~--------~~~~~~~l~~qll~~l~~lH--~~gIVHrDLKp~NI  236 (397)
T 4gyi_A          169 ALYEEGFPVPEPIAQS--RHTIVMSLVDALPMRQVS--------SVPDPASLYADLIALILRLA--KHGLIHGDFNEFNI  236 (397)
T ss_dssp             HHHHTTCSCCCEEEEE--TTEEEEECCSCEEGGGCC--------CCSCHHHHHHHHHHHHHHHH--HTTEECSCCSTTSE
T ss_pred             HHHhcCCCCCeeeecc--CceEEEEecCCccHhhhc--------ccHHHHHHHHHHHHHHHHHH--HCCCcCCCCCHHHE
Confidence            7754443221112222  237999999998885432        11234567899999999999  56799999999999


Q ss_pred             EecCCC----------ceEEcccCCccC
Q 046893          231 LLNADF----------SAKLSDFGLAKD  248 (464)
Q Consensus       231 ll~~~~----------~vkl~DFGla~~  248 (464)
                      ||++++          .+.|+||+-+..
T Consensus       237 Ll~~dgd~~d~~~~~~~~~iID~~Q~V~  264 (397)
T 4gyi_A          237 LIREEKDAEDPSSITLTPIIIXFPQMVS  264 (397)
T ss_dssp             EEEEEECSSCTTSEEEEEEECCCTTCEE
T ss_pred             EEeCCCCcccccccccceEEEEeCCccc
Confidence            998776          389999997653

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.38  E-value=1.2e-12  Score=123.12  Aligned_cols=142  Identities=15%  Similarity=0.034  Sum_probs=108.5

Q ss_pred             hcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCccHHHHHHHHHHHhcCC-CCCcceEEEEEEeCCe
Q 046893           91 TKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLR-HSNLVKLIGYCCEDEH  169 (464)
Q Consensus        91 ~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~  169 (464)
                      -..|++...++.|+++.||++...        +..+++|+...........+.+|+.+|+.+. +..+.++++++...+.
T Consensus        13 l~~~~~~~~~~g~s~~~v~~~~~~--------~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~   84 (263)
T 3tm0_A           13 IEKYRCVKDTEGMSPAKVYKLVGE--------NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGW   84 (263)
T ss_dssp             HTTSEEEECCSCCSSSEEEEEECS--------SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTE
T ss_pred             hccceeEeeccCCCCCeEEEEECC--------CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCc
Confidence            346888888898999999998632        3458999986421122345788999999884 6778899999999999


Q ss_pred             EEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC--------------------------------
Q 046893          170 RILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAE--------------------------------  217 (464)
Q Consensus       170 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~--------------------------------  217 (464)
                      .|+||||++|.+|.+.+.       +......++.+++.+|..||...                                
T Consensus        85 ~~lv~e~i~G~~l~~~~~-------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (263)
T 3tm0_A           85 SNLLMSEADGVLCSEEYE-------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCEN  157 (263)
T ss_dssp             EEEEEECCSSEEHHHHCC-------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGG
T ss_pred             eEEEEEecCCeehhhccC-------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccc
Confidence            999999999999876521       11223467789999999999611                                


Q ss_pred             -------------------------CCeeeccCCCCceEecCCCceEEcccCCcc
Q 046893          218 -------------------------RPVIYRDFKTSNILLNADFSAKLSDFGLAK  247 (464)
Q Consensus       218 -------------------------~~ivHrDlkp~Nill~~~~~vkl~DFGla~  247 (464)
                                               ..++|+|++|.|||++++..+.|+||+.+.
T Consensus       158 ~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T 3tm0_A          158 WEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             GSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred             ccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence                                     348999999999999876566799999764

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.23  E-value=1.1e-11  Score=115.93  Aligned_cols=127  Identities=16%  Similarity=0.051  Sum_probs=92.3

Q ss_pred             eecCceEEEEEEecCCCCCCccceEEEEEEccCCCCccHHHHHHHHHHHhcCCCCC--cceEEEEEEeCCeEEEEEeccC
Q 046893          101 GEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSN--LVKLIGYCCEDEHRILVYEYME  178 (464)
Q Consensus       101 G~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpn--iv~l~~~~~~~~~~~lv~e~~~  178 (464)
                      +.|..+.||++...+       +..+++|+....   ....+..|+.+++.+.+.+  +.++++++...+..++||||++
T Consensus        29 ~gg~~~~v~~~~~~~-------g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~   98 (264)
T 1nd4_A           29 IGCSDAAVFRLSAQG-------RPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVP   98 (264)
T ss_dssp             CTTSSCEEEEEECTT-------SCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCS
T ss_pred             cCCCCceEEEEecCC-------CCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecC
Confidence            456669999986432       334899987653   2245678999998885434  5568888888888999999999


Q ss_pred             CCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC-----------------------------------------
Q 046893          179 SGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAE-----------------------------------------  217 (464)
Q Consensus       179 ~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~-----------------------------------------  217 (464)
                      |.+|.  ..     ....   ..++.+++..|..||...                                         
T Consensus        99 G~~l~--~~-----~~~~---~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  168 (264)
T 1nd4_A           99 GQDLL--SS-----HLAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPA  168 (264)
T ss_dssp             SEETT--TS-----CCCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHH
T ss_pred             CcccC--cC-----cCCH---hHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHH
Confidence            98883  11     1221   256677888888888532                                         


Q ss_pred             ---------------CCeeeccCCCCceEecCCCceEEcccCCcc
Q 046893          218 ---------------RPVIYRDFKTSNILLNADFSAKLSDFGLAK  247 (464)
Q Consensus       218 ---------------~~ivHrDlkp~Nill~~~~~vkl~DFGla~  247 (464)
                                     ..++|+|++|.|||+++++.+.|+|||.+.
T Consensus       169 ~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~  213 (264)
T 1nd4_A          169 ELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG  213 (264)
T ss_dssp             HHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred             HHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence                           129999999999999877667799999875

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=99.15  E-value=9e-11  Score=115.56  Aligned_cols=140  Identities=12%  Similarity=0.159  Sum_probs=103.2

Q ss_pred             CCceeecCceEEEEEEecCCCCCCccceEEEEEEcc--CCCC-ccHHHHHHHHHHHhcCC--CCCcceEEEEEEeC---C
Q 046893           97 DYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELN--RGGY-QGDREWLAEVNYLGQLR--HSNLVKLIGYCCED---E  168 (464)
Q Consensus        97 ~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~--~~~~-~~~~~~~~E~~~l~~l~--hpniv~l~~~~~~~---~  168 (464)
                      .+.|+.|.++.||+....+        ..+++|+..  .... .....+.+|+.+++.|.  +..+.+++.++.+.   +
T Consensus        43 ~~~l~~G~sn~~y~v~~~~--------~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g  114 (359)
T 3dxp_A           43 VEQFKGGQSNPTFKLVTPG--------QTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIG  114 (359)
T ss_dssp             EEECCC-CCSCEEEEECSS--------CEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTS
T ss_pred             EEEcCCcccceEEEEEECC--------ceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccC
Confidence            4568999999999987532        347788765  3221 22346788999999986  45678888888766   3


Q ss_pred             eEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcC--------------------------------
Q 046893          169 HRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGA--------------------------------  216 (464)
Q Consensus       169 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~--------------------------------  216 (464)
                      ..++||||++|..|.+..    ...++...+..++.+++..|..||..                                
T Consensus       115 ~~~~vme~v~G~~l~~~~----~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  190 (359)
T 3dxp_A          115 RAFYIMEFVSGRVLWDQS----LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSE  190 (359)
T ss_dssp             SCEEEEECCCCBCCCCTT----CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHC
T ss_pred             CeEEEEEecCCeecCCCc----cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcC
Confidence            489999999998774421    12467888889999999999999962                                


Q ss_pred             ------------------------CCCeeeccCCCCceEecCCCc--eEEcccCCccC
Q 046893          217 ------------------------ERPVIYRDFKTSNILLNADFS--AKLSDFGLAKD  248 (464)
Q Consensus       217 ------------------------~~~ivHrDlkp~Nill~~~~~--vkl~DFGla~~  248 (464)
                                              ...+||+|+++.|||++.++.  +.|+||+.+..
T Consensus       191 ~~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~  248 (359)
T 3dxp_A          191 TESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL  248 (359)
T ss_dssp             CSCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred             CcCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence                                    246999999999999987653  68999998874

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=99.04  E-value=5.6e-11  Score=114.24  Aligned_cols=182  Identities=20%  Similarity=0.212  Sum_probs=119.0

Q ss_pred             CCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCccHHHHHHHHHHHhcC-CCCC--cceEEEEEEeCC---eE
Q 046893           97 DYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQL-RHSN--LVKLIGYCCEDE---HR  170 (464)
Q Consensus        97 ~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpn--iv~l~~~~~~~~---~~  170 (464)
                      .+.++.|.+..||+..           ..+++|+....  .....+..|+.+|+.+ .+..  +.+++.+....+   ..
T Consensus        25 i~~~~~G~~n~v~~v~-----------~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~   91 (304)
T 3sg8_A           25 IEISGEGNDCIAYEIN-----------RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMS   91 (304)
T ss_dssp             CCEEEECSSEEEEEST-----------TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCS
T ss_pred             eEecCCCCcceEEEEC-----------CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcc
Confidence            3568999999999852           12788885432  2346788999999887 3332  344554443333   34


Q ss_pred             EEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC---------------------------------
Q 046893          171 ILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAE---------------------------------  217 (464)
Q Consensus       171 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~---------------------------------  217 (464)
                      |+||++++|.+|.+....    .++..++..++.+++..|..||...                                 
T Consensus        92 ~~vm~~i~G~~l~~~~~~----~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  167 (304)
T 3sg8_A           92 FAGFTKIKGVPLTPLLLN----NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKG  167 (304)
T ss_dssp             CEEEECCCCEECCHHHHH----TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCH
T ss_pred             eEEEcccCCeECCccccc----cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCc
Confidence            889999999888654332    3677778888888888888888411                                 


Q ss_pred             -----------------------CCeeeccCCCCceEecC--CCceEEcccCCccCCCCCCCcceeeccccCCcc---cC
Q 046893          218 -----------------------RPVIYRDFKTSNILLNA--DFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGY---AA  269 (464)
Q Consensus       218 -----------------------~~ivHrDlkp~Nill~~--~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y---~a  269 (464)
                                             ..++|+|++|.|||++.  ...+.|+||+.+.......  .    ......+   ..
T Consensus       168 ~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~--D----l~~~~~~~~~~~  241 (304)
T 3sg8_A          168 PQMKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDN--D----FISLMEDDEEYG  241 (304)
T ss_dssp             HHHHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTH--H----HHTTCCTTTSCC
T ss_pred             ccHHHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHH--H----HHHHHhhccccC
Confidence                                   24799999999999987  4567899999886422110  0    0001111   22


Q ss_pred             cccccc-----CC---------CCcccchhcHHHHHHHHHhCCCCC
Q 046893          270 PEYVMT-----GH---------LTARSDVYGFGVVLLEMLLGRRAV  301 (464)
Q Consensus       270 PE~~~~-----~~---------~~~~~DvwslG~il~ell~g~~pf  301 (464)
                      |+....     +.         .....+.|++|.++|.+.+|..+|
T Consensus       242 ~~~~~~~l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~  287 (304)
T 3sg8_A          242 MEFVSKILNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW  287 (304)
T ss_dssp             HHHHHHHHHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred             HHHHHHHHHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence            222110     00         112258999999999999998765

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.60  E-value=3e-07  Score=88.21  Aligned_cols=133  Identities=20%  Similarity=0.164  Sum_probs=89.6

Q ss_pred             CceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCccHHHHHHHHHHHhcCCCC---CcceEEEEEE-eCCeEEEE
Q 046893           98 YILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHS---NLVKLIGYCC-EDEHRILV  173 (464)
Q Consensus        98 ~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp---niv~l~~~~~-~~~~~~lv  173 (464)
                      ..++.|....||+.  ..         .+++|+...  ......+..|+.+|..|.+.   .|.+++.++. ..+..++|
T Consensus        25 ~~l~~G~~n~v~~v--g~---------~~VlR~~~~--~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v   91 (306)
T 3tdw_A           25 ESLGEGFRNYAILV--NG---------DWVFRFPKS--QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVG   91 (306)
T ss_dssp             EEEEECSSEEEEEE--TT---------TEEEEEESS--HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEE
T ss_pred             eecCCCcceeEEEE--CC---------EEEEEecCC--chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEE
Confidence            45788988999986  11         278887432  12345688999999998642   2556666664 34567899


Q ss_pred             EeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcC-------------------------------------
Q 046893          174 YEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGA-------------------------------------  216 (464)
Q Consensus       174 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~-------------------------------------  216 (464)
                      ||+++|..|......    .++......++.+++..|..||+.                                     
T Consensus        92 ~e~i~G~~l~~~~~~----~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~  167 (306)
T 3tdw_A           92 YRKVQGQILGEDGMA----VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDES  167 (306)
T ss_dssp             EECCCSEECHHHHHT----TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHH
T ss_pred             EeccCCeECchhhhh----hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchh
Confidence            999999888653221    234444445555555555555532                                     


Q ss_pred             ---------------------CCCeeeccCCCCceEecC---CCc-eEEcccCCcc
Q 046893          217 ---------------------ERPVIYRDFKTSNILLNA---DFS-AKLSDFGLAK  247 (464)
Q Consensus       217 ---------------------~~~ivHrDlkp~Nill~~---~~~-vkl~DFGla~  247 (464)
                                           ...++|+|+++.|||++.   ++. +.|+||+.+.
T Consensus       168 ~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~  223 (306)
T 3tdw_A          168 LRDYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAA  223 (306)
T ss_dssp             HHHHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCE
T ss_pred             hHHHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcC
Confidence                                 234699999999999987   455 4899999875

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.57  E-value=5.1e-07  Score=84.66  Aligned_cols=133  Identities=17%  Similarity=0.071  Sum_probs=92.7

Q ss_pred             eeecCce-EEEEEEecCCCCCCccceEEEEEEccCCCCccHHHHHHHHHHHhcCC-CCCcceEEEEEEeCCeEEEEEecc
Q 046893          100 LGEGGFG-VVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLR-HSNLVKLIGYCCEDEHRILVYEYM  177 (464)
Q Consensus       100 lG~G~fg-~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~~lv~e~~  177 (464)
                      +..|..| .||+......      +..+++|+-..   .....+..|..+|+.|. +--+.+++.++.+.+..++|||++
T Consensus        32 ~~~G~S~~~v~rl~~~~~------~~~~~lk~~~~---~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l  102 (272)
T 4gkh_A           32 DNVGQSGATIYRLYGKPN------APELFLKHGKG---SVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAI  102 (272)
T ss_dssp             EECSSSSCEEEEEECCTT------CCCEEEEEEET---HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECC
T ss_pred             ccCCCcCCeEEEEEecCC------CeEEEEEECCC---CCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEee
Confidence            4556555 6898665433      33478887543   23456788999998874 334678889999999999999999


Q ss_pred             CCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC----------------------------------------
Q 046893          178 ESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAE----------------------------------------  217 (464)
Q Consensus       178 ~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~----------------------------------------  217 (464)
                      +|.++.+.....      ......++.+++..|.-||...                                        
T Consensus       103 ~G~~~~~~~~~~------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  176 (272)
T 4gkh_A          103 PGKTAFQVLEEY------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPV  176 (272)
T ss_dssp             CSEEHHHHHHHC------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCH
T ss_pred             CCccccccccCC------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHH
Confidence            998887654321      1122345556666666666321                                        


Q ss_pred             ----------------CCeeeccCCCCceEecCCCceEEcccCCcc
Q 046893          218 ----------------RPVIYRDFKTSNILLNADFSAKLSDFGLAK  247 (464)
Q Consensus       218 ----------------~~ivHrDlkp~Nill~~~~~vkl~DFGla~  247 (464)
                                      ..++|+|+.+.|||++.++.+-|+||+.+.
T Consensus       177 ~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~  222 (272)
T 4gkh_A          177 EQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG  222 (272)
T ss_dssp             HHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred             HHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence                            127899999999999987777899999875

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.34  E-value=7.6e-07  Score=87.13  Aligned_cols=85  Identities=5%  Similarity=-0.112  Sum_probs=52.5

Q ss_pred             Cce-eecCceEEEEEEecCCCCCCc-cceEEEEEEccCCC---CccHHHHHHHHHHHhcCC-C--CCcceEEEEEEeC--
Q 046893           98 YIL-GEGGFGVVYKGVIDENVRPGY-KTTFVAIKELNRGG---YQGDREWLAEVNYLGQLR-H--SNLVKLIGYCCED--  167 (464)
Q Consensus        98 ~~l-G~G~fg~Vy~a~~~~~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-h--pniv~l~~~~~~~--  167 (464)
                      +.| +.|....+|+....... .+. .+..+++|+.....   ......+..|+.+|+.|. +  -.+.+++.++.+.  
T Consensus        26 ~~l~~~G~~n~~y~v~~~~~~-~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~  104 (357)
T 3ats_A           26 SGVDSTGMSSETIILTARWQQ-DGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV  104 (357)
T ss_dssp             EEECTTSSEEEEEEEEEEEEE-TTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT
T ss_pred             EECCCCCccceEEEEEEeccc-CCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc
Confidence            456 78889999987643000 000 13457888765422   111245678888888774 3  3467788776654  


Q ss_pred             -CeEEEEEeccCCCCHH
Q 046893          168 -EHRILVYEYMESGSLE  183 (464)
Q Consensus       168 -~~~~lv~e~~~~g~L~  183 (464)
                       +..++||||++|..|.
T Consensus       105 ~g~~~~v~e~l~G~~l~  121 (357)
T 3ats_A          105 LGTPFFLMDYVEGVVPP  121 (357)
T ss_dssp             TSSCEEEEECCCCBCCC
T ss_pred             cCCceEEEEecCCCChh
Confidence             3568999999886653

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=98.26  E-value=2.8e-06  Score=84.39  Aligned_cols=76  Identities=16%  Similarity=0.067  Sum_probs=47.6

Q ss_pred             CCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCC-------ccHHHHHHHHHHHhcCCC--CCc-ceEEEEEEe
Q 046893           97 DYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGY-------QGDREWLAEVNYLGQLRH--SNL-VKLIGYCCE  166 (464)
Q Consensus        97 ~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~E~~~l~~l~h--pni-v~l~~~~~~  166 (464)
                      .+.||.|.++.||++.+...      +..++||.......       .....+..|.++|..+..  +.. .+++.+  +
T Consensus        35 ~~~lg~G~~n~vyrv~~~~~------~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d  106 (397)
T 2olc_A           35 CQEIGDGNLNYVFHIYDQEH------DRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--D  106 (397)
T ss_dssp             EEECCSSSSEEEEEEEC----------CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--E
T ss_pred             EEECCCCceEEEEEEEECCC------CcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--c
Confidence            45689999999999975432      34588997643211       122456778888887732  333 355543  3


Q ss_pred             CCeEEEEEeccCCC
Q 046893          167 DEHRILVYEYMESG  180 (464)
Q Consensus       167 ~~~~~lv~e~~~~g  180 (464)
                      .+..++|||++.+.
T Consensus       107 ~~~~~lvmE~l~g~  120 (397)
T 2olc_A          107 TEMAVTVMEDLSHL  120 (397)
T ss_dssp             TTTTEEEECCCTTS
T ss_pred             CCccEEEEEeCCCc
Confidence            45568999999764

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=98.20  E-value=1.1e-05  Score=78.09  Aligned_cols=31  Identities=19%  Similarity=0.233  Sum_probs=27.9

Q ss_pred             CCCeeeccCCCCceEecCCCceEEcccCCcc
Q 046893          217 ERPVIYRDFKTSNILLNADFSAKLSDFGLAK  247 (464)
Q Consensus       217 ~~~ivHrDlkp~Nill~~~~~vkl~DFGla~  247 (464)
                      ...+||+|+++.|||++.++.+.|+||+.+.
T Consensus       221 ~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~  251 (346)
T 2q83_A          221 SPNLCHQDYGTGNTLLGENEQIWVIDLDTVS  251 (346)
T ss_dssp             SCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred             cCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence            4679999999999999878899999999775

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=97.78  E-value=0.0001  Score=70.43  Aligned_cols=136  Identities=16%  Similarity=0.154  Sum_probs=87.9

Q ss_pred             CCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCccHHHHHHHHHHHhcCC---CCCcceEEEEEEeCCeEEEE
Q 046893           97 DYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLR---HSNLVKLIGYCCEDEHRILV  173 (464)
Q Consensus        97 ~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---hpniv~l~~~~~~~~~~~lv  173 (464)
                      .+.|+.|.+..+|+....        +..+++|+....   ....+..|+..|+.|.   ...+.+++.++...+..++|
T Consensus        41 ~~~l~gG~~n~~y~v~~~--------~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lv  109 (312)
T 3jr1_A           41 KEKLYSGEMNEIWLINDE--------VQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLL  109 (312)
T ss_dssp             EEEECCSSSSEEEEEESS--------SCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEE
T ss_pred             eEEeCCccceeeeEEEEC--------CCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEE
Confidence            356899999999997642        234778876532   3456788999888883   35678888888888899999


Q ss_pred             EeccCCCCHH--------H---HHHhhcC-C-------------------CCCHHHHH---HHH----------------
Q 046893          174 YEYMESGSLE--------K---HLLRRVG-C-------------------MLTWSRRM---KIA----------------  203 (464)
Q Consensus       174 ~e~~~~g~L~--------~---~l~~~~~-~-------------------~l~~~~~~---~i~----------------  203 (464)
                      |||++|..+.        .   .|+.... .                   .-+|....   ++.                
T Consensus       110 me~l~G~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~  189 (312)
T 3jr1_A          110 LEALNKSKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNI  189 (312)
T ss_dssp             EECCCCCCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCH
T ss_pred             EEeccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHH
Confidence            9999987641        1   1222111 0                   01343221   011                


Q ss_pred             HHHHHHH-HHH--hcCCCCeeeccCCCCceEecCCCceEEcccC
Q 046893          204 LDAAKGL-AFL--HGAERPVIYRDFKTSNILLNADFSAKLSDFG  244 (464)
Q Consensus       204 ~qi~~~l-~~L--H~~~~~ivHrDlkp~Nill~~~~~vkl~DFG  244 (464)
                      ..++..+ ..|  |.....+||+|+.+.||+++.++ +.|+||.
T Consensus       190 ~~l~~~l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~  232 (312)
T 3jr1_A          190 DLIVQIVADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA  232 (312)
T ss_dssp             HHHHHHHHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred             HHHHHHHHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence            1122222 234  22345799999999999998887 8899974

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=97.76  E-value=0.00011  Score=69.29  Aligned_cols=78  Identities=18%  Similarity=0.137  Sum_probs=53.4

Q ss_pred             CCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCccHHHHHHHHHHHhcCCC--C-CcceEEEEEEeCCeE
Q 046893           94 FRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRH--S-NLVKLIGYCCEDEHR  170 (464)
Q Consensus        94 ~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--p-niv~l~~~~~~~~~~  170 (464)
                      ..-...+|.|..+.||+....+       ++.|.+|+...........|..|+..|+.|.-  + -+.+++.+.    ..
T Consensus        17 v~~v~~~g~G~~~~vyrv~l~D-------G~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~   85 (288)
T 3f7w_A           17 VAAVAERGHSHRWHLYRVELAD-------GTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DR   85 (288)
T ss_dssp             EEEEEEEEEETTEEEEEEEETT-------SCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TT
T ss_pred             eEEEEecCCCCCeEEEEEEECC-------CCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc----Cc
Confidence            3445678999999999998765       45689998655443334567789998888742  1 344555432    23


Q ss_pred             EEEEeccCCCCH
Q 046893          171 ILVYEYMESGSL  182 (464)
Q Consensus       171 ~lv~e~~~~g~L  182 (464)
                      ++||||+.++..
T Consensus        86 ~lv~e~l~~~~~   97 (288)
T 3f7w_A           86 TLAMEWVDERPP   97 (288)
T ss_dssp             EEEEECCCCCCC
T ss_pred             eEEEEeecccCC
Confidence            789999987653

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.62  E-value=0.00026  Score=70.70  Aligned_cols=78  Identities=17%  Similarity=0.222  Sum_probs=47.9

Q ss_pred             CCCeeeccCCCCceEecCCCceEEcccCCccCCCCCCCcceeecccc--CCcccCccccccCC---CCcccchhcHHHHH
Q 046893          217 ERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMG--TYGYAAPEYVMTGH---LTARSDVYGFGVVL  291 (464)
Q Consensus       217 ~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~~---~~~~~DvwslG~il  291 (464)
                      ...++|+||++.|||++.++ ++|+||+.+......  .... ....  ...|++|+......   -....++..+...+
T Consensus       231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~--~Dla-~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (420)
T 2pyw_A          231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMG--FDIG-AYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQT  306 (420)
T ss_dssp             CCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHH--HHHH-HHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHH
T ss_pred             CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchH--HHHH-HHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHH
Confidence            56799999999999998776 999999988742211  0000 0111  13466666543111   11234556788888


Q ss_pred             HHHHhCC
Q 046893          292 LEMLLGR  298 (464)
Q Consensus       292 ~ell~g~  298 (464)
                      |+.+.+.
T Consensus       307 ~~~y~~~  313 (420)
T 2pyw_A          307 WNLFNKR  313 (420)
T ss_dssp             HHHHHHH
T ss_pred             HHHHHHH
Confidence            8887653

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=97.45  E-value=0.00019  Score=68.24  Aligned_cols=71  Identities=8%  Similarity=0.154  Sum_probs=42.2

Q ss_pred             CCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCccHHHHHHHHHHHhcCCCCCc-ceEEEEEEeCCeEEEEEe
Q 046893           97 DYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNL-VKLIGYCCEDEHRILVYE  175 (464)
Q Consensus        97 ~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpni-v~l~~~~~~~~~~~lv~e  175 (464)
                      .+.|+.|....+|+.   ..         +++|+....... ......|+.+++.+..-++ .+++.+  ..+.-++|+|
T Consensus        23 i~~l~gG~tN~~~~~---~~---------~vlR~~~~~~~~-~~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e   87 (301)
T 3dxq_A           23 PLERLGGLTNLVFRA---GD---------LCLRIPGKGTEE-YINRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTR   87 (301)
T ss_dssp             CEEEESCSSEEEEEE---TT---------EEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEE
T ss_pred             eeEcCCcccccccee---ee---------EEEECCCCCccc-eeCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEe
Confidence            566889999999997   22         788877543111 1112457777776642223 355543  3334578999


Q ss_pred             cc-CCCCH
Q 046893          176 YM-ESGSL  182 (464)
Q Consensus       176 ~~-~~g~L  182 (464)
                      |+ +|.+|
T Consensus        88 ~i~~g~~l   95 (301)
T 3dxq_A           88 YIAGAQTM   95 (301)
T ss_dssp             CCTTCEEC
T ss_pred             ecCCCccC
Confidence            99 66544

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=97.45  E-value=0.00032  Score=67.09  Aligned_cols=139  Identities=14%  Similarity=0.110  Sum_probs=74.1

Q ss_pred             ceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCccHHHHHHHHHHHhcCC-----CCCcceEE-E--EEEeCCeE
Q 046893           99 ILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLR-----HSNLVKLI-G--YCCEDEHR  170 (464)
Q Consensus        99 ~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----hpniv~l~-~--~~~~~~~~  170 (464)
                      .|+.|....+|+....+       + .+++|+.....  ....+..|+.++..|.     -|.++... +  +....+..
T Consensus        29 ~i~~G~~n~~~~v~~~~-------g-~~vlk~~~~~~--~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~   98 (322)
T 2ppq_A           29 GIAEGVENSNFLLHTTK-------D-PLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRP   98 (322)
T ss_dssp             EECC---EEEEEEEESS-------C-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEE
T ss_pred             ccCCCcccceEEEEeCC-------c-cEEEEEeCCCC--CHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEE
Confidence            46678888999986533       2 37888876521  1234556777776663     23333211 0  12334677


Q ss_pred             EEEEeccCCCCHHH--------------HHHhhc-C--CC----CC---HHHHHH------------HHHHHHHHHHHHh
Q 046893          171 ILVYEYMESGSLEK--------------HLLRRV-G--CM----LT---WSRRMK------------IALDAAKGLAFLH  214 (464)
Q Consensus       171 ~lv~e~~~~g~L~~--------------~l~~~~-~--~~----l~---~~~~~~------------i~~qi~~~l~~LH  214 (464)
                      ++||+|++|..+..              .++... +  ..    ..   |.....            +...+...+.+++
T Consensus        99 ~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~  178 (322)
T 2ppq_A           99 AALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLA  178 (322)
T ss_dssp             EEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHH
T ss_pred             EEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHH
Confidence            89999998865310              111110 0  00    11   211100            0011333444444


Q ss_pred             c-----CCCCeeeccCCCCceEecCCCceEEcccCCcc
Q 046893          215 G-----AERPVIYRDFKTSNILLNADFSAKLSDFGLAK  247 (464)
Q Consensus       215 ~-----~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~  247 (464)
                      .     ....+||+|+.+.|||++.++.+.|+||+.+.
T Consensus       179 ~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~  216 (322)
T 2ppq_A          179 AHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC  216 (322)
T ss_dssp             HHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             hhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence            1     23469999999999999877656899999775

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=97.43  E-value=0.0008  Score=59.92  Aligned_cols=100  Identities=14%  Similarity=0.051  Sum_probs=64.6

Q ss_pred             CHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCccCCCCCCCcceeec
Q 046893          181 SLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTR  260 (464)
Q Consensus       181 ~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~~~~~~~  260 (464)
                      +|.+.|... +.+++++++|.++.|.+.+|.-+-. +..-..+=+-|..|+|..+|.|-+.+ +.+.             
T Consensus        34 SL~eIL~~~-~~PlsEEqaWALc~Qc~~~L~~~~~-~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~-------------   97 (229)
T 2yle_A           34 SLEEILRLY-NQPINEEQAWAVCYQCCGSLRAAAR-RRQPRHRVRSAAQIRVWRDGAVTLAP-AADD-------------   97 (229)
T ss_dssp             EHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCSGGGEEEETTSCEEECC-C----------------
T ss_pred             cHHHHHHHc-CCCcCHHHHHHHHHHHHHHHHhhhh-cccCCceecCCcceEEecCCceeccc-cccc-------------
Confidence            788877654 6789999999999999999877610 11111233457899999999988764 2111             


Q ss_pred             cccCCcccCccccccCCCCcccchhcHHHHHHHHHhCC
Q 046893          261 VMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGR  298 (464)
Q Consensus       261 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~  298 (464)
                       .....+.+||... ...+.+.=|||||++||..+--.
T Consensus        98 -~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDyg  133 (229)
T 2yle_A           98 -AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYG  133 (229)
T ss_dssp             ----------CCSS-SSSCHHHHHHHHHHHHHHHHTTT
T ss_pred             -ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcC
Confidence             1122466888653 35567788999999999988643

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=97.30  E-value=0.00045  Score=67.89  Aligned_cols=145  Identities=17%  Similarity=0.161  Sum_probs=80.4

Q ss_pred             CceeecCceEEEEEEecCCCC-CCccceEEEEEEccCCCCccHHHHHHHHHHHhcCC-CCCcceEEEEEEeCCeEEEEEe
Q 046893           98 YILGEGGFGVVYKGVIDENVR-PGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLR-HSNLVKLIGYCCEDEHRILVYE  175 (464)
Q Consensus        98 ~~lG~G~fg~Vy~a~~~~~~~-~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~~lv~e  175 (464)
                      +.|..|-...+|+........ ....+..+++++.... ......+.+|.++++.|. +.-..++++++.+    .+|||
T Consensus        56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e  130 (379)
T 3feg_A           56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQ  130 (379)
T ss_dssp             EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEE
T ss_pred             EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEE
Confidence            457778888899987642110 0112345888885332 223456678999998884 3223556655432    28999


Q ss_pred             ccCCCCHHH--------------HHHhh--c----CCCCC--HHHHHHHHHHHHH-------------------HHHHH-
Q 046893          176 YMESGSLEK--------------HLLRR--V----GCMLT--WSRRMKIALDAAK-------------------GLAFL-  213 (464)
Q Consensus       176 ~~~~g~L~~--------------~l~~~--~----~~~l~--~~~~~~i~~qi~~-------------------~l~~L-  213 (464)
                      |++|..|..              .|.+-  .    +....  +..+..+..++..                   .+..| 
T Consensus       131 ~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~  210 (379)
T 3feg_A          131 YIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLR  210 (379)
T ss_dssp             CCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHH
T ss_pred             EecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHH
Confidence            998865421              11110  0    11122  3445555544322                   12222 


Q ss_pred             ---h--cCCCCeeeccCCCCceEecCC----CceEEcccCCcc
Q 046893          214 ---H--GAERPVIYRDFKTSNILLNAD----FSAKLSDFGLAK  247 (464)
Q Consensus       214 ---H--~~~~~ivHrDlkp~Nill~~~----~~vkl~DFGla~  247 (464)
                         .  .....++|+|+.+.|||++.+    +.+.|+||..+.
T Consensus       211 ~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~  253 (379)
T 3feg_A          211 KLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS  253 (379)
T ss_dssp             HHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred             HHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence               2  123468999999999999876    789999998775

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=97.27  E-value=0.0022  Score=61.60  Aligned_cols=32  Identities=28%  Similarity=0.342  Sum_probs=27.7

Q ss_pred             CCCeeeccCCCCceEecCC----CceEEcccCCccC
Q 046893          217 ERPVIYRDFKTSNILLNAD----FSAKLSDFGLAKD  248 (464)
Q Consensus       217 ~~~ivHrDlkp~Nill~~~----~~vkl~DFGla~~  248 (464)
                      ...++|+|+.+.|||++.+    +.+.|+||+.+..
T Consensus       182 ~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~  217 (333)
T 3csv_A          182 DMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL  217 (333)
T ss_dssp             CCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred             CCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence            4579999999999999874    6799999998864

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=97.27  E-value=0.00056  Score=68.50  Aligned_cols=79  Identities=19%  Similarity=0.184  Sum_probs=48.0

Q ss_pred             CceeecCceEEEEEEecCCCCC-CccceEEEEEEccCCCCccHHHHHHHHHHHhcCCCCCc-ceEEEEEEeCCeEEEEEe
Q 046893           98 YILGEGGFGVVYKGVIDENVRP-GYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNL-VKLIGYCCEDEHRILVYE  175 (464)
Q Consensus        98 ~~lG~G~fg~Vy~a~~~~~~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpni-v~l~~~~~~~~~~~lv~e  175 (464)
                      +.|+.|....||++........ ...+..+++|+....  .....+..|+.++..|...++ .++++.+.  +  .+|||
T Consensus        79 ~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~--~~~~~li~E~~~l~~L~~~g~~P~l~~~~~--~--g~v~e  152 (429)
T 1nw1_A           79 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIFS--G--GRLEE  152 (429)
T ss_dssp             EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEET--T--EEEEC
T ss_pred             EEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC--CcHHHHHHHHHHHHHHHhCCCCCcEEEEeC--C--CEEEE
Confidence            4578888899999876431100 011345888887432  112456689998888843333 56666543  2  38999


Q ss_pred             ccCCCCH
Q 046893          176 YMESGSL  182 (464)
Q Consensus       176 ~~~~g~L  182 (464)
                      |++|.+|
T Consensus       153 ~l~G~~l  159 (429)
T 1nw1_A          153 YIPSRPL  159 (429)
T ss_dssp             CCCEEEC
T ss_pred             EeCCccc
Confidence            9986443

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=97.17  E-value=0.0034  Score=59.98  Aligned_cols=140  Identities=13%  Similarity=0.083  Sum_probs=77.5

Q ss_pred             CceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCccHHHHHHHHHHHhcCCCC--CcceEEEE-----EEeCCeE
Q 046893           98 YILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHS--NLVKLIGY-----CCEDEHR  170 (464)
Q Consensus        98 ~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp--niv~l~~~-----~~~~~~~  170 (464)
                      ..|+ |....||+....+       +..+++|+..... .....+..|..++..|...  .+.+++..     ....+..
T Consensus        32 ~~l~-g~~n~~y~v~~~~-------g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~  102 (328)
T 1zyl_A           32 TPLN-SYENRVYQFQDED-------RRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFY  102 (328)
T ss_dssp             EEEC-CSSSEEEEECCTT-------CCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEE
T ss_pred             Eeec-CcccceEEEEcCC-------CCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEE
Confidence            3466 8888999865432       2348899876432 2345667788887776321  23333332     2335667


Q ss_pred             EEEEeccCCCCHH-----H------H---HHhhc-C------CCCCHHHH----------------------HHHHHHHH
Q 046893          171 ILVYEYMESGSLE-----K------H---LLRRV-G------CMLTWSRR----------------------MKIALDAA  207 (464)
Q Consensus       171 ~lv~e~~~~g~L~-----~------~---l~~~~-~------~~l~~~~~----------------------~~i~~qi~  207 (464)
                      ++||++++|..+.     .      .   ++... .      ..+.+...                      ...+..++
T Consensus       103 ~~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~  182 (328)
T 1zyl_A          103 FAVFPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELI  182 (328)
T ss_dssp             EEEEECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHH
T ss_pred             EEEEEecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHH
Confidence            8999999875431     1      1   11100 0      01122111                      01111122


Q ss_pred             HHHHHHh--cCCCCeeeccCCCCceEecCCCceEEcccCCccC
Q 046893          208 KGLAFLH--GAERPVIYRDFKTSNILLNADFSAKLSDFGLAKD  248 (464)
Q Consensus       208 ~~l~~LH--~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~  248 (464)
                      ..+.-+-  .....++|+|+++.|||++ + .+.|+||+.+..
T Consensus       183 ~~l~~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~  223 (328)
T 1zyl_A          183 AAVTAHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN  223 (328)
T ss_dssp             HHHHHHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred             HHHHHHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence            2222111  1245689999999999998 4 899999998763

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=97.13  E-value=0.0016  Score=65.64  Aligned_cols=74  Identities=15%  Similarity=0.043  Sum_probs=44.6

Q ss_pred             CceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCccHHHHHHHHHHHhcCCCCCc-ceEEEEEEeCCeEEEEEec
Q 046893           98 YILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNL-VKLIGYCCEDEHRILVYEY  176 (464)
Q Consensus        98 ~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpni-v~l~~~~~~~~~~~lv~e~  176 (464)
                      +.|+.|-...+|+......      +..+++|+....... .-....|+.++..|...++ .++++++  .+  .+||||
T Consensus       114 ~~lsgG~tN~~y~v~~~~~------~~~~vLRi~g~~~~~-~idR~~E~~vl~~L~~~gl~P~ll~~~--~~--G~v~e~  182 (458)
T 2qg7_A          114 QIINGGITNILIKVKDMSK------QAKYLIRLYGPKTDE-IINREREKKISCILYNKNIAKKIYVFF--TN--GRIEEF  182 (458)
T ss_dssp             EEECC--CEEEEEEEETTT------TEEEEEEEECC-CCS-CSCHHHHHHHHHHHTTSSSBCCEEEEE--TT--EEEEEC
T ss_pred             EEcCCCeEeEEEEEEECCC------CceEEEEECCCChhh-hcCHHHHHHHHHHHHhcCCCCCEEEEe--CC--eEEEEe
Confidence            4577888899999876431      245788886442211 1112478888888864444 4666665  23  259999


Q ss_pred             cCCCCH
Q 046893          177 MESGSL  182 (464)
Q Consensus       177 ~~~g~L  182 (464)
                      ++|.+|
T Consensus       183 I~G~~l  188 (458)
T 2qg7_A          183 MDGYAL  188 (458)
T ss_dssp             CCSEEC
T ss_pred             eCCccC
Confidence            987544

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=96.79  E-value=0.0013  Score=64.22  Aligned_cols=79  Identities=9%  Similarity=0.015  Sum_probs=41.5

Q ss_pred             CceeecCceEEEEEEecCCCC--CCccceEEEEEEccCCCCccHHHHHHHHHHHhcCCCCC-cceEEEEEEeCCeEEEEE
Q 046893           98 YILGEGGFGVVYKGVIDENVR--PGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSN-LVKLIGYCCEDEHRILVY  174 (464)
Q Consensus        98 ~~lG~G~fg~Vy~a~~~~~~~--~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpn-iv~l~~~~~~~~~~~lv~  174 (464)
                      ..|+.|....+|+........  ....+..+++|+..... ........|..+++.|...+ +.++++.+  .  -++||
T Consensus        39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~v~  113 (369)
T 3c5i_A           39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHV-DELYNTISEFEVYKTMSKYKIAPQLLNTF--N--GGRIE  113 (369)
T ss_dssp             EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTG-GGTSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEE
T ss_pred             EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCc-cceecHHHHHHHHHHHHhcCCCCceEEec--C--CcEEE
Confidence            457788888999987542100  00012457888765421 11112356777887774323 34666543  2  26899


Q ss_pred             eccCCCC
Q 046893          175 EYMESGS  181 (464)
Q Consensus       175 e~~~~g~  181 (464)
                      ||++|..
T Consensus       114 e~i~G~~  120 (369)
T 3c5i_A          114 EWLYGDP  120 (369)
T ss_dssp             ECCCSEE
T ss_pred             EEecCCc
Confidence            9998754

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=96.66  E-value=0.013  Score=56.44  Aligned_cols=31  Identities=16%  Similarity=0.157  Sum_probs=27.5

Q ss_pred             CCeeeccCCCCceEecCCCceEEcccCCccC
Q 046893          218 RPVIYRDFKTSNILLNADFSAKLSDFGLAKD  248 (464)
Q Consensus       218 ~~ivHrDlkp~Nill~~~~~vkl~DFGla~~  248 (464)
                      ..++|+|+.+.||+++.++.+.|+||+.+..
T Consensus       206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~  236 (339)
T 3i1a_A          206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML  236 (339)
T ss_dssp             CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred             ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence            4699999999999999888899999987763

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=94.23  E-value=0.06  Score=53.45  Aligned_cols=80  Identities=11%  Similarity=0.028  Sum_probs=44.9

Q ss_pred             CceeecCceEEEEEEecCCCCC-CccceEEEEEEccCCCCccHHHHHHHHHHHhcCC-CCCcceEEEEEEeCCeEEEEEe
Q 046893           98 YILGEGGFGVVYKGVIDENVRP-GYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLR-HSNLVKLIGYCCEDEHRILVYE  175 (464)
Q Consensus        98 ~~lG~G~fg~Vy~a~~~~~~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~~lv~e  175 (464)
                      +.|..|-...+|+......... ...+..+++++..... ...-...+|..+++.+. +.-..++++.+  .+  ++|||
T Consensus        76 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t-~~~idR~~E~~~l~~L~~~gi~P~l~~~~--~~--~~I~e  150 (424)
T 3mes_A           76 KQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV-GKFYDSKVELDVFRYLSNINIAPNIIADF--PE--GRIEE  150 (424)
T ss_dssp             EEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC--CCCCHHHHHHHHHHHHHTTSSCCEEEEE--TT--EEEEE
T ss_pred             EEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc-chhcCHHHHHHHHHHHHhcCCCCCEEEEc--CC--CEEEE
Confidence            4566788888999876531100 0013458888864432 11112346788887774 22234555433  22  68999


Q ss_pred             ccCCCCH
Q 046893          176 YMESGSL  182 (464)
Q Consensus       176 ~~~~g~L  182 (464)
                      |++|..|
T Consensus       151 fI~G~~l  157 (424)
T 3mes_A          151 FIDGEPL  157 (424)
T ss_dssp             CCCSEEC
T ss_pred             EeCCccC
Confidence            9988653

>4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp}

Probab=91.02  E-value=0.46  Score=42.06  Aligned_cols=115  Identities=7%  Similarity=0.086  Sum_probs=78.4

Q ss_pred             CCCCcceEEEEEEeCCeEEEEEeccCCC-CHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceE
Q 046893          153 RHSNLVKLIGYCCEDEHRILVYEYMESG-SLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNIL  231 (464)
Q Consensus       153 ~hpniv~l~~~~~~~~~~~lv~e~~~~g-~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nil  231 (464)
                      .||+++.. .+-..++.+.+.++.-+.+ ++.. +.     .++...++.++.+|+....+++  .  =+|-=|.|+||+
T Consensus        43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~-ik-----~~~~~eKlr~l~ni~~l~~~~~--~--r~tf~L~P~NL~  111 (215)
T 4ann_A           43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDN-IK-----SFTKNEKLRYLLNIKNLEEVNR--T--RYTFVLAPDELF  111 (215)
T ss_dssp             CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGG-GG-----GSCHHHHHHHHHHGGGGGGGGG--S--SEECCCSGGGEE
T ss_pred             cCCcccce-EEEEcccEEEEEEEcCcccCCHHH-HH-----hcCHHHHHHHHHHHHHHHHHhc--C--ceEEEEecceEE
Confidence            58888877 5666677776666654322 2322 22     3788999999999988776665  3  478889999999


Q ss_pred             ecCCCceEEcccCCccCCCCCCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHhCCCCCC
Q 046893          232 LNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVD  302 (464)
Q Consensus       232 l~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~  302 (464)
                      ++.++.++|.-.|+-..                   ++|.     .++...=+-.+=+++..+++++..|.
T Consensus       112 f~~~~~p~i~~RGik~~-------------------l~P~-----~~~ee~fL~qyKAliiall~~K~~Fe  158 (215)
T 4ann_A          112 FTRDGLPIAKTRGLQNV-------------------VDPL-----PVSEAEFLTRYKALVICAFNEKQSFD  158 (215)
T ss_dssp             ECTTSCEEESCCEETTT-------------------BSCC-----CCCHHHHHHHHHHHHHHHHCTTCCHH
T ss_pred             EcCCCCEEEEEccCccC-------------------CCCC-----CCCHHHHHHHHHHHHHHHHcCCCCHH
Confidence            99999999987775432                   1121     12222233456778888999887764

>4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid}

Probab=90.44  E-value=0.79  Score=40.68  Aligned_cols=115  Identities=10%  Similarity=0.070  Sum_probs=76.0

Q ss_pred             CCCCcceEEEEEEeCCeEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHH-HHhcCCCCeeeccCCCCceE
Q 046893          153 RHSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLA-FLHGAERPVIYRDFKTSNIL  231 (464)
Q Consensus       153 ~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~-~LH~~~~~ivHrDlkp~Nil  231 (464)
                      .||++  -..+-.+++.+.+.++.-+++.=...+.     .++...+++++.+|+.-.. +++  .  -+|-=|.|+||+
T Consensus        48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i~-----~~~~~eKlrll~nl~~L~~~~~~--~--r~tf~l~P~NL~  116 (219)
T 4ano_A           48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAIR-----KTTLLSRIRAAIHLVSKVKHHSA--R--RLIFIVCPENLM  116 (219)
T ss_dssp             SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHHH-----TSCHHHHHHHHHHHHHHHSSCCS--S--SEECCCCGGGEE
T ss_pred             cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHHH-----hcCHHHHHHHHHHHHHHHHHhhh--C--ceeEEEeCceEE
Confidence            57877  4445577777777777653332223332     3789999999988887666 555  3  678889999999


Q ss_pred             ecCCCceEEcccCCccCCCCCCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHhCCCCCC
Q 046893          232 LNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVD  302 (464)
Q Consensus       232 l~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~  302 (464)
                      ++.++.++|.-.|+-..                   ++|.-     ++...=+-.+=+++..++.++..|.
T Consensus       117 f~~~~~p~i~hRGi~~~-------------------lpP~e-----~~ee~fl~qyKali~all~~K~~Fe  163 (219)
T 4ano_A          117 FNRALEPFFLHVGVKES-------------------LPPDE-----WDDERLLREVKATVLALTEGEYRFD  163 (219)
T ss_dssp             ECTTCCEEESCCEETTT-------------------BSSCS-----CCHHHHHHHHHHHHHHHTTCSSCHH
T ss_pred             EeCCCcEEEEEcCCccc-------------------CCCCC-----CCHHHHHHHHHHHHHHHHcCCCCHH
Confidence            99999999987775332                   22321     1222223356677888888876553

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=85.70  E-value=0.39  Score=47.12  Aligned_cols=29  Identities=28%  Similarity=0.316  Sum_probs=24.6

Q ss_pred             CeeeccCCCCceEe------cCCCceEEcccCCcc
Q 046893          219 PVIYRDFKTSNILL------NADFSAKLSDFGLAK  247 (464)
Q Consensus       219 ~ivHrDlkp~Nill------~~~~~vkl~DFGla~  247 (464)
                      .++|+|+.+.|||+      +++..+.++||..|.
T Consensus       245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~  279 (401)
T 3g15_A          245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSS  279 (401)
T ss_dssp             EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCE
T ss_pred             eeEEecCCCCeEEEecCcccCcCCeEEEechHhcc
Confidence            36799999999999      456779999998875

>3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A

Probab=84.87  E-value=0.11  Score=52.23  Aligned_cols=63  Identities=6%  Similarity=0.000  Sum_probs=17.9

Q ss_pred             CCCCceeecCceEEEEEEecCCCCCCccceEEEE------EEccCCCCc--cHHHHHHHHHHHhcCCCCCcceEEEEEEe
Q 046893           95 RPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAI------KELNRGGYQ--GDREWLAEVNYLGQLRHSNLVKLIGYCCE  166 (464)
Q Consensus        95 ~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vav------K~~~~~~~~--~~~~~~~E~~~l~~l~hpniv~l~~~~~~  166 (464)
                      .+.+.||   ||.||+|.+...      ...||+      |........  ....+.+|..++..++|||+++.+.|...
T Consensus       145 ~l~~~lG---fG~v~~g~~~~~------~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~~  215 (463)
T 3cxl_A          145 PIYEHVG---YTTLNREPAYKK------HMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKVH  215 (463)
T ss_dssp             CSTTTSS---BCCC---------------CCBGGGC-----------------------------------CBCCCEEEE
T ss_pred             cccccCC---chhhhccccccc------CCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEEe
Confidence            4456777   999999988642      234677      665432222  22457889999999999999999887653

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	464
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	3e-70
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	2e-66
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	7e-66
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	2e-65
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	2e-64
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	4e-64
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	6e-63
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	6e-62
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	1e-61
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	1e-61
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	4e-61
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	5e-61
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	8e-61
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	3e-60
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	4e-60
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	2e-59
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	1e-58
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	9e-58
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	1e-57
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	1e-57
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	4e-57
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	1e-56
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	2e-56
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	2e-56
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	5e-56
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	8e-56
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	1e-55
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	5e-55
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	2e-52
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	6e-52
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	1e-51
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	5e-50
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	2e-48
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	1e-46
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	2e-45
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	2e-45
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	3e-45
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	3e-45
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	3e-45
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	6e-44
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	1e-43
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	8e-42
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	1e-41
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	1e-41
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	5e-41
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	2e-40
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	3e-40
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	6e-40
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	7e-40
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	1e-39
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	2e-39
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	4e-39
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	8e-38
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	3e-36
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	8e-36
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	8e-35
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	4e-34
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	7e-33
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	1e-29
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	2e-29
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	6e-28
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	6e-24
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	4e-17

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  222 bits (566), Expect = 3e-70
 Identities = 75/281 (26%), Positives = 126/281 (44%), Gaps = 30/281 (10%)

Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGY--QGDREWLAEVNYLGQLRHSNL 157
           +G G FG VYKG    +V         A+K LN      Q  + +  EV  L + RH N+
Sbjct: 16  IGSGSFGTVYKGKWHGDV---------AVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNI 66

Query: 158 VKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAE 217
           +  +GY        +V ++ E  SL  HL   +       + + IA   A+G+ +LH   
Sbjct: 67  LLFMGYS-TAPQLAIVTQWCEGSSLYHHL-HIIETKFEMIKLIDIARQTAQGMDYLH--A 122

Query: 218 RPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMT-- 275
           + +I+RD K++NI L+ D + K+ DFGLA        +H   ++ G+  + APE +    
Sbjct: 123 KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQD 182

Query: 276 -GHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRILDPRL 334
               + +SDVY FG+VL E++ G+       P    N  +    ++         L P L
Sbjct: 183 KNPYSFQSDVYAFGIVLYELMTGQ------LPYSNINNRDQIIFMVGRG-----YLSPDL 231

Query: 335 EGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETVQ 375
             +  +     +  L  +CL +    RP+   ++A +E + 
Sbjct: 232 S-KVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLA 271

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  212 bits (541), Expect = 2e-66
 Identities = 79/273 (28%), Positives = 130/273 (47%), Gaps = 28/273 (10%)

Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVK 159
           LG G FG V+ G  + +       T VA+K L +G       +LAE N + QL+H  LV+
Sbjct: 21  LGAGQFGEVWMGYYNGH-------TKVAVKSLKQG-SMSPDAFLAEANLMKQLQHQRLVR 72

Query: 160 LIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERP 219
           L       E   ++ EYME+GSL   L    G  LT ++ + +A   A+G+AF+   ER 
Sbjct: 73  LYA-VVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE--ERN 129

Query: 220 VIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLT 279
            I+RD + +NIL++   S K++DFGLA+     ++            + APE +  G  T
Sbjct: 130 YIHRDLRAANILVSDTLSCKIADFGLARLIE-DNEYTAREGAKFPIKWTAPEAINYGTFT 188

Query: 280 ARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRILDPRLEGQYT 339
            +SDV+ FG++L E++   R       + E         ++ N ++  R++ P       
Sbjct: 189 IKSDVWSFGILLTEIVTHGRIPYPGMTNPE---------VIQNLERGYRMVRPD------ 233

Query: 340 ARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLE 372
                ++  L   C  + P+ RP    + ++LE
Sbjct: 234 -NCPEELYQLMRLCWKERPEDRPTFDYLRSVLE 265

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  212 bits (540), Expect = 7e-66
 Identities = 76/291 (26%), Positives = 122/291 (41%), Gaps = 26/291 (8%)

Query: 99  ILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGD-REWLAEVNYLGQLRHSNL 157
           ++G G FG VY G + +N     K    A+K LNR    G+  ++L E   +    H N+
Sbjct: 34  VIGRGHFGCVYHGTLLDN---DGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 90

Query: 158 VKLIGYCCEDEHRI-LVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGA 216
           + L+G C   E    +V  YM+ G L   +        T    +   L  AKG+ FL   
Sbjct: 91  LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNE-THNPTVKDLIGFGLQVAKGMKFLA-- 147

Query: 217 ERPVIYRDFKTSNILLNADFSAKLSDFGLAKD--GPMGDQTHVSTRVMGTYGYAAPEYVM 274
            +  ++RD    N +L+  F+ K++DFGLA+D      D  H  T       + A E + 
Sbjct: 148 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQ 207

Query: 275 TGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRILDPRL 334
           T   T +SDV+ FGV+L E++          P  + N  +    LL       R+L P  
Sbjct: 208 TQKFTTKSDVWSFGVLLWELMTRGA-----PPYPDVNTFDITVYLLQGR----RLLQPEY 258

Query: 335 EGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETVQSQGAEEEMLQ 385
                      +  +  +C     + RP  S++V+ +  + S    E  + 
Sbjct: 259 -------CPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEHYVH 302

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  210 bits (536), Expect = 2e-65
 Identities = 74/307 (24%), Positives = 132/307 (42%), Gaps = 35/307 (11%)

Query: 79  VDIFTYNEMKLATKFF---------RPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIK 129
           +D FT+ +   A + F         + + ++G G FG V  G       PG +  FVAIK
Sbjct: 4   IDPFTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSG---HLKLPGKREIFVAIK 60

Query: 130 ELNRGGYQGD-REWLAEVNYLGQLRHSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLR 188
            L  G  +   R++L+E + +GQ  H N++ L G   +    +++ E+ME+GSL+  L +
Sbjct: 61  TLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQ 120

Query: 189 RVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKD 248
             G   T  + + +    A G+ +L   +   ++RD    NIL+N++   K+SDFGL++ 
Sbjct: 121 NDGQF-TVIQLVGMLRGIAAGMKYLA--DMNYVHRDLAARNILVNSNLVCKVSDFGLSRF 177

Query: 249 GPMGDQTHVSTRV---MGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSR 305
                     T          + APE +     T+ SDV+ +G+V+ E++         R
Sbjct: 178 LEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGE-----R 232

Query: 306 PSREHNLVEWARPLLNNNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMS 365
           P  +             N+ V+  ++              +  L   C  ++   RP   
Sbjct: 233 PYWD-----------MTNQDVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFG 281

Query: 366 DVVALLE 372
            +V  L+
Sbjct: 282 QIVNTLD 288

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  206 bits (525), Expect = 2e-64
 Identities = 64/273 (23%), Positives = 112/273 (41%), Gaps = 28/273 (10%)

Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVK 159
           LG G FGVV  G              VAIK +  G    + E++ E   +  L H  LV+
Sbjct: 12  LGTGQFGVVKYGKWRGQ-------YDVAIKMIKEG-SMSEDEFIEEAKVMMNLSHEKLVQ 63

Query: 160 LIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERP 219
           L G C +     ++ EYM +G L  +L           + +++  D  + + +L    + 
Sbjct: 64  LYGVCTKQRPIFIITEYMANGCLLNYLREMRHR-FQTQQLLEMCKDVCEAMEYLE--SKQ 120

Query: 220 VIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLT 279
            ++RD    N L+N     K+SDFGL++     D+   S        ++ PE +M    +
Sbjct: 121 FLHRDLAARNCLVNDQGVVKVSDFGLSRYVL-DDEYTSSVGSKFPVRWSPPEVLMYSKFS 179

Query: 280 ARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRILDPRLEGQYT 339
           ++SD++ FGV++ E+    +      P       E       +  + LR+  P L  +  
Sbjct: 180 SKSDIWAFGVLMWEIYSLGK-----MPYERFTNSE----TAEHIAQGLRLYRPHLASE-- 228

Query: 340 ARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLE 372
                KV  + Y C  +    RP    +++ + 
Sbjct: 229 -----KVYTIMYSCWHEKADERPTFKILLSNIL 256

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  206 bits (524), Expect = 4e-64
 Identities = 75/288 (26%), Positives = 126/288 (43%), Gaps = 37/288 (12%)

Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVK 159
           +G G FG+V+ G              VAIK +  G    + +++ E   + +L H  LV+
Sbjct: 13  IGSGQFGLVHLGYWL-------NKDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQ 64

Query: 160 LIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERP 219
           L G C E     LV+E+ME G L  +L  +   +      + + LD  +G+A+L   E  
Sbjct: 65  LYGVCLEQAPICLVFEFMEHGCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLE--EAC 121

Query: 220 VIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLT 279
           VI+RD    N L+  +   K+SDFG+ +     DQ   ST       +A+PE       +
Sbjct: 122 VIHRDLAARNCLVGENQVIKVSDFGMTRFVL-DDQYTSSTGTKFPVKWASPEVFSFSRYS 180

Query: 280 ARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRILDPRLEGQYT 339
           ++SDV+ FGV++ E+    +   ++R + E         ++ +     R+  PRL     
Sbjct: 181 SKSDVWSFGVLMWEVFSEGKIPYENRSNSE---------VVEDISTGFRLYKPRLAST-- 229

Query: 340 ARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETVQSQGAEEEMLQSG 387
                 V  +   C  + P+ RP  S ++  L          E+ +SG
Sbjct: 230 -----HVYQIMNHCWKERPEDRPAFSRLLRQL---------AEIAESG 263

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  202 bits (516), Expect = 6e-63
 Identities = 72/280 (25%), Positives = 118/280 (42%), Gaps = 34/280 (12%)

Query: 99  ILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLV 158
            +G+G FG V  G         Y+   VA+K +        + +LAE + + QLRHSNLV
Sbjct: 14  TIGKGEFGDVMLGD--------YRGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLV 63

Query: 159 KLIGYCCEDEHRI-LVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAE 217
           +L+G   E++  + +V EYM  GSL  +L  R   +L     +K +LD  + + +L    
Sbjct: 64  QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE--G 121

Query: 218 RPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGH 277
              ++RD    N+L++ D  AK+SDFGL K+      T           + APE +    
Sbjct: 122 NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDT-----GKLPVKWTAPEALREKK 176

Query: 278 LTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRILDPRLEGQ 337
            + +SDV+ FG++L E+    R      P     L +          +V +         
Sbjct: 177 FSTKSDVWSFGILLWEIYSFGR-----VPYPRIPLKDVVP-------RVEKGYKMDAPDG 224

Query: 338 YTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETVQSQ 377
                   V  +   C   +   RP    +   LE +++ 
Sbjct: 225 CPP----AVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH 260

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  201 bits (511), Expect = 6e-62
 Identities = 71/278 (25%), Positives = 116/278 (41%), Gaps = 26/278 (9%)

Query: 97  DYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDRE-WLAEVNYLGQLRHS 155
           D  LG G FG V +GV     R   K   VAIK L +G  + D E  + E   + QL + 
Sbjct: 14  DIELGCGNFGSVRQGV----YRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNP 69

Query: 156 NLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHG 215
            +V+LIG  C+ E  +LV E    G L K L+ +    +  S   ++    + G+ +L  
Sbjct: 70  YIVRLIG-VCQAEALMLVMEMAGGGPLHKFLVGKREE-IPVSNVAELLHQVSMGMKYLE- 126

Query: 216 AERPVIYRDFKTSNILLNADFSAKLSDFGLAKD-GPMGDQTHVSTRVMGTYGYAAPEYVM 274
            E+  ++RD    N+LL     AK+SDFGL+K  G         +       + APE + 
Sbjct: 127 -EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECIN 185

Query: 275 TGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRILDPRL 334
               ++RSDV+ +GV + E L   +     +P ++               +V+  ++   
Sbjct: 186 FRKFSSRSDVWSYGVTMWEALSYGQ-----KPYKKM-----------KGPEVMAFIEQGK 229

Query: 335 EGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLE 372
             +       ++  L   C     + RP    V   + 
Sbjct: 230 RMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMR 267

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  200 bits (509), Expect = 1e-61
 Identities = 72/281 (25%), Positives = 131/281 (46%), Gaps = 23/281 (8%)

Query: 94  FRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDR-EWLAEVNYLGQL 152
                ++G G FG VYKG++  +   G K   VAIK L  G  +  R ++L E   +GQ 
Sbjct: 9   VTRQKVIGAGEFGEVYKGMLKTS--SGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 66

Query: 153 RHSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAF 212
            H N+++L G   + +  +++ EYME+G+L+K L  + G   +  + + +    A G+ +
Sbjct: 67  SHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGE-FSVLQLVGMLRGIAAGMKY 125

Query: 213 LHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKD-GPMGDQTHVSTRVMGTYGYAAPE 271
           L       ++RD    NIL+N++   K+SDFGL++      + T+ ++       + APE
Sbjct: 126 LA--NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPE 183

Query: 272 YVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRILD 331
            +     T+ SDV+ FG+V+ E++                          +N +V++ ++
Sbjct: 184 AISYRKFTSASDVWSFGIVMWEVMTYGERPYWEL----------------SNHEVMKAIN 227

Query: 332 PRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLE 372
                         +  L  QC  Q    RP  +D+V++L+
Sbjct: 228 DGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILD 268

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  200 bits (509), Expect = 1e-61
 Identities = 64/292 (21%), Positives = 121/292 (41%), Gaps = 26/292 (8%)

Query: 94  FRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLR 153
               + LG G +G VY+GV  +          VA+K L     +   E+L E   + +++
Sbjct: 19  ITMKHKLGGGQYGEVYEGVWKKYSLT------VAVKTLKEDTMEV-EEFLKEAAVMKEIK 71

Query: 154 HSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFL 213
           H NLV+L+G C  +    ++ E+M  G+L  +L       ++    + +A   +  + +L
Sbjct: 72  HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL 131

Query: 214 HGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYV 273
              ++  I+RD    N L+  +   K++DFGL++    GD             + APE +
Sbjct: 132 E--KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESL 188

Query: 274 MTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRILDPR 333
                + +SDV+ FGV+L E+     +                     +  +V  +L+  
Sbjct: 189 AYNKFSIKSDVWAFGVLLWEIATYGMSPYPG----------------IDLSQVYELLEKD 232

Query: 334 LEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETVQSQGAEEEMLQ 385
              +       KV  L   C   NP  RP  +++    ET+  + +  + ++
Sbjct: 233 YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVE 284

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  199 bits (506), Expect = 4e-61
 Identities = 75/279 (26%), Positives = 117/279 (41%), Gaps = 28/279 (10%)

Query: 94  FRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLR 153
            R +  LG+G FG V+ G  +        TT VAIK L  G       +L E   + +LR
Sbjct: 19  LRLEVKLGQGCFGEVWMGTWN-------GTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLR 70

Query: 154 HSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFL 213
           H  LV+L     E+    +V EYM  GSL   L    G  L   + + +A   A G+A++
Sbjct: 71  HEKLVQLYAVVSEEPI-YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYV 129

Query: 214 HGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYV 273
                  ++RD + +NIL+  +   K++DFGLA+     ++            + APE  
Sbjct: 130 E--RMNYVHRDLRAANILVGENLVCKVADFGLARLIE-DNEYTARQGAKFPIKWTAPEAA 186

Query: 274 MTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRILDPR 333
           + G  T +SDV+ FG++L E+    R                       N++VL  ++  
Sbjct: 187 LYGRFTIKSDVWSFGILLTELTTKGRVPYPG----------------MVNREVLDQVERG 230

Query: 334 LEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLE 372
                       +  L  QC  + P+ RP    + A LE
Sbjct: 231 YRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLE 269

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  200 bits (508), Expect = 5e-61
 Identities = 71/329 (21%), Positives = 123/329 (37%), Gaps = 46/329 (13%)

Query: 71  RQNPGYSNVDIFTYNEMKLATKFFRPDY----ILGEGGFGVVYKGVIDENVRPGYKTTFV 126
             +  Y  VD   Y E  L  +F R +     +LG G FG V        +     +  V
Sbjct: 13  SSDNEYFYVDFREY-EYDLKWEFPRENLEFGKVLGSGAFGKVMNAT-AYGISKTGVSIQV 70

Query: 127 AIKELNRGGYQGDRE-WLAEVNYLGQL-RHSNLVKLIGYCCEDEHRILVYEYMESGSLEK 184
           A+K L       +RE  ++E+  + QL  H N+V L+G C       L++EY   G L  
Sbjct: 71  AVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLN 130

Query: 185 HLLRRVG---------------------CMLTWSRRMKIALDAAKGLAFLHGAERPVIYR 223
           +L  +                        +LT+   +  A   AKG+ FL    +  ++R
Sbjct: 131 YLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE--FKSCVHR 188

Query: 224 DFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSD 283
           D    N+L+      K+ DFGLA+D        V         + APE +  G  T +SD
Sbjct: 189 DLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSD 248

Query: 284 VYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRILDPRLEGQYTARTA 343
           V+ +G++L E+           P             +  +    +++    +        
Sbjct: 249 VWSYGILLWEIFSLGV-----NPYPG----------IPVDANFYKLIQNGFKMDQPFYAT 293

Query: 344 MKVAGLAYQCLSQNPKGRPVMSDVVALLE 372
            ++  +   C + + + RP   ++ + L 
Sbjct: 294 EEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  198 bits (505), Expect = 8e-61
 Identities = 72/303 (23%), Positives = 122/303 (40%), Gaps = 40/303 (13%)

Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWL--AEVNYLGQLRHSNL 157
           +G+G FG V++G         ++   VA+K  +    + +R W   AE+     LRH N+
Sbjct: 11  IGKGRFGEVWRGK--------WRGEEVAVKIFSS---REERSWFREAEIYQTVMLRHENI 59

Query: 158 VKLIGYCCEDE----HRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFL 213
           +  I    +D        LV +Y E GSL  +L R     +T    +K+AL  A GLA L
Sbjct: 60  LGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT---VTVEGMIKLALSTASGLAHL 116

Query: 214 H------GAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQT--HVSTRVMGTY 265
           H        +  + +RD K+ NIL+  + +  ++D GLA        T        +GT 
Sbjct: 117 HMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTK 176

Query: 266 GYAAPEYVMT------GHLTARSDVYGFGVVLLEMLLGRR----AVDKSRPSREHNLVEW 315
            Y APE +             R+D+Y  G+V  E+           D   P  +    + 
Sbjct: 177 RYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP 236

Query: 316 ARPLLNNNKKVLRILDPRLEGQYTARTAMK-VAGLAYQCLSQNPKGRPVMSDVVALLETV 374
           +   +       + L P +  ++ +  A++ +A +  +C   N   R     +   L  +
Sbjct: 237 SVEEM-RKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL 295

Query: 375 QSQ 377
             Q
Sbjct: 296 SQQ 298

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  196 bits (500), Expect = 3e-60
 Identities = 65/296 (21%), Positives = 115/296 (38%), Gaps = 42/296 (14%)

Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDR-EWLAEVNYLGQLRHSNLV 158
           +GEG FG V++      + P    T VA+K L        + ++  E   + +  + N+V
Sbjct: 21  IGEGAFGRVFQAR-APGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIV 79

Query: 159 KLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCM----------------------LTW 196
           KL+G C   +   L++EYM  G L + L                             L+ 
Sbjct: 80  KLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSC 139

Query: 197 SRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTH 256
           + ++ IA   A G+A+L   ER  ++RD  T N L+  +   K++DFGL+++    D   
Sbjct: 140 AEQLCIARQVAAGMAYLS--ERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYK 197

Query: 257 VSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWA 316
                     +  PE +     T  SDV+ +GVVL E+                      
Sbjct: 198 ADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYG------------ 245

Query: 317 RPLLNNNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLE 372
              + + + +  + D  +         +++  L   C S+ P  RP    +  +L+
Sbjct: 246 ---MAHEEVIYYVRDGNIL-ACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQ 297

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  197 bits (501), Expect = 4e-60
 Identities = 70/297 (23%), Positives = 109/297 (36%), Gaps = 36/297 (12%)

Query: 99  ILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDRE-WLAEVNYLGQL-RHSN 156
            LG G FG V +      ++     T VA+K L    +  +RE  ++E+  L  L  H N
Sbjct: 30  TLGAGAFGKVVEATAYGLIKSDAAMT-VAVKMLKPSAHLTEREALMSELKVLSYLGNHMN 88

Query: 157 LVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCM----------------LTWSRRM 200
           +V L+G C      +++ EY   G L   L R+                    L     +
Sbjct: 89  IVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLL 148

Query: 201 KIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTR 260
             +   AKG+AFL    +  I+RD    NILL      K+ DFGLA+D        V   
Sbjct: 149 SFSYQVAKGMAFLA--SKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGN 206

Query: 261 VMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLL 320
                 + APE +     T  SDV+ +G+ L E+     +     P              
Sbjct: 207 ARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS----------- 255

Query: 321 NNNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETVQSQ 377
               K  +++              ++  +   C   +P  RP    +V L+E   S+
Sbjct: 256 ----KFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE 308

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  195 bits (497), Expect = 2e-59
 Identities = 64/308 (20%), Positives = 122/308 (39%), Gaps = 40/308 (12%)

Query: 87  MKLATKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDRE-WLAE 145
           M+L    F     LG G  GVV+K     +         +A K ++       R   + E
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFKVSHKPSGL------VMARKLIHLEIKPAIRNQIIRE 54

Query: 146 VNYLGQLRHSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALD 205
           +  L +     +V   G    D    +  E+M+ GSL++ L +     +      K+++ 
Sbjct: 55  LQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR--IPEQILGKVSIA 112

Query: 206 AAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTY 265
             KGL +L   +  +++RD K SNIL+N+    KL DFG++          ++   +GT 
Sbjct: 113 VIKGLTYLR-EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI----DSMANSFVGTR 167

Query: 266 GYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRR-------------------------- 299
            Y +PE +   H + +SD++  G+ L+EM +GR                           
Sbjct: 168 SYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETP 227

Query: 300 AVDKSRPSREHNLVEWARPLLNNNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPK 359
              ++      +    +RP +   + +  I++       +   +++      +CL +NP 
Sbjct: 228 PRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPA 287

Query: 360 GRPVMSDV 367
            R  +  +
Sbjct: 288 ERADLKQL 295

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  191 bits (487), Expect = 1e-58
 Identities = 72/279 (25%), Positives = 114/279 (40%), Gaps = 28/279 (10%)

Query: 97  DYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGD--REWLAEVNYLGQLRH 154
           D  LG G FG V KG      +       VA+K L           E LAE N + QL +
Sbjct: 12  DKELGSGNFGTVKKGY----YQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDN 67

Query: 155 SNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLH 214
             +V++IG  CE E  +LV E  E G L K+L +     +     +++    + G+ +L 
Sbjct: 68  PYIVRMIG-ICEAESWMLVMEMAELGPLNKYLQQN--RHVKDKNIIELVHQVSMGMKYLE 124

Query: 215 GAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMG-DQTHVSTRVMGTYGYAAPEYV 273
             E   ++RD    N+LL     AK+SDFGL+K      +     T       + APE +
Sbjct: 125 --ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECI 182

Query: 274 MTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRILDPR 333
                +++SDV+ FGV++ E     +     +P R                +V  +L+  
Sbjct: 183 NYYKFSSKSDVWSFGVLMWEAFSYGQ-----KPYRGM-----------KGSEVTAMLEKG 226

Query: 334 LEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLE 372
                 A    ++  L   C + + + RP  + V   L 
Sbjct: 227 ERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLR 265

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  189 bits (482), Expect = 9e-58
 Identities = 73/280 (26%), Positives = 113/280 (40%), Gaps = 26/280 (9%)

Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGY---QGDREWLAEVNYLGQLRHSN 156
           LG+G FGVV +G  D    P  KT  VA+K L        +   +++ EVN +  L H N
Sbjct: 16  LGDGSFGVVRRGEWD---APSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRN 72

Query: 157 LVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGA 216
           L++L G       ++ V E    GSL   L +  G         + A+  A+G+ +L   
Sbjct: 73  LIRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGH-FLLGTLSRYAVQVAEGMGYLE-- 128

Query: 217 ERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHV-STRVMGTYGYAAPEYVMT 275
            +  I+RD    N+LL      K+ DFGL +  P  D  +V        + + APE + T
Sbjct: 129 SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKT 188

Query: 276 GHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRILDPRLE 335
              +  SD + FGV L EM    +      P    N  +    +    +++ R  D    
Sbjct: 189 RTFSHASDTWMFGVTLWEMFTYGQ-----EPWIGLNGSQILHKIDKEGERLPRPED---- 239

Query: 336 GQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETVQ 375
                     +  +  QC +  P+ RP    +   L   Q
Sbjct: 240 ------CPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ 273

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  189 bits (481), Expect = 1e-57
 Identities = 69/284 (24%), Positives = 108/284 (38%), Gaps = 35/284 (12%)

Query: 92  KFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGD--REWLAEVNYL 149
           +F + D  +G G F  VYKG+  E          VA  EL          + +  E   L
Sbjct: 9   RFLKFDIEIGRGSFKTVYKGLDTETTVE------VAWCELQDRKLTKSERQRFKEEAEML 62

Query: 150 GQLRHSNLVKLIGYCCE----DEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALD 205
             L+H N+V+            +  +LV E M SG+L+ +L R    ++           
Sbjct: 63  KGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRF--KVMKIKVLRSWCRQ 120

Query: 206 AAKGLAFLHGAERPVIYRDFKTSNILLNA-DFSAKLSDFGLAKDGPMGDQTHVSTRVMGT 264
             KGL FLH    P+I+RD K  NI +     S K+ D GLA       +   +  V+GT
Sbjct: 121 ILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL----KRASFAKAVIGT 176

Query: 265 YGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNK 324
             + APE +         DVY FG+ +LEM        + + + +               
Sbjct: 177 PEFMAPE-MYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQI-------------- 221

Query: 325 KVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVV 368
              R+        +      +V  +   C+ QN   R  + D++
Sbjct: 222 -YRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLL 264

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  189 bits (482), Expect = 1e-57
 Identities = 65/280 (23%), Positives = 109/280 (38%), Gaps = 31/280 (11%)

Query: 93  FFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQL 152
           F+     LG+G FG VYK    E           A K ++    +   +++ E++ L   
Sbjct: 13  FWEIIGELGDGAFGKVYKAQNKETSV------LAAAKVIDTKSEEELEDYMVEIDILASC 66

Query: 153 RHSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAF 212
            H N+VKL+     + +  ++ E+   G+++  +L      LT S+   +       L +
Sbjct: 67  DHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERP-LTESQIQVVCKQTLDALNY 125

Query: 213 LHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEY 272
           LH  +  +I+RD K  NIL   D   KL+DFG++       Q       +GT  + APE 
Sbjct: 126 LH--DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRR--DSFIGTPYWMAPEV 181

Query: 273 VMT-----GHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVL 327
           VM           ++DV+  G+ L+EM           P  E N +     +  +    L
Sbjct: 182 VMCETSKDRPYDYKADVWSLGITLIEMAEIE------PPHHELNPMRVLLKIAKSEPPTL 235

Query: 328 RILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDV 367
                        R +        +CL +N   R   S +
Sbjct: 236 AQPS---------RWSSNFKDFLKKCLEKNVDARWTTSQL 266

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  189 bits (481), Expect = 4e-57
 Identities = 57/280 (20%), Positives = 111/280 (39%), Gaps = 23/280 (8%)

Query: 94  FRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGG-YQGDREWLAEVNYLGQL 152
           F+   +LG G FG VYKG+             VAIKEL      + ++E L E   +  +
Sbjct: 11  FKKIKVLGSGAFGTVYKGLWIPEGE--KVKIPVAIKELREATSPKANKEILDEAYVMASV 68

Query: 153 RHSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAF 212
            + ++ +L+   C      L+ + M  G L  ++      +      +   +  AKG+ +
Sbjct: 69  DNPHVCRLL-GICLTSTVQLITQLMPFGCLLDYVREHKDNI-GSQYLLNWCVQIAKGMNY 126

Query: 213 LHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEY 272
           L   +R +++RD    N+L+      K++DFGLAK     ++ + +        + A E 
Sbjct: 127 LE--DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 184

Query: 273 VMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRILDP 332
           ++    T +SDV+ +GV + E++         +P                  ++  IL+ 
Sbjct: 185 ILHRIYTHQSDVWSYGVTVWELMTFGS-----KPYDG-----------IPASEISSILEK 228

Query: 333 RLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLE 372
                      + V  +  +C   +   RP   +++    
Sbjct: 229 GERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFS 268

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  186 bits (474), Expect = 1e-56
 Identities = 62/273 (22%), Positives = 107/273 (39%), Gaps = 35/273 (12%)

Query: 99  ILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGD---REWLAEVNYLGQLRHS 155
            LG+G FG VY     ++         +A+K L +   +      +   EV     LRH 
Sbjct: 13  PLGKGKFGNVYLAREKQSKFI------LALKVLFKAQLEKAGVEHQLRREVEIQSHLRHP 66

Query: 156 NLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHG 215
           N+++L GY  +     L+ EY   G++ + L +         R      + A  L++ H 
Sbjct: 67  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK--FDEQRTATYITELANALSYCH- 123

Query: 216 AERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMT 275
             + VI+RD K  N+LL +    K++DFG +   P   +T +     GT  Y  PE +  
Sbjct: 124 -SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTL----CGTLDYLPPEMIEG 178

Query: 276 GHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRILDPRLE 335
                + D++  GV+  E L+G+       P   +   E  + +          +     
Sbjct: 179 RMHDEKVDLWSLGVLCYEFLVGK------PPFEANTYQETYKRISRVEFTFPDFVTEGA- 231

Query: 336 GQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVV 368
                        L  + L  NP  RP++ +V+
Sbjct: 232 -----------RDLISRLLKHNPSQRPMLREVL 253

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  187 bits (475), Expect = 2e-56
 Identities = 68/284 (23%), Positives = 111/284 (39%), Gaps = 38/284 (13%)

Query: 91  TKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREW---LAEVN 147
            K F     +G G FG VY      N         VAIK+++  G Q + +W   + EV 
Sbjct: 14  EKLFSDLREIGHGSFGAVYFARDVRNSEV------VAIKKMSYSGKQSNEKWQDIIKEVR 67

Query: 148 YLGQLRHSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAA 207
           +L +LRH N ++  G    +    LV EY    + +   + +    L       +   A 
Sbjct: 68  FLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKP--LQEVEIAAVTHGAL 125

Query: 208 KGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGY 267
           +GLA+LH     +I+RD K  NILL+     KL DFG A           +   +GT  +
Sbjct: 126 QGLAYLH--SHNMIHRDVKAGNILLSEPGLVKLGDFGSAS------IMAPANSFVGTPYW 177

Query: 268 AAPEYVMT---GHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNK 324
            APE ++    G    + DV+  G+  +E+   +       P    N +           
Sbjct: 178 MAPEVILAMDEGQYDGKVDVWSLGITCIELAERK------PPLFNMNAMSALY------- 224

Query: 325 KVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVV 368
            + +   P L+  + +            CL + P+ RP    ++
Sbjct: 225 HIAQNESPALQSGHWSEYFRN---FVDSCLQKIPQDRPTSEVLL 265

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  187 bits (475), Expect = 2e-56
 Identities = 69/300 (23%), Positives = 118/300 (39%), Gaps = 41/300 (13%)

Query: 94  FRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGD-REWLAEVNYLGQL 152
            +   ++GEG FG V K  I    +        AIK +     + D R++  E+  L +L
Sbjct: 12  IKFQDVIGEGNFGQVLKARI----KKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKL 67

Query: 153 -RHSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCM--------------LTWS 197
             H N++ L+G C    +  L  EY   G+L   L +                   L+  
Sbjct: 68  GHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQ 127

Query: 198 RRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHV 257
           + +  A D A+G+ +L   ++  I+RD    NIL+  ++ AK++DFGL++   +  +   
Sbjct: 128 QLLHFAADVARGMDYLS--QKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKK-- 183

Query: 258 STRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWAR 317
            T       + A E +     T  SDV+ +GV+L E++          P       E   
Sbjct: 184 -TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGG-----TPYCGMTCAELYE 237

Query: 318 PLLNNNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETVQSQ 377
            L        R+  P            +V  L  QC  + P  RP  + ++  L  +  +
Sbjct: 238 KLPQG----YRLEKPL-------NCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE 286

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  185 bits (470), Expect = 5e-56
 Identities = 65/280 (23%), Positives = 116/280 (41%), Gaps = 25/280 (8%)

Query: 99  ILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDRE-WLAEVNYLGQLRHSNL 157
            +GEG FG V++G+      P      VAIK          RE +L E   + Q  H ++
Sbjct: 14  CIGEGQFGDVHQGIYMSPENPALA---VAIKTCKNCTSDSVREKFLQEALTMRQFDHPHI 70

Query: 158 VKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAE 217
           VKLIG   E+    ++ E    G L   L  R    L  +  +  A   +  LA+L    
Sbjct: 71  VKLIGVITEN-PVWIIMELCTLGELRSFLQVRKYS-LDLASLILYAYQLSTALAYLE--S 126

Query: 218 RPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGH 277
           +  ++RD    N+L++++   KL DFGL++        + +++      + APE +    
Sbjct: 127 KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST-YYKASKGKLPIKWMAPESINFRR 185

Query: 278 LTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRILDPRLEGQ 337
            T+ SDV+ FGV + E+L+        +P +     +          ++       +   
Sbjct: 186 FTSASDVWMFGVCMWEILMHGV-----KPFQGVKNNDVI-------GRIENGERLPMPPN 233

Query: 338 YTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETVQSQ 377
                   +  L  +C + +P  RP  +++ A L T+  +
Sbjct: 234 CPP----TLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 269

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  184 bits (468), Expect = 8e-56
 Identities = 67/280 (23%), Positives = 108/280 (38%), Gaps = 31/280 (11%)

Query: 94  FRPDY----ILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDRE-WLAEVNY 148
           F  D+     LGEG +G V   V             VA+K ++        E    E+  
Sbjct: 3   FVEDWDLVQTLGEGAYGEVQLAVNRVTEEA------VAVKIVDMKRAVDCPENIKKEICI 56

Query: 149 LGQLRHSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAK 208
              L H N+VK  G+  E   + L  EY   G L   +   +G  +      +       
Sbjct: 57  NKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG--MPEPDAQRFFHQLMA 114

Query: 209 GLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYA 268
           G+ +LH     + +RD K  N+LL+   + K+SDFGLA      ++  +  ++ GT  Y 
Sbjct: 115 GVVYLH--GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYV 172

Query: 269 APEYVMTGHL-TARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVL 327
           APE +          DV+  G+VL  ML G    D+   S +           ++ K+  
Sbjct: 173 APELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ---------EYSDWKEKK 223

Query: 328 RILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDV 367
             L+P  +        +       + L +NP  R  + D+
Sbjct: 224 TYLNPWKKIDSAPLALLH------KILVENPSARITIPDI 257

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  184 bits (467), Expect = 1e-55
 Identities = 60/284 (21%), Positives = 113/284 (39%), Gaps = 34/284 (11%)

Query: 94  FRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGD--REWLAEVNYLGQ 151
           +   Y +G G +G   K     + +       +  KEL+ G       +  ++EVN L +
Sbjct: 6   YEVLYTIGTGSYGRCQKIRRKSDGKI------LVWKELDYGSMTEAEKQMLVSEVNLLRE 59

Query: 152 LRHSNLVKLIGYCCEDEHRIL--VYEYMESGSLEKHLLR--RVGCMLTWSRRMKIALDAA 207
           L+H N+V+      +  +  L  V EY E G L   + +  +    L     +++     
Sbjct: 60  LKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLT 119

Query: 208 KGLAFLH---GAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGT 264
             L   H        V++RD K +N+ L+   + KL DFGLA+   +   T  +   +GT
Sbjct: 120 LALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI--LNHDTSFAKAFVGT 177

Query: 265 YGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNK 324
             Y +PE +       +SD++  G +L E+           P    +  E A        
Sbjct: 178 PYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALM------PPFTAFSQKELA-------G 224

Query: 325 KVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVV 368
           K+      R+  +Y+     ++  +  + L+     RP + +++
Sbjct: 225 KIREGKFRRIPYRYSD----ELNEIITRMLNLKDYHRPSVEEIL 264

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  183 bits (466), Expect = 5e-55
 Identities = 73/306 (23%), Positives = 138/306 (45%), Gaps = 28/306 (9%)

Query: 76  YSNVDIFTYNEMKLATKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGG 135
           +S  D++  +E ++A +       LG+G FG+VY+GV  + V      T VAIK +N   
Sbjct: 4   FSAADVYVPDEWEVAREKITMSRELGQGSFGMVYEGV-AKGVVKDEPETRVAIKTVNEAA 62

Query: 136 YQGDR-EWLAEVNYLGQLRHSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCM- 193
              +R E+L E + + +    ++V+L+G   + +  +++ E M  G L+ +L      M 
Sbjct: 63  SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMA 122

Query: 194 -------LTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLA 246
                   + S+ +++A + A G+A+L+      ++RD    N ++  DF+ K+ DFG+ 
Sbjct: 123 NNPVLAPPSLSKMIQMAGEIADGMAYLN--ANKFVHRDLAARNCMVAEDFTVKIGDFGMT 180

Query: 247 KDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRP 306
           +D    D      + +    + +PE +  G  T  SDV+ FGVVL E+            
Sbjct: 181 RDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAE------- 233

Query: 307 SREHNLVEWARPLLNNNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSD 366
                        L+N + +  +++  L           +  L   C   NPK RP   +
Sbjct: 234 --------QPYQGLSNEQVLRFVMEGGLL-DKPDNCPDMLFELMRMCWQYNPKMRPSFLE 284

Query: 367 VVALLE 372
           +++ ++
Sbjct: 285 IISSIK 290

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  176 bits (447), Expect = 2e-52
 Identities = 57/277 (20%), Positives = 107/277 (38%), Gaps = 28/277 (10%)

Query: 91  TKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLG 150
            K +     +G+G  G VY  +     +       VAI+++N          + E+  + 
Sbjct: 19  KKKYTRFEKIGQGASGTVYTAMDVATGQE------VAIRQMNLQQQPKKELIINEILVMR 72

Query: 151 QLRHSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGL 210
           + ++ N+V  +      +   +V EY+  GSL   +       +   +   +  +  + L
Sbjct: 73  ENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQAL 129

Query: 211 AFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAP 270
            FLH     VI+RD K+ NILL  D S KL+DFG      +  +    + ++GT  + AP
Sbjct: 130 EFLH--SNQVIHRDIKSDNILLGMDGSVKLTDFGFCA--QITPEQSKRSTMVGTPYWMAP 185

Query: 271 EYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRIL 330
           E V       + D++  G++ +EM+ G        P    N +            +    
Sbjct: 186 EVVTRKAYGPKVDIWSLGIMAIEMIEGE------PPYLNENPLRAL-------YLIATNG 232

Query: 331 DPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDV 367
            P L+         +      +CL  + + R    ++
Sbjct: 233 TPELQNPEKLSAIFR--DFLNRCLDMDVEKRGSAKEL 267

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  175 bits (444), Expect = 6e-52
 Identities = 72/305 (23%), Positives = 112/305 (36%), Gaps = 44/305 (14%)

Query: 99  ILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGD-REWLAEVNYLGQ-LRHSN 156
            LG G FG V +      +        VA+K L  G    + R  ++E+  L     H N
Sbjct: 20  PLGRGAFGQVIEAD-AFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 78

Query: 157 LVKLIGYCCEDEHRI-LVYEYMESGSLEKHLLRRVGCM--------------LTWSRRMK 201
           +V L+G C +    + ++ E+ + G+L  +L  +                  LT    + 
Sbjct: 79  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 138

Query: 202 IALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRV 261
            +   AKG+ FL    R  I+RD    NILL+     K+ DFGLA+D             
Sbjct: 139 YSFQVAKGMEFLA--SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA 196

Query: 262 MGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLN 321
                + APE +     T +SDV+ FGV+L E+           P     + E     L 
Sbjct: 197 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGA-----SPYPGVKIDEEFCRRLK 251

Query: 322 NNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETVQSQGAEE 381
              + +R  D             ++      C    P  RP  S++V  L          
Sbjct: 252 EGTR-MRAPDYTTP---------EMYQTMLDCWHGEPSQRPTFSELVEHL---------G 292

Query: 382 EMLQS 386
            +LQ+
Sbjct: 293 NLLQA 297

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  174 bits (442), Expect = 1e-51
 Identities = 68/295 (23%), Positives = 119/295 (40%), Gaps = 35/295 (11%)

Query: 99  ILGEGGFGVVYKGV-IDENVRPGYKTTFVAIKELNRGGYQGD-REWLAEVNYLGQL-RHS 155
            LGEG FG V     I  +     + T VA+K L     + D  + ++E+  +  + +H 
Sbjct: 20  PLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHK 79

Query: 156 NLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCM--------------LTWSRRMK 201
           N++ L+G C +D    ++ EY   G+L ++L  R                  L+    + 
Sbjct: 80  NIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVS 139

Query: 202 IALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRV 261
            A   A+G+ +L    +  I+RD    N+L+  D   K++DFGLA+D    D    +T  
Sbjct: 140 CAYQVARGMEYLA--SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 197

Query: 262 MGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLN 321
                + APE +     T +SDV+ FGV+L E+     +     P  E            
Sbjct: 198 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE------------ 245

Query: 322 NNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETVQS 376
               + ++L         +    ++  +   C    P  RP    +V  L+ + +
Sbjct: 246 ----LFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA 296

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  169 bits (430), Expect = 5e-50
 Identities = 59/282 (20%), Positives = 100/282 (35%), Gaps = 31/282 (10%)

Query: 94  FRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGD---REWLAEVNYLG 150
           F+   ILGEG F  V         R        AIK L +     +        E + + 
Sbjct: 10  FKFGKILGEGSFSTVVLARELATSRE------YAIKILEKRHIIKENKVPYVTRERDVMS 63

Query: 151 QLRHSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGL 210
           +L H   VKL     +DE       Y ++G L K++ +        +       +    L
Sbjct: 64  RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS--FDETCTRFYTAEIVSAL 121

Query: 211 AFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAP 270
            +LH   + +I+RD K  NILLN D   +++DFG AK      +   +   +GT  Y +P
Sbjct: 122 EYLH--GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSP 179

Query: 271 EYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRIL 330
           E +        SD++  G ++ +++ G        P R  N     + ++          
Sbjct: 180 ELLTEKSACKSSDLWALGCIIYQLVAGL------PPFRAGNEYLIFQKIIKLEYDFPEKF 233

Query: 331 DPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLE 372
            P+               L  + L  +   R    ++     
Sbjct: 234 FPKA------------RDLVEKLLVLDATKRLGCEEMEGYGP 263

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  167 bits (424), Expect = 2e-48
 Identities = 60/271 (22%), Positives = 92/271 (33%), Gaps = 28/271 (10%)

Query: 99  ILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLV 158
            LG G FGVV++                A K +             E+  +  LRH  LV
Sbjct: 33  ELGTGAFGVVHRVTERATGNN------FAAKFVMTPHESDKETVRKEIQTMSVLRHPTLV 86

Query: 159 KLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAER 218
            L     +D   +++YE+M  G L + +       ++    ++      KGL  +H  E 
Sbjct: 87  NLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNK-MSEDEAVEYMRQVCKGLCHMH--EN 143

Query: 219 PVIYRDFKTSNILLNADFS--AKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTG 276
             ++ D K  NI+     S   KL DFGL       D         GT  +AAPE     
Sbjct: 144 NYVHLDLKPENIMFTTKRSNELKLIDFGLTA---HLDPKQSVKVTTGTAEFAAPEVAEGK 200

Query: 277 HLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRILDPRLEG 336
            +   +D++  GV+   +L G        P    N  E     L N K     +D     
Sbjct: 201 PVGYYTDMWSVGVLSYILLSGL------SPFGGENDDE----TLRNVKSCDWNMDDSAFS 250

Query: 337 QYTARTAMKVAGLAYQCLSQNPKGRPVMSDV 367
             +            + L  +P  R  +   
Sbjct: 251 GISE----DGKDFIRKLLLADPNTRMTIHQA 277

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  163 bits (413), Expect = 1e-46
 Identities = 54/277 (19%), Positives = 99/277 (35%), Gaps = 28/277 (10%)

Query: 93  FFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQL 152
           ++     LG G FGVV++ V     R          K +N            E++ + QL
Sbjct: 30  YYDILEELGSGAFGVVHRCVEKATGRV------FVAKFINTPYPLDKYTVKNEISIMNQL 83

Query: 153 RHSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAF 212
            H  L+ L     +    +L+ E++  G L   +       ++ +  +     A +GL  
Sbjct: 84  HHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAE-DYKMSEAEVINYMRQACEGLKH 142

Query: 213 LHGAERPVIYRDFKTSNILLNA--DFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAP 270
           +H  E  +++ D K  NI+       S K+ DFGLA      +          T  +AAP
Sbjct: 143 MH--EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVK---VTTATAEFAAP 197

Query: 271 EYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRIL 330
           E V    +   +D++  GV+   +L G        P    + +E  + +   + +     
Sbjct: 198 EIVDREPVGFYTDMWAIGVLGYVLLSGL------SPFAGEDDLETLQNVKRCDWEFDEDA 251

Query: 331 DPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDV 367
              +  +                L + P+ R  + D 
Sbjct: 252 FSSVSPE--------AKDFIKNLLQKEPRKRLTVHDA 280

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  157 bits (397), Expect = 2e-45
 Identities = 68/292 (23%), Positives = 116/292 (39%), Gaps = 33/292 (11%)

Query: 94  FRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGD---REWLAEVNYLG 150
           +    ILG GG   V+        R       VA+K L     +       +  E     
Sbjct: 9   YELGEILGFGGMSEVHLARDLRLHRD------VAVKVLRADLARDPSFYLRFRREAQNAA 62

Query: 151 QLRHSNLVKLIGYCCEDEHRI----LVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDA 206
            L H  +V +      +        +V EY++  +L   +       +T  R +++  DA
Sbjct: 63  ALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP--MTPKRAIEVIADA 120

Query: 207 AKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKD-GPMGDQTHVSTRVMGTY 265
            + L F H  +  +I+RD K +NI+++A  + K+ DFG+A+     G+    +  V+GT 
Sbjct: 121 CQALNFSH--QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTA 178

Query: 266 GYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKK 325
            Y +PE      + ARSDVY  G VL E+L G        P    + V  A   +  +  
Sbjct: 179 QYLSPEQARGDSVDARSDVYSLGCVLYEVLTGE------PPFTGDSPVSVAYQHVREDPI 232

Query: 326 VLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRP-VMSDVVALLETVQS 376
                   L           +  +  + L++NP+ R    +++ A L  V +
Sbjct: 233 PPSARHEGLSAD--------LDAVVLKALAKNPENRYQTAAEMRADLVRVHN 276

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  158 bits (400), Expect = 2e-45
 Identities = 71/273 (26%), Positives = 107/273 (39%), Gaps = 34/273 (12%)

Query: 94  FRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREW---LAEVNYLG 150
           F    +LG+G FG V+     +  +      F AIK L +     D +    + E   L 
Sbjct: 4   FILHKMLGKGSFGKVFLAEFKKTNQ------FFAIKALKKDVVLMDDDVECTMVEKRVLS 57

Query: 151 -QLRHSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKG 209
               H  L  +       E+   V EY+  G L  H+          SR    A +   G
Sbjct: 58  LAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHK--FDLSRATFYAAEIILG 115

Query: 210 LAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAA 269
           L FLH   + ++YRD K  NILL+ D   K++DFG+ K+  +GD         GT  Y A
Sbjct: 116 LQFLH--SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKT--NTFCGTPDYIA 171

Query: 270 PEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRI 329
           PE ++        D + FGV+L EML+G+       P    +  E    +  +N    R 
Sbjct: 172 PEILLGQKYNHSVDWWSFGVLLYEMLIGQ------SPFHGQDEEELFHSIRMDNPFYPRW 225

Query: 330 LDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRP 362
           L+   +             L  +   + P+ R 
Sbjct: 226 LEKEAK------------DLLVKLFVREPEKRL 246

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  158 bits (400), Expect = 3e-45
 Identities = 54/332 (16%), Positives = 115/332 (34%), Gaps = 48/332 (14%)

Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVK 159
           LG G FG+V++ V   + +          K +   G         E++ L   RH N++ 
Sbjct: 13  LGRGEFGIVHRCVETSSKKT------YMAKFVKVKG-TDQVLVKKEISILNIARHRNILH 65

Query: 160 LIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERP 219
           L       E  ++++E++    + + +       L     +       + L FLH     
Sbjct: 66  LHESFESMEELVMIFEFISGLDIFERINTS-AFELNEREIVSYVHQVCEALQFLH--SHN 122

Query: 220 VIYRDFKTSNILLNADFSA--KLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGH 277
           + + D +  NI+     S+  K+ +FG A+    GD   +   +     Y APE      
Sbjct: 123 IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRL---LFTAPEYYAPEVHQHDV 179

Query: 278 LTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRILDPRLEGQ 337
           ++  +D++  G ++  +L G        P       +    ++N            +   
Sbjct: 180 VSTATDMWSLGTLVYVLLSGI------NPFLAETNQQIIENIMNAEYTFDEEAFKEI--- 230

Query: 338 YTARTAMKVAGLAYQCLSQNPKGRPVMSDVVA--------------LLETVQSQGAEEEM 383
                +++      + L +  K R   S+ +               ++ T++ +     +
Sbjct: 231 -----SIEAMDFVDRLLVKERKSRMTASEALQHPWLKQKIERVSTKVIRTLKHRRYYHTL 285

Query: 384 LQSGGGVVTLYEVPKLSSHNSGDKKRNQSGFS 415
           ++       L  V   +  + G   R+Q G S
Sbjct: 286 IKKD-----LNMVVSAARISCGGAIRSQKGVS 312

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  157 bits (397), Expect = 3e-45
 Identities = 63/290 (21%), Positives = 107/290 (36%), Gaps = 43/290 (14%)

Query: 94  FRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGD---------REWLA 144
           + P  ILG G   VV + +     +        A+K ++  G                L 
Sbjct: 5   YEPKEILGRGVSSVVRRCIHKPTCKE------YAVKIIDVTGGGSFSAEEVQELREATLK 58

Query: 145 EVNYLGQLR-HSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIA 203
           EV+ L ++  H N+++L      +    LV++ M+ G L  +L  +V   L+     KI 
Sbjct: 59  EVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVT--LSEKETRKIM 116

Query: 204 LDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMG 263
               + +  LH  +  +++RD K  NILL+ D + KL+DFG +      D       V G
Sbjct: 117 RALLEVICALH--KLNIVHRDLKPENILLDDDMNIKLTDFGFSC---QLDPGEKLREVCG 171

Query: 264 TYGYAAPEYVMTGHL------TARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWAR 317
           T  Y APE +               D++  GV++  +L G        P      +   R
Sbjct: 172 TPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGS------PPFWHRKQMLMLR 225

Query: 318 PLLNNNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDV 367
            +++ N +                    V  L  + L   P+ R    + 
Sbjct: 226 MIMSGNYQFGSPEWDDYSDT--------VKDLVSRFLVVQPQKRYTAEEA 267

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  157 bits (399), Expect = 3e-45
 Identities = 57/288 (19%), Positives = 104/288 (36%), Gaps = 31/288 (10%)

Query: 84  YNEMKLATKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDRE-W 142
           + + +     +    +LG G F  V      E+ R       VAIK + +   +G     
Sbjct: 1   WKQAEDIRDIYDFRDVLGTGAFSEVILA---EDKRTQ---KLVAIKCIAKKALEGKEGSM 54

Query: 143 LAEVNYLGQLRHSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKI 202
             E+  L +++H N+V L        H  L+ + +  G L   ++ +     T     ++
Sbjct: 55  ENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEK--GFYTERDASRL 112

Query: 203 ALDAAKGLAFLHGAERPVIYRDFKTSNILL---NADFSAKLSDFGLAKDGPMGDQTHVST 259
                  + +LH  +  +++RD K  N+L    + D    +SDFGL+K   M D   V +
Sbjct: 113 IFQVLDAVKYLH--DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSK---MEDPGSVLS 167

Query: 260 RVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPL 319
              GT GY APE +     +   D +  GV+   +L G        P  + N  +    +
Sbjct: 168 TACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGY------PPFYDENDAKLFEQI 221

Query: 320 LNNNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDV 367
           L    +        +                   + ++P+ R      
Sbjct: 222 LKAEYEFDSPYWDDISDS--------AKDFIRHLMEKDPEKRFTCEQA 261

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  154 bits (389), Expect = 6e-44
 Identities = 64/285 (22%), Positives = 110/285 (38%), Gaps = 28/285 (9%)

Query: 99  ILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDRE-----WLAEVNYLGQLR 153
            LGEG F  VYK       +       VAIK++  G     ++      L E+  L +L 
Sbjct: 5   FLGEGQFATVYKARDKNTNQ------IVAIKKIKLGHRSEAKDGINRTALREIKLLQELS 58

Query: 154 HSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFL 213
           H N++ L+       +  LV+++ME+      +++    +LT S      L   +GL +L
Sbjct: 59  HPNIIGLLDAFGHKSNISLVFDFMETDLE--VIIKDNSLVLTPSHIKAYMLMTLQGLEYL 116

Query: 214 HGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYV 273
           H  +  +++RD K +N+LL+ +   KL+DFGLAK    G      T  + T  Y APE +
Sbjct: 117 H--QHWILHRDLKPNNLLLDENGVLKLADFGLAKS--FGSPNRAYTHQVVTRWYRAPELL 172

Query: 274 MTGHL-TARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLV----------EWARPLLNN 322
               +     D++  G +L E+LL    +       +   +          +W       
Sbjct: 173 FGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLP 232

Query: 323 NKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDV 367
           +    +           +     +  L       NP  R   +  
Sbjct: 233 DYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQA 277

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  155 bits (392), Expect = 1e-43
 Identities = 65/295 (22%), Positives = 106/295 (35%), Gaps = 46/295 (15%)

Query: 94  FRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGY---QGDREWLAEVN--- 147
           F    I+G GGFG VY     +  +        A+K L++      QG+   L E     
Sbjct: 6   FSVHRIIGRGGFGEVYGCRKADTGKM------YAMKCLDKKRIKMKQGETLALNERIMLS 59

Query: 148 YLGQLRHSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAA 207
            +       +V +       +    + + M  G L  HL +        +     A +  
Sbjct: 60  LVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFS--EADMRFYAAEII 117

Query: 208 KGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGY 267
            GL  +H   R V+YRD K +NILL+     ++SD GLA D             +GT+GY
Sbjct: 118 LGLEHMH--NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA----SVGTHGY 171

Query: 268 AAPEYVMTG-HLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKV 326
            APE +  G    + +D +  G +L ++L G     + +   +H +       L    ++
Sbjct: 172 MAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT---LTMAVEL 228

Query: 327 LRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETVQSQGAEE 381
                P L              L    L ++   R               +GA+E
Sbjct: 229 PDSFSPELR------------SLLEGLLQRDVNRRL----------GCLGRGAQE 261

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  148 bits (374), Expect = 8e-42
 Identities = 53/296 (17%), Positives = 100/296 (33%), Gaps = 32/296 (10%)

Query: 86  EMKLATKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAE 145
           E+++  ++ R    +G G FG +Y G    ++  G     VAIK           +   E
Sbjct: 2   ELRVGNRY-RLGRKIGSGSFGDIYLG---TDIAAG---EEVAIKLECVK--TKHPQLHIE 52

Query: 146 VNYLGQLRHSNLVKLIGYCCED-EHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIAL 204
                 ++    +  I +C  + ++ ++V E +     +           +    + +A 
Sbjct: 53  SKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLF--NFCSRKFSLKTVLLLAD 110

Query: 205 DAAKGLAFLHGAERPVIYRDFKTSNIL---LNADFSAKLSDFGLAK-----DGPMGDQTH 256
                + ++H   +  I+RD K  N L           + DFGLAK              
Sbjct: 111 QMISRIEYIH--SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYR 168

Query: 257 VSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWA 316
            +  + GT  YA+    +    + R D+   G VL+   LG       + + +    E  
Sbjct: 169 ENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYE-- 226

Query: 317 RPLLNNNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLE 372
                 ++K +      L   Y +    + A     C S     +P  S +  L  
Sbjct: 227 ----RISEKKMSTPIEVLCKGYPS----EFATYLNFCRSLRFDDKPDYSYLRQLFR 274

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  148 bits (373), Expect = 1e-41
 Identities = 51/286 (17%), Positives = 89/286 (31%), Gaps = 33/286 (11%)

Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVK 159
           +GEG FGV+++G    N +       VAIK   R       +   E      L     + 
Sbjct: 13  IGEGSFGVIFEGTNLLNNQQ------VAIKFEPR--RSDAPQLRDEYRTYKLLAGCTGIP 64

Query: 160 LIGYCCED-EHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAER 218
            + Y  ++  H +LV + +  G   + LL   G   +       A      +  +H  E+
Sbjct: 65  NVYYFGQEGLHNVLVIDLL--GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH--EK 120

Query: 219 PVIYRDFKTSNILLNADFS-----AKLSDFGLAK-----DGPMGDQTHVSTRVMGTYGYA 268
            ++YRD K  N L+    S       + DFG+ K                  + GT  Y 
Sbjct: 121 SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYM 180

Query: 269 APEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLR 328
           +    +    + R D+   G V +  L G       + +      E          ++  
Sbjct: 181 SINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYE----------RIGE 230

Query: 329 ILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETV 374
                   +  A    +     +   +      P    +  L   V
Sbjct: 231 KKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKV 276

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  147 bits (372), Expect = 1e-41
 Identities = 62/286 (21%), Positives = 102/286 (35%), Gaps = 37/286 (12%)

Query: 92  KFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLA------E 145
            ++     LG G F VV K                A K + +   +  R  ++      E
Sbjct: 10  DYYDTGEELGSGQFAVVKKCREKSTGLQ------YAAKFIKKRRTKSSRRGVSREDIERE 63

Query: 146 VNYLGQLRHSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALD 205
           V+ L +++H N++ L          IL+ E +  G L   L  +    LT     +    
Sbjct: 64  VSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEK--ESLTEEEATEFLKQ 121

Query: 206 AAKGLAFLHGAERPVIYRDFKTSNILLNAD----FSAKLSDFGLAKDGPMGDQTHVSTRV 261
              G+ +LH     + + D K  NI+L          K+ DFGLA     G++      +
Sbjct: 122 ILNGVYYLH--SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF---KNI 176

Query: 262 MGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLN 321
            GT  + APE V    L   +D++  GV+   +L G        P       E    +  
Sbjct: 177 FGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGA------SPFLGDTKQETLANVSA 230

Query: 322 NNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDV 367
            N           E +Y + T+        + L ++PK R  + D 
Sbjct: 231 VN--------YEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDS 268

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  146 bits (370), Expect = 5e-41
 Identities = 64/273 (23%), Positives = 107/273 (39%), Gaps = 40/273 (14%)

Query: 97  DY----ILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDRE---WLAEVNYL 149
           D+     LG G FG V+      N R      + A+K L +      ++      E   L
Sbjct: 5   DFQILRTLGTGSFGRVHLIRSRHNGR------YYAMKVLKKEIVVRLKQVEHTNDERLML 58

Query: 150 GQLRHSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKG 209
             + H  ++++ G   + +   ++ +Y+E G L    L R             A +    
Sbjct: 59  SIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGEL--FSLLRKSQRFPNPVAKFYAAEVCLA 116

Query: 210 LAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAA 269
           L +LH   + +IYRD K  NILL+ +   K++DFG AK  P    T       GT  Y A
Sbjct: 117 LEYLH--SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTLC-----GTPDYIA 169

Query: 270 PEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRI 329
           PE V T       D + FG+++ EML G        P  + N ++    +LN   +    
Sbjct: 170 PEVVSTKPYNKSIDWWSFGILIYEMLAGY------TPFYDSNTMKTYEKILNAELRFPPF 223

Query: 330 LDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRP 362
            +  ++             L  + ++++   R 
Sbjct: 224 FNEDVK------------DLLSRLITRDLSQRL 244

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  146 bits (368), Expect = 2e-40
 Identities = 66/288 (22%), Positives = 108/288 (37%), Gaps = 29/288 (10%)

Query: 99  ILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDRE-WLAEVNYLGQLRHSNL 157
            +GEG +G+V     + N         VAIK+++   +Q   +  L E+  L + RH N+
Sbjct: 15  YIGEGAYGMVCSAYDNVNKVR------VAIKKISPFEHQTYCQRTLREIKILLRFRHENI 68

Query: 158 VKLIGYCCEDEHRILVYEYME---SGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLH 214
           + +           +   Y+     G+    LL+     L+            +GL ++H
Sbjct: 69  IGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQH--LSNDHICYFLYQILRGLKYIH 126

Query: 215 GAERPVIYRDFKTSNILLNADFSAKLSDFGLAKD-GPMGDQTHVSTRVMGTYGYAAPEYV 273
                V++RD K SN+LLN     K+ DFGLA+   P  D T   T  + T  Y APE +
Sbjct: 127 --SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 184

Query: 274 MTGHLTARS-DVYGFGVVLLEMLLGR-------------RAVDKSRPSREHNLVEWARPL 319
           +      +S D++  G +L EML  R               +       + +L       
Sbjct: 185 LNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLK 244

Query: 320 LNNNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDV 367
             N    L   +     +       K   L  + L+ NP  R  +   
Sbjct: 245 ARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQA 292

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  144 bits (364), Expect = 3e-40
 Identities = 58/286 (20%), Positives = 100/286 (34%), Gaps = 28/286 (9%)

Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREW-----LAEVNYLGQLRH 154
           +GEG +G V+K    +N        FVA+K +     +          +A + +L    H
Sbjct: 15  IGEGAYGKVFKARDLKN-----GGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEH 69

Query: 155 SNLVKLIGYCCEDEHRILVYEYME----SGSLEKHLLRRVGCMLTWSRRMKIALDAAKGL 210
            N+V+L   C            +        L  +L +     +       +     +GL
Sbjct: 70  PNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGL 129

Query: 211 AFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAP 270
            FLH     V++RD K  NIL+ +    KL+DFGLA+   +       T V+ T  Y AP
Sbjct: 130 DFLH--SHRVVHRDLKPQNILVTSSGQIKLADFGLAR---IYSFQMALTSVVVTLWYRAP 184

Query: 271 EYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPL---------LN 321
           E ++        D++  G +  EM   +     S    +   +     L         + 
Sbjct: 185 EVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVA 244

Query: 322 NNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDV 367
             ++       +   ++          L  +CL+ NP  R      
Sbjct: 245 LPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSA 290

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  144 bits (364), Expect = 6e-40
 Identities = 73/272 (26%), Positives = 99/272 (36%), Gaps = 33/272 (12%)

Query: 94  FRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREW---LAEVNYLG 150
           F    +LG+G FG V         R        A+K L +       E    + E   L 
Sbjct: 7   FDYLKLLGKGTFGKVILVREKATGRY------YAMKILRKEVIIAKDEVAHTVTESRVLQ 60

Query: 151 QLRHSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGL 210
             RH  L  L       +    V EY   G L  HL R    + T  R      +    L
Sbjct: 61  NTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRE--RVFTEERARFYGAEIVSAL 118

Query: 211 AFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAP 270
            +LH   R V+YRD K  N++L+ D   K++DFGL K+G     T       GT  Y AP
Sbjct: 119 EYLH--SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATM--KTFCGTPEYLAP 174

Query: 271 EYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRIL 330
           E +         D +G GVV+ EM+ GR       P    +       +L    +  R L
Sbjct: 175 EVLEDNDYGRAVDWWGLGVVMYEMMCGR------LPFYNQDHERLFELILMEEIRFPRTL 228

Query: 331 DPRLEGQYTARTAMKVAGLAYQCLSQNPKGRP 362
            P  +             L    L ++PK R 
Sbjct: 229 SPEAK------------SLLAGLLKKDPKQRL 248

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  143 bits (361), Expect = 7e-40
 Identities = 57/287 (19%), Positives = 102/287 (35%), Gaps = 23/287 (8%)

Query: 94  FRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGY--QGDREWLAEVNYLGQ 151
           F+    +GEG +GVVYK               VA+K++             + E++ L +
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGE------VVALKKIRLDTETEGVPSTAIREISLLKE 57

Query: 152 LRHSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLA 211
           L H N+VKL+     +    LV+E++    L+K +       +             +GLA
Sbjct: 58  LNHPNIVKLLDVIHTENKLYLVFEFLHQD-LKKFMDASALTGIPLPLIKSYLFQLLQGLA 116

Query: 212 FLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPE 271
           F H     V++RD K  N+L+N + + KL+DFGLA+          +  V+  +  A   
Sbjct: 117 FCH--SHRVLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVPVRTYTHEVVTLWYRAPEI 173

Query: 272 YVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRILD 331
            +   + +   D++  G +  EM+  R          +   +       +          
Sbjct: 174 LLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSM 233

Query: 332 PRLEGQYTARTAMKVAG-----------LAYQCLSQNPKGRPVMSDV 367
           P  +  +        +            L  Q L  +P  R      
Sbjct: 234 PDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 280

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  142 bits (358), Expect = 1e-39
 Identities = 59/279 (21%), Positives = 98/279 (35%), Gaps = 47/279 (16%)

Query: 99  ILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDRE------WLAEVNYLGQL 152
           +LG GGFG VY G+   +  P      VAIK + +       E         EV  L ++
Sbjct: 11  LLGSGGFGSVYSGIRVSDNLP------VAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 64

Query: 153 R--HSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGL 210
               S +++L+ +    +  +L+ E  E        +   G  L             + +
Sbjct: 65  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA-LQEELARSFFWQVLEAV 123

Query: 211 AFLHGAERPVIYRDFKTSNILLNAD-FSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAA 269
              H     V++RD K  NIL++ +    KL DFG         +  V T   GT  Y+ 
Sbjct: 124 RHCH--NCGVLHRDIKDENILIDLNRGELKLIDFGSGAL----LKDTVYTDFDGTRVYSP 177

Query: 270 PEYVMTGHLTARS-DVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLR 328
           PE++       RS  V+  G++L +M+ G        P      +   +           
Sbjct: 178 PEWIRYHRYHGRSAAVWSLGILLYDMVCGDI------PFEHDEEIIRGQVFFRQR----- 226

Query: 329 ILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDV 367
            +    +             L   CL+  P  RP   ++
Sbjct: 227 -VSSECQH------------LIRWCLALRPSDRPTFEEI 252

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  141 bits (357), Expect = 2e-39
 Identities = 56/281 (19%), Positives = 107/281 (38%), Gaps = 25/281 (8%)

Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELN--RGGYQGDREWLAEVNYLGQLRHSNL 157
           +GEG +GVVYK   +            A+K++   +         + E++ L +L+HSN+
Sbjct: 10  IGEGTYGVVYKAQNNYG-------ETFALKKIRLEKEDEGIPSTTIREISILKELKHSNI 62

Query: 158 VKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAE 217
           VKL       +  +LV+E+++       LL      L         L    G+A+ H  +
Sbjct: 63  VKLYDVIHTKKRLVLVFEHLDQDLK--KLLDVCEGGLESVTAKSFLLQLLNGIAYCH--D 118

Query: 218 RPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGH 277
           R V++RD K  N+L+N +   K++DFGLA+   +  + +    ++  +  A    + +  
Sbjct: 119 RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYT-HEIVTLWYRAPDVLMGSKK 177

Query: 278 LTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLV----------EWAR-PLLNNNKKV 326
            +   D++  G +  EM+ G         + +   +           W     L      
Sbjct: 178 YSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPN 237

Query: 327 LRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDV 367
             + +P     +          L  + L  +P  R      
Sbjct: 238 FTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQA 278

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  142 bits (358), Expect = 4e-39
 Identities = 51/294 (17%), Positives = 102/294 (34%), Gaps = 39/294 (13%)

Query: 87  MKLATKFFRPDY-----ILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDRE 141
           +++       DY     +LG G  G V +                A+K L         +
Sbjct: 2   LQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEK------FALKMLQD-----CPK 50

Query: 142 WLAEVNYLGQL-RHSNLVKLIGYC----CEDEHRILVYEYMESGSLEKHLLRRVGCMLTW 196
              EV    +  +  ++V+++          +  ++V E ++ G L   +  R     T 
Sbjct: 51  ARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTE 110

Query: 197 SRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNA---DFSAKLSDFGLAKDGPMGD 253
               +I     + + +LH     + +RD K  N+L  +   +   KL+DFG AK+    +
Sbjct: 111 REASEIMKSIGEAIQYLH--SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN 168

Query: 254 QTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLV 313
                     T  Y APE +         D++  GV++  +L G        P   ++ +
Sbjct: 169 SLT---TPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGY------PPFYSNHGL 219

Query: 314 EWARPLLNNNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDV 367
             +  +       +R+          +  + +V  L    L   P  R  +++ 
Sbjct: 220 AISPGMKTR----IRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEF 269

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  139 bits (350), Expect = 8e-38
 Identities = 59/293 (20%), Positives = 101/293 (34%), Gaps = 33/293 (11%)

Query: 94  FRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLR 153
           +    ++G G FGVVY+  + ++         VAIK++     Q  R    E+  + +L 
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGE------LVAIKKVL----QDKRFKNRELQIMRKLD 71

Query: 154 HSNLVKLIGYCCE------DEHRILVYEYMESGSLEKHL-LRRVGCMLTWSRRMKIALDA 206
           H N+V+L  +         + +  LV +Y+            R    L            
Sbjct: 72  HCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQL 131

Query: 207 AKGLAFLHGAERPVIYRDFKTSNILLNAD-FSAKLSDFGLAKDGPMGDQTHVSTRVMGTY 265
            + LA++H     + +RD K  N+LL+ D    KL DFG AK   +       + +   Y
Sbjct: 132 FRSLAYIH--SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ--LVRGEPNVSYICSRY 187

Query: 266 GYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWA------RPL 319
             A          T+  DV+  G VL E+LLG+          +   +           +
Sbjct: 188 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQI 247

Query: 320 LNNNKKVLRILDPRLEGQYTARTAMKVAG-----LAYQCLSQNPKGRPVMSDV 367
              N        P+++     +            L  + L   P  R    + 
Sbjct: 248 REMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEA 300

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  134 bits (337), Expect = 3e-36
 Identities = 59/295 (20%), Positives = 111/295 (37%), Gaps = 37/295 (12%)

Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGD--REWLAEVNYLGQLRHSNL 157
           +G+G FG V+K    +  +       VA+K++     +       L E+  L  L+H N+
Sbjct: 18  IGQGTFGEVFKARHRKTGQK------VALKKVLMENEKEGFPITALREIKILQLLKHENV 71

Query: 158 VKLIGYCCEDEHRI--------LVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKG 209
           V LI  C               LV+++ E           V   L+  +R  +      G
Sbjct: 72  VNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKR--VMQMLLNG 129

Query: 210 LAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVS--TRVMGTYGY 267
           L ++H     +++RD K +N+L+  D   KL+DFGLA+   +   +  +  T  + T  Y
Sbjct: 130 LYYIH--RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWY 187

Query: 268 AAPEYVMTGHL-TARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLV--------EWARP 318
             PE ++         D++G G ++ EM      +  +    +  L+            P
Sbjct: 188 RPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWP 247

Query: 319 LLNNNKKVLRILDPRLEGQYTARTAMKVAG------LAYQCLSQNPKGRPVMSDV 367
            ++N +   ++   + + +                 L  + L  +P  R    D 
Sbjct: 248 NVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDA 302

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  131 bits (331), Expect = 8e-36
 Identities = 57/282 (20%), Positives = 99/282 (35%), Gaps = 25/282 (8%)

Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGY--QGDREWLAEVNYLGQLRHSNL 157
           +GEG +G V+K    E          VA+K +             L E+  L +L+H N+
Sbjct: 10  IGEGTYGTVFKAKNRETHE------IVALKRVRLDDDDEGVPSSALREICLLKELKHKNI 63

Query: 158 VKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAE 217
           V+L      D+   LV+E+ +    +                        KGL F H   
Sbjct: 64  VRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLD--PEIVKSFLFQLLKGLGFCH--S 119

Query: 218 RPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGH 277
           R V++RD K  N+L+N +   KL++FGLA+   +  + + S  V+  +            
Sbjct: 120 RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCY-SAEVVTLWYRPPDVLFGAKL 178

Query: 278 LTARSDVYGFGVVLLEMLLGRRAVDKSRPSREH---NLVEWARPLLNNNKKVLRILDPRL 334
            +   D++  G +  E+    R +       +           P       + ++ D + 
Sbjct: 179 YSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKP 238

Query: 335 EGQYTARTAMKVAG---------LAYQCLSQNPKGRPVMSDV 367
              Y A T++             L    L  NP  R    + 
Sbjct: 239 YPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEA 280

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  130 bits (328), Expect = 8e-35
 Identities = 67/311 (21%), Positives = 114/311 (36%), Gaps = 41/311 (13%)

Query: 82  FTYNEMKLATKFFRPDY----ILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQ 137
           F   E+       R  Y     +G G +G V   V             VAIK+L R    
Sbjct: 4   FYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAK------VAIKKLYRPFQS 57

Query: 138 GD--REWLAEVNYLGQLRHSNLVKLIGYCCEDEHR------ILVYEYMESGSLEKHLLRR 189
               +    E+  L  +RH N++ L+     DE         LV  +M  G+    L++ 
Sbjct: 58  ELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLMKH 115

Query: 190 VGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDG 249
               L   R   +     KGL ++H     +I+RD K  N+ +N D   K+ DFGLA+  
Sbjct: 116 EK--LGEDRIQFLVYQMLKGLRYIH--AAGIIHRDLKPGNLAVNEDCELKILDFGLARQA 171

Query: 250 PMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSRE 309
                + ++  V+  +  A    +     T   D++  G ++ EM+ G+     S    +
Sbjct: 172 ----DSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQ 227

Query: 310 HNLV---------EWARPLLNNNKKVLRILDPRLEGQYTARTAMKVAGLAY----QCLSQ 356
              +         E+ + L ++  K      P LE +  A      + LA     + L  
Sbjct: 228 LKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVL 287

Query: 357 NPKGRPVMSDV 367
           + + R    + 
Sbjct: 288 DAEQRVTAGEA 298

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  128 bits (323), Expect = 4e-34
 Identities = 56/267 (20%), Positives = 93/267 (34%), Gaps = 36/267 (13%)

Query: 99  ILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREW---LAEVNYLGQLRHS 155
            LG G FG V      E+          A+K L++      ++    L E   L  +   
Sbjct: 48  TLGTGSFGRVMLVKHKESGNH------YAMKILDKQKVVKLKQIEHTLNEKRILQAVNFP 101

Query: 156 NLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHG 215
            LVKL     ++ +  +V EY+  G +  HL R      +       A        +LH 
Sbjct: 102 FLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR--FSEPHARFYAAQIVLTFEYLH- 158

Query: 216 AERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMT 275
               +IYRD K  N+L++     +++DFG AK       T     + GT    APE +++
Sbjct: 159 -SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWT-----LCGTPEALAPEIILS 212

Query: 276 GHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRILDPRLE 335
                  D +  GV++ EM  G        P      ++    +++   +        L+
Sbjct: 213 KGYNKAVDWWALGVLIYEMAAGY------PPFFADQPIQIYEKIVSGKVRFPSHFSSDLK 266

Query: 336 GQYTARTAMKVAGLAYQCLSQNPKGRP 362
                        L    L  +   R 
Sbjct: 267 ------------DLLRNLLQVDLTKRF 281

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  124 bits (313), Expect = 7e-33
 Identities = 67/283 (23%), Positives = 107/283 (37%), Gaps = 29/283 (10%)

Query: 94  FRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGD----REWLAEVNYL 149
           F    +LG G +G V+          G      A+K L +               E   L
Sbjct: 26  FELLKVLGTGAYGKVFLVRKISGHDTG---KLYAMKVLKKATIVQKAKTTEHTRTERQVL 82

Query: 150 GQLRHS-NLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAK 208
             +R S  LV L      +    L+ +Y+  G L  HL +R     T         +   
Sbjct: 83  EHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQR--ERFTEHEVQIYVGEIVL 140

Query: 209 GLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYA 268
            L  LH  +  +IYRD K  NILL+++    L+DFGL+K+  + D+T  +    GT  Y 
Sbjct: 141 ALEHLH--KLGIIYRDIKLENILLDSNGHVVLTDFGLSKE-FVADETERAYDFCGTIEYM 197

Query: 269 APEYVMTGH--LTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKV 326
           AP+ V  G        D +  GV++ E+L G           +++  E +R +L +    
Sbjct: 198 APDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFT--VDGEKNSQAEISRRILKSEPPY 255

Query: 327 LRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVA 369
            + +    +             L  + L ++PK R       A
Sbjct: 256 PQEMSALAK------------DLIQRLLMKDPKKRLGCGPRDA 286

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  116 bits (291), Expect = 1e-29
 Identities = 51/342 (14%), Positives = 115/342 (33%), Gaps = 61/342 (17%)

Query: 60  PVPPKKNVNDLRQNPGYSNV------DIFTYNEMKLATKF---FRPDYILGEGGFGVVYK 110
           PVP +  V        Y++V      + + Y    +       ++    LG G +  V++
Sbjct: 2   PVPSRARV--------YTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFE 53

Query: 111 GVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLR-HSNLVKLIGYCCEDEH 169
            +   N         V +K L        ++   E+  L  LR   N++ L     +   
Sbjct: 54  AINITNNEK------VVVKILKP---VKKKKIKREIKILENLRGGPNIITLADIVKDPVS 104

Query: 170 R--ILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKT 227
           R   LV+E++ +   ++         LT         +  K L + H     +++RD K 
Sbjct: 105 RTPALVFEHVNNTDFKQLYQT-----LTDYDIRFYMYEILKALDYCH--SMGIMHRDVKP 157

Query: 228 SNILLNADF-SAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMT-GHLTARSDVY 285
            N++++ +    +L D+GLA+    G +       + +  +  PE ++         D++
Sbjct: 158 HNVMIDHEHRKLRLIDWGLAEFYHPGQEY---NVRVASRYFKGPELLVDYQMYDYSLDMW 214

Query: 286 GFGVVLLEMLLGRRAVDKSRPSREHNL-------VEWARPLLNNNKKVLRILDPRLEGQY 338
             G +L  M+  +        + +  +        E     ++     L      + G++
Sbjct: 215 SLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRH 274

Query: 339 TARTAMKVAG-------------LAYQCLSQNPKGRPVMSDV 367
           + +   +                   + L  + + R    + 
Sbjct: 275 SRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREA 316

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  116 bits (290), Expect = 2e-29
 Identities = 60/306 (19%), Positives = 107/306 (34%), Gaps = 48/306 (15%)

Query: 94  FRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGD--REWLAEVNYLGQ 151
           ++    +G G  G+V         R       VAIK+L+R        +    E+  +  
Sbjct: 19  YQNLKPIGSGAQGIVCAAYDAVLDRN------VAIKKLSRPFQNQTHAKRAYRELVLMKC 72

Query: 152 LRHSNLVKLIGYCC------EDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALD 205
           + H N++ L+          E +   LV E M++   +   +          R   +   
Sbjct: 73  VNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL-----DHERMSYLLYQ 127

Query: 206 AAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTY 265
              G+  LH     +I+RD K SNI++ +D + K+ DFGLA+       + + T  + T 
Sbjct: 128 MLCGIKHLH--SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTR 182

Query: 266 GYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGR----------------RAVDKSRPSRE 309
            Y APE ++        D++  G ++ EM+  +                  +    P   
Sbjct: 183 YYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFM 242

Query: 310 HNLVEWARPLLNNNKKVLRILDPRLEGQYTARTAMKVAG--------LAYQCLSQNPKGR 361
             L    R  + N  K   +  P+L          +           L  + L  +P  R
Sbjct: 243 KKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKR 302

Query: 362 PVMSDV 367
             + D 
Sbjct: 303 ISVDDA 308

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  111 bits (278), Expect = 6e-28
 Identities = 54/289 (18%), Positives = 105/289 (36%), Gaps = 37/289 (12%)

Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGD--REWLAEVNYLGQLRHSNL 157
           +G G +G V       + + G     VA+K+L+R        +    E+  L  ++H N+
Sbjct: 26  VGSGAYGSVCAAF---DTKTG---LRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 79

Query: 158 VKLIGYC-----CEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAF 212
           + L+         E+ + + +  ++    L   +  +    LT      +     +GL +
Sbjct: 80  IGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ---KLTDDHVQFLIYQILRGLKY 136

Query: 213 LHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEY 272
           +H     +I+RD K SN+ +N D   K+ DFGLA+        +V+TR    +  A    
Sbjct: 137 IH--SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR----WYRAPEIM 190

Query: 273 VMTGHLTARSDVYGFGVVLLEMLLGRR--------------AVDKSRPSREHNLVEWARP 318
           +   H     D++  G ++ E+L GR                     P  E      +  
Sbjct: 191 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 250

Query: 319 LLNNNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDV 367
             N  + + ++        +     + V  L  + L  +   R   +  
Sbjct: 251 ARNYIQSLTQMPKMNFANVFIGANPLAVD-LLEKMLVLDSDKRITAAQA 298

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  100 bits (249), Expect = 6e-24
 Identities = 37/214 (17%), Positives = 76/214 (35%), Gaps = 23/214 (10%)

Query: 100 LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVK 159
           LG G F  V+     +++      T VA+K + RG          E+  L ++  ++  K
Sbjct: 21  LGWGHFSTVWLA---KDMVNN---THVAMKIV-RGDKVYTEAAEDEIKLLQRVNDADNTK 73

Query: 160 LIGYCCEDEHRILVYEY--------------MESGSLEKHLLRRVGCMLTWSRRMKIALD 205
                     ++L +                +   +L   + +     +      +I+  
Sbjct: 74  EDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQ 133

Query: 206 AAKGLAFLHGAERPVIYRDFKTSNILLNA-DFSAKLSDFGLAKDGPMGDQTHVSTRVMGT 264
              GL ++H     +I+ D K  N+L+   D    L    +A  G         T  + T
Sbjct: 134 LLLGLDYMHR-RCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQT 192

Query: 265 YGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGR 298
             Y +PE ++       +D++    ++ E++ G 
Sbjct: 193 REYRSPEVLLGAPWGCGADIWSTACLIFELITGD 226

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 77.1 bits (189), Expect = 4e-17
 Identities = 22/160 (13%), Positives = 49/160 (30%), Gaps = 25/160 (15%)

Query: 99  ILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGG----------YQGDREWLAEVNY 148
           ++GEG    V+     E            +K    G             GD  +      
Sbjct: 7   LMGEGKESAVFNCY-SEKFGE------CVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIR 59

Query: 149 LGQLRHSNLVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAK 208
             +     L KL G           Y +  +  L + +  +    +      ++     +
Sbjct: 60  SARNEFRALQKLQGLAVPKV-----YAWEGNAVLMELIDAKELYRVRVENPDEVLDMILE 114

Query: 209 GLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKD 248
            +A  +   R +++ D    N+L++ +    + DF  + +
Sbjct: 115 EVAKFY--HRGIVHGDLSQYNVLVS-EEGIWIIDFPQSVE 151

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	464
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.91
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.56
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	97.98
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	97.94
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	97.01
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	96.98
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	96.08

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.1e-57  Score=427.70  Aligned_cols=264  Identities=27%  Similarity=0.454  Sum_probs=206.2

Q ss_pred             HHhcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCC--CccHHHHHHHHHHHhcCCCCCcceEEEEEEe
Q 046893           89 LATKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGG--YQGDREWLAEVNYLGQLRHSNLVKLIGYCCE  166 (464)
Q Consensus        89 ~~~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~  166 (464)
                      +..++|++.+.||+|+||+||+|++..         .||||+++...  ....+.|.+|+.+|.+++|||||++++++.+
T Consensus         5 i~~~~~~~~~~lG~G~fg~Vy~~~~~~---------~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~   75 (276)
T d1uwha_           5 IPDGQITVGQRIGSGSFGTVYKGKWHG---------DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA   75 (276)
T ss_dssp             CCTTCCCCCSEEEECSSCEEEEEESSS---------EEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS
T ss_pred             cccccEEEEEEEeeCCCcEEEEEEECC---------EEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec
Confidence            445779999999999999999997543         28999987543  2344778999999999999999999998754


Q ss_pred             CCeEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCc
Q 046893          167 DEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLA  246 (464)
Q Consensus       167 ~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla  246 (464)
                       +..+||||||++|+|.+++.... ..+++..++.++.||+.||+|||  .++||||||||+||||+.++.+||+|||+|
T Consensus        76 -~~~~lv~Ey~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~gl~yLH--~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla  151 (276)
T d1uwha_          76 -PQLAIVTQWCEGSSLYHHLHIIE-TKFEMIKLIDIARQTAQGMDYLH--AKSIIHRDLKSNNIFLHEDLTVKIGDFGLA  151 (276)
T ss_dssp             -SSCEEEEECCCEEEHHHHHHTSC-CCCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCCGGGEEEETTSSEEECCCCCS
T ss_pred             -cEEEEEEecCCCCCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHh--cCCEeccccCHHHEEEcCCCCEEEccccce
Confidence             56899999999999999987543 46999999999999999999999  567999999999999999999999999999


Q ss_pred             cCCCCCCCcceeeccccCCcccCccccccC---CCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhcc
Q 046893          247 KDGPMGDQTHVSTRVMGTYGYAAPEYVMTG---HLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNN  323 (464)
Q Consensus       247 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~  323 (464)
                      +...............||+.|||||++.+.   .|+.++|||||||+||||+||+.||.+......  +..    .....
T Consensus       152 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~--~~~----~~~~~  225 (276)
T d1uwha_         152 TVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ--IIF----MVGRG  225 (276)
T ss_dssp             CC------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHH--HHH----HHHHT
T ss_pred             eeccccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHH--HHH----HHhcC
Confidence            875443333344557899999999998643   589999999999999999999999986543211  111    11110


Q ss_pred             cchhhccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhc
Q 046893          324 KKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETVQSQ  377 (464)
Q Consensus       324 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~~~~  377 (464)
                           ...+. ....+..++..+.+||.+||+.||.+|||+.+|++.|+.+.+.
T Consensus       226 -----~~~p~-~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~  273 (276)
T d1uwha_         226 -----YLSPD-LSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARS  273 (276)
T ss_dssp             -----SCCCC-GGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             -----CCCCc-chhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHc
Confidence                 01111 1123344566899999999999999999999999999988653

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.1e-57  Score=425.79  Aligned_cols=253  Identities=25%  Similarity=0.324  Sum_probs=204.1

Q ss_pred             cCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCC-ccHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeE
Q 046893           92 KFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGY-QGDREWLAEVNYLGQLRHSNLVKLIGYCCEDEHR  170 (464)
Q Consensus        92 ~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~  170 (464)
                      ++|++.+.||+|+||+||+|++..+      ++.||||++..... ...+.+.+|+.+|+.++|||||++++++.+++..
T Consensus         5 ~dy~~~~~lG~G~fg~V~~~~~~~~------~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~   78 (271)
T d1nvra_           5 EDWDLVQTLGEGAYGEVQLAVNRVT------EEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQ   78 (271)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETTT------CCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEE
T ss_pred             cceEEEEEEecCcCeEEEEEEECCC------CCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCcee
Confidence            4588899999999999999998765      67799999876433 2335688999999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCccCCC
Q 046893          171 ILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGP  250 (464)
Q Consensus       171 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~  250 (464)
                      |||||||++|+|.+++...  ..+++.++..++.|++.||.|||  +++|+||||||+||||+.++.+||+|||+|+...
T Consensus        79 ~ivmEy~~gg~L~~~l~~~--~~l~e~~~~~i~~qi~~al~ylH--~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~  154 (271)
T d1nvra_          79 YLFLEYCSGGELFDRIEPD--IGMPEPDAQRFFHQLMAGVVYLH--GIGITHRDIKPENLLLDERDNLKISDFGLATVFR  154 (271)
T ss_dssp             EEEEECCTTEEGGGGSBTT--TBCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCCGGGEEECTTCCEEECCCTTCEECE
T ss_pred             EEEEeccCCCcHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHH--HcCCccCcccHHHEEECCCCCEEEccchhheeec
Confidence            9999999999999988653  36999999999999999999999  5679999999999999999999999999998754


Q ss_pred             CCCCcceeeccccCCcccCccccccCCC-CcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhcccchhhc
Q 046893          251 MGDQTHVSTRVMGTYGYAAPEYVMTGHL-TARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRI  329 (464)
Q Consensus       251 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  329 (464)
                      ...........+||+.|||||++.+..+ +.++|||||||+||||++|+.||......... ...+     ...      
T Consensus       155 ~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~-~~~~-----~~~------  222 (271)
T d1nvra_         155 YNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE-YSDW-----KEK------  222 (271)
T ss_dssp             ETTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHH-HHHH-----HTT------
T ss_pred             cCCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHH-HHHH-----hcC------
Confidence            4443344456789999999999988876 57899999999999999999999765422111 1110     000      


Q ss_pred             cCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 046893          330 LDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVA  369 (464)
Q Consensus       330 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  369 (464)
                         ..........+.++.+|+.+||+.||.+|||+.++++
T Consensus       223 ---~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~  259 (271)
T d1nvra_         223 ---KTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKK  259 (271)
T ss_dssp             ---CTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             ---CCCCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence               0000111233457889999999999999999999864

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=9.2e-57  Score=429.92  Aligned_cols=263  Identities=24%  Similarity=0.354  Sum_probs=218.3

Q ss_pred             HHhcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCccHHHHHHHHHHHhcCCCCCcceEEEEEEeCC
Q 046893           89 LATKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVKLIGYCCEDE  168 (464)
Q Consensus        89 ~~~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~  168 (464)
                      +..++|++.+.||+|+||+||+|++..+      ++.||||+++... ...++|.+|+++|++++|||||+++++|.+.+
T Consensus        14 i~~~~~~~~~~iG~G~fg~Vy~a~~~~~------~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~   86 (287)
T d1opja_          14 MERTDITMKHKLGGGQYGEVYEGVWKKY------SLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREP   86 (287)
T ss_dssp             CCGGGEEEEEETTTTTTSSEEEEEEGGG------TEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             ecHHHeEEeeEEeeCCCeEEEEEEECCC------CeEEEEEEECCcc-chHHHHHHHHHHHHhCCCCCEecCCccEeeCC
Confidence            4456788899999999999999998764      6789999987653 44678999999999999999999999999999


Q ss_pred             eEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCccC
Q 046893          169 HRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKD  248 (464)
Q Consensus       169 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~  248 (464)
                      ..+||||||++|+|.+++.......+++..++.|+.||+.||+|||  .++|+||||||+||||+.++.+||+|||+|+.
T Consensus        87 ~~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH--~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~  164 (287)
T d1opja_          87 PFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE--KKNFIHRDLAARNCLVGENHLVKVADFGLSRL  164 (287)
T ss_dssp             SCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCSGGGEEECGGGCEEECCCCCTTT
T ss_pred             eeEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHH--HCCcccCccccCeEEECCCCcEEEccccceee
Confidence            9999999999999999998766678999999999999999999999  57799999999999999999999999999986


Q ss_pred             CCCCCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhcccchhh
Q 046893          249 GPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLR  328 (464)
Q Consensus       249 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  328 (464)
                      ..... ........||+.|+|||++.+..|+.++|||||||+||||++|..||......  ..+.+              
T Consensus       165 ~~~~~-~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~--~~~~~--------------  227 (287)
T d1opja_         165 MTGDT-YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL--SQVYE--------------  227 (287)
T ss_dssp             CCSSS-SEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCH--HHHHH--------------
T ss_pred             cCCCC-ceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchH--HHHHH--------------
Confidence            54322 22333456899999999999999999999999999999999977776543221  11111              


Q ss_pred             ccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhc
Q 046893          329 ILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETVQSQ  377 (464)
Q Consensus       329 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~~~~  377 (464)
                      .+........+..++..+.+||.+||+.||.+|||+.+|++.|+.+...
T Consensus       228 ~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~~  276 (287)
T d1opja_         228 LLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE  276 (287)
T ss_dssp             HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTSS
T ss_pred             HHhcCCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence            1111222233445667899999999999999999999999999887554

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.2e-56  Score=424.59  Aligned_cols=250  Identities=24%  Similarity=0.348  Sum_probs=208.9

Q ss_pred             cCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCccHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeEE
Q 046893           92 KFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVKLIGYCCEDEHRI  171 (464)
Q Consensus        92 ~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~  171 (464)
                      ++|++.+.||+|+||+||+|.+..+      ++.||||++........+.+.+|+.+|+.++|||||+++++|.+.+.+|
T Consensus        20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~------~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~   93 (293)
T d1yhwa1          20 KKYTRFEKIGQGASGTVYTAMDVAT------GQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELW   93 (293)
T ss_dssp             TTBCSCEECCCSSSCEEEEEEBTTT------CCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred             cccEEEEEEecCcCcEEEEEEECCC------CCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEE
Confidence            4699999999999999999998765      6779999997665566678999999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCccCCCC
Q 046893          172 LVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPM  251 (464)
Q Consensus       172 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~  251 (464)
                      ||||||+||+|.+++.+.   .+++..+..++.||+.||.|||  +++|+||||||+||||+.++.+||+|||+|+....
T Consensus        94 ivmEy~~gg~L~~~~~~~---~l~~~~~~~i~~qi~~aL~yLH--~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~  168 (293)
T d1yhwa1          94 VVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLH--SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP  168 (293)
T ss_dssp             EEEECCTTCBHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCS
T ss_pred             EEEEecCCCcHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHH--HCCCcccCCcHHHeEECCCCcEeeccchhheeecc
Confidence            999999999999877653   5999999999999999999999  57799999999999999999999999999986533


Q ss_pred             CCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhcccchhhccC
Q 046893          252 GDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRILD  331 (464)
Q Consensus       252 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  331 (464)
                      ..  ......+||+.|+|||++.+..|+.++|||||||+||+|++|+.||.+.....      .........       .
T Consensus       169 ~~--~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~------~~~~~~~~~-------~  233 (293)
T d1yhwa1         169 EQ--SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR------ALYLIATNG-------T  233 (293)
T ss_dssp             TT--CCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH------HHHHHHHHC-------S
T ss_pred             cc--ccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHH------HHHHHHhCC-------C
Confidence            22  22345789999999999999999999999999999999999999997644211      111111110       0


Q ss_pred             ccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 046893          332 PRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVA  369 (464)
Q Consensus       332 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  369 (464)
                      +  ....+..++..+.+||.+||+.||.+|||+.++++
T Consensus       234 ~--~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  269 (293)
T d1yhwa1         234 P--ELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ  269 (293)
T ss_dssp             C--CCSSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             C--CCCCcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            0  11122344568999999999999999999999864

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-55  Score=417.25  Aligned_cols=258  Identities=26%  Similarity=0.392  Sum_probs=200.8

Q ss_pred             cCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCccHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeEE
Q 046893           92 KFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVKLIGYCCEDEHRI  171 (464)
Q Consensus        92 ~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~  171 (464)
                      ++|++.+.||+|+||+||+|.+.+       ++.||||+++.. ....++|.+|++++++++|||||++++++...+..+
T Consensus         5 ~~~~~~~~iG~G~fg~Vy~~~~~~-------~~~vAvK~i~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~   76 (263)
T d1sm2a_           5 SELTFVQEIGSGQFGLVHLGYWLN-------KDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPIC   76 (263)
T ss_dssp             SCEEEEEEEECCSSCCEEEEEETT-------TEEEEEEECCSS-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred             HHcEEEEEEeeCCCeEEEEEEECC-------CCEEEEEEECCC-cCcHHHHHHHHHHHHhcCCCCcccccceeccCCceE
Confidence            468888999999999999999764       456999999764 345678999999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCccCCCC
Q 046893          172 LVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPM  251 (464)
Q Consensus       172 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~  251 (464)
                      ||||||++|+|.+++... ...+++..++.++.|++.||.|||  .++|+||||||+||||+.++.+||+|||+++....
T Consensus        77 lv~E~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qia~gl~~lH--~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~  153 (263)
T d1sm2a_          77 LVFEFMEHGCLSDYLRTQ-RGLFAAETLLGMCLDVCEGMAYLE--EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD  153 (263)
T ss_dssp             EEEECCTTCBHHHHHHTT-TTCCCHHHHHHHHHHHHHHHHHHH--HTTCCCTTCSGGGEEECGGGCEEECSCC-------
T ss_pred             EEEEecCCCcHHHHhhcc-ccCCCHHHHHHHHHHHHHHHHhhh--ccceeecccchhheeecCCCCeEecccchheeccC
Confidence            999999999999988654 346899999999999999999999  57799999999999999999999999999986533


Q ss_pred             CCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhcccchhhccC
Q 046893          252 GDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRILD  331 (464)
Q Consensus       252 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  331 (464)
                      ... .......||+.|+|||++.+..|+.++|||||||+||||+|+..|+.....     ..+........         
T Consensus       154 ~~~-~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~-----~~~~~~~i~~~---------  218 (263)
T d1sm2a_         154 DQY-TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS-----NSEVVEDISTG---------  218 (263)
T ss_dssp             ------------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCC-----HHHHHHHHHHT---------
T ss_pred             CCc-eeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCC-----HHHHHHHHHhc---------
Confidence            222 223346799999999999999999999999999999999995444433221     11111111111         


Q ss_pred             ccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhc
Q 046893          332 PRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETVQSQ  377 (464)
Q Consensus       332 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~~~~  377 (464)
                        .....+..++.++.+|+.+||+.||.+|||+++|++.|+++.+.
T Consensus       219 --~~~~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~es  262 (263)
T d1sm2a_         219 --FRLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAES  262 (263)
T ss_dssp             --CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             --CCCCCccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhC
Confidence              11122334456899999999999999999999999999988653

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.7e-55  Score=423.56  Aligned_cols=264  Identities=24%  Similarity=0.410  Sum_probs=203.3

Q ss_pred             hcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCc-cHHHHHHHHHHHhcCCCCCcceEEEEEEeCCe
Q 046893           91 TKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQ-GDREWLAEVNYLGQLRHSNLVKLIGYCCEDEH  169 (464)
Q Consensus        91 ~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~  169 (464)
                      .++|++.++||+|+||+||+|.+..+..   ....||||.+...... ..+.|.+|+++|++++|||||++++++...+.
T Consensus        25 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~  101 (299)
T d1jpaa_          25 ISCVKIEQVIGAGEFGEVCSGHLKLPGK---REIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTP  101 (299)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECC------CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred             hhhcEEeeEEeeCCCeEEEEEEEeCCCC---EEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCE
Confidence            3567788899999999999999865422   2456899998764333 33679999999999999999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCccCC
Q 046893          170 RILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDG  249 (464)
Q Consensus       170 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~  249 (464)
                      .+||||||++|+|.+++... ...+++.+++.|+.||+.||.|||  +++|+||||||+||||+.++.+||+|||+|+..
T Consensus       102 ~~iv~Ey~~~g~L~~~~~~~-~~~l~~~~~~~i~~qia~gl~yLH--~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~  178 (299)
T d1jpaa_         102 VMIITEFMENGSLDSFLRQN-DGQFTVIQLVGMLRGIAAGMKYLA--DMNYVHRDLAARNILVNSNLVCKVSDFGLSRFL  178 (299)
T ss_dssp             CEEEEECCTTEEHHHHHHTT-TTCSCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCCGGGEEECTTCCEEECCC------
T ss_pred             EEEEEEecCCCcceeeeccc-cCCCCHHHHHHHHHHHHHHHHHHh--hCCCccCccccceEEECCCCcEEECCcccceEc
Confidence            99999999999999987754 346999999999999999999999  577999999999999999999999999999865


Q ss_pred             CCCCCcc---eeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHhhhcccc
Q 046893          250 PMGDQTH---VSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLL-GRRAVDKSRPSREHNLVEWARPLLNNNKK  325 (464)
Q Consensus       250 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  325 (464)
                      .......   ......||+.|||||++.+..++.++|||||||+||||+| |+.||.+....   .+..   ....    
T Consensus       179 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~---~~~~---~i~~----  248 (299)
T d1jpaa_         179 EDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQ---DVIN---AIEQ----  248 (299)
T ss_dssp             -----------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---HHHH---HHHT----
T ss_pred             cCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHH---HHHH---HHHc----
Confidence            4322211   1222468999999999999999999999999999999998 89999765421   1111   1111    


Q ss_pred             hhhccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhc
Q 046893          326 VLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETVQSQ  377 (464)
Q Consensus       326 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~~~~  377 (464)
                             ......+..++..+.+||.+||+.||.+|||+.+|++.|+.+.+.
T Consensus       249 -------~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~  293 (299)
T d1jpaa_         249 -------DYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRN  293 (299)
T ss_dssp             -------TCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred             -------CCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcC
Confidence                   111123344567899999999999999999999999999987654

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-55  Score=414.74  Aligned_cols=246  Identities=25%  Similarity=0.408  Sum_probs=206.4

Q ss_pred             cCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCC---CccHHHHHHHHHHHhcCCCCCcceEEEEEEeCC
Q 046893           92 KFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGG---YQGDREWLAEVNYLGQLRHSNLVKLIGYCCEDE  168 (464)
Q Consensus        92 ~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~  168 (464)
                      ++|++.+.||+|+||+||+|++..+      ++.||+|++....   ......+.+|+++|+.++|||||++++++.+++
T Consensus         6 ~dy~i~~~iG~G~fg~Vy~~~~~~~------~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~   79 (263)
T d2j4za1           6 EDFEIGRPLGKGKFGNVYLAREKQS------KFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDAT   79 (263)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTT------CCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred             hHeEEEEEEecCCCcEEEEEEECCC------CcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECC
Confidence            4588899999999999999998765      6779999986422   233467889999999999999999999999999


Q ss_pred             eEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCccC
Q 046893          169 HRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKD  248 (464)
Q Consensus       169 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~  248 (464)
                      ..|||||||++|+|.+++.+..  .+++..+..++.||+.||+|||  +++|+||||||+||||+.++.+||+|||+|+.
T Consensus        80 ~~~ivmEy~~~g~L~~~l~~~~--~l~e~~~~~i~~qi~~al~~lH--~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~  155 (263)
T d2j4za1          80 RVYLILEYAPLGTVYRELQKLS--KFDEQRTATYITELANALSYCH--SKRVIHRDIKPENLLLGSAGELKIADFGWSVH  155 (263)
T ss_dssp             EEEEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHH--HTTCCCCCCCGGGEEECTTSCEEECCCCSCSC
T ss_pred             EEEEEEeecCCCcHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHH--HCCeeeeeeccccceecCCCCEeecccceeee
Confidence            9999999999999999987654  6999999999999999999999  57799999999999999999999999999986


Q ss_pred             CCCCCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhcccchhh
Q 046893          249 GPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLR  328 (464)
Q Consensus       249 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  328 (464)
                      ....    .....+||+.|||||++.+..|+.++|||||||+||||++|+.||.+....      +.........     
T Consensus       156 ~~~~----~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~------~~~~~i~~~~-----  220 (263)
T d2j4za1         156 APSS----RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ------ETYKRISRVE-----  220 (263)
T ss_dssp             CCCC----CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHH------HHHHHHHTTC-----
T ss_pred             cCCC----cccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHH------HHHHHHHcCC-----
Confidence            4322    223478999999999999999999999999999999999999999764321      1111111111     


Q ss_pred             ccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 046893          329 ILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVA  369 (464)
Q Consensus       329 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  369 (464)
                         .    .++..++.++.+|+.+||+.||.+|||+.++++
T Consensus       221 ---~----~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~  254 (263)
T d2j4za1         221 ---F----TFPDFVTEGARDLISRLLKHNPSQRPMLREVLE  254 (263)
T ss_dssp             ---C----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             ---C----CCCccCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence               1    122334568999999999999999999999975

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.7e-56  Score=420.50  Aligned_cols=262  Identities=29%  Similarity=0.435  Sum_probs=210.9

Q ss_pred             HHHHhcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCccHHHHHHHHHHHhcCCCCCcceEEEEEEe
Q 046893           87 MKLATKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVKLIGYCCE  166 (464)
Q Consensus        87 ~~~~~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~  166 (464)
                      +++..++|++.+.||+|+||+||+|.+..       ++.||||+++... ...+.|.+|+.+|++++|||||++++++.+
T Consensus         8 wei~~~~~~~~~~iG~G~fg~Vy~~~~~~-------~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~   79 (272)
T d1qpca_           8 WEVPRETLKLVERLGAGQFGEVWMGYYNG-------HTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ   79 (272)
T ss_dssp             TBCCGGGEEEEEEEEEETTEEEEEEEETT-------TEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             eecCHHHeEEeEEEecCCCcEEEEEEECC-------CCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeecc
Confidence            33445678999999999999999999754       4569999997643 445789999999999999999999998754


Q ss_pred             CCeEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCc
Q 046893          167 DEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLA  246 (464)
Q Consensus       167 ~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla  246 (464)
                       +..+||||||++|+|.+++....+..+++..++.|+.||+.||.|||  .++|+||||||+||||+.++.+||+|||+|
T Consensus        80 -~~~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH--~~~ivHrDiKp~NIll~~~~~~Kl~DFGla  156 (272)
T d1qpca_          80 -EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE--ERNYIHRDLRAANILVSDTLSCKIADFGLA  156 (272)
T ss_dssp             -SSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGEEECTTSCEEECCCTTC
T ss_pred             -CCeEEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHH--hCCcccCccchhheeeecccceeeccccce
Confidence             56789999999999999886655556999999999999999999999  577999999999999999999999999999


Q ss_pred             cCCCCCCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhcccch
Q 046893          247 KDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKV  326 (464)
Q Consensus       247 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  326 (464)
                      +...... ........||+.|+|||++.+..++.++|||||||+||||+||..|+......     .+....+. .    
T Consensus       157 ~~~~~~~-~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~-----~~~~~~i~-~----  225 (272)
T d1qpca_         157 RLIEDNE-YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN-----PEVIQNLE-R----  225 (272)
T ss_dssp             EECSSSC-EECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCH-----HHHHHHHH-T----
T ss_pred             EEccCCc-cccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCH-----HHHHHHHH-h----
Confidence            8754322 22233467999999999999999999999999999999999966655432211     11111111 1    


Q ss_pred             hhccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHh
Q 046893          327 LRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETVQS  376 (464)
Q Consensus       327 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~~~  376 (464)
                            ......+..++..+.+|+.+||+.||++|||+.+|++.|+.+..
T Consensus       226 ------~~~~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ft  269 (272)
T d1qpca_         226 ------GYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT  269 (272)
T ss_dssp             ------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ------cCCCCCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhh
Confidence                  11112233455689999999999999999999999999998754

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-55  Score=419.83  Aligned_cols=252  Identities=25%  Similarity=0.389  Sum_probs=207.5

Q ss_pred             cCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCccHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeEE
Q 046893           92 KFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVKLIGYCCEDEHRI  171 (464)
Q Consensus        92 ~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~  171 (464)
                      +.|++.+.||+|+||+||+|.+..+      ++.||||++........+.+.+|+++|++++|||||++++++.+++..+
T Consensus        12 d~Y~i~~~iG~G~fg~Vy~~~~~~~------~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~   85 (288)
T d2jfla1          12 DFWEIIGELGDGAFGKVYKAQNKET------SVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLW   85 (288)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTT------CCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred             cCeEEeEEEeeCCCcEEEEEEECCC------CeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEE
Confidence            4688899999999999999998775      6779999998766566678999999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCccCCCC
Q 046893          172 LVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPM  251 (464)
Q Consensus       172 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~  251 (464)
                      ||||||++|+|.+++.+. ...+++..+..++.||+.||.|||  +++|+||||||+||||+.++.+||+|||+|+....
T Consensus        86 lvmEy~~~g~L~~~~~~~-~~~l~e~~~~~i~~qi~~gL~ylH--~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~  162 (288)
T d2jfla1          86 ILIEFCAGGAVDAVMLEL-ERPLTESQIQVVCKQTLDALNYLH--DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTR  162 (288)
T ss_dssp             EEEECCTTEEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEECTTSCEEECCCTTCEECHH
T ss_pred             EEEecCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHH--HCCEEEeecChhheeECCCCCEEEEechhhhccCC
Confidence            999999999999987654 346999999999999999999999  57799999999999999999999999999975321


Q ss_pred             CCCcceeeccccCCcccCccccc-----cCCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhcccch
Q 046893          252 GDQTHVSTRVMGTYGYAAPEYVM-----TGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKV  326 (464)
Q Consensus       252 ~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  326 (464)
                        ........+||+.|+|||++.     +..|+.++|||||||+||||++|+.||.+......      .........  
T Consensus       163 --~~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~------~~~i~~~~~--  232 (288)
T d2jfla1         163 --TIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRV------LLKIAKSEP--  232 (288)
T ss_dssp             --HHHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGH------HHHHHHSCC--
T ss_pred             --CcccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHH------HHHHHcCCC--
Confidence              112233478999999999884     45689999999999999999999999987543221      111111110  


Q ss_pred             hhccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 046893          327 LRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVA  369 (464)
Q Consensus       327 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  369 (464)
                           +  ....+..++.++.+||.+||+.||.+|||+.++++
T Consensus       233 -----~--~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~  268 (288)
T d2jfla1         233 -----P--TLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ  268 (288)
T ss_dssp             -----C--CCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             -----C--CCCccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                 0  11122345568999999999999999999999875

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-55  Score=416.63  Aligned_cols=253  Identities=22%  Similarity=0.321  Sum_probs=194.1

Q ss_pred             cCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCcc--HHHHHHHHHHHhcCCCCCcceEEEEEEe--C
Q 046893           92 KFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQG--DREWLAEVNYLGQLRHSNLVKLIGYCCE--D  167 (464)
Q Consensus        92 ~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~hpniv~l~~~~~~--~  167 (464)
                      ++|++.+.||+|+||+||+|++..+      ++.||||++.......  .+.+.+|+++|++++|||||++++++.+  .
T Consensus         4 edy~~~~~iG~G~fg~Vy~~~~~~~------~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~   77 (269)
T d2java1           4 EDYEVLYTIGTGSYGRCQKIRRKSD------GKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTN   77 (269)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTT------CCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC---
T ss_pred             hhCEEeEEEecCCCeEEEEEEECCC------CCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCC
Confidence            4688999999999999999998775      6779999997654432  3568899999999999999999999865  4


Q ss_pred             CeEEEEEeccCCCCHHHHHHhh--cCCCCCHHHHHHHHHHHHHHHHHHhcCC---CCeeeccCCCCceEecCCCceEEcc
Q 046893          168 EHRILVYEYMESGSLEKHLLRR--VGCMLTWSRRMKIALDAAKGLAFLHGAE---RPVIYRDFKTSNILLNADFSAKLSD  242 (464)
Q Consensus       168 ~~~~lv~e~~~~g~L~~~l~~~--~~~~l~~~~~~~i~~qi~~~l~~LH~~~---~~ivHrDlkp~Nill~~~~~vkl~D  242 (464)
                      +.+|||||||++|+|.+++.+.  .+..+++..++.++.|++.||.|||+.+   .+|+||||||+||||+.++.+||+|
T Consensus        78 ~~~~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~D  157 (269)
T d2java1          78 TTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGD  157 (269)
T ss_dssp             -CEEEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECC
T ss_pred             CEEEEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEee
Confidence            5689999999999999988653  3457999999999999999999999522   3499999999999999999999999


Q ss_pred             cCCccCCCCCCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhc
Q 046893          243 FGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNN  322 (464)
Q Consensus       243 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~  322 (464)
                      ||+|+.....  .......+||+.|||||++.+..|+.++|||||||+||||++|+.||.+....      +........
T Consensus       158 FG~a~~~~~~--~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~------~~~~~i~~~  229 (269)
T d2java1         158 FGLARILNHD--TSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQK------ELAGKIREG  229 (269)
T ss_dssp             HHHHHHC-------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH------HHHHHHHHT
T ss_pred             ccceeecccC--CCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHH------HHHHHHHcC
Confidence            9999875332  22334578999999999999999999999999999999999999999764321      111111111


Q ss_pred             ccchhhccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 046893          323 NKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVA  369 (464)
Q Consensus       323 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  369 (464)
                      .       .+    ..+..++.++.+||.+||+.||.+|||+.++++
T Consensus       230 ~-------~~----~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~  265 (269)
T d2java1         230 K-------FR----RIPYRYSDELNEIITRMLNLKDYHRPSVEEILE  265 (269)
T ss_dssp             C-------CC----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             C-------CC----CCCcccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence            0       01    122334558999999999999999999999864

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-54  Score=409.96  Aligned_cols=249  Identities=28%  Similarity=0.410  Sum_probs=197.5

Q ss_pred             CCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCc--cHHHHHHHHHHHhcCCCCCcceEEEEEEe----
Q 046893           93 FFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQ--GDREWLAEVNYLGQLRHSNLVKLIGYCCE----  166 (464)
Q Consensus        93 ~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpniv~l~~~~~~----  166 (464)
                      +|++.+.||+|+||+||+|.+..+      +..||+|++......  ..+.|.+|+++|++++|||||+++++|..    
T Consensus        10 y~~~~~~iG~G~fg~Vy~~~~~~~------~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~   83 (270)
T d1t4ha_          10 FLKFDIEIGRGSFKTVYKGLDTET------TVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKG   83 (270)
T ss_dssp             EEEEEEEEEECSSEEEEEEEETTT------CCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSS
T ss_pred             EEEeeeEEecCcCcEEEEEEECCC------CeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeecccc
Confidence            346667899999999999998765      567999998754332  23568899999999999999999999875    


Q ss_pred             CCeEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEec-CCCceEEcccCC
Q 046893          167 DEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLN-ADFSAKLSDFGL  245 (464)
Q Consensus       167 ~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~-~~~~vkl~DFGl  245 (464)
                      ...+|||||||++|+|.+++.+..  .+++..+..++.||+.||.|||+.+.+|+||||||+||||+ .++.+||+|||+
T Consensus        84 ~~~~~ivmE~~~~g~L~~~l~~~~--~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGl  161 (270)
T d1t4ha_          84 KKCIVLVTELMTSGTLKTYLKRFK--VMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGL  161 (270)
T ss_dssp             CEEEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTG
T ss_pred             CCEEEEEEeCCCCCcHHHHHhccc--cccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCc
Confidence            356899999999999999997654  69999999999999999999995444499999999999996 578999999999


Q ss_pred             ccCCCCCCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhcccc
Q 046893          246 AKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKK  325 (464)
Q Consensus       246 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  325 (464)
                      |+....    ......+||+.|||||++.+ .|+.++|||||||+||||++|+.||.......     .........   
T Consensus       162 a~~~~~----~~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~-----~~~~~i~~~---  228 (270)
T d1t4ha_         162 ATLKRA----SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAA-----QIYRRVTSG---  228 (270)
T ss_dssp             GGGCCT----TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHH-----HHHHHHTTT---
T ss_pred             ceeccC----CccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHH-----HHHHHHHcC---
Confidence            985322    12335789999999998865 69999999999999999999999997543211     111111111   


Q ss_pred             hhhccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 046893          326 VLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVA  369 (464)
Q Consensus       326 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  369 (464)
                          ..   ...++...+.++.+||.+||+.||++|||+.|+++
T Consensus       229 ----~~---~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~  265 (270)
T d1t4ha_         229 ----VK---PASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN  265 (270)
T ss_dssp             ----CC---CGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             ----CC---CcccCccCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence                00   11112223447899999999999999999999875

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.7e-55  Score=426.50  Aligned_cols=265  Identities=24%  Similarity=0.372  Sum_probs=213.4

Q ss_pred             HHhcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCC-ccHHHHHHHHHHHhcC-CCCCcceEEEEEEe
Q 046893           89 LATKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGY-QGDREWLAEVNYLGQL-RHSNLVKLIGYCCE  166 (464)
Q Consensus        89 ~~~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~  166 (464)
                      +..++|++.+.||+|+||+||+|++....+. .....||+|.+..... .....+.+|+.+|.++ +|||||++++++.+
T Consensus        34 i~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~  112 (325)
T d1rjba_          34 FPRENLEFGKVLGSGAFGKVMNATAYGISKT-GVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTL  112 (325)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEEESCSSS-SCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             CCHHHeEEeeEEeeCCCeEEEEEEEcCCCcc-cceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEee
Confidence            4456789999999999999999998754322 2345799999865432 3336789999999998 89999999999999


Q ss_pred             CCeEEEEEeccCCCCHHHHHHhhcC---------------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccC
Q 046893          167 DEHRILVYEYMESGSLEKHLLRRVG---------------------CMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDF  225 (464)
Q Consensus       167 ~~~~~lv~e~~~~g~L~~~l~~~~~---------------------~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDl  225 (464)
                      .+..+||||||++|+|.++|..+..                     ..+++..++.++.||+.||.|||  .++||||||
T Consensus       113 ~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH--~~~IiHRDl  190 (325)
T d1rjba_         113 SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE--FKSCVHRDL  190 (325)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHH--HTTEEETTC
T ss_pred             CCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHH--hCCeeeccC
Confidence            9999999999999999999976432                     35899999999999999999999  567999999


Q ss_pred             CCCceEecCCCceEEcccCCccCCCCCCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHh-CCCCCCCC
Q 046893          226 KTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLL-GRRAVDKS  304 (464)
Q Consensus       226 kp~Nill~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~  304 (464)
                      ||+|||++.++.+||+|||+|+...............||+.|||||++.+..|+.++|||||||+||||++ |+.||.+.
T Consensus       191 Kp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~  270 (325)
T d1rjba_         191 AARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGI  270 (325)
T ss_dssp             SGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred             chhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCC
Confidence            99999999999999999999986544444444445778999999999999999999999999999999997 89999765


Q ss_pred             CCcccccHHHHHHHhhhcccchhhccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 046893          305 RPSREHNLVEWARPLLNNNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLE  372 (464)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~  372 (464)
                      ....  .+..    .+.          .......+..++.++.+||.+||+.||.+|||+++|++.|.
T Consensus       271 ~~~~--~~~~----~~~----------~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~  322 (325)
T d1rjba_         271 PVDA--NFYK----LIQ----------NGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG  322 (325)
T ss_dssp             CCSH--HHHH----HHH----------TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             CHHH--HHHH----HHh----------cCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence            4321  1111    111          11122334455678999999999999999999999999885

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-54  Score=410.80  Aligned_cols=253  Identities=27%  Similarity=0.379  Sum_probs=201.6

Q ss_pred             CceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCc--cHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeEEEEEe
Q 046893           98 YILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQ--GDREWLAEVNYLGQLRHSNLVKLIGYCCEDEHRILVYE  175 (464)
Q Consensus        98 ~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e  175 (464)
                      +.||+|+||+||+|.+...    ..++.||||+++.....  ..++|.+|+++|++++|||||++++++.. +..+||||
T Consensus        13 k~iG~G~fG~Vy~~~~~~~----~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE   87 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMK----KVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVME   87 (277)
T ss_dssp             EEEEECSSEEEEEEEEECS----SSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEE
T ss_pred             CCcccCCCeEEEEEEEccC----CcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEE
Confidence            4699999999999987543    13678999999754332  23679999999999999999999999865 45789999


Q ss_pred             ccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCccCCCCCCCc
Q 046893          176 YMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQT  255 (464)
Q Consensus       176 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~~  255 (464)
                      ||++|+|.+++...  ..+++..++.|+.||+.||.|||  +++|+||||||+||||+.++.+||+|||+++........
T Consensus        88 ~~~~g~L~~~l~~~--~~l~~~~~~~i~~qi~~gl~ylH--~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~  163 (277)
T d1xbba_          88 MAELGPLNKYLQQN--RHVKDKNIIELVHQVSMGMKYLE--ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY  163 (277)
T ss_dssp             CCTTEEHHHHHHHC--TTCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSE
T ss_pred             cCCCCcHHHHHhhc--cCCCHHHHHHHHHHHHHHHhhHH--hCCcccCCCcchhhcccccCcccccchhhhhhccccccc
Confidence            99999999988764  36999999999999999999999  567999999999999999999999999999865433222


Q ss_pred             -ceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHhhhcccchhhccCcc
Q 046893          256 -HVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLL-GRRAVDKSRPSREHNLVEWARPLLNNNKKVLRILDPR  333 (464)
Q Consensus       256 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  333 (464)
                       .......||+.|+|||++.+..++.++|||||||++|||++ |+.||.+....   .+..    .+..          .
T Consensus       164 ~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~---~~~~----~i~~----------~  226 (277)
T d1xbba_         164 YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS---EVTA----MLEK----------G  226 (277)
T ss_dssp             EEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH---HHHH----HHHT----------T
T ss_pred             cccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHH---HHHH----HHHc----------C
Confidence             22334679999999999999999999999999999999998 89999864421   1111    1111          1


Q ss_pred             ccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHh
Q 046893          334 LEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETVQS  376 (464)
Q Consensus       334 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~~~  376 (464)
                      .....+..++.++.+||.+||+.||.+|||+.+|++.|+....
T Consensus       227 ~~~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~  269 (277)
T d1xbba_         227 ERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY  269 (277)
T ss_dssp             CCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             CCCCCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHHh
Confidence            1122334556789999999999999999999999999887643

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-54  Score=413.31  Aligned_cols=260  Identities=27%  Similarity=0.370  Sum_probs=207.6

Q ss_pred             cCCCCCCc-eeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCc-cHHHHHHHHHHHhcCCCCCcceEEEEEEeCCe
Q 046893           92 KFFRPDYI-LGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQ-GDREWLAEVNYLGQLRHSNLVKLIGYCCEDEH  169 (464)
Q Consensus        92 ~~~~~~~~-lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~  169 (464)
                      ++|.+... ||+|+||+||+|.+....    .+..||||+++..... ..++|.+|+++|++++|||||++++++.. +.
T Consensus         8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~----~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~   82 (285)
T d1u59a_           8 DNLLIADIELGCGNFGSVRQGVYRMRK----KQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EA   82 (285)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC-------CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SS
T ss_pred             cCeEECCcEEecccCeEEEEEEEecCC----CcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-Ce
Confidence            34555664 999999999999875431    2457999999765433 34679999999999999999999999865 56


Q ss_pred             EEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCccCC
Q 046893          170 RILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDG  249 (464)
Q Consensus       170 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~  249 (464)
                      .|||||||++|+|.+++... ...+++..++.++.|++.||.|||  +++|+||||||+||||+.++.+||+|||+|+..
T Consensus        83 ~~lvmE~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~gL~ylH--~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~  159 (285)
T d1u59a_          83 LMLVMEMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLE--EKNFVHRDLAARNVLLVNRHYAKISDFGLSKAL  159 (285)
T ss_dssp             EEEEEECCTTEEHHHHHTTC-TTTSCHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred             EEEEEEeCCCCcHHHHhhcc-ccCCCHHHHHHHHHHHHHHHHHHH--hCCeecCcCchhheeeccCCceeeccchhhhcc
Confidence            78999999999999987654 346999999999999999999999  577999999999999999999999999999875


Q ss_pred             CCCCCc-ceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHhhhcccchh
Q 046893          250 PMGDQT-HVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLL-GRRAVDKSRPSREHNLVEWARPLLNNNKKVL  327 (464)
Q Consensus       250 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  327 (464)
                      ...... .......||+.|+|||++.+..++.++|||||||+||||+| |+.||.+.....   +..   . +..     
T Consensus       160 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~---~~~---~-i~~-----  227 (285)
T d1u59a_         160 GADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE---VMA---F-IEQ-----  227 (285)
T ss_dssp             TTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHH---HHH---H-HHT-----
T ss_pred             cccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHH---HHH---H-HHc-----
Confidence            433322 22334678999999999999999999999999999999998 999998654221   111   1 111     


Q ss_pred             hccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHh
Q 046893          328 RILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETVQS  376 (464)
Q Consensus       328 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~~~  376 (464)
                           ......+..++.++.+||.+||+.||.+|||+.+|++.|+.+..
T Consensus       228 -----~~~~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~  271 (285)
T d1u59a_         228 -----GKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYY  271 (285)
T ss_dssp             -----TCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             -----CCCCCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence                 11112334556789999999999999999999999999987643

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3e-55  Score=426.57  Aligned_cols=272  Identities=22%  Similarity=0.316  Sum_probs=207.8

Q ss_pred             HHhcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCc-cHHHHHHHHHHHhcCCCCCcceEEEEEEeC
Q 046893           89 LATKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQ-GDREWLAEVNYLGQLRHSNLVKLIGYCCED  167 (464)
Q Consensus        89 ~~~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~  167 (464)
                      +..++|++.+.||+|+||+||+|++..+      ++.||+|+++..... ....+.+|+.+|+.++|||||+++++|.++
T Consensus         3 l~~d~y~~~~~iG~G~fg~V~~~~~~~~------~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~   76 (322)
T d1s9ja_           3 LKDDDFEKISELGAGNGGVVFKVSHKPS------GLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSD   76 (322)
T ss_dssp             CCGGGEEEEEEEECCSSCCEEEEEETTT------TEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECS
T ss_pred             CCccCCEEEEEEecCCCeEEEEEEECCC------CcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC
Confidence            3456799999999999999999998765      788999999765333 346789999999999999999999999999


Q ss_pred             CeEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCcc
Q 046893          168 EHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAK  247 (464)
Q Consensus       168 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~  247 (464)
                      +..|||||||++|+|.+++.+..  .+++..+..++.|++.||.|||+ ..+|+||||||+||||+.++.+||+|||+|+
T Consensus        77 ~~~~iVmEy~~gg~L~~~l~~~~--~l~~~~~~~~~~qil~aL~yLH~-~~~IiHRDiKP~NILl~~~~~vkl~DFGla~  153 (322)
T d1s9ja_          77 GEISICMEHMDGGSLDQVLKKAG--RIPEQILGKVSIAVIKGLTYLRE-KHKIMHRDVKPSNILVNSRGEIKLCDFGVSG  153 (322)
T ss_dssp             SEEEEEEECCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHH-HHCCCCSCCSGGGEEECTTCCEEECCCCCCH
T ss_pred             CEEEEEEEcCCCCcHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHH-hCCEEccccCHHHeeECCCCCEEEeeCCCcc
Confidence            99999999999999999987654  69999999999999999999994 1369999999999999999999999999998


Q ss_pred             CCCCCCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHH-HHHHhh------
Q 046893          248 DGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVE-WARPLL------  320 (464)
Q Consensus       248 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~-~~~~~~------  320 (464)
                      ....    ......+||+.|+|||++.+..|+.++|||||||++|||++|+.||.+........... ......      
T Consensus       154 ~~~~----~~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (322)
T d1s9ja_         154 QLID----SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPR  229 (322)
T ss_dssp             HHHH----HTC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC--------------
T ss_pred             ccCC----CccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcc
Confidence            5321    22334789999999999999999999999999999999999999997654221100000 000000      


Q ss_pred             -hc--------------ccchhh----ccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH--HHHH
Q 046893          321 -NN--------------NKKVLR----ILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVA--LLET  373 (464)
Q Consensus       321 -~~--------------~~~~~~----~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~--~L~~  373 (464)
                       ..              ......    ..............+.++.+|+.+||..||.+|||+.++++  .|..
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~  303 (322)
T d1s9ja_         230 PRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKR  303 (322)
T ss_dssp             ----------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHH
T ss_pred             cccccccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCc
Confidence             00              000000    00000000001113457899999999999999999999986  4544

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-54  Score=413.00  Aligned_cols=266  Identities=26%  Similarity=0.414  Sum_probs=205.3

Q ss_pred             cCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCcc-HHHHHHHHHHHhcCCCCCcceEEEEEEeCCeE
Q 046893           92 KFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQG-DREWLAEVNYLGQLRHSNLVKLIGYCCEDEHR  170 (464)
Q Consensus        92 ~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~  170 (464)
                      ..|++.++||+|+||+||+|.+..+..  .....||||++....... ..+|++|+++|.+++|||||++++++.+.+..
T Consensus         7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~--~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~   84 (283)
T d1mqba_           7 SCVTRQKVIGAGEFGEVYKGMLKTSSG--KKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPM   84 (283)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC-----CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSE
T ss_pred             HHeEeeeEEeeCCCeEEEEEEEeCCCC--EEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCce
Confidence            457788899999999999999875421  124579999987644332 35689999999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCccCCC
Q 046893          171 ILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGP  250 (464)
Q Consensus       171 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~  250 (464)
                      ++|||||.+++|.+++... ...+++..++.++.|++.||.|||  +++|+||||||+||||+.++.+||+|||+++...
T Consensus        85 ~~v~e~~~~~~l~~~~~~~-~~~~~~~~~~~i~~~i~~gl~~lH--~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~  161 (283)
T d1mqba_          85 MIITEYMENGALDKFLREK-DGEFSVLQLVGMLRGIAAGMKYLA--NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLE  161 (283)
T ss_dssp             EEEEECCTTEEHHHHHHHT-TTCSCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred             EEEEEecccCcchhhhhcc-cccccHHHHHHHHHHHHHhhhhcc--ccccccCccccceEEECCCCeEEEcccchhhccc
Confidence            9999999999998877654 346999999999999999999999  5679999999999999999999999999998654


Q ss_pred             CCCC-cceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhcccchhhc
Q 046893          251 MGDQ-THVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRI  329 (464)
Q Consensus       251 ~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  329 (464)
                      .... ........||+.|+|||++.+..++.++|||||||+||||++|..||......  .   +.....          
T Consensus       162 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~--~---~~~~~i----------  226 (283)
T d1mqba_         162 DDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN--H---EVMKAI----------  226 (283)
T ss_dssp             ------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH--H---HHHHHH----------
T ss_pred             CCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCH--H---HHHHHH----------
Confidence            3322 22233457899999999999999999999999999999999976665433211  1   111111          


Q ss_pred             cCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhcC
Q 046893          330 LDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETVQSQG  378 (464)
Q Consensus       330 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~~~~~  378 (464)
                       ........+..++..+.+||.+||+.||.+||++.+|++.|+.+.+..
T Consensus       227 -~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~p  274 (283)
T d1mqba_         227 -NDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAP  274 (283)
T ss_dssp             -HTTCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSG
T ss_pred             -hccCCCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhCc
Confidence             111222333445678999999999999999999999999999887643

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-54  Score=414.34  Aligned_cols=251  Identities=22%  Similarity=0.266  Sum_probs=205.0

Q ss_pred             cCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCC---CccHHHHHHHHHHHhcCCCCCcceEEEEEEeCC
Q 046893           92 KFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGG---YQGDREWLAEVNYLGQLRHSNLVKLIGYCCEDE  168 (464)
Q Consensus        92 ~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~  168 (464)
                      ++|++.+.||+|+||+||+|.+..+      ++.||||++....   ......+.+|+++|++++||||++++++|.+++
T Consensus         8 ~dy~i~~~lG~G~fg~Vy~a~~~~~------~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~   81 (288)
T d1uu3a_           8 EDFKFGKILGEGSFSTVVLARELAT------SREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDE   81 (288)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTT------CCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSS
T ss_pred             CCCEEEEEEeeCCCeEEEEEEECCC------CCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECC
Confidence            4589999999999999999998765      6679999986432   233467899999999999999999999999999


Q ss_pred             eEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCccC
Q 046893          169 HRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKD  248 (464)
Q Consensus       169 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~  248 (464)
                      ..|||||||+||+|.+++....  .+++..+..++.|++.||.|||  .++||||||||+||||+.++.+||+|||+|+.
T Consensus        82 ~~~ivmEy~~gg~L~~~~~~~~--~l~e~~~~~~~~qi~~al~ylH--~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~  157 (288)
T d1uu3a_          82 KLYFGLSYAKNGELLKYIRKIG--SFDETCTRFYTAEIVSALEYLH--GKGIIHRDLKPENILLNEDMHIQITDFGTAKV  157 (288)
T ss_dssp             EEEEEECCCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred             EEEEEEEccCCCCHHHhhhccC--CCCHHHHHHHHHHHHHHHHhhc--cccEEcCcCCccccccCCCceEEeccccccee
Confidence            9999999999999999887654  6999999999999999999999  57799999999999999999999999999987


Q ss_pred             CCCCCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhcccchhh
Q 046893          249 GPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLR  328 (464)
Q Consensus       249 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  328 (464)
                      .............+||+.|+|||++.+..|+.++|||||||+||||++|+.||.+....      +.........     
T Consensus       158 ~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~------~~~~~i~~~~-----  226 (288)
T d1uu3a_         158 LSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEY------LIFQKIIKLE-----  226 (288)
T ss_dssp             CC----------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHTTC-----
T ss_pred             cccCCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHH------HHHHHHHcCC-----
Confidence            65444333445578999999999999999999999999999999999999999864321      1111111111     


Q ss_pred             ccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 046893          329 ILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVAL  370 (464)
Q Consensus       329 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  370 (464)
                         .    .++...+..+.+||.+||+.||.+|||++|++..
T Consensus       227 ---~----~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~  261 (288)
T d1uu3a_         227 ---Y----DFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGY  261 (288)
T ss_dssp             ---C----CCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCH
T ss_pred             ---C----CCCccCCHHHHHHHHHHccCCHhHCcCHHHHcCC
Confidence               1    1223345578999999999999999999998653

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.2e-54  Score=402.87  Aligned_cols=253  Identities=25%  Similarity=0.382  Sum_probs=210.4

Q ss_pred             cCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCccHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeEE
Q 046893           92 KFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVKLIGYCCEDEHRI  171 (464)
Q Consensus        92 ~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~  171 (464)
                      ++|++.+.||+|+||+||+|++.+       +..||||+++... ...++|++|+.++.+++||||+++++++.+++..+
T Consensus         4 ~~~~~~~~iG~G~fg~Vy~~~~~~-------~~~vAvK~l~~~~-~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~   75 (258)
T d1k2pa_           4 KDLTFLKELGTGQFGVVKYGKWRG-------QYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIF   75 (258)
T ss_dssp             CCCCCCCCCCEETTEEEEEEEETT-------TEEEEEEEEESSS-SCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEE
T ss_pred             HHCEEeEEEecCCCeEEEEEEECC-------CCEEEEEEECcCc-CCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceE
Confidence            578999999999999999999753       5679999998654 34578999999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCccCCCC
Q 046893          172 LVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPM  251 (464)
Q Consensus       172 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~  251 (464)
                      +||||+.+|+|.+++.... ..+++..++.++.|++.||.|||  .++|+||||||+|||++.++.+||+|||+++....
T Consensus        76 iv~Ey~~~g~l~~~~~~~~-~~~~~~~~~~i~~qi~~gl~~LH--~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~  152 (258)
T d1k2pa_          76 IITEYMANGCLLNYLREMR-HRFQTQQLLEMCKDVCEAMEYLE--SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD  152 (258)
T ss_dssp             EEEECCTTEEHHHHHHSGG-GCCCHHHHHHHHHHHHHHHHHHH--HTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSS
T ss_pred             EEEEccCCCcHHHhhhccc-cCCcHHHHHHHHHHHHHHHHHHh--hcCcccccccceeEEEcCCCcEEECcchhheeccC
Confidence            9999999999999876543 36899999999999999999999  57799999999999999999999999999986543


Q ss_pred             CCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHhhhcccchhhcc
Q 046893          252 GDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLL-GRRAVDKSRPSREHNLVEWARPLLNNNKKVLRIL  330 (464)
Q Consensus       252 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  330 (464)
                      .... ......||+.|+|||++.+..++.++|||||||++|||+| |+.||.+....      +....+.. .       
T Consensus       153 ~~~~-~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~------~~~~~i~~-~-------  217 (258)
T d1k2pa_         153 DEYT-SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS------ETAEHIAQ-G-------  217 (258)
T ss_dssp             SSCC-CCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHH------HHHHHHHT-T-------
T ss_pred             CCce-eecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHH------HHHHHHHh-C-------
Confidence            3222 2334679999999999999999999999999999999998 89999765421      11111111 1       


Q ss_pred             CccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q 046893          331 DPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLET  373 (464)
Q Consensus       331 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~  373 (464)
                         .....+..++..+.+||.+||+.||.+|||+.++++.|.+
T Consensus       218 ---~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~d  257 (258)
T d1k2pa_         218 ---LRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILD  257 (258)
T ss_dssp             ---CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred             ---CCCCCcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence               1112233455689999999999999999999999998754

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=4.8e-54  Score=414.60  Aligned_cols=253  Identities=21%  Similarity=0.341  Sum_probs=192.6

Q ss_pred             HhcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCc-cHHHHHHHHHHHhcCCCCCcceEEEEEEeCC
Q 046893           90 ATKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQ-GDREWLAEVNYLGQLRHSNLVKLIGYCCEDE  168 (464)
Q Consensus        90 ~~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~  168 (464)
                      ..+.|++.+.||+|+||+||+|.+..+      ++.||||++...... ....+.+|+.+|+.++|||||++++++.+++
T Consensus         7 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~------~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~   80 (307)
T d1a06a_           7 IRDIYDFRDVLGTGAFSEVILAEDKRT------QKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGG   80 (307)
T ss_dssp             GGGTEEEEEESBSGGGGGEEEEEETTT------CCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred             CccceEEEEEEeeccCeEEEEEEECCC------CCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC
Confidence            346799999999999999999998765      677999999765432 2356789999999999999999999999999


Q ss_pred             eEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEec---CCCceEEcccCC
Q 046893          169 HRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLN---ADFSAKLSDFGL  245 (464)
Q Consensus       169 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~---~~~~vkl~DFGl  245 (464)
                      ..|||||||+||+|.+++...  ..+++..+..++.||+.||.|||  +++|+||||||+|||+.   .++.+||+|||+
T Consensus        81 ~~~lvmE~~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~al~ylH--~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~  156 (307)
T d1a06a_          81 HLYLIMQLVSGGELFDRIVEK--GFYTERDASRLIFQVLDAVKYLH--DLGIVHRDLKPENLLYYSLDEDSKIMISDFGL  156 (307)
T ss_dssp             EEEEEECCCCSCBHHHHHHTC--SCCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCCGGGEEESSSSTTCCEEECCC--
T ss_pred             EEEEEEeccCCCcHHHhhhcc--cCCCHHHHHHHHHHHHHHHHhhh--hceeeeEEecccceeecccCCCceEEEeccce
Confidence            999999999999999999764  36999999999999999999999  57799999999999994   578999999999


Q ss_pred             ccCCCCCCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhcccc
Q 046893          246 AKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKK  325 (464)
Q Consensus       246 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  325 (464)
                      |+......   .....+||+.|||||++.+..|+.++|||||||+||||++|+.||.+....      +.........  
T Consensus       157 a~~~~~~~---~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~------~~~~~i~~~~--  225 (307)
T d1a06a_         157 SKMEDPGS---VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDA------KLFEQILKAE--  225 (307)
T ss_dssp             -------------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH------HHHHHHHTTC--
T ss_pred             eEEccCCC---eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHH------HHHHHHhccC--
Confidence            98643222   234478999999999999999999999999999999999999999764321      1111111111  


Q ss_pred             hhhccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 046893          326 VLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVA  369 (464)
Q Consensus       326 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  369 (464)
                            ...........+..+.+|+.+||+.||.+|||+.++++
T Consensus       226 ------~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  263 (307)
T d1a06a_         226 ------YEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQ  263 (307)
T ss_dssp             ------CCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             ------CCCCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence                  11111222344568999999999999999999999875

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=4.3e-54  Score=415.06  Aligned_cols=246  Identities=27%  Similarity=0.401  Sum_probs=201.9

Q ss_pred             cCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCccH---HHHHHHHHHHhcCCCCCcceEEEEEEeCC
Q 046893           92 KFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGD---REWLAEVNYLGQLRHSNLVKLIGYCCEDE  168 (464)
Q Consensus        92 ~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~---~~~~~E~~~l~~l~hpniv~l~~~~~~~~  168 (464)
                      +.|++.+.||+|+||+||+|++..+      ++.||||++........   +.+.+|+++|++++|||||++++++.+++
T Consensus        15 ~~y~~l~~lG~G~fg~Vy~a~~~~~------~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~   88 (309)
T d1u5ra_          15 KLFSDLREIGHGSFGAVYFARDVRN------SEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREH   88 (309)
T ss_dssp             HHEEEEEEEEECSSSEEEEEEETTT------TEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETT
T ss_pred             HhcEeeEEEecCCCeEEEEEEECCC------CcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECC
Confidence            3488899999999999999998765      77899999976544332   56889999999999999999999999999


Q ss_pred             eEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCccC
Q 046893          169 HRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKD  248 (464)
Q Consensus       169 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~  248 (464)
                      ..|||||||.+|+|..++...  ..+++..+..++.||+.||.|||  .++||||||||+||||+.++.+||+|||+|+.
T Consensus        89 ~~~iv~E~~~~g~l~~~~~~~--~~l~e~~~~~i~~qi~~aL~yLH--~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~  164 (309)
T d1u5ra_          89 TAWLVMEYCLGSASDLLEVHK--KPLQEVEIAAVTHGALQGLAYLH--SHNMIHRDVKAGNILLSEPGLVKLGDFGSASI  164 (309)
T ss_dssp             EEEEEEECCSEEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHH--HTTCBCCCCSGGGEEEETTTEEEECCCTTCBS
T ss_pred             EEEEEEEecCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHH--hCCEeccCCCcceEEECCCCCEEEeecccccc
Confidence            999999999999997665543  36999999999999999999999  57799999999999999999999999999986


Q ss_pred             CCCCCCcceeeccccCCcccCcccccc---CCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhcccc
Q 046893          249 GPMGDQTHVSTRVMGTYGYAAPEYVMT---GHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKK  325 (464)
Q Consensus       249 ~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  325 (464)
                      ...      ....+||+.|||||++.+   ..|+.++|||||||+||||++|+.||.+....      +.........  
T Consensus       165 ~~~------~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~------~~~~~i~~~~--  230 (309)
T d1u5ra_         165 MAP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM------SALYHIAQNE--  230 (309)
T ss_dssp             SSS------BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH------HHHHHHHHSC--
T ss_pred             cCC------CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHH------HHHHHHHhCC--
Confidence            422      234689999999999864   45899999999999999999999999764321      1111111110  


Q ss_pred             hhhccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 046893          326 VLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVA  369 (464)
Q Consensus       326 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  369 (464)
                           .+.+   ....++..+.+||.+||+.||.+|||+.++++
T Consensus       231 -----~~~~---~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~  266 (309)
T d1u5ra_         231 -----SPAL---QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK  266 (309)
T ss_dssp             -----CCCC---SCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             -----CCCC---CCCCCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence                 1111   11233458999999999999999999999975

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=3.1e-53  Score=415.91  Aligned_cols=252  Identities=21%  Similarity=0.271  Sum_probs=208.3

Q ss_pred             cCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCccHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeEE
Q 046893           92 KFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVKLIGYCCEDEHRI  171 (464)
Q Consensus        92 ~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~  171 (464)
                      ++|++.+.||+|+||+||+|++..+      ++.||||++........+.+.+|+.+|+.++|||||++++++.+++..|
T Consensus        26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~------g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~   99 (350)
T d1koaa2          26 DHYDIHEELGTGAFGVVHRVTERAT------GNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMV   99 (350)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTT------TEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEE
T ss_pred             cCeEEEEEEecCcCeEEEEEEECCC------CCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence            4799999999999999999998765      7789999997765555577899999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEec--CCCceEEcccCCccCC
Q 046893          172 LVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLN--ADFSAKLSDFGLAKDG  249 (464)
Q Consensus       172 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~--~~~~vkl~DFGla~~~  249 (464)
                      ||||||+||+|.+++.+.. ..+++..+..|+.||+.||.|||  .++||||||||+||||+  .++.+||+|||+|+..
T Consensus       100 ivmE~~~gg~L~~~l~~~~-~~l~e~~~~~i~~qi~~aL~ylH--~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~  176 (350)
T d1koaa2         100 MIYEFMSGGELFEKVADEH-NKMSEDEAVEYMRQVCKGLCHMH--ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHL  176 (350)
T ss_dssp             EEECCCCSCBHHHHHTCTT-SCBCHHHHHHHHHHHHHHHHHHH--HTTEECCCCCGGGEEESSTTSCCEEECCCTTCEEC
T ss_pred             EEEEcCCCCCHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHH--hcCCeeeeechhHeeeccCCCCeEEEeecchheec
Confidence            9999999999999886543 36999999999999999999999  57799999999999995  4578999999999865


Q ss_pred             CCCCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhcccchhhc
Q 046893          250 PMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRI  329 (464)
Q Consensus       250 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  329 (464)
                      ...   .......||+.|||||++.+..|+.++|||||||++|||++|+.||.+...      .+..........     
T Consensus       177 ~~~---~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~------~~~~~~i~~~~~-----  242 (350)
T d1koaa2         177 DPK---QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEND------DETLRNVKSCDW-----  242 (350)
T ss_dssp             CTT---SCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHTCC-----
T ss_pred             ccc---cccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCH------HHHHHHHHhCCC-----
Confidence            332   223447899999999999999999999999999999999999999976432      112222211111     


Q ss_pred             cCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 046893          330 LDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVA  369 (464)
Q Consensus       330 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  369 (464)
                         .........++..+.+||.+||..||.+|||+.++++
T Consensus       243 ---~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~  279 (350)
T d1koaa2         243 ---NMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALE  279 (350)
T ss_dssp             ---CSCCGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred             ---CCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence               1111122234458899999999999999999999875

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=3.5e-53  Score=415.86  Aligned_cols=252  Identities=21%  Similarity=0.284  Sum_probs=208.6

Q ss_pred             cCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCccHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeEE
Q 046893           92 KFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVKLIGYCCEDEHRI  171 (464)
Q Consensus        92 ~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~  171 (464)
                      ++|++.+.||+|+||+||+|++..+      ++.||||++..........+.+|+.+|++|+|||||+++++|.+++.+|
T Consensus        29 d~Y~i~~~lG~G~fg~V~~a~~~~~------~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~  102 (352)
T d1koba_          29 DYYDILEELGSGAFGVVHRCVEKAT------GRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMV  102 (352)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTT------CCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEE
T ss_pred             cceEEEEEEecCCCeEEEEEEECCC------CCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence            4699999999999999999998765      6779999998765455567889999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEec--CCCceEEcccCCccCC
Q 046893          172 LVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLN--ADFSAKLSDFGLAKDG  249 (464)
Q Consensus       172 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~--~~~~vkl~DFGla~~~  249 (464)
                      ||||||+||+|.+++... +..+++.+++.|+.||+.||.|||  +++||||||||+||||+  .++.+||+|||+|+..
T Consensus       103 ivmE~~~gg~L~~~~~~~-~~~l~e~~~~~i~~qi~~aL~ylH--~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~  179 (352)
T d1koba_         103 LILEFLSGGELFDRIAAE-DYKMSEAEVINYMRQACEGLKHMH--EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKL  179 (352)
T ss_dssp             EEEECCCCCBHHHHTTCT-TCCBCHHHHHHHHHHHHHHHHHHH--HTTEECCCCCGGGEEESSTTCCCEEECCCTTCEEC
T ss_pred             EEEEcCCCChHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHH--HCCeeecccccccccccccCCCeEEEeecccceec
Confidence            999999999998877554 346999999999999999999999  57799999999999997  6789999999999875


Q ss_pred             CCCCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhcccchhhc
Q 046893          250 PMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRI  329 (464)
Q Consensus       250 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  329 (464)
                      ....   ......||+.|+|||++.+..|+.++|||||||+||||++|+.||.+....      +.........      
T Consensus       180 ~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~------~~~~~i~~~~------  244 (352)
T d1koba_         180 NPDE---IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL------ETLQNVKRCD------  244 (352)
T ss_dssp             CTTS---CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH------HHHHHHHHCC------
T ss_pred             CCCC---ceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHHhCC------
Confidence            4322   334478999999999999999999999999999999999999999764321      1111111111      


Q ss_pred             cCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 046893          330 LDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVA  369 (464)
Q Consensus       330 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  369 (464)
                        ..+........+.++.+||.+||+.||.+|||+.++++
T Consensus       245 --~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~  282 (352)
T d1koba_         245 --WEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE  282 (352)
T ss_dssp             --CCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             --CCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence              11112222334568899999999999999999999865

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.9e-54  Score=408.14  Aligned_cols=259  Identities=28%  Similarity=0.429  Sum_probs=204.7

Q ss_pred             HhcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCccHHHHHHHHHHHhcCCCCCcceEEEEEEeCCe
Q 046893           90 ATKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVKLIGYCCEDEH  169 (464)
Q Consensus        90 ~~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~  169 (464)
                      ..++|++.+.||+|+||+||+|++..       ++.||||++... ....+.|.+|+.+|++++|||||++++++.+ +.
T Consensus        15 ~~~~~~i~~~iG~G~fg~Vy~~~~~~-------~~~vAiK~l~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~   85 (285)
T d1fmka3          15 PRESLRLEVKLGQGCFGEVWMGTWNG-------TTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EP   85 (285)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETT-------TEEEEEEECCTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SS
T ss_pred             CHHHEEEeeEEeeCCCeEEEEEEECC-------CCEEEEEEECcc-cCCHHHHHHHHHHHHhcccCCEeEEEEEEec-CC
Confidence            34679999999999999999999865       345999999754 3456789999999999999999999999854 56


Q ss_pred             EEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCccCC
Q 046893          170 RILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDG  249 (464)
Q Consensus       170 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~  249 (464)
                      .++|||||.+|+|..++.......+++..++.++.||+.||+|||  .++|+||||||+||||+.++.+||+|||+|+..
T Consensus        86 ~~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH--~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~  163 (285)
T d1fmka3          86 IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE--RMNYVHRDLRAANILVGENLVCKVADFGLARLI  163 (285)
T ss_dssp             CEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCSGGGEEECGGGCEEECCCCTTC--
T ss_pred             eEEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHh--hhheecccccceEEEECCCCcEEEcccchhhhc
Confidence            789999999999999887665557999999999999999999999  567999999999999999999999999999865


Q ss_pred             CCCCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhcccchhhc
Q 046893          250 PMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRI  329 (464)
Q Consensus       250 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  329 (464)
                      ..... .......||+.|+|||++.++.++.++|||||||+||||++|..||......  ..+..+   ..         
T Consensus       164 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~--~~~~~~---i~---------  228 (285)
T d1fmka3         164 EDNEY-TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN--REVLDQ---VE---------  228 (285)
T ss_dssp             -------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH--HHHHHH---HH---------
T ss_pred             cCCCc-eeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCH--HHHHHH---HH---------
Confidence            33222 2233467999999999999999999999999999999999976666543221  111111   11         


Q ss_pred             cCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHh
Q 046893          330 LDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETVQS  376 (464)
Q Consensus       330 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~~~  376 (464)
                        .......+..++.++.+||.+||+.||++||++.+|+++|+.+..
T Consensus       229 --~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~  273 (285)
T d1fmka3         229 --RGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT  273 (285)
T ss_dssp             --TTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTS
T ss_pred             --hcCCCCCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhc
Confidence              111122334456689999999999999999999999999987653

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-53  Score=405.58  Aligned_cols=262  Identities=24%  Similarity=0.342  Sum_probs=201.7

Q ss_pred             HhcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCcc-HHHHHHHHHHHhcCCCCCcceEEEEEEeCC
Q 046893           90 ATKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQG-DREWLAEVNYLGQLRHSNLVKLIGYCCEDE  168 (464)
Q Consensus        90 ~~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~hpniv~l~~~~~~~~  168 (464)
                      ..++|++.+.||+|+||+||+|++..+..   .+..||||.+....... .+.|.+|+.+|++++|||||++++++. ++
T Consensus         5 ~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~---~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~   80 (273)
T d1mp8a_           5 QRERIELGRCIGEGQFGDVHQGIYMSPEN---PALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-EN   80 (273)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEECCC-----CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SS
T ss_pred             CHHHeEEEEEEeeCCCcEEEEEEEecCCc---eeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cC
Confidence            35678999999999999999999865422   24679999986544333 366899999999999999999999985 56


Q ss_pred             eEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCccC
Q 046893          169 HRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKD  248 (464)
Q Consensus       169 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~  248 (464)
                      ..++||||+++|+|.+++... ...+++..++.++.||+.||.|||  +++|+||||||+|||++.++.+||+|||+|+.
T Consensus        81 ~~~iv~E~~~~g~l~~~~~~~-~~~l~~~~~~~~~~qi~~gl~ylH--~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~  157 (273)
T d1mp8a_          81 PVWIIMELCTLGELRSFLQVR-KYSLDLASLILYAYQLSTALAYLE--SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRY  157 (273)
T ss_dssp             SCEEEEECCTTEEHHHHHHHT-TTTSCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCSGGGEEEEETTEEEECC------
T ss_pred             eEEEEEEeccCCcHHhhhhcc-CCCCCHHHHHHHHHHHHHHhhhhc--ccCeeccccchhheeecCCCcEEEccchhhee
Confidence            789999999999999887654 346899999999999999999999  57799999999999999999999999999986


Q ss_pred             CCCCCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHhhhcccchh
Q 046893          249 GPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLL-GRRAVDKSRPSREHNLVEWARPLLNNNKKVL  327 (464)
Q Consensus       249 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  327 (464)
                      ..... ........||+.|+|||++.+..++.++|||||||+||||++ |..||.......   +....   ...     
T Consensus       158 ~~~~~-~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~---~~~~i---~~~-----  225 (273)
T d1mp8a_         158 MEDST-YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND---VIGRI---ENG-----  225 (273)
T ss_dssp             --------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---HHHHH---HTT-----
T ss_pred             ccCCc-ceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHH---HHHHH---HcC-----
Confidence            43322 222344678999999999999999999999999999999998 899997654322   11111   111     


Q ss_pred             hccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHh
Q 046893          328 RILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETVQS  376 (464)
Q Consensus       328 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~~~  376 (464)
                            .....+..++..+.+||.+||..||.+|||+.+|++.|+.+..
T Consensus       226 ------~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~  268 (273)
T d1mp8a_         226 ------ERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE  268 (273)
T ss_dssp             ------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ------CCCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence                  1112334456789999999999999999999999999988754

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.8e-53  Score=405.72  Aligned_cols=252  Identities=24%  Similarity=0.314  Sum_probs=206.6

Q ss_pred             hcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCC------ccHHHHHHHHHHHhcCCCCCcceEEEEE
Q 046893           91 TKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGY------QGDREWLAEVNYLGQLRHSNLVKLIGYC  164 (464)
Q Consensus        91 ~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~hpniv~l~~~~  164 (464)
                      .++|++.+.||+|+||+||+|.+..+      ++.||||++.....      ...+.+.+|+.+|++++|||||+++++|
T Consensus         9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~------~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~   82 (293)
T d1jksa_           9 DDYYDTGEELGSGQFAVVKKCREKST------GLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVY   82 (293)
T ss_dssp             GGTEEEEEEEEECSSEEEEEEEETTT------CCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             ccCEEEeEEEecCCCeEEEEEEECCC------CCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEE
Confidence            46799999999999999999998765      67799999865432      2346789999999999999999999999


Q ss_pred             EeCCeEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCC----ceEE
Q 046893          165 CEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADF----SAKL  240 (464)
Q Consensus       165 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~----~vkl  240 (464)
                      .+.+..|||||||++|+|.+++....  .+++..+..++.|++.||+|||  +++|+||||||+|||++.++    .+||
T Consensus        83 ~~~~~~~iv~E~~~gg~L~~~i~~~~--~l~~~~~~~~~~qi~~al~yLH--~~~ivHrDiKp~Nill~~~~~~~~~vkl  158 (293)
T d1jksa_          83 ENKTDVILILELVAGGELFDFLAEKE--SLTEEEATEFLKQILNGVYYLH--SLQIAHFDLKPENIMLLDRNVPKPRIKI  158 (293)
T ss_dssp             ECSSEEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEESCSSSSSCCEEE
T ss_pred             EECCEEEEEEEcCCCccccchhcccc--ccchhHHHHHHHHHHHHHHhhh--hcceeecccccceEEEecCCCcccceEe
Confidence            99999999999999999999987754  6999999999999999999999  56799999999999998776    5999


Q ss_pred             cccCCccCCCCCCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhh
Q 046893          241 SDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLL  320 (464)
Q Consensus       241 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~  320 (464)
                      +|||+|+......   ......||+.|+|||++.+..++.++|||||||+||||++|+.||.+....      +......
T Consensus       159 ~DfG~a~~~~~~~---~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~------~~~~~i~  229 (293)
T d1jksa_         159 IDFGLAHKIDFGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ------ETLANVS  229 (293)
T ss_dssp             CCCTTCEECTTSC---BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHH
T ss_pred             cchhhhhhcCCCc---cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHH------HHHHHHH
Confidence            9999998654332   233468999999999999999999999999999999999999999864421      1111111


Q ss_pred             hcccchhhccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 046893          321 NNNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVA  369 (464)
Q Consensus       321 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  369 (464)
                      ....        .........++..+.+||.+||+.||.+|||+.++++
T Consensus       230 ~~~~--------~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  270 (293)
T d1jksa_         230 AVNY--------EFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ  270 (293)
T ss_dssp             TTCC--------CCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             hcCC--------CCCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            1111        1111111234457889999999999999999999874

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.2e-52  Score=406.29  Aligned_cols=248  Identities=27%  Similarity=0.352  Sum_probs=206.1

Q ss_pred             cCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCC---CccHHHHHHHHHHHhcCCCCCcceEEEEEEeCC
Q 046893           92 KFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGG---YQGDREWLAEVNYLGQLRHSNLVKLIGYCCEDE  168 (464)
Q Consensus        92 ~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~  168 (464)
                      ++|++.+.||+|+||+||+|++..+      ++.||||++++..   ......+.+|+.+|+.++||||++++++|.+.+
T Consensus         5 ~dy~~~~~lG~G~fg~V~~~~~~~~------~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~   78 (337)
T d1o6la_           5 NDFDYLKLLGKGTFGKVILVREKAT------GRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHD   78 (337)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTT------CCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSS
T ss_pred             HhcEEEEEEecCcCeEEEEEEECCC------CCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeecccc
Confidence            4688999999999999999998765      6789999987532   233467889999999999999999999999999


Q ss_pred             eEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCccC
Q 046893          169 HRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKD  248 (464)
Q Consensus       169 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~  248 (464)
                      .+|+|||||+||+|.+++.+..  .+++..+..++.||+.||.|||  .++||||||||+||||+.+|.+||+|||+|+.
T Consensus        79 ~~~iv~ey~~gg~L~~~~~~~~--~~~e~~~~~~~~qil~al~ylH--~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~  154 (337)
T d1o6la_          79 RLCFVMEYANGGELFFHLSRER--VFTEERARFYGAEIVSALEYLH--SRDVVYRDIKLENLMLDKDGHIKITDFGLCKE  154 (337)
T ss_dssp             EEEEEEECCTTCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHH--HTTCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred             ccccceeccCCCchhhhhhccc--CCcHHHHHHHHHHHhhhhhhhh--hcCccccccCHHHeEecCCCCEEEeecccccc
Confidence            9999999999999999987754  6899999999999999999999  57799999999999999999999999999986


Q ss_pred             CCCCCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhcccchhh
Q 046893          249 GPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLR  328 (464)
Q Consensus       249 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  328 (464)
                      .....  ......+||+.|+|||++.+..|+.++|||||||+||||++|+.||.+....      +.........     
T Consensus       155 ~~~~~--~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~------~~~~~i~~~~-----  221 (337)
T d1o6la_         155 GISDG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE------RLFELILMEE-----  221 (337)
T ss_dssp             SCCTT--CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHHCC-----
T ss_pred             cccCC--cccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHH------HHHHHHhcCC-----
Confidence            43322  2334578999999999999999999999999999999999999999865421      1121111111     


Q ss_pred             ccCccccCccCHHHHHHHHHHHHHhhccCCCCCCC-----HHHHHH
Q 046893          329 ILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPV-----MSDVVA  369 (464)
Q Consensus       329 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~ev~~  369 (464)
                         .    .++..++.++.+||.+||+.||.+|++     +.++++
T Consensus       222 ---~----~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~  260 (337)
T d1o6la_         222 ---I----RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME  260 (337)
T ss_dssp             ---C----CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             ---C----CCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence               1    123334557899999999999999995     555543

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.5e-53  Score=407.31  Aligned_cols=273  Identities=25%  Similarity=0.347  Sum_probs=206.9

Q ss_pred             hHHHHHhcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCc-cHHHHHHHHHHHhcC-CCCCcceEEE
Q 046893           85 NEMKLATKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQ-GDREWLAEVNYLGQL-RHSNLVKLIG  162 (464)
Q Consensus        85 ~~~~~~~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l-~hpniv~l~~  162 (464)
                      ..+++..++|++.+.||+|+||+||+|.+... .....++.||||+++..... ..+.+..|+.++.++ +|+||+.+++
T Consensus         6 ~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~-~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~   84 (299)
T d1ywna1           6 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGI-DKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLG   84 (299)
T ss_dssp             HHHBCCGGGEEEEEEEEECSSCEEEEEEEEST-TSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             ccccccHHHEEEeeEEeecCCeEEEEEEEcCC-CcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeee
Confidence            44555667899999999999999999997653 22345678999998754332 235678888888777 6899999999


Q ss_pred             EEEeC-CeEEEEEeccCCCCHHHHHHhhc--------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCC
Q 046893          163 YCCED-EHRILVYEYMESGSLEKHLLRRV--------------GCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKT  227 (464)
Q Consensus       163 ~~~~~-~~~~lv~e~~~~g~L~~~l~~~~--------------~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp  227 (464)
                      ++... ...++|||||++|+|.+++....              ...+++..++.++.||+.||.|||  +++||||||||
T Consensus        85 ~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH--~~~ivHrDlKp  162 (299)
T d1ywna1          85 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA--SRKCIHRDLAA  162 (299)
T ss_dssp             EECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCCG
T ss_pred             eeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHH--hCCCcCCcCCc
Confidence            88765 46899999999999999997543              235889999999999999999999  56799999999


Q ss_pred             CceEecCCCceEEcccCCccCCCCCCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHhCC-CCCCCCCC
Q 046893          228 SNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGR-RAVDKSRP  306 (464)
Q Consensus       228 ~Nill~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~-~pf~~~~~  306 (464)
                      +||||+.++.+||+|||+|+...............||+.|+|||++.+..++.++|||||||++|||++|. .||.....
T Consensus       163 ~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~  242 (299)
T d1ywna1         163 RNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI  242 (299)
T ss_dssp             GGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCC
T ss_pred             cceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCH
Confidence            99999999999999999998654444333444578999999999999999999999999999999999975 56765432


Q ss_pred             cccccHHHHHHHhhhcccchhhccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHh
Q 046893          307 SREHNLVEWARPLLNNNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETVQS  376 (464)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~~~  376 (464)
                      ..  .+..    .+..          ......+..++.++.+||.+||+.||.+|||+.+|++.|+.+.+
T Consensus       243 ~~--~~~~----~~~~----------~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq  296 (299)
T d1ywna1         243 DE--EFCR----RLKE----------GTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ  296 (299)
T ss_dssp             SH--HHHH----HHHH----------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HH--HHHH----HHhc----------CCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence            11  1111    1111          11112233455689999999999999999999999999988753

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9e-53  Score=408.27  Aligned_cols=262  Identities=22%  Similarity=0.339  Sum_probs=206.2

Q ss_pred             CCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCC-CccHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeEE
Q 046893           93 FFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGG-YQGDREWLAEVNYLGQLRHSNLVKLIGYCCEDEHRI  171 (464)
Q Consensus        93 ~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~  171 (464)
                      .|++.++||+|+||+||+|.+..+...  ....||+|.+.... ....++|.+|+.+|++++|||||++++++.++ ..+
T Consensus        10 dy~~~~~lG~G~fG~Vy~~~~~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~   86 (317)
T d1xkka_          10 EFKKIKVLGSGAFGTVYKGLWIPEGEK--VKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQ   86 (317)
T ss_dssp             TEEEEEEEEECSSEEEEEEEECC------CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEE
T ss_pred             HCEEeeEEecCCCeEEEEEEEcCCCCE--EEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-Cee
Confidence            588999999999999999998764221  23468999886533 34457899999999999999999999999865 567


Q ss_pred             EEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCccCCCC
Q 046893          172 LVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPM  251 (464)
Q Consensus       172 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~  251 (464)
                      ++|||+.+|+|.+++... ...+++..++.++.||+.||.|||  .++||||||||+||||+.++.+||+|||+|+....
T Consensus        87 ~v~e~~~~~~l~~~~~~~-~~~~~~~~~~~i~~qi~~gl~yLH--~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~  163 (317)
T d1xkka_          87 LITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLE--DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA  163 (317)
T ss_dssp             EEEECCTTCBHHHHHHHT-SSSCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTT
T ss_pred             EEEEeccCCccccccccc-ccCCCHHHHHHHHHHHHHHHHHHH--HcCcccCcchhhcceeCCCCCeEeeccccceeccc
Confidence            888999999999987765 457999999999999999999999  56799999999999999999999999999987654


Q ss_pred             CCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHhhhcccchhhcc
Q 046893          252 GDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLL-GRRAVDKSRPSREHNLVEWARPLLNNNKKVLRIL  330 (464)
Q Consensus       252 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  330 (464)
                      ...........||+.|+|||++.++.|+.++|||||||+||||+| |..||.+.....   +....    .         
T Consensus       164 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~---~~~~i----~---------  227 (317)
T d1xkka_         164 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE---ISSIL----E---------  227 (317)
T ss_dssp             TCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGG---HHHHH----H---------
T ss_pred             ccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHH---HHHHH----H---------
Confidence            444444445679999999999999999999999999999999998 788887654221   11111    1         


Q ss_pred             CccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhc
Q 046893          331 DPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETVQSQ  377 (464)
Q Consensus       331 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~~~~  377 (464)
                       .......+..++..+.+|+.+||..||.+|||+.+|++.|+.+...
T Consensus       228 -~~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~~  273 (317)
T d1xkka_         228 -KGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD  273 (317)
T ss_dssp             -HTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred             -cCCCCCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHhC
Confidence             1111123344566899999999999999999999999999887654

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=3.6e-53  Score=408.17  Aligned_cols=269  Identities=25%  Similarity=0.368  Sum_probs=214.4

Q ss_pred             HHHHhcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCcc-HHHHHHHHHHHhcCCCCCcceEEEEEE
Q 046893           87 MKLATKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQG-DREWLAEVNYLGQLRHSNLVKLIGYCC  165 (464)
Q Consensus        87 ~~~~~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~hpniv~l~~~~~  165 (464)
                      ++...++|++.+.||+|+||+||+|++... .....++.||||+++...... .++|.+|+.+|++++||||+++++++.
T Consensus         8 ~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~-~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~   86 (301)
T d1lufa_           8 LEYPRNNIEYVRDIGEGAFGRVFQARAPGL-LPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCA   86 (301)
T ss_dssp             TBCCGGGCEEEEEEEECSSCEEEEEEEETS-STTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred             ccCCHHHcEEeEEEeeCCCeEEEEEEECCC-ccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeec
Confidence            344556799999999999999999997642 122346789999997644332 367999999999999999999999999


Q ss_pred             eCCeEEEEEeccCCCCHHHHHHhhc----------------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeec
Q 046893          166 EDEHRILVYEYMESGSLEKHLLRRV----------------------GCMLTWSRRMKIALDAAKGLAFLHGAERPVIYR  223 (464)
Q Consensus       166 ~~~~~~lv~e~~~~g~L~~~l~~~~----------------------~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHr  223 (464)
                      ..+..++||||+.+|+|.+++....                      ...+++..++.++.|++.||+|||  .++||||
T Consensus        87 ~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH--~~~ivHr  164 (301)
T d1lufa_          87 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS--ERKFVHR  164 (301)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHH--HTTCCCS
T ss_pred             cCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcc--cCCeEee
Confidence            9999999999999999999986432                      124889999999999999999999  5779999


Q ss_pred             cCCCCceEecCCCceEEcccCCccCCCCCCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHhCC-CCCC
Q 046893          224 DFKTSNILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGR-RAVD  302 (464)
Q Consensus       224 Dlkp~Nill~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~-~pf~  302 (464)
                      ||||+||||+.++.+||+|||+|+...............||+.|+|||++.+..|+.++|||||||+||||++|. +||.
T Consensus       165 DlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~  244 (301)
T d1lufa_         165 DLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYY  244 (301)
T ss_dssp             CCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTT
T ss_pred             EEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCC
Confidence            999999999999999999999998544333333444578999999999999999999999999999999999986 5666


Q ss_pred             CCCCcccccHHHHHHHhhhcccchhhccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHH
Q 046893          303 KSRPSREHNLVEWARPLLNNNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETVQ  375 (464)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~~  375 (464)
                      .....      +....+....           ....+..++.++.+||.+||+.||.+||||.+|+++|+++.
T Consensus       245 ~~~~~------e~~~~v~~~~-----------~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~  300 (301)
T d1lufa_         245 GMAHE------EVIYYVRDGN-----------ILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC  300 (301)
T ss_dssp             TSCHH------HHHHHHHTTC-----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred             CCCHH------HHHHHHHcCC-----------CCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence            54321      1111111110           11223345568999999999999999999999999998864

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=6.1e-52  Score=394.93  Aligned_cols=261  Identities=25%  Similarity=0.318  Sum_probs=204.4

Q ss_pred             hcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCcc---HHHHHHHHHHHhcCCCCCcceEEEEEEeC
Q 046893           91 TKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQG---DREWLAEVNYLGQLRHSNLVKLIGYCCED  167 (464)
Q Consensus        91 ~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~hpniv~l~~~~~~~  167 (464)
                      .++|++.+.||+|+||+||+|.+..+      ++.||||++.......   ...+.+|+++|+.++||||+++++++...
T Consensus         6 ~drY~i~~~lG~G~fg~Vy~a~~~~~------~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~   79 (277)
T d1o6ya_           6 SDRYELGEILGFGGMSEVHLARDLRL------HRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAE   79 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTT------TEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEE
T ss_pred             cceeEEeEEEeeCCCeEEEEEEECCC------CCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeec
Confidence            46799999999999999999998765      7789999997654432   25688999999999999999999998765


Q ss_pred             C----eEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEccc
Q 046893          168 E----HRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDF  243 (464)
Q Consensus       168 ~----~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DF  243 (464)
                      +    .+|||||||+|++|.+++....  .+++.+++.++.||+.||.|||  .++|+||||||+||||+.++.++|+||
T Consensus        80 ~~~~~~~~lvmE~~~g~~L~~~~~~~~--~l~~~~~~~i~~qi~~al~~lH--~~~iiHrDiKP~NIll~~~~~~~l~d~  155 (277)
T d1o6ya_          80 TPAGPLPYIVMEYVDGVTLRDIVHTEG--PMTPKRAIEVIADACQALNFSH--QNGIIHRDVKPANIMISATNAVKVMDF  155 (277)
T ss_dssp             CSSSEEEEEEEECCCEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEEETTSCEEECCC
T ss_pred             cCCCceEEEEEECCCCCEehhhhcccC--CCCHHHHHHHHHHHHHHHHHHH--hCCccCccccCcccccCccccceeehh
Confidence            4    4799999999999999887654  6999999999999999999999  577999999999999999999999999


Q ss_pred             CCccCCCCCC-CcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhc
Q 046893          244 GLAKDGPMGD-QTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNN  322 (464)
Q Consensus       244 Gla~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~  322 (464)
                      |+++...... ........+||+.|+|||++.+..++.++|||||||+||||+||+.||.+....      +.....+..
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~------~~~~~~~~~  229 (277)
T d1o6ya_         156 GIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPV------SVAYQHVRE  229 (277)
T ss_dssp             TTCEECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH------HHHHHHHHC
T ss_pred             hhhhhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHH------HHHHHHHhc
Confidence            9987543322 222334578999999999999999999999999999999999999999764321      222222222


Q ss_pred             ccchhhccCccccCccCHHHHHHHHHHHHHhhccCCCCCC-CHHHHHHHHHHHH
Q 046893          323 NKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRP-VMSDVVALLETVQ  375 (464)
Q Consensus       323 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-s~~ev~~~L~~~~  375 (464)
                      ....        .......++..+.+||.+||+.||.+|| +++++++.|..+.
T Consensus       230 ~~~~--------~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~  275 (277)
T d1o6ya_         230 DPIP--------PSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH  275 (277)
T ss_dssp             CCCC--------GGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred             CCCC--------CchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence            1111        1112223445899999999999999999 8999998888764

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.4e-53  Score=398.00  Aligned_cols=252  Identities=28%  Similarity=0.401  Sum_probs=201.1

Q ss_pred             hcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCccHHHHHHHHHHHhcCCCCCcceEEEEEEeC-Ce
Q 046893           91 TKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVKLIGYCCED-EH  169 (464)
Q Consensus        91 ~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~-~~  169 (464)
                      .++|++.+.||+|+||.||+|.+.        ++.||||+++..  ...+.|.+|+++|++++||||+++++++.+. +.
T Consensus         6 ~~~~~~~~~lG~G~fg~Vy~~~~~--------~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~   75 (262)
T d1byga_           6 MKELKLLQTIGKGEFGDVMLGDYR--------GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGG   75 (262)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEET--------TEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--C
T ss_pred             HHHeEEeEEEecCCCeEEEEEEEC--------CeEEEEEEECcH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCc
Confidence            356788899999999999999874        456999999754  3447799999999999999999999998654 56


Q ss_pred             EEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCccCC
Q 046893          170 RILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDG  249 (464)
Q Consensus       170 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~  249 (464)
                      .+|||||+++|+|.+++..+....+++..++.|+.||+.||.|||  .++|+||||||+|||++.++.+||+|||+++..
T Consensus        76 ~~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH--~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~  153 (262)
T d1byga_          76 LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE--GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEA  153 (262)
T ss_dssp             CEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCSGGGEEECTTSCEEECCCCC----
T ss_pred             EEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccc--cCceeccccchHhheecCCCCEeecccccceec
Confidence            899999999999999997654446899999999999999999999  567999999999999999999999999999864


Q ss_pred             CCCCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHhhhcccchhh
Q 046893          250 PMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLL-GRRAVDKSRPSREHNLVEWARPLLNNNKKVLR  328 (464)
Q Consensus       250 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  328 (464)
                      ..     ......+|..|+|||++.+..++.++|||||||++|||+| |+.||......   .+..+..           
T Consensus       154 ~~-----~~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~---~~~~~i~-----------  214 (262)
T d1byga_         154 SS-----TQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK---DVVPRVE-----------  214 (262)
T ss_dssp             -------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG---GHHHHHT-----------
T ss_pred             CC-----CCccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHH---HHHHHHH-----------
Confidence            22     1233578999999999999999999999999999999998 67777654322   2222211           


Q ss_pred             ccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHh
Q 046893          329 ILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETVQS  376 (464)
Q Consensus       329 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~~~  376 (464)
                         .......+..++..+.+||.+||+.||.+|||+.+|++.|+.++.
T Consensus       215 ---~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~  259 (262)
T d1byga_         215 ---KGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT  259 (262)
T ss_dssp             ---TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ---cCCCCCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHh
Confidence               111223344455689999999999999999999999999998864

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=1.5e-51  Score=398.58  Aligned_cols=245  Identities=26%  Similarity=0.346  Sum_probs=204.3

Q ss_pred             cCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCC---CccHHHHHHHHHHHhcCCCCCcceEEEEEEeCC
Q 046893           92 KFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGG---YQGDREWLAEVNYLGQLRHSNLVKLIGYCCEDE  168 (464)
Q Consensus        92 ~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~  168 (464)
                      ++|++.+.||+|+||+||+|++..+      ++.||||++....   ....+.+.+|+.+|+.++|||||++++++.+.+
T Consensus         4 ~dy~i~~~lG~G~fg~Vy~a~~~~~------g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~   77 (316)
T d1fota_           4 QDFQILRTLGTGSFGRVHLIRSRHN------GRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQ   77 (316)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTT------CCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSS
T ss_pred             hHeEEEEEEecCcCcEEEEEEECCC------CCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCC
Confidence            4588999999999999999998765      6779999986432   233467889999999999999999999999999


Q ss_pred             eEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCccC
Q 046893          169 HRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKD  248 (464)
Q Consensus       169 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~  248 (464)
                      ..|+|||||.||+|..++....  .+++..+..++.||+.||.|||  .++|+||||||+||||+.+|.+||+|||+|+.
T Consensus        78 ~~~ivmE~~~gg~l~~~~~~~~--~~~~~~~~~~~~qi~~al~~lH--~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~  153 (316)
T d1fota_          78 QIFMIMDYIEGGELFSLLRKSQ--RFPNPVAKFYAAEVCLALEYLH--SKDIIYRDLKPENILLDKNGHIKITDFGFAKY  153 (316)
T ss_dssp             EEEEEECCCCSCBHHHHHHHTS--SCCHHHHHHHHHHHHHHHHHHH--TTTEECCCCCGGGEEECTTSCEEECCCSSCEE
T ss_pred             eeeeEeeecCCccccccccccc--cccccHHHHHHHHHHHhhhhhc--cCcEEccccCchheeEcCCCCEEEecCccceE
Confidence            9999999999999998887644  6899999999999999999999  67899999999999999999999999999986


Q ss_pred             CCCCCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhcccchhh
Q 046893          249 GPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLR  328 (464)
Q Consensus       249 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  328 (464)
                      ...     .....+||+.|||||++.+..|+.++|||||||+||||++|+.||.+....      +..........    
T Consensus       154 ~~~-----~~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~------~~~~~i~~~~~----  218 (316)
T d1fota_         154 VPD-----VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTM------KTYEKILNAEL----  218 (316)
T ss_dssp             CSS-----CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH------HHHHHHHHCCC----
T ss_pred             ecc-----ccccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHH------HHHHHHHcCCC----
Confidence            432     223478999999999999999999999999999999999999999764321      12222221111    


Q ss_pred             ccCccccCccCHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHH
Q 046893          329 ILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRP-----VMSDVVA  369 (464)
Q Consensus       329 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~ev~~  369 (464)
                              .++...+.++.+++.+||..||.+|+     +++++++
T Consensus       219 --------~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~  256 (316)
T d1fota_         219 --------RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN  256 (316)
T ss_dssp             --------CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred             --------CCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHc
Confidence                    12223445789999999999999996     7887764

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-52  Score=397.72  Aligned_cols=261  Identities=26%  Similarity=0.367  Sum_probs=200.2

Q ss_pred             hcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCC---ccHHHHHHHHHHHhcCCCCCcceEEEEEEeC
Q 046893           91 TKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGY---QGDREWLAEVNYLGQLRHSNLVKLIGYCCED  167 (464)
Q Consensus        91 ~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~  167 (464)
                      .++|++.+.||+|+||+||+|++.....   ....||||+++....   ...++|.+|+.+|+.++|||||++++++.+ 
T Consensus         7 ~~d~~~~~~iG~G~fg~Vy~~~~~~~~~---~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-   82 (273)
T d1u46a_           7 EKDLRLLEKLGDGSFGVVRRGEWDAPSG---KTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-   82 (273)
T ss_dssp             GGGEEEEEECC----CCCEEEEEECTTS---CEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred             hHHeEEEEEEecCCCeEEEEEEEECCCC---cEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-
Confidence            3568899999999999999998765422   245699999876432   223678999999999999999999999965 


Q ss_pred             CeEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCcc
Q 046893          168 EHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAK  247 (464)
Q Consensus       168 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~  247 (464)
                      ...++|||||++|+|.+++..+. ..+++..++.++.|++.||.|||  .++|+||||||+||||+.++.+||+|||+++
T Consensus        83 ~~~~lv~e~~~~~~l~~~~~~~~-~~l~~~~~~~~~~qi~~gl~ylH--~~~iiHrDikp~NIll~~~~~vkl~DfGl~~  159 (273)
T d1u46a_          83 PPMKMVTELAPLGSLLDRLRKHQ-GHFLLGTLSRYAVQVAEGMGYLE--SKRFIHRDLAARNLLLATRDLVKIGDFGLMR  159 (273)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHHG-GGSCHHHHHHHHHHHHHHHHHHH--HTTEECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred             cchheeeeeecCcchhhhhhccc-CCCCHHHHHHHHHHHHHHHHHhh--hCCEeeeeecHHHhccccccceeeccchhhh
Confidence            46789999999999999887654 36999999999999999999999  5679999999999999999999999999999


Q ss_pred             CCCCCCCcc-eeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHhhhcccc
Q 046893          248 DGPMGDQTH-VSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLL-GRRAVDKSRPSREHNLVEWARPLLNNNKK  325 (464)
Q Consensus       248 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  325 (464)
                      ......... ......||..|+|||++.+..++.++|||||||++|||++ |+.||.+....      +........   
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~------~~~~~i~~~---  230 (273)
T d1u46a_         160 ALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS------QILHKIDKE---  230 (273)
T ss_dssp             ECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHH------HHHHHHHTS---
T ss_pred             hcccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHH------HHHHHHHhC---
Confidence            754433322 2334568889999999999999999999999999999998 89999754321      111111111   


Q ss_pred             hhhccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHH
Q 046893          326 VLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETV  374 (464)
Q Consensus       326 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~  374 (464)
                             ......+..++..+.+|+.+||+.||.+|||+.+|++.|.+.
T Consensus       231 -------~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~  272 (273)
T d1u46a_         231 -------GERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA  272 (273)
T ss_dssp             -------CCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             -------CCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence                   111122334456899999999999999999999999999865

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.6e-52  Score=401.56  Aligned_cols=270  Identities=24%  Similarity=0.359  Sum_probs=217.0

Q ss_pred             HHHhcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCc-cHHHHHHHHHHHhcC-CCCCcceEEEEEE
Q 046893           88 KLATKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQ-GDREWLAEVNYLGQL-RHSNLVKLIGYCC  165 (464)
Q Consensus        88 ~~~~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l-~hpniv~l~~~~~  165 (464)
                      ++..++|++.+.||+|+||.||+|++..... ...++.||||+++..... ....|.+|+.++..+ +|||||++++++.
T Consensus        19 ~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~-~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~   97 (311)
T d1t46a_          19 EFPRNRLSFGKTLGAGAFGKVVEATAYGLIK-SDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACT   97 (311)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEEESSSS-TTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             cCCHHHeEEeeEEeecCCeEEEEEEEecccc-CCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEe
Confidence            3445678899999999999999998754221 235788999999765433 335688999999999 6999999999999


Q ss_pred             eCCeEEEEEeccCCCCHHHHHHhhcC----------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCc
Q 046893          166 EDEHRILVYEYMESGSLEKHLLRRVG----------------CMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSN  229 (464)
Q Consensus       166 ~~~~~~lv~e~~~~g~L~~~l~~~~~----------------~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~N  229 (464)
                      +....+||||||++|+|.+++.....                ..+++..+..++.||+.||+|||  .++||||||||+|
T Consensus        98 ~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH--~~~ivHrDLKp~N  175 (311)
T d1t46a_          98 IGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA--SKNCIHRDLAARN  175 (311)
T ss_dssp             SSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCSGGG
T ss_pred             eCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHH--hCCeeeccccccc
Confidence            99999999999999999999876431                25899999999999999999999  5679999999999


Q ss_pred             eEecCCCceEEcccCCccCCCCCCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHhC-CCCCCCCCCcc
Q 046893          230 ILLNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLG-RRAVDKSRPSR  308 (464)
Q Consensus       230 ill~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g-~~pf~~~~~~~  308 (464)
                      ||++.++.+||+|||+++..............+||+.|+|||++.+..++.++|||||||+||||+|+ .+||.......
T Consensus       176 Il~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~  255 (311)
T d1t46a_         176 ILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS  255 (311)
T ss_dssp             EEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSH
T ss_pred             ccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHH
Confidence            99999999999999999976554444455567899999999999999999999999999999999995 55554433211


Q ss_pred             cccHHHHHHHhhhcccchhhccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHh
Q 046893          309 EHNLVEWARPLLNNNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETVQS  376 (464)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~~~  376 (464)
                      .  +..    .+.          .......+..++..+.+||.+||+.||.+|||+.+|+++|+++..
T Consensus       256 ~--~~~----~i~----------~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~  307 (311)
T d1t46a_         256 K--FYK----MIK----------EGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQIS  307 (311)
T ss_dssp             H--HHH----HHH----------HTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             H--HHH----HHh----------cCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhc
Confidence            1  111    111          111112223345689999999999999999999999999987654

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5e-52  Score=399.69  Aligned_cols=270  Identities=25%  Similarity=0.364  Sum_probs=212.5

Q ss_pred             HHhcCCCCCCceeecCceEEEEEEecCCCCC-CccceEEEEEEccCCCCcc-HHHHHHHHHHHhcC-CCCCcceEEEEEE
Q 046893           89 LATKFFRPDYILGEGGFGVVYKGVIDENVRP-GYKTTFVAIKELNRGGYQG-DREWLAEVNYLGQL-RHSNLVKLIGYCC  165 (464)
Q Consensus        89 ~~~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~-~~~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l-~hpniv~l~~~~~  165 (464)
                      +..++|++.+.||+|+||.||+|++...... ...+..||||+++...... ..++.+|+..+.++ +|||||+++++|.
T Consensus        10 i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~   89 (299)
T d1fgka_          10 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT   89 (299)
T ss_dssp             CCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             ccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccc
Confidence            3446788899999999999999987654321 2345679999997654432 36788899999888 7999999999999


Q ss_pred             eCCeEEEEEeccCCCCHHHHHHhhc--------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceE
Q 046893          166 EDEHRILVYEYMESGSLEKHLLRRV--------------GCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNIL  231 (464)
Q Consensus       166 ~~~~~~lv~e~~~~g~L~~~l~~~~--------------~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nil  231 (464)
                      ++...++|||||++|+|.++|..+.              ...+++.+++.++.|++.||+|||  +++||||||||+|||
T Consensus        90 ~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH--~~~ivHrDiKp~NiL  167 (299)
T d1fgka_          90 QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA--SKKCIHRDLAARNVL  167 (299)
T ss_dssp             SSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCSGGGEE
T ss_pred             cCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhh--hCCEEeeeeccccee
Confidence            9999999999999999999997543              235899999999999999999999  567999999999999


Q ss_pred             ecCCCceEEcccCCccCCCCCCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHh-CCCCCCCCCCcccc
Q 046893          232 LNADFSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLL-GRRAVDKSRPSREH  310 (464)
Q Consensus       232 l~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~  310 (464)
                      ++.++.+||+|||+++...............||+.|+|||++.++.|+.++|||||||+||||++ |..||......   
T Consensus       168 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~---  244 (299)
T d1fgka_         168 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE---  244 (299)
T ss_dssp             ECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH---
T ss_pred             ecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHH---
Confidence            99999999999999987654444444455789999999999999999999999999999999998 68888654321   


Q ss_pred             cHHHHHHHhhhcccchhhccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhc
Q 046893          311 NLVEWARPLLNNNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETVQSQ  377 (464)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~~~~  377 (464)
                      .+..    .+...          .....+..++..+.+||.+||+.||.+|||+.+|++.|+.+.+.
T Consensus       245 ~~~~----~i~~~----------~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a~  297 (299)
T d1fgka_         245 ELFK----LLKEG----------HRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVAL  297 (299)
T ss_dssp             HHHH----HHHTT----------CCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHHH----HHHcC----------CCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhhc
Confidence            1111    11111          11122333456899999999999999999999999999988653

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=1.9e-51  Score=405.56  Aligned_cols=249  Identities=24%  Similarity=0.343  Sum_probs=198.7

Q ss_pred             cCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCC---ccHHHHH---HHHHHHhcCCCCCcceEEEEEE
Q 046893           92 KFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGY---QGDREWL---AEVNYLGQLRHSNLVKLIGYCC  165 (464)
Q Consensus        92 ~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~---~E~~~l~~l~hpniv~l~~~~~  165 (464)
                      ++|++.++||+|+||+||+|++..+      ++.||||++.....   .....+.   .|+.+++.++|||||+++++|.
T Consensus         4 ddy~i~~~lG~G~fg~Vy~~~~~~t------~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~   77 (364)
T d1omwa3           4 NDFSVHRIIGRGGFGEVYGCRKADT------GKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFH   77 (364)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTT------CCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEE
T ss_pred             HhCeeeeEEecCCCeEEEEEEECCC------CCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEE
Confidence            5688999999999999999998775      67799999864221   1122333   4477788889999999999999


Q ss_pred             eCCeEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCC
Q 046893          166 EDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGL  245 (464)
Q Consensus       166 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGl  245 (464)
                      +.+..|||||||+||+|.++|.+..  .+++..+..++.||+.||.|||  .++||||||||+||||+.++.+||+|||+
T Consensus        78 ~~~~~~ivmE~~~gg~L~~~l~~~~--~~~e~~~~~~~~qi~~aL~ylH--~~~iiHrDlKP~NILl~~~g~iKl~DFGl  153 (364)
T d1omwa3          78 TPDKLSFILDLMNGGDLHYHLSQHG--VFSEADMRFYAAEIILGLEHMH--NRFVVYRDLKPANILLDEHGHVRISDLGL  153 (364)
T ss_dssp             CSSEEEEEECCCCSCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEECSSSCEEECCCTT
T ss_pred             ECCEEEEEEEecCCCcHHHHHHhcc--cccHHHHHHHHHHHHHHHHHHH--HCCccceeeccceeEEcCCCcEEEeeece
Confidence            9999999999999999999997754  6899999999999999999999  67799999999999999999999999999


Q ss_pred             ccCCCCCCCcceeeccccCCcccCcccccc-CCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhccc
Q 046893          246 AKDGPMGDQTHVSTRVMGTYGYAAPEYVMT-GHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNK  324 (464)
Q Consensus       246 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  324 (464)
                      |+.....    .....+||+.|+|||++.+ ..|+.++|||||||+||||++|+.||.........   ........   
T Consensus       154 a~~~~~~----~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~---~~~~~~~~---  223 (364)
T d1omwa3         154 ACDFSKK----KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH---EIDRMTLT---  223 (364)
T ss_dssp             CEECSSS----CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHH---HHHHHSSS---
T ss_pred             eeecCCC----cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHH---HHHHhccc---
Confidence            9864332    2234689999999999874 56899999999999999999999999865432211   11111000   


Q ss_pred             chhhccCccccCccCHHHHHHHHHHHHHhhccCCCCCCC-----HHHHHH
Q 046893          325 KVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPV-----MSDVVA  369 (464)
Q Consensus       325 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~ev~~  369 (464)
                               ....++..++.++.+||.+||+.||.+||+     ++++++
T Consensus       224 ---------~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~  264 (364)
T d1omwa3         224 ---------MAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  264 (364)
T ss_dssp             ---------CCCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred             ---------CCCCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence                     011122234558899999999999999999     466653

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=5.1e-51  Score=400.30  Aligned_cols=245  Identities=23%  Similarity=0.291  Sum_probs=204.3

Q ss_pred             cCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCC---CccHHHHHHHHHHHhcCCCCCcceEEEEEEeCC
Q 046893           92 KFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGG---YQGDREWLAEVNYLGQLRHSNLVKLIGYCCEDE  168 (464)
Q Consensus        92 ~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~  168 (464)
                      ++|++++.||+|+||+||+|++..+      ++.||||++....   ....+.+++|+++|+.++|||||++++++....
T Consensus        41 d~y~i~~~lG~G~fg~Vy~a~~~~~------g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~  114 (350)
T d1rdqe_          41 DQFDRIKTLGTGSFGRVMLVKHKES------GNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNS  114 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTT------CCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred             cCeEEEEEeecCcCcEEEEEEECCC------CCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccc
Confidence            4688999999999999999998765      6779999986422   233467889999999999999999999999999


Q ss_pred             eEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCccC
Q 046893          169 HRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKD  248 (464)
Q Consensus       169 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~  248 (464)
                      ..++||||+.+|+|.+++.+..  .+++..+..++.||+.||.|||  .++||||||||+||||+.++.+||+|||+|+.
T Consensus       115 ~~~~v~e~~~~g~l~~~l~~~~--~l~e~~~~~i~~qi~~aL~yLH--~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~  190 (350)
T d1rdqe_         115 NLYMVMEYVAGGEMFSHLRRIG--RFSEPHARFYAAQIVLTFEYLH--SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR  190 (350)
T ss_dssp             EEEEEEECCTTCBHHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred             ccccccccccccchhhhHhhcC--CCCHHHHHHHHHHHHHHHHHHH--hCCEecCcCCHHHcccCCCCCEEeeeceeeee
Confidence            9999999999999999987754  6999999999999999999999  56799999999999999999999999999986


Q ss_pred             CCCCCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhcccchhh
Q 046893          249 GPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLR  328 (464)
Q Consensus       249 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  328 (464)
                      ....     ....+||+.|||||++.+..|+.++|||||||+||||++|+.||.+...      ...........     
T Consensus       191 ~~~~-----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~------~~~~~~i~~~~-----  254 (350)
T d1rdqe_         191 VKGR-----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP------IQIYEKIVSGK-----  254 (350)
T ss_dssp             CSSC-----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHCC-----
T ss_pred             cccc-----cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCH------HHHHHHHhcCC-----
Confidence            4321     2346899999999999999999999999999999999999999976432      11111111111     


Q ss_pred             ccCccccCccCHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHH
Q 046893          329 ILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRP-----VMSDVVA  369 (464)
Q Consensus       329 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~ev~~  369 (464)
                         .    ..+..++.++.+||.+||..||.+|+     ++.++++
T Consensus       255 ---~----~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~  293 (350)
T d1rdqe_         255 ---V----RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN  293 (350)
T ss_dssp             ---C----CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred             ---C----CCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence               1    11223455889999999999999994     7888764

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-51  Score=397.37  Aligned_cols=259  Identities=25%  Similarity=0.364  Sum_probs=205.6

Q ss_pred             cCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCC-ccHHHHHHHHHHHhcC-CCCCcceEEEEEEeCCe
Q 046893           92 KFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGY-QGDREWLAEVNYLGQL-RHSNLVKLIGYCCEDEH  169 (464)
Q Consensus        92 ~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~  169 (464)
                      ++|++.++||+|+||+||+|++..+.    ....||||.+..... ...+.|.+|+++|.++ +|||||++++++.+.+.
T Consensus        10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~----~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~   85 (309)
T d1fvra_          10 NDIKFQDVIGEGNFGQVLKARIKKDG----LRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGY   85 (309)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETT----EEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTE
T ss_pred             HHcEEEEEEeeCCCcEEEEEEECCCC----eEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCe
Confidence            56888899999999999999987641    123578888754322 2345789999999999 79999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHhh--------------cCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCC
Q 046893          170 RILVYEYMESGSLEKHLLRR--------------VGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNAD  235 (464)
Q Consensus       170 ~~lv~e~~~~g~L~~~l~~~--------------~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~  235 (464)
                      .++||||+++|+|.++|...              ....+++..++.++.||+.||.|||  .++|+||||||+|||++.+
T Consensus        86 ~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH--~~~iiHrDlkp~NIL~~~~  163 (309)
T d1fvra_          86 LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS--QKQFIHRDLAARNILVGEN  163 (309)
T ss_dssp             EEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGEEECGG
T ss_pred             eEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhh--cCCccccccccceEEEcCC
Confidence            99999999999999998654              2357999999999999999999999  5679999999999999999


Q ss_pred             CceEEcccCCccCCCCCCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHhCCC-CCCCCCCcccccHHH
Q 046893          236 FSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRR-AVDKSRPSREHNLVE  314 (464)
Q Consensus       236 ~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~-pf~~~~~~~~~~~~~  314 (464)
                      +.+||+|||+|+......   ......||..|+|||.+.+..++.++|||||||++|||++|.. ||.....      .+
T Consensus       164 ~~~kl~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~------~~  234 (309)
T d1fvra_         164 YVAKIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC------AE  234 (309)
T ss_dssp             GCEEECCTTCEESSCEEC---CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCH------HH
T ss_pred             CceEEccccccccccccc---cccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCH------HH
Confidence            999999999998543221   2234579999999999999999999999999999999999765 5654321      11


Q ss_pred             HHHHhhhcccchhhccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHh
Q 046893          315 WARPLLNNNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETVQS  376 (464)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~~~  376 (464)
                      ....+..           ......+..++.++.+||.+||+.||++|||+.+|++.|+.+..
T Consensus       235 ~~~~i~~-----------~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~  285 (309)
T d1fvra_         235 LYEKLPQ-----------GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE  285 (309)
T ss_dssp             HHHHGGG-----------TCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHHHHh-----------cCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence            1111111           11122334456689999999999999999999999999998764

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-51  Score=400.10  Aligned_cols=252  Identities=19%  Similarity=0.231  Sum_probs=199.2

Q ss_pred             cCCCCC-CceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCccHHHHHHHHHHHhc-CCCCCcceEEEEEEe---
Q 046893           92 KFFRPD-YILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQ-LRHSNLVKLIGYCCE---  166 (464)
Q Consensus        92 ~~~~~~-~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~-l~hpniv~l~~~~~~---  166 (464)
                      ++|.+. ++||+|+||+||+|.+..+      ++.||||+++.     ...+.+|+.++.+ ++|||||+++++|.+   
T Consensus        11 ~~y~i~~~~lG~G~fg~Vy~a~~~~~------~~~vAiK~i~~-----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~   79 (335)
T d2ozaa1          11 DDYKVTSQVLGLGINGKVLQIFNKRT------QEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYA   79 (335)
T ss_dssp             GTEEEEEEEEEECSSCEEEEEEETTT------CCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEET
T ss_pred             cCEEEeeEEeeeccCeEEEEEEECCC------CCEEEEEEECC-----cHHHHHHHHHHHHhcCCCCCCeEEEEEeeccc
Confidence            457665 5699999999999998765      67799999864     2567789998765 489999999999876   


Q ss_pred             -CCeEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecC---CCceEEcc
Q 046893          167 -DEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNA---DFSAKLSD  242 (464)
Q Consensus       167 -~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~---~~~vkl~D  242 (464)
                       +..+|||||||+||+|.++|.++....+++.++..|+.||+.||+|||  .++|+||||||+|||++.   ++.+||+|
T Consensus        80 ~~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH--~~~iiHRDiKp~NIll~~~~~~~~~Kl~D  157 (335)
T d2ozaa1          80 GRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH--SINIAHRDVKPENLLYTSKRPNAILKLTD  157 (335)
T ss_dssp             TEEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEESCSSTTCCEEECC
T ss_pred             CCCEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHH--HcCCccccccccccccccccccccccccc
Confidence             467899999999999999998765567999999999999999999999  577999999999999975   56799999


Q ss_pred             cCCccCCCCCCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhc
Q 046893          243 FGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNN  322 (464)
Q Consensus       243 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~  322 (464)
                      ||+|+......   .....+||+.|+|||++.+..|+.++|||||||+||+|++|+.||.+.........   .   ...
T Consensus       158 FG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~---~---~~~  228 (335)
T d2ozaa1         158 FGFAKETTSHN---SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPG---M---KTR  228 (335)
T ss_dssp             CTTCEECCCCC---CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------------C
T ss_pred             cceeeeccCCC---ccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHH---H---HHH
Confidence            99998654332   23347899999999999999999999999999999999999999976543221100   0   000


Q ss_pred             ccchhhccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 046893          323 NKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVA  369 (464)
Q Consensus       323 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  369 (464)
                         + ......+.......++.++.+||.+||+.||.+|||+.++++
T Consensus       229 ---i-~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  271 (335)
T d2ozaa1         229 ---I-RMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN  271 (335)
T ss_dssp             ---C-CSCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             ---H-hcCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence               0 000111111122345668999999999999999999999976

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.7e-52  Score=400.85  Aligned_cols=273  Identities=25%  Similarity=0.366  Sum_probs=217.0

Q ss_pred             hHHHHHhcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCc-cHHHHHHHHHHHhcCCCCCcceEEEE
Q 046893           85 NEMKLATKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQ-GDREWLAEVNYLGQLRHSNLVKLIGY  163 (464)
Q Consensus        85 ~~~~~~~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~  163 (464)
                      .++++..++|.+.+.||+|+||+||+|.+.... ....++.||||+++..... ....|.+|+.++++++||||++++++
T Consensus        13 ~~~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~-~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~   91 (308)
T d1p4oa_          13 DEWEVAREKITMSRELGQGSFGMVYEGVAKGVV-KDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGV   91 (308)
T ss_dssp             CTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEE-TTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEE
T ss_pred             cceeecHHHeEEeeEEeeCCCeEEEEEEECCcc-cCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeE
Confidence            345556678899999999999999999875321 1123578999999754332 23568999999999999999999999


Q ss_pred             EEeCCeEEEEEeccCCCCHHHHHHhhc--------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCC
Q 046893          164 CCEDEHRILVYEYMESGSLEKHLLRRV--------GCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNAD  235 (464)
Q Consensus       164 ~~~~~~~~lv~e~~~~g~L~~~l~~~~--------~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~  235 (464)
                      +..++..++|||||.+|+|.+++....        ...+++..+..++.|++.||.|||  .++|+||||||+||||+.+
T Consensus        92 ~~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH--~~~ivHrDlk~~NiLld~~  169 (308)
T d1p4oa_          92 VSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLN--ANKFVHRDLAARNCMVAED  169 (308)
T ss_dssp             ECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHH--HTTCBCSCCSGGGEEECTT
T ss_pred             EecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHh--hCCeeeceEcCCceeecCC
Confidence            999999999999999999999886432        135789999999999999999999  5679999999999999999


Q ss_pred             CceEEcccCCccCCCCCCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHhCC-CCCCCCCCcccccHHH
Q 046893          236 FSAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGR-RAVDKSRPSREHNLVE  314 (464)
Q Consensus       236 ~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~-~pf~~~~~~~~~~~~~  314 (464)
                      +.+||+|||+|+...............||+.|+|||.+.+..++.++|||||||+||||++|. .||.+...      .+
T Consensus       170 ~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~------~~  243 (308)
T d1p4oa_         170 FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN------EQ  243 (308)
T ss_dssp             CCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCH------HH
T ss_pred             ceEEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCH------HH
Confidence            999999999998654333333344567999999999999999999999999999999999985 66654321      22


Q ss_pred             HHHHhhhcccchhhccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhc
Q 046893          315 WARPLLNNNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETVQSQ  377 (464)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~~~~  377 (464)
                      +...+....           ....+..++..+.+||.+||+.||.+|||+.+|++.|+.....
T Consensus       244 ~~~~i~~~~-----------~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~~  295 (308)
T d1p4oa_         244 VLRFVMEGG-----------LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEP  295 (308)
T ss_dssp             HHHHHHTTC-----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCT
T ss_pred             HHHHHHhCC-----------CCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCC
Confidence            222221111           1112334556899999999999999999999999999876543

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.6e-51  Score=393.44  Aligned_cols=261  Identities=26%  Similarity=0.396  Sum_probs=205.1

Q ss_pred             CCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCC-ccHHHHHHHHHHHhcCCCCCcceEEEEEEe-CCeEEEEE
Q 046893           97 DYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGY-QGDREWLAEVNYLGQLRHSNLVKLIGYCCE-DEHRILVY  174 (464)
Q Consensus        97 ~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~~~~~lv~  174 (464)
                      .++||+|+||+||+|.+..+..   ....||||+++.... ...++|.+|+++|++++||||+++++++.. +...++||
T Consensus        32 ~~~iG~G~fg~Vyk~~~~~~~~---~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~  108 (311)
T d1r0pa_          32 NEVIGRGHFGCVYHGTLLDNDG---KKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVL  108 (311)
T ss_dssp             EEEEEEETTEEEEEEEECC-------CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEE
T ss_pred             ceEEeecCCeEEEEEEEECCCC---EEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEE
Confidence            4679999999999999876421   245689999875433 233679999999999999999999999876 46899999


Q ss_pred             eccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCccCCCCCCC
Q 046893          175 EYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPMGDQ  254 (464)
Q Consensus       175 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~  254 (464)
                      |||++|+|.+++... ...+++..++.++.|++.||.|||  .++|+||||||+||||+.++.+||+|||+++.......
T Consensus       109 E~~~~g~l~~~~~~~-~~~~~~~~~~~i~~qia~gL~~lH--~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~  185 (311)
T d1r0pa_         109 PYMKHGDLRNFIRNE-THNPTVKDLIGFGLQVAKGMKFLA--SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF  185 (311)
T ss_dssp             ECCTTCBHHHHHHCT-TCCCBHHHHHHHHHHHHHHHHHHH--HTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTC
T ss_pred             EEeecCchhhhhccc-cccchHHHHHHHHHHHHHhhhhhc--ccCcccCCccHHhEeECCCCCEEEecccchhhcccccc
Confidence            999999999987654 346788999999999999999999  56799999999999999999999999999986543322


Q ss_pred             c--ceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhcccchhhccCc
Q 046893          255 T--HVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLRILDP  332 (464)
Q Consensus       255 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  332 (464)
                      .  .......||..|+|||.+.+..++.++||||||++||||++|+.||......  .   ++....... .        
T Consensus       186 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~--~---~~~~~i~~g-~--------  251 (311)
T d1r0pa_         186 DSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT--F---DITVYLLQG-R--------  251 (311)
T ss_dssp             CCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC-----------CHHHHHTT-C--------
T ss_pred             ccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCH--H---HHHHHHHcC-C--------
Confidence            1  2223357999999999999999999999999999999999988887653211  1   111111111 1        


Q ss_pred             cccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhcCh
Q 046893          333 RLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETVQSQGA  379 (464)
Q Consensus       333 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~~~~~~  379 (464)
                        ....+..++..+.+||.+||+.||++||++.+|++.|+.+.....
T Consensus       252 --~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~~~  296 (311)
T d1r0pa_         252 --RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI  296 (311)
T ss_dssp             --CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCC
T ss_pred             --CCCCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHhhh
Confidence              111223345689999999999999999999999999999876543

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.9e-51  Score=396.10  Aligned_cols=252  Identities=17%  Similarity=0.243  Sum_probs=206.0

Q ss_pred             hcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCccHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeE
Q 046893           91 TKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVKLIGYCCEDEHR  170 (464)
Q Consensus        91 ~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~  170 (464)
                      .++|++.+.||+|+||+||+|.+..+      ++.||||+++... .....+.+|+++|+.++|||||+++++|.+++.+
T Consensus         4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~------~~~~AiK~i~~~~-~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~   76 (321)
T d1tkia_           4 YEKYMIAEDLGRGEFGIVHRCVETSS------KKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEEL   76 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTT------TEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEE
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCC------CcEEEEEEEcCCc-ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEE
Confidence            35689999999999999999998875      6789999997653 3345688999999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCC--CceEEcccCCccC
Q 046893          171 ILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNAD--FSAKLSDFGLAKD  248 (464)
Q Consensus       171 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~--~~vkl~DFGla~~  248 (464)
                      |||||||+||+|.+++... +..+++.++..|+.||+.||.|||  +++|+||||||+|||++.+  +.+||+|||+++.
T Consensus        77 ~lvmE~~~gg~L~~~i~~~-~~~l~e~~~~~i~~qi~~al~yLH--~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~  153 (321)
T d1tkia_          77 VMIFEFISGLDIFERINTS-AFELNEREIVSYVHQVCEALQFLH--SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQ  153 (321)
T ss_dssp             EEEECCCCCCBHHHHHTSS-SCCCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCCGGGEEESSSSCCCEEECCCTTCEE
T ss_pred             EEEEecCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHH--HcCCCcccccccceeecCCCceEEEEcccchhhc
Confidence            9999999999999988654 346999999999999999999999  5779999999999999744  5899999999986


Q ss_pred             CCCCCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhcccchhh
Q 046893          249 GPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVLR  328 (464)
Q Consensus       249 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  328 (464)
                      .....   .....+||+.|+|||.+.+..|+.++|||||||+||+|++|..||......      +............  
T Consensus       154 ~~~~~---~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~------~~~~~i~~~~~~~--  222 (321)
T d1tkia_         154 LKPGD---NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQ------QIIENIMNAEYTF--  222 (321)
T ss_dssp             CCTTC---EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHH------HHHHHHHHTCCCC--
T ss_pred             cccCC---cccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHH------HHHHHHHhCCCCC--
Confidence            53322   234467999999999999999999999999999999999999999865421      1112122111110  


Q ss_pred             ccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 046893          329 ILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVA  369 (464)
Q Consensus       329 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  369 (464)
                            .......++.++.+||.+||..||.+|||+.++++
T Consensus       223 ------~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~  257 (321)
T d1tkia_         223 ------DEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQ  257 (321)
T ss_dssp             ------CHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             ------ChhhccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                  11111123457899999999999999999999976

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=1.6e-50  Score=384.16  Aligned_cols=251  Identities=25%  Similarity=0.343  Sum_probs=204.7

Q ss_pred             cCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCcc---------HHHHHHHHHHHhcCC-CCCcceEE
Q 046893           92 KFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQG---------DREWLAEVNYLGQLR-HSNLVKLI  161 (464)
Q Consensus        92 ~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~---------~~~~~~E~~~l~~l~-hpniv~l~  161 (464)
                      ++|++.+.||+|+||+||+|++..+      ++.||||++.......         .+.+.+|+.+|+.++ ||||++++
T Consensus         3 ~~y~~~~~iG~G~~g~V~~~~~~~~------~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~   76 (277)
T d1phka_           3 ENYEPKEILGRGVSSVVRRCIHKPT------CKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLK   76 (277)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTT------TEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEE
T ss_pred             ccCEEceEEecCcCeEEEEEEECCC------CCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEE
Confidence            5789999999999999999998765      7789999987653321         135789999999997 99999999


Q ss_pred             EEEEeCCeEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEc
Q 046893          162 GYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLS  241 (464)
Q Consensus       162 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~  241 (464)
                      +++.+.+..|||||||++|+|.++|..+.  .+++..+..++.||+.||+|||  .++|+||||||+||||+.++.+||+
T Consensus        77 ~~~~~~~~~~ivmE~~~~g~L~~~l~~~~--~l~e~~~~~~~~qi~~al~~lH--~~~ivHrDlkp~Nill~~~~~~kl~  152 (277)
T d1phka_          77 DTYETNTFFFLVFDLMKKGELFDYLTEKV--TLSEKETRKIMRALLEVICALH--KLNIVHRDLKPENILLDDDMNIKLT  152 (277)
T ss_dssp             EEEECSSEEEEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGEEECTTCCEEEC
T ss_pred             eecccCcceEEEEEcCCCchHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH--HcCCcccccccceEEEcCCCCeEEc
Confidence            99999999999999999999999997654  6999999999999999999999  5679999999999999999999999


Q ss_pred             ccCCccCCCCCCCcceeeccccCCcccCcccccc------CCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHH
Q 046893          242 DFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMT------GHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEW  315 (464)
Q Consensus       242 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~  315 (464)
                      |||+++......   .....+||..|+|||++.+      ..++.++|||||||+||||++|+.||.+.....      .
T Consensus       153 DFG~a~~~~~~~---~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~------~  223 (277)
T d1phka_         153 DFGFSCQLDPGE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQML------M  223 (277)
T ss_dssp             CCTTCEECCTTC---CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------H
T ss_pred             cchheeEccCCC---ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHH------H
Confidence            999998754322   2344789999999999864      346889999999999999999999998654211      1


Q ss_pred             HHHhhhcccchhhccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 046893          316 ARPLLNNNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVA  369 (464)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  369 (464)
                      ..........        .........+.++.+|+.+||+.||.+||++.++++
T Consensus       224 ~~~i~~~~~~--------~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~  269 (277)
T d1phka_         224 LRMIMSGNYQ--------FGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA  269 (277)
T ss_dssp             HHHHHHTCCC--------CCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             HHHHHhCCCC--------CCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence            1111211111        111122235568999999999999999999998864

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-51  Score=398.92  Aligned_cols=248  Identities=28%  Similarity=0.441  Sum_probs=203.1

Q ss_pred             cCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCC---CccHHHHHHHHHHHh-cCCCCCcceEEEEEEeC
Q 046893           92 KFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGG---YQGDREWLAEVNYLG-QLRHSNLVKLIGYCCED  167 (464)
Q Consensus        92 ~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~-~l~hpniv~l~~~~~~~  167 (464)
                      ++|++.+.||+|+||+||+|++..+      ++.||||++.+..   ....+.+..|..++. .++|||||++++++.++
T Consensus         2 ddy~i~~~iG~G~fg~Vy~~~~~~t------~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~   75 (320)
T d1xjda_           2 EDFILHKMLGKGSFGKVFLAEFKKT------NQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTK   75 (320)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTT------TEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred             CCeEEeeEEecCCCcEEEEEEECCC------CCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccC
Confidence            4688999999999999999998765      7889999996431   223355667777665 68999999999999999


Q ss_pred             CeEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCcc
Q 046893          168 EHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAK  247 (464)
Q Consensus       168 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~  247 (464)
                      +..|||||||++|+|.+++....  .+++..+..++.||+.||.|||  .++|+||||||+|||++.++.+||+|||+++
T Consensus        76 ~~~yivmEy~~~g~L~~~i~~~~--~~~e~~~~~~~~qi~~al~ylH--~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~  151 (320)
T d1xjda_          76 ENLFFVMEYLNGGDLMYHIQSCH--KFDLSRATFYAAEIILGLQFLH--SKGIVYRDLKLDNILLDKDGHIKIADFGMCK  151 (320)
T ss_dssp             SEEEEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHH--HTTCBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred             CceeEEEeecCCCcHHHHhhccC--CCCHHHHHHHHHHHHHHHHHHH--hCCeeeccCcccceeecCCCceeccccchhh
Confidence            99999999999999999987654  6899999999999999999999  5679999999999999999999999999998


Q ss_pred             CCCCCCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhcccchh
Q 046893          248 DGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKKVL  327 (464)
Q Consensus       248 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  327 (464)
                      ......  ......+||+.|+|||++.+..|+.++|||||||++|||++|+.||.+....      +........     
T Consensus       152 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~------~~~~~i~~~-----  218 (320)
T d1xjda_         152 ENMLGD--AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEE------ELFHSIRMD-----  218 (320)
T ss_dssp             CCCCTT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHHC-----
T ss_pred             hccccc--ccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHH------HHHHHHHcC-----
Confidence            643322  2334478999999999999999999999999999999999999999865421      111111111     


Q ss_pred             hccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHH-HHHH
Q 046893          328 RILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMS-DVVA  369 (464)
Q Consensus       328 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~-ev~~  369 (464)
                         .+    .++..++.++.+||.+||..||.+||++. ++++
T Consensus       219 ---~~----~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~  254 (320)
T d1xjda_         219 ---NP----FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ  254 (320)
T ss_dssp             ---CC----CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred             ---CC----CCCccCCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence               11    12233456889999999999999999986 6643

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-50  Score=388.12  Aligned_cols=265  Identities=25%  Similarity=0.329  Sum_probs=200.1

Q ss_pred             cCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCc--cHHHHHHHHHHHhcCCCCCcceEEEEEEeCCe
Q 046893           92 KFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQ--GDREWLAEVNYLGQLRHSNLVKLIGYCCEDEH  169 (464)
Q Consensus        92 ~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~  169 (464)
                      ++|++.+.||+|+||+||+|++..+      ++.||||++......  ....+.+|+++|++++|||||++++++.+.+.
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~~~~~~------~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~   75 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKARNKLT------GEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENK   75 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTT------CCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTE
T ss_pred             CCCEeccEEecCcCeEEEEEEECCC------CCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccc
Confidence            4688999999999999999998775      677999999654322  24678999999999999999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCccCC
Q 046893          170 RILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDG  249 (464)
Q Consensus       170 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~  249 (464)
                      .|+||||+.+ .+.+++.......+++..+..++.|++.||.|||  +++||||||||+|||++.++.+||+|||+|+..
T Consensus        76 ~~iv~e~~~~-~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH--~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~  152 (298)
T d1gz8a_          76 LYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH--SHRVLHRDLKPQNLLINTEGAIKLADFGLARAF  152 (298)
T ss_dssp             EEEEEECCSE-EHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCCGGGEEECTTSCEEECSTTHHHHH
T ss_pred             eeEEEeecCC-chhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhh--cCCEEccccCchheeecccCcceeccCCcceec
Confidence            9999999965 5556665555567999999999999999999999  577999999999999999999999999999864


Q ss_pred             CCCCCcceeeccccCCcccCccccccCC-CCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhcccc---
Q 046893          250 PMGDQTHVSTRVMGTYGYAAPEYVMTGH-LTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNKK---  325 (464)
Q Consensus       250 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~---  325 (464)
                      ....  .......||+.|+|||++.... ++.++|||||||++|+|++|+.||.+......  +.............   
T Consensus       153 ~~~~--~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~--~~~i~~~~~~~~~~~~~  228 (298)
T d1gz8a_         153 GVPV--RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQ--LFRIFRTLGTPDEVVWP  228 (298)
T ss_dssp             CCCS--BCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH--HHHHHHHHCCCCTTTST
T ss_pred             cCCc--ccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHH--HHHHHHhcCCCchhhcc
Confidence            3222  2233468999999999877665 57899999999999999999999976532111  11111000000000   


Q ss_pred             -hhhc------cCccccC---ccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 046893          326 -VLRI------LDPRLEG---QYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVA  369 (464)
Q Consensus       326 -~~~~------~~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  369 (464)
                       ....      .......   ......+.++.+|+.+||..||.+|||+.++++
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~  282 (298)
T d1gz8a_         229 GVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA  282 (298)
T ss_dssp             TGGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             ccccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence             0000      0000000   011123457899999999999999999999875

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.2e-51  Score=393.47  Aligned_cols=258  Identities=25%  Similarity=0.302  Sum_probs=192.5

Q ss_pred             CCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCcc-----HHHHHHHHHHHhcCCCCCcceEEEEEEeCCeEE
Q 046893           97 DYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQG-----DREWLAEVNYLGQLRHSNLVKLIGYCCEDEHRI  171 (464)
Q Consensus        97 ~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~-----~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~  171 (464)
                      +++||+|+||+||+|++..+      ++.||||+++......     .+.+.+|+.+|+.++|||||++++++..++..|
T Consensus         3 l~~lG~G~fg~Vy~~~~~~~------~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~   76 (299)
T d1ua2a_           3 LDFLGEGQFATVYKARDKNT------NQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNIS   76 (299)
T ss_dssp             EEEEEEETTEEEEEEECSSC------CSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCE
T ss_pred             ceEeccCcCeEEEEEEECCC------CcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCcee
Confidence            46799999999999998764      6779999987543222     245889999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCccCCCC
Q 046893          172 LVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDGPM  251 (464)
Q Consensus       172 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~  251 (464)
                      |||||+.++++..++.  ....+++..+..++.||+.||+|||  .++|+||||||+|||++.++.+||+|||+|+....
T Consensus        77 ivmE~~~~~~~~~~~~--~~~~l~~~~~~~~~~qil~aL~~lH--~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~  152 (299)
T d1ua2a_          77 LVFDFMETDLEVIIKD--NSLVLTPSHIKAYMLMTLQGLEYLH--QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGS  152 (299)
T ss_dssp             EEEECCSEEHHHHHTT--CCSSCCSSHHHHHHHHHHHHHHHHH--HTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTS
T ss_pred             ehhhhhcchHHhhhhh--cccCCCHHHHHHHHHHHHHHHHHhh--ccceecccCCcceEEecCCCccccccCccccccCC
Confidence            9999998877655433  2346899999999999999999999  57799999999999999999999999999986433


Q ss_pred             CCCcceeeccccCCcccCcccccc-CCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhcc--cc---
Q 046893          252 GDQTHVSTRVMGTYGYAAPEYVMT-GHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNN--KK---  325 (464)
Q Consensus       252 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~--~~---  325 (464)
                      ..  ......+||+.|+|||++.+ ..|+.++|||||||++|||++|..||.+......   .......+...  ..   
T Consensus       153 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~---l~~i~~~~~~~~~~~~~~  227 (299)
T d1ua2a_         153 PN--RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQ---LTRIFETLGTPTEEQWPD  227 (299)
T ss_dssp             CC--CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHHHHHHCCCCTTTSSS
T ss_pred             Cc--ccccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHH---HHHHHHhcCCCChhhccc
Confidence            22  22334689999999998875 4689999999999999999999999976542211   11111110000  00   


Q ss_pred             hhhccC--------ccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 046893          326 VLRILD--------PRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVA  369 (464)
Q Consensus       326 ~~~~~~--------~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  369 (464)
                      ......        ...........+.++.+|+.+||+.||++|||+.|+++
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~  279 (299)
T d1ua2a_         228 MCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK  279 (299)
T ss_dssp             TTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             hhccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhC
Confidence            000000        00000011123457899999999999999999999864

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-50  Score=389.56  Aligned_cols=266  Identities=26%  Similarity=0.362  Sum_probs=200.2

Q ss_pred             cCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCccHHHHHHH--HHHHhcCCCCCcceEEEEEEeCC-
Q 046893           92 KFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAE--VNYLGQLRHSNLVKLIGYCCEDE-  168 (464)
Q Consensus        92 ~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E--~~~l~~l~hpniv~l~~~~~~~~-  168 (464)
                      +.|.+.+.||+|+||+||+|++.        ++.||||++...   ....+..|  +..+..++|||||++++++...+ 
T Consensus         3 ~~~~l~~~iG~G~fg~Vy~~~~~--------g~~vAvK~~~~~---~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~   71 (303)
T d1vjya_           3 RTIVLQESIGKGRFGEVWRGKWR--------GEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNG   71 (303)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEET--------TEEEEEEEECGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECS
T ss_pred             cEEEEEEEEeeCCCeEEEEEEEC--------CEEEEEEEECcc---chhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCC
Confidence            45777889999999999999863        567999998643   33444444  44556789999999999998754 


Q ss_pred             ---eEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcC------CCCeeeccCCCCceEecCCCceE
Q 046893          169 ---HRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGA------ERPVIYRDFKTSNILLNADFSAK  239 (464)
Q Consensus       169 ---~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~------~~~ivHrDlkp~Nill~~~~~vk  239 (464)
                         ..+||||||++|+|.+++.+.   .+++..++.++.|++.||.|||+.      .++||||||||+||||+.++.+|
T Consensus        72 ~~~~~~lv~Ey~~~g~L~~~l~~~---~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~K  148 (303)
T d1vjya_          72 TWTQLWLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCC  148 (303)
T ss_dssp             SSEEEEEEEECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEE
T ss_pred             cceEEEEEEecccCCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeE
Confidence               689999999999999999764   489999999999999999999963      46899999999999999999999


Q ss_pred             EcccCCccCCCCCCCc--ceeeccccCCcccCccccccCC------CCcccchhcHHHHHHHHHhCCCCCCCCCCcccc-
Q 046893          240 LSDFGLAKDGPMGDQT--HVSTRVMGTYGYAAPEYVMTGH------LTARSDVYGFGVVLLEMLLGRRAVDKSRPSREH-  310 (464)
Q Consensus       240 l~DFGla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~------~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~-  310 (464)
                      |+|||+++........  .......||+.|+|||++.+..      ++.++|||||||+||||+||..||......... 
T Consensus       149 l~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~  228 (303)
T d1vjya_         149 IADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPY  228 (303)
T ss_dssp             ECCCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTT
T ss_pred             EEecCccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccch
Confidence            9999999865332221  1233478999999999987643      677899999999999999999887543221110 


Q ss_pred             -------cHHHHHHHhhhcccchhhccCccccCcc-CHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHh
Q 046893          311 -------NLVEWARPLLNNNKKVLRILDPRLEGQY-TARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETVQS  376 (464)
Q Consensus       311 -------~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~~~  376 (464)
                             ............     ..+.+.+...+ .......+.+|+.+||+.||.+|||+.+|++.|+++..
T Consensus       229 ~~~~~~~~~~~~~~~~~~~-----~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~  297 (303)
T d1vjya_         229 YDLVPSDPSVEEMRKVVCE-----QKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ  297 (303)
T ss_dssp             TTTSCSSCCHHHHHHHHTT-----SCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             hhcccccchHHHHHHHHhc-----cccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHH
Confidence                   011111111111     11222222221 23455679999999999999999999999999998864

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.5e-50  Score=381.69  Aligned_cols=241  Identities=24%  Similarity=0.366  Sum_probs=196.1

Q ss_pred             hcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCc------cHHHHHHHHHHHhcCC--CCCcceEEE
Q 046893           91 TKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQ------GDREWLAEVNYLGQLR--HSNLVKLIG  162 (464)
Q Consensus        91 ~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~--hpniv~l~~  162 (464)
                      .++|++.+.||+|+||+||+|++..+      ++.||||++......      ....+.+|+.+|+.++  |||||++++
T Consensus         3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~------~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~   76 (273)
T d1xwsa_           3 ESQYQVGPLLGSGGFGSVYSGIRVSD------NLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLD   76 (273)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTT------CCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEE
T ss_pred             CCeEEEeEEEeeCCCeEEEEEEECCC------CCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEE
Confidence            35799999999999999999998775      677999998653221      1134678999999986  899999999


Q ss_pred             EEEeCCeEEEEEeccCC-CCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecC-CCceEE
Q 046893          163 YCCEDEHRILVYEYMES-GSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNA-DFSAKL  240 (464)
Q Consensus       163 ~~~~~~~~~lv~e~~~~-g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~-~~~vkl  240 (464)
                      ++.+.+..++||||+.+ ++|.+++....  .+++.++..++.|++.||.|||  +++|+||||||+|||++. ++.+||
T Consensus        77 ~~~~~~~~~lv~e~~~~~~~l~~~~~~~~--~l~e~~~~~~~~qi~~al~~lH--~~~iiHrDiKp~NIll~~~~~~vkl  152 (273)
T d1xwsa_          77 WFERPDSFVLILERPEPVQDLFDFITERG--ALQEELARSFFWQVLEAVRHCH--NCGVLHRDIKDENILIDLNRGELKL  152 (273)
T ss_dssp             EEECSSEEEEEEECCSSEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGEEEETTTTEEEE
T ss_pred             EEeeCCeEEEEEEeccCcchHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHH--HCCCccccCcccceEEecCCCeEEE
Confidence            99999999999999976 57777776643  6999999999999999999999  577999999999999985 479999


Q ss_pred             cccCCccCCCCCCCcceeeccccCCcccCccccccCCC-CcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHh
Q 046893          241 SDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHL-TARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPL  319 (464)
Q Consensus       241 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~  319 (464)
                      +|||+|+.....    ......||+.|+|||++.+..+ +.++|||||||+||||++|+.||....        +    .
T Consensus       153 ~DFG~a~~~~~~----~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~--------~----i  216 (273)
T d1xwsa_         153 IDFGSGALLKDT----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE--------E----I  216 (273)
T ss_dssp             CCCTTCEECCSS----CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH--------H----H
T ss_pred             Cccccceecccc----cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch--------H----H
Confidence            999999864322    2334789999999999987765 577999999999999999999996521        0    1


Q ss_pred             hhcccchhhccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 046893          320 LNNNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVA  369 (464)
Q Consensus       320 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  369 (464)
                      ....        .    .++..++.++.+||.+||..||.+|||+.++++
T Consensus       217 ~~~~--------~----~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~  254 (273)
T d1xwsa_         217 IRGQ--------V----FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQN  254 (273)
T ss_dssp             HHCC--------C----CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             hhcc--------c----CCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence            1110        0    111223458899999999999999999999875

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.9e-49  Score=381.74  Aligned_cols=266  Identities=23%  Similarity=0.300  Sum_probs=197.7

Q ss_pred             hcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCC--ccHHHHHHHHHHHhcC---CCCCcceEEEEEE
Q 046893           91 TKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGY--QGDREWLAEVNYLGQL---RHSNLVKLIGYCC  165 (464)
Q Consensus        91 ~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~hpniv~l~~~~~  165 (464)
                      .++|++++.||+|+||+||+|++..+     .++.||||++.....  .....+.+|+.+|+.|   +||||++++++|.
T Consensus         6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~-----~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~   80 (305)
T d1blxa_           6 DQQYECVAEIGEGAYGKVFKARDLKN-----GGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCT   80 (305)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTT-----TTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEE
T ss_pred             cCCEEEEEEEecccCeEEEEEEEECC-----CCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeec
Confidence            46799999999999999999998653     257799999864321  1223456777776665   7999999999986


Q ss_pred             e-----CCeEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEE
Q 046893          166 E-----DEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKL  240 (464)
Q Consensus       166 ~-----~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl  240 (464)
                      .     ....+++|||+.++.+.. ........+++..+..++.|++.||+|||  .++||||||||+|||++.++.+||
T Consensus        81 ~~~~~~~~~~~~~~e~~~~~~~~~-~~~~~~~~~~~~~~~~~~~qi~~aL~yLH--~~~ivHrDiKp~NILi~~~~~~kl  157 (305)
T d1blxa_          81 VSRTDRETKLTLVFEHVDQDLTTY-LDKVPEPGVPTETIKDMMFQLLRGLDFLH--SHRVVHRDLKPQNILVTSSGQIKL  157 (305)
T ss_dssp             EEECSSEEEEEEEEECCSCBHHHH-HHHSCTTCSCHHHHHHHHHHHHHHHHHHH--HTTCCCCCCCGGGEEECTTCCEEE
T ss_pred             ccccccCceEEEEEEeccCCchhh-hhhccCCCCCHHHHHHHHHHHHHHHHHHH--hCCEEecCCCccEEEEcCCCCeee
Confidence            3     246899999998876644 33344557999999999999999999999  577999999999999999999999


Q ss_pred             cccCCccCCCCCCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhh
Q 046893          241 SDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLL  320 (464)
Q Consensus       241 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~  320 (464)
                      +|||+++....   ........||+.|+|||++.+..|+.++|||||||+||||++|+.||.+.......  ........
T Consensus       158 ~dfg~~~~~~~---~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~--~~i~~~~~  232 (305)
T d1blxa_         158 ADFGLARIYSF---QMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQL--GKILDVIG  232 (305)
T ss_dssp             CSCCSCCCCCG---GGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH--HHHHHHHC
T ss_pred             cchhhhhhhcc---cccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHH--HHHHHhhC
Confidence            99999985322   23344578999999999999999999999999999999999999999865432111  11110000


Q ss_pred             hc-------c----cchhhccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 046893          321 NN-------N----KKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVA  369 (464)
Q Consensus       321 ~~-------~----~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  369 (464)
                      ..       .    ..............+....+..+.+||.+||+.||.+|||+.++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~  292 (305)
T d1blxa_         233 LPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  292 (305)
T ss_dssp             CCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             CCchhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence            00       0    0000000011111222334557889999999999999999999875

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=4.6e-49  Score=376.81  Aligned_cols=263  Identities=23%  Similarity=0.301  Sum_probs=197.1

Q ss_pred             cCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCc--cHHHHHHHHHHHhcCCCCCcceEEEEEEeCCe
Q 046893           92 KFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQ--GDREWLAEVNYLGQLRHSNLVKLIGYCCEDEH  169 (464)
Q Consensus        92 ~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~  169 (464)
                      ++|++.+.||+|+||+||+|++..       ++.||||+++.....  ..+.+.+|+.+|++++|||||++++++...+.
T Consensus         2 ~~Y~~~~~iG~G~fg~Vy~~~~~~-------~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~   74 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYGVVYKAQNNY-------GETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKR   74 (286)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETT-------SCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSC
T ss_pred             CCceeccEEecCCCcEEEEEEeCC-------CCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCc
Confidence            478899999999999999998753       567999999764322  24778999999999999999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCccCC
Q 046893          170 RILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDG  249 (464)
Q Consensus       170 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~  249 (464)
                      .+++|||+.++.+..+...  ...+++..+..++.||+.||+|||  +.+||||||||+||||+.++.+||+|||+|...
T Consensus        75 ~~i~~e~~~~~~~~~~~~~--~~~l~~~~~~~i~~qi~~~L~~LH--~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~  150 (286)
T d1ob3a_          75 LVLVFEHLDQDLKKLLDVC--EGGLESVTAKSFLLQLLNGIAYCH--DRRVLHRDLKPQNLLINREGELKIADFGLARAF  150 (286)
T ss_dssp             EEEEEECCSEEHHHHHHTS--TTCCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCCGGGEEECTTSCEEECCTTHHHHH
T ss_pred             eeEEEEeehhhhHHHHHhh--cCCcchhhhHHHHHHHHHHHHHhc--cCcEEecCCCCceeeEcCCCCEEecccccceec
Confidence            9999999987666555433  347999999999999999999999  567999999999999999999999999999764


Q ss_pred             CCCCCcceeeccccCCcccCccccccC-CCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhc------
Q 046893          250 PMGDQTHVSTRVMGTYGYAAPEYVMTG-HLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNN------  322 (464)
Q Consensus       250 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~------  322 (464)
                      ....  .......|++.|+|||.+.+. .++.++|||||||++|||++|+.||.+......  +..........      
T Consensus       151 ~~~~--~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~--~~~i~~~~~~~~~~~~~  226 (286)
T d1ob3a_         151 GIPV--RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQ--LMRIFRILGTPNSKNWP  226 (286)
T ss_dssp             CC-----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH--HHHHHHHHCCCCTTTST
T ss_pred             ccCc--cccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHH--HHHHHHhhCCCChhhcc
Confidence            3222  222335799999999998754 578999999999999999999999976542211  11111100000      


Q ss_pred             -ccchh------hccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 046893          323 -NKKVL------RILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVA  369 (464)
Q Consensus       323 -~~~~~------~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  369 (464)
                       .....      ....+..........+..+.+|+.+||+.||++|||++++++
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~  280 (286)
T d1ob3a_         227 NVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE  280 (286)
T ss_dssp             TGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             chhhhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence             00000      000111111222334558899999999999999999999873

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=2.3e-48  Score=372.92  Aligned_cols=265  Identities=19%  Similarity=0.191  Sum_probs=210.0

Q ss_pred             HhcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCccHHHHHHHHHHHhcCCC-CCcceEEEEEEeCC
Q 046893           90 ATKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRH-SNLVKLIGYCCEDE  168 (464)
Q Consensus        90 ~~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-pniv~l~~~~~~~~  168 (464)
                      ..++|++.+.||+|+||+||+|++..+      ++.||||++.....  ...+.+|++++..|.| +||+.+++++....
T Consensus         3 ig~~Y~i~~~iG~G~fG~Vy~a~~~~~------~~~vAvK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~   74 (293)
T d1csna_           3 VGVHYKVGRRIGEGSFGVIFEGTNLLN------NQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFGQEGL   74 (293)
T ss_dssp             ETTTEEEEEEEEECSSCEEEEEEETTT------TEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEEEETT
T ss_pred             CCCceEEEEEEecCCCeEEEEEEECCC------CCEEEEEEEccccC--cHHHHHHHHHHHHhcCCCCCCEEEEEeecCC
Confidence            356799999999999999999998765      67899999865432  2456788999999965 89999999999999


Q ss_pred             eEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecC-----CCceEEccc
Q 046893          169 HRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNA-----DFSAKLSDF  243 (464)
Q Consensus       169 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~-----~~~vkl~DF  243 (464)
                      ..++||||+ +++|.+++... +..++..++..++.|++.||.|||  .++|+||||||+||||+.     ++.+||+||
T Consensus        75 ~~~~vme~~-~~~l~~~~~~~-~~~~~~~~~~~i~~q~~~~l~~lH--~~giiHrDiKp~Nili~~~~~~~~~~vkl~DF  150 (293)
T d1csna_          75 HNVLVIDLL-GPSLEDLLDLC-GRKFSVKTVAMAAKQMLARVQSIH--EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDF  150 (293)
T ss_dssp             EEEEEEECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHH--TTTEECCCCCGGGEEECCSSSTTTTCEEECCC
T ss_pred             ccEEEEEec-CCCHHHHHHhh-ccchhhHHHHHHHHHHHHHHHHHH--HCCceeccCCccceeecCcccccCCceEEccc
Confidence            999999999 78998887654 457999999999999999999999  677999999999999964     578999999


Q ss_pred             CCccCCCCCCCc-----ceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHH
Q 046893          244 GLAKDGPMGDQT-----HVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARP  318 (464)
Q Consensus       244 Gla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~  318 (464)
                      |+|+........     ......+||+.|||||++.+..++.++|||||||++|||++|+.||.+...............
T Consensus       151 G~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~  230 (293)
T d1csna_         151 GMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGE  230 (293)
T ss_dssp             TTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHH
T ss_pred             ceeEEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHh
Confidence            999865332211     123346899999999999999999999999999999999999999986554333222211110


Q ss_pred             hhhcccchhhccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHh
Q 046893          319 LLNNNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETVQS  376 (464)
Q Consensus       319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~~~  376 (464)
                      ..    .      ..........++.++.+++..||..+|++||+++.+.+.|+++..
T Consensus       231 ~~----~------~~~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~  278 (293)
T d1csna_         231 KK----Q------STPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLE  278 (293)
T ss_dssp             HH----H------HSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHH
T ss_pred             cc----C------CCChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHH
Confidence            00    0      000011122344589999999999999999999999999988754

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=5.4e-48  Score=371.70  Aligned_cols=262  Identities=19%  Similarity=0.204  Sum_probs=201.3

Q ss_pred             cCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCccHHHHHHHHHHHhcCCCCC-cceEEEEEEeCCeE
Q 046893           92 KFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSN-LVKLIGYCCEDEHR  170 (464)
Q Consensus        92 ~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpn-iv~l~~~~~~~~~~  170 (464)
                      ++|++.+.||+|+||+||+|++..+      ++.||||++.....  ..++..|+++++.++|+| |+.+..++.+.+..
T Consensus         7 ~rY~l~~~iG~G~fG~Vy~a~~~~~------~~~vAvK~~~~~~~--~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~   78 (299)
T d1ckia_           7 NRYRLGRKIGSGSFGDIYLGTDIAA------GEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYN   78 (299)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTT------TEEEEEEEEESCTT--SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEE
T ss_pred             CEEEEeEEEeeCCCcEEEEEEECCC------CCEEEEEEEchhcc--CHHHHHHHHHHHHccCCCcccEEEEEEecCCEE
Confidence            5699999999999999999998765      67899999876432  245788999999998766 55556667888899


Q ss_pred             EEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEec---CCCceEEcccCCcc
Q 046893          171 ILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLN---ADFSAKLSDFGLAK  247 (464)
Q Consensus       171 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~---~~~~vkl~DFGla~  247 (464)
                      ++||||+ +++|.+.+... ...+++..+..++.|++.||+|||  .++|+||||||+|||++   .+..+||+|||+|+
T Consensus        79 ~ivme~~-~~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH--~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~  154 (299)
T d1ckia_          79 VMVMELL-GPSLEDLFNFC-SRKFSLKTVLLLADQMISRIEYIH--SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK  154 (299)
T ss_dssp             EEEEECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCCGGGEEECCGGGTTCEEECCCSSCE
T ss_pred             EEEEEEc-CCchhhhhhhc-cCCCcHHHHHHHHHHHHHHHHHHH--HCCeeeccCCHhhccccccCCCceeeeeccCcce
Confidence            9999999 56777766543 457999999999999999999999  57799999999999985   45579999999998


Q ss_pred             CCCCCCCc-----ceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHH-HHHHHhhh
Q 046893          248 DGPMGDQT-----HVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLV-EWARPLLN  321 (464)
Q Consensus       248 ~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~-~~~~~~~~  321 (464)
                      ........     .......||+.|+|||++.+..++.++|||||||++|||++|+.||............ .+......
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~  234 (299)
T d1ckia_         155 KYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMS  234 (299)
T ss_dssp             ECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHH
T ss_pred             eccccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCC
Confidence            65433221     1234468999999999999999999999999999999999999999765443322211 11111000


Q ss_pred             cccchhhccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHh
Q 046893          322 NNKKVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVALLETVQS  376 (464)
Q Consensus       322 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~~~  376 (464)
                      .         +  .......++.++.+|+.+||+.||.+||++.++.+.|+.+..
T Consensus       235 ~---------~--~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~  278 (299)
T d1ckia_         235 T---------P--IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH  278 (299)
T ss_dssp             S---------C--HHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHH
T ss_pred             C---------C--hhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHH
Confidence            0         0  001122344588999999999999999999999999987643

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.9e-48  Score=377.81  Aligned_cols=262  Identities=24%  Similarity=0.327  Sum_probs=193.3

Q ss_pred             hcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCcc--HHHHHHHHHHHhcCCCCCcceEEEEEEeCC
Q 046893           91 TKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQG--DREWLAEVNYLGQLRHSNLVKLIGYCCEDE  168 (464)
Q Consensus        91 ~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~hpniv~l~~~~~~~~  168 (464)
                      .++|++.+.||+|+||+||+|.+..+      ++.||||++.......  .+.+.+|+++|+.++|||||+++++|...+
T Consensus        17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~------~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~   90 (346)
T d1cm8a_          17 RAVYRDLQPVGSGAYGAVCSAVDGRT------GAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDE   90 (346)
T ss_dssp             BSSEEEEEEC------CEEEEEETTT------CCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCS
T ss_pred             CCcEEEEEEEecCCCeEEEEEEECCC------CCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCc
Confidence            46799999999999999999998765      6789999997643322  356889999999999999999999998665


Q ss_pred             ------eEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcc
Q 046893          169 ------HRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSD  242 (464)
Q Consensus       169 ------~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~D  242 (464)
                            .+||||||| +.+|..++...   .+++..+..++.||+.||.|||  +++|+||||||+|||++.++.+||+|
T Consensus        91 ~~~~~~~~~lv~e~~-~~~l~~~~~~~---~l~~~~~~~~~~qi~~aL~~LH--~~~IiHrDiKp~NIL~~~~~~~kl~D  164 (346)
T d1cm8a_          91 TLDDFTDFYLVMPFM-GTDLGKLMKHE---KLGEDRIQFLVYQMLKGLRYIH--AAGIIHRDLKPGNLAVNEDCELKILD  164 (346)
T ss_dssp             STTTCCCCEEEEECC-SEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCCGGGEEECTTCCEEECC
T ss_pred             cccccceEEEEEecc-cccHHHHHHhc---cccHHHHHHHHHHHHHHHHHHH--hCCCcccccCcchhhccccccccccc
Confidence                  579999999 66787765432   5999999999999999999999  56799999999999999999999999


Q ss_pred             cCCccCCCCCCCcceeeccccCCcccCccccccC-CCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHH---
Q 046893          243 FGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTG-HLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARP---  318 (464)
Q Consensus       243 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~---  318 (464)
                      ||+|+.....     .....||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+...............   
T Consensus       165 fg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~  239 (346)
T d1cm8a_         165 FGLARQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPP  239 (346)
T ss_dssp             CTTCEECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCC
T ss_pred             ccceeccCCc-----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCc
Confidence            9999864321     2346899999999998764 578999999999999999999999976542211110000000   


Q ss_pred             --hhhcc-----cchhhcc---CccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 046893          319 --LLNNN-----KKVLRIL---DPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVA  369 (464)
Q Consensus       319 --~~~~~-----~~~~~~~---~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  369 (464)
                        .....     ......+   ............+..+.+||.+||..||.+|||+.++++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~  300 (346)
T d1cm8a_         240 AEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA  300 (346)
T ss_dssp             HHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             HHHHhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence              00000     0000000   000001112233457889999999999999999999986

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-47  Score=374.89  Aligned_cols=259  Identities=26%  Similarity=0.334  Sum_probs=192.6

Q ss_pred             CCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCccHHHHHHHHHHHhcCCCCCcceEEEEEEeC-----
Q 046893           93 FFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNLVKLIGYCCED-----  167 (464)
Q Consensus        93 ~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~-----  167 (464)
                      .|...++||+|+||+||+|++..+      ++.||||++......    +.+|+++|++++||||++++++|...     
T Consensus        21 ~Y~~~k~LG~G~fg~Vy~a~~~~~------~~~vAiK~i~~~~~~----~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~   90 (350)
T d1q5ka_          21 SYTDTKVIGNGSFGVVYQAKLCDS------GELVAIKKVLQDKRF----KNRELQIMRKLDHCNIVRLRYFFYSSGEKKD   90 (350)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTT------CCEEEEEEEECCSSS----CCHHHHHHHHCCCTTBCCEEEEEEEC--CCS
T ss_pred             CcEeeeEEeeCcCeEEEEEEECCC------CCEEEEEEECccchH----HHHHHHHHHhcCCCCCCcEEEEEEecCccCC
Confidence            377788999999999999998875      678999999764322    24799999999999999999998643     


Q ss_pred             -CeEEEEEeccCCCCHHHHHHh--hcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCC-ceEEccc
Q 046893          168 -EHRILVYEYMESGSLEKHLLR--RVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADF-SAKLSDF  243 (464)
Q Consensus       168 -~~~~lv~e~~~~g~L~~~l~~--~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~-~vkl~DF  243 (464)
                       .+.+||||||+++.+ +.+..  .....+++..+..|+.||+.||+|||  +++|+||||||+||||+.++ .+||+||
T Consensus        91 ~~~~~lv~Ey~~~~~~-~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH--~~~IiHrDiKp~NILl~~~~~~~kl~DF  167 (350)
T d1q5ka_          91 EVYLNLVLDYVPETVY-RVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH--SFGICHRDIKPQNLLLDPDTAVLKLCDF  167 (350)
T ss_dssp             CCEEEEEEECCSEEHH-HHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH--TTTEECCCCCGGGEEECTTTCCEEECCC
T ss_pred             ceEEEEEEeccCCccH-HHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHH--hcCCcccCCCcceEEEecCCCceeEecc
Confidence             357899999976543 33332  23457999999999999999999999  67799999999999998775 8999999


Q ss_pred             CCccCCCCCCCcceeeccccCCcccCcccccc-CCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhc
Q 046893          244 GLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMT-GHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNN  322 (464)
Q Consensus       244 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~  322 (464)
                      |+++......   .....+||..|+|||.+.+ ..|+.++|||||||++|||++|+.||.......  .+..........
T Consensus       168 G~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~--~l~~i~~~~g~~  242 (350)
T d1q5ka_         168 GSAKQLVRGE---PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVD--QLVEIIKVLGTP  242 (350)
T ss_dssp             TTCEECCTTS---CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHH--HHHHHHHHHCCC
T ss_pred             cchhhccCCc---ccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHH--HHHHHHHHhCCC
Confidence            9998653322   2234689999999998875 578999999999999999999999997654221  111111100000


Q ss_pred             c--------c-----chhhccCccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 046893          323 N--------K-----KVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVA  369 (464)
Q Consensus       323 ~--------~-----~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  369 (464)
                      .        .     ..................+.++.+|+.+||..||.+|||+.|+++
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~  302 (350)
T d1q5ka_         243 TREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA  302 (350)
T ss_dssp             CHHHHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             hHHhhhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            0        0     000000000111112234557899999999999999999999874

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.7e-48  Score=377.90  Aligned_cols=264  Identities=25%  Similarity=0.289  Sum_probs=193.7

Q ss_pred             cCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCc-cHHHHHHHHHHHhcCCCCCcceEEEEEEeCC--
Q 046893           92 KFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQ-GDREWLAEVNYLGQLRHSNLVKLIGYCCEDE--  168 (464)
Q Consensus        92 ~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~--  168 (464)
                      .+|++++.||+|+||+||+|++..+      ++.||||++...... ..+.+++|+.+|+.++||||+++++++....  
T Consensus         8 ~rY~~~~~LG~G~fg~Vy~~~~~~~------~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~   81 (345)
T d1pmea_           8 PRYTNLSYIGEGAYGMVCSAYDNVN------KVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIE   81 (345)
T ss_dssp             TTEEEEEECC---CCCEEEEEETTT------CSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTT
T ss_pred             CCeEEEEEEeeccCeEEEEEEECCC------CcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeecccc
Confidence            5699999999999999999998765      677999999754332 2357889999999999999999999987653  


Q ss_pred             ---eEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCC
Q 046893          169 ---HRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGL  245 (464)
Q Consensus       169 ---~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGl  245 (464)
                         .++|+ +|+.+|+|.+++...   .+++..+..++.|++.||+|||  +++||||||||+||||+.++.+||+|||+
T Consensus        82 ~~~~~~l~-~~~~~g~L~~~l~~~---~l~~~~i~~i~~qil~al~yLH--~~~iiHRDIKp~NILl~~~~~~kl~DfG~  155 (345)
T d1pmea_          82 QMKDVYLV-THLMGADLYKLLKTQ---HLSNDHICYFLYQILRGLKYIH--SANVLHRDLKPSNLLLNTTCDLKICDFGL  155 (345)
T ss_dssp             TCCCEEEE-EECCCEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred             ccceEEEE-EeecCCchhhhhhcC---CCCHHHHHHHHHHHHHHHHHHH--HCCCcCCCCCcceEEECCCCCEEEcccCc
Confidence               34555 556689999998654   5999999999999999999999  56799999999999999999999999999


Q ss_pred             ccCCCCCCC-cceeeccccCCcccCccccc-cCCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhcc
Q 046893          246 AKDGPMGDQ-THVSTRVMGTYGYAAPEYVM-TGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNN  323 (464)
Q Consensus       246 a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~  323 (464)
                      |+....... .......+||+.|+|||++. +..++.++||||+||++|+|++|+.||................  ....
T Consensus       156 a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~--~~~~  233 (345)
T d1pmea_         156 ARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGIL--GSPS  233 (345)
T ss_dssp             CEECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHH--CSCC
T ss_pred             eeeccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhc--cCCC
Confidence            986433211 12234467999999999885 4567899999999999999999999997654321111110000  0000


Q ss_pred             cc-------------hhhcc--CccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 046893          324 KK-------------VLRIL--DPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVA  369 (464)
Q Consensus       324 ~~-------------~~~~~--~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  369 (464)
                      ..             .....  ............+.++.+|+.+||..||.+|||+.++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~  294 (345)
T d1pmea_         234 QEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA  294 (345)
T ss_dssp             HHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             hhhhhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            00             00000  000000011122347889999999999999999999975

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-47  Score=370.00  Aligned_cols=265  Identities=22%  Similarity=0.282  Sum_probs=193.6

Q ss_pred             cCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCC--ccHHHHHHHHHHHhcCCCCCcceEEEEEEe---
Q 046893           92 KFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGY--QGDREWLAEVNYLGQLRHSNLVKLIGYCCE---  166 (464)
Q Consensus        92 ~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~l~~~~~~---  166 (464)
                      ++|++.+.||+|+||+||+|++..+      ++.||||++.....  .....+.+|+++|+.++||||+++++++..   
T Consensus        10 ~rY~i~~~LG~G~fg~Vy~a~~~~~------~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~   83 (318)
T d3blha1          10 SKYEKLAKIGQGTFGEVFKARHRKT------GQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKAS   83 (318)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEETTT------CCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC---
T ss_pred             CCEEEEEEEecCcCeEEEEEEECCC------CCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccc
Confidence            5688999999999999999998765      67899999865432  234678899999999999999999998855   


Q ss_pred             -----CCeEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEc
Q 046893          167 -----DEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLS  241 (464)
Q Consensus       167 -----~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~  241 (464)
                           ....++||||+.++.+... . .....+++..+..++.|++.||.|||  +++|+||||||+||||+.++.+||+
T Consensus        84 ~~~~~~~~~~iv~e~~~~~~~~~~-~-~~~~~~~~~~~~~i~~qil~~l~~lH--~~~ivHrDlKp~NILl~~~~~~kl~  159 (318)
T d3blha1          84 PYNRCKGSIYLVFDFCEHDLAGLL-S-NVLVKFTLSEIKRVMQMLLNGLYYIH--RNKILHRDMKAANVLITRDGVLKLA  159 (318)
T ss_dssp             -------CEEEEEECCCEEHHHHH-T-CTTCCCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCCGGGEEECTTSCEEEC
T ss_pred             cccccCceEEEEEeccCCCccchh-h-hcccccccHHHHHHHHHHHHHHHHhc--cCCEEecCcCchheeecCCCcEEee
Confidence                 3468999999987665433 2 23447899999999999999999999  5679999999999999999999999


Q ss_pred             ccCCccCCCCCCC--cceeeccccCCcccCccccccC-CCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHH
Q 046893          242 DFGLAKDGPMGDQ--THVSTRVMGTYGYAAPEYVMTG-HLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARP  318 (464)
Q Consensus       242 DFGla~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~  318 (464)
                      |||+++.......  .......+||+.|+|||++.+. .|+.++|||||||++|||++|+.||.+...........   .
T Consensus       160 dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~---~  236 (318)
T d3blha1         160 DFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALIS---Q  236 (318)
T ss_dssp             CCTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH---H
T ss_pred             ecceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHH---H
Confidence            9999976443221  1223346799999999998765 68999999999999999999999997644222111111   1


Q ss_pred             hhhc-ccchhhcc---------CccccCccC-------HHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 046893          319 LLNN-NKKVLRIL---------DPRLEGQYT-------ARTAMKVAGLAYQCLSQNPKGRPVMSDVVA  369 (464)
Q Consensus       319 ~~~~-~~~~~~~~---------~~~~~~~~~-------~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  369 (464)
                      .... ........         .........       ......+.+||.+||+.||++|||++++++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~  304 (318)
T d3blha1         237 LCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN  304 (318)
T ss_dssp             HHCCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             hcCCCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHc
Confidence            1100 00000000         000000000       111346778999999999999999999874

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.6e-47  Score=362.74  Aligned_cols=264  Identities=21%  Similarity=0.268  Sum_probs=203.2

Q ss_pred             cCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCC--ccHHHHHHHHHHHhcCCCCCcceEEEEEEeCCe
Q 046893           92 KFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGY--QGDREWLAEVNYLGQLRHSNLVKLIGYCCEDEH  169 (464)
Q Consensus        92 ~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~  169 (464)
                      ++|++++.||+|+||+||+|++..+      ++.||||+++....  .....+.+|+.+|+.++||||+++++++.....
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~~~~~~------~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~   75 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKAKNRET------HEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKK   75 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTT------CCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred             CCCEeeeEEecCcCeEEEEEEECCC------CcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccc
Confidence            4789999999999999999998775      67799999865433  234778999999999999999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCccCC
Q 046893          170 RILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLAKDG  249 (464)
Q Consensus       170 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~  249 (464)
                      .++||+++.+++|..++...  ..+++..+..++.|++.||+|||  .++|+||||||+|||++.++.+||+|||+|+..
T Consensus        76 ~~iv~~~~~~~~l~~~~~~~--~~~~~~~~~~~~~q~~~aL~~lH--~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~  151 (292)
T d1unla_          76 LTLVFEFCDQDLKKYFDSCN--GDLDPEIVKSFLFQLLKGLGFCH--SRNVLHRDLKPQNLLINRNGELKLANFGLARAF  151 (292)
T ss_dssp             EEEEEECCSEEHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred             eeEEeeeccccccccccccc--cccchhHHHHHHHHHHHHHHHhh--cCCEeeecccCcccccccCCceeeeecchhhcc
Confidence            99999999998887766543  46899999999999999999999  577999999999999999999999999999875


Q ss_pred             CCCCCcceeeccccCCcccCccccccCC-CCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhcc-----
Q 046893          250 PMGDQTHVSTRVMGTYGYAAPEYVMTGH-LTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNN-----  323 (464)
Q Consensus       250 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~-----  323 (464)
                      .....  ......++..|+|||++.+.. ++.++|||||||++|||++|+.||........  ............     
T Consensus       152 ~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~  227 (292)
T d1unla_         152 GIPVR--CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDD--QLKRIFRLLGTPTEEQW  227 (292)
T ss_dssp             CSCCS--CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHH--HHHHHHHHHCCCCTTTC
T ss_pred             cCCCc--cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHH--HHHHHHhhcCCCChhhh
Confidence            43322  223356788999999887654 68999999999999999999999865432211  111111110000     


Q ss_pred             cchhhcc---------CccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 046893          324 KKVLRIL---------DPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVA  369 (464)
Q Consensus       324 ~~~~~~~---------~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  369 (464)
                      .......         ...............+.+|+.+||+.||.+|||++|+++
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~  282 (292)
T d1unla_         228 PSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ  282 (292)
T ss_dssp             TTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             hhhhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            0000000         000111122334557889999999999999999999864

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-47  Score=369.88  Aligned_cols=256  Identities=25%  Similarity=0.334  Sum_probs=201.7

Q ss_pred             cCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCC----ccHHHHHHHHHHHhcCCC-CCcceEEEEEEe
Q 046893           92 KFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGY----QGDREWLAEVNYLGQLRH-SNLVKLIGYCCE  166 (464)
Q Consensus        92 ~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l~h-pniv~l~~~~~~  166 (464)
                      ++|++.+.||+|+||+||+|++..+.   ..++.||||+++....    ...+.+.+|+++|++++| |||+++++++.+
T Consensus        24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~---~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~  100 (322)
T d1vzoa_          24 ENFELLKVLGTGAYGKVFLVRKISGH---DTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT  100 (322)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSST---TTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEE
T ss_pred             hceEEEEEEecCCCeEEEEEEECccC---CCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeecc
Confidence            45889999999999999999875432   2477899999865321    223567899999999966 899999999999


Q ss_pred             CCeEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEcccCCc
Q 046893          167 DEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDFGLA  246 (464)
Q Consensus       167 ~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DFGla  246 (464)
                      ....++||||+.+|+|.+++....  .+++..+..++.||+.||.|||  +++|+||||||+||||+.++.+||+|||+|
T Consensus       101 ~~~~~~v~e~~~~~~L~~~i~~~~--~~~e~~~~~~~~Qi~~al~~lH--~~~ivHrDiKp~Nill~~~~~vkL~DFG~a  176 (322)
T d1vzoa_         101 ETKLHLILDYINGGELFTHLSQRE--RFTEHEVQIYVGEIVLALEHLH--KLGIIYRDIKLENILLDSNGHVVLTDFGLS  176 (322)
T ss_dssp             TTEEEEEECCCCSCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHH--HTTCCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred             CCceeeeeecccccHHHHHHHhcc--cccHHHHHHHHHHHHHHHHHhh--cCCEEeccCCccceeecCCCCEEEeeccch
Confidence            999999999999999999987654  5789999999999999999999  567999999999999999999999999999


Q ss_pred             cCCCCCCCcceeeccccCCcccCccccccC--CCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhccc
Q 046893          247 KDGPMGDQTHVSTRVMGTYGYAAPEYVMTG--HLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNNNK  324 (464)
Q Consensus       247 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  324 (464)
                      +....... .......|++.|+|||.+.+.  .++.++|||||||+||||++|+.||..........  .........  
T Consensus       177 ~~~~~~~~-~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~--~i~~~~~~~--  251 (322)
T d1vzoa_         177 KEFVADET-ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQA--EISRRILKS--  251 (322)
T ss_dssp             EECCGGGG-GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHH--HHHHHHHHC--
T ss_pred             hhhccccc-ccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHH--HHHHhcccC--
Confidence            86533222 223346899999999998764  47889999999999999999999998765433221  111111111  


Q ss_pred             chhhccCccccCccCHHHHHHHHHHHHHhhccCCCCCCC-----HHHHHH
Q 046893          325 KVLRILDPRLEGQYTARTAMKVAGLAYQCLSQNPKGRPV-----MSDVVA  369 (464)
Q Consensus       325 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~ev~~  369 (464)
                                ...++..++.++.+|+.+||..||.+||+     ++++++
T Consensus       252 ----------~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~  291 (322)
T d1vzoa_         252 ----------EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE  291 (322)
T ss_dssp             ----------CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred             ----------CCCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence                      11123345568999999999999999995     566653

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=1.7e-46  Score=365.88  Aligned_cols=259  Identities=16%  Similarity=0.239  Sum_probs=197.3

Q ss_pred             cCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCccHHHHHHHHHHHhcCC-CCCcceEEEEEEeC--C
Q 046893           92 KFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLR-HSNLVKLIGYCCED--E  168 (464)
Q Consensus        92 ~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~--~  168 (464)
                      ++|++.+.||+|+||+||+|++..+      ++.||||+++..   ..+.+.+|+.+|+.+. ||||++++++|...  .
T Consensus        35 d~y~i~~~LG~G~fg~V~~a~~~~~------~~~vAiK~i~~~---~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~  105 (328)
T d3bqca1          35 DDYQLVRKLGRGKYSEVFEAINITN------NEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSR  105 (328)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTT------TEEEEEEEECSS---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTC
T ss_pred             cCeEEEEEEecCcCeEEEEEEECCC------CCEEEEEEECHH---HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCC
Confidence            5699999999999999999998765      788999998753   3567889999999995 99999999999854  5


Q ss_pred             eEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCC-ceEEcccCCcc
Q 046893          169 HRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADF-SAKLSDFGLAK  247 (464)
Q Consensus       169 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~-~vkl~DFGla~  247 (464)
                      ..++|||||.+++|..+.     ..+++..+..++.||+.||.|||  +++|+||||||+||||+.++ .+||+|||+|+
T Consensus       106 ~~~~v~e~~~~~~L~~~~-----~~l~e~~i~~i~~qil~aL~~LH--~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~  178 (328)
T d3bqca1         106 TPALVFEHVNNTDFKQLY-----QTLTDYDIRFYMYEILKALDYCH--SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAE  178 (328)
T ss_dssp             SEEEEEECCCSCBGGGTT-----TSCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEEETTTTEEEECCGGGCE
T ss_pred             ceeEEEeecCCCcHHHHh-----cCCCHHHHHHHHHHHHHHHHHHh--hcccccccccccceEEcCCCCeeeecccccce
Confidence            689999999999996642     25899999999999999999999  56799999999999998655 69999999998


Q ss_pred             CCCCCCCcceeeccccCCcccCccccccC-CCCcccchhcHHHHHHHHHhCCCCCCCCCCccccc--HHH---------H
Q 046893          248 DGPMGDQTHVSTRVMGTYGYAAPEYVMTG-HLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHN--LVE---------W  315 (464)
Q Consensus       248 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~--~~~---------~  315 (464)
                      ......   .....+||..|+|||.+.+. .++.++|||||||++|||++|+.||..........  +..         +
T Consensus       179 ~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~  255 (328)
T d3bqca1         179 FYHPGQ---EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDY  255 (328)
T ss_dssp             ECCTTC---CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHH
T ss_pred             eccCCC---cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhh
Confidence            654332   23346899999999998765 47999999999999999999999997654322110  000         0


Q ss_pred             HHHh-hhcccchhhccC--------ccccCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 046893          316 ARPL-LNNNKKVLRILD--------PRLEGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVA  369 (464)
Q Consensus       316 ~~~~-~~~~~~~~~~~~--------~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  369 (464)
                      .... ............        ...........+.++.+||.+||..||.+|||++++++
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~  318 (328)
T d3bqca1         256 IDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME  318 (328)
T ss_dssp             HHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             hhhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            0000 000000000000        00111112234557899999999999999999999875

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5e-46  Score=366.37  Aligned_cols=262  Identities=23%  Similarity=0.307  Sum_probs=190.2

Q ss_pred             cCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCcc--HHHHHHHHHHHhcCCCCCcceEEEEEEeC--
Q 046893           92 KFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQG--DREWLAEVNYLGQLRHSNLVKLIGYCCED--  167 (464)
Q Consensus        92 ~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~hpniv~l~~~~~~~--  167 (464)
                      ++|++.++||+|+||+||+|++..+      ++.||||++.......  ...+.+|+.+|++++||||++++++|...  
T Consensus        17 ~~Y~i~~~LG~G~fg~V~~~~d~~t------~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~   90 (355)
T d2b1pa1          17 KRYQNLKPIGSGAQGIVCAAYDAVL------DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKT   90 (355)
T ss_dssp             TTEEEEEECSCC--CEEEEEEETTT------TEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCS
T ss_pred             CCeEEEEEeecCcCeEEEEEEECCC------CCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccc
Confidence            6799999999999999999998765      7889999997654332  25688999999999999999999999643  


Q ss_pred             ----CeEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEccc
Q 046893          168 ----EHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDF  243 (464)
Q Consensus       168 ----~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DF  243 (464)
                          ...|+|||||.++ |.+.+.    ..+++..+..++.||+.||.|||  .++|+||||||+|||++.++.+||+||
T Consensus        91 ~~~~~~~~iv~Ey~~~~-l~~~~~----~~~~~~~i~~~~~qil~gl~~LH--~~giiHrDlKP~Nil~~~~~~~kl~df  163 (355)
T d2b1pa1          91 LEEFQDVYLVMELMDAN-LCQVIQ----MELDHERMSYLLYQMLCGIKHLH--SAGIIHRDLKPSNIVVKSDCTLKILDF  163 (355)
T ss_dssp             TTTCCEEEEEEECCSEE-HHHHHT----SCCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCCGGGEEECTTCCEEECCC
T ss_pred             cccCceeEEEEeccchH-HHHhhh----cCCCHHHHHHHHHHHHHHHHHhh--hcccccccCCccccccccccceeeech
Confidence                6889999999664 444443    25899999999999999999999  567999999999999999999999999


Q ss_pred             CCccCCCCCCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHH---------H
Q 046893          244 GLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLV---------E  314 (464)
Q Consensus       244 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~---------~  314 (464)
                      |+++.....   ......+||+.|+|||++.+..++.++||||+||++|+|++|+.||.+.........+         +
T Consensus       164 ~~~~~~~~~---~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~  240 (355)
T d2b1pa1         164 GLARTAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPE  240 (355)
T ss_dssp             CC------------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHH
T ss_pred             hhhhccccc---cccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHH
Confidence            998864332   2334468999999999999999999999999999999999999999765321110000         0


Q ss_pred             HH-------HHhhhccc-----chhhccCccc---cCccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 046893          315 WA-------RPLLNNNK-----KVLRILDPRL---EGQYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVA  369 (464)
Q Consensus       315 ~~-------~~~~~~~~-----~~~~~~~~~~---~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  369 (464)
                      +.       ........     .....+....   ........+..+.+|+.+||..||.+|||++|+++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~  310 (355)
T d2b1pa1         241 FMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ  310 (355)
T ss_dssp             HHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             HHHHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence            00       00000000     0000010000   11122345678999999999999999999999974

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-45  Score=362.95  Aligned_cols=261  Identities=21%  Similarity=0.291  Sum_probs=193.5

Q ss_pred             hcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCc--cHHHHHHHHHHHhcCCCCCcceEEEEEEeC-
Q 046893           91 TKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQ--GDREWLAEVNYLGQLRHSNLVKLIGYCCED-  167 (464)
Q Consensus        91 ~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpniv~l~~~~~~~-  167 (464)
                      .++|++.+.||+|+||+||+|++..+      ++.||||++......  ..+.+.+|+++|+.++|||||++++++... 
T Consensus        17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~------~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~   90 (348)
T d2gfsa1          17 PERYQNLSPVGSGAYGSVCAAFDTKT------GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPAR   90 (348)
T ss_dssp             ETTEEEEEECGGGTTSSEEEEEETTT------TEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCS
T ss_pred             CCCeEEEEEEecCCCeEEEEEEECCC------CCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeecc
Confidence            45799999999999999999998765      788999999765433  235688999999999999999999998643 


Q ss_pred             ----CeEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCCceEEccc
Q 046893          168 ----EHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADFSAKLSDF  243 (464)
Q Consensus       168 ----~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~~vkl~DF  243 (464)
                          ...++||+|+.+|+|.+++..+   .+++.++..++.||+.||+|||  +++|+||||||+|||++.++.+|++||
T Consensus        91 ~~~~~~~~~i~~~~~gg~L~~~~~~~---~l~e~~~~~i~~qil~aL~~LH--~~giiHrDiKp~NILi~~~~~~kl~df  165 (348)
T d2gfsa1          91 SLEEFNDVYLVTHLMGADLNNIVKCQ---KLTDDHVQFLIYQILRGLKYIH--SADIIHRDLKPSNLAVNEDCELKILDF  165 (348)
T ss_dssp             STTTCCCCEEEEECCSEEHHHHHTTC---CCCHHHHHHHHHHHHHHHHHHH--HTTCCCCCCCGGGEEECTTCCEEECCC
T ss_pred             ccccCceEEEEEeecCCchhhhcccc---cccHHHHHHHHHHHHHHHHHHH--hCCCcccccCCcccccccccccccccc
Confidence                3345667777899999988543   5999999999999999999999  567999999999999999999999999


Q ss_pred             CCccCCCCCCCcceeeccccCCcccCccccccC-CCCcccchhcHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHhhhc
Q 046893          244 GLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTG-HLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHNLVEWARPLLNN  322 (464)
Q Consensus       244 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~  322 (464)
                      |++....     .......||..|+|||++.+. .++.++|||||||++|+|++|+.||.+.........+.  ......
T Consensus       166 g~a~~~~-----~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~--~~~~~~  238 (348)
T d2gfsa1         166 GLARHTD-----DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLIL--RLVGTP  238 (348)
T ss_dssp             ----CCT-----GGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH--HHHCCC
T ss_pred             chhcccC-----cccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHH--HhcCCC
Confidence            9997532     122346799999999987765 46889999999999999999999997654221111110  000000


Q ss_pred             ccchhh------------ccCccccC---ccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 046893          323 NKKVLR------------ILDPRLEG---QYTARTAMKVAGLAYQCLSQNPKGRPVMSDVVA  369 (464)
Q Consensus       323 ~~~~~~------------~~~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  369 (464)
                      ......            .+......   ......+..+.+||.+||..||.+|||+.|+++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~  300 (348)
T d2gfsa1         239 GAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA  300 (348)
T ss_dssp             CHHHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             ChHHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhc
Confidence            000000            00000000   001123457889999999999999999999875

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=6.9e-41  Score=330.47  Aligned_cols=265  Identities=18%  Similarity=0.192  Sum_probs=190.4

Q ss_pred             cCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCccHHHHHHHHHHHhcCC-----------CCCcceE
Q 046893           92 KFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLR-----------HSNLVKL  160 (464)
Q Consensus        92 ~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------hpniv~l  160 (464)
                      .+|+++++||+|+||+||+|++..+      ++.||||+++... ...+.+.+|+++|+.+.           |+||+++
T Consensus        13 ~rY~i~~~LG~G~fg~Vy~~~~~~~------g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~   85 (362)
T d1q8ya_          13 ARYILVRKLGWGHFSTVWLAKDMVN------NTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKL   85 (362)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTT------TEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCC
T ss_pred             CcEEEEEEEeeCCCeEEEEEEECCC------CCEEEEEEEeccc-cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEE
Confidence            4599999999999999999998775      7789999997642 22356778898888775           5789999


Q ss_pred             EEEEEe--CCeEEEEEeccCCCC-HHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCC-
Q 046893          161 IGYCCE--DEHRILVYEYMESGS-LEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADF-  236 (464)
Q Consensus       161 ~~~~~~--~~~~~lv~e~~~~g~-L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~-  236 (464)
                      ++++..  ....+++|+++..+. ............+++..+..++.|++.||.|||+ ..+|+||||||+||||+.++ 
T Consensus        86 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~-~~~IvHrDlKp~NIll~~~~~  164 (362)
T d1q8ya_          86 LDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHR-RCGIIHTDIKPENVLMEIVDS  164 (362)
T ss_dssp             CEEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHH-TTCEECSCCSGGGEEEEEEET
T ss_pred             EEEeeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhh-hcCcccccCChhHeeeeccCc
Confidence            988754  356667777665543 3333344445678999999999999999999995 36799999999999997655 


Q ss_pred             -----ceEEcccCCccCCCCCCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHHHHHhCCCCCCCCCCccccc
Q 046893          237 -----SAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLLEMLLGRRAVDKSRPSREHN  311 (464)
Q Consensus       237 -----~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~  311 (464)
                           .++|+|||.+.....     .....+||+.|+|||++.+..++.++|||||||++++|++|+.||..........
T Consensus       165 ~~~~~~~kl~dfg~s~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~  239 (362)
T d1q8ya_         165 PENLIQIKIADLGNACWYDE-----HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTK  239 (362)
T ss_dssp             TTTEEEEEECCCTTCEETTB-----CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------C
T ss_pred             ccccceeeEeeccccccccc-----ccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccc
Confidence                 389999999975322     2234689999999999999999999999999999999999999997543322111


Q ss_pred             H----HHHHHHhhh-------cccc---------hhhccCc----------cccCccCHHHHHHHHHHHHHhhccCCCCC
Q 046893          312 L----VEWARPLLN-------NNKK---------VLRILDP----------RLEGQYTARTAMKVAGLAYQCLSQNPKGR  361 (464)
Q Consensus       312 ~----~~~~~~~~~-------~~~~---------~~~~~~~----------~~~~~~~~~~~~~l~~li~~cl~~dP~~R  361 (464)
                      .    ......+..       ....         ....+..          ..........+..+.+|+.+||..||.+|
T Consensus       240 ~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R  319 (362)
T d1q8ya_         240 DDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKR  319 (362)
T ss_dssp             HHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTC
T ss_pred             hhHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHC
Confidence            1    111110000       0000         0000000          01122345677899999999999999999


Q ss_pred             CCHHHHHH
Q 046893          362 PVMSDVVA  369 (464)
Q Consensus       362 Ps~~ev~~  369 (464)
                      ||++++++
T Consensus       320 pta~e~L~  327 (362)
T d1q8ya_         320 ADAGGLVN  327 (362)
T ss_dssp             BCHHHHHT
T ss_pred             cCHHHHhc
Confidence            99999864

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.91  E-value=1.6e-25  Score=199.47  Aligned_cols=170  Identities=14%  Similarity=0.120  Sum_probs=117.4

Q ss_pred             CCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCc------------------cHHHHHHHHHHHhcCCCCC
Q 046893           95 RPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQ------------------GDREWLAEVNYLGQLRHSN  156 (464)
Q Consensus        95 ~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~------------------~~~~~~~E~~~l~~l~hpn  156 (464)
                      .+.+.||+|+||+||+|.+.+       ++.||||+++.....                  .......|+..+.++.|++
T Consensus         3 ~vg~~IG~G~~g~Vy~a~~~~-------g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~   75 (191)
T d1zara2           3 AIGKLMGEGKESAVFNCYSEK-------FGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLA   75 (191)
T ss_dssp             EEEEEEEECSSEEEEEEEETT-------TEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSS
T ss_pred             hhCCEeeeCcceEEEEEECCC-------CCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCC
Confidence            456789999999999998753       567999987532110                  0122356888999999999


Q ss_pred             cceEEEEEEeCCeEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCceEecCCC
Q 046893          157 LVKLIGYCCEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAERPVIYRDFKTSNILLNADF  236 (464)
Q Consensus       157 iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ivHrDlkp~Nill~~~~  236 (464)
                      ++..+++.  .  .+|+|||+++..+.+         ++......++.|++.+|.|||  ..+|+||||||+|||++++ 
T Consensus        76 v~~~~~~~--~--~~lvme~~~~~~~~~---------l~~~~~~~i~~ql~~~l~~lH--~~giiHrDiKP~NILv~~~-  139 (191)
T d1zara2          76 VPKVYAWE--G--NAVLMELIDAKELYR---------VRVENPDEVLDMILEEVAKFY--HRGIVHGDLSQYNVLVSEE-  139 (191)
T ss_dssp             SCCEEEEE--T--TEEEEECCCCEEGGG---------CCCSCHHHHHHHHHHHHHHHH--HTTEECSCCSTTSEEEETT-
T ss_pred             cceEEEec--C--CEEEEEeeccccccc---------hhhHHHHHHHHHHHHHHHHHh--hCCEEEccCChhheeeeCC-
Confidence            99887653  2  379999998765532         344456678999999999999  5679999999999999865 


Q ss_pred             ceEEcccCCccCCCCCCCcceeeccccCCcccCccccccCCCCcccchhcHHHHHH
Q 046893          237 SAKLSDFGLAKDGPMGDQTHVSTRVMGTYGYAAPEYVMTGHLTARSDVYGFGVVLL  292 (464)
Q Consensus       237 ~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~  292 (464)
                      .++|+|||+|+............+-+.   . -.+ +..+.|+.++|+||+.--+.
T Consensus       140 ~~~liDFG~a~~~~~~~~~~~l~rd~~---~-~~~-~f~r~y~~~~d~~s~~~~~~  190 (191)
T d1zara2         140 GIWIIDFPQSVEVGEEGWREILERDVR---N-IIT-YFSRTYRTEKDINSAIDRIL  190 (191)
T ss_dssp             EEEECCCTTCEETTSTTHHHHHHHHHH---H-HHH-HHHHHHCCCCCHHHHHHHHH
T ss_pred             CEEEEECCCcccCCCCCcHHHHHHHHH---H-HHH-HHcCCCCCcccHHHHHHHHh
Confidence            589999999975432211110000000   0 001 12467889999999865443

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.56  E-value=1.2e-07  Score=86.22  Aligned_cols=147  Identities=16%  Similarity=0.057  Sum_probs=94.5

Q ss_pred             HHHHHhcCCCCCCceeecCceEEEEEEecCCCCCCccceEEEEEEccCCCCccHHHHHHHHHHHhcCC-CCCcceEEEEE
Q 046893           86 EMKLATKFFRPDYILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLR-HSNLVKLIGYC  164 (464)
Q Consensus        86 ~~~~~~~~~~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~  164 (464)
                      ++...-..|+..+..+-++.+.||+....        +..+.+|+...........+.+|...+..+. +--+.+++.++
T Consensus         8 ~l~~~~~~~~~~~~~~G~s~~~v~rv~~~--------~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~   79 (263)
T d1j7la_           8 ELKKLIEKYRCVKDTEGMSPAKVYKLVGE--------NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFE   79 (263)
T ss_dssp             HHHHHHTTSEEEECSCCCSSSEEEEEECS--------SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEE
T ss_pred             HHHHhhhceEEEEcCCCCCCCcEEEEEeC--------CCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEE
Confidence            33344455666555444555789987532        2336778765443333345677888877773 43467788888


Q ss_pred             EeCCeEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC---------------------------
Q 046893          165 CEDEHRILVYEYMESGSLEKHLLRRVGCMLTWSRRMKIALDAAKGLAFLHGAE---------------------------  217 (464)
Q Consensus       165 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~---------------------------  217 (464)
                      ..++..++||++++|.++.......    ..   ...++.+++..+..||+..                           
T Consensus        80 ~~~~~~~lv~~~l~G~~~~~~~~~~----~~---~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  152 (263)
T d1j7la_          80 RHDGWSNLLMSEADGVLCSEEYEDE----QS---PEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLAD  152 (263)
T ss_dssp             EETTEEEEEEECCSSEEHHHHTTTC----SC---HHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSC
T ss_pred             ecCCceEEEEEeccccccccccccc----cc---HHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhh
Confidence            8889999999999998775543211    11   1223444555555555311                           


Q ss_pred             ------------------------------CCeeeccCCCCceEecCCCceEEcccCCcc
Q 046893          218 ------------------------------RPVIYRDFKTSNILLNADFSAKLSDFGLAK  247 (464)
Q Consensus       218 ------------------------------~~ivHrDlkp~Nill~~~~~vkl~DFGla~  247 (464)
                                                    ..++|+|+.|.|||+++++.+-|+||+.+.
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T d1j7la_         153 VDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             CCGGGGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred             hhhhcccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence                                          127899999999999877666799999775

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=97.98  E-value=1.9e-05  Score=70.73  Aligned_cols=73  Identities=15%  Similarity=0.095  Sum_probs=49.0

Q ss_pred             eeecC-ceEEEEEEecCCCCCCccceEEEEEEccCCCCccHHHHHHHHHHHhcCC--CCCcceEEEEEEeCCeEEEEEec
Q 046893          100 LGEGG-FGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLR--HSNLVKLIGYCCEDEHRILVYEY  176 (464)
Q Consensus       100 lG~G~-fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--hpniv~l~~~~~~~~~~~lv~e~  176 (464)
                      +..|. -+.||+.....       +..+++|.......   ..+..|...|+.|.  .-.+.+++.+..+.+..++||++
T Consensus        18 ~~~G~s~~~v~r~~~~~-------~~~~vlK~~~~~~~---~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~   87 (255)
T d1nd4a_          18 QTIGCSDAAVFRLSAQG-------RPVLFVKTDLSGAL---NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGE   87 (255)
T ss_dssp             CSCTTSSCEEEEEECTT-------SCCEEEEEECSCTT---SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEEC
T ss_pred             cCCcccCCeEEEEEeCC-------CCEEEEEeCCccCH---hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEe
Confidence            34444 36789876543       33477887654432   24567777777663  23366778888888899999999


Q ss_pred             cCCCCH
Q 046893          177 MESGSL  182 (464)
Q Consensus       177 ~~~g~L  182 (464)
                      ++|.++
T Consensus        88 i~G~~~   93 (255)
T d1nd4a_          88 VPGQDL   93 (255)
T ss_dssp             CSSEET
T ss_pred             eecccc
Confidence            988665

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=97.94  E-value=2.4e-05  Score=75.14  Aligned_cols=76  Identities=16%  Similarity=0.119  Sum_probs=45.8

Q ss_pred             CceeecCceEEEEEEecCCCCCCccceEEEEEEccC------CCC-ccHHHHHHHHHHHhcCC-C-C-CcceEEEEEEeC
Q 046893           98 YILGEGGFGVVYKGVIDENVRPGYKTTFVAIKELNR------GGY-QGDREWLAEVNYLGQLR-H-S-NLVKLIGYCCED  167 (464)
Q Consensus        98 ~~lG~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~------~~~-~~~~~~~~E~~~l~~l~-h-p-niv~l~~~~~~~  167 (464)
                      +.||.|....||+..+..+      +..++||.-..      ... ....+...|...|..+. + | .+.+++.+  +.
T Consensus        32 ~eig~G~~N~vfrV~~~~~------~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~  103 (392)
T d2pula1          32 QEIGDGNLNYVFHIYDQEH------DRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DT  103 (392)
T ss_dssp             EECCSSSSEEEEEEEC----------CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ET
T ss_pred             EEeCCCceEeEEEEEeCCC------CeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cC
Confidence            4689999999999876553      44578886432      111 12234556887777662 2 2 34555543  45


Q ss_pred             CeEEEEEeccCCCC
Q 046893          168 EHRILVYEYMESGS  181 (464)
Q Consensus       168 ~~~~lv~e~~~~g~  181 (464)
                      ...++|||++.+..
T Consensus       104 ~~~~lvmE~L~~~~  117 (392)
T d2pula1         104 EMAVTVMEDLSHLK  117 (392)
T ss_dssp             TTTEEEECCCTTSE
T ss_pred             CCCEEEEeccCCcc
Confidence            56689999997654

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=97.01  E-value=0.00074  Score=64.41  Aligned_cols=79  Identities=19%  Similarity=0.178  Sum_probs=50.1

Q ss_pred             CceeecCceEEEEEEecCCCCC-CccceEEEEEEccCCCCccHHHHHHHHHHHhcCCCCCc-ceEEEEEEeCCeEEEEEe
Q 046893           98 YILGEGGFGVVYKGVIDENVRP-GYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSNL-VKLIGYCCEDEHRILVYE  175 (464)
Q Consensus        98 ~~lG~G~fg~Vy~a~~~~~~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpni-v~l~~~~~~~~~~~lv~e  175 (464)
                      +.|+.|-.-.+|++...+.... ......|.+++...  ........+|..+++.+.-.++ .++++++.+    .+|||
T Consensus        48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~--~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~e  121 (395)
T d1nw1a_          48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN--PETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEE  121 (395)
T ss_dssp             EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS--CCCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEEC
T ss_pred             EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCC--cchhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEE
Confidence            4678888899999887653211 12234577777653  2233455688888888853344 467776642    58999


Q ss_pred             ccCCCCH
Q 046893          176 YMESGSL  182 (464)
Q Consensus       176 ~~~~g~L  182 (464)
                      |++|..|
T Consensus       122 fi~g~~l  128 (395)
T d1nw1a_         122 YIPSRPL  128 (395)
T ss_dssp             CCCEEEC
T ss_pred             EeccccC
Confidence            9987544

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=96.98  E-value=0.0017  Score=60.06  Aligned_cols=68  Identities=13%  Similarity=0.040  Sum_probs=43.5

Q ss_pred             ceEEEEEEecCCCCCCccceEEEEEEccCCCCccHHHHHHHHHHHhcCCCCC-----cceE--EEEEEeCCeEEEEEecc
Q 046893          105 FGVVYKGVIDENVRPGYKTTFVAIKELNRGGYQGDREWLAEVNYLGQLRHSN-----LVKL--IGYCCEDEHRILVYEYM  177 (464)
Q Consensus       105 fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpn-----iv~l--~~~~~~~~~~~lv~e~~  177 (464)
                      --.||++...+       +..+++|+.... .....++..|...|..|....     .+..  -..+......+.+++++
T Consensus        35 EN~vy~v~~~d-------g~~~VlK~~rp~-~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~  106 (325)
T d1zyla1          35 ENRVYQFQDED-------RRRFVVKFYRPE-RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSV  106 (325)
T ss_dssp             SSEEEEECCTT-------CCCEEEEEECTT-TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECC
T ss_pred             cceeEEEEcCC-------CCEEEEEEeCCC-CCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeec
Confidence            35799987654       445889987543 335577888888887774211     1111  11345567788999999


Q ss_pred             CCC
Q 046893          178 ESG  180 (464)
Q Consensus       178 ~~g  180 (464)
                      .|.
T Consensus       107 ~G~  109 (325)
T d1zyla1         107 GGR  109 (325)
T ss_dssp             CCE
T ss_pred             CCc
Confidence            764

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=96.08  E-value=0.033  Score=50.49  Aligned_cols=32  Identities=28%  Similarity=0.243  Sum_probs=27.9

Q ss_pred             CCCCeeeccCCCCceEecCCCceEEcccCCcc
Q 046893          216 AERPVIYRDFKTSNILLNADFSAKLSDFGLAK  247 (464)
Q Consensus       216 ~~~~ivHrDlkp~Nill~~~~~vkl~DFGla~  247 (464)
                      ...++||+|+.+.||+++.+...-|+||+.|.
T Consensus       181 L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~  212 (316)
T d2ppqa1         181 LPAGVIHADLFQDNVFFLGDELSGLIDFYFAC  212 (316)
T ss_dssp             SCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             cccccccCCcchhhhhcccccceeEecccccc
Confidence            35679999999999999988777899999875